BA Agents|gaba agents|mesh-ancestor
64563095|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563096|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563097|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64563098|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563099|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64563100|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563101|NCT04746209|Blinatumomab|blinatumomab|mesh-list
64563102|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563103|NCT04176419|Acetaminophen|acetaminophen|mesh-list
64563113|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563114|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64563115|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64563116|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64563117|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64563118|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563119|NCT04176419|Analgesics|analgesics|mesh-ancestor
64563120|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64563121|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64563122|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
64563123|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64563124|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64563125|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563126|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64563127|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
64563128|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64563129|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563130|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563131|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64563132|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64563133|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563134|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
64563135|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64563136|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64563137|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563138|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
64563139|NCT04168931|Trastuzumab|trastuzumab|mesh-list
64563140|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563141|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563142|NCT04165967|Nivolumab|nivolumab|mesh-list
64563143|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563154|NCT01285635|Docetaxel|docetaxel|mesh-list
64563155|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563156|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
64563157|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
64563158|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
64563159|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563160|NCT01286259|Disulfiram|disulfiram|mesh-list
64563161|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64563162|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64563163|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563164|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563165|NCT01286805|Bupivacaine|bupivacaine|mesh-list
64563166|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563167|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
64563169|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563170|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
64563171|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563172|NCT01288521|Ketoconazole|ketoconazole|mesh-list
64563173|NCT01288521|Tacrolimus|tacrolimus|mesh-list
64563174|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563175|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
64563176|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563177|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64563178|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563179|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563180|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
64563181|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563182|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64563183|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64563184|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64563185|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
64563187|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64563193|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
64563194|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563195|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563196|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
64563197|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563198|NCT01289067|Satraplatin|satraplatin|mesh-list
64563199|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563200|NCT01248585|Dexamethasone|dexamethasone|mesh-list
64563201|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563202|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
64563203|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
64563204|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563205|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563206|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563207|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
64563208|NCT01248585|Hormones|hormones|mesh-ancestor
64563209|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563210|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64563211|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563212|NCT00632359|Lenalidomide|lenalidomide|mesh-list
64563213|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
64563214|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563215|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64563216|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64563217|NCT00632359|Growth Substances|growth substances|mesh-ancestor
64563218|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
64563219|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563220|NCT03954899|Melatonin|melatonin|mesh-list
64563221|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
64563222|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563223|NCT03954899|Protective Agents|protective agents|mesh-ancestor
64563224|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563226|NCT03934307|Irbesartan|irbesartan|mesh-list
64563227|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64563228|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64563229|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64563231|NCT03924635|Budesonide|budesonide|mesh-list
64563232|NCT03924635|Albuterol|albuterol|mesh-list
64563233|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
64563234|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64563235|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563237|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
64563238|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563239|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563240|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64563241|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
64563242|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
64563243|NCT03924635|Hormones|hormones|mesh-ancestor
64563244|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563245|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64563246|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64563247|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64563248|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
64563249|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563250|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563251|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
64563252|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64563253|NCT04398251|Febuxostat|febuxostat|mesh-list
64563254|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
64563255|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563256|NCT00632203|Temozolomide|temozolomide|mesh-list
64563257|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64563258|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
64563259|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563260|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563261|NCT01289457|Cytarabine|cytarabine|mesh-list
64563262|NCT01289457|Fludarabine|fludarabine|mesh-list
64563263|NCT01289457|Idarubicin|idarubicin|mesh-list
64563264|NCT01289457|Clofarabine|clofarabine|mesh-list
64563265|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563273|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563274|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64563276|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64563277|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563278|NCT03830333|Metronidazole|metronidazole|mesh-list
64563279|NCT03830333|Meropenem|meropenem|mesh-list
64563280|NCT03830333|Tazobactam|tazobactam|mesh-list
64563281|NCT03830333|Ceftolozane|ceftolozane|mesh-list
64563282|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64563283|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563284|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563285|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64563286|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64563287|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64563288|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563289|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563290|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64563291|NCT03830333|Renal Agents|renal agents|mesh-ancestor
64563292|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
64563293|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64563294|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
64563295|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563296|NCT01251315|Expectorants|expectorants|mesh-ancestor
64563297|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
64563298|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64563299|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
64563300|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563301|NCT01251315|Protective Agents|protective agents|mesh-ancestor
64589305|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
64563302|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563303|NCT01251315|Antidotes|antidotes|mesh-ancestor
64563304|NCT03810287|Domperidone|domperidone|mesh-list
64563305|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
64563306|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
64563314|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
64563315|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64563316|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
64563317|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64563318|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
64563319|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563320|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563321|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
64563323|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563324|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563325|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
64563326|NCT03613727|Vitamins|vitamins|mesh-ancestor
64563327|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
64563331|NCT03613727|Protective Agents|protective agents|mesh-ancestor
64563332|NCT01251393|Biperiden|biperiden|mesh-list
64563333|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64563334|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64563335|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
64563336|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
64563337|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563338|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563339|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64563340|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64563341|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
64563351|NCT01255137|Axitinib|axitinib|mesh-list
64563362|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563363|NCT03253133|Analgesics|analgesics|mesh-ancestor
64563364|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
64563365|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563366|NCT01255449|Albuterol|albuterol|mesh-list
64563367|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64563368|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
64563369|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563370|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563371|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64563372|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
64563373|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
64563374|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64563375|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64563377|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64563378|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
64563379|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563380|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563381|NCT00631657|Mirtazapine|mirtazapine|mesh-list
64563382|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
64563383|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563384|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64563385|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
64563386|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
64563387|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563388|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563389|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563390|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64563391|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64563392|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563393|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64563394|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64563395|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64563402|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64563403|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
64563404|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64563405|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563406|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
64563407|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563408|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563409|NCT00631189|Atorvastatin|atorvastatin|mesh-list
64563410|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64563411|NCT00631189|Pravastatin|pravastatin|mesh-list
64563412|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64563413|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64563414|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
64563415|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563416|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64563417|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64563418|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563420|NCT00630877|Niacin|niacin|mesh-list
64563421|NCT00630877|Niacinamide|niacinamide|mesh-list
64563422|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
64347257|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
64563423|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64563424|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64563454|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563455|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563456|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64563457|NCT02915783|Everolimus|everolimus|mesh-list
64563458|NCT02915783|Lenvatinib|lenvatinib|mesh-list
64563459|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563460|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563461|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
64563462|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563463|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64563464|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563465|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563466|NCT02736149|Ubenimex|ubenimex|mesh-list
64563467|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64563468|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
64563469|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563470|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563471|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563472|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64563473|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563474|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
64563475|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563476|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563477|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64563478|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64563479|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
64563480|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64563481|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563482|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563497|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64563498|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563499|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64563500|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
64563501|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
64563502|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
64563503|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
64563504|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563505|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563507|NCT03174197|Atezolizumab|atezolizumab|mesh-list
64563508|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64563509|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64563510|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
64563511|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563512|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563513|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
64563514|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563515|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
64563516|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64563517|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563518|NCT01176461|Nivolumab|nivolumab|mesh-list
64563519|NCT01176461|Vaccines|vaccines|mesh-list
64563520|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64563521|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
64563522|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563523|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563524|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563525|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64563526|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563527|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64563529|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
64563540|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64563541|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563542|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563543|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64563544|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64563545|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563546|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64563547|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
64563548|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
64563549|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
64563550|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
64563551|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563552|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563553|NCT00633997|Vildagliptin|vildagliptin|mesh-list
64563554|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64563555|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563556|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64563557|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
64563558|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563559|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563560|NCT04559347|Bupivacaine|bupivacaine|mesh-list
64563561|NCT04559347|Ropivacaine|ropivacaine|mesh-list
64563562|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563563|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
64563564|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563565|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563566|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
64563567|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563568|NCT00631111|Aspirin|aspirin|mesh-list
64563569|NCT00631111|Ibuprofen|ibuprofen|mesh-list
64563570|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563571|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64563572|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64563573|NCT00631111|Analgesics|analgesics|mesh-ancestor
64563574|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
64563575|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563576|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563577|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563578|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64563579|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64563580|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563581|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64563582|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64563583|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563584|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
64563585|NCT00630799|Leuprolide|leuprolide|mesh-list
64563586|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64563587|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
64563588|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64563589|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563591|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563592|NCT01925287|Curcumin|curcumin|mesh-list
64563593|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64563594|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64563595|NCT01925287|Analgesics|analgesics|mesh-ancestor
64563596|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
64563597|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563598|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563599|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563600|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563601|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563602|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563603|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563605|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563606|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64563607|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
64563608|NCT00667121|Tamoxifen|tamoxifen|mesh-list
64563609|NCT00667121|Gabapentin|gabapentin|mesh-list
64563610|NCT00667121|Dexetimide|dexetimide|mesh-list
64563611|NCT00667121|Citalopram|citalopram|mesh-list
64563612|NCT00667121|Sertraline|sertraline|mesh-list
64563613|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64334725|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563614|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563615|NCT00667121|Analgesics|analgesics|mesh-ancestor
64563616|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
64563617|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563618|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563619|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
64563620|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64563621|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64563622|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563623|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563624|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64563625|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64563626|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563627|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
64563628|NCT00667121|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64563629|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64563630|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64563631|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
64563632|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64563635|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64563636|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
64563637|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
64563638|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64563639|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64563640|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
64563641|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64563657|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563658|NCT04553419|Cephalexin|cephalexin|mesh-list
64563659|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563660|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563661|NCT03097783|Lidocaine|lidocaine|mesh-list
64563662|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563663|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
64563664|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563665|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563666|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
64563667|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563668|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64563669|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64563670|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64563671|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484227|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
64563672|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563673|NCT04346407|Dronabinol|dronabinol|mesh-list
64563674|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
64563675|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563676|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563677|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64563678|NCT04346407|Analgesics|analgesics|mesh-ancestor
64563679|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
64563680|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563681|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64563682|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64563702|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64563703|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64563704|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
64563705|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563710|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
64563711|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64563712|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
64563713|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64563714|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
64563715|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563716|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563717|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
64563718|NCT01920919|Dexamethasone|dexamethasone|mesh-list
64563719|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563720|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
64563721|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
64563722|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563723|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563724|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563726|NCT01920919|Hormones|hormones|mesh-ancestor
64563727|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563728|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64563729|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563730|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
64563731|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64563732|NCT03057847|Velpatasvir|velpatasvir|mesh-list
64563733|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
64563734|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563735|NCT01925911|Midazolam|midazolam|mesh-list
64563736|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64563737|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64563738|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563740|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64563744|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
64563745|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
64563746|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
64563747|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
64563748|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563749|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563750|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64563751|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563752|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64563753|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563754|NCT01921231|Bupivacaine|bupivacaine|mesh-list
64563756|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563757|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
64563758|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563759|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563760|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
64563761|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563762|NCT03056833|Paclitaxel|paclitaxel|mesh-list
64563763|NCT03056833|Carboplatin|carboplatin|mesh-list
64563764|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64563765|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563766|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
64563767|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
64589350|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
64563768|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
64563769|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563770|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64563771|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
64563772|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64563773|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64563774|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64563775|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563776|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563777|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
64563778|NCT03148457|Apixaban|apixaban|mesh-list
64563779|NCT03148457|Edoxaban|edoxaban|mesh-list
64334726|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563780|NCT03148457|Dabigatran|dabigatran|mesh-list
64563781|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64563782|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
64563783|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64563784|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
64563785|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563786|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563787|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
64563789|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
64563790|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563791|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563792|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64563793|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64563794|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
64563795|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563796|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64563797|NCT05249309|Ketamine|ketamine|mesh-list
64563798|NCT05249309|Analgesics|analgesics|mesh-ancestor
64563799|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
64563800|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563801|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563802|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64563803|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64563804|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
64563806|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563807|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64563808|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64563809|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563810|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563824|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64563825|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
64563826|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
64563827|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563828|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563829|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563830|NCT03351647|Ustekinumab|ustekinumab|mesh-list
64563831|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
64563832|NCT05601271|Allopurinol|allopurinol|mesh-list
64563833|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
64563834|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347540|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563835|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64563836|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
64563837|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64563838|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64563839|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
64563840|NCT05601271|Protective Agents|protective agents|mesh-ancestor
64563841|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563842|NCT02392637|Gemcitabine|gemcitabine|mesh-list
64563843|NCT02392637|Paclitaxel|paclitaxel|mesh-list
64563844|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64563845|NCT02392637|Cisplatin|cisplatin|mesh-list
64563846|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64563847|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563848|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
64563849|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
64563850|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
64563851|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563852|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64563853|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
64563868|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64563869|NCT01926769|Metformin|metformin|mesh-list
64563870|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64563871|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563872|NCT04394143|Mannitol|mannitol|mesh-list
64563874|NCT04394143|Diuretics|diuretics|mesh-ancestor
64563875|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
64563876|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563877|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64563878|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
64563879|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563880|NCT01926847|Riociguat|riociguat|mesh-list
64563881|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
64563882|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563883|NCT05586815|Minocycline|minocycline|mesh-list
64563884|NCT05586815|Colistin|colistin|mesh-list
64563885|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64563886|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64563887|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
64563888|NCT05607901|Tacrolimus|tacrolimus|mesh-list
64563889|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64563890|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
64563891|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563905|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563906|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
64563907|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
64563908|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563909|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563910|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64563911|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
64563912|NCT05604859|Hormones|hormones|mesh-ancestor
64563913|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64563914|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64563915|NCT05604859|Protective Agents|protective agents|mesh-ancestor
64563916|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
64563917|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64563918|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64563919|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563920|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
64563921|NCT03133325|Lidocaine|lidocaine|mesh-list
64563922|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
64563923|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
64563924|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563925|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563926|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
64563927|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563928|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64563929|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64563930|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64563940|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563941|NCT04278677|Protective Agents|protective agents|mesh-ancestor
64563942|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563943|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64563944|NCT00638027|Memantine|memantine|mesh-list
64563945|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64563946|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64563947|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
64563951|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64563952|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64563954|NCT03342911|Carboplatin|carboplatin|mesh-list
64563955|NCT03342911|Nivolumab|nivolumab|mesh-list
64563956|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64563957|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64563958|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
64563959|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
64563960|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
64563961|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64563962|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563963|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64563964|NCT05607199|Calcium|calcium|mesh-list
64563965|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64563966|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563973|NCT00636155|Rituximab|rituximab|mesh-list
64563983|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64563984|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64563985|NCT00634907|Warfarin|warfarin|mesh-list
64563986|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
64563987|NCT03430219|Calcium|calcium|mesh-list
64563988|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64563989|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64563990|NCT04124497|Dexamethasone|dexamethasone|mesh-list
64563991|NCT04124497|Daratumumab|daratumumab|mesh-list
64563992|NCT04124497|Pomalidomide|pomalidomide|mesh-list
64563993|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64563994|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
64563995|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
64563996|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64563997|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564002|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564003|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564004|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
64564005|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64564006|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64564007|NCT04124497|Growth Substances|growth substances|mesh-ancestor
64564008|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
64564009|NCT04127851|Cyclosporine|cyclosporine|mesh-list
64564010|NCT04127851|Cyclosporins|cyclosporins|mesh-list
64564011|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564012|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564013|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564014|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
64564015|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564016|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
64564020|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64564021|NCT04394533|Bupivacaine|bupivacaine|mesh-list
64564022|NCT04394533|Prilocaine|prilocaine|mesh-list
64564023|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
64564024|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
64564025|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564026|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564027|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
64564028|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564030|NCT03047005|Bupropion|bupropion|mesh-list
64564031|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64564032|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64564033|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564034|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
64564035|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564036|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64564037|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
64564038|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64564039|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64564040|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64564041|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64564042|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564043|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
64564044|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564045|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64564046|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64564047|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564048|NCT05602129|Heparin|heparin|mesh-list
64564050|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
64564051|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64350046|NCT02213380|Anesthetics|anesthetics|mesh-list
64350049|NCT03488147|Esomeprazole|esomeprazole|mesh-list
64564064|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564067|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564068|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564069|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564070|NCT04129255|Hormones|hormones|mesh-ancestor
64564071|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564072|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564073|NCT03044977|Octreotide|octreotide|mesh-list
64564074|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564075|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564076|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564077|NCT03422731|Alovudine|alovudine|mesh-list
64564078|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
64564079|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564080|NCT04129489|Cannabidiol|cannabidiol|mesh-list
64564081|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
64564082|NCT04128787|Omeprazole|omeprazole|mesh-list
64564083|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64564084|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564085|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64564086|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564087|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564088|NCT04394377|Heparin|heparin|mesh-list
64564089|NCT04394377|Enoxaparin|enoxaparin|mesh-list
64564090|NCT04394377|Calcium heparin|calcium heparin|mesh-list
64564091|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
64564092|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
64564093|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
64564098|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
64564111|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
64564112|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564113|NCT00634751|Capecitabine|capecitabine|mesh-list
64564114|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
64564115|NCT00634751|Sorafenib|sorafenib|mesh-list
64564116|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64564117|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
64564118|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564119|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564120|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64564121|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564122|NCT04396223|Methotrexate|methotrexate|mesh-list
64564123|NCT04396223|Avelumab|avelumab|mesh-list
64564124|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64564125|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
64564126|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64564127|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564128|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64564129|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
64564130|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564131|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564132|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
64564133|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564134|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64564135|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564136|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
64564137|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564140|NCT04396067|Tretinoin|tretinoin|mesh-list
64564158|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
64564159|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564160|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564161|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64564162|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
64350462|NCT01652690|Denosumab|denosumab|mesh-list
64564165|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564166|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64564167|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64564168|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64564169|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564170|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564171|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564172|NCT03236545|Estradiol|estradiol|mesh-list
64564173|NCT03236545|Estrogens|estrogens|mesh-list
64564174|NCT03236545|Hormones|hormones|mesh-ancestor
64564175|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564176|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564177|NCT04126993|Apatinib|apatinib|mesh-list
64564178|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564179|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64564180|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564181|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564182|NCT04127227|Gemcitabine|gemcitabine|mesh-list
64564183|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
64564184|NCT04127227|Pegaspargase|pegaspargase|mesh-list
64564185|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64564186|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
64564188|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564202|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
64564203|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564204|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
64564205|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564206|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64564207|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564208|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350478|NCT02201524|Abrocitinib|abrocitinib|mesh-list
64564210|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564211|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64564212|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
64564213|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64564214|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564215|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
64564216|NCT03828175|Anesthetics|anesthetics|mesh-list
64564217|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350529|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64350530|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350920|NCT03181529|Psilocybin|psilocybin|mesh-list
64564218|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564219|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
64564220|NCT04392973|Favipiravir|favipiravir|mesh-list
64564221|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
64564222|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64564223|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64564224|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564225|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564226|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564227|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564228|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
64564248|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564249|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564250|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
64564251|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64564252|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64564253|NCT04758871|Progesterone|progesterone|mesh-list
64564254|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
64564255|NCT04758871|Progestins|progestins|mesh-ancestor
64564256|NCT04758871|Hormones|hormones|mesh-ancestor
64564257|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564258|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564259|NCT03336203|Allopurinol|allopurinol|mesh-list
64564260|NCT03336203|Febuxostat|febuxostat|mesh-list
64564261|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
64564262|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376471|NCT03228797|Ropivacaine|ropivacaine|mesh-list
64564263|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564264|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
64564265|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564266|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64564267|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
64564268|NCT03336203|Protective Agents|protective agents|mesh-ancestor
64350939|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
64350940|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
64350995|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
64564269|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564271|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564273|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564298|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
64564299|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564301|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564302|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64564303|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564304|NCT03826615|Gabapentin|gabapentin|mesh-list
64564305|NCT03826615|Analgesics|analgesics|mesh-ancestor
64564306|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
64564307|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564308|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564309|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
64564310|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64564311|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64564312|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564313|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64564314|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64564315|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64564316|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564317|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564318|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
64564319|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
64564320|NCT04124887|Listerine|listerine|mesh-list
64564321|NCT04124887|Calcium|calcium|mesh-list
64564322|NCT04124887|Fluorides|fluorides|mesh-list
64564323|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
64564347|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564349|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
64564350|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64564351|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64564352|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64564353|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564354|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564355|NCT03830827|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64564356|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64564358|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564360|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
64564361|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64564362|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64564363|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64564364|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64564365|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64564366|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564367|NCT03098485|Azithromycin|azithromycin|mesh-list
64564368|NCT03098485|Levofloxacin|levofloxacin|mesh-list
64564369|NCT03098485|Ofloxacin|ofloxacin|mesh-list
64564370|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
64564371|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
64564394|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64564395|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64564396|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564397|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564398|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589384|NCT04028024|Urinastatin|urinastatin|mesh-list
64564399|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564401|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
64564402|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564404|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
64564405|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64564406|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
64564407|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564408|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564409|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64564410|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
64564411|NCT03825601|Flumazenil|flumazenil|mesh-list
64564412|NCT03825601|Antidotes|antidotes|mesh-ancestor
64564413|NCT03825601|Protective Agents|protective agents|mesh-ancestor
64564414|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564415|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
64564416|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
64564417|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564418|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564419|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64564420|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64564421|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564422|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64564423|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64564424|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564425|NCT03064867|Rituximab|rituximab|mesh-list
64564426|NCT03064867|Carboplatin|carboplatin|mesh-list
64564427|NCT03064867|Etoposide|etoposide|mesh-list
64564428|NCT03064867|Venetoclax|venetoclax|mesh-list
64564430|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64564431|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564432|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
64564433|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564434|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564435|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64564436|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64564437|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64564438|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351338|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
64351339|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64351482|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
64564439|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564441|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
64564442|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64564443|NCT04120987|Lifitegrast|lifitegrast|mesh-list
64564444|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64564445|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
64564446|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64564447|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64564448|NCT03824665|Fentanyl|fentanyl|mesh-list
64564449|NCT03824665|Nalbuphine|nalbuphine|mesh-list
64564450|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64564451|NCT03824665|Narcotics|narcotics|mesh-ancestor
64564452|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564453|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564454|NCT03824665|Analgesics|analgesics|mesh-ancestor
64564455|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
64564480|NCT04120519|Dexamethasone|dexamethasone|mesh-list
64564481|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
64564482|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564483|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
64564484|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564485|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564486|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64564487|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
64589390|NCT00526591|Everolimus|everolimus|mesh-list
64564488|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564489|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564490|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64564491|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64564492|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
64564493|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
64564494|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564495|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564496|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
64564497|NCT04120519|Hormones|hormones|mesh-ancestor
64564498|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564499|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564500|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
64564501|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64564502|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351602|NCT04749394|Antibodies|antibodies|mesh-list
64564505|NCT04120519|Growth Substances|growth substances|mesh-ancestor
64564506|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
64564508|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64564509|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564510|NCT03014167|Albendazole|albendazole|mesh-list
64564511|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
64564512|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64564513|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64564521|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564522|NCT00630539|Tamoxifen|tamoxifen|mesh-list
64564523|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64564524|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
64564525|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564526|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564527|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564528|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564529|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64564530|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64564533|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64564534|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
64564535|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564536|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564537|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64564538|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
64564539|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
64564540|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64564541|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64564542|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64564543|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64564544|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564545|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564546|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564547|NCT00634517|Albuterol|albuterol|mesh-list
64564548|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64564549|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
64564550|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351829|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
64564555|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64564556|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64564557|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64564558|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64564559|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564560|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564561|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564562|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64564563|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
64564564|NCT01920113|Remifentanil|remifentanil|mesh-list
64564565|NCT01920113|Propofol|propofol|mesh-list
64564566|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64564567|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564568|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564569|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64564570|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
64564571|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
64564572|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64564573|NCT01920113|Analgesics|analgesics|mesh-ancestor
64564574|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
64564575|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564576|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64564577|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64564579|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564580|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564581|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564606|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564607|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564608|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564609|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
64564610|NCT02921893|Hormones|hormones|mesh-ancestor
64564611|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564612|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64564613|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564614|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
64564615|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564616|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564617|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
64564618|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64564619|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64564620|NCT02921893|Growth Substances|growth substances|mesh-ancestor
64564621|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
64564622|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
64564623|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
64352200|NCT01677741|Dabrafenib|dabrafenib|mesh-list
64564626|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64564628|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64564629|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64564630|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564631|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564633|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64564634|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
64564635|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564636|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564637|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564638|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64564639|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64564646|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64564647|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564648|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564649|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
64564650|NCT02983591|Misoprostol|misoprostol|mesh-list
64564652|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
64564653|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64564654|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564655|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64564656|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
64564657|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64564658|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564666|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
64564667|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564668|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564669|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
64564670|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564671|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64564672|NCT03115151|Narcotics|narcotics|mesh-ancestor
64564673|NCT03115151|Analgesics|analgesics|mesh-ancestor
64564674|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64564675|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64564676|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
64564677|NCT01263717|Hormones|hormones|mesh-list
64564678|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
64564679|NCT01263717|Tesamorelin|tesamorelin|mesh-list
64564680|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564681|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564682|NCT01263717|Growth Substances|growth substances|mesh-ancestor
64564684|NCT04120753|Olmesartan|olmesartan|mesh-list
64564685|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564686|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64564688|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564689|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64564690|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564692|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64564693|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64564694|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
64564695|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
64564696|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64564697|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564698|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564699|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64564700|NCT01921361|Analgesics|analgesics|mesh-ancestor
64564701|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
64564702|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564703|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64564705|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64564727|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564728|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64564730|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64564731|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
64564732|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564733|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564735|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64564736|NCT01922141|Ramipril|ramipril|mesh-list
64564737|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564738|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64564739|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64352447|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64564740|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564741|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64564742|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564743|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
64564744|NCT01922141|Diuretics|diuretics|mesh-ancestor
64564745|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
64564746|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64564747|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64564748|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
64564749|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564750|NCT03828019|Cyclosporine|cyclosporine|mesh-list
64564751|NCT03828019|Adalimumab|adalimumab|mesh-list
64564752|NCT03828019|Methotrexate|methotrexate|mesh-list
64564753|NCT03828019|Azathioprine|azathioprine|mesh-list
64564754|NCT03828019|Tacrolimus|tacrolimus|mesh-list
64564776|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64564777|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64564778|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64564779|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
64564780|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564781|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564782|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564783|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64564784|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
64564785|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
64564786|NCT02856295|Enoxaparin|enoxaparin|mesh-list
64564787|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
64564788|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64352712|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564789|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64564790|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564791|NCT01266447|Topotecan|topotecan|mesh-list
64564792|NCT01266447|Veliparib|veliparib|mesh-list
64564793|NCT01266447|Lenograstim|lenograstim|mesh-list
64564794|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64564795|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
64564796|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564797|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64564798|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64564799|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564800|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564801|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564802|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64564803|NCT01922375|Naftopidil|naftopidil|mesh-list
64564804|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64564805|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64564806|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564807|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564808|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564809|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564814|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64564815|NCT03823339|Liraglutide|liraglutide|mesh-list
64564816|NCT03823339|Xultophy|xultophy|mesh-list
64564817|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64352806|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64564819|NCT03823339|Incretins|incretins|mesh-ancestor
64564820|NCT03823339|Hormones|hormones|mesh-ancestor
64564821|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64564822|NCT04395989|Paclitaxel|paclitaxel|mesh-list
64564823|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64564824|NCT04395989|Capecitabine|capecitabine|mesh-list
64564825|NCT04395989|Everolimus|everolimus|mesh-list
64564826|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64564827|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564828|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
64564829|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
64564830|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
64564831|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564832|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64564833|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
64564834|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64564835|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
64564836|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564837|NCT03108131|Atezolizumab|atezolizumab|mesh-list
64564838|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64564839|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564840|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
64564863|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64564864|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64564865|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64564866|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64564867|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564868|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64564869|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64564870|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64564871|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64564872|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64564873|NCT01268553|Treprostinil|treprostinil|mesh-list
64564874|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564875|NCT01922999|Melatonin|melatonin|mesh-list
64564876|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
64564877|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564878|NCT01922999|Protective Agents|protective agents|mesh-ancestor
64564879|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352905|NCT03448835|Atezolizumab|atezolizumab|mesh-list
64564881|NCT01268943|Capecitabine|capecitabine|mesh-list
64564882|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64564883|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
64564884|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564885|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564886|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64564887|NCT01923077|Simvastatin|simvastatin|mesh-list
64564888|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64564908|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
64564909|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564910|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564911|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64564912|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
64564913|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
64564914|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64564915|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64564916|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64564917|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
64564918|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64564919|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564921|NCT05498129|Trace Elements|trace elements|mesh-list
64564922|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564923|NCT01270659|Acetaminophen|acetaminophen|mesh-list
64352997|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64352998|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353001|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
64564929|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64564930|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564931|NCT01270659|Analgesics|analgesics|mesh-ancestor
64564932|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
64564933|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564934|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64564935|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64564936|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
64564937|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
64564938|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64564939|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
64353153|NCT02656173|Mirabegron|mirabegron|mesh-list
64353156|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64564947|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
64564948|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64564949|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64564950|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64564951|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
64564952|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564953|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564954|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64564955|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64564956|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64564957|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
64564958|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353231|NCT04516941|Edoxaban|edoxaban|mesh-list
64353232|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
64564959|NCT01929941|Gemcitabine|gemcitabine|mesh-list
64564960|NCT01929941|Paclitaxel|paclitaxel|mesh-list
64564961|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64564962|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564963|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
64564964|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
64564965|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
64564966|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564990|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64564991|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
64564992|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64564993|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64564994|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64564995|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64564997|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
64564998|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64564999|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565000|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
64589413|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64565001|NCT01920737|Hormones|hormones|mesh-ancestor
64565002|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565003|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565004|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64565006|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64565007|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64565008|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
64565009|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
64565010|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565011|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64565012|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64565013|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
64565014|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565015|NCT01920737|Antidotes|antidotes|mesh-ancestor
64565016|NCT01920737|Protective Agents|protective agents|mesh-ancestor
64565017|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
64565018|NCT01920737|Vitamins|vitamins|mesh-ancestor
64565019|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
64565020|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64565035|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
64353262|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353263|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
64565036|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64565038|NCT01302483|Phenylephrine|phenylephrine|mesh-list
64565039|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
64565040|NCT01302483|Tetracaine|tetracaine|mesh-list
64565041|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
64565042|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
64565043|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565044|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565045|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
64565046|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565047|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64565048|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64565049|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64565050|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565051|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565052|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64565053|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64565054|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
64565055|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565056|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
64565057|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
64565058|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
64565059|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64565060|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353270|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353271|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
64353272|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565061|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64565062|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
64565063|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64565064|NCT01302483|Protective Agents|protective agents|mesh-ancestor
64565065|NCT04769583|Metronidazole|metronidazole|mesh-list
64565066|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565067|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565068|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64565069|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64565070|NCT01279317|Acetic Acid|acetic acid|mesh-list
64565073|NCT01304589|Milnacipran|milnacipran|mesh-list
64565075|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64565076|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64565077|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565078|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565079|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565080|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565081|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64565082|NCT01304589|Analgesics|analgesics|mesh-ancestor
64565083|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
64353318|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64565084|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565085|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
64565086|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64565088|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64565089|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565090|NCT01926197|Leucovorin|leucovorin|mesh-list
64565091|NCT01926197|Fluorouracil|fluorouracil|mesh-list
64565092|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
64565093|NCT01926197|Irinotecan|irinotecan|mesh-list
64565094|NCT01926197|Camptothecin|camptothecin|mesh-list
64565095|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
64565096|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565097|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64565098|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565099|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565100|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
64565101|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565102|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64565103|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64565104|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565105|NCT01926197|Antidotes|antidotes|mesh-ancestor
64565106|NCT01926197|Protective Agents|protective agents|mesh-ancestor
64565119|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565120|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
64565121|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565122|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
64565123|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565124|NCT01305213|Bevacizumab|bevacizumab|mesh-list
64565125|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64565126|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
64565127|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
64565128|NCT01305213|Antibodies|antibodies|mesh-list
64565129|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
64565130|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64565131|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
64565132|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565133|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64565134|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64565135|NCT01305213|Growth Substances|growth substances|mesh-ancestor
64565136|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565137|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
64565138|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
64565139|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64565140|NCT00989963|Beraprost|beraprost|mesh-list
64565141|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64565142|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
64565143|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64565144|NCT01339299|Hormones|hormones|mesh-list
64565145|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565146|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565147|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64565148|NCT01307007|Dextrans|dextrans|mesh-list
64565149|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
64565150|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
64565151|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
64565163|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565164|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64565165|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565166|NCT01923623|Ropivacaine|ropivacaine|mesh-list
64565167|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
64565168|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
64565169|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565170|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565171|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
64565172|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565173|NCT01923857|Enclomiphene|enclomiphene|mesh-list
64565174|NCT01923857|Clomiphene|clomiphene|mesh-list
64565175|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
64565176|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64565177|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
64565178|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565179|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565180|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64565181|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
64565182|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64565183|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64565184|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64565185|NCT03100253|Adalimumab|adalimumab|mesh-list
64565186|NCT03100253|Etanercept|etanercept|mesh-list
64565187|NCT03100253|Golimumab|golimumab|mesh-list
64565188|NCT03100253|Infliximab|infliximab|mesh-list
64565189|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
64565190|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565191|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565192|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
64565193|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565194|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64565206|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
64565207|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565208|NCT03485729|TIC10 compound|tic10 compound|mesh-list
64565209|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565210|NCT01924325|Aspirin|aspirin|mesh-list
64565211|NCT01924325|Apixaban|apixaban|mesh-list
64565212|NCT01924325|Clopidogrel|clopidogrel|mesh-list
64565213|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64565214|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64565215|NCT01924325|Analgesics|analgesics|mesh-ancestor
64565216|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
64565217|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565218|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565219|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565220|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565221|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64565222|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64565223|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565224|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64565225|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64565226|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565227|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
64565228|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64565229|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64565230|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64565231|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
64565232|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565233|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64565234|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
64565235|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64565251|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565252|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64565253|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
64565254|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
64565256|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64565257|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
64565258|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
64565259|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64484228|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64565260|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64565261|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565262|NCT01925729|Phenylephrine|phenylephrine|mesh-list
64565263|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
64565264|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
64565265|NCT01925729|Ephedrine|ephedrine|mesh-list
64565266|NCT01925729|Histamine|histamine|mesh-list
64565267|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64565268|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
64565269|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565270|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565271|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64565272|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
64565273|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
64565274|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64354043|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64354044|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354046|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354047|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354048|NCT03424733|Analgesics|analgesics|mesh-ancestor
64354049|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
64354050|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565275|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64565276|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
64565277|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
64565296|NCT01926665|Dexamethasone|dexamethasone|mesh-list
64565297|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565298|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
64565299|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
64565300|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565301|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565302|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565303|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
64414772|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565305|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565306|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565307|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565309|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64565310|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
64565311|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565312|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64565313|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565314|NCT01926899|Bortezomib|bortezomib|mesh-list
64565315|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565316|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64565317|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64565318|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565319|NCT04395365|Renal Agents|renal agents|mesh-ancestor
64565320|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565321|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
64354108|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565323|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64565324|NCT03430661|Clopidogrel|clopidogrel|mesh-list
64565325|NCT03430661|Ticagrelor|ticagrelor|mesh-list
64565326|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64565327|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64565337|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565338|NCT01927913|Deferasirox|deferasirox|mesh-list
64565339|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64565340|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
64565341|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
64565342|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565343|NCT01928069|Montelukast|montelukast|mesh-list
64565344|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64565345|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
64565346|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64565347|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
64565348|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565349|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565350|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64565351|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64565352|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565353|NCT01928459|Infigratinib|infigratinib|mesh-list
64565354|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565355|NCT01928537|ON 01910|on 01910|mesh-list
64565356|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565357|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64354261|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
64354262|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64354263|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
64565358|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565359|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565360|NCT01307397|Vemurafenib|vemurafenib|mesh-list
64565361|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565381|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565382|NCT01342029|Ranolazine|ranolazine|mesh-list
64565383|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64565384|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565385|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565386|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64565387|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
64565388|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
64565389|NCT05601479|Vitamins|vitamins|mesh-ancestor
64565390|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
64565391|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565392|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
64565393|NCT04275245|Meplazumab|meplazumab|mesh-list
64565394|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
64565395|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565396|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
64354357|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354358|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64354359|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
64354360|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
64354361|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354362|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354363|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64354364|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
64354366|NCT03435133|Ticagrelor|ticagrelor|mesh-list
64565397|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
64565398|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565399|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565400|NCT04394897|Remifentanil|remifentanil|mesh-list
64565401|NCT04394897|Propofol|propofol|mesh-list
64565402|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64565403|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565404|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565405|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64565406|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
64565407|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
64565408|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64565409|NCT04394897|Narcotics|narcotics|mesh-ancestor
64565410|NCT04394897|Analgesics|analgesics|mesh-ancestor
64565411|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
64565412|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565413|NCT05607641|Ketorolac|ketorolac|mesh-list
64565414|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64565425|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565426|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565427|NCT05607017|Losartan|losartan|mesh-list
64565428|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64565429|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64354526|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64565430|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64565431|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64565432|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565433|NCT05603039|Bevacizumab|bevacizumab|mesh-list
64565434|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64565435|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565436|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64565437|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64565438|NCT05603039|Growth Substances|growth substances|mesh-ancestor
64565439|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565440|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64565441|NCT05609903|Paclitaxel|paclitaxel|mesh-list
64565442|NCT05609903|Atezolizumab|atezolizumab|mesh-list
64565443|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64565444|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565445|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
64354619|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354620|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64565446|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
64565447|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
64565448|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565449|NCT03045029|Treprostinil|treprostinil|mesh-list
64565450|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64565451|NCT04161599|Metronidazole|metronidazole|mesh-list
64565452|NCT04161599|Cefuroxime|cefuroxime|mesh-list
64565472|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565473|NCT05608499|Clobetasol|clobetasol|mesh-list
64565474|NCT05608499|Halobetasol|halobetasol|mesh-list
64565475|NCT05608499|Tazarotene|tazarotene|mesh-list
64565476|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
64565477|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
64565478|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64565479|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565480|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
64565481|NCT05608499|Hormones|hormones|mesh-ancestor
64565482|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565483|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565484|NCT05601167|Ritonavir|ritonavir|mesh-list
64565485|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64565486|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64565487|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
64565488|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565489|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565490|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64565491|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64565492|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
64565526|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64565528|NCT05603975|Esketamine|esketamine|mesh-list
64565529|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
64565530|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64565531|NCT03029429|Theophylline|theophylline|mesh-list
64565532|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64565533|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
64354685|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354686|NCT03422575|Analgesics|analgesics|mesh-ancestor
64565534|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565535|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565536|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64565537|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
64565538|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64565539|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565540|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565541|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
64565542|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64565543|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64565544|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
64565545|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565546|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
64565547|NCT04120363|Testosterone|testosterone|mesh-list
64565548|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
64565549|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
64565550|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64565551|NCT04120363|Androgens|androgens|mesh-ancestor
64565552|NCT04120363|Hormones|hormones|mesh-ancestor
64565553|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565554|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565555|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565556|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565557|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
64354725|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
64354727|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354728|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
64354729|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64565571|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565573|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64565575|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565576|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565577|NCT04122755|Analgesics|analgesics|mesh-ancestor
64565578|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
64565579|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565580|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64565581|NCT04129697|Dexamethasone|dexamethasone|mesh-list
64565582|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
64565583|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64565584|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64565585|NCT04129697|Prednisolone|prednisolone|mesh-list
64565586|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
64565587|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64565588|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
64565589|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565590|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
64565591|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
64565592|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565593|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565594|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64565595|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
64565596|NCT04129697|Hormones|hormones|mesh-ancestor
64565597|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565598|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565599|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565600|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64354826|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64354828|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64565603|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565616|NCT05793892|Lidocaine|lidocaine|mesh-list
64565617|NCT05793892|Tetracaine|tetracaine|mesh-list
64565618|NCT05793892|Anesthetics, Local|anesthetics, local|mesh-ancestor
64565623|NCT05793892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565624|NCT05793892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64565625|NCT05793892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64565626|NCT05793892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64565627|NCT05793892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64565628|NCT05793892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565629|NCT05793632|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64565630|NCT05793632|Antidepressive Agents|antidepressive agents|mesh-ancestor
64565631|NCT05793632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64565632|NCT05793632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64565633|NCT05793632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64565634|NCT05793632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565635|NCT05793632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565636|NCT05793359|Methylprednisolone|methylprednisolone|mesh-list
64484229|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
64565637|NCT05793359|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64565638|NCT05793359|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64565640|NCT05793359|Prednisolone acetate|prednisolone acetate|mesh-list
64565641|NCT05793359|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64354885|NCT03420703|Morphine|morphine|mesh-list
64565651|NCT05793359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565652|NCT05793359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64565653|NCT05793359|Protective Agents|protective agents|mesh-ancestor
64565654|NCT05793359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565655|NCT05793359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565656|NCT05793268|Tenofovir|tenofovir|mesh-list
64565657|NCT05793268|Entecavir|entecavir|mesh-list
64565658|NCT05793268|Antiviral Agents|antiviral agents|mesh-ancestor
64565659|NCT05793268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565660|NCT05793268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64565661|NCT05793268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64565662|NCT05793268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565663|NCT05793268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565664|NCT05793268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64565665|NCT05793268|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64565666|NCT05793099|Propolis|propolis|mesh-list
64565667|NCT05793099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565668|NCT05793060|Dexamethasone|dexamethasone|mesh-list
64565669|NCT05793060|Dexamethasone acetate|dexamethasone acetate|mesh-list
64565670|NCT05793060|Dexmedetomidine|dexmedetomidine|mesh-list
64565719|NCT05792644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565720|NCT05792644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565721|NCT05792410|Bevacizumab|bevacizumab|mesh-list
64565724|NCT05792410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565725|NCT05792410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64565726|NCT05792410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64565727|NCT05792410|Growth Substances|growth substances|mesh-ancestor
64565728|NCT05792410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565729|NCT05792410|Growth Inhibitors|growth inhibitors|mesh-ancestor
64565730|NCT05792410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565731|NCT05792410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64565732|NCT05792410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64565733|NCT05792410|Hormone Antagonists|hormone antagonists|mesh-ancestor
64565734|NCT05792410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565735|NCT05792319|Copper|copper|mesh-list
64565736|NCT05792319|Trace Elements|trace elements|mesh-ancestor
64565737|NCT05792319|Micronutrients|micronutrients|mesh-ancestor
64565738|NCT05792319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565739|NCT05792111|Triamcinolone|triamcinolone|mesh-list
64565740|NCT05792111|Lidocaine|lidocaine|mesh-list
64589516|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64565741|NCT05792111|Bupivacaine|bupivacaine|mesh-list
64565742|NCT05792111|Anesthetics, Local|anesthetics, local|mesh-ancestor
64565743|NCT05792111|Anesthetics|anesthetics|mesh-ancestor
64565744|NCT05792111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565745|NCT05792111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355012|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
64355013|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
64355014|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355015|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64355016|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64355048|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64355050|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355051|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
64355052|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355053|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64565746|NCT05792111|Sensory System Agents|sensory system agents|mesh-ancestor
64565764|NCT05789732|Urological Agents|urological agents|mesh-ancestor
64565765|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64565766|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64565767|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64565768|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
64565769|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565770|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565771|NCT05789615|Letermovir|letermovir|mesh-list
64565772|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64565773|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565774|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565775|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565776|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
64565777|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355100|NCT02735707|Amoxicillin|amoxicillin|mesh-list
64355101|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
64355102|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
64355103|NCT02735707|Levofloxacin|levofloxacin|mesh-list
64565778|NCT05783817|Methamphetamine|methamphetamine|mesh-list
64565779|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64565780|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565781|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
64565782|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
64565783|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565784|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
64565785|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64565792|NCT05778617|Ambroxol|ambroxol|mesh-list
64565815|NCT05761080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565816|NCT05761080|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64565817|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64565818|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64565819|NCT05738694|Axitinib|axitinib|mesh-list
64565820|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565821|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355168|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64355202|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355208|NCT00950989|Folic Acid|folic acid|mesh-list
64565822|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565823|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565824|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64565825|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565826|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64565827|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565829|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565830|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565831|NCT05704543|Buprenorphine|buprenorphine|mesh-list
64565832|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64565833|NCT05704543|Narcotics|narcotics|mesh-ancestor
64565834|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565835|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565836|NCT05704543|Analgesics|analgesics|mesh-ancestor
64565837|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
64565838|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565839|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64565861|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64565862|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565863|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64565864|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64565865|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64565866|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
64565867|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64565868|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565869|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64565870|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64565871|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64565872|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64565873|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565874|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
64565875|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64565876|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355331|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
64355332|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64355333|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
64565878|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64565879|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565880|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64565881|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64565882|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64565883|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
64565884|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565885|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64565886|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64565887|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64565888|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64565889|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64565890|NCT05642026|Ropivacaine|ropivacaine|mesh-list
64565891|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
64565892|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
64565893|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64565896|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565898|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64565899|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64565906|NCT05618366|Venetoclax|venetoclax|mesh-list
64565907|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565908|NCT05617742|FAPI-46|fapi-46|mesh-list
64565909|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64565910|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565911|NCT05605535|Paclitaxel|paclitaxel|mesh-list
64565912|NCT05605535|Carboplatin|carboplatin|mesh-list
64565913|NCT05605535|Oregovomab|oregovomab|mesh-list
64565914|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64565915|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565916|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
64565917|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
64565918|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
64565919|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565920|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64565921|NCT05593575|Valsartan|valsartan|mesh-list
64565922|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64565923|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64565924|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64565925|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64565926|NCT05558137|Mivacurium|mivacurium|mesh-list
64355381|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355382|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64565927|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64565928|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64565929|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64565930|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64565942|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565943|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64565944|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
64565945|NCT05521828|Hormones|hormones|mesh-ancestor
64565946|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64565947|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565948|NCT05521828|Progestins|progestins|mesh-ancestor
64565949|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
64565950|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64565951|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
64565952|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64565953|NCT05501769|Everolimus|everolimus|mesh-list
64565954|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64565955|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64565956|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
64565957|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64565958|NCT05468619|Valacyclovir|valacyclovir|mesh-list
64565959|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
64565960|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64565961|NCT05463224|Lazertinib|lazertinib|mesh-list
64566000|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355398|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64355399|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64566001|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
64566002|NCT05392946|Hormones|hormones|mesh-ancestor
64566003|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566004|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566005|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566006|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
64566007|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355456|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64355457|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355458|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355459|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
64355460|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
64355461|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355462|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566011|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64566012|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566013|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566014|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566015|NCT05382546|Ketorolac|ketorolac|mesh-list
64566016|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64566017|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64566018|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64566019|NCT05382546|Analgesics|analgesics|mesh-ancestor
64566020|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
64566021|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566022|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566023|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566024|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566025|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64566026|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566027|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566028|NCT05372133|Morphine|morphine|mesh-list
64566029|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64566049|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566050|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566051|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566053|NCT05292664|Cytarabine|cytarabine|mesh-list
64566054|NCT05292664|Dexamethasone|dexamethasone|mesh-list
64566055|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
64566056|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
64566057|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64566058|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64566059|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64566060|NCT05292664|Cortisone|cortisone|mesh-list
64566061|NCT05292664|Doxorubicin|doxorubicin|mesh-list
64566062|NCT05292664|Methotrexate|methotrexate|mesh-list
64566063|NCT05292664|Vincristine|vincristine|mesh-list
64566064|NCT05292664|Azacitidine|azacitidine|mesh-list
64566065|NCT05292664|Venetoclax|venetoclax|mesh-list
64566066|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
64566067|NCT05292664|Razoxane|razoxane|mesh-list
64566068|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64566069|NCT05292664|BB 1101|bb 1101|mesh-list
64566070|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
64566071|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566074|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566075|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566076|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64566077|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
64566078|NCT05292664|Hormones|hormones|mesh-ancestor
64566092|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
64566098|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64566099|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
64566100|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566101|NCT05292664|Antidotes|antidotes|mesh-ancestor
64566102|NCT05292664|Protective Agents|protective agents|mesh-ancestor
64566103|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
64566105|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
64566106|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64566107|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566108|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566109|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566110|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64566111|NCT05283109|Vaccines|vaccines|mesh-list
64566112|NCT05283109|Poly ICLC|poly iclc|mesh-list
64566113|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
64566114|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566115|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
64566116|NCT05278975|Thiostrepton|thiostrepton|mesh-list
64566117|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64566118|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566119|NCT05278351|Irinotecan|irinotecan|mesh-list
64566120|NCT05278351|Cetuximab|cetuximab|mesh-list
64566121|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64566122|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64566123|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566124|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566125|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566126|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64355622|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64355623|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64566150|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64566152|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566153|NCT05269628|Hormones|hormones|mesh-ancestor
64566154|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566155|NCT05265299|Aspirin|aspirin|mesh-list
64566156|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64566157|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64566158|NCT05265299|Analgesics|analgesics|mesh-ancestor
64566159|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
64566160|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566161|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566162|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566163|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566164|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64566165|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64355636|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64355637|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
64355656|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
64566186|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64566188|NCT05211154|Analgesics|analgesics|mesh-ancestor
64566189|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
64566190|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566191|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566192|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566193|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566194|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64566195|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334730|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64334732|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64334733|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64566204|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64566205|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566206|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566207|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64566208|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
64566209|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566259|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566260|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566261|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566292|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64566293|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566294|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566295|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566296|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566297|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566298|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566299|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
64566300|NCT04935359|Antiviral Agents|antiviral agents|mesh-ancestor
64566301|NCT04935359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566307|NCT04818632|Palbociclib|palbociclib|mesh-list
64566308|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566309|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566310|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
64566311|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566312|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566313|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566314|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566339|NCT04749628|Cannabidiol|cannabidiol|mesh-list
64566340|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
64566341|NCT04729101|Lansoprazole|lansoprazole|mesh-list
64566342|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
64566343|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64566344|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64566345|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64566346|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566347|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566348|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
64566349|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
64566350|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566351|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566353|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64566354|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64566355|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64566361|NCT04673448|Niraparib|niraparib|mesh-list
64566362|NCT04673448|Dostarlimab-gxly|dostarlimab-gxly|mesh-list
64566363|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
64566364|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
64566365|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
64566366|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566367|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64566368|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566369|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566370|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566371|NCT04670081|Niacinamide|niacinamide|mesh-list
64566372|NCT04670081|Niacin|niacin|mesh-list
64356301|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356302|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566378|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566379|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64566380|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
64566381|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566382|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64566383|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
64566384|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
64566385|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64566386|NCT04648280|Fostemsavir|fostemsavir|mesh-list
64566387|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64566388|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64566389|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
64566390|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566391|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64566392|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64566393|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566394|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
64566395|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566396|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566397|NCT04601961|Propofol|propofol|mesh-list
64566398|NCT04601961|Sevoflurane|sevoflurane|mesh-list
64566399|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64566400|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566401|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566402|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64566403|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
64566404|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
64566405|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64566406|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64566414|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566415|NCT04551430|Nivolumab|nivolumab|mesh-list
64566416|NCT04551430|Ipilimumab|ipilimumab|mesh-list
64566417|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566418|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566419|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64566420|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566421|NCT04513314|Valproic Acid|valproic acid|mesh-list
64566422|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64566423|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
64566424|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64566425|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64566426|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64566427|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566428|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566430|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566431|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566432|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
64566433|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64566434|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
64566435|NCT04491877|Vaccines|vaccines|mesh-list
64566436|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
64589567|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566437|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566438|NCT04485559|Everolimus|everolimus|mesh-list
64566439|NCT04485559|Trametinib|trametinib|mesh-list
64566440|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566441|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566442|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
64566443|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566444|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566445|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566446|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566447|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
64566448|NCT04469868|Narcotics|narcotics|mesh-ancestor
64566449|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566455|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64566456|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566457|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566458|NCT04446117|Prednisone|prednisone|mesh-list
64566459|NCT04446117|Atezolizumab|atezolizumab|mesh-list
64566460|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
64566461|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566462|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
64566463|NCT04446117|Hormones|hormones|mesh-ancestor
64566464|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566465|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566466|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566467|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356667|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356668|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566468|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64566469|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566470|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566471|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
64566472|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64566474|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
64566475|NCT04427956|Vitamins|vitamins|mesh-ancestor
64566476|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
64566477|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566478|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64566479|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
64566480|NCT04385277|Vitamin A|vitamin a|mesh-list
64566481|NCT04385277|Irinotecan|irinotecan|mesh-list
64566516|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566517|NCT04287049|Azithromycin|azithromycin|mesh-list
64566518|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64566519|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566520|NCT04282629|Milrinone|milrinone|mesh-list
64566521|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64566522|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64566523|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
64566524|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64566525|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64566526|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566527|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356871|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
64356872|NCT05181527|Serotonin|serotonin|mesh-list
64356873|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64356874|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
64356875|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356876|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64566529|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566531|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
64566532|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566533|NCT04275492|Protective Agents|protective agents|mesh-ancestor
64566534|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566535|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64566536|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64566537|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
64566538|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
64566539|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64566540|NCT04265105|Fluticasone|fluticasone|mesh-list
64566543|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
64566574|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
64566575|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566576|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566587|NCT04031833|Amphotericin B|amphotericin b|mesh-list
64566588|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64566610|NCT03943875|Vaccines|vaccines|mesh-list
64566611|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
64566612|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566613|NCT03933202|Cladribine|cladribine|mesh-list
64566614|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566615|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566616|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
64566617|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566618|NCT03908307|Dexamethasone|dexamethasone|mesh-list
64566619|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
64566620|NCT03908307|BB 1101|bb 1101|mesh-list
64566621|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64566622|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
64566623|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
64566624|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566625|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566626|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64566627|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
64566628|NCT03908307|Hormones|hormones|mesh-ancestor
64566629|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64566630|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64566631|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566632|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
64566633|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566647|NCT03841058|Abaloparatide|abaloparatide|mesh-list
64566662|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
64566663|NCT03684590|Narcotics|narcotics|mesh-ancestor
64566664|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64566665|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566666|NCT03684590|Analgesics|analgesics|mesh-ancestor
64566667|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
64566668|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566669|NCT03631199|Paclitaxel|paclitaxel|mesh-list
64566670|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64356945|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566672|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
64566673|NCT03631199|Pemetrexed|pemetrexed|mesh-list
64566674|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64566675|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64566676|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566677|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566678|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566679|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566680|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566681|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566682|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566683|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64566684|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64566685|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
64566686|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566687|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64566688|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
64566689|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64566690|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
64566691|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566692|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566694|NCT03385304|Iodine|iodine|mesh-list
64566705|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566706|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
64566707|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
64566709|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64566710|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64566711|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
64566712|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566713|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64566714|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64566715|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566716|NCT03331198|Venetoclax|venetoclax|mesh-list
64566717|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566718|NCT03285568|Palbociclib|palbociclib|mesh-list
64566719|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566720|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566721|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566722|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566723|NCT03237780|Atezolizumab|atezolizumab|mesh-list
64566724|NCT03237780|Halichondrin B|halichondrin b|mesh-list
64566725|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64566726|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566727|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
64566733|NCT03185819|Midazolam|midazolam|mesh-list
64566775|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64566776|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
64566778|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
64566779|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
64566780|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566781|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
64566782|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566783|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
64566784|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566785|NCT03038802|Vaccines|vaccines|mesh-list
64566786|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
64566787|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566788|NCT02938793|Durvalumab|durvalumab|mesh-list
64566789|NCT02938793|Tremelimumab|tremelimumab|mesh-list
64566790|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356956|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
64356957|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566799|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566800|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566801|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566802|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566803|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
64566804|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566805|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64566806|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64566807|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566808|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566809|NCT02928224|Antidotes|antidotes|mesh-ancestor
64566810|NCT02928224|Protective Agents|protective agents|mesh-ancestor
64566811|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
64566813|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
64566814|NCT02928224|Hematinics|hematinics|mesh-ancestor
64566815|NCT02837094|Insulin|insulin|mesh-list
64566816|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64566817|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566818|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
64566819|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64566820|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64566821|NCT02836925|Ledipasvir|ledipasvir|mesh-list
64566822|NCT02836925|Velpatasvir|velpatasvir|mesh-list
64566823|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
64566824|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566825|NCT02807636|Gemcitabine|gemcitabine|mesh-list
64566826|NCT02807636|Carboplatin|carboplatin|mesh-list
64566827|NCT02807636|Atezolizumab|atezolizumab|mesh-list
64566828|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566829|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566830|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
64566831|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566832|NCT02807636|Antiviral Agents|antiviral agents|mesh-ancestor
64566833|NCT02807636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566834|NCT02807636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566835|NCT02807636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566836|NCT02807636|Immunologic Factors|immunologic factors|mesh-ancestor
64566837|NCT02807636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566838|NCT02756962|Cytarabine|cytarabine|mesh-list
64566839|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566840|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
64566841|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566842|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566843|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
64357417|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64357418|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
64357422|NCT03379181|Propranolol|propranolol|mesh-list
64566844|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566845|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566855|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64566856|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64566857|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64566858|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64566859|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64566860|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566861|NCT02728037|Analgesics|analgesics|mesh-ancestor
64566862|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
64566863|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64566864|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64566865|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
64566866|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64566867|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64566868|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
64566869|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566870|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
64566871|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566872|NCT02392572|TIC10 compound|tic10 compound|mesh-list
64566873|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566874|NCT02275780|Ritonavir|ritonavir|mesh-list
64566875|NCT02275780|Darunavir|darunavir|mesh-list
64566876|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64566877|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64566878|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64566879|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
64566902|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566903|NCT02141542|Tremelimumab|tremelimumab|mesh-list
64566904|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566907|NCT01828112|Ceritinib|ceritinib|mesh-list
64566908|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566909|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
64566910|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
64566911|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
64566912|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566913|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566914|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64566915|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64566916|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566917|NCT01746836|Ponatinib|ponatinib|mesh-list
64566918|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566919|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566920|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566921|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566922|NCT01269190|Proflavine|proflavine|mesh-list
64566923|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64566924|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64566925|NCT00545077|Bevacizumab|bevacizumab|mesh-list
64566926|NCT00545077|Letrozole|letrozole|mesh-list
64566927|NCT00545077|Fulvestrant|fulvestrant|mesh-list
64566928|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566929|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357432|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64566931|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64566951|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566952|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64566953|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64566954|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64566955|NCT00199862|Antibodies|antibodies|mesh-list
64566956|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
64566957|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566958|NCT00130533|Capecitabine|capecitabine|mesh-list
64566959|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64566960|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
64566961|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64566962|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64566963|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
64566964|NCT00129935|Docetaxel|docetaxel|mesh-list
64566965|NCT00129935|Capecitabine|capecitabine|mesh-list
64566966|NCT00129935|Epirubicin|epirubicin|mesh-list
64589581|NCT00543101|Darunavir|darunavir|mesh-list
64566967|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64566968|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
64566969|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64566970|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64566971|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64566972|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
64566973|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567000|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
64567001|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567002|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64567003|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64567004|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567005|NCT01450111|Lacosamide|lacosamide|mesh-list
64567006|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
64567007|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64567008|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64567009|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64567010|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567011|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64567012|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64567013|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567014|NCT02697253|Incretins|incretins|mesh-ancestor
64567016|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567017|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64567018|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
64567019|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567020|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567021|NCT02660905|Tenofovir|tenofovir|mesh-list
64567022|NCT02660905|Emtricitabine|emtricitabine|mesh-list
64567023|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
64567024|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64567025|NCT02660905|Rilpivirine|rilpivirine|mesh-list
64567042|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567043|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
64567045|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
64567046|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64567047|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64567048|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567049|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567050|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567051|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567052|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567053|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64567054|NCT01450345|Pregabalin|pregabalin|mesh-list
64567056|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
64567057|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567058|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567059|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
64567060|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64567061|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64567062|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567063|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64567094|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567095|NCT03825367|Nivolumab|nivolumab|mesh-list
64567096|NCT03825367|Azacitidine|azacitidine|mesh-list
64567097|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567098|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567099|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64567100|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567101|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567102|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
64567103|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567104|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
64567105|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64567106|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64567107|NCT04273321|Prednisolone|prednisolone|mesh-list
64567108|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
64567109|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64567110|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
64567111|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567112|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
64567113|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
64567114|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567115|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567116|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64567117|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
64567118|NCT04273321|Hormones|hormones|mesh-ancestor
64567144|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64567145|NCT01243476|Lenalidomide|lenalidomide|mesh-list
64567146|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
64567147|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567148|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64567149|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64567150|NCT01243476|Growth Substances|growth substances|mesh-ancestor
64567151|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
64567152|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567153|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
64567154|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64567155|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64567156|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
64567157|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567158|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64567159|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64567160|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567161|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567162|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
64567163|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567164|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567165|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
64567166|NCT01454011|Testosterone|testosterone|mesh-list
64567167|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
64567170|NCT01454011|Androgens|androgens|mesh-ancestor
64567193|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567194|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567195|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
64567196|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64567197|NCT04975932|Estrogens|estrogens|mesh-ancestor
64567198|NCT04975932|Hormones|hormones|mesh-ancestor
64567264|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567265|NCT02906761|Analgesics|analgesics|mesh-ancestor
64567266|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
64357610|NCT04446403|Anesthetics|anesthetics|mesh-list
64567267|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567268|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567269|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567270|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567271|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64567272|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64567273|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567274|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64567275|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64567276|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567278|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
64567279|NCT02905591|Paclitaxel|paclitaxel|mesh-list
64567280|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64567281|NCT02905591|Carboplatin|carboplatin|mesh-list
64567282|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64567283|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567284|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567285|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
64567286|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
64567287|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567288|NCT02905591|Vitamins|vitamins|mesh-ancestor
64567289|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
64567290|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567291|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
64567313|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
64567314|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567315|NCT01451593|Phenytoin|phenytoin|mesh-list
64567316|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
64567317|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64567318|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64567319|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64567320|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567321|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64567322|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64567323|NCT01455103|BMS-936559|bms-936559|mesh-list
64567324|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64567325|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567326|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567327|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
64567328|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567330|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
64567331|NCT04975074|Trace Elements|trace elements|mesh-ancestor
64567332|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
64567333|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567334|NCT04975074|Hematinics|hematinics|mesh-ancestor
64567335|NCT04963998|Copper|copper|mesh-list
64567336|NCT04963998|Trace Elements|trace elements|mesh-ancestor
64567337|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
64567366|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64567367|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64567369|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567370|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64567371|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567372|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567373|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
64567374|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64567375|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567376|NCT01455883|Glimepiride|glimepiride|mesh-list
64567377|NCT01455883|Exenatide|exenatide|mesh-list
64567378|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64567379|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64567380|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567381|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567382|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
64567383|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64567386|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567387|NCT01452217|Secretin|secretin|mesh-list
64567388|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64567389|NCT01452217|Hormones|hormones|mesh-ancestor
64567390|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567391|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567392|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64567394|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567395|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567415|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64567416|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64567417|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
64567418|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64567419|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64567420|NCT03829345|Olaparib|olaparib|mesh-list
64567421|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64567422|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567423|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567424|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567425|NCT01456351|Rituximab|rituximab|mesh-list
64567426|NCT01456351|Fludarabine|fludarabine|mesh-list
64567427|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64567428|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567429|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567430|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
64567431|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567432|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567433|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567434|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64567435|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
64567436|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64567438|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567439|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567440|NCT01452685|Leuprolide|leuprolide|mesh-list
64567441|NCT01452685|Relugolix|relugolix|mesh-list
64567442|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64567443|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
64567444|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64567445|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567446|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567451|NCT01452763|Lansoprazole|lansoprazole|mesh-list
64567452|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
64567453|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64567454|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64567455|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64567456|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567457|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567459|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567460|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567461|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64567462|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64567463|NCT04954014|Growth Substances|growth substances|mesh-ancestor
64567464|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567465|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
64567466|NCT00988559|Imiquimod|imiquimod|mesh-list
64567467|NCT00988559|Vaccines|vaccines|mesh-list
64567468|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
64567469|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567470|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64567471|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567472|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
64567473|NCT02967289|Irinotecan|irinotecan|mesh-list
64357616|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357617|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589631|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64567476|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567477|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567478|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567479|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64567480|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567481|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64567482|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567496|NCT04961970|Fluorouracil|fluorouracil|mesh-list
64567497|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
64567498|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567499|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567500|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
64567501|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567502|NCT04961970|Antiviral Agents|antiviral agents|mesh-ancestor
64567503|NCT04961970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567504|NCT04961970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567505|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567506|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
64567507|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567508|NCT04961970|Antidotes|antidotes|mesh-ancestor
64567509|NCT04961970|Protective Agents|protective agents|mesh-ancestor
64567510|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
64567511|NCT04961970|Vitamins|vitamins|mesh-ancestor
64567512|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
64567513|NCT01311687|Dexamethasone|dexamethasone|mesh-list
64567514|NCT01311687|Pomalidomide|pomalidomide|mesh-list
64567515|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567516|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
64567517|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
64567518|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567519|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567520|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64567521|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
64567522|NCT01311687|Hormones|hormones|mesh-ancestor
64567523|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567524|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567525|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567526|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
64567527|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64567531|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
64567539|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567540|NCT02965027|Prazosin|prazosin|mesh-list
64567541|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64567542|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64567543|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64567544|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64567545|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
64567546|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64567547|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567548|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567549|NCT04961268|Acetaminophen|acetaminophen|mesh-list
64567550|NCT04961268|Ibuprofen|ibuprofen|mesh-list
64567551|NCT04961268|Tramadol|tramadol|mesh-list
64567552|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567553|NCT04961268|Analgesics|analgesics|mesh-ancestor
64567554|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
64567555|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567556|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567557|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
64567558|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64567559|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567560|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567561|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64357654|NCT03460015|Propofol|propofol|mesh-list
64567563|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567565|NCT04961268|Narcotics|narcotics|mesh-ancestor
64567566|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567584|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
64567585|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64567586|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
64567587|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64567588|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567589|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
64567590|NCT01347255|Hormones|hormones|mesh-ancestor
64567591|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567592|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567593|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64567594|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
64567595|NCT02908477|Docetaxel|docetaxel|mesh-list
64567596|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567597|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567598|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
64567599|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
64567600|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567601|NCT04392427|Ribavirin|ribavirin|mesh-list
64567602|NCT04392427|Ivermectin|ivermectin|mesh-list
64567603|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
64567604|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
64567605|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567606|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
64567607|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567608|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64567609|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
64567611|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567612|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
64567613|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567614|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567615|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64567616|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
64567617|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567618|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567620|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
64567621|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
64567622|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64567623|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64567624|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567625|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64567626|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567627|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567628|NCT01455337|Prednisolone|prednisolone|mesh-list
64567629|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
64567630|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567631|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
64567632|NCT01455337|Hormones|hormones|mesh-ancestor
64567633|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567634|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567635|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64567636|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567637|NCT01455337|Protective Agents|protective agents|mesh-ancestor
64567638|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64567639|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567640|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567641|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64567642|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64357660|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
64567643|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
64567644|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64567645|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
64567646|NCT03059316|Labetalol|labetalol|mesh-list
64567647|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
64567648|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
64567665|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64567666|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
64567667|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567668|NCT04943952|Asparaginase|asparaginase|mesh-list
64567669|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567670|NCT04410978|Teriflunomide|teriflunomide|mesh-list
64567671|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64567672|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567673|NCT04410978|Analgesics|analgesics|mesh-ancestor
64567674|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
64567675|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567676|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567677|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567678|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567679|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567680|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
64567681|NCT01352637|Cycloserine|cycloserine|mesh-list
64567682|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64567683|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567684|NCT01352637|Renal Agents|renal agents|mesh-ancestor
64567685|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64567686|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
64567687|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64567688|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
64567689|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567690|NCT03058536|Progesterone|progesterone|mesh-list
64567691|NCT03058536|Progestins|progestins|mesh-ancestor
64567693|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567694|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567695|NCT01314417|Methotrexate|methotrexate|mesh-list
64567696|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64567697|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
64567698|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64567699|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567705|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567706|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64567707|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567708|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
64567709|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567710|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64567711|NCT01457911|Metformin|metformin|mesh-list
64567712|NCT01457911|Glimepiride|glimepiride|mesh-list
64567713|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64567714|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567715|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64567716|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567717|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
64567718|NCT02893423|Ropivacaine|ropivacaine|mesh-list
64567719|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
64567720|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
64567721|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567722|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567723|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
64567724|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567725|NCT05586919|Ethanol|ethanol|mesh-list
64567726|NCT05586919|Polidocanol|polidocanol|mesh-list
64567727|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64567728|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567729|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567730|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567731|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64567732|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64567734|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64567735|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64567736|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
64567738|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64567749|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567750|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567751|NCT01454089|Gemcitabine|gemcitabine|mesh-list
64567752|NCT01454089|Carboplatin|carboplatin|mesh-list
64567753|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567754|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567755|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
64567756|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567757|NCT01454089|Antiviral Agents|antiviral agents|mesh-ancestor
64567758|NCT01454089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567759|NCT01454089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567760|NCT01454089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64567761|NCT01454089|Immunologic Factors|immunologic factors|mesh-ancestor
64567762|NCT01454089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567764|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
64567765|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64567766|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567767|NCT01458067|GSK2636771|gsk2636771|mesh-list
64567768|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567769|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64567770|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567771|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567772|NCT04942860|Methotrexate|methotrexate|mesh-list
64567773|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64567774|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
64567775|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64567776|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567777|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64567778|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
64567779|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567780|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567781|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
64567782|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567783|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64567788|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64567789|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64567790|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567791|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
64567792|NCT04959786|Ribavirin|ribavirin|mesh-list
64567793|NCT04959786|Ivermectin|ivermectin|mesh-list
64567794|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
64567795|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
64567796|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567797|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
64567798|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567799|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64567800|NCT01452451|Exenatide|exenatide|mesh-list
64567801|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64567802|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567803|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64567804|NCT01452451|Incretins|incretins|mesh-ancestor
64567805|NCT01452451|Hormones|hormones|mesh-ancestor
64567806|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567808|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
64567809|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
64567810|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567811|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567812|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64567813|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64567814|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567815|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
64567816|NCT04951128|Coagulants|coagulants|mesh-ancestor
64567817|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
64357783|NCT03231085|Trace Elements|trace elements|mesh-ancestor
64567820|NCT01458301|Relugolix|relugolix|mesh-list
64567821|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64567822|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
64567823|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64567824|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567829|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64567830|NCT03059238|Celecoxib|celecoxib|mesh-list
64567831|NCT03059238|Parecoxib|parecoxib|mesh-list
64567832|NCT03059238|Oxycodone|oxycodone|mesh-list
64567833|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64567834|NCT03059238|Narcotics|narcotics|mesh-ancestor
64589658|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64567835|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567836|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567837|NCT03059238|Analgesics|analgesics|mesh-ancestor
64567838|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
64567839|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567840|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64567841|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567842|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567843|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567844|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64567845|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64567846|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567847|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567848|NCT01891201|Oxytocin|oxytocin|mesh-list
64567849|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
64567850|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64567851|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567852|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
64567853|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64567854|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64567878|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567879|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
64567880|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64567881|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64567882|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64567883|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64567884|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567885|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567886|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64567887|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64567888|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64567889|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
64567890|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567891|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567892|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64567893|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64567894|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
64567895|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567896|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64567897|NCT04941846|Nimodipine|nimodipine|mesh-list
64567898|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64567899|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64567900|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64567901|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567902|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64567903|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567904|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
64567906|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64567907|NCT01891513|Perindopril|perindopril|mesh-list
64567908|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64567909|NCT01891513|Diuretics|diuretics|mesh-list
64567910|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
64567914|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64567915|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567916|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
64567917|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567918|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64567919|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
64567920|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567921|NCT04843423|Cariprazine|cariprazine|mesh-list
64567922|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64567923|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64567924|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567925|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567926|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64567927|NCT01459081|Zanamivir|zanamivir|mesh-list
64567928|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
64567929|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64567930|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567931|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567932|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
64567933|NCT04421196|Analgesics|analgesics|mesh-list
64567934|NCT04421196|Narcotics|narcotics|mesh-ancestor
64567935|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64567936|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567965|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64567966|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64567967|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64567968|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567969|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567971|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567972|NCT03058224|Analgesics|analgesics|mesh-ancestor
64567973|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
64567974|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64567975|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567976|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
64567977|NCT04957212|Carboplatin|carboplatin|mesh-list
64567978|NCT04957212|Docetaxel|docetaxel|mesh-list
64567979|NCT04957212|Trastuzumab|trastuzumab|mesh-list
64567980|NCT04957212|Pertuzumab|pertuzumab|mesh-list
64567981|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567982|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
64567983|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
64567984|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
64567985|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64567986|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567987|NCT02879617|Durvalumab|durvalumab|mesh-list
64567988|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64567989|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64567990|NCT04390789|Calcium|calcium|mesh-list
64567991|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64567992|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64567993|NCT04948164|Naproxen|naproxen|mesh-list
64567994|NCT04948164|Sumatriptan|sumatriptan|mesh-list
64567995|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64567996|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64567997|NCT04948164|Analgesics|analgesics|mesh-ancestor
64567998|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
64568001|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568002|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568003|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
64568004|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64568005|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568006|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568007|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64568008|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64568009|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64568010|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
64568011|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568012|NCT02808871|Pirfenidone|pirfenidone|mesh-list
64568013|NCT02808871|Analgesics|analgesics|mesh-ancestor
64568014|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
64568015|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568016|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568017|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64568018|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568019|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568020|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568021|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568022|NCT01892683|Propofol|propofol|mesh-list
64568023|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
64568024|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568025|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568026|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64568027|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64568028|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
64568029|NCT01459627|Ticagrelor|ticagrelor|mesh-list
64568030|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64568031|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64568032|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64568033|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64568034|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64568039|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
64568040|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
64568041|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64568042|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568043|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568044|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568045|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64568046|NCT04411836|Primaquine|primaquine|mesh-list
64568047|NCT04411836|Tafenoquine|tafenoquine|mesh-list
64568048|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
64568049|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64568050|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64568051|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568052|NCT02467621|Pantoprazole|pantoprazole|mesh-list
64568053|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64357792|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64357793|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
64568054|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568055|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64568056|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568057|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568059|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64568060|NCT04937946|Narcotics|narcotics|mesh-ancestor
64568061|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568062|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568063|NCT04937946|Analgesics|analgesics|mesh-ancestor
64568064|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
64568065|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568066|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64568067|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64568087|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
64568088|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568089|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568090|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64568091|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64568092|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
64568093|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
64568094|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568095|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64568096|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64568097|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568098|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568099|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
64568100|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64568101|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64568102|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64568103|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568104|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568106|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568107|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568108|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64568109|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568110|NCT02181075|Doxorubicin|doxorubicin|mesh-list
64568111|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64568112|NCT02181075|Liver Extracts|liver extracts|mesh-list
64568113|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64568114|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568115|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64568116|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64568117|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568118|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568119|NCT02181075|Hematinics|hematinics|mesh-ancestor
64568128|NCT01361217|Omeprazole|omeprazole|mesh-list
64568129|NCT01361217|Lovastatin|lovastatin|mesh-list
64568130|NCT01361217|L 647318|l 647318|mesh-list
64568131|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
64568132|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64568133|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64568134|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568135|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568137|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64568138|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64568139|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64568140|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
64568141|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
64568144|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568145|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568146|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64568147|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64568148|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568149|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64568150|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64568151|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
64568152|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64568153|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568154|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64568155|NCT01361217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64568156|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64568157|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568158|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
64568159|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64568170|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64568171|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64568172|NCT04271839|Fluticasone|fluticasone|mesh-list
64568173|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
64568174|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568175|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64568176|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
64568177|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568178|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568180|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
64568181|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
64568182|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64568183|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64568184|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64568185|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64568186|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
64568187|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568188|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568191|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568192|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568223|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
64568224|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64568225|NCT04418856|Methamphetamine|methamphetamine|mesh-list
64568226|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64568227|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568228|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
64568229|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
64568230|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568231|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
64568232|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568233|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568234|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
64568235|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64568236|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64568237|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568238|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64568240|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
64568241|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64568242|NCT01454635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64568243|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64568244|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568245|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568246|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568247|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
64568248|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568249|NCT02196831|Tesamorelin|tesamorelin|mesh-list
64568250|NCT02196831|Growth Substances|growth substances|mesh-ancestor
64568251|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568252|NCT04944966|Lumefantrine|lumefantrine|mesh-list
64568253|NCT04944966|Artemether|artemether|mesh-list
64568254|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64568261|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568262|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64568263|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568265|NCT01363479|Palonosetron|palonosetron|mesh-list
64568266|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568267|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
64568268|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
64568269|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568270|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568271|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568272|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
64568273|NCT01363479|Hormones|hormones|mesh-ancestor
64568274|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568275|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64568276|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568277|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64568278|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64568279|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
64568280|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568281|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568282|NCT02792257|Dronabinol|dronabinol|mesh-list
64568283|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
64568284|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568285|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64568286|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568287|NCT02792257|Analgesics|analgesics|mesh-ancestor
64568288|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
64568289|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568290|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64568304|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568305|NCT02181231|Buprenorphine|buprenorphine|mesh-list
64568306|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64568307|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64568308|NCT02181231|Narcotics|narcotics|mesh-ancestor
64568309|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568310|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568311|NCT02181231|Analgesics|analgesics|mesh-ancestor
64568312|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
64568313|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568314|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64568315|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64380537|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64568316|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64568318|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568319|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568320|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64568321|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
64568322|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64568323|NCT04922034|Amoxicillin|amoxicillin|mesh-list
64568324|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64568325|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568327|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64568353|NCT04407390|Niacin|niacin|mesh-list
64568354|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
64568355|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
64568356|NCT04407390|Vitamins|vitamins|mesh-ancestor
64568357|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
64568358|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568359|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64568360|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
64568361|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568362|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64568363|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
64568364|NCT02181387|Acetaminophen|acetaminophen|mesh-list
64568365|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568366|NCT02181387|Analgesics|analgesics|mesh-ancestor
64568367|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
64568368|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568369|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568370|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
64568371|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
64568372|NCT04921878|Analgesics|analgesics|mesh-ancestor
64568373|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
64568374|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568375|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568376|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568377|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64568378|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64568379|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568380|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568381|NCT04351347|Ivermectin|ivermectin|mesh-list
64568382|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64589711|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
64568383|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568384|NCT04932564|Leflunomide|leflunomide|mesh-list
64568400|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64568401|NCT04921566|Diuretics|diuretics|mesh-ancestor
64568402|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
64568403|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568404|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64568405|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64568406|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568407|NCT02655601|Manganese|manganese|mesh-list
64568408|NCT02655601|Temozolomide|temozolomide|mesh-list
64568409|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64568410|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
64568411|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568412|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568413|NCT02655601|Trace Elements|trace elements|mesh-ancestor
64568414|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
64568415|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568416|NCT02652247|Dimercaprol|dimercaprol|mesh-list
64568417|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
64568418|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
64568419|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568420|NCT04934514|Gemcitabine|gemcitabine|mesh-list
64568421|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568422|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64568423|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
64568427|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568428|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568429|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
64568430|NCT04934514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568431|NCT01365819|Varenicline|varenicline|mesh-list
64568432|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64568433|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64568434|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
64568435|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568436|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568437|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568439|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
64568440|NCT02635555|Ephedrine|ephedrine|mesh-list
64568441|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64568442|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
64568443|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
64568444|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568445|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568446|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
64568447|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64568448|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
64568449|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
64568450|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64568451|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64568452|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64568453|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
64568454|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568455|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568456|NCT02635555|Protective Agents|protective agents|mesh-ancestor
64568457|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64568458|NCT01893541|Propranolol|propranolol|mesh-list
64568459|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64568460|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64568461|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
64568477|NCT02771197|Melphalan|melphalan|mesh-list
64568478|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568479|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568480|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568481|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568482|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
64568483|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568484|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64568485|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
64568486|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64568487|NCT01369875|Aldesleukin|aldesleukin|mesh-list
64568488|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
64568489|NCT01369875|Fludarabine|fludarabine|mesh-list
64568490|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568491|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
64568492|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568493|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568494|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64568495|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
64568496|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568497|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568498|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64568499|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64568500|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64568526|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568527|NCT02755597|Dexamethasone|dexamethasone|mesh-list
64568529|NCT02755597|Venetoclax|venetoclax|mesh-list
64568530|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568531|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
64568532|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
64568533|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568534|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568535|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568536|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
64568537|NCT02755597|Hormones|hormones|mesh-ancestor
64568538|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568539|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64568540|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568541|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
64568542|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64568543|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64568544|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
64568545|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568546|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64568547|NCT04920708|Fulvestrant|fulvestrant|mesh-list
64568548|NCT04920708|Palbociclib|palbociclib|mesh-list
64568549|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64568550|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568551|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64568552|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64568553|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
64568571|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568572|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64568573|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64568574|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568575|NCT04405596|Ambroxol|ambroxol|mesh-list
64568576|NCT04405596|Expectorants|expectorants|mesh-ancestor
64568577|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
64568578|NCT01375491|Doxycycline|doxycycline|mesh-list
64568579|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64568580|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568581|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
64568582|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64568583|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64568584|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
64568585|NCT02591251|Povidone|povidone|mesh-list
64568586|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64568587|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
64568588|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
64568589|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64568590|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568591|NCT01325181|Ranibizumab|ranibizumab|mesh-list
64568592|NCT01325181|Verteporfin|verteporfin|mesh-list
64568593|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64568594|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64568595|NCT01325181|Growth Substances|growth substances|mesh-ancestor
64568596|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568597|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
64568598|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568599|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64568600|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
64568601|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64568602|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64568603|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568604|NCT04238637|Durvalumab|durvalumab|mesh-list
64568605|NCT04238637|Tremelimumab|tremelimumab|mesh-list
64568606|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568607|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568608|NCT02588443|Gemcitabine|gemcitabine|mesh-list
64568609|NCT02588443|Paclitaxel|paclitaxel|mesh-list
64568610|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64568611|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568613|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
64568614|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
64568615|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568616|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64568617|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
64568618|NCT02588443|Antiviral Agents|antiviral agents|mesh-ancestor
64568619|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568671|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64568672|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568673|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
64568674|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
64568675|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
64568676|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568677|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64568679|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
64568680|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568681|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568682|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568683|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
64568684|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568685|NCT04037241|Antidotes|antidotes|mesh-ancestor
64568686|NCT04037241|Protective Agents|protective agents|mesh-ancestor
64568687|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
64568688|NCT04037241|Vitamins|vitamins|mesh-ancestor
64568689|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
64568690|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64568691|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64568692|NCT04912128|Growth Substances|growth substances|mesh-ancestor
64568693|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568694|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
64568695|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568696|NCT01327677|Fentanyl|fentanyl|mesh-list
64568698|NCT01327677|Narcotics|narcotics|mesh-ancestor
64568721|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
64568722|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64568723|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64568724|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64568725|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568726|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568727|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
64568728|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64568729|NCT04918524|Aspirin|aspirin|mesh-list
64568730|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
64568731|NCT04918524|Prednisone|prednisone|mesh-list
64568732|NCT04918524|Heparin|heparin|mesh-list
64568733|NCT04918524|Enoxaparin|enoxaparin|mesh-list
64568734|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64568735|NCT04918524|Tinzaparin|tinzaparin|mesh-list
64568736|NCT04918524|Dalteparin|dalteparin|mesh-list
64568737|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568738|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
64568739|NCT04918524|Hormones|hormones|mesh-ancestor
64568740|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568741|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568742|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64568743|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568744|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64568745|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568746|NCT04918524|Analgesics|analgesics|mesh-ancestor
64568747|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
64568748|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568749|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568750|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64568755|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568767|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
64568768|NCT05586763|Metoclopramide|metoclopramide|mesh-list
64568769|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
64568770|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
64568771|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568772|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568773|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568774|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64568775|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64568776|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
64568778|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568779|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
64568780|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
64568781|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64568782|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
64568783|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
64568784|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64568785|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64568786|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64568787|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568788|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
64568789|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
64568790|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
64568791|NCT01328769|Febuxostat|febuxostat|mesh-list
64568792|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
64568793|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568794|NCT02552641|Amoxicillin|amoxicillin|mesh-list
64568795|NCT02552641|Clarithromycin|clarithromycin|mesh-list
64568796|NCT02552641|Esomeprazole|esomeprazole|mesh-list
64568797|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64568798|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568812|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568813|NCT02551237|Capecitabine|capecitabine|mesh-list
64568814|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64568815|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
64568816|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568817|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568818|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
64568819|NCT01378299|Testosterone|testosterone|mesh-list
64568820|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
64568821|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
64568822|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64568823|NCT01378299|Androgens|androgens|mesh-ancestor
64568824|NCT01378299|Hormones|hormones|mesh-ancestor
64568825|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568826|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568827|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64568828|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568829|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
64568830|NCT04929522|Anesthetics|anesthetics|mesh-list
64568831|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64568832|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568833|NCT02549833|Poly I-C|poly i-c|mesh-list
64568834|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64568835|NCT02549833|Poly ICLC|poly iclc|mesh-list
64568836|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
64568837|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
64568838|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568839|NCT02549833|Laxatives|laxatives|mesh-ancestor
64568840|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568841|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
64568842|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568844|NCT02542969|Simvastatin|simvastatin|mesh-list
64568855|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
64568856|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568857|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568858|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64568859|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
64568860|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358356|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568861|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568862|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64568863|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568864|NCT04928586|Pirfenidone|pirfenidone|mesh-list
64568865|NCT04928586|Analgesics|analgesics|mesh-ancestor
64568866|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
64568867|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568868|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568869|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64568870|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64568871|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568872|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568873|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568874|NCT03054168|Goserelin|goserelin|mesh-list
64568875|NCT03054168|Testosterone|testosterone|mesh-list
64568906|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
64568907|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
64568908|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568909|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64568910|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64568911|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64568912|NCT03053856|Paclitaxel|paclitaxel|mesh-list
64568913|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
64568914|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64568915|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568916|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
64358416|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64358417|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358418|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358419|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64358420|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358421|NCT04525729|Rituximab|rituximab|mesh-list
64358427|NCT04525495|Dopamine|dopamine|mesh-list
64568917|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
64568918|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
64568919|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568920|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64568922|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
64568924|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568925|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
64568926|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568927|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64568928|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64568929|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
64568930|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568931|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568932|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64568933|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64568934|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589775|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568935|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64568951|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64568952|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
64568953|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568954|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64568955|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64568956|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
64568957|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
64568958|NCT03053388|Protective Agents|protective agents|mesh-ancestor
64568959|NCT03053544|Metformin|metformin|mesh-list
64568960|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64568961|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568962|NCT02384083|Dexamethasone|dexamethasone|mesh-list
64568963|NCT02384083|Pomalidomide|pomalidomide|mesh-list
64568964|NCT02384083|Filanesib|filanesib|mesh-list
64568965|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64568966|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
64568967|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
64568968|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64568969|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568970|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64568971|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
64568972|NCT02384083|Hormones|hormones|mesh-ancestor
64568973|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64568974|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64568975|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568976|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
64568977|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64568978|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64568979|NCT02384083|Growth Substances|growth substances|mesh-ancestor
64568980|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
64568981|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
64568982|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64568983|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568992|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64568993|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64568994|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
64568995|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64568996|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64568997|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
64568998|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64568999|NCT02484391|Analgesics|analgesics|mesh-ancestor
64569000|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
64569001|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569002|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569003|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569004|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569005|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
64569006|NCT02484391|Protective Agents|protective agents|mesh-ancestor
64569007|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
64569009|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
64569010|NCT03053622|Mirikizumab|mirikizumab|mesh-list
64569011|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64569012|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64569013|NCT03053622|Analgesics|analgesics|mesh-ancestor
64569014|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
64569015|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569016|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569017|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569018|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569019|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64569038|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
64569039|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569040|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569041|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64569043|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
64569044|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569045|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
64569046|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64569047|NCT02460445|Cyproterone|cyproterone|mesh-list
64569048|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64569049|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64569050|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64569051|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
64569052|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64569053|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569054|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64569055|NCT02460445|Estrogens|estrogens|mesh-ancestor
64569056|NCT02460445|Hormones|hormones|mesh-ancestor
64569057|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569058|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
64569059|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
64569060|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569061|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64569062|NCT02455687|Budesonide|budesonide|mesh-list
64569063|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
64569064|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569065|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64569066|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
64569067|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569068|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569069|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64569080|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64569081|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64569082|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569083|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64569084|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
64569085|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64569086|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
64569087|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569088|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569089|NCT02358967|Vitamin E|vitamin e|mesh-list
64569090|NCT02358967|Tocopherols|tocopherols|mesh-list
64569091|NCT02358967|Tocotrienols|tocotrienols|mesh-list
64569092|NCT02358967|Vitamins|vitamins|mesh-ancestor
64569093|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
64569094|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569095|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
64569096|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569097|NCT02358967|Protective Agents|protective agents|mesh-ancestor
64569098|NCT03052998|Ivermectin|ivermectin|mesh-list
64569099|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
64358557|NCT04521517|Imidacloprid|imidacloprid|mesh-list
64569118|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569119|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569121|NCT02352337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569122|NCT02352337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569123|NCT02352337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569124|NCT02352337|Immunologic Factors|immunologic factors|mesh-ancestor
64569125|NCT02352337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569126|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
64569127|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569128|NCT02827201|Gemcitabine|gemcitabine|mesh-list
64569129|NCT02827201|Paclitaxel|paclitaxel|mesh-list
64569130|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64569131|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569132|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
64569133|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
64569134|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
64569135|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569136|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569137|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
64569138|NCT02827201|Antiviral Agents|antiviral agents|mesh-ancestor
64569139|NCT02827201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569140|NCT02827201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569141|NCT02827201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569150|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64569151|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569152|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64569153|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569154|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
64569155|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
64569156|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569157|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
64569158|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64569159|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
64569160|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64569162|NCT01378377|Sirolimus|sirolimus|mesh-list
64569163|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64569164|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569165|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64569166|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569167|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
64569168|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569169|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
64569170|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569171|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
64569172|NCT01378377|Vitamins|vitamins|mesh-ancestor
64569173|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
64569186|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569187|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64569188|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
64569189|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64569190|NCT03009045|Tedizolid|tedizolid|mesh-list
64569191|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
64569192|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
64569193|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64569194|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569195|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64569196|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569197|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569198|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
64569200|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64569201|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64569202|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569203|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64569204|NCT03056274|Metformin|metformin|mesh-list
64569205|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64569206|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359040|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64359041|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569207|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569208|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64569210|NCT03056118|Aspirin|aspirin|mesh-list
64569211|NCT03056118|Clopidogrel|clopidogrel|mesh-list
64569212|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64569213|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64569214|NCT03056118|Analgesics|analgesics|mesh-ancestor
64569215|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
64569216|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569228|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64569229|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64569230|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
64569231|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569232|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64569233|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64569234|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
64569235|NCT00987935|Sorafenib|sorafenib|mesh-list
64569236|NCT00987935|Nintedanib|nintedanib|mesh-list
64569237|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569238|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64569239|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569240|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569241|NCT00987467|Cyclosporine|cyclosporine|mesh-list
64569242|NCT00987467|Cyclosporins|cyclosporins|mesh-list
64569243|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569244|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569245|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569246|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
64569282|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569283|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64569284|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64569285|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64569286|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569287|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569288|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64569289|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
64569290|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64569291|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569292|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
64569293|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64569294|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64569295|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64569296|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64569297|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64569298|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64569299|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64569300|NCT04914936|Antacids|antacids|mesh-ancestor
64569301|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569302|NCT04914390|Paclitaxel|paclitaxel|mesh-list
64569303|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64569304|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569305|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
64569306|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
64569307|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
64569308|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569309|NCT03054948|SMOFlipid|smoflipid|mesh-list
64569325|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569326|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
64569327|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64569328|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64569329|NCT01383759|Dexamethasone|dexamethasone|mesh-list
64569330|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
64569331|NCT01383759|Bortezomib|bortezomib|mesh-list
64569332|NCT01383759|BB 1101|bb 1101|mesh-list
64569333|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569334|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
64569335|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
64569336|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569337|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294585|NCT04818320|Favipiravir|favipiravir|mesh-list
64569338|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64569339|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
64569340|NCT01383759|Hormones|hormones|mesh-ancestor
64569341|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569342|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64569343|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569344|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
64569345|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569346|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569347|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
64569348|NCT01384539|Vitamin D|vitamin d|mesh-list
64569349|NCT01384539|Calcitriol|calcitriol|mesh-list
64569352|NCT01384539|Vitamins|vitamins|mesh-ancestor
64569374|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64569376|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569377|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
64569378|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569379|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64569380|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64569381|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64569382|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64569383|NCT00985751|Vaccines|vaccines|mesh-list
64569384|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64569385|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
64569386|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569387|NCT02337985|Prednisone|prednisone|mesh-list
64569388|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
64569389|NCT02337985|Rituximab|rituximab|mesh-list
64569390|NCT02337985|Doxorubicin|doxorubicin|mesh-list
64569391|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64569392|NCT02337985|Etoposide|etoposide|mesh-list
64569393|NCT02337985|Vincristine|vincristine|mesh-list
64569394|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569395|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
64569396|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569397|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569398|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64569424|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64569425|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64569426|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
64569427|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569428|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569429|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64569430|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64569431|NCT04884516|Vitamin A|vitamin a|mesh-list
64569432|NCT04884516|Vitamins|vitamins|mesh-ancestor
64569433|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
64569434|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569435|NCT04884282|Docetaxel|docetaxel|mesh-list
64569436|NCT04884282|Nivolumab|nivolumab|mesh-list
64569437|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569438|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
64569439|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
64569440|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
64359056|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64569441|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569442|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569443|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64569445|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
64569446|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64569452|NCT02422381|Gemcitabine|gemcitabine|mesh-list
64569478|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569479|NCT01596504|Metformin|metformin|mesh-list
64569480|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
64569481|NCT01596504|Liraglutide|liraglutide|mesh-list
64569482|NCT01596504|Lixisenatide|lixisenatide|mesh-list
64569483|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64569484|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569485|NCT01596504|Incretins|incretins|mesh-ancestor
64569486|NCT01596504|Hormones|hormones|mesh-ancestor
64569487|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569488|NCT02394769|Aspirin|aspirin|mesh-list
64569489|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64569490|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64569491|NCT02394769|Analgesics|analgesics|mesh-ancestor
64569492|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
64569493|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569494|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569495|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569496|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569534|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
64569535|NCT02394535|Paclitaxel|paclitaxel|mesh-list
64569536|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64569537|NCT02394535|Capecitabine|capecitabine|mesh-list
64569538|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64569539|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569540|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
64569541|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
64569542|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
64569543|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569544|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569545|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
64569546|NCT02285959|Bevacizumab|bevacizumab|mesh-list
64569547|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569548|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569549|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64569550|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64569551|NCT02285959|Growth Substances|growth substances|mesh-ancestor
64569552|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569553|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
64569554|NCT01404429|Methotrexate|methotrexate|mesh-list
64569555|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64569556|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
64569557|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64569558|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569559|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569560|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
64569561|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569562|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569563|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
64569577|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569578|NCT05026567|Midazolam|midazolam|mesh-list
64569579|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64569580|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64569581|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64569582|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569583|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64569584|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64359244|NCT03353857|Hormones|hormones|mesh-ancestor
64569585|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64569586|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64569587|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
64569589|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
64569590|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
64569591|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569592|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569593|NCT01391013|Ritonavir|ritonavir|mesh-list
64569594|NCT01391013|Darunavir|darunavir|mesh-list
64569595|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64569596|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64569597|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64569598|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
64569599|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569600|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569601|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64569602|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64569603|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
64569604|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569605|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64569606|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64569621|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
64569622|NCT04899570|Rituximab|rituximab|mesh-list
64569623|NCT04899570|Epirubicin|epirubicin|mesh-list
64569624|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
64569625|NCT04899570|Vindesine|vindesine|mesh-list
64569626|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569627|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
64569628|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569629|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569630|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64569631|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
64569632|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569633|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569634|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64569635|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64569636|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569637|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
64569638|NCT04899570|Hormones|hormones|mesh-ancestor
64569639|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569640|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64569641|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64569642|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64569643|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64569673|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64569674|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
64569675|NCT01391325|Protective Agents|protective agents|mesh-ancestor
64569676|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569677|NCT01980823|Metformin|metformin|mesh-list
64569678|NCT01980823|Atorvastatin|atorvastatin|mesh-list
64569679|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64569680|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569681|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64569682|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64569683|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
64569684|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569685|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64569686|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64569687|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569688|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64569689|NCT01976065|Metronidazole|metronidazole|mesh-list
64569690|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
64569691|NCT01976065|Minocycline|minocycline|mesh-list
64569699|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569700|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64569701|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64569702|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
64569703|NCT04891458|Anesthetics|anesthetics|mesh-list
64569704|NCT04891458|Propofol|propofol|mesh-list
64569716|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64569717|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
64569718|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569719|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569721|NCT04899414|Azacitidine|azacitidine|mesh-list
64569722|NCT04899414|Pegaspargase|pegaspargase|mesh-list
64569723|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569724|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
64569725|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
64569726|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569727|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569728|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64569729|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
64569730|NCT04899414|Hormones|hormones|mesh-ancestor
64569731|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569732|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64569733|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569734|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569735|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
64569736|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569737|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569738|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
64569739|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64569740|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64569741|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569742|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
64569743|NCT03008655|Coagulants|coagulants|mesh-ancestor
64569745|NCT01894633|Amebicides|amebicides|mesh-ancestor
64569746|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64569747|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64569748|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359321|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569757|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64569759|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569760|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569761|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64569762|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
64569763|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64569764|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64569765|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64569766|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
64569767|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569768|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569769|NCT01335789|Oxytocin|oxytocin|mesh-list
64569770|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
64569771|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64569772|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569773|NCT02202135|Vancomycin|vancomycin|mesh-list
64569774|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64569775|NCT02202135|Aztreonam|aztreonam|mesh-list
64569776|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64569777|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569778|NCT01335867|Vigabatrin|vigabatrin|mesh-list
64569779|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
64569780|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569781|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569782|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
64569783|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569784|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569789|NCT00985439|Diclofenac|diclofenac|mesh-list
64295038|NCT04646967|Analgesics|analgesics|mesh-ancestor
64569790|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64569791|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64569792|NCT00985439|Analgesics|analgesics|mesh-ancestor
64569793|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
64569794|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569795|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569796|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569797|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569798|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64569799|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64569800|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569801|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569802|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
64569803|NCT02984111|Hematinics|hematinics|mesh-ancestor
64569804|NCT04412148|Triamcinolone|triamcinolone|mesh-list
64569835|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
64569836|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569837|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569838|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64569839|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
64569841|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64569842|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64569843|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569844|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569845|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
64569846|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569847|NCT01525069|Antiviral Agents|antiviral agents|mesh-ancestor
64569848|NCT01525069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569849|NCT01525069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569850|NCT01525069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64569851|NCT01525069|Immunologic Factors|immunologic factors|mesh-ancestor
64569853|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
64569854|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569855|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64569856|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64381987|NCT02425865|Golimumab|golimumab|mesh-list
64569857|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64569858|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64569859|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64569860|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
64569861|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569864|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
64569879|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569880|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
64569881|NCT01894867|Antacids|antacids|mesh-ancestor
64569882|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569883|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64569884|NCT01521403|Metronidazole|metronidazole|mesh-list
64569885|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569886|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64569887|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64569888|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64569889|NCT04881942|Menthol|menthol|mesh-list
64569890|NCT04881942|Nicotine|nicotine|mesh-list
64569891|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64569892|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
64569893|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64569894|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569895|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64569896|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64569897|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
64569898|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64569899|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569900|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
64569901|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
64569902|NCT03074045|Drospirenone|drospirenone|mesh-list
64569903|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
64569904|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64569931|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64569932|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64569933|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
64569934|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569935|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569936|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64569937|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64569938|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
64569939|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64569940|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295180|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
64569941|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64569942|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64569943|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
64569944|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64569945|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569946|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
64569947|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64569948|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
64569949|NCT03071861|Hematinics|hematinics|mesh-ancestor
64569950|NCT04126811|Apatinib|apatinib|mesh-list
64569951|NCT04126811|Ifosfamide|ifosfamide|mesh-list
64569952|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
64569953|NCT04126811|Pirarubicin|pirarubicin|mesh-list
64569954|NCT04126811|Doxorubicin|doxorubicin|mesh-list
64569955|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569956|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64569957|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569958|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569959|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64569960|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
64569961|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64569975|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64569976|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64569977|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
64569978|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64569979|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64569980|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64569981|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64569983|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64569984|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64569985|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64569986|NCT02230969|Interferons|interferons|mesh-list
64569987|NCT02230969|Interferon-beta|interferon-beta|mesh-list
64569988|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
64569989|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64569990|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
64569991|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64569992|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
64569993|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64569999|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
64570000|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570001|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570002|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570003|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570004|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64570015|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
64570016|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570017|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
64570018|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64570019|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
64570021|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64570022|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570023|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64570024|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570025|NCT01595646|Insulin|insulin|mesh-list
64570026|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64570027|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
64570028|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64570029|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570030|NCT01907191|Bupivacaine|bupivacaine|mesh-list
64570031|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
64570032|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
64570033|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64570060|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64570061|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570062|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
64570063|NCT02317549|Coagulants|coagulants|mesh-ancestor
64570064|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
64570065|NCT05583643|Atorvastatin|atorvastatin|mesh-list
64570066|NCT05583643|Calcium|calcium|mesh-list
64570067|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64570068|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570069|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64570070|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64570071|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64570072|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
64570073|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570074|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64570075|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64570076|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359441|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570077|NCT02225275|Lenalidomide|lenalidomide|mesh-list
64570078|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
64570079|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
64570080|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570081|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64570082|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64570083|NCT02225275|Growth Substances|growth substances|mesh-ancestor
64570084|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
64570085|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570086|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570087|NCT01897441|Paclitaxel|paclitaxel|mesh-list
64570088|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
64570089|NCT01897441|Doxorubicin|doxorubicin|mesh-list
64570090|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64570091|NCT01897441|Trastuzumab|trastuzumab|mesh-list
64570092|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64570093|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64570095|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
64570102|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570103|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570104|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
64570105|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570106|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570107|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64570108|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
64570109|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64570110|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64570111|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64570112|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64570113|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570114|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64570115|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64570116|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
64570117|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570118|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64570119|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64570120|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
64570121|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
64570122|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570151|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64570152|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64570153|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570154|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
64570155|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570156|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64570157|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
64570158|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
64570159|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
64570160|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570161|NCT04897386|Pemetrexed|pemetrexed|mesh-list
64570162|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570163|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570164|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295408|NCT02470767|Anticoagulants|anticoagulants|mesh-list
64570165|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64570166|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64570167|NCT02213107|Dutasteride|dutasteride|mesh-list
64570168|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64570169|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64570170|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570171|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570172|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
64570173|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570174|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570175|NCT04879446|Mitogens|mitogens|mesh-list
64570176|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570177|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570178|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
64570179|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64570180|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64570181|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570182|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
64570183|NCT02618382|Coagulants|coagulants|mesh-ancestor
64570186|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570187|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570188|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570190|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
64570191|NCT02177071|Azathioprine|azathioprine|mesh-list
64570192|NCT02177071|Infliximab|infliximab|mesh-list
64570193|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64570194|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
64570195|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64570196|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570197|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64570198|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
64570199|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570200|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570201|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
64570202|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570203|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64570204|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570205|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
64570206|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570207|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64570208|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570209|NCT02166463|Prednisone|prednisone|mesh-list
64570210|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
64570211|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64570212|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64570236|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64570237|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
64570238|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570239|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570240|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64570241|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64570242|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64570243|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64570244|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570245|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570246|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
64570247|NCT02166463|Hormones|hormones|mesh-ancestor
64359466|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64570248|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570249|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64570250|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64570251|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
64570252|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
64570253|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570254|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
64570255|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
64570256|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570257|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570258|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64589869|NCT03988387|Tenofovir|tenofovir|mesh-list
64570259|NCT02166463|Protective Agents|protective agents|mesh-ancestor
64570260|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
64570261|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
64570262|NCT04889196|Fluorides|fluorides|mesh-list
64570263|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
64570264|NCT04889196|Protective Agents|protective agents|mesh-ancestor
64570265|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570266|NCT03049176|Tenofovir|tenofovir|mesh-list
64570267|NCT03049176|Emtricitabine|emtricitabine|mesh-list
64570268|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64570276|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64570277|NCT01895023|Midazolam|midazolam|mesh-list
64570278|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
64570279|NCT01895023|GABA Modulators|gaba modulators|mesh-list
64570280|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64570281|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64570282|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570283|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64570284|NCT01895023|Analgesics|analgesics|mesh-ancestor
64570285|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
64570286|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570287|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64570288|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64570289|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64570290|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
64570291|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570292|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570293|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64570294|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64570295|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64570296|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64570297|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64570298|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
64570299|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
64570300|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
64570301|NCT04888728|Nebivolol|nebivolol|mesh-list
64570302|NCT04888728|Paroxetine|paroxetine|mesh-list
64570303|NCT04888728|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64570304|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64570305|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64570323|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570324|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570325|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570326|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570328|NCT01428973|Sirolimus|sirolimus|mesh-list
64570329|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64570330|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570331|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64570332|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
64570333|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64570367|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64570368|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570369|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
64570370|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
64359518|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64359519|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64359520|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64570373|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64570374|NCT01475643|Protective Agents|protective agents|mesh-ancestor
64570375|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64570376|NCT01846663|Rifaximin|rifaximin|mesh-list
64570377|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64570378|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570379|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570380|NCT03004001|Atorvastatin|atorvastatin|mesh-list
64570381|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64570382|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64570383|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64570384|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
64570385|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570386|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64570387|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64570388|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570389|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
64570390|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570391|NCT04395222|Fludarabine|fludarabine|mesh-list
64570392|NCT04395222|Melphalan|melphalan|mesh-list
64570393|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
64570394|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64570415|NCT04124081|Entecavir|entecavir|mesh-list
64570417|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570418|NCT04123925|Nivolumab|nivolumab|mesh-list
64570419|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570420|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570421|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570422|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570423|NCT04759079|Antiemetics|antiemetics|mesh-list
64570424|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
64570425|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570426|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570427|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570428|NCT03048942|Paclitaxel|paclitaxel|mesh-list
64570429|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64570430|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570431|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
64570432|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
64570433|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570434|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570435|NCT04393025|Clopidogrel|clopidogrel|mesh-list
64570436|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570437|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570438|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64570439|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64570440|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64570447|NCT05580445|Gemcitabine|gemcitabine|mesh-list
64570450|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
64570451|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570452|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570467|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
64570468|NCT02143219|Leucovorin|leucovorin|mesh-list
64570469|NCT02143219|Folic Acid|folic acid|mesh-list
64570478|NCT02143219|Antidotes|antidotes|mesh-ancestor
64570479|NCT02143219|Protective Agents|protective agents|mesh-ancestor
64570480|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570481|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
64570482|NCT02143219|Vitamins|vitamins|mesh-ancestor
64570483|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
64570484|NCT02143219|Hematinics|hematinics|mesh-ancestor
64570490|NCT04122599|Melatonin|melatonin|mesh-list
64570514|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64570515|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64570516|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570517|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
64570518|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570519|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570520|NCT03830957|Metoprolol|metoprolol|mesh-list
64570521|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64570522|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64570523|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
64570524|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
64570525|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570526|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570527|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64570528|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64570529|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64570530|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
64570531|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359881|NCT04486911|Letrozole|letrozole|mesh-list
64570599|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570601|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64570602|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64570603|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64570604|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64570605|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570607|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570608|NCT05256342|Analgesics|analgesics|mesh-ancestor
64570609|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
64570610|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570611|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
64360037|NCT03955575|Incretins|incretins|mesh-ancestor
64570628|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64570629|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570630|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64570631|NCT04123379|Nivolumab|nivolumab|mesh-list
64570632|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570633|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570634|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570635|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570636|NCT01895881|Estradiol|estradiol|mesh-list
64570637|NCT01895881|Estrogens|estrogens|mesh-ancestor
64570677|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570678|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570680|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
64570681|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570682|NCT04885764|Vaccines|vaccines|mesh-list
64570683|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
64570684|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570685|NCT04311606|Aflibercept|aflibercept|mesh-list
64570686|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64570696|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64570697|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570698|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64570699|NCT02981069|Incretins|incretins|mesh-ancestor
64570701|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570702|NCT02980835|Dexamethasone|dexamethasone|mesh-list
64570703|NCT02980835|Epinephrine|epinephrine|mesh-list
64570704|NCT02980835|Ropivacaine|ropivacaine|mesh-list
64570705|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570706|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
64570707|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
64570708|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570709|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570710|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570711|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
64570712|NCT02980835|Hormones|hormones|mesh-ancestor
64570713|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570735|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570736|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
64570737|NCT03824327|Urological Agents|urological agents|mesh-ancestor
64570738|NCT04871724|Fluconazole|fluconazole|mesh-list
64570739|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
64570740|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570741|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64570742|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64570743|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570744|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570745|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64570746|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
64570747|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570748|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570749|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64570750|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64570751|NCT04871802|Taxifolin|taxifolin|mesh-list
64570752|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64570753|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64570754|NCT04871802|Analgesics|analgesics|mesh-ancestor
64570755|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
64570756|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570757|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570758|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570759|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64570760|NCT04871646|Nafamostat|nafamostat|mesh-list
64570761|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64570762|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64570763|NCT04871646|Analgesics|analgesics|mesh-ancestor
64570764|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
64570765|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570766|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570767|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64570770|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
64570771|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570772|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570773|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64570774|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64570775|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64570776|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64570777|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
64570778|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
64570779|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570780|NCT03589014|Propranolol|propranolol|mesh-list
64570781|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64570782|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64570783|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
64570784|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570785|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570786|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570787|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64570788|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64570789|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
64570797|NCT04884906|Paclitaxel|paclitaxel|mesh-list
64570798|NCT04884906|Cisplatin|cisplatin|mesh-list
64570799|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64570800|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570801|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
64570802|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
64570803|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
64570804|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570805|NCT03826589|Avelumab|avelumab|mesh-list
64570806|NCT03826589|Axitinib|axitinib|mesh-list
64570807|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570808|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570809|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64570810|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570811|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570812|NCT03046758|Metronidazole|metronidazole|mesh-list
64570813|NCT03046758|Fosfomycin|fosfomycin|mesh-list
64570814|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570815|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64570816|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64570817|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64570818|NCT04382664|Nivolumab|nivolumab|mesh-list
64570819|NCT04382664|Ipilimumab|ipilimumab|mesh-list
64570820|NCT04382664|Sargramostim|sargramostim|mesh-list
64570821|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570822|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360122|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64360123|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
64570832|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
64570833|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570834|NCT03825887|Morphine|morphine|mesh-list
64570835|NCT03825887|Nalbuphine|nalbuphine|mesh-list
64570836|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64570837|NCT03825887|Narcotics|narcotics|mesh-ancestor
64383050|NCT02414009|Capecitabine|capecitabine|mesh-list
64570838|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64570839|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570840|NCT03825887|Analgesics|analgesics|mesh-ancestor
64570841|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
64296080|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
64570843|NCT03825809|Acetaminophen|acetaminophen|mesh-list
64570861|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570862|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570864|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64570865|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64570866|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64570867|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64570868|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64570869|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64570870|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570871|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
64570872|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64570873|NCT03825809|Narcotics|narcotics|mesh-ancestor
64570874|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
64570875|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
64570876|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64570877|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
64570878|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
64570879|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64570880|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64570881|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64570882|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64570883|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64570884|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
64570885|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
64570886|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
64570887|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
64570888|NCT03824717|Ropivacaine|ropivacaine|mesh-list
64570889|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
64334746|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64334747|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334748|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64334749|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334750|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64570895|NCT04392557|Metformin|metformin|mesh-list
64570896|NCT04392557|Pioglitazone|pioglitazone|mesh-list
64570897|NCT04392557|Alogliptin|alogliptin|mesh-list
64570898|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64570899|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570900|NCT04392557|Incretins|incretins|mesh-ancestor
64570901|NCT04392557|Hormones|hormones|mesh-ancestor
64570902|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64570903|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64570904|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
64570905|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570906|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570907|NCT02115373|Tepotinib|tepotinib|mesh-list
64570908|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570909|NCT02948543|Mitomycins|mitomycins|mesh-list
64570910|NCT02948543|Mitomycin|mitomycin|mesh-list
64570911|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64570912|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570913|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
64570914|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570915|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64360260|NCT03218137|Adenosine|adenosine|mesh-list
64570916|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64570917|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
64296154|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
64570918|NCT03824171|Vitamin D|vitamin d|mesh-list
64570919|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64570921|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570931|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
64570932|NCT02079181|Protective Agents|protective agents|mesh-ancestor
64570933|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570935|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
64570936|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64570937|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64570938|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
64570939|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
64570940|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570941|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570942|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
64570943|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64570944|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
64570945|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
64570946|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64570947|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64570948|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64570949|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
64570950|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64570951|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570952|NCT02946125|Protective Agents|protective agents|mesh-ancestor
64570953|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64570954|NCT01895257|Leucovorin|leucovorin|mesh-list
64570955|NCT01895257|Fluorouracil|fluorouracil|mesh-list
64570956|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
64570957|NCT01895257|Antidotes|antidotes|mesh-ancestor
64570958|NCT01895257|Protective Agents|protective agents|mesh-ancestor
64570960|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
64570980|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570981|NCT04392713|Ivermectin|ivermectin|mesh-list
64570982|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64570983|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64570984|NCT03823625|Nivolumab|nivolumab|mesh-list
64570985|NCT03823625|Ipilimumab|ipilimumab|mesh-list
64570986|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64570987|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64570988|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64570989|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64570990|NCT02053909|Aspirin|aspirin|mesh-list
64570991|NCT02053909|Ticagrelor|ticagrelor|mesh-list
64570992|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64570993|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64570994|NCT02053909|Analgesics|analgesics|mesh-ancestor
64570995|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
64570996|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64570997|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64570998|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571000|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64571001|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64571002|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571003|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64571004|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64571005|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571006|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
64571026|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571027|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
64571028|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571029|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571030|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64571056|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571057|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
64360272|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360273|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64589896|NCT00478361|Doxorubicin|doxorubicin|mesh-list
64589897|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64360274|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64360275|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64571065|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64571066|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64571067|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296307|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
64571068|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571069|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571070|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571071|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
64571072|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64571073|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
64571074|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64571075|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
64571076|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571077|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64571078|NCT02839265|Protective Agents|protective agents|mesh-ancestor
64571079|NCT00988247|Beclomethasone|beclomethasone|mesh-list
64571080|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571081|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
64571082|NCT00988247|Hormones|hormones|mesh-ancestor
64571090|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64571091|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571092|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571093|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64571094|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64571095|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
64571096|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571097|NCT03044808|Lidocaine|lidocaine|mesh-list
64571098|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
64571099|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
64571100|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571101|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571102|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
64571103|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571104|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64571105|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64571106|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64571107|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571108|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571109|NCT04430166|Antibodies|antibodies|mesh-list
64571110|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64571111|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
64571112|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571113|NCT04877106|Metformin|metformin|mesh-list
64571114|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64571115|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64571116|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571117|NCT04877106|Incretins|incretins|mesh-ancestor
64571118|NCT04877106|Hormones|hormones|mesh-ancestor
64586303|NCT00426517|Sirolimus|sirolimus|mesh-list
64586304|NCT00426517|Busulfan|busulfan|mesh-list
64571134|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571135|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64571136|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64571137|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571138|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571139|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64571140|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
64571141|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571142|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383630|NCT02408003|Simendan|simendan|mesh-list
64571143|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64571144|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64334751|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334752|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334753|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64334754|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64334755|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64334756|NCT02296021|Antacids|antacids|mesh-ancestor
64571145|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64571146|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64571148|NCT04865250|Carboplatin|carboplatin|mesh-list
64571149|NCT04865250|Atezolizumab|atezolizumab|mesh-list
64571150|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64571151|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571152|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
64571153|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
64571154|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
64571155|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571156|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
64571157|NCT04865562|Testosterone|testosterone|mesh-list
64571158|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
64571159|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
64571160|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64571161|NCT04865562|Androgens|androgens|mesh-ancestor
64571162|NCT04865562|Hormones|hormones|mesh-ancestor
64571164|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571165|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64571167|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
64571168|NCT04864782|Paclitaxel|paclitaxel|mesh-list
64571169|NCT04864782|Carboplatin|carboplatin|mesh-list
64571170|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64571171|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571172|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
64571173|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
64571174|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
64571175|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571176|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64571177|NCT04875702|Allopurinol|allopurinol|mesh-list
64571187|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64571188|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
64571189|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571190|NCT04385940|Vitamin D|vitamin d|mesh-list
64571191|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
64571192|NCT04385940|Vitamins|vitamins|mesh-ancestor
64571193|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
64571194|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571195|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64571196|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64571197|NCT00984659|Fluticasone|fluticasone|mesh-list
64571199|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64571200|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571201|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64571202|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
64571203|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571204|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571205|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64571206|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571207|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
64571208|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64571209|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64571210|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64571211|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64571212|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
64571213|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571214|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484230|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571215|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
64571221|NCT04874844|Antibodies|antibodies|mesh-list
64571232|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571233|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64571234|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64571235|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571236|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
64571237|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571238|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571239|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64571240|NCT03046290|Lidocaine|lidocaine|mesh-list
64571241|NCT03046290|Ropivacaine|ropivacaine|mesh-list
64571242|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64571243|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
64571255|NCT04874688|Vitamins|vitamins|mesh-ancestor
64571256|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
64571257|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571258|NCT02932475|Metformin|metformin|mesh-list
64571259|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64571260|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571261|NCT02612064|Fluorides|fluorides|mesh-list
64571262|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
64571263|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
64571274|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571275|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571276|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64571277|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571279|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
64571280|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571281|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64571282|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64571283|NCT04553003|Protective Agents|protective agents|mesh-ancestor
64571284|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
64571285|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64571286|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
64571287|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571288|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64296537|NCT03307551|Propofol|propofol|mesh-list
64571289|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
64571290|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
64571291|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
64571292|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64571293|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64571294|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571295|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
64571296|NCT03044184|Coagulants|coagulants|mesh-ancestor
64571297|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
64571298|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64571299|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64571300|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571301|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64571302|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64571304|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571305|NCT03047772|Atorvastatin|atorvastatin|mesh-list
64571306|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64571307|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64571308|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
64571333|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571334|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64571335|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571336|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571337|NCT02043457|Hormones|hormones|mesh-list
64571338|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571339|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571340|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64589929|NCT03840200|Rucaparib|rucaparib|mesh-list
64571341|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64571342|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64571343|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571344|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571345|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571346|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571347|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
64571348|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64571349|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
64571373|NCT03820193|Celecoxib|celecoxib|mesh-list
64571374|NCT03820193|Ketorolac|ketorolac|mesh-list
64571375|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64571376|NCT03820193|Diazepam|diazepam|mesh-list
64571377|NCT03820193|Gabapentin|gabapentin|mesh-list
64571378|NCT03820193|Hydrocodone|hydrocodone|mesh-list
64571379|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64571380|NCT03820193|Analgesics|analgesics|mesh-ancestor
64571381|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
64571382|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571383|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571384|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
64571385|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64571386|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571387|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571388|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64571389|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64571390|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571391|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571392|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
64571393|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64571394|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64571395|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571396|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64571397|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64336801|NCT02330757|Enclomiphene|enclomiphene|mesh-list
64571398|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64571399|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571401|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64571402|NCT03820193|Narcotics|narcotics|mesh-ancestor
64571403|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
64571404|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571405|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64571406|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
64334758|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334759|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334760|NCT02354313|Lenalidomide|lenalidomide|mesh-list
64571425|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64571426|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571427|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
64571428|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571429|NCT02614560|Fludarabine|fludarabine|mesh-list
64571430|NCT02614560|Melphalan|melphalan|mesh-list
64571431|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571432|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571433|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64571434|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
64571435|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571436|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64571437|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
64571438|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64571439|NCT03828929|Thiamine|thiamine|mesh-list
64571440|NCT03828929|Vitamins|vitamins|mesh-ancestor
64571441|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
64571442|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571443|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
64571445|NCT04873440|Trace Elements|trace elements|mesh-ancestor
64571446|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
64571448|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
64571481|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
64571482|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571498|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64571499|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64571500|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64571501|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
64571502|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571503|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571504|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
64571505|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
64571506|NCT04873284|Dexamethasone|dexamethasone|mesh-list
64571507|NCT04873284|Aprepitant|aprepitant|mesh-list
64571508|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
64571509|NCT04873284|Granisetron|granisetron|mesh-list
64571510|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64571511|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
64571512|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
64571513|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571514|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571515|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64571516|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
64571517|NCT04873284|Hormones|hormones|mesh-ancestor
64571518|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571519|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64571520|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571521|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64571522|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571523|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571524|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64571525|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
64571526|NCT01450865|Flupirtine|flupirtine|mesh-list
64571527|NCT01450865|Analgesics|analgesics|mesh-ancestor
64571528|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
64571531|NCT01308619|Doxycycline|doxycycline|mesh-list
64571537|NCT02611752|Buprenorphine|buprenorphine|mesh-list
64571538|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64571539|NCT02611752|Narcotics|narcotics|mesh-ancestor
64571540|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571541|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571542|NCT02611752|Analgesics|analgesics|mesh-ancestor
64571543|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
64571544|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571545|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64571546|NCT01307605|Rituximab|rituximab|mesh-list
64571547|NCT01307605|Lenalidomide|lenalidomide|mesh-list
64571548|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64571549|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571550|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
64571551|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571552|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571553|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64571554|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64571555|NCT01307605|Growth Substances|growth substances|mesh-ancestor
64571556|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
64571557|NCT04758689|Methotrexate|methotrexate|mesh-list
64571558|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64571559|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
64571560|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64571561|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571562|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571563|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
64571564|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571565|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571597|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
64571598|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571599|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64571600|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64571602|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571604|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334761|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
64334762|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334763|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64334764|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64334765|NCT02354313|Growth Substances|growth substances|mesh-ancestor
64360427|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
64571608|NCT01451879|Rituximab|rituximab|mesh-list
64571609|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64571610|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571611|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
64571612|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571613|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64571614|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571615|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571616|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64571617|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64571618|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
64571619|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571620|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64571621|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64571622|NCT03045198|Azithromycin|azithromycin|mesh-list
64571623|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64571624|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571625|NCT01305499|Azacitidine|azacitidine|mesh-list
64571626|NCT01305499|Entinostat|entinostat|mesh-list
64571627|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571628|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
64571629|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571630|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571631|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571632|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64571633|NCT05417113|Bupivacaine|bupivacaine|mesh-list
64571634|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
64571651|NCT02022709|Citalopram|citalopram|mesh-list
64571652|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
64571653|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64571654|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64571655|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64571656|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64571657|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571658|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571659|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
64571660|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571661|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64571662|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64571663|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64571664|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571665|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360437|NCT02511847|Afatinib|afatinib|mesh-list
64571698|NCT01896349|Citalopram|citalopram|mesh-list
64571699|NCT01896349|Bupropion|bupropion|mesh-list
64571700|NCT01896349|Sertraline|sertraline|mesh-list
64571701|NCT01896349|Fluoxetine|fluoxetine|mesh-list
64571702|NCT01896349|Paroxetine|paroxetine|mesh-list
64571727|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571728|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64571729|NCT01896349|Analgesics|analgesics|mesh-ancestor
64571730|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
64571731|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64571732|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
64571733|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
64571735|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64571736|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64571737|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64571738|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
64571739|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64571740|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64571741|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64571742|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64571758|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571759|NCT00580489|Analgesics|analgesics|mesh-ancestor
64571760|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
64571761|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571762|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64571763|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64571764|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
64571765|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
64571766|NCT01659307|Aspirin|aspirin|mesh-list
64571783|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64571786|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571787|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64571788|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64571789|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64571791|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64571792|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571793|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571794|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64571795|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64571796|NCT04391231|Protective Agents|protective agents|mesh-ancestor
64571797|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571798|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
64571799|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64571800|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
64571801|NCT04872270|Caffeine|caffeine|mesh-list
64571802|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64571803|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571823|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64571824|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571825|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
64571826|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571827|NCT01454609|Analgesics|analgesics|mesh-ancestor
64571828|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64571829|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
64571830|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
64334771|NCT02292667|Narcotics|narcotics|mesh-ancestor
64360521|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571862|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360537|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
64571897|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571898|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571900|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64571902|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64571903|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571904|NCT01456715|Vaccines|vaccines|mesh-list
64571905|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
64571906|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571907|NCT01895569|Metformin|metformin|mesh-list
64571908|NCT01895569|Pioglitazone|pioglitazone|mesh-list
64571909|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64571910|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64571911|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571912|NCT01895569|Incretins|incretins|mesh-ancestor
64571914|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571915|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64571916|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
64571917|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571918|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571919|NCT01457261|Albuterol|albuterol|mesh-list
64571920|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64571921|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
64571922|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64571923|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589953|NCT00450983|Methotrexate|methotrexate|mesh-list
64571924|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64571925|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571926|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
64571927|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64571928|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64571929|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64571930|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64571931|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
64571932|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64571933|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571934|NCT01457495|Edetic Acid|edetic acid|mesh-list
64571935|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
64571936|NCT01457495|Antidotes|antidotes|mesh-ancestor
64571937|NCT01457495|Protective Agents|protective agents|mesh-ancestor
64571938|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571939|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
64571940|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
64571941|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571942|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64571943|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
64571944|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64571945|NCT04778137|Omalizumab|omalizumab|mesh-list
64571946|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64571947|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64571948|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
64571949|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64571950|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64571951|NCT03815929|Estradiol|estradiol|mesh-list
64571952|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64571953|NCT03815929|Estrogens|estrogens|mesh-ancestor
64571954|NCT03815929|Hormones|hormones|mesh-ancestor
64571955|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64571956|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571957|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64571958|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
64571959|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64571960|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64571961|NCT00394147|Gemcitabine|gemcitabine|mesh-list
64571962|NCT00394147|Pemetrexed|pemetrexed|mesh-list
64571963|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64571964|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
64571965|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64571966|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64571968|NCT00394147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571969|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64571970|NCT00394147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64571971|NCT00394147|Immunologic Factors|immunologic factors|mesh-ancestor
64571972|NCT00394147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64571973|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64571974|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64571978|NCT02610816|Fluticasone|fluticasone|mesh-list
64571997|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
64571998|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64571999|NCT00332605|Expectorants|expectorants|mesh-ancestor
64572000|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
64572001|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64572002|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
64572003|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572004|NCT00332605|Protective Agents|protective agents|mesh-ancestor
64572005|NCT00332605|Antidotes|antidotes|mesh-ancestor
64572006|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64572007|NCT01458743|Cephalosporins|cephalosporins|mesh-list
64572008|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64589961|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572009|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572010|NCT01415583|Dexamethasone|dexamethasone|mesh-list
64572011|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572012|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
64572013|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
64572014|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572015|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572016|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572017|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
64572018|NCT01415583|Hormones|hormones|mesh-ancestor
64572019|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572020|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64572021|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572022|NCT01458977|Tenofovir|tenofovir|mesh-list
64572023|NCT01458977|Emtricitabine|emtricitabine|mesh-list
64572024|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64572025|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
64360706|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64572043|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64572044|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64572045|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572046|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572047|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572049|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64572050|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64572051|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64572052|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572053|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572054|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572055|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572056|NCT00256399|Urological Agents|urological agents|mesh-ancestor
64572058|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64572059|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572060|NCT01459211|Dexamethasone|dexamethasone|mesh-list
64572061|NCT01459211|Lenalidomide|lenalidomide|mesh-list
64572062|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572063|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
64572064|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
64572065|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572066|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572067|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572068|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
64572069|NCT01459211|Hormones|hormones|mesh-ancestor
64572070|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572072|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572073|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
64572074|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64572075|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64572076|NCT01459211|Growth Substances|growth substances|mesh-ancestor
64572077|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
64572078|NCT00198991|Cytarabine|cytarabine|mesh-list
64572079|NCT00198991|Dexamethasone|dexamethasone|mesh-list
64572080|NCT00198991|Prednisolone|prednisolone|mesh-list
64572081|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
64572082|NCT00198991|Methotrexate|methotrexate|mesh-list
64572083|NCT00198991|Fludarabine|fludarabine|mesh-list
64572084|NCT00198991|Etoposide|etoposide|mesh-list
64572085|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
64572086|NCT00198991|Vincristine|vincristine|mesh-list
64572087|NCT00198991|Doxorubicin|doxorubicin|mesh-list
64572088|NCT00198991|Daunorubicin|daunorubicin|mesh-list
64572089|NCT00198991|Asparaginase|asparaginase|mesh-list
64572090|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
64572091|NCT00198991|Idarubicin|idarubicin|mesh-list
64572092|NCT00198991|Thioguanine|thioguanine|mesh-list
64572093|NCT00198991|Cladribine|cladribine|mesh-list
64572094|NCT00198991|Vindesine|vindesine|mesh-list
64572095|NCT00198991|Teniposide|teniposide|mesh-list
64572096|NCT00198991|Pegaspargase|pegaspargase|mesh-list
64572097|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572098|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
64572127|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
64572128|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572129|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
64572130|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
64572131|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
64572132|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64572133|NCT01459367|Lansoprazole|lansoprazole|mesh-list
64572134|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
64572135|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64572136|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572137|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64572138|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572139|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572140|NCT04777591|Bupivacaine|bupivacaine|mesh-list
64572141|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64572142|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
64572143|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572144|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572145|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
64572146|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572147|NCT01459601|Cabergoline|cabergoline|mesh-list
64572148|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64572149|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64572150|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
64572151|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
64572152|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572153|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572154|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572155|NCT01418001|Gemcitabine|gemcitabine|mesh-list
64572157|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64572158|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
64572159|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572160|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572161|NCT01418001|Antiviral Agents|antiviral agents|mesh-ancestor
64572162|NCT01418001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572163|NCT01418001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572164|NCT01418001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572165|NCT01418001|Immunologic Factors|immunologic factors|mesh-ancestor
64572166|NCT01418001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572167|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
64572168|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
64572169|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
64572170|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64572171|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64572172|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64572173|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
64572174|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572175|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64572176|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64572177|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572178|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
64572179|NCT01542255|Dacarbazine|dacarbazine|mesh-list
64572181|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572182|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
64572183|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572184|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572185|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64572186|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
64572191|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
64572200|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64572201|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64572202|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64572203|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572204|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572205|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572206|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
64572207|NCT02872259|Trametinib|trametinib|mesh-list
64572208|NCT02872259|Dabrafenib|dabrafenib|mesh-list
64572209|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64572210|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572211|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64572212|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572213|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572214|NCT04776655|Leucovorin|leucovorin|mesh-list
64572215|NCT04776655|Bevacizumab|bevacizumab|mesh-list
64572216|NCT04776655|Cetuximab|cetuximab|mesh-list
64572217|NCT04776655|Fluorouracil|fluorouracil|mesh-list
64572218|NCT04776655|Irinotecan|irinotecan|mesh-list
64572219|NCT04776655|Calcium|calcium|mesh-list
64572220|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
64572221|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64572222|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572223|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64572224|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64572225|NCT04776655|Growth Substances|growth substances|mesh-ancestor
64572226|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572227|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
64572228|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64572229|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
64572232|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572246|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64572247|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64572248|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572249|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64572250|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64572251|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572252|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572253|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572254|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64572255|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
64572256|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64572257|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572258|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64572259|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64572260|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64572261|NCT01459679|Riboflavin|riboflavin|mesh-list
64572262|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64572263|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64572264|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
64297510|NCT02062333|Esmolol|esmolol|mesh-list
64572265|NCT01459679|Vitamins|vitamins|mesh-ancestor
64572266|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
64572267|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572268|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64360783|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360792|NCT04499209|Naproxen|naproxen|mesh-list
64572277|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572279|NCT01455857|Incretins|incretins|mesh-ancestor
64572280|NCT01455857|Hormones|hormones|mesh-ancestor
64572281|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572282|NCT01067287|Pidilizumab|pidilizumab|mesh-list
64572283|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64572284|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572285|NCT03043248|Digoxin|digoxin|mesh-list
64572286|NCT03043248|Midazolam|midazolam|mesh-list
64572287|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64572288|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64572289|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572290|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572291|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64572292|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64572293|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64572294|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64572295|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
64572296|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
64572297|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
64572298|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
64572299|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572300|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572301|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64572327|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572328|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572329|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64572330|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
64334780|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64334781|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64334782|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64360809|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572340|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572341|NCT02856893|Gefitinib|gefitinib|mesh-list
64572342|NCT02856893|Osimertinib|osimertinib|mesh-list
64572343|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572344|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64572345|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572346|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572348|NCT01419795|Lenalidomide|lenalidomide|mesh-list
64572349|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64572350|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572351|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
64572352|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572353|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572354|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64360845|NCT02508805|Analgesics|analgesics|mesh-ancestor
64572379|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
64572380|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572381|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64572382|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64572383|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64572384|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64572385|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64572386|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64336803|NCT02330757|Estradiol|estradiol|mesh-list
64572387|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572388|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572389|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64572391|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64572392|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64572393|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64572394|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64334783|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64334784|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334785|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64334786|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334788|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
64334789|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64572412|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64572413|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
64572414|NCT03043482|Calcitriol|calcitriol|mesh-list
64572415|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64572416|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572417|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64572418|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64572419|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572420|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64572421|NCT03043482|Vitamins|vitamins|mesh-ancestor
64572422|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
64572423|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64572424|NCT04775563|Vaccines|vaccines|mesh-list
64572425|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
64572426|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572427|NCT01480089|Ropivacaine|ropivacaine|mesh-list
64572428|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
64572429|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
64572430|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572431|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572432|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
64572433|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572434|NCT03523975|Rituximab|rituximab|mesh-list
64572457|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
64572458|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
64572459|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
64572460|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
64572461|NCT04857450|Ketamine|ketamine|mesh-list
64572462|NCT04857450|Etomidate|etomidate|mesh-list
64572463|NCT04857450|Analgesics|analgesics|mesh-ancestor
64572464|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
64572465|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572466|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572467|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64572468|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64360905|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64334858|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334859|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64334860|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64334883|NCT03541655|Bupivacaine|bupivacaine|mesh-list
64334884|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
64334885|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
64572481|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
64572482|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572483|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572484|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
64572485|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64572486|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572487|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572488|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64572489|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572490|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572491|NCT03042936|Insulin|insulin|mesh-list
64572492|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64572493|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572495|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64572496|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
64572497|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572498|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572499|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572500|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64572501|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64572502|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572503|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64572504|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
64572505|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
64572506|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64572507|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64572530|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572532|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572533|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572534|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
64572535|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64572536|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572537|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
64572538|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
64572539|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64572540|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64572541|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572542|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572543|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572544|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572545|NCT04390685|Tacrolimus|tacrolimus|mesh-list
64572546|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572547|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
64572548|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572549|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64572550|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572551|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572552|NCT04848246|Bupropion|bupropion|mesh-list
64572553|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64572554|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
64572579|NCT04774627|Talazoparib|talazoparib|mesh-list
64572580|NCT04774627|Veliparib|veliparib|mesh-list
64572581|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64572582|NCT04774627|Rucaparib|rucaparib|mesh-list
64572583|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572584|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572585|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572586|NCT04142658|Warfarin|warfarin|mesh-list
64572587|NCT04142658|Apixaban|apixaban|mesh-list
64572588|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
64572589|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64572590|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
64572591|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64572592|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
64572593|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572594|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572595|NCT01545141|Interferons|interferons|mesh-list
64572596|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
64572597|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
64572598|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64572599|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64572600|NCT01545141|Poly I-C|poly i-c|mesh-list
64572601|NCT01545141|Celecoxib|celecoxib|mesh-list
64572602|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572603|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
64572604|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572605|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
64572606|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572608|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64572631|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572632|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64572634|NCT04855968|Analgesics|analgesics|mesh-list
64572635|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
64572636|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572637|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572638|NCT01545765|Lidocaine|lidocaine|mesh-list
64572639|NCT01545765|Tetracaine|tetracaine|mesh-list
64572640|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
64572641|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
64572642|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572643|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572644|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
64572645|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572646|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64572647|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64572648|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64572649|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64572650|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572653|NCT04856124|Analgesics|analgesics|mesh-ancestor
64572654|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
64572655|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572656|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572657|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64572658|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64334886|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334887|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334888|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
64334889|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334920|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334921|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64335053|NCT02298283|Etoposide|etoposide|mesh-list
64335054|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64335055|NCT02298283|Vincristine|vincristine|mesh-list
64335056|NCT02298283|Bleomycin|bleomycin|mesh-list
64335057|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64335058|NCT02298283|Procarbazine|procarbazine|mesh-list
64335059|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360998|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572661|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572662|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64572663|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64572664|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572665|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572666|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
64572667|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64572668|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64572669|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64572670|NCT04847622|Remdesivir|remdesivir|mesh-list
64572671|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
64572672|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572673|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
64572674|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572675|NCT04781803|Cyclosporine|cyclosporine|mesh-list
64572676|NCT04781803|Cyclosporins|cyclosporins|mesh-list
64572677|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572678|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572679|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572680|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
64572681|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572682|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
64572683|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572684|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
64572685|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572686|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64572687|NCT01422369|Ritonavir|ritonavir|mesh-list
64572688|NCT01422369|Darunavir|darunavir|mesh-list
64572689|NCT01422369|Pitavastatin|pitavastatin|mesh-list
64572690|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64572691|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64572692|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
64572693|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335079|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
64335080|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
64335081|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64335082|NCT02346357|Ropivacaine|ropivacaine|mesh-list
64572694|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572696|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64572697|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
64572698|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572699|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64590019|NCT02984930|Esomeprazole|esomeprazole|mesh-list
64572700|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64572701|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64572702|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64572703|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64572704|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
64572705|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64572706|NCT05023343|Ropivacaine|ropivacaine|mesh-list
64572707|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
64572708|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
64572709|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572710|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572711|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
64572712|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572713|NCT05024513|Fluorouracil|fluorouracil|mesh-list
64572714|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
64572715|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
64572716|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572717|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64572718|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572719|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572721|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572722|NCT04859556|Dipivefrin|dipivefrin|mesh-list
64572737|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572738|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
64572739|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572741|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64572742|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572743|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572744|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572745|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
64572746|NCT05021315|Povidone|povidone|mesh-list
64572747|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
64572748|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
64572749|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64572750|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572751|NCT04859322|Glucagon|glucagon|mesh-list
64572752|NCT04859322|Somatostatin|somatostatin|mesh-list
64572753|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572754|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572755|NCT04859322|Hormones|hormones|mesh-ancestor
64572756|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572757|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
64572758|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64572759|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
64572760|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572761|NCT01427517|Expectorants|expectorants|mesh-ancestor
64335084|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
64335085|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335086|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335087|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
64335088|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335110|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335136|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335137|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64335138|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335139|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335140|NCT02350959|Atorvastatin|atorvastatin|mesh-list
64335141|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64335142|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64335143|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
64335144|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335145|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64335146|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64335147|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335148|NCT02350335|Nicotine|nicotine|mesh-list
64335149|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64335150|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
64335151|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335161|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572765|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572766|NCT01427517|Protective Agents|protective agents|mesh-ancestor
64572767|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572768|NCT01427517|Antidotes|antidotes|mesh-ancestor
64572769|NCT02835131|Pasireotide|pasireotide|mesh-list
64572770|NCT02835131|Hormones|hormones|mesh-ancestor
64572771|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572772|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572773|NCT00840853|Acetaminophen|acetaminophen|mesh-list
64572776|NCT00840853|Analgesics|analgesics|mesh-ancestor
64572777|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
64572778|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572779|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572780|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
64572781|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64572782|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64335162|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335163|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
64335164|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335165|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64335166|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64335167|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64335168|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335185|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
64335186|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335187|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
64335189|NCT02298595|Cetuximab|cetuximab|mesh-list
64335190|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335191|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64335192|NCT02345343|Apixaban|apixaban|mesh-list
64335193|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64335203|NCT03949673|Fasinumab|fasinumab|mesh-list
64335204|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64335205|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64335206|NCT03949673|Analgesics|analgesics|mesh-ancestor
64335207|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
64335208|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335209|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335211|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335212|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64335213|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64335214|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335235|NCT02293681|Infliximab|infliximab|mesh-list
64335236|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
64335237|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572783|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572785|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
64572786|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
64572787|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
64572788|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64572789|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64572790|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
64572791|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
64572792|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572793|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572794|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64572795|NCT04846452|Paclitaxel|paclitaxel|mesh-list
64572796|NCT04846452|Carboplatin|carboplatin|mesh-list
64572797|NCT04846452|Pemetrexed|pemetrexed|mesh-list
64572798|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64572799|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572800|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
64572801|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
64572802|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
64572803|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572804|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572805|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64572806|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64572807|NCT04859244|Remdesivir|remdesivir|mesh-list
64572808|NCT04859244|GS-441524|gs-441524|mesh-list
64572809|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
64572810|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572811|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
64572812|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572813|NCT05028725|Lugol's solution|lugol's solution|mesh-list
64572814|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
64572815|NCT05028725|Coagulants|coagulants|mesh-ancestor
64572816|NCT04779853|Antibodies|antibodies|mesh-list
64572817|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
64572818|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572819|NCT04855110|Warfarin|warfarin|mesh-list
64572824|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572825|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572826|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64572827|NCT01485393|Analgesics|analgesics|mesh-ancestor
64572828|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
64572829|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572830|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64572831|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64572832|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64572833|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572834|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572835|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572836|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64572837|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64572838|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
64572839|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
64572840|NCT04772521|Nicotine|nicotine|mesh-list
64572841|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64572842|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
64572843|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572844|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572845|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64572846|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64572847|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
64572848|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572851|NCT04772287|Paclitaxel|paclitaxel|mesh-list
64572873|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64572874|NCT01890005|Aspirin|aspirin|mesh-list
64298099|NCT02071069|Fluorouracil|fluorouracil|mesh-list
64572875|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64572876|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64572877|NCT01890005|Analgesics|analgesics|mesh-ancestor
64572878|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
64572879|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64572880|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572881|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572882|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572883|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64572884|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64572885|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572886|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64572887|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64572888|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572889|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
64572890|NCT02822573|Donepezil|donepezil|mesh-list
64572891|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64572892|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572893|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572894|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
64572895|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572896|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572897|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
64572898|NCT04854252|Fentanyl|fentanyl|mesh-list
64572899|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64572900|NCT04854252|Narcotics|narcotics|mesh-ancestor
64572901|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64572902|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572903|NCT04854252|Analgesics|analgesics|mesh-ancestor
64572908|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
64572915|NCT04390295|Metformin|metformin|mesh-list
64572916|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64572917|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572918|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
64572919|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64572920|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572921|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64572922|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572923|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
64572924|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64572925|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64572926|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572927|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
64572928|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
64572929|NCT01890629|Metformin|metformin|mesh-list
64572930|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64572931|NCT01890629|Glimepiride|glimepiride|mesh-list
64572932|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64572933|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572934|NCT01890629|Incretins|incretins|mesh-ancestor
64572935|NCT01890629|Hormones|hormones|mesh-ancestor
64572936|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572937|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64572938|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
64572939|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64572940|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572941|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64572942|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572943|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
64572944|NCT01890863|Fluticasone|fluticasone|mesh-list
64572945|NCT01890863|Xhance|xhance|mesh-list
64572946|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64572947|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64572948|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64572953|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64572954|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
64572955|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
64572956|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64572957|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64572958|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64572959|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64572960|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
64572961|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64572962|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572963|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
64572964|NCT01890863|Hormones|hormones|mesh-ancestor
64572965|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64572966|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
64572967|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
64361099|NCT02494687|Domperidone|domperidone|mesh-list
64335239|NCT02259491|Calcium|calcium|mesh-list
64335242|NCT05255523|Capecitabine|capecitabine|mesh-list
64335250|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335252|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64335253|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
64335254|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335255|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335256|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64335257|NCT02298985|Curcumin|curcumin|mesh-list
64335258|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
64335259|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64335260|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64335261|NCT02298985|Analgesics|analgesics|mesh-ancestor
64335262|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
64335263|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335264|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335265|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335266|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335267|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335268|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335269|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335270|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64335271|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335272|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64335273|NCT03149445|Metoprolol|metoprolol|mesh-list
64335274|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64335275|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64335276|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
64335277|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
64335278|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335286|NCT02345187|Micronutrients|micronutrients|mesh-list
64335287|NCT02345187|Trace Elements|trace elements|mesh-list
64335288|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335289|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
64335290|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64335291|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335307|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
64335308|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335309|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64572968|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
64572969|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
64572970|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
64572971|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64572973|NCT02950051|Fludarabine|fludarabine|mesh-list
64572974|NCT02950051|Venetoclax|venetoclax|mesh-list
64572975|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
64572976|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572977|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
64572978|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572979|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64572980|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64572981|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
64572982|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64572983|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64572984|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64572985|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64572986|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64572987|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64572988|NCT01891019|Thalidomide|thalidomide|mesh-list
64572989|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64572990|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
64572991|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64572992|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
64572993|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64572994|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64572995|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64572996|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64572997|NCT01891019|Growth Substances|growth substances|mesh-ancestor
64572998|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
64573000|NCT04374474|Budesonide|budesonide|mesh-list
64573001|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573002|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64573003|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
64573010|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573011|NCT02983097|Cytarabine|cytarabine|mesh-list
64573012|NCT02983097|Dexamethasone|dexamethasone|mesh-list
64573013|NCT02983097|Rituximab|rituximab|mesh-list
64573014|NCT02983097|Carboplatin|carboplatin|mesh-list
64573015|NCT02983097|Lenalidomide|lenalidomide|mesh-list
64573016|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573017|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573018|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
64573019|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573020|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573021|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573022|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
64573023|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
64573024|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573025|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573026|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
64573027|NCT02983097|Hormones|hormones|mesh-ancestor
64573028|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573029|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573030|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64573031|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
64573032|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573033|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
64573034|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573035|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573036|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64573037|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64335310|NCT05255211|Propofol|propofol|mesh-list
64335321|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64335322|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64335323|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335324|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335325|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64335326|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
64335327|NCT02343393|Hydralazine|hydralazine|mesh-list
64335353|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64335354|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
64335355|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335357|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
64335358|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
64335368|NCT02294071|Analgesics|analgesics|mesh-ancestor
64335369|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
64335370|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335384|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64335385|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573038|NCT02983097|Growth Substances|growth substances|mesh-ancestor
64573039|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
64573041|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573042|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573043|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573044|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573045|NCT01891175|Anesthetics|anesthetics|mesh-list
64573046|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573047|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573048|NCT02347865|Denosumab|denosumab|mesh-list
64573049|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64573050|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573051|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
64573053|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
64573054|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64573055|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64573056|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573057|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573058|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573059|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573060|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573061|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64573062|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64573063|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
64573064|NCT01427595|Metformin|metformin|mesh-list
64573065|NCT01427595|Progesterone|progesterone|mesh-list
64573066|NCT01427595|Estradiol|estradiol|mesh-list
64573067|NCT01427595|Estrogens|estrogens|mesh-list
64573068|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64573069|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573088|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573089|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573090|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64573091|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64573092|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
64573093|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573094|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573095|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64573096|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
64573097|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64573098|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64573099|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64573100|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573101|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
64298325|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573102|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64573103|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64573104|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573105|NCT00716443|Lidocaine|lidocaine|mesh-list
64573106|NCT00716443|Tetracaine|tetracaine|mesh-list
64573107|NCT00716443|Benzocaine|benzocaine|mesh-list
64573108|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
64573109|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
64573110|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573111|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573112|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
64573113|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573114|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64335386|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
64335388|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335389|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335390|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64335391|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
64335392|NCT02342925|Metformin|metformin|mesh-list
64335393|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64573115|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64573117|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64386141|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573118|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573119|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64573120|NCT00650143|Lenograstim|lenograstim|mesh-list
64573121|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64573122|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573123|NCT00650143|Incretins|incretins|mesh-ancestor
64573124|NCT00650143|Hormones|hormones|mesh-ancestor
64573125|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573126|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64573127|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
64573128|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573129|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573130|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64573131|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
64573132|NCT04770961|Ropivacaine|ropivacaine|mesh-list
64573133|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
64573134|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
64573135|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573136|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573137|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
64573138|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573139|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
64573140|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64573141|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
64573142|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64573143|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
64573159|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573160|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573161|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573164|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573165|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573166|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573167|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64573168|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
64573169|NCT04778917|Heparin|heparin|mesh-list
64573170|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64573171|NCT04778917|Tinzaparin|tinzaparin|mesh-list
64573172|NCT04778917|Dalteparin|dalteparin|mesh-list
64573173|NCT04778917|Calcium heparin|calcium heparin|mesh-list
64573174|NCT04778917|Calcium|calcium|mesh-list
64573175|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64573176|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298400|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
64573177|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
64573178|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64573179|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64573180|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573181|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
64573182|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573183|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573184|NCT02213289|Nivolumab|nivolumab|mesh-list
64573185|NCT02213289|Trastuzumab|trastuzumab|mesh-list
64573186|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
64573187|NCT02213289|Ramucirumab|ramucirumab|mesh-list
64573188|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573189|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573190|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64335394|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335395|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64335396|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64335397|NCT02344641|Exenatide|exenatide|mesh-list
64335398|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64335399|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335400|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64335401|NCT02344641|Incretins|incretins|mesh-ancestor
64335402|NCT02344641|Hormones|hormones|mesh-ancestor
64335403|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335404|NCT03798743|Docetaxel|docetaxel|mesh-list
64573191|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573192|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
64573193|NCT02779751|Anastrozole|anastrozole|mesh-list
64573194|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573195|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573196|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573197|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64573198|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64573199|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573200|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573201|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64573202|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
64573203|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573204|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573205|NCT05606107|Tofacitinib|tofacitinib|mesh-list
64573206|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
64573207|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573208|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573209|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573210|NCT05606107|Hormones|hormones|mesh-ancestor
64573211|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573213|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
64573242|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573243|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573245|NCT00053989|Hormones|hormones|mesh-ancestor
64573246|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573247|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64573248|NCT00053989|Protective Agents|protective agents|mesh-ancestor
64573249|NCT02752685|Paclitaxel|paclitaxel|mesh-list
64573250|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
64573251|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573252|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573253|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573254|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573255|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
64573256|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573257|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573258|NCT02740595|Nicotine|nicotine|mesh-list
64573259|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64573260|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
64573261|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573262|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573263|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64573264|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64573265|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
64573266|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573267|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573268|NCT02713997|Etanercept|etanercept|mesh-list
64573269|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64573273|NCT02713997|Analgesics|analgesics|mesh-ancestor
64573287|NCT02697227|Nicotine|nicotine|mesh-list
64573288|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64573289|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
64573290|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573291|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573292|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64573293|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64573294|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
64573295|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573296|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361191|NCT03120403|Morphine|morphine|mesh-list
64573297|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64573298|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64573299|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
64573300|NCT02689427|Paclitaxel|paclitaxel|mesh-list
64573301|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64573302|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573303|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573304|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573305|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573306|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
64590117|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590120|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
64573307|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573308|NCT02670707|Cytarabine|cytarabine|mesh-list
64573309|NCT02670707|Prednisone|prednisone|mesh-list
64573310|NCT02670707|Vinblastine|vinblastine|mesh-list
64573311|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573312|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
64573313|NCT02670707|Hormones|hormones|mesh-ancestor
64335405|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335406|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335407|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
64335408|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
64335409|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335410|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
64335411|NCT04083183|Sirolimus|sirolimus|mesh-list
64335412|NCT04083183|Vidarabine|vidarabine|mesh-list
64335413|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
64335414|NCT04083183|Fludarabine|fludarabine|mesh-list
64335418|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64335419|NCT04083183|Antibodies|antibodies|mesh-list
64335420|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
64335421|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64335422|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
64335423|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64335424|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64335425|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335426|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
64335427|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335428|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335429|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64335430|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
64336804|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64573314|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573316|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573317|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573318|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64573319|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
64573320|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573321|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
64573322|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573323|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573324|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
64573325|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573326|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573327|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573328|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64573329|NCT02214615|Carbamazepine|carbamazepine|mesh-list
64573330|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
64573331|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
64573332|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64573333|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573334|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573335|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64573336|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64573338|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
64361197|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
64573339|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573340|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64573341|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590126|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335431|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335432|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335433|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64335434|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335435|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
64335436|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64335437|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64335438|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
64335439|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335440|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335441|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335442|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
64335443|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
64335444|NCT02342769|Dolutegravir|dolutegravir|mesh-list
64335445|NCT02342769|Abacavir|abacavir|mesh-list
64335446|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64573343|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64573344|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64573345|NCT02661503|Dexamethasone|dexamethasone|mesh-list
64573346|NCT02661503|Prednisone|prednisone|mesh-list
64573347|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
64573348|NCT02661503|Dacarbazine|dacarbazine|mesh-list
64573349|NCT02661503|Doxorubicin|doxorubicin|mesh-list
64573350|NCT02661503|Etoposide|etoposide|mesh-list
64573351|NCT02661503|Vincristine|vincristine|mesh-list
64573352|NCT02661503|Bleomycin|bleomycin|mesh-list
64573353|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64573354|NCT02661503|Procarbazine|procarbazine|mesh-list
64573355|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573356|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
64573357|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573358|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573359|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64573360|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
64573361|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573362|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335447|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64335448|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335449|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335450|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64335451|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64335468|NCT03761225|Docetaxel|docetaxel|mesh-list
64335469|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335470|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335471|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
64335472|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64335473|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335474|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335475|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
64335476|NCT03761225|Hormones|hormones|mesh-ancestor
64335477|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335478|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335479|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64335480|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64335481|NCT02349945|Hormones|hormones|mesh-ancestor
64335482|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335483|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335484|NCT02302495|Prednisone|prednisone|mesh-list
64335485|NCT02302495|Melphalan|melphalan|mesh-list
64335486|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335487|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
64335488|NCT02302495|Hormones|hormones|mesh-ancestor
64335489|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335490|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335526|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335527|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64335528|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335529|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64573363|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64573364|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573365|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
64573366|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
64573367|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573368|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573369|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
64573370|NCT02661503|Hormones|hormones|mesh-ancestor
64573371|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573372|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573373|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64573374|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64573375|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64573376|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573377|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573378|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573379|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573380|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
64573381|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573382|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64573383|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64573384|NCT02647385|Lidocaine|lidocaine|mesh-list
64573385|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
64573386|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
64573387|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573388|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573389|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
64573390|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573391|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64573392|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64573393|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64573394|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573395|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573396|NCT03040752|Nifedipine|nifedipine|mesh-list
64573397|NCT03040752|Ritodrine|ritodrine|mesh-list
64336805|NCT02330757|Estrogens|estrogens|mesh-ancestor
64573400|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573401|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64573402|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298630|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
64573403|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
64573404|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
64573405|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64573406|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
64573407|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
64573408|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573409|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64573410|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64573411|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64573412|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
64573413|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573415|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
64573416|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573417|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573418|NCT01431105|Atorvastatin|atorvastatin|mesh-list
64573419|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64361277|NCT03334591|Apatinib|apatinib|mesh-list
64573421|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
64573422|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573423|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64573424|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64573425|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573426|NCT03038958|Prilocaine|prilocaine|mesh-list
64573427|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
64573428|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
64573429|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
64573430|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573431|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573439|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573440|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
64590141|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573441|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573442|NCT02630069|Choline|choline|mesh-list
64573443|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64573444|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
64573445|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64573446|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
64573447|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573448|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573449|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64573450|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
64573451|NCT01431339|Vancomycin|vancomycin|mesh-list
64573452|NCT01431339|Linezolid|linezolid|mesh-list
64573453|NCT01431339|Dalbavancin|dalbavancin|mesh-list
64573454|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64573455|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573456|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64573457|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573458|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573459|NCT02596685|Nicotine|nicotine|mesh-list
64573460|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64573461|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
64573462|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573463|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573464|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64573465|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64573466|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
64573467|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573468|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573469|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
64573470|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
64573483|NCT02588105|Irinotecan|irinotecan|mesh-list
64573484|NCT02588105|Olaparib|olaparib|mesh-list
64573485|NCT02588105|AZD0156|azd0156|mesh-list
64573486|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
64573487|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
64573488|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573489|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64573490|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573491|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573492|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
64573493|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573494|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64573495|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64573496|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573497|NCT02588105|Antidotes|antidotes|mesh-ancestor
64573498|NCT02588105|Protective Agents|protective agents|mesh-ancestor
64573499|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
64573500|NCT02588105|Vitamins|vitamins|mesh-ancestor
64573501|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
64573502|NCT02588105|Hematinics|hematinics|mesh-ancestor
64573503|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64573504|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573505|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64573506|NCT01488279|Dexamethasone|dexamethasone|mesh-list
64573507|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
64335530|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335531|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
64335532|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335567|NCT03737123|Atezolizumab|atezolizumab|mesh-list
64335568|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335569|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335570|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
64335571|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335572|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
64335573|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335574|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335575|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335576|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
64335577|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335578|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335579|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
64335580|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
64335581|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64335582|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64335583|NCT02344095|Paclitaxel|paclitaxel|mesh-list
64335584|NCT02344095|Cisplatin|cisplatin|mesh-list
64335585|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64335586|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335587|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335588|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573509|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573510|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
64573511|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
64573512|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573513|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573514|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573515|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
64573516|NCT01488279|Hormones|hormones|mesh-ancestor
64573517|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573518|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573519|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573520|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
64573521|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573522|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573523|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64573524|NCT01488279|Incretins|incretins|mesh-ancestor
64573525|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64573526|NCT02586623|Droxidopa|droxidopa|mesh-list
64573527|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64573528|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64573529|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
64573559|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64573560|NCT01490931|Analgesics|analgesics|mesh-ancestor
64573561|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
64361288|NCT03334513|Growth Substances|growth substances|mesh-ancestor
64573562|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573563|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573564|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573565|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573566|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64573567|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573568|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573569|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
64573570|NCT02562365|Carboplatin|carboplatin|mesh-list
64573571|NCT02562365|Etoposide|etoposide|mesh-list
64573572|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573573|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
64573574|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573575|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573576|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64573577|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
64573578|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573579|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573580|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64573581|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573582|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64573583|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64573584|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573585|NCT01491633|Dasatinib|dasatinib|mesh-list
64573586|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573607|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573608|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573610|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64573611|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
64573612|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573613|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573614|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
64573615|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64573616|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64573617|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573618|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573619|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
64573620|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573621|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573622|NCT05586347|Nicardipine|nicardipine|mesh-list
64573623|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64573624|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64573625|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64573626|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573627|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64573628|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573629|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
64573630|NCT01436799|Alfentanil|alfentanil|mesh-list
64573631|NCT01436799|Propofol|propofol|mesh-list
64573632|NCT01436799|Desflurane|desflurane|mesh-list
64573633|NCT01436799|Rocuronium|rocuronium|mesh-list
64573634|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64335589|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64335590|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335591|NCT00157339|Insulin|insulin|mesh-list
64335592|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64335593|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64335594|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335596|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
64573635|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573636|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573638|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
64573639|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
64573640|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64573641|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64573642|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64573643|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573644|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64573645|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64573646|NCT01436799|Narcotics|narcotics|mesh-ancestor
64573647|NCT01436799|Analgesics|analgesics|mesh-ancestor
64573648|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
64573649|NCT02507687|Bimatoprost|bimatoprost|mesh-list
64573650|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64573651|NCT04851132|Durvalumab|durvalumab|mesh-list
64573652|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573653|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573654|NCT02504489|Docetaxel|docetaxel|mesh-list
64573655|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573656|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573657|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573658|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64590186|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573659|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573660|NCT02479451|Theophylline|theophylline|mesh-list
64573661|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64573662|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
64573663|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573664|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573665|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64573666|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
64573667|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64573668|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573669|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335597|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64336806|NCT02330757|Hormones|hormones|mesh-ancestor
64573671|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64573672|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64573673|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
64573674|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573675|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64573676|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573677|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573678|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573679|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573680|NCT02415413|Dexamethasone|dexamethasone|mesh-list
64573681|NCT02415413|Lenalidomide|lenalidomide|mesh-list
64573683|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573684|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
64573685|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
64573686|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573687|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573688|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573689|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
64573690|NCT02415413|Hormones|hormones|mesh-ancestor
64573691|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573692|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573693|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573694|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
64573695|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64573696|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64573697|NCT02415413|Growth Substances|growth substances|mesh-ancestor
64573698|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
64573699|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64573700|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
64573701|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335598|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335599|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64335636|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
64335637|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
64335638|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64335639|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335640|NCT02232581|Alovudine|alovudine|mesh-list
64573702|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64573703|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573705|NCT02379377|Fluorides|fluorides|mesh-list
64573706|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64573707|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573708|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
64573709|NCT02379377|Protective Agents|protective agents|mesh-ancestor
64573710|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573711|NCT01894061|Bevacizumab|bevacizumab|mesh-list
64573712|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64573713|NCT01894061|Antibodies|antibodies|mesh-list
64573714|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
64573715|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64573716|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573717|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64590195|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64590196|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64573718|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64573719|NCT01894061|Growth Substances|growth substances|mesh-ancestor
64573720|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573721|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
64573722|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
64573723|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
64573724|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64573725|NCT01561053|Antibodies|antibodies|mesh-list
64573726|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
64573727|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573728|NCT01561833|Sorafenib|sorafenib|mesh-list
64573729|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573730|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573731|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573732|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573733|NCT02607306|Insulin|insulin|mesh-list
64573734|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64573735|NCT02607306|Liraglutide|liraglutide|mesh-list
64573736|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
64573737|NCT02607306|Xultophy|xultophy|mesh-list
64573738|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64335641|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
64335642|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
64573739|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573741|NCT02607306|Hormones|hormones|mesh-ancestor
64573742|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573743|NCT03040128|Minocycline|minocycline|mesh-list
64573744|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64573745|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573746|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
64573747|NCT04850040|Apatinib|apatinib|mesh-list
64573748|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361355|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64573749|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64573751|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573752|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
64573753|NCT03038334|Analgesics|analgesics|mesh-ancestor
64573754|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
64573755|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573756|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573757|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
64573758|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573759|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64573760|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
64573790|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573792|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64573793|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
64573794|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64573795|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573796|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573797|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
64573798|NCT02288195|Capecitabine|capecitabine|mesh-list
64573799|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
64573800|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64573801|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
64573802|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573803|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573804|NCT01563081|Cetirizine|cetirizine|mesh-list
64573805|NCT01563081|Levocetirizine|levocetirizine|mesh-list
64573806|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64573807|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64573808|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
64573809|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
64573810|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573811|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573812|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573813|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64573814|NCT02278601|Fentanyl|fentanyl|mesh-list
64573815|NCT02278601|Ropivacaine|ropivacaine|mesh-list
64335643|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335662|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64335663|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335664|NCT03510793|Anesthetics|anesthetics|mesh-list
64335665|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335666|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335667|NCT05039177|Cetuximab|cetuximab|mesh-list
64335668|NCT05039177|Palbociclib|palbociclib|mesh-list
64335669|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64335670|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335671|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64335672|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335673|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335674|NCT05230797|Zinc|zinc|mesh-list
64335675|NCT05230797|Propolis|propolis|mesh-list
64335676|NCT05230797|Eugenol|eugenol|mesh-list
64335677|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
64335678|NCT05230797|Trace Elements|trace elements|mesh-ancestor
64335679|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
64335680|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573816|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
64573817|NCT02278601|Anesthetics|anesthetics|mesh-list
64573818|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573819|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573820|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
64573821|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573822|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64573823|NCT02278601|Narcotics|narcotics|mesh-ancestor
64573824|NCT02278601|Analgesics|analgesics|mesh-ancestor
64573825|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64573826|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64573827|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
64573828|NCT04833738|Triamcinolone|triamcinolone|mesh-list
64573829|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64573830|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64573831|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
64573832|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64573833|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573834|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
64573835|NCT04833738|Hormones|hormones|mesh-ancestor
64573836|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573837|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573838|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64573839|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
64573840|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573841|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573842|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64573843|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
64573844|NCT04833738|Protective Agents|protective agents|mesh-ancestor
64573845|NCT01441401|Gabapentin|gabapentin|mesh-list
64573846|NCT01441401|Analgesics|analgesics|mesh-ancestor
64573847|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
64573848|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573849|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573850|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
64573856|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64573857|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573858|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590202|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64573859|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
64573860|NCT02268695|Docetaxel|docetaxel|mesh-list
64573861|NCT02268695|Cetuximab|cetuximab|mesh-list
64573862|NCT02268695|Lenograstim|lenograstim|mesh-list
64573863|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573864|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
64573865|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
64573866|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
64573867|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573868|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573869|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64573870|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
64573871|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573872|NCT01495923|Gabapentin|gabapentin|mesh-list
64573873|NCT01495923|Analgesics|analgesics|mesh-ancestor
64573874|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
64573875|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573876|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573877|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
64573878|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64573879|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64573880|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64573881|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64573882|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64573883|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64573884|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573885|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573886|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
64573887|NCT03037944|Drospirenone|drospirenone|mesh-list
64573888|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
64573889|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64573890|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64573891|NCT03037944|Estradiol|estradiol|mesh-list
64335681|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335682|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
64573892|NCT03037944|Estrogens|estrogens|mesh-ancestor
64573893|NCT03037944|Hormones|hormones|mesh-ancestor
64573894|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573895|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573896|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64573897|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
64573898|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64573899|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64573900|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64573901|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64573902|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64573903|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64573904|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
64573905|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64573906|NCT03037944|Diuretics|diuretics|mesh-ancestor
64573907|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
64573908|NCT03060473|Amoxicillin|amoxicillin|mesh-list
64573909|NCT03060473|Azithromycin|azithromycin|mesh-list
64573910|NCT03060473|Erythromycin|erythromycin|mesh-list
64573911|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
64573912|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64573913|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
64573914|NCT03060473|Ampicillin|ampicillin|mesh-list
64573915|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64573916|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573917|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573918|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64573921|NCT03039426|Diclofenac|diclofenac|mesh-list
64573940|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
64590223|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64590224|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
64573941|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590225|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573942|NCT04833036|Irinotecan|irinotecan|mesh-list
64573943|NCT04833036|Cetuximab|cetuximab|mesh-list
64573944|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64573945|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64573946|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573947|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573948|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573949|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64573950|NCT04832880|Remdesivir|remdesivir|mesh-list
64573951|NCT04832880|Dexamethasone|dexamethasone|mesh-list
64573952|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64573953|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
64573954|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
64573955|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64573956|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573957|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64573958|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
64573959|NCT04832880|Hormones|hormones|mesh-ancestor
64573960|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64573961|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64573962|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573963|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
64573964|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573965|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
64573966|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573967|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
64573986|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
64573987|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64573988|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573989|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64573990|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
64573991|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
64573992|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64573993|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64573994|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64573995|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64573996|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64573997|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64573998|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64573999|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
64574000|NCT04824924|Venetoclax|venetoclax|mesh-list
64574001|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574002|NCT04553705|Quinine|quinine|mesh-list
64574003|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
64574004|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64574005|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64574006|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574007|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64574008|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574009|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64574010|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574011|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64574012|NCT04553705|Analgesics|analgesics|mesh-ancestor
64574013|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
64574036|NCT04837170|Analgesics|analgesics|mesh-ancestor
64574037|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
64574038|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574039|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574040|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64574041|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64574042|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
64574043|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
64574044|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574045|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64574046|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64590236|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64574047|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590239|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
64574048|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574049|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
64574050|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64574051|NCT04824612|Triamcinolone|triamcinolone|mesh-list
64574052|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64574053|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64574054|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64574055|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64574056|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
64574057|NCT04824612|Hormones|hormones|mesh-ancestor
64574058|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574059|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574060|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574061|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
64574062|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574063|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574064|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64574065|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
64574066|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64574073|NCT02101775|Gemcitabine|gemcitabine|mesh-list
64574075|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64574077|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574078|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574079|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
64574080|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299303|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
64574081|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574082|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574083|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
64574084|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574086|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64574088|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
64574089|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574091|NCT01568073|Carbidopa|carbidopa|mesh-list
64574092|NCT01568073|Opicapone|opicapone|mesh-list
64574093|NCT01568073|Entacapone|entacapone|mesh-list
64574094|NCT01568073|Benserazide|benserazide|mesh-list
64574095|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64574096|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64574097|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
64574098|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574099|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574100|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574101|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64574102|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574103|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64574104|NCT04274933|Capecitabine|capecitabine|mesh-list
64574105|NCT04274933|Venetoclax|venetoclax|mesh-list
64574106|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64574107|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
64574108|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574126|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574128|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
64574129|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64574130|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64574131|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64574132|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
64574133|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574134|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574135|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64574136|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
64574137|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
64574138|NCT02062463|Hormones|hormones|mesh-ancestor
64574139|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574140|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64574141|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64574142|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64574143|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
64574144|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574145|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574146|NCT01501929|Metoprolol|metoprolol|mesh-list
64574147|NCT01501929|Nebivolol|nebivolol|mesh-list
64574148|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64574149|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64574150|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
64574151|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
64574152|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574173|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64574174|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64574175|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64574176|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574177|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574178|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574179|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64574181|NCT02049047|Everolimus|everolimus|mesh-list
64574182|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574183|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574184|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
64574185|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574186|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64574187|NCT04778358|Hormones|hormones|mesh-ancestor
64574188|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574189|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574191|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64574192|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574193|NCT01449747|Incretins|incretins|mesh-ancestor
64574194|NCT01449747|Hormones|hormones|mesh-ancestor
64574195|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574196|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64335692|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64335693|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64335694|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64335695|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335696|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335697|NCT02349243|Entacapone|entacapone|mesh-list
64335698|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64335699|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64335700|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64335701|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335702|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335703|NCT02341209|Doxycycline|doxycycline|mesh-list
64335704|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335705|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335706|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
64335707|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64335708|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64335709|NCT02349165|Riboflavin|riboflavin|mesh-list
64335710|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
64335711|NCT02349165|Vitamins|vitamins|mesh-ancestor
64335712|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
64335713|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335714|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64574199|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574200|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
64574201|NCT03035838|Aprepitant|aprepitant|mesh-list
64574202|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
64574203|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
64574204|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574205|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574206|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64574207|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64574208|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574209|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574210|NCT01569087|Lenograstim|lenograstim|mesh-list
64574211|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64574212|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
64574213|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574214|NCT02024087|Sorafenib|sorafenib|mesh-list
64574215|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574216|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64574217|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574218|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574219|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
64574220|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
64574221|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335715|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
64335716|NCT03112005|Mydriatics|mydriatics|mesh-list
64335717|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
64335718|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335719|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335720|NCT02306785|Mesalamine|mesalamine|mesh-list
64335721|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64335722|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64335723|NCT02306785|Analgesics|analgesics|mesh-ancestor
64335724|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
64335725|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335741|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335743|NCT04771923|Epinephrine|epinephrine|mesh-list
64335744|NCT04771923|Racepinephrine|racepinephrine|mesh-list
64335745|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
64335746|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
64335747|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64335748|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64335749|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335750|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
64335751|NCT04771923|Coagulants|coagulants|mesh-ancestor
64574222|NCT01895621|Protective Agents|protective agents|mesh-ancestor
64574223|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574224|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
64574225|NCT01895621|Vitamins|vitamins|mesh-ancestor
64574226|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
64574227|NCT01517711|Tramadol|tramadol|mesh-list
64361405|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64361418|NCT03332719|Analgesics|analgesics|mesh-ancestor
64574230|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574231|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574232|NCT01517711|Analgesics|analgesics|mesh-ancestor
64574233|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
64574234|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574236|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64574237|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64574238|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
64574239|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574240|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64574241|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
64574242|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
64574243|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
64574244|NCT04836078|Coagulants|coagulants|mesh-ancestor
64574245|NCT01517243|Sirolimus|sirolimus|mesh-list
64574246|NCT01517243|Sunitinib|sunitinib|mesh-list
64574247|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574248|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64574249|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64574250|NCT01517243|Growth Substances|growth substances|mesh-ancestor
64574251|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574277|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574278|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64574279|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64574280|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
64574281|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574282|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574283|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64574284|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
64574285|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
64574286|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
64574287|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64574288|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64574289|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64574290|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574291|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
64574292|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64574293|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574294|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64574295|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64574296|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574297|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
64574298|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
64335752|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64335753|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64335754|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
64335755|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335756|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335757|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64335784|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
64335785|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335786|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335787|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
64335790|NCT05254899|Antiviral Agents|antiviral agents|mesh-ancestor
64574299|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64574300|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64574301|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64574303|NCT01502787|Nebivolol|nebivolol|mesh-list
64574304|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
64574305|NCT01502787|Giapreza|giapreza|mesh-list
64574306|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
64574307|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64574308|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64574309|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
64574310|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
64574311|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574312|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574313|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64574314|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64574315|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64574317|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574318|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574319|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
64574320|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64574321|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64574322|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64574323|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64574324|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64574349|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
64574350|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590271|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590272|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64574351|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574352|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
64574353|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64574354|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64574355|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
64574356|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64574357|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64574358|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
64574359|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64574360|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64574361|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64574362|NCT02318303|Analgesics|analgesics|mesh-ancestor
64574363|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
64361508|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574367|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64574368|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64574369|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
64574370|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
64574371|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574372|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574373|NCT01451775|Empagliflozin|empagliflozin|mesh-list
64574374|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64574375|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574376|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64574377|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574378|NCT04304040|Antibodies|antibodies|mesh-list
64574379|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64574380|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
64574381|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574382|NCT00156013|Clofarabine|clofarabine|mesh-list
64299606|NCT05050448|Analgesics|analgesics|mesh-ancestor
64335798|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
64335799|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574385|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574386|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574387|NCT01358669|Denosumab|denosumab|mesh-list
64574388|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64574389|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574390|NCT00156247|Acitretin|acitretin|mesh-list
64574391|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
64574392|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
64574393|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64574394|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
64574395|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64574396|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64574397|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64574398|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574399|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574400|NCT01573533|Rituximab|rituximab|mesh-list
64574401|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574402|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574403|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
64335800|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335801|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335802|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64335803|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64335812|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335820|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64335821|NCT05254665|Docetaxel|docetaxel|mesh-list
64335822|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335823|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335824|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
64335825|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
64335826|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335827|NCT03513055|Insulin|insulin|mesh-list
64335828|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64335829|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335831|NCT03510325|Risperidone|risperidone|mesh-list
64335832|NCT03510325|Aripiprazole|aripiprazole|mesh-list
64335833|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64335834|NCT03510325|Amisulpride|amisulpride|mesh-list
64335835|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64335836|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
64335837|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335838|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335839|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335840|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64335897|NCT02307565|Midodrine|midodrine|mesh-list
64335898|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
64335899|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
64335912|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335913|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335914|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64335915|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
64574404|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574405|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64574406|NCT01455519|Hydromorphone|hydromorphone|mesh-list
64574407|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64574408|NCT01455519|Narcotics|narcotics|mesh-ancestor
64574409|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574410|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574411|NCT01455519|Analgesics|analgesics|mesh-ancestor
64574412|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
64574413|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574414|NCT00157573|Sargramostim|sargramostim|mesh-list
64574415|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
64574416|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574417|NCT04822038|Vitamin D|vitamin d|mesh-list
64574418|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
64574419|NCT04822038|Vitamins|vitamins|mesh-ancestor
64574420|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
64574421|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574422|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64574423|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64574424|NCT01576809|Acetaminophen|acetaminophen|mesh-list
64574425|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
64574426|NCT01576809|Phenylephrine|phenylephrine|mesh-list
64574427|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
64574428|NCT01576809|Guaifenesin|guaifenesin|mesh-list
64574429|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64574430|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64574431|NCT01576809|Analgesics|analgesics|mesh-ancestor
64574432|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
64574433|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574434|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574435|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
64574436|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64574437|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
64574438|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
64574439|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
64335916|NCT02307721|Remifentanil|remifentanil|mesh-list
64574445|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64574446|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
64574447|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574448|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574449|NCT01576809|Protective Agents|protective agents|mesh-ancestor
64574450|NCT01576809|Expectorants|expectorants|mesh-ancestor
64574451|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
64574452|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64574453|NCT01456143|Proflavine|proflavine|mesh-list
64361637|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361638|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361639|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64361640|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64361641|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
64574454|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64574455|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574456|NCT01456299|Remifentanil|remifentanil|mesh-list
64574457|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64574458|NCT01456299|Narcotics|narcotics|mesh-ancestor
64574459|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574460|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574461|NCT01456299|Analgesics|analgesics|mesh-ancestor
64574462|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
64574463|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574464|NCT00158743|Digoxin|digoxin|mesh-list
64574465|NCT00158743|Antibodies|antibodies|mesh-list
64574466|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
64574467|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
64574468|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574469|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64574470|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64574471|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574472|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574473|NCT00158743|Protective Agents|protective agents|mesh-ancestor
64574474|NCT00161473|Prazosin|prazosin|mesh-list
64574475|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64574476|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64574477|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64574478|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64574486|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64574487|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64574489|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
64574490|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
64574491|NCT01319981|Rituximab|rituximab|mesh-list
64574492|NCT01319981|Doxorubicin|doxorubicin|mesh-list
64574493|NCT01319981|Methotrexate|methotrexate|mesh-list
64574494|NCT01319981|Vincristine|vincristine|mesh-list
64574495|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
64574496|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64574497|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
64574498|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574499|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
64574500|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574501|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64574502|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64574503|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
64574504|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574505|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574506|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64574507|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574508|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64574509|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
64574510|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
64574511|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574512|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64574513|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
64574514|NCT01319981|Hormones|hormones|mesh-ancestor
64590305|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64574515|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574516|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64574517|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64574518|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64574519|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64574520|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335918|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64335920|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361670|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
64335921|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574521|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64574522|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
64574523|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64574524|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64574525|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
64574526|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
64574527|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64574528|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64574529|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
64574530|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574531|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64574532|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
64574533|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
64574534|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
64574535|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64574536|NCT01319981|Protective Agents|protective agents|mesh-ancestor
64574537|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64574539|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64574540|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
64574541|NCT01458561|Coagulants|coagulants|mesh-ancestor
64574542|NCT01896011|Teriparatide|teriparatide|mesh-list
64574543|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64590325|NCT05362513|Permethrin|permethrin|mesh-list
64590326|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64590327|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590328|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574544|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574545|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64574546|NCT00065611|Dexamethasone|dexamethasone|mesh-list
64574547|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64574548|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
64574549|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
64574550|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574551|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574554|NCT00065611|Hormones|hormones|mesh-ancestor
64574570|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64574571|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64574573|NCT01189643|Irinotecan|irinotecan|mesh-list
64574574|NCT01189643|Temozolomide|temozolomide|mesh-list
64574575|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574576|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574577|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64574578|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64574613|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574614|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
64574615|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574616|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574617|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64574618|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64574619|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
64574620|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
64574621|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574622|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64574623|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64574624|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
64574625|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64590365|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64574626|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
64574627|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
64574628|NCT01064375|Molgramostim|molgramostim|mesh-list
64574629|NCT01064375|Sargramostim|sargramostim|mesh-list
64574630|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574631|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
64574632|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574633|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64574634|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64574635|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
64574636|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574637|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574639|NCT01061411|Sunitinib|sunitinib|mesh-list
64574640|NCT01061411|Dalteparin|dalteparin|mesh-list
64574641|NCT01061411|Tinzaparin|tinzaparin|mesh-list
64574642|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64574643|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574644|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64574646|NCT01061411|Growth Substances|growth substances|mesh-ancestor
64574655|NCT01505673|Liraglutide|liraglutide|mesh-list
64574656|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64574657|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574658|NCT01505673|Incretins|incretins|mesh-ancestor
64574659|NCT01505673|Hormones|hormones|mesh-ancestor
64574660|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574661|NCT04834986|Lenvatinib|lenvatinib|mesh-list
64574662|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574663|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64574664|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574665|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574666|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
64574667|NCT04827966|Listerine|listerine|mesh-list
64574668|NCT04827966|Calcium|calcium|mesh-list
64574669|NCT04827966|Fluorides|fluorides|mesh-list
64574670|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
64574671|NCT04827966|Caseins|caseins|mesh-list
64574672|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64574673|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574674|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64574675|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
64574676|NCT04827966|Protective Agents|protective agents|mesh-ancestor
64574677|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64574678|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574679|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
64574680|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
64574681|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574682|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
64574683|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64574684|NCT02247141|Antibodies|antibodies|mesh-list
64574685|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
64574686|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574687|NCT01896245|Sevoflurane|sevoflurane|mesh-list
64574688|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64574689|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64574690|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
64574691|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
64574694|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
64574695|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64574696|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
64574697|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574698|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
64574699|NCT04821804|Protective Agents|protective agents|mesh-ancestor
64574700|NCT04835064|Gemcitabine|gemcitabine|mesh-list
64574701|NCT04835064|Paclitaxel|paclitaxel|mesh-list
64574702|NCT04835064|Folfirinox|folfirinox|mesh-list
64574703|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64574704|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574705|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
64574706|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
64574707|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
64590408|NCT03840421|Gemcitabine|gemcitabine|mesh-list
64574708|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574709|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64574710|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
64574711|NCT04835064|Antiviral Agents|antiviral agents|mesh-ancestor
64574712|NCT04835064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574713|NCT04835064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574714|NCT04835064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574715|NCT04835064|Immunologic Factors|immunologic factors|mesh-ancestor
64361691|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
64574717|NCT00819221|Doxorubicin|doxorubicin|mesh-list
64574718|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64574719|NCT00819221|Olaparib|olaparib|mesh-list
64574720|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64574721|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574722|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64574723|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64574724|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574725|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574726|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64574727|NCT01507779|Vaccines|vaccines|mesh-list
64574728|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
64574735|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574736|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574737|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64574738|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
64574739|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64574740|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574741|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64574742|NCT00068341|Carboplatin|carboplatin|mesh-list
64574743|NCT00068341|Docetaxel|docetaxel|mesh-list
64574744|NCT00068341|Trastuzumab|trastuzumab|mesh-list
64574745|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574746|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
64574747|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
64574748|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
64574749|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574750|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64574751|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
64574752|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64574753|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
64574754|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574755|NCT02605824|Expectorants|expectorants|mesh-ancestor
64574756|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
64574757|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64335922|NCT02307721|Analgesics|analgesics|mesh-ancestor
64335923|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
64335924|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335925|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64335926|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
64335927|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64335928|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
64335929|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64335930|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
64335931|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335932|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335933|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
64335934|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64335935|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590417|NCT03840421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335936|NCT02348463|Clindamycin|clindamycin|mesh-list
64335937|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
64335938|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
64335939|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335940|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335941|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64335942|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335944|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
64574759|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574760|NCT02605824|Protective Agents|protective agents|mesh-ancestor
64574761|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574762|NCT02605824|Antidotes|antidotes|mesh-ancestor
64574763|NCT01896661|Amlodipine|amlodipine|mesh-list
64574764|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
64574765|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
64574766|NCT01896661|Amiloride|amiloride|mesh-list
64574767|NCT01896661|Calcium|calcium|mesh-list
64574768|NCT01896661|Diuretics|diuretics|mesh-list
64574769|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64574770|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574771|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64574772|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64574773|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574774|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
64574775|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
64574776|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64574777|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64574778|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64574779|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64574780|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64574781|NCT01462773|Interferons|interferons|mesh-list
64574782|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
64574783|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
64574784|NCT01462773|Bortezomib|bortezomib|mesh-list
64574785|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574786|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
64574787|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574788|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
64574803|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574804|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574805|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
64574806|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574808|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574809|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574810|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
64574811|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574812|NCT04834440|Ropivacaine|ropivacaine|mesh-list
64574813|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
64574814|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
64574815|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574816|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574817|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
64574818|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574819|NCT00068575|Interferons|interferons|mesh-list
64574820|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
64574821|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
64574822|NCT00068575|Cisplatin|cisplatin|mesh-list
64574823|NCT00068575|Fluorouracil|fluorouracil|mesh-list
64574824|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574825|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
64574826|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574827|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64574828|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64574829|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
64574830|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574831|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
64574850|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64574851|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64574852|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64574853|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64574854|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
64574855|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574856|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574857|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574858|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
64574859|NCT05617950|Salicylates|salicylates|mesh-list
64574860|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574861|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
64574863|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64574864|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64574865|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64574866|NCT05617950|Analgesics|analgesics|mesh-ancestor
64574867|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
64574868|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64574869|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574870|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64574871|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64574872|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64574873|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574874|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574875|NCT04834752|Esomeprazole|esomeprazole|mesh-list
64574876|NCT04834752|Omeprazole|omeprazole|mesh-list
64590469|NCT04145492|Calcifediol|calcifediol|mesh-list
64574877|NCT04834752|Rabeprazole|rabeprazole|mesh-list
64574878|NCT04834752|Pantoprazole|pantoprazole|mesh-list
64574879|NCT04834752|Lansoprazole|lansoprazole|mesh-list
64574880|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
64574881|NCT04834752|Famotidine|famotidine|mesh-list
64574882|NCT04834752|Ranitidine|ranitidine|mesh-list
64574883|NCT04834752|Cimetidine|cimetidine|mesh-list
64574884|NCT04834752|Nizatidine|nizatidine|mesh-list
64574885|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64574893|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64574894|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574895|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64574896|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64574898|NCT04834674|Antibodies|antibodies|mesh-list
64574899|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
64574900|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574901|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574902|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64574903|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574904|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574905|NCT04826406|Apatinib|apatinib|mesh-list
64574906|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574907|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64574908|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64574909|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574910|NCT05617872|Acetic Acid|acetic acid|mesh-list
64574911|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64300127|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
64574912|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574913|NCT04198727|Capecitabine|capecitabine|mesh-list
64574914|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64574915|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
64574917|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574942|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574943|NCT02605122|Amoxicillin|amoxicillin|mesh-list
64574944|NCT02605122|Azithromycin|azithromycin|mesh-list
64574945|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
64574946|NCT02605122|Erythromycin|erythromycin|mesh-list
64574947|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
64574948|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64574949|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
64361766|NCT03318757|Bupivacaine|bupivacaine|mesh-list
64574951|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
64574952|NCT02605122|Ampicillin|ampicillin|mesh-list
64574953|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64574954|NCT02605122|Solithromycin|solithromycin|mesh-list
64574955|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
64574956|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64574957|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64574958|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64574959|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64574960|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590497|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574961|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64574962|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64574963|NCT01579305|Lidocaine|lidocaine|mesh-list
64574964|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
64574965|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
64574966|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64574967|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64574993|NCT01454102|Pemetrexed|pemetrexed|mesh-list
64574994|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64574995|NCT01454102|Ipilimumab|ipilimumab|mesh-list
64574996|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64574997|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64574998|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
64574999|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
64575000|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
64575001|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575002|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64575003|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64575004|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64575005|NCT01454102|Growth Substances|growth substances|mesh-ancestor
64575006|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575007|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64575008|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575009|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
64575010|NCT01454102|Antiviral Agents|antiviral agents|mesh-ancestor
64575011|NCT01454102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575012|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575013|NCT01454102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575014|NCT01454102|Immunologic Factors|immunologic factors|mesh-ancestor
64575015|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64575016|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64575046|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
64575047|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575048|NCT01509807|Morphine|morphine|mesh-list
64575049|NCT01509807|Bupivacaine|bupivacaine|mesh-list
64575050|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
64575051|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
64575052|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575053|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575054|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
64575055|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575056|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64575057|NCT01509807|Narcotics|narcotics|mesh-ancestor
64575058|NCT01509807|Analgesics|analgesics|mesh-ancestor
64575059|NCT00070135|Methotrexate|methotrexate|mesh-list
64575060|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
64575061|NCT00070135|Fludarabine|fludarabine|mesh-list
64575062|NCT00070135|Busulfan|busulfan|mesh-list
64575063|NCT00070135|Tacrolimus|tacrolimus|mesh-list
64575064|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64575065|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64575066|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
64575067|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64575068|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575069|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575071|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575072|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575073|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
64575074|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575075|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64575076|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335966|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
64590518|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64335967|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335968|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64335969|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335998|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
64575078|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575079|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64575080|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64575081|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
64575082|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64575083|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64575084|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
64575085|NCT01583985|Narcotics|narcotics|mesh-ancestor
64575086|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575087|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575088|NCT01583985|Analgesics|analgesics|mesh-ancestor
64575089|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
64575090|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575091|NCT04816344|Anesthetics|anesthetics|mesh-list
64575092|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575093|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575094|NCT01467999|Guanfacine|guanfacine|mesh-list
64575095|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64575096|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64575097|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64575098|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64575099|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
64575100|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575101|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575102|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575103|NCT05617482|Anesthetics|anesthetics|mesh-list
64575104|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575105|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575106|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
64335999|NCT02307955|Protective Agents|protective agents|mesh-ancestor
64336000|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336001|NCT03147963|Docetaxel|docetaxel|mesh-list
64336002|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336003|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
64336004|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
64336030|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64336031|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64336032|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
64336034|NCT02336139|Velpatasvir|velpatasvir|mesh-list
64336035|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
64336036|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575107|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64575108|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
64575109|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575110|NCT01470027|Expectorants|expectorants|mesh-ancestor
64575111|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
64575112|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64575113|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
64590534|NCT04145102|Propolis|propolis|mesh-list
64590535|NCT04145102|Fluorides|fluorides|mesh-list
64575115|NCT01470027|Protective Agents|protective agents|mesh-ancestor
64575116|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575117|NCT01470027|Antidotes|antidotes|mesh-ancestor
64575118|NCT01470651|Modafinil|modafinil|mesh-list
64575119|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64575120|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575121|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64575122|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64575123|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64575124|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575125|NCT01512225|Domperidone|domperidone|mesh-list
64575126|NCT01512225|Maleic acid|maleic acid|mesh-list
64575127|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575128|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575159|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64575160|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64575161|NCT04781777|Insulin|insulin|mesh-list
64575162|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64575163|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575164|NCT04781075|Bupivacaine|bupivacaine|mesh-list
64575165|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
64575167|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575168|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575169|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
64575170|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575171|NCT01586091|Fexofenadine|fexofenadine|mesh-list
64575172|NCT01586091|Levocetirizine|levocetirizine|mesh-list
64575173|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64575174|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64575175|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
64575176|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
64575177|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575178|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575179|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575180|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64575181|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64575182|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
64575183|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
64575184|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64575185|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
64575186|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64575187|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575188|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64575189|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64575190|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64575191|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64575195|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
64575200|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575201|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575202|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575204|NCT01587027|Methazolamide|methazolamide|mesh-list
64575205|NCT01587027|Theophylline|theophylline|mesh-list
64575206|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64575207|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
64575208|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575209|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575210|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64575211|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
64575212|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64575213|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590557|NCT00550277|Panobinostat|panobinostat|mesh-list
64575214|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575215|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
64575216|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64575217|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64575218|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
64575219|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575220|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64575221|NCT01587027|Protective Agents|protective agents|mesh-ancestor
64575222|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64336054|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336055|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
64336056|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336065|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
64336066|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64336067|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64336069|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336070|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64336071|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64336072|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
64336073|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336074|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336075|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64336076|NCT02309281|Aflibercept|aflibercept|mesh-list
64336077|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64336078|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64336079|NCT02309281|Growth Substances|growth substances|mesh-ancestor
64336080|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336081|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
64336082|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336083|NCT02335281|Mesalamine|mesalamine|mesh-list
64336084|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64336085|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64336086|NCT02335281|Analgesics|analgesics|mesh-ancestor
64336087|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
64336089|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575224|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
64575225|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
64575226|NCT01471340|Prednisone|prednisone|mesh-list
64575227|NCT01471340|Prednisolone|prednisolone|mesh-list
64575228|NCT01471340|Albuterol|albuterol|mesh-list
64575229|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
64575230|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
64575231|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64575232|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
64575233|NCT01471340|Hormones|hormones|mesh-ancestor
64575234|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64575235|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575236|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64575237|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575238|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
64575239|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575240|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64575241|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64575242|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
64575243|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64575244|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64575245|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64590602|NCT00496379|Sagopilone|sagopilone|mesh-list
64575246|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361781|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361782|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361783|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361784|NCT02487355|Analgesics|analgesics|mesh-ancestor
64361785|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64361786|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64361788|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
64575247|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575248|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575249|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
64575250|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64575251|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
64575252|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64575253|NCT04754789|Aspirin|aspirin|mesh-list
64575254|NCT04754789|Ticagrelor|ticagrelor|mesh-list
64575255|NCT04754789|Atorvastatin|atorvastatin|mesh-list
64575256|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64336090|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336091|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336092|NCT02309437|Oxycodone|oxycodone|mesh-list
64336093|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64336094|NCT02309437|Narcotics|narcotics|mesh-ancestor
64336095|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336146|NCT02303587|Protective Agents|protective agents|mesh-ancestor
64575258|NCT04754789|Analgesics|analgesics|mesh-ancestor
64575259|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
64575260|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575261|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575262|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64575263|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575264|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64575265|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64575266|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575267|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64575268|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64575269|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575270|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
64575271|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64575272|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64575273|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
64575274|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64575275|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64575276|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64575277|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64575278|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64575279|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
64575280|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575281|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64575282|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64575283|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64575284|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
64575285|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575286|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64361789|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361790|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361791|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64361792|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
64361793|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64361794|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64361795|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64361796|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
64575287|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64575288|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575294|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
64575295|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
64575296|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
64575297|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575298|NCT04806906|Azacitidine|azacitidine|mesh-list
64575300|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575301|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
64575302|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575303|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575304|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575305|NCT04778813|Artesunate|artesunate|mesh-list
64575306|NCT04778813|Lumefantrine|lumefantrine|mesh-list
64575307|NCT04778813|Artemether|artemether|mesh-list
64575308|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64575309|NCT04778813|Artenimol|artenimol|mesh-list
64575310|NCT04778813|Pyronaridine|pyronaridine|mesh-list
64575311|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
64575312|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64575313|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64575314|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575315|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575316|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
64575317|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
64575318|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64575319|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
64575320|NCT04817982|Dexamethasone|dexamethasone|mesh-list
64575321|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
64575322|NCT04817982|Lidocaine|lidocaine|mesh-list
64575323|NCT04817982|BB 1101|bb 1101|mesh-list
64575324|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64575325|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
64575326|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
64575327|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575328|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575329|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575330|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
64575332|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64575333|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64575334|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575335|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
64575336|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575337|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575338|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
64575339|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
64575340|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575341|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
64575342|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64575343|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64575344|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64575345|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64575346|NCT04779047|Ritonavir|ritonavir|mesh-list
64575347|NCT04779047|Lopinavir|lopinavir|mesh-list
64575348|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
64575349|NCT04779047|Ivermectin|ivermectin|mesh-list
64575350|NCT04779047|Remdesivir|remdesivir|mesh-list
64575351|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64575352|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64575353|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
64575354|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575355|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575356|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64575357|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64575358|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
64590630|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64575359|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575360|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64575361|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64575362|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
64575363|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64575374|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575375|NCT03699995|Lidocaine|lidocaine|mesh-list
64575376|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
64575377|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
64575378|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575379|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575380|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
64575381|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575382|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64575383|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64575384|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64575385|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64575386|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575387|NCT01515345|Clopidogrel|clopidogrel|mesh-list
64575388|NCT01515345|Ticagrelor|ticagrelor|mesh-list
64575389|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64575390|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64575391|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64575392|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64575428|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64575429|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64575430|NCT01515657|Analgesics|analgesics|mesh-ancestor
64575431|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
64575432|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575433|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575434|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64575435|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575436|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64575437|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64575438|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575439|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64575440|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64575441|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300650|NCT02117401|Midazolam|midazolam|mesh-list
64575443|NCT01515891|Opicapone|opicapone|mesh-list
64575444|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64575445|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575446|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575447|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64575448|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64575449|NCT00073957|Cytarabine|cytarabine|mesh-list
64575450|NCT00073957|Rituximab|rituximab|mesh-list
64575451|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64575452|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575453|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
64575454|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575455|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575475|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
64575476|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575477|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64575478|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64575479|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64575480|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
64575481|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64575482|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64575483|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575484|NCT04354428|Hematinics|hematinics|mesh-ancestor
64575485|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
64575486|NCT04354428|Vitamins|vitamins|mesh-ancestor
64575487|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
64575488|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575489|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
64575490|NCT04354428|Protective Agents|protective agents|mesh-ancestor
64575491|NCT02090075|Warfarin|warfarin|mesh-list
64575492|NCT02090075|Apixaban|apixaban|mesh-list
64575493|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
64575494|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64361809|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361810|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575495|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
64575496|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64575497|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
64575498|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575499|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575500|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64575501|NCT04817202|Antibodies|antibodies|mesh-list
64575502|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
64575503|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64575504|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
64336147|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64336148|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336149|NCT03916419|Paclitaxel|paclitaxel|mesh-list
64336150|NCT03916419|Carboplatin|carboplatin|mesh-list
64336175|NCT02301715|Oxytocin|oxytocin|mesh-list
64336176|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
64336177|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336178|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336179|NCT03509545|Torsemide|torsemide|mesh-list
64336180|NCT03509545|Furosemide|furosemide|mesh-list
64336181|NCT03509545|Diuretics|diuretics|mesh-ancestor
64336182|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
64336234|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575506|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575507|NCT04775303|Cyclosporine|cyclosporine|mesh-list
64575508|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64575509|NCT04775303|Cyclosporins|cyclosporins|mesh-list
64575510|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575511|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575512|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575513|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
64575514|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575515|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
64590640|NCT01796951|Aspirin|aspirin|mesh-list
64575516|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575517|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
64575518|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575519|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64575520|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64575521|NCT04816968|Vancomycin|vancomycin|mesh-list
64575522|NCT04816968|Meropenem|meropenem|mesh-list
64575523|NCT04816968|Tazobactam|tazobactam|mesh-list
64575524|NCT04816968|Piperacillin|piperacillin|mesh-list
64575525|NCT04816968|Cefepime|cefepime|mesh-list
64575526|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64575527|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64575528|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575529|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64336235|NCT02331771|Donepezil|donepezil|mesh-list
64336236|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64336237|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336238|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336239|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336240|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336256|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336257|NCT02322190|Methoxsalen|methoxsalen|mesh-list
64336328|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336329|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336330|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336331|NCT02321800|Imipenem|imipenem|mesh-list
64336332|NCT02321800|Cilastatin|cilastatin|mesh-list
64336333|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64336334|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336335|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
64336336|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336337|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336338|NCT02338089|Oxytocin|oxytocin|mesh-list
64361816|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64336339|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
64336340|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336341|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336342|NCT02338245|Capecitabine|capecitabine|mesh-list
64336343|NCT02338245|Lapatinib|lapatinib|mesh-list
64336344|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575530|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575531|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575532|NCT02210247|Bupivacaine|bupivacaine|mesh-list
64575533|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
64575534|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
64575535|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575536|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575537|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
64575538|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575539|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64575540|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
64575541|NCT04806438|Lidocaine|lidocaine|mesh-list
64575542|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
64575543|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
64575544|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575545|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575546|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
64575547|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575548|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64575549|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64575550|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64575551|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590656|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
64575552|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575553|NCT00074035|Pentostatin|pentostatin|mesh-list
64575554|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575555|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64575556|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575557|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575558|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64575559|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64575560|NCT00074269|Cyclosporine|cyclosporine|mesh-list
64575561|NCT00074269|Methotrexate|methotrexate|mesh-list
64575562|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
64575564|NCT00074269|Melphalan|melphalan|mesh-list
64575569|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64575570|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575571|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575573|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575574|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575575|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
64575576|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575577|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64575578|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575579|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
64575580|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575581|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64575582|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
64575583|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575584|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64575585|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64575586|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
64575587|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64575588|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
64575589|NCT00074815|Citalopram|citalopram|mesh-list
64575590|NCT00074815|Fluoxetine|fluoxetine|mesh-list
64575591|NCT00074815|Paroxetine|paroxetine|mesh-list
64575592|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64575593|NCT00074815|Sertraline|sertraline|mesh-list
64575594|NCT00074815|Clomipramine|clomipramine|mesh-list
64300820|NCT02120911|Pertuzumab|pertuzumab|mesh-list
64575595|NCT00074815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64590664|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64575615|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64575616|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64575618|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64575619|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
64575620|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64575621|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575623|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
64575624|NCT05562375|Coagulants|coagulants|mesh-ancestor
64575625|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
64575626|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575627|NCT00075829|Thalidomide|thalidomide|mesh-list
64575628|NCT00075829|Dexamethasone|dexamethasone|mesh-list
64575629|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64575630|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
64575631|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
64575632|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575633|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575634|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575635|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
64575636|NCT00075829|Hormones|hormones|mesh-ancestor
64575637|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64575638|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64575639|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575640|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575641|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
64575642|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
64575643|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64575644|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575645|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64575646|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64575647|NCT00075829|Growth Substances|growth substances|mesh-ancestor
64575648|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
64575649|NCT02218203|Lidocaine|lidocaine|mesh-list
64575650|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
64575651|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
64575652|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
64336355|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575653|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575654|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575655|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
64575656|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575657|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64575658|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64575659|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64575660|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64575661|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575662|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
64575663|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
64575664|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64575665|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64575666|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575667|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
64575668|NCT04771715|Nivolumab|nivolumab|mesh-list
64300880|NCT02122939|Citalopram|citalopram|mesh-list
64575669|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64575670|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361860|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
64361861|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
64361862|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575671|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64575672|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575673|NCT04771559|Antibodies|antibodies|mesh-list
64361864|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
64575674|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
64575675|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575677|NCT02592876|Carboplatin|carboplatin|mesh-list
64575678|NCT02592876|Etoposide|etoposide|mesh-list
64575679|NCT02592876|Ifosfamide|ifosfamide|mesh-list
64575680|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64575681|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575682|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
64575695|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64575696|NCT00585559|Analgesics|analgesics|mesh-ancestor
64575697|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
64575698|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575699|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575700|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
64575701|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
64575702|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575703|NCT00585559|Expectorants|expectorants|mesh-ancestor
64575704|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
64575705|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64575706|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
64575707|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575708|NCT00585559|Protective Agents|protective agents|mesh-ancestor
64575709|NCT00585559|Antidotes|antidotes|mesh-ancestor
64575710|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64575711|NCT02763137|Carbidopa|carbidopa|mesh-list
64575712|NCT02763137|Levodopa|levodopa|mesh-list
64575713|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64575714|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
64575715|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575716|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64575717|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64336356|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64336357|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
64336358|NCT02304211|Insulin|insulin|mesh-list
64336359|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64336360|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336361|NCT02311777|Pregabalin|pregabalin|mesh-list
64336362|NCT02311777|Ketamine|ketamine|mesh-list
64336363|NCT02311777|Analgesics|analgesics|mesh-ancestor
64336364|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
64336365|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336366|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336367|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64336368|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64336369|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
64336370|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
64336371|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336372|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64336373|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64336374|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336375|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336376|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
64336377|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64336378|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64336379|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64336380|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64336381|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64336382|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64336383|NCT03504865|Bupivacaine|bupivacaine|mesh-list
64575720|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575721|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575722|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64575723|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575724|NCT01896739|Vaccines|vaccines|mesh-list
64575725|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
64575726|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575727|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
64361900|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64575728|NCT00176839|Melphalan|melphalan|mesh-list
64575729|NCT00176839|Busulfan|busulfan|mesh-list
64575730|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64575731|NCT00176839|Lenograstim|lenograstim|mesh-list
64575732|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575733|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
64575734|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575735|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575736|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64575737|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
64575738|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575739|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575740|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64575741|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64575742|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
64336384|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
64336385|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
64336386|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336387|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336388|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
64336389|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336390|NCT02304289|Artesunate|artesunate|mesh-list
64336391|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
64336392|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64336402|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336403|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336404|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
64336405|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336406|NCT02338011|Gefitinib|gefitinib|mesh-list
64336407|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336408|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64336409|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336410|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336411|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64336412|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64336413|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
64336414|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336415|NCT02337855|Antacids|antacids|mesh-ancestor
64575746|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
64575747|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575748|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575749|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64575750|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
64575751|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575752|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575753|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64575754|NCT02664155|Vitamin K|vitamin k|mesh-list
64575755|NCT02664155|Heparin|heparin|mesh-list
64575756|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
64575757|NCT02664155|Apixaban|apixaban|mesh-list
64575758|NCT02664155|Vitamins|vitamins|mesh-ancestor
64575759|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
64575760|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575761|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
64575762|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64575763|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64575764|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575765|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64575766|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
64575767|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64575768|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
64575769|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575770|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64575771|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
64575772|NCT02664155|Coagulants|coagulants|mesh-ancestor
64575773|NCT04770389|Ezetimibe|ezetimibe|mesh-list
64590728|NCT01798459|Methylphenidate|methylphenidate|mesh-list
64361907|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64575774|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
64575775|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64361908|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575776|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
64575777|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575778|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64575779|NCT04753619|Niclosamide|niclosamide|mesh-list
64575780|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
64575781|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64575782|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
64575783|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64575784|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575785|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
64575786|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64575787|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64575788|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575789|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
64575790|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64575791|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64575792|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575793|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
64575794|NCT04753151|Coagulants|coagulants|mesh-ancestor
64575795|NCT05606315|Midazolam|midazolam|mesh-list
64575796|NCT05606315|Propofol|propofol|mesh-list
64575797|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64575798|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575799|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575800|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64575801|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
64575802|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
64575803|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64575804|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64575805|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64575806|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64575807|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
64575808|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
64575809|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575810|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575811|NCT05605925|Ivermectin|ivermectin|mesh-list
64575812|NCT05605925|Lumefantrine|lumefantrine|mesh-list
64575813|NCT05605925|Artemether|artemether|mesh-list
64575814|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64575815|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64575824|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64575825|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64575826|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
64575827|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64575828|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575829|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575830|NCT01855607|Menthol|menthol|mesh-list
64575831|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
64575832|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
64575833|NCT01596699|Fludarabine|fludarabine|mesh-list
64575834|NCT01596699|Busulfan|busulfan|mesh-list
64575835|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
64575836|NCT01596699|Clofarabine|clofarabine|mesh-list
64575837|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575838|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575839|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
64575840|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575841|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575842|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
64575843|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575844|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
64575845|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64575846|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64575847|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64575848|NCT01148849|Margetuximab|margetuximab|mesh-list
64575849|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575850|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
64575851|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
64575852|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361916|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
64575853|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
64575854|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575856|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575857|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
64336416|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336417|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64575858|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575859|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575860|NCT05596721|Azithromycin|azithromycin|mesh-list
64575861|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64575862|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575863|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
64575864|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64575865|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64575866|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64575867|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64575868|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575869|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
64575870|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575871|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575872|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64575873|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575874|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64575875|NCT01525173|Bimatoprost|bimatoprost|mesh-list
64575876|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64575877|NCT01525173|Latanoprost|latanoprost|mesh-list
64575878|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64575879|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
64575880|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64575881|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64575882|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64575883|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64575884|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64575885|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575886|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575887|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575889|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
64575890|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575891|NCT03007563|Protective Agents|protective agents|mesh-ancestor
64575892|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575896|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64575897|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575898|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64575899|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64575900|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
64575901|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
64575902|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64575903|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64575904|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64575905|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575906|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575907|NCT01526577|Ticagrelor|ticagrelor|mesh-list
64575908|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64575909|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64575910|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64575911|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64575912|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
64590742|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575913|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64575914|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575915|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575917|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
64575918|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64575919|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575920|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64575921|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64575922|NCT01894451|Growth Substances|growth substances|mesh-ancestor
64575923|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575924|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
64575925|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64575926|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575927|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
64575930|NCT01527045|Fludarabine|fludarabine|mesh-list
64575931|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
64575932|NCT01527045|Atorvastatin|atorvastatin|mesh-list
64575933|NCT01527045|Calcium|calcium|mesh-list
64575934|NCT01527045|Cyclosporins|cyclosporins|mesh-list
64575935|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64575936|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575937|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64575938|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575939|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575940|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
64575941|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590750|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64575942|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575943|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
64575944|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575945|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
64575946|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575947|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
64336418|NCT02320396|Desloratadine|desloratadine|mesh-list
64336419|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64336420|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336444|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336445|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64336446|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
64336447|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336448|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336449|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64336450|NCT03505411|Melatonin|melatonin|mesh-list
64336451|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
64336452|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336453|NCT03505411|Protective Agents|protective agents|mesh-ancestor
64336454|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336455|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336456|NCT02292238|Benphothiamine|benphothiamine|mesh-list
64336457|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64336458|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
64361946|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
64361947|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361948|NCT05105139|Triclosan|triclosan|mesh-list
64361949|NCT05105139|Coal Tar|coal tar|mesh-list
64361950|NCT05105139|Allantoin|allantoin|mesh-list
64361952|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336459|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336461|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
64336462|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336463|NCT02631447|Nivolumab|nivolumab|mesh-list
64336464|NCT02631447|Ipilimumab|ipilimumab|mesh-list
64336465|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336466|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336467|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64336468|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336482|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64336483|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
64336484|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64336485|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64336486|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64336487|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336489|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64336490|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64575949|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64575950|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64575951|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64575952|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64575953|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64575954|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64575955|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64575956|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
64575957|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64575958|NCT00078403|Ribavirin|ribavirin|mesh-list
64575959|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64575960|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
64575961|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575962|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
64575963|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575964|NCT01976585|Poly ICLC|poly iclc|mesh-list
64575965|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
64575966|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
64575967|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64575968|NCT01972919|Gemcitabine|gemcitabine|mesh-list
64575969|NCT01972919|Capecitabine|capecitabine|mesh-list
64590770|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
64575970|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64575971|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
64575972|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64575973|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64575974|NCT01972919|Antiviral Agents|antiviral agents|mesh-ancestor
64575975|NCT01972919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64575976|NCT01972919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64575977|NCT01972919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64575995|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64575996|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64575997|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64575998|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64575999|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576000|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576001|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64576002|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
64576003|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64576004|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
64576005|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64576006|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64576007|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576008|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576011|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64576012|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576013|NCT02592798|Abatacept|abatacept|mesh-list
64576014|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64576015|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576016|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576017|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576018|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
64576019|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576020|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576021|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64576022|NCT01530243|Terazosin|terazosin|mesh-list
64576023|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64576024|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64576025|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
64576026|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576037|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576038|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576039|NCT04797546|Analgesics|analgesics|mesh-ancestor
64576040|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
64576041|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576042|NCT02980809|Apatinib|apatinib|mesh-list
64590806|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64576043|NCT02980809|Topotecan|topotecan|mesh-list
64576044|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576045|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64576046|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576047|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576048|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64576049|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576051|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
64576052|NCT00078559|Promethazine|promethazine|mesh-list
64576053|NCT00078559|Sirolimus|sirolimus|mesh-list
64576054|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64576055|NCT00078559|Nystatin|nystatin|mesh-list
64576056|NCT00078559|Clotrimazole|clotrimazole|mesh-list
64576057|NCT00078559|Miconazole|miconazole|mesh-list
64336491|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64336492|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64336493|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336494|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64336495|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336496|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
64336497|NCT03505255|Neostigmine|neostigmine|mesh-list
64336510|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336511|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64336512|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336530|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64336532|NCT02333565|Octreotide|octreotide|mesh-list
64336533|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336534|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64336535|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
64336536|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336537|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64336538|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64336539|NCT03105375|Omeprazole|omeprazole|mesh-list
64336540|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64336541|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64336542|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64336544|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336545|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
64362005|NCT02483299|Hormones|hormones|mesh-ancestor
64336546|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64336547|NCT02304445|Estrogens|estrogens|mesh-ancestor
64336548|NCT02304445|Hormones|hormones|mesh-ancestor
64576059|NCT00078559|Trimethoprim|trimethoprim|mesh-list
64576060|NCT00078559|Valganciclovir|valganciclovir|mesh-list
64576061|NCT00078559|Acyclovir|acyclovir|mesh-list
64576062|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
64576063|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
64576064|NCT00078559|Tacrolimus|tacrolimus|mesh-list
64576065|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576066|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
64576067|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590834|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64576068|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64576069|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590835|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64576070|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576071|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64576072|NCT00078559|Analgesics|analgesics|mesh-ancestor
64576073|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
64576074|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576075|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
64576076|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64576077|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576078|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64576079|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576080|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
64576081|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64576082|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
64576083|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
64576084|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576085|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
64576086|NCT00078559|Hormones|hormones|mesh-ancestor
64576087|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576088|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64576105|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
64576106|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64576107|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64576108|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64576109|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64576110|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64576111|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64576112|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
64576113|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64576114|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64576115|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64576116|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
64576117|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64576118|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64576119|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64576120|NCT00078559|Ionophores|ionophores|mesh-ancestor
64576121|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576122|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
64576123|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64576124|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576126|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
64576127|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
64576128|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576129|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576130|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64576131|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64576132|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64576153|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64576154|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64576155|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576156|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64576157|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576158|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576159|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64576160|NCT02596620|Renal Agents|renal agents|mesh-ancestor
64576161|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64576162|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576163|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576164|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64576165|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64576166|NCT01531959|Midodrine|midodrine|mesh-list
64576167|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
64576168|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
64576169|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576170|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576171|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64576172|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64576173|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64576174|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64576175|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576176|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576177|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576178|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
64576179|NCT01532349|Vitamin D|vitamin d|mesh-list
64576180|NCT01532349|Vitamins|vitamins|mesh-ancestor
64576181|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
64576182|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576183|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64576184|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64576194|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576195|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576196|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
64590889|NCT03586466|Narcotics|narcotics|mesh-ancestor
64590892|NCT03586466|Analgesics|analgesics|mesh-ancestor
64576197|NCT01533207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576198|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576199|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576200|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
64576201|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576202|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
64576203|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
64576204|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
64576205|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64576206|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64576207|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576208|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64576210|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64576211|NCT00182767|Epothilone B|epothilone b|mesh-list
64576212|NCT00182767|Epothilones|epothilones|mesh-list
64576213|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64576214|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576215|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64576216|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576217|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576218|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576219|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
64576220|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
64576221|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
64576222|NCT01533597|Tamsulosin|tamsulosin|mesh-list
64576223|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
64576224|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64576225|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64576226|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64576227|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576228|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336549|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362024|NCT02489929|Azacitidine|azacitidine|mesh-list
64576229|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576230|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576231|NCT01533597|Urological Agents|urological agents|mesh-ancestor
64576232|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64576233|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64576234|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
64576236|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64576237|NCT03006627|Narcotics|narcotics|mesh-ancestor
64576238|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576239|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576240|NCT03006627|Analgesics|analgesics|mesh-ancestor
64576241|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
64576242|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576243|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
64576244|NCT04796688|Fludarabine|fludarabine|mesh-list
64576245|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576246|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
64576247|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576248|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576249|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64576250|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
64576251|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576252|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576253|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64576255|NCT01535001|Pantoprazole|pantoprazole|mesh-list
64576256|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64576257|NCT01535001|Analgesics|analgesics|mesh-ancestor
64576258|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
64576259|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590922|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576260|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576261|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
64576262|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64576263|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576264|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64576267|NCT03000777|Melatonin|melatonin|mesh-list
64576269|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576270|NCT03000777|Protective Agents|protective agents|mesh-ancestor
64576271|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576272|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576273|NCT03006003|Alendronate|alendronate|mesh-list
64576274|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64576275|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64576276|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576277|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64576278|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
64576279|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576280|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64576281|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64576282|NCT04426734|Dexamethasone|dexamethasone|mesh-list
64576283|NCT04426734|Prednisolone|prednisolone|mesh-list
64576284|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64576285|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
64576286|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64576288|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64576289|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
64576290|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64576291|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
64576292|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
64576293|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576294|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576295|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576314|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576315|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576316|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64576317|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64576318|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
64576320|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576321|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64576322|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64576323|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576324|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576325|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64576326|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64576327|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64576328|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64576329|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64576330|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
64576332|NCT04813848|Fluorides|fluorides|mesh-list
64590935|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64576333|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
64576334|NCT04813848|Protective Agents|protective agents|mesh-ancestor
64576335|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576336|NCT02999841|Vildagliptin|vildagliptin|mesh-list
64576337|NCT02999841|Acarbose|acarbose|mesh-list
64576338|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64576341|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
64576363|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576364|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576366|NCT04803318|Lenvatinib|lenvatinib|mesh-list
64576367|NCT04803318|Trametinib|trametinib|mesh-list
64576368|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576369|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576370|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
64576371|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576372|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64576373|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576374|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576375|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
64576376|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64576377|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
64576378|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576379|NCT04803162|Omeprazole|omeprazole|mesh-list
64576380|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64576381|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576382|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64576383|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576384|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576385|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64576386|NCT02999217|Hematinics|hematinics|mesh-ancestor
64576387|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64576388|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64576389|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
64576390|NCT02980965|Docetaxel|docetaxel|mesh-list
64576391|NCT02980965|Fluorouracil|fluorouracil|mesh-list
64576393|NCT02980965|Epirubicin|epirubicin|mesh-list
64576394|NCT02980965|Leuprolide|leuprolide|mesh-list
64576409|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64576410|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64576411|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576412|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64576413|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
64576414|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576415|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64576416|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64576417|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576418|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64576419|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
64576420|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64576421|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64576422|NCT01538745|Ketamine|ketamine|mesh-list
64576423|NCT01538745|Morphine|morphine|mesh-list
64576424|NCT01538745|Analgesics|analgesics|mesh-ancestor
64576425|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
64576426|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576427|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576428|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64576429|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64576430|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
64576432|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576433|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64576434|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64576435|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590958|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576436|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576438|NCT01538745|Narcotics|narcotics|mesh-ancestor
64576454|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576455|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64576456|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576457|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
64576458|NCT04802928|Isoniazid|isoniazid|mesh-list
64576459|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
64576460|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64576461|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576462|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64576463|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64576464|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
64576465|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576466|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64576467|NCT05365425|Choline|choline|mesh-list
64576468|NCT05365425|Policosanol|policosanol|mesh-list
64576469|NCT05365425|Fenofibrate|fenofibrate|mesh-list
64576470|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64576471|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
64576472|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576473|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64576474|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
64576475|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576476|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
64576477|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64576478|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64576479|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64576480|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576481|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64576482|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576483|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576498|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576500|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
64576501|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576502|NCT04794426|Fluorides|fluorides|mesh-list
64362076|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576503|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
64576504|NCT04794426|Protective Agents|protective agents|mesh-ancestor
64576505|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576506|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64576507|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64576508|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576509|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576510|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64576511|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576512|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576513|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
64576514|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576516|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64576517|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576518|NCT02591238|Melatonin|melatonin|mesh-list
64576519|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
64576520|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576521|NCT02591238|Protective Agents|protective agents|mesh-ancestor
64576522|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576523|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576524|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
64576525|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64576526|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
64576527|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576528|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576529|NCT04793256|Listerine|listerine|mesh-list
64576530|NCT04793256|Fluorides|fluorides|mesh-list
64576531|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
64576538|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64576539|NCT04997811|Valproic Acid|valproic acid|mesh-list
64576540|NCT04997811|Bezafibrate|bezafibrate|mesh-list
64576541|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
64576542|NCT04997811|Danazol|danazol|mesh-list
64576543|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
64576544|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576545|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576546|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
64576547|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576548|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576549|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
64576550|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64576551|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576552|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64576553|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64576554|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64576555|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64576556|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
64576557|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64576558|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64576559|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64576560|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64576561|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64576562|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576563|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64576564|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
64576565|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64591015|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64576566|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64591016|NCT00612235|Analgesics|analgesics|mesh-ancestor
64316331|NCT04428086|Metformin|metformin|mesh-list
64576567|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
64576568|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64576569|NCT05672355|Vaccines|vaccines|mesh-list
64576580|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576581|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64576582|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64576583|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64576584|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64362085|NCT05463367|Tramadol|tramadol|mesh-list
64362086|NCT05463367|Hydrocodone|hydrocodone|mesh-list
64576586|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576587|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576588|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64576589|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576590|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576591|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
64576592|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576593|NCT04814433|Lidocaine|lidocaine|mesh-list
64576594|NCT04814433|Epinephrine|epinephrine|mesh-list
64576595|NCT04814433|Racepinephrine|racepinephrine|mesh-list
64576596|NCT04814433|Bupivacaine|bupivacaine|mesh-list
64576597|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
64576598|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
64576599|NCT04814433|Thrombin|thrombin|mesh-list
64576600|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
64576601|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
64576602|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
64576603|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576604|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576605|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
64576606|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576607|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64576628|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
64576629|NCT03004209|Hematinics|hematinics|mesh-ancestor
64576631|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64576632|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576633|NCT04791774|Caseins|caseins|mesh-list
64576634|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
64576635|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
64576636|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576637|NCT00183469|Lamotrigine|lamotrigine|mesh-list
64576638|NCT00183469|Valproic Acid|valproic acid|mesh-list
64576639|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
64576640|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64576641|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576642|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576643|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64576644|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576645|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64576646|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64576647|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576648|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64576649|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64576650|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576651|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
64576652|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576653|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
64576654|NCT02248155|Pramipexole|pramipexole|mesh-list
64576655|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
64576656|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576657|NCT02248155|Protective Agents|protective agents|mesh-ancestor
64591037|NCT00499109|Docetaxel|docetaxel|mesh-list
64576658|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576659|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64576660|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64576670|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
64576671|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576672|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64576673|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576674|NCT02248233|Nimodipine|nimodipine|mesh-list
64576675|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64576676|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
64576677|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64576679|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576680|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576681|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64576682|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576683|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
64576684|NCT04790838|Fluticasone|fluticasone|mesh-list
64576685|NCT04790838|Xhance|xhance|mesh-list
64576686|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64576687|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64576688|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64576689|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64576690|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
64576691|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576692|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576693|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64576694|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
64576695|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
64576696|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64576697|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64576698|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64576699|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64576700|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576701|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576702|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576703|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
64576706|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
64576707|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64576708|NCT03003273|Amoxicillin|amoxicillin|mesh-list
64576709|NCT03003273|Levofloxacin|levofloxacin|mesh-list
64576710|NCT03003273|Ofloxacin|ofloxacin|mesh-list
64576711|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
64576712|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
64576713|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576714|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64576715|NCT03003273|Renal Agents|renal agents|mesh-ancestor
64576716|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64576717|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576718|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576719|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576720|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576721|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64576722|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64576723|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64576724|NCT05571345|Oxycodone|oxycodone|mesh-list
64576725|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64576726|NCT05571345|Narcotics|narcotics|mesh-ancestor
64576727|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576728|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576729|NCT05571345|Analgesics|analgesics|mesh-ancestor
64576730|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
64591043|NCT00499109|Antiviral Agents|antiviral agents|mesh-ancestor
64576731|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576732|NCT02981121|Metformin|metformin|mesh-list
64576733|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64576755|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576756|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
64576758|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576759|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576760|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64576761|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64576762|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64576763|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64576765|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64576766|NCT04811274|Dimercaprol|dimercaprol|mesh-list
64576767|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
64576768|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
64576769|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576770|NCT04799184|Epinephrine|epinephrine|mesh-list
64576771|NCT04799184|Racepinephrine|racepinephrine|mesh-list
64576772|NCT04799184|Bupivacaine|bupivacaine|mesh-list
64576773|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
64576775|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
64576776|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
64576777|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576778|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576779|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
64576780|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576781|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64576782|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64576783|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
64576784|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576785|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576786|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64576787|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64576788|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
64576789|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64336571|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336573|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64336574|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
64576790|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
64576792|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
64576793|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64576794|NCT05562297|Gemcitabine|gemcitabine|mesh-list
64576795|NCT05562297|Paclitaxel|paclitaxel|mesh-list
64576796|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64576797|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576798|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
64576799|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
64576800|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
64576801|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576802|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64576803|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
64591055|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
64576804|NCT05562297|Antiviral Agents|antiviral agents|mesh-ancestor
64576805|NCT05562297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576806|NCT05562297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576807|NCT05562297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576808|NCT05562297|Immunologic Factors|immunologic factors|mesh-ancestor
64576809|NCT05562297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576810|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64576811|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64576812|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
64576813|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576814|NCT04790136|Cannabidiol|cannabidiol|mesh-list
64576815|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
64576816|NCT04339101|Sirolimus|sirolimus|mesh-list
64576817|NCT04339101|Fludarabine|fludarabine|mesh-list
64576818|NCT04339101|Melphalan|melphalan|mesh-list
64576819|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
64576820|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64576821|NCT04339101|Tacrolimus|tacrolimus|mesh-list
64576822|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576823|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576833|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64576835|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64576837|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64576838|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576839|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
64576840|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576841|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64576842|NCT03002961|Buprenorphine|buprenorphine|mesh-list
64576843|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64576844|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64576845|NCT03002961|Narcotics|narcotics|mesh-ancestor
64576846|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576847|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576848|NCT03002961|Analgesics|analgesics|mesh-ancestor
64576849|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
64576850|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576851|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64576852|NCT03002805|Doxorubicin|doxorubicin|mesh-list
64576853|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64576854|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576855|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64576856|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64576857|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576858|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576859|NCT05401227|Ketamine|ketamine|mesh-list
64576860|NCT05401227|Analgesics|analgesics|mesh-ancestor
64576861|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
64576878|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576879|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
64576880|NCT04786158|Apomorphine|apomorphine|mesh-list
64576881|NCT04786158|Emetics|emetics|mesh-ancestor
64576882|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576883|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
64576884|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576885|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576886|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
64576887|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
64576888|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64576889|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576890|NCT05367687|Apatinib|apatinib|mesh-list
64576891|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576892|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64576893|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576894|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576895|NCT03002493|Rifampin|rifampin|mesh-list
64576896|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64576897|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
64576898|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64576899|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576900|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
64576901|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64576902|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576904|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64576927|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
64362110|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362112|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
64576928|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
64576929|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576930|NCT04786470|Ropivacaine|ropivacaine|mesh-list
64576931|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
64576932|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
64576933|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576934|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576935|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
64576936|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576937|NCT04786002|Busulfan|busulfan|mesh-list
64576938|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
64576939|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576940|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64576941|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
64576942|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576943|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64576944|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64576945|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64576946|NCT04788654|Acetaminophen|acetaminophen|mesh-list
64576947|NCT04788654|Dexamethasone|dexamethasone|mesh-list
64576948|NCT04788654|Celecoxib|celecoxib|mesh-list
64576949|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64576950|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
64576951|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
64362126|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
64362127|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362128|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576952|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576953|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576954|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64576955|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
64576956|NCT04788654|Hormones|hormones|mesh-ancestor
64576958|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64576972|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64576973|NCT04785768|Narcotics|narcotics|mesh-ancestor
64576974|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64576975|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64576976|NCT04785768|Analgesics|analgesics|mesh-ancestor
64576977|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
64576978|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64576979|NCT02223351|Ritonavir|ritonavir|mesh-list
64576980|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64576981|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64576982|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
64576983|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64576984|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64576985|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64576986|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64576987|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
64576988|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64576989|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64576990|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64576997|NCT02223429|Vasopressins|vasopressins|mesh-list
64576998|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
64576999|NCT02223429|Oxytocin|oxytocin|mesh-list
64577000|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577001|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
64577002|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64591087|NCT02125721|Antidotes|antidotes|mesh-ancestor
64577003|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
64577004|NCT02223429|Coagulants|coagulants|mesh-ancestor
64577005|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64577006|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64577007|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
64577008|NCT03002649|Tofacitinib|tofacitinib|mesh-list
64577009|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577022|NCT04785222|Analgesics|analgesics|mesh-ancestor
64577023|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64577024|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64577025|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64577026|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
64577027|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577028|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577029|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
64577030|NCT04808856|Hormones|hormones|mesh-list
64577031|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64577032|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64577033|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
64577034|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577035|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577036|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577037|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
64577038|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
64577039|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577040|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577041|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
64577042|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64577043|NCT04808856|Protective Agents|protective agents|mesh-ancestor
64577044|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577045|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577046|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64577047|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
64577048|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577049|NCT04808622|Protective Agents|protective agents|mesh-ancestor
64577050|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577051|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64577064|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64577066|NCT04784988|Coagulants|coagulants|mesh-ancestor
64577067|NCT04784910|Lansoprazole|lansoprazole|mesh-list
64577068|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
64577069|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64577070|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577071|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64577072|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577073|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577075|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
64577076|NCT01625013|Protective Agents|protective agents|mesh-ancestor
64577077|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577078|NCT00083551|Interferons|interferons|mesh-list
64577079|NCT00083551|Cytarabine|cytarabine|mesh-list
64577080|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
64577081|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
64577082|NCT00083551|Thalidomide|thalidomide|mesh-list
64577083|NCT00083551|Dexamethasone|dexamethasone|mesh-list
64577084|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
64577085|NCT00083551|Melphalan|melphalan|mesh-list
64577086|NCT00083551|Carmustine|carmustine|mesh-list
64577087|NCT00083551|Cisplatin|cisplatin|mesh-list
64577088|NCT00083551|Doxorubicin|doxorubicin|mesh-list
64577089|NCT00083551|Etoposide|etoposide|mesh-list
64577090|NCT00083551|Vincristine|vincristine|mesh-list
64577091|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577092|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
64577093|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577094|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577095|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64577114|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
64577115|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577116|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577117|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
64577118|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
64577119|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
64577120|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
64577121|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
64577122|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577123|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64577124|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64577125|NCT00083551|Growth Substances|growth substances|mesh-ancestor
64577126|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
64577127|NCT01625169|Etravirine|etravirine|mesh-list
64577128|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64577129|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64577130|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577131|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577133|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577134|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64577135|NCT03933813|Hematinics|hematinics|mesh-ancestor
64577136|NCT01628601|Timolol|timolol|mesh-list
64577137|NCT01628601|Bimatoprost|bimatoprost|mesh-list
64577138|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64577139|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64577140|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
64577141|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577142|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577143|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577144|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64336575|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336576|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336577|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
64336578|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336579|NCT02039661|Lidocaine|lidocaine|mesh-list
64336580|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
64336597|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336598|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577145|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64577146|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
64577147|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577148|NCT04091022|Eflornithine|eflornithine|mesh-list
64577149|NCT04091022|Diclofenac|diclofenac|mesh-list
64591112|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577150|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64577151|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64577153|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
64577154|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577155|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577156|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577157|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577158|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64577159|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577160|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577161|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577162|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64577163|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64577164|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64577165|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577166|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64577167|NCT01490918|Metformin|metformin|mesh-list
64577168|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64577169|NCT01490918|Acarbose|acarbose|mesh-list
64577196|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577197|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577198|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
64577199|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577200|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64577201|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64577202|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64577203|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64577204|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577205|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577206|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
64577207|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
64577208|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577209|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
64577210|NCT02995083|Hormones|hormones|mesh-ancestor
64577211|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577213|NCT02995083|Protective Agents|protective agents|mesh-ancestor
64577214|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577215|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577216|NCT03794388|Pregabalin|pregabalin|mesh-list
64577217|NCT03794388|Capsaicin|capsaicin|mesh-list
64577218|NCT03794388|Analgesics|analgesics|mesh-ancestor
64577219|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
64577220|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577221|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577222|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
64577243|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
64577244|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64577245|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64577246|NCT04976868|Analgesics|analgesics|mesh-ancestor
64577247|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
64577248|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577249|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577250|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577251|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577252|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
64577253|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577254|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
64577255|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64577256|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577257|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577258|NCT01632423|Bimatoprost|bimatoprost|mesh-list
64577259|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64577260|NCT05466318|Gemcitabine|gemcitabine|mesh-list
64577262|NCT05466318|Etoposide|etoposide|mesh-list
64577263|NCT05466318|Melphalan|melphalan|mesh-list
64577264|NCT05466318|Busulfan|busulfan|mesh-list
64577265|NCT05466318|Carmustine|carmustine|mesh-list
64577266|NCT05466318|Cladribine|cladribine|mesh-list
64577267|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577268|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
64577269|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577270|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577292|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577294|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577295|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64577296|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577297|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577298|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
64577299|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577300|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577301|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64577302|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64577303|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
64577304|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
64577305|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64577306|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577307|NCT00081263|Celecoxib|celecoxib|mesh-list
64577308|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
64577309|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64577310|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64577311|NCT00081263|Analgesics|analgesics|mesh-ancestor
64577312|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
64577313|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577314|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577315|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577316|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577317|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64577318|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64577319|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577338|NCT05087381|Bromhexine|bromhexine|mesh-list
64577339|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577340|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577341|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64577342|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64577343|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577344|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577345|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64577346|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64577347|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64577348|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64577349|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577350|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
64577351|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64577352|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
64577353|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64577354|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64577355|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64577356|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
64577357|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64577358|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
64577359|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64577360|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577361|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
64577362|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
64577380|NCT00080483|Hormones|hormones|mesh-ancestor
64577385|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
64577386|NCT05248620|Amoxicillin|amoxicillin|mesh-list
64577387|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577388|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577389|NCT01639599|Dexamethasone|dexamethasone|mesh-list
64577390|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
64577391|NCT01639599|Haloperidol|haloperidol|mesh-list
64577392|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
64577393|NCT01639599|BB 1101|bb 1101|mesh-list
64577394|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577395|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
64577396|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
64577397|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577398|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577399|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577400|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
64577401|NCT01639599|Hormones|hormones|mesh-ancestor
64577402|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577403|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577404|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577405|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
64577406|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577407|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591204|NCT03585140|Adapalene|adapalene|mesh-list
64577408|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64577409|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64577410|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577411|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64577412|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64577414|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577415|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64577416|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
64577417|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64577418|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577429|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64577430|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64577431|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577432|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64577433|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577434|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577435|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577437|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64577438|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64577439|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64577440|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64577441|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
64577442|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577443|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577444|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591215|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591216|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591217|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591218|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
64591220|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
64577445|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64577446|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577447|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577448|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
64577449|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64577450|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577451|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
64577475|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64577476|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
64577477|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591259|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
64577478|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
64577479|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
64577480|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
64577482|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
64577483|NCT05346419|Vitamins|vitamins|mesh-ancestor
64577484|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
64577485|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577486|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64577487|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64577488|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64577489|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577490|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64577491|NCT00084409|Iloprost|iloprost|mesh-list
64577492|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64577493|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
64577494|NCT03831165|Acyclovir|acyclovir|mesh-list
64577495|NCT03831165|Melatonin|melatonin|mesh-list
64577496|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
64577497|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577498|NCT03831165|Protective Agents|protective agents|mesh-ancestor
64577499|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577500|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577501|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
64577502|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577503|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64577504|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64577522|NCT03849651|Melphalan|melphalan|mesh-list
64577523|NCT03849651|Thiotepa|thiotepa|mesh-list
64577524|NCT03849651|Fludarabine|fludarabine|mesh-list
64577525|NCT03849651|Blinatumomab|blinatumomab|mesh-list
64577526|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
64577527|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577528|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
64577529|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577530|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577531|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64577532|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
64577533|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577534|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577535|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64577536|NCT05574985|Vaccines|vaccines|mesh-list
64577537|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
64577538|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577539|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
64577540|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64577541|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577542|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577543|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577544|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64577545|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64577546|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591260|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577547|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577548|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577549|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64577550|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
64577551|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64577562|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577563|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577564|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577565|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577566|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577567|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
64577568|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577569|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
64577570|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577571|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577572|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
64577573|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64577574|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
64577575|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
64577576|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
64577577|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64577578|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577579|NCT04714541|Ketamine|ketamine|mesh-list
64577580|NCT04714541|Analgesics|analgesics|mesh-ancestor
64577615|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577616|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577617|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64577618|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
64577619|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577620|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577621|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64577622|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577623|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
64577624|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
64577625|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577626|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577629|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64577630|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64577631|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
64577632|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302867|NCT02435680|Gemcitabine|gemcitabine|mesh-list
64577634|NCT03693807|Fluorouracil|fluorouracil|mesh-list
64577635|NCT03693807|Floxuridine|floxuridine|mesh-list
64577636|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
64577637|NCT03693807|Irinotecan|irinotecan|mesh-list
64577638|NCT03693807|Cetuximab|cetuximab|mesh-list
64577639|NCT03693807|Panitumumab|panitumumab|mesh-list
64577640|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577641|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
64577642|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577643|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577644|NCT03693807|Antiviral Agents|antiviral agents|mesh-ancestor
64577645|NCT03693807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577656|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64577657|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577658|NCT03692403|Quinagolide|quinagolide|mesh-list
64577659|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
64577660|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
64577661|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577662|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577663|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577664|NCT01828710|Folic Acid|folic acid|mesh-list
64577665|NCT01828710|Inositol|inositol|mesh-list
64577666|NCT01828710|Hematinics|hematinics|mesh-ancestor
64577667|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
64577668|NCT01828710|Vitamins|vitamins|mesh-ancestor
64577669|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
64577670|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577671|NCT00088699|Ketamine|ketamine|mesh-list
64577672|NCT00088699|Analgesics|analgesics|mesh-ancestor
64577673|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
64577674|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577675|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577676|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64577677|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64577678|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
64577679|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
64577680|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577681|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64577682|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64577683|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64577684|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577685|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
64362326|NCT05196945|Amoxicillin|amoxicillin|mesh-list
64577686|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64577699|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577700|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
64577701|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577702|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64577703|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577704|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64577705|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64577706|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
64577707|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577708|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302930|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
64577709|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
64577710|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
64577711|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64577712|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577713|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64577714|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
64577715|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577716|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591300|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64591301|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577717|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577718|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577719|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64577721|NCT00347412|Carboplatin|carboplatin|mesh-list
64577722|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64577723|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577724|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
64577725|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
64577726|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
64577727|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577742|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64577743|NCT00193375|Bevacizumab|bevacizumab|mesh-list
64577745|NCT00193375|Irinotecan|irinotecan|mesh-list
64577746|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577747|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577748|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64577749|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64577750|NCT00193375|Growth Substances|growth substances|mesh-ancestor
64577751|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577752|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
64577753|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64577754|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64577755|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577756|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577757|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64577758|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
64577759|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64577760|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577761|NCT04589208|Ketamine|ketamine|mesh-list
64577762|NCT04589208|Analgesics|analgesics|mesh-ancestor
64577763|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
64577764|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577766|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64577793|NCT05614518|Listerine|listerine|mesh-list
64577794|NCT05614518|Fluorides|fluorides|mesh-list
64577795|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
64577796|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
64577797|NCT05614518|Protective Agents|protective agents|mesh-ancestor
64577798|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577799|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64577800|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577801|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64577802|NCT00091507|Insulin|insulin|mesh-list
64362375|NCT03101319|Vitamins|vitamins|mesh-ancestor
64577803|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64577804|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577805|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
64577806|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64577807|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
64577808|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577809|NCT05611086|Expectorants|expectorants|mesh-ancestor
64577810|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
64577811|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64577812|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
64577813|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577814|NCT05611086|Protective Agents|protective agents|mesh-ancestor
64577815|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577816|NCT05611086|Antidotes|antidotes|mesh-ancestor
64577817|NCT05614440|Tramadol|tramadol|mesh-list
64577818|NCT05614440|Anesthetics|anesthetics|mesh-list
64577820|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577821|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577822|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64577823|NCT05614440|Narcotics|narcotics|mesh-ancestor
64577824|NCT05614440|Analgesics|analgesics|mesh-ancestor
64577843|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64591315|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64577844|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591316|NCT00578071|Capecitabine|capecitabine|mesh-list
64577845|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
64577846|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
64577847|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
64577848|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577849|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577850|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
64577851|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577852|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577853|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64577854|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
64577855|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64577856|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64577857|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64577858|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64577859|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577860|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577861|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
64577862|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64577863|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
64577865|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
64577893|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577894|NCT04338984|Fentanyl|fentanyl|mesh-list
64577895|NCT04338984|Ropivacaine|ropivacaine|mesh-list
64577896|NCT04338984|Anesthetics|anesthetics|mesh-list
64577897|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
64577898|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
64577899|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64577900|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577901|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
64577902|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577903|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64577904|NCT04338984|Narcotics|narcotics|mesh-ancestor
64577905|NCT04338984|Analgesics|analgesics|mesh-ancestor
64577906|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64577907|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64577908|NCT00095563|Lapatinib|lapatinib|mesh-list
64577909|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577910|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64577911|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577912|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577913|NCT05473806|Pioglitazone|pioglitazone|mesh-list
64577914|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64577915|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577916|NCT00089609|Thalidomide|thalidomide|mesh-list
64577917|NCT00089609|Prednisone|prednisone|mesh-list
64577918|NCT00089609|Bevacizumab|bevacizumab|mesh-list
64577919|NCT00089609|Docetaxel|docetaxel|mesh-list
64577920|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64577921|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577922|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64577923|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64577933|NCT00089609|Hormones|hormones|mesh-ancestor
64577936|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577937|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
64577938|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
64577939|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64577940|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64577942|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
64577943|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577944|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64577945|NCT00195403|Etanercept|etanercept|mesh-list
64591324|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
64591325|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591326|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64591327|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591328|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591329|NCT00504023|Imiquimod|imiquimod|mesh-list
64577946|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64577947|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64577948|NCT00195403|Analgesics|analgesics|mesh-ancestor
64577949|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
64577950|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577951|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577952|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64577953|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577954|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577955|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577956|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
64577957|NCT04643327|Levetiracetam|levetiracetam|mesh-list
64577958|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
64577959|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
64577960|NCT00095875|Carboplatin|carboplatin|mesh-list
64577961|NCT00095875|Docetaxel|docetaxel|mesh-list
64577962|NCT00095875|Fluorouracil|fluorouracil|mesh-list
64577963|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64577964|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
64577965|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
64577966|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64577967|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64577968|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
64577969|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64577981|NCT03086993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64577982|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64577983|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
64577984|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64577985|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64577986|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
64577987|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64577988|NCT03704363|Infliximab|infliximab|mesh-list
64577989|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
64577990|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64577991|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64577992|NCT04089072|Phenylephrine|phenylephrine|mesh-list
64577993|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
64577994|NCT04089072|Methylene Blue|methylene blue|mesh-list
64577995|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64577996|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
64577997|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
64577998|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64577999|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578000|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
64578001|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64578002|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
64578003|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
64578004|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64578005|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64578006|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64578007|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
64578008|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578026|NCT05612880|Hormones|hormones|mesh-ancestor
64578027|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578028|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578029|NCT03995628|Dexamethasone|dexamethasone|mesh-list
64578030|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578031|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
64578032|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
64578033|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578034|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578035|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64578036|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
64578037|NCT03995628|Hormones|hormones|mesh-ancestor
64578038|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578039|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64578040|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578041|NCT00010439|Alendronate|alendronate|mesh-list
64591334|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
64578042|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64578043|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578044|NCT03908736|Picolinic acid|picolinic acid|mesh-list
64578082|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64578083|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64578084|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64578085|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578086|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578087|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
64578088|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591343|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
64303304|NCT02252809|Hormones|hormones|mesh-ancestor
64578089|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64578090|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64578091|NCT00098059|Famciclovir|famciclovir|mesh-list
64578092|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
64578093|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578094|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64578095|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578096|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578097|NCT02440581|Alendronate|alendronate|mesh-list
64578098|NCT02440581|Teriparatide|teriparatide|mesh-list
64578099|NCT02440581|Cinacalcet|cinacalcet|mesh-list
64578100|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64578101|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578102|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64578103|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64578104|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
64578106|NCT01359150|Tofacitinib|tofacitinib|mesh-list
64578110|NCT00098371|Alvocidib|alvocidib|mesh-list
64578130|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578131|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
64578132|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578133|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578134|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
64578135|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578136|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578137|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578138|NCT04745988|Antidotes|antidotes|mesh-ancestor
64578139|NCT04745988|Protective Agents|protective agents|mesh-ancestor
64578140|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
64578141|NCT04745988|Vitamins|vitamins|mesh-ancestor
64578142|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
64578143|NCT01647945|Tacrolimus|tacrolimus|mesh-list
64578144|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578145|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
64578146|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578147|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64578148|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578149|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578150|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
64578151|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64578152|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64578153|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
64578154|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578155|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578156|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578157|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
64578158|NCT04351191|Chloroquine|chloroquine|mesh-list
64578159|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
64578160|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64578161|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64578162|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578163|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578164|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578170|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591344|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64578171|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578172|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64578173|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64578174|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578175|NCT05557578|Gemcitabine|gemcitabine|mesh-list
64578176|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
64578177|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578178|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
64578179|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578180|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578181|NCT05557578|Antiviral Agents|antiviral agents|mesh-ancestor
64578182|NCT05557578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578183|NCT05557578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578184|NCT05557578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578185|NCT05557578|Immunologic Factors|immunologic factors|mesh-ancestor
64578186|NCT05557578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578187|NCT00201877|Rituximab|rituximab|mesh-list
64578188|NCT00201877|Bortezomib|bortezomib|mesh-list
64578189|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578190|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578191|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
64578192|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578193|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578194|NCT05358691|Durvalumab|durvalumab|mesh-list
64578195|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578196|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578197|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64578198|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
64578200|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
64578201|NCT01490060|Doxorubicin|doxorubicin|mesh-list
64578202|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64578203|NCT01490060|Vincristine|vincristine|mesh-list
64578204|NCT01490060|Ifosfamide|ifosfamide|mesh-list
64578205|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
64578213|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578214|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64578215|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
64578216|NCT01490060|Hormones|hormones|mesh-ancestor
64578217|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578218|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64578219|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578220|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
64578221|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578222|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578223|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64578224|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64578273|NCT01451762|Promethazine|promethazine|mesh-list
64578274|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64578275|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64578276|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578277|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578278|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
64578279|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
64578280|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
64578281|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578282|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
64578283|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
64578284|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64578285|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64578286|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
64578287|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
64578288|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578289|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578290|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64578291|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
64578292|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
64578293|NCT01654107|Nicotine|nicotine|mesh-list
64578294|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64578295|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
64578296|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578297|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578298|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64578299|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64578300|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
64578301|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578302|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578317|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578318|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578319|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64578320|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64578321|NCT01468844|Growth Substances|growth substances|mesh-ancestor
64578322|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578323|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
64578324|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578325|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578326|NCT03029598|Carboplatin|carboplatin|mesh-list
64578327|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
64578328|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578329|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578378|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578379|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578380|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64578381|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
64591369|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578382|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64578383|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64578384|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64578385|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64578386|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578387|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64578388|NCT00003927|Protective Agents|protective agents|mesh-ancestor
64578389|NCT00032591|Thrombin|thrombin|mesh-list
64303602|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578390|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
64578392|NCT01660191|Atorvastatin|atorvastatin|mesh-list
64578393|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64578394|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64578395|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64578396|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
64362428|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64578397|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578434|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
64578435|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578436|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578437|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
64578438|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
64578439|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
64578440|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64578441|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
64578442|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64578443|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
64578444|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64578445|NCT01660893|Protective Agents|protective agents|mesh-ancestor
64578446|NCT01661283|Bevacizumab|bevacizumab|mesh-list
64578447|NCT01661283|Everolimus|everolimus|mesh-list
64578448|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578449|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578450|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64578451|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64578452|NCT01661283|Growth Substances|growth substances|mesh-ancestor
64578453|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578454|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
64578455|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578456|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
64578457|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
64578458|NCT01946373|Fludarabine|fludarabine|mesh-list
64578459|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
64578460|NCT01946373|Interleukin-2|interleukin-2|mesh-list
64578484|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64578485|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64578486|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64578487|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64578488|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578489|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578490|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
64578491|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64578492|NCT01600287|Propofol|propofol|mesh-list
64578493|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64578494|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578495|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578496|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64578497|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
64578498|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
64578499|NCT00040937|Thalidomide|thalidomide|mesh-list
64578500|NCT00040937|Dexamethasone|dexamethasone|mesh-list
64578501|NCT00040937|Prednisone|prednisone|mesh-list
64578502|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
64578503|NCT00040937|Melphalan|melphalan|mesh-list
64578504|NCT00040937|Sargramostim|sargramostim|mesh-list
64578539|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578540|NCT02234427|Aspirin|aspirin|mesh-list
64578541|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64578542|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578544|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
64578545|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578546|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578547|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578548|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578549|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64578550|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64578551|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578552|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64578553|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64578554|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578555|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
64578556|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
64578557|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64578558|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64578559|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578560|NCT01663935|Levodopa|levodopa|mesh-list
64578561|NCT01663935|Carbidopa|carbidopa|mesh-list
64578562|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64578563|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64578564|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
64578565|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578566|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578567|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578568|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64578569|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578570|NCT01664559|Ketorolac|ketorolac|mesh-list
64578571|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64578572|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578579|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64578580|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578581|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578582|NCT00046475|Midodrine|midodrine|mesh-list
64578583|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
64578584|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
64578585|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578586|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362444|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362477|NCT05072691|Antibodies|antibodies|mesh-list
64578587|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64578588|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64578589|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64578590|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64578591|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
64578592|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578593|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578594|NCT01894685|Mesalamine|mesalamine|mesh-list
64578595|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64578596|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578597|NCT01894685|Analgesics|analgesics|mesh-ancestor
64578598|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
64578599|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578600|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578601|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578602|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578603|NCT01695291|Minocycline|minocycline|mesh-list
64578604|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578605|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578606|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
64578607|NCT00048737|Rituximab|rituximab|mesh-list
64578608|NCT00048737|Fludarabine|fludarabine|mesh-list
64578609|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
64578623|NCT01604109|Caseins|caseins|mesh-list
64578624|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64578625|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
64578626|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578627|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578628|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578629|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
64578630|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
64578631|NCT03089957|Urinastatin|urinastatin|mesh-list
64578632|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64578633|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64578634|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
64578635|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578636|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578637|NCT01666197|Diclofenac|diclofenac|mesh-list
64578638|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64578639|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578640|NCT01666197|Analgesics|analgesics|mesh-ancestor
64578641|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
64578642|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578643|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578644|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578645|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578646|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64578647|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578648|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578649|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64578650|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
64578651|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64578652|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64578653|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64578654|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336599|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578655|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578656|NCT00048815|Citalopram|citalopram|mesh-list
64578657|NCT00048815|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64578658|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64578659|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64578660|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578661|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64578662|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
64578663|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362546|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64591440|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
64591442|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64578664|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64578665|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
64578666|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64578667|NCT01605903|Acetaminophen|acetaminophen|mesh-list
64578668|NCT01605903|Ibuprofen|ibuprofen|mesh-list
64578669|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64578670|NCT01605903|Analgesics|analgesics|mesh-ancestor
64578713|NCT01607853|Calcitriol|calcitriol|mesh-list
64578714|NCT01607853|Betamethasone|betamethasone|mesh-list
64578715|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64578716|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
64578717|NCT01607853|Hormones|hormones|mesh-ancestor
64578718|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578719|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578720|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64578721|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
64578722|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64578723|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64578724|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64578725|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578726|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64578727|NCT01607853|Vitamins|vitamins|mesh-ancestor
64578728|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
64578729|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64578730|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64578731|NCT01700517|Anesthetics|anesthetics|mesh-list
64578732|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578733|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578734|NCT00101647|Dasatinib|dasatinib|mesh-list
64578735|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578736|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578737|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578738|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578739|NCT01669785|Listerine|listerine|mesh-list
64578740|NCT01669785|Fluorides|fluorides|mesh-list
64578741|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
64578742|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
64578743|NCT01669785|Protective Agents|protective agents|mesh-ancestor
64578744|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578745|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64578746|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578747|NCT03089645|Docetaxel|docetaxel|mesh-list
64578748|NCT03089645|Durvalumab|durvalumab|mesh-list
64578749|NCT03089645|Tremelimumab|tremelimumab|mesh-list
64578750|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64578751|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578752|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
64578753|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
64578754|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591462|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64591463|NCT00578305|Protective Agents|protective agents|mesh-ancestor
64578755|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578756|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578757|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
64578758|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578759|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
64578760|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578761|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578762|NCT01931033|Oxytocin|oxytocin|mesh-list
64578816|NCT01612221|Protective Agents|protective agents|mesh-ancestor
64578817|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578818|NCT01612221|Antidotes|antidotes|mesh-ancestor
64578819|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
64578820|NCT00105001|Sirolimus|sirolimus|mesh-list
64578821|NCT00105001|Fludarabine|fludarabine|mesh-list
64578822|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
64578823|NCT00105001|Tacrolimus|tacrolimus|mesh-list
64578824|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362616|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578825|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578826|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
64578827|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578828|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578829|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
64578830|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578831|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64578832|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578833|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64578834|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64578835|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
64578836|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64578837|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578838|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
64578839|NCT02642640|Melatonin|melatonin|mesh-list
64578840|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
64578841|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578842|NCT02642640|Protective Agents|protective agents|mesh-ancestor
64578843|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578844|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64578845|NCT01701375|Palbociclib|palbociclib|mesh-list
64578846|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578847|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64578850|NCT05556408|Propofol|propofol|mesh-list
64578858|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64578859|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64578860|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64578861|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64578862|NCT00054353|Cyclosporine|cyclosporine|mesh-list
64578863|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
64578864|NCT00054353|Fludarabine|fludarabine|mesh-list
64578865|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
64578866|NCT00054353|Melphalan|melphalan|mesh-list
64578867|NCT00054353|Cyclosporins|cyclosporins|mesh-list
64578868|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578869|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578870|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
64578871|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578872|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578873|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
64578874|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578917|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64578918|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
64578920|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578921|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64578922|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578923|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
64578924|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578925|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578926|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
64578927|NCT01852890|Gemcitabine|gemcitabine|mesh-list
64578928|NCT01852890|Vitamins|vitamins|mesh-ancestor
64578929|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
64578930|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578931|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578932|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
64578933|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578934|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578935|NCT01852890|Antiviral Agents|antiviral agents|mesh-ancestor
64578936|NCT01852890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362630|NCT02472613|Fluoxetine|fluoxetine|mesh-list
64578938|NCT01852890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578939|NCT01852890|Immunologic Factors|immunologic factors|mesh-ancestor
64578940|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
64578941|NCT01852890|Protective Agents|protective agents|mesh-ancestor
64578942|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
64578943|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578944|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
64578945|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
64578946|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
64578947|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
64578948|NCT01757418|Antibodies|antibodies|mesh-list
64578949|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
64578950|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64578951|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64578959|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578960|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64578961|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64578962|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64578963|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64578964|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
64578965|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64578966|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578967|NCT04739670|Gemcitabine|gemcitabine|mesh-list
64578968|NCT04739670|Bevacizumab|bevacizumab|mesh-list
64591504|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
64591505|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578969|NCT04739670|Carboplatin|carboplatin|mesh-list
64578970|NCT04739670|Atezolizumab|atezolizumab|mesh-list
64578971|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64578972|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578973|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64578974|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64578975|NCT04739670|Growth Substances|growth substances|mesh-ancestor
64578976|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64578977|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
64578978|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578979|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
64578980|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578981|NCT04739670|Antiviral Agents|antiviral agents|mesh-ancestor
64578982|NCT04739670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578983|NCT04739670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578984|NCT04739670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64578985|NCT04739670|Immunologic Factors|immunologic factors|mesh-ancestor
64578986|NCT05549778|Polaprezinc|polaprezinc|mesh-list
64578987|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64578988|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64578989|NCT05286619|Gemcitabine|gemcitabine|mesh-list
64578990|NCT05286619|Carboplatin|carboplatin|mesh-list
64578991|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
64578992|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64578993|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64578995|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64578997|NCT05286619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64578998|NCT05286619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64578999|NCT05286619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579000|NCT05286619|Immunologic Factors|immunologic factors|mesh-ancestor
64579001|NCT05286619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579002|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64579004|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64579005|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
64579006|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64579007|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64579008|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579009|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579010|NCT04329624|Protective Agents|protective agents|mesh-ancestor
64579011|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579012|NCT00559182|Omeprazole|omeprazole|mesh-list
64579013|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64579014|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579015|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64579016|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579017|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579018|NCT00218023|Naltrexone|naltrexone|mesh-list
64579019|NCT00218023|Levodopa|levodopa|mesh-list
64579020|NCT00218023|Carbidopa|carbidopa|mesh-list
64579021|NCT00218023|Modafinil|modafinil|mesh-list
64579022|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64579023|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64579024|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579025|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
64579026|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579027|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64579028|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64579041|NCT00054665|Etoposide|etoposide|mesh-list
64579042|NCT00054665|Vincristine|vincristine|mesh-list
64579043|NCT00054665|Bortezomib|bortezomib|mesh-list
64579044|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579045|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
64579046|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579047|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579048|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64579049|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
64579050|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579051|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579052|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64579053|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64579054|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64579055|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64579056|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579057|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64579058|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
64579059|NCT00054665|Hormones|hormones|mesh-ancestor
64579060|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579061|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64579062|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64579063|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
64579064|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
64579065|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
64579066|NCT00476190|Cytarabine|cytarabine|mesh-list
64579067|NCT00476190|Dexamethasone|dexamethasone|mesh-list
64579068|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
64579069|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64579070|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64579071|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64579073|NCT00476190|Doxorubicin|doxorubicin|mesh-list
64579074|NCT00476190|Methotrexate|methotrexate|mesh-list
64579075|NCT00476190|Etoposide|etoposide|mesh-list
64336600|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64336601|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64336602|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336603|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64336604|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64336605|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579078|NCT00476190|Pegaspargase|pegaspargase|mesh-list
64579079|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579080|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
64579081|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579082|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64362672|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64579083|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64579084|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
64579085|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579086|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579087|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64579088|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64579089|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
64579090|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
64579091|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579092|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579093|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
64579094|NCT00476190|Hormones|hormones|mesh-ancestor
64579095|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579096|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64579097|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64579098|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64579099|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64579100|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579101|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64579102|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
64579103|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64579104|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579105|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
64579106|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
64579107|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64579108|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64591555|NCT03582332|Etoricoxib|etoricoxib|mesh-list
64579109|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64579113|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
64579114|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
64579115|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
64579116|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64579117|NCT05555316|Lenvatinib|lenvatinib|mesh-list
64579118|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579119|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64579120|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579121|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579122|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
64579123|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64579124|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
64579125|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579126|NCT00218491|Expectorants|expectorants|mesh-ancestor
64579127|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
64579128|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64579129|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
64579130|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579131|NCT00218491|Protective Agents|protective agents|mesh-ancestor
64579132|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579133|NCT00218491|Antidotes|antidotes|mesh-ancestor
64579134|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64579135|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64579136|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
64579137|NCT00221299|Hormones|hormones|mesh-list
64304352|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304353|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
64304354|NCT03866174|Niacin|niacin|mesh-list
64304355|NCT03866174|Psilocybin|psilocybin|mesh-list
64304356|NCT03866174|Vitamins|vitamins|mesh-ancestor
64304357|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
64304358|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304359|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
64579138|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
64579141|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64579149|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579150|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579151|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64579152|NCT05554848|Analgesics|analgesics|mesh-ancestor
64579153|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
64579154|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579155|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64579156|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64579157|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64579158|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
64579159|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579160|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579161|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
64579162|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64579163|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
64579164|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64579165|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64579166|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64579167|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
64579168|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64579170|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579171|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
64579172|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579173|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579174|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579175|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
64579176|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591558|NCT03582332|Analgesics|analgesics|mesh-ancestor
64579177|NCT05554224|Liver Extracts|liver extracts|mesh-list
64579178|NCT05554224|Hematinics|hematinics|mesh-ancestor
64579179|NCT05548998|Anesthetics|anesthetics|mesh-list
64579180|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579181|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579190|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579191|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579192|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64579193|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
64579194|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579195|NCT00110461|Aripiprazole|aripiprazole|mesh-list
64579196|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
64579197|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64579198|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64579199|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64579200|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579201|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579202|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
64579203|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
64579204|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579205|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579206|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64579207|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64579208|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
64579209|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64579211|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64579212|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64579213|NCT00061373|Aspirin|aspirin|mesh-list
64579214|NCT00061373|Tinzaparin|tinzaparin|mesh-list
64579240|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64579241|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579242|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579243|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
64579245|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64579246|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591570|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64579247|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579248|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579249|NCT00112723|Alvocidib|alvocidib|mesh-list
64579250|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362736|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64579251|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
64591571|NCT00619723|Choline|choline|mesh-list
64591572|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64591573|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
64591574|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64591575|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
64591576|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591577|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64591578|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64591579|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
64591580|NCT03410615|Durvalumab|durvalumab|mesh-list
64591581|NCT03410615|Tremelimumab|tremelimumab|mesh-list
64591582|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591583|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591584|NCT03582098|Rituximab|rituximab|mesh-list
64591585|NCT03582098|Idelalisib|idelalisib|mesh-list
64429987|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
64579252|NCT00112723|Growth Substances|growth substances|mesh-ancestor
64579253|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579254|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64579255|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579256|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579258|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
64579259|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
64579260|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579261|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64579262|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64579263|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64579264|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579265|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579266|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64579267|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
64579268|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579269|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579270|NCT00115297|Montelukast|montelukast|mesh-list
64579271|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64579272|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
64579273|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64336607|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64336608|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336609|NCT02312635|Cycloserine|cycloserine|mesh-list
64579275|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579276|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579277|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64579278|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64579279|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579280|NCT00116857|Sertraline|sertraline|mesh-list
64579281|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
64579282|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64579283|NCT00116857|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64579284|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64579285|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64579286|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579287|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579288|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
64579289|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579290|NCT01672983|Ritonavir|ritonavir|mesh-list
64579291|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64579292|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64579293|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
64579294|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579295|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579296|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64579297|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64579298|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
64579299|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579300|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64579301|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64579302|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
64579303|NCT00117715|Caffeine|caffeine|mesh-list
64579313|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
64362744|NCT02474563|Prednisone|prednisone|mesh-list
64579314|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
64579315|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64579316|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64579318|NCT00227617|Bevacizumab|bevacizumab|mesh-list
64579319|NCT00227617|Fluorouracil|fluorouracil|mesh-list
64579320|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
64579321|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64579322|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579323|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64579324|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64579325|NCT00227617|Growth Substances|growth substances|mesh-ancestor
64579326|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579327|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
64579328|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
64579329|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579330|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579331|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579373|NCT00063635|Metformin|metformin|mesh-list
64579374|NCT00063635|Vitamins|vitamins|mesh-ancestor
64579375|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
64579376|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579377|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579378|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
64579379|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579380|NCT00063635|Protective Agents|protective agents|mesh-ancestor
64579381|NCT01439126|Clonidine|clonidine|mesh-list
64579382|NCT01439126|Analgesics|analgesics|mesh-ancestor
64579383|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
64579384|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579385|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579386|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64579387|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
64579388|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
64579389|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64579390|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64579391|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64579392|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
64579393|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579394|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579396|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579397|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64579398|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64579399|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64579400|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579401|NCT01615731|Digoxin|digoxin|mesh-list
64579402|NCT01615731|Misoprostol|misoprostol|mesh-list
64579403|NCT01615731|Mifepristone|mifepristone|mesh-list
64336610|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64336611|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336612|NCT02312635|Renal Agents|renal agents|mesh-ancestor
64336613|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64591611|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
64336614|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
64336615|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64336616|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
64336617|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336618|NCT03144453|Atropine|atropine|mesh-list
64336619|NCT03144453|Neostigmine|neostigmine|mesh-list
64336620|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64579405|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
64579406|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64362760|NCT02477995|Vaccines|vaccines|mesh-list
64579407|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579408|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64579409|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579410|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
64579411|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64579412|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64579413|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579414|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579415|NCT01615731|Protective Agents|protective agents|mesh-ancestor
64579416|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64579417|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64579418|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64579419|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64579420|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
64579421|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64579422|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64579423|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
64579424|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579425|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
64579426|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64579427|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64579428|NCT02334800|Palbociclib|palbociclib|mesh-list
64579429|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591626|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64591627|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64591628|NCT00556049|Growth Substances|growth substances|mesh-ancestor
64591629|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
64579430|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64304653|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
64579431|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579432|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579433|NCT01665144|Siponimod|siponimod|mesh-list
64336621|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64336622|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64336623|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
64336624|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336640|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64336641|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336642|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579434|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64579435|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579436|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579437|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
64579438|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579439|NCT01675635|Morphine|morphine|mesh-list
64579440|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64579441|NCT01675635|Narcotics|narcotics|mesh-ancestor
64579442|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579443|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579444|NCT01675635|Analgesics|analgesics|mesh-ancestor
64579445|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
64579446|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579447|NCT01615809|Amphotericin B|amphotericin b|mesh-list
64579448|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64579449|NCT01615809|Amebicides|amebicides|mesh-ancestor
64579450|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64579451|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64579452|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579453|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64579454|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
64579455|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
64579456|NCT01676415|Prednisone|prednisone|mesh-list
64579457|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
64579458|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64579459|NCT01676415|Hormones|hormones|mesh-ancestor
64579460|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579464|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
64579481|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64579482|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64579483|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
64579484|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64579485|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64579486|NCT01678443|Antibodies|antibodies|mesh-list
64579487|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
64579488|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64579489|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
64579490|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579491|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579492|NCT01707225|Octreotide|octreotide|mesh-list
64579493|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579494|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64579495|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579496|NCT01707381|Timolol|timolol|mesh-list
64579497|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579498|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64579499|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64579500|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
64579501|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579502|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579534|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579535|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64579537|NCT00073073|Exemestane|exemestane|mesh-list
64579538|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
64579539|NCT00073073|Calcium|calcium|mesh-list
64579540|NCT00073073|Vitamins|vitamins|mesh-ancestor
64579541|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
64579542|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579543|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64579544|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64579545|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579546|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64579547|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64579548|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579549|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579550|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64579551|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
64579552|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579553|NCT00073073|Antacids|antacids|mesh-ancestor
64579554|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579555|NCT00074165|Cytarabine|cytarabine|mesh-list
64579556|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
64579557|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
64579558|NCT00074165|Rituximab|rituximab|mesh-list
64579559|NCT00074165|Carboplatin|carboplatin|mesh-list
64579560|NCT00074165|Etoposide|etoposide|mesh-list
64579561|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
64579562|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579563|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
64579564|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579565|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579566|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64579576|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579577|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
64579578|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
64579579|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579580|NCT00074165|Antidotes|antidotes|mesh-ancestor
64579581|NCT00074165|Protective Agents|protective agents|mesh-ancestor
64579582|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
64591693|NCT00621049|Docetaxel|docetaxel|mesh-list
64579583|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
64579585|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
64579586|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
64579589|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317010|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
64579590|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64579591|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579592|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579593|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
64579594|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64579595|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
64579596|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
64579597|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579598|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579599|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64579600|NCT05710887|Analgesics|analgesics|mesh-ancestor
64579601|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
64579602|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579603|NCT00075335|Plerixafor|plerixafor|mesh-list
64579628|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579629|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579630|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
64579631|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64579632|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64579633|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579634|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579635|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64579636|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64579637|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
64579638|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579639|NCT01466270|Donepezil|donepezil|mesh-list
64579640|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64579641|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579642|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579643|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
64579644|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579645|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579646|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
64579647|NCT02235987|Octreotide|octreotide|mesh-list
64579648|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64579649|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64579650|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579651|NCT01466192|Ribavirin|ribavirin|mesh-list
64579652|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64579653|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
64579654|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579655|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
64579656|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579657|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
64591711|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64579658|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64579659|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64579670|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579671|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579672|NCT01438814|Metformin|metformin|mesh-list
64579673|NCT01438814|Linagliptin|linagliptin|mesh-list
64579674|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579675|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579676|NCT01438814|Incretins|incretins|mesh-ancestor
64579677|NCT01438814|Hormones|hormones|mesh-ancestor
64579678|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579679|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64579680|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
64579681|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579682|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579683|NCT01681095|Tryptophan|tryptophan|mesh-list
64579684|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64579685|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
64579686|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64579687|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
64579688|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579689|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579690|NCT00121225|Vorinostat|vorinostat|mesh-list
64579691|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579692|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64579693|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579694|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579695|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
64579696|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579697|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579699|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64579700|NCT05545800|Metformin|metformin|mesh-list
64579701|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
64579702|NCT05545800|Empagliflozin|empagliflozin|mesh-list
64579703|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64336643|NCT02332941|Rituximab|rituximab|mesh-list
64336644|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336645|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336646|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
64336647|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336648|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591741|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591743|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64336649|NCT03503227|Aspirin|aspirin|mesh-list
64336650|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
64336651|NCT03503227|Prednisolone|prednisolone|mesh-list
64579704|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579705|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64579706|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579707|NCT00230737|Melatonin|melatonin|mesh-list
64579708|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
64579709|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579710|NCT00230737|Protective Agents|protective agents|mesh-ancestor
64579711|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579712|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579713|NCT04425564|Capecitabine|capecitabine|mesh-list
64579714|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
64579715|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64579716|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
64579717|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579718|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579719|NCT01686165|Rituximab|rituximab|mesh-list
64579720|NCT01686165|Belinostat|belinostat|mesh-list
64579721|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64579722|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64579723|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579724|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
64579725|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579726|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579727|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64579728|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579729|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579730|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
64579731|NCT00123643|Glyburide|glyburide|mesh-list
64579732|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579733|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579734|NCT05698524|Temozolomide|temozolomide|mesh-list
64579735|NCT05698524|Abexinostat|abexinostat|mesh-list
64304958|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
64579736|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64579737|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
64579742|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
64579743|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
64579744|NCT00235573|Vitamins|vitamins|mesh-ancestor
64579745|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
64579746|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579747|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
64579748|NCT00235573|Hematinics|hematinics|mesh-ancestor
64579749|NCT01687179|Sirolimus|sirolimus|mesh-list
64591778|NCT00624013|Sertraline|sertraline|mesh-list
64579750|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
64579751|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64579752|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579753|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64579754|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579755|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
64579756|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579757|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
64579758|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579759|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
64579760|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64579761|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64579762|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579763|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579764|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579765|NCT00124579|Thalidomide|thalidomide|mesh-list
64579766|NCT00124579|Dexamethasone|dexamethasone|mesh-list
64579767|NCT00124579|Bortezomib|bortezomib|mesh-list
64579768|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64579769|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
64579770|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
64579771|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579772|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579775|NCT00124579|Hormones|hormones|mesh-ancestor
64579785|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64579786|NCT00124579|Growth Substances|growth substances|mesh-ancestor
64579787|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
64579788|NCT05550246|Oxybutynin|oxybutynin|mesh-list
64579789|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64579790|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64579791|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64579792|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64579793|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579794|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
64579795|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579796|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579797|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
64579798|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
64579799|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579800|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64579801|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64579802|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
64579803|NCT05550246|Urological Agents|urological agents|mesh-ancestor
64579804|NCT00124735|Rocuronium|rocuronium|mesh-list
64579805|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64579806|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64579807|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64579808|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579809|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579810|NCT05340309|Atezolizumab|atezolizumab|mesh-list
64305033|NCT04433078|Doxycycline|doxycycline|mesh-list
64579811|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64579812|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579813|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
64579814|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579815|NCT00125515|Naltrexone|naltrexone|mesh-list
64579816|NCT00125515|Memantine|memantine|mesh-list
64579817|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64579818|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64579824|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
64579825|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579826|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591804|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
64591805|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64579827|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64579828|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64579829|NCT00125593|Simvastatin|simvastatin|mesh-list
64579830|NCT00125593|Ezetimibe|ezetimibe|mesh-list
64579831|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64579832|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64579833|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
64579834|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579835|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64579836|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64579837|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579838|NCT01689441|Calcitriol|calcitriol|mesh-list
64579839|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64579840|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579841|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64579842|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64579843|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579844|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64579846|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
64579847|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64579848|NCT00236977|Iron|iron|mesh-list
64579849|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64579850|NCT00236977|Trace Elements|trace elements|mesh-ancestor
64579851|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
64579852|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579853|NCT00236977|Hematinics|hematinics|mesh-ancestor
64579854|NCT04753177|Paclitaxel|paclitaxel|mesh-list
64579855|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
64579856|NCT04753177|Doxorubicin|doxorubicin|mesh-list
64579857|NCT04753177|Fulvestrant|fulvestrant|mesh-list
64579858|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64579860|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64579864|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579865|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64579866|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
64579867|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579868|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64579869|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64579870|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
64579871|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64579872|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64579873|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64579874|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64579875|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579876|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64579877|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64579878|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64579879|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
64579880|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64579881|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
64579882|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64579883|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
64579884|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64305122|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
64579885|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64579887|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64579888|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64579889|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64579891|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
64579907|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
64579908|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64579910|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64579911|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579912|NCT05234307|Analgesics|analgesics|mesh-ancestor
64579913|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
64579914|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579915|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579916|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64579917|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
64579918|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64579919|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
64579920|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
64579921|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579922|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64579923|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64579924|NCT04937881|Tenofovir|tenofovir|mesh-list
64579925|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
64579926|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579927|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64579928|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64579929|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579930|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579931|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64579932|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64579933|NCT00238615|Carboplatin|carboplatin|mesh-list
64579934|NCT00238615|Docetaxel|docetaxel|mesh-list
64579935|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336652|NCT03503227|Salicylates|salicylates|mesh-list
64336653|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336654|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
64336655|NCT03503227|Hormones|hormones|mesh-ancestor
64336656|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336669|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336670|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64336671|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336672|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336673|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64336674|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64336675|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64336676|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
64579938|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
64579939|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579940|NCT02243943|Neostigmine|neostigmine|mesh-list
64579941|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64579942|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579943|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579944|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
64579945|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579946|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579948|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
64591835|NCT03029780|Ipilimumab|ipilimumab|mesh-list
64579949|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579950|NCT03088631|Metformin|metformin|mesh-list
64579951|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579952|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579953|NCT00131677|Tenofovir|tenofovir|mesh-list
64579954|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
64579955|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579956|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64305188|NCT05069857|Apatinib|apatinib|mesh-list
64579957|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64579958|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64579959|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579961|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64579962|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
64579963|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64579964|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
64579965|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579966|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579967|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64579968|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64579969|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64579970|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
64336677|NCT02305069|Pioglitazone|pioglitazone|mesh-list
64336679|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64579971|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64579972|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64579973|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64579974|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64579975|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
64579976|NCT00240487|Protective Agents|protective agents|mesh-ancestor
64579977|NCT02126917|Ethanol|ethanol|mesh-list
64579978|NCT02126917|Hydrocodone|hydrocodone|mesh-list
64579979|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64579980|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64579981|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64579982|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579983|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64579984|NCT02126917|Narcotics|narcotics|mesh-ancestor
64579985|NCT02126917|Analgesics|analgesics|mesh-ancestor
64579986|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
64579987|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579988|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
64579989|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
64579990|NCT01895075|Budesonide|budesonide|mesh-list
64579991|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64579992|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64579993|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
64579994|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64579995|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64579996|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64579997|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
64579998|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
64579999|NCT01895075|Hormones|hormones|mesh-ancestor
64580000|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580001|NCT05168475|Rituximab|rituximab|mesh-list
64580002|NCT05168475|Infliximab|infliximab|mesh-list
64580015|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580016|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580017|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580018|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
64580019|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580020|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580021|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580022|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64580023|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580024|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64580025|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64580026|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
64580027|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64580028|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580076|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
64580077|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580078|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580079|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580080|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
64580081|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
64580082|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64580083|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
64580084|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64580085|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64580086|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580087|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64580088|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580089|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580090|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64580091|NCT04783051|Renal Agents|renal agents|mesh-ancestor
64580093|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580094|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580095|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580096|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64580097|NCT00245557|Sertraline|sertraline|mesh-list
64580098|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
64580099|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64580100|NCT00245557|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64580101|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64580102|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580103|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580104|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580105|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
64580106|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580107|NCT00245635|Fluoxetine|fluoxetine|mesh-list
64580108|NCT00245635|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64580115|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64580116|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
64580117|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64580118|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64580119|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64580120|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580121|NCT00141115|Levetiracetam|levetiracetam|mesh-list
64580122|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
64580123|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
64580124|NCT00249379|Acamprosate|acamprosate|mesh-list
64580125|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64580127|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64580128|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64580129|NCT00141739|Analgesics|analgesics|mesh-ancestor
64580130|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
64580132|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580133|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580134|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580135|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64580136|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580137|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
64580138|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64580139|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
64580140|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580141|NCT00086957|Docetaxel|docetaxel|mesh-list
64580142|NCT00086957|Trastuzumab|trastuzumab|mesh-list
64580143|NCT00086957|Gefitinib|gefitinib|mesh-list
64580144|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580145|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
64580146|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
64580147|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
64580148|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580149|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580155|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580156|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580158|NCT00145249|Amphotericin B|amphotericin b|mesh-list
64580159|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64580160|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
64580161|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580162|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64580163|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64580164|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580165|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580166|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64580167|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
64580168|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580169|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580170|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64591883|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
64591888|NCT00581971|Celecoxib|celecoxib|mesh-list
64580171|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64580172|NCT00145249|Amebicides|amebicides|mesh-ancestor
64580173|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64580174|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64580175|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64580176|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64580177|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580178|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64580179|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580180|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580181|NCT00252967|Atorvastatin|atorvastatin|mesh-list
64580182|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64580184|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
64580196|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64580197|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580198|NCT00156923|Naltrexone|naltrexone|mesh-list
64580199|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64580200|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64580201|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580202|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
64580203|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580204|NCT00093041|Zalutumumab|zalutumumab|mesh-list
64580205|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580206|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580207|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64580208|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
64580209|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64580210|NCT01895231|Hematinics|hematinics|mesh-ancestor
64580211|NCT04745663|Iodine|iodine|mesh-list
64580212|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
64362844|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
64580213|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
64580214|NCT04745663|Povidone|povidone|mesh-list
64580215|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64580216|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580217|NCT04745663|Trace Elements|trace elements|mesh-ancestor
64580218|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
64580219|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580220|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
64580221|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
64580222|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
64580223|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64580224|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64580225|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
64580226|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580227|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580228|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591925|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580229|NCT01747577|Urological Agents|urological agents|mesh-ancestor
64580230|NCT00159263|Budesonide|budesonide|mesh-list
64580231|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
64580232|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580234|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
64580235|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580236|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580237|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64580238|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
64580239|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
64580240|NCT00159263|Hormones|hormones|mesh-ancestor
64580241|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580242|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64580243|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64580244|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64580245|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
64580246|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580247|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580248|NCT00159419|Alendronate|alendronate|mesh-list
64580249|NCT00159419|Pamidronate|pamidronate|mesh-list
64580250|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64580251|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580252|NCT00159965|Sertraline|sertraline|mesh-list
64580253|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
64580254|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64580255|NCT00159965|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64580256|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64305482|NCT03063866|Propofol|propofol|mesh-list
64580257|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580258|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580259|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580260|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
64580261|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580262|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
64580263|NCT02926833|Fludarabine|fludarabine|mesh-list
64580275|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
64580276|NCT00096161|Vidarabine|vidarabine|mesh-list
64580277|NCT00096161|Pentostatin|pentostatin|mesh-list
64580278|NCT00096161|Cyclosporins|cyclosporins|mesh-list
64362873|NCT05649943|Androgens|androgens|mesh-list
64580279|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580280|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580281|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580282|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
64580283|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580284|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
64580285|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580286|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
64580287|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580288|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64580289|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64580290|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580291|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64580292|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
64580293|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64580294|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64580295|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
64580296|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
64580297|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64580298|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580299|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
64580300|NCT01898039|Vaccines|vaccines|mesh-list
64580301|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
64580302|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580303|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580304|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580305|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580306|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
64591950|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
64580307|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580316|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580317|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580318|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580319|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64580320|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64580321|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580322|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580323|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
64580324|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64580325|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580326|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580327|NCT00253435|Carboplatin|carboplatin|mesh-list
64580328|NCT00253435|Etoposide|etoposide|mesh-list
64305561|NCT02036723|Growth Substances|growth substances|mesh-ancestor
64580329|NCT00253435|Melphalan|melphalan|mesh-list
64580330|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580331|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64580332|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64580333|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64580334|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580335|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580336|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
64580337|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580338|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580339|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
64580340|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580341|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580342|NCT00253513|Fludarabine|fludarabine|mesh-list
64580343|NCT00253513|Treosulfan|treosulfan|mesh-list
64580344|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580348|NCT05033847|Vaccines|vaccines|mesh-list
64580358|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580359|NCT04930107|Fluconazole|fluconazole|mesh-list
64580360|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
64580361|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580362|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64580363|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64580364|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580365|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580366|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64580367|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
64580368|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580369|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591960|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64580370|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64580371|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64580373|NCT00100841|Bevacizumab|bevacizumab|mesh-list
64580374|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64580375|NCT00100841|Cetuximab|cetuximab|mesh-list
64580376|NCT00100841|Fluorouracil|fluorouracil|mesh-list
64580377|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
64580378|NCT00100841|Antibodies|antibodies|mesh-list
64580379|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
64580380|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64580381|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
64580382|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580383|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64580384|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64580385|NCT00100841|Growth Substances|growth substances|mesh-ancestor
64580389|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
64580403|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580404|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
64580405|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305631|NCT03562169|Thalidomide|thalidomide|mesh-list
64580406|NCT04908579|Analgesics|analgesics|mesh-ancestor
64580407|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64580408|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64580409|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
64580410|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64580411|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64580412|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580413|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580414|NCT00147199|Treprostinil|treprostinil|mesh-list
64580415|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64580416|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64580417|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64580418|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580419|NCT00149227|Valsartan|valsartan|mesh-list
64580420|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
64580421|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64580422|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64580423|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580424|NCT00445965|Antibodies|antibodies|mesh-list
64580425|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64580426|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
64580427|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580428|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
64580429|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64580431|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64580432|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64580433|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580442|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64580443|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
64580444|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580445|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580446|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580447|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64580448|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64580454|NCT02243709|Mifepristone|mifepristone|mesh-list
64580455|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64580456|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
64580457|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64580458|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580459|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64580460|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64580461|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64580462|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
64591987|NCT00627367|Analgesics|analgesics|mesh-ancestor
64580463|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64580464|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64580465|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
64580466|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580467|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
64580468|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64580469|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64580470|NCT00258349|Trastuzumab|trastuzumab|mesh-list
64580471|NCT00258349|Vorinostat|vorinostat|mesh-list
64580472|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580492|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580493|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580495|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
64580496|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580497|NCT05686863|Remifentanil|remifentanil|mesh-list
64580498|NCT05686863|Propofol|propofol|mesh-list
64580499|NCT05686863|Esketamine|esketamine|mesh-list
64580500|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64580501|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580502|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580503|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64580504|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
64580505|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
64580506|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64580507|NCT05686863|Narcotics|narcotics|mesh-ancestor
64580508|NCT05686863|Analgesics|analgesics|mesh-ancestor
64580509|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
64580510|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580511|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
64580512|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64580513|NCT00259285|Pemetrexed|pemetrexed|mesh-list
64580514|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580515|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580516|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580517|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64580518|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64580519|NCT05682339|Quinine|quinine|mesh-list
64580520|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
64580521|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64580522|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64580529|NCT05682339|Analgesics|analgesics|mesh-ancestor
64580537|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580538|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
64362934|NCT05161741|Insulin|insulin|mesh-list
64580539|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
64580540|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
64580541|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580542|NCT02249481|Bupivacaine|bupivacaine|mesh-list
64580543|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
64580544|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
64580545|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580546|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580547|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
64580548|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580549|NCT01717053|Prednisone|prednisone|mesh-list
64580550|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
64580551|NCT01717053|Androgens|androgens|mesh-list
64580552|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580553|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
64580554|NCT01717053|Hormones|hormones|mesh-ancestor
64580555|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580556|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580593|NCT05535738|Adalimumab|adalimumab|mesh-list
64580594|NCT05535738|Triamcinolone|triamcinolone|mesh-list
64580595|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64580596|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64580597|NCT05535738|Betamethasone|betamethasone|mesh-list
64580598|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
64580599|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64580600|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
64580601|NCT05535738|Ustekinumab|ustekinumab|mesh-list
64580602|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64580603|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
64580604|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64580605|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580606|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64580607|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
64580608|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580609|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580610|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64580611|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
64580612|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
64580613|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64580614|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580615|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
64580616|NCT05535738|Hormones|hormones|mesh-ancestor
64580617|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580618|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580619|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
64580620|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580621|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580622|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64580623|NCT00260689|Cyclosporine|cyclosporine|mesh-list
64592008|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592009|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580624|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
64580625|NCT00260689|Cyclosporins|cyclosporins|mesh-list
64580626|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64580627|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
64580628|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336680|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580629|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580630|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580631|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
64580633|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
64580634|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580635|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
64580636|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580637|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64580638|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580639|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580641|NCT00262639|Flumazenil|flumazenil|mesh-list
64580642|NCT00262639|Analgesics|analgesics|mesh-ancestor
64580643|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
64580644|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580645|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580646|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
64580647|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64580648|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64580649|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580650|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64580651|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64580652|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64580653|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580654|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580655|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
64580656|NCT00262639|Antidotes|antidotes|mesh-ancestor
64580657|NCT00262639|Protective Agents|protective agents|mesh-ancestor
64580658|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
64580659|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
64580660|NCT01062451|Candesartan|candesartan|mesh-list
64580661|NCT01062451|Perindopril|perindopril|mesh-list
64580662|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64580663|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64336681|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592056|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
64592057|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64592058|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580665|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580666|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64580668|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580669|NCT04639843|Doxorubicin|doxorubicin|mesh-list
64580670|NCT04639843|Romidepsin|romidepsin|mesh-list
64580671|NCT04639843|Azacitidine|azacitidine|mesh-list
64580673|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64580674|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580675|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64580676|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64580677|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580678|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580679|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64580680|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
64580681|NCT01718691|Rituximab|rituximab|mesh-list
64580682|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580683|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580684|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
64580685|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580686|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580687|NCT05699148|Ivacaftor|ivacaftor|mesh-list
64580688|NCT05699148|Elexacaftor|elexacaftor|mesh-list
64580689|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64580690|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64580691|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580692|NCT04638517|Danazol|danazol|mesh-list
64580693|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64580694|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
64580695|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580696|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580697|NCT04467723|Pirfenidone|pirfenidone|mesh-list
64580698|NCT04467723|Atezolizumab|atezolizumab|mesh-list
64336682|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64336683|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336775|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64336776|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
64580699|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580700|NCT04467723|Analgesics|analgesics|mesh-ancestor
64580701|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
64580702|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592090|NCT00630409|Gemcitabine|gemcitabine|mesh-list
64592091|NCT00630409|Doxorubicin|doxorubicin|mesh-list
64580703|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580704|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64580705|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64580706|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580707|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580708|NCT05539872|Insulin|insulin|mesh-list
64580709|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64580710|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
64580711|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
64580712|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64580713|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64580714|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580715|NCT04425642|Methamphetamine|methamphetamine|mesh-list
64580716|NCT04425642|SMOFlipid|smoflipid|mesh-list
64580717|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64580718|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580719|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
64580720|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
64580721|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580722|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
64580723|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64580724|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580725|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
64580745|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580746|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580747|NCT01665768|Rituximab|rituximab|mesh-list
64580748|NCT01665768|Everolimus|everolimus|mesh-list
64580749|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580750|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580751|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
64580752|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580753|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580754|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580755|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64580756|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
64580757|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580758|NCT04617457|Leucovorin|leucovorin|mesh-list
64580759|NCT04617457|Folic Acid|folic acid|mesh-list
64580760|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
64580761|NCT04617457|Irinotecan|irinotecan|mesh-list
64592123|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64580762|NCT04617457|Fluorouracil|fluorouracil|mesh-list
64580763|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
64580764|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580765|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64580766|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64580767|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580768|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580769|NCT04617457|Antidotes|antidotes|mesh-ancestor
64580770|NCT04617457|Protective Agents|protective agents|mesh-ancestor
64580771|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580772|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
64580773|NCT04617457|Vitamins|vitamins|mesh-ancestor
64580774|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
64580775|NCT04617457|Hematinics|hematinics|mesh-ancestor
64580776|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
64580778|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580790|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580791|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64580792|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64580793|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580795|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64580796|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
64580797|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
64580798|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580799|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
64580800|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580801|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
64580802|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580803|NCT04734210|Betamethasone|betamethasone|mesh-list
64580804|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
64580805|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64580806|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
64580807|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64580808|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580809|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
64580811|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64580812|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580813|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64580814|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
64580815|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
64580816|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580817|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64580818|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580819|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580820|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
64580821|NCT04476511|Vitamin D|vitamin d|mesh-list
64580822|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64580823|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580831|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64580832|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580833|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
64580834|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580835|NCT00026221|Interferons|interferons|mesh-list
64580836|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
64580837|NCT00026221|Bevacizumab|bevacizumab|mesh-list
64580838|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64580839|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580840|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64580841|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64580842|NCT00026221|Growth Substances|growth substances|mesh-ancestor
64580843|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580844|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
64580845|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
64580846|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580847|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
64580848|NCT00028093|Ribavirin|ribavirin|mesh-list
64580849|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64580850|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
64580851|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
64580852|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580853|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
64580854|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580855|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
64580881|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580882|NCT04389229|Aldesleukin|aldesleukin|mesh-list
64362984|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
64580884|NCT04389229|Fludarabine|fludarabine|mesh-list
64580885|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64580886|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
64580887|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580888|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580889|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64580890|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
64580891|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580892|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64580893|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64580894|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64580895|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64580896|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
64580897|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64580898|NCT03861702|Irinotecan|irinotecan|mesh-list
64580901|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64580940|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580941|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
64580942|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64580943|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64580944|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
64580945|NCT02240667|Coagulants|coagulants|mesh-ancestor
64580946|NCT00272311|Aspirin|aspirin|mesh-list
64580947|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64580948|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64580949|NCT00272311|Analgesics|analgesics|mesh-ancestor
64580950|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
64580951|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64580952|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64580953|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64580954|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64580955|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64580956|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64580957|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64580964|NCT00038857|Melphalan|melphalan|mesh-list
64580997|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64580999|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
64581000|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581001|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581002|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
64581003|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581004|NCT01729845|Analgesics|analgesics|mesh-ancestor
64581005|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
64581006|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581007|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
64581008|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
64581009|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
64581010|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64581011|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64581012|NCT01729923|Celecoxib|celecoxib|mesh-list
64581013|NCT01729923|Capecitabine|capecitabine|mesh-list
64581014|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
64581015|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64581016|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
64581017|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581018|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581019|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64581039|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
64581040|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581041|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581042|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581043|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
64581044|NCT02584452|Hormones|hormones|mesh-ancestor
64581045|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581046|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64581047|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581048|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
64581049|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
64581050|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581051|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
64581052|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64581053|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64581065|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581066|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581067|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64363008|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
64581080|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64581081|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64581082|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581083|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64581084|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64581085|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64581086|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64581087|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581088|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
64581089|NCT03520491|Nivolumab|nivolumab|mesh-list
64581090|NCT03520491|Ipilimumab|ipilimumab|mesh-list
64581091|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64581095|NCT05591118|Anticoagulants|anticoagulants|mesh-list
64581110|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64581111|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581112|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
64581113|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
64592177|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64581114|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
64581115|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581116|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64581117|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
64581118|NCT02243007|Antiviral Agents|antiviral agents|mesh-ancestor
64581119|NCT02243007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581120|NCT02243007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581121|NCT02243007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581172|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64581173|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581174|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
64581175|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581176|NCT05316675|Isotretinoin|isotretinoin|mesh-list
64581177|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
64581178|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
64581179|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64581180|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581181|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64581182|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581183|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
64581184|NCT01736865|Vitamin D|vitamin d|mesh-list
64581185|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64581186|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581187|NCT01736865|Vitamins|vitamins|mesh-ancestor
64581188|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
64581213|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
64363040|NCT02472691|Azacitidine|azacitidine|mesh-list
64363041|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
64581247|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581248|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64581249|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581250|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
64581251|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581252|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64581253|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64581254|NCT01745133|Calcitriol|calcitriol|mesh-list
64581255|NCT01745133|Clobetasol|clobetasol|mesh-list
64581256|NCT01745133|Calcipotriene|calcipotriene|mesh-list
64581257|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581258|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
64581259|NCT01745133|Hormones|hormones|mesh-ancestor
64581260|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581261|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581262|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
64581263|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64592216|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
64581264|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64581265|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64581266|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581267|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64581268|NCT01745133|Vitamins|vitamins|mesh-ancestor
64581269|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
64581270|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64581271|NCT05302011|Carboplatin|carboplatin|mesh-list
64581272|NCT05302011|Docetaxel|docetaxel|mesh-list
64581273|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
64581274|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581275|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
64581276|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
64581277|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
64581279|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64581281|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64581282|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581284|NCT04246359|Rituximab|rituximab|mesh-list
64581285|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64581286|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581287|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
64592217|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581288|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581289|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581290|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
64581291|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581292|NCT05213169|Apomorphine|apomorphine|mesh-list
64581293|NCT05213169|Emetics|emetics|mesh-ancestor
64581294|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581295|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
64581296|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581297|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581298|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
64581299|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
64581300|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581301|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581302|NCT05192265|Artesunate|artesunate|mesh-list
64581303|NCT05192265|Lumefantrine|lumefantrine|mesh-list
64581304|NCT05192265|Artemether|artemether|mesh-list
64581305|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64581306|NCT05192265|Pyronaridine|pyronaridine|mesh-list
64581307|NCT05192265|Antimalarials|antimalarials|mesh-list
64363049|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
64581333|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64581334|NCT00106535|Methotrexate|methotrexate|mesh-list
64581335|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64581336|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
64581337|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64581338|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581339|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64581340|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
64581341|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581342|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581343|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
64581344|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581345|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64581346|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581347|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
64581348|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581386|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581387|NCT05696886|Analgesics|analgesics|mesh-ancestor
64581388|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
64581389|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581390|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64581391|NCT01748955|Bupropion|bupropion|mesh-list
64581392|NCT01748955|Paroxetine|paroxetine|mesh-list
64581393|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64581394|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
64581395|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581396|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64581397|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64581398|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64581399|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581400|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
64581401|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581402|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581403|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64581404|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64581405|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581406|NCT01748955|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64581407|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
64581408|NCT05687448|Warfarin|warfarin|mesh-list
64581409|NCT05687448|Apixaban|apixaban|mesh-list
64581410|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
64581411|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64581412|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
64581413|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64581414|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
64592224|NCT00515411|Antidotes|antidotes|mesh-ancestor
64581415|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581416|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581417|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
64581418|NCT05156268|Olaparib|olaparib|mesh-list
64581426|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64581427|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64581428|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581429|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581430|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64581431|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64581432|NCT02255175|Estradiol|estradiol|mesh-list
64581433|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64581434|NCT02255175|Progesterone|progesterone|mesh-list
64581435|NCT02255175|Estrogens|estrogens|mesh-ancestor
64581437|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581438|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581439|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64581441|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64581442|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64581443|NCT02255175|Progestins|progestins|mesh-ancestor
64581444|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64581445|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581446|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
64581447|NCT03899103|Rituximab|rituximab|mesh-list
64581448|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64581449|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581450|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
64581451|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581452|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581453|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64581454|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64581455|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
64581456|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64581457|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581466|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581467|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581468|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64581469|NCT01438424|Lamivudine|lamivudine|mesh-list
64581471|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64581472|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64581473|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581474|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581475|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
64581476|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581477|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64581478|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64581479|NCT04315272|Azithromycin|azithromycin|mesh-list
64581480|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64581481|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581482|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
64581483|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581484|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64581485|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
64581486|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64581487|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
64581488|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
64581489|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581490|NCT05299866|Ketamine|ketamine|mesh-list
64581491|NCT05299866|Esketamine|esketamine|mesh-list
64581492|NCT05299866|Analgesics|analgesics|mesh-ancestor
64581493|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
64581494|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581495|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581496|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64581497|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64581498|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
64581499|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
64592245|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581500|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581503|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581505|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
64581506|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581507|NCT04133376|Nicotine|nicotine|mesh-list
64581508|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64581509|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
64581510|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581511|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581512|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64581513|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64581514|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
64581515|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581516|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581517|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
64581518|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64581519|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
64581520|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581521|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581522|NCT05267886|Dobutamine|dobutamine|mesh-list
64581523|NCT05267886|Milrinone|milrinone|mesh-list
64581524|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64581525|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
64581526|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
64581527|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581528|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581529|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64581530|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64581531|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64581532|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
64581533|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581534|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581535|NCT05267886|Protective Agents|protective agents|mesh-ancestor
64581536|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64581537|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
64581538|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64581539|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64581540|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581545|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
64581546|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581547|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581548|NCT05694936|Cetuximab|cetuximab|mesh-list
64581549|NCT05694936|Panitumumab|panitumumab|mesh-list
64581550|NCT05694936|Valproic Acid|valproic acid|mesh-list
64581551|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64581552|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581553|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
64581554|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581555|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581556|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
64581557|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581558|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581559|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
64581587|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64581588|NCT04592952|Erenumab|erenumab|mesh-list
64581589|NCT04592952|Katacalcin|katacalcin|mesh-list
64581590|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64581591|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333978|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581636|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
64581637|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64581639|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581640|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581641|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64581642|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
64581643|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
64581644|NCT05691426|Protective Agents|protective agents|mesh-ancestor
64581645|NCT05696574|Misoprostol|misoprostol|mesh-list
64581646|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64581654|NCT00112151|Testosterone|testosterone|mesh-list
64581655|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
64581656|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
64581657|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64581658|NCT00112151|Androgens|androgens|mesh-ancestor
64581659|NCT00112151|Hormones|hormones|mesh-ancestor
64581660|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581661|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581662|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64581663|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581664|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
64581665|NCT05162742|Colchicine|colchicine|mesh-list
64581666|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
64581667|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581668|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
64581669|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
64581670|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
64581671|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581675|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581677|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64581678|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
64581679|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581680|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581681|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581682|NCT05669742|Empagliflozin|empagliflozin|mesh-list
64581683|NCT05669742|Olanzapine|olanzapine|mesh-list
64581684|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
64581685|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
64581686|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581687|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581688|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581689|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64581690|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64581691|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581692|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581693|NCT05669742|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64581694|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64581695|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64581696|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581697|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581699|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64581700|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64581701|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
64581702|NCT00177047|Melphalan|melphalan|mesh-list
64581703|NCT00177047|Lenograstim|lenograstim|mesh-list
64581704|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581705|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
64581706|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581707|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581708|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64581709|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
64581710|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581711|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581712|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64581713|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64592256|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
64592257|NCT04405154|Cisplatin|cisplatin|mesh-list
64592259|NCT00586573|Memantine|memantine|mesh-list
64581714|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64581715|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
64581716|NCT00178841|Bexarotene|bexarotene|mesh-list
64581717|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64581718|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581719|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581720|NCT01756209|Acetaminophen|acetaminophen|mesh-list
64581721|NCT01756209|Ibuprofen|ibuprofen|mesh-list
64581722|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64581723|NCT01756209|Analgesics|analgesics|mesh-ancestor
64581724|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
64581725|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581726|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581727|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
64581728|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64581729|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581730|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581731|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64581732|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581733|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581734|NCT00116207|Niacinamide|niacinamide|mesh-list
64581735|NCT00116207|Allopurinol|allopurinol|mesh-list
64581755|NCT00178919|Trimethaphan|trimethaphan|mesh-list
64581756|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
64581757|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581758|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64581759|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64581760|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64581761|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
64581762|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581763|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581764|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64581765|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64581766|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
64581767|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592268|NCT01799005|Micronutrients|micronutrients|mesh-list
64581768|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
64581769|NCT05609682|Gabapentin|gabapentin|mesh-list
64581770|NCT05609682|Analgesics|analgesics|mesh-ancestor
64581771|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
64581772|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581773|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581814|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64581815|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581816|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
64581817|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581818|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64581819|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
64581820|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64581821|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581822|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64581823|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64581824|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64581825|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
64581826|NCT05577000|Fludarabine|fludarabine|mesh-list
64581827|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581828|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
64581829|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581830|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581831|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64581852|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581854|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64581855|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581857|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64581858|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64581859|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64581887|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581888|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581889|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
64581890|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
64581891|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
64581892|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581893|NCT02579928|Midazolam|midazolam|mesh-list
64581894|NCT02579928|Ketamine|ketamine|mesh-list
64581895|NCT02579928|Analgesics|analgesics|mesh-ancestor
64581896|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
64581910|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64581911|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64581912|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581913|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
64581914|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
64336777|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64581915|NCT00183677|Citalopram|citalopram|mesh-list
64581916|NCT00183677|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64581917|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64581918|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64581919|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581920|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64581921|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
64581922|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581923|NCT00183677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64581924|NCT00183677|Antidepressive Agents|antidepressive agents|mesh-ancestor
64581925|NCT00183677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581926|NCT00186017|Olanzapine|olanzapine|mesh-list
64581927|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
64581928|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
64581929|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592304|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581930|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581931|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581932|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64581933|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64581934|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64581935|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64581936|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64581937|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64581938|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363169|NCT02470117|Antacids|antacids|mesh-list
64363172|NCT03310333|Dinoprostone|dinoprostone|mesh-list
64581964|NCT00186875|Dexamethasone|dexamethasone|mesh-list
64581965|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
64581966|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
64581967|NCT00186875|Methotrexate|methotrexate|mesh-list
64581968|NCT00186875|Etoposide|etoposide|mesh-list
64581969|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
64581970|NCT00186875|Vincristine|vincristine|mesh-list
64581971|NCT00186875|Asparaginase|asparaginase|mesh-list
64581972|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
64581973|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
64581974|NCT00186875|Vinblastine|vinblastine|mesh-list
64581975|NCT00186875|Pegaspargase|pegaspargase|mesh-list
64581976|NCT00186875|Teniposide|teniposide|mesh-list
64581977|NCT00186875|BB 1101|bb 1101|mesh-list
64581978|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64581979|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
64581980|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64581981|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64581982|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64581983|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
64581984|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64581985|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64581986|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64581987|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64581988|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
64581989|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
64581990|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64581991|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64581992|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
64581993|NCT00186875|Hormones|hormones|mesh-ancestor
64333979|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64333980|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333982|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581994|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64581995|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64581996|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
64581997|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64581998|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64581999|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
64582000|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64582001|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592318|NCT00516503|Ketamine|ketamine|mesh-list
64592319|NCT00516503|Amitriptyline|amitriptyline|mesh-list
64582002|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
64582003|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64582004|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64582005|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64582006|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64582007|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64582008|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64582009|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
64582010|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582011|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
64582012|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
64582013|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64582015|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
64582016|NCT00551460|Methotrexate|methotrexate|mesh-list
64582017|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
64582018|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
64582019|NCT00551460|Tretinoin|tretinoin|mesh-list
64582053|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582054|NCT02579772|Protective Agents|protective agents|mesh-ancestor
64582055|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582056|NCT02579772|Antidotes|antidotes|mesh-ancestor
64582057|NCT05535036|Dexamethasone|dexamethasone|mesh-list
64582058|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582059|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
64582060|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
64333983|NCT02360709|Sirolimus|sirolimus|mesh-list
64333984|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64333985|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64333986|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64333987|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64333988|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
64333989|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64333990|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
64333991|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64333992|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
64333993|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582062|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582063|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582064|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
64582065|NCT05535036|Hormones|hormones|mesh-ancestor
64582066|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582067|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64582068|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582069|NCT04209114|Nivolumab|nivolumab|mesh-list
64592342|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582070|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592343|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64582071|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582072|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64582073|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582075|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
64582076|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582077|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582078|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
64582079|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582080|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64582081|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64582082|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64582083|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582084|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582085|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64582086|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64582087|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64582088|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64582089|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
64582090|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582091|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582092|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64582094|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
64582100|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64582101|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
64582102|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582103|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
64582104|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64582105|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
64582106|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582107|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582108|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64582109|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
64582110|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582111|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582112|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64582113|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
64582114|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
64582115|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64582116|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582117|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582118|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64592371|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64582119|NCT04953156|Analgesics|analgesics|mesh-ancestor
64582120|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
64582121|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582122|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64582123|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64582124|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64582125|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
64582126|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582127|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363300|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582145|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64582147|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582148|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582149|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582150|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
64582151|NCT04097730|Vitamins|vitamins|mesh-ancestor
64582152|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
64582153|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64582154|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
64582155|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
64582156|NCT04097730|Hormones|hormones|mesh-ancestor
64582157|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582158|NCT00278863|Capecitabine|capecitabine|mesh-list
64582159|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64363305|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363307|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
64334001|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
64334002|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334003|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334004|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64334005|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
64334006|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
64334007|NCT02357277|Hormones|hormones|mesh-ancestor
64334008|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334009|NCT02222441|Pioglitazone|pioglitazone|mesh-list
64334010|NCT02222441|Palbociclib|palbociclib|mesh-list
64334011|NCT02222441|Modafinil|modafinil|mesh-list
64592401|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334012|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64334013|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334014|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334015|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64334016|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334017|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334018|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64334019|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64334020|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64334021|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64334022|NCT02290717|Fluticasone|fluticasone|mesh-list
64334023|NCT02290717|Xhance|xhance|mesh-list
64582179|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582180|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582181|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582182|NCT00187655|Cefotaxime|cefotaxime|mesh-list
64582183|NCT00187655|Cefoxitin|cefoxitin|mesh-list
64582184|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64582185|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582186|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64582187|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582188|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64582189|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582190|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582191|NCT02579616|Lenvatinib|lenvatinib|mesh-list
64582192|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582193|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64582194|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582195|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582196|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
64582197|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64582198|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
64582199|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64582200|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582201|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64582202|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64582203|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64582207|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
64582208|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582209|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582210|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64582211|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64582212|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582213|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64582214|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582234|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
64582235|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582236|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582237|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64582238|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
64582239|NCT04123873|Hormones|hormones|mesh-ancestor
64582251|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582252|NCT02256111|Androgens|androgens|mesh-list
64582253|NCT02256111|Hormones|hormones|mesh-ancestor
64582254|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582255|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582256|NCT01790971|Morphine|morphine|mesh-list
64582257|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64582258|NCT01790971|Narcotics|narcotics|mesh-ancestor
64582259|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582260|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582261|NCT01790971|Analgesics|analgesics|mesh-ancestor
64592436|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592438|NCT00517595|Gemcitabine|gemcitabine|mesh-list
64582262|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
64582263|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582264|NCT00189137|Gemcitabine|gemcitabine|mesh-list
64582265|NCT00189137|Docetaxel|docetaxel|mesh-list
64582266|NCT00189137|Doxorubicin|doxorubicin|mesh-list
64582267|NCT00189137|Ifosfamide|ifosfamide|mesh-list
64582268|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64582269|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
64582270|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582281|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64582282|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64582283|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64582284|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64582285|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
64582286|NCT02099461|Denosumab|denosumab|mesh-list
64582287|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64582288|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582289|NCT04860960|Betadex|betadex|mesh-list
64582290|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
64582291|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582292|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64582293|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64582294|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582295|NCT02256189|Incretins|incretins|mesh-ancestor
64582296|NCT02256189|Hormones|hormones|mesh-ancestor
64582297|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582298|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64582299|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
64582300|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582302|NCT00193037|Docetaxel|docetaxel|mesh-list
64582313|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582315|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64582316|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64582317|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582318|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582319|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582320|NCT05392764|Empagliflozin|empagliflozin|mesh-list
64582321|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64582322|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582323|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64582324|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582325|NCT02866383|Nivolumab|nivolumab|mesh-list
64582326|NCT02866383|Ipilimumab|ipilimumab|mesh-list
64582327|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582328|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582329|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64582330|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582331|NCT01809639|Progesterone|progesterone|mesh-list
64582332|NCT01809639|Progestins|progestins|mesh-ancestor
64582333|NCT01809639|Hormones|hormones|mesh-ancestor
64582334|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582335|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582336|NCT05391750|Venetoclax|venetoclax|mesh-list
64582337|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
64582338|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
64582339|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
64582346|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582348|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582349|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64582350|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582351|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582352|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64582353|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64582354|NCT04677114|Buprenorphine|buprenorphine|mesh-list
64582355|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64582356|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582357|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
64582358|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64582359|NCT04677114|Narcotics|narcotics|mesh-ancestor
64582360|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582361|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582362|NCT04677114|Analgesics|analgesics|mesh-ancestor
64582363|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
64582364|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582365|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64582397|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64582398|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64582399|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582400|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582401|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
64582402|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64582403|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64582404|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64582405|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582406|NCT01767285|Etonogestrel|etonogestrel|mesh-list
64582407|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64582408|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
64582409|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64582410|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582411|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64582412|NCT01465802|Doxycycline|doxycycline|mesh-list
64582413|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
64582414|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64592464|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592501|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582415|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582416|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
64582417|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64582418|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64582419|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582420|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
64582421|NCT01465802|Hormones|hormones|mesh-ancestor
64582422|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582444|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582445|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582446|NCT01813149|Protective Agents|protective agents|mesh-ancestor
64582447|NCT01813149|Analgesics|analgesics|mesh-ancestor
64307650|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
64582448|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64582449|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
64582450|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64582451|NCT03787680|Olaparib|olaparib|mesh-list
64582452|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64582453|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582454|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582455|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582456|NCT00137969|Acetaminophen|acetaminophen|mesh-list
64582457|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
64582458|NCT00137969|Promethazine|promethazine|mesh-list
64582459|NCT00137969|Prednisone|prednisone|mesh-list
64582460|NCT00137969|Rituximab|rituximab|mesh-list
64582461|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582462|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582463|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
64582464|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582465|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582466|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582495|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
64582496|NCT04767308|Fludarabine|fludarabine|mesh-list
64582497|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64582498|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
64582499|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582500|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582501|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64582502|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
64582503|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582504|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582505|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64582506|NCT00138125|Trastuzumab|trastuzumab|mesh-list
64582507|NCT00138125|Fulvestrant|fulvestrant|mesh-list
64582508|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582509|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582510|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64582511|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64582512|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64582513|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
64582514|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582515|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582516|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64582517|NCT01815333|Hematinics|hematinics|mesh-ancestor
64582518|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64582519|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64582520|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
64582521|NCT01465178|Vitamin D|vitamin d|mesh-list
64582522|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64582539|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582540|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
64582541|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582542|NCT00194129|Valproic Acid|valproic acid|mesh-list
64582543|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
64582544|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
64582545|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64582546|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582547|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582548|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
64582549|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64582550|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582551|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582552|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
64582553|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
64582554|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582556|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64582557|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64582558|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582559|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582560|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64582561|NCT01817907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64582562|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64582563|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582564|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582565|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582566|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
64582567|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64582568|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
64582569|NCT01445678|Metronidazole|metronidazole|mesh-list
64582570|NCT01445678|Meropenem|meropenem|mesh-list
64582571|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582572|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64582580|NCT01818063|Paclitaxel|paclitaxel|mesh-list
64582581|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
64582582|NCT01818063|Carboplatin|carboplatin|mesh-list
64582583|NCT01818063|Doxorubicin|doxorubicin|mesh-list
64582584|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64582585|NCT01818063|Veliparib|veliparib|mesh-list
64582586|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64582587|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582588|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
64582589|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
64592511|NCT04393298|Fluorouracil|fluorouracil|mesh-list
64592513|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
64582590|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
64582591|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582592|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64582593|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
64582594|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582595|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582596|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64582597|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
64582598|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64307807|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
64582599|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64582600|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64582631|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582633|NCT01444898|Incretins|incretins|mesh-ancestor
64582634|NCT01444898|Hormones|hormones|mesh-ancestor
64582635|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582636|NCT00201773|Celecoxib|celecoxib|mesh-list
64582637|NCT00201773|Exemestane|exemestane|mesh-list
64582638|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64582639|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582640|NCT00201773|Analgesics|analgesics|mesh-ancestor
64582641|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
64582642|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582643|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582644|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582645|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582646|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64582647|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64582648|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582649|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582650|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582651|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64582667|NCT05643066|Ketamine|ketamine|mesh-list
64582682|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582683|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582684|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
64582685|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64582687|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64582688|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
64582689|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582690|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64582691|NCT00256451|Ethanol|ethanol|mesh-list
64582692|NCT00256451|Naltrexone|naltrexone|mesh-list
64582693|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64582694|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582695|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582696|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582697|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64582698|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64582699|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
64582700|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582701|NCT03582618|Sorafenib|sorafenib|mesh-list
64582702|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582703|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64582704|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592548|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
64582705|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582706|NCT00257309|Tenecteplase|tenecteplase|mesh-list
64582707|NCT00257309|Clopidogrel|clopidogrel|mesh-list
64582708|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64582709|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64582710|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64582711|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64582712|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
64582713|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582714|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582718|NCT01444742|Cytarabine|cytarabine|mesh-list
64582722|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582723|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582724|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
64582725|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582726|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64582727|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
64582728|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582729|NCT01770483|Interferons|interferons|mesh-list
64582730|NCT01770483|Ribavirin|ribavirin|mesh-list
64582731|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
64582732|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
64582733|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582734|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
64582735|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582737|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582738|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
64582739|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582740|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64582741|NCT00257933|Prednisolone|prednisolone|mesh-list
64582742|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64582743|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
64582744|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64582745|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
64582746|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64582747|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
64582773|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582774|NCT00264641|Insulin|insulin|mesh-list
64582775|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64582776|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64582777|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582778|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
64582781|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64592569|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64582782|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582783|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582784|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
64582785|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582786|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582787|NCT00266279|Capecitabine|capecitabine|mesh-list
64582788|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
64582789|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64582790|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
64582791|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582792|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582793|NCT01736085|Nicotine|nicotine|mesh-list
64582794|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64582795|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
64582796|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582797|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582798|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64582799|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64582800|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
64582801|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582802|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582803|NCT00210353|Rituximab|rituximab|mesh-list
64582804|NCT00210353|Chlorambucil|chlorambucil|mesh-list
64582814|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
64582815|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582816|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64582817|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64582818|NCT00267059|Growth Substances|growth substances|mesh-ancestor
64582819|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
64582820|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582821|NCT00213239|Remifentanil|remifentanil|mesh-list
64582822|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64582823|NCT00213239|Narcotics|narcotics|mesh-ancestor
64582824|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64582825|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582826|NCT00213239|Analgesics|analgesics|mesh-ancestor
64582827|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
64582828|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582829|NCT01444430|Budesonide|budesonide|mesh-list
64582830|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64582831|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582832|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64582833|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
64582834|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582835|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582836|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64582837|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
64582838|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
64582839|NCT01444430|Hormones|hormones|mesh-ancestor
64582840|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582841|NCT01774149|Diazepam|diazepam|mesh-list
64582842|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64582843|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
64582844|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
64582845|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
64582846|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582847|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582854|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64582855|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64582856|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64582857|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
64582858|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
64582859|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
64582860|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
64582861|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582862|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582863|NCT01898507|Nicotine|nicotine|mesh-list
64582864|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64582865|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
64582866|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582867|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582868|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64582869|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64582870|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
64582871|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582872|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582873|NCT00267293|Acetaminophen|acetaminophen|mesh-list
64582874|NCT00267293|Ibuprofen|ibuprofen|mesh-list
64582875|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582876|NCT00267293|Analgesics|analgesics|mesh-ancestor
64582877|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
64582878|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582879|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582880|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
64582881|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64582882|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582883|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64582884|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64582886|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582887|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64582888|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
64582889|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64582894|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64582895|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582896|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
64582897|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64582899|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
64582900|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582901|NCT01774851|Paclitaxel|paclitaxel|mesh-list
64582902|NCT01774851|Trastuzumab|trastuzumab|mesh-list
64582903|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64592614|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582904|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582905|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
64582906|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
64582907|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
64582908|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582909|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64582910|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
64582911|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
64582912|NCT02990013|Povidone|povidone|mesh-list
64582913|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64582914|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582915|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
64582916|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
64582917|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
64582918|NCT03440112|Clarithromycin|clarithromycin|mesh-list
64582919|NCT03440112|Flumazenil|flumazenil|mesh-list
64363393|NCT03302845|Omeprazole|omeprazole|mesh-list
64582920|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64582921|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64582922|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64582943|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64582944|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64582945|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582946|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64582948|NCT01419236|Androgens|androgens|mesh-ancestor
64582949|NCT01419236|Hormones|hormones|mesh-ancestor
64582950|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64582951|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582952|NCT03323658|Bexarotene|bexarotene|mesh-list
64582953|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582954|NCT01443026|Lycopene|lycopene|mesh-list
64582955|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64582956|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
64582957|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582958|NCT01443026|Protective Agents|protective agents|mesh-ancestor
64582959|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64582960|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64582961|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64582962|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582963|NCT01879371|Ibuprofen|ibuprofen|mesh-list
64582964|NCT01879371|Caffeine|caffeine|mesh-list
64582965|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64582966|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64582967|NCT01879371|Analgesics|analgesics|mesh-ancestor
64582968|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
64582969|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64582991|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64582992|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64582993|NCT01442714|Growth Substances|growth substances|mesh-ancestor
64582994|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
64582995|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64582996|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64582997|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
64582998|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64582999|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583000|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
64583001|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
64583002|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
64583003|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
64583004|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583005|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583006|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
64583007|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583008|NCT05501574|Tacrolimus|tacrolimus|mesh-list
64583009|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583010|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
64583011|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583012|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64583038|NCT01828515|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64583039|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64583040|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64583041|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583042|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583043|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
64583044|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583045|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64583046|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64583047|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
64583048|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64583049|NCT01828593|Antibodies|antibodies|mesh-list
64363405|NCT03302689|Ropivacaine|ropivacaine|mesh-list
64583050|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
64583051|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583052|NCT01781169|Vitamin D|vitamin d|mesh-list
64583053|NCT01781169|Vitamins|vitamins|mesh-ancestor
64583054|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
64583055|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583056|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64583057|NCT00216125|Docetaxel|docetaxel|mesh-list
64583058|NCT00216125|Etoposide|etoposide|mesh-list
64583090|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64583091|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583092|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583093|NCT00220961|Pioglitazone|pioglitazone|mesh-list
64583094|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64583095|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583096|NCT00222131|Esomeprazole|esomeprazole|mesh-list
64583097|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64583098|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583099|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64583100|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583101|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583102|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64592692|NCT02250014|Sargramostim|sargramostim|mesh-list
64592695|NCT04022096|Lansoprazole|lansoprazole|mesh-list
64583103|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64583104|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64583105|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64583106|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
64583107|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583108|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583109|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64583110|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
64583111|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583112|NCT01782963|Dexamethasone|dexamethasone|mesh-list
64583113|NCT01782963|Lenalidomide|lenalidomide|mesh-list
64583142|NCT05327751|Capecitabine|capecitabine|mesh-list
64583143|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583144|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
64583145|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583146|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583147|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64583148|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583149|NCT05327751|Analgesics|analgesics|mesh-ancestor
64583150|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
64583151|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583152|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583153|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583154|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583155|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64583156|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64583157|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583158|NCT02096861|Infliximab|infliximab|mesh-list
64583159|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
64583160|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583161|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583162|NCT01829919|Paroxetine|paroxetine|mesh-list
64583180|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
64583195|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64583196|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64583197|NCT01830699|Triamcinolone|triamcinolone|mesh-list
64583198|NCT01830699|Rilonacept|rilonacept|mesh-list
64583199|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583200|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
64583201|NCT01830699|Hormones|hormones|mesh-ancestor
64583202|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583203|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583204|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
64583205|NCT00280241|Rituximab|rituximab|mesh-list
64583206|NCT00280241|Fludarabine|fludarabine|mesh-list
64583209|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583210|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583211|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64583212|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
64583250|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64592701|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583251|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583252|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583253|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64583255|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
64583256|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
64583257|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583258|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583259|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64583260|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
64583261|NCT01833741|Bimatoprost|bimatoprost|mesh-list
64583262|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64583263|NCT02261727|Prednisone|prednisone|mesh-list
64583264|NCT02261727|Cortisone|cortisone|mesh-list
64583265|NCT02261727|Theophylline|theophylline|mesh-list
64583266|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583267|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
64583268|NCT02261727|Hormones|hormones|mesh-ancestor
64583269|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583270|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583271|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64583272|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583295|NCT05300841|Estradiol|estradiol|mesh-list
64583301|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583302|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64583303|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
64583304|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64583305|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64583306|NCT05300841|Progestins|progestins|mesh-ancestor
64583307|NCT00232505|Carboplatin|carboplatin|mesh-list
64583308|NCT00232505|Cetuximab|cetuximab|mesh-list
64583309|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583310|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583311|NCT00232583|Metformin|metformin|mesh-list
64583312|NCT00232583|Pioglitazone|pioglitazone|mesh-list
64583313|NCT00232583|Glyburide|glyburide|mesh-list
64583314|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64583315|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583316|NCT00232739|Sirolimus|sirolimus|mesh-list
64583317|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64583318|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583319|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64583320|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583325|NCT01789905|Tigecycline|tigecycline|mesh-list
64583358|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583359|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64583360|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64583361|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583362|NCT00285467|Vitamin D|vitamin d|mesh-list
64583363|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
64583364|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64583365|NCT00285467|Vitamins|vitamins|mesh-ancestor
64583366|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
64583367|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363461|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64583368|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64583369|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64583370|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64583371|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
64583372|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583374|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
64583375|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583376|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583377|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583378|NCT05261321|Analgesics|analgesics|mesh-ancestor
64583379|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
64583380|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583381|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64583382|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64583383|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583384|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583385|NCT05261321|Hormones|hormones|mesh-ancestor
64583386|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583387|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
64583388|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583389|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583394|NCT01794039|Ichthammol|ichthammol|mesh-list
64583397|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
64583398|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
64583399|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583400|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583401|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583402|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
64583403|NCT01794039|Hormones|hormones|mesh-ancestor
64363480|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64583404|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583405|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64583407|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
64583408|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64583409|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64583410|NCT01794039|Growth Substances|growth substances|mesh-ancestor
64583411|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64583412|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
64583413|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583414|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583415|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
64583416|NCT00281827|Gemcitabine|gemcitabine|mesh-list
64583417|NCT00281827|Thalidomide|thalidomide|mesh-list
64583418|NCT00281827|Carboplatin|carboplatin|mesh-list
64583419|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583420|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583421|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
64583422|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583423|NCT00281827|Antiviral Agents|antiviral agents|mesh-ancestor
64583424|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583425|NCT00281827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583426|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583427|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
64583428|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583441|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
64583442|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583443|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64583444|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64583445|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64583446|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
64583447|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583448|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583449|NCT01794741|Fluticasone|fluticasone|mesh-list
64583451|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583452|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64583453|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
64592736|NCT01670084|Cytarabine|cytarabine|mesh-list
64592737|NCT01670084|Dexamethasone|dexamethasone|mesh-list
64583454|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583455|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583456|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64583457|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
64363579|NCT03311425|Dexamethasone|dexamethasone|mesh-list
64583467|NCT02989623|Copper|copper|mesh-list
64583468|NCT02989623|Trace Elements|trace elements|mesh-ancestor
64583469|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
64583470|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583471|NCT00052429|Fluorouracil|fluorouracil|mesh-list
64583472|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583473|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
64583474|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363645|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363647|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583475|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583476|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583477|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
64583478|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583479|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
64583480|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64583481|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583483|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
64583484|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
64583485|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583486|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583487|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
64583488|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583489|NCT00287053|Valproic Acid|valproic acid|mesh-list
64583490|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
64583518|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64583519|NCT00236951|Hematinics|hematinics|mesh-ancestor
64583520|NCT00287287|Lenalidomide|lenalidomide|mesh-list
64583521|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
64583522|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583523|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64583524|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64592758|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
64583525|NCT00287287|Growth Substances|growth substances|mesh-ancestor
64583526|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
64363699|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363705|NCT02466373|Clonidine|clonidine|mesh-list
64583540|NCT00287989|Paclitaxel|paclitaxel|mesh-list
64583541|NCT00287989|Carboplatin|carboplatin|mesh-list
64583542|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64583543|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64583544|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583545|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
64583546|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
64583547|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
64583548|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583549|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64583550|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583551|NCT00288067|Rituximab|rituximab|mesh-list
64583552|NCT00288067|Fenretinide|fenretinide|mesh-list
64583553|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583554|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583555|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
64583556|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583560|NCT00285779|Etanercept|etanercept|mesh-list
64583596|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
64583597|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64583598|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64583599|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64583600|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583601|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583602|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64583603|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
64583604|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583605|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583606|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64583607|NCT01791439|Lidocaine|lidocaine|mesh-list
64583608|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
64583609|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
64583610|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64583611|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583612|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
64583613|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583614|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64583615|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64583616|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64583617|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64583618|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583619|NCT01650701|Rituximab|rituximab|mesh-list
64592797|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583620|NCT01650701|Lenalidomide|lenalidomide|mesh-list
64583621|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64583622|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583637|NCT04058678|Danazol|danazol|mesh-list
64583639|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
64583640|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363874|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
64363875|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64363876|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363913|NCT05122351|Analgesics|analgesics|mesh-ancestor
64583641|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583642|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64583643|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64583644|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64583645|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64583646|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583647|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
64583648|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583649|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583651|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64583652|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64583653|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64583654|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583655|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583656|NCT00291655|Levetiracetam|levetiracetam|mesh-list
64583657|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
64583695|NCT03366415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583696|NCT03366415|Immunologic Factors|immunologic factors|mesh-ancestor
64583697|NCT03366415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583698|NCT00292591|Vitamin D|vitamin d|mesh-list
64583699|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
64583700|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
64583701|NCT00292591|Vitamins|vitamins|mesh-list
64583702|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
64583703|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583704|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64583705|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64583706|NCT01847001|Paclitaxel|paclitaxel|mesh-list
64583707|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64583708|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
64583709|NCT01847001|Doxorubicin|doxorubicin|mesh-list
64583710|NCT01847001|Trastuzumab|trastuzumab|mesh-list
64583711|NCT01847001|Pertuzumab|pertuzumab|mesh-list
64583712|NCT01847001|Propranolol|propranolol|mesh-list
64583713|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64583714|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583715|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
64583716|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
64583717|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
64583718|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583719|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583720|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
64583721|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583722|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583723|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64583742|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583743|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64583744|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583745|NCT01804101|Cytarabine|cytarabine|mesh-list
64583746|NCT01804101|Daunorubicin|daunorubicin|mesh-list
64583747|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583756|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64583757|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64583758|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64583759|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583760|NCT00287729|Pirfenidone|pirfenidone|mesh-list
64583761|NCT00287729|Analgesics|analgesics|mesh-ancestor
64583762|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
64583763|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583764|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583765|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64583766|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583767|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64583768|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64592856|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
64583769|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583770|NCT01433978|Maleic acid|maleic acid|mesh-list
64583771|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583773|NCT00289211|Complement C1s|complement c1s|mesh-list
64583784|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583785|NCT01727193|Azathioprine|azathioprine|mesh-list
64583786|NCT01727193|Leflunomide|leflunomide|mesh-list
64583787|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
64583788|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583789|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583790|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583791|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64583792|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
64583793|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583794|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583795|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583796|NCT00181701|Paclitaxel|paclitaxel|mesh-list
64583797|NCT00181701|Carboplatin|carboplatin|mesh-list
64583798|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64583799|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583800|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
64583801|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
64583802|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
64583803|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583804|NCT01849419|Oxytocin|oxytocin|mesh-list
64583805|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
64583806|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64583807|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583808|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
64583809|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64583810|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583831|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64583832|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64583833|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
64583834|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64583835|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64583836|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64592897|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64592900|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583837|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64583838|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583839|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583840|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583841|NCT01852383|Analgesics|analgesics|mesh-ancestor
64583842|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
64583843|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583844|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
64583845|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64583846|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
64592934|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583848|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583849|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583850|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64583851|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583852|NCT02273115|Oxytocin|oxytocin|mesh-list
64583853|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
64583854|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64583855|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583856|NCT01853085|Bimatoprost|bimatoprost|mesh-list
64583857|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64583858|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64583859|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64583860|NCT02989467|Aprepitant|aprepitant|mesh-list
64583861|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
64583862|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
64583863|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583864|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583869|NCT01853553|Spironolactone|spironolactone|mesh-list
64583870|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64583871|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
64583872|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64583873|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583874|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64583875|NCT01853553|Diuretics|diuretics|mesh-ancestor
64592999|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
64583876|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
64593000|NCT01676558|Rituximab|rituximab|mesh-list
64583877|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
64583878|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64583879|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64583880|NCT05748561|Prednisolone|prednisolone|mesh-list
64583881|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
64364050|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64583905|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
64583906|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583907|NCT05748483|Topiramate|topiramate|mesh-list
64583908|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
64583909|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64583910|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583911|NCT00290615|Bevacizumab|bevacizumab|mesh-list
64583912|NCT00290615|Cetuximab|cetuximab|mesh-list
64583913|NCT00290615|Capecitabine|capecitabine|mesh-list
64583914|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
64583915|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583916|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583917|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64583918|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64583919|NCT00290615|Growth Substances|growth substances|mesh-ancestor
64583920|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583921|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
64583922|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64583923|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
64583924|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583925|NCT01854177|Aprepitant|aprepitant|mesh-list
64583926|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
64583927|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
64583933|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64583934|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583936|NCT01591577|Lapatinib|lapatinib|mesh-list
64583937|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64583938|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
64583939|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583940|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583941|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64583942|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583943|NCT03858231|Acetaminophen|acetaminophen|mesh-list
64583944|NCT03858231|Ibuprofen|ibuprofen|mesh-list
64583945|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64583946|NCT03858231|Analgesics|analgesics|mesh-ancestor
64583947|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
64583948|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64583949|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583950|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
64583951|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64583986|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64583987|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64583988|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
64583989|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64583990|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64583991|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64583992|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64583993|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64583994|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64583995|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64583997|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
64593168|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593175|NCT02141581|Vaccines|vaccines|mesh-list
64584011|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
64584012|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584013|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584014|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64584016|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
64584019|NCT05748093|Cobicistat|cobicistat|mesh-list
64584020|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64584021|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64584022|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
64584023|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584024|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64584025|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64584026|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584027|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584028|NCT00294515|Valganciclovir|valganciclovir|mesh-list
64584029|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
64584030|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584031|NCT00300469|Atorvastatin|atorvastatin|mesh-list
64584032|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64584033|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64584034|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
64364143|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364149|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
64584057|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584058|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584059|NCT02117141|Analgesics|analgesics|mesh-ancestor
64584060|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
64584061|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584062|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
64584063|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
64584064|NCT00299741|Sunitinib|sunitinib|mesh-list
64584065|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584066|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64584067|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64593283|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584068|NCT00299741|Growth Substances|growth substances|mesh-ancestor
64584069|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584090|NCT00248807|Enalaprilat|enalaprilat|mesh-list
64584091|NCT00248807|Enalapril|enalapril|mesh-list
64584092|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64584093|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
64584094|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584095|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584096|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64584097|NCT01860807|Ibudilast|ibudilast|mesh-list
64584098|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64584099|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
64584100|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584101|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584102|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64584103|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
64584104|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64584105|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584106|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584107|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64584108|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
64584110|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584111|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584112|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584113|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584114|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
64584115|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64584116|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64584118|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
64584134|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
64584135|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364167|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364171|NCT03295825|Heparin|heparin|mesh-list
64584141|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584142|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584143|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584145|NCT05185973|Trace Elements|trace elements|mesh-list
64584146|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584147|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
64584148|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64584149|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584150|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
64584151|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64584152|NCT00251225|Docetaxel|docetaxel|mesh-list
64584153|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
64584154|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584155|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
64584156|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
64584157|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64584184|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584185|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64584186|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64584187|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584188|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593459|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
64584189|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64584190|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
64584191|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584192|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584193|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64584195|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
64584196|NCT00559845|Bevacizumab|bevacizumab|mesh-list
64584197|NCT00559845|Fluorouracil|fluorouracil|mesh-list
64584198|NCT00559845|Epirubicin|epirubicin|mesh-list
64584199|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64584209|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64584230|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64584231|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584232|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584233|NCT02261883|Treprostinil|treprostinil|mesh-list
64584234|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64584235|NCT00334633|Metronidazole|metronidazole|mesh-list
64584237|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584238|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584239|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64584240|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64584241|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
64584242|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593508|NCT00680953|Alendronate|alendronate|mesh-list
64593511|NCT00660985|Adapalene|adapalene|mesh-list
64584243|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64584244|NCT01393964|Dexamethasone|dexamethasone|mesh-list
64584245|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
64584246|NCT01393964|Lenalidomide|lenalidomide|mesh-list
64584247|NCT01393964|Elotuzumab|elotuzumab|mesh-list
64309464|NCT03197103|Expectorants|expectorants|mesh-ancestor
64584248|NCT01393964|BB 1101|bb 1101|mesh-list
64584249|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584250|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
64584251|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
64584252|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584253|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584254|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334040|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64334048|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334049|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593558|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
64334050|NCT02360007|Analgesics|analgesics|mesh-ancestor
64334051|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
64334052|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334053|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64334054|NCT02294305|Vortioxetine|vortioxetine|mesh-list
64334055|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
64334056|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334057|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64364210|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64364216|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
64334058|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64334059|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334060|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593618|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
64584255|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
64584256|NCT01393964|Hormones|hormones|mesh-ancestor
64584257|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584258|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64584259|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584260|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
64584261|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584262|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584263|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
64584264|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64584265|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64584266|NCT01393964|Growth Substances|growth substances|mesh-ancestor
64584267|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
64584268|NCT01790555|Diazepam|diazepam|mesh-list
64584269|NCT01790555|Dronabinol|dronabinol|mesh-list
64593682|NCT00662545|Entecavir|entecavir|mesh-list
64584270|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64584271|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
64584272|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
64584273|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
64584274|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584275|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584276|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584277|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64584278|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584279|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64584280|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64584281|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64584282|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64584283|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584284|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64584285|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
64593740|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64584286|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
64584287|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
64584288|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
64584289|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584290|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584293|NCT01790555|Analgesics|analgesics|mesh-ancestor
64584294|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
64584295|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64584296|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64584297|NCT01790555|Hormones|hormones|mesh-ancestor
64584298|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593800|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64593801|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64593802|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
64593807|NCT03528902|Tamoxifen|tamoxifen|mesh-list
64584299|NCT00335725|Hormones|hormones|mesh-list
64584300|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64364226|NCT03372785|Clopidogrel|clopidogrel|mesh-list
64364227|NCT03372785|Ticagrelor|ticagrelor|mesh-list
64584301|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584302|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584304|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
64584305|NCT01393730|Dutasteride|dutasteride|mesh-list
64584306|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584307|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
64584308|NCT01393730|Hormones|hormones|mesh-ancestor
64584309|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584310|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584311|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64584312|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584313|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64584314|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584315|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584316|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
64584317|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64584318|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64584319|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
64584320|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64584321|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584322|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64584323|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
64593925|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593928|NCT00690235|Pramlintide|pramlintide|mesh-list
64584324|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584325|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584326|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584333|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
64584334|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64584335|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
64584336|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584337|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594028|NCT03510884|Niacin|niacin|mesh-list
64584338|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64584339|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
64364267|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64364268|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
64584359|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584360|NCT00553059|Dexamethasone|dexamethasone|mesh-list
64584361|NCT00553059|Dronabinol|dronabinol|mesh-list
64584362|NCT00553059|Palonosetron|palonosetron|mesh-list
64584363|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584364|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
64584365|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
64584366|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584367|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584368|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64584369|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
64584370|NCT00553059|Hormones|hormones|mesh-ancestor
64584371|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584372|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64584373|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584374|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64584376|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
64584377|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584378|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584379|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
64584380|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584382|NCT00553059|Analgesics|analgesics|mesh-ancestor
64584383|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
64594110|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64594115|NCT00671528|Hormones|hormones|mesh-ancestor
64584400|NCT00325403|Treprostinil|treprostinil|mesh-list
64584401|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64364412|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364413|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
64334075|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334076|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336779|NCT02313337|Analgesics|analgesics|mesh-ancestor
64584443|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64584444|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64584445|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
64584446|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584448|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
64584449|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584450|NCT00339079|Fluoxetine|fluoxetine|mesh-list
64584451|NCT00339079|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64584452|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64584453|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64584454|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584455|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584456|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
64584457|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584458|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64584459|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
64584460|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584461|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64584462|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64584463|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584464|NCT01392560|Empagliflozin|empagliflozin|mesh-list
64584465|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64584466|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584467|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64584468|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584469|NCT00342355|Ritonavir|ritonavir|mesh-list
64584470|NCT00342355|Lopinavir|lopinavir|mesh-list
64594223|NCT04703621|Daratumumab|daratumumab|mesh-list
64594239|NCT00698035|Estradiol|estradiol|mesh-list
64584471|NCT00342355|Lamivudine|lamivudine|mesh-list
64584472|NCT00342355|Zidovudine|zidovudine|mesh-list
64584473|NCT00342355|Stavudine|stavudine|mesh-list
64584474|NCT00342355|Didanosine|didanosine|mesh-list
64584475|NCT00342355|Efavirenz|efavirenz|mesh-list
64584482|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64584483|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
64584484|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584485|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64584486|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64594285|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64584487|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64584488|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64584489|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
64584490|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64584491|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64584492|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64584493|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64584494|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64584495|NCT00306163|Fluticasone|fluticasone|mesh-list
64584496|NCT00306163|Ciclesonide|ciclesonide|mesh-list
64584497|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584498|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64584499|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
64584500|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584501|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584502|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64584503|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
64584504|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
64584505|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64584506|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
64594424|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584507|NCT00306163|Hormones|hormones|mesh-ancestor
64584508|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584509|NCT00330161|Vorinostat|vorinostat|mesh-list
64584510|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334078|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334079|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64334080|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
64334081|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64584511|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64584512|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584513|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584515|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
64584516|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584517|NCT00309751|Atorvastatin|atorvastatin|mesh-list
64584518|NCT00309751|Pitavastatin|pitavastatin|mesh-list
64584519|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64584520|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64584521|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
64594489|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594491|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64584522|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584523|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64584524|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64584525|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584526|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64584527|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64584528|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584529|NCT02988999|Erythritol|erythritol|mesh-list
64584530|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
64584531|NCT00313729|Temozolomide|temozolomide|mesh-list
64584532|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64584533|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
64584534|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584535|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364701|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64334082|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64334083|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64334084|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334085|NCT02222519|Bromides|bromides|mesh-list
64594548|NCT00701935|Incretins|incretins|mesh-ancestor
64334086|NCT02222519|Rocuronium|rocuronium|mesh-list
64334087|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
64584545|NCT05266651|Urological Agents|urological agents|mesh-ancestor
64584546|NCT05746689|Sirolimus|sirolimus|mesh-list
64584547|NCT05746689|Prednisone|prednisone|mesh-list
64584548|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64584549|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
64584550|NCT05746689|Hormones|hormones|mesh-ancestor
64584551|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64584552|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584553|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64584554|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584555|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64584556|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64584557|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64584558|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
64584559|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64584560|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
64334088|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64334089|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64334090|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64334091|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334092|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334093|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
64594676|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
64334094|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64334095|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
64334096|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584568|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
64584569|NCT00345865|Carmustine|carmustine|mesh-list
64584570|NCT00345865|Etoposide|etoposide|mesh-list
64584571|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64584572|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
64584573|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584574|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64584575|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64584576|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
64584577|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584578|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64584579|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64584580|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64594775|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64584581|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64584582|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64364772|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364844|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584627|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64584628|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64584629|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584630|NCT05266105|Palbociclib|palbociclib|mesh-list
64334133|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594789|NCT00598507|Sagopilone|sagopilone|mesh-list
64334134|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64334135|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584710|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64584711|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64334163|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334164|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64334165|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64365256|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64365445|NCT04444349|Vitamins|vitamins|mesh-ancestor
64365446|NCT03263533|Vorinostat|vorinostat|mesh-list
64594830|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64584824|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64584825|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64584826|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64584827|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64584828|NCT01792375|Dinoprostone|dinoprostone|mesh-list
64584829|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
64584830|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64594898|NCT03472586|Nivolumab|nivolumab|mesh-list
64584831|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334179|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
64334180|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334181|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
64334182|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
64334183|NCT02352987|Salicylates|salicylates|mesh-list
64334184|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334185|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
64334186|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
64334187|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
64584898|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64584899|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64584900|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
64584901|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64584903|NCT04046744|Analgesics|analgesics|mesh-list
64584904|NCT04046744|Ropivacaine|ropivacaine|mesh-list
64584905|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
64584906|NCT04046744|Anesthetics|anesthetics|mesh-list
64584928|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
64584929|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64584930|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64584931|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64584968|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64584969|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594976|NCT05362799|Letrozole|letrozole|mesh-list
64584970|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64584971|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64584972|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64584973|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
64584974|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365912|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
64584996|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
64366158|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
64366159|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585049|NCT04035278|Vaccines|vaccines|mesh-list
64366429|NCT02516423|Dexamethasone|dexamethasone|mesh-list
64595020|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64585067|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366533|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366534|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366535|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
64366536|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366537|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64366538|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
64585103|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585104|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
64585105|NCT02009449|Antiviral Agents|antiviral agents|mesh-ancestor
64585106|NCT02009449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366687|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366848|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366849|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
64366850|NCT03233893|Calcium|calcium|mesh-list
64366851|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64595086|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
64595087|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
64366852|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366853|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64366854|NCT05597813|Timolol|timolol|mesh-list
64366855|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64366856|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64367041|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64367042|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
64367043|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367067|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64367069|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595142|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64367070|NCT03121547|Analgesics|analgesics|mesh-ancestor
64367071|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
64367072|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367075|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64367080|NCT03241381|Vitamins|vitamins|mesh-ancestor
64367136|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64367137|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
64367138|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
64367172|NCT02501603|Paclitaxel|paclitaxel|mesh-list
64585134|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
64367211|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64367212|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367213|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367214|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367215|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595208|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367216|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64367217|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64367218|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
64367219|NCT00707993|Alogliptin|alogliptin|mesh-list
64367220|NCT00707993|Glipizide|glipizide|mesh-list
64367224|NCT00707993|Hormones|hormones|mesh-ancestor
64367541|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64367542|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64334266|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64334267|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334268|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64334269|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585147|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64310380|NCT03051698|Metronidazole|metronidazole|mesh-list
64595270|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
64585148|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64585149|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595340|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
64585150|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585151|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64585152|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64585153|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64585154|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64585155|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
64585157|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
64585158|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
64367738|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64367739|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64367740|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367741|NCT03096327|Montelukast|montelukast|mesh-list
64367742|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64367743|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
64367744|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64367745|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
64367746|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367747|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367748|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64367785|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64585182|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64585183|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
64334270|NCT03521167|Analgesics|analgesics|mesh-ancestor
64334271|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64334272|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64334273|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64334274|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
64334275|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334276|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64334277|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64334278|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
64334279|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64334280|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64334281|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
64367983|NCT03335579|Analgesics|analgesics|mesh-ancestor
64367984|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
64367987|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
64334282|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64334283|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64334284|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334285|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
64334286|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
64334287|NCT02352519|Anesthetics|anesthetics|mesh-list
64595383|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334288|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
64334289|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334290|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585185|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585187|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585188|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
64585189|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64585190|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64585191|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585192|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585193|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585194|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585195|NCT01429298|Hydromorphone|hydromorphone|mesh-list
64585196|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64585197|NCT01429298|Narcotics|narcotics|mesh-ancestor
64585198|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585200|NCT01429298|Analgesics|analgesics|mesh-ancestor
64585201|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
64585202|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595384|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64368027|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64368028|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64368029|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64368030|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
64368031|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368032|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64368033|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64368034|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368035|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64368036|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64368037|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64368039|NCT03095547|Cyclosporine|cyclosporine|mesh-list
64585222|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64585224|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
64585225|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64585226|NCT00336323|Bevacizumab|bevacizumab|mesh-list
64585227|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585228|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585229|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64585230|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64595492|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595494|NCT00727597|Efavirenz|efavirenz|mesh-list
64595514|NCT00571259|Heparin|heparin|mesh-list
64585231|NCT00336323|Growth Substances|growth substances|mesh-ancestor
64585232|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585233|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
64585234|NCT01427738|Nystatin|nystatin|mesh-list
64585235|NCT01427738|Gentian Violet|gentian violet|mesh-list
64585236|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64585237|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585238|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
64585239|NCT01427738|Ionophores|ionophores|mesh-ancestor
64585240|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64585241|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585242|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64585243|NCT01426958|Ritonavir|ritonavir|mesh-list
64334298|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64334299|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64334300|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64585244|NCT01426958|Afatinib|afatinib|mesh-list
64585245|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64585246|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64585247|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
64585248|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595625|NCT02991157|Nimodipine|nimodipine|mesh-list
64585249|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585250|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64585251|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64585252|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
64585253|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64585254|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64585255|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64585256|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368140|NCT03329183|Irinotecan|irinotecan|mesh-list
64595692|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64368141|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64368142|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64368162|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64368163|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64368164|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
64368165|NCT03328481|Anesthetics|anesthetics|mesh-list
64368166|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368167|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368168|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
64368169|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64585316|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585317|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585318|NCT00338039|Antiviral Agents|antiviral agents|mesh-ancestor
64585319|NCT00338039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595757|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64595758|NCT01277731|Prednisolone|prednisolone|mesh-list
64595759|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
64585320|NCT00338039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585321|NCT00338039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585322|NCT00338039|Immunologic Factors|immunologic factors|mesh-ancestor
64585323|NCT00338039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368237|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334301|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368238|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334302|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595818|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
64595819|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
64595820|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
64595821|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595822|NCT01903005|Buprenorphine|buprenorphine|mesh-list
64595823|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64595824|NCT01903005|Naloxone|naloxone|mesh-list
64595825|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64368239|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
64368240|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64368241|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368242|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368277|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64585379|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585380|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64585381|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64585382|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585383|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585384|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368376|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
64368377|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
64368378|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368379|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368380|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
64368411|NCT03093129|Artesunate|artesunate|mesh-list
64368421|NCT02491697|Capecitabine|capecitabine|mesh-list
64368536|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368560|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368561|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368562|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
64368563|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64368564|NCT05015907|Ropivacaine|ropivacaine|mesh-list
64368565|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
64368566|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
64368567|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368569|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
64585476|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585477|NCT01793753|Propofol|propofol|mesh-list
64585478|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64585479|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585480|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585481|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64585482|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
64585483|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
64585484|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
64585485|NCT00360685|Methotrexate|methotrexate|mesh-list
64585486|NCT00360685|Tacrolimus|tacrolimus|mesh-list
64585487|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64585488|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
64585489|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64585490|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585491|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64585492|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
64585493|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585494|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585495|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
64585496|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368660|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
64368661|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368662|NCT03078465|Clopidogrel|clopidogrel|mesh-list
64596063|NCT00580073|Antidotes|antidotes|mesh-ancestor
64596064|NCT00580073|Protective Agents|protective agents|mesh-ancestor
64585500|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585508|NCT05487456|Menthol|menthol|mesh-list
64585509|NCT05487456|Nicotine|nicotine|mesh-list
64585510|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64585511|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
64585512|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585513|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585514|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64585515|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64585516|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585517|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368777|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585518|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585535|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585536|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64585537|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
64585538|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596189|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
64585539|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585540|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64585541|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64585543|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
64585544|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585545|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64585546|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
64585547|NCT00558519|Hormones|hormones|mesh-ancestor
64368828|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596190|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368829|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368830|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64368831|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
64368832|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64368833|NCT04434105|Triamcinolone|triamcinolone|mesh-list
64368834|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64368835|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64368836|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64596249|NCT01271803|Vemurafenib|vemurafenib|mesh-list
64368837|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368857|NCT03227419|Abatacept|abatacept|mesh-list
64585599|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
64585600|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585601|NCT03554083|Atezolizumab|atezolizumab|mesh-list
64585602|NCT03554083|Vemurafenib|vemurafenib|mesh-list
64585603|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64585604|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585605|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
64585606|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585607|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64585608|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585609|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585610|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
64368909|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
64596310|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368910|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368911|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64368912|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368932|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64368933|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368934|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368936|NCT03091569|Vitamins|vitamins|mesh-ancestor
64368937|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
64368938|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368939|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64368940|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64368941|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368944|NCT04948749|Sirolimus|sirolimus|mesh-list
64585616|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585619|NCT01389596|Analgesics|analgesics|mesh-ancestor
64585620|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
64368945|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64368946|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368947|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64368948|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368949|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
64368950|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64368951|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
64368952|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368953|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
64368954|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368955|NCT02487719|Teferrol|teferrol|mesh-list
64368956|NCT02487719|Hematinics|hematinics|mesh-ancestor
64368957|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64368958|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
64368959|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368960|NCT04940871|Favipiravir|favipiravir|mesh-list
64368963|NCT04939935|Metformin|metformin|mesh-list
64369014|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
64369015|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369016|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369066|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64369067|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64585668|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64585669|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64585670|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
64585671|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369102|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
64585672|NCT02660411|Propofol|propofol|mesh-list
64369104|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64585673|NCT02660411|Sevoflurane|sevoflurane|mesh-list
64369105|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64369106|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64369107|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64596483|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
64369108|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64369109|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369110|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369111|NCT02451475|Amitriptyline|amitriptyline|mesh-list
64369112|NCT02451475|Paroxetine|paroxetine|mesh-list
64369113|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64585685|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585686|NCT02078492|Analgesics|analgesics|mesh-ancestor
64585687|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
64585688|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585689|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585690|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596546|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64585691|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585692|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64585693|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585694|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585696|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64585697|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585698|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64369210|NCT03318419|Pegaspargase|pegaspargase|mesh-list
64369211|NCT03318419|Asparaginase|asparaginase|mesh-list
64369212|NCT03318419|Cladribine|cladribine|mesh-list
64369213|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64369214|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
64369215|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369216|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369217|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
64369218|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369219|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64369399|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
64369400|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
64369401|NCT03073317|Mitogens|mitogens|mesh-list
64596609|NCT03434678|Bupivacaine|bupivacaine|mesh-list
64596610|NCT03434678|Propofol|propofol|mesh-list
64596611|NCT03434678|Rocuronium|rocuronium|mesh-list
64596612|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
64596613|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
64585738|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64585739|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585740|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
64585741|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585742|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585743|NCT04524351|Phenserine|phenserine|mesh-list
64585744|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64585745|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585746|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585747|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
64585748|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64585749|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585750|NCT04523961|Lidocaine|lidocaine|mesh-list
64585751|NCT04523961|Tetracaine|tetracaine|mesh-list
64585752|NCT04523961|Prilocaine|prilocaine|mesh-list
64585753|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64585754|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
64585755|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
64585756|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64585757|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585758|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
64585766|NCT01792505|Imiquimod|imiquimod|mesh-list
64585771|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
64585773|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585774|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64585775|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585776|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585777|NCT00555789|Tacrolimus|tacrolimus|mesh-list
64585778|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64585779|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
64585780|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585781|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64585782|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585783|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596732|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
64585784|NCT04288895|Vortioxetine|vortioxetine|mesh-list
64369425|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64369426|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64369427|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
64585802|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64585803|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64585804|NCT00365209|Analgesics|analgesics|mesh-ancestor
64585805|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
64585806|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64585807|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64585808|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64585809|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64585810|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585811|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64585812|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585813|NCT04417257|Fenretinide|fenretinide|mesh-list
64585814|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64585815|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64585816|NCT04417257|Protective Agents|protective agents|mesh-ancestor
64369498|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
64369499|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64369500|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64369522|NCT03204799|Metformin|metformin|mesh-list
64369523|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64369524|NCT03204799|Ezetimibe|ezetimibe|mesh-list
64369525|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64369526|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369527|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64369528|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64369643|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
64369644|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369645|NCT02451787|Vitamin D|vitamin d|mesh-list
64369646|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
64596782|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
64369647|NCT02451787|Vitamins|vitamins|mesh-ancestor
64369648|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
64369649|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369650|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64369651|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64369676|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369677|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369678|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
64369679|NCT03320915|Vitamin D|vitamin d|mesh-list
64369680|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64369681|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369682|NCT03320915|Vitamins|vitamins|mesh-ancestor
64369683|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
64369684|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64369960|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369961|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64585979|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64585980|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64311279|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
64585981|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64585982|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64585983|NCT01794533|Narcotics|narcotics|mesh-ancestor
64585984|NCT01794533|Analgesics|analgesics|mesh-ancestor
64585985|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64334377|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596899|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370030|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370031|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586040|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
64370032|NCT02483195|Minoxidil|minoxidil|mesh-list
64370033|NCT02483195|Spironolactone|spironolactone|mesh-list
64370034|NCT02483195|Finasteride|finasteride|mesh-list
64370036|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
64586076|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64586077|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586078|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586079|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
64586080|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64596946|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64596947|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64586083|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
64586084|NCT01792037|Midazolam|midazolam|mesh-list
64586085|NCT01792037|Etomidate|etomidate|mesh-list
64586086|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64586087|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
64586088|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64586089|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64586090|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64586091|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586092|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64586093|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64586094|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586095|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64586096|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
64586097|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
64586098|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
64586099|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
64586100|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586101|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586102|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586103|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
64586104|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
64586105|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586106|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64597010|NCT00670241|Hormones|hormones|mesh-ancestor
64370081|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64597011|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586125|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586127|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586128|NCT00318929|Valproic Acid|valproic acid|mesh-list
64586129|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
64586130|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586131|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586132|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
64586133|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586134|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586135|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
64586136|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64586137|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64586138|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586139|NCT00418093|Gemcitabine|gemcitabine|mesh-list
64586140|NCT00418093|Bevacizumab|bevacizumab|mesh-list
64586141|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
64586143|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597058|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
64586144|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586145|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586146|NCT00418093|Growth Substances|growth substances|mesh-ancestor
64586147|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586148|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586149|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586150|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
64586151|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586152|NCT00418093|Antiviral Agents|antiviral agents|mesh-ancestor
64370126|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
64370127|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
64370128|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
64586204|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
64586213|NCT00375973|Analgesics|analgesics|mesh-ancestor
64586214|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
64586215|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586216|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
64586217|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586218|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
64586219|NCT00421603|Topiramate|topiramate|mesh-list
64586220|NCT00421603|Adderall|adderall|mesh-list
64586221|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
64586222|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64597176|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64586223|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334398|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334399|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64370203|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370204|NCT02448199|Analgesics|analgesics|mesh-ancestor
64370205|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
64370206|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370207|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370208|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370209|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64334416|NCT02292121|Cathartics|cathartics|mesh-ancestor
64334417|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334418|NCT02223611|Cisplatin|cisplatin|mesh-list
64334419|NCT02223611|Vinorelbine|vinorelbine|mesh-list
64334420|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370391|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64884267|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884268|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64884269|NCT01944384|Diuretics|diuretics|mesh-ancestor
64334421|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64334423|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
64370484|NCT03195049|Protective Agents|protective agents|mesh-ancestor
64370572|NCT03208465|Incretins|incretins|mesh-ancestor
64884331|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64884332|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
64884333|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
64884334|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884335|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64884337|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884338|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884339|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64884340|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64597245|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
64884341|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64884342|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884343|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884344|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
64884345|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
64884346|NCT01945099|Insulin|insulin|mesh-list
64884347|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64884348|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884349|NCT01945268|Vaccines|vaccines|mesh-list
64884350|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
64884351|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370606|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
64884376|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884377|NCT01945476|Midazolam|midazolam|mesh-list
64884378|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64884379|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64370621|NCT03196843|Raltitrexed|raltitrexed|mesh-list
64884380|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597289|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
64884407|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370631|NCT02476955|Anastrozole|anastrozole|mesh-list
64370632|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64370633|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370634|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
64370647|NCT02634801|Ixekizumab|ixekizumab|mesh-list
64370648|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64370649|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
64597352|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
64370650|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884453|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884454|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64884455|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64370671|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884478|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
64884479|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884480|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884481|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
64884483|NCT05410093|Tocopherols|tocopherols|mesh-list
64884484|NCT05410093|Resveratrol|resveratrol|mesh-list
64884485|NCT05410093|Vitamins|vitamins|mesh-ancestor
64884486|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
64884487|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884488|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
64884489|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884490|NCT05410093|Protective Agents|protective agents|mesh-ancestor
64884491|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884492|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64884493|NCT05409820|Anesthetics|anesthetics|mesh-list
64884494|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884495|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884496|NCT05409339|Mannitol|mannitol|mesh-list
64370672|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370673|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370675|NCT02476799|Fentanyl|fentanyl|mesh-list
64370676|NCT02476799|Ropivacaine|ropivacaine|mesh-list
64370677|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
64370678|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
64370679|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334473|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64597427|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64334474|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64334475|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64334476|NCT03520543|Urological Agents|urological agents|mesh-ancestor
64370736|NCT04986735|Empagliflozin|empagliflozin|mesh-list
64370737|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64370739|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64884602|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884603|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64884604|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597470|NCT00631319|Hydromorphone|hydromorphone|mesh-list
64884605|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64884606|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
64884607|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64884608|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884609|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884610|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64884611|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64597539|NCT05685836|Bevacizumab|bevacizumab|mesh-list
64884612|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
64884613|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64334492|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
64334494|NCT02351895|Trace Elements|trace elements|mesh-ancestor
64334495|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
64334496|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334497|NCT00503035|Celecoxib|celecoxib|mesh-list
64334498|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64884614|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884615|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
64884616|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
64884617|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884618|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884619|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64884620|NCT04773392|Protective Agents|protective agents|mesh-ancestor
64370860|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
64370861|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370862|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370863|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
64884625|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
64884627|NCT04722835|Dimercaprol|dimercaprol|mesh-list
64884628|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64884629|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
64884630|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884631|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597603|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884632|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64597616|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
64884633|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
64884634|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
64884635|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64884636|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64884637|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64884638|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64884666|NCT04476979|Hormones|hormones|mesh-ancestor
64884667|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884668|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64884669|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884670|NCT04411953|Haloperidol|haloperidol|mesh-list
64884671|NCT04411953|Benztropine|benztropine|mesh-list
64884672|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
64884673|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
64884674|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
64597651|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64884675|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884676|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884677|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884678|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64884679|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64884680|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64884681|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64884682|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64884683|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
64884684|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64884685|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884686|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64884687|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64884688|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
64884689|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64884690|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64884691|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64884692|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64884693|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64884711|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64884712|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64884713|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
64884714|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64884715|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64884716|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
64884717|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64884718|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64884719|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64884721|NCT04150614|Ondansetron|ondansetron|mesh-list
64884722|NCT04150614|Granisetron|granisetron|mesh-list
64884723|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64884724|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
64884725|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
64884726|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64884727|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64884728|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64884729|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
64884730|NCT04150614|Hormones|hormones|mesh-ancestor
64884731|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64884732|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64884733|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64884734|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
64334499|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64334500|NCT00503035|Analgesics|analgesics|mesh-ancestor
64334501|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
64884773|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64884775|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64884776|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64884777|NCT03920007|Renal Agents|renal agents|mesh-ancestor
64884778|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
64884779|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64884780|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64884781|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64884782|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64884783|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64884784|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64884785|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64884786|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64370959|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
64484588|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64484589|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484608|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64296575|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64484622|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
64484623|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484624|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484625|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597894|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
64597898|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484626|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
64484627|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64484628|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
64484629|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484630|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484631|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64484632|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
64484633|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64597951|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
64484634|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64484635|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484636|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484637|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484638|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484639|NCT01149850|Bevacizumab|bevacizumab|mesh-list
64484640|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64484641|NCT01149850|Temozolomide|temozolomide|mesh-list
64484643|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
64484644|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64484645|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484646|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64484647|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64484648|NCT01149850|Growth Substances|growth substances|mesh-ancestor
64484649|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598013|NCT04683315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484650|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
64484651|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
64484652|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64296579|NCT03103022|Acetaminophen|acetaminophen|mesh-list
64484653|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
64484654|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484655|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
64296581|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296582|NCT03103022|Analgesics|analgesics|mesh-ancestor
64296583|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
64296584|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296585|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296586|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
64484656|NCT01972841|Mirabegron|mirabegron|mesh-list
64484679|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
64484680|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64484681|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64484682|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64484683|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484685|NCT01708915|Capsaicin|capsaicin|mesh-list
64484686|NCT01708915|Nonivamide|nonivamide|mesh-list
64598072|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64598073|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484687|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
64598085|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
64598123|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484688|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484689|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484690|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
64484691|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
64484692|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
64484693|NCT01708915|Vitamins|vitamins|mesh-ancestor
64484694|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
64484695|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
64484696|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64484697|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
64484698|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484699|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484700|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64484701|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
64484702|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
64484703|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64484704|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
64484705|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484706|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484707|NCT01747915|Pregabalin|pregabalin|mesh-list
64484708|NCT01747915|Analgesics|analgesics|mesh-ancestor
64484709|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
64484710|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484711|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484712|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
64484713|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64484718|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64484719|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484720|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484722|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64484723|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64484724|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
64484725|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
64484726|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484727|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484728|NCT04656041|Paclitaxel|paclitaxel|mesh-list
64484729|NCT04656041|Carboplatin|carboplatin|mesh-list
64484730|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64484731|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484732|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
64484733|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
64484734|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484735|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484736|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64484737|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
64484738|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484739|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64484740|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64484741|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484771|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64484773|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484774|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484775|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64484776|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
64296587|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64296588|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64296589|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64484777|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
64484778|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64484779|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
64484780|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64484781|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
64484782|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484783|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484784|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64484785|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64484786|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64484787|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
64484788|NCT01969565|Dexamethasone|dexamethasone|mesh-list
64484789|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484790|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
64484791|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
64484792|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484793|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484794|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64484795|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
64484796|NCT01969565|Hormones|hormones|mesh-ancestor
64484797|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484798|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484799|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484801|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
64484802|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64484803|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64484814|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484815|NCT01746901|Analgesics|analgesics|mesh-ancestor
64484816|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
64484817|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484818|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64484819|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64484820|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64484821|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64484822|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64484823|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
64484824|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484825|NCT01946165|Prednisone|prednisone|mesh-list
64484826|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
64484827|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484828|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
64484829|NCT01946165|Hormones|hormones|mesh-ancestor
64484830|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484831|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484832|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484833|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484834|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64484835|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484836|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484837|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
64484838|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64484839|NCT01707667|Prucalopride|prucalopride|mesh-list
64484840|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64484841|NCT01707667|Laxatives|laxatives|mesh-ancestor
64598334|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64484842|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64484843|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64484844|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64484845|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
64484846|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484847|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484848|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296594|NCT00702507|Clotrimazole|clotrimazole|mesh-list
64296595|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
64296596|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296597|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64296598|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64296599|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484849|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64484851|NCT01959503|Coagulants|coagulants|mesh-ancestor
64484852|NCT01706575|Interferons|interferons|mesh-list
64484853|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484854|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
64484855|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484856|NCT01725529|Ribavirin|ribavirin|mesh-list
64484857|NCT01725529|Simeprevir|simeprevir|mesh-list
64484858|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
64484859|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484860|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
64484861|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484862|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
64484863|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484864|NCT01744093|Doxycycline|doxycycline|mesh-list
64598456|NCT00654953|Gabapentin|gabapentin|mesh-list
64484865|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64484866|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64484867|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
64484868|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64484869|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64484870|NCT01725451|Testosterone|testosterone|mesh-list
64484871|NCT01725451|Androgens|androgens|mesh-ancestor
64484872|NCT01725451|Hormones|hormones|mesh-ancestor
64484873|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484874|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484875|NCT01707290|Ivacaftor|ivacaftor|mesh-list
64484876|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64484877|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484878|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484879|NCT01717040|Pioglitazone|pioglitazone|mesh-list
64484880|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64484881|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484882|NCT00803062|Paclitaxel|paclitaxel|mesh-list
64484883|NCT00803062|Bevacizumab|bevacizumab|mesh-list
64484884|NCT00803062|Cisplatin|cisplatin|mesh-list
64484894|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598507|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
64484895|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
64484896|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
64484897|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484898|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484899|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64484900|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64484901|NCT00803062|Growth Substances|growth substances|mesh-ancestor
64484902|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484903|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
64484904|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
64484905|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64484906|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64484907|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484908|NCT01743001|Macitentan|macitentan|mesh-list
64484909|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64484910|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64484911|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484912|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64484913|NCT01704079|Calcifediol|calcifediol|mesh-list
64484914|NCT01704079|Vitamins|vitamins|mesh-ancestor
64598560|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64484915|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
64484916|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484917|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64484918|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
64484919|NCT01703845|Olodaterol|olodaterol|mesh-list
64484920|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64484939|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
64484940|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484941|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484946|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64484947|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484948|NCT01703221|Incretins|incretins|mesh-ancestor
64484949|NCT01703221|Hormones|hormones|mesh-ancestor
64484950|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484951|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64484952|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
64484953|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484954|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484955|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
64484956|NCT00803686|Calcitonin|calcitonin|mesh-list
64484957|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64484958|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484959|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64484960|NCT00823966|Delavirdine|delavirdine|mesh-list
64484961|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64484962|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64484963|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484964|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484985|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64484986|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64484988|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485047|NCT05039632|Nivolumab|nivolumab|mesh-list
64485048|NCT05039632|Ipilimumab|ipilimumab|mesh-list
64485049|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64485050|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485051|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64485052|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598616|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64485053|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64485054|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64485055|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485056|NCT01701973|Incretins|incretins|mesh-ancestor
64485057|NCT01701973|Hormones|hormones|mesh-ancestor
64485058|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598624|NCT01963845|Incretins|incretins|mesh-ancestor
64485059|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64485060|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
64485061|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296600|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296601|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64485063|NCT00825370|Hydromorphone|hydromorphone|mesh-list
64485064|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64485065|NCT00825370|Narcotics|narcotics|mesh-ancestor
64485066|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485067|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485096|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64485097|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64485098|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64598644|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485099|NCT01700959|Melatonin|melatonin|mesh-list
64598645|NCT03769155|Nivolumab|nivolumab|mesh-list
64485100|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
64485101|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485102|NCT01700959|Protective Agents|protective agents|mesh-ancestor
64485103|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485104|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485105|NCT00829738|Pantoprazole|pantoprazole|mesh-list
64485106|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64485107|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485108|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64485109|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485110|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485111|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
64485112|NCT01737931|Promethazine|promethazine|mesh-list
64485113|NCT01737931|Dexamethasone|dexamethasone|mesh-list
64485114|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64485115|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
64485152|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485153|NCT00830362|Propranolol|propranolol|mesh-list
64485154|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64485155|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64485156|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
64485157|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485158|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485159|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485160|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64485161|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64485162|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
64485163|NCT01944839|Ranibizumab|ranibizumab|mesh-list
64485164|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64485165|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64485166|NCT01944839|Growth Substances|growth substances|mesh-ancestor
64485167|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485168|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
64485169|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485170|NCT01720225|Azacitidine|azacitidine|mesh-list
64485171|NCT01720225|Decitabine|decitabine|mesh-list
64485172|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485173|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
64485174|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485175|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485178|NCT04548661|Povidone|povidone|mesh-list
64296603|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296604|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296605|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64296606|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64296607|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64296609|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64296610|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296612|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296613|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598754|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64296614|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
64296615|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64485231|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
64485232|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64485233|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
64485234|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
64485235|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64485236|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64485237|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64485238|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
64485239|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64485240|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64598817|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64598818|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64598819|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598820|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
64598841|NCT00658697|Docetaxel|docetaxel|mesh-list
64485241|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64485242|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64485243|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64485244|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64485246|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
64485247|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485248|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485249|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485250|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
64485251|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
64485252|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64485253|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64598877|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485254|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
64485255|NCT00807586|Prednisolone|prednisolone|mesh-list
64485256|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
64485257|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64485258|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
64485259|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485267|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485268|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
64485269|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
64485270|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485271|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485272|NCT01698775|Glipizide|glipizide|mesh-list
64485273|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64485274|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485275|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
64485276|NCT01941095|Chloroquine|chloroquine|mesh-list
64485277|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
64485278|NCT01941095|Methotrexate|methotrexate|mesh-list
64485279|NCT01941095|Azathioprine|azathioprine|mesh-list
64485280|NCT01941095|Leflunomide|leflunomide|mesh-list
64485330|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485331|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
64485332|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485333|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64485334|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64485335|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485336|NCT00832390|Incretins|incretins|mesh-ancestor
64485337|NCT00832390|Hormones|hormones|mesh-ancestor
64296616|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64296617|NCT03301233|Estradiol|estradiol|mesh-list
64296618|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64296620|NCT03301233|Hormones|hormones|mesh-ancestor
64485339|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64485340|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
64485341|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485342|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485344|NCT04644029|Emtricitabine|emtricitabine|mesh-list
64485345|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64485346|NCT04644029|Islatravir|islatravir|mesh-list
64485347|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
64485348|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485349|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64485350|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64485351|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485352|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485353|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64485354|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64485355|NCT00844090|Methylphenidate|methylphenidate|mesh-list
64485356|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64485377|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64485378|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64485379|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485380|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598939|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64485381|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
64485382|NCT00834808|Tramadol|tramadol|mesh-list
64485383|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64485384|NCT00834808|Narcotics|narcotics|mesh-ancestor
64485385|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485386|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485387|NCT00834808|Analgesics|analgesics|mesh-ancestor
64485388|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
64485389|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485390|NCT00850096|Insulin|insulin|mesh-list
64485391|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64485392|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598960|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64485393|NCT00834886|Melatonin|melatonin|mesh-list
64485394|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
64485395|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485396|NCT00834886|Protective Agents|protective agents|mesh-ancestor
64485397|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485398|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485428|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64485429|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
64485430|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485431|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485432|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485433|NCT03856216|Rituximab|rituximab|mesh-list
64485434|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64485435|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64485436|NCT03856216|Methotrexate|methotrexate|mesh-list
64485437|NCT03856216|Fludarabine|fludarabine|mesh-list
64485438|NCT03856216|Melphalan|melphalan|mesh-list
64598964|NCT04445714|Incretins|incretins|mesh-ancestor
64485439|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64485440|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
64485441|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64485442|NCT03856216|Antibodies|antibodies|mesh-list
64485443|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
64485444|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64296621|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296622|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296623|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64485445|NCT03856216|Lenograstim|lenograstim|mesh-list
64485446|NCT03856216|Tacrolimus|tacrolimus|mesh-list
64485447|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64485448|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
64485449|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485450|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485451|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485452|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64485453|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
64485454|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64485455|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485456|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
64485457|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485458|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485459|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485460|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64485461|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485462|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64485468|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64485469|NCT01954121|Carbamazepine|carbamazepine|mesh-list
64485470|NCT01954121|Levetiracetam|levetiracetam|mesh-list
64485471|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
64485472|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
64485473|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
64485474|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64485475|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485476|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485477|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64485478|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64485479|NCT01954121|Analgesics|analgesics|mesh-ancestor
64485480|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
64599077|NCT00702299|Paclitaxel|paclitaxel|mesh-list
64485481|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485482|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64485483|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64485484|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485485|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64485486|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64485487|NCT03643744|Celecoxib|celecoxib|mesh-list
64485488|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64485489|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64485491|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
64485492|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485493|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485494|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64485495|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485496|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64485497|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64485498|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485499|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485512|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64485513|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64485514|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
64296624|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
64296625|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64296626|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64296627|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
64485518|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64485519|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
64485520|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485521|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64485522|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64485523|NCT00841204|Sulindac|sulindac|mesh-list
64485524|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64485525|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64485536|NCT00853840|Maraviroc|maraviroc|mesh-list
64485567|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
64485568|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64485569|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64485570|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64485571|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64485572|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485573|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64599170|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
64485574|NCT00855010|Pioglitazone|pioglitazone|mesh-list
64485575|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64485576|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485577|NCT00842608|Haloperidol|haloperidol|mesh-list
64485578|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
64485579|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64485580|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
64485581|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
64485582|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485583|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485584|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485585|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64485586|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64485587|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485588|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64485589|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64485590|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
64485591|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485592|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485593|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64485594|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
64485595|NCT00856024|Ribavirin|ribavirin|mesh-list
64485596|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64485609|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485610|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64485611|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485612|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
64485613|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64485614|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485615|NCT00857272|Bisacodyl|bisacodyl|mesh-list
64485616|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64296628|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64296629|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64485617|NCT00857272|Cathartics|cathartics|mesh-ancestor
64485618|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485619|NCT00857272|Laxatives|laxatives|mesh-ancestor
64296630|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296631|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296632|NCT03301233|Urological Agents|urological agents|mesh-ancestor
64296633|NCT02581748|Trastuzumab|trastuzumab|mesh-list
64599229|NCT03221426|Vitamins|vitamins|mesh-ancestor
64599230|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
64296634|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296635|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485621|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64485623|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485624|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
64485625|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485626|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485627|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64485628|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
64485629|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485630|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485631|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64485632|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
64485633|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64485634|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64485635|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64485636|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
64485637|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485638|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485639|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485641|NCT02453620|Ipilimumab|ipilimumab|mesh-list
64485642|NCT02453620|Entinostat|entinostat|mesh-list
64485649|NCT04400890|Vitamin D|vitamin d|mesh-list
64485650|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
64599265|NCT01990677|Diuretics|diuretics|mesh-ancestor
64485651|NCT04400890|Resveratrol|resveratrol|mesh-list
64485652|NCT04400890|Vitamins|vitamins|mesh-ancestor
64485653|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
64485654|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485655|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64485656|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64485657|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
64485658|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485659|NCT04400890|Protective Agents|protective agents|mesh-ancestor
64485660|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485661|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64485662|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64485663|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485664|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485665|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485666|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64485667|NCT04351438|Heparin|heparin|mesh-list
64485668|NCT04351438|Citric Acid|citric acid|mesh-list
64485669|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
64485670|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
64485703|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64485704|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64485705|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64485706|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64485707|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
64485708|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64485709|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485710|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
64599316|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
64485711|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485712|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64599318|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
64485713|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64485714|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64485715|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
64485761|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485763|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485764|NCT01857934|Aldesleukin|aldesleukin|mesh-list
64485765|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
64485766|NCT01857934|Melphalan|melphalan|mesh-list
64485768|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
64485769|NCT01857934|Doxorubicin|doxorubicin|mesh-list
64485770|NCT01857934|Etoposide|etoposide|mesh-list
64485771|NCT01857934|Vincristine|vincristine|mesh-list
64485772|NCT01857934|Topotecan|topotecan|mesh-list
64485773|NCT01857934|Interleukin-2|interleukin-2|mesh-list
64485774|NCT01857934|Molgramostim|molgramostim|mesh-list
64485775|NCT01857934|Dinutuximab|dinutuximab|mesh-list
64485776|NCT01857934|Levetiracetam|levetiracetam|mesh-list
64485777|NCT01857934|Isotretinoin|isotretinoin|mesh-list
64485778|NCT01857934|Antibodies|antibodies|mesh-list
64485779|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
64485780|NCT01857934|Sargramostim|sargramostim|mesh-list
64485781|NCT01857934|Lenograstim|lenograstim|mesh-list
64485782|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485783|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
64485784|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485785|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485786|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64485787|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
64485788|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485790|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64485791|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64485814|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485815|NCT00863122|Lapatinib|lapatinib|mesh-list
64599362|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
64485816|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485817|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64485818|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485819|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485820|NCT01604785|Dopamine|dopamine|mesh-list
64485821|NCT01604785|Propofol|propofol|mesh-list
64485822|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
64485823|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64485824|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64485825|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485826|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64485827|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
64485828|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
64485829|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64485830|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
64485831|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
64485832|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64485833|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
64485834|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485835|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485836|NCT01604785|Protective Agents|protective agents|mesh-ancestor
64485837|NCT01681849|Paroxetine|paroxetine|mesh-list
64485838|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64485839|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64485840|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64485841|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485842|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64485843|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
64485844|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485847|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64485857|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485858|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64485859|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
64485860|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
64485861|NCT00863434|Cytarabine|cytarabine|mesh-list
64485862|NCT00863434|Clofarabine|clofarabine|mesh-list
64485863|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64485865|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485867|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
64485868|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64485869|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64485870|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
64485871|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599405|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64485872|NCT04228042|Infigratinib|infigratinib|mesh-list
64485873|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599406|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
64485874|NCT04209790|Temozolomide|temozolomide|mesh-list
64485875|NCT04209790|Benzolamide|benzolamide|mesh-list
64485876|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64485877|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
64485878|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485879|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485880|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64485881|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485882|NCT01718353|Prednisone|prednisone|mesh-list
64485883|NCT01718353|Docetaxel|docetaxel|mesh-list
64485884|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485885|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
64485900|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
64485901|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
64485902|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485903|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
64485904|NCT01696279|Calcium|calcium|mesh-list
64485905|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64485906|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485907|NCT01696279|Antacids|antacids|mesh-ancestor
64599434|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64485908|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485909|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485910|NCT01936181|Infliximab|infliximab|mesh-list
64485911|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
64485912|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64485913|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64485914|NCT01696045|Ipilimumab|ipilimumab|mesh-list
64485915|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64485916|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485917|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64485918|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485919|NCT01935947|Gemcitabine|gemcitabine|mesh-list
64485920|NCT01935947|Azacitidine|azacitidine|mesh-list
64485921|NCT01935947|Docetaxel|docetaxel|mesh-list
64485955|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64485956|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64485957|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64485958|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599480|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64485959|NCT01951157|Gemcitabine|gemcitabine|mesh-list
64485960|NCT01951157|Docetaxel|docetaxel|mesh-list
64485961|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64486017|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64486018|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64486019|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64486020|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
64486021|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64486022|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486023|NCT01933217|Methylphenidate|methylphenidate|mesh-list
64486024|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64486025|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486026|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64486081|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
64486082|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486083|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486084|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64486085|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486086|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486087|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64324893|NCT01344187|Riboflavin|riboflavin|mesh-list
64599541|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
64486088|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
64486089|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486090|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64486091|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64486092|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486097|NCT01929863|Metformin|metformin|mesh-list
64486127|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
64486128|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486129|NCT04768075|Paclitaxel|paclitaxel|mesh-list
64486130|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64486131|NCT04768075|Carboplatin|carboplatin|mesh-list
64486132|NCT04768075|Pemetrexed|pemetrexed|mesh-list
64486133|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599594|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
64486134|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486135|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
64486136|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
64486137|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
64486180|NCT00891436|Xhance|xhance|mesh-list
64486189|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64486190|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
64486191|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64486192|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
64486193|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486194|NCT01711645|Antacids|antacids|mesh-ancestor
64486196|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64486237|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64486238|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
64486239|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486240|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486241|NCT01710709|Aripiprazole|aripiprazole|mesh-list
64486242|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
64486243|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486244|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64486245|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64599651|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486259|NCT05317546|Cannabidiol|cannabidiol|mesh-list
64486300|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64486301|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64486302|NCT02151448|Analgesics|analgesics|mesh-ancestor
64486303|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
64486304|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486305|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486306|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486307|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64486308|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64486309|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486310|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486311|NCT00875212|Calcium|calcium|mesh-list
64486312|NCT00875212|Fluorides|fluorides|mesh-list
64486313|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
64486314|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64599705|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64599706|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599707|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
64599708|NCT02990507|Hormones|hormones|mesh-ancestor
64599709|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599710|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599711|NCT02990507|Androgens|androgens|mesh-ancestor
64599712|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
64599713|NCT03331484|Ticagrelor|ticagrelor|mesh-list
64486359|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486360|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
64486361|NCT01589497|Rifampin|rifampin|mesh-list
64486362|NCT01589497|Isoniazid|isoniazid|mesh-list
64486363|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
64486364|NCT01589497|Ethambutol|ethambutol|mesh-list
64486365|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64486366|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486367|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64486368|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64486369|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486370|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486371|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486372|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64486373|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
64486374|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
64486375|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64486376|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64486416|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486417|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
64486418|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64486419|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64486420|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64486421|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64486422|NCT01927757|Analgesics|analgesics|mesh-ancestor
64486423|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
64486424|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486425|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64486426|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64486427|NCT01913639|Leucovorin|leucovorin|mesh-list
64486428|NCT01913639|Fluorouracil|fluorouracil|mesh-list
64599820|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64599821|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
64599822|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
64486429|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
64486430|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
64486431|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486432|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64486433|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486434|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64486435|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
64486436|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486437|NCT01913639|Antidotes|antidotes|mesh-ancestor
64486438|NCT01913639|Protective Agents|protective agents|mesh-ancestor
64486470|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486471|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486474|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64486475|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64486476|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64486477|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
64486478|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
64486479|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
64486480|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64486481|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64599879|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
64599880|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486482|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64486483|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64486484|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64486485|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64486486|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64486489|NCT01911845|Ribavirin|ribavirin|mesh-list
64486524|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486525|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486526|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64486527|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64486528|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
64486529|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486530|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486531|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
64486532|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64486587|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486588|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486589|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64486590|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486591|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
64486592|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64486593|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64486594|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64486595|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64486596|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64486597|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486598|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
64486599|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486600|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486601|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64486602|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486604|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
64486605|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486606|NCT01904903|Trastuzumab|trastuzumab|mesh-list
64486608|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64486609|NCT01904903|Maytansine|maytansine|mesh-list
64600080|NCT03186326|Aflibercept|aflibercept|mesh-list
64600081|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600082|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600083|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64486610|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64486611|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486612|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64486613|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
64486614|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
64486633|NCT01709305|Acarbose|acarbose|mesh-list
64486634|NCT01709305|Repaglinide|repaglinide|mesh-list
64486635|NCT01709305|Gliclazide|gliclazide|mesh-list
64486636|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64486637|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486638|NCT01709305|Incretins|incretins|mesh-ancestor
64486639|NCT01709305|Hormones|hormones|mesh-ancestor
64486641|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64296637|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64296638|NCT01003028|Narcotics|narcotics|mesh-ancestor
64296639|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296640|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486701|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486702|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486703|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64486704|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
64486705|NCT01903811|Hormones|hormones|mesh-ancestor
64486706|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64486707|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64486708|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486709|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
64486710|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486711|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486712|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
64486713|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
64486714|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486715|NCT01709149|Riluzole|riluzole|mesh-list
64486716|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
64486717|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64600128|NCT04749797|Bupivacaine|bupivacaine|mesh-list
64486718|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64600129|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
64486724|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
64486752|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
64486753|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486754|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
64486755|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
64486756|NCT04416035|Paclitaxel|paclitaxel|mesh-list
64486757|NCT04416035|Bevacizumab|bevacizumab|mesh-list
64486758|NCT04416035|Carboplatin|carboplatin|mesh-list
64486759|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64486760|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64486761|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64486762|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64486763|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64486771|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
64486817|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
64486818|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486819|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486820|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64486883|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64486885|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
64486886|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64486887|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
64486888|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486890|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64486891|NCT03216538|Protective Agents|protective agents|mesh-ancestor
64486892|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64486893|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64486894|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64486895|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486896|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
64486897|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64486899|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
64486900|NCT03218722|Coagulants|coagulants|mesh-ancestor
64486901|NCT00888628|Etanercept|etanercept|mesh-list
64486902|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64486903|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64486940|NCT00889330|Alcaftadine|alcaftadine|mesh-list
64486941|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64486942|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
64296641|NCT01003028|Analgesics|analgesics|mesh-ancestor
64296642|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
64296643|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64486944|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64486945|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64486946|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64486956|NCT03215446|Propofol|propofol|mesh-list
64487008|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487009|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487010|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487011|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487012|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64487013|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64487014|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487015|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64487016|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487017|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
64487018|NCT01919723|Ticagrelor|ticagrelor|mesh-list
64487069|NCT01889069|Prednisone|prednisone|mesh-list
64487070|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
64487071|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64487072|NCT01889069|Rituximab|rituximab|mesh-list
64487073|NCT01889069|Doxorubicin|doxorubicin|mesh-list
64487074|NCT01889069|Vincristine|vincristine|mesh-list
64487075|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487076|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
64487077|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487078|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487079|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64487080|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
64487081|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487082|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487083|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64487084|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487085|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64487086|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64487087|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64487088|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487089|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487090|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
64487091|NCT01889069|Hormones|hormones|mesh-ancestor
64487092|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487093|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64487095|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
64487120|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600256|NCT02995655|Heparin|heparin|mesh-list
64487121|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64487122|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487123|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
64487124|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487125|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
64487126|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487127|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64487128|NCT03217942|Mitogens|mitogens|mesh-list
64487129|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
64487130|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487131|NCT00903448|Omeprazole|omeprazole|mesh-list
64487132|NCT00903448|Lansoprazole|lansoprazole|mesh-list
64487133|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64487135|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64487136|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487137|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487138|NCT00895180|Ramucirumab|ramucirumab|mesh-list
64487139|NCT00895180|Olaratumab|olaratumab|mesh-list
64487140|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487141|NCT01830868|Zonisamide|zonisamide|mesh-list
64487142|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
64487143|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64487144|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64487145|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487146|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64487147|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487148|NCT03213964|Interleukin-2|interleukin-2|mesh-list
64487149|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487150|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487151|NCT03213964|Analgesics|analgesics|mesh-ancestor
64487152|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
64487153|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487159|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64487161|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487162|NCT01830946|Caseins|caseins|mesh-list
64487163|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
64487164|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
64487165|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487166|NCT03213886|Vitamin D|vitamin d|mesh-list
64487167|NCT03213886|Calcifediol|calcifediol|mesh-list
64487168|NCT03213886|Vitamins|vitamins|mesh-ancestor
64487169|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
64487226|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
64487227|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487228|NCT00909064|PENTA|penta|mesh-list
64487229|NCT00909064|Fondaparinux|fondaparinux|mesh-list
64600427|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64487230|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64487231|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
64487232|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64487233|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
64487234|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487235|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487236|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
64487237|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64487238|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64487239|NCT01832896|Ecallantide|ecallantide|mesh-list
64487240|NCT01832896|Analgesics|analgesics|mesh-ancestor
64487241|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
64487242|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487243|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487244|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64600482|NCT03808129|Lidocaine|lidocaine|mesh-list
64487247|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487280|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
64487281|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487282|NCT01720030|Simendan|simendan|mesh-list
64487283|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64487284|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
64487285|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64487286|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64487287|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487288|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600483|NCT03808129|Bupivacaine|bupivacaine|mesh-list
64600485|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
64487289|NCT01720030|Protective Agents|protective agents|mesh-ancestor
64487290|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487291|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
64487292|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64487293|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
64487294|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64487341|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
64487342|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487343|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487344|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64487345|NCT01720498|Remifentanil|remifentanil|mesh-list
64487346|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64487347|NCT01720498|Narcotics|narcotics|mesh-ancestor
64487348|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487349|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487350|NCT01720498|Analgesics|analgesics|mesh-ancestor
64487351|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
64487352|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487353|NCT01672047|Vitamin D|vitamin d|mesh-list
64487354|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
64487355|NCT01672047|Vitamins|vitamins|mesh-ancestor
64487356|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
64487357|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487358|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64487359|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64487360|NCT00911326|Dextrans|dextrans|mesh-list
64487361|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
64487394|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487395|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64487396|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64487397|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
64487398|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487467|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487468|NCT01721434|Simendan|simendan|mesh-list
64487469|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64487470|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
64487471|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64487472|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64487473|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487474|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487475|NCT01721434|Protective Agents|protective agents|mesh-ancestor
64487476|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487530|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487531|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64487532|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
64487533|NCT03215524|Hormones|hormones|mesh-ancestor
64487534|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487535|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64487536|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600543|NCT00749515|Siderophores|siderophores|mesh-ancestor
64487537|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487538|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64487539|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64487593|NCT01672671|Doxorubicin|doxorubicin|mesh-list
64487594|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64487595|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487596|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64487597|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64487598|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64487599|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487600|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64487602|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64487603|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487604|NCT02459457|Paclitaxel|paclitaxel|mesh-list
64487605|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64487606|NCT02459457|Carboplatin|carboplatin|mesh-list
64487607|NCT02459457|Fluorouracil|fluorouracil|mesh-list
64487608|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64487609|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487610|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
64487611|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
64487612|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64487613|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487614|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
64487615|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64487616|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64487617|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
64487618|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487641|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487642|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64487643|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64487644|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487645|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64487646|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64487647|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487648|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
64487649|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64487650|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
64487651|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
64487652|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
64487653|NCT01830322|Gemcitabine|gemcitabine|mesh-list
64487654|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64487655|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
64487656|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487657|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487658|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
64487696|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64487697|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64487698|NCT04378972|Analgesics|analgesics|mesh-ancestor
64487699|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
64487700|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487701|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64487702|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487703|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487762|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487763|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
64487765|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487766|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487767|NCT01726192|Ropivacaine|ropivacaine|mesh-list
64487768|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
64487769|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
64296655|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64296656|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296658|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64600566|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
64600567|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
64600568|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296659|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64296660|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64296661|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64487771|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487773|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487774|NCT01836328|Methadone|methadone|mesh-list
64487775|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64487776|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64487777|NCT01836328|Narcotics|narcotics|mesh-ancestor
64487778|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487779|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487780|NCT01836328|Analgesics|analgesics|mesh-ancestor
64487781|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
64487816|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487817|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64487818|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
64487819|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
64487821|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64487822|NCT01724086|Interferons|interferons|mesh-list
64487823|NCT01724086|Ritonavir|ritonavir|mesh-list
64487824|NCT01724086|Ribavirin|ribavirin|mesh-list
64487825|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
64487826|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
64487827|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64487828|NCT01724086|Simeprevir|simeprevir|mesh-list
64487829|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487876|NCT01724788|Diuretics|diuretics|mesh-ancestor
64487877|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
64487878|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487879|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64487880|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64487881|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487882|NCT01837498|Neostigmine|neostigmine|mesh-list
64487883|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64487884|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487885|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487886|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
64487887|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487897|NCT01837576|Calcipotriene|calcipotriene|mesh-list
64487937|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487938|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
64487939|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487940|NCT04553666|Protective Agents|protective agents|mesh-ancestor
64487941|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64487942|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64600578|NCT01273493|Dexamethasone|dexamethasone|mesh-list
64487943|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64487944|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64487946|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64487947|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487948|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
64487949|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
64487950|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64487951|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
64487952|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64487953|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487954|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
64487955|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64487956|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64487957|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64487958|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64487959|NCT01838434|Lenalidomide|lenalidomide|mesh-list
64487960|NCT01838434|Idelalisib|idelalisib|mesh-list
64487961|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
64487962|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487963|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64487981|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64487982|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64487983|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64487984|NCT04377646|Trace Elements|trace elements|mesh-ancestor
64487985|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
64487986|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487987|NCT01728922|Vitamin D|vitamin d|mesh-list
64487988|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
64487989|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
64487990|NCT01728922|Vitamins|vitamins|mesh-list
64487991|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
64487992|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64487993|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64487994|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64487995|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
64487996|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
64488040|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64488041|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64488042|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488043|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
64488044|NCT04376788|Methylene Blue|methylene blue|mesh-list
64488045|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488046|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488047|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64488048|NCT01714310|Fluoxetine|fluoxetine|mesh-list
64488049|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64488050|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64488051|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64488052|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488053|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488054|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
64488055|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488097|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
64488098|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488099|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64488100|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64488101|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64488102|NCT03407872|Esketamine|esketamine|mesh-list
64488103|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
64488104|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488107|NCT03834610|Androgens|androgens|mesh-ancestor
64488108|NCT03834610|Hormones|hormones|mesh-ancestor
64488109|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488110|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488111|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
64488112|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64488113|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64488114|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488115|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488116|NCT03834610|Urological Agents|urological agents|mesh-ancestor
64488117|NCT01681472|Leucovorin|leucovorin|mesh-list
64488118|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
64488119|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
64488120|NCT01681472|Antidotes|antidotes|mesh-ancestor
64488149|NCT03407404|Narcotics|narcotics|mesh-ancestor
64488150|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64488151|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64488152|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64488153|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64488154|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488155|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
64488156|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
64488157|NCT03830086|Midazolam|midazolam|mesh-list
64488158|NCT03830086|Sufentanil|sufentanil|mesh-list
64488159|NCT03830086|Bupivacaine|bupivacaine|mesh-list
64488160|NCT03830086|Propofol|propofol|mesh-list
64488161|NCT03830086|Sevoflurane|sevoflurane|mesh-list
64488162|NCT03830086|Rocuronium|rocuronium|mesh-list
64600780|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600781|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64600785|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488163|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
64488164|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
64488165|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488166|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488167|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
64488168|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488169|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64488170|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64488171|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
64488172|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64488203|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64488204|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488205|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488206|NCT01047436|Analgesics|analgesics|mesh-ancestor
64488207|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
64488208|NCT03406936|Midazolam|midazolam|mesh-list
64488209|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64488210|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64488211|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488212|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488213|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64488214|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64488215|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64488216|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64488217|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
64488218|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
64488219|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
64488220|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
64488221|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488222|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600822|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600823|NCT01274039|Diuretics|diuretics|mesh-ancestor
64600824|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
64600825|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600826|NCT01274195|Busulfan|busulfan|mesh-list
64600827|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
64600828|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600830|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
64600831|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600832|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64600833|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488223|NCT02240602|Oxycodone|oxycodone|mesh-list
64488224|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488225|NCT02240602|Narcotics|narcotics|mesh-ancestor
64488226|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488227|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488228|NCT02240602|Analgesics|analgesics|mesh-ancestor
64488229|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
64488230|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488231|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
64488232|NCT03406546|Remifentanil|remifentanil|mesh-list
64488233|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64488248|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64488249|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64488250|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488251|NCT01046110|Incretins|incretins|mesh-ancestor
64488252|NCT01046110|Hormones|hormones|mesh-ancestor
64488253|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488254|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64488255|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
64488256|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488257|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488258|NCT01713530|Insulin|insulin|mesh-list
64488259|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64488260|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
64488261|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
64488262|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64488263|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64488264|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488265|NCT01045798|Caspofungin|caspofungin|mesh-list
64488266|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
64488267|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488268|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488269|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488270|NCT02982694|Bevacizumab|bevacizumab|mesh-list
64488271|NCT02982694|Atezolizumab|atezolizumab|mesh-list
64488272|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64488273|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488274|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64488275|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64488279|NCT01712984|Fluconazole|fluconazole|mesh-list
64600856|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488292|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64600862|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64600863|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
64600864|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600865|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600866|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600867|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600871|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64488293|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64488295|NCT00921310|Pemetrexed|pemetrexed|mesh-list
64488296|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488297|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488298|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488299|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64488300|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64488301|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64488302|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488303|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64488304|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
64488305|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296662|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64488306|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
64296664|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488307|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488309|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488310|NCT02241148|Analgesics|analgesics|mesh-ancestor
64488311|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
64488312|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488313|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488315|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
64488323|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
64488344|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
64488345|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
64488346|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488347|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488348|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64488349|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
64488350|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488351|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64488353|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
64600887|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600888|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64600889|NCT00724009|Clofarabine|clofarabine|mesh-list
64600890|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600892|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600893|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600894|NCT01279499|Remifentanil|remifentanil|mesh-list
64600895|NCT01279499|Propofol|propofol|mesh-list
64600896|NCT01279499|Sevoflurane|sevoflurane|mesh-list
64600897|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64488409|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64488410|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64488411|NCT01592708|Erythromycin|erythromycin|mesh-list
64488412|NCT01592708|Ibuprofen|ibuprofen|mesh-list
64488413|NCT01592708|Ketorolac|ketorolac|mesh-list
64488414|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64488415|NCT01592708|Fentanyl|fentanyl|mesh-list
64488416|NCT01592708|Scopolamine|scopolamine|mesh-list
64488417|NCT01592708|Droperidol|droperidol|mesh-list
64488418|NCT01592708|Remifentanil|remifentanil|mesh-list
64488419|NCT01592708|Hydrocodone|hydrocodone|mesh-list
64488420|NCT01592708|Ondansetron|ondansetron|mesh-list
64488421|NCT01592708|Antiemetics|antiemetics|mesh-list
64488422|NCT01592708|Propofol|propofol|mesh-list
64488423|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
64488424|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488425|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488426|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64488427|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64488463|NCT01592708|Hormones|hormones|mesh-ancestor
64488469|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64488470|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64488471|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
64488472|NCT01042522|Paclitaxel|paclitaxel|mesh-list
64488473|NCT01042522|Etoposide|etoposide|mesh-list
64488474|NCT01042522|Cisplatin|cisplatin|mesh-list
64488475|NCT01042522|Carboplatin|carboplatin|mesh-list
64488476|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64488477|NCT01042522|Bleomycin|bleomycin|mesh-list
64488478|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
64600924|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488479|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64488480|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488481|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
64488482|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
64488483|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
64600926|NCT05318443|Paclitaxel|paclitaxel|mesh-list
64488484|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488485|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64488486|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64488487|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488488|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64488489|NCT01702844|Paclitaxel|paclitaxel|mesh-list
64488490|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64488491|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488492|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
64488493|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
64488494|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488495|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488496|NCT01702532|Nicotine|nicotine|mesh-list
64488517|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296665|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600966|NCT01275287|Eculizumab|eculizumab|mesh-list
64600967|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64600968|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600969|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
64600971|NCT01275443|Rilpivirine|rilpivirine|mesh-list
64296666|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296667|NCT03104270|Dexamethasone|dexamethasone|mesh-list
64296668|NCT03104270|Pomalidomide|pomalidomide|mesh-list
64488518|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64488519|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488521|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
64488522|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64488523|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488524|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64488525|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488526|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488527|NCT03404908|Acetaminophen|acetaminophen|mesh-list
64488528|NCT03404908|Dipyrone|dipyrone|mesh-list
64488529|NCT03404908|Ketoprofen|ketoprofen|mesh-list
64488530|NCT03404908|Morphine|morphine|mesh-list
64488531|NCT03404908|Ropivacaine|ropivacaine|mesh-list
64488532|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64488533|NCT03404908|Narcotics|narcotics|mesh-ancestor
64488534|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488535|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488536|NCT03404908|Analgesics|analgesics|mesh-ancestor
64488537|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
64488538|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488571|NCT03401710|Hematinics|hematinics|mesh-ancestor
64488572|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64488573|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64488574|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64488575|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488576|NCT02993523|Azacitidine|azacitidine|mesh-list
64488577|NCT02993523|Venetoclax|venetoclax|mesh-list
64488578|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64488579|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
64488580|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488581|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488582|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488583|NCT01701362|Pregabalin|pregabalin|mesh-list
64488584|NCT01701362|Analgesics|analgesics|mesh-ancestor
64488585|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
64488586|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488587|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488588|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
64488589|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64488590|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64488625|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64488626|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488627|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64488628|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64488629|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488630|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
64488631|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
64488632|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
64488633|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64488634|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64488635|NCT04413890|Dinoprostone|dinoprostone|mesh-list
64488636|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
64488637|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64488638|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488639|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
64488640|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
64488641|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64488642|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
64488643|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488644|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488645|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64488646|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
64488647|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64488648|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64488649|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64488650|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64488651|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488652|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488671|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64488672|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488673|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
64488674|NCT01700192|Loratadine|loratadine|mesh-list
64488675|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64488676|NCT01700192|Epinephrine|epinephrine|mesh-list
64488677|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64488678|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64488679|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64488680|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
64488681|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488682|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488683|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488684|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64488685|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64488686|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
64488728|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64488729|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64488730|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64488731|NCT02242474|Analgesics|analgesics|mesh-ancestor
64488732|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
64488733|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488734|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488735|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64488736|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
64488737|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64488738|NCT03153111|Macitentan|macitentan|mesh-list
64488739|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64488740|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64488741|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488742|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64488743|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
64601046|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
64488744|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64488745|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64488746|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64488747|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
64488748|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64488749|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488750|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488751|NCT04878315|Captopril|captopril|mesh-list
64488774|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64488775|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488776|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
64488777|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64488778|NCT02243098|Digoxin|digoxin|mesh-list
64488779|NCT02243098|Atorvastatin|atorvastatin|mesh-list
64488780|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64488781|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64488782|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
64488783|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488784|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64488785|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64488786|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488787|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64488789|NCT02243098|Protective Agents|protective agents|mesh-ancestor
64488790|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488791|NCT02845323|Nivolumab|nivolumab|mesh-list
64488792|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64488793|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488794|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64488795|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488796|NCT05289063|Atorvastatin|atorvastatin|mesh-list
64488797|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64488798|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64488799|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
64488800|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64488801|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64488802|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64488803|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64488804|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64488805|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64488806|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64488807|NCT01709318|Etonogestrel|etonogestrel|mesh-list
64488808|NCT01709318|Estradiol|estradiol|mesh-list
64488809|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64488810|NCT01709318|Estrogens|estrogens|mesh-ancestor
64488811|NCT01709318|Hormones|hormones|mesh-ancestor
64488812|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488813|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488814|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64488815|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
64488816|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64488817|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64488818|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64488819|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64488872|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64488873|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64488874|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64488875|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64488876|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
64488877|NCT01699178|Testosterone|testosterone|mesh-list
64488878|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
64601106|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
64488879|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
64488880|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64488881|NCT01699178|Androgens|androgens|mesh-ancestor
64488882|NCT01699178|Hormones|hormones|mesh-ancestor
64488883|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64488884|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64488885|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64488886|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64488887|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
64488939|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64488940|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64488941|NCT02243644|Albendazole|albendazole|mesh-list
64488942|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
64488943|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64488944|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64488945|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
64488946|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64488947|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64488948|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
64488949|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
64488950|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
64488955|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64488956|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64488957|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
64488963|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
64489007|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
64489008|NCT02243800|Vitamin D|vitamin d|mesh-list
64489009|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64489010|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489011|NCT02243800|Vitamins|vitamins|mesh-ancestor
64489012|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
64489013|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64489014|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64489015|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64489016|NCT04764045|Ropivacaine|ropivacaine|mesh-list
64601216|NCT01270841|Testosterone|testosterone|mesh-list
64601217|NCT01270841|Androgens|androgens|mesh-ancestor
64601218|NCT01270841|Hormones|hormones|mesh-ancestor
64601219|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601220|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601221|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64601222|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
64601223|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64601224|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
64601225|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64489017|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
64489018|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
64489019|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489020|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489021|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
64489065|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489066|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64489067|NCT01674855|Lenograstim|lenograstim|mesh-list
64489068|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64489069|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
64489070|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489073|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64489074|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
64489075|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489076|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489077|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489078|NCT00924352|Dasatinib|dasatinib|mesh-list
64489079|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489080|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64489124|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489126|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601275|NCT00784849|Methylene Blue|methylene blue|mesh-list
64489127|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64489128|NCT01675557|Vitamin D|vitamin d|mesh-list
64489129|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
64489130|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
64489189|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489190|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64489191|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64489192|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489193|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64489194|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64489195|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489196|NCT03743025|Dulaglutide|dulaglutide|mesh-list
64489198|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489199|NCT03653247|Plerixafor|plerixafor|mesh-list
64489200|NCT03653247|Busulfan|busulfan|mesh-list
64489201|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
64489248|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64489249|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
64489250|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64489251|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64489252|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489253|NCT00925756|Maraviroc|maraviroc|mesh-list
64489254|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64489255|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64489256|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489257|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64489258|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64489259|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
64489260|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489261|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64489307|NCT04372264|Acetaminophen|acetaminophen|mesh-list
64489308|NCT04372264|Ibuprofen|ibuprofen|mesh-list
64489309|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64489310|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64489311|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64489312|NCT04372264|Analgesics|analgesics|mesh-ancestor
64489313|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
64489314|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489315|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489316|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489317|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489318|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64489319|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489320|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489321|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
64489322|NCT02083809|Oxytocin|oxytocin|mesh-list
64489323|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
64489324|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64601373|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601385|NCT03804931|Prednisone|prednisone|mesh-list
64489325|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489326|NCT02244112|Midazolam|midazolam|mesh-list
64489327|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64489328|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64489329|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64489330|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489331|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64489332|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64601427|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
64601430|NCT00761345|Gemcitabine|gemcitabine|mesh-list
64489357|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64489358|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489360|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64489361|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64489362|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489363|NCT03721653|Antidotes|antidotes|mesh-ancestor
64489364|NCT03721653|Protective Agents|protective agents|mesh-ancestor
64489365|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
64489366|NCT03721653|Vitamins|vitamins|mesh-ancestor
64489367|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
64489423|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64489424|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64489425|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64489426|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
64489428|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
64489429|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489430|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489431|NCT04371874|Aspirin|aspirin|mesh-list
64489432|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64489433|NCT04371874|Captopril|captopril|mesh-list
64489434|NCT04371874|Nitrendipine|nitrendipine|mesh-list
64489435|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64489436|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64489438|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
64489464|NCT03629223|Tepotinib|tepotinib|mesh-list
64489481|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489482|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64489483|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489484|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489485|NCT03627741|Triamcinolone|triamcinolone|mesh-list
64489486|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64489487|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64489488|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64489489|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64489490|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
64489492|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64489493|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489494|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489495|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
64489496|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489497|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489498|NCT03626337|Thiamine|thiamine|mesh-list
64489499|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
64489500|NCT03626337|Vitamins|vitamins|mesh-ancestor
64489501|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
64489502|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489503|NCT00929578|Fluphenazine|fluphenazine|mesh-list
64489504|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
64489505|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
64489506|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64489516|NCT03615105|Melphalan|melphalan|mesh-list
64489532|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64489533|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489534|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64489535|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
64489536|NCT04371406|Azithromycin|azithromycin|mesh-list
64489537|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
64601492|NCT00786643|Interferons|interferons|mesh-list
64489538|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64489539|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489540|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
64489541|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64489542|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64489543|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489544|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489545|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489546|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
64489547|NCT03716739|Testosterone|testosterone|mesh-list
64489548|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
64489549|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
64489550|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64489551|NCT03716739|Androgens|androgens|mesh-ancestor
64489583|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64489584|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
64489585|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489586|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489587|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64489588|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
64489589|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64489590|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489651|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489652|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
64489653|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
64489654|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
64489655|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489656|NCT05620654|Paclitaxel|paclitaxel|mesh-list
64489657|NCT05620654|Cisplatin|cisplatin|mesh-list
64489659|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489660|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
64489661|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
64601581|NCT05742607|Carboplatin|carboplatin|mesh-list
64489662|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
64489663|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489665|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64489666|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489669|NCT04357522|Vaccines|vaccines|mesh-list
64489709|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489710|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64489711|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
64489712|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
64489713|NCT03685773|Vitamins|vitamins|mesh-ancestor
64489714|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
64489717|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
64489774|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64489775|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489776|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
64489777|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489778|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
64489779|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
64489780|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
64489781|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489782|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64489783|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489785|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64601642|NCT00789997|Analgesics|analgesics|mesh-ancestor
64489839|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
64489840|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64489841|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64489842|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489843|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64489908|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489909|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64489910|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
64489911|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64489912|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64489913|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64489914|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64489915|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
64489916|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64489917|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64489918|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
64489919|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64489920|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64489921|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
64489922|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
64489924|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
64489925|NCT03794037|Montelukast|montelukast|mesh-list
64489926|NCT03794037|Progesterone|progesterone|mesh-list
64489962|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
64489963|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64489964|NCT04368598|Expectorants|expectorants|mesh-ancestor
64489965|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
64489966|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64489967|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
64489968|NCT04368598|Protective Agents|protective agents|mesh-ancestor
64489969|NCT04368598|Antidotes|antidotes|mesh-ancestor
64489970|NCT05347641|Cytarabine|cytarabine|mesh-list
64489971|NCT05347641|Methotrexate|methotrexate|mesh-list
64489972|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64489973|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
64601741|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64489974|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64489975|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64489976|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64489977|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
64489978|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64489979|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64489980|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
64489981|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64489990|NCT01696058|Olodaterol|olodaterol|mesh-list
64490014|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490015|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490016|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
64490017|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490018|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64490019|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64490020|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64490021|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
64490022|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490023|NCT03580317|Carbamazepine|carbamazepine|mesh-list
64490024|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
64490025|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
64601742|NCT03801733|Analgesics|analgesics|mesh-ancestor
64490026|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64490027|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490028|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490029|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64490030|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64490031|NCT03580317|Analgesics|analgesics|mesh-ancestor
64490032|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
64490033|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490034|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64490035|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64490037|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64490062|NCT04356118|Growth Substances|growth substances|mesh-ancestor
64490063|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
64490064|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
64490065|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
64490066|NCT04361812|Omalizumab|omalizumab|mesh-list
64490067|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64490068|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64490069|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64490070|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
64490071|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
64490072|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490073|NCT04355962|Sevoflurane|sevoflurane|mesh-list
64490126|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
64490127|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490128|NCT01677273|Caseins|caseins|mesh-list
64490129|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
64490130|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
64490131|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490132|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64490133|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64490134|NCT04355806|Vaccines|vaccines|mesh-list
64490135|NCT04355806|Antibodies|antibodies|mesh-list
64490136|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
64490188|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490190|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490191|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490192|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490193|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
64490194|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490195|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490196|NCT03663543|Estrogens|estrogens|mesh-list
64296670|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64296671|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
64296672|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
64296673|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296674|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296675|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490197|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64490198|NCT03663543|Hormones|hormones|mesh-ancestor
64490202|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
64490254|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
64490255|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490256|NCT04355494|Eculizumab|eculizumab|mesh-list
64490257|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64490258|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490259|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
64490260|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490261|NCT00934024|Varenicline|varenicline|mesh-list
64601780|NCT01974687|Itraconazole|itraconazole|mesh-list
64601781|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
64490262|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64601782|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
64296619|NCT03301233|Estrogens|estrogens|mesh-ancestor
64490263|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64490264|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
64490265|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490266|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490267|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490268|NCT03552471|Rucaparib|rucaparib|mesh-list
64490269|NCT03552471|Maytansine|maytansine|mesh-list
64490270|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64490271|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490272|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490273|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490274|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64490307|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64490308|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490309|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490310|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490311|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490312|NCT04355026|Expectorants|expectorants|mesh-ancestor
64490313|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
64490314|NCT03548571|Temozolomide|temozolomide|mesh-list
64490315|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64490316|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
64490317|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490318|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490319|NCT00939562|Doxycycline|doxycycline|mesh-list
64601793|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
64601794|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
64490320|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490321|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490322|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
64490323|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64490324|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64490365|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64490366|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64490367|NCT03539445|Protective Agents|protective agents|mesh-ancestor
64490368|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490370|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
64490371|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490372|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
64490373|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
64490374|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490375|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490376|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64296676|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
64296677|NCT03104270|Hormones|hormones|mesh-ancestor
64296678|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296679|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64296680|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296681|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
64490378|NCT04360876|Hormones|hormones|mesh-ancestor
64490379|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64490380|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64490381|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490382|NCT03537495|Linezolid|linezolid|mesh-list
64490383|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490384|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490385|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64490388|NCT04359550|Antibodies|antibodies|mesh-list
64490420|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490421|NCT04359316|Azithromycin|azithromycin|mesh-list
64490422|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
64490423|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490424|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490425|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
64490426|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64490427|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64490428|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490429|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490430|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490431|NCT03558867|Metformin|metformin|mesh-list
64490432|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64484269|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
64484270|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
64490433|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490434|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
64490435|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64490436|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64490437|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
64490438|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490439|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64490440|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64490441|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490442|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490444|NCT03557385|Analgesics|analgesics|mesh-ancestor
64490445|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
64490446|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490447|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490448|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64490465|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
64490466|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
64490467|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
64490468|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64490469|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490470|NCT05346861|Trastuzumab|trastuzumab|mesh-list
64490471|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490472|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490473|NCT04358614|Ritonavir|ritonavir|mesh-list
64490474|NCT04358614|Lopinavir|lopinavir|mesh-list
64490475|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64490476|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64490477|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
64490478|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490480|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64490523|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490526|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490528|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490529|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490530|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490531|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490532|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
64490533|NCT01670565|Belimumab|belimumab|mesh-list
64490534|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64490535|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490536|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64490538|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64490539|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490540|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490541|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490542|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490543|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
64490544|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490545|NCT01670799|Ketorolac|ketorolac|mesh-list
64490546|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64490547|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64490548|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64490549|NCT01670799|Analgesics|analgesics|mesh-ancestor
64490550|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
64490551|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490552|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490553|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490554|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490555|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64490556|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490558|NCT02404935|Cetuximab|cetuximab|mesh-list
64490564|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490565|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490566|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64490567|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64490568|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601880|NCT01993875|Lubiprostone|lubiprostone|mesh-list
64601881|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64601884|NCT00796705|Adalimumab|adalimumab|mesh-list
64490569|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490570|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
64490571|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
64490572|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64490628|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490629|NCT03032458|Ketorolac|ketorolac|mesh-list
64490630|NCT03032458|Lidocaine|lidocaine|mesh-list
64490631|NCT03032458|Meperidine|meperidine|mesh-list
64490632|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
64490633|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
64490636|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
64601898|NCT00809809|Trace Elements|trace elements|mesh-ancestor
64601899|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
64490696|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601901|NCT00248651|Amitriptyline|amitriptyline|mesh-list
64490697|NCT02401815|Sunitinib|sunitinib|mesh-list
64490698|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490699|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64490700|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64490701|NCT02401815|Growth Substances|growth substances|mesh-ancestor
64490702|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490703|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
64490704|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490705|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490706|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490707|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
64490708|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
64490709|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64490710|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
64490711|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490712|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490713|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490714|NCT03456687|Exenatide|exenatide|mesh-list
64490715|NCT03456687|Glucagon|glucagon|mesh-list
64601959|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601960|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601961|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490716|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64490717|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64490749|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490752|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64490753|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64490754|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64490755|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
64490756|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490816|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64490817|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
64490818|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490819|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
64490820|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64490821|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490822|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490823|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
64490824|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490825|NCT03559114|Dalteparin|dalteparin|mesh-list
64490826|NCT03559114|Tinzaparin|tinzaparin|mesh-list
64490827|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64490828|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
64490829|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64490830|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64490831|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490832|NCT05153590|Liraglutide|liraglutide|mesh-list
64490833|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602013|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64490834|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490835|NCT05153590|Incretins|incretins|mesh-ancestor
64490869|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64490870|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
64490871|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490872|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64490873|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64490874|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
64490875|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490876|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490877|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64490878|NCT00949234|Ritonavir|ritonavir|mesh-list
64490879|NCT00949234|Lopinavir|lopinavir|mesh-list
64490880|NCT00949234|Tenofovir|tenofovir|mesh-list
64490881|NCT00949234|Emtricitabine|emtricitabine|mesh-list
64490882|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64490883|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64490884|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
64490886|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490887|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64490888|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64490889|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
64490897|NCT03090880|Dalteparin|dalteparin|mesh-list
64490925|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64490926|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
64490927|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64490928|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
64490929|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
64490930|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490931|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490932|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490933|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
64490934|NCT05097976|Hormones|hormones|mesh-ancestor
64490935|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64490936|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64490937|NCT05097976|Protective Agents|protective agents|mesh-ancestor
64490938|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64490939|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490940|NCT03030430|Bevacizumab|bevacizumab|mesh-list
64490941|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64490942|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490943|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64490944|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64490945|NCT03030430|Growth Substances|growth substances|mesh-ancestor
64490946|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490947|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
64490948|NCT00089661|Denosumab|denosumab|mesh-list
64490949|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64490950|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490951|NCT00941668|Triclosan|triclosan|mesh-list
64490952|NCT00941668|Fluorides|fluorides|mesh-list
64490953|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
64490954|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
64490965|NCT01597414|Pertuzumab|pertuzumab|mesh-list
64602066|NCT00754247|Vitamin E|vitamin e|mesh-list
64490971|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
64490972|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64490973|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490974|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64490975|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
64490976|NCT04984330|Hormones|hormones|mesh-ancestor
64490977|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64490978|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64490979|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490980|NCT03030196|Denosumab|denosumab|mesh-list
64490981|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64490982|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64490983|NCT00265798|Sorafenib|sorafenib|mesh-list
64490984|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64490985|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64490986|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64490987|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64490988|NCT03035578|Morphine|morphine|mesh-list
64490989|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64490990|NCT03035578|Narcotics|narcotics|mesh-ancestor
64490991|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64490992|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491023|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64491024|NCT04402047|Analgesics|analgesics|mesh-ancestor
64491025|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
64491026|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491027|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491028|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491029|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491030|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64491031|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296682|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296683|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64296684|NCT03104270|Growth Substances|growth substances|mesh-ancestor
64296685|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
64296686|NCT03300765|Apatinib|apatinib|mesh-list
64491034|NCT03017248|Morphine|morphine|mesh-list
64602085|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64602086|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64491035|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64491036|NCT03017248|Analgesics|analgesics|mesh-ancestor
64491037|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
64491038|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491039|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491040|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64491080|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
64491081|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491082|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491084|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
64491085|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491086|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
64491087|NCT03017404|Docetaxel|docetaxel|mesh-list
64491088|NCT03017404|Doxorubicin|doxorubicin|mesh-list
64491089|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64491090|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491149|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491150|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64491151|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
64491152|NCT03023020|Aspirin|aspirin|mesh-list
64491153|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64491154|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64491155|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64491156|NCT03023020|Analgesics|analgesics|mesh-ancestor
64491157|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
64491158|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491159|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491167|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
64491210|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
64491211|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491212|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
64491213|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491214|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
64491215|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491216|NCT00084747|Bortezomib|bortezomib|mesh-list
64491217|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491218|NCT04402671|Glutaral|glutaral|mesh-list
64491219|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
64602120|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602121|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
64491220|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491221|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
64491222|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64491223|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491224|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64491225|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491226|NCT01678365|Metronidazole|metronidazole|mesh-list
64491270|NCT00956254|Narcotics|narcotics|mesh-ancestor
64491271|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491272|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491273|NCT00956254|Analgesics|analgesics|mesh-ancestor
64491274|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
64491275|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491276|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64491277|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64491278|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
64491279|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
64491280|NCT03020680|Ubiquinone|ubiquinone|mesh-list
64491281|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
64491282|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
64296687|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491283|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491284|NCT03020680|Vitamins|vitamins|mesh-ancestor
64296688|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64491327|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64602155|NCT01995045|Bupivacaine|bupivacaine|mesh-list
64602157|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
64491328|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491329|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491330|NCT00946348|Hormones|hormones|mesh-ancestor
64491331|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491394|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491395|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491396|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64491397|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64491398|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491399|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491400|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491401|NCT04402359|Meropenem|meropenem|mesh-list
64491402|NCT04402359|Ceftazidime|ceftazidime|mesh-list
64491403|NCT04402359|Avibactam|avibactam|mesh-list
64491404|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64491405|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491406|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64491407|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491408|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491409|NCT00959764|Calcitonin|calcitonin|mesh-list
64491410|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
64491411|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64491412|NCT00959764|Katacalcin|katacalcin|mesh-list
64491413|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64491414|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491448|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
64491449|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491450|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64491451|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64491452|NCT03088059|Durvalumab|durvalumab|mesh-list
64491453|NCT03088059|Palbociclib|palbociclib|mesh-list
64491454|NCT03088059|Niraparib|niraparib|mesh-list
64491455|NCT03088059|Afatinib|afatinib|mesh-list
64491456|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491457|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491458|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64491459|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491460|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491461|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64491462|NCT03084549|Ropivacaine|ropivacaine|mesh-list
64491463|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
64491502|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64491504|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
64491505|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64491506|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
64491507|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491508|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64491509|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64491510|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491511|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491512|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64491513|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64491514|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
64602204|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491515|NCT03430947|Vemurafenib|vemurafenib|mesh-list
64491516|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491517|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64491518|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491559|NCT03089073|Coagulants|coagulants|mesh-ancestor
64491560|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64491561|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
64491562|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491563|NCT05688813|Anesthetics|anesthetics|mesh-list
64491564|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491565|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491566|NCT03425643|Gemcitabine|gemcitabine|mesh-list
64491567|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
64491568|NCT03425643|Pemetrexed|pemetrexed|mesh-list
64491569|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491570|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64491571|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
64491572|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491573|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
64491574|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491575|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491576|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491577|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
64491578|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491579|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491580|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64491581|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64491582|NCT01009918|Carvedilol|carvedilol|mesh-list
64491583|NCT01009918|Lisinopril|lisinopril|mesh-list
64491605|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
64491606|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491607|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491608|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64491609|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
64491610|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64491611|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
64491612|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
64491613|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64491614|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491615|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
64491616|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64491617|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64491618|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491619|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
64491620|NCT03019198|Coagulants|coagulants|mesh-ancestor
64491621|NCT03083613|Paclitaxel|paclitaxel|mesh-list
64602223|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64491622|NCT03083613|Raltitrexed|raltitrexed|mesh-list
64491623|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64491633|NCT00963508|Permethrin|permethrin|mesh-list
64491659|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602224|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64602225|NCT04760275|Fluoxetine|fluoxetine|mesh-list
64602226|NCT04760275|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64602227|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64491660|NCT05685537|Simendan|simendan|mesh-list
64491661|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64491662|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
64491663|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64491664|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64491665|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491666|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491667|NCT05685537|Protective Agents|protective agents|mesh-ancestor
64491668|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491669|NCT04400721|Ropivacaine|ropivacaine|mesh-list
64491670|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
64491671|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
64491716|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491717|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491718|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64491719|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
64491745|NCT04401345|Bromides|bromides|mesh-list
64491779|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
64491780|NCT03384537|Listerine|listerine|mesh-list
64491781|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64491782|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491783|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
64491784|NCT01884922|Vinblastine|vinblastine|mesh-list
64491785|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64491786|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491787|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
64491788|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
64491794|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
64491795|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491796|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64491797|NCT02162680|Lidocaine|lidocaine|mesh-list
64491798|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
64491799|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
64491800|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64491801|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491802|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
64491803|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491804|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64491805|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64491807|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64491808|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491809|NCT05678673|Nivolumab|nivolumab|mesh-list
64491810|NCT05678673|Sunitinib|sunitinib|mesh-list
64491811|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64491812|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64491813|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64491814|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491815|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64491816|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64491817|NCT05678673|Growth Substances|growth substances|mesh-ancestor
64491818|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491819|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
64491824|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602246|NCT02151487|Clonidine|clonidine|mesh-list
64491825|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64491826|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64491827|NCT01017250|Growth Substances|growth substances|mesh-ancestor
64491828|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491829|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
64491830|NCT00812032|Aspirin|aspirin|mesh-list
64491831|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64491832|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64491833|NCT00812032|Analgesics|analgesics|mesh-ancestor
64491834|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
64491835|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64491836|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491837|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64491838|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64491839|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64491885|NCT05657613|Fluconazole|fluconazole|mesh-list
64491886|NCT05657613|Bosentan|bosentan|mesh-list
64491887|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
64491888|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491889|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64491890|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64491891|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491892|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491893|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64491894|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
64491895|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64491896|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64491897|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64491898|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64491899|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64491900|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64602263|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
64602264|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
64491901|NCT01021618|Dipyridamole|dipyridamole|mesh-list
64491902|NCT01021618|Regadenoson|regadenoson|mesh-list
64491903|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64491904|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64491905|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
64491906|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
64491935|NCT01018420|Colchicine|colchicine|mesh-list
64491936|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64491937|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64491938|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64491939|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64491940|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491976|NCT03373851|Dsuvia|dsuvia|mesh-list
64491991|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64491992|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
64491993|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64491994|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64491995|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64491996|NCT01023724|Ketorolac|ketorolac|mesh-list
64491997|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64491998|NCT01023724|Bromfenac|bromfenac|mesh-list
64602304|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64491999|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64602305|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64492000|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64492001|NCT01023724|Analgesics|analgesics|mesh-ancestor
64492002|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
64492003|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492004|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492005|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492006|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492007|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64492008|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492010|NCT00974818|Mitomycins|mitomycins|mesh-list
64492046|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492047|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
64296689|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296690|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492048|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
64492049|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64492050|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64492051|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
64492052|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492053|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64492054|NCT05613153|Peppermint oil|peppermint oil|mesh-list
64492055|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
64492056|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
64492057|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492058|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492059|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492060|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
64492061|NCT01024972|Mannitol|mannitol|mesh-list
64492062|NCT01024972|Dantrolene|dantrolene|mesh-list
64492063|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64296692|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492064|NCT01024972|Diuretics|diuretics|mesh-ancestor
64492065|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
64296693|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64492066|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492067|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64492068|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64492072|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
64492073|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492074|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492075|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
64492076|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492077|NCT01025830|Lamivudine|lamivudine|mesh-list
64492078|NCT01025830|Nevirapine|nevirapine|mesh-list
64492079|NCT01025830|Stavudine|stavudine|mesh-list
64492080|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
64602356|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64492081|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64492082|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492083|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492084|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492085|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
64492086|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492087|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64492088|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64602386|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492089|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64492090|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64492091|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
64492092|NCT03081039|Gemcitabine|gemcitabine|mesh-list
64492093|NCT03081039|Carboplatin|carboplatin|mesh-list
64492094|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492095|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492096|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
64492097|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492098|NCT03081039|Antiviral Agents|antiviral agents|mesh-ancestor
64492099|NCT03081039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492100|NCT03081039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492101|NCT03081039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602387|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602388|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64602389|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
64602390|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492102|NCT03081039|Immunologic Factors|immunologic factors|mesh-ancestor
64492103|NCT03081039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492104|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
64492105|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64492106|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492107|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492108|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492109|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492110|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
64492111|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64492112|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64492113|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492114|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296694|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64492115|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
64492121|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296695|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
64492123|NCT03348969|Mitomycin|mitomycin|mesh-list
64492124|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64492125|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492126|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
64492127|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492128|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492129|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492130|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
64492131|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64602434|NCT00800839|Fludarabine|fludarabine|mesh-list
64492132|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64602435|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
64492133|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492134|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
64492135|NCT05686005|Coagulants|coagulants|mesh-ancestor
64492136|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
64492137|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64492138|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492176|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
64492177|NCT01027000|Tacrolimus|tacrolimus|mesh-list
64492178|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492179|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
64492180|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492181|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492182|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64492183|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
64492184|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492185|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492186|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64492187|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492188|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64492189|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
64492190|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64492191|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492192|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
64492193|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
64492194|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492195|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64492196|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64492197|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64492229|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64492230|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492231|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492232|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
64492233|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492234|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492235|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64492236|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
64602481|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602482|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602483|NCT02002767|Velpatasvir|velpatasvir|mesh-list
64602484|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
64602485|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492237|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492239|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492240|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492241|NCT05066997|Dexamethasone|dexamethasone|mesh-list
64492242|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
64492243|NCT05066997|BB 1101|bb 1101|mesh-list
64492244|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492245|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
64492246|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
64492247|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492284|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64492285|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492286|NCT03016234|Propofol|propofol|mesh-list
64492287|NCT03016234|Desflurane|desflurane|mesh-list
64492290|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492291|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64492292|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
64492293|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
64492294|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64492295|NCT02167204|Alovudine|alovudine|mesh-list
64492296|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
64492297|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64492298|NCT00982072|Prednisolone|prednisolone|mesh-list
64492299|NCT00982072|Tacrolimus|tacrolimus|mesh-list
64492300|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492301|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
64492302|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492303|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64492304|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492305|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492306|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492307|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
64492308|NCT00982072|Hormones|hormones|mesh-ancestor
64492309|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492310|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64492311|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602566|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64602567|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602569|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
64492312|NCT01899053|Serabelisib|serabelisib|mesh-list
64492313|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492314|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492327|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64492328|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
64492329|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492330|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492331|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64492332|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492333|NCT00983242|Colchicine|colchicine|mesh-list
64492334|NCT00983242|Verapamil|verapamil|mesh-list
64492335|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
64492336|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602628|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64602629|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64602630|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64492337|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
64492338|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
64492339|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
64492340|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492387|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
64492388|NCT01897493|Digoxin|digoxin|mesh-list
64492389|NCT01897493|Evacetrapib|evacetrapib|mesh-list
64492390|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64492391|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64492392|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492393|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492394|NCT01897493|Protective Agents|protective agents|mesh-ancestor
64492398|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
64492449|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64602684|NCT02062905|Dexamethasone|dexamethasone|mesh-list
64602685|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492450|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
64492451|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
64492452|NCT02160808|Secretin|secretin|mesh-list
64492453|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64492454|NCT02160808|Hormones|hormones|mesh-ancestor
64492455|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492456|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492457|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
64492458|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64492459|NCT01886105|Analgesics|analgesics|mesh-ancestor
64492460|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
64492462|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492506|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492507|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492508|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
64492509|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492510|NCT01885559|Telmisartan|telmisartan|mesh-list
64492511|NCT01885559|Lisinopril|lisinopril|mesh-list
64492512|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64492513|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64492514|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64602746|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492515|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64492516|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492517|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
64492518|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492519|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64492520|NCT01885559|Protective Agents|protective agents|mesh-ancestor
64492521|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492522|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
64492523|NCT00994318|Hematinics|hematinics|mesh-ancestor
64492524|NCT00995722|Prednisone|prednisone|mesh-list
64492525|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492526|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
64492527|NCT00995722|Hormones|hormones|mesh-ancestor
64492528|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64492532|NCT04434040|Atezolizumab|atezolizumab|mesh-list
64492554|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64492555|NCT00997204|Analgesics|analgesics|mesh-ancestor
64602799|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602800|NCT02665117|Cathartics|cathartics|mesh-ancestor
64602801|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64602802|NCT02151253|Modafinil|modafinil|mesh-list
64602803|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64602809|NCT02069847|Budesonide|budesonide|mesh-list
64492556|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
64492557|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492558|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492559|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492560|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492620|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64492621|NCT01001806|Nepafenac|nepafenac|mesh-list
64492622|NCT01001806|Bromfenac|bromfenac|mesh-list
64492623|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64492624|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64492625|NCT01001806|Analgesics|analgesics|mesh-ancestor
64492626|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
64492627|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492628|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492629|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492630|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64492631|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64492632|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492633|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492634|NCT04021264|Sufentanil|sufentanil|mesh-list
64492635|NCT04021264|Ropivacaine|ropivacaine|mesh-list
64492636|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
64492637|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
64492638|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492678|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
64492679|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
64492680|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64492682|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64492684|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492685|NCT04757571|Paroxetine|paroxetine|mesh-list
64492686|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64602856|NCT02408445|Androgens|androgens|mesh-ancestor
64602857|NCT02408445|Hormones|hormones|mesh-ancestor
64602863|NCT00388921|Vitamin A|vitamin a|mesh-list
64492687|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64492688|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64492689|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492690|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492691|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
64492692|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492693|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64492731|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64492732|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492733|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
64492734|NCT04614311|Hormones|hormones|mesh-ancestor
64492805|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64492806|NCT04817956|Entrectinib|entrectinib|mesh-list
64492807|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64492808|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492809|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492810|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
64492811|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64602901|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64602902|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64602903|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64602904|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602905|NCT00821821|Edaravone|edaravone|mesh-list
64602906|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64602907|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
64492812|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64492813|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492814|NCT01894919|Vaccines|vaccines|mesh-list
64492815|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
64492816|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492817|NCT04130698|Nicotine|nicotine|mesh-list
64492818|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64492819|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
64492820|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492821|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492822|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64492823|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64492824|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
64492825|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492826|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64492827|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64492828|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64492851|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64492852|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64492853|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64492854|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
64602950|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64602951|NCT00823459|Everolimus|everolimus|mesh-list
64602952|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492855|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
64492856|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64492857|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
64492858|NCT03016000|Thalidomide|thalidomide|mesh-list
64492859|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64492860|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
64492861|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64492862|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
64492863|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64492912|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
64492913|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64492914|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64492915|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
64492916|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64492921|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
64492982|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
64492984|NCT01882985|Lycopene|lycopene|mesh-list
64492985|NCT01882985|Docetaxel|docetaxel|mesh-list
64603001|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64603002|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
64603003|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64492986|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64492987|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
64492988|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
64492989|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64492991|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493047|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64493048|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493049|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64493050|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493051|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
64493052|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64493053|NCT02981446|Latanoprost|latanoprost|mesh-list
64493054|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64493055|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64493056|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64493057|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
64493059|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493060|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493061|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64493062|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64493063|NCT05263947|Growth Substances|growth substances|mesh-ancestor
64603059|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603060|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603061|NCT02349477|Gabapentin|gabapentin|mesh-list
64603062|NCT02349477|Analgesics|analgesics|mesh-ancestor
64603063|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
64493064|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493065|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
64493066|NCT04415567|Lenvatinib|lenvatinib|mesh-list
64493067|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493068|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64493069|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493071|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
64493093|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64493094|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64493095|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493096|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493097|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603108|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603109|NCT02025075|Rocuronium|rocuronium|mesh-list
64603122|NCT00241631|Xhance|xhance|mesh-list
64493098|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64493099|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64493100|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
64493101|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64493102|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
64493103|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64493104|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64493105|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493106|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493107|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64493108|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64493149|NCT01055704|Analgesics|analgesics|mesh-ancestor
64493150|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
64493151|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493152|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
64493153|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
64493154|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64493155|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64493157|NCT03280017|Analgesics|analgesics|mesh-ancestor
64493158|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
64493159|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493160|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493161|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64493162|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64493163|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
64493164|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
64493165|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64493166|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64493167|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64493168|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493169|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493170|NCT01882439|Tofacitinib|tofacitinib|mesh-list
64493171|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64493172|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493173|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493174|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
64493196|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493197|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
64493198|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493199|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493200|NCT01109056|Cyclosporine|cyclosporine|mesh-list
64493201|NCT01109056|Cyclosporins|cyclosporins|mesh-list
64493202|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493203|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493204|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493205|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
64493206|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493207|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
64493208|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493209|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
64493210|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493211|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64493213|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64493214|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
64493215|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603168|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64493216|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603169|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64603170|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
64493217|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64493218|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493219|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64493220|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64493245|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64493246|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64493247|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493248|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
64296696|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296697|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493249|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64493251|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
64493252|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64493253|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64493254|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64493308|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64493309|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
64493310|NCT03819465|Antiviral Agents|antiviral agents|mesh-ancestor
64493311|NCT03819465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493312|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493313|NCT03819465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493314|NCT03819465|Immunologic Factors|immunologic factors|mesh-ancestor
64493315|NCT03819465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493316|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64493317|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64603183|NCT00765947|Diuretics|diuretics|mesh-ancestor
64603184|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
64603185|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64603186|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
64493318|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64493319|NCT01111318|Empagliflozin|empagliflozin|mesh-list
64493320|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64493371|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
64493372|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64493373|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64493374|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603229|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603230|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64493375|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64493376|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64493377|NCT01064284|Factor VIII|factor viii|mesh-list
64493378|NCT01064284|Coagulants|coagulants|mesh-ancestor
64493382|NCT01064362|Heparin|heparin|mesh-list
64493383|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64493384|NCT01064362|Tinzaparin|tinzaparin|mesh-list
64493385|NCT01064362|Dalteparin|dalteparin|mesh-list
64493442|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64493443|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
64493444|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493445|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64493446|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64493447|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493448|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296712|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296714|NCT03300609|Leucovorin|leucovorin|mesh-list
64296715|NCT03300609|Folic Acid|folic acid|mesh-list
64493454|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493455|NCT04398771|Valsartan|valsartan|mesh-list
64493480|NCT01068964|Bimatoprost|bimatoprost|mesh-list
64493481|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64493482|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64493483|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64493484|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64493485|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
64493486|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493487|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493493|NCT05111145|Ivacaftor|ivacaftor|mesh-list
64493543|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
64493544|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
64493545|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493546|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493547|NCT01117948|Lornoxicam|lornoxicam|mesh-list
64493548|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64603347|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
64603348|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603349|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603350|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64603357|NCT05718531|Aspirin|aspirin|mesh-list
64493549|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64493550|NCT01117948|Analgesics|analgesics|mesh-ancestor
64493551|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
64493554|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493608|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64493609|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
64493610|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493611|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493612|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64493613|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493614|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
64493615|NCT02287311|Fludarabine|fludarabine|mesh-list
64493616|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493617|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
64493618|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493669|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493670|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64493671|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64493672|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
64493673|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64493674|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296718|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64493675|NCT01122316|Metformin|metformin|mesh-list
64493676|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64493677|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493678|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
64493679|NCT03049449|Fludarabine|fludarabine|mesh-list
64493680|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493681|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
64493682|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493683|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493684|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64493685|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
64493686|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493687|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493688|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64493689|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64493690|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64493691|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493692|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64493716|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
64493718|NCT03186027|Vitamins|vitamins|mesh-ancestor
64493719|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
64493720|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493721|NCT02595892|Gemcitabine|gemcitabine|mesh-list
64493722|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64603410|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64603411|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493723|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
64493724|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493725|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493726|NCT02595892|Antiviral Agents|antiviral agents|mesh-ancestor
64493727|NCT02595892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493728|NCT02595892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493729|NCT02595892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64493730|NCT02595892|Immunologic Factors|immunologic factors|mesh-ancestor
64493731|NCT02595892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493732|NCT04397913|Acetaminophen|acetaminophen|mesh-list
64493733|NCT04397913|Ibuprofen|ibuprofen|mesh-list
64493734|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64493735|NCT04397913|Analgesics|analgesics|mesh-ancestor
64493736|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
64493737|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493738|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493739|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
64603437|NCT02038023|Dextrans|dextrans|mesh-list
64603438|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
64493740|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64493741|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64493742|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493743|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64493762|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493763|NCT01077310|Naltrexone|naltrexone|mesh-list
64493764|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64493765|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64493766|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493767|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
64493768|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493769|NCT02989857|Ivosidenib|ivosidenib|mesh-list
64296719|NCT03300609|Panitumumab|panitumumab|mesh-list
64296720|NCT03300609|Fluorouracil|fluorouracil|mesh-list
64603497|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64603498|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296721|NCT03300609|Capecitabine|capecitabine|mesh-list
64296722|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
64296723|NCT03300609|Antibodies|antibodies|mesh-list
64296724|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
64296725|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64296726|NCT03300609|Calcium|calcium|mesh-list
64296727|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
64296728|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
64296729|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296730|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493771|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603557|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
64493772|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493773|NCT02393937|Metronidazole|metronidazole|mesh-list
64493774|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64493775|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64493824|NCT01876823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64493825|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64493826|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64493827|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
64493828|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64493829|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
64493830|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64493891|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493893|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
64493894|NCT01787409|Vitamins|vitamins|mesh-ancestor
64493895|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
64493896|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493897|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64493898|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64603621|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64493899|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
64493900|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64493901|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64493902|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493903|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493904|NCT05307718|Anticoagulants|anticoagulants|mesh-list
64493952|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64493953|NCT01035346|Analgesics|analgesics|mesh-ancestor
64493954|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
64493955|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64493956|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64493957|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603622|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64603623|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
64603624|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64603625|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603639|NCT00771875|Hormones|hormones|mesh-ancestor
64493958|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64493959|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64493960|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64493961|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64493962|NCT01085344|Factor VIII|factor viii|mesh-list
64493963|NCT01085344|Coagulants|coagulants|mesh-ancestor
64493964|NCT01035658|Doxorubicin|doxorubicin|mesh-list
64493965|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64494012|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64494013|NCT02984397|Ketotifen|ketotifen|mesh-list
64494014|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
64494015|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
64494016|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64494017|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
64494018|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
64494019|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494020|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494021|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494022|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64494023|NCT01922427|RNS60|rns60|mesh-list
64494024|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64494025|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64494029|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494030|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494031|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494032|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64494033|NCT01088464|Necitumumab|necitumumab|mesh-list
64494034|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64494035|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494036|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494037|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
64494038|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494060|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603722|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603723|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603724|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64603725|NCT02388321|Narcotics|narcotics|mesh-ancestor
64494061|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
64494062|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64494063|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64494064|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494065|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64494066|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494067|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
64494068|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494069|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
64494070|NCT03169881|Hematinics|hematinics|mesh-ancestor
64494071|NCT01092676|Ibuprofen|ibuprofen|mesh-list
64494072|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64494073|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64494074|NCT01092676|Analgesics|analgesics|mesh-ancestor
64494075|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
64494076|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494077|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494078|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494079|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494083|NCT05273320|Dronabinol|dronabinol|mesh-list
64494103|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494105|NCT01039792|Vitamins|vitamins|mesh-ancestor
64494106|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
64494107|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494108|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
64494109|NCT01041274|Citalopram|citalopram|mesh-list
64603776|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603777|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64494110|NCT01041274|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64494111|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64494112|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64494121|NCT00635349|Meloxicam|meloxicam|mesh-list
64494157|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494159|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64494160|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64494161|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494162|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494163|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64494164|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64494175|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
64494176|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64494178|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494179|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494180|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494181|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64494183|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64494200|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494201|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494202|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494203|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494204|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64494250|NCT03683524|Cobicistat|cobicistat|mesh-list
64494251|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64494252|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64494253|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64494254|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494255|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494256|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64494257|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64494258|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
64494310|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64494311|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64603820|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64603821|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64603822|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603823|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603824|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603826|NCT02394951|Analgesics|analgesics|mesh-ancestor
64603827|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
64603828|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603829|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603830|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
64603831|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64603832|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64603834|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64494313|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494316|NCT01163656|Trace Elements|trace elements|mesh-ancestor
64494317|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
64494366|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494367|NCT01171690|Teriparatide|teriparatide|mesh-list
64494368|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64494369|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494370|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64494371|NCT05396742|Ravulizumab|ravulizumab|mesh-list
64494372|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64494373|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64494426|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64494427|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64494473|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64603844|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64603846|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64494474|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494475|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494476|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
64494486|NCT05376228|Vancomycin|vancomycin|mesh-list
64494511|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64494512|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494513|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
64603902|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
64603903|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603907|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
64494515|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494516|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494517|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64494518|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
64494519|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
64494520|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
64494521|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64494522|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64494523|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64494524|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64494525|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
64494526|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64494527|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64603969|NCT00791219|Itraconazole|itraconazole|mesh-list
64603970|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64603971|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
64603972|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603973|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64494528|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
64494529|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494530|NCT01175980|Vorinostat|vorinostat|mesh-list
64494533|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494553|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494554|NCT01922817|Saxagliptin|saxagliptin|mesh-list
64494555|NCT01922817|Incretins|incretins|mesh-ancestor
64494556|NCT01922817|Hormones|hormones|mesh-ancestor
64494557|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296731|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64296733|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
64296734|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296735|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64296736|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296737|NCT03300609|Antidotes|antidotes|mesh-ancestor
64296738|NCT03300609|Protective Agents|protective agents|mesh-ancestor
64296739|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
64296740|NCT03300609|Vitamins|vitamins|mesh-ancestor
64296741|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
64296742|NCT03300609|Hematinics|hematinics|mesh-ancestor
64494558|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604025|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64494559|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64494561|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494562|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604026|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64604027|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
64604028|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604029|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604035|NCT05416073|Esketamine|esketamine|mesh-list
64494563|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64494564|NCT04397289|Heparin|heparin|mesh-list
64494565|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
64494566|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
64494567|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64494568|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64494569|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494570|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64494571|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
64494572|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64494573|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
64494574|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494575|NCT00634179|Prednisone|prednisone|mesh-list
64494576|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
64494577|NCT00634179|Rituximab|rituximab|mesh-list
64494595|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64494596|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
64494597|NCT00634179|Hormones|hormones|mesh-ancestor
64494598|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64494599|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64494600|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64494601|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
64494602|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
64494603|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
64494604|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
64494605|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
64494606|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494607|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64494644|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64494646|NCT01181674|Insulin|insulin|mesh-list
64494647|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64494648|NCT01181674|Metformin|metformin|mesh-list
64494649|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
64604138|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296743|NCT00583778|Ipratropium|ipratropium|mesh-list
64296744|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64296745|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
64296746|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604140|NCT03835013|Exenatide|exenatide|mesh-list
64296747|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296748|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64296749|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
64296750|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64296751|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
64296752|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296753|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494659|NCT01183312|Antidotes|antidotes|mesh-ancestor
64494704|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
64494705|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
64494706|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64494707|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64494708|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494709|NCT01185028|Interferons|interferons|mesh-list
64494711|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
64494712|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494713|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
64494714|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64494715|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
64494716|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494717|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64494718|NCT05282706|Peppermint oil|peppermint oil|mesh-list
64494719|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
64494720|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
64494721|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494722|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494723|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494725|NCT02187016|Listerine|listerine|mesh-list
64494759|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64494760|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64494761|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494762|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
64494763|NCT02188576|Coagulants|coagulants|mesh-ancestor
64494764|NCT02189122|Aspirin|aspirin|mesh-list
64494766|NCT02189122|Kininogens|kininogens|mesh-list
64322256|NCT02226601|Aprepitant|aprepitant|mesh-list
64323341|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604188|NCT03973229|Hormones|hormones|mesh-ancestor
64604189|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604190|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604191|NCT03782103|Ethanol|ethanol|mesh-list
64604192|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
64604193|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64604194|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64604195|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604196|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604197|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604198|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
64604200|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
64323739|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64323740|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64323741|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64323742|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
64323743|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64323744|NCT02578771|Methylene Blue|methylene blue|mesh-list
64323745|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296757|NCT03300531|Hormones|hormones|mesh-ancestor
64328505|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64328506|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604215|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328507|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328508|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
64328509|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64328510|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328511|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64328512|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64328513|NCT03537287|Progesterone|progesterone|mesh-list
64328514|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
64328515|NCT03537287|Progestins|progestins|mesh-ancestor
64328672|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
64328673|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604280|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
64604281|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64328674|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604282|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64604283|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64328675|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328676|NCT02665689|Ranibizumab|ranibizumab|mesh-list
64328677|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64328678|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64328679|NCT02665689|Growth Substances|growth substances|mesh-ancestor
64328680|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328681|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
64328686|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64328687|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328688|NCT00563563|Naltrexone|naltrexone|mesh-list
64328689|NCT00563563|Bupropion|bupropion|mesh-list
64328690|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64328691|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64328692|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328732|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604340|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604341|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64604342|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604343|NCT00803543|Valacyclovir|valacyclovir|mesh-list
64604344|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
64328733|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64328734|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
64328735|NCT02180087|Ketoprofen|ketoprofen|mesh-list
64328736|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64328737|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328738|NCT02180087|Analgesics|analgesics|mesh-ancestor
64328739|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
64296758|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64328740|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296759|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296760|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64296761|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
64296762|NCT02467335|Fostemsavir|fostemsavir|mesh-list
64296763|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64296764|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328741|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604396|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64328743|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64328744|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64328745|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64328746|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328748|NCT02184299|Prednisone|prednisone|mesh-list
64328749|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64328750|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
64328751|NCT02184299|Hormones|hormones|mesh-ancestor
64328887|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64328888|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64328889|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
64328892|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
64328893|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328894|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
64328895|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604397|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604398|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64604399|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604400|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64604401|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604402|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604403|NCT04923113|Antacids|antacids|mesh-ancestor
64604404|NCT02499328|Durvalumab|durvalumab|mesh-list
64604405|NCT02499328|Tremelimumab|tremelimumab|mesh-list
64604406|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604407|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328899|NCT02390817|Neostigmine|neostigmine|mesh-list
64328915|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64328916|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64328917|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
64328918|NCT00537043|Protective Agents|protective agents|mesh-ancestor
64328919|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64328920|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64328921|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64328922|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
64328923|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64328924|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64328925|NCT05041101|Halichondrin B|halichondrin b|mesh-list
64328926|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
64328927|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
64328928|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
64328929|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64328930|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64328931|NCT00387907|Trastuzumab|trastuzumab|mesh-list
64328932|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64328933|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64329369|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64329370|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64329371|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64329372|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
64329373|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64329374|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64329375|NCT02664441|Exenatide|exenatide|mesh-list
64329376|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64329377|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329378|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64329379|NCT02664441|Incretins|incretins|mesh-ancestor
64329380|NCT02664441|Hormones|hormones|mesh-ancestor
64329381|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329382|NCT02191007|Calcitriol|calcitriol|mesh-list
64329383|NCT02191007|Betamethasone|betamethasone|mesh-list
64329384|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
64329385|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64329386|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
64329387|NCT02191007|Calcipotriene|calcipotriene|mesh-list
64604432|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
64329388|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64329389|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64329390|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
64329391|NCT02191007|Hormones|hormones|mesh-ancestor
64329392|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64329393|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64329394|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64329395|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
64329402|NCT02191007|Vitamins|vitamins|mesh-ancestor
64668507|NCT01691690|Analgesics|analgesics|mesh-ancestor
64668508|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
64668509|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64668510|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64668511|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64668512|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668513|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
64668514|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
64668515|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668516|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604469|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
64604470|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668517|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604471|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64604472|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64604473|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64668518|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
64668519|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64668520|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64668521|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
64668522|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668523|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64668524|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
64668525|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64668527|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64668528|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
64668529|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296765|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
64296766|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296767|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64296768|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64296769|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296771|NCT02809820|Carvedilol|carvedilol|mesh-list
64296772|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64668530|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64668531|NCT02283827|Phenytoin|phenytoin|mesh-list
64668532|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
64668533|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64668534|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64668535|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64668536|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668591|NCT00374985|Docetaxel|docetaxel|mesh-list
64668617|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64668619|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64668620|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668621|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
64668622|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
64668623|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
64668624|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668625|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64668626|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
64668627|NCT01921751|Antiviral Agents|antiviral agents|mesh-ancestor
64668628|NCT01921751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668629|NCT01921751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668630|NCT01921751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64668631|NCT01921751|Immunologic Factors|immunologic factors|mesh-ancestor
64668632|NCT01921751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668633|NCT02958345|Vaccines|vaccines|mesh-list
64668634|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
64668635|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668636|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
64668637|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64668638|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
64668639|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668640|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
64668663|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668664|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
64668665|NCT01924169|Lenalidomide|lenalidomide|mesh-list
64668666|NCT01924169|Vaccines|vaccines|mesh-list
64668667|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
64668668|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668669|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64668670|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64668671|NCT01924169|Growth Substances|growth substances|mesh-ancestor
64668672|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
64668673|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668674|NCT02958969|Apixaban|apixaban|mesh-list
64668675|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64668758|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64668760|NCT01926977|Ranibizumab|ranibizumab|mesh-list
64668761|NCT01926977|Aflibercept|aflibercept|mesh-list
64668762|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64668763|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64668764|NCT01926977|Growth Substances|growth substances|mesh-ancestor
64668765|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668766|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
64668767|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604706|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604707|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64604708|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64604709|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
64668768|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
64668769|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
64668770|NCT01928693|Besifloxacin|besifloxacin|mesh-list
64668771|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64668772|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64668773|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64668774|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668775|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668776|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64668777|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64668778|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668779|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668780|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296775|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
64296776|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
64668781|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64668782|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
64668783|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64668788|NCT01928849|Valproic Acid|valproic acid|mesh-list
64668794|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668795|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
64668796|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64668797|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668798|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668800|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64668801|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668802|NCT01944293|Midazolam|midazolam|mesh-list
64668803|NCT01944293|Ketamine|ketamine|mesh-list
64668804|NCT01944293|Analgesics|analgesics|mesh-ancestor
64604798|NCT03839537|Protective Agents|protective agents|mesh-ancestor
64604799|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
64668805|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
64668806|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668807|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668808|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64668809|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64668810|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
64668812|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668813|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64668814|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64668815|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604800|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
64604801|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64668816|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668822|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
64668853|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668854|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64296783|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296784|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
64668909|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64296786|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64296787|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604859|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
64668910|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668911|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64668999|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
64669000|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669001|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669003|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669004|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64669005|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604927|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604931|NCT00821951|Vorinostat|vorinostat|mesh-list
64669006|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604996|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64604997|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64669008|NCT04903470|Cathartics|cathartics|mesh-ancestor
64669009|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669010|NCT04903470|Laxatives|laxatives|mesh-ancestor
64669011|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64669012|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64669013|NCT01647932|Diuretics|diuretics|mesh-ancestor
64669014|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
64669015|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669016|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64669040|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64669042|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669043|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669044|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
64669045|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669046|NCT02389452|Hylan|hylan|mesh-list
64669047|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
64669048|NCT02389452|Protective Agents|protective agents|mesh-ancestor
64669049|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669050|NCT02365584|Lanreotide|lanreotide|mesh-list
64669051|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669052|NCT02342418|Tedizolid|tedizolid|mesh-list
64669053|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
64669054|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64669059|NCT05727449|Anesthetics|anesthetics|mesh-list
64669101|NCT04707027|Aflibercept|aflibercept|mesh-list
64669102|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64669103|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64605058|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669104|NCT04707027|Growth Substances|growth substances|mesh-ancestor
64669105|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669106|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
64669107|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669108|NCT01602068|Dexamethasone|dexamethasone|mesh-list
64669110|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
64669111|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64605118|NCT00862745|Fesoterodine|fesoterodine|mesh-list
64669112|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64669113|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
64669114|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
64669115|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669116|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669117|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669118|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
64669119|NCT01602068|Hormones|hormones|mesh-ancestor
64424497|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64605188|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
64296788|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64296789|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
64296790|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64296791|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64296793|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64296794|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
64296795|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296796|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669120|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64605253|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605254|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605255|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605256|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64605267|NCT00835861|Insulin|insulin|mesh-list
64669121|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64669122|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669123|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
64669124|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64669125|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
64669126|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
64484316|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64669127|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605313|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669128|NCT02978157|Amoxicillin|amoxicillin|mesh-list
64669129|NCT02978157|Levofloxacin|levofloxacin|mesh-list
64669131|NCT02978157|Tetracycline|tetracycline|mesh-list
64669132|NCT02978157|Esomeprazole|esomeprazole|mesh-list
64669133|NCT02978157|Bismuth|bismuth|mesh-list
64669134|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64669135|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669136|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64669137|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669204|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669206|NCT01602692|Epinephrine|epinephrine|mesh-list
64669207|NCT01602692|Racepinephrine|racepinephrine|mesh-list
64669208|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64669209|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
64669252|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
64669253|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669254|NCT01706666|Dexamethasone|dexamethasone|mesh-list
64669255|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
64669256|NCT01706666|Lenalidomide|lenalidomide|mesh-list
64669257|NCT01706666|Bortezomib|bortezomib|mesh-list
64669258|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669259|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
64669260|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669261|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64669262|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64669263|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
64669264|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669265|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669290|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669291|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64605379|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605380|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64669293|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669294|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669295|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
64669296|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
64669297|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
64605717|NCT02456857|Bevacizumab|bevacizumab|mesh-list
64605871|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605943|NCT00338377|Analgesics|analgesics|mesh-ancestor
64669298|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
64669299|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
64669300|NCT05400993|Docetaxel|docetaxel|mesh-list
64669301|NCT05400993|Epirubicin|epirubicin|mesh-list
64606177|NCT05311813|Enoxaparin|enoxaparin|mesh-list
64669302|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669303|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
64669304|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669305|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64669306|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64669307|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
64669311|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64669330|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64296799|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64296800|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296801|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296802|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
64296803|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64606628|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64296804|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64296805|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
64669331|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64669332|NCT02288273|Exenatide|exenatide|mesh-list
64669333|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64669335|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64669336|NCT02288273|Incretins|incretins|mesh-ancestor
64669337|NCT02288273|Hormones|hormones|mesh-ancestor
64669338|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669339|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64669340|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
64669341|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669342|NCT01606124|Protective Agents|protective agents|mesh-ancestor
64606696|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64669343|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669344|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64669345|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64669346|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669347|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64669348|NCT01607450|Glucagon|glucagon|mesh-list
64669388|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
64669389|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64669390|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
64669391|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64669392|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
64669393|NCT01640834|Glucagon|glucagon|mesh-list
64669394|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669395|NCT01640834|Hormones|hormones|mesh-ancestor
64669396|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669397|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669398|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
64669399|NCT03029273|Fludarabine|fludarabine|mesh-list
64669400|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669401|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
64669402|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669403|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64669404|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64669405|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
64669406|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669407|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606755|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606756|NCT03219853|Protective Agents|protective agents|mesh-ancestor
64606757|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606758|NCT03219853|Trace Elements|trace elements|mesh-ancestor
64606771|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
64606772|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606773|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64606774|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606775|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606776|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
64606777|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606778|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
64606779|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606781|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
64606782|NCT03215797|Norepinephrine|norepinephrine|mesh-list
64669408|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64669409|NCT05316935|Letrozole|letrozole|mesh-list
64669430|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
64669431|NCT05738759|Anesthetics|anesthetics|mesh-list
64669432|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669433|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669434|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
64669435|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64669436|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
64669437|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669438|NCT05738681|Expectorants|expectorants|mesh-ancestor
64296809|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64296810|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296811|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64296813|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64296815|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296816|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
64296817|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606813|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606814|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606815|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606816|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606817|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606818|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64606819|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
64606821|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64606822|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606823|NCT01834885|Fluticasone|fluticasone|mesh-list
64606824|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64296818|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64296819|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296821|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
64296822|NCT02786498|Vitamins|vitamins|mesh-ancestor
64669439|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
64669440|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64669441|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
64669442|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669443|NCT05738681|Protective Agents|protective agents|mesh-ancestor
64669444|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669445|NCT05738681|Antidotes|antidotes|mesh-ancestor
64669446|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64669447|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
64669448|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669449|NCT02288819|Diuretics|diuretics|mesh-list
64669450|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64669451|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
64669452|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669453|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669477|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64669478|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
64669479|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606861|NCT04380103|Irinotecan|irinotecan|mesh-list
64669480|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
64669481|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64669482|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
64669483|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
64606862|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606863|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606866|NCT04380103|Growth Substances|growth substances|mesh-ancestor
64606867|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606868|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
64606869|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64606870|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
64606871|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606872|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64606873|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64606874|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606875|NCT01954966|Progesterone|progesterone|mesh-list
64606876|NCT01954966|Progestins|progestins|mesh-ancestor
64606877|NCT01954966|Hormones|hormones|mesh-ancestor
64606878|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64606879|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606880|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64606881|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64606882|NCT03836599|Allopurinol|allopurinol|mesh-list
64606883|NCT03836599|Verinurad|verinurad|mesh-list
64606884|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
64606885|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669485|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
64669486|NCT05710874|Protective Agents|protective agents|mesh-ancestor
64669487|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669488|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
64669489|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64669490|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64669491|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
64669543|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669544|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64669545|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64669546|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669547|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64669548|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64669549|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
64669550|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64669551|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669552|NCT02986685|Rabeprazole|rabeprazole|mesh-list
64669553|NCT02986685|Trimebutine|trimebutine|mesh-list
64669554|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606887|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
64606888|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606889|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64606890|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
64606891|NCT03836599|Protective Agents|protective agents|mesh-ancestor
64606892|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606893|NCT01839097|Prednisone|prednisone|mesh-list
64606894|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
64606895|NCT01839097|Doxorubicin|doxorubicin|mesh-list
64606896|NCT01839097|Vincristine|vincristine|mesh-list
64606897|NCT01839097|Belinostat|belinostat|mesh-list
64606898|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606899|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
64606900|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606901|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606902|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64669555|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669556|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64669557|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669558|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64669559|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
64669560|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
64669561|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669562|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669564|NCT05227001|Menthol|menthol|mesh-list
64669565|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64669566|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669567|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
64669568|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
64669569|NCT01610570|Plicamycin|plicamycin|mesh-list
64669570|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64484318|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669571|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669572|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64669584|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64669585|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64669586|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64669587|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
64669588|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
64669589|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
64669590|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
64669591|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606930|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64606931|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
64606932|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606933|NCT01839253|Atenolol|atenolol|mesh-list
64606934|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64606935|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64606936|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64606937|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
64606938|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
64606939|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606940|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669592|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669593|NCT01611662|Gemcitabine|gemcitabine|mesh-list
64669594|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669595|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64669596|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
64669597|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669598|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
64669599|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669600|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669601|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669602|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
64669603|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669604|NCT05200481|Carboplatin|carboplatin|mesh-list
64669605|NCT05200481|Pemetrexed|pemetrexed|mesh-list
64669606|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669607|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424498|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64669608|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669609|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64669610|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64669611|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64669612|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64669613|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64669614|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64669615|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64669687|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64669688|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
64606987|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
64606988|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606989|NCT04380025|Protective Agents|protective agents|mesh-ancestor
64606990|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64606991|NCT01836679|Paclitaxel|paclitaxel|mesh-list
64606992|NCT01836679|Carboplatin|carboplatin|mesh-list
64606993|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64606994|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606995|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606996|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606997|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606998|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606999|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64607000|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
64607001|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607002|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64607003|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
64607004|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607010|NCT00369538|Losartan|losartan|mesh-list
64669689|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669690|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669691|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64669740|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64669741|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669742|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
64669743|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
64669744|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
64669745|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669746|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64669747|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64669748|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669749|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64669750|NCT01658228|Donepezil|donepezil|mesh-list
64669751|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64669752|NCT01658228|Citalopram|citalopram|mesh-list
64669753|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64669754|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669755|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669756|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
64669757|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669795|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64669796|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64669797|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64607016|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607017|NCT00369538|Diuretics|diuretics|mesh-ancestor
64607018|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
64607019|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607020|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64607021|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64607022|NCT05177848|Nicotine|nicotine|mesh-list
64607023|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64607024|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
64607025|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607026|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607027|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64607028|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64607029|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
64607030|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607031|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607032|NCT02489734|Sevoflurane|sevoflurane|mesh-list
64607033|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64607034|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64607035|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
64607036|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
64607037|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607038|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607039|NCT02490670|Cephalexin|cephalexin|mesh-list
64669798|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64669799|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64669800|NCT02249702|Gemcitabine|gemcitabine|mesh-list
64669801|NCT02249702|Docetaxel|docetaxel|mesh-list
64669802|NCT02249702|Trabectedin|trabectedin|mesh-list
64669803|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64669804|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
64669805|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669806|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669807|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
64669808|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669809|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669810|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669811|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
64669812|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669813|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
64669814|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
64669815|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
64669816|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64669817|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
64669819|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64669820|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64669822|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
64607040|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607041|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607042|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
64607043|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607044|NCT05451472|Calcium|calcium|mesh-list
64607045|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
64607046|NCT05451472|Hormones|hormones|mesh-list
64607047|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64607048|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607049|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669848|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64669849|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
64607050|NCT03218059|Methotrexate|methotrexate|mesh-list
64669850|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669851|NCT02683265|Methylphenidate|methylphenidate|mesh-list
64669852|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64669853|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669854|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64669855|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64669856|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64669857|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669858|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
64669859|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64669860|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
64669861|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
64669862|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
64669863|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64669864|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607079|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
64607080|NCT02494102|Modafinil|modafinil|mesh-list
64607081|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64607082|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607083|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64607084|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64607085|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64607086|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607087|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
64296824|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296825|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64296826|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64296827|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64296828|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64296829|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296830|NCT02597660|Hormones|hormones|mesh-list
64296831|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296832|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296833|NCT02419664|Edotreotide|edotreotide|mesh-list
64296834|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64296835|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296836|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
64296837|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64296838|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296839|NCT04435574|Lactoferrin|lactoferrin|mesh-list
64296840|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296841|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
64296842|NCT03104426|Hematinics|hematinics|mesh-ancestor
64296843|NCT02163356|Ketoconazole|ketoconazole|mesh-list
64296844|NCT02163356|Vincristine|vincristine|mesh-list
64296845|NCT02163356|Fenretinide|fenretinide|mesh-list
64607127|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64607128|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
64607129|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
64607130|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64607131|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64607132|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64607133|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64607134|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
64607135|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
64607136|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607137|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607138|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
64607139|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
64607140|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
64607141|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64607142|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64607143|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64607144|NCT02494336|Ropivacaine|ropivacaine|mesh-list
64607145|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
64607146|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
64296846|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64296847|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296848|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
64669865|NCT02988843|Bevacizumab|bevacizumab|mesh-list
64669866|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64669867|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64669868|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64669886|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669887|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669888|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64669890|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64669891|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64669892|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669893|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669894|NCT02992028|Vitamins|vitamins|mesh-list
64669895|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
64669896|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669897|NCT03165981|Vaccines|vaccines|mesh-list
64669898|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64669899|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
64669900|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669904|NCT03170661|Rocuronium|rocuronium|mesh-list
64607162|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
64607163|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607164|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607165|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
64607166|NCT02495038|Rocuronium|rocuronium|mesh-list
64607167|NCT02495038|Atracurium|atracurium|mesh-list
64607168|NCT02495038|Cisatracurium|cisatracurium|mesh-list
64607169|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64607170|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64607171|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64607172|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607173|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669924|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64669925|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
64669926|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669927|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
64669928|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
64669929|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64669930|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64669931|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669932|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669933|NCT00375297|Urological Agents|urological agents|mesh-ancestor
64669934|NCT02234570|Oxfendazole|oxfendazole|mesh-list
64669935|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
64669936|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64669937|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64669938|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
64669939|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64669940|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
64607204|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607205|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607206|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64607207|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
64607208|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
64607209|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64607210|NCT01720615|Narcotics|narcotics|mesh-ancestor
64607211|NCT01720615|Analgesics|analgesics|mesh-ancestor
64607212|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
64607213|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669941|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669942|NCT02240030|Levodopa|levodopa|mesh-list
64669943|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64669944|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64669945|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
64669949|NCT05183828|Letrozole|letrozole|mesh-list
64669975|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
64607253|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424499|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
64669976|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64669977|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64669978|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64669979|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64669980|NCT04316871|Morphine|morphine|mesh-list
64607254|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
64607255|NCT04937452|Rotigotine|rotigotine|mesh-list
64607256|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
64607257|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
64607258|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607259|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607260|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607261|NCT01838707|Fentanyl|fentanyl|mesh-list
64607262|NCT01838707|Morphine|morphine|mesh-list
64669981|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64669982|NCT04316871|Narcotics|narcotics|mesh-ancestor
64669983|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64669984|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669985|NCT04316871|Analgesics|analgesics|mesh-ancestor
64669986|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
64669987|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64669988|NCT05364567|Vitamin D|vitamin d|mesh-list
64669989|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
64669990|NCT05364567|Vitamins|vitamins|mesh-ancestor
64669991|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
64607305|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64669992|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64669993|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64669994|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64669995|NCT00375765|Dutasteride|dutasteride|mesh-list
64607306|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
64607307|NCT02506660|Hormones|hormones|mesh-ancestor
64607308|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607309|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64607310|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607311|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
64670027|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
64670028|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64670029|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64670030|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670031|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670032|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64670033|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64670034|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
64670035|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670036|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64670037|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64670038|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64670039|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64670040|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64670041|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
64670042|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64670043|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670044|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64670045|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64670047|NCT03282669|Hydromorphone|hydromorphone|mesh-list
64670048|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64670049|NCT03282669|Narcotics|narcotics|mesh-ancestor
64670050|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670051|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670052|NCT03282669|Analgesics|analgesics|mesh-ancestor
64670053|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
64670054|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670055|NCT00375843|Citalopram|citalopram|mesh-list
64607356|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64607357|NCT01726465|Prednisolone|prednisolone|mesh-list
64607358|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
64607359|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64607360|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
64607361|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64607362|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607363|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
64670056|NCT00375843|Sertraline|sertraline|mesh-list
64670057|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64670058|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64670059|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64670060|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670196|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64670197|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
64670198|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64670246|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64670248|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
64670249|NCT03186261|Protective Agents|protective agents|mesh-ancestor
64670250|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670251|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64607398|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607399|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64607400|NCT00912301|Cathartics|cathartics|mesh-ancestor
64607401|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64607402|NCT04850638|Furosemide|furosemide|mesh-list
64607403|NCT04850638|Diuretics|diuretics|mesh-ancestor
64607404|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
64607406|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64607407|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64607408|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607409|NCT05326776|Oxytocin|oxytocin|mesh-list
64607410|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
64607411|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64670252|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296850|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
64296851|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296852|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
64670253|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
64670254|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
64670255|NCT02589353|Acarbose|acarbose|mesh-list
64670351|NCT03194373|Carboplatin|carboplatin|mesh-list
64670352|NCT03194373|Palbociclib|palbociclib|mesh-list
64670353|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670354|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64670355|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670356|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670357|NCT05066061|Analgesics|analgesics|mesh-list
64670358|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
64670359|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
64670360|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670414|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670416|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
64670417|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64670418|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64670419|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
64607448|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64607449|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
64607450|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607451|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607452|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64607453|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64607454|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
64607455|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
64607456|NCT04307238|Anesthetics|anesthetics|mesh-list
64670420|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670421|NCT04960215|Ubiquinone|ubiquinone|mesh-list
64670422|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
64670423|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
64670424|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670425|NCT04960215|Vitamins|vitamins|mesh-ancestor
64670426|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64607494|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64670427|NCT02333045|Maraviroc|maraviroc|mesh-list
64670430|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670533|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64670534|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64670535|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670536|NCT02175173|Rufinamide|rufinamide|mesh-list
64670537|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
64670538|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64607495|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
64607496|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607497|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607498|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64607499|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64607500|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64607501|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607502|NCT00363844|Incretins|incretins|mesh-ancestor
64670539|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64607503|NCT00363844|Hormones|hormones|mesh-ancestor
64670540|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64670541|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670542|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
64670543|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64670585|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
64670586|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
64670587|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670588|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64670589|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64670590|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670591|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607541|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64607542|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64607543|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64607544|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64607545|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64607546|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
64607547|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64607548|NCT05532072|Sirolimus|sirolimus|mesh-list
64607549|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
64607552|NCT05532072|Prednisolone|prednisolone|mesh-list
64670592|NCT04501523|Capecitabine|capecitabine|mesh-list
64670593|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64670594|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
64670595|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670642|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670643|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670644|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64670645|NCT01769027|Azithromycin|azithromycin|mesh-list
64670646|NCT01769027|Penicillins|penicillins|mesh-list
64670648|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64670649|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64670650|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
64670651|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64670652|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64670653|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64670654|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64670655|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670656|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670658|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670659|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
64670660|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
64670661|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64670662|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670663|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64670664|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670665|NCT04706949|Carboplatin|carboplatin|mesh-list
64670666|NCT04706949|Pemetrexed|pemetrexed|mesh-list
64670691|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64670692|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64670693|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
64670694|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64670695|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
64670696|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
64670697|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
64670698|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64670699|NCT03296163|Paclitaxel|paclitaxel|mesh-list
64670700|NCT03296163|Bevacizumab|bevacizumab|mesh-list
64670701|NCT03296163|Carboplatin|carboplatin|mesh-list
64670702|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64670703|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670704|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64670705|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64670706|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
64670707|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670708|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64670709|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64670710|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64670711|NCT03296163|Growth Substances|growth substances|mesh-ancestor
64670712|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670713|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
64670714|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
64670715|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
64670716|NCT00376155|Amodiaquine|amodiaquine|mesh-list
64670748|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64670749|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64670750|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
64670805|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607633|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607634|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64607635|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607636|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
64607637|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607638|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
64607639|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607640|NCT02426658|Pemetrexed|pemetrexed|mesh-list
64607641|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607642|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607643|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607644|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64607645|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64607647|NCT02311920|Ipilimumab|ipilimumab|mesh-list
64607648|NCT02311920|Temozolomide|temozolomide|mesh-list
64607649|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64607650|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607651|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64670807|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
64670808|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64670809|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670810|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64670811|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
64670812|NCT03232749|Hormones|hormones|mesh-ancestor
64670813|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64670814|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64670864|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670865|NCT01688336|Antidotes|antidotes|mesh-ancestor
64670866|NCT01688336|Protective Agents|protective agents|mesh-ancestor
64670867|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670868|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
64670869|NCT01688336|Vitamins|vitamins|mesh-ancestor
64670870|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
64670871|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
64607670|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607671|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607672|NCT00867659|Cetrorelix|cetrorelix|mesh-list
64670872|NCT01963481|Exemestane|exemestane|mesh-list
64607673|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64670873|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64670874|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
64607674|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
64607675|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64607676|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607677|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
64607678|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607679|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
64607680|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64607681|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64607682|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607683|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
64607684|NCT04560010|Coagulants|coagulants|mesh-ancestor
64607685|NCT05531058|Vaccines|vaccines|mesh-list
64670875|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607686|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
64670876|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64670877|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64670878|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
64670879|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670880|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64670909|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64670910|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64670911|NCT03449433|Insulin|insulin|mesh-list
64670912|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64670913|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
64670914|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
64670915|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64670916|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
64670917|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64670918|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670919|NCT03241485|Morphine|morphine|mesh-list
64670920|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64670921|NCT03241485|Narcotics|narcotics|mesh-ancestor
64670922|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64670923|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64670924|NCT03241485|Analgesics|analgesics|mesh-ancestor
64670925|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
64607708|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64607709|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607711|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64607712|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64607713|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64607714|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
64607715|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607716|NCT00829049|Adapalene|adapalene|mesh-list
64607717|NCT00829049|Tazarotene|tazarotene|mesh-list
64607718|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64607719|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64607720|NCT00829049|Analgesics|analgesics|mesh-ancestor
64607728|NCT02859064|Lanreotide|lanreotide|mesh-list
64670926|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671012|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64671013|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64671014|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64671015|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64671016|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64671017|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64671018|NCT01999985|Dasatinib|dasatinib|mesh-list
64671019|NCT01999985|Afatinib|afatinib|mesh-list
64671020|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671021|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64671022|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671023|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671024|NCT01968317|Metformin|metformin|mesh-list
64671025|NCT01968317|Megestrol|megestrol|mesh-list
64671026|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
64671027|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64671028|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671029|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64671030|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64671031|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64671032|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
64671033|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64607750|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64607751|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607752|NCT00869141|Timolol|timolol|mesh-list
64607753|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64607754|NCT00869141|Dorzolamide|dorzolamide|mesh-list
64607755|NCT00869141|Brinzolamide|brinzolamide|mesh-list
64607756|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64607757|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64607758|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
64607759|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607760|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607761|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607762|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64607763|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64607776|NCT04260022|Blinatumomab|blinatumomab|mesh-list
64671034|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64671035|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64671036|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671037|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671038|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
64671039|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64671040|NCT01971593|Eplerenone|eplerenone|mesh-list
64671041|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64671042|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
64671043|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671046|NCT01971593|Diuretics|diuretics|mesh-ancestor
64671052|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671053|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
64671054|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
64671055|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671056|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671057|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671058|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
64607788|NCT04077424|Vaccines|vaccines|mesh-list
64671059|NCT02986451|Hormones|hormones|mesh-ancestor
64671060|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671061|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671062|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671063|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
64671064|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64671065|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64671066|NCT02986451|Growth Substances|growth substances|mesh-ancestor
64671067|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
64607789|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
64607790|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
64607791|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607792|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
64607793|NCT01727869|Cetuximab|cetuximab|mesh-list
64607794|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64607795|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64671068|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64671069|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671070|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64671071|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671110|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
64671111|NCT02007863|Fludarabine|fludarabine|mesh-list
64671112|NCT02007863|Melphalan|melphalan|mesh-list
64671113|NCT02007863|Busulfan|busulfan|mesh-list
64671114|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671115|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671116|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64671117|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
64671118|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671119|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64671120|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
64671121|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64671122|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64671123|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607828|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607829|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607830|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64607831|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607832|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607833|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
64607834|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64607835|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
64607836|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607837|NCT01728571|Vitamin D|vitamin d|mesh-list
64607838|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
64607839|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
64607840|NCT01728571|Vitamins|vitamins|mesh-list
64607841|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
64671124|NCT02305277|Opicapone|opicapone|mesh-list
64607842|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671194|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671195|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671197|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64671198|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
64671199|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671200|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671201|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
64671202|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64671203|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
64671204|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671206|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64671208|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64671209|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671210|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671211|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671212|NCT03482973|Bupivacaine|bupivacaine|mesh-list
64671213|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
64671214|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
64671215|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64671216|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671217|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
64671218|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671245|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64671246|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671247|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671248|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671249|NCT02057939|Hormones|hormones|mesh-ancestor
64671250|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671251|NCT03496467|Nepafenac|nepafenac|mesh-list
64607870|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607871|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
64607872|NCT03408145|Protective Agents|protective agents|mesh-ancestor
64607873|NCT02475772|Cisplatin|cisplatin|mesh-list
64607874|NCT02475772|Doxorubicin|doxorubicin|mesh-list
64607875|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64607876|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607877|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64607878|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64607879|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64607880|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607881|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607882|NCT00915655|Ritonavir|ritonavir|mesh-list
64671252|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64671253|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64671254|NCT03496467|Analgesics|analgesics|mesh-ancestor
64671255|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
64671256|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671257|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671258|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671259|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296858|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
64671260|NCT00482690|Nicotine|nicotine|mesh-list
64671261|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64671262|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
64671263|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671264|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671265|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64671266|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64671267|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
64671268|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671269|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607902|NCT03835507|Hematinics|hematinics|mesh-ancestor
64607903|NCT05524974|Paclitaxel|paclitaxel|mesh-list
64607904|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
64607905|NCT05524974|Apatinib|apatinib|mesh-list
64607906|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64607907|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607908|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
64607909|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
64607910|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
64607911|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607912|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607913|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607914|NCT00870467|Adalimumab|adalimumab|mesh-list
64607915|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607916|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607917|NCT00370318|Acetaminophen|acetaminophen|mesh-list
64607918|NCT00370318|Vaccines|vaccines|mesh-list
64607919|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64607920|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
64671270|NCT02058251|Oxytocin|oxytocin|mesh-list
64607921|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671271|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
64671293|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671295|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64671356|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
64671357|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
64671358|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671359|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671360|NCT01713608|Artefenomel|artefenomel|mesh-list
64671361|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
64296859|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296860|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296861|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64296862|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64296863|NCT02163356|Protective Agents|protective agents|mesh-ancestor
64296865|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
64296866|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
64671362|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64671363|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64671364|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671365|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64671366|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671367|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671368|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671369|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
64671370|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64607939|NCT00872027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64607940|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64607941|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64607942|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607943|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607944|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
64607945|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607946|NCT00872027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64607947|NCT00872027|Antidepressive Agents|antidepressive agents|mesh-ancestor
64607948|NCT00872027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64607949|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
64607950|NCT01854814|Losartan|losartan|mesh-list
64607951|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64607952|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607953|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64607954|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
64607955|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607956|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607957|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607958|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671371|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671372|NCT02018627|Glucagon|glucagon|mesh-list
64671373|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64671374|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64671375|NCT02018627|Hormones|hormones|mesh-ancestor
64671376|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64671377|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671378|NCT02018627|Incretins|incretins|mesh-ancestor
64671379|NCT03476330|Quercetin|quercetin|mesh-list
64671380|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
64671381|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671382|NCT03476330|Protective Agents|protective agents|mesh-ancestor
64671383|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671384|NCT04413344|Bromocriptine|bromocriptine|mesh-list
64671385|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64671386|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64671387|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
64671397|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64671398|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671399|NCT01717898|Prednisone|prednisone|mesh-list
64671400|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
64671401|NCT01717898|Dactolisib|dactolisib|mesh-list
64671402|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64671403|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
64671404|NCT01717898|Hormones|hormones|mesh-ancestor
64671405|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607967|NCT02576652|Demeclocycline|demeclocycline|mesh-list
64671406|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607968|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607969|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607970|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64607971|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607972|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607973|NCT01743742|Vitamins|vitamins|mesh-list
64607974|NCT01743742|Vitamin E|vitamin e|mesh-list
64607975|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
64607976|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671407|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64671408|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671409|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64671410|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671411|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671414|NCT01737944|Methotrexate|methotrexate|mesh-list
64671448|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671449|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64671451|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671452|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
64671453|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64671454|NCT01741454|Tamsulosin|tamsulosin|mesh-list
64671455|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64671456|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64671457|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64671458|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64671459|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
64671460|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671461|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671462|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671463|NCT01741454|Urological Agents|urological agents|mesh-ancestor
64671464|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64296867|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64296868|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
64296869|NCT02021006|Cefixime|cefixime|mesh-list
64671506|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671507|NCT02024477|Saxagliptin|saxagliptin|mesh-list
64671508|NCT02024477|Incretins|incretins|mesh-ancestor
64671510|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608006|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64608007|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64608008|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
64608009|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608010|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
64608011|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64608016|NCT01729663|Interferons|interferons|mesh-list
64671511|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671512|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64671513|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
64671514|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671515|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671516|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64671517|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
64671518|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64671519|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
64671520|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671521|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
64671522|NCT02024711|Protective Agents|protective agents|mesh-ancestor
64671523|NCT02071823|Opicapone|opicapone|mesh-list
64671524|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64671525|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671526|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608045|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
64608046|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64608047|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64608048|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608049|NCT05529888|Isotretinoin|isotretinoin|mesh-list
64608050|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
64608051|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
64608052|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608053|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608054|NCT05518578|Huperzine A|huperzine a|mesh-list
64608055|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64608056|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608057|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608058|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
64608059|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608060|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608061|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64608066|NCT04196530|Atezolizumab|atezolizumab|mesh-list
64671527|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64671528|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64671529|NCT02029703|Hylan|hylan|mesh-list
64671530|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
64671531|NCT02029703|Protective Agents|protective agents|mesh-ancestor
64671532|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671533|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64671670|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
64671671|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64671672|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
64671673|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608086|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608087|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608088|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608089|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608090|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64608091|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608092|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608094|NCT04297254|Lenvatinib|lenvatinib|mesh-list
64671674|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671675|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
64671676|NCT01745822|Tenofovir|tenofovir|mesh-list
64671677|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
64671678|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64671680|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64671681|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671682|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671683|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64671684|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64671685|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
64671686|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
64671730|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
64671774|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671775|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671776|NCT01748240|Azacitidine|azacitidine|mesh-list
64671777|NCT01748240|Vorinostat|vorinostat|mesh-list
64671778|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64671779|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
64671780|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671781|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64671782|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64671783|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64671784|NCT01748942|Dexamethasone|dexamethasone|mesh-list
64671785|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
64671786|NCT01748942|Ichthammol|ichthammol|mesh-list
64608144|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
64608145|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
64608146|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608147|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608148|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64608149|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608150|NCT05528718|Analgesics|analgesics|mesh-ancestor
64608151|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
64608152|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608153|NCT03407209|Anesthetics|anesthetics|mesh-list
64608154|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
64608155|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608156|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608157|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
64671787|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64671788|NCT01748942|BB 1101|bb 1101|mesh-list
64671834|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64671835|NCT05718011|Analgesics|analgesics|mesh-ancestor
64671836|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
64671837|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64671838|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64671839|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64671840|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64671841|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608181|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608182|NCT05517330|Afatinib|afatinib|mesh-list
64608183|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608187|NCT05517174|Vaccines|vaccines|mesh-list
64671842|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671843|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671844|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64671845|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64671846|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
64671847|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
64671848|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64671849|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64671850|NCT05717933|Hormones|hormones|mesh-list
64671851|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608244|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608245|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64608246|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
64608247|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608248|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64608249|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
64671852|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671853|NCT01730846|Doxazosin|doxazosin|mesh-list
64671854|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64671855|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64671856|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64671857|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64671858|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
64671859|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671860|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64671861|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671862|NCT02314403|Rituximab|rituximab|mesh-list
64671863|NCT02314403|Abatacept|abatacept|mesh-list
64671864|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64671879|NCT02052635|Clopidogrel|clopidogrel|mesh-list
64671880|NCT02052635|Ticagrelor|ticagrelor|mesh-list
64671881|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64671882|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64671883|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64671884|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64671885|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
64671886|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64671888|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671922|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
64671923|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64671925|NCT01749956|Protective Agents|protective agents|mesh-ancestor
64671926|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
64671927|NCT01749956|Vitamins|vitamins|mesh-ancestor
64671928|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
64671929|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64671930|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64671931|NCT01749956|Growth Substances|growth substances|mesh-ancestor
64671932|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
64672053|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672054|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672055|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64672056|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672057|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
64608304|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608305|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608306|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672058|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672059|NCT02373137|Protective Agents|protective agents|mesh-ancestor
64672060|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64672061|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
64672062|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
64672063|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64608307|NCT03871036|Paclitaxel|paclitaxel|mesh-list
64608308|NCT03871036|Durvalumab|durvalumab|mesh-list
64608309|NCT03871036|Tremelimumab|tremelimumab|mesh-list
64608310|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64608311|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672064|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
64672065|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
64672066|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64672067|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64672068|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64672069|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
64672070|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672071|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672072|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64672105|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64672106|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608335|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64608336|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608337|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64608338|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
64608339|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608340|NCT04996134|Domperidone|domperidone|mesh-list
64608341|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
64608342|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
64296872|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64672107|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672108|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64672109|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64672110|NCT00354731|Protective Agents|protective agents|mesh-ancestor
64672111|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672112|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
64672113|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64296873|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296874|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64672114|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
64296876|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
64296877|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64296878|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64296879|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64296880|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296881|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608391|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
64608392|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
64608393|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608394|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608396|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608397|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64608398|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64608399|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64608401|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608402|NCT02742532|Oxytocin|oxytocin|mesh-list
64608403|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
64608404|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64608405|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608406|NCT05521386|Caffeine|caffeine|mesh-list
64296882|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64296883|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64672116|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
64672117|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
64397488|NCT01970488|Adalimumab|adalimumab|mesh-list
64672167|NCT01763606|Aspirin|aspirin|mesh-list
64672168|NCT01763606|Enoxaparin|enoxaparin|mesh-list
64672169|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64672170|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672171|NCT01763606|Analgesics|analgesics|mesh-ancestor
64672172|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
64672173|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672174|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672175|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672176|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64672177|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64672178|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64672179|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672180|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64672181|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64672182|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672183|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
64608435|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64608436|NCT04984980|Growth Substances|growth substances|mesh-ancestor
64608437|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608438|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
64608439|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64608440|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
64608441|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608442|NCT04984980|Antiviral Agents|antiviral agents|mesh-ancestor
64608443|NCT04984980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608444|NCT04984980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608445|NCT04984980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64608446|NCT04984980|Immunologic Factors|immunologic factors|mesh-ancestor
64608447|NCT00370786|Bevacizumab|bevacizumab|mesh-list
64608448|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608449|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608450|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64608452|NCT00370786|Growth Substances|growth substances|mesh-ancestor
64672184|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
64672185|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
64672186|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64672187|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64672188|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64672223|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
64672224|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672225|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
64672226|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672227|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672228|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64672229|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64672230|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64672231|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672269|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672270|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672271|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64608471|NCT04979832|Sargramostim|sargramostim|mesh-list
64608472|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608473|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608474|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64608475|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64608476|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
64608477|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608478|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608479|NCT05521152|Norepinephrine|norepinephrine|mesh-list
64608480|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64608481|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608482|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608483|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608484|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608485|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608486|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
64608487|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
64672272|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672275|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672276|NCT02386319|Protective Agents|protective agents|mesh-ancestor
64672277|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672278|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672279|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64672280|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
64672414|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672415|NCT01420874|Antidotes|antidotes|mesh-ancestor
64672416|NCT01420874|Protective Agents|protective agents|mesh-ancestor
64672417|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
64608511|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608512|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
64608513|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608514|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64608515|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
64608516|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608517|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64608518|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64608520|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608521|NCT04295850|Aspirin|aspirin|mesh-list
64608522|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64608523|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64672418|NCT01420874|Vitamins|vitamins|mesh-ancestor
64672450|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64672451|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672452|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672453|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672454|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
64672455|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672456|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64672457|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
64672458|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64672459|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64672460|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64672461|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
64672462|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
64672463|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672464|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64672465|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64672466|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
64672467|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64672468|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64296884|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64672503|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672504|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64672505|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64672506|NCT01784666|Isradipine|isradipine|mesh-list
64672507|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64672508|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64672509|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64608563|NCT03323398|Durvalumab|durvalumab|mesh-list
64333961|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
64608564|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608565|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608566|NCT00890981|Denosumab|denosumab|mesh-list
64608567|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64608568|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608569|NCT05515770|Cabotegravir|cabotegravir|mesh-list
64608570|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64608571|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64608572|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64672510|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672512|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672567|NCT04259645|Bupivacaine|bupivacaine|mesh-list
64672568|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
64672569|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
64672570|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672571|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296885|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64296886|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
64296887|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64296888|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
64296889|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
64296890|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672573|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672574|NCT01787006|Fluorouracil|fluorouracil|mesh-list
64672575|NCT01787006|Cetuximab|cetuximab|mesh-list
64672576|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672577|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
64672578|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672579|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64672580|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64672581|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
64672582|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672626|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64608600|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
64608601|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
64608603|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608604|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64608605|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64608606|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64608607|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608608|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64608609|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608610|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608611|NCT05348980|Phenylephrine|phenylephrine|mesh-list
64608612|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
64608613|NCT05348980|Synephrine|synephrine|mesh-list
64608614|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64608615|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
64608616|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
64608617|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608618|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608619|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
64672627|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672628|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672629|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64672630|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
64672631|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672632|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64672633|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
64672634|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64672635|NCT00357149|Cisplatin|cisplatin|mesh-list
64672636|NCT00357149|Docetaxel|docetaxel|mesh-list
64672637|NCT00357149|Fluorouracil|fluorouracil|mesh-list
64608632|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608633|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608634|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64334045|NCT02360007|Buprenorphine|buprenorphine|mesh-list
64608635|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
64608636|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672638|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64672639|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
64672640|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
64672641|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
64672642|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672643|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
64672644|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64672645|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64672646|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
64672647|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672648|NCT04903652|Vinorelbine|vinorelbine|mesh-list
64672655|NCT04071821|Cetirizine|cetirizine|mesh-list
64672676|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608688|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64608689|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
64608690|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
64608691|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64608692|NCT05310305|Antibodies|antibodies|mesh-list
64608693|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
64608694|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672677|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64672678|NCT01789814|Clopidogrel|clopidogrel|mesh-list
64672679|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64672680|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64672681|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64672682|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64672683|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64672684|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
64672685|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296891|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296892|NCT03867110|Atorvastatin|atorvastatin|mesh-list
64424500|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296893|NCT03867110|Ezetimibe|ezetimibe|mesh-list
64296894|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64296895|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64296896|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
64672686|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608746|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608747|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
64608748|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64608749|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608750|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64608751|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64672687|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672689|NCT00356447|Estrogens|estrogens|mesh-ancestor
64672690|NCT00356447|Hormones|hormones|mesh-ancestor
64672691|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672692|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672693|NCT01736852|Oxytocin|oxytocin|mesh-list
64672694|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
64672695|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64672696|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672697|NCT01810952|Insulin|insulin|mesh-list
64672698|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64672699|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
64672735|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
64672736|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
64672737|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672738|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672739|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
64672784|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64672785|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64672786|NCT03974789|Dexamethasone|dexamethasone|mesh-list
64672787|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672788|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
64672789|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
64608799|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
64608800|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608801|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608802|NCT02973958|Analgesics|analgesics|mesh-ancestor
64608803|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
64608804|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64608805|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608806|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608807|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64608808|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608809|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608810|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64608811|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64608812|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
64608813|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
64608814|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64608815|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64608816|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
64608817|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608818|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608820|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
64672790|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672791|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672792|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64672793|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
64672794|NCT03974789|Hormones|hormones|mesh-ancestor
64672795|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64672820|NCT03883763|Bupivacaine|bupivacaine|mesh-list
64672821|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
64672822|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
64672823|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64672824|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672825|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
64672826|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672827|NCT01798394|Progesterone|progesterone|mesh-list
64672828|NCT01798394|Progestins|progestins|mesh-ancestor
64672831|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672931|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64672932|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64672933|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64608831|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64608832|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64608833|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
64608834|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608835|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64608837|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64608838|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
64608839|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
64608840|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608841|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608842|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
64608843|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608844|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
64608845|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64608846|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
64608847|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608848|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
64608849|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64608851|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64672934|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608852|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64672935|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
64672936|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64672937|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64672997|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64672998|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
64672999|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
64673000|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673001|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673002|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673003|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
64673006|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64673065|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673066|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673067|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
64673068|NCT03595449|Lidocaine|lidocaine|mesh-list
64673069|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
64673070|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
64673071|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673133|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64673134|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
64673135|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
64673136|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
64673137|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673138|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
64673139|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
64673140|NCT03541941|Bupivacaine|bupivacaine|mesh-list
64673141|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
64673142|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
64673143|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673144|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673145|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
64608866|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608867|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64608868|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
64608869|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
64608870|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64608871|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64608873|NCT02760862|Mannitol|mannitol|mesh-list
64673146|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673147|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
64673148|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673149|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64673150|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673151|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673152|NCT03556761|Furosemide|furosemide|mesh-list
64673153|NCT03556761|Diuretics|diuretics|mesh-ancestor
64673154|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
64673155|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673156|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64673157|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64673158|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673159|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
64673160|NCT03559179|Narcotics|narcotics|mesh-ancestor
64673161|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673162|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673163|NCT03559179|Analgesics|analgesics|mesh-ancestor
64673164|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
64673165|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673166|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
64673167|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64673168|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673171|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673182|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64673209|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673210|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64673211|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673212|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673213|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
64673214|NCT02363946|Promethazine|promethazine|mesh-list
64608903|NCT05720559|Hematinics|hematinics|mesh-ancestor
64608904|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
64608905|NCT02761252|Montelukast|montelukast|mesh-list
64608906|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64608907|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
64608908|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64608909|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
64608910|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608911|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608912|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64673215|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64673216|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64673217|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64673218|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673219|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
64673220|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
64673221|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
64673222|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673223|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
64673224|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
64673225|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673226|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64673227|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
64673266|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64673268|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673269|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673270|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64673271|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64673272|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64673273|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64673274|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64673275|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
64673276|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
64673277|NCT01803074|Ritonavir|ritonavir|mesh-list
64673278|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64673279|NCT01803074|Tenofovir|tenofovir|mesh-list
64673280|NCT01803074|Emtricitabine|emtricitabine|mesh-list
64608936|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608937|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64608938|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64608939|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608940|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608941|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608942|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608944|NCT03304379|Diclofenac|diclofenac|mesh-list
64608945|NCT03304379|Fasinumab|fasinumab|mesh-list
64608946|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64673329|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64673330|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64673331|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64673332|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673463|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
64673464|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64673465|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
64673466|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673467|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673468|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
64673469|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64608977|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608978|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64608979|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608980|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64608982|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64608983|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673470|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64673471|NCT01835912|Citric Acid|citric acid|mesh-list
64673472|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
64673473|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
64673474|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64673475|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
64673476|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
64673477|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296898|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64296899|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64296900|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296901|NCT03865082|Nivolumab|nivolumab|mesh-list
64296902|NCT03865082|Ipilimumab|ipilimumab|mesh-list
64673480|NCT05747768|Atorvastatin|atorvastatin|mesh-list
64673499|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
64673500|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64673501|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64609035|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
64609036|NCT01044433|Capecitabine|capecitabine|mesh-list
64609037|NCT01044433|Lapatinib|lapatinib|mesh-list
64609038|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64609039|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
64609040|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609041|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609042|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64609043|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609044|NCT03400969|Glycerol|glycerol|mesh-list
64609045|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64609046|NCT03400969|Protective Agents|protective agents|mesh-ancestor
64609047|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609048|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
64673502|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673503|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
64673504|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64673505|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
64673506|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
64673507|NCT04923776|Carboplatin|carboplatin|mesh-list
64673510|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673511|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64673512|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64673513|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64673514|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673515|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673516|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
64673518|NCT04410159|Povidone|povidone|mesh-list
64673519|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
64609081|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64609082|NCT01042093|Clonidine|clonidine|mesh-list
64609083|NCT01042093|Epinephrine|epinephrine|mesh-list
64609084|NCT01042093|Ropivacaine|ropivacaine|mesh-list
64609085|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
64609086|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
64609087|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609088|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609089|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
64334478|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
64609090|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609091|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64609092|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64609093|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
64673556|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
64673557|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
64673558|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
64673559|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
64673560|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673561|NCT03402243|Menthol|menthol|mesh-list
64673562|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
64673563|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
64673564|NCT01841606|Ondansetron|ondansetron|mesh-list
64673565|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
64673566|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
64673567|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673568|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673569|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673570|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
64296903|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673571|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
64673572|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64673573|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
64673574|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609128|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64609129|NCT01041859|Narcotics|narcotics|mesh-ancestor
64673575|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673576|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64609130|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609131|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609132|NCT01041859|Analgesics|analgesics|mesh-ancestor
64609133|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
64609134|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609135|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64609136|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64609137|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609138|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673577|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64296904|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673579|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64424613|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64296905|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64609169|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64296906|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296907|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64296908|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
64609170|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
64609171|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609172|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
64609173|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
64609174|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
64609175|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609176|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609201|NCT00372658|Lidocaine|lidocaine|mesh-list
64296909|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64296910|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64296911|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673611|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673612|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
64673613|NCT05745974|Coagulants|coagulants|mesh-ancestor
64673614|NCT05745038|Zaleplon|zaleplon|mesh-list
64673615|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
64673616|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64673617|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609226|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64609227|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64609228|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609229|NCT01043029|Pioglitazone|pioglitazone|mesh-list
64609230|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64609231|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673618|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673619|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
64484347|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64484348|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484349|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484350|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
64484351|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64484352|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484353|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484354|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64673693|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673748|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
64673749|NCT00558896|Hormones|hormones|mesh-ancestor
64673750|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64673751|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64673752|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673753|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
64673754|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64673755|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64673756|NCT00558896|Growth Substances|growth substances|mesh-ancestor
64673757|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
64673758|NCT01857362|Nitisinone|nitisinone|mesh-list
64673760|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609288|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609289|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609290|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64609291|NCT02973724|Remifentanil|remifentanil|mesh-list
64609292|NCT02973724|Propofol|propofol|mesh-list
64609293|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
64609294|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609295|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609296|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64609297|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64609298|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
64609299|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64609300|NCT02973724|Narcotics|narcotics|mesh-ancestor
64609301|NCT02973724|Analgesics|analgesics|mesh-ancestor
64609302|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
64609303|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609304|NCT05456542|Dexamethasone|dexamethasone|mesh-list
64609305|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609306|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
64609307|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
64609308|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609309|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673762|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64673773|NCT01859078|Digoxin|digoxin|mesh-list
64673802|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64673803|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
64673804|NCT00558272|Saracatinib|saracatinib|mesh-list
64673805|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64673806|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673807|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673808|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673809|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673810|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
64673811|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64673812|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64673821|NCT03666663|Lidocaine|lidocaine|mesh-list
64673865|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64673866|NCT03415581|Narcotics|narcotics|mesh-ancestor
64673867|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609318|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64609319|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609320|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609321|NCT05455918|Paclitaxel|paclitaxel|mesh-list
64609322|NCT05455918|Ifosfamide|ifosfamide|mesh-list
64609323|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64609324|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609325|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
64609326|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
64609327|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
64609328|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609329|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64609330|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
64296913|NCT03102398|Urological Agents|urological agents|mesh-ancestor
64296914|NCT01187810|Cytarabine|cytarabine|mesh-list
64296915|NCT01187810|Methotrexate|methotrexate|mesh-list
64673868|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296916|NCT01187810|Fenretinide|fenretinide|mesh-list
64296917|NCT01187810|Retinamide|retinamide|mesh-list
64296918|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64296919|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
64296920|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64609365|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64609366|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
64609367|NCT04225078|Loperamide|loperamide|mesh-list
64609368|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
64609369|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64609370|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609371|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64609372|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64609373|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296921|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296922|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64296923|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
64296924|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296925|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296926|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
64296927|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296928|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64296929|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296930|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
64296931|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64673869|NCT03415581|Analgesics|analgesics|mesh-ancestor
64673870|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
64673871|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399231|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64673872|NCT00557492|Gemcitabine|gemcitabine|mesh-list
64673873|NCT00557492|Bevacizumab|bevacizumab|mesh-list
64673874|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64673875|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673876|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64673877|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64673878|NCT00557492|Growth Substances|growth substances|mesh-ancestor
64673879|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609426|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609427|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609428|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609429|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
64609430|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609431|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609432|NCT04033354|Paclitaxel|paclitaxel|mesh-list
64609433|NCT04033354|Carboplatin|carboplatin|mesh-list
64673889|NCT01865708|Ethanol|ethanol|mesh-list
64673923|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673924|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673925|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64673926|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64673927|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
64673928|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64673929|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673931|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64673932|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64673933|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64673934|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673935|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64673936|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64673983|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
64673984|NCT03705273|BB 1101|bb 1101|mesh-list
64673985|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64673986|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
64673987|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
64609471|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64609472|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609473|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
64609474|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609475|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609476|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64609506|NCT00918931|Obatoclax|obatoclax|mesh-list
64673988|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64673989|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64673990|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64674048|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674049|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674050|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64674051|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64674052|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
64674053|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674226|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
64674227|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64674228|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674229|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64674230|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64674231|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
64674232|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674233|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64674235|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
64609521|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609522|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609523|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64609524|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64609525|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609526|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64609527|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64609528|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609529|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
64609547|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609548|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609549|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64609550|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64609551|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
64674296|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674297|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674298|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64674366|NCT00553202|Prednisolone|prednisolone|mesh-list
64674367|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
64674368|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
64674369|NCT00553202|Busulfan|busulfan|mesh-list
64674370|NCT00553202|Methotrexate|methotrexate|mesh-list
64609579|NCT02781454|Mexiletine|mexiletine|mesh-list
64609580|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64674371|NCT00553202|Tacrolimus|tacrolimus|mesh-list
64674372|NCT00553202|Cyclosporins|cyclosporins|mesh-list
64609581|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64609582|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64609583|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609584|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609585|NCT00892697|Ribavirin|ribavirin|mesh-list
64609586|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64609587|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
64674373|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
64674374|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64674375|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64674376|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
64674377|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64674378|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
64674379|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674380|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674382|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
64674497|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64674499|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64674500|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64674501|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674565|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674566|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674568|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64674569|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64674570|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674571|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64609633|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
64609634|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64609635|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609636|NCT03214055|Mannitol|mannitol|mesh-list
64609637|NCT03214055|Diuretics|diuretics|mesh-list
64609638|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64609639|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
64609640|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609641|NCT03405337|Factor VIII|factor viii|mesh-list
64609642|NCT03405337|Coagulants|coagulants|mesh-ancestor
64609643|NCT01831661|Metformin|metformin|mesh-list
64674572|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64609644|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64674574|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
64674603|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
64674604|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64674605|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
64674606|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674607|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674608|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64674609|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
64674610|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
64674611|NCT00551642|Protective Agents|protective agents|mesh-ancestor
64674612|NCT02799212|Somatostatin|somatostatin|mesh-list
64674613|NCT02799212|Hormones|hormones|mesh-ancestor
64674614|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674615|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674616|NCT04690322|Factor VIII|factor viii|mesh-list
64674617|NCT04690322|BAX 855|bax 855|mesh-list
64674618|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64674619|NCT04690322|Coagulants|coagulants|mesh-ancestor
64674620|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
64674621|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609679|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64674622|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
64609680|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
64609681|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609682|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609683|NCT03400267|Acetaminophen|acetaminophen|mesh-list
64609684|NCT03400267|Fentanyl|fentanyl|mesh-list
64609685|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64609686|NCT03400267|Narcotics|narcotics|mesh-ancestor
64609687|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609688|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674623|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
64674624|NCT02648282|Vaccines|vaccines|mesh-list
64674635|NCT04004481|Morphine|morphine|mesh-list
64674646|NCT03997851|Analgesics|analgesics|mesh-ancestor
64296932|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64296934|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296935|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64674647|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
64674648|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296936|NCT01187810|Protective Agents|protective agents|mesh-ancestor
64674649|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674650|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
64674651|NCT03989427|Listerine|listerine|mesh-list
64674652|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
64674653|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
64674654|NCT03989427|Protective Agents|protective agents|mesh-ancestor
64674655|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674656|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64674657|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674658|NCT03007719|Fluorides|fluorides|mesh-list
64674659|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
64609726|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
64674660|NCT03007719|Protective Agents|protective agents|mesh-ancestor
64674661|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674662|NCT02985801|Pancrelipase|pancrelipase|mesh-list
64674696|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64674697|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
64674698|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674699|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64674700|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
64674701|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
64674702|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64674703|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
64674704|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64674705|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64674706|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64674804|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674805|NCT02749617|Apixaban|apixaban|mesh-list
64674806|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64674807|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
64674808|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64674809|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
64609728|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609729|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64609730|NCT03219359|Protective Agents|protective agents|mesh-ancestor
64609731|NCT04380857|Dexamethasone|dexamethasone|mesh-list
64609732|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609733|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
64609734|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
64609735|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609736|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609737|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609738|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
64609739|NCT04380857|Hormones|hormones|mesh-ancestor
64609740|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609741|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64609742|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609743|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64674810|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674811|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674812|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
64674813|NCT02749227|Pasireotide|pasireotide|mesh-list
64674814|NCT02749227|Hormones|hormones|mesh-ancestor
64674815|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64674816|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674817|NCT02746263|Acetaminophen|acetaminophen|mesh-list
64674818|NCT02746263|Morphine|morphine|mesh-list
64674819|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64674820|NCT02746263|Narcotics|narcotics|mesh-ancestor
64674821|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674822|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674823|NCT02746263|Analgesics|analgesics|mesh-ancestor
64674824|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
64674825|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674826|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64674827|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
64674828|NCT01394211|Anastrozole|anastrozole|mesh-list
64674829|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64674830|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674831|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64609744|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609745|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609746|NCT02903446|Denosumab|denosumab|mesh-list
64609747|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64609748|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609750|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64609751|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64609752|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609753|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296951|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64296952|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64296953|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64296954|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
64674832|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64674833|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674835|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64674905|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
64674906|NCT01383447|Entinostat|entinostat|mesh-list
64674907|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64674908|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674909|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64674910|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674911|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674912|NCT02300298|Docetaxel|docetaxel|mesh-list
64674913|NCT02300298|Nintedanib|nintedanib|mesh-list
64674914|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64674915|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
64674916|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
64674941|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64674942|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64674943|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64674944|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674945|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64674946|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64674947|NCT01309581|Ketamine|ketamine|mesh-list
64674948|NCT01309581|Methohexital|methohexital|mesh-list
64674949|NCT01309581|Analgesics|analgesics|mesh-ancestor
64674950|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
64674951|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609788|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64609789|NCT00014911|Tacrolimus|tacrolimus|mesh-list
64609790|NCT00014911|Daclizumab|daclizumab|mesh-list
64609791|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609792|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
64609793|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609794|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64609795|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609796|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609797|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64609798|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609799|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64609800|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609801|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
64609802|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64609803|NCT00014911|Renal Agents|renal agents|mesh-ancestor
64609804|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
64609805|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64609806|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64674952|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674953|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64609807|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64674954|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64674955|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
64674956|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
64674957|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64674958|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64674959|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64674960|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64674961|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674962|NCT05289050|Ketamine|ketamine|mesh-list
64674963|NCT05289050|Esketamine|esketamine|mesh-list
64674978|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64674979|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
64674980|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64674981|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296957|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296958|NCT03308396|Durvalumab|durvalumab|mesh-list
64296959|NCT03308396|Guadecitabine|guadecitabine|mesh-list
64674982|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64609812|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64609813|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64609814|NCT01832675|Bupivacaine|bupivacaine|mesh-list
64609815|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
64674983|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674984|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
64674985|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609816|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
64609817|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609818|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609819|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
64674986|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
64674987|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64674988|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64674989|NCT01885910|Doxycycline|doxycycline|mesh-list
64674990|NCT01885910|Dapsone|dapsone|mesh-list
64674991|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64674992|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64674993|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
64674994|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64674995|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64674996|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64674997|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64674998|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64674999|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
64675000|NCT02658357|Risperidone|risperidone|mesh-list
64675037|NCT01280643|Bevacizumab|bevacizumab|mesh-list
64675038|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64675039|NCT01280643|Cetuximab|cetuximab|mesh-list
64675040|NCT01280643|Fluorouracil|fluorouracil|mesh-list
64675041|NCT01280643|Capecitabine|capecitabine|mesh-list
64675042|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
64675043|NCT01280643|Irinotecan|irinotecan|mesh-list
64675044|NCT01280643|Antibodies|antibodies|mesh-list
64675045|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
64675046|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64675047|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
64609856|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609857|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64609858|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64609859|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64609860|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609861|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609862|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609863|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609864|NCT04347577|Analgesics|analgesics|mesh-ancestor
64609865|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
64609866|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675048|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675049|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64675084|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675085|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675086|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64675087|NCT02298192|Liraglutide|liraglutide|mesh-list
64675088|NCT02298192|Xultophy|xultophy|mesh-list
64675089|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64675090|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675091|NCT02298192|Incretins|incretins|mesh-ancestor
64675092|NCT02298192|Hormones|hormones|mesh-ancestor
64675094|NCT01893632|Gabapentin|gabapentin|mesh-list
64675123|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675124|NCT03781479|Amifampridine|amifampridine|mesh-list
64675125|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64675126|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675127|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675128|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64675129|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64675130|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675131|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64675132|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64609894|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609895|NCT03213353|Protective Agents|protective agents|mesh-ancestor
64609896|NCT03213353|Expectorants|expectorants|mesh-ancestor
64609897|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
64609898|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64609899|NCT02240017|Gemcitabine|gemcitabine|mesh-list
64609900|NCT02240017|Carboplatin|carboplatin|mesh-list
64609901|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609902|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64609903|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
64609904|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609905|NCT02240017|Antiviral Agents|antiviral agents|mesh-ancestor
64609906|NCT02240017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609907|NCT02240017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609908|NCT02240017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609909|NCT02240017|Immunologic Factors|immunologic factors|mesh-ancestor
64609911|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
64609912|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609913|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
64609914|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
64675133|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64675134|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64296960|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296961|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296962|NCT03102242|Atezolizumab|atezolizumab|mesh-list
64296963|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296964|NCT02720523|Upadacitinib|upadacitinib|mesh-list
64296965|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64296966|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64296967|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380797|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380798|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
64380799|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64380800|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
64380801|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64380802|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64675135|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675137|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675138|NCT01223001|Analgesics|analgesics|mesh-ancestor
64675139|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
64675140|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675141|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
64675142|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64675143|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
64675144|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
64675147|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64675175|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64675176|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675177|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675178|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64609931|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609932|NCT03836807|Analgesics|analgesics|mesh-ancestor
64609933|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
64675179|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
64609934|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609935|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609936|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609937|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609938|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64609939|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609940|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609941|NCT02240173|Haloperidol|haloperidol|mesh-list
64609942|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
64609943|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
64609944|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
64609945|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675181|NCT02468583|Triamcinolone|triamcinolone|mesh-list
64609947|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64675182|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64675183|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64675185|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64675186|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64675187|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
64675188|NCT02468583|Hormones|hormones|mesh-ancestor
64675189|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675191|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675270|NCT02277548|Analgesics|analgesics|mesh-ancestor
64675271|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
64675272|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675309|NCT03020030|Razoxane|razoxane|mesh-list
64675311|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675312|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
64675313|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675314|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64675315|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64675316|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
64675317|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675326|NCT03020030|Hormones|hormones|mesh-ancestor
64675383|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64675385|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64675386|NCT03756818|Paclitaxel|paclitaxel|mesh-list
64675388|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64675389|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675390|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
64675391|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
64675392|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
64609957|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
64609958|NCT02240641|Lacidipine|lacidipine|mesh-list
64609959|NCT02240641|Diuretics|diuretics|mesh-list
64609960|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64609961|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64609962|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64609963|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64609965|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609966|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64675393|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675394|NCT01065051|Riociguat|riociguat|mesh-list
64675395|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
64296968|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296969|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296970|NCT02646332|Amoxicillin|amoxicillin|mesh-list
64296971|NCT02646332|Metronidazole|metronidazole|mesh-list
64296972|NCT02646332|Clarithromycin|clarithromycin|mesh-list
64609996|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64296973|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
64675396|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675397|NCT01048125|Nitroprusside|nitroprusside|mesh-list
64675419|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
64675420|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64675421|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675422|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675423|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64675424|NCT01901588|Analgesics|analgesics|mesh-ancestor
64675425|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
64675426|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675427|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64675428|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64675429|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64675430|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
64675528|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64675529|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
64675531|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675532|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64675533|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675534|NCT00378183|Risperidone|risperidone|mesh-list
64675535|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64675536|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
64675537|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675538|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675539|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675540|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64675541|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64675542|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64675543|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64675544|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64675545|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
64675546|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64675547|NCT01906658|Hormones|hormones|mesh-ancestor
64675548|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675549|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675550|NCT01908062|Naltrexone|naltrexone|mesh-list
64675551|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64675552|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64675553|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675554|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
64675555|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675556|NCT00924807|Sorafenib|sorafenib|mesh-list
64609997|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64609998|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64609999|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610000|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610001|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64610002|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64610005|NCT03404479|Celecoxib|celecoxib|mesh-list
64675557|NCT00924807|Leuprolide|leuprolide|mesh-list
64675558|NCT00924807|Bicalutamide|bicalutamide|mesh-list
64675559|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675560|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64675570|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675572|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64675573|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
64675574|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675575|NCT00896025|Expectorants|expectorants|mesh-ancestor
64675576|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675577|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64675579|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675580|NCT00896025|Protective Agents|protective agents|mesh-ancestor
64675581|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675582|NCT00896025|Antidotes|antidotes|mesh-ancestor
64675583|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
64675584|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
64675585|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64675586|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64675591|NCT03734601|Tacrolimus|tacrolimus|mesh-list
64675619|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675620|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675621|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
64675622|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675623|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610011|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675624|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675625|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
64675626|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675627|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
64675628|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
64675629|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
64675630|NCT00832299|Leucovorin|leucovorin|mesh-list
64675631|NCT00832299|Fluorouracil|fluorouracil|mesh-list
64675632|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
64610012|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610013|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610014|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610015|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64610017|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675633|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
64675634|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675635|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64675636|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675637|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675677|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
64675678|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64675679|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64675680|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675681|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64675682|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675683|NCT00816777|Irinotecan|irinotecan|mesh-list
64675684|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64675685|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64675686|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64675687|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296975|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64296976|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675688|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675689|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
64675690|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64675691|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
64296977|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64296978|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64675692|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675693|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675695|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675696|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64675839|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64675840|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675841|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
64675842|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675843|NCT00379509|Lapatinib|lapatinib|mesh-list
64675885|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64675886|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64675887|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675888|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
64675889|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675890|NCT05600517|Fluorides|fluorides|mesh-list
64610048|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610049|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675891|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
64675892|NCT05600517|Protective Agents|protective agents|mesh-ancestor
64675893|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675894|NCT01745913|Fludarabine|fludarabine|mesh-list
64675895|NCT01745913|Melphalan|melphalan|mesh-list
64675896|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
64675897|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675898|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675899|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64675900|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
64675901|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675902|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64675903|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
64675904|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64675905|NCT05600127|Avelumab|avelumab|mesh-list
64675906|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64675907|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675908|NCT01691079|Bromides|bromides|mesh-list
64675909|NCT01691079|Ipratropium|ipratropium|mesh-list
64675910|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
64675911|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64675912|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
64675913|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64675914|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675930|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64675931|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64675932|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64675933|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64675934|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64675935|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64675936|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64675937|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
64675938|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64675939|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64675940|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64675941|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
64675942|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64675943|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
64675944|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
64675945|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
64675946|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64675947|NCT05599347|Azithromycin|azithromycin|mesh-list
64675948|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64675949|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675950|NCT01621737|Oxytocin|oxytocin|mesh-list
64675951|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
64675952|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610084|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64675953|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64675954|NCT00379665|Cisplatin|cisplatin|mesh-list
64675955|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64675956|NCT00357383|Azithromycin|azithromycin|mesh-list
64675957|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64675958|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64675982|NCT01648751|Hormones|hormones|mesh-ancestor
64675983|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64675984|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676049|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
64676070|NCT05722301|Hormones|hormones|mesh-ancestor
64676122|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
64676123|NCT05721755|Fluorouracil|fluorouracil|mesh-list
64676124|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64676125|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64676126|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676127|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
64676128|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
64676129|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
64676130|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676131|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401485|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676133|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64676134|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676135|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
64676136|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676137|NCT00570531|Paclitaxel|paclitaxel|mesh-list
64676138|NCT00570531|Bevacizumab|bevacizumab|mesh-list
64676139|NCT00570531|Fluorouracil|fluorouracil|mesh-list
64676140|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64676141|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676142|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
64676143|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
64676144|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
64610109|NCT01834235|Gemcitabine|gemcitabine|mesh-list
64610110|NCT01834235|Paclitaxel|paclitaxel|mesh-list
64610111|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64610112|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610113|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
64610114|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
64610115|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
64610116|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610130|NCT03211871|Analgesics|analgesics|mesh-ancestor
64676145|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676146|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380803|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380804|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64380805|NCT03189953|Exenatide|exenatide|mesh-list
64380806|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380807|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380811|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380812|NCT02204085|Decitabine|decitabine|mesh-list
64676147|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64380813|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64380814|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
64380815|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380816|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380817|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380818|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
64380819|NCT04314843|Fludarabine|fludarabine|mesh-list
64380820|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380821|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
64380822|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380823|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380824|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64380825|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
64380826|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676148|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64676149|NCT00570531|Growth Substances|growth substances|mesh-ancestor
64676150|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676151|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
64676152|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
64676166|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676168|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676170|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64676171|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64676172|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
64676173|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64676174|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64676175|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676176|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676177|NCT05721443|Cetuximab|cetuximab|mesh-list
64676178|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64676179|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676180|NCT00523809|Bevacizumab|bevacizumab|mesh-list
64610145|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
64676181|NCT00523809|Fludarabine|fludarabine|mesh-list
64676182|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
64676183|NCT00523809|Melphalan|melphalan|mesh-list
64676184|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
64676185|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64610146|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610147|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64610148|NCT03217409|Ezetimibe|ezetimibe|mesh-list
64610149|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64610150|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64676186|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64676187|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676188|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64676189|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64676190|NCT00523809|Growth Substances|growth substances|mesh-ancestor
64676191|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676192|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
64676193|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64676194|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
64676195|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676210|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64676211|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64676212|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676213|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64676214|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64676215|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676216|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
64676217|NCT00357773|Azithromycin|azithromycin|mesh-list
64676218|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64676219|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676220|NCT00487461|Simvastatin|simvastatin|mesh-list
64676221|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64676256|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64676257|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676258|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64676259|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
64676260|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676261|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
64676262|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64676263|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676264|NCT00305643|Celecoxib|celecoxib|mesh-list
64676265|NCT00305643|Capecitabine|capecitabine|mesh-list
64676266|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64676267|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
64676268|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676269|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676270|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64676271|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676272|NCT00305643|Analgesics|analgesics|mesh-ancestor
64676273|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
64676274|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676275|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676276|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676277|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676278|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64676279|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64676280|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676281|NCT03004105|Durvalumab|durvalumab|mesh-list
64401634|NCT05738161|Magrolimab|magrolimab|mesh-list
64676282|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64676283|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676284|NCT00271011|Irinotecan|irinotecan|mesh-list
64676285|NCT00271011|Cetuximab|cetuximab|mesh-list
64676286|NCT00271011|Mitomycins|mitomycins|mesh-list
64676287|NCT00271011|Mitomycin|mitomycin|mesh-list
64676288|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64676297|NCT03312530|Atezolizumab|atezolizumab|mesh-list
64676298|NCT03312530|Venetoclax|venetoclax|mesh-list
64676299|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610166|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64610168|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64676300|NCT05697965|Vancomycin|vancomycin|mesh-list
64676301|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64676302|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676303|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
64676304|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64676305|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676306|NCT05720273|Calcitriol|calcitriol|mesh-list
64676307|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64676308|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676309|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64676310|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676311|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676312|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64676313|NCT05720273|Vitamins|vitamins|mesh-ancestor
64676314|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
64676315|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64676316|NCT00183963|Tamoxifen|tamoxifen|mesh-list
64676317|NCT00183963|Fulvestrant|fulvestrant|mesh-list
64676318|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64676319|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
64676320|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676321|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676322|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64676323|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676324|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64676335|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64676336|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
64676337|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
64676338|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64676339|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64676340|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676341|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
64676342|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
64676343|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676344|NCT04317807|Levetiracetam|levetiracetam|mesh-list
64676345|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
64676346|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
64676347|NCT00118053|Carboplatin|carboplatin|mesh-list
64676348|NCT00118053|Docetaxel|docetaxel|mesh-list
64676350|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676351|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
64676352|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
64676353|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
64676354|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676355|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64676356|NCT04225611|Dexamethasone|dexamethasone|mesh-list
64401717|NCT03066011|Voriconazole|voriconazole|mesh-list
64676357|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676358|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
64676388|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
64676389|NCT00357851|Coagulants|coagulants|mesh-ancestor
64676390|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64676391|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64676392|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
64676393|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676394|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676395|NCT05664659|Misoprostol|misoprostol|mesh-list
64676396|NCT05664659|Oxytocin|oxytocin|mesh-list
64676397|NCT05664659|Carbetocin|carbetocin|mesh-list
64676398|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
64676399|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64676400|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610218|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
64610219|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
64610220|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610221|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610223|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
64610224|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
64610225|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610226|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610227|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
64610228|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610229|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64610230|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64610231|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64610232|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676401|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64676402|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
64676403|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64676404|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64676405|NCT00358319|Valproic Acid|valproic acid|mesh-list
64676406|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
64676407|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676408|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676409|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
64676410|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676411|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676412|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
64676413|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64676414|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64676415|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676416|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
64676417|NCT05663801|Ketamine|ketamine|mesh-list
64296979|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64296980|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676418|NCT05663801|Bupivacaine|bupivacaine|mesh-list
64676419|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
64676420|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
64676421|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296981|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296982|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64610253|NCT01835639|Vitamins|vitamins|mesh-ancestor
64610254|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
64610255|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610256|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64610257|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64610258|NCT01839149|Oxytocin|oxytocin|mesh-list
64610259|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
64610260|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610261|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610262|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
64610263|NCT01839383|Calcium|calcium|mesh-list
64610264|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64610265|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610266|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64610267|NCT00901199|Deferasirox|deferasirox|mesh-list
64610268|NCT00901199|Deferoxamine|deferoxamine|mesh-list
64610269|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64610270|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
64296983|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64296984|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64296985|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64296986|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64296987|NCT00015002|Betamethasone|betamethasone|mesh-list
64610288|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610289|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296988|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676422|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676488|NCT02681211|Promethazine|promethazine|mesh-list
64676489|NCT02681211|Ketorolac|ketorolac|mesh-list
64676490|NCT02681211|Metoclopramide|metoclopramide|mesh-list
64676491|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64676492|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64676493|NCT02681211|Analgesics|analgesics|mesh-ancestor
64676494|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
64676495|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676583|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64676584|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
64676585|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610290|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610291|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
64610292|NCT00906503|Hormones|hormones|mesh-ancestor
64610293|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610294|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64610295|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676586|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676587|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676588|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64676589|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64676590|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64676591|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
64676592|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64676593|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676594|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64676595|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64676596|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64676598|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64676623|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676624|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676625|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64676626|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64676627|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676628|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676629|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
64676630|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676631|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64610337|NCT01837043|Cyclosporins|cyclosporins|mesh-list
64610338|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64610339|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610340|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
64610341|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610342|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610343|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610344|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
64610345|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610346|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
64610347|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610349|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676632|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
64676633|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64676634|NCT00000213|Fluoxetine|fluoxetine|mesh-list
64676635|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64676636|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64676637|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64676638|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676639|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64676640|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
64676641|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676642|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64676643|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
64676644|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64676645|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64676646|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64676647|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676648|NCT00000219|Buprenorphine|buprenorphine|mesh-list
64676674|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
64676675|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
64676723|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
64676724|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676725|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64676726|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64676727|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
64676728|NCT05637671|Urological Agents|urological agents|mesh-ancestor
64676729|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64676730|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64676785|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676786|NCT00000237|Analgesics|analgesics|mesh-ancestor
64676787|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
64676788|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64676789|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64676790|NCT00000765|Zidovudine|zidovudine|mesh-list
64676791|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
64676792|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676793|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64676800|NCT00000243|Buprenorphine|buprenorphine|mesh-list
64676853|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676854|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
64676855|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676856|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676857|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64676858|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
64676859|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676860|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676861|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64676862|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64676863|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
64676913|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64676914|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64676915|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64676916|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
64676917|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64676918|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64676919|NCT00001689|Vincristine|vincristine|mesh-list
64676920|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64676921|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64676922|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
64676923|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64610377|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64676924|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64676925|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64676926|NCT00001713|Heparin|heparin|mesh-list
64676927|NCT00001713|Plasminogen|plasminogen|mesh-list
64677045|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677047|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64677048|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64677049|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
64677050|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677114|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64677115|NCT00000885|Lamivudine|lamivudine|mesh-list
64677116|NCT00000885|Zidovudine|zidovudine|mesh-list
64677117|NCT00000885|Efavirenz|efavirenz|mesh-list
64677118|NCT00000885|Abacavir|abacavir|mesh-list
64677119|NCT00000885|Stavudine|stavudine|mesh-list
64677120|NCT00000885|Didanosine|didanosine|mesh-list
64677121|NCT00000885|Adefovir|adefovir|mesh-list
64677122|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64677123|NCT00000885|Nelfinavir|nelfinavir|mesh-list
64677124|NCT00000885|Indinavir|indinavir|mesh-list
64677125|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64677126|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677127|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677128|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677129|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
64677130|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677131|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677132|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677133|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
64677134|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64677135|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64677136|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64677137|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64677138|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64677139|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64677140|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64677141|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64677142|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
64677143|NCT01647282|Minocycline|minocycline|mesh-list
64677162|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
64677163|NCT00000909|Aldesleukin|aldesleukin|mesh-list
64610392|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610393|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610394|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64677164|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610396|NCT04372849|Insulin|insulin|mesh-list
64677165|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677166|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677167|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
64677168|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677169|NCT05444699|Prednisolone|prednisolone|mesh-list
64677170|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64677171|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
64677172|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64677173|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
64677174|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64677175|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
64677176|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64677177|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
64677179|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677287|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64677288|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64677289|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64677290|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
64677291|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64677292|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677293|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
64677294|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64677295|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
64677296|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677297|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64677298|NCT00001893|Etanercept|etanercept|mesh-list
64677299|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64677349|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64677350|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64677351|NCT00001911|Growth Substances|growth substances|mesh-ancestor
64677352|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
64677353|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677419|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64677420|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64610424|NCT01837667|Docetaxel|docetaxel|mesh-list
64610425|NCT01837667|LB100|lb100|mesh-list
64610426|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610427|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
64610428|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
64610429|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
64610430|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677421|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64677422|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677423|NCT00001023|Azithromycin|azithromycin|mesh-list
64677424|NCT00001023|Clarithromycin|clarithromycin|mesh-list
64677425|NCT00001023|Rifabutin|rifabutin|mesh-list
64677426|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64677429|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677484|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64677485|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402841|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64677486|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64677487|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677489|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64677490|NCT00001059|Bleomycin|bleomycin|mesh-list
64677491|NCT00001059|Vincristine|vincristine|mesh-list
64677492|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64677493|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677494|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64677495|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64677496|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677497|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677542|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677543|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677544|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
64677545|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296991|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64677546|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64677547|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64677548|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
64677549|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677551|NCT00001095|Zidovudine|zidovudine|mesh-list
64610460|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
64677552|NCT00001095|Nevirapine|nevirapine|mesh-list
64677553|NCT00001095|Stavudine|stavudine|mesh-list
64677554|NCT00001095|Indinavir|indinavir|mesh-list
64610461|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610462|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610463|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64610464|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677672|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64677673|NCT00002037|Trifluridine|trifluridine|mesh-list
64677674|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
64677675|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677676|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
64677677|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64677678|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
64677679|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677680|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
64677681|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677682|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677683|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64677684|NCT05270057|Prednisone|prednisone|mesh-list
64677734|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64677735|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
64677736|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677737|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677738|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64677739|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64677740|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64677741|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64677742|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64677743|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64677797|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64677798|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64677799|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
64610496|NCT01830335|Analgesics|analgesics|mesh-ancestor
64610497|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
64610498|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610499|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610500|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610501|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610502|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
64610503|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
64610504|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610536|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64610537|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610538|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610539|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677800|NCT05029973|Bevacizumab|bevacizumab|mesh-list
64677801|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64677802|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677803|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64677804|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64677805|NCT05029973|Growth Substances|growth substances|mesh-ancestor
64677806|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677807|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
64677864|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64677865|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64677866|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403221|NCT03060005|Dextrans|dextrans|mesh-list
64677867|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677868|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64677869|NCT00002079|Miglustat|miglustat|mesh-list
64677870|NCT00002079|Zidovudine|zidovudine|mesh-list
64677931|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64677932|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64677933|NCT00002103|Leucovorin|leucovorin|mesh-list
64677934|NCT00002103|Trimetrexate|trimetrexate|mesh-list
64677935|NCT00002103|Calcium|calcium|mesh-list
64677936|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
64677937|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64677938|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64677939|NCT00002103|Antidotes|antidotes|mesh-ancestor
64610540|NCT04371601|Oseltamivir|oseltamivir|mesh-list
64610541|NCT04371601|Hormones|hormones|mesh-list
64610542|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610543|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610544|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
64610545|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610546|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610547|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610548|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
64610549|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
64677940|NCT00002103|Protective Agents|protective agents|mesh-ancestor
64403301|NCT02749513|Itraconazole|itraconazole|mesh-list
64677963|NCT00360191|Buspirone|buspirone|mesh-list
64296998|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296999|NCT02061007|Misonidazole|misonidazole|mesh-list
64297000|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297001|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64678065|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678066|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64678068|NCT04983407|Antiviral Agents|antiviral agents|mesh-ancestor
64678069|NCT04983407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678070|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678071|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678072|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
64678073|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678075|NCT00001569|Cisplatin|cisplatin|mesh-list
64678076|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64678082|NCT00001587|Melphalan|melphalan|mesh-list
64678128|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64678129|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678130|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610571|NCT02242513|Lidocaine|lidocaine|mesh-list
64610572|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
64610573|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
64610574|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610575|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610576|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
64610577|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610578|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64610579|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64610580|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64610581|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610582|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610583|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64610584|NCT03409679|Murepavadin|murepavadin|mesh-list
64610585|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610586|NCT04371367|Avdoralimab|avdoralimab|mesh-list
64610587|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610588|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
64678131|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678132|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64610590|NCT02242591|Ropivacaine|ropivacaine|mesh-list
64678133|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
64678134|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64678135|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678136|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678191|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678192|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678193|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
64678194|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678195|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678198|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
64678261|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678262|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64678263|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64678264|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
64678470|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678471|NCT00002397|Lamivudine|lamivudine|mesh-list
64678472|NCT00002397|Stavudine|stavudine|mesh-list
64678473|NCT00002397|Nelfinavir|nelfinavir|mesh-list
64610604|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
64610605|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610606|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610607|NCT01726205|Pregabalin|pregabalin|mesh-list
64610608|NCT01726205|Ropivacaine|ropivacaine|mesh-list
64610609|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
64610610|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
64610611|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610615|NCT01726205|Analgesics|analgesics|mesh-ancestor
64678474|NCT00002397|Saquinavir|saquinavir|mesh-list
64678475|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678542|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678543|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678544|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64678545|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64678546|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
64678547|NCT00002415|Tenofovir|tenofovir|mesh-list
64678681|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678682|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
64678683|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678684|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64678752|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64678754|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64678755|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
64610652|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
64610653|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610654|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64610655|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
64610656|NCT04370431|Edaravone|edaravone|mesh-list
64610657|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64610658|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
64610659|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610660|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64610661|NCT04370431|Protective Agents|protective agents|mesh-ancestor
64610662|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610663|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64678756|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
64610664|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610666|NCT03835871|Beclomethasone|beclomethasone|mesh-list
64678757|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64678759|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
64678822|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
64678823|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678824|NCT00002253|Octreotide|octreotide|mesh-list
64678825|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64678826|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64678827|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64678884|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678885|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64678886|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64678958|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64678959|NCT00002265|Zalcitabine|zalcitabine|mesh-list
64678960|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
64678961|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64678962|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64678963|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64678964|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64678965|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
64678966|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64678967|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64678968|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64678970|NCT04933331|Fluorides|fluorides|mesh-list
64678971|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
64679022|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679023|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679024|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679025|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64679026|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64679027|NCT00002277|Amebicides|amebicides|mesh-ancestor
64679028|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64679029|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64679030|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610762|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64610763|NCT02157103|Growth Substances|growth substances|mesh-ancestor
64610764|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610765|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
64610766|NCT00924001|Aldesleukin|aldesleukin|mesh-list
64610767|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
64610768|NCT00924001|Fludarabine|fludarabine|mesh-list
64610769|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610770|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
64610771|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610772|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679031|NCT04469075|Clindamycin|clindamycin|mesh-list
64679032|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
64679086|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64679087|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
64679088|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679089|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679090|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64679091|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64679092|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64679093|NCT04832087|Teduglutide|teduglutide|mesh-list
64679094|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679152|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679153|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679154|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679155|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64679156|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64679157|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
64679158|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610807|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679159|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64679160|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64679162|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
64679163|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679164|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64679165|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
64679166|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
64679167|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64679168|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64297014|NCT03103568|Tolbutamide|tolbutamide|mesh-list
64610808|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610809|NCT03401515|Propranolol|propranolol|mesh-list
64610810|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64610811|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64610812|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
64610813|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484300|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297015|NCT03103568|Metoprolol|metoprolol|mesh-list
64297018|NCT03103568|Nitisinone|nitisinone|mesh-list
64297019|NCT03103568|Diuretics|diuretics|mesh-ancestor
64297020|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
64297021|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297022|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64297023|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64679169|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679170|NCT00002547|Cytarabine|cytarabine|mesh-list
64679171|NCT00002547|Cyclosporine|cyclosporine|mesh-list
64679209|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
64679210|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679211|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679212|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64679213|NCT00002553|Trace Elements|trace elements|mesh-ancestor
64679214|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
64679216|NCT00002559|Ifosfamide|ifosfamide|mesh-list
64679217|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64679218|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679219|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
64679225|NCT00002565|Cytarabine|cytarabine|mesh-list
64610845|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610846|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
64610847|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610848|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64610849|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64610850|NCT01727531|Analgesics|analgesics|mesh-ancestor
64610851|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
64610852|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610853|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610854|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610856|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
64610857|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
64610858|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
64610859|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64610860|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610861|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610862|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64610863|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64610864|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679281|NCT00002571|Etoposide|etoposide|mesh-list
64679282|NCT00002571|Vincristine|vincristine|mesh-list
64610865|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679283|NCT00002571|Bleomycin|bleomycin|mesh-list
64679284|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
64679285|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679286|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
64679287|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679288|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64679299|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
64679324|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
64679325|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64679326|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64679327|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64679328|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64679329|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64679330|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64679331|NCT04797767|Cytarabine|cytarabine|mesh-list
64679332|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64610878|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610879|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
64610880|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610881|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64610882|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64610883|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64610884|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610885|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610886|NCT01721525|Ribavirin|ribavirin|mesh-list
64679333|NCT04797767|Venetoclax|venetoclax|mesh-list
64679334|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
64679335|NCT04797767|Cladribine|cladribine|mesh-list
64679336|NCT04797767|Lenograstim|lenograstim|mesh-list
64679337|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679338|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
64679339|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679340|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679341|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
64679342|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679343|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679344|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
64679345|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679346|NCT04797767|Analgesics|analgesics|mesh-ancestor
64679347|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
64679348|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679349|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64679350|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64679351|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679352|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64679353|NCT00360815|Insulin|insulin|mesh-list
64679354|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64679355|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679356|NCT00002583|Vinorelbine|vinorelbine|mesh-list
64679357|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611000|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611001|NCT00929383|Hemostatics|hemostatics|mesh-list
64611002|NCT00929383|Coagulants|coagulants|mesh-ancestor
64611003|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
64611004|NCT01722539|Piperaquine|piperaquine|mesh-list
64611005|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
64611006|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64611007|NCT01722539|Albendazole|albendazole|mesh-list
64611008|NCT01722539|Praziquantel|praziquantel|mesh-list
64611009|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
64611010|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64611011|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64611012|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611025|NCT04765111|Rituximab|rituximab|mesh-list
64679358|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64679360|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
64679361|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
64679363|NCT00002589|Aldesleukin|aldesleukin|mesh-list
64679415|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64679416|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679417|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679418|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679420|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
64679421|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
64679422|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679423|NCT05752305|Dexamethasone|dexamethasone|mesh-list
64679424|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
64679425|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64679426|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64611052|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64611053|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64611054|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
64611055|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611056|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64611057|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64611058|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
64611059|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64611061|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
64679427|NCT05752305|Prednisolone|prednisolone|mesh-list
64679428|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
64679453|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
64679454|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679455|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679456|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679457|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
64679458|NCT04343729|Hormones|hormones|mesh-ancestor
64679459|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679460|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64679461|NCT04343729|Protective Agents|protective agents|mesh-ancestor
64679462|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404810|NCT04909931|Vitamin D|vitamin d|mesh-list
64679463|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679464|NCT00002631|Fluorouracil|fluorouracil|mesh-list
64679465|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679466|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
64611104|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611105|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611106|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64611107|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
64611108|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611109|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64611110|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64611111|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
64679467|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679468|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679469|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64679470|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
64679471|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679472|NCT00002637|Interferons|interferons|mesh-list
64679473|NCT00002637|Aldesleukin|aldesleukin|mesh-list
64679474|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
64679476|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679477|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
64679478|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679479|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64679480|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64679481|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
64679482|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679483|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64679555|NCT05806307|Arginine Vasopressin|arginine vasopressin|mesh-list
64679556|NCT05806307|Epinephrine|epinephrine|mesh-list
64679557|NCT05806307|Bupivacaine|bupivacaine|mesh-list
64679558|NCT05806307|Misoprostol|misoprostol|mesh-list
64679559|NCT05806307|Ethamsylate|ethamsylate|mesh-list
64611155|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
64611156|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64611157|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
64611158|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611159|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611160|NCT03833999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64611161|NCT03833999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64611162|NCT03833999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611163|NCT03833999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64679560|NCT05806307|Oxytocin|oxytocin|mesh-list
64679561|NCT05806307|Carbetocin|carbetocin|mesh-list
64679562|NCT05806307|Anesthetics, Local|anesthetics, local|mesh-ancestor
64679563|NCT05806307|Anesthetics|anesthetics|mesh-ancestor
64679568|NCT05806307|Oxytocics|oxytocics|mesh-ancestor
64679606|NCT05806060|Vinorelbine|vinorelbine|mesh-list
64679607|NCT05806060|Carboplatin|carboplatin|mesh-list
64679608|NCT05806060|Capecitabine|capecitabine|mesh-list
64679609|NCT05806060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64679610|NCT05806060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679611|NCT05806060|Tubulin Modulators|tubulin modulators|mesh-ancestor
64679612|NCT05806060|Antimitotic Agents|antimitotic agents|mesh-ancestor
64679613|NCT05806060|Mitosis Modulators|mitosis modulators|mesh-ancestor
64679614|NCT05806060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679615|NCT05806060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64679616|NCT05806060|Antimetabolites|antimetabolites|mesh-ancestor
64611200|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611202|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64611203|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
64611204|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611205|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611206|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64679617|NCT05806047|Fulvestrant|fulvestrant|mesh-list
64611211|NCT04355845|Sumatriptan|sumatriptan|mesh-list
64679618|NCT05806047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64679619|NCT05806047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679620|NCT05806047|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64679671|NCT05805800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64679673|NCT05805800|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64679674|NCT05805800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64679675|NCT05805800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64679676|NCT05805800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679677|NCT05805800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679678|NCT05805800|Serotonin Agents|serotonin agents|mesh-ancestor
64679679|NCT05805800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64679680|NCT05805761|Anti-Infective Agents|anti-infective agents|mesh-list
64679681|NCT05805761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64679682|NCT05805683|Calcitonin|calcitonin|mesh-list
64679683|NCT05805683|Salmon calcitonin|salmon calcitonin|mesh-list
64679684|NCT05805683|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64679685|NCT05805683|Katacalcin|katacalcin|mesh-list
64679711|NCT05805553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64679712|NCT05805553|Anabolic Agents|anabolic agents|mesh-ancestor
64679713|NCT05805553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64679721|NCT05805436|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64679722|NCT05805436|Laxatives|laxatives|mesh-ancestor
64679723|NCT05805436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64679725|NCT05804747|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64679726|NCT05804747|Antithrombins|antithrombins|mesh-ancestor
64679727|NCT05804747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64679728|NCT05804747|Protease Inhibitors|protease inhibitors|mesh-ancestor
64679729|NCT05804747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679730|NCT05804747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611256|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611257|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611258|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611259|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64611260|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64611261|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
64611262|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
64611263|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64611264|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
64611265|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611266|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679731|NCT05804747|Anticoagulants|anticoagulants|mesh-ancestor
64679732|NCT05804513|Lixisenatide|lixisenatide|mesh-list
64679733|NCT05804513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64679734|NCT05804513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679735|NCT05800938|Isosorbide|isosorbide|mesh-list
64679736|NCT05800938|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64679737|NCT05800938|Diuretics|diuretics|mesh-ancestor
64679738|NCT05800938|Natriuretic Agents|natriuretic agents|mesh-ancestor
64679739|NCT05800938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679740|NCT05797935|Dapagliflozin|dapagliflozin|mesh-list
64679741|NCT05797935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64679742|NCT05797935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297024|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297096|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297097|NCT04968158|Acetaminophen|acetaminophen|mesh-list
64297098|NCT04968158|Etoricoxib|etoricoxib|mesh-list
64297099|NCT04968158|Tramadol|tramadol|mesh-list
64679824|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64679825|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64679826|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64679828|NCT05741164|Propranolol|propranolol|mesh-list
64679829|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64679830|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679831|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64679832|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64679833|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
64679834|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679835|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679836|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611291|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679837|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64611292|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
64611293|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611294|NCT02909140|Lidocaine|lidocaine|mesh-list
64611295|NCT02909140|Phenylephrine|phenylephrine|mesh-list
64611296|NCT02909140|Epinephrine|epinephrine|mesh-list
64611330|NCT01724879|Dasatinib|dasatinib|mesh-list
64405181|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64679838|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64679839|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
64679840|NCT05730712|Trastuzumab|trastuzumab|mesh-list
64679842|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64679881|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
64679882|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64679883|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
64679884|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64679922|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
64679923|NCT05627635|Hematinics|hematinics|mesh-ancestor
64679924|NCT05607004|Exemestane|exemestane|mesh-list
64679925|NCT05607004|Goserelin|goserelin|mesh-list
64679926|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64679970|NCT05540522|Vaccines|vaccines|mesh-list
64679971|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
64679972|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679973|NCT05511870|Etripamil|etripamil|mesh-list
64679974|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64679975|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64611332|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64611333|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611334|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611335|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
64611336|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611337|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
64611338|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611339|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611340|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64611341|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
64611342|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679976|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64679977|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64679978|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64679980|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
64680132|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680133|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64680134|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64680135|NCT05259839|Dexamethasone|dexamethasone|mesh-list
64680136|NCT05259839|Lenalidomide|lenalidomide|mesh-list
64680164|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64680165|NCT05161156|Bromides|bromides|mesh-list
64680166|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
64680167|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64680168|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
64680169|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680170|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297100|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64297101|NCT04968158|Analgesics|analgesics|mesh-ancestor
64680171|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64297102|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
64297103|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297104|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297105|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
64297106|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64611373|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
64611374|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611375|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611376|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64611377|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64611378|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64611379|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611380|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64611381|NCT01729403|Metformin|metformin|mesh-list
64611382|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64611384|NCT04364581|Letrozole|letrozole|mesh-list
64297107|NCT04968158|Narcotics|narcotics|mesh-ancestor
64297108|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64680172|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
64680173|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
64680174|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64680175|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
64680176|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680177|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680178|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
64680179|NCT05147662|Factor VIII|factor viii|mesh-list
64680180|NCT05147662|Coagulants|coagulants|mesh-ancestor
64680181|NCT05132101|Palbociclib|palbociclib|mesh-list
64680182|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680183|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64680184|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680185|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680186|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
64680187|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64680188|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64680189|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680190|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
64680191|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
64680192|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680334|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64611415|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611416|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611417|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64611418|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64611419|NCT00913913|Growth Substances|growth substances|mesh-ancestor
64611420|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611421|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
64611422|NCT00373594|Rituximab|rituximab|mesh-list
64611423|NCT00373594|Fludarabine|fludarabine|mesh-list
64611424|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611425|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611426|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
64611427|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680335|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680336|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64680337|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
64680338|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64680339|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680340|NCT04665739|Everolimus|everolimus|mesh-list
64680341|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64680342|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680343|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680388|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
64680389|NCT04613596|Pemetrexed|pemetrexed|mesh-list
64680390|NCT04613596|Adagrasib|adagrasib|mesh-list
64680391|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680392|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680393|NCT04613596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680394|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680395|NCT04613596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64680396|NCT04613596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64680397|NCT04612790|Benralizumab|benralizumab|mesh-list
64680398|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64680444|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64611455|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
64611456|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611457|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611458|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611459|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611466|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
64680445|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
64680446|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64680447|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680448|NCT04522323|Lenvatinib|lenvatinib|mesh-list
64680449|NCT04522323|Axitinib|axitinib|mesh-list
64680450|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680451|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64680452|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680453|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680454|NCT04471987|Interleukin-12|interleukin-12|mesh-list
64680455|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64680456|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
64680457|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611504|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
64611505|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
64611506|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
64611507|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611508|NCT04347187|Anticoagulants|anticoagulants|mesh-list
64611509|NCT00920075|Alendronate|alendronate|mesh-list
64611510|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64611511|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611532|NCT01049009|Metoprolol|metoprolol|mesh-list
64680458|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64680459|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64680460|NCT04471987|Growth Substances|growth substances|mesh-ancestor
64680461|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
64680462|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680463|NCT04471428|Docetaxel|docetaxel|mesh-list
64680464|NCT04471428|Atezolizumab|atezolizumab|mesh-list
64680465|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680466|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680467|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
64680468|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680469|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680470|NCT04447768|Venetoclax|venetoclax|mesh-list
64680471|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
64680472|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680473|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680474|NCT04405037|Alvimopan|alvimopan|mesh-list
64680475|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64680476|NCT04389177|Paclitaxel|paclitaxel|mesh-list
64680477|NCT04389177|Cisplatin|cisplatin|mesh-list
64680478|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
64680487|NCT04365257|Prazosin|prazosin|mesh-list
64680488|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
64680489|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
64611568|NCT02920918|Incretins|incretins|mesh-ancestor
64611569|NCT02920918|Hormones|hormones|mesh-ancestor
64611570|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611571|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64611572|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
64611573|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611574|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611575|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64611576|NCT03403049|Gemcitabine|gemcitabine|mesh-list
64611577|NCT03403049|Capecitabine|capecitabine|mesh-list
64611578|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64611579|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680490|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64680491|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64680492|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
64680493|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64680494|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680495|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680496|NCT04341545|Letrozole|letrozole|mesh-list
64680498|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64680499|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64680500|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680501|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680502|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64680503|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64680504|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680505|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680506|NCT04248829|Gefitinib|gefitinib|mesh-list
64680507|NCT04248829|Lazertinib|lazertinib|mesh-list
64611605|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64611606|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
64611607|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64611608|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64611609|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64611610|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64611611|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611612|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611613|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
64611614|NCT02921386|Testosterone|testosterone|mesh-list
64611615|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
64611616|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
64680508|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680509|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64680510|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680511|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680512|NCT04220021|Metformin|metformin|mesh-list
64680521|NCT04191304|Benralizumab|benralizumab|mesh-list
64680534|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64680535|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
64680536|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680537|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64680538|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
64680539|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
64680540|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
64680541|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64611653|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64680605|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
64680606|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680607|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611654|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64611655|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611656|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64611657|NCT02802514|Incretins|incretins|mesh-ancestor
64611658|NCT02802514|Hormones|hormones|mesh-ancestor
64611659|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611660|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
64611661|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
64611662|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64611663|NCT00944671|Famotidine|famotidine|mesh-list
64611664|NCT00944671|Calcium|calcium|mesh-list
64611668|NCT00944671|Antacids|antacids|mesh-ancestor
64680608|NCT04145700|Antiviral Agents|antiviral agents|mesh-ancestor
64680609|NCT04145700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680610|NCT04145700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680611|NCT04145700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680612|NCT04145700|Immunologic Factors|immunologic factors|mesh-ancestor
64680613|NCT04145700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680614|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680615|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
64680616|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680617|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
64680618|NCT04145349|Vinorelbine|vinorelbine|mesh-list
64680619|NCT04145349|Ramucirumab|ramucirumab|mesh-list
64680620|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680621|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
64680622|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680623|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64680790|NCT03778957|Growth Substances|growth substances|mesh-ancestor
64680791|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680792|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
64680794|NCT03767933|Ibuprofen|ibuprofen|mesh-list
64680795|NCT03767933|Hydromorphone|hydromorphone|mesh-list
64680796|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64680797|NCT03767933|Analgesics|analgesics|mesh-ancestor
64680798|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
64680799|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680800|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680801|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
64611703|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
64611704|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611705|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
64611706|NCT01045967|Lansoprazole|lansoprazole|mesh-list
64611707|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
64611708|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64611709|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64611710|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64611711|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611712|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611713|NCT02808052|Minocycline|minocycline|mesh-list
64611714|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64611715|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611716|NCT02924350|Fluorides|fluorides|mesh-list
64611717|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
64611718|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
64611719|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
64611720|NCT02924350|Protective Agents|protective agents|mesh-ancestor
64611721|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611722|NCT02344498|Tenofovir|tenofovir|mesh-list
64611723|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
64611724|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611725|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64680802|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64680803|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611726|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64680804|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64680805|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64680806|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680807|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680808|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64680809|NCT03767933|Narcotics|narcotics|mesh-ancestor
64680854|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64680855|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680886|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64680887|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64680888|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680889|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
64680890|NCT03192397|Sirolimus|sirolimus|mesh-list
64680891|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
64680892|NCT03192397|Melphalan|melphalan|mesh-list
64680893|NCT03192397|Fludarabine|fludarabine|mesh-list
64680894|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
64680895|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64680896|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
64611728|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611729|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64611730|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64611731|NCT00945139|Bevacizumab|bevacizumab|mesh-list
64611732|NCT00945139|Doxorubicin|doxorubicin|mesh-list
64611733|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611734|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611735|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64611737|NCT00945139|Growth Substances|growth substances|mesh-ancestor
64680897|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680898|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64680899|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64680900|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
64680901|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680902|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680903|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64297109|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64297110|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64680904|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64611775|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64680905|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
64297111|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297112|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64297113|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64297114|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611776|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64611777|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611778|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611779|NCT03798691|Vaccines|vaccines|mesh-list
64611780|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
64611781|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611782|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
64611806|NCT04353505|Ketorolac|ketorolac|mesh-list
64297115|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297116|NCT02059915|Oxycodone|oxycodone|mesh-list
64297117|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64297118|NCT02059915|Narcotics|narcotics|mesh-ancestor
64297119|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297120|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680907|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64680909|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64680910|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680911|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680912|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
64680916|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64680917|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64680918|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680920|NCT03072238|Prednisolone|prednisolone|mesh-list
64680921|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64680933|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680934|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64680935|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64680936|NCT02937818|Carboplatin|carboplatin|mesh-list
64611827|NCT02929927|Eusol|eusol|mesh-list
64611828|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
64611829|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611830|NCT02427451|Venetoclax|venetoclax|mesh-list
64611831|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
64611832|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611833|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680937|NCT02937818|Durvalumab|durvalumab|mesh-list
64680938|NCT02937818|Olaparib|olaparib|mesh-list
64680939|NCT02937818|Tremelimumab|tremelimumab|mesh-list
64680940|NCT02937818|Adavosertib|adavosertib|mesh-list
64680941|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680942|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64680943|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64680944|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64680945|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64680946|NCT02867267|Thymalfasin|thymalfasin|mesh-list
64680947|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64680948|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
64680949|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680950|NCT02821832|Rifampin|rifampin|mesh-list
64680951|NCT02821832|Isoniazid|isoniazid|mesh-list
64680952|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
64680953|NCT02821832|Ethambutol|ethambutol|mesh-list
64680954|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64680955|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
64680956|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64680957|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680958|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
64680959|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64680967|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64680968|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64680969|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64297121|NCT02059915|Analgesics|analgesics|mesh-ancestor
64297122|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
64611877|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64611878|NCT03035617|Bupivacaine|bupivacaine|mesh-list
64611879|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
64611880|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
64611881|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297123|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297124|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
64297125|NCT02471404|Glimepiride|glimepiride|mesh-list
64297126|NCT02471404|Saxagliptin|saxagliptin|mesh-list
64297127|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64680970|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
64680971|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64680973|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64680974|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64680975|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
64680976|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64680977|NCT02799602|Docetaxel|docetaxel|mesh-list
64680978|NCT02799602|Androgens|androgens|mesh-list
64680979|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64680980|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
64680981|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
64611921|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64611922|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64611923|NCT04361461|Azithromycin|azithromycin|mesh-list
64611924|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
64611925|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64611926|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611927|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
64611928|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64611929|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64611930|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611931|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611932|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611934|NCT03002506|Ceftolozane|ceftolozane|mesh-list
64611935|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64611936|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64680982|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
64680983|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611937|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64680984|NCT02799602|Hormones|hormones|mesh-ancestor
64681025|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681026|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681027|NCT02542657|Clarithromycin|clarithromycin|mesh-list
64681028|NCT02542657|Dexamethasone|dexamethasone|mesh-list
64681029|NCT02542657|Pomalidomide|pomalidomide|mesh-list
64681030|NCT02542657|Ixazomib|ixazomib|mesh-list
64681031|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681032|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
64681033|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
64681034|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681035|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681036|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681038|NCT02542657|Hormones|hormones|mesh-ancestor
64681039|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681040|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681041|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681042|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611963|NCT00939991|Temozolomide|temozolomide|mesh-list
64611964|NCT00939991|Vorinostat|vorinostat|mesh-list
64611965|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611966|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611967|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64611968|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64611969|NCT00939991|Growth Substances|growth substances|mesh-ancestor
64611970|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611971|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
64611972|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64611973|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
64611974|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611975|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64611976|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611978|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
64681043|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64681044|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681045|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64681046|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681047|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64681048|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64681049|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
64681050|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64681051|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64681052|NCT02542657|Growth Substances|growth substances|mesh-ancestor
64681053|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
64681054|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
64681055|NCT02303171|Enoxaparin|enoxaparin|mesh-list
64681056|NCT02303171|Warfarin|warfarin|mesh-list
64681057|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
64681058|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64681059|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64681118|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
64681119|NCT01653678|Vitamins|vitamins|mesh-list
64681120|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
64681121|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681124|NCT01370811|Mandelic Acids|mandelic acids|mesh-list
64681162|NCT01323569|Hormones|hormones|mesh-ancestor
64681163|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681164|NCT01323465|Rifampin|rifampin|mesh-list
64681165|NCT01323465|Ketoconazole|ketoconazole|mesh-list
64681166|NCT01323465|Nabiximols|nabiximols|mesh-list
64681167|NCT01323465|Omeprazole|omeprazole|mesh-list
64681168|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64681169|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681170|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64681171|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681172|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681173|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64681174|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
64681175|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64681176|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681177|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
64612005|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64612006|NCT03033589|Bupivacaine|bupivacaine|mesh-list
64612007|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64681178|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64612008|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
64612009|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
64681179|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64681180|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64681181|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64681182|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64681183|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64681185|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
64681212|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
64681213|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64681214|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681215|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64681216|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64681217|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64681218|NCT01322139|Analgesics|analgesics|mesh-ancestor
64681219|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
64297128|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297130|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297131|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64297132|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297133|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
64612038|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64612039|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
64612040|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612041|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
64612042|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64681220|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681221|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
64681223|NCT01176006|Fludarabine|fludarabine|mesh-list
64681224|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
64681225|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681226|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
64681227|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681228|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681229|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681230|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
64681231|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681232|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681233|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681234|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64681235|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
64681236|NCT01169259|Vitamin D|vitamin d|mesh-list
64681237|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
64681238|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
64681261|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681262|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681263|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
64681264|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612087|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612088|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612089|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
64612090|NCT03002974|Triamcinolone|triamcinolone|mesh-list
64612092|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64612093|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64612094|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64612095|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612096|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
64612097|NCT03002974|Hormones|hormones|mesh-ancestor
64612098|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612099|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612100|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64612101|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
64681265|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681266|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681267|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64681268|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64681269|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64681270|NCT00885326|Growth Substances|growth substances|mesh-ancestor
64681271|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
64681272|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64681273|NCT00715442|Sunitinib|sunitinib|mesh-list
64681274|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681275|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64681276|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64297134|NCT02471404|Incretins|incretins|mesh-ancestor
64297135|NCT02471404|Hormones|hormones|mesh-ancestor
64297136|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681277|NCT00715442|Growth Substances|growth substances|mesh-ancestor
64297137|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64297138|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
64297139|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297140|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
64297141|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64297142|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297143|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64297145|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
64297146|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
64612126|NCT04941703|Cathartics|cathartics|mesh-ancestor
64612127|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612128|NCT04359823|Lovastatin|lovastatin|mesh-list
64612129|NCT04359823|L 647318|l 647318|mesh-list
64612130|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
64612131|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64612132|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64612133|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
64612134|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612135|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64612136|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64612137|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612138|NCT03008590|Naltrexone|naltrexone|mesh-list
64612139|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64612140|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64681278|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612141|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681279|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
64681280|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64681281|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681282|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681283|NCT00606138|Ranibizumab|ranibizumab|mesh-list
64681284|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64681285|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64681286|NCT00606138|Growth Substances|growth substances|mesh-ancestor
64681287|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681288|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
64681289|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681290|NCT00390793|Cytarabine|cytarabine|mesh-list
64681368|NCT00002643|Topotecan|topotecan|mesh-list
64681369|NCT00002643|Amifostine|amifostine|mesh-list
64681370|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681371|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
64681372|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681373|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64681374|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64612161|NCT00955513|Analgesics|analgesics|mesh-ancestor
64612162|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
64681375|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
64681376|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681377|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681378|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64681379|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64681380|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681452|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681453|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681454|NCT00002679|Tamoxifen|tamoxifen|mesh-list
64612163|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612164|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612165|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612166|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612167|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64612168|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612169|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612171|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64612172|NCT00935311|Hydrocodone|hydrocodone|mesh-list
64612174|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64681455|NCT00002679|Paclitaxel|paclitaxel|mesh-list
64681456|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
64681457|NCT00002679|Doxorubicin|doxorubicin|mesh-list
64681458|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64681459|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681460|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681461|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681462|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681463|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681465|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64681516|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
64681517|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681518|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64681519|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64612195|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
64612196|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
64612197|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681520|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681521|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64681522|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64681523|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
64681524|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681525|NCT00002691|Antidotes|antidotes|mesh-ancestor
64681526|NCT00002691|Protective Agents|protective agents|mesh-ancestor
64681527|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
64681528|NCT00002691|Vitamins|vitamins|mesh-ancestor
64681529|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
64681530|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
64612198|NCT02946892|Carvedilol|carvedilol|mesh-list
64681531|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681585|NCT00002715|Hormones|hormones|mesh-ancestor
64612199|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64612200|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64612201|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612202|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612203|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612204|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612205|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64612207|NCT02946892|Protective Agents|protective agents|mesh-ancestor
64612208|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64612209|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612210|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64612211|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
64612212|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64612221|NCT03402113|Midazolam|midazolam|mesh-list
64681586|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64681587|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681588|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681589|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64681628|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681629|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681630|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
64681631|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681633|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64681634|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681635|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681636|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64681637|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64681638|NCT04739345|Protective Agents|protective agents|mesh-ancestor
64297147|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297148|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297149|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
64297150|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297151|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64297152|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64297153|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64297154|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297155|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297156|NCT03100994|Bupivacaine|bupivacaine|mesh-list
64681639|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681640|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
64681641|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64681642|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
64681643|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64681644|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64681645|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64681646|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64681647|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681648|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
64681649|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681650|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681651|NCT01625455|Aprepitant|aprepitant|mesh-list
64681652|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
64681653|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
64681654|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681655|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681673|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64681674|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64681676|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
64681677|NCT00002733|Aldesleukin|aldesleukin|mesh-list
64681678|NCT00002733|Cimetidine|cimetidine|mesh-list
64612227|NCT03402113|Analgesics|analgesics|mesh-ancestor
64612228|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
64681679|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681680|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
64681681|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681682|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
64681683|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681684|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64681685|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64681686|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64681687|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64681688|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64681689|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
64681690|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
64681691|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64681692|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681693|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64681694|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64681695|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681696|NCT04311671|Ivermectin|ivermectin|mesh-list
64681697|NCT04311671|Albendazole|albendazole|mesh-list
64681698|NCT04311671|Moxidectin|moxidectin|mesh-list
64681701|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
64681726|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
64681727|NCT00002751|Antibodies|antibodies|mesh-list
64681728|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64681729|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
64681730|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681731|NCT00002757|Cytarabine|cytarabine|mesh-list
64681732|NCT00002757|Prednisone|prednisone|mesh-list
64681733|NCT00002757|Prednisolone|prednisolone|mesh-list
64681734|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
64681735|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64681736|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64681737|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64407133|NCT04843553|Niacin|niacin|mesh-list
64681738|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
64681739|NCT00002757|Doxorubicin|doxorubicin|mesh-list
64681740|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64681741|NCT00002757|Methotrexate|methotrexate|mesh-list
64297157|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
64297158|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
64297159|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297160|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297161|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
64297162|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612252|NCT01725113|Vitamins|vitamins|mesh-ancestor
64297163|NCT04160936|Bupivacaine|bupivacaine|mesh-list
64297164|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
64681742|NCT00002757|Etoposide|etoposide|mesh-list
64681743|NCT00002757|Vincristine|vincristine|mesh-list
64681776|NCT00002763|Interferons|interferons|mesh-list
64681777|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
64681778|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681779|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
64681780|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64681781|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
64681782|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681783|NCT00002775|Docetaxel|docetaxel|mesh-list
64681784|NCT00002775|Estramustine|estramustine|mesh-list
64681785|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681786|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
64681787|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
64681788|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
64681789|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681790|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64681791|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
64681792|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64681793|NCT01631149|Rocuronium|rocuronium|mesh-list
64681794|NCT01631149|Atracurium|atracurium|mesh-list
64681795|NCT01631149|Mivacurium|mivacurium|mesh-list
64681798|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64681834|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
64681835|NCT00002793|Leucovorin|leucovorin|mesh-list
64681888|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64681889|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64681890|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64681891|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407224|NCT03042923|Mannitol|mannitol|mesh-list
64681892|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64681893|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64681894|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64681895|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681896|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64681897|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681899|NCT04003649|Ipilimumab|ipilimumab|mesh-list
64681900|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64681901|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64681902|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64681903|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64681904|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
64681905|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64681907|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64612285|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612286|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
64612287|NCT03031327|Protective Agents|protective agents|mesh-ancestor
64612288|NCT03401957|Cetuximab|cetuximab|mesh-list
64681949|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64612289|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64612291|NCT04358965|Misoprostol|misoprostol|mesh-list
64681995|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
64681997|NCT00361517|Amebicides|amebicides|mesh-ancestor
64681998|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64681999|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64682000|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682001|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64682002|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
64682003|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64682004|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682005|NCT03920267|BMS-986165|bms-986165|mesh-list
64297167|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297168|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
64682006|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
64682007|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64612312|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682008|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612313|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64612314|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64612315|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64682009|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682010|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
64682011|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64682012|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682013|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682014|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64682032|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64612366|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612367|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64612368|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64682033|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682035|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64682036|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
64682037|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64682038|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64682039|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64682040|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64682041|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
64682042|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64682043|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64682044|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
64682045|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682046|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
64682047|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64682048|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64682050|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64682051|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682052|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
64682053|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
64682054|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
64682055|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682056|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
64682057|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
64682058|NCT04387201|Dulaglutide|dulaglutide|mesh-list
64682059|NCT04387201|Vitamins|vitamins|mesh-ancestor
64682060|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
64682061|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612369|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612370|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612371|NCT03030937|Irinotecan|irinotecan|mesh-list
64612372|NCT03030937|Apatinib|apatinib|mesh-list
64612373|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64682063|NCT04387201|Hematinics|hematinics|mesh-ancestor
64682132|NCT01637935|Pioglitazone|pioglitazone|mesh-list
64682133|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682189|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
64682190|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64407543|NCT03036605|BB 1101|bb 1101|mesh-list
64682191|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64682192|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64682193|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
64682194|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682195|NCT01642147|Anesthetics|anesthetics|mesh-list
64682196|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682197|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682198|NCT04584749|Lidocaine|lidocaine|mesh-list
64682199|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
64682210|NCT05502315|Nivolumab|nivolumab|mesh-list
64682220|NCT00362141|Levetiracetam|levetiracetam|mesh-list
64682221|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
64682222|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
64682223|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
64682224|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
64682225|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64682226|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64682227|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682228|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682229|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682230|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682231|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64682232|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64682233|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682235|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64682236|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682237|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64682238|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682239|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682240|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64682241|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
64682242|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
64682243|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682244|NCT03002935|Vitamins|vitamins|mesh-ancestor
64682245|NCT03788291|Rituximab|rituximab|mesh-list
64612396|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612397|NCT02246023|Propofol|propofol|mesh-list
64612398|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64612403|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
64682246|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
64682247|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682248|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682249|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
64682250|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682251|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64682252|NCT04593459|Metformin|metformin|mesh-list
64682253|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64682254|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682255|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
64682256|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
64682257|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64682258|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64682261|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682263|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64682264|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
64682265|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682266|NCT03251924|Nivolumab|nivolumab|mesh-list
64682267|NCT03251924|Ipilimumab|ipilimumab|mesh-list
64682268|NCT03251924|Antibodies|antibodies|mesh-list
64682269|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
64682270|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
64682271|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
64682272|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612427|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64612428|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
64612429|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612430|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612431|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
64612432|NCT05706987|Lidocaine|lidocaine|mesh-list
64612433|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
64612434|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
64612435|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612436|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612437|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
64612438|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612439|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64682273|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64682274|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682275|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64682276|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682277|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
64682278|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64682279|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682280|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682281|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64682282|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64682283|NCT03767075|Atezolizumab|atezolizumab|mesh-list
64682284|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682303|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64682304|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64682306|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682307|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682373|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64682374|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
64682375|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682376|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64682377|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682378|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
64682379|NCT01654861|Gemcitabine|gemcitabine|mesh-list
64682380|NCT01654861|Vitamins|vitamins|mesh-ancestor
64682440|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
64682441|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64682442|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
64682444|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64682445|NCT01655563|Tacrolimus|tacrolimus|mesh-list
64682446|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64682447|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
64682448|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682452|NCT01655719|Pioglitazone|pioglitazone|mesh-list
64682507|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682508|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
64682509|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64682510|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64682511|NCT01350141|Bococizumab|bococizumab|mesh-list
64682512|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64682513|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64682514|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
64682574|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
64682575|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682576|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682577|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
64612467|NCT02959359|Ribavirin|ribavirin|mesh-list
64337870|NCT01480583|Trastuzumab|trastuzumab|mesh-list
64612468|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
64612469|NCT02959359|Ledipasvir|ledipasvir|mesh-list
64612470|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
64612471|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612472|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
64612473|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612474|NCT02829034|Ranolazine|ranolazine|mesh-list
64682578|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682579|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64682580|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64682581|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64682582|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682583|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682630|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682631|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682632|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682633|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
64682636|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
64682768|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64682769|NCT00000357|Narcotics|narcotics|mesh-ancestor
64682770|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297170|NCT03103334|Methotrexate|methotrexate|mesh-list
64297171|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64297172|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
64682771|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682772|NCT00000357|Analgesics|analgesics|mesh-ancestor
64682773|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
64682774|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682775|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64682777|NCT05095311|Nedocromil|nedocromil|mesh-list
64682778|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64682779|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64682810|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64682811|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64682812|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
64682813|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64682814|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64682815|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682816|NCT04330755|Protective Agents|protective agents|mesh-ancestor
64682817|NCT01608295|Paroxetine|paroxetine|mesh-list
64682818|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
64682819|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64682820|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64682821|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64682822|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682823|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682824|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682825|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
64682826|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682827|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64682828|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612491|NCT00924209|Antiviral Agents|antiviral agents|mesh-ancestor
64612492|NCT00924209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64682829|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64682830|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64682831|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64682832|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64682833|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64682834|NCT04713189|Fentanyl|fentanyl|mesh-list
64682835|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64682836|NCT04713189|Narcotics|narcotics|mesh-ancestor
64682837|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64682838|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64682839|NCT04713189|Analgesics|analgesics|mesh-ancestor
64682840|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
64682841|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64682842|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64682843|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64682845|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
64682903|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64682904|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297173|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64297174|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297175|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64682905|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
64682906|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
64682907|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64682908|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682909|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
64682910|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64682911|NCT00000441|Analgesics|analgesics|mesh-ancestor
64682912|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
64682913|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64682914|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682915|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64682917|NCT00000447|Naltrexone|naltrexone|mesh-list
64682963|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64682964|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64682965|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64682966|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64682968|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683031|NCT00000483|Vitamins|vitamins|mesh-ancestor
64683032|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
64683033|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64683034|NCT05276973|Paclitaxel|paclitaxel|mesh-list
64683035|NCT05276973|Carboplatin|carboplatin|mesh-list
64683036|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64683043|NCT00000507|Streptokinase|streptokinase|mesh-list
64683094|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612518|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612519|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64612520|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612521|NCT03406247|Nivolumab|nivolumab|mesh-list
64612522|NCT03406247|Ipilimumab|ipilimumab|mesh-list
64683095|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683096|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683097|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64683098|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64683099|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
64683100|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64683101|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64683102|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
64683160|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683161|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683163|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64683164|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
64612542|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64612543|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64612544|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612545|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612546|NCT05717361|Analgesics|analgesics|mesh-ancestor
64612549|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
64683165|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683166|NCT01621009|Bupropion|bupropion|mesh-list
64683167|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64683168|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
64683169|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64683170|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64683171|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64683173|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683174|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
64683175|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683217|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683218|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64683219|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683220|NCT01621477|Cytarabine|cytarabine|mesh-list
64683221|NCT01621477|Plerixafor|plerixafor|mesh-list
64683222|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
64683223|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
64683224|NCT01621477|Busulfan|busulfan|mesh-list
64683225|NCT01621477|Clofarabine|clofarabine|mesh-list
64683226|NCT01621477|Tacrolimus|tacrolimus|mesh-list
64683227|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
64683228|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64683229|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683230|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
64683231|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683232|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683233|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64683234|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
64683235|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683236|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683237|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64683238|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64683239|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
64683240|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
64683241|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683242|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64683243|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683244|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64683246|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
64683266|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64683267|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64683268|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683389|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408745|NCT05016349|Vitamins|vitamins|mesh-ancestor
64683390|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64683391|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64683441|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683442|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
64683443|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64683444|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
64683445|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64612626|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683446|NCT00000729|Foscarnet|foscarnet|mesh-list
64683447|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64683448|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
64683449|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64683450|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64683451|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64683452|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683453|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683454|NCT03438773|Tacrolimus|tacrolimus|mesh-list
64683455|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683456|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
64683502|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64683503|NCT05700266|Analgesics|analgesics|mesh-ancestor
64683504|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
64683505|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683506|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683507|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683508|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683509|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64683510|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64683511|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683512|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64612627|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
64683513|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64683514|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612628|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
64612629|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612630|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612631|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612632|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
64612633|NCT04374071|Hormones|hormones|mesh-ancestor
64612634|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612635|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64612636|NCT04374071|Protective Agents|protective agents|mesh-ancestor
64612638|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683526|NCT04340193|Nivolumab|nivolumab|mesh-list
64683563|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64683564|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64683565|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64683566|NCT05681702|Analgesics|analgesics|mesh-ancestor
64683568|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683569|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683570|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64683571|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683572|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64683626|NCT00421811|Melphalan|melphalan|mesh-list
64683628|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
64683629|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683630|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683631|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64683632|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683633|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
64683634|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683635|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
64683636|NCT03363893|Fulvestrant|fulvestrant|mesh-list
64683694|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
64683695|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64683696|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64683697|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
64683698|NCT04342247|Hormones|hormones|mesh-ancestor
64683699|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64683700|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683701|NCT04342247|Androgens|androgens|mesh-ancestor
64683702|NCT05738642|Thrombin|thrombin|mesh-list
64612662|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612663|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64612664|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612665|NCT05716347|Vaccines|vaccines|mesh-list
64612666|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
64612667|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612668|NCT02959840|Ondansetron|ondansetron|mesh-list
64612669|NCT02959840|Metoclopramide|metoclopramide|mesh-list
64612670|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
64612671|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
64612672|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612673|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612674|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612675|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
64612676|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
64612677|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64612678|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
64612681|NCT02959840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64683761|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64683762|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64683763|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64683764|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64683765|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
64683766|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64683767|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683769|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64683770|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
64683773|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64683824|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64683825|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64683826|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64683827|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683828|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64683940|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64683941|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64683942|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
64683943|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64683944|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64683945|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612693|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64612694|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612695|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64612696|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64612697|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612698|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612700|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64612701|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64612702|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
64612703|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612704|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64612706|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64612707|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612708|NCT02959996|Bupivacaine|bupivacaine|mesh-list
64612709|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
64683946|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64683948|NCT04230681|Hydromorphone|hydromorphone|mesh-list
64683949|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64684005|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
64684006|NCT03467373|Rituximab|rituximab|mesh-list
64684007|NCT03467373|Doxorubicin|doxorubicin|mesh-list
64684008|NCT03467373|Vincristine|vincristine|mesh-list
64684009|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
64684010|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684011|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
64684012|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684025|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
64684133|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64684135|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612737|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
64612738|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
64684136|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64684137|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64684138|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684139|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409497|NCT02597933|Nintedanib|nintedanib|mesh-list
64684140|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64684141|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64684142|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
64684143|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684175|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684176|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684177|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684178|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684179|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
64684180|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64684181|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684182|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684183|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64684184|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
64612739|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
64612740|NCT02240459|Fesoterodine|fesoterodine|mesh-list
64612741|NCT02240459|Oxybutynin|oxybutynin|mesh-list
64612742|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64612743|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64612744|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
64612745|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612746|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612747|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612748|NCT02240459|Urological Agents|urological agents|mesh-ancestor
64684185|NCT04330677|Oxytocin|oxytocin|mesh-list
64684186|NCT04330677|Estrogens|estrogens|mesh-list
64684187|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
64684188|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64684189|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684190|NCT04330677|Hormones|hormones|mesh-ancestor
64297176|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
64297177|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297178|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297179|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297180|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297181|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64380827|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380828|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64380830|NCT03192293|Fulvestrant|fulvestrant|mesh-list
64380831|NCT03192293|Simvastatin|simvastatin|mesh-list
64380832|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380833|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380834|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64380835|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64380836|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
64380837|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380838|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64380839|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64380847|NCT02439125|Eltoprazine|eltoprazine|mesh-list
64380855|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380857|NCT01604265|Analgesics|analgesics|mesh-ancestor
64380858|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
64380859|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380860|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612765|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612766|NCT02240927|Enoxaparin|enoxaparin|mesh-list
64612767|NCT02240927|Warfarin|warfarin|mesh-list
64612768|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
64612769|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
64612770|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64612771|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64612772|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612774|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64612775|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64612776|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
64612777|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
64612778|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612779|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612780|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380861|NCT04483427|Ketorolac|ketorolac|mesh-list
64380862|NCT04483427|Nalbuphine|nalbuphine|mesh-list
64380863|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64380864|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64380865|NCT04483427|Analgesics|analgesics|mesh-ancestor
64380866|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
64380867|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380868|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380869|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684191|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684192|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
64684193|NCT04965116|Progestins|progestins|mesh-list
64684194|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64684195|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684196|NCT04965116|Hormones|hormones|mesh-ancestor
64684197|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64684198|NCT02422615|Fulvestrant|fulvestrant|mesh-list
64684199|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64684200|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684271|NCT03166761|Triamcinolone|triamcinolone|mesh-list
64684272|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64684273|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64684274|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64684275|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64684282|NCT03166761|Hormones|hormones|mesh-ancestor
64684426|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612802|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612803|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612804|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612805|NCT00930293|Dexetimide|dexetimide|mesh-list
64612806|NCT00930293|Citalopram|citalopram|mesh-list
64612807|NCT00930293|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64612808|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64612809|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612810|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612811|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612812|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
64684427|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
64684428|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684429|NCT02250703|Midazolam|midazolam|mesh-list
64684430|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
64684431|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64684432|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684433|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684434|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64684435|NCT02250703|Analgesics|analgesics|mesh-ancestor
64684436|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
64684437|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684438|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64684439|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64684487|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64684488|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
64684489|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
64684490|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64684491|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684492|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64684493|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64684494|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64684495|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612840|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
64684552|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64684553|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684555|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64684556|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684557|NCT02372630|Incretins|incretins|mesh-ancestor
64684623|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64684624|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684625|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
64612841|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612842|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64612843|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
64338252|NCT01234025|Hormones|hormones|mesh-ancestor
64612844|NCT04347005|Protective Agents|protective agents|mesh-ancestor
64612845|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612847|NCT00358293|Analgesics|analgesics|mesh-ancestor
64612848|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
64612849|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612850|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612851|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
64612852|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64612853|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64684626|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684627|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684628|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64684681|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64684682|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684683|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
64684684|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684686|NCT02975141|Paclitaxel|paclitaxel|mesh-list
64684687|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64684688|NCT02975141|Afatinib|afatinib|mesh-list
64684689|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684690|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684691|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684692|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684693|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684694|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612871|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
64612872|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612873|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64612874|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64612875|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
64612876|NCT02241083|Protective Agents|protective agents|mesh-ancestor
64612877|NCT04372589|Heparin|heparin|mesh-list
64612878|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
64612879|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64612880|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64684695|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64612881|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684696|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
64612882|NCT04364399|Vaccines|vaccines|mesh-list
64684697|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
64684698|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684730|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684731|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64684732|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64684733|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64684734|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64684735|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
64684736|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
64684737|NCT05316649|Chrysarobin|chrysarobin|mesh-list
64684738|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64410107|NCT05157711|Antacids|antacids|mesh-ancestor
64684739|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64684794|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684795|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684796|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684797|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684798|NCT03083405|Opipramol|opipramol|mesh-list
64612918|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
64612919|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
64612921|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612922|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612923|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64612924|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612925|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64612927|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64612928|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64612929|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612930|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64612931|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
64612933|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
64612934|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
64612935|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612936|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612937|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64684799|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64684800|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
64684801|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64684802|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64684803|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64684804|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64684805|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684806|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
64684807|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64684808|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684853|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684854|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684855|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64684856|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684858|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684859|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64684860|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64684861|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64684862|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
64612960|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612961|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612962|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612963|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612964|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64612965|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64612966|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
64612967|NCT02241941|Daptomycin|daptomycin|mesh-list
64612968|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64612969|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612970|NCT05316129|Hormones|hormones|mesh-list
64612971|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64612972|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612973|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684863|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64684867|NCT00002937|Paclitaxel|paclitaxel|mesh-list
64684868|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64684869|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684870|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684871|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684872|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
64297182|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297183|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
64297184|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297185|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64684873|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684875|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684876|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
64684877|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
64684878|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
64684880|NCT02918955|Cisplatin|cisplatin|mesh-list
64684905|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684906|NCT05315557|Terlipressin|terlipressin|mesh-list
64684907|NCT05315557|Vasopressins|vasopressins|mesh-list
64684908|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
64684909|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
64684910|NCT05315557|Coagulants|coagulants|mesh-ancestor
64684911|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64684912|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64684913|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
64684914|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684915|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64684916|NCT00002955|Leucovorin|leucovorin|mesh-list
64684917|NCT00002955|Trimetrexate|trimetrexate|mesh-list
64613003|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64613004|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613005|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64613006|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64613007|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64613009|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64613010|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64613011|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613012|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613013|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64613015|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
64613016|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613017|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613018|NCT05513391|Vaccines|vaccines|mesh-list
64613019|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
64613020|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613021|NCT04371341|Bupivacaine|bupivacaine|mesh-list
64613023|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
64684918|NCT00002955|Fluorouracil|fluorouracil|mesh-list
64684919|NCT00002955|Calcium|calcium|mesh-list
64684920|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
64684921|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64684922|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64684923|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
64684924|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64684925|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64684926|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64684927|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64684928|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
64684929|NCT00002955|Antidotes|antidotes|mesh-ancestor
64684957|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64684959|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
64684960|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64684961|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64684962|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64684963|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64613029|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64613030|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
64613031|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613032|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613033|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613034|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64613035|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64684964|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64684965|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64684966|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
64684967|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685019|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685020|NCT02767557|Gemcitabine|gemcitabine|mesh-list
64685021|NCT02767557|Paclitaxel|paclitaxel|mesh-list
64685022|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685023|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685024|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685025|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685026|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685086|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64685087|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613080|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613081|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64613083|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64613084|NCT03030157|Pirarubicin|pirarubicin|mesh-list
64613085|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613086|NCT00359385|Alendronate|alendronate|mesh-list
64613087|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64613088|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613089|NCT03029455|Ivacaftor|ivacaftor|mesh-list
64613090|NCT03029455|VX-659|vx-659|mesh-list
64613091|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64613092|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64685088|NCT00003021|Bizelesin|bizelesin|mesh-list
64685089|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685090|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685091|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685092|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
64685094|NCT03839823|Gemcitabine|gemcitabine|mesh-list
64297186|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64685155|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64613131|NCT02242877|Telmisartan|telmisartan|mesh-list
64685156|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685157|NCT00003057|Octreotide|octreotide|mesh-list
64685158|NCT00003057|Loperamide|loperamide|mesh-list
64685159|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
64685160|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64685161|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64685162|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685163|NCT00003063|Leucovorin|leucovorin|mesh-list
64685164|NCT00003063|Interferons|interferons|mesh-list
64685165|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
64685166|NCT00003063|Levamisole|levamisole|mesh-list
64685167|NCT00003063|Fluorouracil|fluorouracil|mesh-list
64685168|NCT00003063|Calcium|calcium|mesh-list
64685169|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
64685170|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64685171|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685172|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
64685175|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685216|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
64685217|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64685218|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64685219|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64685220|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64685221|NCT00003087|Paclitaxel|paclitaxel|mesh-list
64685222|NCT00003087|Cisplatin|cisplatin|mesh-list
64685223|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685224|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685225|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
64613195|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613196|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613197|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64613198|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
64613199|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64613200|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64613201|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64613202|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
64613203|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64613210|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
64685226|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685227|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685228|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685229|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
64685230|NCT00003093|Carboplatin|carboplatin|mesh-list
64685231|NCT00003093|Doxorubicin|doxorubicin|mesh-list
64685276|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685277|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685278|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
64685279|NCT00003105|Antiviral Agents|antiviral agents|mesh-ancestor
64685280|NCT00003105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685281|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685282|NCT00003105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685283|NCT00003105|Immunologic Factors|immunologic factors|mesh-ancestor
64685284|NCT00003105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685285|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685286|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685287|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685340|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64685341|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64685342|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64685343|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685344|NCT03965923|Tenofovir|tenofovir|mesh-list
64685345|NCT03965923|Emtricitabine|emtricitabine|mesh-list
64685346|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64685347|NCT03965923|Dapivirine|dapivirine|mesh-list
64685406|NCT02210559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685407|NCT00003129|Valrubicin|valrubicin|mesh-list
64613294|NCT04368377|Aspirin|aspirin|mesh-list
64613295|NCT04368377|PENTA|penta|mesh-list
64338727|NCT05414084|Phenol|phenol|mesh-list
64613296|NCT04368377|Tirofiban|tirofiban|mesh-list
64613297|NCT04368377|Fondaparinux|fondaparinux|mesh-list
64613298|NCT04368377|Clopidogrel|clopidogrel|mesh-list
64613299|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64613334|NCT04361513|Hormones|hormones|mesh-ancestor
64685408|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613357|NCT05593341|Analgesics|analgesics|mesh-ancestor
64613433|NCT00358371|Floxacillin|floxacillin|mesh-list
64613508|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64685409|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685410|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685411|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685412|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685413|NCT00003135|Doxorubicin|doxorubicin|mesh-list
64685473|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685474|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
64685475|NCT00003141|Thiotepa|thiotepa|mesh-list
64613581|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64685476|NCT00003141|Cisplatin|cisplatin|mesh-list
64685477|NCT00003141|Carboplatin|carboplatin|mesh-list
64685478|NCT00003141|Etoposide|etoposide|mesh-list
64685479|NCT00003141|Vincristine|vincristine|mesh-list
64685480|NCT00003141|Lenograstim|lenograstim|mesh-list
64685481|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685482|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
64685544|NCT01746043|Minocycline|minocycline|mesh-list
64685545|NCT01746043|Modafinil|modafinil|mesh-list
64685546|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614175|NCT05027919|Narcotics|narcotics|mesh-ancestor
64614253|NCT05017311|Citalopram|citalopram|mesh-list
64685547|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685548|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64614324|NCT00984139|Vaccines|vaccines|mesh-list
64685549|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685550|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64685551|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64685552|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64685553|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685554|NCT05635903|Diazepam|diazepam|mesh-list
64685555|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64685556|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
64685557|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
64685558|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
64685559|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685560|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685561|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64685563|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64685564|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64685565|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64685571|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
64685597|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685602|NCT01754389|Methotrexate|methotrexate|mesh-list
64685603|NCT01754389|Bortezomib|bortezomib|mesh-list
64614765|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64685662|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685663|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614910|NCT01502917|Antibodies|antibodies|mesh-list
64297187|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
64297188|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685664|NCT01756885|Varenicline|varenicline|mesh-list
64685665|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64685666|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64685667|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
64685668|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685669|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614982|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
64685670|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685671|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
64685672|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64685673|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685674|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685675|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685676|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64685677|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
64685678|NCT05554939|Fludarabine|fludarabine|mesh-list
64685679|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
64685680|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685681|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
64685682|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685683|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64685684|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64685685|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
64615353|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
64685686|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685687|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685688|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64615424|NCT04341883|Paclitaxel|paclitaxel|mesh-list
64685689|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685690|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
64685691|NCT01760785|Valproic Acid|valproic acid|mesh-list
64685701|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64685702|NCT04062097|Vitamin K|vitamin k|mesh-list
64685703|NCT04062097|Dabigatran|dabigatran|mesh-list
64685704|NCT04062097|Vitamins|vitamins|mesh-ancestor
64685705|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
64685706|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685707|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
64685708|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64685709|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
64685710|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685768|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
64685769|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64685770|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685771|NCT01766713|Ezetimibe|ezetimibe|mesh-list
64685772|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64685773|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64685774|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
64685775|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685776|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64685777|NCT01767103|Deferiprone|deferiprone|mesh-list
64685778|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64685779|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
64685780|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
64685781|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615642|NCT00634244|Growth Substances|growth substances|mesh-ancestor
64615643|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64685782|NCT01769209|Cytarabine|cytarabine|mesh-list
64685783|NCT01769209|Dexamethasone|dexamethasone|mesh-list
64685784|NCT01769209|Doxorubicin|doxorubicin|mesh-list
64685785|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64685786|NCT01769209|Methotrexate|methotrexate|mesh-list
64685787|NCT01769209|Vincristine|vincristine|mesh-list
64685788|NCT01769209|Bortezomib|bortezomib|mesh-list
64685789|NCT01769209|Asparaginase|asparaginase|mesh-list
64685790|NCT01769209|Pegaspargase|pegaspargase|mesh-list
64685791|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615852|NCT01929278|Tretinoin|tretinoin|mesh-list
64685792|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
64685793|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
64685794|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64685795|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685796|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64685797|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
64685798|NCT01769209|Hormones|hormones|mesh-ancestor
64685799|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64685800|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64685801|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685802|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64685803|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64685804|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64685805|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615923|NCT03933397|Analgesics|analgesics|mesh-ancestor
64615984|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615991|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
64685806|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685807|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64685808|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
64685809|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64685810|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64616228|NCT01050907|Miltefosine|miltefosine|mesh-list
64685812|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
64685813|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64685814|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64685815|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
64685816|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64685817|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64297190|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64297191|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297192|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616531|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
64297193|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297194|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297195|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64685818|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
64685819|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297196|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64297198|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
64616900|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
64616974|NCT03503578|Analgesics|analgesics|mesh-ancestor
64685862|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685864|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64685865|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
64685866|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64685867|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
64685868|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685869|NCT01673867|Docetaxel|docetaxel|mesh-list
64685870|NCT01673867|Nivolumab|nivolumab|mesh-list
64685871|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685872|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685873|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685874|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685875|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617578|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64685876|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685877|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64685878|NCT01777945|Docetaxel|docetaxel|mesh-list
64685879|NCT01777945|Capecitabine|capecitabine|mesh-list
64617825|NCT00939731|Crizotinib|crizotinib|mesh-list
64685880|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685881|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685882|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685883|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685884|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685885|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685887|NCT03012581|Nivolumab|nivolumab|mesh-list
64685888|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685889|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685890|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64685891|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617894|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64617959|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617960|NCT02245451|Analgesics|analgesics|mesh-ancestor
64685892|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64685893|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64685895|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64685896|NCT05473273|Progesterone|progesterone|mesh-list
64685897|NCT05473273|Estrogens|estrogens|mesh-ancestor
64685898|NCT05473273|Hormones|hormones|mesh-ancestor
64685899|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64685900|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685901|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64618050|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64618051|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64618052|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618053|NCT03030287|Paclitaxel|paclitaxel|mesh-list
64297202|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297203|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297204|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297205|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297206|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64297207|NCT02063269|Protective Agents|protective agents|mesh-ancestor
64297208|NCT00794846|Cetirizine|cetirizine|mesh-list
64297209|NCT00794846|Desloratadine|desloratadine|mesh-list
64297210|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64297211|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64297212|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64685903|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64685904|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64685906|NCT05451043|Gemcitabine|gemcitabine|mesh-list
64685907|NCT05451043|Paclitaxel|paclitaxel|mesh-list
64685908|NCT05451043|Durvalumab|durvalumab|mesh-list
64685909|NCT05451043|Tremelimumab|tremelimumab|mesh-list
64685910|NCT05451043|Propranolol|propranolol|mesh-list
64685911|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64685912|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64685913|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
64685914|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
64685915|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
64685916|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64685917|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64685918|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
64685919|NCT05451043|Antiviral Agents|antiviral agents|mesh-ancestor
64685920|NCT05451043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64685921|NCT05451043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618251|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64685922|NCT05451043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343609|NCT00394121|Xhance|xhance|mesh-list
64618252|NCT00952133|Dexamethasone|dexamethasone|mesh-list
64618253|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
64618255|NCT00952133|BB 1101|bb 1101|mesh-list
64618256|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618257|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
64618258|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
64618259|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618260|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685923|NCT05451043|Immunologic Factors|immunologic factors|mesh-ancestor
64685924|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64685925|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64685949|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64685950|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64685951|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64685952|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64685953|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
64411303|NCT01697527|Analgesics|analgesics|mesh-ancestor
64618318|NCT05506488|Quercetin|quercetin|mesh-list
64685954|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64685956|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64685957|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
64686018|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
64297213|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
64686019|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686020|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686021|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
64686022|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686023|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686024|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686025|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
64686026|NCT02115997|Hormones|hormones|mesh-ancestor
64686027|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686028|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64686029|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
64686030|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
64686031|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686033|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64686035|NCT01805323|Dexamethasone|dexamethasone|mesh-list
64686077|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686078|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686079|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686080|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64686081|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686082|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
64686083|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686084|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64686085|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64686086|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
64686087|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618751|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
64686088|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64686089|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
64686090|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
64686091|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
64686092|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686093|NCT01808755|Trimethoprim|trimethoprim|mesh-list
64686108|NCT02694809|Estrogens|estrogens|mesh-list
64686133|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64686134|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64686135|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686136|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686137|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
64686138|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686139|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64686140|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64686141|NCT01790659|Gentamicins|gentamicins|mesh-list
64618972|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618973|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618974|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64618975|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64618976|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64618977|NCT00962039|Citalopram|citalopram|mesh-list
64686142|NCT01790659|Paromomycin|paromomycin|mesh-list
64686143|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64618987|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64686144|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297215|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297216|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297217|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297218|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64297219|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297220|NCT00794768|Fexofenadine|fexofenadine|mesh-list
64297221|NCT00794768|Desloratadine|desloratadine|mesh-list
64297222|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64297223|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297224|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686145|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64686150|NCT00544115|Cyclosporine|cyclosporine|mesh-list
64686195|NCT01733953|Atorvastatin|atorvastatin|mesh-list
64686196|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64686197|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64686198|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
64686199|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686200|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64686201|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64686202|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686203|NCT00362921|Carmustine|carmustine|mesh-list
64686204|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64686205|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64686206|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
64686207|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686208|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686209|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619334|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64619335|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619337|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619338|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64619339|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686210|NCT01734889|Nitisinone|nitisinone|mesh-list
64686211|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686212|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619341|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
64619342|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619343|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619344|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
64619345|NCT03797872|Hormones|hormones|mesh-ancestor
64619346|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619347|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64619348|NCT03797872|Protective Agents|protective agents|mesh-ancestor
64619349|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64619350|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619351|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619352|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686213|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64686214|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64686215|NCT01796665|Clindamycin|clindamycin|mesh-list
64686216|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
64686217|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
64686218|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64686219|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686220|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686246|NCT01800877|Norepinephrine|norepinephrine|mesh-list
64686247|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64686248|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64686249|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371053|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371055|NCT03948347|Liraglutide|liraglutide|mesh-list
64371090|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371091|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371092|NCT00705341|Fluticasone|fluticasone|mesh-list
64371094|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64371095|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
64686250|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686251|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686252|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686253|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686254|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64686255|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64686256|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
64411606|NCT05700617|Dobutamine|dobutamine|mesh-list
64686257|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686258|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64371298|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371299|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371300|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64371301|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64371303|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371304|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64371305|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64371306|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
64371307|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371308|NCT03312179|Incretins|incretins|mesh-list
64371309|NCT03312179|Hormones|hormones|mesh-ancestor
64371310|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371311|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371312|NCT02468531|Xenon|xenon|mesh-list
64371313|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64371314|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
64371340|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371342|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371343|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371344|NCT02468999|Insulin|insulin|mesh-list
64371345|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64371347|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371350|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
64371351|NCT03311321|Vitamins|vitamins|mesh-ancestor
64446885|NCT01507246|Morphine|morphine|mesh-list
64686259|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
64686260|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
64686261|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
64686262|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64686263|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
64686264|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64686303|NCT04744571|Metoprolol|metoprolol|mesh-list
64686304|NCT04744571|Clopidogrel|clopidogrel|mesh-list
64686305|NCT04744571|Ticagrelor|ticagrelor|mesh-list
64686306|NCT04744571|Atorvastatin|atorvastatin|mesh-list
64686307|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64371398|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64371399|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64371400|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371401|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64371402|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64371403|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64371404|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64371405|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
64371408|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371410|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
64371411|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
64371412|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371413|NCT03303677|Vancomycin|vancomycin|mesh-list
64371414|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
64371415|NCT03303677|Gentamicins|gentamicins|mesh-list
64371416|NCT03303677|Mupirocin|mupirocin|mesh-list
64371417|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64371418|NCT03303677|Trimethoprim|trimethoprim|mesh-list
64371419|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
64371420|NCT03303677|Budesonide|budesonide|mesh-list
64371421|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371427|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
64447159|NCT02140645|Hormones|hormones|mesh-ancestor
64447160|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447161|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64447162|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
64447163|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447164|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447165|NCT02140411|Ranibizumab|ranibizumab|mesh-list
64447166|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64447167|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64686308|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64686309|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686310|NCT04744571|Analgesics|analgesics|mesh-ancestor
64686311|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
64447171|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686312|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297225|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297226|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297227|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64447172|NCT02139943|Canagliflozin|canagliflozin|mesh-list
64447173|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64371430|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371432|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64371433|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64686313|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297228|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64297229|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
64297230|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
64297231|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64686314|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686315|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447221|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
64686316|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64447222|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447224|NCT01462318|Midazolam|midazolam|mesh-list
64447225|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
64447226|NCT01462318|Caffeine|caffeine|mesh-list
64447227|NCT01462318|Omeprazole|omeprazole|mesh-list
64447228|NCT01462318|Warfarin|warfarin|mesh-list
64686317|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64686318|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686319|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64686320|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64686321|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686358|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64686359|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
64686360|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686361|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
64686362|NCT02257957|Protective Agents|protective agents|mesh-ancestor
64686363|NCT02524769|Estrogens|estrogens|mesh-list
64686364|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64686365|NCT02524769|Hormones|hormones|mesh-ancestor
64686366|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686367|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686423|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64447274|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447275|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64447276|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64447277|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447278|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447279|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447280|NCT04079686|Cefazolin|cefazolin|mesh-list
64447281|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686424|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64686425|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64686426|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686427|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686428|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686429|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
64686430|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64686431|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64686432|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371462|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64371463|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371464|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64371465|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371466|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
64371467|NCT03303209|Narcotics|narcotics|mesh-ancestor
64371468|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686433|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
64686434|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
64686436|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64686437|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686438|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64686439|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686440|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
64686443|NCT02531321|Estradiol|estradiol|mesh-list
64686477|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686478|NCT02417831|Urological Agents|urological agents|mesh-ancestor
64686479|NCT02419547|Fentanyl|fentanyl|mesh-list
64686480|NCT02419547|Midazolam|midazolam|mesh-list
64686481|NCT02419547|Propofol|propofol|mesh-list
64686482|NCT02419547|Sevoflurane|sevoflurane|mesh-list
64447380|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447381|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64686483|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64686484|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686485|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686486|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64686487|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
64686488|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
64686489|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64686541|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64371560|NCT03302039|Bupivacaine|bupivacaine|mesh-list
64371561|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
64447427|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
64447428|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447429|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64447430|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64447431|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64447432|NCT02105636|Docetaxel|docetaxel|mesh-list
64447433|NCT02105636|Methotrexate|methotrexate|mesh-list
64447434|NCT02105636|Nivolumab|nivolumab|mesh-list
64447435|NCT02105636|Cetuximab|cetuximab|mesh-list
64447436|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447437|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
64686542|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64686543|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686544|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686545|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297233|NCT02060851|Trace Elements|trace elements|mesh-ancestor
64297234|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
64297235|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297236|NCT00779636|Desloratadine|desloratadine|mesh-list
64297237|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64297238|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297239|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297240|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297241|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686547|NCT02420015|Nicotine|nicotine|mesh-list
64686548|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64686549|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
64686550|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686551|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686552|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64447524|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447525|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
64447526|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64447527|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447528|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447529|NCT02123966|Sirolimus|sirolimus|mesh-list
64447530|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64447531|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447532|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64371646|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64371647|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371648|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64371649|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64371650|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
64371651|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64447534|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
64447535|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686553|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64686554|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
64686555|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686558|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
64686597|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686599|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
64686600|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371663|NCT02467595|Bromides|bromides|mesh-list
64686601|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686602|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64447599|NCT02139644|Hormones|hormones|mesh-ancestor
64686603|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64686666|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64686667|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686668|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686669|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64686670|NCT00363935|Analgesics|analgesics|mesh-ancestor
64371879|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
64686671|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
64686672|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686673|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64686674|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64686675|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64686728|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
64686729|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686730|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64686731|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64686732|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686733|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686734|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686735|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686794|NCT02545907|Dexamethasone|dexamethasone|mesh-list
64686795|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686796|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
64686797|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
64447769|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447770|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64447772|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64447773|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
64447774|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447775|NCT03836105|Cemiplimab|cemiplimab|mesh-list
64447776|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64447777|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447778|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
64447779|NCT02123108|Tacrolimus|tacrolimus|mesh-list
64447780|NCT02123108|Basiliximab|basiliximab|mesh-list
64372056|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64372057|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64372058|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686798|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686799|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686800|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64686801|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
64686802|NCT02545907|Hormones|hormones|mesh-ancestor
64297242|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64297243|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64297244|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
64297245|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
64297246|NCT02060929|Esketamine|esketamine|mesh-list
64447814|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297247|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
64297248|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297249|NCT00757562|Desloratadine|desloratadine|mesh-list
64380870|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380871|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64380872|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380873|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380874|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64380875|NCT04483427|Narcotics|narcotics|mesh-ancestor
64380876|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380877|NCT01664247|Liraglutide|liraglutide|mesh-list
64380878|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380879|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380880|NCT01664247|Incretins|incretins|mesh-ancestor
64380881|NCT01664247|Hormones|hormones|mesh-ancestor
64380883|NCT02441465|Vemurafenib|vemurafenib|mesh-list
64380888|NCT02438657|Lidocaine|lidocaine|mesh-list
64372142|NCT04490213|Laxatives|laxatives|mesh-ancestor
64372143|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64447865|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447866|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447867|NCT02096042|Azacitidine|azacitidine|mesh-list
64447868|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64447869|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64447870|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
64447871|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447872|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447873|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447874|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64447875|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
64447876|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
64380902|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64380903|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447878|NCT02069366|Dronabinol|dronabinol|mesh-list
64686803|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64686804|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64686805|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686806|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64686807|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
64686808|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
64686809|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64686810|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64686811|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64686812|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64686849|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64686851|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64686853|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686920|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686921|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447896|NCT02068508|Pioglitazone|pioglitazone|mesh-list
64447897|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447898|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447899|NCT02207231|Adalimumab|adalimumab|mesh-list
64447900|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64447901|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64447902|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447903|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
64447904|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447905|NCT02206685|Methadone|methadone|mesh-list
64447906|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64447907|NCT02206685|Narcotics|narcotics|mesh-ancestor
64447908|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447909|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447910|NCT02206685|Analgesics|analgesics|mesh-ancestor
64447911|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
64686922|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686923|NCT02501135|Bupivacaine|bupivacaine|mesh-list
64686924|NCT02501135|Ropivacaine|ropivacaine|mesh-list
64686925|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
64686926|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
64686927|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64686928|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64686929|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
64372212|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64372213|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64372214|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372215|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64372216|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64372217|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
64372218|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
64372219|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
64372220|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686930|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64686931|NCT02550743|Capecitabine|capecitabine|mesh-list
64686932|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64686933|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
64686934|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686935|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64686936|NCT02437253|Adalimumab|adalimumab|mesh-list
64686937|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64686938|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686939|NCT01829503|Cytarabine|cytarabine|mesh-list
64686940|NCT01829503|Decitabine|decitabine|mesh-list
64686973|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64686974|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64686975|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64686976|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64686977|NCT02504723|Carvedilol|carvedilol|mesh-list
64686978|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64686979|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64686980|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
64686981|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64686983|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372240|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447991|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447992|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447993|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
64447994|NCT01884675|Ambrisentan|ambrisentan|mesh-list
64447995|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64447996|NCT01884597|Ranibizumab|ranibizumab|mesh-list
64447997|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64447998|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64297250|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64297251|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297252|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447999|NCT01884597|Growth Substances|growth substances|mesh-ancestor
64448000|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448001|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297253|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297254|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297255|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64297256|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64297257|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
64297258|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
64297259|NCT03299517|Lidocaine|lidocaine|mesh-list
64297260|NCT03299517|Amiodarone|amiodarone|mesh-list
64687045|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
64687046|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
64687047|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687048|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687049|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
64448029|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64448030|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448031|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448033|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
64448034|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448035|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448036|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64448037|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
64448038|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64448039|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64448040|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
64448041|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64448042|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64448043|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64448044|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
64448045|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64448046|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64372247|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372248|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64448063|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64448064|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448065|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
64448066|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64448067|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64448068|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687050|NCT02508077|Leucovorin|leucovorin|mesh-list
64687051|NCT02508077|Folic Acid|folic acid|mesh-list
64687052|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64687053|NCT02508077|Panitumumab|panitumumab|mesh-list
64687054|NCT02508077|Fluorouracil|fluorouracil|mesh-list
64687055|NCT02508077|Irinotecan|irinotecan|mesh-list
64687056|NCT02508077|Camptothecin|camptothecin|mesh-list
64687057|NCT02508077|Antibodies|antibodies|mesh-list
64687058|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
64687059|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64687060|NCT02508077|Calcium|calcium|mesh-list
64687061|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
64687062|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
64687063|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687064|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687065|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64687066|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64687067|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
64687068|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687069|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64687070|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687071|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64687072|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64448078|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
64448079|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448080|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
64448081|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64448082|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64372286|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64372287|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
64372288|NCT02465645|Protective Agents|protective agents|mesh-ancestor
64372289|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64372290|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372291|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64448084|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64448085|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64448086|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
64687073|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687074|NCT02508077|Antidotes|antidotes|mesh-ancestor
64297261|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64687075|NCT02508077|Protective Agents|protective agents|mesh-ancestor
64687076|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
64687077|NCT02508077|Vitamins|vitamins|mesh-ancestor
64687078|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
64687079|NCT02508077|Hematinics|hematinics|mesh-ancestor
64687080|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64687081|NCT00558259|Dabigatran|dabigatran|mesh-list
64687082|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
64687083|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64687084|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
64687085|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687086|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687137|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687138|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64687139|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687140|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687141|NCT05446883|Paclitaxel|paclitaxel|mesh-list
64687142|NCT05446883|Carboplatin|carboplatin|mesh-list
64687143|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64687144|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687203|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
64687204|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
64687205|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64297264|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297265|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448108|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448110|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64372307|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64372308|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64372309|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64372310|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64372311|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372312|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372313|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297266|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
64297267|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297268|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64297269|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64297270|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448164|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448165|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64448166|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64297271|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297272|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
64448167|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
64448168|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448169|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448170|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448171|NCT01500382|Urological Agents|urological agents|mesh-ancestor
64372314|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448172|NCT02137837|Everolimus|everolimus|mesh-list
64448173|NCT02137837|Fulvestrant|fulvestrant|mesh-list
64448174|NCT02137837|Anastrozole|anastrozole|mesh-list
64448175|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448176|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448192|NCT01483690|Decitabine|decitabine|mesh-list
64297273|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64687207|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687209|NCT04218773|Phenylephrine|phenylephrine|mesh-list
64687210|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
64687211|NCT04218773|Norepinephrine|norepinephrine|mesh-list
64687212|NCT04218773|Synephrine|synephrine|mesh-list
64687214|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
64687270|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687271|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687272|NCT01834261|Oxytocin|oxytocin|mesh-list
64687273|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
64687274|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64687275|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687276|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
64687277|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64687278|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64687279|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448225|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
64448226|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
64448227|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
64448228|NCT01483690|Analgesics|analgesics|mesh-ancestor
64448229|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
64448230|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64448231|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64448232|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64687280|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
64687281|NCT02578901|Coagulants|coagulants|mesh-ancestor
64687282|NCT02579057|Furosemide|furosemide|mesh-list
64687283|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64687284|NCT02579057|Diuretics|diuretics|mesh-ancestor
64687285|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
64687286|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687326|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687327|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687328|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448265|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
64687329|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64687330|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64687331|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64687394|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64687395|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
64687396|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687397|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687398|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64448307|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64448308|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
64448309|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448310|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448311|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64448312|NCT02075047|Ziprasidone|ziprasidone|mesh-list
64448313|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64448314|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
64448315|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448316|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448317|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687399|NCT02585843|Diuretics|diuretics|mesh-ancestor
64687400|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
64687401|NCT01838317|Pioglitazone|pioglitazone|mesh-list
64687402|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64687403|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687404|NCT05249231|Fluorides|fluorides|mesh-list
64687405|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
64687406|NCT05249231|Protective Agents|protective agents|mesh-ancestor
64448362|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64687407|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687408|NCT05249153|Sufentanil|sufentanil|mesh-list
64687409|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
64687410|NCT05249153|Dsuvia|dsuvia|mesh-list
64687411|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64687412|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687413|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687414|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64448429|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448430|NCT01499368|Omeprazole|omeprazole|mesh-list
64372480|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687415|NCT05249153|Analgesics|analgesics|mesh-ancestor
64687416|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
64687417|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687444|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687445|NCT02989519|Progesterone|progesterone|mesh-list
64687446|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
64687447|NCT02989519|Progestins|progestins|mesh-ancestor
64687448|NCT02989519|Hormones|hormones|mesh-ancestor
64687449|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687450|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687451|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64687452|NCT02429375|Mocetinostat|mocetinostat|mesh-list
64448486|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448493|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
64687509|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687510|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687511|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
64687512|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687513|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64687514|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64687519|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
64687575|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64448542|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64448543|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64372645|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372646|NCT03062787|Triamcinolone|triamcinolone|mesh-list
64372647|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64372648|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64372649|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
64372650|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64372651|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64372652|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
64687576|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687577|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
64687578|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687579|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687581|NCT02599649|Azacitidine|azacitidine|mesh-list
64687582|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64687583|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687584|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64687585|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687639|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687640|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64687641|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64687642|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687643|NCT02271984|Praziquantel|praziquantel|mesh-list
64687644|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
64687645|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64687647|NCT02604173|Budesonide|budesonide|mesh-list
64687704|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64687705|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64687706|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64687707|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64448565|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687708|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64687709|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64687710|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
64687711|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
64687712|NCT02815033|Choline|choline|mesh-list
64687713|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
64687714|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64687715|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
64448566|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
64448567|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448568|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448569|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64448570|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448571|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
64448572|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
64448573|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64448574|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
64448575|NCT01645475|Coagulants|coagulants|mesh-ancestor
64448576|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64448577|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
64448578|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448579|NCT04767113|Heparin|heparin|mesh-list
64448580|NCT04767113|Calcium heparin|calcium heparin|mesh-list
64372741|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64687716|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687717|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64687718|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64687719|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
64687720|NCT05589181|Buprenorphine|buprenorphine|mesh-list
64687721|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64687722|NCT05589181|Narcotics|narcotics|mesh-ancestor
64687723|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687760|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64687761|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64687762|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64687763|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64687764|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687765|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687766|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
64687767|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64687768|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64687769|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64372742|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372743|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64372744|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64372745|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
64372746|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
64372747|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
64372748|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
64372749|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64372750|NCT03502785|Atezolizumab|atezolizumab|mesh-list
64448581|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
64448582|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64448583|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64448584|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448585|NCT04774991|Azithromycin|azithromycin|mesh-list
64448586|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64448587|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687770|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64687771|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64687772|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687773|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
64687775|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687776|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64687777|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687815|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64687817|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
64687818|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64687819|NCT02608229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687820|NCT02608229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64687821|NCT02608229|Immunologic Factors|immunologic factors|mesh-ancestor
64687822|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687881|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64687882|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64687883|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
64687884|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64687885|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687886|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64687887|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
64687888|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
64687889|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64687945|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64687946|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64687947|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64687948|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64687949|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64687950|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
64448603|NCT01499134|Nebivolol|nebivolol|mesh-list
64687951|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64687952|NCT05731973|Sufentanil|sufentanil|mesh-list
64687953|NCT05731973|Oxycodone|oxycodone|mesh-list
64687954|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
64687955|NCT05731973|Bupivacaine|bupivacaine|mesh-list
64687956|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
64687957|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
64687958|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64687959|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448604|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64448605|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64688005|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
64688006|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688007|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64688008|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
64688010|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64688011|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64688012|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688069|NCT04484623|Dexamethasone|dexamethasone|mesh-list
64688070|NCT04484623|Bortezomib|bortezomib|mesh-list
64688071|NCT04484623|Pomalidomide|pomalidomide|mesh-list
64688072|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64688073|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
64688074|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
64688075|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688076|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688077|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64688078|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
64688079|NCT04484623|Hormones|hormones|mesh-ancestor
64688080|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64688135|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64688136|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
64688137|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64688138|NCT04734197|Lifitegrast|lifitegrast|mesh-list
64688139|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64372800|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64372801|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372802|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372803|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64448653|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64448654|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64448655|NCT01498120|Rotigotine|rotigotine|mesh-list
64448656|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
64448657|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
64448658|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448659|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448660|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448661|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64448663|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448664|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448665|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
64448666|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448667|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
64448668|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64448669|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64448670|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448671|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
64448672|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
64688140|NCT04734197|Cyclosporins|cyclosporins|mesh-list
64688141|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64688142|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688143|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688144|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688145|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
64688146|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688147|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
64688149|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
64688196|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64688198|NCT05688215|Antidotes|antidotes|mesh-ancestor
64688199|NCT05688215|Protective Agents|protective agents|mesh-ancestor
64688200|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
64688201|NCT05688215|Vitamins|vitamins|mesh-ancestor
64688202|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
64688203|NCT05688215|Hematinics|hematinics|mesh-ancestor
64688204|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
64688205|NCT00557401|Baclofen|baclofen|mesh-list
64688206|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64688207|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688208|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64688209|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688210|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64688211|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
64688212|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
64688213|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688214|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688215|NCT02264353|Donepezil|donepezil|mesh-list
64688216|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64297275|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448673|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64448674|NCT02197247|Rifampin|rifampin|mesh-list
64448675|NCT02197247|Osimertinib|osimertinib|mesh-list
64448676|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64448677|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
64448678|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64448679|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448680|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
64372804|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64688217|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688218|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372805|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64372806|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64372807|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64297276|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297277|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64297278|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64688219|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
64688251|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64688252|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64688253|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64688254|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
64688255|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372842|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372843|NCT03296657|Fluorides|fluorides|mesh-list
64372844|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
64372845|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
64372846|NCT03296657|Protective Agents|protective agents|mesh-ancestor
64372854|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372855|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372856|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
64372857|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448699|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688256|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688257|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688258|NCT00553657|Urological Agents|urological agents|mesh-ancestor
64688259|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64688260|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64688261|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688315|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688316|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
64448761|NCT01623752|Etanercept|etanercept|mesh-list
64448762|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64448763|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64688317|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448765|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
64448775|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448777|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
64448778|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448779|NCT02219477|Ritonavir|ritonavir|mesh-list
64448780|NCT02219477|Ribavirin|ribavirin|mesh-list
64448781|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64448782|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64448783|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
64448784|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448785|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688319|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64688320|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64688321|NCT01871077|Analgesics|analgesics|mesh-ancestor
64688322|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
64688323|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688324|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688325|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64688326|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688327|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64688328|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688329|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688330|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
64688331|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64688332|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
64688335|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
64448825|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64448826|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372931|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64372932|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688368|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688369|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
64688444|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688445|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
64688446|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64688447|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
64688448|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688449|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688450|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64688512|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64688513|NCT05588999|Analgesics|analgesics|mesh-ancestor
64688514|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
64372967|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
64372968|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372969|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64372970|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64372972|NCT01670721|Antidotes|antidotes|mesh-ancestor
64688515|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688516|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688517|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64688518|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688519|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64688520|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688521|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688522|NCT01643928|Rituximab|rituximab|mesh-list
64688523|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64448898|NCT01454596|Fludarabine|fludarabine|mesh-list
64448899|NCT01454596|Mitogens|mitogens|mesh-list
64448900|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448901|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
64448902|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448903|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448904|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64448905|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
64448906|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372998|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64448908|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64448909|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
64448917|NCT04541290|Tacrolimus|tacrolimus|mesh-list
64688524|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688525|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
64688526|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448943|NCT02116777|Temozolomide|temozolomide|mesh-list
64448944|NCT02116777|Talazoparib|talazoparib|mesh-list
64448945|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64688527|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688528|NCT04234997|Suvorexant|suvorexant|mesh-list
64688569|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64688570|NCT05588297|Growth Substances|growth substances|mesh-ancestor
64688571|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688572|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
64688573|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64688574|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
64688575|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688576|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64688578|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64688635|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64688636|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64688637|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
64688638|NCT05586971|Protective Agents|protective agents|mesh-ancestor
64688639|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688640|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
64688641|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688642|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64448946|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
64448947|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688643|NCT03559049|Carboplatin|carboplatin|mesh-list
64688644|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
64688645|NCT03559049|Pemetrexed|pemetrexed|mesh-list
64688646|NCT03559049|Rucaparib|rucaparib|mesh-list
64688647|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688648|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688649|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484483|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
64688650|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688654|NCT05559437|Bupivacaine|bupivacaine|mesh-list
64688691|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64688692|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64688693|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64688694|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
64688695|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64688696|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64688697|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
64688698|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64688699|NCT04339361|Lidocaine|lidocaine|mesh-list
64688700|NCT04339361|Dinoprostone|dinoprostone|mesh-list
64688701|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
64688702|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
64688703|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688704|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688705|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
64688706|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688707|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64688748|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
64688749|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688750|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64688751|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64688752|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64688753|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
64688754|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688755|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688756|NCT02654483|Serlopitant|serlopitant|mesh-list
64688811|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688812|NCT02659787|Analgesics|analgesics|mesh-ancestor
64688813|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
64688814|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688815|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64688817|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64373058|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64373059|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
64373060|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64688818|NCT05044871|Bevacizumab|bevacizumab|mesh-list
64688819|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64688820|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688821|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
64688822|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
64688823|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
64688838|NCT02271594|Insulin|insulin|mesh-list
64688875|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64449022|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64449023|NCT01492426|Ribavirin|ribavirin|mesh-list
64688876|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64449024|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64449025|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
64449026|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449027|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
64449028|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449029|NCT01453348|Vaccines|vaccines|mesh-list
64449030|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
64449031|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449032|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
64449033|NCT01475734|Incretins|incretins|mesh-ancestor
64449034|NCT01475734|Hormones|hormones|mesh-ancestor
64449035|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449036|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449037|NCT02189837|Atorvastatin|atorvastatin|mesh-list
64449038|NCT02189837|Evolocumab|evolocumab|mesh-list
64449039|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64449042|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
64688877|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64688878|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64688879|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688880|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688881|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
64688882|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64688883|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414185|NCT02495883|Ethanol|ethanol|mesh-list
64688884|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64688885|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688886|NCT02205047|Fluorouracil|fluorouracil|mesh-list
64449068|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688889|NCT02205047|Pertuzumab|pertuzumab|mesh-list
64449069|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
64449070|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
64449071|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449072|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64373118|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
64373119|NCT04156581|Hormones|hormones|mesh-ancestor
64688935|NCT02672111|Buprenorphine|buprenorphine|mesh-list
64688936|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64688937|NCT02672111|Narcotics|narcotics|mesh-ancestor
64688938|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688939|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688940|NCT02672111|Analgesics|analgesics|mesh-ancestor
64688941|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
64449103|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449105|NCT04418219|Interferons|interferons|mesh-list
64449106|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
64449107|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
64449108|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
64449109|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
64449110|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449111|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
64688942|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449112|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449113|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449114|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64449115|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
64449116|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449117|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688943|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64688945|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64688946|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64688947|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64688948|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64688949|NCT05432843|Pregabalin|pregabalin|mesh-list
64688950|NCT05432843|Analgesics|analgesics|mesh-ancestor
64688951|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
64688952|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64688953|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688954|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
64688955|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64449141|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
64449142|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449143|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64449144|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
64449145|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
64449146|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449147|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449148|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688956|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64688957|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414250|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
64688958|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64688959|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64688960|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64688961|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64688962|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64688963|NCT05411471|Vaccines|vaccines|mesh-list
64688964|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
64688966|NCT02677493|Vaccines|vaccines|mesh-list
64688979|NCT02680301|Hormones|hormones|mesh-ancestor
64373222|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
64373223|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
64688980|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64688981|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64688982|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64688983|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
64688984|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64688986|NCT02680457|Insulin|insulin|mesh-list
64689048|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
64689049|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689050|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
64689051|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689052|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373224|NCT02730429|Letrozole|letrozole|mesh-list
64373225|NCT02730429|Palbociclib|palbociclib|mesh-list
64373226|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373227|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64373228|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64373229|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449177|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64449178|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64449179|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449180|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
64449181|NCT01474486|Thiamine|thiamine|mesh-list
64449182|NCT01474486|Micronutrients|micronutrients|mesh-list
64449183|NCT01474486|Trace Elements|trace elements|mesh-list
64449184|NCT01474486|Vitamins|vitamins|mesh-ancestor
64449185|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449186|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
64449187|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64449188|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64449189|NCT01451398|Insulin|insulin|mesh-list
64449191|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449192|NCT02073565|Everolimus|everolimus|mesh-list
64689053|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
64689054|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689055|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689056|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64689057|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
64689058|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64689113|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689114|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689115|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64689116|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64689117|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64689118|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
64689119|NCT05648526|Ketamine|ketamine|mesh-list
64449203|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64449204|NCT01450696|Capecitabine|capecitabine|mesh-list
64449205|NCT01450696|Trastuzumab|trastuzumab|mesh-list
64449206|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449207|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64449208|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
64449209|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449210|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64449211|NCT02070991|Macitentan|macitentan|mesh-list
64449212|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64449213|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64449214|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449215|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64373230|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373231|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64373232|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
64373233|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373234|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373235|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64689120|NCT05648526|Analgesics|analgesics|mesh-ancestor
64689121|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
64689122|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689123|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689124|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64689125|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64689126|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
64689127|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
64689128|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689129|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64689130|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64689131|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689132|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689133|NCT02705807|Epoprostenol|epoprostenol|mesh-list
64449229|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64449230|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
64449231|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64449232|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64449233|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64449234|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64449235|NCT02113579|Fluorides|fluorides|mesh-list
64449236|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
64449237|NCT02113579|Protective Agents|protective agents|mesh-ancestor
64449238|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449239|NCT01474018|Bromocriptine|bromocriptine|mesh-list
64449240|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64449241|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64449242|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
64373315|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64373316|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64689134|NCT02705807|Tezosentan|tezosentan|mesh-list
64689135|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64689136|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64689137|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
64689162|NCT05278715|Growth Substances|growth substances|mesh-ancestor
64689163|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689164|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
64689165|NCT02712047|Fluticasone|fluticasone|mesh-list
64449258|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449259|NCT04075240|Aspirin|aspirin|mesh-list
64449260|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
64449261|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64449262|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64449263|NCT04075240|Analgesics|analgesics|mesh-ancestor
64449264|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
64449265|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449268|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449269|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64449270|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64449271|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449272|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64449273|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64449274|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449275|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
64449276|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64449281|NCT02070757|Meropenem|meropenem|mesh-list
64689167|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689168|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64689169|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
64689170|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689171|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689172|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64689173|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
64689174|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
64373356|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64373357|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373358|NCT00777127|Analgesics|analgesics|mesh-ancestor
64373359|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
64449363|NCT01449682|Hormones|hormones|mesh-ancestor
64689175|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64689176|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64689177|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64689178|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689179|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
64689180|NCT00369239|Risperidone|risperidone|mesh-list
64689181|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64689182|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
64689183|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449389|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
64449390|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
64449391|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
64449392|NCT02166047|Vesatolimod|vesatolimod|mesh-list
64449393|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
64449394|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449395|NCT01831089|Paclitaxel|paclitaxel|mesh-list
64449396|NCT01831089|Bevacizumab|bevacizumab|mesh-list
64449397|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64449398|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449399|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
64449400|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
64449401|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
64373415|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64373417|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64373418|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
64373420|NCT02448901|Edoxaban|edoxaban|mesh-list
64689184|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689185|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689213|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689214|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689215|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64689216|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64689217|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64689218|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64689219|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64689220|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64689221|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689222|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
64689223|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689224|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689226|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64689227|NCT02721017|Narcotics|narcotics|mesh-ancestor
64689228|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449429|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449430|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
64449431|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64373442|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689229|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689230|NCT02721017|Analgesics|analgesics|mesh-ancestor
64689231|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
64689232|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689233|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64689234|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64689235|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
64689236|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
64414552|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64689262|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
64297279|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64297280|NCT00651404|Ezetimibe|ezetimibe|mesh-list
64373443|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64373444|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64373445|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373446|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373447|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64373449|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64373450|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64449432|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64449434|NCT02097823|Aprepitant|aprepitant|mesh-list
64449435|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
64449436|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
64449437|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689264|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689265|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689266|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689267|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
64689268|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
64689269|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64689270|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64689271|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689272|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689273|NCT03614663|Cannabidiol|cannabidiol|mesh-list
64689274|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
64689275|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
64689276|NCT00085735|Lomustine|lomustine|mesh-list
64689277|NCT00085735|Cisplatin|cisplatin|mesh-list
64689278|NCT00085735|Vincristine|vincristine|mesh-list
64689279|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689280|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
64689281|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689282|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64689283|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64689284|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
64689285|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689286|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689287|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64689288|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64689308|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64373463|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64449440|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64449441|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64449442|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449443|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64449444|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64449445|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64449446|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64449447|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449448|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449449|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
64449450|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64449451|NCT01857063|Montelukast|montelukast|mesh-list
64449452|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64449455|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
64689309|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64689310|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
64689311|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689312|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689313|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64689314|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64689315|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
64689316|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297281|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64297282|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64297283|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
64297284|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297285|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64297286|NCT00651014|Ezetimibe|ezetimibe|mesh-list
64297287|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64297288|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64297289|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
64297290|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297291|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64689317|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64689318|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64689319|NCT02726789|Interferons|interferons|mesh-list
64689320|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
64689321|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
64689322|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64689324|NCT02726789|REP 2139|rep 2139|mesh-list
64689325|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689326|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
64689327|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689328|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
64449482|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64449483|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
64449484|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449485|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
64449486|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449487|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64449488|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449489|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64449490|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
64449491|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64449492|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449493|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
64689329|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689342|NCT01944319|Meropenem|meropenem|mesh-list
64689358|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689359|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
64689360|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64689361|NCT05020145|Vaccines|vaccines|mesh-list
64689362|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
64689429|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
64689430|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
64689431|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64449514|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64449515|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449516|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449517|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64449518|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64689432|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449519|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
64449520|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
64449521|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449522|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449523|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64449524|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64449525|NCT02110225|Mitogens|mitogens|mesh-list
64449526|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
64449527|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449528|NCT04756505|Interleukin-12|interleukin-12|mesh-list
64449546|NCT02162771|Prednisone|prednisone|mesh-list
64689433|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64689434|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689435|NCT04770155|Bosentan|bosentan|mesh-list
64689436|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
64689437|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
64689438|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64689439|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64689440|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689441|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689442|NCT04770155|Urological Agents|urological agents|mesh-ancestor
64689443|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64689445|NCT04744181|Folic Acid|folic acid|mesh-list
64689491|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64689492|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
64373497|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373498|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373499|NCT03190603|Celecoxib|celecoxib|mesh-list
64689493|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64689494|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689558|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373500|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64373501|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373502|NCT03190603|Analgesics|analgesics|mesh-ancestor
64414857|NCT03051529|Anesthetics|anesthetics|mesh-list
64689559|NCT05446805|Corticosterone|corticosterone|mesh-list
64297292|NCT04435418|Apixaban|apixaban|mesh-list
64297293|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64297294|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
64297295|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64297296|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
64297297|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297298|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297299|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
64297300|NCT04563338|Bevacizumab|bevacizumab|mesh-list
64297301|NCT04563338|Atezolizumab|atezolizumab|mesh-list
64297302|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64689562|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
64689563|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
64689564|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689628|NCT05444777|Analgesics|analgesics|mesh-ancestor
64689629|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
64689630|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689631|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689632|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64689633|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64689634|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
64689635|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
64689636|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64689637|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64689638|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64449609|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64449610|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
64449611|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64449612|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
64449613|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
64449614|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64449615|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
64449616|NCT01830543|Coagulants|coagulants|mesh-ancestor
64449617|NCT02109445|Gemcitabine|gemcitabine|mesh-list
64449618|NCT02109445|Paclitaxel|paclitaxel|mesh-list
64449619|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64449620|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64449621|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689758|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64689759|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64689760|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64689761|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64689762|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64689763|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689764|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689765|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64689819|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64689820|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64689821|NCT02466581|Analgesics|analgesics|mesh-ancestor
64689822|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
64689823|NCT01951963|Ketamine|ketamine|mesh-list
64373556|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64373557|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64373558|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64373559|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64373560|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64689824|NCT01951963|Morphine|morphine|mesh-list
64373589|NCT03193957|Analgesics|analgesics|mesh-ancestor
64373590|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
64449647|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64449648|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
64449649|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64449650|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64449651|NCT01623271|Gabapentin|gabapentin|mesh-list
64689825|NCT01951963|Analgesics|analgesics|mesh-ancestor
64689826|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
64689827|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64689828|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689829|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64689830|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64689911|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
64689912|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64689913|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64689914|NCT01897285|Laxatives|laxatives|mesh-ancestor
64689915|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449716|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449718|NCT02106403|Disinfectants|disinfectants|mesh-list
64449719|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449720|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
64449721|NCT02133131|Grazoprevir|grazoprevir|mesh-list
64689916|NCT00370253|Terlipressin|terlipressin|mesh-list
64449722|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64449723|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
64449724|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449725|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
64449726|NCT02106325|Promethazine|promethazine|mesh-list
64449727|NCT02106325|Ketamine|ketamine|mesh-list
64449728|NCT02106325|Analgesics|analgesics|mesh-ancestor
64449729|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
64449730|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449731|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373643|NCT02458547|Propofol|propofol|mesh-list
64689917|NCT00370253|Norepinephrine|norepinephrine|mesh-list
64689918|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64689919|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64297303|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689920|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64689921|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64689922|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64689923|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64689924|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689925|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449752|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
64449753|NCT02184611|Bromides|bromides|mesh-list
64449754|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
64449755|NCT02066311|Nelfinavir|nelfinavir|mesh-list
64449756|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64449757|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64449758|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
64449759|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449760|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449761|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64449762|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64449763|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
64449764|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449765|NCT01625611|Naltrexone|naltrexone|mesh-list
64449766|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64449767|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64449768|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449769|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
64373648|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64689971|NCT04338191|Leucovorin|leucovorin|mesh-list
64689972|NCT04338191|Fluorouracil|fluorouracil|mesh-list
64689973|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
64689974|NCT04338191|Irinotecan|irinotecan|mesh-list
64689975|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
64689976|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
64689977|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64689978|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64689979|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64689980|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64689981|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
64689986|NCT04338191|Antidotes|antidotes|mesh-ancestor
64449794|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449795|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
64449796|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64449797|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64449798|NCT02183675|Diuretics|diuretics|mesh-ancestor
64449799|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
64449800|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64449801|NCT02183519|Capsaicin|capsaicin|mesh-list
64449803|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
64449804|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
64449805|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449806|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449807|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64690037|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64690038|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690039|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64449808|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64449809|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
64449810|NCT02132195|Hormones|hormones|mesh-ancestor
64449811|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449812|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449813|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449814|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373656|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64373657|NCT02458625|Trace Elements|trace elements|mesh-ancestor
64373658|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
64373659|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373660|NCT02458625|Hematinics|hematinics|mesh-ancestor
64690040|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64690041|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690043|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64690044|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64690045|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64690046|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
64690047|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690048|NCT05180825|Trametinib|trametinib|mesh-list
64690049|NCT05180825|Vinblastine|vinblastine|mesh-list
64690050|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690051|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64690052|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690055|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64690096|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690097|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690098|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
64690099|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690100|NCT04021121|Linezolid|linezolid|mesh-list
64690101|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690102|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690103|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64690104|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690105|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690106|NCT05062577|Buprenorphine|buprenorphine|mesh-list
64297304|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64297305|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64690107|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64690108|NCT05062577|ASP8062|asp8062|mesh-list
64690109|NCT05062577|Naloxone|naloxone|mesh-list
64690110|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64449820|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449821|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
64690156|NCT03970655|Ropivacaine|ropivacaine|mesh-list
64690157|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
64690158|NCT03970655|BB 1101|bb 1101|mesh-list
64690159|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690160|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
64415460|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
64690161|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
64690162|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690163|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690164|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449822|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449823|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449824|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64449825|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
64690165|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
64449826|NCT01625377|Everolimus|everolimus|mesh-list
64449827|NCT01625377|Tacrolimus|tacrolimus|mesh-list
64449828|NCT01625377|Basiliximab|basiliximab|mesh-list
64449829|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449860|NCT02047045|Serotonin|serotonin|mesh-list
64690166|NCT03970655|Hormones|hormones|mesh-ancestor
64690167|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690168|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64690169|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690170|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
64690171|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690172|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690173|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
64690174|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
64690175|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690176|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
64690177|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64690178|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64690179|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690180|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690202|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64690203|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64690204|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690205|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64449870|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449871|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64449872|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449873|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449874|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
64449875|NCT01829295|Prednisone|prednisone|mesh-list
64449876|NCT01829295|Methotrexate|methotrexate|mesh-list
64449877|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449878|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
64449879|NCT01829295|Hormones|hormones|mesh-ancestor
64449880|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449881|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449882|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64449883|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449884|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64449885|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
64449886|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64449887|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64449888|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
64449889|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449890|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
64449891|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449892|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64449893|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449894|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
64690206|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64690207|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
64690208|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64690209|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64690210|NCT04969211|Iloperidone|iloperidone|mesh-list
64690211|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64690213|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690214|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690215|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64690216|NCT01901575|Remifentanil|remifentanil|mesh-list
64690217|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64690218|NCT01901575|Narcotics|narcotics|mesh-ancestor
64690219|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690220|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449895|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449896|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64449897|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64449898|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64449899|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
64449900|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64449901|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449902|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
64449903|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64449904|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64449905|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
64449906|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449907|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449908|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64449909|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
64449910|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64449911|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64690221|NCT01901575|Analgesics|analgesics|mesh-ancestor
64690222|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
64690223|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690224|NCT03754049|Dexamethasone|dexamethasone|mesh-list
64690225|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
64690226|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64690227|NCT03754049|BB 1101|bb 1101|mesh-list
64690228|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690229|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
64373748|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64373749|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
64373750|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373751|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373752|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
64373753|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449922|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449923|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64449924|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64690230|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
64690231|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449925|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64449926|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
64449927|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449928|NCT02092285|Golimumab|golimumab|mesh-list
64690232|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297307|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297308|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297310|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64297311|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64297312|NCT02062255|Analgesics|analgesics|mesh-ancestor
64297313|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
64690233|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64690245|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
64690246|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690247|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64449972|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449973|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64449974|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64449975|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
64449976|NCT01827267|Sirolimus|sirolimus|mesh-list
64373834|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64373835|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
64373836|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64690248|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373837|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
64373838|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690249|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690250|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64690251|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
64690252|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
64690253|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690254|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
64690255|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690256|NCT01901809|Protective Agents|protective agents|mesh-ancestor
64690257|NCT04947527|Fluorides|fluorides|mesh-list
64690258|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
64690259|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
64690260|NCT04947527|Protective Agents|protective agents|mesh-ancestor
64690262|NCT05005403|Pembrolizumab|pembrolizumab|mesh-list
64373922|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373923|NCT05065775|Analgesics|analgesics|mesh-ancestor
64373924|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
64373925|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690314|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
64690315|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
64690316|NCT04679831|Praziquantel|praziquantel|mesh-list
64373926|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64450007|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450008|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450009|NCT01854645|Bromides|bromides|mesh-list
64690317|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
64450010|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
64450011|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64450012|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
64450013|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450014|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373929|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
64373930|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373931|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373932|NCT03266159|Trametinib|trametinib|mesh-list
64373933|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373935|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690318|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64690319|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690320|NCT01908751|Vitamin D|vitamin d|mesh-list
64690321|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
64690322|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
64690323|NCT01908751|Vitamins|vitamins|mesh-list
64690324|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
64690383|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64690384|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
64690385|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690386|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690387|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
64690389|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64690390|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
64690450|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690451|NCT04748887|Protective Agents|protective agents|mesh-ancestor
64450029|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64450030|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450031|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
64373969|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373970|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373971|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64373972|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64373973|NCT02458079|Protective Agents|protective agents|mesh-ancestor
64373974|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373975|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
64373976|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64373977|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
64373978|NCT03264911|Amoxicillin|amoxicillin|mesh-list
64373979|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64373980|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373981|NCT03265223|Ropivacaine|ropivacaine|mesh-list
64374001|NCT02456363|Analgesics|analgesics|mesh-ancestor
64374002|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
64374003|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374004|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374005|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374006|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690452|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690453|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
64690454|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64690455|NCT01916629|Protective Agents|protective agents|mesh-ancestor
64690456|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690457|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297316|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64297317|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297318|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64297319|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64690459|NCT03298451|Durvalumab|durvalumab|mesh-list
64690513|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64690515|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64690516|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64690517|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690518|NCT04184609|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64690519|NCT04184609|Cholinergic Agents|cholinergic agents|mesh-ancestor
64690520|NCT03273023|Chromium|chromium|mesh-list
64690521|NCT03273023|Everolimus|everolimus|mesh-list
64690522|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690579|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
64690580|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690581|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
64690582|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
64690583|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690584|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690585|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64690586|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
64690587|NCT05349071|Hormones|hormones|mesh-ancestor
64690588|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64690589|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64690590|NCT05349071|Protective Agents|protective agents|mesh-ancestor
64690591|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64690592|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690593|NCT01929889|Iloperidone|iloperidone|mesh-list
64690594|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64690595|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64690596|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64690597|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690598|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64690599|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64690600|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690601|NCT04335461|Anesthetics|anesthetics|mesh-list
64690602|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
64690630|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690631|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64690632|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690633|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690635|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690636|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64690637|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690638|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690639|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
64690640|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64690641|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64690642|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
64690643|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690644|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64690645|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64690646|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450041|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690647|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690648|NCT02287909|Clopidogrel|clopidogrel|mesh-list
64690649|NCT02287909|Ticagrelor|ticagrelor|mesh-list
64690658|NCT04335383|Antibodies|antibodies|mesh-list
64690683|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64690684|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64690685|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690686|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64690687|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64297320|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690688|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
64690689|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690690|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690691|NCT02327195|Methylphenidate|methylphenidate|mesh-list
64690692|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64690693|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690694|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64690695|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64690696|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64690698|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
64690743|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
64690744|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64690745|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
64690746|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64690747|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690748|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64690749|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
64690750|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690751|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
64690752|NCT05688475|Dexamethasone|dexamethasone|mesh-list
64690753|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64690754|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
64690755|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
64690756|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690757|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690758|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64690759|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
64690762|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64690801|NCT02767271|Luliconazole|luliconazole|mesh-list
64690802|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
64690803|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690804|NCT05647993|Azithromycin|azithromycin|mesh-list
64690805|NCT05647993|Cefazolin|cefazolin|mesh-list
64297321|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64297322|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64297323|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690806|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64690807|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64690808|NCT02741687|Insulin|insulin|mesh-list
64690872|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64690873|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
64690874|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64690875|NCT04778839|Paclitaxel|paclitaxel|mesh-list
64690876|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64690877|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64690878|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64690879|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
64690880|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
64690881|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
64690936|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64690937|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64690938|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64690939|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64690940|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
64691007|NCT04669171|Growth Substances|growth substances|mesh-ancestor
64691008|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
64691009|NCT05545891|Aripiprazole|aripiprazole|mesh-list
64691010|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
64691011|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64691012|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64691013|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64691014|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691015|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691074|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64691075|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691076|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691077|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64691078|NCT05323721|Renal Agents|renal agents|mesh-ancestor
64691079|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
64691080|NCT05288075|Charcoal|charcoal|mesh-list
64691081|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64691082|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64691083|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64691084|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
64691085|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691086|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691087|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691088|NCT05288075|Antidotes|antidotes|mesh-ancestor
64691089|NCT05288075|Protective Agents|protective agents|mesh-ancestor
64691090|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
64691091|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64691092|NCT05272787|Protective Agents|protective agents|mesh-ancestor
64691093|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691094|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
64691095|NCT05145569|Paclitaxel|paclitaxel|mesh-list
64691096|NCT05145569|Carboplatin|carboplatin|mesh-list
64691097|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64691098|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691099|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
64691100|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
64691101|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
64691102|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691121|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691124|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64691125|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
64691126|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64691127|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64691128|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691129|NCT04535401|Antidotes|antidotes|mesh-ancestor
64691130|NCT04535401|Protective Agents|protective agents|mesh-ancestor
64691132|NCT04535401|Vitamins|vitamins|mesh-ancestor
64691187|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64691188|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691191|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64691192|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691193|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
64691194|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
64691195|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
64691196|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691197|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691198|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
64691199|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
64691200|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691201|NCT04365049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691202|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64691205|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
64691245|NCT04706507|Ganciclovir|ganciclovir|mesh-list
64691246|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64691247|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
64691248|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691249|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64691250|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691251|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691252|NCT03047473|Avelumab|avelumab|mesh-list
64691253|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691254|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691255|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
64691256|NCT03339635|Testosterone|testosterone|mesh-list
64691257|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
64691258|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
64450048|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450049|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450051|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
64691259|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64691260|NCT03339635|Androgens|androgens|mesh-ancestor
64691261|NCT03339635|Hormones|hormones|mesh-ancestor
64691262|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691304|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
64691305|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691306|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691307|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64691308|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
64691309|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
64691313|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64691371|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691372|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691373|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
64691374|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691375|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64691376|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
64691377|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691378|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64691379|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64691380|NCT02633137|Growth Substances|growth substances|mesh-ancestor
64691381|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
64691434|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691436|NCT00373451|Calcium heparin|calcium heparin|mesh-list
64691437|NCT00373451|Bivalirudin|bivalirudin|mesh-list
64691438|NCT00373451|Abciximab|abciximab|mesh-list
64691439|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
64691440|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64691441|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64691442|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691443|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
64691444|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64691445|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
64691446|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691448|NCT01387763|Interferons|interferons|mesh-list
64691499|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691500|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691501|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64691502|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64691503|NCT04982237|Growth Substances|growth substances|mesh-ancestor
64691504|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691505|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
64691506|NCT01996657|Warfarin|warfarin|mesh-list
64691507|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
64691508|NCT04227847|Azacitidine|azacitidine|mesh-list
64297326|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297327|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297328|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
64297329|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297330|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
64297331|NCT05547243|Vaccines|vaccines|mesh-list
64297332|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
64297333|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297334|NCT03100604|Sevoflurane|sevoflurane|mesh-list
64691509|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691510|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
64691511|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691512|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691514|NCT02316379|Xenon|xenon|mesh-list
64691557|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691558|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
64691559|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691560|NCT02788097|Progesterone|progesterone|mesh-list
64691561|NCT02788097|Progestins|progestins|mesh-ancestor
64691562|NCT02788097|Hormones|hormones|mesh-ancestor
64691563|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450057|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64691564|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691566|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64691624|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
64691625|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64691626|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64691627|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691628|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691629|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
64691630|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
64691631|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64691632|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
64691634|NCT02882711|Analgesics|analgesics|mesh-ancestor
64691635|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
64691636|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691637|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691638|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64691639|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64691640|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
64691642|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297335|NCT03100604|Desflurane|desflurane|mesh-list
64297336|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64297337|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64297338|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
64297339|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
64297340|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297341|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297342|NCT00398294|Simvastatin|simvastatin|mesh-list
64297343|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64297346|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691647|NCT02794337|Sorafenib|sorafenib|mesh-list
64691682|NCT02895035|Analgesics|analgesics|mesh-ancestor
64691683|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
64691684|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691685|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691686|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64691687|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691688|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64691689|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
64691690|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64691691|NCT02895035|Protective Agents|protective agents|mesh-ancestor
64691693|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
64691694|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
64691695|NCT02802449|Calcifediol|calcifediol|mesh-list
64691696|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64691697|NCT02802449|Vitamins|vitamins|mesh-list
64691698|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
64691699|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691700|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64691701|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64691702|NCT02803229|Amphetamine|amphetamine|mesh-list
64691703|NCT02803229|Adderall|adderall|mesh-list
64691706|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
64691742|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691743|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64691744|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64691745|NCT04147351|Growth Substances|growth substances|mesh-ancestor
64691746|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691747|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
64691748|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
64691749|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64691750|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691751|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691752|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64691753|NCT02004613|Analgesics|analgesics|mesh-ancestor
64691754|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
64691755|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64691756|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64691757|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64691758|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64691759|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
64691760|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380904|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380905|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64380906|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64380907|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
64380908|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64380909|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
64380910|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
64380911|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
64380912|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64380913|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
64380914|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64380915|NCT01441947|Fulvestrant|fulvestrant|mesh-list
64380916|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64380917|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380918|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64380919|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64380920|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
64380921|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380922|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380923|NCT03192059|Aspirin|aspirin|mesh-list
64380924|NCT03192059|Vitamin D|vitamin d|mesh-list
64380925|NCT03192059|Curcumin|curcumin|mesh-list
64380926|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
64380939|NCT03192059|Vitamins|vitamins|mesh-ancestor
64380953|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380954|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
64380955|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64380956|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64380957|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64380958|NCT02441075|Ethanol|ethanol|mesh-list
64380959|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64380960|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380961|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380962|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380963|NCT05562999|Bromides|bromides|mesh-list
64380964|NCT05562999|Rocuronium|rocuronium|mesh-list
64691761|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691762|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
64691763|NCT01754779|Citric Acid|citric acid|mesh-list
64691764|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
64691765|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
64691766|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64691799|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64691800|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64691801|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
64691802|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691803|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64691804|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691805|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64691806|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
64691807|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64691808|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64691809|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691810|NCT02896907|Antidotes|antidotes|mesh-ancestor
64691811|NCT02896907|Protective Agents|protective agents|mesh-ancestor
64691812|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
64691813|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
64691814|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64691815|NCT02005549|Bevacizumab|bevacizumab|mesh-list
64691816|NCT02005549|Docetaxel|docetaxel|mesh-list
64691817|NCT02005549|Capecitabine|capecitabine|mesh-list
64691818|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691819|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691820|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64691821|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64691822|NCT02005549|Growth Substances|growth substances|mesh-ancestor
64691823|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691824|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
64691825|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
64691826|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
64691827|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
64691847|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64691848|NCT01716806|Dacarbazine|dacarbazine|mesh-list
64691849|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64691850|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691851|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64691852|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691853|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64691854|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
64691856|NCT04492358|Colchicine|colchicine|mesh-list
64691857|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64691858|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
64691859|NCT04492358|Hormones|hormones|mesh-ancestor
64691860|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691861|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64691862|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64691863|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64691864|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
64691865|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691866|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64691867|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
64691868|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484497|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
64691873|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64691898|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
64691899|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691900|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64691901|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691908|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
64691909|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
64691910|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64691911|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64691912|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691913|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64691914|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691915|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691916|NCT01959685|Enclomiphene|enclomiphene|mesh-list
64691917|NCT01959685|Clomiphene|clomiphene|mesh-list
64691918|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
64691919|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64691920|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
64297348|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64297349|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297351|NCT04823403|Ipilimumab|ipilimumab|mesh-list
64297352|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297353|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297354|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64691921|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64691923|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64691924|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
64691961|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64691962|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64691963|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
64691964|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64691965|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691966|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
64691967|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
64691968|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64691969|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64691970|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64691971|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64691972|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64691973|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64691975|NCT02301416|Phentermine|phentermine|mesh-list
64692022|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
64692023|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64692024|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692025|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64692026|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64692027|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64692028|NCT01988246|Aflibercept|aflibercept|mesh-list
64692029|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64692030|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64692031|NCT01988246|Growth Substances|growth substances|mesh-ancestor
64692032|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692033|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
64692034|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692035|NCT01990898|Cyclosporine|cyclosporine|mesh-list
64450066|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692036|NCT01990898|Cyclosporins|cyclosporins|mesh-list
64692037|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692038|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692039|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64692040|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
64692041|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692042|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
64692043|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692047|NCT01960387|Cytarabine|cytarabine|mesh-list
64692075|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692076|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692077|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692078|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64692079|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64692080|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
64692082|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692084|NCT02059070|Ropivacaine|ropivacaine|mesh-list
64692085|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
64692086|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
64692087|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692088|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692089|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
64692090|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692091|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
64692092|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64692093|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
64692094|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692095|NCT01962961|Expectorants|expectorants|mesh-ancestor
64692096|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
64692097|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64692098|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
64692125|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64692126|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692127|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64692128|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692129|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692131|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
64692132|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692133|NCT01967641|Buprenorphine|buprenorphine|mesh-list
64692134|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64692135|NCT01967641|Naloxone|naloxone|mesh-list
64692148|NCT02913521|Diclofenac|diclofenac|mesh-list
64692187|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374030|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374031|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64374032|NCT03263741|Paclitaxel|paclitaxel|mesh-list
64374033|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64374034|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
64692188|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64374035|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64374036|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374037|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
64374038|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374068|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64374069|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374070|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374071|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64692189|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64692190|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692191|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692192|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64692193|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
64692194|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
64692195|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692196|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64692197|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
64692198|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692199|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64692200|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
64692245|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
64692246|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64692247|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64692248|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64692250|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692251|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692252|NCT02308501|Alcaftadine|alcaftadine|mesh-list
64692253|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64692254|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
64692255|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
64692256|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692257|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692258|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692259|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64692303|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64692304|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692305|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450069|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692306|NCT02916407|Sevoflurane|sevoflurane|mesh-list
64692307|NCT02916407|Desflurane|desflurane|mesh-list
64692308|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64692309|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64692310|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
64692311|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
64692312|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692313|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692314|NCT02918357|Edetic Acid|edetic acid|mesh-list
64692315|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64692363|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692364|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
64692365|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692366|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
64692367|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
64692368|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
64692369|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692370|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692371|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
64692372|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692373|NCT02833415|Empagliflozin|empagliflozin|mesh-list
64692374|NCT02833415|Glycerol|glycerol|mesh-list
64692375|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64450070|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450071|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64450072|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64450073|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64450074|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64450075|NCT02155985|Aspirin|aspirin|mesh-list
64450076|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64692376|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692377|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64692378|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692379|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64692380|NCT02833415|Protective Agents|protective agents|mesh-ancestor
64692381|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64692382|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64692383|NCT02012348|Triclocarban|triclocarban|mesh-list
64692384|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64692385|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64692414|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692415|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64692416|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64692417|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692418|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
64692419|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
64692420|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
64692421|NCT02018653|Calcium|calcium|mesh-list
64692422|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64692423|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692424|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64692425|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692426|NCT02923895|Fluorides|fluorides|mesh-list
64692427|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
64692428|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
64692429|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
64692430|NCT02923895|Protective Agents|protective agents|mesh-ancestor
64692431|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692432|NCT01973348|Methamphetamine|methamphetamine|mesh-list
64692433|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64692434|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692435|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
64692436|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
64692437|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692438|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
64692439|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374074|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64374075|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64692440|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692441|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
64692461|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692462|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692463|NCT00374075|Valproic Acid|valproic acid|mesh-list
64692464|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
64692465|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692466|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692467|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
64692468|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692469|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692470|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
64692471|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64374076|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692472|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692473|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64374077|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
64692474|NCT01973335|Spironolactone|spironolactone|mesh-list
64692475|NCT01973335|Acetazolamide|acetazolamide|mesh-list
64692476|NCT01973335|Bumetanide|bumetanide|mesh-list
64692477|NCT01973335|Diuretics|diuretics|mesh-list
64692478|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64692480|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
64692512|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692513|NCT02021929|Sorafenib|sorafenib|mesh-list
64692514|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297355|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297356|NCT03493646|Azacitidine|azacitidine|mesh-list
64297357|NCT03493646|Cc-486|cc-486|mesh-list
64297358|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64692515|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64692516|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692517|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692518|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64692519|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64692520|NCT02023411|Teriparatide|teriparatide|mesh-list
64692521|NCT02023411|Hormones|hormones|mesh-list
64692522|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
64692523|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692524|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692525|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64692526|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64692528|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
64692529|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692530|NCT02934191|Acetaminophen|acetaminophen|mesh-list
64692531|NCT02934191|Celecoxib|celecoxib|mesh-list
64692532|NCT02934191|Oxycodone|oxycodone|mesh-list
64692533|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
64692536|NCT02934191|Analgesics|analgesics|mesh-ancestor
64692567|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692568|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692569|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692570|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
64692571|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
64692572|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374150|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64374151|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
64374152|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64374153|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64374154|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64374158|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374159|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374160|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374161|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64450080|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450081|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450082|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692573|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692574|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
64692576|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692577|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64692578|NCT01977781|Protective Agents|protective agents|mesh-ancestor
64692579|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64297360|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297361|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297362|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297363|NCT05500443|Vitamin K|vitamin k|mesh-list
64297364|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
64297365|NCT05500443|Vitamin MK 7|vitamin mk 7|mesh-list
64297366|NCT05500443|Vitamins|vitamins|mesh-ancestor
64297367|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
64297368|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297369|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64297370|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64692581|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
64692582|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64692583|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64692584|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64692622|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64692623|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64692624|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
64692625|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64692626|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
64692627|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64692628|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64692629|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692630|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64450083|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450084|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64692631|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692632|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64692633|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64692634|NCT02869451|Bupropion|bupropion|mesh-list
64692635|NCT02869451|Nicotine|nicotine|mesh-list
64692636|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64692637|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
64692638|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692639|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692640|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64692641|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64692642|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
64450085|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64450087|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64692643|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64692644|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692645|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64692646|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
64692647|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64692651|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
64692667|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64692668|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64692669|NCT01979276|Dexamethasone|dexamethasone|mesh-list
64692670|NCT01979276|Pomalidomide|pomalidomide|mesh-list
64692672|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692673|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
64692674|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
64692675|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692676|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692677|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64692734|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
64692735|NCT02019758|Hormones|hormones|mesh-ancestor
64692736|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64692737|NCT01980589|Dexamethasone|dexamethasone|mesh-list
64692738|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
64692739|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64692740|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
64692741|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692742|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692799|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692800|NCT01981772|Lidocaine|lidocaine|mesh-list
64692801|NCT01981772|Epinephrine|epinephrine|mesh-list
64692802|NCT01981772|Racepinephrine|racepinephrine|mesh-list
64692803|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
64297371|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297372|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
64297373|NCT05500443|Coagulants|coagulants|mesh-ancestor
64297374|NCT05244200|Insulin|insulin|mesh-list
64297375|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64297376|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692804|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
64692805|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
64692824|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
64692868|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64450108|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450109|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
64450110|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450111|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
64450112|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450113|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64692869|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64692870|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64692871|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
64692872|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692873|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64692936|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64692938|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64692939|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64692940|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693007|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693008|NCT02059213|Palbociclib|palbociclib|mesh-list
64693009|NCT02059213|Leuprolide|leuprolide|mesh-list
64693010|NCT02059213|Goserelin|goserelin|mesh-list
64693011|NCT02059213|Bicalutamide|bicalutamide|mesh-list
64693012|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693013|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64693014|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693073|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64693074|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64693075|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693076|NCT02062177|Midazolam|midazolam|mesh-list
64693077|NCT02062177|Propofol|propofol|mesh-list
64693078|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64693079|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693080|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693081|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64693082|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
64693083|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
64693084|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64693085|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64693086|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693088|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
64693135|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693136|NCT02312882|Tofacitinib|tofacitinib|mesh-list
64693137|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64693138|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693139|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693140|NCT02877095|Furosemide|furosemide|mesh-list
64693141|NCT02877095|Diuretics|diuretics|mesh-ancestor
64693142|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
64693143|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693144|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64693145|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693146|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693147|NCT02877485|Triamcinolone|triamcinolone|mesh-list
64450128|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450129|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64450130|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
64450131|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450132|NCT02178059|Terbutaline|terbutaline|mesh-list
64693148|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64693149|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64693150|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64693151|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693152|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
64693153|NCT02877485|Hormones|hormones|mesh-ancestor
64693154|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693155|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693187|NCT02359058|Ramucirumab|ramucirumab|mesh-list
64693188|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693189|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64693190|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
64693191|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693192|NCT02404610|Propofol|propofol|mesh-list
64693193|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64693194|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693195|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693196|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64693197|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
64693198|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
64693199|NCT03028103|Repaglinide|repaglinide|mesh-list
64693200|NCT03028103|Fluconazole|fluconazole|mesh-list
64693201|NCT03028103|Omeprazole|omeprazole|mesh-list
64693202|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64693203|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64693204|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64693243|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64693244|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64693245|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693246|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693247|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693248|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693249|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64693250|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
64693251|NCT00374465|Protective Agents|protective agents|mesh-ancestor
64693252|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64693253|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693254|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64693255|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
64693303|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64450166|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64450167|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64450168|NCT02090413|Analgesics|analgesics|mesh-ancestor
64450169|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
64450170|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450171|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450172|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450173|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450174|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64450175|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64693304|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
64693305|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693306|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693307|NCT02043704|Acetaminophen|acetaminophen|mesh-list
64693308|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693372|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
64693373|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693374|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693375|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
64693376|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64693377|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64693378|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64693379|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
64693380|NCT02044796|Cytarabine|cytarabine|mesh-list
64693381|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64693382|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
64693383|NCT02044796|Cladribine|cladribine|mesh-list
64693384|NCT02044796|Lenograstim|lenograstim|mesh-list
64693385|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64693386|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
64693387|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693388|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693389|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
64693390|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693395|NCT02044796|Analgesics|analgesics|mesh-ancestor
64693429|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693430|NCT02045264|Analgesics|analgesics|mesh-ancestor
64693431|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
64693432|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693433|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693434|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693435|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64693436|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64693437|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64693438|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693491|NCT02412644|Analgesics|analgesics|mesh-ancestor
64693492|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
64693493|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693494|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693495|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693496|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64693497|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64693498|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64693499|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693501|NCT02413034|Vancomycin|vancomycin|mesh-list
64693553|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64450190|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
64374256|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693554|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
64374259|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64297380|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297381|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297382|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64297383|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64297384|NCT03451370|Growth Substances|growth substances|mesh-ancestor
64297385|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693556|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693557|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693558|NCT02050334|Caffeic acid|caffeic acid|mesh-list
64693559|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
64693560|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693561|NCT02050334|Protective Agents|protective agents|mesh-ancestor
64693562|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693563|NCT02371850|Nicotine|nicotine|mesh-list
64693616|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
64693617|NCT02996591|Ketamine|ketamine|mesh-list
64693618|NCT02996591|Bupivacaine|bupivacaine|mesh-list
64693619|NCT02996591|Mepivacaine|mepivacaine|mesh-list
64693620|NCT02996591|Anesthetics|anesthetics|mesh-list
64693621|NCT02996591|Propofol|propofol|mesh-list
64693622|NCT02996591|Sevoflurane|sevoflurane|mesh-list
64693623|NCT02996591|BB 1101|bb 1101|mesh-list
64693624|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693625|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
64693626|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
64693627|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693628|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693629|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64693630|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
64693631|NCT02996591|Hormones|hormones|mesh-ancestor
64693632|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693633|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64693634|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693635|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
64693636|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693637|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693638|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64693639|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64693640|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
64693641|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64693654|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
64693667|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64693668|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64693669|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
64693670|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693671|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64693672|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64693673|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
64693674|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64693675|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
64693676|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64693677|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64450209|NCT02062879|Hydromorphone|hydromorphone|mesh-list
64450210|NCT02062879|Analgesics|analgesics|mesh-ancestor
64450211|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
64693731|NCT03068897|Tizanidine|tizanidine|mesh-list
64450212|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374289|NCT04488107|Letrozole|letrozole|mesh-list
64693732|NCT03068897|Baclofen|baclofen|mesh-list
64693733|NCT03068897|Metaxalone|metaxalone|mesh-list
64693734|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64693735|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64693736|NCT03068897|Analgesics|analgesics|mesh-ancestor
64297386|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297387|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64297388|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
64693737|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
64693738|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64693739|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693740|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64693741|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64693742|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64693743|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693744|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693745|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64693746|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64693747|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64693748|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
64693762|NCT03069677|Midazolam|midazolam|mesh-list
64693787|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64693788|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693789|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64693790|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
64693791|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64693792|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693793|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64693794|NCT05405465|Golimumab|golimumab|mesh-list
64693795|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64693796|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374295|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64693798|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
64693848|NCT03177395|Antidotes|antidotes|mesh-ancestor
64693849|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
64693850|NCT05282069|DA-8010|da-8010|mesh-list
64693851|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64693852|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64693853|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693854|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693855|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693856|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693857|NCT05282069|Urological Agents|urological agents|mesh-ancestor
64693858|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
64693860|NCT03179345|Gabapentin|gabapentin|mesh-list
64693861|NCT03179345|Analgesics|analgesics|mesh-ancestor
64693862|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
64693911|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
64693912|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693913|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693914|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64693915|NCT03091673|Glucagon|glucagon|mesh-list
64374296|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
64374297|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374298|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374299|NCT04974723|Teriparatide|teriparatide|mesh-list
64693916|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64693918|NCT03091673|Hormones|hormones|mesh-ancestor
64693979|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64693980|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64693981|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
64693982|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64693983|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64693984|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64693985|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64693986|NCT05304455|Heparin|heparin|mesh-list
64693987|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64693988|NCT05304455|Tinzaparin|tinzaparin|mesh-list
64419303|NCT02393547|Varenicline|varenicline|mesh-list
64694042|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694043|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
64694044|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694045|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694047|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64694048|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64694049|NCT04603937|Growth Substances|growth substances|mesh-ancestor
64694110|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
64694111|NCT02393378|Vitamins|vitamins|mesh-ancestor
64694112|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
64694113|NCT04949477|Acetaminophen|acetaminophen|mesh-list
64694114|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
64694115|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64694116|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694180|NCT05423834|Tenofovir|tenofovir|mesh-list
64374310|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450223|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64694181|NCT05423834|Entecavir|entecavir|mesh-list
64694182|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
64694183|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694184|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64694185|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64694186|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450224|NCT02062879|Narcotics|narcotics|mesh-ancestor
64450225|NCT02062645|Amlodipine|amlodipine|mesh-list
64450226|NCT02062645|Valsartan|valsartan|mesh-list
64450227|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
64450228|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64450229|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64450230|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450237|NCT04700839|Metformin|metformin|mesh-list
64374319|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64374321|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
64374322|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64374323|NCT03254849|Empagliflozin|empagliflozin|mesh-list
64374324|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64374325|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64374326|NCT03254849|Diuretics|diuretics|mesh-ancestor
64374327|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
64374328|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374329|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64374330|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64694187|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694188|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64694246|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64694248|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694249|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694250|NCT00355628|Analgesics|analgesics|mesh-ancestor
64694251|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
64694252|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694253|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64694254|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64694255|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
64694256|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
64694257|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
64694258|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64694259|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
64694260|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
64694261|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694262|NCT02049385|Diazoxide|diazoxide|mesh-list
64694263|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64694264|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
64694265|NCT03717155|Gemcitabine|gemcitabine|mesh-list
64694266|NCT03717155|Carboplatin|carboplatin|mesh-list
64694267|NCT03717155|Cetuximab|cetuximab|mesh-list
64694268|NCT03717155|Avelumab|avelumab|mesh-list
64694269|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694270|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64694271|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
64694272|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694273|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
64694274|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694293|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64694294|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694296|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64694297|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64694298|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
64694299|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
64694300|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694301|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694302|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64694303|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64694304|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64694305|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
64694306|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694307|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694308|NCT02051335|Scopolamine|scopolamine|mesh-list
64694309|NCT02051335|Donepezil|donepezil|mesh-list
64694310|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64694352|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694353|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64694354|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
64694355|NCT05272826|Hormones|hormones|mesh-ancestor
64694356|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694357|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694358|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694359|NCT03458429|Lenograstim|lenograstim|mesh-list
64694360|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64694363|NCT03291197|Bupivacaine|bupivacaine|mesh-list
64694417|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694418|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694419|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
64374334|NCT04963881|Antibodies|antibodies|mesh-list
64374335|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
64450262|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64450263|NCT01824693|Fludarabine|fludarabine|mesh-list
64694420|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694421|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
64694422|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694423|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694424|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
64694425|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64694426|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694479|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64694480|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
64694481|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
64694482|NCT04630964|Vitamins|vitamins|mesh-ancestor
64694483|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
64694484|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694485|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
64694486|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64694487|NCT03138161|Nivolumab|nivolumab|mesh-list
64694488|NCT03138161|Ipilimumab|ipilimumab|mesh-list
64694489|NCT03138161|Trabectedin|trabectedin|mesh-list
64694490|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64694491|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694495|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
64694543|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
64694544|NCT04525820|Vitamins|vitamins|mesh-list
64694545|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64694546|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
64694547|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694548|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64694549|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64694550|NCT05570708|Psilocybin|psilocybin|mesh-list
64694551|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
64694552|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694553|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64694554|NCT05117450|Heparin|heparin|mesh-list
64694555|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
64694609|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64694610|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694611|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64694612|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
64694613|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694614|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694615|NCT00356252|Carotenoids|carotenoids|mesh-list
64694616|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
64694676|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64694677|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64694678|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64694679|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
64694680|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694681|NCT04319588|Anesthetics|anesthetics|mesh-list
64694682|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
64694683|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64694684|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374344|NCT04487951|Vitamins|vitamins|mesh-ancestor
64374345|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
64694685|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
64694742|NCT03323801|Isotretinoin|isotretinoin|mesh-list
64694743|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694744|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
64694745|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694746|NCT04450355|Nefopam|nefopam|mesh-list
64694747|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64694748|NCT04450355|Analgesics|analgesics|mesh-ancestor
64694749|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
64694750|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694751|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694752|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
64694753|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64694754|NCT02352259|Bleomycin|bleomycin|mesh-list
64694755|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64694756|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694757|NCT03326999|Bupivacaine|bupivacaine|mesh-list
64694758|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
64694759|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
64694760|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380965|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
64380966|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64380967|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64380968|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64380969|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380970|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380971|NCT02438345|Leronlimab|leronlimab|mesh-list
64380972|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64380973|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64380974|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380976|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64380977|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
64380978|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380979|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
64380980|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
64380981|NCT03191981|Lenalidomide|lenalidomide|mesh-list
64380982|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380983|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
64380984|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380985|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380986|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64380987|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
64380988|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380990|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64380991|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380992|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64380993|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64380994|NCT03191981|Growth Substances|growth substances|mesh-ancestor
64380995|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
64380996|NCT05535075|Vancomycin|vancomycin|mesh-list
64380997|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64380998|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380999|NCT05530785|Bevacizumab|bevacizumab|mesh-list
64381000|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64694761|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694762|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
64694763|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64694764|NCT02397265|Insulin|insulin|mesh-list
64694765|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64694767|NCT00356720|Azithromycin|azithromycin|mesh-list
64694796|NCT03203681|Hormones|hormones|mesh-ancestor
64694797|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450287|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64694798|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694799|NCT03203681|Androgens|androgens|mesh-ancestor
64694800|NCT02399917|Azacitidine|azacitidine|mesh-list
64694801|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64694802|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
64694803|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694804|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694805|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694806|NCT00356486|Ribavirin|ribavirin|mesh-list
64694807|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64694808|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
64694809|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
64694810|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694811|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
64694812|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694813|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
64694815|NCT03331835|Brodalumab|brodalumab|mesh-list
64694853|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64694854|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694855|NCT02354833|Protective Agents|protective agents|mesh-ancestor
64694856|NCT03337724|Paclitaxel|paclitaxel|mesh-list
64694857|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64694858|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694859|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
64694860|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
64694861|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
64694863|NCT03838484|Nicotine|nicotine|mesh-list
64694920|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694921|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64297390|NCT03991832|Durvalumab|durvalumab|mesh-list
64297391|NCT03991832|Olaparib|olaparib|mesh-list
64297392|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297393|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694922|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
64374360|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694924|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64694925|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64694926|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64694927|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64694928|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
64694929|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
64694930|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
64694931|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
64694932|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
64694933|NCT03216356|Cycloserine|cycloserine|mesh-list
64694934|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64694935|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64694936|NCT03216356|Renal Agents|renal agents|mesh-ancestor
64694937|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64694938|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
64694939|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64694940|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
64694941|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694942|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
64694943|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64694944|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694970|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694971|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694972|NCT03038672|Nivolumab|nivolumab|mesh-list
64694973|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
64694974|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
64694975|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64694976|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420271|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64694977|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64694978|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64694979|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64694981|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694982|NCT00358124|Metformin|metformin|mesh-list
64694983|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
64694984|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
64694985|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64694986|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64694987|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
64694988|NCT00358202|Cefepime|cefepime|mesh-list
64694989|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64695023|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
64695024|NCT00357188|Ritonavir|ritonavir|mesh-list
64695025|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64695095|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
64695096|NCT02362321|Hormones|hormones|mesh-ancestor
64695097|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695098|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64695099|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695100|NCT00354991|Losartan|losartan|mesh-list
64695101|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64695107|NCT00354991|Diuretics|diuretics|mesh-ancestor
64695163|NCT02367859|Dabrafenib|dabrafenib|mesh-list
64695164|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695165|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64695235|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64695236|NCT02385097|Ropivacaine|ropivacaine|mesh-list
64695237|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
64297394|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64297395|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297396|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297397|NCT01361594|Insulin|insulin|mesh-list
64297398|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64297399|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64297400|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297401|NCT04435028|Ketotifen|ketotifen|mesh-list
64695308|NCT03906071|Docetaxel|docetaxel|mesh-list
64695309|NCT03906071|Nivolumab|nivolumab|mesh-list
64695310|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695311|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
64695312|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
64695313|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
64695314|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695315|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64695316|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64695317|NCT01721876|Cytarabine|cytarabine|mesh-list
64695318|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64695319|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
64695320|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374384|NCT04953741|Xhance|xhance|mesh-list
64695321|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695322|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
64695323|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695324|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64695325|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
64695326|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695361|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64695362|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64695363|NCT05620771|Bevacizumab|bevacizumab|mesh-list
64695364|NCT05620771|Atezolizumab|atezolizumab|mesh-list
64695365|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64695366|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695367|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64695368|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64695369|NCT05620771|Growth Substances|growth substances|mesh-ancestor
64695370|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695371|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
64695372|NCT05419297|Buprenorphine|buprenorphine|mesh-list
64695373|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64695374|NCT05419297|Narcotics|narcotics|mesh-ancestor
64695375|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695376|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695377|NCT05419297|Analgesics|analgesics|mesh-ancestor
64695378|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
64695379|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695380|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64695381|NCT03226457|Empagliflozin|empagliflozin|mesh-list
64695382|NCT03226457|Furosemide|furosemide|mesh-list
64695383|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64695384|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695385|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64297402|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
64695386|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695387|NCT03226457|Diuretics|diuretics|mesh-ancestor
64695388|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
64695391|NCT03226691|Plerixafor|plerixafor|mesh-list
64695409|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
64695410|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695411|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64695413|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
64695414|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695415|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695423|NCT03228017|Aspirin|aspirin|mesh-list
64374420|NCT03259529|Antiviral Agents|antiviral agents|mesh-ancestor
64374421|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374422|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374423|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64374424|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64374425|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64374426|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
64374428|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
64374430|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
64374431|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64374432|NCT03252665|Urological Agents|urological agents|mesh-ancestor
64695477|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
64695478|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64695479|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64695480|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695481|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
64695482|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
64695483|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64695484|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
64695485|NCT00376337|Micafungin|micafungin|mesh-list
64695486|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
64695487|NCT00376337|Clotrimazole|clotrimazole|mesh-list
64695488|NCT00376337|Miconazole|miconazole|mesh-list
64695542|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
64695543|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695544|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
64695545|NCT02979223|Protective Agents|protective agents|mesh-ancestor
64695546|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695547|NCT02979223|Vitamins|vitamins|mesh-ancestor
64695548|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
64695613|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64695614|NCT05716256|Urinastatin|urinastatin|mesh-list
64695615|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64695616|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64695617|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
64695618|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695619|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695621|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64695622|NCT00356083|Narcotics|narcotics|mesh-ancestor
64695623|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695625|NCT00356083|Analgesics|analgesics|mesh-ancestor
64695678|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695679|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695680|NCT04706897|Lidocaine|lidocaine|mesh-list
64695681|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
64374478|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64695682|NCT04706897|Ketamine|ketamine|mesh-list
64695683|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
64695684|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
64374479|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64374480|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64374506|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64695685|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695686|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695687|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
64695688|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695689|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64695690|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64695691|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64695694|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64695737|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695738|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64695739|NCT02978066|Anesthetics|anesthetics|mesh-list
64695740|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695741|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695742|NCT00003399|Dexamethasone|dexamethasone|mesh-list
64695805|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
64695806|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695807|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695808|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695809|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
64695810|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64695873|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64695874|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64695875|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
64695876|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695877|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695878|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
64695880|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64695882|NCT05349188|Melatonin|melatonin|mesh-list
64695883|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
64695884|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695940|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695941|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64695942|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64695943|NCT03443063|Lemborexant|lemborexant|mesh-list
64695944|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64695945|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64695946|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64695947|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64695948|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64695949|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64695950|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64695951|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64695952|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64695953|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64695954|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484521|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
64695955|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64695994|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64695996|NCT04735445|Hematinics|hematinics|mesh-ancestor
64374570|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64374571|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64374572|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64374573|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
64374574|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
64374604|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64695997|NCT00003231|Docetaxel|docetaxel|mesh-list
64695998|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64695999|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
64696000|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
64696001|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
64696002|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696003|NCT00003405|Interferons|interferons|mesh-list
64696004|NCT00003405|Cytarabine|cytarabine|mesh-list
64696005|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
64696006|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
64696007|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
64696008|NCT00003405|Idoxuridine|idoxuridine|mesh-list
64696009|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
64696010|NCT00003405|Idarubicin|idarubicin|mesh-list
64696011|NCT00003405|Isotretinoin|isotretinoin|mesh-list
64696012|NCT00003405|Amifostine|amifostine|mesh-list
64696013|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696055|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696056|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
64696057|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696058|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696059|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64696060|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
64696061|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696062|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696063|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64696064|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64696065|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64696066|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64696067|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696068|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64696069|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696070|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64696071|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
64696072|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696073|NCT04344158|Sorafenib|sorafenib|mesh-list
64696074|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696075|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64696076|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696077|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696078|NCT00003249|Ketoconazole|ketoconazole|mesh-list
64297405|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
64297406|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
64297407|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696080|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
64696081|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696082|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64696084|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696097|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696098|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64696099|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64374611|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696100|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696101|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374613|NCT03058263|Neostigmine|neostigmine|mesh-list
64374614|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64696103|NCT03269435|Bupivacaine|bupivacaine|mesh-list
64696104|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
64696106|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696107|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696108|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
64696161|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
64696163|NCT04477837|Edoxaban|edoxaban|mesh-list
64696164|NCT04477837|Dabigatran|dabigatran|mesh-list
64696165|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64696166|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
64696167|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64696168|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
64696169|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696170|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696171|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
64696172|NCT04469491|Interferons|interferons|mesh-list
64696173|NCT04469491|Interferon Type I|interferon type i|mesh-list
64696174|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696175|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
64696176|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696177|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64696178|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696179|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
64696180|NCT02264574|Chlorambucil|chlorambucil|mesh-list
64696181|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696218|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
64696219|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
64696220|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696221|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696222|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
64696223|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64696224|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64374646|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374647|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696225|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64696226|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64696227|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64696228|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696229|NCT00376727|Cetuximab|cetuximab|mesh-list
64696230|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696231|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696232|NCT05468606|Imiquimod|imiquimod|mesh-list
64696233|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64696234|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
64696235|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696236|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696237|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
64696238|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
64696239|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64696240|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
64696241|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297408|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696242|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696243|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64696244|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
64696245|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64696246|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
64696248|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696260|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696261|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64696262|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696263|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64696264|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64696265|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
64696266|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64696267|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64696268|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64696283|NCT05071352|Nefopam|nefopam|mesh-list
64450560|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
64450561|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
64450562|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
64450563|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374679|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
64374680|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64374681|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64450572|NCT02150213|Hormones|hormones|mesh-ancestor
64696325|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696326|NCT02263326|Lamivudine|lamivudine|mesh-list
64696327|NCT02263326|Dolutegravir|dolutegravir|mesh-list
64696328|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64696329|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64696330|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64696332|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696333|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
64696335|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64696336|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64696337|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64696338|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
64696339|NCT05463848|Temozolomide|temozolomide|mesh-list
64696340|NCT05463848|Olaparib|olaparib|mesh-list
64696341|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64696342|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696343|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64696383|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696384|NCT05461508|Amoxicillin|amoxicillin|mesh-list
64696385|NCT05461508|Fucoidan|fucoidan|mesh-list
64696386|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64696387|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696388|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64696389|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696390|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
64696391|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696392|NCT00356941|Docetaxel|docetaxel|mesh-list
64696393|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
64696394|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696395|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
64696396|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374719|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374720|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64696397|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
64696398|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696399|NCT03450083|Benralizumab|benralizumab|mesh-list
64696443|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64696444|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64696445|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696447|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64696448|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
64696449|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696450|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696451|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
64696452|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696456|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
64696506|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64696507|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64696508|NCT00360386|Clopidogrel|clopidogrel|mesh-list
64696509|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64696510|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64696511|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64696512|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64696513|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
64696514|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696515|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696516|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696517|NCT02977208|Gabapentin|gabapentin|mesh-list
64696518|NCT02977208|Analgesics|analgesics|mesh-ancestor
64696522|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
64696573|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
64696574|NCT02259348|Interleukin-2|interleukin-2|mesh-list
64696575|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64696576|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
64696577|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696578|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696579|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64696580|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
64696581|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696582|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64696583|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64696586|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
64696641|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64696642|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
64696643|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696644|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696645|NCT03592121|Protective Agents|protective agents|mesh-ancestor
64696646|NCT04332809|Gentamicins|gentamicins|mesh-list
64696647|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64696648|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696649|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64696650|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696651|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696652|NCT03596723|Prednisolone|prednisolone|mesh-list
64696653|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64696654|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
64696655|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64696656|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
64696657|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64696658|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
64696659|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696660|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
64696662|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450606|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64450618|NCT02090114|Hormones|hormones|mesh-ancestor
64374790|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
64374791|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374792|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374794|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
64696663|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696664|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64696693|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696694|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64696695|NCT03472469|Analgesics|analgesics|mesh-ancestor
64696696|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
64696697|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
64696698|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64696699|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64696700|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64696701|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64696702|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64696703|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64696704|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64696705|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696707|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64696708|NCT03472469|Narcotics|narcotics|mesh-ancestor
64696709|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64696710|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64696711|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64696712|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64696713|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696714|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
64696715|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64696717|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
64696718|NCT04926233|Olodaterol|olodaterol|mesh-list
64696719|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64696720|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
64696731|NCT04943159|Afamelanotide|afamelanotide|mesh-list
64696744|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64696745|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696746|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696747|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
64696748|NCT03112603|Sirolimus|sirolimus|mesh-list
64696749|NCT03112603|Rituximab|rituximab|mesh-list
64696750|NCT03112603|Methotrexate|methotrexate|mesh-list
64696751|NCT03112603|Everolimus|everolimus|mesh-list
64696811|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64696812|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
64696813|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64696814|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64696815|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64696816|NCT02959112|Indomethacin|indomethacin|mesh-list
64696817|NCT02959112|Epinephrine|epinephrine|mesh-list
64696818|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64696819|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64696820|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
64696821|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696822|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696823|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696824|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64696825|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64696826|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
64696871|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
64696873|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64696875|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64696876|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
64696877|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696878|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64696879|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64696880|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
64696881|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64696882|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696883|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64696884|NCT01642914|Linaclotide|linaclotide|mesh-list
64696885|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64696889|NCT04497116|Gemcitabine|gemcitabine|mesh-list
64696941|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64696942|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64696943|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
64696944|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64696945|NCT02256540|Protective Agents|protective agents|mesh-ancestor
64696946|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64696947|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64696954|NCT05646264|S 20098|s 20098|mesh-list
64696955|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64696958|NCT01640184|Vitamin D|vitamin d|mesh-list
64697008|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64697009|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
64697010|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697012|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64697013|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422305|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
64697014|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
64697015|NCT04825496|Fludarabine|fludarabine|mesh-list
64697016|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697017|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
64697018|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697019|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697020|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64697021|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
64697022|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697023|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697024|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64697025|NCT04434092|Eculizumab|eculizumab|mesh-list
64697026|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64697027|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697028|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
64697062|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697063|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
64697064|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697065|NCT00360776|Tipifarnib|tipifarnib|mesh-list
64697066|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697067|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
64697068|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697069|NCT04342910|Paclitaxel|paclitaxel|mesh-list
64697070|NCT04342910|Irinotecan|irinotecan|mesh-list
64697071|NCT04342910|Apatinib|apatinib|mesh-list
64697072|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64374869|NCT04938297|Rituximab|rituximab|mesh-list
64697073|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697074|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
64697075|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
64697076|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
64697077|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697078|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64697079|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64697080|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697081|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64697082|NCT04714073|Itraconazole|itraconazole|mesh-list
64697083|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
64697084|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697116|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697117|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64697118|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
64697119|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297413|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
64297414|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297416|NCT05060198|Artemether|artemether|mesh-list
64297417|NCT05060198|Piperaquine|piperaquine|mesh-list
64297418|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64297419|NCT05060198|Artenimol|artenimol|mesh-list
64297420|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
64697120|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697121|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64697122|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64697123|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697125|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697126|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697127|NCT04342598|Vitamin D|vitamin d|mesh-list
64697128|NCT04342598|Vitamins|vitamins|mesh-ancestor
64697129|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
64697130|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697132|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64697174|NCT05334108|Ecopipam|ecopipam|mesh-list
64697175|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64697176|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697177|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697178|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697179|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697180|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64697181|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
64697182|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697183|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697184|NCT03984656|Lidocaine|lidocaine|mesh-list
64697185|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
64697186|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
64697187|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697188|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697189|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
64697190|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697191|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64697192|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64697193|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64697194|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64697195|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697196|NCT05299944|Cannabidiol|cannabidiol|mesh-list
64697197|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
64697198|NCT04329494|Leucovorin|leucovorin|mesh-list
64697199|NCT04329494|Cisplatin|cisplatin|mesh-list
64697200|NCT04329494|Doxorubicin|doxorubicin|mesh-list
64697201|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64697202|NCT04329494|Fluorouracil|fluorouracil|mesh-list
64697203|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
64697204|NCT04329494|Irinotecan|irinotecan|mesh-list
64697205|NCT04329494|Daunorubicin|daunorubicin|mesh-list
64697206|NCT04329494|Mitomycins|mitomycins|mesh-list
64697207|NCT04329494|Mitomycin|mitomycin|mesh-list
64697217|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
64697218|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697219|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64697221|NCT04329494|Protective Agents|protective agents|mesh-ancestor
64697222|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
64697223|NCT04329494|Vitamins|vitamins|mesh-ancestor
64697224|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
64697225|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
64697226|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64697227|NCT03655301|Metformin|metformin|mesh-list
64697228|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697284|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64297421|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64697285|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64297422|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64697286|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697287|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697288|NCT05650476|Talazoparib|talazoparib|mesh-list
64697289|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64697290|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697291|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697292|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697293|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
64697294|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64697295|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64697296|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697297|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
64697298|NCT03954314|Coagulants|coagulants|mesh-ancestor
64697299|NCT03952130|Insulin|insulin|mesh-list
64697300|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64697301|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
64697302|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
64697303|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697304|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697305|NCT04852068|Vaccines|vaccines|mesh-list
64697306|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
64697315|NCT05430828|Evolocumab|evolocumab|mesh-list
64697336|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64697337|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64697338|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697339|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64697340|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
64697341|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697342|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64697343|NCT05430048|Bisoprolol|bisoprolol|mesh-list
64697344|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64697345|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64697346|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
64697347|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
64697348|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697349|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697396|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64697397|NCT04184999|Protective Agents|protective agents|mesh-ancestor
64697399|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64697400|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64697401|NCT03912428|Analgesics|analgesics|mesh-ancestor
64697402|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
64697403|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697404|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697405|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697406|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697407|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64697408|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64697409|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697410|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697455|NCT00361088|Tipifarnib|tipifarnib|mesh-list
64697456|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697457|NCT04172402|Gemcitabine|gemcitabine|mesh-list
64697458|NCT04172402|Nivolumab|nivolumab|mesh-list
64697459|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64697460|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
64697461|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697462|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697463|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
64697464|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697465|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697466|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64697468|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697469|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697470|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64697514|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64697515|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64697516|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64697517|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64697518|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64697519|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64697520|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64697521|NCT05142228|Erenumab|erenumab|mesh-list
64697522|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64697577|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
64697578|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697579|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697580|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64697581|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
64697582|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
64697583|NCT02975258|Protective Agents|protective agents|mesh-ancestor
64697584|NCT02975258|Miotics|miotics|mesh-ancestor
64697585|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64697586|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64697587|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64697588|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64697589|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
64697590|NCT05114460|Naloxone|naloxone|mesh-list
64697591|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64697592|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697593|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
64697594|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697595|NCT04844814|Prednisone|prednisone|mesh-list
64697596|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64697597|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697598|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
64697599|NCT04844814|Hormones|hormones|mesh-ancestor
64697600|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64697601|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697602|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64697603|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697604|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697605|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64697606|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64697607|NCT04833114|Carboplatin|carboplatin|mesh-list
64697608|NCT04833114|Etoposide|etoposide|mesh-list
64697620|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697621|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64697622|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
64697624|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64697625|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697626|NCT05314673|Bevacizumab|bevacizumab|mesh-list
64697627|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697628|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697629|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64697630|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64697631|NCT05314673|Growth Substances|growth substances|mesh-ancestor
64697632|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697633|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
64697634|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
64697635|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
64697636|NCT04112069|Pancrelipase|pancrelipase|mesh-list
64697637|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64697638|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697639|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64697640|NCT03785210|Vancomycin|vancomycin|mesh-list
64697641|NCT03785210|Nivolumab|nivolumab|mesh-list
64697642|NCT03785210|Tadalafil|tadalafil|mesh-list
64697643|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697644|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697645|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64697646|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450714|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450715|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64450716|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
64450717|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
64450718|NCT02149199|Hormones|hormones|mesh-ancestor
64450719|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450720|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64450721|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64450722|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64450723|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
64450724|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697647|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64697648|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64697666|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697667|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697668|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
64697669|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64697670|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64697671|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697672|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64697673|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64697674|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697675|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697676|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697677|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64697678|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
64697679|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64697680|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64697681|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
64697682|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422984|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64697683|NCT02976272|Bortezomib|bortezomib|mesh-list
64697684|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697685|NCT00361790|Aripiprazole|aripiprazole|mesh-list
64697686|NCT00361790|Citalopram|citalopram|mesh-list
64697715|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697716|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64697717|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
64697718|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697724|NCT04564872|Hormones|hormones|mesh-ancestor
64697785|NCT00361166|Pimavanserin|pimavanserin|mesh-list
64697786|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64697787|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64697788|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64697789|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697790|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64697791|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697793|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64697794|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64697795|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
64697796|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697848|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697850|NCT00361244|Cetuximab|cetuximab|mesh-list
64697851|NCT00361244|Sunitinib|sunitinib|mesh-list
64697852|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64697853|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64697854|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697855|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697856|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64697857|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64697858|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64697859|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64697860|NCT00361244|Growth Substances|growth substances|mesh-ancestor
64697861|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697862|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
64697863|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64697864|NCT03390686|Paclitaxel|paclitaxel|mesh-list
64697865|NCT03390686|Bevacizumab|bevacizumab|mesh-list
64697866|NCT03390686|Carboplatin|carboplatin|mesh-list
64697867|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64697903|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64697904|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64697905|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697906|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
64697907|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
64423205|NCT05334277|Pemetrexed|pemetrexed|mesh-list
64697908|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
64697909|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64697910|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64697911|NCT00361322|Analgesics|analgesics|mesh-ancestor
64697912|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
64697913|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64697914|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64697915|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64697916|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64697917|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64697918|NCT02974712|Fentanyl|fentanyl|mesh-list
64697960|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64297423|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297425|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
64297426|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64297427|NCT04478084|Antibodies|antibodies|mesh-list
64297428|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
64297429|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297430|NCT03098888|Dimercaprol|dimercaprol|mesh-list
64297431|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
64297432|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
64297433|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297434|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
64297435|NCT03098810|Astringents|astringents|mesh-ancestor
64297436|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297437|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297438|NCT02464761|Verteporfin|verteporfin|mesh-list
64297439|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64697961|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64697962|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64697963|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64697964|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
64697965|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
64697966|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
64697967|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
64697968|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64697969|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64697970|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64697971|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64697972|NCT04957368|Analgesics|analgesics|mesh-ancestor
64697973|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
64697974|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698019|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64698020|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64698021|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
64698022|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64698024|NCT04829760|Cathartics|cathartics|mesh-ancestor
64698025|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64698036|NCT05289804|Lidocaine|lidocaine|mesh-list
64698037|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
64698038|NCT05289804|Prilocaine|prilocaine|mesh-list
64698039|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64698040|NCT05289804|Anesthetics|anesthetics|mesh-list
64698041|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698042|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698057|NCT04817826|Durvalumab|durvalumab|mesh-list
64698089|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64698090|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698091|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698092|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64698093|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64698094|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
64698095|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698096|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64698097|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698098|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
64698099|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64698100|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64698101|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698102|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
64698103|NCT04448184|Coagulants|coagulants|mesh-ancestor
64698104|NCT04426968|Interferons|interferons|mesh-list
64698105|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698106|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
64698107|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698108|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64698109|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
64698144|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698145|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
64698146|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374982|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
64374983|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374984|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64374985|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64450800|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450801|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698147|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
64698148|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698149|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64698150|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
64698151|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64698152|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64698153|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64698154|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
64698155|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698156|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698157|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
64698159|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64698160|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64698161|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
64698162|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698163|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698164|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698196|NCT04211909|Velpatasvir|velpatasvir|mesh-list
64698197|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
64698198|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698199|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
64698200|NCT04223843|Olodaterol|olodaterol|mesh-list
64698201|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64698202|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
64698203|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698204|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698205|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64698207|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
64698261|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64698262|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64698263|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698264|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698265|NCT05722561|Nicotine|nicotine|mesh-list
64698266|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64698267|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
64698268|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698269|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698281|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
64698282|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698283|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698284|NCT05722405|Lenalidomide|lenalidomide|mesh-list
64698285|NCT05722405|Ixazomib|ixazomib|mesh-list
64698286|NCT05722405|Glycine|glycine|mesh-list
64698332|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
64698333|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698334|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64698335|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64698336|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698337|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698338|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64698339|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
64698340|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698341|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698342|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64698345|NCT00357643|Vitamin D|vitamin d|mesh-list
64698346|NCT00357643|Calcium|calcium|mesh-list
64698347|NCT00357643|Vitamins|vitamins|mesh-ancestor
64698348|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
64698349|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698350|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64698351|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64698352|NCT04812912|Hormones|hormones|mesh-list
64698353|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423655|NCT05208619|Anesthetics|anesthetics|mesh-list
64698354|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698355|NCT04232358|Anesthetics|anesthetics|mesh-list
64698356|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698357|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698358|NCT05395494|Cycloserine|cycloserine|mesh-list
64698359|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64698360|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698361|NCT05395494|Renal Agents|renal agents|mesh-ancestor
64698362|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64698363|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
64698372|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698373|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64698374|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64698375|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
64698376|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698378|NCT03504410|Fludarabine|fludarabine|mesh-list
64698380|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
64698381|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698382|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64698383|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
64698384|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698385|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64698386|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
64698437|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698438|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698439|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
64698440|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64698441|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64698442|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698443|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64698444|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64698445|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64698446|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698447|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698448|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
64698449|NCT05363514|Naltrexone|naltrexone|mesh-list
64698450|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64698451|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64698452|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698453|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
64698454|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698455|NCT05721079|Methoxsalen|methoxsalen|mesh-list
64698456|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64698457|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
64698458|NCT00362570|Temozolomide|temozolomide|mesh-list
64698459|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64698460|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
64698461|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698462|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698463|NCT00357253|Capecitabine|capecitabine|mesh-list
64698464|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64698465|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
64450844|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450845|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64450846|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64450847|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64450848|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
64450849|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450850|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450851|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64450852|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64450853|NCT04726592|Analgesics|analgesics|mesh-ancestor
64450854|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
64450855|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698466|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698467|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698468|NCT03541902|Sunitinib|sunitinib|mesh-list
64698469|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698476|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698477|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698480|NCT02386735|Prednisone|prednisone|mesh-list
64698481|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64698482|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
64698483|NCT02386735|Hormones|hormones|mesh-ancestor
64381001|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381002|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64698484|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698485|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698488|NCT02068430|Riboflavin|riboflavin|mesh-list
64698543|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64698544|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
64698545|NCT02445326|Hormones|hormones|mesh-ancestor
64698546|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698547|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64698548|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698549|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
64698550|NCT04344457|Azithromycin|azithromycin|mesh-list
64698551|NCT04344457|Indomethacin|indomethacin|mesh-list
64698552|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
64698553|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64698554|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64698555|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698556|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381003|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64381004|NCT05530785|Growth Substances|growth substances|mesh-ancestor
64698557|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381005|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698558|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381006|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
64381007|NCT05530395|Testosterone|testosterone|mesh-list
64381008|NCT05530395|Androgens|androgens|mesh-ancestor
64381009|NCT05530395|Hormones|hormones|mesh-ancestor
64450874|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450875|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
64450876|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450877|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64450878|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64450879|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64450880|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381010|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381011|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381012|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
64381013|NCT05389995|Methamphetamine|methamphetamine|mesh-list
64381014|NCT05389995|Citric Acid|citric acid|mesh-list
64381015|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
64381016|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
64381017|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64381018|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
64381021|NCT05389995|Diuretics|diuretics|mesh-ancestor
64381031|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381032|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
64381033|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64381034|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64381035|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64381036|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64381038|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381039|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381040|NCT03191903|Triamcinolone|triamcinolone|mesh-list
64381041|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64381042|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64381043|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64381044|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381045|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
64381046|NCT03191903|Hormones|hormones|mesh-ancestor
64381047|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381048|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381049|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381050|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
64381051|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381052|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698559|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64698601|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698602|NCT00355693|Propofol|propofol|mesh-list
64698603|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64698604|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698605|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698606|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64698607|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
64698608|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
64698609|NCT02448368|Verinurad|verinurad|mesh-list
64698610|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
64698611|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698612|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64698613|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64698614|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
64698615|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698616|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64698617|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64698618|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
64698619|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
64698620|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698621|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698622|NCT03496662|Gemcitabine|gemcitabine|mesh-list
64698623|NCT03496662|Paclitaxel|paclitaxel|mesh-list
64698624|NCT03496662|Nivolumab|nivolumab|mesh-list
64698625|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64698626|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698627|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
64698628|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
64450890|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64698629|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
64698630|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698631|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64698632|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
64698644|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64698645|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64698646|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64698647|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698648|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698649|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
64698650|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698651|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698652|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64698653|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698654|NCT05719831|Amoxicillin|amoxicillin|mesh-list
64698655|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698656|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698657|NCT01152541|Riboflavin|riboflavin|mesh-list
64698658|NCT01152541|Dextrans|dextrans|mesh-list
64297441|NCT02462889|Aflibercept|aflibercept|mesh-list
64698659|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64698660|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
64297442|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64297443|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64297444|NCT02462889|Growth Substances|growth substances|mesh-ancestor
64297445|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297446|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297447|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297448|NCT02462577|Morphine|morphine|mesh-list
64297449|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64297450|NCT02462577|Narcotics|narcotics|mesh-ancestor
64297451|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297453|NCT02462577|Analgesics|analgesics|mesh-ancestor
64297454|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
64698662|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
64698663|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698664|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64698665|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
64698666|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
64698667|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
64698668|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
64698669|NCT01638546|Temozolomide|temozolomide|mesh-list
64698670|NCT01638546|Veliparib|veliparib|mesh-list
64698693|NCT05723341|Morphine|morphine|mesh-list
64698694|NCT05723341|Bupivacaine|bupivacaine|mesh-list
64698695|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
64698696|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
64698697|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698698|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698699|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
64698700|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698701|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64698702|NCT05723341|Narcotics|narcotics|mesh-ancestor
64698703|NCT05723341|Analgesics|analgesics|mesh-ancestor
64375094|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
64375096|NCT03238703|Toremifene|toremifene|mesh-list
64375097|NCT03238703|Letrozole|letrozole|mesh-list
64375098|NCT03238703|Anastrozole|anastrozole|mesh-list
64375099|NCT03238703|Exemestane|exemestane|mesh-list
64375100|NCT03238703|Citric Acid|citric acid|mesh-list
64375101|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
64698704|NCT05718583|Butyric Acid|butyric acid|mesh-list
64698705|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
64698706|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
64698707|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64698708|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698709|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698710|NCT00363350|Rituximab|rituximab|mesh-list
64698711|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698712|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698713|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
64698714|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698715|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64698716|NCT05717335|Thrombin|thrombin|mesh-list
64698717|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
64698718|NCT05717335|Coagulants|coagulants|mesh-ancestor
64698719|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
64698720|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64698721|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698727|NCT04341818|Vitamins|vitamins|mesh-list
64698740|NCT02451488|Sargramostim|sargramostim|mesh-list
64698741|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
64698742|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698743|NCT03172494|Insulin|insulin|mesh-list
64698744|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64698745|NCT03172494|Liraglutide|liraglutide|mesh-list
64698746|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
64297455|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297456|NCT02462499|Eplerenone|eplerenone|mesh-list
64297457|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64297458|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
64381054|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64381055|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381079|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381080|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64450914|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381081|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64381082|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64381083|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381084|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
64381085|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381086|NCT02437721|Folic Acid|folic acid|mesh-list
64381087|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
64381088|NCT02437721|Hematinics|hematinics|mesh-ancestor
64381089|NCT02437721|Vitamins|vitamins|mesh-ancestor
64381090|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
64698747|NCT03172494|Xultophy|xultophy|mesh-list
64698748|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64381091|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381092|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
64381093|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381094|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
64698749|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698750|NCT03172494|Incretins|incretins|mesh-ancestor
64698751|NCT03172494|Hormones|hormones|mesh-ancestor
64698752|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64698753|NCT02452346|Tosedostat|tosedostat|mesh-list
64698754|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698756|NCT02959255|Esomeprazole|esomeprazole|mesh-list
64698801|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
64698802|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64698803|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698804|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
64698805|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698806|NCT03140670|Rucaparib|rucaparib|mesh-list
64698807|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64698808|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698809|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698810|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698811|NCT02453672|Bevacizumab|bevacizumab|mesh-list
64698812|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64698813|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698814|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64698815|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64698819|NCT03119064|Irinotecan|irinotecan|mesh-list
64698858|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64698859|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64698860|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64698861|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64698862|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698864|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64698865|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64698866|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698868|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
64698922|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64698923|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698924|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64698925|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64698926|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64698927|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450950|NCT02053610|Rituximab|rituximab|mesh-list
64450951|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
64698928|NCT05346601|Chiauranib|chiauranib|mesh-list
64698929|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64698930|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64698931|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64698932|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698933|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
64698934|NCT05325073|Hematinics|hematinics|mesh-ancestor
64698935|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64698936|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698938|NCT04344379|Azithromycin|azithromycin|mesh-list
64698939|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
64698940|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64698941|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698942|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
64698970|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64698971|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
64698972|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64698973|NCT05511025|Acetaminophen|acetaminophen|mesh-list
64698974|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64698975|NCT05511025|Analgesics|analgesics|mesh-ancestor
64698976|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
64698977|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64698978|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64698979|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
64698980|NCT05679193|Propranolol|propranolol|mesh-list
64698981|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64698982|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64699033|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
64699034|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450963|NCT04701008|Ketamine|ketamine|mesh-list
64450964|NCT04701008|Analgesics|analgesics|mesh-ancestor
64699035|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699036|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699037|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699038|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64699039|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64699040|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699041|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699042|NCT00359359|Sagopilone|sagopilone|mesh-list
64699096|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699098|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699099|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699100|NCT00608972|Bevacizumab|bevacizumab|mesh-list
64699101|NCT00608972|Carboplatin|carboplatin|mesh-list
64699102|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699103|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699104|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64699105|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64699106|NCT00608972|Growth Substances|growth substances|mesh-ancestor
64699107|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699156|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64699157|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699158|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699159|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
64699161|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
64699162|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699164|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
64699165|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699166|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64699167|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
64699168|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
64699169|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699170|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699171|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64699172|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
64699173|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699174|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699175|NCT05648058|Analgesics|analgesics|mesh-ancestor
64450999|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64451000|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451001|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64451002|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64451003|NCT01621880|Growth Substances|growth substances|mesh-ancestor
64451004|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451005|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
64451006|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451008|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
64451009|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699177|NCT05649085|Chromium|chromium|mesh-list
64699178|NCT05649085|Trace Elements|trace elements|mesh-ancestor
64699179|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
64699180|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699182|NCT05639712|Morphine|morphine|mesh-list
64699183|NCT05639712|Oxycodone|oxycodone|mesh-list
64699184|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64699185|NCT05639712|Narcotics|narcotics|mesh-ancestor
64699186|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64699206|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699207|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297459|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297460|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699208|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699209|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699210|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64699211|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699212|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
64699213|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64699214|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699215|NCT05630833|Renal Agents|renal agents|mesh-ancestor
64699216|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699217|NCT00359671|Docetaxel|docetaxel|mesh-list
64297461|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64297463|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
64699218|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699268|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699269|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699270|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64699271|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699272|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699274|NCT05064085|Cemiplimab|cemiplimab|mesh-list
64699275|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64699276|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
64699277|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699278|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699280|NCT04871191|Rituximab|rituximab|mesh-list
64699332|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699333|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
64699334|NCT04833907|Hormones|hormones|mesh-ancestor
64699335|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699336|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699337|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64699338|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699339|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
64699340|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
64699341|NCT02976259|Dolutegravir|dolutegravir|mesh-list
64699342|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64699343|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64699344|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699345|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699346|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64699347|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64699348|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
64699349|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699350|NCT00360295|Azithromycin|azithromycin|mesh-list
64699390|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64699391|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699392|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699393|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64699394|NCT00360607|Renal Agents|renal agents|mesh-ancestor
64699395|NCT00360763|Candesartan|candesartan|mesh-list
64699396|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
64699397|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64699398|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64699399|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64699400|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699401|NCT04032301|Ketamine|ketamine|mesh-list
64699402|NCT04032301|Analgesics|analgesics|mesh-ancestor
64699403|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
64699407|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64699447|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64699448|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699449|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699450|NCT04730635|Donepezil|donepezil|mesh-list
64699451|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64699452|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699453|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699454|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
64699455|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699456|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699457|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
64699458|NCT04686799|Doxycycline|doxycycline|mesh-list
64699459|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699460|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699461|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
64699462|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64699463|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64699464|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
64699465|NCT04676035|Vitamin K|vitamin k|mesh-list
64699466|NCT04676035|Midazolam|midazolam|mesh-list
64699467|NCT04676035|Omeprazole|omeprazole|mesh-list
64699469|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64699470|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64699471|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297464|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64699472|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297465|NCT02464683|Vitamin D|vitamin d|mesh-list
64297466|NCT02464683|Vitamins|vitamins|mesh-ancestor
64297467|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
64297468|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297469|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64297470|NCT02061631|Dexamethasone|dexamethasone|mesh-list
64297471|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
64297472|NCT02061631|Docetaxel|docetaxel|mesh-list
64297473|NCT02061631|BB 1101|bb 1101|mesh-list
64297474|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699501|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
64699502|NCT04359199|Nivolumab|nivolumab|mesh-list
64699503|NCT04359199|Cetuximab|cetuximab|mesh-list
64699504|NCT04359199|Durvalumab|durvalumab|mesh-list
64699505|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699506|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699507|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64699508|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699509|NCT03875911|Mitomycins|mitomycins|mesh-list
64699510|NCT03875911|Mitomycin|mitomycin|mesh-list
64699511|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64451030|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
64451031|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
64451032|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375248|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
64375249|NCT02622321|Coagulants|coagulants|mesh-ancestor
64375250|NCT02187172|Ustekinumab|ustekinumab|mesh-list
64375251|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699512|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699513|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
64699514|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699515|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64699516|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699517|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64699518|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64699519|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64699520|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699521|NCT00361075|Estradiol|estradiol|mesh-list
64699522|NCT00361075|Estrogens|estrogens|mesh-list
64699523|NCT00361075|Progesterone|progesterone|mesh-list
64699524|NCT00361075|Hormones|hormones|mesh-ancestor
64699525|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699526|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699527|NCT00361075|Progestins|progestins|mesh-ancestor
64699528|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64297475|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
64297476|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
64297477|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297478|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297479|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64297480|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
64297481|NCT02061631|Hormones|hormones|mesh-ancestor
64297482|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297483|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64297484|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297485|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
64297486|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699545|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699546|NCT00362089|Analgesics|analgesics|mesh-ancestor
64699547|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
64699548|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699549|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64699550|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64699551|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699552|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699553|NCT00362089|Hormones|hormones|mesh-ancestor
64699554|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699555|NCT04666987|Liraglutide|liraglutide|mesh-list
64699556|NCT04666987|Xultophy|xultophy|mesh-list
64451033|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64451034|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64699557|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64699558|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699559|NCT04666987|Incretins|incretins|mesh-ancestor
64699560|NCT04666987|Hormones|hormones|mesh-ancestor
64699561|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699562|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
64699563|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699564|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699565|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
64699566|NCT03822637|Albuterol|albuterol|mesh-list
64699567|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64699568|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64699569|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
64699570|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699571|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699572|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64699574|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
64699592|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699593|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699594|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64699595|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64699596|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
64699597|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699598|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699599|NCT04342819|Empagliflozin|empagliflozin|mesh-list
64699600|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64699601|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699602|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64297487|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297488|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
64699603|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699604|NCT02412306|Blinatumomab|blinatumomab|mesh-list
64699605|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699606|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
64699607|NCT05616468|Fludarabine|fludarabine|mesh-list
64297489|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
64699608|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699609|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
64699610|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699611|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699612|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699613|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
64699614|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699615|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699616|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64699617|NCT03764293|Sorafenib|sorafenib|mesh-list
64699618|NCT03764293|Apatinib|apatinib|mesh-list
64699619|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699620|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64699621|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699622|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699623|NCT03659136|Everolimus|everolimus|mesh-list
64699624|NCT03659136|Exemestane|exemestane|mesh-list
64699625|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699629|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64699630|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64699631|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699632|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699633|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64699634|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
64699635|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424933|NCT02450539|Docetaxel|docetaxel|mesh-list
64699636|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
64699637|NCT03654768|Dasatinib|dasatinib|mesh-list
64699638|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64699639|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699640|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64699641|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699642|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699643|NCT01352221|Ferric maltol|ferric maltol|mesh-list
64699686|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699687|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699688|NCT05195034|Analgesics|analgesics|mesh-ancestor
64699689|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
64699690|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699691|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64297490|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
64297492|NCT03098342|Methylene Blue|methylene blue|mesh-list
64297493|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297494|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297495|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
64297496|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297497|NCT05059418|Clonazepam|clonazepam|mesh-list
64297498|NCT05059418|Capsaicin|capsaicin|mesh-list
64297499|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
64297500|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297501|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
64297502|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297503|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381095|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
64381096|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
64381097|NCT05533983|Nivolumab|nivolumab|mesh-list
64381099|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381138|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
64381140|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
64381141|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
64381142|NCT02435771|Vitamin D|vitamin d|mesh-list
64381143|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64381144|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699692|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64699693|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64699694|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
64699695|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451087|NCT02079805|Telmisartan|telmisartan|mesh-list
64699696|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699697|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
64699698|NCT05496894|Analgesics|analgesics|mesh-ancestor
64699699|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
64699700|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699701|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699702|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699703|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64699704|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64699705|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699706|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699707|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
64699708|NCT02065362|Fludarabine|fludarabine|mesh-list
64699709|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699710|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
64699711|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699712|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699713|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699729|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699730|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
64297507|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297508|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297509|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
64297511|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64297512|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381145|NCT02435771|Vitamins|vitamins|mesh-ancestor
64381146|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
64381147|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64381148|NCT02440841|Itraconazole|itraconazole|mesh-list
64381149|NCT02440841|Rifampin|rifampin|mesh-list
64381150|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
64381151|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381152|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64381153|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64381154|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381155|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381156|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64381157|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
64375392|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375393|NCT03056703|Aspirin|aspirin|mesh-list
64375394|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64375395|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64375396|NCT03056703|Analgesics|analgesics|mesh-ancestor
64375397|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
64375398|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375399|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451093|NCT02037295|Vancomycin|vancomycin|mesh-list
64375400|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451103|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451104|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451105|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
64451106|NCT02079649|Hormones|hormones|mesh-ancestor
64451107|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451108|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64381158|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381159|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381160|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64381172|NCT02576145|Daclizumab|daclizumab|mesh-list
64381188|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64381189|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64381191|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
64381192|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381193|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381194|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64381195|NCT02435537|Narcotics|narcotics|mesh-ancestor
64381196|NCT02576067|Methotrexate|methotrexate|mesh-list
64381197|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64381198|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
64381199|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381202|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
64381246|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381247|NCT02575833|Analgesics|analgesics|mesh-ancestor
64381248|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
64381249|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381250|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381251|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
64381252|NCT02709083|Dasatinib|dasatinib|mesh-list
64381253|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451113|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
64451117|NCT02036515|Hormones|hormones|mesh-ancestor
64699732|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699733|NCT02389218|Sotalol|sotalol|mesh-list
64699734|NCT02389218|Flecainide|flecainide|mesh-list
64699735|NCT02389218|Propafenone|propafenone|mesh-list
64699736|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64699737|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64699738|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
64699739|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699740|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699741|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699742|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64699743|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
64699744|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
64699745|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699746|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64699747|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64699748|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64699749|NCT01953120|Abatacept|abatacept|mesh-list
64699750|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64699751|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699752|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699753|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699754|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
64699755|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699756|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699757|NCT01634100|Empagliflozin|empagliflozin|mesh-list
64699758|NCT01634100|Rifampin|rifampin|mesh-list
64699759|NCT01634100|Probenecid|probenecid|mesh-list
64699773|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64699774|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64699775|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64699776|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64699777|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
64699778|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
64699779|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699780|NCT01634100|Renal Agents|renal agents|mesh-ancestor
64699781|NCT03662659|Nivolumab|nivolumab|mesh-list
64297513|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297514|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64297515|NCT02062333|Analgesics|analgesics|mesh-ancestor
64297516|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
64297517|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297518|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64297519|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64451159|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375454|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64375455|NCT03056391|Analgesics|analgesics|mesh-ancestor
64375456|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
64375457|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375458|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375459|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
64375460|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
64375461|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297520|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64381255|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381256|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381257|NCT02709005|Monolaurin|monolaurin|mesh-list
64381258|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
64381259|NCT02709005|Protective Agents|protective agents|mesh-ancestor
64381260|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381261|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
64381262|NCT03188471|Aspirin|aspirin|mesh-list
64381263|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381264|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64381266|NCT03188471|Analgesics|analgesics|mesh-ancestor
64381298|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64381299|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
64381300|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381301|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381302|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381303|NCT05192889|Leucovorin|leucovorin|mesh-list
64381304|NCT05192889|Cytarabine|cytarabine|mesh-list
64381305|NCT05192889|Dexamethasone|dexamethasone|mesh-list
64381306|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
64699782|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64699783|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699784|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64699785|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699787|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
64699788|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
64699789|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64699790|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64699791|NCT03661645|BB 1101|bb 1101|mesh-list
64699792|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451173|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
64451174|NCT02021318|Hematinics|hematinics|mesh-ancestor
64451175|NCT02020616|Metformin|metformin|mesh-list
64451176|NCT02020616|Exenatide|exenatide|mesh-list
64451177|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451178|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699793|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
64699794|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
64699795|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699796|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699797|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699798|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
64699799|NCT03661645|Hormones|hormones|mesh-ancestor
64699800|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699808|NCT01633944|Buprenorphine|buprenorphine|mesh-list
64699821|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699822|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
64699823|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699824|NCT00589316|Iodine|iodine|mesh-list
64699825|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
64699826|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
64699827|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
64699828|NCT00589316|Fludarabine|fludarabine|mesh-list
64699829|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
64699830|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64699831|NCT00589316|Tacrolimus|tacrolimus|mesh-list
64699832|NCT00589316|Antibodies|antibodies|mesh-list
64699833|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
64699834|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64699835|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699836|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
64699837|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699838|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699839|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699840|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
64375500|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
64699841|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699842|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699843|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64699844|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64699845|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
64699846|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64699847|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699848|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64699849|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64699850|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
64699851|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699852|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699863|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64699864|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
64699865|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699866|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699867|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
64699868|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64699870|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64699871|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64699872|NCT04786548|Celecoxib|celecoxib|mesh-list
64699873|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64699874|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64699875|NCT04786548|Analgesics|analgesics|mesh-ancestor
64699876|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
64699877|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699878|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64699879|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699880|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64699881|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64699882|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64699883|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699884|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699885|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64699916|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64699917|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
64414790|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699918|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699919|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699920|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64699921|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64699923|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
64699924|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64699925|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64699926|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
64699927|NCT00003423|Hormones|hormones|mesh-ancestor
64699928|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64699929|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64699930|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64699931|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
64699932|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64699933|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64699934|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
64425222|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64699935|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
64699936|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699937|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64699938|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64381307|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
64381308|NCT05192889|Methotrexate|methotrexate|mesh-list
64381309|NCT05192889|Etoposide|etoposide|mesh-list
64381310|NCT05192889|Vincristine|vincristine|mesh-list
64381311|NCT05192889|Venetoclax|venetoclax|mesh-list
64381312|NCT05192889|Asparaginase|asparaginase|mesh-list
64381313|NCT05192889|Dasatinib|dasatinib|mesh-list
64381314|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
64381315|NCT05192889|Pegaspargase|pegaspargase|mesh-list
64381316|NCT05192889|Blinatumomab|blinatumomab|mesh-list
64381317|NCT05192889|Navitoclax|navitoclax|mesh-list
64381318|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381319|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
64381320|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381321|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381322|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64381323|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
64381324|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381325|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381326|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64451268|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451269|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
64451270|NCT02030821|Coagulants|coagulants|mesh-ancestor
64451271|NCT02052739|Brexanolone|brexanolone|mesh-list
64451272|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
64451273|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451274|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381327|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381328|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
64381329|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
64381346|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64381347|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64381348|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
64381349|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381350|NCT05192889|Antidotes|antidotes|mesh-ancestor
64381351|NCT05192889|Protective Agents|protective agents|mesh-ancestor
64381352|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
64381353|NCT05192889|Vitamins|vitamins|mesh-ancestor
64381354|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
64381355|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
64381356|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
64381357|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
64699963|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64699964|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64699965|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64699966|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64699967|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
64699968|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64699969|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64699970|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
64699971|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
64375550|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64699972|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64699973|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64699974|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64699975|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64699976|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64699981|NCT00003273|Vitamins|vitamins|mesh-ancestor
64700023|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64700024|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64700025|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64700026|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700027|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
64700028|NCT00003435|Melphalan|melphalan|mesh-list
64375551|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375552|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64375553|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64375554|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64375555|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451541|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64451543|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451544|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
64700029|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64700030|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700031|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
64700032|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700033|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700034|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700035|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700036|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
64700037|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700038|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700039|NCT00003441|Irofulven|irofulven|mesh-list
64700040|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700041|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
64700042|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700043|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700044|NCT00002805|Cobalt|cobalt|mesh-list
64700045|NCT00002805|Cytarabine|cytarabine|mesh-list
64700046|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
64700047|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64700048|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64700049|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64700050|NCT00002805|Methotrexate|methotrexate|mesh-list
64700051|NCT00002805|Etoposide|etoposide|mesh-list
64700052|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
64700053|NCT00002805|Cladribine|cladribine|mesh-list
64700054|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64297523|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297524|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64297527|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
64700055|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
64700056|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64700063|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700064|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64700065|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700066|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
64700067|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451593|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451594|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
64451595|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64451596|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64451597|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64451598|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64700068|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64700069|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700070|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700071|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700072|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
64700073|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700074|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700075|NCT00002805|Analgesics|analgesics|mesh-ancestor
64700076|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
64700077|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700078|NCT00002805|Trace Elements|trace elements|mesh-ancestor
64700079|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
64700080|NCT00003297|Topotecan|topotecan|mesh-list
64700081|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
64700082|NCT00003297|Thiotepa|thiotepa|mesh-list
64700083|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64700084|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700085|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700086|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700087|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700088|NCT00003297|Analgesics|analgesics|mesh-ancestor
64700089|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
64700090|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700091|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700092|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700093|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700094|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
64700095|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700096|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700097|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
64700098|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
64700102|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
64700103|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700104|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700105|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700106|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
64700107|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700108|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700109|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700110|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700111|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700112|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700113|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700114|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700115|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700116|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700117|NCT00003447|Gemcitabine|gemcitabine|mesh-list
64700118|NCT00003447|Vinorelbine|vinorelbine|mesh-list
64700119|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700120|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
64700121|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700122|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700123|NCT00003447|Antiviral Agents|antiviral agents|mesh-ancestor
64700124|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700125|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700126|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700127|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
64700128|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700129|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700148|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700149|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
64700150|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700151|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700152|NCT00002823|Etoposide|etoposide|mesh-list
64700153|NCT00002823|Vinorelbine|vinorelbine|mesh-list
64700154|NCT00002823|Vinblastine|vinblastine|mesh-list
64700155|NCT00002823|Vindesine|vindesine|mesh-list
64700156|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700157|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700158|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700159|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700160|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700161|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700162|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700163|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700164|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
64451619|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
64451620|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
64451621|NCT04594239|Protective Agents|protective agents|mesh-ancestor
64451623|NCT04585737|Lamivudine|lamivudine|mesh-list
64451624|NCT04585737|Emtricitabine|emtricitabine|mesh-list
64451625|NCT04585737|Dolutegravir|dolutegravir|mesh-list
64700165|NCT00361621|Prednisone|prednisone|mesh-list
64700166|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
64700167|NCT00361621|Rituximab|rituximab|mesh-list
64700168|NCT00361621|Doxorubicin|doxorubicin|mesh-list
64700169|NCT00361621|Vincristine|vincristine|mesh-list
64700170|NCT00361621|Bortezomib|bortezomib|mesh-list
64700171|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700172|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
64700173|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700174|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700175|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700176|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
64700177|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700178|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700179|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700191|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700192|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700193|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700194|NCT00003327|Paclitaxel|paclitaxel|mesh-list
64700195|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700196|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700197|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700198|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700199|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700200|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297528|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297529|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
64700201|NCT00003339|Interleukin-12|interleukin-12|mesh-list
64700202|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
64700203|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64700204|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
64700205|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700206|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64700207|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64700208|NCT00003339|Growth Substances|growth substances|mesh-ancestor
64700209|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64700210|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375859|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375860|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64375861|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64700211|NCT00002829|Interferons|interferons|mesh-list
64375862|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
64451649|NCT01844583|Esomeprazole|esomeprazole|mesh-list
64451650|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64451651|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451652|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64451653|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700212|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
64700213|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
64700214|NCT00002829|Etoposide|etoposide|mesh-list
64700215|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700216|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
64700217|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700218|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700219|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700220|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
64700236|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700237|NCT00003345|Irinotecan|irinotecan|mesh-list
64297530|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700238|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700239|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64700240|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700241|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700242|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700243|NCT03596905|Plecanatide|plecanatide|mesh-list
64700244|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64700245|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
64700246|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700247|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64700249|NCT00002835|Interferons|interferons|mesh-list
64700250|NCT00002835|Cytarabine|cytarabine|mesh-list
64700251|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
64700252|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
64700253|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64700254|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64700255|NCT00002835|Prednisolone|prednisolone|mesh-list
64700256|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
64700257|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
64700258|NCT00002835|Melphalan|melphalan|mesh-list
64700259|NCT00002835|Ifosfamide|ifosfamide|mesh-list
64700260|NCT00002835|Carmustine|carmustine|mesh-list
64451667|NCT04742075|Durvalumab|durvalumab|mesh-list
64700261|NCT00002835|Cisplatin|cisplatin|mesh-list
64700262|NCT00002835|Methotrexate|methotrexate|mesh-list
64700263|NCT00002835|Etoposide|etoposide|mesh-list
64700264|NCT00002835|Vincristine|vincristine|mesh-list
64700265|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
64700266|NCT00002835|Idarubicin|idarubicin|mesh-list
64700267|NCT00002835|Bleomycin|bleomycin|mesh-list
64700268|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
64700269|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64700270|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
64700271|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700281|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
64700282|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64700283|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700285|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700286|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700287|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64700288|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64700289|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700290|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700291|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700292|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
64700293|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700294|NCT00002835|Antidotes|antidotes|mesh-ancestor
64700295|NCT00002835|Protective Agents|protective agents|mesh-ancestor
64700296|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
64700297|NCT00002835|Vitamins|vitamins|mesh-ancestor
64700298|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
64700299|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700300|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700301|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700302|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700304|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
64700305|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700306|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64700307|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
64700308|NCT00002835|Hormones|hormones|mesh-ancestor
64700309|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700310|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64700327|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
64700328|NCT00003351|Irinotecan|irinotecan|mesh-list
64700329|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64700330|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700331|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451714|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451715|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375957|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
64375958|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375959|NCT04890561|Lemborexant|lemborexant|mesh-list
64451720|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
64700332|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700333|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700334|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64700335|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64700336|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64700337|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
64700340|NCT00002847|Interferons|interferons|mesh-list
64700391|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64425683|NCT02256969|Renal Agents|renal agents|mesh-ancestor
64700392|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64700393|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700394|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700395|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
64700396|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700397|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64700398|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64700399|NCT00002865|Leucovorin|leucovorin|mesh-list
64700401|NCT00002865|Cytarabine|cytarabine|mesh-list
64700402|NCT00002865|Dexamethasone|dexamethasone|mesh-list
64700403|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
64700404|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64700405|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64700406|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64700407|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
64700408|NCT00002865|Ifosfamide|ifosfamide|mesh-list
64700409|NCT00002865|Doxorubicin|doxorubicin|mesh-list
64700410|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64700411|NCT00002865|Methotrexate|methotrexate|mesh-list
64700412|NCT00002865|Etoposide|etoposide|mesh-list
64700413|NCT00002865|Vincristine|vincristine|mesh-list
64700414|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
64700415|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700416|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
64700417|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700418|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451760|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64700419|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700420|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
64700421|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700436|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700437|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64700438|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
64700439|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64700440|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700441|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
64700442|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700443|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64700444|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64700445|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700446|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
64700447|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700448|NCT00002865|Antidotes|antidotes|mesh-ancestor
64700449|NCT00002865|Protective Agents|protective agents|mesh-ancestor
64700450|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
64700452|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
64700453|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700454|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700455|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700456|NCT00002865|Trace Elements|trace elements|mesh-ancestor
64700457|NCT00361309|Sunitinib|sunitinib|mesh-list
64700458|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700459|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64700460|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64700461|NCT00361309|Growth Substances|growth substances|mesh-ancestor
64700462|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700463|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
64700464|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64700465|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700480|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
64700481|NCT04530487|Fludarabine|fludarabine|mesh-list
64376050|NCT04882683|Prednisone|prednisone|mesh-list
64700482|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
64700483|NCT04530487|Etoposide|etoposide|mesh-list
64700484|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
64700485|NCT04530487|Melphalan|melphalan|mesh-list
64700486|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
64700487|NCT04530487|Thiotepa|thiotepa|mesh-list
64700488|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
64700489|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64700490|NCT04530487|Tacrolimus|tacrolimus|mesh-list
64700491|NCT04530487|Cyclosporins|cyclosporins|mesh-list
64700492|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
64700493|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64700494|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
64700495|NCT04530487|Antibodies|antibodies|mesh-list
64700496|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
64700497|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64700498|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64700499|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700540|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64700541|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700542|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700543|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700544|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700545|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700547|NCT03504241|Sirolimus|sirolimus|mesh-list
64700548|NCT03504241|Prednisone|prednisone|mesh-list
64700549|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
64700551|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700552|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
64700553|NCT03504241|Hormones|hormones|mesh-ancestor
64700554|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700603|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
64700604|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700605|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64700606|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64700607|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64700608|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64700609|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700611|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64297532|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297533|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64700612|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
64297534|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451839|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64451840|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
64451841|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700613|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700614|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700615|NCT00003543|Fluorouracil|fluorouracil|mesh-list
64700616|NCT00003543|Vincristine|vincristine|mesh-list
64700617|NCT00003543|Carmustine|carmustine|mesh-list
64700618|NCT00003543|Streptozocin|streptozocin|mesh-list
64700619|NCT00003543|Antibodies|antibodies|mesh-list
64700620|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64700621|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
64700622|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425903|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
64700623|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
64700624|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700625|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700626|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700627|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700628|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700629|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700630|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700631|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700632|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700633|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
64451855|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64700634|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700635|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
64451856|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64451857|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451858|NCT02050321|Vemurafenib|vemurafenib|mesh-list
64451890|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451891|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
64451892|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451893|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
64451894|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451895|NCT02016482|Adalimumab|adalimumab|mesh-list
64451896|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451897|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451898|NCT02028871|Insulin|insulin|mesh-list
64451899|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451900|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451901|NCT02028715|Acetaminophen|acetaminophen|mesh-list
64451902|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64451903|NCT02028715|Analgesics|analgesics|mesh-ancestor
64451904|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
64451907|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
64700636|NCT00003549|Fluorouracil|fluorouracil|mesh-list
64700641|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700642|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700643|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
64700644|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700645|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700646|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700647|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
64700648|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700649|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64700650|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
64700651|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64700652|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700653|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700654|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64700655|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64700656|NCT00002883|Fluorouracil|fluorouracil|mesh-list
64700657|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700658|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
64376103|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376104|NCT02181634|Gemcitabine|gemcitabine|mesh-list
64376105|NCT02181634|Paclitaxel|paclitaxel|mesh-list
64376106|NCT02181634|Antimetabolites|antimetabolites|mesh-list
64376107|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64376108|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376109|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
64451936|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451937|NCT02038790|Analgesics|analgesics|mesh-ancestor
64451938|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
64451939|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451940|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64451941|NCT02027311|Midazolam|midazolam|mesh-list
64700659|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700660|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64700661|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700662|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
64297535|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297537|NCT02063425|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64297538|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64700663|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700665|NCT00002889|Goserelin|goserelin|mesh-list
64700666|NCT00002889|Flutamide|flutamide|mesh-list
64700667|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64700668|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
64700669|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64700672|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700684|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64700685|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700687|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700688|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64700689|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700690|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700691|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700692|NCT00003951|Exatecan|exatecan|mesh-list
64700693|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64700694|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700695|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700696|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425978|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
64700698|NCT00003957|Cytarabine|cytarabine|mesh-list
64700699|NCT00003957|Paclitaxel|paclitaxel|mesh-list
64700700|NCT00003957|Etoposide|etoposide|mesh-list
64700701|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
64700702|NCT00003957|Melphalan|melphalan|mesh-list
64700703|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
64700704|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700705|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700706|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700707|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700708|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700709|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700710|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700711|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
64700712|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700713|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700714|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700715|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
64700716|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700721|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
64700725|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
64700726|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700727|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
64700728|NCT00004833|Antibodies|antibodies|mesh-list
64700729|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
64700730|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64700731|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64700732|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
64700733|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700734|NCT00003555|Paclitaxel|paclitaxel|mesh-list
64700735|NCT00003555|Amifostine|amifostine|mesh-list
64700736|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700737|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700738|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700739|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700740|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700741|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700742|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64700743|NCT00003555|Protective Agents|protective agents|mesh-ancestor
64700744|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700745|NCT00003963|Rituximab|rituximab|mesh-list
64700746|NCT00003963|Vinorelbine|vinorelbine|mesh-list
64700747|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64700748|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700749|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
64700750|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700751|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700752|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700753|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700754|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700757|NCT00004845|Naproxen|naproxen|mesh-list
64700769|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700770|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426051|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
64700771|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64700772|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
64700773|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700774|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64700775|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700776|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700779|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700780|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64700781|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64700830|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700831|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700832|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
64700833|NCT00003573|Cisplatin|cisplatin|mesh-list
64700834|NCT00003573|Etoposide|etoposide|mesh-list
64700835|NCT00003573|Vincristine|vincristine|mesh-list
64700836|NCT00003573|Lenograstim|lenograstim|mesh-list
64700837|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64700838|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
64700839|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700840|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700841|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700842|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
64700843|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700844|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700845|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64452041|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452042|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64452043|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64452044|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
64452045|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
64376286|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
64376318|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376319|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376320|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
64452048|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
64452049|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
64452050|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700846|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700847|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700849|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700850|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64700851|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700852|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700853|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700854|NCT03468985|Nivolumab|nivolumab|mesh-list
64700855|NCT03468985|Ipilimumab|ipilimumab|mesh-list
64700856|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64700857|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700858|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64700859|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700860|NCT00003585|Interferons|interferons|mesh-list
64700861|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
64700862|NCT00003585|Aldesleukin|aldesleukin|mesh-list
64700863|NCT00003585|Fluorouracil|fluorouracil|mesh-list
64700864|NCT00003585|Isotretinoin|isotretinoin|mesh-list
64700874|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64700875|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64700876|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64700878|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700879|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700880|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
64700881|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700944|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700945|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64700946|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64700947|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
64700948|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64700949|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700950|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64700951|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64700952|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
64700953|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
64700954|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64700955|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452076|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64376364|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
64700956|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
64700957|NCT00003603|Hormones|hormones|mesh-ancestor
64700958|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64700959|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64700960|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64700961|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64700962|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64700963|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64700964|NCT00004887|Paclitaxel|paclitaxel|mesh-list
64700965|NCT00004887|Vinblastine|vinblastine|mesh-list
64700966|NCT00004887|Carboplatin|carboplatin|mesh-list
64700967|NCT00004887|Ifosfamide|ifosfamide|mesh-list
64700968|NCT00004887|Mitomycins|mitomycins|mesh-list
64700969|NCT00004887|Mitomycin|mitomycin|mesh-list
64700970|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64700971|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700972|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
64297539|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297540|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297541|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297542|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
64297543|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64700973|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
64700974|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
64700975|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297544|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64297546|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297547|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64297548|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64700985|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64700986|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64700987|NCT00004893|Growth Substances|growth substances|mesh-ancestor
64452097|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452098|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64452099|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376451|NCT00700271|Amlodipine|amlodipine|mesh-list
64700988|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
64700989|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64700991|NCT04513951|Fluorouracil|fluorouracil|mesh-list
64700993|NCT04513951|Irinotecan|irinotecan|mesh-list
64701055|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64452131|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701056|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701057|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
64701058|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701059|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701060|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
64701061|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701062|NCT00004029|Sargramostim|sargramostim|mesh-list
64701063|NCT00004029|Vaccines|vaccines|mesh-list
64701064|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
64701065|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701066|NCT00362323|Metformin|metformin|mesh-list
64701067|NCT00362323|Fenofibrate|fenofibrate|mesh-list
64701068|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64701069|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701070|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64701071|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
64701072|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701073|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64701074|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
64701075|NCT00004917|Hematinics|hematinics|mesh-ancestor
64701076|NCT00421915|Etanercept|etanercept|mesh-list
64701077|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64701078|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64701079|NCT00421915|Analgesics|analgesics|mesh-ancestor
64701080|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
64701081|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701082|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701083|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701088|NCT00362713|Ipilimumab|ipilimumab|mesh-list
64701102|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701103|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701104|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701105|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
64701106|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701107|NCT00004059|Fluorouracil|fluorouracil|mesh-list
64701108|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64701109|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
64701110|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701111|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701112|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701113|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701114|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
64701115|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701116|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64701117|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701120|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
64701121|NCT00003633|Estramustine|estramustine|mesh-list
64701122|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701123|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701124|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701125|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701126|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701128|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
64701149|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701150|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701152|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
64701153|NCT00003639|Dexamethasone|dexamethasone|mesh-list
64701154|NCT00003639|Idarubicin|idarubicin|mesh-list
64701155|NCT00003639|Chlorambucil|chlorambucil|mesh-list
64701156|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701157|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
64701158|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
64701159|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701160|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701161|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701162|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
64701163|NCT00003639|Hormones|hormones|mesh-ancestor
64701164|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701165|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701166|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701167|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
64701168|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701169|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
64701170|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64452211|NCT02038010|Maytansine|maytansine|mesh-list
64452212|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
64452213|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
64452214|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452215|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452216|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64452217|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
64376590|NCT03226145|Cathartics|cathartics|mesh-ancestor
64701203|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701204|NCT00004071|Analgesics|analgesics|mesh-ancestor
64701205|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
64701206|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701207|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701208|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701209|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701210|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701211|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701212|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
64701214|NCT00004077|Ifosfamide|ifosfamide|mesh-list
64701215|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701216|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701217|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701218|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701219|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701220|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701221|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701222|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
64701223|NCT00004083|Cisplatin|cisplatin|mesh-list
64701224|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701225|NCT00004941|Infliximab|infliximab|mesh-list
64701226|NCT00004941|Antibodies|antibodies|mesh-list
64701227|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64701228|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
64701229|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701231|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701232|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701233|NCT00003657|Carboplatin|carboplatin|mesh-list
64701234|NCT00003657|Etoposide|etoposide|mesh-list
64701235|NCT00003657|Ifosfamide|ifosfamide|mesh-list
64701251|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701252|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701253|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701254|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701255|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701256|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701258|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701259|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701260|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
64701261|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701262|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
64701263|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701264|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64701265|NCT00004095|Gemcitabine|gemcitabine|mesh-list
64701266|NCT00004095|Irinotecan|irinotecan|mesh-list
64701267|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701268|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
64701269|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701270|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701271|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
64701272|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701273|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701274|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701279|NCT00003663|Dexamethasone|dexamethasone|mesh-list
64701300|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701301|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701302|NCT00004113|Temozolomide|temozolomide|mesh-list
64701303|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701304|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
64426581|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
64701305|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701307|NCT00004125|Tamoxifen|tamoxifen|mesh-list
64701308|NCT00004125|Paclitaxel|paclitaxel|mesh-list
64701309|NCT00004125|Docetaxel|docetaxel|mesh-list
64701310|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
64701365|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
64701366|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701367|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701368|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701369|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701370|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701371|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701372|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
64701373|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
64701374|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64701375|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64701376|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701377|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
64701378|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64701379|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701380|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
64701381|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701383|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64701384|NCT00384657|Trace Elements|trace elements|mesh-ancestor
64701385|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
64701386|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701417|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701418|NCT00004179|Prednisone|prednisone|mesh-list
64701419|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
64701420|NCT00004179|Rituximab|rituximab|mesh-list
64701421|NCT00004179|Doxorubicin|doxorubicin|mesh-list
64701422|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64701423|NCT00004179|Vincristine|vincristine|mesh-list
64701424|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64452291|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701425|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
64701426|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701427|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701428|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701429|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
64701430|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701431|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701432|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64414791|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
64701433|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64701434|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701435|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701436|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701437|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701438|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701439|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
64701440|NCT00004179|Hormones|hormones|mesh-ancestor
64701441|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701442|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701443|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701444|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701445|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701446|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701458|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64701459|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64701460|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64701461|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701463|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
64701464|NCT00004197|Doxorubicin|doxorubicin|mesh-list
64701465|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64701466|NCT00004197|Vincristine|vincristine|mesh-list
64701467|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
64701468|NCT00004197|Sargramostim|sargramostim|mesh-list
64701469|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64701470|NCT00004197|Vaccines|vaccines|mesh-list
64701471|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701472|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
64701473|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701474|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64701475|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701476|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
64701477|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701478|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701479|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64701480|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701481|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701482|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701483|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701484|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701485|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
64701486|NCT00004197|Hormones|hormones|mesh-ancestor
64701487|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701488|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701502|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701504|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701505|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
64701506|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701507|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701508|NCT00005037|Temozolomide|temozolomide|mesh-list
64701509|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701510|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
64701511|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701512|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701513|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
64701514|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701515|NCT00004209|Mitomycins|mitomycins|mesh-list
64701516|NCT00004209|Mitomycin|mitomycin|mesh-list
64701517|NCT00004209|Vinblastine|vinblastine|mesh-list
64701518|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701519|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701520|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
64701521|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701522|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64701523|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701524|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701525|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701526|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701527|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701528|NCT00005049|Carboplatin|carboplatin|mesh-list
64701548|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701549|NCT00004221|Paclitaxel|paclitaxel|mesh-list
64452306|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452307|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
64701550|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
64701551|NCT00004221|Carboplatin|carboplatin|mesh-list
64701552|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64701553|NCT00004221|Topotecan|topotecan|mesh-list
64701554|NCT00004221|Lenograstim|lenograstim|mesh-list
64701555|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701556|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701557|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701558|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701559|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701560|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701612|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
64701613|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64701614|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701615|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
64701616|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701617|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701618|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701619|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701620|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
64701621|NCT00004233|Antidotes|antidotes|mesh-ancestor
64701622|NCT00004233|Protective Agents|protective agents|mesh-ancestor
64701623|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
64701673|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64701674|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701675|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701676|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64701677|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
64701678|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701679|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701680|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
64701681|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64452340|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452341|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376771|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452342|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297551|NCT05071118|Analgesics|analgesics|mesh-ancestor
64701682|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
64701683|NCT00003729|Cytarabine|cytarabine|mesh-list
64297552|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
64297553|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297554|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297555|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
64297556|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64701684|NCT00003729|Fludarabine|fludarabine|mesh-list
64701685|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
64701686|NCT00003729|Idarubicin|idarubicin|mesh-list
64297557|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297558|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701687|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701688|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701689|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
64701690|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701691|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701692|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
64701693|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701694|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
64701695|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701696|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64701697|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701698|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701699|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701700|NCT00004263|Cytarabine|cytarabine|mesh-list
64701701|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64701702|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64701703|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
64701704|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701706|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
64701714|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
64701715|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701716|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701717|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701718|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701719|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701720|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701721|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
64701722|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64701723|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701724|NCT00004275|Hormones|hormones|mesh-list
64701725|NCT00004275|Oxandrolone|oxandrolone|mesh-list
64376805|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701726|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701727|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701728|NCT00004275|Androgens|androgens|mesh-ancestor
64701729|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
64701730|NCT00003741|Antibodies|antibodies|mesh-list
64701731|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64701732|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
64414792|NCT02419755|Hormones|hormones|mesh-ancestor
64701733|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701735|NCT00003747|Temozolomide|temozolomide|mesh-list
64701736|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701737|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64701738|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
64701739|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701740|NCT00004311|Leuprolide|leuprolide|mesh-list
64701741|NCT00004311|Spironolactone|spironolactone|mesh-list
64701742|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64701743|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
64701744|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64701754|NCT00004317|Leucovorin|leucovorin|mesh-list
64701757|NCT00004317|Spiramycin|spiramycin|mesh-list
64701758|NCT00004317|Calcium|calcium|mesh-list
64701759|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
64452462|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64452463|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64452464|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452465|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452466|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64452467|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64452468|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64701760|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64701761|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701762|NCT00004317|Antidotes|antidotes|mesh-ancestor
64701763|NCT00004317|Protective Agents|protective agents|mesh-ancestor
64297559|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64701764|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
64701765|NCT00004317|Vitamins|vitamins|mesh-ancestor
64701766|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
64701767|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
64297560|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64297561|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64701768|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64701769|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64701770|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701771|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64701772|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701773|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701774|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64701775|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
64701776|NCT00005091|Exatecan|exatecan|mesh-list
64701777|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701778|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701779|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701810|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
64701811|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
64701812|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452505|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64701813|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701814|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
64452506|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
64452507|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452508|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64452509|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452510|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452511|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64452512|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64452513|NCT04676204|Analgesics|analgesics|mesh-ancestor
64452514|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
64452515|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452516|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452518|NCT02010632|Clopidogrel|clopidogrel|mesh-list
64701815|NCT00004323|Hormones|hormones|mesh-ancestor
64701816|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701817|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64701818|NCT00004323|Protective Agents|protective agents|mesh-ancestor
64701819|NCT00003753|Dexamethasone|dexamethasone|mesh-list
64701820|NCT00003753|Irinotecan|irinotecan|mesh-list
64701821|NCT00003753|Floxuridine|floxuridine|mesh-list
64701822|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64701823|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
64701824|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
64701825|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64701826|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701827|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64701828|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
64701829|NCT00003753|Hormones|hormones|mesh-ancestor
64427107|NCT04929379|Fenofibrate|fenofibrate|mesh-list
64701830|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64701831|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64701832|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701833|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64701834|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701835|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701836|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701837|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64452532|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452533|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
64452534|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452535|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452536|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
64701838|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
64701853|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701854|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64701855|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64701856|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64701857|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64701923|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64701924|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64701925|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64701926|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
64701927|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64701928|NCT00003783|Antidotes|antidotes|mesh-ancestor
64701929|NCT00003783|Protective Agents|protective agents|mesh-ancestor
64701930|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
64701931|NCT00003783|Vitamins|vitamins|mesh-ancestor
64701932|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
64701933|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
64701934|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
64701935|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
64701937|NCT00003789|Melphalan|melphalan|mesh-list
64701987|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
64701988|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
64701989|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64701990|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64701991|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64701992|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64701993|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64701994|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64701995|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64701996|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64701997|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64701998|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
64701999|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64702000|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64702001|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
64702003|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
64702043|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64702044|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
64702045|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64702046|NCT00385125|Rituximab|rituximab|mesh-list
64702047|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64377071|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64377072|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452606|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
64452607|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
64702048|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702049|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702050|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
64702051|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702052|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702053|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702054|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
64702055|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702056|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64702057|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64702058|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
64702059|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702060|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
64702061|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
64702062|NCT00004551|Nicotine|nicotine|mesh-list
64702063|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64702064|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
64702065|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702066|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702067|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64702068|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64702069|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
64702070|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64702071|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702072|NCT02678312|Enalapril|enalapril|mesh-list
64702073|NCT02678312|Enalaprilat|enalaprilat|mesh-list
64702074|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64702082|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64702083|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702084|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702085|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702086|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702087|NCT00003849|Rituximab|rituximab|mesh-list
64702088|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702089|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702090|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
64702091|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702092|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702093|NCT00004575|Miconazole|miconazole|mesh-list
64702094|NCT00004575|Bradykinin|bradykinin|mesh-list
64702095|NCT00004575|Kininogens|kininogens|mesh-list
64702096|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702097|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702098|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
64702099|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702137|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702138|NCT00004647|Mexiletine|mexiletine|mesh-list
64702139|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64702140|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64702141|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64452669|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64452677|NCT01836549|Imetelstat|imetelstat|mesh-list
64377152|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64702142|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64702143|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702144|NCT02469116|Carboplatin|carboplatin|mesh-list
64702145|NCT02469116|Docetaxel|docetaxel|mesh-list
64702146|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702147|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
64702148|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
64702149|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
64702150|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702151|NCT00362960|Losartan|losartan|mesh-list
64702152|NCT00362960|Olmesartan|olmesartan|mesh-list
64702153|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64702154|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64702155|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64702156|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64702157|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64702188|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702189|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
64702190|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702191|NCT00004689|Clarithromycin|clarithromycin|mesh-list
64702192|NCT00004689|Rifampin|rifampin|mesh-list
64702193|NCT00004689|Ethambutol|ethambutol|mesh-list
64702194|NCT00004689|Streptomycin|streptomycin|mesh-list
64702195|NCT00004689|Thioacetazone|thioacetazone|mesh-list
64297562|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297563|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297564|NCT03559400|Gentamicins|gentamicins|mesh-list
64297565|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64297566|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297567|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64297568|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297569|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297570|NCT03464019|Etripamil|etripamil|mesh-list
64297571|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64702197|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702198|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64702199|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702200|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702201|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64702202|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377174|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377175|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64377176|NCT04872231|Voriconazole|voriconazole|mesh-list
64702203|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64702204|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
64702205|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
64702206|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64702207|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64702208|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64702213|NCT00004695|Interleukin-2|interleukin-2|mesh-list
64702240|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64702241|NCT00004755|Allopurinol|allopurinol|mesh-list
64702242|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
64702243|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702244|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702245|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
64702246|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702247|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64702248|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
64702249|NCT00004755|Protective Agents|protective agents|mesh-ancestor
64702250|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702251|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64702252|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64702253|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702254|NCT00003897|Sargramostim|sargramostim|mesh-list
64945560|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64702255|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
64702256|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702257|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
64702258|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702259|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64702260|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702261|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
64702262|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64702263|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
64702264|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702265|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64452764|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64452765|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
64452766|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452767|NCT01801917|Siponimod|siponimod|mesh-list
64452768|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64452769|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452770|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64452771|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
64702266|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
64702267|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702268|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
64702285|NCT00004785|Hormones|hormones|mesh-ancestor
64702286|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702287|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64702288|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702289|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64702290|NCT00004785|Protective Agents|protective agents|mesh-ancestor
64702291|NCT00004815|Hormones|hormones|mesh-list
64702292|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702293|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702294|NCT02279823|Minoxidil|minoxidil|mesh-list
64297572|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297573|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297574|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64297575|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297576|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
64297577|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
64297578|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297579|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702295|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64702296|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64702297|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
64702299|NCT04040361|Ramucirumab|ramucirumab|mesh-list
64702300|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64702301|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702302|NCT00386061|Rimonabant|rimonabant|mesh-list
64702303|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64702304|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64702305|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64702306|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64702307|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702308|NCT00386061|Hormones|hormones|mesh-ancestor
64702309|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702310|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702311|NCT00005571|Eculizumab|eculizumab|mesh-list
64702312|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64702331|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702332|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702333|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702334|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702335|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702337|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
64702338|NCT00005589|Melphalan|melphalan|mesh-list
64702339|NCT00005589|Carmustine|carmustine|mesh-list
64702340|NCT00005589|Rituximab|rituximab|mesh-list
64702341|NCT00005589|Etoposide|etoposide|mesh-list
64427626|NCT01889602|Topiramate|topiramate|mesh-list
64702396|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
64702397|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64702398|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702399|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702400|NCT00005607|Antidotes|antidotes|mesh-ancestor
64702401|NCT00005607|Protective Agents|protective agents|mesh-ancestor
64702402|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
64702403|NCT00005607|Vitamins|vitamins|mesh-ancestor
64702404|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
64702405|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
64702407|NCT00005613|Etoposide|etoposide|mesh-list
64702408|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702409|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
64702410|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702411|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702412|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702413|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
64702414|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702415|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702416|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64702417|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64702418|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702419|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702420|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702422|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702423|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
64702426|NCT00005631|Rituximab|rituximab|mesh-list
64702445|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
64702446|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702447|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702448|NCT00005643|Doxorubicin|doxorubicin|mesh-list
64702449|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64702450|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702451|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702452|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702453|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702454|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702455|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702456|NCT00005649|Paclitaxel|paclitaxel|mesh-list
64702457|NCT00005649|Capecitabine|capecitabine|mesh-list
64702458|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64702459|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702460|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
64702461|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
64702462|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
64702463|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702464|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64702465|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
64702466|NCT00005673|Capravirine|capravirine|mesh-list
64702467|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64702468|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64702469|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702470|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702471|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
64702472|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64702473|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64702474|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64702486|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702487|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
64702489|NCT02974933|Apatinib|apatinib|mesh-list
64702490|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702491|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702492|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702493|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64702494|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64702496|NCT00005769|Hormones|hormones|mesh-list
64702497|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64702498|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702549|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64702550|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
64702551|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64702552|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
64702553|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702554|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64702555|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702556|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702558|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64702559|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702560|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702561|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702562|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702563|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
64702564|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64702565|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702566|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64702567|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702568|NCT01689987|Sirolimus|sirolimus|mesh-list
64702606|NCT01680939|Narcotics|narcotics|mesh-ancestor
64702607|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64702608|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702609|NCT01680939|Analgesics|analgesics|mesh-ancestor
64702610|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
64702611|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64702612|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64702613|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64702614|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64702615|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64702616|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64702617|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702618|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702619|NCT01689597|Morphine|morphine|mesh-list
64702620|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64702621|NCT01689597|Narcotics|narcotics|mesh-ancestor
64702622|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64702623|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702624|NCT01689597|Analgesics|analgesics|mesh-ancestor
64702625|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
64702626|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452923|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
64452924|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
64377274|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64377275|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
64452959|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
64452960|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64452961|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452962|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
64452963|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64702661|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702662|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64702663|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
64702664|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64702665|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
64297580|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297581|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
64297582|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64297583|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297584|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297585|NCT05069870|Itraconazole|itraconazole|mesh-list
64297586|NCT05069870|Rifampin|rifampin|mesh-list
64297587|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
64297588|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
64297589|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297590|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64702666|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
64702667|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
64702668|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702669|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
64702670|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
64702671|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
64702673|NCT02483000|Vitamins|vitamins|mesh-ancestor
64702724|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64702725|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
64702726|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64702727|NCT04829799|Protective Agents|protective agents|mesh-ancestor
64702728|NCT01789333|Riboflavin|riboflavin|mesh-list
64702729|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64702730|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64702731|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
64702732|NCT01789333|Vitamins|vitamins|mesh-ancestor
64702733|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
64702734|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702735|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64702736|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
64702737|NCT02524106|Bococizumab|bococizumab|mesh-list
64702738|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64702739|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64702740|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
64702741|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702742|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64377280|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64702858|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702859|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64702861|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64702862|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702863|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64702864|NCT00362947|Parnaparin|parnaparin|mesh-list
64702865|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
64702866|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64702867|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64702868|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702869|NCT00363025|Daunorubicin|daunorubicin|mesh-list
64702870|NCT00363025|Idarubicin|idarubicin|mesh-list
64702871|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64702872|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64702873|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64702874|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64702875|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702876|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702877|NCT02444143|Tacrolimus|tacrolimus|mesh-list
64702878|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64702879|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
64702880|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702881|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64702882|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702883|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702884|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
64702885|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64428168|NCT05269017|Hormones|hormones|mesh-ancestor
64702887|NCT02445859|Cefuroxime|cefuroxime|mesh-list
64702902|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
64702903|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64702904|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702905|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297591|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64297592|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297593|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297594|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64297595|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
64381358|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64381359|NCT05327439|Nicotine|nicotine|mesh-list
64381360|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64381361|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
64381362|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381363|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64702906|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64702907|NCT02420041|Triamcinolone|triamcinolone|mesh-list
64702908|NCT02420041|Lidocaine|lidocaine|mesh-list
64702909|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
64702910|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
64702911|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64702967|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
64702968|NCT02424968|Cyclosporins|cyclosporins|mesh-list
64702969|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
64702970|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64702971|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64702986|NCT02424799|GSK2646264|gsk2646264|mesh-list
64703035|NCT02493452|Plecanatide|plecanatide|mesh-list
64377393|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377394|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377395|NCT04377087|Olaparib|olaparib|mesh-list
64453158|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64453159|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453160|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453161|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64453162|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453163|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64453164|NCT02006576|Ibuprofen|ibuprofen|mesh-list
64453165|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64453166|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64453167|NCT02006576|Analgesics|analgesics|mesh-ancestor
64453168|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
64703036|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64703037|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
64703038|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703039|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64703040|NCT02429869|Everolimus|everolimus|mesh-list
64703041|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703102|NCT02436031|Desipramine|desipramine|mesh-list
64703103|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64703104|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
64703105|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64703106|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703107|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703108|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64703170|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703171|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703172|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64703173|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703174|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703175|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64703176|NCT02519023|Narcotics|narcotics|mesh-ancestor
64703177|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64703178|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64703179|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
64703180|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703181|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64703235|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64703236|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703237|NCT02524561|Progestins|progestins|mesh-ancestor
64703238|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64703305|NCT02535806|Bortezomib|bortezomib|mesh-list
64945565|NCT05438043|Pomalidomide|pomalidomide|mesh-list
64703306|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
64945566|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703377|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703378|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64703379|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64703380|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
64703381|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
64703382|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945567|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
64703383|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64703384|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64703385|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703386|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703387|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64703388|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
64703389|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64703390|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703391|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377397|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703392|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64703393|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703432|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64703433|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64703434|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64703435|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703436|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64703500|NCT02506868|Hematinics|hematinics|mesh-ancestor
64703501|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
64703502|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64703503|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
64703504|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703574|NCT02511236|Nicotine|nicotine|mesh-list
64703575|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64703576|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
64703577|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703578|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703579|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64703580|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64703581|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
64703582|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703583|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703584|NCT02551094|Colchicine|colchicine|mesh-list
64703638|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703639|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64703640|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64377411|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
64377412|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64377414|NCT04859361|Imiquimod|imiquimod|mesh-list
64703711|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64703712|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703713|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
64703714|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703715|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64703716|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
64703717|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703718|NCT02568644|Ketoprofen|ketoprofen|mesh-list
64703719|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64703720|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64703721|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64703722|NCT02568644|Analgesics|analgesics|mesh-ancestor
64703723|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
64381364|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64381365|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64381366|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
64381368|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381400|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381401|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381402|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64381403|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64381404|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64381405|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
64381406|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
64381407|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
64381408|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64381409|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
64381410|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
64381411|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381412|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
64381413|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
64703724|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64703725|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703726|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64703769|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64703770|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64703771|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64703772|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64703773|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703774|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64703775|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
64703776|NCT02541565|Hormones|hormones|mesh-ancestor
64703837|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64703838|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64703839|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297596|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297597|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64703840|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
64703841|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64453241|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453242|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
64453243|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377458|NCT03206723|Narcotics|narcotics|mesh-ancestor
64703842|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703843|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64703902|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64703903|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64703904|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64703905|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64703906|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703907|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297598|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64703908|NCT02596022|Ketamine|ketamine|mesh-list
64703909|NCT02596022|Analgesics|analgesics|mesh-ancestor
64703910|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
64703967|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64703968|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
64703969|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64703970|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64703971|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704036|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704037|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704038|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64704039|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64704105|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64453270|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64704106|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704107|NCT04741880|Lidocaine|lidocaine|mesh-list
64704168|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64704169|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
64704170|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
64704171|NCT01575834|Denosumab|denosumab|mesh-list
64704236|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
64704237|NCT00366470|Vitamin D|vitamin d|mesh-list
64704238|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64704239|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704308|NCT04326764|Panobinostat|panobinostat|mesh-list
64704309|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297599|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64704310|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64704311|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704312|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704379|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64704381|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704382|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64704383|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64704384|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704385|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704386|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64704387|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
64704388|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64704442|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
64704514|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704515|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704516|NCT02243202|Canagliflozin|canagliflozin|mesh-list
64704583|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
64704584|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704585|NCT04219280|Methylphenidate|methylphenidate|mesh-list
64704586|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64704655|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704657|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64704658|NCT05588336|Narcotics|narcotics|mesh-ancestor
64704659|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64704660|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64704661|NCT05588336|Analgesics|analgesics|mesh-ancestor
64704662|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
64704663|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704664|NCT02564497|Abatacept|abatacept|mesh-list
64704665|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64704666|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704667|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64704720|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64704722|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64704723|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64704724|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
64704725|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64704726|NCT03926624|Analgesics|analgesics|mesh-ancestor
64704727|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
64704728|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64704729|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64704730|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
64704731|NCT05588102|Citalopram|citalopram|mesh-list
64704732|NCT05588102|Fluoxetine|fluoxetine|mesh-list
64704733|NCT05588102|Paroxetine|paroxetine|mesh-list
64704734|NCT05588102|Sertraline|sertraline|mesh-list
64704735|NCT05588102|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64704736|NCT05588102|Serotonin|serotonin|mesh-list
64704737|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64704738|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64704739|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704740|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704741|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
64704758|NCT03551210|Ofloxacin|ofloxacin|mesh-list
64704849|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64704850|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64704851|NCT04341727|Azithromycin|azithromycin|mesh-list
64704923|NCT02489227|Adalimumab|adalimumab|mesh-list
64704924|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64704926|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
64704998|NCT00422396|Fenofibrate|fenofibrate|mesh-list
64704999|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64705000|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
64705005|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
64705065|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64705066|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64705067|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
64705068|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64705069|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705136|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64705137|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64705138|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
64705210|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64705211|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64705214|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
64705283|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705284|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64705285|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64705286|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64705287|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64705350|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64705351|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64705426|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64705501|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705502|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64705504|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64705505|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64705506|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
64705507|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64705568|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64705569|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64705640|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64705641|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705642|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64705643|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
64705711|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64705712|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
64705713|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64705715|NCT04592809|Ketamine|ketamine|mesh-list
64705716|NCT04592809|Analgesics|analgesics|mesh-ancestor
64705717|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
64705718|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705719|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705720|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64705723|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
64945590|NCT05426525|Empagliflozin|empagliflozin|mesh-list
64945591|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64705784|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64705785|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705852|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705853|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64705921|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64705922|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
64705994|NCT02239926|Ranolazine|ranolazine|mesh-list
64705995|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64705996|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706028|NCT04781088|Paclitaxel|paclitaxel|mesh-list
64706065|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706067|NCT04074265|Epinephrine|epinephrine|mesh-list
64706068|NCT04074265|Ropivacaine|ropivacaine|mesh-list
64706069|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
64706070|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
64706071|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297600|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
64297601|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64945595|NCT05423106|Tenofovir|tenofovir|mesh-list
64297602|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
64706130|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
64706132|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706133|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706135|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
64706136|NCT04684212|Dabigatran|dabigatran|mesh-list
64706137|NCT04684212|Edoxaban|edoxaban|mesh-list
64706200|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706201|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64706202|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
64706203|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706271|NCT02672917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706272|NCT01632306|Leucovorin|leucovorin|mesh-list
64706273|NCT01632306|Gemcitabine|gemcitabine|mesh-list
64706274|NCT01632306|Paclitaxel|paclitaxel|mesh-list
64453340|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453341|NCT01597973|Meropenem|meropenem|mesh-list
64453342|NCT01597973|Colistin|colistin|mesh-list
64453343|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64453344|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377518|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377519|NCT03038607|Aspirin|aspirin|mesh-list
64377520|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64377521|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377522|NCT03038607|Analgesics|analgesics|mesh-ancestor
64377523|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
64377524|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453345|NCT02047253|Acyclovir|acyclovir|mesh-list
64453346|NCT02047253|Dexamethasone|dexamethasone|mesh-list
64706275|NCT01632306|Fluorouracil|fluorouracil|mesh-list
64706276|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
64706277|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64706278|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706279|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
64706339|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64706340|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706341|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
64706342|NCT02650856|Coagulants|coagulants|mesh-ancestor
64706343|NCT02168478|Neomycin|neomycin|mesh-list
64706344|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64706345|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64706346|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64706347|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706348|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706349|NCT00367874|Buprenorphine|buprenorphine|mesh-list
64706350|NCT00367874|Valproic Acid|valproic acid|mesh-list
64706351|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64706352|NCT00367874|Narcotics|narcotics|mesh-ancestor
64706353|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706354|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706355|NCT00367874|Analgesics|analgesics|mesh-ancestor
64706356|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
64706358|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64706359|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
64706360|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706361|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706362|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
64706392|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64706393|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706396|NCT05073692|Liraglutide|liraglutide|mesh-list
64706467|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64706468|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706469|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
64706538|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64706610|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
64706611|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64706612|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64706613|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64706614|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64706615|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706616|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706617|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
64706618|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706619|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64706620|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706621|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706622|NCT02666846|Ibuprofen|ibuprofen|mesh-list
64706623|NCT02666846|Diclofenac|diclofenac|mesh-list
64706624|NCT02666846|Salicylates|salicylates|mesh-list
64706670|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64706671|NCT02645617|Imidacloprid|imidacloprid|mesh-list
64706676|NCT02694601|Caffeine|caffeine|mesh-list
64706742|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
64706743|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
64706744|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64706745|NCT02697188|Androgens|androgens|mesh-ancestor
64706746|NCT02697188|Hormones|hormones|mesh-ancestor
64706747|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64706748|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706749|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64706750|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706751|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
64706752|NCT04707560|Heparin|heparin|mesh-list
64706753|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
64706754|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64706755|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64706756|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706757|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64706758|NCT02653183|Laxatives|laxatives|mesh-ancestor
64706759|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64706760|NCT02701400|Durvalumab|durvalumab|mesh-list
64706761|NCT02701400|Ipilimumab|ipilimumab|mesh-list
64706762|NCT02701400|Tremelimumab|tremelimumab|mesh-list
64706763|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64706764|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64706765|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64706766|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64706791|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64706792|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
64706793|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64706794|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
64706795|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64706796|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64706797|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64706798|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64706799|NCT00368030|Eszopiclone|eszopiclone|mesh-list
64706800|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64706801|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64706802|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706803|NCT02656069|Glucagon|glucagon|mesh-list
64432046|NCT02484911|Olanzapine|olanzapine|mesh-list
64706804|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64706805|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64706809|NCT02656069|Incretins|incretins|mesh-ancestor
64706847|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64706848|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706849|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64706921|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64706991|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64706992|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
64707064|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707065|NCT02730884|ON 01910|on 01910|mesh-list
64707066|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707135|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
64707136|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64707137|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707138|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64707139|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707140|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707141|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64707142|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64707143|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64707144|NCT03609008|Cromakalim|cromakalim|mesh-list
64707145|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64707146|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64707147|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
64707148|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707149|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707150|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64707192|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64707193|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707262|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707263|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707265|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64707347|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
64945604|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64707420|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64707421|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64377566|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377569|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64377571|NCT03038217|Capecitabine|capecitabine|mesh-list
64707422|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64707423|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707424|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707425|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707426|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
64707427|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64707428|NCT05444738|Oxytocin|oxytocin|mesh-list
64707432|NCT05243953|Cromakalim|cromakalim|mesh-list
64707480|NCT04700761|Analgesics|analgesics|mesh-ancestor
64707481|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
64707482|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64707483|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
64707550|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64707552|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64707553|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707554|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64707623|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64707634|NCT05064319|Gabapentin|gabapentin|mesh-list
64707697|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64707698|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707699|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
64707765|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707766|NCT04747496|Edoxaban|edoxaban|mesh-list
64707767|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64707768|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
64707769|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64707770|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
64707771|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64707772|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707773|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
64707830|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64707831|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64707832|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64707833|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64707834|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
64707835|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64707836|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707837|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707838|NCT04704596|Anesthetics|anesthetics|mesh-list
64707839|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64707840|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64707841|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
64707889|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64707890|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64707891|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64707892|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64707957|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708036|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
64708037|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
64708038|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708039|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708040|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
64708041|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708042|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297603|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708043|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64708044|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
64708045|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64377574|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
64708046|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64297604|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64297605|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64297606|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64297607|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64708047|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64708055|NCT02966756|Venetoclax|venetoclax|mesh-list
64708096|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708097|NCT02618720|Ornidazole|ornidazole|mesh-list
64708098|NCT02618720|Amebicides|amebicides|mesh-ancestor
64708099|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64708100|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64708101|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64708102|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64708103|NCT03758989|Prednisone|prednisone|mesh-list
64708104|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
64708105|NCT03758989|Rituximab|rituximab|mesh-list
64708106|NCT03758989|Doxorubicin|doxorubicin|mesh-list
64708107|NCT03758989|Vincristine|vincristine|mesh-list
64708108|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708109|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
64708110|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708111|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708112|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64708113|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
64708114|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708115|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708116|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64708117|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708118|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64708119|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64708120|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64708124|NCT03758989|Hormones|hormones|mesh-ancestor
64708198|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64708199|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708200|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708201|NCT00370370|Triamcinolone|triamcinolone|mesh-list
64708202|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64708203|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64708204|NCT00370370|Bevacizumab|bevacizumab|mesh-list
64708205|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64708206|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708207|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708208|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64708209|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64708210|NCT00370370|Growth Substances|growth substances|mesh-ancestor
64708211|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708212|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
64708213|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708214|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
64708215|NCT00370370|Hormones|hormones|mesh-ancestor
64708255|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64708256|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64708257|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64708258|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
64708259|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708260|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708261|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64708262|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708263|NCT00371527|Ipratropium|ipratropium|mesh-list
64708264|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64708265|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
64708266|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708267|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453371|NCT02096003|Analgesics|analgesics|mesh-ancestor
64708268|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64708269|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
64708311|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64708312|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297608|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64297609|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64708313|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
64708314|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708315|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64708316|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708317|NCT02582905|Choline|choline|mesh-list
64708318|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64708319|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
64708320|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64708321|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
64708322|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708323|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708324|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64708325|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
64708326|NCT05454332|Caffeine|caffeine|mesh-list
64708327|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64708328|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708329|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64708330|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708331|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708332|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64708333|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64708361|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64708362|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64708363|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
64708364|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708365|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708366|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64708367|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
64708368|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
64708369|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
64708370|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
64708371|NCT05453552|Busulfan|busulfan|mesh-list
64708372|NCT05453552|Fludarabine|fludarabine|mesh-list
64708373|NCT05453552|Decitabine|decitabine|mesh-list
64708374|NCT05453552|Lenograstim|lenograstim|mesh-list
64708375|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708376|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
64708377|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708378|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708379|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64708380|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
64708382|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708416|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64708417|NCT04891718|Nivolumab|nivolumab|mesh-list
64708418|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64708419|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708420|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64708422|NCT03770689|Capecitabine|capecitabine|mesh-list
64708486|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
64708487|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453397|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708488|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708489|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
64708490|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708491|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64708492|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64708493|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64708494|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64708495|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708496|NCT05203562|Letrozole|letrozole|mesh-list
64708545|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64708546|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
64708547|NCT02196558|Quetmolimab|quetmolimab|mesh-list
64708548|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708549|NCT04852484|Ketamine|ketamine|mesh-list
64708550|NCT04852484|Morphine|morphine|mesh-list
64708551|NCT04852484|Anesthetics|anesthetics|mesh-list
64708552|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
64708614|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64708615|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
64708616|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708617|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708618|NCT05413369|Metformin|metformin|mesh-list
64708619|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
64708620|NCT05413369|Lixisenatide|lixisenatide|mesh-list
64708621|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64708622|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64708623|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708624|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708679|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708680|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708682|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708683|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708684|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64708685|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64708686|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64708687|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64708740|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64708741|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64708742|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64708743|NCT05349032|Curcumin|curcumin|mesh-list
64708744|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64708745|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64708746|NCT05349032|Analgesics|analgesics|mesh-ancestor
64708747|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
64708748|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708749|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708808|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64708809|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64708812|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708813|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64708814|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
64708815|NCT05032183|Hormones|hormones|mesh-ancestor
64434067|NCT01799590|Topiramate|topiramate|mesh-list
64708875|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64708876|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64708877|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64708878|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708879|NCT02756624|Cetirizine|cetirizine|mesh-list
64708880|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64453424|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64708881|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64708882|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64708883|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
64708884|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
64708885|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64708886|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64708887|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708888|NCT02958800|Olanzapine|olanzapine|mesh-list
64708889|NCT02958800|Risperidone|risperidone|mesh-list
64708933|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64708934|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64708935|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64708936|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64708937|NCT04587973|Analgesics|analgesics|mesh-ancestor
64708938|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
64708939|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64708940|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64708941|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64708999|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709000|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
64709001|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
64709002|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
64709003|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709004|NCT04336904|Favipiravir|favipiravir|mesh-list
64709005|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
64709006|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709007|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
64709008|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709009|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709010|NCT02194998|Ritonavir|ritonavir|mesh-list
64709011|NCT02194998|Ribavirin|ribavirin|mesh-list
64709012|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64709013|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64709014|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
64709015|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709061|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709062|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709063|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64709064|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64709065|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
64709066|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
64709067|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64709068|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64709069|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64709070|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709071|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709072|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
64709123|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
64709124|NCT04337918|Protective Agents|protective agents|mesh-ancestor
64709126|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
64709128|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64945608|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709129|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709130|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
64709188|NCT05339581|Lenvatinib|lenvatinib|mesh-list
64709189|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709190|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709191|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64709192|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709193|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709194|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
64709195|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64709196|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
64709197|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709198|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
64709251|NCT02224560|Cannabidiol|cannabidiol|mesh-list
64709252|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
64709253|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
64709324|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709325|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709326|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64709391|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
64709392|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
64709393|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
64709394|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709395|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64709396|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
64709397|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709398|NCT00371995|Amphotericin B|amphotericin b|mesh-list
64709399|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64709400|NCT00371995|Miltefosine|miltefosine|mesh-list
64709401|NCT00371995|Amebicides|amebicides|mesh-ancestor
64709402|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64709403|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64709404|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709405|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64709406|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
64709407|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709408|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
64709409|NCT04767074|Guaifenesin|guaifenesin|mesh-list
64709410|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64709411|NCT04767074|Expectorants|expectorants|mesh-ancestor
64709412|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709443|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709444|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64709445|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709516|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
64709517|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709518|NCT00966914|Protective Agents|protective agents|mesh-ancestor
64709519|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709520|NCT03229057|Metformin|metformin|mesh-list
64709521|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64709522|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297611|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
64297612|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64297613|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64709530|NCT04430959|Candesartan|candesartan|mesh-list
64709587|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
64709588|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64709589|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64709590|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709591|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64709592|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64709593|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709594|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64709595|NCT04336189|Renal Agents|renal agents|mesh-ancestor
64709602|NCT04101877|Bevacizumab|bevacizumab|mesh-list
64709603|NCT04101877|Aflibercept|aflibercept|mesh-list
64709666|NCT04333628|Chloroquine|chloroquine|mesh-list
64709667|NCT04333628|Amebicides|amebicides|mesh-ancestor
64709668|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64709669|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64709670|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709671|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
64709672|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64709673|NCT00373412|Vaccines|vaccines|mesh-list
64709674|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
64709675|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709676|NCT00373178|Metformin|metformin|mesh-list
64709677|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
64709732|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377658|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
64709733|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709734|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64709735|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
64709798|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64709799|NCT02902172|Analgesics|analgesics|mesh-ancestor
64709800|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
64709801|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709802|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709866|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709867|NCT02908490|Urological Agents|urological agents|mesh-ancestor
64435113|NCT02394665|Temozolomide|temozolomide|mesh-list
64709868|NCT02911844|Fulvestrant|fulvestrant|mesh-list
64297622|NCT05275491|Calcium|calcium|mesh-list
64297623|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
64297624|NCT05275491|Hormones|hormones|mesh-list
64297625|NCT05275491|Mitogens|mitogens|mesh-list
64297626|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64297627|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297628|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297629|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
64297630|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297631|NCT04584255|Niraparib|niraparib|mesh-list
64709869|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64945613|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709870|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64709871|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64709872|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64709873|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
64709874|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709875|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709876|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
64709877|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64453438|NCT04670666|Incretins|incretins|mesh-ancestor
64709878|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64709879|NCT02790788|Prednisolone|prednisolone|mesh-list
64709880|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
64709881|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
64709882|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64709883|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64709884|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
64709885|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64709886|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
64709887|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
64709888|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709889|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709890|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64709910|NCT02781571|Velpatasvir|velpatasvir|mesh-list
64709911|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
64709912|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64709913|NCT02918630|Nicotine|nicotine|mesh-list
64709914|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64709915|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
64709916|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64709917|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64709918|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64709919|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64709920|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
64709921|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64709922|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64709969|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64709970|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64709972|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64709973|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
64709974|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64709975|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64709976|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64710036|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710037|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710038|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64710052|NCT03003949|Estradiol|estradiol|mesh-list
64710108|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710109|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64710110|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64710111|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64710112|NCT00374348|Aripiprazole|aripiprazole|mesh-list
64710180|NCT02812238|Vitamins|vitamins|mesh-ancestor
64710181|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
64710182|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710183|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64710184|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
64297632|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64297633|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297634|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297635|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710185|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710186|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64710187|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
64710188|NCT03015961|Bupivacaine|bupivacaine|mesh-list
64710189|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
64710190|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
64710191|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453470|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453471|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453472|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453473|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64710192|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710193|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
64710194|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710242|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710243|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710244|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64710245|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64945618|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710246|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
64710247|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710248|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64710249|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64710250|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
64710251|NCT02934698|Ivacaftor|ivacaftor|mesh-list
64710252|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64710253|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64710254|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710255|NCT03021343|Colchicine|colchicine|mesh-list
64710256|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
64710300|NCT03027661|Bupivacaine|bupivacaine|mesh-list
64710301|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
64710302|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
64710303|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710304|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710370|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710371|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710372|NCT00373802|Phenylephrine|phenylephrine|mesh-list
64710373|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
64710374|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64710442|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710443|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64710444|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
64710445|NCT03033511|Hormones|hormones|mesh-ancestor
64710446|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710447|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64710448|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710449|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
64710453|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
64710508|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64710582|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64710583|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710584|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710586|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64710587|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710588|NCT05829603|Harmine|harmine|mesh-list
64710648|NCT05829187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64710649|NCT05829187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710650|NCT05829148|Pregabalin|pregabalin|mesh-list
64710651|NCT05829148|Dexmedetomidine|dexmedetomidine|mesh-list
64297650|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
64710653|NCT05829148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64710654|NCT05829148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64710655|NCT05829148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710656|NCT05829148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64710657|NCT05829148|Analgesics|analgesics|mesh-ancestor
64710658|NCT05829148|Sensory System Agents|sensory system agents|mesh-ancestor
64710659|NCT05829148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64710660|NCT05829148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64710661|NCT05829148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64710662|NCT05829148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64710663|NCT05829148|Adrenergic Agents|adrenergic agents|mesh-ancestor
64710664|NCT05829148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453478|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
64453479|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64710665|NCT05829148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710666|NCT05829148|Anticonvulsants|anticonvulsants|mesh-ancestor
64710667|NCT05829148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64710668|NCT05829148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64710669|NCT05829148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64710670|NCT05829148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64710671|NCT05829148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64710715|NCT05828836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710717|NCT05828836|Gout Suppressants|gout suppressants|mesh-ancestor
64710718|NCT05828836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64710719|NCT05828836|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64710720|NCT05828836|Antioxidants|antioxidants|mesh-ancestor
64710721|NCT05828836|Protective Agents|protective agents|mesh-ancestor
64710722|NCT05828836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710723|NCT05828810|Chlorhexidine|chlorhexidine|mesh-list
64710724|NCT05828810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64710725|NCT05828810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710726|NCT05828810|Disinfectants|disinfectants|mesh-ancestor
64710769|NCT05828199|Ketamine|ketamine|mesh-list
64710816|NCT05827796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710817|NCT05827796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64710819|NCT05827796|Antiviral Agents|antiviral agents|mesh-ancestor
64710820|NCT05827796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710821|NCT05827796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64710822|NCT05827796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64710823|NCT05827796|Immunologic Factors|immunologic factors|mesh-ancestor
64710824|NCT05827796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710825|NCT05827770|Temozolomide|temozolomide|mesh-list
64710826|NCT05827770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64710827|NCT05827770|Alkylating Agents|alkylating agents|mesh-ancestor
64710828|NCT05827770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64710829|NCT05827770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64710830|NCT05827705|Ephedrine|ephedrine|mesh-list
64710831|NCT05827705|Pseudoephedrine|pseudoephedrine|mesh-list
64710832|NCT05827705|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64710833|NCT05827705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710834|NCT05827705|Sympathomimetics|sympathomimetics|mesh-ancestor
64710849|NCT05827497|Methotrexate|methotrexate|mesh-list
64710873|NCT05827263|Antifungal Agents|antifungal agents|mesh-ancestor
64710874|NCT05827263|Keratolytic Agents|keratolytic agents|mesh-ancestor
64710875|NCT05827263|Dermatologic Agents|dermatologic agents|mesh-ancestor
64710954|NCT05821296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64710962|NCT05813587|Meplazumab|meplazumab|mesh-list
64710963|NCT05813587|Antiviral Agents|antiviral agents|mesh-ancestor
64710964|NCT05813587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64710984|NCT05790213|Androgens|androgens|mesh-list
64710985|NCT05790213|Hormones|hormones|mesh-ancestor
64710986|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64710987|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64710988|NCT05786066|Ketamine|ketamine|mesh-list
64710989|NCT05786066|Analgesics|analgesics|mesh-ancestor
64710990|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
64710991|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297663|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711086|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711087|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711172|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
64711173|NCT05675319|Hormones|hormones|mesh-ancestor
64453480|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453481|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64711174|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64711333|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64711334|NCT05504083|Renal Agents|renal agents|mesh-ancestor
64711335|NCT05503030|Nintedanib|nintedanib|mesh-list
64711336|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711337|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64711338|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711339|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711340|NCT05491187|Fentanyl|fentanyl|mesh-list
64711400|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64711401|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64711402|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711403|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711404|NCT05461053|Lidocaine|lidocaine|mesh-list
64711405|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
64711406|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
64711407|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711408|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711409|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
64711410|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711411|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64945626|NCT05402553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64711546|NCT05330377|Cytarabine|cytarabine|mesh-list
64711547|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
64711548|NCT05330377|Cladribine|cladribine|mesh-list
64711549|NCT05330377|Lenograstim|lenograstim|mesh-list
64711550|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64711551|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
64711552|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711553|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711554|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
64711555|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711556|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64711616|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
64711617|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64711618|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64711619|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64711620|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
64711621|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711622|NCT05288062|Dexamethasone|dexamethasone|mesh-list
64711623|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
64711624|NCT05288062|Lenalidomide|lenalidomide|mesh-list
64711625|NCT05288062|Pomalidomide|pomalidomide|mesh-list
64297682|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64297683|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711626|NCT05288062|Ichthammol|ichthammol|mesh-list
64711627|NCT05288062|BB 1101|bb 1101|mesh-list
64711706|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
64711707|NCT05151640|Nintedanib|nintedanib|mesh-list
64711708|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711709|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64711710|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711711|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711712|NCT05148234|Decitabine|decitabine|mesh-list
64711713|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64711714|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
64711715|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453486|NCT02040779|Albuterol|albuterol|mesh-list
64711716|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711723|NCT05116189|Paclitaxel|paclitaxel|mesh-list
64711829|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711830|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
64711831|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64711832|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64711833|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64711834|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64711835|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711836|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
64711837|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711838|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711839|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64711840|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711842|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64711843|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
64711844|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711845|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711846|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64711847|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64711848|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
64711849|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711850|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711851|NCT05019222|Anesthetics|anesthetics|mesh-list
64711852|NCT05019222|Sevoflurane|sevoflurane|mesh-list
64711853|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711878|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64711879|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
64711880|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64711881|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64711882|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711883|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
64711884|NCT04996368|Coagulants|coagulants|mesh-ancestor
64711885|NCT04994444|Nicotine|nicotine|mesh-list
64711886|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64711887|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
64711888|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64711889|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711890|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64711891|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64711892|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
64711893|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711894|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711895|NCT04992507|Anesthetics|anesthetics|mesh-list
64711896|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64711897|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711899|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64711900|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64711901|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64711902|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
64711903|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64711904|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711905|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64711906|NCT04987892|Urological Agents|urological agents|mesh-ancestor
64711907|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
64711908|NCT04976634|Lenvatinib|lenvatinib|mesh-list
64711909|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64711910|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711917|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64711918|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
64711919|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
64711920|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64711921|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64711922|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
64711923|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
64711924|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
64711925|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64711926|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64711927|NCT04966663|Gemcitabine|gemcitabine|mesh-list
64711928|NCT04966663|Carboplatin|carboplatin|mesh-list
64712003|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64712004|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712016|NCT04889118|Lenvatinib|lenvatinib|mesh-list
64712017|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712018|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712019|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712020|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712021|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484587|NCT03906526|Nivolumab|nivolumab|mesh-list
64712057|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712058|NCT04819971|Docetaxel|docetaxel|mesh-list
64712059|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
64712060|NCT04819971|Trastuzumab|trastuzumab|mesh-list
64712061|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712062|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
64712063|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
64712064|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
64712065|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712066|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712067|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64712068|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
64712107|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64712108|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64712109|NCT04712097|Growth Substances|growth substances|mesh-ancestor
64712110|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
64712111|NCT04708470|Entinostat|entinostat|mesh-list
64712112|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712113|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64712114|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712115|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712119|NCT04704154|Nivolumab|nivolumab|mesh-list
64712120|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712121|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712178|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712179|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
64712180|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712181|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64712187|NCT04670978|Bevacizumab|bevacizumab|mesh-list
64712188|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712189|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712190|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64712335|NCT04505774|Clopidogrel|clopidogrel|mesh-list
64712336|NCT04505774|Ticagrelor|ticagrelor|mesh-list
64712337|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64712338|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64712339|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64712340|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64712341|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
64712342|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64712343|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712344|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712345|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
64712346|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64712400|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64712401|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64712402|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712403|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
64712404|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64712405|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
64712406|NCT04414748|Cetrorelix|cetrorelix|mesh-list
64712407|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
64712408|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64712409|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
64712410|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64712411|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712412|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
64712413|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64712414|NCT04414748|Progestins|progestins|mesh-ancestor
64712415|NCT04414748|Hormones|hormones|mesh-ancestor
64712421|NCT04395196|Choline|choline|mesh-list
64712543|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
64712544|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64712545|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64297684|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297686|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
64297687|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
64297688|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297689|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297690|NCT02462265|Analgesics|analgesics|mesh-ancestor
64297691|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
64297692|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64712546|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64712547|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
64712548|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64712550|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64712551|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64712552|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712639|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
64712640|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
64712641|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
64712642|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712643|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64712644|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
64712645|NCT04100018|Hormones|hormones|mesh-ancestor
64712646|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64712647|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712648|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64377831|NCT01668147|Efavirenz|efavirenz|mesh-list
64377832|NCT01668147|Loperamide|loperamide|mesh-list
64377833|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
64377834|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64377835|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64377836|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64377837|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377865|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377866|NCT04315701|Cemiplimab|cemiplimab|mesh-list
64377867|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64377868|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377869|NCT03036501|Risdiplam|risdiplam|mesh-list
64377870|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64377871|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377873|NCT04851015|Trimethoprim|trimethoprim|mesh-list
64712649|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712650|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64712651|NCT04093323|Interferons|interferons|mesh-list
64712652|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
64712653|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
64712657|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
64712658|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712698|NCT04058067|Growth Substances|growth substances|mesh-ancestor
64712699|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712700|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
64712701|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712705|NCT04047472|Aflibercept|aflibercept|mesh-list
64712706|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64712707|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64712708|NCT04047472|Growth Substances|growth substances|mesh-ancestor
64712776|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64712777|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712778|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64712779|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712780|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
64712781|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64712782|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
64712783|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712784|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
64712785|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64712786|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712787|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
64712788|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64297697|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64297698|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64297699|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
64712789|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
64712790|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712853|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64712854|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712863|NCT03718767|Nivolumab|nivolumab|mesh-list
64712864|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64712865|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712866|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64712867|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712871|NCT03680053|Cetrorelix|cetrorelix|mesh-list
64712872|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
64712873|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64712874|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
64712875|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64712876|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712877|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
64712878|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64712879|NCT03680053|Progestins|progestins|mesh-ancestor
64712880|NCT03680053|Hormones|hormones|mesh-ancestor
64712881|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
64712882|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64712883|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712884|NCT03672630|Azithromycin|azithromycin|mesh-list
64712885|NCT03672630|Rifampin|rifampin|mesh-list
64712886|NCT03672630|Ethambutol|ethambutol|mesh-list
64712887|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64712888|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64712889|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64712912|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64712913|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64712914|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
64712916|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712985|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64712986|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64712987|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297700|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
64297701|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297702|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297703|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297704|NCT02461719|Cyclosporine|cyclosporine|mesh-list
64297705|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64297706|NCT02461719|Cyclosporins|cyclosporins|mesh-list
64297707|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297708|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712988|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712989|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
64712990|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64712991|NCT03547973|Gemcitabine|gemcitabine|mesh-list
64712992|NCT03547973|Carboplatin|carboplatin|mesh-list
64712993|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
64712995|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64712996|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64712997|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
64712998|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64712999|NCT03547973|Antiviral Agents|antiviral agents|mesh-ancestor
64713000|NCT03547973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713001|NCT03547973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713002|NCT03547973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713003|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
64713004|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713005|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713019|NCT03471364|Ketoconazole|ketoconazole|mesh-list
64713020|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
64713021|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713038|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713039|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64713040|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
64713041|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713042|NCT03456076|Antiviral Agents|antiviral agents|mesh-ancestor
64713043|NCT03456076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713044|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713045|NCT03456076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713046|NCT03456076|Immunologic Factors|immunologic factors|mesh-ancestor
64713047|NCT03456076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713048|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64713049|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64713168|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713169|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713170|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64713171|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64713172|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
64713174|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64713175|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64713176|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64713239|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713240|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64713241|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
64713242|NCT03007147|Hormones|hormones|mesh-ancestor
64713243|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64713244|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64713245|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64713246|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713247|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64713248|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64713249|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64377914|NCT04850235|Paclitaxel|paclitaxel|mesh-list
64713305|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713306|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
64713307|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713308|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713309|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64713310|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64713311|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64713312|NCT02989597|Dexamethasone|dexamethasone|mesh-list
64713313|NCT02989597|Sufentanil|sufentanil|mesh-list
64713314|NCT02989597|Ketamine|ketamine|mesh-list
64713315|NCT02989597|Remifentanil|remifentanil|mesh-list
64713316|NCT02989597|Methadone|methadone|mesh-list
64713317|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64713318|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
64713319|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
64713320|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64713321|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713324|NCT02989597|Hormones|hormones|mesh-ancestor
64713386|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
64713387|NCT02856425|Nintedanib|nintedanib|mesh-list
64713388|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713389|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713390|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713391|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713392|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713393|NCT02839642|Rivastigmine|rivastigmine|mesh-list
64713394|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64713395|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713397|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
64713464|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64713465|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
64713466|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297711|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713467|NCT02598661|Imetelstat|imetelstat|mesh-list
64713468|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
64297712|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
64297713|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297714|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297715|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297716|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64297717|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64297719|NCT04322643|Nivolumab|nivolumab|mesh-list
64297720|NCT04322643|Durvalumab|durvalumab|mesh-list
64297721|NCT04322643|Avelumab|avelumab|mesh-list
64297722|NCT04322643|Atezolizumab|atezolizumab|mesh-list
64297723|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297724|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297725|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64297726|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713469|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64713470|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713471|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64713478|NCT02567409|Gemcitabine|gemcitabine|mesh-list
64713479|NCT02567409|Cisplatin|cisplatin|mesh-list
64713480|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713481|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64713482|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
64713483|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713484|NCT02567409|Antiviral Agents|antiviral agents|mesh-ancestor
64713490|NCT02443727|Oxytocin|oxytocin|mesh-list
64713536|NCT02278120|Tamoxifen|tamoxifen|mesh-list
64713537|NCT02278120|Letrozole|letrozole|mesh-list
64713538|NCT02278120|Anastrozole|anastrozole|mesh-list
64713539|NCT02278120|Goserelin|goserelin|mesh-list
64713540|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713541|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64713542|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64713543|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453559|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64713544|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713545|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64713546|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
64713548|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713647|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64713648|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64713649|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
64713650|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64713651|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713652|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64713653|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64713654|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64713655|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64297728|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64713656|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64297729|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
64297730|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297731|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713708|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
64713709|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64713710|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64713711|NCT01703949|Nivolumab|nivolumab|mesh-list
64713712|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64713713|NCT01703949|Antibodies|antibodies|mesh-list
64713714|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
64713715|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64713716|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
64713717|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
64713718|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713723|NCT01517100|Nabilone|nabilone|mesh-list
64713765|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64713766|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
64713767|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713768|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
64713769|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64713770|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64713771|NCT01169337|Lenalidomide|lenalidomide|mesh-list
64713772|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
64713773|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713774|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64713775|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64713776|NCT01169337|Growth Substances|growth substances|mesh-ancestor
64713777|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
64713778|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713794|NCT00621192|Meropenem|meropenem|mesh-list
64297733|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64297734|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
64297735|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297736|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297737|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64297738|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64297739|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
64297740|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297741|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297742|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
64297743|NCT02064049|Velpatasvir|velpatasvir|mesh-list
64297744|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64297745|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
64297746|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297747|NCT02064829|Paclitaxel|paclitaxel|mesh-list
64417185|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64417186|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
64417187|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417188|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417189|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64417190|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
64453568|NCT02035553|Pimavanserin|pimavanserin|mesh-list
64417205|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297748|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64297749|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64297750|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417207|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417208|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
64439109|NCT00565851|Paclitaxel|paclitaxel|mesh-list
64713899|NCT00024622|Levodopa|levodopa|mesh-list
64713900|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64713901|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64713902|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
64713903|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64713904|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713905|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64713925|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64417209|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417210|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417211|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
64417212|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64417213|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417214|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417215|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417216|NCT04820101|Analgesics|analgesics|mesh-ancestor
64417217|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
64417218|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417219|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64417220|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64417221|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64417222|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
64417223|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417224|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297751|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
64297752|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64297753|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
64297754|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713927|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64713953|NCT00001337|Rituximab|rituximab|mesh-list
64713954|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64713955|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64713956|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
64713957|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450541|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
64450901|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
64451199|NCT01622660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451872|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64452563|NCT01985126|Hormones|hormones|mesh-ancestor
64452696|NCT02030600|Insulin|insulin|mesh-list
64452918|NCT02007434|Loratadine|loratadine|mesh-list
64453312|NCT01445548|Sirolimus|sirolimus|mesh-list
64494782|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
64494842|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
64494843|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494844|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494845|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
64494846|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64494847|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64494848|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64494849|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64494850|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64494851|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64494852|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453577|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64494853|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494855|NCT05439408|Dasatinib|dasatinib|mesh-list
64494856|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494857|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64494858|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494860|NCT03011476|Donepezil|donepezil|mesh-list
64494898|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64494899|NCT01189240|R04929097|r04929097|mesh-list
64494900|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494901|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64494902|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64494903|NCT01189240|Growth Substances|growth substances|mesh-ancestor
64494904|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494905|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297755|NCT02064517|Calcium|calcium|mesh-list
64297756|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64297757|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297758|NCT02067949|Simvastatin|simvastatin|mesh-list
64297759|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64297760|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64297761|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
64297762|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297763|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64494906|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
64494907|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64494909|NCT03467334|Simethicone|simethicone|mesh-list
64494963|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64494964|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
64494965|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64494966|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64494967|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64494968|NCT02611830|Vedolizumab|vedolizumab|mesh-list
64494969|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64494970|NCT03461718|Fentanyl|fentanyl|mesh-list
64494971|NCT03461718|Midazolam|midazolam|mesh-list
64494972|NCT03461718|Ketamine|ketamine|mesh-list
64494973|NCT03461718|Analgesics|analgesics|mesh-ancestor
64494974|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
64494975|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64494976|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494977|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64495025|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
64495026|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
64495027|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495028|NCT03466632|Analgesics|analgesics|mesh-ancestor
64495029|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
64495030|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495031|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64495032|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64495034|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495035|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495036|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495037|NCT05339334|Ritonavir|ritonavir|mesh-list
64495038|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64495039|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64495087|NCT03466242|Analgesics|analgesics|mesh-ancestor
64495088|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
64495089|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495090|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64495091|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64495092|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64495093|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495094|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495095|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377956|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64377957|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64495096|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64495097|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64495098|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
64495099|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
64495148|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
64495149|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495150|NCT03460860|Tocopherols|tocopherols|mesh-list
64495151|NCT03460860|Vitamin E|vitamin e|mesh-list
64495152|NCT03460860|Tocotrienols|tocotrienols|mesh-list
64495153|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
64495154|NCT03460860|Lycopene|lycopene|mesh-list
64495155|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
64495156|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495164|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495165|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
64495166|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64495228|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495229|NCT03460470|Urological Agents|urological agents|mesh-ancestor
64495231|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
64495232|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64495233|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495236|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64495238|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495239|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495240|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
64495241|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495242|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64495243|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
64495244|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495245|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64495246|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
64495247|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495248|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
64495249|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495284|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64495285|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64495286|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495288|NCT01105312|Panobinostat|panobinostat|mesh-list
64495289|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495290|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64495291|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64495292|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495293|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495294|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64495295|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
64495296|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495297|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495298|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64495299|NCT04488978|Amlodipine|amlodipine|mesh-list
64495342|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
64495343|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64495344|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64495345|NCT04453332|Progestins|progestins|mesh-ancestor
64495346|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
64495347|NCT03456570|Progestins|progestins|mesh-ancestor
64495348|NCT03456570|Hormones|hormones|mesh-ancestor
64495349|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495350|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495351|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64495352|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64495353|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64297764|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64297766|NCT02068339|Oltipraz|oltipraz|mesh-list
64297767|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
64297768|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377958|NCT04830579|Analgesics|analgesics|mesh-ancestor
64377959|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
64377960|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377987|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297769|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
64297770|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64297771|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
64297772|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64297773|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64297774|NCT02068339|Protective Agents|protective agents|mesh-ancestor
64495355|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495356|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495357|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495358|NCT03468348|Analgesics|analgesics|mesh-ancestor
64495359|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
64495360|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495361|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
64495362|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64495363|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
64495364|NCT03464682|Atorvastatin|atorvastatin|mesh-list
64495365|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64495366|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64495367|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
64495368|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495369|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64495370|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64495371|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495372|NCT03464058|Rabeprazole|rabeprazole|mesh-list
64495373|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64495374|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495375|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64495378|NCT03451734|Metformin|metformin|mesh-list
64495379|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
64495400|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64495422|NCT01199926|Vitamin D|vitamin d|mesh-list
64495423|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
64495424|NCT01199926|Vitamins|vitamins|mesh-ancestor
64495425|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
64495426|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495427|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64495429|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
64495486|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64495487|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
64495488|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64495489|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495490|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64495491|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64495492|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
64495493|NCT03010072|Hematinics|hematinics|mesh-ancestor
64495494|NCT03462810|Cabotegravir|cabotegravir|mesh-list
64495495|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64495496|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64495497|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495498|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495499|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64495500|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64495501|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
64495502|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495503|NCT01219738|Budesonide|budesonide|mesh-list
64495543|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495544|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495545|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64495546|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64495547|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
64495548|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495549|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64495550|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64495551|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
64495553|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
64495554|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
64377988|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64377989|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377990|NCT04427787|Lanreotide|lanreotide|mesh-list
64377991|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495555|NCT01222234|Calcitriol|calcitriol|mesh-list
64495556|NCT01222234|Vitamins|vitamins|mesh-list
64495605|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64495606|NCT04155840|Antibodies|antibodies|mesh-list
64495607|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
64495608|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64495609|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
64495610|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495611|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495612|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64495613|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64495614|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
64495615|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495616|NCT03448770|Lactulose|lactulose|mesh-list
64495617|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64495618|NCT03443778|Dexamethasone|dexamethasone|mesh-list
64495619|NCT03443778|Bupivacaine|bupivacaine|mesh-list
64495620|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64495663|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495664|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495665|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495666|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64495667|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64495668|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64495669|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
64495670|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64495685|NCT01158820|Fentanyl|fentanyl|mesh-list
64495731|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
64495732|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495733|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64495734|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495735|NCT04956042|Cytarabine|cytarabine|mesh-list
64495736|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64495737|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
64495801|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495802|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
64495803|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64495804|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
64495805|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495807|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64495808|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495809|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64495810|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64495811|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64495812|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495813|NCT01228084|Sulforaphane|sulforaphane|mesh-list
64495814|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64495815|NCT01228084|Protective Agents|protective agents|mesh-ancestor
64495816|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495817|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64495818|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64495819|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64495820|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64495821|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64495822|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64495823|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
64495824|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64495825|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495826|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495827|NCT04901208|Nicotine|nicotine|mesh-list
64495828|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64495843|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495844|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64495845|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64495915|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
64495916|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64495917|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64495918|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64495919|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
64495920|NCT03449940|Diclofenac|diclofenac|mesh-list
64495921|NCT03449940|Lidocaine|lidocaine|mesh-list
64495922|NCT03449940|Analgesics|analgesics|mesh-list
64495923|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
64495924|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
64495927|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
64495981|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64495982|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64495984|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64495985|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64495986|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
64945641|NCT05379322|Analgesics|analgesics|mesh-ancestor
64495987|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
64495989|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64495990|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64495991|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496047|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496048|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64496049|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
64496050|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496051|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496052|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
64496053|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496054|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64496055|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64496056|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
64496057|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496058|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64496111|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64496112|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64496113|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64496115|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
64496116|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64496117|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
64496118|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
64496119|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64496177|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496178|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64496179|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64496180|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496181|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496182|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64496183|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
64496184|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
64496185|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64496186|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64496189|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64496239|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
64496240|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
64496241|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496242|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496243|NCT01282138|Analgesics|analgesics|mesh-ancestor
64496244|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
64496245|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496246|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496305|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64496306|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496307|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496309|NCT05054868|Oxycodone|oxycodone|mesh-list
64496310|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64496311|NCT05054868|Narcotics|narcotics|mesh-ancestor
64496312|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496313|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496314|NCT05054868|Analgesics|analgesics|mesh-ancestor
64496315|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
64496371|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64496372|NCT03436836|Narcotics|narcotics|mesh-ancestor
64496373|NCT03436836|Analgesics|analgesics|mesh-ancestor
64496374|NCT03444012|Ticagrelor|ticagrelor|mesh-list
64496375|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64496376|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64496377|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64496378|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64496379|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
64496380|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496381|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496382|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496383|NCT03440034|Pioglitazone|pioglitazone|mesh-list
64297776|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297777|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64297778|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64297779|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297781|NCT02065843|Midazolam|midazolam|mesh-list
64496432|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
64496433|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496434|NCT01872689|Pirfenidone|pirfenidone|mesh-list
64496435|NCT01872689|Analgesics|analgesics|mesh-ancestor
64496436|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
64496501|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496502|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496504|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496505|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64496506|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64496507|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64496508|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64496509|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496510|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
64496511|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496564|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496566|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
64496567|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496568|NCT03432468|Valsartan|valsartan|mesh-list
64496569|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64496570|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64496571|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64496573|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
64496632|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64496633|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496634|NCT03428880|Morphine|morphine|mesh-list
64496635|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64496636|NCT03428880|Narcotics|narcotics|mesh-ancestor
64496637|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496638|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496639|NCT03428880|Analgesics|analgesics|mesh-ancestor
64496640|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
64496641|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496642|NCT01923831|Dexamethasone|dexamethasone|mesh-list
64496643|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
64297788|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297789|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64297790|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
64297791|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
64297792|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
64297793|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
64297794|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64496644|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496645|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
64496646|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
64496647|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496651|NCT01923831|Hormones|hormones|mesh-ancestor
64496688|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64496689|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496690|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496691|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64496692|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64496693|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64496694|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64496695|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
64496696|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
64496697|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
64496698|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
64496703|NCT03085563|Analgesics|analgesics|mesh-ancestor
64496750|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64496751|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496752|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496753|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64496754|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64496755|NCT00630825|Dulaglutide|dulaglutide|mesh-list
64496756|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64496757|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496758|NCT03434340|Dexamethasone|dexamethasone|mesh-list
64496759|NCT03434340|Granisetron|granisetron|mesh-list
64496760|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496761|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
64496762|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
64496763|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496764|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496765|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64496766|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
64496769|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64496806|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
64496807|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
64496808|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496809|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
64496810|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496811|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64496812|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64496813|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496814|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64496870|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496871|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496872|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64496873|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64496874|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64496875|NCT01286818|Leucovorin|leucovorin|mesh-list
64496876|NCT01286818|Fluorouracil|fluorouracil|mesh-list
64496877|NCT01286818|Irinotecan|irinotecan|mesh-list
64496878|NCT01286818|Ramucirumab|ramucirumab|mesh-list
64496879|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64496880|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
64496881|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
64377997|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
64377998|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
64377999|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378000|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378001|NCT04829487|Vitamin D|vitamin d|mesh-list
64496882|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297795|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297798|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64297799|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297800|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297801|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64297802|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
64297803|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
64496883|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64496884|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496931|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64496933|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496934|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496935|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64496936|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64496937|NCT00635193|Growth Substances|growth substances|mesh-ancestor
64496938|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496939|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
64496940|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
64496941|NCT00630201|Buprenorphine|buprenorphine|mesh-list
64496942|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64496943|NCT00630201|Narcotics|narcotics|mesh-ancestor
64496944|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64496945|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496946|NCT00630201|Analgesics|analgesics|mesh-ancestor
64496947|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
64496948|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496949|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64496950|NCT01925547|Curcumin|curcumin|mesh-list
64496951|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64496952|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64496953|NCT01925547|Analgesics|analgesics|mesh-ancestor
64496954|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
64496955|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496956|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64496957|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496958|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64496959|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64496960|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64496961|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64496962|NCT03122301|Bupivacaine|bupivacaine|mesh-list
64496973|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64496974|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
64496975|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
64496976|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64496977|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497041|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497042|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64497043|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497044|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497045|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64497046|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64297808|NCT02065063|Trametinib|trametinib|mesh-list
64297809|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297810|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64297811|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297812|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497048|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64497049|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
64497050|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497051|NCT01339858|Expectorants|expectorants|mesh-ancestor
64497054|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
64497106|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497107|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497108|NCT01341730|Pioglitazone|pioglitazone|mesh-list
64378004|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
64378005|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378006|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64378007|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64497109|NCT01341730|Atorvastatin|atorvastatin|mesh-list
64497110|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64497111|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64497112|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
64497113|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497114|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64497115|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64497116|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497117|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64497166|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497167|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64497168|NCT01922193|Hormones|hormones|mesh-ancestor
64497169|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497170|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497237|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64497238|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
64497239|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497240|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
64497241|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
64497242|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64497243|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64497244|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
64497245|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497246|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497247|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64497250|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64497302|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64497303|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497304|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497305|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497306|NCT01928901|Thymol|thymol|mesh-list
64497307|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497308|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64497309|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
64497314|NCT04395105|Dexamethasone|dexamethasone|mesh-list
64497315|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497316|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
64497317|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
64497318|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497319|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497320|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64497321|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
64497322|NCT04395105|Hormones|hormones|mesh-ancestor
64497323|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497327|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
64497328|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
64497329|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497365|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497366|NCT01925937|Vitamins|vitamins|mesh-ancestor
64497367|NCT03430362|Scopolamine|scopolamine|mesh-list
64497368|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64497369|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64497370|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
64497436|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497437|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
64497438|NCT03427944|Coagulants|coagulants|mesh-ancestor
64497439|NCT03429972|Paclitaxel|paclitaxel|mesh-list
64497440|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64497441|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497442|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497443|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
64497444|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378008|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
64378009|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64497445|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497446|NCT05601999|Tenecteplase|tenecteplase|mesh-list
64497447|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64497448|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64497449|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497450|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
64497451|NCT03079167|Hematinics|hematinics|mesh-ancestor
64497452|NCT03079011|Letrozole|letrozole|mesh-list
64497453|NCT03079011|Fulvestrant|fulvestrant|mesh-list
64497454|NCT03079011|Palbociclib|palbociclib|mesh-list
64497455|NCT03079011|Anastrozole|anastrozole|mesh-list
64497456|NCT03079011|Exemestane|exemestane|mesh-list
64497474|NCT03427554|Tretinoin|tretinoin|mesh-list
64497492|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64497493|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497494|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64497495|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64497496|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497497|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64497498|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64497499|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64497500|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
64497501|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64497502|NCT03128346|Narcotics|narcotics|mesh-ancestor
64497503|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64497557|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64497558|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64497559|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64497560|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64497561|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64497563|NCT03422796|Sumatriptan|sumatriptan|mesh-list
64497564|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64497565|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
64497566|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64497626|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497627|NCT01350388|Febuxostat|febuxostat|mesh-list
64497628|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
64497629|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497697|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64497698|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64497699|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64497700|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497702|NCT03608358|Hormones|hormones|mesh-ancestor
64497703|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64497704|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64497705|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
64497764|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
64497765|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497766|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497767|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497768|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64497769|NCT03529422|Durvalumab|durvalumab|mesh-list
64497837|NCT03421002|Micafungin|micafungin|mesh-list
64497838|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
64497840|NCT00754260|Caffeine|caffeine|mesh-list
64497908|NCT03393741|Epothilones|epothilones|mesh-list
64497909|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
64497910|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64497912|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64497913|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497914|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497915|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
64497916|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497917|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64497918|NCT01352182|Pioglitazone|pioglitazone|mesh-list
64378043|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64497919|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64497921|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
64497972|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
64497973|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64497974|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
64497975|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64497976|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64497977|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
64497978|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
64497979|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
64497980|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
64497981|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64497982|NCT00983853|Ribavirin|ribavirin|mesh-list
64497983|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64498036|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498038|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
64297815|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297816|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64297817|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64297818|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
64498039|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
64498040|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64297819|NCT00813423|Sunitinib|sunitinib|mesh-list
64297820|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297821|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64297822|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64297823|NCT00813423|Growth Substances|growth substances|mesh-ancestor
64297824|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297825|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297826|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64297827|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297828|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297829|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
64297830|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64297831|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64297832|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297833|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498041|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64498043|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498044|NCT00981747|Urological Agents|urological agents|mesh-ancestor
64498049|NCT03046251|Natalizumab|natalizumab|mesh-list
64498099|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
64498100|NCT03009526|Piperaquine|piperaquine|mesh-list
64498101|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
64498102|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64498104|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
64498105|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64498106|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64498107|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498108|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64498109|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498110|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498112|NCT03009526|Renal Agents|renal agents|mesh-ancestor
64498161|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498162|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64498163|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498164|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498165|NCT01298128|NuvaRing|nuvaring|mesh-list
64498166|NCT01298128|Desogestrel|desogestrel|mesh-list
64498167|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64498168|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
64498169|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64498225|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498227|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498228|NCT04352062|Protective Agents|protective agents|mesh-ancestor
64498229|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498230|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498231|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64498232|NCT04352062|Renal Agents|renal agents|mesh-ancestor
64498233|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64498234|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64498235|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498236|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498284|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498285|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64498286|NCT01358266|Sirolimus|sirolimus|mesh-list
64498287|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64498288|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498289|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64498290|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498291|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
64498292|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498293|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
64498294|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498295|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64498296|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64498297|NCT01870973|Analgesics|analgesics|mesh-list
64498298|NCT01870973|Anesthetics|anesthetics|mesh-list
64498337|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
64498338|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498339|NCT01360450|Clonidine|clonidine|mesh-list
64498340|NCT01360450|Analgesics|analgesics|mesh-ancestor
64498341|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
64498342|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498343|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498344|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64498345|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
64498346|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
64498347|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64498348|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64498349|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64498350|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
64498351|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498352|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498353|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
64498354|NCT01303744|Analgesics|analgesics|mesh-ancestor
64498393|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64498394|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498395|NCT01271686|Bimatoprost|bimatoprost|mesh-list
64498396|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64498397|NCT01854047|Albuterol|albuterol|mesh-list
64498398|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64498399|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
64498400|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498401|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498402|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64498403|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
64498404|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
64498405|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64498406|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64498407|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64297835|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
64297836|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64498408|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64498409|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
64498410|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498411|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297837|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297838|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
64297839|NCT01652872|Hematinics|hematinics|mesh-ancestor
64297840|NCT02065219|Bupivacaine|bupivacaine|mesh-list
64297841|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
64297842|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
64297843|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297844|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297845|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
64297846|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297847|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
64297848|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64297849|NCT03560011|Antibodies|antibodies|mesh-list
64297850|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
64297851|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297852|NCT02069665|Ribavirin|ribavirin|mesh-list
64297853|NCT02069665|Ibuprofen|ibuprofen|mesh-list
64297854|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
64297855|NCT02069665|Albuterol|albuterol|mesh-list
64378052|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64378053|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
64378054|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64297856|NCT02069665|Guaifenesin|guaifenesin|mesh-list
64498413|NCT04605731|Ipilimumab|ipilimumab|mesh-list
64498414|NCT04605731|Tremelimumab|tremelimumab|mesh-list
64498415|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
64498416|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64498417|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
64498418|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64498419|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498420|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
64498421|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498441|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
64498442|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498443|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64498444|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498446|NCT01307956|Protective Agents|protective agents|mesh-ancestor
64498447|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
64498448|NCT01307956|Vitamins|vitamins|mesh-ancestor
64498449|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
64498450|NCT01307956|Hematinics|hematinics|mesh-ancestor
64498451|NCT01870739|Amlodipine|amlodipine|mesh-list
64498452|NCT01870739|Valsartan|valsartan|mesh-list
64498453|NCT01870739|Olmesartan|olmesartan|mesh-list
64498454|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64498455|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64498456|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64498503|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498504|NCT03009604|Emollients|emollients|mesh-ancestor
64498505|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
64498506|NCT01275664|Dexamethasone|dexamethasone|mesh-list
64498507|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
64498508|NCT01275664|Cisplatin|cisplatin|mesh-list
64498509|NCT01275664|Carboplatin|carboplatin|mesh-list
64498510|NCT01275664|Aprepitant|aprepitant|mesh-list
64498511|NCT01275664|Granisetron|granisetron|mesh-list
64498512|NCT01275664|Ichthammol|ichthammol|mesh-list
64498513|NCT01275664|BB 1101|bb 1101|mesh-list
64498514|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64498515|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
64498516|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
64498517|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498518|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498519|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498566|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64498567|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64498568|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498569|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498571|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64498572|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64498574|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
64498637|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64498638|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64498640|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498641|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498642|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64498643|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64498644|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
64498645|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498646|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64498647|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64498648|NCT01375660|Vitamin D|vitamin d|mesh-list
64498649|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
64498705|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
64498706|NCT01962792|Hormones|hormones|mesh-ancestor
64378086|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64378088|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64378089|NCT04828395|Paclitaxel|paclitaxel|mesh-list
64378090|NCT04828395|Etoposide|etoposide|mesh-list
64378091|NCT04828395|Cisplatin|cisplatin|mesh-list
64498707|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498708|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64498709|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498710|NCT01849055|Celecoxib|celecoxib|mesh-list
64498711|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64498712|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64498713|NCT01849055|Analgesics|analgesics|mesh-ancestor
64498714|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
64498715|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498716|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498717|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64498718|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64498719|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64498720|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64498721|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64498722|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498723|NCT01404832|Lansoprazole|lansoprazole|mesh-list
64498724|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
64498725|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64498726|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498727|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64498753|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64498754|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64498755|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64498756|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64498757|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64498758|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64498759|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
64498760|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498814|NCT01380106|Growth Substances|growth substances|mesh-ancestor
64498815|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
64498816|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498817|NCT01381120|Acetaminophen|acetaminophen|mesh-list
64498818|NCT01381120|Oxycodone|oxycodone|mesh-list
64498819|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
64498820|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64498821|NCT01381120|Analgesics|analgesics|mesh-ancestor
64498822|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
64498823|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498824|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498825|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
64498826|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64498827|NCT01381120|Narcotics|narcotics|mesh-ancestor
64498828|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64498829|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64297862|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64297863|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64297864|NCT02069665|Analgesics|analgesics|mesh-ancestor
64297865|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
64498830|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64498831|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
64498843|NCT01316770|Hormones|hormones|mesh-ancestor
64498873|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
64498874|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64498875|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498876|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64498877|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
64498878|NCT01411696|Hormones|hormones|mesh-ancestor
64498879|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64498880|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64498881|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498882|NCT01412164|Sirolimus|sirolimus|mesh-list
64498883|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64498884|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64498885|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64498886|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498887|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
64498888|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498931|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64498932|NCT03415386|Anticoagulants|anticoagulants|mesh-list
64498933|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64498934|NCT01865747|Everolimus|everolimus|mesh-list
64498935|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64498936|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64498937|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
64498938|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64498939|NCT03424746|Edetic Acid|edetic acid|mesh-list
64498940|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
64498999|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64499000|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
64499001|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64499002|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499003|NCT03414840|Atorvastatin|atorvastatin|mesh-list
64499004|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64499005|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64499006|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
64499007|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499008|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64499009|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64499010|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499011|NCT03418974|Atorvastatin|atorvastatin|mesh-list
64499012|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64499013|NCT03418974|Pitavastatin|pitavastatin|mesh-list
64499014|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64499059|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499060|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
64499061|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64499062|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64499063|NCT03127800|Morphine|morphine|mesh-list
64499064|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64499065|NCT03127800|Narcotics|narcotics|mesh-ancestor
64499066|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499067|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499068|NCT03127800|Analgesics|analgesics|mesh-ancestor
64499069|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
64499070|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297885|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
64297886|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64499072|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64499073|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64297887|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
64499074|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499075|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64499076|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499077|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499079|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64499080|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
64499111|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499112|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499113|NCT01390870|Urological Agents|urological agents|mesh-ancestor
64499114|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64499115|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64499116|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64499117|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499118|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499179|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
64499180|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
64499181|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64499182|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499183|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64499184|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
64499185|NCT01831817|Protective Agents|protective agents|mesh-ancestor
64499186|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64499248|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499249|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499250|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
64499251|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
64499252|NCT03411798|Methotrexate|methotrexate|mesh-list
64499253|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64499254|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
64499255|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499256|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499257|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499258|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
64499259|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499260|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499261|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499305|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
64499306|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499307|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64499308|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
64499309|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499310|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64499311|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64499312|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
64499333|NCT01423162|Vitamins|vitamins|mesh-ancestor
64499373|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64499374|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
64499375|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499376|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499377|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499378|NCT03411252|Urological Agents|urological agents|mesh-ancestor
64499379|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64499380|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
64499443|NCT03403842|Narcotics|narcotics|mesh-ancestor
64499444|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499445|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378181|NCT02601027|Bupivacaine|bupivacaine|mesh-list
64378182|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
64378183|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
64378184|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378185|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378226|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64378227|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378228|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378229|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64378230|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64378231|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378232|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378233|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499446|NCT03403842|Analgesics|analgesics|mesh-ancestor
64499447|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
64499448|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64945665|NCT05351801|Hormones|hormones|mesh-ancestor
64945666|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64499449|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64499450|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64499451|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
64499452|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
64499453|NCT01398982|Bupivacaine|bupivacaine|mesh-list
64499455|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
64499502|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64499503|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64499504|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64499505|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499506|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499507|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64499576|NCT03393702|Gabapentin|gabapentin|mesh-list
64499577|NCT03393702|Analgesics|analgesics|mesh-ancestor
64499578|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
64499579|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499580|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499581|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
64499582|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64499583|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64499584|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499585|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64499586|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64499641|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499642|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499643|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
64499644|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499645|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64499646|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64499647|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64499648|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499649|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499650|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64499651|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499652|NCT03399474|Analgesics|analgesics|mesh-ancestor
64499654|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64499701|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499702|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64499703|NCT01829243|Milnacipran|milnacipran|mesh-list
64499704|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
64499705|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64499706|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64499707|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64499708|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499709|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499710|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499711|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64499712|NCT01829243|Analgesics|analgesics|mesh-ancestor
64499761|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64499762|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
64499763|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499832|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
64499833|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64499834|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
64499835|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499836|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499837|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64378310|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64499838|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64499840|NCT01827839|Vaccines|vaccines|mesh-list
64499841|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
64499842|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499843|NCT04709250|Bupivacaine|bupivacaine|mesh-list
64499844|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
64499845|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
64499846|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64499847|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499848|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
64499891|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64499892|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64499893|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499895|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64499896|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
64499897|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64499898|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945669|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
64499899|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64499900|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64499901|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
64499902|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64499903|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499904|NCT01477762|Dexamethasone|dexamethasone|mesh-list
64499905|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64499912|NCT01477762|Hormones|hormones|mesh-ancestor
64499950|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64499951|NCT01436266|Folic Acid|folic acid|mesh-list
64499952|NCT01436266|Misoprostol|misoprostol|mesh-list
64499953|NCT01436266|Vitamins|vitamins|mesh-ancestor
64499954|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
64499955|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64499956|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64499958|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64499959|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64500018|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64500019|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64500020|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500021|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500022|NCT01544998|Urological Agents|urological agents|mesh-ancestor
64500023|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
64500024|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500025|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
64500026|NCT03391830|Atorvastatin|atorvastatin|mesh-list
64500027|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64500028|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64500029|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
64500030|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500033|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500079|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
64500080|NCT01545700|BB 1101|bb 1101|mesh-list
64500081|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500082|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
64500083|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
64500084|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500085|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500086|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500087|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
64500147|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500148|NCT03994146|Analgesics|analgesics|mesh-ancestor
64500149|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
64500150|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500151|NCT01547806|Plerixafor|plerixafor|mesh-list
64500152|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64378385|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378386|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
64378387|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64378388|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
64500153|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64500154|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
64500155|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64500156|NCT01445626|Dexamethasone|dexamethasone|mesh-list
64500157|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500158|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
64500214|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500215|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500217|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
64500218|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64500219|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
64500220|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64500221|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64500222|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500223|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64500224|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500225|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64500227|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500273|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500274|NCT00782184|Atorvastatin|atorvastatin|mesh-list
64500275|NCT00782184|Simvastatin|simvastatin|mesh-list
64500276|NCT00782184|Ezetimibe|ezetimibe|mesh-list
64500277|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64500278|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64500279|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64500280|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
64500285|NCT03397914|Colistin|colistin|mesh-list
64500337|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64500338|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500339|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64500342|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500343|NCT03125694|Pioglitazone|pioglitazone|mesh-list
64500344|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64500345|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64500346|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500402|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500404|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
64500405|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64297916|NCT02069977|Aripiprazole|aripiprazole|mesh-list
64500406|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64500407|NCT02214628|Growth Substances|growth substances|mesh-ancestor
64500408|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297917|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
64297918|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297919|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64297920|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64297921|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297922|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297923|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
64297924|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
64500410|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64500411|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500412|NCT01495858|Analgesics|analgesics|mesh-ancestor
64500468|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64500469|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500470|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64500471|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500472|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
64500473|NCT01498588|Doxorubicin|doxorubicin|mesh-list
64378389|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64378390|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64378391|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378392|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378393|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64378394|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64500474|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500475|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
64500476|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500477|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500478|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64500479|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
64500481|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500528|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500529|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
64500530|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500531|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64500532|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64500533|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64500534|NCT01557322|Analgesics|analgesics|mesh-ancestor
64500535|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
64500536|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500537|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500538|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64500539|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64500540|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64500541|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
64500587|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64500588|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
64500590|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64500591|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500592|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64500593|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
64500594|NCT01464190|Sevelamer|sevelamer|mesh-list
64500595|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
64500596|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
64500597|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500598|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64500599|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64500600|NCT01563406|Ethanol|ethanol|mesh-list
64500646|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945671|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945672|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64945673|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297925|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500648|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64500649|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
64500650|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500651|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500709|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500710|NCT04446234|Risperidone|risperidone|mesh-list
64500711|NCT04446234|Aripiprazole|aripiprazole|mesh-list
64500712|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64500713|NCT04446234|Ziprasidone|ziprasidone|mesh-list
64500714|NCT04446234|Amisulpride|amisulpride|mesh-list
64500715|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64500716|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
64500717|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500718|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500719|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945674|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64500720|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64500721|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64500722|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500768|NCT05565976|Biguanides|biguanides|mesh-list
64500769|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64500770|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64500771|NCT05565976|Meglitinide|meglitinide|mesh-list
64500772|NCT05565976|Clopidogrel|clopidogrel|mesh-list
64500773|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64500774|NCT05565976|Atorvastatin|atorvastatin|mesh-list
64500775|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64500776|NCT05565976|Pravastatin|pravastatin|mesh-list
64500777|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500778|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64500779|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64500780|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
64500781|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500782|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64500783|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64500784|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500785|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64500816|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
64500817|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500818|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500819|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
64500820|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500821|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
64500822|NCT05565664|Ketamine|ketamine|mesh-list
64500823|NCT05565664|Analgesics|analgesics|mesh-ancestor
64500824|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
64500825|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64500826|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500827|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64500828|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64500829|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
64500830|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
64500831|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64500832|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64500833|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64500834|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500871|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64500872|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500873|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64500874|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64500875|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
64500876|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500877|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500878|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64500879|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64500880|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64500881|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
64500882|NCT01515046|Gemcitabine|gemcitabine|mesh-list
64500883|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64500884|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
64500886|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64500931|NCT04671030|Neostigmine|neostigmine|mesh-list
64500932|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64500933|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945684|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64500934|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64500935|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
64500936|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64500937|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500938|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64500995|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64500996|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
64500997|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64500998|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64500999|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501000|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64501001|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64501002|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64501003|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501004|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501005|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
64378432|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378445|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501007|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501008|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945685|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501009|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64501010|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501011|NCT03386838|Carboplatin|carboplatin|mesh-list
64501012|NCT03386838|Fluorouracil|fluorouracil|mesh-list
64501014|NCT03386838|Cetuximab|cetuximab|mesh-list
64501015|NCT03386838|Linrodostat|linrodostat|mesh-list
64501016|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501017|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
64501018|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501044|NCT01516684|Propofol|propofol|mesh-list
64501045|NCT01516684|Anesthetics|anesthetics|mesh-list
64501046|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501047|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501048|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
64501049|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501050|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64501051|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64501059|NCT01516684|Narcotics|narcotics|mesh-ancestor
64501111|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
64501112|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501113|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64501114|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64501115|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64501116|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64501117|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
64501118|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501119|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64501120|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
64501121|NCT04445922|Anastrozole|anastrozole|mesh-list
64501172|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64501173|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501174|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64501175|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64501176|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501177|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
64501178|NCT02969928|Amoxicillin|amoxicillin|mesh-list
64501179|NCT02969928|Metronidazole|metronidazole|mesh-list
64501180|NCT02969928|Clarithromycin|clarithromycin|mesh-list
64501181|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64501182|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501183|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64501184|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64501185|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64501186|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501187|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501188|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64501189|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64501190|NCT02968446|Vitamin D|vitamin d|mesh-list
64501191|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
64501192|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
64501193|NCT02968446|Vitamins|vitamins|mesh-ancestor
64501194|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
64501226|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501227|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64501228|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64501229|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501230|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501231|NCT03378648|Bromides|bromides|mesh-list
64945689|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
64501232|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
64501233|NCT01519882|Rotigotine|rotigotine|mesh-list
64945690|NCT05299073|Denosumab|denosumab|mesh-list
64501234|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
64501235|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
64378482|NCT03200561|Hormones|hormones|mesh-ancestor
64378483|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378484|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501236|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501237|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501238|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501239|NCT01576276|Ketorolac|ketorolac|mesh-list
64501240|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64501281|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64501282|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64501283|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501285|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64501286|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501287|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64501288|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64501289|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501290|NCT02346630|Levodopa|levodopa|mesh-list
64501291|NCT02346630|Carbidopa|carbidopa|mesh-list
64501292|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64501293|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64501295|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501296|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501343|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64501344|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64501345|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64501346|NCT03124524|Estradiol|estradiol|mesh-list
64501347|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64501348|NCT03124524|Estrogens|estrogens|mesh-ancestor
64501349|NCT03124524|Hormones|hormones|mesh-ancestor
64501350|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501351|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501352|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64501353|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
64501354|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64501355|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64501356|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64501357|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64501358|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64501359|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
64501360|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64501361|NCT03124524|Diuretics|diuretics|mesh-ancestor
64501362|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
64501363|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64501396|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501397|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64501398|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
64501399|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501400|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501401|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
64501402|NCT03124680|Narcotics|narcotics|mesh-ancestor
64501403|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501404|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501463|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501464|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64501465|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
64501466|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
64501467|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
64501468|NCT03007654|Coagulants|coagulants|mesh-ancestor
64501469|NCT03374514|Dexamethasone|dexamethasone|mesh-list
64501470|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501471|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
64501472|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
64378486|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378535|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378536|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378537|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
64378538|NCT02596971|Hormones|hormones|mesh-ancestor
64378539|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378540|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64501473|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501474|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501475|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501476|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
64501477|NCT03374514|Hormones|hormones|mesh-ancestor
64501478|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64501480|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501521|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64501522|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64501523|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64501525|NCT03381066|Pemetrexed|pemetrexed|mesh-list
64501526|NCT03381066|Vinorelbine|vinorelbine|mesh-list
64501527|NCT03381066|Gefitinib|gefitinib|mesh-list
64501528|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501529|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501530|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501531|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64501532|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64501533|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64501534|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
64501535|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64501543|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
64501580|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64501581|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501582|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
64501583|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64297926|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501584|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64501585|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64297927|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64297929|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
64297930|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64501586|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64501587|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501588|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
64501589|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501590|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501591|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64501592|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501593|NCT03006874|Esomeprazole|esomeprazole|mesh-list
64501594|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64501595|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64501637|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64501638|NCT01584388|Rituximab|rituximab|mesh-list
64501639|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501640|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501641|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
64501642|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501643|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501644|NCT01584544|Capecitabine|capecitabine|mesh-list
64501690|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
64501691|NCT01586962|Ephedrine|ephedrine|mesh-list
64501692|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501693|NCT01586962|Analgesics|analgesics|mesh-ancestor
64501694|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
64501695|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501696|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501697|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
64501698|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64501699|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
64501700|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64501701|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
64501702|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
64501703|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64501704|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64501752|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64501753|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
64378542|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
64501754|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501755|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501756|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64501757|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64501758|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64501759|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64501760|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64501762|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64501765|NCT03063021|Expectorants|expectorants|mesh-ancestor
64501816|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64501817|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
64501818|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501819|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64501822|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64501823|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64501824|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64501825|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501826|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
64501827|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64501878|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64501879|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64501880|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64501881|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64501882|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64501883|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64501884|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64501946|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64501947|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64501948|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64501949|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
64501950|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64501951|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64501952|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64501953|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64501954|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64501955|NCT03005704|Analgesics|analgesics|mesh-ancestor
64501956|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
64501957|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64501958|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64501959|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64501960|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64501961|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64501962|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64501963|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502000|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502001|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502002|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64502003|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64502004|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
64502005|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502006|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64378565|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
64378566|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
64502007|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64502008|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
64502009|NCT03001570|Cetuximab|cetuximab|mesh-list
64502010|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502011|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502012|NCT03005548|Morphine|morphine|mesh-list
64502013|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64502061|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64502062|NCT03001102|Povidone|povidone|mesh-list
64502063|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502064|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
64502065|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
64502066|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
64502067|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
64502068|NCT03000946|Octreotide|octreotide|mesh-list
64502069|NCT03000946|Somatostatin|somatostatin|mesh-list
64502126|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502128|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502129|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502130|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
64502131|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502132|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64502133|NCT05035888|Phenylephrine|phenylephrine|mesh-list
64502134|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
64502136|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64502137|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64502138|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
64502139|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
64502140|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502141|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502142|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
64502186|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
64502187|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502188|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502190|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
64502191|NCT03000634|Hormones|hormones|mesh-ancestor
64502192|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502193|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64502194|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502195|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
64502196|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64502197|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64502198|NCT03000634|Growth Substances|growth substances|mesh-ancestor
64502199|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
64502249|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64502250|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64502251|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502252|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502253|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64502254|NCT04523844|Brinzolamide|brinzolamide|mesh-list
64502255|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64502257|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64502315|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502316|NCT05672680|Bupivacaine|bupivacaine|mesh-list
64378618|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
64378619|NCT04793529|Vitamin D|vitamin d|mesh-list
64378620|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64378621|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378622|NCT04793529|Vitamins|vitamins|mesh-ancestor
64378623|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
64378627|NCT03232307|Rituximab|rituximab|mesh-list
64502317|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502318|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
64502319|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502320|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502321|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
64502322|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502323|NCT05672524|Trastuzumab|trastuzumab|mesh-list
64502324|NCT05672524|Tucatinib|tucatinib|mesh-list
64502325|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502326|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502379|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
64502380|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64502382|NCT03368274|Hormones|hormones|mesh-ancestor
64502383|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502384|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297938|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297939|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64297940|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64297941|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
64297942|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
64297943|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502385|NCT02247544|Trabectedin|trabectedin|mesh-list
64297944|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64502442|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64502444|NCT04073056|Bupivacaine|bupivacaine|mesh-list
64502445|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502446|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
64502447|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502448|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502449|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
64502450|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502451|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
64502453|NCT03361098|Exenatide|exenatide|mesh-list
64502508|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64502509|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502510|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
64502511|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
64502512|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
64502513|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502514|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64502575|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
64502576|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64502577|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64502578|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64502579|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64502580|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502581|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502583|NCT03357900|Propofol|propofol|mesh-list
64297945|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64297946|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378702|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64378703|NCT03231683|Narcotics|narcotics|mesh-ancestor
64378704|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
64378705|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64378706|NCT02593773|Interferons|interferons|mesh-list
64378707|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
64378708|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378709|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
64297947|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297948|NCT02443402|Insulin|insulin|mesh-list
64297951|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64297952|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
64297953|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
64297954|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64297955|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297956|NCT02443402|Incretins|incretins|mesh-ancestor
64297957|NCT02443402|Hormones|hormones|mesh-ancestor
64297958|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297959|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64297960|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
64297961|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502584|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64502585|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502586|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502587|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64502637|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64502638|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
64502639|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502640|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945712|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64502641|NCT03123276|Gemcitabine|gemcitabine|mesh-list
64502642|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
64502643|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64502644|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
64945713|NCT05287425|Povidone|povidone|mesh-list
64502645|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502646|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502647|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
64502648|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502649|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502665|NCT03359070|Miconazole|miconazole|mesh-list
64502693|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502694|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64502695|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
64502697|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64502698|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502699|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64502700|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64502758|NCT03356964|Hormones|hormones|mesh-list
64502759|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64502760|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64502761|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502762|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
64502763|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64502764|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64502765|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64502766|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502767|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297962|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297963|NCT02067013|Ranibizumab|ranibizumab|mesh-list
64297964|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64297965|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64297966|NCT02067013|Growth Substances|growth substances|mesh-ancestor
64297967|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297968|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297969|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297970|NCT03298581|Clobetasol|clobetasol|mesh-list
64297971|NCT03298581|Halobetasol|halobetasol|mesh-list
64297972|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64297973|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64297974|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
64297975|NCT03298581|Hormones|hormones|mesh-ancestor
64297976|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64297977|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297978|NCT02412670|Gemcitabine|gemcitabine|mesh-list
64502823|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
64502824|NCT03364842|Furosemide|furosemide|mesh-list
64502825|NCT03364842|Diuretics|diuretics|mesh-ancestor
64502826|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
64502827|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502828|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64502829|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64502830|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502831|NCT03364764|Sirolimus|sirolimus|mesh-list
64502832|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64502891|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64502892|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
64502893|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502894|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64502895|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
64502896|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64502897|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64502898|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64502899|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
64502901|NCT03354624|Mitogens|mitogens|mesh-list
64502959|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
64502960|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64502961|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64502962|NCT03355716|Fentanyl|fentanyl|mesh-list
64502963|NCT03355716|Ketamine|ketamine|mesh-list
64502964|NCT03355716|Morphine|morphine|mesh-list
64502965|NCT03355716|Bupivacaine|bupivacaine|mesh-list
64502966|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
64502967|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
64502968|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64502969|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64502970|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
64502971|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503022|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503023|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64503024|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64503025|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64503027|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
64503028|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503029|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503030|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503031|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
64503032|NCT01626664|Gemcitabine|gemcitabine|mesh-list
64503033|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
64503050|NCT04515966|Lidocaine|lidocaine|mesh-list
64503085|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503087|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64503089|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64503090|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64503091|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503092|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64503093|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64503094|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64503151|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64503152|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
64503153|NCT03353298|Protective Agents|protective agents|mesh-ancestor
64503154|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503156|NCT02509546|Analgesics|analgesics|mesh-ancestor
64503157|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
64503158|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503159|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503217|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64503218|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
64503219|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
64503220|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503221|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503222|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64503223|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
64503224|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503225|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64503226|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64503227|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64503228|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
64503229|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64503231|NCT01638052|Clonidine|clonidine|mesh-list
64945718|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945719|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945720|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945721|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64945722|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64945723|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64945724|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
64945725|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
64945726|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64945727|NCT05276492|Prednisone|prednisone|mesh-list
64945728|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64945729|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
64945730|NCT05276492|Hormones|hormones|mesh-ancestor
64945731|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64945732|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945772|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945773|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64945774|NCT05192850|Metformin|metformin|mesh-list
64945775|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64945776|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945777|NCT05174065|Apremilast|apremilast|mesh-list
64945778|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64945779|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945780|NCT05174065|Analgesics|analgesics|mesh-ancestor
64945781|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
64945790|NCT05111717|Desflurane|desflurane|mesh-list
64945836|NCT05083247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484684|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
64945837|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
64945838|NCT05077527|Fludarabine|fludarabine|mesh-list
64503281|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64503282|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64945839|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64945840|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
64945841|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945842|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945898|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
64945899|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64945900|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64945901|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64945902|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
64297980|NCT02412670|Carboplatin|carboplatin|mesh-list
64297981|NCT02412670|Doxorubicin|doxorubicin|mesh-list
64945903|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945904|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64945905|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64945906|NCT05012189|Oseltamivir|oseltamivir|mesh-list
64945908|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
64945909|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64503283|NCT04443270|Analgesics|analgesics|mesh-ancestor
64503284|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
64945910|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945954|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64945955|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64945956|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64945957|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64945958|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64945959|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64946021|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64946022|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
64946023|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
64946024|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64946025|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64946026|NCT04846348|Analgesics|analgesics|mesh-ancestor
64946027|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946028|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946029|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64946030|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946031|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64946032|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
64946084|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946085|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64946086|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64946087|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64946088|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946089|NCT04667104|Tenofovir|tenofovir|mesh-list
64946090|NCT04667104|Entecavir|entecavir|mesh-list
64946091|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64946092|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
64946093|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946148|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64946149|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946150|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64946151|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946152|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
64946153|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946154|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
64946155|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946156|NCT04584112|Paclitaxel|paclitaxel|mesh-list
64946158|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
64946214|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64946215|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
64946216|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64946217|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946218|NCT04499274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64946219|NCT04499274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64946220|NCT04499274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297982|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64297983|NCT02412670|Methotrexate|methotrexate|mesh-list
64297984|NCT02412670|Vinblastine|vinblastine|mesh-list
64297985|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297986|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64946221|NCT04499274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64946222|NCT04499274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64946223|NCT04497961|Lenalidomide|lenalidomide|mesh-list
64946224|NCT04497961|Daratumumab|daratumumab|mesh-list
64946225|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
64946226|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946227|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64946228|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64946229|NCT04497961|Growth Substances|growth substances|mesh-ancestor
64946230|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
64946274|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
64946275|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946276|NCT04351555|Carboplatin|carboplatin|mesh-list
64946277|NCT04351555|Pemetrexed|pemetrexed|mesh-list
64946278|NCT04351555|Osimertinib|osimertinib|mesh-list
64946279|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64485123|NCT01737931|Hormones|hormones|mesh-ancestor
64946280|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946281|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946282|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64503294|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946283|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64946284|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64378903|NCT04791345|BB 1101|bb 1101|mesh-list
64378904|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378905|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
64378906|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
64946286|NCT04321993|Remdesivir|remdesivir|mesh-list
64946334|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946335|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64946336|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
64946337|NCT04300127|Pioglitazone|pioglitazone|mesh-list
64946340|NCT04296305|Hydromorphone|hydromorphone|mesh-list
64946408|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64946409|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946410|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
64946411|NCT04182997|Dexamethasone|dexamethasone|mesh-list
64946412|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946413|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
64946414|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
64946415|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946416|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946418|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
64946470|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64946471|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64946472|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
64946473|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946474|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64946475|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64946476|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946478|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64946479|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946480|NCT04023331|Copper|copper|mesh-list
64946481|NCT04023331|Trace Elements|trace elements|mesh-ancestor
64946482|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
64946483|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946484|NCT03984565|Cannabidiol|cannabidiol|mesh-list
64946485|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
64946486|NCT03982693|Edetic Acid|edetic acid|mesh-list
64946487|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
64946497|NCT03965195|Vaccines|vaccines|mesh-list
64946526|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64946527|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946528|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946529|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
64946530|NCT03862859|Warfarin|warfarin|mesh-list
64946531|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
64946532|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
64946533|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64946534|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946535|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64946536|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946537|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946538|NCT03846310|Carboplatin|carboplatin|mesh-list
64946539|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
64946540|NCT03846310|Pemetrexed|pemetrexed|mesh-list
64946541|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946542|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378930|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64378931|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
64378932|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378933|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64378934|NCT03231215|Dexamethasone|dexamethasone|mesh-list
64378935|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378936|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
64378938|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378939|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946543|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946544|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946545|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64946546|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64946547|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
64946548|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64946549|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64946550|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
64946551|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
64503301|NCT03352362|Analgesics|analgesics|mesh-ancestor
64946576|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
64946577|NCT03737240|Liraglutide|liraglutide|mesh-list
64946578|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
64946580|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64946581|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946582|NCT03737240|Incretins|incretins|mesh-ancestor
64946583|NCT03737240|Hormones|hormones|mesh-ancestor
64946584|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946585|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
64946586|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946587|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946588|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
64946589|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946590|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946591|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
64946592|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946593|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946594|NCT03596164|Teduglutide|teduglutide|mesh-list
64946595|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64946596|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64946597|NCT03596164|Protective Agents|protective agents|mesh-ancestor
64946598|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946599|NCT03556332|Dexamethasone|dexamethasone|mesh-list
64946600|NCT03556332|Lenalidomide|lenalidomide|mesh-list
64946626|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64946627|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
64946628|NCT03539900|Naltrexone|naltrexone|mesh-list
64946629|NCT03539900|Bupropion|bupropion|mesh-list
64946630|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64378949|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
64378950|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
64378953|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64378954|NCT03526185|Nivolumab|nivolumab|mesh-list
64378955|NCT03526185|Ipilimumab|ipilimumab|mesh-list
64378960|NCT02445599|Dipyrone|dipyrone|mesh-list
64946631|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64946632|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946633|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
64946634|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946635|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64946636|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
64946637|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64946642|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
64946682|NCT03492125|Rituximab|rituximab|mesh-list
64946683|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
64946684|NCT03492125|Venetoclax|venetoclax|mesh-list
64946685|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
64946686|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946687|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946688|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
64946689|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946690|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64946691|NCT03476798|Bevacizumab|bevacizumab|mesh-list
64946692|NCT03476798|Rucaparib|rucaparib|mesh-list
64946693|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946694|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946695|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64946696|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64946747|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946748|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
64946749|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64946750|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946751|NCT03432741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64946752|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64946753|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64946754|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64946755|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64946815|NCT03297606|Vemurafenib|vemurafenib|mesh-list
64946816|NCT03297606|Crizotinib|crizotinib|mesh-list
64946817|NCT03297606|Tucatinib|tucatinib|mesh-list
64946818|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64946819|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946820|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64946821|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946822|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64946823|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946824|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64503303|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64946881|NCT03098225|Hormones|hormones|mesh-ancestor
64946882|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64946883|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64946884|NCT03098225|Protective Agents|protective agents|mesh-ancestor
64946885|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64946886|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64946887|NCT03017131|Aldesleukin|aldesleukin|mesh-list
64946888|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
64946889|NCT03017131|Decitabine|decitabine|mesh-list
64946890|NCT03017131|Interleukin-2|interleukin-2|mesh-list
64946911|NCT02990468|Cisplatin|cisplatin|mesh-list
64946944|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64946945|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64946946|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64946947|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64946948|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64946949|NCT02882100|Vaccines|vaccines|mesh-list
64946950|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
64946951|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946952|NCT02855944|Gemcitabine|gemcitabine|mesh-list
64946953|NCT02855944|Paclitaxel|paclitaxel|mesh-list
64946954|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64946955|NCT02855944|Cisplatin|cisplatin|mesh-list
64946956|NCT02855944|Carboplatin|carboplatin|mesh-list
64379052|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64379053|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64379054|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379055|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64485789|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503304|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64946957|NCT02855944|Rucaparib|rucaparib|mesh-list
64946958|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64946959|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947001|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
64947002|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947003|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947004|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64947005|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947006|NCT02603848|Ibuprofen|ibuprofen|mesh-list
64947007|NCT02603848|Morphine|morphine|mesh-list
64947008|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64947009|NCT02603848|Narcotics|narcotics|mesh-ancestor
64947010|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947066|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947068|NCT02409342|Carboplatin|carboplatin|mesh-list
64947069|NCT02409342|Pemetrexed|pemetrexed|mesh-list
64947070|NCT02409342|Atezolizumab|atezolizumab|mesh-list
64947071|NCT02409342|Antibodies|antibodies|mesh-list
64947072|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64947073|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
64947074|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947075|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947076|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947077|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
64947078|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947129|NCT01998971|Melphalan|melphalan|mesh-list
64947130|NCT01998971|Bortezomib|bortezomib|mesh-list
64947131|NCT01998971|Daratumumab|daratumumab|mesh-list
64947132|NCT01998971|Pomalidomide|pomalidomide|mesh-list
64947133|NCT01998971|Montelukast|montelukast|mesh-list
64947134|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947135|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
64947136|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
64947137|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947138|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947139|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64947140|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
64947141|NCT01998971|Hormones|hormones|mesh-ancestor
64947144|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947193|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947194|NCT01900574|Golimumab|golimumab|mesh-list
64947195|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64947196|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947197|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947198|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
64947199|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947200|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
64947201|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947258|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64947259|NCT05772871|Levamisole|levamisole|mesh-list
64379056|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379057|NCT02445053|Ivacaftor|ivacaftor|mesh-list
64379079|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379080|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64947261|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64947262|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
64947263|NCT05772871|Hormones|hormones|mesh-ancestor
64947264|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947265|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947266|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947267|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947268|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64947326|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297999|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
64298000|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64298001|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
64298002|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64298003|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947327|NCT05772364|Calcium, Dietary|calcium, dietary|mesh-list
64298004|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64298005|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64298006|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
64298007|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
64947328|NCT05772364|Calcium|calcium|mesh-list
64947329|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64947330|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947331|NCT05772364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64503306|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947387|NCT05771480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947388|NCT05771480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947389|NCT05771480|Immunologic Factors|immunologic factors|mesh-ancestor
64947390|NCT05771480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947391|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947395|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
64947396|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64947397|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64947398|NCT05771181|Vitamin E|vitamin e|mesh-list
64947399|NCT05771181|Vitamins|vitamins|mesh-ancestor
64947400|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
64947401|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947402|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
64947403|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947448|NCT05766800|Pemetrexed|pemetrexed|mesh-list
64947449|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64947450|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947451|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
64947452|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
64947453|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
64947454|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947455|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947456|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64947457|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64947458|NCT05766410|Letrozole|letrozole|mesh-list
64947459|NCT05766410|Palbociclib|palbociclib|mesh-list
64947460|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947461|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64947470|NCT05757011|Bupivacaine|bupivacaine|mesh-list
64947505|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
64947506|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947508|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947509|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947510|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
64947511|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947512|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947513|NCT05724134|Insulin|insulin|mesh-list
64947514|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64947515|NCT05724134|Octreotide|octreotide|mesh-list
64947516|NCT05724134|Glucagon|glucagon|mesh-list
64947517|NCT05724134|Hormones|hormones|mesh-list
64947518|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64947519|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947520|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64947521|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64947522|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64947524|NCT05715073|Caffeine|caffeine|mesh-list
64947559|NCT05694637|Varenicline|varenicline|mesh-list
64947560|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64947561|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64947562|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
64947563|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947564|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298011|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298012|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64298013|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298014|NCT02070133|Simvastatin|simvastatin|mesh-list
64947565|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947566|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
64947567|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
64947568|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64947569|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64947570|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947571|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947572|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947621|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947623|NCT05655949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947624|NCT05655949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947625|NCT05655949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947626|NCT05655949|Immunologic Factors|immunologic factors|mesh-ancestor
64947627|NCT05655949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947628|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64947629|NCT05650736|Abrocitinib|abrocitinib|mesh-list
64947630|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64947631|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503311|NCT01598740|Spironolactone|spironolactone|mesh-list
64947632|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947633|NCT05646992|Azathioprine|azathioprine|mesh-list
64947634|NCT05646992|Tacrolimus|tacrolimus|mesh-list
64947635|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64947636|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
64947637|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947638|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64947639|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947640|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947645|NCT05637606|Etilefrine|etilefrine|mesh-list
64947672|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64947673|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
64947674|NCT05549206|Vaccines|vaccines|mesh-list
64947675|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
64947676|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947677|NCT05533684|Gabapentin|gabapentin|mesh-list
64947678|NCT05533684|Analgesics|analgesics|mesh-ancestor
64947679|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
64947680|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947681|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947682|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
64947683|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64947684|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64947685|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379143|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64379144|NCT02572791|Mupirocin|mupirocin|mesh-list
64379145|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64379146|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379147|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
64379148|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
64379149|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64947686|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64947687|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64947730|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64947731|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
64947733|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64947734|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64947735|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947736|NCT05433961|Xenon|xenon|mesh-list
64947737|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64947739|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
64947793|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64947794|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
64947795|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64947796|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64947797|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64947798|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947799|NCT05287906|Protective Agents|protective agents|mesh-ancestor
64947800|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947862|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64947864|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
64947865|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
64947866|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947867|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947868|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
64947869|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64947870|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64947871|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64947928|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503313|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
64947929|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64947930|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64947931|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
64947932|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947933|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64947934|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
64947935|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64947936|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64947937|NCT04785118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64947938|NCT04785118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64947939|NCT04785118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64947940|NCT04785118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64947941|NCT04785118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64947942|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64947943|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
64947989|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64947990|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
64947991|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64947992|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64947993|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
64947994|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
64947995|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64947996|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64947997|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
64947998|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64947999|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64948000|NCT04752163|Antidotes|antidotes|mesh-ancestor
64948052|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948054|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
64948055|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948056|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64948057|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64948058|NCT04702256|Protective Agents|protective agents|mesh-ancestor
64948118|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64948119|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948121|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64298016|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64298017|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
64298018|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298019|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64298020|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64298021|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298022|NCT02070289|PF-06372865|pf-06372865|mesh-list
64948122|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64948123|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64948124|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64948125|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948126|NCT04616807|Mexiletine|mexiletine|mesh-list
64948127|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64948128|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64948129|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64948130|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64948131|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948132|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
64948133|NCT04608630|Denosumab|denosumab|mesh-list
64948134|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64948135|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948136|NCT04603183|Paclitaxel|paclitaxel|mesh-list
64948137|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64948138|NCT04603183|Letrozole|letrozole|mesh-list
64948169|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
64948170|NCT04556773|Paclitaxel|paclitaxel|mesh-list
64948171|NCT04556773|Capecitabine|capecitabine|mesh-list
64948172|NCT04556773|Trastuzumab|trastuzumab|mesh-list
64948173|NCT04556773|Durvalumab|durvalumab|mesh-list
64948174|NCT04556773|Fulvestrant|fulvestrant|mesh-list
64948175|NCT04556773|Anastrozole|anastrozole|mesh-list
64948176|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948177|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948178|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
64948179|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948180|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948233|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948234|NCT04508725|Growth Substances|growth substances|mesh-ancestor
64948235|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948237|NCT04490057|Nicotine|nicotine|mesh-list
64948238|NCT04490057|Varenicline|varenicline|mesh-list
64948239|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64948240|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
64948241|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948242|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948243|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64948244|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64948295|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948296|NCT04410796|Carboplatin|carboplatin|mesh-list
64948297|NCT04410796|Pemetrexed|pemetrexed|mesh-list
64948298|NCT04410796|Osimertinib|osimertinib|mesh-list
64948299|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948300|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948301|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948302|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64948303|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64948360|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64948362|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
64948363|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948364|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379150|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64379151|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379152|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948365|NCT04220489|Ketamine|ketamine|mesh-list
64948366|NCT04220489|Analgesics|analgesics|mesh-ancestor
64948367|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
64948368|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948369|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948370|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64948371|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64948372|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
64948373|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
64948374|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64487188|NCT01738646|Bevacizumab|bevacizumab|mesh-list
64948375|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64948376|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64487258|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
64948377|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948378|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948411|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298023|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
64948412|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948413|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64948414|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64948415|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64948416|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
64948417|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948418|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948419|NCT04166331|Protective Agents|protective agents|mesh-ancestor
64948422|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948477|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
64948478|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948479|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948480|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64948481|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
64948544|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948545|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
64948546|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948547|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64948548|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64948549|NCT03776071|Temozolomide|temozolomide|mesh-list
64948550|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64948551|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
64948552|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948553|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948554|NCT03671811|Megestrol|megestrol|mesh-list
64948555|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
64948556|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64948557|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64948558|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64948603|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948604|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64948605|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64948606|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64948607|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948608|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64948609|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64948610|NCT03589729|Protective Agents|protective agents|mesh-ancestor
64948611|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
64948612|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
64948613|NCT03585686|Cytarabine|cytarabine|mesh-list
64948614|NCT03585686|Vemurafenib|vemurafenib|mesh-list
64948615|NCT03585686|Cladribine|cladribine|mesh-list
64948616|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64948617|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
64948618|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948619|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948620|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
64948621|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379154|NCT01626352|Ofatumumab|ofatumumab|mesh-list
64948622|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948623|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
64948624|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948625|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64948627|NCT03543969|Nivolumab|nivolumab|mesh-list
64948655|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64948656|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948658|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
64948724|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64948725|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948727|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948728|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
64948729|NCT03315897|Hematinics|hematinics|mesh-ancestor
64948730|NCT03299660|Fluorouracil|fluorouracil|mesh-list
64948731|NCT03299660|Capecitabine|capecitabine|mesh-list
64948732|NCT03299660|Avelumab|avelumab|mesh-list
64948733|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
64948761|NCT03179930|Entinostat|entinostat|mesh-list
64948790|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
64948791|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948792|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64948793|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948794|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
64948795|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948796|NCT02899611|Valproic Acid|valproic acid|mesh-list
64948797|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
64948798|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948799|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948800|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
64948801|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64948802|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948803|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
64948804|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64948805|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64948807|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
64948847|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
64948848|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64948849|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64948850|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64948851|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64948852|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64948853|NCT02586831|Analgesics|analgesics|mesh-ancestor
64948854|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
64948855|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948856|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948857|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64948858|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64948859|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
64948860|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64948863|NCT02586831|Incretins|incretins|mesh-ancestor
64948909|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64948910|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64948911|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64948912|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
64948913|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
64948915|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64948916|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948917|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64948918|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
64948919|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64948920|NCT02511418|Simvastatin|simvastatin|mesh-list
64948921|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64948922|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64948923|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
64948924|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948968|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503320|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64948969|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64948971|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64948972|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64948973|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64948974|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64948975|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
64949032|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949033|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949034|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949035|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949036|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949037|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949038|NCT00018668|Olanzapine|olanzapine|mesh-list
64949039|NCT00018668|Risperidone|risperidone|mesh-list
64949040|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64949041|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64503322|NCT03348696|Dexamethasone|dexamethasone|mesh-list
64949042|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
64949043|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503323|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
64949044|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949045|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949046|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64949047|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64949048|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64949049|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64949050|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64949051|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
64949052|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
64949053|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
64949054|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949055|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949056|NCT00018668|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64949057|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64949058|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64949059|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
64949060|NCT00042354|Clofarabine|clofarabine|mesh-list
64949061|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949065|NCT00042393|Adefovir|adefovir|mesh-list
64949071|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949072|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949073|NCT00042471|Pramlintide|pramlintide|mesh-list
64949141|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949142|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64949143|NCT00038922|Oprelvekin|oprelvekin|mesh-list
64949214|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949215|NCT00039117|Cytarabine|cytarabine|mesh-list
64949216|NCT00039117|Daunorubicin|daunorubicin|mesh-list
64949217|NCT00039117|Oblimersen|oblimersen|mesh-list
64949218|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949219|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
64949220|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949221|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949222|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
64949223|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949224|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949226|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949227|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64949275|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64949276|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
64949277|NCT00019409|Methotrexate|methotrexate|mesh-list
64949278|NCT00019409|Vincristine|vincristine|mesh-list
64949279|NCT00019409|Daunorubicin|daunorubicin|mesh-list
64949280|NCT00019409|Asparaginase|asparaginase|mesh-list
64949281|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
64949282|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949283|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
64949284|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949285|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949286|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949287|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
64949288|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949289|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949290|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949335|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
64949336|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949337|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949338|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949339|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
64949340|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949341|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949342|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949343|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64949344|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
64949347|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64949397|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949398|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
64949399|NCT00039468|Thalidomide|thalidomide|mesh-list
64949400|NCT00039468|Irinotecan|irinotecan|mesh-list
64949401|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64949402|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949403|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949404|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949405|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949406|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949407|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
64949408|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949416|NCT00019838|Fludarabine|fludarabine|mesh-list
64949458|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949460|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949461|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64298027|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949462|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949463|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949464|NCT00019994|Aldesleukin|aldesleukin|mesh-list
64298029|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298030|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
64298031|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298032|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298033|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298034|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
64298035|NCT02072083|Ketamine|ketamine|mesh-list
64298036|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64949465|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
64949466|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949467|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949468|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949469|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
64949470|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949471|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64949472|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
64949473|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379353|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
64379354|NCT02589639|Empagliflozin|empagliflozin|mesh-list
64379369|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
64949475|NCT00039663|Pravastatin|pravastatin|mesh-list
64949476|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
64949514|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949515|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949516|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64949517|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64949519|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
64949520|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949521|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64949522|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949578|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949579|NCT00020345|Antiviral Agents|antiviral agents|mesh-ancestor
64949580|NCT00020345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949581|NCT00020345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949582|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949583|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
64949584|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949585|NCT00040053|Ondansetron|ondansetron|mesh-list
64949586|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
64949587|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
64949588|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64949589|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949590|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64949591|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
64949592|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
64949593|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64949594|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
64949595|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64949596|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949597|NCT00040053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64949598|NCT00040053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64949599|NCT00040053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64949600|NCT00040053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64949601|NCT00040053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64949602|NCT00020462|Aldesleukin|aldesleukin|mesh-list
64949603|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949604|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949605|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949606|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
64949607|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949625|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949626|NCT00020501|Antidotes|antidotes|mesh-ancestor
64949627|NCT00020501|Protective Agents|protective agents|mesh-ancestor
64949628|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
64949629|NCT00020501|Vitamins|vitamins|mesh-ancestor
64949630|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
64949631|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949632|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
64949633|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949634|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
64949635|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64949636|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
64949691|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
64949692|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
64949693|NCT00020696|Tirapazamine|tirapazamine|mesh-list
64949694|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949695|NCT02970630|Everolimus|everolimus|mesh-list
64949696|NCT02970630|Tacrolimus|tacrolimus|mesh-list
64949697|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949698|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
64949699|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949700|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64949701|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949702|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949703|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949704|NCT00020735|Toremifene|toremifene|mesh-list
64949705|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64949706|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949707|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64949708|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64949709|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
64949710|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64949711|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949712|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64949713|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
64949714|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949715|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
64949716|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949717|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64949718|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64949736|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949737|NCT00040599|Labetuzumab|labetuzumab|mesh-list
64949738|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949739|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949740|NCT00020930|Cetuximab|cetuximab|mesh-list
64949741|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64949742|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949743|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
64949744|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949745|NCT00040794|Paclitaxel|paclitaxel|mesh-list
64949746|NCT00040794|Carboplatin|carboplatin|mesh-list
64949747|NCT00040794|Gefitinib|gefitinib|mesh-list
64949748|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949749|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949750|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949751|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949752|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949755|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949796|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949797|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64949798|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64949799|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64949800|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64949801|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949802|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64949803|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949804|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949805|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949806|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64949807|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
64949809|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949810|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949811|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949812|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949813|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949853|NCT00041106|Immunologic Factors|immunologic factors|mesh-ancestor
64949854|NCT00041106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949855|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949856|NCT00021320|Paclitaxel|paclitaxel|mesh-list
64949857|NCT00021320|Fluorouracil|fluorouracil|mesh-list
64949858|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64298037|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64949859|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949860|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
64949861|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
64949862|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
64949863|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298038|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298039|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298040|NCT02072083|Analgesics|analgesics|mesh-ancestor
64298041|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
64298042|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298043|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64949864|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
64298044|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64298045|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64379390|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64379391|NCT02151682|Narcotics|narcotics|mesh-ancestor
64379392|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298046|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64298047|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298048|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298049|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64298050|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64949865|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949867|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
64949912|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949913|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64949914|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64949915|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64949916|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
64949917|NCT00021398|Antidotes|antidotes|mesh-ancestor
64949918|NCT00021398|Protective Agents|protective agents|mesh-ancestor
64949919|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
64949920|NCT00021398|Vitamins|vitamins|mesh-ancestor
64949921|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
64949922|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64949923|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
64949924|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64949925|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
64949926|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64949927|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64949928|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949929|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64949930|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64949933|NCT00049023|Octreotide|octreotide|mesh-list
64949965|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64949966|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64949967|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64949968|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64949969|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64949970|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64949971|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64949972|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
64298052|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
64298053|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64298054|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64298055|NCT02070679|Vitamin E|vitamin e|mesh-list
64298056|NCT02070679|Tocopherols|tocopherols|mesh-list
64298057|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
64298059|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
64298060|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298061|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
64298062|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298063|NCT02070679|Protective Agents|protective agents|mesh-ancestor
64298064|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64298065|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
64949973|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64949974|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64949975|NCT00049101|Leucovorin|leucovorin|mesh-list
64949976|NCT00049101|Fluorouracil|fluorouracil|mesh-list
64298066|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64949977|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
64949978|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64949979|NCT00049101|Calcium|calcium|mesh-list
64950023|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950024|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950025|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298067|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64950026|NCT00049296|Thalidomide|thalidomide|mesh-list
64950027|NCT00049296|Docetaxel|docetaxel|mesh-list
64950028|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950029|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
64950030|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950031|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950032|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950033|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950034|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
64950035|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950036|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
64950037|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950038|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950039|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64298068|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64298069|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
64950080|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
64950082|NCT00049413|Pentostatin|pentostatin|mesh-list
64950083|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950085|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950086|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950087|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64298070|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64488893|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64950088|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
64950089|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950091|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950092|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64950143|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64950144|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64950145|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64950150|NCT00049569|Hormones|hormones|mesh-ancestor
64950214|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
64950215|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
64950221|NCT00049725|Daclizumab|daclizumab|mesh-list
64950286|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64950287|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950288|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298071|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298072|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64298073|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64298074|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64298075|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64298076|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298077|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64298078|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64950289|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950359|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
64950360|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950361|NCT00050661|Daclizumab|daclizumab|mesh-list
64950362|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950363|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
64950364|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950365|NCT00050817|Clopidogrel|clopidogrel|mesh-list
64950366|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64950367|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64950423|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950424|NCT00023348|Isoniazid|isoniazid|mesh-list
64950425|NCT00023348|Rifabutin|rifabutin|mesh-list
64950426|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
64950427|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298079|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298080|NCT02072317|Raltitrexed|raltitrexed|mesh-list
64298081|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298082|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
64298083|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298084|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379407|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298085|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64298086|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298087|NCT01651000|Calcifediol|calcifediol|mesh-list
64298088|NCT01651000|Vitamins|vitamins|mesh-ancestor
64298089|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
64298090|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298091|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64298092|NCT02469610|Bupivacaine|bupivacaine|mesh-list
64298093|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
64298094|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
64298095|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298096|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298097|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
64298098|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64950428|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950429|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64950430|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64950431|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
64950432|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950433|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64950434|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64950436|NCT00050895|Lopinavir|lopinavir|mesh-list
64950481|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64950482|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
64950483|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
64950484|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64950485|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64950486|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64950548|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950549|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64950622|NCT00398034|Androgens|androgens|mesh-ancestor
64950623|NCT00398034|Hormones|hormones|mesh-ancestor
64950624|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64950625|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950692|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950693|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950694|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64950761|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64950762|NCT00024245|Renal Agents|renal agents|mesh-ancestor
64950764|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950765|NCT00024284|Carboplatin|carboplatin|mesh-list
64950766|NCT00024284|Irinotecan|irinotecan|mesh-list
64950767|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950768|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64950769|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64950770|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950771|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950772|NCT00052026|Carvedilol|carvedilol|mesh-list
64298101|NCT02071069|Cetuximab|cetuximab|mesh-list
64298102|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
64950773|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64379490|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
64379491|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379492|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379493|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
64379494|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379552|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64950774|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64950775|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
64950776|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64950777|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64950778|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950779|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64950780|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
64950781|NCT00052026|Protective Agents|protective agents|mesh-ancestor
64950782|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64950815|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
64950816|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64950817|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
64950818|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64950819|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
64950821|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
64950886|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64950887|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
64950888|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64950889|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298103|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298104|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298106|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298107|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
64950957|NCT00395252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64950958|NCT00395252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64950959|NCT00395252|Immunologic Factors|immunologic factors|mesh-ancestor
64950960|NCT00395252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951027|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
64951028|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951029|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951030|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
64951098|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951099|NCT00053001|Growth Substances|growth substances|mesh-ancestor
64951100|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951101|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951103|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
64951104|NCT00025103|Melphalan|melphalan|mesh-list
64951105|NCT00025103|Carboplatin|carboplatin|mesh-list
64951106|NCT00025103|Doxorubicin|doxorubicin|mesh-list
64951107|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64951164|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64951239|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64951240|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
64951241|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951242|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64951243|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64951244|NCT00025337|Growth Substances|growth substances|mesh-ancestor
64951245|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951246|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
64951247|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
64951248|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
64951249|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951250|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64951251|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951252|NCT00025337|Antidotes|antidotes|mesh-ancestor
64951301|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951302|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64951303|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951304|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64951305|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951306|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951308|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951369|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
64951370|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951371|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64379553|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64379576|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
64379577|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379579|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
64951434|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951435|NCT00026078|Docetaxel|docetaxel|mesh-list
64951436|NCT00026078|Ifosfamide|ifosfamide|mesh-list
64951437|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951438|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
64951439|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
64951440|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
64951441|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951442|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64951443|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
64951444|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64951447|NCT00026156|Docetaxel|docetaxel|mesh-list
64951498|NCT00054288|Antiviral Agents|antiviral agents|mesh-ancestor
64951499|NCT00054288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951500|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64951501|NCT00054288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64951502|NCT00054288|Immunologic Factors|immunologic factors|mesh-ancestor
64951503|NCT00054288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951504|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64951505|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64951564|NCT00054483|Bortezomib|bortezomib|mesh-list
64951565|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951566|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
64951567|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951634|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
64951635|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951705|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64951706|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64951707|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64951708|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
64951709|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951710|NCT00055302|Anastrozole|anastrozole|mesh-list
64951773|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64951774|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951775|NCT00027521|Bleomycin|bleomycin|mesh-list
64951776|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64951777|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951845|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
64951846|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
64951847|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64951848|NCT00055809|Bevacizumab|bevacizumab|mesh-list
64951849|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64951850|NCT00055809|Antibodies|antibodies|mesh-list
64951851|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
64951852|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64379582|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64951915|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64951916|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951917|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
64951920|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298108|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951986|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298109|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64298110|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64298111|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298112|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64298113|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
64298114|NCT02076373|Hematinics|hematinics|mesh-ancestor
64951987|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64951988|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64951989|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64951994|NCT04730973|Evolocumab|evolocumab|mesh-list
64952056|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64952057|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952058|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952059|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
64952060|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
64952061|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
64952062|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
64952063|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64952110|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952176|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952177|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64952178|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952179|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
64952180|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952181|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
64952182|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64952183|NCT00398463|Protective Agents|protective agents|mesh-ancestor
64952234|NCT00423696|Leucovorin|leucovorin|mesh-list
64952235|NCT00423696|Bevacizumab|bevacizumab|mesh-list
64952236|NCT00423696|Fluorouracil|fluorouracil|mesh-list
64952237|NCT00423696|Capecitabine|capecitabine|mesh-list
64952238|NCT00423696|Irinotecan|irinotecan|mesh-list
64952239|NCT00423696|Calcium|calcium|mesh-list
64952240|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
64952241|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64952242|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952243|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64952244|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64952245|NCT00423696|Growth Substances|growth substances|mesh-ancestor
64952249|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
64379641|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379642|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64952300|NCT00029822|Alfuzosin|alfuzosin|mesh-list
64952301|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64379643|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379644|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64379645|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64379719|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379720|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379721|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
64379754|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64379755|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
64379760|NCT05553093|Hormones|hormones|mesh-ancestor
64952302|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64952370|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
64952371|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952372|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952444|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64952445|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64952446|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64952448|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952513|NCT00057798|Vinorelbine|vinorelbine|mesh-list
64952514|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952590|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64298115|NCT02072785|Vincristine|vincristine|mesh-list
64298116|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64298117|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298118|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
64952591|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64952592|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952593|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952594|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64952595|NCT00030875|Bortezomib|bortezomib|mesh-list
64952596|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64503405|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64952597|NCT00058071|Amifostine|amifostine|mesh-list
64503406|NCT01601236|Hormones|hormones|mesh-ancestor
64491384|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64952598|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64952599|NCT00058071|Protective Agents|protective agents|mesh-ancestor
64952600|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952602|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64952644|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64952645|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
64952647|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952715|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64952716|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64952718|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
64952786|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
64952787|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952788|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952789|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64952790|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64298120|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
64298121|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298122|NCT02469298|Oseltamivir|oseltamivir|mesh-list
64298123|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
64298124|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298125|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952791|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64952792|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64952793|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952794|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64952795|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952796|NCT00058968|Analgesics|analgesics|mesh-ancestor
64952847|NCT00031616|Brivudine|brivudine|mesh-list
64952848|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
64952849|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
64952850|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64952851|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64952852|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64952853|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64952854|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
64952855|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64952856|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
64952857|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64952858|NCT00031655|Cyclosporine|cyclosporine|mesh-list
64952859|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
64952860|NCT00031655|Fludarabine|fludarabine|mesh-list
64952909|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64952978|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
64952979|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64952980|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953047|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953048|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953049|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953052|NCT00032279|Visilizumab|visilizumab|mesh-list
64953121|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953122|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953123|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953127|NCT00060411|Vitamins|vitamins|mesh-ancestor
64953189|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64953190|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64953191|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953192|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64953193|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
64953195|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953257|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953258|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64953259|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64953260|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64953261|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
64953262|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953324|NCT00033254|Growth Substances|growth substances|mesh-ancestor
64953325|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
64953326|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953328|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64953329|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
64953330|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953331|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953332|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64953333|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64953334|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
64503420|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64503421|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
64953335|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64953336|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379813|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379815|NCT02109562|Risperidone|risperidone|mesh-list
64953348|NCT00033332|Hormones|hormones|mesh-ancestor
64953382|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64953383|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64953384|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953385|NCT00033449|Gefitinib|gefitinib|mesh-list
64953386|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953387|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64953388|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953389|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953390|NCT00061152|Capsaicin|capsaicin|mesh-list
64298126|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298127|NCT02076451|DS-8273a|ds-8273a|mesh-list
64298128|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64298129|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298130|NCT02071303|Celecoxib|celecoxib|mesh-list
64953391|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
64953392|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
64953393|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
64953394|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953395|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953396|NCT00033566|S 3304|s 3304|mesh-list
64953442|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64953444|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64953513|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64953514|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64953516|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
64953517|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64953579|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
64953580|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953581|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64953582|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64953583|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64953584|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953585|NCT00396500|Vitamin A|vitamin a|mesh-list
64953586|NCT00396500|Albendazole|albendazole|mesh-list
64953587|NCT00396500|Vitamins|vitamins|mesh-ancestor
64953588|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
64953645|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64953646|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953647|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64953648|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
64953714|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953715|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64953784|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953785|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953786|NCT00062244|Oblimersen|oblimersen|mesh-list
64953787|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64953788|NCT00035009|Aprepitant|aprepitant|mesh-list
64953851|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64953852|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953853|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64953854|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
64953920|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64953921|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64953922|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
64503434|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503435|NCT03347916|Gabapentin|gabapentin|mesh-list
64503436|NCT03347916|Analgesics|analgesics|mesh-ancestor
64953990|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64953991|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64953992|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64953993|NCT00035984|Incretins|incretins|mesh-ancestor
64953994|NCT00035984|Hormones|hormones|mesh-ancestor
64379874|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379875|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379876|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64379877|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64379878|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64953995|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64953996|NCT00063141|Irinotecan|irinotecan|mesh-list
64953997|NCT00063141|Cetuximab|cetuximab|mesh-list
64954004|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
64954053|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64954054|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64954059|NCT00036335|Analgesics|analgesics|mesh-ancestor
64954125|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
64298132|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64954126|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
64298133|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298134|NCT02071303|Analgesics|analgesics|mesh-ancestor
64298135|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
64954127|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954129|NCT00063726|Bortezomib|bortezomib|mesh-list
64954197|NCT00037115|Methotrexate|methotrexate|mesh-list
64954198|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64954199|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
64954200|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64954201|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954202|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954203|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
64954204|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954261|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954262|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
64954263|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64954264|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954331|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64954332|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
64954400|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
64954401|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64954402|NCT00398658|Clindamycin|clindamycin|mesh-list
64954403|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
64954404|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
64954405|NCT00398658|Gentamicins|gentamicins|mesh-list
64954406|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64954407|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64954408|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64954409|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954410|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954411|NCT00038207|Vincristine|vincristine|mesh-list
64954412|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64954413|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954414|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
64954415|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
64954416|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
64954418|NCT00398697|Gemcitabine|gemcitabine|mesh-list
64954457|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954458|NCT00065559|Celecoxib|celecoxib|mesh-list
64954529|NCT00069966|Pixantrone|pixantrone|mesh-list
64954530|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954531|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379904|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
64954532|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
64954533|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954534|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298137|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298138|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64298139|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298140|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64954599|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64954600|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
64954601|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954602|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954603|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64954668|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64954679|NCT00066339|Gefitinib|gefitinib|mesh-list
64954742|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64954743|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64954744|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
64954815|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64954816|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
64954817|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503448|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954888|NCT00066846|Bevacizumab|bevacizumab|mesh-list
64954889|NCT00066846|Fluorouracil|fluorouracil|mesh-list
64298141|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64381414|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381415|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381416|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64381417|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64954891|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
64954892|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64954893|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64954894|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64954895|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64954896|NCT00066846|Growth Substances|growth substances|mesh-ancestor
64954897|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64954898|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
64954952|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
64381418|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381419|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381420|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381421|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64381422|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64381423|NCT03187457|Metronidazole|metronidazole|mesh-list
64381424|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381425|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381426|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64381447|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
64381448|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379928|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64381449|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381450|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64381451|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64381452|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64381453|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381454|NCT05532111|Hormones|hormones|mesh-ancestor
64381455|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381456|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64381457|NCT04299867|Metronidazole|metronidazole|mesh-list
64381458|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381459|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381460|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64381461|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64381462|NCT02433587|Aspirin|aspirin|mesh-list
64381463|NCT02433587|Clopidogrel|clopidogrel|mesh-list
64381464|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64381465|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64381466|NCT02433587|Analgesics|analgesics|mesh-ancestor
64381467|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
64381468|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381469|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381470|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381471|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381472|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64381473|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64381474|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381475|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64381476|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64381477|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64954953|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64954954|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64955022|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955023|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
64955024|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955025|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64955026|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64955089|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
64955090|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955163|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64955164|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64955165|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64955166|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64955167|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64955169|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64955232|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
64955233|NCT01331018|Lenograstim|lenograstim|mesh-list
64955234|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64955235|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
64955236|NCT01331018|Hormones|hormones|mesh-ancestor
64955237|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64955238|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955239|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64955240|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955241|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64955298|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
64955299|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380069|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64380070|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64380072|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380102|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955300|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955367|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
64955368|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955369|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955370|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503518|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64503519|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64503521|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
64298142|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298143|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298144|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298145|NCT02071303|Narcotics|narcotics|mesh-ancestor
64298146|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298147|NCT02076529|Ramosetron|ramosetron|mesh-list
64381478|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
64381479|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64381480|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64381481|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64381482|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
64381483|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381484|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64381485|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64381486|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64381487|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64381488|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381489|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381490|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381491|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64381492|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
64381493|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64381494|NCT05307627|Naltrexone|naltrexone|mesh-list
64381495|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64381496|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64381497|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381498|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
64381499|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381500|NCT03190733|Fludarabine|fludarabine|mesh-list
64503522|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64503523|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64503524|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
64503525|NCT02378298|Hormones|hormones|mesh-ancestor
64503526|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64503527|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64503528|NCT02378298|Protective Agents|protective agents|mesh-ancestor
64380111|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503529|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64503530|NCT02253108|Everolimus|everolimus|mesh-list
64503581|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64503582|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
64503583|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64503584|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64503648|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64503649|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503650|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64503651|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64503652|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64503653|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
64503655|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
64503656|NCT01650298|Coagulants|coagulants|mesh-ancestor
64503657|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
64503658|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64503711|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64503712|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
64503713|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
64955376|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
64955377|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64503781|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64503782|NCT02516436|Narcotics|narcotics|mesh-ancestor
64503789|NCT03347526|Vigabatrin|vigabatrin|mesh-list
64503856|NCT02506998|Histamine|histamine|mesh-list
64503857|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
64503930|NCT02506842|Fluorouracil|fluorouracil|mesh-list
64503931|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
64503932|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
64503933|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504001|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
64504002|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298149|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
64504003|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504004|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64504005|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504006|NCT02506140|Aspirin|aspirin|mesh-list
64504007|NCT02506140|Clopidogrel|clopidogrel|mesh-list
64504008|NCT02506140|Ticagrelor|ticagrelor|mesh-list
64504009|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64504063|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504064|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504065|NCT02511366|Caseins|caseins|mesh-list
64504066|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
64504067|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
64504068|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298150|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64504069|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
64504070|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64504071|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504072|NCT04443036|Paclitaxel|paclitaxel|mesh-list
64504129|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504130|NCT04499118|Paclitaxel|paclitaxel|mesh-list
64504200|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504201|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
64504202|NCT02505282|Coagulants|coagulants|mesh-ancestor
64504276|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64380213|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504277|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504278|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64504348|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504421|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64504422|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
64504423|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504424|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504425|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64504426|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64504427|NCT02508246|Cisplatin|cisplatin|mesh-list
64504428|NCT02508246|Docetaxel|docetaxel|mesh-list
64504429|NCT02508246|Adavosertib|adavosertib|mesh-list
64504430|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504431|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
64504432|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
64504433|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
64298151|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504436|NCT01617148|Aflibercept|aflibercept|mesh-list
64298152|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298153|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64298154|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
64298155|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298156|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298157|NCT02411578|Glucagon|glucagon|mesh-list
64298158|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64298159|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298160|NCT02411578|Hormones|hormones|mesh-ancestor
64504485|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
64504486|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380294|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380295|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64380296|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64380297|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380326|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
64380327|NCT04677855|Hormones|hormones|mesh-ancestor
64380328|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380329|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380330|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64380331|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380332|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64380333|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64380334|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64504487|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504488|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64504489|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64504490|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64504491|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64504492|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504550|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64504551|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64504552|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64504553|NCT01705288|Morphine|morphine|mesh-list
64504554|NCT01705288|Narcotics|narcotics|mesh-list
64504555|NCT01705288|Anesthetics|anesthetics|mesh-list
64504556|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64504557|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64504558|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64504559|NCT01705288|Analgesics|analgesics|mesh-ancestor
64298161|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504616|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64955393|NCT00202423|Nabiximols|nabiximols|mesh-list
64504617|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504618|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
64504620|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64504626|NCT03344094|Interferons|interferons|mesh-list
64504686|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64298162|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298163|NCT02411578|Incretins|incretins|mesh-ancestor
64298164|NCT02076685|Isoniazid|isoniazid|mesh-list
64298165|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
64298166|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298167|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298168|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64298169|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64298170|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
64298171|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298173|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
64298174|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
64298175|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
64298176|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298177|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504687|NCT03341988|Ritonavir|ritonavir|mesh-list
64504688|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64504689|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64380388|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
64380389|NCT04062201|Levofloxacin|levofloxacin|mesh-list
64298178|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64504690|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
64504691|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64955394|NCT00202423|Analgesics|analgesics|mesh-ancestor
64955395|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
64504692|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504693|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64504694|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64504695|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
64504696|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504697|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64504748|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64504749|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64504822|NCT05118490|Rifapentine|rifapentine|mesh-list
64504823|NCT05118490|Rifampin|rifampin|mesh-list
64504824|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
64504825|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64504826|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64504827|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64504828|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64504829|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
64504888|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504889|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64504890|NCT04898920|Dexamethasone|dexamethasone|mesh-list
64504891|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64504892|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
64504893|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
64504957|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64504958|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64504959|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
64504960|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64504961|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64504962|NCT01690546|Naltrexone|naltrexone|mesh-list
64504963|NCT01690546|Buprenorphine|buprenorphine|mesh-list
64504964|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64504965|NCT01690546|Naloxone|naloxone|mesh-list
64504966|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64505024|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64505025|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505026|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64505027|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64505028|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
64505029|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505030|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64505032|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505094|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
64505095|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
64505096|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64505097|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64505098|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64505099|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64505100|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
64505101|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505102|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380510|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
64380511|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380512|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380513|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
64380514|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380515|NCT03496779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505103|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
64505104|NCT04461418|Hormones|hormones|mesh-ancestor
64298179|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
64505105|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505106|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505107|NCT04305496|Fulvestrant|fulvestrant|mesh-list
64505108|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64505109|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505110|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64505111|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64505112|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
64505113|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505142|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64955400|NCT00202462|Hormones|hormones|mesh-ancestor
64955401|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505144|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505145|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505146|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64505147|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64505148|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
64505202|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505203|NCT03120468|Protective Agents|protective agents|mesh-ancestor
64505204|NCT03120468|Antidotes|antidotes|mesh-ancestor
64505205|NCT01712230|Leuprolide|leuprolide|mesh-list
64505267|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505268|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64505269|NCT04494828|Analgesics|analgesics|mesh-ancestor
64505270|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
64505271|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505272|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64505273|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64505274|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64505275|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
64505276|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505277|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298195|NCT02071537|Chloroquine|chloroquine|mesh-list
64298196|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64298197|NCT02071537|Carboplatin|carboplatin|mesh-list
64298198|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298199|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298200|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
64298201|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298202|NCT02071537|Antiviral Agents|antiviral agents|mesh-ancestor
64298203|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298204|NCT02071537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380557|NCT00591227|Insulin|insulin|mesh-list
64298205|NCT02071537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298206|NCT02071537|Immunologic Factors|immunologic factors|mesh-ancestor
64298207|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298208|NCT02071537|Amebicides|amebicides|mesh-ancestor
64298209|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64298210|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64505278|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
64505330|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505331|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64505332|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64505333|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505334|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505335|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64505336|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
64505337|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64505338|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505339|NCT02491242|Dolutegravir|dolutegravir|mesh-list
64505340|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64505341|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64505342|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505343|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505344|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64505387|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64505460|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
64505461|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505462|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64505463|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64505464|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64505465|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64505466|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64505467|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64505468|NCT03329118|Simvastatin|simvastatin|mesh-list
64505469|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64505522|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64505523|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64505524|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505592|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505593|NCT03109080|Olaparib|olaparib|mesh-list
64505594|NCT03109080|Adenosine|adenosine|mesh-list
64505595|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64505596|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505597|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505598|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505599|NCT03109080|Analgesics|analgesics|mesh-ancestor
64505600|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
64505601|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505602|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505652|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
64505653|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
64505654|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505655|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505658|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64505659|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64505660|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505661|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505662|NCT02492178|Artesunate|artesunate|mesh-list
64505663|NCT02492178|Quinine|quinine|mesh-list
64505664|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
64380762|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505669|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
64505719|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505720|NCT03469492|Insulin|insulin|mesh-list
64505721|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64505722|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505723|NCT03331770|Latanoprost|latanoprost|mesh-list
64505724|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64505725|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64505726|NCT05469412|Midazolam|midazolam|mesh-list
64505736|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
64505786|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505787|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64505857|NCT03320538|Rabeprazole|rabeprazole|mesh-list
64505858|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64505859|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64505860|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64505861|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505862|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64505863|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
64505864|NCT03322878|Analgesics|analgesics|mesh-ancestor
64505865|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
64505866|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505867|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64505868|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
64298213|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64298214|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298215|NCT02071537|Analgesics|analgesics|mesh-ancestor
64298216|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
64298217|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298218|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64505869|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64505870|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64505872|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64505873|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64505913|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
64505914|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64505915|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64505916|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64505917|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
64505918|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298220|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
64298221|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
64298222|NCT02076841|Interferons|interferons|mesh-list
64298223|NCT02076841|Interferon-beta|interferon-beta|mesh-list
64298224|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
64505919|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64505922|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
64505923|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64505924|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64505925|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64505926|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64380809|NCT03189953|Incretins|incretins|mesh-ancestor
64380810|NCT03189953|Hormones|hormones|mesh-ancestor
64380842|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380843|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64380844|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64380845|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
64380846|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380848|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64380849|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
64380854|NCT02441933|Taxane|taxane|mesh-list
64505927|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
64505973|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64505974|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64506048|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506049|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64506050|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64506051|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
64506111|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
64506113|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64506114|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64506115|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64506116|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64506117|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
64506118|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506119|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506172|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506173|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64506241|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506242|NCT05113186|Lenvatinib|lenvatinib|mesh-list
64506243|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506244|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64506312|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64506314|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64506316|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64506317|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
64506318|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506319|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506381|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64506382|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64506383|NCT03315000|Fluticasone|fluticasone|mesh-list
64506385|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64506394|NCT02482818|Pregabalin|pregabalin|mesh-list
64506453|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506454|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
64506455|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64955433|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64506512|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64506513|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506514|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506515|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
64506516|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64506517|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64506518|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64506519|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380884|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380885|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64380886|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380887|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506520|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506521|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
64506522|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64506523|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506524|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64506525|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506526|NCT01810666|Factor VIII|factor viii|mesh-list
64506527|NCT01810666|Coagulants|coagulants|mesh-ancestor
64506529|NCT02482272|Adefovir|adefovir|mesh-list
64506530|NCT02482272|Entecavir|entecavir|mesh-list
64506531|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64955442|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64506532|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64506533|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506534|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506535|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
64506536|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506537|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64506538|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64506539|NCT01766440|Calcitriol|calcitriol|mesh-list
64506540|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64506541|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506542|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64506554|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
64506555|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
64506556|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64506557|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506558|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506622|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506623|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506624|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506625|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64506627|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506628|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64506629|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64506630|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64506631|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506632|NCT02485548|Fluorouracil|fluorouracil|mesh-list
64506633|NCT02485548|Raltitrexed|raltitrexed|mesh-list
64298225|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506634|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506635|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
64506636|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506680|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955447|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64506681|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64506683|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506684|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506685|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
64506686|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506687|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64506688|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506689|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
64506690|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380948|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64380949|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64380950|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64506691|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64506693|NCT01769170|Brincidofovir|brincidofovir|mesh-list
64506694|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
64506695|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506696|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506697|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506733|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506734|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
64506735|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506736|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506738|NCT02480400|Citalopram|citalopram|mesh-list
64298226|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
64298227|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298228|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
64298229|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298230|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64298231|NCT02442310|Deferiprone|deferiprone|mesh-list
64298232|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64298233|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
64298234|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
64298235|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298236|NCT02071615|Caffeine|caffeine|mesh-list
64298237|NCT02071615|Methylphenidate|methylphenidate|mesh-list
64298238|NCT02071615|Modafinil|modafinil|mesh-list
64298239|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64298240|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298241|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64506739|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64506757|NCT02725710|Gabapentin|gabapentin|mesh-list
64506800|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64506801|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64506802|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64506869|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64506871|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64506872|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506873|NCT02472600|Colistin|colistin|mesh-list
64506874|NCT02472600|Polymyxins|polymyxins|mesh-list
64506875|NCT02472600|Neomycin|neomycin|mesh-list
64506876|NCT02472600|Omeprazole|omeprazole|mesh-list
64506877|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64506878|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506879|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64506880|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506881|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506882|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298242|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298243|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506929|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64506930|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506931|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381057|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
64381058|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381059|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381060|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64381061|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
64381062|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
64381063|NCT05534685|Hormones|hormones|mesh-ancestor
64381064|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381065|NCT04303689|Colchicine|colchicine|mesh-list
64506932|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64506934|NCT01746238|Doxorubicin|doxorubicin|mesh-list
64506935|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64506936|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64506937|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64506938|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64506939|NCT01746238|Growth Substances|growth substances|mesh-ancestor
64506940|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506941|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
64298244|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64298245|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64506942|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64506943|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64506944|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64506945|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506946|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506947|NCT02472054|Cyclosporine|cyclosporine|mesh-list
64506948|NCT02472054|Prednisolone|prednisolone|mesh-list
64506949|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64506950|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
64506951|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64506952|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
64506953|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
64506954|NCT02472054|Cyclosporins|cyclosporins|mesh-list
64506955|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64506956|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
64506957|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64506958|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506959|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64506974|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
64506975|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64955454|NCT00071838|Daclizumab|daclizumab|mesh-list
64506976|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64506977|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64506978|NCT02472054|Protective Agents|protective agents|mesh-ancestor
64506979|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64506980|NCT01782898|Esmolol|esmolol|mesh-list
64506981|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64506982|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64381108|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
64381109|NCT02436395|Povidone|povidone|mesh-list
64381110|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
64381111|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
64381112|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64381113|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381114|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64381115|NCT02436083|Cefuroxime|cefuroxime|mesh-list
64506983|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64506984|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
64506985|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298246|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
64298247|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298251|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
64298320|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
64298321|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298322|NCT02074267|Gabapentin|gabapentin|mesh-list
64298323|NCT02074267|Analgesics|analgesics|mesh-ancestor
64298324|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
64298326|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298327|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
64506986|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64506987|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64506989|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
64507029|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507030|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
64507031|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
64507032|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507033|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507034|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507035|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
64507036|NCT02725008|Hormones|hormones|mesh-ancestor
64507037|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507038|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64507039|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507040|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
64507041|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507043|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
64507044|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64507045|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507046|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507047|NCT02471820|Dexamethasone|dexamethasone|mesh-list
64507048|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
64955455|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64507049|NCT02471820|Lenalidomide|lenalidomide|mesh-list
64507050|NCT02471820|Doxorubicin|doxorubicin|mesh-list
64507051|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64507053|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507054|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
64507055|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
64507056|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507057|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507058|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507059|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
64507060|NCT02471820|Hormones|hormones|mesh-ancestor
64507061|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507072|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64507073|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64507074|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64381163|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381164|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
64381165|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64381166|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64507075|NCT02477280|Methylphenidate|methylphenidate|mesh-list
64507076|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64507077|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507078|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64507079|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64507080|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507081|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507082|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
64507083|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507130|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
64507131|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
64507132|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507201|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64507202|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507203|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
64507204|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64507205|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64507206|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64507207|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
64507208|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507209|NCT01806779|Bupropion|bupropion|mesh-list
64507210|NCT01806779|Nicotine|nicotine|mesh-list
64507211|NCT01806779|Varenicline|varenicline|mesh-list
64507212|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64507264|NCT01806545|Coagulants|coagulants|mesh-ancestor
64507265|NCT01847014|Macitentan|macitentan|mesh-list
64507266|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64955459|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
64507267|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64955460|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507268|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507269|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64507270|NCT01847638|Nepafenac|nepafenac|mesh-list
64507271|NCT01847638|Bromfenac|bromfenac|mesh-list
64507272|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64507273|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64507274|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64298328|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64298329|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64298330|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298331|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64298332|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64298333|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64298334|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507275|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64507277|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
64507278|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507279|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507280|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507281|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507282|NCT05329090|Rituximab|rituximab|mesh-list
64507283|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507284|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507285|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
64507286|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507287|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507288|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
64507289|NCT02474628|Calcium|calcium|mesh-list
64507290|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64507291|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507292|NCT02474628|Antacids|antacids|mesh-ancestor
64381167|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64507293|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507294|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64507302|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507303|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507304|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
64507305|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64507306|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64507307|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64507308|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507309|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507310|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
64507311|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507312|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507313|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64507314|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507316|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64507317|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
64507318|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64507319|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64507320|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64507321|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
64507322|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507323|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507324|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507325|NCT01797484|Ranolazine|ranolazine|mesh-list
64507326|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64507327|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507328|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298335|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507329|NCT01798264|Exenatide|exenatide|mesh-list
64507330|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507331|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507333|NCT01798264|Incretins|incretins|mesh-ancestor
64507346|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64507347|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507348|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
64507349|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64507350|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
64507352|NCT01782131|Posaconazole|posaconazole|mesh-list
64507353|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
64507354|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507355|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64507356|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507357|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507358|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507359|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64507406|NCT01856530|Oxytocin|oxytocin|mesh-list
64298336|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
64298337|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64298338|NCT02077777|Mesalamine|mesalamine|mesh-list
64298339|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64298340|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298341|NCT02077777|Analgesics|analgesics|mesh-ancestor
64298342|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
64298343|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298344|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298345|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64298346|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298347|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
64381187|NCT02435537|Analgesics|analgesics|mesh-ancestor
64507408|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64507409|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507410|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
64507412|NCT05302336|Doxorubicin|doxorubicin|mesh-list
64507413|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64507414|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955461|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64955462|NCT00202891|Sisomicin|sisomicin|mesh-list
64507415|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
64507416|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955463|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64507417|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507418|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64507419|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
64507420|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507421|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507462|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64507463|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507464|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64507465|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64507466|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64507467|NCT01766128|Zonisamide|zonisamide|mesh-list
64507468|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
64507469|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64507470|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507471|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298357|NCT03298191|Ritodrine|ritodrine|mesh-list
64298358|NCT03298191|Calcium|calcium|mesh-list
64298359|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64298360|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298362|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
64298363|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298364|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
64298365|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298366|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64298367|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
64298368|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64298369|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298370|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
64298371|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64298372|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
64298373|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
64507472|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64507473|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507474|NCT02859558|Tenofovir|tenofovir|mesh-list
64507475|NCT02859558|Emtricitabine|emtricitabine|mesh-list
64507476|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64507477|NCT02859558|Cobicistat|cobicistat|mesh-list
64507478|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64507479|NCT02859558|Elvitegravir|elvitegravir|mesh-list
64507480|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64507481|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
64507482|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507483|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64507513|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507514|NCT00704808|Temozolomide|temozolomide|mesh-list
64507515|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64507585|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64507586|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507587|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64381207|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64381208|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381209|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
64381210|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381211|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64381213|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64507588|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64507589|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64507590|NCT01866592|Adalimumab|adalimumab|mesh-list
64507591|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507592|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507593|NCT01375608|Decitabine|decitabine|mesh-list
64507594|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64507595|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
64507596|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507598|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507599|NCT01868776|Lidocaine|lidocaine|mesh-list
64507600|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
64507601|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
64298374|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64298375|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64298376|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64298377|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
64298378|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298379|NCT01369615|Oxycodone|oxycodone|mesh-list
64507602|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507603|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507604|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
64507605|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507606|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64507607|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64507608|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64507609|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64507610|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507611|NCT00704418|Bromfenac|bromfenac|mesh-list
64507612|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64507613|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64507614|NCT00704418|Analgesics|analgesics|mesh-ancestor
64507615|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
64507618|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64507627|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507628|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64507629|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64507630|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
64507631|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507632|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64507633|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64507634|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64507635|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64507637|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
64507638|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507639|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64955466|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298380|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298381|NCT01369615|Narcotics|narcotics|mesh-ancestor
64298382|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298383|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298384|NCT01369615|Analgesics|analgesics|mesh-ancestor
64298385|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
64298386|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298387|NCT02077933|Everolimus|everolimus|mesh-list
64298388|NCT02077933|Exemestane|exemestane|mesh-list
64298389|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64955467|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381214|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507640|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
64507641|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507642|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64507643|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507644|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64507645|NCT04837066|Imidacloprid|imidacloprid|mesh-list
64507646|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
64507647|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507648|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507649|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507650|NCT04807894|Testosterone|testosterone|mesh-list
64507651|NCT04807894|Androgens|androgens|mesh-ancestor
64507652|NCT04807894|Hormones|hormones|mesh-ancestor
64507653|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298390|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298391|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
64298392|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298393|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64298394|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64298395|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298396|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298397|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64298398|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
64298399|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298401|NCT02078089|Morphine|morphine|mesh-list
64298402|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298403|NCT02078089|Narcotics|narcotics|mesh-ancestor
64298404|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64507655|NCT01874392|Insulin|insulin|mesh-list
64507656|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64507657|NCT01874392|Pancrelipase|pancrelipase|mesh-list
64507658|NCT01874392|Pancreatin|pancreatin|mesh-list
64507659|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507661|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381229|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381230|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381231|NCT03189329|Lidocaine|lidocaine|mesh-list
64381232|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
64381233|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
64381234|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
64381235|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381236|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381237|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
64381238|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381239|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64381272|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64381273|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381274|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64381275|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64507662|NCT00576654|Irinotecan|irinotecan|mesh-list
64507663|NCT00576654|Camptothecin|camptothecin|mesh-list
64507664|NCT00576654|Veliparib|veliparib|mesh-list
64507665|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64507666|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64507667|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507668|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507669|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507670|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64507671|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64507673|NCT05542264|Risperidone|risperidone|mesh-list
64507674|NCT05542264|Aripiprazole|aripiprazole|mesh-list
64507675|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64507676|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
64507677|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64507678|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
64507679|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64507681|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507716|NCT02473302|Tocotrienols|tocotrienols|mesh-list
64507717|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
64507718|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
64507719|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507720|NCT02473302|Protective Agents|protective agents|mesh-ancestor
64507721|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507722|NCT02473302|Vitamins|vitamins|mesh-ancestor
64507723|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
64507724|NCT05747326|Capecitabine|capecitabine|mesh-list
64507725|NCT05747326|Vinorelbine|vinorelbine|mesh-list
64507726|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64298405|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298406|NCT02078089|Analgesics|analgesics|mesh-ancestor
64298407|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
64507727|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
64298408|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298409|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
64298410|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64298411|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64298412|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64298413|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298414|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64298415|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64298416|NCT02074891|Tenofovir|tenofovir|mesh-list
64298417|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
64298418|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298419|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64507729|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507730|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64507731|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
64507732|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
64507733|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
64507734|NCT03108300|Doxorubicin|doxorubicin|mesh-list
64507735|NCT03108300|Propranolol|propranolol|mesh-list
64507736|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64507737|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507738|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64507739|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64298420|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64298421|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381285|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
64381286|NCT03188159|Vinorelbine|vinorelbine|mesh-list
64381287|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64381288|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381289|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
64298422|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298423|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64298424|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64298426|NCT02078167|Red yeast rice|red yeast rice|mesh-list
64298427|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64298428|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64298429|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64298430|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
64298431|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298432|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298433|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64298434|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64298435|NCT02078323|Linaclotide|linaclotide|mesh-list
64507740|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507741|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507742|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64507743|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64507744|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
64507761|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507762|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507763|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64507764|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64507765|NCT03832894|Estradiol|estradiol|mesh-list
64507766|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64507767|NCT03832894|Progesterone|progesterone|mesh-list
64507768|NCT03832894|Estrogens|estrogens|mesh-ancestor
64507769|NCT03832894|Hormones|hormones|mesh-ancestor
64507770|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507771|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507773|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
64507822|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64507823|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64507825|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507826|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
64507828|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64507829|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507830|NCT03310242|Vitamin D|vitamin d|mesh-list
64507831|NCT03310242|Vitamins|vitamins|mesh-ancestor
64298437|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
64298438|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298439|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64298440|NCT02075749|Triamcinolone|triamcinolone|mesh-list
64298441|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64298442|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64298443|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64298444|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64298445|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
64298446|NCT02075749|Hormones|hormones|mesh-ancestor
64298447|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298448|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298449|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64298450|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
64298451|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298452|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381373|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64381374|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298453|NCT02081287|Inositol|inositol|mesh-list
64507833|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507834|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64507835|NCT00557128|Lisinopril|lisinopril|mesh-list
64507836|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64507837|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
64507838|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507839|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507840|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64507841|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64507842|NCT00557128|Protective Agents|protective agents|mesh-ancestor
64507843|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507844|NCT03312582|Metformin|metformin|mesh-list
64507845|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64507847|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
64507870|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64507871|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507873|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64507874|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507875|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64507876|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507877|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507878|NCT00557830|Sorafenib|sorafenib|mesh-list
64298454|NCT02081287|Lamotrigine|lamotrigine|mesh-list
64298455|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
64298456|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64298457|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64298458|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298459|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64298460|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298461|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64507879|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507880|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64507881|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64507882|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507883|NCT00557440|Fluticasone|fluticasone|mesh-list
64507885|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
64507886|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64507926|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64507927|NCT02468856|Modafinil|modafinil|mesh-list
64507928|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64507929|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507930|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64507931|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64507932|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64507933|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507935|NCT05224336|Psilocybin|psilocybin|mesh-list
64507936|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64381375|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381376|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
64381377|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
64381378|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64381379|NCT02433899|Dexamethasone|dexamethasone|mesh-list
64381380|NCT02433899|Epinephrine|epinephrine|mesh-list
64381445|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381446|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64381512|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381513|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381515|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64955475|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64507937|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
64507938|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507939|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64507940|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
64507941|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
64507942|NCT05224336|Vitamins|vitamins|mesh-ancestor
64507943|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
64507944|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507945|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
64507946|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64507947|NCT03303378|Melatonin|melatonin|mesh-list
64507948|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
64507949|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507950|NCT03303378|Protective Agents|protective agents|mesh-ancestor
64507976|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507977|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64507978|NCT00553306|Aldesleukin|aldesleukin|mesh-list
64507979|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
64507980|NCT00553306|Interleukin-2|interleukin-2|mesh-list
64507981|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64507982|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
64298462|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64298463|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298464|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64298465|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64298466|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
64298467|NCT02081287|Vitamins|vitamins|mesh-ancestor
64298468|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
64298469|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64507983|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64507984|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64507985|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64507986|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
64507987|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64507988|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64507989|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64298470|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64298471|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64298472|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64507990|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64507991|NCT00553306|Analgesics|analgesics|mesh-ancestor
64508034|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64508035|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64508036|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64508037|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
64508038|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508039|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508040|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
64508041|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64508042|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381521|NCT02433041|Haloperidol|haloperidol|mesh-list
64381522|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
64381523|NCT02433041|Analgesics|analgesics|mesh-ancestor
64381524|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
64508043|NCT03307902|Imiquimod|imiquimod|mesh-list
64508044|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64508045|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
64508046|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508047|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508048|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
64508049|NCT04929808|Emollients|emollients|mesh-list
64508050|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508051|NCT03302364|Risperidone|risperidone|mesh-list
64508052|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64508053|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
64508054|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508055|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508056|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508057|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64508058|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64508059|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508060|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64298473|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508061|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64508062|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
64508063|NCT02467920|Exenatide|exenatide|mesh-list
64508064|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64508065|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298474|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64298475|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64298476|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298477|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
64298478|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298479|NCT04918069|Capsaicin|capsaicin|mesh-list
64298480|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
64298481|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
64298482|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
64298483|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508066|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64508067|NCT02467920|Incretins|incretins|mesh-ancestor
64508068|NCT02467920|Hormones|hormones|mesh-ancestor
64508069|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508070|NCT04927312|Metronidazole|metronidazole|mesh-list
64508072|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64508073|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64508074|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64508075|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
64508076|NCT03307590|Bupivacaine|bupivacaine|mesh-list
64508077|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
64508078|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
64508079|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508080|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508081|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
64508082|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508083|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64381640|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
64381641|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381642|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381643|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64381644|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64381645|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64381646|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381648|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508085|NCT03307590|Analgesics|analgesics|mesh-ancestor
64955477|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508086|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64955478|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
64508127|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508128|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64508129|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508130|NCT04874038|Lidocaine|lidocaine|mesh-list
64508131|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
64508132|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
64508133|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64508134|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508135|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
64508136|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508137|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64508138|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64508139|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64508140|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64508141|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508142|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64508143|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
64508144|NCT03301974|Coagulants|coagulants|mesh-ancestor
64508145|NCT03306732|Thiamine|thiamine|mesh-list
64508146|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
64508147|NCT03306732|Vitamins|vitamins|mesh-ancestor
64508148|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
64508181|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64508182|NCT04630834|Analgesics|analgesics|mesh-ancestor
64508183|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
64508184|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508185|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508186|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
64508187|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64508188|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64508189|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508190|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64508191|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508192|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381683|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64508193|NCT03301350|Paclitaxel|paclitaxel|mesh-list
64508194|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
64508195|NCT03301350|Carboplatin|carboplatin|mesh-list
64508196|NCT03301350|Doxorubicin|doxorubicin|mesh-list
64508197|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508214|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
64508240|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64508241|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298484|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508242|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
64508243|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508245|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298486|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298487|NCT02083315|Narcotics|narcotics|mesh-ancestor
64298488|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298489|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298490|NCT02083315|Analgesics|analgesics|mesh-ancestor
64298491|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
64298492|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298493|NCT03559387|Lenograstim|lenograstim|mesh-list
64298494|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64298495|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
64298496|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298497|NCT05519059|Paclitaxel|paclitaxel|mesh-list
64508324|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64508325|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
64508326|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508327|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
64508328|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508412|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64508413|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
64508414|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64508415|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
64508416|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508417|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508418|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64508419|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64508421|NCT05438550|Amoxicillin|amoxicillin|mesh-list
64508466|NCT05587062|Growth Substances|growth substances|mesh-ancestor
64508467|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508468|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
64508469|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508470|NCT02463006|Methamphetamine|methamphetamine|mesh-list
64298498|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508471|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64508472|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508473|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
64508474|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
64508475|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64508476|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
64508477|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508527|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64508528|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
64508529|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64508530|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508531|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64508533|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64508539|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
64508595|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64508596|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508597|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
64494235|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
64298499|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298500|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
64298501|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
64955490|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64508598|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64508599|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508600|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508661|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
64508662|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508663|NCT01770743|Vaccines|vaccines|mesh-list
64508664|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
64508665|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64508666|NCT01777997|Tenofovir|tenofovir|mesh-list
64508667|NCT01777997|Emtricitabine|emtricitabine|mesh-list
64508668|NCT01777997|Rilpivirine|rilpivirine|mesh-list
64508669|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
64508670|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508671|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64508725|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64508726|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508727|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64508728|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64508729|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508730|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
64508731|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64508732|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64508733|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64508734|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
64508735|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64508736|NCT01886872|Rituximab|rituximab|mesh-list
64508737|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64508738|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64508739|NCT01886872|Antibodies|antibodies|mesh-list
64508749|NCT01768559|Insulin|insulin|mesh-list
64508785|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508786|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64508787|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64508788|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64508789|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64508790|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
64508791|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64508792|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64508793|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
64508794|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
64508795|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508796|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64508797|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64508798|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64508799|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64508800|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64508801|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64508802|NCT00653068|Antidotes|antidotes|mesh-ancestor
64508803|NCT00653068|Protective Agents|protective agents|mesh-ancestor
64508804|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
64508806|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
64508807|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
64508808|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
64508809|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
64508810|NCT00653068|Hematinics|hematinics|mesh-ancestor
64508811|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
64508812|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
64508813|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64508814|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508815|NCT05608785|Capecitabine|capecitabine|mesh-list
64508816|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
64508817|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64508822|NCT03037437|Sorafenib|sorafenib|mesh-list
64381826|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508824|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64508825|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508826|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508828|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64508844|NCT01775501|Protective Agents|protective agents|mesh-ancestor
64508845|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
64508846|NCT01775501|Vitamins|vitamins|mesh-ancestor
64508847|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
64508848|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64508849|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508850|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
64508851|NCT04346667|Chloroquine|chloroquine|mesh-list
64508852|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
64508853|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64508854|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64508855|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64508856|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64508857|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64508858|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64508859|NCT04346667|Amebicides|amebicides|mesh-ancestor
64508872|NCT03024489|Cetuximab|cetuximab|mesh-list
64508873|NCT03024489|Palbociclib|palbociclib|mesh-list
64508875|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64508903|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64508906|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64508910|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64508973|NCT04127721|Methotrexate|methotrexate|mesh-list
64508974|NCT04127721|Fludarabine|fludarabine|mesh-list
64508975|NCT04127721|Busulfan|busulfan|mesh-list
64508976|NCT04127721|Tacrolimus|tacrolimus|mesh-list
64509001|NCT02996721|Vitamin D|vitamin d|mesh-list
64509044|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64509045|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
64509046|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64509047|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381501|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381502|NCT04425135|Carboplatin|carboplatin|mesh-list
64381503|NCT04425135|Apatinib|apatinib|mesh-list
64381504|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381505|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64381506|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381507|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381508|NCT02573883|Clobetasol|clobetasol|mesh-list
64381509|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381510|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
64381511|NCT02573883|Hormones|hormones|mesh-ancestor
64381514|NCT02432885|Enalapril|enalapril|mesh-list
64381525|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381526|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381528|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64381529|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
64381530|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
64381531|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381532|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64381533|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64381863|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64381864|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
64381866|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381932|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381933|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381934|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64381935|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
64381967|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381534|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381535|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509116|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509117|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64509118|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64509119|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509124|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
64509185|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64509186|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509187|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
64509188|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
64509189|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64509190|NCT04126083|Lofexidine|lofexidine|mesh-list
64509191|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64509192|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64509193|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509194|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
64509195|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509196|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64509198|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64509251|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509252|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509253|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
64509254|NCT03829371|Hormones|hormones|mesh-ancestor
64509255|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509256|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64509257|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509258|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
64509259|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64509260|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64509261|NCT03829371|Growth Substances|growth substances|mesh-ancestor
64509262|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
64509263|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64509310|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509311|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509312|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64509383|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
64509384|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509385|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509386|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
64509387|NCT03004287|Hormones|hormones|mesh-ancestor
64509388|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509452|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509453|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64509454|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
64509455|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
64509456|NCT02974257|Thiamine|thiamine|mesh-list
64509457|NCT02974257|Vitamins|vitamins|mesh-ancestor
64509458|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
64509459|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509460|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
64509461|NCT01736189|Adalimumab|adalimumab|mesh-list
64509462|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509463|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509464|NCT02970981|Nivolumab|nivolumab|mesh-list
64509465|NCT02970981|Ipilimumab|ipilimumab|mesh-list
64298502|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
64298503|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298504|NCT02079337|Rocuronium|rocuronium|mesh-list
64298505|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64298506|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64298507|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64298508|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298509|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298510|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
64298511|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64509466|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64509467|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509468|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64509470|NCT03374800|Pantoprazole|pantoprazole|mesh-list
64509513|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509514|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64509515|NCT01762943|Progestins|progestins|mesh-ancestor
64509516|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64509517|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
64509518|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64509519|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509520|NCT04392063|Melatonin|melatonin|mesh-list
64509521|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
64509522|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509523|NCT04392063|Protective Agents|protective agents|mesh-ancestor
64509524|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509527|NCT01903798|Prednisolone|prednisolone|mesh-list
64509572|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
64509573|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509574|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
64509575|NCT02918721|Lidocaine|lidocaine|mesh-list
64509576|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
64509646|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64509647|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
64509648|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509649|NCT03820245|Protective Agents|protective agents|mesh-ancestor
64509650|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509651|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64509652|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64509653|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509655|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64509656|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64509657|NCT03826485|Pranlukast|pranlukast|mesh-list
64509658|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64509659|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
64509661|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
64509705|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509706|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64509707|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
64509709|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64509710|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64298512|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64382006|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382007|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382008|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382009|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
64382010|NCT02426723|Hormones|hormones|mesh-ancestor
64382011|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382012|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64382013|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382014|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
64509711|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64509755|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509756|NCT01915108|Analgesics|analgesics|mesh-ancestor
64509757|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
64509758|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509759|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
64509760|NCT03825471|Anesthetics|anesthetics|mesh-list
64509761|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64509762|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298513|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64509763|NCT03825471|Narcotics|narcotics|mesh-ancestor
64509764|NCT03825471|Analgesics|analgesics|mesh-ancestor
64509820|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
64509821|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64509886|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298514|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
64298515|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298516|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64509888|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64509890|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64509891|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64509892|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64509893|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64955540|NCT00410644|Hydromorphone|hydromorphone|mesh-list
64955541|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64955542|NCT00410644|Narcotics|narcotics|mesh-ancestor
64509953|NCT01606319|Ibuprofen|ibuprofen|mesh-list
64509954|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64509955|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64509956|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64509957|NCT01606319|Analgesics|analgesics|mesh-ancestor
64509958|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
64509959|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64509960|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64509961|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
64509962|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64509963|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64509964|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64509965|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64509966|NCT01452711|Lansoprazole|lansoprazole|mesh-list
64510007|NCT02947581|Albendazole|albendazole|mesh-list
64510008|NCT02947581|Praziquantel|praziquantel|mesh-list
64510009|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
64510010|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64955543|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64955544|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64955545|NCT00410644|Analgesics|analgesics|mesh-ancestor
64955546|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
64510065|NCT04391361|Analgesics|analgesics|mesh-ancestor
64510066|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
64510067|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64510068|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64510069|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64510070|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64510071|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64510131|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510132|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510133|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64510202|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510278|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
64510349|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510350|NCT04390815|Insulin|insulin|mesh-list
64510351|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64510352|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64510353|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510354|NCT01456611|Diclofenac|diclofenac|mesh-list
64510355|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64510356|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64510357|NCT01456611|Analgesics|analgesics|mesh-ancestor
64510358|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
64510360|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510361|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64510362|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64510363|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64510364|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510365|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510366|NCT01456689|Midazolam|midazolam|mesh-list
64510367|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64510368|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64510369|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64510402|NCT05827159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64510403|NCT05827081|Letrozole|letrozole|mesh-list
64510404|NCT05827081|Leuprolide|leuprolide|mesh-list
64510405|NCT05827081|Goserelin|goserelin|mesh-list
64510406|NCT05827081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510407|NCT05827081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64510408|NCT05827081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64510410|NCT05827081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510411|NCT05827081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64510412|NCT05827081|Hormone Antagonists|hormone antagonists|mesh-ancestor
64510413|NCT05827081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510414|NCT05827081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510415|NCT05827081|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64510416|NCT05827081|Fertility Agents|fertility agents|mesh-ancestor
64510417|NCT05827081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64510418|NCT05827081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64510419|NCT05827068|Vaccines|vaccines|mesh-list
64510420|NCT05827068|Immunologic Factors|immunologic factors|mesh-ancestor
64510421|NCT05827068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510441|NCT05827042|Tenecteplase|tenecteplase|mesh-list
64510442|NCT05827042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64510443|NCT05827042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64510477|NCT05826964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510478|NCT05826964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64510479|NCT05826964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64510480|NCT05826964|Immunologic Factors|immunologic factors|mesh-ancestor
64510481|NCT05826964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510482|NCT05826964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64510483|NCT05826964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510484|NCT05826964|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64510486|NCT05826964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64510487|NCT05826964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64510488|NCT05826964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510489|NCT05826964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64510490|NCT05826964|Antifungal Agents|antifungal agents|mesh-ancestor
64955564|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64955565|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
64510534|NCT05826574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64510535|NCT05826574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64510536|NCT05826574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64382023|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
64382024|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382045|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
64382046|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382047|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382048|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64382049|NCT02426177|Labetalol|labetalol|mesh-list
64382050|NCT02426177|Nifedipine|nifedipine|mesh-list
64298526|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298527|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298528|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64298529|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298530|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64510646|NCT05825573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510647|NCT05825573|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64510648|NCT05825573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64510649|NCT05825573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510650|NCT05825573|Hemostatics|hemostatics|mesh-ancestor
64510651|NCT05825573|Coagulants|coagulants|mesh-ancestor
64510666|NCT05825430|Bupivacaine|bupivacaine|mesh-list
64510667|NCT05825430|Anesthetics|anesthetics|mesh-list
64955566|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64510726|NCT05825066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64510727|NCT05825066|Mitosis Modulators|mitosis modulators|mesh-ancestor
64510728|NCT05825066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64510729|NCT05825066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64510730|NCT05825066|Antimetabolites|antimetabolites|mesh-ancestor
64510731|NCT05825066|Antiviral Agents|antiviral agents|mesh-ancestor
64510732|NCT05825066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64510733|NCT05825066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64510734|NCT05825066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64510735|NCT05825066|Immunologic Factors|immunologic factors|mesh-ancestor
64510736|NCT05825066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64510737|NCT05824897|Vitamin D|vitamin d|mesh-list
64510738|NCT05824897|Vitamins|vitamins|mesh-ancestor
64955568|NCT00071955|Sargramostim|sargramostim|mesh-list
64510739|NCT05824897|Micronutrients|micronutrients|mesh-ancestor
64510784|NCT05824767|Angiotensin II|angiotensin ii|mesh-list
64510786|NCT05824767|Angiotensinogen|angiotensinogen|mesh-list
64510787|NCT05824767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64510789|NCT05824767|Protease Inhibitors|protease inhibitors|mesh-ancestor
64510898|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
64510899|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
64510900|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64510901|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64511060|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
64511061|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64511062|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64511063|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511064|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64511066|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
64511067|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511068|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64511069|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64511070|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64511071|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
64511072|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511074|NCT05664737|Luspatercept|luspatercept|mesh-list
64511277|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511278|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511279|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
64511280|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
64955577|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
64511281|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511282|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511283|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
64511284|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511348|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382063|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64511349|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511350|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64511351|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64511352|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
64511353|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64511354|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64511355|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
64511356|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
64511482|NCT05359237|Vincristine|vincristine|mesh-list
64511483|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64511484|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511485|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
64511486|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
64511487|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
64511488|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511489|NCT05357989|Phenserine|phenserine|mesh-list
64511490|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64511491|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511492|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511493|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
64511494|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64511495|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511503|NCT05346354|Ravulizumab|ravulizumab|mesh-list
64511504|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64511546|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
64511547|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
64511548|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
64511549|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64511652|NCT05239741|Growth Substances|growth substances|mesh-ancestor
64511653|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511654|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
64511655|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
64511656|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511657|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64511658|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64511659|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
64511660|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64511661|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64511662|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511663|NCT05239741|Antidotes|antidotes|mesh-ancestor
64511664|NCT05239741|Protective Agents|protective agents|mesh-ancestor
64511665|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
64511666|NCT05239741|Vitamins|vitamins|mesh-ancestor
64511713|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64511714|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64511715|NCT05151731|Growth Substances|growth substances|mesh-ancestor
64511716|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511717|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
64511718|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511725|NCT05136677|Carboplatin|carboplatin|mesh-list
64511726|NCT05136677|Nivolumab|nivolumab|mesh-list
64511727|NCT05136677|Pemetrexed|pemetrexed|mesh-list
64511728|NCT05136677|Ipilimumab|ipilimumab|mesh-list
64511729|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64511730|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64511731|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64511784|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511785|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64511786|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64511787|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
64511788|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
64511789|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511790|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64511791|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64511792|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
64511793|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64382064|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
64382065|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
64511794|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
64511795|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
64511854|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64511855|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511856|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
64511857|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64511858|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
64511859|NCT04994132|Dactinomycin|dactinomycin|mesh-list
64955585|NCT00203788|Risperidone|risperidone|mesh-list
64511860|NCT04994132|Cactinomycin|cactinomycin|mesh-list
64511861|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
64511862|NCT04994132|Vincristine|vincristine|mesh-list
64511863|NCT04994132|Vinorelbine|vinorelbine|mesh-list
64511932|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
64511933|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
64511934|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64511935|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64511936|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
64511937|NCT04923893|Hormones|hormones|mesh-ancestor
64424501|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511938|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64511939|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64511940|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64511941|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64511942|NCT04923893|Growth Substances|growth substances|mesh-ancestor
64511943|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
64511944|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
64511945|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64511946|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64511947|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511948|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64511949|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64511950|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64955587|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
64955588|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64955589|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64511959|NCT04911166|Atezolizumab|atezolizumab|mesh-list
64511985|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64511986|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64511987|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64511989|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
64512000|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512001|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512002|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
64512003|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512004|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64512005|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64512092|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
64512093|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512094|NCT04767022|Paclitaxel|paclitaxel|mesh-list
64382067|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64382068|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64382069|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
64382070|NCT02426099|Spironolactone|spironolactone|mesh-list
64382071|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64382072|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
64382073|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382074|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382099|NCT02073682|Tinzaparin|tinzaparin|mesh-list
64382100|NCT02073682|Dalteparin|dalteparin|mesh-list
64382101|NCT02073682|Edoxaban|edoxaban|mesh-list
64512095|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64512096|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64512097|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512098|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
64512099|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
64512100|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
64512101|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512102|NCT04764162|Choline|choline|mesh-list
64512103|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
64512139|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64512140|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64512141|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64512147|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
64512148|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
64512149|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64512150|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64512151|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64512217|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
64512218|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512228|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64494322|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64955591|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64955592|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64955593|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64512295|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64512296|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512297|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64512298|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512299|NCT04519619|Aflibercept|aflibercept|mesh-list
64512300|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64512301|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64512302|NCT04519619|Growth Substances|growth substances|mesh-ancestor
64512303|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512368|NCT04461639|Factor VIII|factor viii|mesh-list
64512472|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64512473|NCT04364945|Narcotics|narcotics|mesh-ancestor
64512474|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64512475|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64512476|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
64512477|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
64512483|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
64512484|NCT04322318|Ifosfamide|ifosfamide|mesh-list
64512485|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
64512486|NCT04322318|Carboplatin|carboplatin|mesh-list
64512691|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64512692|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
64512693|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64512694|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512695|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64512696|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64512697|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
64512698|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
64512699|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64512754|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
64512755|NCT04011345|Vitamins|vitamins|mesh-ancestor
64512756|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
64512757|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64512758|NCT04001829|Paclitaxel|paclitaxel|mesh-list
64512759|NCT04001829|Docetaxel|docetaxel|mesh-list
64512760|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64512761|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64512762|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64512763|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
64512764|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
64512821|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64512822|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64512823|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
64512824|NCT03959085|Hormones|hormones|mesh-ancestor
64512825|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64512826|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64512827|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
64512828|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64512942|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
64512943|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64512944|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
64513071|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
64513072|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64513073|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513074|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
64513075|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64513077|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64513078|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
64513079|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64513080|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64513081|NCT03533582|Gemcitabine|gemcitabine|mesh-list
64513149|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513150|NCT03409367|Emollients|emollients|mesh-list
64513151|NCT03409367|Petrolatum|petrolatum|mesh-list
64513152|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
64513166|NCT03168464|Nivolumab|nivolumab|mesh-list
64513167|NCT03168464|Ipilimumab|ipilimumab|mesh-list
64513168|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513169|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513170|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64513171|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513268|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
64513269|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64513270|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64513271|NCT02811510|Dronabinol|dronabinol|mesh-list
64513272|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
64513273|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64513274|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64513275|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64513276|NCT02811510|Analgesics|analgesics|mesh-ancestor
64513277|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
64513278|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64513279|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64513280|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64513281|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382104|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64382105|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382106|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64513302|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513324|NCT02778971|Flutemetamol|flutemetamol|mesh-list
64513325|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64513332|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
64513374|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
64513375|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
64513376|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64513378|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
64513483|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64513484|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
64513485|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64513486|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298531|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64298532|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298533|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381542|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64381543|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
64381544|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64381545|NCT02429921|Selenium|selenium|mesh-list
64381546|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
64381547|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381548|NCT02429921|Protective Agents|protective agents|mesh-ancestor
64381549|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64321197|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381552|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64298759|NCT02089399|Olmesartan|olmesartan|mesh-list
64298760|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64298761|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64298762|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64298763|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
64298764|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298765|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64381585|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64381586|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
64381612|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64381613|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64381614|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381615|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64381616|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
64381617|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381618|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
64381619|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64381620|NCT03186053|Protective Agents|protective agents|mesh-ancestor
64299016|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64299017|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299019|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64299020|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299021|NCT02095405|Caffeine|caffeine|mesh-list
64299022|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64382113|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64299023|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299024|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64299025|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299026|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299027|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64299094|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
64299095|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299106|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64299107|NCT03097406|Imidacloprid|imidacloprid|mesh-list
64299108|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
64299109|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299110|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299111|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299112|NCT03099590|Puerarin|puerarin|mesh-list
64334808|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334810|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334811|NCT02232971|Glucagon|glucagon|mesh-list
64417247|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64417248|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334812|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64334814|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334815|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334816|NCT02296333|Ondansetron|ondansetron|mesh-list
64334817|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
64334818|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
64334819|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334822|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
64334823|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
64334824|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64334825|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
64334826|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334827|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334829|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64334830|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334831|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64334832|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64334834|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64334835|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334836|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
64382114|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64382115|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382116|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382117|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64382118|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
64382119|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382120|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382121|NCT02706899|Azacitidine|azacitidine|mesh-list
64382122|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64382123|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
64382124|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382125|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417249|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334839|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334841|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64334842|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
64334843|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64334844|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
64334845|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417250|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64417251|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64417255|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
64417256|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
64417257|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
64417280|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417281|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417282|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
64417283|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417284|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64417285|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64334846|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334847|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
64299113|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
64299114|NCT04999761|Futibatinib|futibatinib|mesh-list
64299115|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299116|NCT05054426|Methotrexate|methotrexate|mesh-list
64299117|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64299118|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
64299119|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64299120|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299121|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64299122|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
64299123|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299124|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417287|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64417288|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
64417289|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64334868|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334869|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64334870|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64334871|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334872|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334873|NCT03146481|Aceclofenac|aceclofenac|mesh-list
64334874|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64334875|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64334876|NCT03146481|Analgesics|analgesics|mesh-ancestor
64334877|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
64334878|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334879|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334880|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64334881|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64334882|NCT03541655|Celecoxib|celecoxib|mesh-list
64334891|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417290|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
64334895|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64334896|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64299125|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299126|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299127|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64299128|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382161|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
64299129|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
64299130|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417291|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417292|NCT04826497|Nicorandil|nicorandil|mesh-list
64417293|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64417294|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417295|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
64417296|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
64417297|NCT04826497|Vitamins|vitamins|mesh-ancestor
64417298|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
64417299|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334902|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64334903|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64334904|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64334905|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
64417301|NCT04819243|Talazoparib|talazoparib|mesh-list
64417302|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334906|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417303|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64417304|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417305|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417306|NCT02604589|Hydromorphone|hydromorphone|mesh-list
64417307|NCT02604589|Bupivacaine|bupivacaine|mesh-list
64417308|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
64417309|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
64417342|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417343|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417344|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417345|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64334908|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334909|NCT04581473|Paclitaxel|paclitaxel|mesh-list
64334910|NCT04581473|Irinotecan|irinotecan|mesh-list
64334911|NCT04581473|Apatinib|apatinib|mesh-list
64334912|NCT04581473|Antibodies|antibodies|mesh-list
64334913|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64334914|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334916|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
64334917|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
64334918|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334919|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
64417346|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64334922|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64334923|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334924|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64334925|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
64334926|NCT02229617|Testosterone|testosterone|mesh-list
64334927|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
64334928|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
64334929|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64334930|NCT02229617|Androgens|androgens|mesh-ancestor
64417348|NCT02604199|Entecavir|entecavir|mesh-list
64417349|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
64417350|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64417351|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
64417352|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417353|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64417377|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
64382166|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64382167|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
64382168|NCT02424461|Ofloxacin|ofloxacin|mesh-list
64382169|NCT02424461|Levofloxacin|levofloxacin|mesh-list
64417387|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417389|NCT04797793|Adapalene|adapalene|mesh-list
64334931|NCT02229617|Hormones|hormones|mesh-ancestor
64334932|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334933|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417395|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417396|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417397|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417398|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417399|NCT04796857|Lenalidomide|lenalidomide|mesh-list
64417400|NCT04796857|Antibodies|antibodies|mesh-list
64417401|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
64417402|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417403|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64334937|NCT02347059|Dopamine|dopamine|mesh-list
64417404|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64417434|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
64417435|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417436|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417437|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64334939|NCT02347059|Pramipexole|pramipexole|mesh-list
64334940|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
64334941|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64334942|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64417440|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
64417441|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
64334944|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64334945|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334946|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334947|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
64334948|NCT02347059|Protective Agents|protective agents|mesh-ancestor
64417443|NCT04805827|Analgesics|analgesics|mesh-ancestor
64417444|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
64334950|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
64334951|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
64334952|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334953|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64417452|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64417453|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64417454|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417455|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417456|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
64417458|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
64417459|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64417460|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
64417461|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417462|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417463|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64417464|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64417465|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
64417466|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417467|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417468|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
64417469|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
64417470|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
64417471|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
64417472|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64417473|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417474|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417475|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
64417476|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64417478|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417479|NCT04814485|Paclitaxel|paclitaxel|mesh-list
64334954|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64334955|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334956|NCT02296567|Bevacizumab|bevacizumab|mesh-list
64334957|NCT02296567|Ranibizumab|ranibizumab|mesh-list
64334958|NCT02296567|Aflibercept|aflibercept|mesh-list
64417480|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64417481|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64417482|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417483|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
64299131|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64299133|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64299134|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299135|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
64299136|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299138|NCT02463513|Vitamins|vitamins|mesh-list
64334960|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64334961|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64334962|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64334963|NCT02296567|Growth Substances|growth substances|mesh-ancestor
64417484|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
64417485|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
64417486|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417489|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
64417490|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
64417491|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
64417492|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
64417493|NCT04804423|Protective Agents|protective agents|mesh-ancestor
64417494|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417495|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64417496|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417497|NCT04794049|Lactulose|lactulose|mesh-list
64417498|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64417499|NCT04794127|Pioglitazone|pioglitazone|mesh-list
64417500|NCT04794127|Trabectedin|trabectedin|mesh-list
64417501|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64417502|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417503|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64417504|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
64417505|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417506|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417507|NCT04804267|Linaclotide|linaclotide|mesh-list
64417508|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64417509|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
64417510|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417511|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382280|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382281|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
64382282|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382283|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382284|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64382285|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
64382286|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382288|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64382289|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64417512|NCT04813471|Folic Acid|folic acid|mesh-list
64417535|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417537|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64334968|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64334969|NCT02289937|Ropivacaine|ropivacaine|mesh-list
64334970|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
64334971|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
64334972|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64334973|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64334974|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
64417538|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64334978|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64334979|NCT03519061|Budesonide|budesonide|mesh-list
64417539|NCT04792723|Analgesics|analgesics|mesh-ancestor
64417540|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
64417541|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417542|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417547|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417548|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64417549|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64334982|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
64334983|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64334984|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417550|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417551|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
64417552|NCT04792333|Firibastat|firibastat|mesh-list
64417553|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417554|NCT04802785|Aspirin|aspirin|mesh-list
64417555|NCT04802785|Domperidone|domperidone|mesh-list
64417556|NCT04802785|Melatonin|melatonin|mesh-list
64417557|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64334985|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64334986|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
64417558|NCT04802785|Simethicone|simethicone|mesh-list
64417559|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64417561|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
64417562|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
64417563|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64334989|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64334991|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64334992|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64417564|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
64417565|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
64417582|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417583|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
64417584|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
64417585|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
64334993|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
64334994|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64334995|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64417586|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64417587|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64417588|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
64382291|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64382292|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64382293|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382294|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382295|NCT03178721|Calcium|calcium|mesh-list
64382296|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64417589|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417590|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
64417591|NCT04802785|Emollients|emollients|mesh-ancestor
64417592|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417593|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
64417594|NCT04802785|Antacids|antacids|mesh-ancestor
64417595|NCT02598193|Pirfenidone|pirfenidone|mesh-list
64417596|NCT02598193|Nintedanib|nintedanib|mesh-list
64417597|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417598|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64417599|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334996|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64334997|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64334998|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
64334999|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
64335000|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64335001|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335002|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335003|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
64299181|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299182|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
64299183|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64299184|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64417603|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417604|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417605|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64417606|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417607|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335005|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335006|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417608|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417610|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64417611|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335008|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
64335009|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
64335010|NCT03515707|Busulfan|busulfan|mesh-list
64335011|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64417612|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
64417613|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417614|NCT04801303|Calcitriol|calcitriol|mesh-list
64417615|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64417616|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335012|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335013|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64335014|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64335016|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335017|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
64382297|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382298|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
64382299|NCT02421029|Edetic Acid|edetic acid|mesh-list
64382300|NCT02421029|Calcium|calcium|mesh-list
64382301|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
64424550|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417617|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64335018|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335020|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335021|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64335022|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64335023|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
64335024|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
64335025|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335026|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64335027|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64417618|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64299190|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64417619|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335029|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335030|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
64335031|NCT02298205|Hormones|hormones|mesh-ancestor
64335032|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335033|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417621|NCT04801303|Vitamins|vitamins|mesh-ancestor
64417622|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
64417623|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64417648|NCT02388165|Vaccines|vaccines|mesh-list
64417649|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
64417650|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417651|NCT04811911|Methotrexate|methotrexate|mesh-list
64417652|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64417653|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
64417654|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64417655|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417656|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64417657|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
64335035|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
64335036|NCT02346201|Methylphenidate|methylphenidate|mesh-list
64335037|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64335038|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417658|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417659|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417660|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417661|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417667|NCT04788979|Melatonin|melatonin|mesh-list
64417668|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
64417669|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417670|NCT04788979|Protective Agents|protective agents|mesh-ancestor
64417671|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335039|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64382304|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64382334|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64382335|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382336|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
64382337|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382338|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
64335040|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64335041|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335042|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335044|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335045|NCT03514771|Valacyclovir|valacyclovir|mesh-list
64335046|NCT03514771|Isotretinoin|isotretinoin|mesh-list
64335047|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
64335048|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335049|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
64335050|NCT02298283|Prednisone|prednisone|mesh-list
64335051|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
64335052|NCT02298283|Doxorubicin|doxorubicin|mesh-list
64335062|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417672|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299191|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299192|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64299193|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64299194|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64299195|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
64299196|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64299197|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64299198|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
64299199|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64299200|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
64417673|NCT04811209|Analgesics|analgesics|mesh-list
64417699|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417700|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417701|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64335063|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64335064|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
64335065|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335066|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417702|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
64417703|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64417704|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64417705|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417706|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
64417707|NCT04788121|Coagulants|coagulants|mesh-ancestor
64417708|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
64417709|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64417710|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64417711|NCT04810819|Prednisolone|prednisolone|mesh-list
64417712|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
64417714|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64335068|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64335069|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64335070|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64417716|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417717|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
64335071|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335072|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335073|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
64335074|NCT02298283|Hormones|hormones|mesh-ancestor
64335075|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335076|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64335077|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64335078|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335090|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64335092|NCT03146247|Analgesics|analgesics|mesh-ancestor
64335093|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
64335094|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382339|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382340|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382341|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64382343|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382344|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417718|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
64417719|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417720|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417721|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64335095|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335096|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335097|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335098|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64417746|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335099|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64335100|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417748|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64417749|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64417750|NCT04810585|Growth Substances|growth substances|mesh-ancestor
64335101|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335102|NCT03263273|Minocycline|minocycline|mesh-list
64335103|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335104|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335105|NCT03146325|Metronidazole|metronidazole|mesh-list
64335106|NCT03146325|Tetracycline|tetracycline|mesh-list
64335107|NCT03146325|Omeprazole|omeprazole|mesh-list
64335108|NCT03146325|Bismuth|bismuth|mesh-list
64335109|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335113|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64335114|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64335115|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64335116|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335117|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335118|NCT03146325|Antacids|antacids|mesh-ancestor
64335119|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64335120|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64335121|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64335122|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335123|NCT02233049|Everolimus|everolimus|mesh-list
64335124|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64335125|NCT02233049|Dasatinib|dasatinib|mesh-list
64335126|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335127|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335128|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
64335129|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335130|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64335131|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299201|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64299202|NCT04155008|Analgesics|analgesics|mesh-ancestor
64299203|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
64299204|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64299205|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64299206|NCT05044364|Clevidipine|clevidipine|mesh-list
64299207|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64299208|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64299209|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382345|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64382347|NCT02072434|Warfarin|warfarin|mesh-list
64382348|NCT02072434|Edoxaban|edoxaban|mesh-list
64382349|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
64382350|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64382351|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64382352|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299210|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64299211|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299212|NCT03993717|Vaccines|vaccines|mesh-list
64299213|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
64335132|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335133|NCT02350725|Furosemide|furosemide|mesh-list
64335134|NCT02350725|Diuretics|diuretics|mesh-ancestor
64335135|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
64335152|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335154|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64335155|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
64335156|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335157|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335158|NCT02293447|Lidocaine|lidocaine|mesh-list
64335159|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
64335160|NCT02293447|Anesthetics|anesthetics|mesh-list
64335169|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335170|NCT04464811|Furosemide|furosemide|mesh-list
64335171|NCT04464811|Diuretics|diuretics|mesh-ancestor
64335172|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
64335173|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335174|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64335175|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335176|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335178|NCT02293525|Oxycodone|oxycodone|mesh-list
64335179|NCT02293525|Ropivacaine|ropivacaine|mesh-list
64335180|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64335181|NCT02293525|Narcotics|narcotics|mesh-ancestor
64335182|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335183|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335184|NCT02293525|Analgesics|analgesics|mesh-ancestor
64335188|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
64335195|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64335196|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
64335197|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335198|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335199|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
64335200|NCT03949673|Celecoxib|celecoxib|mesh-list
64335201|NCT03949673|Diclofenac|diclofenac|mesh-list
64335202|NCT03949673|Naproxen|naproxen|mesh-list
64335215|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335216|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
64335217|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
64299214|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299215|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
64299216|NCT04150640|Nivolumab|nivolumab|mesh-list
64299217|NCT04150640|Trastuzumab|trastuzumab|mesh-list
64299218|NCT04150640|Fluorouracil|fluorouracil|mesh-list
64299219|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
64335219|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64335220|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335222|NCT02350179|Coagulants|coagulants|mesh-ancestor
64335223|NCT02233205|Gemcitabine|gemcitabine|mesh-list
64335224|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335225|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
64335226|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335227|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335228|NCT02233205|Antiviral Agents|antiviral agents|mesh-ancestor
64335229|NCT02233205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335230|NCT02233205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335231|NCT02233205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335233|NCT02233205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335234|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64335279|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335280|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64335281|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64382353|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64382378|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64335282|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64335283|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
64335284|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335285|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335292|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335293|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64335295|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
64335296|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335297|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64335298|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64335299|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64335300|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
64335301|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335302|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335303|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
64335304|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335305|NCT05624801|Vitamin D|vitamin d|mesh-list
64335306|NCT05624801|Vitamins|vitamins|mesh-ancestor
64335311|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64335312|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335313|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335314|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64335315|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
64335316|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
64335317|NCT03514381|Doxorubicin|doxorubicin|mesh-list
64335319|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64335320|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335328|NCT02343393|Isosorbide|isosorbide|mesh-list
64335329|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64335330|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64335331|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64335332|NCT02343393|Diuretics|diuretics|mesh-ancestor
64335333|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
64335334|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335335|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
64335336|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64335337|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335338|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64335339|NCT03896009|Meloxicam|meloxicam|mesh-list
64299220|NCT04150640|Irinotecan|irinotecan|mesh-list
64299221|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64299222|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335345|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335346|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335348|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335349|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64335350|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64335351|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335352|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335356|NCT02344875|Dotinurad|dotinurad|mesh-list
64335359|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335360|NCT02344875|Renal Agents|renal agents|mesh-ancestor
64335361|NCT03145623|Grazoprevir|grazoprevir|mesh-list
64335362|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64335363|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
64335364|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335365|NCT02294071|Acetaminophen|acetaminophen|mesh-list
64335366|NCT02294071|Ibuprofen|ibuprofen|mesh-list
64335367|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64335371|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335372|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
64335373|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64335374|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335375|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335376|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64335377|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417751|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335378|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335379|NCT02233439|Galactogogues|galactogogues|mesh-list
64335380|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335381|NCT02350023|Betamethasone|betamethasone|mesh-list
64335382|NCT02350023|Latanoprost|latanoprost|mesh-list
64335383|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64335387|NCT02350023|Hormones|hormones|mesh-ancestor
64335452|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
64335459|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335460|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335461|NCT03766295|Antiviral Agents|antiviral agents|mesh-ancestor
64335462|NCT03766295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335463|NCT03766295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335464|NCT03766295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335465|NCT03766295|Immunologic Factors|immunologic factors|mesh-ancestor
64335466|NCT03766295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335467|NCT03761225|Prednisone|prednisone|mesh-list
64335491|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64335492|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335493|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64417752|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
64417753|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417754|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
64417755|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299223|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
64417756|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
64417757|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
64417758|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
64417759|NCT04809649|Itraconazole|itraconazole|mesh-list
64417766|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64417767|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
64417768|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335495|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335498|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
64335499|NCT03747575|Astegolimab|astegolimab|mesh-list
64335500|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64335501|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335502|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
64335505|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
64335506|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64335507|NCT02813447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64335508|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64335509|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64335510|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335511|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335512|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
64335513|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335514|NCT02342145|Cyclosporine|cyclosporine|mesh-list
64335515|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
64335516|NCT02342145|Methotrexate|methotrexate|mesh-list
64335517|NCT02342145|Cyclosporins|cyclosporins|mesh-list
64417769|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417770|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64417771|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64335519|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64335520|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
64335521|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64335522|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335523|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335524|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
64335525|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335533|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64335534|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
64335535|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335536|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64335538|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64417772|NCT04786795|Pancreatin|pancreatin|mesh-list
64417773|NCT04786795|Pancrelipase|pancrelipase|mesh-list
64417774|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64417775|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64335540|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335541|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
64335542|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64335543|NCT02349399|Cyproterone|cyproterone|mesh-list
64335544|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
64335545|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64335546|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64417776|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
64417777|NCT02596945|Hematinics|hematinics|mesh-ancestor
64417778|NCT04786327|Edetic Acid|edetic acid|mesh-list
64417779|NCT04786327|Mitogens|mitogens|mesh-list
64417803|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64417804|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64335548|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
64335549|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64335550|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335551|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64335552|NCT02349399|Estrogens|estrogens|mesh-ancestor
64417805|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417806|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417807|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
64417808|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
64417809|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417810|NCT04023019|Thrombin|thrombin|mesh-list
64335554|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335555|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
64335556|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
64335557|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335558|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64335559|NCT02306473|Mannitol|mannitol|mesh-list
64335560|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64335561|NCT02306473|Diuretics|diuretics|mesh-ancestor
64335562|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
64335563|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335564|NCT03737123|Gemcitabine|gemcitabine|mesh-list
64335565|NCT03737123|Carboplatin|carboplatin|mesh-list
64335566|NCT03737123|Docetaxel|docetaxel|mesh-list
64335600|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335602|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64335603|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
64335604|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417811|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
64417812|NCT04023019|Coagulants|coagulants|mesh-ancestor
64417813|NCT04785547|Blinatumomab|blinatumomab|mesh-list
64299224|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417814|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417815|NCT03938389|Valsartan|valsartan|mesh-list
64299225|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64299226|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64417816|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64417818|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64417819|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64417820|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417821|NCT03843853|Bevacizumab|bevacizumab|mesh-list
64417822|NCT03843853|Pemetrexed|pemetrexed|mesh-list
64417823|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64417824|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417825|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64417826|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64335614|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
64335615|NCT03676751|Azithromycin|azithromycin|mesh-list
64335616|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335617|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335618|NCT02302729|Micronutrients|micronutrients|mesh-list
64417827|NCT03843853|Growth Substances|growth substances|mesh-ancestor
64417828|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417829|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
64417830|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417831|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417832|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64417859|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64417861|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64417862|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64417863|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
64417864|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299227|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
64299228|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417867|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417868|NCT05613361|Colistin|colistin|mesh-list
64417875|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417876|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417878|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417879|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417880|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335619|NCT02302729|Trace Elements|trace elements|mesh-list
64335620|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335621|NCT03513601|Rituximab|rituximab|mesh-list
64335622|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64335623|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335624|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
64335625|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417934|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417935|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417936|NCT05269849|Sirolimus|sirolimus|mesh-list
64417937|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64417938|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417939|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64382379|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417940|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417941|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
64417942|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64417943|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
64417944|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417945|NCT05240131|Atezolizumab|atezolizumab|mesh-list
64417946|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417947|NCT05188339|Heparin|heparin|mesh-list
64417948|NCT05188339|Citric Acid|citric acid|mesh-list
64417949|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
64417950|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
64417951|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64335627|NCT03647111|Crizotinib|crizotinib|mesh-list
64335628|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335629|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64335630|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335631|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335632|NCT03507829|Insulin|insulin|mesh-list
64335633|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64335634|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
64335635|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
64335644|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
64335645|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335646|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64335647|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64335648|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335649|NCT02341833|Sevoflurane|sevoflurane|mesh-list
64335650|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64335651|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64335652|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
64335653|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
64335654|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335655|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335656|NCT02337231|Borage oil|borage oil|mesh-list
64335657|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335658|NCT03507751|Meropenem|meropenem|mesh-list
64335659|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64335660|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335661|NCT02306629|Epratuzumab|epratuzumab|mesh-list
64335683|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
64335684|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64335685|NCT05230797|Protective Agents|protective agents|mesh-ancestor
64335689|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335690|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64335691|NCT02299687|Omeprazole|omeprazole|mesh-list
64335726|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335727|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335728|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64335730|NCT02299765|Carboplatin|carboplatin|mesh-list
64335731|NCT02299765|Gefitinib|gefitinib|mesh-list
64335732|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335733|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64335734|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
64335735|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335736|NCT02299765|Antiviral Agents|antiviral agents|mesh-ancestor
64335737|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335738|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335739|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64335740|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
64335742|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64335760|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335761|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64335762|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
64335764|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
64335765|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64335766|NCT04718415|Paclitaxel|paclitaxel|mesh-list
64335767|NCT04718415|Carboplatin|carboplatin|mesh-list
64382383|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
64382384|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382385|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64382386|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382387|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64335768|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64335769|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335770|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
64335771|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
64335772|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
64335773|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335774|NCT04598321|Talazoparib|talazoparib|mesh-list
64335775|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64335776|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335777|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335778|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335779|NCT05254899|Gemcitabine|gemcitabine|mesh-list
64335780|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
64335781|NCT05254899|Pegaspargase|pegaspargase|mesh-list
64335782|NCT05254899|Antibodies|antibodies|mesh-list
64299230|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64299231|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64299232|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299233|NCT04959981|Osimertinib|osimertinib|mesh-list
64299234|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299235|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64299236|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299237|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299238|NCT05054114|Interferons|interferons|mesh-list
64335805|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64335806|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64335807|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
64335808|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64335809|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
64335810|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64335811|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64335813|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64335814|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64335815|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335816|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
64335817|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64335818|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64335819|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64335842|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64335843|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64335855|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64335856|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64335857|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64335858|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64335859|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64335860|NCT03507127|Varenicline|varenicline|mesh-list
64335861|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64335862|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64335863|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
64299239|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
64299240|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299241|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
64335873|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382391|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64382392|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64382393|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382394|NCT04734262|Paclitaxel|paclitaxel|mesh-list
64382395|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64382396|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64382397|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417952|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
64417953|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
64335875|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
64335876|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335878|NCT04636437|Lamivudine|lamivudine|mesh-list
64335879|NCT04636437|Emtricitabine|emtricitabine|mesh-list
64335880|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
64335881|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
64335882|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64335883|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64335884|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64417954|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417955|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64417956|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64417957|NCT05613205|Vaccines|vaccines|mesh-list
64417958|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
64417959|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417960|NCT05614765|Ezetimibe|ezetimibe|mesh-list
64335885|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335886|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299243|NCT04665531|Ropivacaine|ropivacaine|mesh-list
64335887|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64335888|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64335889|NCT02307487|Mitomycins|mitomycins|mesh-list
64335890|NCT02307487|Mitomycin|mitomycin|mesh-list
64335891|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64335892|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335893|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
64335894|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335895|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64335896|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335900|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335901|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335902|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64335903|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64335904|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64299244|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
64299245|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
64299246|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299247|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299248|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
64299249|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299250|NCT01369069|Insulin|insulin|mesh-list
64299251|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64335905|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64335906|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
64382398|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
64382399|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
64382400|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
64382401|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382402|NCT02100670|Diclofenac|diclofenac|mesh-list
64335907|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64335908|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335910|NCT03510013|Sevoflurane|sevoflurane|mesh-list
64335911|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
64335917|NCT02307721|Naloxone|naloxone|mesh-list
64335970|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64335971|NCT02300623|Analgesics|analgesics|mesh-ancestor
64335972|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
64335973|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335974|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335975|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
64335976|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64335977|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64335978|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
64335979|NCT04463953|Dexamethasone|dexamethasone|mesh-list
64335980|NCT04463953|Ixazomib|ixazomib|mesh-list
64335981|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
64417961|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64417962|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64335982|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64335983|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
64335984|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
64335985|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64335986|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64335987|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64335988|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
64335990|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64335991|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64335992|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64335993|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
64335994|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64335995|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64335996|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64335997|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
64336005|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
64336006|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336007|NCT02348307|Dotinurad|dotinurad|mesh-list
64336008|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
64336009|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
64336010|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336011|NCT02348307|Renal Agents|renal agents|mesh-ancestor
64336012|NCT02340117|Gemcitabine|gemcitabine|mesh-list
64336028|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336033|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
64382453|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64382454|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336039|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64336040|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336041|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
64336042|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
64336043|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
64336044|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417963|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
64417964|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417965|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64417966|NCT02590003|Paclitaxel|paclitaxel|mesh-list
64336045|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64336046|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336047|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64336048|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64336049|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336050|NCT02301091|Mitomycins|mitomycins|mesh-list
64336051|NCT02301091|Mitomycin|mitomycin|mesh-list
64336052|NCT02301091|Pirarubicin|pirarubicin|mesh-list
64336053|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64336057|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64336058|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336059|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
64336060|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
64336061|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64336062|NCT02335593|Hematinics|hematinics|mesh-ancestor
64336063|NCT02335593|Astringents|astringents|mesh-ancestor
64336064|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336068|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
64336096|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336097|NCT02309437|Analgesics|analgesics|mesh-ancestor
64336098|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
64336099|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336100|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
64336101|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64336102|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64417967|NCT02590003|Carboplatin|carboplatin|mesh-list
64336103|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382457|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382458|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382459|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
64382460|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382461|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64382462|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382463|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
64382464|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382465|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64336105|NCT02335359|Coagulants|coagulants|mesh-ancestor
64336106|NCT03511261|Curcumin|curcumin|mesh-list
64336107|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64336108|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64336109|NCT03511261|Analgesics|analgesics|mesh-ancestor
64417968|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64336110|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
64336111|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336112|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336113|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336114|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417969|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417988|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417989|NCT04988035|Remdesivir|remdesivir|mesh-list
64417990|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
64336115|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336116|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336117|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336118|NCT03509701|Antibodies|antibodies|mesh-list
64336119|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
64417991|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417992|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
64417993|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417994|NCT05473819|Anesthetics|anesthetics|mesh-list
64417995|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418001|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
64418002|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418003|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418004|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336122|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336123|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336124|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64336125|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64336126|NCT03511183|Growth Substances|growth substances|mesh-ancestor
64336127|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336128|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
64418005|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336131|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64336133|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
64336134|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64336135|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
64336136|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336137|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
64382492|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
64382493|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
64382494|NCT05517213|Etoposide|etoposide|mesh-list
64382495|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382496|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
64382497|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382498|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382499|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64382501|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382502|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382503|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64382504|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64382505|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64418006|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64418007|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64336138|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
64336139|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336140|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336141|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64336142|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
64336144|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336145|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64336152|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64336153|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336154|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
64336155|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
64336156|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
64336157|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336158|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336160|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336161|NCT03107871|Valganciclovir|valganciclovir|mesh-list
64336162|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
64336163|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336164|NCT03064113|Ipratropium|ipratropium|mesh-list
64336165|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64336166|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
64336167|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336168|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336169|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64336170|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
64336172|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336173|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336174|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336183|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336184|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64336185|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64336186|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336187|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64336188|NCT02301949|Thalidomide|thalidomide|mesh-list
64336189|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299255|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
64299256|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64299257|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64299258|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
64299259|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
64299260|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299261|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382506|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64382507|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382508|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
64382509|NCT05516589|Paclitaxel|paclitaxel|mesh-list
64382510|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64382511|NCT05516589|Afatinib|afatinib|mesh-list
64382512|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64382513|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382514|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
64382515|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
64382531|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382532|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299262|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64299263|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64299264|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64299265|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
64418008|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418009|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64418010|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64418011|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336190|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
64336191|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336192|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
64336193|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64336194|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336195|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64336196|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64418013|NCT05473741|Risperidone|risperidone|mesh-list
64418014|NCT05473741|Aripiprazole|aripiprazole|mesh-list
64418015|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64418016|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
64336197|NCT02301949|Growth Substances|growth substances|mesh-ancestor
64336198|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
64336199|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336200|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64336201|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
64299266|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299267|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299268|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64299269|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64299270|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64299271|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64299272|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
64299273|NCT03957681|Brodalumab|brodalumab|mesh-list
64299274|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299275|NCT05043740|Evolocumab|evolocumab|mesh-list
64299276|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64299277|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299278|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
64299279|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299280|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64418020|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418022|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64418023|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418039|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
64336218|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336219|NCT02303899|Antiviral Agents|antiviral agents|mesh-ancestor
64336220|NCT02303899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336221|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336222|NCT02303899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64336223|NCT02303899|Immunologic Factors|immunologic factors|mesh-ancestor
64336224|NCT02303899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336225|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64336226|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64382540|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64336227|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64336228|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64336229|NCT03510871|Nivolumab|nivolumab|mesh-list
64336230|NCT03510871|Ipilimumab|ipilimumab|mesh-list
64336231|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336232|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336233|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64336241|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336242|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
64336243|NCT02334501|Lansoprazole|lansoprazole|mesh-list
64336244|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
64336245|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64336246|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64418040|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418041|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418042|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336247|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64336248|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336249|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336250|NCT02331927|Aflibercept|aflibercept|mesh-list
64336251|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64336252|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64336253|NCT02331927|Growth Substances|growth substances|mesh-ancestor
64336254|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336255|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
64336258|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64336259|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
64336261|NCT02304055|Carbetocin|carbetocin|mesh-list
64336262|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
64336263|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336264|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336265|NCT02310295|Triamcinolone|triamcinolone|mesh-list
64336266|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64299281|NCT03928275|Aldesleukin|aldesleukin|mesh-list
64299282|NCT03928275|Interleukin-2|interleukin-2|mesh-list
64299283|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
64299284|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299285|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64299286|NCT03928275|Analgesics|analgesics|mesh-ancestor
64299287|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
64299288|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336345|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
64336346|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336347|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336348|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64336349|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336350|NCT02332005|Choline|choline|mesh-list
64336351|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
64336352|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64336353|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
64336354|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336394|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336395|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382541|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
64382542|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382543|NCT01624090|Plicamycin|plicamycin|mesh-list
64382544|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64382545|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382546|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64382550|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336396|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
64336397|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
64336398|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64336399|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
64336400|NCT02292784|Atosiban|atosiban|mesh-list
64336401|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
64336421|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336422|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336423|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336424|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64336425|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64336426|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
64336427|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
64336428|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64336429|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
64336430|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64336431|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
64336432|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336433|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336434|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64336435|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64336436|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336437|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
64336438|NCT02310997|Melphalan|melphalan|mesh-list
64336439|NCT02310997|Busulfan|busulfan|mesh-list
64336440|NCT02310997|Fludarabine|fludarabine|mesh-list
64336441|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64336442|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
64299289|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299290|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64299291|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64299292|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
64299293|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299294|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64299295|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
64299296|NCT05043896|Tadalafil|tadalafil|mesh-list
64299297|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
64299298|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64299299|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64299300|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336443|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336470|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64336471|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
64336472|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336473|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336475|NCT03504475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64336476|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64336477|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64336478|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336479|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336480|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
64336481|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336488|NCT02327247|Felodipine|felodipine|mesh-list
64336513|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336516|NCT02311231|Calcium heparin|calcium heparin|mesh-list
64336517|NCT02311231|Bivalirudin|bivalirudin|mesh-list
64336518|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
64336519|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64336520|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64382551|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64382553|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64382554|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382556|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
64382557|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382561|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
64336521|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299301|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299302|NCT05043896|Urological Agents|urological agents|mesh-ancestor
64299304|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64299305|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64299306|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
64299307|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299308|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299309|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299310|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
64299311|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
64299312|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299314|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64299315|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
64299316|NCT03096704|Vitamin D|vitamin d|mesh-list
64299317|NCT03096704|Vitamins|vitamins|mesh-ancestor
64299318|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
64299319|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299320|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64299321|NCT02099695|Oxybutynin|oxybutynin|mesh-list
64299322|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
64299323|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
64299324|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336522|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
64336523|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64336524|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
64336525|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336526|NCT03508999|Metronidazole|metronidazole|mesh-list
64336527|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336528|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64336529|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64336531|NCT02333565|Everolimus|everolimus|mesh-list
64336552|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336553|NCT02316301|Misoprostol|misoprostol|mesh-list
64336554|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64336555|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
64336556|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64336557|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336558|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64336559|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64336560|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
64299325|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336561|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
64336562|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64336563|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64336564|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336566|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
64336567|NCT02316535|Capecitabine|capecitabine|mesh-list
64336568|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64336569|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
64336570|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336572|NCT02333253|Cetrorelix|cetrorelix|mesh-list
64336582|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336583|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336584|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
64336585|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336586|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64336587|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64336588|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64336589|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64336590|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336592|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64382563|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64382564|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64382565|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64382566|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
64336593|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64336594|NCT02326779|Analgesics|analgesics|mesh-ancestor
64336595|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
64336596|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336606|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
64336626|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64336627|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
64336628|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
64336629|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
64336630|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64336631|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64336632|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
64336633|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336634|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336635|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64336636|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336637|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64336638|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
64336639|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336657|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336658|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64336659|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336664|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
64336665|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64336666|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64336668|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
64336685|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64336687|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336688|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336689|NCT02317237|Anesthetics|anesthetics|mesh-list
64336690|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336691|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336692|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64336694|NCT02332473|Sargramostim|sargramostim|mesh-list
64336695|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
64336696|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336697|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
64336698|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336699|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336700|NCT03501433|Niacinamide|niacinamide|mesh-list
64336701|NCT03501433|Niacin|niacin|mesh-list
64336702|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
64336703|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
64336754|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336755|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
64336756|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
64336757|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336758|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336759|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64418043|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418044|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64418045|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64418046|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64418048|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418049|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
64336760|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
64336761|NCT02332629|Hormones|hormones|mesh-ancestor
64336762|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336763|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64336764|NCT02332629|Protective Agents|protective agents|mesh-ancestor
64299326|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64299327|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64299328|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
64299329|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299330|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299331|NCT02099695|Urological Agents|urological agents|mesh-ancestor
64299332|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
64299333|NCT05066516|Linagliptin|linagliptin|mesh-list
64299334|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64299335|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299336|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64299337|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336765|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64336766|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336767|NCT02313337|Fentanyl|fentanyl|mesh-list
64336768|NCT02313337|Midazolam|midazolam|mesh-list
64336769|NCT02313337|Anesthetics|anesthetics|mesh-list
64336770|NCT02313337|Propofol|propofol|mesh-list
64336771|NCT02313337|Atracurium|atracurium|mesh-list
64336772|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336819|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64336820|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336821|NCT02305615|Bevacizumab|bevacizumab|mesh-list
64336822|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336823|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336824|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64336825|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64336826|NCT02305615|Growth Substances|growth substances|mesh-ancestor
64336827|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336828|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
64336829|NCT02305693|Letrozole|letrozole|mesh-list
64336830|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336831|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64336832|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64336874|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
64336875|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336876|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336877|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336878|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336879|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336880|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299339|NCT05066516|Hormones|hormones|mesh-ancestor
64336881|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299340|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299341|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64299342|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
64299343|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299344|NCT02097589|Atorvastatin|atorvastatin|mesh-list
64299345|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64299346|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
64299347|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299348|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64299349|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299350|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
64336883|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
64336884|NCT02305927|Vitamins|vitamins|mesh-ancestor
64336885|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
64336886|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336889|NCT02440009|Itraconazole|itraconazole|mesh-list
64336935|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
64336936|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336937|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336938|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
64336939|NCT04463875|Riboflavin|riboflavin|mesh-list
64336940|NCT04463875|Ubiquinone|ubiquinone|mesh-list
64382574|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
64382575|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382609|NCT03180593|Valsartan|valsartan|mesh-list
64382610|NCT03180593|Nebivolol|nebivolol|mesh-list
64382611|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64382612|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64382613|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64336941|NCT04463875|Andrographolide|andrographolide|mesh-list
64336942|NCT04463875|Vitamins|vitamins|mesh-ancestor
64336943|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
64336944|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336945|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
64336946|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64336947|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64336948|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336949|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64336950|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64336951|NCT04463875|Analgesics|analgesics|mesh-ancestor
64336952|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
64336958|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
64336968|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
64336969|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64336970|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336971|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336972|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
64336973|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
64336974|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336999|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337000|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337001|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337002|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
64337003|NCT02319343|Hormones|hormones|mesh-ancestor
64337004|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337005|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64337006|NCT02319343|Protective Agents|protective agents|mesh-ancestor
64337007|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64337008|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337009|NCT02319499|Vitamin A|vitamin a|mesh-list
64337010|NCT02319499|Iron|iron|mesh-list
64382649|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382650|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337011|NCT02319499|Zinc|zinc|mesh-list
64337012|NCT02319499|Vitamins|vitamins|mesh-ancestor
64337013|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
64337014|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337015|NCT02319499|Trace Elements|trace elements|mesh-ancestor
64337029|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
64337030|NCT03502135|Phenylephrine|phenylephrine|mesh-list
64337031|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
64337032|NCT03502135|Tetracaine|tetracaine|mesh-list
64337033|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
64337034|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
64337035|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337049|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64337050|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
64337051|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64337052|NCT03502135|Protective Agents|protective agents|mesh-ancestor
64337053|NCT02315287|Pioglitazone|pioglitazone|mesh-list
64337054|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64337055|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337056|NCT02319577|Vinorelbine|vinorelbine|mesh-list
64337057|NCT02319577|Gefitinib|gefitinib|mesh-list
64337058|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64337059|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337060|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
64337080|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418051|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418052|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418053|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64418054|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64418055|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418056|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
64418057|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418058|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
64418059|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64418060|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
64418061|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418062|NCT04481035|Expectorants|expectorants|mesh-ancestor
64418063|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
64418070|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64418071|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64418072|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
64337083|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64337084|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64337085|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64337086|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418073|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418074|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
64418075|NCT03032107|Trastuzumab|trastuzumab|mesh-list
64418076|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64418077|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418078|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418079|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64337087|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337088|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
64337089|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337090|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64337091|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
64337092|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64337093|NCT02447419|Gefitinib|gefitinib|mesh-list
64337094|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382653|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64382654|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64382675|NCT03180281|Incretins|incretins|mesh-ancestor
64382676|NCT03180281|Hormones|hormones|mesh-ancestor
64337095|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64337096|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337097|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337102|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337103|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
64337104|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
64337105|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
64337106|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337107|NCT02324413|Clonidine|clonidine|mesh-list
64337108|NCT02324413|Analgesics|analgesics|mesh-ancestor
64337109|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
64337110|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337116|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64337118|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337119|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337120|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337121|NCT03498703|Azathioprine|azathioprine|mesh-list
64337122|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
64381625|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381626|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381627|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64381628|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
64381629|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381630|NCT02429453|Thrombin|thrombin|mesh-list
64381631|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
64381632|NCT02429453|Coagulants|coagulants|mesh-ancestor
64381633|NCT02428751|Prednisone|prednisone|mesh-list
64381634|NCT02428751|Rituximab|rituximab|mesh-list
64381635|NCT02428751|Doxorubicin|doxorubicin|mesh-list
64381636|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64381656|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
64381657|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64381658|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64381659|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381660|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64337123|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337124|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64418080|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418081|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418082|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418083|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64418097|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
64418098|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418099|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418100|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64418101|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418102|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64418103|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418104|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418105|NCT02197039|Esomeprazole|esomeprazole|mesh-list
64418106|NCT02197039|Pantoprazole|pantoprazole|mesh-list
64418107|NCT02197039|Hemostatics|hemostatics|mesh-list
64418108|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64418109|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64418110|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64418111|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337126|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337127|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
64337128|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337129|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418112|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418113|NCT02197039|Coagulants|coagulants|mesh-ancestor
64418114|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64418115|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
64418116|NCT05557903|Antibodies|antibodies|mesh-list
64418117|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
64382677|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382678|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64382679|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382680|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418118|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64337131|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64337132|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64337133|NCT02324491|Growth Substances|growth substances|mesh-ancestor
64337134|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337135|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
64337136|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337137|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64337138|NCT03494257|Brinzolamide|brinzolamide|mesh-list
64337162|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64337163|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64337164|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64337165|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64337166|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
64418119|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
64418120|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418121|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418122|NCT02386839|Mecasermin|mecasermin|mesh-list
64418123|NCT02386839|Growth Substances|growth substances|mesh-ancestor
64418124|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418125|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64418126|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
64418127|NCT05347459|Empagliflozin|empagliflozin|mesh-list
64418128|NCT05347459|Linagliptin|linagliptin|mesh-list
64418129|NCT05347459|Canagliflozin|canagliflozin|mesh-list
64418131|NCT05347459|Saxagliptin|saxagliptin|mesh-list
64418132|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64418133|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418134|NCT05347459|Incretins|incretins|mesh-ancestor
64418135|NCT05347459|Hormones|hormones|mesh-ancestor
64418136|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418137|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64418138|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
64418139|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418140|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418143|NCT05346445|Citalopram|citalopram|mesh-list
64418144|NCT05346445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64418145|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64418146|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64418147|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337168|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337169|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337171|NCT03498235|Sevoflurane|sevoflurane|mesh-list
64337172|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64337173|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337174|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337175|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64337176|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
64337177|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
64337196|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337199|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
64337200|NCT04461925|Dexamethasone|dexamethasone|mesh-list
64337201|NCT04461925|Enoxaparin|enoxaparin|mesh-list
64337202|NCT04461925|Anticoagulants|anticoagulants|mesh-list
64337203|NCT04461925|Hormones|hormones|mesh-list
64337204|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337205|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
64337206|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
64337207|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337208|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337209|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337210|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
64337212|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64337213|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299351|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337214|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337215|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337216|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64337217|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64337218|NCT02325583|Midazolam|midazolam|mesh-list
64337219|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64337220|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64337221|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337222|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337223|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64337224|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64337225|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64337226|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64418148|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337227|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
64337228|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
64337229|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
64337230|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
64337231|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337232|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337233|NCT02321293|Curcumin|curcumin|mesh-list
64337234|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64337235|NCT02321293|Gefitinib|gefitinib|mesh-list
64337236|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337237|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64299352|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299353|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64337238|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337239|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337240|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64337241|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64337254|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64337255|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337256|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
64337257|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
64337258|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
64337260|NCT02321371|Lactulose|lactulose|mesh-list
64337261|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64337263|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337264|NCT04002037|Dexamethasone|dexamethasone|mesh-list
64337265|NCT04002037|Triamcinolone|triamcinolone|mesh-list
64337266|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64337267|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64337268|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64337269|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337270|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
64337288|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337289|NCT03546829|Vancomycin|vancomycin|mesh-list
64337290|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64337291|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337292|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
64337293|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64337294|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64337295|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64337296|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64337297|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382691|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382692|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64382693|NCT03117023|Analgesics|analgesics|mesh-ancestor
64382694|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
64382695|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382696|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64337298|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
64337299|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337300|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337301|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64337302|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337304|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64337305|NCT05118685|Hormones|hormones|mesh-ancestor
64337306|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337307|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337308|NCT03493087|Vitamin K|vitamin k|mesh-list
64337309|NCT03493087|Vitamins|vitamins|mesh-ancestor
64337310|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
64337311|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337312|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64337313|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64337314|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337315|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
64337316|NCT03493087|Coagulants|coagulants|mesh-ancestor
64337317|NCT03136627|Nivolumab|nivolumab|mesh-list
64337336|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64337339|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
64337340|NCT04881955|Ecopipam|ecopipam|mesh-list
64337341|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64337342|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64337343|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337344|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337345|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64337346|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64337347|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
64337348|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337349|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337350|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
64418173|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337351|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64337354|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
64337355|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337356|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337357|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
64337358|NCT03492931|Ticagrelor|ticagrelor|mesh-list
64337359|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64337360|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64337361|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64337377|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337378|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64337379|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64337381|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
64337382|NCT02234921|Imiquimod|imiquimod|mesh-list
64337383|NCT02234921|Vaccines|vaccines|mesh-list
64337384|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
64337385|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337386|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337387|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337388|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64337389|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
64337390|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337391|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337392|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64337393|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64337394|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
64337396|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64337397|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64337406|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
64337407|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337409|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64382702|NCT02097238|Halichondrin B|halichondrin b|mesh-list
64382703|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
64337410|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337411|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337412|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64337414|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
64337415|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337416|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64337417|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64337418|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64337419|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337420|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337421|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337422|NCT02259647|Sorafenib|sorafenib|mesh-list
64337440|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
64337441|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
64337442|NCT03490123|Azithromycin|azithromycin|mesh-list
64337443|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64337444|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337445|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
64337446|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64337447|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337448|NCT02182687|Doxorubicin|doxorubicin|mesh-list
64337449|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64337450|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64337451|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337532|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64337533|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
64337534|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64337535|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64337555|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
64418174|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418175|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64418176|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
64418177|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
64418178|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64418179|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64418180|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64418181|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64418182|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
64418183|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418184|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418185|NCT02385669|Ipilimumab|ipilimumab|mesh-list
64418186|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337556|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337558|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64337559|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64337560|NCT02934529|Growth Substances|growth substances|mesh-ancestor
64337561|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337562|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
64337563|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
64337564|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337568|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64337569|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64337570|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337571|NCT02934529|Antidotes|antidotes|mesh-ancestor
64337572|NCT02934529|Protective Agents|protective agents|mesh-ancestor
64337573|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
64337574|NCT02934529|Vitamins|vitamins|mesh-ancestor
64337575|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
64337576|NCT02934529|Hematinics|hematinics|mesh-ancestor
64337577|NCT02638805|Metformin|metformin|mesh-list
64418187|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418188|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64382704|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
64382705|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418189|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418190|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
64418191|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64418192|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64418193|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418194|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
64337580|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64337581|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337583|NCT02638805|Hormones|hormones|mesh-ancestor
64337584|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337585|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64337586|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
64337587|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64337588|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337589|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337590|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64337591|NCT02261675|Analgesics|analgesics|mesh-ancestor
64337592|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
64337593|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418195|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
64418197|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64418198|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64418199|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64418220|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
64418221|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
64418222|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418224|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64418225|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337594|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64337595|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64337596|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64337597|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337598|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337599|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337600|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64337602|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64337603|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64337604|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
64337605|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337606|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64418226|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64337607|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64337608|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337609|NCT02620553|Insulin|insulin|mesh-list
64337610|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64337611|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64337612|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337613|NCT04588727|Aspirin|aspirin|mesh-list
64337614|NCT04588727|Ticagrelor|ticagrelor|mesh-list
64337615|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64337616|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64337617|NCT04588727|Analgesics|analgesics|mesh-ancestor
64337618|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
64337623|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64337624|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64337625|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337626|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64337627|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64337628|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337629|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
64337630|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64337646|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64337647|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64337648|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
64418227|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418228|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
64418229|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418230|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
64418231|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418232|NCT05542615|Pirfenidone|pirfenidone|mesh-list
64418233|NCT05542615|Analgesics|analgesics|mesh-ancestor
64418234|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
64418235|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418236|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418237|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64418238|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64418239|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337649|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337650|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64337651|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64337652|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337653|NCT02262455|Doxorubicin|doxorubicin|mesh-list
64337654|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64337655|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64337656|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337657|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64337658|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64337659|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337660|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337661|NCT02262533|Atenolol|atenolol|mesh-list
64337662|NCT02262533|Apixaban|apixaban|mesh-list
64337663|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64337664|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
64337665|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64337666|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
64337667|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418241|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418242|NCT05700721|Niraparib|niraparib|mesh-list
64337668|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337671|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64337672|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
64337673|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
64337674|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337675|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337676|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64337677|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64337678|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64337679|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337680|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337681|NCT02262611|Telmisartan|telmisartan|mesh-list
64337682|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64337683|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64337690|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
64337691|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337692|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
64337693|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
64337694|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
64337695|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337696|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418243|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64337697|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337698|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
64337699|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64337700|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
64337701|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64382735|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
64382736|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
64382738|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64382739|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
64382740|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
64382741|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337702|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64337703|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337704|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64337706|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64337707|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337708|NCT02580305|Memantine|memantine|mesh-list
64337709|NCT02580305|Donepezil|donepezil|mesh-list
64337710|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
64337711|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64337712|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418244|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337713|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337716|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337717|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
64337718|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64418245|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418246|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418247|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
64418248|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418283|NCT05548075|Psilocybin|psilocybin|mesh-list
64337720|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
64337721|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64337722|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64337723|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64337724|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
64337725|NCT02515175|Vaccines|vaccines|mesh-list
64337726|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
64418284|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64418285|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
64418286|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418287|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64337727|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337728|NCT02513303|Sirolimus|sirolimus|mesh-list
64337729|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64337730|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337731|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64337732|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337733|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
64337734|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337735|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
64418288|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64418289|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
64418290|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418291|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418292|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64418293|NCT05554003|Temozolomide|temozolomide|mesh-list
64337736|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337739|NCT01616303|Oregovomab|oregovomab|mesh-list
64337740|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64337741|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337742|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
64337743|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
64337744|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
64337745|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337747|NCT01590719|Leucovorin|leucovorin|mesh-list
64337779|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337781|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64337782|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337783|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64337784|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64337785|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337786|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337787|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382742|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
64382743|NCT02422589|Ceritinib|ceritinib|mesh-list
64382744|NCT02422589|Midazolam|midazolam|mesh-list
64382746|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64382747|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64337788|NCT02264093|Propranolol|propranolol|mesh-list
64337789|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64337790|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64337791|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
64299354|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299355|NCT03836001|Serlopitant|serlopitant|mesh-list
64299356|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64299357|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299358|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299359|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337793|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337794|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337795|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64337797|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
64337798|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
64337799|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64337800|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64337801|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
64337802|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337811|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337812|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337813|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64337814|NCT01516073|Fluticasone|fluticasone|mesh-list
64337815|NCT01516073|Xhance|xhance|mesh-list
64337816|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337817|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64337818|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
64337819|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337820|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337821|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64337822|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
64337830|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
64337831|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
64337832|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337834|NCT01495013|Atorvastatin|atorvastatin|mesh-list
64337835|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64418294|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64418295|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
64418296|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418297|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418298|NCT05541757|Heparin|heparin|mesh-list
64418299|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
64418300|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64418301|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64418319|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
64418320|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418321|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418322|NCT04325503|Levodopa|levodopa|mesh-list
64418323|NCT04325503|Carbidopa|carbidopa|mesh-list
64418324|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64418325|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64418326|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
64418327|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418328|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418329|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418330|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64337837|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
64337838|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337839|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64337840|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64337841|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337842|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64337843|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64337844|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337845|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382753|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64382754|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
64382755|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
64382776|NCT02416739|Vitamins|vitamins|mesh-ancestor
64337846|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
64337861|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337862|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64337863|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
64337864|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337865|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64337867|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64337868|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64337869|NCT01480583|Alovudine|alovudine|mesh-list
64337872|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337889|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64337890|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337891|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64337892|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337893|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337894|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64337895|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64337994|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337995|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337996|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64337997|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64337998|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337999|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64338000|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64338002|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338003|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338004|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64338005|NCT04476173|Morphine|morphine|mesh-list
64338006|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
64338009|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338010|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338012|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
64338013|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338014|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64338015|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
64338035|NCT01355393|Sargramostim|sargramostim|mesh-list
64338036|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
64338037|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338038|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
64338039|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338040|NCT02266355|Omalizumab|omalizumab|mesh-list
64338041|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64338042|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64338044|NCT01348919|Dexamethasone|dexamethasone|mesh-list
64338049|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
64338050|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338051|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338052|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338053|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
64338054|NCT01348919|Hormones|hormones|mesh-ancestor
64338055|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338056|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64338057|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338058|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
64418331|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418332|NCT05540977|Donepezil|donepezil|mesh-list
64338059|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64338060|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64338061|NCT01348919|Growth Substances|growth substances|mesh-ancestor
64338062|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
64338063|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
64338064|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
64338065|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338066|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338110|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338111|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338113|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
64338114|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338115|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64338117|NCT02267681|Alfentanil|alfentanil|mesh-list
64338118|NCT02267681|Propofol|propofol|mesh-list
64338119|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64338120|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338121|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338122|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64338123|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
64338124|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
64418333|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64418334|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418335|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418336|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
64418337|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338125|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64338126|NCT02267681|Narcotics|narcotics|mesh-ancestor
64338127|NCT02267681|Analgesics|analgesics|mesh-ancestor
64338128|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
64338129|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338130|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64338131|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
64338132|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64338133|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64338134|NCT05177939|Prednisolone|prednisolone|mesh-list
64338135|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
64338136|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64338137|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
64338138|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
64338139|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64338153|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64338155|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
64338156|NCT05174507|Empagliflozin|empagliflozin|mesh-list
64338157|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64338167|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338168|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338169|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338170|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338171|NCT02267915|Rituximab|rituximab|mesh-list
64338172|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418338|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418339|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
64418340|NCT05547685|Methylene Blue|methylene blue|mesh-list
64418341|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338174|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
64338175|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338176|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338177|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
64338178|NCT02268149|Prednisone|prednisone|mesh-list
64338179|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338180|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
64338182|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338183|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338184|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64338185|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338186|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64338187|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
64338188|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338189|NCT01255709|Epinephrine|epinephrine|mesh-list
64338190|NCT01255709|Racepinephrine|racepinephrine|mesh-list
64338193|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64338194|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
64338195|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382782|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64382783|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
64382784|NCT02416583|Oxytocin|oxytocin|mesh-list
64338196|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338197|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338198|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64338199|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64338202|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64418342|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418344|NCT05540587|Edoxaban|edoxaban|mesh-list
64418345|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
64418346|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64418347|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
64338205|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
64338206|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64338208|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
64338209|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
64338210|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338211|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338212|NCT01253603|Fluticasone|fluticasone|mesh-list
64338214|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
64338217|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
64338218|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338219|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338220|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64338221|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
64338222|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64338223|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64338224|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64338225|NCT01253603|Growth Substances|growth substances|mesh-ancestor
64338226|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
64338227|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338228|NCT02268383|Luspatercept|luspatercept|mesh-list
64418348|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64418349|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
64418350|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418351|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418352|NCT05540431|Charcoal|charcoal|mesh-list
64418353|NCT05540431|Antidotes|antidotes|mesh-ancestor
64418354|NCT05540431|Protective Agents|protective agents|mesh-ancestor
64418430|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
64418431|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418432|NCT05550025|Apatinib|apatinib|mesh-list
64418433|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418434|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64418435|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418436|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418437|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
64418438|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64338229|NCT02268383|Hematinics|hematinics|mesh-ancestor
64338230|NCT01329419|Adefovir|adefovir|mesh-list
64338231|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64338232|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
64338233|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338234|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64338235|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64338236|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338237|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338238|NCT01235039|Insulin|insulin|mesh-list
64338239|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
64338240|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64338241|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64338242|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338243|NCT01234025|Prednisone|prednisone|mesh-list
64338244|NCT01234025|Docetaxel|docetaxel|mesh-list
64338247|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
64338248|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
64382785|NCT02416583|Dinoprostone|dinoprostone|mesh-list
64382786|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
64382787|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381668|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64381669|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
64381670|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381671|NCT02432651|Xanthohumol|xanthohumol|mesh-list
64381672|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381673|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64381674|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64381675|NCT02432651|Growth Substances|growth substances|mesh-ancestor
64381676|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381677|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
64381678|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64381679|NCT02707757|Hematinics|hematinics|mesh-ancestor
64381680|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
64381681|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64414856|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64414858|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414859|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414861|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64414862|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414863|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64414864|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414865|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414891|NCT02576639|CNP520|cnp520|mesh-list
64414912|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
64414913|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
64414914|NCT05529875|Propofol|propofol|mesh-list
64414915|NCT05529875|Sevoflurane|sevoflurane|mesh-list
64414916|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64414917|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414918|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414919|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64414920|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
64414921|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
64414922|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64414923|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64414924|NCT03051451|Metformin|metformin|mesh-list
64414925|NCT03051451|Fluoxetine|fluoxetine|mesh-list
64414926|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64414927|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414928|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64414929|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64414930|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414931|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414932|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414933|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
64414934|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64418459|NCT02580877|Methamphetamine|methamphetamine|mesh-list
64418460|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64418461|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418462|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64418463|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
64418464|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
64418465|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418466|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
64418467|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418468|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418469|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
64418470|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64418471|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64299360|NCT02465866|Promethazine|promethazine|mesh-list
64299361|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
64418519|NCT05678647|Iron|iron|mesh-list
64418520|NCT05678647|Trace Elements|trace elements|mesh-ancestor
64414935|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
64414936|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64414937|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64414938|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64414939|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414940|NCT02417961|Benralizumab|benralizumab|mesh-list
64414941|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64414942|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
64414943|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
64414944|NCT02869217|Fludarabine|fludarabine|mesh-list
64414952|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414953|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64414954|NCT04883125|Pioglitazone|pioglitazone|mesh-list
64299362|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299363|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64414955|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64414956|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414989|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414990|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
64415063|NCT02332577|Pristinamycin|pristinamycin|mesh-list
64415064|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64415065|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415066|NCT02326805|Metronidazole|metronidazole|mesh-list
64415067|NCT02326805|Vaccines|vaccines|mesh-list
64415068|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
64415069|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415070|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415071|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64415206|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64415207|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64299364|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
64415360|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64415361|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64415362|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
64415426|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415427|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
64415428|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415429|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415430|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
64415547|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415564|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415566|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64415567|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415568|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415569|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
64415570|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415571|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415630|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64415641|NCT04622735|Nefopam|nefopam|mesh-list
64415695|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415696|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64415697|NCT05531435|Anesthetics|anesthetics|mesh-list
64415698|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
64415785|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
64415786|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
64415787|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415788|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415789|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64415790|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64415792|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64415897|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415898|NCT04872907|Fluorides|fluorides|mesh-list
64415899|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
64415900|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
64415901|NCT04872907|Protective Agents|protective agents|mesh-ancestor
64382805|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64382806|NCT02416115|Morphine|morphine|mesh-list
64382807|NCT02416115|Ramosetron|ramosetron|mesh-list
64382808|NCT02416115|Naloxone|naloxone|mesh-list
64382809|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64415976|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64415977|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
64415978|NCT05506319|Coagulants|coagulants|mesh-ancestor
64415979|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64415980|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
64415981|NCT05505539|Fluorouracil|fluorouracil|mesh-list
64416093|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64416094|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64416096|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416097|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64416164|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416165|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416254|NCT04861207|Cladribine|cladribine|mesh-list
64416255|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416256|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416257|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
64416258|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416332|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416333|NCT03045133|Morphine|morphine|mesh-list
64416334|NCT03045133|Methadone|methadone|mesh-list
64416335|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64416336|NCT03045133|Narcotics|narcotics|mesh-ancestor
64416337|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416338|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416404|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64416405|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64416406|NCT03041779|Acetaminophen|acetaminophen|mesh-list
64416407|NCT03041779|Diclofenac|diclofenac|mesh-list
64416408|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64416409|NCT03041779|Analgesics|analgesics|mesh-ancestor
64416467|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416468|NCT02607865|Incretins|incretins|mesh-ancestor
64416469|NCT02607865|Hormones|hormones|mesh-ancestor
64416470|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416471|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64416472|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416473|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416474|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416475|NCT04856137|Paclitaxel|paclitaxel|mesh-list
64416476|NCT04856137|Rituximab|rituximab|mesh-list
64416527|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64416529|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416530|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
64416531|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416532|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416533|NCT04848181|Urological Agents|urological agents|mesh-ancestor
64416534|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
64416535|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416598|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64416600|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64416602|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
64416692|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416693|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416694|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417391|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417392|NCT04797793|Analgesics|analgesics|mesh-ancestor
64417393|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
64417394|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417477|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417560|NCT04802785|Citric Acid|citric acid|mesh-list
64417662|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64417663|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64417664|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
64417665|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417666|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64417760|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
64417761|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382810|NCT02416115|Narcotics|narcotics|mesh-ancestor
64417762|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64417763|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64417764|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417765|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417870|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64417871|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64417872|NCT05613361|Analgesics|analgesics|mesh-ancestor
64417873|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
64417874|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417877|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64417996|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417997|NCT04330729|Aspirin|aspirin|mesh-list
64417998|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64417999|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64418000|NCT04330729|Analgesics|analgesics|mesh-ancestor
64418064|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64418251|NCT05542381|Nepafenac|nepafenac|mesh-list
64418252|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64418280|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64418281|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
64418356|NCT05553067|Antibodies|antibodies|mesh-list
64418357|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
64418358|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418380|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
64418381|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418382|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64418383|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418508|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
64418509|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418510|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
64418511|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
64418513|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
64418545|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299366|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299367|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299368|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299369|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64299371|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64418551|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
64418552|NCT05461261|Docetaxel|docetaxel|mesh-list
64418553|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64418554|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
64418767|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
64418555|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418556|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
64418557|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418558|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418559|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418560|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64418561|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
64418562|NCT05461261|Hormones|hormones|mesh-ancestor
64418563|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418564|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418938|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
64418565|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64418566|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
64418567|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
64418568|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418569|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64418570|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64418571|NCT05461261|Protective Agents|protective agents|mesh-ancestor
64418572|NCT02586025|Docetaxel|docetaxel|mesh-list
64418605|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418606|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64418607|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418608|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418609|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
64418610|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64418611|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64418612|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418613|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418614|NCT02582671|Ritonavir|ritonavir|mesh-list
64418615|NCT02582671|Ribavirin|ribavirin|mesh-list
64418616|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64418627|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
64418628|NCT05696977|Cyclosporine|cyclosporine|mesh-list
64418629|NCT05696977|Cyclosporins|cyclosporins|mesh-list
64418630|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418631|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418632|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418633|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
64418634|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418635|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
64418636|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418637|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
64418638|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418639|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64418640|NCT05051449|Ketamine|ketamine|mesh-list
64418641|NCT05051449|Analgesics|analgesics|mesh-ancestor
64418642|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
64418643|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419646|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418644|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418645|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64418646|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64418647|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
64418648|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
64418653|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418654|NCT02585713|Dalteparin|dalteparin|mesh-list
64418655|NCT02585713|Tinzaparin|tinzaparin|mesh-list
64418657|NCT02585713|Apixaban|apixaban|mesh-list
64418658|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64418659|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
64419979|NCT04582669|Hormones|hormones|mesh-ancestor
64418660|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64418661|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
64418663|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418664|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
64418665|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64418668|NCT05678257|Bevacizumab|bevacizumab|mesh-list
64418669|NCT05678257|Fluorouracil|fluorouracil|mesh-list
64418670|NCT05678257|Irinotecan|irinotecan|mesh-list
64418671|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
64418672|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418673|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418674|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418675|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64418676|NCT05678257|Growth Substances|growth substances|mesh-ancestor
64418677|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418678|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
64418679|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
64418680|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418718|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418719|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
64418743|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418745|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64418746|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418747|NCT02582515|Cycloserine|cycloserine|mesh-list
64418748|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64418749|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418750|NCT02582515|Renal Agents|renal agents|mesh-ancestor
64418751|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64418752|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
64418754|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
64418755|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418756|NCT02579629|Ropivacaine|ropivacaine|mesh-list
64418757|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
64418759|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418760|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420630|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
64418761|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
64418762|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418763|NCT05677633|Sargramostim|sargramostim|mesh-list
64418764|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
64418765|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418766|NCT05677555|Colchicine|colchicine|mesh-list
64418768|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418836|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
64418837|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64418838|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64418839|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64418840|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418841|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64418842|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418843|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64418874|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64418883|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418884|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418885|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418886|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421151|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
64418888|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64418889|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418908|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
64418909|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418910|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418911|NCT05696431|Fluorides|fluorides|mesh-list
64418912|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
64418913|NCT05696431|Protective Agents|protective agents|mesh-ancestor
64418915|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
64418916|NCT05628883|Fludarabine|fludarabine|mesh-list
64418917|NCT05628883|Interleukin-2|interleukin-2|mesh-list
64418918|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418919|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
64418920|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418921|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418922|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64421383|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64421384|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
64421385|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421386|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421387|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421388|NCT02535715|Insulin|insulin|mesh-list
64421389|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64421390|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64418923|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
64418924|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418925|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418926|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64418927|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64418929|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
64418930|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418931|NCT05575219|Clonidine|clonidine|mesh-list
64418932|NCT05575219|Analgesics|analgesics|mesh-ancestor
64421436|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64418933|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
64418934|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418935|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418936|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64382813|NCT02416115|Analgesics|analgesics|mesh-ancestor
64418937|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
64418939|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64418940|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64418942|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
64418943|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418944|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418971|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418972|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64418973|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64418974|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
64418975|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418976|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64418977|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64418978|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
64418979|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64418980|NCT05569681|Bemiparin|bemiparin|mesh-list
64418981|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
64418982|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64418984|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418997|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418998|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418999|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64419000|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
64419001|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419002|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419003|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64419004|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64419005|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64419006|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64419007|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419008|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419009|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
64419010|NCT00352027|Hormones|hormones|mesh-ancestor
64419011|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419012|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419013|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419014|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
64419015|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419016|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419017|NCT04084717|Crizotinib|crizotinib|mesh-list
64422411|NCT02364999|Paclitaxel|paclitaxel|mesh-list
64419018|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419019|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64419020|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419033|NCT04076059|Androgens|androgens|mesh-list
64419034|NCT04076059|Hormones|hormones|mesh-ancestor
64419035|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419036|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419037|NCT02576977|Dexamethasone|dexamethasone|mesh-list
64419038|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
64419039|NCT02576977|Pomalidomide|pomalidomide|mesh-list
64419040|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419041|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
64419042|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
64419043|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419044|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419045|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419046|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
64419048|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419049|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64299372|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299373|NCT05052008|Analgesics|analgesics|mesh-ancestor
64299374|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
64382814|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
64382835|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382836|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382838|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64299375|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419053|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64419054|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419055|NCT02576977|Growth Substances|growth substances|mesh-ancestor
64419056|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
64419057|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64419058|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
64419059|NCT04016389|Paclitaxel|paclitaxel|mesh-list
64419060|NCT04016389|Carboplatin|carboplatin|mesh-list
64419061|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419062|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419063|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
64419064|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419065|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419066|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419067|NCT03908437|Buprenorphine|buprenorphine|mesh-list
64419068|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64419071|NCT03908437|Narcotics|narcotics|mesh-ancestor
64419072|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419073|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419075|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
64419076|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419077|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64419078|NCT04425187|Bevacizumab|bevacizumab|mesh-list
64419079|NCT04425187|Gefitinib|gefitinib|mesh-list
64423295|NCT01659151|Analgesics|analgesics|mesh-ancestor
64419080|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419081|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419082|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64419083|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419103|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419104|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
64423359|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
64419105|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419106|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419107|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419108|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419109|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
64419110|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64419111|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419113|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64419114|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64419115|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419116|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419117|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
64419118|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419119|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419120|NCT05529355|Tegafur|tegafur|mesh-list
64419121|NCT05529355|Endostar protein|endostar protein|mesh-list
64419122|NCT05529355|Endostatins|endostatins|mesh-list
64419123|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64419124|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
64423579|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64419125|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419126|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419127|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64419128|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419129|NCT05529355|Growth Substances|growth substances|mesh-ancestor
64419169|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419170|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419172|NCT02813785|Atezolizumab|atezolizumab|mesh-list
64382839|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64382841|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64382843|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64382844|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419173|NCT02813785|Antibodies|antibodies|mesh-list
64419174|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
64419175|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419176|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419177|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
64419178|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419179|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419180|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419192|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64419193|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64419194|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
64419195|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419196|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419197|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424404|NCT05010421|Clobetasol|clobetasol|mesh-list
64419198|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
64419199|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
64419200|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419201|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
64419202|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64419203|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
64419205|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64424573|NCT02354235|Canagliflozin|canagliflozin|mesh-list
64419206|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419207|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
64419208|NCT02431897|Estrogens|estrogens|mesh-list
64419209|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64419210|NCT02431897|Hormones|hormones|mesh-ancestor
64419211|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419212|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419213|NCT05532163|Natalizumab|natalizumab|mesh-list
64419214|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
64424810|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64419215|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419216|NCT05532085|Analgesics|analgesics|mesh-list
64419217|NCT05532085|Anesthetics|anesthetics|mesh-list
64419218|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419219|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419220|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
64419221|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419234|NCT01640587|Piperaquine|piperaquine|mesh-list
64419235|NCT01640587|Artenimol|artenimol|mesh-list
64419236|NCT01640587|Mefloquine|mefloquine|mesh-list
64419237|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
64419238|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64419239|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64419240|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419241|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419242|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
64419243|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
64419244|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64419245|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
64419246|NCT01610713|Nabiximols|nabiximols|mesh-list
64419273|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
64419275|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
64419276|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
64425291|NCT02463331|Prednisone|prednisone|mesh-list
64419277|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419278|NCT05526469|Bupivacaine|bupivacaine|mesh-list
64419279|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
64419280|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
64425471|NCT05416229|Psilocybin|psilocybin|mesh-list
64419281|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419282|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419283|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
64419284|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382850|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
64382851|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
64425562|NCT02436889|Mirabegron|mirabegron|mesh-list
64419286|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
64419287|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419288|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419289|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64419290|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64419291|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
64419292|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419293|NCT02380287|Antibodies|antibodies|mesh-list
64419294|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64419295|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
64419328|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
64419329|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419330|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419331|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64419332|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64419333|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419334|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425791|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
64419336|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64419362|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64419363|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419374|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64419375|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64419376|NCT05122741|Analgesics|analgesics|mesh-ancestor
64419377|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
64419378|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419379|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419380|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426249|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419383|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64419384|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419385|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64419386|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64419387|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419406|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64419407|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419408|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419409|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419411|NCT02340975|Tremelimumab|tremelimumab|mesh-list
64419412|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64426378|NCT04446039|Citalopram|citalopram|mesh-list
64382862|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382863|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382864|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
64382865|NCT02415569|Bisacodyl|bisacodyl|mesh-list
64382866|NCT02415569|Cathartics|cathartics|mesh-ancestor
64382867|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382890|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64382893|NCT02415179|Fluticasone|fluticasone|mesh-list
64382894|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
64382895|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
64382896|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64419413|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419414|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426469|NCT03591861|Carmustine|carmustine|mesh-list
64419416|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419417|NCT02392377|Leucovorin|leucovorin|mesh-list
64419418|NCT02392377|Paclitaxel|paclitaxel|mesh-list
64419419|NCT02392377|Carboplatin|carboplatin|mesh-list
64419420|NCT02392377|Fluorouracil|fluorouracil|mesh-list
64419421|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
64419423|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
64426793|NCT02233647|Cocaine|cocaine|mesh-list
64419424|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419425|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419426|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
64419427|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419428|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419505|NCT02569957|Expectorants|expectorants|mesh-ancestor
64419506|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
64419515|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419516|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64419518|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419519|NCT05521633|Metformin|metformin|mesh-list
64419520|NCT05521633|Pioglitazone|pioglitazone|mesh-list
64419521|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64419522|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381682|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381703|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381704|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
64381705|NCT05518383|Cytarabine|cytarabine|mesh-list
64381706|NCT05518383|Dexamethasone|dexamethasone|mesh-list
64381707|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
64381708|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
64381713|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64419524|NCT04411693|Aflibercept|aflibercept|mesh-list
64419525|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419526|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
64419527|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
64419528|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419529|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419530|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419531|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
64419532|NCT04411693|Hormones|hormones|mesh-ancestor
64428136|NCT02132247|Analgesics|analgesics|mesh-ancestor
64381714|NCT05518383|Methotrexate|methotrexate|mesh-list
64419533|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419534|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419535|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419536|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64428203|NCT01933594|Romidepsin|romidepsin|mesh-list
64419537|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419538|NCT04411693|Growth Substances|growth substances|mesh-ancestor
64419539|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
64419540|NCT02336607|Metoprolol|metoprolol|mesh-list
64419541|NCT02336607|Felodipine|felodipine|mesh-list
64419542|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64419543|NCT02336607|Lisinopril|lisinopril|mesh-list
64419545|NCT02336607|Diuretics|diuretics|mesh-ancestor
64419546|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
64419547|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419573|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
64419574|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419575|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419577|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64419578|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64419579|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64381715|NCT05518383|Etoposide|etoposide|mesh-list
64382897|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64382898|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382899|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64382900|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
64382901|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382902|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381727|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381728|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381729|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64419580|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
64419581|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381730|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381731|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
64419587|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419589|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
64419590|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64419591|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419592|NCT04292743|Leucovorin|leucovorin|mesh-list
64428605|NCT04422275|Budesonide|budesonide|mesh-list
64419593|NCT04292743|Fluorouracil|fluorouracil|mesh-list
64419611|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
64419612|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64419613|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64419614|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64428745|NCT05323487|Bumetanide|bumetanide|mesh-list
64419615|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64419616|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419617|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419618|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419619|NCT05086393|Analgesics|analgesics|mesh-ancestor
64419620|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
64428979|NCT02155881|Hormones|hormones|mesh-ancestor
64419621|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419622|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
64419623|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64419624|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
64419625|NCT02571049|Sumatriptan|sumatriptan|mesh-list
64419626|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64419627|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64419628|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64429070|NCT02118597|Interferons|interferons|mesh-list
64419629|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
64419630|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419631|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419632|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429134|NCT05254925|Emollients|emollients|mesh-ancestor
64419635|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419636|NCT04295941|Trazodone|trazodone|mesh-list
64419637|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64419638|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64419639|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419640|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419641|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64419642|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64419643|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64381732|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
64381733|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381734|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381751|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64381752|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64381753|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
64381754|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381755|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
64381756|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
64381757|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
64381758|NCT02432027|Betamethasone|betamethasone|mesh-list
64381759|NCT02432027|Calcipotriene|calcipotriene|mesh-list
64381760|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381761|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
64419650|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64419651|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419663|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419664|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419665|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64429241|NCT02175771|Hormones|hormones|mesh-ancestor
64419666|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64419668|NCT05515315|Nedaplatin|nedaplatin|mesh-list
64419669|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419670|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419671|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
64419672|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419673|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429348|NCT05239091|Lidocaine|lidocaine|mesh-list
64419674|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419676|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64419677|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419678|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419679|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64419680|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
64419682|NCT04847947|Vitamin D|vitamin d|mesh-list
64419683|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
64419684|NCT04847947|Vitamins|vitamins|mesh-ancestor
64419685|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
64419686|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419687|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64419688|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64419689|NCT05514925|Bevacizumab|bevacizumab|mesh-list
64419690|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419691|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419692|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64419693|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419694|NCT05514925|Growth Substances|growth substances|mesh-ancestor
64419695|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419696|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
64419697|NCT05514847|Aspirin|aspirin|mesh-list
64419698|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64419700|NCT05514847|Analgesics|analgesics|mesh-ancestor
64419701|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
64419702|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429758|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
64419703|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419711|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419712|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
64419713|NCT05510323|Prednisolone|prednisolone|mesh-list
64419714|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64419749|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419750|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
64419752|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419753|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419754|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419778|NCT04812379|Aripiprazole|aripiprazole|mesh-list
64419779|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
64419780|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64419781|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64419782|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64419783|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419784|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419785|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
64419786|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
64419787|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586456|NCT00429403|Goserelin|goserelin|mesh-list
64419788|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419789|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64419790|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64419792|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64419793|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64382904|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
64586520|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
64419794|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64419795|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64419796|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
64419797|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64419798|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
64586593|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
64419799|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64419800|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
64419801|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419802|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419830|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419831|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419832|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64419834|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419835|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419836|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64419837|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64419838|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419839|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
64419841|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
64419842|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419843|NCT05509153|Expectorants|expectorants|mesh-ancestor
64419844|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
64419845|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64419847|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419848|NCT05509153|Protective Agents|protective agents|mesh-ancestor
64419849|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586948|NCT00467389|Donepezil|donepezil|mesh-list
64419850|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64419851|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64419852|NCT04584853|Tamoxifen|tamoxifen|mesh-list
64419853|NCT04584853|Letrozole|letrozole|mesh-list
64419876|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419878|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
64419879|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64419880|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587151|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419889|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64419890|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64419891|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64419892|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419893|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419894|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
64419895|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299397|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299398|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419896|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64587433|NCT00412841|Atorvastatin|atorvastatin|mesh-list
64419898|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64419899|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64419917|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64419918|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64419919|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64419920|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419921|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419922|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64419923|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419924|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419925|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64299400|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
64299401|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
64299402|NCT05065658|Posaconazole|posaconazole|mesh-list
64299403|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
64419926|NCT02311881|Acetaminophen|acetaminophen|mesh-list
64419927|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64419928|NCT02311881|Analgesics|analgesics|mesh-ancestor
64419929|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
64419930|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419931|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419933|NCT02565511|CNP520|cnp520|mesh-list
64419934|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419935|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587718|NCT01396148|Sunitinib|sunitinib|mesh-list
64419936|NCT04549051|Anesthetics|anesthetics|mesh-list
64419937|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
64419938|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419939|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419940|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
64419941|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419942|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
64419943|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64419944|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64419945|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419946|NCT05505253|Vitamins|vitamins|mesh-ancestor
64419947|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
64419948|NCT04697719|Aspirin|aspirin|mesh-list
64419949|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64419950|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64419951|NCT04697719|Analgesics|analgesics|mesh-ancestor
64419952|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
64419953|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419954|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419955|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419957|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64419973|NCT04582669|Triamcinolone|triamcinolone|mesh-list
64587921|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
64419974|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64419975|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64587982|NCT00534833|Vaccines|vaccines|mesh-list
64419977|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419978|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
64588051|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64419980|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419981|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419982|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419983|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
64419984|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419985|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419986|NCT02335983|Dexamethasone|dexamethasone|mesh-list
64419987|NCT02335983|Lenalidomide|lenalidomide|mesh-list
64419988|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419989|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
64419990|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
64419991|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419992|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419993|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419994|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
64419996|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419997|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419998|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588271|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
64419999|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
64420000|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64420001|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64420002|NCT02335983|Growth Substances|growth substances|mesh-ancestor
64420003|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
64420004|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
64420005|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
64420006|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64420012|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64420013|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64420014|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64420015|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64420016|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420049|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
64588472|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
64420050|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420051|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420052|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64420053|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
64420054|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
64420055|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64420056|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64588543|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588544|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588545|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
64420058|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64420059|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
64420079|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420080|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420081|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64420082|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
64420083|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64420084|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
64420085|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
64588693|NCT00504751|Rituximab|rituximab|mesh-list
64420086|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420087|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420088|NCT04572763|Venetoclax|venetoclax|mesh-list
64420089|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420090|NCT05093959|Metformin|metformin|mesh-list
64420091|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64420092|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420093|NCT04411537|Capecitabine|capecitabine|mesh-list
64420095|NCT04411537|Antibodies|antibodies|mesh-list
64382905|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
64382906|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64382907|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64382908|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64382909|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64420096|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
64420097|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420098|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64420099|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
64420100|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420101|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420102|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64420103|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64588822|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420104|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420105|NCT04630171|Anesthetics|anesthetics|mesh-list
64588824|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
64420106|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588956|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64420107|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420108|NCT05503147|Nabiximols|nabiximols|mesh-list
64420109|NCT05503147|Analgesics|analgesics|mesh-ancestor
64420110|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
64299404|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299405|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64299406|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64299407|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64299408|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64420111|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420112|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420114|NCT04619095|Cathartics|cathartics|mesh-ancestor
64420115|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64420116|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64420117|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64420118|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420119|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
64420120|NCT05502991|Bevacizumab|bevacizumab|mesh-list
64589094|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
64420158|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64420159|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420192|NCT02559505|Vaccines|vaccines|mesh-list
64420193|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
64420194|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420195|NCT04471597|Bupivacaine|bupivacaine|mesh-list
64420196|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
64420197|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
64420198|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420199|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420200|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
64420201|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420238|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64420239|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64420240|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
64420241|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64420289|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420290|NCT05494567|Urological Agents|urological agents|mesh-ancestor
64420291|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64420292|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64420293|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64420294|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64420295|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420296|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420297|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64420298|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64420299|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
64420301|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
64420302|NCT04339777|Busulfan|busulfan|mesh-list
64420303|NCT04339777|Fludarabine|fludarabine|mesh-list
64420304|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
64382919|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64382952|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64382953|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64382954|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64382955|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
64420305|NCT04339777|Tacrolimus|tacrolimus|mesh-list
64420306|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420307|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
64589444|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
64420308|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420309|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64420310|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64420311|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
64420313|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420314|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64420315|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64420316|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420317|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64420318|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64420319|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
64420320|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64420321|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420322|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420323|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
64420325|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420327|NCT05494411|Mitomycin|mitomycin|mesh-list
64420328|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64420329|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420330|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
64420331|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420332|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64420333|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420335|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420336|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420337|NCT04080895|Lumefantrine|lumefantrine|mesh-list
64420338|NCT04080895|Artemether|artemether|mesh-list
64420339|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64420353|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420354|NCT04279561|Edetic Acid|edetic acid|mesh-list
64420356|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
64420357|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
64420358|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420359|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
64420360|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64420361|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64420362|NCT01662895|Deferoxamine|deferoxamine|mesh-list
64420363|NCT01662895|Siderophores|siderophores|mesh-ancestor
64420364|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64420365|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
64420366|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
64420367|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420369|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64420370|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
64420371|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64590063|NCT03934814|Rituximab|rituximab|mesh-list
64420372|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420373|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64420374|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420376|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420377|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64420378|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420379|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420380|NCT05498857|Ephedrine|ephedrine|mesh-list
64420381|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64420382|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420383|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
64420384|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
64420392|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64590421|NCT00492089|Bevacizumab|bevacizumab|mesh-list
64420393|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420394|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420395|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64382957|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382960|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64382961|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590486|NCT04147754|Narcotics|narcotics|mesh-ancestor
64420396|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64420397|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
64420398|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64420399|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64590562|NCT03921242|Metformin|metformin|mesh-list
64420400|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420401|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
64420448|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
64420449|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64420450|NCT02555683|Growth Substances|growth substances|mesh-ancestor
64420451|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420452|NCT02554981|Cyclosporine|cyclosporine|mesh-list
64420453|NCT02554981|Cyclosporins|cyclosporins|mesh-list
64420485|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
64420486|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420487|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
64420488|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64420489|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64420490|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64420491|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64299409|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64299410|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299411|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299412|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64299413|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
64420513|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
64420514|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420515|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64420516|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
64420517|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420518|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420519|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64420520|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64420521|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64420522|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
64420523|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
64590896|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
64420524|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64420525|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64420526|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420528|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
64420529|NCT05484817|Hormones|hormones|mesh-list
64420530|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64420531|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420532|NCT05484583|Carboplatin|carboplatin|mesh-list
64420533|NCT05484583|Etoposide|etoposide|mesh-list
64420534|NCT05484583|Durvalumab|durvalumab|mesh-list
64420535|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64591035|NCT00499109|Gemcitabine|gemcitabine|mesh-list
64420536|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420537|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64420538|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64420539|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64591107|NCT00615433|Olanzapine|olanzapine|mesh-list
64420540|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420541|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420542|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420543|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
64420544|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420546|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
64420547|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420548|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299414|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299415|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299416|NCT02102815|Dexamethasone|dexamethasone|mesh-list
64420550|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64420551|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
64420552|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420554|NCT05479357|Carbetocin|carbetocin|mesh-list
64591307|NCT03620123|Nivolumab|nivolumab|mesh-list
64420555|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
64420556|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64420557|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420558|NCT05487391|Paclitaxel|paclitaxel|mesh-list
64420559|NCT05487391|Vinorelbine|vinorelbine|mesh-list
64420560|NCT05487391|Carboplatin|carboplatin|mesh-list
64420589|NCT04274179|Lamotrigine|lamotrigine|mesh-list
64420590|NCT04274179|Valproic Acid|valproic acid|mesh-list
64420591|NCT04274179|Ethosuximide|ethosuximide|mesh-list
64591385|NCT03589040|Darunavir|darunavir|mesh-list
64420593|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64420594|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64420595|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420596|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64420597|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420598|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64420599|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64420600|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420601|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64420602|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64420603|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420604|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
64420605|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420606|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
64420617|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
64420618|NCT04268407|Amoxicillin|amoxicillin|mesh-list
64420619|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
64420620|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
64420621|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64420622|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64420623|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420624|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64420625|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420626|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420627|NCT05487001|Dexamethasone|dexamethasone|mesh-list
64420628|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420629|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
64420631|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420647|NCT05475613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420648|NCT05475379|Vaccines|vaccines|mesh-list
64383000|NCT01663857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383001|NCT01663857|Immunologic Factors|immunologic factors|mesh-ancestor
64383030|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64383031|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64420649|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
64420650|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420651|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
64420652|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
64420653|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420654|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
64420655|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420656|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420657|NCT03684811|Gemcitabine|gemcitabine|mesh-list
64420658|NCT03684811|Nivolumab|nivolumab|mesh-list
64420659|NCT03684811|Azacitidine|azacitidine|mesh-list
64592703|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
64420660|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420661|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64420662|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
64420663|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420664|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
64420665|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420666|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420667|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420668|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
64420669|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420699|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64420700|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
64420701|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64420702|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64420703|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
64420704|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64420705|NCT04542733|Everolimus|everolimus|mesh-list
64420706|NCT04542733|Tacrolimus|tacrolimus|mesh-list
64420707|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420708|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
64420709|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420710|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64420711|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420712|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420713|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420715|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
64420716|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420718|NCT05477797|Ixazomib|ixazomib|mesh-list
64420719|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
64420727|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420728|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420729|NCT03386929|Palbociclib|palbociclib|mesh-list
64420730|NCT03386929|Avelumab|avelumab|mesh-list
64420731|NCT03386929|Axitinib|axitinib|mesh-list
64420732|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420733|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64420734|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420735|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420736|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420737|NCT05472337|Colchicine|colchicine|mesh-list
64420738|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
64420739|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64420740|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
64420741|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
64420742|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
64383033|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383034|NCT04887831|Gemcitabine|gemcitabine|mesh-list
64383035|NCT04887831|Carboplatin|carboplatin|mesh-list
64383036|NCT04887831|Avelumab|avelumab|mesh-list
64383037|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383038|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64383039|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
64383040|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383041|NCT04887831|Antiviral Agents|antiviral agents|mesh-ancestor
64593402|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
64420743|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420744|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420745|NCT05472259|Leucovorin|leucovorin|mesh-list
64420746|NCT05472259|Fluorouracil|fluorouracil|mesh-list
64420747|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
64420748|NCT05472259|Irinotecan|irinotecan|mesh-list
64420749|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
64420750|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420751|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64299436|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
64299437|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
64299438|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299439|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383047|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383048|NCT02414009|Leucovorin|leucovorin|mesh-list
64383096|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
64383097|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
64383098|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383099|NCT00704483|Hematinics|hematinics|mesh-ancestor
64383100|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
64383101|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383102|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64383109|NCT05511441|Aspirin|aspirin|mesh-list
64383110|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64383111|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64383112|NCT05511441|Analgesics|analgesics|mesh-ancestor
64383113|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
64383114|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420764|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
64420765|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64299440|NCT02102971|Liver Extracts|liver extracts|mesh-list
64299441|NCT02102971|Hematinics|hematinics|mesh-ancestor
64299443|NCT05043350|Famotidine|famotidine|mesh-list
64299444|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64299445|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299446|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64299447|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
64299448|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
64299449|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299450|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299451|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299452|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
64299462|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299463|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299464|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
64383115|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383116|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383117|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383118|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64383119|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64383120|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383121|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64383122|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64383123|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383124|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
64383125|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64383126|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64383128|NCT02413541|Polymyxin B|polymyxin b|mesh-list
64383130|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383132|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64383133|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
64383157|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
64383158|NCT02569437|Hormones|hormones|mesh-ancestor
64383159|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383160|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64383161|NCT02569437|Protective Agents|protective agents|mesh-ancestor
64383162|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64299465|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64299466|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64299467|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299468|NCT02103049|Ezetimibe|ezetimibe|mesh-list
64299469|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64299470|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299471|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
64420777|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420778|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64420780|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420781|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64420782|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420783|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64420784|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420785|NCT02554279|Menotropins|menotropins|mesh-list
64420786|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64420833|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64420834|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64420835|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64420836|NCT02370615|Protective Agents|protective agents|mesh-ancestor
64420837|NCT02307513|Apremilast|apremilast|mesh-list
64420838|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64383163|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383164|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64383165|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383166|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
64383167|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64420839|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64420840|NCT02307513|Analgesics|analgesics|mesh-ancestor
64420841|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
64420842|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420843|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420844|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420845|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64420846|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64420847|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64420848|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594356|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64594357|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594364|NCT02168829|Aspirin|aspirin|mesh-list
64594365|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
64594366|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64594367|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64420849|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420851|NCT02328105|Carboplatin|carboplatin|mesh-list
64420852|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64383168|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64383169|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64383170|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64383171|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
64383172|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64383173|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64383174|NCT02412449|Glycine|glycine|mesh-list
64383175|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
64383176|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383177|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383178|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383180|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64383181|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
64383182|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64383183|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
64383184|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64383185|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
64383186|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420853|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64594496|NCT01677962|Poly ICLC|poly iclc|mesh-list
64420854|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420855|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
64420856|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
64420857|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
64420858|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420859|NCT02305797|Lorazepam|lorazepam|mesh-list
64420860|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
64420861|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
64420862|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
64420863|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420864|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420865|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64420866|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64420867|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420868|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64420869|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64420870|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64420871|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
64420888|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420889|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
64420890|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420891|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420892|NCT03570619|Nivolumab|nivolumab|mesh-list
64420893|NCT03570619|Ipilimumab|ipilimumab|mesh-list
64420894|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420895|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420896|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64420897|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420898|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
64420899|NCT04539379|Analgesics|analgesics|mesh-ancestor
64420900|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
64594832|NCT03086564|Hormones|hormones|mesh-ancestor
64420901|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420902|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420904|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420905|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64420906|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
64420907|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64420908|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594894|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
64420909|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420910|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64420911|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
64383384|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64383385|NCT02410031|Cyproterone|cyproterone|mesh-list
64383386|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
64383387|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64383388|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64383389|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64383390|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
64383391|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64420912|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64420913|NCT05470075|Tramadol|tramadol|mesh-list
64299473|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299474|NCT03099278|Ezetimibe|ezetimibe|mesh-list
64299475|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64299476|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299477|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
64299478|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299479|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299480|NCT02172651|Vitamin D|vitamin d|mesh-list
64299481|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
64299482|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
64299483|NCT02172651|Vitamins|vitamins|mesh-list
64299484|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
64299485|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299486|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64420914|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64420915|NCT05470075|Narcotics|narcotics|mesh-ancestor
64420916|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420917|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420918|NCT05470075|Analgesics|analgesics|mesh-ancestor
64420919|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
64420920|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420921|NCT05481619|Vedolizumab|vedolizumab|mesh-list
64420922|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64420923|NCT02305563|Cytarabine|cytarabine|mesh-list
64420924|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64420925|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
64383407|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383408|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383409|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64383410|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64383411|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64383412|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64383413|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
64383414|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383415|NCT02067676|Antacids|antacids|mesh-ancestor
64383416|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383417|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64383436|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383437|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64383438|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
64383439|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383440|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383441|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64383442|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
64383443|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
64383445|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383447|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64420926|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420927|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420928|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
64420929|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420930|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420931|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
64420932|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420933|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
64420963|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
64420964|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420965|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
64420966|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64420967|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
64420968|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420969|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420970|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64420971|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
64420972|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
64420973|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64420974|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
64420975|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420976|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420977|NCT05284643|Bevacizumab|bevacizumab|mesh-list
64420988|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64420989|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64420990|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420991|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
64420992|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
64420993|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
64420995|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
64383450|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383451|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64383452|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383453|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383454|NCT02065570|Adalimumab|adalimumab|mesh-list
64383455|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383457|NCT02408705|Acetaminophen|acetaminophen|mesh-list
64420996|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381762|NCT02432027|Hormones|hormones|mesh-ancestor
64381763|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381764|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420997|NCT04532645|Olaparib|olaparib|mesh-list
64381765|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64381766|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
64381767|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
64381768|NCT02428439|Lamotrigine|lamotrigine|mesh-list
64381769|NCT02428439|Bupropion|bupropion|mesh-list
64381770|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64381771|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
64381772|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64381773|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64381774|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64381775|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64381776|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381777|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
64383466|NCT02408705|Incretins|incretins|mesh-ancestor
64383467|NCT02408705|Hormones|hormones|mesh-ancestor
64383468|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383469|NCT05509569|Icatibant|icatibant|mesh-list
64383470|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64383471|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64383472|NCT05509569|Analgesics|analgesics|mesh-ancestor
64383473|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
64383475|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383476|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383492|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
64383493|NCT05507697|Vitamins|vitamins|mesh-ancestor
64383494|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
64383495|NCT04292223|Pimavanserin|pimavanserin|mesh-list
64381778|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381779|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381780|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64381781|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64381782|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381783|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
64381784|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64381785|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64381786|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64381787|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64381788|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383496|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64383497|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64383498|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64383499|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64383500|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381789|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64381790|NCT03186443|Pregabalin|pregabalin|mesh-list
64420998|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64420999|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421000|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421001|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421002|NCT02560025|Cytarabine|cytarabine|mesh-list
64421003|NCT02560025|Daunorubicin|daunorubicin|mesh-list
64421004|NCT02560025|Idarubicin|idarubicin|mesh-list
64421005|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64421006|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
64421007|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421008|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421009|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
64421010|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421011|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421012|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
64421013|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421014|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64421015|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64383503|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64383504|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64383506|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383507|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383508|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64421016|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64595513|NCT00571259|Gentamicins|gentamicins|mesh-list
64421017|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421018|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64421019|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64421020|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421021|NCT04524455|Dexamethasone|dexamethasone|mesh-list
64421022|NCT04524455|Blinatumomab|blinatumomab|mesh-list
64421023|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421024|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
64421025|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
64421026|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421027|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421028|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421029|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
64421030|NCT04524455|Hormones|hormones|mesh-ancestor
64383509|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
64383510|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64383511|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64383513|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383515|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64383516|NCT03174041|Midazolam|midazolam|mesh-list
64383517|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64383518|NCT03174041|Simvastatin|simvastatin|mesh-list
64383519|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64383520|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64383521|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383522|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383523|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64383526|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64383527|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
64383528|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
64383529|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
64383530|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
64383531|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383532|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383533|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64383534|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64383535|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
64383565|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64383566|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421031|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595642|NCT04386499|Protective Agents|protective agents|mesh-ancestor
64595645|NCT00573287|Risperidone|risperidone|mesh-list
64421032|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64421033|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421034|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
64421035|NCT04411901|Vitamin D|vitamin d|mesh-list
64595713|NCT01277185|Calcium|calcium|mesh-list
64421036|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64421037|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421038|NCT04411901|Vitamins|vitamins|mesh-ancestor
64421039|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
64421040|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64421041|NCT05508815|Methotrexate|methotrexate|mesh-list
64421042|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64383567|NCT03173963|Empagliflozin|empagliflozin|mesh-list
64383568|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64383569|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383570|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64383571|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383572|NCT05507229|Vaccines|vaccines|mesh-list
64383573|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
64383574|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383575|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
64383576|NCT03173417|Fludarabine|fludarabine|mesh-list
64383577|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383669|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64383670|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383672|NCT02701985|Petesicatib|petesicatib|mesh-list
64383673|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383674|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383675|NCT02406521|Sorafenib|sorafenib|mesh-list
64383676|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64383677|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383710|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383711|NCT05502705|Lidocaine|lidocaine|mesh-list
64383712|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
64383713|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
64421043|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
64421071|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421072|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64595868|NCT05734911|Niraparib|niraparib|mesh-list
64421073|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
64421074|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421075|NCT02566889|Infliximab|infliximab|mesh-list
64421076|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
64421077|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421078|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421079|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
64421080|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64421081|NCT05507957|Ethanol|ethanol|mesh-list
64421082|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
64421083|NCT05507957|Disinfectants|disinfectants|mesh-list
64421084|NCT05507957|Povidone|povidone|mesh-list
64381791|NCT03186443|Gabapentin|gabapentin|mesh-list
64381792|NCT03186443|Analgesics|analgesics|mesh-ancestor
64381793|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
64421085|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64383714|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383715|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383716|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
64383717|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383718|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64383770|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383771|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383772|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64383773|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64383775|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381794|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381795|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381796|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
64381797|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64381798|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64381799|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381800|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64381801|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64421115|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64421116|NCT05563571|Prednisolone|prednisolone|mesh-list
64421117|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
64421118|NCT05563571|Lidocaine|lidocaine|mesh-list
64421119|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64596393|NCT03080324|Fentanyl|fentanyl|mesh-list
64421120|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
64299487|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64299489|NCT02103205|Lactoferrin|lactoferrin|mesh-list
64299490|NCT02103205|Trace Elements|trace elements|mesh-ancestor
64383778|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383779|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383780|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64383781|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
64383782|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383783|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383784|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
64383785|NCT05508009|Melphalan|melphalan|mesh-list
64383786|NCT05508009|Rituximab|rituximab|mesh-list
64383787|NCT05508009|Fludarabine|fludarabine|mesh-list
64383788|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383790|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383791|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383792|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64383793|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
64383794|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383795|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383796|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64383797|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383799|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64383826|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383827|NCT05366283|Sargramostim|sargramostim|mesh-list
64383828|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
64383829|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383830|NCT02565381|Nicotine|nicotine|mesh-list
64299491|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
64299492|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299493|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299494|NCT03290703|Rabeprazole|rabeprazole|mesh-list
64299495|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64299496|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421135|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421138|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64421139|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64421141|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64421142|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421143|NCT02717507|Carvedilol|carvedilol|mesh-list
64596733|NCT03432650|Hormones|hormones|mesh-ancestor
64421144|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64421145|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64421146|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
64421147|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421148|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596864|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64421184|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64421185|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64421186|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64421189|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64421190|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421191|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64421192|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383831|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64383832|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
64383833|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383834|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383835|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64383836|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64383837|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
64383838|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383839|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383840|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
64383841|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
64421193|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
64421194|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421195|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
64421196|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421197|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64421198|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421199|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383907|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383908|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
64383909|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64383910|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64383911|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383912|NCT02061280|Fluticasone|fluticasone|mesh-list
64383913|NCT02061280|Xhance|xhance|mesh-list
64383914|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64383915|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64383916|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383917|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64383918|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
64383919|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383974|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383976|NCT05504577|Coagulants|coagulants|mesh-ancestor
64383977|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
64383978|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64383979|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64383980|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383981|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64383982|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64383983|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383984|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383985|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
64421200|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64421201|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64421202|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421204|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64421205|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597132|NCT00246259|Risperidone|risperidone|mesh-list
64597196|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
64299500|NCT02408068|Dexamethasone|dexamethasone|mesh-list
64299501|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
64299502|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64299503|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64299504|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64299505|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383986|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
64383987|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64383988|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64383989|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383990|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383991|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383992|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383993|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
64383994|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
64383995|NCT05504265|Analgesics|analgesics|mesh-ancestor
64383996|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
64299506|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
64299507|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
64299508|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421236|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64421238|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
64421239|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
64421240|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
64421241|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
64421242|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
64421243|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
64421244|NCT04085237|Ropivacaine|ropivacaine|mesh-list
64421246|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
64421247|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421248|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421249|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
64421250|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421251|NCT04080869|Vitamin A|vitamin a|mesh-list
64421252|NCT04080869|Tretinoin|tretinoin|mesh-list
64421253|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
64421254|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421255|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
64421256|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
64421257|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
64421258|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383997|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383998|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383999|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64384000|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64384001|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384003|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64384004|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384005|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384007|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
64384008|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384009|NCT04916613|Androgens|androgens|mesh-list
64421259|NCT04080869|Protective Agents|protective agents|mesh-ancestor
64421260|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421261|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64421262|NCT04080869|Vitamins|vitamins|mesh-ancestor
64421263|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
64421264|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64597737|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
64299510|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421267|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
64421268|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421269|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421270|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64421283|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
64421284|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64421285|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421287|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421289|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64421290|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64384011|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384012|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384013|NCT04740099|Naloxone|naloxone|mesh-list
64384014|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64384030|NCT02564211|Hormones|hormones|mesh-ancestor
64384031|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384032|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64384033|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
64384034|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384035|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384036|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64384037|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
64384038|NCT04639245|Fludarabine|fludarabine|mesh-list
64384039|NCT04639245|Atezolizumab|atezolizumab|mesh-list
64384040|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64421291|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64421292|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64421293|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421294|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64421295|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
64421296|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64421297|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64421298|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64421299|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
64421300|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64421301|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421302|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64421303|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64421304|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64421305|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64421306|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421307|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64384041|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64384042|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64384043|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
64384044|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384045|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384046|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64384047|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
64384048|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384049|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384050|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64384052|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
64421308|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
64421309|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64421310|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64421311|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64421312|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421313|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421328|NCT05485883|Lenvatinib|lenvatinib|mesh-list
64421329|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421330|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64421331|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421332|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421333|NCT04273607|Heparin|heparin|mesh-list
64421348|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421349|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421350|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421351|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64421352|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64421353|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421354|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64421355|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64598198|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
64421356|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421357|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
64421358|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64384053|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384055|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64384056|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384057|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384058|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64384059|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
64384060|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
64384061|NCT05500677|Lidocaine|lidocaine|mesh-list
64384064|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
64384065|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
64384066|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421359|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64421360|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64421361|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
64421362|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421363|NCT05476003|Midazolam|midazolam|mesh-list
64421364|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64421365|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64421366|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421367|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421374|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
64421375|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
64421376|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421377|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421378|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64421379|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
64421380|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421381|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
64421382|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
64421391|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421392|NCT02336815|Dexamethasone|dexamethasone|mesh-list
64421393|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421394|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
64421395|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
64421396|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421403|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421405|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421406|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421407|NCT05434039|Analgesics|analgesics|mesh-ancestor
64421408|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
64384067|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384068|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
64384069|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421409|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421410|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421411|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421412|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421413|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421414|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421415|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421417|NCT05466175|Vincristine|vincristine|mesh-list
64421418|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421419|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
64421420|NCT05466175|Hormones|hormones|mesh-ancestor
64421421|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64421422|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421423|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64421424|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421425|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64421426|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
64421427|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
64421428|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
64598522|NCT03916263|Metformin|metformin|mesh-list
64421429|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384070|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64384071|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64384072|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64384073|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384140|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384141|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384142|NCT04417582|Incretins|incretins|mesh-ancestor
64384143|NCT04417582|Hormones|hormones|mesh-ancestor
64384144|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384145|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384146|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384147|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64384148|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64384149|NCT02040766|Beclomethasone|beclomethasone|mesh-list
64384150|NCT02040766|Albuterol|albuterol|mesh-list
64384151|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
64421431|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64421432|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64421433|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
64421434|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421435|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299517|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64299518|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
64299519|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421454|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64421455|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421456|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64421457|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421458|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299531|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299533|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299534|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
64299535|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
64299536|NCT03290625|Ketamine|ketamine|mesh-list
64299537|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64299538|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299539|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299540|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64299541|NCT03290625|Analgesics|analgesics|mesh-ancestor
64384153|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384154|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421495|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64421496|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64421497|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
64421498|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421499|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421500|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64421501|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
64421502|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64421503|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
64421504|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421505|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
64421506|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421507|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421508|NCT02556203|Analgesics|analgesics|mesh-ancestor
64384155|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64384156|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
64384157|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
64384158|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384159|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64384160|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64384161|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64384162|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
64384163|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384164|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384165|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384166|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
64384167|NCT02040766|Hormones|hormones|mesh-ancestor
64384222|NCT02088034|Metformin|metformin|mesh-list
64384223|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384224|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384225|NCT02037256|Bortezomib|bortezomib|mesh-list
64384226|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384227|NCT02035696|Vaccines|vaccines|mesh-list
64384228|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
64384229|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384230|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
64384231|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
64384232|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64384233|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64384234|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421509|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
64421510|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421511|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421512|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421513|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64421548|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
64421549|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
64421550|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421551|NCT05485259|Protective Agents|protective agents|mesh-ancestor
64421552|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421553|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
64384235|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384236|NCT02057458|Urological Agents|urological agents|mesh-ancestor
64384237|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
64384239|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384240|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384241|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
64384242|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384243|NCT02056288|Fentanyl|fentanyl|mesh-list
64384244|NCT02056288|Ropivacaine|ropivacaine|mesh-list
64384245|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
64384246|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
64384247|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384248|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384250|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384251|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64384252|NCT02056288|Narcotics|narcotics|mesh-ancestor
64384253|NCT02056288|Analgesics|analgesics|mesh-ancestor
64384280|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64384281|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64384282|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
64384283|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421554|NCT05485259|Vitamins|vitamins|mesh-ancestor
64421555|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
64421587|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421588|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421589|NCT05496179|Laxatives|laxatives|mesh-ancestor
64421590|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64421591|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64421592|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
64384285|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64384287|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64384288|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64384289|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64384290|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64384291|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64384293|NCT03170687|Calpastatin|calpastatin|mesh-list
64421593|NCT05484401|Ibuprofen|ibuprofen|mesh-list
64421594|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421595|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64598675|NCT03726879|Paclitaxel|paclitaxel|mesh-list
64421596|NCT05484401|Analgesics|analgesics|mesh-ancestor
64421597|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
64421598|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421599|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421600|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421601|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421635|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64421637|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381802|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64381803|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381804|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64381805|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64384294|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64384295|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
64384296|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384297|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384299|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64384300|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384301|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64384302|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384335|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384336|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64384337|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384338|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384339|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
64384340|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384341|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
64384342|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64384343|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
64384368|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384370|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64384373|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64384374|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64384375|NCT04481789|Urological Agents|urological agents|mesh-ancestor
64384376|NCT04481789|Diuretics|diuretics|mesh-ancestor
64384377|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
64384378|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384380|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64381806|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64381807|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381827|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381830|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
64421639|NCT04139213|Analgesics|analgesics|mesh-ancestor
64421640|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
64421641|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421645|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
64384384|NCT04481789|Protective Agents|protective agents|mesh-ancestor
64384385|NCT02402465|Fluticasone|fluticasone|mesh-list
64384386|NCT02402465|Xhance|xhance|mesh-list
64384387|NCT02402465|Azelastine|azelastine|mesh-list
64384388|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384389|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64384390|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
64384391|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384392|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384393|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64384394|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
64384512|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421646|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
64421647|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421648|NCT05494775|Growth Substances|growth substances|mesh-ancestor
64421649|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421651|NCT05488925|Diclofenac|diclofenac|mesh-list
64421652|NCT05488925|Piroxicam|piroxicam|mesh-list
64598694|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
64421653|NCT05488925|Tramadol|tramadol|mesh-list
64421654|NCT05488925|Vitamins|vitamins|mesh-ancestor
64421655|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
64421656|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421657|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421658|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421659|NCT05488925|Analgesics|analgesics|mesh-ancestor
64421660|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
64421661|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384516|NCT02400281|Etoposide|etoposide|mesh-list
64384517|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
64384518|NCT02400281|Azacitidine|azacitidine|mesh-list
64384519|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
64384520|NCT02400281|Idarubicin|idarubicin|mesh-list
64384521|NCT02400281|Crenolanib|crenolanib|mesh-list
64384522|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384523|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64384524|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
64384525|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384526|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64384527|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
64384528|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384529|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
64421662|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421663|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421664|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421665|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421666|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421667|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64421668|NCT05488925|Narcotics|narcotics|mesh-ancestor
64421669|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421670|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
64421671|NCT05488925|Protective Agents|protective agents|mesh-ancestor
64421672|NCT05494385|Gabapentin|gabapentin|mesh-list
64421673|NCT05494385|Analgesics|analgesics|mesh-ancestor
64421674|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
64421675|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421676|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421677|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
64421678|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64384530|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384531|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64384532|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64384533|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64384534|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384535|NCT02400281|Analgesics|analgesics|mesh-ancestor
64384536|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
64384597|NCT05498025|Antidotes|antidotes|mesh-ancestor
64384598|NCT05498025|Protective Agents|protective agents|mesh-ancestor
64384599|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384600|NCT02699099|Vitamin A|vitamin a|mesh-list
64384601|NCT02699099|Vaccines|vaccines|mesh-list
64384602|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
64384603|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384604|NCT02699099|Vitamins|vitamins|mesh-ancestor
64384605|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
64384606|NCT02400047|Dexamethasone|dexamethasone|mesh-list
64421679|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64421680|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421681|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64421682|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64421683|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64421684|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421685|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421686|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
64421687|NCT05482763|Itraconazole|itraconazole|mesh-list
64421688|NCT05482763|Terbinafine|terbinafine|mesh-list
64421689|NCT05482763|Ciclopirox|ciclopirox|mesh-list
64421690|NCT05482763|Amorolfine|amorolfine|mesh-list
64421691|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
64421692|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598748|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421697|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64421698|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
64421699|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384607|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
64384609|NCT02400047|BB 1101|bb 1101|mesh-list
64384610|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384611|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
64421700|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421704|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64421706|NCT05482295|Vaccines|vaccines|mesh-list
64421707|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
64421708|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421709|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
64421710|NCT04245839|Fludarabine|fludarabine|mesh-list
64421711|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421712|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
64421713|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421714|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421733|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64421734|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
64421735|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421736|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421737|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64421738|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
64421739|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384613|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384614|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384615|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384616|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
64384617|NCT02400047|Hormones|hormones|mesh-ancestor
64384618|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64421744|NCT04051619|Oxytocin|oxytocin|mesh-list
64421745|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
64421746|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64421747|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421748|NCT03907475|Gemcitabine|gemcitabine|mesh-list
64598766|NCT04672382|Analgesics|analgesics|mesh-ancestor
64421749|NCT03907475|Paclitaxel|paclitaxel|mesh-list
64421750|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64421751|NCT03907475|Carboplatin|carboplatin|mesh-list
64421752|NCT03907475|Doxorubicin|doxorubicin|mesh-list
64421753|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64421754|NCT03907475|Capecitabine|capecitabine|mesh-list
64421755|NCT03907475|Durvalumab|durvalumab|mesh-list
64421756|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
64421757|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64421758|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
64421759|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64421760|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421761|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
64421762|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
64421763|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
64421764|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384637|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384638|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384639|NCT02417207|Entecavir|entecavir|mesh-list
64384640|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
64384641|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384642|NCT02698475|Ustekinumab|ustekinumab|mesh-list
64384643|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384644|NCT02399657|Dexamethasone|dexamethasone|mesh-list
64384645|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384646|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
64384647|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
64384648|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384649|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384650|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384651|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
64384652|NCT02399657|Hormones|hormones|mesh-ancestor
64384653|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384655|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384656|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
64384657|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64384658|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384659|NCT04278729|Apixaban|apixaban|mesh-list
64384660|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64384661|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
64421765|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64421766|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
64421767|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
64421768|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421769|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598812|NCT00551447|Ezetimibe|ezetimibe|mesh-list
64421771|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
64421796|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64421797|NCT05487521|Protective Agents|protective agents|mesh-ancestor
64421798|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64421799|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421800|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
64421801|NCT05481281|Ketamine|ketamine|mesh-list
64421802|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64421803|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598857|NCT03873116|Berotralstat|berotralstat|mesh-list
64421814|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421815|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64421816|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64421817|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
64421818|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
64421819|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64421820|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64421835|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
64421836|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64421837|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64421838|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421839|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421840|NCT02558231|Urological Agents|urological agents|mesh-ancestor
64599127|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
64599128|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
64421841|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64421842|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64421843|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64599198|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
64421844|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64421845|NCT05493371|Empagliflozin|empagliflozin|mesh-list
64421846|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64384662|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64384663|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
64384664|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384665|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384666|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
64421847|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599336|NCT00704717|Ribavirin|ribavirin|mesh-list
64421848|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64421849|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421850|NCT05486819|Propofol|propofol|mesh-list
64421851|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64421852|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421865|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421867|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421868|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421869|NCT05475431|Bismuth|bismuth|mesh-list
64421870|NCT05475431|Antacids|antacids|mesh-ancestor
64421871|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421872|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421873|NCT05492669|Lidocaine|lidocaine|mesh-list
64421874|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
64421875|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
64421876|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421877|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421878|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
64421879|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421880|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64421881|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64421882|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64421912|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
64421913|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64421914|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
64421915|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
64384668|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384672|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384673|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384674|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
64384690|NCT04480775|Triamcinolone|triamcinolone|mesh-list
64384691|NCT04480775|Bupivacaine|bupivacaine|mesh-list
64384692|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64384693|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
64384694|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
64384695|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
64384696|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384697|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384698|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
64384699|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384700|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421916|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64421917|NCT02554721|Protective Agents|protective agents|mesh-ancestor
64421918|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64421919|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64421920|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
64421921|NCT03810911|Hematinics|hematinics|mesh-ancestor
64421922|NCT02552225|Amitriptyline|amitriptyline|mesh-list
64421923|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64421924|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
64421925|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64421926|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421927|NCT02552225|Analgesics|analgesics|mesh-ancestor
64299542|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
64299543|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299544|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64299545|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64299546|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64299547|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
64299548|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299549|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421936|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421938|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64421939|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
64421940|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421941|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421942|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64421943|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64421944|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
64421945|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421946|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421948|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384720|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64384722|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384723|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64384724|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
64384725|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384726|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384727|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384728|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64384729|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64384730|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64384731|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64384732|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
64421949|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64421950|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421951|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421952|NCT03418961|Carvedilol|carvedilol|mesh-list
64421953|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64421954|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64421955|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
64421956|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421957|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421958|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421959|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64421960|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
64421961|NCT03418961|Protective Agents|protective agents|mesh-ancestor
64599702|NCT02990507|Testosterone|testosterone|mesh-list
64421962|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64421963|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64421964|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64421965|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
64421966|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64421967|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64421968|NCT05479175|Ibuprofen|ibuprofen|mesh-list
64421969|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421970|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421971|NCT05479175|Analgesics|analgesics|mesh-ancestor
64421972|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
64421973|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421974|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421975|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421976|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599756|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
64599761|NCT04115384|Insulin|insulin|mesh-list
64421977|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421978|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421979|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421980|NCT02534935|Vaccines|vaccines|mesh-list
64421981|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
64421982|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421983|NCT02544451|Ivacaftor|ivacaftor|mesh-list
64421984|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64421985|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64599829|NCT03809455|Fentanyl|fentanyl|mesh-list
64299550|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64299551|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64299552|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
64299553|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
64299554|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64384733|NCT03176849|Vitamin D|vitamin d|mesh-list
64384734|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
64384735|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
64384791|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64384792|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384793|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384795|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
64384796|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384797|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64384798|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64384799|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299555|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64299556|NCT02250781|TIC10 compound|tic10 compound|mesh-list
64422016|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
64422017|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
64422019|NCT02880293|Thiotepa|thiotepa|mesh-list
64422020|NCT02880293|Fludarabine|fludarabine|mesh-list
64422021|NCT02880293|Tacrolimus|tacrolimus|mesh-list
64422022|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422023|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
64422024|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422025|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422026|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64422027|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
64422028|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422029|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422030|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64599943|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
64422031|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64422032|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422033|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64422034|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64422035|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
64422036|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64422037|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422038|NCT02865551|Anesthetics|anesthetics|mesh-list
64422039|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422040|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422066|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64422067|NCT02533453|Incretins|incretins|mesh-ancestor
64422068|NCT02533453|Hormones|hormones|mesh-ancestor
64422069|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422070|NCT05424835|Capecitabine|capecitabine|mesh-list
64600001|NCT01279681|Calcium|calcium|mesh-list
64422071|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64422073|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422074|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422075|NCT02533375|Adalimumab|adalimumab|mesh-list
64422076|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384805|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64384808|NCT04272801|Anastrozole|anastrozole|mesh-list
64384809|NCT04272801|Exemestane|exemestane|mesh-list
64384810|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384811|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64384812|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64384813|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384814|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384815|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64384859|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
64384860|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384861|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384862|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64422077|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422078|NCT01553149|Lenalidomide|lenalidomide|mesh-list
64422079|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
64600063|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64422080|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422081|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422082|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64422083|NCT01553149|Growth Substances|growth substances|mesh-ancestor
64422084|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
64422085|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422172|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64422173|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64601192|NCT01272635|Hormones|hormones|mesh-ancestor
64422183|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64422184|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422185|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64422186|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422189|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422190|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64422191|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
64422192|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422194|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
64422195|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
64422196|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422197|NCT05476991|Aspirin|aspirin|mesh-list
64422198|NCT05476991|Colchicine|colchicine|mesh-list
64422199|NCT05476991|Ticagrelor|ticagrelor|mesh-list
64422200|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422201|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422202|NCT05476991|Analgesics|analgesics|mesh-ancestor
64299557|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299558|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
64299559|NCT03099122|Prednisone|prednisone|mesh-list
64299560|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
64384864|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384866|NCT03168191|Nicotine|nicotine|mesh-list
64384867|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64384868|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
64384869|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384870|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384871|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64384872|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64384873|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
64299561|NCT03099122|Tacrolimus|tacrolimus|mesh-list
64299562|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
64422208|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64422213|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422215|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64422216|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64422217|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64422218|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
64422219|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422221|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422222|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
64422223|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422224|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422226|NCT02327169|Irinotecan|irinotecan|mesh-list
64422227|NCT02327169|Cetuximab|cetuximab|mesh-list
64422228|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64422229|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422230|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422231|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
64422232|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422233|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422234|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64422235|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64422236|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422237|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422238|NCT02327013|Vortioxetine|vortioxetine|mesh-list
64422239|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
64422240|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64422241|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64384874|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384875|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384876|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
64384877|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384879|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384880|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384881|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64384882|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64384883|NCT04280055|Psilocybin|psilocybin|mesh-list
64384884|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
64384885|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384886|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64384887|NCT05499117|Fluoxetine|fluoxetine|mesh-list
64384888|NCT05499117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64384889|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64384907|NCT01663233|Amlodipine|amlodipine|mesh-list
64384908|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64384909|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64384910|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64384911|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384912|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422242|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64422243|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422244|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422245|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64422246|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64422247|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64422248|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422249|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422250|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
64422251|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64422252|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64422253|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64422254|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64422255|NCT02301975|Fluticasone|fluticasone|mesh-list
64422257|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64422258|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422260|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
64422261|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422262|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602016|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
64422264|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
64422265|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
64422266|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64384915|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
64384916|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64384917|NCT05494281|Anesthetics|anesthetics|mesh-list
64384918|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
64384919|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384920|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384921|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
64384922|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384923|NCT05494047|Vaccines|vaccines|mesh-list
64384924|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
64384925|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384926|NCT05493969|Lamivudine|lamivudine|mesh-list
64384927|NCT05493969|Dolutegravir|dolutegravir|mesh-list
64384928|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64384929|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64384930|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384931|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384932|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
64384933|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384935|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64384936|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64384937|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64384938|NCT05493657|Aspirin|aspirin|mesh-list
64384939|NCT05493657|Clopidogrel|clopidogrel|mesh-list
64384940|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64602079|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64422267|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64422268|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64422269|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64422270|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
64422271|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422272|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422273|NCT04882839|Psilocybin|psilocybin|mesh-list
64422274|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
64602151|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422275|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422276|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64422277|NCT02300259|Itraconazole|itraconazole|mesh-list
64422296|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64422297|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
64422298|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64422299|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64422300|NCT02300259|Urological Agents|urological agents|mesh-ancestor
64422301|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64422302|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64422303|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64422304|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64422306|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64422308|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
64422309|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422310|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
64422311|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64422312|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64422313|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422314|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
64422315|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
64422316|NCT02366091|Methotrexate|methotrexate|mesh-list
64422317|NCT02366091|Colchicine|colchicine|mesh-list
64422318|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64422319|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
64422320|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64422321|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422322|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64422324|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422325|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384942|NCT05493657|Analgesics|analgesics|mesh-ancestor
64422326|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
64422327|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422328|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64422329|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422330|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
64422354|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422355|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422356|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64422359|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422360|NCT02546765|Analgesics|analgesics|mesh-ancestor
64422361|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
64422362|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422363|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64422364|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64422365|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64422366|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
64422367|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422368|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422370|NCT02553629|Rocuronium|rocuronium|mesh-list
64422371|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64422372|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64422373|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64422374|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422375|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422376|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
64422377|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422378|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
64422379|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422380|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422381|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64422383|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602817|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
64422384|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422385|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64422386|NCT03029351|Exenatide|exenatide|mesh-list
64422387|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602891|NCT02019069|Daunorubicin|daunorubicin|mesh-list
64422388|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422389|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64422400|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
64422401|NCT02365233|Saxagliptin|saxagliptin|mesh-list
64422402|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64422403|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384943|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
64384969|NCT05492565|Tenofovir|tenofovir|mesh-list
64384970|NCT05492565|Emtricitabine|emtricitabine|mesh-list
64384971|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
64384972|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384973|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64384974|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64422431|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422432|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422434|NCT02321319|Hydromorphone|hydromorphone|mesh-list
64422446|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422447|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422448|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
64422449|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422450|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422451|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
64422452|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422453|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
64422454|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422455|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64422467|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422469|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64422470|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422471|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
64422472|NCT05450965|Onvansertib|onvansertib|mesh-list
64603479|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
64603484|NCT00768599|Econazole|econazole|mesh-list
64603532|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603674|NCT03808259|Ketamine|ketamine|mesh-list
64422503|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
64422504|NCT02293395|Clopidogrel|clopidogrel|mesh-list
64422505|NCT02293395|Ticagrelor|ticagrelor|mesh-list
64422506|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422507|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422508|NCT02293395|Analgesics|analgesics|mesh-ancestor
64422510|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422511|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422512|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422513|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422516|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422517|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64422541|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422542|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64422543|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
64422544|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422545|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299564|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
64299565|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64299566|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
64299567|NCT03099122|Hormones|hormones|mesh-ancestor
64422546|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64299568|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422562|NCT05401279|Immunologic Factors|immunologic factors|mesh-ancestor
64422563|NCT05401279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422564|NCT05451095|Ketamine|ketamine|mesh-list
64422565|NCT05451095|Analgesics|analgesics|mesh-ancestor
64384976|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384978|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64384979|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
64384980|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
64384981|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64384982|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
64384983|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384984|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422566|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
64422567|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422568|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422569|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64422570|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64422579|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422580|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422582|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
64422583|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422584|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422585|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422586|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422587|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64422588|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64422589|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422590|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422591|NCT02532283|Oseltamivir|oseltamivir|mesh-list
64422592|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
64299571|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299572|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299573|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
64422610|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422611|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64422612|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422613|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422614|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422615|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422616|NCT01349881|Analgesics|analgesics|mesh-ancestor
64384985|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64384986|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64384987|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64384988|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384989|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384990|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
64384991|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64384992|NCT04176705|Triamcinolone|triamcinolone|mesh-list
64385043|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422617|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
64422618|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422619|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422620|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422621|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422622|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64422623|NCT02953457|Durvalumab|durvalumab|mesh-list
64422624|NCT02953457|Ipilimumab|ipilimumab|mesh-list
64422625|NCT02953457|Olaparib|olaparib|mesh-list
64422627|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64422628|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
64422629|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64422671|NCT05398705|Protective Agents|protective agents|mesh-ancestor
64422673|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422674|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422677|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64422678|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
64422689|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64422690|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64604279|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604346|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
64422691|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64422692|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422702|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64604415|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604416|NCT00805493|Riluzole|riluzole|mesh-list
64422703|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64422704|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64422705|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64422706|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604483|NCT04845490|Mitomycins|mitomycins|mesh-list
64422709|NCT05415709|Carboplatin|carboplatin|mesh-list
64422710|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64422711|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64422712|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422713|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422714|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
64299574|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64299575|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299576|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299577|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64299578|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64299579|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
64299580|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64422726|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422727|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422728|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64422729|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
64422730|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422732|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64422733|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64422734|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
64422735|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
64422736|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422737|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64422738|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604895|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422739|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64422740|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64422741|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
64422742|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64422743|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64422744|NCT02552303|Modafinil|modafinil|mesh-list
64604963|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64422745|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64422746|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422747|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64422748|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64422749|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64422750|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385044|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64385045|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
64385046|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385047|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385049|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64385050|NCT05489601|Narcotics|narcotics|mesh-ancestor
64385052|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385054|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
64385055|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385056|NCT04016805|Venetoclax|venetoclax|mesh-list
64385057|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
64385058|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385059|NCT04276155|Anticoagulants|anticoagulants|mesh-list
64385061|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
64385062|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64385063|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385064|NCT05488899|Trace Elements|trace elements|mesh-ancestor
64385065|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
64385066|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385068|NCT05483439|Carboplatin|carboplatin|mesh-list
64385069|NCT05483439|Docetaxel|docetaxel|mesh-list
64422751|NCT01660711|Leucovorin|leucovorin|mesh-list
64422752|NCT01660711|Fluorouracil|fluorouracil|mesh-list
64422753|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
64422754|NCT01660711|Irinotecan|irinotecan|mesh-list
64422755|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
64422756|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422757|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64422772|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64422773|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64605167|NCT04952194|Entacapone|entacapone|mesh-list
64299581|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299582|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
64422790|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64422792|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
64422793|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422794|NCT02543801|Ketorolac|ketorolac|mesh-list
64422795|NCT02543801|Clonidine|clonidine|mesh-list
64422796|NCT02543801|Epinephrine|epinephrine|mesh-list
64605519|NCT00357747|Docetaxel|docetaxel|mesh-list
64422797|NCT02543801|Bupivacaine|bupivacaine|mesh-list
64422798|NCT02543801|Ropivacaine|ropivacaine|mesh-list
64422805|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64422806|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64422807|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
64422808|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422809|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422810|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64605769|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64422811|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64422813|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64422814|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
64422815|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
64422816|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
64422817|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64422818|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64605909|NCT02710630|Dabigatran|dabigatran|mesh-list
64422856|NCT05394103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422857|NCT05394103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422858|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
64422859|NCT05411159|Anesthetics|anesthetics|mesh-list
64422891|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64422893|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422894|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
64385073|NCT05483439|Antibodies|antibodies|mesh-list
64385074|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64385075|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385076|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
64385112|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
64385113|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
64385114|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
64385115|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385165|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64385166|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64385167|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64385168|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64422895|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422897|NCT02292771|Atosiban|atosiban|mesh-list
64422898|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
64422899|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422900|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422901|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
64422902|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64422903|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
64422904|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64423012|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423013|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64423014|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64423015|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
64423016|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64423017|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423018|NCT02531113|Ozanimod|ozanimod|mesh-list
64423019|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64423020|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423021|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64423022|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
64423023|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606188|NCT03214627|Iron|iron|mesh-list
64423024|NCT05441527|Muramidase|muramidase|mesh-list
64423025|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423026|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64423027|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64385169|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385170|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64385172|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385173|NCT03602859|Niraparib|niraparib|mesh-list
64385174|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64385176|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385177|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385178|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64385180|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385181|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
64385182|NCT05476731|Clotrimazole|clotrimazole|mesh-list
64385183|NCT05476731|Miconazole|miconazole|mesh-list
64385184|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385185|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64385186|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64385187|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64385188|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423028|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423041|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423042|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423044|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64423045|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423046|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64423047|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423048|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606524|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423049|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64423050|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64423052|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64606588|NCT04380181|Epinephrine|epinephrine|mesh-list
64423053|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64423054|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423055|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423056|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423062|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64423063|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423064|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64423065|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
64423066|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423068|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64423069|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64423070|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64423071|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64423072|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423073|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423074|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423075|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423076|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423077|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423078|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
64423079|NCT05376553|Docetaxel|docetaxel|mesh-list
64423080|NCT05376553|Cemiplimab|cemiplimab|mesh-list
64423081|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423082|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
64423089|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423090|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423091|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64423092|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64423093|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
64606864|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64385189|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385190|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64385191|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
64385192|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64606865|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64423094|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423095|NCT05591755|Ketotifen|ketotifen|mesh-list
64423096|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64423097|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64423098|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64423099|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64606909|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64423100|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64423101|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64423102|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423103|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423104|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423105|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423106|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423107|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
64423108|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
64385193|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385194|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64385195|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64385331|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385332|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385412|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385413|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385414|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
64385415|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385416|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385417|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64385418|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
64385419|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64385420|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385421|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64423109|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64423110|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
64423111|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
64423112|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64423114|NCT05610085|Phenobarbital|phenobarbital|mesh-list
64423115|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
64423116|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
64423117|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423118|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423119|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423120|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64423121|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64423122|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423123|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423124|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
64299584|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423146|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
64423147|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
64423148|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423149|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423150|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
64423151|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423152|NCT05509933|Budesonide|budesonide|mesh-list
64423153|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423154|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64423155|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
64423156|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423157|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423158|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64423159|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
64423160|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
64423161|NCT05509933|Hormones|hormones|mesh-ancestor
64423162|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423163|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64423164|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64423165|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
64423166|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423167|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64423168|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64423169|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
64423170|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
64423171|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423172|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423173|NCT04248595|Azacitidine|azacitidine|mesh-list
64423174|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
64423175|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64423176|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
64607368|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
64299585|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299586|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64299587|NCT03099122|Protective Agents|protective agents|mesh-ancestor
64299588|NCT02103361|Ustekinumab|ustekinumab|mesh-list
64423202|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423204|NCT05334277|Carboplatin|carboplatin|mesh-list
64423206|NCT05334277|Aflutinib|aflutinib|mesh-list
64423207|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423208|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423209|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64423210|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64423211|NCT05334277|Growth Substances|growth substances|mesh-ancestor
64423212|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423213|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
64607575|NCT05531994|Montelukast|montelukast|mesh-list
64423214|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423215|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423216|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64423217|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64423218|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64423219|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64607646|NCT02311920|Nivolumab|nivolumab|mesh-list
64423220|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
64423221|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64423222|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64423223|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64423224|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423225|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423227|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607710|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
64423276|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64423277|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64423278|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423279|NCT01659151|Aldesleukin|aldesleukin|mesh-list
64423280|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
64423281|NCT01659151|Fludarabine|fludarabine|mesh-list
64423282|NCT01659151|Interleukin-2|interleukin-2|mesh-list
64423283|NCT01659151|Vemurafenib|vemurafenib|mesh-list
64423284|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64423285|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64423286|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
64423287|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423288|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423289|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64423290|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
64423291|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299590|NCT04335201|Defibrotide|defibrotide|mesh-list
64299591|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64299592|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64299593|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299594|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64299595|NCT03295851|Iron|iron|mesh-list
64299596|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
64299597|NCT03295851|Trace Elements|trace elements|mesh-ancestor
64299598|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
64299599|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299600|NCT03096470|Anesthetics|anesthetics|mesh-list
64299601|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423308|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423309|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423310|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423311|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423312|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64423313|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64423314|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423315|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64423316|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64423317|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608948|NCT03304379|Analgesics|analgesics|mesh-ancestor
64423318|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
64423319|NCT05516953|Baclofen|baclofen|mesh-list
64423320|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64423321|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423322|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64423323|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423324|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64423325|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
64423326|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
64423327|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423328|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385422|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64385423|NCT03167177|Growth Substances|growth substances|mesh-ancestor
64385424|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
64385425|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
64385426|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64385427|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64385428|NCT03167177|Antidotes|antidotes|mesh-ancestor
64385429|NCT03167177|Protective Agents|protective agents|mesh-ancestor
64385430|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
64385432|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
64385433|NCT02392169|Methylphenidate|methylphenidate|mesh-list
64423329|NCT02522767|Mesalamine|mesalamine|mesh-list
64423330|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423331|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423332|NCT02522767|Analgesics|analgesics|mesh-ancestor
64423333|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
64423334|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423335|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423336|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423337|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423338|NCT02522377|Midazolam|midazolam|mesh-list
64299602|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299603|NCT05050448|Diclofenac|diclofenac|mesh-list
64299604|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64299605|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64299607|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
64299608|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423351|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609270|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423352|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423353|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64423354|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423355|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64423356|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64423357|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64423358|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
64423360|NCT05345509|Donepezil|donepezil|mesh-list
64609335|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423361|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64423362|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423393|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423394|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64423395|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
64385435|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385436|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64385437|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64385464|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385465|NCT03167957|Amphotericin B|amphotericin b|mesh-list
64385466|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64385467|NCT03167957|Amebicides|amebicides|mesh-ancestor
64385468|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64385469|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64385470|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385471|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64385472|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
64385473|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
64385474|NCT03166397|Nivolumab|nivolumab|mesh-list
64385475|NCT03166397|Fludarabine|fludarabine|mesh-list
64385476|NCT03166397|Ipilimumab|ipilimumab|mesh-list
64385477|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385478|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
64385479|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385480|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423396|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423397|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423398|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64423399|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
64609404|NCT03020303|Spironolactone|spironolactone|mesh-list
64423400|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
64423401|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64423402|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423403|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423404|NCT05314621|Analgesics|analgesics|mesh-ancestor
64609530|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64609531|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64609532|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64609533|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
64609534|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609543|NCT02778880|Fentanyl|fentanyl|mesh-list
64609544|NCT02778880|Ketamine|ketamine|mesh-list
64609545|NCT02778880|Analgesics|analgesics|mesh-ancestor
64609546|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
64609561|NCT05310929|Labetalol|labetalol|mesh-list
64423405|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
64423406|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423407|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64423408|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64423409|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
64423410|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
64423411|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381831|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381832|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64381833|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
64381834|NCT02432261|ST 1435|st 1435|mesh-list
64381835|NCT02432261|Testosterone|testosterone|mesh-list
64385483|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385484|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385485|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64385486|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385487|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64385515|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385516|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385517|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381836|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
64381837|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
64381838|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64381839|NCT02432261|Androgens|androgens|mesh-ancestor
64381840|NCT02432261|Hormones|hormones|mesh-ancestor
64381841|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381842|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381843|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64381844|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381845|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
64381846|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64381847|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
64381848|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381849|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64381850|NCT02428283|Remifentanil|remifentanil|mesh-list
64381851|NCT02428283|Ropivacaine|ropivacaine|mesh-list
64381852|NCT02428283|Sevoflurane|sevoflurane|mesh-list
64381853|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
64381854|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
64381855|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381856|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381857|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
64381858|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423420|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64423428|NCT05313997|Diclofenac|diclofenac|mesh-list
64423429|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423430|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423431|NCT05313997|Analgesics|analgesics|mesh-ancestor
64423432|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
64423433|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423434|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423435|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423436|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423437|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64423438|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423439|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423442|NCT05259241|Coagulants|coagulants|mesh-ancestor
64423443|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
64423444|NCT05511415|Oxytocin|oxytocin|mesh-list
64423445|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64385518|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
64385519|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
64385520|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64385521|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
64385522|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385524|NCT05475873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64385525|NCT05475873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64385526|NCT05475873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385527|NCT05475873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64423446|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423447|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423448|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423449|NCT05511415|Analgesics|analgesics|mesh-ancestor
64423450|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
64423451|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423452|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64423453|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64423454|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423455|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423456|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423457|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423458|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
64423459|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64423460|NCT01657903|Listerine|listerine|mesh-list
64423461|NCT01657903|Fluorides|fluorides|mesh-list
64423462|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
64423463|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
64299609|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299610|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64299611|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423464|NCT01657903|Protective Agents|protective agents|mesh-ancestor
64423471|NCT05256823|Analgesics|analgesics|mesh-ancestor
64423472|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
64423473|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423474|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423475|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423476|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385528|NCT05475873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64385529|NCT05471661|PENTA|penta|mesh-list
64385530|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
64385531|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64385532|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64385533|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385534|NCT05480631|Mitogens|mitogens|mesh-list
64385535|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
64385536|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385537|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
64385538|NCT02542605|Erenumab|erenumab|mesh-list
64385539|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64385577|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385612|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423477|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64423478|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64423479|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423480|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423481|NCT05255653|Cisplatin|cisplatin|mesh-list
64423482|NCT05255653|Carboplatin|carboplatin|mesh-list
64423483|NCT05255653|Durvalumab|durvalumab|mesh-list
64423484|NCT05255653|Olaparib|olaparib|mesh-list
64423485|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64423486|NCT05255653|Megestrol|megestrol|mesh-list
64423487|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
64423488|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
64423489|NCT05255653|Progestins|progestins|mesh-list
64423490|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423506|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64423507|NCT05255653|Hormones|hormones|mesh-ancestor
64423508|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423509|NCT05284591|Daratumumab|daratumumab|mesh-list
64423510|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423511|NCT04243837|Pirfenidone|pirfenidone|mesh-list
64423512|NCT04243837|Analgesics|analgesics|mesh-ancestor
64423513|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
64423514|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423515|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423516|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423517|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423518|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423519|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423521|NCT05253937|Epinephrine|epinephrine|mesh-list
64423522|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64423523|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423524|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423525|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423526|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423527|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423528|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64423529|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64423530|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
64423531|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423532|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64610019|NCT04380467|Vitamin D|vitamin d|mesh-list
64381859|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64381860|NCT02428283|Narcotics|narcotics|mesh-ancestor
64381861|NCT02428283|Analgesics|analgesics|mesh-ancestor
64381862|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64381865|NCT02427893|Vemurafenib|vemurafenib|mesh-list
64381867|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64381868|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385614|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64385615|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64385653|NCT05431725|Vaccines|vaccines|mesh-list
64385654|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
64385655|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385656|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64385657|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64385658|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
64385659|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381869|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381870|NCT03184493|Metformin|metformin|mesh-list
64381871|NCT03184493|Celecoxib|celecoxib|mesh-list
64381872|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64381873|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381874|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64381875|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64336812|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64336813|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64336814|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
64336815|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64336816|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
64336817|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64336818|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64336833|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336834|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610216|NCT03216707|Capsaicin|capsaicin|mesh-list
64336835|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64336836|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
64336837|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64336838|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336839|NCT02317861|Febuxostat|febuxostat|mesh-list
64336840|NCT02317861|Verinurad|verinurad|mesh-list
64336841|NCT02317861|Benzbromarone|benzbromarone|mesh-list
64336842|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
64336843|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336844|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
64336845|NCT02317861|Renal Agents|renal agents|mesh-ancestor
64336846|NCT02318017|Methylphenidate|methylphenidate|mesh-list
64336847|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64336848|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336849|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64336850|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64336851|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64336852|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336857|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336858|NCT02313805|Insulin|insulin|mesh-list
64336859|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64336860|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336861|NCT03132493|Nivolumab|nivolumab|mesh-list
64336862|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64336863|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336864|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64336865|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336866|NCT02313883|Taurolidine|taurolidine|mesh-list
64336867|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336868|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64336869|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336870|NCT03500653|Curcumin|curcumin|mesh-list
64336871|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64336872|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64336873|NCT03500653|Analgesics|analgesics|mesh-ancestor
64336887|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64336888|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64336890|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
64336891|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
64336892|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336893|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64336894|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64336895|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336926|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64336927|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64336928|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
64336929|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
64336930|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
64336932|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64336933|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64336934|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64336953|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64336954|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64336955|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64336956|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64336957|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64336959|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64336960|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
64336961|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64336963|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336964|NCT02306239|Terlipressin|terlipressin|mesh-list
64336965|NCT02306239|Norepinephrine|norepinephrine|mesh-list
64336966|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64336967|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64336975|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64610673|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
64610674|NCT03402295|Thalidomide|thalidomide|mesh-list
64336976|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64336977|NCT02319187|Irinotecan|irinotecan|mesh-list
64336978|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64336979|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64336980|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64336981|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336982|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64336983|NCT02319265|Melatonin|melatonin|mesh-list
64336984|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
64336985|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64336986|NCT02319265|Protective Agents|protective agents|mesh-ancestor
64336987|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336988|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64336989|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
64610728|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
64336990|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64336991|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64336992|NCT02319343|Prednisolone|prednisolone|mesh-list
64336993|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
64336994|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64336995|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
64336996|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64336997|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
64381876|NCT03184493|Analgesics|analgesics|mesh-ancestor
64336998|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
64337017|NCT03499639|Ribavirin|ribavirin|mesh-list
64337018|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64337019|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64337020|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
64337021|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337022|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337023|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64337024|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64337025|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
64337026|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337027|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64337036|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337037|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
64337038|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337039|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64337040|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64337041|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337042|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337043|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337044|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
64337045|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
64337046|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
64337047|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64337048|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
64610855|NCT01727531|Filaricides|filaricides|mesh-ancestor
64337061|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
64337062|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
64337063|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337064|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64337065|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610978|NCT04357093|Listerine|listerine|mesh-list
64337067|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337069|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64337070|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337071|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337072|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64337074|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
64337075|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337076|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64337077|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64337078|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64385711|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64385712|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64385714|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
64385715|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385716|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385717|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385718|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385719|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64337098|NCT02319889|Paclitaxel|paclitaxel|mesh-list
64337099|NCT02319889|Carboplatin|carboplatin|mesh-list
64337100|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64337101|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64423534|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
64337111|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337112|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64337113|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
64337114|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
64381877|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
64381888|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381889|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381890|NCT02431325|Teduglutide|teduglutide|mesh-list
64381891|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64381892|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64381893|NCT02431325|Protective Agents|protective agents|mesh-ancestor
64381894|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381895|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
64381896|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
64381897|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
64381898|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381899|NCT02103478|Decitabine|decitabine|mesh-list
64385721|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385722|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385723|NCT02684357|Ustekinumab|ustekinumab|mesh-list
64385724|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64385725|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
64385726|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
64381900|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64381901|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
64381903|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381904|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381905|NCT02431013|Cilostazol|cilostazol|mesh-list
64381906|NCT02431013|Simvastatin|simvastatin|mesh-list
64381907|NCT02431013|Pravastatin|pravastatin|mesh-list
64381908|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64381909|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64381910|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
64337115|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64337139|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64423535|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
64337140|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64337141|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64385729|NCT03115073|Miconazole|miconazole|mesh-list
64385730|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64385731|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385732|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
64385733|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64385734|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64385735|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385736|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385737|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64385738|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
64385739|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385740|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385741|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64385742|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64385743|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
64385744|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64385745|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385746|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
64385747|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
64385748|NCT03165929|Analgesics|analgesics|mesh-ancestor
64337143|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337144|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337145|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337146|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337147|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64337148|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337150|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64337151|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337152|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64337153|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337154|NCT02320045|Exenatide|exenatide|mesh-list
64385750|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385751|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385787|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64385789|NCT03142893|Ganirelix|ganirelix|mesh-list
64385790|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385791|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
64385792|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
64337155|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64337156|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337157|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64337158|NCT02320045|Incretins|incretins|mesh-ancestor
64337160|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337161|NCT02320357|Clopidogrel|clopidogrel|mesh-list
64337178|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64337179|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64337180|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
64611933|NCT03002506|Tazobactam|tazobactam|mesh-list
64337181|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64337182|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
64337183|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337184|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
64385793|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385794|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385841|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64385842|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385843|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64385844|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385845|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
64385846|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385847|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
64385848|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385849|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64385850|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385851|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385853|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64337185|NCT03491761|Protective Agents|protective agents|mesh-ancestor
64337186|NCT03132103|Vitamin D|vitamin d|mesh-list
64337187|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
64337189|NCT03132103|Vitamins|vitamins|mesh-list
64337190|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
64337191|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337192|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64612206|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
64337193|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64337194|NCT04635943|Ivermectin|ivermectin|mesh-list
64337195|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64337211|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612273|NCT01042535|Tryptophan|tryptophan|mesh-list
64337244|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337245|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337246|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337247|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337248|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
64337249|NCT03491527|Pemetrexed|pemetrexed|mesh-list
64337250|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337251|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337252|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337262|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337271|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
64337272|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337273|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337274|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337275|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
64337276|NCT04002037|Hormones|hormones|mesh-ancestor
64337277|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337278|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64337279|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337280|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337281|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
64337282|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337283|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337284|NCT03491371|Apatinib|apatinib|mesh-list
64337285|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337286|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64337287|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385854|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
64337303|NCT05118685|Estrogens|estrogens|mesh-list
64337318|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337319|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337320|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64337321|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337322|NCT02922985|Acetaminophen|acetaminophen|mesh-list
64337323|NCT02922985|Ketorolac|ketorolac|mesh-list
64337324|NCT02922985|Bupivacaine|bupivacaine|mesh-list
64337325|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
64337326|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
64337327|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337328|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337329|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
64337330|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337331|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64337332|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64337333|NCT02922985|Analgesics|analgesics|mesh-ancestor
64612459|NCT03403205|Choline|choline|mesh-list
64337334|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337362|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64337363|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
64337364|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337365|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337366|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337367|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
64337368|NCT04715191|Fludarabine|fludarabine|mesh-list
64337369|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
64337370|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337371|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
64337372|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337373|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337374|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64337375|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
64337376|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337398|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
64337399|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337400|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
64337401|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337402|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337403|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337405|NCT02321761|Analgesics|analgesics|mesh-ancestor
64337423|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337424|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64337425|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337426|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337427|NCT02321839|Ranibizumab|ranibizumab|mesh-list
64337428|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64385855|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64385856|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385857|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64385858|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64385859|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
64385860|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
64385861|NCT01661595|Tadalafil|tadalafil|mesh-list
64385862|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
64337429|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64337430|NCT02321839|Growth Substances|growth substances|mesh-ancestor
64337431|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337432|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
64337433|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337434|NCT03490279|Lactoferrin|lactoferrin|mesh-list
64337435|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337436|NCT02750345|Nitisinone|nitisinone|mesh-list
64337437|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64337438|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337439|NCT01329263|Menthol|menthol|mesh-list
64337513|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64612796|NCT02851108|Primaquine|primaquine|mesh-list
64337514|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64337515|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64337516|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
64337517|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613014|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
64337518|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337519|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613082|NCT05495061|Latanoprost|latanoprost|mesh-list
64337521|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64337522|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64337523|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337524|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423536|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64337525|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337526|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337527|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64337528|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
64337536|NCT04939363|Venetoclax|venetoclax|mesh-list
64337537|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
64337538|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337539|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337540|NCT02236403|Metronidazole|metronidazole|mesh-list
64337541|NCT02236403|Ivermectin|ivermectin|mesh-list
64385863|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64385864|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64385865|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385866|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385867|NCT01661595|Urological Agents|urological agents|mesh-ancestor
64385868|NCT03004443|Infliximab|infliximab|mesh-list
64385871|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385872|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
64337542|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337543|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64337544|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64337545|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64337546|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64337547|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337548|NCT02934529|Leucovorin|leucovorin|mesh-list
64337549|NCT02934529|Folic Acid|folic acid|mesh-list
64337550|NCT02934529|Bevacizumab|bevacizumab|mesh-list
64337551|NCT02934529|Cetuximab|cetuximab|mesh-list
64337565|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64337566|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337619|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337620|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337621|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337622|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423537|NCT05218603|Bortezomib|bortezomib|mesh-list
64337631|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64337632|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64337633|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
64337634|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337636|NCT02262299|Analgesics|analgesics|mesh-ancestor
64337637|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
64299612|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64299613|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299614|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299616|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64299617|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
64337638|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337639|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337640|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64337641|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64337642|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337643|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337644|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337684|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64337685|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64337686|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337687|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64337688|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64337689|NCT02262611|Diuretics|diuretics|mesh-ancestor
64613868|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
64337705|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337746|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337748|NCT01590719|Folic Acid|folic acid|mesh-list
64337749|NCT01590719|Fluorouracil|fluorouracil|mesh-list
64337750|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
64337751|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
64337752|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
64337753|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337754|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64337755|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337756|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337757|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
64337758|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337759|NCT01590719|Antidotes|antidotes|mesh-ancestor
64337760|NCT01590719|Protective Agents|protective agents|mesh-ancestor
64337761|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
64337762|NCT01590719|Vitamins|vitamins|mesh-ancestor
64337763|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
64337765|NCT01536041|Montelukast|montelukast|mesh-list
64337766|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64337767|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
64337768|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64337769|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
64337770|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64337771|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614059|NCT00979615|Analgesics|analgesics|mesh-ancestor
64337772|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64337773|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64423538|NCT05218603|Daratumumab|daratumumab|mesh-list
64337774|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337776|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337777|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337778|NCT01522469|Crenolanib|crenolanib|mesh-list
64337803|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64337804|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
64337805|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64337806|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
64337807|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337808|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614198|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
64337809|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64337810|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
64337824|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64337825|NCT01495247|Paclitaxel|paclitaxel|mesh-list
64337826|NCT01495247|Dactolisib|dactolisib|mesh-list
64337827|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64337828|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614552|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337849|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64337850|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64337851|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64337852|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
64337854|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337855|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337856|NCT02264171|Urological Agents|urological agents|mesh-ancestor
64337857|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
64337858|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337859|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64337871|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337873|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
64337874|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337876|NCT01470131|Bortezomib|bortezomib|mesh-list
64337877|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64337878|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
64337879|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
64337880|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337881|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337882|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337883|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
64337884|NCT01470131|Hormones|hormones|mesh-ancestor
64337885|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615133|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337886|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64337887|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337896|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
64337897|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64337898|NCT01464437|Metformin|metformin|mesh-list
64337899|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64337900|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337901|NCT01461317|Etrolizumab|etrolizumab|mesh-list
64337902|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64337903|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
64337904|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337905|NCT01449071|Epratuzumab|epratuzumab|mesh-list
64337906|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337907|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615493|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64337910|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337911|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
64337912|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337914|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
64337915|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
64337916|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64337917|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337918|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
64337919|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64337920|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64337971|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64337972|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337974|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337975|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64337976|NCT02265809|Aldesleukin|aldesleukin|mesh-list
64337977|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64337978|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64337979|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64337980|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
64337981|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64337982|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
64337983|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64337984|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
64337985|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64337986|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
64337987|NCT01372475|Protective Agents|protective agents|mesh-ancestor
64337988|NCT00156065|Haloperidol|haloperidol|mesh-list
64337989|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
64337990|NCT00156065|Asenapine|asenapine|mesh-list
64337991|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
64337992|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
64338007|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64338008|NCT04476173|Narcotics|narcotics|mesh-ancestor
64338016|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
64338017|NCT01554956|Plasminogen|plasminogen|mesh-list
64338018|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64338019|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64338020|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338021|NCT01360853|Gemcitabine|gemcitabine|mesh-list
64338022|NCT01360853|ON 01910|on 01910|mesh-list
64338023|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64338024|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
64338025|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616221|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
64338026|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338027|NCT01360853|Antiviral Agents|antiviral agents|mesh-ancestor
64338028|NCT01360853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338029|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338030|NCT01360853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616289|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
64338031|NCT01360853|Immunologic Factors|immunologic factors|mesh-ancestor
64338032|NCT01360853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616290|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338043|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
64338045|NCT01348919|Lenalidomide|lenalidomide|mesh-list
64338046|NCT01348919|Delanzomib|delanzomib|mesh-list
64338047|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338067|NCT02266511|Tamsulosin|tamsulosin|mesh-list
64338068|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64338069|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64338070|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64338071|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
64338072|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616505|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
64385873|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64338073|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616575|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338074|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338075|NCT02266511|Urological Agents|urological agents|mesh-ancestor
64338076|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
64338077|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338078|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64338079|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64338080|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64338081|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338082|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338083|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338084|NCT01298687|Travoprost|travoprost|mesh-list
64338085|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64616713|NCT01063075|Carboplatin|carboplatin|mesh-list
64616785|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
64338103|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338104|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338106|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616872|NCT01075399|Imidazole|imidazole|mesh-list
64338108|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64338109|NCT01262261|Narcotics|narcotics|mesh-ancestor
64616999|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
64338140|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
64338141|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64338142|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338143|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
64338144|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
64338145|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617148|NCT01079143|Everolimus|everolimus|mesh-list
64338146|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338147|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338148|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
64338150|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338151|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64338152|NCT05177939|Protective Agents|protective agents|mesh-ancestor
64338191|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
64617295|NCT05620277|Tocopherols|tocopherols|mesh-list
64338192|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64338215|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338216|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64338245|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338246|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
64414793|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617508|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
64414794|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64414795|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414796|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64617585|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
64414797|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64414798|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64414799|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414800|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414801|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64414802|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
64414803|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64414804|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414815|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
64617872|NCT01130077|Poly ICLC|poly iclc|mesh-list
64617947|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
64414829|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414830|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
64414831|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414832|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
64414833|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385874|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385875|NCT02957097|Gabapentin|gabapentin|mesh-list
64385876|NCT02957097|Analgesics|analgesics|mesh-ancestor
64385877|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
64414834|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414835|NCT04887493|Alprostadil|alprostadil|mesh-list
64414836|NCT04887493|Misoprostol|misoprostol|mesh-list
64414837|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64414838|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
64414839|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64414840|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414841|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64414842|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64414843|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
64414844|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64618547|NCT01008059|Analgesics|analgesics|mesh-ancestor
64414845|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
64414846|NCT04887493|Urological Agents|urological agents|mesh-ancestor
64414848|NCT02486757|Progesterone|progesterone|mesh-list
64414849|NCT02486757|Estrogens|estrogens|mesh-ancestor
64414850|NCT02486757|Hormones|hormones|mesh-ancestor
64618693|NCT00953849|Vitamins|vitamins|mesh-ancestor
64423539|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414851|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414852|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414866|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64414867|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64414868|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
64414869|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414870|NCT04897477|Azacitidine|azacitidine|mesh-list
64414871|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64414872|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414873|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
64414874|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414875|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414876|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414877|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64423540|NCT05280769|Lobeline|lobeline|mesh-list
64414885|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414887|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
64414888|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414889|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619276|NCT03809182|Analgesics|analgesics|mesh-ancestor
64414908|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64414909|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414910|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64620299|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
64414957|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
64414959|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64414960|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414961|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414962|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64414963|NCT05474183|Analgesics|analgesics|mesh-ancestor
64620528|NCT05510310|Oxytocin|oxytocin|mesh-list
64414964|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
64414965|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414966|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64414973|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64414974|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
64414975|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
64620780|NCT02972294|Iron|iron|mesh-list
64414976|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64414977|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64414978|NCT04885777|Lidocaine|lidocaine|mesh-list
64414979|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
64414981|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414982|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414983|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
64414984|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414985|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64414986|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64414987|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64423543|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
64414988|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414992|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64414993|NCT02632721|Decitabine|decitabine|mesh-list
64414994|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414995|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
64423544|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414996|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414997|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414998|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414999|NCT05529095|Apomorphine|apomorphine|mesh-list
64415000|NCT05529095|Emetics|emetics|mesh-ancestor
64415002|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
64415003|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415004|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415005|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
64415006|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
64415007|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415008|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415009|NCT01596127|Rituximab|rituximab|mesh-list
64415020|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
64621650|NCT05095116|Xhance|xhance|mesh-list
64415021|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
64415022|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
64415023|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415024|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415025|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
64415026|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
64415027|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415029|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415030|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
64415031|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415032|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64415033|NCT04895059|Ezetimibe|ezetimibe|mesh-list
64621890|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
64415034|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64415035|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64415036|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
64415037|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415038|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64415039|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64415053|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64385879|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385880|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
64385881|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64385882|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64385883|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385884|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64385917|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
64415054|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64415055|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415056|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64622469|NCT05599828|Famotidine|famotidine|mesh-list
64415057|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64415058|NCT04895137|Growth Substances|growth substances|mesh-ancestor
64415059|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415060|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
64415061|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
64415062|NCT02332577|Amoxicillin|amoxicillin|mesh-list
64415072|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64415097|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415099|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64415100|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415101|NCT04884997|Temozolomide|temozolomide|mesh-list
64415102|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64415103|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
64423546|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64415104|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415105|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415106|NCT04885075|Midazolam|midazolam|mesh-list
64415107|NCT04885075|Diazepam|diazepam|mesh-list
64415108|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64415109|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64415110|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423547|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64415111|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385922|NCT05286437|Lenvatinib|lenvatinib|mesh-list
64385923|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385924|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385926|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64386029|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
64386030|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386031|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64386032|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64386033|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
64386034|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
64386035|NCT03959241|Methotrexate|methotrexate|mesh-list
64415112|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64415113|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64415114|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64415115|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64415116|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
64415117|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
64415118|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
64415119|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
64415120|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415121|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415122|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
64415123|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
64415124|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
64415125|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415126|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415127|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64415128|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64415129|NCT01610687|Nabiximols|nabiximols|mesh-list
64623773|NCT00623974|Calcitriol|calcitriol|mesh-list
64415152|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623849|NCT00421954|Ziprasidone|ziprasidone|mesh-list
64415155|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64386038|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
64386039|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386040|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386041|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64386042|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
64386043|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386079|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386080|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
64415156|NCT04878835|Growth Substances|growth substances|mesh-ancestor
64624000|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
64415157|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415158|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
64415159|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299618|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299619|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64299620|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64299621|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299622|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299623|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64299624|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
64299625|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299626|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415164|NCT04872283|Ketorolac|ketorolac|mesh-list
64415165|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64415166|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64415167|NCT04872283|Oxycodone|oxycodone|mesh-list
64423557|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415168|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64415169|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64415170|NCT04872283|Analgesics|analgesics|mesh-ancestor
64415171|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
64415172|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415173|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415174|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64386081|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386102|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386103|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64386104|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64386106|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
64386108|NCT02055820|Doxorubicin|doxorubicin|mesh-list
64386109|NCT02055820|Vincristine|vincristine|mesh-list
64386110|NCT02055820|Venetoclax|venetoclax|mesh-list
64386111|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
64386112|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386113|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
64415175|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415176|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64415177|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64624737|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64415178|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415179|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64415180|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64415181|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624817|NCT02904954|Durvalumab|durvalumab|mesh-list
64415188|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415189|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64415190|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625112|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
64415191|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415192|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
64415193|NCT04389073|Bevacizumab|bevacizumab|mesh-list
64415194|NCT04389073|Capecitabine|capecitabine|mesh-list
64415195|NCT04389073|Vinorelbine|vinorelbine|mesh-list
64299627|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64299628|NCT05389813|Pregabalin|pregabalin|mesh-list
64299629|NCT05389813|Oxycodone|oxycodone|mesh-list
64299630|NCT05389813|Analgesics|analgesics|mesh-ancestor
64299631|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
64299632|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415196|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415200|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64415202|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415203|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415204|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64625618|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64415205|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64415209|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
64415210|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415211|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
64415212|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64415213|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
64415214|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
64415215|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
64415216|NCT04371445|Dexamethasone|dexamethasone|mesh-list
64415217|NCT04371445|Prednisolone|prednisolone|mesh-list
64415218|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64415219|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
64415220|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64415221|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
64415222|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64415223|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
64415224|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64415225|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
64415226|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
64415227|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626143|NCT02688140|Analgesics|analgesics|mesh-ancestor
64415228|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415229|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415230|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
64415231|NCT04371445|Hormones|hormones|mesh-ancestor
64415232|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626202|NCT00001570|Vinblastine|vinblastine|mesh-list
64415233|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64415234|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415235|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64415236|NCT04371445|Protective Agents|protective agents|mesh-ancestor
64415237|NCT03049267|Apremilast|apremilast|mesh-list
64626423|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64415238|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64415239|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64415240|NCT03049267|Analgesics|analgesics|mesh-ancestor
64415241|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
64415242|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415243|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415244|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626574|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
64415245|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386115|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386116|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64386117|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
64386118|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386119|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386120|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386124|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64386125|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386126|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64386127|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
64386128|NCT02055820|Hormones|hormones|mesh-ancestor
64386129|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386130|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64415246|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64415247|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64415248|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415249|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415251|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
64415275|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415277|NCT05257993|Antiviral Agents|antiviral agents|mesh-ancestor
64415278|NCT05257993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415279|NCT05257993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626947|NCT02168855|Nicotine|nicotine|mesh-list
64415280|NCT05257993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415281|NCT05257993|Immunologic Factors|immunologic factors|mesh-ancestor
64415282|NCT05257993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415283|NCT05533073|Etoricoxib|etoricoxib|mesh-list
64415284|NCT05533073|Tramadol|tramadol|mesh-list
64627099|NCT01241539|Dabigatran|dabigatran|mesh-list
64415285|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64627160|NCT01928576|Nivolumab|nivolumab|mesh-list
64415287|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415288|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415289|NCT05533073|Analgesics|analgesics|mesh-ancestor
64415290|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
64415291|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627613|NCT00002476|Leucovorin|leucovorin|mesh-list
64415292|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64415293|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64386131|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64386133|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
64386134|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
64386135|NCT05408559|Sulforaphane|sulforaphane|mesh-list
64386136|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64386207|NCT01374425|Antidotes|antidotes|mesh-ancestor
64386208|NCT01374425|Protective Agents|protective agents|mesh-ancestor
64386209|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
64386211|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
64386212|NCT02085460|Rebamipide|rebamipide|mesh-list
64386213|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64386214|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415294|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64627775|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
64415302|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415304|NCT04050553|Hormones|hormones|mesh-ancestor
64423559|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64415305|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64415306|NCT03946891|Furosemide|furosemide|mesh-list
64415307|NCT03946891|Diuretics|diuretics|mesh-ancestor
64415308|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
64415317|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64415318|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415319|NCT04300049|Incretins|incretins|mesh-ancestor
64415321|NCT03849625|Acetaminophen|acetaminophen|mesh-list
64423560|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
64415322|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64415323|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64415324|NCT03849625|Analgesics|analgesics|mesh-ancestor
64415325|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
64415326|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415327|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415328|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628352|NCT04868708|Carboplatin|carboplatin|mesh-list
64415329|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64299633|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415331|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64415332|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628497|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
64415333|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64415334|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64628588|NCT00002578|Antidotes|antidotes|mesh-ancestor
64415336|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
64415337|NCT03612973|Insulin|insulin|mesh-list
64628651|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
64415339|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628729|NCT04194554|Leuprolide|leuprolide|mesh-list
64415340|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64415341|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
64415342|NCT03049345|Methylene Blue|methylene blue|mesh-list
64628950|NCT00002692|Antidotes|antidotes|mesh-ancestor
64415344|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415345|NCT03300817|Poly ICLC|poly iclc|mesh-list
64415346|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
64415347|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
64415348|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415350|NCT05526911|Lamivudine|lamivudine|mesh-list
64415351|NCT05526911|Dolutegravir|dolutegravir|mesh-list
64415352|NCT05526911|Digoxin|digoxin|mesh-list
64415353|NCT05526911|Midazolam|midazolam|mesh-list
64415354|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64415355|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64415356|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629313|NCT05167175|Olaparib|olaparib|mesh-list
64299634|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
64299635|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64299636|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64299637|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299638|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64299639|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64299640|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64299641|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299642|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64299643|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64299644|NCT05389813|Narcotics|narcotics|mesh-ancestor
64299645|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64299646|NCT02100787|Laxatives|laxatives|mesh-ancestor
64299647|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299648|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64299649|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64299650|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299651|NCT04718805|Darunavir|darunavir|mesh-list
64415374|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64415375|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64415377|NCT05526911|Protective Agents|protective agents|mesh-ancestor
64415387|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64415388|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64415390|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415391|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64415392|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64415393|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415394|NCT02574845|Diuretics|diuretics|mesh-ancestor
64415395|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
64415396|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64415397|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64415398|NCT05334485|Bromides|bromides|mesh-list
64415399|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64630853|NCT02494258|Cc-486|cc-486|mesh-list
64415400|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
64415401|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64415402|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415403|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415404|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
64415405|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415406|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415408|NCT05231941|Ropivacaine|ropivacaine|mesh-list
64415409|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
64415410|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
64415411|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631158|NCT04775576|Anesthetics|anesthetics|mesh-list
64415412|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631230|NCT05423210|Atezolizumab|atezolizumab|mesh-list
64415415|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64415416|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64415417|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64415418|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64415419|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415421|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
64415422|NCT05146739|Leucovorin|leucovorin|mesh-list
64415423|NCT05146739|Cytarabine|cytarabine|mesh-list
64415424|NCT05146739|Fludarabine|fludarabine|mesh-list
64415425|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415431|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415432|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
64415433|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415434|NCT05146739|Antidotes|antidotes|mesh-ancestor
64415435|NCT05146739|Protective Agents|protective agents|mesh-ancestor
64631763|NCT00003178|Idarubicin|idarubicin|mesh-list
64415436|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
64415437|NCT05146739|Vitamins|vitamins|mesh-ancestor
64415438|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
64415439|NCT05522231|Everolimus|everolimus|mesh-list
64415441|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415442|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415443|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
64415478|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64415479|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64415481|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415482|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64415483|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64415484|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415485|NCT03044587|Leucovorin|leucovorin|mesh-list
64415486|NCT03044587|Gemcitabine|gemcitabine|mesh-list
64415487|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415506|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415507|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415508|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64415509|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
64415510|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
64415511|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64415512|NCT05525351|Analgesics|analgesics|mesh-ancestor
64415513|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
64415514|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415515|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64415516|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64415517|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64415518|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64415519|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415520|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415521|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64415522|NCT05525351|Narcotics|narcotics|mesh-ancestor
64415523|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
64415524|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415525|NCT05521763|Vaccines|vaccines|mesh-list
64415526|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
64415527|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415528|NCT05100017|Methocarbamol|methocarbamol|mesh-list
64415529|NCT05100017|Oxybutynin|oxybutynin|mesh-list
64415530|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
64415531|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
64415532|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415533|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415534|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64299662|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299665|NCT05042336|Lenvatinib|lenvatinib|mesh-list
64415538|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415539|NCT05100017|Urological Agents|urological agents|mesh-ancestor
64415540|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64415541|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64415542|NCT04865185|Ethanol|ethanol|mesh-list
64415543|NCT04865185|Lidocaine|lidocaine|mesh-list
64415544|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64415545|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415546|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415572|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
64415573|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
64415574|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
64415575|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
64415576|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415577|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64415578|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
64415579|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
64415580|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423561|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415581|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415582|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415583|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64415584|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
64415585|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64415586|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
64415587|NCT05092451|Fludarabine|fludarabine|mesh-list
64415588|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
64415589|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415590|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
64415591|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415592|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415593|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64415594|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
64415595|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415596|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415597|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64415598|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632068|NCT00002884|Fluorouracil|fluorouracil|mesh-list
64415599|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
64415601|NCT04864717|Isotretinoin|isotretinoin|mesh-list
64415602|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64415603|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632188|NCT00003262|Bleomycin|bleomycin|mesh-list
64415621|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
64415622|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64632349|NCT00384124|Imiquimod|imiquimod|mesh-list
64415623|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
64415624|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64415625|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64415626|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
64415627|NCT04869709|Hormones|hormones|mesh-ancestor
64415628|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299670|NCT03096392|Insulin|insulin|mesh-list
64299671|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64299672|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
64299673|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64299674|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299675|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
64299676|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64299677|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64415629|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299678|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415644|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
64415645|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415646|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415648|NCT05531591|Aripiprazole|aripiprazole|mesh-list
64415649|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
64415650|NCT05531591|Bupropion|bupropion|mesh-list
64415651|NCT05531591|Nortriptyline|nortriptyline|mesh-list
64633590|NCT05774964|Vitamins|vitamins|mesh-ancestor
64633682|NCT05638594|Hormones|hormones|mesh-list
64299681|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64299682|NCT02460393|Antibodies|antibodies|mesh-list
64299683|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
64299684|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64299685|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
64415652|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64415653|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
64633991|NCT04895566|Antibodies|antibodies|mesh-list
64634058|NCT04779320|Vedolizumab|vedolizumab|mesh-list
64415659|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
64415660|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415661|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415662|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64415663|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64415664|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415665|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64634449|NCT03298087|Leuprolide|leuprolide|mesh-list
64415672|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64415673|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64415674|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64415676|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
64415677|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64634602|NCT01970865|Crizotinib|crizotinib|mesh-list
64415678|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64415679|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
64415680|NCT05048615|Itraconazole|itraconazole|mesh-list
64415681|NCT05048615|Azacitidine|azacitidine|mesh-list
64415682|NCT05048615|Venetoclax|venetoclax|mesh-list
64415683|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415684|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
64415685|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415686|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415687|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415688|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
64415689|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415690|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64415691|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64415692|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64415693|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
64299686|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299687|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415700|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415701|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
64635335|NCT00005596|Antidotes|antidotes|mesh-ancestor
64415702|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415703|NCT05517239|Gemcitabine|gemcitabine|mesh-list
64415704|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
64415705|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415706|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
64415707|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415708|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415709|NCT05517239|Antiviral Agents|antiviral agents|mesh-ancestor
64415710|NCT05517239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415711|NCT05517239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415712|NCT05517239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415713|NCT05517239|Immunologic Factors|immunologic factors|mesh-ancestor
64415714|NCT05517239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415716|NCT05519813|Pioglitazone|pioglitazone|mesh-list
64415717|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64415718|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415719|NCT02613403|Ribavirin|ribavirin|mesh-list
64415720|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
64415721|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
64415722|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415723|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
64635914|NCT00005812|Temozolomide|temozolomide|mesh-list
64415724|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415725|NCT05002127|Paclitaxel|paclitaxel|mesh-list
64415726|NCT05002127|Trastuzumab|trastuzumab|mesh-list
64415727|NCT05002127|Ramucirumab|ramucirumab|mesh-list
64415728|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64415729|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415730|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
64415731|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
64636224|NCT01304407|Calcium|calcium|mesh-list
64636284|NCT01411501|Mosapride|mosapride|mesh-list
64415756|NCT05531123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415757|NCT05531123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415758|NCT05531123|Immunologic Factors|immunologic factors|mesh-ancestor
64415760|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
64415761|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
64415762|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64415763|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64415764|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415765|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415766|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636663|NCT00118352|Cyclosporine|cyclosporine|mesh-list
64415767|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415768|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
64415769|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64415770|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64415771|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415772|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
64415773|NCT03044041|Coagulants|coagulants|mesh-ancestor
64415774|NCT05518799|Midazolam|midazolam|mesh-list
64415775|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64415776|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64636948|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415777|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415778|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415779|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64637095|NCT00265616|Pentobarbital|pentobarbital|mesh-list
64415780|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64415781|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64637325|NCT05448378|Vitamins|vitamins|mesh-ancestor
64415783|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
64415784|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
64637392|NCT02397720|Azacitidine|azacitidine|mesh-list
64415791|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415793|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64637464|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637613|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
64415794|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415795|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415796|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
64299688|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64415797|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299689|NCT02250859|Minocycline|minocycline|mesh-list
64299690|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299691|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
64299692|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64299693|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299694|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
64415821|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415822|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64415823|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64415824|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64639585|NCT01222091|Analgesics|analgesics|mesh-ancestor
64415825|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64415826|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
64415827|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639656|NCT01189409|Sennosides|sennosides|mesh-list
64415828|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415829|NCT04873531|Neostigmine|neostigmine|mesh-list
64415830|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64415831|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415832|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415833|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
64415834|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639895|NCT00353834|Exenatide|exenatide|mesh-list
64639951|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64415835|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640049|NCT00318812|Iron|iron|mesh-list
64640104|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
64640181|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
64640256|NCT05385432|Tacrolimus|tacrolimus|mesh-list
64640642|NCT00373334|Nizatidine|nizatidine|mesh-list
64415836|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64415837|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
64640698|NCT05268120|Doxycycline|doxycycline|mesh-list
64415838|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415839|NCT04862845|Pregabalin|pregabalin|mesh-list
64415840|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64415841|NCT04862845|Analgesics|analgesics|mesh-ancestor
64415842|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
64640771|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
64415843|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415844|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415845|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
64415846|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64415847|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64415852|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415853|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64415854|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64415855|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64415856|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415857|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
64415860|NCT04862377|Poractant alfa|poractant alfa|mesh-list
64415861|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64415862|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64415863|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
64415864|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415865|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415866|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64415867|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
64415868|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
64415869|NCT04862377|Hormones|hormones|mesh-ancestor
64641646|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
64415870|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64415881|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64415883|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
64415884|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
64415885|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64415886|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415887|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415888|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
64299699|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299700|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64299701|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64299702|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
64299703|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299704|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299705|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64299706|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64299708|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
64299709|NCT02101255|Protective Agents|protective agents|mesh-ancestor
64415889|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415890|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415891|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64415892|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
64415893|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64415894|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64415895|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64415896|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64415902|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415903|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
64641972|NCT00539942|PENTA|penta|mesh-list
64415904|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
64415905|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64415906|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
64415907|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415908|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415909|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64415910|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
64415911|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
64415912|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64415913|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
64415914|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642306|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415915|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642449|NCT00555464|Prednisolone|prednisolone|mesh-list
64415916|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64415917|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64415918|NCT05512013|Ibuprofen|ibuprofen|mesh-list
64299710|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299712|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
64299713|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299714|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64299715|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64299716|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642598|NCT05080218|Ixekizumab|ixekizumab|mesh-list
64415921|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64642672|NCT05140278|Artesunate|artesunate|mesh-list
64415922|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64415923|NCT05512013|Analgesics|analgesics|mesh-ancestor
64415924|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
64415925|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415926|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415927|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64415928|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415929|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64299717|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299718|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64415930|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415931|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415932|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64415933|NCT04894643|Gemcitabine|gemcitabine|mesh-list
64415934|NCT04894643|Paclitaxel|paclitaxel|mesh-list
64643035|NCT05127876|Ephedrine|ephedrine|mesh-list
64415935|NCT04894643|Capecitabine|capecitabine|mesh-list
64415936|NCT04894643|Pancrelipase|pancrelipase|mesh-list
64415937|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64415948|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415949|NCT04894643|Immunologic Factors|immunologic factors|mesh-ancestor
64415950|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643326|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64643329|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
64415951|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415952|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
64643474|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64415953|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64415954|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
64415955|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415956|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415957|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64415958|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
64415959|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
64415961|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
64415962|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643841|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
64415963|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415965|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
64415967|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64415968|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64415969|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
64643999|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
64415970|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64415971|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415972|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415973|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
64415974|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
64415975|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415982|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
64415983|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415984|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415985|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299719|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
64415986|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644204|NCT00572468|Simvastatin|simvastatin|mesh-list
64299720|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299723|NCT02104297|Remifentanil|remifentanil|mesh-list
64415988|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415991|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415993|NCT05514275|Endostatins|endostatins|mesh-list
64415994|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415995|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
64415996|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415997|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415998|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64415999|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64416000|NCT05514275|Growth Substances|growth substances|mesh-ancestor
64416001|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416002|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
64416051|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
64416052|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
64645003|NCT01588561|Nicotine|nicotine|mesh-list
64416053|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416054|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416055|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416056|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
64416057|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416058|NCT05513729|Pioglitazone|pioglitazone|mesh-list
64416059|NCT05513729|Canagliflozin|canagliflozin|mesh-list
64645297|NCT03006835|Clopidogrel|clopidogrel|mesh-list
64299725|NCT02104297|Narcotics|narcotics|mesh-ancestor
64416060|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64299726|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299727|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299728|NCT02104297|Analgesics|analgesics|mesh-ancestor
64299729|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
64299730|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299731|NCT02106481|Ropivacaine|ropivacaine|mesh-list
64299732|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
64299733|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
64299734|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299735|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299736|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
64299737|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299738|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64299741|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299742|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64299744|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64299745|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64299747|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
64299748|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64416063|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416064|NCT05504603|Rituximab|rituximab|mesh-list
64416065|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
64416066|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416067|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416068|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
64416069|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416070|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416071|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64416072|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645890|NCT00595556|Zonisamide|zonisamide|mesh-list
64416073|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416074|NCT05504213|Fulvestrant|fulvestrant|mesh-list
64416075|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416076|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416077|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64416078|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64299749|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
64416082|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
64416083|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416084|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646412|NCT01235195|Sertraline|sertraline|mesh-list
64416087|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64416088|NCT02564471|Atovaquone|atovaquone|mesh-list
64416098|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64416099|NCT02564471|Analgesics|analgesics|mesh-ancestor
64416100|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
64416101|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416102|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416103|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416104|NCT02564471|Filaricides|filaricides|mesh-ancestor
64416117|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
64416118|NCT05512481|Temozolomide|temozolomide|mesh-list
64416119|NCT05512481|Apatinib|apatinib|mesh-list
64416120|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64416121|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
64416122|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416123|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416124|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64416125|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416126|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
64416127|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64416128|NCT02563067|Growth Substances|growth substances|mesh-ancestor
64416129|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416130|NCT02568683|Vincristine|vincristine|mesh-list
64416131|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64416132|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299750|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416134|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
64416135|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
64416136|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416137|NCT05502731|Adalimumab|adalimumab|mesh-list
64299751|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
64299752|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
64416142|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
64416143|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
64416144|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416145|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416147|NCT05510141|Analgesics|analgesics|mesh-ancestor
64647407|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64416148|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
64416149|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416150|NCT05503043|Lidocaine|lidocaine|mesh-list
64647490|NCT04385264|Mannitol|mannitol|mesh-list
64416151|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
64416152|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
64416153|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416154|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416155|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
64416156|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416157|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64416158|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64648001|NCT00780494|Growth Substances|growth substances|mesh-ancestor
64416159|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64648079|NCT00781898|Naltrexone|naltrexone|mesh-list
64416160|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648147|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416161|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416162|NCT02563925|Durvalumab|durvalumab|mesh-list
64416163|NCT02563925|Tremelimumab|tremelimumab|mesh-list
64416167|NCT01663727|Bevacizumab|bevacizumab|mesh-list
64416174|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416176|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64416177|NCT01663727|Growth Substances|growth substances|mesh-ancestor
64416178|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416179|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
64416180|NCT03042325|Alogliptin|alogliptin|mesh-list
64416181|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64416182|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416183|NCT03042325|Incretins|incretins|mesh-ancestor
64416184|NCT03042325|Hormones|hormones|mesh-ancestor
64416185|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416186|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64416187|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416188|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416189|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416190|NCT01594333|Methotrexate|methotrexate|mesh-list
64416191|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64416192|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
64416193|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64416194|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416195|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64416196|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
64416197|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416198|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416199|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
64416200|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416201|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64648657|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64416202|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416203|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
64416204|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416205|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64416206|NCT04342039|Budesonide|budesonide|mesh-list
64416207|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416208|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64416209|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
64416210|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416211|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416212|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64416213|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
64416214|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
64299753|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299754|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416215|NCT04342039|Hormones|hormones|mesh-ancestor
64299755|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299757|NCT05047874|Hormones|hormones|mesh-ancestor
64299758|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299759|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64299760|NCT05047874|Protective Agents|protective agents|mesh-ancestor
64416223|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64416224|NCT04338529|Antacids|antacids|mesh-ancestor
64416225|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649453|NCT00806234|Ziprasidone|ziprasidone|mesh-list
64416226|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416227|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
64416228|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
64416229|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64416230|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64649890|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
64416231|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416232|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416233|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416253|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416259|NCT04858087|Lumefantrine|lumefantrine|mesh-list
64416260|NCT04858087|Artemether|artemether|mesh-list
64416261|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64416262|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
64416263|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64416264|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64416265|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416266|NCT03041935|Acetaminophen|acetaminophen|mesh-list
64416267|NCT03041935|Dexamethasone|dexamethasone|mesh-list
64416268|NCT03041935|Ketorolac|ketorolac|mesh-list
64416269|NCT03041935|Morphine|morphine|mesh-list
64416270|NCT03041935|Remifentanil|remifentanil|mesh-list
64416271|NCT03041935|Ondansetron|ondansetron|mesh-list
64416272|NCT03041935|Propofol|propofol|mesh-list
64299761|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416273|NCT03041935|Ropivacaine|ropivacaine|mesh-list
64416274|NCT03041935|Sevoflurane|sevoflurane|mesh-list
64416275|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416276|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
64416277|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
64650633|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64416278|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416279|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416280|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416283|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416284|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416286|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64416287|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416288|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64651238|NCT01519271|Rivastigmine|rivastigmine|mesh-list
64424551|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416289|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
64416290|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
64416291|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64416302|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64416303|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
64416304|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651389|NCT01520207|Mannitol|mannitol|mesh-list
64416305|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416306|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64416307|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64416308|NCT03041935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64416310|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64416311|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416312|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64416313|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416314|NCT03042013|Naquotinib|naquotinib|mesh-list
64416315|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416316|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64416317|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416318|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416319|NCT03042871|Ranibizumab|ranibizumab|mesh-list
64416320|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64651665|NCT05312294|Vaccines|vaccines|mesh-list
64416321|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64416322|NCT03042871|Growth Substances|growth substances|mesh-ancestor
64416323|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416324|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
64416325|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416326|NCT03042637|Tacrolimus|tacrolimus|mesh-list
64416327|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416328|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
64416329|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416330|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64416331|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416339|NCT03045133|Analgesics|analgesics|mesh-ancestor
64416340|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
64416341|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416342|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
64651871|NCT01833572|Gefitinib|gefitinib|mesh-list
64416343|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
64416344|NCT02609659|Ritonavir|ritonavir|mesh-list
64416345|NCT02609659|Ribavirin|ribavirin|mesh-list
64416346|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64416347|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64416348|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416349|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652162|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416350|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652243|NCT01837394|Acetaminophen|acetaminophen|mesh-list
64416351|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64416352|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64416353|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
64416354|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416355|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64416356|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64416357|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
64416358|NCT04429711|Ivermectin|ivermectin|mesh-list
64652313|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
64416359|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64416360|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652386|NCT04969224|Ivacaftor|ivacaftor|mesh-list
64416369|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416370|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64299762|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299763|NCT04488705|Albuterol|albuterol|mesh-list
64299764|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64299765|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
64299766|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299767|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299768|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64299769|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
64299770|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
64299771|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64299772|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64416373|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64416374|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416375|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652531|NCT01725776|Milrinone|milrinone|mesh-list
64416376|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64416377|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652600|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416378|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377971|NCT04816461|Artenimol|artenimol|mesh-list
64416380|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64416381|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652965|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64416391|NCT04856371|Letrozole|letrozole|mesh-list
64416392|NCT04856371|Fulvestrant|fulvestrant|mesh-list
64416393|NCT04856371|Palbociclib|palbociclib|mesh-list
64416394|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416395|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64416396|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64416397|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416398|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653558|NCT03400592|Irinotecan|irinotecan|mesh-list
64416399|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64416400|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
64653645|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416401|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416402|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653720|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416403|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416410|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
64416411|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416412|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416414|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64416415|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416416|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416417|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64416418|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416419|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416421|NCT02612779|Nivolumab|nivolumab|mesh-list
64416422|NCT02612779|Pomalidomide|pomalidomide|mesh-list
64416423|NCT02612779|Elotuzumab|elotuzumab|mesh-list
64416424|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416426|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
64416427|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416434|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654234|NCT03207347|Niraparib|niraparib|mesh-list
64416435|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416448|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
64416449|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416450|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299773|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64416451|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416452|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416453|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64416454|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416455|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416456|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64416457|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
64416458|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
64416459|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416460|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
64416461|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64416462|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
64416463|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416464|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64416466|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64655548|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
64416477|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64416478|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416479|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64416480|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64416481|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64416482|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655767|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416483|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416484|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
64416485|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299774|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64299775|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
64416492|NCT04855279|Protective Agents|protective agents|mesh-ancestor
64299776|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416493|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656056|NCT01016678|Naproxen|naproxen|mesh-list
64416494|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64416495|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656294|NCT03018626|Prednisone|prednisone|mesh-list
64416514|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64416515|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
64656357|NCT00975650|Testosterone|testosterone|mesh-list
64416516|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64416517|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
64416518|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64416519|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416520|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64416521|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416522|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416523|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
64416525|NCT04848181|Cyproterone|cyproterone|mesh-list
64416526|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64299777|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299778|NCT02106637|Varenicline|varenicline|mesh-list
64299779|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64299780|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64299781|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
64299782|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299783|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299784|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299785|NCT05062304|Fluticasone|fluticasone|mesh-list
64299786|NCT05062304|Xhance|xhance|mesh-list
64299788|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64299789|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
64299790|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299791|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299792|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64424552|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299793|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
64299794|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299795|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64299796|NCT05047328|Inolimomab|inolimomab|mesh-list
64299797|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299798|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
64416576|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64416577|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657819|NCT01100606|Pancreatin|pancreatin|mesh-list
64416578|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416579|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416581|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416582|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658186|NCT02411292|Enoxaparin|enoxaparin|mesh-list
64416583|NCT04839445|Anesthetics|anesthetics|mesh-list
64416584|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416585|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416586|NCT04845607|Amiodarone|amiodarone|mesh-list
64416587|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64416588|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
64299799|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299800|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
64299801|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64299802|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
64299803|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64416589|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64658477|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
64416590|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416591|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658548|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
64416592|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64416593|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64416594|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64416595|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416596|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64416597|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64416601|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416603|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416623|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64416625|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416626|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
64416627|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64416629|NCT03040531|Hormones|hormones|mesh-ancestor
64416630|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416631|NCT04838665|Phenylephrine|phenylephrine|mesh-list
64416632|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
64416633|NCT04838665|Tropicamide|tropicamide|mesh-list
64416634|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
64416635|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64416636|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
64416637|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
64416638|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658680|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416639|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416640|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
64416641|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64416643|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
64658823|NCT04423029|Nivolumab|nivolumab|mesh-list
64416644|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64416645|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64416647|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
64416648|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416649|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416650|NCT04838665|Protective Agents|protective agents|mesh-ancestor
64416651|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64299813|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299814|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64299815|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299816|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64299817|NCT02104843|Asunaprevir|asunaprevir|mesh-list
64299818|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64299819|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64416688|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
64416689|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416690|NCT03038503|Terlipressin|terlipressin|mesh-list
64416695|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64660653|NCT01310582|Desflurane|desflurane|mesh-list
64416697|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64416699|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
64416700|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
64416701|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416702|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416703|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64416704|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
64416705|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64416706|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416730|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416731|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64416732|NCT04852081|Tamoxifen|tamoxifen|mesh-list
64416733|NCT04852081|Letrozole|letrozole|mesh-list
64416734|NCT04852081|Fulvestrant|fulvestrant|mesh-list
64416735|NCT04852081|Palbociclib|palbociclib|mesh-list
64416736|NCT04852081|Anastrozole|anastrozole|mesh-list
64416737|NCT04852081|Exemestane|exemestane|mesh-list
64416738|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299821|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299822|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299823|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64299824|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299825|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
64299826|NCT05041790|Choline|choline|mesh-list
64416739|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64416740|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64299827|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
64299828|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64416746|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662394|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416747|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416748|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64416749|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64416750|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64416751|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64416752|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64416753|NCT04851457|Tirofiban|tirofiban|mesh-list
64416754|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64416755|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64662897|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64416756|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416757|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64416758|NCT02608099|Apixaban|apixaban|mesh-list
64416759|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64663042|NCT02701257|Glucagon|glucagon|mesh-list
64416760|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
64416761|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64416762|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416763|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416764|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416765|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
64416767|NCT04850755|Ipilimumab|ipilimumab|mesh-list
64416768|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416769|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416770|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64416771|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416773|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
64416774|NCT04842487|Rituximab|rituximab|mesh-list
64416775|NCT04842487|Vincristine|vincristine|mesh-list
64663437|NCT04226495|Sufentanil|sufentanil|mesh-list
64416776|NCT04842487|Lenalidomide|lenalidomide|mesh-list
64416777|NCT04842487|Doxorubicin|doxorubicin|mesh-list
64416778|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64416798|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64416799|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64416800|NCT04842487|Growth Substances|growth substances|mesh-ancestor
64416801|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
64416802|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64664452|NCT04375605|Docetaxel|docetaxel|mesh-list
64416803|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64416804|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64416805|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416806|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
64416807|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64416808|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
64416809|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664679|NCT02421588|Topotecan|topotecan|mesh-list
64664894|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64665060|NCT05454345|Isoniazid|isoniazid|mesh-list
64416810|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416811|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64416812|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
64416813|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64416815|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665114|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665116|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
64665180|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416816|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665253|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
64416817|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64416818|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
64416819|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
64416823|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416824|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
64665497|NCT02762331|Vitamins|vitamins|mesh-ancestor
64416825|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
64416826|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64416827|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416828|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665543|NCT01562678|Liraglutide|liraglutide|mesh-list
64416829|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
64416830|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64416831|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416832|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416833|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
64416834|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416835|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416836|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
64416838|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
64416839|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416840|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416841|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64416842|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
64299829|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
64416843|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64416844|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
64416876|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64416877|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64416878|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
64665829|NCT00372801|Ibuprofen|ibuprofen|mesh-list
64416879|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64416880|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416881|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64416882|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64299830|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299831|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299832|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299833|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
64299834|NCT02105077|Anesthetics|anesthetics|mesh-list
64299835|NCT02105077|Xenon|xenon|mesh-list
64299836|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299837|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299838|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64299839|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
64299840|NCT02101567|Oxytocin|oxytocin|mesh-list
64299841|NCT02101567|Carbetocin|carbetocin|mesh-list
64299842|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
64299843|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64299845|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
64416883|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64416884|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416885|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64416910|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
64416911|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665915|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64665977|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416912|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64416913|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64416914|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
64416915|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666127|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416916|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416917|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64416918|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64416919|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
64416920|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64416921|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
64416926|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64416927|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64416928|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64416929|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666578|NCT01584518|Furosemide|furosemide|mesh-list
64416930|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
64416931|NCT04831255|Hormones|hormones|mesh-ancestor
64416932|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416933|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416962|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64416963|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64416965|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
64666632|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64416966|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416967|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416968|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416969|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416970|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64416971|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64416972|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416973|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416975|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416976|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
64416977|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
64416978|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416979|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417036|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
64666987|NCT02218190|Alvimopan|alvimopan|mesh-list
64417037|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64417038|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64299852|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
64299853|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417077|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417078|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
64417079|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64417081|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64417082|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417083|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417084|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64417085|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64667795|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64417105|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417107|NCT04829695|Lumefantrine|lumefantrine|mesh-list
64417108|NCT04829695|Artemether|artemether|mesh-list
64417109|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64417110|NCT04829695|Amodiaquine|amodiaquine|mesh-list
64417111|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
64417112|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64417113|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64417114|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417115|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417125|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668090|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64417126|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64417127|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64417128|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64417129|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
64417130|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417131|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417132|NCT03035695|Hemostatics|hemostatics|mesh-list
64417133|NCT03035695|Coagulants|coagulants|mesh-ancestor
64417134|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
64417135|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417137|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
64417138|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417139|NCT04828525|Dexamethasone|dexamethasone|mesh-list
64417140|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417141|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
64417143|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417144|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417172|NCT05617885|Leuprolide|leuprolide|mesh-list
64417173|NCT05617885|Goserelin|goserelin|mesh-list
64417174|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64417175|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64299854|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
64299855|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
64299856|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299857|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64299858|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64299859|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299860|NCT02105155|Tacrolimus|tacrolimus|mesh-list
64417177|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64668371|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668372|NCT01915823|Fluticasone|fluticasone|mesh-list
64668374|NCT01915823|Azelastine|azelastine|mesh-list
64417178|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668375|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64417179|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64417181|NCT05617885|Hormones|hormones|mesh-ancestor
64417182|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417183|NCT02605837|Budesonide|budesonide|mesh-list
64619364|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
64619365|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
64619366|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64619367|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619368|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619369|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619370|NCT04498351|Analgesics|analgesics|mesh-ancestor
64619371|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
64619372|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299866|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619373|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64619374|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64619375|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64344735|NCT03531437|Progestins|progestins|mesh-ancestor
64619376|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64619377|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619378|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619379|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
64619380|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64619381|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
64619382|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64619383|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619384|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64619385|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
64619386|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64299867|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64619387|NCT02186665|Calcitriol|calcitriol|mesh-list
64619388|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64619389|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619390|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64619391|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619392|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619393|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64619394|NCT02186665|Vitamins|vitamins|mesh-ancestor
64619395|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
64619396|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64619397|NCT01172197|Ropivacaine|ropivacaine|mesh-list
64619398|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
64619399|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
64619400|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
64619401|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619402|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619403|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
64619404|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619405|NCT04141930|Baloxavir|baloxavir|mesh-list
64619406|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
64619407|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619408|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619409|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619410|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64619411|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64619412|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619413|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64619414|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64619415|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619416|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619417|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
64619418|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619419|NCT03746002|Metolazone|metolazone|mesh-list
64619420|NCT03746002|Furosemide|furosemide|mesh-list
64619421|NCT03746002|Diuretics|diuretics|mesh-ancestor
64619422|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
64619423|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619424|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64619425|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619426|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619427|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64619428|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64619429|NCT04089982|Varenicline|varenicline|mesh-list
64619430|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64619431|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64619432|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
64619433|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619434|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619435|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619436|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64619437|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
64619438|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64619439|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
64619440|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619441|NCT03783130|Antacids|antacids|mesh-ancestor
64619442|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619444|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64619445|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64619446|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
64619447|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619448|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619449|NCT03439046|Letrozole|letrozole|mesh-list
64619450|NCT03439046|Fulvestrant|fulvestrant|mesh-list
64619451|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619452|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64619453|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64619454|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619455|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619456|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64619457|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
64619458|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619459|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619460|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64619461|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64619462|NCT00983918|Propofol|propofol|mesh-list
64619463|NCT00983918|Sevoflurane|sevoflurane|mesh-list
64619464|NCT00983918|Desflurane|desflurane|mesh-list
64619465|NCT00983918|Isoflurane|isoflurane|mesh-list
64619466|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64619467|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619468|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619469|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64619470|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
64619471|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
64619472|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64619473|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64619474|NCT01926236|Leucovorin|leucovorin|mesh-list
64619475|NCT01926236|Folic Acid|folic acid|mesh-list
64619476|NCT01926236|Fluorouracil|fluorouracil|mesh-list
64619477|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
64619478|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
64619480|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619481|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619482|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619483|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619484|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
64619485|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619486|NCT01926236|Antidotes|antidotes|mesh-ancestor
64619487|NCT01926236|Protective Agents|protective agents|mesh-ancestor
64299868|NCT03294525|Mirtazapine|mirtazapine|mesh-list
64299869|NCT03294525|Citalopram|citalopram|mesh-list
64299870|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
64299871|NCT03294525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64299872|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64299873|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64299874|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619488|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
64619490|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
64619491|NCT01926236|Hematinics|hematinics|mesh-ancestor
64619492|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
64619493|NCT00983528|Clofarabine|clofarabine|mesh-list
64619494|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64619495|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619496|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619497|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
64619498|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619499|NCT00983372|Colchicine|colchicine|mesh-list
64619500|NCT00983372|Diltiazem|diltiazem|mesh-list
64619501|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
64619502|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619503|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
64619504|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
64619505|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
64619506|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619507|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619508|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64619509|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64619510|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619511|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64619512|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619513|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
64619514|NCT01173211|Vaccines|vaccines|mesh-list
64619515|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
64619516|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619517|NCT00983294|Azithromycin|azithromycin|mesh-list
64619518|NCT00983294|Colchicine|colchicine|mesh-list
64619519|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64484307|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64619520|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619521|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
64619522|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619523|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
64619524|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
64619525|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
64619526|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619527|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619528|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
64619529|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64619530|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64619531|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619532|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64619533|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64619534|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
64619535|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64619536|NCT05601830|Cytarabine|cytarabine|mesh-list
64619537|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
64619538|NCT05601830|Fludarabine|fludarabine|mesh-list
64299875|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299876|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
64299877|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299878|NCT03294525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64299879|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64299880|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299881|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64299882|NCT03294525|Analgesics|analgesics|mesh-ancestor
64299883|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
64299884|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
64299885|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64299886|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
64619539|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619540|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
64619541|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619542|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619543|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64619544|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
64619545|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619546|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619547|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64619548|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619549|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
64619550|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
64619551|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619552|NCT00982280|Tapentadol|tapentadol|mesh-list
64619553|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64619555|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619556|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619557|NCT00982280|Analgesics|analgesics|mesh-ancestor
64619558|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
64619559|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619560|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64300232|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64619562|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619563|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619564|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
64619565|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619566|NCT03069326|Thalidomide|thalidomide|mesh-list
64619567|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619568|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
64619569|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619570|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
64619571|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64619572|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619573|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64619574|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64619575|NCT03069326|Growth Substances|growth substances|mesh-ancestor
64619576|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
64619577|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619578|NCT01175395|Triamcinolone|triamcinolone|mesh-list
64619579|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64619580|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64619581|NCT01175395|Ranibizumab|ranibizumab|mesh-list
64619582|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64619583|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619584|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
64619585|NCT01175395|Hormones|hormones|mesh-ancestor
64619586|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619587|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619588|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619589|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
64619590|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619591|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619592|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64619593|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64619594|NCT01175395|Growth Substances|growth substances|mesh-ancestor
64619595|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
64619596|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619597|NCT03011905|Acetaminophen|acetaminophen|mesh-list
64619598|NCT03011905|Dexamethasone|dexamethasone|mesh-list
64619599|NCT03011905|Etoricoxib|etoricoxib|mesh-list
64619600|NCT03011905|Oxycodone|oxycodone|mesh-list
64619602|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619603|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
64619604|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
64619605|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619606|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619607|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619608|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
64619609|NCT03011905|Hormones|hormones|mesh-ancestor
64619610|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619611|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64619612|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619613|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
64619614|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
64619615|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619616|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
64619617|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619618|NCT03011905|Analgesics|analgesics|mesh-ancestor
64619619|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
64619620|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64619621|NCT03011905|Narcotics|narcotics|mesh-ancestor
64619622|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619623|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619624|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64619625|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64619626|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619628|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
64619629|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619630|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64619631|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619632|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619633|NCT04769713|Ropivacaine|ropivacaine|mesh-list
64619634|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
64619635|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
64619636|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619637|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619638|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
64619639|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619640|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64619641|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
64619642|NCT00980798|Hydromorphone|hydromorphone|mesh-list
64619643|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64619644|NCT00980798|Narcotics|narcotics|mesh-ancestor
64619645|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619646|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619647|NCT00980798|Analgesics|analgesics|mesh-ancestor
64619648|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
64619649|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619650|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
64619651|NCT01177189|Vitamins|vitamins|mesh-ancestor
64619652|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
64619653|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619654|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
64619655|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619656|NCT01177189|Protective Agents|protective agents|mesh-ancestor
64619657|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
64619658|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64619659|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
64619660|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619661|NCT01177735|Pomalidomide|pomalidomide|mesh-list
64619662|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
64619663|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619664|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64619665|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64619666|NCT01177735|Growth Substances|growth substances|mesh-ancestor
64619667|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
64424553|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
64619668|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619669|NCT01135069|Tretinoin|tretinoin|mesh-list
64619670|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619671|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
64619672|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
64619673|NCT01178281|Thalidomide|thalidomide|mesh-list
64619674|NCT01178281|Pomalidomide|pomalidomide|mesh-list
64619675|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
64619676|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619677|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64619678|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64619679|NCT01178281|Growth Substances|growth substances|mesh-ancestor
64619680|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
64619681|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619684|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64619685|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619686|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
64619687|NCT01178827|Oxybutynin|oxybutynin|mesh-list
64619688|NCT01178827|Trospium chloride|trospium chloride|mesh-list
64619689|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
64619690|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
64619691|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619692|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619693|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64619694|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64619695|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
64619696|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619697|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619698|NCT01178827|Urological Agents|urological agents|mesh-ancestor
64619699|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64619700|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619701|NCT01178827|Renal Agents|renal agents|mesh-ancestor
64619702|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
64299887|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
64299888|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64299889|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64299898|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
64619703|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64619704|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
64619705|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619706|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619707|NCT02181517|Ranibizumab|ranibizumab|mesh-list
64619708|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64619709|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64619710|NCT02181517|Growth Substances|growth substances|mesh-ancestor
64619711|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619712|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
64619713|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619714|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64619715|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64619716|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
64619717|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619718|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619719|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64619720|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64619721|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64619722|NCT01181323|Vaccines|vaccines|mesh-list
64619723|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
64619724|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619725|NCT03872947|Leucovorin|leucovorin|mesh-list
64619726|NCT03872947|Gemcitabine|gemcitabine|mesh-list
64619727|NCT03872947|Bevacizumab|bevacizumab|mesh-list
64619728|NCT03872947|Carboplatin|carboplatin|mesh-list
64619729|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
64619730|NCT03872947|Nivolumab|nivolumab|mesh-list
64619731|NCT03872947|Irinotecan|irinotecan|mesh-list
64619732|NCT03872947|Topotecan|topotecan|mesh-list
64619733|NCT03872947|Imiquimod|imiquimod|mesh-list
64619734|NCT03872947|Ramucirumab|ramucirumab|mesh-list
64619735|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619736|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619737|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64619738|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64619739|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64619740|NCT03872947|Growth Substances|growth substances|mesh-ancestor
64619741|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619742|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
64619743|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619744|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
64619745|NCT03872947|Antiviral Agents|antiviral agents|mesh-ancestor
64619746|NCT03872947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619747|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619748|NCT03872947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619749|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
64619750|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64619751|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64619752|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64619753|NCT03872947|Antidotes|antidotes|mesh-ancestor
64619754|NCT03872947|Protective Agents|protective agents|mesh-ancestor
64619755|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
64619757|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
64619758|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64619759|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
64619760|NCT02246881|Factor VIII|factor viii|mesh-list
64619761|NCT02246881|Coagulants|coagulants|mesh-ancestor
64619762|NCT00980330|Ribavirin|ribavirin|mesh-list
64619763|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64619764|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
64619765|NCT00980330|Simeprevir|simeprevir|mesh-list
64619766|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
64299903|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299904|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
64299905|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
64619767|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299908|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
64619769|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619770|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619771|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
64619772|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619773|NCT01138735|Adapalene|adapalene|mesh-list
64619774|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64619775|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64619776|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
64619777|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619778|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619779|NCT01138735|Analgesics|analgesics|mesh-ancestor
64619780|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
64619781|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619782|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619783|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619784|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619785|NCT00980174|Denosumab|denosumab|mesh-list
64619786|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64619787|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619788|NCT03064568|Misoprostol|misoprostol|mesh-list
64619789|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64619790|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
64619791|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64619792|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619793|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64619794|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619795|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
64619796|NCT01138969|Esomeprazole|esomeprazole|mesh-list
64619797|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64619798|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619799|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64619800|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619801|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619802|NCT01139515|Eletriptan|eletriptan|mesh-list
64619803|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64619804|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
64619805|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619806|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619807|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619808|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64619809|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64619810|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64619811|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619812|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619813|NCT00987272|Analgesics|analgesics|mesh-ancestor
64619814|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
64619815|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619816|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619817|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619818|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619819|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64619820|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64619821|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64619822|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
64619823|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
64299914|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299915|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299916|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64299917|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
64299918|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299919|NCT03283059|Donepezil|donepezil|mesh-list
64299920|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64619825|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619826|NCT03709459|Doxycycline|doxycycline|mesh-list
64619827|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64619828|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619829|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
64619830|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64619831|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64619839|NCT00986882|Ibuprofen|ibuprofen|mesh-list
64619840|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619841|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619842|NCT00986882|Analgesics|analgesics|mesh-ancestor
64619843|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
64619844|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619845|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619846|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619847|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619848|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64619849|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619850|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619851|NCT00981656|Fluorouracil|fluorouracil|mesh-list
64619852|NCT00981656|Mitomycins|mitomycins|mesh-list
64619853|NCT00981656|Mitomycin|mitomycin|mesh-list
64619854|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619855|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
64619856|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299932|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619857|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619858|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299933|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64299935|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64619859|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
64299936|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64299937|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299938|NCT03554395|Antibodies|antibodies|mesh-list
64299939|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64299940|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
64299941|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299942|NCT03282825|Paclitaxel|paclitaxel|mesh-list
64299943|NCT03282825|Decitabine|decitabine|mesh-list
64299944|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64299945|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299946|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64619860|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299947|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64619861|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64619862|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
64619863|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64619864|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619865|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
64619866|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64619868|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
64619869|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619870|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64619871|NCT01927328|Hematinics|hematinics|mesh-ancestor
64619872|NCT04552808|Yimitasvir|yimitasvir|mesh-list
64619873|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
64619874|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619875|NCT01927406|Timolol|timolol|mesh-list
64619876|NCT01927406|Bimatoprost|bimatoprost|mesh-list
64619877|NCT01927406|Travoprost|travoprost|mesh-list
64619878|NCT01927406|Latanoprost|latanoprost|mesh-list
64299948|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64619879|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619880|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64619881|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64619882|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
64619883|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619884|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619885|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64619886|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64619887|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64619888|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64619889|NCT01182493|Insulin|insulin|mesh-list
64619890|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64619891|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619892|NCT01927484|Methotrexate|methotrexate|mesh-list
64619893|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64619894|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
64619895|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64619896|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619897|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619898|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
64619899|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619900|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619901|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64619902|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619903|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64619904|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619905|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
64619906|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619907|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64300264|NCT03292965|Neostigmine|neostigmine|mesh-list
64619908|NCT01927874|Bupivacaine|bupivacaine|mesh-list
64299949|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299950|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64299951|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
64299952|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299953|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64299954|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64299955|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299956|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
64299957|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299958|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64619909|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
64619910|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
64619911|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619912|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619913|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
64619914|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619915|NCT05607446|Montelukast|montelukast|mesh-list
64619916|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64619917|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
64619918|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64619919|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
64619920|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619921|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619922|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64619923|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64619924|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619925|NCT02185339|Rocuronium|rocuronium|mesh-list
64619926|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64619927|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64619928|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64619929|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619930|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619932|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64619933|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619934|NCT01928498|Paclitaxel|paclitaxel|mesh-list
64619935|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64619936|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619937|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
64619938|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
64619940|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619941|NCT04558502|Amoxicillin|amoxicillin|mesh-list
64619942|NCT04558502|Clarithromycin|clarithromycin|mesh-list
64619943|NCT04558502|Minocycline|minocycline|mesh-list
64619944|NCT04558502|Esomeprazole|esomeprazole|mesh-list
64619945|NCT04558502|Bismuth|bismuth|mesh-list
64619946|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64619947|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619948|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64619949|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619950|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64619951|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619952|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619953|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64619954|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64619955|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64619956|NCT04558502|Antacids|antacids|mesh-ancestor
64619957|NCT01218997|Naltrexone|naltrexone|mesh-list
64619958|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64619959|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64300283|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
64619961|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
64619962|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619963|NCT01219777|Paclitaxel|paclitaxel|mesh-list
64619964|NCT01219777|Bevacizumab|bevacizumab|mesh-list
64619965|NCT01219777|Carboplatin|carboplatin|mesh-list
64619966|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64619967|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299961|NCT05356897|Trifluridine|trifluridine|mesh-list
64299962|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64299963|NCT05356897|Trastuzumab|trastuzumab|mesh-list
64299964|NCT05356897|Tucatinib|tucatinib|mesh-list
64299965|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
64299966|NCT05356897|Antibodies|antibodies|mesh-list
64299967|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
64619968|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
64619969|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
64619970|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
64619971|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619972|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64619973|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64619974|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64619975|NCT01219777|Growth Substances|growth substances|mesh-ancestor
64619976|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619977|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
64619978|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64619979|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345337|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64619980|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619981|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64619982|NCT04759742|Ropivacaine|ropivacaine|mesh-list
64619983|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
64619984|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
64619985|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296052|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296053|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
64619986|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619987|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
64619988|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619990|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
64619991|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64619992|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619993|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64619994|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
64619995|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
64619996|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619997|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619998|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619999|NCT01928888|Antacids|antacids|mesh-ancestor
64620000|NCT04556084|Blinatumomab|blinatumomab|mesh-list
64620001|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620002|NCT04394234|Warfarin|warfarin|mesh-list
64620003|NCT04394234|Anticoagulants|anticoagulants|mesh-list
64620004|NCT02569710|Simeprevir|simeprevir|mesh-list
64620005|NCT02569710|Odalasvir|odalasvir|mesh-list
64620006|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
64620007|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620008|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
64620009|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620010|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296058|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296059|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296061|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
64296062|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620011|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
64620012|NCT04550624|Lenvatinib|lenvatinib|mesh-list
64620013|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620014|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620015|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64620016|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620017|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620018|NCT04550546|Nystatin|nystatin|mesh-list
64620019|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620020|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620021|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
64620022|NCT04550546|Ionophores|ionophores|mesh-ancestor
64620023|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620024|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620026|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
64620027|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620028|NCT04589832|Entrectinib|entrectinib|mesh-list
64620029|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64620030|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620031|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620032|NCT05506410|Cytarabine|cytarabine|mesh-list
64620033|NCT05506410|Prednisone|prednisone|mesh-list
64620034|NCT05506410|Rituximab|rituximab|mesh-list
64620035|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64620036|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620037|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620038|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
64620039|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299973|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620040|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620041|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620042|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
64620043|NCT05506410|Hormones|hormones|mesh-ancestor
64620044|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620045|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64620046|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620047|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
64620048|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620049|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
64620050|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620051|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620052|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64620053|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
64345415|NCT02728102|Lenalidomide|lenalidomide|mesh-list
64299974|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
64620054|NCT05506332|Venetoclax|venetoclax|mesh-list
64620055|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
64299975|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299976|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64299977|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299979|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299980|NCT03288051|Dobutamine|dobutamine|mesh-list
64299981|NCT03288051|Norepinephrine|norepinephrine|mesh-list
64299982|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64299983|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64299984|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
64299985|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299986|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299987|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299988|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
64620056|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620058|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620059|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620060|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620061|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
64620062|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620063|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64620064|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620065|NCT05604638|Tenecteplase|tenecteplase|mesh-list
64620066|NCT05604638|Tirofiban|tirofiban|mesh-list
64620067|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64620068|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64620069|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620070|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64620071|NCT05609630|Upadacitinib|upadacitinib|mesh-list
64620072|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64620073|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64620074|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620075|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620076|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620077|NCT03033758|Budesonide|budesonide|mesh-list
64620078|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
64620079|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64299989|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
64299990|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299991|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64299992|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64299993|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64299994|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64299995|NCT03288051|Protective Agents|protective agents|mesh-ancestor
64299996|NCT05035472|Phenylephrine|phenylephrine|mesh-list
64299997|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
64299998|NCT05035472|Norepinephrine|norepinephrine|mesh-list
64299999|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64300000|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64620080|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64620081|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
64620082|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620083|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620084|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64620085|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
64620086|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
64620087|NCT03033758|Hormones|hormones|mesh-ancestor
64620088|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620089|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64620090|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64620091|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64620092|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
64620093|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620094|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620095|NCT01016483|Gemcitabine|gemcitabine|mesh-list
64620096|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620097|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
64620098|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620099|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620100|NCT01016483|Antiviral Agents|antiviral agents|mesh-ancestor
64620101|NCT01016483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620102|NCT01016483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620103|NCT01016483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620104|NCT01016483|Immunologic Factors|immunologic factors|mesh-ancestor
64620105|NCT01016483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620106|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
64620107|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
64620108|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620109|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620110|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64620111|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620112|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620113|NCT00955253|Guanfacine|guanfacine|mesh-list
64620114|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64620115|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64620116|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64300001|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
64300002|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
64620117|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64620118|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64620119|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620120|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620121|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620122|NCT04394390|Vitamin D|vitamin d|mesh-list
64620123|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
64620124|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
64620125|NCT04394390|Vitamins|vitamins|mesh-list
64620126|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
64620127|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300003|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300004|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300005|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
64300006|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
64620128|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64620129|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64620130|NCT05604794|Ketamine|ketamine|mesh-list
64620132|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
64620133|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620134|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620135|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64620136|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64620137|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
64620138|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
64620139|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620140|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64620141|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64620142|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620143|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620144|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64620145|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
64620146|NCT04120454|Ramucirumab|ramucirumab|mesh-list
64620148|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
64620149|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64620150|NCT04120454|Lexatumumab|lexatumumab|mesh-list
64620151|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
64620152|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620153|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620154|NCT01017653|Irinotecan|irinotecan|mesh-list
64300007|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
64300008|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64300009|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64300010|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64300011|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
64300012|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300013|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300014|NCT05035472|Protective Agents|protective agents|mesh-ancestor
64300016|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
64300017|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
64300018|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300019|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300020|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
64300021|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300022|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64300023|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64300024|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64300025|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620155|NCT01017653|Panitumumab|panitumumab|mesh-list
64620156|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64620157|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64620158|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620159|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620160|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620161|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620162|NCT00966641|Naproxen|naproxen|mesh-list
64620163|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64620164|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64620165|NCT00966641|Analgesics|analgesics|mesh-ancestor
64620166|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
64620167|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620168|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620169|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620170|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620171|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
64620172|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64620173|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620174|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620175|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
64620176|NCT00970073|Tacrolimus|tacrolimus|mesh-list
64620177|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
64620178|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64620179|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620180|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
64620181|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620182|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64620183|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620184|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620185|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64620186|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620187|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64620188|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
64620189|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620190|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300026|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300027|NCT02107729|Lidocaine|lidocaine|mesh-list
64300028|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
64300029|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
64300030|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300031|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300032|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
64300033|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300034|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64300035|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64300036|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64620191|NCT00971633|Ondansetron|ondansetron|mesh-list
64620192|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
64620193|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
64620194|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620195|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620196|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64620197|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
64620198|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620199|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64620200|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
64620201|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620202|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620203|NCT00971633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64345569|NCT03682276|Nivolumab|nivolumab|mesh-list
64620204|NCT00971633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64620205|NCT00971633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620206|NCT00971633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64620207|NCT00971633|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64620208|NCT05511246|Ethanol|ethanol|mesh-list
64620209|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64620210|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620211|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620212|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620213|NCT00971789|Sirolimus|sirolimus|mesh-list
64620214|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64620215|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620216|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620217|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64620218|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620219|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
64620220|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620221|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
64620222|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620223|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64620224|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620225|NCT05510778|Charcoal|charcoal|mesh-list
64620226|NCT05510778|Antidotes|antidotes|mesh-ancestor
64620227|NCT05510778|Protective Agents|protective agents|mesh-ancestor
64620228|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620229|NCT00972335|Bevacizumab|bevacizumab|mesh-list
64620230|NCT00972335|Everolimus|everolimus|mesh-list
64620231|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64300037|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620232|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300038|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300039|NCT02437318|Fulvestrant|fulvestrant|mesh-list
64300040|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64300041|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300042|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64620233|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64620234|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64620235|NCT00972335|Growth Substances|growth substances|mesh-ancestor
64620236|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620237|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
64620238|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620239|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
64620240|NCT02337530|Carboplatin|carboplatin|mesh-list
64620241|NCT02337530|Pemetrexed|pemetrexed|mesh-list
64620242|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620243|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620244|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620245|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64620246|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64620247|NCT03341156|Thrombin|thrombin|mesh-list
64620248|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
64620249|NCT03341156|Coagulants|coagulants|mesh-ancestor
64620250|NCT04122560|Fluconazole|fluconazole|mesh-list
64620251|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
64620252|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620253|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64620254|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64620255|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620256|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620257|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64620258|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
64620259|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620260|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620261|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64620262|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64620263|NCT02569242|Paclitaxel|paclitaxel|mesh-list
64620264|NCT02569242|Docetaxel|docetaxel|mesh-list
64620267|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620268|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
64620269|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
64300043|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64300044|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
64300045|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300046|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300047|NCT03282513|Ivosidenib|ivosidenib|mesh-list
64300048|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620270|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
64620271|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620272|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620273|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64620274|NCT04124588|Hemostatics|hemostatics|mesh-list
64620275|NCT04124588|Coagulants|coagulants|mesh-ancestor
64620276|NCT05501340|Molgramostim|molgramostim|mesh-list
64620277|NCT05501340|Sargramostim|sargramostim|mesh-list
64620278|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620279|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
64620280|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620282|NCT00972725|Amebicides|amebicides|mesh-ancestor
64620283|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64620284|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64620285|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620286|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
64620287|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620288|NCT05600660|Rituximab|rituximab|mesh-list
64620289|NCT05600660|Methotrexate|methotrexate|mesh-list
64620290|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620291|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620292|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
64620293|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620294|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620295|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64620296|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
64620297|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64620298|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620300|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620301|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620302|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620303|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64620304|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620305|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64620306|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
64620307|NCT00972959|Dexamethasone|dexamethasone|mesh-list
64620308|NCT00972959|Bortezomib|bortezomib|mesh-list
64620309|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620310|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
64620311|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
64620312|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620313|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620314|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64620315|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
64620316|NCT00972959|Hormones|hormones|mesh-ancestor
64620317|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620318|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64620319|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620320|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64300049|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300050|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300053|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
64300054|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620321|NCT05609240|Cefuroxime|cefuroxime|mesh-list
64620322|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
64620323|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620324|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620325|NCT00973739|Lapatinib|lapatinib|mesh-list
64620326|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620327|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64620328|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620329|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620330|NCT00974051|Insulin|insulin|mesh-list
64620331|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64620332|NCT00974051|Terbutaline|terbutaline|mesh-list
64620333|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
64620334|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64620335|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620336|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64620337|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
64620338|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620339|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64620340|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
64620341|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
64620342|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
64620343|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64620344|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64620345|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64620346|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
64620347|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620348|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620349|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
64620350|NCT03017963|Antidotes|antidotes|mesh-ancestor
64620351|NCT03017963|Protective Agents|protective agents|mesh-ancestor
64620352|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620353|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
64620354|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620355|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
64300055|NCT02107807|Cathartics|cathartics|mesh-ancestor
64300056|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64300057|NCT01673282|Lacosamide|lacosamide|mesh-list
64300058|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
64300059|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64300060|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64300061|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64300062|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620357|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620358|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
64620359|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
64620360|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64620361|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
64620362|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620364|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64620365|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64620366|NCT04129424|Insulin|insulin|mesh-list
64620367|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64620368|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620369|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
64620370|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64620371|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
64620372|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620373|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620374|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64620375|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64620376|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64620377|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
64620378|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620379|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620380|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64620381|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64620382|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
64620383|NCT00955487|Protective Agents|protective agents|mesh-ancestor
64620384|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
64620385|NCT04120922|Calcium|calcium|mesh-list
64620386|NCT04120922|Sevelamer|sevelamer|mesh-list
64620387|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64620388|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620389|NCT04120922|Antacids|antacids|mesh-ancestor
64620390|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620392|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
64620393|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
64620394|NCT01663740|Valganciclovir|valganciclovir|mesh-list
64620395|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
64620396|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620397|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
64620398|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64620399|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
64620400|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620401|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
64620402|NCT02984228|Protective Agents|protective agents|mesh-ancestor
64620403|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64620404|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64620405|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64620406|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
64620407|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620408|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64620409|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64620410|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620411|NCT03828032|Mannitol|mannitol|mesh-list
64620412|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64620413|NCT03828032|Diuretics|diuretics|mesh-ancestor
64620414|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
64620415|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620416|NCT03827876|Calcitriol|calcitriol|mesh-list
64620417|NCT03827876|Betamethasone|betamethasone|mesh-list
64620418|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64620419|NCT03827876|Calcipotriene|calcipotriene|mesh-list
64620420|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620421|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
64620422|NCT03827876|Hormones|hormones|mesh-ancestor
64620423|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620424|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620425|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64620426|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
64300063|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64300065|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300066|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300067|NCT02113813|Naquotinib|naquotinib|mesh-list
64300068|NCT02113813|Midazolam|midazolam|mesh-list
64300069|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64300070|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64300071|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300072|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300073|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64300074|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64300075|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64300076|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64300077|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
64300078|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
64300079|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
64300080|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
64300081|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300082|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300083|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300084|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64300085|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300086|NCT03095144|Anesthetics|anesthetics|mesh-list
64620427|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64620428|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64620429|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620430|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620431|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64620433|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
64620434|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64620435|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620437|NCT03898934|Vitamins|vitamins|mesh-ancestor
64620438|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
64620439|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620440|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64620441|NCT04128800|Apatinib|apatinib|mesh-list
64620442|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620443|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424554|NCT02286843|Trastuzumab|trastuzumab|mesh-list
64300088|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300089|NCT03095222|Ketamine|ketamine|mesh-list
64300090|NCT03095222|Analgesics|analgesics|mesh-ancestor
64620444|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620445|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620446|NCT04129112|Propofol|propofol|mesh-list
64620447|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
64620448|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620449|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300091|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
64300092|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300093|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300094|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64300095|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64300096|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
64300098|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300099|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64300100|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64300101|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300102|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300103|NCT02113891|Eculizumab|eculizumab|mesh-list
64300104|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64300105|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300106|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
64300107|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620450|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64620451|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64620452|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
64620453|NCT01608893|Metoprolol|metoprolol|mesh-list
64620454|NCT01608893|Carvedilol|carvedilol|mesh-list
64620455|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64620456|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64620457|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
64620458|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
64620459|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620460|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620461|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64620462|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64620463|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64620464|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
64300108|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
64300109|NCT03095378|Tetracycline|tetracycline|mesh-list
64300110|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64300111|NCT03095378|Citric Acid|citric acid|mesh-list
64620465|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620466|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620467|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
64620468|NCT01608893|Protective Agents|protective agents|mesh-ancestor
64620469|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64620470|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64300112|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
64300113|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64300114|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300115|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300117|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64300118|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
64300119|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
64300120|NCT05025098|Azacitidine|azacitidine|mesh-list
64300121|NCT05025098|Venetoclax|venetoclax|mesh-list
64300122|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64300123|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
64300124|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300125|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300126|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300128|NCT05038202|Bromides|bromides|mesh-list
64300129|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
64300130|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300131|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64300132|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64620471|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64620472|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
64620473|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64620474|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64620475|NCT04128878|Sotalol|sotalol|mesh-list
64620476|NCT04128878|Dofetilide|dofetilide|mesh-list
64620477|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64620478|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64620479|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
64620480|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620481|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620482|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620483|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64620484|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
64620485|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
64620486|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620487|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64620488|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620489|NCT00979745|Afamelanotide|afamelanotide|mesh-list
64620490|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620491|NCT00042341|Clofarabine|clofarabine|mesh-list
64620492|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620493|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
64620494|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620495|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620496|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64620497|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
64620498|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
64620499|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620500|NCT04759196|Topiramate|topiramate|mesh-list
64300133|NCT02114359|Cisplatin|cisplatin|mesh-list
64300134|NCT02114359|Fluorouracil|fluorouracil|mesh-list
64300135|NCT02114359|Capecitabine|capecitabine|mesh-list
64300136|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
64300137|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300138|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
64300139|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300141|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300142|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
64300143|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300144|NCT02110303|Ticagrelor|ticagrelor|mesh-list
64300145|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64620501|NCT04759196|Levetiracetam|levetiracetam|mesh-list
64620502|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
64620503|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64620504|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620505|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
64620506|NCT04128254|Apixaban|apixaban|mesh-list
64620507|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64620508|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
64620509|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64620510|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
64620512|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620514|NCT04128020|Nivolumab|nivolumab|mesh-list
64620515|NCT04128020|Azacitidine|azacitidine|mesh-list
64620516|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620517|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620518|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64620519|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620520|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620521|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
64620522|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620524|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64620525|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620526|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
64620527|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620529|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
64620530|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64620531|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620532|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64620533|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
64620534|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64620535|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64620536|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620537|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620538|NCT01022567|Ertapenem|ertapenem|mesh-list
64620539|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620540|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620541|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
64620542|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64620543|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620544|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64620545|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620546|NCT04411524|Capecitabine|capecitabine|mesh-list
64620547|NCT04411524|Irinotecan|irinotecan|mesh-list
64620548|NCT04411524|Antibodies|antibodies|mesh-list
64620549|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
64620550|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620551|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64620552|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
64620553|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620554|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620555|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64620556|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64620557|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620558|NCT04127396|Sorafenib|sorafenib|mesh-list
64620559|NCT04127396|Lenvatinib|lenvatinib|mesh-list
64620560|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
64620561|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620562|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64620563|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620564|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620565|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64620566|NCT04127396|Estrogens|estrogens|mesh-ancestor
64620567|NCT04127396|Hormones|hormones|mesh-ancestor
64300390|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
64620568|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620569|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620570|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64620571|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
64620572|NCT04120064|Vitamin D|vitamin d|mesh-list
64620573|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64620574|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620575|NCT04120064|Vitamins|vitamins|mesh-ancestor
64620576|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
64620577|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64620578|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
64620579|NCT00982007|Hematinics|hematinics|mesh-ancestor
64620580|NCT04814940|Menotropins|menotropins|mesh-list
64620581|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64620582|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
64345953|NCT02595905|Cisplatin|cisplatin|mesh-list
64620583|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64620584|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620585|NCT05042934|Irinotecan|irinotecan|mesh-list
64620586|NCT05042934|Camptothecin|camptothecin|mesh-list
64620587|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64300146|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64300147|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64300148|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64300149|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
64300150|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300151|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300152|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300154|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64300155|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
64300156|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300157|NCT02108353|Melatonin|melatonin|mesh-list
64300158|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
64620588|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64620589|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620590|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620591|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620592|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64620593|NCT05505006|Folic Acid|folic acid|mesh-list
64620594|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
64620595|NCT05505006|Hematinics|hematinics|mesh-ancestor
64620596|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
64620597|NCT05505006|Vitamins|vitamins|mesh-ancestor
64620598|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
64620599|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620600|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
64620601|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
64620602|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620603|NCT02979548|Ondansetron|ondansetron|mesh-list
64620604|NCT02979548|Aprepitant|aprepitant|mesh-list
64620605|NCT02979548|Metoclopramide|metoclopramide|mesh-list
64300159|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300160|NCT02108353|Protective Agents|protective agents|mesh-ancestor
64620606|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
64620607|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
64620608|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620609|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620610|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64620611|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
64620612|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620613|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64620614|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
64620615|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620616|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620617|NCT02979548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64620618|NCT02979548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64620619|NCT02979548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300404|NCT03292185|Incretins|incretins|mesh-ancestor
64620620|NCT02979548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64620621|NCT02979548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64620622|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64620623|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64620624|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64620625|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
64620626|NCT03821246|Atezolizumab|atezolizumab|mesh-list
64620627|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64620628|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300161|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300162|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300163|NCT04157751|Empagliflozin|empagliflozin|mesh-list
64620629|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
64620630|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620631|NCT03826316|Nalbuphine|nalbuphine|mesh-list
64620632|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64620633|NCT03826316|Narcotics|narcotics|mesh-ancestor
64620634|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620635|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620636|NCT03826316|Analgesics|analgesics|mesh-ancestor
64620637|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
64620638|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620639|NCT04393610|Lidocaine|lidocaine|mesh-list
64620640|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
64620641|NCT04393610|Fentanyl|fentanyl|mesh-list
64620642|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
64620643|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
64620644|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620645|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620646|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
64620647|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620648|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64620649|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64620650|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64620651|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620652|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620653|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64300164|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64300165|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300166|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64300167|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300168|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
64300169|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64300170|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300171|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64300172|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64300173|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300174|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300175|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300176|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64300177|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64300178|NCT02110459|Murepavadin|murepavadin|mesh-list
64300179|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64300181|NCT03287505|Aripiprazole|aripiprazole|mesh-list
64620654|NCT04393610|Narcotics|narcotics|mesh-ancestor
64620655|NCT04393610|Analgesics|analgesics|mesh-ancestor
64620656|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64620657|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64620658|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
64620659|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
64620660|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64620661|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64620662|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
64620663|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64620664|NCT03820466|Aspirin|aspirin|mesh-list
64300194|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
64300195|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64620665|NCT03820466|Atorvastatin|atorvastatin|mesh-list
64300196|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64620666|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64620668|NCT03820466|Analgesics|analgesics|mesh-ancestor
64620669|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
64620670|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620671|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620672|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620673|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620674|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64620675|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64620676|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620677|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64620678|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64620679|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620680|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
64620681|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64620682|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64620683|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
64620684|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64620685|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64620686|NCT03826004|Clemastine|clemastine|mesh-list
64620687|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
64620688|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
64620689|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64300417|NCT04239339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64620690|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
64300197|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64620691|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
64620692|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620693|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620694|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620695|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64620696|NCT02338076|Petrolatum|petrolatum|mesh-list
64620697|NCT02338076|Emollients|emollients|mesh-ancestor
64620698|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
64300198|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64300199|NCT03090698|Triamcinolone|triamcinolone|mesh-list
64300200|NCT03090698|Hylan|hylan|mesh-list
64300201|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300202|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
64300203|NCT03090698|Hormones|hormones|mesh-ancestor
64300204|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620699|NCT03822962|Acetaminophen|acetaminophen|mesh-list
64620700|NCT03822962|Ibuprofen|ibuprofen|mesh-list
64620701|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64620702|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64620703|NCT03822962|Analgesics|analgesics|mesh-ancestor
64620704|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
64620705|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620706|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620707|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620708|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620709|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64620710|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620711|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620712|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
64620713|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64620714|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
64620715|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64620716|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64620717|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64620718|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620719|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620720|NCT01222117|Plasminogen|plasminogen|mesh-list
64620721|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64620722|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
64620723|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64620724|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64381999|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382000|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64382001|NCT02426723|Dexamethasone|dexamethasone|mesh-list
64382002|NCT02426723|Lenalidomide|lenalidomide|mesh-list
64382025|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382026|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382027|NCT02425241|Vaccines|vaccines|mesh-list
64382028|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
64382029|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382030|NCT03182855|Ticagrelor|ticagrelor|mesh-list
64382031|NCT03182855|Cangrelor|cangrelor|mesh-list
64382032|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64382033|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64382034|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64382035|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64382036|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
64382037|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382038|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382039|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382040|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
64382041|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382042|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64382043|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382044|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382075|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64382076|NCT02426099|Diuretics|diuretics|mesh-ancestor
64382077|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
64382078|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64382079|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
64382080|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382081|NCT02425709|Diclofenac|diclofenac|mesh-list
64382082|NCT02425709|Tramadol|tramadol|mesh-list
64382083|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64382084|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64382085|NCT02425709|Analgesics|analgesics|mesh-ancestor
64382086|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
64382087|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382088|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382089|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382090|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382091|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64382092|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382093|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382094|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64382095|NCT02425709|Narcotics|narcotics|mesh-ancestor
64382096|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382097|NCT02073682|Heparin|heparin|mesh-list
64620725|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620726|NCT03825380|Bimatoprost|bimatoprost|mesh-list
64620727|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64620728|NCT01222195|Lenalidomide|lenalidomide|mesh-list
64620729|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
64620730|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
64620731|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620732|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64620733|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64620734|NCT01222195|Growth Substances|growth substances|mesh-ancestor
64620735|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
64620736|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300205|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300207|NCT03090698|Protective Agents|protective agents|mesh-ancestor
64300208|NCT03293511|Oxytocin|oxytocin|mesh-list
64300209|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
64300210|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64300211|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300212|NCT02251171|Ritonavir|ritonavir|mesh-list
64300213|NCT02251171|Tipranavir|tipranavir|mesh-list
64300214|NCT02251171|Rifabutin|rifabutin|mesh-list
64300215|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64300216|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64620738|NCT01222273|Vitamin D|vitamin d|mesh-list
64620739|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
64620740|NCT01222273|Vitamins|vitamins|mesh-ancestor
64620741|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
64620742|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620743|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64620744|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64620746|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64620747|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64620748|NCT03161912|Growth Substances|growth substances|mesh-ancestor
64620749|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620750|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
64620751|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620752|NCT01222585|Metronidazole|metronidazole|mesh-list
64300217|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
64300218|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300219|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300221|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64300222|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
64300223|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300224|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64300225|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64620753|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620754|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620755|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64620756|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64620757|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64620758|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
64300226|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620773|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64620774|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
64620775|NCT01142947|Hormones|hormones|mesh-ancestor
64620776|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620777|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620778|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64620779|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
64620781|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
64620782|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64620783|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
64620784|NCT02972294|Trace Elements|trace elements|mesh-ancestor
64620785|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
64620786|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620787|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64620788|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64620789|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620790|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
64620791|NCT02972294|Coagulants|coagulants|mesh-ancestor
64620792|NCT02972294|Hematinics|hematinics|mesh-ancestor
64620793|NCT02969798|Metformin|metformin|mesh-list
64620794|NCT02969798|Pioglitazone|pioglitazone|mesh-list
64620795|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
64620796|NCT02969798|Saxagliptin|saxagliptin|mesh-list
64620797|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64620798|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620799|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64620800|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620801|NCT02969798|Incretins|incretins|mesh-ancestor
64620803|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620804|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64620805|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
64620806|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620807|NCT02983214|Cilostazol|cilostazol|mesh-list
64620808|NCT02983214|Clopidogrel|clopidogrel|mesh-list
64620809|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64620810|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64620811|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64620812|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64620815|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620816|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620817|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64620818|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
64620819|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620820|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64620821|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
64620822|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64620823|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64620824|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
64620825|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64620826|NCT02983214|Protective Agents|protective agents|mesh-ancestor
64620827|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64620828|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64620829|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620831|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
64620832|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620833|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620834|NCT03824834|Morphine|morphine|mesh-list
64620835|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64620836|NCT03824834|Narcotics|narcotics|mesh-ancestor
64620837|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620838|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620839|NCT03824834|Analgesics|analgesics|mesh-ancestor
64620840|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
64620841|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620842|NCT03829124|Ketamine|ketamine|mesh-list
64620843|NCT03829124|Propofol|propofol|mesh-list
64620844|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64620845|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620846|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620847|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64620848|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
64620849|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
64620850|NCT03829124|Analgesics|analgesics|mesh-ancestor
64620851|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
64620852|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620853|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64620854|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64620855|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64620856|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620859|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64620860|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64620861|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64620862|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64620863|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64620864|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620865|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
64620866|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620867|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446254|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64446255|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64620868|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64620869|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64620870|NCT03047330|Leuprolide|leuprolide|mesh-list
64620871|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64620872|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
64620873|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64620874|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620875|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64620876|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620877|NCT03008408|Everolimus|everolimus|mesh-list
64620878|NCT03008408|Letrozole|letrozole|mesh-list
64620879|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620880|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620881|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
64620882|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620883|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64620884|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64620885|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620886|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620887|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64620888|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
64620889|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64620890|NCT04393220|Bevacizumab|bevacizumab|mesh-list
64620891|NCT04393220|Nivolumab|nivolumab|mesh-list
64620892|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620893|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620894|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64620895|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64620896|NCT04393220|Growth Substances|growth substances|mesh-ancestor
64620897|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620898|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
64620899|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64620900|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620901|NCT01025453|Sirolimus|sirolimus|mesh-list
64620902|NCT01025453|Sorafenib|sorafenib|mesh-list
64620903|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620904|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64620905|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620906|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620907|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64620908|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620909|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64620910|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
64620911|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64620912|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
64620913|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620915|NCT05394233|Pemetrexed|pemetrexed|mesh-list
64620916|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620917|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620918|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64620919|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64620920|NCT05394233|Growth Substances|growth substances|mesh-ancestor
64620921|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620922|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
64620923|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446279|NCT01920555|Midazolam|midazolam|mesh-list
64620926|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64620928|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64620929|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620930|NCT00982553|Ribavirin|ribavirin|mesh-list
64620931|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
64620932|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
64620933|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620934|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
64620935|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64620936|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64620937|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64620938|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64620939|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64620940|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620941|NCT02943590|Atorvastatin|atorvastatin|mesh-list
64620942|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64620943|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64620944|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
64620945|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620949|NCT02939300|Nivolumab|nivolumab|mesh-list
64620950|NCT02939300|Ipilimumab|ipilimumab|mesh-list
64620951|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620952|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620953|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64620954|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620955|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
64620956|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64620957|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620958|NCT04392128|Azithromycin|azithromycin|mesh-list
64620959|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
64620960|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64346317|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64620962|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
64620963|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64620964|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64620965|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620966|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620967|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64620969|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64620970|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64620971|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620972|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
64620973|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620974|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620975|NCT02891954|Canagliflozin|canagliflozin|mesh-list
64620976|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64620977|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620978|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64620979|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620980|NCT02565186|Lasmiditan|lasmiditan|mesh-list
64620981|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64620982|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
64620983|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64620984|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620985|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64620986|NCT02883062|Paclitaxel|paclitaxel|mesh-list
64620987|NCT02883062|Carboplatin|carboplatin|mesh-list
64620988|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64620989|NCT02883062|Atezolizumab|atezolizumab|mesh-list
64620990|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64620991|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64620992|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64620993|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
64620994|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
64620995|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
64620996|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64620997|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
64620998|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621002|NCT04694586|Ethambutol|ethambutol|mesh-list
64621003|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64621004|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
64621005|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64621006|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621007|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
64621008|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64621009|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621010|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621011|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64621012|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64621013|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64621014|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64621015|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64621016|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64621017|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64621018|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64621019|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
64621020|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64621021|NCT04274816|Tremelimumab|tremelimumab|mesh-list
64621022|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621023|NCT03252938|Avelumab|avelumab|mesh-list
64621024|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621025|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621026|NCT05509374|Dexamethasone|dexamethasone|mesh-list
64621027|NCT05509374|Pomalidomide|pomalidomide|mesh-list
64621028|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621029|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
64621030|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
64621031|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621032|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621033|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621034|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
64621035|NCT05509374|Hormones|hormones|mesh-ancestor
64621036|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621037|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64300468|NCT02119117|Vitamins|vitamins|mesh-ancestor
64621038|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621039|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
64621043|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
64621044|NCT04124822|Prednisolone|prednisolone|mesh-list
64621045|NCT04124822|Piroxicam|piroxicam|mesh-list
64621046|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621047|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
64621048|NCT04124822|Hormones|hormones|mesh-ancestor
64621049|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621050|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621051|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64621052|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621053|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621054|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64621055|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621056|NCT04124822|Analgesics|analgesics|mesh-ancestor
64621057|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
64621058|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621059|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64621060|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621061|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621062|NCT05504694|Ofatumumab|ofatumumab|mesh-list
64621063|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621064|NCT02854670|Capsaicin|capsaicin|mesh-list
64621065|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
64621066|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
64621067|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
64621068|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621069|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621070|NCT02937272|Gemcitabine|gemcitabine|mesh-list
64621071|NCT02937272|Paclitaxel|paclitaxel|mesh-list
64621072|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64446306|NCT02156492|Atorvastatin|atorvastatin|mesh-list
64446307|NCT02156492|Simvastatin|simvastatin|mesh-list
64446308|NCT02156492|Evacetrapib|evacetrapib|mesh-list
64446309|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64446310|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64446311|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
64621075|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
64621076|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
64621077|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621078|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64621079|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
64621080|NCT02937272|Antiviral Agents|antiviral agents|mesh-ancestor
64621081|NCT02937272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621082|NCT02937272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621083|NCT02937272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64621084|NCT02937272|Immunologic Factors|immunologic factors|mesh-ancestor
64621085|NCT02937272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621087|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64621088|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621089|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621090|NCT03519308|Gemcitabine|gemcitabine|mesh-list
64621091|NCT03519308|Paclitaxel|paclitaxel|mesh-list
64621092|NCT03519308|Nivolumab|nivolumab|mesh-list
64621093|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64621094|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621095|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
64621096|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
64621097|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
64621098|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621099|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64621100|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
64621101|NCT03519308|Antiviral Agents|antiviral agents|mesh-ancestor
64621102|NCT03519308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621103|NCT03519308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621104|NCT03519308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64621105|NCT03519308|Immunologic Factors|immunologic factors|mesh-ancestor
64621106|NCT03519308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621107|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621108|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64621113|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64621114|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
64621115|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
64621116|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621117|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621119|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621120|NCT02565108|Cannabidiol|cannabidiol|mesh-list
64621121|NCT02565108|Clobazam|clobazam|mesh-list
64621122|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
64621123|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64621124|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64621125|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621126|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621127|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64621128|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64621129|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
64621130|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
64621131|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621132|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621133|NCT03821168|Bevacizumab|bevacizumab|mesh-list
64621134|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
64621135|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621136|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621137|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64621138|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64621139|NCT03821168|Growth Substances|growth substances|mesh-ancestor
64621140|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621141|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
64621142|NCT03821168|Hematinics|hematinics|mesh-ancestor
64621143|NCT01454180|Leucovorin|leucovorin|mesh-list
64621144|NCT01454180|Gemcitabine|gemcitabine|mesh-list
64621145|NCT01454180|Capecitabine|capecitabine|mesh-list
64621146|NCT01454180|Fluorouracil|fluorouracil|mesh-list
64621147|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64621148|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
64621149|NCT01454180|Folfirinox|folfirinox|mesh-list
64621150|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64621151|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
64300577|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621152|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621153|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621154|NCT01454180|Antiviral Agents|antiviral agents|mesh-ancestor
64621155|NCT01454180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621156|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621157|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446330|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64446331|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64446332|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621168|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
64621169|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64621170|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64621171|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621172|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621173|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64621174|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64621175|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
64621177|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621178|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621179|NCT05564286|Dexamethasone|dexamethasone|mesh-list
64621180|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
64621181|NCT05564286|Aprepitant|aprepitant|mesh-list
64621182|NCT05564286|Tropisetron|tropisetron|mesh-list
64621183|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621184|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
64621185|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
64621186|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621187|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621188|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621189|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
64621191|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621192|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64621193|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621194|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64621195|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621196|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621197|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64621198|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64621199|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
64621200|NCT01454804|Trastuzumab|trastuzumab|mesh-list
64621201|NCT01454804|Lapatinib|lapatinib|mesh-list
64621202|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621203|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621204|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64621205|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621206|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621207|NCT03820622|Paclitaxel|paclitaxel|mesh-list
64621208|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64621209|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64621210|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621211|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
64446334|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621212|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
64621213|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
64621214|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621215|NCT05504382|Naproxen|naproxen|mesh-list
64621216|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64621217|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621218|NCT05504382|Analgesics|analgesics|mesh-ancestor
64621219|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
64621220|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621221|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621222|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621223|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621224|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
64621225|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64621226|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621227|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621228|NCT03823040|Oxiconazole|oxiconazole|mesh-list
64621229|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
64621230|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621231|NCT02566902|Albuterol|albuterol|mesh-list
64621232|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64621233|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
64621234|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621235|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300585|NCT03552601|Methamphetamine|methamphetamine|mesh-list
64621236|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64621237|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
64621238|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
64621239|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64621240|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64621241|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64621242|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64621243|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
64621244|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621245|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621246|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64446338|NCT04641195|Vitamins|vitamins|mesh-list
64621247|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64621248|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64446339|NCT04641195|Zinc|zinc|mesh-list
64446340|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
64446341|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621250|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621251|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621252|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621254|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
64621255|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621256|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
64621257|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64621258|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
64621259|NCT02902484|Nintedanib|nintedanib|mesh-list
64621260|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621261|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64621272|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
64621273|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621274|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
64621275|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64621276|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64621277|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621279|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
64621280|NCT02564796|Trace Elements|trace elements|mesh-ancestor
64621281|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
64621282|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621283|NCT02564796|Hematinics|hematinics|mesh-ancestor
64621284|NCT03829436|Nivolumab|nivolumab|mesh-list
64621285|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621286|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621287|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64446404|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446405|NCT02177942|Micronutrients|micronutrients|mesh-list
64446406|NCT02177942|Trace Elements|trace elements|mesh-list
64446407|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446408|NCT02155322|Interferons|interferons|mesh-list
64446409|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
64446410|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
64621292|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64621293|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621294|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621295|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64621296|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64621298|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64621299|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
64621300|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
64621301|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
64621302|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
64621303|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621304|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621305|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64621306|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621307|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64621308|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621309|NCT04273100|Lenvatinib|lenvatinib|mesh-list
64621310|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621311|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64621312|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621313|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621314|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
64621315|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64621316|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
64621317|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64621318|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
64621319|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621320|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621335|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621336|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64621337|NCT01455896|Incretins|incretins|mesh-ancestor
64621338|NCT01455896|Hormones|hormones|mesh-ancestor
64621344|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621345|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
64621346|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
64621347|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621348|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621349|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621350|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
64621351|NCT05560542|Hormones|hormones|mesh-ancestor
64621352|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621353|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64621354|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621355|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64621356|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64621357|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64621358|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64621359|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
64621360|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
64621361|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
64621362|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64621363|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64621364|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
64621365|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621366|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621367|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
64621368|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64621369|NCT05560308|Trastuzumab|trastuzumab|mesh-list
64621370|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64621371|NCT05560308|Maytansine|maytansine|mesh-list
64621372|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621373|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621374|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621375|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64621376|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
64621377|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
64621378|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
64621385|NCT04843046|Pioglitazone|pioglitazone|mesh-list
64621386|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64621387|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621388|NCT01456208|Norepinephrine|norepinephrine|mesh-list
64621389|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
64621390|NCT01456208|Giapreza|giapreza|mesh-list
64621391|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
64621392|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64621393|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64621394|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
64621395|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621396|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621397|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621398|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
64621399|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
64621400|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621401|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64621402|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64621403|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
64621404|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621405|NCT05436522|Propofol|propofol|mesh-list
64621406|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64621407|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621408|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446452|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64621409|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64621410|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
64621411|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
64621412|NCT03780010|Paclitaxel|paclitaxel|mesh-list
64621413|NCT03780010|Carboplatin|carboplatin|mesh-list
64346806|NCT02302547|Ritonavir|ritonavir|mesh-list
64621414|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64621415|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621416|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
64621417|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
64621418|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
64621419|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621420|NCT03826550|Diclofenac|diclofenac|mesh-list
64621421|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64621422|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621423|NCT03826550|Analgesics|analgesics|mesh-ancestor
64621424|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
64621425|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621426|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621427|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621428|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621429|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64621430|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621431|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621432|NCT03827018|Prednisone|prednisone|mesh-list
64621433|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
64446472|NCT02985658|Vinorelbine|vinorelbine|mesh-list
64446473|NCT02985658|Veliparib|veliparib|mesh-list
64446474|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446475|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64446476|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
64446477|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
64446478|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
64446479|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446480|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64621442|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
64621443|NCT05325762|Propofol|propofol|mesh-list
64621444|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64621445|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621446|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621447|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64621448|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
64621449|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
64621450|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621451|NCT05325762|Analgesics|analgesics|mesh-ancestor
64621452|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
64621453|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621454|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64621455|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64621456|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64621457|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
64621458|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621459|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621460|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
64621461|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64621462|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64621463|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621464|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64621465|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64621466|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
64621467|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64621468|NCT05498064|Ensartinib|ensartinib|mesh-list
64621469|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621470|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64621471|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621472|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621473|NCT03767062|Topiramate|topiramate|mesh-list
64621474|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
64621475|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64621476|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621477|NCT01456364|Ticagrelor|ticagrelor|mesh-list
64621478|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64621479|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64621480|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64621481|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64621482|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64621483|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
64621484|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621485|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484308|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64621486|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621488|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64446488|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64621489|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
64621490|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621491|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64621492|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
64621493|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
64621494|NCT04281420|Vitamins|vitamins|mesh-ancestor
64621495|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
64621496|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621497|NCT03765502|Glucagon|glucagon|mesh-list
64621498|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64621499|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621500|NCT03765502|Hormones|hormones|mesh-ancestor
64621501|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621502|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621503|NCT03765502|Incretins|incretins|mesh-ancestor
64621504|NCT04447716|Rituximab|rituximab|mesh-list
64621505|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64621506|NCT04447716|Lenalidomide|lenalidomide|mesh-list
64621507|NCT04447716|Venetoclax|venetoclax|mesh-list
64621508|NCT04447716|Piperidine|piperidine|mesh-list
64621509|NCT04447716|Antibodies|antibodies|mesh-list
64621510|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
64621511|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64621512|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
64621513|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621514|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446490|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64446491|NCT04752566|Eculizumab|eculizumab|mesh-list
64621521|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64621522|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64621523|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64621525|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
64621526|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621527|NCT05285124|Protective Agents|protective agents|mesh-ancestor
64621528|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621529|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621530|NCT01450046|Vitamin E|vitamin e|mesh-list
64621531|NCT01450046|Tocopherols|tocopherols|mesh-list
64621532|NCT01450046|Tocotrienols|tocotrienols|mesh-list
64621533|NCT01450046|Vitamins|vitamins|mesh-ancestor
64621534|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
64621535|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621536|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
64621537|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621538|NCT01450046|Protective Agents|protective agents|mesh-ancestor
64621539|NCT05497596|Vitamin D|vitamin d|mesh-list
64621540|NCT05497596|Vitamins|vitamins|mesh-ancestor
64621541|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
64621542|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621543|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64621544|NCT01450124|Boswellic acid|boswellic acid|mesh-list
64446511|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446512|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
64446513|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446514|NCT02137772|Letermovir|letermovir|mesh-list
64446515|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64446516|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446517|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446518|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446519|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
64446520|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446521|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64621548|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
64621549|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621550|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621551|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621552|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621553|NCT05243862|Atezolizumab|atezolizumab|mesh-list
64621554|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621555|NCT03751124|Norethindrone|norethindrone|mesh-list
64621556|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
64621558|NCT03751124|Relugolix|relugolix|mesh-list
64621559|NCT03751124|Estrogens|estrogens|mesh-ancestor
64621560|NCT03751124|Hormones|hormones|mesh-ancestor
64621561|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621562|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621563|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64621564|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
64621565|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64621566|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64621567|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64621568|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64621569|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64621570|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
64621571|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
64621572|NCT02861300|Capecitabine|capecitabine|mesh-list
64446553|NCT02136914|Amantadine|amantadine|mesh-list
64446554|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64446580|NCT01553188|Prednisone|prednisone|mesh-list
64621573|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64621574|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
64621575|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621576|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621577|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
64621578|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621579|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621580|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64621581|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621582|NCT04081324|Lasmiditan|lasmiditan|mesh-list
64621583|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64621584|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
64621585|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621586|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621587|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621588|NCT04042324|Heparin|heparin|mesh-list
64621589|NCT04042324|Calcium heparin|calcium heparin|mesh-list
64621590|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
64621591|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621592|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64621593|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64621594|NCT04391660|Ethanol|ethanol|mesh-list
64621595|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64621597|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64621598|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64621599|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621600|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621601|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621602|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
64621603|NCT04842422|Imiquimod|imiquimod|mesh-list
64446595|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
64621604|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64621605|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
64621606|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621607|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621608|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
64621609|NCT04066426|Acetaminophen|acetaminophen|mesh-list
64621610|NCT04066426|Dexamethasone|dexamethasone|mesh-list
64621611|NCT04066426|Naproxen|naproxen|mesh-list
64621612|NCT04066426|Codeine|codeine|mesh-list
64621613|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621614|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
64621615|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
64621616|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621617|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621618|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621619|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
64621620|NCT04066426|Hormones|hormones|mesh-ancestor
64621621|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621622|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64621623|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621624|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621625|NCT04066426|Analgesics|analgesics|mesh-ancestor
64621626|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
64621627|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
64621628|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64621629|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621630|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
64621631|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64621632|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621633|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621634|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64621635|NCT04066426|Narcotics|narcotics|mesh-ancestor
64621636|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621637|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
64621638|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
64621639|NCT01450514|Pipamperone|pipamperone|mesh-list
64621640|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64347000|NCT02322099|Antacids|antacids|mesh-ancestor
64621641|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
64621642|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621643|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621644|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621645|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64621646|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64621647|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621648|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64621649|NCT05095116|Fluticasone|fluticasone|mesh-list
64621651|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621652|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64446633|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446634|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64621653|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
64446635|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
64446636|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446637|NCT04098718|Prednisolone|prednisolone|mesh-list
64446638|NCT04098718|Benralizumab|benralizumab|mesh-list
64446639|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621659|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64621660|NCT02899052|Dexamethasone|dexamethasone|mesh-list
64621661|NCT02899052|Venetoclax|venetoclax|mesh-list
64621662|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446657|NCT01527682|Dorzolamide|dorzolamide|mesh-list
64621670|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64621671|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64621672|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621673|NCT04758728|Epinephrine|epinephrine|mesh-list
64621674|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64621675|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64621676|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
64621677|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446671|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446672|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64446673|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64446674|NCT01516216|Growth Substances|growth substances|mesh-ancestor
64621680|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64621681|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64621682|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
64621683|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621684|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64621685|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
64621686|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
64621687|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
64621688|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64621689|NCT02559570|Linaclotide|linaclotide|mesh-list
64621690|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64621691|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
64621692|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621693|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64621694|NCT04051684|Ropivacaine|ropivacaine|mesh-list
64621695|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
64621696|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
64621697|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621698|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621699|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
64621700|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621701|NCT04840862|Rifabutin|rifabutin|mesh-list
64621702|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64621703|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621704|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64621705|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
64621706|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
64621707|NCT04840238|Vitamin D|vitamin d|mesh-list
64621708|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64621709|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621710|NCT04840238|Vitamins|vitamins|mesh-ancestor
64621711|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
64621714|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
64621715|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
64621716|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621717|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621718|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
64621719|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621720|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64621721|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64621722|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64621723|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64621724|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621725|NCT04272788|Infliximab|infliximab|mesh-list
64621726|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
64621732|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
64621733|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
64621734|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621735|NCT01457690|Protective Agents|protective agents|mesh-ancestor
64621736|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621737|NCT01457690|Vitamins|vitamins|mesh-ancestor
64621738|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
64621739|NCT05497206|Metronidazole|metronidazole|mesh-list
64621740|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621741|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64621742|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64621743|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64621744|NCT01451060|Ephedrine|ephedrine|mesh-list
64621745|NCT01451060|Metaraminol|metaraminol|mesh-list
64621746|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64621747|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621748|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
64621749|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
64621750|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621751|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64621752|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
64621753|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621754|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621755|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64621756|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64621757|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64621758|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
64621759|NCT04904562|Giapreza|giapreza|mesh-list
64621760|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
64621761|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64621762|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64621764|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621765|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621766|NCT01143181|Brincidofovir|brincidofovir|mesh-list
64621767|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
64621769|NCT01451294|Phenylephrine|phenylephrine|mesh-list
64621770|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
64621771|NCT01451294|Ephedrine|ephedrine|mesh-list
64621772|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64621773|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
64621774|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
64621775|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621776|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621777|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
64621778|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64621779|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
64621780|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
64621781|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64621782|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64621783|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64621784|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
64621785|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621786|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621787|NCT01451294|Protective Agents|protective agents|mesh-ancestor
64621788|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64621789|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
64621791|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64621792|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
64621793|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621794|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621795|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64446713|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446714|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
64446715|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
64446716|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446717|NCT01514422|Minocycline|minocycline|mesh-list
64446718|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64446719|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446720|NCT01524796|Pregabalin|pregabalin|mesh-list
64621806|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
64621807|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
64621808|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621809|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621810|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
64621811|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621812|NCT01451840|Lidocaine|lidocaine|mesh-list
64621813|NCT01451840|Remifentanil|remifentanil|mesh-list
64621814|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
64621815|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
64621816|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621817|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621818|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
64621821|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64621822|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64621823|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64621824|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621825|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64621826|NCT01451840|Narcotics|narcotics|mesh-ancestor
64621827|NCT01451840|Analgesics|analgesics|mesh-ancestor
64621828|NCT01451918|Resveratrol|resveratrol|mesh-list
64621829|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
64621830|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621831|NCT01451918|Protective Agents|protective agents|mesh-ancestor
64621832|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621833|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621834|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64621835|NCT00378196|Ranibizumab|ranibizumab|mesh-list
64621839|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621840|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
64621841|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621843|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621844|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64621845|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
64621846|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621847|NCT01188109|Antiviral Agents|antiviral agents|mesh-ancestor
64621848|NCT01188109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64621849|NCT01188109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621864|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621865|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
64621866|NCT02886962|Vitamin K|vitamin k|mesh-list
64621867|NCT02886962|Vitamins|vitamins|mesh-ancestor
64621868|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
64621869|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621870|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64621871|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64621872|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621873|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
64621874|NCT02886962|Coagulants|coagulants|mesh-ancestor
64621875|NCT05495958|Vitamin D|vitamin d|mesh-list
64621876|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64621877|NCT05495958|Vitamins|vitamins|mesh-ancestor
64621878|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
64621879|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621880|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64621881|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64621882|NCT04011592|Ketamine|ketamine|mesh-list
64621883|NCT04011592|Analgesics|analgesics|mesh-ancestor
64621884|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
64621888|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64621889|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
64621891|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621892|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64621893|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64621894|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621895|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621896|NCT01458470|Memantine|memantine|mesh-list
64621897|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64621898|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64621899|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
64621900|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621901|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621902|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621903|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64621904|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64621905|NCT05028062|Naltrexone|naltrexone|mesh-list
64621906|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64621907|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64621908|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621909|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
64621910|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64621911|NCT04222062|Carmustine|carmustine|mesh-list
64621912|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64621913|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
64621914|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621915|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621916|NCT05025488|Poly ICLC|poly iclc|mesh-list
64621917|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
64621918|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
64621919|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621920|NCT01452542|Eliglustat|eliglustat|mesh-list
64621921|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621922|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621923|NCT01458548|Rituximab|rituximab|mesh-list
64621924|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621925|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621926|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
64621927|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621928|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621929|NCT05027204|Docetaxel|docetaxel|mesh-list
64621930|NCT05027204|Nivolumab|nivolumab|mesh-list
64621931|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64621932|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
64621933|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
64621934|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
64621935|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621936|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64621937|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64621939|NCT01458626|Paroxetine|paroxetine|mesh-list
64621940|NCT01458626|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64621941|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64621942|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64621943|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621944|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64621945|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
64621946|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621947|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64621948|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
64621949|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64621950|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64621951|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64621952|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621953|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64621954|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
64621955|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
64621956|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64621957|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64621958|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64621959|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64621960|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64621961|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64621962|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
64621963|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64621964|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64621965|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64621966|NCT00377806|Diclofenac|diclofenac|mesh-list
64621967|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64621968|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621969|NCT00377806|Analgesics|analgesics|mesh-ancestor
64621970|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
64621971|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446785|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446786|NCT01511536|Prednisone|prednisone|mesh-list
64621972|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621973|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64621974|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64621975|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64621976|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621977|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621978|NCT02559414|Aspirin|aspirin|mesh-list
64621979|NCT02559414|Clopidogrel|clopidogrel|mesh-list
64621980|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64621981|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64621982|NCT02559414|Analgesics|analgesics|mesh-ancestor
64621983|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
64621984|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446787|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
64446788|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446789|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
64446790|NCT01511536|Hormones|hormones|mesh-ancestor
64446792|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64621990|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64621991|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64621992|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64621993|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64621994|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
64621995|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64621996|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64621997|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64621998|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
64621999|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622000|NCT03527264|Nivolumab|nivolumab|mesh-list
64622001|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622002|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622003|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64622004|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622005|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64622006|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64622007|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64622008|NCT04713904|Estradiol|estradiol|mesh-list
64622009|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64622010|NCT04713904|Estrogens|estrogens|mesh-ancestor
64622011|NCT04713904|Hormones|hormones|mesh-ancestor
64622012|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622013|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622014|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64622015|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
64622016|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64622017|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64622018|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64622019|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64622020|NCT03995680|Mebendazole|mebendazole|mesh-list
64622021|NCT03995680|Piperazine|piperazine|mesh-list
64622022|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
64622023|NCT03995680|DMP 777|dmp 777|mesh-list
64622024|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
64622025|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
64622026|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64622027|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622028|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
64622029|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
64622030|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
64622031|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622032|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622033|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446803|NCT01510912|Analgesics|analgesics|mesh-ancestor
64446804|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
64446805|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446806|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446807|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446812|NCT01510756|Sorafenib|sorafenib|mesh-list
64622042|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
64622043|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622044|NCT05490342|Antibodies|antibodies|mesh-list
64622045|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
64622046|NCT05490342|Paraproteins|paraproteins|mesh-list
64622047|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
64622048|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622049|NCT05495100|Azacitidine|azacitidine|mesh-list
64622050|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
64622051|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64622052|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
64622053|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622054|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622055|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622056|NCT05495100|Analgesics|analgesics|mesh-ancestor
64622057|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
64622058|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622059|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622061|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64622062|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
64622063|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64622064|NCT03325114|Diuretics|diuretics|mesh-ancestor
64622065|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
64622066|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622067|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64622068|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64622069|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622070|NCT01453400|Aspirin|aspirin|mesh-list
64622071|NCT01453400|Acetaminophen|acetaminophen|mesh-list
64622072|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64622073|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64622074|NCT01453400|Analgesics|analgesics|mesh-ancestor
64622075|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
64622076|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622077|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622078|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622079|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622080|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64622081|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64622082|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622083|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64622084|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64622085|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622086|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
64622087|NCT05025644|Dobutamine|dobutamine|mesh-list
64622088|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64622089|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
64622090|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
64622091|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622092|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622093|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64622094|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64622095|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64622096|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
64622107|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622109|NCT03992482|Antibodies|antibodies|mesh-list
64622110|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
64622111|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64622112|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64622113|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
64622114|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622115|NCT00377494|Vaccines|vaccines|mesh-list
64622116|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
64622117|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622118|NCT01459250|S 20098|s 20098|mesh-list
64622119|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64622120|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622121|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622122|NCT04303156|Islatravir|islatravir|mesh-list
64622123|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
64622124|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622125|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622126|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622127|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64622128|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64622129|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64622130|NCT04390334|Efavirenz|efavirenz|mesh-list
64622132|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64622133|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64622134|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622135|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622136|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
64622137|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622138|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64622139|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64622140|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64622141|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64622142|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64622143|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64622144|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64622145|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622146|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64622147|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
64622148|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
64622149|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622150|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622151|NCT02880020|Nivolumab|nivolumab|mesh-list
64622152|NCT02880020|Ipilimumab|ipilimumab|mesh-list
64622153|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622164|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64622165|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64622166|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
64622167|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622168|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622169|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622170|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64622171|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622173|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622174|NCT05489952|Iron|iron|mesh-list
64622176|NCT05489952|Trace Elements|trace elements|mesh-ancestor
64622177|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
64622178|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622179|NCT05489952|Hematinics|hematinics|mesh-ancestor
64622180|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
64622181|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64622182|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
64622183|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622184|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
64622185|NCT01459640|Protective Agents|protective agents|mesh-ancestor
64622186|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
64622187|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64622188|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622189|NCT01500772|Ribavirin|ribavirin|mesh-list
64622190|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64622191|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
64622192|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622193|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
64622194|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622195|NCT04272476|Fluoxetine|fluoxetine|mesh-list
64622196|NCT04272476|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64622197|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64622198|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64622199|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622200|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622201|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
64622202|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622215|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622217|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64622218|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
64622219|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622220|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64622221|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64622222|NCT05489796|Ketorolac|ketorolac|mesh-list
64622223|NCT05489796|Fentanyl|fentanyl|mesh-list
64622224|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64622225|NCT05489796|Narcotics|narcotics|mesh-ancestor
64622226|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622227|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622228|NCT05489796|Analgesics|analgesics|mesh-ancestor
64622229|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
64622230|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622231|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64622232|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64622233|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
64622234|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
64622235|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64622236|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64622237|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622238|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622239|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64622240|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622241|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622243|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347590|NCT05091177|Neostigmine|neostigmine|mesh-list
64622244|NCT01890902|Ketoprofen|ketoprofen|mesh-list
64622245|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64622246|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64622247|NCT01890902|Analgesics|analgesics|mesh-ancestor
64622248|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
64622249|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622250|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622251|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622252|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622253|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64622254|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622255|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622256|NCT04423926|Prednisolone|prednisolone|mesh-list
64622257|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
64622258|NCT04423926|Doxorubicin|doxorubicin|mesh-list
64622259|NCT04423926|Vincristine|vincristine|mesh-list
64622260|NCT04423926|Lenalidomide|lenalidomide|mesh-list
64622261|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622262|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
64622263|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622264|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622265|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64622266|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
64446822|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64446823|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622267|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622268|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446824|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64446826|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446827|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64446828|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64446829|NCT01545388|Metformin|metformin|mesh-list
64446830|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64446831|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64446832|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446834|NCT01545388|Hormones|hormones|mesh-ancestor
64622274|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64622275|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
64622276|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
64622277|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
64622278|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64622279|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64622280|NCT04423926|Growth Substances|growth substances|mesh-ancestor
64622281|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
64622282|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622283|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
64622285|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622286|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64622287|NCT03979066|Atezolizumab|atezolizumab|mesh-list
64622288|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622289|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
64622290|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622291|NCT05489406|Dolutegravir|dolutegravir|mesh-list
64622292|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64622293|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64622294|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622295|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622296|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64622297|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64622298|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
64622299|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622300|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64622301|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622302|NCT01472692|Febuxostat|febuxostat|mesh-list
64622303|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
64622304|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622305|NCT05020028|Cannabidiol|cannabidiol|mesh-list
64622306|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
64622307|NCT00378820|Caseins|caseins|mesh-list
64622308|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
64622309|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
64622310|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622311|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64622312|NCT02558400|Latanoprost|latanoprost|mesh-list
64446839|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446840|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
64446841|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
64446842|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622322|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
64622323|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622324|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
64622325|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622326|NCT05493618|Dexamethasone|dexamethasone|mesh-list
64622327|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
64622328|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622329|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
64622330|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
64622331|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622332|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622333|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622334|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
64622335|NCT05493618|Hormones|hormones|mesh-ancestor
64622336|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622337|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64622338|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622339|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622340|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
64622341|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64622343|NCT04139304|Prednisone|prednisone|mesh-list
64622344|NCT04139304|Cortisone|cortisone|mesh-list
64622345|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
64622346|NCT04139304|Doxorubicin|doxorubicin|mesh-list
64622347|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64622348|NCT04139304|Etoposide|etoposide|mesh-list
64622349|NCT04139304|Vincristine|vincristine|mesh-list
64622350|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
64622351|NCT04139304|Daunorubicin|daunorubicin|mesh-list
64622352|NCT04139304|Daratumumab|daratumumab|mesh-list
64622353|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
64622354|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622355|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
64622356|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622357|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622358|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64622359|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
64622360|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622362|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64622363|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64622364|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64622365|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64622366|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622367|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622369|NCT04139304|Hormones|hormones|mesh-ancestor
64622370|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622371|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64622372|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64622373|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
64622374|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
64622375|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
64622376|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
64622377|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
64622378|NCT05020574|Cephalexin|cephalexin|mesh-list
64622379|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64622380|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622381|NCT02936206|Tamoxifen|tamoxifen|mesh-list
64622382|NCT02936206|Fulvestrant|fulvestrant|mesh-list
64622383|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64622384|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
64622385|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622386|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622387|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64622388|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622389|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64622390|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64622391|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64622392|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64622393|NCT01891526|Tretinoin|tretinoin|mesh-list
64622394|NCT01891526|Alitretinoin|alitretinoin|mesh-list
64347744|NCT02307305|Naloxone|naloxone|mesh-list
64622395|NCT01891526|Isotretinoin|isotretinoin|mesh-list
64622396|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622397|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
64622398|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
64622399|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
64622400|NCT01406860|Promethazine|promethazine|mesh-list
64622401|NCT01406860|Droperidol|droperidol|mesh-list
64622402|NCT01406860|Metoclopramide|metoclopramide|mesh-list
64622403|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64622404|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64622405|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622406|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622407|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
64622408|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
64622409|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
64622410|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622411|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
64622412|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
64622413|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622414|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64622415|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
64622416|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
64622417|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622424|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
64622425|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64622426|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64622427|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64622428|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64622429|NCT04138212|Paclitaxel|paclitaxel|mesh-list
64622430|NCT04138212|Cisplatin|cisplatin|mesh-list
64622431|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64622432|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622433|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
64622434|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
64622435|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
64622436|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622437|NCT02773576|Risperidone|risperidone|mesh-list
64622438|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64622439|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
64622447|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64622448|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
64622449|NCT05022758|Warfarin|warfarin|mesh-list
64622450|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
64622451|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
64622452|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64622453|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
64622454|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64622455|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
64622456|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622457|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622458|NCT05021978|Pramoxine|pramoxine|mesh-list
64622459|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
64622460|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
64622461|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622462|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622463|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
64622464|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622465|NCT04280406|Azithromycin|azithromycin|mesh-list
64622466|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64622467|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622468|NCT05599828|Omeprazole|omeprazole|mesh-list
64622470|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64622471|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622472|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64622473|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622474|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622475|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64622476|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
64622477|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
64622478|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622479|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622480|NCT01350232|Cytarabine|cytarabine|mesh-list
64622481|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
64622482|NCT01350232|Rituximab|rituximab|mesh-list
64622483|NCT01350232|Fludarabine|fludarabine|mesh-list
64622484|NCT01350232|Bortezomib|bortezomib|mesh-list
64622485|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622486|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
64622493|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64622494|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622495|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64622497|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
64622498|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622499|NCT02822378|Vitamin D|vitamin d|mesh-list
64622500|NCT02822378|Calcium|calcium|mesh-list
64622501|NCT02822378|Vitamins|vitamins|mesh-ancestor
64622502|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
64622503|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622504|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64622505|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64622506|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
64622507|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64622508|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622509|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622510|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64622511|NCT05493228|Analgesics|analgesics|mesh-ancestor
64622512|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
64622513|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622514|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64622515|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64622516|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64622517|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
64622518|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446866|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446867|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446868|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446869|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446870|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64446871|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446872|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
64446873|NCT01518946|Midodrine|midodrine|mesh-list
64446874|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
64446875|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
64446876|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446877|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622525|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622526|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622527|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64622528|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622529|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64622530|NCT01891916|Caseins|caseins|mesh-list
64622531|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
64622532|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
64622533|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622534|NCT01313416|Gemcitabine|gemcitabine|mesh-list
64622535|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64622536|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
64622537|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622538|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622539|NCT01313416|Antiviral Agents|antiviral agents|mesh-ancestor
64622540|NCT01313416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622541|NCT01313416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622542|NCT01313416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622543|NCT01313416|Immunologic Factors|immunologic factors|mesh-ancestor
64622544|NCT01313416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622545|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
64622546|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622547|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622548|NCT05499234|Acetaminophen|acetaminophen|mesh-list
64622549|NCT05499234|Meperidine|meperidine|mesh-list
64622550|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64622552|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
64622553|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622554|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622555|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
64622556|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64622557|NCT05499234|Narcotics|narcotics|mesh-ancestor
64622558|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622559|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64622560|NCT01269034|Insulin|insulin|mesh-list
64622561|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64622562|NCT01269034|Exenatide|exenatide|mesh-list
64622563|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
64622564|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
64622565|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
64622566|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64622567|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622568|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64622569|NCT01269034|Incretins|incretins|mesh-ancestor
64622570|NCT01269034|Hormones|hormones|mesh-ancestor
64622571|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622572|NCT05599126|Lorazepam|lorazepam|mesh-list
64622573|NCT05599126|Mianserin|mianserin|mesh-list
64622574|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
64622575|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
64622576|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
64622577|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446884|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622578|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622579|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622586|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
64622587|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622588|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622589|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64622590|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64622591|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
64622592|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64622593|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
64622594|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
64622595|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64622596|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
64622597|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64622598|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
64622599|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
64622600|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64622601|NCT01892150|Protective Agents|protective agents|mesh-ancestor
64622602|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622603|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
64622604|NCT02663752|Deferasirox|deferasirox|mesh-list
64622605|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64622606|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
64622607|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
64622608|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622609|NCT01253668|Antibodies|antibodies|mesh-list
64622610|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64622611|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
64622612|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622613|NCT01890200|Ribavirin|ribavirin|mesh-list
64622614|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64622615|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
64622616|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622617|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
64622618|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622619|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64622620|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64622621|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64622622|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64622623|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622624|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64622625|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64622626|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64622627|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
64622628|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622629|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622630|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64622631|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64622632|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
64622633|NCT05586620|Mitomycins|mitomycins|mesh-list
64622634|NCT05586620|Mitomycin|mitomycin|mesh-list
64622635|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64622636|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622637|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
64622638|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622639|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64622647|NCT01893788|Diuretics|diuretics|mesh-ancestor
64622648|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
64622649|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64622650|NCT01231750|Capsaicin|capsaicin|mesh-list
64622651|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
64622652|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
64622653|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
64622654|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622655|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622656|NCT05488860|Triamcinolone|triamcinolone|mesh-list
64622657|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64622658|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64622659|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64622660|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
64622661|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64622662|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622663|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
64622664|NCT05488860|Hormones|hormones|mesh-ancestor
64622665|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622666|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622667|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622668|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
64622669|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622670|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622671|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
64622672|NCT02549716|Acetaminophen|acetaminophen|mesh-list
64622673|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64622674|NCT02549716|Analgesics|analgesics|mesh-ancestor
64622675|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
64622676|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622677|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622678|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
64622687|NCT02534038|Quinidine|quinidine|mesh-list
64622688|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
64622689|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
64622690|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
64622691|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64622692|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64622693|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622694|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622695|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622696|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64622697|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64622698|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
64622699|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64622700|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
64622701|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64622702|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64622703|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622705|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64622706|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64622707|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
64622708|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64622710|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64622711|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64622712|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64622713|NCT01202110|Propranolol|propranolol|mesh-list
64622714|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64446886|NCT01507246|Bupivacaine|bupivacaine|mesh-list
64446887|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
64446888|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
64622717|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622718|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622719|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622720|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64622721|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64622722|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
64622724|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64622725|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
64622727|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
64622728|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
64622729|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64622730|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622731|NCT02556918|Incretins|incretins|mesh-ancestor
64622732|NCT02556918|Hormones|hormones|mesh-ancestor
64622733|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622734|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64622735|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
64622736|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622737|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622738|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
64622739|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
64622740|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64622741|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64622742|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622743|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622744|NCT00379756|Urological Agents|urological agents|mesh-ancestor
64622745|NCT02518750|Cytarabine|cytarabine|mesh-list
64622746|NCT02518750|Dexamethasone|dexamethasone|mesh-list
64622747|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
64622748|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
64622749|NCT02518750|Methotrexate|methotrexate|mesh-list
64622750|NCT02518750|Etoposide|etoposide|mesh-list
64622751|NCT02518750|Vincristine|vincristine|mesh-list
64622752|NCT02518750|Bortezomib|bortezomib|mesh-list
64622753|NCT02518750|Asparaginase|asparaginase|mesh-list
64622754|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
64622755|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
64622756|NCT02518750|Clofarabine|clofarabine|mesh-list
64622757|NCT02518750|Panobinostat|panobinostat|mesh-list
64622758|NCT02518750|Pegaspargase|pegaspargase|mesh-list
64622759|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622760|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
64622761|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622762|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64622763|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64622764|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
64622765|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622766|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622767|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64446889|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446890|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446891|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
64446892|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446893|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64446894|NCT01507246|Narcotics|narcotics|mesh-ancestor
64446895|NCT01507246|Analgesics|analgesics|mesh-ancestor
64446896|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
64446897|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
64622776|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64622777|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64622778|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
64622779|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64622780|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64622781|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
64622782|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
64622783|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622784|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64622785|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64622786|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64622787|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64622788|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64622789|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
64622790|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622791|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
64622792|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
64622793|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64622794|NCT02518750|Analgesics|analgesics|mesh-ancestor
64622795|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
64622796|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64622797|NCT01194856|Ritonavir|ritonavir|mesh-list
64622798|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64622799|NCT01194856|Efavirenz|efavirenz|mesh-list
64622800|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64622801|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64622802|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
64622803|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622804|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622806|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64622807|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
64622808|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622809|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64622810|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64622811|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64622819|NCT01182610|Carboplatin|carboplatin|mesh-list
64622820|NCT01182610|Fluorouracil|fluorouracil|mesh-list
64622821|NCT01182610|Panitumumab|panitumumab|mesh-list
64622822|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64622823|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622824|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64622825|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64622826|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64622827|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622828|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
64622829|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64622830|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622831|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
64622832|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622833|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622834|NCT05491902|Flutemetamol|flutemetamol|mesh-list
64622835|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64622836|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622837|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
64622838|NCT05485896|Lenvatinib|lenvatinib|mesh-list
64622839|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622840|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622841|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64622842|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622843|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622844|NCT05526430|Harmine|harmine|mesh-list
64622845|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
64622846|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622847|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64622848|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64622849|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622850|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622851|NCT05507398|Metformin|metformin|mesh-list
64622852|NCT05507398|Atorvastatin|atorvastatin|mesh-list
64622853|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64622854|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622855|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64622856|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64622857|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
64622858|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622859|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64622860|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64622861|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622863|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64622864|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64622865|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
64622866|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622867|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622868|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622885|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64622886|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
64622887|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622888|NCT02317276|Triamcinolone|triamcinolone|mesh-list
64622889|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64622890|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64622891|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64622892|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622893|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
64622894|NCT02317276|Hormones|hormones|mesh-ancestor
64622895|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622896|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622897|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64622898|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
64622899|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64622900|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622901|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
64622902|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64622903|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64622904|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64622905|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64622906|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622907|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
64622908|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622909|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446902|NCT02073448|Adapalene|adapalene|mesh-list
64622926|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64622927|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622928|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64622929|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622930|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
64622931|NCT02297230|Paclitaxel|paclitaxel|mesh-list
64622932|NCT02297230|Capecitabine|capecitabine|mesh-list
64622933|NCT02297230|Trastuzumab|trastuzumab|mesh-list
64622934|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64622935|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622936|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
64622937|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
64622938|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
64622939|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622940|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64622941|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
64622942|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64622947|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64622948|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
64622949|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622950|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622951|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622952|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64622953|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64622954|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622955|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
64622956|NCT02253394|Ambrisentan|ambrisentan|mesh-list
64622957|NCT02253394|Spironolactone|spironolactone|mesh-list
64622958|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64622959|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
64622960|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622961|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622962|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64622963|NCT02253394|Diuretics|diuretics|mesh-ancestor
64622964|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
64622965|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64622966|NCT05479032|Amantadine|amantadine|mesh-list
64622967|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64622968|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64622969|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
64622970|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622971|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
64622972|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64622973|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622974|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622975|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64622976|NCT05479032|Analgesics|analgesics|mesh-ancestor
64622977|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
64622978|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622979|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
64622980|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64622981|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64622982|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64622983|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
64622984|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
64622985|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64622986|NCT05484648|Dexamethasone|dexamethasone|mesh-list
64622987|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
64622988|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64622989|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
64622990|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
64622991|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64622992|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64622993|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64622994|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
64622995|NCT05484648|Hormones|hormones|mesh-ancestor
64622996|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64622997|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64622998|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64622999|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64623009|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623010|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
64623011|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
64623012|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64623013|NCT05478954|Amodiaquine|amodiaquine|mesh-list
64623014|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
64623015|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64623016|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64623017|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623018|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64623019|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623020|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623021|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64623022|NCT05478954|Renal Agents|renal agents|mesh-ancestor
64623023|NCT02137096|Carboplatin|carboplatin|mesh-list
64623024|NCT02137096|Etoposide|etoposide|mesh-list
64623025|NCT02137096|Ifosfamide|ifosfamide|mesh-list
64623026|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
64623027|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623028|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64623029|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64623030|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64623031|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623032|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623033|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64623034|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
64623035|NCT02130622|Promethazine|promethazine|mesh-list
64623036|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
64623037|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
64623038|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
64623039|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64623040|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
64623041|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
64623042|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623043|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623044|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623045|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64623046|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64623047|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64623048|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623052|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623053|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
64623054|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
64623055|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64623057|NCT02134912|Crizotinib|crizotinib|mesh-list
64623058|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623059|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623060|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623061|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64623062|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64623063|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64623064|NCT02094352|Ketamine|ketamine|mesh-list
64623065|NCT02094352|Analgesics|analgesics|mesh-ancestor
64623066|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
64623067|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623068|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623069|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64623070|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64623071|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
64623072|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
64623073|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623074|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64623075|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64623076|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623077|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623078|NCT01188421|Clonidine|clonidine|mesh-list
64623079|NCT01188421|Buprenorphine|buprenorphine|mesh-list
64623080|NCT01188421|Tramadol|tramadol|mesh-list
64623081|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64623082|NCT01188421|Naloxone|naloxone|mesh-list
64446905|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64446907|NCT02073448|Analgesics|analgesics|mesh-ancestor
64446908|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
64446909|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446910|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446911|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446912|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623092|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
64623093|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
64623094|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64623095|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64623096|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64623097|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
64623098|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623099|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623100|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
64623101|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64623102|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64623103|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623105|NCT03780894|Coagulants|coagulants|mesh-ancestor
64623106|NCT01006018|Pioglitazone|pioglitazone|mesh-list
64623107|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64623108|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64623109|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623110|NCT01006018|Incretins|incretins|mesh-ancestor
64623111|NCT01006018|Hormones|hormones|mesh-ancestor
64623112|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623113|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64623114|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
64623115|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623116|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623117|NCT00996502|Prednisone|prednisone|mesh-list
64623118|NCT00996502|Bevacizumab|bevacizumab|mesh-list
64623119|NCT00996502|Docetaxel|docetaxel|mesh-list
64623120|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64623121|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623122|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623123|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64623124|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64623125|NCT00996502|Growth Substances|growth substances|mesh-ancestor
64623126|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623127|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
64623128|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
64623129|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623130|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623131|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623132|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623133|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
64623134|NCT00996502|Hormones|hormones|mesh-ancestor
64623135|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623136|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64623137|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64623138|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623147|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623149|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
64623150|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623151|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623152|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64623153|NCT02027272|Hormones|hormones|mesh-ancestor
64623154|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623155|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64623156|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623157|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
64623158|NCT05475444|Chitosan|chitosan|mesh-list
64623159|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64623160|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623161|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64623162|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64623163|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623164|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623165|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623166|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64623167|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64623168|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64623169|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64623170|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
64623171|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64623172|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
64623173|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
64623174|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
64623175|NCT05475444|Coagulants|coagulants|mesh-ancestor
64623176|NCT03472092|Amitriptyline|amitriptyline|mesh-list
64623184|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623185|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64623186|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64623187|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64623188|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623189|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
64623190|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623191|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
64623192|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623193|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
64623194|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64623195|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64623196|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623197|NCT01996852|Urological Agents|urological agents|mesh-ancestor
64623198|NCT05478330|Flutamide|flutamide|mesh-list
64623199|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
64623200|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
64623201|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623202|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623203|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64623204|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623205|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64623206|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64623207|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623208|NCT04331626|Gemcitabine|gemcitabine|mesh-list
64623209|NCT04331626|Nivolumab|nivolumab|mesh-list
64623210|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64623211|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
64623212|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623213|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623214|NCT04331626|Antiviral Agents|antiviral agents|mesh-ancestor
64623215|NCT04331626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623216|NCT04331626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623217|NCT04331626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64623218|NCT04331626|Immunologic Factors|immunologic factors|mesh-ancestor
64623229|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64623231|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623232|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64623233|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64623234|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623235|NCT01973062|Rituximab|rituximab|mesh-list
64623236|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64623237|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623238|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623239|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
64623240|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623241|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623242|NCT03661320|Gemcitabine|gemcitabine|mesh-list
64623243|NCT03661320|Nivolumab|nivolumab|mesh-list
64623244|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623245|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64623246|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
64623247|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623248|NCT03661320|Antiviral Agents|antiviral agents|mesh-ancestor
64623249|NCT03661320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623250|NCT03661320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623258|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
64623259|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
64623260|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623262|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
64623263|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623264|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64623265|NCT04549116|Progesterone|progesterone|mesh-list
64623266|NCT04549116|Progestins|progestins|mesh-ancestor
64623267|NCT04549116|Hormones|hormones|mesh-ancestor
64623268|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623269|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623270|NCT00947284|Nalbuphine|nalbuphine|mesh-list
64623271|NCT00947284|Naloxone|naloxone|mesh-list
64623272|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64623273|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623274|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
64623275|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623276|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64623277|NCT00947284|Narcotics|narcotics|mesh-ancestor
64623278|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623279|NCT00947284|Analgesics|analgesics|mesh-ancestor
64623280|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64623281|NCT00932152|Bevacizumab|bevacizumab|mesh-list
64623282|NCT00932152|Fulvestrant|fulvestrant|mesh-list
64623283|NCT00932152|Anastrozole|anastrozole|mesh-list
64623284|NCT00932152|Analgesics|analgesics|mesh-list
64623285|NCT00932152|Antiemetics|antiemetics|mesh-list
64623286|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623287|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623288|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64623289|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64623290|NCT00932152|Growth Substances|growth substances|mesh-ancestor
64623291|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623292|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
64623293|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623294|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64623295|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64623296|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64623297|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
64623298|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623299|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64623300|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64623301|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623302|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623303|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
64623304|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623305|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
64623306|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64623307|NCT01916590|Bupivacaine|bupivacaine|mesh-list
64623308|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
64623309|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
64623318|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623320|NCT05474898|Analgesics|analgesics|mesh-ancestor
64623321|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
64623322|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623323|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623324|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
64623325|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623326|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64623327|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
64623328|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64623329|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64623330|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623331|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64623332|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
64623333|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64424607|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623334|NCT03428958|Leucovorin|leucovorin|mesh-list
64623335|NCT03428958|Bevacizumab|bevacizumab|mesh-list
64623336|NCT03428958|Cetuximab|cetuximab|mesh-list
64623337|NCT03428958|Panitumumab|panitumumab|mesh-list
64623338|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
64623339|NCT03428958|Irinotecan|irinotecan|mesh-list
64623340|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
64623341|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623342|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623343|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64623344|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64623345|NCT03428958|Growth Substances|growth substances|mesh-ancestor
64623346|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446913|NCT01487200|Triamcinolone|triamcinolone|mesh-list
64446914|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64446915|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64446916|NCT01487200|FX006|fx006|mesh-list
64446917|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64446918|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446919|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
64623347|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
64623348|NCT03428958|Antidotes|antidotes|mesh-ancestor
64623349|NCT03428958|Protective Agents|protective agents|mesh-ancestor
64623350|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
64623351|NCT03428958|Vitamins|vitamins|mesh-ancestor
64623352|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
64623353|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64623354|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64623355|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623356|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623357|NCT01844206|Morphine|morphine|mesh-list
64623358|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64623359|NCT01844206|Narcotics|narcotics|mesh-ancestor
64623360|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623361|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623362|NCT01844206|Analgesics|analgesics|mesh-ancestor
64623363|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
64623364|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623365|NCT03626454|Norepinephrine|norepinephrine|mesh-list
64623366|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64623367|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64623368|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64623369|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
64623370|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623371|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623372|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623373|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
64623374|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
64623375|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623376|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64623377|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
64623378|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623379|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
64623380|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64623381|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64623382|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623383|NCT01830790|Urological Agents|urological agents|mesh-ancestor
64623385|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64623386|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623387|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
64623388|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623389|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623390|NCT03950076|Edoxaban|edoxaban|mesh-list
64623391|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64623392|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
64623393|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64623394|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
64623395|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623396|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623397|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
64623398|NCT05292976|Albuterol|albuterol|mesh-list
64446920|NCT01487200|Hormones|hormones|mesh-ancestor
64446921|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446922|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446923|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446924|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
64446925|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446926|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446927|NCT01505608|Irinotecan|irinotecan|mesh-list
64623399|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
64623400|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64623402|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623403|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623404|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64623405|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
64623406|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
64623407|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64623408|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64623409|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64623410|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64623411|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
64623412|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623413|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623414|NCT05292976|Miotics|miotics|mesh-ancestor
64623415|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64623416|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64623417|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64623418|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64623419|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
64623420|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
64623421|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64623422|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64623423|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64623424|NCT00850720|Vasopressins|vasopressins|mesh-list
64623425|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623426|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
64623427|NCT00850720|Coagulants|coagulants|mesh-ancestor
64623428|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64623429|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64623430|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
64623431|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623432|NCT00843310|Dexamethasone|dexamethasone|mesh-list
64623433|NCT00843310|Lenalidomide|lenalidomide|mesh-list
64623434|NCT00843310|Melphalan|melphalan|mesh-list
64623435|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623436|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
64623437|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
64623438|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623439|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623440|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64623441|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
64623442|NCT00843310|Hormones|hormones|mesh-ancestor
64623443|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623444|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64623445|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623446|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
64623447|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64623448|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64623449|NCT00843310|Growth Substances|growth substances|mesh-ancestor
64623450|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
64623451|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64623452|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
64623453|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623454|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64623456|NCT00809458|Vitamin E|vitamin e|mesh-list
64623457|NCT00809458|Tocopherols|tocopherols|mesh-list
64623458|NCT00809458|Tocotrienols|tocotrienols|mesh-list
64623459|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
64623460|NCT00809458|Vitamins|vitamins|mesh-ancestor
64623461|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
64623462|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623463|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
64623464|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623465|NCT00809458|Protective Agents|protective agents|mesh-ancestor
64623466|NCT01701622|Febuxostat|febuxostat|mesh-list
64623467|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
64623468|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623469|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
64623470|NCT00786682|Docetaxel|docetaxel|mesh-list
64623471|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623473|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623474|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623475|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623476|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
64623477|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64623478|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64623479|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623480|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623481|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623482|NCT01675960|Gabapentin|gabapentin|mesh-list
64623483|NCT01675960|Analgesics|analgesics|mesh-ancestor
64623484|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
64623485|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623486|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623487|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
64623488|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64623489|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64623490|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623491|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64623492|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64623493|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64623494|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623495|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623496|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
64623497|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64623498|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64623499|NCT01607320|Clomiphene|clomiphene|mesh-list
64623500|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
64623501|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64623502|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
64623503|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623504|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623505|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64623506|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
64623507|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64623508|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64623509|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64623510|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64623511|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
64623512|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64623513|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64623514|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64623515|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623516|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64623517|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64623518|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64623519|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64623520|NCT01606150|Lidocaine|lidocaine|mesh-list
64623521|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
64623522|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
64446928|NCT01505608|Temozolomide|temozolomide|mesh-list
64446929|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64446930|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64446931|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446932|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446933|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446934|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64623533|NCT01602016|Folic Acid|folic acid|mesh-list
64623534|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
64623535|NCT01602016|Antidotes|antidotes|mesh-ancestor
64623536|NCT01602016|Protective Agents|protective agents|mesh-ancestor
64623537|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623538|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
64623539|NCT01602016|Vitamins|vitamins|mesh-ancestor
64623540|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
64623541|NCT01602016|Hematinics|hematinics|mesh-ancestor
64623542|NCT00731770|Fluticasone|fluticasone|mesh-list
64623544|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64623545|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64623546|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623547|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64623548|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
64623549|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623550|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623551|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64623552|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
64623553|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
64623554|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64623555|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64623556|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64623557|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64623558|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
64623559|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623560|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623561|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
64623562|NCT00731770|Hormones|hormones|mesh-ancestor
64623563|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623564|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
64623565|NCT00719914|Eptifibatide|eptifibatide|mesh-list
64623566|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64623567|NCT01566370|Zonisamide|zonisamide|mesh-list
64623568|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
64623569|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64623570|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64623571|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623572|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64623579|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623581|NCT01558492|Carboplatin|carboplatin|mesh-list
64623582|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64623583|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623584|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
64623585|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623586|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623587|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623588|NCT03579472|Halichondrin B|halichondrin b|mesh-list
64623589|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623590|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
64623591|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623592|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623593|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623594|NCT05286190|Bupivacaine|bupivacaine|mesh-list
64623595|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
64623596|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
64623597|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623598|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623600|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623601|NCT03399552|Avelumab|avelumab|mesh-list
64623602|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64446935|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
64446936|NCT01486966|Insulin|insulin|mesh-list
64446937|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64446938|NCT01486966|Metformin|metformin|mesh-list
64446939|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
64446940|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
64446941|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
64446942|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
64446943|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
64446944|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64446945|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446946|NCT04080076|Tacrolimus|tacrolimus|mesh-list
64446947|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64623608|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623609|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623611|NCT05477004|Analgesics|analgesics|mesh-ancestor
64623612|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
64623613|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623614|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623615|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64623616|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64623617|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
64623618|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
64623619|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623620|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64623621|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64623622|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623623|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623624|NCT05482464|Caseins|caseins|mesh-list
64623625|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
64623626|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
64623627|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623628|NCT01530880|Acetaminophen|acetaminophen|mesh-list
64623629|NCT01530880|Ibuprofen|ibuprofen|mesh-list
64623630|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64623631|NCT01530880|Analgesics|analgesics|mesh-ancestor
64623632|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
64623633|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623634|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623635|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
64623636|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64623637|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623638|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623639|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64623640|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623641|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446948|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
64446949|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446950|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64446951|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446952|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623651|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623653|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
64623654|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623655|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64623656|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
64623657|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64623658|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64623659|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64623660|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623661|NCT01475500|Dimercaprol|dimercaprol|mesh-list
64623662|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
64623663|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
64623664|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623665|NCT02551692|Nicotine|nicotine|mesh-list
64623666|NCT02551692|Varenicline|varenicline|mesh-list
64623667|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64623668|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
64623669|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623670|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623671|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64623672|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64623673|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
64623674|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623675|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623676|NCT00542542|Fentanyl|fentanyl|mesh-list
64623677|NCT00542542|Midazolam|midazolam|mesh-list
64623678|NCT00542542|Propofol|propofol|mesh-list
64623679|NCT00542542|Ropivacaine|ropivacaine|mesh-list
64623680|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64623681|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623682|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623683|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64623684|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
64623695|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64623696|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
64623697|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
64623698|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623699|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623700|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
64623701|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
64623702|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64623703|NCT05471544|Amodiaquine|amodiaquine|mesh-list
64623704|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
64623705|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64623706|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64623707|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623708|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64623709|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623710|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623711|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64623712|NCT05471544|Renal Agents|renal agents|mesh-ancestor
64623713|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
64623714|NCT03333486|Fludarabine|fludarabine|mesh-list
64623715|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
64623716|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64623717|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
64623718|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623719|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623720|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64623721|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
64623722|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623723|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623724|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64623725|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64623726|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
64623727|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
64623728|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64623729|NCT02598778|Listerine|listerine|mesh-list
64338555|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338556|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64338557|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64338558|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
64338571|NCT01745588|Hormones|hormones|mesh-ancestor
64623730|NCT02598778|Fluorides|fluorides|mesh-list
64623731|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
64623732|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
64623733|NCT02598778|Protective Agents|protective agents|mesh-ancestor
64623734|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623735|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64623736|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623737|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
64623747|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64623749|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
64623750|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623751|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623752|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623753|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64623754|NCT00634972|Ketorolac|ketorolac|mesh-list
64623755|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64623756|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64623758|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
64338642|NCT05533229|Morphine|morphine|mesh-list
64338910|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339378|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
64339666|NCT01657292|Octenidine|octenidine|mesh-list
64340272|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
64623759|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64623760|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623761|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623762|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623763|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64623764|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623765|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623766|NCT00529282|Vancomycin|vancomycin|mesh-list
64623767|NCT00529282|Cefepime|cefepime|mesh-list
64623768|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
64623769|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64623770|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64623771|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623772|NCT00623974|Teriparatide|teriparatide|mesh-list
64623774|NCT00623974|Calcium|calcium|mesh-list
64623775|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
64623776|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64623777|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623778|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64623779|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64623780|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64623781|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623782|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64623783|NCT00623974|Vitamins|vitamins|mesh-ancestor
64623784|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
64623785|NCT02550288|Atorvastatin|atorvastatin|mesh-list
64623786|NCT02550288|Ezetimibe|ezetimibe|mesh-list
64623787|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64623788|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64623789|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
64623790|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623791|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64623792|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64623793|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623794|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
64623795|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
64623798|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64623799|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64623800|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623801|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64623802|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340831|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
64341414|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
64623803|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623804|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64623805|NCT00380146|Renal Agents|renal agents|mesh-ancestor
64623806|NCT00496756|Sorafenib|sorafenib|mesh-list
64623807|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623808|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64623809|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623810|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623811|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
64623812|NCT00500890|Carboplatin|carboplatin|mesh-list
64623813|NCT00500890|Etoposide|etoposide|mesh-list
64623814|NCT00500890|Vincristine|vincristine|mesh-list
64623815|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64623816|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
64623817|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623818|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623819|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64341639|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64342012|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342013|NCT02277587|Hormones|hormones|mesh-ancestor
64342014|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342015|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342016|NCT00663767|Celecoxib|celecoxib|mesh-list
64342017|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
64342018|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64342019|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342020|NCT00663767|Analgesics|analgesics|mesh-ancestor
64342021|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
64342022|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342023|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342024|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342025|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342026|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64342027|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342285|NCT02357368|Copper|copper|mesh-list
64623820|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
64623821|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623822|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623823|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64623824|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64623825|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64623826|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64623827|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623828|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
64623829|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623830|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623831|NCT00000736|Zidovudine|zidovudine|mesh-list
64623832|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
64623833|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623834|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64623835|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64623837|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
64623838|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623839|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64623840|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64623841|NCT00379522|Vasopressins|vasopressins|mesh-list
64623842|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
64446953|NCT01900431|Leucovorin|leucovorin|mesh-list
64446954|NCT01900431|Folic Acid|folic acid|mesh-list
64446955|NCT01900431|Prednisone|prednisone|mesh-list
64446956|NCT01900431|Methotrexate|methotrexate|mesh-list
64446957|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
64446958|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446959|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
64446960|NCT01900431|Hormones|hormones|mesh-ancestor
64446961|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446962|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446963|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64446964|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446965|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64623846|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64623847|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
64623848|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623850|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64623852|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64623853|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623854|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623855|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64623856|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64623857|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64623858|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64623859|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64623860|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
64623861|NCT01662336|Ritonavir|ritonavir|mesh-list
64623862|NCT01662336|Lopinavir|lopinavir|mesh-list
64623863|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64343566|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64343567|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64343568|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343569|NCT00327743|Capecitabine|capecitabine|mesh-list
64343570|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64343571|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
64343574|NCT02285075|Temocillin|temocillin|mesh-list
64343637|NCT02480114|Analgesics|analgesics|mesh-ancestor
64343782|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344007|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344008|NCT03478423|Analgesics|analgesics|mesh-ancestor
64344009|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
64344010|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344952|NCT04839731|Fluorouracil|fluorouracil|mesh-list
64344953|NCT04839731|Calcipotriene|calcipotriene|mesh-list
64344954|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
64344964|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64344965|NCT03525509|Narcotics|narcotics|mesh-ancestor
64344966|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344968|NCT03525509|Analgesics|analgesics|mesh-ancestor
64345034|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64345035|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
64345036|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
64345037|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
64345038|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345039|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623864|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64623865|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
64623866|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623867|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623868|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64623869|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64623870|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
64623871|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623872|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64345284|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345531|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345840|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
64345942|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345943|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345944|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64345945|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64345946|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
64345947|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345948|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64345949|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
64345950|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
64345951|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
64345952|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64345954|NCT02595905|Veliparib|veliparib|mesh-list
64345955|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345956|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64345957|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345958|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346011|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
64346355|NCT03521063|Hormones|hormones|mesh-ancestor
64346978|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64346979|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346980|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346981|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
64623873|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64623874|NCT00000766|Ganciclovir|ganciclovir|mesh-list
64623875|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64623876|NCT00000766|Foscarnet|foscarnet|mesh-list
64623877|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64623878|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
64623879|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623880|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64623881|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623882|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623883|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64623884|NCT00000772|Ribavirin|ribavirin|mesh-list
64623885|NCT00000772|Didanosine|didanosine|mesh-list
64623886|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
64623887|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623888|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
64623889|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623890|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64623891|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64623892|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623893|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64623894|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64623895|NCT00572260|Daptomycin|daptomycin|mesh-list
64623896|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64623897|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623898|NCT00000778|Pyridoxine|pyridoxine|mesh-list
64347362|NCT03739099|Pancrelipase|pancrelipase|mesh-list
64623899|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
64623900|NCT00000778|Levofloxacin|levofloxacin|mesh-list
64446966|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
64623901|NCT00000778|Ofloxacin|ofloxacin|mesh-list
64446967|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64446968|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64446969|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
64623902|NCT00000778|Isoniazid|isoniazid|mesh-list
64623903|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64623904|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623905|NCT00000778|Renal Agents|renal agents|mesh-ancestor
64623913|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64623914|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
64623915|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64623916|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64623917|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
64347613|NCT03505151|BI 409306|bi 409306|mesh-list
64347691|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
64347692|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347693|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347694|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347695|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64347696|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347697|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
64347698|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64347699|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64347700|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347746|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64347747|NCT02307305|Analgesics|analgesics|mesh-ancestor
64347748|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
64347749|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347750|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347751|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
64347752|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64347753|NCT02307305|Narcotics|narcotics|mesh-ancestor
64347754|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347755|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64347756|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347757|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347758|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64347759|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64623918|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64623919|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
64623921|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
64623922|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623923|NCT05600686|Prednisone|prednisone|mesh-list
64623924|NCT05600686|Cortisone|cortisone|mesh-list
64623925|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
64623926|NCT05600686|Rituximab|rituximab|mesh-list
64623927|NCT05600686|Doxorubicin|doxorubicin|mesh-list
64623928|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64623929|NCT05600686|Etoposide|etoposide|mesh-list
64347788|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
64347789|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347801|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64347802|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64347803|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
64347804|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347805|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347806|NCT05718297|Durvalumab|durvalumab|mesh-list
64347807|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64347808|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347809|NCT04448431|Vortioxetine|vortioxetine|mesh-list
64347810|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64347811|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
64623930|NCT05600686|Vincristine|vincristine|mesh-list
64623931|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
64623932|NCT05600686|Daunorubicin|daunorubicin|mesh-list
64623933|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
64623934|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64623935|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64623936|NCT05600686|Antibodies|antibodies|mesh-list
64623937|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
64623938|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64623939|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64623940|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
64623941|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64623942|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64623943|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64623944|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
64623945|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623946|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64623947|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64623948|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64623949|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64623950|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64623951|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623952|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64623953|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
64623954|NCT05600686|Hormones|hormones|mesh-ancestor
64623955|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64623956|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64347862|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
64347863|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347865|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
64347880|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64347881|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
64347882|NCT01678131|Liver Extracts|liver extracts|mesh-list
64347883|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
64347884|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347885|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
64347886|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347887|NCT01678131|Hematinics|hematinics|mesh-ancestor
64347888|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347889|NCT04579783|Triamcinolone|triamcinolone|mesh-list
64347890|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64347891|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64623957|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64623958|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
64623959|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623960|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
64623961|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
64623962|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
64623963|NCT00000796|Pyridoxine|pyridoxine|mesh-list
64623964|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
64623965|NCT00000796|Levofloxacin|levofloxacin|mesh-list
64623966|NCT00000796|Cycloserine|cycloserine|mesh-list
64623968|NCT00000796|Isoniazid|isoniazid|mesh-list
64623969|NCT00000796|Amikacin|amikacin|mesh-list
64623970|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
64623971|NCT00000796|Ethambutol|ethambutol|mesh-list
64623972|NCT00000796|Clofazimine|clofazimine|mesh-list
64623973|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64623974|NCT00000796|Streptomycin|streptomycin|mesh-list
64623975|NCT00000796|Ethionamide|ethionamide|mesh-list
64623976|NCT00000796|Capreomycin|capreomycin|mesh-list
64623977|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64623978|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64623979|NCT00000796|Renal Agents|renal agents|mesh-ancestor
64623980|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64347990|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347991|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347992|NCT04266379|Insulin|insulin|mesh-list
64347993|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64347994|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64347995|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347996|NCT02308319|Tenofovir|tenofovir|mesh-list
64347997|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
64347998|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347999|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64348000|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64348001|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348002|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348003|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64348004|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64348005|NCT02312375|Amlodipine|amlodipine|mesh-list
64348006|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64348007|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64348008|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348009|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64623981|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64623982|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64623983|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64623985|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349318|NCT02323139|Azacitidine|azacitidine|mesh-list
64623986|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64623987|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64623988|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64623989|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
64623990|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
64623991|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64348070|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348071|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348072|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
64348073|NCT02449031|Tobramycin|tobramycin|mesh-list
64348074|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348075|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348076|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
64348078|NCT01680861|Everolimus|everolimus|mesh-list
64348125|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348126|NCT05093907|Capecitabine|capecitabine|mesh-list
64348127|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348128|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
64348129|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348130|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348131|NCT02228980|Vaccines|vaccines|mesh-list
64348132|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
64348133|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348134|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
64348135|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
64348136|NCT03783091|Hematinics|hematinics|mesh-ancestor
64348137|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
64348138|NCT03783091|Vitamins|vitamins|mesh-ancestor
64348139|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
64348140|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348141|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
64348142|NCT05057481|Rituximab|rituximab|mesh-list
64348165|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348167|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64348168|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64348193|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64623992|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64623993|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64623994|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64623995|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64623996|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64623997|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64623998|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64623999|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64624001|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64624002|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
64624004|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
64624005|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624006|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64348194|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64348195|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348196|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348197|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
64348198|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
64348199|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348200|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348201|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348202|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
64348203|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348204|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348206|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
64348207|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348208|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64348209|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64624007|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64624008|NCT00000802|Dapsone|dapsone|mesh-list
64624009|NCT00000802|Atovaquone|atovaquone|mesh-list
64624010|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624011|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
64624012|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64624013|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64624014|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64624015|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624016|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624017|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
64624018|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64624019|NCT02389946|Sirolimus|sirolimus|mesh-list
64624020|NCT02389946|Everolimus|everolimus|mesh-list
64624021|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624022|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624023|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
64624024|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624025|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64624026|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624027|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64624028|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
64624029|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
64624030|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624031|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64624032|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348280|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
64348281|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64348282|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64348283|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64348284|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348285|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348286|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64348287|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64348288|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348289|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348290|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348291|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
64348292|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64624033|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624034|NCT00268450|Gemcitabine|gemcitabine|mesh-list
64624035|NCT00268450|Paclitaxel|paclitaxel|mesh-list
64624036|NCT00268450|Bevacizumab|bevacizumab|mesh-list
64624037|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64624038|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624056|NCT00000808|Nevirapine|nevirapine|mesh-list
64624057|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624058|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624059|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624060|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624061|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
64624062|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624063|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624064|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624065|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64624066|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64624067|NCT01892384|BI 409306|bi 409306|mesh-list
64624068|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64348343|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348344|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348345|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
64348346|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348347|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64348348|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64348349|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64348350|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348351|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348353|NCT02309879|Narcotics|narcotics|mesh-ancestor
64348354|NCT02309879|Analgesics|analgesics|mesh-ancestor
64348355|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
64348356|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64348357|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64348358|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
64348359|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64348360|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
64348361|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348362|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348363|NCT02476786|Tamoxifen|tamoxifen|mesh-list
64624069|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624070|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624071|NCT00000814|Zidovudine|zidovudine|mesh-list
64624072|NCT00000814|Nevirapine|nevirapine|mesh-list
64624073|NCT00000814|Didanosine|didanosine|mesh-list
64624074|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
64624075|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624076|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624081|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624082|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624083|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64624084|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64348364|NCT02476786|Fulvestrant|fulvestrant|mesh-list
64348365|NCT02476786|Anastrozole|anastrozole|mesh-list
64348366|NCT02476786|Goserelin|goserelin|mesh-list
64348367|NCT02476786|Exemestane|exemestane|mesh-list
64348368|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64348369|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
64348370|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348371|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348372|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64348373|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348374|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64348375|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64348390|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
64348391|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348392|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624085|NCT02661932|Letrozole|letrozole|mesh-list
64624086|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624087|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64624088|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64624089|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624090|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624091|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64624092|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
64624093|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64624094|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624096|NCT02658890|Ipilimumab|ipilimumab|mesh-list
64624097|NCT02658890|Linrodostat|linrodostat|mesh-list
64624098|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64624099|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624100|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64624101|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624102|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624103|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
64624104|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64624105|NCT00177970|Antibodies|antibodies|mesh-list
64624106|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
64624107|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
64348426|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348427|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348428|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
64348429|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348430|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64348431|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
64348432|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
64348433|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348434|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
64348435|NCT03636165|Hormones|hormones|mesh-ancestor
64348436|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348437|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64348438|NCT03636165|Protective Agents|protective agents|mesh-ancestor
64348439|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64348440|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348441|NCT03521037|Rucaparib|rucaparib|mesh-list
64348442|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64348443|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348444|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348445|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348446|NCT02310347|Dronabinol|dronabinol|mesh-list
64348447|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
64348451|NCT02310347|Analgesics|analgesics|mesh-ancestor
64348466|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64624108|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64624109|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
64624110|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624111|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64624112|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
64624113|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624114|NCT00088972|Celecoxib|celecoxib|mesh-list
64624115|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64624116|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64624117|NCT00088972|Analgesics|analgesics|mesh-ancestor
64624118|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
64624119|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624120|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624121|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624122|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64624123|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64624124|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64624125|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624126|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624127|NCT00089128|Gemcitabine|gemcitabine|mesh-list
64624128|NCT00089128|Irinotecan|irinotecan|mesh-list
64624129|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624130|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
64624131|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624132|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624133|NCT00089128|Antiviral Agents|antiviral agents|mesh-ancestor
64624135|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349471|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
64624136|NCT00089128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348471|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348472|NCT02758431|Androgens|androgens|mesh-ancestor
64348473|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64348474|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348475|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
64348476|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64348477|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348478|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348479|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64348480|NCT04429425|Anesthetics|anesthetics|mesh-list
64348481|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348482|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348483|NCT03502889|Ropivacaine|ropivacaine|mesh-list
64348484|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
64348485|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
64348501|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
64348505|NCT02738879|Metformin|metformin|mesh-list
64624138|NCT00089128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624139|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64624140|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64624141|NCT00000838|Lamivudine|lamivudine|mesh-list
64624142|NCT00000838|Zidovudine|zidovudine|mesh-list
64624143|NCT00000838|Stavudine|stavudine|mesh-list
64624144|NCT00000838|Didanosine|didanosine|mesh-list
64624145|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624146|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624147|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624148|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624149|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
64624151|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624152|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624153|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
64624154|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
64624155|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64624156|NCT00001768|Antibodies|antibodies|mesh-list
64624157|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
64624158|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64624159|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
64624160|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624161|NCT00000844|Interferons|interferons|mesh-list
64624162|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
64624163|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624164|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
64624165|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348515|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348516|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348517|NCT03253913|Sirolimus|sirolimus|mesh-list
64348518|NCT03253913|Resveratrol|resveratrol|mesh-list
64348519|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348520|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348521|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64348523|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
64624166|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
64624167|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624168|NCT00014560|Antibodies|antibodies|mesh-list
64624169|NCT00014560|Sargramostim|sargramostim|mesh-list
64624170|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64624171|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
64624172|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624173|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
64624174|NCT00020722|Ifosfamide|ifosfamide|mesh-list
64624175|NCT00020722|Thiotepa|thiotepa|mesh-list
64624176|NCT00020722|Carboplatin|carboplatin|mesh-list
64624177|NCT00020722|Etoposide|etoposide|mesh-list
64624178|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
64624179|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624180|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
64624181|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624182|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446973|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64446974|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348571|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348572|NCT04657809|Insulin|insulin|mesh-list
64348573|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64348574|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348575|NCT05350917|Maleic acid|maleic acid|mesh-list
64348576|NCT05350917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348577|NCT05350917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348578|NCT02311205|Sorafenib|sorafenib|mesh-list
64446975|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
64446976|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446977|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64446978|NCT01900431|Antidotes|antidotes|mesh-ancestor
64446979|NCT01900431|Protective Agents|protective agents|mesh-ancestor
64446980|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
64446981|NCT01900431|Vitamins|vitamins|mesh-ancestor
64446982|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
64446983|NCT01900431|Hematinics|hematinics|mesh-ancestor
64624188|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64624189|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64624190|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64624191|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624192|NCT02649764|Cytarabine|cytarabine|mesh-list
64624193|NCT02649764|Fludarabine|fludarabine|mesh-list
64624194|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
64624195|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348680|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64348681|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348682|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348684|NCT03502343|Paclitaxel|paclitaxel|mesh-list
64348685|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64348686|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348687|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
64348688|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
64348689|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
64348690|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348691|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348692|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
64348693|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
64348694|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348724|NCT02224846|Tadalafil|tadalafil|mesh-list
64348725|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
64348726|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64348727|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64348728|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348729|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624196|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624197|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
64624198|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624199|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624200|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
64624201|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624202|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
64624203|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624204|NCT04051996|Decitabine|decitabine|mesh-list
64624205|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624206|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
64624207|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349562|NCT05007145|Paclitaxel|paclitaxel|mesh-list
64624208|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348748|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64348749|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64348750|NCT05150431|Analgesics|analgesics|mesh-ancestor
64348751|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
64348752|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348753|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348754|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64348755|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64348756|NCT03501251|Albendazole|albendazole|mesh-list
64348757|NCT03501251|Moxidectin|moxidectin|mesh-list
64348758|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
64348759|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64348761|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
64348762|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64348763|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64348764|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64348765|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64348766|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64348767|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348768|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348769|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
64348770|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64624209|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624210|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64624211|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624212|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
64624213|NCT02126878|Hormones|hormones|mesh-ancestor
64624214|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64624215|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624216|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348803|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
64348804|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348805|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348806|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64348807|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64348808|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
64348809|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64348810|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64348811|NCT02317601|Prednisolone|prednisolone|mesh-list
64348812|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
64348814|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
64348815|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64348816|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
64348817|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
64348818|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348819|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348820|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348821|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
64348822|NCT02317601|Hormones|hormones|mesh-ancestor
64348823|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348824|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64348825|NCT02317601|Protective Agents|protective agents|mesh-ancestor
64348826|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64348827|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348828|NCT05101785|Lidocaine|lidocaine|mesh-list
64348829|NCT05101785|Epinephrine|epinephrine|mesh-list
64348830|NCT05101785|Racepinephrine|racepinephrine|mesh-list
64348831|NCT05101785|Carticaine|carticaine|mesh-list
64348832|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
64348847|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348848|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64348849|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64624217|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
64624219|NCT02634008|Ribavirin|ribavirin|mesh-list
64624220|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64624221|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64624222|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
64624223|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624224|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624225|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624226|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624227|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
64348854|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
64348855|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64348856|NCT02315573|Lidocaine|lidocaine|mesh-list
64348857|NCT02315573|Epinephrine|epinephrine|mesh-list
64348858|NCT02315573|Racepinephrine|racepinephrine|mesh-list
64348859|NCT02315573|Bupivacaine|bupivacaine|mesh-list
64348860|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
64348861|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
64348862|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
64348863|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348864|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348865|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
64348866|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348867|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64348868|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64624228|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624229|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64624230|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64624231|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
64624232|NCT00000850|Indinavir|indinavir|mesh-list
64624233|NCT00000850|Sargramostim|sargramostim|mesh-list
64624234|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
64624235|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624236|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64624237|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64624238|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
64624239|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624240|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624241|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624242|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624243|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
64624253|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624254|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624255|NCT00001810|Voriconazole|voriconazole|mesh-list
64348905|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64348906|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348907|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348908|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348909|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64348910|NCT02317679|Bosentan|bosentan|mesh-list
64348911|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64348912|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64348913|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348914|NCT03475381|Ivacaftor|ivacaftor|mesh-list
64624256|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
64624257|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624258|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64624259|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64624260|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624261|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624262|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64624263|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
64624264|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64624265|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624266|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64624267|NCT00000862|Zidovudine|zidovudine|mesh-list
64624268|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
64624269|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624270|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624271|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624272|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624273|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
64624274|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624275|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624276|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624277|NCT02344472|Paclitaxel|paclitaxel|mesh-list
64624278|NCT02344472|Vinorelbine|vinorelbine|mesh-list
64624279|NCT02344472|Docetaxel|docetaxel|mesh-list
64624280|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64624281|NCT02344472|Capecitabine|capecitabine|mesh-list
64624282|NCT02344472|Trastuzumab|trastuzumab|mesh-list
64624283|NCT02344472|Letrozole|letrozole|mesh-list
64624284|NCT02344472|Fulvestrant|fulvestrant|mesh-list
64624285|NCT02344472|Anastrozole|anastrozole|mesh-list
64624286|NCT02344472|Pertuzumab|pertuzumab|mesh-list
64624287|NCT02344472|Exemestane|exemestane|mesh-list
64624288|NCT02344472|Goserelin|goserelin|mesh-list
64624289|NCT02344472|Leuprolide|leuprolide|mesh-list
64624290|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64348943|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
64348944|NCT03500783|Protective Agents|protective agents|mesh-ancestor
64348946|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
64348947|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
64348948|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348949|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348950|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
64348951|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348952|NCT02320877|Methaqualone|methaqualone|mesh-list
64348953|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64348954|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348955|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348956|NCT01322971|Metronidazole|metronidazole|mesh-list
64348957|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624291|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624293|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
64624294|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
64624295|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624296|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624297|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
64624298|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64624299|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64624300|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64624301|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348971|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64348972|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348973|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
64348974|NCT00424099|Methylphenidate|methylphenidate|mesh-list
64348975|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64348976|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348977|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64348978|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64348980|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348981|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
64348982|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348983|NCT01378429|Ciclesonide|ciclesonide|mesh-list
64348984|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
64348986|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348987|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348989|NCT01599754|Axitinib|axitinib|mesh-list
64348990|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348991|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64348992|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348993|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348994|NCT02321267|Ranibizumab|ranibizumab|mesh-list
64348995|NCT02321267|Aflibercept|aflibercept|mesh-list
64624313|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64624315|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624316|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
64624317|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64624318|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64624319|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624320|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
64624321|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624322|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624323|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64624324|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64624325|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
64348996|NCT02321267|Verteporfin|verteporfin|mesh-list
64348997|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64348998|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64348999|NCT02321267|Growth Substances|growth substances|mesh-ancestor
64349000|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349001|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
64349002|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349003|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64349004|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349005|NCT02318537|Cannabidiol|cannabidiol|mesh-list
64349006|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64349007|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
64349025|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349026|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349027|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64349028|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349029|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
64349030|NCT02319161|Calcium|calcium|mesh-list
64349031|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64349032|NCT02319161|Esmolol|esmolol|mesh-list
64349033|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349034|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349035|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64349036|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
64349037|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349038|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349040|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64349041|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
64624326|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624327|NCT00000868|Antacids|antacids|mesh-ancestor
64624328|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624329|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64624330|NCT02628626|Clonidine|clonidine|mesh-list
64624331|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64624332|NCT02628626|Analgesics|analgesics|mesh-ancestor
64624333|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
64349047|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
64349048|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
64349049|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64349050|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64349051|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
64349052|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
64349053|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349054|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349055|NCT03109691|Dexamethasone|dexamethasone|mesh-list
64349056|NCT03109691|Bupivacaine|bupivacaine|mesh-list
64349057|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349058|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
64349059|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
64349060|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349061|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349062|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64349063|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
64349064|NCT03109691|Hormones|hormones|mesh-ancestor
64349065|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349140|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
64624334|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624335|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624336|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64624337|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
64624338|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
64624339|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64624340|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64624341|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64624342|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
64624343|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624344|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624361|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
64349179|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64349180|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296067|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
64349182|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349183|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64349184|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64349185|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64349186|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64349187|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64349188|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64349189|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349190|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349191|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349192|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
64349193|NCT01356628|Palbociclib|palbociclib|mesh-list
64349194|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349195|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64349196|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349197|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349198|NCT02319941|Clopidogrel|clopidogrel|mesh-list
64349199|NCT02319941|Ticagrelor|ticagrelor|mesh-list
64349200|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64349201|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64349202|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64349203|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64349204|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
64624362|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
64624363|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
64349694|NCT03530995|Omeprazole|omeprazole|mesh-list
64624364|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624365|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624366|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
64624367|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624368|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64624369|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64624370|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64624371|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64624372|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349205|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349206|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349207|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349209|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
64349210|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64349211|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349212|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349213|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64349214|NCT05164627|Analgesics|analgesics|mesh-ancestor
64349215|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
64349216|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624373|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64624374|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64624375|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
64624377|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64624378|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64624379|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
64624380|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64624381|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
64624392|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624393|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64624394|NCT00000880|Cyclosporine|cyclosporine|mesh-list
64624395|NCT00000880|Cyclosporins|cyclosporins|mesh-list
64624396|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624397|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624398|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624399|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
64624400|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624401|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
64624402|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624403|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349308|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
64349309|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64349310|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349311|NCT01378117|Incretins|incretins|mesh-ancestor
64349312|NCT01378117|Hormones|hormones|mesh-ancestor
64349313|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349314|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64349315|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
64349316|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349317|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349319|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64349320|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
64349321|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349322|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349323|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349324|NCT02325245|Metformin|metformin|mesh-list
64349325|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64349326|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349351|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349360|NCT02323451|Chitosan|chitosan|mesh-list
64349361|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
64349362|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64349363|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
64349364|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349365|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
64349366|NCT02323451|Protective Agents|protective agents|mesh-ancestor
64624404|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64624405|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64624406|NCT02308280|Bortezomib|bortezomib|mesh-list
64624407|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624408|NCT02795156|Afatinib|afatinib|mesh-list
64624409|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624410|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64624411|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624412|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624413|NCT02599454|Atezolizumab|atezolizumab|mesh-list
64624414|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624415|NCT02279654|Lenalidomide|lenalidomide|mesh-list
64624416|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
64624417|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624418|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64349367|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64349368|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64349369|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
64349370|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349371|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64349372|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
64349373|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
64349374|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
64349375|NCT02323451|Coagulants|coagulants|mesh-ancestor
64349377|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349378|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349379|NCT02323607|Cytarabine|cytarabine|mesh-list
64349380|NCT02323607|Decitabine|decitabine|mesh-list
64624419|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64624420|NCT02279654|Growth Substances|growth substances|mesh-ancestor
64624422|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624423|NCT02780024|Metformin|metformin|mesh-list
64624424|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64624425|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624426|NCT02268656|Propofol|propofol|mesh-list
64624427|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64624428|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349450|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
64349451|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349452|NCT05479045|Nivolumab|nivolumab|mesh-list
64349453|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349454|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349455|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64349465|NCT04034459|Leucovorin|leucovorin|mesh-list
64349497|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349498|NCT03779243|Protective Agents|protective agents|mesh-ancestor
64349499|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349500|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349501|NCT03757013|Apremilast|apremilast|mesh-list
64349502|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64349503|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64349504|NCT03757013|Analgesics|analgesics|mesh-ancestor
64349505|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
64349506|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349507|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349508|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349509|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64349510|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64349511|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64349512|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349513|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349515|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624429|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624430|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64624431|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
64624432|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
64624433|NCT02564978|Minocycline|minocycline|mesh-list
64446991|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64446992|NCT01948791|Protective Agents|protective agents|mesh-ancestor
64624456|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
64624457|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
64624458|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64624459|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64624460|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
64624461|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624462|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624463|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
64624475|NCT02232152|Vitamins|vitamins|mesh-ancestor
64624476|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
64624477|NCT02229656|Olaparib|olaparib|mesh-list
64624478|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64624479|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624480|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624481|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624482|NCT00001870|Acetylcholine|acetylcholine|mesh-list
64624483|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
64624484|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64624485|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
64349530|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349531|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
64349533|NCT05131867|Milrinone|milrinone|mesh-list
64349534|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64349535|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64349536|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
64349537|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64349538|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64349539|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349540|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624486|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624487|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624488|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624489|NCT03252600|Dexamethasone|dexamethasone|mesh-list
64624490|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
64624491|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
64624492|NCT03252600|Lenalidomide|lenalidomide|mesh-list
64624493|NCT03252600|Elotuzumab|elotuzumab|mesh-list
64624494|NCT03252600|Ichthammol|ichthammol|mesh-list
64624495|NCT03252600|BB 1101|bb 1101|mesh-list
64624496|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624497|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
64624498|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624499|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64349582|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64349583|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349584|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349585|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
64349586|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
64349587|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349588|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349589|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64349590|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64349591|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
64624500|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64624501|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
64624502|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624503|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624504|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64624505|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624507|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
64624508|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624509|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64624510|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
64624511|NCT03252600|Hormones|hormones|mesh-ancestor
64624512|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64624513|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64624514|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64349734|NCT02207530|Durvalumab|durvalumab|mesh-list
64349735|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349736|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349738|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
64349739|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349740|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
64349741|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349742|NCT02616055|XL647|xl647|mesh-list
64349743|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349744|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64349745|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349746|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349747|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64349748|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
64349749|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349750|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349751|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64349752|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349753|NCT02786537|Ritonavir|ritonavir|mesh-list
64349754|NCT02786537|Ribavirin|ribavirin|mesh-list
64349755|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
64349756|NCT02786537|Grazoprevir|grazoprevir|mesh-list
64349757|NCT02786537|Ledipasvir|ledipasvir|mesh-list
64349758|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64349759|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64349760|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64349761|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
64349762|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349763|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624515|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64624526|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624527|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64624528|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64624529|NCT02749526|Growth Substances|growth substances|mesh-ancestor
64624530|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624531|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
64624532|NCT00000916|Lamivudine|lamivudine|mesh-list
64624533|NCT00000916|Zidovudine|zidovudine|mesh-list
64624534|NCT00000916|Stavudine|stavudine|mesh-list
64624535|NCT00000916|Didanosine|didanosine|mesh-list
64624536|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64624537|NCT00000916|Indinavir|indinavir|mesh-list
64624538|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
64624539|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624540|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624541|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624542|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349784|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64349785|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349787|NCT02252536|Analgesics|analgesics|mesh-ancestor
64349788|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
64349789|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349790|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349791|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
64349792|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64349795|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64624543|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
64624544|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624545|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624546|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624547|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
64624548|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624549|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
64624550|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64624551|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64624552|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
64624553|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64624554|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64624555|NCT02744612|Antibodies|antibodies|mesh-list
64624562|NCT02548364|Vitamin D|vitamin d|mesh-list
64624563|NCT02548364|Calcifediol|calcifediol|mesh-list
64624564|NCT02548364|Vitamins|vitamins|mesh-ancestor
64300752|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64624565|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
64624566|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349854|NCT03130153|Aspirin|aspirin|mesh-list
64349868|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64349869|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64349870|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349872|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349873|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
64349874|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
64349875|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349876|NCT03466333|Enalapril|enalapril|mesh-list
64349877|NCT03466333|Enalaprilat|enalaprilat|mesh-list
64349878|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349879|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349880|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64349881|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
64349882|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64349883|NCT05382715|Ozanimod|ozanimod|mesh-list
64349884|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64624567|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64624568|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64624569|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624571|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64624572|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624574|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64624575|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
64624576|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
64624577|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624578|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624579|NCT00000178|Prednisone|prednisone|mesh-list
64624580|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624581|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
64624582|NCT00000178|Hormones|hormones|mesh-ancestor
64624583|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64624584|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624585|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64349909|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
64349910|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349912|NCT03490097|Simvastatin|simvastatin|mesh-list
64349913|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64349914|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64349915|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
64349916|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349917|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64349918|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64349919|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349920|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
64349921|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349922|NCT04453735|Atorvastatin|atorvastatin|mesh-list
64349923|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64624586|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624587|NCT02530034|Antibodies|antibodies|mesh-list
64624588|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64624589|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
64624590|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624591|NCT05480280|Leucovorin|leucovorin|mesh-list
64624592|NCT05480280|Fluorouracil|fluorouracil|mesh-list
64624593|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
64624594|NCT05480280|Calcium|calcium|mesh-list
64624595|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
64624596|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64624597|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624598|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
64624599|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624600|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64624601|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624602|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624603|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
64624604|NCT05480280|Antidotes|antidotes|mesh-ancestor
64624605|NCT05480280|Protective Agents|protective agents|mesh-ancestor
64349984|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64349985|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64349986|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349987|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349988|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349989|NCT02215252|Pregabalin|pregabalin|mesh-list
64349990|NCT02215252|Analgesics|analgesics|mesh-ancestor
64349991|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
64349992|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349993|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349994|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
64349995|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64349996|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349997|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349998|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349999|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64350000|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64350001|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350002|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350004|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64350005|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350006|NCT02204410|Methylphenidate|methylphenidate|mesh-list
64350007|NCT02204410|Amphetamine|amphetamine|mesh-list
64350008|NCT02204410|Adderall|adderall|mesh-list
64350009|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
64350010|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64624606|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
64624607|NCT05480280|Vitamins|vitamins|mesh-ancestor
64624608|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
64624609|NCT00001906|Interleukin-12|interleukin-12|mesh-list
64624610|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64624611|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64624612|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
64624613|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624614|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64624627|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624629|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64624630|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
64624631|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624632|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64624633|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624634|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
64624635|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624636|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
64624637|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64624638|NCT00000946|Protective Agents|protective agents|mesh-ancestor
64624639|NCT02543346|Cetirizine|cetirizine|mesh-list
64624640|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64624641|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64624642|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64624643|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
64624644|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
64624645|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624646|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624647|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624648|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64624649|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
64624650|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64350013|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64350014|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350015|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350016|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
64350017|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350018|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
64350019|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
64350020|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350021|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
64350022|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64350023|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
64350024|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
64350025|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624651|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
64624652|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624653|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
64624654|NCT04390100|Protective Agents|protective agents|mesh-ancestor
64624655|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
64624656|NCT04390100|Coagulants|coagulants|mesh-ancestor
64624657|NCT00000202|Buprenorphine|buprenorphine|mesh-list
64624658|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64624659|NCT00000202|Narcotics|narcotics|mesh-ancestor
64624660|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624661|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350072|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64350073|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
64350074|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350075|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350076|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
64350077|NCT03489317|Metformin|metformin|mesh-list
64350078|NCT03489317|Amlodipine|amlodipine|mesh-list
64350079|NCT03489317|Simvastatin|simvastatin|mesh-list
64350080|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64350081|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350082|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64350083|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64350084|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350085|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350086|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64350087|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
64350088|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64624670|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624672|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
64624673|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624674|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64624676|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64624677|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64624678|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
64624679|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624680|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
64624681|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624682|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624683|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624684|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64624685|NCT00001930|Analgesics|analgesics|mesh-ancestor
64624686|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
64350149|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296068|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350160|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64350161|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350162|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350163|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64350164|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
64350165|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
64350166|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
64350167|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350168|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64350169|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64350170|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64350171|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64350172|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64350173|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350174|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64350175|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
64350176|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
64350177|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
64350178|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350179|NCT04388501|Atorvastatin|atorvastatin|mesh-list
64350180|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64350181|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64350182|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
64350183|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350184|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64350185|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64350186|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624687|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624688|NCT00000964|Foscarnet|foscarnet|mesh-list
64624689|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64624690|NCT00000964|Ranitidine|ranitidine|mesh-list
64624691|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64624692|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64624693|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64624694|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64624695|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
64624696|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
64624697|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624698|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624699|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350187|NCT02249182|Ribavirin|ribavirin|mesh-list
64350188|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
64350189|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64350190|NCT02249182|Ledipasvir|ledipasvir|mesh-list
64350191|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
64350192|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350193|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
64350234|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64350235|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64350236|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64350237|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350238|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350239|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350240|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350241|NCT02248480|Analgesics|analgesics|mesh-ancestor
64350242|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
64350243|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350244|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
64350245|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350246|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
64350247|NCT01653158|Docetaxel|docetaxel|mesh-list
64350248|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350249|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
64350250|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
64350251|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
64350252|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350253|NCT00701207|Nicotine|nicotine|mesh-list
64350254|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64624700|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
64624701|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624702|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624703|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624704|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624705|NCT00000976|Zidovudine|zidovudine|mesh-list
64624706|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
64624707|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
64624708|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624709|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624710|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64350260|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
64350261|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350262|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350263|NCT02247466|Rocuronium|rocuronium|mesh-list
64350264|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64350265|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64350266|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64350267|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350268|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350269|NCT03417479|Gabapentin|gabapentin|mesh-list
64350270|NCT03417479|Analgesics|analgesics|mesh-ancestor
64350271|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
64350272|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350273|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350274|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
64350275|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64350276|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64350298|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
64624711|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624712|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
64624713|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624714|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624717|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624718|NCT00000226|Buprenorphine|buprenorphine|mesh-list
64624719|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64624720|NCT00000226|Narcotics|narcotics|mesh-ancestor
64624721|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624722|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624723|NCT00000226|Analgesics|analgesics|mesh-ancestor
64624724|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
64350320|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350321|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64350322|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64350324|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350325|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
64350326|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64350327|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350328|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350329|NCT03486509|Afatinib|afatinib|mesh-list
64350330|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350334|NCT04460807|Exemestane|exemestane|mesh-list
64624725|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624726|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64624727|NCT00000982|Zidovudine|zidovudine|mesh-list
64624728|NCT00000982|Didanosine|didanosine|mesh-list
64624729|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
64624730|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624731|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624732|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624733|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624734|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
64624735|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624736|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64350373|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64350374|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350375|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350376|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64350377|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350379|NCT05152355|Budesonide|budesonide|mesh-list
64350380|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64350381|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64350382|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
64350383|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350384|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350385|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64350386|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
64350387|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
64350389|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350390|NCT02246764|Timolol|timolol|mesh-list
64350391|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64350392|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64350393|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350394|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64350395|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64350396|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
64350397|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624738|NCT02549196|Donepezil|donepezil|mesh-list
64624739|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
64624740|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64624741|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624742|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624743|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
64624744|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624745|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624746|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
64350398|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350399|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64350400|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64350402|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
64350403|NCT03484091|Protective Agents|protective agents|mesh-ancestor
64350404|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350405|NCT03486353|Azacitidine|azacitidine|mesh-list
64350408|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350409|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350410|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350411|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64350412|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64350413|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64350414|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64350415|NCT02431676|Metformin|metformin|mesh-list
64350416|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64350418|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64350419|NCT03483545|Hormones|hormones|mesh-ancestor
64350420|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350421|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350422|NCT03483389|Ethanol|ethanol|mesh-list
64350423|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64350427|NCT03486119|Nivolumab|nivolumab|mesh-list
64624747|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64624748|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64624749|NCT02549196|Urological Agents|urological agents|mesh-ancestor
64624750|NCT00000988|Stavudine|stavudine|mesh-list
64624751|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
64624752|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624753|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624754|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624755|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624756|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
64624757|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350603|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64350604|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
64350605|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350606|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350607|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350608|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
64350609|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
64350610|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350611|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64350612|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
64350613|NCT03478475|Vitamin D|vitamin d|mesh-list
64350614|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64350615|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350616|NCT03478475|Vitamins|vitamins|mesh-ancestor
64350617|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
64624758|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624759|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624760|NCT00000232|Buprenorphine|buprenorphine|mesh-list
64624761|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64624762|NCT00000232|Narcotics|narcotics|mesh-ancestor
64624763|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624764|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624765|NCT00000232|Analgesics|analgesics|mesh-ancestor
64624766|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
64350717|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
64350718|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64350719|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64350720|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350721|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
64350722|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
64350723|NCT02133742|Axitinib|axitinib|mesh-list
64350724|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64350725|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350726|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64350727|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350728|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350729|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
64350730|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
64350731|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350732|NCT02133664|Protective Agents|protective agents|mesh-ancestor
64350733|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350734|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
64350736|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
64350737|NCT02133352|Ranolazine|ranolazine|mesh-list
64350738|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64350739|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350761|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
64350762|NCT02555657|Vinorelbine|vinorelbine|mesh-list
64350763|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64350764|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
64424610|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64624767|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624768|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64624769|NCT00000238|Buprenorphine|buprenorphine|mesh-list
64624779|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624780|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624781|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624783|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
64624784|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624785|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624786|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64350765|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350766|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350767|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
64350768|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350769|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350770|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64350771|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
64350772|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350838|NCT05157893|Analgesics|analgesics|mesh-list
64350867|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64350868|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350869|NCT03645863|Iron|iron|mesh-list
64350870|NCT03645863|Trace Elements|trace elements|mesh-ancestor
64350871|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
64350872|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350873|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64350874|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
64350875|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64350876|NCT04503707|Hormones|hormones|mesh-ancestor
64350877|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350878|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350879|NCT03470597|Iodine|iodine|mesh-list
64350880|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64350881|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350882|NCT03470597|Trace Elements|trace elements|mesh-ancestor
64350883|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
64350885|NCT02522897|Ranibizumab|ranibizumab|mesh-list
64624787|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624788|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
64624789|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624790|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624791|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624792|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
64624793|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64624794|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
64624795|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624796|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624797|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64350956|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350957|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
64350958|NCT05160623|Povidone|povidone|mesh-list
64350959|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
64350960|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
64350961|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64350962|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350963|NCT04713137|Erythritol|erythritol|mesh-list
64350964|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
64350965|NCT04456985|Folic Acid|folic acid|mesh-list
64350966|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
64350967|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
64350968|NCT04456985|Vitamins|vitamins|mesh-ancestor
64350969|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
64350970|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350971|NCT04456985|Hematinics|hematinics|mesh-ancestor
64350972|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
64350973|NCT03469583|Entecavir|entecavir|mesh-list
64350974|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
64350975|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350976|NCT05159531|Tenofovir|tenofovir|mesh-list
64350977|NCT05159531|Emtricitabine|emtricitabine|mesh-list
64350978|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
64350979|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350980|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64351018|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64351019|NCT02421341|Fentanyl|fentanyl|mesh-list
64351020|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
64351021|NCT02421341|Analgesics|analgesics|mesh-list
64351022|NCT02421341|Narcotics|narcotics|mesh-ancestor
64351023|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351071|NCT05390255|Omalizumab|omalizumab|mesh-list
64624798|NCT00001006|Protective Agents|protective agents|mesh-ancestor
64624799|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624800|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624801|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624802|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624803|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
64624804|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624805|NCT00001954|Etanercept|etanercept|mesh-list
64624806|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64624807|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64624808|NCT00001954|Analgesics|analgesics|mesh-ancestor
64624809|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
64624810|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624811|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624812|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624813|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64624814|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64624815|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64624816|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
64624818|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64624819|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64624820|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624821|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
64624830|NCT00000250|Analgesics|analgesics|mesh-ancestor
64300819|NCT02120911|Trastuzumab|trastuzumab|mesh-list
64624831|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
64624832|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624834|NCT03244020|Enoxaparin|enoxaparin|mesh-list
64624835|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64624836|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64624837|NCT03244020|Analgesics|analgesics|mesh-ancestor
64624838|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
64624839|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624840|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624841|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624842|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351077|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64351078|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64351079|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
64351080|NCT04456829|Resveratrol|resveratrol|mesh-list
64351081|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
64351087|NCT02492867|Paclitaxel|paclitaxel|mesh-list
64624843|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64624844|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64624845|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624846|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64624847|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64624848|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624849|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
64624850|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
64624851|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
64624852|NCT00000262|Sevoflurane|sevoflurane|mesh-list
64624853|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64624854|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64624855|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
64624856|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
64351173|NCT05030155|Azathioprine|azathioprine|mesh-list
64351174|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64351175|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
64351176|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351177|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351178|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64351179|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
64351180|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351181|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351182|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64351183|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
64351184|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64351185|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
64351186|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64351187|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
64351189|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
64351287|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351288|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351289|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64351290|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64351291|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
64351292|NCT03376763|Aripiprazole|aripiprazole|mesh-list
64351293|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
64351294|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64351295|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64351296|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64351297|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351298|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624857|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64624858|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624859|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64624860|NCT00000262|Analgesics|analgesics|mesh-ancestor
64624861|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
64624862|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624863|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64624864|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
64624865|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624866|NCT02891538|Protective Agents|protective agents|mesh-ancestor
64624867|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624868|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64624869|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64624871|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64624872|NCT00001024|Zidovudine|zidovudine|mesh-list
64624873|NCT00001024|Didanosine|didanosine|mesh-list
64624874|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
64624875|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624876|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64624877|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64624878|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624879|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
64624888|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64624889|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64624890|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624891|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
64624892|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624893|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624894|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64624895|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64624896|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624898|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64624899|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624900|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
64351302|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351303|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64351304|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64351305|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
64351340|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64351356|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64351357|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
64351358|NCT01857115|Hormones|hormones|mesh-ancestor
64351359|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351360|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64351361|NCT03453541|Ketorolac|ketorolac|mesh-list
64624901|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624902|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64300862|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64624903|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64624904|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
64624905|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64624906|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
64624907|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624908|NCT00001042|Antacids|antacids|mesh-ancestor
64624909|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624910|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64624911|NCT00982865|Niacinamide|niacinamide|mesh-list
64624912|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
64624913|NCT00982865|Vitamins|vitamins|mesh-ancestor
64624914|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
64624915|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624916|NCT00001054|Valacyclovir|valacyclovir|mesh-list
64624917|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
64624918|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624919|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
64624920|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351394|NCT05322499|Irinotecan|irinotecan|mesh-list
64351395|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64351396|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351397|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64351398|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64351399|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64351400|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351401|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64351402|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64351403|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351404|NCT03449173|Sunitinib|sunitinib|mesh-list
64351405|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351406|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64351407|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64351408|NCT03449173|Growth Substances|growth substances|mesh-ancestor
64351409|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351410|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
64351411|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351412|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624921|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624922|NCT01226719|Leucovorin|leucovorin|mesh-list
64624923|NCT01226719|Fluorouracil|fluorouracil|mesh-list
64624924|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
64624925|NCT01226719|Irinotecan|irinotecan|mesh-list
64624926|NCT01226719|Panitumumab|panitumumab|mesh-list
64624927|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
64624934|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64624935|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64624936|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64624937|NCT01226719|Antidotes|antidotes|mesh-ancestor
64624938|NCT01226719|Protective Agents|protective agents|mesh-ancestor
64624939|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
64624940|NCT01226719|Vitamins|vitamins|mesh-ancestor
64624941|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
64624942|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64624943|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
64624944|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64624945|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
64624946|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351448|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64351449|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
64351450|NCT05322187|Lenvatinib|lenvatinib|mesh-list
64351451|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64351453|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351481|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351485|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
64351486|NCT05579249|Liraglutide|liraglutide|mesh-list
64351487|NCT05579249|Topiramate|topiramate|mesh-list
64351488|NCT05579249|Orlistat|orlistat|mesh-list
64351489|NCT05579249|Phentermine|phentermine|mesh-list
64351490|NCT05579249|Naltrexone|naltrexone|mesh-list
64351491|NCT05579249|Bupropion|bupropion|mesh-list
64351492|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64351493|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64624947|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64624948|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64624949|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
64624950|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624951|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
64624952|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64624953|NCT00001072|Protective Agents|protective agents|mesh-ancestor
64624954|NCT04331470|Ritonavir|ritonavir|mesh-list
64624955|NCT04331470|Lopinavir|lopinavir|mesh-list
64351662|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64351663|NCT03447925|Analgesics|analgesics|mesh-ancestor
64351664|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
64351665|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351666|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351667|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351668|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351669|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64351670|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351704|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
64351705|NCT04311073|Coagulants|coagulants|mesh-ancestor
64351804|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64351805|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64351806|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64351807|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
64351808|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64351809|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64351810|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64351811|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64351812|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64351813|NCT04817501|Edetic Acid|edetic acid|mesh-list
64351814|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
64351856|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64351857|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
64351858|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351859|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351860|NCT01378325|Protective Agents|protective agents|mesh-ancestor
64351861|NCT03854903|Fulvestrant|fulvestrant|mesh-list
64351862|NCT03854903|Palbociclib|palbociclib|mesh-list
64382872|NCT02415335|BB 1101|bb 1101|mesh-list
64624956|NCT04331470|Chloroquine|chloroquine|mesh-list
64624957|NCT04331470|Levamisole|levamisole|mesh-list
64624958|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
64447011|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447013|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
64447014|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447015|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447016|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
64447017|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64447018|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447019|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447020|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447021|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64447022|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64351863|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64351864|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351890|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64351891|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
64351892|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351893|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351894|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64351895|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64351896|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351897|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
64351898|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
64351899|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351900|NCT05174845|Protective Agents|protective agents|mesh-ancestor
64351901|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351902|NCT05174845|Vitamins|vitamins|mesh-ancestor
64351947|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351949|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
64351950|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351951|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
64351953|NCT05303311|Narcotics|narcotics|mesh-ancestor
64352010|NCT05102071|Empagliflozin|empagliflozin|mesh-list
64352011|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447023|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447024|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
64447025|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64624959|NCT04331470|Budesonide|budesonide|mesh-list
64624965|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624966|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64624967|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64624968|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
64624969|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64624970|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64624971|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64624972|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64624973|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64624974|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
64624975|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64624976|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624977|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64624978|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
64624981|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64624982|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64624983|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64624984|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64624985|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
64624986|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64624987|NCT04331470|Amebicides|amebicides|mesh-ancestor
64624988|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64624989|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64624990|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
64624991|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64624992|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
64624993|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
64624994|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64352012|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352013|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64352014|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352021|NCT03443869|Valganciclovir|valganciclovir|mesh-list
64352022|NCT03443869|Acyclovir|acyclovir|mesh-list
64352023|NCT03443869|Letermovir|letermovir|mesh-list
64352024|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
64352025|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352026|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64352027|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352028|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64624995|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
64624996|NCT00001090|Sargramostim|sargramostim|mesh-list
64624997|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
64624998|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64624999|NCT01147627|Insulin|insulin|mesh-list
64625000|NCT01147627|Pioglitazone|pioglitazone|mesh-list
64625001|NCT01147627|Exenatide|exenatide|mesh-list
64625002|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
64625003|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64625004|NCT01147627|Protamines|protamines|mesh-list
64625005|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64625006|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625007|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64625008|NCT01147627|Incretins|incretins|mesh-ancestor
64625009|NCT01147627|Hormones|hormones|mesh-ancestor
64625010|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625011|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
64625012|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352062|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352063|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
64352064|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
64352065|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352066|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352067|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352068|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
64352069|NCT03237611|Hormones|hormones|mesh-ancestor
64352070|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352080|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64352081|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352082|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64352144|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64352145|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64352146|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352147|NCT02811523|Doxorubicin|doxorubicin|mesh-list
64352148|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64625013|NCT01147627|Coagulants|coagulants|mesh-ancestor
64625014|NCT02548962|Dexamethasone|dexamethasone|mesh-list
64625015|NCT02548962|Pomalidomide|pomalidomide|mesh-list
64447026|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64447027|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
64447028|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
64625016|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64625017|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
64625018|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
64625024|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625026|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625027|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
64625028|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64625029|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64625030|NCT02548962|Growth Substances|growth substances|mesh-ancestor
64625031|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
64625032|NCT00000274|Flupenthixol|flupenthixol|mesh-list
64625033|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64625034|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64625035|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64625036|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625037|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625038|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64625039|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64625040|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
64625041|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625042|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352308|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352309|NCT03463967|Protective Agents|protective agents|mesh-ancestor
64352310|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352311|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64352366|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64352367|NCT05096715|Growth Substances|growth substances|mesh-ancestor
64352368|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352369|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
64352370|NCT04984889|Protein C|protein c|mesh-list
64352371|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
64352372|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64352373|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64352374|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352375|NCT05099601|Silymarin|silymarin|mesh-list
64352376|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
64352377|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352378|NCT05099601|Protective Agents|protective agents|mesh-ancestor
64352379|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352380|NCT03736629|Azithromycin|azithromycin|mesh-list
64352381|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64352382|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352383|NCT03461783|Charcoal|charcoal|mesh-list
64352384|NCT03461783|Antidotes|antidotes|mesh-ancestor
64352385|NCT03461783|Protective Agents|protective agents|mesh-ancestor
64625043|NCT02743598|Liraglutide|liraglutide|mesh-list
64625044|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64625045|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625046|NCT02743598|Incretins|incretins|mesh-ancestor
64625047|NCT02743598|Hormones|hormones|mesh-ancestor
64625048|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625049|NCT00000280|Nimodipine|nimodipine|mesh-list
64625050|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64625051|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64625052|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625053|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625054|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64625055|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625056|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
64625057|NCT00000286|Nefazodone|nefazodone|mesh-list
64352386|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352387|NCT01677507|Timolol|timolol|mesh-list
64352388|NCT01677507|Latanoprost|latanoprost|mesh-list
64352390|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64352398|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64352399|NCT04796363|Anesthetics|anesthetics|mesh-list
64352400|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352401|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352402|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64352403|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64352404|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
64352406|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352407|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352408|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352409|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352410|NCT05103813|Beraprost|beraprost|mesh-list
64352411|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64352412|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
64352413|NCT03461627|Fluticasone|fluticasone|mesh-list
64352414|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64352415|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64352416|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352417|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64625058|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64625059|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64625060|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625061|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625062|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625063|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625064|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64625065|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
64352467|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64352468|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
64352469|NCT05103501|Fluorouracil|fluorouracil|mesh-list
64352470|NCT05103501|Cisplatin|cisplatin|mesh-list
64352471|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64352472|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64352473|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352474|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
64352475|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352476|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64352477|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352478|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
64352479|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352480|NCT02522117|Atorvastatin|atorvastatin|mesh-list
64352481|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64352482|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64352483|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
64352492|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
64625066|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64625067|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64625068|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64625069|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
64625070|NCT01188577|Epinephrine|epinephrine|mesh-list
64625071|NCT01188577|Racepinephrine|racepinephrine|mesh-list
64625072|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
64625073|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64625074|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64625075|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
64625076|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625080|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64625081|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
64625082|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625083|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64625084|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
64625086|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
64352514|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64352515|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64352516|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64352517|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352518|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
64352519|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64352520|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64352521|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
64352522|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64352523|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
64352524|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352525|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
64352526|NCT04557527|Protective Agents|protective agents|mesh-ancestor
64352527|NCT02522039|Timolol|timolol|mesh-list
64352528|NCT02522039|Dorzolamide|dorzolamide|mesh-list
64352529|NCT02522039|Latanoprost|latanoprost|mesh-list
64352530|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64352531|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64352532|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
64352533|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352534|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352535|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352536|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64352544|NCT04430699|Cisplatin|cisplatin|mesh-list
64625087|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64625088|NCT02507336|Thalidomide|thalidomide|mesh-list
64625089|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64625090|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
64625091|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625092|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
64625093|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625094|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625095|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64625096|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64625097|NCT02507336|Growth Substances|growth substances|mesh-ancestor
64352548|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64352549|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
64352550|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352551|NCT04358003|Coal Tar|coal tar|mesh-list
64352552|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
64352553|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
64352554|NCT04519905|Paclitaxel|paclitaxel|mesh-list
64352555|NCT04519905|Carboplatin|carboplatin|mesh-list
64352556|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64352557|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352558|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
64352559|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
64352560|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
64352561|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352562|NCT04423341|Cannabidiol|cannabidiol|mesh-list
64352563|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
64352564|NCT03378479|Posaconazole|posaconazole|mesh-list
64352565|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
64352566|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352567|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64352568|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64352569|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64352570|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64352571|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64352572|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352573|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352574|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64352575|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
64352576|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625098|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
64625099|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625100|NCT00000292|Cocaine|cocaine|mesh-list
64625101|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
64625102|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
64625103|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625104|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625105|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
64625106|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625107|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64625108|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64625109|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64352628|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352629|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64352630|NCT04636671|Protective Agents|protective agents|mesh-ancestor
64352631|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64352632|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64352633|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352634|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64352635|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352636|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352637|NCT03126539|Sulforaphane|sulforaphane|mesh-list
64352638|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64352639|NCT03126539|Protective Agents|protective agents|mesh-ancestor
64352640|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352641|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352667|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64352668|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
64352669|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352670|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352671|NCT04019873|Lamivudine|lamivudine|mesh-list
64352672|NCT04019873|Rilpivirine|rilpivirine|mesh-list
64352673|NCT04019873|Dolutegravir|dolutegravir|mesh-list
64352674|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64352675|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64352676|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352677|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296079|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625110|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625111|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625113|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625114|NCT00000298|Buprenorphine|buprenorphine|mesh-list
64625115|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64625117|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64625118|NCT00000298|Narcotics|narcotics|mesh-ancestor
64625119|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625120|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625121|NCT00000298|Analgesics|analgesics|mesh-ancestor
64625122|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
64625123|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625124|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64353371|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64353373|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
64353374|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
64353375|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353376|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64353413|NCT03433001|Ixazomib|ixazomib|mesh-list
64353432|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353433|NCT03797469|Niacinamide|niacinamide|mesh-list
64353435|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
64353436|NCT03797469|Vitamins|vitamins|mesh-ancestor
64353437|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
64353438|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353439|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
64353440|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64353441|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
64353443|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64625125|NCT00000304|Amphetamine|amphetamine|mesh-list
64625126|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
64625127|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64625128|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625129|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
64625130|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
64625131|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625132|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
64625133|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625134|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625135|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
64625136|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64625137|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64625139|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64625140|NCT02548650|Aspirin|aspirin|mesh-list
64625141|NCT02548650|Clopidogrel|clopidogrel|mesh-list
64625142|NCT02548650|Vorapaxar|vorapaxar|mesh-list
64625143|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64625144|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64625145|NCT02548650|Analgesics|analgesics|mesh-ancestor
64625146|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
64353529|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64353530|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
64353531|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353532|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
64353533|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353534|NCT02991807|Everolimus|everolimus|mesh-list
64353535|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353536|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64353537|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
64353538|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353539|NCT04380311|Tacrolimus|tacrolimus|mesh-list
64353540|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64353541|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
64353542|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353543|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64353544|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353574|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353575|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
64353576|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353577|NCT02387216|Docetaxel|docetaxel|mesh-list
64353578|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353579|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
64353580|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
64353581|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
64353582|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353583|NCT03431909|Aspirin|aspirin|mesh-list
64353596|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64625147|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625148|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625149|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64625150|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64625151|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64625152|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64625153|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625154|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64625155|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64625156|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625157|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
64625158|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64625159|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64625160|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64625161|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
64625162|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625163|NCT00000310|Risperidone|risperidone|mesh-list
64625164|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64625165|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
64353597|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353598|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64353599|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64353600|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353601|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
64353602|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64353603|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64353604|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
64353605|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64353606|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64353607|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64353719|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64353720|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353721|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64353722|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64353723|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353724|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353725|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64353726|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
64353727|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353728|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353732|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
64625166|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625167|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625168|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625169|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64625171|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625172|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64625173|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64625174|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
64625175|NCT02734004|Bevacizumab|bevacizumab|mesh-list
64625176|NCT02734004|Durvalumab|durvalumab|mesh-list
64625177|NCT02734004|Olaparib|olaparib|mesh-list
64625178|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64625179|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625180|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64625181|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64353737|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64353739|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64353740|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353741|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353742|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353743|NCT03861611|Ibuprofen|ibuprofen|mesh-list
64353744|NCT03861611|Diclofenac|diclofenac|mesh-list
64353745|NCT03861611|Ketorolac|ketorolac|mesh-list
64353746|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64353747|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353748|NCT03861611|Analgesics|analgesics|mesh-ancestor
64353749|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
64353752|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64625182|NCT02734004|Growth Substances|growth substances|mesh-ancestor
64625183|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625184|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
64625185|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64625186|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625187|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625189|NCT01227655|Carbidopa|carbidopa|mesh-list
64625190|NCT01227655|Opicapone|opicapone|mesh-list
64625191|NCT01227655|Benserazide|benserazide|mesh-list
64625192|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64625193|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64625194|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
64625195|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625196|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350527|NCT05152667|Hormones|hormones|mesh-ancestor
64625197|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625198|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64625199|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625200|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64625201|NCT00000316|Cocaine|cocaine|mesh-list
64625202|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
64625203|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
64625204|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353859|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64353860|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
64353861|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64353862|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353863|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64353867|NCT02732639|Interferons|interferons|mesh-list
64353885|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
64353886|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353887|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353888|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64353889|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
64353890|NCT02412878|Hormones|hormones|mesh-ancestor
64625205|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625206|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
64625207|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625208|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64625209|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64625210|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64625211|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625212|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625213|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
64625214|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625215|NCT00001990|Atovaquone|atovaquone|mesh-list
64625216|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353962|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353963|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353964|NCT04449185|Amoxicillin|amoxicillin|mesh-list
64353965|NCT04449185|Clarithromycin|clarithromycin|mesh-list
64353966|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353967|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353968|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64353969|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353970|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353971|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64353972|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64353973|NCT03426761|Vancomycin|vancomycin|mesh-list
64353974|NCT03426761|Cefazolin|cefazolin|mesh-list
64353975|NCT03426761|Daptomycin|daptomycin|mesh-list
64353976|NCT03426761|Dalbavancin|dalbavancin|mesh-list
64353977|NCT03426761|Nafcillin|nafcillin|mesh-list
64353978|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353979|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353980|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
64353981|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
64353982|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
64353983|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353985|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64625217|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
64625218|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64625219|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64625220|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625221|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625222|NCT01026623|Sirolimus|sirolimus|mesh-list
64625223|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64625224|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625225|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625226|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64625227|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625228|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
64625229|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64354241|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354242|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64354243|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64354244|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
64354245|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354246|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
64354247|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354273|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354274|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
64354275|NCT03436303|Progestins|progestins|mesh-ancestor
64354276|NCT03436303|Hormones|hormones|mesh-ancestor
64354277|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354278|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354279|NCT03436225|Dexamethasone|dexamethasone|mesh-list
64354280|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
64354281|NCT03436225|Budesonide|budesonide|mesh-list
64354282|NCT03436225|Albuterol|albuterol|mesh-list
64354283|NCT03436225|BB 1101|bb 1101|mesh-list
64354284|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354285|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
64354301|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
64354405|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354406|NCT03434275|Meloxicam|meloxicam|mesh-list
64354407|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354408|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354483|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354484|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64354485|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354487|NCT03605719|Dexamethasone|dexamethasone|mesh-list
64625230|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
64625231|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625232|NCT00001996|Atovaquone|atovaquone|mesh-list
64625233|NCT00001996|Pentamidine|pentamidine|mesh-list
64625234|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625235|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
64625236|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64625237|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64625238|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625239|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300903|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64625240|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
64625241|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64625243|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
64625244|NCT02725424|Trastuzumab|trastuzumab|mesh-list
64625246|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
64625247|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
64625248|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
64625249|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625250|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64625251|NCT01189279|Bimatoprost|bimatoprost|mesh-list
64625252|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64625253|NCT00001108|Ritonavir|ritonavir|mesh-list
64625254|NCT00001108|Nelfinavir|nelfinavir|mesh-list
64625255|NCT00001108|Saquinavir|saquinavir|mesh-list
64625256|NCT00001108|Lamivudine|lamivudine|mesh-list
64625257|NCT00001108|Nevirapine|nevirapine|mesh-list
64625259|NCT00001108|Didanosine|didanosine|mesh-list
64625260|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64625261|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64625262|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
64625263|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625264|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625265|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64447029|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
64447030|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
64447031|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64447032|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64447033|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
64625266|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625267|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
64625268|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625269|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64625270|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64354780|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
64354781|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354782|NCT03421717|Chitosan|chitosan|mesh-list
64354783|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64354784|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64354785|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
64354786|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354787|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64354788|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
64354789|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
64354791|NCT03421717|Coagulants|coagulants|mesh-ancestor
64354792|NCT03427801|Hematinics|hematinics|mesh-list
64354793|NCT03416569|Prazosin|prazosin|mesh-list
64354794|NCT03416569|Nicotine|nicotine|mesh-list
64354795|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64354796|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
64354797|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625271|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625272|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625273|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64625274|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64625275|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
64625276|NCT02157974|Exenatide|exenatide|mesh-list
64625277|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64625278|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625279|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64625280|NCT02157974|Incretins|incretins|mesh-ancestor
64625281|NCT02157974|Hormones|hormones|mesh-ancestor
64354799|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64354800|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64354801|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
64354802|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354803|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354804|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64354910|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354911|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354912|NCT03415711|Analgesics|analgesics|mesh-ancestor
64354913|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
64354951|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64354952|NCT03419923|Citric Acid|citric acid|mesh-list
64354953|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
64354954|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
64354955|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64354956|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
64354957|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
64354958|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354959|NCT03426553|Riboflavin|riboflavin|mesh-list
64354960|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
64354961|NCT03426553|Vitamins|vitamins|mesh-ancestor
64354962|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
64354963|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354964|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64354965|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
64354966|NCT03415087|Fentanyl|fentanyl|mesh-list
64354967|NCT03415087|Bupivacaine|bupivacaine|mesh-list
64354968|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
64354969|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
64625282|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625283|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
64625284|NCT00000328|Narcotics|narcotics|mesh-ancestor
64625285|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625286|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625287|NCT00000328|Analgesics|analgesics|mesh-ancestor
64625288|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
64625289|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625290|NCT00380224|Olanzapine|olanzapine|mesh-list
64625291|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
64625292|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
64625293|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625294|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355583|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64355584|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355585|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64355712|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355713|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355714|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
64355715|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64355789|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355790|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355791|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355792|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
64355793|NCT04448015|Narcotics|narcotics|mesh-ancestor
64355794|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355795|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355796|NCT04448015|Analgesics|analgesics|mesh-ancestor
64355797|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
64355798|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355799|NCT01328041|Dolutegravir|dolutegravir|mesh-list
64355800|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64355801|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64355802|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355803|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355804|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64355805|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64355806|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
64625295|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64625296|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64625297|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64625298|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625299|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64625300|NCT00380224|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64625301|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64625302|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625303|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355839|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64355840|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
64355841|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355842|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64355843|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64355844|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
64355845|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355846|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355847|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64355848|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64355849|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
64355850|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
64355851|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355852|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
64625304|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625305|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
64625306|NCT00002002|Leucovorin|leucovorin|mesh-list
64625307|NCT00002002|Trimethoprim|trimethoprim|mesh-list
64625308|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
64625309|NCT00002002|Calcium|calcium|mesh-list
64625310|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
64625311|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64625312|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625313|NCT00002002|Antidotes|antidotes|mesh-ancestor
64625314|NCT00002002|Protective Agents|protective agents|mesh-ancestor
64625315|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
64625316|NCT00002002|Vitamins|vitamins|mesh-ancestor
64447039|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
64447040|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
64447041|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
64447042|NCT01485796|Antibodies|antibodies|mesh-list
64447043|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
64447044|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64447045|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64447046|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
64447048|NCT01897233|Ivacaftor|ivacaftor|mesh-list
64625331|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64355917|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64355918|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
64355919|NCT03424291|Apatinib|apatinib|mesh-list
64355920|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355921|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355922|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355923|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355969|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
64355971|NCT03411941|Aflibercept|aflibercept|mesh-list
64355972|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64355973|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64355974|NCT03411941|Growth Substances|growth substances|mesh-ancestor
64355975|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355976|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
64355983|NCT03406819|Tirofiban|tirofiban|mesh-list
64356063|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64356064|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356065|NCT05168059|Clevidipine|clevidipine|mesh-list
64625332|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64625333|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625334|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625335|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625336|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625337|NCT02535000|Analgesics|analgesics|mesh-ancestor
64625338|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
64625339|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625340|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
64625341|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356066|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64356067|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64356068|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356069|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64356070|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356071|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
64356072|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64356073|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
64356075|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64356076|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356077|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64356078|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64356079|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356080|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356081|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356082|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64356083|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64356189|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356190|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356191|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356192|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356193|NCT03393403|Analgesics|analgesics|mesh-ancestor
64625342|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
64625343|NCT00380380|Vildagliptin|vildagliptin|mesh-list
64625344|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64625345|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625346|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64625347|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
64625348|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625349|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625350|NCT01228903|Allopurinol|allopurinol|mesh-list
64625351|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
64625352|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356228|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64356229|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356230|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356231|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356232|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64356233|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64356234|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
64356235|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64356236|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356238|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
64356239|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64356240|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64356241|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356242|NCT05188053|Analgesics|analgesics|mesh-ancestor
64356243|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64356244|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356245|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64356246|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356314|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64356315|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64356316|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64356317|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64356318|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356319|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
64356320|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
64356321|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64356322|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64356323|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64356324|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356325|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64356393|NCT02520479|Pegaspargase|pegaspargase|mesh-list
64625353|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625354|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
64625355|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64625356|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64625357|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
64625358|NCT01228903|Protective Agents|protective agents|mesh-ancestor
64625359|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625360|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64625368|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
64625369|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625370|NCT00001126|Cidofovir|cidofovir|mesh-list
64625371|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
64625372|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625373|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625374|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625375|NCT00002008|Sargramostim|sargramostim|mesh-list
64356463|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356464|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64356465|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356466|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
64356467|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
64356468|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64356469|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
64356470|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
64356488|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356489|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
64356490|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
64356491|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
64356492|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356494|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64356495|NCT04167761|Glipizide|glipizide|mesh-list
64356496|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356497|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64356498|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356499|NCT03401177|Naproxen|naproxen|mesh-list
64356500|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64356501|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356502|NCT03401177|Analgesics|analgesics|mesh-ancestor
64356503|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
64625376|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
64625377|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625378|NCT00001132|Abacavir|abacavir|mesh-list
64625379|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625380|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625381|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625382|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625383|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
64625384|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447054|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64447055|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447056|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447057|NCT01946529|Sirolimus|sirolimus|mesh-list
64447058|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
64447059|NCT01946529|Temozolomide|temozolomide|mesh-list
64447060|NCT01946529|Ifosfamide|ifosfamide|mesh-list
64447061|NCT01946529|Bevacizumab|bevacizumab|mesh-list
64447062|NCT01946529|Doxorubicin|doxorubicin|mesh-list
64356527|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
64356528|NCT03398473|Hematinics|hematinics|mesh-ancestor
64356530|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
64356531|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356532|NCT04535791|Vitamin D|vitamin d|mesh-list
64356533|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
64356534|NCT04535791|Vitamins|vitamins|mesh-ancestor
64356535|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
64356536|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356537|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64356538|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64356539|NCT03395873|Decitabine|decitabine|mesh-list
64356540|NCT03395873|Avelumab|avelumab|mesh-list
64356541|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64356542|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
64356602|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356603|NCT04928521|Bupivacaine|bupivacaine|mesh-list
64356604|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
64356605|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
64356607|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356608|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
64356609|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356610|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
64356611|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
64356616|NCT03391843|Cetuximab|cetuximab|mesh-list
64447063|NCT01946529|Etoposide|etoposide|mesh-list
64447064|NCT01946529|Vincristine|vincristine|mesh-list
64447065|NCT01946529|Sorafenib|sorafenib|mesh-list
64447066|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447067|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
64625401|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64625402|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64625403|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
64625404|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625405|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625406|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64625407|NCT00002014|Zidovudine|zidovudine|mesh-list
64625408|NCT00002014|Didanosine|didanosine|mesh-list
64625409|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
64625410|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625411|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625412|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625413|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625414|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
64625415|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625416|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625417|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625418|NCT00000334|Buprenorphine|buprenorphine|mesh-list
64625419|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64356624|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356625|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64356736|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
64356737|NCT04249297|Progestins|progestins|mesh-ancestor
64356738|NCT04249297|Hormones|hormones|mesh-ancestor
64356739|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356740|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356741|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
64356799|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64356800|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356801|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356802|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356803|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356804|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64356805|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64356806|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
64356807|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
64356808|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64625420|NCT00000334|Narcotics|narcotics|mesh-ancestor
64625434|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625435|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625436|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
64625437|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625438|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625439|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625440|NCT00002026|Acyclovir|acyclovir|mesh-list
64625441|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
64625442|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625443|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
64625444|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
64625445|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
64625446|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64625447|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64625448|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625449|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447068|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356825|NCT03126461|Ipilimumab|ipilimumab|mesh-list
64356826|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356827|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356828|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64356829|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356831|NCT03394001|Ketorolac|ketorolac|mesh-list
64356832|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64356833|NCT03394001|Lidocaine|lidocaine|mesh-list
64356834|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
64356835|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
64356836|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356837|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356838|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
64356839|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356840|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64356841|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64356842|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64356843|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64356844|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356845|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64356846|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356847|NCT03394001|Analgesics|analgesics|mesh-ancestor
64356848|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64625450|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625451|NCT00002032|Rifabutin|rifabutin|mesh-list
64625452|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625453|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625454|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64625455|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
64625456|NCT01229527|Meperidine|meperidine|mesh-list
64625457|NCT01229527|Remifentanil|remifentanil|mesh-list
64625458|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64625459|NCT01229527|Narcotics|narcotics|mesh-ancestor
64625460|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356849|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356850|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64356851|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356852|NCT03393767|Ranibizumab|ranibizumab|mesh-list
64356853|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64356854|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64356855|NCT03393767|Growth Substances|growth substances|mesh-ancestor
64356856|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356857|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
64356858|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356860|NCT03389321|Riociguat|riociguat|mesh-list
64356861|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64356862|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64356863|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356864|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64356865|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
64356866|NCT03393377|Valsartan|valsartan|mesh-list
64356867|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64356902|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64356903|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356904|NCT00664937|Montelukast|montelukast|mesh-list
64356914|NCT00540839|Fluticasone|fluticasone|mesh-list
64625461|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625462|NCT01229527|Analgesics|analgesics|mesh-ancestor
64625463|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
64625464|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625465|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64625466|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
64625467|NCT02723162|Varenicline|varenicline|mesh-list
64625468|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64625469|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64625470|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64625471|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
64625472|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625473|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625474|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625475|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
64625476|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625478|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
64625479|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64625480|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
64625481|NCT02723162|Protective Agents|protective agents|mesh-ancestor
64625482|NCT02723162|Antidotes|antidotes|mesh-ancestor
64625483|NCT00000358|Lofexidine|lofexidine|mesh-list
64625484|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64625485|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64625486|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625487|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
64356987|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64356988|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356989|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356990|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
64356991|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
64356992|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
64356993|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
64356994|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356995|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356996|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64356997|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64356998|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356999|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64357000|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64357001|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
64357002|NCT03395665|Estradiol|estradiol|mesh-list
64357003|NCT03395665|Progesterone|progesterone|mesh-list
64357004|NCT03395665|Estrogens|estrogens|mesh-ancestor
64357005|NCT03395665|Hormones|hormones|mesh-ancestor
64357006|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357011|NCT00535405|Ezetimibe|ezetimibe|mesh-list
64625488|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625489|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64625490|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64625491|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64625492|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
64625493|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625494|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625495|NCT00000376|Desipramine|desipramine|mesh-list
64625496|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64625497|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
64625498|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64625499|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350818|NCT02824679|Scopolamine|scopolamine|mesh-list
64447083|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447084|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64447085|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
64447086|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
64447087|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
64625500|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625501|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64625502|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64625504|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64625505|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625506|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357018|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357019|NCT03390595|Gemcitabine|gemcitabine|mesh-list
64357020|NCT03390595|Carboplatin|carboplatin|mesh-list
64357021|NCT03390595|Avelumab|avelumab|mesh-list
64357022|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357023|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64357024|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
64357025|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357026|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
64357027|NCT03390595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357028|NCT03390595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357029|NCT03390595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64357030|NCT03390595|Immunologic Factors|immunologic factors|mesh-ancestor
64357034|NCT00271817|Niacinamide|niacinamide|mesh-list
64357052|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64357053|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357054|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357055|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64357056|NCT03388541|Analgesics|analgesics|mesh-ancestor
64357057|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
64357058|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357059|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64357060|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64625508|NCT02143388|Capecitabine|capecitabine|mesh-list
64625509|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625510|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64625511|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
64625512|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625513|NCT00001228|Interferons|interferons|mesh-list
64625514|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625515|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
64625516|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625517|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64625518|NCT02483936|Olmesartan|olmesartan|mesh-list
64625519|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64357065|NCT00092989|Montelukast|montelukast|mesh-list
64357066|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64357067|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
64357068|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64357069|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
64357070|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357071|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357072|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64357073|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64357074|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357075|NCT03388463|Omeprazole|omeprazole|mesh-list
64357076|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64357077|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64357078|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64357079|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357080|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357081|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
64625520|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
64625521|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64625522|NCT02483936|Diuretics|diuretics|mesh-ancestor
64625523|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
64625524|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625525|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64625526|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625527|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625528|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64625529|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64625530|NCT00002038|Fluconazole|fluconazole|mesh-list
64625531|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
64625532|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625533|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64625534|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64625535|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625536|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625537|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64357111|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357112|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357113|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64357114|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64357115|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
64357116|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357118|NCT03126071|Bevacizumab|bevacizumab|mesh-list
64357128|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
64357129|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64357130|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64357131|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357132|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357133|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64357135|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64357136|NCT03392051|Clopidogrel|clopidogrel|mesh-list
64357137|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64357138|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64357158|NCT03386591|Naloxone|naloxone|mesh-list
64625538|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
64625539|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625540|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625541|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64625542|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64625543|NCT01894334|Edaravone|edaravone|mesh-list
64625544|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
64625545|NCT01894334|Urinastatin|urinastatin|mesh-list
64625546|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64625547|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64625548|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625549|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
64625551|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64625552|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
64625553|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64625554|NCT01894334|Protective Agents|protective agents|mesh-ancestor
64625555|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625556|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64625557|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64625558|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
64357159|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64357160|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357163|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
64357193|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64357194|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64357195|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357196|NCT03268811|Teduglutide|teduglutide|mesh-list
64357198|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64357199|NCT03268811|Protective Agents|protective agents|mesh-ancestor
64357200|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357201|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
64357202|NCT03385967|Ropivacaine|ropivacaine|mesh-list
64357203|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64357204|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625559|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625560|NCT00002044|Zidovudine|zidovudine|mesh-list
64625561|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
64625562|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625563|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625564|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625565|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625566|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
64625567|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625568|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625569|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625570|NCT00001282|Zidovudine|zidovudine|mesh-list
64625571|NCT00001282|Interleukin-2|interleukin-2|mesh-list
64625572|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625573|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64625574|NCT00001282|Analgesics|analgesics|mesh-ancestor
64625575|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
64625576|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625577|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625578|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
64625579|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625580|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625581|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625582|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625583|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
64625584|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625585|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625586|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625587|NCT02478320|Ilorasertib|ilorasertib|mesh-list
64625588|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625589|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64625590|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625591|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625592|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
64625593|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64625594|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625595|NCT00001300|Doxorubicin|doxorubicin|mesh-list
64625596|NCT00001300|Ifosfamide|ifosfamide|mesh-list
64625597|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64625598|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625599|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64625600|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64625601|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625602|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625603|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64625604|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
64625605|NCT00000400|Alendronate|alendronate|mesh-list
64625606|NCT00000400|Teriparatide|teriparatide|mesh-list
64625607|NCT00000400|Hormones|hormones|mesh-list
64357236|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357237|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64357238|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
64357239|NCT02732015|Hormones|hormones|mesh-ancestor
64357240|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357241|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64357253|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
64625608|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
64447098|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64625620|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
64625621|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625622|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625623|NCT00002050|Thymopentin|thymopentin|mesh-list
64625624|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64625625|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
64625626|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625627|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
64625628|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64625629|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
64625630|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625631|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
64625632|NCT04389866|Protective Agents|protective agents|mesh-ancestor
64625633|NCT00000412|Alendronate|alendronate|mesh-list
64625634|NCT00000412|Calcitriol|calcitriol|mesh-list
64625635|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64357256|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
64357257|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357258|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64357259|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64357260|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357261|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64357262|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64357263|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64357264|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
64357265|NCT02732015|Protective Agents|protective agents|mesh-ancestor
64357266|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64357267|NCT02520245|Cemiplimab|cemiplimab|mesh-list
64357268|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64357269|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357270|NCT03537833|Pemetrexed|pemetrexed|mesh-list
64357271|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357272|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357273|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357274|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64357275|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64357276|NCT03439085|Durvalumab|durvalumab|mesh-list
64357277|NCT03439085|Interleukin-12|interleukin-12|mesh-list
64357278|NCT03439085|Vaccines|vaccines|mesh-list
64357279|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
64357280|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64625636|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625637|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64625638|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64625639|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625640|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625641|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64625642|NCT00000412|Vitamins|vitamins|mesh-ancestor
64625643|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
64357289|NCT03439085|Growth Substances|growth substances|mesh-ancestor
64357290|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
64357291|NCT01964807|Nicotine|nicotine|mesh-list
64357292|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64357293|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
64357294|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357295|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357296|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64357297|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64357298|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
64357299|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357300|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357301|NCT01164995|Carboplatin|carboplatin|mesh-list
64357302|NCT01164995|Adavosertib|adavosertib|mesh-list
64357335|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64357336|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64357337|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357338|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357340|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
64357341|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357342|NCT04448717|Antibodies|antibodies|mesh-list
64357343|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
64357344|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357345|NCT05174195|Desogestrel|desogestrel|mesh-list
64357346|NCT05174195|Etonogestrel|etonogestrel|mesh-list
64357347|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64357348|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64357349|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64357350|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
64357356|NCT05174195|Hormones|hormones|mesh-ancestor
64625644|NCT00002056|Pentamidine|pentamidine|mesh-list
64625645|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
64625646|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625647|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64625648|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64625649|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64625650|NCT03110562|Dexamethasone|dexamethasone|mesh-list
64625651|NCT03110562|Bortezomib|bortezomib|mesh-list
64625652|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64625653|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
64625654|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
64625655|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625656|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625657|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64625658|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
64625659|NCT03110562|Hormones|hormones|mesh-ancestor
64625660|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625661|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64625662|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357358|NCT05238727|Mepivacaine|mepivacaine|mesh-list
64357359|NCT05238727|Carticaine|carticaine|mesh-list
64357360|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
64357361|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
64357362|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357363|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357364|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
64357365|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357366|NCT03754153|Atropine|atropine|mesh-list
64357367|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64357368|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64357369|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64357370|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
64357371|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357372|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357373|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64357374|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
64357375|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
64357376|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
64357377|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64357378|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64357404|NCT02520817|Vitamins|vitamins|mesh-list
64357487|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64357488|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64357489|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64357490|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
64625663|NCT00380614|Lamivudine|lamivudine|mesh-list
64625669|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625670|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625671|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625673|NCT00000430|Estrogens|estrogens|mesh-list
64625674|NCT00000430|Progestins|progestins|mesh-list
64625675|NCT00000430|Hormones|hormones|mesh-ancestor
64625676|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625677|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625678|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64625679|NCT00380770|Lamivudine|lamivudine|mesh-list
64625680|NCT00380770|Stavudine|stavudine|mesh-list
64625681|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
64625682|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625683|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625684|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625685|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625686|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
64625687|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625688|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625689|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625691|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
64625692|NCT01231399|Leucovorin|leucovorin|mesh-list
64625693|NCT01231399|Fluorouracil|fluorouracil|mesh-list
64625694|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
64625695|NCT01231399|Everolimus|everolimus|mesh-list
64625696|NCT01231399|Calcium|calcium|mesh-list
64625697|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
64625698|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64625699|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625700|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64625701|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
64357551|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357552|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357553|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64357554|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64357555|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64357556|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
64357557|NCT03378713|Testosterone|testosterone|mesh-list
64357558|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
64357559|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
64357560|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64357561|NCT03378713|Androgens|androgens|mesh-ancestor
64357562|NCT03378713|Hormones|hormones|mesh-ancestor
64357563|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357564|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357565|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64357566|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357567|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
64625702|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625703|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64625704|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625705|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64625706|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
64625707|NCT01231399|Antidotes|antidotes|mesh-ancestor
64625708|NCT01231399|Protective Agents|protective agents|mesh-ancestor
64625709|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
64625710|NCT01231399|Vitamins|vitamins|mesh-ancestor
64625711|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
64625712|NCT00002062|Spiramycin|spiramycin|mesh-list
64625713|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625714|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625715|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
64625716|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64625717|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64357580|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357581|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357582|NCT03381833|Hepcidins|hepcidins|mesh-list
64357583|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357584|NCT02976337|Naloxone|naloxone|mesh-list
64357585|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64357681|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357682|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357684|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64357685|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357686|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
64357687|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357688|NCT03374345|Mitogens|mitogens|mesh-ancestor
64357689|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
64357690|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357691|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
64357692|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64357693|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357694|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
64357695|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
64357696|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357697|NCT02814695|Protective Agents|protective agents|mesh-ancestor
64357698|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357699|NCT02814695|Vitamins|vitamins|mesh-ancestor
64357700|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
64357701|NCT03386305|Tacrolimus|tacrolimus|mesh-list
64357702|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64357703|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
64357704|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625718|NCT01231633|Dexamethasone|dexamethasone|mesh-list
64625719|NCT01231633|Bevacizumab|bevacizumab|mesh-list
64625720|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64625721|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625722|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64625723|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64351041|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
64625724|NCT01231633|Growth Substances|growth substances|mesh-ancestor
64625725|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625726|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
64625727|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64625728|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
64625729|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
64625730|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625731|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64625732|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
64625733|NCT01231633|Hormones|hormones|mesh-ancestor
64625734|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625735|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64625736|NCT00000442|Naltrexone|naltrexone|mesh-list
64625737|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64357707|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357708|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64357709|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357710|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
64357711|NCT05237323|Azathioprine|azathioprine|mesh-list
64357712|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64357713|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357714|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64357715|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
64357716|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357717|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357718|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357719|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625738|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64625739|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625740|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
64625741|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625742|NCT00002068|Fluconazole|fluconazole|mesh-list
64625743|NCT00002068|Amphotericin B|amphotericin b|mesh-list
64625744|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64625745|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
64625746|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625747|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64625748|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64625749|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625750|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625751|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64625752|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
64625753|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357748|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357749|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64357751|NCT03380689|Growth Substances|growth substances|mesh-ancestor
64357752|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357753|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
64357754|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64357755|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64357756|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357757|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357758|NCT03380533|Buprenorphine|buprenorphine|mesh-list
64357759|NCT03380533|Tramadol|tramadol|mesh-list
64357760|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64357761|NCT03380533|Narcotics|narcotics|mesh-ancestor
64357762|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357763|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357764|NCT03380533|Analgesics|analgesics|mesh-ancestor
64357765|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
64357766|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357767|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64357768|NCT03386149|Loxoprofen|loxoprofen|mesh-list
64357769|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64357770|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64357771|NCT03386149|Analgesics|analgesics|mesh-ancestor
64357815|NCT04436965|Cisplatin|cisplatin|mesh-list
64625754|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625755|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64447113|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64447114|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64447115|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447116|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447117|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447118|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
64447119|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64447120|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64447121|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447123|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64447124|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64625756|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64625758|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64625759|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64625760|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625761|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64625762|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64357825|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357827|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
64357828|NCT03090997|Resveratrol|resveratrol|mesh-list
64357829|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
64357830|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357831|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
64357832|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357833|NCT03090997|Protective Agents|protective agents|mesh-ancestor
64357834|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357835|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64357836|NCT04446091|Irinotecan|irinotecan|mesh-list
64357837|NCT04446091|Apatinib|apatinib|mesh-list
64357838|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64357849|NCT04445935|Bivalirudin|bivalirudin|mesh-list
64625763|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64625764|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
64625765|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625766|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625767|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64625768|NCT00000448|Naltrexone|naltrexone|mesh-list
64625769|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64625770|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64625771|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625772|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
64357868|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357869|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357870|NCT02051309|Guanfacine|guanfacine|mesh-list
64357871|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64357872|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64357873|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64357874|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64357875|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
64357876|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357877|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357878|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357879|NCT00372073|Roscovitine|roscovitine|mesh-list
64357880|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357881|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
64357882|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357883|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357884|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357885|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357886|NCT03373409|Albuterol|albuterol|mesh-list
64357887|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64357888|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
64357889|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357890|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357891|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64357892|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
64625773|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625774|NCT00001318|Interferons|interferons|mesh-list
64625775|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
64625776|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625777|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
64625778|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625779|NCT00002074|Fluconazole|fluconazole|mesh-list
64625780|NCT00002074|Amphotericin B|amphotericin b|mesh-list
64625781|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64625782|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
64625783|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625784|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64625785|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64625786|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625787|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625788|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64625789|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
64357956|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64357957|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64357958|NCT04445311|Ivermectin|ivermectin|mesh-list
64357959|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64357960|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357961|NCT03384121|Rifampin|rifampin|mesh-list
64357962|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64357963|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
64357964|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357965|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357966|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
64358003|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64358004|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64358005|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358006|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358007|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358008|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64625790|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64625791|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625792|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64625793|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64625794|NCT00002074|Amebicides|amebicides|mesh-ancestor
64625795|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64625796|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64625797|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625798|NCT00001354|Zidovudine|zidovudine|mesh-list
64625799|NCT00001354|Interleukin-2|interleukin-2|mesh-list
64625800|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625801|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64625803|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
64625804|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625805|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625806|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
64625807|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625808|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64447125|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447126|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64447127|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64447128|NCT01504204|Analgesics|analgesics|mesh-ancestor
64447129|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
64447130|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447131|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447132|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358032|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64358033|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
64358034|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64358035|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64358036|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358037|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64358038|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
64358039|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
64358040|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
64358041|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64358042|NCT03383185|Progestins|progestins|mesh-list
64358043|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64625809|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625810|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625811|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
64625812|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625813|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625814|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625815|NCT00000454|Nicotine|nicotine|mesh-list
64625816|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64625817|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
64625818|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625819|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625820|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64625821|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64625822|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
64625823|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625824|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625825|NCT00002080|Rifabutin|rifabutin|mesh-list
64625826|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64625827|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625828|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64625829|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
64625830|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
64625831|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64447138|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625833|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
64625834|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625835|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64625836|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358081|NCT03377335|Metformin|metformin|mesh-list
64358082|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
64358083|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358084|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358085|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64358086|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358087|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
64358088|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
64358089|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64358090|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64358091|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
64358092|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358093|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358094|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358095|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625837|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625838|NCT00000496|Aspirin|aspirin|mesh-list
64625839|NCT00000496|Dipyridamole|dipyridamole|mesh-list
64625840|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64625841|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64625842|NCT00000496|Analgesics|analgesics|mesh-ancestor
64625843|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
64625844|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625845|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625846|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64625847|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64625848|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64625849|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64625850|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625851|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64625852|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64625853|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625854|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
64625855|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64625856|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
64625857|NCT00002086|Interferons|interferons|mesh-list
64447139|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447140|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64447141|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64447142|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64447143|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447144|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447145|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447146|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64447147|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64447148|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
64625858|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
64625859|NCT00002086|Zidovudine|zidovudine|mesh-list
64625860|NCT00002086|Zalcitabine|zalcitabine|mesh-list
64625861|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625862|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
64625863|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625864|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
64625865|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625866|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
64625867|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625868|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625869|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625870|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625871|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625872|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64625873|NCT01151449|R04929097|r04929097|mesh-list
64625874|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625875|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358123|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
64358124|NCT04445779|Ubiquinone|ubiquinone|mesh-list
64358125|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
64358126|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
64358127|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358128|NCT04445779|Vitamins|vitamins|mesh-ancestor
64358129|NCT03377101|Fulvestrant|fulvestrant|mesh-list
64358130|NCT03377101|Palbociclib|palbociclib|mesh-list
64358131|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64358132|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625877|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
64625878|NCT00001384|Doxorubicin|doxorubicin|mesh-list
64625879|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64625880|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64625881|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625882|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
64625883|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
64625884|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
64625885|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625886|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64625887|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
64625888|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447153|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
64447154|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447155|NCT02140645|Linagliptin|linagliptin|mesh-list
64447619|NCT04798469|Hormones|hormones|mesh-ancestor
64625889|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447642|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625890|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64625891|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
64625892|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64625893|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64625894|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64625895|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64625896|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625897|NCT01151761|Gemcitabine|gemcitabine|mesh-list
64625899|NCT01151761|Carboplatin|carboplatin|mesh-list
64625900|NCT01151761|Fluorouracil|fluorouracil|mesh-list
64625901|NCT01151761|Capecitabine|capecitabine|mesh-list
64625902|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625903|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64625904|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
64625905|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625906|NCT01151761|Antiviral Agents|antiviral agents|mesh-ancestor
64625907|NCT01151761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625908|NCT01151761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625909|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64625910|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
64625911|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625912|NCT00002092|Cimetidine|cimetidine|mesh-list
64625913|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64625914|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64625915|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64625916|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
64625917|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
64625918|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625919|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625920|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625921|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64358202|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358203|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358204|NCT03372265|Ropivacaine|ropivacaine|mesh-list
64358205|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
64358206|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
64358207|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358208|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358211|NCT03372109|Calcium|calcium|mesh-list
64358241|NCT02520115|Dexamethasone|dexamethasone|mesh-list
64358242|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
64358243|NCT02520115|Valproic Acid|valproic acid|mesh-list
64358244|NCT02520115|Ichthammol|ichthammol|mesh-list
64358245|NCT02520115|BB 1101|bb 1101|mesh-list
64447643|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625922|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64447644|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
64447645|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447697|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447698|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447699|NCT02241785|Natalizumab|natalizumab|mesh-list
64447700|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
64447701|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447702|NCT02241551|Gemcitabine|gemcitabine|mesh-list
64625923|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447703|NCT02241551|Paclitaxel|paclitaxel|mesh-list
64447920|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
64625924|NCT02122562|Ketamine|ketamine|mesh-list
64625925|NCT02122562|Analgesics|analgesics|mesh-ancestor
64625926|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
64625927|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625928|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625929|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64625930|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64625931|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
64625932|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
64625933|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64625934|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64625935|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64625936|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625937|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625938|NCT00002098|Didanosine|didanosine|mesh-list
64625939|NCT00002098|Lentinan|lentinan|mesh-list
64625940|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
64358246|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358247|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
64358248|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
64358249|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358250|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358251|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64358252|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
64358254|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358255|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64358256|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358257|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
64358258|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358259|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358260|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
64358261|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
64358262|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358263|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
64358264|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64358265|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358266|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64358267|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
64625941|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625942|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64625943|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64625944|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625945|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
64625946|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64625947|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64625948|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64351270|NCT03468439|Phenol|phenol|mesh-list
64625949|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64625950|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
64625951|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625952|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625954|NCT02705300|Tocotrienols|tocotrienols|mesh-list
64625955|NCT02705300|Vitamin E|vitamin e|mesh-list
64625956|NCT02705300|Tocopherols|tocopherols|mesh-list
64625957|NCT02705300|Fluorouracil|fluorouracil|mesh-list
64625958|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
64625959|NCT02705300|Irinotecan|irinotecan|mesh-list
64625960|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
64625961|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625962|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
64625963|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625964|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64625965|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625966|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64625967|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
64625968|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64625969|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64625970|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64625971|NCT02705300|Antidotes|antidotes|mesh-ancestor
64625972|NCT02705300|Protective Agents|protective agents|mesh-ancestor
64625973|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
64625974|NCT02705300|Vitamins|vitamins|mesh-ancestor
64448047|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64625975|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
64625976|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
64448048|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64448049|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64625977|NCT01196377|Albuterol|albuterol|mesh-list
64358306|NCT03371173|Hematinics|hematinics|mesh-ancestor
64358307|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
64358308|NCT03371095|Infliximab|infliximab|mesh-list
64358309|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64358310|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
64358311|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358312|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64358313|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64358314|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
64358315|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358316|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358317|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64358318|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
64358322|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
64358366|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64358368|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
64358369|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
64448050|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448052|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448053|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448054|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64448055|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448056|NCT01862991|Digoxin|digoxin|mesh-list
64625979|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
64625980|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64625981|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64625982|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64625983|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
64625984|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
64625985|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64625986|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64625987|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64625988|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64625989|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
64625990|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64625991|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64625992|NCT00001426|Paclitaxel|paclitaxel|mesh-list
64625993|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
64625994|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64625995|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64625996|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
64625997|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
64625998|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
64625999|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448057|NCT01862991|Misoprostol|misoprostol|mesh-list
64358387|NCT03370159|Protective Agents|protective agents|mesh-ancestor
64358388|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358389|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
64358390|NCT03370159|Vitamins|vitamins|mesh-ancestor
64358391|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
64358392|NCT04522297|Octreotide|octreotide|mesh-list
64358393|NCT04522297|Epinephrine|epinephrine|mesh-list
64358394|NCT04522297|Midodrine|midodrine|mesh-list
64358534|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64358535|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358536|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358537|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64358538|NCT04523623|Narcotics|narcotics|mesh-ancestor
64358539|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358540|NCT03368131|Capecitabine|capecitabine|mesh-list
64358541|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
64358542|NCT03368131|Trastuzumab|trastuzumab|mesh-list
64358543|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64358544|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
64358545|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358546|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448058|NCT01862991|Mifepristone|mifepristone|mesh-list
64448059|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64448060|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
64448061|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64448062|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448111|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
64448112|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448113|NCT02202161|Metformin|metformin|mesh-list
64448114|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64448115|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64626000|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626001|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
64626002|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626003|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626004|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64626005|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
64626006|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64626007|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
64626008|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626009|NCT00002104|Thalidomide|thalidomide|mesh-list
64626010|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626011|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
64626012|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626013|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
64626014|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64626015|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626016|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64626017|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64626018|NCT00002104|Growth Substances|growth substances|mesh-ancestor
64626019|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
64626020|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626021|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
64626022|NCT00001438|Tretinoin|tretinoin|mesh-list
64626023|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626024|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
64626025|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626026|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
64358584|NCT04521049|Hormones|hormones|mesh-ancestor
64358585|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358586|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358587|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64358588|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
64358589|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358590|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358592|NCT02267343|Nivolumab|nivolumab|mesh-list
64358637|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
64358638|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358639|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64358640|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64358641|NCT03360955|Anesthetics|anesthetics|mesh-list
64358642|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358643|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358644|NCT00584025|Levetiracetam|levetiracetam|mesh-list
64358648|NCT01735461|Calcium|calcium|mesh-list
64626027|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626028|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
64626029|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626030|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64626031|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626032|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626033|NCT00000574|Ibuprofen|ibuprofen|mesh-list
64626034|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64626035|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64626036|NCT00000574|Analgesics|analgesics|mesh-ancestor
64626037|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
64626038|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626039|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626040|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626041|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626042|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64626043|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448207|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448208|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64448209|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448210|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
64448211|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448418|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
64448419|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
64448420|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64448431|NCT01499368|Famotidine|famotidine|mesh-list
64448432|NCT01499368|Lafutidine|lafutidine|mesh-list
64382098|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64382126|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382127|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
64382128|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
64382129|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64382130|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64382131|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382132|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382133|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382134|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382135|NCT02424695|Gabapentin|gabapentin|mesh-list
64382136|NCT02424695|Analgesics|analgesics|mesh-ancestor
64626044|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626045|NCT00002110|Zidovudine|zidovudine|mesh-list
64626046|NCT00002110|Cysteamine|cysteamine|mesh-list
64626047|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
64626048|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626049|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626050|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626051|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626052|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
64358650|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358651|NCT01735461|Antacids|antacids|mesh-ancestor
64358652|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358653|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64358654|NCT01595841|Sirolimus|sirolimus|mesh-list
64358655|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64358656|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358657|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64358658|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626053|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626054|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626055|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626056|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64626057|NCT00001450|Paclitaxel|paclitaxel|mesh-list
64626058|NCT00001450|Cisplatin|cisplatin|mesh-list
64626059|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64626060|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626061|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
64626062|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
64626063|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
64626064|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626065|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
64626066|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64626067|NCT00000580|Antibodies|antibodies|mesh-list
64626068|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
64626069|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64626070|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
64626071|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626072|NCT00002116|Cidofovir|cidofovir|mesh-list
64626073|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
64626074|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626075|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626076|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626077|NCT00001498|Leucovorin|leucovorin|mesh-list
64626078|NCT00001498|Paclitaxel|paclitaxel|mesh-list
64626079|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
64626080|NCT00001498|Doxorubicin|doxorubicin|mesh-list
64626081|NCT00001498|Fluorouracil|fluorouracil|mesh-list
64626082|NCT00001498|Methotrexate|methotrexate|mesh-list
64626083|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64358670|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358671|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
64358672|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358673|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64358674|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64358675|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64358676|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358677|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358679|NCT05405049|Narcotics|narcotics|mesh-ancestor
64358680|NCT05405049|Analgesics|analgesics|mesh-ancestor
64358681|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64358682|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64448433|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64448434|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448435|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64448437|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448438|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64448439|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
64448440|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
64448441|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448442|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448443|NCT01835145|Temozolomide|temozolomide|mesh-list
64448444|NCT01835145|Dacarbazine|dacarbazine|mesh-list
64448445|NCT01835145|Imidazole|imidazole|mesh-list
64448446|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64448447|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
64448448|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448504|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64448505|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
64626084|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626085|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
64626086|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
64626087|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
64626088|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626089|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626090|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
64626091|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626092|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626093|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64626094|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
64626095|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64358710|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64358711|NCT02801097|Irinotecan|irinotecan|mesh-list
64358712|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64358713|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64358714|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358715|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358716|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358717|NCT03367195|Omeprazole|omeprazole|mesh-list
64358718|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64358719|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64358720|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64358721|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358722|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358723|NCT02672475|Paclitaxel|paclitaxel|mesh-list
64626096|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64626097|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64626098|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64626099|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626100|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
64626101|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64626102|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64626103|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
64626104|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64626105|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626106|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64626107|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626108|NCT00001498|Antidotes|antidotes|mesh-ancestor
64626109|NCT00001498|Protective Agents|protective agents|mesh-ancestor
64626110|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
64626111|NCT00001498|Vitamins|vitamins|mesh-ancestor
64626112|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
64626113|NCT00001504|Tretinoin|tretinoin|mesh-list
64626114|NCT00001504|Alitretinoin|alitretinoin|mesh-list
64626115|NCT00001504|Isotretinoin|isotretinoin|mesh-list
64626116|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626117|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
64626118|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626119|NCT02688140|Cytarabine|cytarabine|mesh-list
64626120|NCT02688140|Methotrexate|methotrexate|mesh-list
64626121|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
64626122|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
64626123|NCT02688140|Idarubicin|idarubicin|mesh-list
64358744|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358745|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64358746|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
64358747|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64358748|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64358749|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64358750|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358751|NCT05126901|Ferric maltol|ferric maltol|mesh-list
64358752|NCT05126901|Hematinics|hematinics|mesh-ancestor
64358753|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
64358754|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626124|NCT02688140|Tretinoin|tretinoin|mesh-list
64626125|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
64626126|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64626127|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
64626128|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64626129|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626130|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64626131|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
64626132|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626133|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626134|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626135|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448507|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64448508|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64448509|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
64448510|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448511|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64448513|NCT02201771|Ticagrelor|ticagrelor|mesh-list
64448514|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64448515|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64448516|NCT02201771|Analgesics|analgesics|mesh-ancestor
64626136|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64626137|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626138|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
64626139|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626140|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626141|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
64626142|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626144|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
64626145|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626146|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64626147|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64626148|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64626149|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
64626150|NCT05456490|Bupivacaine|bupivacaine|mesh-list
64626151|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
64626152|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
64626153|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64626154|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626155|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
64626156|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626157|NCT00002122|Azithromycin|azithromycin|mesh-list
64626158|NCT00002122|Rifabutin|rifabutin|mesh-list
64626159|NCT00002122|Fluconazole|fluconazole|mesh-list
64626160|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64626161|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626162|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
64626163|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64626164|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64626165|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626166|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358788|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
64358835|NCT05124951|Carboplatin|carboplatin|mesh-list
64358836|NCT05124951|Etoposide|etoposide|mesh-list
64358837|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
64358838|NCT05124951|Ifosfamide|ifosfamide|mesh-list
64358839|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358840|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64358841|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64358842|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64626167|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64626168|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
64626169|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626170|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626171|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64626172|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64626173|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64626174|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
64626175|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64351497|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64626176|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64626177|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626178|NCT00001534|Losartan|losartan|mesh-list
64626179|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64626180|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64626181|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64626182|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64626183|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626185|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
64626186|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64626187|NCT01027559|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64626188|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64626189|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358851|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358852|NCT05124717|Metformin|metformin|mesh-list
64358853|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358854|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358855|NCT04139655|Colchicine|colchicine|mesh-list
64358856|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
64358857|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626190|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626191|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448629|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
64448631|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626192|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
64626193|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626195|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64626196|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
64626197|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626198|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626199|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626200|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626201|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626203|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64626204|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626205|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
64626206|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
64626207|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
64626208|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626209|NCT00000628|Zidovudine|zidovudine|mesh-list
64626210|NCT00000628|L-697661|l-697661|mesh-list
64626211|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
64626212|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626213|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626214|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626215|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626216|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
64626217|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626218|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626219|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626220|NCT00000634|Nevirapine|nevirapine|mesh-list
64626221|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626222|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626223|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626224|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626225|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
64626226|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626227|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626228|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626229|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64626230|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64626231|NCT01661790|Bevacizumab|bevacizumab|mesh-list
64626232|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64626233|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626234|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64358911|NCT03684213|Vitamins|vitamins|mesh-ancestor
64358922|NCT03365479|Iloprost|iloprost|mesh-list
64358923|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64358924|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
64358925|NCT03355027|Atorvastatin|atorvastatin|mesh-list
64358928|NCT03355027|Ezetimibe|ezetimibe|mesh-list
64358961|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64358962|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64358963|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358965|NCT02519335|Protective Agents|protective agents|mesh-ancestor
64626235|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64626236|NCT01661790|Growth Substances|growth substances|mesh-ancestor
64626237|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626238|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64626239|NCT00002134|Ganciclovir|ganciclovir|mesh-list
64626240|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64626241|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
64626242|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626243|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626244|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626245|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626246|NCT00985907|Bortezomib|bortezomib|mesh-list
64626247|NCT00985907|Melphalan|melphalan|mesh-list
64626248|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64626249|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448745|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
64448746|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64448747|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64448748|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64626250|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64626252|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626253|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64626254|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626255|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
64626256|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626257|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64626258|NCT00002140|Azithromycin|azithromycin|mesh-list
64626259|NCT00002140|Clarithromycin|clarithromycin|mesh-list
64626260|NCT00002140|Ethambutol|ethambutol|mesh-list
64626261|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64626262|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626263|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64626264|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626265|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626266|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64626267|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64359204|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
64359205|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64359206|NCT03353857|Norethindrone|norethindrone|mesh-list
64359207|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
64359208|NCT03353857|Desogestrel|desogestrel|mesh-list
64359209|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64359210|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64359211|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359212|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359213|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64359220|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
64359270|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64359271|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
64359272|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
64359273|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359274|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64359275|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64359276|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64626268|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
64626269|NCT00000658|Leucovorin|leucovorin|mesh-list
64626270|NCT00000658|Cytarabine|cytarabine|mesh-list
64626271|NCT00000658|Dexamethasone|dexamethasone|mesh-list
64626272|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
64626273|NCT00000658|Doxorubicin|doxorubicin|mesh-list
64626274|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64626275|NCT00000658|Methotrexate|methotrexate|mesh-list
64626276|NCT00000658|Vincristine|vincristine|mesh-list
64626277|NCT00000658|Bleomycin|bleomycin|mesh-list
64448757|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626278|NCT00000658|Allopurinol|allopurinol|mesh-list
64626279|NCT00000658|Sargramostim|sargramostim|mesh-list
64626280|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
64626281|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626282|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
64626283|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626284|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626285|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64626286|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
64626287|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448766|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626288|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448767|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448768|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448769|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448770|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448771|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448772|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
64448773|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64448774|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64448797|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64448798|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
64626289|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64626290|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626291|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
64359597|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
64359703|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
64359704|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359705|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359706|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
64359707|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64359708|NCT03121963|Narcotics|narcotics|mesh-ancestor
64359756|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64359768|NCT04507165|Anesthetics|anesthetics|mesh-list
64359769|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359770|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359771|NCT04507165|Narcotics|narcotics|mesh-ancestor
64359772|NCT04507165|Analgesics|analgesics|mesh-ancestor
64359773|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
64359774|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359775|NCT04475991|Maraviroc|maraviroc|mesh-list
64626292|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
64626293|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626294|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64626295|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
64626296|NCT00000658|Hormones|hormones|mesh-ancestor
64626297|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626298|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64626299|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64626300|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64626301|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64626302|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626303|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64626304|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
64626305|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64626306|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64626307|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
64626308|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626309|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64626310|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626311|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
64626312|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626313|NCT00000658|Antidotes|antidotes|mesh-ancestor
64626314|NCT00000658|Protective Agents|protective agents|mesh-ancestor
64626315|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
64626316|NCT00000658|Vitamins|vitamins|mesh-ancestor
64626317|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
64626318|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64626319|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
64626320|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
64626321|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
64626323|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64626324|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
64626325|NCT02684474|HBOC 201|hboc 201|mesh-list
64626326|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
64626327|NCT01027793|Tretinoin|tretinoin|mesh-list
64626328|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626329|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
64626330|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626331|NCT00002146|Foscarnet|foscarnet|mesh-list
64448977|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
64448978|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448979|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64448980|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64448981|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
64448982|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64448983|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
64448984|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64448985|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448986|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448987|NCT01630811|Quinidine|quinidine|mesh-list
64448988|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
64448994|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448995|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448996|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64626332|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64626333|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
64626334|NCT00002146|Analgesics|analgesics|mesh-ancestor
64626335|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
64626336|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626337|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626338|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
64626339|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64626340|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64626341|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
64626342|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64626343|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64626344|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626345|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64626346|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
64626347|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64626348|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
64626349|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626350|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626351|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626352|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626353|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
64626354|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64626355|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64626356|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626358|NCT04389554|Coagulants|coagulants|mesh-ancestor
64626359|NCT03051516|Vaccines|vaccines|mesh-list
64626360|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
64626361|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626362|NCT01029587|Eculizumab|eculizumab|mesh-list
64626363|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64626364|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626365|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
64626366|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626367|NCT00000664|Zidovudine|zidovudine|mesh-list
64626368|NCT00000664|Interleukin-2|interleukin-2|mesh-list
64626369|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626370|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64626371|NCT00000664|Analgesics|analgesics|mesh-ancestor
64626372|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
64626373|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626374|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626375|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
64626376|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626377|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626378|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626379|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626380|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
64626381|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448997|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64448998|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
64448999|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64449000|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
64359818|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359819|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64359820|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359821|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
64359822|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359823|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
64359824|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64359825|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
64359826|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449001|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64449002|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64449003|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449004|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449005|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64449006|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64449007|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
64626382|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626383|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626384|NCT00000670|Zidovudine|zidovudine|mesh-list
64626385|NCT00000670|Probenecid|probenecid|mesh-list
64626386|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
64626387|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626388|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626389|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626390|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626391|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
64626392|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626393|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626394|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64359855|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
64359856|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359857|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359858|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359859|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64359860|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64359861|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
64359872|NCT04505995|Azacitidine|azacitidine|mesh-list
64359885|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359886|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359887|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64359888|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
64359889|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626395|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
64626396|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
64626397|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626398|NCT00000670|Renal Agents|renal agents|mesh-ancestor
64626399|NCT02020070|Ipilimumab|ipilimumab|mesh-list
64626400|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64626401|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626402|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64626403|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359956|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359957|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359959|NCT03347461|Hormones|hormones|mesh-ancestor
64359960|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359961|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359962|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359963|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359964|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359965|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359966|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359967|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64359968|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64359969|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64359970|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64359971|NCT03351517|Tapentadol|tapentadol|mesh-list
64359972|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64359973|NCT03351517|Narcotics|narcotics|mesh-ancestor
64360112|NCT01868451|Vinblastine|vinblastine|mesh-list
64360114|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360130|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64360132|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360133|NCT02517619|Dexamethasone|dexamethasone|mesh-list
64360134|NCT02517619|Prednisolone|prednisolone|mesh-list
64360135|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64360136|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
64360137|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64626404|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
64351721|NCT04602533|Durvalumab|durvalumab|mesh-list
64626405|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64626406|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626407|NCT00000694|Interferons|interferons|mesh-list
64626408|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
64626409|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
64626411|NCT00000694|Sargramostim|sargramostim|mesh-list
64626412|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626413|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
64626414|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626415|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
64626416|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626417|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
64626418|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626419|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626420|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626421|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626422|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626424|NCT01894412|Etanercept|etanercept|mesh-list
64360202|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64360203|NCT04086147|Tenecteplase|tenecteplase|mesh-list
64360204|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64360205|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64360206|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360207|NCT03161223|Azacitidine|azacitidine|mesh-list
64360208|NCT03161223|Durvalumab|durvalumab|mesh-list
64360209|NCT03161223|Romidepsin|romidepsin|mesh-list
64360210|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360211|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
64360213|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360476|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64360477|NCT02505997|Midazolam|midazolam|mesh-list
64360478|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64360487|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
64626425|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64626426|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64626427|NCT01894412|Analgesics|analgesics|mesh-ancestor
64626428|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
64626429|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626430|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626431|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626432|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626433|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64626434|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626435|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
64626437|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
64626438|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626439|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626440|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626441|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626442|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
64626443|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449287|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64626444|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64449288|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449289|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449290|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64626445|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626446|NCT00002164|Nelfinavir|nelfinavir|mesh-list
64626447|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64360826|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
64361248|NCT03335059|Mitomycins|mitomycins|mesh-list
64361427|NCT03332329|Entecavir|entecavir|mesh-list
64361541|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361757|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64361921|NCT02483923|Ropivacaine|ropivacaine|mesh-list
64362048|NCT02483221|Analgesics|analgesics|mesh-ancestor
64362273|NCT03103893|Sirolimus|sirolimus|mesh-list
64626448|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64626449|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
64626450|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626451|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626452|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626453|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626454|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
64626455|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626456|NCT00000706|Zidovudine|zidovudine|mesh-list
64626457|NCT00000706|Quinine|quinine|mesh-list
64626458|NCT00000706|Probenecid|probenecid|mesh-list
64626459|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
64626460|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626461|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626462|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626463|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626464|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
64626465|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626466|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626467|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626468|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
64626469|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64626470|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64626471|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64626472|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626473|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64626474|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626475|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64626476|NCT00000706|Analgesics|analgesics|mesh-ancestor
64626477|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
64351798|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
64626478|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
64626479|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
64362656|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
64363634|NCT00702949|Pregabalin|pregabalin|mesh-list
64363807|NCT05727163|Analgesics|analgesics|mesh-ancestor
64626480|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626481|NCT00000706|Renal Agents|renal agents|mesh-ancestor
64626482|NCT00988325|Oseltamivir|oseltamivir|mesh-list
64626483|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
64626484|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626485|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626486|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626487|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
64626488|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64626489|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
64626490|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626491|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
64626492|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626493|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
64626494|NCT00002302|Hematinics|hematinics|mesh-ancestor
64626495|NCT00002170|Nelfinavir|nelfinavir|mesh-list
64626496|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64449291|NCT02070757|Renal Agents|renal agents|mesh-ancestor
64449292|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64449293|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64449294|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64449295|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449296|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
64449297|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64449298|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449299|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626497|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64626498|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
64626499|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626500|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626501|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626502|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626503|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
64626504|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626505|NCT00002308|Stavudine|stavudine|mesh-list
64626506|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
64626507|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626508|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626509|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626510|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626511|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
64626512|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626513|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64364247|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
64364370|NCT03370835|Metoprolol|metoprolol|mesh-list
64626514|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626515|NCT00000724|Leucovorin|leucovorin|mesh-list
64626516|NCT00000724|Trimetrexate|trimetrexate|mesh-list
64626517|NCT00000724|Calcium|calcium|mesh-list
64626518|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
64626519|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64626520|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626521|NCT00000724|Antidotes|antidotes|mesh-ancestor
64626522|NCT00000724|Protective Agents|protective agents|mesh-ancestor
64626523|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
64626524|NCT00000724|Vitamins|vitamins|mesh-ancestor
64626525|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
64626526|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
64626527|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626528|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64626529|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
64626530|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626531|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626532|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64626533|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626534|NCT00000730|Leucovorin|leucovorin|mesh-list
64626535|NCT00000730|Trimethoprim|trimethoprim|mesh-list
64626536|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64449300|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64449301|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64449302|NCT01625845|Protective Agents|protective agents|mesh-ancestor
64449303|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449304|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
64449305|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64449306|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
64449307|NCT01473940|Gemcitabine|gemcitabine|mesh-list
64449308|NCT01473940|Ipilimumab|ipilimumab|mesh-list
64449309|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64449310|NCT01473940|Antibodies|antibodies|mesh-list
64626537|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
64626538|NCT00000730|Pentamidine|pentamidine|mesh-list
64626539|NCT00000730|Trimetrexate|trimetrexate|mesh-list
64365386|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365563|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366515|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626540|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
64626541|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
64626542|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626543|NCT00000730|Antidotes|antidotes|mesh-ancestor
64626544|NCT00000730|Protective Agents|protective agents|mesh-ancestor
64626545|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
64626546|NCT00000730|Vitamins|vitamins|mesh-ancestor
64626547|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
64626548|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626549|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
64626550|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
64626551|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626552|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64626553|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
64626554|NCT00000730|Hormones|hormones|mesh-ancestor
64626555|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626556|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64626557|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626558|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64626559|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626560|NCT00000730|Renal Agents|renal agents|mesh-ancestor
64626561|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
64626562|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64626563|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64626564|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64626565|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626566|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626567|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64626568|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64626569|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64626570|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
64626571|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64626572|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64626573|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64626575|NCT00002176|Stavudine|stavudine|mesh-list
64626576|NCT00002176|Didanosine|didanosine|mesh-list
64626577|NCT00002176|Nelfinavir|nelfinavir|mesh-list
64626578|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
64626579|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626580|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
64626582|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626583|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626584|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
64626585|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626586|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
64626587|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626588|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626589|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626590|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64449311|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
64449312|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64449313|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
64449314|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449316|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
64449317|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449318|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449319|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
64449320|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449321|NCT01473940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449324|NCT01832727|Dexamethasone|dexamethasone|mesh-list
64626591|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64626592|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
64626594|NCT01990196|Trametinib|trametinib|mesh-list
64626595|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366730|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366846|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
64626596|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64626597|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626598|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626599|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
64626600|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64626601|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626602|NCT00002182|Megestrol|megestrol|mesh-list
64626603|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
64626604|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64626605|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64626606|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64626607|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
64626608|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64300947|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64626609|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626610|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64626611|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64626612|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64626613|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626614|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
64626615|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64626617|NCT00002320|Zidovudine|zidovudine|mesh-list
64626618|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626619|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626620|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626621|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626622|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
64626623|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626624|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626625|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626626|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
64626627|NCT02167217|Prednisolone|prednisolone|mesh-list
64626628|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64626629|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
64367107|NCT03236155|Narcotics|narcotics|mesh-ancestor
64367481|NCT03341429|Liraglutide|liraglutide|mesh-list
64367795|NCT05032287|Urological Agents|urological agents|mesh-ancestor
64626630|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64626631|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
64626632|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64626633|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
64626634|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626635|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
64626636|NCT02167217|Hormones|hormones|mesh-ancestor
64626637|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626638|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626639|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64626640|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626641|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
64626642|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
64626643|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626644|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64626645|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64626646|NCT02167217|Protective Agents|protective agents|mesh-ancestor
64626647|NCT00002326|Zidovudine|zidovudine|mesh-list
64626648|NCT00002326|Adefovir|adefovir|mesh-list
64626649|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
64449327|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
64449328|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449329|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449330|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449331|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
64449333|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449334|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64449336|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64626650|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626651|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626652|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626653|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626655|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626656|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626657|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626658|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64626659|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64368072|NCT04968951|Metronidazole|metronidazole|mesh-list
64626660|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626661|NCT01152697|Haloperidol|haloperidol|mesh-list
64626662|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
64626663|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
64626664|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
64626665|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626666|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626667|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64626668|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64626669|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64626670|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64626671|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64626672|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64626673|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
64626674|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64626675|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626676|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64626677|NCT00002188|Alitretinoin|alitretinoin|mesh-list
64626679|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626681|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64626682|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
64626683|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626684|NCT05571644|Leucovorin|leucovorin|mesh-list
64626685|NCT05571644|Fluorouracil|fluorouracil|mesh-list
64626686|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
64626687|NCT05571644|Irinotecan|irinotecan|mesh-list
64626688|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
64626689|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
64626690|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626691|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64626692|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626693|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626694|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
64626695|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626696|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64626697|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64626698|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626699|NCT05571644|Antidotes|antidotes|mesh-ancestor
64626700|NCT05571644|Protective Agents|protective agents|mesh-ancestor
64626701|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
64626702|NCT05571644|Vitamins|vitamins|mesh-ancestor
64369488|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64626703|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
64626704|NCT03011281|Tofacitinib|tofacitinib|mesh-list
64626705|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64626706|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626707|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626708|NCT00002194|Clarithromycin|clarithromycin|mesh-list
64626709|NCT00002194|Erythromycin|erythromycin|mesh-list
64626710|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
64626711|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64626712|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
64626713|NCT00002194|Nevirapine|nevirapine|mesh-list
64626715|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449337|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
64449338|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64449339|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64449458|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64626716|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64626717|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626718|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626719|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64626720|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64626721|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626722|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626723|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
64626724|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626725|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626726|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64626727|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64626728|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64626729|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
64626730|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626731|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64626732|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626733|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626735|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64626736|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
64626737|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626738|NCT04756622|Expectorants|expectorants|mesh-ancestor
64626739|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
64626740|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64626741|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
64626742|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626743|NCT04756622|Protective Agents|protective agents|mesh-ancestor
64626744|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626746|NCT00002344|Azithromycin|azithromycin|mesh-list
64626747|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64626748|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626749|NCT01198327|Ranibizumab|ranibizumab|mesh-list
64626750|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64449461|NCT01856907|Metformin|metformin|mesh-list
64449462|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64449463|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64449464|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449465|NCT01856907|Incretins|incretins|mesh-ancestor
64449466|NCT01856907|Hormones|hormones|mesh-ancestor
64449467|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449468|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64449469|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
64449470|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449471|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449473|NCT02097745|Methotrexate|methotrexate|mesh-list
64449474|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64626751|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64626752|NCT01198327|Growth Substances|growth substances|mesh-ancestor
64626753|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626754|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
64626755|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626756|NCT00002200|Abacavir|abacavir|mesh-list
64449475|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626757|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626758|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626759|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626760|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626761|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
64626762|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626763|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626764|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626765|NCT00002356|Fomivirsen|fomivirsen|mesh-list
64626766|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
64449476|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
64626767|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626768|NCT00994175|Pioglitazone|pioglitazone|mesh-list
64626769|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64626770|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626771|NCT00002206|Adefovir|adefovir|mesh-list
64626772|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64626773|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
64626774|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626775|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626776|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626777|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626778|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626779|NCT02403986|Lidocaine|lidocaine|mesh-list
64626780|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
64626781|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
64626782|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64626783|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626784|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
64626785|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626786|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64484310|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626787|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64626788|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64626789|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64626790|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626791|NCT00002212|Bexarotene|bexarotene|mesh-list
64626792|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626793|NCT00002362|Emtricitabine|emtricitabine|mesh-list
64626794|NCT00002362|Efavirenz|efavirenz|mesh-list
64626795|NCT00002362|Abacavir|abacavir|mesh-list
64626796|NCT00002362|Stavudine|stavudine|mesh-list
64626797|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
64626798|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626799|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626800|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626801|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626802|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626803|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64449477|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626804|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64449478|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449506|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64449507|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449508|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449509|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626805|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64626806|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64626807|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64626808|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64626809|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64626810|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64626812|NCT02168309|Labetalol|labetalol|mesh-list
64626813|NCT02168309|Nifedipine|nifedipine|mesh-list
64626814|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64626815|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64626816|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626817|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64626818|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626819|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
64626820|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
64626821|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64626822|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64626823|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64626824|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
64626825|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64626826|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64626827|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
64626828|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
64626829|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626830|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64626831|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64626832|NCT00002368|Lamivudine|lamivudine|mesh-list
64626833|NCT00002368|Nevirapine|nevirapine|mesh-list
64626834|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626835|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626836|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626837|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626838|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
64626839|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626840|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626841|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64449557|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449558|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626842|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64626843|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64626844|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
64626845|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64626846|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
64626847|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
64626848|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64626849|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626850|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626851|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64626852|NCT01199965|Analgesics|analgesics|mesh-ancestor
64626853|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
64626854|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626855|NCT00995501|Insulin|insulin|mesh-list
64449559|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64449560|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64449589|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449590|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64449591|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64449593|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
64626856|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64370132|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64626857|NCT00995501|Dexamethasone|dexamethasone|mesh-list
64626858|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
64626859|NCT00995501|Anesthetics|anesthetics|mesh-list
64626860|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
64352173|NCT02611817|Vedolizumab|vedolizumab|mesh-list
64626862|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64626863|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626864|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626865|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
64626866|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
64626867|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626868|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64626869|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
64626870|NCT00995501|Hormones|hormones|mesh-ancestor
64626871|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626872|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64626873|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626874|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
64626875|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626876|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626877|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64626878|NCT00995501|Cathartics|cathartics|mesh-ancestor
64626879|NCT00002374|Ritonavir|ritonavir|mesh-list
64626880|NCT00002374|Nelfinavir|nelfinavir|mesh-list
64626881|NCT00002374|Saquinavir|saquinavir|mesh-list
64626882|NCT00002374|Stavudine|stavudine|mesh-list
64626883|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64626884|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64626885|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
64449594|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449595|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626886|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626887|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626888|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626889|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626890|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
64449596|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449597|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64449598|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64449673|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449674|NCT02095873|Protective Agents|protective agents|mesh-ancestor
64449675|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449676|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449677|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64449678|NCT02094937|Fluticasone|fluticasone|mesh-list
64449680|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449681|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64449682|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
64449683|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449684|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626892|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64626893|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64626894|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
64626895|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626896|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626897|NCT00002380|Nelfinavir|nelfinavir|mesh-list
64626898|NCT00002380|Saquinavir|saquinavir|mesh-list
64626899|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64626900|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64626901|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
64626902|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626903|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626904|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626905|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626906|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
64626907|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370228|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64626908|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64626909|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64626910|NCT00002386|Lamivudine|lamivudine|mesh-list
64626911|NCT00002386|Zidovudine|zidovudine|mesh-list
64626912|NCT00002386|Stavudine|stavudine|mesh-list
64626913|NCT00002386|Didanosine|didanosine|mesh-list
64626914|NCT00002386|Zalcitabine|zalcitabine|mesh-list
64626915|NCT00002386|Indinavir|indinavir|mesh-list
64626916|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64626917|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64626918|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626919|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626920|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
64626921|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626922|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64626923|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64626924|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
64626925|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64626926|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64626927|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
64626928|NCT01942694|Vitamin D|vitamin d|mesh-list
64626929|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
64626930|NCT01942694|Vitamins|vitamins|mesh-ancestor
64626931|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
64626932|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626933|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64626934|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64626936|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
64626937|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626938|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64626939|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64626941|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626942|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64626943|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
64626944|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64626945|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626946|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64626948|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64626949|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
64626950|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449694|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64449695|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
64449696|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449697|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
64449698|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449699|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
64370543|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64370717|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
64370816|NCT04860635|Celecoxib|celecoxib|mesh-list
64449700|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
64449701|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
64626951|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626952|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64626953|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64449702|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626954|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
64626957|NCT05751850|Leucovorin|leucovorin|mesh-list
64626958|NCT05751850|Gemcitabine|gemcitabine|mesh-list
64626959|NCT05751850|Paclitaxel|paclitaxel|mesh-list
64449703|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64626960|NCT05751850|Fluorouracil|fluorouracil|mesh-list
64626961|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
64626962|NCT05751850|Calcium|calcium|mesh-list
64626963|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
64626964|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64626965|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64626966|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
64626967|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
64626968|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
64626969|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626970|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64626971|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
64626972|NCT05751850|Antiviral Agents|antiviral agents|mesh-ancestor
64626973|NCT05751850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64626974|NCT05751850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64626975|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64626976|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
64626977|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626978|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64626979|NCT05751850|Antidotes|antidotes|mesh-ancestor
64626980|NCT05751850|Protective Agents|protective agents|mesh-ancestor
64626981|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
64626982|NCT05751850|Vitamins|vitamins|mesh-ancestor
64626983|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
64626984|NCT01938248|Aspirin|aspirin|mesh-list
64626985|NCT01938248|Apixaban|apixaban|mesh-list
64626986|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64626987|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64626988|NCT01938248|Analgesics|analgesics|mesh-ancestor
64626989|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
64626990|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64626991|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64626992|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64626993|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64626994|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64626995|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64626996|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64626997|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64626998|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64626999|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627000|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
64627001|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64627002|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
64627003|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64627004|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627005|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
64627006|NCT00002230|Efavirenz|efavirenz|mesh-list
64627007|NCT00002230|Stavudine|stavudine|mesh-list
64371145|NCT00704405|Interferons|interferons|mesh-list
64627008|NCT00002230|Didanosine|didanosine|mesh-list
64627010|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627011|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627012|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484311|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627013|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627014|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
64627015|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449704|NCT02186015|Vitamin D|vitamin d|mesh-list
64449705|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
64449706|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
64449707|NCT02186015|Vitamins|vitamins|mesh-list
64449708|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
64449709|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627016|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64627017|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64627018|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64627019|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64627020|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64627021|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64627022|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627023|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
64627024|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
64627025|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64627026|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627027|NCT03009877|Fentanyl|fentanyl|mesh-list
64627028|NCT03009877|Midazolam|midazolam|mesh-list
64627029|NCT03009877|Propofol|propofol|mesh-list
64627030|NCT03009877|Rocuronium|rocuronium|mesh-list
64627031|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64627032|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64627033|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627034|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64627035|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
64627036|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
64627037|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64627038|NCT03009877|Narcotics|narcotics|mesh-ancestor
64627039|NCT03009877|Analgesics|analgesics|mesh-ancestor
64627040|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
64371213|NCT03309215|Trace Elements|trace elements|mesh-ancestor
64627041|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627042|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64627043|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64627044|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64627045|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64627046|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
64627047|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
64627048|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627049|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627050|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64627051|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64627052|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64627053|NCT00002392|Thalidomide|thalidomide|mesh-list
64627054|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627055|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
64627056|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627057|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
64627058|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627059|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627060|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64627061|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64627062|NCT00002392|Growth Substances|growth substances|mesh-ancestor
64627063|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
64449710|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64449711|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64449712|NCT02066389|Upadacitinib|upadacitinib|mesh-list
64449713|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64449714|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64449715|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449833|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449834|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449835|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449836|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64627064|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627065|NCT00002398|Adefovir|adefovir|mesh-list
64627066|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64627067|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
64627068|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627069|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627070|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627071|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627072|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627073|NCT00997139|Polymyxins|polymyxins|mesh-list
64627074|NCT00997139|Neomycin|neomycin|mesh-list
64627075|NCT00997139|Bacitracin|bacitracin|mesh-list
64627076|NCT00997139|Polymyxin B|polymyxin b|mesh-list
64627078|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627079|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627080|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64627081|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627082|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627083|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64627085|NCT00002236|Delavirdine|delavirdine|mesh-list
64627086|NCT00002236|Indinavir|indinavir|mesh-list
64627087|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
64627088|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627089|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627090|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627091|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627092|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
64627093|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627094|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64627095|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627096|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64627097|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64627098|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627100|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
64627101|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64627102|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627103|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627104|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627105|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
64627106|NCT04998617|Curcumin|curcumin|mesh-list
64627107|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64627108|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64627109|NCT04998617|Analgesics|analgesics|mesh-ancestor
64627110|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
64627111|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627112|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627113|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64627115|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627116|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627117|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627118|NCT00002404|Valacyclovir|valacyclovir|mesh-list
64627119|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
64627120|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627121|NCT05593757|Quinidine|quinidine|mesh-list
64627122|NCT05593757|Verapamil|verapamil|mesh-list
64627123|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64627124|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64627125|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64627126|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627127|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64627128|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627129|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
64627130|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64627131|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64627132|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
64627133|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627134|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
64627135|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64627136|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64627137|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627138|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627139|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64627140|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64627141|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
64627142|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64627143|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64627144|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64627145|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64627146|NCT01242241|Propofol|propofol|mesh-list
64627147|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64627148|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64627149|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627150|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64627151|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
64627152|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
64627153|NCT02393690|Iodine|iodine|mesh-list
64627154|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
64627155|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64627156|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627158|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
64627159|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627161|NCT01928576|Azacitidine|azacitidine|mesh-list
64627162|NCT01928576|Entinostat|entinostat|mesh-list
64627163|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64627164|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627165|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64627166|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627167|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627168|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
64627169|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627170|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64627171|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
64627172|NCT01200433|Propofol|propofol|mesh-list
64627173|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64627174|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64627175|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627176|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64627177|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
64627178|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
64627179|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64627180|NCT01200433|Analgesics|analgesics|mesh-ancestor
64627181|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
64627182|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627183|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64627184|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64627185|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64449837|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64449838|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
64449839|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64449840|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449841|NCT02132117|Phenylephrine|phenylephrine|mesh-list
64449842|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
64449843|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64627186|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
64372418|NCT02462837|Mirabegron|mirabegron|mesh-list
64627187|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627188|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627190|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64627191|NCT04416269|Metformin|metformin|mesh-list
64627192|NCT04416269|Pioglitazone|pioglitazone|mesh-list
64627193|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64627194|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64627195|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627196|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627197|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627198|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627199|NCT00002410|Lamivudine|lamivudine|mesh-list
64627200|NCT00002410|Zidovudine|zidovudine|mesh-list
64627201|NCT00002410|Indinavir|indinavir|mesh-list
64627202|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627203|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627204|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627205|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627206|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
64627207|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627208|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64627209|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627210|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
64627211|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64627212|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64627213|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627214|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
64627215|NCT01243333|Alovudine|alovudine|mesh-list
64627216|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
64627217|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64627218|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64627219|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627220|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
64627221|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
64627222|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627223|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627224|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627225|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627226|NCT01924052|Calcitonin|calcitonin|mesh-list
64627227|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64627228|NCT01924052|Katacalcin|katacalcin|mesh-list
64627229|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64627230|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627231|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64627232|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
64627234|NCT00002416|Emtricitabine|emtricitabine|mesh-list
64627235|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627236|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627237|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627238|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627239|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
64627240|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627241|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64627242|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627243|NCT00002254|Alovudine|alovudine|mesh-list
64627244|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
64627245|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627246|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
64627247|NCT01897454|Leucovorin|leucovorin|mesh-list
64627248|NCT01897454|Folic Acid|folic acid|mesh-list
64627249|NCT01897454|Gemcitabine|gemcitabine|mesh-list
64449858|NCT02132117|Protective Agents|protective agents|mesh-ancestor
64627250|NCT01897454|Fluorouracil|fluorouracil|mesh-list
64627251|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
64627252|NCT01897454|Irinotecan|irinotecan|mesh-list
64627253|NCT01897454|Camptothecin|camptothecin|mesh-list
64627254|NCT01897454|Calcium|calcium|mesh-list
64627255|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
64627256|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627257|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
64627258|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627259|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627260|NCT01897454|Antiviral Agents|antiviral agents|mesh-ancestor
64627261|NCT01897454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627262|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627263|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627264|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
64627265|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627266|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64627267|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64627268|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64627269|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64627271|NCT01897454|Protective Agents|protective agents|mesh-ancestor
64627272|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
64627273|NCT01897454|Vitamins|vitamins|mesh-ancestor
64627274|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
64627275|NCT01897454|Hematinics|hematinics|mesh-ancestor
64627276|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627277|NCT01243567|Timolol|timolol|mesh-list
64627278|NCT01243567|Bimatoprost|bimatoprost|mesh-list
64627279|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64627280|NCT01243567|Latanoprost|latanoprost|mesh-list
64627281|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64627282|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64627283|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64627284|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
64627285|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627286|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627287|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627288|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64627289|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64627290|NCT01001195|Bimatoprost|bimatoprost|mesh-list
64627291|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64627292|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64627293|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64627294|NCT00381472|Ropinirole|ropinirole|mesh-list
64627295|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64627296|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64627297|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
64627298|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
64627299|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627300|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627301|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627302|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64627303|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64627304|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64627305|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64627306|NCT01460654|Alendronate|alendronate|mesh-list
64627307|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
64382877|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627309|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
64627310|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
64627311|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64627312|NCT01460654|Androgens|androgens|mesh-ancestor
64627313|NCT01460654|Hormones|hormones|mesh-ancestor
64627314|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449947|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
64627315|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627316|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64627318|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
64449948|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64627320|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
64627321|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64627322|NCT01001975|Protective Agents|protective agents|mesh-ancestor
64627323|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627324|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
64627325|NCT01459484|Cisplatin|cisplatin|mesh-list
64627326|NCT01459484|Doxorubicin|doxorubicin|mesh-list
64627327|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64627328|NCT01459484|Methotrexate|methotrexate|mesh-list
64627329|NCT01459484|Ifosfamide|ifosfamide|mesh-list
64627330|NCT01459484|Mifamurtide|mifamurtide|mesh-list
64627331|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
64627332|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627333|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64627334|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64627335|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64627336|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627337|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627338|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64627339|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
64627340|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64627341|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627342|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627343|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
64627344|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64627345|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64627346|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627347|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
64627348|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627349|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627350|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64627351|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
64450124|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
64450145|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
64450146|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450147|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450148|NCT02128217|Ribavirin|ribavirin|mesh-list
64450149|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
64450150|NCT02128217|Ledipasvir|ledipasvir|mesh-list
64450151|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64450152|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
64450153|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450154|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
64450155|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450156|NCT01628549|Sarecycline|sarecycline|mesh-list
64450157|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627352|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64627353|NCT00002260|Alovudine|alovudine|mesh-list
64627354|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
64627355|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627357|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64627358|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
64627359|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64627360|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
64627361|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627362|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627363|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64627364|NCT00002266|Protective Agents|protective agents|mesh-ancestor
64627365|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627366|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627367|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627368|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627369|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
64627370|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627371|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
64627373|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64627374|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64627375|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627376|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64627377|NCT05751304|Analgesics|analgesics|mesh-ancestor
64627378|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
64627379|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627380|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64627381|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64627382|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64627383|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
64627384|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627385|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627386|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64627387|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64627388|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
64627389|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
64627390|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64627391|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64627392|NCT01202071|Rabeprazole|rabeprazole|mesh-list
64627393|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64627394|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64627395|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64627396|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627397|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627399|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
64450158|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450159|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
64450160|NCT02127125|Sevelamer|sevelamer|mesh-list
64450161|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
64450162|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
64450163|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450164|NCT02090413|Aspirin|aspirin|mesh-list
64450165|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64450221|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450222|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627400|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627402|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64627403|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627404|NCT00002272|Foscarnet|foscarnet|mesh-list
64627405|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
64627406|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
64627407|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627408|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627409|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627410|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300980|NCT03281187|Androgens|androgens|mesh-ancestor
64627411|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627412|NCT01002755|Lenalidomide|lenalidomide|mesh-list
64627413|NCT01002755|Ofatumumab|ofatumumab|mesh-list
64627414|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64627415|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
64627416|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627417|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64627418|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64627419|NCT01002755|Growth Substances|growth substances|mesh-ancestor
64627420|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
64627421|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627422|NCT00002434|Leucovorin|leucovorin|mesh-list
64627423|NCT00002434|Trimetrexate|trimetrexate|mesh-list
64627424|NCT00002434|Calcium|calcium|mesh-list
64627425|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
64627426|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64627427|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627428|NCT00002434|Antidotes|antidotes|mesh-ancestor
64627429|NCT00002434|Protective Agents|protective agents|mesh-ancestor
64627430|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
64627431|NCT00002434|Vitamins|vitamins|mesh-ancestor
64627432|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
64627433|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
64627434|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627435|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627436|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
64627437|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627438|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627439|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64627440|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627441|NCT00002278|Diclazuril|diclazuril|mesh-list
64627442|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
64627443|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64627444|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64627445|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627446|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
64627447|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
64627448|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
64627449|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627450|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627451|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64627452|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64450231|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450232|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64450233|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450234|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
64450235|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64627453|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
64627454|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
64627455|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627456|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627457|NCT01003301|Omalizumab|omalizumab|mesh-list
64450236|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64450238|NCT04700839|Canagliflozin|canagliflozin|mesh-list
64627458|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64627459|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64627460|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
64627461|NCT00002440|Ritonavir|ritonavir|mesh-list
64627462|NCT00002440|Nelfinavir|nelfinavir|mesh-list
64627463|NCT00002440|Indinavir|indinavir|mesh-list
64627464|NCT00002440|Saquinavir|saquinavir|mesh-list
64627465|NCT00002440|Amprenavir|amprenavir|mesh-list
64627467|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64627468|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64627469|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627470|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627471|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450241|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627472|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64352772|NCT01166633|Atorvastatin|atorvastatin|mesh-list
64627473|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627474|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
64627475|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627476|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64627477|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64627478|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627479|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627480|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64627481|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
64627482|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627483|NCT01421810|Dexamethasone|dexamethasone|mesh-list
64627484|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64627485|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
64627486|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
64627487|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627488|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627489|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64627490|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
64627491|NCT01421810|Hormones|hormones|mesh-ancestor
64627492|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64627493|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64627494|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627495|NCT00002284|Zidovudine|zidovudine|mesh-list
64627496|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
64627497|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627498|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627499|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64450242|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450243|NCT02043301|Bococizumab|bococizumab|mesh-list
64450244|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64450245|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64450246|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
64450247|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450248|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64450250|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64450251|NCT01598753|Narcotics|narcotics|mesh-ancestor
64450252|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450253|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450254|NCT01598753|Analgesics|analgesics|mesh-ancestor
64450255|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
64627500|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627501|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
64627502|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627503|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64627504|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627505|NCT01243957|Fluoxetine|fluoxetine|mesh-list
64627506|NCT01243957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64627507|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64627508|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64627509|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627510|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627511|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
64627512|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627513|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64627514|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
64627515|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64627516|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64627517|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64627518|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627519|NCT00002446|Fluconazole|fluconazole|mesh-list
64627521|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
64373772|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
64627522|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627523|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64627524|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64450261|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
64627526|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627527|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64627528|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
64627529|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64627530|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627531|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64627532|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64627533|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64627534|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64627535|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64627536|NCT01884740|Bevacizumab|bevacizumab|mesh-list
64627537|NCT01884740|Cetuximab|cetuximab|mesh-list
64627538|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64627539|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627540|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64627541|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64627542|NCT01884740|Growth Substances|growth substances|mesh-ancestor
64627543|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627544|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
64627545|NCT00002290|Zidovudine|zidovudine|mesh-list
64627546|NCT00002290|Acyclovir|acyclovir|mesh-list
64627547|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
64627548|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627549|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627550|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627551|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627552|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
64627553|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450296|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450298|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64450299|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450300|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
64450301|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64450302|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64450303|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64450304|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
64450307|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
64627554|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64373899|NCT05074589|Antidotes|antidotes|mesh-ancestor
64627555|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627556|NCT01003769|Acetic Acid|acetic acid|mesh-list
64627557|NCT01003769|Lenalidomide|lenalidomide|mesh-list
64627558|NCT01003769|Retinol acetate|retinol acetate|mesh-list
64627559|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
64627560|NCT01003769|Gossypol|gossypol|mesh-list
64627561|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
64627562|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627563|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64627564|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64627565|NCT01003769|Growth Substances|growth substances|mesh-ancestor
64627566|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
64627567|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627568|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627569|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627570|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64627571|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64627572|NCT01003769|Protective Agents|protective agents|mesh-ancestor
64627573|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64627574|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
64627575|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64627576|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627577|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64627578|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64627579|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64627581|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64627582|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64627583|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627584|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627585|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627586|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64627587|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627588|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
64627589|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627590|NCT01004393|Bromides|bromides|mesh-list
64627591|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
64627592|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
64450308|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64450309|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64450310|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450311|NCT01622569|Fluticasone|fluticasone|mesh-list
64450312|NCT01622569|Xhance|xhance|mesh-list
64450313|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450314|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64450315|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
64450316|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450317|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450318|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64450319|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
64450320|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
64450321|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64450322|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64450323|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627598|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64627599|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
64627600|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627601|NCT00002470|Interferons|interferons|mesh-list
64627602|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
64627603|NCT00002470|Fluorouracil|fluorouracil|mesh-list
64627604|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
64627605|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627606|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627607|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627608|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627609|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
64627610|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627611|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
64627612|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627614|NCT00002476|Cobalt|cobalt|mesh-list
64627615|NCT00002476|Fluorouracil|fluorouracil|mesh-list
64627616|NCT00002476|Methotrexate|methotrexate|mesh-list
64627617|NCT00002476|Vincristine|vincristine|mesh-list
64627618|NCT00002476|Bleomycin|bleomycin|mesh-list
64352921|NCT04527393|Analgesics|analgesics|mesh-ancestor
64627619|NCT00002476|Calcium|calcium|mesh-list
64627620|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
64627621|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64627622|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627623|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
64627624|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627625|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627626|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627627|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627628|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
64627629|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64627630|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
64627631|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64627632|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
64627633|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627634|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64627635|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627636|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627637|NCT00002476|Antidotes|antidotes|mesh-ancestor
64627638|NCT00002476|Protective Agents|protective agents|mesh-ancestor
64627639|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
64627641|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
64627642|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627643|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
64627644|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
64627645|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
64627646|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64627647|NCT00002476|Trace Elements|trace elements|mesh-ancestor
64627648|NCT01876628|Clindamycin|clindamycin|mesh-list
64627652|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627653|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627654|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64627655|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627656|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627657|NCT01004705|Aspirin|aspirin|mesh-list
64627658|NCT01004705|Ramipril|ramipril|mesh-list
64627659|NCT01004705|Simvastatin|simvastatin|mesh-list
64627660|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64627662|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
64627663|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627664|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64627665|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64627666|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627667|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64627668|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64627669|NCT01004705|Analgesics|analgesics|mesh-ancestor
64627670|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
64627671|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627672|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627673|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64627674|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627675|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64627676|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64627677|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64627678|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64627679|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
64627680|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64627681|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627682|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64627683|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
64627684|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
64627685|NCT00002482|Antibodies|antibodies|mesh-list
64627686|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627687|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
64627688|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627689|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627690|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64627691|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
64627692|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627693|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627694|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64627695|NCT01004939|PENTA|penta|mesh-list
64627696|NCT01004939|Fondaparinux|fondaparinux|mesh-list
64627697|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64374548|NCT02454881|Narcotics|narcotics|mesh-ancestor
64627698|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
64627699|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64627700|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627701|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627702|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627704|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64627705|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64627706|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
64627707|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64627708|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
64627709|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64627710|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
64627711|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627712|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627713|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
64627714|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
64300999|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
64627716|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627717|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
64627718|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627719|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627720|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64627721|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
64627722|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627723|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627724|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64627725|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627726|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64627727|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64627728|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627729|NCT01245595|Aminophylline|aminophylline|mesh-list
64627730|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64627731|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
64627732|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627733|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627734|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64627735|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
64627736|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64627737|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64627738|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627739|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627740|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64627741|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64627742|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
64627743|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627744|NCT01245595|Protective Agents|protective agents|mesh-ancestor
64627746|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64627747|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627749|NCT00002494|Cobalt|cobalt|mesh-list
64627750|NCT00002494|Cytarabine|cytarabine|mesh-list
64627751|NCT00002494|Dexamethasone|dexamethasone|mesh-list
64627752|NCT00002494|Prednisone|prednisone|mesh-list
64627753|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
64627754|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64627755|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64627756|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64627757|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
64627758|NCT00002494|Ifosfamide|ifosfamide|mesh-list
64627759|NCT00002494|Doxorubicin|doxorubicin|mesh-list
64627760|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64374839|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
64627763|NCT00002494|Vincristine|vincristine|mesh-list
64627764|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
64627765|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627766|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
64627767|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627768|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627769|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64627770|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
64627771|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627772|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627773|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64627774|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64627776|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
64627777|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627778|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64627779|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
64627780|NCT00002494|Hormones|hormones|mesh-ancestor
64627781|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64627782|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64627783|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64627784|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64627785|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64627786|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627787|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64627788|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
64627789|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64627790|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627791|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
64627792|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
64627793|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64450336|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450337|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450338|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450339|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450340|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64450341|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450342|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450343|NCT02152007|Sirolimus|sirolimus|mesh-list
64450344|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450345|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627794|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627795|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627796|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
64627797|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627798|NCT00002494|Antidotes|antidotes|mesh-ancestor
64627799|NCT00002494|Protective Agents|protective agents|mesh-ancestor
64627800|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
64627801|NCT00002494|Vitamins|vitamins|mesh-ancestor
64627802|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
64627803|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
64627804|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
64627805|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
64627806|NCT00002494|Trace Elements|trace elements|mesh-ancestor
64627807|NCT04991324|Vitamin D|vitamin d|mesh-list
64627808|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
64627809|NCT04991324|Vitamins|vitamins|mesh-ancestor
64627810|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
64627811|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627812|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64627813|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64627814|NCT00002506|Interferons|interferons|mesh-list
64627815|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
64627816|NCT00002506|Isotretinoin|isotretinoin|mesh-list
64627817|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627818|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
64627819|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301017|NCT02437162|Golimumab|golimumab|mesh-list
64627820|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
64627821|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627822|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
64627823|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
64627824|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64627825|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627826|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64627827|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
64627828|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627829|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627830|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627831|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627832|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
64627833|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64627834|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64627835|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64627836|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64627837|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627838|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
64627839|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64627840|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627841|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64627842|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627843|NCT01357772|Tamoxifen|tamoxifen|mesh-list
64627844|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64627845|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
64627846|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64627847|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627848|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64627849|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627850|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64627851|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64627852|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64627853|NCT03866837|Micronutrients|micronutrients|mesh-list
64627854|NCT03866837|Trace Elements|trace elements|mesh-list
64627855|NCT03866837|Lactoferrin|lactoferrin|mesh-list
64627856|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627857|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627858|NCT05750446|Riociguat|riociguat|mesh-list
64627865|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627866|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627868|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627869|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
64627870|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
64627871|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
64627872|NCT04456517|Ranolazine|ranolazine|mesh-list
64627873|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64627874|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64627875|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627876|NCT01840046|Interleukin-2|interleukin-2|mesh-list
64627877|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627878|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64627879|NCT01840046|Analgesics|analgesics|mesh-ancestor
64627880|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
64627881|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627882|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627883|NCT00437216|Clobetasol|clobetasol|mesh-list
64627884|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64627885|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
64627886|NCT00437216|Hormones|hormones|mesh-ancestor
64627887|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64627888|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627890|NCT00002524|Cytarabine|cytarabine|mesh-list
64627891|NCT00002524|Zidovudine|zidovudine|mesh-list
64627892|NCT00002524|Trimethoprim|trimethoprim|mesh-list
64627893|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
64627894|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64627895|NCT00002524|Pentamidine|pentamidine|mesh-list
64627896|NCT00002524|Prednisone|prednisone|mesh-list
64627897|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
64627898|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64627899|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64627900|NCT00002524|Prednisolone|prednisolone|mesh-list
64627901|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
64627902|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
64627903|NCT00002524|Ifosfamide|ifosfamide|mesh-list
64627904|NCT00002524|Doxorubicin|doxorubicin|mesh-list
64627905|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64627906|NCT00002524|Fluorouracil|fluorouracil|mesh-list
64627907|NCT00002524|Methotrexate|methotrexate|mesh-list
64627908|NCT00002524|Etoposide|etoposide|mesh-list
64627909|NCT00002524|Vincristine|vincristine|mesh-list
64627910|NCT00002524|Bleomycin|bleomycin|mesh-list
64627911|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64627912|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
64627913|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
64627914|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64627915|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
64627916|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627917|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64627918|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64627919|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
64627920|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627921|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627922|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64627923|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64627924|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64627925|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64353224|NCT03439709|Lanreotide|lanreotide|mesh-list
64627926|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627927|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
64627928|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64627930|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
64627931|NCT00002524|Hormones|hormones|mesh-ancestor
64627932|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64627933|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64627934|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64627936|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64627937|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
64627938|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64627939|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64627940|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627941|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
64627942|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64627943|NCT00002524|Antidotes|antidotes|mesh-ancestor
64627944|NCT00002524|Protective Agents|protective agents|mesh-ancestor
64627945|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
64627946|NCT00002524|Vitamins|vitamins|mesh-ancestor
64627947|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
64627948|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
64627949|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
64627950|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
64627951|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
64627952|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
64627953|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64627954|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64627955|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64627956|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64627957|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64627958|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64627959|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64627960|NCT00002524|Renal Agents|renal agents|mesh-ancestor
64627961|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
64627962|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64627963|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64627964|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64627965|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64627966|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64627967|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64627968|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
64627969|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64627970|NCT01824836|Anastrozole|anastrozole|mesh-list
64627971|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64627972|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627973|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64627974|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64627975|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64627976|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375794|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375795|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64375796|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64375797|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64375798|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
64375800|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
64375801|NCT04908813|Trastuzumab|trastuzumab|mesh-list
64627977|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64627978|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
64627979|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64627980|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64627981|NCT00002536|Vincristine|vincristine|mesh-list
64627982|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64627983|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64627984|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
64627985|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
64627986|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
64627987|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64627988|NCT01203319|Vaccines|vaccines|mesh-list
64627989|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
64628003|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628004|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
64628006|NCT01204255|Lorazepam|lorazepam|mesh-list
64628007|NCT01204255|Haloperidol|haloperidol|mesh-list
64628008|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
64628009|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64628010|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64628011|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628012|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628013|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
64628014|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
64628015|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
64628016|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628017|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
64628018|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
64628019|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64628020|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64628021|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
64628022|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
64628023|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628024|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628025|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64628026|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
64628027|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628028|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64628029|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64628030|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64628031|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64628032|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
64628033|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64628034|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
64628035|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64628036|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
64628037|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
64628048|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628049|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628050|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
64628051|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376218|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64628052|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628053|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628054|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64628055|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628056|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628057|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628058|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
64628059|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628060|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64628061|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
64628062|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628063|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628064|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64628065|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64628066|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64628067|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
64628068|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628069|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628070|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64628071|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64628072|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64628073|NCT01156597|Pioglitazone|pioglitazone|mesh-list
64628074|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64628075|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628076|NCT01823198|Aldesleukin|aldesleukin|mesh-list
64628077|NCT01823198|Fludarabine|fludarabine|mesh-list
64628078|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
64353378|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628080|NCT01823198|Interleukin-2|interleukin-2|mesh-list
64628081|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628082|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628083|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
64628084|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628085|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628086|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
64628087|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628088|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
64628089|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628090|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628091|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64628096|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64628097|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
64628098|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628100|NCT05750056|Sufentanil|sufentanil|mesh-list
64628101|NCT05750056|Dsuvia|dsuvia|mesh-list
64628102|NCT05750056|Propofol|propofol|mesh-list
64628103|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
64628104|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
64628105|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628106|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628107|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
64628108|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628109|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64628110|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64628111|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64628112|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64628113|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628114|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64628115|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64628116|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
64628117|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64628119|NCT05750056|Analgesics|analgesics|mesh-ancestor
64628120|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64628121|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
64628122|NCT03011125|Lansoprazole|lansoprazole|mesh-list
64628123|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64628124|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64628125|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64628126|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628127|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628128|NCT05749900|Gemcitabine|gemcitabine|mesh-list
64628129|NCT05749900|Nivolumab|nivolumab|mesh-list
64628130|NCT05749900|Trastuzumab|trastuzumab|mesh-list
64628131|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628132|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628133|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
64628134|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628135|NCT05749900|Antiviral Agents|antiviral agents|mesh-ancestor
64628136|NCT05749900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628137|NCT05749900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628138|NCT05749900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628139|NCT05749900|Immunologic Factors|immunologic factors|mesh-ancestor
64628140|NCT05749900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628141|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64628142|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64628143|NCT03442751|Riboflavin|riboflavin|mesh-list
64628144|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64628145|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64628146|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
64628147|NCT03442751|Vitamins|vitamins|mesh-ancestor
64628148|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
64628149|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628150|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64450346|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64628151|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628152|NCT05749666|Prednisolone|prednisolone|mesh-list
64628153|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64628157|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64628158|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
64628159|NCT05749666|Tofacitinib|tofacitinib|mesh-list
64628160|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628161|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
64628162|NCT05749666|Hormones|hormones|mesh-ancestor
64628163|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628164|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628165|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628166|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628168|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
64628169|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628170|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64628171|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64628172|NCT05749666|Protective Agents|protective agents|mesh-ancestor
64628173|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64628174|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628175|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628176|NCT05449535|Omalizumab|omalizumab|mesh-list
64628177|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64628178|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64628179|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
64628180|NCT05749276|Daratumumab|daratumumab|mesh-list
64628181|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628182|NCT05749042|Cisplatin|cisplatin|mesh-list
64628183|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628184|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
64628185|NCT02940509|Ketamine|ketamine|mesh-list
64628186|NCT02940509|Analgesics|analgesics|mesh-ancestor
64628187|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
64628188|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628189|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628190|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64628191|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64628192|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
64628193|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
64628194|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628195|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64628196|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64376517|NCT02452385|Vorolanib|vorolanib|mesh-list
64628197|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450353|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
64450354|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64450355|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
64450356|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64450357|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450358|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450359|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
64450360|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450361|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628202|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64628203|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64628204|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
64628205|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628206|NCT02530697|Miltefosine|miltefosine|mesh-list
64628207|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64628208|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
64628209|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64628210|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628211|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628212|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64628213|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64628214|NCT02530697|Protective Agents|protective agents|mesh-ancestor
64628215|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628216|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
64628217|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64628218|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
64628219|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
64628220|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628221|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628222|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64628223|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64628224|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64628225|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
64628226|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64628227|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64628228|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64628229|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628230|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
64628231|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64628232|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628233|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628234|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64628235|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64628236|NCT04094207|Protective Agents|protective agents|mesh-ancestor
64628237|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628238|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
64628239|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64628241|NCT02144831|Aspirin|aspirin|mesh-list
64628242|NCT02144831|Clopidogrel|clopidogrel|mesh-list
64628243|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64628244|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64628245|NCT02144831|Analgesics|analgesics|mesh-ancestor
64628246|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
64628247|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628248|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628249|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628250|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628251|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64628252|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64628253|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628262|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628263|NCT05276219|Furosemide|furosemide|mesh-list
64628264|NCT05276219|Isosorbide|isosorbide|mesh-list
64628265|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64628266|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64628267|NCT05276219|Diuretics|diuretics|mesh-ancestor
64628268|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
64628269|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628270|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64628271|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64628272|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628273|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64628274|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
64628275|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64628276|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
64628277|NCT05232461|Celecoxib|celecoxib|mesh-list
64628278|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64628279|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64628280|NCT05232461|Analgesics|analgesics|mesh-ancestor
64628281|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
64628282|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628283|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628284|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628285|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628286|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64628287|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64628288|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628289|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628290|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64628291|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628292|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628293|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628294|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628295|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64628296|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64628297|NCT01804790|Capecitabine|capecitabine|mesh-list
64628298|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628299|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
64628300|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628301|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628302|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
64628303|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628304|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64628305|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628316|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628318|NCT01313702|Lisinopril|lisinopril|mesh-list
64628319|NCT01313702|Simvastatin|simvastatin|mesh-list
64628320|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64628321|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64628322|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
64628323|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628324|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64628325|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64628326|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628327|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64628328|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
64628329|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64628330|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64376941|NCT03047733|Tacrolimus|tacrolimus|mesh-list
64376942|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376943|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
64376944|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376945|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64376946|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628331|NCT01313702|Protective Agents|protective agents|mesh-ancestor
64628332|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628333|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64628334|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
64628335|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
64628336|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628337|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64628339|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64628340|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
64628341|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628342|NCT05742958|Morphine|morphine|mesh-list
64628343|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64628344|NCT05742958|Narcotics|narcotics|mesh-ancestor
64628345|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628346|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628347|NCT05742958|Analgesics|analgesics|mesh-ancestor
64628348|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
64628349|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628350|NCT04868708|Paclitaxel|paclitaxel|mesh-list
64628351|NCT04868708|Bevacizumab|bevacizumab|mesh-list
64628353|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628354|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628355|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
64628356|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628357|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
64628358|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628368|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64628369|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64628370|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64628371|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64628372|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628373|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
64628374|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628375|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628376|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64353680|NCT03431285|Ketamine|ketamine|mesh-list
64628377|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64628378|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628379|NCT05513872|Nicotine|nicotine|mesh-list
64628380|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64628381|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
64628382|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628383|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628384|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64628385|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64628386|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
64628387|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628388|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628389|NCT05498272|Olaparib|olaparib|mesh-list
64628390|NCT05498272|Leuprolide|leuprolide|mesh-list
64628391|NCT05498272|Goserelin|goserelin|mesh-list
64628392|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64628393|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64628394|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628395|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628396|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628397|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64628398|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
64628399|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628400|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628401|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628402|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
64628403|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64628404|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
64628405|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64628407|NCT05445856|Methadone|methadone|mesh-list
64628408|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64628409|NCT05445856|Narcotics|narcotics|mesh-ancestor
64628410|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628411|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628412|NCT05445856|Analgesics|analgesics|mesh-ancestor
64628413|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
64628416|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64628417|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
64628418|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
64628419|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
64628420|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
64628421|NCT05481112|Buprenorphine|buprenorphine|mesh-list
64628422|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64628423|NCT05481112|Narcotics|narcotics|mesh-ancestor
64628424|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628425|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628426|NCT05481112|Analgesics|analgesics|mesh-ancestor
64628427|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
64628428|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628429|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64628430|NCT05543278|Amiodarone|amiodarone|mesh-list
64628431|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64628432|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
64628433|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64628434|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64628435|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628436|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64628437|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64628438|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64628439|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628440|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64628441|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64628442|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64628443|NCT00382330|Ciclopirox|ciclopirox|mesh-list
64628444|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
64628445|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628446|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
64628447|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64628448|NCT05520892|Antibodies|antibodies|mesh-list
64628449|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
64450368|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64450369|NCT02176421|Lidocaine|lidocaine|mesh-list
64450370|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
64450371|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
64450372|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450373|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628450|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64628451|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
64628462|NCT00002548|Carmustine|carmustine|mesh-list
64628463|NCT00002548|Doxorubicin|doxorubicin|mesh-list
64628464|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64628465|NCT00002548|Vincristine|vincristine|mesh-list
64628466|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628467|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
64628468|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628470|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628471|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
64628472|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628473|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628474|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628475|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628476|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
64628477|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
64628478|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377111|NCT01628692|Ribavirin|ribavirin|mesh-list
64377242|NCT04849845|Insulin|insulin|mesh-list
64377346|NCT04849299|Cyclosporine|cyclosporine|mesh-list
64628479|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64628480|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
64628481|NCT00002548|Hormones|hormones|mesh-ancestor
64628482|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628483|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628484|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64628485|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628486|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628487|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628488|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
64628489|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628490|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628491|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
64628492|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628493|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
64628494|NCT02087306|Brincidofovir|brincidofovir|mesh-list
64628495|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
64628507|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628508|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628509|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64628511|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628512|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628513|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
64628514|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628515|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628516|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64628517|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64628518|NCT00002560|Antibodies|antibodies|mesh-list
64628519|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64628520|NCT00002560|Sargramostim|sargramostim|mesh-list
64628521|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
64628522|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628523|NCT00254384|Cisplatin|cisplatin|mesh-list
64628524|NCT00254384|Docetaxel|docetaxel|mesh-list
64628525|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64628526|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628527|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
64628528|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628529|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
64628530|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628531|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64628532|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628533|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
64628535|NCT00002566|Carboplatin|carboplatin|mesh-list
64628536|NCT00002566|Etoposide|etoposide|mesh-list
64628537|NCT00002566|Vinblastine|vinblastine|mesh-list
64628538|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377640|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
64382879|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
64628539|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
64628540|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628541|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628542|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628543|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
64628544|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628545|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628546|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628547|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628548|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628554|NCT00002572|Aldesleukin|aldesleukin|mesh-list
64628555|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
64628556|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628557|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64628558|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64628559|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
64628560|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628561|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
64628562|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628563|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628564|NCT00002578|Leucovorin|leucovorin|mesh-list
64628565|NCT00002578|Cytarabine|cytarabine|mesh-list
64628566|NCT00002578|Methotrexate|methotrexate|mesh-list
64628567|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
64628568|NCT00002578|Calcium|calcium|mesh-list
64628569|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
64628570|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64628571|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628572|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64450389|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64450390|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450391|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64450392|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
64450393|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450394|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450395|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450396|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450397|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
64450398|NCT02042443|Antidotes|antidotes|mesh-ancestor
64450399|NCT02042443|Protective Agents|protective agents|mesh-ancestor
64450400|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
64450401|NCT02042443|Vitamins|vitamins|mesh-ancestor
64450402|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
64450403|NCT02042443|Hematinics|hematinics|mesh-ancestor
64628574|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628575|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628576|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
64628577|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628578|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628579|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628580|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628581|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64628582|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628583|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
64628584|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628585|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64628586|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
64628587|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378277|NCT04807335|Ketamine|ketamine|mesh-list
64378345|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
64378458|NCT04801485|Inositol|inositol|mesh-list
64378459|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
64378460|NCT04801485|Vitamins|vitamins|mesh-ancestor
64378461|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
64378462|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628589|NCT00002578|Protective Agents|protective agents|mesh-ancestor
64628590|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
64628591|NCT00002578|Vitamins|vitamins|mesh-ancestor
64628592|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
64628593|NCT00002590|Leucovorin|leucovorin|mesh-list
64628594|NCT00002590|Cytarabine|cytarabine|mesh-list
64628595|NCT00002590|Prednisone|prednisone|mesh-list
64628596|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
64628597|NCT00002590|Doxorubicin|doxorubicin|mesh-list
64628598|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64628599|NCT00002590|Methotrexate|methotrexate|mesh-list
64628600|NCT00002590|Etoposide|etoposide|mesh-list
64628601|NCT00002590|Vincristine|vincristine|mesh-list
64628602|NCT00002590|Daunorubicin|daunorubicin|mesh-list
64628603|NCT00002590|Asparaginase|asparaginase|mesh-list
64628604|NCT00002590|Pegaspargase|pegaspargase|mesh-list
64628605|NCT00002590|Thioguanine|thioguanine|mesh-list
64450434|NCT04723862|Diuretics|diuretics|mesh-ancestor
64450435|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
64450436|NCT02092220|Pancrelipase|pancrelipase|mesh-list
64450437|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64450438|NCT02066402|Linezolid|linezolid|mesh-list
64450439|NCT02066402|Tedizolid|tedizolid|mesh-list
64450440|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
64450441|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450442|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450443|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64450444|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450445|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450446|NCT02060383|Metformin|metformin|mesh-list
64450447|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64450448|NCT02060383|Liraglutide|liraglutide|mesh-list
64450449|NCT02060383|Pasireotide|pasireotide|mesh-list
64450450|NCT02060383|Somatostatin|somatostatin|mesh-list
64450451|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450452|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450455|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450456|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64450457|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
64450458|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628616|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64628617|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628618|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628619|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628620|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628621|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
64628622|NCT00002590|Hormones|hormones|mesh-ancestor
64628623|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628624|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628625|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64628626|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
64628627|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628628|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628629|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
64628630|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628631|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64628632|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64628633|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628634|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
64628635|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628636|NCT00002590|Antidotes|antidotes|mesh-ancestor
64628637|NCT00002590|Protective Agents|protective agents|mesh-ancestor
64378668|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378669|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64378670|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64378671|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
64378672|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
64378673|NCT02450279|Edetic Acid|edetic acid|mesh-list
64628638|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
64628639|NCT00002590|Vitamins|vitamins|mesh-ancestor
64628640|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
64628641|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
64628642|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628643|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
64628644|NCT01273610|Trastuzumab|trastuzumab|mesh-list
64628645|NCT01273610|Lapatinib|lapatinib|mesh-list
64628646|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64628647|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628648|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64628649|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450459|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628658|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628659|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628660|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
64628661|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628662|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628663|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628664|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628665|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628666|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628667|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628668|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64628669|NCT00199082|Cytarabine|cytarabine|mesh-list
64628670|NCT00199082|Dexamethasone|dexamethasone|mesh-list
64628671|NCT00199082|Prednisolone|prednisolone|mesh-list
64628672|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
64628673|NCT00199082|Ifosfamide|ifosfamide|mesh-list
64628674|NCT00199082|Rituximab|rituximab|mesh-list
64628675|NCT00199082|Methotrexate|methotrexate|mesh-list
64628676|NCT00199082|Vincristine|vincristine|mesh-list
64628677|NCT00199082|Doxorubicin|doxorubicin|mesh-list
64628678|NCT00199082|Vindesine|vindesine|mesh-list
64628679|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628680|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
64628681|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628682|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628683|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628684|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
64628685|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628686|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628687|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64628688|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64628689|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628690|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
64628691|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
64628692|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628693|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64628694|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
64628696|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628697|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628713|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64628714|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628715|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628716|NCT00194090|Celecoxib|celecoxib|mesh-list
64628717|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64628718|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64628719|NCT00194090|Analgesics|analgesics|mesh-ancestor
64628720|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
64628721|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628722|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628723|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628724|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628725|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64628726|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64628727|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378674|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
64378675|NCT02450279|Antidotes|antidotes|mesh-ancestor
64378676|NCT02450279|Protective Agents|protective agents|mesh-ancestor
64628728|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628730|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
64628731|NCT04194554|Niraparib|niraparib|mesh-list
64628732|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64628733|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
64628734|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628735|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628736|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628737|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628739|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628740|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450475|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64628750|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64628751|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64628752|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628753|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628754|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64628755|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
64628756|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628757|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628758|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628759|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64354045|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
64628760|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64628761|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64628763|NCT00002620|Carmustine|carmustine|mesh-list
64628764|NCT00002620|Mitolactol|mitolactol|mesh-list
64628765|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628766|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
64628767|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628768|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628769|NCT00002620|Trace Elements|trace elements|mesh-ancestor
64628770|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
64378741|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378742|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64378744|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64378745|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
64378746|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64378747|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
64378748|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378749|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378753|NCT02448251|Abivertinib|abivertinib|mesh-list
64628771|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628772|NCT00002632|Paclitaxel|paclitaxel|mesh-list
64628773|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628774|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628775|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
64628776|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
64628777|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
64628778|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628779|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64628780|NCT00002638|Cytarabine|cytarabine|mesh-list
64628782|NCT00002638|Carmustine|carmustine|mesh-list
64628783|NCT00002638|Etoposide|etoposide|mesh-list
64628784|NCT00002638|Sargramostim|sargramostim|mesh-list
64628785|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628786|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
64628787|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628788|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628789|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628790|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
64628791|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628801|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628802|NCT04136366|Methotrexate|methotrexate|mesh-list
64628803|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64628804|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
64628805|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628806|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628807|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628808|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
64628809|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628810|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628811|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628812|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628813|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64628814|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628815|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
64628816|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628817|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64628818|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64628819|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64628820|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628821|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628822|NCT01896440|Ondansetron|ondansetron|mesh-list
64628823|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
64628824|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
64628825|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628826|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628827|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64628828|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
64628829|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
64628830|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64628831|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
64450476|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64450477|NCT02124161|Vaccines|vaccines|mesh-list
64450478|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64450479|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
64450481|NCT02117570|Vaccines|vaccines|mesh-list
64628833|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628834|NCT01896440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64628835|NCT01896440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64628836|NCT01896440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628837|NCT01896440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64628838|NCT01896440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64628839|NCT00002650|Folic Acid|folic acid|mesh-list
64628840|NCT00002650|Hematinics|hematinics|mesh-ancestor
64628841|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
64628842|NCT00002650|Vitamins|vitamins|mesh-ancestor
64628843|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
64628844|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378923|NCT02445989|NuvaRing|nuvaring|mesh-list
64379023|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64628845|NCT00002656|NSC 366140|nsc 366140|mesh-list
64628846|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628847|NCT05073718|Aspirin|aspirin|mesh-list
64628848|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64628849|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64628850|NCT05073718|Analgesics|analgesics|mesh-ancestor
64628851|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
64628852|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628853|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628854|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628855|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628857|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64628858|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628859|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64628860|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64628861|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64628862|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
64628863|NCT00002662|Paclitaxel|paclitaxel|mesh-list
64628864|NCT00002662|Docetaxel|docetaxel|mesh-list
64628865|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64628866|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628867|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
64628868|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
64301251|NCT03079076|Bupivacaine|bupivacaine|mesh-list
64628870|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628871|NCT00054314|IDN 5109|idn 5109|mesh-list
64628872|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628873|NCT01743950|Bevacizumab|bevacizumab|mesh-list
64628874|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64628875|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628876|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64628877|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64628878|NCT01743950|Growth Substances|growth substances|mesh-ancestor
64628879|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628880|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
64628881|NCT00002674|Cytarabine|cytarabine|mesh-list
64628882|NCT00002674|Etoposide|etoposide|mesh-list
64628883|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
64379249|NCT04787289|Growth Substances|growth substances|mesh-ancestor
64379250|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379251|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
64379253|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
64379453|NCT02174848|Deferiprone|deferiprone|mesh-list
64379454|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64379455|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
64379456|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
64379457|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379458|NCT02151058|Listerine|listerine|mesh-list
64379459|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
64379460|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
64379461|NCT02151058|Protective Agents|protective agents|mesh-ancestor
64379462|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379463|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64379464|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379465|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
64379466|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
64379467|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450485|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450486|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450487|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
64450488|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450489|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
64450490|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450491|NCT04411160|Protective Agents|protective agents|mesh-ancestor
64450492|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64450493|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
64628884|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
64628885|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64450494|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628891|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64628893|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
64628894|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64628895|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628896|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
64628897|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628898|NCT00002674|Analgesics|analgesics|mesh-ancestor
64628899|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
64628900|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628901|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
64628902|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64628903|NCT01743872|Dextrans|dextrans|mesh-list
64628904|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
64628905|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
64628906|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
64628907|NCT00002680|Tamoxifen|tamoxifen|mesh-list
64628908|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
64354196|NCT03432871|Niacinamide|niacinamide|mesh-list
64628909|NCT00002680|Melphalan|melphalan|mesh-list
64628910|NCT00002680|Thiotepa|thiotepa|mesh-list
64628911|NCT00002680|Megestrol|megestrol|mesh-list
64628912|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
64628913|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64628914|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
64628915|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628916|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64628917|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64628918|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
64628919|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64628920|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628921|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64301261|NCT03280407|Leucovorin|leucovorin|mesh-list
64628924|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628925|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628926|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64628927|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64628928|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64628929|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64628930|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64628931|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64628932|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
64628933|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64628934|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64628935|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64628936|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
64628937|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64628938|NCT00002692|Leucovorin|leucovorin|mesh-list
64628939|NCT00002692|Fluorouracil|fluorouracil|mesh-list
64628940|NCT00002692|Calcium|calcium|mesh-list
64628949|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
64628951|NCT00002692|Protective Agents|protective agents|mesh-ancestor
64379469|NCT02149264|Androgens|androgens|mesh-ancestor
64379514|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64379515|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64379516|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64379517|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
64379518|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628952|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
64628953|NCT00002692|Vitamins|vitamins|mesh-ancestor
64628954|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
64628955|NCT05293210|Dexamethasone|dexamethasone|mesh-list
64628956|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64628957|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
64628958|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
64628959|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628960|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628962|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
64628963|NCT05293210|Hormones|hormones|mesh-ancestor
64628964|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64628965|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64628966|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64628967|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
64628968|NCT01895348|Remifentanil|remifentanil|mesh-list
64628969|NCT01895348|Propofol|propofol|mesh-list
64628970|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64628971|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64628972|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628973|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64628974|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
64628975|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
64628976|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64628977|NCT01895348|Analgesics|analgesics|mesh-ancestor
64628978|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
64628979|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628980|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64628981|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64628982|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64628983|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
64628984|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64628985|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354269|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64628986|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64628993|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64628994|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64628995|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64628997|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
64628998|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64628999|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64629000|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379520|NCT02173054|Adapalene|adapalene|mesh-list
64379521|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64379522|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64379523|NCT02173054|Analgesics|analgesics|mesh-ancestor
64379524|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
64379525|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379574|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64379575|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64379606|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629001|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629002|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64629003|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64629005|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629006|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629008|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629009|NCT01121588|Crizotinib|crizotinib|mesh-list
64629010|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629011|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629012|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629013|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629014|NCT05266846|Bevacizumab|bevacizumab|mesh-list
64629015|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
64629016|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64629017|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629018|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64629019|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64629020|NCT05266846|Growth Substances|growth substances|mesh-ancestor
64301269|NCT03280407|Antidotes|antidotes|mesh-ancestor
64629021|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629022|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
64629023|NCT01113476|Gemcitabine|gemcitabine|mesh-list
64629024|NCT01113476|Paclitaxel|paclitaxel|mesh-list
64629025|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64629026|NCT01113476|Bevacizumab|bevacizumab|mesh-list
64629027|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64629028|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629029|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
64629030|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
64629031|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
64629032|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629033|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64629034|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64629035|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64629036|NCT01113476|Growth Substances|growth substances|mesh-ancestor
64629037|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629038|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
64629039|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629040|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
64629042|NCT01113476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629043|NCT01113476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629044|NCT01113476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629045|NCT01113476|Immunologic Factors|immunologic factors|mesh-ancestor
64629046|NCT05260684|Trametinib|trametinib|mesh-list
64629047|NCT05260684|Vemurafenib|vemurafenib|mesh-list
64629048|NCT05260684|Dabrafenib|dabrafenib|mesh-list
64629049|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629050|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629051|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629052|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301276|NCT03078842|Trace Elements|trace elements|mesh-ancestor
64629053|NCT01107236|Naproxen|naproxen|mesh-list
64629054|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64629055|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64629056|NCT01107236|Analgesics|analgesics|mesh-ancestor
64629057|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
64629058|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629059|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629060|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629061|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629062|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
64629063|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64629064|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629065|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629066|NCT00002704|Leucovorin|leucovorin|mesh-list
64629067|NCT00002704|Cytarabine|cytarabine|mesh-list
64379941|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64379942|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
64629068|NCT00002704|Dexamethasone|dexamethasone|mesh-list
64629069|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
64629070|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64629071|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64629072|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64629073|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
64629074|NCT00002704|Thiotepa|thiotepa|mesh-list
64629075|NCT00002704|Methotrexate|methotrexate|mesh-list
64629076|NCT00002704|Etoposide|etoposide|mesh-list
64629077|NCT00002704|Vincristine|vincristine|mesh-list
64629078|NCT00002704|Daunorubicin|daunorubicin|mesh-list
64629079|NCT00002704|Asparaginase|asparaginase|mesh-list
64629080|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
64629081|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
64629082|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629083|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
64629084|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629085|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629086|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629087|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
64629088|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629089|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629090|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64629091|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629092|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
64629093|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
64629094|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629095|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629096|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
64629097|NCT00002704|Hormones|hormones|mesh-ancestor
64629098|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629099|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629100|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64629101|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
64629102|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64450502|NCT02151773|Vaccines|vaccines|mesh-list
64450503|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
64629117|NCT00002704|Vitamins|vitamins|mesh-ancestor
64629118|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
64629119|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
64629120|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
64629121|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
64629122|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64629123|NCT00002716|Leucovorin|leucovorin|mesh-list
64629124|NCT00002716|Dexamethasone|dexamethasone|mesh-list
64629125|NCT00002716|Fluorouracil|fluorouracil|mesh-list
64629126|NCT00002716|Floxuridine|floxuridine|mesh-list
64629127|NCT00002716|Calcium|calcium|mesh-list
64629128|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
64629129|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629130|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
64629131|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
64629132|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629133|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629134|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629135|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
64629136|NCT00002716|Hormones|hormones|mesh-ancestor
64629137|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629138|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629139|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629140|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64629142|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379946|NCT02141620|Antidotes|antidotes|mesh-ancestor
64629143|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629144|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629145|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
64629146|NCT00002716|Antidotes|antidotes|mesh-ancestor
64629147|NCT00002716|Protective Agents|protective agents|mesh-ancestor
64629148|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
64629149|NCT00002716|Vitamins|vitamins|mesh-ancestor
64629150|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
64629151|NCT02533674|Gemcitabine|gemcitabine|mesh-list
64629152|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629153|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
64629154|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629155|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629156|NCT02533674|Antiviral Agents|antiviral agents|mesh-ancestor
64629157|NCT02533674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629158|NCT02533674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629159|NCT02533674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629160|NCT02533674|Immunologic Factors|immunologic factors|mesh-ancestor
64629161|NCT02533674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629162|NCT00002722|Leucovorin|leucovorin|mesh-list
64629163|NCT00002722|Fluorouracil|fluorouracil|mesh-list
64629164|NCT00002722|Calcium|calcium|mesh-list
64629165|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
64629166|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629167|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64629169|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
64629170|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629171|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629172|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629173|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
64629174|NCT00002722|Antidotes|antidotes|mesh-ancestor
64629175|NCT00002722|Protective Agents|protective agents|mesh-ancestor
64629176|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
64629177|NCT00002722|Vitamins|vitamins|mesh-ancestor
64629178|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
64629179|NCT00002734|Interferons|interferons|mesh-list
64629180|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
64629181|NCT00002734|Paclitaxel|paclitaxel|mesh-list
64629182|NCT00002734|Topotecan|topotecan|mesh-list
64629183|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64629184|NCT00002734|Antibodies|antibodies|mesh-list
64629185|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
64629186|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64629187|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64629188|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629189|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64629190|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64629191|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64629192|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629193|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
64629194|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629195|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
64629196|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629197|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64629198|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629199|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629200|NCT04783610|Ethanol|ethanol|mesh-list
64629201|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64629202|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629203|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629204|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629206|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
64629207|NCT00002740|Carboplatin|carboplatin|mesh-list
64629208|NCT00002740|Doxorubicin|doxorubicin|mesh-list
64629209|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64629210|NCT00002740|Etoposide|etoposide|mesh-list
64629211|NCT00002740|Vincristine|vincristine|mesh-list
64629212|NCT00002740|Lenograstim|lenograstim|mesh-list
64629213|NCT00002740|Mesna|mesna|mesh-list
64629214|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629215|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
64379989|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64629216|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629217|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629218|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629219|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
64629220|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629221|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629227|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64629228|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64629229|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
64629230|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
64629231|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
64629232|NCT00002740|Protective Agents|protective agents|mesh-ancestor
64629233|NCT00002740|Trace Elements|trace elements|mesh-ancestor
64629234|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
64629235|NCT00002746|Aldesleukin|aldesleukin|mesh-list
64629236|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629237|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64629238|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64629239|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
64629240|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629241|NCT01049945|Dexamethasone|dexamethasone|mesh-list
64629242|NCT01049945|Lenalidomide|lenalidomide|mesh-list
64629243|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64629244|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629245|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
64629246|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
64629247|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629248|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629249|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629250|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
64629252|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629253|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629254|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629255|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
64629256|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64629257|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64629258|NCT01049945|Growth Substances|growth substances|mesh-ancestor
64629259|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
64629260|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629261|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
64629262|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629264|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64629265|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
64629266|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629267|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
64629268|NCT05465226|Narcotics|narcotics|mesh-ancestor
64629269|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629270|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629271|NCT05465226|Analgesics|analgesics|mesh-ancestor
64629272|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
64629273|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629274|NCT05070754|Cantharidin|cantharidin|mesh-list
64629275|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629276|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629277|NCT01050647|Castor Oil|castor oil|mesh-list
64629278|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
64629279|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64629280|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64629281|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
64629282|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629283|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629284|NCT01050647|Progestins|progestins|mesh-ancestor
64629285|NCT01050647|Hormones|hormones|mesh-ancestor
64629286|NCT01050647|Cathartics|cathartics|mesh-ancestor
64629287|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629288|NCT04825678|Erenumab|erenumab|mesh-list
64629289|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64629290|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629291|NCT04825678|Analgesics|analgesics|mesh-ancestor
64629292|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
64629293|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629294|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629296|NCT00002764|Doxorubicin|doxorubicin|mesh-list
64629297|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64629298|NCT00002764|Ifosfamide|ifosfamide|mesh-list
64629299|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64629300|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629301|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64629302|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629303|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629304|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629305|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629306|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
64629307|NCT01688492|Ipilimumab|ipilimumab|mesh-list
64629308|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64629309|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629310|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64629311|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629312|NCT05167175|Prednisone|prednisone|mesh-list
64629314|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
64629315|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629316|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
64629317|NCT05167175|Hormones|hormones|mesh-ancestor
64629318|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629319|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629320|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629321|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629322|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64629323|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629324|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629325|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64629326|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
64629327|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64629328|NCT00002788|Dexamethasone|dexamethasone|mesh-list
64629329|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
64629330|NCT00002788|Etoposide|etoposide|mesh-list
64629331|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629332|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
64629333|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629334|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629335|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629336|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
64629337|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629338|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629339|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64629340|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629341|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
64629342|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
64629343|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629344|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64450518|NCT02091986|Hormones|hormones|mesh-ancestor
64629345|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
64629346|NCT00002788|Hormones|hormones|mesh-ancestor
64301324|NCT03280095|Codeine|codeine|mesh-list
64629347|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629348|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629349|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64629350|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64629351|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629352|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629353|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
64629354|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
64629355|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64629356|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64629357|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629358|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629359|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629360|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629361|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
64629362|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
64629363|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629364|NCT04783792|Protective Agents|protective agents|mesh-ancestor
64629365|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629366|NCT04783792|Vitamins|vitamins|mesh-ancestor
64354640|NCT03173053|Renal Agents|renal agents|mesh-ancestor
64629367|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
64629368|NCT05002816|Elotuzumab|elotuzumab|mesh-list
64629369|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629370|NCT01676402|Vaccines|vaccines|mesh-list
64629371|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
64629372|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629373|NCT01052831|Naltrexone|naltrexone|mesh-list
64629374|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64629375|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64450530|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
64450531|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
64450532|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450533|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450534|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
64450535|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450536|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450537|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64450538|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
64450539|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64450540|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450542|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
64450543|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450544|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450579|NCT02091206|Cannabidiol|cannabidiol|mesh-list
64450580|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
64450581|NCT02062658|Ketamine|ketamine|mesh-list
64629376|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629377|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
64629378|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629380|NCT04330300|Verapamil|verapamil|mesh-list
64629381|NCT04330300|Felodipine|felodipine|mesh-list
64629382|NCT04330300|Amlodipine|amlodipine|mesh-list
64629383|NCT04330300|Valsartan|valsartan|mesh-list
64629384|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64629385|NCT04330300|Telmisartan|telmisartan|mesh-list
64629386|NCT04330300|Candesartan|candesartan|mesh-list
64629387|NCT04330300|Ramipril|ramipril|mesh-list
64629388|NCT04330300|Olmesartan|olmesartan|mesh-list
64629389|NCT04330300|Enalapril|enalapril|mesh-list
64629390|NCT04330300|Lisinopril|lisinopril|mesh-list
64629391|NCT04330300|Irbesartan|irbesartan|mesh-list
64629392|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
64629393|NCT04330300|Perindopril|perindopril|mesh-list
64629394|NCT04330300|Diltiazem|diltiazem|mesh-list
64629395|NCT04330300|Benazepril|benazepril|mesh-list
64629396|NCT04330300|Captopril|captopril|mesh-list
64629397|NCT04330300|Indapamide|indapamide|mesh-list
64629398|NCT04330300|Nicardipine|nicardipine|mesh-list
64629399|NCT04330300|Nimodipine|nimodipine|mesh-list
64629400|NCT04330300|Quinapril|quinapril|mesh-list
64629401|NCT04330300|Metolazone|metolazone|mesh-list
64629402|NCT04330300|Trandolapril|trandolapril|mesh-list
64629403|NCT04330300|Fosinopril|fosinopril|mesh-list
64629404|NCT04330300|Eprosartan|eprosartan|mesh-list
64629405|NCT04330300|Nitrendipine|nitrendipine|mesh-list
64629406|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
64629407|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
64629408|NCT04330300|Nifedipine|nifedipine|mesh-list
64629409|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
64629410|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64629411|NCT04330300|Diuretics|diuretics|mesh-list
64629412|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64629413|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64629414|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629415|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64629416|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301336|NCT04463030|Vitamins|vitamins|mesh-list
64629419|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64629420|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64629421|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
64629422|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64629423|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
64629424|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629425|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
64629426|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64629427|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64629428|NCT04330300|Protective Agents|protective agents|mesh-ancestor
64629429|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
64629430|NCT04352855|Tazobactam|tazobactam|mesh-list
64629431|NCT04352855|Ceftolozane|ceftolozane|mesh-list
64629432|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64629433|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64629434|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629435|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64629436|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629437|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629438|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64629439|NCT04352855|Renal Agents|renal agents|mesh-ancestor
64629440|NCT04757584|Propranolol|propranolol|mesh-list
64629441|NCT04757584|Metoprolol|metoprolol|mesh-list
64629442|NCT04757584|Atenolol|atenolol|mesh-list
64629443|NCT04757584|Sotalol|sotalol|mesh-list
64629444|NCT04757584|Nadolol|nadolol|mesh-list
64629445|NCT04757584|Acebutolol|acebutolol|mesh-list
64629446|NCT04757584|Carvedilol|carvedilol|mesh-list
64629447|NCT04757584|Nebivolol|nebivolol|mesh-list
64450582|NCT02062658|Analgesics|analgesics|mesh-ancestor
64629448|NCT04757584|Bisoprolol|bisoprolol|mesh-list
64629449|NCT04757584|Labetalol|labetalol|mesh-list
64629450|NCT04757584|Pindolol|pindolol|mesh-list
64629451|NCT04757584|Betaxolol|betaxolol|mesh-list
64629452|NCT04757584|Penbutolol|penbutolol|mesh-list
64629453|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64629454|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64629455|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
64629456|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629457|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629458|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629459|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64629460|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64629461|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
64629462|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
64629463|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
64629464|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629465|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64629466|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
64629467|NCT04757584|Protective Agents|protective agents|mesh-ancestor
64629468|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64629469|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64629470|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64629471|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64629472|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64629473|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64629474|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64629475|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64629476|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
64629477|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64629478|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
64629479|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
64629480|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64629481|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64629482|NCT04782128|Growth Substances|growth substances|mesh-ancestor
64629483|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629484|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
64629485|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629486|NCT04354012|Gentian Violet|gentian violet|mesh-list
64629487|NCT04354012|Methylene Blue|methylene blue|mesh-list
64629488|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629489|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629490|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64629491|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629492|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
64629493|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64629494|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
64629495|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64629496|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629497|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64629498|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64629499|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64629500|NCT00382642|Ondansetron|ondansetron|mesh-list
64629501|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
64629502|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
64629503|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629504|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450594|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450595|NCT02115308|Regadenoson|regadenoson|mesh-list
64450596|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64450597|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64450598|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
64450599|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
64450600|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629505|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64380669|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
64380755|NCT05663073|Amlodipine|amlodipine|mesh-list
64629506|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
64629507|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
64629508|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64629509|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
64629510|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629511|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629512|NCT00382642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64629513|NCT00382642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64629514|NCT00382642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629515|NCT00382642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64629516|NCT00382642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64629518|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64629519|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629520|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64629521|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
64629522|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629523|NCT04338022|Teriflunomide|teriflunomide|mesh-list
64629524|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64629525|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354790|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
64629526|NCT04338022|Analgesics|analgesics|mesh-ancestor
64629527|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
64629528|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629529|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629530|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629531|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629532|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629533|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
64629534|NCT01054625|Zalutumumab|zalutumumab|mesh-list
64629535|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64629536|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629537|NCT02544750|Cannabidiol|cannabidiol|mesh-list
64629538|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
64629539|NCT01662050|Cytarabine|cytarabine|mesh-list
64629540|NCT01662050|Rituximab|rituximab|mesh-list
64629541|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64629542|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64629543|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629544|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
64629545|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629546|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629547|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629548|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
64629549|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629550|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
64629551|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629552|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629553|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629554|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
64450607|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64450608|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450609|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450610|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450611|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
64450612|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
64450614|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
64450615|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
64629555|NCT04748848|Azacitidine|azacitidine|mesh-list
64629557|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
64629558|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629559|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
64629560|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629561|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629562|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629563|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64629564|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
64629565|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64629566|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64629567|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64629568|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629569|NCT01620788|Losartan|losartan|mesh-list
64629570|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64629571|NCT01620788|Indapamide|indapamide|mesh-list
64629572|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64629573|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64629574|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64629575|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64629576|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629577|NCT01620788|Diuretics|diuretics|mesh-ancestor
64629578|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
64629579|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629580|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64629581|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64629582|NCT03014843|Bromides|bromides|mesh-list
64629583|NCT03014843|Naloxone|naloxone|mesh-list
64629584|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
64629585|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
64629586|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64629587|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629588|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
64629589|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629590|NCT04294264|Trifluridine|trifluridine|mesh-list
64629591|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
64629592|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629593|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
64629594|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629595|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
64450624|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64629596|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629597|NCT05081375|Enoxaparin|enoxaparin|mesh-list
64629598|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
64629599|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64629600|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64629601|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629602|NCT04755062|Micronutrients|micronutrients|mesh-list
64629603|NCT04755062|Trace Elements|trace elements|mesh-list
64629604|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629605|NCT03852797|Ketamine|ketamine|mesh-list
64629606|NCT03852797|Propofol|propofol|mesh-list
64629607|NCT03852797|Etomidate|etomidate|mesh-list
64629608|NCT03852797|Oxytocin|oxytocin|mesh-list
64629609|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64450625|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450626|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450627|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
64450629|NCT04742036|Paclitaxel|paclitaxel|mesh-list
64629610|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629611|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629612|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64629613|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
64629614|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
64629615|NCT03852797|Analgesics|analgesics|mesh-ancestor
64629616|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
64629617|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629618|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64629619|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64629620|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64381367|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381369|NCT03187691|Amphotericin B|amphotericin b|mesh-list
64381587|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64629621|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629622|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629623|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
64629624|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64629625|NCT01055171|Propranolol|propranolol|mesh-list
64629626|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64629627|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64629628|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
64629629|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629630|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629631|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629632|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64629633|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64629634|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
64629635|NCT01057277|Everolimus|everolimus|mesh-list
64629636|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629637|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629638|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
64629639|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629640|NCT00866840|Riluzole|riluzole|mesh-list
64629641|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
64629642|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64629643|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64629644|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629645|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629646|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629647|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64629648|NCT00866840|Protective Agents|protective agents|mesh-ancestor
64629650|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64629651|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64629652|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
64629653|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
64629654|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629655|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629656|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629657|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
64629658|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64629659|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
64629660|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629661|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629662|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64629663|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
64450639|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64450640|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
64450641|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450642|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450643|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
64450644|NCT02111096|Metformin|metformin|mesh-list
64450645|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64450646|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64629664|NCT01058993|Plerixafor|plerixafor|mesh-list
64450647|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450743|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64629665|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64629666|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64629667|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
64629668|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629669|NCT04652518|Pirfenidone|pirfenidone|mesh-list
64629670|NCT04652518|Analgesics|analgesics|mesh-ancestor
64629671|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
64629672|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629673|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629674|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64629675|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64381609|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64381611|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64381716|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
64381717|NCT05518383|Vincristine|vincristine|mesh-list
64629676|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629677|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629678|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629679|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64629680|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629681|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629682|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629683|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629684|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
64629685|NCT03850379|Levofloxacin|levofloxacin|mesh-list
64629687|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64629688|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629689|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64629690|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629691|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629692|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629693|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629694|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64629695|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64629696|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64629697|NCT03850379|Renal Agents|renal agents|mesh-ancestor
64629698|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64629699|NCT03014687|Cefdinir|cefdinir|mesh-list
64629700|NCT03014687|Cephalosporins|cephalosporins|mesh-list
64629701|NCT03014687|Trimethoprim|trimethoprim|mesh-list
64450744|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450745|NCT02058368|Tamsulosin|tamsulosin|mesh-list
64450746|NCT02058368|Dutasteride|dutasteride|mesh-list
64450747|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64450748|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64450749|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64450750|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
64450751|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629702|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
64629703|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629704|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64629705|NCT03014687|Renal Agents|renal agents|mesh-ancestor
64629706|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
64629707|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64629708|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64629709|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64629710|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629711|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629712|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64629713|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64629714|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64629715|NCT04199572|Acetaminophen|acetaminophen|mesh-list
64629716|NCT04199572|Diclofenac|diclofenac|mesh-list
64629717|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64629718|NCT04199572|Analgesics|analgesics|mesh-ancestor
64629719|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
64629720|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629721|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629722|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
64629723|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64629724|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629725|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629726|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64629727|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629728|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381718|NCT05518383|Idarubicin|idarubicin|mesh-list
64381719|NCT05518383|Carboplatin|carboplatin|mesh-list
64381720|NCT05518383|BB 1101|bb 1101|mesh-list
64381721|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381722|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
64381723|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381724|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629729|NCT00383032|Mifepristone|mifepristone|mesh-list
64629731|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
64629732|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64629733|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629734|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64629735|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64629736|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64629737|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
64629738|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64629739|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64629740|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
64629741|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629742|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
64629743|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64629744|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64450752|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450753|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450754|NCT02058368|Urological Agents|urological agents|mesh-ancestor
64450755|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64450756|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64450757|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450758|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
64450773|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64450774|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450775|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450776|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64450777|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64629745|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64629747|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64629749|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629750|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64629751|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64629752|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
64629753|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
64629754|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629755|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629756|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64629757|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629758|NCT04302454|Leuprolide|leuprolide|mesh-list
64381878|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381879|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381880|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381881|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64381882|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64381883|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381884|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381885|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
64381886|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381887|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629759|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64629760|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
64629761|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64629762|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629763|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629764|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629766|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64629767|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64629768|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629769|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629770|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64629771|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629772|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629773|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
64629774|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64629775|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
64629776|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64629777|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629779|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64629780|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64629781|NCT01059929|Fentanyl|fentanyl|mesh-list
64629782|NCT01059929|Midazolam|midazolam|mesh-list
64629783|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
64629784|NCT01059929|Propofol|propofol|mesh-list
64629785|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64629786|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629787|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629788|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64629789|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
64629790|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
64629791|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64629792|NCT01059929|Analgesics|analgesics|mesh-ancestor
64629793|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
64450778|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64450779|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450780|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450781|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450782|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
64450783|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64450784|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
64450785|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64450786|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64450787|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629795|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64629796|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64629797|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64629798|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
64629799|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629800|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629801|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64629802|NCT01059929|Narcotics|narcotics|mesh-ancestor
64629803|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64629804|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64629805|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64629806|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64629807|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
64629808|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
64629809|NCT04828031|Vitamin D|vitamin d|mesh-list
64629810|NCT04828031|Vitamins|vitamins|mesh-ancestor
64629811|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
64629812|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629813|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64629814|NCT04162522|Citalopram|citalopram|mesh-list
64629815|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
64629816|NCT04162522|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64629817|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64629818|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64629819|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629820|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64629821|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
64629822|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629823|NCT04162522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64629825|NCT04162522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64629826|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
64629827|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
64629828|NCT04896658|Dexamethasone|dexamethasone|mesh-list
64629829|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
64629830|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629831|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
64629832|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629833|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629834|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629835|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
64450788|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64450789|NCT02106884|Gemcitabine|gemcitabine|mesh-list
64450790|NCT02106884|Paclitaxel|paclitaxel|mesh-list
64450791|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64450792|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450793|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
64450794|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
64450795|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
64450796|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450797|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450798|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
64450799|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
64629836|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629837|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629838|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64629839|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629840|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
64629841|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
64629842|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629843|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382369|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64382370|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64382371|NCT02139046|Analgesics|analgesics|mesh-ancestor
64382372|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
64382373|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382374|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382375|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382376|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382377|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
64629844|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
64629846|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629847|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629848|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
64629849|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64629850|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64629851|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
64629852|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629853|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64629854|NCT04156828|Gemcitabine|gemcitabine|mesh-list
64629855|NCT04156828|Dexamethasone|dexamethasone|mesh-list
64629856|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
64629857|NCT04156828|Rituximab|rituximab|mesh-list
64629858|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64629859|NCT04156828|Carboplatin|carboplatin|mesh-list
64629860|NCT04156828|Antibodies|antibodies|mesh-list
64629861|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
64629862|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64629863|NCT04156828|Lenograstim|lenograstim|mesh-list
64629864|NCT04156828|BB 1101|bb 1101|mesh-list
64629865|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
64629866|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629867|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629868|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629869|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629870|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
64629871|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
64629872|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629873|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629874|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
64629875|NCT04156828|Hormones|hormones|mesh-ancestor
64629876|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629877|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64629878|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629879|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
64629880|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629881|NCT04156828|Antiviral Agents|antiviral agents|mesh-ancestor
64629882|NCT04156828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629883|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629884|NCT04156828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629885|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64629886|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
64629887|NCT01063049|Bisacodyl|bisacodyl|mesh-list
64629888|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64629889|NCT01063049|Cathartics|cathartics|mesh-ancestor
64629890|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629891|NCT01063049|Laxatives|laxatives|mesh-ancestor
64629892|NCT04883242|Dexamethasone|dexamethasone|mesh-list
64629894|NCT04883242|Pomalidomide|pomalidomide|mesh-list
64629895|NCT04883242|Ichthammol|ichthammol|mesh-list
64629896|NCT04883242|BB 1101|bb 1101|mesh-list
64629897|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64450924|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64450925|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64629898|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64629899|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
64629900|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
64629901|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64629902|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355193|NCT01236521|Analgesics|analgesics|mesh-list
64629903|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629904|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
64629906|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64629907|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64382421|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382422|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64382423|NCT02069392|Nicotine|nicotine|mesh-list
64382444|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64382445|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382446|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629908|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629909|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
64629910|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629911|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629912|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
64629913|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64629914|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64629915|NCT04883242|Growth Substances|growth substances|mesh-ancestor
64629916|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
64629917|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
64629918|NCT04104178|Clindamycin|clindamycin|mesh-list
64629919|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
64629920|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
64629921|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64629922|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629923|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64629924|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629925|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629926|NCT03661138|Upadacitinib|upadacitinib|mesh-list
64629927|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64629928|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629929|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629930|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629931|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629932|NCT04588792|Furosemide|furosemide|mesh-list
64629933|NCT04588792|Diuretics|diuretics|mesh-ancestor
64629934|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
64629935|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629936|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64629937|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64629938|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629940|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
64629941|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629942|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64629943|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64629944|NCT04075396|Lazertinib|lazertinib|mesh-list
64629945|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629946|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629947|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629948|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
64450926|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450927|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450928|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
64451047|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64629950|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64629951|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
64629952|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64629953|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629954|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64629955|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
64629956|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629957|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629958|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
64629959|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629960|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64629961|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64629962|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
64629963|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64629964|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64629965|NCT02181738|Doxorubicin|doxorubicin|mesh-list
64629966|NCT02181738|Nivolumab|nivolumab|mesh-list
64629967|NCT02181738|Dacarbazine|dacarbazine|mesh-list
64629968|NCT02181738|Vinblastine|vinblastine|mesh-list
64629969|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64629970|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629971|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64629972|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64629973|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629974|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64629975|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64629976|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64355253|NCT03416231|Docetaxel|docetaxel|mesh-list
64629977|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64629978|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
64629979|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64629980|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
64629981|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
64629982|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
64629983|NCT03998488|Psyllium|psyllium|mesh-list
64629984|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
64629985|NCT03998488|Cathartics|cathartics|mesh-ancestor
64629986|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64629987|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
64629988|NCT05426304|S 20098|s 20098|mesh-list
64629989|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64629990|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64629991|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64629992|NCT03955198|Durvalumab|durvalumab|mesh-list
64629993|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64629994|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629995|NCT04494958|Palbociclib|palbociclib|mesh-list
64629996|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64629997|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64629998|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64629999|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630000|NCT00382954|Bortezomib|bortezomib|mesh-list
64630001|NCT00382954|Idarubicin|idarubicin|mesh-list
64630002|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630003|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64451048|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64451049|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64451050|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64451051|NCT02059135|Antithrombins|antithrombins|mesh-list
64630004|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630005|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630006|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451052|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
64630007|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630008|NCT03342196|Fludarabine|fludarabine|mesh-list
64630009|NCT03342196|Melphalan|melphalan|mesh-list
64630010|NCT03342196|Thiotepa|thiotepa|mesh-list
64630011|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630012|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630013|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630014|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
64630015|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630016|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630017|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
64630018|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630019|NCT03274492|Prednisone|prednisone|mesh-list
64630020|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
64630021|NCT03274492|Rituximab|rituximab|mesh-list
64630022|NCT03274492|Doxorubicin|doxorubicin|mesh-list
64630023|NCT03274492|Vincristine|vincristine|mesh-list
64630024|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64630025|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
64630026|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630027|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
64630028|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630029|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630030|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630031|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
64630032|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630033|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630034|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630035|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64630036|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64630037|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630038|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630039|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630040|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64630041|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
64630042|NCT03274492|Hormones|hormones|mesh-ancestor
64630043|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630044|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630045|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630046|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630047|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630048|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630049|NCT01246063|Dexamethasone|dexamethasone|mesh-list
64630050|NCT01246063|Doxorubicin|doxorubicin|mesh-list
64630051|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64630052|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301426|NCT04940390|Analgesics|analgesics|mesh-ancestor
64630053|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
64630054|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
64630055|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630056|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630057|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64630058|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
64630059|NCT01246063|Hormones|hormones|mesh-ancestor
64630060|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630061|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630062|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630063|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64630064|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630065|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630066|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451059|NCT04720105|Tazarotene|tazarotene|mesh-list
64451060|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
64451061|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
64451062|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64451063|NCT04695769|Ribavirin|ribavirin|mesh-list
64451064|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
64451067|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
64630067|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630068|NCT03836014|Dexamethasone|dexamethasone|mesh-list
64630069|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
64630070|NCT03836014|Lenalidomide|lenalidomide|mesh-list
64630071|NCT03836014|Daratumumab|daratumumab|mesh-list
64630072|NCT03836014|BB 1101|bb 1101|mesh-list
64630073|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64630074|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64630075|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
64630076|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
64630077|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630078|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630079|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64630080|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
64630081|NCT03836014|Hormones|hormones|mesh-ancestor
64630082|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630083|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630084|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630085|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
64630086|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630087|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630088|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
64630089|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64630090|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64630091|NCT03836014|Growth Substances|growth substances|mesh-ancestor
64630092|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
64630093|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
64630094|NCT01205503|Doxorubicin|doxorubicin|mesh-list
64630095|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630096|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
64630097|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630098|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630099|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630100|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
64630101|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630102|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630103|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630104|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64630105|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630106|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630107|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630109|NCT03187834|Azithromycin|azithromycin|mesh-list
64630110|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64630111|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64630112|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630113|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64630114|NCT03187834|Renal Agents|renal agents|mesh-ancestor
64630115|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
64630116|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64630117|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64630118|NCT01206595|Bupivacaine|bupivacaine|mesh-list
64630119|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
64630120|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
64630121|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382773|NCT02416739|Niacin|niacin|mesh-list
64630122|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630123|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
64451069|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
64630124|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451070|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451071|NCT02038933|Nivolumab|nivolumab|mesh-list
64451072|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64451073|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451074|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64630125|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64630126|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64355402|NCT03413371|Analgesics|analgesics|mesh-ancestor
64630127|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630128|NCT01158703|Aspirin|aspirin|mesh-list
64630129|NCT01158703|Clopidogrel|clopidogrel|mesh-list
64630130|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64630131|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64630132|NCT01158703|Analgesics|analgesics|mesh-ancestor
64630133|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
64630134|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630135|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630136|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64630137|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630138|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64630139|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64630140|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630141|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64630142|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64630143|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630144|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
64630145|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64630146|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64630147|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64630148|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
64630149|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630150|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
64630151|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64630152|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
64630153|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630154|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630155|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64630156|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
64630157|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64630159|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630160|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630161|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64630162|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
64630163|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
64630164|NCT03009643|Protective Agents|protective agents|mesh-ancestor
64630165|NCT04275232|Plasminogen|plasminogen|mesh-list
64630166|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64630167|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64630168|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630169|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64630170|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
64630171|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630172|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64630173|NCT03091660|Vaccines|vaccines|mesh-list
64451096|NCT02079649|Dexamethasone|dexamethasone|mesh-list
64451097|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64451098|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64451099|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451100|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
64451101|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
64451102|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630174|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
64630175|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
64630176|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630177|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64630178|NCT04385368|Durvalumab|durvalumab|mesh-list
64630179|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64630180|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630181|NCT03786796|Olaparib|olaparib|mesh-list
64630182|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64630183|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630184|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630185|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630186|NCT03779854|Vidarabine|vidarabine|mesh-list
64630187|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
64630188|NCT03779854|Busulfan|busulfan|mesh-list
64630189|NCT03779854|Thiotepa|thiotepa|mesh-list
64630190|NCT03779854|Methotrexate|methotrexate|mesh-list
64630191|NCT03779854|Fludarabine|fludarabine|mesh-list
64630192|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
64630193|NCT03779854|Tacrolimus|tacrolimus|mesh-list
64630194|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630195|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
64630196|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630197|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630198|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630199|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
64630200|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630201|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630202|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630203|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64630204|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
64630205|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630206|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630207|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
64630208|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
64630209|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630210|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64301430|NCT02788279|Antibodies|antibodies|mesh-list
64630211|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630212|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64630213|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
64630214|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630215|NCT03089866|Midazolam|midazolam|mesh-list
64630216|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64630217|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64630218|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64630219|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630220|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64630221|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64630222|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64630223|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64630224|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
64630225|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
64630226|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
64630227|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
64630228|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382137|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
64382138|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382139|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382140|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
64382151|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
64382152|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
64382153|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64382154|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382156|NCT02422277|Urological Agents|urological agents|mesh-ancestor
64382172|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64382173|NCT02424461|Renal Agents|renal agents|mesh-ancestor
64382174|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64383074|NCT02413853|Calcium|calcium|mesh-list
64382175|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64382176|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382177|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382178|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382179|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64382180|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64382181|NCT02072824|Pregabalin|pregabalin|mesh-list
64382182|NCT02072824|Analgesics|analgesics|mesh-ancestor
64630229|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630231|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64630232|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630233|NCT00002896|Leucovorin|leucovorin|mesh-list
64630234|NCT00002896|Cobalt|cobalt|mesh-list
64630235|NCT00002896|Fluorouracil|fluorouracil|mesh-list
64630236|NCT00002896|Calcium|calcium|mesh-list
64630237|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
64630238|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64630239|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630240|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
64630241|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630242|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630243|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630244|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630245|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
64630246|NCT00002896|Antidotes|antidotes|mesh-ancestor
64630247|NCT00002896|Protective Agents|protective agents|mesh-ancestor
64630248|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
64630249|NCT00002896|Vitamins|vitamins|mesh-ancestor
64630250|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
64630251|NCT00002896|Trace Elements|trace elements|mesh-ancestor
64630252|NCT03077542|Sirolimus|sirolimus|mesh-list
64630253|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
64630254|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
64630255|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
64630256|NCT03077542|Pentostatin|pentostatin|mesh-list
64630257|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630258|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
64630259|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630260|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630261|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630262|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
64301448|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
64630263|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630264|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630265|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630266|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64630267|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630268|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64630269|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
64630270|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64630271|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
64630272|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630273|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630274|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64630275|NCT01249027|Everolimus|everolimus|mesh-list
64630276|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630277|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630278|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
64630279|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630280|NCT00002902|Irinotecan|irinotecan|mesh-list
64630281|NCT00002902|Raltitrexed|raltitrexed|mesh-list
64630282|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64630283|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64451135|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451293|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630284|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630285|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630286|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630287|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630288|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
64630289|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64630290|NCT02992756|Mitogens|mitogens|mesh-list
64630291|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630292|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630293|NCT01250899|Vitamin D|vitamin d|mesh-list
64630294|NCT01250899|Vitamins|vitamins|mesh-ancestor
64630295|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
64301461|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630296|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630297|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64630298|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64630299|NCT01212445|Laxatives|laxatives|mesh-list
64630300|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64630301|NCT00002908|Vincristine|vincristine|mesh-list
64630302|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
64630303|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630304|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630305|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630306|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630307|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630308|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630309|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64630310|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
64630311|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630312|NCT00002914|Piritrexim|piritrexim|mesh-list
64630313|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630314|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64630315|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630316|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630317|NCT00002920|Tamoxifen|tamoxifen|mesh-list
64630318|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64630319|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
64630320|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64630321|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
64630322|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630323|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630324|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630325|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630326|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64630327|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64630328|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64630329|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64630330|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64630331|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64630332|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
64630333|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630334|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64451294|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451295|NCT01823679|Capecitabine|capecitabine|mesh-list
64451296|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64451297|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
64451298|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451299|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451300|NCT01823289|Itraconazole|itraconazole|mesh-list
64451301|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
64301470|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301471|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64630335|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64630336|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64301472|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
64301476|NCT02788513|BI 425809|bi 425809|mesh-list
64630338|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64630339|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630340|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630341|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
64630342|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630343|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630344|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
64630345|NCT01161121|Adenosine|adenosine|mesh-list
64630346|NCT01161121|Regadenoson|regadenoson|mesh-list
64630347|NCT01161121|Analgesics|analgesics|mesh-ancestor
64630348|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
64630349|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630350|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630351|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64630352|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
64630353|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64630354|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
64630355|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
64630356|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630357|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630358|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64630359|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
64630360|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
64630361|NCT03010579|Hematinics|hematinics|mesh-list
64630362|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
64630363|NCT01214083|Naltrexone|naltrexone|mesh-list
64630364|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64630365|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64630366|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64630367|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630369|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630370|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
64630371|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630373|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
64630374|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64630375|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
64630376|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630377|NCT01214083|Protective Agents|protective agents|mesh-ancestor
64630378|NCT01214083|Antidotes|antidotes|mesh-ancestor
64630379|NCT01254877|Ondansetron|ondansetron|mesh-list
64630380|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
64630381|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
64630382|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630383|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630384|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64630385|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
64630386|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
64630387|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64630388|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
64630389|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630390|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630391|NCT01254877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64630392|NCT01254877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64630393|NCT01254877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64630394|NCT01254877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64451305|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383095|NCT00704483|Sevelamer|sevelamer|mesh-list
64383134|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383146|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64383147|NCT02569437|Prednisolone|prednisolone|mesh-list
64383148|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
64383149|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64383150|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
64383151|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383152|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
64383153|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
64451306|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451307|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64451324|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64451326|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64630395|NCT01254877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64630396|NCT02189317|Bupivacaine|bupivacaine|mesh-list
64630397|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
64630398|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
64630399|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64630401|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
64630402|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630404|NCT03713944|Carboplatin|carboplatin|mesh-list
64630405|NCT03713944|Pemetrexed|pemetrexed|mesh-list
64630406|NCT03713944|Atezolizumab|atezolizumab|mesh-list
64630407|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64630408|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630409|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64630410|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64630411|NCT03713944|Growth Substances|growth substances|mesh-ancestor
64630412|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630413|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
64630414|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630415|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630416|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64630417|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630418|NCT01214161|Lidocaine|lidocaine|mesh-list
64630419|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
64630420|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
64630421|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64630422|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630423|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
64630424|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630425|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64630426|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64383155|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383156|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64383189|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383190|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383191|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64383192|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630427|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64630428|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64630429|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630430|NCT02945800|Gemcitabine|gemcitabine|mesh-list
64630431|NCT02945800|Paclitaxel|paclitaxel|mesh-list
64630432|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630434|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630435|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630436|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630437|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630438|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630439|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
64630440|NCT02945800|Antiviral Agents|antiviral agents|mesh-ancestor
64630441|NCT02945800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630442|NCT02945800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630443|NCT02945800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630444|NCT02945800|Immunologic Factors|immunologic factors|mesh-ancestor
64630445|NCT02945800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630446|NCT02981329|Metformin|metformin|mesh-list
64630447|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64630448|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630449|NCT00383656|Hormones|hormones|mesh-list
64630450|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630451|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630452|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
64630453|NCT01214317|Analgesics|analgesics|mesh-ancestor
64630454|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
64630455|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630456|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630457|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630458|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630459|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630460|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630461|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630462|NCT00383812|Bevacizumab|bevacizumab|mesh-list
64630463|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64630464|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630465|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64630466|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64630467|NCT00383812|Growth Substances|growth substances|mesh-ancestor
64630468|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630469|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
64630470|NCT02189629|Trifarotene|trifarotene|mesh-list
64630471|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64630472|NCT00002926|Cytarabine|cytarabine|mesh-list
64630473|NCT00002926|Etoposide|etoposide|mesh-list
64630474|NCT00002926|Idarubicin|idarubicin|mesh-list
64630475|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630476|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630477|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630478|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630479|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630480|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630481|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630482|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
64630483|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
64630484|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630485|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630486|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
64630487|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630490|NCT01281007|Famciclovir|famciclovir|mesh-list
64630491|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
64630492|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630493|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630494|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630495|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630497|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
64630498|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630499|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630500|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630501|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630502|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630503|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630504|NCT01281475|Levodopa|levodopa|mesh-list
64630505|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64630506|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64630507|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
64630508|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630509|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630510|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630511|NCT00002932|Cisplatin|cisplatin|mesh-list
64630512|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630513|NCT01572662|Methotrexate|methotrexate|mesh-list
64630514|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
64630515|NCT01572662|Fludarabine|fludarabine|mesh-list
64630516|NCT01572662|Busulfan|busulfan|mesh-list
64630517|NCT01572662|Tacrolimus|tacrolimus|mesh-list
64630518|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64630519|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
64630520|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630521|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451330|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451331|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
64451332|NCT01822821|Acetaminophen|acetaminophen|mesh-list
64451333|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64451334|NCT01822821|Analgesics|analgesics|mesh-ancestor
64451338|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
64630523|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
64630524|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630525|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630526|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
64630527|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630528|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64630529|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630530|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
64630531|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630532|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630533|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64630534|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
64630535|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630536|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630538|NCT02822092|Aripiprazole|aripiprazole|mesh-list
64630539|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64630540|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
64630541|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383228|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64383229|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
64383230|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383231|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64383232|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64383233|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383234|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
64383235|NCT05515185|Fludarabine|fludarabine|mesh-list
64383237|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
64630542|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630543|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630544|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64630545|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64630546|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64630547|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64630548|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64630549|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
64630550|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
64630551|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
64630552|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64630553|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64630554|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64630555|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64630556|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64630557|NCT01258153|MEN 11420|men 11420|mesh-list
64630558|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64630559|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
64630560|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630561|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630562|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64630563|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
64630564|NCT01555268|Cytarabine|cytarabine|mesh-list
64630565|NCT01555268|Trebananib|trebananib|mesh-list
64630566|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630567|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
64630568|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630569|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630570|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
64630571|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630572|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630573|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
64630574|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630575|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64630576|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64630577|NCT01555268|Growth Substances|growth substances|mesh-ancestor
64630578|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
64630579|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64451342|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64451343|NCT01822665|Analgesics|analgesics|mesh-ancestor
64451344|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
64451379|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
64451380|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451382|NCT01821729|Fluorouracil|fluorouracil|mesh-list
64451383|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
64451384|NCT01821729|Folfirinox|folfirinox|mesh-list
64451385|NCT01821729|Losartan|losartan|mesh-list
64630580|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630581|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
64630582|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64630583|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
64630584|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630585|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64630586|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630587|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630588|NCT04781270|Bevacizumab|bevacizumab|mesh-list
64630589|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64630590|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383275|NCT04871529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383276|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
64383277|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383278|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383279|NCT02044510|Mirabegron|mirabegron|mesh-list
64630591|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64630592|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64630593|NCT04781270|Growth Substances|growth substances|mesh-ancestor
64630594|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630595|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
64630597|NCT00003388|Prednisone|prednisone|mesh-list
64630598|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
64630599|NCT00003388|Doxorubicin|doxorubicin|mesh-list
64630600|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64630601|NCT00003388|Methotrexate|methotrexate|mesh-list
64630602|NCT00003388|Vincristine|vincristine|mesh-list
64630603|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630604|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
64630605|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630606|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630607|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630608|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
64630609|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630610|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630611|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630612|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64630613|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630614|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630615|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630616|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64630617|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
64630618|NCT00003388|Hormones|hormones|mesh-ancestor
64630619|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630620|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630621|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64630622|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
64630623|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630624|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630625|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
64630626|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
64630627|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64630628|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630629|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
64630630|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301523|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630632|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630633|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630634|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630635|NCT00003394|Paclitaxel|paclitaxel|mesh-list
64630636|NCT00003394|Carboplatin|carboplatin|mesh-list
64630637|NCT00003394|Leuprolide|leuprolide|mesh-list
64630638|NCT00003394|Goserelin|goserelin|mesh-list
64630639|NCT00003394|Estramustine|estramustine|mesh-list
64630640|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64451450|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
64451451|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451452|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630641|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630642|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630643|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630644|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630645|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630646|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64383288|NCT02411903|Clopidogrel|clopidogrel|mesh-list
64383289|NCT02411903|Atorvastatin|atorvastatin|mesh-list
64383290|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64383308|NCT05510895|Cetuximab|cetuximab|mesh-list
64630647|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
64630648|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630649|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630650|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630651|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630652|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
64630654|NCT00003400|Vinorelbine|vinorelbine|mesh-list
64630655|NCT00003400|Carmustine|carmustine|mesh-list
64630656|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630657|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
64630658|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630659|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630660|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
64630661|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630662|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630663|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630664|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630665|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630666|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630667|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630669|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
64301530|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64630672|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64630673|NCT00002944|Carboplatin|carboplatin|mesh-list
64630674|NCT00002944|Vincristine|vincristine|mesh-list
64630675|NCT00002944|Thioguanine|thioguanine|mesh-list
64630676|NCT00002944|Lomustine|lomustine|mesh-list
64630677|NCT00002944|Procarbazine|procarbazine|mesh-list
64630678|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630679|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630680|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630681|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630682|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630683|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630684|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630685|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
64630686|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630687|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
64630688|NCT04778072|Iron|iron|mesh-list
64630689|NCT04778072|Trace Elements|trace elements|mesh-ancestor
64630690|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
64630691|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630692|NCT00002950|Topotecan|topotecan|mesh-list
64630693|NCT00002950|Sargramostim|sargramostim|mesh-list
64630694|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64451513|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64630695|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630696|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451514|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451515|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451516|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383310|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630697|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630698|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630699|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
64630700|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630702|NCT00777140|Siderophores|siderophores|mesh-ancestor
64630703|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64630704|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
64630705|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
64630706|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630707|NCT00003406|Carboplatin|carboplatin|mesh-list
64630708|NCT00003406|Docetaxel|docetaxel|mesh-list
64630709|NCT00003406|Ifosfamide|ifosfamide|mesh-list
64630710|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630711|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630712|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630713|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630714|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630715|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630716|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
64630717|NCT00003412|Interleukin-12|interleukin-12|mesh-list
64630718|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64630719|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
64630720|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630721|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64630722|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64630723|NCT00003412|Growth Substances|growth substances|mesh-ancestor
64630724|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
64630726|NCT04301492|Vortioxetine|vortioxetine|mesh-list
64630727|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
64630728|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64630729|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64630730|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64630731|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356002|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
64630732|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630733|NCT04301492|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64630734|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64630736|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630737|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630738|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
64630739|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64630740|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64630741|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64630742|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64630744|NCT04780958|Vitamins|vitamins|mesh-ancestor
64630745|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
64630746|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630747|NCT00002968|Edrecolomab|edrecolomab|mesh-list
64451530|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64451531|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451532|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64451533|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64451534|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64451535|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451536|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451537|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64451538|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
64451539|NCT01846299|Ranibizumab|ranibizumab|mesh-list
64451540|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64630748|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64630749|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
64630750|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630751|NCT04780412|Alprostadil|alprostadil|mesh-list
64630752|NCT04780412|Misoprostol|misoprostol|mesh-list
64630753|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64630754|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
64630755|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630756|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630757|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64630758|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64630759|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
64630760|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64630761|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
64630762|NCT04780412|Urological Agents|urological agents|mesh-ancestor
64630763|NCT00002974|Carboplatin|carboplatin|mesh-list
64301534|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64301535|NCT02458209|Bococizumab|bococizumab|mesh-list
64301536|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64301537|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64301538|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
64301539|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301540|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64301541|NCT02127151|Talazoparib|talazoparib|mesh-list
64301542|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64301543|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630764|NCT00002974|Etoposide|etoposide|mesh-list
64630765|NCT00002974|Ifosfamide|ifosfamide|mesh-list
64630766|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630767|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630768|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64630769|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630770|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630771|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630772|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630773|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
64630774|NCT00754364|Gemcitabine|gemcitabine|mesh-list
64630775|NCT00754364|Carboplatin|carboplatin|mesh-list
64630776|NCT00754364|Pemetrexed|pemetrexed|mesh-list
64451557|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451558|NCT01846221|Analgesics|analgesics|mesh-ancestor
64451559|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
64451560|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451561|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64451562|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64630777|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630778|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630779|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
64630780|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630781|NCT00754364|Antiviral Agents|antiviral agents|mesh-ancestor
64630782|NCT00754364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630783|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630784|NCT00754364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630785|NCT00754364|Immunologic Factors|immunologic factors|mesh-ancestor
64630786|NCT00754364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630787|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64630788|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630789|NCT02612896|Praziquantel|praziquantel|mesh-list
64630790|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
64630791|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64630792|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630794|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630795|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
64630796|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630797|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630798|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301545|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630799|NCT00002986|Topotecan|topotecan|mesh-list
64630800|NCT00002986|Carmustine|carmustine|mesh-list
64630801|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64630802|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630803|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383614|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64383615|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64383616|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64383617|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
64630804|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630805|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630806|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630807|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
64630808|NCT00003418|Tamoxifen|tamoxifen|mesh-list
64356074|NCT02375295|Trimethoprim|trimethoprim|mesh-list
64630809|NCT00003418|Exemestane|exemestane|mesh-list
64630810|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630811|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64630812|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
64630813|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630814|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630815|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630816|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630817|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64630818|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64630819|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64630820|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64630821|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64630822|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630823|NCT04777838|Amitriptyline|amitriptyline|mesh-list
64630824|NCT04777838|Citalopram|citalopram|mesh-list
64630825|NCT04777838|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64630826|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64630827|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64630828|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630829|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64630830|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
64451563|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
64451564|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
64451565|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64451566|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
64451567|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
64451568|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64451569|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64630831|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630833|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
64630834|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64630835|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630836|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64630837|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64630838|NCT04777838|Analgesics|analgesics|mesh-ancestor
64630839|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
64630840|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64301551|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301552|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301553|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301554|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64301555|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64301556|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64630851|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64630852|NCT02494258|Azacitidine|azacitidine|mesh-list
64630854|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630855|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
64630856|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630857|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630858|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630859|NCT00002998|Gemcitabine|gemcitabine|mesh-list
64630860|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630861|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630862|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
64630863|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630864|NCT00002998|Antiviral Agents|antiviral agents|mesh-ancestor
64630865|NCT00002998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630866|NCT00002998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630867|NCT00002998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630868|NCT00002998|Immunologic Factors|immunologic factors|mesh-ancestor
64630869|NCT00002998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630870|NCT00003004|Paclitaxel|paclitaxel|mesh-list
64630871|NCT00003004|Alvocidib|alvocidib|mesh-list
64630872|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630873|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630874|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630875|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
64630876|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630877|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630878|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
64630879|NCT00003004|Growth Substances|growth substances|mesh-ancestor
64630887|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630888|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
64630889|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630891|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630892|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630893|NCT00003436|Cytarabine|cytarabine|mesh-list
64630894|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
64630895|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64451573|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451574|NCT01845831|Metformin|metformin|mesh-list
64451575|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
64451576|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64451577|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451578|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451579|NCT01845831|Incretins|incretins|mesh-ancestor
64451580|NCT01845831|Hormones|hormones|mesh-ancestor
64451581|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451582|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64630896|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64630897|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64630898|NCT00003436|Methotrexate|methotrexate|mesh-list
64630899|NCT00003436|Etoposide|etoposide|mesh-list
64630900|NCT00003436|Daunorubicin|daunorubicin|mesh-list
64630901|NCT00003436|Asparaginase|asparaginase|mesh-list
64630902|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
64630903|NCT00003436|Amsacrine|amsacrine|mesh-list
64630904|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64630905|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
64630906|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64630907|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630908|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64630909|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
64630910|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630911|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630912|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
64630913|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630914|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64630915|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630916|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
64630917|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630918|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64630919|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64630922|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
64630923|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64630924|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64630925|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64630926|NCT00003436|Analgesics|analgesics|mesh-ancestor
64630927|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
64630928|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630929|NCT02432378|Celecoxib|celecoxib|mesh-list
64630930|NCT02432378|Cisplatin|cisplatin|mesh-list
64630931|NCT02432378|Vaccines|vaccines|mesh-list
64630932|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
64630933|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630934|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630935|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64630936|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64630937|NCT02432378|Analgesics|analgesics|mesh-ancestor
64630938|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
64630939|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64630940|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64630941|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630942|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64630943|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64630944|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630945|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451584|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630946|NCT00003466|Temozolomide|temozolomide|mesh-list
64630947|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630948|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
64630949|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451585|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451680|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
64451681|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451682|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64451683|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451684|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451685|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451686|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
64630951|NCT00003478|Antibodies|antibodies|mesh-list
64630952|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64630953|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
64630954|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630955|NCT00003016|Tamoxifen|tamoxifen|mesh-list
64630956|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64356237|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
64630957|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
64630958|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64630959|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630960|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64630961|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630962|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64301559|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64301560|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64301562|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64301563|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383695|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64383696|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383697|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383698|NCT05508633|Mebeverine|mebeverine|mesh-list
64383699|NCT05508633|Alverine|alverine|mesh-list
64383700|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
64383701|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
64383702|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383703|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383704|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
64383705|NCT04482257|Irinotecan|irinotecan|mesh-list
64301564|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
64630965|NCT00003022|Antibodies|antibodies|mesh-list
64630966|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64630967|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
64630968|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630969|NCT01258387|Mitogens|mitogens|mesh-list
64630970|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
64630971|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630972|NCT00003484|Irinotecan|irinotecan|mesh-list
64630973|NCT00003484|Carmustine|carmustine|mesh-list
64630974|NCT00003484|Antibodies|antibodies|mesh-list
64630975|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64630976|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
64630977|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630978|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64630979|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64630980|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64630981|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630982|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630983|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630984|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
64630985|NCT00003490|Prednisone|prednisone|mesh-list
64630986|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
64630987|NCT00003490|Vincristine|vincristine|mesh-list
64630988|NCT00003490|Sargramostim|sargramostim|mesh-list
64630989|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64630990|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
64630991|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64630992|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64630993|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64630994|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
64630995|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64630996|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64630997|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64630998|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64630999|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
64631000|NCT00003490|Hormones|hormones|mesh-ancestor
64451692|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451693|NCT02138825|Riociguat|riociguat|mesh-list
64451694|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
64451695|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451696|NCT02138747|Mirabegron|mirabegron|mesh-list
64451697|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64451698|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64631001|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64631002|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64631003|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631004|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631005|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631006|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631007|NCT00003034|Doxorubicin|doxorubicin|mesh-list
64631008|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64631009|NCT00003034|Ranpirnase|ranpirnase|mesh-list
64631010|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631011|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631012|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631013|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631014|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631015|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631016|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64631017|NCT03584516|Prednisone|prednisone|mesh-list
64631018|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
64631019|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64631020|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64631021|NCT03584516|Prednisolone|prednisolone|mesh-list
64631022|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
64631023|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64631024|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
64631025|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64631026|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
64631027|NCT03584516|Hormones|hormones|mesh-ancestor
64631028|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64631029|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631030|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64631031|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631032|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
64631033|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
64631034|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631035|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64631036|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64631037|NCT03584516|Protective Agents|protective agents|mesh-ancestor
64631038|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
64631039|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64631040|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631041|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451704|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451705|NCT02138747|Urological Agents|urological agents|mesh-ancestor
64451706|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64451707|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64451708|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
64451709|NCT02105285|Carteolol|carteolol|mesh-list
64451710|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64451711|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64451712|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64451728|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451729|NCT02030041|Vitamin D|vitamin d|mesh-list
64451730|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
64451731|NCT02030041|Simvastatin|simvastatin|mesh-list
64451732|NCT02030041|Vitamins|vitamins|mesh-ancestor
64451733|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
64631042|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64631043|NCT00383890|Analgesics|analgesics|mesh-ancestor
64631044|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
64631045|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631046|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64631047|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64631048|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64631049|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
64631050|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631053|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64631054|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
64631055|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631056|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64631057|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64631058|NCT00003046|Growth Substances|growth substances|mesh-ancestor
64631059|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
64631060|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631061|NCT00003052|Doxorubicin|doxorubicin|mesh-list
64631062|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64631063|NCT00003052|Etoposide|etoposide|mesh-list
64631064|NCT00003052|Ifosfamide|ifosfamide|mesh-list
64631065|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631066|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631067|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631068|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631069|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631070|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631071|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631072|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631073|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
64383750|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
64383874|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
64631074|NCT00003058|Troglitazone|troglitazone|mesh-list
64631075|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64631076|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631077|NCT04775732|Infliximab|infliximab|mesh-list
64631078|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631079|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64631080|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631081|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64631082|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64631083|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64631084|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631085|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631086|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64631087|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64631088|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64631089|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
64631090|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631091|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631092|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64631093|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64631094|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
64631095|NCT00003064|Paclitaxel|paclitaxel|mesh-list
64631096|NCT00003064|Etoposide|etoposide|mesh-list
64631097|NCT00003064|Carboplatin|carboplatin|mesh-list
64451734|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451735|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64451736|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64451744|NCT01844505|Nivolumab|nivolumab|mesh-list
64631099|NCT00003064|Thiotepa|thiotepa|mesh-list
64631100|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
64631101|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631102|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631103|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631104|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631105|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631106|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631107|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64356421|NCT03392623|Niacin|niacin|mesh-list
64631108|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631109|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631110|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
64631111|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631112|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64631113|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631114|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
64631115|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631116|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631118|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64631119|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631120|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631121|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631122|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631123|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
64631124|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64631125|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631126|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
64631127|NCT01269424|Temozolomide|temozolomide|mesh-list
64631128|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64631129|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631130|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
64631131|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631132|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631133|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631134|NCT03395912|Anesthetics|anesthetics|mesh-list
64631135|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
64631136|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383948|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383949|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64631137|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631138|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
64631139|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631140|NCT00384436|Citalopram|citalopram|mesh-list
64631141|NCT00384436|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64631142|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64301573|NCT03072992|Paclitaxel|paclitaxel|mesh-list
64631145|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631146|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
64631147|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631148|NCT00384436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64631149|NCT00384436|Antidepressive Agents|antidepressive agents|mesh-ancestor
64631150|NCT00384436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64631152|NCT00003562|Docetaxel|docetaxel|mesh-list
64451750|NCT01994720|Aspirin|aspirin|mesh-list
64451751|NCT01994720|Ticagrelor|ticagrelor|mesh-list
64451752|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64451753|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64451754|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64451755|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64451780|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64451781|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
64631153|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631154|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631155|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631156|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631157|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631159|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631160|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631162|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
64631163|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631164|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64631165|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64631166|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
64631167|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631168|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64631169|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
64631170|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631171|NCT00003070|Enalapril|enalapril|mesh-list
64631172|NCT00003070|Enalaprilat|enalaprilat|mesh-list
64631173|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631174|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631175|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64631176|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
64631177|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64631178|NCT00003076|Eflornithine|eflornithine|mesh-list
64631179|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631180|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64631181|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64356472|NCT03126695|Ticagrelor|ticagrelor|mesh-list
64631182|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64631183|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631184|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64631185|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631188|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64631189|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
64631190|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631191|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631192|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64631193|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64631194|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
64631195|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631196|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631197|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64631198|NCT00003082|Antibodies|antibodies|mesh-list
64631199|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
64383950|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
64451782|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451783|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451784|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64451785|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64451786|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
64451787|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64451859|NCT02050321|Acitretin|acitretin|mesh-list
64451860|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451861|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64451862|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451863|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451864|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
64451865|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
64451866|NCT02017015|Gemcitabine|gemcitabine|mesh-list
64631201|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
64631202|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631203|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631204|NCT00003088|Paclitaxel|paclitaxel|mesh-list
64631205|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
64631206|NCT00003088|Doxorubicin|doxorubicin|mesh-list
64631207|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64631208|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631209|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631210|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631211|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631212|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631213|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631214|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631215|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
64631216|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631217|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631218|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631219|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
64631220|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631223|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631224|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631225|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
64631226|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631227|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
64631228|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
64631229|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631231|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631232|NCT00755560|Albendazole|albendazole|mesh-list
64631233|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
64631234|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64631235|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631236|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
64631237|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64631238|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64631239|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631240|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631241|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631242|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631243|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631244|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
64631245|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64631246|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631247|NCT00003118|Fluorouracil|fluorouracil|mesh-list
64631248|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631249|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
64631250|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631251|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631252|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631253|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
64451868|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64451869|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384081|NCT04511013|Nivolumab|nivolumab|mesh-list
64451870|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64451871|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64451873|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451874|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64451875|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
64451876|NCT02017015|Antiviral Agents|antiviral agents|mesh-ancestor
64631254|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631255|NCT05358704|Leucovorin|leucovorin|mesh-list
64631256|NCT05358704|Fluorouracil|fluorouracil|mesh-list
64356529|NCT03395951|Diuretics|diuretics|mesh-list
64631257|NCT05358704|Capecitabine|capecitabine|mesh-list
64631258|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
64631259|NCT05358704|Irinotecan|irinotecan|mesh-list
64631260|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
64631261|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631263|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631264|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631265|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
64631266|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631267|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64631268|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631269|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631270|NCT05358704|Antidotes|antidotes|mesh-ancestor
64631271|NCT05358704|Protective Agents|protective agents|mesh-ancestor
64631272|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
64631273|NCT05358704|Vitamins|vitamins|mesh-ancestor
64631274|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
64631275|NCT00003124|Leuprolide|leuprolide|mesh-list
64631276|NCT00003124|Flutamide|flutamide|mesh-list
64631277|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64631278|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
64631279|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64631280|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631281|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64631282|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631283|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
64631284|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
64451877|NCT02017015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451878|NCT02017015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451879|NCT02017015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451880|NCT02017015|Immunologic Factors|immunologic factors|mesh-ancestor
64451881|NCT02017015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451882|NCT02016625|Cyclosporine|cyclosporine|mesh-list
64451883|NCT02016625|Tacrolimus|tacrolimus|mesh-list
64451884|NCT02016625|Cyclosporins|cyclosporins|mesh-list
64451885|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451886|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
64451887|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451888|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64451889|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451905|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451906|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451908|NCT02016170|Ticagrelor|ticagrelor|mesh-list
64451909|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64451910|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64451911|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64631285|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64631286|NCT00003580|Amifostine|amifostine|mesh-list
64631287|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64631288|NCT00003580|Protective Agents|protective agents|mesh-ancestor
64631289|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631290|NCT00056498|Risperidone|risperidone|mesh-list
64631291|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64631292|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
64631293|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631294|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631295|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631296|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64631297|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64384088|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
64631298|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631299|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64631300|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64631301|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
64631302|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
64631303|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
64631304|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64631305|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64631306|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631307|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631308|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631309|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631310|NCT00003130|Paclitaxel|paclitaxel|mesh-list
64631321|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
64631322|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631323|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631324|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631325|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631326|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631327|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631328|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631329|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631330|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
64631331|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64631332|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64631333|NCT00059228|Estradiol|estradiol|mesh-list
64631334|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64631336|NCT00059228|Hormones|hormones|mesh-ancestor
64631337|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64631338|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451912|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64451913|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64451914|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
64451915|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451916|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451917|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451918|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64451919|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
64451920|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64451921|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64451922|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64631339|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64631340|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
64631341|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64631342|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64631343|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64631344|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64631345|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631346|NCT00062738|Paroxetine|paroxetine|mesh-list
64631347|NCT00062738|Nortriptyline|nortriptyline|mesh-list
64631348|NCT00062738|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64631349|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64301592|NCT03267771|Hormones|hormones|mesh-ancestor
64301593|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301594|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301595|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64301596|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
64631351|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631352|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631353|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
64631354|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631355|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64631356|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
64631357|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64631358|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64631359|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64631360|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631361|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64631362|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64631363|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
64631364|NCT00063362|Lamotrigine|lamotrigine|mesh-list
64631365|NCT00063362|Valproic Acid|valproic acid|mesh-list
64631366|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
64631367|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
64631368|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64631369|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631370|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631371|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
64451923|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64451924|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451925|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451926|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
64451927|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451928|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64451929|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64451930|NCT02038790|Buprenorphine|buprenorphine|mesh-list
64451931|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64451932|NCT02038790|Naloxone|naloxone|mesh-list
64451933|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64451934|NCT02038790|Narcotics|narcotics|mesh-ancestor
64451935|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451958|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64451959|NCT02027311|Narcotics|narcotics|mesh-ancestor
64631372|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64631373|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631374|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631375|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
64631376|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64631377|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64631378|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64631379|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64631380|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64631381|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
64631382|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631383|NCT00064844|Nicotine|nicotine|mesh-list
64631384|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64631385|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
64631386|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631387|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631389|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64631390|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
64631391|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631392|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631393|NCT02668562|Ticagrelor|ticagrelor|mesh-list
64631394|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64631395|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64631396|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64631397|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64631398|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
64631399|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631400|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631401|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631402|NCT00067028|Cytarabine|cytarabine|mesh-list
64631403|NCT00067028|Clofarabine|clofarabine|mesh-list
64631404|NCT00067028|Idarubicin|idarubicin|mesh-list
64451960|NCT02027311|Analgesics|analgesics|mesh-ancestor
64451961|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
64451962|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451963|NCT02047903|Afatinib|afatinib|mesh-list
64451964|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384114|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384116|NCT02093026|Protective Agents|protective agents|mesh-ancestor
64384202|NCT02058940|Hormones|hormones|mesh-ancestor
64451965|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64451966|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451967|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451968|NCT02047513|Gemcitabine|gemcitabine|mesh-list
64451969|NCT02047513|Paclitaxel|paclitaxel|mesh-list
64451970|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64451971|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631405|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631406|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
64631407|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631408|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631409|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
64631410|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631411|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631412|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
64631413|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631414|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631415|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631416|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631417|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631418|NCT00067808|Decitabine|decitabine|mesh-list
64631419|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631420|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
64631421|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631422|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631423|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631424|NCT05174312|Diuretics|diuretics|mesh-list
64631427|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
64631428|NCT00493870|Docetaxel|docetaxel|mesh-list
64631429|NCT00493870|Doxorubicin|doxorubicin|mesh-list
64631430|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631431|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
64631432|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631433|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631434|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631435|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
64631436|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631437|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631438|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631439|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631440|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
64452028|NCT01843023|Analgesics|analgesics|mesh-ancestor
64452029|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
64452030|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452031|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64452114|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
64631442|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631443|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631444|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631445|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631446|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
64631447|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64631448|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64631449|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631450|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
64631451|NCT03287336|Coagulants|coagulants|mesh-ancestor
64631452|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
64631453|NCT00003136|Carboplatin|carboplatin|mesh-list
64631454|NCT00003136|Amifostine|amifostine|mesh-list
64452219|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
64452220|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452221|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
64452222|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452223|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452224|NCT04678154|Vancomycin|vancomycin|mesh-list
64384331|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
64384332|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384333|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452225|NCT04678154|Tobramycin|tobramycin|mesh-list
64452226|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64452227|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452228|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
64452229|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631455|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631456|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
64631457|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631458|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631459|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631460|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
64631461|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452398|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64452399|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
64631463|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631464|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64631465|NCT00003136|Protective Agents|protective agents|mesh-ancestor
64631466|NCT00003592|Paclitaxel|paclitaxel|mesh-list
64631467|NCT00003592|Methotrexate|methotrexate|mesh-list
64631468|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631469|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631470|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631471|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631472|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631473|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631474|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64452499|NCT04676204|Teriflunomide|teriflunomide|mesh-list
64452500|NCT04676204|Cladribine|cladribine|mesh-list
64452501|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64452502|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64452504|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452529|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452557|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
64452558|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64631475|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
64631476|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64631477|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631478|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631480|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631481|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631482|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64631483|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631484|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
64631485|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631486|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64631487|NCT00003598|Tretinoin|tretinoin|mesh-list
64631488|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631489|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
64631490|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631491|NCT00003604|Aldesleukin|aldesleukin|mesh-list
64631492|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631493|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64631494|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64631495|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
64631496|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631497|NCT00002794|Carboplatin|carboplatin|mesh-list
64631498|NCT00002794|Vincristine|vincristine|mesh-list
64631499|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452676|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64452678|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
64452679|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452680|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631500|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631501|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631502|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631503|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64452784|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452785|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64452786|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64384349|NCT02402621|Fentanyl|fentanyl|mesh-list
64452788|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
64631504|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631505|NCT00003610|Capsaicin|capsaicin|mesh-list
64631506|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
64631509|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631510|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631511|NCT00003616|Irinotecan|irinotecan|mesh-list
64631512|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64631513|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631514|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631515|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631516|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631517|NCT01063829|Letermovir|letermovir|mesh-list
64631518|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64631519|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631520|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631521|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631522|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
64452789|NCT04177082|Vitamins|vitamins|mesh-ancestor
64452790|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
64452791|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452792|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64452793|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631523|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631524|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
64631525|NCT00072566|Bevacizumab|bevacizumab|mesh-list
64631526|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64631527|NCT00072566|Antibodies|antibodies|mesh-list
64631528|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
64631529|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64631530|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
64631531|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
64631532|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631533|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
64452896|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384431|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64384432|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64384436|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
64384489|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
64384490|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64384491|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
64384492|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384493|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384494|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64384495|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384496|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384497|NCT02418533|Menotropins|menotropins|mesh-list
64384498|NCT02418533|Hormones|hormones|mesh-list
64384499|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64384569|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452897|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631534|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631535|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631536|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631537|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
64631538|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631539|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631540|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631541|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64631542|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64631543|NCT00072566|Growth Substances|growth substances|mesh-ancestor
64631544|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
64631545|NCT00003622|Paclitaxel|paclitaxel|mesh-list
64631546|NCT00003622|Vinorelbine|vinorelbine|mesh-list
64631547|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631548|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631549|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631550|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631551|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631552|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631553|NCT00003148|Aldesleukin|aldesleukin|mesh-list
64356830|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64452984|NCT02073929|Incretins|incretins|mesh-ancestor
64631554|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631555|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64631556|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64631557|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
64631559|NCT00384046|Testosterone|testosterone|mesh-list
64631560|NCT00384046|Androgens|androgens|mesh-ancestor
64631561|NCT00384046|Hormones|hormones|mesh-ancestor
64631562|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64631563|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631564|NCT00002800|Cytarabine|cytarabine|mesh-list
64631565|NCT00002800|Etoposide|etoposide|mesh-list
64631566|NCT00002800|Idarubicin|idarubicin|mesh-list
64631567|NCT00002800|Lintuzumab|lintuzumab|mesh-list
64452985|NCT02073929|Hormones|hormones|mesh-ancestor
64452986|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452987|NCT02113007|Rituximab|rituximab|mesh-list
64452988|NCT02113007|Temozolomide|temozolomide|mesh-list
64452989|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452990|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452991|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
64452997|NCT02005471|Rituximab|rituximab|mesh-list
64453004|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631568|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631570|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631571|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631572|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631573|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631574|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631575|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
64631576|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
64631577|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631578|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631579|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
64631580|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631581|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631582|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64631583|NCT05061992|Lactulose|lactulose|mesh-list
64631584|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64631585|NCT00002806|Vincristine|vincristine|mesh-list
64631586|NCT00002806|Lomustine|lomustine|mesh-list
64631587|NCT00002806|Procarbazine|procarbazine|mesh-list
64631588|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64453078|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64453079|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64631589|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631590|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
64384570|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384571|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
64631591|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631592|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631593|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631594|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631595|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
64631596|NCT00003160|Paclitaxel|paclitaxel|mesh-list
64631597|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64301619|NCT03551197|Hormones|hormones|mesh-ancestor
64631598|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631600|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631601|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631602|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631603|NCT00002812|Cytarabine|cytarabine|mesh-list
64631604|NCT00002812|Dexamethasone|dexamethasone|mesh-list
64631605|NCT00002812|Prednisone|prednisone|mesh-list
64631606|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
64631607|NCT00002812|Doxorubicin|doxorubicin|mesh-list
64631608|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64631609|NCT00002812|Methotrexate|methotrexate|mesh-list
64631610|NCT00002812|Vincristine|vincristine|mesh-list
64631611|NCT00002812|Daunorubicin|daunorubicin|mesh-list
64631612|NCT00002812|Asparaginase|asparaginase|mesh-list
64631613|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
64631614|NCT00002812|Idarubicin|idarubicin|mesh-list
64631615|NCT00002812|Pegaspargase|pegaspargase|mesh-list
64631616|NCT00002812|Thioguanine|thioguanine|mesh-list
64631617|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631618|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
64631619|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631620|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631621|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631622|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
64631623|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631624|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631625|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631626|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384687|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64384688|NCT04480775|Prednisolone|prednisolone|mesh-list
64384736|NCT03176849|Vitamins|vitamins|mesh-list
64384820|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64384821|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64384822|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64384823|NCT02396303|Carbetocin|carbetocin|mesh-list
64384824|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
64384825|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384826|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384827|NCT01918527|Capecitabine|capecitabine|mesh-list
64384828|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
64384829|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64384830|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
64384831|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384832|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384833|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64384834|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453380|NCT02059187|Insulin|insulin|mesh-list
64631627|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
64631628|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
64631629|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631630|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64631631|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
64631636|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631637|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631638|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631639|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64631640|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
64631641|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64631642|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631644|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631645|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64631646|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64631647|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
64453517|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453518|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453519|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64453520|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64453521|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64453522|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64453523|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64453524|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
64453525|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453585|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453586|NCT04709471|Nicotine|nicotine|mesh-list
64453587|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64453588|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
64453589|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453590|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453591|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64453592|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64453593|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
64453594|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453595|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453596|NCT01959529|Insulin|insulin|mesh-list
64453597|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64631657|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64631658|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64631659|NCT01258855|Growth Substances|growth substances|mesh-ancestor
64631660|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631661|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
64631662|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631663|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64631664|NCT01258855|Analgesics|analgesics|mesh-ancestor
64631665|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
64631666|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631667|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64631668|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64631669|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
64631670|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631671|NCT00003166|Vincristine|vincristine|mesh-list
64631672|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
64631673|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631674|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631675|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631676|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631677|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631678|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631679|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64631680|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
64631681|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631682|NCT00003172|Interferons|interferons|mesh-list
64631683|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
64631684|NCT00003172|Docetaxel|docetaxel|mesh-list
64631685|NCT00003172|Doxorubicin|doxorubicin|mesh-list
64631686|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64631687|NCT00003172|Fluorouracil|fluorouracil|mesh-list
64631688|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
64631690|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631691|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631692|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631702|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631704|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631705|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
64631706|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64631708|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64631709|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631710|NCT02191033|Nicotine|nicotine|mesh-list
64357033|NCT00271817|Niacin|niacin|mesh-list
64631711|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64631712|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
64631713|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631714|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631715|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64631716|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64631717|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
64631718|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631719|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631720|NCT00002818|Cytarabine|cytarabine|mesh-list
64631721|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631722|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
64631723|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631724|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631725|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
64631736|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631737|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631738|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631739|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631740|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64631741|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
64631742|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64631744|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631745|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
64631746|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631747|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64631748|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631749|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
64631750|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631751|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64631752|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631753|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631754|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631755|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631756|NCT00002824|Ganciclovir|ganciclovir|mesh-list
64631757|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64631758|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
64631759|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631760|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64631761|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631762|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631764|NCT00003178|Cladribine|cladribine|mesh-list
64631765|NCT00003178|Lenograstim|lenograstim|mesh-list
64631766|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64631767|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
64631768|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631769|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64384848|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384849|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64631770|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631771|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631772|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631773|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631774|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631775|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631776|NCT01260649|Ketamine|ketamine|mesh-list
64631777|NCT01260649|Anesthetics|anesthetics|mesh-list
64631778|NCT01260649|Analgesics|analgesics|mesh-ancestor
64631779|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
64631780|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631781|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631782|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64631783|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64631784|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
64631785|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631786|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64631788|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64631789|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631790|NCT01260883|Ketorolac|ketorolac|mesh-list
64631791|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64631792|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64631793|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64631794|NCT01260883|Analgesics|analgesics|mesh-ancestor
64631795|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
64631796|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631797|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631802|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631804|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64631805|NCT00423202|Ambrisentan|ambrisentan|mesh-list
64631806|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64631807|NCT00003184|Vaccines|vaccines|mesh-list
64631808|NCT00003184|Sargramostim|sargramostim|mesh-list
64631809|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
64631810|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
64631811|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631812|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64631813|NCT00003190|Cytarabine|cytarabine|mesh-list
64631814|NCT00003190|Etoposide|etoposide|mesh-list
64631815|NCT00003190|Daunorubicin|daunorubicin|mesh-list
64631816|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
64631817|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631818|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631819|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631820|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64385010|NCT04176705|Hormones|hormones|mesh-ancestor
64385011|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294190|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64294191|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
64294192|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64294193|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
64294194|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64294195|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64631821|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631822|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631823|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631824|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
64631825|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
64631826|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631827|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631828|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
64631829|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631830|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64631831|NCT00003652|Fluorouracil|fluorouracil|mesh-list
64631832|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631833|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
64631834|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631835|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631836|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631837|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
64631838|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631839|NCT04773236|Lidocaine|lidocaine|mesh-list
64631840|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
64631841|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
64631842|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64631843|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631844|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
64631845|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64631846|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64631847|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64631848|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64631850|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631851|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
64631852|NCT00003658|Rituximab|rituximab|mesh-list
64631853|NCT00003658|Pentostatin|pentostatin|mesh-list
64631856|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631857|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631858|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631859|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
64631860|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631861|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631862|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631863|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64631864|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64631865|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631866|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
64631867|NCT00002836|Thiotepa|thiotepa|mesh-list
64631868|NCT00002836|Carmustine|carmustine|mesh-list
64631869|NCT00002836|Cisplatin|cisplatin|mesh-list
64631875|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631876|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
64631877|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631878|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631879|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631880|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64294202|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
64631881|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631882|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631883|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631885|NCT00003664|Interferons|interferons|mesh-list
64631886|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
64631887|NCT00003664|Aldesleukin|aldesleukin|mesh-list
64631888|NCT00003664|Fluorouracil|fluorouracil|mesh-list
64631889|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64631890|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
64631891|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631892|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631893|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
64631894|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631895|NCT00003664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631896|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631897|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
64631898|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631900|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64631901|NCT00003196|Cyclosporine|cyclosporine|mesh-list
64631902|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
64631903|NCT00003196|Cyclosporins|cyclosporins|mesh-list
64631904|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631905|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631906|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631907|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
64631908|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631909|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
64631910|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631911|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
64631912|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631922|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
64631923|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631924|NCT00003202|Antiviral Agents|antiviral agents|mesh-ancestor
64631925|NCT00003202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64631926|NCT00003202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631927|NCT00003202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64631928|NCT00003202|Immunologic Factors|immunologic factors|mesh-ancestor
64631929|NCT00003202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631930|NCT00002854|Paclitaxel|paclitaxel|mesh-list
64631945|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64631946|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
64631947|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64631948|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64631949|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64631950|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631953|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64631954|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
64631955|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64631956|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631957|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64631958|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64631959|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64631960|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64631961|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
64631962|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294208|NCT05020327|Amoxicillin|amoxicillin|mesh-list
64294209|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64294210|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294211|NCT02478879|Teriparatide|teriparatide|mesh-list
64294212|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
64385311|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
64631963|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631964|NCT00003214|Paclitaxel|paclitaxel|mesh-list
64631965|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
64631966|NCT00003214|Carboplatin|carboplatin|mesh-list
64631967|NCT00003214|Doxorubicin|doxorubicin|mesh-list
64631968|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64631969|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64631970|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64631971|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
64631972|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
64631973|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
64631974|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64631976|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
64631977|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64631978|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64631997|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
64631998|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64631999|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
64632000|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632001|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632002|NCT00002866|Docetaxel|docetaxel|mesh-list
64632003|NCT00002866|Epirubicin|epirubicin|mesh-list
64632004|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632005|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632017|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
64632018|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64632019|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64632020|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632021|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632022|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
64632024|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
64632025|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632026|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
64632027|NCT00003232|Hormones|hormones|mesh-ancestor
64632028|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632029|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632030|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64632031|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632032|NCT00003232|Analgesics|analgesics|mesh-ancestor
64632033|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
64632034|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632035|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632036|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632037|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632038|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632039|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64632040|NCT00002878|Dexamethasone|dexamethasone|mesh-list
64632041|NCT00002878|Doxorubicin|doxorubicin|mesh-list
64632042|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632056|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632057|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632059|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632063|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632064|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
64632065|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632066|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632067|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632069|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632070|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
64632071|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632072|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632073|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632074|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
64632075|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632080|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
64632081|NCT00003682|Doxorubicin|doxorubicin|mesh-list
64632082|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64385384|NCT02392793|Irinotecan|irinotecan|mesh-list
64385385|NCT02392793|Temozolomide|temozolomide|mesh-list
64385386|NCT02392793|Talazoparib|talazoparib|mesh-list
64383003|NCT02414165|Flucytosine|flucytosine|mesh-list
64632083|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64632084|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
64632085|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632086|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632113|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632114|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64632115|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64632116|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632119|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
64632120|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632121|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632122|NCT00003934|Cytarabine|cytarabine|mesh-list
64632123|NCT00003934|Methotrexate|methotrexate|mesh-list
64632126|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
64632128|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64632129|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
64632130|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64632131|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632132|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632133|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
64632134|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632135|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632142|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632143|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
64632144|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632145|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632146|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632147|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632148|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
64632149|NCT00003694|Cytarabine|cytarabine|mesh-list
64632150|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
64632151|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632152|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
64632153|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632154|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632155|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
64632158|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
64632159|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632160|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632161|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64632163|NCT00003250|Fenretinide|fenretinide|mesh-list
64632164|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632165|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64632166|NCT00003250|Protective Agents|protective agents|mesh-ancestor
64632167|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632168|NCT00003256|Alvocidib|alvocidib|mesh-list
64632169|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632170|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
64632171|NCT00003256|Growth Substances|growth substances|mesh-ancestor
64632172|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632173|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64632174|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632175|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632178|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
64632181|NCT04679480|Cemiplimab|cemiplimab|mesh-list
64632182|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64632183|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632184|NCT00003262|Prednisone|prednisone|mesh-list
64632185|NCT00003262|Doxorubicin|doxorubicin|mesh-list
64632186|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632187|NCT00003262|Epirubicin|epirubicin|mesh-list
64632189|NCT00003262|Etoposide|etoposide|mesh-list
64632190|NCT00003262|Vincristine|vincristine|mesh-list
64294213|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294214|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64294215|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64294217|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
64294218|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
64294219|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632191|NCT00003262|Vinblastine|vinblastine|mesh-list
64632192|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
64632193|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632194|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632195|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632196|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632197|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632198|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632199|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632200|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
64632201|NCT00003262|Hormones|hormones|mesh-ancestor
64632202|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632203|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632204|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64632205|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632206|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632207|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632208|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632209|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
64632210|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632214|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
64632215|NCT00003700|Methotrexate|methotrexate|mesh-list
64632216|NCT00003700|Vincristine|vincristine|mesh-list
64632217|NCT00003700|Daunorubicin|daunorubicin|mesh-list
64632218|NCT00003700|Asparaginase|asparaginase|mesh-list
64632219|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
64632220|NCT00003700|Allopurinol|allopurinol|mesh-list
64632221|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
64632222|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632223|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
64632224|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632225|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632226|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632227|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
64632228|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632229|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632238|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64632239|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632240|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
64632241|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
64632242|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632247|NCT00003700|Antidotes|antidotes|mesh-ancestor
64632248|NCT00003700|Protective Agents|protective agents|mesh-ancestor
64632249|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
64632250|NCT00003700|Vitamins|vitamins|mesh-ancestor
64632251|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
64632252|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632253|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632254|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632255|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632256|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632257|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632258|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632259|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
64632260|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64632261|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
64632262|NCT00003706|Pemetrexed|pemetrexed|mesh-list
64632263|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632264|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632265|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632266|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64632267|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632268|NCT00003958|Dactinomycin|dactinomycin|mesh-list
64632269|NCT00003958|Cactinomycin|cactinomycin|mesh-list
64632270|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
64632272|NCT00003958|Topotecan|topotecan|mesh-list
64632273|NCT00003958|Sargramostim|sargramostim|mesh-list
64632274|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385795|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64385796|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
64632275|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
64632276|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632277|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632280|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632281|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632282|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632283|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632284|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632285|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632286|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632287|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632288|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632289|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632290|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64632291|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632292|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632293|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64632294|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632295|NCT00003712|Sirolimus|sirolimus|mesh-list
64632296|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64632297|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632298|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632299|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632300|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
64632301|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632302|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
64632303|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632305|NCT00003268|Idarubicin|idarubicin|mesh-list
64632306|NCT00003268|Amifostine|amifostine|mesh-list
64632307|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632308|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
64632309|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632310|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632311|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
64632312|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632313|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632314|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
64632315|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632319|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632320|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64632321|NCT00003268|Protective Agents|protective agents|mesh-ancestor
64632322|NCT00083720|Cetuximab|cetuximab|mesh-list
64632323|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64632324|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632326|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
64632327|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
64632328|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632329|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64632330|NCT00003280|Rituximab|rituximab|mesh-list
64632331|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64632332|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632333|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
64632334|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632336|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
64632337|NCT02106572|Mitomycins|mitomycins|mesh-list
64632338|NCT02106572|Mitomycin|mitomycin|mesh-list
64632339|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632340|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632341|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
64632342|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632343|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632345|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64385797|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385798|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64632346|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64632347|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
64632348|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632350|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64632351|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
64632352|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632353|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632354|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
64632355|NCT00003718|Temozolomide|temozolomide|mesh-list
64632356|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632357|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
64632358|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632359|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632360|NCT00003970|Irinotecan|irinotecan|mesh-list
64632361|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632362|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632363|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632364|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632365|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632366|NCT00085436|Interferons|interferons|mesh-list
64632367|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
64632368|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
64632372|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632373|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632375|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632376|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64632377|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64632378|NCT00384202|Tacrolimus|tacrolimus|mesh-list
64632379|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632380|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
64632381|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632382|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64632383|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632384|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632386|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
64632387|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64632388|NCT00086138|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64632389|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64632390|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64632391|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632392|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64632393|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
64632394|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632396|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
64632397|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632398|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64632399|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64632401|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
64632402|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632403|NCT00384280|Rifampin|rifampin|mesh-list
64632407|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632408|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
64632409|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632410|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632411|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632412|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64632413|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64632414|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64632415|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64632416|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64632417|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64632418|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
64632419|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632420|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64632421|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632422|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632423|NCT00003730|Fluorouracil|fluorouracil|mesh-list
64632424|NCT00003730|Vinorelbine|vinorelbine|mesh-list
64632425|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
64632426|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632427|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632428|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632429|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632430|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
64632431|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632433|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632434|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632435|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632436|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64632437|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
64632438|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632439|NCT00003292|Ifosfamide|ifosfamide|mesh-list
64632440|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632441|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
64632442|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632444|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64632445|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64632446|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64632447|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64632448|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632449|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64632450|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64632451|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64632452|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64632453|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64632454|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64632455|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632456|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64632457|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64632458|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
64632459|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64632460|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64632461|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
64632462|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
64632463|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632464|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64632465|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
64632466|NCT00003994|Carboplatin|carboplatin|mesh-list
64632467|NCT00003994|Fluorouracil|fluorouracil|mesh-list
64632468|NCT00003994|Vincristine|vincristine|mesh-list
64632470|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632471|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
64632472|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632474|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632475|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
64632476|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632477|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632478|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632479|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632480|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632481|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64632482|NCT00003994|Protective Agents|protective agents|mesh-ancestor
64632483|NCT00003742|Paclitaxel|paclitaxel|mesh-list
64632484|NCT00003742|Irinotecan|irinotecan|mesh-list
64632485|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632486|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632487|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632489|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632490|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385902|NCT03162185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64385903|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64632493|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632494|NCT00003304|Temozolomide|temozolomide|mesh-list
64632498|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632499|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
64632500|NCT00004006|Carboplatin|carboplatin|mesh-list
64632501|NCT00004006|Doxorubicin|doxorubicin|mesh-list
64632502|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632503|NCT00004006|Etoposide|etoposide|mesh-list
64632504|NCT00004006|Topotecan|topotecan|mesh-list
64632505|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632506|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
64632507|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632508|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632509|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632510|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
64632511|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632512|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632513|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632514|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632522|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
64632523|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632524|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632525|NCT00003316|Antiviral Agents|antiviral agents|mesh-ancestor
64632526|NCT00003316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632527|NCT00003316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632528|NCT00003316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632529|NCT00003316|Immunologic Factors|immunologic factors|mesh-ancestor
64632530|NCT00003316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632531|NCT00089024|Leucovorin|leucovorin|mesh-list
64632532|NCT00089024|Gemcitabine|gemcitabine|mesh-list
64632533|NCT00089024|Fluorouracil|fluorouracil|mesh-list
64632534|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
64632535|NCT00089024|Calcium|calcium|mesh-list
64632536|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
64632537|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632538|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
64632539|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632540|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632542|NCT00089024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632543|NCT00089024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632544|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632545|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
64632546|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632547|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64632548|NCT00089024|Antidotes|antidotes|mesh-ancestor
64632549|NCT00089024|Protective Agents|protective agents|mesh-ancestor
64632550|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
64632551|NCT00089024|Vitamins|vitamins|mesh-ancestor
64632552|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
64632553|NCT00003322|Paclitaxel|paclitaxel|mesh-list
64632554|NCT00003322|Cisplatin|cisplatin|mesh-list
64632555|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632556|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632557|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632561|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
64632562|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64632563|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64632564|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64632565|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632566|NCT00003748|Irinotecan|irinotecan|mesh-list
64632567|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632568|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632569|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385907|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
64632570|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632571|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632572|NCT00089102|Gemcitabine|gemcitabine|mesh-list
64632577|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632578|NCT00089102|Antiviral Agents|antiviral agents|mesh-ancestor
64632579|NCT00089102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632580|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632581|NCT00089102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632582|NCT00089102|Immunologic Factors|immunologic factors|mesh-ancestor
64632583|NCT00089102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632584|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632585|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632586|NCT00004012|Capecitabine|capecitabine|mesh-list
64632587|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632588|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
64632589|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632590|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632591|NCT00003754|Thalidomide|thalidomide|mesh-list
64632592|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
64632596|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632597|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632598|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
64632599|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632600|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632601|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632602|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
64632603|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64632604|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632605|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64632606|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64632607|NCT00003754|Growth Substances|growth substances|mesh-ancestor
64632608|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
64632619|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64632620|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
64632622|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632624|NCT00003334|Doxorubicin|doxorubicin|mesh-list
64632625|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632626|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632627|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632628|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632629|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632630|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632631|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632632|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632633|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632634|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632635|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632637|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64632638|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632639|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632640|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632641|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
64632642|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632643|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
64632644|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632645|NCT00003760|Irofulven|irofulven|mesh-list
64632646|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632647|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
64632648|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632649|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632650|NCT04771754|Dolutegravir|dolutegravir|mesh-list
64632651|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64632653|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632661|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632662|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632663|NCT00004030|Doxorubicin|doxorubicin|mesh-list
64385931|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385932|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632664|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632665|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632666|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632667|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632668|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632669|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632670|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632671|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
64632672|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
64632673|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64632674|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64632675|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632676|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632678|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632679|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
64632680|NCT00003340|Topotecan|topotecan|mesh-list
64632681|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632682|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
64632683|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632684|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632685|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632686|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
64632687|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632688|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632693|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
64632694|NCT00004036|Carboplatin|carboplatin|mesh-list
64632695|NCT00004036|Sargramostim|sargramostim|mesh-list
64632696|NCT00004036|Amifostine|amifostine|mesh-list
64632698|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
64632699|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632700|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632701|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632702|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
64632703|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632704|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632705|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632706|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64632707|NCT00004036|Protective Agents|protective agents|mesh-ancestor
64632708|NCT00003346|Acetaminophen|acetaminophen|mesh-list
64632709|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
64632710|NCT00003346|Carmustine|carmustine|mesh-list
64632711|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64632712|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64632713|NCT00003346|Analgesics|analgesics|mesh-ancestor
64632714|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
64632715|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64632716|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632717|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
64632718|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
64632719|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632720|NCT00003346|Expectorants|expectorants|mesh-ancestor
64632721|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
64632722|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64632723|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
64385947|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385948|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385949|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64385950|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64385951|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385964|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385991|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385992|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385993|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
64385995|NCT02533401|Fludarabine|fludarabine|mesh-list
64385996|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385997|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
64385998|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385999|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386000|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64386001|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
64386002|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386003|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386004|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386005|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294245|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64294246|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64294249|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
64632724|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632725|NCT00003346|Protective Agents|protective agents|mesh-ancestor
64632728|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
64632729|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632730|NCT00096122|Cytarabine|cytarabine|mesh-list
64632731|NCT00096122|Idarubicin|idarubicin|mesh-list
64632732|NCT00096122|Tipifarnib|tipifarnib|mesh-list
64632733|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632734|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
64294250|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294251|NCT04353128|Protective Agents|protective agents|mesh-ancestor
64294252|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294253|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294254|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64294255|NCT04263350|Cobicistat|cobicistat|mesh-list
64294256|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64294257|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64294258|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
64294259|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294260|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294263|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
64294264|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294265|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64294266|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64294267|NCT03562585|Antibodies|antibodies|mesh-list
64632735|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632736|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632737|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
64632738|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632739|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632745|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632746|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
64632747|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632748|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632749|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632750|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632751|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294277|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64294278|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64294279|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294281|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294282|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294284|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
64294285|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
64294286|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294287|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294288|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294289|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64294290|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64294291|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
64294292|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294293|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294294|NCT01371643|Octreotide|octreotide|mesh-list
64632754|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
64632755|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64632756|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
64632757|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632758|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632759|NCT00003784|Prednisone|prednisone|mesh-list
64632760|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
64632761|NCT00003784|Doxorubicin|doxorubicin|mesh-list
64632762|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632763|NCT00003784|Vincristine|vincristine|mesh-list
64632764|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
64632765|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64294318|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294319|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294323|NCT03023462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64294324|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64294325|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64294326|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64294327|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
64294328|NCT02824952|Osimertinib|osimertinib|mesh-list
64294329|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294330|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64294331|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294332|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294334|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64294335|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
64294336|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64294337|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294338|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64294339|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64294340|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64294341|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
64294342|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64294343|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64294344|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
64294345|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294346|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
64294347|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64294348|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64294349|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64294350|NCT02821819|Hormones|hormones|mesh-ancestor
64294351|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294352|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294353|NCT04500548|Nivolumab|nivolumab|mesh-list
64294355|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294356|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294357|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64294358|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294360|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
64294361|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294375|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294376|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64294379|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294381|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294382|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294383|NCT00094016|Beclomethasone|beclomethasone|mesh-list
64294384|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64294386|NCT00094016|Hormones|hormones|mesh-ancestor
64294396|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294397|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64294398|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294399|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294400|NCT05134220|Calcium|calcium|mesh-list
64294401|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64294402|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294403|NCT03562507|Nivolumab|nivolumab|mesh-list
64294404|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294405|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294406|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64294407|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294408|NCT03954379|Dexamethasone|dexamethasone|mesh-list
64294409|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
64294410|NCT03954379|Analgesics|analgesics|mesh-list
64632766|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
64632767|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632768|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632769|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632770|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
64632773|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632774|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632775|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632776|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632777|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632778|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632779|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
64632780|NCT00003784|Hormones|hormones|mesh-ancestor
64632781|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632782|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64294422|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294423|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64294424|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294425|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
64294428|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294429|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
64294430|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
64632783|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632784|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632785|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632786|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632787|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
64632788|NCT00003352|Docetaxel|docetaxel|mesh-list
64632793|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632794|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632795|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632796|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
64632797|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632798|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632799|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632800|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632801|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632802|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632803|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632804|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632805|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632806|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294432|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64294434|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
64294435|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64294436|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
64294437|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64294438|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
64294441|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294442|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294443|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
64294444|NCT02036125|Hormones|hormones|mesh-ancestor
64294445|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294446|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64294447|NCT02036125|Protective Agents|protective agents|mesh-ancestor
64383004|NCT02414165|Bevacizumab|bevacizumab|mesh-list
64383005|NCT02414165|Temozolomide|temozolomide|mesh-list
64294449|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294450|NCT02818777|Cannabidiol|cannabidiol|mesh-list
64294451|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
64294452|NCT05128916|Terbinafine|terbinafine|mesh-list
64294453|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
64294454|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294455|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294456|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294467|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294468|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64294470|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
64294472|NCT05704933|Ipilimumab|ipilimumab|mesh-list
64632807|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64632808|NCT00004048|Doxorubicin|doxorubicin|mesh-list
64632809|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632811|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
64632812|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64632813|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
64632814|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632815|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632816|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632817|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632818|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632819|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632820|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632821|NCT00003358|Gemcitabine|gemcitabine|mesh-list
64632822|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294475|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64294477|NCT05132270|Thalidomide|thalidomide|mesh-list
64294478|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
64294479|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64294481|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294482|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
64294483|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64294484|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294485|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64294486|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64294487|NCT05132270|Growth Substances|growth substances|mesh-ancestor
64294488|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
64294489|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294490|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
64294516|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294517|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64294518|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64294519|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294521|NCT05121038|Protective Agents|protective agents|mesh-ancestor
64294522|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
64294523|NCT05121038|Vitamins|vitamins|mesh-ancestor
64294524|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
64294525|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294526|NCT05097794|Indapamide|indapamide|mesh-list
64294527|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64294528|NCT05097794|Diuretics|diuretics|mesh-ancestor
64294530|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294532|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64294535|NCT02036281|Neurokinin A|neurokinin a|mesh-list
64632823|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632824|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
64632825|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632826|NCT00003358|Antiviral Agents|antiviral agents|mesh-ancestor
64632827|NCT00003358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632828|NCT00003358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632829|NCT00003358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632830|NCT00003358|Immunologic Factors|immunologic factors|mesh-ancestor
64632831|NCT00003358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632832|NCT00004060|Exatecan|exatecan|mesh-list
64632838|NCT00384826|Paclitaxel|paclitaxel|mesh-list
64294537|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294538|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294539|NCT02036359|Docetaxel|docetaxel|mesh-list
64294540|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64294541|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294543|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
64294544|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294545|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294546|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64632839|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64632840|NCT00384826|Carboplatin|carboplatin|mesh-list
64358104|NCT04445857|Calcitonin|calcitonin|mesh-list
64632841|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632843|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632844|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632845|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632846|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632847|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64632848|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632849|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
64632850|NCT00003364|Doxorubicin|doxorubicin|mesh-list
64294547|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294549|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64294550|NCT04635644|Narcotics|narcotics|mesh-ancestor
64294551|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294552|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383006|NCT02414165|Lomustine|lomustine|mesh-list
64632851|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632852|NCT00003364|Etoposide|etoposide|mesh-list
64632853|NCT00003364|Vincristine|vincristine|mesh-list
64632854|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632855|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
64632856|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632857|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632858|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632859|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
64632860|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294555|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294556|NCT02036437|Misoprostol|misoprostol|mesh-list
64294557|NCT02036437|Dinoprostone|dinoprostone|mesh-list
64294558|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64294559|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
64294560|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64294561|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294562|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64294563|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294564|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
64294565|NCT05027360|Nitroprusside|nitroprusside|mesh-list
64294566|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64294567|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
64294568|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64294569|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294570|NCT02036983|Anesthetics|anesthetics|mesh-list
64294572|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294573|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294574|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
64294575|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294576|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
64294577|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632861|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632862|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64632863|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64632864|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632865|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632866|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632867|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632872|NCT00004066|Docetaxel|docetaxel|mesh-list
64632873|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64294578|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
64294579|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294580|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294581|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64294582|NCT05689177|Vaccines|vaccines|mesh-list
64294583|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
64294584|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294586|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
64294587|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294591|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64294592|NCT02475135|Cobicistat|cobicistat|mesh-list
64294593|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64294594|NCT02475135|Elvitegravir|elvitegravir|mesh-list
64294595|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64294596|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
64294597|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294598|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64294599|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64294602|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64294603|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64294604|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64294606|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
64632874|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
64632875|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632876|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632877|NCT00004066|Antiviral Agents|antiviral agents|mesh-ancestor
64632878|NCT00004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632879|NCT00004066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632880|NCT00004066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632881|NCT00004066|Immunologic Factors|immunologic factors|mesh-ancestor
64632882|NCT00004066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294608|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64294609|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64294611|NCT05161754|Coagulants|coagulants|mesh-ancestor
64294612|NCT05714631|Lidocaine|lidocaine|mesh-list
64294613|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
64294614|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
64294615|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294616|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294617|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
64294618|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294619|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64294620|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64294621|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64294622|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64294624|NCT05118620|Bupivacaine|bupivacaine|mesh-list
64294625|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
64294626|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
64294627|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294628|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294629|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
64294630|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294631|NCT02814643|Benralizumab|benralizumab|mesh-list
64294632|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64294633|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
64294634|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
64294635|NCT05080790|Interleukin-2|interleukin-2|mesh-list
64294636|NCT05080790|Dinutuximab|dinutuximab|mesh-list
64294637|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294648|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64294649|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64294650|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294651|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294652|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
64294653|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294654|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294655|NCT05714553|Leucovorin|leucovorin|mesh-list
64294656|NCT05714553|Docetaxel|docetaxel|mesh-list
64632883|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632884|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632888|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
64632889|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632890|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632891|NCT00003376|Paclitaxel|paclitaxel|mesh-list
64632892|NCT00003376|Vinblastine|vinblastine|mesh-list
64632893|NCT00003376|Carboplatin|carboplatin|mesh-list
64632894|NCT00003376|Doxorubicin|doxorubicin|mesh-list
64294684|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
64294685|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294686|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
64294687|NCT05360511|Hematinics|hematinics|mesh-ancestor
64294688|NCT02724111|Rocuronium|rocuronium|mesh-list
64294689|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64294692|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294693|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294694|NCT02480751|Beraprost|beraprost|mesh-list
64294695|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64294696|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
64294697|NCT05346159|Androgens|androgens|mesh-list
64294698|NCT05346159|Hormones|hormones|mesh-ancestor
64294699|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294700|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294701|NCT04227314|Apremilast|apremilast|mesh-list
64294702|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64294703|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64294704|NCT04227314|Analgesics|analgesics|mesh-ancestor
64294705|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
64294706|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294707|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294708|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64294709|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64294710|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64294711|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64294712|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294713|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294715|NCT04223648|Ipilimumab|ipilimumab|mesh-list
64294716|NCT04223648|Durvalumab|durvalumab|mesh-list
64294717|NCT04223648|Tremelimumab|tremelimumab|mesh-list
64294718|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64632895|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64632896|NCT00003376|Methotrexate|methotrexate|mesh-list
64632897|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64632898|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632899|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
64632900|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
64632901|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
64632903|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64294719|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294720|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64294721|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294723|NCT02814175|Methotrexate|methotrexate|mesh-list
64294724|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64294725|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
64294726|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64294727|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294728|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64294729|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
64294730|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294731|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294732|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
64294733|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294734|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64294735|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64294736|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
64294737|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64294738|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64294739|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64294740|NCT02475057|Hormones|hormones|mesh-list
64294741|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64294744|NCT05312151|Psilocybin|psilocybin|mesh-list
64632904|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64632905|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632906|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632907|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64632908|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
64632909|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64632910|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632911|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632912|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
64632913|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
64632914|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64294765|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294766|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64294767|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64294768|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294769|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
64294773|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294774|NCT02048215|Ephedrine|ephedrine|mesh-list
64294775|NCT02048215|Caffeine|caffeine|mesh-list
64294776|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64294777|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294778|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64294779|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294780|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294781|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64294782|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64294783|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
64294784|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294785|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
64294786|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
64294787|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294788|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64294789|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
64294791|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64294792|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64294793|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
64294794|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294795|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294796|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294797|NCT04849832|Urological Agents|urological agents|mesh-ancestor
64294799|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64294803|NCT02048293|Analgesics|analgesics|mesh-ancestor
64632915|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632916|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
64632917|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64632918|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632920|NCT00003382|Topotecan|topotecan|mesh-list
64632921|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64632922|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
64632923|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632924|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632925|NCT00003382|Antiviral Agents|antiviral agents|mesh-ancestor
64632926|NCT00003382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632927|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632928|NCT00003382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64632929|NCT00003382|Immunologic Factors|immunologic factors|mesh-ancestor
64632930|NCT00003382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632931|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64632932|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64632933|NCT00004834|Imipramine|imipramine|mesh-list
64632934|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64632935|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
64632936|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64632937|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64632938|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64632939|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64632940|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632941|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
64632942|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64632943|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632945|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
64632946|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632947|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632948|NCT00004852|Lamivudine|lamivudine|mesh-list
64632949|NCT00004852|Zidovudine|zidovudine|mesh-list
64632950|NCT00004852|Efavirenz|efavirenz|mesh-list
64632951|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64632952|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64632953|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294844|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294846|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64294847|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294848|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
64294849|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
64294850|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64294851|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64294852|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294853|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294854|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294855|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64294856|NCT02474433|Misoprostol|misoprostol|mesh-list
64294857|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64294858|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
64632954|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632955|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
64632956|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64632959|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
64632960|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64632961|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64632962|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64632963|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64632964|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64632965|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64632966|NCT00004858|Genistein|genistein|mesh-list
64294886|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294887|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294888|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64294889|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64294890|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64294891|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294892|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294893|NCT02472249|Norepinephrine|norepinephrine|mesh-list
64294895|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64294896|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
64294897|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294898|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294901|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
64294902|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294903|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64294904|NCT02313194|Buspirone|buspirone|mesh-list
64294905|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64294906|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64294907|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294908|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294909|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64294911|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
64632967|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
64632968|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64632969|NCT00004858|Protective Agents|protective agents|mesh-ancestor
64632970|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632971|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632972|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64632973|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64632974|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632975|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
64294954|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64294955|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
64294957|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64632976|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64632977|NCT00004858|Estrogens|estrogens|mesh-ancestor
64632978|NCT00004858|Hormones|hormones|mesh-ancestor
64632979|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64632980|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
64632981|NCT00004864|Docetaxel|docetaxel|mesh-list
64632987|NCT00003796|Irofulven|irofulven|mesh-list
64632988|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64632989|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
64294958|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64294959|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
64294963|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64294964|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294965|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64294966|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294967|NCT04767711|Prednisolone|prednisolone|mesh-list
64294968|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358253|NCT02520115|Hormones|hormones|mesh-ancestor
64632990|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64632991|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632992|NCT00003802|NSC 366140|nsc 366140|mesh-list
64632993|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64632994|NCT02972866|Budesonide|budesonide|mesh-list
64632995|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64632996|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64294969|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
64294971|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294972|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294973|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64294974|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294975|NCT02473809|Liraglutide|liraglutide|mesh-list
64294976|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64294977|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294978|NCT02473809|Incretins|incretins|mesh-ancestor
64294981|NCT03976934|Tamsulosin|tamsulosin|mesh-list
64632997|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
64632999|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633000|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64633001|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
64633002|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
64633003|NCT02972866|Hormones|hormones|mesh-ancestor
64633004|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633005|NCT00003808|Theophylline|theophylline|mesh-list
64294982|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64294983|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64294984|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64294985|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
64294986|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294987|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294988|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294990|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64294991|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64294992|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
64294993|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633006|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64633007|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
64633008|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633009|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633010|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64633011|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
64633012|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64633013|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294994|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294995|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64294996|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
64294998|NCT02416180|Hormones|hormones|mesh-ancestor
64294999|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633014|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633015|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
64633016|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64633017|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64633018|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
64633019|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633020|NCT00003814|Eflornithine|eflornithine|mesh-list
64633021|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633022|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64633023|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64633024|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64633025|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633026|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64633027|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633028|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633029|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
64633030|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
64295000|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
64295001|NCT02473575|Caffeine|caffeine|mesh-list
64295002|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64295003|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295004|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64295005|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295006|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295007|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64295008|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64295011|NCT03770546|Betamethasone|betamethasone|mesh-list
64295012|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295014|NCT03770546|Hormones|hormones|mesh-ancestor
64295015|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295016|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295017|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64295018|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
64295019|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
64295021|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295022|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295023|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64633031|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
64633032|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633033|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633034|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633035|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
64633041|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
64633042|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64295024|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295025|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295027|NCT04646967|Ibuprofen|ibuprofen|mesh-list
64295028|NCT04646967|Ketorolac|ketorolac|mesh-list
64295029|NCT04646967|Bupivacaine|bupivacaine|mesh-list
64295030|NCT04646967|Sevoflurane|sevoflurane|mesh-list
64295031|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64295032|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
64633043|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633044|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64633045|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64633046|NCT00003850|Growth Substances|growth substances|mesh-ancestor
64633047|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
64633048|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633050|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64633051|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64633052|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
64295039|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
64295040|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64295041|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295042|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64295043|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64295044|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295045|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295046|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64295048|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
64295049|NCT05341323|Ketamine|ketamine|mesh-list
64295050|NCT05341323|Bupivacaine|bupivacaine|mesh-list
64295051|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
64295052|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
64295053|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295054|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295055|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
64295057|NCT05341323|Analgesics|analgesics|mesh-ancestor
64295058|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64633053|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633054|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633055|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633056|NCT00004078|Irinotecan|irinotecan|mesh-list
64633057|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64633058|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633059|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633060|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633061|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633062|NCT00003856|Temoporfin|temoporfin|mesh-list
64633063|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633064|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64633065|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
64633066|NCT00014222|Paclitaxel|paclitaxel|mesh-list
64633067|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
64633068|NCT00014222|Doxorubicin|doxorubicin|mesh-list
64633069|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64633070|NCT00014222|Fluorouracil|fluorouracil|mesh-list
64633085|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633086|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64633087|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633088|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633089|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633090|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
64633091|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633092|NCT00014222|Hematinics|hematinics|mesh-ancestor
64633093|NCT00004870|Irinotecan|irinotecan|mesh-list
64633094|NCT00004870|Oblimersen|oblimersen|mesh-list
64633095|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64295060|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
64295061|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64295062|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64295063|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295064|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295066|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
64295067|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295068|NCT04622865|Protective Agents|protective agents|mesh-ancestor
64295069|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295070|NCT02473185|Methylphenidate|methylphenidate|mesh-list
64295071|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64295072|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295073|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64633096|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633097|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633098|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633099|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633100|NCT00004084|Epratuzumab|epratuzumab|mesh-list
64633101|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633102|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633103|NCT00004876|Thalidomide|thalidomide|mesh-list
64633104|NCT00004876|Carboplatin|carboplatin|mesh-list
64633105|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633106|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633107|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
64633109|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
64633110|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64633111|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633112|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64633113|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64633114|NCT00004876|Growth Substances|growth substances|mesh-ancestor
64633115|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
64633116|NCT00003862|Leucovorin|leucovorin|mesh-list
64633117|NCT00003862|Paclitaxel|paclitaxel|mesh-list
64633118|NCT00003862|Fluorouracil|fluorouracil|mesh-list
64633119|NCT00003862|Calcium|calcium|mesh-list
64633120|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
64633121|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633122|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633123|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633124|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633125|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633126|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633127|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64633128|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633129|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
64633130|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633140|NCT00003868|Antibodies|antibodies|mesh-list
64633141|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64633142|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633143|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
64295075|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295076|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295078|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295079|NCT02445586|Docetaxel|docetaxel|mesh-list
64295080|NCT02445586|Trastuzumab|trastuzumab|mesh-list
64295081|NCT02445586|Pertuzumab|pertuzumab|mesh-list
64295082|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295083|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633144|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633145|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633146|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64633147|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
64301846|NCT03262545|Apatinib|apatinib|mesh-list
64633150|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633151|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64633152|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
64633153|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64295087|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295088|NCT02471547|Mitomycins|mitomycins|mesh-list
64295089|NCT02471547|Mitomycin|mitomycin|mesh-list
64295090|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64295091|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295092|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
64295093|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295094|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64295095|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295096|NCT02477631|Deferiprone|deferiprone|mesh-list
64295097|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64295098|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
64295099|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
64295100|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295101|NCT01674062|Trastuzumab|trastuzumab|mesh-list
64295102|NCT01674062|Pertuzumab|pertuzumab|mesh-list
64295103|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295104|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295105|NCT02472873|Ethanol|ethanol|mesh-list
64295106|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64633154|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633155|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
64633156|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
64633157|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633158|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64633159|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64633160|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64633161|NCT00003874|Antibodies|antibodies|mesh-list
64633162|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
64633163|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64633164|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
64295108|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295109|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295111|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64295113|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
64295114|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633165|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633166|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633167|NCT00004090|Gemcitabine|gemcitabine|mesh-list
64633168|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633169|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633170|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
64633171|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633172|NCT00004090|Antiviral Agents|antiviral agents|mesh-ancestor
64295116|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295117|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295118|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64295119|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295120|NCT05283356|Ticagrelor|ticagrelor|mesh-list
64295121|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64295122|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64295123|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64295124|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64295125|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
64295126|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295127|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633173|NCT00004090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633174|NCT00004090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633190|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
64633191|NCT00004102|Antidotes|antidotes|mesh-ancestor
64633192|NCT00004102|Protective Agents|protective agents|mesh-ancestor
64633193|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
64633194|NCT00004102|Vitamins|vitamins|mesh-ancestor
64633195|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
64633196|NCT00003880|Paclitaxel|paclitaxel|mesh-list
64295128|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295130|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
64295131|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64295132|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64295133|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64295134|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295135|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295136|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
64295137|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
64295138|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295139|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295140|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64295141|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64295143|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64295144|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64295145|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64295146|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64295147|NCT05243186|Methylphenidate|methylphenidate|mesh-list
64295148|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64295149|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295150|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64295151|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64295152|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64633200|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633201|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633202|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633203|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633204|NCT00004108|Exatecan|exatecan|mesh-list
64633205|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64633206|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633207|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633208|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633209|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295153|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295154|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
64295155|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295157|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
64295158|NCT02808182|Niacinamide|niacinamide|mesh-list
64295159|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64295160|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
64295161|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295162|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64295163|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
64295164|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
64295165|NCT02808182|Vitamins|vitamins|mesh-ancestor
64295166|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
64295167|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295169|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64295170|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64295171|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
64295172|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
64295173|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295175|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64633210|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
64633212|NCT00004900|Carboplatin|carboplatin|mesh-list
64633213|NCT00004900|Etoposide|etoposide|mesh-list
64633214|NCT00004900|Anastrozole|anastrozole|mesh-list
64633215|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633216|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
64633217|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633218|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64358484|NCT02518789|Narcotics|narcotics|mesh-ancestor
64633219|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64633220|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
64295176|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64295177|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295179|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64295181|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64295183|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
64295184|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295185|NCT05217758|Mifepristone|mifepristone|mesh-list
64295186|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64295187|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
64295188|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64295189|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295190|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64295191|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64295192|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64295193|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
64295194|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64295196|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
64295197|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295198|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
64295199|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64295200|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64295201|NCT02051023|Fluorometholone|fluorometholone|mesh-list
64295202|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
64295203|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64295204|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64295205|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295206|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
64295207|NCT02051023|Hormones|hormones|mesh-ancestor
64295208|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295209|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633221|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633223|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633224|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633225|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633226|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633227|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633228|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64295212|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64295213|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64295214|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295216|NCT05192798|Bevacizumab|bevacizumab|mesh-list
64295217|NCT05192798|Apatinib|apatinib|mesh-list
64295218|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64295219|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295220|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295221|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
64295222|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295223|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295224|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295225|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295226|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64295227|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64295228|NCT05192798|Growth Substances|growth substances|mesh-ancestor
64295229|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295230|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
64295231|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64295232|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295233|NCT02048683|Sevoflurane|sevoflurane|mesh-list
64295234|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64295235|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64295236|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
64295238|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295241|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64295242|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64295243|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295244|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
64295245|NCT03108807|Coagulants|coagulants|mesh-ancestor
64295246|NCT02048761|Metformin|metformin|mesh-list
64633229|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64633230|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64633231|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64633244|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633245|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633246|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633247|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633248|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
64295247|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64295248|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295249|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64295251|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64295253|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295254|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295256|NCT02048917|Varenicline|varenicline|mesh-list
64295257|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64295258|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
64295259|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64295260|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64633249|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
64633250|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633251|NCT00004126|Paclitaxel|paclitaxel|mesh-list
64633252|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
64633253|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633254|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633255|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633256|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633257|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633272|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64295261|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64295262|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64295263|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295264|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
64295265|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295266|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295267|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64295268|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64295270|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64295271|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64295272|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
64295274|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64295275|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295276|NCT02472717|Incretins|incretins|mesh-ancestor
64295277|NCT02472717|Hormones|hormones|mesh-ancestor
64633273|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
64633274|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633275|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633276|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633277|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633278|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633279|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633280|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64633287|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64633288|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64633289|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
64633290|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633291|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64633292|NCT00004918|Sargramostim|sargramostim|mesh-list
64633293|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64633294|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
64633295|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633296|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64633298|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633299|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633300|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633301|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
64633303|NCT00004132|Etoposide|etoposide|mesh-list
64633304|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633305|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
64633306|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633314|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633315|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633316|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633317|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64633318|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64633319|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633320|NCT05776979|Lenalidomide|lenalidomide|mesh-list
64633321|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
64633322|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633323|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64633324|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64633325|NCT05776979|Growth Substances|growth substances|mesh-ancestor
64633326|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
64633327|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633328|NCT05776953|Ketorolac|ketorolac|mesh-list
64633329|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64633330|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633331|NCT05776953|Analgesics|analgesics|mesh-ancestor
64633332|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
64633333|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633334|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295278|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295279|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
64295280|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64295281|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64633335|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633336|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633337|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64633338|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633339|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633340|NCT05776940|Dexamethasone|dexamethasone|mesh-list
64633341|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
64633342|NCT05776940|Bortezomib|bortezomib|mesh-list
64633343|NCT05776940|Daratumumab|daratumumab|mesh-list
64633345|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64633346|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633348|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
64633349|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633350|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633351|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64633352|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
64633353|NCT05776940|Hormones|hormones|mesh-ancestor
64633354|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633355|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64633356|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633357|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
64633358|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633359|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633360|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
64633361|NCT05776888|Ofatumumab|ofatumumab|mesh-list
64633365|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633366|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633367|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64633368|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295291|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295292|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64295293|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
64295295|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295296|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64295297|NCT02049073|Protective Agents|protective agents|mesh-ancestor
64295298|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64295320|NCT04398914|Pertuzumab|pertuzumab|mesh-list
64633369|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633370|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64633371|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633373|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
64633374|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633375|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633376|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295331|NCT02807623|Ibuprofen|ibuprofen|mesh-list
64295332|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64295333|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64295334|NCT02807623|Analgesics|analgesics|mesh-ancestor
64295335|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
64295336|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295337|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295338|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295339|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64295362|NCT02049229|Everolimus|everolimus|mesh-list
64295397|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
64633377|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633379|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633380|NCT05776524|Gemcitabine|gemcitabine|mesh-list
64633381|NCT05776524|Paclitaxel|paclitaxel|mesh-list
64633382|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633383|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633390|NCT05776524|Antiviral Agents|antiviral agents|mesh-ancestor
64301889|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64633391|NCT05776524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633392|NCT05776524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633393|NCT05776524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64295482|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633399|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64633400|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
64633401|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633402|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633406|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633407|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64633408|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633409|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633410|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633411|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295484|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64295487|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
64295488|NCT02053519|Vitamins|vitamins|mesh-ancestor
64295489|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
64295490|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295491|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64295492|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64295493|NCT02053597|Paclitaxel|paclitaxel|mesh-list
64295494|NCT02053597|Doxorubicin|doxorubicin|mesh-list
64295498|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295499|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295500|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295501|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64295513|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295514|NCT04163900|Antiviral Agents|antiviral agents|mesh-ancestor
64295515|NCT04163900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295516|NCT04163900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295517|NCT04163900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64295531|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
64295539|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
64633412|NCT05776212|Fluorides|fluorides|mesh-list
64633413|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
64633414|NCT05776212|Protective Agents|protective agents|mesh-ancestor
64633415|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633416|NCT05776186|Bupivacaine|bupivacaine|mesh-list
64633417|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
64633418|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
64633419|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633420|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633421|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
64633422|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633423|NCT05776056|Methylphenidate|methylphenidate|mesh-list
64633424|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64633425|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633426|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64633427|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64633428|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64633429|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633430|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
64633431|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633432|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
64633433|NCT05776043|Empagliflozin|empagliflozin|mesh-list
64633436|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64633437|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633438|NCT05776030|Methamphetamine|methamphetamine|mesh-list
64633439|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64295540|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295541|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295542|NCT01334515|Isotretinoin|isotretinoin|mesh-list
64295543|NCT01334515|Sargramostim|sargramostim|mesh-list
64295544|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295563|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64295564|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64295565|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295566|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
64295579|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64295580|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64295581|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
64295582|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633440|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633441|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
64633442|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
64633443|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633445|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633446|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633447|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
64633448|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64633449|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64633450|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64633451|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64633460|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
64633461|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64633462|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633463|NCT05775965|Analgesics|analgesics|mesh-ancestor
64633464|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
64633465|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633466|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633467|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633468|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633469|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64633470|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64633471|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633475|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
64633476|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64633477|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
64633478|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64633479|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
64633480|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
64295608|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64295609|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
64295610|NCT02056717|Hormones|hormones|mesh-ancestor
64295611|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295612|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64295613|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295614|NCT02802865|Letrozole|letrozole|mesh-list
64295615|NCT02802865|Clomiphene|clomiphene|mesh-list
64295616|NCT02802865|Enclomiphene|enclomiphene|mesh-list
64295617|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
64295618|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295619|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295624|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
64295625|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64295626|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295627|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64295628|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
64633481|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
64633482|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64633483|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64633484|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633485|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
64633486|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
64633488|NCT05775900|Capecitabine|capecitabine|mesh-list
64633489|NCT05775900|Cetuximab|cetuximab|mesh-list
64633490|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633491|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
64633492|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633493|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633494|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295629|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64295630|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64295631|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64295633|NCT02414932|Ketamine|ketamine|mesh-list
64295634|NCT02414932|Analgesics|analgesics|mesh-ancestor
64295635|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
64295636|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295637|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295639|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64295640|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
64295641|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
64295642|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633495|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64633496|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633497|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633498|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
64633499|NCT05775861|Ropivacaine|ropivacaine|mesh-list
64633500|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64633501|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633502|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295643|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64295644|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64295645|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295647|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64295648|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64295649|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64295650|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64295651|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64295652|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
64295654|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
64295655|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64295656|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
64295657|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
64295658|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295659|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295660|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64295661|NCT02476929|Analgesics|analgesics|mesh-ancestor
64295662|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
64633508|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64633510|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
64633511|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633512|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633513|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
64633514|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
64633515|NCT05775770|Insulin|insulin|mesh-list
64633516|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358802|NCT04518475|Rituximab|rituximab|mesh-list
64295665|NCT02726997|Carboplatin|carboplatin|mesh-list
64295666|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64295667|NCT02726997|Durvalumab|durvalumab|mesh-list
64295668|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
64295670|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
64295671|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295672|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295673|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
64295674|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295675|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295676|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295677|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295678|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
64295679|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295680|NCT02057107|Docetaxel|docetaxel|mesh-list
64295681|NCT02057107|Cetuximab|cetuximab|mesh-list
64295682|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295683|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
64295684|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295685|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295695|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64295696|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
64295698|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64295699|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295700|NCT02058667|Paclitaxel|paclitaxel|mesh-list
64295701|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295702|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295703|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
64295704|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295705|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
64383007|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633517|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633518|NCT05775731|Hemostatics|hemostatics|mesh-list
64633519|NCT05775731|Coagulants|coagulants|mesh-ancestor
64633520|NCT05775705|Antibodies|antibodies|mesh-list
64633521|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
64633522|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633523|NCT05775692|Fluconazole|fluconazole|mesh-list
64633524|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
64633525|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295706|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295707|NCT02470455|Atorvastatin|atorvastatin|mesh-list
64295708|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64295709|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64295712|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64295714|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295715|NCT02057263|Alendronate|alendronate|mesh-list
64295716|NCT02057263|Diphosphonates|diphosphonates|mesh-list
64295718|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295720|NCT05550909|Lumefantrine|lumefantrine|mesh-list
64295721|NCT05550909|Artemether|artemether|mesh-list
64295722|NCT05550909|Primaquine|primaquine|mesh-list
64295723|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64295724|NCT05550909|Amodiaquine|amodiaquine|mesh-list
64295725|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
64295726|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
64633526|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64633527|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64633528|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633529|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633530|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64633531|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
64633534|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64633535|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64633536|NCT05775536|Aspirin|aspirin|mesh-list
64633537|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64633538|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633539|NCT05775536|Analgesics|analgesics|mesh-ancestor
64633542|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633543|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633544|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633545|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64633546|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64633547|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633548|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64633549|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64633550|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633551|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
64633552|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
64633553|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
64295727|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64295728|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64295729|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295730|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295731|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
64295732|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
64295733|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64295734|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
64295736|NCT02054299|Proguanil|proguanil|mesh-list
64295737|NCT02054299|Sumatriptan|sumatriptan|mesh-list
64295738|NCT02054299|Amitriptyline|amitriptyline|mesh-list
64295739|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64295746|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295747|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633554|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633555|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633556|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
64633557|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633559|NCT05775289|Carboplatin|carboplatin|mesh-list
64633560|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
64633561|NCT05775289|Pemetrexed|pemetrexed|mesh-list
64633562|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633563|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295749|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
64295750|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64295751|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64295752|NCT02054299|Analgesics|analgesics|mesh-ancestor
64295753|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
64295754|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295755|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64295763|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
64295764|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64295766|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295767|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
64633564|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633565|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633566|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633567|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633568|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633569|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633570|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64633571|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64633572|NCT05775159|Bevacizumab|bevacizumab|mesh-list
64633573|NCT05775159|Lenvatinib|lenvatinib|mesh-list
64633583|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295768|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64295769|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
64295770|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64295771|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
64295772|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
64295788|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64295789|NCT00704535|Ezetimibe|ezetimibe|mesh-list
64633585|NCT05774964|Vitamin A|vitamin a|mesh-list
64633587|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
64633588|NCT05774964|Cetuximab|cetuximab|mesh-list
64633589|NCT05774964|Tegafur|tegafur|mesh-list
64633591|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
64633592|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633593|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633594|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633595|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633596|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64633597|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64633598|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64633599|NCT05774964|Hematinics|hematinics|mesh-ancestor
64633600|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
64633601|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633603|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
64633621|NCT05774899|Venetoclax|venetoclax|mesh-list
64633622|NCT05774899|Lenvatinib|lenvatinib|mesh-list
64633623|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633624|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64633625|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633626|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633627|NCT05774704|Curcumin|curcumin|mesh-list
64633628|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64633629|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633630|NCT05774704|Analgesics|analgesics|mesh-ancestor
64633631|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
64295827|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64295828|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
64295829|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295830|NCT03893955|Paclitaxel|paclitaxel|mesh-list
64295831|NCT03893955|Carboplatin|carboplatin|mesh-list
64295832|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64295833|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295834|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
64295835|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295836|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295837|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295838|NCT02648204|Dulaglutide|dulaglutide|mesh-list
64295839|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64295840|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295841|NCT03310749|Metformin|metformin|mesh-list
64295842|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64295843|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295845|NCT01217931|Everolimus|everolimus|mesh-list
64295852|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
64295853|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64295854|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
64295855|NCT05291325|Linaclotide|linaclotide|mesh-list
64295856|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64633632|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633633|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633634|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633635|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633638|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633639|NCT05774691|Heparin|heparin|mesh-list
64633640|NCT05774691|Calcium heparin|calcium heparin|mesh-list
64633641|NCT05774691|Protamines|protamines|mesh-list
64633642|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
64633643|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64633644|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64295876|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295877|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295878|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
64295879|NCT02058277|Aprepitant|aprepitant|mesh-list
64295880|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
64295881|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
64295882|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295883|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633645|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633646|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
64633647|NCT05774691|Coagulants|coagulants|mesh-ancestor
64633648|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64633649|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64633650|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64633651|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
64633652|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64295926|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64295927|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64295928|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64295937|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295953|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295974|NCT04079738|Ixazomib|ixazomib|mesh-list
64295975|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295976|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
64295977|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295987|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64295989|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295990|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295991|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64295992|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64295993|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
64295994|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295995|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295996|NCT03313323|Ipilimumab|ipilimumab|mesh-list
64633653|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
64633654|NCT05773950|Aprepitant|aprepitant|mesh-list
64633655|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
64633656|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
64633657|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633658|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633659|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64633660|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64633661|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296021|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
64296023|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64296024|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
64296025|NCT05302232|Hormones|hormones|mesh-ancestor
64416900|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64416901|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416902|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416903|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416904|NCT03036085|Epinephrine|epinephrine|mesh-list
64416905|NCT03036085|Bupivacaine|bupivacaine|mesh-list
64416906|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
64416907|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
64416908|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416909|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416934|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416935|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
64416936|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417025|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64417026|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64417027|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417268|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
64417270|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64417271|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
64383008|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633662|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633663|NCT05773222|Apixaban|apixaban|mesh-list
64633664|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64633665|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
64633666|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64633667|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
64633668|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633669|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633670|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
64633671|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64633672|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
64633673|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
64418419|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64418593|NCT05123365|Expectorants|expectorants|mesh-ancestor
64633674|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633675|NCT05645692|Atezolizumab|atezolizumab|mesh-list
64633676|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633677|NCT05638594|Carboplatin|carboplatin|mesh-list
64633678|NCT05638594|Docetaxel|docetaxel|mesh-list
64633679|NCT05638594|Trastuzumab|trastuzumab|mesh-list
64633680|NCT05638594|Letrozole|letrozole|mesh-list
64633681|NCT05638594|Pertuzumab|pertuzumab|mesh-list
64633683|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633684|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633687|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633688|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633689|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633690|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633692|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64633693|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633694|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64633695|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
64633696|NCT05635227|Dexamethasone|dexamethasone|mesh-list
64633697|NCT05635227|Olanzapine|olanzapine|mesh-list
64633698|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64633699|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633700|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
64633701|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
64633702|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633703|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633704|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64633706|NCT05635227|Hormones|hormones|mesh-ancestor
64633707|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633708|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64633709|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633710|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64633711|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64633712|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633713|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64633714|NCT05635227|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64633715|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64633729|NCT05512819|Vaccines|vaccines|mesh-list
64633730|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64633731|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
64633734|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64633735|NCT05493475|Narcotics|narcotics|mesh-ancestor
64633736|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633737|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633738|NCT05493475|Analgesics|analgesics|mesh-ancestor
64633739|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
64633740|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633741|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64633742|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64633743|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
64359003|NCT04443517|Propofol|propofol|mesh-list
64633744|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
64633745|NCT05463341|Fentanyl|fentanyl|mesh-list
64633746|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64633747|NCT05463341|Narcotics|narcotics|mesh-ancestor
64633748|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633749|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633750|NCT05463341|Analgesics|analgesics|mesh-ancestor
64633751|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
64633752|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633753|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64633754|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64633755|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
64633756|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
64633757|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
64633758|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633759|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633760|NCT05429970|Etodolac|etodolac|mesh-list
64633761|NCT05429970|Propofol|propofol|mesh-list
64633762|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64633763|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633764|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633765|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64633767|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
64633768|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64420209|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420212|NCT05497063|Renal Agents|renal agents|mesh-ancestor
64633769|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64633770|NCT05429970|Analgesics|analgesics|mesh-ancestor
64633771|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
64633772|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633773|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633774|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64633775|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64633776|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64633777|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633778|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633779|NCT05408429|Vaccines|vaccines|mesh-list
64633780|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64633781|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
64633782|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633783|NCT05376904|Ropivacaine|ropivacaine|mesh-list
64633784|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
64633785|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
64633786|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633787|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633788|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
64633789|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633798|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64633800|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
64633801|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64633802|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
64633803|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64633804|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
64633805|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
64633806|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633807|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633808|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64633809|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
64633810|NCT05329740|Hormones|hormones|mesh-ancestor
64633811|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633812|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64633822|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633823|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
64633824|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64633825|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
64633826|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64633827|NCT05297851|Riboflavin|riboflavin|mesh-list
64633828|NCT05297851|Niacinamide|niacinamide|mesh-list
64633830|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
64633831|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
64633832|NCT05297851|Vitamins|vitamins|mesh-ancestor
64633833|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
64633834|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633835|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64633836|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
64633839|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633840|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64633841|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
64633842|NCT05295589|Paclitaxel|paclitaxel|mesh-list
64633843|NCT05295589|Doxorubicin|doxorubicin|mesh-list
64633844|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64633845|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64633846|NCT05295589|Topotecan|topotecan|mesh-list
64633847|NCT05295589|Olaparib|olaparib|mesh-list
64633848|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64421832|NCT02558231|Selexipag|selexipag|mesh-list
64633849|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64633850|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633851|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
64633852|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633853|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633854|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633855|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64633856|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64633857|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64633858|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422049|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
64633859|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64633860|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
64633861|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633862|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633863|NCT05252598|Psilocybin|psilocybin|mesh-list
64633864|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
64633865|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633866|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64633867|NCT05223829|Brexanolone|brexanolone|mesh-list
64633868|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
64633869|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633870|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633871|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633872|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
64633873|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
64633874|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
64633875|NCT05217446|Cetuximab|cetuximab|mesh-list
64633876|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633877|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633878|NCT05180006|Bevacizumab|bevacizumab|mesh-list
64633879|NCT05180006|Trastuzumab|trastuzumab|mesh-list
64633880|NCT05180006|Pertuzumab|pertuzumab|mesh-list
64633881|NCT05180006|Atezolizumab|atezolizumab|mesh-list
64633882|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633893|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633894|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633895|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633896|NCT05144854|Capecitabine|capecitabine|mesh-list
64633897|NCT05144854|Tegafur|tegafur|mesh-list
64633898|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
64633899|NCT05144854|Nivolumab|nivolumab|mesh-list
64633900|NCT05144854|Ipilimumab|ipilimumab|mesh-list
64633901|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633902|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
64422528|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64633903|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633904|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633905|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633906|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64633907|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
64633908|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64633924|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633925|NCT05042817|Sufentanil|sufentanil|mesh-list
64633926|NCT05042817|Morphine|morphine|mesh-list
64633927|NCT05042817|Prilocaine|prilocaine|mesh-list
64422844|NCT02470091|Denosumab|denosumab|mesh-list
64422922|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64422923|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64422924|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64422925|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64422926|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64422927|NCT02291679|Linaclotide|linaclotide|mesh-list
64422928|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64422929|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
64422930|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422931|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422933|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64422934|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64422935|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422938|NCT02360475|Vaccines|vaccines|mesh-list
64633928|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64633929|NCT05042817|Narcotics|narcotics|mesh-ancestor
64633930|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64633931|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633932|NCT05042817|Analgesics|analgesics|mesh-ancestor
64633933|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
64633934|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633937|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
64633938|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
64633939|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
64422980|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
64422981|NCT00843037|Sunitinib|sunitinib|mesh-list
64422982|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422983|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422985|NCT00843037|Growth Substances|growth substances|mesh-ancestor
64633940|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64633941|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
64633942|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64633943|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633944|NCT05042505|Incretins|incretins|mesh-ancestor
64633945|NCT05042505|Hormones|hormones|mesh-ancestor
64633946|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64633947|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64633948|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
64633949|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633950|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424254|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424255|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64424256|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424257|NCT02315625|Everolimus|everolimus|mesh-list
64424258|NCT02315625|Sunitinib|sunitinib|mesh-list
64424259|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424260|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424261|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
64424262|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424270|NCT02357979|Fluorides|fluorides|mesh-list
64424614|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633951|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64633952|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
64633953|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64633954|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633955|NCT04933227|Capecitabine|capecitabine|mesh-list
64633956|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
64633957|NCT04933227|Atezolizumab|atezolizumab|mesh-list
64633958|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64633959|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
64633960|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633961|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633962|NCT04929392|Paclitaxel|paclitaxel|mesh-list
64425809|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633963|NCT04929392|Carboplatin|carboplatin|mesh-list
64633964|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
64633965|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64633966|NCT04929392|Lenvatinib|lenvatinib|mesh-list
64633970|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
64633971|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
64633972|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633973|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64359243|NCT03353857|Estrogens|estrogens|mesh-ancestor
64633974|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64633975|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64633976|NCT04914234|Metoprolol|metoprolol|mesh-list
64633977|NCT04914234|Atenolol|atenolol|mesh-list
64633978|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64633979|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64633980|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
64633981|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
64633982|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64633983|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633984|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64633985|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64633986|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64633987|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
64633988|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64633989|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64633990|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64633992|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
64633993|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64426506|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64633994|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
64633995|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64633996|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64633997|NCT04882085|Ceftazidime|ceftazidime|mesh-list
64633998|NCT04882085|Avibactam|avibactam|mesh-list
64633999|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64634001|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634002|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64426640|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64426641|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
64426642|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426643|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634003|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634004|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634006|NCT04820309|Trospium chloride|trospium chloride|mesh-list
64634007|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
64634008|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
64634009|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634010|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634011|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64634012|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64634013|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
64634014|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634015|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634016|NCT04820309|Urological Agents|urological agents|mesh-ancestor
64634017|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64634018|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64634019|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64634020|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64634021|NCT04818086|Buprenorphine|buprenorphine|mesh-list
64634022|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64634023|NCT04818086|Lemborexant|lemborexant|mesh-list
64634024|NCT04818086|Naloxone|naloxone|mesh-list
64634025|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64634026|NCT04818086|Narcotics|narcotics|mesh-ancestor
64634027|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634028|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634029|NCT04818086|Analgesics|analgesics|mesh-ancestor
64634030|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
64634031|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634032|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64634033|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64634034|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634035|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634036|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64634037|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64634038|NCT04802161|Cytarabine|cytarabine|mesh-list
64427307|NCT02392507|Paclitaxel|paclitaxel|mesh-list
64634039|NCT04802161|Daunorubicin|daunorubicin|mesh-list
64634040|NCT04802161|Pomalidomide|pomalidomide|mesh-list
64427671|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634041|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634042|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
64429407|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
64429468|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429469|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
64429470|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429471|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429472|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
64429474|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429477|NCT04228289|Oxytocin|oxytocin|mesh-list
64429710|NCT05095961|Hormones|hormones|mesh-ancestor
64429712|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634043|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634044|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634045|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
64634047|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359310|NCT04373733|Favipiravir|favipiravir|mesh-list
64634065|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634066|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64634067|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64634068|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
64634069|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634070|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634071|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64634072|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430325|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
64634073|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634074|NCT04762199|Osimertinib|osimertinib|mesh-list
64431297|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
64634075|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431677|NCT02038881|Vaccines|vaccines|mesh-list
64431905|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634076|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634077|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634078|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634079|NCT04737187|Trifluridine|trifluridine|mesh-list
64634080|NCT04737187|Bevacizumab|bevacizumab|mesh-list
64634093|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64634094|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64634095|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634096|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
64634097|NCT04733157|Coagulants|coagulants|mesh-ancestor
64634098|NCT04723147|Levodopa|levodopa|mesh-list
64634099|NCT04723147|Carbidopa|carbidopa|mesh-list
64634100|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64634101|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64634102|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64634103|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
64634104|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634105|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432543|NCT02278471|Losartan|losartan|mesh-list
64432544|NCT02278471|Amlodipine|amlodipine|mesh-list
64432545|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64432546|NCT02278471|Atorvastatin|atorvastatin|mesh-list
64432547|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64432548|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64432549|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
64432550|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432551|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64432552|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64432553|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634106|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432629|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
64432928|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432933|NCT02264821|Morphine|morphine|mesh-list
64433137|NCT04594018|Minoxidil|minoxidil|mesh-list
64634107|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64634108|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433917|NCT02452463|Nintedanib|nintedanib|mesh-list
64434091|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634109|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64634110|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
64634111|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
64634113|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
64634114|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64634115|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634116|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634117|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634118|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634119|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
64634120|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634121|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634122|NCT04662710|Leucovorin|leucovorin|mesh-list
64634124|NCT04662710|Capecitabine|capecitabine|mesh-list
64634125|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
64634126|NCT04662710|Lenvatinib|lenvatinib|mesh-list
64634127|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
64634128|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634129|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634130|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634131|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
64634132|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634133|NCT04662710|Antidotes|antidotes|mesh-ancestor
64634134|NCT04662710|Protective Agents|protective agents|mesh-ancestor
64634135|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634136|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
64634137|NCT04662710|Vitamins|vitamins|mesh-ancestor
64634138|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
64434738|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
64634140|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634143|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
64634144|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
64634145|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634146|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634147|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64634148|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64634149|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
64436020|NCT02325401|Metformin|metformin|mesh-list
64634150|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634151|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634152|NCT04659174|Urological Agents|urological agents|mesh-ancestor
64634153|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64634154|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64634155|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64634156|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64634157|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
64634158|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64634159|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634160|NCT04643405|Gemcitabine|gemcitabine|mesh-list
64634162|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634163|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634164|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634165|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634166|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634167|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634168|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634169|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
64634170|NCT04643405|Antiviral Agents|antiviral agents|mesh-ancestor
64634171|NCT04643405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634172|NCT04643405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634173|NCT04643405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634175|NCT04643405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634177|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634178|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64634179|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64634180|NCT04633122|Growth Substances|growth substances|mesh-ancestor
64634182|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
64634183|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634184|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436659|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436961|NCT05813015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634185|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634186|NCT04628026|Venetoclax|venetoclax|mesh-list
64634187|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634188|NCT04569747|Tamoxifen|tamoxifen|mesh-list
64634189|NCT04569747|Trastuzumab|trastuzumab|mesh-list
64634190|NCT04569747|Pertuzumab|pertuzumab|mesh-list
64634191|NCT04569747|Letrozole|letrozole|mesh-list
64634192|NCT04569747|Anastrozole|anastrozole|mesh-list
64634193|NCT04569747|Leuprolide|leuprolide|mesh-list
64634194|NCT04569747|Exemestane|exemestane|mesh-list
64634195|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437234|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
64438068|NCT04405167|Ixazomib|ixazomib|mesh-list
64634196|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634197|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64634198|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64634199|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634200|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634201|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64634202|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
64634203|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634204|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634205|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634206|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64634207|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64634208|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64634209|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64634210|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
64634211|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64634212|NCT04543942|Ethanol|ethanol|mesh-list
64634213|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64634214|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634215|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634218|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634220|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
64634221|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
64438307|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
64438309|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
64438707|NCT03215810|Analgesics|analgesics|mesh-ancestor
64634222|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634223|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634224|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
64634225|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634226|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64634227|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64634228|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64634238|NCT04439318|Protective Agents|protective agents|mesh-ancestor
64634239|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634240|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64634241|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
64634242|NCT04439279|Trametinib|trametinib|mesh-list
64634243|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64634244|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634245|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634246|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634247|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634248|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64634249|NCT04439279|Protective Agents|protective agents|mesh-ancestor
64634250|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634251|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64634252|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
64634253|NCT04439227|Adavosertib|adavosertib|mesh-list
64440090|NCT01646177|Etanercept|etanercept|mesh-list
64634254|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634255|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634256|NCT04439201|Palbociclib|palbociclib|mesh-list
64634257|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634258|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634259|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634260|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634261|NCT04439188|GSK2636771|gsk2636771|mesh-list
64634262|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634263|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634265|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634276|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
64634277|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64634278|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634279|NCT04273165|Etravirine|etravirine|mesh-list
64634280|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64634281|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64634282|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634283|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634284|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
64634285|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634286|NCT04256421|Carboplatin|carboplatin|mesh-list
64634287|NCT04256421|Etoposide|etoposide|mesh-list
64634288|NCT04256421|Atezolizumab|atezolizumab|mesh-list
64634289|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634290|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634291|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64442213|NCT05369468|Bupivacaine|bupivacaine|mesh-list
64443374|NCT01710358|Adalimumab|adalimumab|mesh-list
64443670|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64634292|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634293|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634294|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634295|NCT04236414|Olaparib|olaparib|mesh-list
64634296|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64634297|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634298|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634299|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634300|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64634301|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64444062|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64444063|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64444064|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
64444065|NCT04115878|Urological Agents|urological agents|mesh-ancestor
64444066|NCT01587274|Acetaminophen|acetaminophen|mesh-list
64444067|NCT01587274|Naproxen|naproxen|mesh-list
64444068|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64444069|NCT01587274|Oxycodone|oxycodone|mesh-list
64444070|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
64444071|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64444072|NCT01587274|Analgesics|analgesics|mesh-ancestor
64444073|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
64444074|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444075|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444077|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64444093|NCT01587118|Asenapine|asenapine|mesh-list
64634302|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634304|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634305|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634306|NCT04041128|Olaparib|olaparib|mesh-list
64634307|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64634308|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634309|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634310|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634314|NCT03951753|Tirzepatide|tirzepatide|mesh-list
64634315|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64634316|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444123|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64444124|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444125|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64444126|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444127|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444129|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64444130|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64444131|NCT01922739|Hydrocodone|hydrocodone|mesh-list
64444132|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64444133|NCT01922739|Narcotics|narcotics|mesh-ancestor
64444134|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444135|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444136|NCT01922739|Analgesics|analgesics|mesh-ancestor
64444137|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
64444138|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444139|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
64444140|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
64444141|NCT02236988|Thalidomide|thalidomide|mesh-list
64444143|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64444144|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64444145|NCT02236988|Analgesics|analgesics|mesh-ancestor
64444146|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
64444147|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444148|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444149|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64444173|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
64444174|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64444175|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64444176|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444177|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444178|NCT04769414|Gemcitabine|gemcitabine|mesh-list
64444179|NCT04769414|Fluorouracil|fluorouracil|mesh-list
64444180|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64444181|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
64444182|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444183|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444184|NCT04769414|Antiviral Agents|antiviral agents|mesh-ancestor
64444185|NCT04769414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444186|NCT04769414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444187|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444188|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
64444207|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64444208|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64444209|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
64444210|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64444225|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64444226|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
64444227|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
64444228|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
64444249|NCT01641809|Cabotegravir|cabotegravir|mesh-list
64444256|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64444257|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64444258|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64444259|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64444260|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64444261|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64444262|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64444263|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64444264|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64444265|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64444267|NCT01632566|Simvastatin|simvastatin|mesh-list
64444268|NCT01632566|LY3031207|ly3031207|mesh-list
64444269|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64444272|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444273|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64444274|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64444275|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444276|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64444277|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64444279|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
64444280|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444281|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444286|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
64444287|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
64634317|NCT03951753|Incretins|incretins|mesh-ancestor
64634318|NCT03951753|Hormones|hormones|mesh-ancestor
64634319|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634320|NCT03947671|Acetaminophen|acetaminophen|mesh-list
64634321|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64634322|NCT03947671|Analgesics|analgesics|mesh-ancestor
64634323|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
64634324|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634325|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634326|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
64634327|NCT03941964|Azacitidine|azacitidine|mesh-list
64634328|NCT03941964|Decitabine|decitabine|mesh-list
64634329|NCT03941964|Venetoclax|venetoclax|mesh-list
64634330|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634331|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
64634332|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634333|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634334|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634335|NCT03932201|Factor VIII|factor viii|mesh-list
64634336|NCT03932201|Coagulants|coagulants|mesh-ancestor
64634337|NCT03859024|Acetaminophen|acetaminophen|mesh-list
64634338|NCT03859024|Dexamethasone|dexamethasone|mesh-list
64634339|NCT03859024|Ibuprofen|ibuprofen|mesh-list
64634340|NCT03859024|Celecoxib|celecoxib|mesh-list
64634341|NCT03859024|Oxycodone|oxycodone|mesh-list
64634342|NCT03859024|Gabapentin|gabapentin|mesh-list
64634343|NCT03859024|Bupivacaine|bupivacaine|mesh-list
64634344|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634345|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
64359608|NCT03122665|Analgesics|analgesics|mesh-ancestor
64634346|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
64634347|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634348|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634349|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634350|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
64634351|NCT03859024|Hormones|hormones|mesh-ancestor
64444296|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444297|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64444299|NCT05650151|Vitamins|vitamins|mesh-ancestor
64444300|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
64444301|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444302|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64444303|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
64444304|NCT02174731|Hematinics|hematinics|mesh-ancestor
64444305|NCT01922037|Omalizumab|omalizumab|mesh-list
64444306|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64444307|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64444308|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
64444309|NCT02282813|Calcitriol|calcitriol|mesh-list
64444310|NCT02282813|Calcifediol|calcifediol|mesh-list
64444311|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64444312|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64444313|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444314|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64444315|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444316|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444317|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64444318|NCT02282813|Vitamins|vitamins|mesh-ancestor
64444319|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
64444358|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64444359|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
64444360|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
64444361|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444362|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444363|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64444364|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
64444365|NCT01586806|Hormones|hormones|mesh-ancestor
64444366|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444367|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444368|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444369|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
64444370|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444388|NCT05544071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64444389|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64444390|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444391|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444393|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
64444394|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444395|NCT05619653|Prednisolone|prednisolone|mesh-list
64444407|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64444408|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444409|NCT02143843|Bimatoprost|bimatoprost|mesh-list
64444410|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64444411|NCT05598905|Pregabalin|pregabalin|mesh-list
64444412|NCT05598905|Lacosamide|lacosamide|mesh-list
64444413|NCT05598905|Oxycodone|oxycodone|mesh-list
64444414|NCT05598905|Analgesics|analgesics|mesh-ancestor
64444415|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
64634352|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634354|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634355|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
64634356|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
64634357|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634358|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
64634359|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64634360|NCT03859024|Analgesics|analgesics|mesh-ancestor
64634361|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
64634362|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64634363|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634364|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64634365|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634366|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444439|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444441|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
64444442|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444443|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
64444444|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64444445|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64444446|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64444447|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
64444448|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444449|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444450|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444451|NCT05497583|Factor VIII|factor viii|mesh-list
64444452|NCT05497583|Coagulants|coagulants|mesh-ancestor
64444453|NCT02253992|Nivolumab|nivolumab|mesh-list
64444454|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64444455|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444456|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64444457|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444458|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
64444459|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64444460|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444461|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
64444462|NCT01585558|Tamoxifen|tamoxifen|mesh-list
64444463|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64444464|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
64444468|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444491|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444492|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64444493|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64444494|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
64444495|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64444496|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444497|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64444498|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
64444499|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
64444500|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444501|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64444506|NCT02231918|Pramipexole|pramipexole|mesh-list
64444533|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444534|NCT02230904|Rotigotine|rotigotine|mesh-list
64444535|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
64444536|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
64444537|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444538|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444539|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634367|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64634368|NCT03859024|Narcotics|narcotics|mesh-ancestor
64634369|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64634370|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
64634371|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64634372|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64634373|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64634374|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64634375|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64634376|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634377|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
64634379|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634380|NCT03836261|Venetoclax|venetoclax|mesh-list
64444565|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444566|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444567|NCT02247440|Interferons|interferons|mesh-list
64444569|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444570|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
64444571|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444572|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
64444573|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444574|NCT04844099|Piperaquine|piperaquine|mesh-list
64444575|NCT04844099|Artenimol|artenimol|mesh-list
64444576|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
64444577|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64444578|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64444579|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444580|NCT04857203|Vitamin D|vitamin d|mesh-list
64444581|NCT04857203|Vitamins|vitamins|mesh-ancestor
64444582|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
64444583|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444584|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64444586|NCT05381597|Calcipotriene|calcipotriene|mesh-list
64444587|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
64444588|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444589|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64444591|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444592|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
64444593|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444594|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
64444595|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
64444596|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64444597|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64634381|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
64634382|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
64634383|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634384|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634385|NCT03808077|Rocuronium|rocuronium|mesh-list
64634386|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64634387|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64634391|NCT03630705|Vaccines|vaccines|mesh-list
64634392|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
64634393|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634394|NCT03603184|Paclitaxel|paclitaxel|mesh-list
64634395|NCT03603184|Carboplatin|carboplatin|mesh-list
64634396|NCT03603184|Atezolizumab|atezolizumab|mesh-list
64634397|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634398|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634399|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634400|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634401|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634402|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634403|NCT03586999|Nivolumab|nivolumab|mesh-list
64444598|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444600|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64444601|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
64444602|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444603|NCT04660643|Tirzepatide|tirzepatide|mesh-list
64444604|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64444605|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444606|NCT04660643|Incretins|incretins|mesh-ancestor
64444607|NCT04660643|Hormones|hormones|mesh-ancestor
64444608|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444609|NCT04659317|Oxycodone|oxycodone|mesh-list
64444610|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64444611|NCT04659317|Narcotics|narcotics|mesh-ancestor
64444612|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444613|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444614|NCT04659317|Analgesics|analgesics|mesh-ancestor
64444615|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
64444616|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444617|NCT03602261|Calcifediol|calcifediol|mesh-list
64444618|NCT03602261|Vitamins|vitamins|mesh-ancestor
64444619|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
64444620|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444621|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64444622|NCT02141659|Relugolix|relugolix|mesh-list
64444623|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
64444624|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
64444640|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
64444641|NCT02170207|Lansoprazole|lansoprazole|mesh-list
64444642|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
64444643|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64444644|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64444645|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64444646|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444647|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444648|NCT05382299|Gemcitabine|gemcitabine|mesh-list
64444649|NCT05382299|Paclitaxel|paclitaxel|mesh-list
64444650|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64444670|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64444671|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
64444674|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64444675|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444677|NCT04577417|Amphetamine|amphetamine|mesh-list
64444678|NCT04577417|Adderall|adderall|mesh-list
64444679|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
64444680|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64444681|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64444682|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444729|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64444730|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64444731|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64444732|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64444747|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64444748|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64444757|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
64444758|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64444759|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64444760|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444761|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444762|NCT04562285|Antibodies|antibodies|mesh-list
64444829|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444830|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64444831|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444832|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444833|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64444834|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64444835|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64444836|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
64444837|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
64444838|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
64444839|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64444840|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444841|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64444842|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444878|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64444879|NCT02168816|Trimethoprim|trimethoprim|mesh-list
64444880|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
64444881|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444882|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64444883|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64444885|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444886|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444887|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64444888|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64634404|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634405|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634406|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64634407|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634408|NCT03507452|BAY 2287411|bay 2287411|mesh-list
64634409|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64634410|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634411|NCT03493490|Diclofenac|diclofenac|mesh-list
64634412|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64634413|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64444911|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64444912|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444913|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
64444914|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
64444915|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
64444916|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444917|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64444918|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
64444919|NCT04481009|Antiviral Agents|antiviral agents|mesh-ancestor
64444920|NCT04481009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444921|NCT04481009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444922|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444923|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
64444924|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444926|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634414|NCT03493490|Analgesics|analgesics|mesh-ancestor
64634415|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
64634416|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634417|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634418|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634419|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634420|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64634421|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634422|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634423|NCT03414658|Trastuzumab|trastuzumab|mesh-list
64634424|NCT03414658|Avelumab|avelumab|mesh-list
64444927|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
64444928|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
64444929|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
64444930|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444931|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
64444932|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444933|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444934|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
64444935|NCT01628107|Hematinics|hematinics|mesh-ancestor
64444936|NCT04745377|Antibodies|antibodies|mesh-list
64444937|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
64444938|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444939|NCT01583530|Belimumab|belimumab|mesh-list
64444940|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444941|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
64444942|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444943|NCT01639001|Carboplatin|carboplatin|mesh-list
64444944|NCT01639001|Pemetrexed|pemetrexed|mesh-list
64444945|NCT01639001|Crizotinib|crizotinib|mesh-list
64444946|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444947|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444948|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444949|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64444950|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64444951|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64444952|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
64444953|NCT02168270|Temozolomide|temozolomide|mesh-list
64444954|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64444979|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444981|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64444982|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64634425|NCT03414658|Vinorelbine|vinorelbine|mesh-list
64634426|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634427|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634428|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634439|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634440|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634441|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634442|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
64634443|NCT03377491|Antiviral Agents|antiviral agents|mesh-ancestor
64634444|NCT03377491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634445|NCT03377491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634446|NCT03377491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64301998|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
64634447|NCT03377491|Immunologic Factors|immunologic factors|mesh-ancestor
64634448|NCT03377491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444996|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64444997|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64444998|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444999|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445000|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445001|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64445002|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64445003|NCT02224274|Clopidogrel|clopidogrel|mesh-list
64445004|NCT02224274|Ticagrelor|ticagrelor|mesh-list
64445005|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64445006|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64445007|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64445008|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64445009|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
64445010|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445011|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445012|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634450|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64634451|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
64634452|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64634453|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634456|NCT03297359|Dalteparin|dalteparin|mesh-list
64634457|NCT03297359|Tinzaparin|tinzaparin|mesh-list
64634458|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64634459|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
64634460|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64445057|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
64445059|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445060|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64445061|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64445062|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
64445063|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
64445064|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64386098|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
64634461|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64634462|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634468|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
64634469|NCT03197506|Temozolomide|temozolomide|mesh-list
64634470|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634471|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634472|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64634473|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
64445065|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64445066|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64445067|NCT04791059|Narcotics|narcotics|mesh-ancestor
64445068|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64445069|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
64445070|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445071|NCT05402111|Olanzapine|olanzapine|mesh-list
64445072|NCT05402111|Risperidone|risperidone|mesh-list
64445073|NCT05402111|Aripiprazole|aripiprazole|mesh-list
64445074|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64445075|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
64386099|NCT05421819|Vitamins|vitamins|mesh-list
64445076|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64445077|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
64445081|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64445082|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445083|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445085|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
64445086|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
64445087|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
64445088|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445089|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445090|NCT05402111|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64445091|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64634474|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634475|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
64634476|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634477|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634478|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
64634479|NCT03126630|Maytansine|maytansine|mesh-list
64634480|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634481|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634482|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634483|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634484|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634485|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634486|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445124|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445125|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445126|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445127|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
64445128|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
64445129|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64445130|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445131|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64445132|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64445133|NCT01583374|Growth Substances|growth substances|mesh-ancestor
64445134|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
64445135|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445136|NCT04245215|Ustekinumab|ustekinumab|mesh-list
64445137|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
64445138|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
64445139|NCT05387759|Aticaprant|aticaprant|mesh-list
64386100|NCT05421819|Calcium|calcium|mesh-list
64634487|NCT02941783|Factor VIII|factor viii|mesh-list
64634488|NCT02941783|Coagulants|coagulants|mesh-ancestor
64634489|NCT02889081|Vitamin D|vitamin d|mesh-list
64634490|NCT02889081|Vitamins|vitamins|mesh-ancestor
64634491|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
64634492|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634493|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64634494|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
64634496|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634497|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445140|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64445141|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445142|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64445143|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64445144|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445145|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445146|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445147|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445148|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64445149|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
64445150|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445152|NCT04721015|Osimertinib|osimertinib|mesh-list
64445153|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445154|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64445155|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64445156|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64445157|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445158|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634498|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64634500|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
64634501|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634502|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64634503|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64634506|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634507|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634508|NCT02840539|Cytarabine|cytarabine|mesh-list
64634509|NCT02840539|Dexamethasone|dexamethasone|mesh-list
64634510|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
64634511|NCT02840539|Bortezomib|bortezomib|mesh-list
64634512|NCT02840539|BB 1101|bb 1101|mesh-list
64634513|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634514|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
64634515|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
64634516|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634517|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634518|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445159|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445161|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
64445162|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64634519|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
64634520|NCT02840539|Hormones|hormones|mesh-ancestor
64634521|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634522|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634523|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634524|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
64634525|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634526|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634527|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634528|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
64634529|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
64634530|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634531|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634532|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
64634533|NCT02825160|Iloprost|iloprost|mesh-list
64634534|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64445163|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64445164|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445165|NCT04809311|Insulin|insulin|mesh-list
64445166|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64445168|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64445169|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64445170|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445171|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445172|NCT04809311|Hormones|hormones|mesh-ancestor
64445173|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445174|NCT04809311|Incretins|incretins|mesh-ancestor
64445175|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
64445176|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445177|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445178|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64445179|NCT02164916|Cetuximab|cetuximab|mesh-list
64445180|NCT02164916|Irinotecan|irinotecan|mesh-list
64634535|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
64634536|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
64634544|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634546|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634547|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634548|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634549|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634550|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634551|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
64445206|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64445207|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445208|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445209|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445210|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445211|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64445212|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
64445213|NCT04794569|Tinzaparin|tinzaparin|mesh-list
64445214|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64445215|NCT04794569|Dalteparin|dalteparin|mesh-list
64445216|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
64445217|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64445218|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
64445219|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64445220|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
64445221|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445222|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445223|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
64445224|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64445225|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64445226|NCT05651789|Propranolol|propranolol|mesh-list
64445227|NCT05651789|Carvedilol|carvedilol|mesh-list
64386101|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
64634552|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
64634553|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634554|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634555|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
64634556|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634557|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64634558|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
64634559|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64634560|NCT02291055|Durvalumab|durvalumab|mesh-list
64634561|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634562|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634563|NCT02118584|Etrolizumab|etrolizumab|mesh-list
64634564|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634565|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
64634566|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634567|NCT02112864|Dexamethasone|dexamethasone|mesh-list
64634568|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634569|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
64634570|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
64634571|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634575|NCT02112864|Hormones|hormones|mesh-ancestor
64634576|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634578|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634579|NCT02106988|Dexamethasone|dexamethasone|mesh-list
64634580|NCT02106988|Carboplatin|carboplatin|mesh-list
64445228|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64445229|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64445230|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
64445231|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445232|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445233|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445234|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64445235|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64445236|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
64445238|NCT05651789|Protective Agents|protective agents|mesh-ancestor
64445239|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64445240|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445241|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445242|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64445243|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64445244|NCT05651633|Lidocaine|lidocaine|mesh-list
64445245|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
64445246|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
64445247|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445256|NCT02999477|Paclitaxel|paclitaxel|mesh-list
64445257|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
64445258|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64445259|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445260|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
64445261|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
64445262|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
64445263|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445265|NCT02222558|Testosterone|testosterone|mesh-list
64445273|NCT02975999|Coagulants|coagulants|mesh-ancestor
64445274|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64445275|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64445276|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
64445277|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445278|NCT04807517|Buspirone|buspirone|mesh-list
64445279|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64445280|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64445281|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445282|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445285|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
64445300|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445301|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64445302|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64445303|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
64445304|NCT04013555|Tryptophan|tryptophan|mesh-list
64445305|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64445306|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
64445307|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445310|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64445312|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445313|NCT04013555|Protective Agents|protective agents|mesh-ancestor
64445314|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445315|NCT04013555|Antidotes|antidotes|mesh-ancestor
64445316|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64445317|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
64445318|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445320|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
64445321|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445322|NCT02220920|Canagliflozin|canagliflozin|mesh-list
64445323|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64445324|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445325|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64445326|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445327|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
64445328|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
64445329|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
64445330|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445331|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634581|NCT02106988|Etoposide|etoposide|mesh-list
64634582|NCT02106988|Ifosfamide|ifosfamide|mesh-list
64634583|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
64634584|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634585|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
64634586|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
64634587|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634588|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634589|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634590|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
64634591|NCT02106988|Hormones|hormones|mesh-ancestor
64634592|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634593|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634594|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634595|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634596|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634597|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634598|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302023|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
64634600|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64634601|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
64634603|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634604|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64634605|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634608|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64445332|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445334|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64445335|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445336|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445337|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64445338|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
64445339|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445340|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445353|NCT03943901|Prednisone|prednisone|mesh-list
64445355|NCT03943901|Rituximab|rituximab|mesh-list
64445356|NCT03943901|Doxorubicin|doxorubicin|mesh-list
64445357|NCT03943901|Vincristine|vincristine|mesh-list
64445358|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445359|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
64445360|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445361|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64445362|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64445363|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
64445386|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445387|NCT04790279|Amlodipine|amlodipine|mesh-list
64445388|NCT04790279|Nifedipine|nifedipine|mesh-list
64445389|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64445390|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64445391|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445392|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445393|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445394|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445395|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
64445396|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
64445397|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64445409|NCT03877289|Oxybutynin|oxybutynin|mesh-list
64634609|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634610|NCT00723697|Buprenorphine|buprenorphine|mesh-list
64634611|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64634612|NCT00723697|Narcotics|narcotics|mesh-ancestor
64634613|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634623|NCT00684073|Narcotics|narcotics|mesh-ancestor
64634624|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634625|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634626|NCT00684073|Analgesics|analgesics|mesh-ancestor
64634627|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
64634628|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634629|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64445410|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445411|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
64445412|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
64445413|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445414|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445415|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64445416|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64445417|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
64445418|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445419|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445420|NCT03877289|Urological Agents|urological agents|mesh-ancestor
64445422|NCT02530463|Ipilimumab|ipilimumab|mesh-list
64445423|NCT02530463|Azacitidine|azacitidine|mesh-list
64445424|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445425|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445426|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64445427|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445428|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64445429|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
64445430|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445431|NCT05554679|Metformin|metformin|mesh-list
64445432|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64634630|NCT00603109|Rimonabant|rimonabant|mesh-list
64634631|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64634632|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64634633|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64634634|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634647|NCT00199095|Idarubicin|idarubicin|mesh-list
64634648|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634649|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
64445433|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445434|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
64445435|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64445436|NCT05494619|Antibodies|antibodies|mesh-list
64445437|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
64445438|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64445440|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445441|NCT01583218|Enoxaparin|enoxaparin|mesh-list
64445442|NCT01583218|Betrixaban|betrixaban|mesh-list
64445443|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
64445444|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64445445|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64445446|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445447|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64445448|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
64445449|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64445450|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
64445451|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445452|NCT01634555|Leucovorin|leucovorin|mesh-list
64445453|NCT01634555|Folic Acid|folic acid|mesh-list
64445454|NCT01634555|Fluorouracil|fluorouracil|mesh-list
64445455|NCT01634555|Irinotecan|irinotecan|mesh-list
64445456|NCT01634555|Ramucirumab|ramucirumab|mesh-list
64445457|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
64445458|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
64445459|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445460|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64445461|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445462|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445478|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64445479|NCT05355155|Growth Substances|growth substances|mesh-ancestor
64445480|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445481|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
64445482|NCT01634243|Rotigotine|rotigotine|mesh-list
64445483|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
64445484|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
64445485|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445486|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445513|NCT04814615|Daratumumab|daratumumab|mesh-list
64445514|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445516|NCT03800693|Fluorouracil|fluorouracil|mesh-list
64445517|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
64445518|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
64445519|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445520|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64445521|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445522|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445523|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
64445524|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445526|NCT03800693|Protective Agents|protective agents|mesh-ancestor
64445527|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
64445528|NCT03800693|Vitamins|vitamins|mesh-ancestor
64445529|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
64445530|NCT04814537|Bupivacaine|bupivacaine|mesh-list
64445531|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
64445551|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64445552|NCT03774875|Analgesics|analgesics|mesh-ancestor
64445553|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
64445554|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445555|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445556|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64445557|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64445558|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64445559|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64445577|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445578|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
64445579|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
64445580|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64445581|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64445582|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64445583|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
64445584|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
64445591|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
64634650|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359914|NCT05135013|Diuretics|diuretics|mesh-ancestor
64634651|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634652|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64634653|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
64634654|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634655|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634656|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64634657|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634658|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
64445617|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64445618|NCT02161718|Olanzapine|olanzapine|mesh-list
64445619|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
64445620|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
64445621|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445622|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445623|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445624|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64445625|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64445626|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445627|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445628|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64445629|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64445630|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445631|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445632|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445633|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
64445634|NCT03734237|Vaccines|vaccines|mesh-list
64445635|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
64634659|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
64634660|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634661|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634662|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
64634663|NCT00199095|Hormones|hormones|mesh-ancestor
64634664|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634678|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634679|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634680|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634681|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64445636|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445637|NCT02074631|Vitamin D|vitamin d|mesh-list
64445638|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
64445639|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
64445640|NCT02074631|Pamidronate|pamidronate|mesh-list
64445641|NCT02074631|Calcium|calcium|mesh-list
64445642|NCT02074631|Vitamins|vitamins|mesh-ancestor
64445643|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
64445644|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445645|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445646|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64445647|NCT04813991|Ibuprofen|ibuprofen|mesh-list
64445648|NCT04813991|Oxycodone|oxycodone|mesh-list
64445649|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64445651|NCT04813991|Analgesics|analgesics|mesh-ancestor
64445652|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
64445653|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445654|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445655|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64445656|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64445657|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64445658|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445659|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445660|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64445663|NCT03624101|Ivacaftor|ivacaftor|mesh-list
64445664|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64445665|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445666|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445668|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
64445669|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445670|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
64445671|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445673|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64445674|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445675|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445676|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
64445677|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445678|NCT04801589|Midazolam|midazolam|mesh-list
64445680|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64445681|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445682|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445683|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64445684|NCT04801589|Analgesics|analgesics|mesh-ancestor
64445685|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
64445686|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445687|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64445688|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64445692|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445693|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64445694|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64445695|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64445696|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445697|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64445698|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
64445699|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
64445700|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
64445701|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
64445702|NCT01580488|Calcitriol|calcitriol|mesh-list
64445703|NCT01580488|Calcipotriene|calcipotriene|mesh-list
64445704|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64445705|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
64445707|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634682|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634683|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634685|NCT00199056|Dexamethasone|dexamethasone|mesh-list
64634686|NCT00199056|Prednisolone|prednisolone|mesh-list
64634687|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
64634688|NCT00199056|Ifosfamide|ifosfamide|mesh-list
64634689|NCT00199056|Methotrexate|methotrexate|mesh-list
64634690|NCT00199056|Fludarabine|fludarabine|mesh-list
64634691|NCT00199056|Vincristine|vincristine|mesh-list
64634692|NCT00199056|Doxorubicin|doxorubicin|mesh-list
64445711|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64445712|NCT01580488|Vitamins|vitamins|mesh-ancestor
64445713|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
64445714|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64445715|NCT01580020|Dexamethasone|dexamethasone|mesh-list
64445716|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64445717|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
64445718|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
64445719|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445720|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445721|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445722|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
64445723|NCT01580020|Hormones|hormones|mesh-ancestor
64445724|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445725|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64445726|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445727|NCT01579318|Interleukin-12|interleukin-12|mesh-list
64445728|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64445729|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
64445730|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445731|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64445732|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64445733|NCT01579318|Growth Substances|growth substances|mesh-ancestor
64445734|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
64445735|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445736|NCT01578850|Etanercept|etanercept|mesh-list
64445737|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64445738|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64445739|NCT01578850|Analgesics|analgesics|mesh-ancestor
64445740|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
64445741|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445742|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445743|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64445744|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64445745|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445746|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445747|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
64445749|NCT01539538|Morphine|morphine|mesh-list
64634693|NCT00199056|Daunorubicin|daunorubicin|mesh-list
64634694|NCT00199056|Asparaginase|asparaginase|mesh-list
64634695|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
64634696|NCT00199056|Idarubicin|idarubicin|mesh-list
64634697|NCT00199056|Thioguanine|thioguanine|mesh-list
64634698|NCT00199056|Vindesine|vindesine|mesh-list
64634699|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634700|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
64634702|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634703|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64634704|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
64445755|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
64445756|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445757|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64445758|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64445759|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
64445760|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
64445761|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
64445762|NCT01562548|Guaifenesin|guaifenesin|mesh-list
64445763|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64445764|NCT01562548|Expectorants|expectorants|mesh-ancestor
64445765|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
64445766|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64445767|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64445768|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
64634705|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634706|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634707|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64634708|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634710|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
64634711|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634712|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634713|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
64634714|NCT00199056|Hormones|hormones|mesh-ancestor
64634715|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64634716|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64634717|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64634718|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
64445769|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445770|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445771|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445772|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
64445773|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64445775|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
64445776|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634719|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64634720|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634721|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
64634722|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
64634723|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634724|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64634725|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64634726|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
64634727|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634728|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64445777|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
64445778|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64445780|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64445781|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64445782|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64445783|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64445785|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
64445786|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445787|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445788|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445789|NCT01562314|Cannabidiol|cannabidiol|mesh-list
64445790|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
64445791|NCT04112368|Estradiol|estradiol|mesh-list
64445792|NCT04112368|Progesterone|progesterone|mesh-list
64445793|NCT04112368|Estrogens|estrogens|mesh-ancestor
64445794|NCT04112368|Hormones|hormones|mesh-ancestor
64445796|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634729|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634730|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634731|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634732|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64634733|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634734|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634735|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
64634737|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445817|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64445818|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64445819|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
64445820|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
64445821|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445822|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445823|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445824|NCT04410094|Itraconazole|itraconazole|mesh-list
64445825|NCT04410094|Rifampin|rifampin|mesh-list
64445826|NCT04410094|Lazertinib|lazertinib|mesh-list
64445827|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
64445829|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64445830|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64445831|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445832|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379304|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64445833|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64445834|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
64445835|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445836|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445837|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64445838|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64445839|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
64445840|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64445841|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
64445842|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64445843|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64445844|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64445845|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64445846|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64445847|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64445848|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64445849|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64445850|NCT01576042|Amiodarone|amiodarone|mesh-list
64445851|NCT01576042|Sotalol|sotalol|mesh-list
64445852|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64445853|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
64445854|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64445855|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445878|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64445879|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
64445880|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
64445881|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64445882|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
64445883|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445886|NCT04102618|Atezolizumab|atezolizumab|mesh-list
64445887|NCT04102618|Letrozole|letrozole|mesh-list
64445888|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634738|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634739|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634740|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
64302052|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64634741|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634742|NCT00198978|Cytarabine|cytarabine|mesh-list
64634743|NCT00198978|Dexamethasone|dexamethasone|mesh-list
64634744|NCT00198978|Prednisolone|prednisolone|mesh-list
64634745|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
64634746|NCT00198978|Rituximab|rituximab|mesh-list
64634747|NCT00198978|Methotrexate|methotrexate|mesh-list
64634748|NCT00198978|Vincristine|vincristine|mesh-list
64634749|NCT00198978|Asparaginase|asparaginase|mesh-list
64634750|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
64634751|NCT00198978|Idarubicin|idarubicin|mesh-list
64634752|NCT00198978|Lenograstim|lenograstim|mesh-list
64634753|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634754|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
64634755|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634756|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634757|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64445908|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445909|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64445910|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445911|NCT05168657|Pancrelipase|pancrelipase|mesh-list
64445912|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445913|NCT04443569|Lidocaine|lidocaine|mesh-list
64445914|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
64445915|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
64445916|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445917|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445918|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
64445919|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445920|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64445921|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64445922|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64445923|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445924|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445925|NCT01792583|Modafinil|modafinil|mesh-list
64445926|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64445927|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445928|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64445929|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64445930|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64445931|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445933|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445935|NCT03508895|Caseins|caseins|mesh-list
64445936|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
64445937|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
64445938|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445939|NCT03507491|Gemcitabine|gemcitabine|mesh-list
64445940|NCT03507491|Paclitaxel|paclitaxel|mesh-list
64445941|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64445944|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
64445945|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
64445946|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634766|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634767|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634769|NCT00198978|Hormones|hormones|mesh-ancestor
64424504|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64634773|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
64634774|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64634775|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634776|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
64634777|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
64634778|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634779|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64634780|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64634781|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
64634782|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634783|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634784|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634785|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634786|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634787|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64445952|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445953|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
64445954|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445955|NCT04626791|Cytarabine|cytarabine|mesh-list
64445956|NCT04626791|Prednisone|prednisone|mesh-list
64445957|NCT04626791|Cortisone|cortisone|mesh-list
64445958|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
64445959|NCT04626791|Rituximab|rituximab|mesh-list
64445960|NCT04626791|Doxorubicin|doxorubicin|mesh-list
64445961|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64445962|NCT04626791|Bortezomib|bortezomib|mesh-list
64445963|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
64445964|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64445965|NCT04626791|Antibodies|antibodies|mesh-list
64445966|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
64445967|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64445968|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445969|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
64445970|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445971|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64445972|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64445973|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
64445974|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445975|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445976|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64445977|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64445978|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64445979|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64445980|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445981|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64445982|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
64445983|NCT04626791|Hormones|hormones|mesh-ancestor
64445984|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445985|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64445986|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64445987|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
64445988|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
64445989|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445990|NCT04566653|Calcium|calcium|mesh-list
64445991|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
64445992|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445993|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445997|NCT04521569|Regadenoson|regadenoson|mesh-list
64445998|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64445999|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64446000|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
64446001|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
64446002|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446003|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634788|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64634789|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634790|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634792|NCT00109395|Lorazepam|lorazepam|mesh-list
64634793|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64634794|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64634795|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634796|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446015|NCT01574716|Immunologic Factors|immunologic factors|mesh-ancestor
64446016|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446017|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
64446018|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
64446019|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
64446021|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64446022|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64446023|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64446024|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446025|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
64446026|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446027|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
64446028|NCT01559116|Olodaterol|olodaterol|mesh-list
64446029|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64446030|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
64446031|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446032|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446033|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64446034|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446035|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
64446036|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64446037|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
64446038|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446039|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446040|NCT01574326|Sevelamer|sevelamer|mesh-list
64446041|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
64446052|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446053|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64446054|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64446055|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446056|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64446057|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446058|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
64446072|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64446073|NCT01534078|Doxorubicin|doxorubicin|mesh-list
64446074|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64446075|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64446076|NCT01534078|Dacarbazine|dacarbazine|mesh-list
64446077|NCT01534078|Vinblastine|vinblastine|mesh-list
64446078|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64446079|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446080|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64446081|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64446082|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446084|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64634797|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64634798|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64634799|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64634800|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64634801|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
64634802|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
64634803|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
64634804|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
64634805|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64634806|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634807|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
64634808|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
64634809|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
64446089|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
64446090|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
64446092|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64446093|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446096|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64446097|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446098|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446101|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446102|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446103|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
64446104|NCT01573000|Antibodies|antibodies|mesh-list
64446105|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
64446106|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
64446107|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446108|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446109|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
64446110|NCT01572844|Antidotes|antidotes|mesh-ancestor
64446111|NCT01572844|Protective Agents|protective agents|mesh-ancestor
64446112|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446113|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
64446114|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446116|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64446117|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446119|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
64446120|NCT03918850|Buprenorphine|buprenorphine|mesh-list
64446121|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64446122|NCT03918850|Narcotics|narcotics|mesh-ancestor
64446123|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446124|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634810|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634811|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634812|NCT01215643|Ribavirin|ribavirin|mesh-list
64634813|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64634814|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
64634815|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634816|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
64634817|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634818|NCT00004924|Paclitaxel|paclitaxel|mesh-list
64634819|NCT00004924|Irinotecan|irinotecan|mesh-list
64634820|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64446125|NCT03918850|Analgesics|analgesics|mesh-ancestor
64446126|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
64446127|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446128|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64446129|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
64446130|NCT01533922|Olodaterol|olodaterol|mesh-list
64446131|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64446132|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
64446133|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446134|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446135|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64446136|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446137|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
64446138|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64446139|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
64634821|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634822|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634823|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634824|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634825|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634826|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64634827|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634828|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634829|NCT00004144|Gemcitabine|gemcitabine|mesh-list
64634830|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
64634832|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
64634834|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446141|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446143|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64446144|NCT01533688|Cathartics|cathartics|mesh-ancestor
64446145|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64446146|NCT01533688|Laxatives|laxatives|mesh-ancestor
64446147|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
64446148|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
64446149|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446150|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64446151|NCT02217878|Morphine|morphine|mesh-list
64446152|NCT02217878|Ticagrelor|ticagrelor|mesh-list
64446153|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64446154|NCT02217878|Narcotics|narcotics|mesh-ancestor
64446155|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446156|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446158|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
64446159|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446160|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64446161|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64446162|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64446163|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64446164|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
64446165|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446166|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446167|NCT02217566|Prednisone|prednisone|mesh-list
64446168|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
64446169|NCT02217566|Androgens|androgens|mesh-list
64446170|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634835|NCT00004144|Antiviral Agents|antiviral agents|mesh-ancestor
64634836|NCT00004144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634837|NCT00004144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634838|NCT00004144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634839|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
64634840|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634841|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64634843|NCT00004150|Fluorouracil|fluorouracil|mesh-list
64634844|NCT00004150|Calcium|calcium|mesh-list
64634845|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
64634846|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64634847|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634848|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
64634849|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634850|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634851|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634852|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634853|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
64634854|NCT00004150|Antidotes|antidotes|mesh-ancestor
64634855|NCT00004150|Protective Agents|protective agents|mesh-ancestor
64634856|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
64634857|NCT00004150|Vitamins|vitamins|mesh-ancestor
64634858|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
64634859|NCT00004930|Doxorubicin|doxorubicin|mesh-list
64634860|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64634861|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64634862|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634863|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634864|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634865|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634866|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634867|NCT00003928|Gemcitabine|gemcitabine|mesh-list
64634868|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634869|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634870|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
64634871|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446179|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446181|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64446182|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
64446183|NCT02217410|Tacrolimus|tacrolimus|mesh-list
64446184|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446185|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
64446186|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446187|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64446188|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446189|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446190|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64446191|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446192|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64446193|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
64446194|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64446195|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446197|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
64446198|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446199|NCT02217332|Protective Agents|protective agents|mesh-ancestor
64446200|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634872|NCT00003928|Antiviral Agents|antiviral agents|mesh-ancestor
64634873|NCT00003928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634874|NCT00003928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634875|NCT00003928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634879|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64360131|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634881|NCT00004162|Vincristine|vincristine|mesh-list
64634882|NCT00004162|Sargramostim|sargramostim|mesh-list
64634883|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64634884|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634885|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634886|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634887|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446201|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64446202|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64446203|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
64446204|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
64446205|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446207|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
64446208|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446209|NCT04755218|Misoprostol|misoprostol|mesh-list
64446210|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64430033|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430035|NCT04989491|Rituximab|rituximab|mesh-list
64430036|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64430037|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430038|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
64430039|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430040|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430041|NCT05018117|Nicotine|nicotine|mesh-list
64430042|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64430043|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
64430044|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430045|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430046|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64430047|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64430048|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430049|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430050|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430051|NCT05016869|Capecitabine|capecitabine|mesh-list
64430052|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64430053|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
64430054|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430154|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64430155|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430156|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64430157|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430158|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430159|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64430160|NCT02514473|Ivacaftor|ivacaftor|mesh-list
64430161|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64430162|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430163|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430164|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64430165|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64430166|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430167|NCT02513771|Incretins|incretins|mesh-ancestor
64430169|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430170|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64634888|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634889|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64634890|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
64634891|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64634892|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634893|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634895|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
64634896|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64634897|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634898|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
64634899|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634900|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64634901|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634902|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
64634903|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
64634904|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
64634906|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64634917|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634918|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64634919|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
64634920|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634921|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64634922|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64634923|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
64634924|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64430190|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
64430191|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430192|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430193|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64430194|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64430195|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
64430196|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430200|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64430201|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
64430210|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430211|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
64430212|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64634925|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64634926|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64634927|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64634928|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64634929|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634930|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64634931|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64634932|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64634943|NCT00004990|Dexamethasone|dexamethasone|mesh-list
64634944|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64634945|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
64634946|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
64634947|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430236|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64430237|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
64430238|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
64430239|NCT02068443|Metformin|metformin|mesh-list
64430240|NCT02068443|Alogliptin|alogliptin|mesh-list
64430241|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64430243|NCT02068443|Incretins|incretins|mesh-ancestor
64430311|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64430313|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430314|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430315|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64430316|NCT02483585|Erenumab|erenumab|mesh-list
64430317|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64430319|NCT02483585|Analgesics|analgesics|mesh-ancestor
64634948|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634949|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64634950|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
64634951|NCT00004990|Hormones|hormones|mesh-ancestor
64634960|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64634961|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
64634962|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64634963|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64634964|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64634966|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
64634967|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64634968|NCT00004186|Carboplatin|carboplatin|mesh-list
64634969|NCT00004186|Etoposide|etoposide|mesh-list
64634970|NCT00004186|Topotecan|topotecan|mesh-list
64634971|NCT00004186|Ifosfamide|ifosfamide|mesh-list
64430406|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64430407|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64430408|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64430409|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430410|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430411|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430412|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64430413|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64430414|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
64430415|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64430416|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64430471|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430472|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64430473|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64430474|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430475|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430476|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64430478|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430479|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430480|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64430481|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64430482|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64430534|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64430535|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
64430536|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430537|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430538|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
64430539|NCT02100657|Dexamethasone|dexamethasone|mesh-list
64430540|NCT02100657|Bortezomib|bortezomib|mesh-list
64430541|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430542|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
64430622|NCT02480153|Adalimumab|adalimumab|mesh-list
64430623|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430624|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430625|NCT04972253|Infigratinib|infigratinib|mesh-list
64430626|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430627|NCT02500979|Insulin|insulin|mesh-list
64430628|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64430629|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
64430645|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430646|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430647|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64430648|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430649|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430650|NCT01906372|Hormones|hormones|mesh-list
64430693|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64430694|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64430695|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64430696|NCT01904032|Vitamin D|vitamin d|mesh-list
64430697|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
64430698|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
64430699|NCT01904032|Vitamins|vitamins|mesh-list
64430700|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
64430701|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430783|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
64430784|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64430785|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430786|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
64430787|NCT05112952|Lazertinib|lazertinib|mesh-list
64430788|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64430789|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430791|NCT01872910|Celecoxib|celecoxib|mesh-list
64634972|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64634973|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64634974|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64634975|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634976|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64634977|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634978|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64634979|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64634981|NCT00004192|Cytarabine|cytarabine|mesh-list
64634982|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
64634983|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64634984|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64634985|NCT00004192|Prednisolone|prednisolone|mesh-list
64634986|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
64634987|NCT00004192|Etoposide|etoposide|mesh-list
64634988|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64634989|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
64634990|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302219|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
64634993|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64634994|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430865|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430866|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430867|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430868|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430869|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64430870|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
64430871|NCT04939883|Protective Agents|protective agents|mesh-ancestor
64430872|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64430873|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430901|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64430902|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430903|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64430957|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64430958|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430959|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
64430960|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
64430961|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
64430962|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430963|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64430964|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64430965|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64430966|NCT02366143|Growth Substances|growth substances|mesh-ancestor
64430967|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430968|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
64430969|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
64430975|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430976|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64430977|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64430979|NCT02096835|Tropisetron|tropisetron|mesh-list
64430993|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
64430994|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430995|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430996|NCT02294773|Letrozole|letrozole|mesh-list
64430997|NCT02294773|Clomiphene|clomiphene|mesh-list
64430998|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430999|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64431000|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64431008|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
64634995|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64634996|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64634997|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
64634998|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
64634999|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635000|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635001|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
64635002|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635003|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635004|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
64635005|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
64635006|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635007|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431018|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431019|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64431020|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64431021|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64431022|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64431023|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431024|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
64431025|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431026|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431108|NCT01864018|Glycine|glycine|mesh-list
64431109|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64431110|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
64431111|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431112|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431113|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64431114|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
64431115|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431116|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431168|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
64431170|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
64431171|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431172|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64431173|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64431174|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431175|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431176|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
64431177|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
64431178|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431179|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431180|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64431181|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64431182|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
64431183|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64431184|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64431185|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64431186|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64635008|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
64635009|NCT00004192|Hormones|hormones|mesh-ancestor
64635010|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635011|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64635012|NCT00004192|Protective Agents|protective agents|mesh-ancestor
64635013|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64635014|NCT00005002|Lamivudine|lamivudine|mesh-list
64635015|NCT00005002|Zidovudine|zidovudine|mesh-list
64635016|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64635019|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64635020|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635022|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
64635023|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635024|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635025|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64635026|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
64635027|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64635028|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64635029|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
64635030|NCT00004198|Sargramostim|sargramostim|mesh-list
64635031|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64635032|NCT00004198|Vaccines|vaccines|mesh-list
64635033|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
64635034|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635035|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64635036|NCT01264705|Sorafenib|sorafenib|mesh-list
64635037|NCT01264705|Bavituximab|bavituximab|mesh-list
64635038|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64635039|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635040|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64431222|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64431223|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64431224|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64431235|NCT02359435|Clarithromycin|clarithromycin|mesh-list
64431236|NCT02359435|Pantoprazole|pantoprazole|mesh-list
64431238|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431239|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64431240|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64431241|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64431242|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431243|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431244|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64431245|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64431264|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
64431265|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64431266|NCT01612156|Lidocaine|lidocaine|mesh-list
64431267|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
64431268|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
64431269|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431270|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431271|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
64431348|NCT02358343|Sertraline|sertraline|mesh-list
64431349|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
64431350|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431351|NCT02358343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64431352|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64431353|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431354|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431355|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431356|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
64431357|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431358|NCT02289079|Bupivacaine|bupivacaine|mesh-list
64431359|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
64431360|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
64635045|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635046|NCT00004204|Temozolomide|temozolomide|mesh-list
64635047|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64635048|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
64635050|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635051|NCT01217515|Diltiazem|diltiazem|mesh-list
64635052|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64635053|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64635054|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64635055|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635056|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64635057|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635058|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
64431367|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64431369|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64431370|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64431371|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64431372|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431373|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64431374|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
64431375|NCT02318095|Antiviral Agents|antiviral agents|mesh-ancestor
64431376|NCT02318095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431377|NCT02318095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431378|NCT02318095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64431379|NCT02318095|Immunologic Factors|immunologic factors|mesh-ancestor
64431380|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431382|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64431383|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431388|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431389|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431390|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
64431391|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431393|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
64431394|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431395|NCT02473913|Protective Agents|protective agents|mesh-ancestor
64431396|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431397|NCT02316847|Diazepam|diazepam|mesh-list
64431398|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64431399|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
64431400|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
64431401|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
64431415|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
64431416|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
64431417|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431418|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431419|NCT02473445|Cysteamine|cysteamine|mesh-list
64431420|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64431421|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431422|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
64431423|NCT02473367|Antacids|antacids|mesh-list
64431424|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64431425|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64431426|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
64431429|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64431430|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431431|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431432|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431433|NCT04965701|Osimertinib|osimertinib|mesh-list
64431434|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431435|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64431436|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431437|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431485|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64431487|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64431488|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431489|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
64431490|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431491|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431496|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431497|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64431498|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
64431499|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
64431500|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431501|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635060|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64635061|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
64635062|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635063|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635064|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635065|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64635066|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64635067|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64635068|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431565|NCT02039505|Vedolizumab|vedolizumab|mesh-list
64431566|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431567|NCT02095197|Triamcinolone|triamcinolone|mesh-list
64431568|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431569|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
64431570|NCT02095197|Hormones|hormones|mesh-ancestor
64431571|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431572|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431573|NCT02039427|Dexamethasone|dexamethasone|mesh-list
64431578|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431579|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431580|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431581|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
64431583|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431584|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64431585|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431586|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64431587|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64431588|NCT02039427|Analgesics|analgesics|mesh-ancestor
64431589|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
64431590|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431591|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64431592|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431593|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431594|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64431618|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431619|NCT01896232|Cinacalcet|cinacalcet|mesh-list
64431620|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64431621|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431622|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
64431623|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
64431624|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431625|NCT02460224|Spartalizumab|spartalizumab|mesh-list
64431709|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431710|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64431711|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64431712|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
64431713|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431714|NCT02058147|Insulin|insulin|mesh-list
64431721|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
64431722|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64431723|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
64431750|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
64431751|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431752|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64431753|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64635069|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64635070|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
64635071|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64635072|NCT03009799|Laxatives|laxatives|mesh-ancestor
64635073|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64635074|NCT00005026|Paclitaxel|paclitaxel|mesh-list
64635075|NCT00005026|Carboplatin|carboplatin|mesh-list
64635076|NCT00005026|Topotecan|topotecan|mesh-list
64635077|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64635078|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431808|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431809|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
64431810|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
64431811|NCT02038647|Paclitaxel|paclitaxel|mesh-list
64431812|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64431813|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431814|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
64431815|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
64431816|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
64431817|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431818|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
64431819|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64431820|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431821|NCT02037477|Esomeprazole|esomeprazole|mesh-list
64431822|NCT02037477|Rabeprazole|rabeprazole|mesh-list
64431823|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64431824|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431825|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64431826|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431827|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431828|NCT02057523|Hormones|hormones|mesh-list
64431829|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64431830|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64431831|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
64431832|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431849|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431850|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431851|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64431854|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431855|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64431856|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64635079|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635080|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635092|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64635093|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635094|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635095|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635096|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64635097|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64635098|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635099|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64635100|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64635101|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64635102|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64635103|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
64431860|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431861|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431862|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431863|NCT01855750|Prednisone|prednisone|mesh-list
64431864|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
64431865|NCT01855750|Rituximab|rituximab|mesh-list
64431869|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
64431870|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431871|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431872|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64431873|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
64431874|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431875|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431876|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64431877|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64431878|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64431879|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64431880|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64431881|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431882|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431883|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
64431884|NCT01855750|Hormones|hormones|mesh-ancestor
64431885|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431886|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64431887|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64431888|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635104|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
64635105|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
64635106|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64635107|NCT00004216|Cefixime|cefixime|mesh-list
64360353|NCT03136029|Protective Agents|protective agents|mesh-ancestor
64635108|NCT00004216|Trimethoprim|trimethoprim|mesh-list
64635109|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
64635110|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64635112|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64635113|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64431912|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431913|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
64431914|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64431915|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64431916|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64431917|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
64431918|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431919|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
64431920|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
64431921|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64431923|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
64431924|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
64431925|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
64431927|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431928|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64431929|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64431930|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
64431931|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431932|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64431933|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64431934|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431936|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431977|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431978|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64431979|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64431980|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64431981|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
64431982|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
64431983|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64431984|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
64431985|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431986|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432031|NCT01891864|Etanercept|etanercept|mesh-list
64635114|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635115|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635116|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635117|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64635118|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635119|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64635120|NCT00004216|Renal Agents|renal agents|mesh-ancestor
64635121|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
64635122|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64635123|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64635124|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64635125|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64635126|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64635127|NCT00005032|Paclitaxel|paclitaxel|mesh-list
64635128|NCT00005032|Oblimersen|oblimersen|mesh-list
64635129|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64635130|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635131|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635132|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635133|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635134|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635135|NCT00005038|Aldesleukin|aldesleukin|mesh-list
64432078|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432079|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432080|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
64432081|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64432082|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
64432083|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432084|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
64432085|NCT01891396|Protective Agents|protective agents|mesh-ancestor
64432086|NCT04616014|Insulin|insulin|mesh-list
64432087|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64432088|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432090|NCT02451917|Insulin|insulin|mesh-list
64432154|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432155|NCT02340962|Interferons|interferons|mesh-list
64432156|NCT02340962|Ribavirin|ribavirin|mesh-list
64432157|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
64432158|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
64432159|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432160|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
64432161|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432162|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
64432184|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
64432185|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432186|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432187|NCT02451137|Insulin|insulin|mesh-list
64432265|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
64432266|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
64432267|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
64432299|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
64432300|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432301|NCT02366468|Ranibizumab|ranibizumab|mesh-list
64432302|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64432303|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64432306|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
64432307|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432308|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64446212|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64432443|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64432444|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
64432445|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432446|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64432447|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432448|NCT02280421|Cyclosporine|cyclosporine|mesh-list
64432449|NCT02280421|Cyclosporins|cyclosporins|mesh-list
64432450|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432451|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432452|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432481|NCT02359994|Hemostatics|hemostatics|mesh-list
64432482|NCT02359994|Coagulants|coagulants|mesh-ancestor
64432483|NCT04905446|Niacinamide|niacinamide|mesh-list
64432484|NCT04905446|Niacin|niacin|mesh-list
64432485|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
64432486|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
64432487|NCT04905446|Vitamins|vitamins|mesh-ancestor
64432488|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
64432490|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64432491|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
64432492|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432493|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64432494|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
64432495|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
64432496|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432581|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64432582|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
64432583|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
64432584|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64432585|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
64432586|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432587|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64432588|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64432589|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64432590|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432634|NCT01850524|Hormones|hormones|mesh-ancestor
64635136|NCT00005038|Histamine|histamine|mesh-list
64635137|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
64635138|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635139|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635140|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64635141|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
64635142|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635143|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
64635144|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
64635145|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635146|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432713|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64432714|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64432716|NCT02270983|Linaclotide|linaclotide|mesh-list
64432717|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64432718|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
64432719|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432721|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64432722|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64432723|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432724|NCT02324270|Diclofenac|diclofenac|mesh-list
64432725|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
64432726|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64432727|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64432728|NCT02324270|Analgesics|analgesics|mesh-ancestor
64432729|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
64432730|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432786|NCT01846624|Staurosporine|staurosporine|mesh-list
64432787|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64432800|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
64432801|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
64432802|NCT01827670|Protective Agents|protective agents|mesh-ancestor
64432803|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432804|NCT01844830|Phenylephrine|phenylephrine|mesh-list
64432805|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
64432806|NCT01844830|Tetracaine|tetracaine|mesh-list
64432807|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
64432808|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
64432809|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432810|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432811|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
64432812|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635147|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635148|NCT00019682|Aldesleukin|aldesleukin|mesh-list
64635149|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64635151|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635152|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64635153|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
64635154|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635155|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64635156|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
64635157|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635158|NCT00005050|Fluorouracil|fluorouracil|mesh-list
64635159|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
64635160|NCT00005050|Eniluracil|eniluracil|mesh-list
64635161|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
64635162|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635163|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635164|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635165|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635166|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
64635167|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635168|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635169|NCT00005578|Prednisone|prednisone|mesh-list
64635170|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
64635171|NCT00005578|Doxorubicin|doxorubicin|mesh-list
64432867|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64432868|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64432869|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
64432870|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
64432871|NCT02354690|Fludarabine|fludarabine|mesh-list
64432872|NCT02354690|Interleukin-2|interleukin-2|mesh-list
64432873|NCT02354690|Vemurafenib|vemurafenib|mesh-list
64432874|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432875|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
64432876|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432877|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432878|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64432879|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
64432880|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432881|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635172|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64635173|NCT00005578|Etoposide|etoposide|mesh-list
64635174|NCT00005578|Vincristine|vincristine|mesh-list
64635175|NCT00005578|Bleomycin|bleomycin|mesh-list
64635176|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
64635177|NCT00005578|Razoxane|razoxane|mesh-list
64635178|NCT00005578|Lenograstim|lenograstim|mesh-list
64635179|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635180|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
64635181|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635182|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635189|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64635190|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64635191|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635192|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635194|NCT00005578|Hormones|hormones|mesh-ancestor
64635195|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432905|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432906|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432907|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64432913|NCT02350478|Hormones|hormones|mesh-ancestor
64432914|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432915|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64432916|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
64432917|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432947|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432948|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432949|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432950|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
64432951|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64432952|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64432956|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
64635196|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64635197|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64635198|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64635199|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635200|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635201|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635202|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64635203|NCT00005578|Protective Agents|protective agents|mesh-ancestor
64635204|NCT00022490|Cytarabine|cytarabine|mesh-list
64635205|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
64635206|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635207|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
64635208|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635209|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635210|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
64635211|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635212|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433000|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64433001|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433002|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
64433003|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64433004|NCT02319668|Listerine|listerine|mesh-list
64433005|NCT02319668|Fluorides|fluorides|mesh-list
64433006|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
64433008|NCT02319668|Protective Agents|protective agents|mesh-ancestor
64433009|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433010|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64433012|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
64433013|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
64433014|NCT02092467|Adalimumab|adalimumab|mesh-list
64433015|NCT02092467|Etanercept|etanercept|mesh-list
64433016|NCT02092467|Tofacitinib|tofacitinib|mesh-list
64433017|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635213|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
64635214|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635215|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64635216|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635217|NCT00386230|Zidovudine|zidovudine|mesh-list
64635218|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
64635219|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635220|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64635221|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64635222|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635223|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
64635224|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635225|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635226|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64635227|NCT00097448|Prednisone|prednisone|mesh-list
64635228|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
64635229|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64635230|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64635231|NCT00097448|Prednisolone|prednisolone|mesh-list
64635232|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
64635233|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64635234|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
64635235|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635236|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
64635237|NCT00097448|Hormones|hormones|mesh-ancestor
64635238|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635239|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635240|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64635241|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433065|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64433066|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
64433067|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64433068|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
64433069|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433070|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433071|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
64433072|NCT02091921|Ticagrelor|ticagrelor|mesh-list
64433073|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64433074|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64433075|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64433099|NCT02461745|Ritonavir|ritonavir|mesh-list
64433100|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
64433101|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433102|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
64433103|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433104|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64433105|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64433106|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
64635242|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
64635243|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
64635244|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635245|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64635246|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64635247|NCT00097448|Protective Agents|protective agents|mesh-ancestor
64635248|NCT00004246|Fludarabine|fludarabine|mesh-list
64635249|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
64635250|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635251|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635252|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
64635253|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635254|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635255|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
64635256|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433107|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433108|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64433109|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64433110|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64433111|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64433112|NCT02034435|Amlodipine|amlodipine|mesh-list
64433113|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64433114|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64433115|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433116|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433117|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64433119|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
64433120|NCT02033889|Insulin|insulin|mesh-list
64433121|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64433122|NCT02033889|Metformin|metformin|mesh-list
64433123|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
64433124|NCT02033889|Glimepiride|glimepiride|mesh-list
64433125|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
64433126|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
64433146|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433148|NCT04594018|Urological Agents|urological agents|mesh-ancestor
64433149|NCT02054481|Ustekinumab|ustekinumab|mesh-list
64433150|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64433151|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
64433152|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
64433165|NCT02032407|Dapsone|dapsone|mesh-list
64433166|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433167|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
64433168|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64433169|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64433170|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64433171|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433172|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433173|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
64433174|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64433175|NCT01843660|Acetaminophen|acetaminophen|mesh-list
64433176|NCT01843660|Tramadol|tramadol|mesh-list
64433177|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433178|NCT01843660|Analgesics|analgesics|mesh-ancestor
64433179|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
64433180|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635257|NCT00028262|Cysteamine|cysteamine|mesh-list
64635258|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64635259|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635260|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
64635261|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64635262|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
64635263|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635264|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635265|NCT00004252|Leucovorin|leucovorin|mesh-list
64635266|NCT00004252|Fluorouracil|fluorouracil|mesh-list
64635267|NCT00004252|Calcium|calcium|mesh-list
64635268|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
64635269|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64433240|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64433241|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64433242|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64433243|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64433244|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433245|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64433246|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
64433247|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64433248|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64433249|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
64433277|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64433278|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433279|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433280|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
64433281|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433282|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
64433283|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64433284|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433286|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64433289|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635270|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635271|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
64635272|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635273|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635275|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635276|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
64635277|NCT00004252|Antidotes|antidotes|mesh-ancestor
64635278|NCT00004252|Protective Agents|protective agents|mesh-ancestor
64635279|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
64635280|NCT00004252|Vitamins|vitamins|mesh-ancestor
64635282|NCT00005590|Levofloxacin|levofloxacin|mesh-list
64635283|NCT00005590|Ofloxacin|ofloxacin|mesh-list
64635284|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64635285|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635286|NCT00005590|Renal Agents|renal agents|mesh-ancestor
64635287|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64635288|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64635289|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64635290|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635291|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635292|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635293|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64635294|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635295|NCT00005596|Leucovorin|leucovorin|mesh-list
64635296|NCT00005596|Cytarabine|cytarabine|mesh-list
64635297|NCT00005596|Dexamethasone|dexamethasone|mesh-list
64635298|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
64635299|NCT00005596|Methotrexate|methotrexate|mesh-list
64635300|NCT00005596|Vincristine|vincristine|mesh-list
64635301|NCT00005596|Daunorubicin|daunorubicin|mesh-list
64635302|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
64635303|NCT00005596|Pegaspargase|pegaspargase|mesh-list
64433323|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433324|NCT02029989|Chrysarobin|chrysarobin|mesh-list
64433325|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64433327|NCT02029989|Analgesics|analgesics|mesh-ancestor
64635304|NCT00005596|Thioguanine|thioguanine|mesh-list
64635305|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
64635306|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635307|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
64635308|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635309|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635310|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64635311|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
64635312|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635313|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635314|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64433396|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64433397|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64433398|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64433399|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64433400|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
64433422|NCT02022657|Tenofovir|tenofovir|mesh-list
64433424|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64433425|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
64433426|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433427|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64433428|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64433429|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433431|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635315|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635316|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
64635317|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
64635318|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635319|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64635320|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
64635321|NCT00005596|Hormones|hormones|mesh-ancestor
64635322|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635323|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64635324|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64635340|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64635341|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635342|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635349|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
64635350|NCT00005068|Irinotecan|irinotecan|mesh-list
64635351|NCT00005068|Calcium|calcium|mesh-list
64433488|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433489|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433490|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433491|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433492|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64433493|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433494|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433545|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433546|NCT05370599|Losartan|losartan|mesh-list
64433547|NCT05370599|Amlodipine|amlodipine|mesh-list
64433548|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
64433549|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
64433550|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64433551|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433552|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433553|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64433554|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433555|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
64433556|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64433557|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64433558|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64433559|NCT05370599|Diuretics|diuretics|mesh-ancestor
64433560|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
64433561|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64433562|NCT02412761|Amlodipine|amlodipine|mesh-list
64433563|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64433564|NCT02412761|Lisinopril|lisinopril|mesh-list
64635352|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
64635353|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64635354|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635355|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
64635356|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635357|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635358|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635359|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635360|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
64635361|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64635362|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64635363|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635364|NCT00005068|Antidotes|antidotes|mesh-ancestor
64635365|NCT00005068|Protective Agents|protective agents|mesh-ancestor
64635366|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
64635368|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
64635369|NCT00004264|Docetaxel|docetaxel|mesh-list
64635370|NCT00004264|Amifostine|amifostine|mesh-list
64635371|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433650|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433651|NCT02020941|Dexamethasone|dexamethasone|mesh-list
64433652|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433653|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
64433654|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
64433655|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433656|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433657|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433658|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
64433659|NCT02020941|Hormones|hormones|mesh-ancestor
64433660|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433661|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64433662|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433663|NCT01823224|Acetaminophen|acetaminophen|mesh-list
64433665|NCT01823224|Analgesics|analgesics|mesh-ancestor
64635372|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635373|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635374|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635375|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635376|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64635377|NCT00004264|Protective Agents|protective agents|mesh-ancestor
64635378|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635380|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635381|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
64635382|NCT00005074|Growth Substances|growth substances|mesh-ancestor
64635383|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635384|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64635385|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635386|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635387|NCT00005602|Carboplatin|carboplatin|mesh-list
64635388|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635389|NCT00004276|Thalidomide|thalidomide|mesh-list
64635390|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635391|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
64635392|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635393|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
64635394|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64635395|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635396|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64635397|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64635398|NCT00004276|Growth Substances|growth substances|mesh-ancestor
64635399|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
64635400|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635401|NCT00004288|Olsalazine|olsalazine|mesh-list
64433710|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
64433711|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
64433712|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433713|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433714|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433715|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
64433716|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635402|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64635403|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64635404|NCT00004288|Analgesics|analgesics|mesh-ancestor
64635405|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
64635406|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635407|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635408|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635409|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635410|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433717|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64433718|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
64433719|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64433720|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64433721|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433722|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433723|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
64433724|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
64433725|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433726|NCT01611298|Vaccines|vaccines|mesh-list
64433727|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
64433728|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433729|NCT01822132|Naltrexone|naltrexone|mesh-list
64433730|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64433731|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64433732|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433733|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
64433734|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433735|NCT01821898|Budesonide|budesonide|mesh-list
64433736|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433737|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64433738|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
64433756|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
64433757|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433758|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433759|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
64433760|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64635417|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635420|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635421|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635422|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
64635423|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635424|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635425|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635426|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635427|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64635428|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
64635429|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64635430|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
64635431|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64635432|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635433|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64635434|NCT00005614|Gemcitabine|gemcitabine|mesh-list
64635435|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635436|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
64635437|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635438|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635439|NCT00005614|Antiviral Agents|antiviral agents|mesh-ancestor
64635440|NCT00005614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635441|NCT00005614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635442|NCT00005614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635443|NCT00005614|Immunologic Factors|immunologic factors|mesh-ancestor
64635444|NCT00005614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433761|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433762|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433763|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64433764|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64433765|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64433766|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433767|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64433768|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64433810|NCT03232918|Oxytocin|oxytocin|mesh-list
64433811|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
64433812|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64433813|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433814|NCT01610596|Halobetasol|halobetasol|mesh-list
64433815|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64433816|NCT01818700|Buprenorphine|buprenorphine|mesh-list
64433817|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64433818|NCT01818700|Narcotics|narcotics|mesh-ancestor
64433857|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433858|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433876|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64433877|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433878|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
64433880|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
64433881|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433882|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64635446|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635447|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64635448|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635452|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
64635453|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64635454|NCT00004300|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64635455|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64635456|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64635457|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433961|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
64433962|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
64433963|NCT01816048|Protective Agents|protective agents|mesh-ancestor
64433964|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433965|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64433966|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433967|NCT01612858|Metformin|metformin|mesh-list
64433968|NCT01612858|Pioglitazone|pioglitazone|mesh-list
64433969|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433984|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64433985|NCT02431559|Durvalumab|durvalumab|mesh-list
64433986|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64433987|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433988|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64433989|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64433990|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433991|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433992|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433993|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64433994|NCT04926545|Fluorouracil|fluorouracil|mesh-list
64433995|NCT04926545|Irinotecan|irinotecan|mesh-list
64433996|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
64433997|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433998|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64433999|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635458|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635459|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
64635460|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635461|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64635462|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64635463|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
64635464|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635465|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
64635466|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
64635467|NCT00005626|Irinotecan|irinotecan|mesh-list
64635468|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64635469|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64635470|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635471|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434000|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434001|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
64434002|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434003|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64434004|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64434005|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434006|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64434007|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64635472|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635473|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
64635474|NCT00005092|Thiotepa|thiotepa|mesh-list
64635475|NCT00005092|Methoxsalen|methoxsalen|mesh-list
64635478|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
64635479|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635480|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635481|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64635482|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
64635483|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635484|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635487|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
64434094|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434095|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64434096|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64434097|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
64434098|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64434099|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64434100|NCT01814878|Acetaminophen|acetaminophen|mesh-list
64434101|NCT01814878|Tramadol|tramadol|mesh-list
64434102|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434103|NCT01814878|Analgesics|analgesics|mesh-ancestor
64434104|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
64434105|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434106|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434107|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
64434108|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64434109|NCT01814878|Narcotics|narcotics|mesh-ancestor
64434110|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434111|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
64434113|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434115|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
64434116|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
64434117|NCT04602754|Empagliflozin|empagliflozin|mesh-list
64434118|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64434119|NCT04602754|Calcium|calcium|mesh-list
64434123|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64635489|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635490|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64635491|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64635492|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635493|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635494|NCT00005104|Metformin|metformin|mesh-list
64635495|NCT00005104|Clomiphene|clomiphene|mesh-list
64635496|NCT00005104|Enclomiphene|enclomiphene|mesh-list
64635497|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
64635498|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64635499|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635500|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64635501|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
64635502|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635503|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64635504|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
64635505|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64434143|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64434144|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434145|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434146|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
64434147|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434148|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434149|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64434150|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434151|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
64635507|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64635508|NCT00005110|Albuterol|albuterol|mesh-list
64635509|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64635510|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64635511|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
64635512|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635513|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635514|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64635515|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
64635516|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64635517|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64635518|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64635519|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
64635521|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635522|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
64635523|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64635524|NCT00004330|Hormones|hormones|mesh-list
64635525|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635526|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635527|NCT00005644|Gemcitabine|gemcitabine|mesh-list
64635528|NCT00005644|Paclitaxel|paclitaxel|mesh-list
64635529|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64635530|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635531|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
64434153|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434154|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434155|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
64434156|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434157|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434158|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64434159|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64434160|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
64434161|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434162|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434163|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434164|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434165|NCT01810432|Evacetrapib|evacetrapib|mesh-list
64434166|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64434167|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64434168|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
64434169|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434170|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64434171|NCT04908449|Bupivacaine|bupivacaine|mesh-list
64434172|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
64434173|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
64635532|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635533|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635534|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635535|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64635536|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
64635537|NCT00005644|Antiviral Agents|antiviral agents|mesh-ancestor
64635538|NCT00005644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635539|NCT00005644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635540|NCT00005644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635541|NCT00005644|Immunologic Factors|immunologic factors|mesh-ancestor
64635543|NCT00005668|Itraconazole|itraconazole|mesh-list
64434182|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434183|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434184|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434185|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434186|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
64434187|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434188|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
64434189|NCT02430311|Paclitaxel|paclitaxel|mesh-list
64434190|NCT02430311|Olaparib|olaparib|mesh-list
64434191|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64434192|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434193|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
64434194|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
64434195|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
64434196|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434249|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434250|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64434251|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
64434252|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
64434253|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
64434254|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434255|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434256|NCT02403635|Midazolam|midazolam|mesh-list
64434257|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64434277|NCT02402933|Incretins|incretins|mesh-ancestor
64434320|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64434321|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
64434322|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434323|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434324|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64434325|NCT01867294|Diuretics|diuretics|mesh-ancestor
64434326|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
64434327|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64434328|NCT01867294|Protective Agents|protective agents|mesh-ancestor
64434330|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64434331|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434352|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434353|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434354|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434355|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64434356|NCT01865812|Cathartics|cathartics|mesh-ancestor
64434357|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434358|NCT01808092|Meropenem|meropenem|mesh-list
64434359|NCT01808092|Ceftazidime|ceftazidime|mesh-list
64434360|NCT01808092|Avibactam|avibactam|mesh-list
64434361|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64434362|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434363|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434434|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64434435|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
64434437|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434438|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64434439|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
64434440|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
64434441|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64434442|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64434443|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64434444|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
64434530|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434532|NCT02420717|Cytarabine|cytarabine|mesh-list
64434533|NCT02420717|Dexamethasone|dexamethasone|mesh-list
64434534|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
64434535|NCT02420717|Prednisone|prednisone|mesh-list
64434539|NCT02420717|Doxorubicin|doxorubicin|mesh-list
64434540|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64434541|NCT02420717|Methotrexate|methotrexate|mesh-list
64434542|NCT02420717|Vincristine|vincristine|mesh-list
64434543|NCT02420717|Daunorubicin|daunorubicin|mesh-list
64434544|NCT02420717|Dasatinib|dasatinib|mesh-list
64434545|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
64434546|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64434547|NCT02420717|Antibodies|antibodies|mesh-list
64434548|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
64434551|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434552|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
64434553|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434554|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434567|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434568|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64434569|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
64434570|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434571|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64434584|NCT02420717|Antidotes|antidotes|mesh-ancestor
64434593|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64434594|NCT02016105|Adalimumab|adalimumab|mesh-list
64434597|NCT02400749|Apremilast|apremilast|mesh-list
64434598|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64434599|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434600|NCT02400749|Analgesics|analgesics|mesh-ancestor
64434601|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
64434602|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434603|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434604|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434605|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434606|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64434607|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64434608|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434676|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
64434677|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434678|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
64434679|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64434680|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
64434682|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64434683|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
64434684|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
64434685|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434687|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
64635544|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
64635545|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635546|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64635547|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635548|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635549|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635550|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64635551|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
64635552|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635553|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635554|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64635555|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
64635556|NCT00030992|Promethazine|promethazine|mesh-list
64635557|NCT00030992|Ranitidine|ranitidine|mesh-list
64635558|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64635559|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64434714|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64434715|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64434716|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64434717|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64434718|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64434719|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64434720|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
64434721|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
64434722|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
64434723|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434724|NCT01624467|Necitumumab|necitumumab|mesh-list
64434725|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434739|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434740|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434741|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64434742|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64434743|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434744|NCT01993017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64434745|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
64434746|NCT01988493|Sorafenib|sorafenib|mesh-list
64434747|NCT01988493|Tepotinib|tepotinib|mesh-list
64434748|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434749|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64434750|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434751|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434752|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
64434753|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64434759|NCT02081001|Hormones|hormones|mesh-ancestor
64434760|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434761|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434762|NCT02080221|Leucovorin|leucovorin|mesh-list
64434763|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
64434764|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434765|NCT02080221|Antidotes|antidotes|mesh-ancestor
64434766|NCT02080221|Protective Agents|protective agents|mesh-ancestor
64434767|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434768|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
64434769|NCT02080221|Vitamins|vitamins|mesh-ancestor
64434812|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64434813|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434814|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434815|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434816|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
64434817|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
64434818|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434819|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434820|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64434821|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64434822|NCT01988103|Growth Substances|growth substances|mesh-ancestor
64434823|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
64434824|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434825|NCT02013375|Sirolimus|sirolimus|mesh-list
64434826|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
64434827|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
64434842|NCT02079519|Bevacizumab|bevacizumab|mesh-list
64635560|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64635561|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64635562|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635563|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
64635564|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
64635565|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
64635580|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
64635581|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64635582|NCT00004360|Diuretics|diuretics|mesh-ancestor
64635583|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
64635584|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635585|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64635586|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434877|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
64434878|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64434879|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64434880|NCT02011113|Growth Substances|growth substances|mesh-ancestor
64434881|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
64434883|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64434884|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
64434885|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64434886|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434887|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64434888|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
64434889|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434890|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434891|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
64434892|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434893|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64434894|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434895|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
64434896|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434897|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64434898|NCT01620489|Liraglutide|liraglutide|mesh-list
64434899|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64434900|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434901|NCT01620489|Incretins|incretins|mesh-ancestor
64434919|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434920|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434921|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434922|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434923|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64434924|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64434925|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434926|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434927|NCT01787032|Ketoconazole|ketoconazole|mesh-list
64434928|NCT01787032|Voriconazole|voriconazole|mesh-list
64434929|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
64434959|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
64434960|NCT01736254|Evacetrapib|evacetrapib|mesh-list
64434961|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64434962|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
64434963|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434964|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64434965|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64434966|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64434967|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434968|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64434969|NCT01785472|Olmesartan|olmesartan|mesh-list
64434970|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64434971|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64434972|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64434973|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64434974|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64434975|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434976|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
64434977|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434978|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434979|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
64434989|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64434990|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
64434999|NCT01735630|Inositol|inositol|mesh-list
64635587|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635588|NCT00385450|Nelfinavir|nelfinavir|mesh-list
64635589|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64635590|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64635591|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
64635592|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635593|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635594|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635595|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64635596|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
64635597|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635598|NCT00004390|Morphine|morphine|mesh-list
64635599|NCT00004390|Methadone|methadone|mesh-list
64635600|NCT00004390|Nortriptyline|nortriptyline|mesh-list
64635601|NCT00004390|Desipramine|desipramine|mesh-list
64435013|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435014|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435015|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435016|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435017|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435018|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64435019|NCT01734850|Busulfan|busulfan|mesh-list
64435021|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435022|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435023|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
64435024|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435025|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64435026|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435027|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64435029|NCT01766050|Losartan|losartan|mesh-list
64435030|NCT01766050|Midazolam|midazolam|mesh-list
64435031|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
64435032|NCT01766050|Caffeine|caffeine|mesh-list
64435034|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64435035|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64435036|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435037|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435038|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64435039|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64435040|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64435041|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64435042|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
64435043|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
64435044|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
64435045|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
64435058|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64435059|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435060|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64435061|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
64435062|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
64435063|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64435064|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64435065|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64435066|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435067|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435068|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
64435069|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435070|NCT02341625|Nivolumab|nivolumab|mesh-list
64435071|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435072|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435135|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435136|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
64435137|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435138|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435139|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435140|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
64435141|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435142|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64635602|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64635603|NCT00004390|Narcotics|narcotics|mesh-ancestor
64635604|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64635605|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635606|NCT00004390|Analgesics|analgesics|mesh-ancestor
64635607|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
64635622|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635623|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635624|NCT00004402|Calcitriol|calcitriol|mesh-list
64635625|NCT00004402|Interferons|interferons|mesh-list
64435176|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64435177|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64435178|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64435179|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
64435180|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64435181|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64435182|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435183|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435186|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64446215|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435242|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435243|NCT01648283|Analgesics|analgesics|mesh-ancestor
64435244|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
64435245|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435246|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
64435247|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
64435248|NCT01649297|Empagliflozin|empagliflozin|mesh-list
64435249|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64435250|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435251|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435252|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435310|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64435311|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64435312|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64435313|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435314|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64435315|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64435317|NCT02348216|Fludarabine|fludarabine|mesh-list
64435318|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435319|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
64435320|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435321|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435322|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64435387|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64435388|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435389|NCT02311478|Trace Elements|trace elements|mesh-ancestor
64435390|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
64435391|NCT02281760|Trametinib|trametinib|mesh-list
64435392|NCT02281760|Dabrafenib|dabrafenib|mesh-list
64435393|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64435394|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435396|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635626|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
64635627|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635628|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
64635629|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635630|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64635631|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635632|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64635633|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64435479|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64435480|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64435481|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435482|NCT02358863|Antidotes|antidotes|mesh-ancestor
64435483|NCT02358863|Protective Agents|protective agents|mesh-ancestor
64435484|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435485|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
64435486|NCT02358863|Vitamins|vitamins|mesh-ancestor
64435487|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
64435488|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64435547|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64435548|NCT02010255|Ledipasvir|ledipasvir|mesh-list
64435550|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435551|NCT04666701|Ketorolac|ketorolac|mesh-list
64435552|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64435553|NCT04666701|Scopolamine|scopolamine|mesh-list
64446216|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
64435554|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64435555|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64435557|NCT04666701|Analgesics|analgesics|mesh-ancestor
64435558|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
64435559|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435560|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435561|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435563|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64435564|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435565|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435616|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435617|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64435618|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435619|NCT02312219|Folic Acid|folic acid|mesh-list
64435620|NCT02312219|Methotrexate|methotrexate|mesh-list
64435621|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64435622|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
64435623|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64435624|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435625|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435626|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
64435627|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435628|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435673|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64435674|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64435675|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435676|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64435677|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64435678|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64435679|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435680|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
64435681|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435682|NCT01983969|Pyridoxine|pyridoxine|mesh-list
64435683|NCT01983969|Gemcitabine|gemcitabine|mesh-list
64435768|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435769|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435770|NCT02310581|Buprenorphine|buprenorphine|mesh-list
64435771|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64435772|NCT02310581|Narcotics|narcotics|mesh-ancestor
64435773|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435774|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435775|NCT02310581|Analgesics|analgesics|mesh-ancestor
64435779|NCT04892693|Talazoparib|talazoparib|mesh-list
64435795|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64435796|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64435797|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64435806|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64435807|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
64435808|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435809|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435813|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435814|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
64435815|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435816|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
64635634|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635635|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64635636|NCT00004402|Vitamins|vitamins|mesh-ancestor
64635637|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
64635638|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64635639|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
64635640|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64635641|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64635643|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
64435845|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
64435846|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64435847|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
64435848|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435849|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435850|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
64435851|NCT02348489|Guadecitabine|guadecitabine|mesh-list
64435852|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435853|NCT01966107|Bromides|bromides|mesh-list
64435854|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
64435855|NCT01982331|Vaccines|vaccines|mesh-list
64435856|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
64435857|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435858|NCT02326025|Doxorubicin|doxorubicin|mesh-list
64435859|NCT02326025|Olaratumab|olaratumab|mesh-list
64435860|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64435861|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435862|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64435863|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64435864|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435865|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435866|NCT01619865|Edotreotide|edotreotide|mesh-list
64435867|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64296044|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64435888|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635644|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635646|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64635647|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635648|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64635649|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
64635650|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635651|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64635652|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
64635654|NCT00004426|Hormones|hormones|mesh-list
64635655|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635656|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635657|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64635658|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
64635659|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64635660|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64635661|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635662|NCT00004438|Leuprolide|leuprolide|mesh-list
64635663|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64635664|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
64435906|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435907|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64435908|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435920|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
64435921|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
64435934|NCT04672005|Protective Agents|protective agents|mesh-ancestor
64435935|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
64435936|NCT04672005|Vitamins|vitamins|mesh-ancestor
64435937|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
64435938|NCT04416399|Budesonide|budesonide|mesh-list
64435939|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435940|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64435942|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435943|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435944|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64435945|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
64435946|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
64435947|NCT04416399|Hormones|hormones|mesh-ancestor
64435948|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435949|NCT02282345|Talazoparib|talazoparib|mesh-list
64435950|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64435951|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296045|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64435952|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435953|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435954|NCT01732822|Clopidogrel|clopidogrel|mesh-list
64435956|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64435957|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64446217|NCT02181842|Pioglitazone|pioglitazone|mesh-list
64435958|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64435959|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64435960|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
64435961|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435963|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435980|NCT02004093|Immunologic Factors|immunologic factors|mesh-ancestor
64435981|NCT02004093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435982|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435983|NCT01641367|Tenofovir|tenofovir|mesh-list
64435984|NCT01641367|Emtricitabine|emtricitabine|mesh-list
64435985|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
64436002|NCT02325713|Praziquantel|praziquantel|mesh-list
64436003|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
64436004|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64436005|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436076|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436077|NCT01965327|Interferons|interferons|mesh-list
64436078|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
64436079|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436080|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
64436081|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436082|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
64436083|NCT04872595|Melphalan|melphalan|mesh-list
64436084|NCT04872595|Busulfan|busulfan|mesh-list
64436085|NCT04872595|Thiotepa|thiotepa|mesh-list
64436180|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64436181|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436182|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64436183|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436184|NCT01763164|Dacarbazine|dacarbazine|mesh-list
64436185|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436186|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
64436187|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436188|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436189|NCT01782742|Bexarotene|bexarotene|mesh-list
64436251|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436252|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436253|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64436254|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64436255|NCT01600885|Guanfacine|guanfacine|mesh-list
64436256|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64436257|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64436258|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64436259|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64436260|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436261|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436309|NCT04608331|Analgesics|analgesics|mesh-ancestor
64436310|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
64436311|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436312|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64436313|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64436314|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64436315|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436323|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
64436420|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
64436421|NCT01999179|Dabigatran|dabigatran|mesh-list
64436425|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64436426|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64436427|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436428|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64436429|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
64436430|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64436431|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
64436432|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436433|NCT01977729|Sertraline|sertraline|mesh-list
64436434|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
64436435|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64436436|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64436437|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64436438|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64436439|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436440|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436441|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
64436442|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436443|NCT01998399|Ticagrelor|ticagrelor|mesh-list
64635665|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64635666|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635667|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64635668|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635672|NCT02197273|Epinephrine|epinephrine|mesh-list
64635673|NCT02197273|Fentanyl|fentanyl|mesh-list
64635674|NCT02197273|Morphine|morphine|mesh-list
64635675|NCT02197273|Bupivacaine|bupivacaine|mesh-list
64635676|NCT02197273|Ropivacaine|ropivacaine|mesh-list
64635677|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
64635678|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
64635679|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436530|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436531|NCT01975701|Infigratinib|infigratinib|mesh-list
64436532|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436533|NCT01962987|Diclofenac|diclofenac|mesh-list
64436534|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64436550|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436551|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436552|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
64436553|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436554|NCT01637623|Allopurinol|allopurinol|mesh-list
64436555|NCT01637623|Losartan|losartan|mesh-list
64436556|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64436557|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64436558|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64436559|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64436560|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436561|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
64436562|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436563|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
64436564|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436565|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64436566|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
64436567|NCT01637623|Protective Agents|protective agents|mesh-ancestor
64436568|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436569|NCT01995825|Lamotrigine|lamotrigine|mesh-list
64436570|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
64436571|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64436572|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64436573|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436574|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64436575|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436576|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64436577|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64436578|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436579|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64436580|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64436581|NCT05309629|Carboplatin|carboplatin|mesh-list
64436582|NCT05309629|Etoposide|etoposide|mesh-list
64436583|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635680|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635681|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
64635682|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635683|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64635684|NCT02197273|Narcotics|narcotics|mesh-ancestor
64635685|NCT02197273|Analgesics|analgesics|mesh-ancestor
64635686|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64635687|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64635688|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
64635689|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64436696|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436697|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
64436698|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436699|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436700|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436701|NCT05218915|Dulaglutide|dulaglutide|mesh-list
64436702|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64635690|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64635691|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
64635693|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635709|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635711|NCT00004444|Streptomycin|streptomycin|mesh-list
64635712|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64635713|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635714|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64635715|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64635716|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64635717|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635718|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635720|NCT00004450|Interferon-beta|interferon-beta|mesh-list
64635722|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635723|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
64635724|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635736|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635737|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64635738|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64436769|NCT05814354|Immunologic Factors|immunologic factors|mesh-ancestor
64436770|NCT05814354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436771|NCT05814302|Acetaminophen|acetaminophen|mesh-list
64436773|NCT05814302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64436774|NCT05814302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64436775|NCT05814302|Analgesics|analgesics|mesh-ancestor
64436776|NCT05814302|Sensory System Agents|sensory system agents|mesh-ancestor
64436777|NCT05814302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436778|NCT05814302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436779|NCT05814302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436780|NCT05814302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436781|NCT05814302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64436782|NCT05814302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436783|NCT05814302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436830|NCT05813600|Ritonavir|ritonavir|mesh-list
64436831|NCT05813600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64436832|NCT05813600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64436833|NCT05813600|Protease Inhibitors|protease inhibitors|mesh-ancestor
64436835|NCT05813600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436836|NCT05813600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64436837|NCT05813600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64436838|NCT05813600|Antiviral Agents|antiviral agents|mesh-ancestor
64436845|NCT05813522|Aflutinib|aflutinib|mesh-list
64635739|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635740|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64635741|NCT00004468|Vitamins|vitamins|mesh-ancestor
64635742|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
64635743|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64635748|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635749|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635750|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635751|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64635753|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
64635754|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635755|NCT00005764|Lamivudine|lamivudine|mesh-list
64635756|NCT00005764|Zidovudine|zidovudine|mesh-list
64635757|NCT00005764|Abacavir|abacavir|mesh-list
64635758|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64635759|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64635761|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635762|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635763|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
64635764|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436885|NCT05813314|Natriuretic Agents|natriuretic agents|mesh-ancestor
64436886|NCT05813314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436887|NCT05813288|Pramipexole|pramipexole|mesh-list
64436888|NCT05813288|Antioxidants|antioxidants|mesh-ancestor
64436889|NCT05813288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436890|NCT05813288|Protective Agents|protective agents|mesh-ancestor
64436891|NCT05813288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436892|NCT05813288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64436893|NCT05813288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64635765|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635766|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64635767|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
64635768|NCT01289275|Nicotine|nicotine|mesh-list
64635769|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64635770|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
64635771|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635772|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635773|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64635774|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64635775|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
64635776|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635777|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635778|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
64635779|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64635780|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635781|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
64635782|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635783|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635792|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64635793|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64436933|NCT05813132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436934|NCT05813132|Antimetabolites|antimetabolites|mesh-ancestor
64436935|NCT05813132|Antiviral Agents|antiviral agents|mesh-ancestor
64436936|NCT05813132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436937|NCT05813132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436938|NCT05813132|Immunologic Factors|immunologic factors|mesh-ancestor
64436939|NCT05813132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436940|NCT05813132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436941|NCT05813132|Alkylating Agents|alkylating agents|mesh-ancestor
64436942|NCT05813132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64436943|NCT05813106|Dexmedetomidine|dexmedetomidine|mesh-list
64436944|NCT05813106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64436971|NCT05811403|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64436972|NCT05811403|Disinfectants|disinfectants|mesh-ancestor
64436973|NCT05811403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436974|NCT05811403|Antioxidants|antioxidants|mesh-ancestor
64436975|NCT05811403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436976|NCT05811403|Protective Agents|protective agents|mesh-ancestor
64436977|NCT05811403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436978|NCT05811403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64436979|NCT05811403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64436980|NCT05811403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436981|NCT05811403|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64436984|NCT05808582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436985|NCT05808582|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64436986|NCT05808582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64436988|NCT05808582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436989|NCT05808582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436990|NCT05802849|Acetazolamide|acetazolamide|mesh-list
64436991|NCT05802849|Anticonvulsants|anticonvulsants|mesh-ancestor
64437007|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64437008|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64437009|NCT05788289|Growth Substances|growth substances|mesh-ancestor
64437010|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
64437011|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437095|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437096|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437097|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
64437098|NCT05732883|Hormones|hormones|mesh-ancestor
64437100|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437101|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437103|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64437104|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64437107|NCT05720455|Fexofenadine|fexofenadine|mesh-list
64635794|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635796|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635797|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635798|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64635799|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635800|NCT00004486|Fluoxetine|fluoxetine|mesh-list
64635801|NCT00004486|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64635802|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64635803|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437175|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
64437176|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437177|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437178|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
64437179|NCT05662397|Cemiplimab|cemiplimab|mesh-list
64437180|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437181|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437182|NCT05654623|Fulvestrant|fulvestrant|mesh-list
64437183|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437184|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437185|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64437186|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64437187|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
64437188|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437189|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437195|NCT05627596|Nicotine|nicotine|mesh-list
64437196|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64437197|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
64437198|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437199|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437200|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64437201|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64437202|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
64437203|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437204|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437209|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
64437210|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437211|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437212|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
64437213|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64437215|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437263|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
64437264|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
64437265|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437266|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
64437267|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437269|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64437340|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437347|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64437348|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437355|NCT05465941|Irinotecan|irinotecan|mesh-list
64437356|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64437357|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64437358|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437359|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437360|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437379|NCT05403450|Decitabine|decitabine|mesh-list
64437445|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437446|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64437447|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
64437448|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64437449|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64437450|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437451|NCT05287191|Protective Agents|protective agents|mesh-ancestor
64437452|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
64437453|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64437454|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64437455|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64437456|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64437457|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64437458|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64437517|NCT05206682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64437518|NCT05206682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437519|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437520|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437521|NCT05197842|Prednisone|prednisone|mesh-list
64437522|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
64437523|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
64437524|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437525|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
64437526|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437527|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437528|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64437529|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
64437530|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437531|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437532|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64437551|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
64437613|NCT05129748|Protective Agents|protective agents|mesh-ancestor
64437614|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
64437615|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437616|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
64437617|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64437618|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437619|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
64437620|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
64437622|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64437623|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437723|NCT04969887|Nivolumab|nivolumab|mesh-list
64437724|NCT04969887|Ipilimumab|ipilimumab|mesh-list
64437725|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437726|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437727|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64437728|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437729|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
64437730|NCT04933084|Narcotics|narcotics|mesh-ancestor
64437731|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437732|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437733|NCT04933084|Analgesics|analgesics|mesh-ancestor
64437734|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
64437735|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437736|NCT04930887|Bupivacaine|bupivacaine|mesh-list
64437737|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
64437738|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
64437740|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437741|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
64437782|NCT04895358|Paclitaxel|paclitaxel|mesh-list
64437804|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437805|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437806|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437807|NCT04853446|Dexamethasone|dexamethasone|mesh-list
64437808|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
64437810|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437811|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
64437812|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
64437813|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437815|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437901|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437909|NCT04725188|Docetaxel|docetaxel|mesh-list
64437910|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
64437911|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437912|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437913|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437914|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437915|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437916|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437919|NCT04704505|Androgens|androgens|mesh-list
64437920|NCT04704505|Hormones|hormones|mesh-ancestor
64437923|NCT04657081|Decitabine|decitabine|mesh-list
64438033|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438034|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438035|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64438036|NCT04429516|Morphine|morphine|mesh-list
64438037|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64438038|NCT04429516|Narcotics|narcotics|mesh-ancestor
64438039|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438040|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635804|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635805|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635806|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
64635807|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635808|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64635809|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
64635810|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64635811|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64438110|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64438111|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438112|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438113|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64438114|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438115|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64438117|NCT04375631|Cyclosporine|cyclosporine|mesh-list
64438126|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
64438127|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438128|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438186|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438187|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438188|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
64438209|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438210|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64438212|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64438213|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438214|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64438215|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64438216|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64438217|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64438218|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64438219|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64438220|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
64438221|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438222|NCT04212793|Bevacizumab|bevacizumab|mesh-list
64438223|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438227|NCT04212793|Growth Substances|growth substances|mesh-ancestor
64635812|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635818|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
64635819|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635820|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635821|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64635822|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64635823|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438334|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438335|NCT04023227|Valsartan|valsartan|mesh-list
64438336|NCT04023227|Enalapril|enalapril|mesh-list
64438348|NCT04022135|Vitamins|vitamins|mesh-ancestor
64438349|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
64438350|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438351|NCT04001777|Osimertinib|osimertinib|mesh-list
64438352|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438353|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438354|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438355|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438357|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64438358|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438359|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
64438360|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438361|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438362|NCT03977012|Buprenorphine|buprenorphine|mesh-list
64438363|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64438364|NCT03977012|Narcotics|narcotics|mesh-ancestor
64438365|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438366|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438379|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64438380|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438381|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438382|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438383|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438384|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
64438385|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438386|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438387|NCT03915964|Adalimumab|adalimumab|mesh-list
64438388|NCT03915964|Etanercept|etanercept|mesh-list
64438389|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64438390|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438391|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438392|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64438393|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438394|NCT03915964|Analgesics|analgesics|mesh-ancestor
64438395|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
64438396|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438397|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438398|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438417|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64438418|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64438420|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438421|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64438422|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64438423|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438424|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64635824|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
64635825|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64635826|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635827|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64635828|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
64635829|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64635830|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635831|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64635832|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64635833|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
64635834|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64635835|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
64635836|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635837|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635838|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64635839|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
64635840|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64635841|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
64438466|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
64438467|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438468|NCT03809884|Expectorants|expectorants|mesh-ancestor
64438469|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
64438470|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
64438471|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
64438472|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438473|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438474|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64438475|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438476|NCT03768427|Atorvastatin|atorvastatin|mesh-list
64438477|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64438478|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64635847|NCT00005776|Protective Agents|protective agents|mesh-ancestor
64635848|NCT01290445|Varenicline|varenicline|mesh-list
64635850|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64635851|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
64635852|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635853|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635854|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635856|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64635857|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
64635858|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635859|NCT01290913|Omalizumab|omalizumab|mesh-list
64635860|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64438515|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64438516|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64438517|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
64438518|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438522|NCT03702270|Penicillins|penicillins|mesh-list
64438523|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64438524|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438525|NCT03672539|Cytarabine|cytarabine|mesh-list
64438526|NCT03672539|Daunorubicin|daunorubicin|mesh-list
64438527|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
64438528|NCT03672539|Calicheamicins|calicheamicins|mesh-list
64438558|NCT03657160|Vedolizumab|vedolizumab|mesh-list
64438559|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438561|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64438562|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438563|NCT03598309|Analgesics|analgesics|mesh-ancestor
64438565|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438566|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438567|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438568|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64635861|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64635862|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
64635863|NCT00004552|Acamprosate|acamprosate|mesh-list
64635864|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64635865|NCT00101660|Dasatinib|dasatinib|mesh-list
64635866|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635867|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64635868|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635869|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635870|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
64635871|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64635872|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635873|NCT00005800|Docetaxel|docetaxel|mesh-list
64635874|NCT00005800|Doxorubicin|doxorubicin|mesh-list
64635875|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64635876|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635877|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635878|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635879|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635880|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635881|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64635882|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64635883|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438614|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438615|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438616|NCT03477175|Sorafenib|sorafenib|mesh-list
64438617|NCT03477175|Lenvatinib|lenvatinib|mesh-list
64438618|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438619|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438620|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438628|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438629|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
64438630|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438631|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438656|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438657|NCT03311308|Metformin|metformin|mesh-list
64438658|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
64438659|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64438660|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438661|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438662|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438663|NCT03288545|Gemcitabine|gemcitabine|mesh-list
64438664|NCT03288545|Carboplatin|carboplatin|mesh-list
64635884|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635885|NCT00004564|Clopidogrel|clopidogrel|mesh-list
64635886|NCT00004564|Atorvastatin|atorvastatin|mesh-list
64635887|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64635888|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64635889|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
64635890|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438665|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
64438666|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438667|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438668|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
64438669|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438670|NCT03288545|Antiviral Agents|antiviral agents|mesh-ancestor
64438671|NCT03288545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438672|NCT03288545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438673|NCT03288545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438674|NCT03288545|Immunologic Factors|immunologic factors|mesh-ancestor
64438675|NCT03288545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438676|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438677|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64438679|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438681|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64438682|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438683|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64438684|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64438685|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438686|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438687|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64438688|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
64438689|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438690|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438691|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
64438692|NCT03215810|Nivolumab|nivolumab|mesh-list
64438693|NCT03215810|Fludarabine|fludarabine|mesh-list
64438694|NCT03215810|Interleukin-2|interleukin-2|mesh-list
64438700|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
64438701|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438702|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438703|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64635892|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64635893|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635894|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64635895|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64635896|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64635897|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64635898|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
64635899|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635900|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635901|NCT01268527|Calcipotriene|calcipotriene|mesh-list
64635902|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
64635903|NCT00005806|Paclitaxel|paclitaxel|mesh-list
64635904|NCT00005806|Carboplatin|carboplatin|mesh-list
64635905|NCT00005806|Gefitinib|gefitinib|mesh-list
64635906|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64635907|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635908|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
64635909|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
64635910|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
64635911|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438704|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438705|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64438706|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438708|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
64438709|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438710|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64438711|NCT03179449|Hematinics|hematinics|mesh-ancestor
64438712|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64438713|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64438714|NCT03132454|Dexamethasone|dexamethasone|mesh-list
64438715|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
64438716|NCT03132454|Sorafenib|sorafenib|mesh-list
64635912|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64635913|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635915|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64635916|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
64635917|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635918|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635919|NCT01270555|Bupropion|bupropion|mesh-list
64635920|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64635923|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64635924|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64635925|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64635926|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635927|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
64635928|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64635929|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438751|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438752|NCT02964078|Analgesics|analgesics|mesh-ancestor
64438753|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
64438754|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438755|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438756|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64438757|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64438758|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
64438759|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438760|NCT02960659|Metformin|metformin|mesh-list
64438761|NCT02960659|Liraglutide|liraglutide|mesh-list
64635930|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64635931|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635932|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635933|NCT00004582|Ritonavir|ritonavir|mesh-list
64635934|NCT00004582|Lopinavir|lopinavir|mesh-list
64635935|NCT00004582|Efavirenz|efavirenz|mesh-list
64635936|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64635937|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64302397|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302399|NCT03069950|Protective Agents|protective agents|mesh-ancestor
64635940|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635941|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64635942|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64438845|NCT02491632|Ichthammol|ichthammol|mesh-list
64438846|NCT02491632|BB 1101|bb 1101|mesh-list
64438847|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438848|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
64438849|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
64438850|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438851|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438852|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438853|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
64438854|NCT02491632|Hormones|hormones|mesh-ancestor
64438855|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438856|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64438857|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438858|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
64438859|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438860|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438861|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
64438862|NCT02421939|Cytarabine|cytarabine|mesh-list
64438863|NCT02421939|Fludarabine|fludarabine|mesh-list
64438864|NCT02421939|Etoposide|etoposide|mesh-list
64438865|NCT02421939|Azacitidine|azacitidine|mesh-list
64438866|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
64438867|NCT02421939|Idarubicin|idarubicin|mesh-list
64438868|NCT02421939|Lenograstim|lenograstim|mesh-list
64438869|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438870|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438885|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64438886|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438887|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
64438888|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64438889|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438890|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438891|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438892|NCT02409810|Analgesics|analgesics|mesh-ancestor
64438893|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
64438894|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438895|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64438896|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64438897|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64438898|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
64438899|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438900|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438901|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64438902|NCT02324608|Cetuximab|cetuximab|mesh-list
64438903|NCT02324608|Antibodies|antibodies|mesh-list
64438904|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
64438905|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64635943|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
64635944|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64635945|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64635946|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64635947|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64635948|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64635949|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64635950|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64635951|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64635952|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64635953|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64635955|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
64635956|NCT00004690|Protective Agents|protective agents|mesh-ancestor
64635957|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635958|NCT00004696|Morphine|morphine|mesh-list
64635959|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64635960|NCT00004696|Narcotics|narcotics|mesh-ancestor
64635961|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64635962|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635963|NCT00004696|Analgesics|analgesics|mesh-ancestor
64635965|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64635966|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
64635967|NCT00004744|Antibodies|antibodies|mesh-list
64635968|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
64635970|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64635971|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
64635972|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635973|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
64635974|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64438929|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438960|NCT01983462|Diuretics|diuretics|mesh-ancestor
64438961|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
64438962|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438963|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64438966|NCT01983462|Analgesics|analgesics|mesh-ancestor
64439010|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
64439011|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439012|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439013|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439014|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
64439015|NCT01919086|Hormones|hormones|mesh-ancestor
64439016|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439017|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64439018|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439019|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
64439020|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64439021|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64439022|NCT01919086|Growth Substances|growth substances|mesh-ancestor
64439079|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64439080|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64439081|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64439082|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439083|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
64439084|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439085|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439086|NCT00981058|Gemcitabine|gemcitabine|mesh-list
64635975|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64635976|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64635977|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64635978|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64635979|NCT01292005|Protective Agents|protective agents|mesh-ancestor
64635980|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635981|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
64635982|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64439105|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64439106|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64439107|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439110|NCT00565851|Docetaxel|docetaxel|mesh-list
64439126|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64439127|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64439128|NCT00565851|Growth Substances|growth substances|mesh-ancestor
64439129|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439130|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
64439131|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
64439132|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439133|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
64439134|NCT00565851|Antiviral Agents|antiviral agents|mesh-ancestor
64439268|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64439269|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64439270|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439271|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
64439272|NCT02619253|Vorinostat|vorinostat|mesh-list
64439273|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439274|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439275|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64439356|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
64439357|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64439358|NCT01945593|Factor VIII|factor viii|mesh-list
64439359|NCT01945593|BAX 855|bax 855|mesh-list
64439360|NCT01945593|Coagulants|coagulants|mesh-ancestor
64439361|NCT01945281|Amphotericin B|amphotericin b|mesh-list
64439362|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64439364|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
64439365|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
64439366|NCT01945281|Amebicides|amebicides|mesh-ancestor
64439367|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64439368|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64439369|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439370|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64439371|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
64635983|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
64635984|NCT00004762|Cladribine|cladribine|mesh-list
64635985|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64635986|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64635987|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
64635988|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64635999|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
64636000|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636001|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636002|NCT00004804|Interferons|interferons|mesh-list
64636004|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636005|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
64636006|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439413|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64439414|NCT01973439|Abacavir|abacavir|mesh-list
64439415|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
64439416|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64439417|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64439418|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439419|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439420|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
64439421|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439422|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64439423|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64439424|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
64439425|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64439426|NCT01973283|Citalopram|citalopram|mesh-list
64439427|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
64439428|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64439429|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64439430|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64439455|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
64439456|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64439457|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
64439461|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439462|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
64439463|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
64439464|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64439465|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64439499|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439500|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
64439501|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
64439502|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439503|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439504|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439505|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
64439506|NCT01971645|Hormones|hormones|mesh-ancestor
64439551|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64439552|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439553|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439555|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439556|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
64439557|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439558|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439559|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
64439623|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
64439624|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
64439626|NCT01707004|Fludarabine|fludarabine|mesh-list
64439627|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
64439628|NCT01707004|Azacitidine|azacitidine|mesh-list
64439629|NCT01707004|Decitabine|decitabine|mesh-list
64439630|NCT01707004|Tacrolimus|tacrolimus|mesh-list
64439631|NCT01707004|Lenograstim|lenograstim|mesh-list
64439632|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636007|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
64636008|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636009|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
64636010|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64636011|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
64636012|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
64636013|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636014|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64439676|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
64439677|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
64439678|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439679|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439680|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
64439681|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
64439682|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439683|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439684|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439685|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
64439686|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439687|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439688|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64439689|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64439690|NCT01969851|Lacosamide|lacosamide|mesh-list
64439691|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
64439692|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64439693|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64439694|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64439695|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439696|NCT01938573|Gemcitabine|gemcitabine|mesh-list
64439697|NCT01938573|Sirolimus|sirolimus|mesh-list
64439698|NCT01938573|Cisplatin|cisplatin|mesh-list
64439699|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439700|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439701|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
64439702|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439704|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439705|NCT01938573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439706|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439707|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
64439711|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
64439712|NCT05546515|Suvorexant|suvorexant|mesh-list
64439713|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
64439714|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64439719|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439722|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64439723|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439724|NCT03542695|Trace Elements|trace elements|mesh-ancestor
64439725|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
64439764|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64439765|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64439766|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64439767|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
64439768|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439769|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439790|NCT01747447|Vitamin D|vitamin d|mesh-list
64439791|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
64439792|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
64439793|NCT01747447|Vitamins|vitamins|mesh-list
64636015|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
64636016|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64636017|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636018|NCT00004816|Antibodies|antibodies|mesh-list
64636019|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64636020|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
64636021|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636022|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
64636023|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
64636024|NCT01341301|Tacrolimus|tacrolimus|mesh-list
64636025|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636026|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
64636027|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636028|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439806|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439807|NCT01287091|Rabeprazole|rabeprazole|mesh-list
64439808|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64439809|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439810|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64439811|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439812|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439814|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64439815|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439816|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64439817|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64439818|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64439819|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439820|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
64439821|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439822|NCT01258933|Ofatumumab|ofatumumab|mesh-list
64439823|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439824|NCT02539459|Everolimus|everolimus|mesh-list
64439825|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439826|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439827|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
64439828|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439829|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
64439830|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64439831|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439832|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
64439833|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439834|NCT01634113|Bromides|bromides|mesh-list
64439835|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
64636029|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64636031|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636032|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636033|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64636034|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64636035|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636036|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64636037|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64439839|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439840|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64439841|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
64439842|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
64439843|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64439844|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
64439845|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439846|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439847|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
64439848|NCT01937715|Bevacizumab|bevacizumab|mesh-list
64439849|NCT01937715|Gedatolisib|gedatolisib|mesh-list
64439861|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64439862|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64439863|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439864|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
64439865|NCT01937559|Coagulants|coagulants|mesh-ancestor
64439866|NCT01918371|Ranibizumab|ranibizumab|mesh-list
64439867|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64439868|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64439896|NCT01916109|Carboplatin|carboplatin|mesh-list
64439897|NCT01916109|Panitumumab|panitumumab|mesh-list
64439898|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439899|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439900|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
64439901|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439902|NCT01916109|Antiviral Agents|antiviral agents|mesh-ancestor
64439903|NCT01916109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439909|NCT01958619|Artefenomel|artefenomel|mesh-list
64636038|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
64636039|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64636040|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636041|NCT01273207|Cyclosporine|cyclosporine|mesh-list
64636042|NCT01273207|Cyclosporins|cyclosporins|mesh-list
64636043|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636044|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636045|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636046|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
64636047|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636048|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
64636049|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636050|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636051|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636052|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64636053|NCT01342549|Naltrexone|naltrexone|mesh-list
64636054|NCT01342549|Valproic Acid|valproic acid|mesh-list
64636055|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64636056|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64439939|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439941|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439942|NCT00942331|Antiviral Agents|antiviral agents|mesh-ancestor
64296046|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64636057|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636058|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
64636059|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636060|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
64636061|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636062|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636065|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
64636066|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64636067|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636068|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64636069|NCT01295515|Interferons|interferons|mesh-list
64636070|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
64636071|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
64636072|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64636073|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636074|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
64439943|NCT00942331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439944|NCT00942331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439945|NCT00942331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439946|NCT04787341|Panitumumab|panitumumab|mesh-list
64439947|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439948|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439949|NCT00630565|Dexamethasone|dexamethasone|mesh-list
64439950|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
64439951|NCT00630565|Busulfan|busulfan|mesh-list
64439952|NCT00630565|Etoposide|etoposide|mesh-list
64439953|NCT00630565|Sargramostim|sargramostim|mesh-list
64439954|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439955|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
64439956|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439957|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439958|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64439959|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
64439960|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439961|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439962|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64439963|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439964|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
64439965|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
64439966|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439967|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439968|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
64439969|NCT00630565|Hormones|hormones|mesh-ancestor
64439970|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439971|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64439972|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64439973|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64439974|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64439975|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439976|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64439977|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64439983|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64439984|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64439985|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
64439986|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439987|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439988|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64439989|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64439990|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
64439991|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64439992|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64439993|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
64439997|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
64439999|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440000|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64440001|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64440002|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440003|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440004|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64440005|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64440007|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
64636075|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636076|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
64636077|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636078|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
64636079|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64636080|NCT00101816|Dasatinib|dasatinib|mesh-list
64636081|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636082|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64636083|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636084|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636085|NCT00102518|Aripiprazole|aripiprazole|mesh-list
64636086|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
64636087|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64636088|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64636089|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64440027|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
64440028|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440029|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440030|NCT04798027|Vaccines|vaccines|mesh-list
64440031|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
64440032|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440033|NCT04797325|Prednisolone|prednisolone|mesh-list
64440034|NCT04797325|Infliximab|infliximab|mesh-list
64440035|NCT04797325|Vedolizumab|vedolizumab|mesh-list
64440036|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64440037|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
64440038|NCT04797325|Hormones|hormones|mesh-ancestor
64440039|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440040|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440041|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64440042|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440043|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440044|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
64440045|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440077|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440148|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440149|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64440150|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440151|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440153|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
64440154|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440155|NCT01957215|Indomethacin|indomethacin|mesh-list
64440158|NCT01957215|Analgesics|analgesics|mesh-ancestor
64636090|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636091|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636092|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
64636093|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
64636094|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636095|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636096|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64440175|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64440176|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64440177|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440178|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440179|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440180|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64440181|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64440182|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64440184|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64440185|NCT02322281|Gemcitabine|gemcitabine|mesh-list
64440186|NCT02322281|Paclitaxel|paclitaxel|mesh-list
64440187|NCT02322281|Docetaxel|docetaxel|mesh-list
64440188|NCT02322281|Pemetrexed|pemetrexed|mesh-list
64440189|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64440194|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440195|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64440196|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
64440197|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
64440198|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440199|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440200|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440201|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
64440202|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440206|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
64440234|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64440235|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
64440236|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440237|NCT02320721|Insulin|insulin|mesh-list
64440238|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64440239|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
64440240|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440241|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440242|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64440243|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
64440244|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64440245|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
64440319|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
64440320|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64440321|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
64440327|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440328|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64440329|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
64440330|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
64440331|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440332|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440333|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440334|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
64440335|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440336|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64440337|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64440338|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440340|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
64440341|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64440342|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440343|NCT02207491|Timolol|timolol|mesh-list
64440344|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64440372|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440373|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440374|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
64440375|NCT04761133|Povidone|povidone|mesh-list
64440376|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
64440377|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
64440378|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64440379|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440380|NCT02233309|Anesthetics|anesthetics|mesh-list
64440381|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440382|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440383|NCT02280044|Rifaximin|rifaximin|mesh-list
64440384|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440385|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440386|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440387|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
64636097|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64636098|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
64636099|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64636100|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64636104|NCT00103376|Androgens|androgens|mesh-list
64636105|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
64636106|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636107|NCT00103376|Hormones|hormones|mesh-ancestor
64636108|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636109|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636113|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64636114|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
64636115|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636116|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636117|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636118|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64636119|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64636120|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636121|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64636122|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
64440433|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64440434|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64440435|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64440436|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440437|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440438|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440439|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64440440|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440441|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440442|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64440443|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64440444|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440445|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636123|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
64636124|NCT01296763|Irinotecan|irinotecan|mesh-list
64636125|NCT01296763|Olaparib|olaparib|mesh-list
64636126|NCT01296763|Mitomycins|mitomycins|mesh-list
64636127|NCT01296763|Mitomycin|mitomycin|mesh-list
64636128|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636129|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64636130|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64636131|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440490|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440491|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440492|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440493|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64440494|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
64440495|NCT02230891|Protective Agents|protective agents|mesh-ancestor
64440496|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64440497|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64440498|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64440499|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
64440500|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64440501|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64440503|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64440504|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
64440505|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440507|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64440562|NCT02304926|Simvastatin|simvastatin|mesh-list
64440563|NCT02304926|Ezetimibe|ezetimibe|mesh-list
64440564|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64440565|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64440566|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64440568|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440569|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64440580|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
64440582|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
64440583|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64440584|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64440585|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440632|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
64440640|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
64440641|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440642|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
64440643|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
64440644|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64440645|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
64440646|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440647|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440648|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64440649|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
64440650|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
64440651|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64440652|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440653|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440654|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440657|NCT02275052|Albuterol|albuterol|mesh-list
64636132|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636133|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64636134|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64636135|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
64636136|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64636137|NCT01349491|Ranolazine|ranolazine|mesh-list
64636138|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64636139|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64636140|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636141|NCT01280695|Pioglitazone|pioglitazone|mesh-list
64636142|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636143|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636144|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
64636145|NCT00103844|Dasatinib|dasatinib|mesh-list
64636146|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636147|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64636149|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636150|NCT01402375|Acetaminophen|acetaminophen|mesh-list
64636151|NCT01402375|Oxycodone|oxycodone|mesh-list
64636152|NCT01402375|Hydrocodone|hydrocodone|mesh-list
64636153|NCT01402375|Codeine|codeine|mesh-list
64636154|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636155|NCT01402375|Analgesics|analgesics|mesh-ancestor
64636156|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
64440666|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64440667|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64440668|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64440669|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440670|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440671|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440672|NCT05649020|Prilocaine|prilocaine|mesh-list
64440673|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
64440674|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
64440675|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440676|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440677|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
64440678|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440679|NCT04869488|Prednisone|prednisone|mesh-list
64440680|NCT04869488|Apatinib|apatinib|mesh-list
64440681|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
64440682|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64440683|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
64440684|NCT04869488|Hormones|hormones|mesh-ancestor
64440697|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64440702|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440703|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440704|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440705|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64440706|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64440707|NCT01646021|Sirolimus|sirolimus|mesh-list
64440791|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440792|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440793|NCT02269241|Drospirenone|drospirenone|mesh-list
64440794|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64440795|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
64440796|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440797|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440798|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64440799|NCT02269241|Diuretics|diuretics|mesh-ancestor
64440800|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
64440801|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
64440803|NCT01750294|Diuretics|diuretics|mesh-ancestor
64636157|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636158|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636159|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
64636160|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64636161|NCT01402375|Narcotics|narcotics|mesh-ancestor
64636162|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636163|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
64636165|NCT01302379|Metformin|metformin|mesh-list
64636166|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636167|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636168|NCT01351753|Metformin|metformin|mesh-list
64636169|NCT01351753|Topiramate|topiramate|mesh-list
64636170|NCT01351753|Orlistat|orlistat|mesh-list
64636171|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636172|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636173|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
64636174|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636175|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636176|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64636177|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64636178|NCT00104858|Cyclosporine|cyclosporine|mesh-list
64636179|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
64636180|NCT00104858|Rituximab|rituximab|mesh-list
64636181|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64636182|NCT00104858|Fludarabine|fludarabine|mesh-list
64636183|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
64636184|NCT00104858|Antibodies|antibodies|mesh-list
64636185|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
64636186|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64636187|NCT00104858|Cyclosporins|cyclosporins|mesh-list
64636188|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
64636189|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636190|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636191|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636192|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636193|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
64636194|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636195|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636196|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636197|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
64636198|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636199|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636200|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64636201|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64636202|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64636203|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
64636204|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440854|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440855|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440856|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
64440857|NCT02266433|Hormones|hormones|mesh-ancestor
64440858|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440859|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64440877|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440878|NCT02273180|Insulin|insulin|mesh-list
64440879|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64440881|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
64440882|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440883|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440901|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64440902|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
64440903|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64440904|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
64440905|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64440906|NCT01745380|Protective Agents|protective agents|mesh-ancestor
64440907|NCT04550104|Olaparib|olaparib|mesh-list
64440908|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64440909|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440910|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440912|NCT05648318|Lactulose|lactulose|mesh-list
64440960|NCT02169271|Aspirin|aspirin|mesh-list
64440961|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64440962|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64440963|NCT02169271|Analgesics|analgesics|mesh-ancestor
64440964|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
64440965|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440966|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440967|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64440968|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440969|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64440970|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64440971|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441002|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64441003|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441004|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441005|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64441006|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64441007|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64441008|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64441009|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
64441010|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
64441011|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
64441012|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
64441013|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441022|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64441024|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441025|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441048|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64441049|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64441051|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
64441052|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441053|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
64441054|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441055|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441056|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64441057|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
64441058|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441112|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64441113|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64441114|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64441115|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64441116|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64441117|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64441118|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
64441119|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64441183|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
64441184|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441185|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441186|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
64441197|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
64441198|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64441199|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64441200|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64441201|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441202|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64441203|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64441204|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441246|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441247|NCT02164981|Nitroprusside|nitroprusside|mesh-list
64441256|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64441258|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64441259|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
64441260|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441261|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441262|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64441263|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64441264|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
64441265|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441266|NCT05648591|Iloperidone|iloperidone|mesh-list
64441267|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64636205|NCT01407523|Levetiracetam|levetiracetam|mesh-list
64636206|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
64636207|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
64636208|NCT00047060|Cyclosporine|cyclosporine|mesh-list
64636209|NCT00047060|Fludarabine|fludarabine|mesh-list
64636211|NCT00047060|Cyclosporins|cyclosporins|mesh-list
64636223|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636225|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64636227|NCT00106106|Acamprosate|acamprosate|mesh-list
64636228|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64636229|NCT01304641|Atorvastatin|atorvastatin|mesh-list
64636230|NCT01304641|Simvastatin|simvastatin|mesh-list
64636231|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64636232|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64636233|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
64636234|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636235|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64441328|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64441329|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64441330|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
64441331|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64441332|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441333|NCT01642589|Vaccines|vaccines|mesh-list
64441334|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
64441335|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441336|NCT01954251|Vaccines|vaccines|mesh-list
64441337|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
64441388|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
64441389|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441390|NCT04188223|Vaccines|vaccines|mesh-list
64441391|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
64441392|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441393|NCT02220907|Canagliflozin|canagliflozin|mesh-list
64441394|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64441396|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441457|NCT02266706|Tazobactam|tazobactam|mesh-list
64441458|NCT02266706|Ceftolozane|ceftolozane|mesh-list
64441459|NCT02266706|Cephalosporins|cephalosporins|mesh-list
64441460|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64441461|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
64441462|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64441463|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636236|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64361491|NCT03324139|Tinzaparin|tinzaparin|mesh-list
64636237|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636238|NCT04753112|Valsartan|valsartan|mesh-list
64636239|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64636240|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64636241|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64636242|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64636243|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636245|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64636246|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636249|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441532|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441534|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441535|NCT02194465|Spironolactone|spironolactone|mesh-list
64441536|NCT02194465|Tadalafil|tadalafil|mesh-list
64441537|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64441538|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
64441539|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
64441540|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64441541|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64441542|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441543|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441544|NCT02194465|Urological Agents|urological agents|mesh-ancestor
64441549|NCT02194465|Diuretics|diuretics|mesh-ancestor
64636250|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636251|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64636252|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64636253|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
64636254|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636255|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64636256|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636257|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636258|NCT01410409|Acetaminophen|acetaminophen|mesh-list
64636259|NCT01410409|Pantoprazole|pantoprazole|mesh-list
64636260|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636261|NCT01410409|Analgesics|analgesics|mesh-ancestor
64636262|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
64636263|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441603|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64441604|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64441606|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
64441607|NCT01632241|Belimumab|belimumab|mesh-list
64441608|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441609|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
64441610|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441611|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
64441612|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64441613|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441614|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441615|NCT01741792|Blinatumomab|blinatumomab|mesh-list
64441616|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441617|NCT02289950|Farletuzumab|farletuzumab|mesh-list
64441625|NCT01740388|Besifloxacin|besifloxacin|mesh-list
64636264|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636265|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
64636266|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64636267|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64636268|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64636269|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636271|NCT01410565|Apaziquone|apaziquone|mesh-list
64636272|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636273|NCT01357135|Metformin|metformin|mesh-list
64636274|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64636275|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64636276|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636277|NCT01357135|Incretins|incretins|mesh-ancestor
64636278|NCT01357135|Hormones|hormones|mesh-ancestor
64636279|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636280|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64636281|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
64636282|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636283|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441668|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64441669|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64441670|NCT02260934|Prednisolone|prednisolone|mesh-list
64441671|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
64636287|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
64636288|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64636289|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
64636290|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
64636291|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636292|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64636293|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64636294|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
64441728|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64441729|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441730|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64441731|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64441732|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64441733|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441734|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
64441735|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
64441736|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64441737|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64441738|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
64441739|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64441740|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64441741|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64441743|NCT02260154|Alverine|alverine|mesh-list
64441798|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64441799|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
64441800|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
64441801|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441802|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441803|NCT01738594|Romidepsin|romidepsin|mesh-list
64441804|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64441805|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441806|NCT01697956|Beclomethasone|beclomethasone|mesh-list
64441807|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441808|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
64441809|NCT01697956|Hormones|hormones|mesh-ancestor
64441814|NCT01697800|Tadalafil|tadalafil|mesh-list
64441939|NCT05642702|Protective Agents|protective agents|mesh-ancestor
64441940|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
64441941|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64442030|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442031|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442032|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64442033|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64442041|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
64442042|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
64442043|NCT05650268|Vitamins|vitamins|mesh-list
64442044|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
64442045|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442046|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64442047|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64442048|NCT04835870|Prednisone|prednisone|mesh-list
64442049|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
64442050|NCT04835870|Rituximab|rituximab|mesh-list
64442051|NCT04835870|Doxorubicin|doxorubicin|mesh-list
64442052|NCT04835870|Vincristine|vincristine|mesh-list
64442053|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
64442054|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442055|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
64442056|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442094|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442095|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442096|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64442097|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442098|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
64442099|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442100|NCT04654208|Palbociclib|palbociclib|mesh-list
64442101|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442121|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442123|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
64442124|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
64442134|NCT04844216|Lidocaine|lidocaine|mesh-list
64636295|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636296|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636297|NCT01310179|Fludarabine|fludarabine|mesh-list
64636298|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
64636299|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636300|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636301|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
64636302|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636303|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636304|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
64636305|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636306|NCT01412281|Vaccines|vaccines|mesh-list
64442153|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442154|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442155|NCT05327738|Atezolizumab|atezolizumab|mesh-list
64442184|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64442186|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
64442187|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442188|NCT04621526|Analgesics|analgesics|mesh-ancestor
64442189|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
64442190|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442191|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64442192|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64442193|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64442246|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442247|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442248|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442249|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
64442250|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442251|NCT04831736|Ketamine|ketamine|mesh-list
64442252|NCT04831736|Analgesics|analgesics|mesh-ancestor
64442253|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
64442254|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442255|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442256|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64442259|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
64636307|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
64636310|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
64636311|NCT01359007|Irinotecan|irinotecan|mesh-list
64636312|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636313|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64636314|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64636315|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636316|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361565|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
64636317|NCT01359007|Antidotes|antidotes|mesh-ancestor
64636318|NCT01359007|Protective Agents|protective agents|mesh-ancestor
64636319|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636320|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
64636321|NCT01359007|Vitamins|vitamins|mesh-ancestor
64636322|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
64636323|NCT01414153|Bevacizumab|bevacizumab|mesh-list
64636324|NCT01414153|Ranibizumab|ranibizumab|mesh-list
64636325|NCT01414153|Aflibercept|aflibercept|mesh-list
64636326|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64636327|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636328|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442293|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442294|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442295|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
64442297|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442298|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442299|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442300|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
64442301|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442302|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442303|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64442304|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64442305|NCT01713946|Everolimus|everolimus|mesh-list
64442306|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
64442307|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442308|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442309|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
64442310|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442311|NCT04464512|Sufentanil|sufentanil|mesh-list
64442312|NCT04464512|Buprenorphine|buprenorphine|mesh-list
64442331|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442332|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
64442333|NCT04839692|Protective Agents|protective agents|mesh-ancestor
64442336|NCT04421378|Carmustine|carmustine|mesh-list
64442337|NCT04421378|Lomustine|lomustine|mesh-list
64442338|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442339|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442356|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442357|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
64442358|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64442361|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64442368|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442369|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
64442370|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442371|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442372|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64442373|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442374|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
64442375|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64442376|NCT05324462|Xultophy|xultophy|mesh-list
64442377|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64442378|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442379|NCT05324462|Incretins|incretins|mesh-ancestor
64442380|NCT05324462|Hormones|hormones|mesh-ancestor
64442381|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442382|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64442383|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64442384|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64442395|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64442413|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442415|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
64442416|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64442417|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442498|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442499|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442500|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442501|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64442502|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442503|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442504|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
64442505|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64442506|NCT04419038|Mitomycins|mitomycins|mesh-list
64442507|NCT04419038|Mitomycin|mitomycin|mesh-list
64442508|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64636329|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64636330|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64636331|NCT01414153|Growth Substances|growth substances|mesh-ancestor
64302468|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
64636332|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636333|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
64636334|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
64636335|NCT01311895|Hydromorphone|hydromorphone|mesh-list
64636336|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64636337|NCT01311895|Narcotics|narcotics|mesh-ancestor
64636338|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636339|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636340|NCT01311895|Analgesics|analgesics|mesh-ancestor
64636341|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
64636342|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636343|NCT01362127|Cisplatin|cisplatin|mesh-list
64636344|NCT01362127|Carboplatin|carboplatin|mesh-list
64636345|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
64636346|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442572|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442573|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442592|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
64442593|NCT04016090|Vitamins|vitamins|mesh-ancestor
64442594|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
64442595|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442596|NCT04809974|Niacinamide|niacinamide|mesh-list
64442597|NCT04809974|Vitamins|vitamins|mesh-ancestor
64442598|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
64442599|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442600|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
64442601|NCT04691960|Metformin|metformin|mesh-list
64442602|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64442603|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442604|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
64442644|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64442645|NCT04808882|Dalteparin|dalteparin|mesh-list
64442646|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
64442647|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64442648|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64442649|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442650|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
64442651|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64442652|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442653|NCT05652374|Renal Agents|renal agents|mesh-ancestor
64442654|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64442655|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64442656|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64636347|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
64636348|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64636349|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636350|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636358|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
64636359|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424505|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636406|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
64636407|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64636408|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442736|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442737|NCT04793906|Iron|iron|mesh-list
64442738|NCT04793906|Trace Elements|trace elements|mesh-ancestor
64442739|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
64442740|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442741|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
64442742|NCT02216071|Dexamethasone|dexamethasone|mesh-list
64442743|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
64442744|NCT02216071|BB 1101|bb 1101|mesh-list
64442745|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442746|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
64442754|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442755|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442756|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
64442757|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442758|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442759|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64442760|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442761|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64442762|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64442763|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64442764|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64442766|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64442767|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64442768|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64442769|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64442770|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442771|NCT02188459|Bupropion|bupropion|mesh-list
64442772|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64442777|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442778|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442779|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
64442780|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442781|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442782|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64442783|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64442784|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442785|NCT02743364|Simvastatin|simvastatin|mesh-list
64636409|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
64636410|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
64636411|NCT02568566|Vaccines|vaccines|mesh-list
64636412|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
64636413|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636414|NCT00151814|Olmesartan|olmesartan|mesh-list
64636415|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64636416|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64636420|NCT00153842|Bexarotene|bexarotene|mesh-list
64636421|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636422|NCT01314001|Nicotine|nicotine|mesh-list
64636423|NCT01314001|Varenicline|varenicline|mesh-list
64636424|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64636425|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
64636426|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636427|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636428|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64636429|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64636430|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
64636431|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636432|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636433|NCT01363999|Atorvastatin|atorvastatin|mesh-list
64636434|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
64636435|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64636436|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64442862|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64442863|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442889|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442890|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442891|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442892|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442894|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64442895|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64442896|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64442898|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442899|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442900|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64636438|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636439|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64636440|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64636441|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636443|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636444|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64636445|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64636446|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636447|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64636448|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
64636449|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
64442940|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442941|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
64442942|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64442943|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64442944|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64442945|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64442946|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
64442947|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442948|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442950|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
64442951|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64442952|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442953|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
64442956|NCT01635764|Adalimumab|adalimumab|mesh-list
64636450|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636451|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636452|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64636453|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64636454|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636455|NCT00258128|Analgesics|analgesics|mesh-ancestor
64636456|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
64636457|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636458|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636459|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64636460|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636461|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
64636462|NCT01364623|Testosterone|testosterone|mesh-list
64636463|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
64636464|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
64636465|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64636467|NCT01364623|Hormones|hormones|mesh-ancestor
64443000|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64443001|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443002|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443003|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64443004|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64443005|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
64443006|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443008|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64443009|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443012|NCT04787744|Docetaxel|docetaxel|mesh-list
64443013|NCT04787744|Leuprolide|leuprolide|mesh-list
64443014|NCT04787744|Goserelin|goserelin|mesh-list
64443015|NCT04787744|Bicalutamide|bicalutamide|mesh-list
64636468|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636470|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64636471|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636472|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
64636473|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
64636474|NCT00258206|Rituximab|rituximab|mesh-list
64636475|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636476|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
64636477|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443063|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
64443064|NCT04786964|Dexamethasone|dexamethasone|mesh-list
64443065|NCT04786964|Carboplatin|carboplatin|mesh-list
64443066|NCT04786964|Pemetrexed|pemetrexed|mesh-list
64443067|NCT04786964|Vitamins|vitamins|mesh-ancestor
64443068|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
64443069|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443070|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443071|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
64443072|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
64443073|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443074|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443075|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
64443076|NCT04786964|Hormones|hormones|mesh-ancestor
64443077|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443078|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64443079|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443080|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443081|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443082|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64443083|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64443085|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
64443086|NCT04269200|Paclitaxel|paclitaxel|mesh-list
64443087|NCT04269200|Carboplatin|carboplatin|mesh-list
64443088|NCT04269200|Durvalumab|durvalumab|mesh-list
64443089|NCT04269200|Olaparib|olaparib|mesh-list
64443090|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64443091|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64443092|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636478|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636479|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64636480|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
64636481|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636482|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636483|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64636484|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636485|NCT01063907|Bortezomib|bortezomib|mesh-list
64636486|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636487|NCT01316263|Olaratumab|olaratumab|mesh-list
64636488|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636489|NCT03015857|Phenylephrine|phenylephrine|mesh-list
64636490|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
64636491|NCT03015857|Norepinephrine|norepinephrine|mesh-list
64636492|NCT03015857|Fentanyl|fentanyl|mesh-list
64636493|NCT03015857|Bupivacaine|bupivacaine|mesh-list
64636494|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
64636495|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
64636496|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636497|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636498|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
64636499|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636500|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64636501|NCT03015857|Narcotics|narcotics|mesh-ancestor
64443103|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443121|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443122|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443123|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64443124|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64443125|NCT05173298|Growth Substances|growth substances|mesh-ancestor
64443126|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443168|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443169|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443170|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64443171|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64443172|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443173|NCT03965468|Paclitaxel|paclitaxel|mesh-list
64443174|NCT03965468|Carboplatin|carboplatin|mesh-list
64443175|NCT03965468|Durvalumab|durvalumab|mesh-list
64443176|NCT03965468|Tremelimumab|tremelimumab|mesh-list
64443177|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64443178|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443179|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
64443180|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
64443181|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
64443182|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443183|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443184|NCT01469156|Ranibizumab|ranibizumab|mesh-list
64443185|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64443186|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64636502|NCT03015857|Analgesics|analgesics|mesh-ancestor
64636504|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64636505|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
64636507|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
64636508|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
64636509|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
64636510|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64636511|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
64636512|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
64636513|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64636514|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64636515|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64636516|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
64636517|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443225|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443227|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
64443228|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443229|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443230|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443231|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
64443232|NCT03651128|Hormones|hormones|mesh-ancestor
64443241|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
64443242|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443243|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443244|NCT00664898|Bortezomib|bortezomib|mesh-list
64443245|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443246|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
64443247|NCT04827992|Narcotics|narcotics|mesh-ancestor
64443248|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443249|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443250|NCT04827992|Analgesics|analgesics|mesh-ancestor
64443251|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
64443252|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443253|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64443254|NCT04776980|Hematinics|hematinics|mesh-ancestor
64443255|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64443256|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64443257|NCT02187055|Adalimumab|adalimumab|mesh-list
64443258|NCT02187055|Methotrexate|methotrexate|mesh-list
64443259|NCT02187055|Tofacitinib|tofacitinib|mesh-list
64636518|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636519|NCT03015857|Protective Agents|protective agents|mesh-ancestor
64636520|NCT03295487|Estrogens|estrogens|mesh-list
64636521|NCT03295487|Hormones|hormones|mesh-ancestor
64636522|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636523|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636524|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
64636525|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636526|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443273|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443274|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64443275|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443276|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443277|NCT00119366|Iodine|iodine|mesh-list
64443278|NCT00119366|Cyclosporine|cyclosporine|mesh-list
64443279|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
64443280|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64443281|NCT00119366|Fludarabine|fludarabine|mesh-list
64443282|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
64443283|NCT00119366|Antibodies|antibodies|mesh-list
64443284|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
64443285|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64443286|NCT00119366|Cyclosporins|cyclosporins|mesh-list
64443287|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
64443288|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443289|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443290|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443291|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
64443292|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636527|NCT03015701|Mifepristone|mifepristone|mesh-list
64636528|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64636529|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
64636530|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64636531|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636532|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64636533|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64636534|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64636535|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
64443326|NCT02137369|Citalopram|citalopram|mesh-list
64443327|NCT02137369|Sertraline|sertraline|mesh-list
64443328|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
64443329|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64443330|NCT02137369|Serotonin|serotonin|mesh-list
64443331|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64443332|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64443333|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443334|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443335|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
64443336|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443337|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64443338|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64443339|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64443340|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64443341|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
64443342|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
64443343|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443344|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64443345|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64443346|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
64443347|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64443348|NCT02135107|Rabeprazole|rabeprazole|mesh-list
64443349|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64443350|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443351|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64443366|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443367|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64443368|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
64443369|NCT02186821|Ceritinib|ceritinib|mesh-list
64443370|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443372|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443395|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64443453|NCT01907217|Methohexital|methohexital|mesh-list
64443454|NCT01907217|Succinylcholine|succinylcholine|mesh-list
64443455|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64443456|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64443458|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443459|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443460|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64443461|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
64443568|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443569|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443602|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64443603|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64443604|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
64443605|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443606|NCT01591096|Plasminogen|plasminogen|mesh-list
64443700|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64443701|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
64443702|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443703|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
64443704|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443705|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64443706|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443707|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443708|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443709|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443802|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443803|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443804|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64443805|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64443806|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
64443807|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64443808|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64443869|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
64443870|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443871|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443872|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
64443873|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443874|NCT01627327|Fluticasone|fluticasone|mesh-list
64443875|NCT01627327|Xhance|xhance|mesh-list
64443876|NCT01627327|Bromides|bromides|mesh-list
64443877|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
64443878|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443879|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64443880|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
64443881|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443882|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443883|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64443884|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
64443885|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
64443886|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64443887|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
64443888|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64443889|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
64443890|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443891|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443921|NCT01687270|Ribavirin|ribavirin|mesh-list
64443922|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
64443923|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443924|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
64443925|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443926|NCT01588990|Leucovorin|leucovorin|mesh-list
64443927|NCT01588990|Bevacizumab|bevacizumab|mesh-list
64443928|NCT01588990|Capecitabine|capecitabine|mesh-list
64443929|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
64443930|NCT01588990|Irinotecan|irinotecan|mesh-list
64443931|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443932|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443933|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64443934|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64443935|NCT01588990|Growth Substances|growth substances|mesh-ancestor
64443936|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443937|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
64443938|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443939|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
64443940|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443941|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64443942|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64443943|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443973|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443974|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64443975|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64443976|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443977|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64443978|NCT02125279|Vitamins|vitamins|mesh-ancestor
64443979|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
64443980|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64443981|NCT02124811|Minocycline|minocycline|mesh-list
64443983|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443984|NCT02148445|Nicotine|nicotine|mesh-list
64443985|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64443998|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
64636536|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64636537|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64636538|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
64636539|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636540|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
64636541|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64636542|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64636543|NCT03047135|Olaparib|olaparib|mesh-list
64636544|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64636545|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444111|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64444112|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
64444113|NCT01952145|Liraglutide|liraglutide|mesh-list
64444114|NCT01952145|Xultophy|xultophy|mesh-list
64444115|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64444116|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444117|NCT01952145|Incretins|incretins|mesh-ancestor
64444118|NCT01952145|Hormones|hormones|mesh-ancestor
64444733|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64444734|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64444735|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64444737|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
64444738|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64444739|NCT04740697|Tamoxifen|tamoxifen|mesh-list
64444740|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64446563|NCT02136914|Analgesics|analgesics|mesh-ancestor
64450429|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64450430|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
64450431|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450432|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451119|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64451120|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451121|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451122|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451308|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
64451309|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451310|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451311|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64451313|NCT01822899|Xhance|xhance|mesh-list
64451314|NCT01822899|Bromides|bromides|mesh-list
64451315|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64451316|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451317|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64451318|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
64451319|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451320|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636546|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361858|NCT04941573|Xenon|xenon|mesh-list
64636547|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636549|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
64636550|NCT04780061|Vitamins|vitamins|mesh-list
64636551|NCT04780061|Vitamin K|vitamin k|mesh-list
64636552|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
64636553|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
64636554|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636555|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64636556|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64636557|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451352|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
64451353|NCT01822587|Propranolol|propranolol|mesh-list
64451354|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64451355|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64451356|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451357|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451358|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451359|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451360|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64451361|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64451362|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
64451364|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
64451365|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451366|NCT04588233|Protective Agents|protective agents|mesh-ancestor
64451367|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451368|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451369|NCT01821963|Interferons|interferons|mesh-list
64451370|NCT01821963|Ribavirin|ribavirin|mesh-list
64451371|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
64451372|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
64451373|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64636559|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64636560|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
64636566|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64636567|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636568|NCT02973737|Capecitabine|capecitabine|mesh-list
64636569|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636570|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
64636571|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636572|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636573|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
64636574|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636575|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636577|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
64451403|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64451404|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451405|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
64451406|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
64451407|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
64451408|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451409|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
64451410|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451411|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
64451412|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64451413|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64636578|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64636579|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636580|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
64636581|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64636582|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636583|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636584|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636585|NCT01072643|Analgesics|analgesics|mesh-ancestor
64636589|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64636590|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64636591|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451470|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451472|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64451473|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
64451474|NCT02117687|Glycerol|glycerol|mesh-list
64451478|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
64452382|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64452383|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64452574|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64452575|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
64452576|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
64452577|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452932|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452992|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452993|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452994|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64452995|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
64453114|NCT02098733|Glimepiride|glimepiride|mesh-list
64636592|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636593|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636594|NCT01076231|Etoposide|etoposide|mesh-list
64636595|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
64636596|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
64636597|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636598|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64636599|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64636600|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64636601|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636602|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636603|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
64636604|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636607|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
64636608|NCT00117962|Carboplatin|carboplatin|mesh-list
64636609|NCT00117962|Pemetrexed|pemetrexed|mesh-list
64636610|NCT00117962|Cetuximab|cetuximab|mesh-list
64636611|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636612|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636613|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636614|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64636615|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64636616|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636617|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
64636618|NCT00118274|Vaccines|vaccines|mesh-list
64636619|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
64636620|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
64636621|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636622|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636623|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636624|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64636625|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
64636626|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636627|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636628|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64636629|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64636630|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
64636631|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64636632|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636633|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
64636634|NCT00166166|Fluconazole|fluconazole|mesh-list
64636635|NCT00166166|Nitroprusside|nitroprusside|mesh-list
64636636|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
64636637|NCT00166166|Acetylcholine|acetylcholine|mesh-list
64636638|NCT00166166|Bradykinin|bradykinin|mesh-list
64636639|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64636640|NCT00166166|Kininogens|kininogens|mesh-list
64636641|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
64636642|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636643|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64636644|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64636645|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636646|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636647|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64636648|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
64636649|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64636650|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636651|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64636652|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64636655|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64636656|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64636657|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
64636658|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636659|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64636660|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
64636661|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64636662|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64636664|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
64636665|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64636667|NCT00118352|Fludarabine|fludarabine|mesh-list
64636668|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
64636670|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
64636671|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64636672|NCT00118352|Cyclosporins|cyclosporins|mesh-list
64636673|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
64636674|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636675|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636676|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636677|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
64636678|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636679|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636680|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636681|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
64636682|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636683|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636684|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636685|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64636686|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64636687|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64636688|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
64636689|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64636690|NCT01111331|Empagliflozin|empagliflozin|mesh-list
64636691|NCT01111331|Warfarin|warfarin|mesh-list
64636692|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
64636693|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64636694|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636696|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636697|NCT00167102|Alefacept|alefacept|mesh-list
64636698|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636699|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
64636700|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636701|NCT01859819|Cytarabine|cytarabine|mesh-list
64636702|NCT01859819|Rituximab|rituximab|mesh-list
64636703|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64636704|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636705|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
64636706|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636707|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636708|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636709|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
64636727|NCT02176031|Natalizumab|natalizumab|mesh-list
64636728|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64636729|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
64636730|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
64636731|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636732|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636733|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64636734|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
64636735|NCT02176031|Hormones|hormones|mesh-ancestor
64636746|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636747|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636748|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
64636749|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636751|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64636752|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64636753|NCT01077401|Growth Substances|growth substances|mesh-ancestor
64636754|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636755|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
64636756|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636757|NCT01316341|Empagliflozin|empagliflozin|mesh-list
64636758|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64636759|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636760|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636761|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636762|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64636763|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
64636764|NCT01112735|Coagulants|coagulants|mesh-ancestor
64636765|NCT03014297|Everolimus|everolimus|mesh-list
64636766|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
64636767|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636768|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636769|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
64636770|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636771|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64636772|NCT01034111|Metformin|metformin|mesh-list
64636773|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64636774|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636775|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636776|NCT01034111|Incretins|incretins|mesh-ancestor
64636777|NCT01034111|Hormones|hormones|mesh-ancestor
64424506|NCT02313909|Analgesics|analgesics|mesh-ancestor
64636791|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64636792|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64377608|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64636793|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64636794|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64636795|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636796|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64636797|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64636802|NCT00118742|Sirolimus|sirolimus|mesh-list
64636803|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
64636804|NCT00118742|Tacrolimus|tacrolimus|mesh-list
64636805|NCT00118742|Cyclosporins|cyclosporins|mesh-list
64636806|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636807|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
64636808|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636809|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64636810|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636811|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636812|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
64636813|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636814|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
64377609|NCT04843839|Analgesics|analgesics|mesh-ancestor
64636815|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636816|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64636817|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636818|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64636819|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
64636820|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64636821|NCT01317667|Vaccines|vaccines|mesh-list
64636822|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
64636823|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636824|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
64636825|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636826|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
64636827|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636828|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636829|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64636830|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
64636831|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636832|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636848|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64636849|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636851|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
64636852|NCT01366885|Vitamins|vitamins|mesh-ancestor
64636853|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
64636854|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636855|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64636856|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64636857|NCT01899170|Carfentanil|carfentanil|mesh-list
64636858|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64636859|NCT01899170|Narcotics|narcotics|mesh-ancestor
64636860|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64636861|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636862|NCT01899170|Analgesics|analgesics|mesh-ancestor
64636863|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
64636864|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636865|NCT01425229|Bosentan|bosentan|mesh-list
64636866|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64636868|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636869|NCT00258362|Carboplatin|carboplatin|mesh-list
64636870|NCT00258362|Docetaxel|docetaxel|mesh-list
64636871|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636872|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
64636873|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
64636874|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
64636875|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636876|NCT00258830|Vaccines|vaccines|mesh-list
64636877|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
64636878|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636880|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636881|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64636888|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64636890|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
64636891|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636892|NCT00123110|Metformin|metformin|mesh-list
64636893|NCT00123110|Leuprolide|leuprolide|mesh-list
64636894|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64636895|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636896|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64636897|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
64636898|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64636899|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64636900|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636901|NCT01425853|Celecoxib|celecoxib|mesh-list
64636902|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64636906|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636907|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636909|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636910|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64636911|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64636912|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636913|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636914|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64636915|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64636916|NCT01426867|Brinzolamide|brinzolamide|mesh-list
64636917|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64636918|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64636919|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64636920|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64636921|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64636922|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
64636923|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377610|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
64636924|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636926|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64636927|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636928|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
64636929|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64636930|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64636931|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64636932|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64636933|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636934|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
64636935|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64636936|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636937|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64636938|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64636939|NCT01427881|Cyclosporine|cyclosporine|mesh-list
64636940|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
64636941|NCT01427881|Busulfan|busulfan|mesh-list
64636942|NCT01427881|Fludarabine|fludarabine|mesh-list
64636943|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
64636944|NCT01427881|Cyclosporins|cyclosporins|mesh-list
64636945|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64636946|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
64636949|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64636950|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
64636951|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636952|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636953|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64636954|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636955|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
64636956|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64636957|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
64636958|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636959|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636960|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64636961|NCT02112734|Vitamin D|vitamin d|mesh-list
64636962|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
64636963|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
64636964|NCT02112734|Vitamins|vitamins|mesh-list
64636965|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
64636966|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636967|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64636976|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
64636977|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64636978|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
64636979|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64636980|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64636981|NCT01319851|Alefacept|alefacept|mesh-list
64636983|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
64636984|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64636985|NCT04351867|Docetaxel|docetaxel|mesh-list
64636986|NCT04351867|Capecitabine|capecitabine|mesh-list
64636987|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
64636988|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64636989|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
64636990|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
64636991|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
64636992|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64636993|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64636994|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
64636995|NCT00262730|Temozolomide|temozolomide|mesh-list
64636996|NCT00262730|Poly ICLC|poly iclc|mesh-list
64636997|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64362248|NCT05245227|Misoprostol|misoprostol|mesh-list
64636998|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
64636999|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637000|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637001|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
64637002|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
64637003|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637004|NCT04262934|Vitamin D|vitamin d|mesh-list
64637005|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
64637006|NCT04262934|Vitamins|vitamins|mesh-ancestor
64637007|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
64637008|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637009|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64637010|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64637011|NCT00262964|Niacin|niacin|mesh-list
64637012|NCT00262964|Fenofibrate|fenofibrate|mesh-list
64637013|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64637014|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
64637015|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637016|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64637017|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
64637018|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
64637019|NCT00262964|Vitamins|vitamins|mesh-ancestor
64637020|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
64637021|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637030|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637033|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64637034|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64637035|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
64637036|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
64637037|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637038|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637039|NCT01322815|Leucovorin|leucovorin|mesh-list
64637040|NCT01322815|Fluorouracil|fluorouracil|mesh-list
64637041|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
64637042|NCT01322815|Irinotecan|irinotecan|mesh-list
64637043|NCT01322815|Bevacizumab|bevacizumab|mesh-list
64637044|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
64637045|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
64637046|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637047|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64637048|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637049|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637050|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
64637051|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637052|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64637053|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64637054|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637055|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637056|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64637057|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64637058|NCT01322815|Growth Substances|growth substances|mesh-ancestor
64637059|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
64377611|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637060|NCT01322815|Antidotes|antidotes|mesh-ancestor
64637061|NCT01322815|Protective Agents|protective agents|mesh-ancestor
64637062|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
64637063|NCT01322815|Vitamins|vitamins|mesh-ancestor
64637064|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
64637065|NCT00176228|Lamotrigine|lamotrigine|mesh-list
64637066|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
64637067|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64637068|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64637069|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637070|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64637071|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637072|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64637073|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64637074|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637075|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64637079|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64637080|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637093|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637096|NCT00265616|Thiopental|thiopental|mesh-list
64637097|NCT00265616|Propofol|propofol|mesh-list
64637098|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64637099|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637100|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637101|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64637102|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
64637103|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
64637104|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
64637105|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
64637106|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
64637107|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637108|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637109|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64637110|NCT00176852|Vidarabine|vidarabine|mesh-list
64637111|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
64637112|NCT00176852|Busulfan|busulfan|mesh-list
64637113|NCT00176852|Fludarabine|fludarabine|mesh-list
64637114|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
64637115|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
64637116|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64637117|NCT00176852|Lenograstim|lenograstim|mesh-list
64637118|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637119|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
64637120|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637121|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637122|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64637124|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637125|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637126|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64637127|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64637128|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
64637129|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
64637130|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637131|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64637132|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637133|NCT01323517|Dactinomycin|dactinomycin|mesh-list
64637142|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64637143|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637144|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
64637145|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637146|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64637147|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637148|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64637149|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64637150|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637151|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64637152|NCT01323595|Celecoxib|celecoxib|mesh-list
64637153|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64637154|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64637155|NCT01323595|Analgesics|analgesics|mesh-ancestor
64637156|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
64637157|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637158|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637159|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637160|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637161|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64637162|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64637163|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637164|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302677|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302678|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64637165|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64637166|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64637167|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637168|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64637169|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637170|NCT01431391|Leuprolide|leuprolide|mesh-list
64637171|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64637172|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
64637173|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64637174|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338284|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64338285|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64338286|NCT01186991|Growth Substances|growth substances|mesh-ancestor
64338287|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338288|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
64338289|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
64338290|NCT02268773|Aspirin|aspirin|mesh-list
64338291|NCT02268773|Dipyridamole|dipyridamole|mesh-list
64338292|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
64338394|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338395|NCT01027013|Protective Agents|protective agents|mesh-ancestor
64338425|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64338426|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338427|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338428|NCT01012895|Interferons|interferons|mesh-list
64338429|NCT01012895|Ribavirin|ribavirin|mesh-list
64338430|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
64338431|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
64338432|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64338433|NCT01012895|Asunaprevir|asunaprevir|mesh-list
64338434|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338435|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
64637175|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637176|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637177|NCT03009097|Atorvastatin|atorvastatin|mesh-list
64637178|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64637192|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64637193|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64637194|NCT01325311|Protective Agents|protective agents|mesh-ancestor
64637195|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637196|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64637197|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338572|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338573|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64338574|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338575|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64338576|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338577|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64338578|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338816|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338817|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64338818|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64338819|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64338820|NCT02317510|Anesthetics|anesthetics|mesh-list
64338821|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338824|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
64338925|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
64338926|NCT04662723|Losartan|losartan|mesh-list
64338927|NCT04662723|Ramipril|ramipril|mesh-list
64338928|NCT04662723|Lisinopril|lisinopril|mesh-list
64339008|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339009|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
64339010|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339011|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339021|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
64339119|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
64339120|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
64339121|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339122|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339123|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
64339125|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339126|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64339127|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64339128|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64339129|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64339130|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339131|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64339132|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
64339133|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64339175|NCT04022967|Lamivudine|lamivudine|mesh-list
64339217|NCT01646320|Hormones|hormones|mesh-ancestor
64339218|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339219|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64339220|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
64339221|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339223|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
64339224|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
64339225|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339239|NCT05330858|Rabeprazole|rabeprazole|mesh-list
64339287|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64339288|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64339289|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64339290|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339291|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339292|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339293|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64339294|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64339295|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64339296|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64339297|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64339298|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64637198|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637199|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
64637200|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64637201|NCT01325311|Estrogens|estrogens|mesh-ancestor
64637202|NCT01325311|Hormones|hormones|mesh-ancestor
64637203|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637204|NCT01432015|Aprepitant|aprepitant|mesh-list
64637205|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
64637206|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
64637207|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
64637208|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637209|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637210|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339363|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
64339364|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64339538|NCT02431767|Growth Substances|growth substances|mesh-ancestor
64339539|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
64339540|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339541|NCT05313620|Adalimumab|adalimumab|mesh-list
64339542|NCT05313620|Golimumab|golimumab|mesh-list
64339543|NCT05313620|Infliximab|infliximab|mesh-list
64339544|NCT05313620|Tofacitinib|tofacitinib|mesh-list
64339545|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339649|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
64339650|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
64339651|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339652|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
64339653|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339654|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339763|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339764|NCT00902291|Antiviral Agents|antiviral agents|mesh-ancestor
64339765|NCT00902291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339793|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339794|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339795|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339796|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339797|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64339798|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339944|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64339945|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339946|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339947|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
64339948|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339949|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339950|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64339951|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339952|NCT04474457|Favipiravir|favipiravir|mesh-list
64339953|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
64339954|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339955|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64339956|NCT00880217|Methylphenidate|methylphenidate|mesh-list
64339957|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64339958|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64339959|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339960|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64339961|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64339990|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
64339992|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64340048|NCT02283658|Letrozole|letrozole|mesh-list
64340049|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340050|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340051|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
64340052|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340053|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64340054|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64340055|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340056|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340080|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64340081|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
64340082|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340083|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340084|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64340085|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64340086|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64340143|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64340144|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64340145|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
64340146|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340147|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340148|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340149|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64340251|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340287|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340288|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64340289|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
64340290|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340291|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340323|NCT00850577|Carboplatin|carboplatin|mesh-list
64340324|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64340325|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64340326|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340414|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340415|NCT00838799|Pregabalin|pregabalin|mesh-list
64340416|NCT00838799|Analgesics|analgesics|mesh-ancestor
64340417|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
64340418|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340419|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340420|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
64340421|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64340422|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340423|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340424|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340516|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340517|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340518|NCT00925535|Rifabutin|rifabutin|mesh-list
64340519|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64340520|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340521|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64340522|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
64637211|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64637212|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637213|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637214|NCT01080677|Propranolol|propranolol|mesh-list
64637215|NCT01080677|Caffeine|caffeine|mesh-list
64637216|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64637217|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637218|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64637219|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637220|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637221|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64637232|NCT01378273|Hematinics|hematinics|mesh-ancestor
64340627|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64340628|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340629|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340630|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340631|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340632|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340633|NCT00834743|Metformin|metformin|mesh-list
64340635|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340637|NCT00834587|Glipizide|glipizide|mesh-list
64340638|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340639|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340640|NCT00834431|Famciclovir|famciclovir|mesh-list
64340641|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
64340642|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340657|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340658|NCT05191004|Fulvestrant|fulvestrant|mesh-list
64340688|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
64340689|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64340690|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
64340692|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64340693|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
64340694|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340695|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
64340696|NCT00833495|Hormones|hormones|mesh-ancestor
64340697|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340698|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340859|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64340860|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340861|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340862|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340863|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340864|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340865|NCT05169008|Vaccines|vaccines|mesh-list
64340866|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
64340867|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340868|NCT02270944|Vaccines|vaccines|mesh-list
64637233|NCT01432405|Pioglitazone|pioglitazone|mesh-list
64637234|NCT01432405|Exenatide|exenatide|mesh-list
64637235|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64637236|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637237|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64637238|NCT01432405|Incretins|incretins|mesh-ancestor
64637239|NCT01432405|Hormones|hormones|mesh-ancestor
64637240|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637241|NCT01432561|Cysteamine|cysteamine|mesh-list
64637242|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64637243|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637244|NCT01116401|Leuprolide|leuprolide|mesh-list
64637245|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64637246|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
64637247|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64637248|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637249|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637250|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637251|NCT03008317|Chromium|chromium|mesh-list
64637252|NCT03008317|Trace Elements|trace elements|mesh-ancestor
64637253|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
64637254|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637255|NCT01433107|Terbinafine|terbinafine|mesh-list
64637256|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
64637257|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637258|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637259|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637260|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
64637261|NCT01082939|Rituximab|rituximab|mesh-list
64637262|NCT01082939|Fludarabine|fludarabine|mesh-list
64637263|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
64637264|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
64637265|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637266|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
64637267|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637268|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637269|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64637270|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
64637271|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637272|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637273|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64637283|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637284|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637285|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64637286|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
64637287|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637288|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64637289|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64637290|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64637291|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64637292|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
64637293|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637294|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637296|NCT02941926|Leuprolide|leuprolide|mesh-list
64637297|NCT02941926|Goserelin|goserelin|mesh-list
64340916|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340917|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
64340918|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64340963|NCT04991402|Dolutegravir|dolutegravir|mesh-list
64340964|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64340965|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64340966|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64340967|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340968|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340969|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64340970|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
64340971|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637298|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637299|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64362556|NCT03136809|Copper|copper|mesh-list
64637300|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64637301|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637302|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637303|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64637304|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
64637305|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637306|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637308|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
64637309|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64341017|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341018|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341019|NCT04209218|Hormones|hormones|mesh-ancestor
64341020|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341021|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341022|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341023|NCT04218968|Carvedilol|carvedilol|mesh-list
64341024|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64341025|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64341026|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
64341027|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341028|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341029|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341030|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64341031|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
64341032|NCT04218968|Protective Agents|protective agents|mesh-ancestor
64341033|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64341034|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64341155|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64341156|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
64341157|NCT04214678|Hormones|hormones|mesh-ancestor
64341158|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341160|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341351|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341352|NCT03260881|Incretins|incretins|mesh-ancestor
64341353|NCT03260881|Hormones|hormones|mesh-ancestor
64341354|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341355|NCT03238495|Metformin|metformin|mesh-list
64341356|NCT03238495|Carboplatin|carboplatin|mesh-list
64341357|NCT03238495|Docetaxel|docetaxel|mesh-list
64341358|NCT03238495|Trastuzumab|trastuzumab|mesh-list
64341359|NCT03238495|Pertuzumab|pertuzumab|mesh-list
64341360|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341361|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341369|NCT02536339|Pertuzumab|pertuzumab|mesh-list
64637310|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637311|NCT05422092|Pioglitazone|pioglitazone|mesh-list
64637312|NCT05422092|Canagliflozin|canagliflozin|mesh-list
64637313|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64637314|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637315|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64637316|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637317|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
64637318|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64637319|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64341397|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341398|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
64341399|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341400|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341401|NCT02322853|Tamoxifen|tamoxifen|mesh-list
64341402|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64341499|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64341500|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
64341502|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341503|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341504|NCT03675815|Ritonavir|ritonavir|mesh-list
64341505|NCT03675815|Darunavir|darunavir|mesh-list
64341506|NCT03675815|Tenofovir|tenofovir|mesh-list
64341507|NCT03675815|Lamivudine|lamivudine|mesh-list
64341508|NCT03675815|Emtricitabine|emtricitabine|mesh-list
64341509|NCT03675815|Dolutegravir|dolutegravir|mesh-list
64341510|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64341511|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64341512|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64341513|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
64341514|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341515|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341516|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64341518|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
64341691|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64341710|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64341711|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341713|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341714|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341715|NCT01352585|Anagrelide|anagrelide|mesh-list
64341716|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64341717|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64341720|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
64341797|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341798|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
64341799|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64341800|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
64341817|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64341821|NCT01352507|Urological Agents|urological agents|mesh-ancestor
64341980|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341981|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
64341982|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341983|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64341984|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64341985|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
64341986|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341987|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342033|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342034|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
64342035|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
64342036|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
64342037|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637320|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637321|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
64637322|NCT05448456|Coagulants|coagulants|mesh-ancestor
64637324|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
64637326|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
64637327|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637328|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
64637329|NCT01434121|Vitamins|vitamins|mesh-ancestor
64637341|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64637342|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637343|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64637344|NCT01084265|Hormones|hormones|mesh-list
64637345|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64637346|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637347|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637348|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64342061|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64342062|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64342063|NCT02279537|Growth Substances|growth substances|mesh-ancestor
64342064|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342065|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
64342066|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342067|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
64342096|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64342097|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64342098|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64342099|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342100|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342101|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
64342102|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342212|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64342213|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64342214|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342215|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64342216|NCT00734435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64342217|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64342218|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342225|NCT04040231|Nivolumab|nivolumab|mesh-list
64342305|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342329|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
64342330|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342331|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64342333|NCT03483415|Analgesics|analgesics|mesh-ancestor
64342334|NCT03487003|Bromides|bromides|mesh-list
64342335|NCT03487003|Rocuronium|rocuronium|mesh-list
64342336|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
64342337|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64342338|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64342339|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64342340|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342341|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342342|NCT03486925|Oxytocin|oxytocin|mesh-list
64342343|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
64342471|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64342472|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
64342473|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342474|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64342475|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64342476|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342477|NCT04179019|Amlodipine|amlodipine|mesh-list
64342478|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64342479|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64342484|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
64342596|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64342618|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342619|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342621|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64342622|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64342623|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64342624|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64342625|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342626|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64342627|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342628|NCT03476941|Clindamycin|clindamycin|mesh-list
64342629|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
64342630|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
64342631|NCT03476941|Gentamicins|gentamicins|mesh-list
64342632|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64342633|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342635|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342691|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64342693|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
64342694|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64342695|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64342696|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
64342697|NCT02281721|Antacids|antacids|mesh-ancestor
64342728|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64342729|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
64342730|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342731|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64342732|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64342733|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342734|NCT00589823|Fentanyl|fentanyl|mesh-list
64342735|NCT00589823|Morphine|morphine|mesh-list
64342736|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64342737|NCT00589823|Narcotics|narcotics|mesh-ancestor
64342801|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64342899|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64342900|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
64342901|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64342902|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342903|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64342904|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
64342905|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343045|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64343046|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64343047|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64343048|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
64343049|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343050|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343051|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64343052|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64343053|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
64343054|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343055|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
64343056|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64343057|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343058|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343059|NCT00465959|Trospium chloride|trospium chloride|mesh-list
64343060|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
64343132|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
64343133|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343134|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343135|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343138|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
64343139|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343142|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64343250|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343251|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343253|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64343280|NCT02284529|Antidotes|antidotes|mesh-ancestor
64343281|NCT02284529|Protective Agents|protective agents|mesh-ancestor
64343282|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
64343283|NCT02284529|Vitamins|vitamins|mesh-ancestor
64343285|NCT02482298|Ticagrelor|ticagrelor|mesh-list
64343420|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343421|NCT04470791|Antivenins|antivenins|mesh-list
64343422|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
64343423|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343424|NCT00364247|Tapentadol|tapentadol|mesh-list
64343425|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64343426|NCT00364247|Narcotics|narcotics|mesh-ancestor
64343427|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637349|NCT01084499|Letrozole|letrozole|mesh-list
64637350|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637351|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64637352|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64637353|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637354|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637355|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64637356|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
64343524|NCT00343109|Sargramostim|sargramostim|mesh-list
64343525|NCT00343109|Vaccines|vaccines|mesh-list
64343526|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
64343527|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343528|NCT02481830|Nivolumab|nivolumab|mesh-list
64343529|NCT02481830|Topotecan|topotecan|mesh-list
64343531|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343532|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343533|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64343534|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343535|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64343536|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64343537|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343540|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
64343541|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343542|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343543|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
64343544|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343545|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343549|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
64343550|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343551|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64343552|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64343606|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343607|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343608|NCT00394121|Fluticasone|fluticasone|mesh-list
64637357|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637358|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637359|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
64637360|NCT01118273|Promethazine|promethazine|mesh-list
64637361|NCT01118273|Ibuprofen|ibuprofen|mesh-list
64637362|NCT01118273|Naproxen|naproxen|mesh-list
64637363|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637364|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64637365|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64637366|NCT01118273|Analgesics|analgesics|mesh-ancestor
64343624|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343625|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343660|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
64343661|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
64343662|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
64343664|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64343665|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64343666|NCT00299507|Growth Substances|growth substances|mesh-ancestor
64343667|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343668|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
64343669|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343696|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64343697|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64343699|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64343700|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343701|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64343702|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
64343703|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64343704|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343705|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64343706|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64343707|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64343708|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
64637367|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
64637368|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637369|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637370|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637371|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637372|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64637375|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64637376|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64637377|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343745|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
64343746|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
64343747|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343748|NCT02479412|Albuterol|albuterol|mesh-list
64343750|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
64343751|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343752|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637378|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
64637380|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
64637381|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
64637382|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637384|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
64637385|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
64637386|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637387|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64637388|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
64637389|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637393|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637394|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637395|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64637396|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637397|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64637398|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
64637399|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343858|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64343859|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343860|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343861|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343862|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343863|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64343864|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64343866|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343867|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64343868|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
64343869|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
64343870|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
64637400|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64637401|NCT01085903|Modafinil|modafinil|mesh-list
64637402|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64637403|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637404|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64637405|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64637406|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64637407|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637408|NCT01118741|Disulfiram|disulfiram|mesh-list
64637409|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64637410|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64637411|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637412|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343916|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64343917|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
64343918|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343919|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343920|NCT00380653|Sapacitabine|sapacitabine|mesh-list
64343921|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637413|NCT01439815|Fluticasone|fluticasone|mesh-list
64637414|NCT01439815|Xhance|xhance|mesh-list
64637416|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64637417|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
64637418|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637419|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637420|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64637421|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
64637422|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637423|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64637424|NCT01332253|Ibuprofen|ibuprofen|mesh-list
64637425|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64343988|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343989|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343990|NCT03475615|Paclitaxel|paclitaxel|mesh-list
64343991|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
64343992|NCT03475615|Tegafur|tegafur|mesh-list
64343993|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64343994|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343995|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
64343996|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
64343997|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
64344087|NCT05084599|Metaraminol|metaraminol|mesh-list
64344088|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
64344089|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
64344090|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344091|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344092|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64344093|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64344094|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64344096|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
64344097|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637426|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64637427|NCT01332253|Analgesics|analgesics|mesh-ancestor
64637428|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
64637429|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637430|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637431|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637432|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637433|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64637442|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637443|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
64637444|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
64637445|NCT01384591|Losartan|losartan|mesh-list
64637446|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64344124|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
64344125|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344126|NCT02446886|Hormones|hormones|mesh-list
64344127|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64344164|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344165|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344166|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64344167|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
64344188|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64344189|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64344190|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344191|NCT04864210|Bupivacaine|bupivacaine|mesh-list
64344192|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
64344193|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
64344194|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344195|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344196|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
64344197|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344198|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
64344199|NCT01641640|Ribavirin|ribavirin|mesh-list
64344200|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
64344201|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344214|NCT04848688|Moxidectin|moxidectin|mesh-list
64637447|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64637448|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64637449|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64637450|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64637451|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637452|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
64637453|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637456|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64637457|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
64637458|NCT01384591|Protective Agents|protective agents|mesh-ancestor
64637459|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637460|NCT01384591|Antidotes|antidotes|mesh-ancestor
64637461|NCT01086605|Pixantrone|pixantrone|mesh-list
64637462|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64344222|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344223|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344238|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344239|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64344240|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64344241|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64344242|NCT05069740|Analgesics|analgesics|mesh-ancestor
64344243|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
64344244|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344245|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344246|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344247|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344248|NCT01601626|Pyridoxine|pyridoxine|mesh-list
64344249|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
64344250|NCT01601626|Ritonavir|ritonavir|mesh-list
64344251|NCT01601626|Lopinavir|lopinavir|mesh-list
64344252|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
64344253|NCT01601626|Rifampin|rifampin|mesh-list
64344254|NCT01601626|Isoniazid|isoniazid|mesh-list
64344256|NCT01601626|Ethambutol|ethambutol|mesh-list
64344257|NCT01601626|Rifabutin|rifabutin|mesh-list
64344258|NCT01601626|Vitamins|vitamins|mesh-ancestor
64344259|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
64344260|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637463|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64637465|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637466|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637467|NCT00265850|Leucovorin|leucovorin|mesh-list
64637468|NCT00265850|Folic Acid|folic acid|mesh-list
64637469|NCT00265850|Bevacizumab|bevacizumab|mesh-list
64637470|NCT00265850|Cetuximab|cetuximab|mesh-list
64637471|NCT00265850|Fluorouracil|fluorouracil|mesh-list
64637472|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
64637473|NCT00265850|Irinotecan|irinotecan|mesh-list
64637474|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
64637475|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637476|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637477|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64344276|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
64344277|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64344278|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
64344279|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64344280|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64344281|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64637478|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64637479|NCT00265850|Growth Substances|growth substances|mesh-ancestor
64637480|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637481|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
64637482|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
64637483|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637484|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64637485|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637486|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
64637487|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64637488|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64637489|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637490|NCT00265850|Antidotes|antidotes|mesh-ancestor
64637499|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64344368|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344369|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344370|NCT04984798|Vitamin E|vitamin e|mesh-list
64344371|NCT04984798|Tocopherols|tocopherols|mesh-list
64344372|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
64344373|NCT04984798|Vitamins|vitamins|mesh-ancestor
64344374|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
64344375|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344376|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
64344377|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344378|NCT04984798|Protective Agents|protective agents|mesh-ancestor
64637500|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637501|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637502|NCT00125528|Cycloserine|cycloserine|mesh-list
64637503|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64637504|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637505|NCT00125528|Renal Agents|renal agents|mesh-ancestor
64637506|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64637507|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
64637508|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64637509|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
64344593|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
64344594|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344595|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64344617|NCT03529331|Oxycodone|oxycodone|mesh-list
64344618|NCT03529331|Hydrocodone|hydrocodone|mesh-list
64344619|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64344620|NCT03529331|Narcotics|narcotics|mesh-ancestor
64344621|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344622|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344623|NCT03529331|Analgesics|analgesics|mesh-ancestor
64344624|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
64344625|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344626|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64344627|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
64344628|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
64344629|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
64344630|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64344631|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344632|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344727|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344728|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64344729|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
64344730|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64344731|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64344754|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344755|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344756|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344757|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
64344758|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344759|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64637510|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637511|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
64637512|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
64637513|NCT01390909|Lactitol|lactitol|mesh-list
64637514|NCT01390909|Cathartics|cathartics|mesh-ancestor
64637515|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637516|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637517|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64637518|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64637519|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64344770|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
64344771|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
64344772|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
64344773|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344774|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344775|NCT03531281|Sirolimus|sirolimus|mesh-list
64344776|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
64344777|NCT03531281|Etoposide|etoposide|mesh-list
64344778|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
64344779|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
64344780|NCT03531281|Tacrolimus|tacrolimus|mesh-list
64344781|NCT03531281|Mitogens|mitogens|mesh-list
64344782|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344783|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
64344784|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344785|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344786|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64344873|NCT05446571|Valacyclovir|valacyclovir|mesh-list
64344874|NCT05446571|Letermovir|letermovir|mesh-list
64344875|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
64344876|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344877|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64344878|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344879|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344880|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344881|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
64344882|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64344883|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637520|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64637521|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64637522|NCT01042145|Dexamethasone|dexamethasone|mesh-list
64637523|NCT01042145|Prednisone|prednisone|mesh-list
64637524|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637525|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
64637526|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
64637527|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637528|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637529|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637531|NCT01042145|Hormones|hormones|mesh-ancestor
64637532|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637533|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637534|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637535|NCT01043393|Desoximetasone|desoximetasone|mesh-list
64637536|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637537|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
64637539|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637540|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637541|NCT01087931|Bupivacaine|bupivacaine|mesh-list
64637542|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
64637543|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
64345152|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345153|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345154|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
64345155|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
64345156|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345157|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345161|NCT04837924|Acetaminophen|acetaminophen|mesh-list
64345237|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64345238|NCT03275285|Dexamethasone|dexamethasone|mesh-list
64345239|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64345240|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
64345241|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
64345242|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345243|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345244|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345245|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
64345246|NCT03275285|Hormones|hormones|mesh-ancestor
64345247|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345249|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345251|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
64345252|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64345253|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345254|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
64345255|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
64345256|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
64345257|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345258|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637544|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637545|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637546|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
64637547|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637548|NCT01336933|Prednisone|prednisone|mesh-list
64637556|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637557|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64637558|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
64637559|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302699|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64637560|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637561|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64637562|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637563|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
64637565|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345259|NCT04831450|Cemiplimab|cemiplimab|mesh-list
64345260|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345261|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345262|NCT04830982|Diazoxide|diazoxide|mesh-list
64345263|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64345264|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
64345265|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
64345266|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345267|NCT05302804|Menthol|menthol|mesh-list
64345268|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
64345269|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
64345270|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
64345271|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345272|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345273|NCT04820452|Aflibercept|aflibercept|mesh-list
64345274|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64345275|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64345276|NCT04820452|Growth Substances|growth substances|mesh-ancestor
64345314|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345335|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64345336|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
64345338|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
64345339|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345340|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345341|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
64345343|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64345344|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
64345345|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64345347|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
64637566|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637567|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64637568|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64637569|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64637570|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637571|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
64637572|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
64637573|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
64637574|NCT03009409|Ketamine|ketamine|mesh-list
64637575|NCT03009409|Analgesics|analgesics|mesh-ancestor
64637576|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
64637577|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345350|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64345351|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345352|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345353|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345354|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345355|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
64345356|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345357|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345358|NCT02917096|Vidarabine|vidarabine|mesh-list
64345359|NCT02917096|Sirolimus|sirolimus|mesh-list
64345360|NCT02917096|Fludarabine|fludarabine|mesh-list
64345361|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
64345362|NCT02917096|Melphalan|melphalan|mesh-list
64345363|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
64345364|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64345365|NCT02917096|Tacrolimus|tacrolimus|mesh-list
64345366|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345367|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64345368|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
64345369|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637578|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637579|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64637580|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64637581|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
64637582|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
64637583|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637584|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64637585|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64637586|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637587|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637588|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
64637589|NCT00176930|Busulfan|busulfan|mesh-list
64637590|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637591|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
64637592|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637606|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637607|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637608|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
64345417|NCT02728102|Molgramostim|molgramostim|mesh-list
64345418|NCT02728102|Vaccines|vaccines|mesh-list
64345419|NCT02728102|Sargramostim|sargramostim|mesh-list
64345420|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
64345421|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345422|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64345423|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64345424|NCT02728102|Growth Substances|growth substances|mesh-ancestor
64345425|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
64345426|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345427|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64345457|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345458|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637609|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637610|NCT01441843|Lorazepam|lorazepam|mesh-list
64637611|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
64637612|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
64637614|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637615|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637616|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637617|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64637618|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637619|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64637620|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64637621|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64637622|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
64637623|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
64637624|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345628|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64345629|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
64345630|NCT03781960|Nivolumab|nivolumab|mesh-list
64345631|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345632|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345657|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64345658|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
64345659|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64345660|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345662|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345663|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345664|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64345665|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345666|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64345667|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345668|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345669|NCT02441114|Fluticasone|fluticasone|mesh-list
64345670|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
64345671|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64345672|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64345673|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64345674|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64345675|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
64345676|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345677|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345678|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64345679|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
64345680|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637625|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637626|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
64637627|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64637628|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64637629|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64637630|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64637631|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637632|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
64637633|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637634|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637635|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64637636|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637637|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
64637638|NCT01089569|Exenatide|exenatide|mesh-list
64637639|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64345681|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64345709|NCT05235256|Hormones|hormones|mesh-ancestor
64345710|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345711|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64345712|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345713|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
64345714|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
64345715|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64345716|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
64345717|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64345718|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64345719|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64345720|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64345721|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345722|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
64345723|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345724|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
64345725|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345726|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345727|NCT04791514|Treprostinil|treprostinil|mesh-list
64345728|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64345753|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345754|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345755|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
64345756|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345757|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64637640|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637641|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64637642|NCT01089569|Incretins|incretins|mesh-ancestor
64637643|NCT01089569|Hormones|hormones|mesh-ancestor
64637644|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637645|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
64637646|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64637647|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64345764|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
64345765|NCT01038778|Interleukin-2|interleukin-2|mesh-list
64345767|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64345768|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64345769|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345770|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64345771|NCT01038778|Analgesics|analgesics|mesh-ancestor
64345772|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
64345773|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345774|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345775|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64345776|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64345777|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
64345778|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345779|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64345853|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64345854|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345855|NCT03046511|Cefazolin|cefazolin|mesh-list
64345856|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345888|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
64345889|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64345890|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64345892|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64345940|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345941|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345976|NCT02532257|Growth Substances|growth substances|mesh-ancestor
64345977|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
64345978|NCT03524261|Antibodies|antibodies|mesh-list
64345979|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64345980|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
64345981|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345982|NCT03386721|Gemcitabine|gemcitabine|mesh-list
64345983|NCT03386721|Atezolizumab|atezolizumab|mesh-list
64345984|NCT03386721|Vinorelbine|vinorelbine|mesh-list
64346040|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346041|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346042|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346043|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346044|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64346045|NCT04105270|Carboplatin|carboplatin|mesh-list
64346046|NCT04105270|Pemetrexed|pemetrexed|mesh-list
64346047|NCT04105270|Durvalumab|durvalumab|mesh-list
64346048|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637648|NCT00128180|Prednisolone|prednisolone|mesh-list
64637649|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
64637650|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64637666|NCT01121939|Pertuzumab|pertuzumab|mesh-list
64637667|NCT01121939|Octreotide|octreotide|mesh-list
64637668|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637669|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637670|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64637671|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64637672|NCT01121939|Growth Substances|growth substances|mesh-ancestor
64637673|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637675|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637676|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637678|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64637680|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346140|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346141|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346142|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64346143|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64346144|NCT05392257|Growth Substances|growth substances|mesh-ancestor
64346145|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
64346146|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346147|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346148|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346149|NCT02240680|Linagliptin|linagliptin|mesh-list
64346150|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64346151|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346152|NCT02240680|Incretins|incretins|mesh-ancestor
64346153|NCT02240680|Hormones|hormones|mesh-ancestor
64346184|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
64346185|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
64346235|NCT03899961|Carbetocin|carbetocin|mesh-list
64346273|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
64346274|NCT02294279|Hormones|hormones|mesh-ancestor
64346275|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346276|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346277|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64346278|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
64346279|NCT02294357|Dexamethasone|dexamethasone|mesh-list
64346280|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
64346281|NCT02294357|Prednisone|prednisone|mesh-list
64346282|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
64346283|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64346284|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64346285|NCT02294357|Prednisolone|prednisolone|mesh-list
64346286|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
64637681|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637682|NCT01897844|Somatostatin|somatostatin|mesh-list
64637683|NCT01897844|Hormones|hormones|mesh-ancestor
64637684|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637685|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637686|NCT00131378|Hormones|hormones|mesh-list
64637687|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637688|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637689|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
64637690|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64637691|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
64637692|NCT01445821|Fludarabine|fludarabine|mesh-list
64637693|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
64637694|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637695|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
64637700|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637701|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637702|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64637703|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637705|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
64637706|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637707|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64637708|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
64637709|NCT01445821|Hormones|hormones|mesh-ancestor
64637710|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637711|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64346380|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
64346381|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64346409|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64346410|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346411|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
64346412|NCT04465175|Analgesics|analgesics|mesh-ancestor
64346413|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
64346414|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346415|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346416|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
64346417|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346418|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64637712|NCT01445821|Protective Agents|protective agents|mesh-ancestor
64637713|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637714|NCT00182000|Cycloserine|cycloserine|mesh-list
64637715|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64637716|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637717|NCT00182000|Renal Agents|renal agents|mesh-ancestor
64637718|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64637719|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
64637720|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64637721|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
64637725|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64637726|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
64637727|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
64637728|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637729|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637730|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64637731|NCT03013439|Hematinics|hematinics|mesh-ancestor
64637732|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64637733|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64637734|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64637735|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64637736|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637737|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637738|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637739|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64637740|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
64637741|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64637742|NCT01093469|Decanoic acid|decanoic acid|mesh-list
64637743|NCT01093469|Petrolatum|petrolatum|mesh-list
64637744|NCT01093469|Emollients|emollients|mesh-ancestor
64637745|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637746|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
64637747|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637748|NCT02543658|Neostigmine|neostigmine|mesh-list
64637749|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64637750|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346499|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346500|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
64346501|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64346634|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346635|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346636|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346637|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346668|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64346669|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346670|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346671|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
64346672|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
64346674|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
64346675|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346676|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346680|NCT02460380|Vitamins|vitamins|mesh-ancestor
64346725|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346726|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64346727|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64346728|NCT03132623|Analgesics|analgesics|mesh-ancestor
64346729|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
64346730|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346765|NCT02834403|Amlodipine|amlodipine|mesh-list
64346766|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64346950|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347016|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
64347017|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347018|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347019|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64347020|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
64347021|NCT04464005|Analgesics|analgesics|mesh-ancestor
64347136|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64347137|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347138|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347139|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64347140|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
64347141|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347142|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347143|NCT03509285|Cenobamate|cenobamate|mesh-list
64637751|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637752|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
64637753|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637754|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637755|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64637756|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
64637757|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637766|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
64637767|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637768|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637769|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637770|NCT00132002|Vorinostat|vorinostat|mesh-list
64637771|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637772|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64347218|NCT03309007|Metformin|metformin|mesh-list
64347219|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
64347220|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64347221|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347222|NCT03309007|Antacids|antacids|mesh-ancestor
64347223|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347224|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347225|NCT03508817|Atropine|atropine|mesh-list
64347226|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64347227|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64347228|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64347252|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347253|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347254|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
64347255|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347256|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64637773|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637774|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637775|NCT00183794|Gemcitabine|gemcitabine|mesh-list
64637776|NCT00183794|Docetaxel|docetaxel|mesh-list
64637777|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64637778|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
64637779|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637780|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64637781|NCT00183794|Antiviral Agents|antiviral agents|mesh-ancestor
64637782|NCT00183794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347320|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
64347321|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64347322|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
64347323|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347324|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
64347325|NCT04464629|Hormones|hormones|mesh-ancestor
64347326|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347327|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347328|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64637783|NCT00183794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637784|NCT00183794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637785|NCT00183794|Immunologic Factors|immunologic factors|mesh-ancestor
64637786|NCT00183794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637787|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64637788|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64637789|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64637790|NCT00270296|Ritonavir|ritonavir|mesh-list
64637791|NCT00270296|Lopinavir|lopinavir|mesh-list
64637792|NCT00270296|Lamivudine|lamivudine|mesh-list
64637793|NCT00270296|Zidovudine|zidovudine|mesh-list
64637794|NCT00270296|Nevirapine|nevirapine|mesh-list
64347461|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64347462|NCT02235298|Metformin|metformin|mesh-list
64347463|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
64347464|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64347465|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347466|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64637795|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64637796|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64637797|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64637798|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
64637799|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64637800|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637801|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64637802|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64637803|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
64637804|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347467|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347497|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64347498|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
64347499|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347500|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347501|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64347502|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64347503|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347504|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
64347505|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
64347506|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347507|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347508|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
64347509|NCT03942887|Hormones|hormones|mesh-ancestor
64347510|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347511|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64347525|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
64347526|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
64347527|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347528|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347529|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347530|NCT04539951|Memantine|memantine|mesh-list
64347531|NCT04539951|Aripiprazole|aripiprazole|mesh-list
64347532|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
64347533|NCT04539951|Sertraline|sertraline|mesh-list
64347560|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64347561|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64347562|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64347563|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64347564|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347565|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64347566|NCT04539327|Rucaparib|rucaparib|mesh-list
64347567|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64347568|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347569|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347592|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347658|NCT00821587|Cyclosporins|cyclosporins|mesh-list
64347659|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347660|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
64347661|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347662|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64347663|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347664|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347665|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
64347666|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347790|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347793|NCT04457323|Metoprolol|metoprolol|mesh-list
64348103|NCT02229214|Phentermine|phentermine|mesh-list
64348104|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
64348105|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64348106|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348107|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64348108|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
64348109|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64348110|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
64348111|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
64348112|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348113|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
64348114|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348115|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348144|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349129|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
64349130|NCT02322203|Vitamins|vitamins|mesh-ancestor
64349131|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
64349132|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349133|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64349134|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64349648|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349650|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349651|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
64349652|NCT05385523|Dexamethasone|dexamethasone|mesh-list
64349653|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349654|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
64350059|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64350060|NCT02202850|Analgesics|analgesics|mesh-ancestor
64350061|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
64350062|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350063|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350064|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64350065|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64350066|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350447|NCT04349579|Rifamycins|rifamycins|mesh-list
64350474|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64350475|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350476|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64350477|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350479|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64350480|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350502|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
64637805|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64637823|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637826|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
64637827|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64637828|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64637829|NCT01049243|Fluocinonide|fluocinonide|mesh-list
64637830|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64637831|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
64637832|NCT01049243|Hormones|hormones|mesh-ancestor
64637833|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64637834|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637835|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64637836|NCT03013205|Triamcinolone|triamcinolone|mesh-list
64637849|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637851|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
64637852|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637853|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
64637854|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637855|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64637856|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64637857|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64637858|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64637860|NCT01094717|Acitretin|acitretin|mesh-list
64637861|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637862|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
64637863|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64637864|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64637865|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637866|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
64637867|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637868|NCT01095887|Eculizumab|eculizumab|mesh-list
64350833|NCT03202667|Empagliflozin|empagliflozin|mesh-list
64350834|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64350835|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350836|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64350911|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
64350912|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64350913|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64637869|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64637870|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637871|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
64637872|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637873|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64637874|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64637875|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350945|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64350946|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64350993|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64350996|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350997|NCT03469271|Calcitriol|calcitriol|mesh-list
64350998|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64350999|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64351000|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351001|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64351002|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351003|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351004|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64351005|NCT03469271|Vitamins|vitamins|mesh-ancestor
64351006|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
64351007|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64351008|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
64351009|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64637876|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64637877|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
64637878|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637879|NCT03110315|Suvorexant|suvorexant|mesh-list
64637880|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64637893|NCT05307341|Analgesics|analgesics|mesh-ancestor
64637894|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
64637895|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351323|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64351324|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
64351325|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
64351326|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351327|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351329|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351330|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64351331|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
64351332|NCT05170711|Anesthetics|anesthetics|mesh-list
64351333|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351334|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351335|NCT03454945|Doxycycline|doxycycline|mesh-list
64351336|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64351337|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351483|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
64351484|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64351557|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64351558|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
64351559|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
64351560|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351561|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351562|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351563|NCT05313659|Ketamine|ketamine|mesh-list
64351564|NCT05313659|Analgesics|analgesics|mesh-ancestor
64351565|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
64351566|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351567|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351568|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64351569|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64351570|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
64351571|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
64637896|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64637897|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64637898|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
64637899|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
64637900|NCT01100255|Ketamine|ketamine|mesh-list
64637901|NCT01100255|Analgesics|analgesics|mesh-ancestor
64637902|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
64637903|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637904|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637905|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64637906|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64637907|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
64637908|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
64637909|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637910|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64637912|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637913|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637914|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
64351743|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64351744|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64351745|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
64351746|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
64351747|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
64351748|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64351749|NCT04923659|Analgesics|analgesics|mesh-ancestor
64351750|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
64351751|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64351752|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351753|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64351754|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64351755|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64351756|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64351757|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64351758|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
64351759|NCT05398679|Amoxicillin|amoxicillin|mesh-list
64351837|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64351838|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64351839|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351840|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64351841|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351842|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351843|NCT01378325|Phenylephrine|phenylephrine|mesh-list
64351844|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
64351845|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64351846|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
64351847|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
64351848|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351849|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351850|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
64351851|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64351852|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
64351853|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
64351854|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64351909|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64351910|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64351911|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351912|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64351913|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352187|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
64352188|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
64352189|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352190|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352191|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
64352192|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352193|NCT02557139|Belumosudil|belumosudil|mesh-list
64352194|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64352195|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352196|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352197|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
64352198|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
64352199|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352201|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352202|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64352203|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352204|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352205|NCT02457221|Prednisone|prednisone|mesh-list
64352206|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
64352207|NCT02457221|Tacrolimus|tacrolimus|mesh-list
64352208|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352209|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
64352210|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352211|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64352223|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352224|NCT05263895|Ritonavir|ritonavir|mesh-list
64352225|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64352226|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64352227|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
64352251|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352253|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64352254|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64352255|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
64352256|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
64352257|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352258|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352259|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352260|NCT05101005|Sirolimus|sirolimus|mesh-list
64352261|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64352262|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352263|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64352264|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352265|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
64352273|NCT05015387|Procyanidin|procyanidin|mesh-list
64352456|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64352457|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
64352458|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64352459|NCT04452929|Protective Agents|protective agents|mesh-ancestor
64352460|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64352461|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64352604|NCT05115123|Analgesics|analgesics|mesh-ancestor
64352605|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
64352693|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637915|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64637916|NCT03012347|Protective Agents|protective agents|mesh-ancestor
64637917|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637918|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
64637919|NCT01100723|Vitamin D|vitamin d|mesh-list
64637920|NCT01100723|Calcitriol|calcitriol|mesh-list
64637921|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64637922|NCT01100723|Cinacalcet|cinacalcet|mesh-list
64637923|NCT01100723|Vitamins|vitamins|mesh-ancestor
64637924|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
64637925|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637926|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64637927|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64637928|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64637929|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64424507|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
64352809|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64352810|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352811|NCT05104437|Vaccines|vaccines|mesh-list
64352812|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
64352813|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352945|NCT01709123|Trace Elements|trace elements|mesh-ancestor
64352946|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
64352947|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352948|NCT01301807|Panobinostat|panobinostat|mesh-list
64352949|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352950|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64352951|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352952|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352953|NCT04962893|Vaccines|vaccines|mesh-list
64352954|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
64352955|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352956|NCT03443141|Vitamin E|vitamin e|mesh-list
64353165|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64353166|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353167|NCT04418895|Leucovorin|leucovorin|mesh-list
64353168|NCT04418895|Fluorouracil|fluorouracil|mesh-list
64353169|NCT04418895|Capecitabine|capecitabine|mesh-list
64353202|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64353203|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353204|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353205|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353206|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64637950|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637951|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637952|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64637953|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64637954|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
64637955|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
64637960|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637961|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
64637962|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64353249|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353250|NCT04542837|Lenvatinib|lenvatinib|mesh-list
64353251|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353252|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64353253|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353254|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353255|NCT02655237|Leuprolide|leuprolide|mesh-list
64353256|NCT02655237|Relugolix|relugolix|mesh-list
64353257|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64353258|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
64353259|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64353260|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353261|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353264|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
64353265|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353266|NCT03443999|Sirolimus|sirolimus|mesh-list
64353267|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353268|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353269|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64353273|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
64353274|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353275|NCT03890133|Pregabalin|pregabalin|mesh-list
64353276|NCT03890133|Analgesics|analgesics|mesh-ancestor
64353277|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
64353293|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353294|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353295|NCT03443921|Paclitaxel|paclitaxel|mesh-list
64353296|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64353297|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353298|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64353303|NCT03443843|Xhance|xhance|mesh-list
64353304|NCT03443843|Loratadine|loratadine|mesh-list
64353305|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
64353306|NCT03443843|Ephedrine|ephedrine|mesh-list
64353307|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353308|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64353309|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
64353310|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353311|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353312|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64353313|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353314|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
64353315|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64353316|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
64353317|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64353319|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
64353320|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
64353321|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353322|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637963|NCT02246855|Antibodies|antibodies|mesh-list
64637964|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
64637967|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64637968|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637969|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64637970|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64637971|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353591|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353592|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353593|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353594|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353595|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64353663|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353664|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353665|NCT03431597|Micronutrients|micronutrients|mesh-list
64353666|NCT03431597|Trace Elements|trace elements|mesh-list
64353667|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353836|NCT03429179|Analgesics|analgesics|mesh-ancestor
64353837|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
64353838|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353839|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
64353840|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
64354020|NCT03425669|Methylphenidate|methylphenidate|mesh-list
64354021|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64354022|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354027|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
64354107|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354109|NCT03441373|Histamine|histamine|mesh-list
64354110|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
64354111|NCT03441373|Glutarimide|glutarimide|mesh-list
64354112|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
64354113|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
64354114|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354115|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354345|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354346|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354347|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64354348|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64354349|NCT03435289|Gemcitabine|gemcitabine|mesh-list
64354350|NCT03435289|Paclitaxel|paclitaxel|mesh-list
64354351|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64354352|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64637972|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637974|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64637975|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
64637976|NCT00185900|Nifedipine|nifedipine|mesh-list
64637977|NCT00185900|Analgesics|analgesics|mesh-ancestor
64637978|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
64637979|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64637980|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637982|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64637983|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64637984|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
64637985|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64637986|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64637987|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64637988|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64637989|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
64637990|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64637991|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
64637992|NCT00186056|Mifepristone|mifepristone|mesh-list
64637993|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64637994|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
64637995|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64637996|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64637997|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64637998|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64638005|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
64638006|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64638007|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64638008|NCT00186446|Bupropion|bupropion|mesh-list
64638009|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64638010|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
64638011|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64638012|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64638013|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64638014|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64638015|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638016|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
64638017|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354572|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354574|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
64354575|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354576|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354577|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354578|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354579|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354581|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354627|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354628|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64354629|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64354630|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
64354631|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
64354632|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64354633|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64354634|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64354635|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64354636|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64354637|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64354638|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64354653|NCT03109795|Analgesics|analgesics|mesh-ancestor
64638018|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638019|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64638020|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64638021|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638022|NCT00136760|Bupropion|bupropion|mesh-list
64638023|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64638024|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
64638025|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64354695|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354696|NCT02412722|Paclitaxel|paclitaxel|mesh-list
64354697|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64354698|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354699|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
64354700|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
64354701|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
64354722|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354723|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354730|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64354731|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64354732|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354733|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354734|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
64354740|NCT02935309|Lenvatinib|lenvatinib|mesh-list
64638026|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64638027|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64638029|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638030|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
64638031|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638032|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638033|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64638034|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64638035|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638036|NCT00189098|Trimethoprim|trimethoprim|mesh-list
64638037|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64638038|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
64638039|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64638040|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638041|NCT00189098|Renal Agents|renal agents|mesh-ancestor
64638042|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
64638043|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64638044|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64638058|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638059|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64354864|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354865|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354866|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354868|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64354869|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64354870|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
64354871|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638060|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64638061|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64638062|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64638063|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638064|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638065|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638066|NCT04751318|Analgesics|analgesics|mesh-ancestor
64638067|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
64638068|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638069|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
64638070|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64638071|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
64638072|NCT01107665|Paclitaxel|paclitaxel|mesh-list
64638073|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64638074|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638075|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638076|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638077|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
64638078|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354929|NCT03415555|Acetaminophen|acetaminophen|mesh-list
64354930|NCT03415555|Oxycodone|oxycodone|mesh-list
64354931|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354932|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354933|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354934|NCT03415555|Analgesics|analgesics|mesh-ancestor
64354935|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
64354936|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354937|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
64354938|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64354939|NCT03415555|Narcotics|narcotics|mesh-ancestor
64354940|NCT03415477|Denosumab|denosumab|mesh-list
64354941|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64354942|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354943|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
64354944|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
64354945|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355054|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64355055|NCT02521051|Bevacizumab|bevacizumab|mesh-list
64355079|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
64355080|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355081|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355082|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
64355083|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64355084|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64355086|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
64355087|NCT02639065|Durvalumab|durvalumab|mesh-list
64355088|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64355089|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355090|NCT02735707|Aspirin|aspirin|mesh-list
64355091|NCT02735707|Vitamins|vitamins|mesh-list
64355092|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
64355093|NCT02735707|Interferons|interferons|mesh-list
64355094|NCT02735707|Ritonavir|ritonavir|mesh-list
64355203|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355204|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64355205|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
64355207|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64355209|NCT00950989|Methotrexate|methotrexate|mesh-list
64355210|NCT00950989|Brodalumab|brodalumab|mesh-list
64355211|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64355245|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355247|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64638079|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
64638080|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64638081|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638082|NCT01447225|Gemcitabine|gemcitabine|mesh-list
64638083|NCT01447225|Carboplatin|carboplatin|mesh-list
64638084|NCT01447225|Pemetrexed|pemetrexed|mesh-list
64638085|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638099|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64638100|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638101|NCT00277394|Heparin|heparin|mesh-list
64638102|NCT00277394|Tinzaparin|tinzaparin|mesh-list
64638103|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
64638104|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64638105|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64638106|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638107|NCT01450189|Tenofovir|tenofovir|mesh-list
64638108|NCT01450189|Emtricitabine|emtricitabine|mesh-list
64638109|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
64638110|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64638111|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
64638112|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638113|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64638114|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64638115|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638116|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638117|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64638118|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64638119|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64638120|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64638121|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
64638122|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638123|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64638124|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638125|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638126|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
64638127|NCT01474213|Remifentanil|remifentanil|mesh-list
64638128|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64638129|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638130|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638131|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64638132|NCT01474213|Analgesics|analgesics|mesh-ancestor
64638144|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64638145|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
64638146|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638147|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638148|NCT01474915|Promethazine|promethazine|mesh-list
64638149|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
64638150|NCT01474915|Dexamethasone|dexamethasone|mesh-list
64638151|NCT01474915|Ondansetron|ondansetron|mesh-list
64638152|NCT01474915|Aprepitant|aprepitant|mesh-list
64638153|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64638154|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
64638155|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
64638156|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638157|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638158|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355354|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64355355|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
64355372|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
64355373|NCT01602315|Cetuximab|cetuximab|mesh-list
64355389|NCT03413371|Ropivacaine|ropivacaine|mesh-list
64355390|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
64355391|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
64355392|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355393|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355394|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
64355395|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355396|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64355397|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64355400|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355401|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64355403|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
64355404|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
64355405|NCT05116995|Ticagrelor|ticagrelor|mesh-list
64355406|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64355442|NCT05116371|Estradiol|estradiol|mesh-list
64638161|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638162|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64638163|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638164|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
64638165|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
64638166|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64638167|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
64638168|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638169|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638170|NCT01474915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64638171|NCT01474915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64638172|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638173|NCT01474915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64638174|NCT01474915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64638175|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64638176|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64355523|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64355524|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64355525|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64355526|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
64355527|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355528|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355529|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355530|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64355531|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
64355532|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64355533|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
64355534|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355535|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
64355536|NCT03413059|Triamcinolone|triamcinolone|mesh-list
64355537|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64355538|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64355540|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64355541|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64638177|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
64638178|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
64638179|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64638180|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64638181|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64638182|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
64638183|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
64638195|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638196|NCT01899794|Urological Agents|urological agents|mesh-ancestor
64638197|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64355608|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64355609|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355610|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355611|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
64355612|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355613|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64355614|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
64355615|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64355616|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64355617|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64355618|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355619|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
64355620|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
64355621|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64355624|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64355625|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64355626|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64355627|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64355628|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64355629|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
64355630|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355631|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355657|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
64355673|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64355674|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
64355675|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64355676|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355677|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
64355678|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64355679|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355680|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355681|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64356007|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356008|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356009|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
64356010|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64356011|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64356012|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
64356013|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356014|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64356048|NCT04737603|Narcotics|narcotics|mesh-ancestor
64356155|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356156|NCT03612921|Amantadine|amantadine|mesh-list
64356157|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64356158|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64356159|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
64356160|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356161|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
64356162|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356163|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356164|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356165|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356166|NCT03612921|Analgesics|analgesics|mesh-ancestor
64356167|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
64356168|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356265|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64356267|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356268|NCT03407027|Triamcinolone|triamcinolone|mesh-list
64356269|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64356270|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64356271|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64356272|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64356273|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
64356275|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356287|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64356288|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
64356289|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
64356290|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356291|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356292|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64356293|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
64356294|NCT01602224|Hormones|hormones|mesh-ancestor
64356459|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356460|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64356461|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64356647|NCT03395171|Vitamins|vitamins|mesh-ancestor
64356648|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
64356649|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356650|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64356651|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64356652|NCT03395977|Febuxostat|febuxostat|mesh-list
64356653|NCT03395977|Rasburicase|rasburicase|mesh-list
64356654|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
64356655|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356656|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
64356657|NCT02678143|Sirolimus|sirolimus|mesh-list
64356882|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
64356883|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64356884|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64356886|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
64356887|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356888|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356889|NCT01889303|Docetaxel|docetaxel|mesh-list
64356890|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356891|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
64356892|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638198|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638199|NCT01899794|Renal Agents|renal agents|mesh-ancestor
64638208|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638209|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64638210|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638211|NCT02099084|Teduglutide|teduglutide|mesh-list
64638212|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64638213|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64638214|NCT02099084|Protective Agents|protective agents|mesh-ancestor
64638215|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638216|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
64357429|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64357430|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64357431|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
64357433|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64357434|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64357435|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
64357436|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357437|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357439|NCT03379103|Sevoflurane|sevoflurane|mesh-list
64357440|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64357482|NCT03383315|Analgesics|analgesics|mesh-ancestor
64357661|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
64357662|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64357663|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64357664|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
64357665|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64357666|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357667|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64357668|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64357669|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
64357670|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357671|NCT03375515|Hydromorphone|hydromorphone|mesh-list
64357672|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64357780|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357781|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357782|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
64357784|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
64357786|NCT03385135|Allopurinol|allopurinol|mesh-list
64358179|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358180|NCT03381859|Grazoprevir|grazoprevir|mesh-list
64358181|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64358182|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
64358183|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358184|NCT03381781|Cytarabine|cytarabine|mesh-list
64358319|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64358320|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64358321|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358365|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64358422|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64358423|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358424|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
64358425|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358426|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64358428|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64358429|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
64358430|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
64638217|NCT00281918|Rituximab|rituximab|mesh-list
64638218|NCT00281918|Fludarabine|fludarabine|mesh-list
64638219|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
64638220|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638221|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
64638222|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638223|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638224|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64638225|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
64638226|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638227|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638228|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64638229|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638230|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64638231|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
64638232|NCT00201734|Paclitaxel|paclitaxel|mesh-list
64638233|NCT00201734|Carboplatin|carboplatin|mesh-list
64638234|NCT00201734|Capecitabine|capecitabine|mesh-list
64638235|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64424518|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
64638237|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638238|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64359046|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359047|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
64359048|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359049|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
64359050|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64359051|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64359052|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
64359053|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64359322|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
64359323|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359324|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359325|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359326|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
64359327|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359328|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
64359329|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
64359361|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359363|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
64359364|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359365|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359366|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64359367|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
64359368|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64359404|NCT04287855|Hormones|hormones|mesh-ancestor
64638239|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64638240|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638241|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64638242|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
64638243|NCT00203216|Levetiracetam|levetiracetam|mesh-list
64638244|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
64638245|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
64638246|NCT05156060|Ketamine|ketamine|mesh-list
64638247|NCT05156060|Gabapentin|gabapentin|mesh-list
64638248|NCT05156060|Analgesics|analgesics|mesh-ancestor
64638249|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
64359407|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359408|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
64359409|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64359410|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64359411|NCT04287855|Growth Substances|growth substances|mesh-ancestor
64359412|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
64359413|NCT04435587|Ritonavir|ritonavir|mesh-list
64359414|NCT04435587|Darunavir|darunavir|mesh-list
64359415|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
64359416|NCT04435587|Ivermectin|ivermectin|mesh-list
64359417|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64359443|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
64359444|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
64359445|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359446|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359447|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
64359448|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359449|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359451|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
64359493|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359494|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64359495|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64359496|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64359497|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359498|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359499|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64359500|NCT01503489|Norepinephrine|norepinephrine|mesh-list
64359501|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
64359502|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
64359503|NCT01503489|Serotonin|serotonin|mesh-list
64359504|NCT01503489|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64359505|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64359506|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64359507|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
64359508|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359511|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
64359669|NCT03122353|Calcipotriene|calcipotriene|mesh-list
64359670|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64359671|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359672|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
64359673|NCT03122353|Hormones|hormones|mesh-ancestor
64359674|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359675|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359676|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64359677|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
64359678|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
64359679|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64359680|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64359681|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64359882|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359883|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64359884|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64359982|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359983|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
64359984|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359986|NCT03346525|Penicillin G|penicillin g|mesh-list
64359988|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
64638251|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638252|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64638253|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64638254|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
64638255|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
64638256|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638257|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64638258|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64638259|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638260|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638261|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
64638262|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360120|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64360121|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
64360124|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
64360125|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
64360126|NCT04147221|Imipenem|imipenem|mesh-list
64360127|NCT04147221|Relebactam|relebactam|mesh-list
64360128|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64360158|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64360159|NCT03892395|Vitamin D|vitamin d|mesh-list
64360160|NCT03892395|Vitamins|vitamins|mesh-list
64360161|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
64360162|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
64360163|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360164|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64360165|NCT04481451|Ropivacaine|ropivacaine|mesh-list
64360167|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
64360168|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360169|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360170|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
64360171|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360172|NCT03376659|Bevacizumab|bevacizumab|mesh-list
64360173|NCT03376659|Durvalumab|durvalumab|mesh-list
64360174|NCT03376659|Capecitabine|capecitabine|mesh-list
64360175|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64360249|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360251|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64360252|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64360253|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
64360261|NCT03218137|Verapamil|verapamil|mesh-list
64360263|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
64360264|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360265|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360266|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64360267|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
64360268|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64360269|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
64360288|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64360289|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
64360290|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360291|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360292|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64360293|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360294|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
64360393|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64360394|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64360422|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64360423|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64360424|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64360425|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64360426|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360428|NCT02506777|Protective Agents|protective agents|mesh-ancestor
64360495|NCT02511067|Growth Substances|growth substances|mesh-ancestor
64360496|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360497|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
64360498|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360499|NCT02505841|Ropivacaine|ropivacaine|mesh-list
64360500|NCT02505841|Succinylcholine|succinylcholine|mesh-list
64360501|NCT02505841|Curare|curare|mesh-list
64360502|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
64360503|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
64360504|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360505|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360506|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
64360507|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360508|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64360509|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64360524|NCT04499989|Isoniazid|isoniazid|mesh-list
64360585|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
64360586|NCT03343873|Propofol|propofol|mesh-list
64360658|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360659|NCT02504359|Cytarabine|cytarabine|mesh-list
64360660|NCT02504359|Methotrexate|methotrexate|mesh-list
64360687|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64360688|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64360690|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360703|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64360800|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64360801|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360802|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64360803|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360804|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64360805|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360806|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360807|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64360808|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64360810|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64360811|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
64360842|NCT02508805|Tizanidine|tizanidine|mesh-list
64360843|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64360844|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64360846|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
64360847|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360848|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360849|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64360850|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64360851|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64360852|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360854|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
64638263|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64638264|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64638265|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
64638267|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
64638268|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64638269|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638270|NCT00210470|Zinc|zinc|mesh-list
64638272|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
64638273|NCT00210470|Omeprazole|omeprazole|mesh-list
64638274|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638275|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
64638276|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638277|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638278|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64638279|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
64638280|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360886|NCT02502565|Uric Acid|uric acid|mesh-list
64360887|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
64360888|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360889|NCT02502565|Protective Agents|protective agents|mesh-ancestor
64360890|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360891|NCT04498897|Acamprosate|acamprosate|mesh-list
64360892|NCT04498897|Vortioxetine|vortioxetine|mesh-list
64360893|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
64360894|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360895|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360896|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64360897|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360898|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360899|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64360910|NCT02502877|Midazolam|midazolam|mesh-list
64638281|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638282|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64638283|NCT00210470|Trace Elements|trace elements|mesh-ancestor
64638284|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
64638285|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64638286|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64638287|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64638288|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638289|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64638290|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64360991|NCT02507635|Levocetirizine|levocetirizine|mesh-list
64360992|NCT02507635|Desloratadine|desloratadine|mesh-list
64360993|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64360994|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64360995|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
64360996|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
64360997|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360999|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361000|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64361001|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
64361002|NCT04495933|Vaccines|vaccines|mesh-list
64361003|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64361004|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
64361005|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361025|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361026|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361028|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64361062|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64361088|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
64361089|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361090|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
64361091|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361092|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64361093|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361094|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64361194|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361195|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361196|NCT03120403|Analgesics|analgesics|mesh-ancestor
64361198|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361199|NCT03335293|Epinephrine|epinephrine|mesh-list
64361200|NCT03335293|Racepinephrine|racepinephrine|mesh-list
64361201|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
64361202|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64361203|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64361204|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361205|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361206|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361335|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361336|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361338|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361339|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64361340|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
64361341|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361342|NCT03342079|Analgesics|analgesics|mesh-ancestor
64361343|NCT04494763|Propranolol|propranolol|mesh-list
64361393|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64361394|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361395|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361396|NCT02491723|Azithromycin|azithromycin|mesh-list
64361397|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64361398|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361399|NCT03332719|Etanercept|etanercept|mesh-list
64361400|NCT03332719|Methotrexate|methotrexate|mesh-list
64361401|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64361499|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361500|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64361501|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64361502|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
64361503|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361504|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361505|NCT02488603|Tamoxifen|tamoxifen|mesh-list
64361506|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64361672|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361673|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64361674|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361675|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
64361676|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361677|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361678|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361682|NCT03322969|Paclitaxel|paclitaxel|mesh-list
64638291|NCT00210470|Analgesics|analgesics|mesh-ancestor
64638292|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
64638293|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638294|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64638295|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
64638296|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
64638297|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64638298|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64638299|NCT01108445|Everolimus|everolimus|mesh-list
64638300|NCT01108445|Sunitinib|sunitinib|mesh-list
64638301|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638302|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638303|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
64361773|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
64361774|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
64361775|NCT02487355|Bupivacaine|bupivacaine|mesh-list
64361776|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
64361777|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
64361778|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361779|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361780|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
64361797|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361798|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
64361799|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64361800|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361801|NCT01876953|Cytarabine|cytarabine|mesh-list
64361802|NCT01876953|Dasatinib|dasatinib|mesh-list
64361804|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64361805|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
64361806|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361807|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361808|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
64361811|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
64361812|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361813|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361814|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361815|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64361817|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64361818|NCT03321955|Ziconotide|ziconotide|mesh-list
64361819|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64361820|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64361849|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361850|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361854|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361855|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361856|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361857|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361859|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64361863|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638304|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638305|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64638306|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64638307|NCT01108445|Growth Substances|growth substances|mesh-ancestor
64638308|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
64638309|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64638310|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638311|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638312|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64362006|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362007|NCT01597479|Anesthetics|anesthetics|mesh-list
64362008|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
64362009|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
64362010|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362011|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362012|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
64362013|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362014|NCT03316963|Neostigmine|neostigmine|mesh-list
64362015|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64362016|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362017|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362018|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
64362019|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362020|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362021|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64362022|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
64362023|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362058|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
64362059|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362060|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64362061|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64362062|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64362063|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64362064|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64362073|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64362074|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64362075|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
64362077|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64638313|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64638314|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638315|NCT01108757|Renal Agents|renal agents|mesh-ancestor
64638316|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638317|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
64638318|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64638319|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64638320|NCT04352153|Febuxostat|febuxostat|mesh-list
64638321|NCT04352153|Citric Acid|citric acid|mesh-list
64638322|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
64638323|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64362078|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64362079|NCT05463367|Acetaminophen|acetaminophen|mesh-list
64362080|NCT05463367|Naproxen|naproxen|mesh-list
64362081|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64362082|NCT05463367|Oxymorphone|oxymorphone|mesh-list
64362083|NCT05463367|Morphine|morphine|mesh-list
64362084|NCT05463367|Oxycodone|oxycodone|mesh-list
64362087|NCT05463367|Codeine|codeine|mesh-list
64362088|NCT05463367|Levodopa|levodopa|mesh-list
64362089|NCT05463367|Carbidopa|carbidopa|mesh-list
64362090|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64362091|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64362092|NCT05463367|Narcotics|narcotics|mesh-ancestor
64362093|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362094|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362096|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
64362097|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362098|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64362099|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
64362100|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64362101|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362102|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64362103|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
64362104|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64362105|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362118|NCT02485873|Vitamin K|vitamin k|mesh-list
64362125|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64362129|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
64362130|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64362131|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64362132|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
64362133|NCT02485873|Coagulants|coagulants|mesh-ancestor
64362134|NCT04412421|Vitamins|vitamins|mesh-list
64362135|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
64362157|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362158|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
64362159|NCT02485249|Hormones|hormones|mesh-ancestor
64362168|NCT03320629|Apatinib|apatinib|mesh-list
64362230|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
64362231|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362232|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362233|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
64362234|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362235|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362236|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64362237|NCT02476825|Fluticasone|fluticasone|mesh-list
64362324|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362325|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64362327|NCT05196945|Clarithromycin|clarithromycin|mesh-list
64362328|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
64362329|NCT05196945|Esomeprazole|esomeprazole|mesh-list
64362330|NCT05196945|Bismuth|bismuth|mesh-list
64362331|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362332|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64362333|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362419|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64362420|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362421|NCT03885921|Atorvastatin|atorvastatin|mesh-list
64362422|NCT03885921|Simvastatin|simvastatin|mesh-list
64362423|NCT03885921|Ezetimibe|ezetimibe|mesh-list
64362424|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64362425|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64362426|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
64362427|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362430|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362586|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
64362610|NCT02474953|Analgesics|analgesics|mesh-ancestor
64362611|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
64362612|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362613|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362614|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362615|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64362617|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362742|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362743|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362745|NCT02474563|Bortezomib|bortezomib|mesh-list
64362746|NCT02474563|Melphalan|melphalan|mesh-list
64362747|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362748|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
64362749|NCT02474563|Hormones|hormones|mesh-ancestor
64362750|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638324|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
64638325|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
64638326|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638327|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
64638328|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638329|NCT05215067|Docetaxel|docetaxel|mesh-list
64638330|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638331|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638332|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638333|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
64638334|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638335|NCT01162733|Vancomycin|vancomycin|mesh-list
64638336|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638337|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638338|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
64638339|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
64638340|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638341|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
64638342|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638343|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638344|NCT05410860|Etripamil|etripamil|mesh-list
64638345|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64638346|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362781|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64362782|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
64362783|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362784|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362785|NCT03913845|Lidocaine|lidocaine|mesh-list
64362786|NCT03913845|Epinephrine|epinephrine|mesh-list
64362787|NCT03913845|Racepinephrine|racepinephrine|mesh-list
64362788|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
64362803|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362804|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64362805|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64362807|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64362808|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
64362809|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
64362810|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
64362811|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64362812|NCT00705523|Varenicline|varenicline|mesh-list
64362813|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64362814|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64362815|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
64362816|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362817|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362818|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362819|NCT03903939|Iloprost|iloprost|mesh-list
64362820|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64362821|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
64362822|NCT05676931|Docetaxel|docetaxel|mesh-list
64362823|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362824|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
64362825|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
64362826|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
64362827|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362828|NCT05065905|Interferons|interferons|mesh-list
64362829|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
64362830|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362831|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
64362832|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362901|NCT05061147|Azacitidine|azacitidine|mesh-list
64362902|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64362921|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362923|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362924|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
64362925|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362926|NCT04470843|Acetazolamide|acetazolamide|mesh-list
64362927|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
64363001|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64363002|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
64363003|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363004|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363005|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
64363006|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363007|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363053|NCT02470663|Calcium|calcium|mesh-list
64638347|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638348|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64638349|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638350|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
64638351|NCT01131065|Antibodies|antibodies|mesh-list
64638352|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
64638353|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64638354|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64363065|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363096|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64363097|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363098|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363099|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363100|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64363101|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64363102|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363103|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363104|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363105|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
64363106|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64363107|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64363108|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64363109|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64363111|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363126|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
64363127|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363128|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64363129|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64363130|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64363131|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363132|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363133|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64363134|NCT02864251|Carboplatin|carboplatin|mesh-list
64363135|NCT02864251|Nivolumab|nivolumab|mesh-list
64363136|NCT02864251|Pemetrexed|pemetrexed|mesh-list
64363137|NCT02864251|Ipilimumab|ipilimumab|mesh-list
64363138|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363139|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363142|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363143|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64363144|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64363145|NCT02757859|Pancrelipase|pancrelipase|mesh-list
64363146|NCT02757859|Pancreatin|pancreatin|mesh-list
64363147|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363148|NCT02468791|Rituximab|rituximab|mesh-list
64363149|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363218|NCT02299999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363219|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363220|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64363221|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64363222|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64363223|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64363224|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
64363225|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363226|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
64363355|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363356|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363379|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363380|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64363381|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
64363382|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
64363383|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
64363384|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64363385|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363386|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64363387|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64363388|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
64363389|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363390|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64363454|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
64363455|NCT03302299|Isoniazid|isoniazid|mesh-list
64363456|NCT03302299|Vitamins|vitamins|mesh-ancestor
64363457|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
64363458|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363459|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
64363460|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
64363462|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363464|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64363508|NCT03301207|Midazolam|midazolam|mesh-list
64363509|NCT03301207|Bupropion|bupropion|mesh-list
64363510|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
64363511|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64363512|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64363513|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64363514|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64363515|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638355|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
64638356|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638357|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64638358|NCT01165541|Mirtazapine|mirtazapine|mesh-list
64638359|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
64638360|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64638361|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64638362|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64638363|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363584|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
64363585|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64363586|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
64363587|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64363588|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
64363589|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
64363590|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363591|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363592|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363594|NCT03311425|Hormones|hormones|mesh-ancestor
64363662|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
64363663|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
64363664|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363665|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
64363666|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64363667|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64363668|NCT04791475|Analgesics|analgesics|mesh-ancestor
64363669|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64363670|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64363690|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363691|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363693|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363694|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363695|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64363754|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64363755|NCT02466919|Renal Agents|renal agents|mesh-ancestor
64363756|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64363757|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64363758|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363759|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64363760|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64363761|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363762|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64363763|NCT05727163|Leucovorin|leucovorin|mesh-list
64363764|NCT05727163|Dexamethasone|dexamethasone|mesh-list
64363765|NCT05727163|Anisodamine|anisodamine|mesh-list
64363766|NCT05727163|Bevacizumab|bevacizumab|mesh-list
64363767|NCT05727163|Fluorouracil|fluorouracil|mesh-list
64363768|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
64363769|NCT05727163|Irinotecan|irinotecan|mesh-list
64363770|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
64363771|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363772|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363773|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64363774|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64363818|NCT05302531|Amoxicillin|amoxicillin|mesh-list
64363819|NCT05302531|Levofloxacin|levofloxacin|mesh-list
64363820|NCT05302531|Ofloxacin|ofloxacin|mesh-list
64363821|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64363822|NCT05302531|Trimethoprim|trimethoprim|mesh-list
64363823|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
64363824|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64363825|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363826|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64363954|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64363955|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
64363956|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363957|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363958|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64363959|NCT02465749|Vitamins|vitamins|mesh-list
64363960|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
64363961|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364099|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64364100|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
64364101|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64364102|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364104|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64364105|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
64364106|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64364107|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
64364118|NCT03734653|Androgens|androgens|mesh-ancestor
64364120|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364162|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
64364163|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364164|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
64364165|NCT02973997|Lenvatinib|lenvatinib|mesh-list
64364166|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64364168|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64364169|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364170|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364172|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
64364173|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64364174|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64364194|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64364195|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
64364203|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364204|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364205|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
64364206|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364207|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364208|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64364209|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
64364211|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64364212|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64364219|NCT02713867|Nivolumab|nivolumab|mesh-list
64364342|NCT03371069|Methylphenidate|methylphenidate|mesh-list
64364343|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64364344|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364345|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64364346|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64364347|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364349|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
64364352|NCT03294577|Docetaxel|docetaxel|mesh-list
64364415|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64364446|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64364447|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64364448|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
64364449|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364450|NCT02460211|Vitamin D|vitamin d|mesh-list
64364451|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
64364452|NCT02460211|Vitamins|vitamins|mesh-ancestor
64364453|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
64364454|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364455|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64364557|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
64364558|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364559|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364560|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64364561|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64364562|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
64364563|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
64364564|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364593|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64364594|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64364595|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364596|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64364597|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364598|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364599|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64364601|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364694|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
64364695|NCT03363815|Coagulants|coagulants|mesh-ancestor
64364696|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364697|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64364698|NCT03363659|Copper|copper|mesh-list
64364699|NCT03363659|Temozolomide|temozolomide|mesh-list
64364700|NCT03363659|Disulfiram|disulfiram|mesh-list
64364702|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
64364703|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364743|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
64364783|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64364784|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364785|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
64364786|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
64364787|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
64364788|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364789|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364790|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
64364791|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364792|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364793|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64364794|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
64364795|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64364796|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64364797|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64364798|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64364799|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364800|NCT03298321|Azacitidine|azacitidine|mesh-list
64364802|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
64364803|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364804|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364805|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364806|NCT04527055|Metronidazole|metronidazole|mesh-list
64364807|NCT04527055|Tetracycline|tetracycline|mesh-list
64638364|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638365|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64638366|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
64638381|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638382|NCT04087460|Vaccines|vaccines|mesh-list
64638383|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64638384|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
64638385|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638386|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64638387|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64638388|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64638389|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64364859|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
64364860|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364861|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
64364862|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64364863|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
64364864|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364865|NCT04523675|Expectorants|expectorants|mesh-ancestor
64364866|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
64364867|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64364868|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
64364887|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64364888|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
64364889|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364890|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364891|NCT03297931|Iproplatin|iproplatin|mesh-list
64364892|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364893|NCT03284593|Azacitidine|azacitidine|mesh-list
64364894|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64638390|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638391|NCT04062656|Leucovorin|leucovorin|mesh-list
64638392|NCT04062656|Folic Acid|folic acid|mesh-list
64638393|NCT04062656|Docetaxel|docetaxel|mesh-list
64638394|NCT04062656|Fluorouracil|fluorouracil|mesh-list
64638395|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
64638396|NCT04062656|Nivolumab|nivolumab|mesh-list
64638397|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638398|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638399|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638400|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
64638401|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638402|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
64638403|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64638404|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638405|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
64364943|NCT02460055|Dexamethasone|dexamethasone|mesh-list
64364944|NCT02460055|Fentanyl|fentanyl|mesh-list
64364945|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
64364946|NCT02460055|Ondansetron|ondansetron|mesh-list
64364947|NCT02460055|Propofol|propofol|mesh-list
64364948|NCT02460055|Sevoflurane|sevoflurane|mesh-list
64364949|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64364950|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
64364951|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
64364952|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364953|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364954|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64364955|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
64364956|NCT02460055|Hormones|hormones|mesh-ancestor
64364957|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364958|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64364959|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364960|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64364961|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364962|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64364963|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
64364964|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
64364965|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64364966|NCT02460055|Narcotics|narcotics|mesh-ancestor
64364967|NCT02460055|Analgesics|analgesics|mesh-ancestor
64638406|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638407|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638408|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64638409|NCT04062656|Antidotes|antidotes|mesh-ancestor
64638410|NCT04062656|Protective Agents|protective agents|mesh-ancestor
64638411|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
64638423|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
64638424|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64638425|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638426|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638427|NCT00218426|Naltrexone|naltrexone|mesh-list
64638428|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64638429|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64638430|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638431|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
64364981|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64364982|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64364983|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
64365014|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365016|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64365017|NCT03282643|Tinzaparin|tinzaparin|mesh-list
64365018|NCT03282643|Dalteparin|dalteparin|mesh-list
64365019|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
64365020|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
64365021|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64365022|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64365023|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365024|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64365025|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
64365044|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
64365045|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
64365046|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64365047|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64365048|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64365049|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64365050|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365052|NCT03920527|Itraconazole|itraconazole|mesh-list
64365053|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
64365054|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365055|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64365056|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64365057|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365058|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365059|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64365060|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
64365061|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365063|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64365065|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64365066|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
64365132|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365133|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365134|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64365135|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64365136|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64365137|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64365138|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
64365139|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
64365172|NCT03365141|Tacrolimus|tacrolimus|mesh-list
64638432|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638433|NCT01134575|Rituximab|rituximab|mesh-list
64638434|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64638435|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638436|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638437|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
64638438|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638439|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638440|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64638441|NCT01790672|Ethanol|ethanol|mesh-list
64638442|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64638443|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638444|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638445|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638446|NCT00223262|Lamotrigine|lamotrigine|mesh-list
64638447|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
64638448|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64638449|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64365258|NCT03359057|Vitamins|vitamins|mesh-ancestor
64365259|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
64365260|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64365261|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64365262|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64365263|NCT02714569|Atorvastatin|atorvastatin|mesh-list
64365264|NCT02714569|Simvastatin|simvastatin|mesh-list
64365265|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64365266|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64365267|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
64365268|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365269|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64365270|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64365274|NCT04522037|Narcotics|narcotics|mesh-ancestor
64365275|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365276|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365277|NCT04522037|Analgesics|analgesics|mesh-ancestor
64365278|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
64365279|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365280|NCT03357653|Losartan|losartan|mesh-list
64365281|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64365282|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64365283|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64365284|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64365286|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64365292|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
64365293|NCT03357575|Protective Agents|protective agents|mesh-ancestor
64365331|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365332|NCT04444817|Tacrolimus|tacrolimus|mesh-list
64365333|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365334|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
64365364|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64365365|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365367|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64365368|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
64365399|NCT03263689|Morphine|morphine|mesh-list
64638450|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638451|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64638460|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
64638461|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638462|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638463|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64638464|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638465|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64638466|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64638467|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64638468|NCT00290810|Bevacizumab|bevacizumab|mesh-list
64638469|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64638470|NCT00290810|Antibodies|antibodies|mesh-list
64638471|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
64638472|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64638473|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638474|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64638475|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64638476|NCT00290810|Growth Substances|growth substances|mesh-ancestor
64638477|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638478|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
64365466|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
64365467|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64365468|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365469|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
64365470|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365471|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
64365472|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365473|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64365474|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365475|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64365476|NCT02458183|Vaccines|vaccines|mesh-list
64365477|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
64365478|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365479|NCT04444193|Durvalumab|durvalumab|mesh-list
64365480|NCT04444193|Lenvatinib|lenvatinib|mesh-list
64365481|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64365482|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64365483|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365484|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
64365485|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638479|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
64638480|NCT04042142|Glucagon|glucagon|mesh-list
64638481|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64638482|NCT04042142|Hormones|hormones|mesh-ancestor
64638483|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638484|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638485|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
64638486|NCT01138475|Vitamin D|vitamin d|mesh-list
64365521|NCT03353909|Protective Agents|protective agents|mesh-ancestor
64365523|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64365524|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365525|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64365526|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365528|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365529|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365530|NCT03263065|Psyllium|psyllium|mesh-list
64365531|NCT03263065|Cathartics|cathartics|mesh-ancestor
64365532|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64365533|NCT02518373|Omeprazole|omeprazole|mesh-list
64365534|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64365535|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64365536|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64365537|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365701|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365702|NCT03352115|Prednisolone|prednisolone|mesh-list
64365703|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365704|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
64365705|NCT03352115|Hormones|hormones|mesh-ancestor
64365706|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365707|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365708|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64365709|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638487|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64638488|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638489|NCT01138475|Vitamins|vitamins|mesh-ancestor
64638490|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
64638491|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64638492|NCT00293540|Tamoxifen|tamoxifen|mesh-list
64638493|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64638494|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
64638495|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638496|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365771|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64365791|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365792|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64365794|NCT04505657|Lidocaine|lidocaine|mesh-list
64365795|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365796|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
64365797|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365798|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365800|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365801|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64365802|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64365803|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64365804|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64365805|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365806|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64365807|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365808|NCT04505657|Analgesics|analgesics|mesh-ancestor
64365809|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365810|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365811|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64365812|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64365813|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365814|NCT03259243|Bupivacaine|bupivacaine|mesh-list
64365815|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365816|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
64365817|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365818|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365819|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
64365820|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365822|NCT03517969|Docetaxel|docetaxel|mesh-list
64365826|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
64365857|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
64365858|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365859|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64365860|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
64365861|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
64365862|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64365863|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
64365866|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64365867|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
64365868|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64365869|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
64365902|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365903|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
64365904|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
64638497|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64638498|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638499|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64638500|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64638501|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64638502|NCT03012113|Mirabegron|mirabegron|mesh-list
64638503|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64638504|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64638505|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64638506|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638507|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638508|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638526|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638527|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64638528|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64638529|NCT00294632|Growth Substances|growth substances|mesh-ancestor
64638530|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
64638532|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64638533|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64638534|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64638535|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638536|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638537|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638538|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638539|NCT01898624|Urological Agents|urological agents|mesh-ancestor
64638540|NCT01140191|Gentamicins|gentamicins|mesh-list
64638541|NCT01140191|Paromomycin|paromomycin|mesh-list
64638542|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64366038|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
64366070|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64366071|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366072|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366075|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366165|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366166|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64366167|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
64366168|NCT04487587|Olaparib|olaparib|mesh-list
64366169|NCT04487587|Cediranib|cediranib|mesh-list
64366170|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64366171|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366172|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366173|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366174|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64366176|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64366177|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64366178|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366180|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64366181|NCT02454751|Narcotics|narcotics|mesh-ancestor
64366208|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64366209|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366210|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64366211|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
64366213|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
64366254|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64366255|NCT04502849|Vitamin E|vitamin e|mesh-list
64366256|NCT04502849|Tocopherols|tocopherols|mesh-list
64366257|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
64366258|NCT04502849|Vitamins|vitamins|mesh-ancestor
64366259|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
64366260|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366261|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
64366262|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366263|NCT04502849|Protective Agents|protective agents|mesh-ancestor
64366322|NCT03245671|Hormones|hormones|mesh-ancestor
64366323|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366324|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64366325|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366326|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
64366327|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366328|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366428|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
64366430|NCT02516423|Lenalidomide|lenalidomide|mesh-list
64366431|NCT02516423|Ixazomib|ixazomib|mesh-list
64366432|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64366433|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
64366434|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
64366435|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366436|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366437|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366438|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
64366439|NCT02516423|Hormones|hormones|mesh-ancestor
64366440|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366441|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64366442|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366443|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
64366444|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64366445|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64366494|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64366495|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366496|NCT03239353|Entecavir|entecavir|mesh-list
64366497|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
64366498|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366499|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
64366539|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64366540|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64366541|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366542|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64366695|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64366696|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64366697|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
64366698|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64366699|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64366700|NCT03235141|Azithromycin|azithromycin|mesh-list
64366701|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64366702|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638543|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638544|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64638545|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638546|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638547|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64638548|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64638549|NCT01141049|Gabapentin|gabapentin|mesh-list
64638550|NCT01141049|Analgesics|analgesics|mesh-ancestor
64638551|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
64638565|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64638566|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64638567|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363838|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64638568|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638569|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64638570|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638571|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
64638572|NCT04391309|Remdesivir|remdesivir|mesh-list
64638573|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
64638574|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638575|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
64366795|NCT02515565|Erythromycin|erythromycin|mesh-list
64366796|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
64366797|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64366798|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
64366799|NCT02515565|Cephalosporins|cephalosporins|mesh-list
64366800|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64366801|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366802|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366803|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64366804|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366805|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366806|NCT05600075|Insulin|insulin|mesh-list
64366807|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64366808|NCT05600075|Glycolic acid|glycolic acid|mesh-list
64366857|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
64366887|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638576|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638577|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
64638578|NCT01167569|Vitamins|vitamins|mesh-ancestor
64638579|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
64638580|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638581|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
64638582|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638583|NCT01167569|Protective Agents|protective agents|mesh-ancestor
64366988|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366989|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64367010|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367021|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
64367022|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
64367023|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367024|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367025|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64367026|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64367027|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64367028|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367029|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367030|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367031|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64367032|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64367033|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367034|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
64367035|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
64367036|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64367037|NCT03236623|Menthol|menthol|mesh-list
64367076|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367077|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367078|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367081|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
64367082|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367169|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367170|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367171|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64367173|NCT02501603|Afatinib|afatinib|mesh-list
64367174|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64367183|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367207|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
64367208|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367210|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64367221|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64367222|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367345|NCT05504057|Amantadine|amantadine|mesh-list
64367346|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
64367347|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64367348|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64367349|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64367350|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
64367552|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367553|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64367554|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64367555|NCT05035485|Phenylephrine|phenylephrine|mesh-list
64367556|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
64367557|NCT05035485|Norepinephrine|norepinephrine|mesh-list
64367558|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64367559|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64367560|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
64367561|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
64367562|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367563|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367564|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
64367565|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
64367637|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
64367822|NCT02496299|Bupivacaine|bupivacaine|mesh-list
64367823|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367824|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
64367826|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367827|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367872|NCT03337607|Celecoxib|celecoxib|mesh-list
64367902|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367905|NCT03336437|Estrogens|estrogens|mesh-ancestor
64367906|NCT03336437|Hormones|hormones|mesh-ancestor
64367909|NCT03337373|Cisatracurium|cisatracurium|mesh-list
64368097|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368098|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
64368130|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
64368131|NCT03329261|Clopidogrel|clopidogrel|mesh-list
64368132|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64368133|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64368134|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64368135|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64368136|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
64368137|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368138|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368139|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368170|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64368171|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
64368279|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368280|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368281|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64368282|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64368284|NCT05024877|Androgens|androgens|mesh-ancestor
64368285|NCT05024877|Hormones|hormones|mesh-ancestor
64368313|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64368314|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64368316|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
64368317|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
64368318|NCT05464433|Analgesics|analgesics|mesh-ancestor
64368319|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
64368320|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368321|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368466|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
64368467|NCT03331523|Calcipotriene|calcipotriene|mesh-list
64368493|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368494|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64368495|NCT05463809|Narcotics|narcotics|mesh-ancestor
64368496|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
64368497|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64368498|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
64368508|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
64638584|NCT00296192|Rotigotine|rotigotine|mesh-list
64638585|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
64638586|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
64638587|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638588|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638594|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638595|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638596|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64638597|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638598|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638600|NCT00297596|Trastuzumab|trastuzumab|mesh-list
64638601|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638602|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638603|NCT00298610|Artesunate|artesunate|mesh-list
64638604|NCT00298610|Atovaquone|atovaquone|mesh-list
64638605|NCT00298610|Proguanil|proguanil|mesh-list
64638606|NCT00298610|Quinidine|quinidine|mesh-list
64638607|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64638608|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
64638609|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64638610|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64638611|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638612|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638613|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
64638614|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
64638615|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64638616|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
64638617|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638618|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638619|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
64368696|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64368697|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368698|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368699|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368700|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64368797|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64368798|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
64368799|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368800|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368804|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368805|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64368806|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64368807|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64368808|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64368809|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64368815|NCT03320447|Prilocaine|prilocaine|mesh-list
64638620|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64638621|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64638622|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638623|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638624|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638626|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64638627|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64638629|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64638630|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64638631|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64638632|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64638633|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64638634|NCT01144949|Silodosin|silodosin|mesh-list
64638635|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64638636|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64638637|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64638638|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638639|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638640|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638641|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638642|NCT01144949|Urological Agents|urological agents|mesh-ancestor
64638643|NCT00215930|Gemcitabine|gemcitabine|mesh-list
64638644|NCT00215930|Carboplatin|carboplatin|mesh-list
64638653|NCT00215930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638654|NCT00215930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638655|NCT00215930|Immunologic Factors|immunologic factors|mesh-ancestor
64368906|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368907|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64368942|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
64369058|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
64369059|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369060|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64369061|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369068|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369069|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369070|NCT02487407|Protective Agents|protective agents|mesh-ancestor
64369071|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369267|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64369533|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369534|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369535|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64369536|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369537|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64369538|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64369539|NCT03204331|Norethindrone|norethindrone|mesh-list
64369540|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
64369695|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369696|NCT03220009|Nivolumab|nivolumab|mesh-list
64369697|NCT03220009|Ipilimumab|ipilimumab|mesh-list
64369698|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369699|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369700|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64369701|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369737|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369738|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
64369739|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638656|NCT00215930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638657|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638658|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638659|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
64638660|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64638661|NCT01145183|Doxazosin|doxazosin|mesh-list
64638662|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64638663|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64638664|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64638665|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64638666|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638667|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638668|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638669|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638670|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64638671|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638672|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64369883|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369885|NCT02484053|Rituximab|rituximab|mesh-list
64369886|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369887|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369888|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
64369889|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369890|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369918|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369919|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64369920|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64369921|NCT01374919|Hematinics|hematinics|mesh-ancestor
64369922|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64369923|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64369924|NCT03202615|Lactoferrin|lactoferrin|mesh-list
64369925|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369926|NCT03202459|Pregabalin|pregabalin|mesh-list
64369927|NCT03202459|Gabapentin|gabapentin|mesh-list
64369928|NCT03202459|Analgesics|analgesics|mesh-ancestor
64369929|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
64369930|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369978|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
64369979|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369980|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64369981|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64369982|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64369983|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64369984|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369985|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64369986|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64369987|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64369988|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64370022|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
64370124|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64370125|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64370129|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
64370130|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370189|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370190|NCT03201835|Analgesics|analgesics|mesh-ancestor
64370191|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
64370192|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370193|NCT02478515|Ranibizumab|ranibizumab|mesh-list
64370194|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64370195|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64370196|NCT02478515|Growth Substances|growth substances|mesh-ancestor
64370198|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
64370352|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64370353|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64370354|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64370355|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370376|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64370377|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64370380|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370381|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370382|NCT03195673|Urological Agents|urological agents|mesh-ancestor
64370383|NCT02481791|Remifentanil|remifentanil|mesh-list
64370385|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64370386|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370387|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370390|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
64370601|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370602|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64370603|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64370604|NCT02446795|Growth Substances|growth substances|mesh-ancestor
64370605|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370607|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64370608|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370609|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370610|NCT02477267|Buprenorphine|buprenorphine|mesh-list
64370611|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64370725|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64370726|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370728|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370729|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370731|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64370732|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64370733|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370734|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
64638673|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638674|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638675|NCT04128722|Sirolimus|sirolimus|mesh-list
64638676|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638677|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638678|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64638679|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638680|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
64638681|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64638682|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
64638683|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638684|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
64638685|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
64638686|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64638687|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64638688|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638689|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638690|NCT01169519|Urological Agents|urological agents|mesh-ancestor
64370955|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64370956|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64370957|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370993|NCT03108989|Neostigmine|neostigmine|mesh-list
64370994|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64370995|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370996|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370997|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
64370998|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370999|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371000|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64371020|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371021|NCT02470559|Aldesleukin|aldesleukin|mesh-list
64371022|NCT02470559|Interleukin-2|interleukin-2|mesh-list
64371023|NCT02470559|Sargramostim|sargramostim|mesh-list
64371024|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64371025|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371026|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64371027|NCT02470559|Analgesics|analgesics|mesh-ancestor
64371028|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
64296082|NCT04490967|Silybin|silybin|mesh-list
64296083|NCT04490967|Silymarin|silymarin|mesh-list
64296084|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
64296092|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64296093|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296094|NCT04490967|Analgesics|analgesics|mesh-ancestor
64296095|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
64638691|NCT04071977|Antioxidants|antioxidants|mesh-list
64638692|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638693|NCT04071977|Protective Agents|protective agents|mesh-ancestor
64638694|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638695|NCT02101190|Opicapone|opicapone|mesh-list
64638696|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64638697|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638703|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64638704|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64638705|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64638706|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638707|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638709|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64638710|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64638711|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638712|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638713|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638714|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638715|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64638716|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64638717|NCT03011645|Ziprasidone|ziprasidone|mesh-list
64363986|NCT04927975|Upadacitinib|upadacitinib|mesh-list
64638718|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64638719|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
64638720|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638721|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638722|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638723|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64638724|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64638725|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638726|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64638727|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64638728|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
64296096|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296097|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64296098|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296099|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64296100|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296102|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296103|NCT04214834|Morphine|morphine|mesh-list
64296104|NCT04214834|Methadone|methadone|mesh-list
64296105|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64296106|NCT04214834|Narcotics|narcotics|mesh-ancestor
64296107|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296108|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296109|NCT04214834|Analgesics|analgesics|mesh-ancestor
64296110|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
64296114|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64296115|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
64296116|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296117|NCT03312777|Tramadol|tramadol|mesh-list
64296118|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64296119|NCT03312777|Narcotics|narcotics|mesh-ancestor
64296120|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296121|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296122|NCT03312777|Analgesics|analgesics|mesh-ancestor
64296123|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
64296126|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
64296127|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296135|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64296136|NCT03738878|Substance P|substance p|mesh-list
64296137|NCT03738878|Neurokinin A|neurokinin a|mesh-list
64296138|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64296139|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296140|NCT03738878|Incretins|incretins|mesh-ancestor
64296141|NCT03738878|Hormones|hormones|mesh-ancestor
64296142|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296178|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296179|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296180|NCT01506986|Metronidazole|metronidazole|mesh-list
64296181|NCT01506986|Clarithromycin|clarithromycin|mesh-list
64296182|NCT01506986|Lansoprazole|lansoprazole|mesh-list
64296185|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64296186|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64296187|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64296188|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64296189|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296198|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64296199|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64296200|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64296201|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296202|NCT02714894|Clozapine|clozapine|mesh-list
64296203|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64296204|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
64296205|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296206|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296207|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296208|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64296255|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296256|NCT03308955|Analgesics|analgesics|mesh-ancestor
64296257|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
64296258|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296259|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64296260|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
64296261|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296262|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64296263|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64296264|NCT03308643|Oxytocin|oxytocin|mesh-list
64296265|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
64296266|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64638729|NCT01149785|Ketoconazole|ketoconazole|mesh-list
64638730|NCT01149785|Crizotinib|crizotinib|mesh-list
64638731|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
64638732|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638733|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64638734|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64638735|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638736|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638737|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64638738|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
64638739|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638740|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638741|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64638742|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638743|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64638744|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64638745|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638746|NCT03011567|Acetaminophen|acetaminophen|mesh-list
64638747|NCT03011567|Ibuprofen|ibuprofen|mesh-list
64638748|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296288|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64296289|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64296291|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64296292|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
64296293|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296294|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296295|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64296296|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64296298|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296299|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638750|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
64638751|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638752|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638753|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
64638757|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64638758|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638759|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638760|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
64638761|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
64638762|NCT01173029|Diuretics|diuretics|mesh-list
64638763|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64638764|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64638765|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
64638766|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64638767|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64638768|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638769|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
64638770|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638771|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
64296302|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
64296303|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296304|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296305|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64296306|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
64296308|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64296309|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64296310|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64296311|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64296312|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
64296313|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296314|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296315|NCT03308253|Vancomycin|vancomycin|mesh-list
64296323|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
64296325|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296326|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
64296327|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296328|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64296350|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
64296351|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296352|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64296353|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64296355|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296358|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64296360|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64296370|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64296371|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64296372|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64296393|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64296394|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638772|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638773|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64638774|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
64638775|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638776|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64638777|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
64638778|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64638779|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64297883|NCT02069665|Expectorants|expectorants|mesh-ancestor
64638780|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64638782|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638783|NCT01151813|Varenicline|varenicline|mesh-list
64638784|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64638785|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64638786|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
64638787|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638788|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638789|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638790|NCT03877991|Cannabidiol|cannabidiol|mesh-list
64638791|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
64638792|NCT03835949|Atezolizumab|atezolizumab|mesh-list
64638793|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638794|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
64638795|NCT03660683|Saxagliptin|saxagliptin|mesh-list
64638796|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64638797|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638799|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638801|NCT03660683|Hormones|hormones|mesh-ancestor
64638809|NCT01179113|Esmolol|esmolol|mesh-list
64298352|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298521|NCT02079727|Celecoxib|celecoxib|mesh-list
64298720|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64298721|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
64298722|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298723|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64298787|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
64298820|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64298822|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
64298823|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298825|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64638810|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64638811|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64638812|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64638813|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64638814|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638815|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638816|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638817|NCT01152515|Remifentanil|remifentanil|mesh-list
64638818|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64638819|NCT01152515|Narcotics|narcotics|mesh-ancestor
64638820|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638821|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638822|NCT01152515|Analgesics|analgesics|mesh-ancestor
64638823|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
64638824|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638825|NCT03011177|Linagliptin|linagliptin|mesh-list
64299137|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64299392|NCT02439970|Brincidofovir|brincidofovir|mesh-list
64299393|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
64299394|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299891|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64299892|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64299894|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
64299895|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64299896|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64299897|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64638839|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64638840|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638841|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64638842|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638843|NCT03418805|Ibuprofen|ibuprofen|mesh-list
64638844|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64638845|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64638846|NCT03418805|Analgesics|analgesics|mesh-ancestor
64638847|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
64638848|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638849|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638850|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64638851|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638852|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64638853|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638854|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446243|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64446245|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446246|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446247|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64446248|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446249|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
64446250|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64446251|NCT01920711|Valsartan|valsartan|mesh-list
64446252|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64446253|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64446256|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446257|NCT02180438|Tenofovir|tenofovir|mesh-list
64446258|NCT02180438|Emtricitabine|emtricitabine|mesh-list
64446259|NCT02180438|Cobicistat|cobicistat|mesh-list
64446260|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64446261|NCT02180438|Elvitegravir|elvitegravir|mesh-list
64446262|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
64446263|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446264|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64446265|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64446266|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446267|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446268|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64446269|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64446272|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64446286|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64446287|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
64446288|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
64446289|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446290|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64446291|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64446292|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446293|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446294|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64446295|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64446296|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64446297|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64638855|NCT01156571|Clopidogrel|clopidogrel|mesh-list
64638856|NCT01156571|Cangrelor|cangrelor|mesh-list
64638857|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64638858|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64638859|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64638860|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64638861|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
64638862|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638863|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638864|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638865|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
64638866|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64638867|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
64638868|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638869|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638870|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64638871|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446298|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64446299|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
64446301|NCT02156804|Nivolumab|nivolumab|mesh-list
64446302|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64446303|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446304|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64446305|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638872|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64638873|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
64638877|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
64638878|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
64638879|NCT01220687|Protective Agents|protective agents|mesh-ancestor
64638880|NCT03010865|Butyric Acid|butyric acid|mesh-list
64638881|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
64638882|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
64638883|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638884|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638885|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638886|NCT01157429|Cycloserine|cycloserine|mesh-list
64638887|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64638888|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64638889|NCT01157429|Renal Agents|renal agents|mesh-ancestor
64638890|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64446312|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446313|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64446314|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64446316|NCT04753970|Cilostazol|cilostazol|mesh-list
64446317|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64446318|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
64446319|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446320|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446321|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64446322|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446323|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64446324|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64446325|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446326|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64446327|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
64446328|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64446329|NCT04753970|Protective Agents|protective agents|mesh-ancestor
64446335|NCT04641195|Vitamin D|vitamin d|mesh-list
64446336|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
64446337|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
64446342|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64446343|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64446344|NCT04641195|Trace Elements|trace elements|mesh-ancestor
64446345|NCT02213042|Trastuzumab|trastuzumab|mesh-list
64446346|NCT02213042|Lapatinib|lapatinib|mesh-list
64446347|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64446348|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64446349|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446350|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64446351|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446352|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446353|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64446358|NCT04418180|Fenofibrate|fenofibrate|mesh-list
64638891|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
64638892|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64638893|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
64638894|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638895|NCT00234884|Adalimumab|adalimumab|mesh-list
64638896|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64638897|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638898|NCT04388774|Ketamine|ketamine|mesh-list
64638899|NCT04388774|Analgesics|analgesics|mesh-ancestor
64638900|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
64638901|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638902|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638903|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64638904|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64638905|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
64638906|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
64446397|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
64446398|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446399|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446400|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446401|NCT01557244|Urological Agents|urological agents|mesh-ancestor
64446402|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
64446403|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
64446412|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446413|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
64446414|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446415|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
64446416|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446417|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64446418|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64446419|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64446420|NCT02209454|Analgesics|analgesics|mesh-ancestor
64446421|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
64446422|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446423|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446424|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446425|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446426|NCT01557166|Liraglutide|liraglutide|mesh-list
64446427|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64638907|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638908|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64638909|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64638910|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64638911|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638912|NCT01602666|Carboplatin|carboplatin|mesh-list
64638913|NCT01602666|Etoposide|etoposide|mesh-list
64638914|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
64638915|NCT01602666|Ifosfamide|ifosfamide|mesh-list
64638916|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
64638917|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
64638921|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64638922|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638923|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638924|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64638925|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
64638926|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
64638927|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
64638928|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638929|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638930|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
64638931|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64446429|NCT01557166|Incretins|incretins|mesh-ancestor
64446430|NCT01557166|Hormones|hormones|mesh-ancestor
64446431|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446432|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
64446433|NCT01556932|Promethazine|promethazine|mesh-list
64446434|NCT01556932|Lorazepam|lorazepam|mesh-list
64446435|NCT01556932|Haloperidol|haloperidol|mesh-list
64446436|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64446437|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64446438|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446439|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446440|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
64446441|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
64446442|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
64446443|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446444|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
64446445|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
64446446|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64446447|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64446448|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
64446449|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
64446468|NCT02985736|Hormones|hormones|mesh-ancestor
64446489|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64446492|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64446493|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446494|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
64446495|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446496|NCT01571362|Naltrexone|naltrexone|mesh-list
64446497|NCT01571362|Oxycodone|oxycodone|mesh-list
64446498|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64446499|NCT01571362|Narcotics|narcotics|mesh-ancestor
64446500|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446501|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446502|NCT01571362|Analgesics|analgesics|mesh-ancestor
64446503|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
64446505|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64638932|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638933|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64638934|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638935|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638936|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
64638937|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64638938|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64638939|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638941|NCT05441592|Coagulants|coagulants|mesh-ancestor
64638942|NCT05415462|Vaccines|vaccines|mesh-list
64638943|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
64638944|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638945|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64638946|NCT00300482|Calcium|calcium|mesh-list
64638947|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64638948|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638949|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64638950|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64638951|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
64638952|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446522|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64446524|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446525|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446526|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64446527|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446528|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64446529|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64446530|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64446531|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
64446532|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446533|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446535|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446536|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446537|NCT01530334|Gefitinib|gefitinib|mesh-list
64446538|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446539|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64446540|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446541|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446542|NCT01570192|Vancomycin|vancomycin|mesh-list
64446543|NCT01570192|Gentamicins|gentamicins|mesh-list
64446544|NCT01570192|Meropenem|meropenem|mesh-list
64446545|NCT01570192|Linezolid|linezolid|mesh-list
64446546|NCT01570192|Tobramycin|tobramycin|mesh-list
64446548|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64446569|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64446570|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
64446571|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446572|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446573|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446575|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64446576|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446577|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
64446578|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446579|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446604|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446605|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
64446606|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64446608|NCT01518244|Brinzolamide|brinzolamide|mesh-list
64446609|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446610|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446611|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64446612|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64446613|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
64446614|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446642|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446643|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446644|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64446645|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446646|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64446647|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
64446648|NCT02174276|Tenofovir|tenofovir|mesh-list
64446649|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
64446675|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446676|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
64446677|NCT01516216|Vitamins|vitamins|mesh-ancestor
64446678|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
64446679|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64446680|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
64446681|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446682|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64446683|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446684|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
64446685|NCT01516216|Antidotes|antidotes|mesh-ancestor
64446686|NCT01516216|Protective Agents|protective agents|mesh-ancestor
64446687|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
64446688|NCT01950819|Cyclosporine|cyclosporine|mesh-list
64446690|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
64446691|NCT01950819|Tacrolimus|tacrolimus|mesh-list
64446692|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
64446693|NCT01950819|Cyclosporins|cyclosporins|mesh-list
64446694|NCT01950819|Basiliximab|basiliximab|mesh-list
64446695|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446696|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
64446697|NCT01950819|Hormones|hormones|mesh-ancestor
64446698|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446699|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446700|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64446701|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446702|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
64446703|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
64446704|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446705|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64446706|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64446707|NCT01950819|Protective Agents|protective agents|mesh-ancestor
64446708|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446709|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
64446710|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64446711|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446712|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638953|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64638954|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64638955|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638956|NCT05439876|Melatonin|melatonin|mesh-list
64638957|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
64638958|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638959|NCT05439876|Protective Agents|protective agents|mesh-ancestor
64638960|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303101|NCT02455869|Alendronate|alendronate|mesh-list
64638961|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638963|NCT00301028|Carboplatin|carboplatin|mesh-list
64638964|NCT00301028|Cetuximab|cetuximab|mesh-list
64638965|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64638966|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638967|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
64638968|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
64638969|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
64446721|NCT01524796|Analgesics|analgesics|mesh-ancestor
64446722|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
64446723|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446724|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446725|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
64446726|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64446727|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64446728|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446729|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64446730|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64446731|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64446732|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446733|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64446734|NCT01547728|Antithrombins|antithrombins|mesh-list
64446735|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
64446736|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64446737|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
64446738|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446739|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446740|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
64446741|NCT01523392|Clopidogrel|clopidogrel|mesh-list
64446742|NCT01523392|Ticagrelor|ticagrelor|mesh-list
64446743|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64446744|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64446745|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64446746|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64446747|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
64638970|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638971|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638972|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64638973|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638974|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64638986|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
64638987|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64638988|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64638989|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64638990|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64638991|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64638992|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64638993|NCT05414214|Anesthetics|anesthetics|mesh-list
64638994|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638995|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64638996|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
64638997|NCT05014230|Narcotics|narcotics|mesh-ancestor
64446761|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446762|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446763|NCT01950741|Aflibercept|aflibercept|mesh-list
64446764|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64446765|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64446766|NCT01950741|Growth Substances|growth substances|mesh-ancestor
64446767|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446768|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
64446769|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446770|NCT01950273|Rituximab|rituximab|mesh-list
64446771|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64638998|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64638999|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639000|NCT05014230|Analgesics|analgesics|mesh-ancestor
64639001|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
64639002|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639003|NCT01896284|Aflibercept|aflibercept|mesh-list
64639004|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64639005|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64639006|NCT01896284|Growth Substances|growth substances|mesh-ancestor
64639007|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639008|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
64639009|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639010|NCT05438160|Coal Tar|coal tar|mesh-list
64639011|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
64446772|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446773|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
64446774|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446775|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446777|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446778|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64446779|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64446780|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446781|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446782|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64446783|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
64446784|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446791|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446793|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64446794|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446795|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64446796|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446797|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446798|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
64446799|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64446800|NCT01510912|Diclofenac|diclofenac|mesh-list
64446801|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64446802|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64446808|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446809|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64446810|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446811|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639012|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
64639013|NCT03954990|Metronidazole|metronidazole|mesh-list
64639015|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64639016|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64639017|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64639018|NCT01478581|Dexamethasone|dexamethasone|mesh-list
64639019|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639020|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
64639021|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
64639022|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639023|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639024|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639025|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
64639026|NCT01478581|Hormones|hormones|mesh-ancestor
64639027|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639028|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64639029|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639051|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64639052|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64639053|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64639054|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
64639055|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639056|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639057|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639058|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64639059|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64639060|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
64446815|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446816|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446817|NCT01522456|Tretinoin|tretinoin|mesh-list
64446818|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
64446819|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446820|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
64446821|NCT01521364|Clarithromycin|clarithromycin|mesh-list
64446833|NCT01545388|Incretins|incretins|mesh-ancestor
64446835|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446836|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64446837|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
64446838|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446843|NCT01544920|Interferons|interferons|mesh-list
64446845|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
64446846|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
64446847|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64446848|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446849|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
64446850|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446851|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
64639061|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
64639062|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
64639069|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
64639070|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64639071|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639072|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639073|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639074|NCT01791296|Analgesics|analgesics|mesh-ancestor
64639075|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
64639076|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639077|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64639078|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64639079|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64639080|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
64639081|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639082|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446852|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446853|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
64446854|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446855|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64446856|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
64446857|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
64446858|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446859|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
64446860|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446862|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64446863|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64446864|NCT01543204|Analgesics|analgesics|mesh-ancestor
64446865|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
64639083|NCT01479127|Silicon|silicon|mesh-list
64639084|NCT01479127|Levodopa|levodopa|mesh-list
64639085|NCT01479127|Carbidopa|carbidopa|mesh-list
64639086|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64639087|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64639088|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
64639089|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639090|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639091|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639092|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64639093|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639094|NCT01479127|Trace Elements|trace elements|mesh-ancestor
64639095|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
64639096|NCT03917966|Docetaxel|docetaxel|mesh-list
64639097|NCT03917966|Apatinib|apatinib|mesh-list
64639098|NCT03917966|Nedaplatin|nedaplatin|mesh-list
64639099|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639100|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
64639101|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
64639102|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
64639103|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639104|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64639105|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639106|NCT00243152|Lamotrigine|lamotrigine|mesh-list
64639107|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
64639108|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64639109|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64639110|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639111|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64639112|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639113|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64639114|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64639115|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639116|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64639117|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64639118|NCT01453075|Valacyclovir|valacyclovir|mesh-list
64639119|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
64639120|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639121|NCT01791374|Rilotumumab|rilotumumab|mesh-list
64639122|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64639123|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639124|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639131|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639132|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
64639133|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64639134|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64639136|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
64639137|NCT00248534|Rituximab|rituximab|mesh-list
64639138|NCT00248534|Temozolomide|temozolomide|mesh-list
64446878|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64446879|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64446880|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64446881|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64446882|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
64446883|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639139|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64639140|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
64639141|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639142|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639143|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
64639144|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639145|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639146|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64639147|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
64639148|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639149|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639150|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
64639151|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
64639152|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639153|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639154|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
64639155|NCT00248534|Hormones|hormones|mesh-ancestor
64639156|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639157|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64639158|NCT00248534|Protective Agents|protective agents|mesh-ancestor
64639159|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64639160|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64639161|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64639162|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64446900|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446901|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446903|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64446904|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
64639163|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64639164|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639166|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639167|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64639168|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
64639169|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64639170|NCT05266820|Thalidomide|thalidomide|mesh-list
64639171|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639172|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
64639173|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639174|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
64639175|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64639176|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446971|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
64446972|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446984|NCT01948791|Rivastigmine|rivastigmine|mesh-list
64446985|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64446986|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446987|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446988|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
64446989|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446990|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447002|NCT01947855|Empagliflozin|empagliflozin|mesh-list
64447003|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64447004|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447005|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447006|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447007|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
64447008|NCT01888497|Promethazine|promethazine|mesh-list
64447009|NCT01888497|Triazolam|triazolam|mesh-list
64639179|NCT05266820|Growth Substances|growth substances|mesh-ancestor
64639180|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
64639181|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639182|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
64639183|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
64639185|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64639186|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639187|NCT01454791|Analgesics|analgesics|mesh-ancestor
64639188|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
64447069|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447070|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64447071|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
64447072|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447073|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447074|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64447075|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64447076|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64447077|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64447078|NCT01946529|Growth Substances|growth substances|mesh-ancestor
64447079|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
64447080|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64447081|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64447082|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64447089|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64447090|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447091|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
64447093|NCT01463098|Lemborexant|lemborexant|mesh-list
64447094|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64447095|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64447096|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447097|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447099|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
64447100|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
64447101|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447102|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447103|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64447104|NCT01462942|Bromides|bromides|mesh-list
64447105|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
64447106|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64447107|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
64447108|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447109|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639189|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639190|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639191|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639192|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639193|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64639194|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639195|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447919|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447921|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64639197|NCT02099006|Ketamine|ketamine|mesh-list
64639198|NCT02099006|Gabapentin|gabapentin|mesh-list
64639199|NCT02099006|Amitriptyline|amitriptyline|mesh-list
64639200|NCT02099006|Baclofen|baclofen|mesh-list
64639201|NCT02099006|Loperamide|loperamide|mesh-list
64639202|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
64639203|NCT02099006|Analgesics|analgesics|mesh-ancestor
64639204|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
64639205|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639206|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448754|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64449952|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64449953|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
64449954|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64450239|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64450240|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450256|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450257|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
64450366|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
64450367|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450374|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
64450375|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450376|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64450377|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64450378|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64450379|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450380|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450381|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
64450499|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64450500|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
64450501|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
64450504|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450505|NCT02151461|Metformin|metformin|mesh-list
64450506|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450507|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450508|NCT02091986|Budesonide|budesonide|mesh-list
64450509|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64450521|NCT02117024|Paclitaxel|paclitaxel|mesh-list
64452018|NCT02024971|Metformin|metformin|mesh-list
64639207|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64639208|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64639209|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
64639210|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
64639211|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639212|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64639213|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64639214|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452981|NCT02073929|Liraglutide|liraglutide|mesh-list
64453290|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453292|NCT01471054|Hormones|hormones|mesh-ancestor
64453293|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453294|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64453295|NCT01978184|Gemcitabine|gemcitabine|mesh-list
64453296|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
64453297|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64453299|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
64639215|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639216|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
64639217|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64639218|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64639219|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64639220|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
64639221|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64639222|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64639223|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64639224|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
64639225|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
64639226|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64639227|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639228|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639229|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639230|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64639231|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639232|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64639233|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
64639234|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64639235|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64639245|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
64639246|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639247|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639248|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639249|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
64639250|NCT05266196|Topotecan|topotecan|mesh-list
64639251|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639252|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
64639253|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639254|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639255|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64639256|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
64639257|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639258|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639259|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64639260|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64639261|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64639262|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639263|NCT05265962|Decitabine|decitabine|mesh-list
64639264|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64639265|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
64639266|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639267|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639268|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639269|NCT00324896|Eszopiclone|eszopiclone|mesh-list
64639270|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64639271|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639272|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639273|NCT01479517|Tetracaine|tetracaine|mesh-list
64639274|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
64639275|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
64639276|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639277|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639278|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
64639279|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639280|NCT01480219|Voriconazole|voriconazole|mesh-list
64639281|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
64639282|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639283|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64639290|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639291|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64639294|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64639295|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639297|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
64639298|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639299|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639300|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639301|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639303|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639304|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639305|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
64639306|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64639307|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639308|NCT01392703|Dasatinib|dasatinib|mesh-list
64639309|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639310|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64639311|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364592|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
64639312|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639313|NCT01392859|Levocetirizine|levocetirizine|mesh-list
64639314|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64639315|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64639316|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
64639317|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
64639318|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639319|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639320|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639321|NCT01457521|Ibuprofen|ibuprofen|mesh-list
64639322|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64639323|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639324|NCT01457521|Analgesics|analgesics|mesh-ancestor
64639325|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
64639326|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639327|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639328|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639329|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639330|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64639331|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639332|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639333|NCT00325442|Treprostinil|treprostinil|mesh-list
64639334|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64639335|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64639336|NCT01393717|Antibodies|antibodies|mesh-list
64639337|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
64639338|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64639347|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639348|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
64639349|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639350|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
64639351|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639353|NCT01481545|Bevacizumab|bevacizumab|mesh-list
64639354|NCT01481545|Fluorouracil|fluorouracil|mesh-list
64639355|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
64639356|NCT01481545|Raltitrexed|raltitrexed|mesh-list
64639357|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
64639358|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639359|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639360|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64639361|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64639362|NCT01481545|Growth Substances|growth substances|mesh-ancestor
64639363|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639364|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
64639365|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
64639366|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639367|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64639368|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639369|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
64639370|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64639371|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639372|NCT01481545|Antidotes|antidotes|mesh-ancestor
64639373|NCT01481545|Protective Agents|protective agents|mesh-ancestor
64639374|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
64639375|NCT01481545|Vitamins|vitamins|mesh-ancestor
64639376|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
64639379|NCT01482091|Narcotics|narcotics|mesh-ancestor
64639380|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639381|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639382|NCT01482091|Analgesics|analgesics|mesh-ancestor
64639383|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
64639384|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639385|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64639386|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64639387|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
64639388|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
64639389|NCT00327392|Fospropofol|fospropofol|mesh-list
64639390|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64639391|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639392|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639393|NCT03007238|Aldesleukin|aldesleukin|mesh-list
64639394|NCT03007238|Interleukin-2|interleukin-2|mesh-list
64639395|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639396|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639397|NCT03007238|Analgesics|analgesics|mesh-ancestor
64639398|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
64639399|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639400|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639401|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64639402|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64639403|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
64639404|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639405|NCT01791608|Zinc|zinc|mesh-list
64639406|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
64639407|NCT01791608|Trace Elements|trace elements|mesh-ancestor
64639408|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
64639409|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639410|NCT01791608|Astringents|astringents|mesh-ancestor
64639411|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
64639412|NCT04346030|Triamcinolone|triamcinolone|mesh-list
64639413|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64639414|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64639415|NCT04346030|Lidocaine|lidocaine|mesh-list
64639416|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64639417|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
64639418|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
64639419|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639420|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639421|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
64639422|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639423|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64639424|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64639425|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64639426|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64639427|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639428|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639429|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
64639430|NCT04346030|Hormones|hormones|mesh-ancestor
64639431|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639432|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639433|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
64639434|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639435|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
64639436|NCT05075330|Narcotics|narcotics|mesh-ancestor
64639437|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639438|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639439|NCT05075330|Analgesics|analgesics|mesh-ancestor
64639440|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
64639441|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639442|NCT02108288|Carteolol|carteolol|mesh-list
64639443|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64639444|NCT02108288|Latanoprost|latanoprost|mesh-list
64639445|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64639446|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64639447|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64639448|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
64639449|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639466|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639467|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639469|NCT02106494|Hormones|hormones|mesh-ancestor
64639470|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639471|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64639472|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639473|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
64639474|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
64639475|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64639476|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
64639477|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639478|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639479|NCT02106494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64639480|NCT02106494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64639481|NCT02106494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639482|NCT02106494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64639483|NCT02106494|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64639484|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64639485|NCT00335504|Sulindac|sulindac|mesh-list
64639486|NCT00335504|Atorvastatin|atorvastatin|mesh-list
64639487|NCT00335504|Calcium|calcium|mesh-list
64639494|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64639495|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64639496|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639497|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64639498|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639499|NCT00335504|Analgesics|analgesics|mesh-ancestor
64639500|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
64639501|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639502|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639512|NCT01183481|Aprepitant|aprepitant|mesh-list
64639513|NCT01183481|Granisetron|granisetron|mesh-list
64639514|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
64639515|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
64639516|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639517|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639518|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639519|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64639520|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639521|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639522|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64639523|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
64639524|NCT01183559|Paclitaxel|paclitaxel|mesh-list
64639525|NCT01183559|Carboplatin|carboplatin|mesh-list
64639526|NCT01183559|Fluorouracil|fluorouracil|mesh-list
64639527|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64639528|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639529|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
64639530|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
64639531|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
64639532|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639533|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
64639534|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64639535|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639536|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
64639537|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639538|NCT01184417|Phenobarbital|phenobarbital|mesh-list
64639539|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
64639540|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64639541|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639542|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639543|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64639544|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64639545|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639546|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639547|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
64639548|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
64639553|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64639554|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
64639555|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
64639556|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639592|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639594|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64639595|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
64639597|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64639598|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639599|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64639600|NCT01336140|Aminophylline|aminophylline|mesh-list
64639601|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64639602|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
64639603|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639604|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639605|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64639606|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
64639607|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64639608|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64639609|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639610|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639611|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64639612|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64639613|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
64364899|NCT03361397|Lidocaine|lidocaine|mesh-list
64639614|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639615|NCT01336140|Protective Agents|protective agents|mesh-ancestor
64639616|NCT01184885|Sirolimus|sirolimus|mesh-list
64639617|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
64639618|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64639619|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639620|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639621|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64639622|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639623|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
64639624|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639625|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
64639626|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639627|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639628|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64379314|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639629|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
64639630|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64639631|NCT01187381|Trastuzumab|trastuzumab|mesh-list
64639632|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639633|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639634|NCT01225289|Vitamin A|vitamin a|mesh-list
64639635|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
64639636|NCT01225289|Vitamins|vitamins|mesh-ancestor
64639637|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
64639638|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639642|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64639643|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639644|NCT01161563|Leuprolide|leuprolide|mesh-list
64639645|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64639646|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64639647|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
64639648|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64639649|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639650|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64639651|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639652|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
64639653|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64639654|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
64639655|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64639657|NCT01189409|Laxatives|laxatives|mesh-ancestor
64639658|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639659|NCT03010475|Furosemide|furosemide|mesh-list
64639660|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64639661|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64639662|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64639663|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
64639664|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639665|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64639666|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64639667|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639668|NCT03010475|Diuretics|diuretics|mesh-ancestor
64639669|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
64639670|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639671|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64639672|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64639673|NCT02191865|Nintedanib|nintedanib|mesh-list
64639674|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639675|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64639676|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639677|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639678|NCT04352465|Methotrexate|methotrexate|mesh-list
64639679|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64639680|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
64639681|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64639682|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639683|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64639684|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
64639685|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639686|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639687|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
64639688|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639689|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64639690|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639691|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
64639692|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639693|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64639694|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
64639695|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64639707|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639709|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639710|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64639711|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64639712|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
64639713|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639714|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639715|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
64639716|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
64639717|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64639718|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639719|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64639720|NCT01192139|Metformin|metformin|mesh-list
64639721|NCT01192139|Saxagliptin|saxagliptin|mesh-list
64639722|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64639723|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639724|NCT01192139|Incretins|incretins|mesh-ancestor
64639725|NCT01192139|Hormones|hormones|mesh-ancestor
64639727|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64639728|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
64639729|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639730|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639731|NCT04892186|Inositol|inositol|mesh-list
64639732|NCT04892186|Metformin|metformin|mesh-list
64639733|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64639734|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639735|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
64639736|NCT04892186|Vitamins|vitamins|mesh-ancestor
64639737|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
64639738|NCT01229423|Bimatoprost|bimatoprost|mesh-list
64639739|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64639740|NCT01229891|Vitamin D|vitamin d|mesh-list
64639741|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
64639742|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
64639743|NCT01229891|Vitamins|vitamins|mesh-list
64639744|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
64639745|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639746|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64639747|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64639749|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
64639750|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639751|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64639752|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64639753|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639754|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639755|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64639765|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639766|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639768|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64639769|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64639770|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639771|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
64639772|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639773|NCT00349388|Mesalamine|mesalamine|mesh-list
64639774|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64639775|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64639776|NCT00349388|Analgesics|analgesics|mesh-ancestor
64639777|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
64639778|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64639779|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639780|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64639781|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639782|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
64639783|NCT00349778|Melphalan|melphalan|mesh-list
64639784|NCT00349778|Carmustine|carmustine|mesh-list
64639785|NCT00349778|Etoposide|etoposide|mesh-list
64639786|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
64639787|NCT00349778|Lenograstim|lenograstim|mesh-list
64639788|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639789|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
64639790|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639791|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639792|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64639793|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
64639794|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639795|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639796|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64639797|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64639798|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64639799|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64639800|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639801|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64639802|NCT00305084|Doxorubicin|doxorubicin|mesh-list
64639803|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64639804|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639805|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64639806|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64639807|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639809|NCT00305162|Clopidogrel|clopidogrel|mesh-list
64639810|NCT00305162|Cangrelor|cangrelor|mesh-list
64639811|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64639812|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64379474|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64639813|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64639814|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64639815|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
64639816|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639817|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639818|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639819|NCT00351416|Letrozole|letrozole|mesh-list
64639820|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64639821|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
64639822|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639823|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64639824|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379475|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64639825|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639826|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64639827|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
64639828|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639829|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639830|NCT00305942|Carboplatin|carboplatin|mesh-list
64639831|NCT00305942|Topotecan|topotecan|mesh-list
64639832|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639833|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64639834|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64639835|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639836|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639837|NCT02527200|Liraglutide|liraglutide|mesh-list
64639838|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64639839|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639840|NCT02527200|Incretins|incretins|mesh-ancestor
64639841|NCT02527200|Hormones|hormones|mesh-ancestor
64639842|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639844|NCT00352976|Sirolimus|sirolimus|mesh-list
64639845|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
64639846|NCT00352976|Fludarabine|fludarabine|mesh-list
64639847|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639848|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
64639849|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639850|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64639851|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64639852|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
64639853|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639854|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639855|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64639856|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64639857|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64639858|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
64639859|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64639860|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639861|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64639862|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
64639863|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64639864|NCT00306488|Antioxidants|antioxidants|mesh-list
64639865|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64639866|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639867|NCT00306488|Protective Agents|protective agents|mesh-ancestor
64639879|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64639880|NCT00310076|Thalidomide|thalidomide|mesh-list
64639881|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64639882|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
64639883|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639884|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
64639885|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64639886|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639887|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64639888|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64639889|NCT00310076|Growth Substances|growth substances|mesh-ancestor
64639890|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
64639891|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64639894|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
64639896|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64639897|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639898|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64639899|NCT00353834|Incretins|incretins|mesh-ancestor
64639900|NCT00353834|Hormones|hormones|mesh-ancestor
64639901|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64639902|NCT05344404|Niacinamide|niacinamide|mesh-list
64639903|NCT05344404|Niacin|niacin|mesh-list
64639904|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
64639905|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
64639906|NCT05344404|Vitamins|vitamins|mesh-ancestor
64639907|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
64639908|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639909|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64639910|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
64639911|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639912|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64639913|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
64639927|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64639928|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639929|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639931|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64639932|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64639933|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64639934|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
64639935|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
64639936|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
64639937|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
64639938|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639939|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639940|NCT01793870|Carvedilol|carvedilol|mesh-list
64639941|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64639942|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64639943|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
64639944|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64639945|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639946|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639947|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64639948|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
64639949|NCT01793870|Protective Agents|protective agents|mesh-ancestor
64639950|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64639952|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64639953|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
64639954|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64639955|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64639956|NCT01793948|Metformin|metformin|mesh-list
64639957|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64639958|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639959|NCT00355394|Metoclopramide|metoclopramide|mesh-list
64639974|NCT02105324|Pancreatin|pancreatin|mesh-list
64639975|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64639976|NCT02105558|Anesthetics|anesthetics|mesh-list
64639977|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64639978|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639979|NCT02106962|Bacitracin|bacitracin|mesh-list
64639980|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
64639981|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64639982|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64639983|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64639984|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
64639985|NCT02106962|Coagulants|coagulants|mesh-ancestor
64639986|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64639987|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639988|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64639989|NCT00315146|Pioglitazone|pioglitazone|mesh-list
64639990|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64365272|NCT04522037|Morphine|morphine|mesh-list
64639991|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64639993|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
64639994|NCT01792700|Metronidazole|metronidazole|mesh-list
64639995|NCT01792700|Tetracycline|tetracycline|mesh-list
64639996|NCT01792700|Esomeprazole|esomeprazole|mesh-list
64639997|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64639998|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64639999|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64640000|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640001|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640002|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640003|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640004|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64640005|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64640016|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640017|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64640018|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
64640019|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
64640020|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
64640021|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64640022|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64640023|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
64640024|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640025|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640026|NCT00316862|Irinotecan|irinotecan|mesh-list
64640027|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640028|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64640029|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640031|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640032|NCT00317720|Trastuzumab|trastuzumab|mesh-list
64640033|NCT00317720|Everolimus|everolimus|mesh-list
64640034|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640035|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640036|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640037|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
64640038|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640039|NCT00357032|Belinostat|belinostat|mesh-list
64640040|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640041|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64640042|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640043|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640044|NCT00357734|Gefitinib|gefitinib|mesh-list
64640045|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640046|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64640047|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640048|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640050|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64640051|NCT00318812|Trace Elements|trace elements|mesh-ancestor
64640052|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
64640053|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640054|NCT00318812|Hematinics|hematinics|mesh-ancestor
64640055|NCT00980460|Sirolimus|sirolimus|mesh-list
64640056|NCT00980460|Cisplatin|cisplatin|mesh-list
64640057|NCT00980460|Doxorubicin|doxorubicin|mesh-list
64640058|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64640059|NCT00980460|Fluorouracil|fluorouracil|mesh-list
64640060|NCT00980460|Irinotecan|irinotecan|mesh-list
64640061|NCT00980460|Vincristine|vincristine|mesh-list
64640062|NCT00980460|Camptothecin|camptothecin|mesh-list
64640063|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
64640064|NCT00980460|Razoxane|razoxane|mesh-list
64382183|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
64382184|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640079|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64640080|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
64640081|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
64640082|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640083|NCT00980460|Hematinics|hematinics|mesh-ancestor
64640084|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64640085|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640086|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
64640087|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64640088|NCT00980460|Protective Agents|protective agents|mesh-ancestor
64640089|NCT00362882|Docetaxel|docetaxel|mesh-list
64640090|NCT00362882|Bortezomib|bortezomib|mesh-list
64640091|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640092|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
64640093|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
64640094|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640095|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640096|NCT00365144|Bevacizumab|bevacizumab|mesh-list
64640097|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64640098|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640099|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640100|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64640101|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64640102|NCT00365144|Growth Substances|growth substances|mesh-ancestor
64640103|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640105|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64640106|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640107|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640108|NCT05339022|Coal Tar|coal tar|mesh-list
64640109|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
64640110|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
64640121|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
64640122|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640123|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64640124|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640125|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640126|NCT03809000|Leuprolide|leuprolide|mesh-list
64640127|NCT03809000|Goserelin|goserelin|mesh-list
64640128|NCT03809000|Bicalutamide|bicalutamide|mesh-list
64640129|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64640130|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640131|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64640132|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
64640133|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64640134|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64640135|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640136|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
64640137|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
64640138|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64640139|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
64640140|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640141|NCT05334654|Enoxaparin|enoxaparin|mesh-list
64640142|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
64640143|NCT05334654|Bivalirudin|bivalirudin|mesh-list
64640144|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
64640147|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640148|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
64640149|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64640150|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
64640151|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640152|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
64640153|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640154|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64640155|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64640156|NCT03561584|Analgesics|analgesics|mesh-ancestor
64640157|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
64640158|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640159|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640160|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640161|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64640162|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64640163|NCT00389610|Pancrelipase|pancrelipase|mesh-list
64640164|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64640165|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64640166|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640167|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64640168|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640183|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64640185|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640186|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
64640187|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640188|NCT03932136|Sulforaphane|sulforaphane|mesh-list
64640189|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64640190|NCT03932136|Protective Agents|protective agents|mesh-ancestor
64640191|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640192|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640193|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64640194|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64640195|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640196|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64640197|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64640198|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
64640199|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640200|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640201|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64640202|NCT00390182|Gemcitabine|gemcitabine|mesh-list
64640203|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64640204|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
64640205|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640206|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640207|NCT00390182|Antiviral Agents|antiviral agents|mesh-ancestor
64640208|NCT00390182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640209|NCT00390182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640210|NCT00390182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640211|NCT00390182|Immunologic Factors|immunologic factors|mesh-ancestor
64640212|NCT00390182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640214|NCT05366868|Vildagliptin|vildagliptin|mesh-list
64640215|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64640226|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640227|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
64640228|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640229|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64640230|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
64640231|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64640232|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64640233|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64640234|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
64640235|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640236|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
64640237|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640239|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
64640240|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
64640241|NCT05329428|Vitamins|vitamins|mesh-list
64640242|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
64640243|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640244|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64640245|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64640246|NCT01794572|Melphalan|melphalan|mesh-list
64640247|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64640248|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
64640249|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640250|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640251|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64640252|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640253|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
64640254|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640255|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
64640257|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64640258|NCT05385432|Basiliximab|basiliximab|mesh-list
64640259|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64640260|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
64640261|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
64640262|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640263|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64640264|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640265|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640266|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64640275|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64640277|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640278|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
64640279|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64640280|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640281|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640282|NCT02528214|Prednisone|prednisone|mesh-list
64640283|NCT02528214|Prednisolone|prednisolone|mesh-list
64640284|NCT02528214|Albuterol|albuterol|mesh-list
64640285|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640286|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
64640287|NCT02528214|Hormones|hormones|mesh-ancestor
64640288|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64640289|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640290|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64640291|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640292|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
64640293|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365572|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
64640294|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64640295|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64640296|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
64640297|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
64640298|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64640299|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64640300|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64640301|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64640302|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
64640303|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640304|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640305|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64640306|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
64640307|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64640308|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64640333|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640334|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
64640335|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640336|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64640337|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64640338|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
64640339|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640340|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640341|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64640347|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64640348|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
64640349|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64640350|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64640351|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
64640352|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
64640353|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64640354|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64640355|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64640356|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
64640357|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640358|NCT00392834|Antidotes|antidotes|mesh-ancestor
64640359|NCT00392834|Protective Agents|protective agents|mesh-ancestor
64640360|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
64640361|NCT00392834|Vitamins|vitamins|mesh-ancestor
64640362|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
64640363|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
64640364|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
64640365|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640366|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640367|NCT05363670|Albuterol|albuterol|mesh-list
64640368|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64640369|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
64640370|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640371|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640372|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64640373|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
64640374|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
64640375|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64640376|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64640377|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64640378|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64640379|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
64640380|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640381|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640382|NCT00393380|Teriparatide|teriparatide|mesh-list
64640383|NCT00393380|Hormones|hormones|mesh-list
64640384|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
64640385|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64640386|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640387|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64640388|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64640389|NCT05361642|Lidocaine|lidocaine|mesh-list
64640390|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
64640391|NCT05361642|Bupivacaine|bupivacaine|mesh-list
64640392|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
64640393|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
64640394|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640395|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640396|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
64640397|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640398|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64640399|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64640400|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64640410|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640411|NCT00395876|Tenecteplase|tenecteplase|mesh-list
64640412|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64640413|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64640414|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640415|NCT02662634|Paclitaxel|paclitaxel|mesh-list
64640416|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64640417|NCT02662634|Cisplatin|cisplatin|mesh-list
64640418|NCT02662634|Carboplatin|carboplatin|mesh-list
64640419|NCT02662634|Pemetrexed|pemetrexed|mesh-list
64640420|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64640421|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338253|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338254|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338255|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64338267|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338268|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338269|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338270|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
64338271|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64338272|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338273|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338274|NCT01186991|Paclitaxel|paclitaxel|mesh-list
64338275|NCT01186991|Bevacizumab|bevacizumab|mesh-list
64640422|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
64640423|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
64640424|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640425|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640426|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640427|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64640428|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64640429|NCT00396032|Tenecteplase|tenecteplase|mesh-list
64640430|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64640431|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64640432|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640433|NCT02277782|Fentanyl|fentanyl|mesh-list
64640434|NCT02277782|Hydromorphone|hydromorphone|mesh-list
64640435|NCT02277782|Bupivacaine|bupivacaine|mesh-list
64640436|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
64640437|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
64640438|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640440|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
64640441|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640442|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64640444|NCT02277782|Analgesics|analgesics|mesh-ancestor
64640445|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64640455|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64640456|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64640457|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
64640458|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640459|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640461|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
64640462|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
64640463|NCT02271230|Vitamins|vitamins|mesh-list
64640464|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
64640465|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640466|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64640467|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64640468|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
64640469|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64640470|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640471|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64640472|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640473|NCT05514990|Dexamethasone|dexamethasone|mesh-list
64640474|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
64640475|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
64640476|NCT05514990|Bortezomib|bortezomib|mesh-list
64640477|NCT05514990|Ichthammol|ichthammol|mesh-list
64640478|NCT05514990|BB 1101|bb 1101|mesh-list
64640479|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640480|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
64640481|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
64640482|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640483|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640484|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64640485|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
64640486|NCT05514990|Hormones|hormones|mesh-ancestor
64338330|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640487|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64640488|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64640489|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640490|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
64640491|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640492|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640493|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640494|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
64640495|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
64640496|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64640497|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640499|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64640500|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64640501|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
64365799|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
64640522|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64640523|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640524|NCT00397904|Irinotecan|irinotecan|mesh-list
64640525|NCT00397904|Cetuximab|cetuximab|mesh-list
64640526|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640527|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64640528|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640529|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338700|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64640530|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640531|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640532|NCT00398918|Zonisamide|zonisamide|mesh-list
64640533|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
64640534|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64640546|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
64640547|NCT05314998|Irinotecan|irinotecan|mesh-list
64640548|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
64640549|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64640550|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
64640551|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640552|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640553|NCT05314998|Antiviral Agents|antiviral agents|mesh-ancestor
64640554|NCT05314998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640555|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640556|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640557|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
64640558|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640559|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64640560|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640561|NCT05314998|Antidotes|antidotes|mesh-ancestor
64640562|NCT05314998|Protective Agents|protective agents|mesh-ancestor
64640563|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
64640564|NCT05314998|Vitamins|vitamins|mesh-ancestor
64640565|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
64640566|NCT05314998|Hematinics|hematinics|mesh-ancestor
64640567|NCT00370838|Clonidine|clonidine|mesh-list
64640568|NCT00370838|Levetiracetam|levetiracetam|mesh-list
64640569|NCT00370838|Analgesics|analgesics|mesh-ancestor
64640570|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
64640571|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640572|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640573|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64640574|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
64640575|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
64640580|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640581|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640583|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
64640584|NCT01795430|Etoposide|etoposide|mesh-list
64640585|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
64640586|NCT01795430|Melphalan|melphalan|mesh-list
64640587|NCT01795430|Busulfan|busulfan|mesh-list
64640588|NCT01795430|Topotecan|topotecan|mesh-list
64640589|NCT01795430|Ifosfamide|ifosfamide|mesh-list
64640590|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64640591|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640592|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64640593|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640594|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640595|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640596|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64640597|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
64640598|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64640599|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640601|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640602|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64640603|NCT04750382|Gemcitabine|gemcitabine|mesh-list
64640604|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640605|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64640606|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
64640607|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640608|NCT04750382|Antiviral Agents|antiviral agents|mesh-ancestor
64640609|NCT04750382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640610|NCT04750382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640611|NCT04750382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640612|NCT04750382|Immunologic Factors|immunologic factors|mesh-ancestor
64640613|NCT04750382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640614|NCT05347212|Nivolumab|nivolumab|mesh-list
64640615|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640616|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640617|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64640618|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640619|NCT00401882|Metoprolol|metoprolol|mesh-list
64640620|NCT00401882|Epinephrine|epinephrine|mesh-list
64640621|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64640622|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64640623|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
64640624|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640625|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640626|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640627|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64640628|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64640629|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
64640630|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640631|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64640638|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
64640639|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64640640|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64339279|NCT02285920|Diuretics|diuretics|mesh-ancestor
64640641|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64640643|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64640644|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64640645|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64640646|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
64640648|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640649|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640650|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640651|NCT04749914|Dabigatran|dabigatran|mesh-list
64640652|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64640653|NCT04749914|Lasmiditan|lasmiditan|mesh-list
64640654|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64640655|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64640656|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
64640657|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640658|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64640659|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64640660|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640661|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
64640662|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64640663|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
64640664|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
64640665|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64640666|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
64640667|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640668|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640669|NCT00402194|Losartan|losartan|mesh-list
64640670|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64640671|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64640672|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64339673|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64339820|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339821|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64339822|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64339823|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64339824|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339825|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339826|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640673|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64640674|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640675|NCT05305404|Dexamethasone|dexamethasone|mesh-list
64640676|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
64640677|NCT05305404|BB 1101|bb 1101|mesh-list
64640678|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640679|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
64640680|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
64640681|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640682|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640683|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64640684|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
64640685|NCT05305404|Hormones|hormones|mesh-ancestor
64640686|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64640687|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64640688|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640689|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
64640690|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640691|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640693|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
64640694|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640695|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640696|NCT00402896|Growth Substances|growth substances|mesh-ancestor
64640700|NCT05268120|Trimethoprim|trimethoprim|mesh-list
64640701|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64640702|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640703|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
64640704|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64640705|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64640706|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64640707|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
64640708|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
64640709|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64640710|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640711|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640712|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64640713|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64640714|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64640715|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64640716|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64341746|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
64640717|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64640718|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64640719|NCT05268120|Renal Agents|renal agents|mesh-ancestor
64640720|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64640721|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64640722|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64640723|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64640724|NCT00405704|Trimethoprim|trimethoprim|mesh-list
64640731|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64640732|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64640733|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64640734|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640735|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640736|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64640737|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64640738|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64640739|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343271|NCT02284529|Leucovorin|leucovorin|mesh-list
64640740|NCT01657266|Nepafenac|nepafenac|mesh-list
64640741|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64640742|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64640743|NCT01657266|Analgesics|analgesics|mesh-ancestor
64640744|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
64640745|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640746|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640747|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640748|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64640749|NCT00375830|Diphosphonates|diphosphonates|mesh-list
64640750|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
64640751|NCT00375830|Listerine|listerine|mesh-list
64640752|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
64640753|NCT00375830|Fluorides|fluorides|mesh-list
64640754|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
64640755|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64640756|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
64640757|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
64640758|NCT00375830|Protective Agents|protective agents|mesh-ancestor
64640759|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640760|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64640761|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344145|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
64640762|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64640763|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64640764|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
64640765|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
64640766|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64640767|NCT05286008|Dexamethasone|dexamethasone|mesh-list
64640768|NCT05286008|Ropivacaine|ropivacaine|mesh-list
64640769|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640770|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
64640772|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640773|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640774|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64640775|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
64640776|NCT05286008|Hormones|hormones|mesh-ancestor
64640777|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344340|NCT03471325|Methamphetamine|methamphetamine|mesh-list
64344452|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64344669|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
64640778|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64640779|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640780|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
64640791|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64640792|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
64640793|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640794|NCT05302284|Antiviral Agents|antiviral agents|mesh-ancestor
64640795|NCT05302284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345169|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
64640796|NCT05302284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640797|NCT05302284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640798|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
64640799|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640800|NCT05263284|Venetoclax|venetoclax|mesh-list
64640801|NCT05263284|Adenosine|adenosine|mesh-list
64640802|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640803|NCT05263284|Analgesics|analgesics|mesh-ancestor
64640804|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
64640805|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640806|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640807|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64640808|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
64345881|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64346792|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
64347378|NCT02305355|Atorvastatin|atorvastatin|mesh-list
64640809|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64640810|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
64640811|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
64640812|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640813|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640814|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
64640815|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64640816|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640817|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640818|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64640819|NCT05300802|Analgesics|analgesics|mesh-ancestor
64640820|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
64640821|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640822|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64366096|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
64640823|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64640824|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64640827|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640828|NCT05299476|Bevacizumab|bevacizumab|mesh-list
64640829|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640830|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640831|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64640832|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64640833|NCT05299476|Growth Substances|growth substances|mesh-ancestor
64640834|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640843|NCT00405938|Growth Substances|growth substances|mesh-ancestor
64640844|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640845|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
64640846|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64640847|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64640848|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64640849|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
64640850|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64640851|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64640852|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64640853|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640854|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640855|NCT05299398|Trazodone|trazodone|mesh-list
64640856|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64640857|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64640858|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640859|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640860|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64640861|NCT05299398|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64640862|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64640863|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64640864|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640865|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640866|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
64640868|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
64640870|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64640871|NCT01793480|Narcotics|narcotics|mesh-ancestor
64640872|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640873|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348932|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
64640874|NCT01793480|Analgesics|analgesics|mesh-ancestor
64640875|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
64640887|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
64640888|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
64640889|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64640890|NCT05299008|Bethanechol|bethanechol|mesh-list
64640891|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64640892|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
64640893|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640894|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640895|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64366175|NCT04833413|Insulin|insulin|mesh-list
64640897|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
64640898|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64640899|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640900|NCT05258292|Insulin|insulin|mesh-list
64640901|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64640902|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640903|NCT00378326|Tacrolimus|tacrolimus|mesh-list
64640904|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640905|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
64640906|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640907|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64640908|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640909|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640910|NCT05256264|Ketamine|ketamine|mesh-list
64640911|NCT05256264|Analgesics|analgesics|mesh-ancestor
64640912|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
64640913|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640914|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640915|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64640916|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64640917|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
64640927|NCT00379574|Vincristine|vincristine|mesh-list
64640929|NCT00379574|Lenograstim|lenograstim|mesh-list
64640930|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640931|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
64640932|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640933|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64640934|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64640935|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
64640936|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640937|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640938|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64640939|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64640940|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64640941|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640942|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640943|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64640944|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
64640945|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
64640946|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640947|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64640948|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
64640949|NCT00379574|Hormones|hormones|mesh-ancestor
64640950|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64640951|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64640952|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64640953|NCT05256108|Oxycodone|oxycodone|mesh-list
64640954|NCT05256108|Tramadol|tramadol|mesh-list
64640955|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64640956|NCT05256108|Narcotics|narcotics|mesh-ancestor
64640957|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64640958|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640959|NCT05256108|Analgesics|analgesics|mesh-ancestor
64640960|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
64349076|NCT03497351|Urapidil|urapidil|mesh-list
64640961|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64640962|NCT00407654|Aflibercept|aflibercept|mesh-list
64640963|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
64640964|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64640965|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64640966|NCT00407654|Growth Substances|growth substances|mesh-ancestor
64640967|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640969|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640970|NCT05484492|Calcium|calcium|mesh-list
64640971|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64640972|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640973|NCT00407888|Paclitaxel|paclitaxel|mesh-list
64640974|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64640975|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
64640976|NCT00407888|Doxorubicin|doxorubicin|mesh-list
64640977|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64640978|NCT00407888|Trastuzumab|trastuzumab|mesh-list
64640979|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64640980|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64640981|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
64640982|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
64640983|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
64640984|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64640985|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64640986|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
64640987|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64640988|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64640989|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64640992|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64640993|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64640994|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64640995|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64640996|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64640998|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
64640999|NCT00407966|Alvocidib|alvocidib|mesh-list
64641000|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64641001|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
64641002|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641003|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641004|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
64641005|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641006|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64641007|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
64641008|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641009|NCT00407966|Analgesics|analgesics|mesh-ancestor
64641010|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
64641011|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641012|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64641013|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64641014|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641015|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
64641016|NCT00407966|Growth Substances|growth substances|mesh-ancestor
64641017|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641018|NCT00408200|Sotalol|sotalol|mesh-list
64641019|NCT00408200|Flecainide|flecainide|mesh-list
64641020|NCT00408200|Propafenone|propafenone|mesh-list
64641021|NCT00408200|Dofetilide|dofetilide|mesh-list
64641022|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64641023|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64641024|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641025|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641026|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641027|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641028|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64641029|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
64641030|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
64641031|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641032|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64641033|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64641061|NCT05250050|Renal Agents|renal agents|mesh-ancestor
64641062|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64641067|NCT05250050|Diuretics|diuretics|mesh-ancestor
64641068|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
64641069|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641070|NCT05250050|Expectorants|expectorants|mesh-ancestor
64641071|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
64641072|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
64641073|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64641074|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641075|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64641076|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64641077|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64641078|NCT05294328|Aceclidine|aceclidine|mesh-list
64641079|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64641080|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64641081|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64641082|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64641083|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641084|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641085|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641086|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641087|NCT05294328|Miotics|miotics|mesh-ancestor
64641088|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
64641089|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641090|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64641091|NCT05254626|Pioglitazone|pioglitazone|mesh-list
64641092|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
64641093|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64641095|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64641096|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641098|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
64641099|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641100|NCT05292690|Caffeine|caffeine|mesh-list
64641101|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64641102|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641103|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64641104|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641105|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641106|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64641107|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64641108|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
64641109|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641110|NCT00382148|Omalizumab|omalizumab|mesh-list
64641111|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64641112|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64641113|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
64641114|NCT05292066|Pregabalin|pregabalin|mesh-list
64641115|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64641116|NCT05292066|Analgesics|analgesics|mesh-ancestor
64641117|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
64641118|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641119|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641120|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
64641121|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64366397|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641136|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
64641137|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64641138|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641139|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64641140|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64641141|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
64641142|NCT05189756|Aprepitant|aprepitant|mesh-list
64641143|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
64641144|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
64641145|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
64641146|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641147|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641148|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64641150|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641151|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641153|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64641154|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641155|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641156|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64641157|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64641158|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641159|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641160|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
64641177|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64641178|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64641179|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
64641180|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641181|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641182|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64641183|NCT05143502|Fluticasone|fluticasone|mesh-list
64641184|NCT05143502|Xhance|xhance|mesh-list
64641185|NCT05143502|Prednisolone|prednisolone|mesh-list
64641186|NCT05143502|Montelukast|montelukast|mesh-list
64641187|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64641188|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64641189|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
64641190|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641191|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641192|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64641193|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
64641194|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
64641195|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64641196|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
64641197|NCT05143502|Hormones|hormones|mesh-ancestor
64641198|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64641199|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64641200|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641211|NCT00409292|Everolimus|everolimus|mesh-list
64641212|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641213|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64641214|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
64641215|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641216|NCT05246046|Bromides|bromides|mesh-list
64641217|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
64641218|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64641219|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
64641220|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641221|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641222|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64641223|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
64641224|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
64641225|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64641226|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
64641227|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641228|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641229|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
64641230|NCT00383942|Misoprostol|misoprostol|mesh-list
64641231|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64641232|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
64641233|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64641234|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641235|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64641236|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64641237|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
64641238|NCT05245968|Sunitinib|sunitinib|mesh-list
64641239|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
64641240|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641241|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64641242|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64641243|NCT05245968|Growth Substances|growth substances|mesh-ancestor
64641244|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641260|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
64641261|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641262|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64641263|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64641264|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64641265|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641266|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641267|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64641268|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
64641269|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641270|NCT05474040|Morphine|morphine|mesh-list
64641271|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64641272|NCT05474040|Narcotics|narcotics|mesh-ancestor
64641273|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641274|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641275|NCT05474040|Analgesics|analgesics|mesh-ancestor
64641276|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
64641277|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641278|NCT00410150|Albuterol|albuterol|mesh-list
64641279|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64641280|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
64641281|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641282|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641283|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64641302|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64641303|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641304|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64641305|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641306|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641307|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641308|NCT01657500|Gentamicins|gentamicins|mesh-list
64641309|NCT01657500|Dextrans|dextrans|mesh-list
64641310|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64641311|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641312|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641313|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64641314|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641324|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
64641325|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641326|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64641327|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64641328|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64641329|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641330|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64641331|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64641332|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641333|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641334|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
64641335|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641336|NCT01658904|Melphalan|melphalan|mesh-list
64641337|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
64641338|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641339|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64641340|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
64641341|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641342|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641343|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64641344|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64641345|NCT05284812|Vaccines|vaccines|mesh-list
64641346|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
64641347|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641348|NCT05238948|Midazolam|midazolam|mesh-list
64641349|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64641350|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64641351|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641352|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641353|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64641354|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64641355|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641356|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64641357|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
64641358|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
64641359|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
64641360|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
64641361|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641362|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641363|NCT00385580|Dasatinib|dasatinib|mesh-list
64641364|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641376|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641378|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64641379|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641380|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64641381|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64641382|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641383|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64641384|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
64641385|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
64641386|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
64641387|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
64641388|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641389|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641390|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64641391|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64641392|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
64641393|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64641394|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64641395|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641396|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64641397|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64641398|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64641399|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64641400|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
64641401|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641402|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
64641403|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64641404|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64641405|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
64641406|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
64641407|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64641408|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64641410|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64641411|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641412|NCT00455702|Renal Agents|renal agents|mesh-ancestor
64641413|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64641414|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
64641415|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641416|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
64641431|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641432|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64641433|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641434|NCT05235516|Cisplatin|cisplatin|mesh-list
64641435|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641436|NCT00411398|Memantine|memantine|mesh-list
64641437|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64641438|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64641439|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
64641440|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641441|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641442|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641443|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64641444|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64641445|NCT05231694|Mitogens|mitogens|mesh-list
64641446|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
64641447|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641448|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64641449|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64641450|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64641451|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641452|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641453|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641454|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641455|NCT00457730|Analgesics|analgesics|mesh-ancestor
64641456|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
64641457|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641471|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64641473|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641474|NCT00389168|Atenolol|atenolol|mesh-list
64641475|NCT00389168|Irbesartan|irbesartan|mesh-list
64641476|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64641477|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64641478|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64379482|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
64379483|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
64641479|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641480|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64641481|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
64641482|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
64641483|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641484|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641485|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64641486|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64641487|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64641488|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641489|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641490|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64641491|NCT00462020|Metronidazole|metronidazole|mesh-list
64641492|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
64641493|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
64641494|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
64641495|NCT00462020|Ampicillin|ampicillin|mesh-list
64484312|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64641496|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64641497|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641498|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
64641499|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64641500|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64641501|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641502|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641512|NCT00414206|Mecamylamine|mecamylamine|mesh-list
64641513|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64641514|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64641515|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
64641516|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641517|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641518|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64641519|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64641520|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
64641521|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641522|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641523|NCT05480046|Risperidone|risperidone|mesh-list
64641524|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64641525|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
64641526|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641527|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641528|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641529|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64641530|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64641531|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641532|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641533|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64641534|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
64641535|NCT04241640|Nefopam|nefopam|mesh-list
64641536|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64641537|NCT04241640|Analgesics|analgesics|mesh-ancestor
64641538|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
64641539|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641540|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303306|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64641542|NCT00462332|Fludarabine|fludarabine|mesh-list
64641543|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
64641544|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
64641545|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641546|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64641547|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
64382185|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382186|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
64382187|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64382188|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64382189|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382190|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64382191|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64382192|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64382193|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382194|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64382211|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64382212|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
64641563|NCT00462644|Analgesics|analgesics|mesh-ancestor
64641564|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
64641565|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641566|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64641567|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64641568|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
64641569|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
64641570|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64641571|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64641572|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64641573|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641574|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
64641575|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
64641576|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641577|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641578|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64641579|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64641580|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64641581|NCT00462722|Ibuprofen|ibuprofen|mesh-list
64641582|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64641583|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64641584|NCT00462722|Analgesics|analgesics|mesh-ancestor
64641585|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
64641586|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641587|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641588|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64641589|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64641590|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64641591|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641592|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641609|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641610|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64641611|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64641612|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64641614|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
64641615|NCT00528788|Vitamins|vitamins|mesh-ancestor
64641616|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
64641617|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641618|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64641619|NCT00414518|Ritonavir|ritonavir|mesh-list
64641620|NCT00414518|Lopinavir|lopinavir|mesh-list
64641621|NCT00414518|Tenofovir|tenofovir|mesh-list
64641622|NCT00414518|Emtricitabine|emtricitabine|mesh-list
64641623|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64641624|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64641625|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
64641626|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641627|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641628|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64641629|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64641630|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
64641636|NCT01795664|Fluticasone|fluticasone|mesh-list
64641638|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64641639|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64641640|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64641641|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64641642|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
64641643|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641644|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641645|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64641647|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
64641648|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64641649|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64641650|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64641651|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64641652|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641653|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641654|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641655|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
64641656|NCT01795664|Hormones|hormones|mesh-ancestor
64641657|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64641658|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
64641659|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
64641660|NCT05271084|Dexetimide|dexetimide|mesh-list
64641661|NCT05271084|Citalopram|citalopram|mesh-list
64641662|NCT05271084|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64641663|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64641664|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641665|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641666|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641667|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
64641668|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641669|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64641670|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641671|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641672|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64641673|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64641674|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
64641675|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
64641676|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641677|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64641678|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64641679|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
64641680|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64641681|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641682|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64641683|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64641684|NCT05271084|Protective Agents|protective agents|mesh-ancestor
64641685|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
64641686|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64641687|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
64641688|NCT00531518|Lamotrigine|lamotrigine|mesh-list
64641689|NCT00531518|Aripiprazole|aripiprazole|mesh-list
64641701|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641702|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641703|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64641704|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64641705|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641706|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64641707|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64641708|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641709|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
64641710|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64641711|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64641712|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
64641713|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64641714|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64641715|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64641716|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64641717|NCT00531518|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64641718|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
64641719|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64641720|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64484313|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
64641721|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64641722|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
64641723|NCT00533546|Protein C|protein c|mesh-list
64641724|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
64641725|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64641726|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64641727|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641728|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641729|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64641730|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64641731|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64641732|NCT00534794|Analgesics|analgesics|mesh-ancestor
64641733|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
64641740|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64641741|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
64641742|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
64641743|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641744|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641745|NCT01658436|Dactolisib|dactolisib|mesh-list
64641746|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641747|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
64641748|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64641749|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641750|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641751|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64641752|NCT05168280|Analgesics|analgesics|mesh-ancestor
64641753|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
64641754|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641755|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64641756|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64641757|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64641758|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641759|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641760|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641761|NCT05053854|Talazoparib|talazoparib|mesh-list
64641762|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64641763|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641764|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641765|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641766|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64641767|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
64641768|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
64641769|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
64641770|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
64641771|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64641772|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641773|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641774|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64641775|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64641776|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641777|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641778|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641779|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64641780|NCT00465530|Gentamicins|gentamicins|mesh-list
64641781|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641782|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641783|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64641784|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641785|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641786|NCT00466310|Risperidone|risperidone|mesh-list
64641787|NCT00466310|Aripiprazole|aripiprazole|mesh-list
64641788|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64641789|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
64641795|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641796|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64641797|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64641798|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
64641799|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
64641800|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
64641801|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64641802|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64641803|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64641805|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
64641806|NCT03463460|Sunitinib|sunitinib|mesh-list
64641807|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64641808|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641809|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64641810|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64641811|NCT03463460|Growth Substances|growth substances|mesh-ancestor
64641812|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641813|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
64641814|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64641815|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641816|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641817|NCT00535652|Ertapenem|ertapenem|mesh-list
64641818|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641819|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641820|NCT00418028|Capecitabine|capecitabine|mesh-list
64641821|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64641822|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
64641823|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641824|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641826|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64641827|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641828|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
64641829|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641830|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64641831|NCT00537680|Ubiquinone|ubiquinone|mesh-list
64641832|NCT00537680|Idebenone|idebenone|mesh-list
64641833|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
64641834|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641835|NCT00537680|Protective Agents|protective agents|mesh-ancestor
64641836|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641837|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
64641838|NCT00538304|Bimatoprost|bimatoprost|mesh-list
64641839|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64641840|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64641841|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64641842|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
64641843|NCT00538616|Propofol|propofol|mesh-list
64641844|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64641845|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641846|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641847|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64641848|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
64641849|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
64641850|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64641851|NCT00538616|Analgesics|analgesics|mesh-ancestor
64641859|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641860|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64641861|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64641862|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641863|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
64641883|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641884|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641885|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64641886|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641887|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641888|NCT00469508|Modafinil|modafinil|mesh-list
64641889|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64641890|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641891|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64641892|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64641893|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64641894|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641895|NCT05096832|Vaccines|vaccines|mesh-list
64641896|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
64641897|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641898|NCT00470600|Ibuprofen|ibuprofen|mesh-list
64641899|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64641900|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64641901|NCT00470600|Analgesics|analgesics|mesh-ancestor
64641902|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
64641903|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641904|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641905|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64641906|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64641907|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64641908|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641909|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641910|NCT00471068|Timolol|timolol|mesh-list
64641911|NCT00471068|Travoprost|travoprost|mesh-list
64641912|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64641913|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64641914|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641915|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641916|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641917|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641918|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64641919|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64641920|NCT00471380|Timolol|timolol|mesh-list
64641921|NCT00471380|Travoprost|travoprost|mesh-list
64641922|NCT00471380|Dorzolamide|dorzolamide|mesh-list
64641923|NCT00471380|Brinzolamide|brinzolamide|mesh-list
64641927|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641928|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641929|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641930|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64641931|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64641932|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64641933|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641935|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64641936|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
64641937|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641938|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64641939|NCT00538850|Fentanyl|fentanyl|mesh-list
64641940|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64641941|NCT00538850|Narcotics|narcotics|mesh-ancestor
64641942|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64641943|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641945|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
64641946|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64641947|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64641948|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64641949|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
64641950|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
64641951|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64641952|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64641953|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64641954|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64641955|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641956|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
64641957|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64641958|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641959|NCT00418574|Abagovomab|abagovomab|mesh-list
64641960|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64641961|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641962|NCT00473642|Ranibizumab|ranibizumab|mesh-list
64641963|NCT00473642|Verteporfin|verteporfin|mesh-list
64641964|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64641965|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64641966|NCT00473642|Growth Substances|growth substances|mesh-ancestor
64641967|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64641968|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
64641969|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64641970|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64641971|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
64641973|NCT00539942|Fondaparinux|fondaparinux|mesh-list
64641974|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64641975|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
64641976|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64641977|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
64641978|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64641979|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641980|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
64641981|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64641982|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64641983|NCT00419666|Calcitriol|calcitriol|mesh-list
64641988|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64641989|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64641990|NCT00419666|Vitamins|vitamins|mesh-ancestor
64641992|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64641993|NCT00540722|Acetic Acid|acetic acid|mesh-list
64641994|NCT00540722|Retinol acetate|retinol acetate|mesh-list
64641995|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
64641996|NCT00540722|Gossypol|gossypol|mesh-list
64641997|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64641998|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64641999|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64642000|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
64642001|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642002|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64642003|NCT00540722|Protective Agents|protective agents|mesh-ancestor
64642004|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642005|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64642006|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
64642007|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64642008|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64642009|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64642010|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64642011|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64642012|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
64642013|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64642014|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
64642015|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642016|NCT00542750|Expectorants|expectorants|mesh-ancestor
64642017|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
64642018|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64642019|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
64642020|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642021|NCT00542750|Protective Agents|protective agents|mesh-ancestor
64642022|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642023|NCT00542750|Antidotes|antidotes|mesh-ancestor
64642024|NCT00475904|Gabapentin|gabapentin|mesh-list
64642025|NCT00475904|Analgesics|analgesics|mesh-ancestor
64642026|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
64642027|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642028|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642029|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
64642030|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64642031|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64642032|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642033|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642034|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64642035|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64642036|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642037|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642038|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
64642039|NCT00420992|Naltrexone|naltrexone|mesh-list
64642040|NCT00420992|Morphine|morphine|mesh-list
64642046|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
64642047|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642048|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64642049|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64642051|NCT00423878|Risperidone|risperidone|mesh-list
64642052|NCT00423878|Aripiprazole|aripiprazole|mesh-list
64642053|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64642054|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64642055|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
64642056|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642057|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642058|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642059|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64642060|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64642061|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642062|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642063|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64642064|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
64642065|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
64642066|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
64642067|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642068|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642069|NCT00423878|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64642070|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64642071|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642072|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
64642073|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
64642074|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64642075|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64642076|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64642077|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64642078|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
64642079|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64642080|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642081|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642082|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642083|NCT00480740|Analgesics|analgesics|mesh-ancestor
64642084|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
64642085|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642086|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64379530|NCT04225221|Leuprolide|leuprolide|mesh-list
64642087|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64642088|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64642089|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
64642090|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642091|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642092|NCT00424502|Rituximab|rituximab|mesh-list
64642093|NCT00424502|Methotrexate|methotrexate|mesh-list
64642094|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64642098|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642099|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64642100|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
64642101|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64642102|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64303364|NCT02135887|Vitamins|vitamins|mesh-ancestor
64642103|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
64642104|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642105|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
64642106|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642107|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64642108|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642109|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64642110|NCT00425672|Interleukin-2|interleukin-2|mesh-list
64642111|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
64642112|NCT00425672|Immunotoxins|immunotoxins|mesh-list
64642113|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642114|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642115|NCT00425672|Analgesics|analgesics|mesh-ancestor
64642116|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
64642117|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642118|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642119|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
64642120|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
64642121|NCT00544076|Alprostadil|alprostadil|mesh-list
64642122|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642123|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
64642124|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64642125|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64642126|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642127|NCT00544076|Urological Agents|urological agents|mesh-ancestor
64642128|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64642129|NCT00544778|Doxorubicin|doxorubicin|mesh-list
64642130|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64642131|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
64642133|NCT00544778|Ifosfamide|ifosfamide|mesh-list
64642134|NCT00544778|Razoxane|razoxane|mesh-list
64642135|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64642136|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642137|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64642138|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64642139|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642140|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642141|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64642142|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642143|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64642144|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
64642145|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64642146|NCT00544778|Protective Agents|protective agents|mesh-ancestor
64642147|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
64642148|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
64642149|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
64642150|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642151|NCT00486824|Indomethacin|indomethacin|mesh-list
64642152|NCT00486824|Nifedipine|nifedipine|mesh-list
64642153|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64642154|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642155|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642156|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64642157|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642162|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642163|NCT00486824|Analgesics|analgesics|mesh-ancestor
64642164|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
64642165|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642166|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642167|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367450|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642168|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
64642169|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64642170|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642171|NCT00489086|Tazarotene|tazarotene|mesh-list
64642172|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
64642173|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
64642174|NCT00489866|Aripiprazole|aripiprazole|mesh-list
64642175|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
64642176|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642177|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64642178|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64642179|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642180|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642181|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
64642182|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
64642183|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642184|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642185|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64642187|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
64642188|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64642189|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64642190|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64642191|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64642192|NCT00546104|Dasatinib|dasatinib|mesh-list
64642193|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303402|NCT02245841|Hormones|hormones|mesh-ancestor
64642195|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642196|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642197|NCT00546728|Metformin|metformin|mesh-list
64642198|NCT00546728|Exenatide|exenatide|mesh-list
64642199|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64642200|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642201|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64642202|NCT00546728|Incretins|incretins|mesh-ancestor
64642203|NCT00546728|Hormones|hormones|mesh-ancestor
64642204|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642205|NCT00547586|Bromides|bromides|mesh-list
64642206|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
64642207|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
64642208|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64642209|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642210|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
64642211|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642212|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
64642213|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64642214|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642222|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642224|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64642225|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
64642226|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642227|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64642228|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64642229|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642230|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642231|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
64642232|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64642233|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64642234|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64642235|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642239|NCT00492206|Cetuximab|cetuximab|mesh-list
64642240|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64642241|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642242|NCT00431132|Estradiol|estradiol|mesh-list
64642243|NCT00431132|Estrogens|estrogens|mesh-ancestor
64642244|NCT00431132|Hormones|hormones|mesh-ancestor
64642245|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642246|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642247|NCT00493064|Niacin|niacin|mesh-list
64642248|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
64642249|NCT00493064|Niacinamide|niacinamide|mesh-list
64642250|NCT00493064|Prednisolone|prednisolone|mesh-list
64642251|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64642252|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
64642253|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64642254|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
64642255|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64642256|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
64642257|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642258|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
64642259|NCT00493064|Hormones|hormones|mesh-ancestor
64642260|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642261|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642262|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642263|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642264|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
64642265|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
64642266|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642267|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642268|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64642269|NCT00493064|Protective Agents|protective agents|mesh-ancestor
64642270|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64642271|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
64642272|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642273|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64642274|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
64642275|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
64642276|NCT00493064|Vitamins|vitamins|mesh-ancestor
64642277|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
64642278|NCT00552422|Domperidone|domperidone|mesh-list
64642279|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
64642286|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642287|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642288|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
64642289|NCT00432458|Thalidomide|thalidomide|mesh-list
64642290|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642291|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
64642293|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
64642294|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64642295|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642296|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64642297|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64642298|NCT00432458|Growth Substances|growth substances|mesh-ancestor
64642299|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
64642300|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642301|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64642303|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64642304|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642305|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642307|NCT00433550|Capecitabine|capecitabine|mesh-list
64642308|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
64642310|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64642311|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
64642312|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642313|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642314|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64642315|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64642316|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642317|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
64642318|NCT02208037|Maraviroc|maraviroc|mesh-list
64642319|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
64642320|NCT02208037|Methotrexate|methotrexate|mesh-list
64642321|NCT02208037|Bortezomib|bortezomib|mesh-list
64642322|NCT02208037|Tacrolimus|tacrolimus|mesh-list
64642323|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642324|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
64642325|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642326|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642327|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64642328|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
64642329|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642330|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642331|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64642332|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64642333|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
64642334|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64642335|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64642337|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
64642338|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642339|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64642340|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64642341|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64642342|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64642348|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64642349|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64642350|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64642351|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
64642352|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64642354|NCT03007927|Bupivacaine|bupivacaine|mesh-list
64642355|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642356|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
64642357|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
64642358|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642359|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642360|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642361|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
64642362|NCT03007927|Hormones|hormones|mesh-ancestor
64642363|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642364|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642365|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642366|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
64642367|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
64642368|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642369|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
64642370|NCT05041842|Trastuzumab|trastuzumab|mesh-list
64642371|NCT05041842|Pertuzumab|pertuzumab|mesh-list
64642372|NCT05041842|Tucatinib|tucatinib|mesh-list
64642373|NCT05041842|Hormones|hormones|mesh-list
64642374|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64642375|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642376|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642377|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642378|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64642379|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642380|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642382|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
64642383|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642384|NCT00496340|Rituximab|rituximab|mesh-list
64642385|NCT00496340|Busulfan|busulfan|mesh-list
64642386|NCT00496340|Pentostatin|pentostatin|mesh-list
64642387|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64642388|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642389|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
64642390|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642391|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642392|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
64642393|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642394|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642395|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64642396|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64642397|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64367677|NCT03095235|Riboflavin|riboflavin|mesh-list
64642398|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642399|NCT05090358|Canagliflozin|canagliflozin|mesh-list
64642400|NCT05090358|Fulvestrant|fulvestrant|mesh-list
64642408|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64642409|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642410|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64642411|NCT00496808|Trastuzumab|trastuzumab|mesh-list
64642412|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64642413|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642414|NCT05148078|Anesthetics|anesthetics|mesh-list
64642415|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642416|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642418|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64642419|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64642420|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64642421|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64642422|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
64642423|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642424|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642425|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642426|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
64642427|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
64642428|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64642429|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642430|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642431|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
64642432|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642433|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64642434|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64642435|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642436|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642437|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64642438|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
64642439|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642440|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642441|NCT00555152|Lapatinib|lapatinib|mesh-list
64642442|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642443|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64642444|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642445|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642446|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64642447|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303427|NCT02242799|Artesunate|artesunate|mesh-list
64642448|NCT00555464|Prednisone|prednisone|mesh-list
64642450|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64642451|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
64642452|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64642453|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
64642454|NCT00555464|Vincristine|vincristine|mesh-list
64642455|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64642456|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
64642457|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642463|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642464|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64642466|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
64642467|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
64367751|NCT03098121|Grazoprevir|grazoprevir|mesh-list
64642468|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642469|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
64642470|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
64642471|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642472|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642473|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64642474|NCT00555464|Protective Agents|protective agents|mesh-ancestor
64642475|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
64642476|NCT01795976|Fludarabine|fludarabine|mesh-list
64642477|NCT01795976|Interleukin-2|interleukin-2|mesh-list
64642478|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642479|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
64642480|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642481|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642482|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64642483|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
64642484|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642485|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642486|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64642487|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642489|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
64642490|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642491|NCT01461733|Amiodarone|amiodarone|mesh-list
64642492|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64642493|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
64642494|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64642495|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642496|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642497|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64642498|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64642499|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64642500|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642501|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64642502|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64642503|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64642504|NCT01462279|Thiamine|thiamine|mesh-list
64642505|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
64642506|NCT01462279|Vitamins|vitamins|mesh-ancestor
64642507|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
64642508|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642509|NCT00435812|Vaccines|vaccines|mesh-list
64642510|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
64642511|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642512|NCT05081466|Vitamin D|vitamin d|mesh-list
64642519|NCT01464229|Iloperidone|iloperidone|mesh-list
64642520|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64642521|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64642522|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642523|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642524|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642525|NCT00556478|Lidocaine|lidocaine|mesh-list
64642526|NCT00556478|Prilocaine|prilocaine|mesh-list
64642527|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64642528|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
64642529|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
64642530|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642531|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642532|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
64642533|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642534|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64642535|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64642536|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64642537|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642538|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642539|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64642540|NCT00500240|Insulin|insulin|mesh-list
64367825|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
64642541|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64642542|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
64642543|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
64642544|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64642545|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642546|NCT01469767|Fluocinonide|fluocinonide|mesh-list
64642547|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642548|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
64642549|NCT01469767|Hormones|hormones|mesh-ancestor
64642550|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642551|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642552|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64642553|NCT05029596|Heparin|heparin|mesh-list
64642554|NCT05029596|Calcium heparin|calcium heparin|mesh-list
64642555|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
64642556|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64642557|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64642558|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642559|NCT03246620|Diazepam|diazepam|mesh-list
64642560|NCT03246620|Haloperidol|haloperidol|mesh-list
64642561|NCT03246620|Olanzapine|olanzapine|mesh-list
64642562|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
64642563|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
64642564|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
64642565|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642567|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642568|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64642569|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64642570|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642571|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642572|NCT03246620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64642573|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64642574|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642575|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642576|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642577|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
64642578|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64642579|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
64642580|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64642581|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64642582|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
64642583|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64642584|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64642585|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64642586|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64642587|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64642588|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
64642589|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
64642590|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
64642591|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
64642592|NCT05080218|Adalimumab|adalimumab|mesh-list
64642593|NCT05080218|Etanercept|etanercept|mesh-list
64642594|NCT05080218|Golimumab|golimumab|mesh-list
64642595|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64642596|NCT05080218|Abatacept|abatacept|mesh-list
64642597|NCT05080218|Upadacitinib|upadacitinib|mesh-list
64642599|NCT05080218|Tofacitinib|tofacitinib|mesh-list
64642600|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642601|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642602|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64642603|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642604|NCT05080218|Analgesics|analgesics|mesh-ancestor
64642605|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
64642606|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642607|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642608|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642609|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642610|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
64642611|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64642612|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642613|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642614|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64642615|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642616|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64642617|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
64642618|NCT01470859|Levodopa|levodopa|mesh-list
64642619|NCT01470859|Carbidopa|carbidopa|mesh-list
64367903|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642620|NCT01470859|Pramipexole|pramipexole|mesh-list
64642621|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64642622|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64642623|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64642624|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
64642625|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642626|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642627|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303466|NCT02138383|Hormones|hormones|mesh-ancestor
64642640|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64642641|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642642|NCT01471639|Analgesics|analgesics|mesh-ancestor
64642643|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
64642644|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642645|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642646|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642647|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642648|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64642649|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642650|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642651|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
64642652|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64642653|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642654|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642655|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642656|NCT05622656|Analgesics|analgesics|mesh-ancestor
64642657|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
64642658|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642659|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64642660|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64642661|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64642662|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
64642663|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642664|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642665|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64642666|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
64642673|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
64642674|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64642675|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64642676|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642677|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642678|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
64642679|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
64642680|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64642681|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
64642682|NCT00436904|Rituximab|rituximab|mesh-list
64642683|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
64642684|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64642685|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642686|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
64642687|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642688|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642689|NCT00438854|Dasatinib|dasatinib|mesh-list
64642690|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642691|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64642692|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642693|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367978|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64642694|NCT01485055|Infliximab|infliximab|mesh-list
64642695|NCT01485055|Basiliximab|basiliximab|mesh-list
64642696|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
64642697|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642698|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642699|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642700|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
64642701|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642702|NCT05028348|Dexamethasone|dexamethasone|mesh-list
64642703|NCT05028348|Pomalidomide|pomalidomide|mesh-list
64642705|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642706|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
64642707|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
64642708|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642709|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642710|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642711|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
64642712|NCT05028348|Hormones|hormones|mesh-ancestor
64642713|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642714|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642715|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642716|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
64642717|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64642718|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64642719|NCT05028348|Growth Substances|growth substances|mesh-ancestor
64642720|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
64642721|NCT01486615|Melatonin|melatonin|mesh-list
64642722|NCT01486615|Alprazolam|alprazolam|mesh-list
64642723|NCT01486615|Azaperone|azaperone|mesh-list
64642724|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
64642728|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642729|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64642730|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64642731|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64642732|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64642733|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
64642734|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
64642735|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642736|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64642737|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64642738|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
64642739|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64642740|NCT00503750|Vinorelbine|vinorelbine|mesh-list
64642741|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642742|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64642743|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
64642744|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
64642745|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
64642746|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642747|NCT05077332|Celecoxib|celecoxib|mesh-list
64642748|NCT05077332|Famotidine|famotidine|mesh-list
64642749|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64642750|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64642751|NCT05077332|Analgesics|analgesics|mesh-ancestor
64642752|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
64642753|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642754|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642755|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642756|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642757|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64642758|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64642759|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642760|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642761|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64642762|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642763|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64642764|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
64642765|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
64642766|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642767|NCT05076006|PF-06700841|pf-06700841|mesh-list
64642768|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64642769|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642770|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642772|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64642773|NCT04227678|Heparin|heparin|mesh-list
64642774|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
64642775|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64642776|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64642777|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642778|NCT00508118|Nicardipine|nicardipine|mesh-list
64642779|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64642780|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64642781|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642782|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642783|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64642784|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642798|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642799|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642800|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64642801|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
64642802|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642803|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642805|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642806|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
64642807|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642808|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64642809|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64642810|NCT05021094|Estradiol|estradiol|mesh-list
64642811|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64642812|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
64642813|NCT05021094|Estrogens|estrogens|mesh-ancestor
64642814|NCT05021094|Hormones|hormones|mesh-ancestor
64642815|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642816|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642817|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64642818|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
64642819|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64642820|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64642822|NCT01364298|Pregabalin|pregabalin|mesh-list
64642823|NCT01364298|Gabapentin|gabapentin|mesh-list
64642824|NCT01364298|Analgesics|analgesics|mesh-ancestor
64642825|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
64642826|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642827|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642828|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
64642829|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64642830|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64642831|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642832|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64642838|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64642839|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642840|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
64642841|NCT04421742|Beclomethasone|beclomethasone|mesh-list
64642842|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
64642843|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64642844|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
64642845|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642846|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642847|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64642848|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
64642849|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64642850|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64642851|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64642852|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
64642853|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642854|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642855|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642856|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
64642857|NCT04421742|Hormones|hormones|mesh-ancestor
64642858|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642859|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
64642860|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64642861|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
64642862|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642863|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642864|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64642865|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
64642866|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64642867|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64642868|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64642869|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64642870|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642871|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642872|NCT01488409|Acipimox|acipimox|mesh-list
64642873|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64642874|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
64642875|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642876|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64642877|NCT01488877|Spironolactone|spironolactone|mesh-list
64642878|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64642879|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
64642880|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303487|NCT02252419|Hormones|hormones|mesh-ancestor
64642881|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642889|NCT01364922|Analgesics|analgesics|mesh-ancestor
64642890|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
64642891|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64642892|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642893|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
64642894|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64642895|NCT01364922|Narcotics|narcotics|mesh-ancestor
64642896|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642897|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
64642898|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
64642899|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64642900|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64642901|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642903|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
64642904|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642905|NCT01489969|Protective Agents|protective agents|mesh-ancestor
64642906|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642907|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64642908|NCT00509288|Aldesleukin|aldesleukin|mesh-list
64642909|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
64642910|NCT00509288|Fludarabine|fludarabine|mesh-list
64642911|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642912|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
64642913|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642914|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64642915|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64642916|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
64642917|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642919|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64642920|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64642921|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64642922|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
64642923|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642924|NCT00442364|Polidocanol|polidocanol|mesh-list
64642925|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64642926|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64642927|NCT00510224|Octreotide|octreotide|mesh-list
64642928|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642929|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642940|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642941|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64642942|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
64642943|NCT00511706|Hormones|hormones|mesh-ancestor
64642944|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64642945|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64642946|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642947|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64642948|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64642949|NCT00511706|Growth Substances|growth substances|mesh-ancestor
64642950|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
64642951|NCT05067894|Vaccines|vaccines|mesh-list
64642952|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
64642953|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642954|NCT01493947|Metronidazole|metronidazole|mesh-list
64642955|NCT01493947|Ivermectin|ivermectin|mesh-list
64642958|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64642959|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64642960|NCT00445484|Lenalidomide|lenalidomide|mesh-list
64642961|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64642962|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
64642963|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642964|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64642965|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64642966|NCT00445484|Growth Substances|growth substances|mesh-ancestor
64642967|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
64642968|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642969|NCT01495585|Lonafarnib|lonafarnib|mesh-list
64642970|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642971|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642972|NCT00446264|Sirolimus|sirolimus|mesh-list
64642973|NCT00446264|Tacrolimus|tacrolimus|mesh-list
64642974|NCT00446264|Daclizumab|daclizumab|mesh-list
64642975|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642976|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
64642977|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64642978|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64642979|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64642980|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642981|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64642982|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64642983|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64642984|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64642985|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
64642986|NCT01495819|Nicotine|nicotine|mesh-list
64642994|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64642995|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64642996|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
64642997|NCT04214886|Fludarabine|fludarabine|mesh-list
64642998|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64642999|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
64643001|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643002|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643003|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
64643004|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643005|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643006|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64643007|NCT05011266|Buprenorphine|buprenorphine|mesh-list
64643008|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64643009|NCT05011266|Naloxone|naloxone|mesh-list
64643010|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64643011|NCT05011266|Narcotics|narcotics|mesh-ancestor
64643012|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643013|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643014|NCT05011266|Analgesics|analgesics|mesh-ancestor
64643015|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
64643016|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643017|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64643018|NCT00512876|Bevacizumab|bevacizumab|mesh-list
64643019|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643020|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643021|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64643022|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64643023|NCT00512876|Growth Substances|growth substances|mesh-ancestor
64643024|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643025|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
64643026|NCT05062980|Docetaxel|docetaxel|mesh-list
64643027|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
64643028|NCT05062980|Ramucirumab|ramucirumab|mesh-list
64643029|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643030|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
64643031|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
64643032|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
64643033|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643034|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643036|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
64643037|NCT05127876|Ondansetron|ondansetron|mesh-list
64643038|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
64643039|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
64643040|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643041|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643042|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64643043|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
64643044|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
64643045|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64643046|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
64643047|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643048|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643049|NCT05127876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64643050|NCT05127876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64643051|NCT05127876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643052|NCT05127876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64643053|NCT05127876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64643054|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64643055|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
64643056|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64643057|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
64643058|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64643059|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64643060|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
64643061|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
64643063|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
64643064|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64643065|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64643066|NCT05009862|Analgesics|analgesics|mesh-ancestor
64643067|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
64643068|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643069|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643070|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643071|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643072|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64643073|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64643074|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643075|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64643076|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64643077|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643078|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
64643079|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64643080|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
64643081|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64643082|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
64643083|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
64643084|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
64643085|NCT01496131|Goserelin|goserelin|mesh-list
64643086|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
64379534|NCT04225221|Hormones|hormones|mesh-ancestor
64379538|NCT04225221|Progestins|progestins|mesh-ancestor
64643087|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643088|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643089|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643090|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643091|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
64643092|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643093|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643101|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643102|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643103|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643104|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
64643105|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643106|NCT00450242|Lidocaine|lidocaine|mesh-list
64643107|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
64643108|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
64643109|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643110|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643111|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
64643112|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643113|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64643114|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64643115|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64643116|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643117|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643118|NCT00517010|Ranibizumab|ranibizumab|mesh-list
64643119|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64643120|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64643121|NCT00517010|Growth Substances|growth substances|mesh-ancestor
64643122|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643123|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
64643124|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643125|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
64643126|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
64643127|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64643128|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643129|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64643130|NCT00519584|Bupivacaine|bupivacaine|mesh-list
64643131|NCT00519584|Ropivacaine|ropivacaine|mesh-list
64643132|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
64643133|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
64643134|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643135|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643136|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
64643137|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643138|NCT05122884|Milrinone|milrinone|mesh-list
64643139|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64643140|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64643141|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
64643142|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64643143|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64643144|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643145|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643146|NCT05122884|Protective Agents|protective agents|mesh-ancestor
64643151|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64643152|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64643153|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64643154|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643155|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64643156|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643157|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64643158|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643159|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643160|NCT01395043|Epinephrine|epinephrine|mesh-list
64643161|NCT01395043|Bupivacaine|bupivacaine|mesh-list
64643162|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
64643163|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
64643164|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643165|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643166|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
64643167|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643168|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64643169|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64643170|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64643171|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643172|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643173|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64643174|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64643175|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
64643176|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64643177|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
64643178|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
64643179|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
64643180|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64643181|NCT00521456|Ketorolac|ketorolac|mesh-list
64643182|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64643183|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64643184|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64643185|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64643186|NCT00521456|Analgesics|analgesics|mesh-ancestor
64643187|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
64643188|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643189|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643190|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643191|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643192|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64643193|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643194|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643195|NCT03813108|Lumefantrine|lumefantrine|mesh-list
64643196|NCT03813108|Artemether|artemether|mesh-list
64643197|NCT03813108|Mefloquine|mefloquine|mesh-list
64643198|NCT03813108|Atovaquone|atovaquone|mesh-list
64643199|NCT03813108|Proguanil|proguanil|mesh-list
64643206|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643207|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643208|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
64643209|NCT01796366|Insulin|insulin|mesh-list
64643210|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64643211|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
64643212|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64643213|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643214|NCT03326180|Bupivacaine|bupivacaine|mesh-list
64643215|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
64643216|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
64643217|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643218|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643219|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
64643220|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643221|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64643222|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64643223|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64643224|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643225|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643226|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
64643227|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643228|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643229|NCT05119920|Pilocarpine|pilocarpine|mesh-list
64643230|NCT05119920|Miotics|miotics|mesh-ancestor
64643231|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
64643232|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643233|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643234|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64643235|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64643236|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643237|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643238|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643239|NCT01796444|Hormones|hormones|mesh-list
64643240|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643241|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643242|NCT01542541|Rifaximin|rifaximin|mesh-list
64643243|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64643244|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643245|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64643246|NCT00524264|Ketorolac|ketorolac|mesh-list
64643247|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64643248|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64643249|NCT00524264|Analgesics|analgesics|mesh-ancestor
64643258|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
64643259|NCT00452426|Narcotics|narcotics|mesh-ancestor
64643260|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643261|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643262|NCT00452426|Analgesics|analgesics|mesh-ancestor
64643263|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
64643264|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643265|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
64643266|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643267|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64643268|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643269|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643271|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643272|NCT00524576|Vaccines|vaccines|mesh-list
64643273|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
64643274|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643275|NCT04950660|Caffeine|caffeine|mesh-list
64643276|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64643277|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643278|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64643279|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643280|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643281|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64643282|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64643283|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
64643284|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643285|NCT02516202|Estradiol|estradiol|mesh-list
64643286|NCT02516202|Estrogens|estrogens|mesh-ancestor
64643287|NCT02516202|Hormones|hormones|mesh-ancestor
64643288|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643289|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643290|NCT00526058|Clotrimazole|clotrimazole|mesh-list
64643291|NCT00526058|Miconazole|miconazole|mesh-list
64643292|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64643293|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643294|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
64643295|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64643296|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64643297|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643298|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643299|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64643300|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
64303553|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643301|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643302|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643313|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643315|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643316|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
64643317|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643318|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643319|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64643320|NCT04521140|Dexamethasone|dexamethasone|mesh-list
64643321|NCT04521140|Prednisolone|prednisolone|mesh-list
64643322|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64643323|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
64643324|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64643325|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
64643327|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
64643328|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643330|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
64643331|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643332|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643333|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64643334|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
64643335|NCT04521140|Hormones|hormones|mesh-ancestor
64643336|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643337|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64643338|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643339|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64643340|NCT04521140|Protective Agents|protective agents|mesh-ancestor
64643341|NCT02124044|Asunaprevir|asunaprevir|mesh-list
64643342|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
64643343|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643344|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643345|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
64643346|NCT01502761|Analgesics|analgesics|mesh-ancestor
64643347|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
64643348|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643349|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643350|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
64643351|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643352|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64643357|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64643359|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64643360|NCT01504477|Bortezomib|bortezomib|mesh-list
64643361|NCT01504477|Panitumumab|panitumumab|mesh-list
64643362|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643363|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643364|NCT02124512|Rifaximin|rifaximin|mesh-list
64643365|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64368655|NCT03230227|Bupivacaine|bupivacaine|mesh-list
64643366|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643367|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64643368|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
64643369|NCT01504711|Aprepitant|aprepitant|mesh-list
64643370|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
64643371|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
64643372|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643373|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643374|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64643375|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64643376|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643377|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643378|NCT02209519|Metronidazole|metronidazole|mesh-list
64643379|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643380|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64643381|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64643382|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64643383|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
64643384|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64643385|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64643386|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64643387|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643388|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643389|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643390|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643391|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
64643392|NCT04946370|Androgens|androgens|mesh-list
64643393|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64643394|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643395|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643396|NCT04946370|Hormones|hormones|mesh-ancestor
64643397|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643398|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643400|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643402|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64643403|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643404|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643405|NCT01797848|Ribavirin|ribavirin|mesh-list
64643406|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64643407|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
64643408|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643409|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
64643410|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643412|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643413|NCT01398943|Protective Agents|protective agents|mesh-ancestor
64643414|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643415|NCT01550341|Buprenorphine|buprenorphine|mesh-list
64643418|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64643419|NCT01550341|Narcotics|narcotics|mesh-ancestor
64643420|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643421|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643422|NCT01550341|Analgesics|analgesics|mesh-ancestor
64643423|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
64643424|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643425|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64643426|NCT03946358|Atezolizumab|atezolizumab|mesh-list
64643427|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643428|NCT02125292|Mesalamine|mesalamine|mesh-list
64643429|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64643430|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64643431|NCT02125292|Analgesics|analgesics|mesh-ancestor
64643433|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643434|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643435|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643436|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643438|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64643439|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643440|NCT01653912|Paclitaxel|paclitaxel|mesh-list
64643441|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64643443|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64643444|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643445|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
64643446|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
64643447|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
64643448|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643449|NCT04132388|Adalimumab|adalimumab|mesh-list
64643450|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643451|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643452|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
64643453|NCT03693014|Nivolumab|nivolumab|mesh-list
64643454|NCT03693014|Ipilimumab|ipilimumab|mesh-list
64643455|NCT03693014|Atezolizumab|atezolizumab|mesh-list
64643456|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643457|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643458|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64643459|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643460|NCT04081688|Atezolizumab|atezolizumab|mesh-list
64643461|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64643462|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
64643463|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
64643464|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643465|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
64643466|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643467|NCT02514174|Afatinib|afatinib|mesh-list
64643468|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643469|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64643470|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643471|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643472|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
64643473|NCT02132468|Combretastatin|combretastatin|mesh-list
64643475|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643476|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
64643496|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643497|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64643498|NCT01508455|Narcotics|narcotics|mesh-ancestor
64643499|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64643500|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64643501|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
64643502|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
64643503|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64643504|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64643505|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64643506|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
64643507|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
64643508|NCT03095612|Docetaxel|docetaxel|mesh-list
64643509|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643512|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
64643513|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643514|NCT01509625|Fulvestrant|fulvestrant|mesh-list
64643515|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64643516|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643517|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64643518|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64643519|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
64643520|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643521|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643522|NCT02482428|Imiquimod|imiquimod|mesh-list
64643523|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64643524|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
64643525|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643526|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643527|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
64643528|NCT01510327|Aspirin|aspirin|mesh-list
64643529|NCT01510327|Everolimus|everolimus|mesh-list
64643530|NCT01510327|Ticlopidine|ticlopidine|mesh-list
64643531|NCT01510327|Clopidogrel|clopidogrel|mesh-list
64643532|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64643533|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64643534|NCT01510327|Analgesics|analgesics|mesh-ancestor
64643535|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
64643536|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643537|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643538|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643539|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643540|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64643541|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64643542|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643543|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64643544|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64643545|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643546|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
64643547|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643548|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643549|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
64643550|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64643551|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64643552|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64643553|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
64643554|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643555|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64643556|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64643557|NCT01401595|Dexetimide|dexetimide|mesh-list
64643558|NCT01401595|Citalopram|citalopram|mesh-list
64643559|NCT01401595|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64643560|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64643562|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643563|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643564|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
64643565|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643566|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64643569|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64643570|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64643571|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
64643573|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643574|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64643575|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64643576|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643577|NCT01511809|Ritonavir|ritonavir|mesh-list
64643578|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64643579|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64643580|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64643581|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
64643582|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643585|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64643586|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
64643587|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643588|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64643589|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64643590|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
64643591|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64643592|NCT02480712|Velpatasvir|velpatasvir|mesh-list
64643593|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
64643594|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643595|NCT03916094|Trastuzumab|trastuzumab|mesh-list
64643596|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643597|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643598|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
64643599|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643600|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643601|NCT00115700|Prednisolone|prednisolone|mesh-list
64643602|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
64643604|NCT00115700|Vincristine|vincristine|mesh-list
64643605|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643606|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
64643607|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643608|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643609|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643610|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
64643611|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643612|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643613|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64643614|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643615|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64643616|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
64643617|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
64643618|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64643619|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643620|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
64643621|NCT00115700|Hormones|hormones|mesh-ancestor
64643622|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643623|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64643626|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
64643627|NCT03243890|Vitamin D|vitamin d|mesh-list
64643628|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
64643629|NCT03243890|Vitamin K|vitamin k|mesh-list
64643630|NCT03243890|Vitamin MK 7|vitamin mk 7|mesh-list
64643631|NCT03243890|Vitamins|vitamins|mesh-ancestor
64643639|NCT03243890|Coagulants|coagulants|mesh-ancestor
64643641|NCT00560612|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64643642|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64643643|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643644|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643645|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643646|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
64643647|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643648|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64643649|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
64643650|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64643651|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64643652|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64643653|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643654|NCT01556347|Rituximab|rituximab|mesh-list
64643655|NCT01556347|Bortezomib|bortezomib|mesh-list
64643656|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
64643657|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64643658|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64643659|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643660|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643661|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
64643662|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643663|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643664|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643665|NCT00561002|Vaccines|vaccines|mesh-list
64643666|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
64643667|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643668|NCT03236792|Dexamethasone|dexamethasone|mesh-list
64643669|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
64643670|NCT03236792|Ixazomib|ixazomib|mesh-list
64643671|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643672|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
64643673|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643674|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643675|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643676|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
64643677|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643678|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643679|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64643680|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64643681|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
64643682|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
64643683|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643684|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64643685|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
64643686|NCT03236792|Hormones|hormones|mesh-ancestor
64643706|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
64643707|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643708|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64643709|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643710|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643711|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
64643712|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643713|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643714|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64643715|NCT03143270|Nivolumab|nivolumab|mesh-list
64643716|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643717|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643718|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64643719|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643732|NCT05566093|Polidocanol|polidocanol|mesh-list
64643733|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64643734|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643735|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643736|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643737|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64643738|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64643739|NCT01558063|Ketamine|ketamine|mesh-list
64643740|NCT01558063|Analgesics|analgesics|mesh-ancestor
64643741|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
64369034|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
64643742|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643743|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643744|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64643745|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64643746|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
64643747|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
64643748|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643749|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64643750|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64643751|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643752|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643753|NCT03641846|Tadalafil|tadalafil|mesh-list
64643754|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
64643755|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64643756|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64643757|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643758|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643759|NCT03641846|Urological Agents|urological agents|mesh-ancestor
64643760|NCT03474458|Doxycycline|doxycycline|mesh-list
64643761|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64643762|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64643763|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
64643764|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64643765|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64643766|NCT01516957|Brodalumab|brodalumab|mesh-list
64643767|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64643768|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
64643769|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
64643770|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643771|NCT01519063|Naltrexone|naltrexone|mesh-list
64643772|NCT01519063|Memantine|memantine|mesh-list
64643773|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64643774|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64643786|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64643787|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643788|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
64643789|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64643790|NCT05565625|Protective Agents|protective agents|mesh-ancestor
64643791|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643792|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
64643793|NCT00754208|Methylphenidate|methylphenidate|mesh-list
64643794|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64643795|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643796|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64643797|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64643798|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643799|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643800|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
64643801|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643802|NCT01562041|Ranolazine|ranolazine|mesh-list
64643803|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64643804|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643805|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643806|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
64643807|NCT00634166|Amphotericin B|amphotericin b|mesh-list
64643808|NCT00634166|Clotrimazole|clotrimazole|mesh-list
64643809|NCT00634166|Miconazole|miconazole|mesh-list
64643810|NCT00634166|Bacitracin|bacitracin|mesh-list
64643812|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64643813|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
64643814|NCT00634166|Amebicides|amebicides|mesh-ancestor
64643815|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64643816|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64643817|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64643818|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64643819|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64643820|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643821|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643823|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
64643824|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643825|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643826|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64643827|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64643828|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64643830|NCT00565370|Sorafenib|sorafenib|mesh-list
64643831|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643832|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64643833|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
64643834|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643835|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64643836|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643837|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
64643838|NCT03303950|Busulfan|busulfan|mesh-list
64643839|NCT03303950|Fludarabine|fludarabine|mesh-list
64643840|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64643842|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643843|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64643844|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64643845|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
64643846|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643847|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643848|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64643849|NCT01563055|Ofatumumab|ofatumumab|mesh-list
64643850|NCT01563055|Chlorambucil|chlorambucil|mesh-list
64643851|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643852|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64303659|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64643853|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
64643854|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643855|NCT00565916|Estradiol|estradiol|mesh-list
64643856|NCT00565916|Estrogens|estrogens|mesh-list
64643857|NCT00565916|Progesterone|progesterone|mesh-list
64643858|NCT00565916|Hormones|hormones|mesh-ancestor
64643859|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64643860|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643861|NCT00565916|Progestins|progestins|mesh-ancestor
64643862|NCT03258320|Docetaxel|docetaxel|mesh-list
64643863|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
64643864|NCT03258320|Satraplatin|satraplatin|mesh-list
64643865|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643866|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
64643867|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
64643868|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
64643869|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643870|NCT03258320|Analgesics|analgesics|mesh-ancestor
64643871|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
64643872|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643873|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643874|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64643875|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64643876|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64643877|NCT01797926|Losartan|losartan|mesh-list
64643878|NCT01797926|Amlodipine|amlodipine|mesh-list
64643879|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64643880|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64643881|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64643882|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643883|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64643887|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64643888|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64643889|NCT03008083|Clopidogrel|clopidogrel|mesh-list
64643891|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64643892|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64643893|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64643894|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64643896|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643897|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643898|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643899|NCT05559398|Glenzocimab|glenzocimab|mesh-list
64643900|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
64643901|NCT00566150|Levetiracetam|levetiracetam|mesh-list
64643902|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
64643903|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
64643904|NCT00566540|Paclitaxel|paclitaxel|mesh-list
64643905|NCT00566540|Cisplatin|cisplatin|mesh-list
64643906|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64643907|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643910|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
64643911|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643912|NCT00567008|Varenicline|varenicline|mesh-list
64643913|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64643914|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64643915|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643916|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643917|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643918|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643919|NCT00567320|Varenicline|varenicline|mesh-list
64643920|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64643921|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64643922|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643923|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643924|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643925|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643926|NCT01522417|Tirofiban|tirofiban|mesh-list
64643927|NCT01522417|Eptifibatide|eptifibatide|mesh-list
64643928|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64643929|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64643930|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643931|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64643938|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64643939|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
64643940|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643941|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643942|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64643943|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64643944|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643945|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643946|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643947|NCT03094286|Durvalumab|durvalumab|mesh-list
64643948|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64643949|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64643950|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
64643951|NCT03071666|Vitamins|vitamins|mesh-ancestor
64643952|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
64643953|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643954|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
64643955|NCT05533580|Sufentanil|sufentanil|mesh-list
64643956|NCT05533580|Dsuvia|dsuvia|mesh-list
64643957|NCT05533580|Propofol|propofol|mesh-list
64643958|NCT05533580|Cisatracurium|cisatracurium|mesh-list
64643959|NCT05533580|Atracurium|atracurium|mesh-list
64643960|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64643961|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643962|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643963|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64643964|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
64643965|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
64643966|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64643967|NCT05533580|Narcotics|narcotics|mesh-ancestor
64643968|NCT05533580|Analgesics|analgesics|mesh-ancestor
64643969|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
64643970|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643971|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64643972|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64643973|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64643974|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64643975|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64643976|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64643977|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
64643978|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643979|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643981|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
64643982|NCT02129426|Ketamine|ketamine|mesh-list
64643983|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64643984|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64643985|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64643986|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64643987|NCT02129426|Analgesics|analgesics|mesh-ancestor
64643988|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
64643989|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64643994|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64643995|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64643996|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64643997|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64643998|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
64644000|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64644001|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64644002|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64644003|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64644004|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64644005|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644008|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
64644009|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64644010|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644011|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644012|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64644013|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64644014|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
64644015|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64644016|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64644017|NCT02429570|Analgesics|analgesics|mesh-ancestor
64644018|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
64644019|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644020|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644021|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644023|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64644024|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644025|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644026|NCT05409716|Hemostatics|hemostatics|mesh-list
64644027|NCT05409716|Coagulants|coagulants|mesh-ancestor
64644028|NCT05395910|Paclitaxel|paclitaxel|mesh-list
64644029|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64644030|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644031|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
64644040|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644041|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644043|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
64644044|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644045|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64644046|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
64644047|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644048|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64644049|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64644050|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
64644051|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
64644052|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644053|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64644054|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64644055|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
64644056|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64644057|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64644058|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644059|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
64644060|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
64644061|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64644063|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64644064|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64644065|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64644066|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64644067|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64644068|NCT01566409|Laxatives|laxatives|mesh-ancestor
64644069|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644071|NCT02184416|Sorafenib|sorafenib|mesh-list
64644072|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644073|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644074|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
64644075|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644076|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64644077|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644078|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644079|NCT01568905|Nicotine|nicotine|mesh-list
64644080|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64644081|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
64644082|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644083|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644084|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64644085|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64644092|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644093|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644094|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
64644095|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644096|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644097|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64644098|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644099|NCT02132936|Calcipotriene|calcipotriene|mesh-list
64644100|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
64644101|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
64644102|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64644103|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644104|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644105|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64644106|NCT01528891|Analgesics|analgesics|mesh-ancestor
64644107|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
64644108|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644109|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64644110|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64644111|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64644112|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
64644113|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644114|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644115|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
64644116|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64644117|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64644118|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64644119|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644120|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644121|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
64644122|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644123|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644124|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64644125|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644127|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64644128|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64644129|NCT01667120|Analgesics|analgesics|mesh-ancestor
64644130|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
64644131|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644132|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644133|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644134|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644135|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64644136|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644137|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644138|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
64644139|NCT01529827|Methotrexate|methotrexate|mesh-list
64644140|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
64644141|NCT01529827|Fludarabine|fludarabine|mesh-list
64644146|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64644147|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644148|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64644149|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
64644150|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644151|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644152|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
64644153|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644154|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64644155|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644156|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
64644157|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644158|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64644159|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64644160|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64644161|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64644162|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
64644163|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64644164|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644165|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64644166|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
64644167|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64644169|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644170|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
64644171|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
64644172|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644173|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644174|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644175|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
64644177|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64644178|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64644179|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644180|NCT00569660|Azacitidine|azacitidine|mesh-list
64644181|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64644182|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
64644183|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644184|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644185|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644186|NCT01573273|Oxytocin|oxytocin|mesh-list
64644187|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
64644188|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64644189|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644190|NCT00572234|Bupropion|bupropion|mesh-list
64303710|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644191|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64644194|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64644195|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64644196|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644197|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644198|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
64644199|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644200|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644201|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64644202|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64644203|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644205|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64644206|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64644207|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
64644208|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644209|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64644210|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64644211|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644212|NCT02339246|Tacrolimus|tacrolimus|mesh-list
64644213|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644214|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
64644215|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644216|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64644217|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644218|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644219|NCT00572936|Timolol|timolol|mesh-list
64644220|NCT00572936|Dorzolamide|dorzolamide|mesh-list
64644221|NCT00572936|Latanoprost|latanoprost|mesh-list
64644222|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64644223|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64644224|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
64644225|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644226|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644227|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644228|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64644229|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64644230|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64644231|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64644232|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64644233|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644234|NCT05041946|Methylphenidate|methylphenidate|mesh-list
64644235|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64644236|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644237|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64644238|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64644239|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644250|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644251|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644252|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644253|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64644254|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644256|NCT05004896|Ketamine|ketamine|mesh-list
64644257|NCT05004896|Analgesics|analgesics|mesh-ancestor
64644258|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
64644259|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644260|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644261|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64644262|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64644263|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
64644264|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
64644265|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644266|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64644267|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64644268|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644269|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644270|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64644271|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64644272|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64644273|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64644274|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644275|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
64644276|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
64644277|NCT00576680|Temozolomide|temozolomide|mesh-list
64644279|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64644280|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
64644281|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644282|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644283|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644284|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
64644285|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644286|NCT04866602|Atovaquone|atovaquone|mesh-list
64644287|NCT04866602|Proguanil|proguanil|mesh-list
64644288|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64644289|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644297|NCT00578552|Analgesics|analgesics|mesh-ancestor
64644298|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
64644299|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644300|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644301|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
64644302|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64644303|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64644304|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644305|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644306|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64644307|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64644308|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644309|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644310|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
64644311|NCT01532089|Bevacizumab|bevacizumab|mesh-list
64644312|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64644313|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64644314|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
64644316|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
64644317|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64644318|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
64644319|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644320|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64644321|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64644322|NCT01532089|Growth Substances|growth substances|mesh-ancestor
64644323|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644324|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64644325|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
64644326|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64644327|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644328|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644329|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
64644330|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
64644331|NCT00579878|Methotrexate|methotrexate|mesh-list
64644332|NCT00579878|Leflunomide|leflunomide|mesh-list
64644333|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64644334|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
64644335|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64644336|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644337|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64644338|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
64644339|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644340|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644341|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
64644342|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644343|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64644344|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644345|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
64644346|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644347|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64644348|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
64644349|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64644350|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64644357|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644358|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644359|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64644363|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644364|NCT05246072|Ivermectin|ivermectin|mesh-list
64644365|NCT05246072|Colchicine|colchicine|mesh-list
64644366|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
64644367|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644368|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
64644369|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
64644370|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
64644371|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644372|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644373|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64644374|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349099|NCT01378975|Vemurafenib|vemurafenib|mesh-list
64644376|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64644377|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644378|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644379|NCT05245994|Carboplatin|carboplatin|mesh-list
64644380|NCT05245994|Etoposide|etoposide|mesh-list
64644381|NCT05245994|Durvalumab|durvalumab|mesh-list
64644382|NCT05245994|Olaparib|olaparib|mesh-list
64644383|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644384|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64644385|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64644386|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64644387|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644388|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644389|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644390|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64644391|NCT05245604|Cyclosporine|cyclosporine|mesh-list
64644392|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64644393|NCT05245604|Cyclosporins|cyclosporins|mesh-list
64644394|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644395|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644411|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644412|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
64644413|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64644414|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644415|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644416|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64644417|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644418|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644419|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
64644420|NCT00581048|Vitamin E|vitamin e|mesh-list
64644421|NCT00581048|Tocopherols|tocopherols|mesh-list
64644422|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
64644423|NCT00581048|Vitamins|vitamins|mesh-ancestor
64644424|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
64644425|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644426|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
64644427|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644428|NCT00581048|Protective Agents|protective agents|mesh-ancestor
64644429|NCT01798472|Cimetidine|cimetidine|mesh-list
64644430|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64644431|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644432|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64644433|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
64644434|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
64644435|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644436|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644437|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644438|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64644439|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64644450|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
64644451|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
64644452|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644453|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644454|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644455|NCT01579513|Hormones|hormones|mesh-ancestor
64644456|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64644457|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64644458|NCT01579513|Protective Agents|protective agents|mesh-ancestor
64644459|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64644460|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644461|NCT01534897|Dabrafenib|dabrafenib|mesh-list
64644462|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644463|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64644464|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644465|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644466|NCT05121350|Epirubicin|epirubicin|mesh-list
64644467|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64644468|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644469|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64644470|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64644471|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644472|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644473|NCT00583622|Gemcitabine|gemcitabine|mesh-list
64644474|NCT00583622|Bevacizumab|bevacizumab|mesh-list
64644475|NCT00583622|Carboplatin|carboplatin|mesh-list
64644476|NCT00583622|Docetaxel|docetaxel|mesh-list
64644477|NCT00583622|Melphalan|melphalan|mesh-list
64644478|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644479|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644480|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64644481|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64644482|NCT00583622|Growth Substances|growth substances|mesh-ancestor
64644483|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644484|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
64644485|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64644486|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
64644488|NCT00583622|Antiviral Agents|antiviral agents|mesh-ancestor
64644489|NCT00583622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369786|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644490|NCT00583622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644491|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644492|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
64644493|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
64644494|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
64644495|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
64644496|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64644497|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
64644498|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64644500|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
64644501|NCT00583700|Vitamins|vitamins|mesh-ancestor
64644502|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
64644503|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644504|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
64644505|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644506|NCT00583700|Protective Agents|protective agents|mesh-ancestor
64644507|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64644508|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644509|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64644510|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64644511|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
64644512|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64644514|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644515|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644516|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
64644517|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
64644518|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64644519|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64644520|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644521|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644522|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644523|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644524|NCT04257188|Anesthetics|anesthetics|mesh-list
64644525|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644526|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644527|NCT04224428|Fexofenadine|fexofenadine|mesh-list
64644528|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64644537|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644538|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644539|NCT00584948|Memantine|memantine|mesh-list
64644540|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64644541|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64644542|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
64644543|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644544|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644545|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644546|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64644547|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64644548|NCT00605072|Metoprolol|metoprolol|mesh-list
64644549|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64644550|NCT00605072|Candesartan|candesartan|mesh-list
64644551|NCT00605072|Lisinopril|lisinopril|mesh-list
64644552|NCT00605072|Nifedipine|nifedipine|mesh-list
64644553|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64644554|NCT00605072|Diuretics|diuretics|mesh-ancestor
64644555|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
64644556|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644557|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64644558|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644559|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644560|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64644561|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
64644562|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
64644563|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644564|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64644565|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64369873|NCT02484209|Metformin|metformin|mesh-list
64644566|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64644567|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
64644568|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644569|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64644570|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64644571|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64644572|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64644573|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
64644574|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
64644575|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64644584|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64644585|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64644586|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644587|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644588|NCT00585104|Protective Agents|protective agents|mesh-ancestor
64644589|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644590|NCT00585182|Enoxaparin|enoxaparin|mesh-list
64644591|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
64644592|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64644593|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64644594|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644595|NCT00585650|Etanercept|etanercept|mesh-list
64644596|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64644597|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64644598|NCT00585650|Analgesics|analgesics|mesh-ancestor
64644599|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
64644600|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644601|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644602|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644603|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644604|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644605|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644606|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
64644607|NCT04856228|Lidocaine|lidocaine|mesh-list
64644608|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
64644609|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
64644610|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644611|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644612|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
64644613|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644614|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64644615|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64644616|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64644617|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644618|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644619|NCT00605384|Tenofovir|tenofovir|mesh-list
64644620|NCT00605384|Lamivudine|lamivudine|mesh-list
64644628|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644630|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64644631|NCT00586196|Donepezil|donepezil|mesh-list
64644632|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64644633|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644634|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644635|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
64644636|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369945|NCT04991181|Zamicastat|zamicastat|mesh-list
64644637|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644638|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
64644639|NCT00605696|Insulin|insulin|mesh-list
64644640|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64644641|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644642|NCT00587132|Secretin|secretin|mesh-list
64644643|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644644|NCT00587132|Hormones|hormones|mesh-ancestor
64644645|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64644646|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644647|NCT00587678|Simvastatin|simvastatin|mesh-list
64644648|NCT00587678|Ezetimibe|ezetimibe|mesh-list
64644649|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64644650|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64644651|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
64644652|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644653|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64644654|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64644655|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644656|NCT02138006|Insulin|insulin|mesh-list
64644657|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64644658|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64644659|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644660|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
64644661|NCT04545008|Famotidine|famotidine|mesh-list
64644662|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64644663|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
64644664|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644665|NCT04545008|Expectorants|expectorants|mesh-ancestor
64644666|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
64644667|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64644669|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644670|NCT04545008|Protective Agents|protective agents|mesh-ancestor
64644671|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644672|NCT04545008|Antidotes|antidotes|mesh-ancestor
64644673|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64644674|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644675|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64644676|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
64644677|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
64644680|NCT04527770|Midazolam|midazolam|mesh-list
64644681|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644682|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
64644683|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
64644684|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644685|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644686|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644687|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
64644688|NCT04527770|Hormones|hormones|mesh-ancestor
64644689|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64644690|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64644691|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644692|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64644693|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64644694|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644695|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64644696|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64644697|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644698|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64644699|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
64644700|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
64644701|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
64644702|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
64644703|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644704|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644705|NCT01798940|Pioglitazone|pioglitazone|mesh-list
64644724|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
64644725|NCT00668564|Busulfan|busulfan|mesh-list
64644726|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
64644727|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644728|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
64644729|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644730|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644731|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64644732|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
64644733|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644734|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644735|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64644736|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644737|NCT00610688|Vitamin D|vitamin d|mesh-list
64644748|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64644749|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64644750|NCT00669578|Growth Substances|growth substances|mesh-ancestor
64644751|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
64644752|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644753|NCT02137382|Pancrelipase|pancrelipase|mesh-list
64644754|NCT02137382|Pancreatin|pancreatin|mesh-list
64644755|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644756|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64644757|NCT00611468|Topotecan|topotecan|mesh-list
64644758|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644759|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64644760|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644761|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644762|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64644763|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64644764|NCT00670202|Fasudil|fasudil|mesh-list
64644765|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64644766|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644767|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644768|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64644769|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644770|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
64644771|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64644772|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644773|NCT00670982|Bevacizumab|bevacizumab|mesh-list
64644774|NCT00670982|Trastuzumab|trastuzumab|mesh-list
64644775|NCT00670982|Vinorelbine|vinorelbine|mesh-list
64644776|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644777|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644778|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64644779|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64644780|NCT00670982|Growth Substances|growth substances|mesh-ancestor
64644781|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644795|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64644796|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
64644797|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64644798|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644801|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644802|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
64644803|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644804|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644805|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64644806|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
64644807|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644808|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644809|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64644810|NCT04220684|Cytarabine|cytarabine|mesh-list
64644811|NCT04220684|Fludarabine|fludarabine|mesh-list
64644812|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644813|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64644814|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
64644815|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644816|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64644817|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
64644818|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644819|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
64644820|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644821|NCT00613028|Bevacizumab|bevacizumab|mesh-list
64644822|NCT00613028|Etoposide|etoposide|mesh-list
64644823|NCT00613028|Temozolomide|temozolomide|mesh-list
64644824|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644825|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644833|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64644834|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644835|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644836|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64644837|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
64644839|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64644840|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644841|NCT00614198|Caseins|caseins|mesh-list
64644842|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
64644843|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
64644844|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644845|NCT00616772|Choline|choline|mesh-list
64644846|NCT00616772|Atorvastatin|atorvastatin|mesh-list
64644847|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
64644848|NCT00616772|Fenofibrate|fenofibrate|mesh-list
64644849|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64644850|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64644851|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
64644852|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644853|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64644854|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64644855|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644856|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
64644857|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64644858|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
64644859|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64644860|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64644861|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64644862|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64370156|NCT02482961|Colistin|colistin|mesh-list
64644863|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
64644864|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64644865|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64644874|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
64644875|NCT00673712|Narcotics|narcotics|mesh-ancestor
64644876|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644877|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644878|NCT00673712|Analgesics|analgesics|mesh-ancestor
64644879|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
64644880|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644881|NCT04062032|Aspirin|aspirin|mesh-list
64644882|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64644883|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64644884|NCT04062032|Analgesics|analgesics|mesh-ancestor
64644885|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
64644886|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644887|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644888|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644889|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644890|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64644891|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64644892|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644893|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64644894|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64644895|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644896|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
64644897|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64644898|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
64644899|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64644900|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64303881|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64644901|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64644902|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644903|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644905|NCT03722966|Varenicline|varenicline|mesh-list
64644906|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64644907|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
64644912|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
64644913|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644914|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644915|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
64644916|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644917|NCT01582477|Bupivacaine|bupivacaine|mesh-list
64644918|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
64644919|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
64644920|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64644921|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644922|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
64644923|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644924|NCT03001687|Vitamin D|vitamin d|mesh-list
64644925|NCT03001687|Vitamins|vitamins|mesh-ancestor
64644926|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
64644927|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644928|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64644929|NCT03001609|Abivertinib|abivertinib|mesh-list
64644930|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64644931|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644932|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644933|NCT03007381|Ketorolac|ketorolac|mesh-list
64644934|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64644935|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64644936|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370234|NCT03198637|Cisatracurium|cisatracurium|mesh-list
64644937|NCT03007381|Analgesics|analgesics|mesh-ancestor
64644938|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
64644939|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64644940|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644941|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64644942|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64644943|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64644944|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644945|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644946|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64644947|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64644948|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64644949|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
64644950|NCT01585207|Vigabatrin|vigabatrin|mesh-list
64644951|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
64644952|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644953|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644954|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
64644955|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64644956|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644957|NCT03007303|Olanzapine|olanzapine|mesh-list
64644958|NCT03007303|Risperidone|risperidone|mesh-list
64644959|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64644960|NCT03007303|Ziprasidone|ziprasidone|mesh-list
64644961|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
64644962|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64644963|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
64644977|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64644978|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64644980|NCT01585441|Finasteride|finasteride|mesh-list
64644981|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64644982|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64644983|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64644984|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644985|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
64644986|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64644987|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64644988|NCT01585441|Urological Agents|urological agents|mesh-ancestor
64644989|NCT00617942|Paclitaxel|paclitaxel|mesh-list
64644990|NCT00617942|Carboplatin|carboplatin|mesh-list
64644991|NCT00617942|Trastuzumab|trastuzumab|mesh-list
64644992|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64644993|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64644994|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
64644995|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
64644996|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
64644997|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64644998|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64644999|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
64645000|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645001|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645002|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64645004|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64645005|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
64645006|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645007|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645008|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64645009|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64645010|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
64645017|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64645018|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645019|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645021|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
64645022|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645023|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645024|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64645025|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64645026|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
64645027|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64645028|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64645029|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64645030|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64645032|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64645033|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64645034|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64645035|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
64645036|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645037|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645038|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645039|NCT01589263|Urological Agents|urological agents|mesh-ancestor
64645040|NCT01590979|Ranolazine|ranolazine|mesh-list
64645041|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64645042|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645043|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645044|NCT00619970|Rifaximin|rifaximin|mesh-list
64645045|NCT00619970|Lactulose|lactulose|mesh-list
64645046|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64645047|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64645048|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645049|NCT01591837|Vaccines|vaccines|mesh-list
64645050|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
64645051|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645052|NCT01592851|Fluorides|fluorides|mesh-list
64645053|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
64645054|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
64645055|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
64645056|NCT01592851|Protective Agents|protective agents|mesh-ancestor
64645057|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645058|NCT00675584|Budesonide|budesonide|mesh-list
64645059|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645060|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64645061|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
64645062|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645063|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645064|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64645076|NCT00676364|Lidocaine|lidocaine|mesh-list
64645077|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
64645078|NCT00676364|Anesthetics|anesthetics|mesh-list
64645079|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645080|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645081|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
64645082|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645083|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64645084|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64645085|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64645086|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645087|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645090|NCT00676676|Hormones|hormones|mesh-ancestor
64645091|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645092|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645093|NCT00677924|Zalutumumab|zalutumumab|mesh-list
64645094|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64645095|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645096|NCT03177122|Inositol|inositol|mesh-list
64645097|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
64645098|NCT03177122|Vitamins|vitamins|mesh-ancestor
64645099|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
64645100|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645101|NCT00621530|Ketorolac|ketorolac|mesh-list
64645102|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64645103|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64645104|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645105|NCT00621530|Analgesics|analgesics|mesh-ancestor
64645106|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
64645107|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645108|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645109|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645110|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645111|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64645121|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64645122|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64645123|NCT00621686|Growth Substances|growth substances|mesh-ancestor
64645124|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645125|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
64645126|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64645127|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645128|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645129|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
64645130|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645131|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64645132|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645133|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645135|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645136|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
64645137|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645138|NCT00623012|Sirolimus|sirolimus|mesh-list
64645139|NCT00623012|Tacrolimus|tacrolimus|mesh-list
64645140|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64645141|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
64645142|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303934|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645143|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64645144|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645145|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645146|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64645147|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645148|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64645149|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645150|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
64645151|NCT02592356|Lenvatinib|lenvatinib|mesh-list
64645152|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645153|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64645154|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645155|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645156|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
64645157|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
64645158|NCT02446964|Fludarabine|fludarabine|mesh-list
64645159|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
64645160|NCT02446964|Tacrolimus|tacrolimus|mesh-list
64645161|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64645167|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645168|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645169|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64645170|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64645171|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
64645172|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64645173|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645174|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64645175|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64645176|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
64645177|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64645178|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645179|NCT01799954|Vaccines|vaccines|mesh-list
64645180|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
64645181|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645182|NCT00623714|Fluticasone|fluticasone|mesh-list
64645184|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645185|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64645186|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
64645187|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645188|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645189|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64645190|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
64645191|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645192|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64645193|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64645194|NCT02174822|Paroxetine|paroxetine|mesh-list
64645195|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64645196|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64645197|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645198|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645199|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645200|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645201|NCT02174822|Analgesics|analgesics|mesh-ancestor
64645203|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645204|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
64645205|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64645206|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
64645207|NCT02174822|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64645208|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
64645209|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64645210|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64645211|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64645212|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645213|NCT00624416|Prednisolone|prednisolone|mesh-list
64645214|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64645215|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
64645216|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64645217|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
64645218|NCT00624416|Cortisone|cortisone|mesh-list
64645219|NCT00624416|Isoproterenol|isoproterenol|mesh-list
64645220|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64645221|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
64645232|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64645233|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64645234|NCT00624416|Protective Agents|protective agents|mesh-ancestor
64645235|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64645236|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64645237|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
64645238|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645239|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645240|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64645241|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64645242|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
64645243|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64645244|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
64645245|NCT01872260|Letrozole|letrozole|mesh-list
64645246|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645247|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64645248|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64645249|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645250|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645251|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64645252|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
64645253|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645254|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645255|NCT00626210|Modafinil|modafinil|mesh-list
64645256|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64645257|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645258|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64645259|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64645260|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64645262|NCT00653276|Cyclosporine|cyclosporine|mesh-list
64645263|NCT00653276|Ezetimibe|ezetimibe|mesh-list
64645264|NCT00653276|Cyclosporins|cyclosporins|mesh-list
64645265|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645266|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645267|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64645268|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
64645269|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645270|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
64645271|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645272|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645292|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
64645293|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64645294|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64645295|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64645296|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64645298|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64645299|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64645300|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64645301|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64645302|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
64645305|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645306|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
64645307|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
64645308|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64645309|NCT03006757|Protective Agents|protective agents|mesh-ancestor
64645310|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645318|NCT03000127|Hormones|hormones|mesh-ancestor
64645319|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645320|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645321|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
64645322|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64645323|NCT02999815|Antibodies|antibodies|mesh-list
64645324|NCT02999815|Antitoxins|antitoxins|mesh-list
64645325|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
64645326|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645327|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
64645328|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64645329|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645330|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645331|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645332|NCT05134363|Analgesics|analgesics|mesh-ancestor
64645333|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
64645334|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645335|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64645336|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64645337|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64645338|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
64645344|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64645345|NCT03006679|Vaborbactam|vaborbactam|mesh-list
64645346|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64645347|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645348|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64645349|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645350|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645351|NCT03006445|Dotinurad|dotinurad|mesh-list
64645352|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
64645353|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
64645354|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645355|NCT03006445|Renal Agents|renal agents|mesh-ancestor
64645356|NCT05011123|Vaccines|vaccines|mesh-list
64645357|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
64645358|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645359|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
64645360|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
64645361|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64645362|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
64645363|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
64645364|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645365|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645366|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645367|NCT03006211|Analgesics|analgesics|mesh-ancestor
64645368|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
64645369|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645370|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64645371|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
64645372|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64645373|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
64645374|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64645375|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
64645376|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645385|NCT02247505|Tamsulosin|tamsulosin|mesh-list
64645386|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
64645387|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64303946|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64303953|NCT05284214|Ipilimumab|ipilimumab|mesh-list
64645389|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645390|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645391|NCT02247505|Urological Agents|urological agents|mesh-ancestor
64645392|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64645393|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64645394|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64645395|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64645396|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645397|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645398|NCT04707625|Aflibercept|aflibercept|mesh-list
64645399|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64645400|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64645401|NCT04707625|Growth Substances|growth substances|mesh-ancestor
64645402|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645403|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
64645404|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645405|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64645406|NCT02248129|Telmisartan|telmisartan|mesh-list
64645407|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64645408|NCT02248129|Diuretics|diuretics|mesh-ancestor
64645409|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
64645410|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645411|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64645412|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645413|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645414|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64645415|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64645416|NCT02248207|Pramipexole|pramipexole|mesh-list
64645417|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
64645418|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645419|NCT02248207|Protective Agents|protective agents|mesh-ancestor
64645420|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645421|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64645422|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64645423|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
64645424|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
64645425|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645426|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
64645427|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64645431|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645432|NCT05672095|Selenium|selenium|mesh-list
64645433|NCT05672095|Niraparib|niraparib|mesh-list
64645434|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64645435|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645436|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645437|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645438|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
64645439|NCT05672095|Protective Agents|protective agents|mesh-ancestor
64645440|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645441|NCT05672095|Trace Elements|trace elements|mesh-ancestor
64645442|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
64645443|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
64645444|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64645445|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645447|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
64645448|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64645449|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645450|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645451|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645452|NCT00684242|Lenalidomide|lenalidomide|mesh-list
64645453|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
64645456|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64645457|NCT00684242|Growth Substances|growth substances|mesh-ancestor
64645458|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
64645459|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645460|NCT00651560|Simvastatin|simvastatin|mesh-list
64645461|NCT00651560|Ezetimibe|ezetimibe|mesh-list
64645462|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64645463|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64645464|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
64645465|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645466|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64645467|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64645468|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645469|NCT00684554|Buprenorphine|buprenorphine|mesh-list
64645470|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64645471|NCT00684554|Narcotics|narcotics|mesh-ancestor
64645472|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645473|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645474|NCT00684554|Analgesics|analgesics|mesh-ancestor
64645475|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
64645476|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645477|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64645478|NCT00551876|Simvastatin|simvastatin|mesh-list
64645479|NCT00551876|Ezetimibe|ezetimibe|mesh-list
64645480|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64645481|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64645482|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
64645483|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645484|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64645485|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64645486|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645487|NCT04451863|Caryophyllene|caryophyllene|mesh-list
64645488|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645489|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645490|NCT04451863|Analgesics|analgesics|mesh-ancestor
64645491|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
64645492|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645493|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64645495|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645496|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64645497|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64645503|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645506|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64645507|NCT00251576|Tinzaparin|tinzaparin|mesh-list
64645508|NCT00251576|Dalteparin|dalteparin|mesh-list
64645509|NCT00251576|Tirofiban|tirofiban|mesh-list
64645510|NCT00251576|Simvastatin|simvastatin|mesh-list
64645511|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
64645512|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64645513|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64645514|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645515|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64645516|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64645517|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
64645518|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64645519|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64645520|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645521|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64645522|NCT04387604|Ranibizumab|ranibizumab|mesh-list
64645523|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64645524|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64645525|NCT04387604|Growth Substances|growth substances|mesh-ancestor
64645526|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645527|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
64645528|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645529|NCT03005665|Acetazolamide|acetazolamide|mesh-list
64645530|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
64645531|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64645532|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645533|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645535|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
64645542|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645544|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645545|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645547|NCT04386811|Vitamins|vitamins|mesh-ancestor
64645548|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
64645549|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64645550|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
64645551|NCT04357873|Vorinostat|vorinostat|mesh-list
64645552|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64645553|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645554|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64645555|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645556|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645557|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64645558|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
64645559|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645560|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
64645561|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
64645562|NCT05671081|Analgesics|analgesics|mesh-list
64645563|NCT05671081|Narcotics|narcotics|mesh-list
64645564|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64645565|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645566|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645567|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645568|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
64645569|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645570|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64645571|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64645572|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64645573|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64645574|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645575|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645576|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
64645577|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64645578|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
64645579|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64645580|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645581|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64645582|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
64645583|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64645584|NCT00630734|Ritonavir|ritonavir|mesh-list
64645585|NCT00630734|Darunavir|darunavir|mesh-list
64645586|NCT00630734|Pravastatin|pravastatin|mesh-list
64645589|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
64645590|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645591|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645592|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64645593|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64645594|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
64645595|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645596|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64645601|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64645602|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64645604|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370905|NCT05249621|Diuretics|diuretics|mesh-ancestor
64645605|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64645606|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64645607|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64645608|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645609|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645610|NCT00631358|Dexamethasone|dexamethasone|mesh-list
64645611|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645612|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
64645613|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
64645614|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645615|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645616|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64645617|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
64645618|NCT00631358|Hormones|hormones|mesh-ancestor
64645619|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645620|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64645621|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645622|NCT02248753|Metoprolol|metoprolol|mesh-list
64645625|NCT02248753|Verapamil|verapamil|mesh-list
64645626|NCT02248753|Flecainide|flecainide|mesh-list
64645627|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64645628|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64645629|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
64645630|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
64645631|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645632|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645633|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64645634|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64645635|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64645636|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
64645637|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64645638|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645639|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64645640|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645641|NCT02248753|Protective Agents|protective agents|mesh-ancestor
64645642|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
64645643|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64645644|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645645|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64645646|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64645647|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64645648|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64645649|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64645650|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64645651|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64645652|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64645653|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64645655|NCT00687674|Lenalidomide|lenalidomide|mesh-list
64645656|NCT00687674|Sorafenib|sorafenib|mesh-list
64645657|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645658|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
64645659|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
64645660|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645661|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645662|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64645663|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
64645664|NCT00687674|Hormones|hormones|mesh-ancestor
64645665|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645666|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64645667|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645668|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
64645669|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64645670|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64645671|NCT00687674|Growth Substances|growth substances|mesh-ancestor
64645672|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
64645673|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64645674|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645675|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645676|NCT04143061|Vaccines|vaccines|mesh-list
64645677|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
64645678|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645679|NCT00687908|Adapalene|adapalene|mesh-list
64645680|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64645681|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370976|NCT04448873|Sirolimus|sirolimus|mesh-list
64645682|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64645683|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645684|NCT00687908|Analgesics|analgesics|mesh-ancestor
64645685|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
64645686|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645687|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645688|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645689|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645690|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64645691|NCT00689078|Prednisolone|prednisolone|mesh-list
64645692|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64645693|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
64645694|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64645695|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
64645696|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
64645697|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64645698|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
64645699|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64645700|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
64645701|NCT00689078|Hormones|hormones|mesh-ancestor
64645702|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645703|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645704|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64645705|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645706|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
64645707|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
64645708|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645709|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64645710|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64645711|NCT00689078|Protective Agents|protective agents|mesh-ancestor
64645712|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64645713|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64645717|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645718|NCT03005353|Clotrimazole|clotrimazole|mesh-list
64645719|NCT03005353|Miconazole|miconazole|mesh-list
64645720|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64645721|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645722|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
64645723|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64645724|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64645725|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645726|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645727|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64645728|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
64645729|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645730|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645731|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64645732|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64645734|NCT00588536|Methotrexate|methotrexate|mesh-list
64645735|NCT00588536|Thioguanine|thioguanine|mesh-list
64645736|NCT00588536|Calcium|calcium|mesh-list
64645737|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
64645738|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64645739|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645740|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64645741|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
64645742|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64645743|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64645744|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
64645745|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645746|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645747|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645748|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645749|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64645750|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64645751|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
64645752|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645753|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64645755|NCT00588536|Protective Agents|protective agents|mesh-ancestor
64645756|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
64645757|NCT00588536|Vitamins|vitamins|mesh-ancestor
64645758|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
64645759|NCT03977233|Leucovorin|leucovorin|mesh-list
64645760|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
64645761|NCT03977233|Irinotecan|irinotecan|mesh-list
64645762|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645763|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64645764|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64645765|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645767|NCT03977233|Antidotes|antidotes|mesh-ancestor
64645768|NCT03977233|Protective Agents|protective agents|mesh-ancestor
64645769|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645770|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
64645772|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
64645773|NCT03951649|Acetaminophen|acetaminophen|mesh-list
64645774|NCT03951649|Caffeine|caffeine|mesh-list
64645775|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645776|NCT03951649|Analgesics|analgesics|mesh-ancestor
64645777|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
64645778|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645779|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645780|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
64645798|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64645799|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
64645800|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645801|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64645802|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64645803|NCT00592124|Tenofovir|tenofovir|mesh-list
64645804|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
64645805|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645806|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64645807|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64645808|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645809|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645810|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64645811|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64645812|NCT02221219|Indomethacin|indomethacin|mesh-list
64645813|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64645816|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
64645817|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645818|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645825|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645826|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645827|NCT03875287|Decitabine|decitabine|mesh-list
64645828|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64645829|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
64645830|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645831|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645832|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645833|NCT00593450|Bevacizumab|bevacizumab|mesh-list
64645834|NCT00593450|Ranibizumab|ranibizumab|mesh-list
64645835|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64645836|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645837|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64645838|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64645839|NCT00593450|Growth Substances|growth substances|mesh-ancestor
64645840|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645841|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
64645842|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64645843|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
64645844|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64645845|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64645846|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64645847|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645848|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645849|NCT00594230|Panobinostat|panobinostat|mesh-list
64645850|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645851|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64645852|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645853|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645854|NCT00594308|Cyclosporine|cyclosporine|mesh-list
64645855|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
64645856|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
64645857|NCT00594308|Fludarabine|fludarabine|mesh-list
64645858|NCT00594308|Cyclosporins|cyclosporins|mesh-list
64645859|NCT00594308|Basiliximab|basiliximab|mesh-list
64645860|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64645861|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
64645863|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645864|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64645865|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
64645866|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645867|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645868|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64645869|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645870|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
64645871|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64645872|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645878|NCT02137538|Letrozole|letrozole|mesh-list
64645879|NCT02137538|Anastrozole|anastrozole|mesh-list
64645880|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645881|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64645882|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64645883|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645884|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645886|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
64645887|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64645888|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645889|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64645891|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
64645892|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64645893|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645894|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645895|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64645896|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645897|NCT00595790|Vaccines|vaccines|mesh-list
64645898|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
64645899|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645900|NCT00595946|Lubiprostone|lubiprostone|mesh-list
64645901|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64645902|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645903|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645904|NCT00597038|Dasatinib|dasatinib|mesh-list
64645905|NCT00597038|Dacarbazine|dacarbazine|mesh-list
64645906|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645907|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64645908|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645909|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645910|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64645911|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
64645912|NCT00597428|Lubiprostone|lubiprostone|mesh-list
64645913|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64645914|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64645915|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645916|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64645917|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64645918|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64645919|NCT00597818|Analgesics|analgesics|mesh-ancestor
64645920|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
64645921|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645923|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645924|NCT00597896|Pramipexole|pramipexole|mesh-list
64645925|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
64645926|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645927|NCT00597896|Protective Agents|protective agents|mesh-ancestor
64645928|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645929|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64645930|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64645947|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
64645948|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64645949|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
64645950|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645951|NCT03843541|Protective Agents|protective agents|mesh-ancestor
64645952|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645953|NCT03843541|Antidotes|antidotes|mesh-ancestor
64645954|NCT00639158|Choline|choline|mesh-list
64645955|NCT00639158|Atorvastatin|atorvastatin|mesh-list
64645956|NCT00639158|Ezetimibe|ezetimibe|mesh-list
64645958|NCT00639158|Fenofibrate|fenofibrate|mesh-list
64645959|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64645960|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64645961|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
64645962|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64645963|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64645964|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64645965|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64645966|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
64645968|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
64645969|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
64645970|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64645971|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64645972|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645979|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64645980|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645981|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64645982|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
64645983|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
64645984|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64645985|NCT00601718|Rituximab|rituximab|mesh-list
64645986|NCT00601718|Carboplatin|carboplatin|mesh-list
64645987|NCT00601718|Etoposide|etoposide|mesh-list
64645988|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
64645989|NCT00601718|Ifosfamide|ifosfamide|mesh-list
64645990|NCT00601718|Vorinostat|vorinostat|mesh-list
64645991|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64645992|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64645993|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
64645994|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64645995|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64645996|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64645997|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64645998|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64645999|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646000|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646001|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64646002|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
64646003|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64646004|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
64646005|NCT00601796|Tretinoin|tretinoin|mesh-list
64646006|NCT00601796|Vaccines|vaccines|mesh-list
64646007|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
64646008|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646009|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646010|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64646011|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304087|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646012|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
64646013|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646014|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646015|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64646016|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
64646017|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
64646018|NCT00693992|Sunitinib|sunitinib|mesh-list
64646019|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646020|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646021|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64646022|NCT00693992|Growth Substances|growth substances|mesh-ancestor
64646023|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646024|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
64646025|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64646026|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646027|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646028|NCT00645710|Gemcitabine|gemcitabine|mesh-list
64646029|NCT00645710|Floxuridine|floxuridine|mesh-list
64646036|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646038|NCT00645710|Antiviral Agents|antiviral agents|mesh-ancestor
64646039|NCT00645710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646040|NCT00645710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646041|NCT00645710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646042|NCT00603044|Fluticasone|fluticasone|mesh-list
64646043|NCT00603044|Xhance|xhance|mesh-list
64646044|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646045|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64646046|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
64646047|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646048|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646049|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64646050|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
64646051|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
64646052|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64646053|NCT00646646|Midazolam|midazolam|mesh-list
64646054|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
64646055|NCT00646646|Propofol|propofol|mesh-list
64646056|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64646057|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646058|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646059|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64371349|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
64646060|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
64646061|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
64646062|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64646063|NCT00646646|Analgesics|analgesics|mesh-ancestor
64646064|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
64646065|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646066|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64646067|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64646068|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64646069|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
64646070|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646071|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646072|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64646073|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64646074|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646087|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646088|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64646090|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646091|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
64646092|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646093|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
64646094|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64646095|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646096|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646097|NCT00650078|Prednisone|prednisone|mesh-list
64646098|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646099|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
64646100|NCT00650078|Hormones|hormones|mesh-ancestor
64646101|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646103|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64646104|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646106|NCT01799486|Telbivudine|telbivudine|mesh-list
64646107|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
64646108|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646109|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64646110|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64646111|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646112|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646113|NCT00650546|Exenatide|exenatide|mesh-list
64646114|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64646115|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646116|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64646117|NCT00650546|Incretins|incretins|mesh-ancestor
64646118|NCT00650546|Hormones|hormones|mesh-ancestor
64646119|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646120|NCT01386710|Bevacizumab|bevacizumab|mesh-list
64646121|NCT01386710|Carboplatin|carboplatin|mesh-list
64646122|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64646123|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646124|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646125|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64646126|NCT01386710|Growth Substances|growth substances|mesh-ancestor
64646134|NCT00651482|Bevacizumab|bevacizumab|mesh-list
64646135|NCT00651482|Everolimus|everolimus|mesh-list
64646137|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646138|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646139|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64646141|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646142|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
64646143|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646144|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
64646145|NCT00654836|Bevacizumab|bevacizumab|mesh-list
64646146|NCT00654836|Carboplatin|carboplatin|mesh-list
64646147|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64646148|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64646149|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646150|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646151|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64646152|NCT00654836|Growth Substances|growth substances|mesh-ancestor
64646153|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646154|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
64646155|NCT02997800|Labetalol|labetalol|mesh-list
64646156|NCT02997800|Fentanyl|fentanyl|mesh-list
64646157|NCT02997800|Esmolol|esmolol|mesh-list
64646158|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64646159|NCT02997800|Narcotics|narcotics|mesh-ancestor
64646160|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646163|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
64646164|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646165|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64646166|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64646167|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
64646168|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
64646169|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64646170|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64646171|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64646172|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
64646173|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646174|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646175|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64646176|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
64646177|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
64646182|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646183|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
64646184|NCT00701714|Hematinics|hematinics|mesh-ancestor
64646185|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
64646186|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64646187|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64646188|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
64646189|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646190|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64646191|NCT00656630|Naltrexone|naltrexone|mesh-list
64646192|NCT00656630|Acamprosate|acamprosate|mesh-list
64646193|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64646194|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64646195|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646196|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
64646197|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646199|NCT01362998|Morphine|morphine|mesh-list
64646200|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64646201|NCT01362998|Narcotics|narcotics|mesh-ancestor
64646202|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646203|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646204|NCT01362998|Analgesics|analgesics|mesh-ancestor
64646205|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
64646206|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646207|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64646208|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64646209|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
64646210|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
64646211|NCT02998268|Paclitaxel|paclitaxel|mesh-list
64646214|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64646215|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646216|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
64646217|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
64646218|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646219|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646220|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64646222|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
64646223|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646224|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64646225|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
64646226|NCT02997332|Docetaxel|docetaxel|mesh-list
64646227|NCT02997332|Fluorouracil|fluorouracil|mesh-list
64646228|NCT02997332|Durvalumab|durvalumab|mesh-list
64646229|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646230|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
64646231|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
64646232|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646233|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646234|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
64646242|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646243|NCT04345094|Protective Agents|protective agents|mesh-ancestor
64646244|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646245|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64646246|NCT00702884|Sunitinib|sunitinib|mesh-list
64646247|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646248|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646249|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64646250|NCT00702884|Growth Substances|growth substances|mesh-ancestor
64646251|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646252|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
64646253|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64646254|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646255|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646256|NCT00703508|Metformin|metformin|mesh-list
64646257|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64646258|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646259|NCT01284335|Gemcitabine|gemcitabine|mesh-list
64646260|NCT01284335|Docetaxel|docetaxel|mesh-list
64646261|NCT01284335|Temozolomide|temozolomide|mesh-list
64646262|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64646263|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646264|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64646265|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
64646266|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646267|NCT01284335|Antiviral Agents|antiviral agents|mesh-ancestor
64646268|NCT01284335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646269|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646270|NCT01284335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646271|NCT01284335|Immunologic Factors|immunologic factors|mesh-ancestor
64646272|NCT01284335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646273|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
64646274|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
64646275|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646276|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64646277|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
64646278|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64646279|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
64646281|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
64646282|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646283|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646284|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64646285|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
64646286|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64646287|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64646288|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64646289|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
64646290|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646291|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646292|NCT01230593|Tobramycin|tobramycin|mesh-list
64646298|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
64646299|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
64646300|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646301|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646302|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64646303|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
64646304|NCT01230593|Hormones|hormones|mesh-ancestor
64646305|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646306|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64646307|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646308|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
64646309|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646310|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646311|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64646312|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646313|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64646314|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64646316|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64646317|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64646318|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64646319|NCT01195025|Analgesics|analgesics|mesh-ancestor
64646320|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
64646321|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646322|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646323|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646324|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64646325|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
64646326|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
64646327|NCT01231841|Cyclosporine|cyclosporine|mesh-list
64646328|NCT01231841|Cyclosporins|cyclosporins|mesh-list
64646329|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
64646330|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64646332|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646333|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646334|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646335|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
64646336|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646337|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
64646338|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646339|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
64646340|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64646341|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64646343|NCT00703664|Vorinostat|vorinostat|mesh-list
64646344|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646345|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64646346|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646347|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646348|NCT00658736|Triamcinolone|triamcinolone|mesh-list
64646349|NCT00658736|Bupivacaine|bupivacaine|mesh-list
64646350|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
64646351|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
64646355|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646356|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646357|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
64646358|NCT00658736|Hormones|hormones|mesh-ancestor
64646359|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646360|NCT00659360|Saracatinib|saracatinib|mesh-list
64646361|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646362|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646363|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646364|NCT01197833|Polidocanol|polidocanol|mesh-list
64646365|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64646366|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64646367|NCT01287377|Nicotine|nicotine|mesh-list
64646368|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64646369|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
64646370|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646371|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646372|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64646373|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64646374|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
64646375|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646376|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646377|NCT04270370|Atorvastatin|atorvastatin|mesh-list
64646378|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64646379|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64646380|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
64646381|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646382|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64646383|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64646384|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646385|NCT01288781|Acetazolamide|acetazolamide|mesh-list
64646386|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
64646387|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64646388|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646389|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646390|NCT01288781|Diuretics|diuretics|mesh-ancestor
64646391|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
64646392|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646393|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
64646394|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646397|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64646398|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646399|NCT02990078|Urological Agents|urological agents|mesh-ancestor
64646401|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64646402|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64646403|NCT01288859|Analgesics|analgesics|mesh-ancestor
64646404|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
64646405|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646406|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646407|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646408|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64646409|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646410|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646411|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646413|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
64646414|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646415|NCT01235195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64646416|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64646434|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646435|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64646436|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64646438|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646439|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64646440|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646441|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646442|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
64646443|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646444|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64646445|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
64646446|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64646447|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64646448|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64646450|NCT01235897|Trastuzumab|trastuzumab|mesh-list
64646451|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64646452|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646453|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
64646454|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
64646455|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646456|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646464|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64646465|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646466|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646467|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646468|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64646469|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64646470|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646471|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646473|NCT00703976|Bevacizumab|bevacizumab|mesh-list
64646474|NCT00703976|Cetuximab|cetuximab|mesh-list
64646476|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64646477|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646478|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64646479|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64646481|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646482|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
64646483|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646484|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646485|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64646486|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64646487|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
64646488|NCT00661544|Melphalan|melphalan|mesh-list
64646489|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
64646490|NCT00661544|Vitamins|vitamins|mesh-ancestor
64646492|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646493|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64646494|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
64646495|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646496|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646497|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64646498|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646499|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
64646500|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
64646501|NCT00661544|Protective Agents|protective agents|mesh-ancestor
64646502|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64646503|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
64646504|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646505|NCT01511042|Norepinephrine|norepinephrine|mesh-list
64646506|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
64646507|NCT01511042|Giapreza|giapreza|mesh-list
64646518|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64646519|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64646520|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
64646521|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646522|NCT02979392|Paclitaxel|paclitaxel|mesh-list
64646523|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64646525|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
64646526|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
64646527|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646528|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646529|NCT02999906|Treprostinil|treprostinil|mesh-list
64646530|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64646540|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
64646542|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64646543|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646544|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64646545|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646546|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646547|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64646548|NCT00664430|Vitamins|vitamins|mesh-ancestor
64646549|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
64646550|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64646551|NCT01292447|Lidocaine|lidocaine|mesh-list
64646552|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
64646553|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
64646554|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646555|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646556|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
64646557|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646559|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64646560|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64646561|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646562|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646564|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
64646565|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
64646566|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
64646567|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64646568|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646569|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64646570|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646571|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646572|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64646573|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64646574|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64646575|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64646576|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64646577|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
64646578|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64646579|NCT02195921|Antiemetics|antiemetics|mesh-list
64646580|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
64646581|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646582|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646586|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646587|NCT02189213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64646588|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64646589|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646590|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646591|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646592|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
64646593|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646594|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64646595|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64646596|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64646597|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
64646599|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64646600|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64646601|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646602|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64646603|NCT00666848|Enalapril|enalapril|mesh-list
64646604|NCT00666848|Enalaprilat|enalaprilat|mesh-list
64646605|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64646606|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646607|NCT00666848|Incretins|incretins|mesh-ancestor
64646608|NCT00666848|Hormones|hormones|mesh-ancestor
64646609|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646610|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64646611|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
64646612|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646613|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646614|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64646615|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64646616|NCT00667004|Ecabet|ecabet|mesh-list
64646617|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64646618|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64646619|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646620|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64646621|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64646622|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
64646624|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646625|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64646626|NCT00667004|Protective Agents|protective agents|mesh-ancestor
64646627|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646628|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646629|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
64646630|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64646631|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646632|NCT01028846|Diazoxide|diazoxide|mesh-list
64646633|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64646634|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
64646635|NCT04386122|Loxoprofen|loxoprofen|mesh-list
64646636|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64646638|NCT04386122|Analgesics|analgesics|mesh-ancestor
64646639|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
64646640|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646641|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646642|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646643|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64646644|NCT03009461|Sorafenib|sorafenib|mesh-list
64646645|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646646|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64646647|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646648|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646649|NCT02990702|Bupivacaine|bupivacaine|mesh-list
64646650|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
64646651|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
64646652|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646653|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646654|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
64646655|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646656|NCT02995304|Midazolam|midazolam|mesh-list
64646657|NCT02995304|Morphine|morphine|mesh-list
64646658|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64646659|NCT02995304|Narcotics|narcotics|mesh-ancestor
64646660|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646661|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646664|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646665|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64646666|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64646667|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64646668|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646669|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646670|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64646671|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
64646672|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
64646673|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
64646674|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
64646675|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646676|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646677|NCT02990858|Leronlimab|leronlimab|mesh-list
64646678|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64646679|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64646680|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646681|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64646682|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64646683|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
64646684|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646685|NCT00725504|Lidocaine|lidocaine|mesh-list
64646686|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
64646687|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
64646688|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646689|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646695|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646696|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646698|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
64646699|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646700|NCT03830684|Protective Agents|protective agents|mesh-ancestor
64646701|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646702|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646705|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646706|NCT02990546|Midodrine|midodrine|mesh-list
64646707|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
64646708|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
64646709|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646710|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646711|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64646712|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64646713|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64646714|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64646715|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
64646716|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646717|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646718|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64646719|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64646720|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64646721|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64646722|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646723|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646724|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646725|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646726|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64646727|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
64646728|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646729|NCT01294163|Propofol|propofol|mesh-list
64646730|NCT01294163|Sevoflurane|sevoflurane|mesh-list
64646740|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
64646741|NCT01294319|Spironolactone|spironolactone|mesh-list
64646742|NCT01294319|Mifepristone|mifepristone|mesh-list
64646744|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646745|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
64646746|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
64646747|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646748|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646749|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64646750|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
64646751|NCT01294319|Hormones|hormones|mesh-ancestor
64646752|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646753|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64646754|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646755|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
64646756|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646757|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646758|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64646759|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
64646760|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64646762|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
64646763|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64646764|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
64646765|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64646766|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64646767|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64646768|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64646769|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
64646770|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64646771|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64646772|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
64646773|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64646774|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64646776|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
64646777|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64646778|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64646780|NCT02990312|Maraviroc|maraviroc|mesh-list
64646781|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64646782|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646783|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64646784|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646785|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
64646786|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646787|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
64646788|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646789|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64646790|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64646791|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646792|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64646793|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64646794|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
64646795|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64646796|NCT01295879|Vitamin D|vitamin d|mesh-list
64646797|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
64646798|NCT01295879|Vitamins|vitamins|mesh-ancestor
64646799|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
64646800|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646801|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64646802|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64646803|NCT01244633|Ecopipam|ecopipam|mesh-list
64646804|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64646805|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646806|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646807|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646808|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646809|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64646810|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
64646811|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646812|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646813|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
64646814|NCT01296191|Besifloxacin|besifloxacin|mesh-list
64646815|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64646816|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646817|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64646818|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64646819|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646820|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646821|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646822|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64646823|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
64646824|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646825|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64646826|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646827|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646830|NCT01210079|Analgesics|analgesics|mesh-ancestor
64646831|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
64646838|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646839|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64646840|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64646841|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646842|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646843|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
64646844|NCT01245647|Naltrexone|naltrexone|mesh-list
64646845|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64646846|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64646847|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646848|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
64646849|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646850|NCT00708110|Dolutegravir|dolutegravir|mesh-list
64646851|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64646852|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64646853|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646854|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646855|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64646856|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64646857|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
64646871|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64646872|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646873|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64646874|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64646890|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646891|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64646892|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646893|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646894|NCT02992418|Vaccines|vaccines|mesh-list
64646895|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
64646896|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646897|NCT01276730|Interferons|interferons|mesh-list
64646898|NCT01276730|Tretinoin|tretinoin|mesh-list
64646899|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646900|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
64646901|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646902|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
64646903|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
64646904|NCT01298063|Afatinib|afatinib|mesh-list
64646905|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646906|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64646907|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646908|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646909|NCT02999594|Tramadol|tramadol|mesh-list
64646910|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64646911|NCT02999594|Narcotics|narcotics|mesh-ancestor
64646912|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646913|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646914|NCT02999594|Analgesics|analgesics|mesh-ancestor
64646915|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
64646916|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646917|NCT01298219|Lubiprostone|lubiprostone|mesh-list
64646918|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64646919|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64646924|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
64646925|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64646927|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64646928|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
64646929|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
64646930|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646931|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646932|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64646933|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
64646934|NCT02322242|Hormones|hormones|mesh-ancestor
64646935|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64646936|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64646937|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646938|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
64646939|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64646940|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646941|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64646942|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
64646943|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
64646944|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646945|NCT02993588|Melatonin|melatonin|mesh-list
64646946|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
64646947|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646948|NCT02993588|Protective Agents|protective agents|mesh-ancestor
64646949|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646950|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64646951|NCT01270178|Entecavir|entecavir|mesh-list
64646952|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
64646953|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372250|NCT05626101|Gemcitabine|gemcitabine|mesh-list
64646954|NCT01270412|Mitogens|mitogens|mesh-list
64646955|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
64646956|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
64646957|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646958|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64646960|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646961|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
64646962|NCT01270412|Protective Agents|protective agents|mesh-ancestor
64646963|NCT02992496|Midazolam|midazolam|mesh-list
64646964|NCT02992496|Ketamine|ketamine|mesh-list
64646965|NCT02992496|Analgesics|analgesics|mesh-ancestor
64646966|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
64646967|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64646969|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64646975|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64646976|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64646977|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64646978|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64646979|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64646980|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64646981|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64646982|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64646983|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
64646985|NCT00729482|Everolimus|everolimus|mesh-list
64646986|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646987|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64646988|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
64646989|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64646990|NCT01270490|Interferons|interferons|mesh-list
64646991|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
64646992|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64646993|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
64646994|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64646995|NCT01278056|Deferasirox|deferasirox|mesh-list
64646996|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64646998|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
64646999|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647000|NCT02992652|Allopurinol|allopurinol|mesh-list
64647001|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
64647002|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647003|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647004|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
64647005|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647006|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64647007|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
64647008|NCT02992652|Protective Agents|protective agents|mesh-ancestor
64647009|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647010|NCT01270724|Gemcitabine|gemcitabine|mesh-list
64647011|NCT01270724|Paclitaxel|paclitaxel|mesh-list
64647012|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
64647013|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64647014|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647015|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
64647016|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
64647017|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
64647018|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647019|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64647020|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
64647021|NCT01270724|Antiviral Agents|antiviral agents|mesh-ancestor
64647022|NCT01270724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647023|NCT01270724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647024|NCT01270724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647025|NCT01270724|Immunologic Factors|immunologic factors|mesh-ancestor
64647026|NCT01270724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647027|NCT00709826|Gemcitabine|gemcitabine|mesh-list
64647036|NCT00709826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647037|NCT00709826|Immunologic Factors|immunologic factors|mesh-ancestor
64647038|NCT00709826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647039|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64647040|NCT01271114|Terlipressin|terlipressin|mesh-list
64647041|NCT01271114|Norepinephrine|norepinephrine|mesh-list
64647042|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64647044|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647045|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647046|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647047|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647048|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
64647049|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
64647050|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647051|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64647052|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64647054|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647055|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64647056|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
64647057|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647058|NCT02992340|Antiviral Agents|antiviral agents|mesh-ancestor
64647059|NCT02992340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647060|NCT02992340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647061|NCT02992340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647062|NCT02992340|Immunologic Factors|immunologic factors|mesh-ancestor
64647064|NCT00711464|Modafinil|modafinil|mesh-list
64647065|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64647066|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647067|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64647079|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64647080|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647082|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647083|NCT01278446|Caseins|caseins|mesh-list
64647084|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
64647085|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
64647086|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647087|NCT02339558|Nivolumab|nivolumab|mesh-list
64647088|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647089|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647090|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64647091|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647092|NCT00731198|Drotaverin|drotaverin|mesh-list
64647093|NCT00731198|Scopolamine|scopolamine|mesh-list
64647094|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64647095|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64647096|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
64647097|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
64647098|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647099|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647100|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647101|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
64647102|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64647103|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
64647104|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372413|NCT02462915|Narcotics|narcotics|mesh-ancestor
64647105|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647106|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64647107|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
64647119|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
64647120|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647121|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
64647122|NCT00712244|Protective Agents|protective agents|mesh-ancestor
64647123|NCT02991950|Parnaparin|parnaparin|mesh-list
64647124|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
64647125|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64647126|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64647127|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647128|NCT01271582|Leucovorin|leucovorin|mesh-list
64647129|NCT01271582|Irinotecan|irinotecan|mesh-list
64647130|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64647131|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64647132|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647133|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647134|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647136|NCT01271582|Protective Agents|protective agents|mesh-ancestor
64647137|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647138|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
64647139|NCT01271582|Vitamins|vitamins|mesh-ancestor
64647140|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
64647141|NCT01271660|Pregabalin|pregabalin|mesh-list
64647142|NCT01271660|Analgesics|analgesics|mesh-ancestor
64647143|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
64647144|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647145|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647146|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
64647147|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64647148|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64647149|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647150|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64647151|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64647152|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64647153|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647154|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64647155|NCT00731588|Biotin|biotin|mesh-list
64647156|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
64647157|NCT00731588|Vitamins|vitamins|mesh-ancestor
64647158|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
64647159|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647168|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64647169|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64647170|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64647171|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64647172|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64647174|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647175|NCT00717626|Factor VIII|factor viii|mesh-list
64647176|NCT00717626|Coagulants|coagulants|mesh-ancestor
64647177|NCT01272128|Interferons|interferons|mesh-list
64647178|NCT01272128|Interferon-beta|interferon-beta|mesh-list
64647179|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
64647180|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647181|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
64647182|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647183|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
64647184|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647185|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64647186|NCT00719186|Letrozole|letrozole|mesh-list
64647187|NCT00719186|Clomiphene|clomiphene|mesh-list
64647188|NCT00719186|Enclomiphene|enclomiphene|mesh-list
64647189|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
64647190|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647191|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647192|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64647193|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64647194|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647195|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64647196|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
64647197|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647198|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647199|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64647200|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
64647201|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64647202|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64647203|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64647204|NCT00721136|Heparin|heparin|mesh-list
64647205|NCT00721136|Warfarin|warfarin|mesh-list
64647206|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
64647207|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64647208|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64647209|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647210|NCT00737204|Modafinil|modafinil|mesh-list
64647211|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64647212|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647214|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64647215|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64647216|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647217|NCT00722072|Sorafenib|sorafenib|mesh-list
64647234|NCT01275170|Omeprazole|omeprazole|mesh-list
64647235|NCT01275170|Cilastatin|cilastatin|mesh-list
64647236|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64647237|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64647238|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647239|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647240|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64647241|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64647242|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64647243|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64647244|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
64647245|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
64647246|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
64647254|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64647255|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
64647256|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64647257|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647258|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64647259|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64647260|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647261|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
64647262|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64647263|NCT04385654|Axitinib|axitinib|mesh-list
64647264|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647265|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64647266|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647267|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647268|NCT01273064|Interferons|interferons|mesh-list
64647269|NCT01273064|Ribavirin|ribavirin|mesh-list
64647270|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647271|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
64647272|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647273|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
64647274|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647275|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
64647276|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
64647277|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647278|NCT01272908|Rituximab|rituximab|mesh-list
64647279|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647280|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647281|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
64647282|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647283|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647284|NCT01271504|Sorafenib|sorafenib|mesh-list
64647285|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647286|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64647287|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647288|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647290|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647291|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647292|NCT00741026|Olanzapine|olanzapine|mesh-list
64647293|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
64647294|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
64647295|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647296|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647297|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647298|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64647299|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64647300|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647306|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647307|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
64647308|NCT00741104|Infliximab|infliximab|mesh-list
64647309|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
64305048|NCT05212571|Ketamine|ketamine|mesh-list
64647310|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647311|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647312|NCT01273298|Bisoprolol|bisoprolol|mesh-list
64647313|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64647314|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
64647315|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
64647316|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647317|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647318|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64647319|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64647320|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64647321|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647322|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647323|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647324|NCT01270802|Tenofovir|tenofovir|mesh-list
64647325|NCT01270802|Emtricitabine|emtricitabine|mesh-list
64647326|NCT01270802|Efavirenz|efavirenz|mesh-list
64647327|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
64647328|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
64647329|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647330|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64647331|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64647332|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647333|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647334|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64647335|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64647336|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64647337|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64647338|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64647339|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64647340|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64647341|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64647342|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64647343|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64647345|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64647346|NCT01273454|Narcotics|narcotics|mesh-ancestor
64647347|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647348|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647349|NCT01273454|Analgesics|analgesics|mesh-ancestor
64647350|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
64647352|NCT01270256|Budesonide|budesonide|mesh-list
64647353|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647354|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64647355|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
64647356|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647357|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647358|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64647359|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
64647360|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
64647361|NCT01270256|Hormones|hormones|mesh-ancestor
64647362|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647363|NCT01279694|Prednisone|prednisone|mesh-list
64647364|NCT01279694|Melphalan|melphalan|mesh-list
64647365|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647366|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
64647367|NCT01279694|Hormones|hormones|mesh-ancestor
64647368|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647369|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647370|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64647371|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647372|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64647374|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647375|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64647376|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647377|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
64647378|NCT01273532|Tapentadol|tapentadol|mesh-list
64647379|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64647380|NCT01273532|Narcotics|narcotics|mesh-ancestor
64647381|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647382|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647383|NCT01273532|Analgesics|analgesics|mesh-ancestor
64647384|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
64647385|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647386|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64647387|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64647388|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64647389|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647390|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647391|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647392|NCT00744380|Midazolam|midazolam|mesh-list
64647393|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
64647394|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64647395|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647396|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647397|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64647400|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647401|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64647402|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64647421|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349302|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64647423|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
64647424|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647425|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64647426|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
64647427|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64647428|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
64647429|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647430|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64647431|NCT00744848|Epinephrine|epinephrine|mesh-list
64647455|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
64647456|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
64647457|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
64647458|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647459|NCT01278134|Ritonavir|ritonavir|mesh-list
64647460|NCT01278134|Ribavirin|ribavirin|mesh-list
64647476|NCT01271348|Etoricoxib|etoricoxib|mesh-list
64647477|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64647478|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64647479|NCT01271348|Analgesics|analgesics|mesh-ancestor
64647480|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
64647481|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647482|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647484|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647485|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64647486|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64647487|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647488|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647489|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
64647491|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
64647492|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64647493|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64647494|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647495|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647496|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647497|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647498|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64647500|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
64647501|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647502|NCT00746954|Acetazolamide|acetazolamide|mesh-list
64647503|NCT00746954|Buspirone|buspirone|mesh-list
64647504|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
64647505|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64647506|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647507|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647508|NCT00746954|Diuretics|diuretics|mesh-ancestor
64647509|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
64647510|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647512|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64647513|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647514|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64647515|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64647516|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
64647517|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647518|NCT00752102|Calcitriol|calcitriol|mesh-list
64647519|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64647520|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647521|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64647522|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64647523|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647524|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64647525|NCT00752102|Vitamins|vitamins|mesh-ancestor
64647526|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
64647527|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64647529|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64647530|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
64647531|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647532|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
64647533|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647534|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
64647535|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
64647536|NCT01279616|Busulfan|busulfan|mesh-list
64647537|NCT01279616|Rituximab|rituximab|mesh-list
64647538|NCT01279616|Fludarabine|fludarabine|mesh-list
64647539|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
64647541|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
64647542|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647543|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
64647544|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647545|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305262|NCT03145675|Enoxaparin|enoxaparin|mesh-list
64647546|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64647548|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647549|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647550|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64647551|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647552|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64647553|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
64647554|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64647555|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372885|NCT02461667|Metformin|metformin|mesh-list
64647556|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64647562|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64647563|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
64647564|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64647565|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
64647566|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64647567|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
64647568|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647569|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
64647570|NCT01275638|Hormones|hormones|mesh-ancestor
64647571|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647572|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647573|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64647574|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647575|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
64647576|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
64647577|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647578|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647579|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64647580|NCT01275638|Protective Agents|protective agents|mesh-ancestor
64647581|NCT00724568|Dexamethasone|dexamethasone|mesh-list
64647582|NCT00724568|Lenalidomide|lenalidomide|mesh-list
64647583|NCT00724568|Bortezomib|bortezomib|mesh-list
64647584|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647585|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
64647586|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
64647587|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647588|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647589|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647590|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
64647591|NCT00724568|Hormones|hormones|mesh-ancestor
64647592|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647593|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64647594|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647595|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
64647596|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64647597|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64647598|NCT00724568|Growth Substances|growth substances|mesh-ancestor
64647599|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
64647600|NCT01274000|Ramosetron|ramosetron|mesh-list
64647601|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
64647602|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
64647603|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647604|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647605|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647606|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64647607|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
64647608|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647609|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647617|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647618|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
64647619|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
64647620|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
64647621|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647622|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305398|NCT03545347|Nandrolone|nandrolone|mesh-list
64647623|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
64647624|NCT04274426|Antiviral Agents|antiviral agents|mesh-ancestor
64647625|NCT04274426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647626|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647627|NCT04274426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647628|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
64647629|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647630|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64647631|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64647632|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64647633|NCT04272320|Bupivacaine|bupivacaine|mesh-list
64647634|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
64647635|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
64647636|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647637|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647638|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
64647639|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647641|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647642|NCT01277822|Losartan|losartan|mesh-list
64647643|NCT01277822|Amlodipine|amlodipine|mesh-list
64647644|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64647645|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64647646|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64647647|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647648|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64647649|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647650|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
64647651|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64647652|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64647653|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64647654|NCT00249002|Paclitaxel|paclitaxel|mesh-list
64647655|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64647656|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64647657|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647658|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
64647659|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
64647660|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
64647661|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647662|NCT00748826|Infliximab|infliximab|mesh-list
64647663|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
64647664|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647665|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647666|NCT00246740|Doxycycline|doxycycline|mesh-list
64647667|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64647668|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647669|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
64647670|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64647671|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64647672|NCT01274624|Leucovorin|leucovorin|mesh-list
64647673|NCT01274624|Bevacizumab|bevacizumab|mesh-list
64647674|NCT01274624|Fluorouracil|fluorouracil|mesh-list
64647675|NCT01274624|Irinotecan|irinotecan|mesh-list
64647676|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647677|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647678|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64647679|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64647680|NCT01274624|Growth Substances|growth substances|mesh-ancestor
64647681|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647682|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
64647683|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
64647684|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647685|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64647686|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64647687|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
64647688|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64647690|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647691|NCT01274624|Antidotes|antidotes|mesh-ancestor
64647692|NCT01274624|Protective Agents|protective agents|mesh-ancestor
64647693|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
64647694|NCT01274624|Vitamins|vitamins|mesh-ancestor
64647695|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
64647696|NCT00761930|Listerine|listerine|mesh-list
64647697|NCT00761930|Triclosan|triclosan|mesh-list
64647698|NCT00761930|Fluorides|fluorides|mesh-list
64305693|NCT02048969|Flumazenil|flumazenil|mesh-list
64647699|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
64647700|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
64647701|NCT00761930|Protective Agents|protective agents|mesh-ancestor
64647702|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647703|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64647704|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647705|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64647706|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64647707|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
64647708|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647709|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64647711|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647712|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64647713|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647714|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647715|NCT01275014|Dexamethasone|dexamethasone|mesh-list
64647716|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647717|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
64647718|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
64647719|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647725|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64647727|NCT01275248|Ondansetron|ondansetron|mesh-list
64647728|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
64647729|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
64647730|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647731|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647732|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647733|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
64647734|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
64647735|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64647736|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
64647737|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647738|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647739|NCT01275248|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64647740|NCT01275248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64647741|NCT01275248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647742|NCT01275248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64647743|NCT01275248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64647744|NCT00756236|Metoprolol|metoprolol|mesh-list
64647745|NCT00756236|Esmolol|esmolol|mesh-list
64647746|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64647747|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64647748|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
64647749|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
64647750|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647751|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647752|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64647753|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64647754|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64647755|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647756|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647757|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647758|NCT00762320|Ritonavir|ritonavir|mesh-list
64647759|NCT00762320|Lopinavir|lopinavir|mesh-list
64647760|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64647761|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64647762|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
64647763|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647764|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647765|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64647766|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64647767|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
64647768|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647769|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64647770|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64647772|NCT00244712|Lamivudine|lamivudine|mesh-list
64647773|NCT00244712|Emtricitabine|emtricitabine|mesh-list
64647774|NCT00244712|Abacavir|abacavir|mesh-list
64647775|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
64647776|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647777|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64647778|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64647779|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647780|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647781|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64647786|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64647787|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647788|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64647789|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64647790|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64647791|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
64647792|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64647793|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64647794|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
64647795|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647796|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
64647797|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64647798|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64647800|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
64647801|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
64647802|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647803|NCT00243932|Vitamins|vitamins|mesh-ancestor
64647804|NCT00243386|Factor VIII|factor viii|mesh-list
64647805|NCT00243386|Coagulants|coagulants|mesh-ancestor
64647806|NCT03807362|CC-11050|cc-11050|mesh-list
64647807|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64647808|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64647809|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647810|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647811|NCT01275560|Metronidazole|metronidazole|mesh-list
64647812|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647813|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64647814|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64647815|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64647816|NCT00762710|Prazosin|prazosin|mesh-list
64647817|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64647818|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64647819|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64647820|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64647821|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647822|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647823|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647824|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647825|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64647826|NCT00756548|Laxatives|laxatives|mesh-ancestor
64647827|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64647828|NCT00243074|Cediranib|cediranib|mesh-list
64647829|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647830|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647831|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647832|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64647833|NCT00241358|Plerixafor|plerixafor|mesh-list
64647834|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64647835|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64647836|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
64647837|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647838|NCT00778310|Methylphenidate|methylphenidate|mesh-list
64647839|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64647840|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647841|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64647847|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
64647848|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647849|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647851|NCT01247285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64647852|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64647853|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64647854|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647856|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
64647857|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647858|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64647859|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
64647860|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64647861|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64647862|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64647863|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647864|NCT03806582|Norepinephrine|norepinephrine|mesh-list
64647865|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64647866|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64647867|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
64647868|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647869|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647870|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647872|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
64647873|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647874|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64647875|NCT00779558|Heparin|heparin|mesh-list
64647876|NCT00779558|Calcium heparin|calcium heparin|mesh-list
64647877|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
64647878|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64647879|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64647880|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647881|NCT00758342|Travoprost|travoprost|mesh-list
64647882|NCT00758342|Brinzolamide|brinzolamide|mesh-list
64647883|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64647884|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64647885|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647886|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647887|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64647888|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64647889|NCT01301183|Estradiol|estradiol|mesh-list
64647890|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64647891|NCT01301183|Mecasermin|mecasermin|mesh-list
64647892|NCT01301183|Estrogens|estrogens|mesh-ancestor
64647893|NCT01301183|Hormones|hormones|mesh-ancestor
64647894|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647902|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64647903|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64647904|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
64647905|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64647906|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647907|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647908|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64647909|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64647911|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64647912|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64647913|NCT01213199|Analgesics|analgesics|mesh-ancestor
64647914|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
64647915|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647916|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647917|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64647918|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64647919|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
64647920|NCT03809702|Pregabalin|pregabalin|mesh-list
64647921|NCT03809702|Analgesics|analgesics|mesh-ancestor
64647922|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
64647923|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647924|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647925|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
64647926|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64647927|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64647928|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647929|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64647930|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64647931|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64647932|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647933|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64647935|NCT03806036|Clomiphene|clomiphene|mesh-list
64647936|NCT03806036|Enclomiphene|enclomiphene|mesh-list
64647937|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
64647939|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
64647940|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647941|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64647942|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64647943|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
64647945|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64647946|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
64647947|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64647948|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64647949|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64647950|NCT00780026|Insulin|insulin|mesh-list
64647951|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64647952|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647953|NCT01214057|Remifentanil|remifentanil|mesh-list
64647954|NCT01214057|Propofol|propofol|mesh-list
64647955|NCT01214057|Sevoflurane|sevoflurane|mesh-list
64647956|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64647957|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64647958|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647959|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64647971|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64647973|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64647974|NCT03809546|Analgesics|analgesics|mesh-ancestor
64647975|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
64647976|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64647977|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64647978|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64647979|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64647980|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647981|NCT03809546|Hormones|hormones|mesh-ancestor
64647982|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64647983|NCT03809312|Amoxicillin|amoxicillin|mesh-list
64647984|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
64647985|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
64647986|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64647987|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64647988|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64647989|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647990|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64647991|NCT01247363|Globalagliatin|globalagliatin|mesh-list
64647992|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
64647993|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64647994|NCT00780494|Bevacizumab|bevacizumab|mesh-list
64647995|NCT00780494|Carboplatin|carboplatin|mesh-list
64647996|NCT00780494|Capecitabine|capecitabine|mesh-list
64647997|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64647998|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64647999|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64648000|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64648002|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648003|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
64648004|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64648005|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
64648006|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648011|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64648012|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648013|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
64648014|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64648015|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648016|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64648017|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
64648018|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648019|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648020|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648021|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648022|NCT01214759|Tenofovir|tenofovir|mesh-list
64648023|NCT01214759|Emtricitabine|emtricitabine|mesh-list
64648024|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
64648025|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64648027|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648028|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64648029|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64648030|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648031|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648032|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64648033|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64648034|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64648035|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64648055|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
64648056|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
64648057|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64648058|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64648059|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648060|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648061|NCT00781508|Urological Agents|urological agents|mesh-ancestor
64648062|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
64648063|NCT03805568|Remifentanil|remifentanil|mesh-list
64648064|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64648065|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648066|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648067|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648068|NCT03805568|Analgesics|analgesics|mesh-ancestor
64648069|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
64648070|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648071|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64648093|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648094|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64648095|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648096|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648098|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
64648099|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64648100|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648101|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64648102|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648103|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648106|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
64648107|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648108|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64648109|NCT03808844|Propofol|propofol|mesh-list
64648110|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64648111|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648112|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648113|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64648114|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
64648115|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
64648116|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64648117|NCT03809078|Bombesin|bombesin|mesh-list
64648118|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64648119|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648120|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306557|NCT02068625|Rasagiline|rasagiline|mesh-list
64648121|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648123|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64648124|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648125|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648126|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648127|NCT05310968|Aspirin|aspirin|mesh-list
64648128|NCT05310968|Tirofiban|tirofiban|mesh-list
64648129|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64648137|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64648138|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64306576|NCT02068937|Furosemide|furosemide|mesh-list
64648139|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648140|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64648141|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64648142|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648144|NCT03805178|Abatacept|abatacept|mesh-list
64648145|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64648146|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648148|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64648149|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
64648150|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648151|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648152|NCT01303835|Naltrexone|naltrexone|mesh-list
64648153|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64648154|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64648155|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648156|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
64648157|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648158|NCT01250717|Dexamethasone|dexamethasone|mesh-list
64648159|NCT01250717|Goserelin|goserelin|mesh-list
64648160|NCT01250717|Estramustine|estramustine|mesh-list
64648161|NCT01250717|Docetaxel|docetaxel|mesh-list
64648162|NCT01250717|Bicalutamide|bicalutamide|mesh-list
64648163|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648164|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
64648165|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
64648166|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648167|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648168|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648169|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
64648170|NCT01250717|Hormones|hormones|mesh-ancestor
64648171|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648172|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64648173|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648174|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
64648182|NCT03804866|Doxorubicin|doxorubicin|mesh-list
64648183|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64648184|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64648185|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648186|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64648187|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64648188|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648189|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648190|NCT01251575|Cyclosporine|cyclosporine|mesh-list
64648191|NCT01251575|Sirolimus|sirolimus|mesh-list
64648192|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
64648193|NCT01251575|Fludarabine|fludarabine|mesh-list
64648194|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
64648195|NCT01251575|Cyclosporins|cyclosporins|mesh-list
64648196|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648197|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64648198|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
64648199|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648200|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64648201|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
64648202|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648203|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648204|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
64648205|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648206|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
64648211|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
64648212|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648213|NCT00782756|Bevacizumab|bevacizumab|mesh-list
64648214|NCT00782756|Temozolomide|temozolomide|mesh-list
64648215|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64648216|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648217|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64648218|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64648219|NCT00782756|Growth Substances|growth substances|mesh-ancestor
64648220|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648221|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
64648222|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64648224|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648225|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
64648226|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64648227|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
64648228|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648229|NCT01306175|Empagliflozin|empagliflozin|mesh-list
64648230|NCT01306175|Digoxin|digoxin|mesh-list
64648231|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64648232|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64648233|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648234|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648235|NCT01306175|Protective Agents|protective agents|mesh-ancestor
64648236|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648237|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64648238|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64648239|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
64648240|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64648241|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648242|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64648243|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64648244|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648245|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648246|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
64648247|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648248|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
64648249|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64648250|NCT01216241|Daptomycin|daptomycin|mesh-list
64648251|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648252|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648253|NCT01216397|Metformin|metformin|mesh-list
64648254|NCT01216397|Linagliptin|linagliptin|mesh-list
64648255|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64648256|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648257|NCT01216397|Incretins|incretins|mesh-ancestor
64648258|NCT01216397|Hormones|hormones|mesh-ancestor
64648259|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648260|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64648261|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
64648262|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648263|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648265|NCT04345406|Enalapril|enalapril|mesh-list
64648266|NCT04345406|Captopril|captopril|mesh-list
64648267|NCT04345406|Amebicides|amebicides|mesh-ancestor
64648268|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64648270|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648271|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
64648272|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648273|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64648274|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
64648275|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648276|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648277|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64648278|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
64648279|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64648280|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648281|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64648282|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64648283|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648284|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648285|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
64648286|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648287|NCT01216943|Timolol|timolol|mesh-list
64648288|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64648289|NCT01216943|Bimatoprost|bimatoprost|mesh-list
64648290|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64648291|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64306887|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
64648292|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64648293|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64648294|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
64648295|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648296|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648297|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648298|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64648299|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64648300|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64648307|NCT00783614|Analgesics|analgesics|mesh-ancestor
64648308|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
64648309|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648310|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648311|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648312|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648313|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64648314|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64648315|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648316|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64648318|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648319|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
64648320|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
64648321|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648322|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
64648323|NCT01252745|Testosterone|testosterone|mesh-list
64648324|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
64648325|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
64648326|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64648327|NCT01252745|Androgens|androgens|mesh-ancestor
64648329|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648330|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648331|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64648332|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648333|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
64648334|NCT04278872|SJX-653|sjx-653|mesh-list
64648336|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648337|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648338|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
64648339|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64648340|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
64648342|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
64648343|NCT03807596|Protective Agents|protective agents|mesh-ancestor
64648344|NCT01217411|R04929097|r04929097|mesh-list
64648345|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648346|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648347|NCT01253525|Paclitaxel|paclitaxel|mesh-list
64648348|NCT01253525|Ramucirumab|ramucirumab|mesh-list
64648349|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64648350|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648351|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
64648352|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
64648353|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
64648354|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648355|NCT00768716|Acetaminophen|acetaminophen|mesh-list
64307002|NCT04961918|Durvalumab|durvalumab|mesh-list
64648356|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648357|NCT00768716|Analgesics|analgesics|mesh-ancestor
64648358|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
64648359|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648360|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648361|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
64648362|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64648363|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64648364|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64648365|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648366|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648367|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64648368|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648369|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648370|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
64648371|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648372|NCT05583188|Gemcitabine|gemcitabine|mesh-list
64648373|NCT05583188|Paclitaxel|paclitaxel|mesh-list
64648374|NCT05583188|Vinorelbine|vinorelbine|mesh-list
64648377|NCT05583188|Pemetrexed|pemetrexed|mesh-list
64648378|NCT05583188|Carboplatin|carboplatin|mesh-list
64648379|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64373682|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64648380|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648381|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
64648382|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
64648383|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
64648384|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648385|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64648386|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
64648387|NCT05583188|Antiviral Agents|antiviral agents|mesh-ancestor
64648388|NCT05583188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648389|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648390|NCT05583188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64648391|NCT05583188|Immunologic Factors|immunologic factors|mesh-ancestor
64648392|NCT05583188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648393|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64648394|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64648395|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64648396|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64648397|NCT01218971|Naltrexone|naltrexone|mesh-list
64648398|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64648399|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64648400|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648401|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
64648402|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648403|NCT05743244|Abrocitinib|abrocitinib|mesh-list
64648405|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648406|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648407|NCT03837626|Amiloride|amiloride|mesh-list
64648408|NCT03837626|Diuretics|diuretics|mesh-ancestor
64648409|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
64648410|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648411|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64648412|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64648413|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648414|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648415|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64648416|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64648418|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
64648419|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64648420|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648421|NCT04351919|Azithromycin|azithromycin|mesh-list
64648422|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
64648423|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648424|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648425|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
64648426|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64648427|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64648428|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648429|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648430|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648431|NCT00769886|Ketotifen|ketotifen|mesh-list
64648432|NCT00769886|Naphazoline|naphazoline|mesh-list
64648433|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
64648434|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
64648435|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64648436|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
64648437|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
64648438|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648439|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648440|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648445|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
64648446|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64648447|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
64648448|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64648449|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64648450|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648452|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
64648453|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648454|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648455|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373758|NCT03280277|Hematinics|hematinics|mesh-ancestor
64307250|NCT03058094|Pemetrexed|pemetrexed|mesh-list
64648458|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64648459|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64648460|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
64648461|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
64648462|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648463|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648464|NCT01309451|Dexamethasone|dexamethasone|mesh-list
64648465|NCT01309451|Bevacizumab|bevacizumab|mesh-list
64648466|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64648467|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648468|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64648469|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64648470|NCT01309451|Growth Substances|growth substances|mesh-ancestor
64648471|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648472|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
64648473|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648474|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
64648475|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
64648476|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648477|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648479|NCT01309451|Hormones|hormones|mesh-ancestor
64648480|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648481|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64648482|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
64648483|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64648484|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648486|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
64648487|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64648488|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64648489|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648490|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648491|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648492|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648493|NCT00795002|Cytarabine|cytarabine|mesh-list
64648494|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
64648495|NCT00795002|Alvocidib|alvocidib|mesh-list
64648496|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64648497|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
64648498|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648499|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648500|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
64648501|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648502|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64648503|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
64648504|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648505|NCT00795002|Analgesics|analgesics|mesh-ancestor
64307341|NCT03238131|Albendazole|albendazole|mesh-list
64648506|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
64648507|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648508|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64648509|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64648510|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648511|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
64648512|NCT00795002|Growth Substances|growth substances|mesh-ancestor
64648513|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64648515|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
64648516|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
64648517|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648518|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648519|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648520|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64648521|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64648522|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648523|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64648524|NCT03802838|Amisulpride|amisulpride|mesh-list
64648525|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64648526|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64648527|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648528|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648529|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64648530|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64648531|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
64648534|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64648535|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
64648536|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64648538|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64648539|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648540|NCT00772304|Analgesics|analgesics|mesh-ancestor
64648541|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
64648542|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648544|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648545|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648546|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64648547|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64648548|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64648549|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
64648550|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
64648551|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648552|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648553|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64648554|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
64648555|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64648556|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
64648557|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64648558|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648559|NCT01310231|Metformin|metformin|mesh-list
64648560|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64648561|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648562|NCT00789074|Varenicline|varenicline|mesh-list
64648563|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64648564|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64648565|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
64648566|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648567|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648568|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648569|NCT01338857|Sorafenib|sorafenib|mesh-list
64648570|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648571|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64648572|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648573|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648574|NCT01339013|Anesthetics|anesthetics|mesh-list
64648575|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648576|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648577|NCT03834506|Dexamethasone|dexamethasone|mesh-list
64648578|NCT03834506|Prednisone|prednisone|mesh-list
64648580|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
64648586|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648587|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
64648588|NCT03834506|Hormones|hormones|mesh-ancestor
64648589|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648590|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64648591|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648592|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
64648593|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
64648594|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
64648595|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648596|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64648597|NCT01339091|Vancomycin|vancomycin|mesh-list
64648598|NCT01339091|Linezolid|linezolid|mesh-list
64648599|NCT01339091|Dalbavancin|dalbavancin|mesh-list
64648600|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648601|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648602|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64648603|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648604|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648606|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
64648607|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648608|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
64648609|NCT03832010|Hormones|hormones|mesh-ancestor
64648610|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648611|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648612|NCT01339247|Halofantrine|halofantrine|mesh-list
64648613|NCT01339247|Paroxetine|paroxetine|mesh-list
64648614|NCT01339247|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64648615|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64648616|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648617|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648618|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648619|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
64648620|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648621|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64648622|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
64648623|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64648624|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64648625|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64648626|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648627|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
64648628|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64648629|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64648630|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648631|NCT00772772|Vitamin D|vitamin d|mesh-list
64648632|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
64648633|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
64648634|NCT00772772|Vitamins|vitamins|mesh-list
64648635|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
64648640|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648641|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648642|NCT01310855|Gefitinib|gefitinib|mesh-list
64648643|NCT01310855|Cediranib|cediranib|mesh-list
64648644|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648645|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648646|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648647|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64648648|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
64648649|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64648650|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
64648651|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648652|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648653|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64648654|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
64648655|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64648656|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64648658|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
64648659|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307820|NCT03234699|Bupropion|bupropion|mesh-list
64307821|NCT03234699|Omeprazole|omeprazole|mesh-list
64648660|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648661|NCT05477108|Budesonide|budesonide|mesh-list
64648662|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
64648663|NCT05477108|Charcoal|charcoal|mesh-list
64648664|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648665|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64648666|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
64648667|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648668|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648669|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64648670|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
64648671|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
64648672|NCT05477108|Hormones|hormones|mesh-ancestor
64648673|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648674|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64648675|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64648676|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64648677|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
64648678|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648679|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648686|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64648687|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648688|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64648689|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648690|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64648691|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648692|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648694|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
64648695|NCT03802214|Vedolizumab|vedolizumab|mesh-list
64648696|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648697|NCT03801746|Cyclosporine|cyclosporine|mesh-list
64648698|NCT03801746|Rifampin|rifampin|mesh-list
64648699|NCT03801746|Probenecid|probenecid|mesh-list
64648700|NCT03801746|Cyclosporins|cyclosporins|mesh-list
64648701|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307939|NCT03057314|Antacids|antacids|mesh-ancestor
64648702|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648704|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
64648705|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648706|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
64648707|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648708|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
64648709|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648710|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64648711|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64648712|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
64648713|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648714|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
64648715|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64648716|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64648717|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64648718|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64648719|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64648720|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64648721|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64648722|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
64648723|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
64648724|NCT03801746|Renal Agents|renal agents|mesh-ancestor
64648725|NCT03801668|Paclitaxel|paclitaxel|mesh-list
64648726|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
64648727|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64648728|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64648729|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648730|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
64648731|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
64648732|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
64648739|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648740|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64648741|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64648742|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
64648743|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
64648744|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648745|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64648746|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64648747|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648748|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648749|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
64648750|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64648751|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
64648752|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
64648753|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64648754|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64374057|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64648755|NCT02199041|Prednisolone|prednisolone|mesh-list
64648756|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
64648757|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
64648758|NCT02199041|Melphalan|melphalan|mesh-list
64648759|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
64648760|NCT02199041|Thiotepa|thiotepa|mesh-list
64648761|NCT02199041|Fludarabine|fludarabine|mesh-list
64648762|NCT02199041|Tacrolimus|tacrolimus|mesh-list
64648763|NCT02199041|Lenograstim|lenograstim|mesh-list
64648764|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64648765|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
64648766|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64648784|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
64648785|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648786|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648787|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
64648789|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648790|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64648800|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
64648801|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648802|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648803|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64648804|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
64648805|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308225|NCT04917458|Vitamin D|vitamin d|mesh-list
64648806|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648807|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64648808|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64648809|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
64648810|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64648811|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648812|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64648813|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64648814|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
64648815|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64648816|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64648818|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
64648819|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648821|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
64648822|NCT03801590|Vitamins|vitamins|mesh-ancestor
64648823|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
64648824|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648825|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64648826|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
64648827|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64648828|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64648829|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64648830|NCT00775658|Analgesics|analgesics|mesh-ancestor
64648831|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
64648832|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648833|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648834|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64648835|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64648836|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64648837|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64648838|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64648839|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
64648840|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
64648841|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648842|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648843|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64648844|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648845|NCT00799604|Clevidipine|clevidipine|mesh-list
64648846|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64648847|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648848|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308653|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64648849|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64648853|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64648854|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
64648855|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648857|NCT01259063|Antiviral Agents|antiviral agents|mesh-ancestor
64648859|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648860|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64648861|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
64648862|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648863|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
64648864|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64648865|NCT04383548|Antibodies|antibodies|mesh-list
64648866|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
64648867|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648868|NCT01313897|Bortezomib|bortezomib|mesh-list
64648869|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648870|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64648871|NCT04351763|Amiodarone|amiodarone|mesh-list
64648873|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64648874|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
64648875|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64648876|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648877|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648878|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64648879|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64648880|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64308996|NCT02310568|PF-06372865|pf-06372865|mesh-list
64648881|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648882|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64648883|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64648884|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64309070|NCT02447679|Tegafur|tegafur|mesh-list
64648885|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64648886|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64648887|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648888|NCT00801398|Oxymorphone|oxymorphone|mesh-list
64648889|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64648890|NCT00801398|Narcotics|narcotics|mesh-ancestor
64648891|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648892|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648894|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
64648895|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648896|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64648897|NCT01342523|Nicotine|nicotine|mesh-list
64648898|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64648899|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
64648900|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648901|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648902|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64648903|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64648904|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
64648905|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648910|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
64648911|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648912|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648913|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64648914|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64648915|NCT02199743|Haloperidol|haloperidol|mesh-list
64648916|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
64648917|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64648918|NCT02199743|Perphenazine|perphenazine|mesh-list
64648919|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
64648920|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
64648921|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648922|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648923|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64648924|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64648925|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64309427|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64648926|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64648927|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64648928|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64309558|NCT02151721|Gefitinib|gefitinib|mesh-list
64648929|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
64648930|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309632|NCT02343406|Temozolomide|temozolomide|mesh-list
64648931|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648932|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64648933|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64648934|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64648935|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64648936|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
64648937|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64309733|NCT02444559|Analgesics|analgesics|mesh-ancestor
64648938|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64648939|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
64648940|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64648941|NCT00776594|Bevacizumab|bevacizumab|mesh-list
64648942|NCT00776594|Bicalutamide|bicalutamide|mesh-list
64648943|NCT00776594|Androgens|androgens|mesh-list
64648944|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64648945|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648947|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64648948|NCT00776594|Growth Substances|growth substances|mesh-ancestor
64648949|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648950|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
64648952|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64648953|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
64648956|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64648957|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64648958|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648959|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
64648960|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64648961|NCT02193347|Temozolomide|temozolomide|mesh-list
64648962|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64648964|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648965|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64648966|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64648967|NCT01318967|Furosemide|furosemide|mesh-list
64648969|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
64648970|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648971|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64648972|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648973|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648974|NCT01319045|Iloprost|iloprost|mesh-list
64648975|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64648976|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
64648977|NCT01348607|Methylphenidate|methylphenidate|mesh-list
64648978|NCT01348607|Modafinil|modafinil|mesh-list
64648979|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64648980|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648981|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64648982|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64648983|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64648984|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64648985|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
64648986|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64648987|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64648988|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64648989|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64648990|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
64648991|NCT01268111|Vitamin D|vitamin d|mesh-list
64648992|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64648993|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64648994|NCT01268111|Vitamins|vitamins|mesh-ancestor
64648995|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
64648996|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64648997|NCT01349231|Ketamine|ketamine|mesh-list
64648998|NCT01349231|Analgesics|analgesics|mesh-ancestor
64648999|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
64649000|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649001|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649002|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64649004|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
64649005|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
64649006|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649007|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64649008|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64649009|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649010|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649011|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
64649012|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
64649014|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64649015|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
64310816|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649016|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649017|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649018|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64649019|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
64310916|NCT02157571|Ofloxacin|ofloxacin|mesh-list
64649020|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649021|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649022|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64649023|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64649024|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649025|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64649026|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64649027|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
64649028|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64649029|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649030|NCT01321151|Resveratrol|resveratrol|mesh-list
64649031|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
64649032|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649033|NCT01321151|Protective Agents|protective agents|mesh-ancestor
64649034|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649035|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649036|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64649037|NCT01350947|Azacitidine|azacitidine|mesh-list
64649038|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64649039|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
64649040|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649041|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649042|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649045|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649046|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649047|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64649048|NCT01269047|Incretins|incretins|mesh-ancestor
64649049|NCT01269047|Hormones|hormones|mesh-ancestor
64649050|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649051|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
64649052|NCT03800264|Bisoprolol|bisoprolol|mesh-list
64649053|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374352|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64649054|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64649055|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
64649056|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
64649058|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649059|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64649060|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64649061|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64649062|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
64649063|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649064|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649066|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64649067|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
64649068|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649069|NCT05287724|Expectorants|expectorants|mesh-ancestor
64649070|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
64649071|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64649072|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
64649085|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64649086|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
64649087|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649088|NCT01321541|Antiviral Agents|antiviral agents|mesh-ancestor
64649089|NCT01321541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649090|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649091|NCT01321541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64649092|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64649093|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64649094|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64649095|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64649096|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649097|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649098|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
64649099|NCT05201612|Olaparib|olaparib|mesh-list
64649100|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64649101|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649102|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64649103|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649104|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649105|NCT01271855|Glycerol|glycerol|mesh-list
64649106|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311593|NCT03555617|Itraconazole|itraconazole|mesh-list
64649107|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64649108|NCT01271855|Protective Agents|protective agents|mesh-ancestor
64649109|NCT04865978|Warfarin|warfarin|mesh-list
64649110|NCT04865978|Apixaban|apixaban|mesh-list
64649111|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
64649112|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64649113|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
64649114|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64649115|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
64649116|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649117|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382213|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382214|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382215|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
64649118|NCT01354145|Celecoxib|celecoxib|mesh-list
64382216|NCT03181685|Cetrorelix|cetrorelix|mesh-list
64649123|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649124|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649125|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311678|NCT02093585|Tenofovir|tenofovir|mesh-list
64311735|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
64311736|NCT03555929|Dexamethasone|dexamethasone|mesh-list
64311737|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311738|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
64311739|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
64649136|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649137|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649138|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
64649139|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
64649140|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649141|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64649142|NCT02196857|Azacitidine|azacitidine|mesh-list
64649143|NCT02196857|Sorafenib|sorafenib|mesh-list
64649144|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64649146|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649147|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649148|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649149|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64649150|NCT01272245|Cytarabine|cytarabine|mesh-list
64649151|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
64649152|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64649153|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
64649154|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649155|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649156|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
64649157|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649158|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64649159|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
64649160|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649161|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64649162|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64649163|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649165|NCT00802100|Benztropine|benztropine|mesh-list
64649166|NCT00802100|Olanzapine|olanzapine|mesh-list
64649167|NCT00802100|Aripiprazole|aripiprazole|mesh-list
64649168|NCT00802100|Perphenazine|perphenazine|mesh-list
64649169|NCT00802100|Simvastatin|simvastatin|mesh-list
64649170|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649171|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649172|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64649173|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64649174|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
64649175|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649176|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64649177|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64649184|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64649185|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649186|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64649187|NCT00802100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64649188|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64649189|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64312251|NCT02250833|Amlodipine|amlodipine|mesh-list
64649190|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649192|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
64649193|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
64649194|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
64649195|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64649196|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64649197|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64649198|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64649199|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64649200|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64649201|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64649202|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64649203|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
64374502|NCT04952571|Growth Substances|growth substances|mesh-ancestor
64649204|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64649205|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64649206|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
64649207|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64649209|NCT00809276|Busulfan|busulfan|mesh-list
64649210|NCT00809276|Fludarabine|fludarabine|mesh-list
64649211|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64649212|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
64649213|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649214|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649215|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64649216|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
64312499|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
64649217|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649218|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649219|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64649220|NCT00802412|Topiramate|topiramate|mesh-list
64649223|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649224|NCT01355705|Aspirin|aspirin|mesh-list
64649225|NCT01355705|Dexamethasone|dexamethasone|mesh-list
64649236|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
64649238|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649239|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64649240|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649241|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
64649242|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649243|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649244|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64649245|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649246|NCT01355705|Analgesics|analgesics|mesh-ancestor
64649247|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
64649248|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649249|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64649250|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64649251|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64649252|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64649253|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
64649254|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
64649255|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64312702|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
64649256|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64649257|NCT01355705|Growth Substances|growth substances|mesh-ancestor
64649258|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
64649259|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
64649260|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649261|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
64649262|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
64649263|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
64649264|NCT00802880|Dacarbazine|dacarbazine|mesh-list
64649265|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64649266|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
64649267|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649268|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649269|NCT05118854|Cisplatin|cisplatin|mesh-list
64649270|NCT05118854|Carboplatin|carboplatin|mesh-list
64649271|NCT05118854|Pemetrexed|pemetrexed|mesh-list
64649272|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649273|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649274|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649275|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64649279|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64649280|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64649281|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
64649282|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649283|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313109|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
64649284|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64649285|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
64649287|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
64649288|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64649289|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64649291|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649292|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649293|NCT05116202|Nivolumab|nivolumab|mesh-list
64649295|NCT05116202|Atezolizumab|atezolizumab|mesh-list
64649296|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64649297|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649298|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64649299|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649300|NCT05089526|Lidocaine|lidocaine|mesh-list
64649301|NCT05089526|Fentanyl|fentanyl|mesh-list
64649302|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
64649303|NCT05089526|Ketamine|ketamine|mesh-list
64649304|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
64649305|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
64649306|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349435|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649307|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649308|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
64649310|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64649311|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64649312|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64649313|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649314|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649315|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64649316|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649318|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64649319|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64649320|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64649321|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
64649322|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649323|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64649324|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64649325|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
64649326|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64649327|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64649328|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64649329|NCT05089526|Narcotics|narcotics|mesh-ancestor
64649330|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64649334|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649335|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649336|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64649337|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
64649339|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649340|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649341|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
64313950|NCT02123069|Nitroprusside|nitroprusside|mesh-list
64649342|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64649343|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64649346|NCT04645550|Aspirin|aspirin|mesh-list
64649347|NCT04645550|Heparin|heparin|mesh-list
64649348|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64649349|NCT04645550|Tinzaparin|tinzaparin|mesh-list
64649350|NCT04645550|Dalteparin|dalteparin|mesh-list
64649351|NCT04645550|Dipyridamole|dipyridamole|mesh-list
64649352|NCT04645550|Warfarin|warfarin|mesh-list
64649353|NCT04645550|Apixaban|apixaban|mesh-list
64649354|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64649355|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649356|NCT04645550|Analgesics|analgesics|mesh-ancestor
64374649|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
64649357|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
64649358|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649359|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649360|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649361|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649362|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64649363|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64649364|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649365|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64649366|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64649367|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649368|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
64649369|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
64649370|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64649371|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
64649372|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64649373|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
64649375|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
64649376|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
64649377|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64649378|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649379|NCT05032820|Lenalidomide|lenalidomide|mesh-list
64649380|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
64649381|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649382|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64649383|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64649384|NCT05032820|Growth Substances|growth substances|mesh-ancestor
64649385|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
64649390|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649391|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64649392|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64649393|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64649394|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649395|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649396|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64649398|NCT01274897|Cathartics|cathartics|mesh-ancestor
64649399|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64649400|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
64649401|NCT02323217|Idazoxan|idazoxan|mesh-list
64649402|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64649403|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64649404|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64649405|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
64649406|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649407|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649408|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649409|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
64649410|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64649411|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64649412|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649413|NCT04382768|Ibuprofen|ibuprofen|mesh-list
64314316|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64649414|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64649415|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649416|NCT04382768|Analgesics|analgesics|mesh-ancestor
64649417|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
64649418|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649419|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649420|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649421|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649422|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64649423|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314430|NCT02125643|Caffeine|caffeine|mesh-list
64649424|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649426|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64649428|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649429|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649430|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
64649431|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649432|NCT04155164|Metformin|metformin|mesh-list
64649433|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649434|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649435|NCT00806078|Quinine|quinine|mesh-list
64649436|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
64649437|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64649438|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64649439|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649440|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64649441|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649442|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64649443|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649444|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649446|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
64649447|NCT00806234|Metformin|metformin|mesh-list
64649448|NCT00806234|Olanzapine|olanzapine|mesh-list
64649449|NCT00806234|Risperidone|risperidone|mesh-list
64649450|NCT00806234|Aripiprazole|aripiprazole|mesh-list
64649451|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64649452|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64649454|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64649455|NCT00806234|Asenapine|asenapine|mesh-list
64649462|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
64649463|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649464|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649465|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64649466|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64649467|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649468|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64649469|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64649470|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
64649471|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
64649472|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
64649473|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649474|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64649475|NCT00806234|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64649476|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64649477|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649478|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
64649479|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
64649480|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64649481|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64649482|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64649483|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64649484|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64649485|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64649486|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64649487|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649488|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64649489|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64649490|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64349563|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64349602|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
64649491|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
64649492|NCT04493138|Azacitidine|azacitidine|mesh-list
64649493|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64649495|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649496|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649497|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649500|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
64649501|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
64649502|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64649504|NCT01275365|Hormones|hormones|mesh-ancestor
64649505|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649506|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649507|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64649508|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649511|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64649512|NCT00811850|Dorzolamide|dorzolamide|mesh-list
64649513|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64649514|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64649515|NCT00811850|Maleic acid|maleic acid|mesh-list
64649516|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649517|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649518|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64649519|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64649520|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
64649521|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649522|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649523|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64649524|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64649525|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64649526|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64649527|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64649528|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64649529|NCT03678506|Apixaban|apixaban|mesh-list
64649530|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64649532|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64649533|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
64649534|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649535|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649536|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
64649537|NCT00844298|Cytarabine|cytarabine|mesh-list
64649538|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64649539|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
64649540|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649541|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649542|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
64649543|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649544|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64649545|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
64649546|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649548|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
64649557|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64649558|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649559|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64649562|NCT00845000|Carbidopa|carbidopa|mesh-list
64649563|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64649564|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64649565|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
64649567|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649568|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649569|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64649571|NCT01330043|Bupropion|bupropion|mesh-list
64649572|NCT01330043|Nicotine|nicotine|mesh-list
64649573|NCT01330043|Varenicline|varenicline|mesh-list
64649574|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64649575|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
64649576|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649577|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649578|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64649579|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64649580|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
64649581|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649582|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649583|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64374885|NCT04937907|Benazepril|benazepril|mesh-list
64649591|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64649592|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649594|NCT01330355|Besifloxacin|besifloxacin|mesh-list
64649595|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64649596|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649597|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64649598|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64649599|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64649600|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64649601|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649602|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649603|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649604|NCT02193815|Calcitriol|calcitriol|mesh-list
64649605|NCT02193815|Calcipotriene|calcipotriene|mesh-list
64649606|NCT02193815|Tofacitinib|tofacitinib|mesh-list
64649607|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64649609|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649610|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
64649611|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64649612|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649613|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64649614|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649615|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64649616|NCT02193815|Vitamins|vitamins|mesh-ancestor
64649617|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
64649618|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64649619|NCT01277081|Acetaminophen|acetaminophen|mesh-list
64649620|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649621|NCT01277081|Analgesics|analgesics|mesh-ancestor
64649622|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
64649623|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649624|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649625|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
64649627|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64649648|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64649649|NCT01332071|Metformin|metformin|mesh-list
64649650|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
64649651|NCT01332071|Maleic acid|maleic acid|mesh-list
64649652|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649653|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649654|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649655|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649656|NCT01277159|Dexamethasone|dexamethasone|mesh-list
64649657|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
64649658|NCT01277159|Buprenorphine|buprenorphine|mesh-list
64649680|NCT01362959|Nicotine|nicotine|mesh-list
64649681|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64649682|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
64315474|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649683|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649684|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649685|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64649686|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64649687|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
64315506|NCT04790708|Octreotide|octreotide|mesh-list
64649689|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649690|NCT01332461|Fluticasone|fluticasone|mesh-list
64649691|NCT01332461|Xhance|xhance|mesh-list
64649692|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64649693|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649694|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64649696|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649697|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649698|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64649699|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
64649700|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
64649701|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64649702|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64649703|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64649704|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64649705|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
64649706|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649707|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649709|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64649710|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649711|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64649712|NCT01280123|Pioglitazone|pioglitazone|mesh-list
64649713|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649714|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649715|NCT03608696|Buprenorphine|buprenorphine|mesh-list
64649716|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64649717|NCT03608696|Narcotics|narcotics|mesh-ancestor
64649720|NCT03608696|Analgesics|analgesics|mesh-ancestor
64649721|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
64649722|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649723|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64649724|NCT01334723|Finasteride|finasteride|mesh-list
64649725|NCT01334723|Dutasteride|dutasteride|mesh-list
64649726|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
64649727|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64649728|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649729|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649731|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649734|NCT04311710|Nivolumab|nivolumab|mesh-list
64649735|NCT04311710|Ipilimumab|ipilimumab|mesh-list
64649736|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64649737|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649738|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64649740|NCT01334957|Ibuprofen|ibuprofen|mesh-list
64649741|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64649742|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649743|NCT01334957|Analgesics|analgesics|mesh-ancestor
64649744|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
64649745|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649746|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649747|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649748|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649749|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64649750|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649751|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649752|NCT01402427|Verapamil|verapamil|mesh-list
64649753|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64649754|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64649755|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64649756|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649757|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64649759|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
64649760|NCT03637400|Doxycycline|doxycycline|mesh-list
64649761|NCT03637400|Trimethoprim|trimethoprim|mesh-list
64649762|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
64649763|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64649764|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649765|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
64649766|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64315717|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
64649772|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649774|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64649775|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64649776|NCT01365611|Fluticasone|fluticasone|mesh-list
64649777|NCT01365611|Xhance|xhance|mesh-list
64649778|NCT01365611|Ketorolac|ketorolac|mesh-list
64649779|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64649780|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649781|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64649782|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
64649783|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649784|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649785|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64649786|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
64649787|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
64649788|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64649789|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64649790|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64649791|NCT01365611|Analgesics|analgesics|mesh-ancestor
64649792|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
64649793|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64649794|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64649795|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315750|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64649796|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649797|NCT01472549|Ethanol|ethanol|mesh-list
64649798|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
64649799|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64649800|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649801|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649802|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649804|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64649806|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649807|NCT01404923|Mebeverine|mebeverine|mesh-list
64649808|NCT01404923|Alverine|alverine|mesh-list
64649809|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
64649810|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
64649811|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649812|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649813|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
64649815|NCT01368263|Anastrozole|anastrozole|mesh-list
64649816|NCT01368263|Goserelin|goserelin|mesh-list
64649817|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649818|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64649819|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64649820|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649821|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649822|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64649823|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
64649824|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649825|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649826|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64649828|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64649829|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64649831|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64649834|NCT00815360|Growth Substances|growth substances|mesh-ancestor
64649835|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649836|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
64649837|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649838|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649839|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
64649840|NCT00815360|Hormones|hormones|mesh-ancestor
64315909|NCT04787276|Rifaximin|rifaximin|mesh-list
64649841|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649842|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64649843|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
64649844|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649845|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649846|NCT01474109|Macitentan|macitentan|mesh-list
64649847|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64649848|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64649849|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649850|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64649851|NCT01405937|Ribavirin|ribavirin|mesh-list
64649852|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
64649853|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649854|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
64649855|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649857|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64649858|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
64649859|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649860|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649861|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64649862|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64649863|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
64649864|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649865|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649866|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
64649868|NCT01368809|Fentanyl|fentanyl|mesh-list
64649869|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64649870|NCT01368809|Narcotics|narcotics|mesh-ancestor
64649871|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649872|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649873|NCT01368809|Analgesics|analgesics|mesh-ancestor
64649874|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
64649875|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649876|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64649877|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64649878|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
64649879|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
64649880|NCT01369745|Prednisone|prednisone|mesh-list
64316006|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64649884|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64649885|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
64649887|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64649888|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
64649889|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649891|NCT01369745|Hormones|hormones|mesh-ancestor
64649892|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649893|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649894|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64649895|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649896|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
64649908|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64649910|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649911|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64649912|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64649913|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649914|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649915|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649916|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64649917|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
64649918|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64649919|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649920|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64649921|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64649922|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64649923|NCT01407575|Buprenorphine|buprenorphine|mesh-list
64649924|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64649925|NCT01407575|Narcotics|narcotics|mesh-ancestor
64649926|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64649927|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649928|NCT01407575|Analgesics|analgesics|mesh-ancestor
64649929|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
64649930|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649931|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64649932|NCT01476449|Ranibizumab|ranibizumab|mesh-list
64316131|NCT00103285|Folic Acid|folic acid|mesh-list
64649933|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64649934|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64316237|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
64649936|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649937|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
64649938|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649945|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
64649946|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
64649947|NCT01477463|Vitamins|vitamins|mesh-list
64649948|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
64649949|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649950|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64649951|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64649952|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64649954|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64649955|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
64649956|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64649957|NCT01375127|Tofacitinib|tofacitinib|mesh-list
64649958|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64649959|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375263|NCT03057015|Hormones|hormones|mesh-ancestor
64649960|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649962|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649963|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64649964|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649965|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649966|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
64649967|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64649968|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64649969|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
64649970|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316391|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64649971|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64649972|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64649973|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64649974|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649975|NCT01376297|Dexamethasone|dexamethasone|mesh-list
64649976|NCT01376297|Aprepitant|aprepitant|mesh-list
64649977|NCT01376297|Palonosetron|palonosetron|mesh-list
64649978|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64649979|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
64649980|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
64649981|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64649982|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64649983|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64649984|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
64649985|NCT01376297|Hormones|hormones|mesh-ancestor
64649986|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649987|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64649988|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64649989|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64649990|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64649991|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64649992|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64649994|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
64649996|NCT00859040|Hormones|hormones|mesh-ancestor
64349672|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64649997|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64649998|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650001|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
64650002|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
64650003|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650004|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650005|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
64650006|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650007|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64650009|NCT02669186|Analgesics|analgesics|mesh-ancestor
64650010|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64650011|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64650012|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
64650013|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64650014|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64650015|NCT00859508|Estradiol|estradiol|mesh-list
64650016|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64650018|NCT00859508|Hormones|hormones|mesh-ancestor
64650019|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650020|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650021|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64650022|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
64650023|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64650024|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64650025|NCT01377467|Denosumab|denosumab|mesh-list
64650026|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64650027|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650028|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
64650029|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64650031|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
64650032|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650033|NCT02348762|Expectorants|expectorants|mesh-ancestor
64650042|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650043|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
64650044|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64650045|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650046|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650047|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650048|NCT01377623|Analgesics|analgesics|mesh-ancestor
64316644|NCT03810794|Donepezil|donepezil|mesh-list
64650051|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64650052|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64650053|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64650054|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650055|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650062|NCT01490723|Methotrexate|methotrexate|mesh-list
64650063|NCT01490723|Fludarabine|fludarabine|mesh-list
64650064|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
64650065|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64650066|NCT01490723|Tacrolimus|tacrolimus|mesh-list
64650067|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
64650068|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64650069|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64650070|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64650071|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650072|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
64650073|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650075|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64650076|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
64650077|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64650078|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64650079|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
64650080|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650081|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349692|NCT03530995|Itraconazole|itraconazole|mesh-list
64349693|NCT03530995|Rifampin|rifampin|mesh-list
64650082|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650083|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64650084|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650085|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64650086|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650087|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64650088|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64650089|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64650090|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
64650091|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64650092|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64650093|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
64650094|NCT01491113|Levetiracetam|levetiracetam|mesh-list
64650095|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
64650097|NCT03839498|Axitinib|axitinib|mesh-list
64650098|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650099|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650100|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650105|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
64650106|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650107|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650108|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64650109|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64650110|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
64650112|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650113|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64650115|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650116|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650117|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64650118|NCT02252432|Narcotics|narcotics|mesh-ancestor
64650119|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
64650120|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
64650121|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
64650122|NCT01492673|Bevacizumab|bevacizumab|mesh-list
64650124|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650125|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
64650126|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650127|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650128|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64650129|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
64650130|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650132|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64650133|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64650134|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64650135|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64650136|NCT01492673|Growth Substances|growth substances|mesh-ancestor
64650137|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
64650138|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64650140|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650142|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64650143|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650144|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
64650145|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650146|NCT00818324|Protective Agents|protective agents|mesh-ancestor
64650148|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650154|NCT01419275|Xenon|xenon|mesh-list
64650155|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64650156|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
64650157|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
64650159|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650160|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
64650161|NCT02155010|Bupivacaine|bupivacaine|mesh-list
64650162|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
64650163|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
64650164|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650165|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650166|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
64650167|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650168|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64650169|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650171|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64650172|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64650174|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
64317125|NCT00707889|Leucovorin|leucovorin|mesh-list
64650175|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650176|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650178|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
64650179|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64650180|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650181|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650182|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650184|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
64650185|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650186|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64650187|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64650188|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64650189|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650190|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650192|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64650193|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
64650194|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64650195|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
64650196|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
64650197|NCT01379183|Erythromycin|erythromycin|mesh-list
64650198|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
64650199|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64650200|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
64650201|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64650202|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650203|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650204|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64650205|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650206|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317221|NCT02408679|Vitamin D|vitamin d|mesh-list
64650208|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64650209|NCT01380197|Narcotics|narcotics|mesh-ancestor
64650210|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650211|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650212|NCT01380197|Analgesics|analgesics|mesh-ancestor
64650213|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
64650214|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650215|NCT00862784|Leucovorin|leucovorin|mesh-list
64650216|NCT00862784|Folic Acid|folic acid|mesh-list
64650217|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
64650218|NCT00862784|Fluorouracil|fluorouracil|mesh-list
64650219|NCT00862784|Ramucirumab|ramucirumab|mesh-list
64650220|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64650221|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
64650222|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650223|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
64650224|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650225|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64650226|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650227|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
64650228|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650230|NCT00862784|Protective Agents|protective agents|mesh-ancestor
64650231|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
64650233|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
64317251|NCT02418273|Denosumab|denosumab|mesh-list
64650234|NCT00862784|Hematinics|hematinics|mesh-ancestor
64650235|NCT00864032|Sorafenib|sorafenib|mesh-list
64650236|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650237|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650238|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650239|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650240|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64650246|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650247|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650248|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64650249|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
64650250|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64650251|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64650252|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
64650253|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
64650254|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64317261|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
64317262|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
64650255|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650256|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650257|NCT01419977|Dalteparin|dalteparin|mesh-list
64650258|NCT01419977|Tinzaparin|tinzaparin|mesh-list
64650259|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64650260|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
64650261|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64650262|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64650263|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650265|NCT01499147|Fludarabine|fludarabine|mesh-list
64650266|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
64650267|NCT01499147|Melphalan|melphalan|mesh-list
64650268|NCT01499147|Busulfan|busulfan|mesh-list
64650269|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
64650270|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650272|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
64650273|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650277|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
64650278|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650279|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64650280|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
64650281|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64650282|NCT00823082|Antithrombins|antithrombins|mesh-list
64650283|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
64317303|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64317304|NCT01664624|Incretins|incretins|mesh-ancestor
64317305|NCT01664624|Hormones|hormones|mesh-ancestor
64317306|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317307|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64317308|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
64317309|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64317310|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64317311|NCT03173781|Droxidopa|droxidopa|mesh-list
64317312|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64317313|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64317314|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64317315|NCT05540834|Plasminogen|plasminogen|mesh-list
64650284|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64650285|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
64650286|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650287|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650289|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
64650298|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64650299|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
64650300|NCT05236634|Tadalafil|tadalafil|mesh-list
64650301|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
64650302|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64650303|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
64650305|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650306|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650307|NCT05236634|Urological Agents|urological agents|mesh-ancestor
64650308|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64650309|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650310|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650311|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650312|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
64650313|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64650314|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64650315|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64650316|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650317|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
64650318|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650319|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650320|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64650321|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650322|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
64650323|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64650324|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
64650326|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64650327|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
64650328|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64650329|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
64650330|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64650331|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
64650332|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650333|NCT01424033|Expectorants|expectorants|mesh-ancestor
64650347|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650348|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
64650349|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650351|NCT00825266|Bosentan|bosentan|mesh-list
64650352|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64650353|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650354|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64650355|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64650356|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650357|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64650358|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64650359|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
64650360|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650361|NCT01385189|Antacids|antacids|mesh-ancestor
64650362|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650363|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650364|NCT01386983|Finasteride|finasteride|mesh-list
64650365|NCT01386983|Dutasteride|dutasteride|mesh-list
64650366|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64650367|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64650368|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650369|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650370|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
64650371|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650372|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650373|NCT01386983|Urological Agents|urological agents|mesh-ancestor
64650374|NCT01387139|Ketamine|ketamine|mesh-list
64650375|NCT01387139|Propofol|propofol|mesh-list
64650376|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64317538|NCT03176199|Oxycodone|oxycodone|mesh-list
64650377|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650378|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650379|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64650381|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
64650382|NCT01387139|Analgesics|analgesics|mesh-ancestor
64650383|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
64650384|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650389|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650391|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64650392|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
64650393|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650394|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650396|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
64650398|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64650399|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
64650400|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650401|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650402|NCT00825344|Etanercept|etanercept|mesh-list
64650403|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64650404|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650405|NCT00825344|Analgesics|analgesics|mesh-ancestor
64650406|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
64650407|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650408|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650409|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650410|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650411|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650412|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650413|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
64650415|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64650416|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64650417|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
64650418|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650419|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64650420|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650421|NCT00825500|Loxapine|loxapine|mesh-list
64650422|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64650423|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64650424|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650425|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650426|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64650427|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64650428|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
64650429|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650430|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650431|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
64650432|NCT01505933|Propofol|propofol|mesh-list
64650433|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64650434|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650437|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
64650438|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
64650439|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650440|NCT01505933|Analgesics|analgesics|mesh-ancestor
64650441|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
64650442|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650443|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64650445|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64650446|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650447|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349864|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64349865|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64650448|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650451|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650452|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650453|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650454|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650455|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64650456|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64650457|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64650458|NCT00872534|Aspirin|aspirin|mesh-list
64650459|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64650460|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650462|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
64650463|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650464|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650465|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650466|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650467|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64650468|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64650469|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650470|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64650471|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64650479|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64650480|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
64650481|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650482|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650483|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64650484|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
64650485|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
64650486|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64650487|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64650489|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64650490|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650491|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650492|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650493|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650494|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
64650495|NCT02513160|Hormones|hormones|mesh-ancestor
64650496|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650498|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650499|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
64650500|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650501|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650502|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64650503|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
64317826|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64317828|NCT05695664|Analgesics|analgesics|mesh-ancestor
64650504|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650505|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650506|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64650507|NCT02480010|Pertuzumab|pertuzumab|mesh-list
64650508|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64650509|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650510|NCT00876200|Minoxidil|minoxidil|mesh-list
64650511|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64317839|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64650513|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
64650514|NCT02512302|Bromides|bromides|mesh-list
64650515|NCT02512302|Charcoal|charcoal|mesh-list
64650522|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650523|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650525|NCT02512302|Protective Agents|protective agents|mesh-ancestor
64650527|NCT01507181|Ketamine|ketamine|mesh-list
64650528|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
64650529|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
64650530|NCT01507181|Analgesics|analgesics|mesh-ancestor
64650531|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
64650532|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650533|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650534|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64650535|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64650536|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
64650537|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
64650538|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650539|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64650540|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650541|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650542|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64650543|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64650544|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64650545|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64650546|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64650547|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
64650548|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
64650549|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64650550|NCT01428245|Estradiol|estradiol|mesh-list
64650551|NCT01428245|Estrogens|estrogens|mesh-list
64650552|NCT01428245|Progesterone|progesterone|mesh-list
64650553|NCT01428245|Hormones|hormones|mesh-ancestor
64650554|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650555|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650556|NCT01428245|Progestins|progestins|mesh-ancestor
64650557|NCT00877370|Ertapenem|ertapenem|mesh-list
64650558|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64650559|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650560|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
64650561|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64650562|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650564|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650566|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650567|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650568|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650569|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650570|NCT00878228|Ondansetron|ondansetron|mesh-list
64650571|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
64650572|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
64650573|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650574|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650575|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650576|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
64650577|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
64650579|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
64650580|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650584|NCT00878228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650586|NCT00878228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64650588|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64650589|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64650590|NCT01429259|Meropenem|meropenem|mesh-list
64650591|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64650592|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650593|NCT05177198|Clindamycin|clindamycin|mesh-list
64650594|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
64650595|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
64650596|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64650597|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650598|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64650599|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650600|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650602|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
64318009|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
64650603|NCT01392989|Cyclosporins|cyclosporins|mesh-list
64650604|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
64650605|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64650606|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650607|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650608|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650609|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
64650610|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650612|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650613|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
64650614|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650615|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64650616|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64650617|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650618|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64650619|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
64650620|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64650621|NCT01393457|Levodopa|levodopa|mesh-list
64650622|NCT01393457|Carbidopa|carbidopa|mesh-list
64650623|NCT01393457|Ropinirole|ropinirole|mesh-list
64650624|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64650625|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64650626|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
64650627|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650628|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650629|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650630|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64650631|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650632|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
64650634|NCT04985760|Vaccines|vaccines|mesh-list
64650635|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
64650636|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
64650637|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650638|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64650639|NCT04985760|Antacids|antacids|mesh-ancestor
64650641|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650643|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64650644|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64650645|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64650646|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64650649|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650652|NCT02479230|Vaccines|vaccines|mesh-list
64650653|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
64650654|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650655|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64650656|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
64650657|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650658|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650659|NCT02479230|Antiviral Agents|antiviral agents|mesh-ancestor
64650660|NCT02479230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650661|NCT02479230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650662|NCT02479230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650663|NCT04985136|Sorafenib|sorafenib|mesh-list
64650664|NCT04985136|Apatinib|apatinib|mesh-list
64650665|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650666|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650667|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650668|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650669|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
64650670|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64650671|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64650672|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650673|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
64650674|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650675|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650676|NCT04411446|Vitamin D|vitamin d|mesh-list
64650677|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
64650678|NCT04411446|Vitamins|vitamins|mesh-ancestor
64650679|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
64650680|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318231|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650681|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64650682|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64650683|NCT01510379|Promethazine|promethazine|mesh-list
64650684|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
64650685|NCT01510379|Ondansetron|ondansetron|mesh-list
64650686|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
64650687|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
64650688|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650689|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650690|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650692|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
64650693|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64650694|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
64650695|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650696|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650697|NCT01510379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64650698|NCT01510379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64650699|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650700|NCT01510379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64650701|NCT01510379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64650702|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64650703|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
64650704|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
64318330|NCT02168881|Misoprostol|misoprostol|mesh-list
64650705|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64650706|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64650707|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64650708|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
64650710|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
64650712|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64650714|NCT01510457|Milnacipran|milnacipran|mesh-list
64650715|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
64650716|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64650717|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64650718|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64318407|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650719|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650721|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650724|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
64650725|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650726|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
64650727|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64650728|NCT04983966|Desflurane|desflurane|mesh-list
64650729|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64650730|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
64650731|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
64650732|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650733|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650734|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
64650735|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64650736|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650737|NCT02478372|Bupivacaine|bupivacaine|mesh-list
64650738|NCT02478372|Ropivacaine|ropivacaine|mesh-list
64650739|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
64650740|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
64650741|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
64650742|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650743|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650744|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
64650745|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650746|NCT01511315|Ustekinumab|ustekinumab|mesh-list
64650747|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
64650748|NCT01654536|Ciclesonide|ciclesonide|mesh-list
64650749|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
64650750|NCT01654536|Hormones|hormones|mesh-ancestor
64650751|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650752|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650753|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64650754|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
64650755|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64650756|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650757|NCT02509026|Etanercept|etanercept|mesh-list
64650758|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64650759|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650761|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
64650762|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650763|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650764|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650765|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650766|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64650767|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650768|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
64650769|NCT03439280|Dexamethasone|dexamethasone|mesh-list
64650770|NCT03439280|Pomalidomide|pomalidomide|mesh-list
64650771|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650772|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
64650773|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
64650779|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650780|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64650781|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650782|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
64650783|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64650784|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64650785|NCT03439280|Growth Substances|growth substances|mesh-ancestor
64650786|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
64650787|NCT00828074|Sorafenib|sorafenib|mesh-list
64650788|NCT00828074|Vinorelbine|vinorelbine|mesh-list
64650789|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650790|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650791|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650792|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650793|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64650794|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
64650795|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
64650796|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
64650797|NCT03434444|Propranolol|propranolol|mesh-list
64650798|NCT03434444|Oxytocin|oxytocin|mesh-list
64650799|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
64650800|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64650801|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650802|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64650803|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64650804|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650805|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650806|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650807|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64318691|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318692|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318693|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
64650808|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64650809|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
64650810|NCT04382300|Thalidomide|thalidomide|mesh-list
64650811|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650812|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
64650813|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650814|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
64650815|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64650816|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64650817|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64650818|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64650819|NCT04382300|Growth Substances|growth substances|mesh-ancestor
64650835|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64650836|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64650837|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64650838|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64650839|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650841|NCT00828542|Hormones|hormones|mesh-ancestor
64650842|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650843|NCT01395329|Metoprolol|metoprolol|mesh-list
64650844|NCT01395329|Nebivolol|nebivolol|mesh-list
64650845|NCT01395329|Nitroprusside|nitroprusside|mesh-list
64650846|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
64650849|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64650850|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64650851|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
64650852|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
64650853|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650854|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650855|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64650856|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64650857|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64318798|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
64318799|NCT04516447|Antiviral Agents|antiviral agents|mesh-ancestor
64318800|NCT04516447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318801|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650858|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650859|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650860|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650861|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
64650862|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64650863|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64650864|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64650865|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64650866|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64650867|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
64650868|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64650869|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64650871|NCT00882206|Prednisone|prednisone|mesh-list
64650872|NCT00882206|Doxorubicin|doxorubicin|mesh-list
64650873|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64650874|NCT00882206|Methotrexate|methotrexate|mesh-list
64650875|NCT00882206|Vincristine|vincristine|mesh-list
64650876|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
64650878|NCT00882206|Asparaginase|asparaginase|mesh-list
64650879|NCT00882206|Vorinostat|vorinostat|mesh-list
64650880|NCT00882206|Pegaspargase|pegaspargase|mesh-list
64650881|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64650882|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650883|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64650884|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64650885|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650886|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650887|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64650888|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
64650889|NCT00882206|Hormones|hormones|mesh-ancestor
64650890|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650891|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650892|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64650893|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64650894|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
64650895|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64338256|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64338257|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338258|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64338259|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338260|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338261|NCT01207115|Naproxen|naproxen|mesh-list
64338262|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64338263|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650896|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64650897|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
64650898|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
64650899|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64650900|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650901|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
64650902|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650903|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64650904|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
64650906|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64650907|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
64650908|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
64650909|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
64650910|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650911|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64650912|NCT00831272|Naltrexone|naltrexone|mesh-list
64650913|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64650914|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64319058|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650915|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650916|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
64650917|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650918|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64650919|NCT01512251|Vemurafenib|vemurafenib|mesh-list
64650920|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650921|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64650922|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650923|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650924|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64650925|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64650926|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650929|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650930|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64650931|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
64650932|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650933|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650935|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64650936|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650937|NCT01512797|Incretins|incretins|mesh-ancestor
64650938|NCT01512797|Hormones|hormones|mesh-ancestor
64650939|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64650940|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64376239|NCT05256693|Vancomycin|vancomycin|mesh-list
64650941|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
64650942|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64650943|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650944|NCT05620940|Naltrexone|naltrexone|mesh-list
64338264|NCT01207115|Analgesics|analgesics|mesh-ancestor
64650945|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64338265|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
64338266|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650946|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64650947|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650948|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
64650949|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650950|NCT01395797|Pioglitazone|pioglitazone|mesh-list
64650951|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64650952|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650953|NCT05124704|Ropivacaine|ropivacaine|mesh-list
64650954|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
64650955|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
64650956|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650957|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650958|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
64650959|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650960|NCT02203019|Fentanyl|fentanyl|mesh-list
64650961|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
64650962|NCT02203019|Propofol|propofol|mesh-list
64650963|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64650964|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64650965|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650966|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64650967|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
64650969|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64650970|NCT02203019|Analgesics|analgesics|mesh-ancestor
64650971|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
64650972|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64650973|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64650974|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64650975|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64650976|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64650977|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64650978|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650981|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64650983|NCT05000450|Fludarabine|fludarabine|mesh-list
64650984|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64650985|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
64650986|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64650987|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64650990|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64650991|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64650992|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64650994|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
64650995|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
64650996|NCT00886262|Coagulants|coagulants|mesh-ancestor
64650997|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64650998|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64650999|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
64651000|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651004|NCT00887510|Diuretics|diuretics|mesh-ancestor
64651005|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
64651006|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651008|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64338302|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64651017|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64651018|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651019|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
64651022|NCT03247088|Fludarabine|fludarabine|mesh-list
64651023|NCT03247088|Sorafenib|sorafenib|mesh-list
64651024|NCT03247088|Tacrolimus|tacrolimus|mesh-list
64651025|NCT03247088|Lenograstim|lenograstim|mesh-list
64651026|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651027|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
64651028|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651029|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651030|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64651031|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
64651032|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651034|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64651035|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64651036|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64651037|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651038|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64651039|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64651040|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
64651041|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64651042|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651043|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64651045|NCT01397591|Ofatumumab|ofatumumab|mesh-list
64651046|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651047|NCT03855332|Cilostazol|cilostazol|mesh-list
64651048|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
64651049|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
64651050|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64651051|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64651052|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651053|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651061|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64651062|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64651063|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64651064|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64651065|NCT03855332|Protective Agents|protective agents|mesh-ancestor
64651066|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64651075|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651076|NCT03808610|Cytarabine|cytarabine|mesh-list
64651077|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
64651078|NCT03808610|Dexamethasone|dexamethasone|mesh-list
64651079|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
64651080|NCT03808610|Prednisone|prednisone|mesh-list
64651081|NCT03808610|Cortisone|cortisone|mesh-list
64651082|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
64651083|NCT03808610|Rituximab|rituximab|mesh-list
64651084|NCT03808610|Methotrexate|methotrexate|mesh-list
64651085|NCT03808610|Vincristine|vincristine|mesh-list
64651086|NCT03808610|Venetoclax|venetoclax|mesh-list
64651087|NCT03808610|Asparaginase|asparaginase|mesh-list
64651088|NCT03808610|Pegaspargase|pegaspargase|mesh-list
64651089|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64651090|NCT03808610|Antibodies|antibodies|mesh-list
64651091|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
64651092|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64651093|NCT03808610|BB 1101|bb 1101|mesh-list
64651094|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651095|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
64338326|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338327|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338328|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64338329|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651096|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651097|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651098|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64338331|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64651100|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651101|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651102|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64651103|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651104|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
64651105|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
64651106|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651119|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
64651120|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64651121|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64651122|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
64651123|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651124|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64651125|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
64651126|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
64651128|NCT01514513|Permethrin|permethrin|mesh-list
64651129|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651130|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651131|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
64651132|NCT04981860|Povidone|povidone|mesh-list
64651133|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
64651134|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
64651135|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64319514|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651138|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
64651139|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64651140|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
64651141|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64651142|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651143|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64651145|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651146|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651147|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64651148|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651149|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64651150|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651151|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
64651152|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651153|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64651154|NCT04979520|Brodalumab|brodalumab|mesh-list
64338336|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64338337|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64338338|NCT01173497|Irinotecan|irinotecan|mesh-list
64338339|NCT01173497|Iniparib|iniparib|mesh-list
64338340|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64338341|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64338342|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338343|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651155|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
64651156|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
64651161|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651162|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
64651163|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651164|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651166|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651167|NCT02504892|Everolimus|everolimus|mesh-list
64651168|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376462|NCT02613507|Docetaxel|docetaxel|mesh-list
64651169|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651170|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
64651171|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651172|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64651173|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
64651174|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651175|NCT00890162|Omalizumab|omalizumab|mesh-list
64651176|NCT00890162|Epinephrine|epinephrine|mesh-list
64651177|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64651178|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64651180|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651181|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651182|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651183|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64651184|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64651185|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
64651186|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651187|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64651188|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
64651189|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
64651191|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64651193|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
64319634|NCT01606202|Nabiximols|nabiximols|mesh-list
64651194|NCT01433081|Analgesics|analgesics|mesh-ancestor
64651195|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
64651196|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319639|NCT05529290|Acetaminophen|acetaminophen|mesh-list
64651197|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651198|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
64651199|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651200|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64651201|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
64319655|NCT05528588|Diuretics|diuretics|mesh-ancestor
64651203|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651204|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651205|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64651206|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
64651207|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64651208|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
64651209|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651210|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
64651211|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651212|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651213|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64651214|NCT01401023|Tigecycline|tigecycline|mesh-list
64651215|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64651216|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651217|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64651218|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338344|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651219|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651220|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
64651222|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
64651223|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651224|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651226|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651227|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64651228|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
64651229|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64651230|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651231|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651232|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64651233|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
64651234|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64651235|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
64651236|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64651237|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651239|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64651240|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651241|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651243|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651244|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651245|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64651246|NCT01519271|Protective Agents|protective agents|mesh-ancestor
64651248|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64651249|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
64651250|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64651251|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651252|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64651253|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64651254|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64651256|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64651257|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64651258|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
64651259|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651260|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
64651261|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64651262|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64651263|NCT02210195|Aprepitant|aprepitant|mesh-list
64651264|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
64651265|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
64651266|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651267|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651268|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64651269|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64319783|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64651270|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651271|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338359|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
64338361|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64338362|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651272|NCT01437449|Carboplatin|carboplatin|mesh-list
64651273|NCT01437449|Docetaxel|docetaxel|mesh-list
64651274|NCT01437449|Cetuximab|cetuximab|mesh-list
64651275|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651278|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
64651279|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651280|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64651281|NCT00836888|Nivolumab|nivolumab|mesh-list
64651282|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64651284|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64651285|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651286|NCT02262026|Saracatinib|saracatinib|mesh-list
64651287|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651288|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651289|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651291|NCT00889226|Pitavastatin|pitavastatin|mesh-list
64651292|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64651293|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64651294|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
64651295|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651296|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64651297|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64651298|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651299|NCT00837200|Doxorubicin|doxorubicin|mesh-list
64651300|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64651301|NCT00837200|Asparaginase|asparaginase|mesh-list
64651302|NCT00837200|Pegaspargase|pegaspargase|mesh-list
64651303|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64651304|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651305|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64651306|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64651307|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651308|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651309|NCT00837512|Insulin|insulin|mesh-list
64651310|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64651311|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64651312|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651314|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
64651315|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64651316|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64651317|NCT00837590|Analgesics|analgesics|mesh-ancestor
64651318|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
64651319|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651320|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651321|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651322|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651323|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64651324|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651325|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651326|NCT00837902|Atenolol|atenolol|mesh-list
64651327|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64651328|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64651329|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
64651330|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
64651331|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651332|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651333|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64651334|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64651335|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64338380|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338381|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338382|NCT01057667|Ribavirin|ribavirin|mesh-list
64338383|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64338384|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
64338385|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651337|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651338|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651340|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
64651341|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651343|NCT00839540|Micafungin|micafungin|mesh-list
64651344|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
64651346|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651347|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651348|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
64651349|NCT02966912|Antacids|antacids|mesh-ancestor
64651350|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651351|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64651353|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64651354|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
64651355|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651356|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651357|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64651358|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64651359|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
64651360|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651361|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651362|NCT01437605|Poly I-C|poly i-c|mesh-list
64651363|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
64651364|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
64651365|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651366|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
64651367|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651368|NCT02684006|Sunitinib|sunitinib|mesh-list
64651369|NCT02684006|Avelumab|avelumab|mesh-list
64651371|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338389|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64338390|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64338391|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64338392|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338393|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
64338396|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338397|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338398|NCT01138163|Docetaxel|docetaxel|mesh-list
64338399|NCT01138163|Bavituximab|bavituximab|mesh-list
64338400|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338401|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
64338402|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
64338403|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
64338404|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338405|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64338406|NCT01022801|Entecavir|entecavir|mesh-list
64651372|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64651373|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64651375|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651376|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
64651377|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64651378|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651379|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651380|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64651382|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64651383|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64651384|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64651385|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651386|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651387|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64651388|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64376691|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
64651390|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64651391|NCT01520207|Diuretics|diuretics|mesh-ancestor
64651392|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
64651393|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651394|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
64651395|NCT01203722|Sirolimus|sirolimus|mesh-list
64651396|NCT01203722|Fludarabine|fludarabine|mesh-list
64651397|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
64651398|NCT01203722|Tacrolimus|tacrolimus|mesh-list
64651399|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651400|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651401|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651402|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
64651403|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651404|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64651405|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651406|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651407|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64651408|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
64651409|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64651410|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64651411|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64320072|NCT02180503|Linagliptin|linagliptin|mesh-list
64651414|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338407|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
64338408|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338409|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
64338410|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64338411|NCT05628389|Nicotine|nicotine|mesh-list
64338412|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64338413|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
64338414|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338415|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338416|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64338417|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64338418|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
64651415|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
64651416|NCT01520519|Rituximab|rituximab|mesh-list
64338419|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651417|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64651418|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651419|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
64651420|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651421|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651422|NCT03008057|Vitamin D|vitamin d|mesh-list
64651423|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
64651424|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
64651425|NCT03008057|Vitamins|vitamins|mesh-list
64651426|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
64651428|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64651429|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64651431|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
64651432|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
64651433|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651434|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651435|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
64651436|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651437|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64651438|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64651439|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64651440|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651441|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651442|NCT03216668|Silymarin|silymarin|mesh-list
64651443|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
64651444|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651445|NCT03216668|Protective Agents|protective agents|mesh-ancestor
64651446|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651447|NCT02548832|Bezafibrate|bezafibrate|mesh-list
64651448|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64651449|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
64651450|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386226|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
64386227|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
64386228|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64386229|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64386230|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64386231|NCT02084134|BB 1101|bb 1101|mesh-list
64386232|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64386233|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
64386234|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
64386235|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386236|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386237|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64386238|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
64386239|NCT02084134|Hormones|hormones|mesh-ancestor
64386240|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386241|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64386242|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386243|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
64386244|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386247|NCT01374269|Celecoxib|celecoxib|mesh-list
64651451|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64651452|NCT03216278|Metformin|metformin|mesh-list
64651453|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
64651454|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64651455|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651456|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64338445|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
64338446|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
64651457|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651464|NCT05310344|Paclitaxel|paclitaxel|mesh-list
64651465|NCT05310344|Bevacizumab|bevacizumab|mesh-list
64338447|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
64651467|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64651468|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651469|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
64651470|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
64651471|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
64651472|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386270|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
64651473|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64651474|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64651475|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64651477|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651478|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
64651479|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
64651480|NCT04382144|Bupivacaine|bupivacaine|mesh-list
64651481|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
64338457|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651482|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
64651483|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651484|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651485|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
64651486|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651488|NCT03215966|Macitentan|macitentan|mesh-list
64651489|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
64386337|NCT03163121|Vaccines|vaccines|mesh-list
64386339|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386340|NCT03114371|Oxytocin|oxytocin|mesh-list
64386341|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
64386342|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64386343|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386344|NCT04905407|Azacitidine|azacitidine|mesh-list
64386345|NCT04905407|Venetoclax|venetoclax|mesh-list
64386346|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386347|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
64386349|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651490|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64651491|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64651492|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651493|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651494|NCT03215966|Urological Agents|urological agents|mesh-ancestor
64651495|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64338458|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64338459|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
64338460|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338461|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338462|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64338463|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64338464|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64338497|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
64338498|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338499|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338500|NCT05401916|Acetaminophen|acetaminophen|mesh-list
64338501|NCT05401916|Ibuprofen|ibuprofen|mesh-list
64338502|NCT05401916|Tramadol|tramadol|mesh-list
64651496|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64651497|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64651499|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64386389|NCT03158129|Docetaxel|docetaxel|mesh-list
64386390|NCT03158129|Nivolumab|nivolumab|mesh-list
64386391|NCT03158129|Pemetrexed|pemetrexed|mesh-list
64386392|NCT03158129|Ipilimumab|ipilimumab|mesh-list
64386393|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386394|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
64386395|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
64386396|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
64386397|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386398|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386399|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64386400|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386401|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64386402|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64386403|NCT02397083|Everolimus|everolimus|mesh-list
64386404|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
64386405|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386406|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386407|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
64386408|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386409|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64386410|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
64386411|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64386412|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64386413|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64651502|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64651503|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64651504|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651505|NCT01441037|Danazol|danazol|mesh-list
64651506|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64651507|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
64651508|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651509|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651510|NCT00891878|Capecitabine|capecitabine|mesh-list
64651511|NCT00891878|Sunitinib|sunitinib|mesh-list
64651512|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386451|NCT01738139|Ipilimumab|ipilimumab|mesh-list
64386452|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
64386454|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338503|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64338504|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338505|NCT05401916|Analgesics|analgesics|mesh-ancestor
64338506|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
64338507|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338508|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338509|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338510|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338511|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64338512|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386455|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64386456|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651513|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
64651514|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651515|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651516|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64651517|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64651518|NCT00891878|Growth Substances|growth substances|mesh-ancestor
64651519|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651520|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
64651521|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64386457|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64386458|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386460|NCT01729091|Melphalan|melphalan|mesh-list
64386461|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
64386462|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64386463|NCT01729091|Elotuzumab|elotuzumab|mesh-list
64386464|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
64386465|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386466|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64386467|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64386468|NCT01729091|Growth Substances|growth substances|mesh-ancestor
64386469|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
64651522|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651523|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
64651524|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64651525|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651526|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
64651527|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64651528|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64386511|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386512|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386513|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64386515|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
64386516|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386517|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64386518|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64386519|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
64386520|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64386521|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64386522|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386523|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
64386524|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386525|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386526|NCT05675033|Bevacizumab|bevacizumab|mesh-list
64386527|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386528|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386529|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64386530|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64386531|NCT05675033|Growth Substances|growth substances|mesh-ancestor
64386532|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386534|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
64386535|NCT05674877|Ketamine|ketamine|mesh-list
64386536|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
64386537|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64386538|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338526|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64338534|NCT05401214|Prednisone|prednisone|mesh-list
64338541|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338542|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338544|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651531|NCT03838328|Coagulants|coagulants|mesh-ancestor
64651532|NCT01526213|Fexofenadine|fexofenadine|mesh-list
64651533|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64651534|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64651535|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64651536|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
64651537|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
64651538|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651539|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651540|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651542|NCT01549223|Oxytocin|oxytocin|mesh-list
64651543|NCT01549223|Methylergonovine|methylergonovine|mesh-list
64386539|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386540|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64386541|NCT05674877|Analgesics|analgesics|mesh-ancestor
64386542|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
64386543|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386544|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64386545|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64386546|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64386547|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
64386548|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386549|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386550|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64386551|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64386552|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
64386553|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
64386554|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64386555|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64386556|NCT05674877|Narcotics|narcotics|mesh-ancestor
64386557|NCT04103489|Eculizumab|eculizumab|mesh-list
64386558|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64386559|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386560|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
64386561|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651545|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
64651546|NCT01549223|Maleic acid|maleic acid|mesh-list
64651547|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
64651548|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64651549|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651550|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64651551|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
64651552|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64651553|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64651554|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651555|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651556|NCT00895934|Azacitidine|azacitidine|mesh-list
64651558|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
64651559|NCT00895934|Calicheamicins|calicheamicins|mesh-list
64651560|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64651561|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
64386577|NCT02390921|Hematinics|hematinics|mesh-ancestor
64651562|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651563|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651564|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651565|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64338551|NCT02532374|Nicotine|nicotine|mesh-list
64338552|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64338553|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
64338554|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338559|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338560|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338561|NCT01745588|Clarithromycin|clarithromycin|mesh-list
64338562|NCT01745588|Dexamethasone|dexamethasone|mesh-list
64338563|NCT01745588|Pomalidomide|pomalidomide|mesh-list
64651566|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64651567|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64651570|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651572|NCT01550471|Hormones|hormones|mesh-ancestor
64651573|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651574|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651575|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64651576|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
64651577|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64651578|NCT00896012|Sirolimus|sirolimus|mesh-list
64386729|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64386730|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64386731|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64386732|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386733|NCT02383121|Midodrine|midodrine|mesh-list
64386734|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
64386735|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
64386736|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386737|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386738|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64386739|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64386740|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64386741|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64386742|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
64386743|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386744|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386745|NCT02387021|Ropivacaine|ropivacaine|mesh-list
64386746|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
64386747|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
64386748|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386753|NCT02386943|Saxagliptin|saxagliptin|mesh-list
64651579|NCT00896012|Tacrolimus|tacrolimus|mesh-list
64651580|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651581|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
64651582|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651583|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64651584|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651585|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651586|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64651587|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651588|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64651589|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651590|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
64651591|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
64651592|NCT03215264|Entinostat|entinostat|mesh-list
64386780|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651594|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64651595|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64651596|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651597|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651598|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651599|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651600|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386867|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338564|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338565|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
64338566|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
64338567|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338568|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338569|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64386868|NCT02385617|Octreotide|octreotide|mesh-list
64386869|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64386870|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64386871|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386872|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
64386873|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
64386874|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
64386875|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386876|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386877|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
64386878|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386879|NCT02385461|Heparin|heparin|mesh-list
64386880|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64386881|NCT02385461|Tinzaparin|tinzaparin|mesh-list
64386882|NCT02385461|Dalteparin|dalteparin|mesh-list
64651601|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64651603|NCT01447511|Fluconazole|fluconazole|mesh-list
64651604|NCT01447511|Warfarin|warfarin|mesh-list
64651605|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
64651606|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64651607|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
64651608|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64651609|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651610|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
64651611|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64651612|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651613|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651614|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64651615|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64651616|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64387003|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
64387004|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387005|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387006|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
64387007|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387008|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64387009|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387010|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
64387011|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387012|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64387013|NCT02383823|Estradiol|estradiol|mesh-list
64387014|NCT02383823|Estrogens|estrogens|mesh-list
64387015|NCT02383823|Hormones|hormones|mesh-ancestor
64387016|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387017|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387018|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64387019|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64651617|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64338598|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64338599|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338600|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338601|NCT01281176|Paclitaxel|paclitaxel|mesh-list
64338602|NCT01281176|Carboplatin|carboplatin|mesh-list
64338603|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64338604|NCT01281176|Vorinostat|vorinostat|mesh-list
64338605|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64338613|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
64651618|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64651619|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64651620|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
64651621|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64651622|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64651623|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64651624|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
64387050|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387051|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
64387052|NCT02377193|Tacrolimus|tacrolimus|mesh-list
64387053|NCT02377193|Basiliximab|basiliximab|mesh-list
64387054|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387055|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
64387056|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387057|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64387058|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387059|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387060|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64387061|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387062|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64387063|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
64387064|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387065|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387066|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64387067|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
64387068|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387070|NCT04688021|Cyclosporine|cyclosporine|mesh-list
64387071|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
64651625|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651626|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651627|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64651628|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64651630|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64651631|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651632|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64651633|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64651634|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651635|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651636|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
64651637|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651638|NCT04380818|Ritonavir|ritonavir|mesh-list
64651639|NCT04380818|Lopinavir|lopinavir|mesh-list
64387086|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387087|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
64387088|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
64387089|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387090|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387091|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
64387092|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
64387093|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64387094|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64338621|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338622|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
64338623|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
64338624|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
64387095|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64387096|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
64387097|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387098|NCT02053246|Nebivolol|nebivolol|mesh-list
64387099|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64387100|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
64387101|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64387102|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64387103|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64387104|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387105|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387106|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387107|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387108|NCT04678661|Insulin|insulin|mesh-list
64387109|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64387110|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387111|NCT02379299|Hormones|hormones|mesh-list
64387112|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651642|NCT04380818|Heparin|heparin|mesh-list
64651643|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64651644|NCT04380818|Tinzaparin|tinzaparin|mesh-list
64651645|NCT04380818|Dalteparin|dalteparin|mesh-list
64651646|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64651647|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64387114|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
64387115|NCT02376881|Hematinics|hematinics|mesh-ancestor
64387116|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
64387117|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
64387118|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387119|NCT02376803|Warfarin|warfarin|mesh-list
64387120|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
64387121|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64387122|NCT04210427|Laxatives|laxatives|mesh-ancestor
64387123|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387124|NCT04132427|Vancomycin|vancomycin|mesh-list
64387125|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
64387126|NCT04132427|Citric Acid|citric acid|mesh-list
64387127|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
64387128|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
64387129|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64387130|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
64387131|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
64387132|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338640|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338643|NCT05533229|Bupivacaine|bupivacaine|mesh-list
64338644|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
64338645|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
64338646|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338647|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338648|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
64338649|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338650|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64387133|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387134|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387136|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387137|NCT02031640|Beclomethasone|beclomethasone|mesh-list
64387139|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
64387140|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
64651648|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
64651649|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651650|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651651|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64651652|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64651653|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
64651654|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651655|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64651656|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64651657|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
64387141|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387142|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387143|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64387144|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
64387145|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
64387146|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64387147|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64387148|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64387149|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64387150|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387151|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387152|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387153|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387154|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
64387155|NCT02031640|Hormones|hormones|mesh-ancestor
64387156|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387157|NCT02376413|Trastuzumab|trastuzumab|mesh-list
64387158|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387159|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387160|NCT02378441|Metformin|metformin|mesh-list
64387161|NCT02378441|Atorvastatin|atorvastatin|mesh-list
64651658|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64651659|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64651660|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64651661|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
64651662|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64651663|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64651664|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651666|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
64651667|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651668|NCT01550705|Isoniazid|isoniazid|mesh-list
64387183|NCT04600427|Anesthetics|anesthetics|mesh-list
64338665|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338666|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338667|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
64338668|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387184|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387185|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387186|NCT04595981|Cisplatin|cisplatin|mesh-list
64387187|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387188|NCT02378129|Methamphetamine|methamphetamine|mesh-list
64387206|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387208|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
64387209|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64387210|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64387211|NCT02375867|Prednisolone|prednisolone|mesh-list
64387212|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
64387213|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64387214|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
64387215|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387216|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
64387217|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
64387218|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387219|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387220|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387221|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
64387222|NCT02375867|Hormones|hormones|mesh-ancestor
64387223|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387231|NCT04540133|BB 1101|bb 1101|mesh-list
64651669|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
64651670|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64651671|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651672|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64651673|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64651674|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
64651675|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651676|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64651677|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64387243|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
64387244|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387245|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387246|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
64387247|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64651678|NCT01831700|Lisinopril|lisinopril|mesh-list
64651679|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
64651680|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64651681|NCT01831700|Diuretics|diuretics|mesh-ancestor
64651682|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
64651683|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651684|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64387311|NCT02371577|Growth Substances|growth substances|mesh-ancestor
64387312|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
64387313|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387314|NCT02373449|Ketamine|ketamine|mesh-list
64338704|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387315|NCT02373449|Analgesics|analgesics|mesh-ancestor
64338705|NCT01054196|Lenalidomide|lenalidomide|mesh-list
64338706|NCT01054196|Melphalan|melphalan|mesh-list
64338707|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
64338708|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338709|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64338710|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64338711|NCT01054196|Growth Substances|growth substances|mesh-ancestor
64387316|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
64651691|NCT01831700|Protective Agents|protective agents|mesh-ancestor
64651692|NCT01531439|Naloxone|naloxone|mesh-list
64651693|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64651694|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651695|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
64651696|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651697|NCT03214874|Torsemide|torsemide|mesh-list
64651698|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64651699|NCT03214874|Diuretics|diuretics|mesh-ancestor
64651700|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
64387370|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387371|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387372|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64387373|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387374|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387375|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64387377|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64387378|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64387379|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64387380|NCT03765983|Trastuzumab|trastuzumab|mesh-list
64387381|NCT03765983|GDC-0084|gdc-0084|mesh-list
64387382|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387383|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387384|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387385|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387386|NCT02372903|Palmidrol|palmidrol|mesh-list
64387387|NCT02372903|Analgesics|analgesics|mesh-ancestor
64338752|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387388|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
64387389|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387390|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387391|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64651701|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651702|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64651703|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651704|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651705|NCT02504268|Methotrexate|methotrexate|mesh-list
64651706|NCT02504268|Abatacept|abatacept|mesh-list
64651707|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64651708|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
64651709|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64651710|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651711|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64651712|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
64387392|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387393|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387394|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387395|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
64387396|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387397|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64387398|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64387399|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387400|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387401|NCT02372903|Hormones|hormones|mesh-ancestor
64387402|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387403|NCT02372591|Buprenorphine|buprenorphine|mesh-list
64387404|NCT02372591|Hydromorphone|hydromorphone|mesh-list
64387405|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64387406|NCT02372591|Narcotics|narcotics|mesh-ancestor
64338753|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64338754|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
64338755|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651713|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651715|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
64651716|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651717|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64651718|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651719|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
64651720|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651721|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64651722|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64651723|NCT01532141|Opicapone|opicapone|mesh-list
64651724|NCT01532141|Rasagiline|rasagiline|mesh-list
64651725|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64651726|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651727|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651728|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64651729|NCT01532141|Protective Agents|protective agents|mesh-ancestor
64651730|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651731|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64651732|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64651733|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64651734|NCT00904826|Eculizumab|eculizumab|mesh-list
64387436|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64387437|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
64387438|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64387439|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651735|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64651736|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651737|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
64651738|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651739|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64651740|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64651741|NCT01448525|Bimatoprost|bimatoprost|mesh-list
64651742|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64387485|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64387486|NCT02365493|Cefazolin|cefazolin|mesh-list
64387487|NCT02365493|Lactams|lactams|mesh-list
64387488|NCT02365493|beta-Lactams|beta-lactams|mesh-list
64387489|NCT02365493|Floxacillin|floxacillin|mesh-list
64387490|NCT02365493|Cloxacillin|cloxacillin|mesh-list
64387491|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387492|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387493|NCT02365181|Ropivacaine|ropivacaine|mesh-list
64387494|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
64387495|NCT02365181|Anesthetics|anesthetics|mesh-list
64387496|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387498|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
64651743|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64651744|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64651745|NCT01654302|Lidocaine|lidocaine|mesh-list
64651746|NCT01654302|Tetracaine|tetracaine|mesh-list
64651747|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
64651748|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
64651749|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651750|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651751|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
64651752|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651753|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64651754|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64651755|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64651756|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651757|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651758|NCT01832558|Eplerenone|eplerenone|mesh-list
64338762|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64338763|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
64338764|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
64338765|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651759|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64651760|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377095|NCT02503319|Oxytocin|oxytocin|mesh-list
64651761|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651762|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651763|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64651764|NCT01832558|Diuretics|diuretics|mesh-ancestor
64651765|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
64651766|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64651767|NCT02476422|Ibuprofen|ibuprofen|mesh-list
64651768|NCT02476422|Diclofenac|diclofenac|mesh-list
64387551|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
64387552|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387553|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387554|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64651769|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64651770|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64651772|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
64651773|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651774|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651775|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651776|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651777|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64651778|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651779|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651781|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64651782|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651783|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64651784|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
64651785|NCT01552343|Coagulants|coagulants|mesh-ancestor
64651786|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64651787|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
64651788|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651789|NCT02475564|Resveratrol|resveratrol|mesh-list
64651790|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
64651791|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651792|NCT02475564|Protective Agents|protective agents|mesh-ancestor
64651793|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651794|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651795|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64651796|NCT00893984|Nebivolol|nebivolol|mesh-list
64651797|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64651798|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
64387675|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387676|NCT04479371|Bupivacaine|bupivacaine|mesh-list
64387677|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
64387678|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
64387679|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387680|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651799|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64651801|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64651802|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
64651803|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651804|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651805|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651806|NCT01832870|Ipilimumab|ipilimumab|mesh-list
64387730|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387731|NCT02794571|Paclitaxel|paclitaxel|mesh-list
64387732|NCT02794571|Etoposide|etoposide|mesh-list
64387733|NCT02794571|Bevacizumab|bevacizumab|mesh-list
64338771|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
64338772|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
64338773|NCT05077215|Lenvatinib|lenvatinib|mesh-list
64387734|NCT02794571|Carboplatin|carboplatin|mesh-list
64338774|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387735|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
64387746|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64387747|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64387748|NCT02794571|Growth Substances|growth substances|mesh-ancestor
64387749|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387750|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
64387751|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387752|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
64387753|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64387754|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64387755|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387756|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64387757|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64651807|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387792|NCT02365727|Clonidine|clonidine|mesh-list
64651808|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651809|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64651810|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651811|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
64651812|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64651813|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651814|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651815|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
64651816|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651817|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651818|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
64651819|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64651820|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
64651821|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64651822|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
64651823|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651824|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651825|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
64651826|NCT01832948|Leucovorin|leucovorin|mesh-list
64651827|NCT01832948|Folic Acid|folic acid|mesh-list
64651828|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
64651829|NCT01832948|Endostar protein|endostar protein|mesh-list
64651830|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
64651831|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651832|NCT01832948|Antidotes|antidotes|mesh-ancestor
64651833|NCT01832948|Protective Agents|protective agents|mesh-ancestor
64388084|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651834|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651835|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
64651836|NCT01832948|Vitamins|vitamins|mesh-ancestor
64651837|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
64651838|NCT01832948|Hematinics|hematinics|mesh-ancestor
64651839|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64651840|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64338795|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338796|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64651841|NCT01832948|Growth Substances|growth substances|mesh-ancestor
64338800|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651842|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
64651843|NCT01533077|Levodopa|levodopa|mesh-list
64651844|NCT01533077|Carbidopa|carbidopa|mesh-list
64388158|NCT02352311|Urological Agents|urological agents|mesh-ancestor
64388159|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64388160|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64388161|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
64388162|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388163|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388164|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64388165|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388166|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64388167|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388168|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388169|NCT02351765|Cisplatin|cisplatin|mesh-list
64388170|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388171|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
64388172|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
64388173|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64388174|NCT02351687|Albendazole|albendazole|mesh-list
64388175|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
64388176|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64651845|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64651847|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64651848|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64651849|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
64651850|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651851|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651852|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651853|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64651854|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388205|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
64388206|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
64388207|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388208|NCT02355119|Gemcitabine|gemcitabine|mesh-list
64388209|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64388210|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
64388211|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388212|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388213|NCT02355119|Antiviral Agents|antiviral agents|mesh-ancestor
64388214|NCT02355119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388215|NCT02355119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388219|NCT03149939|Febuxostat|febuxostat|mesh-list
64651855|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64651856|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
64651857|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
64651858|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64651860|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64651861|NCT01534013|Pancrelipase|pancrelipase|mesh-list
64651862|NCT01534013|Pancreatin|pancreatin|mesh-list
64651863|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64651864|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388268|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
64338871|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338872|NCT05554406|Cytarabine|cytarabine|mesh-list
64338873|NCT05554406|Azacitidine|azacitidine|mesh-list
64388269|NCT03159845|Astringents|astringents|mesh-ancestor
64388270|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
64388271|NCT02350751|MEDI8852|medi8852|mesh-list
64388272|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
64388273|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388274|NCT02350985|Propranolol|propranolol|mesh-list
64388275|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64651866|NCT03211988|Entinostat|entinostat|mesh-list
64651867|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651868|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64651869|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651870|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651872|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651873|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64651874|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651875|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651876|NCT01833728|Acetaminophen|acetaminophen|mesh-list
64651877|NCT01833728|Propacetamol|propacetamol|mesh-list
64651878|NCT01833728|Nefopam|nefopam|mesh-list
64651879|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64388276|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64388277|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64388278|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
64388279|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388280|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388281|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388282|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64388283|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64388284|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
64651883|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651884|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64651885|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64651886|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651887|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
64651888|NCT03213392|Anesthetics|anesthetics|mesh-list
64651889|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651890|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651891|NCT03219788|Remifentanil|remifentanil|mesh-list
64388285|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64388286|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64388287|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388288|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64388289|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
64388290|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64388291|NCT02354261|Itraconazole|itraconazole|mesh-list
64388292|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
64388293|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651903|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338919|NCT04662723|Canagliflozin|canagliflozin|mesh-list
64338920|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64651904|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
64651905|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
64651906|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651907|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377222|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64651908|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338968|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338969|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
64338970|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338971|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64338976|NCT02328729|Epinephrine|epinephrine|mesh-list
64651910|NCT03219710|Hormones|hormones|mesh-ancestor
64651911|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64651912|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64651913|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651914|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
64651915|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
64651916|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64651917|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
64651918|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651919|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651920|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64651921|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64651922|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651923|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64651924|NCT03219710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64651925|NCT03219710|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64651926|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64651927|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651928|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64651930|NCT00899600|Analgesics|analgesics|mesh-ancestor
64651931|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
64651932|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651933|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651935|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64651936|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
64651937|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
64651938|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64651939|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64651940|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64651941|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651942|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651943|NCT03219554|Palbociclib|palbociclib|mesh-list
64651944|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651945|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64651946|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64651947|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651949|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64651950|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
64651951|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651952|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64651953|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64651954|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
64651955|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651956|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651957|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64651958|NCT01451411|Conivaptan|conivaptan|mesh-list
64339036|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64339037|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339038|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339039|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339040|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339041|NCT05337566|Azithromycin|azithromycin|mesh-list
64339042|NCT05337566|Cefuroxime|cefuroxime|mesh-list
64651959|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64651960|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651961|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
64651962|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651963|NCT03837938|Dipropizine|dipropizine|mesh-list
64651964|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
64651965|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
64651966|NCT01554683|Levetiracetam|levetiracetam|mesh-list
64651967|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
64651968|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
64651969|NCT00905060|Temozolomide|temozolomide|mesh-list
64651970|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64651971|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
64651972|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651973|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64651974|NCT01535573|Dexetimide|dexetimide|mesh-list
64651975|NCT01535573|Citalopram|citalopram|mesh-list
64651976|NCT01535573|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64651977|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64651978|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64651979|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64651980|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64651981|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
64651982|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64651983|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64651984|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
64651985|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64651986|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64651987|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64651988|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
64651989|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
64651990|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64651991|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64651992|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64651993|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
64651994|NCT01834508|Entecavir|entecavir|mesh-list
64651995|NCT01834508|Adefovir|adefovir|mesh-list
64651996|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
64651997|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64651998|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64651999|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64339090|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64339091|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64339092|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
64339093|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339094|NCT03110757|Antacids|antacids|mesh-ancestor
64339095|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339096|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339097|NCT05303792|Cytarabine|cytarabine|mesh-list
64339098|NCT05303792|Dexamethasone|dexamethasone|mesh-list
64339099|NCT05303792|Prednisone|prednisone|mesh-list
64339100|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
64339101|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
64339102|NCT05303792|Rituximab|rituximab|mesh-list
64339103|NCT05303792|Doxorubicin|doxorubicin|mesh-list
64339104|NCT05303792|Methotrexate|methotrexate|mesh-list
64652000|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652001|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652003|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64652004|NCT03213002|Capecitabine|capecitabine|mesh-list
64652005|NCT03213002|Temozolomide|temozolomide|mesh-list
64652006|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64652007|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
64652008|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652009|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652010|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64652011|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
64652013|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
64652014|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652015|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652016|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652017|NCT03218852|Prednisone|prednisone|mesh-list
64652018|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
64652019|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652020|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
64652021|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652022|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652023|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64652024|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
64652025|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652026|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652027|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64652028|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64652029|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
64652030|NCT03218852|Hormones|hormones|mesh-ancestor
64652031|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64652032|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64652033|NCT01834898|Oxycodone|oxycodone|mesh-list
64652034|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64652036|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652037|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652038|NCT01834898|Analgesics|analgesics|mesh-ancestor
64652039|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
64652040|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652041|NCT01557959|Docetaxel|docetaxel|mesh-list
64652042|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64652043|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652044|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
64339154|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64339155|NCT03145467|Analgesics|analgesics|mesh-ancestor
64339156|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
64339157|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339158|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339159|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
64652045|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
64339162|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
64652046|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
64652047|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652048|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64652049|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652050|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
64652051|NCT03212456|Ropivacaine|ropivacaine|mesh-list
64652052|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
64652053|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
64652054|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652055|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652057|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652058|NCT03212456|Narcotics|narcotics|mesh-ancestor
64652059|NCT03212456|Analgesics|analgesics|mesh-ancestor
64652060|NCT03217838|Azacitidine|azacitidine|mesh-list
64652061|NCT03217838|Venetoclax|venetoclax|mesh-list
64652062|NCT03217838|Pyrazole|pyrazole|mesh-list
64652063|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64388768|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
64652065|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652067|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652068|NCT01558661|Axitinib|axitinib|mesh-list
64652069|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652070|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64652071|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652072|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652073|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
64652074|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652075|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
64652076|NCT02502864|Docetaxel|docetaxel|mesh-list
64652077|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652078|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
64652079|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652080|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652081|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64652082|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
64652083|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652084|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652085|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64652086|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
64652087|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
64652088|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
64652089|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
64652090|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64652092|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64652093|NCT03217292|Narcotics|narcotics|mesh-ancestor
64652094|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652095|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652096|NCT03217292|Analgesics|analgesics|mesh-ancestor
64652097|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
64652098|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652099|NCT03217448|Warfarin|warfarin|mesh-list
64652100|NCT03217448|Dabigatran|dabigatran|mesh-list
64652101|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
64652102|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
64652103|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64652104|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
64652105|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652106|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390145|NCT03183739|ASP8062|asp8062|mesh-list
64652108|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
64652109|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64652110|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64652111|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64652112|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
64652113|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390238|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652114|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652115|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652116|NCT01457573|Urological Agents|urological agents|mesh-ancestor
64652117|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64652118|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64652119|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
64652120|NCT01560143|Tigecycline|tigecycline|mesh-list
64652121|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652122|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652123|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64652124|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652125|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652126|NCT01836224|Terlipressin|terlipressin|mesh-list
64652127|NCT01836224|Norepinephrine|norepinephrine|mesh-list
64652128|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64652129|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64652130|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64652131|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64390635|NCT05392673|Bilirubin|bilirubin|mesh-list
64652132|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
64652133|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652134|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390731|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
64652135|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652136|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
64652137|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
64652138|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652140|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64652141|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652142|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64652143|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64652144|NCT01836536|Growth Substances|growth substances|mesh-ancestor
64652145|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652146|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
64652147|NCT03216980|Antioxidants|antioxidants|mesh-list
64390822|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
64652148|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652149|NCT03216980|Protective Agents|protective agents|mesh-ancestor
64652150|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652151|NCT00895232|Iron|iron|mesh-list
64339317|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339318|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64339319|NCT04249232|Abaloparatide|abaloparatide|mesh-list
64339320|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64339321|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339322|NCT05079087|Midazolam|midazolam|mesh-list
64652152|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64652153|NCT00895232|Trace Elements|trace elements|mesh-ancestor
64652154|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
64652155|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390961|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652156|NCT00895232|Hematinics|hematinics|mesh-ancestor
64652157|NCT03211052|Leuprolide|leuprolide|mesh-list
64652158|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64652159|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
64652160|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64652161|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652163|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652164|NCT01560923|Tryptophan|tryptophan|mesh-list
64652165|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64652166|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
64652167|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64652168|NCT01839032|Vinorelbine|vinorelbine|mesh-list
64652169|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652170|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64652171|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
64652172|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
64652173|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
64652174|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652175|NCT01457885|Busulfan|busulfan|mesh-list
64652176|NCT01457885|Clofarabine|clofarabine|mesh-list
64652177|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
64652178|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652179|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652180|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
64652181|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652182|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64652183|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652184|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64391372|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
64652185|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64652186|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
64652187|NCT01460225|Lubiprostone|lubiprostone|mesh-list
64652188|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64652189|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652190|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652191|NCT01561469|Vancomycin|vancomycin|mesh-list
64652192|NCT01561469|Linezolid|linezolid|mesh-list
64652193|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652194|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339331|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
64339332|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339333|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64339334|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64339335|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339336|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339337|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64339338|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64339371|NCT03561831|Propofol|propofol|mesh-list
64652195|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64652196|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652197|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652198|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64652199|NCT01561703|Amoxicillin|amoxicillin|mesh-list
64652200|NCT01561703|Azithromycin|azithromycin|mesh-list
64652201|NCT01561703|Clindamycin|clindamycin|mesh-list
64652202|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
64652206|NCT01561703|Cefaclor|cefaclor|mesh-list
64652207|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652208|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64652209|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652210|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652211|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64652212|NCT01839500|Trastuzumab|trastuzumab|mesh-list
64652213|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64391865|NCT01603277|Antibodies|antibodies|mesh-list
64652214|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652215|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
64652216|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64652217|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652218|NCT02501928|Fesoterodine|fesoterodine|mesh-list
64652219|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64652220|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64652221|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
64652222|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652223|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652224|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652225|NCT02501928|Urological Agents|urological agents|mesh-ancestor
64652227|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64652228|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652229|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652230|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
64652231|NCT01462253|Clofarabine|clofarabine|mesh-list
64652232|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652233|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
64652234|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652235|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652236|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64652237|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
64652238|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652239|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652240|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64652241|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64652242|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
64652244|NCT01837394|Morphine|morphine|mesh-list
64339384|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652245|NCT01837394|Ondansetron|ondansetron|mesh-list
64392148|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
64652246|NCT01837394|Metoclopramide|metoclopramide|mesh-list
64652247|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64339385|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339386|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339387|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
64339388|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339389|NCT05289830|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64652249|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652250|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652251|NCT01837394|Analgesics|analgesics|mesh-ancestor
64652252|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
64652253|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652254|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64652255|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
64652258|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64652259|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
64652260|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
64652261|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64652262|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
64652263|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652264|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652265|NCT01837394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64652266|NCT01837394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64652267|NCT01837394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64652268|NCT01837394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64652269|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64652270|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64652271|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
64652272|NCT01462565|Epoprostenol|epoprostenol|mesh-list
64652273|NCT01462565|Tezosentan|tezosentan|mesh-list
64652274|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64652275|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64652276|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
64652277|NCT01837628|Lidocaine|lidocaine|mesh-list
64652278|NCT01837628|Mineral Oil|mineral oil|mesh-list
64652279|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
64652280|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
64392423|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652281|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652282|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652283|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
64652284|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652285|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64652286|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64652287|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64652288|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64392537|NCT03171727|Heparin|heparin|mesh-list
64652289|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652291|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
64652292|NCT01462877|Fenofibrate|fenofibrate|mesh-list
64339416|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339417|NCT05259800|Peppermint oil|peppermint oil|mesh-list
64339418|NCT05259800|Mineral Oil|mineral oil|mesh-list
64339419|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
64339420|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
64339421|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652293|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64339422|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652294|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
64652295|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652296|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64652298|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64652299|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64652300|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
64652301|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652303|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64392751|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
64652304|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652305|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
64652306|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
64652307|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64652308|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
64652309|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64652310|NCT01839812|Cosyntropin|cosyntropin|mesh-list
64652311|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64652312|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64652314|NCT01839812|Hormones|hormones|mesh-ancestor
64392904|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392905|NCT04670471|Analgesics|analgesics|mesh-ancestor
64652315|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64652316|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652317|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652318|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652319|NCT04939272|Venetoclax|venetoclax|mesh-list
64652320|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652321|NCT01839890|Paclitaxel|paclitaxel|mesh-list
64652322|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64652323|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652324|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
64652325|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
64652326|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
64652327|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652328|NCT02205983|Acetaminophen|acetaminophen|mesh-list
64652329|NCT02205983|Hydromorphone|hydromorphone|mesh-list
64652330|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64652331|NCT02205983|Analgesics|analgesics|mesh-ancestor
64652332|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
64652333|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652334|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652335|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
64652336|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64652337|NCT02205983|Narcotics|narcotics|mesh-ancestor
64652338|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339441|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
64339442|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64339443|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64339444|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339446|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64339447|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64339448|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339449|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339450|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652339|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64652340|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64652341|NCT03210038|Lidocaine|lidocaine|mesh-list
64652342|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
64652344|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652345|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652346|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
64652347|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652348|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64652349|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64652350|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64652351|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652352|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652354|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64652355|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652356|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
64652357|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652358|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652359|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
64652360|NCT01464359|Busulfan|busulfan|mesh-list
64652361|NCT01464359|Fludarabine|fludarabine|mesh-list
64652362|NCT01464359|Interleukin-2|interleukin-2|mesh-list
64652363|NCT01464359|Allopurinol|allopurinol|mesh-list
64652364|NCT01464359|Levetiracetam|levetiracetam|mesh-list
64652365|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652366|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
64652367|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652368|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652369|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64652371|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652372|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652373|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64652374|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
64652375|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64652376|NCT01464359|Analgesics|analgesics|mesh-ancestor
64652377|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
64652378|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652379|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
64652380|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
64652381|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652382|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
64652383|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64652384|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
64652385|NCT01464359|Protective Agents|protective agents|mesh-ancestor
64652387|NCT04969224|Elexacaftor|elexacaftor|mesh-list
64652388|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64652389|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339463|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339464|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652390|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652391|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
64339465|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64652393|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
64652394|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652396|NCT01838252|Protective Agents|protective agents|mesh-ancestor
64652397|NCT01838330|Psyllium|psyllium|mesh-list
64652398|NCT01838330|Cathartics|cathartics|mesh-ancestor
64652399|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64652400|NCT02498652|Allopurinol|allopurinol|mesh-list
64652401|NCT02498652|Verinurad|verinurad|mesh-list
64652402|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
64652403|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652404|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652405|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
64652406|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652407|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64652408|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
64652409|NCT02498652|Protective Agents|protective agents|mesh-ancestor
64652410|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652411|NCT03213158|Ixazomib|ixazomib|mesh-list
64652412|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652413|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
64652414|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393693|NCT03906617|Bupivacaine|bupivacaine|mesh-list
64652415|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652417|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652418|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652420|NCT03219476|Tamoxifen|tamoxifen|mesh-list
64652421|NCT03219476|Letrozole|letrozole|mesh-list
64652422|NCT03219476|Anastrozole|anastrozole|mesh-list
64339498|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
64339499|NCT02285062|Prednisone|prednisone|mesh-list
64339500|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
64339501|NCT02285062|Rituximab|rituximab|mesh-list
64339502|NCT02285062|Doxorubicin|doxorubicin|mesh-list
64339503|NCT02285062|Vincristine|vincristine|mesh-list
64339504|NCT02285062|Lenalidomide|lenalidomide|mesh-list
64339505|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339521|NCT02285062|Hormones|hormones|mesh-ancestor
64339547|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339548|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339549|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64339550|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339551|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339552|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64339553|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339554|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
64339555|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339556|NCT04571697|Methotrexate|methotrexate|mesh-list
64339557|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64339558|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
64339559|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64339560|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652423|NCT03219476|Exemestane|exemestane|mesh-list
64652424|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652425|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64652427|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652428|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652429|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64652430|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
64652431|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64652432|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652433|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64652434|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64652435|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64652436|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64652437|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64394004|NCT02402725|Dexamethasone|dexamethasone|mesh-list
64652438|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64652439|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
64652441|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64652442|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652443|NCT01724606|Sorafenib|sorafenib|mesh-list
64652444|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652445|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64652446|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652447|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652448|NCT03217136|Metronidazole|metronidazole|mesh-list
64652449|NCT03217136|Meropenem|meropenem|mesh-list
64652450|NCT03217136|Tazobactam|tazobactam|mesh-list
64652451|NCT03217136|Ceftolozane|ceftolozane|mesh-list
64652452|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64652453|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652454|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652455|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64652456|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64339561|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64339562|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
64339563|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339564|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339565|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339566|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652457|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64652458|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652459|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652460|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64652462|NCT03219164|Aztreonam|aztreonam|mesh-list
64652463|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652464|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652465|NCT01720238|Lamivudine|lamivudine|mesh-list
64652466|NCT01720238|Adefovir|adefovir|mesh-list
64652467|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
64652469|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64652470|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64652471|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652472|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652473|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
64652474|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652475|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64652476|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64652477|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
64652478|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64652479|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652480|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652481|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64394428|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64652482|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64652483|NCT03836222|Protective Agents|protective agents|mesh-ancestor
64652484|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652485|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
64652486|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64652487|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
64652488|NCT01830218|Anesthetics|anesthetics|mesh-list
64652489|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339789|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64652490|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652491|NCT00910208|Morphine|morphine|mesh-list
64652492|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64652493|NCT00910208|Narcotics|narcotics|mesh-ancestor
64652494|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652495|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652496|NCT00910208|Analgesics|analgesics|mesh-ancestor
64394589|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
64652497|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
64652498|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652499|NCT01566539|Vasopressins|vasopressins|mesh-list
64652500|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
64652501|NCT01566539|Lorazepam|lorazepam|mesh-list
64652502|NCT01566539|Oxytocin|oxytocin|mesh-list
64652503|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
64652504|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64652505|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652506|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
64652507|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
64652508|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
64652509|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652510|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64652511|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64652512|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652513|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64652514|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64394727|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64394728|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652515|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64652516|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
64652517|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
64652518|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339790|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64339791|NCT03832647|Analgesics|analgesics|mesh-ancestor
64339792|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
64652519|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652520|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
64652521|NCT01566539|Coagulants|coagulants|mesh-ancestor
64652522|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64652523|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64652524|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
64652525|NCT04967664|Capsaicin|capsaicin|mesh-list
64652526|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
64652527|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
64652528|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
64652529|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652530|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652532|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64652533|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64652534|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
64652535|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64652536|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64652537|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652538|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652540|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652541|NCT01830296|Morphine|morphine|mesh-list
64652542|NCT01830296|Remifentanil|remifentanil|mesh-list
64652543|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64652544|NCT01830296|Narcotics|narcotics|mesh-ancestor
64652545|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652546|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652547|NCT01830296|Analgesics|analgesics|mesh-ancestor
64652548|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
64652549|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652551|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64652552|NCT05564819|Analgesics|analgesics|mesh-ancestor
64652553|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
64652554|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652555|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652556|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
64652557|NCT01720394|Dinoprostone|dinoprostone|mesh-list
64652558|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
64652559|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64652560|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652561|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64652562|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64652563|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64652564|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652565|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
64652566|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652567|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
64652568|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64652569|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64652570|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64339866|NCT00890591|Olmesartan|olmesartan|mesh-list
64339867|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64339868|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64339869|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64339870|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339871|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339872|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64652571|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652572|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652573|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
64652574|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652575|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652576|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64652577|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652578|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
64652580|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64652581|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652583|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
64652584|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64652585|NCT01720628|Angiogenin|angiogenin|mesh-list
64652586|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64652587|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64652588|NCT01720628|Growth Substances|growth substances|mesh-ancestor
64652589|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652590|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
64652591|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64652592|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
64652593|NCT01569191|Epinastine|epinastine|mesh-list
64652594|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64652595|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64652596|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
64652597|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
64652599|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652601|NCT03409874|Diclofenac|diclofenac|mesh-list
64652602|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64652603|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64652604|NCT03409874|Analgesics|analgesics|mesh-ancestor
64652605|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
64652606|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652607|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652608|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64652609|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652610|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64652611|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652612|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652613|NCT01726088|Modafinil|modafinil|mesh-list
64652614|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64652615|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652616|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64339884|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339885|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
64339886|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339887|NCT03140787|Lidocaine|lidocaine|mesh-list
64339888|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
64339889|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
64339890|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339905|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339906|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339907|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64339909|NCT03317223|Amoxicillin|amoxicillin|mesh-list
64652617|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64652618|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64652619|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652621|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
64652622|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652623|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
64652625|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64652626|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64652627|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64652628|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
64652629|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652630|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64652631|NCT05562089|Paclitaxel|paclitaxel|mesh-list
64652632|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64652633|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652634|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
64652635|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
64652636|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
64652637|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652638|NCT01726478|Oxytocin|oxytocin|mesh-list
64652639|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
64652640|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64652641|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652642|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
64652643|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
64652644|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64652645|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64652646|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652647|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652648|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652649|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652651|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64652652|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64652653|NCT03409250|Growth Substances|growth substances|mesh-ancestor
64652654|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652655|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
64652656|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652658|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64652659|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652661|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339918|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64339919|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64339920|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339921|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64652667|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652668|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652669|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64652670|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652671|NCT01721798|Copper|copper|mesh-list
64652672|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
64652673|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64652674|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
64652675|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64652676|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652677|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64652678|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64652679|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64652680|NCT01721798|Trace Elements|trace elements|mesh-ancestor
64652681|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
64652682|NCT02497404|Fludarabine|fludarabine|mesh-list
64652683|NCT02497404|Azacitidine|azacitidine|mesh-list
64652684|NCT02497404|Melphalan|melphalan|mesh-list
64652686|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652687|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64652688|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
64652689|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652690|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652691|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
64652692|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652693|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652694|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64652696|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64652697|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64339936|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339937|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652698|NCT01573169|Enoxaparin|enoxaparin|mesh-list
64652699|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
64652700|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64652701|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64395953|NCT03103685|Ticagrelor|ticagrelor|mesh-list
64652702|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652704|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64652705|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64652706|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64652708|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652709|NCT02218307|Mupirocin|mupirocin|mesh-list
64652710|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652711|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652712|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64652713|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652714|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652715|NCT01722110|Indomethacin|indomethacin|mesh-list
64652716|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64652717|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64652719|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
64652720|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652721|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652722|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64652723|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64652724|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
64652725|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
64652726|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64652727|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64652728|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652729|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652730|NCT01573949|Metformin|metformin|mesh-list
64652731|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64652732|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652733|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64652734|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
64652735|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64652736|NCT01574183|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64652737|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64652738|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652739|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339983|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
64339984|NCT00966953|Protective Agents|protective agents|mesh-ancestor
64339985|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339986|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64339987|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339988|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64340003|NCT05247320|Sotalol|sotalol|mesh-list
64652740|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652742|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652743|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64652744|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64652746|NCT01574807|Mepivacaine|mepivacaine|mesh-list
64652747|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
64652748|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
64652749|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652750|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652751|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
64652752|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652753|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64652754|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64652755|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64652756|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64652757|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652758|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64652759|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64652760|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
64652761|NCT01728272|Metoprolol|metoprolol|mesh-list
64652762|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64652763|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64652764|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
64652765|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
64652766|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652767|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652768|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64652769|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64652770|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64652771|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
64652773|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652775|NCT03835286|Vitamins|vitamins|mesh-ancestor
64652776|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
64652777|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652778|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
64652779|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652781|NCT04377386|Vitamin D|vitamin d|mesh-list
64652782|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
64652783|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
64652784|NCT04377386|Vitamins|vitamins|mesh-list
64652785|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
64652786|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652787|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64652788|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64652789|NCT01728740|Metformin|metformin|mesh-list
64652790|NCT01728740|Acarbose|acarbose|mesh-list
64396639|NCT01946152|Ichthammol|ichthammol|mesh-list
64652792|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652793|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64652794|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652795|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652796|NCT01728818|Gemcitabine|gemcitabine|mesh-list
64652799|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
64652801|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652802|NCT01728818|Antiviral Agents|antiviral agents|mesh-ancestor
64652803|NCT01728818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652804|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652805|NCT01728818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652806|NCT01728818|Immunologic Factors|immunologic factors|mesh-ancestor
64652807|NCT01728818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652808|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64652809|NCT01728974|Anesthetics|anesthetics|mesh-list
64652810|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652811|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652812|NCT03407300|Docetaxel|docetaxel|mesh-list
64652814|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
64652815|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
64652816|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
64652817|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652818|NCT01722968|Paclitaxel|paclitaxel|mesh-list
64652819|NCT01722968|Bevacizumab|bevacizumab|mesh-list
64652820|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64652821|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652822|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
64652823|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
64652824|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
64652825|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652826|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64652827|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64652828|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64652829|NCT01722968|Growth Substances|growth substances|mesh-ancestor
64652830|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652833|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
64652834|NCT04379180|Tadalafil|tadalafil|mesh-list
64652835|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
64652836|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64652837|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64652838|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652839|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652840|NCT04379180|Urological Agents|urological agents|mesh-ancestor
64652841|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64652842|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64652843|NCT01576523|Complement C1s|complement c1s|mesh-list
64652844|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64652845|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64652846|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
64652847|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340077|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
64340078|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340079|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340094|NCT05456165|Ipilimumab|ipilimumab|mesh-list
64340110|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
64340111|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64340112|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64340122|NCT05165966|Vaccines|vaccines|mesh-list
64652849|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64652850|NCT03406676|Methylene Blue|methylene blue|mesh-list
64652851|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652852|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652853|NCT03001739|Urapidil|urapidil|mesh-list
64652854|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64652855|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
64652856|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64652857|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
64652858|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652859|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652860|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652861|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64652862|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64652863|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64652864|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
64652866|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
64652867|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64652868|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652869|NCT03006965|Factor VIII|factor viii|mesh-list
64652870|NCT03006965|BAX 855|bax 855|mesh-list
64652871|NCT03006965|Coagulants|coagulants|mesh-ancestor
64652872|NCT04379102|Anesthetics|anesthetics|mesh-list
64652873|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
64652874|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652875|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652876|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
64652877|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652878|NCT02469246|Lamivudine|lamivudine|mesh-list
64652879|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64652880|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64652881|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652882|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652883|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
64652884|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652885|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64652886|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64652887|NCT01723202|Trametinib|trametinib|mesh-list
64652888|NCT01723202|Dabrafenib|dabrafenib|mesh-list
64652889|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652890|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64652891|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652892|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652894|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
64652895|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652897|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64652898|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64652899|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652900|NCT01726946|Ribavirin|ribavirin|mesh-list
64397053|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652901|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
64652902|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652903|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
64652904|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652906|NCT01723670|Analgesics|analgesics|mesh-ancestor
64652907|NCT01723670|Sensory System Agents|sensory system agents|mesh-ancestor
64652908|NCT01723670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652909|NCT01723670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652910|NCT01723670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64652911|NCT01723670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64652912|NCT01723670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64652913|NCT01723670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340128|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
64340129|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
64340130|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64340131|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64652916|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652918|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64652919|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652920|NCT02469090|Apomorphine|apomorphine|mesh-list
64652921|NCT02469090|Emetics|emetics|mesh-ancestor
64652922|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652923|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
64652924|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64652925|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64652926|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
64652927|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
64652928|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652929|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652930|NCT02496000|Insulin|insulin|mesh-list
64652931|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64652932|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652933|NCT02517528|Ritonavir|ritonavir|mesh-list
64652934|NCT02517528|Ribavirin|ribavirin|mesh-list
64652935|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64652936|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64652937|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
64652938|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652939|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652940|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64652941|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64652942|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
64652943|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652944|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64652945|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64652946|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
64652947|NCT01727336|Axitinib|axitinib|mesh-list
64652948|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652949|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64652950|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652951|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652952|NCT01578707|Ofatumumab|ofatumumab|mesh-list
64652953|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652954|NCT03835442|Baclofen|baclofen|mesh-list
64652955|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64652956|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652957|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64652958|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340136|NCT03138759|Probenecid|probenecid|mesh-list
64340137|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
64340138|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
64340139|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340140|NCT03138759|Renal Agents|renal agents|mesh-ancestor
64340141|NCT03079921|Propranolol|propranolol|mesh-list
64340154|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340155|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340156|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64652959|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64652960|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
64652961|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
64652962|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64652963|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652964|NCT01722656|Aflibercept|aflibercept|mesh-list
64652966|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64652967|NCT01722656|Growth Substances|growth substances|mesh-ancestor
64340170|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652970|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64652971|NCT04963764|Amoxicillin|amoxicillin|mesh-list
64397144|NCT02374567|Pipamperone|pipamperone|mesh-list
64652972|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652973|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652975|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
64652976|NCT03405584|Esomeprazole|esomeprazole|mesh-list
64652977|NCT03405584|Bismuth|bismuth|mesh-list
64652978|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64652979|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64652980|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64652981|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64652982|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64652983|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64652984|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64652985|NCT03405584|Antacids|antacids|mesh-ancestor
64652986|NCT03405584|Diuretics|diuretics|mesh-ancestor
64652987|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
64652988|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652989|NCT03405584|Expectorants|expectorants|mesh-ancestor
64652990|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
64652991|NCT03007121|Sufentanil|sufentanil|mesh-list
64652992|NCT03007121|Morphine|morphine|mesh-list
64652994|NCT03007121|Bupivacaine|bupivacaine|mesh-list
64652995|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
64652996|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
64652997|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64652998|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64652999|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
64653000|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653001|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64653002|NCT03007121|Narcotics|narcotics|mesh-ancestor
64340285|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
64340286|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340292|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64340293|NCT00851045|Leucovorin|leucovorin|mesh-list
64653003|NCT03007121|Analgesics|analgesics|mesh-ancestor
64653004|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64340294|NCT00851045|Bevacizumab|bevacizumab|mesh-list
64340295|NCT00851045|Fluorouracil|fluorouracil|mesh-list
64653010|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653013|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
64653014|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64653017|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653018|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653019|NCT02981459|Mirabegron|mirabegron|mesh-list
64653020|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64653021|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64653022|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64653023|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
64653024|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653025|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653026|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653027|NCT02981459|Urological Agents|urological agents|mesh-ancestor
64653028|NCT01724138|Deferasirox|deferasirox|mesh-list
64653029|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64653031|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
64653032|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653033|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64653034|NCT03006809|Metronidazole|metronidazole|mesh-list
64653035|NCT03006809|Vancomycin|vancomycin|mesh-list
64653036|NCT03006809|Neomycin|neomycin|mesh-list
64653037|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653038|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64653039|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64653040|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64653041|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653042|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653043|NCT01580423|Aprepitant|aprepitant|mesh-list
64653044|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
64653045|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
64653046|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653047|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653048|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64653049|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64653050|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653051|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653053|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64653054|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653055|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653056|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64653057|NCT01049984|Protective Agents|protective agents|mesh-ancestor
64653058|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653060|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64653061|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
64340341|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340342|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340343|NCT00838981|Analgesics|analgesics|mesh-ancestor
64653065|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64653066|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64653067|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653068|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64653070|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
64653071|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64653072|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653073|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
64653074|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64653075|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
64653076|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653077|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653078|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64653079|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
64397383|NCT05047055|Rifampin|rifampin|mesh-list
64653080|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64653081|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64653082|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64653083|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
64653084|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653085|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653086|NCT02494596|Capecitabine|capecitabine|mesh-list
64653087|NCT02494596|Pertuzumab|pertuzumab|mesh-list
64653088|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64340355|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64653089|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
64653090|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653091|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653092|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653093|NCT01048502|Fenofibrate|fenofibrate|mesh-list
64653094|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64653095|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
64653096|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653097|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64653098|NCT01583543|Olaparib|olaparib|mesh-list
64653099|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64653100|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653101|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653103|NCT01724372|Aripiprazole|aripiprazole|mesh-list
64653104|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
64653105|NCT01724372|Fluoxetine|fluoxetine|mesh-list
64653106|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
64653107|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64653108|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64653109|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653110|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653111|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
64653112|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
64653113|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340381|NCT03140397|Hormones|hormones|mesh-ancestor
64653114|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653116|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64653117|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
64653118|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64653119|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64653120|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64653121|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64653122|NCT01724372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64398228|NCT03160651|Hormones|hormones|mesh-ancestor
64653123|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64653124|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653125|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64653126|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64653127|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64653128|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398537|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64398604|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398605|NCT02349841|Amoxicillin|amoxicillin|mesh-list
64398606|NCT02349841|Meropenem|meropenem|mesh-list
64398607|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
64398608|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
64398609|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64398610|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653129|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
64653130|NCT02464410|Narcotics|narcotics|mesh-ancestor
64653131|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653132|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653133|NCT02464410|Analgesics|analgesics|mesh-ancestor
64653134|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
64653135|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653136|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
64653137|NCT03006419|Basiliximab|basiliximab|mesh-list
64653138|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
64653139|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653140|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653141|NCT03405272|Antibodies|antibodies|mesh-list
64653142|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64653143|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
64653144|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653145|NCT03405194|Efavirenz|efavirenz|mesh-list
64653146|NCT03405194|Cobicistat|cobicistat|mesh-list
64653147|NCT03405194|Elvitegravir|elvitegravir|mesh-list
64653148|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64653149|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64653150|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653151|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653152|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
64653153|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653154|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64653155|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64653156|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64653157|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64653158|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64653159|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64340385|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
64340386|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340387|NCT05235542|Paclitaxel|paclitaxel|mesh-list
64340388|NCT05235542|Docetaxel|docetaxel|mesh-list
64653160|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64653161|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64653162|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64653163|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64653164|NCT03006107|Piroxicam|piroxicam|mesh-list
64653165|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64653166|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64653167|NCT03006107|Analgesics|analgesics|mesh-ancestor
64653168|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
64653169|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653170|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653171|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64653172|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653173|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64653174|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401860|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
64653175|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653176|NCT01046396|Adapalene|adapalene|mesh-list
64653177|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64653178|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64653179|NCT01046396|Analgesics|analgesics|mesh-ancestor
64653180|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
64653181|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653182|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402482|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653183|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64653184|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653185|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
64653186|NCT01046084|Lansoprazole|lansoprazole|mesh-list
64653187|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
64653188|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64653189|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64653190|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64653191|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653192|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653193|NCT01045694|Triamcinolone|triamcinolone|mesh-list
64653194|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64653195|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64653197|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
64402724|NCT03063905|Analgesics|analgesics|mesh-ancestor
64653199|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64653200|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64653201|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
64653202|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
64402954|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
64653203|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653204|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653205|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
64653206|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653207|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64653208|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64653209|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64653210|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653211|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653212|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64340400|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64340401|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64340431|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340432|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340433|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653213|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
64653214|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653215|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64653216|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64653217|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
64653219|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64653220|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653221|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
64653222|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653224|NCT01586975|Clopidogrel|clopidogrel|mesh-list
64653225|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64653226|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64653227|NCT01586975|Analgesics|analgesics|mesh-ancestor
64653228|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
64404171|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64653229|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653230|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653232|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653233|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64653234|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64653235|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653236|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64653237|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64653238|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653240|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64653241|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64653242|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64653243|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
64653244|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653245|NCT03000413|Fentanyl|fentanyl|mesh-list
64653246|NCT03000413|Ketamine|ketamine|mesh-list
64653247|NCT03000413|Analgesics|analgesics|mesh-ancestor
64653248|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
64653249|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653250|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653251|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64653252|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64653253|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
64653254|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
64653255|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653256|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64653257|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64653258|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653259|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653260|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64653261|NCT03000413|Narcotics|narcotics|mesh-ancestor
64653262|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64653263|NCT01724918|Lacosamide|lacosamide|mesh-list
64653264|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
64653265|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64653266|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64653267|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653268|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340442|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64340443|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
64340444|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64340445|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64340446|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64340448|NCT03134729|Ropivacaine|ropivacaine|mesh-list
64653270|NCT01588457|Valproic Acid|valproic acid|mesh-list
64653271|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64653272|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
64653274|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64653275|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64653276|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64653277|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653278|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653279|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653280|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653281|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
64653282|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
64653283|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64653284|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653285|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64653286|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64653287|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
64653288|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653289|NCT03005639|Vemurafenib|vemurafenib|mesh-list
64653290|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653291|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64653292|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653293|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653294|NCT01590875|Adenosine|adenosine|mesh-list
64653295|NCT01590875|Analgesics|analgesics|mesh-ancestor
64653296|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
64653297|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653298|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653299|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64653300|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
64653301|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64653302|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
64653303|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
64653304|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653305|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340456|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64653306|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64653307|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64653308|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653309|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64653310|NCT01725230|Simvastatin|simvastatin|mesh-list
64408256|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
64653311|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64653312|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64653313|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
64653314|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653315|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64653316|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64653317|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653319|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
64653320|NCT01591733|Irinotecan|irinotecan|mesh-list
64340473|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340474|NCT05202080|Analgesics|analgesics|mesh-ancestor
64340475|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
64340476|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653321|NCT01591733|Folfirinox|folfirinox|mesh-list
64340478|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64653322|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64653324|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653325|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653326|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64653327|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64653328|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653329|NCT03005405|Methamphetamine|methamphetamine|mesh-list
64653330|NCT03005405|Fluorides|fluorides|mesh-list
64653331|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
64653332|NCT03005405|Protective Agents|protective agents|mesh-ancestor
64653333|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653334|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64653335|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
64653336|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
64408797|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653337|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653338|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
64653339|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653340|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378644|NCT03232307|Hormones|hormones|mesh-ancestor
64653342|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64653343|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64653344|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653345|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64653346|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64653347|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64653348|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
64653349|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653350|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653351|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64409368|NCT04994119|Warfarin|warfarin|mesh-list
64653352|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
64653353|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64653354|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64653355|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64653356|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
64653357|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653358|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653360|NCT03005483|Analgesics|analgesics|mesh-ancestor
64653361|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
64653362|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653363|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653364|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
64653365|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64653366|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64653367|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653368|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64653369|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64653370|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64340539|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64340540|NCT02276560|Cisplatin|cisplatin|mesh-list
64340541|NCT02276560|Pemetrexed|pemetrexed|mesh-list
64340542|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64653371|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653372|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653373|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
64653375|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
64653376|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
64653377|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653378|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653379|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64653380|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64653381|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64653382|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
64653383|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653384|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653385|NCT01593215|Urological Agents|urological agents|mesh-ancestor
64653386|NCT05404919|Tenofovir|tenofovir|mesh-list
64653387|NCT05404919|Entecavir|entecavir|mesh-list
64653388|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
64653389|NCT05404919|Antibodies|antibodies|mesh-list
64653390|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
64653391|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64653392|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64653393|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
64653394|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653395|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64653396|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64653397|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653398|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653399|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64653400|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64411941|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
64653401|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
64653402|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653403|NCT03005015|Doxorubicin|doxorubicin|mesh-list
64653404|NCT03005015|Lenvatinib|lenvatinib|mesh-list
64412365|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
64653405|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64653406|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653407|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64653408|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64653409|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653410|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653411|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64653412|NCT03005171|Lidocaine|lidocaine|mesh-list
64653413|NCT03005171|Bupivacaine|bupivacaine|mesh-list
64653414|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
64653416|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653417|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653418|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
64653419|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653420|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64653421|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64340606|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64340607|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64340608|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
64340609|NCT00835211|Coagulants|coagulants|mesh-ancestor
64340610|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64340611|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
64653422|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64653423|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653424|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653426|NCT01041638|Aldesleukin|aldesleukin|mesh-list
64653427|NCT01041638|Interleukin-2|interleukin-2|mesh-list
64653428|NCT01041638|Tretinoin|tretinoin|mesh-list
64653429|NCT01041638|Dinutuximab|dinutuximab|mesh-list
64653430|NCT01041638|Isotretinoin|isotretinoin|mesh-list
64653431|NCT01041638|Sargramostim|sargramostim|mesh-list
64653432|NCT01041638|Vitamins|vitamins|mesh-ancestor
64653433|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
64653434|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653435|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653436|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64653437|NCT01041638|Analgesics|analgesics|mesh-ancestor
64653438|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
64653439|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653440|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
64653441|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64653442|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64415461|NCT03044743|Fludarabine|fludarabine|mesh-list
64653443|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
64653444|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653445|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
64653446|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
64653447|NCT03004625|Ribavirin|ribavirin|mesh-list
64653448|NCT03004625|Asunaprevir|asunaprevir|mesh-list
64653449|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
64653450|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653451|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
64653452|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653453|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
64653454|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653456|NCT05566301|Ticagrelor|ticagrelor|mesh-list
64653457|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64653458|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64653459|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64653460|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64653461|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
64416431|NCT02612779|Hormones|hormones|mesh-ancestor
64653462|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653463|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653464|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653465|NCT03404024|Mitogens|mitogens|mesh-list
64653466|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
64653467|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653468|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
64653469|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653470|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653471|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
64653472|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653473|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653474|NCT01725542|Ribavirin|ribavirin|mesh-list
64416892|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
64653475|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64340645|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340646|NCT04875767|Coal Tar|coal tar|mesh-list
64340647|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
64340648|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
64340649|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64340650|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64653476|NCT01725542|Asunaprevir|asunaprevir|mesh-list
64653477|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
64653478|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340652|NCT00834275|Cefadroxil|cefadroxil|mesh-list
64653479|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
64653480|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653481|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
64653482|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653483|NCT01725620|Etanercept|etanercept|mesh-list
64653484|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64653485|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64653486|NCT01725620|Analgesics|analgesics|mesh-ancestor
64653487|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
64653488|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653489|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653490|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64653491|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653493|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653494|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
64653496|NCT01045460|Melphalan|melphalan|mesh-list
64653497|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653498|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
64653499|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653500|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653501|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64653502|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
64653503|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653504|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653505|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64653506|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64653507|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
64653508|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64653509|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64653510|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64653511|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653512|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653513|NCT05014919|Vortioxetine|vortioxetine|mesh-list
64417354|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64653514|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
64653515|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64653516|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64653517|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64653518|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653519|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653520|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64417432|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
64653521|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64653522|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653523|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653524|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653526|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64653527|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64653528|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64653529|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64417643|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653530|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
64653531|NCT05620862|Analgesics|analgesics|mesh-ancestor
64417674|NCT04811209|Anesthetics|anesthetics|mesh-list
64653532|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
64653533|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653534|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653535|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653536|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64653537|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64340700|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653538|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653539|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653540|NCT03406286|Tolvaptan|tolvaptan|mesh-list
64653541|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64653542|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653543|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
64418096|NCT01650519|Analgesics|analgesics|mesh-ancestor
64653544|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653545|NCT05672537|Gemcitabine|gemcitabine|mesh-list
64653546|NCT05672537|Durvalumab|durvalumab|mesh-list
64653547|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653548|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64653549|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
64653550|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653551|NCT05672537|Antiviral Agents|antiviral agents|mesh-ancestor
64653552|NCT05672537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653553|NCT05672537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653554|NCT05672537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653555|NCT05672537|Immunologic Factors|immunologic factors|mesh-ancestor
64653556|NCT05672537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653557|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653559|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
64653560|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64653561|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64653562|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653569|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64653571|NCT00919802|Oxytocin|oxytocin|mesh-list
64653572|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
64653573|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64653574|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418808|NCT02395653|Fentanyl|fentanyl|mesh-list
64653575|NCT02222129|Bupivacaine|bupivacaine|mesh-list
64653576|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
64653577|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
64653578|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653579|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653580|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
64653581|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653583|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653584|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653592|NCT03401294|Leucovorin|leucovorin|mesh-list
64653593|NCT03401294|Bevacizumab|bevacizumab|mesh-list
64653594|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
64653595|NCT03401294|Irinotecan|irinotecan|mesh-list
64419091|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
64653596|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653597|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653598|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64653599|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64653600|NCT03401294|Growth Substances|growth substances|mesh-ancestor
64653601|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653602|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
64653603|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64653604|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64653605|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653606|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340714|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340715|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
64340716|NCT05386979|Anesthetics|anesthetics|mesh-list
64340717|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340718|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340719|NCT05386979|Narcotics|narcotics|mesh-ancestor
64340720|NCT05386979|Analgesics|analgesics|mesh-ancestor
64653608|NCT03401294|Protective Agents|protective agents|mesh-ancestor
64653609|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
64653610|NCT03401294|Vitamins|vitamins|mesh-ancestor
64653611|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
64653616|NCT02980991|Pemetrexed|pemetrexed|mesh-list
64653617|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653618|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419360|NCT05523661|Dasatinib|dasatinib|mesh-list
64653619|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653620|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64653621|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64653622|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
64653623|NCT03402698|Vitamin D|vitamin d|mesh-list
64653624|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64653625|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653626|NCT03402698|Vitamins|vitamins|mesh-ancestor
64653627|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
64653628|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64653629|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
64653630|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64653631|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653632|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
64653633|NCT02248181|Pramipexole|pramipexole|mesh-list
64653634|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
64419727|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419728|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419729|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64653635|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653636|NCT02248181|Protective Agents|protective agents|mesh-ancestor
64653637|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653638|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64653639|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64653640|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
64653641|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
64653642|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653643|NCT03003143|Vigabatrin|vigabatrin|mesh-list
64653644|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
64419818|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653646|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653647|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
64653648|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653649|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653650|NCT02462928|Ranibizumab|ranibizumab|mesh-list
64653651|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64653652|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64653653|NCT02462928|Growth Substances|growth substances|mesh-ancestor
64653654|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653655|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
64653656|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653657|NCT03002831|Tegafur|tegafur|mesh-list
64653658|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64653659|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
64653660|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653661|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653662|NCT02248259|Itraconazole|itraconazole|mesh-list
64653664|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
64653665|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653666|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64653667|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64653668|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653669|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653670|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64653671|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
64653672|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64653673|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653674|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64653675|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64653677|NCT04526951|Tenecteplase|tenecteplase|mesh-list
64653678|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64653680|NCT04526951|Analgesics|analgesics|mesh-ancestor
64653681|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
64653682|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653683|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653684|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64653685|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653686|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64653687|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64653688|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420725|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653689|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64653690|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64653691|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653692|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
64653693|NCT04956432|Allopurinol|allopurinol|mesh-list
64653694|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
64653695|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653696|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653697|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
64653698|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653699|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64653700|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
64653701|NCT04956432|Protective Agents|protective agents|mesh-ancestor
64653702|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653703|NCT02248415|Anesthetics|anesthetics|mesh-list
64653704|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653705|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340726|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
64653706|NCT02248571|Bevacizumab|bevacizumab|mesh-list
64653707|NCT02248571|Capecitabine|capecitabine|mesh-list
64653708|NCT02248571|Everolimus|everolimus|mesh-list
64653709|NCT02248571|Exemestane|exemestane|mesh-list
64653710|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653711|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653713|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64653714|NCT02248571|Growth Substances|growth substances|mesh-ancestor
64653715|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653716|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
64653717|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64653719|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653721|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
64653722|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64653723|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64421542|NCT04424459|Narcotics|narcotics|mesh-ancestor
64653724|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653725|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64653726|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
64421644|NCT05494775|Mitogens|mitogens|mesh-list
64653727|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64653728|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64653729|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64653730|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653732|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64653733|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653735|NCT03002675|Incretins|incretins|mesh-ancestor
64653736|NCT03002675|Hormones|hormones|mesh-ancestor
64653737|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64653738|NCT02246270|Heparin|heparin|mesh-list
64653739|NCT02246270|Calcium heparin|calcium heparin|mesh-list
64653740|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
64653741|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64653742|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64653743|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653744|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64653745|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64340728|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
64653746|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64653747|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653748|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653749|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64653750|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653751|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653752|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
64653753|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653754|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
64653755|NCT04374188|Levofloxacin|levofloxacin|mesh-list
64653757|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64653758|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653759|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64653760|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64653761|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653762|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653763|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653764|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64653765|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64422932|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
64653766|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64653767|NCT04374188|Renal Agents|renal agents|mesh-ancestor
64653768|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
64653769|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653770|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653771|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653773|NCT03401606|Remifentanil|remifentanil|mesh-list
64653774|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64653775|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653776|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653777|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64653778|NCT03401606|Analgesics|analgesics|mesh-ancestor
64653779|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
64653780|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653781|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64653782|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64653783|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64653784|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
64653785|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653786|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653787|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64653788|NCT03401606|Narcotics|narcotics|mesh-ancestor
64653789|NCT02516592|Fluticasone|fluticasone|mesh-list
64653790|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64653791|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423200|NCT05304871|Cefazolin|cefazolin|mesh-list
64340744|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64653792|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64653793|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
64340745|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340746|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
64340747|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64340748|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653794|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653795|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653796|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64653797|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
64653798|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
64653799|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64653800|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64653801|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64653802|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64653803|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
64653804|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653805|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653806|NCT03401372|Doxycycline|doxycycline|mesh-list
64653807|NCT03401372|Dexamethasone|dexamethasone|mesh-list
64653808|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
64653809|NCT03401372|Bortezomib|bortezomib|mesh-list
64653810|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653812|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653813|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653814|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64653815|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
64653816|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653817|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653818|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64653819|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64653821|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
64653822|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653823|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64653824|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
64653825|NCT03401372|Hormones|hormones|mesh-ancestor
64653826|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64653827|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64653828|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64653829|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653830|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
64653831|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64653832|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64653833|NCT04934904|Ropivacaine|ropivacaine|mesh-list
64653834|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
64653835|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
64653836|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653837|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424747|NCT02493751|Avelumab|avelumab|mesh-list
64653838|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
64653839|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653841|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
64653842|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
64653843|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653844|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653845|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
64653846|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653847|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64653848|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64653849|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64653850|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64653851|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653852|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64653853|NCT04955574|Metronidazole|metronidazole|mesh-list
64653854|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64653855|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653856|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
64653857|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64653860|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
64653861|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653862|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64653863|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64653864|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653865|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653867|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653868|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64653869|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653870|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653871|NCT02221349|Listerine|listerine|mesh-list
64653872|NCT02221349|Fluorides|fluorides|mesh-list
64653873|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
64653874|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
64653875|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
64653876|NCT02221349|Protective Agents|protective agents|mesh-ancestor
64653877|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653878|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64653879|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653880|NCT02461758|Vaccines|vaccines|mesh-list
64653881|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
64653882|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653883|NCT02461290|Rituximab|rituximab|mesh-list
64653884|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64653885|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653886|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
64653887|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653888|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653889|NCT04376528|Cyclosporine|cyclosporine|mesh-list
64653890|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
64653891|NCT04376528|Cyclosporins|cyclosporins|mesh-list
64653892|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653893|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653894|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653895|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
64653896|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653897|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
64653898|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653899|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
64653900|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653901|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64653902|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64653903|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653904|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64653905|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
64653906|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64653907|NCT04200443|Temozolomide|temozolomide|mesh-list
64653908|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64653909|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
64653910|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653911|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64653913|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64653914|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653915|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340763|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340764|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340765|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340766|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340767|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
64340768|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64653916|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
64653917|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653919|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64653920|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64653921|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64653922|NCT04373018|Eusol|eusol|mesh-list
64653923|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64427736|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
64653925|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
64653926|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
64653927|NCT04934748|Phenylephrine|phenylephrine|mesh-list
64653928|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
64653929|NCT04934748|Norepinephrine|norepinephrine|mesh-list
64653930|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64653931|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
64653932|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
64653933|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653934|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653935|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
64653936|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64653937|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
64653938|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
64653939|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64653940|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64653941|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64653942|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
64653943|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653944|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653946|NCT04594733|Minocycline|minocycline|mesh-list
64653947|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64653948|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653949|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
64653950|NCT02223065|Saxagliptin|saxagliptin|mesh-list
64653951|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64653952|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653953|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64653954|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653955|NCT02223065|Incretins|incretins|mesh-ancestor
64653956|NCT02223065|Hormones|hormones|mesh-ancestor
64653957|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64653958|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64653959|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
64653960|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653961|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64653962|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653963|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
64653964|NCT02241200|Hematinics|hematinics|mesh-ancestor
64653965|NCT02241278|Ketamine|ketamine|mesh-list
64653966|NCT02241278|Analgesics|analgesics|mesh-ancestor
64653967|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
64653968|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64653969|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653970|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64653971|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64653972|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
64653973|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
64653974|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64653975|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64653976|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64653977|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64653978|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653980|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
64340799|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340800|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
64340801|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64653981|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64653982|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64653983|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
64653984|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64653985|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64653986|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64653987|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653988|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64653989|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
64653990|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64653991|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64653992|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64653993|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653995|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
64653996|NCT04372316|Vitamins|vitamins|mesh-ancestor
64653997|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
64653998|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64653999|NCT02221739|Ipilimumab|ipilimumab|mesh-list
64654000|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654001|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654002|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64654003|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654004|NCT02241356|Methamphetamine|methamphetamine|mesh-list
64654005|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64654006|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654007|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
64340810|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64340811|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340812|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340813|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
64340814|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340815|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340816|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64340827|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64340828|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
64340829|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64340830|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340832|NCT05114096|Hormones|hormones|mesh-ancestor
64340834|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654008|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
64654009|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654010|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
64429916|NCT02075073|Trastuzumab|trastuzumab|mesh-list
64654011|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654012|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654013|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430277|NCT02507219|Ibuprofen|ibuprofen|mesh-list
64654014|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64654015|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64654016|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64654017|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64654018|NCT04365686|Propofol|propofol|mesh-list
64654019|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64654020|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654021|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430897|NCT02497781|Ceftazidime|ceftazidime|mesh-list
64654022|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64654023|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
64654024|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
64654025|NCT02241590|Entecavir|entecavir|mesh-list
64654026|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
64654027|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654028|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
64654029|NCT04083755|Hematinics|hematinics|mesh-ancestor
64654030|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
64654031|NCT04372082|Niclosamide|niclosamide|mesh-list
64654032|NCT04372082|Diltiazem|diltiazem|mesh-list
64654033|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
64654034|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64654035|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64654036|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654037|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654038|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654039|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654040|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340878|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654041|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64654042|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64654043|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64654044|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654045|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
64654046|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
64654047|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64654048|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
64654049|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
64340879|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340880|NCT05648734|Analgesics|analgesics|mesh-ancestor
64340881|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
64340882|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340883|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340884|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64340885|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64340886|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340887|NCT02365558|Omeprazole|omeprazole|mesh-list
64654050|NCT05363111|Daratumumab|daratumumab|mesh-list
64654051|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64340888|NCT02365558|Evacetrapib|evacetrapib|mesh-list
64654052|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64432166|NCT01852942|Losartan|losartan|mesh-list
64654053|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654054|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
64654055|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654056|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
64654057|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
64654058|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654060|NCT03983993|Niraparib|niraparib|mesh-list
64654061|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654062|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654063|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64654064|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654065|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654067|NCT02489448|Tremelimumab|tremelimumab|mesh-list
64654068|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432398|NCT02284009|Incretins|incretins|mesh-ancestor
64654069|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654070|NCT00926588|Analgesics|analgesics|mesh-list
64654071|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
64654072|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654073|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654074|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
64654075|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
64654076|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64654077|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64654078|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654079|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432525|NCT04860505|Doxycycline|doxycycline|mesh-list
64654080|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654081|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654082|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
64654083|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64654084|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654085|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64654086|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64654087|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654088|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654089|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654090|NCT04364906|Anesthetics|anesthetics|mesh-list
64654091|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654092|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654094|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64654095|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654096|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64654097|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654098|NCT02488980|Mefloquine|mefloquine|mesh-list
64654099|NCT02488980|Tafenoquine|tafenoquine|mesh-list
64654100|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
64654101|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64654102|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64654103|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654104|NCT02227667|Durvalumab|durvalumab|mesh-list
64654105|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654106|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654107|NCT02242214|Misoprostol|misoprostol|mesh-list
64654108|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64340931|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340933|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
64340934|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340935|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340937|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340938|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654109|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
64654110|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64654111|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654112|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64654113|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64654114|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
64654115|NCT03702725|Dexamethasone|dexamethasone|mesh-list
64654116|NCT03702725|Lenalidomide|lenalidomide|mesh-list
64654117|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64654118|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
64654119|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
64654120|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654121|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654122|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64654123|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
64654125|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654126|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64654127|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654129|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64654130|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64654131|NCT03702725|Growth Substances|growth substances|mesh-ancestor
64654132|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
64654133|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
64654134|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64654135|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654136|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654137|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654139|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
64654140|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654141|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64654142|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64654143|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64654144|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
64654145|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654146|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654148|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
64654149|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654150|NCT02242292|Scopolamine|scopolamine|mesh-list
64654151|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64654152|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64654153|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
64654154|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
64654155|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654156|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654157|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64654158|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
64654159|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64654160|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
64434428|NCT01772368|Xhance|xhance|mesh-list
64654161|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654162|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654163|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64654164|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
64379468|NCT02149264|Testosterone|testosterone|mesh-list
64654165|NCT02242370|Telmisartan|telmisartan|mesh-list
64654166|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64654167|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64654168|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64654169|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654172|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64654173|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654174|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64340942|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
64340943|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
64340944|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340945|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
64654175|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64654176|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64654177|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654178|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
64654179|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654180|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
64654181|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64654182|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64654183|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
64654185|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64654186|NCT03399539|Dexamethasone|dexamethasone|mesh-list
64654187|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
64654188|NCT03399539|Venetoclax|venetoclax|mesh-list
64654189|NCT03399539|Ixazomib|ixazomib|mesh-list
64654190|NCT03399539|Ichthammol|ichthammol|mesh-list
64654191|NCT03399539|BB 1101|bb 1101|mesh-list
64654192|NCT03399539|Glycine|glycine|mesh-list
64654193|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64654194|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
64654195|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
64654196|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654197|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654198|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64654199|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
64654200|NCT03399539|Hormones|hormones|mesh-ancestor
64654201|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654202|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64654203|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654204|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654205|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
64654206|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654207|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
64654208|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
64654209|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654210|NCT04347200|Anticoagulants|anticoagulants|mesh-list
64654211|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64654212|NCT04364516|Vitamin K|vitamin k|mesh-list
64654213|NCT04364516|Anticoagulants|anticoagulants|mesh-list
64654214|NCT04364516|Vitamins|vitamins|mesh-ancestor
64654215|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
64654216|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654217|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64654218|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64654219|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654220|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
64654221|NCT04364516|Coagulants|coagulants|mesh-ancestor
64654222|NCT01623869|Trebananib|trebananib|mesh-list
64654223|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64654224|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64654225|NCT01623869|Growth Substances|growth substances|mesh-ancestor
64654226|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654227|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
64654228|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654229|NCT02242838|Telmisartan|telmisartan|mesh-list
64654230|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64654231|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64654232|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64654233|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340951|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64340952|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340953|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
64340954|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340955|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654235|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64654236|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654237|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654238|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654240|NCT03203525|Sirolimus|sirolimus|mesh-list
64654241|NCT03203525|Bevacizumab|bevacizumab|mesh-list
64379543|NCT05555667|Propofol|propofol|mesh-list
64436458|NCT01731886|Melphalan|melphalan|mesh-list
64654242|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64654243|NCT03203525|Doxorubicin|doxorubicin|mesh-list
64654244|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64654245|NCT03203525|Fluorouracil|fluorouracil|mesh-list
64654246|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
64654247|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
64654248|NCT03203525|Antibodies|antibodies|mesh-list
64654249|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
64654250|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64654251|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
64654252|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654253|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64654254|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64654255|NCT03203525|Growth Substances|growth substances|mesh-ancestor
64654256|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654257|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
64654258|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
64654259|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64436545|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
64654260|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64654261|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64654262|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654263|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654265|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436652|NCT05226325|Analgesics|analgesics|mesh-ancestor
64654266|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654267|NCT03203525|Antidotes|antidotes|mesh-ancestor
64654268|NCT03203525|Protective Agents|protective agents|mesh-ancestor
64654269|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
64654270|NCT03203525|Vitamins|vitamins|mesh-ancestor
64654271|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
64654272|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64654273|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654274|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
64654275|NCT02249039|Clonidine|clonidine|mesh-list
64654276|NCT02249039|Analgesics|analgesics|mesh-ancestor
64436953|NCT05813106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64654277|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
64654278|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654279|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654280|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64654282|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
64654283|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64654284|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64654285|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64654286|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
64654287|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654288|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340977|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340978|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340979|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
64340980|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
64340981|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340982|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340983|NCT05038982|Abrocitinib|abrocitinib|mesh-list
64340984|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64654289|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
64654290|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64654291|NCT04370288|Methylene Blue|methylene blue|mesh-list
64654292|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654293|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
64654294|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654295|NCT04370288|Protective Agents|protective agents|mesh-ancestor
64654296|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
64654297|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654298|NCT04370288|Expectorants|expectorants|mesh-ancestor
64654299|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
64654300|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64654301|NCT04370288|Antidotes|antidotes|mesh-ancestor
64654302|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654303|NCT02993705|Trabectedin|trabectedin|mesh-list
64654304|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64654306|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654307|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654308|NCT02243618|Rebamipide|rebamipide|mesh-list
64654309|NCT02243618|Polaprezinc|polaprezinc|mesh-list
64654310|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64654311|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64654312|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
64437832|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
64654313|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654314|NCT02243618|Protective Agents|protective agents|mesh-ancestor
64654315|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654316|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654317|NCT02243852|Hormones|hormones|mesh-list
64654318|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654319|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654320|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
64654321|NCT03150329|Vorinostat|vorinostat|mesh-list
64654322|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654323|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654324|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64654325|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654326|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654327|NCT03102125|Regadenoson|regadenoson|mesh-list
64654328|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64654329|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64654331|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
64654332|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654333|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654334|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654335|NCT04369586|Meplazumab|meplazumab|mesh-list
64654336|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
64438345|NCT04022135|Folic Acid|folic acid|mesh-list
64654337|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340985|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654338|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
64654339|NCT02231177|Olodaterol|olodaterol|mesh-list
64654340|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64654341|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
64654342|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340986|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340987|NCT04224740|Cisplatin|cisplatin|mesh-list
64340988|NCT04224740|Carboplatin|carboplatin|mesh-list
64341036|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
64341037|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64341038|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64341039|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
64341040|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64341041|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341042|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64654344|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64654345|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
64654346|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
64654347|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64654348|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
64654349|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654350|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654351|NCT03283007|Nintedanib|nintedanib|mesh-list
64438696|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
64654352|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654353|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64654354|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654355|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654356|NCT02244086|Bupivacaine|bupivacaine|mesh-list
64654357|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
64654358|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
64654359|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654360|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654361|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
64654362|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654363|NCT01630109|Metoclopramide|metoclopramide|mesh-list
64654364|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
64654365|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
64654366|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654367|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654368|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64654369|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64654370|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64654371|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
64654372|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654373|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654374|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64654375|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64654376|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654378|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
64654379|NCT01632215|Analgesics|analgesics|mesh-ancestor
64654380|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
64654381|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654382|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654383|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64654384|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64439292|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
64654385|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654386|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64654387|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64654388|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64654389|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654390|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654391|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
64654392|NCT02244242|Tamsulosin|tamsulosin|mesh-list
64654393|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64439650|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
64654394|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64341043|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341044|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64341045|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
64341046|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64341047|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64341050|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
64654395|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64654396|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
64654397|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654398|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654399|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654400|NCT02244242|Urological Agents|urological agents|mesh-ancestor
64654401|NCT03127631|Atorvastatin|atorvastatin|mesh-list
64654402|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64654403|NCT03127631|Simvastatin|simvastatin|mesh-list
64654404|NCT03127631|Pravastatin|pravastatin|mesh-list
64654405|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64654406|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64654407|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64654408|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
64654409|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654410|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64654411|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64440063|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440064|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654412|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654413|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
64654414|NCT02244320|Tamsulosin|tamsulosin|mesh-list
64654415|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64654416|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64654417|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64654418|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
64654419|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654420|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654421|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654422|NCT02244320|Urological Agents|urological agents|mesh-ancestor
64654423|NCT02244632|Bevacizumab|bevacizumab|mesh-list
64654424|NCT02244632|Fluorouracil|fluorouracil|mesh-list
64654425|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
64654426|NCT02244632|Irinotecan|irinotecan|mesh-list
64654427|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654428|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654429|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64440112|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64654430|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64654431|NCT02244632|Growth Substances|growth substances|mesh-ancestor
64654432|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654433|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
64654434|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
64341057|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341058|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341059|NCT02268058|Acetaminophen|acetaminophen|mesh-list
64341060|NCT02268058|Ibuprofen|ibuprofen|mesh-list
64341061|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64341062|NCT02268058|Analgesics|analgesics|mesh-ancestor
64341063|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
64341064|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341081|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341082|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64341083|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64341084|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64341085|NCT05025800|Growth Substances|growth substances|mesh-ancestor
64341086|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
64341087|NCT05022524|Acetic Acid|acetic acid|mesh-list
64341088|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64654435|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654436|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64654437|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654438|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
64654439|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64654440|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64654441|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654443|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64654444|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
64654445|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654446|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654447|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64654448|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64654449|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
64654450|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654451|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654453|NCT02244710|Ticagrelor|ticagrelor|mesh-list
64654454|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64654455|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64654456|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64654457|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64654458|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
64654459|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654460|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654461|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654462|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
64654463|NCT04362332|Chloroquine|chloroquine|mesh-list
64654464|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64654465|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
64654466|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64654467|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64654468|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654469|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654470|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654471|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654472|NCT04362332|Amebicides|amebicides|mesh-ancestor
64654473|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64654474|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654475|NCT04362332|Analgesics|analgesics|mesh-ancestor
64654476|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
64654477|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654478|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654479|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64654480|NCT04362332|Filaricides|filaricides|mesh-ancestor
64654481|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
64654482|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
64654483|NCT02308241|Ribavirin|ribavirin|mesh-list
64654484|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
64654485|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654486|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
64654487|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654488|NCT00932282|Omalizumab|omalizumab|mesh-list
64654489|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64654490|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64654491|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
64654492|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
64654493|NCT02159495|Fludarabine|fludarabine|mesh-list
64654494|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
64654495|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654496|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
64654497|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654498|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64341089|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341090|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
64341091|NCT02267746|Tazarotene|tazarotene|mesh-list
64341092|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
64654499|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64654500|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
64654501|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654502|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654503|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64654504|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64440950|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64654505|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
64654506|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64654508|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64654509|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654510|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654511|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
64654512|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654513|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64654514|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64654515|NCT02245022|Tenofovir|tenofovir|mesh-list
64654516|NCT02245022|Lamivudine|lamivudine|mesh-list
64654518|NCT02245022|Dolutegravir|dolutegravir|mesh-list
64654519|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
64654520|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654521|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64654522|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64654523|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654524|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654525|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64654526|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64654527|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64654528|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64654529|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64654530|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64654531|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64654532|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64654533|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64441323|NCT02260817|Choline|choline|mesh-list
64654575|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
64654576|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654577|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64654578|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64654579|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
64654580|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
64654581|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
64654582|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654583|NCT04376216|Prednisone|prednisone|mesh-list
64654584|NCT04376216|Prednisolone|prednisolone|mesh-list
64654585|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64654586|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
64654587|NCT04376216|Hormones|hormones|mesh-ancestor
64441988|NCT01696942|Mesalamine|mesalamine|mesh-list
64654588|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654589|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654590|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64654591|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654592|NCT02452320|Acetaminophen|acetaminophen|mesh-list
64341099|NCT04970108|Telmisartan|telmisartan|mesh-list
64341100|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64341101|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341102|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64654593|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654594|NCT02452320|Analgesics|analgesics|mesh-ancestor
64654595|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
64654596|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654597|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654598|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
64654599|NCT02459964|Fentanyl|fentanyl|mesh-list
64654600|NCT02459964|Hydromorphone|hydromorphone|mesh-list
64654601|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64654602|NCT02459964|Narcotics|narcotics|mesh-ancestor
64654603|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442517|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
64654604|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654605|NCT02459964|Analgesics|analgesics|mesh-ancestor
64654606|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
64654607|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654608|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64654609|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64443046|NCT05180942|Atorvastatin|atorvastatin|mesh-list
64654610|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
64654611|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
64654612|NCT01635101|Acetaminophen|acetaminophen|mesh-list
64654613|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654614|NCT01635101|Analgesics|analgesics|mesh-ancestor
64654615|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
64654616|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654617|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654618|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
64654619|NCT02087111|Interferons|interferons|mesh-list
64654620|NCT02087111|Ribavirin|ribavirin|mesh-list
64654621|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
64654622|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
64654623|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64341113|NCT05059028|Oxytocin|oxytocin|mesh-list
64341114|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
64654624|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654625|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
64654626|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654627|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
64654628|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654629|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
64341115|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64341116|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654630|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654632|NCT00932438|Bevacizumab|bevacizumab|mesh-list
64654633|NCT00932438|Fluorouracil|fluorouracil|mesh-list
64654634|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
64654635|NCT00932438|Irinotecan|irinotecan|mesh-list
64654636|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341117|NCT04205552|Nivolumab|nivolumab|mesh-list
64654642|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
64654643|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
64654644|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444128|NCT01904721|Bimatoprost|bimatoprost|mesh-list
64654645|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64654646|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654647|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
64654648|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64654649|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64654650|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654651|NCT00932438|Antidotes|antidotes|mesh-ancestor
64654652|NCT00932438|Protective Agents|protective agents|mesh-ancestor
64654653|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
64654654|NCT00932438|Vitamins|vitamins|mesh-ancestor
64654655|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
64654656|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
64654657|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64654658|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64654659|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654660|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
64654661|NCT01869413|Coagulants|coagulants|mesh-ancestor
64654662|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
64654663|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64654664|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654665|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654666|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654667|NCT02982512|Analgesics|analgesics|mesh-ancestor
64654668|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
64654669|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654670|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64654671|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64654672|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64654673|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
64654674|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654675|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654676|NCT01555697|Memantine|memantine|mesh-list
64654677|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64654678|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64654679|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
64654680|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654681|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654682|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654683|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64654684|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64654685|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
64654686|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64341143|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341144|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341145|NCT04215146|Paclitaxel|paclitaxel|mesh-list
64341146|NCT04215146|Avelumab|avelumab|mesh-list
64341147|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64654687|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64654688|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444298|NCT05650151|Vitamin D|vitamin d|mesh-list
64654689|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
64654690|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654691|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654692|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
64654693|NCT02451930|Necitumumab|necitumumab|mesh-list
64654694|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654695|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654696|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
64654697|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64654698|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
64654699|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654700|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
64654702|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
64654703|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654704|NCT00928694|Fenofibrate|fenofibrate|mesh-list
64654705|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64654706|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
64654707|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654709|NCT01639157|Buspirone|buspirone|mesh-list
64654710|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64654711|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64654712|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654713|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654714|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64654715|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64654716|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
64654717|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654718|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654719|NCT02451696|Everolimus|everolimus|mesh-list
64444435|NCT02143141|Morphine|morphine|mesh-list
64654720|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654721|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654722|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
64654723|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654724|NCT00928772|Midazolam|midazolam|mesh-list
64654725|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64654726|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64654727|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654728|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654729|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64654730|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64654731|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64654732|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64654733|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
64654734|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
64654735|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
64654736|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
64341172|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64341173|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341174|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341175|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
64341176|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341177|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64341178|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64341179|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64341180|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
64341181|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654737|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654738|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654739|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64654740|NCT02459418|Hormones|hormones|mesh-ancestor
64654741|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654742|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654743|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
64654744|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
64654745|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
64654746|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64654747|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64654748|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654749|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654750|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654751|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654752|NCT00695279|Vaccines|vaccines|mesh-list
64654753|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
64654754|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654756|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64654757|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654758|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654759|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654760|NCT01598207|Dronabinol|dronabinol|mesh-list
64654761|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
64654762|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654763|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64654764|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654765|NCT01598207|Analgesics|analgesics|mesh-ancestor
64444599|NCT05417165|Vaccines|vaccines|mesh-list
64654766|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
64654767|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654768|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64654769|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64654770|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341185|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
64341186|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64341187|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
64341188|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64341189|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64341190|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64341191|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64341192|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64341193|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64341195|NCT05008484|Vitamin D|vitamin d|mesh-list
64654773|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654775|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64654776|NCT01640171|Lidocaine|lidocaine|mesh-list
64654777|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
64654778|NCT01640171|Anesthetics|anesthetics|mesh-list
64654779|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
64654780|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654781|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654782|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
64654783|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654784|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64444694|NCT01683058|Aripiprazole|aripiprazole|mesh-list
64654785|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64654786|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64654787|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64654788|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444756|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64654789|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64654790|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654792|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654793|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64654794|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654795|NCT04361474|Budesonide|budesonide|mesh-list
64654796|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64654797|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64654798|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
64654799|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654800|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654801|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64654802|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
64654803|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
64654805|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654807|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
64444884|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654808|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654809|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
64654810|NCT02245334|Povidone|povidone|mesh-list
64654811|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
64654812|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
64654813|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64654814|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654815|NCT04762160|Rituximab|rituximab|mesh-list
64654816|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654817|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654818|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
64654819|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341216|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341217|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
64341218|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341219|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341220|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341221|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341222|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64341223|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341224|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341244|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654822|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64654823|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64654824|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64654825|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
64654826|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654827|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654828|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654829|NCT04356872|Doxorubicin|doxorubicin|mesh-list
64654830|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64654831|NCT04356872|Ifosfamide|ifosfamide|mesh-list
64654832|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64654833|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654834|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64654835|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64654836|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654837|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654838|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64654839|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
64654840|NCT02487108|Acetaminophen|acetaminophen|mesh-list
64654841|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64654842|NCT02487108|Hydrocodone|hydrocodone|mesh-list
64654843|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64654844|NCT02487108|Analgesics|analgesics|mesh-ancestor
64654845|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
64654846|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654847|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654848|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
64654850|NCT02487108|Narcotics|narcotics|mesh-ancestor
64654851|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654852|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
64654853|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
64654854|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64654855|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64654856|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654857|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
64654858|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64654859|NCT02487030|Ledipasvir|ledipasvir|mesh-list
64654860|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
64654861|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654862|NCT02486952|Prednisone|prednisone|mesh-list
64654863|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
64654864|NCT02486952|Rituximab|rituximab|mesh-list
64654865|NCT02486952|Vincristine|vincristine|mesh-list
64654866|NCT02486952|Doxorubicin|doxorubicin|mesh-list
64654867|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64654868|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654869|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
64654870|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654871|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64654872|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64654873|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
64341246|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341247|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64341248|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341249|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341250|NCT04945148|Metformin|metformin|mesh-list
64654874|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654875|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654876|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64654877|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64654879|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
64654881|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654882|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64445058|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654883|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64654885|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
64654886|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
64654887|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64654888|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64654889|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64654890|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654891|NCT02486796|Ubiquinone|ubiquinone|mesh-list
64654892|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
64654893|NCT02486796|Melatonin|melatonin|mesh-list
64654894|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
64654895|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654896|NCT02486796|Protective Agents|protective agents|mesh-ancestor
64654897|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654898|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654899|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
64654900|NCT02486796|Vitamins|vitamins|mesh-ancestor
64654901|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
64654902|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
64654903|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
64445084|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64654904|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654905|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654906|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
64654907|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654909|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64654910|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64654911|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64654912|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654913|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64654914|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64654915|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64654916|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64654917|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
64380222|NCT04425681|Bevacizumab|bevacizumab|mesh-list
64654918|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
64654919|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
64654920|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
64654921|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654922|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654924|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64654925|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654926|NCT01600703|Incretins|incretins|mesh-ancestor
64654927|NCT01600703|Hormones|hormones|mesh-ancestor
64654928|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654929|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64341261|NCT05003570|Remifentanil|remifentanil|mesh-list
64341262|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64341263|NCT05003570|Narcotics|narcotics|mesh-ancestor
64341264|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64341265|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654930|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
64654931|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654934|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64654935|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64654936|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64654937|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64654938|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654939|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
64654940|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654941|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654942|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64654943|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64654944|NCT01605539|Cannabidiol|cannabidiol|mesh-list
64654945|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
64654946|NCT02458638|Atezolizumab|atezolizumab|mesh-list
64654948|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
64654949|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654950|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654951|NCT01607411|Fluorides|fluorides|mesh-list
64654952|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
64654953|NCT01607411|Protective Agents|protective agents|mesh-ancestor
64654954|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654955|NCT01691339|Vaccines|vaccines|mesh-list
64654956|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
64654957|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654958|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
64654959|NCT02233751|Testosterone|testosterone|mesh-list
64654960|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
64654961|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
64654962|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64654963|NCT02233751|Androgens|androgens|mesh-ancestor
64654964|NCT02233751|Hormones|hormones|mesh-ancestor
64654965|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654966|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654967|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64654968|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654969|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
64654970|NCT01607645|Cytarabine|cytarabine|mesh-list
64654971|NCT01607645|Decitabine|decitabine|mesh-list
64654972|NCT01607645|Azacitidine|azacitidine|mesh-list
64654973|NCT01607645|Idarubicin|idarubicin|mesh-list
64654974|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64654975|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
64654976|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654977|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64654978|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
64654979|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64654980|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64654981|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
64341296|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64341297|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64341298|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654982|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654983|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64654984|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64654985|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64654986|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64341300|NCT00730639|Nivolumab|nivolumab|mesh-list
64654988|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64654989|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
64654990|NCT01647581|Hormones|hormones|mesh-ancestor
64654991|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64654992|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64654993|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64654994|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64654995|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
64654996|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64654997|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64654998|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64655000|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655001|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
64655002|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655003|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655004|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64655005|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655006|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
64655007|NCT01649609|Sirolimus|sirolimus|mesh-list
64655008|NCT01649609|Tacrolimus|tacrolimus|mesh-list
64655009|NCT01649609|Antimetabolites|antimetabolites|mesh-list
64655010|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655011|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
64655012|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655013|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64655014|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655015|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655016|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64655017|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655018|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64655019|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
64655020|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64655021|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655022|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
64655023|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64655024|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64655026|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64445365|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655028|NCT02449902|Hormones|hormones|mesh-ancestor
64655029|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64655030|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655031|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64655033|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64655034|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64655035|NCT02449044|Tolvaptan|tolvaptan|mesh-list
64341415|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
64341416|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341417|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341418|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64341419|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64341420|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64341424|NCT03496831|Adalimumab|adalimumab|mesh-list
64655038|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
64655039|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655040|NCT04942626|Capecitabine|capecitabine|mesh-list
64655041|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64655042|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655043|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
64655044|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655046|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64655047|NCT04942470|Propolis|propolis|mesh-list
64655048|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655049|NCT02228681|Tamoxifen|tamoxifen|mesh-list
64655050|NCT02228681|Everolimus|everolimus|mesh-list
64655051|NCT02228681|Letrozole|letrozole|mesh-list
64655052|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64655054|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655055|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655056|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
64655057|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655058|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64655059|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64655060|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655061|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655062|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64655063|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
64655064|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64655065|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64655066|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64655067|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64655068|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64655069|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64655071|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64655073|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64655074|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64655075|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64655076|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64655078|NCT00942578|Bevacizumab|bevacizumab|mesh-list
64655079|NCT00942578|Lenalidomide|lenalidomide|mesh-list
64655080|NCT00942578|Docetaxel|docetaxel|mesh-list
64655081|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64655082|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655083|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64655084|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64655085|NCT00942578|Growth Substances|growth substances|mesh-ancestor
64341435|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
64341469|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
64341470|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
64341471|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341472|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
64341473|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341474|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64341476|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
64655087|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
64655088|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
64655089|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
64655090|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
64655091|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655092|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655093|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
64655094|NCT00942578|Hormones|hormones|mesh-ancestor
64655095|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64655096|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64655097|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
64655098|NCT02229461|Aspirin|aspirin|mesh-list
64655099|NCT02229461|Naproxen|naproxen|mesh-list
64655100|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64655101|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64445571|NCT04755764|Labetalol|labetalol|mesh-list
64655103|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
64655104|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655105|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655106|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655107|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64655108|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64655109|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64655110|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655111|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64655112|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64655113|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655114|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
64655115|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
64655116|NCT04641104|Thiamine|thiamine|mesh-list
64655117|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
64655118|NCT04641104|Vitamins|vitamins|mesh-ancestor
64655119|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
64655120|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655121|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
64655122|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64655123|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655124|NCT02237417|Aripiprazole|aripiprazole|mesh-list
64655125|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
64341486|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64341487|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341498|NCT00724841|Obatoclax|obatoclax|mesh-list
64341524|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64341525|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
64341526|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64341527|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64341528|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64655128|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64655129|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655130|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655131|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
64655132|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
64655133|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655134|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655135|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64655136|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64655137|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
64655138|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64655139|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64655140|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64655141|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64655142|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
64655143|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
64655144|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655145|NCT04603898|Protective Agents|protective agents|mesh-ancestor
64655146|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655147|NCT04603898|Vitamins|vitamins|mesh-ancestor
64655148|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
64655149|NCT04356170|Docetaxel|docetaxel|mesh-list
64655150|NCT04356170|Fluorouracil|fluorouracil|mesh-list
64655151|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655152|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
64655153|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
64655154|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
64655155|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655156|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
64655157|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655158|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655159|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
64655160|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655162|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64655163|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64655164|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64655165|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
64341548|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
64341549|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64341550|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64655168|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655169|NCT02245490|Urological Agents|urological agents|mesh-ancestor
64655172|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64655173|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64655174|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655175|NCT00934934|Anidulafungin|anidulafungin|mesh-list
64655176|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
64655177|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655178|NCT01650545|Cyclosporine|cyclosporine|mesh-list
64655179|NCT01650545|Sirolimus|sirolimus|mesh-list
64655180|NCT01650545|Tacrolimus|tacrolimus|mesh-list
64655181|NCT01650545|Cyclosporins|cyclosporins|mesh-list
64655182|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655183|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
64655184|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655185|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64655186|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655187|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655188|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
64655189|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655190|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
64655191|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64655192|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64655193|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64655194|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655195|NCT01651793|Caffeine|caffeine|mesh-list
64655196|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64655197|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655198|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64655199|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655200|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655201|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64655202|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64655203|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
64341596|NCT03487939|Fluorouracil|fluorouracil|mesh-list
64655204|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655205|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
64655206|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64655207|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64655208|NCT01652495|Prednisolone|prednisolone|mesh-list
64655209|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
64655210|NCT01652495|Triamcinolone|triamcinolone|mesh-list
64655211|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64655212|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64655213|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64655214|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
64655215|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64655216|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655217|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
64655218|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
64655219|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655220|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655221|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64655222|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
64655224|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64655225|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64655226|NCT01652495|Protective Agents|protective agents|mesh-ancestor
64341633|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
64341634|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64655227|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341635|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
64341636|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655229|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341702|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655230|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
64655231|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655232|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655233|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64655234|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
64655235|NCT00935792|Everolimus|everolimus|mesh-list
64655236|NCT00935792|Antibodies|antibodies|mesh-list
64655237|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
64655238|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64655239|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
64655240|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341703|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
64341704|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341705|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655241|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655242|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341706|NCT02011321|Clevidipine|clevidipine|mesh-list
64655243|NCT01699607|Amphetamine|amphetamine|mesh-list
64655244|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
64655245|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64655246|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655247|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
64655248|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
64655249|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655250|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
64655251|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655252|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655253|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
64655254|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64655255|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64655256|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655257|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64655258|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
64341881|NCT00774761|Fluticasone|fluticasone|mesh-list
64655259|NCT04355468|Anesthetics|anesthetics|mesh-list
64655260|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655261|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655262|NCT04355468|Narcotics|narcotics|mesh-ancestor
64655263|NCT04355468|Analgesics|analgesics|mesh-ancestor
64655264|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
64655265|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655266|NCT01653509|Acyclovir|acyclovir|mesh-list
64655267|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
64341883|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
64341884|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341885|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64341886|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
64341887|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655268|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655269|NCT01614509|Triamcinolone|triamcinolone|mesh-list
64655270|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64655271|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64655272|NCT01614509|Bevacizumab|bevacizumab|mesh-list
64655273|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64655274|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64655275|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655276|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64655277|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64655278|NCT01614509|Growth Substances|growth substances|mesh-ancestor
64655279|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655280|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
64655281|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655283|NCT01614509|Hormones|hormones|mesh-ancestor
64655284|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341929|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341930|NCT02273609|Vitamin K|vitamin k|mesh-list
64655285|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655286|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
64655287|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349955|NCT03466021|Hormones|hormones|mesh-ancestor
64655288|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655289|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64655290|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64655291|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655292|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655293|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64655294|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655295|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655296|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
64655297|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342072|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342073|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
64655298|NCT00943202|Vaccines|vaccines|mesh-list
64655299|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
64655300|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655301|NCT01654445|Tenecteplase|tenecteplase|mesh-list
64655302|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64655303|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64655304|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655305|NCT01703039|Riluzole|riluzole|mesh-list
64655306|NCT01703039|Sertraline|sertraline|mesh-list
64655307|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
64655308|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64655309|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64655310|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64655311|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655312|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655313|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655314|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
64342074|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342075|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342076|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64342077|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342078|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
64342079|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64342080|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64655317|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64655318|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64655319|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64655320|NCT01703039|Protective Agents|protective agents|mesh-ancestor
64655321|NCT01656629|Vitamin D|vitamin d|mesh-list
64655322|NCT01656629|Alendronate|alendronate|mesh-list
64655323|NCT01656629|Teriparatide|teriparatide|mesh-list
64655324|NCT01656629|Calcium|calcium|mesh-list
64655325|NCT01656629|Vitamins|vitamins|mesh-ancestor
64655326|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
64655327|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655328|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64655329|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64655330|NCT01703507|Ipilimumab|ipilimumab|mesh-list
64655331|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64655332|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655333|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64655334|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655335|NCT02158520|Paclitaxel|paclitaxel|mesh-list
64655336|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64655337|NCT02158520|Bevacizumab|bevacizumab|mesh-list
64655338|NCT02158520|Ipilimumab|ipilimumab|mesh-list
64655339|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64655340|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
64655341|NCT02158520|Antibodies|antibodies|mesh-list
64655342|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
64655343|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64655344|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
64655345|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64655346|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655347|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
64342120|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64342121|NCT00743795|Ribavirin|ribavirin|mesh-list
64342122|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64342123|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
64342124|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342125|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
64655348|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
64655350|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655351|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64655352|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64655354|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655355|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
64655356|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
64655357|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64655359|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
64655360|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655361|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
64655362|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655363|NCT01617083|Azithromycin|azithromycin|mesh-list
64655364|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64655365|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655366|NCT04359524|Vitamin D|vitamin d|mesh-list
64655367|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
64655368|NCT04359524|Vitamins|vitamins|mesh-ancestor
64655369|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
64655370|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655371|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64655372|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64655374|NCT01658657|Amlodipine|amlodipine|mesh-list
64655375|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64655377|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
64655378|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64655379|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64655380|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655381|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655382|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64655383|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655384|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
64655385|NCT01658657|Diuretics|diuretics|mesh-ancestor
64655386|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
64655387|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64655388|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64655389|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
64342262|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
64342263|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64655390|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
64655391|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655392|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64655393|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64655394|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64655395|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
64655396|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655397|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64655398|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
64655399|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655400|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64655401|NCT01658657|Protective Agents|protective agents|mesh-ancestor
64655403|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64655404|NCT04359212|Tinzaparin|tinzaparin|mesh-list
64655405|NCT04359212|Dalteparin|dalteparin|mesh-list
64655406|NCT04359212|PENTA|penta|mesh-list
64655407|NCT04359212|Fondaparinux|fondaparinux|mesh-list
64655408|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
64655409|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64655410|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64655411|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655412|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64655413|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
64655414|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64655415|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
64655416|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655417|NCT01620047|Fentanyl|fentanyl|mesh-list
64655418|NCT01620047|Ropivacaine|ropivacaine|mesh-list
64655419|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
64655420|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
64655421|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655422|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342264|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342265|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342266|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342267|NCT05647642|Analgesics|analgesics|mesh-ancestor
64342268|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
64655423|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
64342272|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64655424|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655425|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64655427|NCT01620047|Analgesics|analgesics|mesh-ancestor
64655428|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64655429|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64655430|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
64655431|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64655432|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64655433|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655434|NCT00944450|Incretins|incretins|mesh-ancestor
64655435|NCT00944450|Hormones|hormones|mesh-ancestor
64342324|NCT03483415|Bupivacaine|bupivacaine|mesh-list
64342325|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
64342326|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
64655437|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64655438|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
64655439|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655440|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655441|NCT03875144|Cisplatin|cisplatin|mesh-list
64655442|NCT03875144|Doxorubicin|doxorubicin|mesh-list
64655443|NCT03875144|Pemetrexed|pemetrexed|mesh-list
64655444|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655445|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64380748|NCT03192371|Vaccines|vaccines|mesh-list
64655446|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64655447|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64655448|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655449|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655450|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64655451|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64655452|NCT01661621|Doxazosin|doxazosin|mesh-list
64655453|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64655454|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64342430|NCT05647330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342431|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
64342432|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64342448|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64342449|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
64655455|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64655456|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64655457|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64655458|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
64655459|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655460|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655461|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655462|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64655463|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64655464|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
64655465|NCT01661621|Urological Agents|urological agents|mesh-ancestor
64655466|NCT01620593|Metformin|metformin|mesh-list
64655467|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64655468|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655469|NCT00939536|Zolpidem|zolpidem|mesh-list
64655470|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64655471|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64655472|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655473|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655474|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64655475|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
64655476|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
64655477|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655478|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655479|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64655480|NCT04358354|Fluorouracil|fluorouracil|mesh-list
64655481|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
64655482|NCT04358354|Irinotecan|irinotecan|mesh-list
64655483|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
64342532|NCT02353468|Bortezomib|bortezomib|mesh-list
64342533|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342534|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
64342550|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64655484|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655485|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655487|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655488|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
64655489|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655490|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64655491|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64655492|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655493|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
64655494|NCT03516968|Vitamin D|vitamin d|mesh-list
64655495|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64655496|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655497|NCT03516968|Vitamins|vitamins|mesh-ancestor
64655498|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
64655499|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64655500|NCT04355156|Axitinib|axitinib|mesh-list
64655501|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655502|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64655503|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655504|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655505|NCT03320018|Minocycline|minocycline|mesh-list
64342609|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
64342610|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
64342657|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
64655506|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64655507|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655509|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64655510|NCT03032666|Velpatasvir|velpatasvir|mesh-list
64655511|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
64655512|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655513|NCT04354376|Telmisartan|telmisartan|mesh-list
64655514|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
64655515|NCT04354376|Diuretics|diuretics|mesh-list
64655516|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64655517|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
64655518|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64655519|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64655520|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64655521|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655522|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
64380829|NCT03192293|Metformin|metformin|mesh-list
64655523|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655524|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655525|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64655526|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64655527|NCT02777372|Sertraline|sertraline|mesh-list
64655528|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
64655529|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64655530|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64655531|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64655532|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655533|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342717|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342718|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64342719|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342720|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342721|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
64342751|NCT00581477|Droxidopa|droxidopa|mesh-list
64655534|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655535|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
64655536|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655537|NCT01622543|Leucovorin|leucovorin|mesh-list
64655538|NCT01622543|Bevacizumab|bevacizumab|mesh-list
64655539|NCT01622543|Fluorouracil|fluorouracil|mesh-list
64655540|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
64655541|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64655542|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655543|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64655544|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64655545|NCT01622543|Growth Substances|growth substances|mesh-ancestor
64655546|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342767|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342768|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342788|NCT03480997|Albuterol|albuterol|mesh-list
64655570|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655571|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655573|NCT01623323|Xhance|xhance|mesh-list
64655574|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655575|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64655576|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
64655577|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655578|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655579|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64655580|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
64655581|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
64342854|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
64655582|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64380891|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
64342855|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342856|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655602|NCT01709747|Hydromorphone|hydromorphone|mesh-list
64655604|NCT01709747|Narcotics|narcotics|mesh-ancestor
64655605|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655606|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655607|NCT01709747|Analgesics|analgesics|mesh-ancestor
64655608|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
64655609|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655610|NCT03031808|Lidocaine|lidocaine|mesh-list
64655611|NCT03031808|Rocuronium|rocuronium|mesh-list
64655612|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
64655613|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
64655614|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655615|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655616|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
64655617|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655618|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64655619|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64655620|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64655621|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655622|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655623|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64655624|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64655625|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64655626|NCT01662791|Rifaximin|rifaximin|mesh-list
64655627|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64342940|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64342941|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
64342942|NCT05646394|Coagulants|coagulants|mesh-ancestor
64342943|NCT00563459|Topiramate|topiramate|mesh-list
64342944|NCT00563459|Levetiracetam|levetiracetam|mesh-list
64342945|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
64342946|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64342947|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655629|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64655630|NCT03035084|Vitamin D|vitamin d|mesh-list
64655631|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
64655632|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
64655633|NCT03035084|Vitamins|vitamins|mesh-list
64655634|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
64655635|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655636|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64655637|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64655638|NCT03034850|Doxorubicin|doxorubicin|mesh-list
64655639|NCT03034850|Fluorouracil|fluorouracil|mesh-list
64655640|NCT03034850|Ifosfamide|ifosfamide|mesh-list
64655641|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64655642|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655643|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64655644|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64655645|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655646|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655647|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
64655648|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655649|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655650|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
64655651|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655652|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64655653|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
64655654|NCT01663259|Cetuximab|cetuximab|mesh-list
64655655|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64655656|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655657|NCT03031184|Mirtazapine|mirtazapine|mesh-list
64655658|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
64655659|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64655660|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64343027|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
64343028|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343029|NCT00481325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64343030|NCT00481325|Antidepressive Agents|antidepressive agents|mesh-ancestor
64343031|NCT00481325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343032|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
64343033|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64655661|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
64655665|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655666|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64655667|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64655668|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655669|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64655670|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64655671|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64655672|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
64655673|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64655674|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64655676|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64655677|NCT02238977|Bupropion|bupropion|mesh-list
64655678|NCT02238977|Fluoxetine|fluoxetine|mesh-list
64655679|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64655680|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
64655681|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64655682|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64655683|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64655684|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655685|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655686|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
64655687|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655689|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64655690|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64655691|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655692|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64655693|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
64655694|NCT05361395|Carboplatin|carboplatin|mesh-list
64655695|NCT05361395|Etoposide|etoposide|mesh-list
64655696|NCT05361395|Atezolizumab|atezolizumab|mesh-list
64655697|NCT05361395|Durvalumab|durvalumab|mesh-list
64655698|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655699|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64655700|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64655701|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64655702|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655703|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655704|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64655705|NCT03034382|Lidocaine|lidocaine|mesh-list
64655706|NCT03034382|Epinephrine|epinephrine|mesh-list
64655707|NCT03034382|Morphine|morphine|mesh-list
64655708|NCT03034382|Nalbuphine|nalbuphine|mesh-list
64655709|NCT03034382|Bupivacaine|bupivacaine|mesh-list
64655710|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
64655711|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
64655712|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655713|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655714|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
64655715|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655716|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64655717|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64655718|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64655719|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655720|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655721|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64655722|NCT03034382|Narcotics|narcotics|mesh-ancestor
64655723|NCT03034382|Analgesics|analgesics|mesh-ancestor
64655724|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64655725|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64655726|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
64655727|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655728|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64655729|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64655730|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
64655731|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64655732|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
64655733|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
64655734|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
64655735|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64655736|NCT01664741|Nicotine|nicotine|mesh-list
64343178|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343179|NCT00457457|Tamsulosin|tamsulosin|mesh-list
64343180|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64343194|NCT03472651|Flupenthixol|flupenthixol|mesh-list
64655737|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64655738|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
64655739|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655740|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655741|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64655742|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64655743|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
64655744|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655745|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655746|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
64655747|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64655748|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64655749|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655750|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
64655751|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64655752|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655753|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655754|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64655756|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
64655757|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655758|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64655759|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64655760|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64655761|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
64655762|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655763|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655764|NCT02022644|Irinotecan|irinotecan|mesh-list
64655765|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64655766|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64655768|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655769|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655770|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64655771|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655772|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64655773|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655774|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655775|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
64655776|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
64655777|NCT03030716|Procyanidin|procyanidin|mesh-list
64655778|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64655779|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655780|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
64655781|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655782|NCT03030716|Protective Agents|protective agents|mesh-ancestor
64655783|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655784|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64655785|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64655786|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655787|NCT04353362|Amoxicillin|amoxicillin|mesh-list
64655788|NCT04353362|Metronidazole|metronidazole|mesh-list
64655789|NCT04353362|Ofloxacin|ofloxacin|mesh-list
64655790|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64655791|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343315|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343316|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343317|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64343318|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64343319|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64343320|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
64343321|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
64343322|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64343323|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64343324|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64343350|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
64343351|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343352|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343353|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64343354|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
64655793|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64655794|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64655796|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64655797|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64655798|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655799|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655800|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655801|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64343368|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64655803|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
64655804|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64655806|NCT00946478|Analgesics|analgesics|mesh-ancestor
64655807|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
64655808|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655809|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655810|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655811|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64655812|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
64655813|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655814|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
64655815|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64655816|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655817|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655818|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
64655819|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64655820|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381125|NCT02435927|Leucovorin|leucovorin|mesh-list
64655821|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64655823|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64655824|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64655825|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655826|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655827|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
64655828|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655829|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64655830|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64655831|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64655832|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64655833|NCT03030560|Lidocaine|lidocaine|mesh-list
64655834|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
64655835|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
64655836|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655837|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655838|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
64655839|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655840|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64655841|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64655842|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64655843|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64655844|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655845|NCT03033368|Rilpivirine|rilpivirine|mesh-list
64655846|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64655847|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64655848|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343504|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343505|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343506|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343507|NCT00344045|Acetaminophen|acetaminophen|mesh-list
64343514|NCT02256436|Paclitaxel|paclitaxel|mesh-list
64655849|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655851|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655852|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64655853|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64655854|NCT03031262|Cytarabine|cytarabine|mesh-list
64655855|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655856|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
64655857|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655858|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655859|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
64655860|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655861|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655862|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
64655863|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655864|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
64655865|NCT03032978|Calcium|calcium|mesh-list
64655866|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64655867|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655868|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64655869|NCT03030248|Vancomycin|vancomycin|mesh-list
64655870|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64655871|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655872|NCT03028532|Clomiphene|clomiphene|mesh-list
64655873|NCT03028532|Enclomiphene|enclomiphene|mesh-list
64655874|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
64655875|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64655876|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
64655877|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64655878|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655879|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64655881|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64655882|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64655883|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64655884|NCT03017768|Tryptophan|tryptophan|mesh-list
64655885|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64655886|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
64655887|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64655888|NCT01006538|Ranibizumab|ranibizumab|mesh-list
64655889|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64655890|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64655891|NCT01006538|Growth Substances|growth substances|mesh-ancestor
64655892|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655893|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
64655894|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655895|NCT03017222|Ondansetron|ondansetron|mesh-list
64655897|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
64655898|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
64655899|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655900|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655901|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64655902|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
64655903|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
64655904|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64655905|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
64343561|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343562|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
64343563|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343564|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343565|NCT00330473|Insulin|insulin|mesh-list
64655906|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64655907|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343572|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655908|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64655909|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64655910|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655911|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64655912|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64655913|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64655914|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64655915|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
64655916|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64655917|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
64655918|NCT01010282|Glycerol|glycerol|mesh-list
64655919|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64655920|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64655921|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64655922|NCT01010282|Protective Agents|protective agents|mesh-ancestor
64655923|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655924|NCT01010282|Laxatives|laxatives|mesh-ancestor
64655925|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64655926|NCT03016988|Cytarabine|cytarabine|mesh-list
64655927|NCT03016988|Fludarabine|fludarabine|mesh-list
64655928|NCT03016988|Bortezomib|bortezomib|mesh-list
64655929|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655930|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655931|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
64655932|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655933|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655934|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
64655935|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655936|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
64655937|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655938|NCT03017066|Anesthetics|anesthetics|mesh-list
64655939|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64655940|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655942|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64655943|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64655944|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64655945|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343579|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64655947|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
64655949|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64655950|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
64655951|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655952|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655953|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
64655954|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64655955|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64655956|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
64655957|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655958|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64655959|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64655960|NCT01668017|Niacinamide|niacinamide|mesh-list
64655961|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
64655962|NCT01668017|Vitamins|vitamins|mesh-ancestor
64655963|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
64655964|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655965|NCT01010984|Doxorubicin|doxorubicin|mesh-list
64655966|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64655967|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655968|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64655969|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64655970|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343640|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64655971|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343641|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64343642|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
64343643|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
64343644|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64343645|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
64343646|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64655972|NCT05214599|Budesonide|budesonide|mesh-list
64343647|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655973|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64655974|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64655975|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
64655976|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655977|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655978|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64655979|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
64655980|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
64655981|NCT05214599|Hormones|hormones|mesh-ancestor
64655982|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64655983|NCT01011218|Modafinil|modafinil|mesh-list
64655984|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64655985|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655986|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64655987|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64655988|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64655989|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64655990|NCT05201183|Fludarabine|fludarabine|mesh-list
64655991|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64655992|NCT03023306|Antiemetics|antiemetics|mesh-list
64655993|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
64655994|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64655995|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64655996|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64655997|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
64655998|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64655999|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656000|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64656001|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656002|NCT05184101|Heparin|heparin|mesh-list
64656003|NCT05184101|Calcium heparin|calcium heparin|mesh-list
64656004|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
64343827|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343828|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343829|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64343830|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
64343831|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64656006|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64656007|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656009|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
64656010|NCT01014728|Propofol|propofol|mesh-list
64656011|NCT01014728|Sevoflurane|sevoflurane|mesh-list
64656012|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64656013|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656014|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656015|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64656016|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
64656017|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
64656018|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64656019|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64656020|NCT01015586|Lamotrigine|lamotrigine|mesh-list
64656021|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
64656022|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64656023|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656024|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656025|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64656026|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656027|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64656028|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64656029|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656030|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64656031|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64656032|NCT01680653|Glucagon|glucagon|mesh-list
64656033|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64656034|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656035|NCT01680653|Hormones|hormones|mesh-ancestor
64656036|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656037|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344021|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
64344022|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344023|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344024|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64656038|NCT01680653|Incretins|incretins|mesh-ancestor
64656039|NCT02448810|Fluorouracil|fluorouracil|mesh-list
64656040|NCT02448810|Panitumumab|panitumumab|mesh-list
64656041|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
64656042|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656043|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64381342|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656045|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656046|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
64656047|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656048|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64656049|NCT01680887|Varenicline|varenicline|mesh-list
64656050|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64656051|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64656052|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
64656053|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656054|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656055|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656057|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64656058|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64656059|NCT01016678|Analgesics|analgesics|mesh-ancestor
64656060|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
64656061|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656062|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656063|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64656064|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656065|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
64656066|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64656067|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656068|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656069|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64344056|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64344057|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344058|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
64344059|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344060|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64344061|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64344062|NCT03478033|Rifampin|rifampin|mesh-list
64344063|NCT03478033|Rifabutin|rifabutin|mesh-list
64344064|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64344065|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
64344066|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64656072|NCT01016834|Sumatriptan|sumatriptan|mesh-list
64656073|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64656074|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64656075|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64656076|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
64656077|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656078|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656079|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656080|NCT04923594|Mazindol|mazindol|mesh-list
64656081|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64656082|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656083|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64656084|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64656085|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656086|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656087|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656088|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656089|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64656090|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
64656091|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64656092|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
64656093|NCT00961532|Coagulants|coagulants|mesh-ancestor
64656094|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64656095|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
64656096|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656097|NCT02447718|Vaccines|vaccines|mesh-list
64656098|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64656099|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
64656100|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656101|NCT03016442|Dinoprostone|dinoprostone|mesh-list
64656102|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
64656103|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64656104|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344129|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
64344130|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344131|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344132|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344133|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344134|NCT04351243|Gimsilumab|gimsilumab|mesh-list
64344135|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344136|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
64344137|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656106|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656107|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
64656108|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64656109|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64656110|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
64656111|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656112|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64656113|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
64656114|NCT00963872|Fludarabine|fludarabine|mesh-list
64656115|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
64656116|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656117|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
64656118|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656119|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344159|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
64344160|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64344161|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344162|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64344163|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
64344169|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64656121|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
64656122|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656123|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656124|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64656125|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64656126|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
64656127|NCT00964496|Thalidomide|thalidomide|mesh-list
64656128|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
64656129|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656130|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
64656131|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656132|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
64656133|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64656134|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656135|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64656136|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64656137|NCT00964496|Growth Substances|growth substances|mesh-ancestor
64656138|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
64656139|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656140|NCT00964496|Hematinics|hematinics|mesh-ancestor
64656141|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
64656142|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
64656144|NCT01685411|Allopurinol|allopurinol|mesh-list
64656145|NCT01685411|Levetiracetam|levetiracetam|mesh-list
64656146|NCT01685411|Tacrolimus|tacrolimus|mesh-list
64656147|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64656148|NCT01685411|Lenograstim|lenograstim|mesh-list
64656149|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656150|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
64656151|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656152|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656153|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64344297|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344298|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344299|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344300|NCT02737501|Crizotinib|crizotinib|mesh-list
64656154|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
64344305|NCT04848220|APD791|apd791|mesh-list
64344338|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656156|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656157|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64656158|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64656159|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64656160|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656161|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64656162|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64656163|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
64656164|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64656165|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656167|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
64656168|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
64656169|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
64656170|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64656173|NCT02243813|Psilocybin|psilocybin|mesh-list
64656174|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
64656175|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656176|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64656177|NCT02991209|Testosterone|testosterone|mesh-list
64656178|NCT02991209|Androgens|androgens|mesh-ancestor
64344410|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656179|NCT02991209|Hormones|hormones|mesh-ancestor
64656180|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656181|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656182|NCT03019562|Fentanyl|fentanyl|mesh-list
64656183|NCT03019562|Oxycodone|oxycodone|mesh-list
64656184|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64656185|NCT03019562|Narcotics|narcotics|mesh-ancestor
64656186|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656187|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656188|NCT03019562|Analgesics|analgesics|mesh-ancestor
64656189|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
64656190|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656191|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64656192|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64656193|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
64656194|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
64656195|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64656196|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64656197|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64656198|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
64656199|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656200|NCT00969878|Antacids|antacids|mesh-ancestor
64656201|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656202|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656203|NCT05677919|Venetoclax|venetoclax|mesh-list
64656204|NCT05677919|Pyrazole|pyrazole|mesh-list
64656205|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656206|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656207|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656208|NCT00970814|Levetiracetam|levetiracetam|mesh-list
64656209|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
64656210|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
64656211|NCT02486406|Ritonavir|ritonavir|mesh-list
64656212|NCT02486406|Ribavirin|ribavirin|mesh-list
64656213|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64656214|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344471|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344472|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
64344473|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344475|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344477|NCT00004907|Busulfan|busulfan|mesh-list
64656215|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
64656216|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344478|NCT00004907|Etoposide|etoposide|mesh-list
64344479|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656217|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656218|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64656219|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64656220|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
64656221|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656222|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64656223|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64656224|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
64656225|NCT01688609|Paclitaxel|paclitaxel|mesh-list
64656226|NCT01688609|Trastuzumab|trastuzumab|mesh-list
64656227|NCT01688609|Lapatinib|lapatinib|mesh-list
64656228|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64656229|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656230|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
64656231|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
64656232|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
64656233|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656234|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64656235|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64656236|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656237|NCT02485158|Dronabinol|dronabinol|mesh-list
64656238|NCT02485158|Amphetamine|amphetamine|mesh-list
64656239|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
64656240|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64656241|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656242|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
64656243|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
64656244|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656245|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
64656246|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656247|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656248|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656249|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64656250|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64656252|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64656253|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
64656254|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64656255|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64656257|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
64656258|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64656259|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64656260|NCT02485158|Hormones|hormones|mesh-ancestor
64656261|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656262|NCT02455518|Acetaminophen|acetaminophen|mesh-list
64656263|NCT02455518|Ibuprofen|ibuprofen|mesh-list
64656264|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64656265|NCT02455518|Oxycodone|oxycodone|mesh-list
64656266|NCT02455518|Hydrocodone|hydrocodone|mesh-list
64656267|NCT02455518|Codeine|codeine|mesh-list
64656268|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64656269|NCT02455518|Analgesics|analgesics|mesh-ancestor
64381567|NCT02432807|Vancomycin|vancomycin|mesh-list
64656270|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
64656271|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656272|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656273|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
64656274|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64344556|NCT00002429|Didanosine|didanosine|mesh-list
64656275|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64656276|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344557|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64344558|NCT00002429|Nelfinavir|nelfinavir|mesh-list
64344559|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64344560|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64344561|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656278|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656279|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656280|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64656281|NCT02455518|Narcotics|narcotics|mesh-ancestor
64656282|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656283|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
64656284|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
64656285|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64656286|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64656287|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64656288|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64656289|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64656290|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656291|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656292|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656293|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656295|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
64656296|NCT03018626|Rituximab|rituximab|mesh-list
64656297|NCT03018626|Doxorubicin|doxorubicin|mesh-list
64656298|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64656299|NCT03018626|Etoposide|etoposide|mesh-list
64656300|NCT03018626|Vincristine|vincristine|mesh-list
64656301|NCT03018626|Bleomycin|bleomycin|mesh-list
64656302|NCT03018626|Vindesine|vindesine|mesh-list
64656303|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656304|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
64656305|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656306|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656307|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64656308|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
64656309|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656310|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656311|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64656312|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64656313|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64656314|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64656315|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64656316|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656317|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64656318|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
64656319|NCT03018626|Hormones|hormones|mesh-ancestor
64656320|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344611|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656321|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64656322|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64656325|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
64656326|NCT01689779|Vitamin D|vitamin d|mesh-list
64656327|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
64656328|NCT01689779|Vitamins|vitamins|mesh-ancestor
64656329|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
64656330|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656331|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64656335|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64656336|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656337|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
64656338|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
64656339|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
64656340|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656341|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64656342|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64656343|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64656344|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
64656345|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656346|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656347|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64656348|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
64656349|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
64656350|NCT00974246|Hormones|hormones|mesh-ancestor
64656351|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656352|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
64656353|NCT00974480|Tretinoin|tretinoin|mesh-list
64656354|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656355|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
64656356|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
64656358|NCT00975650|Androgens|androgens|mesh-ancestor
64656359|NCT00975650|Hormones|hormones|mesh-ancestor
64656360|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656361|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656362|NCT00979940|Atorvastatin|atorvastatin|mesh-list
64656363|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64656364|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64656365|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
64344794|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344795|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64344796|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64344797|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344798|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64656366|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446099|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446100|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
64656367|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64656368|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64656369|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656370|NCT03018236|Ethanol|ethanol|mesh-list
64656371|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
64656372|NCT03018236|Cocaine|cocaine|mesh-list
64344849|NCT04192019|Hormones|hormones|mesh-ancestor
64656373|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64656374|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64656375|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656376|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656377|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656378|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
64656379|NCT03018236|Expectorants|expectorants|mesh-ancestor
64656380|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
64656381|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64656382|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
64656383|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656384|NCT03018236|Protective Agents|protective agents|mesh-ancestor
64344946|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64344947|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656387|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
64656388|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
64656389|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656390|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64656391|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64656392|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64656393|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656394|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
64656395|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656397|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64656398|NCT02873195|Capecitabine|capecitabine|mesh-list
64656399|NCT02873195|Atezolizumab|atezolizumab|mesh-list
64656400|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
64656401|NCT02873195|Antibodies|antibodies|mesh-list
64656402|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
64656403|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64656404|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
64446118|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
64656405|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656406|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64656407|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64656408|NCT02873195|Growth Substances|growth substances|mesh-ancestor
64656409|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656410|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
64656411|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
64656412|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64656413|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
64656414|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656415|NCT02817659|Glucagon|glucagon|mesh-list
64656416|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656417|NCT02817659|Hormones|hormones|mesh-ancestor
64656418|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656419|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656420|NCT02659241|Adavosertib|adavosertib|mesh-list
64656421|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656422|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656424|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64345031|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
64345032|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64345033|NCT04842682|Diazepam|diazepam|mesh-list
64345040|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345041|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64345042|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656426|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656427|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656428|NCT00982592|Leucovorin|leucovorin|mesh-list
64656429|NCT00982592|Fluorouracil|fluorouracil|mesh-list
64656430|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
64656431|NCT00982592|Calcium|calcium|mesh-list
64656432|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
64656433|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64656434|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656435|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
64345078|NCT04925284|Nivolumab|nivolumab|mesh-list
64656437|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64656438|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656439|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656440|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
64656442|NCT00982592|Protective Agents|protective agents|mesh-ancestor
64656443|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
64656444|NCT00982592|Vitamins|vitamins|mesh-ancestor
64656445|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
64656446|NCT00983216|Ketoconazole|ketoconazole|mesh-list
64656447|NCT00983216|Colchicine|colchicine|mesh-list
64656448|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
64656449|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656450|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
64656451|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
64656452|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
64656453|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656454|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656455|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
64656456|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656457|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64656458|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64656459|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656460|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64656461|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
64656462|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656463|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656464|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64656465|NCT01788020|Dexamethasone|dexamethasone|mesh-list
64656466|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
64656467|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
64656468|NCT01788020|Rituximab|rituximab|mesh-list
64656469|NCT01788020|Bortezomib|bortezomib|mesh-list
64656470|NCT01788020|BB 1101|bb 1101|mesh-list
64345176|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345177|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64345178|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345179|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345180|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
64656471|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656472|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
64656473|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656474|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656475|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64656476|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
64656477|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656478|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656479|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64656480|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64656481|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64656482|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
64656483|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
64656484|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656485|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656486|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
64656487|NCT01788020|Hormones|hormones|mesh-ancestor
64656488|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656489|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64656490|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
64656491|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656493|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64656494|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656495|NCT02249585|Trace Elements|trace elements|mesh-ancestor
64656496|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
64656497|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656498|NCT05478863|Caffeine|caffeine|mesh-list
64656499|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64656500|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656501|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64656502|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446140|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656503|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656504|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64656505|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64656506|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
64656507|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656508|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
64656509|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64656510|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656511|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656512|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64656513|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64656514|NCT01774487|Protective Agents|protective agents|mesh-ancestor
64656515|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656516|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64656517|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64656518|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
64656519|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
64656520|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64656521|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656522|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656523|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
64656524|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656525|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656526|NCT02161484|Bupivacaine|bupivacaine|mesh-list
64656527|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
64656528|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
64656529|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656530|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656531|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
64656532|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656533|NCT00988832|Infliximab|infliximab|mesh-list
64656534|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
64656535|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656536|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656537|NCT01023776|Vaccines|vaccines|mesh-list
64656538|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
64656539|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656540|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
64656541|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64656542|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64349956|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656543|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64656544|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656545|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656546|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
64656547|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656548|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656549|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64656550|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656551|NCT00990236|Enoxaparin|enoxaparin|mesh-list
64656552|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
64656553|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
64656554|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64656555|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64656556|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656557|NCT01024010|Vidarabine|vidarabine|mesh-list
64656558|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
64656559|NCT01024010|Ofatumumab|ofatumumab|mesh-list
64656560|NCT01024010|Pentostatin|pentostatin|mesh-list
64656561|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64656562|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656563|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
64656564|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656565|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656566|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64656567|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
64656568|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656569|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656570|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64656571|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64656572|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656573|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
64656574|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
64656575|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656576|NCT02484690|Ranibizumab|ranibizumab|mesh-list
64656577|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64656578|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64656579|NCT02484690|Growth Substances|growth substances|mesh-ancestor
64656580|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656581|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
64656582|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656583|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64656584|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656585|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64656586|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656587|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656588|NCT01654224|Vaccines|vaccines|mesh-list
64656589|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
64656590|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656591|NCT02447328|Fulvestrant|fulvestrant|mesh-list
64656592|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64656593|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656594|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64656595|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64656596|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
64656597|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656598|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656599|NCT02447250|Albuterol|albuterol|mesh-list
64656600|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64656601|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
64656602|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656603|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656604|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64656605|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
64656606|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
64656607|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64656609|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64656610|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64656611|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656612|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656613|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656614|NCT00993200|Warfarin|warfarin|mesh-list
64656615|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
64656616|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64656617|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64656619|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
64656620|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656621|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64656622|NCT02447172|Gentamicins|gentamicins|mesh-list
64656623|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64656624|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656625|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64656626|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656627|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656628|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64656629|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64656630|NCT04200066|Tamoxifen|tamoxifen|mesh-list
64656631|NCT04200066|Temozolomide|temozolomide|mesh-list
64656632|NCT04200066|Maprotiline|maprotiline|mesh-list
64656633|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64656634|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
64656635|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656636|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656637|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64656638|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
64656639|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656640|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656641|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64656642|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64656643|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64656644|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64656645|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64656646|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
64656647|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64656648|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64656649|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64656650|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656651|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656652|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656653|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64345290|NCT04458922|Atezolizumab|atezolizumab|mesh-list
64345291|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64345292|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345293|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
64345294|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656654|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64656655|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64656657|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656659|NCT04005716|Carboplatin|carboplatin|mesh-list
64656660|NCT04005716|Etoposide|etoposide|mesh-list
64656661|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
64656662|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656663|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64656664|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64656665|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64656666|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656667|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656668|NCT00994760|Fentanyl|fentanyl|mesh-list
64656669|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64656670|NCT00994760|Narcotics|narcotics|mesh-ancestor
64656671|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656672|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656673|NCT00994760|Analgesics|analgesics|mesh-ancestor
64656674|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
64656675|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656676|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64656677|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64656678|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
64656679|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
64656680|NCT00995072|Metoprolol|metoprolol|mesh-list
64656681|NCT00995072|Nebivolol|nebivolol|mesh-list
64656682|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64656683|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64656684|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
64656685|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
64656686|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656687|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656688|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64656689|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64656690|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64656692|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656693|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656694|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
64656695|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64656696|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64656697|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64656699|NCT01027910|Abexinostat|abexinostat|mesh-list
64656700|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64656701|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656702|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64656703|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64656704|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656705|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656706|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64656707|NCT01031420|Doxorubicin|doxorubicin|mesh-list
64656708|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64656709|NCT01031420|Methotrexate|methotrexate|mesh-list
64656710|NCT01031420|Vinblastine|vinblastine|mesh-list
64656711|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64656712|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656713|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64656714|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64656715|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656716|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656717|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64656718|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
64656719|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64656720|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656721|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64345313|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656723|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
64656724|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64656725|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64656726|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
64656727|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656728|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64656729|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64656730|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
64656731|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
64656732|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
64656733|NCT01031498|Ondansetron|ondansetron|mesh-list
64656734|NCT01031498|Palonosetron|palonosetron|mesh-list
64656735|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
64656736|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
64656737|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656738|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656739|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656740|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
64656741|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
64656742|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64656743|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
64656744|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656745|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656746|NCT01031498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64656747|NCT01031498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64656748|NCT01031498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656749|NCT01031498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64656750|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64656751|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64656752|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
64656753|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
64656754|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64656755|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64656756|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656757|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656758|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64656759|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64656760|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656761|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656764|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656765|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
64656766|NCT00998426|Antibodies|antibodies|mesh-list
64656767|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
64656768|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64656769|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64656770|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
64656771|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
64656772|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656773|NCT00998582|Tenofovir|tenofovir|mesh-list
64656774|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
64656775|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656776|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64656777|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64656778|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656779|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656780|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64656781|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64656782|NCT02168660|Vitamin D|vitamin d|mesh-list
64656783|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
64656784|NCT02168660|Vitamins|vitamins|mesh-ancestor
64656785|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
64656786|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656787|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64656788|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64345324|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656789|NCT01003106|Ranibizumab|ranibizumab|mesh-list
64345330|NCT02987686|Infliximab|infliximab|mesh-list
64656791|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64656792|NCT01003106|Growth Substances|growth substances|mesh-ancestor
64656793|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656794|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
64656795|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656796|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64656797|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
64656798|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656799|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
64656800|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64656801|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64656802|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64656803|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656804|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656805|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
64656806|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656807|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656808|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64656809|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656811|NCT01004354|Vitamin D|vitamin d|mesh-list
64656812|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64656813|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656814|NCT01004354|Vitamins|vitamins|mesh-ancestor
64656815|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
64656816|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64656817|NCT02641028|Aticaprant|aticaprant|mesh-list
64656818|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64656819|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656820|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
64656821|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656822|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64656823|NCT02417064|Citalopram|citalopram|mesh-list
64656824|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64656825|NCT02417064|Sertraline|sertraline|mesh-list
64656826|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
64656827|NCT02417064|Esketamine|esketamine|mesh-list
64656828|NCT02417064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64656829|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64656830|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64656831|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656832|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656833|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
64656834|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656835|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64656836|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64656837|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656838|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64656839|NCT02417064|Analgesics|analgesics|mesh-ancestor
64656840|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
64656841|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
64656842|NCT01004744|Anastrozole|anastrozole|mesh-list
64656843|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64656844|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656845|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64345332|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345333|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345334|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
64345342|NCT05277922|Nitroprusside|nitroprusside|mesh-list
64345372|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656846|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64656847|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656848|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656849|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64656850|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
64656851|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656852|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656853|NCT01005290|Ramipril|ramipril|mesh-list
64656854|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64656855|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
64656856|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656857|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656858|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64656859|NCT04478474|Ganciclovir|ganciclovir|mesh-list
64656860|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64656861|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
64656862|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656863|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64656864|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656865|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656866|NCT05592860|Insulin|insulin|mesh-list
64656867|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64656868|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656869|NCT01051778|Aspirin|aspirin|mesh-list
64382164|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64656870|NCT01051778|Heparin|heparin|mesh-list
64656871|NCT01051778|Enoxaparin|enoxaparin|mesh-list
64656872|NCT01051778|Calcium heparin|calcium heparin|mesh-list
64656873|NCT01051778|Calcium|calcium|mesh-list
64656874|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64656875|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656876|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64656877|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64656878|NCT01051778|Analgesics|analgesics|mesh-ancestor
64656879|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
64656880|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656881|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64656882|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64656883|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64656884|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64656885|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656886|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64656887|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64656888|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349961|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64656889|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
64656890|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
64656891|NCT02169440|Opicapone|opicapone|mesh-list
64656892|NCT02169440|Warfarin|warfarin|mesh-list
64656893|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
64656894|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64656895|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656896|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656897|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64656898|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64656899|NCT03015350|Sevoflurane|sevoflurane|mesh-list
64656900|NCT03015350|Desflurane|desflurane|mesh-list
64656901|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64656902|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64656903|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
64345383|NCT04194424|Metformin|metformin|mesh-list
64345384|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64345385|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345386|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
64345387|NCT02473640|Esomeprazole|esomeprazole|mesh-list
64345388|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64345389|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345390|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64656904|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
64656905|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64656906|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656907|NCT01054742|Ribavirin|ribavirin|mesh-list
64656908|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64656909|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
64656910|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656911|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
64656912|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656913|NCT04171466|Metronidazole|metronidazole|mesh-list
64656914|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
64656915|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64656916|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64656917|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64656918|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64656919|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64656920|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64656921|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656922|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656923|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656924|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64656925|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64656926|NCT02170376|Levodopa|levodopa|mesh-list
64656927|NCT02170376|Carbidopa|carbidopa|mesh-list
64656928|NCT02170376|Opicapone|opicapone|mesh-list
64656929|NCT02170376|Entacapone|entacapone|mesh-list
64656930|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64656931|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64656932|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
64656933|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656934|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656935|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656936|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64656937|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656938|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64656939|NCT02170532|Albuterol|albuterol|mesh-list
64656940|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64656941|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
64656942|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656943|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656944|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64656945|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
64656946|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
64656947|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64345428|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
64345429|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345433|NCT02502734|Xhance|xhance|mesh-list
64656948|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64656949|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64656950|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64656951|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
64656952|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656953|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656954|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
64656955|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64656956|NCT05509634|Dexamethasone|dexamethasone|mesh-list
64656957|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
64656958|NCT05509634|Palonosetron|palonosetron|mesh-list
64656959|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
64656960|NCT05509634|Aprepitant|aprepitant|mesh-list
64656961|NCT05509634|BB 1101|bb 1101|mesh-list
64656962|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64656963|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
64656964|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
64656965|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64656966|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656967|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64656968|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
64656969|NCT05509634|Hormones|hormones|mesh-ancestor
64656970|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656971|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64656972|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656973|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
64656974|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64656975|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656976|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64656977|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64656978|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
64656979|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64656980|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64656981|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
64656982|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
64656983|NCT02175212|Androgens|androgens|mesh-list
64656984|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64656985|NCT02175212|Hormones|hormones|mesh-ancestor
64656986|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64656987|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64656988|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
64656989|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64656990|NCT02175212|Protective Agents|protective agents|mesh-ancestor
64656991|NCT02175212|Vitamins|vitamins|mesh-ancestor
64656992|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
64656993|NCT02175212|Estrogens|estrogens|mesh-ancestor
64656994|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64656995|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64656996|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
64656997|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
64656998|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64656999|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
64657000|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657001|NCT03014882|Expectorants|expectorants|mesh-ancestor
64657002|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
64657003|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64657004|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
64657005|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657006|NCT03014882|Protective Agents|protective agents|mesh-ancestor
64657007|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657008|NCT03014882|Antidotes|antidotes|mesh-ancestor
64657009|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64657010|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
64657011|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64657012|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64657013|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430034|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657014|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657016|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64657017|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
64657018|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657019|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657020|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64382312|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64657022|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
64657023|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657024|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657025|NCT01062230|Bortezomib|bortezomib|mesh-list
64657026|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657027|NCT01064882|Bimatoprost|bimatoprost|mesh-list
64657028|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64657029|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64657030|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64657031|NCT01065506|Nicotine|nicotine|mesh-list
64657032|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64657033|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
64657034|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657035|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657036|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64657037|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64657038|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
64657039|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657040|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657041|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64657042|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657043|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657044|NCT03811886|Natalizumab|natalizumab|mesh-list
64657045|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
64657046|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657047|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64657048|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64657049|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64657050|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
64657051|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657052|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64657053|NCT01066520|Diclofenac|diclofenac|mesh-list
64657054|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64657055|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64657056|NCT01066520|Analgesics|analgesics|mesh-ancestor
64657057|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
64657058|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657059|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657060|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64657061|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64657062|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64657063|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657064|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657065|NCT03014804|Nivolumab|nivolumab|mesh-list
64657066|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64657067|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657068|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64657069|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657070|NCT05224388|Heparin|heparin|mesh-list
64657071|NCT05224388|Enoxaparin|enoxaparin|mesh-list
64657072|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
64657073|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64657074|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64657075|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657076|NCT03520790|Gemcitabine|gemcitabine|mesh-list
64657077|NCT03520790|Paclitaxel|paclitaxel|mesh-list
64657078|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64657079|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657080|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
64657081|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
64657082|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
64657083|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657084|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64657085|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
64657086|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
64657087|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657088|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657089|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657090|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
64657091|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657093|NCT02416908|Plerixafor|plerixafor|mesh-list
64657094|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
64657095|NCT02416908|Cladribine|cladribine|mesh-list
64657096|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64657097|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
64657098|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657099|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657100|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
64657101|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657102|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657103|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
64657104|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657105|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64657106|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64657107|NCT01070810|Thiamine|thiamine|mesh-list
64657108|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
64657109|NCT01070810|Vitamins|vitamins|mesh-ancestor
64657110|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
64657111|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657112|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64657113|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64657114|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657115|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64657116|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64657117|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64657118|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657119|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
64657120|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657121|NCT05150756|Lidocaine|lidocaine|mesh-list
64657122|NCT05150756|Morphine|morphine|mesh-list
64657123|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
64657124|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
64657125|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657126|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657127|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
64657128|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657129|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64657130|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64657131|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64657132|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64657133|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657134|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64657135|NCT05150756|Narcotics|narcotics|mesh-ancestor
64657136|NCT05150756|Analgesics|analgesics|mesh-ancestor
64657137|NCT01072136|Azithromycin|azithromycin|mesh-list
64657138|NCT01072136|Cefixime|cefixime|mesh-list
64657139|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64657140|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345473|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64345474|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64345475|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345476|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345478|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345479|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64345480|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
64657142|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64657143|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
64657144|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64657145|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657146|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64657148|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657149|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657150|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
64657151|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657152|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64657153|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657154|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
64657155|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64657156|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64657157|NCT05070650|Acetaminophen|acetaminophen|mesh-list
64657158|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
64657159|NCT05070650|Phenylephrine|phenylephrine|mesh-list
64657160|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
64657161|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64657162|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64657163|NCT05070650|Analgesics|analgesics|mesh-ancestor
64657164|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
64657165|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657166|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657167|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
64657168|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
64657169|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382466|NCT05525481|Tamoxifen|tamoxifen|mesh-list
64657170|NCT05070650|Expectorants|expectorants|mesh-ancestor
64657172|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64657173|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
64657174|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657175|NCT05070650|Protective Agents|protective agents|mesh-ancestor
64657176|NCT05070650|Antidotes|antidotes|mesh-ancestor
64657177|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64657178|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
64657179|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
64657180|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
64657181|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64657182|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
64657183|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64657184|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64657185|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64657186|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
64657187|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657188|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
64657189|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64657190|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657191|NCT03005444|Enoxaparin|enoxaparin|mesh-list
64657192|NCT03005444|Nadroparin|nadroparin|mesh-list
64657193|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
64657194|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64657195|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
64657196|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64657197|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
64657198|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657199|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345485|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64345486|NCT04253626|Hematinics|hematinics|mesh-ancestor
64657200|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
64657201|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64345490|NCT03840148|Cefepime|cefepime|mesh-list
64657202|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64657203|NCT01076270|Plerixafor|plerixafor|mesh-list
64657204|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64657205|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64657206|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
64657207|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657208|NCT01076504|Carboplatin|carboplatin|mesh-list
64657210|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657211|NCT01076972|Ritonavir|ritonavir|mesh-list
64657212|NCT01076972|Lopinavir|lopinavir|mesh-list
64657213|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64657214|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64657215|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
64657216|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657217|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657218|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64657219|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64657220|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
64657221|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657222|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64657223|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64657224|NCT02174432|Nalbuphine|nalbuphine|mesh-list
64657225|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64657226|NCT02174432|Narcotics|narcotics|mesh-ancestor
64657227|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657228|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657229|NCT02174432|Analgesics|analgesics|mesh-ancestor
64657230|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
64657231|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657232|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
64657233|NCT02176382|Denosumab|denosumab|mesh-list
64657234|NCT02176382|Teriparatide|teriparatide|mesh-list
64657235|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64657236|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657237|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64657239|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
64657240|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
64657241|NCT01077596|Serotonin|serotonin|mesh-list
64657242|NCT01077596|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64657243|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64657244|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64657245|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64657246|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64657247|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64657248|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657249|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
64657250|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657251|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657252|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64657253|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64657254|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345501|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345502|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345503|NCT04222504|Tenofovir|tenofovir|mesh-list
64345504|NCT04222504|Emtricitabine|emtricitabine|mesh-list
64657255|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64657256|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
64657257|NCT02740868|Xenon|xenon|mesh-list
64657258|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64657259|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
64657260|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
64657261|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657262|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657263|NCT02414958|Empagliflozin|empagliflozin|mesh-list
64657264|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64430060|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
64657265|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657266|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64657267|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657268|NCT03016208|Misoprostol|misoprostol|mesh-list
64657269|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64657270|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
64657271|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64657272|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657273|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64657274|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657275|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
64657276|NCT03013790|Melatonin|melatonin|mesh-list
64657277|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
64657278|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657279|NCT03013790|Protective Agents|protective agents|mesh-ancestor
64657280|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657281|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657282|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64657283|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64657284|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64657285|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657287|NCT02485184|Warfarin|warfarin|mesh-list
64657288|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64657289|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
64657290|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64657291|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
64657292|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657293|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657294|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657295|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64657296|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64657297|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
64657298|NCT03015818|Calcium|calcium|mesh-list
64657299|NCT03015818|Fluorides|fluorides|mesh-list
64657300|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64657301|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657302|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
64657303|NCT03015818|Protective Agents|protective agents|mesh-ancestor
64657304|NCT01080248|Gemcitabine|gemcitabine|mesh-list
64657305|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64657306|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
64657307|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657308|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657309|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
64345526|NCT03774472|Letrozole|letrozole|mesh-list
64345527|NCT03774472|Palbociclib|palbociclib|mesh-list
64345528|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345529|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64345530|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64345532|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345533|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64657310|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657311|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657312|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657313|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
64657314|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657316|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64657317|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657318|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657319|NCT02452476|Poractant alfa|poractant alfa|mesh-list
64657320|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64382635|NCT01623310|Xhance|xhance|mesh-list
64657321|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
64657322|NCT01082588|Pravastatin|pravastatin|mesh-list
64657323|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64657324|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64657325|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
64657326|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657327|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64657328|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64657329|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657330|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
64657331|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64657332|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657334|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657335|NCT02441946|Anastrozole|anastrozole|mesh-list
64657336|NCT02441946|Loperamide|loperamide|mesh-list
64657337|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
64657338|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64657339|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657340|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64657341|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64657342|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657343|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657344|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64657345|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
64657346|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657347|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657348|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657349|NCT01083368|Sirolimus|sirolimus|mesh-list
64657350|NCT01083368|Bevacizumab|bevacizumab|mesh-list
64657351|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64657352|NCT01083368|Antibodies|antibodies|mesh-list
64657353|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
64657354|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64657355|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657356|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64657357|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64657358|NCT01083368|Growth Substances|growth substances|mesh-ancestor
64657359|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657360|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
64657361|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
64657362|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64657363|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657364|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64657365|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
64657366|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657367|NCT02387580|Artefenomel|artefenomel|mesh-list
64657368|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
64657369|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64657370|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64657371|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657372|NCT02440854|Afatinib|afatinib|mesh-list
64657373|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657374|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64657375|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657376|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657377|NCT01084148|V0034CR|v0034cr|mesh-list
64657378|NCT01084148|Emollients|emollients|mesh-ancestor
64657379|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
64657380|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
64657381|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64657382|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64657383|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657384|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
64657385|NCT01085006|Coagulants|coagulants|mesh-ancestor
64657386|NCT01085786|Amoxicillin|amoxicillin|mesh-list
64657387|NCT01085786|Metronidazole|metronidazole|mesh-list
64657388|NCT01085786|Clarithromycin|clarithromycin|mesh-list
64657389|NCT01085786|Esomeprazole|esomeprazole|mesh-list
64657390|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64657391|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657392|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64657393|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64657394|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64657395|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657396|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64657397|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657398|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657399|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64657400|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64657401|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64657402|NCT02170220|Vortioxetine|vortioxetine|mesh-list
64657403|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
64657404|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64657405|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64382760|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
64657406|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64657407|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657408|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657409|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64657410|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64657411|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64657412|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657413|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657414|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
64657415|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64657416|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64657417|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64657418|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64657419|NCT01036802|Warfarin|warfarin|mesh-list
64657420|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
64657421|NCT01037192|Vancomycin|vancomycin|mesh-list
64345539|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64345540|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657423|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657424|NCT02386098|Ritonavir|ritonavir|mesh-list
64657425|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64657426|NCT02386098|Tenofovir|tenofovir|mesh-list
64657427|NCT02386098|Dolutegravir|dolutegravir|mesh-list
64657428|NCT02386098|BMS-955176|bms-955176|mesh-list
64657429|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64657430|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64657431|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
64657432|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657433|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657434|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64657435|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64657436|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
64657437|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657438|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64657439|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64657440|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64657441|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64657442|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64657443|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64657444|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
64657445|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64657446|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
64657447|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
64657448|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657449|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657450|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657451|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64657452|NCT01089062|Analgesics|analgesics|mesh-ancestor
64430118|NCT04944095|Antibodies|antibodies|mesh-list
64657453|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
64657454|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657455|NCT02412618|Misoprostol|misoprostol|mesh-list
64657456|NCT02412618|Mifepristone|mifepristone|mesh-list
64657457|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64657458|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
64657459|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64657460|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657461|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64657462|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657463|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
64657464|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64657465|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64657466|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64657467|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64657468|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
64657469|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64657470|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64657471|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
64657472|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657473|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
64657474|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64657475|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64657476|NCT02179892|Acetaminophen|acetaminophen|mesh-list
64657477|NCT02179892|Dexamethasone|dexamethasone|mesh-list
64657478|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
64657479|NCT02179892|Bupivacaine|bupivacaine|mesh-list
64382837|NCT04482881|Isosorbide|isosorbide|mesh-list
64657480|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64657481|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
64657482|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
64657483|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657484|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657485|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657486|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
64657487|NCT02179892|Hormones|hormones|mesh-ancestor
64657488|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657489|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64657490|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657491|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
64657493|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657494|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
64657495|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64657496|NCT02179892|Analgesics|analgesics|mesh-ancestor
64657497|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
64657498|NCT01092338|Vitamin D|vitamin d|mesh-list
64657499|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
64657500|NCT01092338|Vitamins|vitamins|mesh-ancestor
64657501|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
64657502|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657503|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64657504|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64657505|NCT01110434|Topiramate|topiramate|mesh-list
64657506|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
64657507|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64657508|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657509|NCT01042496|Lamotrigine|lamotrigine|mesh-list
64657510|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
64657511|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64657512|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430136|NCT02141295|Vitamins|vitamins|mesh-ancestor
64657513|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657514|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64657515|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657516|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64657517|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64657518|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657519|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64657520|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64657521|NCT01111058|Everolimus|everolimus|mesh-list
64657522|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657523|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657524|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
64657525|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657526|NCT01094522|Morphine|morphine|mesh-list
64657527|NCT01094522|Methadone|methadone|mesh-list
64657528|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64657529|NCT01094522|Narcotics|narcotics|mesh-ancestor
64657530|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657531|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657532|NCT01094522|Analgesics|analgesics|mesh-ancestor
64657533|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
64657534|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657535|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
64657536|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
64657537|NCT02178800|Cabotegravir|cabotegravir|mesh-list
64657538|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64657539|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64657540|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657541|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657542|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64657543|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64345579|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345580|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64657545|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657546|NCT01044212|Psyllium|psyllium|mesh-list
64657547|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64657548|NCT01044212|Cathartics|cathartics|mesh-ancestor
64657549|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657550|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
64657551|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64657552|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64657553|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64657554|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657555|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657556|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64657557|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64657558|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64657559|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64657560|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
64657561|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657562|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657563|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64657564|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64657565|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
64657566|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64657567|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64657568|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
64657569|NCT00585195|Itraconazole|itraconazole|mesh-list
64657570|NCT00585195|Rifampin|rifampin|mesh-list
64657571|NCT00585195|Crizotinib|crizotinib|mesh-list
64657572|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
64657573|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657574|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64657575|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64657576|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657577|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657578|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64657579|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
64657580|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657581|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657582|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64657583|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64657584|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
64657585|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64657586|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
64657587|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64657588|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64657589|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64657590|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64657591|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64657592|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64657593|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64657594|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657595|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64657596|NCT01113398|Bevacizumab|bevacizumab|mesh-list
64657597|NCT01113398|Rilotumumab|rilotumumab|mesh-list
64657598|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64657599|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657600|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64657601|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64657602|NCT01113398|Growth Substances|growth substances|mesh-ancestor
64657603|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657604|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
64657605|NCT03013556|Tenofovir|tenofovir|mesh-list
64657606|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64657607|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
64657608|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
64657609|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657610|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64657611|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64657612|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657613|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657614|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64657615|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64657616|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
64657617|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657618|NCT01113632|Ofatumumab|ofatumumab|mesh-list
64657619|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657620|NCT00458835|Ciclesonide|ciclesonide|mesh-list
64657621|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
64657622|NCT00458835|Hormones|hormones|mesh-ancestor
64657623|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657624|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657625|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64657626|NCT01044758|Levetiracetam|levetiracetam|mesh-list
64657627|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
64657628|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
64657629|NCT01115582|Cholic Acids|cholic acids|mesh-list
64657630|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657632|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64657633|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64657634|NCT03013400|Analgesics|analgesics|mesh-ancestor
64657635|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
64657636|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657637|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657638|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64657639|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64657640|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64657641|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657642|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
64657643|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657644|NCT03013400|Protective Agents|protective agents|mesh-ancestor
64657646|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657647|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64657648|NCT02439138|Idelalisib|idelalisib|mesh-list
64657649|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657650|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657651|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657652|NCT01097642|Cetuximab|cetuximab|mesh-list
64657653|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64657654|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657655|NCT01048658|Sevoflurane|sevoflurane|mesh-list
64657656|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64657657|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64657658|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
64657659|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
64657660|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657661|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657662|NCT04341675|Sirolimus|sirolimus|mesh-list
64657663|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64657664|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657665|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64657666|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657667|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
64657668|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657669|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
64657670|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657671|NCT02445807|Clobetasol|clobetasol|mesh-list
64657672|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64657673|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
64657674|NCT02445807|Hormones|hormones|mesh-ancestor
64657675|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657676|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657677|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64657678|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64657679|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657681|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64657682|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
64657683|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657684|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657685|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64657686|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64657687|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
64657688|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657689|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657690|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
64657691|NCT01099202|Hematinics|hematinics|mesh-ancestor
64657692|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
64657693|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
64657694|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64430168|NCT02513771|Hormones|hormones|mesh-ancestor
64657695|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657697|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
64657698|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64657699|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
64657700|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657701|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657702|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
64657703|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
64657704|NCT00363285|Hormones|hormones|mesh-list
64657705|NCT00363285|Cyproterone|cyproterone|mesh-list
64657706|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657707|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657709|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
64657710|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657711|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64657712|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
64657713|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64657714|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
64657715|NCT02424357|Povidone|povidone|mesh-list
64657716|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64657717|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64657718|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
64657719|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
64657720|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64657721|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657722|NCT02425449|Succinylcholine|succinylcholine|mesh-list
64657723|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64657724|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64657725|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64657726|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657727|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657728|NCT02455167|Ribavirin|ribavirin|mesh-list
64657729|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
64657730|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
64657731|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657732|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
64657733|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657734|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64657735|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64657736|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64657737|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
64657738|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657739|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64430174|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64657740|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64657741|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657742|NCT02435901|Cyclosporine|cyclosporine|mesh-list
64657743|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
64657745|NCT02435901|Melphalan|melphalan|mesh-list
64657746|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
64657747|NCT02435901|Tacrolimus|tacrolimus|mesh-list
64657748|NCT02435901|Cyclosporins|cyclosporins|mesh-list
64657749|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657750|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657751|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657752|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
64657753|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657754|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64657755|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657756|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
64657757|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657758|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
64657759|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64657760|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64657761|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64657762|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
64657763|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64657764|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64657765|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
64657766|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64657767|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64657768|NCT02437383|Propranolol|propranolol|mesh-list
64657769|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64657770|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64657771|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
64657772|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657773|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657774|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657775|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64657776|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64657777|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
64657778|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
64657779|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64383140|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
64657780|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64657781|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657783|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
64657784|NCT01099358|Fluorouracil|fluorouracil|mesh-list
64657785|NCT01099358|Cetuximab|cetuximab|mesh-list
64657786|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657787|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
64657788|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657789|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64657790|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657791|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
64657792|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657793|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64657794|NCT01118624|Vitamins|vitamins|mesh-list
64657795|NCT01118624|Folic Acid|folic acid|mesh-list
64657796|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
64657797|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
64657798|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
64657799|NCT01118624|Aminopterin|aminopterin|mesh-list
64657800|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
64657801|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657803|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64657804|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657805|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345597|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657806|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657807|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
64657808|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
64657809|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657810|NCT02439879|Protective Agents|protective agents|mesh-ancestor
64657811|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657812|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
64657813|NCT02439879|Vitamins|vitamins|mesh-ancestor
64657814|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
64657815|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
64657816|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64657817|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657818|NCT01100606|Pancrelipase|pancrelipase|mesh-list
64657820|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657821|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
64657822|NCT03013010|Tegafur|tegafur|mesh-list
64657823|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657824|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64657825|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
64657826|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657827|NCT02518191|Goserelin|goserelin|mesh-list
64657828|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64657829|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657830|NCT01119794|Bortezomib|bortezomib|mesh-list
64657831|NCT01119794|Ofatumumab|ofatumumab|mesh-list
64657832|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657833|NCT02926196|Avelumab|avelumab|mesh-list
64657834|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64657835|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657836|NCT02819024|Alovudine|alovudine|mesh-list
64657837|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
64657838|NCT02819024|Dexamethasone|dexamethasone|mesh-list
64657839|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
64657840|NCT02819024|Ichthammol|ichthammol|mesh-list
64657841|NCT02819024|BB 1101|bb 1101|mesh-list
64657842|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64657843|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
64657844|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
64657845|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657846|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657847|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657848|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
64657849|NCT02819024|Hormones|hormones|mesh-ancestor
64657850|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657851|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64657852|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657853|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
64657854|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383218|NCT05520645|Propofol|propofol|mesh-list
64657855|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657856|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
64657857|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
64657858|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657859|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
64430209|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64657860|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64657861|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64657862|NCT01103414|Pioglitazone|pioglitazone|mesh-list
64657863|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64657864|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657866|NCT02180828|Clotrimazole|clotrimazole|mesh-list
64657867|NCT02180828|Miconazole|miconazole|mesh-list
64657868|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
64657869|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657870|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64657871|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64657872|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657873|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345610|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64345611|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345613|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64657874|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64657875|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
64657876|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657877|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657878|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64657879|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64657880|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64657881|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64657882|NCT02525523|Alicaforsen|alicaforsen|mesh-list
64657883|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64657884|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657885|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
64657886|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657887|NCT02528409|Vortioxetine|vortioxetine|mesh-list
64657888|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
64657889|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64657890|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64657891|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64657892|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657893|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657895|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64657896|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64657897|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657898|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657899|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
64657900|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64657901|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64657902|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64657903|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64657904|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
64657905|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64657906|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64657907|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64657908|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
64657909|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657910|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657911|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657912|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
64657913|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64657914|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64657915|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657916|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64657917|NCT03013634|Analgesics|analgesics|mesh-ancestor
64657918|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
64657919|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657920|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64657921|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64657922|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64657923|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
64657924|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64657925|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657926|NCT02980094|Vitamins|vitamins|mesh-list
64657927|NCT02980094|Vitamin E|vitamin e|mesh-list
64657928|NCT02980094|Tocopherols|tocopherols|mesh-list
64657929|NCT02980094|Tocotrienols|tocotrienols|mesh-list
64657930|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
64657931|NCT02980094|Selenium|selenium|mesh-list
64657932|NCT02980094|Antioxidants|antioxidants|mesh-list
64657933|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
64657934|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657935|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657936|NCT02980094|Protective Agents|protective agents|mesh-ancestor
64657937|NCT02980094|Trace Elements|trace elements|mesh-ancestor
64657938|NCT03013322|Physostigmine|physostigmine|mesh-list
64657939|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64657940|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657941|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657942|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
64657943|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382217|NCT03181685|Progesterone|progesterone|mesh-list
64382218|NCT03181685|Progestins|progestins|mesh-ancestor
64382219|NCT03181685|Hormones|hormones|mesh-ancestor
64382220|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657944|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657946|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
64657947|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64657948|NCT02469597|Furosemide|furosemide|mesh-list
64657949|NCT02469597|Diuretics|diuretics|mesh-ancestor
64657950|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
64657951|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657952|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64657953|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64657954|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657955|NCT02183792|Furosemide|furosemide|mesh-list
64657956|NCT02183792|Tolvaptan|tolvaptan|mesh-list
64657957|NCT02183792|Diuretics|diuretics|mesh-ancestor
64657958|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
64657959|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657960|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64657961|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64657962|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657963|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64657964|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64657965|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64657966|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657967|NCT00363519|Incretins|incretins|mesh-ancestor
64657968|NCT00363519|Hormones|hormones|mesh-ancestor
64657969|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64657970|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64657971|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
64657972|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657973|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657974|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
64657975|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657976|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64657977|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657978|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657979|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
64657980|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64657981|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657982|NCT02475837|Vorapaxar|vorapaxar|mesh-list
64657983|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64657984|NCT01124786|Gemcitabine|gemcitabine|mesh-list
64657985|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64657986|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
64657987|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64657988|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64657989|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
64657990|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64657991|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64657992|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64657993|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
64657994|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64657995|NCT01125098|Amoxicillin|amoxicillin|mesh-list
64657996|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
64657997|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64657998|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345620|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
64345621|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345622|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345623|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64345624|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64345625|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
64657999|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658000|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64658001|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658002|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383366|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
64658004|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64658005|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64658006|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658007|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
64658008|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658009|NCT02322320|Lenalidomide|lenalidomide|mesh-list
64658010|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
64658011|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658012|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64658013|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64658014|NCT02322320|Growth Substances|growth substances|mesh-ancestor
64658015|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
64658016|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658017|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
64658018|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64658019|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658020|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64658021|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658022|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
64658023|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658024|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658025|NCT01127438|Fospropofol|fospropofol|mesh-list
64658026|NCT01127438|Propofol|propofol|mesh-list
64658027|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64658028|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658029|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658030|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64658031|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
64658032|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
64658033|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
64658034|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64658035|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658036|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658037|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64658038|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64658039|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658040|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658041|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658042|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64658043|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
64658044|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64658045|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658046|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64658047|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64658048|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64658050|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64658051|NCT05307458|Naloxone|naloxone|mesh-list
64658052|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64658053|NCT05307458|Narcotics|narcotics|mesh-ancestor
64658054|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658055|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658056|NCT05307458|Analgesics|analgesics|mesh-ancestor
64658057|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
64658058|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345638|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64345639|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345640|NCT02499146|Letrozole|letrozole|mesh-list
64345641|NCT02499146|Palbociclib|palbociclib|mesh-list
64658059|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64658060|NCT02481219|Erythromycin|erythromycin|mesh-list
64658061|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
64658062|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64658063|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
64658064|NCT02481219|Metoclopramide|metoclopramide|mesh-list
64658065|NCT02481219|Bisacodyl|bisacodyl|mesh-list
64658066|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64658067|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
64658068|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
64658069|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658070|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658071|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658072|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64658073|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64658074|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
64658075|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658076|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658077|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64383444|NCT02409563|Hormones|hormones|mesh-ancestor
64658078|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658079|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64658080|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658081|NCT02481219|Cathartics|cathartics|mesh-ancestor
64658082|NCT02481219|Laxatives|laxatives|mesh-ancestor
64658083|NCT02481297|Rituximab|rituximab|mesh-list
64658084|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658085|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658086|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
64658087|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658088|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658090|NCT02481375|Trace Elements|trace elements|mesh-list
64658091|NCT02481375|Micronutrients|micronutrients|mesh-list
64658092|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658093|NCT01164098|Rituximab|rituximab|mesh-list
64658094|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658095|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658096|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
64658097|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658098|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658099|NCT01165112|Rituximab|rituximab|mesh-list
64658100|NCT01165112|Carboplatin|carboplatin|mesh-list
64658101|NCT01165112|Etoposide|etoposide|mesh-list
64658102|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64658103|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658104|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658105|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
64658106|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658107|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658108|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64658109|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64345648|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
64345649|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345650|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345651|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64345652|NCT01634854|Misoprostol|misoprostol|mesh-list
64345653|NCT01634854|Oxytocin|oxytocin|mesh-list
64345654|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
64345655|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64658110|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64345656|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345661|NCT05651464|Vancomycin|vancomycin|mesh-list
64658111|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345683|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64658112|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658113|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64658114|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
64658116|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64658117|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
64658118|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64430289|NCT02483975|Albuterol|albuterol|mesh-list
64430290|NCT02483975|Montelukast|montelukast|mesh-list
64658119|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658120|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658121|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658122|NCT02556333|Tenofovir|tenofovir|mesh-list
64658123|NCT02556333|Emtricitabine|emtricitabine|mesh-list
64658124|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
64658125|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658126|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64658127|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64658128|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658129|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658130|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64658131|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64658132|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64658133|NCT02411448|Gefitinib|gefitinib|mesh-list
64658134|NCT02411448|Osimertinib|osimertinib|mesh-list
64658135|NCT02411448|Ramucirumab|ramucirumab|mesh-list
64658136|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658137|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64658138|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658139|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658140|NCT01166126|Sirolimus|sirolimus|mesh-list
64658141|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658142|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658143|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64658144|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658145|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
64658146|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658147|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
64658148|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658149|NCT05306990|Atorvastatin|atorvastatin|mesh-list
64658150|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64658151|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64658152|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64658153|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
64658154|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658155|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64658156|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64658157|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658158|NCT02557035|Dexamethasone|dexamethasone|mesh-list
64658159|NCT02557035|Palonosetron|palonosetron|mesh-list
64658160|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64658161|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
64658162|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
64658163|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658164|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658165|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658166|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
64658167|NCT02557035|Hormones|hormones|mesh-ancestor
64658168|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658169|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658170|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658171|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64658172|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64658173|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
64658174|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658175|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658176|NCT04341207|Azithromycin|azithromycin|mesh-list
64658177|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
64658178|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658179|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658180|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
64658181|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64658182|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64658183|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658184|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658185|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658187|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
64658188|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64658189|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64658190|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658192|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64658193|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64658194|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
64658195|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658196|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
64658197|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658198|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658199|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658200|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64658202|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
64658203|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658204|NCT01167452|Trimethoprim|trimethoprim|mesh-list
64658205|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64658206|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
64658207|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64658208|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658209|NCT01167452|Renal Agents|renal agents|mesh-ancestor
64658210|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
64658211|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64658212|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64658213|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64658214|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658215|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658216|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64658217|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64658218|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64658219|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658220|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
64658221|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64658222|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658223|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658224|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64658225|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64658226|NCT02487225|Protective Agents|protective agents|mesh-ancestor
64383618|NCT02065336|Entecavir|entecavir|mesh-list
64658227|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658228|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
64658229|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64658230|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
64658231|NCT02384850|Leucovorin|leucovorin|mesh-list
64658232|NCT02384850|Folic Acid|folic acid|mesh-list
64658234|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
64658235|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
64345686|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345687|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64345688|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64345689|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64345690|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345691|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
64345692|NCT02441114|Hormones|hormones|mesh-ancestor
64658236|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
64658237|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658238|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64658239|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658240|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658241|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
64658242|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658243|NCT02384850|Antidotes|antidotes|mesh-ancestor
64658244|NCT02384850|Protective Agents|protective agents|mesh-ancestor
64658245|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
64658246|NCT02384850|Vitamins|vitamins|mesh-ancestor
64658247|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
64658248|NCT02384850|Hematinics|hematinics|mesh-ancestor
64658249|NCT02558829|Insulin|insulin|mesh-list
64658250|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64658251|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64658252|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658253|NCT02487303|Acetaminophen|acetaminophen|mesh-list
64658254|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64658255|NCT02487303|Analgesics|analgesics|mesh-ancestor
64658256|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
64658257|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658258|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658259|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
64658260|NCT01168934|Crizotinib|crizotinib|mesh-list
64658261|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658262|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64658263|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658264|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658265|NCT05305508|Mannitol|mannitol|mesh-list
64658266|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
64658267|NCT05305508|Calcium|calcium|mesh-list
64658268|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64658269|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658270|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64658271|NCT05305508|Diuretics|diuretics|mesh-ancestor
64658272|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
64658273|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
64658274|NCT05305508|Coagulants|coagulants|mesh-ancestor
64658275|NCT01170884|Timolol|timolol|mesh-list
64658276|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64658277|NCT01170884|Bimatoprost|bimatoprost|mesh-list
64658278|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64658279|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64658280|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658281|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64658282|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64658283|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
64658284|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658285|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658286|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64658287|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64658288|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64658289|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64658290|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64658291|NCT01171118|Physostigmine|physostigmine|mesh-list
64658292|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64658293|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658294|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658295|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
64658296|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658297|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345695|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
64345696|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
64345697|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345698|NCT02498444|Treprostinil|treprostinil|mesh-list
64658298|NCT01171118|Miotics|miotics|mesh-ancestor
64345699|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64658299|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
64658300|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658301|NCT03011918|Vitamin D|vitamin d|mesh-list
64345700|NCT05235256|Dexamethasone|dexamethasone|mesh-list
64658302|NCT03011918|Vitamins|vitamins|mesh-ancestor
64658303|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
64658304|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658305|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64658307|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658308|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
64658309|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64658310|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64658311|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64658312|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658313|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658314|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
64658315|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658316|NCT01136798|Exenatide|exenatide|mesh-list
64658317|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64658318|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658319|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64658320|NCT01136798|Incretins|incretins|mesh-ancestor
64658321|NCT01136798|Hormones|hormones|mesh-ancestor
64658322|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658323|NCT01172522|Fexofenadine|fexofenadine|mesh-list
64658324|NCT01172522|Terfenadine|terfenadine|mesh-list
64658325|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64658326|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64658327|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64658328|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
64658329|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
64658330|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658331|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658332|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658333|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
64658334|NCT01172600|Entonox|entonox|mesh-list
64658335|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64658336|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
64658337|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
64658338|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658339|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658340|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64658341|NCT01172600|Analgesics|analgesics|mesh-ancestor
64658342|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
64658343|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658344|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64658345|NCT02246816|Opium|opium|mesh-list
64658346|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64658347|NCT02246816|Narcotics|narcotics|mesh-ancestor
64658348|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658349|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658350|NCT02246816|Analgesics|analgesics|mesh-ancestor
64658351|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
64658352|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658353|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
64658354|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658355|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
64658356|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
64658357|NCT01137890|Zonisamide|zonisamide|mesh-list
64658358|NCT01137890|Cocaine|cocaine|mesh-list
64658359|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
64658360|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64658361|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64345704|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
64345705|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345706|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345707|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658362|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658363|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64658364|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658365|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
64658366|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
64658367|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658368|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
64658369|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658370|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64658371|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64658372|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64658373|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
64658374|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658376|NCT01138124|Analgesics|analgesics|mesh-ancestor
64658377|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
64658378|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658379|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658380|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
64658381|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64658382|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64658383|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658384|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64658385|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64658386|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64658387|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658388|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658389|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
64658390|NCT02560779|Sorafenib|sorafenib|mesh-list
64658391|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658392|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64658393|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658394|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658395|NCT01138514|Clindamycin|clindamycin|mesh-list
64658396|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
64658397|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
64658398|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64658399|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658400|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658401|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64658402|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658403|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658404|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
64658405|NCT02561481|Sulforaphane|sulforaphane|mesh-list
64658406|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64658407|NCT02561481|Protective Agents|protective agents|mesh-ancestor
64658408|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658409|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658410|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
64430425|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
64658411|NCT01173848|Vitamin D|vitamin d|mesh-list
64658412|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
64658413|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64658414|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658415|NCT01173848|Vitamins|vitamins|mesh-ancestor
64658416|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
64658417|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64658418|NCT01174082|Vaccines|vaccines|mesh-list
64658419|NCT01174082|Sargramostim|sargramostim|mesh-list
64658420|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
64345734|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64345735|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64345736|NCT04596826|Analgesics|analgesics|mesh-ancestor
64345737|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
64345738|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658421|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658422|NCT05254418|Dulaglutide|dulaglutide|mesh-list
64658423|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64658424|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658425|NCT01175798|Vitamin D|vitamin d|mesh-list
64658426|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
64658427|NCT01175798|Vitamins|vitamins|mesh-ancestor
64658428|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
64658429|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658430|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64658431|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64658432|NCT02246894|Factor VIII|factor viii|mesh-list
64658433|NCT02246894|Coagulants|coagulants|mesh-ancestor
64658434|NCT05177510|Mifepristone|mifepristone|mesh-list
64658435|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64658436|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
64658437|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64658438|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658439|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64658440|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64658441|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64658442|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
64658443|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64658444|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64658445|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
64658446|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658447|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
64658448|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64658449|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64658451|NCT03011996|Clarithromycin|clarithromycin|mesh-list
64658452|NCT03011996|Pantoprazole|pantoprazole|mesh-list
64658453|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658454|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658455|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64658456|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383822|NCT01662999|Hormones|hormones|mesh-ancestor
64658457|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658458|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64658459|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64658460|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64658461|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658462|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64658463|NCT01178216|Rituximab|rituximab|mesh-list
64658464|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658465|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658466|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
64658467|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658468|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658469|NCT01178528|Carvedilol|carvedilol|mesh-list
64658470|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64658471|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64658472|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
64658473|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658474|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658475|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658476|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64658478|NCT01178528|Protective Agents|protective agents|mesh-ancestor
64345749|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
64345750|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345751|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345752|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
64345780|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345781|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658479|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64658480|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64658481|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64658482|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
64658483|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64658484|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64658485|NCT02980250|Domperidone|domperidone|mesh-list
64658486|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
64658487|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
64658488|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658489|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658490|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658491|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64658492|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
64658493|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658494|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658495|NCT02491437|Progesterone|progesterone|mesh-list
64658496|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
64658497|NCT02491437|Progestins|progestins|mesh-ancestor
64658498|NCT02491437|Hormones|hormones|mesh-ancestor
64658499|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658500|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658501|NCT02383758|Bisacodyl|bisacodyl|mesh-list
64658502|NCT02383758|Glycerol|glycerol|mesh-list
64658503|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64658504|NCT02383758|Protective Agents|protective agents|mesh-ancestor
64658505|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658506|NCT02383758|Cathartics|cathartics|mesh-ancestor
64658507|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658508|NCT02383758|Laxatives|laxatives|mesh-ancestor
64658509|NCT02492451|Progesterone|progesterone|mesh-list
64658510|NCT02492451|Progestins|progestins|mesh-ancestor
64658511|NCT02492451|Hormones|hormones|mesh-ancestor
64658512|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658513|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658514|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64658515|NCT02410278|Montelukast|montelukast|mesh-list
64658516|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64658517|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
64658518|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64658519|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
64658520|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658521|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658522|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64658523|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64658524|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658525|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64658526|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658527|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
64658528|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
64658529|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
64658530|NCT01181258|Rituximab|rituximab|mesh-list
64658531|NCT01181258|Fludarabine|fludarabine|mesh-list
64658532|NCT01181258|Interleukin-2|interleukin-2|mesh-list
64658533|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658534|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
64658535|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658536|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658537|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64658538|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
64345786|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64345787|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
64345788|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
64345789|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430458|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345790|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658539|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658540|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658541|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64658542|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658543|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64658545|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
64658546|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658547|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658549|NCT01181258|Hormones|hormones|mesh-ancestor
64658550|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658551|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64658552|NCT01181258|Protective Agents|protective agents|mesh-ancestor
64658553|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64658554|NCT01181258|Analgesics|analgesics|mesh-ancestor
64658555|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
64658556|NCT02570139|Protective Agents|protective agents|mesh-list
64658557|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658558|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64658559|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
64658560|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658561|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
64658562|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658563|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64658564|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64658565|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
64658566|NCT02494713|Ketoconazole|ketoconazole|mesh-list
64658567|NCT02494713|Docetaxel|docetaxel|mesh-list
64658568|NCT02494713|Doxorubicin|doxorubicin|mesh-list
64658569|NCT02494713|Estramustine|estramustine|mesh-list
64658570|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658571|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
64658572|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
64658573|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
64658574|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658575|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64658576|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64658577|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64658578|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658579|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
64658580|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658581|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64658582|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64658583|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64658584|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
64658585|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658586|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658587|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64658588|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64658589|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
64658590|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658592|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64658593|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658594|NCT02382276|Nalmefene|nalmefene|mesh-list
64658595|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64658596|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658597|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
64658598|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658599|NCT02571153|Ketamine|ketamine|mesh-list
64658600|NCT02571153|Analgesics|analgesics|mesh-ancestor
64658601|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
64658602|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658603|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658604|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64658605|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64658606|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
64658607|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
64658608|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658609|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64658610|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64658611|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658612|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658613|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64658614|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
64658615|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658616|NCT04573322|Protective Agents|protective agents|mesh-ancestor
64658617|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658618|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64658619|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658620|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
64658621|NCT01143818|Testosterone|testosterone|mesh-list
64658622|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
64658623|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
64658624|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64658625|NCT01143818|Androgens|androgens|mesh-ancestor
64658626|NCT01143818|Hormones|hormones|mesh-ancestor
64658627|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658628|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658629|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658630|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658631|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
64658632|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64658633|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
64658634|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658635|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
64658636|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64658637|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64658638|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64658639|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64658640|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658641|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
64658642|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658643|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658644|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64658645|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658646|NCT01650558|Chloroquine|chloroquine|mesh-list
64658647|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64658648|NCT01650558|Amebicides|amebicides|mesh-ancestor
64658649|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64658650|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64658651|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658652|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
64658653|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658654|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64658655|NCT01650558|Renal Agents|renal agents|mesh-ancestor
64658656|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64658658|NCT02579343|Citalopram|citalopram|mesh-list
64658659|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64658660|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64658661|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64658662|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658663|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658664|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
64658665|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658666|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64658667|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
64658668|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64658669|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64658670|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64658671|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
64658672|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
64658673|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658674|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64658675|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64658676|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
64658678|NCT01144442|Carboplatin|carboplatin|mesh-list
64658679|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64658681|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
64658682|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
64658683|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
64658684|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658686|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658687|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
64658688|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658689|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658690|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64658691|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64658693|NCT02501265|Varenicline|varenicline|mesh-list
64658694|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64658695|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
64658696|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658697|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658698|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64658699|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64658700|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
64658701|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658702|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658703|NCT02408016|Aldesleukin|aldesleukin|mesh-list
64658704|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
64658705|NCT02408016|Interleukin-2|interleukin-2|mesh-list
64658706|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658707|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
64658708|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658709|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64658710|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64658711|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
64658712|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658713|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658714|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64658715|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64658716|NCT02408016|Analgesics|analgesics|mesh-ancestor
64658717|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
64658718|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658719|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64430477|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
64658720|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64658721|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
64658722|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64658723|NCT02579421|Progesterone|progesterone|mesh-list
64658724|NCT02579421|Progestins|progestins|mesh-ancestor
64658725|NCT02579421|Hormones|hormones|mesh-ancestor
64658726|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658727|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658729|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64658730|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658731|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658732|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
64658733|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658734|NCT01186250|Pioglitazone|pioglitazone|mesh-list
64345795|NCT04420624|Colchicine|colchicine|mesh-list
64345796|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
64345797|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345803|NCT04782778|Bupivacaine|bupivacaine|mesh-list
64658736|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658737|NCT01186406|Bevacizumab|bevacizumab|mesh-list
64658738|NCT01186406|Temozolomide|temozolomide|mesh-list
64658739|NCT01186406|Carmustine|carmustine|mesh-list
64658740|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658741|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658742|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64658743|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64658744|NCT01186406|Growth Substances|growth substances|mesh-ancestor
64658745|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658746|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
64658747|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64658748|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
64658749|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658750|NCT02407704|Lorazepam|lorazepam|mesh-list
64658751|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64658752|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64658753|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64384115|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64658754|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64658755|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658756|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658757|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658758|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64658759|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
64658760|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64658761|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
64658762|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
64658763|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
64658764|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658765|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658766|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64658767|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658768|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64658769|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64658770|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
64658772|NCT02581839|Dexamethasone|dexamethasone|mesh-list
64658773|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
64658774|NCT02581839|Ondansetron|ondansetron|mesh-list
64658776|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64658777|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
64658778|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
64658779|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658780|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658781|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658782|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
64658783|NCT02581839|Hormones|hormones|mesh-ancestor
64658784|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658785|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658786|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658787|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
64658788|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658789|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658790|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
64658791|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
64658792|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64658793|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
64658794|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658795|NCT02581839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64658796|NCT02581839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64345813|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
64345814|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658797|NCT02581839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658798|NCT02581839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64658799|NCT02581839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64658800|NCT02504775|Acetaminophen|acetaminophen|mesh-list
64658801|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64658802|NCT02504775|Analgesics|analgesics|mesh-ancestor
64658803|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
64658804|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658805|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658806|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
64658807|NCT02504931|Sertraline|sertraline|mesh-list
64658808|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
64658809|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64658810|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64658811|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64658812|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64658813|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658814|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658815|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
64658816|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658817|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
64658818|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64658819|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64658820|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658821|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
64658822|NCT02584725|Coagulants|coagulants|mesh-ancestor
64658824|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658825|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658826|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64658827|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658828|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64658829|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64658830|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658831|NCT01186562|Incretins|incretins|mesh-ancestor
64658832|NCT01186562|Hormones|hormones|mesh-ancestor
64658833|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658834|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64658835|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
64658836|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658837|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658838|NCT01187498|Oxybutynin|oxybutynin|mesh-list
64658839|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
64658840|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
64658841|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658842|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658843|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64658844|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64658845|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
64658846|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658847|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658848|NCT01187498|Urological Agents|urological agents|mesh-ancestor
64658849|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64658850|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
64658851|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64658852|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64658853|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64345824|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
64345825|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345826|NCT04047797|Rituximab|rituximab|mesh-list
64345827|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64345828|NCT04047797|Ixazomib|ixazomib|mesh-list
64345829|NCT04047797|Antibodies|antibodies|mesh-list
64345830|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
64345831|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64345832|NCT04047797|Glycine|glycine|mesh-list
64345833|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
64658855|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64658856|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658857|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64658858|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64658859|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64658860|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658861|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658862|NCT01149434|Everolimus|everolimus|mesh-list
64658863|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658864|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64658865|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
64658866|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658867|NCT01150760|Alvimopan|alvimopan|mesh-list
64658868|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658869|NCT01150838|Propofol|propofol|mesh-list
64658870|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64430531|NCT04171726|Edoxaban|edoxaban|mesh-list
64658871|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658872|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658873|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64658874|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
64658875|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
64658876|NCT01189292|Dexamethasone|dexamethasone|mesh-list
64658877|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64658878|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
64658879|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
64658880|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658881|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658882|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658883|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
64658884|NCT01189292|Hormones|hormones|mesh-ancestor
64658885|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658886|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658887|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658888|NCT01189370|Sorafenib|sorafenib|mesh-list
64658889|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658890|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64658891|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658892|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658893|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64658894|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64658895|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64658896|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658897|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658898|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64658899|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64658900|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658901|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
64658902|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658903|NCT03010202|Dexamethasone|dexamethasone|mesh-list
64658904|NCT03010202|Rituximab|rituximab|mesh-list
64658905|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64658906|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345834|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345835|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345836|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345837|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345838|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
64658907|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
64345839|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64658908|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658910|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64658911|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
64658912|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
64658913|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658914|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658915|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
64658916|NCT03010202|Hormones|hormones|mesh-ancestor
64658917|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658918|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658919|NCT01191320|Enclomiphene|enclomiphene|mesh-list
64658920|NCT01191320|Clomiphene|clomiphene|mesh-list
64658921|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
64658922|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64658923|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
64658924|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658925|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658926|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64658927|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
64658928|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64658929|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64658930|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64658931|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
64658932|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658933|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64430544|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658935|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658936|NCT01191398|Atropine|atropine|mesh-list
64658937|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
64658938|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64658939|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64658940|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64658941|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
64658942|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658943|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658944|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64658945|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
64658946|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
64658947|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
64658948|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64658949|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64658950|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
64658951|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64658952|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658953|NCT01191476|Propofol|propofol|mesh-list
64658954|NCT01191476|Sevoflurane|sevoflurane|mesh-list
64658955|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64658956|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64658957|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658958|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64658959|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
64658960|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
64658961|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64658962|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64658963|NCT02508207|Ivacaftor|ivacaftor|mesh-list
64658964|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64658965|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64658966|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658967|NCT02509065|Pancrelipase|pancrelipase|mesh-list
64658968|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658969|NCT01194674|Plasminogen|plasminogen|mesh-list
64658970|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64658971|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64658972|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64658973|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64658974|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
64658975|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64658976|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64658977|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64658978|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
64658979|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64658980|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658981|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64658982|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64658983|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64658984|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658985|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658987|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64658988|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64658989|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
64658990|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
64658991|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64658992|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64658993|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64658994|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
64658995|NCT01154192|Hormones|hormones|mesh-ancestor
64658996|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64658997|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64658998|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64658999|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64659000|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
64659001|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659002|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659003|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64659004|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64659005|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659006|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659007|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659008|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64659009|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64659010|NCT01195922|Sirolimus|sirolimus|mesh-list
64659011|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659012|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659013|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64659014|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659015|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
64659016|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659017|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
64659018|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659019|NCT03809780|Dexamethasone|dexamethasone|mesh-list
64659020|NCT03809780|Lenalidomide|lenalidomide|mesh-list
64659021|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659022|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
64659023|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
64659024|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659025|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659026|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659027|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
64659028|NCT03809780|Hormones|hormones|mesh-ancestor
64659029|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659030|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659031|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659032|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
64659033|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64659034|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64659035|NCT03809780|Growth Substances|growth substances|mesh-ancestor
64659036|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
64659037|NCT02512575|Prednisolone|prednisolone|mesh-list
64659038|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659039|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
64345849|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64345850|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
64345851|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659040|NCT02512575|Hormones|hormones|mesh-ancestor
64659041|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659042|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659043|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659044|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659045|NCT01199744|Zanamivir|zanamivir|mesh-list
64659046|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
64659047|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659048|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659049|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659050|NCT03702374|Antioxidants|antioxidants|mesh-list
64659051|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659052|NCT03702374|Protective Agents|protective agents|mesh-ancestor
64659053|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659054|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
64659055|NCT02512809|Isoflurane|isoflurane|mesh-list
64659056|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64659057|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659058|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659059|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64659060|NCT02512809|Analgesics|analgesics|mesh-ancestor
64659061|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
64659062|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659063|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64659064|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64659065|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64659066|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430559|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64659067|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659068|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659069|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64659070|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
64659071|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
64659072|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64659073|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64659074|NCT01202162|Sevoflurane|sevoflurane|mesh-list
64659075|NCT01202162|Desflurane|desflurane|mesh-list
64659076|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64659077|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64659078|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
64659079|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
64659080|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659081|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659082|NCT01159262|Fentanyl|fentanyl|mesh-list
64659083|NCT01159262|Midazolam|midazolam|mesh-list
64659084|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
64659085|NCT01159262|Morphine|morphine|mesh-list
64659086|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64659087|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659088|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659089|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64659090|NCT01159262|Analgesics|analgesics|mesh-ancestor
64659091|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
64659092|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659093|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64659095|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64659096|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
64659097|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659098|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345862|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345863|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345864|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
64345865|NCT02468648|Velpatasvir|velpatasvir|mesh-list
64345866|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
64659099|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64659100|NCT01159262|Narcotics|narcotics|mesh-ancestor
64659101|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64659102|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64659103|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
64659104|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
64659105|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64659106|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64659107|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64659108|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
64659109|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
64659110|NCT04378959|Lidocaine|lidocaine|mesh-list
64659111|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
64659112|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
64659113|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659114|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659115|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
64659116|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659117|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659118|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64659119|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64659120|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659121|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659122|NCT03011060|Capecitabine|capecitabine|mesh-list
64659123|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64659124|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
64659125|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659126|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659128|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
64659129|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64659130|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659131|NCT04377711|Ciclesonide|ciclesonide|mesh-list
64659132|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
64659133|NCT04377711|Hormones|hormones|mesh-ancestor
64659134|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659135|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659136|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64659137|NCT04366713|Capecitabine|capecitabine|mesh-list
64659138|NCT04366713|Loperamide|loperamide|mesh-list
64659139|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
64659140|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64659141|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
64659142|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659143|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659144|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659145|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
64659146|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659147|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659148|NCT02976441|Temozolomide|temozolomide|mesh-list
64659149|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64659150|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
64659151|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659152|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659153|NCT00363753|Aspirin|aspirin|mesh-list
64659154|NCT00363753|Clopidogrel|clopidogrel|mesh-list
64659155|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64659156|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64659157|NCT00363753|Analgesics|analgesics|mesh-ancestor
64659158|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
64659159|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659160|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659161|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659162|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659163|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64659164|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64659165|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659166|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64659167|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64659168|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659169|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
64659170|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64659171|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64659173|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
64659174|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659175|NCT02434770|Vaccines|vaccines|mesh-list
64659176|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
64659177|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659178|NCT01203644|Bupivacaine|bupivacaine|mesh-list
64659179|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
64659180|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
64659181|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659182|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659183|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
64659184|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659185|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
64659186|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659187|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
64659188|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64659189|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64659190|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64659191|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64659192|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
64659193|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659194|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659195|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659196|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64659197|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
64659198|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659199|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64659200|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
64659201|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64659202|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64659203|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64659204|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
64659205|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
64659206|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64659207|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659208|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64659209|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659210|NCT00363909|Dexetimide|dexetimide|mesh-list
64659211|NCT00363909|Citalopram|citalopram|mesh-list
64659212|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64659213|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64659214|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659215|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659216|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659217|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
64659218|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659219|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64659220|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
64659221|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64659222|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64659223|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64659224|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
64659225|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
64345872|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64345873|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64345874|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659226|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659228|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64659229|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
64659230|NCT01205828|Temozolomide|temozolomide|mesh-list
64659231|NCT01205828|Veliparib|veliparib|mesh-list
64659232|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64659233|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
64659234|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659235|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659236|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64659237|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659238|NCT02515305|Clindamycin|clindamycin|mesh-list
64659239|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
64659240|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
64659241|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64659242|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659243|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659244|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64659245|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659246|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659247|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
64659248|NCT01206452|Prednisone|prednisone|mesh-list
64659249|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659250|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
64659251|NCT01206452|Hormones|hormones|mesh-ancestor
64659252|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659253|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659254|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659255|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659256|NCT01206608|Bupivacaine|bupivacaine|mesh-list
64659257|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
64659258|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
64659259|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659260|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659261|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
64659262|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659263|NCT03010436|Benralizumab|benralizumab|mesh-list
64659264|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64659265|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
64659266|NCT02432040|Atorvastatin|atorvastatin|mesh-list
64659267|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64659268|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64659269|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
64659270|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659271|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64659272|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64659273|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659274|NCT02517021|Dexamethasone|dexamethasone|mesh-list
64659275|NCT02517021|Palonosetron|palonosetron|mesh-list
64659276|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659277|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
64659278|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
64659279|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659280|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659281|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659282|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
64659284|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659285|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659286|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659287|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64659288|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64659289|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
64659290|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659291|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659292|NCT02431806|Milnacipran|milnacipran|mesh-list
64659293|NCT02431806|Fluoxetine|fluoxetine|mesh-list
64659294|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
64659295|NCT02431806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64659296|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64659297|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659298|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659299|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659300|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
64659301|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659302|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64659303|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
64659304|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64659305|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64659306|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64659307|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659308|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64659309|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64659310|NCT02431806|Analgesics|analgesics|mesh-ancestor
64659311|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
64659312|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659313|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
64659314|NCT05159193|Carboplatin|carboplatin|mesh-list
64659315|NCT05159193|Docetaxel|docetaxel|mesh-list
64659316|NCT05159193|Doxorubicin|doxorubicin|mesh-list
64659317|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64659318|NCT05159193|Trastuzumab|trastuzumab|mesh-list
64659319|NCT05159193|Pertuzumab|pertuzumab|mesh-list
64659320|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659321|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
64659322|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659323|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659324|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64659325|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
64659326|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659327|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659328|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64659329|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
64659330|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
64659331|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
64659332|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64659333|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64659334|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64659335|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659336|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659337|NCT05220813|Lidocaine|lidocaine|mesh-list
64659338|NCT05220813|Bupivacaine|bupivacaine|mesh-list
64659339|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
64659340|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
64659341|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659342|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659343|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
64659344|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659345|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659346|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64659347|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64659348|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659349|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659351|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
64659352|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659353|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
64659354|NCT01650246|Renal Agents|renal agents|mesh-ancestor
64659355|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
64659356|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659357|NCT01212302|Clopidogrel|clopidogrel|mesh-list
64659358|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659359|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659360|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64659361|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64659362|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64659363|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64659364|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
64659365|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659366|NCT01284296|Chrysarobin|chrysarobin|mesh-list
64659367|NCT01284296|Lidocaine|lidocaine|mesh-list
64659368|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64659369|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
64659370|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659371|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659372|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
64659373|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659374|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659375|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64659376|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64659377|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659378|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659379|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64659380|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64659381|NCT01284296|Analgesics|analgesics|mesh-ancestor
64659382|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659383|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659385|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64659386|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64659387|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659388|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659389|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659390|NCT01652664|Timolol|timolol|mesh-list
64659391|NCT01652664|Travoprost|travoprost|mesh-list
64659392|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64659393|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64659394|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64659395|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64659396|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
64659397|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659398|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659399|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659400|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659401|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64659402|NCT04055649|Paclitaxel|paclitaxel|mesh-list
64659403|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64659404|NCT04055649|TIC10 compound|tic10 compound|mesh-list
64659405|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64659406|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659407|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
64659408|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
64659409|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
64659410|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659411|NCT04899492|Nicotine|nicotine|mesh-list
64659412|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64659413|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
64659414|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659415|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659416|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64659417|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64659418|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
64659419|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659420|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659421|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
64384806|NCT04272801|Tamoxifen|tamoxifen|mesh-list
64659422|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64659423|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430714|NCT02325739|Spartalizumab|spartalizumab|mesh-list
64659425|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64659427|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64659428|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64659429|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64659430|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659431|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659432|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
64659433|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659434|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659435|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64659436|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64659437|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659438|NCT01222832|Bacitracin|bacitracin|mesh-list
64659439|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64659440|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659441|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659442|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
64659443|NCT04298229|Diuretics|diuretics|mesh-list
64659444|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64659445|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659446|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64659447|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659448|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
64659449|NCT04297605|Paclitaxel|paclitaxel|mesh-list
64659450|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
64659451|NCT04297605|Pemetrexed|pemetrexed|mesh-list
64659452|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64659453|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659454|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
64659455|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
64659456|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
64659457|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659458|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659459|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659460|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64659461|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64659462|NCT02379390|Prednisone|prednisone|mesh-list
64659463|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
64659464|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659465|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
64659466|NCT02379390|Hormones|hormones|mesh-ancestor
64659467|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659468|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659469|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659470|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659471|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64659472|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659473|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659474|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
64659475|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64659477|NCT03904251|Daunorubicin|daunorubicin|mesh-list
64659478|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
64659479|NCT03904251|Calicheamicins|calicheamicins|mesh-list
64659480|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64659481|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
64659482|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659484|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
64345899|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345900|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345901|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345902|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
64345903|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345904|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
64345905|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345906|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345907|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64345908|NCT04240756|Amphetamine|amphetamine|mesh-list
64659485|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659486|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659487|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
64659488|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659489|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64659490|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64659491|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64659492|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659493|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659494|NCT04932915|Niclosamide|niclosamide|mesh-list
64659495|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
64659496|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64659497|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
64659498|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64659499|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659500|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
64659501|NCT01223378|Latanoprost|latanoprost|mesh-list
64659502|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64659503|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64659504|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
64659505|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64659506|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659507|NCT01224626|Linezolid|linezolid|mesh-list
64659508|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659509|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659510|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64659511|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659512|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659513|NCT03708627|Bimatoprost|bimatoprost|mesh-list
64659514|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64659515|NCT01289522|Cetuximab|cetuximab|mesh-list
64350199|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659516|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659517|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659518|NCT01226420|Alefacept|alefacept|mesh-list
64659519|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
64659520|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
64659521|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659522|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
64659523|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
64659524|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659525|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659526|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64659527|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659528|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659529|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
64659530|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64659531|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659532|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64659533|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659534|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
64659535|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64659536|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
64659537|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64659538|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345910|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345911|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
64345912|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
64345913|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345914|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
64345915|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659539|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
64659540|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
64659541|NCT00365001|Methotrexate|methotrexate|mesh-list
64659542|NCT00365001|Simvastatin|simvastatin|mesh-list
64430740|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64430741|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
64659543|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64659545|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64659546|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659547|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64659548|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
64659549|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659550|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659551|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
64659552|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659553|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64659554|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659555|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
64659556|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659557|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64659558|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64659559|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64659560|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64659561|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64659562|NCT01289912|Everolimus|everolimus|mesh-list
64659563|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659564|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659565|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
64659566|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659567|NCT03192345|Cemiplimab|cemiplimab|mesh-list
64659568|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64384954|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
64659569|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659570|NCT04246047|Dexamethasone|dexamethasone|mesh-list
64659572|NCT04246047|Daratumumab|daratumumab|mesh-list
64659573|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659574|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
64659575|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
64659576|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659577|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659578|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659579|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
64659580|NCT04246047|Hormones|hormones|mesh-ancestor
64659581|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659582|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659583|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659584|NCT04250805|Lidocaine|lidocaine|mesh-list
64659585|NCT04250805|Ropivacaine|ropivacaine|mesh-list
64659586|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
64659587|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
64659588|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659589|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659590|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
64659591|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659592|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659593|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64659594|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64659595|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64345963|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345964|NCT02532257|Rituximab|rituximab|mesh-list
64345965|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64345966|NCT02532257|Lenalidomide|lenalidomide|mesh-list
64345967|NCT02532257|Antibodies|antibodies|mesh-list
64345968|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
64345969|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64659596|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659597|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
64659599|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659600|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659601|NCT01227434|Palbociclib|palbociclib|mesh-list
64659602|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659603|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64659604|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659605|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659606|NCT01714739|Nivolumab|nivolumab|mesh-list
64659607|NCT01714739|Ipilimumab|ipilimumab|mesh-list
64659608|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
64659609|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659610|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659611|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64659612|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659613|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
64659614|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659615|NCT05440383|Leuprolide|leuprolide|mesh-list
64659616|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64659617|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
64659618|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64659619|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659620|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659621|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659622|NCT02377479|Letrozole|letrozole|mesh-list
64659623|NCT02377479|Clomiphene|clomiphene|mesh-list
64659624|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659625|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64659626|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64659627|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659628|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659629|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64659630|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
64659631|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659632|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659633|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64659634|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
64659635|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64659636|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64659637|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64659638|NCT01291784|Antibodies|antibodies|mesh-list
64659639|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64659640|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
64659641|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659642|NCT04205409|Nivolumab|nivolumab|mesh-list
64385060|NCT05488899|Iodine|iodine|mesh-list
64659643|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659644|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659645|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64659646|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659647|NCT00609791|Paclitaxel|paclitaxel|mesh-list
64345975|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64345985|NCT03386721|Antibodies|antibodies|mesh-list
64345986|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
64345987|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345988|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64345989|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
64345990|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345991|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345992|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
64659648|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64659649|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64659650|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659651|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
64659652|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
64659653|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
64659654|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659655|NCT05457959|Poly I-C|poly i-c|mesh-list
64659656|NCT05457959|Nivolumab|nivolumab|mesh-list
64659657|NCT05457959|Ipilimumab|ipilimumab|mesh-list
64659658|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64659659|NCT05457959|Vaccines|vaccines|mesh-list
64659660|NCT05457959|Poly ICLC|poly iclc|mesh-list
64659661|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
64659662|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659663|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659664|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659665|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64659666|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659667|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
64659668|NCT05457959|Laxatives|laxatives|mesh-ancestor
64659669|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659670|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
64659671|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659672|NCT05457647|Riboflavin|riboflavin|mesh-list
64659673|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
64659674|NCT05457647|Vitamins|vitamins|mesh-ancestor
64659675|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
64659676|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659677|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64659678|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
64659679|NCT05455697|Prednisone|prednisone|mesh-list
64659680|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
64659681|NCT05455697|Rituximab|rituximab|mesh-list
64659682|NCT05455697|Doxorubicin|doxorubicin|mesh-list
64659683|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64659684|NCT05455697|Vincristine|vincristine|mesh-list
64659685|NCT05455697|Daunorubicin|daunorubicin|mesh-list
64659686|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
64659687|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659688|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
64659689|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659690|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659691|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64659692|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
64659693|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659694|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659695|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64659696|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659697|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64659698|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64659699|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64659700|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659701|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659702|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
64659703|NCT05455697|Hormones|hormones|mesh-ancestor
64659704|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659705|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659706|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64659707|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
64659708|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
64659709|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
64345993|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345994|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346003|NCT02246218|Glycerol|glycerol|mesh-list
64659711|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64659712|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64659713|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
64659714|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659715|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64659716|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64659717|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659718|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659719|NCT05439629|Ranibizumab|ranibizumab|mesh-list
64659720|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64659721|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64659722|NCT05439629|Growth Substances|growth substances|mesh-ancestor
64659723|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659724|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
64659725|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659726|NCT01229228|Naproxen|naproxen|mesh-list
64659727|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64659728|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64659729|NCT01229228|Analgesics|analgesics|mesh-ancestor
64659730|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
64659731|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659732|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659733|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659734|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659735|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
64659736|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64659737|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659738|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659739|NCT01292252|Teriparatide|teriparatide|mesh-list
64659740|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
64659741|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659742|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64659743|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64659744|NCT02192684|Pioglitazone|pioglitazone|mesh-list
64659745|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64659746|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659747|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
64659748|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64659749|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659750|NCT00003407|Cytarabine|cytarabine|mesh-list
64659751|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
64659752|NCT00003407|Amifostine|amifostine|mesh-list
64659753|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64659754|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
64659755|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659756|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659757|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
64659758|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659759|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659760|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
64659761|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659762|NCT00003407|Analgesics|analgesics|mesh-ancestor
64659763|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
64659764|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659765|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64659766|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64659767|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659768|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64346006|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346007|NCT05073939|Oxytocin|oxytocin|mesh-list
64346008|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
64346009|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64346010|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659770|NCT04838717|Doxycycline|doxycycline|mesh-list
64659771|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659772|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659773|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
64659774|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64659775|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64659776|NCT01710137|Varenicline|varenicline|mesh-list
64659777|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64659778|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64659779|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
64659780|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659781|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659782|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659783|NCT01710839|Ranibizumab|ranibizumab|mesh-list
64659784|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64659785|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64659786|NCT01710839|Growth Substances|growth substances|mesh-ancestor
64659787|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659788|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
64659789|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659790|NCT01215110|Bedaquiline|bedaquiline|mesh-list
64659791|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
64659792|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659793|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659794|NCT02980757|Gliclazide|gliclazide|mesh-list
64659795|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64659796|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659798|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64659799|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64659800|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64659801|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64659802|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64659803|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
64659804|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659805|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659806|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659807|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659808|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64659809|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64659810|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64659811|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64659812|NCT01292642|Nicotine|nicotine|mesh-list
64659813|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64659814|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
64659815|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659816|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659817|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64659818|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64659819|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
64659820|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659821|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659822|NCT01231334|Clindamycin|clindamycin|mesh-list
64659823|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
64659824|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
64659825|NCT01231334|Dapsone|dapsone|mesh-list
64659826|NCT01231334|Adapalene|adapalene|mesh-list
64659827|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64659828|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659829|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659830|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64659831|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659832|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659833|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
64659834|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64659835|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64659836|NCT01231334|Analgesics|analgesics|mesh-ancestor
64659837|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
64659838|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659839|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659840|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659841|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659842|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
64659843|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64659844|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64659845|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64659846|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
64659847|NCT04771481|Metoclopramide|metoclopramide|mesh-list
64659848|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
64659849|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
64659850|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659851|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659852|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659853|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64659854|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64659855|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
64659856|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659857|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659858|NCT01292798|Ranibizumab|ranibizumab|mesh-list
64659859|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64659860|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64659861|NCT01292798|Growth Substances|growth substances|mesh-ancestor
64659862|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659863|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
64659864|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659865|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
64659866|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64659867|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64659868|NCT03009500|Prednisolone|prednisolone|mesh-list
64659869|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
64659870|NCT03009500|Lidocaine|lidocaine|mesh-list
64385246|NCT05481645|Paclitaxel|paclitaxel|mesh-list
64659871|NCT03009500|Bupivacaine|bupivacaine|mesh-list
64659872|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64659873|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
64659874|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
64659875|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
64659876|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64659877|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659878|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
64659879|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659880|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659881|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64659882|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64659883|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659884|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659885|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659886|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
64659887|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
64659888|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659889|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
64659890|NCT03009500|Hormones|hormones|mesh-ancestor
64659891|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659892|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64659893|NCT03009500|Protective Agents|protective agents|mesh-ancestor
64659894|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659895|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659896|NCT03901469|Talazoparib|talazoparib|mesh-list
64659897|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64659898|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659899|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659900|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659901|NCT01715207|Atenolol|atenolol|mesh-list
64659902|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64659903|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64659905|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
64659906|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659907|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659908|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64659909|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64659911|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
64659912|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659913|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659914|NCT01716221|Dexetimide|dexetimide|mesh-list
64659915|NCT01716221|Bupropion|bupropion|mesh-list
64659916|NCT01716221|Citalopram|citalopram|mesh-list
64659917|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64659918|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
64659919|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64659920|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64659921|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64659922|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64659923|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659924|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
64659925|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64659926|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659927|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64659928|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64659929|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659930|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64659931|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
64659932|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64659933|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64659934|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
64659935|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
64659936|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659937|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64659938|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64659939|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
64659940|NCT01215344|Diphosphonates|diphosphonates|mesh-list
64659941|NCT01215344|Dexamethasone|dexamethasone|mesh-list
64659942|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
64659943|NCT01215344|Doxorubicin|doxorubicin|mesh-list
64659944|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64659945|NCT01215344|Lenalidomide|lenalidomide|mesh-list
64659946|NCT01215344|Bortezomib|bortezomib|mesh-list
64659947|NCT01215344|BB 1101|bb 1101|mesh-list
64659948|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64659949|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
64659950|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
64659951|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64659952|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659953|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659954|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
64659955|NCT01215344|Hormones|hormones|mesh-ancestor
64659956|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64659957|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64659958|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659959|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
64659960|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659961|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659962|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64346019|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
64346020|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
64346021|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346022|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346023|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64346024|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64346025|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64659963|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64659964|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64659965|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
64659966|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64659968|NCT01215344|Growth Substances|growth substances|mesh-ancestor
64659969|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
64659970|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64659971|NCT01231412|Cyclosporine|cyclosporine|mesh-list
64659972|NCT01231412|Sirolimus|sirolimus|mesh-list
64659973|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
64659974|NCT01231412|Fludarabine|fludarabine|mesh-list
64659975|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
64659976|NCT01231412|Cyclosporins|cyclosporins|mesh-list
64659977|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64659978|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64659979|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
64659980|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64659981|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64659982|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
64659983|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64659984|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64659985|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
64659986|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64659987|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
64659988|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64659989|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64659990|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64659991|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64659992|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
64659993|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64659994|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64659995|NCT01719653|Laxatives|laxatives|mesh-ancestor
64659996|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64659997|NCT04580771|Cisplatin|cisplatin|mesh-list
64659998|NCT04580771|Vaccines|vaccines|mesh-list
64659999|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
64660000|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660001|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660002|NCT01720277|Vaccines|vaccines|mesh-list
64660003|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
64660004|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660005|NCT04514393|Methotrexate|methotrexate|mesh-list
64660006|NCT04514393|Temozolomide|temozolomide|mesh-list
64660007|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64660008|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
64660009|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64660010|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660011|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64660012|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
64660013|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660014|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660015|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
64660016|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660017|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64660018|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64660019|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
64660020|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660021|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64660022|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64346028|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64346029|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64346030|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64346031|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346032|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346033|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
64346034|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
64346035|NCT01023737|Vorinostat|vorinostat|mesh-list
64660023|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
64430906|NCT02497469|Adalimumab|adalimumab|mesh-list
64660024|NCT01232504|Molgramostim|molgramostim|mesh-list
64660025|NCT01232504|Lenograstim|lenograstim|mesh-list
64660026|NCT01232504|Sargramostim|sargramostim|mesh-list
64660027|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64660028|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
64660029|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660030|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660031|NCT01737593|Acetaminophen|acetaminophen|mesh-list
64660032|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660033|NCT01737593|Analgesics|analgesics|mesh-ancestor
64660034|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
64660035|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660036|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660037|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
64660038|NCT01217840|Vitamin D|vitamin d|mesh-list
64660039|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
64660040|NCT01217840|Vitamins|vitamins|mesh-ancestor
64660041|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
64660042|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660043|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64660044|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64660045|NCT01721603|Trametinib|trametinib|mesh-list
64660046|NCT01721603|Dabrafenib|dabrafenib|mesh-list
64660047|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660048|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64660049|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660050|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660051|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
64660052|NCT01296542|Besifloxacin|besifloxacin|mesh-list
64660053|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64660054|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660055|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64660056|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660057|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660058|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660059|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660060|NCT01234766|Rituximab|rituximab|mesh-list
64660061|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64660062|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64660063|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660064|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
64660065|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660066|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660067|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64660068|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
64660069|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660070|NCT01234922|Losartan|losartan|mesh-list
64660071|NCT01234922|Ramipril|ramipril|mesh-list
64660072|NCT01234922|Lisinopril|lisinopril|mesh-list
64660073|NCT01234922|Benazepril|benazepril|mesh-list
64660074|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64660075|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64660076|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64660077|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64660078|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660079|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64660080|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
64660081|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660082|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64660083|NCT01234922|Protective Agents|protective agents|mesh-ancestor
64346037|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64346038|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64346039|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346058|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660084|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660085|NCT01337336|Fluticasone|fluticasone|mesh-list
64660086|NCT01337336|Xhance|xhance|mesh-list
64660087|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
64660088|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64430912|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64430913|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64660089|NCT01337336|Ipratropium|ipratropium|mesh-list
64660090|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64660091|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660092|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64660093|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
64660094|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660095|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660096|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64660097|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
64660098|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
64660099|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64660100|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
64660101|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
64660102|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660103|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660104|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64660105|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64660106|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64660107|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
64660109|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
64660110|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
64660111|NCT01242644|Ketorolac|ketorolac|mesh-list
64660112|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64660113|NCT01242644|Morphine|morphine|mesh-list
64660114|NCT01242644|Ropivacaine|ropivacaine|mesh-list
64660115|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64660116|NCT01242644|Narcotics|narcotics|mesh-ancestor
64660117|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660118|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660119|NCT01242644|Analgesics|analgesics|mesh-ancestor
64660120|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
64660121|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660122|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
64660123|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
64660124|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64660125|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660126|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660127|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660128|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64660129|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660131|NCT01303406|Idebenone|idebenone|mesh-list
64660132|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
64660133|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660134|NCT01303406|Protective Agents|protective agents|mesh-ancestor
64660135|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660136|NCT03619707|Progesterone|progesterone|mesh-list
64660137|NCT03619707|Progestins|progestins|mesh-ancestor
64660138|NCT03619707|Hormones|hormones|mesh-ancestor
64660139|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64660140|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660141|NCT02597907|Aprepitant|aprepitant|mesh-list
64660142|NCT02597907|Palonosetron|palonosetron|mesh-list
64660143|NCT02597907|Ramosetron|ramosetron|mesh-list
64660144|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
64660145|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
64660146|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660147|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660148|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64660149|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64660150|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660151|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660152|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64660154|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
64660155|NCT02600325|Grazoprevir|grazoprevir|mesh-list
64660156|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64660157|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
64660158|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660159|NCT02600715|Morphine|morphine|mesh-list
64660160|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64660161|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64660162|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64660163|NCT02600715|Narcotics|narcotics|mesh-ancestor
64660164|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660165|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660166|NCT02600715|Analgesics|analgesics|mesh-ancestor
64660167|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
64660168|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660169|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64660170|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64660171|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64660172|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385554|NCT02723955|Pemetrexed|pemetrexed|mesh-list
64660173|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
64660174|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660175|NCT04743297|Dinoprostone|dinoprostone|mesh-list
64660176|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
64660177|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64660178|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660179|NCT04180371|Nivolumab|nivolumab|mesh-list
64660180|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64660181|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660182|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64660183|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660184|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
64660185|NCT04176783|Narcotics|narcotics|mesh-ancestor
64660186|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660187|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660188|NCT04176783|Analgesics|analgesics|mesh-ancestor
64660189|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
64660190|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660191|NCT00365313|Celecoxib|celecoxib|mesh-list
64660192|NCT00365313|Esomeprazole|esomeprazole|mesh-list
64660193|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64660194|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660195|NCT00365313|Analgesics|analgesics|mesh-ancestor
64660196|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
64660197|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660198|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660199|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346064|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64346065|NCT02243176|Saxagliptin|saxagliptin|mesh-list
64346066|NCT02243176|Acarbose|acarbose|mesh-list
64346067|NCT02243176|Incretins|incretins|mesh-ancestor
64346068|NCT02243176|Hormones|hormones|mesh-ancestor
64346069|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346070|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346071|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64346072|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
64660200|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660201|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64660202|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64660203|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430951|NCT02366143|Paclitaxel|paclitaxel|mesh-list
64660204|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660205|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64660206|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64660207|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64660209|NCT03113487|Vaccines|vaccines|mesh-list
64660210|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
64660211|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660212|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64660213|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660214|NCT02605395|Rabeprazole|rabeprazole|mesh-list
64660215|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64660216|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64660217|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64660218|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660219|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660220|NCT04166721|Atezolizumab|atezolizumab|mesh-list
64660221|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660222|NCT04343001|Aspirin|aspirin|mesh-list
64660223|NCT04343001|Losartan|losartan|mesh-list
64660224|NCT04343001|Simvastatin|simvastatin|mesh-list
64660225|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64660226|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660227|NCT04343001|Analgesics|analgesics|mesh-ancestor
64660228|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
64660229|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660230|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660231|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660232|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660233|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64660234|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64660235|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660236|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660237|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64660238|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660239|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
64660240|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64660241|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64660242|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
64660243|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64660244|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64660245|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64660246|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64660247|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64660248|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64660249|NCT02865135|Vaccines|vaccines|mesh-list
64660250|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
64660251|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660252|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
64660253|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64660254|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64660255|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660256|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
64660257|NCT04742205|Coagulants|coagulants|mesh-ancestor
64660258|NCT04743063|Losartan|losartan|mesh-list
64660259|NCT04743063|Valsartan|valsartan|mesh-list
64660260|NCT04743063|Telmisartan|telmisartan|mesh-list
64660261|NCT04743063|Candesartan|candesartan|mesh-list
64660262|NCT04743063|Olmesartan|olmesartan|mesh-list
64660263|NCT04743063|Irbesartan|irbesartan|mesh-list
64660264|NCT04743063|Eprosartan|eprosartan|mesh-list
64660265|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
64660266|NCT04743063|Giapreza|giapreza|mesh-list
64660267|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64660268|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64660269|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
64660270|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64660271|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64660272|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660273|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64660274|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64660275|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64660276|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
64660277|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660278|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
64660279|NCT01739699|Acetaminophen|acetaminophen|mesh-list
64660280|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660281|NCT01739699|Analgesics|analgesics|mesh-ancestor
64660282|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
64660283|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660284|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660285|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
64660286|NCT04154787|Rituximab|rituximab|mesh-list
64660287|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64660288|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660289|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
64660290|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660291|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660292|NCT01740713|Deferiprone|deferiprone|mesh-list
64660293|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64660294|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
64660295|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
64660296|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660297|NCT02613117|Fluorides|fluorides|mesh-list
64660298|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
64346108|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64346109|NCT04534257|Sirolimus|sirolimus|mesh-list
64346110|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64346111|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346112|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64346113|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346114|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
64346115|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64346116|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
64346117|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346118|NCT03416153|Paclitaxel|paclitaxel|mesh-list
64346119|NCT03416153|Carboplatin|carboplatin|mesh-list
64346120|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64346121|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346122|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
64346123|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
64346124|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
64660299|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
64660300|NCT02613117|Protective Agents|protective agents|mesh-ancestor
64660301|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660302|NCT01742117|Clopidogrel|clopidogrel|mesh-list
64660303|NCT01742117|Ticagrelor|ticagrelor|mesh-list
64660304|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660305|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64660306|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64660307|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64660308|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
64660309|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660310|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660311|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430974|NCT02098395|Hormones|hormones|mesh-ancestor
64660312|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
64660313|NCT02613897|Saxagliptin|saxagliptin|mesh-list
64660314|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64660315|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660316|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64660317|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660318|NCT02613897|Incretins|incretins|mesh-ancestor
64660319|NCT02613897|Hormones|hormones|mesh-ancestor
64660320|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64660321|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64385704|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
64660322|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
64660323|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660324|NCT02615535|Alprostadil|alprostadil|mesh-list
64660325|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660326|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
64660327|NCT02615535|Urological Agents|urological agents|mesh-ancestor
64660328|NCT05732181|Lidocaine|lidocaine|mesh-list
64660329|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
64660330|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
64660331|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660332|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660333|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
64660334|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660335|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64660336|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64660337|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64660338|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64660339|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660340|NCT01342172|Lenalidomide|lenalidomide|mesh-list
64660341|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
64660342|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660343|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64660344|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64660345|NCT01342172|Growth Substances|growth substances|mesh-ancestor
64660346|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
64660347|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660348|NCT01243112|Lidocaine|lidocaine|mesh-list
64660349|NCT01243112|Epinephrine|epinephrine|mesh-list
64660358|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346125|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346126|NCT03522935|Elafin|elafin|mesh-list
64346127|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
64346128|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346129|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346130|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
64346134|NCT05392257|Rituximab|rituximab|mesh-list
64660359|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64660360|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64660361|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64660362|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64660363|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660364|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64660366|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
64660367|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660368|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64660369|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64660370|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
64660371|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64660372|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
64660374|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
64660375|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64660376|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
64660377|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
64660378|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64660379|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
64660380|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64660381|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660382|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64660383|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64660384|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660385|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64660386|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660387|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660388|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660389|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660390|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64660391|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64385779|NCT03142893|Ketoconazole|ketoconazole|mesh-list
64660400|NCT01743521|Ribavirin|ribavirin|mesh-list
64660401|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
64660402|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660403|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
64660404|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660405|NCT00361803|Topotecan|topotecan|mesh-list
64660406|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64660407|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660408|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660409|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660410|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660411|NCT00361881|Acyclovir|acyclovir|mesh-list
64660412|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
64660413|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
64660414|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660415|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660416|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
64660417|NCT01743677|Tofacitinib|tofacitinib|mesh-list
64660418|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64660419|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346156|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
64346157|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346158|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346159|NCT05391867|Sorafenib|sorafenib|mesh-list
64346160|NCT05391867|Lenvatinib|lenvatinib|mesh-list
64350220|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
64346161|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346162|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346163|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346165|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
64660420|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64660421|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660422|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660423|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660425|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64660426|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64660427|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
64660428|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
64660429|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660431|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
64660432|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660433|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64660434|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64660435|NCT01246076|Growth Substances|growth substances|mesh-ancestor
64660436|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
64660437|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660438|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
64660439|NCT00364455|Hematinics|hematinics|mesh-ancestor
64660440|NCT04080531|Vaccines|vaccines|mesh-list
64660441|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
64660442|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660443|NCT01307462|Fluticasone|fluticasone|mesh-list
64660444|NCT01307462|Xhance|xhance|mesh-list
64660445|NCT01307462|Azithromycin|azithromycin|mesh-list
64660446|NCT01307462|Montelukast|montelukast|mesh-list
64660447|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660448|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64660449|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
64660450|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660451|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660452|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64660453|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
64660454|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
64660455|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64660456|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64660457|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660458|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64660459|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
64660460|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64660461|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64660462|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64660463|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660464|NCT05731089|Aflibercept|aflibercept|mesh-list
64660465|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64660466|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64660467|NCT05731089|Growth Substances|growth substances|mesh-ancestor
64346168|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346169|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
64346170|NCT03110679|Protective Agents|protective agents|mesh-ancestor
64346171|NCT05391789|Urinastatin|urinastatin|mesh-list
64346172|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64346173|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64346174|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
64346175|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346176|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346177|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
64346178|NCT04699071|Lenvatinib|lenvatinib|mesh-list
64346179|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346180|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660468|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660469|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64660470|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660471|NCT05653713|Lenograstim|lenograstim|mesh-list
64660472|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64660473|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
64660474|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660475|NCT01307618|Interleukin-12|interleukin-12|mesh-list
64660476|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64660477|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
64660478|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660479|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64660480|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64660481|NCT01307618|Growth Substances|growth substances|mesh-ancestor
64660482|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
64660483|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660484|NCT01307930|Anidulafungin|anidulafungin|mesh-list
64660485|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
64660486|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660487|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64660488|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660489|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660490|NCT01746095|Vancomycin|vancomycin|mesh-list
64660491|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64660492|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660493|NCT05730777|Paclitaxel|paclitaxel|mesh-list
64660494|NCT05730777|Carboplatin|carboplatin|mesh-list
64660495|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64660496|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660497|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
64660498|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
64660499|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
64660500|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660501|NCT04425239|Leucovorin|leucovorin|mesh-list
64660502|NCT04425239|Folic Acid|folic acid|mesh-list
64660503|NCT04425239|Fluorouracil|fluorouracil|mesh-list
64660504|NCT04425239|Irinotecan|irinotecan|mesh-list
64660505|NCT04425239|Panitumumab|panitumumab|mesh-list
64660506|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
64660507|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
64660508|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660509|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64660510|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660511|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64660512|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
64660513|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346181|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346182|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346183|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346197|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
64346198|NCT03967288|Procaine|procaine|mesh-list
64346199|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
64346200|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
64346201|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346202|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346203|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
64346204|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346205|NCT04167111|Vitamin D|vitamin d|mesh-list
64346206|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
64660514|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64660515|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660516|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660517|NCT04425239|Antidotes|antidotes|mesh-ancestor
64660518|NCT04425239|Protective Agents|protective agents|mesh-ancestor
64660519|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
64660520|NCT04425239|Vitamins|vitamins|mesh-ancestor
64660521|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
64660522|NCT04425239|Hematinics|hematinics|mesh-ancestor
64660523|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64660524|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
64660525|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64660526|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64660527|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64660528|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64660529|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660530|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
64660531|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660532|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660533|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64660534|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660535|NCT00366093|Eszopiclone|eszopiclone|mesh-list
64660536|NCT00366093|Zopiclone|zopiclone|mesh-list
64660537|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64660538|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660539|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660540|NCT04379999|Aspirin|aspirin|mesh-list
64660541|NCT04379999|Atorvastatin|atorvastatin|mesh-list
64660542|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64660543|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660544|NCT04379999|Analgesics|analgesics|mesh-ancestor
64660545|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
64660546|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385925|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64660547|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660548|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660549|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660550|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64660551|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64660552|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660553|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660554|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64660555|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660556|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
64660557|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64660558|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64660559|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
64660560|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64660561|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64660562|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
64660563|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64660564|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64431068|NCT01644643|Ceftazidime|ceftazidime|mesh-list
64660565|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660566|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
64660567|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64660568|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
64660569|NCT05730621|Aspirin|aspirin|mesh-list
64660570|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
64660571|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64660573|NCT05730621|Analgesics|analgesics|mesh-ancestor
64660574|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
64660575|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660576|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660577|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660578|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660579|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64660580|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64660581|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660582|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660583|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64660584|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660585|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
64660586|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64660587|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
64660588|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660589|NCT01346072|Tolvaptan|tolvaptan|mesh-list
64660590|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64660591|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660592|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
64660593|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660594|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
64660595|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64660596|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
64660597|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660598|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660599|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64660600|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
64660601|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64660602|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
64660603|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660604|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660605|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64660606|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
64660607|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
64660608|NCT04292483|Protective Agents|protective agents|mesh-ancestor
64660609|NCT05363007|Leucovorin|leucovorin|mesh-list
64660610|NCT05363007|Irinotecan|irinotecan|mesh-list
64660611|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64660612|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660613|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660614|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660615|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660616|NCT05363007|Antidotes|antidotes|mesh-ancestor
64660617|NCT05363007|Protective Agents|protective agents|mesh-ancestor
64660618|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660619|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
64660620|NCT05363007|Vitamins|vitamins|mesh-ancestor
64660621|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
64660622|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
64660623|NCT01347008|Citric Acid|citric acid|mesh-list
64484314|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660624|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
64660625|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
64660626|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64660627|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
64660628|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
64660629|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660630|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
64346207|NCT04167111|Vitamins|vitamins|mesh-ancestor
64346208|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
64346209|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346212|NCT03962062|Moxidectin|moxidectin|mesh-list
64660631|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64660632|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64660633|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660634|NCT01347008|Urological Agents|urological agents|mesh-ancestor
64660635|NCT05343429|Aspirin|aspirin|mesh-list
64660636|NCT05343429|Benzydamine|benzydamine|mesh-list
64660637|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64660638|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660639|NCT05343429|Analgesics|analgesics|mesh-ancestor
64660640|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
64660641|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660642|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660643|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660644|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660645|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64660646|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64660647|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660648|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660649|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64660650|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660651|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
64660652|NCT01310582|Sevoflurane|sevoflurane|mesh-list
64660654|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660655|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64660656|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
64660657|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
64660658|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660659|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660660|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
64660661|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64660662|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660663|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
64660664|NCT05193591|Autoantibodies|autoantibodies|mesh-list
64660665|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
64660666|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660667|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64660668|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64660669|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64660670|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660671|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660672|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64660673|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431102|NCT01864018|Dexamethasone|dexamethasone|mesh-list
64660674|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660675|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
64660676|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660677|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
64660678|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64660679|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660680|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660681|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660682|NCT05099055|Analgesics|analgesics|mesh-ancestor
64660683|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
64660684|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660685|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64660686|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64660687|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64660688|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
64660689|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660690|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660692|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
64660693|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660694|NCT05561751|Propranolol|propranolol|mesh-list
64660695|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64660696|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64660697|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
64660698|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660699|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660700|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660701|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64660702|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64660703|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
64660704|NCT05556681|Sirolimus|sirolimus|mesh-list
64660705|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64660706|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660707|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64660708|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660709|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
64660710|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64660711|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
64660712|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660713|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
64660714|NCT05081193|Testosterone|testosterone|mesh-list
64660715|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
64660716|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
64660717|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64660718|NCT05081193|Androgens|androgens|mesh-ancestor
64660719|NCT05081193|Hormones|hormones|mesh-ancestor
64660720|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431119|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
64660721|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660722|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64660723|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660724|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
64660725|NCT01349972|Cytarabine|cytarabine|mesh-list
64660726|NCT01349972|Daunorubicin|daunorubicin|mesh-list
64660727|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
64660728|NCT01349972|Alvocidib|alvocidib|mesh-list
64660729|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64660730|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
64660731|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660732|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660733|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
64660734|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660735|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64660736|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
64660737|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660738|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64660739|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64660740|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660741|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660742|NCT01349972|Analgesics|analgesics|mesh-ancestor
64660743|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
64660744|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660745|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
64660746|NCT01349972|Growth Substances|growth substances|mesh-ancestor
64660747|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346217|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64346218|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346219|NCT02239510|Linaclotide|linaclotide|mesh-list
64346220|NCT02239510|Sennosides|sennosides|mesh-list
64346221|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64346222|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
64350221|NCT03487133|Dexamethasone|dexamethasone|mesh-list
64660749|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64660750|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660751|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
64660752|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
64660753|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64660754|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64660755|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660757|NCT01248104|Coagulants|coagulants|mesh-ancestor
64660758|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
64660759|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64660760|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
64660761|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660762|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660763|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64660764|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
64660765|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64660766|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
64660767|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660768|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660769|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64660770|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
64660771|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
64660772|NCT01748045|Protective Agents|protective agents|mesh-ancestor
64660773|NCT01312766|Menotropins|menotropins|mesh-list
64660774|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64660775|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
64660776|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64660777|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660778|NCT01749215|Topiramate|topiramate|mesh-list
64660779|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
64660780|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64660781|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660782|NCT04522167|Aflibercept|aflibercept|mesh-list
64660783|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64660784|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64660785|NCT04522167|Growth Substances|growth substances|mesh-ancestor
64660786|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660787|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64660788|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660790|NCT01248416|Anastrozole|anastrozole|mesh-list
64346241|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64346242|NCT02462486|Growth Substances|growth substances|mesh-ancestor
64346243|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346244|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
64346245|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346246|NCT03521219|Apatinib|apatinib|mesh-list
64346247|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346248|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346249|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346250|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346251|NCT05318157|Emedastine|emedastine|mesh-list
64346252|NCT05318157|Budesonide|budesonide|mesh-list
64660791|NCT01248416|Hormones|hormones|mesh-list
64660792|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64660793|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64660794|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660795|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660796|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64660797|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660798|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660799|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64660800|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
64660801|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64660802|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
64660803|NCT01749293|Busulfan|busulfan|mesh-list
64660804|NCT01749293|Fludarabine|fludarabine|mesh-list
64660805|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64660806|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
64660807|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660808|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660809|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64660810|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
64660811|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660812|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660813|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64660814|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
64660815|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64660816|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64660817|NCT01250210|Estradiol|estradiol|mesh-list
64660818|NCT01250210|Estrogens|estrogens|mesh-ancestor
64660819|NCT01250210|Hormones|hormones|mesh-ancestor
64660820|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64660821|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660822|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64660823|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
64660824|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64660825|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64660826|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64660827|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64660828|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64660829|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64660830|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
64660831|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
64660832|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64660833|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660834|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64660835|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64660836|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660837|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660838|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660839|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64660840|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64660841|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64660842|NCT01749605|Renal Agents|renal agents|mesh-ancestor
64346253|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64346254|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64346255|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346256|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64346257|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
64346258|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346259|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346296|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346297|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64660849|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660850|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64660852|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64660853|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
64660854|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660855|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660856|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64660857|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
64660859|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64660860|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64660861|NCT01750931|Analgesics|analgesics|mesh-ancestor
64660862|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
64660863|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660864|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660865|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64660866|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64660867|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64660868|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64660869|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660870|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660871|NCT01731041|Ticagrelor|ticagrelor|mesh-list
64660872|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660873|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64660874|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64660875|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64660876|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
64660877|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660878|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660879|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660880|NCT04486833|Osimertinib|osimertinib|mesh-list
64346301|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64346302|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346303|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
64346304|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346305|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346306|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
64346307|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64346308|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64346309|NCT02294357|Growth Substances|growth substances|mesh-ancestor
64346310|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
64346311|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64660881|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660882|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64660883|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660884|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660885|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64660886|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660887|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660888|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660889|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64660891|NCT01752413|Hematinics|hematinics|mesh-ancestor
64660892|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64660893|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64660894|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64660895|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660896|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660897|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64660898|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64660899|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64660900|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64660901|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
64660902|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660903|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660904|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64660905|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64660906|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
64660907|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64660908|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64660909|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
64660910|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
64660911|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660912|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
64660913|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660914|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660915|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64660916|NCT01732445|Danazol|danazol|mesh-list
64660917|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64660918|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64660919|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
64660920|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386370|NCT03114215|Biotin|biotin|mesh-list
64660921|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660922|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64660923|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660924|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660925|NCT01250834|Dulaglutide|dulaglutide|mesh-list
64660926|NCT01250834|Atorvastatin|atorvastatin|mesh-list
64660927|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64660928|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64346312|NCT02294357|Protective Agents|protective agents|mesh-ancestor
64346313|NCT03880539|Vancomycin|vancomycin|mesh-list
64346314|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64346315|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346316|NCT02291705|Tramadol|tramadol|mesh-list
64346318|NCT02291705|Narcotics|narcotics|mesh-ancestor
64346319|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346320|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346321|NCT02291705|Analgesics|analgesics|mesh-ancestor
64346322|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
64346323|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346324|NCT03518021|Naloxone|naloxone|mesh-list
64346325|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64660930|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660931|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64660932|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64660933|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660934|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64660935|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660936|NCT04387695|Sorafenib|sorafenib|mesh-list
64660937|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64660938|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64660939|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660940|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660941|NCT01354652|Lamivudine|lamivudine|mesh-list
64660942|NCT01354652|Entecavir|entecavir|mesh-list
64660943|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64660944|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64660945|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660946|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660947|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
64660948|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64660949|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64660950|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64660951|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
64660952|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64660953|NCT04348383|Defibrotide|defibrotide|mesh-list
64660954|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64660955|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64660956|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660957|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64660959|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64660960|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
64660961|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660962|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64660963|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
64660964|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
64660965|NCT01250990|Vitamins|vitamins|mesh-ancestor
64660966|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
64660967|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660968|NCT02990975|Ketamine|ketamine|mesh-list
64660969|NCT02990975|Analgesics|analgesics|mesh-ancestor
64660970|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
64660971|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64660972|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660973|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64660974|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64660975|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
64660976|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
64660977|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660978|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64660979|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64660980|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64660981|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660982|NCT01315574|Travoprost|travoprost|mesh-list
64660983|NCT01315574|Latanoprost|latanoprost|mesh-list
64660984|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64660985|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64660986|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64660987|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
64660988|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
64660989|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64660990|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64660991|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64660992|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
64660993|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64660994|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64660995|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660997|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64660998|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64660999|NCT01754909|Enalapril|enalapril|mesh-list
64661000|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64661001|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
64661002|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661003|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661004|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64661005|NCT04375527|Nivolumab|nivolumab|mesh-list
64661006|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64661007|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661008|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64661009|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661010|NCT04297995|Carboplatin|carboplatin|mesh-list
64661011|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661012|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
64661013|NCT04340349|Bromhexine|bromhexine|mesh-list
64661014|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
64661015|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64661016|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64661017|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661018|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661019|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661020|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661021|NCT04340349|Expectorants|expectorants|mesh-ancestor
64661022|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
64661023|NCT04268771|Rituximab|rituximab|mesh-list
64661024|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64661025|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661026|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
64661027|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661028|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661029|NCT04267809|Vitamin D|vitamin d|mesh-list
64661030|NCT04267809|Metformin|metformin|mesh-list
64661031|NCT04267809|Calcium|calcium|mesh-list
64661032|NCT04267809|Vitamins|vitamins|mesh-ancestor
64661033|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
64661034|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661035|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64661036|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64661037|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64661038|NCT02242409|Gemcitabine|gemcitabine|mesh-list
64661039|NCT02242409|Paclitaxel|paclitaxel|mesh-list
64661040|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64661041|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64661042|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661043|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
64661044|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
64661045|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
64661046|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661047|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64661048|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
64661049|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
64661050|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661051|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661052|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64661053|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
64661054|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661055|NCT00366873|Calcium|calcium|mesh-list
64661056|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64661057|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661058|NCT05317325|Vaccines|vaccines|mesh-list
64661059|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
64661060|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661061|NCT04182399|Zonisamide|zonisamide|mesh-list
64661062|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
64661063|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64661064|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661065|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661066|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64661067|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661068|NCT04246619|Pregabalin|pregabalin|mesh-list
64661069|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64661070|NCT04246619|Analgesics|analgesics|mesh-ancestor
64661071|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
64661072|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661073|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661074|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
64661075|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64661076|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661077|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661078|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64661079|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64661080|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64661081|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661082|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661083|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64661084|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64661085|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661086|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
64661087|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
64661089|NCT01757561|Sevoflurane|sevoflurane|mesh-list
64661090|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64661091|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661092|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661093|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64661094|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
64661095|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
64661096|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64661097|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64661098|NCT02618187|Vancomycin|vancomycin|mesh-list
64661099|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64661100|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661101|NCT05316857|Itraconazole|itraconazole|mesh-list
64661102|NCT05316857|Rifampin|rifampin|mesh-list
64661103|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
64661104|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661105|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64661106|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64661107|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661108|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661109|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64661110|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
64661111|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661112|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661113|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64661114|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64661115|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
64661116|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64661117|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
64661118|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64661119|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64661120|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64661121|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64661122|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64661123|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64661124|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64661125|NCT01759277|Anesthetics|anesthetics|mesh-list
64661126|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
64661127|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661128|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661129|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
64661130|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661131|NCT02618343|Ondansetron|ondansetron|mesh-list
64661132|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
64661133|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
64661134|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661135|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661136|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64661137|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
64661138|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
64661139|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64661140|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
64661141|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661142|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661143|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64661145|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661146|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661147|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64661148|NCT02991053|Ketamine|ketamine|mesh-list
64661149|NCT02991053|Analgesics|analgesics|mesh-ancestor
64661150|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
64661151|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661152|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661153|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64661154|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64661155|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
64661156|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
64661157|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661158|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64661159|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64661160|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661161|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661162|NCT01251536|Cetuximab|cetuximab|mesh-list
64661163|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64661164|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661166|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
64661167|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
64661168|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661169|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661170|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
64661171|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661172|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64661173|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64661174|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64661175|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661176|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661177|NCT01355588|Ketorolac|ketorolac|mesh-list
64661178|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64661179|NCT01355588|Lidocaine|lidocaine|mesh-list
64661180|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
64661181|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
64661182|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661183|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661184|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
64346339|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64346340|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
64346341|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346342|NCT02294591|Protective Agents|protective agents|mesh-ancestor
64346343|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661185|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661186|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64661187|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64661188|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64661189|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661190|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661191|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64661192|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64661193|NCT01355588|Analgesics|analgesics|mesh-ancestor
64661194|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64661195|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661196|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64661197|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661198|NCT02621619|Acetaminophen|acetaminophen|mesh-list
64661199|NCT02621619|Hydromorphone|hydromorphone|mesh-list
64661200|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64661201|NCT02621619|Analgesics|analgesics|mesh-ancestor
64661202|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
64661203|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661204|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661205|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
64661206|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64661207|NCT02621619|Narcotics|narcotics|mesh-ancestor
64661208|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661209|NCT01253642|Docetaxel|docetaxel|mesh-list
64661210|NCT01253642|Phenelzine|phenelzine|mesh-list
64661211|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661212|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
64661213|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
64661214|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
64661215|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661216|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
64661217|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661218|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64661219|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661221|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64661222|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64661223|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661224|NCT01357148|Incretins|incretins|mesh-ancestor
64661225|NCT01357148|Hormones|hormones|mesh-ancestor
64431381|NCT02317627|Belumosudil|belumosudil|mesh-list
64661226|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661227|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64661228|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
64661229|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661230|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661231|NCT02623803|Lidocaine|lidocaine|mesh-list
64661232|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
64661233|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
64661234|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661235|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661236|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
64661237|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661238|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64661239|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64346347|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346348|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64346349|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
64346350|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346351|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346352|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64346353|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
64346354|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
64346357|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64661240|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64661241|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661242|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661243|NCT02322788|Terbutaline|terbutaline|mesh-list
64661244|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64661245|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
64661246|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661247|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661248|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64661249|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
64661250|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
64661251|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
64661252|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64661253|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64661254|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64661255|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64661256|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
64661257|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661258|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661259|NCT02625207|Maraviroc|maraviroc|mesh-list
64661260|NCT02625207|Darunavir|darunavir|mesh-list
64661261|NCT02625207|Cobicistat|cobicistat|mesh-list
64661262|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64661263|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64661264|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64661265|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661266|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64661267|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64661268|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
64661269|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661270|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64661271|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64661272|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64661273|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
64661274|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661275|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64661276|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64661277|NCT05315999|Palonosetron|palonosetron|mesh-list
64661278|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
64661279|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
64431392|NCT02473913|Silymarin|silymarin|mesh-list
64661280|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346358|NCT03520985|Dexamethasone|dexamethasone|mesh-list
64346359|NCT03520985|Pomalidomide|pomalidomide|mesh-list
64346360|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346361|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
64346362|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
64346363|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346364|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346365|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64346366|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
64346367|NCT03520985|Hormones|hormones|mesh-ancestor
64346382|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64346383|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64346384|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
64346385|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
64346386|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346387|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661282|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64661283|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64661284|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64661285|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
64661286|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661287|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661289|NCT01763645|Bevacizumab|bevacizumab|mesh-list
64661290|NCT01763645|Carboplatin|carboplatin|mesh-list
64661291|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64661292|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661293|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
64661294|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
64661295|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
64661296|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661297|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64661298|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64661299|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64661300|NCT01763645|Growth Substances|growth substances|mesh-ancestor
64661301|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661302|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
64661303|NCT02253173|Estradiol|estradiol|mesh-list
64661304|NCT02253173|Estrogens|estrogens|mesh-ancestor
64661305|NCT02253173|Hormones|hormones|mesh-ancestor
64661306|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661307|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661308|NCT03924791|Dexamethasone|dexamethasone|mesh-list
64661309|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
64661310|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64661311|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64661312|NCT03924791|Prednisolone|prednisolone|mesh-list
64661313|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
64661314|NCT03924791|Lidocaine|lidocaine|mesh-list
64661315|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64661316|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
64661317|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64661318|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
64661319|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
64661320|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661321|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661322|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64661323|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
64661324|NCT03924791|Hormones|hormones|mesh-ancestor
64661325|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661326|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64661327|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661328|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
64661329|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
64661330|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661331|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
64661332|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64661333|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64661334|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64661335|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661336|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661337|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64661338|NCT03924791|Protective Agents|protective agents|mesh-ancestor
64661339|NCT01318694|Ribavirin|ribavirin|mesh-list
64661340|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64661341|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
64661342|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661343|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
64661344|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661345|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64661347|NCT01361048|Metronidazole|metronidazole|mesh-list
64661348|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661349|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64661350|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64661351|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64661352|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
64661353|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
64661354|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661355|NCT01766219|Protective Agents|protective agents|mesh-ancestor
64661356|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661357|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
64661358|NCT01766219|Vitamins|vitamins|mesh-ancestor
64661360|NCT01767155|Doxorubicin|doxorubicin|mesh-list
64661361|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64661362|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64661363|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661364|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64431427|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431428|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64661365|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64661366|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661367|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661369|NCT01362686|Donepezil|donepezil|mesh-list
64661370|NCT01362686|Galantamine|galantamine|mesh-list
64661371|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64661372|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661373|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661374|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
64661375|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661376|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661377|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
64661378|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64661379|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
64661380|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661381|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64661382|NCT01362686|Protective Agents|protective agents|mesh-ancestor
64661383|NCT01322048|Propranolol|propranolol|mesh-list
64661384|NCT01322048|Clonidine|clonidine|mesh-list
64661385|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64661386|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64661387|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64661388|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661389|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661390|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661391|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64661392|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64661393|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
64661394|NCT01322048|Analgesics|analgesics|mesh-ancestor
64661395|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
64661396|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661397|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
64661398|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
64661399|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64661400|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64661401|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64661402|NCT01322360|Morphine|morphine|mesh-list
64661403|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64661404|NCT01322360|Narcotics|narcotics|mesh-ancestor
64661405|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661406|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661407|NCT01322360|Analgesics|analgesics|mesh-ancestor
64661408|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
64661409|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661410|NCT04351724|Ritonavir|ritonavir|mesh-list
64661411|NCT04351724|Lopinavir|lopinavir|mesh-list
64661412|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
64661414|NCT04351724|Remdesivir|remdesivir|mesh-list
64661415|NCT04351724|Candesartan|candesartan|mesh-list
64661416|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
64661417|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
64661418|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64661419|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64661420|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
64661421|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661422|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661423|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64661424|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64661425|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
64661426|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661427|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64661428|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64661429|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64661430|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
64661431|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64661432|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
64661433|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
64661434|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64661435|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64661436|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661437|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64661438|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64661440|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
64661441|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
64661442|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64661443|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64661444|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
64386829|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
64661445|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661446|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64661447|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64661448|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661449|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661450|NCT04351412|Fluorides|fluorides|mesh-list
64661451|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
64661452|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
64661453|NCT04351412|Protective Agents|protective agents|mesh-ancestor
64661454|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661455|NCT01364090|Interferons|interferons|mesh-list
64661456|NCT01364090|Ribavirin|ribavirin|mesh-list
64661457|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
64661458|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
64661459|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64661460|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661461|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
64661462|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661463|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
64661464|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661465|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
64661466|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661467|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
64661468|NCT03684785|Cemiplimab|cemiplimab|mesh-list
64661469|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64661470|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661471|NCT01364558|Diazepam|diazepam|mesh-list
64661472|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64661473|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
64661474|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
64661475|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
64661476|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661477|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661478|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64661479|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64661480|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661481|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64661482|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64661483|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64661484|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64661485|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661486|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64661487|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
64661488|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
64661489|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
64661490|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
64661491|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661492|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661493|NCT01323140|Testosterone|testosterone|mesh-list
64661494|NCT01323140|Androgens|androgens|mesh-ancestor
64661495|NCT01323140|Hormones|hormones|mesh-ancestor
64661496|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661497|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661498|NCT03516305|Alprazolam|alprazolam|mesh-list
64661499|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64661500|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661501|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661502|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64661503|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64661504|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661505|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
64661506|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
64661507|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661508|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661509|NCT03823287|Aflibercept|aflibercept|mesh-list
64661510|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64661511|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64661512|NCT03823287|Growth Substances|growth substances|mesh-ancestor
64661513|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661515|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661516|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
64661517|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64661518|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661519|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661520|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
64661521|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661522|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661523|NCT02626611|Omalizumab|omalizumab|mesh-list
64661524|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64661525|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64661526|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
64661527|NCT01260662|Ketamine|ketamine|mesh-list
64661528|NCT01260662|Propofol|propofol|mesh-list
64661529|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64661530|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661531|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661532|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64661533|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
64661534|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
64661535|NCT01260662|Analgesics|analgesics|mesh-ancestor
64661536|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
64661537|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661538|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64661539|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64346389|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64346390|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
64346391|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346392|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64346394|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
64661540|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64661541|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661542|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661543|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
64661544|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64661545|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64661546|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661547|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
64661548|NCT02327117|Coagulants|coagulants|mesh-ancestor
64661549|NCT01365650|Fluticasone|fluticasone|mesh-list
64661550|NCT01365650|Xhance|xhance|mesh-list
64661551|NCT01365650|Ketorolac|ketorolac|mesh-list
64661552|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64661553|NCT01365650|Phenylephrine|phenylephrine|mesh-list
64661554|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
64661555|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64661556|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64661557|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
64661558|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661559|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661560|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64661561|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
64661562|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
64661563|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64661564|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64661565|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64661566|NCT01365650|Analgesics|analgesics|mesh-ancestor
64661567|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
64661568|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661569|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64661570|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661571|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661572|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64661573|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64661574|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
64661575|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661576|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
64661577|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
64661578|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64661579|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64661580|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
64661581|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64661582|NCT01365650|Protective Agents|protective agents|mesh-ancestor
64661583|NCT01324700|Dexetimide|dexetimide|mesh-list
64661584|NCT01324700|Citalopram|citalopram|mesh-list
64661585|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64661586|NCT01324700|Serotonin|serotonin|mesh-list
64661587|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64661588|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661589|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661590|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661591|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
64661592|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661593|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64661594|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
64661595|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661596|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64661597|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64661598|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
64661599|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
64661600|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661601|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64661602|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64661603|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
64661604|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64661606|NCT04769297|Analgesics|analgesics|mesh-ancestor
64661607|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
64661608|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661609|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661610|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64661611|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64661612|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
64661614|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661615|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64661616|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64661617|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661618|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661619|NCT02631057|Warfarin|warfarin|mesh-list
64661620|NCT02631057|Dabigatran|dabigatran|mesh-list
64661621|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
64661622|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
64661623|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64661624|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
64661625|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661626|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661627|NCT02631525|Propofol|propofol|mesh-list
64661628|NCT02631525|Desflurane|desflurane|mesh-list
64661629|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64661630|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661631|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661632|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64661633|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
64661634|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
64661635|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64661636|NCT03162497|Azithromycin|azithromycin|mesh-list
64661637|NCT03162497|Doxycycline|doxycycline|mesh-list
64661638|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64661639|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661640|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
64661641|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64661642|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64661643|NCT05190315|Temozolomide|temozolomide|mesh-list
64661644|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
64661645|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64661646|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
64661647|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661648|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661650|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
64661651|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661652|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661653|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64661654|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64661655|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64661656|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661657|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661658|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64661659|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
64661660|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661661|NCT05167643|Anastrozole|anastrozole|mesh-list
64661662|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64661663|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661664|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64346404|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64346405|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346406|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
64346407|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346426|NCT03158883|Avelumab|avelumab|mesh-list
64661665|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64661666|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661667|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661669|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
64661670|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661671|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387069|NCT04688021|Cytarabine|cytarabine|mesh-list
64661673|NCT01366196|Analgesics|analgesics|mesh-ancestor
64661674|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
64661675|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661676|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661677|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
64661678|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64661679|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661680|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661681|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64661682|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64661683|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64661684|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661685|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64661686|NCT01366976|Acetaminophen|acetaminophen|mesh-list
64661687|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64661688|NCT01366976|Analgesics|analgesics|mesh-ancestor
64661689|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
64661690|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661691|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661692|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
64661693|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
64661694|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64661695|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64661696|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
64661697|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661698|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661699|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661700|NCT01777217|Urological Agents|urological agents|mesh-ancestor
64661701|NCT02251379|Fluticasone|fluticasone|mesh-list
64661702|NCT02251379|Xhance|xhance|mesh-list
64661703|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64661704|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64661706|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661707|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661708|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64661709|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
64661710|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
64661711|NCT02251379|Hormones|hormones|mesh-ancestor
64661712|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661713|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
64661714|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64661715|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
64346434|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346435|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64346436|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
64346437|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346438|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64346439|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346440|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64661716|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64661717|NCT02255357|Oxytocin|oxytocin|mesh-list
64661718|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
64661719|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64661720|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661721|NCT02255513|Methylphenidate|methylphenidate|mesh-list
64661722|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64661723|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661724|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64661725|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64661726|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64661727|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661728|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
64661729|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661730|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
64661731|NCT01778465|Salicylates|salicylates|mesh-list
64661732|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64661733|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64661734|NCT01778465|Analgesics|analgesics|mesh-ancestor
64661735|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
64661736|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661737|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661738|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64661739|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661740|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64661741|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661742|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661743|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661744|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
64661745|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
64661746|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
64661747|NCT01779167|Thalidomide|thalidomide|mesh-list
64661748|NCT01779167|Rituximab|rituximab|mesh-list
64661749|NCT01779167|Lenalidomide|lenalidomide|mesh-list
64661750|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64661751|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661752|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
64661753|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661754|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64350439|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
64661755|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64661756|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64661757|NCT01779167|Growth Substances|growth substances|mesh-ancestor
64661758|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64661759|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64661760|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
64661761|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64661764|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
64661765|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64661766|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661767|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64661768|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64661769|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64661770|NCT02251613|Epinastine|epinastine|mesh-list
64661771|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64661772|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64661773|NCT02251613|Analgesics|analgesics|mesh-ancestor
64661774|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
64661775|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661776|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661777|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346451|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346452|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346453|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64346454|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346468|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346469|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
64661778|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661779|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64661780|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64661781|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64661782|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
64661783|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
64661784|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661785|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661786|NCT02865473|Pilocarpine|pilocarpine|mesh-list
64661787|NCT02865473|Miotics|miotics|mesh-ancestor
64661788|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
64661789|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661790|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661791|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64661792|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64661793|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
64661794|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661795|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661796|NCT02850419|Doxorubicin|doxorubicin|mesh-list
64661797|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64661798|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64661799|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661800|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64661801|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64661802|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661803|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661804|NCT02841371|Edetic Acid|edetic acid|mesh-list
64661805|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
64661806|NCT02841371|Antidotes|antidotes|mesh-ancestor
64661807|NCT02841371|Protective Agents|protective agents|mesh-ancestor
64661808|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661810|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
64661811|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661812|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64661813|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
64661814|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64661815|NCT01783847|Prednisolone|prednisolone|mesh-list
64661816|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64661817|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
64661818|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64387205|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
64661819|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
64661820|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
64661822|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
64661823|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64661824|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
64661825|NCT01783847|Hormones|hormones|mesh-ancestor
64661826|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661827|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661828|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64661829|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661830|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
64661831|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
64661832|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661833|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64661834|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64661835|NCT01783847|Protective Agents|protective agents|mesh-ancestor
64661836|NCT01783847|Hematinics|hematinics|mesh-ancestor
64661837|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
64661838|NCT02620865|Leucovorin|leucovorin|mesh-list
64661839|NCT02620865|Folic Acid|folic acid|mesh-list
64661840|NCT02620865|Gemcitabine|gemcitabine|mesh-list
64661841|NCT02620865|Aldesleukin|aldesleukin|mesh-list
64661842|NCT02620865|Paclitaxel|paclitaxel|mesh-list
64661843|NCT02620865|Camptothecin|camptothecin|mesh-list
64661844|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64661845|NCT02620865|Fluorouracil|fluorouracil|mesh-list
64661846|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
64661847|NCT02620865|Irinotecan|irinotecan|mesh-list
64661848|NCT02620865|Interleukin-2|interleukin-2|mesh-list
64661849|NCT02620865|Antibodies|antibodies|mesh-list
64661850|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
64661851|NCT02620865|Sargramostim|sargramostim|mesh-list
64661852|NCT02620865|Calcium|calcium|mesh-list
64661853|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
64661854|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64661855|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661856|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
64661857|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
64661858|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
64661859|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661860|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
64661861|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661862|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64661863|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
64661864|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
64661865|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661866|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661867|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64661868|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64661869|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64661870|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64661871|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64661872|NCT02620865|Antidotes|antidotes|mesh-ancestor
64661873|NCT02620865|Protective Agents|protective agents|mesh-ancestor
64661874|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
64661875|NCT02620865|Vitamins|vitamins|mesh-ancestor
64661876|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
64661877|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64661878|NCT02620865|Analgesics|analgesics|mesh-ancestor
64661879|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
64661880|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661881|NCT02620865|Hematinics|hematinics|mesh-ancestor
64661882|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64661883|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64661884|NCT02585375|Latanoprost|latanoprost|mesh-list
64661885|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64661886|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64661887|NCT02516813|Peposertib|peposertib|mesh-list
64431574|NCT02039427|Ketorolac|ketorolac|mesh-list
64661889|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661890|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346471|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64346472|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
64346473|NCT04543227|Narcotics|narcotics|mesh-ancestor
64346474|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346475|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346476|NCT04543227|Analgesics|analgesics|mesh-ancestor
64346477|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
64346478|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346479|NCT04542993|Zinc|zinc|mesh-list
64346480|NCT04542993|Resveratrol|resveratrol|mesh-list
64346481|NCT04542993|Picolinic acid|picolinic acid|mesh-list
64346482|NCT04542993|Trace Elements|trace elements|mesh-ancestor
64346483|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
64346484|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346485|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
64346486|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346487|NCT04542993|Protective Agents|protective agents|mesh-ancestor
64661892|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64661893|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661894|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661895|NCT01786343|Decitabine|decitabine|mesh-list
64661896|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64661897|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
64661898|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661899|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661900|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661901|NCT03362775|Propofol|propofol|mesh-list
64661902|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64661903|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64661904|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661905|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64661906|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
64661907|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
64661908|NCT01786967|Fesoterodine|fesoterodine|mesh-list
64661909|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64661910|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64661911|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
64661912|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661913|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661914|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661915|NCT01786967|Urological Agents|urological agents|mesh-ancestor
64661916|NCT02392871|Trametinib|trametinib|mesh-list
64661917|NCT02392871|Dabrafenib|dabrafenib|mesh-list
64661918|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661919|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64661920|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661921|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661922|NCT02382575|Rituximab|rituximab|mesh-list
64661923|NCT02382575|Tacrolimus|tacrolimus|mesh-list
64661924|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64661925|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64661926|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661927|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
64661928|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661929|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661930|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64661931|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661932|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661933|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
64661934|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64661935|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661936|NCT01807871|Nicotine|nicotine|mesh-list
64661937|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64661938|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
64661939|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661940|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661941|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64661942|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64661943|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
64661944|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661945|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661946|NCT01091831|Dexamethasone|dexamethasone|mesh-list
64661947|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
64661948|NCT01091831|Melphalan|melphalan|mesh-list
64661949|NCT01091831|Lenalidomide|lenalidomide|mesh-list
64661950|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64661951|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
64661952|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661953|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64661954|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64661955|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
64661956|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661957|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64661958|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64661959|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64661961|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
64661962|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64661963|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64661964|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
64661966|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64661967|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64661968|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64661969|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64661970|NCT01091831|Growth Substances|growth substances|mesh-ancestor
64661971|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
64661972|NCT01263938|Atorvastatin|atorvastatin|mesh-list
64661973|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64661974|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64661975|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
64661976|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661977|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64661978|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64661979|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64661980|NCT02327741|Clopidogrel|clopidogrel|mesh-list
64661981|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64661982|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64661983|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64661984|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64661985|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
64661986|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64661987|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64661988|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661989|NCT00367185|Thalidomide|thalidomide|mesh-list
64661990|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64661991|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
64661992|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64661993|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
64346491|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
64346492|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
64346494|NCT02292173|Sorafenib|sorafenib|mesh-list
64346517|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346518|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346519|NCT02461160|Midazolam|midazolam|mesh-list
64346520|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64346521|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64346522|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346523|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346524|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64346525|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64346526|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64346527|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64346528|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
64661994|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64661995|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64661996|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64661997|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64661998|NCT00367185|Growth Substances|growth substances|mesh-ancestor
64661999|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
64662000|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662001|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64662002|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64662003|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662004|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64662005|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64662006|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662007|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662008|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
64662009|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662010|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
64662011|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64662012|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662013|NCT01267136|Acetaminophen|acetaminophen|mesh-list
64662014|NCT01267136|Tramadol|tramadol|mesh-list
64662015|NCT01267136|Codeine|codeine|mesh-list
64662016|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662017|NCT01267136|Analgesics|analgesics|mesh-ancestor
64662018|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
64662019|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662020|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662021|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
64662022|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64662023|NCT01267136|Narcotics|narcotics|mesh-ancestor
64662024|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662025|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
64662026|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662027|NCT01370564|Diuretics|diuretics|mesh-list
64662028|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
64662029|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346529|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
64346530|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
64346531|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
64346532|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346533|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346534|NCT02296073|Fentanyl|fentanyl|mesh-list
64346535|NCT02296073|Midazolam|midazolam|mesh-list
64346536|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
64346537|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64662030|NCT00367263|Ciclesonide|ciclesonide|mesh-list
64662031|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
64662032|NCT00367263|Hormones|hormones|mesh-ancestor
64414785|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662033|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662034|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662035|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64662037|NCT01267292|Methylphenidate|methylphenidate|mesh-list
64662038|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64662039|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662040|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64662041|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64662042|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662043|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662044|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
64662045|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662046|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64662047|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64662048|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662049|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64662050|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64662051|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
64662052|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64662053|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
64662054|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
64662055|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662056|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662057|NCT01371110|Midazolam|midazolam|mesh-list
64662058|NCT01371110|Ketamine|ketamine|mesh-list
64662059|NCT01371110|Analgesics|analgesics|mesh-ancestor
64662060|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
64662061|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662062|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662063|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64662064|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64662065|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
64662066|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
64662067|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662068|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64662069|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64662070|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662071|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662072|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64662073|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64662074|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64662075|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64662076|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64662077|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
64662078|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
64662079|NCT01791491|Abatacept|abatacept|mesh-list
64662080|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64662081|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662082|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662083|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662084|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
64662085|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662086|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662087|NCT00367419|Erythromycin|erythromycin|mesh-list
64662088|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
64662089|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64662090|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
64662091|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64662092|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662093|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431595|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
64662094|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64346541|NCT02296073|Analgesics|analgesics|mesh-ancestor
64662095|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662096|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662098|NCT01372202|Fluorouracil|fluorouracil|mesh-list
64662099|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
64662100|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64662101|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662102|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
64662103|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
64662104|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
64662105|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662106|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
64662107|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64662108|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662109|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
64662110|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662112|NCT01811147|Serotonin|serotonin|mesh-list
64662113|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64662114|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64662115|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64662116|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662117|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662118|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662119|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662120|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
64662121|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
64662122|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662123|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64662124|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64662125|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
64662126|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64662127|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662128|NCT01373450|Liraglutide|liraglutide|mesh-list
64662129|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64662130|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662131|NCT01373450|Incretins|incretins|mesh-ancestor
64662133|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346548|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346549|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346550|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64346551|NCT02296073|Narcotics|narcotics|mesh-ancestor
64346552|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64346553|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64346554|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
64346555|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
64346556|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64346557|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64346558|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64346559|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
64346560|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
64346561|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64346562|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64350484|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346563|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64346564|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64346566|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
64346567|NCT02293187|Vitamins|vitamins|mesh-ancestor
64662135|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662136|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662137|NCT01793285|Analgesics|analgesics|mesh-ancestor
64662138|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
64662139|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662140|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662141|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662142|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662143|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64662144|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662145|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
64662146|NCT05049525|Itraconazole|itraconazole|mesh-list
64662147|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64662148|NCT05049525|Terbinafine|terbinafine|mesh-list
64662149|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
64662150|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662151|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64662152|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64662153|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662154|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662155|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64662156|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
64662157|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662158|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662159|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64662160|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
64431599|NCT01896856|Guadecitabine|guadecitabine|mesh-list
64662161|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
64662162|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64662163|NCT02639637|Valsartan|valsartan|mesh-list
64662164|NCT02639637|Enalaprilat|enalaprilat|mesh-list
64662165|NCT02639637|Enalapril|enalapril|mesh-list
64662166|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64662167|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662168|NCT02639637|Incretins|incretins|mesh-ancestor
64662169|NCT02639637|Hormones|hormones|mesh-ancestor
64662170|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662171|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64662172|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
64662173|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662174|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662175|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64662176|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64346568|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
64346569|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346570|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64346571|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346572|NCT02296463|Vaccines|vaccines|mesh-list
64346573|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
64346574|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346575|NCT02495168|Budesonide|budesonide|mesh-list
64346576|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
64346577|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64346597|NCT03518489|Lappaconitine|lappaconitine|mesh-list
64350490|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64350492|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662177|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64662178|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64662179|NCT01332188|Cetirizine|cetirizine|mesh-list
64662180|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64662181|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64662182|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64662183|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
64662184|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
64662185|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662186|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662187|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662188|NCT01794455|Candesartan|candesartan|mesh-list
64662189|NCT01794455|Sertraline|sertraline|mesh-list
64662190|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
64662191|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64662192|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64662193|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64662194|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662195|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662196|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662197|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
64662198|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662199|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64662200|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64662201|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64662202|NCT01332500|Naproxen|naproxen|mesh-list
64662203|NCT01332500|Sumatriptan|sumatriptan|mesh-list
64662204|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662205|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662206|NCT01332500|Analgesics|analgesics|mesh-ancestor
64662207|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
64662208|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662209|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662210|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662211|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662212|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
64662213|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64662214|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662215|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662216|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64662217|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64662218|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64662219|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
64662220|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662221|NCT01812005|Rituximab|rituximab|mesh-list
64662222|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64662223|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662224|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
64662225|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662226|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662227|NCT01332578|Acetaminophen|acetaminophen|mesh-list
64662228|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
64662229|NCT01332578|Phenylephrine|phenylephrine|mesh-list
64662230|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
64662232|NCT01332578|Analgesics|analgesics|mesh-ancestor
64662233|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
64662234|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662235|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662236|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
64662237|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
64662238|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662239|NCT01332578|Protective Agents|protective agents|mesh-ancestor
64662241|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
64662242|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64662243|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
64662244|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
64662245|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
64662246|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64662247|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
64662248|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662249|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64662250|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64662251|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64662252|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662254|NCT01333592|Mitiglinide|mitiglinide|mesh-list
64662255|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64662256|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662257|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
64662258|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64662259|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662260|NCT01734161|Dexamethasone|dexamethasone|mesh-list
64662261|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662262|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
64662263|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
64662264|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662265|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662266|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64662267|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
64662268|NCT01734161|Hormones|hormones|mesh-ancestor
64662269|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662270|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64662271|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662272|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64662273|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
64662274|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662275|NCT01797575|Aspirin|aspirin|mesh-list
64662276|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
64662277|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64662278|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662279|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662280|NCT01797575|Analgesics|analgesics|mesh-ancestor
64662281|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
64662282|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346598|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64346599|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64346600|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64346601|NCT03518489|Analgesics|analgesics|mesh-ancestor
64346602|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
64346603|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346604|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662283|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662284|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662285|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662286|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64662287|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64662288|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662289|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64662290|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64662291|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662292|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
64662293|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
64662294|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662295|NCT01797575|Expectorants|expectorants|mesh-ancestor
64662296|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662297|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64662298|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
64662299|NCT01797575|Protective Agents|protective agents|mesh-ancestor
64662300|NCT01797575|Antidotes|antidotes|mesh-ancestor
64662301|NCT02641353|Thalidomide|thalidomide|mesh-list
64662302|NCT02641353|Apremilast|apremilast|mesh-list
64662303|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662304|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662305|NCT02641353|Analgesics|analgesics|mesh-ancestor
64662306|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
64662307|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662308|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662309|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662310|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662311|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64662312|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64662313|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662314|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662315|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662316|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
64662317|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
64662318|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64662319|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662320|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64662321|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64662322|NCT02641353|Growth Substances|growth substances|mesh-ancestor
64662323|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
64662324|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662325|NCT01378520|Ketoconazole|ketoconazole|mesh-list
64662326|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
64662327|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662328|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64662329|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64662330|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662331|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662332|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64662333|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
64662334|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662335|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662336|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64662337|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
64662338|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64662339|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346609|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346610|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346611|NCT02293889|Vitamin D|vitamin d|mesh-list
64346612|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
64346613|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
64662340|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662342|NCT01378988|Analgesics|analgesics|mesh-ancestor
64662343|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
64662344|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662345|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64662346|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64662347|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64662348|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662349|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662350|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662352|NCT01335620|Emtricitabine|emtricitabine|mesh-list
64662353|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
64662354|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
64662355|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662356|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64662357|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64662358|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662359|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662360|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64662361|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64662362|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64662363|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64662364|NCT01335932|Ganciclovir|ganciclovir|mesh-list
64662365|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
64662366|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
64662367|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662368|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64662369|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662370|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662371|NCT01273766|Deferasirox|deferasirox|mesh-list
64662372|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64662373|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
64662374|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
64662375|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662376|NCT02450331|Atezolizumab|atezolizumab|mesh-list
64662377|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662378|NCT01814813|Bevacizumab|bevacizumab|mesh-list
64662379|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64662380|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662381|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64662382|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64662383|NCT01814813|Growth Substances|growth substances|mesh-ancestor
64662384|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662385|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
64662386|NCT01403246|Lenalidomide|lenalidomide|mesh-list
64662387|NCT01403246|Chlorambucil|chlorambucil|mesh-list
64662388|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
64662389|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662390|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64662391|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64662392|NCT01403246|Growth Substances|growth substances|mesh-ancestor
64346624|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346625|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64346626|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346627|NCT03514667|Curcumin|curcumin|mesh-list
64346630|NCT03514667|Analgesics|analgesics|mesh-ancestor
64346638|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346639|NCT04465097|Exemestane|exemestane|mesh-list
64346640|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346641|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64346642|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64346643|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662393|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
64662395|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64662396|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
64662397|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662399|NCT01734551|Morphine|morphine|mesh-list
64662400|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64662401|NCT01734551|Narcotics|narcotics|mesh-ancestor
64662402|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662403|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662404|NCT01734551|Analgesics|analgesics|mesh-ancestor
64662405|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
64662406|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662407|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64662408|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
64662409|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
64662410|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64662411|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64662412|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64662413|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662414|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662415|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662416|NCT01404260|Gemcitabine|gemcitabine|mesh-list
64662417|NCT01404260|Carboplatin|carboplatin|mesh-list
64662418|NCT01404260|Gefitinib|gefitinib|mesh-list
64662419|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662420|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64662421|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
64662422|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662423|NCT01404260|Antiviral Agents|antiviral agents|mesh-ancestor
64662424|NCT01404260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662425|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662426|NCT01404260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662427|NCT01404260|Immunologic Factors|immunologic factors|mesh-ancestor
64662428|NCT01404260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662429|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64662431|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64662432|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64662433|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64662434|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64662435|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64662436|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662437|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64662438|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64662439|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64662440|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
64662441|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662442|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662443|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64662444|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64662445|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
64662446|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662447|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
64662448|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64662449|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
64662450|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662451|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662452|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64662453|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662454|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
64662455|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64346644|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346645|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64346646|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
64346647|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346649|NCT02493764|Linezolid|linezolid|mesh-list
64662456|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
64662457|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662458|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662460|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662461|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662462|NCT01799213|Analgesics|analgesics|mesh-ancestor
64662463|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
64662464|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662465|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662466|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662467|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662468|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64662469|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64662470|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662471|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662472|NCT01383200|Lidocaine|lidocaine|mesh-list
64662473|NCT01383200|Tetracaine|tetracaine|mesh-list
64662474|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
64662475|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
64662476|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662477|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662478|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
64662479|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662480|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64662481|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64662482|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64662483|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662484|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662485|NCT04868877|Osimertinib|osimertinib|mesh-list
64662486|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662487|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64662488|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662489|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662490|NCT05588037|Dexamethasone|dexamethasone|mesh-list
64662491|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
64662492|NCT05588037|BB 1101|bb 1101|mesh-list
64662493|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662494|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
64662495|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
64387883|NCT04372433|Azacitidine|azacitidine|mesh-list
64662496|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662497|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662498|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64662499|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
64662500|NCT05588037|Hormones|hormones|mesh-ancestor
64662501|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662502|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64662503|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662504|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
64662505|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346652|NCT02493764|Imipenem|imipenem|mesh-list
64346653|NCT02493764|Relebactam|relebactam|mesh-list
64346654|NCT02493764|Cilastatin|cilastatin|mesh-list
64346655|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64346656|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346657|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64346658|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346659|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662506|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662508|NCT02194088|Atropine|atropine|mesh-list
64662509|NCT02194088|Analgesics|analgesics|mesh-list
64662510|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662511|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662512|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
64662513|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662514|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662515|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662516|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662517|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64662518|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662519|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662520|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64662521|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64662522|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64662524|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64662525|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662526|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
64662527|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
64662528|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64662529|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64662530|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
64662531|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662532|NCT02023593|Leucovorin|leucovorin|mesh-list
64662533|NCT02023593|Fluorouracil|fluorouracil|mesh-list
64662534|NCT02023593|Irinotecan|irinotecan|mesh-list
64662535|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
64662536|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662537|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64662538|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662539|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662540|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
64662541|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662542|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64662543|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64662544|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662545|NCT02023593|Antidotes|antidotes|mesh-ancestor
64662546|NCT02023593|Protective Agents|protective agents|mesh-ancestor
64662547|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
64662548|NCT02023593|Vitamins|vitamins|mesh-ancestor
64662549|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
64662550|NCT01978431|Cocaine|cocaine|mesh-list
64662551|NCT01978431|Methylphenidate|methylphenidate|mesh-list
64662552|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64662553|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662554|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64662555|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64662556|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662557|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662558|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
64662559|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662560|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
64662561|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
64662562|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662563|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
64662564|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662565|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64662566|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
64662567|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64662568|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387961|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662569|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662570|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64662571|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662572|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64662573|NCT02685267|Prednisone|prednisone|mesh-list
64662574|NCT02685267|Docetaxel|docetaxel|mesh-list
64662575|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662576|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
64662577|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
64662578|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
64662579|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662580|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662581|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
64662582|NCT02685267|Hormones|hormones|mesh-ancestor
64662583|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662584|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662585|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64662586|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
64662587|NCT02257541|Infigratinib|infigratinib|mesh-list
64662588|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662589|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64662590|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662591|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662592|NCT01817855|AZD7624|azd7624|mesh-list
64662593|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64662594|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662595|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662596|NCT00368121|Dexamethasone|dexamethasone|mesh-list
64662597|NCT00368121|Cetuximab|cetuximab|mesh-list
64662598|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662599|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
64662600|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
64662601|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662602|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662603|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64662604|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
64662605|NCT00368121|Hormones|hormones|mesh-ancestor
64662606|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662607|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64662608|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662609|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64662610|NCT00367497|Cytarabine|cytarabine|mesh-list
64662611|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
64662612|NCT00367497|Rituximab|rituximab|mesh-list
64662613|NCT00367497|Etoposide|etoposide|mesh-list
64662614|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64662615|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662616|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
64662617|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662618|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662619|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64662620|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64662621|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64662622|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662623|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662624|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64662625|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
64662626|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
64662627|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662628|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662629|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662630|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
64662631|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
64662632|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662633|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64662634|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
64662635|NCT00367497|Hormones|hormones|mesh-ancestor
64662636|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662637|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64662638|NCT00367497|Protective Agents|protective agents|mesh-ancestor
64662639|NCT01387178|Fluticasone|fluticasone|mesh-list
64662640|NCT01387178|Xhance|xhance|mesh-list
64662641|NCT01387178|Bromides|bromides|mesh-list
64662642|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
64662643|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64662644|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662645|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64662646|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
64662647|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662648|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662649|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64662650|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662651|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
64662652|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64662653|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
64662654|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64662655|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
64662656|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662657|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662658|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64662659|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64662660|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64662661|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662662|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
64662663|NCT01805297|Aflibercept|aflibercept|mesh-list
64662664|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64662665|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64662666|NCT01805297|Growth Substances|growth substances|mesh-ancestor
64662667|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662668|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
64662669|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346687|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
64346688|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64346689|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
64346690|NCT02299115|Vigabatrin|vigabatrin|mesh-list
64346691|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64346692|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
64346693|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346694|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
64346695|NCT02299115|Hormones|hormones|mesh-ancestor
64662670|NCT01389284|Naproxen|naproxen|mesh-list
64662671|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662672|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662674|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
64662675|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662676|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662677|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662678|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662679|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
64662680|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64662681|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662682|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662683|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64662684|NCT01794143|Liraglutide|liraglutide|mesh-list
64662685|NCT01794143|Glimepiride|glimepiride|mesh-list
64662686|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64662687|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64662688|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662689|NCT01794143|Incretins|incretins|mesh-ancestor
64662690|NCT01794143|Hormones|hormones|mesh-ancestor
64662691|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662692|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
64662693|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662694|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662695|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64662696|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662697|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
64662698|NCT01547741|Paclitaxel|paclitaxel|mesh-list
64662699|NCT01547741|Docetaxel|docetaxel|mesh-list
64662700|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
64662701|NCT01547741|Doxorubicin|doxorubicin|mesh-list
64662702|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64662703|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662704|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
64662705|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
64662706|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
64662707|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662708|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662709|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
64662710|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662711|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662712|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64662713|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
64662714|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64662715|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64662716|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64662717|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64662718|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662719|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64662721|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
64662722|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662723|NCT01473368|Amoxicillin|amoxicillin|mesh-list
64350543|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350544|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
64350545|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
64350546|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350547|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
64350548|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64350549|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
64662724|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
64662725|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
64350550|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
64662726|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64662727|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64662728|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662729|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64662730|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346696|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346697|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346698|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64346699|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346700|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
64346701|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
64346703|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64662731|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662733|NCT04351490|Vitamin D|vitamin d|mesh-list
64662734|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64662735|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662736|NCT04351490|Vitamins|vitamins|mesh-ancestor
64662737|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
64662738|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64662739|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
64662740|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64662741|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64662742|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64662743|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662744|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662745|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
64662746|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662747|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662748|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64662749|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662750|NCT03008252|Caseins|caseins|mesh-list
64662751|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
64662752|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
64662753|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662754|NCT05328635|Candesartan|candesartan|mesh-list
64662755|NCT05328635|Gabapentin|gabapentin|mesh-list
64662756|NCT05328635|Analgesics|analgesics|mesh-ancestor
64662757|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
64662758|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662759|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662760|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
64662761|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64662762|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64662763|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662764|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64662765|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64662766|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64662767|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662768|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662769|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
64662770|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64662771|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64662772|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64662773|NCT01391858|Pregabalin|pregabalin|mesh-list
64662774|NCT01391858|Analgesics|analgesics|mesh-ancestor
64662775|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
64662776|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662777|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662778|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
64662779|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64662780|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64662781|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662782|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64662783|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64662784|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64662785|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662786|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64662787|NCT05587257|Minoxidil|minoxidil|mesh-list
64662788|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64662789|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
64662790|NCT01825655|Cetirizine|cetirizine|mesh-list
64662791|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64662792|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64662793|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64388183|NCT02351687|Renal Agents|renal agents|mesh-ancestor
64662795|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
64662796|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662797|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662798|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662799|NCT02249663|Fluticasone|fluticasone|mesh-list
64662800|NCT02249663|Xhance|xhance|mesh-list
64662801|NCT02249663|Azelastine|azelastine|mesh-list
64662802|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662803|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64662804|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
64662805|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662806|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662807|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64662808|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662809|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
64662810|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64662811|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64662812|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662813|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662814|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64662815|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64662816|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
64662817|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
64662818|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662819|NCT04237623|Sargramostim|sargramostim|mesh-list
64662820|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
64662821|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662822|NCT01825889|Evacetrapib|evacetrapib|mesh-list
64662823|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64662824|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64662825|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
64662826|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662827|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64662828|NCT02692755|Letrozole|letrozole|mesh-list
64662829|NCT02692755|Fulvestrant|fulvestrant|mesh-list
64662830|NCT02692755|Palbociclib|palbociclib|mesh-list
64662831|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662832|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64662833|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64662834|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662835|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662836|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64662837|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64662838|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346704|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64346705|NCT02299115|Protective Agents|protective agents|mesh-ancestor
64346706|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
64346707|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346708|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346709|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
64346710|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346711|NCT03515369|Liver Extracts|liver extracts|mesh-list
64346712|NCT03515369|Hematinics|hematinics|mesh-ancestor
64346713|NCT03515213|Fenofibrate|fenofibrate|mesh-list
64346714|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64662839|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662840|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64662841|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64662842|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64662843|NCT01829399|Epinephrine|epinephrine|mesh-list
64662844|NCT01829399|Bupivacaine|bupivacaine|mesh-list
64662845|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
64662846|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
64662847|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662848|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662849|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
64662850|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662851|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64662852|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64662853|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662854|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662855|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662856|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64662857|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64662859|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64662860|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662861|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
64662862|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
64662863|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64662864|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
64662865|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64662866|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
64662867|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662868|NCT01394510|Expectorants|expectorants|mesh-ancestor
64662869|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662870|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64662871|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
64662872|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662873|NCT01394510|Protective Agents|protective agents|mesh-ancestor
64662874|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662875|NCT01394510|Antidotes|antidotes|mesh-ancestor
64662876|NCT05580549|Ethanol|ethanol|mesh-list
64662877|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64662878|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662879|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662880|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662881|NCT05327777|Oxycodone|oxycodone|mesh-list
64662882|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64662883|NCT05327777|Narcotics|narcotics|mesh-ancestor
64662884|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662885|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662886|NCT05327777|Analgesics|analgesics|mesh-ancestor
64662887|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
64662888|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662889|NCT05327309|Bleomycin|bleomycin|mesh-list
64350561|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350562|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350563|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64350564|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64350565|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
64350566|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64350580|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350581|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64350583|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64350584|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350586|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64350587|NCT03131375|Analgesics|analgesics|mesh-ancestor
64662890|NCT05327309|Propranolol|propranolol|mesh-list
64662891|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64662892|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64662893|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
64662894|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662895|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662896|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662898|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64662899|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
64662900|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64662901|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662902|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64662903|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
64662904|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662905|NCT05326841|Vitamin D|vitamin d|mesh-list
64662906|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
64662907|NCT05326841|Vitamins|vitamins|mesh-ancestor
64662908|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
64662909|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662910|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64662911|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64662912|NCT01412372|Mesalamine|mesalamine|mesh-list
64662913|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64662914|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64662915|NCT01412372|Analgesics|analgesics|mesh-ancestor
64662916|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
64662917|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662918|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662919|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64662920|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662921|NCT01414010|Amoxicillin|amoxicillin|mesh-list
64662922|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64662923|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662924|NCT01415960|Leuprolide|leuprolide|mesh-list
64662925|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64662926|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
64662927|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64662928|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662929|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64662930|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64662931|NCT01833845|Ribavirin|ribavirin|mesh-list
64662932|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
64662933|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
64350588|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
64350589|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350590|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64350591|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64350592|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64350593|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64350594|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350595|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662934|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662935|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
64662936|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662937|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
64662938|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64662939|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64662940|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662941|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662942|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64662943|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
64662944|NCT01416194|Diphosphonates|diphosphonates|mesh-list
64662945|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64662946|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
64662947|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64662948|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662949|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64662950|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64662951|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64662953|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64662954|NCT01416584|Narcotics|narcotics|mesh-ancestor
64662955|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64662956|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662957|NCT01416584|Analgesics|analgesics|mesh-ancestor
64662958|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
64662959|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662960|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
64662961|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
64662962|NCT02698215|Naltrexone|naltrexone|mesh-list
64662963|NCT02698215|Varenicline|varenicline|mesh-list
64662964|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64662965|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64662966|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662967|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
64662968|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662969|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64662970|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64346732|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346733|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64346734|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64346735|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346736|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
64346737|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64346739|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
64662971|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
64662972|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662973|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662974|NCT04172961|Cyclosporine|cyclosporine|mesh-list
64662975|NCT04172961|Lifitegrast|lifitegrast|mesh-list
64662976|NCT04172961|Cyclosporins|cyclosporins|mesh-list
64662977|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64662978|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662979|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64662980|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
64662981|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662982|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
64662983|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64662984|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
64662985|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64662986|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64662987|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64662988|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64662989|NCT01480232|Nicotine|nicotine|mesh-list
64662990|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64662991|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
64662992|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64662993|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64662994|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64662997|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64662998|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64662999|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
64663000|NCT04049799|Narcotics|narcotics|mesh-ancestor
64663001|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663002|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663003|NCT04049799|Analgesics|analgesics|mesh-ancestor
64663004|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
64663005|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663006|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
64663007|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663008|NCT05437575|Fentanyl|fentanyl|mesh-list
64346740|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346741|NCT02298101|Edetic Acid|edetic acid|mesh-list
64346742|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
64346743|NCT02298101|Antidotes|antidotes|mesh-ancestor
64346744|NCT02298101|Protective Agents|protective agents|mesh-ancestor
64346745|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346746|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
64663009|NCT05437575|Ketamine|ketamine|mesh-list
64663010|NCT05437575|Analgesics|analgesics|mesh-ancestor
64663011|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
64663012|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663013|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663014|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64663015|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64663016|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
64663017|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
64663018|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663019|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64663020|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64663021|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663022|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663023|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663024|NCT05437575|Narcotics|narcotics|mesh-ancestor
64663025|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64663026|NCT03008876|Acetaminophen|acetaminophen|mesh-list
64663027|NCT03008876|Ibuprofen|ibuprofen|mesh-list
64663028|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64663029|NCT03008876|Analgesics|analgesics|mesh-ancestor
64663030|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
64663031|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663032|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663033|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
64663034|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64663035|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663036|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663037|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64663038|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663039|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663040|NCT05414487|Ofatumumab|ofatumumab|mesh-list
64663041|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663043|NCT02701257|Pancrelipase|pancrelipase|mesh-list
64663044|NCT02701257|Pancreatin|pancreatin|mesh-list
64663045|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64663046|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64663047|NCT02701257|Hormones|hormones|mesh-ancestor
64663048|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663049|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663050|NCT02701257|Incretins|incretins|mesh-ancestor
64663051|NCT01836029|Carboplatin|carboplatin|mesh-list
64663052|NCT01836029|Fluorouracil|fluorouracil|mesh-list
64663053|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663054|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
64663055|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663056|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64663057|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64663058|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
64663059|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663060|NCT02703909|Rocuronium|rocuronium|mesh-list
64663061|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64663062|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64663063|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64663064|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663065|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663066|NCT01836185|Evacetrapib|evacetrapib|mesh-list
64663067|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64663068|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64663070|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663071|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64663072|NCT02706249|Enoxaparin|enoxaparin|mesh-list
64663073|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
64663074|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64663075|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64663076|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663077|NCT04740021|Carboplatin|carboplatin|mesh-list
64663078|NCT04740021|Etoposide|etoposide|mesh-list
64663079|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663080|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64663081|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64663082|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64663083|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663084|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663085|NCT02708433|Lidocaine|lidocaine|mesh-list
64663086|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
64663087|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
64663088|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663089|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663090|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
64663091|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663092|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64663093|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64663094|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64663095|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663096|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663098|NCT03575013|Avelumab|avelumab|mesh-list
64663099|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663100|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
64663101|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
64663102|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
64663103|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663104|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64663105|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
64663106|NCT00559637|Hematinics|hematinics|mesh-ancestor
64663107|NCT03349281|Cytarabine|cytarabine|mesh-list
64663108|NCT03349281|Dexamethasone|dexamethasone|mesh-list
64663109|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
64663110|NCT03349281|Doxorubicin|doxorubicin|mesh-list
64663111|NCT03349281|Methotrexate|methotrexate|mesh-list
64663112|NCT03349281|Vincristine|vincristine|mesh-list
64663113|NCT03349281|Asparaginase|asparaginase|mesh-list
64663115|NCT03349281|Pevonedistat|pevonedistat|mesh-list
64663116|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663117|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
64663118|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
64663119|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663120|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663121|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64663122|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
64663123|NCT03349281|Hormones|hormones|mesh-ancestor
64663124|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663125|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663126|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663127|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64663128|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64663129|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64663130|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663131|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663132|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64346836|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346837|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64346838|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64346839|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64663133|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
64663134|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64663135|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64663136|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
64663137|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
64663138|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64663139|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64663140|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
64663141|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663142|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64663143|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
64663144|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663145|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64663146|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
64663147|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
64663148|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64663149|NCT03206151|Leucovorin|leucovorin|mesh-list
64663150|NCT03206151|Folic Acid|folic acid|mesh-list
64663151|NCT03206151|Fluorouracil|fluorouracil|mesh-list
64663152|NCT03206151|Irinotecan|irinotecan|mesh-list
64663153|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
64663154|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
64663155|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350596|NCT03475589|Apatinib|apatinib|mesh-list
64350597|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350626|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350627|NCT02523755|Ropivacaine|ropivacaine|mesh-list
64350628|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
64350629|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
64350630|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350657|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350658|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350659|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64350660|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
64350661|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64663156|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64663157|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663158|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64663159|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
64663160|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663161|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64663162|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64663163|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663164|NCT03206151|Antidotes|antidotes|mesh-ancestor
64663165|NCT03206151|Protective Agents|protective agents|mesh-ancestor
64663166|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
64663167|NCT03206151|Vitamins|vitamins|mesh-ancestor
64663168|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
64663169|NCT03206151|Hematinics|hematinics|mesh-ancestor
64663170|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64663171|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
64663172|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64663173|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663174|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
64663175|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663176|NCT02714283|Azithromycin|azithromycin|mesh-list
64663177|NCT02714283|Erythromycin|erythromycin|mesh-list
64663178|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64663179|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663180|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64663181|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64346843|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64346844|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64346845|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64346846|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64346847|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64346848|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64346850|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
64346851|NCT01190787|Melphalan|melphalan|mesh-list
64346852|NCT01190787|Bortezomib|bortezomib|mesh-list
64346853|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64346854|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
64663182|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663183|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663184|NCT04814927|Copper|copper|mesh-list
64663185|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64663186|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
64663187|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
64663188|NCT04814927|Etonogestrel|etonogestrel|mesh-list
64663189|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64663190|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
64663191|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64663192|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663193|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64663194|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64663195|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64663196|NCT04814927|Trace Elements|trace elements|mesh-ancestor
64663197|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
64663198|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64663199|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64663200|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663201|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663202|NCT04810949|Vitamin D|vitamin d|mesh-list
64663203|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
64663204|NCT04810949|Vitamins|vitamins|mesh-ancestor
64663205|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
64663206|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663207|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64663208|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64663209|NCT04795583|Prednisone|prednisone|mesh-list
64663210|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663211|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
64663212|NCT04795583|Hormones|hormones|mesh-ancestor
64663213|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663214|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663215|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663216|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663217|NCT01843751|Buprenorphine|buprenorphine|mesh-list
64663218|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64663219|NCT01843751|Naloxone|naloxone|mesh-list
64663220|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663221|NCT01843751|Narcotics|narcotics|mesh-ancestor
64663222|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663223|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663225|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
64663226|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663227|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64663228|NCT02722239|Metformin|metformin|mesh-list
64663229|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
64663230|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64663231|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663232|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64663233|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663234|NCT02578641|Gemcitabine|gemcitabine|mesh-list
64663235|NCT02578641|Carboplatin|carboplatin|mesh-list
64663236|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663237|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64663238|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
64663239|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663240|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
64663241|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663242|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663243|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64346855|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346856|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346857|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64346858|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
64346859|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663244|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
64663245|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663247|NCT05084859|Docetaxel|docetaxel|mesh-list
64663248|NCT05084859|Panitumumab|panitumumab|mesh-list
64663249|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663250|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
64663251|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
64663252|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
64663253|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350662|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64350663|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64350664|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350666|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64350667|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
64350668|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350670|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64350671|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64350672|NCT02553161|Citalopram|citalopram|mesh-list
64350673|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64663254|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663255|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
64663256|NCT05084859|Hormones|hormones|mesh-ancestor
64663257|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663258|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663259|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663260|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64663261|NCT02431260|INCB054329|incb054329|mesh-list
64663262|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663263|NCT02055963|Minocycline|minocycline|mesh-list
64663264|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64663265|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663266|NCT01848041|Phenylephrine|phenylephrine|mesh-list
64663267|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
64663268|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64663269|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64663270|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64663271|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64663272|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
64663273|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663274|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663275|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663276|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
64663277|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
64663278|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663279|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
64663280|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64663281|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
64663282|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64663284|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64663285|NCT01848041|Protective Agents|protective agents|mesh-ancestor
64663286|NCT02724033|Dexamethasone|dexamethasone|mesh-list
64663287|NCT02724033|Ondansetron|ondansetron|mesh-list
64663288|NCT02724033|Antiemetics|antiemetics|mesh-list
64663289|NCT02724033|Bupivacaine|bupivacaine|mesh-list
64663290|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663291|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
64663292|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663293|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663294|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64663295|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
64663296|NCT02724033|Hormones|hormones|mesh-ancestor
64663297|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663298|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663299|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663300|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663302|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
64663303|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663304|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
64346874|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
64346875|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64346876|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346877|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
64346878|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64346879|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
64346880|NCT03510611|Ensartinib|ensartinib|mesh-list
64346881|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663305|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
64663306|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
64663307|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64663308|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
64663309|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663310|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64663311|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64663312|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64663313|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64663314|NCT02724423|Diazepam|diazepam|mesh-list
64663315|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64663316|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
64663317|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
64663318|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
64663319|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663320|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663321|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64663322|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64663323|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663324|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64663325|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64663326|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64663327|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64663328|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64663329|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64663330|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
64663331|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
64663332|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
64663333|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
64663334|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663335|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663336|NCT02989259|Apatinib|apatinib|mesh-list
64663337|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663338|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64663339|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663340|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663341|NCT04950621|Propofol|propofol|mesh-list
64663342|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64663343|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663344|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663345|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64663346|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
64663347|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
64663348|NCT05737121|Lidocaine|lidocaine|mesh-list
64663349|NCT05737121|Heparin|heparin|mesh-list
64663350|NCT05737121|Calcium heparin|calcium heparin|mesh-list
64663351|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
64663352|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
64663353|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663354|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663355|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
64663356|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663357|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64663358|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64663359|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64346882|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346883|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663360|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663361|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663362|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
64663363|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64663364|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64663366|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64663367|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64663368|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663369|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663370|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64663371|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64663372|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
64663373|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663374|NCT01848899|Bivalirudin|bivalirudin|mesh-list
64663375|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
64663376|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64663377|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
64663378|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663379|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663380|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
64663382|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
64663383|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
64663384|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
64663385|NCT02731833|Protective Agents|protective agents|mesh-ancestor
64663386|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663387|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64663388|NCT01852019|Cangrelor|cangrelor|mesh-list
64663389|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64663390|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64663391|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64663392|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64663393|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
64663394|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663395|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663396|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663397|NCT04457219|Hemostatics|hemostatics|mesh-list
64663398|NCT04457219|Coagulants|coagulants|mesh-ancestor
64663399|NCT02430480|Goserelin|goserelin|mesh-list
64663400|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663401|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663402|NCT01852175|Ticagrelor|ticagrelor|mesh-list
64663403|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64663404|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64663405|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64663406|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64663407|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64663408|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
64663409|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663410|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663411|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663413|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64663414|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663415|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346898|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346899|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346900|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64346901|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346902|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346903|NCT02489630|Ketamine|ketamine|mesh-list
64346904|NCT02489630|Analgesics|analgesics|mesh-list
64663416|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64663417|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
64663418|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663419|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663420|NCT01852955|Acetaminophen|acetaminophen|mesh-list
64663421|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64663422|NCT01852955|Analgesics|analgesics|mesh-ancestor
64663423|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
64663424|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663425|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663426|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
64663427|NCT00558467|Pramipexole|pramipexole|mesh-list
64663428|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
64663429|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663430|NCT00558467|Protective Agents|protective agents|mesh-ancestor
64663431|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663432|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64663433|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64663434|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
64663435|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
64663436|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663438|NCT04226495|Dsuvia|dsuvia|mesh-list
64663439|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663440|NCT04226495|Narcotics|narcotics|mesh-ancestor
64663441|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663442|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663443|NCT04226495|Analgesics|analgesics|mesh-ancestor
64350675|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350676|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350677|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350678|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
64350679|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350680|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64350681|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
64350682|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350684|NCT03473093|Morphine|morphine|mesh-list
64350685|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64350686|NCT03473093|Narcotics|narcotics|mesh-ancestor
64350687|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350688|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350689|NCT03473093|Analgesics|analgesics|mesh-ancestor
64350690|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
64663444|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
64663445|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663446|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64663447|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64663448|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
64663449|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
64663450|NCT02401230|Tenofovir|tenofovir|mesh-list
64663451|NCT02401230|Emtricitabine|emtricitabine|mesh-list
64414786|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
64663452|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64663453|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
64663454|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663455|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64663456|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64663457|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663458|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663459|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64663460|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64663461|NCT01854359|Idebenone|idebenone|mesh-list
64663462|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
64663463|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663464|NCT01854359|Protective Agents|protective agents|mesh-ancestor
64663465|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663466|NCT01854593|Bevacizumab|bevacizumab|mesh-list
64663467|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64663468|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663469|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64663470|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64663471|NCT01854593|Growth Substances|growth substances|mesh-ancestor
64663472|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663473|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
64663474|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64663475|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
64388844|NCT02336477|Mexiletine|mexiletine|mesh-list
64663476|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
64663477|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663478|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663479|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
64350699|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350700|NCT02523131|Insulin|insulin|mesh-list
64350701|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64350702|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350703|NCT04339049|Lidocaine|lidocaine|mesh-list
64350704|NCT04339049|Misoprostol|misoprostol|mesh-list
64350705|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
64350706|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
64350707|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350708|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350709|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
64350710|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350711|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64350712|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64350713|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64663480|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64663481|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
64663482|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663483|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663484|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64663485|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
64663486|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64663487|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
64663488|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663489|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663490|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64663491|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
64663492|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
64663493|NCT02734953|Protective Agents|protective agents|mesh-ancestor
64663494|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64663495|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64663496|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663497|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663498|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64663499|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663500|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663501|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
64663502|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663505|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
64663506|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663507|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64663508|NCT02428296|Sirolimus|sirolimus|mesh-list
64663509|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64663510|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663511|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64663512|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663513|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
64663514|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64663515|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
64663516|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663517|NCT02643615|Propofol|propofol|mesh-list
64663518|NCT02643615|Desflurane|desflurane|mesh-list
64663519|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64663520|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663521|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663522|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64663523|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
64663524|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
64663525|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64663527|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663528|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64663529|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663530|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663531|NCT05679479|Meplazumab|meplazumab|mesh-list
64663532|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
64663533|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663534|NCT01421186|Dexamethasone|dexamethasone|mesh-list
64663535|NCT01421186|Lenalidomide|lenalidomide|mesh-list
64663536|NCT01421186|Pomalidomide|pomalidomide|mesh-list
64663537|NCT01421186|Felzartamab|felzartamab|mesh-list
64663538|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663539|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
64663540|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
64663541|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663542|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663543|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64663544|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
64663545|NCT01421186|Hormones|hormones|mesh-ancestor
64663546|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663547|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663548|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663549|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
64663550|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64663551|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64663552|NCT01421186|Growth Substances|growth substances|mesh-ancestor
64663553|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
64663555|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663556|NCT01860287|Narcotics|narcotics|mesh-ancestor
64663557|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663558|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663559|NCT01860287|Analgesics|analgesics|mesh-ancestor
64663560|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
64663561|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663562|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64663563|NCT01421498|Lifitegrast|lifitegrast|mesh-list
64663564|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64663565|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64663567|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
64663568|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663569|NCT01860521|Sufentanil|sufentanil|mesh-list
64663570|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
64663571|NCT01860521|Gemeprost|gemeprost|mesh-list
64663572|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663573|NCT01860521|Narcotics|narcotics|mesh-ancestor
64663574|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663575|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663576|NCT01860521|Analgesics|analgesics|mesh-ancestor
64663577|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
64663578|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663579|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64663580|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64663581|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
64663582|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
64663583|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
64663584|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64663585|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
64663586|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64663587|NCT01400906|Fluticasone|fluticasone|mesh-list
64663588|NCT01400906|Xhance|xhance|mesh-list
64663589|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663590|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64663591|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
64663592|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663593|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663594|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64663595|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
64663596|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
64663597|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64663598|NCT00367653|Azithromycin|azithromycin|mesh-list
64663599|NCT00367653|Chloroquine|chloroquine|mesh-list
64663600|NCT00367653|Mefloquine|mefloquine|mesh-list
64663601|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64346919|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64346920|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64346921|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64346922|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346923|NCT05089383|Progesterone|progesterone|mesh-list
64346925|NCT05089383|Hormones|hormones|mesh-ancestor
64663602|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663603|NCT00367653|Amebicides|amebicides|mesh-ancestor
64663604|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64663605|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64663606|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
64663607|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663608|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
64663609|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64663610|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663611|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663612|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64663614|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
64663615|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663616|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64663617|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64663618|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64663619|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
64663620|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663621|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663622|NCT05445297|Amiodarone|amiodarone|mesh-list
64663623|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64663624|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
64663625|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64663626|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663627|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663628|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64663629|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64663630|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64663631|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663632|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64663633|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64663634|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64663635|NCT00556673|Fluticasone|fluticasone|mesh-list
64663636|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
64663637|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64663638|NCT00556673|Maleic acid|maleic acid|mesh-list
64663639|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663640|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64663641|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
64663642|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663643|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663644|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64663645|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
64663646|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
64663647|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64663648|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64663649|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64663650|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64663651|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
64663652|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663653|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663654|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663655|NCT01422434|Calcitriol|calcitriol|mesh-list
64663656|NCT01422434|Betamethasone|betamethasone|mesh-list
64663657|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
64663658|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64663659|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
64663660|NCT01422434|Calcipotriene|calcipotriene|mesh-list
64663661|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64663662|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663663|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
64346936|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64346937|NCT03512873|Analgesics|analgesics|mesh-ancestor
64346938|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
64346939|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346940|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346941|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663664|NCT01422434|Hormones|hormones|mesh-ancestor
64663665|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663666|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663667|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64663668|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64663669|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
64663670|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64663671|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64663672|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663673|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663674|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64663675|NCT01422434|Vitamins|vitamins|mesh-ancestor
64663677|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64663678|NCT05434065|Celecoxib|celecoxib|mesh-list
64663679|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64663680|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64663681|NCT05434065|Analgesics|analgesics|mesh-ancestor
64663682|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
64663683|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663684|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663685|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663686|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663687|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64663688|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64663689|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663690|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663691|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64663692|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663693|NCT02270255|Lidocaine|lidocaine|mesh-list
64663694|NCT02270255|Ropivacaine|ropivacaine|mesh-list
64663695|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
64663696|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
64663697|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663698|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663699|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
64663700|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663701|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64663702|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64663703|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64663704|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663705|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663706|NCT02651259|Vitamins|vitamins|mesh-list
64663707|NCT02651259|Pyridoxine|pyridoxine|mesh-list
64663708|NCT02651259|Pyridoxal|pyridoxal|mesh-list
64663710|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
64663712|NCT02651259|Rifapentine|rifapentine|mesh-list
64663713|NCT02651259|Rifamycins|rifamycins|mesh-list
64663714|NCT02651259|Hydrazine|hydrazine|mesh-list
64663715|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
64663716|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663717|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
64663718|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64663719|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663720|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64663721|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64663722|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
64663723|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663724|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64663725|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64663726|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
64663727|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663728|NCT02271425|Evacetrapib|evacetrapib|mesh-list
64663729|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64346952|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64663730|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64663731|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
64663732|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663733|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64663734|NCT05442411|Parecoxib|parecoxib|mesh-list
64663735|NCT05442411|Ropivacaine|ropivacaine|mesh-list
64663736|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
64663737|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
64663738|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663739|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663740|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
64663741|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663742|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64663743|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64663744|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663745|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663746|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64663747|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64663748|NCT05442411|Analgesics|analgesics|mesh-ancestor
64663749|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663750|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663752|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663753|NCT05654363|Narcotics|narcotics|mesh-ancestor
64663754|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663755|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663756|NCT05654363|Analgesics|analgesics|mesh-ancestor
64663757|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
64663758|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663759|NCT02651415|Perindopril|perindopril|mesh-list
64663760|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64663761|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
64663762|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663763|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663764|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64663765|NCT00555425|Buprenorphine|buprenorphine|mesh-list
64663766|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64663767|NCT00555425|Naloxone|naloxone|mesh-list
64663768|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663769|NCT00555425|Narcotics|narcotics|mesh-ancestor
64663770|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663771|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663772|NCT00555425|Analgesics|analgesics|mesh-ancestor
64663773|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
64663774|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663775|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64663776|NCT05444751|Anesthetics|anesthetics|mesh-list
64663777|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
64663778|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663779|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663780|NCT05444673|Cisplatin|cisplatin|mesh-list
64663781|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663782|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
64663783|NCT04338633|Calcium|calcium|mesh-list
64663785|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663786|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64663787|NCT01488188|Vaccines|vaccines|mesh-list
64663788|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
64663789|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663790|NCT01489670|Bimatoprost|bimatoprost|mesh-list
64663791|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64346962|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64346963|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64346964|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64346965|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346967|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
64663792|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64663793|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64663794|NCT01427504|Etravirine|etravirine|mesh-list
64663795|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64663796|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64663797|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663798|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663799|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
64663800|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663801|NCT03169361|Ixazomib|ixazomib|mesh-list
64663802|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663803|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
64663804|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663805|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663806|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
64663807|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
64663808|NCT03021083|Fentanyl|fentanyl|mesh-list
64663809|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64663810|NCT03021083|Narcotics|narcotics|mesh-ancestor
64663811|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64663812|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663813|NCT03021083|Analgesics|analgesics|mesh-ancestor
64663814|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
64663815|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663816|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64663817|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64663818|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
64663819|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
64346972|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346973|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
64346974|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346975|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64346976|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
64346977|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64346982|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64346983|NCT02322099|Alendronate|alendronate|mesh-list
64346984|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
64346985|NCT02322099|Vitamin D|vitamin d|mesh-list
64346986|NCT02322099|Tenofovir|tenofovir|mesh-list
64346987|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
64346988|NCT02322099|Calcium|calcium|mesh-list
64346989|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346990|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346991|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
64346992|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346993|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64346994|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64346995|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346996|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346997|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64346998|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64663820|NCT03000257|Venetoclax|venetoclax|mesh-list
64663822|NCT02945813|Metformin|metformin|mesh-list
64663823|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64663824|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663825|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64663826|NCT05387811|Diuretics|diuretics|mesh-list
64663827|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
64663828|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663830|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
64663831|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
64663832|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
64663833|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663834|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663835|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64663836|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64663837|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
64663838|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663839|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663840|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
64663841|NCT05339373|Aceclofenac|aceclofenac|mesh-list
64663842|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64663843|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64663844|NCT05339373|Analgesics|analgesics|mesh-ancestor
64663845|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
64663846|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663847|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663848|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663849|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663851|NCT05439993|Tepotinib|tepotinib|mesh-list
64663852|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64663853|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663854|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64663855|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64663856|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64663857|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663858|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64663859|NCT00554099|Mesalamine|mesalamine|mesh-list
64663860|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663861|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64663862|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64663863|NCT00554099|Analgesics|analgesics|mesh-ancestor
64663864|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
64663865|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663866|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663867|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346999|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64347001|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347002|NCT02322099|Vitamins|vitamins|mesh-ancestor
64347003|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
64347004|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
64347005|NCT02487446|Bromides|bromides|mesh-list
64347006|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
64347007|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347008|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64347009|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64347010|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64347011|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
64347012|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347013|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663868|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347035|NCT02303327|Androgens|androgens|mesh-list
64663870|NCT04048161|Tacrolimus|tacrolimus|mesh-list
64663871|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64663872|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
64663873|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663874|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64663875|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663876|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663877|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64663878|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663879|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64663880|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
64663881|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64663882|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663883|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
64663884|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64663885|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64663886|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663887|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
64663888|NCT02664909|Coagulants|coagulants|mesh-ancestor
64663889|NCT03974217|Talazoparib|talazoparib|mesh-list
64663890|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64663891|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663892|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663893|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663894|NCT00368589|Atorvastatin|atorvastatin|mesh-list
64663895|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64663896|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64663897|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
64663898|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663899|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64663900|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64663901|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663903|NCT00553319|Adderall|adderall|mesh-list
64663904|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64663905|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663906|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
64663907|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
64663908|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663909|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
64663910|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663911|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663912|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
64663913|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64663914|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64663915|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663916|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64663917|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64663918|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64663919|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
64663920|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663921|NCT01868633|Dexamethasone|dexamethasone|mesh-list
64663922|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64663923|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
64663924|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
64663925|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663926|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663927|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347037|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347038|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347039|NCT03510221|Antioxidants|antioxidants|mesh-list
64347040|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347041|NCT03510221|Protective Agents|protective agents|mesh-ancestor
64663929|NCT01868633|Hormones|hormones|mesh-ancestor
64663930|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64663931|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64663932|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663933|NCT04738773|Naltrexone|naltrexone|mesh-list
64663934|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64663935|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64663936|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663937|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
64663938|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663939|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
64663940|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64663941|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663942|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
64663943|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64663944|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64663945|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64663946|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663947|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663948|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
64663949|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64663950|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663951|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64663952|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663953|NCT02676375|Bupropion|bupropion|mesh-list
64663954|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64663955|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
64663956|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64663957|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64663958|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64663959|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64663960|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663963|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663964|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64663965|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64663966|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663967|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
64663968|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
64663969|NCT01871441|Tacrolimus|tacrolimus|mesh-list
64663970|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64663971|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
64663972|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663973|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64663974|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64663976|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663977|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663978|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64663979|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64663980|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347046|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64347047|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347048|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64347049|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
64347050|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
64347051|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347052|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347053|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64663981|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64663982|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64663983|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
64663984|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64663985|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64663986|NCT04338711|Tofacitinib|tofacitinib|mesh-list
64663987|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64663988|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64663989|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64663990|NCT01874951|Naltrexone|naltrexone|mesh-list
64663991|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64663992|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64663993|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64663994|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
64663995|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64663996|NCT04739241|Insulin|insulin|mesh-list
64663997|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64663998|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64663999|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664000|NCT03024437|Bevacizumab|bevacizumab|mesh-list
64664001|NCT03024437|Atezolizumab|atezolizumab|mesh-list
64664002|NCT03024437|Entinostat|entinostat|mesh-list
64664003|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664004|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664005|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664006|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64664007|NCT03024437|Growth Substances|growth substances|mesh-ancestor
64664008|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664009|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664010|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64664011|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664012|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664014|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64664015|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
64664016|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
64664017|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664018|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664019|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664020|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64664021|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64664022|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347054|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64347055|NCT03509831|Protective Agents|protective agents|mesh-ancestor
64347056|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64347057|NCT02303483|Niacinamide|niacinamide|mesh-list
64347058|NCT02303483|Niacin|niacin|mesh-list
64347059|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
64347060|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
64347061|NCT02303483|Vitamins|vitamins|mesh-ancestor
64664023|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664024|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64664025|NCT01489826|Protective Agents|protective agents|mesh-ancestor
64664027|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64664028|NCT02677623|Diuretics|diuretics|mesh-ancestor
64664029|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
64664030|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664031|NCT02677701|Azithromycin|azithromycin|mesh-list
64664032|NCT02677701|Tobramycin|tobramycin|mesh-list
64664033|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64664034|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664035|NCT01543178|Rifaximin|rifaximin|mesh-list
64664036|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64664037|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664038|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664039|NCT05052957|Temozolomide|temozolomide|mesh-list
64664040|NCT05052957|Carmustine|carmustine|mesh-list
64664041|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
64664042|NCT05052957|Lenograstim|lenograstim|mesh-list
64664043|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64664044|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
64664045|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664046|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64664047|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
64664048|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664049|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664050|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664052|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664053|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664054|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
64664055|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664056|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64664057|NCT01543568|Aflibercept|aflibercept|mesh-list
64664058|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664059|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64664060|NCT01543568|Growth Substances|growth substances|mesh-ancestor
64664061|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664062|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664063|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664064|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64664065|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664066|NCT02375724|Bromides|bromides|mesh-list
64664067|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
64664068|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64664069|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64664070|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
64664071|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664072|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664073|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64664074|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
64664075|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64664076|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64664077|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64664078|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
64664079|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664080|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664082|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
64664083|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664084|NCT02424630|Ropivacaine|ropivacaine|mesh-list
64664085|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
64664086|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
64664087|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664088|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664089|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
64664090|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664091|NCT02397408|Choline|choline|mesh-list
64664092|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
64664093|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64664094|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
64664095|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664096|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664097|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64664098|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
64664099|NCT02397096|Ritonavir|ritonavir|mesh-list
64664100|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64664101|NCT02397096|Tenofovir|tenofovir|mesh-list
64664102|NCT02397096|Lamivudine|lamivudine|mesh-list
64664103|NCT02397096|Cobicistat|cobicistat|mesh-list
64664104|NCT02397096|Elvitegravir|elvitegravir|mesh-list
64664105|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64664106|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
64664107|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64664108|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664109|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347062|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
64347063|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347064|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64347065|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
64347066|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347067|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64347068|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
64347073|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347074|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347076|NCT02303639|Sotalol|sotalol|mesh-list
64347077|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64347078|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
64347079|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64347080|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350714|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350715|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350740|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350741|NCT04418128|Nafamostat|nafamostat|mesh-list
64350742|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64350743|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64350744|NCT04418128|Analgesics|analgesics|mesh-ancestor
64350745|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
64347081|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347082|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64347083|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64664110|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64664111|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64664112|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
64664113|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664114|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64664115|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64664116|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64664117|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64664118|NCT02396316|Aflibercept|aflibercept|mesh-list
64664119|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664120|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64664121|NCT02396316|Growth Substances|growth substances|mesh-ancestor
64664122|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664123|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664124|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664125|NCT02682381|Teduglutide|teduglutide|mesh-list
64664126|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664127|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64664128|NCT02682381|Protective Agents|protective agents|mesh-ancestor
64664129|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664130|NCT04915950|APD791|apd791|mesh-list
64664131|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64664132|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64664133|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
64664134|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664135|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664136|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664137|NCT04976595|Testosterone|testosterone|mesh-list
64664138|NCT04976595|Androgens|androgens|mesh-ancestor
64664139|NCT04976595|Hormones|hormones|mesh-ancestor
64664140|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350746|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350747|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350748|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64350749|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64350750|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
64350751|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
64350752|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350753|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350754|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64350755|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64350757|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64350758|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
64350759|NCT02555657|Gemcitabine|gemcitabine|mesh-list
64350760|NCT02555657|Capecitabine|capecitabine|mesh-list
64350773|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64350774|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64350775|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
64350776|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
64664141|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664142|NCT03033303|Isotretinoin|isotretinoin|mesh-list
64664143|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
64664144|NCT00367965|Eszopiclone|eszopiclone|mesh-list
64664145|NCT00367965|Zopiclone|zopiclone|mesh-list
64664146|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64664147|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664148|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664149|NCT02904291|Amlodipine|amlodipine|mesh-list
64664150|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64664151|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64664152|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347084|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64347085|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347086|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64347087|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64347088|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64347089|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64347090|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64347091|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
64347092|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347093|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347094|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
64347095|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
64347096|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664153|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664154|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64664155|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664156|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
64664158|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64664159|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64664160|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
64664161|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664162|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664163|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664165|NCT02683707|Fentanyl|fentanyl|mesh-list
64664166|NCT02683707|Midazolam|midazolam|mesh-list
64664167|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
64664168|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
64664169|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664170|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664171|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
64664172|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664173|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64664174|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64664175|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64664176|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64664177|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664178|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64664179|NCT02683707|Narcotics|narcotics|mesh-ancestor
64664180|NCT02683707|Analgesics|analgesics|mesh-ancestor
64664181|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64664182|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64664183|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
64664184|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64664185|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64664186|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64664187|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64347097|NCT02303873|Alendronate|alendronate|mesh-list
64347098|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64347099|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347100|NCT04757493|Prucalopride|prucalopride|mesh-list
64347101|NCT04757493|Laxatives|laxatives|mesh-ancestor
64347102|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347103|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64347113|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347114|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347115|NCT04406415|Nafamostat|nafamostat|mesh-list
64347116|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64347117|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64664190|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664191|NCT02371980|Vortioxetine|vortioxetine|mesh-list
64664192|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
64664193|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64664194|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64664195|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64664196|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664197|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664198|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64664199|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64664200|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64664201|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664202|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664203|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
64664204|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64664205|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64664206|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64350777|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
64350779|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
64350780|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350781|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64350782|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64350783|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350784|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350785|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64350786|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64350787|NCT03990077|Docetaxel|docetaxel|mesh-list
64350788|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350789|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
64350790|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
64350791|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
64350792|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350793|NCT05134415|Menthol|menthol|mesh-list
64664207|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64664209|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664210|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64664211|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
64664212|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664213|NCT02867865|Antiviral Agents|antiviral agents|mesh-ancestor
64664214|NCT02867865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664215|NCT02867865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664216|NCT02867865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664217|NCT02867865|Immunologic Factors|immunologic factors|mesh-ancestor
64664218|NCT02867865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664219|NCT02833233|Nivolumab|nivolumab|mesh-list
64664220|NCT02833233|Ipilimumab|ipilimumab|mesh-list
64664221|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664222|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664223|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64664224|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664225|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
64664226|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
64664227|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
64664228|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664229|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664230|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
64664231|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664232|NCT05447871|Bupivacaine|bupivacaine|mesh-list
64389590|NCT02326727|Narcotics|narcotics|mesh-ancestor
64664233|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
64664234|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
64347118|NCT04406415|Analgesics|analgesics|mesh-ancestor
64347119|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
64347120|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347121|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347122|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347123|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347124|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
64347125|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
64347126|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664235|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664236|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664238|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664239|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
64664240|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664241|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664243|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664244|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664245|NCT04772235|Osimertinib|osimertinib|mesh-list
64664246|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664247|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64664248|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664249|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664250|NCT04766463|Morphine|morphine|mesh-list
64664251|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64664252|NCT04766463|Narcotics|narcotics|mesh-ancestor
64664253|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664254|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664255|NCT04766463|Analgesics|analgesics|mesh-ancestor
64664256|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
64664257|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664258|NCT00823563|Adenosine|adenosine|mesh-list
64664259|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
64664260|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
64664261|NCT00823563|Analgesics|analgesics|mesh-ancestor
64664262|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
64664263|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664264|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664265|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64664267|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
64664268|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
64664269|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664270|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664271|NCT05447169|Antibodies|antibodies|mesh-list
64664272|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
64664273|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664274|NCT04704453|Amitriptyline|amitriptyline|mesh-list
64664275|NCT04704453|Capsaicin|capsaicin|mesh-list
64664276|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
64664277|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
64664278|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
64664279|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664280|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664281|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64664282|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
64664283|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64664284|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64664285|NCT04704453|Analgesics|analgesics|mesh-ancestor
64664286|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64664287|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64664288|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64664289|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664290|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
64347127|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347128|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64350794|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
64350795|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
64350796|NCT03380507|Thiamine|thiamine|mesh-list
64350797|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
64350798|NCT03380507|Vitamins|vitamins|mesh-ancestor
64350799|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
64350800|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350801|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64350802|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
64350805|NCT03471455|Isotretinoin|isotretinoin|mesh-list
64350806|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
64350807|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350808|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64350809|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64350810|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347129|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64347167|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347168|NCT03135795|Parecoxib|parecoxib|mesh-list
64347169|NCT03135795|Sufentanil|sufentanil|mesh-list
64347170|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
64347171|NCT03135795|Remifentanil|remifentanil|mesh-list
64664291|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664293|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664294|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664295|NCT05451147|Metformin|metformin|mesh-list
64664296|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64664297|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664298|NCT04553367|Meropenem|meropenem|mesh-list
64664299|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64664300|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664301|NCT00369837|Clevidipine|clevidipine|mesh-list
64664302|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64664303|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64664304|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664305|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64664306|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664307|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
64664308|NCT05449899|Busulfan|busulfan|mesh-list
64664309|NCT05449899|Fludarabine|fludarabine|mesh-list
64664310|NCT05449899|Decitabine|decitabine|mesh-list
64664311|NCT05449899|Lenograstim|lenograstim|mesh-list
64664312|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664313|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
64664314|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664315|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64664316|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64664317|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
64664318|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664319|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664320|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64664321|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64664322|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
64664323|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664324|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64664325|NCT05441631|Insulin|insulin|mesh-list
64664326|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64664327|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64664328|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664329|NCT01546454|Leuprolide|leuprolide|mesh-list
64664330|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64664331|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64664332|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
64664333|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64664334|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64664335|NCT01546454|Estradiol|estradiol|mesh-list
64664336|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64664337|NCT01546454|Progesterone|progesterone|mesh-list
64664338|NCT01546454|Estrogens|estrogens|mesh-ancestor
64664339|NCT01546454|Hormones|hormones|mesh-ancestor
64664340|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664341|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664342|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64664343|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
64664344|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64664345|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64664346|NCT01546454|Progestins|progestins|mesh-ancestor
64664347|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64664348|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
64664349|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64664350|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664351|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64664352|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64664353|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64664354|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64664355|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
64664356|NCT00368901|Hematinics|hematinics|mesh-ancestor
64664357|NCT05430867|Memantine|memantine|mesh-list
64664358|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64664360|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
64664361|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664362|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664363|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664364|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64664365|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64664366|NCT05448885|Gemcitabine|gemcitabine|mesh-list
64664367|NCT05448885|Cisplatin|cisplatin|mesh-list
64664368|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664369|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64664370|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
64664371|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664372|NCT05448885|Antiviral Agents|antiviral agents|mesh-ancestor
64664373|NCT05448885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664374|NCT05448885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664375|NCT05448885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664376|NCT05448885|Immunologic Factors|immunologic factors|mesh-ancestor
64664377|NCT05448885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664378|NCT01547000|Guanfacine|guanfacine|mesh-list
64664379|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64664380|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64664381|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64664382|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64664383|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
64664384|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664385|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664386|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664387|NCT00369603|Donepezil|donepezil|mesh-list
64664388|NCT00369603|Galantamine|galantamine|mesh-list
64664389|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64347172|NCT03135795|Dsuvia|dsuvia|mesh-list
64347173|NCT03135795|Bromides|bromides|mesh-list
64347174|NCT03135795|Propofol|propofol|mesh-list
64347175|NCT03135795|Sevoflurane|sevoflurane|mesh-list
64347176|NCT03135795|Citric Acid|citric acid|mesh-list
64347177|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
64347178|NCT03135795|Rocuronium|rocuronium|mesh-list
64347179|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64347180|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347181|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347182|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64347183|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
64347184|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
64347229|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64347230|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64347231|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
64347232|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347233|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347234|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64664390|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664391|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664392|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
64664393|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664394|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664395|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
64664396|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64664397|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
64664398|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664399|NCT02980016|Isoniazid|isoniazid|mesh-list
64664400|NCT02980016|Rifapentine|rifapentine|mesh-list
64664401|NCT02980016|Rifampin|rifampin|mesh-list
64664402|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
64664403|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64664404|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664405|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64664406|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64664407|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
64664408|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664409|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64664410|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64664411|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
64664412|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64664413|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664414|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64664415|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64664416|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64664417|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64664418|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64664419|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64664420|NCT01493180|Rebamipide|rebamipide|mesh-list
64664421|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64664422|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
64664423|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64664424|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64664425|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
64664426|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664427|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
64664428|NCT01493180|Protective Agents|protective agents|mesh-ancestor
64664429|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64664430|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664432|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664433|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664434|NCT01431014|Dexamethasone|dexamethasone|mesh-list
64664435|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
64664436|NCT01431014|BB 1101|bb 1101|mesh-list
64664437|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64664438|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
64664439|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
64347235|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
64347236|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
64347237|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
64347238|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64347239|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64347240|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
64347241|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347242|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347244|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
64347245|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347246|NCT01678209|Methylphenidate|methylphenidate|mesh-list
64347247|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64664440|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664441|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664442|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664443|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
64664444|NCT01431014|Hormones|hormones|mesh-ancestor
64664445|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664446|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64664447|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664449|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664450|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664451|NCT04375605|Leucovorin|leucovorin|mesh-list
64664453|NCT04375605|Fluorouracil|fluorouracil|mesh-list
64664454|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
64664455|NCT04375605|Calcium|calcium|mesh-list
64664456|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
64664457|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389816|NCT05076695|Trastuzumab|trastuzumab|mesh-list
64664458|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
64664459|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
64664460|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
64664461|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664462|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64664463|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664464|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
64664465|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64664466|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664467|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
64664468|NCT04375605|Antidotes|antidotes|mesh-ancestor
64664469|NCT04375605|Protective Agents|protective agents|mesh-ancestor
64664470|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
64664471|NCT04375605|Vitamins|vitamins|mesh-ancestor
64664472|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
64664473|NCT01431170|Trimethoprim|trimethoprim|mesh-list
64664474|NCT01431170|Polymyxins|polymyxins|mesh-list
64664475|NCT01431170|Polymyxin B|polymyxin b|mesh-list
64664476|NCT01431170|Besifloxacin|besifloxacin|mesh-list
64664477|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
64664478|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64664479|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664480|NCT01431170|Renal Agents|renal agents|mesh-ancestor
64664481|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
64664482|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64664483|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64664484|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64664485|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664486|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664487|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64347249|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347250|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64347251|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64347281|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64347282|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347283|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
64347284|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
64347285|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347286|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347287|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379565|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64379566|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379567|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379568|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64379569|NCT04425993|Diuretics|diuretics|mesh-ancestor
64379570|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
64379571|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379572|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64347288|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
64347289|NCT05158699|Hormones|hormones|mesh-ancestor
64664488|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64664489|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64664490|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64664491|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64664492|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64664493|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664494|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64664495|NCT05448183|Gemcitabine|gemcitabine|mesh-list
64664496|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
64664497|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64664498|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
64664499|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664501|NCT05448183|Antiviral Agents|antiviral agents|mesh-ancestor
64664502|NCT05448183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664503|NCT05448183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664504|NCT05448183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664505|NCT05448183|Immunologic Factors|immunologic factors|mesh-ancestor
64664506|NCT05448183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664507|NCT04732455|Lidocaine|lidocaine|mesh-list
64664508|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64664509|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
64664510|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
64664511|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664512|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664513|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
64664514|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664516|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64664517|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64664518|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64664519|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664520|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64664521|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64664522|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664523|NCT04732455|Analgesics|analgesics|mesh-ancestor
64664524|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
64664525|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64664526|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
64664527|NCT04306965|Apremilast|apremilast|mesh-list
64664528|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64664529|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64664530|NCT04306965|Analgesics|analgesics|mesh-ancestor
64664531|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
64664532|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664533|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664534|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64664535|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347290|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347291|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64347292|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347293|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
64347294|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347295|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347296|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347297|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
64347298|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64347299|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64347300|NCT05158699|Analgesics|analgesics|mesh-ancestor
64347301|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
64664536|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64664537|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64664538|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664539|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664541|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64664542|NCT01431794|Gemcitabine|gemcitabine|mesh-list
64664543|NCT01431794|Paclitaxel|paclitaxel|mesh-list
64664544|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64664545|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664546|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64664547|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64664548|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64664549|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664550|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64664551|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
64664552|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
64664553|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664554|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664555|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664556|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
64664557|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664558|NCT01497860|Vinorelbine|vinorelbine|mesh-list
64664559|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64664560|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664561|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
64664562|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
64664563|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
64664564|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664565|NCT02213900|Haloperidol|haloperidol|mesh-list
64664566|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
64664567|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
64664568|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
64664569|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347332|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347333|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347334|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64347335|NCT04464629|Protective Agents|protective agents|mesh-ancestor
64347336|NCT02304887|Denosumab|denosumab|mesh-list
64347337|NCT02304887|Teriparatide|teriparatide|mesh-list
64347338|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64347339|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347340|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64347341|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64347342|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64347343|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347344|NCT03512171|Amphetamine|amphetamine|mesh-list
64347345|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
64347346|NCT03512171|Fallypride|fallypride|mesh-list
64379573|NCT03971643|Vilobelimab|vilobelimab|mesh-list
64379607|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379609|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64379610|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64379611|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379612|NCT02705859|Trastuzumab|trastuzumab|mesh-list
64379613|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64379614|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379615|NCT05549583|Metformin|metformin|mesh-list
64379616|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64379617|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64379618|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379619|NCT05549583|Incretins|incretins|mesh-ancestor
64347347|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64347348|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347349|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
64664570|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664571|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664572|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64664574|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664575|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64664576|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64664577|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
64664578|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664579|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664580|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64664581|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
64664582|NCT05365893|Losartan|losartan|mesh-list
64664583|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
64664584|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64664585|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64664586|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664587|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664588|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664589|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64664590|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64664591|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64664592|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64664593|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64664594|NCT02370888|Lenalidomide|lenalidomide|mesh-list
64664595|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
64664596|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664597|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664598|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64664599|NCT02370888|Growth Substances|growth substances|mesh-ancestor
64664600|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664601|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664602|NCT05358873|Antibodies|antibodies|mesh-list
64664603|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
64664604|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664605|NCT02214290|Caffeine|caffeine|mesh-list
64664606|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64664607|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664608|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64664609|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664610|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379730|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
64379731|NCT05553717|Carvedilol|carvedilol|mesh-list
64379732|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64379733|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64379734|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
64379735|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379736|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379737|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379738|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64379739|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
64379740|NCT05553717|Protective Agents|protective agents|mesh-ancestor
64379741|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64379782|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
64664611|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64664612|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64664613|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
64664614|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664615|NCT03160911|Hemostatics|hemostatics|mesh-list
64664616|NCT03160911|Coagulants|coagulants|mesh-ancestor
64664617|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
64664618|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664619|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664620|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64664621|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
64664622|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664623|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64664624|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64664625|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664626|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664627|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664628|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64664629|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64664631|NCT04635189|Lenalidomide|lenalidomide|mesh-list
64664632|NCT04635189|Daratumumab|daratumumab|mesh-list
64664633|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64664634|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
64664635|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
64664636|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664637|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664638|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664639|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
64664641|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664642|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64664643|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664644|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
64664645|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664646|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64664647|NCT04635189|Growth Substances|growth substances|mesh-ancestor
64664648|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664649|NCT01551056|Cetirizine|cetirizine|mesh-list
64664650|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64664651|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64664652|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64664653|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
64664654|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
64664655|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664656|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664657|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664658|NCT05227131|Capecitabine|capecitabine|mesh-list
64664659|NCT05227131|Tucatinib|tucatinib|mesh-list
64664660|NCT05227131|Margetuximab|margetuximab|mesh-list
64664661|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64664662|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
64664663|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664664|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664665|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64664666|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664667|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
64664668|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
64664669|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64664670|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64664671|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664672|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664673|NCT01499498|Urological Agents|urological agents|mesh-ancestor
64664674|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64664675|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64664676|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664677|NCT02421588|Doxorubicin|doxorubicin|mesh-list
64664678|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64664680|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64664681|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664682|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64664683|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64390042|NCT02027428|Paclitaxel|paclitaxel|mesh-list
64664684|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664685|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664686|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64664688|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64664689|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
64664690|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
64664691|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664692|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664693|NCT02688309|Dexamethasone|dexamethasone|mesh-list
64664694|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64664695|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
64664696|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
64664697|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664698|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664699|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664701|NCT02688309|Hormones|hormones|mesh-ancestor
64664702|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664703|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64664704|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664705|NCT00370851|Bevacizumab|bevacizumab|mesh-list
64664706|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664707|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664708|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664709|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64664710|NCT00370851|Growth Substances|growth substances|mesh-ancestor
64664711|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664712|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664713|NCT05124171|Vaccines|vaccines|mesh-list
64664714|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
64664715|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664716|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
64664717|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64664718|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664719|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64664720|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64664721|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664723|NCT00371007|Hormones|hormones|mesh-ancestor
64664724|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664725|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64664726|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
64347350|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
64347351|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347352|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
64347353|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347354|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347355|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
64347356|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64347357|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64347358|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347359|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64347360|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64347361|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64347363|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664727|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664728|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664729|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64664730|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64664731|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664732|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64664733|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664735|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
64664736|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64664737|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64664738|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64664739|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664740|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664741|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64664742|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64664743|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
64664744|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664745|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664746|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
64664747|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64664748|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64664749|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664750|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
64664751|NCT04387305|Coagulants|coagulants|mesh-ancestor
64664752|NCT02421120|Tazobactam|tazobactam|mesh-list
64664753|NCT02421120|Ceftolozane|ceftolozane|mesh-list
64664754|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64664755|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64664756|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664757|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64664760|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64664761|NCT02421120|Renal Agents|renal agents|mesh-ancestor
64664762|NCT03022877|Simendan|simendan|mesh-list
64664763|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64664764|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
64664765|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64664766|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64664767|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664768|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664769|NCT03022877|Protective Agents|protective agents|mesh-ancestor
64664770|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664774|NCT02420262|Insulin|insulin|mesh-list
64664775|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64664776|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
64664777|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
64664778|NCT02420262|Liraglutide|liraglutide|mesh-list
64664779|NCT02420262|Xultophy|xultophy|mesh-list
64664780|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64664781|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664782|NCT02420262|Incretins|incretins|mesh-ancestor
64664783|NCT02420262|Hormones|hormones|mesh-ancestor
64664784|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664785|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64664786|NCT02520141|Ramucirumab|ramucirumab|mesh-list
64664787|NCT02520141|Antibodies|antibodies|mesh-list
64664788|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
64664789|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64664790|NCT02520141|Lexatumumab|lexatumumab|mesh-list
64664791|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
64664792|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664793|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664794|NCT00369993|Fluticasone|fluticasone|mesh-list
64664796|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64664797|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64664798|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64664799|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
64664800|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664801|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664802|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64664803|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
64664804|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
64664805|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64664806|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64664807|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64664808|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64664809|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
64664810|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664811|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664812|NCT00552305|Lacosamide|lacosamide|mesh-list
64664813|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
64664814|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64664815|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64664816|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64664817|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664818|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
64664819|NCT02278887|Fludarabine|fludarabine|mesh-list
64664820|NCT02278887|Ipilimumab|ipilimumab|mesh-list
64664821|NCT02278887|Interleukin-2|interleukin-2|mesh-list
64664822|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664823|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
64664824|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664825|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64664826|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64664827|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
64664828|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664829|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664830|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64664831|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664832|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64664833|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64664835|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
64664836|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664837|NCT04168203|Apixaban|apixaban|mesh-list
64664838|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64664839|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
64664840|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64664841|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
64664842|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664843|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664844|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
64664845|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
64664846|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64664847|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664848|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664849|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64664850|NCT05020821|Analgesics|analgesics|mesh-ancestor
64664851|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
64664852|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664853|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64664855|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64664856|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
64664857|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64664858|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664859|NCT04135989|Everolimus|everolimus|mesh-list
64664860|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664861|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664862|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
64664863|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664864|NCT02011971|Vinpocetine|vinpocetine|mesh-list
64432194|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664865|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64664866|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664867|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664868|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
64664869|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64664870|NCT02011971|Protective Agents|protective agents|mesh-ancestor
64664871|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664872|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
64664873|NCT01854255|Cisplatin|cisplatin|mesh-list
64664874|NCT01854255|Doxorubicin|doxorubicin|mesh-list
64664875|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64664876|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664877|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64664878|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64664879|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64664880|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664881|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664882|NCT01555281|Nelfinavir|nelfinavir|mesh-list
64664883|NCT01555281|Dexamethasone|dexamethasone|mesh-list
64664884|NCT01555281|Lenalidomide|lenalidomide|mesh-list
64664885|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64664886|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
64664887|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
64664888|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664889|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664890|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664891|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
64664892|NCT01555281|Hormones|hormones|mesh-ancestor
64664893|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664895|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664896|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
64664897|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664898|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64664899|NCT01555281|Growth Substances|growth substances|mesh-ancestor
64664900|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664901|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64664902|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64664903|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
64664904|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664905|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664906|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64664907|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64664908|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
64664910|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
64664911|NCT04938765|Analgesics|analgesics|mesh-ancestor
64664912|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
64664913|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64664914|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664915|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
64664916|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64664918|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
64664919|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64664920|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64664921|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664922|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64664923|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
64664924|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64664925|NCT00370539|Triamcinolone|triamcinolone|mesh-list
64664926|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64664927|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64664928|NCT00370539|Bevacizumab|bevacizumab|mesh-list
64664929|NCT00370539|Verteporfin|verteporfin|mesh-list
64664930|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64664931|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664932|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664933|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64664934|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64379786|NCT04757740|Hormones|hormones|mesh-ancestor
64664935|NCT00370539|Growth Substances|growth substances|mesh-ancestor
64664936|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664937|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
64664938|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64664939|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
64664940|NCT00370539|Hormones|hormones|mesh-ancestor
64664941|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664942|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64664943|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
64664944|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664945|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664946|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64664947|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
64664948|NCT03996057|Methenamine|methenamine|mesh-list
64664949|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
64664950|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
64664951|NCT03996057|Estrogens|estrogens|mesh-list
64664952|NCT03996057|Hormones|hormones|mesh-ancestor
64664953|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664954|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664955|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64664956|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64664957|NCT03996057|Renal Agents|renal agents|mesh-ancestor
64664958|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64664959|NCT03150875|Docetaxel|docetaxel|mesh-list
64664960|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664961|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
64347380|NCT02305355|Simvastatin|simvastatin|mesh-list
64347381|NCT02305355|Pravastatin|pravastatin|mesh-list
64347382|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64347383|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64347384|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
64347385|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347386|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64347387|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64347388|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347389|NCT03511703|Apatinib|apatinib|mesh-list
64432254|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64664962|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
64664963|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
64664964|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664966|NCT04900623|Cisplatin|cisplatin|mesh-list
64664967|NCT04900623|Carboplatin|carboplatin|mesh-list
64664968|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64664969|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664970|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
64664971|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
64664972|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
64664973|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664974|NCT00552071|Octreotide|octreotide|mesh-list
64664975|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64664976|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64664977|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664978|NCT00673335|Letrozole|letrozole|mesh-list
64432255|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64664979|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664980|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64664981|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64664982|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664983|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64664984|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64664985|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
64664986|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64664987|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64664988|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64664989|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664990|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664991|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347390|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347391|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64347392|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347393|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347394|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64347395|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64347396|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64347397|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347398|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347420|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64664993|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
64664994|NCT05523323|Lenvatinib|lenvatinib|mesh-list
64664995|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64664996|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64664997|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64664998|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64664999|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665000|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
64665001|NCT04880889|Thiamine|thiamine|mesh-list
64665002|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
64665003|NCT04880889|Vitamins|vitamins|mesh-ancestor
64665004|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
64665005|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665006|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
64665007|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665008|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665009|NCT00551759|Docetaxel|docetaxel|mesh-list
64665010|NCT00551759|Fluorouracil|fluorouracil|mesh-list
64665011|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
64665012|NCT00551759|Cetuximab|cetuximab|mesh-list
64665013|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665014|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
64665015|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
64665016|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
64665017|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665018|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
64665019|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64665020|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64665021|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
64665022|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665023|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665025|NCT04849377|Carboplatin|carboplatin|mesh-list
64665026|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665027|NCT03776487|Fluorouracil|fluorouracil|mesh-list
64665028|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
64665029|NCT03776487|Nivolumab|nivolumab|mesh-list
64665030|NCT03776487|Ipilimumab|ipilimumab|mesh-list
64665031|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
64665032|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665033|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64665034|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665035|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64665036|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
64665037|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665038|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665039|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64665040|NCT05511779|Brincidofovir|brincidofovir|mesh-list
64665041|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
64665042|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665043|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
64665044|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64665045|NCT00551525|Analgesics|analgesics|mesh-ancestor
64665046|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
64665047|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665048|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665049|NCT03716349|Anesthetics|anesthetics|mesh-list
64665050|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
64665051|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665052|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665053|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
64665054|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665055|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64665056|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
64347421|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347422|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
64347423|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347424|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
64347425|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64665058|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
64665061|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
64665062|NCT05454345|Ethambutol|ethambutol|mesh-list
64665063|NCT05454345|Rifapentine|rifapentine|mesh-list
64665064|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
64665065|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64665066|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665067|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64665068|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64665069|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665070|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665071|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665072|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64665073|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
64665074|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
64665075|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64665076|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64665077|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64665078|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64665079|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64665080|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64665081|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64665082|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64665083|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64665084|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
64665085|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64665086|NCT03558087|Gemcitabine|gemcitabine|mesh-list
64665087|NCT03558087|Nivolumab|nivolumab|mesh-list
64665088|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665089|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64665090|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
64665091|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665092|NCT03558087|Antiviral Agents|antiviral agents|mesh-ancestor
64665093|NCT03558087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665094|NCT03558087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432342|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665095|NCT03558087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64665096|NCT03558087|Immunologic Factors|immunologic factors|mesh-ancestor
64665097|NCT03558087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665098|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665099|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64665100|NCT04459611|Paclitaxel|paclitaxel|mesh-list
64665101|NCT04459611|Carboplatin|carboplatin|mesh-list
64665102|NCT04459611|Pemetrexed|pemetrexed|mesh-list
64665103|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64665104|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64665105|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665106|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
64665107|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
64665108|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
64665109|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347429|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
64347430|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347431|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64347432|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64347433|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347434|NCT02305823|Aripiprazole|aripiprazole|mesh-list
64347435|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64347436|NCT02305823|Ziprasidone|ziprasidone|mesh-list
64347437|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
64347438|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665110|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665111|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64665112|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64665113|NCT00370617|Metformin|metformin|mesh-list
64665115|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665117|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64665118|NCT01553708|Mitogens|mitogens|mesh-list
64665119|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
64379789|NCT04757740|Protective Agents|protective agents|mesh-ancestor
64665120|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665121|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64665122|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665123|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64665124|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64665125|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
64665126|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64665127|NCT02370498|Paclitaxel|paclitaxel|mesh-list
64665128|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
64665129|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64665130|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665131|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
64665132|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
64665133|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484315|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665134|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665135|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665136|NCT01554488|Fluticasone|fluticasone|mesh-list
64665137|NCT01554488|Xhance|xhance|mesh-list
64665138|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64665139|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64665140|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
64665141|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665142|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665143|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64665144|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
64665145|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
64665146|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64665147|NCT04293393|Paclitaxel|paclitaxel|mesh-list
64665148|NCT04293393|Docetaxel|docetaxel|mesh-list
64665149|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
64665150|NCT04293393|Doxorubicin|doxorubicin|mesh-list
64665151|NCT04293393|Letrozole|letrozole|mesh-list
64665152|NCT04293393|Leuprolide|leuprolide|mesh-list
64665153|NCT04293393|Goserelin|goserelin|mesh-list
64665154|NCT04293393|Taxane|taxane|mesh-list
64665155|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64665156|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347439|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64347440|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64347441|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347442|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347443|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
64347444|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
64347445|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347446|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347468|NCT02305901|Repaglinide|repaglinide|mesh-list
64665157|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
64665158|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
64665159|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
64665160|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347469|NCT02305901|Bupropion|bupropion|mesh-list
64347470|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64347471|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
64347472|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665162|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
64432379|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665163|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665164|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64665165|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64665166|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
64665167|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64665168|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64665169|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64665170|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64665171|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665172|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64665173|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64665174|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64665175|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
64665176|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665177|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64665179|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64665181|NCT02347332|Methotrexate|methotrexate|mesh-list
64665182|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64665183|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
64665184|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64665185|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665186|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64665187|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
64665188|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665189|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665190|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
64665191|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665192|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64665193|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64665194|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
64665195|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64665196|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64665197|NCT01502306|Nicotine|nicotine|mesh-list
64665198|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64665199|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
64665200|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665201|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665202|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64665203|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64665204|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
64665205|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665206|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390565|NCT03138785|Renal Agents|renal agents|mesh-ancestor
64347473|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64347474|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64347475|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347476|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347477|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
64347478|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347479|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347480|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64347481|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64665207|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64665208|NCT03325959|Analgesics|analgesics|mesh-ancestor
64665209|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
64665210|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665211|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665212|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665213|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665215|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64665216|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64665217|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665218|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
64665219|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
64665220|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64665221|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
64665222|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665223|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
64665224|NCT05451381|Propofol|propofol|mesh-list
64665225|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64665226|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665227|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665228|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64665229|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
64665230|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
64665231|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64665232|NCT05451381|Analgesics|analgesics|mesh-ancestor
64665233|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
64665234|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665235|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64665236|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64665237|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64665238|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
64665239|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665240|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665241|NCT05450913|Lidocaine|lidocaine|mesh-list
64665242|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
64665243|NCT05450913|Anesthetics|anesthetics|mesh-list
64665244|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665245|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665246|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
64665247|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665248|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64665249|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64665250|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64665251|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665252|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665254|NCT05446779|Epinephrine|epinephrine|mesh-list
64665255|NCT05446779|Racepinephrine|racepinephrine|mesh-list
64665256|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
64347486|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64347487|NCT03942887|Prednisolone|prednisolone|mesh-list
64347488|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
64347489|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
64347490|NCT03942887|Rituximab|rituximab|mesh-list
64347491|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64347492|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
64347493|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347494|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
64347495|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347496|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347512|NCT03942887|Protective Agents|protective agents|mesh-ancestor
64347513|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64347514|NCT02234596|Nintedanib|nintedanib|mesh-list
64665258|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64665259|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64665260|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
64665261|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665262|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665263|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665264|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64665265|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64665266|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
64665267|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665268|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64665269|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
64665270|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
64665271|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
64665272|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64665273|NCT02215070|Pasireotide|pasireotide|mesh-list
64665274|NCT02215070|Hormones|hormones|mesh-ancestor
64665275|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665276|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665277|NCT04000737|Sorafenib|sorafenib|mesh-list
64665278|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432428|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
64665279|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64665280|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665281|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665282|NCT02347098|Atorvastatin|atorvastatin|mesh-list
64665283|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64665284|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64665285|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64665286|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
64665287|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665288|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64665289|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665290|NCT03708237|Gabapentin|gabapentin|mesh-list
64665291|NCT03708237|Ropinirole|ropinirole|mesh-list
64665292|NCT03708237|Analgesics|analgesics|mesh-ancestor
64665293|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
64665294|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665295|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665296|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
64665297|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64665298|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64665299|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665300|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665301|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64665302|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64414787|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
64665303|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665304|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665305|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
64665306|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64665307|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64665308|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
64665309|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
64665311|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
64665312|NCT04895592|Ichthammol|ichthammol|mesh-list
64347515|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347516|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64347517|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347518|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347519|NCT02305979|Loratadine|loratadine|mesh-list
64347520|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
64665313|NCT04895592|BB 1101|bb 1101|mesh-list
64665314|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64665315|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
64665316|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
64665317|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665318|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665319|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665320|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
64665321|NCT04895592|Hormones|hormones|mesh-ancestor
64665322|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665323|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64665324|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665326|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665327|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665328|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
64665329|NCT01556594|Glucagon|glucagon|mesh-list
64665330|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64665331|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665332|NCT01556594|Hormones|hormones|mesh-ancestor
64665333|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665334|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665335|NCT01556594|Incretins|incretins|mesh-ancestor
64665336|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
64665337|NCT00371319|Tacrolimus|tacrolimus|mesh-list
64665338|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64665339|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
64665340|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665341|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64665342|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665343|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665344|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64665345|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665346|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64665347|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
64665348|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64665349|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665351|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665352|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347570|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347571|NCT02234362|Vortioxetine|vortioxetine|mesh-list
64347572|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
64379801|NCT02112448|Ketorolac|ketorolac|mesh-list
64347573|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64347574|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64347575|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64347576|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347577|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347578|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64347579|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64347580|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665353|NCT03465111|Hormones|hormones|mesh-list
64665354|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64665355|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64665356|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
64665357|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665358|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665359|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665360|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665361|NCT01440764|Furosemide|furosemide|mesh-list
64665362|NCT01440764|Diuretics|diuretics|mesh-ancestor
64665363|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
64665364|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665365|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64665366|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665367|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665368|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
64665369|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64665370|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665371|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665372|NCT05283837|Pertuzumab|pertuzumab|mesh-list
64665373|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665374|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665375|NCT02209610|Fentanyl|fentanyl|mesh-list
64665377|NCT02209610|Narcotics|narcotics|mesh-ancestor
64665378|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665379|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665380|NCT02209610|Analgesics|analgesics|mesh-ancestor
64665381|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
64665382|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665383|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64665384|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64665385|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
64665386|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
64665387|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64665388|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64665389|NCT05244993|Paclitaxel|paclitaxel|mesh-list
64665390|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64665391|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665392|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64665393|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64665394|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64665395|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665396|NCT03289299|Dexamethasone|dexamethasone|mesh-list
64665397|NCT03289299|Lenalidomide|lenalidomide|mesh-list
64665398|NCT03289299|Daratumumab|daratumumab|mesh-list
64665399|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64665400|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
64665401|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
64665402|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665403|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665404|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665405|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
64665406|NCT03289299|Hormones|hormones|mesh-ancestor
64665407|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665408|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64665409|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665410|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
64665411|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64347581|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347582|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347583|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
64347584|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64347585|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64665412|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64665413|NCT03289299|Growth Substances|growth substances|mesh-ancestor
64665414|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
64665415|NCT05132439|Metformin|metformin|mesh-list
64665416|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665417|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665418|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64665419|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64665420|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64665421|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665422|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665423|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665424|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665425|NCT01558700|Analgesics|analgesics|mesh-ancestor
64665426|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
64665427|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665428|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
64665429|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64390785|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64665430|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
64665431|NCT02757105|Ondansetron|ondansetron|mesh-list
64665432|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
64665433|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
64665434|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665435|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665436|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665437|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
64665438|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
64665439|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64665440|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
64665441|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665442|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665443|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64665444|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64665445|NCT02757105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665446|NCT02757105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665447|NCT02757105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64665448|NCT05083845|Anesthetics|anesthetics|mesh-list
64432489|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665449|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
64665450|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665451|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665452|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
64665453|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665454|NCT00371553|Sunitinib|sunitinib|mesh-list
64665455|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665456|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64665457|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64665458|NCT00371553|Growth Substances|growth substances|mesh-ancestor
64347622|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
64347623|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347624|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347625|NCT02896855|Docetaxel|docetaxel|mesh-list
64347626|NCT02896855|Trastuzumab|trastuzumab|mesh-list
64347627|NCT02896855|Pertuzumab|pertuzumab|mesh-list
64347628|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347629|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
64347630|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
64665459|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665460|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
64665461|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64665462|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665463|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665464|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
64665465|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665466|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665467|NCT01507220|Morphine|morphine|mesh-list
64665468|NCT01507220|Bupivacaine|bupivacaine|mesh-list
64665469|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
64665470|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
64665471|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665472|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665473|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
64665474|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665475|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64665476|NCT01507220|Narcotics|narcotics|mesh-ancestor
64665477|NCT01507220|Analgesics|analgesics|mesh-ancestor
64665478|NCT01509404|Valganciclovir|valganciclovir|mesh-list
64665479|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
64665480|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665481|NCT01562132|Fluconazole|fluconazole|mesh-list
64665482|NCT01562132|Flucytosine|flucytosine|mesh-list
64665483|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
64665484|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665485|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64665486|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64665487|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665488|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665489|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64665490|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
64665491|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665492|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665493|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64665494|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64665495|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
64347640|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347641|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
64347642|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347643|NCT02232802|Enoxaparin|enoxaparin|mesh-list
64347644|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
64347645|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
64347646|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64347647|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64347648|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347649|NCT04463459|Vitamins|vitamins|mesh-list
64347650|NCT04463459|Vitamin E|vitamin e|mesh-list
64347651|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
64347652|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347653|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
64347655|NCT04463459|Protective Agents|protective agents|mesh-ancestor
64347667|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
64347668|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347669|NCT02434328|Aflibercept|aflibercept|mesh-list
64347670|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64665498|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
64665499|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665500|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
64665501|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665502|NCT02762331|Protective Agents|protective agents|mesh-ancestor
64665503|NCT02762799|Lenograstim|lenograstim|mesh-list
64665504|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64665505|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
64665506|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665508|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64665509|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665510|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
64665511|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
64665512|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
64665513|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665514|NCT01509638|Bupivacaine|bupivacaine|mesh-list
64665515|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
64665516|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
64665517|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665518|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665519|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
64665520|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665521|NCT04336917|Lidocaine|lidocaine|mesh-list
64665522|NCT04336917|Bupivacaine|bupivacaine|mesh-list
64665523|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
64665524|NCT04336917|Anesthetics|anesthetics|mesh-list
64665525|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665526|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665528|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665529|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64665530|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64665531|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64665532|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665533|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665534|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
64665535|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64665536|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64665537|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
64665538|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665539|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64665540|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64665541|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665542|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665544|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665545|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665546|NCT01562678|Incretins|incretins|mesh-ancestor
64665547|NCT01562678|Hormones|hormones|mesh-ancestor
64665548|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665549|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
64665550|NCT02767869|Antacids|antacids|mesh-ancestor
64665551|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665552|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665553|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64665554|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
64665555|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
64347671|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64347672|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64347673|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64347674|NCT02434328|Growth Substances|growth substances|mesh-ancestor
64347675|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347676|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
64347677|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347678|NCT04785274|Chrysarobin|chrysarobin|mesh-list
64665564|NCT02770365|Estrogens|estrogens|mesh-ancestor
64665565|NCT02770365|Hormones|hormones|mesh-ancestor
64665566|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665567|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665568|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64665569|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
64665570|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64665571|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64665572|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
64665573|NCT02770521|Treprostinil|treprostinil|mesh-list
64665574|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665575|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665576|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64665577|NCT02346240|Etanercept|etanercept|mesh-list
64665578|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
64390956|NCT02624765|Digoxin|digoxin|mesh-list
64665579|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64665580|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64665582|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
64665583|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665584|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665585|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64665586|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64665587|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665588|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64665589|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
64665590|NCT01511978|Amifampridine|amifampridine|mesh-list
64347679|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64347680|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64347681|NCT04785274|Analgesics|analgesics|mesh-ancestor
64347682|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
64347683|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347684|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347685|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347686|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347687|NCT04778176|Levodopa|levodopa|mesh-list
64347688|NCT04778176|Carbidopa|carbidopa|mesh-list
64347689|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64347690|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64347701|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
64347702|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
64347703|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665591|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64347704|NCT05076253|Ivermectin|ivermectin|mesh-list
64347705|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64665592|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665593|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665594|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64665595|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665596|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665597|NCT02772783|Insulin|insulin|mesh-list
64665598|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64665599|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665600|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665601|NCT02774343|Pioglitazone|pioglitazone|mesh-list
64665602|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665603|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665604|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64665605|NCT05349045|Antibodies|antibodies|mesh-list
64665606|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
64665607|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665608|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64665609|NCT05349045|Growth Substances|growth substances|mesh-ancestor
64665610|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
64665611|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665612|NCT02392104|Warfarin|warfarin|mesh-list
64665613|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
64665614|NCT04336605|Analgesics|analgesics|mesh-list
64665615|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
64665616|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665617|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665618|NCT01450826|Ondansetron|ondansetron|mesh-list
64665619|NCT01450826|Aprepitant|aprepitant|mesh-list
64665620|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
64432576|NCT05565235|Analgesics|analgesics|mesh-ancestor
64432577|NCT02278003|Propofol|propofol|mesh-list
64665621|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
64665622|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665623|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665624|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665625|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
64665626|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
64665627|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64665628|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
64665629|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347706|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347707|NCT05077839|Trifluridine|trifluridine|mesh-list
64347708|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
64347709|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347710|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
64347711|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347712|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
64347713|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64347714|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
64347715|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64347716|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
64665630|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665631|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64665632|NCT01450826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64665633|NCT01450826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665634|NCT01450826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665635|NCT01450826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64665636|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64665637|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64665638|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
64665639|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665640|NCT05349903|Protective Agents|protective agents|mesh-ancestor
64665641|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665642|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64665643|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64665644|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665645|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64665646|NCT05349825|Losartan|losartan|mesh-list
64665647|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64665648|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64665649|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64665650|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64665651|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665652|NCT01451996|Loratadine|loratadine|mesh-list
64665653|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
64665654|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
64665655|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64665656|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64665657|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64665658|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
64665659|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
64665660|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665661|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665662|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665663|NCT01512446|Alendronate|alendronate|mesh-list
64665664|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64665665|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665666|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
64665667|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
64665668|NCT04334967|Vitamins|vitamins|mesh-ancestor
64665669|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
64665670|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665671|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
64665672|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64665673|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64665674|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665675|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665676|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665677|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64665678|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
64665679|NCT04334967|Protective Agents|protective agents|mesh-ancestor
64665680|NCT04335123|Losartan|losartan|mesh-list
64665681|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64665682|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64665683|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64665684|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64665685|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347717|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347718|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347719|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
64347720|NCT03132233|Calcium|calcium|mesh-list
64347721|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64347722|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347723|NCT02307227|Paclitaxel|paclitaxel|mesh-list
64347724|NCT02307227|Docetaxel|docetaxel|mesh-list
64347725|NCT02307227|Trastuzumab|trastuzumab|mesh-list
64665686|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64347726|NCT02307227|Epirubicin|epirubicin|mesh-list
64665687|NCT02742987|Clopidogrel|clopidogrel|mesh-list
64665688|NCT02742987|Ticagrelor|ticagrelor|mesh-list
64665689|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64665690|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64665691|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64665692|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64665693|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
64665694|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665695|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665696|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665697|NCT05450055|Lidocaine|lidocaine|mesh-list
64665698|NCT05450055|Analgesics|analgesics|mesh-list
64665699|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
64665700|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
64665701|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665702|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665703|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
64665704|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665705|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64665706|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64665707|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64665708|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665709|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665710|NCT02743377|Rolipram|rolipram|mesh-list
64665711|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
64665712|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665713|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64665714|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64665715|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665716|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665717|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
64665718|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64665719|NCT05437965|Hormones|hormones|mesh-ancestor
64665720|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665721|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665722|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
64665723|NCT00372099|Calcitonin|calcitonin|mesh-list
64665724|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
64665725|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64665726|NCT00372099|Katacalcin|katacalcin|mesh-list
64391083|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
64377737|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377738|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64377753|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
64377755|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64377756|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377757|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
64377758|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377759|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64665727|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64347727|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64347728|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347729|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
64347730|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
64347731|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
64347732|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347733|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64347734|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64347735|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64665728|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665729|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64665730|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
64665731|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
64665732|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64665733|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665734|NCT01454414|Permethrin|permethrin|mesh-list
64665735|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665736|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665737|NCT04335513|Insulin|insulin|mesh-list
64665738|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665739|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665740|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
64665741|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64665742|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
64665743|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665744|NCT01568528|Oxytocin|oxytocin|mesh-list
64665745|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
64665746|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64665747|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665748|NCT05223231|Antibodies|antibodies|mesh-list
64665749|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
64665750|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
64665751|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665752|NCT05013255|Pioglitazone|pioglitazone|mesh-list
64665753|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64665754|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665755|NCT01461668|Retapamulin|retapamulin|mesh-list
64665756|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64665757|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665758|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
64665759|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
64665760|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665761|NCT05177991|Bupivacaine|bupivacaine|mesh-list
64665762|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
64665763|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
64665764|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665765|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665766|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
64665767|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665768|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64432671|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64665769|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
64347736|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64347737|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347738|NCT02307305|Acetaminophen|acetaminophen|mesh-list
64347739|NCT02307305|Celecoxib|celecoxib|mesh-list
64347740|NCT02307305|Naproxen|naproxen|mesh-list
64347741|NCT02307305|Oxycodone|oxycodone|mesh-list
64347742|NCT02307305|Tramadol|tramadol|mesh-list
64347743|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64347745|NCT02307305|Esomeprazole|esomeprazole|mesh-list
64347766|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64347767|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347768|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347769|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
64347770|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64347771|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
64347772|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
64347773|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64347774|NCT02660229|Morphine|morphine|mesh-list
64432675|NCT01832038|Lacosamide|lacosamide|mesh-list
64665770|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64665771|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64665772|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64665773|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
64665774|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64665775|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665776|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64665777|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64665778|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64665779|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64665780|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665782|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
64665783|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64665784|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
64665785|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665786|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665787|NCT04737837|Lacosamide|lacosamide|mesh-list
64665788|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
64665789|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64665790|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64665791|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665792|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665793|NCT04826133|Calcitriol|calcitriol|mesh-list
64665794|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64665795|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64665796|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665797|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64665798|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665799|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391179|NCT05737511|Diazepam|diazepam|mesh-list
64665800|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64665801|NCT04826133|Vitamins|vitamins|mesh-ancestor
64665802|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
64665803|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64665804|NCT05456763|Butyric Acid|butyric acid|mesh-list
64665805|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
64665806|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
64347776|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64347777|NCT02660229|Narcotics|narcotics|mesh-ancestor
64347778|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347779|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347780|NCT02660229|Analgesics|analgesics|mesh-ancestor
64347781|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
64347782|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347783|NCT02307383|Lactitol|lactitol|mesh-list
64347784|NCT02307383|Cathartics|cathartics|mesh-ancestor
64347785|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347786|NCT02232178|Bupivacaine|bupivacaine|mesh-list
64347787|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
64347822|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
64347823|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64347824|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64665807|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665808|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665809|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665810|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64665811|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64665812|NCT02369874|Durvalumab|durvalumab|mesh-list
64665813|NCT02369874|Tremelimumab|tremelimumab|mesh-list
64665814|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64379804|NCT02112448|Analgesics|analgesics|mesh-ancestor
64665815|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64665816|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665817|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
64665818|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665819|NCT00372645|Folic Acid|folic acid|mesh-list
64665820|NCT00372645|Hematinics|hematinics|mesh-ancestor
64665821|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
64665823|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
64665824|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665825|NCT00372723|Infliximab|infliximab|mesh-list
64665826|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
64665827|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665828|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64665830|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64665831|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64665832|NCT00372801|Analgesics|analgesics|mesh-ancestor
64665833|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
64665834|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665835|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665836|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64665837|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64665838|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64665839|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64665840|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347825|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64347826|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64347827|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64347828|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64347829|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347830|NCT02307695|Saxagliptin|saxagliptin|mesh-list
64347831|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64347864|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64347866|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347867|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347868|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64347869|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
64347870|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
64347871|NCT03504527|Hormones|hormones|mesh-ancestor
64347872|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347873|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
64347874|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64665841|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64665842|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665843|NCT04771299|Cariprazine|cariprazine|mesh-list
64665844|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64665845|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64665846|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665847|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665848|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665849|NCT05455359|Famotidine|famotidine|mesh-list
64665850|NCT05455359|Prucalopride|prucalopride|mesh-list
64665851|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64665852|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64665853|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64665854|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
64665855|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
64665856|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665857|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665858|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665859|NCT05455359|Laxatives|laxatives|mesh-ancestor
64665860|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64665861|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64665862|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
64665863|NCT00373503|Lofexidine|lofexidine|mesh-list
64665864|NCT00373503|Dronabinol|dronabinol|mesh-list
64665865|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
64350815|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665866|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665867|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64665868|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64665869|NCT00373503|Analgesics|analgesics|mesh-ancestor
64665870|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
64665871|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665872|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64665873|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64665874|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665875|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665876|NCT00373503|Hormones|hormones|mesh-ancestor
64665877|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665878|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64665879|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64665880|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64665881|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64665882|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64665883|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64665885|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
64665886|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665887|NCT01515176|Ofatumumab|ofatumumab|mesh-list
64665888|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64347875|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
64347876|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347877|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347878|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
64347879|NCT01678131|Ribavirin|ribavirin|mesh-list
64347900|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347901|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347902|NCT02231164|Docetaxel|docetaxel|mesh-list
64347903|NCT02231164|Nintedanib|nintedanib|mesh-list
64347904|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347905|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
64665889|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665891|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665914|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64665916|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
64665917|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665918|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64665919|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64665920|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
64665921|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
64665922|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64665923|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665924|NCT01515566|Fentanyl|fentanyl|mesh-list
64665925|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64665926|NCT01515566|Narcotics|narcotics|mesh-ancestor
64665927|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665928|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665929|NCT01515566|Analgesics|analgesics|mesh-ancestor
64665930|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
64665931|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665932|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64665933|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64665934|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
64665935|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
64665936|NCT02522715|Prednisone|prednisone|mesh-list
64665937|NCT02522715|Cortisone|cortisone|mesh-list
64665938|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64665939|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
64665940|NCT02522715|Hormones|hormones|mesh-ancestor
64665941|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64665942|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665943|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64665944|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64665945|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
64665946|NCT02453373|Plasminogen|plasminogen|mesh-list
64665947|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64665948|NCT02453373|Propofol|propofol|mesh-list
64665949|NCT02453373|Etomidate|etomidate|mesh-list
64665950|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64665951|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665952|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665953|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64665954|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
64665955|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
64665956|NCT02453373|Analgesics|analgesics|mesh-ancestor
64665957|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
64665958|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665959|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64665960|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
64665961|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64665962|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64665963|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665964|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64665965|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
64665966|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64665967|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64665968|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64665969|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
64665970|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
64665971|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665972|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
64665973|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665974|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64665975|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64665976|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64665978|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64665979|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
64665980|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64665981|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64665982|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64665983|NCT01516268|Sufentanil|sufentanil|mesh-list
64665984|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64665985|NCT01516268|Narcotics|narcotics|mesh-ancestor
64665986|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64665987|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64665988|NCT01516268|Analgesics|analgesics|mesh-ancestor
64665989|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
64665990|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64665991|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64665992|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64665993|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
64665994|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
64665995|NCT05440968|Chrysarobin|chrysarobin|mesh-list
64665996|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64665997|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64665998|NCT05440968|Analgesics|analgesics|mesh-ancestor
64665999|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
64666000|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432720|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666001|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666002|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666003|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666004|NCT01516424|Risperidone|risperidone|mesh-list
64666005|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64666006|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
64666007|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666008|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666009|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666010|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64666011|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64666012|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666013|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64666014|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64666015|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
64666016|NCT02368314|Enoxaparin|enoxaparin|mesh-list
64666017|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
64666018|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
64666019|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64666020|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64666021|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666022|NCT01463384|Minocycline|minocycline|mesh-list
64347912|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347913|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
64347914|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
64347915|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347916|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347917|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347918|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
64347919|NCT03506789|Hormones|hormones|mesh-ancestor
64347920|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347921|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64666023|NCT01463384|Tetracycline|tetracycline|mesh-list
64391387|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666025|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666026|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64666027|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666028|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666029|NCT02785185|Clobetasol|clobetasol|mesh-list
64666030|NCT02785185|Halobetasol|halobetasol|mesh-list
64666031|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64666032|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666033|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
64666034|NCT02785185|Hormones|hormones|mesh-ancestor
64666035|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666036|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666037|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
64666038|NCT02787057|Vancomycin|vancomycin|mesh-list
64666039|NCT02787057|Ceftazidime|ceftazidime|mesh-list
64666040|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64666041|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666042|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64666043|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64666044|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666045|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666046|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666047|NCT01972347|Trametinib|trametinib|mesh-list
64666048|NCT01972347|Dabrafenib|dabrafenib|mesh-list
64666049|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666050|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64666051|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666052|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666053|NCT01468532|Prednisone|prednisone|mesh-list
64666054|NCT01468532|Docetaxel|docetaxel|mesh-list
64666055|NCT01468532|Pasireotide|pasireotide|mesh-list
64666056|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666057|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
64666058|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
64666059|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
64666060|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666061|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666062|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
64666063|NCT01468532|Hormones|hormones|mesh-ancestor
64666064|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666065|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666066|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64347923|NCT02312297|Minocycline|minocycline|mesh-list
64347924|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64347925|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347926|NCT05108974|Choline|choline|mesh-list
64347927|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
64350822|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
64347928|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64347929|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
64347930|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347931|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347932|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64347933|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
64347934|NCT03473431|Ketamine|ketamine|mesh-list
64347935|NCT03473431|Analgesics|analgesics|mesh-ancestor
64347936|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
64666070|NCT05062317|Capecitabine|capecitabine|mesh-list
64666071|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
64666073|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64666074|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666075|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64666076|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64666077|NCT05062317|Growth Substances|growth substances|mesh-ancestor
64666078|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666079|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
64666080|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
64666081|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666082|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64666083|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64666084|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
64666085|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64666086|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64666087|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666088|NCT05062317|Antidotes|antidotes|mesh-ancestor
64666089|NCT05062317|Protective Agents|protective agents|mesh-ancestor
64666090|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
64666092|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
64666093|NCT01469234|Loratadine|loratadine|mesh-list
64666094|NCT01469234|Fexofenadine|fexofenadine|mesh-list
64666095|NCT01469234|Terfenadine|terfenadine|mesh-list
64666096|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
64666097|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666098|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64666099|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64666100|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64666101|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
64666102|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
64666103|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666104|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666105|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666106|NCT05045937|Vitamin D|vitamin d|mesh-list
64666107|NCT05045937|Vitamins|vitamins|mesh-list
64666108|NCT05045937|Ivermectin|ivermectin|mesh-list
64666109|NCT05045937|Remdesivir|remdesivir|mesh-list
64666110|NCT05045937|Ibuprofen|ibuprofen|mesh-list
64666111|NCT05045937|Budesonide|budesonide|mesh-list
64666112|NCT05045937|Melatonin|melatonin|mesh-list
64666113|NCT05045937|Albuterol|albuterol|mesh-list
64666114|NCT05045937|Quercetin|quercetin|mesh-list
64666115|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666116|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
64666117|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64666118|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666119|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666120|NCT05045937|Analgesics|analgesics|mesh-ancestor
64666121|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
64666122|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666123|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666124|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666125|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666126|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64666128|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64666129|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
64666130|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64666131|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666132|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
64666133|NCT05045937|Hormones|hormones|mesh-ancestor
64666134|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666135|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
64666136|NCT05045937|Protective Agents|protective agents|mesh-ancestor
64666138|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
64666139|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64666140|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64666141|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64666142|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64666143|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
64666144|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666145|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64666146|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666147|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
64666148|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
64666149|NCT00373581|Cocaine|cocaine|mesh-list
64666150|NCT00373581|Vigabatrin|vigabatrin|mesh-list
64666151|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
64666152|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
64666153|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666154|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666155|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
64666156|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666157|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64666158|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64666159|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64666160|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666161|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666162|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
64666163|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666164|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
64666165|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666166|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
64666167|NCT01470170|Alfentanil|alfentanil|mesh-list
64666168|NCT01470170|Propofol|propofol|mesh-list
64666169|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64666170|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666171|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666172|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64666173|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
64666174|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
64666175|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64666176|NCT01470170|Narcotics|narcotics|mesh-ancestor
64391538|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
64666177|NCT01470170|Analgesics|analgesics|mesh-ancestor
64666178|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
64666179|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666180|NCT04311567|Methotrexate|methotrexate|mesh-list
64666182|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64432732|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666183|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
64666184|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64666185|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666186|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64666187|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
64666188|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666189|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666190|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666191|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666192|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64666193|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64666194|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
64666195|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666196|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64666197|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64666198|NCT04259775|Insulin|insulin|mesh-list
64666199|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64666200|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666201|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64382221|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382222|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64382223|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
64382224|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64382225|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
64382226|NCT02424071|Melatonin|melatonin|mesh-list
64382227|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
64382228|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382229|NCT02424071|Protective Agents|protective agents|mesh-ancestor
64666202|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666203|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666204|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
64666205|NCT01573052|Gabapentin|gabapentin|mesh-list
64666206|NCT01573052|Analgesics|analgesics|mesh-ancestor
64666207|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
64666208|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666209|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666210|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
64666211|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64666212|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64666213|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666214|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64666215|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64666216|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64666217|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666218|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666219|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
64666220|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64666221|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64666222|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
64666223|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
64666224|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
64666225|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64666226|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666227|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
64666228|NCT01523834|Panobinostat|panobinostat|mesh-list
64666229|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666230|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64666231|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666232|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666233|NCT01472432|Vildagliptin|vildagliptin|mesh-list
64666234|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64666235|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666236|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64666237|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
64666238|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666239|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666240|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
64666241|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64666242|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666243|NCT01524302|Levofloxacin|levofloxacin|mesh-list
64666244|NCT01524302|Ofloxacin|ofloxacin|mesh-list
64666245|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64666246|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64666247|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666248|NCT01524302|Renal Agents|renal agents|mesh-ancestor
64666249|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64666250|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64666251|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64666252|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666253|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347937|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347938|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347939|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64347940|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64347941|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
64347942|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
64347949|NCT02378805|Ramipril|ramipril|mesh-list
64666255|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64666256|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64666258|NCT04958811|Atezolizumab|atezolizumab|mesh-list
64666259|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64666260|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666261|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64666262|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64666263|NCT04958811|Growth Substances|growth substances|mesh-ancestor
64350823|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666264|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666265|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
64666334|NCT01577966|Analgesics|analgesics|mesh-ancestor
64666335|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
64666336|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666337|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666338|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666339|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666340|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666342|NCT02802501|Piperaquine|piperaquine|mesh-list
64666344|NCT02802501|Tafenoquine|tafenoquine|mesh-list
64666345|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
64666346|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64666347|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64666348|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666349|NCT01528592|Levodopa|levodopa|mesh-list
64666350|NCT01528592|Carbidopa|carbidopa|mesh-list
64666351|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64666352|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64666353|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64666354|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
64666355|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666356|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666357|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666358|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64666359|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666360|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64666361|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
64666362|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
64666363|NCT01578278|Fluticasone|fluticasone|mesh-list
64666364|NCT01578278|Xhance|xhance|mesh-list
64666365|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
64666366|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666367|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64666368|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
64666369|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666370|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666371|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64666372|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666373|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666374|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64666375|NCT02803749|Buspirone|buspirone|mesh-list
64666376|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64666377|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64666378|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666379|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666380|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64666381|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64666382|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
64666383|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666384|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666385|NCT01578980|Pancrelipase|pancrelipase|mesh-list
64666386|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666387|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64666388|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666389|NCT00372879|Vitamin E|vitamin e|mesh-list
64666390|NCT00372879|Vitamins|vitamins|mesh-ancestor
64666391|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
64666392|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666393|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
64666394|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666395|NCT00372879|Protective Agents|protective agents|mesh-ancestor
64666396|NCT02806869|Ibuprofen|ibuprofen|mesh-list
64666397|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666398|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666399|NCT02806869|Analgesics|analgesics|mesh-ancestor
64666400|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
64666401|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666402|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666403|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666404|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666405|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64666406|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666407|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666408|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
64666409|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64666410|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666411|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666412|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
64666413|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666414|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666415|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64666416|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64666417|NCT05564858|Antibodies|antibodies|mesh-list
64666418|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64666419|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
64666420|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
64666421|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666422|NCT02814279|Dipyrone|dipyrone|mesh-list
64666423|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
64666424|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64666425|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666426|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
64666427|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666428|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666429|NCT02814279|Analgesics|analgesics|mesh-ancestor
64666430|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
64666431|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666432|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666433|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666434|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666435|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
64666436|NCT00373659|Ranibizumab|ranibizumab|mesh-list
64666437|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64666438|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64666439|NCT00373659|Growth Substances|growth substances|mesh-ancestor
64666440|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666441|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
64666442|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666443|NCT02885025|Fluticasone|fluticasone|mesh-list
64666444|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347952|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64347957|NCT02378805|Diuretics|diuretics|mesh-ancestor
64347961|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347962|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64347977|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64347978|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64347979|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347980|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666445|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64666446|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
64666447|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666448|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666449|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64666450|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666451|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666452|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64666453|NCT01580618|Tenecteplase|tenecteplase|mesh-list
64666454|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64666455|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64666456|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666457|NCT01581710|Montelukast|montelukast|mesh-list
64666458|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64666459|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666460|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64666461|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
64666462|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666463|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666464|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64666465|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64666466|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666467|NCT01582490|Bupivacaine|bupivacaine|mesh-list
64666468|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
64666469|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
64666470|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666471|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666472|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
64666473|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666474|NCT01582880|Riboflavin|riboflavin|mesh-list
64666475|NCT01582880|Vitamins|vitamins|mesh-ancestor
64666476|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
64666477|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666478|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
64666479|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64666480|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666481|NCT02889393|Teduglutide|teduglutide|mesh-list
64666482|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666483|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64666484|NCT02889393|Protective Agents|protective agents|mesh-ancestor
64666485|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347981|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347982|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
64347983|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347984|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
64347985|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
64347986|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
64347987|NCT02230306|Vemurafenib|vemurafenib|mesh-list
64347988|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348023|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64348024|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
64348025|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666486|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
64666487|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64666488|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666489|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666490|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666491|NCT02818569|Analgesics|analgesics|mesh-ancestor
64666492|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
64666493|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666494|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64666495|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64432818|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
64666496|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64666497|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
64666498|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666499|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666501|NCT03581409|Cilostazol|cilostazol|mesh-list
64666502|NCT03581409|Clopidogrel|clopidogrel|mesh-list
64666503|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64666504|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666505|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666506|NCT03581409|Analgesics|analgesics|mesh-ancestor
64666507|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
64666508|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666509|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666510|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666511|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666512|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64666513|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64666514|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666515|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64666516|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64666517|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666518|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
64666519|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64666520|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64666521|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64666522|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
64666523|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666524|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64666525|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
64666526|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64666527|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666528|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
64666529|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64666530|NCT03581409|Protective Agents|protective agents|mesh-ancestor
64666531|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64666532|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64666533|NCT03566667|Metoprolol|metoprolol|mesh-list
64666534|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64666535|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64666536|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
64666537|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
64666539|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666540|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64666541|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64666542|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64666543|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
64666544|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666545|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666546|NCT01533116|Levodopa|levodopa|mesh-list
64666547|NCT01533116|Carbidopa|carbidopa|mesh-list
64666548|NCT01533116|Opicapone|opicapone|mesh-list
64666549|NCT01533116|Benserazide|benserazide|mesh-list
64666550|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64666551|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64666552|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
64666553|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666554|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666555|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666556|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64666557|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666558|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64666559|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
64666560|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
64666561|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64666562|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
64666563|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666564|NCT03510741|Expectorants|expectorants|mesh-ancestor
64666565|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666566|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64666567|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
64666568|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666569|NCT03510741|Protective Agents|protective agents|mesh-ancestor
64666570|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666571|NCT03510741|Antidotes|antidotes|mesh-ancestor
64666572|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
64666573|NCT05556044|Empagliflozin|empagliflozin|mesh-list
64666574|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64666575|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666576|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64666577|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666579|NCT01584518|Diuretics|diuretics|mesh-ancestor
64666580|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
64666581|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666582|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64666583|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666584|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666585|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
64666586|NCT02901249|Sertraline|sertraline|mesh-list
64666587|NCT02901249|Nortriptyline|nortriptyline|mesh-list
64666588|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
64666589|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64666590|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64666591|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64666592|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666593|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666594|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666595|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
64666596|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666597|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666598|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
64666599|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64666600|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666601|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64666602|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64666603|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
64666604|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64666605|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64666607|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666608|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64666609|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
64666610|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666611|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
64666612|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64666613|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
64666614|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666615|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
64666616|NCT01586312|Protective Agents|protective agents|mesh-ancestor
64666617|NCT00373893|Lidocaine|lidocaine|mesh-list
64666618|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
64666619|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
64666620|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666621|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666622|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
64666623|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666624|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64666625|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64666626|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64666627|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666628|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666629|NCT02977299|Aripiprazole|aripiprazole|mesh-list
64666630|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64666631|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
64666633|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64666634|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64666635|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666636|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666637|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
64666638|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
64666639|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666640|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666641|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64666642|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64666643|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
64666644|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64666645|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64666646|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64666647|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64666648|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64666649|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64666650|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666651|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64666653|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
64666654|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666655|NCT02903121|Tamoxifen|tamoxifen|mesh-list
64666656|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64666657|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
64666658|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666659|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666660|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64666661|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666662|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64666663|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64666664|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64666665|NCT02638701|Infliximab|infliximab|mesh-list
64666666|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666667|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666668|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666669|NCT02904915|Lidocaine|lidocaine|mesh-list
64666670|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
64666671|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
64666672|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666673|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666674|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
64666675|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666676|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64666677|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64666678|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64666679|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666680|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666681|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64666682|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64666683|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666684|NCT02278185|Leuprolide|leuprolide|mesh-list
64666685|NCT02278185|Goserelin|goserelin|mesh-list
64666686|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64666687|NCT02278185|Tryptophan|tryptophan|mesh-list
64666688|NCT02278185|Androgens|androgens|mesh-list
64666689|NCT02278185|Hormones|hormones|mesh-ancestor
64666690|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666691|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666692|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64666693|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
64666694|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64666695|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64666696|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666697|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
64666698|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64666699|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
64666700|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64666701|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64666702|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
64666703|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64666704|NCT01535924|Gemcitabine|gemcitabine|mesh-list
64666705|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64666706|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64666707|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
64666708|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666709|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666710|NCT01535924|Antiviral Agents|antiviral agents|mesh-ancestor
64666711|NCT01535924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666712|NCT01535924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666713|NCT01535924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64666714|NCT01535924|Immunologic Factors|immunologic factors|mesh-ancestor
64666715|NCT01535924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666716|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64666717|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
64666718|NCT02909439|Neostigmine|neostigmine|mesh-list
64666719|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64666720|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666721|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666722|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
64666723|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666724|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666725|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64666726|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
64666727|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666728|NCT01536938|Calcitriol|calcitriol|mesh-list
64666729|NCT01536938|Betamethasone|betamethasone|mesh-list
64666730|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
64666731|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64666732|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
64666733|NCT01536938|Calcipotriene|calcipotriene|mesh-list
64666734|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64666735|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666736|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
64666737|NCT01536938|Hormones|hormones|mesh-ancestor
64666738|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666739|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666740|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64666741|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666742|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666743|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64666744|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64666745|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666746|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666747|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64666749|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
64666750|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64666751|NCT01588418|Exenatide|exenatide|mesh-list
64666752|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64666753|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666754|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64666755|NCT01588418|Incretins|incretins|mesh-ancestor
64666756|NCT01588418|Hormones|hormones|mesh-ancestor
64666757|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666758|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
64666759|NCT03007160|Diuretics|diuretics|mesh-ancestor
64666760|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
64666761|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666762|NCT03007160|Expectorants|expectorants|mesh-ancestor
64666763|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
64666764|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64666765|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
64666766|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64666767|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64666768|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64666769|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666770|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666771|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
64666772|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666773|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666774|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64666775|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666776|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64666777|NCT02914119|Rocuronium|rocuronium|mesh-list
64666778|NCT02914119|Mivacurium|mivacurium|mesh-list
64392139|NCT05087615|Ondansetron|ondansetron|mesh-list
64666780|NCT02914119|Succinylcholine|succinylcholine|mesh-list
64666781|NCT02914119|Neostigmine|neostigmine|mesh-list
64666782|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64666783|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64666784|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64666785|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666786|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666787|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64666788|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666789|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666790|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
64666791|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666792|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64666793|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
64666794|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64666795|NCT01589510|Bimatoprost|bimatoprost|mesh-list
64666796|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64666797|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64666798|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64666799|NCT02914509|Travoprost|travoprost|mesh-list
64666800|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64666801|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
64666802|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64666803|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64382230|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382231|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382232|NCT03178955|Etanercept|etanercept|mesh-list
64382233|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64382234|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64382235|NCT03178955|Analgesics|analgesics|mesh-ancestor
64382238|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382239|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666804|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666805|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
64666806|NCT02840097|Coagulants|coagulants|mesh-ancestor
64666807|NCT02841033|Daratumumab|daratumumab|mesh-list
64666808|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666809|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64666810|NCT02988089|Amoxicillin|amoxicillin|mesh-list
64666811|NCT02988089|Metronidazole|metronidazole|mesh-list
64666812|NCT02988089|Clarithromycin|clarithromycin|mesh-list
64666813|NCT02988089|Levofloxacin|levofloxacin|mesh-list
64666814|NCT02988089|Ofloxacin|ofloxacin|mesh-list
64666815|NCT02988089|Tetracycline|tetracycline|mesh-list
64666816|NCT02988089|Tinidazole|tinidazole|mesh-list
64666817|NCT02988089|Furazolidone|furazolidone|mesh-list
64666818|NCT02988089|Bismuth|bismuth|mesh-list
64666819|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64666820|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666821|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64666822|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64666823|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64666824|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666825|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666826|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64666827|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64666828|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64666829|NCT02988089|Renal Agents|renal agents|mesh-ancestor
64666830|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64666831|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64666832|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666833|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64666834|NCT02988089|Antacids|antacids|mesh-ancestor
64666835|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666836|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64666837|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64666838|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64666839|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
64666840|NCT02430233|Progesterone|progesterone|mesh-list
64666841|NCT02430233|Progestins|progestins|mesh-ancestor
64666842|NCT02430233|Hormones|hormones|mesh-ancestor
64666843|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348038|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348039|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
64348040|NCT05095077|Tadalafil|tadalafil|mesh-list
64348041|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
64348042|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64348043|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64666844|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666845|NCT01589978|Aspirin|aspirin|mesh-list
64666846|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
64666847|NCT01589978|Salicylates|salicylates|mesh-list
64666848|NCT01589978|Ticlopidine|ticlopidine|mesh-list
64666849|NCT01589978|Clopidogrel|clopidogrel|mesh-list
64666850|NCT01589978|Ticagrelor|ticagrelor|mesh-list
64666851|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64666852|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666853|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666854|NCT01589978|Analgesics|analgesics|mesh-ancestor
64666855|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
64666856|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666857|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666858|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666859|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432903|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
64666860|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64666861|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64666862|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666863|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64666864|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64666865|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666866|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
64666867|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64666868|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64666869|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64666870|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
64666871|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666872|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666873|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
64666874|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
64666875|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
64666876|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64666877|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64666878|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
64666879|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64350828|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
64666880|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666881|NCT01592006|Ribavirin|ribavirin|mesh-list
64666882|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64666883|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
64666884|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666885|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
64666886|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666887|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
64666888|NCT00551291|Prednisone|prednisone|mesh-list
64666889|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
64666890|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666891|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
64666892|NCT00551291|Hormones|hormones|mesh-ancestor
64666893|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64666894|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666895|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64666896|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666897|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64666898|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64666899|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
64666900|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64666901|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666902|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666903|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666904|NCT00551291|Hematinics|hematinics|mesh-ancestor
64666905|NCT02981264|Lidocaine|lidocaine|mesh-list
64666906|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
64666907|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
64666908|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64666909|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666911|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666912|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64666913|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64666914|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64666915|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64666916|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666918|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64666919|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666920|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64666921|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
64666922|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666923|NCT01593722|Ivermectin|ivermectin|mesh-list
64666924|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
64666925|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64666926|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64666927|NCT01593722|Filaricides|filaricides|mesh-ancestor
64666928|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
64666929|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
64392288|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
64666930|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64666931|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666932|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666933|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
64666934|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64666935|NCT01594424|Antibodies|antibodies|mesh-list
64666936|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
64666937|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64666938|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
64666939|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666940|NCT01595282|Ibuprofen|ibuprofen|mesh-list
64666941|NCT01595282|Ketorolac|ketorolac|mesh-list
64666942|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64666943|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64666944|NCT01595282|Analgesics|analgesics|mesh-ancestor
64666945|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
64666946|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666947|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666948|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64666949|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64666950|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64666951|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666952|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666953|NCT01595516|Metoprolol|metoprolol|mesh-list
64666954|NCT01595516|Nebivolol|nebivolol|mesh-list
64666955|NCT01595516|Bradykinin|bradykinin|mesh-list
64666956|NCT01595516|Kininogens|kininogens|mesh-list
64666957|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666958|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64666959|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64666960|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64666961|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
64666962|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
64666963|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64666964|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64666965|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64666966|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64666967|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
64666968|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64666970|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64666971|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64666972|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64666973|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64666974|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
64666975|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64666976|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
64666977|NCT01596842|Vitamin D|vitamin d|mesh-list
64666978|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64666979|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64666980|NCT01596842|Vitamins|vitamins|mesh-ancestor
64666981|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
64666982|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64666983|NCT02217800|Octreotide|octreotide|mesh-list
64666984|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666985|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64666986|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666988|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64666989|NCT03006614|Gemcitabine|gemcitabine|mesh-list
64666990|NCT03006614|Cisplatin|cisplatin|mesh-list
64666991|NCT03006614|Docetaxel|docetaxel|mesh-list
64666992|NCT03006614|Capecitabine|capecitabine|mesh-list
64666993|NCT03006614|Trastuzumab|trastuzumab|mesh-list
64666994|NCT03006614|Vinorelbine|vinorelbine|mesh-list
64666995|NCT03006614|Epirubicin|epirubicin|mesh-list
64666996|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64666997|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64666998|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
64666999|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667000|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
64667001|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667002|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667003|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667004|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
64667005|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667006|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
64667007|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
64667008|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
64667009|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64667010|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64667011|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64667012|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64667013|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64667014|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64667015|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64667017|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
64667018|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64667019|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667020|NCT02981030|Misoprostol|misoprostol|mesh-list
64667021|NCT02981030|Mifepristone|mifepristone|mesh-list
64667022|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64667023|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
64667024|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64667025|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667026|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64667027|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667028|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
64667029|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64667030|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64667031|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64667032|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64667033|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
64667034|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64667035|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64667036|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
64382240|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382241|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382242|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382243|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
64382244|NCT01598506|Hydromorphone|hydromorphone|mesh-list
64382245|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64382246|NCT01598506|Narcotics|narcotics|mesh-ancestor
64382247|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382248|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382249|NCT01598506|Analgesics|analgesics|mesh-ancestor
64667037|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667039|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64667040|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64667041|NCT03006146|Molgramostim|molgramostim|mesh-list
64667042|NCT03006146|Sargramostim|sargramostim|mesh-list
64667043|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
64433007|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
64667044|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667045|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667046|NCT00551213|Capecitabine|capecitabine|mesh-list
64667047|NCT00551213|Irinotecan|irinotecan|mesh-list
64667048|NCT00551213|Cetuximab|cetuximab|mesh-list
64667049|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64667050|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
64667051|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667052|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667053|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64667054|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64667055|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667056|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64667057|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
64667058|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64667059|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667060|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64667061|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
64667062|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64667063|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667064|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667065|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667066|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
64667067|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64667068|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667069|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433059|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
64433061|NCT02036775|Ambroxol|ambroxol|mesh-list
64667070|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667071|NCT01684397|Bevacizumab|bevacizumab|mesh-list
64667072|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64667073|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
64667074|NCT01684397|Antibodies|antibodies|mesh-list
64667075|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
64667076|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64667077|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
64667078|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667079|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64667080|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64667081|NCT01684397|Growth Substances|growth substances|mesh-ancestor
64667082|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667083|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
64667084|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
64667085|NCT03005678|Denosumab|denosumab|mesh-list
64667086|NCT03005678|Alendronate|alendronate|mesh-list
64667087|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64667088|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667089|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
64667090|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64667091|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
64667092|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667093|NCT03008889|Expectorants|expectorants|mesh-ancestor
64667094|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
64667095|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64667096|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
64667097|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667098|NCT03008889|Protective Agents|protective agents|mesh-ancestor
64667099|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667100|NCT03008889|Antidotes|antidotes|mesh-ancestor
64667101|NCT04980482|Interferons|interferons|mesh-list
64667102|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
64667103|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
64667105|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667106|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
64667107|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667108|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
64667109|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667110|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64667111|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
64667112|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667113|NCT03000218|Metformin|metformin|mesh-list
64667114|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64667115|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667116|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667117|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64667118|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667119|NCT03010683|Metformin|metformin|mesh-list
64667120|NCT03010683|Liraglutide|liraglutide|mesh-list
64667121|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667122|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667123|NCT03010683|Incretins|incretins|mesh-ancestor
64667124|NCT03010683|Hormones|hormones|mesh-ancestor
64667125|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667126|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
64667127|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64667128|NCT02918097|Risperidone|risperidone|mesh-list
64667129|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
64433118|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667130|NCT02918097|Sertraline|sertraline|mesh-list
64667131|NCT02918097|Nortriptyline|nortriptyline|mesh-list
64667132|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64667133|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
64667134|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667135|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667136|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667137|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64667138|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64667139|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667140|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64667141|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64667142|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
64667143|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
64667144|NCT02918097|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64667145|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64667146|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64667147|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667148|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
64667149|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64667150|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64667151|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
64667153|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667154|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667155|NCT02999204|Vitamin D|vitamin d|mesh-list
64667156|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
64667157|NCT02999204|Vitamins|vitamins|mesh-ancestor
64667158|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
64667159|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667160|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64667161|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64667162|NCT03012477|Adavosertib|adavosertib|mesh-list
64667163|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667164|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667165|NCT02919111|Edetic Acid|edetic acid|mesh-list
64667166|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64667167|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
64667168|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
64667169|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667170|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
64667171|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64667172|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64667174|NCT02999126|Propofol|propofol|mesh-list
64667175|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64667176|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667177|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667178|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64667179|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
64667180|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
64667181|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64667182|NCT02999126|Narcotics|narcotics|mesh-ancestor
64667183|NCT02999126|Analgesics|analgesics|mesh-ancestor
64667184|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
64667185|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667186|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
64667187|NCT03019887|Haloperidol|haloperidol|mesh-list
64667188|NCT03019887|Olanzapine|olanzapine|mesh-list
64667189|NCT03019887|Risperidone|risperidone|mesh-list
64667190|NCT03019887|Aripiprazole|aripiprazole|mesh-list
64667191|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64667192|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64667193|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
64667194|NCT03019887|Perphenazine|perphenazine|mesh-list
64667195|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64667196|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
64667197|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667198|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667199|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667200|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64667201|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64667202|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667203|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64667204|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64667206|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
64667207|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
64667208|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667209|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667210|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64667211|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64667212|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64667213|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
64667214|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
64667215|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64667216|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64667217|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64667218|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64667219|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64667220|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64667221|NCT03019887|Analgesics|analgesics|mesh-ancestor
64667222|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
64667223|NCT02998970|Empagliflozin|empagliflozin|mesh-list
64667224|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64667225|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667226|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667227|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667228|NCT05406752|Acetaminophen|acetaminophen|mesh-list
64667229|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64667230|NCT05406752|Analgesics|analgesics|mesh-ancestor
64667231|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
64392596|NCT02408185|Colistin|colistin|mesh-list
64667232|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667233|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667234|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
64667235|NCT02247362|Vaccines|vaccines|mesh-list
64667236|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
64667237|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
64667239|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
64667240|NCT02920749|Anesthetics|anesthetics|mesh-list
64667242|NCT02920749|Sevoflurane|sevoflurane|mesh-list
64667243|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667244|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667245|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64667246|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64667247|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
64667248|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64667249|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64667250|NCT02248142|Pramipexole|pramipexole|mesh-list
64667251|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
64667252|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667253|NCT02248142|Protective Agents|protective agents|mesh-ancestor
64667254|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667255|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64667256|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64667257|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
64667258|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
64433423|NCT02022657|Emtricitabine|emtricitabine|mesh-list
64667259|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667261|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
64667262|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64667263|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
64667264|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
64667265|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
64667266|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667267|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667268|NCT02248220|Pramipexole|pramipexole|mesh-list
64667269|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
64667270|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667271|NCT02248220|Protective Agents|protective agents|mesh-ancestor
64667272|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667273|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64667274|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64667275|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
64667276|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
64667277|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667278|NCT02921061|Cytarabine|cytarabine|mesh-list
64667279|NCT02921061|Decitabine|decitabine|mesh-list
64667280|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64667281|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
64667282|NCT02921061|Cladribine|cladribine|mesh-list
64667283|NCT02921061|Lenograstim|lenograstim|mesh-list
64667284|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348077|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
64348079|NCT01680861|Tacrolimus|tacrolimus|mesh-list
64348080|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348081|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
64348082|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348083|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64348084|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348085|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348086|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667285|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
64667286|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348087|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64667288|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
64667289|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667290|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667291|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
64433481|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667292|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667293|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64667294|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667295|NCT02921061|Analgesics|analgesics|mesh-ancestor
64667296|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
64667297|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667298|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64667299|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64667300|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64667301|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64667302|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64667303|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64667304|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667306|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64667307|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667308|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
64667309|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
64348094|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
64348095|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348096|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348097|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
64348098|NCT01680861|Hormones|hormones|mesh-ancestor
64348102|NCT02229214|Topiramate|topiramate|mesh-list
64348117|NCT02308553|Nintedanib|nintedanib|mesh-list
64348118|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64348119|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348120|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
64348121|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
64348122|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
64348123|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348124|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64348169|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64348170|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64348171|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64667310|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667311|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
64667312|NCT04523480|Testosterone|testosterone|mesh-list
64667313|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
64667314|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
64667315|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64667316|NCT04523480|Androgens|androgens|mesh-ancestor
64667317|NCT04523480|Hormones|hormones|mesh-ancestor
64433516|NCT01843348|Everolimus|everolimus|mesh-list
64667318|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667319|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667320|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64667321|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667322|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
64667324|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64667325|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667326|NCT02859441|Ranibizumab|ranibizumab|mesh-list
64667327|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64667328|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64667329|NCT02859441|Growth Substances|growth substances|mesh-ancestor
64667330|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667331|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
64667332|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667333|NCT01880099|Galantamine|galantamine|mesh-list
64667334|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
64667335|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667336|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667337|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
64667338|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667339|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667340|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64667341|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
64348190|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64348191|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348192|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64348243|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348244|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348245|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348246|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667342|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667344|NCT05183204|Metformin|metformin|mesh-list
64667345|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667346|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667347|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
64667348|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64667349|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
64667350|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
64667351|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667352|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667353|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64667354|NCT02860845|Clindamycin|clindamycin|mesh-list
64667355|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
64667356|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
64667358|NCT02860845|Miconazole|miconazole|mesh-list
64667359|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
64667360|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667361|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64667362|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667363|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667364|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64667365|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64667366|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64667367|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64667368|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
64667369|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667370|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667371|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64667372|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64667373|NCT03003884|Propofol|propofol|mesh-list
64667374|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64667375|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667376|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667377|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64433643|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433644|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64667378|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
64667379|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
64667381|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64667382|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
64667383|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667384|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348247|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
64348248|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348249|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348250|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64348251|NCT04430985|Antidotes|antidotes|mesh-ancestor
64348252|NCT04430985|Protective Agents|protective agents|mesh-ancestor
64348253|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
64348254|NCT04430985|Vitamins|vitamins|mesh-ancestor
64348255|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
64348256|NCT03365635|Ribavirin|ribavirin|mesh-list
64348257|NCT03365635|Grazoprevir|grazoprevir|mesh-list
64348258|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64348259|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
64348260|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348261|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
64667385|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64667386|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
64667387|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
64667388|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64667389|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64667390|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64667391|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64667392|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
64667393|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667394|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667396|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667397|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667398|NCT04466618|Heparin|heparin|mesh-list
64667399|NCT04466618|Calcium heparin|calcium heparin|mesh-list
64667400|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64667401|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
64667402|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64667403|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64667404|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667405|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64667406|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64667407|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64667409|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64667410|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64667411|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64667412|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
64667413|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
64667414|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667415|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667416|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667417|NCT05140694|Empagliflozin|empagliflozin|mesh-list
64667418|NCT05140694|Dulaglutide|dulaglutide|mesh-list
64667419|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64667420|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64667421|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667422|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667423|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667424|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
64667425|NCT02987699|Leucovorin|leucovorin|mesh-list
64667426|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
64667427|NCT02987699|Fluorouracil|fluorouracil|mesh-list
64667428|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
64667429|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348262|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348263|NCT02901184|Spironolactone|spironolactone|mesh-list
64348264|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64348265|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
64348266|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348267|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348273|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348274|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64348275|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348276|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348277|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64348278|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64348279|NCT04456777|Vortioxetine|vortioxetine|mesh-list
64667430|NCT02987699|Antidotes|antidotes|mesh-ancestor
64667431|NCT02987699|Protective Agents|protective agents|mesh-ancestor
64667432|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667433|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
64667434|NCT02987699|Vitamins|vitamins|mesh-ancestor
64667435|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
64667436|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
64667437|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667438|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64667439|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667440|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
64667442|NCT03003728|Elotuzumab|elotuzumab|mesh-list
64667443|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64667444|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
64667445|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667446|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667447|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64667448|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667449|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
64667450|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667451|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
64667452|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64667453|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64667454|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667455|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
64667456|NCT05672810|Coagulants|coagulants|mesh-ancestor
64667457|NCT00559247|Asunaprevir|asunaprevir|mesh-list
64667458|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
64667459|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667460|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667461|NCT03003416|Dexamethasone|dexamethasone|mesh-list
64667462|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64667463|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
64667464|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
64667465|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667466|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667468|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
64667470|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667471|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64667472|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667473|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
64667474|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
64667475|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64667476|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
64667477|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667478|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667479|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64667480|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
64667481|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64667482|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64667483|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64667484|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
64667485|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667486|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667487|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
64667488|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64667489|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
64667490|NCT03028467|Folic Acid|folic acid|mesh-list
64667491|NCT03028467|Methotrexate|methotrexate|mesh-list
64667492|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64667493|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
64348317|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64348318|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
64348319|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348320|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
64348321|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64348322|NCT03130855|Carticaine|carticaine|mesh-list
64348323|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
64667494|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64667495|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667496|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64667497|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
64667498|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667499|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667500|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
64667501|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667502|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64667503|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667504|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
64667505|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64667506|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64667507|NCT03028467|Hematinics|hematinics|mesh-ancestor
64667508|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
64667509|NCT03028467|Vitamins|vitamins|mesh-ancestor
64667510|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
64667511|NCT04327310|Meplazumab|meplazumab|mesh-list
64667512|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
64667513|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667514|NCT02222870|Vaccines|vaccines|mesh-list
64667515|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
64667516|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667517|NCT02223260|Dabigatran|dabigatran|mesh-list
64667518|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
64667519|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64667520|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
64667521|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667522|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667523|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
64667524|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
64667525|NCT02863263|Povidone|povidone|mesh-list
64667526|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
64667527|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
64667528|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64667529|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667531|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348325|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348326|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348327|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
64348328|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348329|NCT02309801|Daidzin|daidzin|mesh-list
64348330|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64348331|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348332|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348333|NCT04456387|Factor VIII|factor viii|mesh-list
64348334|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64348335|NCT04456387|Coagulants|coagulants|mesh-ancestor
64348336|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
64348337|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348338|NCT02309879|Lidocaine|lidocaine|mesh-list
64348339|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
64667533|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64667534|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64667535|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667536|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667537|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667538|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64667539|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64667540|NCT01887587|Dexamethasone|dexamethasone|mesh-list
64392900|NCT04670471|Remifentanil|remifentanil|mesh-list
64667541|NCT01887587|Doxorubicin|doxorubicin|mesh-list
64667542|NCT01887587|Vincristine|vincristine|mesh-list
64667544|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64667545|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
64667546|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
64667547|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667548|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667549|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667550|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
64667551|NCT01887587|Hormones|hormones|mesh-ancestor
64667552|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667553|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64667554|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667555|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64667556|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64667557|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64667558|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667559|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667560|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64667561|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
64667562|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
64667563|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
64667564|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
64667565|NCT03029091|Losartan|losartan|mesh-list
64667566|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64667567|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64667568|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64667569|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64667570|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667571|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
64348340|NCT02309879|Remifentanil|remifentanil|mesh-list
64348342|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
64348376|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64348377|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64348378|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64348379|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64348380|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348381|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348383|NCT02820961|Entinostat|entinostat|mesh-list
64348384|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667572|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667573|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
64667574|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
64667575|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
64667576|NCT00374205|Artesunate|artesunate|mesh-list
64667577|NCT00374205|Lumefantrine|lumefantrine|mesh-list
64667578|NCT00374205|Artemether|artemether|mesh-list
64667579|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64667580|NCT00374205|Amodiaquine|amodiaquine|mesh-list
64667581|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
64667582|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64667583|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64667584|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667585|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667586|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
64667587|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
64667588|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64667589|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
64667590|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
64667591|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64667592|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64667593|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64667594|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64667595|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667596|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
64667597|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667598|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667599|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64667600|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667601|NCT05672342|Dronabinol|dronabinol|mesh-list
64667602|NCT05672342|Cannabidiol|cannabidiol|mesh-list
64667603|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
64667604|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
64667605|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667606|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64667607|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64348385|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64348386|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64348387|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348388|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348389|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64433879|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
64667608|NCT05672342|Analgesics|analgesics|mesh-ancestor
64667609|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
64667611|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64667612|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64667613|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667614|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667616|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667618|NCT03029715|Remifentanil|remifentanil|mesh-list
64667619|NCT03029715|Propofol|propofol|mesh-list
64667620|NCT03029715|Desflurane|desflurane|mesh-list
64667621|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64667622|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667623|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667624|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64667625|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
64667626|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
64667627|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64667628|NCT03029715|Analgesics|analgesics|mesh-ancestor
64667629|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
64667630|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667631|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64667632|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64667633|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64667634|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
64667635|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667636|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667637|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64667638|NCT03029715|Narcotics|narcotics|mesh-ancestor
64667639|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64667640|NCT00555035|Dolutegravir|dolutegravir|mesh-list
64667641|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64667642|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64667644|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667645|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64667646|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64667647|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
64667648|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667649|NCT04015700|Coal Tar|coal tar|mesh-list
64667650|NCT04015700|Vaccines|vaccines|mesh-list
64667651|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
64667652|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667653|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
64667654|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
64667655|NCT03035955|Azelaic acid|azelaic acid|mesh-list
64667656|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667657|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
64667658|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
64667659|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64667660|NCT02927223|Atropine|atropine|mesh-list
64667661|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64667662|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64667663|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64667664|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
64667665|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667666|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667667|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64667668|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
64667669|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
64667670|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
64667671|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64667672|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64667673|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
64667674|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667675|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667676|NCT03002792|Anesthetics|anesthetics|mesh-list
64667677|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667678|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667679|NCT05672108|Mitomycins|mitomycins|mesh-list
64667680|NCT05672108|Mitomycin|mitomycin|mesh-list
64667681|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
64667682|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64667683|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667684|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
64667685|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667686|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64667687|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667688|NCT02927457|GSK2646264|gsk2646264|mesh-list
64667689|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64667690|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667691|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667692|NCT01891331|Fluconazole|fluconazole|mesh-list
64667693|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
64667694|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434112|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
64434114|NCT02407223|Ustekinumab|ustekinumab|mesh-list
64667695|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64667696|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64667697|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667698|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667699|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64667700|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
64667701|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667702|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667703|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64667704|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64667705|NCT02247518|Tadalafil|tadalafil|mesh-list
64667706|NCT02247518|Tamsulosin|tamsulosin|mesh-list
64667707|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
64667708|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64667709|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64667710|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667711|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667712|NCT02247518|Urological Agents|urological agents|mesh-ancestor
64667713|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64667714|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64667715|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64348448|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348449|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64348450|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64348452|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
64348453|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348454|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64348455|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64348456|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348457|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348458|NCT02310347|Hormones|hormones|mesh-ancestor
64348459|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348460|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
64348461|NCT02758431|Anastrozole|anastrozole|mesh-list
64348462|NCT02758431|Testosterone|testosterone|mesh-list
64667717|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667718|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667719|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
64667720|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64667721|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64667722|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667723|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
64667724|NCT02867163|Coagulants|coagulants|mesh-ancestor
64667725|NCT04067609|Dexamethasone|dexamethasone|mesh-list
64667726|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64667727|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
64667728|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
64667729|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667730|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667731|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667732|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
64667733|NCT04067609|Hormones|hormones|mesh-ancestor
64667734|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667735|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64667736|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667737|NCT03022097|Bromides|bromides|mesh-list
64667738|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
64667739|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64667740|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
64667741|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667742|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667743|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64667744|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
64667745|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64667746|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64667747|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64667748|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
64667749|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667750|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667751|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
64667753|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667754|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667755|NCT03691610|Vaccines|vaccines|mesh-list
64667756|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
64667757|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667758|NCT03039543|Rocuronium|rocuronium|mesh-list
64667759|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64667760|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64667761|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64667762|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667763|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667764|NCT04047875|Norethindrone|norethindrone|mesh-list
64667765|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
64667766|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64667767|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64667768|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64667769|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
64667770|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64667771|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667772|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64667773|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64667775|NCT03002090|Trace Elements|trace elements|mesh-ancestor
64667776|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
64667777|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667778|NCT02328755|Methotrexate|methotrexate|mesh-list
64667779|NCT02328755|Tacrolimus|tacrolimus|mesh-list
64667780|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64667781|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
64667782|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64667783|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667784|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64667786|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667787|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667788|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
64667789|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667790|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64667791|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667792|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
64434274|NCT02402933|Hormones|hormones|mesh-ancestor
64667793|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64667794|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64667796|NCT02870283|Carbamazepine|carbamazepine|mesh-list
64667797|NCT02870283|Valproic Acid|valproic acid|mesh-list
64667798|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64667799|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667800|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667801|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
64667802|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64667803|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667804|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667805|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
64667806|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
64667807|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667808|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64667809|NCT02870283|Analgesics|analgesics|mesh-ancestor
64667810|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
64667811|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667812|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64667813|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64667814|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64667815|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64667816|NCT02931045|Clopidogrel|clopidogrel|mesh-list
64667817|NCT02931045|Ticagrelor|ticagrelor|mesh-list
64667818|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64667819|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64667820|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64667821|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64667822|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
64667823|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667824|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667825|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667826|NCT03040011|Dexamethasone|dexamethasone|mesh-list
64667827|NCT03040011|Bupivacaine|bupivacaine|mesh-list
64667828|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64667829|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
64667830|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
64667831|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667832|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667833|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667834|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
64667835|NCT03040011|Hormones|hormones|mesh-ancestor
64667836|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348463|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
64348464|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
64348465|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64348486|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348487|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667837|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64667838|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667839|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
64667840|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
64667841|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667842|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
64667843|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
64667844|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667845|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
64667846|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667847|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667848|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64667849|NCT03040479|Lasmiditan|lasmiditan|mesh-list
64667850|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64667851|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
64667852|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667853|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667854|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667855|NCT02872857|Galantamine|galantamine|mesh-list
64667856|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64667857|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667858|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667859|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
64667860|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64667861|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667862|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64667863|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
64667864|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667865|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
64667866|NCT02996318|Sirolimus|sirolimus|mesh-list
64667867|NCT02996318|Paclitaxel|paclitaxel|mesh-list
64667868|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64667869|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667870|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
64667871|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
64667872|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
64434329|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
64667873|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667874|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64667875|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667876|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64667877|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
64667878|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64667879|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
64667880|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667882|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64667883|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
64667884|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667885|NCT05197751|Antacids|antacids|mesh-ancestor
64667886|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667887|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667888|NCT02994602|ST 1435|st 1435|mesh-list
64667889|NCT02994602|Testosterone|testosterone|mesh-list
64667890|NCT02994602|Androgens|androgens|mesh-ancestor
64667891|NCT02994602|Hormones|hormones|mesh-ancestor
64667892|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667893|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667894|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64667895|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
64667896|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64667897|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64667898|NCT03297710|Trifluridine|trifluridine|mesh-list
64667900|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667901|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
64667902|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667903|NCT04350671|Interferons|interferons|mesh-list
64667904|NCT04350671|Ritonavir|ritonavir|mesh-list
64667905|NCT04350671|Lopinavir|lopinavir|mesh-list
64667906|NCT04350671|Interferon-beta|interferon-beta|mesh-list
64667907|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
64667908|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
64667909|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667910|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
64667911|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64667912|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64667913|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64667914|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
64667915|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667916|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667917|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64667918|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64667919|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64667920|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64667921|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
64667922|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64667923|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64667924|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64667925|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
64667926|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667927|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64667929|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64667930|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667931|NCT05166083|Testosterone|testosterone|mesh-list
64667932|NCT05166083|Androgens|androgens|mesh-ancestor
64667933|NCT05166083|Hormones|hormones|mesh-ancestor
64667934|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667935|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667936|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64667937|NCT04826354|Ezetimibe|ezetimibe|mesh-list
64667938|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64667939|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64667940|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
64667941|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667942|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64667943|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64667945|NCT04707794|Sevoflurane|sevoflurane|mesh-list
64667946|NCT04707794|Desflurane|desflurane|mesh-list
64667947|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64667948|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64667949|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
64667950|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
64667951|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64667952|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667953|NCT04667312|Durvalumab|durvalumab|mesh-list
64667954|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64667955|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667956|NCT02759588|Bevacizumab|bevacizumab|mesh-list
64667957|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64667958|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667959|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64667960|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64667961|NCT02759588|Growth Substances|growth substances|mesh-ancestor
64667962|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667963|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
64348488|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
64348489|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348490|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64348491|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
64667964|NCT03045861|Cobicistat|cobicistat|mesh-list
64348492|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64667965|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
64667966|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64667967|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64667968|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
64350901|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64667969|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434436|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667970|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64667971|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64667972|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64667973|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64667975|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64667976|NCT02697344|Acetic Acid|acetic acid|mesh-list
64667977|NCT02697344|Dexamethasone|dexamethasone|mesh-list
64667978|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
64667979|NCT02697344|Lenalidomide|lenalidomide|mesh-list
64667980|NCT02697344|Retinol acetate|retinol acetate|mesh-list
64667981|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
64667983|NCT02697344|BB 1101|bb 1101|mesh-list
64667984|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64667985|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
64667986|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
64667987|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64667988|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64667989|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64667990|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
64667991|NCT02697344|Hormones|hormones|mesh-ancestor
64667992|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64667993|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64667994|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64667995|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
64667996|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64667997|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64667998|NCT02697344|Growth Substances|growth substances|mesh-ancestor
64667999|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
64668000|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
64668001|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668002|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668003|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668004|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668005|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64668006|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64668007|NCT02697344|Protective Agents|protective agents|mesh-ancestor
64668008|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64668009|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
64668010|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64668011|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64668012|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64668013|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64668014|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64668015|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
64668016|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64668017|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
64668018|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668019|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64668020|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668021|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64668022|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668023|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64668024|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668026|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
64668027|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668028|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
64668029|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668030|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668032|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
64668033|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668034|NCT04976777|Dexamethasone|dexamethasone|mesh-list
64668035|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668038|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668039|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668040|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668041|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
64668042|NCT04976777|Hormones|hormones|mesh-ancestor
64668043|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350903|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
64668044|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64668045|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668046|NCT02247596|Resveratrol|resveratrol|mesh-list
64668047|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
64668048|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668049|NCT02247596|Protective Agents|protective agents|mesh-ancestor
64668050|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668051|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668052|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64668053|NCT03686657|Metformin|metformin|mesh-list
64668054|NCT03686657|Celecoxib|celecoxib|mesh-list
64668056|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64668057|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668058|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64668059|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64668060|NCT03686657|Analgesics|analgesics|mesh-ancestor
64668061|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
64668062|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668063|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668064|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668065|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64668066|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64668067|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668068|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348496|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348498|NCT05098119|Carboplatin|carboplatin|mesh-list
64348499|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64348500|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348540|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
64348541|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64348542|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64393417|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
64668069|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64668070|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64668071|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64668072|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
64668073|NCT02476058|Promethazine|promethazine|mesh-list
64668074|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64668075|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64668076|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668077|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668078|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
64668079|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
64668080|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
64668081|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668082|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
64668083|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
64668084|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668085|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64668086|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
64668087|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
64668088|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668089|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668091|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
64668092|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668094|NCT02143466|Osimertinib|osimertinib|mesh-list
64668095|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64434595|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668096|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434596|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668097|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668099|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668100|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64668101|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668102|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668103|NCT03050619|Empagliflozin|empagliflozin|mesh-list
64668104|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64668105|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668106|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64668107|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668108|NCT02071394|Xenon|xenon|mesh-list
64668109|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64668110|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
64668111|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
64668112|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668113|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668114|NCT01911065|Vaccines|vaccines|mesh-list
64668115|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
64668116|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668117|NCT02995772|Tamoxifen|tamoxifen|mesh-list
64668118|NCT02995772|Fluorouracil|fluorouracil|mesh-list
64668119|NCT02995772|Letrozole|letrozole|mesh-list
64668120|NCT02995772|Anastrozole|anastrozole|mesh-list
64668121|NCT02995772|Exemestane|exemestane|mesh-list
64668122|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64668123|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
64668124|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668125|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348543|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348544|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64348546|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64348547|NCT03468907|Tenofovir|tenofovir|mesh-list
64348548|NCT03468907|Telbivudine|telbivudine|mesh-list
64668126|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668127|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64668128|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
64668129|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668130|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668131|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64668132|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64668133|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
64668134|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668135|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64668136|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64668137|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64668138|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64668141|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
64668142|NCT02987465|Hematinics|hematinics|mesh-ancestor
64668143|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64668144|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64668146|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668147|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668148|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668149|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
64668150|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
64668151|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668152|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64668153|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
64668154|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64668155|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
64668156|NCT04895579|Durvalumab|durvalumab|mesh-list
64668157|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64668158|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668159|NCT02227316|Acetaminophen|acetaminophen|mesh-list
64668160|NCT02227316|Ibuprofen|ibuprofen|mesh-list
64668161|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64668162|NCT02227316|Analgesics|analgesics|mesh-ancestor
64668163|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
64668164|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668165|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668166|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
64668167|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64668168|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668169|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668170|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64668171|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668172|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668173|NCT00555971|Omalizumab|omalizumab|mesh-list
64668174|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64668175|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64668176|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
64668177|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
64668178|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
64668179|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
64668180|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348594|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64348596|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348597|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
64348598|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348599|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64348600|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348601|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64348602|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64348603|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64668181|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668182|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668183|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64668184|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64668185|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668186|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668187|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64668188|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
64668189|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668190|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668191|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
64668193|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
64668194|NCT01850108|Fludarabine|fludarabine|mesh-list
64668195|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
64434681|NCT02343263|Bupivacaine|bupivacaine|mesh-list
64668196|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64668198|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668199|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668200|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64668201|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
64668202|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668203|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668204|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64668205|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64668206|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64668207|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
64668208|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668209|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668210|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668211|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
64668212|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
64668214|NCT01822652|Fludarabine|fludarabine|mesh-list
64668215|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
64668216|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64668217|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
64668218|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668219|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393569|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
64668220|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64668221|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
64668222|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668223|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668224|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64668225|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64668226|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64668227|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
64668228|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64668229|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64668230|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668231|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668232|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64668233|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64668234|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668235|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
64668236|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668237|NCT01338740|Adalimumab|adalimumab|mesh-list
64668238|NCT01338740|Infliximab|infliximab|mesh-list
64668239|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668240|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668241|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
64350906|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
64668242|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668243|NCT02944461|Dapsone|dapsone|mesh-list
64668244|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668245|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
64668246|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64668247|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64668248|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64668249|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668250|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668252|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668253|NCT05376722|Prednisone|prednisone|mesh-list
64668254|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668255|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
64668256|NCT05376722|Hormones|hormones|mesh-ancestor
64668257|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668258|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668259|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64668260|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668261|NCT04737057|Fluorides|fluorides|mesh-list
64668262|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
64668263|NCT04737057|Protective Agents|protective agents|mesh-ancestor
64668264|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668265|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64668266|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64668267|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64668268|NCT03111381|Analgesics|analgesics|mesh-ancestor
64668269|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
64668270|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668271|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668272|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668273|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64668274|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64668275|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668276|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668277|NCT02946489|Ketamine|ketamine|mesh-list
64668278|NCT02946489|Analgesics|analgesics|mesh-ancestor
64668279|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
64668280|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668281|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668282|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64668283|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64668284|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
64668285|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
64668286|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668287|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64668288|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64668289|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668290|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668291|NCT02949921|Lidocaine|lidocaine|mesh-list
64668292|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
64668293|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
64668294|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668295|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668296|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
64668297|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668298|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64668299|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64668300|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64668301|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64668302|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668303|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64348604|NCT05390749|Growth Substances|growth substances|mesh-ancestor
64348605|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
64348606|NCT02813655|Cosyntropin|cosyntropin|mesh-list
64348607|NCT02813655|Hormones|hormones|mesh-ancestor
64348608|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668305|NCT02227706|Coagulants|coagulants|mesh-ancestor
64668306|NCT03112863|Vitamin A|vitamin a|mesh-list
64668307|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
64668308|NCT03112863|Vitamins|vitamins|mesh-ancestor
64668309|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
64668310|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668311|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
64668312|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668313|NCT03112863|Protective Agents|protective agents|mesh-ancestor
64668314|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64434882|NCT01987479|Methotrexate|methotrexate|mesh-list
64668315|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668316|NCT05257460|Insulin|insulin|mesh-list
64668317|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64668318|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
64668319|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64668320|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668321|NCT02950467|Psilocybin|psilocybin|mesh-list
64668322|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64668323|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
64668324|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668325|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64668326|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64668327|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
64668328|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668329|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668330|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64668331|NCT01930487|Antioxidants|antioxidants|mesh-list
64668332|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668333|NCT01930487|Protective Agents|protective agents|mesh-ancestor
64668334|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668335|NCT03864068|Inositol|inositol|mesh-list
64668336|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
64668337|NCT03864068|Vitamins|vitamins|mesh-ancestor
64668338|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
64668339|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668340|NCT03063255|Anesthetics|anesthetics|mesh-list
64668341|NCT03063255|Mepivacaine|mepivacaine|mesh-list
64668342|NCT03063255|Rocuronium|rocuronium|mesh-list
64668343|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668344|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668345|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64668346|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64668347|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64668348|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668349|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
64668350|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
64668351|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64668352|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64668353|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434918|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
64668354|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64668355|NCT05245292|Antibodies|antibodies|mesh-list
64668356|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
64668357|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64668358|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
64668359|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
64668360|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668361|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668362|NCT03115827|Carbidopa|carbidopa|mesh-list
64668363|NCT03115827|Droxidopa|droxidopa|mesh-list
64668364|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64668365|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64668366|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
64668367|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668368|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668369|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668377|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
64668378|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668379|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668380|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64668381|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
64668382|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668383|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64668384|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64668385|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668386|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668387|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64668388|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64668389|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
64668390|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
64668391|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668392|NCT05199194|Tenecteplase|tenecteplase|mesh-list
64668393|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64668394|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64668395|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668396|NCT01916681|Misoprostol|misoprostol|mesh-list
64668397|NCT01916681|Oxytocin|oxytocin|mesh-list
64668398|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
64668399|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64668400|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668401|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64668402|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
64668403|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64668404|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668405|NCT05735951|Stiripentol|stiripentol|mesh-list
64668406|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
64668407|NCT01917773|Octreotide|octreotide|mesh-list
64668408|NCT01917773|Bisacodyl|bisacodyl|mesh-list
64668409|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668410|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64668411|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668412|NCT01917773|Cathartics|cathartics|mesh-ancestor
64668413|NCT01917773|Laxatives|laxatives|mesh-ancestor
64668414|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64668415|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668416|NCT01934231|Amoxicillin|amoxicillin|mesh-list
64668417|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
64668418|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
64668419|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64668420|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668421|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668422|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64668423|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64668424|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64668425|NCT01935791|Glucagon|glucagon|mesh-list
64668426|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64668427|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668428|NCT01935791|Hormones|hormones|mesh-ancestor
64348628|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348629|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348630|NCT05331807|Vitamin D|vitamin d|mesh-list
64348631|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
64348632|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
64348633|NCT05331807|Vitamins|vitamins|mesh-list
64348634|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
64348635|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668429|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668430|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668431|NCT01935791|Incretins|incretins|mesh-ancestor
64668432|NCT03074409|Oxytocin|oxytocin|mesh-list
64668433|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
64668434|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64668435|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668436|NCT02955147|Prednisone|prednisone|mesh-list
64668437|NCT02955147|Ustekinumab|ustekinumab|mesh-list
64668438|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668439|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
64668440|NCT02955147|Hormones|hormones|mesh-ancestor
64668441|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64668442|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668443|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64668444|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64668445|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
64668446|NCT03119181|Lidocaine|lidocaine|mesh-list
64668447|NCT03119181|Epinephrine|epinephrine|mesh-list
64668448|NCT03119181|Racepinephrine|racepinephrine|mesh-list
64668449|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64668450|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
64668451|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
64668452|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
64668453|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64668454|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668455|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
64668456|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668457|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64668458|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64668459|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64668460|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64668461|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348636|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64348637|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64348638|NCT02314325|Factor VIII|factor viii|mesh-list
64348639|NCT02314325|Coagulants|coagulants|mesh-ancestor
64348640|NCT02630641|Hormones|hormones|mesh-list
64348641|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348642|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348643|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
64348644|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64348645|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348646|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64348647|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348648|NCT02513329|Bupivacaine|bupivacaine|mesh-list
64348649|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
64348650|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
64348651|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348652|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348653|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
64668462|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64668463|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64668464|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
64668465|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64668466|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64668467|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64668468|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
64668469|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64668470|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
64668471|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
64668472|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
64668473|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64668474|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
64668475|NCT01691534|Clofazimine|clofazimine|mesh-list
64668476|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
64668477|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64668478|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64668479|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668480|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
64668481|NCT01691690|Acetaminophen|acetaminophen|mesh-list
64668482|NCT01691690|Dexamethasone|dexamethasone|mesh-list
64668483|NCT01691690|Midazolam|midazolam|mesh-list
64668484|NCT01691690|Morphine|morphine|mesh-list
64668485|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
64668486|NCT01691690|Ondansetron|ondansetron|mesh-list
64668487|NCT01691690|Propofol|propofol|mesh-list
64668488|NCT01691690|Sevoflurane|sevoflurane|mesh-list
64668489|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64668490|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
64668491|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
64668492|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64668493|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64668494|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64668495|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
64668496|NCT01691690|Hormones|hormones|mesh-ancestor
64435033|NCT01766050|Omeprazole|omeprazole|mesh-list
64300229|NCT02110537|Flecainide|flecainide|mesh-list
64300230|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64300231|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64300233|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64300234|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300235|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
64300236|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64300237|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300238|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300239|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300240|NCT03293277|Analgesics|analgesics|mesh-ancestor
64300241|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
64300247|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300248|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300249|NCT02108743|Albuterol|albuterol|mesh-list
64300250|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64300251|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
64300252|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300253|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300254|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64300255|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
64300256|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
64300277|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300278|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300279|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64300280|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
64300281|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
64300282|NCT05032118|Analgesics|analgesics|mesh-ancestor
64300284|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300285|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64300286|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64435253|NCT01648205|Ranolazine|ranolazine|mesh-list
64300305|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300306|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300307|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64300314|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300315|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300317|NCT03292731|Hormones|hormones|mesh-ancestor
64300318|NCT03553303|Valsartan|valsartan|mesh-list
64300319|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64300320|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64300321|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64300322|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64300323|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300324|NCT03286959|Calcium|calcium|mesh-list
64300325|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64300326|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300327|NCT03292575|Anticoagulants|anticoagulants|mesh-list
64300328|NCT02115529|Nabilone|nabilone|mesh-list
64300329|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
64300330|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
64300331|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300332|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300333|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64300334|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64300335|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64300336|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300337|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64300338|NCT01652716|Exenatide|exenatide|mesh-list
64300350|NCT02251249|Analgesics|analgesics|mesh-ancestor
64300370|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64435454|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
64300373|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300374|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300375|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64300376|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64300377|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
64300378|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300380|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
64300381|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300382|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
64300383|NCT05017454|Valproic Acid|valproic acid|mesh-list
64300384|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300385|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
64348658|NCT02314481|Vemurafenib|vemurafenib|mesh-list
64348659|NCT02314481|Maytansine|maytansine|mesh-list
64348660|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348661|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348695|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348696|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348697|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
64348698|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348699|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64300386|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64300387|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
64300388|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435556|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300401|NCT03292185|Xultophy|xultophy|mesh-list
64300402|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64300403|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300405|NCT03292185|Hormones|hormones|mesh-ancestor
64300406|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300407|NCT04239339|Citalopram|citalopram|mesh-list
64300408|NCT04239339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64300409|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64300410|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64300422|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300423|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
64300429|NCT02109913|Everolimus|everolimus|mesh-list
64300430|NCT02109913|Exemestane|exemestane|mesh-list
64300431|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300432|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300433|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
64300434|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300435|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64300436|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64300437|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300438|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300439|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64300440|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
64300443|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300444|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
64300445|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64300446|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
64300447|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
64300448|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64300449|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
64300450|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300451|NCT02116465|Levodopa|levodopa|mesh-list
64300452|NCT02116465|Carbidopa|carbidopa|mesh-list
64300453|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64300454|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64300455|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64300456|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
64300457|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300458|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300459|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300460|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64300461|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300462|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64300463|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
64300464|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
64300465|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64300466|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64300467|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
64300469|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
64300470|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300471|NCT05016128|Ketamine|ketamine|mesh-list
64300472|NCT05016128|Esketamine|esketamine|mesh-list
64300486|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
64300487|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64300558|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64300559|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64348700|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
64348701|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348702|NCT04345887|Spironolactone|spironolactone|mesh-list
64348703|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64348704|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
64348705|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348706|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300561|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300563|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
64300564|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300565|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300566|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64300567|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64300568|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64300569|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64300570|NCT02111707|Indomethacin|indomethacin|mesh-list
64300571|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64300572|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300573|NCT02111707|Analgesics|analgesics|mesh-ancestor
64300574|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
64300575|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300576|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300578|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300579|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
64300580|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
64300581|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64300582|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64300583|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300584|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300586|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64300587|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300588|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
64300589|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
64300590|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300591|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
64300649|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300651|NCT02117401|Ketamine|ketamine|mesh-list
64300652|NCT02117401|Remifentanil|remifentanil|mesh-list
64300653|NCT02117401|Propofol|propofol|mesh-list
64300654|NCT02117401|Mivacurium|mivacurium|mesh-list
64300655|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64300656|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300657|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300658|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64300659|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
64300660|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
64300661|NCT02117401|Analgesics|analgesics|mesh-ancestor
64300662|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
64300663|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300664|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64348707|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64348708|NCT04345887|Diuretics|diuretics|mesh-ancestor
64348709|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
64348710|NCT02316899|Linaclotide|linaclotide|mesh-list
64348711|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64348712|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
64348713|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348714|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348715|NCT02314871|Morphine|morphine|mesh-list
64348716|NCT02314871|Pirinitramide|pirinitramide|mesh-list
64348717|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64348718|NCT02314871|Narcotics|narcotics|mesh-ancestor
64348721|NCT02314871|Analgesics|analgesics|mesh-ancestor
64300666|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64300667|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300668|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300682|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300684|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300686|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64300687|NCT02251483|Antibodies|antibodies|mesh-list
64300737|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300738|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
64300739|NCT03553537|Hormones|hormones|mesh-ancestor
64300740|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300741|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64300742|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64300743|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
64300744|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
64300745|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
64300746|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64300747|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
64300748|NCT04434170|Valsartan|valsartan|mesh-list
64436011|NCT04877639|Analgesics|analgesics|mesh-ancestor
64300757|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300758|NCT03085784|Aflibercept|aflibercept|mesh-list
64300759|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64300760|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64300761|NCT03085784|Growth Substances|growth substances|mesh-ancestor
64300762|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300763|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
64300764|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64300765|NCT05021276|Basiliximab|basiliximab|mesh-list
64300766|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64300767|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
64300768|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300770|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64300771|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300772|NCT05014490|Analgesics|analgesics|mesh-ancestor
64300773|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
64300774|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300776|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300777|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300794|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
64300795|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64300796|NCT05027126|Vitamins|vitamins|mesh-ancestor
64300797|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
64300798|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300799|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64300800|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64300801|NCT05027126|Analgesics|analgesics|mesh-ancestor
64348722|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
64348723|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348789|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64348790|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
64348791|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
64348792|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64348793|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
64348794|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348795|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348796|NCT02315495|Saxagliptin|saxagliptin|mesh-list
64300802|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
64300803|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300804|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300805|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300806|NCT05027126|Hematinics|hematinics|mesh-ancestor
64300807|NCT02120677|Itraconazole|itraconazole|mesh-list
64300808|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
64300809|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300810|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64300811|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64300812|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300813|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300814|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64300815|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
64300816|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64300843|NCT02112643|Selenium|selenium|mesh-list
64300844|NCT02112643|Selenic Acid|selenic acid|mesh-list
64300845|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
64300846|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436093|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300848|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300849|NCT02112643|Trace Elements|trace elements|mesh-ancestor
64300850|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
64300851|NCT02112721|Vitamin D|vitamin d|mesh-list
64300852|NCT02112721|Vitamins|vitamins|mesh-ancestor
64300853|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
64300854|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300855|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64300856|NCT04434248|Ritonavir|ritonavir|mesh-list
64300857|NCT04434248|Lopinavir|lopinavir|mesh-list
64300858|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
64300859|NCT04434248|Chloroquine|chloroquine|mesh-list
64300860|NCT04434248|Favipiravir|favipiravir|mesh-list
64300861|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64300863|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
64300864|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64300865|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300866|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64300867|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64300868|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
64300869|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300870|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64300871|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64300872|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
64300873|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64300874|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64300875|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64300877|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64300889|NCT02122939|Antidepressive Agents|antidepressive agents|mesh-ancestor
64300890|NCT02122939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64300891|NCT02121457|Selenium|selenium|mesh-list
64300892|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
64300893|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300894|NCT02121457|Protective Agents|protective agents|mesh-ancestor
64300895|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300896|NCT02121457|Trace Elements|trace elements|mesh-ancestor
64300897|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
64300898|NCT02251795|Aspirin|aspirin|mesh-list
64300899|NCT02251795|Ritonavir|ritonavir|mesh-list
64300900|NCT02251795|Darunavir|darunavir|mesh-list
64300901|NCT02251795|Tipranavir|tipranavir|mesh-list
64300902|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64300904|NCT02251795|Analgesics|analgesics|mesh-ancestor
64300905|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
64300906|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64300907|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300908|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64300909|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436179|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
64300933|NCT05013164|Vitamins|vitamins|mesh-ancestor
64300939|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
64300940|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
64300941|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
64300942|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300943|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64300944|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64300945|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
64300946|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300948|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64300949|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
64301126|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64301149|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301151|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
64437621|NCT05127746|Donepezil|donepezil|mesh-list
64437645|NCT05109234|Brivaracetam|brivaracetam|mesh-list
64301184|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64301185|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64301187|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
64301188|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301189|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301190|NCT02122627|Vitamin D|vitamin d|mesh-list
64301191|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
64301192|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
64301193|NCT02122627|Vitamins|vitamins|mesh-list
64301194|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
64301195|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301196|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64301197|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64301198|NCT02122705|Remifentanil|remifentanil|mesh-list
64301199|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64301200|NCT02122705|Narcotics|narcotics|mesh-ancestor
64301201|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301202|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301203|NCT02122705|Analgesics|analgesics|mesh-ancestor
64301204|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
64301205|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301206|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64301207|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64301208|NCT03384225|Cytarabine|cytarabine|mesh-list
64301209|NCT03384225|Fludarabine|fludarabine|mesh-list
64301210|NCT03384225|Busulfan|busulfan|mesh-list
64301211|NCT03384225|Cladribine|cladribine|mesh-list
64301212|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301213|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64301214|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
64301215|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301216|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64301217|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
64301218|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301219|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
64301220|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301221|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
64301222|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64301223|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64301224|NCT05019326|Andrographolide|andrographolide|mesh-list
64301225|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301226|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64438160|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438161|NCT04285229|Ixekizumab|ixekizumab|mesh-list
64438162|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
64438163|NCT04282668|Tretinoin|tretinoin|mesh-list
64438164|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438165|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
64438166|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
64438167|NCT04266301|Azacitidine|azacitidine|mesh-list
64438431|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
64438564|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
64301244|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301245|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64301246|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64301247|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64301248|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
64301249|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64301250|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301252|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
64301253|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
64301254|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301256|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
64301257|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301263|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
64301275|NCT03078842|Zinc|zinc|mesh-list
64439782|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
64301278|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301280|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
64301281|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301283|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
64301285|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64301286|NCT03270033|BB 1101|bb 1101|mesh-list
64301287|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301288|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
64301289|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
64301290|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440549|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
64301295|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441794|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301297|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301298|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
64301299|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301300|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301301|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64443698|NCT02152345|Abatacept|abatacept|mesh-list
64301302|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301303|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64301304|NCT03270033|Analgesics|analgesics|mesh-ancestor
64301305|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
64443855|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64301306|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64301307|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64301308|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64301309|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
64301310|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348802|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64348833|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
64348834|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
64348835|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301360|NCT03269955|Thrombin|thrombin|mesh-list
64301361|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
64301362|NCT03269955|Coagulants|coagulants|mesh-ancestor
64301363|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
64301364|NCT05006846|Narcotics|narcotics|mesh-ancestor
64301365|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64301366|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301367|NCT05006846|Analgesics|analgesics|mesh-ancestor
64301368|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
64301369|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301370|NCT05001074|Tacrolimus|tacrolimus|mesh-list
64301371|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64301372|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
64301373|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301374|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64301375|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301376|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301377|NCT02457520|Isotretinoin|isotretinoin|mesh-list
64301380|NCT02457585|Infliximab|infliximab|mesh-list
64301381|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64301382|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64301383|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64301384|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301385|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
64301386|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
64301387|NCT02457507|Vitamins|vitamins|mesh-ancestor
64301388|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
64301389|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301390|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
64348839|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64348840|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64348841|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64348842|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348843|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348844|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64348845|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64348846|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
64348915|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64348916|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348917|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348918|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64348919|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64348920|NCT04535505|Erythromycin|erythromycin|mesh-list
64301392|NCT03265197|Lidocaine|lidocaine|mesh-list
64301393|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
64301394|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
64301424|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301431|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
64301432|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301433|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301435|NCT03264651|Anastrozole|anastrozole|mesh-list
64301436|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64301437|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301438|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64301439|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64301440|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301441|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301442|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64301443|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
64301444|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301445|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348928|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348929|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348930|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
64301451|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301453|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
64301454|NCT03078062|Hormones|hormones|mesh-ancestor
64301455|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301456|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64301457|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301458|NCT02435992|Ozanimod|ozanimod|mesh-list
64301460|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339110|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301462|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
64301463|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301464|NCT02457351|Itraconazole|itraconazole|mesh-list
64301465|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
64301466|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301467|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64301468|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64340460|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
64301473|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64301474|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301475|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64301478|NCT03077828|Carboplatin|carboplatin|mesh-list
64301479|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
64341742|NCT03484507|Protective Agents|protective agents|mesh-ancestor
64342238|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
64301484|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
64301485|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301486|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64301487|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344393|NCT02230163|Antibodies|antibodies|mesh-list
64344638|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64416663|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351328|NCT03467893|Antacids|antacids|mesh-list
64351601|NCT04749394|Apatinib|apatinib|mesh-list
64352857|NCT04520997|Viscosupplements|viscosupplements|mesh-ancestor
64301493|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
64301494|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
64301495|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
64301496|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
64301585|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301586|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64301587|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64301588|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64301589|NCT03267771|Progesterone|progesterone|mesh-list
64301590|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
64301591|NCT03267771|Progestins|progestins|mesh-ancestor
64348940|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348941|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64348942|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
64349008|NCT04462523|Prednisolone|prednisolone|mesh-list
64301703|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301705|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
64349009|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349010|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
64301706|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64301707|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64301709|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64301710|NCT03266601|Interferons|interferons|mesh-list
64301711|NCT03266601|Ribavirin|ribavirin|mesh-list
64301712|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64301713|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
64301714|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64301715|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
64301716|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64301717|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64301718|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64301719|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
64301720|NCT02458755|Atorvastatin|atorvastatin|mesh-list
64302199|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302200|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64302201|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
64302202|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302203|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64302204|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
64302205|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
64302206|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64302207|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64302208|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64302209|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302210|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
64302211|NCT02455401|Remifentanil|remifentanil|mesh-list
64302212|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64302213|NCT02455401|Narcotics|narcotics|mesh-ancestor
64302214|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302215|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302216|NCT02455401|Analgesics|analgesics|mesh-ancestor
64302238|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64302239|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
64302240|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64302241|NCT02134093|Analgesics|analgesics|mesh-ancestor
64302242|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
64302243|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302244|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64302245|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64302246|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64302247|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
64302248|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302249|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302250|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64302251|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64302252|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64302253|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64302254|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
64302255|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
64302256|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64302257|NCT02134093|Narcotics|narcotics|mesh-ancestor
64302258|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64302259|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64302260|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64302261|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64302262|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64302263|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
64302265|NCT03074786|Emtricitabine|emtricitabine|mesh-list
64416670|NCT01668667|Analgesics|analgesics|mesh-ancestor
64302405|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302407|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
64302482|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302483|NCT03071042|Docetaxel|docetaxel|mesh-list
64302484|NCT03071042|Apatinib|apatinib|mesh-list
64302486|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
64302488|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
64302489|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302490|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64302491|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302493|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64302494|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302495|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
64302496|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
64302498|NCT04989140|Pomalidomide|pomalidomide|mesh-list
64302499|NCT04989140|Ixazomib|ixazomib|mesh-list
64302500|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64302501|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
64302502|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
64302503|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64302504|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302505|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64302506|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
64302507|NCT04989140|Hormones|hormones|mesh-ancestor
64302508|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64302509|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64302510|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302511|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
64302512|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64302513|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64302514|NCT04989140|Growth Substances|growth substances|mesh-ancestor
64302817|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302818|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356885|NCT02421263|Psilocybin|psilocybin|mesh-list
64302849|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
64302850|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
64302851|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64302852|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64302853|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64302854|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64302855|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302856|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
64302857|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
64302858|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64302859|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302860|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64302861|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64302862|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
64302863|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64302864|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64302869|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64302870|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64302871|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
64302872|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64302873|NCT02435680|Antiviral Agents|antiviral agents|mesh-ancestor
64302874|NCT02435680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64302875|NCT02435680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64302876|NCT02435680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64302877|NCT02435680|Immunologic Factors|immunologic factors|mesh-ancestor
64302878|NCT02435680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64302880|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
64349018|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349019|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64349020|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349021|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
64349022|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64303120|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303121|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303122|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64303123|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
64303124|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303126|NCT03576053|Serotonin|serotonin|mesh-list
64303127|NCT03576053|Histamine|histamine|mesh-list
64303128|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
64303129|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
64357613|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
64303160|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303161|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64357644|NCT03380975|Montelukast|montelukast|mesh-list
64303255|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64303256|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64303257|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64303258|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64303259|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303260|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303261|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
64303262|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303263|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303264|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64303265|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303277|NCT03571919|Lidocaine|lidocaine|mesh-list
64303278|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
64303279|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
64303280|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303281|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303282|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
64303283|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303284|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64303285|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64303286|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64303287|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416677|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303312|NCT02137525|Morphine|morphine|mesh-list
64303320|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64303321|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64349071|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
64303323|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
64303325|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64303326|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303327|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
64303328|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303329|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64303330|NCT02842073|Naltrexone|naltrexone|mesh-list
64303331|NCT02842073|Bupropion|bupropion|mesh-list
64303332|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64416678|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64303340|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64303341|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64303342|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303343|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303344|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
64303345|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303346|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64303347|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64303348|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303349|NCT02135887|Leucovorin|leucovorin|mesh-list
64303350|NCT02135887|Folic Acid|folic acid|mesh-list
64303351|NCT02135887|Fluorouracil|fluorouracil|mesh-list
64303352|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
64303353|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
64303354|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
64360280|NCT02512471|Ropivacaine|ropivacaine|mesh-list
64303380|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303381|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64303382|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64303383|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303384|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64303386|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64303387|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64303388|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303389|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303390|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
64303391|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64303392|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64303393|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303394|NCT05579119|Incretins|incretins|mesh-ancestor
64303399|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303400|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303401|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64303403|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64303404|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303405|NCT05709041|Anesthetics|anesthetics|mesh-list
64303406|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303407|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303440|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64303441|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
64303442|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64303443|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64303444|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303445|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303471|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303472|NCT02138539|Hydroquinone|hydroquinone|mesh-list
64303473|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
64303474|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349082|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303475|NCT02138539|Protective Agents|protective agents|mesh-ancestor
64303476|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303477|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64303478|NCT02252419|Acetaminophen|acetaminophen|mesh-list
64303479|NCT02252419|Dexamethasone|dexamethasone|mesh-list
64303480|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64303481|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
64303482|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
64303483|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303484|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303485|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303510|NCT01367275|Irinotecan|irinotecan|mesh-list
64303511|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64303512|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64303513|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303514|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303515|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303516|NCT02138929|Everolimus|everolimus|mesh-list
64303517|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303518|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64303519|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
64360858|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
64303533|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303534|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303535|NCT02842853|Vaccines|vaccines|mesh-list
64303536|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
64303537|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303538|NCT02139241|Ramosetron|ramosetron|mesh-list
64303539|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
64303540|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
64303541|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303542|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303543|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64303544|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64303545|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
64303546|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303547|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303573|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64303575|NCT02130739|Propofol|propofol|mesh-list
64303576|NCT02130739|Ropivacaine|ropivacaine|mesh-list
64303577|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
64303578|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303579|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303580|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64303581|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64303582|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
64303583|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
64303613|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303614|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64303616|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
64303617|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64303618|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64303619|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64303620|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64303621|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
64303622|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303623|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303625|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64303626|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64303627|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64303628|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303629|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416681|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361803|NCT01876953|Idarubicin|idarubicin|mesh-list
64303733|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303734|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303736|NCT03566303|Vitamin K|vitamin k|mesh-list
64303737|NCT03566303|Warfarin|warfarin|mesh-list
64303738|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
64303739|NCT03566303|Vitamins|vitamins|mesh-ancestor
64303740|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
64303741|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362619|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
64303748|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303804|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
64303805|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64350983|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303806|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303807|NCT04916548|Ketamine|ketamine|mesh-list
64303808|NCT04916548|Analgesics|analgesics|mesh-ancestor
64303809|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
64303815|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
64303816|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64303817|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64303818|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64303819|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64303820|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303821|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
64303822|NCT03567629|Leucovorin|leucovorin|mesh-list
64303823|NCT03567629|Bevacizumab|bevacizumab|mesh-list
64303836|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64303837|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
64303838|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64303839|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64303841|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303842|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64303843|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64303844|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
64303845|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64303846|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64303847|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303848|NCT03567629|Antidotes|antidotes|mesh-ancestor
64303849|NCT03567629|Protective Agents|protective agents|mesh-ancestor
64303850|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
64303851|NCT03567629|Vitamins|vitamins|mesh-ancestor
64303852|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
64303853|NCT02783599|Doxorubicin|doxorubicin|mesh-list
64303855|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64303856|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303857|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64303858|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64303859|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64303860|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64303861|NCT03567395|Melatonin|melatonin|mesh-list
64303862|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
64303982|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
64303983|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
64303985|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64303986|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64303987|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
64304012|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
64304013|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64304014|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
64304015|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304016|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304017|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
64304018|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64304019|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304020|NCT05004116|Irinotecan|irinotecan|mesh-list
64304021|NCT05004116|Temozolomide|temozolomide|mesh-list
64304080|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304082|NCT05728892|Melatonin|melatonin|mesh-list
64304083|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
64304084|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304085|NCT05728892|Protective Agents|protective agents|mesh-ancestor
64304086|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304088|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
64304135|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64304136|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64304137|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
64304138|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64304139|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
64304140|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304141|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
64304142|NCT05728346|Protective Agents|protective agents|mesh-ancestor
64304202|NCT03065504|Turmeric extract|turmeric extract|mesh-list
64304203|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
64304204|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304205|NCT03065504|Protective Agents|protective agents|mesh-ancestor
64350992|NCT05604131|Deferiprone|deferiprone|mesh-list
64304206|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304207|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64304209|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64304270|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64304271|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
64304272|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304273|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304274|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64304275|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304276|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304277|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64304278|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
64304279|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304280|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
64304332|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64304333|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
64304334|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304335|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
64304336|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64304337|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64304338|NCT03893630|Aspirin|aspirin|mesh-list
64304360|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64304361|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
64304362|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304363|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64304364|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
64304365|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
64304366|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304367|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
64304368|NCT03065816|Antacids|antacids|mesh-ancestor
64304369|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304370|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304385|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64304386|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304387|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64304388|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
64304389|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
64304390|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64304391|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64304392|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64304393|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64304394|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
64304395|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
64304396|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304397|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304398|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64304399|NCT05619848|Narcotics|narcotics|mesh-ancestor
64304400|NCT05619848|Analgesics|analgesics|mesh-ancestor
64304401|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
64304418|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
64304419|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304420|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364941|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
64304652|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64304700|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64304701|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
64304702|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64304703|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304704|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64304705|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
64304706|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304707|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349096|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349097|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
64304708|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
64304709|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304710|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64304711|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304712|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
64304713|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304714|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64304715|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64304717|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64304718|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64304719|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64304720|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304721|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
64304736|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64304737|NCT00109837|Dexamethasone|dexamethasone|mesh-list
64304738|NCT00109837|Prednisone|prednisone|mesh-list
64304739|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
64304740|NCT00109837|Doxorubicin|doxorubicin|mesh-list
64304741|NCT00109837|Methotrexate|methotrexate|mesh-list
64304742|NCT00109837|Vincristine|vincristine|mesh-list
64304743|NCT00109837|Daunorubicin|daunorubicin|mesh-list
64304744|NCT00109837|Asparaginase|asparaginase|mesh-list
64304745|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
64304746|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
64304747|NCT00109837|Thioguanine|thioguanine|mesh-list
64304748|NCT00109837|Allopurinol|allopurinol|mesh-list
64304749|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64304750|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
64304751|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64304752|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64304753|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64304754|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
64304756|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64304757|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64304758|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64304760|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
64304761|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64304762|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64304764|NCT00109837|Hormones|hormones|mesh-ancestor
64304765|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64304766|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64304767|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64304768|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64304769|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64304770|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64304771|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64304772|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
64304773|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64304795|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64304797|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64304798|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
64304799|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64304800|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64304801|NCT05229445|Insulin|insulin|mesh-list
64305071|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
64369601|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
64305113|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64305114|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
64305115|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64305116|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305117|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64305118|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
64349104|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
64305119|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305121|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
64305123|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305184|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
64305185|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305189|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64305195|NCT02971891|Diuretics|diuretics|mesh-ancestor
64305250|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64305251|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305252|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305253|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305254|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
64305255|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305256|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64305257|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64305258|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64305259|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64305260|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64305261|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305263|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
64305264|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
64305265|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64305274|NCT04251715|Floxuridine|floxuridine|mesh-list
64305275|NCT04251715|BB 1101|bb 1101|mesh-list
64305276|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
64305278|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
64305279|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
64305280|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305281|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305282|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305283|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
64305284|NCT04251715|Hormones|hormones|mesh-ancestor
64305285|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305286|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305287|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305288|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
64305289|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305290|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305315|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305316|NCT02035943|Insulin|insulin|mesh-list
64305317|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64305318|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64305319|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305320|NCT03819413|Antibodies|antibodies|mesh-list
64305321|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
64305322|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
64305323|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305324|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64305325|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305326|NCT02394028|Etrolizumab|etrolizumab|mesh-list
64305327|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305328|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
64305329|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305330|NCT04079621|Primaquine|primaquine|mesh-list
64305331|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
64305332|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64305362|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
64305363|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305364|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64305365|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305366|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305368|NCT03063788|Trace Elements|trace elements|mesh-ancestor
64349150|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
64349151|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64305389|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305390|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64305391|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
64305392|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305393|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305394|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64305395|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305397|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
64305399|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
64305412|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305413|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305414|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305415|NCT02427958|Leuprolide|leuprolide|mesh-list
64305416|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64305417|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
64305418|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64305419|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350994|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
64305420|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305421|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305422|NCT03715127|Psilocybin|psilocybin|mesh-list
64305423|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
64305424|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305425|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64305426|NCT02260037|Epinastine|epinastine|mesh-list
64305427|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64305428|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
64305429|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
64305430|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305431|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305432|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305433|NCT02036489|Prednisone|prednisone|mesh-list
64305434|NCT02036489|Vincristine|vincristine|mesh-list
64305435|NCT02036489|Daunorubicin|daunorubicin|mesh-list
64305436|NCT02036489|Asparaginase|asparaginase|mesh-list
64305437|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
64305438|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64305439|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
64305440|NCT02036489|Hormones|hormones|mesh-ancestor
64305441|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305442|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305443|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305444|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305445|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64305446|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64305447|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64305448|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64305449|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305457|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
64305458|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64305459|NCT02392624|Omalizumab|omalizumab|mesh-list
64305460|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64305461|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64349159|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305463|NCT02047565|Edoxaban|edoxaban|mesh-list
64305464|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64305465|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
64305466|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64305467|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
64305468|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305469|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305470|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
64305471|NCT05701241|Octreotide|octreotide|mesh-list
64305472|NCT05701241|Lanreotide|lanreotide|mesh-list
64305473|NCT05701241|Somatostatin|somatostatin|mesh-list
64305474|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305475|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305476|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305477|NCT05701241|Hormones|hormones|mesh-ancestor
64305478|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305479|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305480|NCT03063866|Fentanyl|fentanyl|mesh-list
64305481|NCT03063866|Midazolam|midazolam|mesh-list
64305483|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64305493|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305494|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64305495|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64305496|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64305497|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64305498|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
64305500|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305501|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305502|NCT02037191|Methotrexate|methotrexate|mesh-list
64305503|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64305504|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
64305505|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64305506|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305507|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305508|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
64305509|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305510|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305511|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64305512|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305513|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64305514|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305515|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
64305516|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305517|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64305518|NCT04980170|Amoxicillin|amoxicillin|mesh-list
64305519|NCT04980170|Clindamycin|clindamycin|mesh-list
64305520|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
64305521|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
64305522|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64305523|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
64305524|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
64305525|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64305526|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305527|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64305533|NCT02387164|Vitamins|vitamins|mesh-ancestor
64305534|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
64305535|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305536|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64305537|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64305538|NCT02047799|Calcitriol|calcitriol|mesh-list
64305539|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64305540|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305541|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64349243|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64305542|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305543|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305544|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64305546|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
64305547|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64305548|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
64305549|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64305550|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305551|NCT02392234|Ivacaftor|ivacaftor|mesh-list
64305552|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64305553|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305554|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305555|NCT02036723|Bevacizumab|bevacizumab|mesh-list
64305556|NCT02036723|Ranibizumab|ranibizumab|mesh-list
64305557|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305558|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305559|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64305560|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64305562|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305563|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
64305564|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64305565|NCT02036879|Norethindrone|norethindrone|mesh-list
64305566|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
64305574|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
64305575|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64305576|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64305577|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64305578|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64305579|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64305580|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64305581|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
64305582|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64305583|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
64305584|NCT02963090|Topotecan|topotecan|mesh-list
64305585|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305586|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305587|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64305588|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64305589|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305590|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305591|NCT02048423|Ketamine|ketamine|mesh-list
64305592|NCT02048423|Analgesics|analgesics|mesh-ancestor
64305593|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
64305594|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305595|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305596|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64305599|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
64305600|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305601|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64305602|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64305603|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305617|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305618|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305619|NCT04979468|Lamivudine|lamivudine|mesh-list
64305620|NCT04979468|Dolutegravir|dolutegravir|mesh-list
64305621|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64305622|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64305623|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305624|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305625|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
64305626|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305627|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64305628|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64349256|NCT03494387|Protective Agents|protective agents|mesh-ancestor
64305629|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64305630|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64305633|NCT03562169|Ixazomib|ixazomib|mesh-list
64305634|NCT03562169|Glycine|glycine|mesh-list
64305635|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64305636|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
64305637|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
64305638|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305639|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305640|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305641|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
64305642|NCT03562169|Hormones|hormones|mesh-ancestor
64305643|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305644|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305645|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305646|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305647|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
64305648|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
64305649|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64305662|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305663|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64305664|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305665|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305666|NCT02050529|Labetalol|labetalol|mesh-list
64305667|NCT02050529|Hydralazine|hydralazine|mesh-list
64305668|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64305669|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64305670|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
64305671|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305672|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305673|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305674|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64305675|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
64305676|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
64305677|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305678|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64305679|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64305680|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
64305681|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64305682|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64305683|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
64305684|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64305685|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64305686|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305687|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305688|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64305696|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305700|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305703|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64305704|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64305705|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64305706|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305707|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
64305708|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64305709|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
64305710|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305711|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305712|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64305713|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
64305714|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349262|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349287|NCT03821545|Analgesics|analgesics|mesh-ancestor
64305716|NCT02620280|Carboplatin|carboplatin|mesh-list
64305717|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64305718|NCT02620280|Atezolizumab|atezolizumab|mesh-list
64305719|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64305720|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305721|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
64305722|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
64305723|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
64305724|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305725|NCT02806973|Glucagon|glucagon|mesh-list
64305726|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305727|NCT02806973|Hormones|hormones|mesh-ancestor
64305728|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305733|NCT02037737|Abatacept|abatacept|mesh-list
64305743|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
64305744|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305745|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305746|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64305747|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64305748|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
64305750|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305756|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305757|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305758|NCT02037815|Mannitol|mannitol|mesh-list
64305759|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64305760|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64305761|NCT02037815|Diuretics|diuretics|mesh-ancestor
64305762|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
64305763|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305764|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64305765|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64305766|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
64305767|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305768|NCT02053727|Abatacept|abatacept|mesh-list
64305769|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64305770|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305771|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305772|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305773|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
64305774|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305775|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305776|NCT02051153|Modafinil|modafinil|mesh-list
64305777|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64305778|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305779|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64305780|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64305781|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64305782|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305783|NCT02807363|Leuprolide|leuprolide|mesh-list
64305784|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64305785|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
64305786|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64305787|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305788|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305789|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305790|NCT02051231|Oxytocin|oxytocin|mesh-list
64305791|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
64305792|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64349295|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64349296|NCT02324933|Narcotics|narcotics|mesh-ancestor
64305793|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305794|NCT02051387|Cannabidiol|cannabidiol|mesh-list
64305795|NCT02051387|Olanzapine|olanzapine|mesh-list
64305796|NCT02051387|Risperidone|risperidone|mesh-list
64305797|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64305798|NCT02051387|Amisulpride|amisulpride|mesh-list
64305799|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64370595|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
64305800|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
64305801|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64305802|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305803|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305804|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64305805|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64305806|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64305807|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64305808|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64305809|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
64305810|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
64305811|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
64305812|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305813|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305818|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
64305819|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64305821|NCT02426086|Imetelstat|imetelstat|mesh-list
64305822|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
64305823|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305824|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305825|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64305826|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
64305827|NCT02426086|Vitamins|vitamins|mesh-ancestor
64305828|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
64305829|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305830|NCT02052167|Methotrexate|methotrexate|mesh-list
64305831|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64305832|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
64305833|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64349331|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
64305834|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305835|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64305837|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305838|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305839|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
64305840|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305841|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64305842|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64305843|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
64305844|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305845|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64305846|NCT03573947|Paclitaxel|paclitaxel|mesh-list
64305847|NCT03573947|Nivolumab|nivolumab|mesh-list
64305848|NCT03573947|Ipilimumab|ipilimumab|mesh-list
64305849|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64305850|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305851|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
64305852|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
64305853|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
64305854|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305855|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64305856|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64305858|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64305859|NCT03524417|Antibodies|antibodies|mesh-list
64305860|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
64305861|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305862|NCT02054429|Insulin|insulin|mesh-list
64305863|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64305864|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64305865|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305866|NCT03806543|Vancomycin|vancomycin|mesh-list
64305867|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64305868|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305869|NCT02052323|Artesunate|artesunate|mesh-list
64305870|NCT02052323|Mefloquine|mefloquine|mesh-list
64305871|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
64305872|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64305882|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64305883|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64305884|NCT02056223|Analgesics|analgesics|mesh-ancestor
64305886|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305887|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305888|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64305889|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305890|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64305891|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305892|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305893|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
64305894|NCT02056379|Dexamethasone|dexamethasone|mesh-list
64305895|NCT02056379|Budesonide|budesonide|mesh-list
64305896|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64305897|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
64305898|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
64305899|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305900|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305901|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64305902|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
64305903|NCT02056379|Hormones|hormones|mesh-ancestor
64305904|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64305905|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64305906|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305907|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64305908|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64305909|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
64305910|NCT02383966|Carboplatin|carboplatin|mesh-list
64305911|NCT02383966|Fluorouracil|fluorouracil|mesh-list
64305912|NCT02383966|Cetuximab|cetuximab|mesh-list
64305913|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305942|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
64349479|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64305943|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64305944|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305945|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64305946|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64305947|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64305951|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64305952|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305954|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
64305955|NCT02056847|Pitavastatin|pitavastatin|mesh-list
64305956|NCT02056847|Calcium|calcium|mesh-list
64305957|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64305958|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305959|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64305960|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64305961|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64305962|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64305963|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
64305964|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305965|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305966|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64305967|NCT02052713|Tamsulosin|tamsulosin|mesh-list
64305968|NCT02052713|Dutasteride|dutasteride|mesh-list
64305969|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64305970|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64305971|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64305972|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64305984|NCT02057003|Ledipasvir|ledipasvir|mesh-list
64305985|NCT02057003|Velpatasvir|velpatasvir|mesh-list
64305986|NCT02057003|Simeprevir|simeprevir|mesh-list
64305987|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
64305988|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64305989|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
64305990|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64305991|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64305992|NCT02055911|Ranibizumab|ranibizumab|mesh-list
64349617|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
64305993|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64305994|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64305995|NCT02055911|Growth Substances|growth substances|mesh-ancestor
64305996|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64305997|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
64305998|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64305999|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64306000|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
64306001|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306002|NCT02390362|Rituximab|rituximab|mesh-list
64306003|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64306004|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306005|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
64306006|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306007|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306009|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
64306010|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64306011|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64306012|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64306013|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306031|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306033|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
64306034|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306035|NCT02801669|Edoxaban|edoxaban|mesh-list
64306036|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64306037|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
64306038|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64306039|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
64306040|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306041|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306053|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64306054|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64306055|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64349677|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349678|NCT02217982|Simethicone|simethicone|mesh-list
64306056|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64306057|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64306059|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64306060|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64306061|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64306062|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306063|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306064|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64306065|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306067|NCT02058875|Cyclosporine|cyclosporine|mesh-list
64306068|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
64306069|NCT02058875|Prednisone|prednisone|mesh-list
64306070|NCT02058875|Cyclosporins|cyclosporins|mesh-list
64306071|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306072|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
64306073|NCT02058875|Hormones|hormones|mesh-ancestor
64306074|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306075|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306076|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64306077|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306078|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306079|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306080|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306081|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
64306082|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
64306083|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306084|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64306085|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306086|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64349776|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64349777|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349778|NCT04461665|Vitamin D|vitamin d|mesh-list
64349779|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
64349781|NCT04461665|Vitamins|vitamins|mesh-list
64306087|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64306088|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64306089|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
64306090|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64306107|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64306108|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64306109|NCT04978688|Relugolix|relugolix|mesh-list
64306110|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
64306111|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
64306112|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306113|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306114|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
64306115|NCT04434326|Vorolanib|vorolanib|mesh-list
64306116|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64306117|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306118|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306119|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
64306120|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64306121|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64306122|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64306123|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306124|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306125|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
64306126|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306127|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306128|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64306129|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306130|NCT02172872|Decitabine|decitabine|mesh-list
64306131|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64306132|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
64306133|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306134|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306135|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306136|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
64306137|NCT02059655|Bimatoprost|bimatoprost|mesh-list
64306138|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64306139|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64306140|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64306141|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64306142|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349938|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
64306154|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64306155|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64306156|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306157|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
64306158|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306159|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64306160|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64306161|NCT02058173|Analgesics|analgesics|mesh-ancestor
64306162|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
64306163|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306164|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306165|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306166|NCT02058173|Filaricides|filaricides|mesh-ancestor
64306167|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
64306168|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
64306169|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
64306170|NCT02060201|Saxagliptin|saxagliptin|mesh-list
64306186|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306187|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64306189|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
64306190|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64306191|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306192|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306193|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64306194|NCT02058485|Analgesics|analgesics|mesh-ancestor
64306195|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
64306196|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350103|NCT02212678|Protective Agents|protective agents|mesh-ancestor
64350104|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350105|NCT02212678|Antidotes|antidotes|mesh-ancestor
64306197|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64306198|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64306199|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64306200|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
64306201|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306202|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306203|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64306204|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64306205|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64306206|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64306207|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64306208|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
64306209|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
64306218|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
64306219|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306221|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
64306227|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306228|NCT02059967|Paclitaxel|paclitaxel|mesh-list
64306229|NCT02059967|Carboplatin|carboplatin|mesh-list
64306230|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64306231|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306232|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
64306233|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
64306234|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
64306235|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306236|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64306237|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64350222|NCT03487133|Bortezomib|bortezomib|mesh-list
64350223|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64350224|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
64306238|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306239|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306240|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
64306241|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306243|NCT02061449|Poly ICLC|poly iclc|mesh-list
64306244|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
64306245|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
64306246|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306247|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64306248|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306249|NCT02060591|Bupivacaine|bupivacaine|mesh-list
64306250|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64306251|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
64306268|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306269|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64350491|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64306270|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64306271|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
64306272|NCT02796755|Riluzole|riluzole|mesh-list
64306273|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
64306274|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64306275|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64306276|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306277|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306278|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306279|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64306280|NCT02796755|Protective Agents|protective agents|mesh-ancestor
64306281|NCT02061917|Lobeline|lobeline|mesh-list
64306282|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64306283|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
64306284|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306285|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370674|NCT02476799|Ketorolac|ketorolac|mesh-list
64306324|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
64306325|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64306326|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
64306327|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306328|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306329|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64306330|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
64306331|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64306332|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64306333|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64306334|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
64306335|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306336|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306337|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
64306338|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64306339|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
64306340|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
64306359|NCT02378506|Analgesics|analgesics|mesh-ancestor
64306360|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
64306361|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306362|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306363|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306364|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306365|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64306366|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306367|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
64306368|NCT02794883|Durvalumab|durvalumab|mesh-list
64306369|NCT02794883|Ipilimumab|ipilimumab|mesh-list
64306370|NCT02794883|Tremelimumab|tremelimumab|mesh-list
64306371|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
64306372|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64306373|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
64306374|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64306375|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306376|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
64306377|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306378|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64306379|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306381|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64306382|NCT02063789|Antibodies|antibodies|mesh-list
64306383|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
64306384|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306385|NCT02063945|Risperidone|risperidone|mesh-list
64306386|NCT02063945|Methylphenidate|methylphenidate|mesh-list
64350585|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306387|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64306388|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
64306389|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306390|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306391|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306392|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64306393|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64306394|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306395|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64306396|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64350669|NCT03477461|Terlipressin|terlipressin|mesh-list
64306397|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
64306398|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64306399|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64306400|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64306411|NCT01370603|Ezetimibe|ezetimibe|mesh-list
64306412|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64306413|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64306414|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
64306415|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306416|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64306417|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64306418|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306419|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
64306420|NCT02659397|Atorvastatin|atorvastatin|mesh-list
64306421|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64306422|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64306423|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
64306424|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306425|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64306426|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64306427|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306428|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306429|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306430|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
64306431|NCT02347072|Bromides|bromides|mesh-list
64306432|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
64306433|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
64306434|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64306435|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
64306436|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306437|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351038|NCT05162417|Methylene Blue|methylene blue|mesh-list
64306438|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64306439|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
64306440|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64306449|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
64306450|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64306451|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64306452|NCT02064491|Paclitaxel|paclitaxel|mesh-list
64306453|NCT02064491|Docetaxel|docetaxel|mesh-list
64306454|NCT02064491|Cisplatin|cisplatin|mesh-list
64306455|NCT02064491|Carboplatin|carboplatin|mesh-list
64350756|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64306456|NCT02064491|Pemetrexed|pemetrexed|mesh-list
64306457|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64306458|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64306459|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306476|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306478|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
64306479|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
64306480|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306481|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64306482|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64306483|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306484|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306485|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64306486|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
64306487|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306488|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306489|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64306490|NCT02068079|Vemurafenib|vemurafenib|mesh-list
64350803|NCT03471455|Itraconazole|itraconazole|mesh-list
64350804|NCT03471455|Terbinafine|terbinafine|mesh-list
64306493|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64306494|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306495|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306496|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
64306497|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
64306498|NCT02793947|Epinephrine|epinephrine|mesh-list
64306499|NCT02793947|Morphine|morphine|mesh-list
64306500|NCT02793947|Ropivacaine|ropivacaine|mesh-list
64306501|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64350887|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64306502|NCT02793947|Narcotics|narcotics|mesh-ancestor
64350888|NCT02522897|Growth Substances|growth substances|mesh-ancestor
64306503|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306504|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306506|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
64370784|NCT04891809|Hormones|hormones|mesh-ancestor
64306510|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64306511|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64306512|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
64306513|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306514|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306515|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64306516|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64306517|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
64306518|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64351050|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306519|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
64306520|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
64306521|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
64306522|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64306523|NCT02068235|Ponesimod|ponesimod|mesh-list
64306524|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64306525|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306526|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306527|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
64306528|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306529|NCT01370213|Interleukin-2|interleukin-2|mesh-list
64306530|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64306531|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306532|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64306533|NCT01370213|Analgesics|analgesics|mesh-ancestor
64306534|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
64306535|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306536|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306537|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
64306538|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306539|NCT02066207|Atorvastatin|atorvastatin|mesh-list
64351153|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64306540|NCT02066207|Fenofibrate|fenofibrate|mesh-list
64306541|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64306542|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64306543|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
64306544|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306545|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64306546|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64306548|NCT01370525|Esomeprazole|esomeprazole|mesh-list
64306555|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306556|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306558|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64306559|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306560|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306561|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64306562|NCT02068625|Protective Agents|protective agents|mesh-ancestor
64306563|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306564|NCT02068859|Diclofenac|diclofenac|mesh-list
64306565|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64306566|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64306567|NCT02068859|Analgesics|analgesics|mesh-ancestor
64306568|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
64306569|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306570|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370824|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306571|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306573|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64306574|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306575|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306577|NCT02068937|Diuretics|diuretics|mesh-ancestor
64306578|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
64306579|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306580|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64306581|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306582|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306583|NCT02066675|Trabectedin|trabectedin|mesh-list
64306584|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64306585|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
64306586|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306587|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306588|NCT02072135|Bupivacaine|bupivacaine|mesh-list
64306589|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
64306590|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
64306591|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351276|NCT05165303|Lidocaine|lidocaine|mesh-list
64351277|NCT05165303|Propofol|propofol|mesh-list
64351278|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
64351279|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
64306592|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306593|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
64306594|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306595|NCT02067065|Propofol|propofol|mesh-list
64306596|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64306597|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306598|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306599|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64306600|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
64306601|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
64306602|NCT02067143|Cytarabine|cytarabine|mesh-list
64306603|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64306604|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
64306605|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306606|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306607|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
64306608|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306609|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306610|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
64306611|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306643|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64351429|NCT04754035|Venetoclax|venetoclax|mesh-list
64306644|NCT04976816|Betamethasone|betamethasone|mesh-list
64306645|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
64306646|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64306647|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
64306648|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64306649|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64306650|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306651|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
64306652|NCT04976816|Hormones|hormones|mesh-ancestor
64306653|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64306654|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306655|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306656|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
64306657|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306673|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
64306674|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64306675|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64306676|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64306677|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64306678|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306679|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306680|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64306681|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64306683|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64306684|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306685|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
64306686|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
64306687|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64306688|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64306689|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306690|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
64306691|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64306692|NCT02067377|Antibodies|antibodies|mesh-list
64306693|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
64306694|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306695|NCT02073149|Iron|iron|mesh-list
64306696|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
64306697|NCT02073149|Trace Elements|trace elements|mesh-ancestor
64306698|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
64306699|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306700|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64306701|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
64306702|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
64306703|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306704|NCT02625974|Nifurtimox|nifurtimox|mesh-list
64306714|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306715|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306716|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
64306717|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306718|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64306719|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64351623|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351624|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306720|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64306721|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64306722|NCT02073227|Metformin|metformin|mesh-list
64306723|NCT02073227|Canagliflozin|canagliflozin|mesh-list
64306724|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64306725|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306726|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64306727|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306728|NCT03060044|Fluticasone|fluticasone|mesh-list
64306730|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64306731|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64306739|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
64306740|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
64306741|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64306742|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64306743|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64306744|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64306745|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
64306746|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306747|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306748|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
64306749|NCT03060044|Hormones|hormones|mesh-ancestor
64306751|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
64306752|NCT03060044|Antidotes|antidotes|mesh-ancestor
64306753|NCT03060044|Protective Agents|protective agents|mesh-ancestor
64306754|NCT02070653|Ticagrelor|ticagrelor|mesh-list
64306755|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64306756|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64306757|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64306758|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64306759|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
64306760|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306761|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306762|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306763|NCT04831892|Isosorbide|isosorbide|mesh-list
64306764|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64306765|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64306766|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64306767|NCT04831892|Diuretics|diuretics|mesh-ancestor
64306768|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
64306769|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306770|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
64306771|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64306772|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371032|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64306774|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64306775|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64306776|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
64306777|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306778|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306779|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306780|NCT03062150|Cycloserine|cycloserine|mesh-list
64306781|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
64306782|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64306783|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306784|NCT03062150|Renal Agents|renal agents|mesh-ancestor
64306794|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306796|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
64306797|NCT02076659|Methotrexate|methotrexate|mesh-list
64306798|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64306799|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
64306800|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64306801|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306802|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64306803|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
64306804|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306805|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64306806|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
64306807|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306808|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64306809|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64306810|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
64306811|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64306812|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64306813|NCT04975724|Citalopram|citalopram|mesh-list
64306814|NCT04975724|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64306815|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64351767|NCT05398679|Rifampin|rifampin|mesh-list
64306816|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306817|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306819|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
64306820|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306821|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64306822|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
64306823|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64306824|NCT02076815|Anagrelide|anagrelide|mesh-list
64306825|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64306826|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64306827|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306828|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64306829|NCT02071043|Capecitabine|capecitabine|mesh-list
64306832|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
64306865|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64306866|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64306867|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306868|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
64306869|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306870|NCT04963088|Capecitabine|capecitabine|mesh-list
64306871|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
64306872|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64351866|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64306873|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
64306874|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306920|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
64306921|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
64306949|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64306950|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306952|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64306953|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64306954|NCT02071433|Trace Elements|trace elements|mesh-ancestor
64306955|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
64306956|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306957|NCT04962308|Vaccines|vaccines|mesh-list
64306958|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
64306970|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64306971|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64306972|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64306973|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306974|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64306975|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64306976|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64306996|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64306997|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64306998|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64306999|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307000|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64307001|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64307003|NCT04961918|Lenvatinib|lenvatinib|mesh-list
64307004|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307005|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307006|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307007|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307008|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307009|NCT04954040|Azithromycin|azithromycin|mesh-list
64351931|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351932|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351935|NCT05303311|Meperidine|meperidine|mesh-list
64307011|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64307012|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307013|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
64307014|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64307015|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64307016|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307017|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307018|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307019|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
64307020|NCT04424654|Testosterone|testosterone|mesh-list
64307021|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
64307022|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
64307023|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64307024|NCT04424654|Androgens|androgens|mesh-ancestor
64307025|NCT04424654|Hormones|hormones|mesh-ancestor
64307026|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307027|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307028|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64307029|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307030|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
64307052|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307054|NCT04968002|Apatinib|apatinib|mesh-list
64307055|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307056|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307057|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307058|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307059|NCT04961138|Lenvatinib|lenvatinib|mesh-list
64307060|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307061|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307062|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307063|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307064|NCT03061136|Clonazepam|clonazepam|mesh-list
64307065|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
64307066|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
64307067|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
64307068|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307069|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307078|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
64307079|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64307080|NCT02080169|Fentanyl|fentanyl|mesh-list
64307081|NCT02080169|Midazolam|midazolam|mesh-list
64307082|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
64307083|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64307084|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307085|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307086|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64307087|NCT02080169|Analgesics|analgesics|mesh-ancestor
64307088|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
64307089|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307090|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64307091|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64307092|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64352039|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
64307093|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
64307094|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307095|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307096|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64307097|NCT02080169|Narcotics|narcotics|mesh-ancestor
64307098|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64307099|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64307100|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
64307101|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
64307102|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64307103|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64307104|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64307105|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
64307106|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
64307107|NCT02078063|Mepivacaine|mepivacaine|mesh-list
64307108|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
64307109|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
64307110|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307111|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307112|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
64307113|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307114|NCT04951856|Evolocumab|evolocumab|mesh-list
64307115|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64307116|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64307117|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
64307118|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307119|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64307120|NCT04951232|Cinepazide|cinepazide|mesh-list
64307121|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
64307122|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
64307139|NCT02076191|Decitabine|decitabine|mesh-list
64307140|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64307141|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
64307142|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307143|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307144|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307145|NCT02080715|Tolcapone|tolcapone|mesh-list
64307146|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64307147|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64307148|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64307149|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307150|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307151|NCT04965662|Tenofovir|tenofovir|mesh-list
64307152|NCT04965662|Emtricitabine|emtricitabine|mesh-list
64307153|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64307154|NCT04965662|Maraviroc|maraviroc|mesh-list
64307155|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
64307156|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307157|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64307158|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64307159|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307160|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307161|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64307162|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64307163|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64307164|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64307165|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64307166|NCT02078609|Midostaurin|midostaurin|mesh-list
64307167|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307180|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64307181|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64307182|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
64307183|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307184|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307185|NCT02083991|Prednisolone|prednisolone|mesh-list
64352137|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307186|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
64307187|NCT02083991|Basiliximab|basiliximab|mesh-list
64352138|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
64307188|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307189|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
64307190|NCT02083991|Hormones|hormones|mesh-ancestor
64307191|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307192|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307193|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64307194|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307195|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
64307196|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307197|NCT02081027|Riluzole|riluzole|mesh-list
64307198|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
64307199|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64352177|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64352181|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
64307238|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64307239|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307240|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307241|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64307292|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307293|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307294|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307295|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307297|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
64307298|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307299|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
64307300|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64307301|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
64307302|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64352315|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
64352316|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64352317|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
64307303|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64307304|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
64307305|NCT03241563|Triamcinolone|triamcinolone|mesh-list
64307306|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
64307307|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307308|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
64307309|NCT03241563|Hormones|hormones|mesh-ancestor
64307310|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307311|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307312|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64307313|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307314|NCT03241641|Tenofovir|tenofovir|mesh-list
64307315|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
64307316|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307317|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64307318|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64307319|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352397|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64307321|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64307322|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64307323|NCT04486521|Siltuximab|siltuximab|mesh-list
64307324|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307325|NCT04955834|Insulin|insulin|mesh-list
64307326|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64307327|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307328|NCT03241407|Triclosan|triclosan|mesh-list
64307329|NCT03241407|Fluorides|fluorides|mesh-list
64307330|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
64307331|NCT03241407|Protective Agents|protective agents|mesh-ancestor
64307332|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307333|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64307334|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307335|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64307336|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64307337|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
64307338|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307339|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64307340|NCT03238131|Ivermectin|ivermectin|mesh-list
64307342|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64307343|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307344|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
64307345|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
64307346|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64307347|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64307377|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307378|NCT04946162|Urological Agents|urological agents|mesh-ancestor
64307379|NCT02084225|Lidocaine|lidocaine|mesh-list
64307380|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
64307381|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
64307382|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307383|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307388|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64307389|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307390|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307391|NCT04945694|Fentanyl|fentanyl|mesh-list
64307392|NCT04945694|Propofol|propofol|mesh-list
64307393|NCT04945694|Sevoflurane|sevoflurane|mesh-list
64307394|NCT04945694|Atracurium|atracurium|mesh-list
64307395|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64307396|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307397|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307398|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64307399|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
64307400|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
64307401|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64307402|NCT04945694|Narcotics|narcotics|mesh-ancestor
64307403|NCT04945694|Analgesics|analgesics|mesh-ancestor
64307404|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
64307405|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307406|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64307407|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64307408|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64307409|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64307410|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64307411|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64307412|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64307413|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64307414|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
64307415|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307416|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307417|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64307418|NCT02084303|Hematinics|hematinics|mesh-ancestor
64307419|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64352620|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
64307420|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64307421|NCT02420847|Gemcitabine|gemcitabine|mesh-list
64307422|NCT02420847|Doxorubicin|doxorubicin|mesh-list
64307423|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64307425|NCT02420847|Glycine|glycine|mesh-list
64307426|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64307427|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
64307428|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307429|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307430|NCT02420847|Antiviral Agents|antiviral agents|mesh-ancestor
64307431|NCT02420847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307432|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307433|NCT02420847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307434|NCT02420847|Immunologic Factors|immunologic factors|mesh-ancestor
64307435|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307436|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64307437|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64307438|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64307439|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
64307461|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64307462|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307463|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64307464|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307465|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307466|NCT03240939|Tadalafil|tadalafil|mesh-list
64307473|NCT03240939|Urological Agents|urological agents|mesh-ancestor
64307474|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64307475|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64307476|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
64307477|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307478|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307479|NCT02624492|Rituximab|rituximab|mesh-list
64307480|NCT02624492|BI 836826|bi 836826|mesh-list
64307481|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307482|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307483|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
64307484|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307485|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307486|NCT03240783|Dexamethasone|dexamethasone|mesh-list
64307487|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
64307488|NCT03240783|Betamethasone|betamethasone|mesh-list
64307489|NCT03240783|BB 1101|bb 1101|mesh-list
64307490|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307491|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
64307492|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
64307493|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307494|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307495|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307501|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
64307502|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307503|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307504|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64307505|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
64307506|NCT03237507|Paclitaxel|paclitaxel|mesh-list
64307507|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
64307508|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64307509|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307510|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
64307511|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
64307512|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
64307513|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307514|NCT04945226|Finasteride|finasteride|mesh-list
64307515|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64307516|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64307517|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307518|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307519|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
64307520|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307521|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307522|NCT04945226|Urological Agents|urological agents|mesh-ancestor
64307523|NCT01975831|Durvalumab|durvalumab|mesh-list
64307524|NCT01975831|Tremelimumab|tremelimumab|mesh-list
64307525|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307526|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307527|NCT04945070|Insulin|insulin|mesh-list
64352783|NCT03596073|Calcipotriene|calcipotriene|mesh-list
64307528|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64307529|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307531|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64307532|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
64307538|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307539|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64307540|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307541|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307542|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
64307543|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307544|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64307545|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64307546|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64307547|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
64307548|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307549|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307550|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64307551|NCT03240549|Bevacizumab|bevacizumab|mesh-list
64307552|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307553|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307554|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64307555|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64307556|NCT03240549|Growth Substances|growth substances|mesh-ancestor
64307557|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307558|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
64307559|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
64307560|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
64307561|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64307562|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64307563|NCT04933292|Prednisolone|prednisolone|mesh-list
64307564|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
64307565|NCT04933292|Azathioprine|azathioprine|mesh-list
64307566|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64307567|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
64307568|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64307580|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307581|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307582|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
64307584|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307585|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64307586|NCT04933292|Protective Agents|protective agents|mesh-ancestor
64307587|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64307588|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
64307589|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64352828|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64307590|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307591|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
64307592|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307594|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64307600|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64307601|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307602|NCT03237117|Hormones|hormones|mesh-list
64307603|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64307604|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307605|NCT03239691|ACT-709478|act-709478|mesh-list
64307606|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64307607|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307608|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307609|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64307610|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307611|NCT04944602|Omalizumab|omalizumab|mesh-list
64307612|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64307613|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64307614|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
64307615|NCT03253107|Trastuzumab|trastuzumab|mesh-list
64307616|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307617|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307618|NCT03236883|Gemcitabine|gemcitabine|mesh-list
64307619|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64307620|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
64307621|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307622|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307623|NCT03236883|Antiviral Agents|antiviral agents|mesh-ancestor
64307624|NCT03236883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307625|NCT03236883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307626|NCT03236883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64307627|NCT03236883|Immunologic Factors|immunologic factors|mesh-ancestor
64307628|NCT03236883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307629|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
64307630|NCT03236961|Metronidazole|metronidazole|mesh-list
64307631|NCT03236961|Levofloxacin|levofloxacin|mesh-list
64307632|NCT03236961|Ertapenem|ertapenem|mesh-list
64307633|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64307634|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307635|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64307636|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64307637|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307638|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307639|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307640|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64307641|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64307642|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64307643|NCT03236961|Renal Agents|renal agents|mesh-ancestor
64307644|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64307645|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64307646|NCT05234619|Ketorolac|ketorolac|mesh-list
64307647|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64307648|NCT05234619|Lidocaine|lidocaine|mesh-list
64307663|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307664|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307665|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64307666|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307667|NCT04921904|Ramucirumab|ramucirumab|mesh-list
64307668|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352876|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352877|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64307671|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
64307672|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307673|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
64307674|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64307675|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
64307676|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
64307677|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64307678|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64307679|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307680|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
64307681|NCT04427618|Coagulants|coagulants|mesh-ancestor
64307682|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
64307683|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64307684|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64307685|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307686|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64307687|NCT03236727|Analgesics|analgesics|mesh-ancestor
64307688|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
64307689|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307690|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64307691|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64307692|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64307693|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64307694|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307695|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307696|NCT03236493|PF-06700841|pf-06700841|mesh-list
64307697|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307698|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307711|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64307712|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64307713|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64307714|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
64307715|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
64307716|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
64307717|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
64307718|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307719|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307720|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
64307721|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
64307722|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307723|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64307724|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64307725|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64307726|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307727|NCT02792231|Teriflunomide|teriflunomide|mesh-list
64307729|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64307730|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307731|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
64307732|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307733|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64307734|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64307735|NCT02792231|Analgesics|analgesics|mesh-ancestor
64307736|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
64307737|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307738|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64307739|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307740|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371453|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64307754|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64307755|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
64307756|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307757|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
64307758|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307759|NCT04931108|Atenolol|atenolol|mesh-list
64307760|NCT04931108|Nitrendipine|nitrendipine|mesh-list
64307761|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64307762|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64307763|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
64307764|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
64307765|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307766|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307767|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64307768|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64307769|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64307770|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
64307771|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307772|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307773|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64307774|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64307797|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307798|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307800|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64307801|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64307802|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64307803|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307829|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64307830|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64351059|NCT05161403|Protective Agents|protective agents|mesh-ancestor
64351060|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
64351061|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64351062|NCT03166085|Paclitaxel|paclitaxel|mesh-list
64351064|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64307831|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
64307832|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
64307833|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
64307834|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
64307835|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307836|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307837|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
64307863|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64307864|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307865|NCT02081339|Ranibizumab|ranibizumab|mesh-list
64307866|NCT02081339|Aflibercept|aflibercept|mesh-list
64307867|NCT02081339|Verteporfin|verteporfin|mesh-list
64307868|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64307869|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64307870|NCT02081339|Growth Substances|growth substances|mesh-ancestor
64307871|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307872|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64307873|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307874|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64307875|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
64307877|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64307878|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307879|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64307880|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
64307881|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307882|NCT03234387|Acetylcholine|acetylcholine|mesh-list
64307883|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307884|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
64307885|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64307886|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
64307887|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64307888|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307889|NCT03235947|Trimethoprim|trimethoprim|mesh-list
64307890|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
64307891|NCT03235947|Fosfomycin|fosfomycin|mesh-list
64307892|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64307893|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307895|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
64307896|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64307897|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64307898|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64307899|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307900|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307901|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64307902|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64307903|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64307904|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64307905|NCT03057470|Insulin|insulin|mesh-list
64307906|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64307907|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64307908|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307909|NCT02871401|Valganciclovir|valganciclovir|mesh-list
64307910|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
64307911|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307912|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
64307913|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307914|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307915|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307916|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307917|NCT02085005|Capecitabine|capecitabine|mesh-list
64307918|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
64307927|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307928|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
64307929|NCT03235869|Durvalumab|durvalumab|mesh-list
64307930|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307931|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307932|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64307933|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
64307934|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307935|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
64351066|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
64351067|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
64351068|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
64351069|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351070|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
64351095|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351096|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351097|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
64351099|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64351100|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
64351101|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351102|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351103|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351105|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
64351106|NCT05389943|Vitamin D|vitamin d|mesh-list
64351107|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
64351108|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
64307936|NCT03057314|Calcium|calcium|mesh-list
64352992|NCT04923737|Analgesics|analgesics|mesh-ancestor
64307937|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64307940|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307941|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64307942|NCT02576509|Nivolumab|nivolumab|mesh-list
64307943|NCT02576509|Sorafenib|sorafenib|mesh-list
64307944|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64307945|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307946|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64307947|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307948|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64307949|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307950|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64307951|NCT02081495|Doxorubicin|doxorubicin|mesh-list
64307952|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64307953|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64307954|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64307955|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64307956|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64307957|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64307958|NCT03056846|Sulfalene|sulfalene|mesh-list
64307959|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64307960|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64307968|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64307969|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
64307970|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64307971|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64307972|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64307973|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64308000|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64308001|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351109|NCT05389943|Vitamins|vitamins|mesh-list
64351125|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351127|NCT04492033|Irinotecan|irinotecan|mesh-list
64308002|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308003|NCT04919252|Vedolizumab|vedolizumab|mesh-list
64308004|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308005|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
64308006|NCT04919174|Remifentanil|remifentanil|mesh-list
64308007|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64308008|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308009|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308026|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308027|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308028|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
64308029|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308030|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64308031|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64308032|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64308033|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64308034|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308035|NCT05143489|Lidocaine|lidocaine|mesh-list
64308036|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
64308037|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
64308038|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308039|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308040|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
64308041|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308042|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64308043|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64308044|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64308045|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353021|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64308046|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308047|NCT02085317|Nitroprusside|nitroprusside|mesh-list
64308048|NCT02085317|Acetylcholine|acetylcholine|mesh-list
64308050|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
64308051|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64308052|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308053|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64308054|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
64308055|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308057|NCT03234153|Durvalumab|durvalumab|mesh-list
64308065|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308067|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64308068|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
64308069|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
64308075|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64308076|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64308077|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64308078|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308079|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64308080|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64308081|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64308082|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
64308083|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64351128|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64351129|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351130|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
64351131|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
64351132|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
64351133|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351134|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64351135|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64351136|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308084|NCT04918862|Granisetron|granisetron|mesh-list
64308085|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
64308086|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
64308087|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308088|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308089|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308090|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64308091|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
64308092|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308093|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308094|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
64308095|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64308096|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308097|NCT02081885|Chitosan|chitosan|mesh-list
64308098|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64308099|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64308100|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
64308101|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308102|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64308103|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
64308104|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
64308105|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
64308106|NCT02081885|Coagulants|coagulants|mesh-ancestor
64308107|NCT04431206|Oxytocin|oxytocin|mesh-list
64308108|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
64308109|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64308110|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308111|NCT03235245|Nivolumab|nivolumab|mesh-list
64308112|NCT03235245|Ipilimumab|ipilimumab|mesh-list
64353026|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64308113|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308114|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308115|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64308116|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308117|NCT02452281|Ipilimumab|ipilimumab|mesh-list
64308118|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308119|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308120|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64308121|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308122|NCT02452125|Nicotine|nicotine|mesh-list
64308123|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64308124|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
64308125|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308126|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308127|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64308128|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64308129|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
64308146|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
64308147|NCT04928066|Hormones|hormones|mesh-ancestor
64308148|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64308149|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308150|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64308151|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308152|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64308153|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308179|NCT03222687|Prednisone|prednisone|mesh-list
64308180|NCT03222687|Tacrolimus|tacrolimus|mesh-list
64308181|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64308182|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
64308183|NCT03222687|Hormones|hormones|mesh-ancestor
64308184|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64308185|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308186|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64308187|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308188|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64308190|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64308191|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308192|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308193|NCT03055442|Inositol|inositol|mesh-list
64308194|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
64308195|NCT03055442|Vitamins|vitamins|mesh-ancestor
64308196|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
64308197|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308198|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
64308199|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
64308200|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308201|NCT03226431|Protective Agents|protective agents|mesh-ancestor
64308202|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308203|NCT03226431|Vitamins|vitamins|mesh-ancestor
64308204|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
64308205|NCT02451579|Cetirizine|cetirizine|mesh-list
64371635|NCT03301025|Pregabalin|pregabalin|mesh-list
64308212|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308213|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308215|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
64308216|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
64308217|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308218|NCT03233295|Vitamin D|vitamin d|mesh-list
64308219|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
64308220|NCT03233295|Vitamins|vitamins|mesh-ancestor
64308221|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
64308222|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308223|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64308224|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64308226|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
64308227|NCT04917458|Vitamins|vitamins|mesh-ancestor
64308228|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
64308229|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308230|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64308231|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64308232|NCT03225963|Temozolomide|temozolomide|mesh-list
64308233|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64308234|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
64308235|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308236|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308237|NCT03221907|Pregabalin|pregabalin|mesh-list
64308238|NCT03221907|Analgesics|analgesics|mesh-ancestor
64308239|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
64308240|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353095|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
64308241|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308242|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
64308261|NCT03107481|Analgesics|analgesics|mesh-ancestor
64308262|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
64308263|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308264|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308265|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
64308266|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64308267|NCT03107481|Narcotics|narcotics|mesh-ancestor
64308268|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308269|NCT04934852|Ephedrine|ephedrine|mesh-list
64308270|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
64308271|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64308272|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308273|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
64308274|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
64308275|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308276|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64308277|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308278|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308279|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308280|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64308281|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64308282|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
64308283|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
64308284|NCT04934618|Irinotecan|irinotecan|mesh-list
64308285|NCT04934618|Apatinib|apatinib|mesh-list
64308286|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64308287|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64308288|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308289|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308290|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308291|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64308292|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64308293|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64308294|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308295|NCT04916522|Colchicine|colchicine|mesh-list
64308296|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
64308297|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64308298|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
64353343|NCT03783351|Ticagrelor|ticagrelor|mesh-list
64308299|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
64308300|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
64308301|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308302|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308303|NCT04407650|Metformin|metformin|mesh-list
64308304|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64308305|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64308306|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308307|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64308324|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
64308325|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353379|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353380|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
64308326|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308328|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64308329|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64308330|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64308331|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64308332|NCT04913402|Sufentanil|sufentanil|mesh-list
64308334|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64308335|NCT04913402|Narcotics|narcotics|mesh-ancestor
64308336|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308337|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308338|NCT04913402|Analgesics|analgesics|mesh-ancestor
64308339|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
64308340|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308341|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64308342|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64308343|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
64308344|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
64308345|NCT04912934|Insulin|insulin|mesh-list
64308346|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64308347|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308348|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64308349|NCT04915586|Plasminogen|plasminogen|mesh-list
64308350|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64308351|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64308352|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308353|NCT03232125|Ramosetron|ramosetron|mesh-list
64308354|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
64308370|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308372|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64308373|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64308374|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64308375|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64308376|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371662|NCT02467595|Fentanyl|fentanyl|mesh-list
64308384|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308385|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308386|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64353461|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
64308387|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308388|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64308389|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64308390|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
64308391|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308392|NCT03220425|Insulin|insulin|mesh-list
64308393|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64308394|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
64308395|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
64308396|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
64308397|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
64308398|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64308399|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308400|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64308401|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64308413|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308414|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64308415|NCT03220113|Thiamine|thiamine|mesh-list
64308416|NCT03220113|Dexamethasone|dexamethasone|mesh-list
64308417|NCT03220113|Lidocaine|lidocaine|mesh-list
64308418|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64308419|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
64308420|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
64308421|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353546|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64308422|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308424|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
64308425|NCT03220113|Hormones|hormones|mesh-ancestor
64308426|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64308427|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64308428|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308429|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
64308430|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
64308431|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308432|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
64308433|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64308434|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64308435|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64308436|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64308437|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308438|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
64308439|NCT03220113|Vitamins|vitamins|mesh-ancestor
64308440|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
64308441|NCT02254525|Ibuprofen|ibuprofen|mesh-list
64308442|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64308443|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64308444|NCT02254525|Analgesics|analgesics|mesh-ancestor
64308445|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
64308446|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308447|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308448|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64308450|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64308451|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308452|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308454|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
64308455|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
64353638|NCT02417246|Metoprolol|metoprolol|mesh-list
64308457|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64308458|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308459|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308460|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
64308461|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64308462|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308463|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308464|NCT02143531|Haloperidol|haloperidol|mesh-list
64308465|NCT02143531|Ondansetron|ondansetron|mesh-list
64308466|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
64308467|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
64308468|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
64308469|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353709|NCT02819635|Upadacitinib|upadacitinib|mesh-list
64308470|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308471|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308472|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
64308473|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
64308474|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64308475|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
64308476|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308477|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308487|NCT04485117|Propofol|propofol|mesh-list
64308494|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64308495|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64308496|NCT00803569|Sargramostim|sargramostim|mesh-list
64308497|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
64308498|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308499|NCT02143687|Sevoflurane|sevoflurane|mesh-list
64308500|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64308501|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64308502|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
64308503|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
64308504|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308505|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308506|NCT02143765|Acarbose|acarbose|mesh-list
64351144|NCT04453423|Pemetrexed|pemetrexed|mesh-list
64308507|NCT02143765|Mitiglinide|mitiglinide|mesh-list
64308508|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64308509|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308510|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308511|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64308512|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308513|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
64308514|NCT02148367|Hematinics|hematinics|mesh-ancestor
64308515|NCT00482833|Methotrexate|methotrexate|mesh-list
64308516|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
64308517|NCT00482833|Idarubicin|idarubicin|mesh-list
64308518|NCT00482833|Tretinoin|tretinoin|mesh-list
64308519|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
64371713|NCT02467673|Hormones|hormones|mesh-ancestor
64308520|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64308521|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
64308543|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64308544|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64308545|NCT04485429|Prednisolone|prednisolone|mesh-list
64308546|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
64353816|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
64308549|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
64308550|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64308551|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
64353817|NCT02413346|Sarecycline|sarecycline|mesh-list
64308553|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308554|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308555|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64308556|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
64308557|NCT04485429|Hormones|hormones|mesh-ancestor
64308558|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64308559|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64308560|NCT04485429|Protective Agents|protective agents|mesh-ancestor
64308561|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64308562|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308563|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
64308564|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64308565|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64308566|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308567|NCT00112957|Vaccines|vaccines|mesh-list
64308568|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
64353925|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
64353926|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353929|NCT02022059|Lidocaine|lidocaine|mesh-list
64308569|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308571|NCT02140801|Ticagrelor|ticagrelor|mesh-list
64308572|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64308573|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64308574|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64308575|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64308576|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
64308577|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308579|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308586|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
64308587|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308588|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
64354077|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64354079|NCT02692339|Hormones|hormones|mesh-ancestor
64308589|NCT03214653|Propofol|propofol|mesh-list
64308590|NCT03214653|Sevoflurane|sevoflurane|mesh-list
64308591|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64308592|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308593|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308594|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64308595|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
64308596|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
64308600|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64308601|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
64308602|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308603|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308604|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308605|NCT02141113|Guanfacine|guanfacine|mesh-list
64308606|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64308607|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64308608|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64308609|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64308636|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
64308637|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
64308638|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
64308639|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
64308640|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308641|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308642|NCT03208257|Esmolol|esmolol|mesh-list
64308643|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64308644|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64308645|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64308646|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308647|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308648|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308649|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308650|NCT02141425|Peficitinib|peficitinib|mesh-list
64308651|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308652|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308654|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
64308655|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308656|NCT02148913|Melphalan|melphalan|mesh-list
64308657|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64308659|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
64308690|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
64308691|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64308692|NCT03211065|Antibodies|antibodies|mesh-list
64308693|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
64308694|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308695|NCT02149459|Metformin|metformin|mesh-list
64308696|NCT02149459|Biguanides|biguanides|mesh-list
64308698|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308699|NCT02376790|Etanercept|etanercept|mesh-list
64308700|NCT02376790|Methotrexate|methotrexate|mesh-list
64308701|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64371833|NCT03299387|Renal Agents|renal agents|mesh-ancestor
64308702|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
64308703|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64308704|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308705|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64308706|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
64308707|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308708|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308709|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
64308710|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308711|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64308712|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64308713|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
64308714|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64308715|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64308716|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64308717|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64308718|NCT02376790|Analgesics|analgesics|mesh-ancestor
64308719|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
64308723|NCT02141737|Lidocaine|lidocaine|mesh-list
64308735|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64354192|NCT02521441|Lenograstim|lenograstim|mesh-list
64308736|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64308737|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64308738|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308739|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64308740|NCT02141737|Narcotics|narcotics|mesh-ancestor
64308741|NCT02141737|Analgesics|analgesics|mesh-ancestor
64308742|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64308743|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64308744|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
64308745|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64308746|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64308747|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64308748|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64308749|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
64308750|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
64308751|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308752|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64308753|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64308754|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64308755|NCT02254447|Candesartan|candesartan|mesh-list
64308756|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
64308788|NCT03209427|Narcotics|narcotics|mesh-ancestor
64308789|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308790|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308791|NCT03209427|Analgesics|analgesics|mesh-ancestor
64308792|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
64308793|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308794|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
64308795|NCT03544723|Nivolumab|nivolumab|mesh-list
64308796|NCT03544723|Durvalumab|durvalumab|mesh-list
64308797|NCT03544723|Atezolizumab|atezolizumab|mesh-list
64308798|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308799|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308800|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64308801|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308802|NCT03209661|Menthol|menthol|mesh-list
64308803|NCT03209661|Nicotine|nicotine|mesh-list
64308804|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64308805|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
64308806|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308807|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308808|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64308809|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64308810|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
64308811|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308812|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308813|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
64308814|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
64308847|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
64308848|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308849|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308850|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64308851|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64308852|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64308853|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64308854|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64308855|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
64308856|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
64354286|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
64308857|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
64308858|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
64308859|NCT04898374|Gemcitabine|gemcitabine|mesh-list
64308860|NCT04898374|Cisplatin|cisplatin|mesh-list
64308861|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308862|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64308863|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
64308864|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308865|NCT04898374|Antiviral Agents|antiviral agents|mesh-ancestor
64308866|NCT04898374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308867|NCT04898374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308868|NCT04898374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64308869|NCT04898374|Immunologic Factors|immunologic factors|mesh-ancestor
64308870|NCT04898374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308871|NCT02521311|Clemastine|clemastine|mesh-list
64308872|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
64308873|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
64308874|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64308875|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
64308876|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
64308877|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64308887|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308888|NCT03206931|Selitrectinib|selitrectinib|mesh-list
64308889|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308890|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308891|NCT02344342|Diuretics|diuretics|mesh-list
64308892|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
64308893|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308894|NCT02452437|Oxycodone|oxycodone|mesh-list
64371968|NCT03069339|Carvedilol|carvedilol|mesh-list
64308895|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64308896|NCT02452437|Narcotics|narcotics|mesh-ancestor
64354304|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64308897|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308898|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308899|NCT02452437|Analgesics|analgesics|mesh-ancestor
64308900|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
64308901|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308902|NCT03208413|Thalidomide|thalidomide|mesh-list
64308903|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64308904|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
64308905|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308906|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
64308907|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64308908|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308909|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64308910|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64308911|NCT03208413|Growth Substances|growth substances|mesh-ancestor
64308912|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
64308913|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308914|NCT03201159|Pentamidine|pentamidine|mesh-list
64308915|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
64308916|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308917|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64308920|NCT02149927|Sevoflurane|sevoflurane|mesh-list
64308932|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64308933|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
64308934|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64308935|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308936|NCT02142829|Bupivacaine|bupivacaine|mesh-list
64308937|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
64354431|NCT03430609|Hormones|hormones|mesh-list
64308938|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
64308939|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308940|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308941|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
64308942|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308943|NCT03200691|Antibodies|antibodies|mesh-list
64308944|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
64308945|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308946|NCT02150161|Lidocaine|lidocaine|mesh-list
64308947|NCT02150161|Fentanyl|fentanyl|mesh-list
64308948|NCT02150161|Ketamine|ketamine|mesh-list
64308949|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
64308950|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
64308951|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64308952|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308953|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
64308954|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64308955|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64308956|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64308957|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64308958|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64308959|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308960|NCT02150161|Analgesics|analgesics|mesh-ancestor
64308961|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64308962|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64308978|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308979|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64308980|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
64308981|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64308982|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
64308983|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308984|NCT02150317|Sorafenib|sorafenib|mesh-list
64308985|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
64308986|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308987|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64308988|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64308989|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64308990|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64308991|NCT02150317|Estrogens|estrogens|mesh-ancestor
64308992|NCT02150317|Hormones|hormones|mesh-ancestor
64372055|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64308998|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
64351145|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64308999|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309000|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309001|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309002|NCT02448069|Argatroban|argatroban|mesh-list
64309003|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
64309004|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64309005|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
64309006|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309008|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
64309022|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64309023|NCT03199989|Capecitabine|capecitabine|mesh-list
64309024|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
64309025|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64309026|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
64309027|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309028|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309029|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
64309030|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309031|NCT03195543|Thrombin|thrombin|mesh-list
64354451|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309032|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
64309033|NCT03195543|Coagulants|coagulants|mesh-ancestor
64309034|NCT03204669|Trace Elements|trace elements|mesh-list
64309035|NCT03204669|Micronutrients|micronutrients|mesh-list
64309036|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309037|NCT03199677|Apatinib|apatinib|mesh-list
64309038|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309039|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64309040|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309041|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309042|NCT02780167|Abrocitinib|abrocitinib|mesh-list
64309043|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64309044|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309045|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309046|NCT02447757|Remifentanil|remifentanil|mesh-list
64309047|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64309048|NCT02447757|Narcotics|narcotics|mesh-ancestor
64309049|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309050|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309051|NCT02447757|Analgesics|analgesics|mesh-ancestor
64309052|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
64309053|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309054|NCT02447835|Olanzapine|olanzapine|mesh-list
64309055|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
64309056|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
64309057|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309058|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309060|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64309061|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64309062|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309063|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64309064|NCT02447835|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64309065|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64309066|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372060|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
64309074|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309076|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64309077|NCT03203967|Narcotics|narcotics|mesh-ancestor
64309078|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309079|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309080|NCT03203967|Analgesics|analgesics|mesh-ancestor
64309081|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
64354460|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309082|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309083|NCT03204045|Fentanyl|fentanyl|mesh-list
64309084|NCT03204045|Oxycodone|oxycodone|mesh-list
64309108|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
64309109|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309110|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64309111|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
64309112|NCT03195153|Protective Agents|protective agents|mesh-ancestor
64309113|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309114|NCT03195309|Fentanyl|fentanyl|mesh-list
64309115|NCT03195309|Ropivacaine|ropivacaine|mesh-list
64309116|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
64309117|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
64309118|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309119|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309120|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
64309121|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309122|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64309123|NCT03195309|Narcotics|narcotics|mesh-ancestor
64309124|NCT03195309|Analgesics|analgesics|mesh-ancestor
64309125|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64309126|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64309127|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
64309128|NCT03198819|Cefotaxime|cefotaxime|mesh-list
64309129|NCT03198819|Cefoxitin|cefoxitin|mesh-list
64309130|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64309131|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309132|NCT02447601|Simvastatin|simvastatin|mesh-list
64309133|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64309134|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64309135|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
64309136|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309137|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64309138|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64309139|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309140|NCT03118713|Metformin|metformin|mesh-list
64309141|NCT03118713|Glimepiride|glimepiride|mesh-list
64309142|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
64309143|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64309144|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309145|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64309146|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309147|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
64309148|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64309149|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309150|NCT03198585|Empagliflozin|empagliflozin|mesh-list
64309151|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64309152|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309153|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64309154|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309155|NCT02447289|Midazolam|midazolam|mesh-list
64309156|NCT02447289|Ketamine|ketamine|mesh-list
64309157|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64309158|NCT02447289|Analgesics|analgesics|mesh-ancestor
64309159|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
64309160|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309161|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309162|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64309163|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64309164|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
64309165|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
64309166|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309167|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64309190|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
64309191|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309192|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
64309193|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309194|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309195|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64309196|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
64309197|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309198|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309199|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64309200|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
64309201|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
64309202|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64309203|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
64309204|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309205|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309206|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
64309207|NCT03203031|Anesthetics|anesthetics|mesh-list
64309208|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309209|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309210|NCT03118479|Anastrozole|anastrozole|mesh-list
64309211|NCT03118479|Testosterone|testosterone|mesh-list
64309212|NCT03118479|Androgens|androgens|mesh-ancestor
64309213|NCT03118479|Hormones|hormones|mesh-ancestor
64309214|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64309215|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309216|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64309217|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309236|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64309237|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64309239|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
64309240|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64309241|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309242|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64309243|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64309244|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64309245|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64309246|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309247|NCT03202875|Insulin|insulin|mesh-list
64309248|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64309249|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
64309250|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
64309251|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64309252|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64309253|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309254|NCT03197571|Leucovorin|leucovorin|mesh-list
64309255|NCT03197571|Paclitaxel|paclitaxel|mesh-list
64309261|NCT03197571|Avelumab|avelumab|mesh-list
64309262|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64309282|NCT03197571|Antidotes|antidotes|mesh-ancestor
64309286|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
64309287|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64309288|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64309289|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64309290|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
64309291|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64309292|NCT02446977|Riboflavin|riboflavin|mesh-list
64309293|NCT02446977|Vitamins|vitamins|mesh-ancestor
64309294|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
64309295|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309296|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
64309297|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64309298|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
64309299|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
64309300|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
64309301|NCT02447055|Melphalan|melphalan|mesh-list
64309302|NCT02447055|Fludarabine|fludarabine|mesh-list
64309303|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
64309304|NCT02447055|Tacrolimus|tacrolimus|mesh-list
64309305|NCT02447055|Lenograstim|lenograstim|mesh-list
64309306|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309307|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
64309308|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309309|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309310|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64309311|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
64309312|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309313|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309314|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64309315|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64309330|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309331|NCT03197493|Levodopa|levodopa|mesh-list
64309332|NCT03197493|Carbidopa|carbidopa|mesh-list
64309333|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64309334|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64309335|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64309336|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
64309337|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309338|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309339|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309340|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64309341|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309342|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64309343|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
64309344|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
64309345|NCT02450175|Everolimus|everolimus|mesh-list
64309346|NCT02450175|Letrozole|letrozole|mesh-list
64309347|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309348|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64354715|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309367|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
64354717|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
64309369|NCT02261077|Scopolamine|scopolamine|mesh-list
64309370|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64309371|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64309372|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
64309373|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
64309374|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309375|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309376|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64309377|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
64309378|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64309379|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
64309380|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309381|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309382|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64309383|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
64309408|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309409|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64309410|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
64309412|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309414|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309415|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
64309416|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64309417|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309418|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64309419|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
64309420|NCT02446353|Megestrol|megestrol|mesh-list
64309421|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64309422|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309423|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
64309424|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64309425|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309426|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64309428|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64309429|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
64309430|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64309461|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64309462|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
64309463|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309465|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
64309466|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64309467|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
64309468|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309469|NCT03197103|Protective Agents|protective agents|mesh-ancestor
64309470|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309473|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
64309474|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309475|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309476|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
64309477|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309478|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309479|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
64309480|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64309481|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354824|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309482|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64309484|NCT03201861|Docetaxel|docetaxel|mesh-list
64309485|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64309486|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64309487|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309488|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
64309489|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
64309490|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
64309491|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309492|NCT03194685|FF-10101|ff-10101|mesh-list
64309493|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64309506|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309507|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64309508|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64309509|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
64309510|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64309511|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64309512|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64309513|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64309514|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64309515|NCT03196401|Durvalumab|durvalumab|mesh-list
64309516|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64309517|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309518|NCT02150707|Liraglutide|liraglutide|mesh-list
64309519|NCT02150707|Exenatide|exenatide|mesh-list
64309520|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64309521|NCT02150707|Glucagon|glucagon|mesh-list
64309522|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64309523|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64309524|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309525|NCT02150707|Incretins|incretins|mesh-ancestor
64309526|NCT02150707|Hormones|hormones|mesh-ancestor
64309527|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64309528|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64309529|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64309530|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
64309531|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309532|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309533|NCT03196479|Ketamine|ketamine|mesh-list
64309534|NCT03196479|Propofol|propofol|mesh-list
64309535|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64309536|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309537|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309538|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64309539|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
64309540|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
64309541|NCT03196479|Analgesics|analgesics|mesh-ancestor
64309542|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
64309543|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309544|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64309545|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64309546|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64309547|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309548|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309550|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
64309551|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64309552|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309553|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354867|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
64309555|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64309556|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309557|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309559|NCT02151721|Vorinostat|vorinostat|mesh-list
64309560|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309561|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64309562|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309563|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309564|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64309565|NCT03201393|Acetaminophen|acetaminophen|mesh-list
64309566|NCT03201393|Naltrexone|naltrexone|mesh-list
64309567|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64309568|NCT03201393|Analgesics|analgesics|mesh-ancestor
64309569|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
64309570|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309571|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309572|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
64309573|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64309574|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64309575|NCT03192969|Abatacept|abatacept|mesh-list
64309576|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
64309579|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309583|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309584|NCT03192969|Hormones|hormones|mesh-ancestor
64309585|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64309586|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
64309587|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
64309588|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309589|NCT03194139|Protective Agents|protective agents|mesh-ancestor
64309590|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309591|NCT03118167|Antioxidants|antioxidants|mesh-list
64309592|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309593|NCT03118167|Protective Agents|protective agents|mesh-ancestor
64309594|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309595|NCT00189267|Imiquimod|imiquimod|mesh-list
64309596|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64309597|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
64309598|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309599|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309600|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
64309601|NCT02444949|Cisplatin|cisplatin|mesh-list
64309602|NCT02444949|Endostar protein|endostar protein|mesh-list
64309604|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64309605|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64309606|NCT02444949|Growth Substances|growth substances|mesh-ancestor
64309607|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309608|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
64309609|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64309610|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64309631|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309633|NCT02343406|Lomustine|lomustine|mesh-list
64309634|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64309635|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
64309636|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309637|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309638|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
64309639|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309640|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
64309641|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309642|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309643|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64309644|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
64309645|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309646|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309647|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64309648|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
64309649|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64309650|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
64309651|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309652|NCT03193749|Amiodarone|amiodarone|mesh-list
64309678|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309679|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
64309680|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309681|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309682|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64309683|NCT02444637|Protective Agents|protective agents|mesh-ancestor
64309684|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
64351196|NCT04453345|Methotrexate|methotrexate|mesh-list
64309685|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64309686|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
64309687|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64309688|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309689|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64309690|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64309691|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64309692|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64309693|NCT02710071|Nebivolol|nebivolol|mesh-list
64309694|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64309695|NCT02710071|Diuretics|diuretics|mesh-ancestor
64309696|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
64309697|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309698|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64309699|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64309700|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309701|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
64309702|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64309703|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64309704|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64309705|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
64309706|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309707|NCT02443545|Deferiprone|deferiprone|mesh-list
64309708|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64309719|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64309720|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309721|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355037|NCT03426085|Hormones|hormones|mesh-ancestor
64309722|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
64309740|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
64309741|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309742|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309743|NCT03190239|Pemetrexed|pemetrexed|mesh-list
64309744|NCT03190239|Apatinib|apatinib|mesh-list
64309745|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309746|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309747|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309748|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64309749|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64372251|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64372284|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309753|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64309754|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309755|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309756|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
64309757|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309758|NCT02443311|Betamethasone|betamethasone|mesh-list
64309759|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
64309760|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64309761|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
64309762|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
64309763|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64309764|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309765|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
64309766|NCT02443311|Hormones|hormones|mesh-ancestor
64309767|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64309768|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309769|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64309770|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
64351203|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351204|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64351205|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
64351206|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64351207|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64351208|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
64309771|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64309801|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309802|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64309803|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64309804|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64309805|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309806|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
64309807|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64309808|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64309809|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
64309810|NCT02373202|Protective Agents|protective agents|mesh-ancestor
64309811|NCT03192111|Entinostat|entinostat|mesh-list
64309812|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309813|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64309814|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309815|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309816|NCT02622074|Paclitaxel|paclitaxel|mesh-list
64309817|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64309818|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
64309819|NCT02622074|Carboplatin|carboplatin|mesh-list
64309820|NCT02622074|Doxorubicin|doxorubicin|mesh-list
64309821|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
64309822|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64309823|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309824|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
64309825|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
64309826|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
64355039|NCT03418597|Anesthetics|anesthetics|mesh-list
64309827|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309829|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
64309830|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309831|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309832|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64309833|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
64309842|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64309843|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64309845|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
64309846|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309847|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309848|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309849|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309850|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64309851|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309852|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309853|NCT05438758|Ketamine|ketamine|mesh-list
64309854|NCT05438758|Esketamine|esketamine|mesh-list
64309855|NCT05438758|Analgesics|analgesics|mesh-ancestor
64309856|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
64309857|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309858|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309859|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64309860|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64309861|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
64309862|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
64309863|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64309864|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64309865|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64309866|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309867|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309889|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
64309890|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
64309891|NCT02342704|Natalizumab|natalizumab|mesh-list
64309892|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64309893|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
64309894|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309895|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64309896|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309897|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309898|NCT02442453|Turmeric extract|turmeric extract|mesh-list
64309899|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
64351211|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309900|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309901|NCT02442453|Protective Agents|protective agents|mesh-ancestor
64355064|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
64309902|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309903|NCT02438397|Insulin|insulin|mesh-list
64309904|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64309905|NCT02438397|Metformin|metformin|mesh-list
64309906|NCT02438397|Acarbose|acarbose|mesh-list
64309907|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64309908|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309909|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64309910|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309911|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309912|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
64309913|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64309914|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64309915|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64309916|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64309917|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309918|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
64309919|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64309933|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
64309934|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64309935|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309936|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309937|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64309938|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64309939|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309940|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
64309941|NCT02442063|Paclitaxel|paclitaxel|mesh-list
64309942|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64309943|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64309944|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309945|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
64309946|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
64309947|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
64309948|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309949|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64309950|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64309951|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64309952|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
64309953|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309954|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309955|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64309956|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
64309957|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64309958|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
64309959|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64309960|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309961|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309962|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64372394|NCT02462915|Lidocaine|lidocaine|mesh-list
64309965|NCT03054662|Coagulants|coagulants|mesh-ancestor
64309966|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
64309967|NCT04922996|Calcium|calcium|mesh-list
64309968|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64309970|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
64309971|NCT04922996|Coagulants|coagulants|mesh-ancestor
64309972|NCT04913480|Durvalumab|durvalumab|mesh-list
64309973|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64309974|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309975|NCT02441907|Aflibercept|aflibercept|mesh-list
64309976|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64309977|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64309978|NCT02441907|Growth Substances|growth substances|mesh-ancestor
64309979|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309980|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
64309981|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64309982|NCT02437461|Triamcinolone|triamcinolone|mesh-list
64309983|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64309984|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64309985|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64309986|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64309987|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
64309988|NCT02437461|Hormones|hormones|mesh-ancestor
64309989|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64309990|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64309991|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64309992|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
64309993|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64309994|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64309995|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
64309996|NCT04910594|Hematinics|hematinics|mesh-ancestor
64309997|NCT02441673|Ephedrine|ephedrine|mesh-list
64309998|NCT02441673|Meperidine|meperidine|mesh-list
64309999|NCT02441673|Tramadol|tramadol|mesh-list
64310000|NCT02441673|Nefopam|nefopam|mesh-list
64310001|NCT02441673|Metoclopramide|metoclopramide|mesh-list
64310002|NCT02441673|Ranitidine|ranitidine|mesh-list
64310003|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64310017|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64310018|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64310019|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
64310020|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310021|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310022|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64310023|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
64310024|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64310025|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310026|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64310027|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64310028|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
64310029|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
64310030|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64310031|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310032|NCT04910126|Doxorubicin|doxorubicin|mesh-list
64310033|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64310034|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64310035|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310036|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64310037|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64310038|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310070|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372470|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
64310094|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310096|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64355184|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64310097|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310098|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64310099|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310100|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310101|NCT04902638|Dexamethasone|dexamethasone|mesh-list
64310102|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64310103|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
64310104|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
64372482|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64372483|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372520|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
64310105|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351221|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64351222|NCT04453345|Growth Substances|growth substances|mesh-ancestor
64351223|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
64351224|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
64351225|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351226|NCT03464539|Chitosan|chitosan|mesh-list
64310106|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310107|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310108|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
64310109|NCT04902638|Hormones|hormones|mesh-ancestor
64310110|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310111|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64310112|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310113|NCT02617628|Naltrexone|naltrexone|mesh-list
64310114|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64310115|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64310116|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310117|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
64310118|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310119|NCT03053414|Vitamin D|vitamin d|mesh-list
64310120|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
64310121|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
64310122|NCT03053414|Vitamins|vitamins|mesh-ancestor
64310123|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
64310124|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310125|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64310126|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64310127|NCT04892732|Budesonide|budesonide|mesh-list
64310128|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
64310129|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64310130|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64310131|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
64310132|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310145|NCT02308540|Vaccines|vaccines|mesh-list
64355228|NCT00950989|Vitamins|vitamins|mesh-ancestor
64310146|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64310147|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
64310148|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310149|NCT02308228|Metformin|metformin|mesh-list
64310150|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64310151|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310152|NCT03051932|Acetaminophen|acetaminophen|mesh-list
64310153|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310154|NCT03051932|Analgesics|analgesics|mesh-ancestor
64310155|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
64310156|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310157|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310158|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
64310159|NCT04900532|Tocotrienols|tocotrienols|mesh-list
64310160|NCT04900532|Vitamin E|vitamin e|mesh-list
64310161|NCT04900532|Tocopherols|tocopherols|mesh-list
64310162|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
64310163|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310164|NCT04900532|Protective Agents|protective agents|mesh-ancestor
64310165|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310166|NCT04900532|Vitamins|vitamins|mesh-ancestor
64310167|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
64310168|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
64310169|NCT04900766|Analgesics|analgesics|mesh-ancestor
64310170|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
64310214|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
64310215|NCT04890626|BB 1101|bb 1101|mesh-list
64310216|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64310217|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
64310218|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
64310219|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310220|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310221|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310222|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
64310224|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310225|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64310226|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310227|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
64310228|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310229|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310230|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
64310231|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351232|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
64310232|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64310233|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64310234|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64310235|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64310236|NCT04907864|Ibuprofen|ibuprofen|mesh-list
64310237|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64310238|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310239|NCT04907864|Analgesics|analgesics|mesh-ancestor
64310240|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
64310241|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310242|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310243|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64310244|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310245|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64310246|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310247|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310252|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
64310253|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64310254|NCT04907474|Tropicamide|tropicamide|mesh-list
64310255|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64310256|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64310257|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
64310258|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
64310259|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310260|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310261|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
64310262|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64310263|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
64310264|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
64310265|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64310266|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64310267|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64310268|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310269|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310270|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310271|NCT04907474|Protective Agents|protective agents|mesh-ancestor
64310272|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64310273|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64310274|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
64310275|NCT04899050|Cannabidiol|cannabidiol|mesh-list
64310276|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
64310277|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
64310278|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64310279|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310280|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
64310281|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
64310316|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64310317|NCT04404140|Docetaxel|docetaxel|mesh-list
64310318|NCT04404140|Atezolizumab|atezolizumab|mesh-list
64310319|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310320|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
64310321|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
64310322|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
64310323|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310324|NCT04898504|Floxuridine|floxuridine|mesh-list
64310325|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64310326|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
64310327|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310328|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310329|NCT04890470|Vasopressins|vasopressins|mesh-list
64310330|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
64310331|NCT04890470|Oxytocin|oxytocin|mesh-list
64310332|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
64310333|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64310334|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310335|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
64310336|NCT04890470|Coagulants|coagulants|mesh-ancestor
64310337|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64310338|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64310339|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
64351239|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
64310340|NCT04889768|Antibodies|antibodies|mesh-list
64310341|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
64310385|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64310386|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64310387|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64310388|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64310389|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310390|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310391|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310392|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64310393|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64310394|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64310396|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
64310397|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310398|NCT04896164|Curcumin|curcumin|mesh-list
64310399|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64310408|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310409|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310410|NCT04887818|Lidocaine|lidocaine|mesh-list
64310411|NCT04887818|Diltiazem|diltiazem|mesh-list
64310412|NCT04887818|Nifedipine|nifedipine|mesh-list
64310413|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
64310414|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
64310415|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310416|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310417|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
64310418|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310419|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64310420|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64310421|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64310422|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64310423|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310424|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64310425|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64310426|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
64310427|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
64310428|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64310429|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64310430|NCT04883996|Pilocarpine|pilocarpine|mesh-list
64310431|NCT04883996|Miotics|miotics|mesh-ancestor
64310432|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
64310433|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310434|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310435|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64310436|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64310437|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
64310438|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310439|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310440|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
64310441|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64310442|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
64310443|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64310444|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310445|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
64310446|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
64351245|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351246|NCT05166005|Vitamin D|vitamin d|mesh-list
64351247|NCT05166005|Vitamins|vitamins|mesh-ancestor
64351248|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
64351249|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351250|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64351251|NCT03464305|Aspirin|aspirin|mesh-list
64351252|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64310447|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64310448|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
64310449|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310450|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
64310476|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64310477|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64310478|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
64310479|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
64310480|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64310481|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64310482|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310483|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310484|NCT04882826|Urological Agents|urological agents|mesh-ancestor
64310485|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
64310486|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64310487|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
64310488|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310489|NCT04481048|Expectorants|expectorants|mesh-ancestor
64310490|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
64310491|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64310492|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
64310493|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310494|NCT04481048|Protective Agents|protective agents|mesh-ancestor
64310495|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310496|NCT04481048|Antidotes|antidotes|mesh-ancestor
64310497|NCT04309916|Esomeprazole|esomeprazole|mesh-list
64310498|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64310499|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310500|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64310501|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310502|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310503|NCT01596062|Cyclosporine|cyclosporine|mesh-list
64310504|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
64310505|NCT01596062|Everolimus|everolimus|mesh-list
64310506|NCT01596062|Cyclosporins|cyclosporins|mesh-list
64310507|NCT01596062|Basiliximab|basiliximab|mesh-list
64310508|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310509|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310518|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310519|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64310520|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64310521|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
64310522|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64310523|NCT02614898|Eculizumab|eculizumab|mesh-list
64310524|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64355501|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64355502|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310525|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64310526|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
64310527|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310528|NCT02145091|Psilocybin|psilocybin|mesh-list
64310529|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64310530|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
64310531|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310532|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64310533|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64310534|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
64310535|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310536|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310537|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64310538|NCT03352934|Avelumab|avelumab|mesh-list
64310539|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64310540|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310541|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
64310542|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
64310543|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310544|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310545|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64310546|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
64310547|NCT04881110|Liraglutide|liraglutide|mesh-list
64310548|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64310549|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310550|NCT04881110|Incretins|incretins|mesh-ancestor
64310551|NCT04881110|Hormones|hormones|mesh-ancestor
64310553|NCT02152423|Enoxaparin|enoxaparin|mesh-list
64310554|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
64310557|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310582|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310584|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310585|NCT03154580|Antidotes|antidotes|mesh-ancestor
64310605|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310606|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64310607|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64310608|NCT02145715|Growth Substances|growth substances|mesh-ancestor
64310609|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
64310610|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64310611|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310612|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310613|NCT04871750|Caseins|caseins|mesh-list
64310614|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
64310615|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
64310616|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310637|NCT02152579|Isosorbide|isosorbide|mesh-list
64310638|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64310639|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64310640|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64310641|NCT02152579|Diuretics|diuretics|mesh-ancestor
64310642|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
64310643|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310644|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
64310645|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64310646|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310647|NCT02155777|Norinyl|norinyl|mesh-list
64310648|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64310649|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64310650|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64310651|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
64310652|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64310653|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310654|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64310655|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64310656|NCT02145949|Tryptophan|tryptophan|mesh-list
64310657|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64310658|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
64310659|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64310660|NCT00806390|Metoprolol|metoprolol|mesh-list
64310661|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64310676|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64310677|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310678|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310679|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64310680|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310681|NCT02769481|Glimepiride|glimepiride|mesh-list
64310682|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
64310683|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64310684|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64310685|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310686|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64310687|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
64310688|NCT04877210|Insulin|insulin|mesh-list
64310689|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64310690|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64310691|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310692|NCT02152969|Amlodipine|amlodipine|mesh-list
64310693|NCT02152969|Telmisartan|telmisartan|mesh-list
64310694|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
64310695|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64310696|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64310697|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64310698|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310699|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64310727|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64310728|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355572|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310729|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355575|NCT04753437|Amoxicillin|amoxicillin|mesh-list
64310731|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
64310732|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64310733|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64310734|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64310735|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64310736|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
64310737|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
64310738|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310739|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351253|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64351254|NCT03464305|Analgesics|analgesics|mesh-ancestor
64351255|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
64351256|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351257|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351258|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351259|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351260|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64351261|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64351262|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351263|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64351264|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64351265|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351266|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
64351267|NCT05165615|Insulin|insulin|mesh-list
64351268|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64351269|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310740|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
64310741|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310742|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64310743|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
64310744|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310745|NCT04862767|Aldesleukin|aldesleukin|mesh-list
64310746|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310747|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64310748|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64310749|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
64310750|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310751|NCT02146261|Quetmolimab|quetmolimab|mesh-list
64310752|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310753|NCT02153281|Phenelzine|phenelzine|mesh-list
64310754|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
64310755|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64310756|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64310757|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310758|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310759|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
64310771|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310772|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310773|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
64310774|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310775|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64310776|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64310777|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64310778|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64310779|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310780|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64310781|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64310782|NCT02769247|Analgesics|analgesics|mesh-ancestor
64310783|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64310784|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310785|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
64310786|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64310787|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310788|NCT02153437|Sotalol|sotalol|mesh-list
64310789|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64310790|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64310791|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310792|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310793|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310794|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310795|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64310796|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
64310797|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
64310799|NCT02146651|Insulin|insulin|mesh-list
64310818|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
64310819|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
64310820|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64310821|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64310822|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64310823|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310824|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
64310825|NCT02153593|Coagulants|coagulants|mesh-ancestor
64310826|NCT02154217|Timolol|timolol|mesh-list
64310827|NCT02154217|Bimatoprost|bimatoprost|mesh-list
64310828|NCT02154217|Latanoprost|latanoprost|mesh-list
64310829|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64310830|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64310831|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
64310832|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64310833|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310834|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310835|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64310836|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64310841|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310843|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310844|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64310845|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64310846|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310847|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64310848|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
64310849|NCT02767765|Hematinics|hematinics|mesh-ancestor
64310851|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64310852|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310853|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
64310854|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64310855|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
64310856|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310857|NCT02157181|Rituximab|rituximab|mesh-list
64310858|NCT02157181|Cladribine|cladribine|mesh-list
64310859|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64310860|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310861|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
64310862|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310863|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64310864|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64310865|NCT02159287|Heparin|heparin|mesh-list
64310866|NCT02159287|Calcium heparin|calcium heparin|mesh-list
64310867|NCT02159287|Enoxaparin|enoxaparin|mesh-list
64310868|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
64310869|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
64310870|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64310873|NCT05005273|Nivolumab|nivolumab|mesh-list
64310908|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64310909|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310910|NCT03541681|Hormones|hormones|mesh-ancestor
64310911|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310912|NCT02157415|Polihexanide|polihexanide|mesh-list
64310913|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
64310914|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310915|NCT02157571|Levofloxacin|levofloxacin|mesh-list
64310917|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
64310918|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
64310919|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64310920|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64310921|NCT02157571|Renal Agents|renal agents|mesh-ancestor
64310922|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64310923|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64310924|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64310925|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310926|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310927|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355640|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310928|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64310929|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64310930|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64310932|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
64310958|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64310959|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
64310960|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64310961|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
64310962|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
64310963|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
64310965|NCT02159911|Misoprostol|misoprostol|mesh-list
64310966|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64310967|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
64310968|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64351418|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351419|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64351420|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64351421|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64351422|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64351423|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
64351425|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
64351426|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
64351427|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351428|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351430|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351431|NCT05322265|Epinephrine|epinephrine|mesh-list
64351432|NCT05322265|Racepinephrine|racepinephrine|mesh-list
64351433|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
64351434|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64351435|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64351452|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351454|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351455|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351456|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351457|NCT02164864|Aspirin|aspirin|mesh-list
64351458|NCT02164864|Warfarin|warfarin|mesh-list
64351459|NCT02164864|Dabigatran|dabigatran|mesh-list
64310969|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310970|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64310971|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310972|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
64310973|NCT03542617|Dexamethasone|dexamethasone|mesh-list
64310974|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64310975|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
64310976|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
64310977|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64310978|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64310979|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64310980|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
64310981|NCT03542617|Hormones|hormones|mesh-ancestor
64310982|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64310983|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64310984|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64310985|NCT04878770|Cyclosporine|cyclosporine|mesh-list
64310986|NCT04878770|Cyclosporins|cyclosporins|mesh-list
64310987|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64310989|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64311005|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311006|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311007|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64311008|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64311009|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311010|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64311011|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311012|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64311013|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64311014|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64311015|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
64311016|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311017|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
64311018|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
64311019|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64311020|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64311021|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64311022|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64351460|NCT02164864|Clopidogrel|clopidogrel|mesh-list
64351461|NCT02164864|Ticagrelor|ticagrelor|mesh-list
64351462|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64351463|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64351464|NCT02164864|Analgesics|analgesics|mesh-ancestor
64351465|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
64351466|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351467|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351468|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351469|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351470|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64311023|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
64311024|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
64311025|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64311027|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64311028|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64355709|NCT03424759|Osimertinib|osimertinib|mesh-list
64311029|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311030|NCT02086097|Analgesics|analgesics|mesh-ancestor
64311031|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
64311032|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311037|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311038|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311039|NCT02307682|Aflibercept|aflibercept|mesh-list
64311040|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64311041|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64311042|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64311043|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64311044|NCT02307682|Growth Substances|growth substances|mesh-ancestor
64311045|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311046|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
64311047|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311048|NCT02088515|Docetaxel|docetaxel|mesh-list
64311049|NCT02088515|Nedaplatin|nedaplatin|mesh-list
64311050|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311051|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
64311052|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
64311053|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
64311054|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311055|NCT02086253|BQ 788|bq 788|mesh-list
64311056|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64311057|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64311058|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311059|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64311060|NCT04870502|Clomiphene|clomiphene|mesh-list
64311061|NCT04870502|Enclomiphene|enclomiphene|mesh-list
64311062|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
64311063|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64311064|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
64311065|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311066|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311067|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64311068|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
64311069|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64311084|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311085|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311086|NCT03049046|Caffeic acid|caffeic acid|mesh-list
64311087|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
64372847|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372848|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
64372849|NCT03296579|Aminophylline|aminophylline|mesh-list
64372850|NCT03296579|Albuterol|albuterol|mesh-list
64372851|NCT03296579|Ipratropium|ipratropium|mesh-list
64372852|NCT03296579|Analgesics|analgesics|mesh-ancestor
64372853|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
64311088|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311089|NCT03049046|Protective Agents|protective agents|mesh-ancestor
64311090|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311091|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
64311092|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
64311094|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311095|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311096|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
64311097|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311098|NCT04874246|Vasopressins|vasopressins|mesh-list
64311099|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
64311100|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
64311101|NCT04874246|Coagulants|coagulants|mesh-ancestor
64311102|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64311103|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64311104|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
64311105|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311106|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64311107|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355723|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311108|NCT03048110|Itraconazole|itraconazole|mesh-list
64311109|NCT03048110|Rifampin|rifampin|mesh-list
64311110|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
64311111|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311112|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64311118|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311119|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311120|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64311122|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
64311123|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64311125|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64311126|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64311127|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64311128|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64311129|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64311130|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64311131|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64311132|NCT05256758|Fenofibrate|fenofibrate|mesh-list
64311133|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64311134|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
64311135|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311136|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64311137|NCT02791763|Glycine|glycine|mesh-list
64311138|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
64311139|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351471|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64351472|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351473|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64351474|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64351475|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351476|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
64351477|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64351478|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64351479|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64311140|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311141|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311142|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
64311143|NCT02086409|Vitamin D|vitamin d|mesh-list
64311144|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
64311145|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
64311146|NCT02086409|Vitamins|vitamins|mesh-list
64311147|NCT02086409|Calcium|calcium|mesh-list
64311148|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
64311152|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
64311160|NCT02088983|Choline|choline|mesh-list
64311161|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64311162|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
64311163|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64311164|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
64311165|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311166|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311167|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64311168|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
64311169|NCT02089061|Atorvastatin|atorvastatin|mesh-list
64311170|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64311171|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64311172|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64311173|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
64311174|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311175|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64311176|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64311177|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311178|NCT02082665|Dabrafenib|dabrafenib|mesh-list
64311179|NCT02082665|Midazolam|midazolam|mesh-list
64311181|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64311182|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64311183|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311184|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311186|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64311187|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64355731|NCT04640571|Enalaprilat|enalaprilat|mesh-list
64311188|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64311189|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
64311207|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
64355732|NCT04640571|Enalapril|enalapril|mesh-list
64311208|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311209|NCT02341456|Paclitaxel|paclitaxel|mesh-list
64311210|NCT02341456|Carboplatin|carboplatin|mesh-list
64311211|NCT02341456|Adavosertib|adavosertib|mesh-list
64351480|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
64351506|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351507|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351508|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
64351509|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351510|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64351511|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64351512|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351513|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
64311212|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64311213|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311214|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
64311215|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
64311216|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
64311217|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311218|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373107|NCT03294551|Vaccines|vaccines|mesh-list
64311241|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
64311242|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311243|NCT02370784|Atorvastatin|atorvastatin|mesh-list
64311244|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64311245|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64311246|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
64311247|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311248|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64373139|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64311261|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64311262|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311263|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64311264|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64311266|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311267|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311268|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64311269|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64311270|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64311271|NCT01595438|Renal Agents|renal agents|mesh-ancestor
64311272|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
64351514|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64351515|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64351516|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64351517|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
64351518|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
64351519|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
64351520|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
64351521|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64351522|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64351523|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64351524|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351526|NCT01998529|Amifostine|amifostine|mesh-list
64351527|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351536|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
64351537|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351538|NCT03448549|Capecitabine|capecitabine|mesh-list
64351539|NCT03448549|Tegafur|tegafur|mesh-list
64351540|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
64311273|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64311274|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64311275|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64311276|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64311277|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64311278|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64311280|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64311281|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311282|NCT02340520|Theophylline|theophylline|mesh-list
64311283|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64311284|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
64311285|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311286|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311287|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64311288|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
64311289|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64311290|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351541|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64351542|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
64351543|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311291|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311292|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
64311293|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64311294|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64311295|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
64311296|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311297|NCT02087579|Olanzapine|olanzapine|mesh-list
64311298|NCT02087579|Risperidone|risperidone|mesh-list
64311332|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64311333|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64311334|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
64311335|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311336|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311337|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311338|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64311339|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311341|NCT02339506|Hormones|hormones|mesh-ancestor
64355742|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64311342|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311344|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
64311349|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311351|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
64311352|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311353|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311354|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311355|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
64311356|NCT02087813|Hormones|hormones|mesh-ancestor
64351544|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351545|NCT03679091|Clopidogrel|clopidogrel|mesh-list
64351546|NCT03679091|Ticagrelor|ticagrelor|mesh-list
64351547|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64351548|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64351549|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64351550|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64351551|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
64311357|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311358|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64351552|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311359|NCT02087813|Protective Agents|protective agents|mesh-ancestor
64351553|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311360|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64311361|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311362|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311363|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311364|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64311365|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64311366|NCT02089529|Ibuprofen|ibuprofen|mesh-list
64311367|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64311368|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311369|NCT02089529|Analgesics|analgesics|mesh-ancestor
64311370|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
64311371|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311372|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311373|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311375|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64311376|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311377|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311378|NCT02090933|Celecoxib|celecoxib|mesh-list
64311379|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64311380|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311381|NCT02090933|Analgesics|analgesics|mesh-ancestor
64311382|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
64311383|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311384|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311385|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64311386|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64311387|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64311388|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64351554|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351555|NCT01628926|Ropinirole|ropinirole|mesh-list
64351556|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64351573|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64351574|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64351575|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379978|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311389|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311390|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311391|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
64311392|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64311393|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311394|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311395|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311421|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311422|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
64311423|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
64311424|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
64311425|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64311427|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64355749|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
64311428|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
64311429|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311430|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311431|NCT04884802|Protective Agents|protective agents|mesh-ancestor
64311432|NCT02089841|Lumefantrine|lumefantrine|mesh-list
64311433|NCT02089841|Artemether|artemether|mesh-list
64311434|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64311435|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
64311436|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64311437|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64311438|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311439|NCT03045770|Leucovorin|leucovorin|mesh-list
64311440|NCT03045770|Paclitaxel|paclitaxel|mesh-list
64311441|NCT03045770|Fluorouracil|fluorouracil|mesh-list
64311442|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
64311443|NCT03045770|Irinotecan|irinotecan|mesh-list
64311444|NCT03045770|Calcium|calcium|mesh-list
64311445|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
64311446|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64311475|NCT02091401|Analgesics|analgesics|mesh-ancestor
64351576|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311476|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
64311477|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311478|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311479|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
64311480|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311481|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64311482|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
64311483|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64311484|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64311485|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311486|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64311487|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
64311488|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64311489|NCT01594970|Bimatoprost|bimatoprost|mesh-list
64311490|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64311491|NCT04869176|Caffeine|caffeine|mesh-list
64311492|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
64311493|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351577|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
64351578|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351579|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351580|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
64351581|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
64351582|NCT03436199|Amantadine|amantadine|mesh-list
64351583|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64351584|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64311494|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64311495|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311496|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64311497|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311498|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64311499|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64311500|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
64311501|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311502|NCT03557255|Simendan|simendan|mesh-list
64311503|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64311504|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
64311505|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64311506|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64311507|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311508|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311509|NCT03557255|Protective Agents|protective agents|mesh-ancestor
64311510|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311511|NCT04868552|Naloxone|naloxone|mesh-list
64311512|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64311513|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311514|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
64311515|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355780|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
64355781|NCT00148629|DMP 777|dmp 777|mesh-list
64311550|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64311551|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311552|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
64311554|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64311586|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64311587|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64311588|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
64311589|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64351585|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
64351597|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
64351598|NCT02131324|Hormones|hormones|mesh-ancestor
64351599|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351620|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64351621|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
64351622|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351625|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351627|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
64351628|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351629|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
64351630|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
64311590|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64311591|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311592|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
64311594|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
64311595|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311596|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64311597|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64311598|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311599|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311600|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64311601|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
64311602|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311603|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311604|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64311605|NCT02098889|Scopolamine|scopolamine|mesh-list
64311606|NCT02098889|Bromides|bromides|mesh-list
64311607|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64311608|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
64311609|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64311610|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
64311611|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
64311612|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311613|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311614|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311615|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
64311616|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64311617|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
64355814|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64311619|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311622|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64311623|NCT01369199|Entecavir|entecavir|mesh-list
64311624|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
64311625|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311626|NCT02097017|Lidocaine|lidocaine|mesh-list
64311627|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
64311628|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
64311629|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311630|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351631|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
64351632|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351633|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351634|NCT05321329|Capecitabine|capecitabine|mesh-list
64351635|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64351636|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
64351637|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351638|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351639|NCT02521831|Bupivacaine|bupivacaine|mesh-list
64351640|NCT02521831|Anesthetics|anesthetics|mesh-list
64351641|NCT02521831|Isoflurane|isoflurane|mesh-list
64351642|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
64311631|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
64311632|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311633|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64311634|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64311635|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64311636|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64311637|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311638|NCT02097173|Methotrexate|methotrexate|mesh-list
64311639|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64311640|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
64311641|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64311642|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311643|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64311644|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
64311645|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311646|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311647|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
64311670|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
64311671|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
64311672|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311677|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
64311679|NCT02093585|Abacavir|abacavir|mesh-list
64311680|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
64311681|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311682|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64311683|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64311684|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311685|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311686|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64311687|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64311688|NCT02099357|Vitamin D|vitamin d|mesh-list
64311689|NCT02099357|Vitamins|vitamins|mesh-ancestor
64311690|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
64311691|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311692|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64311693|NCT02093741|Factor VIII|factor viii|mesh-list
64311694|NCT02093741|Coagulants|coagulants|mesh-ancestor
64355904|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311697|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64311698|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311699|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311700|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64311701|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
64311716|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64311717|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64311719|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
64311720|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
64351643|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351644|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351645|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
64351646|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351647|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64351648|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
64351649|NCT01425541|Progesterone|progesterone|mesh-list
64351650|NCT01425541|Estradiol|estradiol|mesh-list
64351651|NCT01425541|Estrogens|estrogens|mesh-list
64351652|NCT01425541|Progestins|progestins|mesh-ancestor
64351653|NCT01425541|Hormones|hormones|mesh-ancestor
64351654|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311721|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311722|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64311723|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64311724|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64311725|NCT02250599|Growth Substances|growth substances|mesh-ancestor
64311726|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311727|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
64311728|NCT02094053|Donepezil|donepezil|mesh-list
64311729|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64311730|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311731|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311793|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311794|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64311795|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64311796|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64311797|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64311798|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64311799|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64311802|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
64311803|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64311804|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
64311805|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
64311806|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311813|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311814|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311816|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64311817|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64311818|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
64311819|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64311820|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351655|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351656|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
64351657|NCT03447925|Salicylates|salicylates|mesh-list
64351658|NCT03447925|Petrolatum|petrolatum|mesh-list
64351659|NCT03447925|Emollients|emollients|mesh-ancestor
64351660|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
64351661|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64351671|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351672|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351673|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
64351674|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
64351675|NCT04928183|Nitroprusside|nitroprusside|mesh-list
64351676|NCT04928183|Phenylephrine|phenylephrine|mesh-list
64351677|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
64351678|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
64311821|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311822|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64311823|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
64311824|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64311825|NCT02094599|Dronabinol|dronabinol|mesh-list
64311826|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
64311827|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311828|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64311829|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64311830|NCT02094599|Analgesics|analgesics|mesh-ancestor
64311831|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
64311832|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311833|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64311834|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64311835|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311836|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311837|NCT02094599|Hormones|hormones|mesh-ancestor
64311838|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355938|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
64311840|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
64311841|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311842|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
64311843|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
64311844|NCT02100605|Ephedrine|ephedrine|mesh-list
64311845|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64311846|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
64311847|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64311848|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311849|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
64311850|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
64311851|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311852|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
64311853|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311854|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311855|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64311856|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64311857|NCT02100761|Voriconazole|voriconazole|mesh-list
64311858|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
64311859|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311860|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64373236|NCT04971759|Fentanyl|fentanyl|mesh-list
64311861|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64351679|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64351680|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
64351681|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
64351682|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351683|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351684|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
64351685|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64351686|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
64351687|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
64311863|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311864|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64311865|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
64311866|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64311867|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311869|NCT02100917|Trastuzumab|trastuzumab|mesh-list
64311889|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
64311890|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
64311891|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64311892|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64311893|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
64311894|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
64311895|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311896|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311897|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64311898|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
64311899|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
64311900|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64311901|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64311902|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64311903|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64311904|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
64311905|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64311906|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64311907|NCT03555383|Hemostatics|hemostatics|mesh-list
64311908|NCT03555383|Coagulants|coagulants|mesh-ancestor
64311910|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
64311911|NCT02101151|Vitamins|vitamins|mesh-ancestor
64311912|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
64311913|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64311914|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64311916|NCT02101229|Insulin|insulin|mesh-list
64311944|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64311945|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64311946|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64311947|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64311948|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
64311949|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64311950|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64311951|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
64311952|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64355948|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64311953|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64311954|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64311955|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64311956|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64311957|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64311958|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64311959|NCT02103023|Imiquimod|imiquimod|mesh-list
64311960|NCT02103023|Vaccines|vaccines|mesh-list
64311961|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
64311990|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351688|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64351689|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64351690|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64351691|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
64351692|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351693|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351694|NCT04928183|Protective Agents|protective agents|mesh-ancestor
64351695|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
64311991|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64311992|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64311993|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
64311994|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312008|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64312009|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64312010|NCT03554447|Protective Agents|protective agents|mesh-ancestor
64312011|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
64312012|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64312013|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
64312014|NCT02103335|Dexamethasone|dexamethasone|mesh-list
64312015|NCT02103335|Pomalidomide|pomalidomide|mesh-list
64312016|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312017|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
64312018|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
64312019|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312020|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312021|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64312022|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
64312024|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312025|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64312026|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312027|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
64312028|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64312029|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64312030|NCT02103335|Growth Substances|growth substances|mesh-ancestor
64312031|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
64312055|NCT02103569|Estradiol|estradiol|mesh-list
64312056|NCT02103569|Asunaprevir|asunaprevir|mesh-list
64312057|NCT02103569|Estrogens|estrogens|mesh-ancestor
64312058|NCT02103569|Hormones|hormones|mesh-ancestor
64351696|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
64312059|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312060|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312061|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64312062|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
64312063|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64312064|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64312065|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64312066|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64312067|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64312068|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
64312069|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351697|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64351698|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
64351699|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64351700|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
64351701|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64351702|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64351703|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312070|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312071|NCT02103647|Pregabalin|pregabalin|mesh-list
64312072|NCT02103647|Analgesics|analgesics|mesh-ancestor
64312073|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
64312074|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312075|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312076|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
64312085|NCT02109965|Midazolam|midazolam|mesh-list
64312107|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312108|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
64312109|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
64312111|NCT02789657|Carboplatin|carboplatin|mesh-list
64312112|NCT02789657|Trastuzumab|trastuzumab|mesh-list
64312113|NCT02789657|Pertuzumab|pertuzumab|mesh-list
64312114|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64312115|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312116|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
64312117|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
64312118|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
64312119|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312120|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64312121|NCT03555071|Vaccines|vaccines|mesh-list
64312122|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
64312123|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312124|NCT02609984|Atezolizumab|atezolizumab|mesh-list
64312125|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312126|NCT02107079|Melatonin|melatonin|mesh-list
64312127|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
64312128|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312129|NCT02107079|Protective Agents|protective agents|mesh-ancestor
64312130|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312131|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312132|NCT02107235|ON 01910|on 01910|mesh-list
64312133|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351706|NCT03447691|Remifentanil|remifentanil|mesh-list
64351707|NCT03447691|Anesthetics|anesthetics|mesh-list
64351708|NCT03447691|Propofol|propofol|mesh-list
64351709|NCT03447691|Desflurane|desflurane|mesh-list
64351710|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351711|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351712|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64351713|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64351714|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
64351715|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64351716|NCT03447691|Narcotics|narcotics|mesh-ancestor
64351717|NCT03447691|Analgesics|analgesics|mesh-ancestor
64312134|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64312135|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312136|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312137|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
64312138|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64312139|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312140|NCT02103725|Analgesics|analgesics|mesh-ancestor
64351718|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
64312141|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
64312150|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312151|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312152|NCT03042260|Trimethoprim|trimethoprim|mesh-list
64312153|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64312154|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
64312155|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64312156|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312157|NCT03042260|Renal Agents|renal agents|mesh-ancestor
64312158|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
64312159|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64312160|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64312161|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64351719|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312162|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312163|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312164|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64312165|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64312166|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64312167|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64312168|NCT02110355|Trametinib|trametinib|mesh-list
64312169|NCT02110355|Dabrafenib|dabrafenib|mesh-list
64312170|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312171|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64312172|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312174|NCT02107391|Leuprolide|leuprolide|mesh-list
64312201|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64312202|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312203|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64351720|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64312204|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64351722|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351766|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
64351768|NCT05398679|Linezolid|linezolid|mesh-list
64351769|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64351770|NCT05398679|Tedizolid|tedizolid|mesh-list
64351771|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
64312205|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
64312206|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64312207|NCT03554915|Midazolam|midazolam|mesh-list
64312208|NCT03554915|Ketamine|ketamine|mesh-list
64312213|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64312214|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64312215|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
64312216|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
64312217|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312218|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64312219|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64312220|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312221|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356031|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64312223|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64351772|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
64351773|NCT05398679|Cefaclor|cefaclor|mesh-list
64351774|NCT05398679|Trimethoprim|trimethoprim|mesh-list
64312224|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64312225|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312226|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312227|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
64312228|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
64312229|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
64312230|NCT03044522|Narcotics|narcotics|mesh-ancestor
64312231|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312232|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312233|NCT03044522|Analgesics|analgesics|mesh-ancestor
64312234|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
64312235|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312236|NCT03044366|Anesthetics|anesthetics|mesh-list
64312237|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312238|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312239|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
64312240|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64312241|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
64312253|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64312254|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64312255|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351775|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
64351776|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
64351777|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64312256|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312257|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64312258|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351778|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64351779|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351780|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64351781|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64351782|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351783|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351784|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312259|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
64312260|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64312261|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64312262|NCT02110745|Propofol|propofol|mesh-list
64312263|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64312264|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351785|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64351786|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
64312265|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312266|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64312284|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312285|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312286|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64312287|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
64312289|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312290|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64312291|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312292|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64312293|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351787|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64312294|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64312295|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
64312296|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
64312297|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64312298|NCT03041948|Narcotics|narcotics|mesh-ancestor
64312299|NCT03041948|Analgesics|analgesics|mesh-ancestor
64351788|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351789|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64312300|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
64351790|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64312301|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312302|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
64312303|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64312304|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64312305|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
64312306|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
64312307|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64312308|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
64351791|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64373416|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351792|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64312330|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
64312331|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
64312332|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64312333|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64351793|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64351794|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64351795|NCT05398679|Renal Agents|renal agents|mesh-ancestor
64351796|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64312334|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64312335|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312336|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64312337|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64312338|NCT02611778|Ranibizumab|ranibizumab|mesh-list
64312352|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312354|NCT04856852|Temozolomide|temozolomide|mesh-list
64312355|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64312356|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
64312357|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312358|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312359|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64312360|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312369|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312370|NCT02711553|Antiviral Agents|antiviral agents|mesh-ancestor
64312371|NCT02711553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312372|NCT02711553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312373|NCT02711553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64312374|NCT02711553|Immunologic Factors|immunologic factors|mesh-ancestor
64312375|NCT02711553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312376|NCT01453179|Diclofenac|diclofenac|mesh-list
64312377|NCT01453179|Imiquimod|imiquimod|mesh-list
64312378|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64312379|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312380|NCT01453179|Analgesics|analgesics|mesh-ancestor
64312400|NCT03188445|Protective Agents|protective agents|mesh-ancestor
64312401|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312402|NCT03188445|Vitamins|vitamins|mesh-ancestor
64312403|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
64312404|NCT03188445|Trace Elements|trace elements|mesh-ancestor
64312405|NCT03188445|Hematinics|hematinics|mesh-ancestor
64312406|NCT04483635|Vitamin D|vitamin d|mesh-list
64312407|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
64312408|NCT04483635|Vitamins|vitamins|mesh-ancestor
64312409|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
64312410|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312411|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64312412|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64312413|NCT04865900|Antibodies|antibodies|mesh-list
64312414|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
64312415|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351797|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64351799|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
64312416|NCT03191721|Triclosan|triclosan|mesh-list
64312417|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
64312418|NCT03191721|Fluorides|fluorides|mesh-list
64312419|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
64351800|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64351801|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64351802|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64351803|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64351865|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64312420|NCT03191721|Protective Agents|protective agents|mesh-ancestor
64312421|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312422|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64312423|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64312424|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64312425|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
64312426|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312427|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64312428|NCT03188289|Chitosan|chitosan|mesh-list
64312429|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
64312430|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64312431|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
64312432|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312433|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
64312455|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
64312456|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
64312457|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312458|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64312459|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312460|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
64312461|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312540|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64312541|NCT02434029|Budesonide|budesonide|mesh-list
64312542|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312543|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64312687|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64312688|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64312689|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64312690|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64312691|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64312692|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312693|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312694|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64312727|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
64312728|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312729|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312730|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
64312731|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312732|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64312733|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64312734|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
64312735|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64312736|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64312737|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64312738|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64312739|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64312740|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312741|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312742|NCT04851392|Dronabinol|dronabinol|mesh-list
64312743|NCT04851392|Cannabidiol|cannabidiol|mesh-list
64351867|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
64351868|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351869|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351870|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351871|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351872|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351873|NCT01093573|Azacitidine|azacitidine|mesh-list
64351874|NCT01093573|Midostaurin|midostaurin|mesh-list
64351875|NCT01093573|Staurosporine|staurosporine|mesh-list
64351876|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64351877|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
64351878|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312744|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
64312759|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
64312760|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312761|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
64312762|NCT02429193|Hormones|hormones|mesh-ancestor
64312763|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312764|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312765|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64312766|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312767|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64312768|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312769|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312770|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
64312771|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64312772|NCT04859738|Lidocaine|lidocaine|mesh-list
64312773|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
64312774|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
64312775|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312776|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312777|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
64312783|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312784|NCT02429271|Clopidogrel|clopidogrel|mesh-list
64312785|NCT02429271|Ticagrelor|ticagrelor|mesh-list
64312786|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64356186|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
64356187|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
64312787|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64312788|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64312789|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64312790|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
64312792|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351880|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351881|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351882|NCT03367741|Nivolumab|nivolumab|mesh-list
64351883|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351884|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351885|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64351886|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351887|NCT03402503|Montelukast|montelukast|mesh-list
64351888|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64351889|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
64351903|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
64351904|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
64312793|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312795|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
64312796|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312797|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312798|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64312799|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64312800|NCT04851002|Mitogens|mitogens|mesh-list
64312801|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
64312802|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312803|NCT04844996|Ezetimibe|ezetimibe|mesh-list
64312804|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64312805|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64312806|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
64312807|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312808|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64312809|NCT02425137|Gemcitabine|gemcitabine|mesh-list
64312810|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64312811|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
64312813|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312828|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64312829|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
64312830|NCT04841018|Hormones|hormones|mesh-ancestor
64312831|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312832|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64312833|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312834|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
64312835|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312836|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312837|NCT04840550|Lansoprazole|lansoprazole|mesh-list
64312838|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
64312839|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64312840|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64312841|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64312842|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312843|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312844|NCT03182595|Acetaminophen|acetaminophen|mesh-list
64312845|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312846|NCT03182595|Analgesics|analgesics|mesh-ancestor
64351905|NCT04155203|Mupirocin|mupirocin|mesh-list
64351906|NCT04155203|Calcium|calcium|mesh-list
64351907|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64351908|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351914|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351915|NCT04238143|Complement Factor H|complement factor h|mesh-list
64351916|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64351917|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64351918|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
64351919|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351920|NCT04073615|Trifluridine|trifluridine|mesh-list
64351921|NCT04073615|Apatinib|apatinib|mesh-list
64312847|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
64312848|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312849|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312850|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
64312851|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
64312852|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
64312853|NCT02429037|Cisplatin|cisplatin|mesh-list
64312854|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64312855|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
64312856|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64312857|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64312858|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64312859|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64312860|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64312861|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312862|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312863|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64312864|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64312865|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312866|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
64312867|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312882|NCT04833218|Analgesics|analgesics|mesh-ancestor
64312883|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
64312884|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312885|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
64312886|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
64312887|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64312888|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64312889|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64312890|NCT04833374|Prednisone|prednisone|mesh-list
64312891|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
64351922|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351923|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351924|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351925|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351926|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
64351927|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
64351928|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351929|NCT03344965|Olaparib|olaparib|mesh-list
64351930|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64351933|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351934|NCT05303311|Dexamethasone|dexamethasone|mesh-list
64351936|NCT05303311|Bupivacaine|bupivacaine|mesh-list
64351937|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351938|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
64312892|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64312893|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64312894|NCT04833374|Prednisolone|prednisolone|mesh-list
64312895|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
64312896|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64312897|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
64312898|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64312899|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
64312900|NCT04833374|Hormones|hormones|mesh-ancestor
64312901|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64312902|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312903|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64312904|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356313|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356326|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
64356327|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356328|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64312905|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
64312906|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
64312907|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312908|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64312909|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64312910|NCT04833374|Protective Agents|protective agents|mesh-ancestor
64312911|NCT04843982|Esketamine|esketamine|mesh-list
64312912|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
64312914|NCT02707965|Topiramate|topiramate|mesh-list
64312915|NCT02707965|Lamotrigine|lamotrigine|mesh-list
64312916|NCT02707965|Zonisamide|zonisamide|mesh-list
64312917|NCT02707965|Carbamazepine|carbamazepine|mesh-list
64312918|NCT02707965|Phenytoin|phenytoin|mesh-list
64312919|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
64312920|NCT02707965|Levetiracetam|levetiracetam|mesh-list
64312921|NCT02707965|Valproic Acid|valproic acid|mesh-list
64312922|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
64312923|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64312924|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312925|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
64312926|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64312927|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351939|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
64351940|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351941|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351942|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64351943|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
64351946|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64351952|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64351954|NCT05303311|Analgesics|analgesics|mesh-ancestor
64351955|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64351959|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
64312928|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312929|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64312930|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64312935|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
64312936|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64312937|NCT02707965|Analgesics|analgesics|mesh-ancestor
64312938|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
64312939|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312940|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64312941|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64312942|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312943|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
64312944|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312945|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64312946|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64312947|NCT04839536|Sevoflurane|sevoflurane|mesh-list
64312948|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64312949|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64312950|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
64312951|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
64312952|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312953|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312954|NCT02428257|Ephedrine|ephedrine|mesh-list
64312955|NCT02428257|Bupivacaine|bupivacaine|mesh-list
64312956|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
64312957|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
64312958|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64312959|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64312960|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
64356394|NCT02520479|Asparaginase|asparaginase|mesh-list
64312961|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64312962|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64312964|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
64312965|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64312966|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
64312967|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312968|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312978|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
64312979|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
64351960|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351961|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351962|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
64351963|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351964|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351965|NCT02974621|Bevacizumab|bevacizumab|mesh-list
64351966|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64351967|NCT02974621|Olaparib|olaparib|mesh-list
64351968|NCT02974621|Cediranib|cediranib|mesh-list
64351969|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
64351970|NCT02974621|Antibodies|antibodies|mesh-list
64351971|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
64351972|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64351973|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
64351974|NCT02974621|Maleic acid|maleic acid|mesh-list
64312980|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64312981|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64312982|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64312983|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
64312984|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312985|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64312986|NCT04839224|Protective Agents|protective agents|mesh-ancestor
64312988|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64312989|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
64312990|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313008|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
64313010|NCT02424201|Protective Agents|protective agents|mesh-ancestor
64313024|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313025|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
64313026|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313027|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
64313028|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64313029|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
64313030|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64313031|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313032|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64313033|NCT00702273|Progesterone|progesterone|mesh-list
64313034|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64313036|NCT00702273|Progestins|progestins|mesh-ancestor
64313037|NCT00702273|Hormones|hormones|mesh-ancestor
64313038|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313039|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313040|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
64313041|NCT02433795|Rituximab|rituximab|mesh-list
64313042|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64313043|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64313044|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313045|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
64313046|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313047|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313048|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64313049|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
64313067|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
64313068|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313069|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313070|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313071|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
64313072|NCT02424435|Hormones|hormones|mesh-ancestor
64313073|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313074|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64313075|NCT02424435|Protective Agents|protective agents|mesh-ancestor
64313076|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64313077|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313078|NCT04842968|Methylene Blue|methylene blue|mesh-list
64313079|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313080|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313082|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313083|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64313084|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356416|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64313085|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313086|NCT03038282|Chromium|chromium|mesh-list
64313087|NCT03038282|Chromous chloride|chromous chloride|mesh-list
64351975|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351976|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64351977|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64351978|NCT02974621|Growth Substances|growth substances|mesh-ancestor
64313088|NCT03038282|Trace Elements|trace elements|mesh-ancestor
64313089|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
64313090|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313091|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
64313092|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313093|NCT03038282|Protective Agents|protective agents|mesh-ancestor
64313097|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313098|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
64313099|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
64313100|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313101|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313102|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313103|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
64313104|NCT02424045|Hormones|hormones|mesh-ancestor
64313105|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313106|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64313107|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313108|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64313110|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313111|NCT03037970|Becaplermin|becaplermin|mesh-list
64313112|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
64313113|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
64313114|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64313115|NCT03037970|Growth Substances|growth substances|mesh-ancestor
64313116|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313117|NCT04841720|Metformin|metformin|mesh-list
64313118|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64313119|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313120|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
64313121|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64313122|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313123|NCT03039842|Valproic Acid|valproic acid|mesh-list
64313124|NCT03039842|Memantine|memantine|mesh-list
64313125|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
64313126|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64313127|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64313128|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
64313129|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313130|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313131|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313132|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64313133|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64313134|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
64313135|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
64313136|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
64313137|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313138|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
64313139|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
64313140|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64313141|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313142|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64313143|NCT03181815|Cytarabine|cytarabine|mesh-list
64313144|NCT03181815|Cladribine|cladribine|mesh-list
64313169|NCT03185871|Celecoxib|celecoxib|mesh-list
64313170|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64313171|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64313172|NCT03185871|Analgesics|analgesics|mesh-ancestor
64313173|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
64313174|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313175|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313176|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313177|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313178|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64351986|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
64313179|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64313180|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313181|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313182|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64313183|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64313198|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64313199|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64313200|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64313201|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
64313202|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313203|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313205|NCT03037736|Fluorouracil|fluorouracil|mesh-list
64313206|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64313207|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313208|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64313209|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64313210|NCT03037736|Growth Substances|growth substances|mesh-ancestor
64313211|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313212|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
64313213|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
64313214|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313215|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64313216|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313217|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
64313218|NCT04838132|Ropivacaine|ropivacaine|mesh-list
64313219|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
64313220|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
64313221|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313222|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313223|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
64313224|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313225|NCT03037892|Fentanyl|fentanyl|mesh-list
64313226|NCT03037892|Midazolam|midazolam|mesh-list
64313227|NCT03037892|Remifentanil|remifentanil|mesh-list
64313228|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64313230|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313231|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313232|NCT03037892|Analgesics|analgesics|mesh-ancestor
64313233|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
64313234|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313235|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64313236|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64313237|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
64313238|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
64313239|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64313240|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64313266|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313268|NCT03180723|Rituximab|rituximab|mesh-list
64313269|NCT03180723|Cyclosporins|cyclosporins|mesh-list
64313270|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64313271|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313272|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
64313273|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356425|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313275|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313276|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313277|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313278|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
64313279|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313280|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
64313281|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64313282|NCT04841096|Metformin|metformin|mesh-list
64313283|NCT04841096|Glimepiride|glimepiride|mesh-list
64313284|NCT04841096|Vildagliptin|vildagliptin|mesh-list
64313285|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64313286|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313287|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64313288|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313289|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
64373707|NCT03269591|Diclofenac|diclofenac|mesh-list
64313302|NCT02426697|Analgesics|analgesics|mesh-ancestor
64313303|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
64313304|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313305|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64313306|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64313307|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
64313310|NCT03039608|Triamcinolone|triamcinolone|mesh-list
64313311|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313312|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
64313313|NCT03039608|Hormones|hormones|mesh-ancestor
64313314|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313315|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313316|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64313317|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313318|NCT02423811|Fursultiamin|fursultiamin|mesh-list
64313319|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
64313320|NCT02423811|Vitamins|vitamins|mesh-ancestor
64313321|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
64313322|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313324|NCT04837664|Curcumin|curcumin|mesh-list
64313325|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64313326|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64313327|NCT04837664|Analgesics|analgesics|mesh-ancestor
64313328|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
64313329|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313330|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313331|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313332|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313333|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313334|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313335|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313336|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64313337|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313338|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
64313339|NCT04837664|Ionophores|ionophores|mesh-ancestor
64356474|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64356476|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64313374|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
64313375|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64313376|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313377|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313378|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64313379|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64313380|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64313381|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
64313382|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
64313383|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313384|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64313386|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
64313387|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
64313388|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
64313389|NCT02426619|Protective Agents|protective agents|mesh-ancestor
64313390|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313391|NCT02108483|Dapsone|dapsone|mesh-list
64313392|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313393|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
64313394|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64313395|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64313396|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64313397|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313398|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313399|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
64313400|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64313401|NCT01648348|Bevacizumab|bevacizumab|mesh-list
64313402|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64313403|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
64313404|NCT01648348|Antibodies|antibodies|mesh-list
64313405|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
64313406|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64313407|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
64313408|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313409|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64313410|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64313417|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64313418|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313419|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
64313420|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
64313421|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313422|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313423|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313424|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
64313425|NCT03180255|Hormones|hormones|mesh-ancestor
64313426|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313427|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64313428|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313429|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
64313430|NCT02431221|Perhexiline|perhexiline|mesh-list
64313431|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64313432|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313433|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313434|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64313435|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313436|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
64313437|NCT02108639|Asunaprevir|asunaprevir|mesh-list
64313438|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
64313439|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313440|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313441|NCT03180099|Bupivacaine|bupivacaine|mesh-list
64313442|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
64313443|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
64313444|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356518|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313445|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313446|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
64313447|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313449|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
64313450|NCT04770272|Carboplatin|carboplatin|mesh-list
64313451|NCT04770272|Atezolizumab|atezolizumab|mesh-list
64313452|NCT04770272|Epirubicin|epirubicin|mesh-list
64313453|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64313454|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64313455|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313456|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
64313457|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
64313458|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
64313459|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313460|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64313461|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
64313462|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313463|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313464|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64313517|NCT02426463|Narcotics|narcotics|mesh-ancestor
64313518|NCT02426463|Analgesics|analgesics|mesh-ancestor
64313519|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
64313539|NCT02108795|Narcotics|narcotics|mesh-ancestor
64313540|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313541|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313542|NCT02108795|Analgesics|analgesics|mesh-ancestor
64313543|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
64313544|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313545|NCT02431143|Miltefosine|miltefosine|mesh-list
64313546|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
64313547|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313548|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313549|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64313550|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64313551|NCT02302846|Ixazomib|ixazomib|mesh-list
64313552|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313553|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
64313554|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313555|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313556|NCT02431065|Ropivacaine|ropivacaine|mesh-list
64313557|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
64313558|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
64313559|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313560|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313561|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
64313562|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313563|NCT04836806|Cetirizine|cetirizine|mesh-list
64313564|NCT04836806|Famotidine|famotidine|mesh-list
64313565|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64313566|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64313567|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64313568|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
64313569|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
64313580|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64313581|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64313582|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313583|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
64313584|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
64313585|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
64313586|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313587|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313588|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64313589|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64313590|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
64313591|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313592|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
64313593|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64313594|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
64313595|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373845|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
64373880|NCT03267329|Telmisartan|telmisartan|mesh-list
64313644|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64313645|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
64313646|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64313648|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
64313649|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64313650|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
64313652|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
64313653|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313654|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313656|NCT02113943|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64313657|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64313658|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313659|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313660|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64313661|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
64313662|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313663|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64313664|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
64313665|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64313666|NCT02114021|Betamethasone|betamethasone|mesh-list
64313667|NCT02114021|Lidocaine|lidocaine|mesh-list
64313668|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
64313669|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
64313670|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64313671|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313672|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
64313673|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313674|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64313675|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64313676|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64313680|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
64313684|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
64313685|NCT04826822|Dexamethasone|dexamethasone|mesh-list
64313686|NCT04826822|Spironolactone|spironolactone|mesh-list
64313687|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64313688|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
64313689|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
64356568|NCT03126097|Hormones|hormones|mesh-ancestor
64356570|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64313690|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64313691|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313693|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
64313695|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64313696|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64313697|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313698|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64313699|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
64313700|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64313701|NCT04826822|Diuretics|diuretics|mesh-ancestor
64313702|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
64313703|NCT02251457|Ranolazine|ranolazine|mesh-list
64313704|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64313705|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64313706|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313707|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
64313708|NCT02112305|Analgesics|analgesics|mesh-ancestor
64313709|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
64313721|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64313723|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64313724|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64313725|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
64313726|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313727|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64313728|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64313729|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313730|NCT02251223|Ritonavir|ritonavir|mesh-list
64313731|NCT02251223|Tipranavir|tipranavir|mesh-list
64313732|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64313733|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64313820|NCT05618912|Emollients|emollients|mesh-ancestor
64313821|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
64313824|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
64313825|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64313826|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313827|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313828|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
64313829|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64313830|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356590|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64313832|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64313833|NCT03036800|Liraglutide|liraglutide|mesh-list
64313834|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64374080|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313902|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
64374122|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374141|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64313936|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313937|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313939|NCT02113631|Ribavirin|ribavirin|mesh-list
64313940|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
64313941|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
64313942|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64313943|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374163|NCT04975971|Dexamethasone|dexamethasone|mesh-list
64313959|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64313961|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64313962|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
64313963|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
64313964|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64313965|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64313989|NCT04807166|Carboplatin|carboplatin|mesh-list
64313990|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64313991|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64313992|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
64313993|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
64313994|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
64313995|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313996|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64313997|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64313998|NCT02251925|Estradiol|estradiol|mesh-list
64313999|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64314000|NCT02251925|Estrogens|estrogens|mesh-ancestor
64314001|NCT02251925|Hormones|hormones|mesh-ancestor
64314002|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314003|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314004|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64314005|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
64314006|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64314007|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64314008|NCT03552653|Vitamin D|vitamin d|mesh-list
64314009|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
64314010|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
64314011|NCT03552653|Vitamins|vitamins|mesh-list
64314012|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
64314013|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314014|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64314015|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64314162|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
64314163|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356678|NCT03395093|Fentanyl|fentanyl|mesh-list
64314164|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64314165|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64314166|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314167|NCT02124005|Bupivacaine|bupivacaine|mesh-list
64314168|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
64314169|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
64314170|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314171|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314172|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
64314173|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314174|NCT03551873|Plecanatide|plecanatide|mesh-list
64314175|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64314176|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
64314177|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314178|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314179|NCT02117765|Ustekinumab|ustekinumab|mesh-list
64314180|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
64314181|NCT02121119|Lidocaine|lidocaine|mesh-list
64314182|NCT02121119|Bupivacaine|bupivacaine|mesh-list
64314183|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
64314184|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
64314185|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314186|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314187|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
64314188|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314189|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64314200|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64314201|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
64314202|NCT02121197|Hormones|hormones|mesh-ancestor
64314203|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314204|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64314205|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314206|NCT02124317|Paclitaxel|paclitaxel|mesh-list
64314207|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64314208|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64314209|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314210|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
64314211|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
64314212|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
64314213|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314214|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
64314215|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314216|NCT02121353|Ranibizumab|ranibizumab|mesh-list
64314217|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314218|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314219|NCT02121353|Growth Substances|growth substances|mesh-ancestor
64314220|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314221|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
64314222|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314223|NCT05617430|Leucovorin|leucovorin|mesh-list
64314224|NCT05617430|Bevacizumab|bevacizumab|mesh-list
64314225|NCT05617430|Fluorouracil|fluorouracil|mesh-list
64314226|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
64314227|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314228|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314229|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314230|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314231|NCT05617430|Growth Substances|growth substances|mesh-ancestor
64314232|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314233|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
64314234|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
64374427|NCT03252665|Nicorandil|nicorandil|mesh-list
64314291|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64314293|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
64314294|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314295|NCT04812860|Tramadol|tramadol|mesh-list
64314296|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64314297|NCT04812860|Narcotics|narcotics|mesh-ancestor
64314298|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64314299|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314300|NCT04812860|Analgesics|analgesics|mesh-ancestor
64314301|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
64314302|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314303|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
64314304|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64314305|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64314306|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64314307|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
64314308|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
64314309|NCT04427540|Oxytocin|oxytocin|mesh-list
64314310|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
64314311|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64314312|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314313|NCT04801940|Apixaban|apixaban|mesh-list
64314314|NCT04801940|Atorvastatin|atorvastatin|mesh-list
64314315|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64314317|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
64314360|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64314361|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64314362|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64314363|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314364|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314365|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314366|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64314367|NCT02122055|Narcotics|narcotics|mesh-ancestor
64314368|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64314369|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64314370|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64314371|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64314372|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
64314373|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
64314374|NCT02125409|Aspirin|aspirin|mesh-list
64314375|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64314376|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314377|NCT02125409|Analgesics|analgesics|mesh-ancestor
64314378|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
64314379|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314380|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314381|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314382|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64314383|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64314384|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64314385|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314386|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64314387|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64314388|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314389|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
64356721|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64356722|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
64356723|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314391|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314392|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374564|NCT04951713|Rifampin|rifampin|mesh-list
64314524|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
64314525|NCT05272865|Dronabinol|dronabinol|mesh-list
64314526|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
64314527|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314528|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64314529|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314530|NCT05272865|Analgesics|analgesics|mesh-ancestor
64314590|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
64314591|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314655|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
64314656|NCT04785716|Niraparib|niraparib|mesh-list
64314657|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64314658|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314659|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314660|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314661|NCT01367249|Bromfenac|bromfenac|mesh-list
64314662|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64314663|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64314664|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64314665|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64314713|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314714|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64374980|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314818|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314819|NCT02136875|Fluticasone|fluticasone|mesh-list
64314821|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64314822|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64314823|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64314824|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
64314825|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64314826|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314827|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64314828|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
64314829|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64314830|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64314831|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64314832|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64314833|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64314834|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314835|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314836|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314837|NCT02129933|Bevacizumab|bevacizumab|mesh-list
64314838|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64314839|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314840|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64314841|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64314842|NCT02129933|Growth Substances|growth substances|mesh-ancestor
64314843|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314844|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
64314845|NCT02132897|Carbamazepine|carbamazepine|mesh-list
64314846|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
64314847|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
64375037|NCT03241901|Lumefantrine|lumefantrine|mesh-list
64314926|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64314927|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64314928|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
64314929|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64314930|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
64314931|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314932|NCT02137265|Clomiphene|clomiphene|mesh-list
64314934|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
64314935|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64314936|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314937|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64314938|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
64314939|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64314940|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64314941|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64314942|NCT02592434|Tofacitinib|tofacitinib|mesh-list
64314943|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64314944|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64314968|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
64314969|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64314970|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314971|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64314972|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64314973|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
64314974|NCT02137733|Protective Agents|protective agents|mesh-ancestor
64314975|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64314976|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315087|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64315088|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64315089|NCT04091126|Growth Substances|growth substances|mesh-ancestor
64315090|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
64315091|NCT04026776|Allopurinol|allopurinol|mesh-list
64356762|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315092|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
64315093|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315094|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315095|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
64315096|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64315097|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64315098|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
64315099|NCT04026776|Protective Agents|protective agents|mesh-ancestor
64315100|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315143|NCT03535298|Interferon-beta|interferon-beta|mesh-list
64315144|NCT03535298|Teriflunomide|teriflunomide|mesh-list
64315145|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
64315146|NCT03535298|Ofatumumab|ofatumumab|mesh-list
64315147|NCT03535298|Cladribine|cladribine|mesh-list
64315148|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
64315149|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64315150|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
64315151|NCT03535298|Natalizumab|natalizumab|mesh-list
64315152|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64315153|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
64315154|NCT03535298|Ozanimod|ozanimod|mesh-list
64315155|NCT03535298|Ponesimod|ponesimod|mesh-list
64315156|NCT03535298|Siponimod|siponimod|mesh-list
64315157|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64315158|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315159|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
64315162|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
64315163|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315164|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64315165|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64315166|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315167|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
64315168|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64315169|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64315170|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64315171|NCT03535298|Analgesics|analgesics|mesh-ancestor
64315172|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
64315173|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315174|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64315175|NCT02134379|Clotrimazole|clotrimazole|mesh-list
64315176|NCT02134379|Miconazole|miconazole|mesh-list
64315177|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64315178|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64315179|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
64315180|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64315181|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64315182|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64315183|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315184|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64315185|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
64315186|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315187|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315188|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64352038|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315189|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64315191|NCT03511118|Topiramate|topiramate|mesh-list
64315192|NCT03511118|Azithromycin|azithromycin|mesh-list
64315211|NCT03511118|Trazodone|trazodone|mesh-list
64315212|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
64315213|NCT03511118|Methylphenidate|methylphenidate|mesh-list
64315214|NCT03511118|Citalopram|citalopram|mesh-list
64315215|NCT03511118|Sertraline|sertraline|mesh-list
64315216|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64315217|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
64315218|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64315219|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64315220|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315221|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64315222|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64315223|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
64315325|NCT04792034|Cocaine|cocaine|mesh-list
64315326|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
64315327|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
64315328|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315329|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315330|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
64315331|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64315332|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64315333|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64315334|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64315335|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315336|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315337|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
64315338|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64315392|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
64315393|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
64315394|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64356795|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64315395|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64315397|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64315540|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64315541|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64315542|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64315543|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64315544|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315545|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64315546|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315547|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64315548|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64315549|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315697|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64315699|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315700|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64315701|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64315702|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64315828|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315829|NCT05574881|Trastuzumab|trastuzumab|mesh-list
64315830|NCT05574881|Pertuzumab|pertuzumab|mesh-list
64315831|NCT05574881|Fulvestrant|fulvestrant|mesh-list
64315832|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64315833|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64315834|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64315835|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64315836|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64315837|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
64315838|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64315839|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315840|NCT05612984|Aspirin|aspirin|mesh-list
64315841|NCT05612984|Folic Acid|folic acid|mesh-list
64315842|NCT05612984|Micronutrients|micronutrients|mesh-list
64315843|NCT05612984|Trace Elements|trace elements|mesh-list
64315844|NCT05612984|Calcium|calcium|mesh-list
64315845|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64315846|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315847|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64376045|NCT03050229|Empagliflozin|empagliflozin|mesh-list
64315873|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
64315874|NCT05424263|Calcium|calcium|mesh-list
64315875|NCT05424263|Calcium acetate|calcium acetate|mesh-list
64315876|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64315877|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315878|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64315880|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64315881|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64315882|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
64315883|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
64356932|NCT03389087|Etoposide|etoposide|mesh-list
64315885|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
64315886|NCT05398757|Propofol|propofol|mesh-list
64315887|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64315888|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64315889|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315890|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64315891|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
64315892|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
64315893|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64315894|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64315895|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64315896|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64315897|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
64315898|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
64315899|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316002|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64316019|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64316020|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
64316021|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64316022|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316023|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64316278|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316279|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316282|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64316283|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316284|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64316285|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64316286|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316310|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64316311|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
64316312|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316313|NCT01666652|Antacids|antacids|mesh-ancestor
64316314|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316315|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64316316|NCT03998813|Ropivacaine|ropivacaine|mesh-list
64316317|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
64316318|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
64316319|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316320|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316321|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
64316322|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316323|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64316324|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
64316325|NCT05174585|Antibodies|antibodies|mesh-list
64356985|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316326|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
64316514|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
64356986|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64357031|NCT03390595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357032|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64357036|NCT00271817|Simvastatin|simvastatin|mesh-list
64357037|NCT00271817|Ezetimibe|ezetimibe|mesh-list
64357039|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64316516|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64316517|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64316518|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352083|NCT03237611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64352084|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64352086|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64316519|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316521|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316522|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316523|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
64316525|NCT03661307|Venetoclax|venetoclax|mesh-list
64316526|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64316527|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
64316528|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316529|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316530|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316531|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
64316532|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64316533|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316534|NCT02425605|Sorafenib|sorafenib|mesh-list
64316535|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316536|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64316537|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316538|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316539|NCT02422563|Paclitaxel|paclitaxel|mesh-list
64316540|NCT02422563|Carboplatin|carboplatin|mesh-list
64316541|NCT02422563|Ifosfamide|ifosfamide|mesh-list
64316542|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64316543|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316544|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
64377124|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316601|NCT05551910|Narcotics|narcotics|mesh-ancestor
64316602|NCT05551910|Analgesics|analgesics|mesh-ancestor
64316603|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
64316604|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316605|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
64316606|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316607|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
64316608|NCT05699720|Analgesics|analgesics|mesh-ancestor
64316609|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
64316610|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316611|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316613|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316614|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64316615|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
64316618|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316619|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64316620|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
64316621|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64316622|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
64316623|NCT05546762|Povidone|povidone|mesh-list
64316624|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
64316625|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
64316626|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64316627|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316628|NCT03863288|Oxytocin|oxytocin|mesh-list
64316629|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
64316630|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64316631|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316632|NCT03535883|Anticoagulants|anticoagulants|mesh-list
64316633|NCT03535883|Coagulants|coagulants|mesh-list
64316634|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
64357117|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357120|NCT03126071|Irinotecan|irinotecan|mesh-list
64357121|NCT03126071|Raltitrexed|raltitrexed|mesh-list
64357122|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64357123|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316635|NCT05551598|Analgesics|analgesics|mesh-ancestor
64316636|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
64316637|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316638|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316639|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316640|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64316641|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64316642|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316643|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316645|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64316646|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316647|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316648|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
64316649|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316650|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316651|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
64316652|NCT03185793|Benzbromarone|benzbromarone|mesh-list
64316653|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
64316654|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
64316655|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316656|NCT03185793|Renal Agents|renal agents|mesh-ancestor
64316735|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316736|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64316737|NCT03173066|Hematinics|hematinics|mesh-ancestor
64316738|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64316739|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64316740|NCT05546060|Dexamethasone|dexamethasone|mesh-list
64316741|NCT05546060|Etoposide|etoposide|mesh-list
64316742|NCT05546060|Venetoclax|venetoclax|mesh-list
64316743|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64316744|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
64316745|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
64316746|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316747|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316768|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
64316769|NCT02416869|Hormones|hormones|mesh-ancestor
64316770|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64316771|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64316772|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316773|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
64316774|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316775|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316776|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
64316777|NCT02588612|Fludarabine|fludarabine|mesh-list
64316778|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64316779|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
64316780|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316781|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64316782|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64316783|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
64316784|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316785|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316786|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64316787|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
64316788|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
64316789|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316790|NCT03540979|Letrozole|letrozole|mesh-list
64316791|NCT03540979|Progesterone|progesterone|mesh-list
64316792|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357164|NCT03386279|Abrocitinib|abrocitinib|mesh-list
64357176|NCT03391427|Lidocaine|lidocaine|mesh-list
64316793|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64316794|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64316795|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316824|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64316825|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64316826|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316827|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316828|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316829|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316830|NCT05550506|Analgesics|analgesics|mesh-ancestor
64316831|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
64316832|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64316833|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
64316834|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316835|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
64316837|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64316838|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64316839|NCT02163655|Furosemide|furosemide|mesh-list
64316840|NCT02163655|Diuretics|diuretics|mesh-ancestor
64316841|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
64316842|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316843|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64316844|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64316845|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316846|NCT02410083|Aspirin|aspirin|mesh-list
64316847|NCT02410083|Clopidogrel|clopidogrel|mesh-list
64316848|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64316879|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64316880|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
64316881|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
64316882|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
64316883|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316884|NCT02166853|Midazolam|midazolam|mesh-list
64316885|NCT02166853|Sevoflurane|sevoflurane|mesh-list
64316886|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64316887|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64316888|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64316889|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64316890|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64316891|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64316892|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64316893|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64316894|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
64316895|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
64316896|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
64316897|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
64316898|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64316899|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316900|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64316901|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64316902|NCT02162251|Donepezil|donepezil|mesh-list
64316903|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64316904|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64316905|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64316906|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
64316907|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377488|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357180|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357181|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317096|NCT02409537|Protective Agents|protective agents|mesh-ancestor
64317097|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317328|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64317330|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317331|NCT02407899|Vitamins|vitamins|mesh-ancestor
64317332|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
64317441|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
64317442|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64317443|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317444|NCT02417337|Analgesics|analgesics|mesh-ancestor
64317445|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
64317446|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64317447|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317448|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64317449|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64317450|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64416685|NCT03040219|Hematinics|hematinics|mesh-ancestor
64317862|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317863|NCT03172533|Dienogest|dienogest|mesh-list
64317864|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64317865|NCT03172533|Estradiol|estradiol|mesh-list
64317866|NCT03172533|Estrogens|estrogens|mesh-ancestor
64317867|NCT03172533|Hormones|hormones|mesh-ancestor
64317868|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64317869|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64317870|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64317871|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
64317872|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64317873|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64317874|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64317875|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64317876|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64317877|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
64317878|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64317879|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317881|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64317882|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
64318144|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64318145|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64318146|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318147|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318148|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64318149|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64318150|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64318151|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64318152|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
64318154|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
64318155|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
64318156|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318157|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318158|NCT02400879|Sufentanil|sufentanil|mesh-list
64318159|NCT02400879|Remifentanil|remifentanil|mesh-list
64318160|NCT02400879|Sevoflurane|sevoflurane|mesh-list
64318161|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64318162|NCT02400879|Narcotics|narcotics|mesh-ancestor
64318278|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318279|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64318280|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64318281|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
64318283|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318284|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64318285|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64357303|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318286|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318287|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318288|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64318289|NCT02172001|Hematinics|hematinics|mesh-ancestor
64318290|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
64318291|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64318292|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64318293|NCT05535998|Estrogens|estrogens|mesh-ancestor
64318294|NCT05535998|Hormones|hormones|mesh-ancestor
64318295|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318296|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318374|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318375|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318376|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64318377|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
64318378|NCT02172235|Pioglitazone|pioglitazone|mesh-list
64318379|NCT02172235|Empagliflozin|empagliflozin|mesh-list
64318380|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318381|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318382|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64318383|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318386|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318387|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318388|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
64318389|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64318390|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318391|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
64318392|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64318393|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318394|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64318395|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
64318396|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64318397|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318398|NCT05297864|Niraparib|niraparib|mesh-list
64318399|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64318400|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318401|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318402|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318447|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
64318448|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318449|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318450|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64318451|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
64380602|NCT03194009|Metformin|metformin|mesh-list
64380603|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318497|NCT02174887|Antiviral Agents|antiviral agents|mesh-ancestor
64318498|NCT02174887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318499|NCT02174887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318500|NCT02174887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64318501|NCT02174887|Immunologic Factors|immunologic factors|mesh-ancestor
64318502|NCT02174887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318503|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64318504|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
64318505|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
64318506|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318508|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
64318558|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64318559|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318560|NCT02758171|Incretins|incretins|mesh-ancestor
64318561|NCT02758171|Hormones|hormones|mesh-ancestor
64318562|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318563|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64318564|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318565|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318566|NCT00101101|Aldesleukin|aldesleukin|mesh-list
64318567|NCT00101101|Dexamethasone|dexamethasone|mesh-list
64318569|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
64318570|NCT00101101|Doxorubicin|doxorubicin|mesh-list
64318813|NCT04067648|Analgesics|analgesics|mesh-ancestor
64318892|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318893|NCT02176135|Auranofin|auranofin|mesh-list
64318894|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64318895|NCT02176213|Dexamethasone|dexamethasone|mesh-list
64318896|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
64318897|NCT02176213|Pomalidomide|pomalidomide|mesh-list
64318898|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64318899|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
64318900|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352092|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352093|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
64352094|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352095|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64352096|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352097|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64352098|NCT02951377|Dexamethasone|dexamethasone|mesh-list
64352099|NCT02951377|Lidocaine|lidocaine|mesh-list
64352100|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352101|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
64352102|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
64352103|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352106|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
64318901|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64318902|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64318903|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
64318904|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318905|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318906|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64318907|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64318908|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
64318909|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
64318910|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64318911|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64318912|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
64318913|NCT02176213|Hormones|hormones|mesh-ancestor
64318914|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318915|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64318916|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64318917|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64318918|NCT02176213|Growth Substances|growth substances|mesh-ancestor
64318919|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
64318920|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
64318921|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
64318922|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
64318923|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64318924|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64318925|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64318926|NCT04305002|Exenatide|exenatide|mesh-list
64318932|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64318933|NCT02253797|Ritonavir|ritonavir|mesh-list
64318934|NCT02253797|Tipranavir|tipranavir|mesh-list
64318935|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64318936|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64318937|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
64318938|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318939|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318940|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64318941|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64318942|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
64318943|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64318944|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64318945|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64318946|NCT04620746|Penicillins|penicillins|mesh-list
64318947|NCT04620746|Penicillin G|penicillin g|mesh-list
64381392|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64318948|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357379|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
64319006|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
64319065|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319066|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64319067|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64319116|NCT02579096|Protective Agents|protective agents|mesh-ancestor
64319117|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319118|NCT02578862|Propofol|propofol|mesh-list
64319119|NCT02578862|Sevoflurane|sevoflurane|mesh-list
64319120|NCT02578862|Isoflurane|isoflurane|mesh-list
64319121|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64319122|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64319123|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319124|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64319126|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
64319127|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64319128|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64319129|NCT02578706|Aspirin|aspirin|mesh-list
64319130|NCT02578706|Clopidogrel|clopidogrel|mesh-list
64319131|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64319132|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64319133|NCT02578706|Analgesics|analgesics|mesh-ancestor
64319134|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
64319135|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64319136|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381697|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319137|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64319138|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64319139|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64319140|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64319210|NCT03365882|Cetuximab|cetuximab|mesh-list
64319211|NCT03365882|Pertuzumab|pertuzumab|mesh-list
64319212|NCT03365882|Irinotecan|irinotecan|mesh-list
64319213|NCT03365882|Camptothecin|camptothecin|mesh-list
64319214|NCT03365882|Antibodies|antibodies|mesh-list
64319215|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
64319216|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64319217|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
64319218|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319219|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357386|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64357387|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64357388|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319220|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64319221|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64319222|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319226|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319227|NCT05593328|Bevacizumab|bevacizumab|mesh-list
64319228|NCT05593328|Onvansertib|onvansertib|mesh-list
64319229|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64319230|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319231|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64319232|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64319233|NCT05593328|Growth Substances|growth substances|mesh-ancestor
64319234|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319235|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
64319236|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319237|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319238|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319239|NCT02578316|Lenvatinib|lenvatinib|mesh-list
64319240|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64319241|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64319242|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64319243|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64319244|NCT05532878|Apixaban|apixaban|mesh-list
64319245|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64319246|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
64319247|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64319248|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
64319249|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381821|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381822|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320069|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320070|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64320071|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
64320073|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64320074|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320075|NCT02180503|Incretins|incretins|mesh-ancestor
64320076|NCT02180503|Hormones|hormones|mesh-ancestor
64320077|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64320078|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64320079|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
64320080|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320081|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320083|NCT02177851|Trace Elements|trace elements|mesh-ancestor
64320084|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
64320085|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320086|NCT05075876|Granisetron|granisetron|mesh-list
64320087|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
64320088|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
64384138|NCT04417582|Liraglutide|liraglutide|mesh-list
64386245|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386248|NCT01374269|Naproxen|naproxen|mesh-list
64384286|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64386249|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64386250|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64352112|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
64386251|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64386252|NCT01374269|Analgesics|analgesics|mesh-ancestor
64386253|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
64386254|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386255|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386256|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
64386257|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64357455|NCT03383393|Adenosine|adenosine|mesh-list
64386258|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64386259|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64384371|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386261|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386262|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
64386263|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
64386264|NCT05036681|Futibatinib|futibatinib|mesh-list
64386265|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386266|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386267|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64386268|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64386269|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386271|NCT03163589|Hematinics|hematinics|mesh-ancestor
64386272|NCT03163277|Emtricitabine|emtricitabine|mesh-list
64386273|NCT03163277|Maraviroc|maraviroc|mesh-list
64386274|NCT03163277|Darunavir|darunavir|mesh-list
64386275|NCT03163277|Cobicistat|cobicistat|mesh-list
64386276|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64386277|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
64386278|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384538|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64386279|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64386280|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64386281|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386282|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386283|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64386284|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64386285|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64386286|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64386287|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64386288|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64386289|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64386290|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
64386291|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64386292|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64386293|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
64386294|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386295|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386296|NCT05401097|Azacitidine|azacitidine|mesh-list
64386297|NCT05401097|Venetoclax|venetoclax|mesh-list
64386298|NCT05401097|Ivosidenib|ivosidenib|mesh-list
64386299|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386300|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
64386302|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386312|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64386313|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64386314|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386315|NCT02679755|Letrozole|letrozole|mesh-list
64386316|NCT02679755|Palbociclib|palbociclib|mesh-list
64386317|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386318|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64386319|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64386320|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386321|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386322|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64386323|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
64357467|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386324|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357468|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64386326|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64386327|NCT02675231|Trastuzumab|trastuzumab|mesh-list
64386328|NCT02675231|Fulvestrant|fulvestrant|mesh-list
64386329|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386330|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386331|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64386332|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64386333|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64386334|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
64386335|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386336|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386348|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386350|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386351|NCT03162653|Allopurinol|allopurinol|mesh-list
64386352|NCT03162653|Mannitol|mannitol|mesh-list
64386353|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
64386354|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386355|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386356|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
64386357|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386358|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64386359|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
64386360|NCT03162653|Protective Agents|protective agents|mesh-ancestor
64386361|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386362|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64386363|NCT03162653|Diuretics|diuretics|mesh-ancestor
64386364|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
64386365|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
64386366|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386367|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386368|NCT04708067|Atezolizumab|atezolizumab|mesh-list
64386369|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386371|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
64386372|NCT03114215|Vitamins|vitamins|mesh-ancestor
64386373|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
64386374|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386375|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
64384671|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386378|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386379|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64386380|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64386381|NCT05675813|Azacitidine|azacitidine|mesh-list
64386382|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386383|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
64386384|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386385|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386386|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386387|NCT03158129|Cisplatin|cisplatin|mesh-list
64386388|NCT03158129|Carboplatin|carboplatin|mesh-list
64386414|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64386415|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
64386416|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386417|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386418|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64386419|NCT01932125|Bevacizumab|bevacizumab|mesh-list
64357491|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357493|NCT03394729|Propolis|propolis|mesh-list
64386420|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386421|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386422|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64386423|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64386424|NCT01932125|Growth Substances|growth substances|mesh-ancestor
64386425|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386426|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
64386470|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386471|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64386472|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
64386473|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386474|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386475|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386477|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64386478|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64386479|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386480|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
64386481|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
64386482|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
64386483|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386485|NCT01515527|Decitabine|decitabine|mesh-list
64386486|NCT01515527|Cladribine|cladribine|mesh-list
64386487|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386488|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
64386489|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386490|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386491|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
64386492|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386493|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386494|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
64386495|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386496|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386497|NCT02670551|Cariprazine|cariprazine|mesh-list
64386498|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64386499|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64386500|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386501|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386502|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64386503|NCT01430351|Metformin|metformin|mesh-list
64386504|NCT01430351|Mefloquine|mefloquine|mesh-list
64386505|NCT01430351|Temozolomide|temozolomide|mesh-list
64386506|NCT01430351|Memantine|memantine|mesh-list
64386507|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64386508|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386509|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64384816|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
64386564|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64386565|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386566|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386567|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64386569|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
64386570|NCT02391077|Povidone|povidone|mesh-list
64386571|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386572|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64386573|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
64386574|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
64386575|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
64386576|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64386578|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
64386579|NCT02390843|Topotecan|topotecan|mesh-list
64386580|NCT02390843|Simvastatin|simvastatin|mesh-list
64386581|NCT02390843|Lenograstim|lenograstim|mesh-list
64386582|NCT02390843|Mitogens|mitogens|mesh-list
64357509|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357512|NCT03387241|Fluticasone|fluticasone|mesh-list
64386584|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
64386585|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386586|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386587|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64386588|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
64386589|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386590|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386591|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386592|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64386593|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64386594|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
64386595|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64386596|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64386597|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386598|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64386599|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64386600|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
64386601|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64386602|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64386603|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64386604|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64386605|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
64386606|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386607|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64386608|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64386609|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386610|NCT03806309|Leucovorin|leucovorin|mesh-list
64386611|NCT03806309|Fluorouracil|fluorouracil|mesh-list
64386612|NCT03806309|Irinotecan|irinotecan|mesh-list
64386613|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
64386615|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386616|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386617|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386618|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
64386619|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386620|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64386621|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64386622|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386624|NCT03806309|Protective Agents|protective agents|mesh-ancestor
64386625|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
64386626|NCT03806309|Vitamins|vitamins|mesh-ancestor
64386627|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
64386628|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
64386629|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64386630|NCT03489629|Minocycline|minocycline|mesh-list
64386631|NCT03489629|Trimethoprim|trimethoprim|mesh-list
64386632|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
64386633|NCT03489629|Mupirocin|mupirocin|mesh-list
64386634|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64386635|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64386636|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386637|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
64386638|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64386639|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64386640|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64386641|NCT03489629|Renal Agents|renal agents|mesh-ancestor
64386642|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
64386643|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64386644|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64386645|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64386646|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386647|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386648|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64386649|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64386665|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386666|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64386667|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
64386668|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386669|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386670|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386671|NCT02388035|Cefotaxime|cefotaxime|mesh-list
64384977|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64386672|NCT02388035|Cefoxitin|cefoxitin|mesh-list
64386673|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64386674|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386675|NCT02389439|Artesunate|artesunate|mesh-list
64386676|NCT02389439|Pyronaridine|pyronaridine|mesh-list
64386677|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
64386678|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64386679|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64386680|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386681|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386682|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
64386683|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
64386684|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64386685|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
64386686|NCT02663687|Complement C1s|complement c1s|mesh-list
64386687|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64386688|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64386689|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
64386690|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386691|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64386692|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386693|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64386694|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64386712|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64386713|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64386714|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386715|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386716|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64386717|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64386718|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64386719|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64386720|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64386721|NCT02387567|Lidocaine|lidocaine|mesh-list
64386722|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
64386723|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
64386724|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386725|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385067|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
64386726|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
64386727|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386728|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64386749|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386750|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
64386751|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386752|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64386754|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64386755|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386756|NCT02386943|Incretins|incretins|mesh-ancestor
64386757|NCT02386943|Hormones|hormones|mesh-ancestor
64386758|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386759|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64386760|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
64386761|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386762|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386763|NCT02084056|Metformin|metformin|mesh-list
64386764|NCT02084056|Linagliptin|linagliptin|mesh-list
64386775|NCT04714372|Fludarabine|fludarabine|mesh-list
64386776|NCT04714372|Daratumumab|daratumumab|mesh-list
64386777|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386778|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
64385175|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386779|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385179|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
64386782|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
64386783|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386784|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386785|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386786|NCT04787471|Riboflavin|riboflavin|mesh-list
64386787|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
64386788|NCT04787471|Vitamins|vitamins|mesh-ancestor
64386789|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
64386790|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386791|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64386792|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
64386793|NCT02386397|Gemcitabine|gemcitabine|mesh-list
64386794|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
64386795|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386796|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
64386797|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386798|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386799|NCT02386397|Antiviral Agents|antiviral agents|mesh-ancestor
64386800|NCT02386397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386801|NCT02386397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386802|NCT02386397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386803|NCT02386397|Immunologic Factors|immunologic factors|mesh-ancestor
64386804|NCT02386397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386805|NCT02386475|Dexetimide|dexetimide|mesh-list
64386806|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64386807|NCT02386475|Citalopram|citalopram|mesh-list
64386808|NCT02386475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64386809|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64386810|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64386811|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386812|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386813|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
64386814|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386815|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64386816|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
64386817|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64386818|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64386819|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64386820|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
64386821|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
64386822|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386823|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64386824|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64386825|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
64386826|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64386827|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
64386828|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
64386856|NCT02382263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386857|NCT02382263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386858|NCT02382263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386859|NCT02382263|Immunologic Factors|immunologic factors|mesh-ancestor
64357539|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386860|NCT02382263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386863|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
64386864|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
64416720|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
64386866|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386883|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
64386884|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64386885|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64386886|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386887|NCT02381717|Morphine|morphine|mesh-list
64386888|NCT02381717|Bupivacaine|bupivacaine|mesh-list
64386889|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
64386890|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
64386899|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386900|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386902|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64386903|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
64386904|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386905|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386906|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64386907|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64386908|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
64386909|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386910|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386911|NCT02381249|Octreotide|octreotide|mesh-list
64386912|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64386913|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64386914|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386919|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386920|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386921|NCT02384915|Prilocaine|prilocaine|mesh-list
64386922|NCT02384915|Mepivacaine|mepivacaine|mesh-list
64386923|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
64386924|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386925|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386927|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
64386928|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386929|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
64386930|NCT04895735|Pemetrexed|pemetrexed|mesh-list
64386931|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386932|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386933|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386934|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386935|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64357591|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
64386936|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64386937|NCT02384837|Sirolimus|sirolimus|mesh-list
64386938|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64386939|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386940|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64386941|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386942|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
64386943|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386944|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
64386945|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386946|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
64386947|NCT03105791|Narcotics|narcotics|mesh-ancestor
64386948|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386949|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386950|NCT03105791|Analgesics|analgesics|mesh-ancestor
64386951|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
64386952|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386953|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
64386954|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64386955|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64386956|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386957|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
64386958|NCT02384135|Coagulants|coagulants|mesh-ancestor
64386959|NCT02380625|Azithromycin|azithromycin|mesh-list
64386960|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64386961|NCT02380625|Sunitinib|sunitinib|mesh-list
64386962|NCT02380625|Irbesartan|irbesartan|mesh-list
64386963|NCT02380625|Atorvastatin|atorvastatin|mesh-list
64386964|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64386965|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64386966|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
64386967|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386968|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64386969|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64386970|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386971|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386972|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64385728|NCT03115073|Clotrimazole|clotrimazole|mesh-list
64386974|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386975|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64386976|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64386977|NCT02380625|Growth Substances|growth substances|mesh-ancestor
64386978|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386979|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
64386980|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64386981|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64386982|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64386984|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64386985|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
64386986|NCT02380313|Hormones|hormones|mesh-ancestor
64386987|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386988|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386989|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64386990|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386991|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64386992|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64387020|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387021|NCT02380001|Analgesics|analgesics|mesh-ancestor
64387022|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
64387023|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387024|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357639|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
64387025|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387026|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387027|NCT02379767|Harmine|harmine|mesh-list
64387028|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
64387029|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387030|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64387031|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64387032|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387033|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387034|NCT02661815|Paclitaxel|paclitaxel|mesh-list
64387035|NCT02661815|Bevacizumab|bevacizumab|mesh-list
64387036|NCT02661815|Ricolinostat|ricolinostat|mesh-list
64387037|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64352122|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387038|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387040|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
64387041|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
64387042|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387043|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387044|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64387045|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64387046|NCT02661815|Growth Substances|growth substances|mesh-ancestor
64387047|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387048|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
64387049|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64387072|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
64387073|NCT04688021|Busulfan|busulfan|mesh-list
64387074|NCT04688021|Cyclosporins|cyclosporins|mesh-list
64387075|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64387076|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
64387077|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387078|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
64387079|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387080|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387081|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64387082|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
64387083|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385852|NCT02546193|Misoprostol|misoprostol|mesh-list
64387173|NCT04072445|Camptothecin|camptothecin|mesh-list
64387174|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64387175|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64387176|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385869|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
64385870|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387177|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387179|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64387180|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
64387181|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
64387182|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387224|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64387225|NCT02375867|Protective Agents|protective agents|mesh-ancestor
64387226|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64387227|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387228|NCT04540133|Dexamethasone|dexamethasone|mesh-list
64387229|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
64387230|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64387232|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387233|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
64387234|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
64387235|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387236|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387237|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387238|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
64387239|NCT04540133|Hormones|hormones|mesh-ancestor
64387240|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387241|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64357679|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
64387248|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387249|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387250|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387251|NCT02375243|Analgesics|analgesics|mesh-ancestor
64387252|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
64387253|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387254|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64386036|NCT03959241|Tacrolimus|tacrolimus|mesh-list
64386107|NCT02055820|Rituximab|rituximab|mesh-list
64387255|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64387256|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64387257|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387258|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387259|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387260|NCT02374931|Estradiol|estradiol|mesh-list
64387261|NCT02374931|Estrogens|estrogens|mesh-ancestor
64387262|NCT02374931|Hormones|hormones|mesh-ancestor
64387263|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387264|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387265|NCT02377661|Amlodipine|amlodipine|mesh-list
64387266|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64387267|NCT02377661|Olmesartan|olmesartan|mesh-list
64387268|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64387269|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64387270|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64387271|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387272|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387273|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64387274|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387275|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
64387276|NCT02377661|Diuretics|diuretics|mesh-ancestor
64387277|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
64387278|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64387279|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64387280|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64387281|NCT02372357|Posaconazole|posaconazole|mesh-list
64387282|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
64387283|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387284|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64387285|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64387286|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64387287|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64387288|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64387290|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387302|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387303|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64387304|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387305|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387306|NCT02371577|Lenalidomide|lenalidomide|mesh-list
64387307|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
64387308|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387309|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64387310|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64387317|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387318|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387319|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64387320|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64387321|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
64387322|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
64387323|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387324|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64387325|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64387330|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387331|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387332|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
64387333|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387334|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64387335|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
64387336|NCT02371421|Protective Agents|protective agents|mesh-ancestor
64387337|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387338|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64387339|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
64387340|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387341|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387342|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387343|NCT03959891|Letrozole|letrozole|mesh-list
64387344|NCT03959891|Fulvestrant|fulvestrant|mesh-list
64387345|NCT03959891|Palbociclib|palbociclib|mesh-list
64387346|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64387347|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387348|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64387349|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387350|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387351|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64387352|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
64387353|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387354|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387357|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64387358|NCT02373215|Nalbuphine|nalbuphine|mesh-list
64387359|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64387360|NCT02373215|Narcotics|narcotics|mesh-ancestor
64387361|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387362|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387363|NCT02373215|Analgesics|analgesics|mesh-ancestor
64387364|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
64387365|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387366|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
64387367|NCT03785249|Cetuximab|cetuximab|mesh-list
64387368|NCT03785249|Afatinib|afatinib|mesh-list
64387369|NCT03785249|Adagrasib|adagrasib|mesh-list
64387412|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64387413|NCT02372669|Chitosan|chitosan|mesh-list
64387414|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64387415|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64387416|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
64387417|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387418|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64387419|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
64387420|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
64387421|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
64387422|NCT02372669|Coagulants|coagulants|mesh-ancestor
64387423|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64387424|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
64387425|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64387426|NCT02369939|Fluorouracil|fluorouracil|mesh-list
64387427|NCT02369939|Mitomycins|mitomycins|mesh-list
64387428|NCT02369939|Mitomycin|mitomycin|mesh-list
64387429|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
64387430|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387431|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387434|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
64387435|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387440|NCT02369549|Curcumin|curcumin|mesh-list
64387444|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
64387445|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387446|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387447|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387448|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387449|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387450|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387451|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387453|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
64387454|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387455|NCT02365415|Sirolimus|sirolimus|mesh-list
64387456|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387457|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387458|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64387460|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
64387461|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387462|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
64387463|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387465|NCT02369081|Doxazosin|doxazosin|mesh-list
64387466|NCT02369081|Spironolactone|spironolactone|mesh-list
64387467|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64387468|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
64387469|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387470|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387471|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64387472|NCT02369081|Diuretics|diuretics|mesh-ancestor
64387473|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
64387474|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64387475|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
64387476|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
64387477|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387478|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64387479|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64387480|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64387481|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387482|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387483|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387484|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64387497|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387499|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387500|NCT05653895|Metformin|metformin|mesh-list
64387501|NCT05653895|Resveratrol|resveratrol|mesh-list
64387502|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64387503|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387504|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
64387505|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387506|NCT05653895|Protective Agents|protective agents|mesh-ancestor
64387507|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387508|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64387509|NCT02364479|Etanercept|etanercept|mesh-list
64387510|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64387511|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64357813|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357901|NCT03379987|Morphine|morphine|mesh-list
64387514|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387515|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387516|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387517|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387518|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387519|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387520|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
64387521|NCT05653817|Paclitaxel|paclitaxel|mesh-list
64387522|NCT05653817|Apatinib|apatinib|mesh-list
64387523|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64387531|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387532|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
64387533|NCT02052310|Hematinics|hematinics|mesh-ancestor
64387534|NCT02368379|Metyrapone|metyrapone|mesh-list
64387535|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
64387536|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387537|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387538|NCT02051296|Minocycline|minocycline|mesh-list
64387539|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387540|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387542|NCT02367755|Propofol|propofol|mesh-list
64387543|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64387544|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387545|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387546|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64387547|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
64387548|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
64387549|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
64387550|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
64387555|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64387556|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64387557|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
64387558|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
64387559|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387561|NCT02364089|Epinephrine|epinephrine|mesh-list
64387562|NCT02364089|Racepinephrine|racepinephrine|mesh-list
64387563|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
64387564|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64387565|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64387566|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
64387567|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387573|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387574|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64387575|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
64387576|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
64387577|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
64387578|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64387579|NCT02363699|Lidocaine|lidocaine|mesh-list
64387580|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
64387581|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
64387582|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387583|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387584|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
64387585|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387586|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64387587|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64387588|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64387589|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387590|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387591|NCT02049814|Metformin|metformin|mesh-list
64387592|NCT02049814|Acarbose|acarbose|mesh-list
64387593|NCT02049814|Voglibose|voglibose|mesh-list
64387594|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64387595|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387596|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64357915|NCT03379909|Metformin|metformin|mesh-list
64387598|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387600|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64387602|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387603|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387604|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64387605|NCT03344159|Diuretics|diuretics|mesh-ancestor
64387606|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
64387607|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
64387608|NCT03324113|Promethazine|promethazine|mesh-list
64387609|NCT03324113|Dexamethasone|dexamethasone|mesh-list
64387610|NCT03324113|Naphazoline|naphazoline|mesh-list
64387611|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64387612|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387613|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
64387614|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
64387615|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387616|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387617|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387618|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
64387619|NCT03324113|Hormones|hormones|mesh-ancestor
64387620|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387621|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64387622|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387623|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64387645|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64387646|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64387647|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387648|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64387649|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
64387650|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64387651|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387652|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64387653|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64387654|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387655|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387656|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
64387657|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387659|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387660|NCT02367053|Hormones|hormones|mesh-ancestor
64387661|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387662|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387663|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64387664|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64387665|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64387666|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
64387667|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387668|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64387669|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64387670|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387671|NCT02366975|Testosterone|testosterone|mesh-list
64387672|NCT02366975|Androgens|androgens|mesh-ancestor
64387673|NCT02366975|Hormones|hormones|mesh-ancestor
64387674|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387681|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
64387682|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387683|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
64357924|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387684|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64387685|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
64387686|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64387687|NCT02366585|Cyclosporine|cyclosporine|mesh-list
64387688|NCT02366585|Cyclosporins|cyclosporins|mesh-list
64387689|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387690|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387691|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387692|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
64387693|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387694|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
64387695|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387696|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64387698|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64387699|NCT02079532|Rituximab|rituximab|mesh-list
64387700|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64387701|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387702|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
64387703|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387704|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387705|NCT02958917|Pirfenidone|pirfenidone|mesh-list
64387706|NCT02958917|Analgesics|analgesics|mesh-ancestor
64387707|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
64387708|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387709|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387710|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64387711|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387712|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387713|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387714|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387715|NCT02362529|Minocycline|minocycline|mesh-list
64387716|NCT02362529|Celecoxib|celecoxib|mesh-list
64387717|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64387718|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387719|NCT02362529|Analgesics|analgesics|mesh-ancestor
64387720|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
64387721|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387722|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387725|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64387726|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64387727|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387728|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387729|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387758|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
64387759|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64387760|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64387761|NCT02769689|Prednisolone|prednisolone|mesh-list
64387762|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
64387763|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64387764|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
64387765|NCT02769689|Natalizumab|natalizumab|mesh-list
64387766|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387767|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
64387768|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
64387769|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387770|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387772|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
64387773|NCT02769689|Hormones|hormones|mesh-ancestor
64387774|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387775|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64387776|NCT02769689|Protective Agents|protective agents|mesh-ancestor
64387777|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64387778|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387779|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
64387780|NCT02365571|Itraconazole|itraconazole|mesh-list
64387781|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
64387782|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387784|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64387785|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387786|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387787|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64387788|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
64387789|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64387790|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387791|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64387793|NCT02365727|Epinephrine|epinephrine|mesh-list
64387794|NCT02365727|Bupivacaine|bupivacaine|mesh-list
64387795|NCT02365727|Ropivacaine|ropivacaine|mesh-list
64387819|NCT02365805|Paclitaxel|paclitaxel|mesh-list
64387820|NCT02365805|Docetaxel|docetaxel|mesh-list
64387821|NCT02365805|Fluorouracil|fluorouracil|mesh-list
64387822|NCT02365805|Epirubicin|epirubicin|mesh-list
64387823|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
64387824|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64387825|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387826|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
64387827|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
64387828|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
64387829|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387830|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
64387831|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387832|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387833|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
64352130|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352131|NCT03444649|Cytarabine|cytarabine|mesh-list
64352132|NCT03444649|Daunorubicin|daunorubicin|mesh-list
64352133|NCT03444649|Idarubicin|idarubicin|mesh-list
64387834|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387835|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64387836|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64387837|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64387838|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387839|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387840|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64387841|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
64387842|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64387843|NCT03112889|Valproic Acid|valproic acid|mesh-list
64387844|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
64387845|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387846|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387847|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
64387848|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387849|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387850|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
64387863|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
64387865|NCT02361905|Leuprolide|leuprolide|mesh-list
64387866|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
64387867|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64387868|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
64387869|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64387870|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387871|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64387872|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387873|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64387874|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
64387875|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64387876|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
64387877|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64387878|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416721|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357945|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357946|NCT05172739|Narcotics|narcotics|mesh-ancestor
64387885|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387886|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
64387887|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387888|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387889|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64387890|NCT02358707|Ibuprofen|ibuprofen|mesh-list
64387891|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64387892|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64387893|NCT02358707|Analgesics|analgesics|mesh-ancestor
64387894|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
64387895|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387896|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387897|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64387898|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64387901|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387902|NCT02360501|Docetaxel|docetaxel|mesh-list
64387903|NCT02360501|Capecitabine|capecitabine|mesh-list
64387904|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387905|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
64387906|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
64387907|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
64387908|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387909|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64387910|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
64387911|NCT02360423|Sirolimus|sirolimus|mesh-list
64387912|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64387913|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387914|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64387915|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387916|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
64387917|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387918|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
64387919|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387921|NCT02358161|Paclitaxel|paclitaxel|mesh-list
64387922|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64387923|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64387924|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
64387925|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
64387926|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
64387929|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
64387949|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64387950|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
64387951|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64387952|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64387953|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64357984|NCT03378427|Doxycycline|doxycycline|mesh-list
64387957|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387958|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64387959|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64387960|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64387963|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
64387964|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
64387965|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64387966|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64387967|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64387968|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64387969|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64387970|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387971|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64387972|NCT02357615|Nifedipine|nifedipine|mesh-list
64387973|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64387974|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64387975|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64387978|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
64387992|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64387993|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
64387994|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
64387995|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64387996|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
64387997|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64387998|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64387999|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
64388000|NCT02359643|Aspirin|aspirin|mesh-list
64388001|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64388002|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64388003|NCT02359643|Analgesics|analgesics|mesh-ancestor
64388004|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
64388005|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388006|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388007|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64388008|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388009|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64388010|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64388011|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388012|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64388013|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64388014|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388015|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
64388016|NCT02359721|Clarithromycin|clarithromycin|mesh-list
64388017|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388018|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388019|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64388020|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388021|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388022|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64388023|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64388024|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
64388033|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357992|NCT03378427|Tedizolid|tedizolid|mesh-list
64357993|NCT03378427|Teicoplanin|teicoplanin|mesh-list
64388040|NCT02357225|Bromides|bromides|mesh-list
64388041|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64388042|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
64388043|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64388044|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388045|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388046|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388047|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388048|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388049|NCT02357069|Etanercept|etanercept|mesh-list
64388050|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64388051|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64388052|NCT02357069|Analgesics|analgesics|mesh-ancestor
64388053|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
64388054|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388055|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388056|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64388058|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64388059|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64388060|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
64388061|NCT02356913|Nicotine|nicotine|mesh-list
64388062|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64388063|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
64388064|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388065|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388066|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64388067|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64388068|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
64388072|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64388073|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388074|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64388075|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64388076|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64388077|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388078|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64388079|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64388080|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388081|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
64388082|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64388083|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
64388085|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388086|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64388087|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388088|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64388089|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
64358056|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64358057|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
64358060|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388090|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388092|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64388093|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
64388095|NCT02356835|Protective Agents|protective agents|mesh-ancestor
64388096|NCT02352701|Amoxicillin|amoxicillin|mesh-list
64388097|NCT02352701|Levofloxacin|levofloxacin|mesh-list
64388098|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388099|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388100|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64388101|NCT02352701|Renal Agents|renal agents|mesh-ancestor
64388102|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64388103|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64388104|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388105|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388106|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388107|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64388108|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64388109|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64388110|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388111|NCT02356445|Methotrexate|methotrexate|mesh-list
64388112|NCT02356445|Azathioprine|azathioprine|mesh-list
64388113|NCT02356445|Infliximab|infliximab|mesh-list
64388114|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64388115|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
64388116|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64388117|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388118|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64388119|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
64388120|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388121|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388122|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
64388123|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388124|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64388125|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64388126|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
64388127|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64388128|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64388129|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64388130|NCT02356679|Ethanol|ethanol|mesh-list
64388131|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64388132|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388133|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388134|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388147|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
64388148|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
64388149|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
64388150|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64358112|NCT03373825|Fentanyl|fentanyl|mesh-list
64388154|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64388155|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64388156|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388157|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388177|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64388178|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64388179|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64388180|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388181|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388182|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64388184|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
64388185|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
64388186|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64388187|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
64388188|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
64388189|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
64388190|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388191|NCT02355509|Acarbose|acarbose|mesh-list
64388192|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64388193|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388194|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388195|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64388196|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388197|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
64388198|NCT02355197|Vitamins|vitamins|mesh-ancestor
64388199|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
64388225|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64388226|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388227|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
64388228|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64388229|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
64388230|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64388231|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64388232|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388233|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
64388234|NCT02354885|Coagulants|coagulants|mesh-ancestor
64388235|NCT02354807|Mirabegron|mirabegron|mesh-list
64388245|NCT03159845|Ofloxacin|ofloxacin|mesh-list
64388248|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
64388249|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64388250|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352143|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64388251|NCT03159845|Renal Agents|renal agents|mesh-ancestor
64388252|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64388253|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64388254|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64388255|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64388256|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388257|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64388258|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64388259|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64358154|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358155|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358156|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
64358157|NCT03376555|Acetylcholine|acetylcholine|mesh-list
64358158|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
64388260|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
64388261|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64358159|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64388265|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388266|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64388400|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64388401|NCT03147677|Irbesartan|irbesartan|mesh-list
64388402|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64388403|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64388404|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64388405|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388406|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64388520|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388521|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64388522|NCT04478513|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64388523|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64388524|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388525|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64388526|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64388527|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
64388627|NCT02345681|Furosemide|furosemide|mesh-list
64388628|NCT02345681|Diuretics|diuretics|mesh-ancestor
64388629|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
64388630|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64388631|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64388632|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64388766|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64388767|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
64389885|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64389886|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64389887|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389888|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389889|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64389890|NCT02428777|Narcotics|narcotics|mesh-ancestor
64389891|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64389892|NCT02432053|Tacrolimus|tacrolimus|mesh-list
64389893|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64389894|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
64389895|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389896|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64389897|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64389898|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64389899|NCT03141827|Insulin|insulin|mesh-list
64389900|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64389901|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389902|NCT03190681|Methylphenidate|methylphenidate|mesh-list
64389903|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64389904|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64389953|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
64389954|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64389955|NCT03143465|Katacalcin|katacalcin|mesh-list
64389956|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
64352182|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64389957|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64389976|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64389977|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
64389978|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64389979|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64389980|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
64390013|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
64390014|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390015|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64390016|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390017|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64390018|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
64390019|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390020|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64390054|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390055|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390056|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64390097|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390099|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64390100|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390101|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390102|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64390245|NCT05078177|Rituximab|rituximab|mesh-list
64390246|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64390247|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390248|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
64390249|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390250|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64390251|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
64390252|NCT05081687|Irinotecan|irinotecan|mesh-list
64390253|NCT05081687|Folfirinox|folfirinox|mesh-list
64390254|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390255|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64390256|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64390257|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390258|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390259|NCT05080985|Bupivacaine|bupivacaine|mesh-list
64390260|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
64390261|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
64390262|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390263|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390264|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
64390265|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390267|NCT03139487|Tinzaparin|tinzaparin|mesh-list
64390268|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64390269|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
64390271|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64390272|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
64390273|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64390274|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
64390275|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390276|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390277|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
64390278|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64390279|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64390280|NCT04976387|Acetaminophen|acetaminophen|mesh-list
64390281|NCT04976387|Ibuprofen|ibuprofen|mesh-list
64390282|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64390283|NCT04976387|Hydrocodone|hydrocodone|mesh-list
64390284|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64390285|NCT04976387|Analgesics|analgesics|mesh-ancestor
64390286|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
64390287|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390288|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390289|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
64390290|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64390291|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64390292|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64390293|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64390294|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390295|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390296|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64390297|NCT04976387|Narcotics|narcotics|mesh-ancestor
64390301|NCT03139253|Amoxicillin|amoxicillin|mesh-list
64390329|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390330|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
64390377|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64390378|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
64390379|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390380|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390381|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64390382|NCT05022563|Warfarin|warfarin|mesh-list
64390383|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
64390384|NCT05022563|Dabigatran|dabigatran|mesh-list
64390385|NCT05022563|Apixaban|apixaban|mesh-list
64390386|NCT05022563|Anticoagulants|anticoagulants|mesh-list
64390387|NCT05022563|Edoxaban|edoxaban|mesh-list
64390388|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64390389|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
64390390|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64390458|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390460|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390461|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390462|NCT03194165|Ritonavir|ritonavir|mesh-list
64390463|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64390509|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390510|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
64390511|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64390512|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
64390513|NCT01993888|Coagulants|coagulants|mesh-ancestor
64390514|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
64390515|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64390545|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
64390546|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
64390547|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390548|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64390549|NCT03138785|Itraconazole|itraconazole|mesh-list
64390550|NCT03138785|Voriconazole|voriconazole|mesh-list
64390551|NCT03138785|Levofloxacin|levofloxacin|mesh-list
64390552|NCT03138785|Ofloxacin|ofloxacin|mesh-list
64390553|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
64390554|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390555|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64358229|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390556|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64390557|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358230|NCT03371797|Amlodipine|amlodipine|mesh-list
64390575|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64390576|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390577|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64390580|NCT02018458|Paclitaxel|paclitaxel|mesh-list
64390633|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64390634|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390636|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
64390637|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390638|NCT05392673|Protective Agents|protective agents|mesh-ancestor
64390639|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390640|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
64390641|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
64390642|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390651|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390652|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64390654|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390655|NCT01993186|Glycerol|glycerol|mesh-list
64390656|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64390661|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390662|NCT03196427|Vedolizumab|vedolizumab|mesh-list
64390663|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64390664|NCT02420665|Acetic Acid|acetic acid|mesh-list
64390665|NCT02420665|Proflavine|proflavine|mesh-list
64390666|NCT02420665|Retinol acetate|retinol acetate|mesh-list
64390667|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64390668|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390669|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64390670|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
64390671|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390672|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64390673|NCT02420665|Protective Agents|protective agents|mesh-ancestor
64390674|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390675|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64390683|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390684|NCT04482907|Hormones|hormones|mesh-list
64390685|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64390686|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390687|NCT02420509|Leucovorin|leucovorin|mesh-list
64390688|NCT02420509|Capecitabine|capecitabine|mesh-list
64390689|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390690|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390691|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64390692|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
64390693|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390694|NCT02420509|Antidotes|antidotes|mesh-ancestor
64390695|NCT02420509|Protective Agents|protective agents|mesh-ancestor
64390696|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
64390697|NCT02420509|Vitamins|vitamins|mesh-ancestor
64390698|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
64390699|NCT03193853|Paclitaxel|paclitaxel|mesh-list
64390700|NCT03193853|Serabelisib|serabelisib|mesh-list
64390701|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64390702|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390703|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
64358282|NCT03369847|Budesonide|budesonide|mesh-list
64390705|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
64390736|NCT02416063|Analgesics|analgesics|mesh-ancestor
64390737|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
64390738|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390739|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64390740|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64390741|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64390742|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
64390743|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390744|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390746|NCT01828697|Dalteparin|dalteparin|mesh-list
64390747|NCT01828697|Tinzaparin|tinzaparin|mesh-list
64390748|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64390749|NCT01828697|Nadroparin|nadroparin|mesh-list
64390750|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
64390751|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
64390752|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64390794|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390796|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
64390797|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390798|NCT04482985|Meclizine|meclizine|mesh-list
64390799|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
64390800|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
64390801|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390802|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390803|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352229|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390804|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64390805|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
64390806|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
64390807|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390808|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390809|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64390810|NCT05385263|Nivolumab|nivolumab|mesh-list
64390811|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64390812|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390813|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64390814|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390815|NCT03180229|Granisetron|granisetron|mesh-list
64390816|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
64390817|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
64390818|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390819|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390820|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64390821|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64390823|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64390827|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390828|NCT03178123|Interferons|interferons|mesh-list
64390829|NCT03178123|Antibodies|antibodies|mesh-list
64390862|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390863|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64390864|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
64390865|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64390866|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390867|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
64390868|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
64390890|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64390891|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64390892|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64390893|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64390894|NCT02419651|Narcotics|narcotics|mesh-ancestor
64390895|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390896|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64358295|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
64390900|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
64390901|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
64390902|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390903|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390904|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
64390905|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390906|NCT02414503|Oxytocin|oxytocin|mesh-list
64390907|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
64390910|NCT03137615|Anesthetics|anesthetics|mesh-list
64390911|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
64390912|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64390913|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390914|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
64390915|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64390916|NCT03415061|Insulin|insulin|mesh-list
64390917|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64390918|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64390919|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64390920|NCT05088083|Paclitaxel|paclitaxel|mesh-list
64390921|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64390922|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64390923|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
64390930|NCT05087693|Albuterol|albuterol|mesh-list
64390951|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
64390952|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64390953|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
64390954|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
64390955|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
64390957|NCT02624765|Sotalol|sotalol|mesh-list
64390958|NCT02624765|Flecainide|flecainide|mesh-list
64390959|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64390960|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64390962|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391011|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64391012|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391013|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64358304|NCT04526353|Urological Agents|urological agents|mesh-ancestor
64391054|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64391056|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
64391057|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64391058|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64391059|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391060|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391061|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
64391089|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64391090|NCT02419105|Androgens|androgens|mesh-ancestor
64391130|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64391131|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
64391132|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
64391133|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64391134|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64391135|NCT04643249|Analgesics|analgesics|mesh-ancestor
64391136|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
64391137|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391138|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64391159|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64391160|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64391161|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391162|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391163|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64391164|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
64391185|NCT05737511|Clonazepam|clonazepam|mesh-list
64391186|NCT05737511|Dexetimide|dexetimide|mesh-list
64391187|NCT05737511|Olanzapine|olanzapine|mesh-list
64391188|NCT05737511|Alprazolam|alprazolam|mesh-list
64391189|NCT05737511|Mirtazapine|mirtazapine|mesh-list
64391190|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
64391191|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
64391192|NCT05737511|Risperidone|risperidone|mesh-list
64391193|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64391194|NCT05737511|Citalopram|citalopram|mesh-list
64391195|NCT05737511|Bupropion|bupropion|mesh-list
64391196|NCT05737511|Sertraline|sertraline|mesh-list
64391197|NCT05737511|Fluoxetine|fluoxetine|mesh-list
64391216|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64391217|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391218|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391219|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
64391220|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64391221|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
64391222|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64391223|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64391224|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
64391250|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
64391251|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64391252|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64391253|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64391254|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
64391255|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64391256|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64391257|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64391258|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64391259|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64391260|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64391261|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
64391262|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
64391263|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64391264|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64391265|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64391266|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64391267|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64391268|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
64391272|NCT03179839|Sertraline|sertraline|mesh-list
64391303|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64391304|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391306|NCT05735639|Dalteparin|dalteparin|mesh-list
64391307|NCT05735639|Tinzaparin|tinzaparin|mesh-list
64391308|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64391309|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
64391310|NCT05735639|Apixaban|apixaban|mesh-list
64391311|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
64391312|NCT05735639|Dabigatran|dabigatran|mesh-list
64391313|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64391314|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
64391315|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64391316|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
64391317|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391318|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391319|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
64391320|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64294201|NCT02824627|Oxytocin|oxytocin|mesh-list
64391321|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64391322|NCT04483219|Antibodies|antibodies|mesh-list
64391323|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
64391324|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391325|NCT03176563|Fosfomycin|fosfomycin|mesh-list
64391326|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64391327|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391328|NCT03827447|Vancomycin|vancomycin|mesh-list
64391329|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64391330|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391331|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
64391332|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64391333|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
64391334|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391335|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
64391336|NCT01680497|Protective Agents|protective agents|mesh-ancestor
64391337|NCT02423395|Orphenadrine|orphenadrine|mesh-list
64391348|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
64391349|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391350|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391351|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
64391352|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64391353|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391354|NCT05694689|Vitamin D|vitamin d|mesh-list
64391355|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
64391356|NCT05694689|Vitamins|vitamins|mesh-ancestor
64391357|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
64391358|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391359|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64391360|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64358446|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64358447|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64358448|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358449|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358450|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64358451|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64358452|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64358453|NCT03362047|Macitentan|macitentan|mesh-list
64391361|NCT02423239|Gemcitabine|gemcitabine|mesh-list
64391362|NCT02423239|Paclitaxel|paclitaxel|mesh-list
64391363|NCT02423239|Sorafenib|sorafenib|mesh-list
64391365|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64358454|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64391374|NCT02423239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391375|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391376|NCT02423239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391377|NCT02423239|Immunologic Factors|immunologic factors|mesh-ancestor
64391378|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391379|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64391380|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64391381|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
64391382|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
64391383|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391384|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391402|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64391403|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
64294220|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294221|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294222|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64294223|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
64294224|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294225|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294227|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
64294228|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64294229|NCT03070951|OBE2109|obe2109|mesh-list
64294230|NCT03070951|Hormone Antagonists|hormone antagonists|mesh-ancestor
64391410|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391412|NCT02417389|Cinacalcet|cinacalcet|mesh-list
64391413|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64391414|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391426|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391427|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391428|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
64391429|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391430|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64391431|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
64391432|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
64391433|NCT01680341|Insulin|insulin|mesh-list
64391434|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64391435|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
64391436|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
64391469|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64391470|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
64391472|NCT02412475|Fludarabine|fludarabine|mesh-list
64391473|NCT02412475|Sorafenib|sorafenib|mesh-list
64391474|NCT02412475|Decitabine|decitabine|mesh-list
64391475|NCT02412475|Vorinostat|vorinostat|mesh-list
64391476|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391477|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64391478|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
64391479|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391480|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391481|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
64391482|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391483|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
64391484|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391487|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64391488|NCT04543643|Carvedilol|carvedilol|mesh-list
64391523|NCT03199157|Analgesics|analgesics|mesh-ancestor
64391524|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
64391525|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391526|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64391544|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64391545|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391546|NCT02416999|Bevacizumab|bevacizumab|mesh-list
64391547|NCT02416999|Temozolomide|temozolomide|mesh-list
64391548|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64391549|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64391550|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64391602|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
64391603|NCT03177109|Protective Agents|protective agents|mesh-ancestor
64391604|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391605|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64391606|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64391607|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
64391608|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391609|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391610|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391612|NCT02421913|Analgesics|analgesics|mesh-ancestor
64391613|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
64391614|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391615|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391616|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64391617|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64391618|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
64391619|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
64391620|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391621|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64391622|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64391623|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64391624|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391625|NCT03179293|Propofol|propofol|mesh-list
64391685|NCT02411149|Ropivacaine|ropivacaine|mesh-list
64391686|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
64391687|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64391688|NCT02411149|Narcotics|narcotics|mesh-ancestor
64391701|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64391702|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64391703|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
64391704|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64391705|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
64391706|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
64391707|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
64391708|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64391733|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64391734|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391735|NCT03175081|Ropivacaine|ropivacaine|mesh-list
64391736|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
64391737|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
64391738|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391739|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391740|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
64391741|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391742|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
64391743|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64391744|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64391745|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391768|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64391769|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391770|NCT01619878|Lumefantrine|lumefantrine|mesh-list
64391771|NCT01619878|Artemether|artemether|mesh-list
64391782|NCT01989208|Cathartics|cathartics|mesh-ancestor
64391783|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391784|NCT01619410|Clindamycin|clindamycin|mesh-list
64391785|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
64391786|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
64391787|NCT01619410|Linezolid|linezolid|mesh-list
64391788|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64391789|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64391790|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64391791|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64391792|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391793|NCT04666714|Pregabalin|pregabalin|mesh-list
64391794|NCT04666714|Analgesics|analgesics|mesh-ancestor
64391795|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
64391796|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391797|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391798|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
64391799|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64391800|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64391801|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64391802|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64391803|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64391814|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391815|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
64391816|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
64391817|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391818|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391819|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64391820|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
64391822|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64391823|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64391871|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64391872|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64391873|NCT01678313|Analgesics|analgesics|mesh-ancestor
64391874|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
64358511|NCT02929485|Bromocriptine|bromocriptine|mesh-list
64391875|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391876|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64391877|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391878|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64391879|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64391912|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64391913|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64391914|NCT01603121|Analgesics|analgesics|mesh-ancestor
64391915|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
64391916|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64391917|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64391918|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64391919|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64391921|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
64391922|NCT02449265|Doxorubicin|doxorubicin|mesh-list
64391923|NCT02449265|Vincristine|vincristine|mesh-list
64392003|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64392004|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64392005|NCT01988662|Growth Substances|growth substances|mesh-ancestor
64392006|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392007|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
64392008|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392009|NCT00127673|Sertraline|sertraline|mesh-list
64392010|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
64392011|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64392012|NCT00127673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64392013|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64392014|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64392015|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392016|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392017|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
64392018|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392019|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
64392020|NCT02449187|Metformin|metformin|mesh-list
64392021|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64392022|NCT02449187|Calcium|calcium|mesh-list
64392023|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64392024|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392025|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64392026|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64392027|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64392050|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
64392051|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64392070|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
64392071|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
64392072|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392073|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392074|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
64358525|NCT04523623|Oxycodone|oxycodone|mesh-list
64358527|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64392076|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64392231|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
64392232|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64392233|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
64392234|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392235|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
64392236|NCT02448407|Protective Agents|protective agents|mesh-ancestor
64392237|NCT05099471|Dexamethasone|dexamethasone|mesh-list
64392238|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
64392239|NCT05099471|Rituximab|rituximab|mesh-list
64392240|NCT05099471|Venetoclax|venetoclax|mesh-list
64392259|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64392260|NCT05098847|Lenvatinib|lenvatinib|mesh-list
64392261|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392262|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64392263|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392264|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392265|NCT04517357|Apatinib|apatinib|mesh-list
64392268|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392269|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392270|NCT02012296|Mifepristone|mifepristone|mesh-list
64392271|NCT02012296|Androgens|androgens|mesh-list
64392272|NCT02012296|Hormones|hormones|mesh-ancestor
64392273|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64392274|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392275|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64392276|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
64392277|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64294261|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64392299|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392300|NCT04658836|Triamcinolone|triamcinolone|mesh-list
64392378|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
64392415|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64392417|NCT05102045|Memantine|memantine|mesh-list
64392418|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
64392419|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64392420|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64392421|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
64392422|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392424|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392425|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64392426|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64392427|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392428|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
64392429|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
64392430|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
64392431|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64392432|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64392433|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64392434|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392435|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392439|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
64392514|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64392515|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392516|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392517|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64392519|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
64358569|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358570|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64392521|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
64392522|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392523|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64392524|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64392525|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64392526|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392527|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392528|NCT03168997|Memantine|memantine|mesh-list
64392529|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64392530|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64392531|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
64392532|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64392533|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392534|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392535|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64392536|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64392538|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64392539|NCT03171727|Tinzaparin|tinzaparin|mesh-list
64392540|NCT03171727|Dalteparin|dalteparin|mesh-list
64392541|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
64392542|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64392543|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64392544|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392545|NCT02400931|Rocuronium|rocuronium|mesh-list
64392546|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64392547|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64392548|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64392549|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392550|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392551|NCT03116269|Aspirin|aspirin|mesh-list
64392552|NCT03116269|Cilostazol|cilostazol|mesh-list
64392553|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64392554|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64392555|NCT03116269|Analgesics|analgesics|mesh-ancestor
64392556|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
64392557|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392558|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392559|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64392560|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392561|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64392562|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64392563|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392564|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64392565|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64392566|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392567|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
64392568|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64392569|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
64392570|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64392571|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
64392572|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
64392573|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64392651|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64392652|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392653|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64392654|NCT02699125|Guanfacine|guanfacine|mesh-list
64392655|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64392656|NCT02699125|Diuretics|diuretics|mesh-ancestor
64392657|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
64392687|NCT02400385|Growth Substances|growth substances|mesh-ancestor
64392688|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392689|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
64392690|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64392691|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358591|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358593|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64358594|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392694|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64392732|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64392733|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64392734|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392735|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
64392737|NCT04530539|Vitamins|vitamins|mesh-ancestor
64392738|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
64392739|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392740|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
64392741|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392742|NCT04530539|Protective Agents|protective agents|mesh-ancestor
64392743|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64392745|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64392746|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392747|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
64392748|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
64392749|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
64392750|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392752|NCT04719065|Analgesics|analgesics|mesh-ancestor
64392753|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
64392754|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64392755|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392756|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392757|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64392758|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64392798|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392799|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64392800|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
64392801|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64392802|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392803|NCT02850263|Aflibercept|aflibercept|mesh-list
64392804|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64392805|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64392806|NCT02850263|Growth Substances|growth substances|mesh-ancestor
64392807|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392808|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
64392809|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392810|NCT04481815|Rituximab|rituximab|mesh-list
64392811|NCT04481815|Methotrexate|methotrexate|mesh-list
64352247|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
64392812|NCT04481815|Lenalidomide|lenalidomide|mesh-list
64392813|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64392814|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64392815|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
64392816|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392817|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64392818|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64392822|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
64392866|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64392867|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64392868|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64392869|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64392870|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64392871|NCT02398357|Nadroparin|nadroparin|mesh-list
64392872|NCT02398357|Warfarin|warfarin|mesh-list
64392873|NCT02398357|Calcium|calcium|mesh-list
64392874|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64392875|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64392876|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
64392877|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64392878|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64392879|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64392880|NCT02398201|Bezafibrate|bezafibrate|mesh-list
64358595|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64392948|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
64392949|NCT02404519|Vitamin K|vitamin k|mesh-list
64392950|NCT02404519|Vitamin MK 7|vitamin mk 7|mesh-list
64392951|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64392952|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64392954|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
64393017|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393018|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64393079|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393080|NCT04832009|Vitamins|vitamins|mesh-ancestor
64393081|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
64393082|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64393083|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64393084|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64393085|NCT03129113|Metformin|metformin|mesh-list
64393086|NCT03129113|Maraviroc|maraviroc|mesh-list
64393087|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64393088|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393089|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64393090|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64393105|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64393107|NCT05104931|Analgesics|analgesics|mesh-ancestor
64393108|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
64393109|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393110|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393111|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393112|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393113|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64393156|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64393158|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64393159|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64393160|NCT05110469|Narcotics|narcotics|mesh-ancestor
64393161|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64393162|NCT02404051|Everolimus|everolimus|mesh-list
64393163|NCT02404051|Fulvestrant|fulvestrant|mesh-list
64393164|NCT02404051|Exemestane|exemestane|mesh-list
64393165|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393166|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393167|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
64393168|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393169|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64393170|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64393171|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64393172|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
64393173|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352280|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393174|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64393175|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64393176|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393177|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393190|NCT03170323|Cyclosporins|cyclosporins|mesh-list
64393191|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393192|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393193|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393194|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
64358604|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
64393196|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
64393197|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393198|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
64393199|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393200|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64393201|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64393202|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393203|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64393204|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
64393223|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393459|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64393460|NCT05113511|Growth Substances|growth substances|mesh-ancestor
64393461|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393462|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
64393463|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64393663|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393694|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393695|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
64393696|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
64393697|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393698|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393699|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64393700|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
64393701|NCT03906617|Hormones|hormones|mesh-ancestor
64393702|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393703|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64393704|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393727|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393729|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393730|NCT02184767|Loxapine|loxapine|mesh-list
64393731|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64393732|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64393733|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393735|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64393765|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64393766|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
64393767|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393768|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393779|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
64393795|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64393797|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
64393798|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393799|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
64393800|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
64393801|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
64393802|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393803|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393804|NCT03096041|Analgesics|analgesics|mesh-list
64393805|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
64393806|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393843|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393844|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
64393845|NCT02394847|Propofol|propofol|mesh-list
64393846|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64393847|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64393848|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393849|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64393850|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
64393851|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
64393852|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
64393853|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64393854|NCT05021861|Estradiol|estradiol|mesh-list
64393855|NCT05021861|Cyproterone|cyproterone|mesh-list
64393856|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
64393858|NCT05021861|Hormones|hormones|mesh-ancestor
64393859|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352282|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64393860|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393861|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64393862|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
64393863|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64393864|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64393865|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64393866|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64393867|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
64393868|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
64393869|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393870|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64393871|NCT02403037|Dexamethasone|dexamethasone|mesh-list
64393872|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
64393873|NCT02403037|Antiemetics|antiemetics|mesh-list
64393874|NCT02403037|Emetics|emetics|mesh-list
64393885|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393886|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
64393887|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393888|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393889|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
64393890|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64393891|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393892|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64393893|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64393894|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
64393895|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393896|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
64393897|NCT04480333|Remdesivir|remdesivir|mesh-list
64393898|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
64393899|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64393900|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
64393901|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393902|NCT04480333|Protective Agents|protective agents|mesh-ancestor
64393903|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358630|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64358631|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64358632|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358633|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358634|NCT03367585|Vitamin D|vitamin d|mesh-list
64393904|NCT03166891|Chiauranib|chiauranib|mesh-list
64393905|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393906|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64393907|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393908|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393909|NCT01980940|Etoricoxib|etoricoxib|mesh-list
64393915|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393916|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393917|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64393918|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393919|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64393925|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64393926|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
64393927|NCT01960114|Acetaminophen|acetaminophen|mesh-list
64393928|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64393929|NCT01960114|Analgesics|analgesics|mesh-ancestor
64393930|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
64393931|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393932|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393933|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
64393934|NCT04752527|Sorafenib|sorafenib|mesh-list
64393935|NCT04752527|Decitabine|decitabine|mesh-list
64393936|NCT04752527|Venetoclax|venetoclax|mesh-list
64393937|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393938|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64393939|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64393947|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393948|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64393949|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393950|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
64393951|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393953|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
64393954|NCT03169777|Bevacizumab|bevacizumab|mesh-list
64393955|NCT03169777|Fluorouracil|fluorouracil|mesh-list
64393956|NCT03169777|Capecitabine|capecitabine|mesh-list
64393957|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
64393958|NCT03169777|Nivolumab|nivolumab|mesh-list
64393959|NCT03169777|Cetuximab|cetuximab|mesh-list
64393960|NCT03169777|Fulvestrant|fulvestrant|mesh-list
64393961|NCT03169777|Avelumab|avelumab|mesh-list
64393962|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64393963|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393964|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64393965|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
64393966|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393967|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64393968|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64393969|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
64393970|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64393971|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64393972|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64393973|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64393988|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64393990|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64393991|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64393992|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64393993|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64393994|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64393995|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
64393996|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
64393997|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64393998|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64393999|NCT02092571|Progesterone|progesterone|mesh-list
64394000|NCT02092571|Progestins|progestins|mesh-ancestor
64394001|NCT02092571|Hormones|hormones|mesh-ancestor
64294275|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
64294276|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64394016|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64394017|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394019|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394020|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394021|NCT02394145|Clopidogrel|clopidogrel|mesh-list
64394022|NCT02394145|Ticagrelor|ticagrelor|mesh-list
64394023|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64394024|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64394025|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64394026|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64394027|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
64394028|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394029|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394030|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394031|NCT02004886|Metformin|metformin|mesh-list
64394032|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394033|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394034|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
64394035|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64394036|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394040|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
64394064|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394065|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64394066|NCT04435925|Fentanyl|fentanyl|mesh-list
64394067|NCT04435925|Remifentanil|remifentanil|mesh-list
64394071|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394072|NCT04435925|Analgesics|analgesics|mesh-ancestor
64394073|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
64394074|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394075|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64394076|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64394077|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
64394078|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
64394079|NCT04649476|Cisplatin|cisplatin|mesh-list
64394080|NCT04649476|Docetaxel|docetaxel|mesh-list
64394081|NCT04649476|Fluorouracil|fluorouracil|mesh-list
64394082|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394083|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
64394117|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64394118|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394120|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394121|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64394122|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394123|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394124|NCT03251729|Progesterone|progesterone|mesh-list
64394125|NCT03251729|Progestins|progestins|mesh-ancestor
64394126|NCT03251729|Hormones|hormones|mesh-ancestor
64394127|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394128|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394134|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
64394136|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64394137|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
64394138|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394139|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394140|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64394141|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
64394142|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394143|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394144|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64394145|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64394147|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394148|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
64394149|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394150|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394151|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
64394180|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394181|NCT02402413|Androgens|androgens|mesh-list
64394182|NCT02402413|Hormones|hormones|mesh-ancestor
64394183|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394184|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394185|NCT02393443|Oxytocin|oxytocin|mesh-list
64394193|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64394194|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394195|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394196|NCT01977898|Morphine|morphine|mesh-list
64394197|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64394198|NCT01977898|Narcotics|narcotics|mesh-ancestor
64394199|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394200|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394201|NCT01977898|Analgesics|analgesics|mesh-ancestor
64394202|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
64394203|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394204|NCT05744479|Metformin|metformin|mesh-list
64394205|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394206|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394208|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64394209|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
64394222|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64394224|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
64394226|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64394227|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
64394228|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64394229|NCT02401945|Aflibercept|aflibercept|mesh-list
64394230|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64394231|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64394232|NCT02401945|Growth Substances|growth substances|mesh-ancestor
64394233|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394234|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
64394235|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394236|NCT02003014|Pioglitazone|pioglitazone|mesh-list
64394237|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394238|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394239|NCT01977352|Bupivacaine|bupivacaine|mesh-list
64394240|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394241|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
64394242|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394243|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358826|NCT05052099|Bevacizumab|bevacizumab|mesh-list
64394244|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
64394245|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394247|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394248|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
64394249|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394250|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394251|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
64394252|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394253|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64394254|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64394255|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64394256|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64394257|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394258|NCT05117021|Bupivacaine|bupivacaine|mesh-list
64394259|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
64394260|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
64394261|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394310|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
64394311|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394312|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
64394313|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64394314|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394315|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394316|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394317|NCT02687815|Vitamin D|vitamin d|mesh-list
64394318|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
64394319|NCT02687815|Vitamins|vitamins|mesh-ancestor
64394320|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
64394321|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394322|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64394323|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64394324|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
64394325|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64394326|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394327|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
64394328|NCT01959334|Glucagon|glucagon|mesh-list
64394329|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64394330|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64394331|NCT01959334|Hormones|hormones|mesh-ancestor
64394332|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394333|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394334|NCT01959334|Incretins|incretins|mesh-ancestor
64394335|NCT01958476|Morphine|morphine|mesh-list
64394336|NCT01958476|Methadone|methadone|mesh-list
64394337|NCT01958476|Phenobarbital|phenobarbital|mesh-list
64394338|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64394339|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64394340|NCT01958476|Narcotics|narcotics|mesh-ancestor
64394341|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394342|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394343|NCT01958476|Analgesics|analgesics|mesh-ancestor
64394344|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
64394345|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394362|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
64394363|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394364|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394365|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394366|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64394367|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64394368|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394369|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394370|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
64358901|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358904|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
64394371|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394372|NCT01057121|Lenalidomide|lenalidomide|mesh-list
64394373|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
64394374|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394391|NCT04210349|Vaccines|vaccines|mesh-list
64394392|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
64394393|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394394|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
64394395|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394396|NCT04746989|Allopurinol|allopurinol|mesh-list
64394397|NCT04746989|Probenecid|probenecid|mesh-list
64394398|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
64394399|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394400|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394401|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
64394402|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394403|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64394407|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
64394408|NCT04746989|Renal Agents|renal agents|mesh-ancestor
64394409|NCT04393103|Atropine|atropine|mesh-list
64394410|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64394411|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64394412|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64394413|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64394414|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
64394415|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394416|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394417|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64394418|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
64394419|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
64394420|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
64394421|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64394422|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64394423|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
64394424|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394425|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394426|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64394427|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64394429|NCT04671953|Metformin|metformin|mesh-list
64394430|NCT04671953|BMS-986165|bms-986165|mesh-list
64394431|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394432|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394433|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
64394434|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64394435|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394436|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394532|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64394533|NCT05746351|Fentanyl|fentanyl|mesh-list
64394534|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
64394535|NCT05746351|Nalbuphine|nalbuphine|mesh-list
64394536|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64394537|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394547|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394548|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352303|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64394551|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64394552|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64394553|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
64394554|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
64394555|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64394556|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
64394557|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64394558|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394559|NCT05403281|Incretins|incretins|mesh-ancestor
64394560|NCT05403281|Hormones|hormones|mesh-ancestor
64358933|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64358935|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394561|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394562|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64394563|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
64394564|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394565|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394566|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64394567|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64394587|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64394590|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
64394591|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
64394592|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394593|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394594|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64394595|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64394600|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394601|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64394602|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394603|NCT05403125|Listerine|listerine|mesh-list
64394604|NCT05403125|Fluorides|fluorides|mesh-list
64394605|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
64394611|NCT05701423|Natalizumab|natalizumab|mesh-list
64394612|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
64394613|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394614|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
64394615|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
64394616|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64394617|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64394618|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394619|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394620|NCT02795351|Urological Agents|urological agents|mesh-ancestor
64394621|NCT05403047|Tenofovir|tenofovir|mesh-list
64394622|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
64394623|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394624|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64394625|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64394626|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394627|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394628|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64394629|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64394630|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
64394633|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64358944|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64358945|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64394634|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64394635|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394636|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352329|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352330|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352334|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
64352335|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
64352336|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352337|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352338|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352339|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
64394637|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394638|NCT03927443|Bimatoprost|bimatoprost|mesh-list
64394639|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64394640|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
64394641|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64394642|NCT05124353|Protective Agents|protective agents|mesh-ancestor
64394643|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394644|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
64394645|NCT03913247|Metronidazole|metronidazole|mesh-list
64394646|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394647|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64394648|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64394649|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64394651|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
64394652|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
64394653|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64394654|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394656|NCT01999972|Crizotinib|crizotinib|mesh-list
64394657|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394658|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64394659|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394660|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394661|NCT04055389|Antithrombins|antithrombins|mesh-list
64394662|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
64394663|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64394664|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
64394665|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394666|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394667|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
64394668|NCT05697055|Ritonavir|ritonavir|mesh-list
64394674|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64394675|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64394678|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64352340|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
64394679|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64394681|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64394682|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64394683|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394684|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64394685|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64394686|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
64394687|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64394688|NCT01999894|Memantine|memantine|mesh-list
64394689|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64352341|NCT05100303|Cytarabine|cytarabine|mesh-list
64352342|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
64352343|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64394690|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64394691|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
64394692|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394693|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394694|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394695|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64358988|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64358989|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64394697|NCT01976806|Aspirin|aspirin|mesh-list
64394698|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64394699|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394700|NCT01976806|Analgesics|analgesics|mesh-ancestor
64394701|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
64394705|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64394706|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64394707|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64394708|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394709|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64394710|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64394711|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394712|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
64394713|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64394714|NCT01976728|Hormones|hormones|mesh-ancestor
64394715|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394716|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394717|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64394718|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64394719|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394720|NCT03165253|Amoxicillin|amoxicillin|mesh-list
64394721|NCT03165253|Clarithromycin|clarithromycin|mesh-list
64394722|NCT03165253|Omeprazole|omeprazole|mesh-list
64394723|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64394724|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394725|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64394726|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64394729|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394730|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64394753|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394754|NCT01976338|Ranibizumab|ranibizumab|mesh-list
64394766|NCT02506517|Afatinib|afatinib|mesh-list
64394767|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394768|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64394769|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394770|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394771|NCT04657939|Pioglitazone|pioglitazone|mesh-list
64394772|NCT04657939|Liraglutide|liraglutide|mesh-list
64394783|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394784|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64394800|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
64394801|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394802|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64394803|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64394804|NCT04500275|Vancomycin|vancomycin|mesh-list
64394805|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64394806|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64394807|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64394808|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64394809|NCT04503161|Estradiol|estradiol|mesh-list
64394810|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64394811|NCT04503161|Estrogens|estrogens|mesh-ancestor
64394812|NCT04503161|Hormones|hormones|mesh-ancestor
64394813|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352344|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
64352350|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
64352351|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352352|NCT05100303|Analgesics|analgesics|mesh-ancestor
64352353|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
64352354|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352355|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64352356|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64394831|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64394832|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394833|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64394834|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394835|NCT01288625|Amifostine|amifostine|mesh-list
64394836|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64394844|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359009|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
64394848|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
64394849|NCT02674399|Protective Agents|protective agents|mesh-ancestor
64394850|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394851|NCT03161509|Acetaminophen|acetaminophen|mesh-list
64394852|NCT03161509|Lamotrigine|lamotrigine|mesh-list
64394853|NCT03161509|Carbamazepine|carbamazepine|mesh-list
64394854|NCT03161509|Phenytoin|phenytoin|mesh-list
64394855|NCT03161509|Valproic Acid|valproic acid|mesh-list
64394856|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
64394857|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64394858|NCT03161509|Analgesics|analgesics|mesh-ancestor
64394859|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
64394860|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394861|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394862|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
64394863|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64394864|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64394865|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394866|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64394867|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64394868|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64394877|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64394878|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64394879|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64394880|NCT02676895|Vaccines|vaccines|mesh-list
64394881|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
64394882|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394883|NCT04440085|Midodrine|midodrine|mesh-list
64394884|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
64394885|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
64394886|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64394887|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394888|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64394889|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64394890|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64394891|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64394892|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
64394893|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394894|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394895|NCT05129033|Omalizumab|omalizumab|mesh-list
64394896|NCT05129033|Itraconazole|itraconazole|mesh-list
64394897|NCT05129033|Prednisone|prednisone|mesh-list
64394898|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64394899|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
64394900|NCT05129033|Hormones|hormones|mesh-ancestor
64394901|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352357|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352358|NCT03462173|Yimitasvir|yimitasvir|mesh-list
64394902|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394903|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64394904|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64394919|NCT05128721|Vaccines|vaccines|mesh-list
64394920|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
64394921|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394922|NCT05128175|Levodopa|levodopa|mesh-list
64394923|NCT05128175|Carbidopa|carbidopa|mesh-list
64394924|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64394925|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64394926|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64394927|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
64394928|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64394929|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394930|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394931|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64394932|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64394933|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64394934|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
64352359|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
64394935|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
64394937|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64394938|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
64394939|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
64394940|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394941|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
64394943|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64394944|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394945|NCT05127707|Analgesics|analgesics|mesh-ancestor
64394946|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
64394974|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64394975|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64394976|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
64394977|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64394978|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64394979|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64394980|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64394985|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64395010|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395011|NCT05279963|Amitriptyline|amitriptyline|mesh-list
64395012|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64395013|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
64395014|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64395015|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64395016|NCT05279963|Analgesics|analgesics|mesh-ancestor
64395017|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
64395018|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64395019|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64395020|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64395021|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64395022|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64395023|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64395114|NCT05051293|Hormones|hormones|mesh-ancestor
64395931|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64395932|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64395933|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64396291|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396292|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
64396293|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396294|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396295|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64396296|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
64396297|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352393|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396298|NCT01998958|Esketamine|esketamine|mesh-list
64396299|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
64396300|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64396301|NCT02386111|Sunitinib|sunitinib|mesh-list
64396302|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396303|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64396304|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64396306|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396307|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
64396308|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64396309|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396310|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396311|NCT02386033|Atorvastatin|atorvastatin|mesh-list
64396312|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64396313|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396314|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
64396315|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396316|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396317|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64396319|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64396320|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64396321|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64396322|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396323|NCT02381275|Tenofovir|tenofovir|mesh-list
64396345|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64396346|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396347|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64396365|NCT01998880|Rituximab|rituximab|mesh-list
64396366|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
64396367|NCT01998880|Chlorambucil|chlorambucil|mesh-list
64396368|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64396369|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64396370|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
64396371|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64396372|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64396373|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64396374|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
64396375|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396376|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64396377|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64359037|NCT03364075|Serotonin|serotonin|mesh-list
64396984|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
64396985|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
64396986|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64396987|NCT00650663|Simvastatin|simvastatin|mesh-list
64396988|NCT00650663|Ezetimibe|ezetimibe|mesh-list
64396989|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64396990|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64396991|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
64396992|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64396993|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64396994|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64396995|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64396996|NCT02368717|Mesalamine|mesalamine|mesh-list
64396997|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64396998|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64396999|NCT02368717|Analgesics|analgesics|mesh-ancestor
64397000|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
64352395|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64352430|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352431|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
64352433|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352434|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
64352435|NCT03435939|Losartan|losartan|mesh-list
64352436|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64352437|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64397252|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64397253|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64397255|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
64397256|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64359551|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397449|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64397450|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
64397451|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
64397452|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64397453|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397454|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397455|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64397456|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64397457|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397459|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64397460|NCT05059145|Fluconazole|fluconazole|mesh-list
64397461|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64397462|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64397463|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
64397464|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64397465|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
64397466|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64397490|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64397491|NCT03097835|Anesthetics|anesthetics|mesh-list
64397492|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64397493|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416785|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397510|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64397511|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64397512|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397513|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397514|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
64397515|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397516|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64397517|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64397518|NCT05058755|Growth Substances|growth substances|mesh-ancestor
64397521|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
64397543|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397544|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397545|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64397546|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
64397547|NCT05057663|Fluorouracil|fluorouracil|mesh-list
64352438|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64397548|NCT05057663|Bleomycin|bleomycin|mesh-list
64397549|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
64397550|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397551|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64352439|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64397552|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359906|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
64359907|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64397553|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64397554|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
64397555|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397556|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64397558|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64397559|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
64397560|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397561|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397562|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64397563|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64397596|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64397597|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397598|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64397599|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397600|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397601|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397603|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397604|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64397605|NCT01952080|Protective Agents|protective agents|mesh-ancestor
64397606|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397607|NCT01951378|Albuterol|albuterol|mesh-list
64397608|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64397609|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
64397610|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397611|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397612|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64397613|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
64397614|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
64397639|NCT05054465|Venetoclax|venetoclax|mesh-list
64397651|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64397652|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64397653|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397654|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397655|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64397656|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
64397657|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64397658|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64397659|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
64397660|NCT01361009|Pramipexole|pramipexole|mesh-list
64397661|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
64397662|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397663|NCT01361009|Protective Agents|protective agents|mesh-ancestor
64397664|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397665|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64397670|NCT02373163|Amlodipine|amlodipine|mesh-list
64397707|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64352602|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352603|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397708|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
64397709|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
64397710|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
64397711|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397712|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397713|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359950|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
64397714|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64397716|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64397773|NCT02365675|Laxatives|laxatives|mesh-ancestor
64397774|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397775|NCT02365675|Emollients|emollients|mesh-ancestor
64397777|NCT05052437|Capecitabine|capecitabine|mesh-list
64397778|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64397779|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
64397780|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397781|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397782|NCT05052359|Lectins|lectins|mesh-list
64397783|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
64397784|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
64397785|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397786|NCT05052359|Coagulants|coagulants|mesh-ancestor
64397787|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
64397788|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64397835|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397836|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64397837|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64397838|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64397839|NCT01969084|Linagliptin|linagliptin|mesh-list
64397840|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64397841|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64397842|NCT01969084|Incretins|incretins|mesh-ancestor
64397843|NCT01969084|Hormones|hormones|mesh-ancestor
64397844|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397845|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64397896|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397897|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64397898|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64397969|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64397970|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64397971|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64397972|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64397973|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64397974|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
64397975|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
64397976|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64397977|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64397978|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
64397979|NCT05049473|Hormones|hormones|mesh-ancestor
64397980|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64397981|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64397982|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64397983|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64397984|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64397985|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64397987|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
64398021|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352607|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
64352619|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
64352621|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352622|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398022|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64398023|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398024|NCT02357563|Leuprolide|leuprolide|mesh-list
64398025|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
64398026|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64398027|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
64398028|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398031|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398089|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64398090|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64398091|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
64398092|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398093|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398094|NCT02361619|Analgesics|analgesics|mesh-ancestor
64360003|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64360004|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
64360005|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398095|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
64398096|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398117|NCT02352025|Equol|equol|mesh-list
64398155|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
64398156|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398157|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64398158|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
64398159|NCT05047991|Antiviral Agents|antiviral agents|mesh-ancestor
64398160|NCT05047991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64398161|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398162|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398163|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
64398221|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398222|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
64398223|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
64398224|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398225|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398226|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64398227|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
64398229|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64398230|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64398231|NCT03160651|Protective Agents|protective agents|mesh-ancestor
64398232|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64398233|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398234|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
64398235|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64398236|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
64398281|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64398282|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
64398283|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64398284|NCT05024825|Narcotics|narcotics|mesh-ancestor
64398285|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
64398286|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398287|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
64398288|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
64398346|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64398347|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
64398348|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64398349|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64398350|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
64398351|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
64398352|NCT03093389|Resveratrol|resveratrol|mesh-list
64398353|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
64398354|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398355|NCT03093389|Protective Agents|protective agents|mesh-ancestor
64398356|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398357|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352623|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352681|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64352682|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64352683|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64352684|NCT04771689|Buprenorphine|buprenorphine|mesh-list
64398358|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64398359|NCT01949116|Folic Acid|folic acid|mesh-list
64398360|NCT01949116|Methotrexate|methotrexate|mesh-list
64398361|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64398362|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
64398363|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64398403|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64398404|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398405|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64398406|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64398407|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64398408|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64398471|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360013|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
64398472|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64398473|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64398474|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398476|NCT04434365|Clopidogrel|clopidogrel|mesh-list
64398477|NCT04434365|Atorvastatin|atorvastatin|mesh-list
64398478|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64398479|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64398480|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64398481|NCT04434365|Analgesics|analgesics|mesh-ancestor
64398482|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
64398535|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398536|NCT05031143|Triamcinolone|triamcinolone|mesh-list
64398674|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398675|NCT03091595|Drospirenone|drospirenone|mesh-list
64398676|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64398677|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64398678|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64398743|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398744|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
64398745|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398746|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64398747|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
64398811|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398812|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
64398813|NCT03146533|Fludarabine|fludarabine|mesh-list
64398814|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64398815|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
64398816|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64398880|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64398881|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
64398882|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
64398883|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
64398884|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64398885|NCT02343679|Ceritinib|ceritinib|mesh-list
64398886|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64398887|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64398888|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64398889|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64398891|NCT02348905|Hormones|hormones|mesh-ancestor
64398941|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64398942|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64398943|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
64398944|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
64398945|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
64398946|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64398947|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64399007|NCT02342587|Lapatinib|lapatinib|mesh-list
64399008|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352686|NCT04771689|Naloxone|naloxone|mesh-list
64399009|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64399010|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399011|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399082|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
64399141|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399142|NCT05014685|Antacids|antacids|mesh-ancestor
64399143|NCT05014685|Diuretics|diuretics|mesh-ancestor
64399145|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399146|NCT05014685|Expectorants|expectorants|mesh-ancestor
64399147|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
64399148|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
64399149|NCT03111901|Interleukin-2|interleukin-2|mesh-list
64399150|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64399151|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399152|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64399153|NCT03111901|Analgesics|analgesics|mesh-ancestor
64399154|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
64399203|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64399204|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64399205|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399206|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64399207|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64399271|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
64399272|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64294520|NCT05121038|Antidotes|antidotes|mesh-ancestor
64399273|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64399274|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399275|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64399276|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64399277|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64399335|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399336|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399338|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
64399339|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
64399340|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
64399341|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64399342|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64399343|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399344|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399345|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399346|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64399397|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
64399398|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399399|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399400|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399401|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64399402|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64399403|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64399404|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399405|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64399406|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64399407|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64399460|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
64399461|NCT03105349|Ribavirin|ribavirin|mesh-list
64399462|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
64399463|NCT03105349|Grazoprevir|grazoprevir|mesh-list
64399464|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64399465|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
64399467|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
64399530|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399531|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64399532|NCT02334475|Protective Agents|protective agents|mesh-ancestor
64352691|NCT04771689|Analgesics|analgesics|mesh-ancestor
64399533|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64399534|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64399600|NCT02637323|Triamcinolone|triamcinolone|mesh-list
64360054|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
64399601|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64399602|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64399603|NCT02637323|FX006|fx006|mesh-list
64399604|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64399605|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64399606|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
64399607|NCT02637323|Hormones|hormones|mesh-ancestor
64399608|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399609|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399610|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64399665|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64399666|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399667|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399668|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64399669|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
64399671|NCT03079895|Nicotine|nicotine|mesh-list
64399672|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64399673|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
64399674|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399675|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399676|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64399677|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64399678|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
64399727|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64399728|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64399729|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64399730|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64399731|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64399797|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64399798|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64399799|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
64399800|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
64399801|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
64399802|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
64399803|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64399804|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399805|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64399806|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64399807|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64399808|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
64399809|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64399810|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64399811|NCT03111511|Estrogens|estrogens|mesh-ancestor
64399812|NCT03111511|Hormones|hormones|mesh-ancestor
64399813|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64399815|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
64399856|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64399857|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64399858|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
64399859|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64399860|NCT05077813|Vitamin D|vitamin d|mesh-list
64399861|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
64360084|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64399864|NCT05077813|Minocycline|minocycline|mesh-list
64399921|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
64399994|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64399995|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
64399996|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64399998|NCT05002517|Prednisolone|prednisolone|mesh-list
64400064|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64400065|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
64400066|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
64400067|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
64400068|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
64352774|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64352775|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64352776|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
64352777|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352778|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64400069|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400137|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400138|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
64400139|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64400140|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
64400141|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400142|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64400143|NCT03073265|Apixaban|apixaban|mesh-list
64400144|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64400145|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
64400146|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64400203|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400204|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
64400208|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64400209|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400210|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
64400211|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
64400215|NCT02328079|Protective Agents|protective agents|mesh-ancestor
64400267|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64400268|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64400269|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
64400270|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64400271|NCT03074591|Hematinics|hematinics|mesh-ancestor
64400272|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
64400273|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64400274|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
64400275|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64400276|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400277|NCT03111433|Ubiquinone|ubiquinone|mesh-list
64400278|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
64400279|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400280|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
64400281|NCT03111433|Vitamins|vitamins|mesh-ancestor
64400282|NCT03915613|Insulin|insulin|mesh-list
64400333|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
64400335|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360106|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64360150|NCT02517619|Hormones|hormones|mesh-ancestor
64400336|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400337|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
64400338|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400339|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400340|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64400341|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64400342|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400343|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400344|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64400345|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64400346|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
64400392|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64400393|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64400394|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400395|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400397|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
64400398|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64400399|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
64400400|NCT03074123|Cosyntropin|cosyntropin|mesh-list
64400402|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400403|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400404|NCT02327299|Fesoterodine|fesoterodine|mesh-list
64400405|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64400406|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64400450|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400451|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400452|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400453|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
64400454|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400455|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400456|NCT03073889|Ropivacaine|ropivacaine|mesh-list
64400457|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
64400458|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
64400459|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64400460|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400461|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
64400462|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400463|NCT03071705|Metformin|metformin|mesh-list
64400464|NCT03071705|Gefitinib|gefitinib|mesh-list
64400465|NCT03071705|Afatinib|afatinib|mesh-list
64400466|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64400467|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400506|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400507|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400508|NCT02037919|Etonogestrel|etonogestrel|mesh-list
64400509|NCT02037919|Desogestrel|desogestrel|mesh-list
64400510|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64400511|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
64400512|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64400513|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400514|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64400515|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64400516|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64400517|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64400518|NCT02037919|Progestins|progestins|mesh-ancestor
64400519|NCT02037919|Hormones|hormones|mesh-ancestor
64400520|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400521|NCT03139591|Dexamethasone|dexamethasone|mesh-list
64400522|NCT03139591|Lidocaine|lidocaine|mesh-list
64400562|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400563|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64400564|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400565|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400567|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64400568|NCT04986371|Niraparib|niraparib|mesh-list
64352814|NCT03179943|Atezolizumab|atezolizumab|mesh-list
64400569|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64400570|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64400573|NCT04988945|Durvalumab|durvalumab|mesh-list
64400625|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64400626|NCT02659813|Copper|copper|mesh-list
64400627|NCT02659813|Nickel|nickel|mesh-list
64400628|NCT02659813|Trace Elements|trace elements|mesh-ancestor
64400629|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
64400630|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400631|NCT04985435|Adalimumab|adalimumab|mesh-list
64400632|NCT04985435|Etanercept|etanercept|mesh-list
64400633|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400634|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64400635|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64400636|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64400637|NCT04985435|Analgesics|analgesics|mesh-ancestor
64400638|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
64400639|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400640|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400641|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64400642|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64400644|NCT05084365|Sulforaphane|sulforaphane|mesh-list
64400685|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64400686|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64400687|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64400688|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64400689|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64400690|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64400691|NCT03227263|Bevacizumab|bevacizumab|mesh-list
64400692|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64400693|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400694|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64400695|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64400696|NCT03227263|Growth Substances|growth substances|mesh-ancestor
64400697|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400698|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
64400699|NCT04985201|Irinotecan|irinotecan|mesh-list
64400700|NCT04985201|Simvastatin|simvastatin|mesh-list
64400701|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64400708|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
64400738|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64400739|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
64400740|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
64400741|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64400742|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
64400743|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64400807|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
64400808|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64400809|NCT04452461|Leucovorin|leucovorin|mesh-list
64400810|NCT04452461|Gemcitabine|gemcitabine|mesh-list
64400811|NCT04452461|Paclitaxel|paclitaxel|mesh-list
64400880|NCT05214911|Desloratadine|desloratadine|mesh-list
64400881|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64400882|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
64400883|NCT05214911|Hormones|hormones|mesh-ancestor
64400884|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64400949|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400950|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
64400951|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64400952|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
64400953|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64400954|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
64400955|NCT03906877|Protective Agents|protective agents|mesh-ancestor
64400956|NCT03867799|Nivolumab|nivolumab|mesh-list
64400957|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64400958|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64400961|NCT05086081|Ticagrelor|ticagrelor|mesh-list
64401012|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64401013|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64401014|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64401015|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401016|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64401017|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401018|NCT04858711|Analgesics|analgesics|mesh-ancestor
64401019|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64401020|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64401021|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64401022|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
64401023|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401074|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64401075|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64401076|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64401077|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64401078|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401079|NCT04705727|Budesonide|budesonide|mesh-list
64401142|NCT02985619|Growth Substances|growth substances|mesh-ancestor
64401143|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401144|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
64401147|NCT02985619|Hormones|hormones|mesh-ancestor
64401213|NCT01794793|Cabergoline|cabergoline|mesh-list
64401214|NCT01794793|Pasireotide|pasireotide|mesh-list
64401215|NCT01794793|Somatostatin|somatostatin|mesh-list
64401216|NCT01794793|Hormones|hormones|mesh-ancestor
64401217|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401218|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401282|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401283|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401284|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401285|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401286|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401287|NCT04439357|Trametinib|trametinib|mesh-list
64401288|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64401289|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401290|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64401314|NCT03630835|Annexin A5|annexin a5|mesh-list
64401347|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
64401348|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
64401349|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
64401350|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401351|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401352|NCT04405063|Paclitaxel|paclitaxel|mesh-list
64401353|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401354|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401355|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401356|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401357|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401358|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401359|NCT05090449|Losartan|losartan|mesh-list
64401361|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64401362|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64401407|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
64401408|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401409|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401410|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64401478|NCT03136237|Berotralstat|berotralstat|mesh-list
64401479|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401552|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64401553|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64401554|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64401622|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401623|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64401624|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401625|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352834|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64401626|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64401627|NCT03066557|Estrogens|estrogens|mesh-ancestor
64401629|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64401630|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294533|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401632|NCT05738161|Gemcitabine|gemcitabine|mesh-list
64401633|NCT05738161|Cisplatin|cisplatin|mesh-list
64401635|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401636|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64401637|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
64401638|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401639|NCT05738161|Antiviral Agents|antiviral agents|mesh-ancestor
64401678|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
64401679|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
64401680|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
64401681|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401683|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64401684|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64401685|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401686|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64401687|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64401688|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
64401689|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64401690|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64401691|NCT05188313|Paclitaxel|paclitaxel|mesh-list
64401692|NCT05188313|Carboplatin|carboplatin|mesh-list
64401693|NCT05188313|Trastuzumab|trastuzumab|mesh-list
64401694|NCT05188313|Pertuzumab|pertuzumab|mesh-list
64401695|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64401696|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401733|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64401734|NCT03135769|Avelumab|avelumab|mesh-list
64401735|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64360229|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401736|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401737|NCT03123211|Veliparib|veliparib|mesh-list
64401738|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64401739|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64401740|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401741|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401742|NCT05520749|Luspatercept|luspatercept|mesh-list
64401743|NCT05520749|Hematinics|hematinics|mesh-ancestor
64401744|NCT03073525|Atezolizumab|atezolizumab|mesh-list
64401745|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401746|NCT02563015|Vitamin D|vitamin d|mesh-list
64401747|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
64401748|NCT02563015|Vitamins|vitamins|mesh-ancestor
64401749|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
64401750|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401793|NCT05727475|Protective Agents|protective agents|mesh-ancestor
64401794|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401795|NCT05091775|Mesalamine|mesalamine|mesh-list
64401796|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64401797|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64401798|NCT05091775|Analgesics|analgesics|mesh-ancestor
64401859|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64401861|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64401862|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64401863|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64352864|NCT05109585|Antibodies|antibodies|mesh-list
64352883|NCT05283161|Dronabinol|dronabinol|mesh-list
64352884|NCT05283161|Cannabidiol|cannabidiol|mesh-list
64401864|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64401866|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64401868|NCT04447235|Losartan|losartan|mesh-list
64401869|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64401879|NCT01700569|Leucovorin|leucovorin|mesh-list
64401926|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64401927|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64401928|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64401930|NCT02819479|Growth Substances|growth substances|mesh-ancestor
64401999|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64402000|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64402001|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
64402002|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64402003|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64402004|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402005|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
64402066|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402067|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64402068|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402137|NCT01117441|Prednisone|prednisone|mesh-list
64402138|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
64402139|NCT01117441|Ifosfamide|ifosfamide|mesh-list
64402140|NCT01117441|Doxorubicin|doxorubicin|mesh-list
64402141|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64402142|NCT01117441|Methotrexate|methotrexate|mesh-list
64402143|NCT01117441|Fludarabine|fludarabine|mesh-list
64402144|NCT01117441|Etoposide|etoposide|mesh-list
64402145|NCT01117441|Vincristine|vincristine|mesh-list
64402146|NCT01117441|Daunorubicin|daunorubicin|mesh-list
64402151|NCT01117441|Vindesine|vindesine|mesh-list
64402206|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
64402207|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64402208|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402209|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
64402210|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64402236|NCT03511625|Hormones|hormones|mesh-ancestor
64402279|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
64402280|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64360304|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64402282|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64402283|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64402284|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64402285|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64402286|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64402287|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64402288|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64402289|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
64402291|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64402292|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
64402293|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64402340|NCT04625530|Coagulants|coagulants|mesh-ancestor
64402341|NCT04625530|Hematinics|hematinics|mesh-ancestor
64402342|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64402343|NCT01916824|Mirtazapine|mirtazapine|mesh-list
64402344|NCT01916824|Citalopram|citalopram|mesh-list
64402345|NCT01916824|Bupropion|bupropion|mesh-list
64402346|NCT01916824|Fluoxetine|fluoxetine|mesh-list
64402347|NCT01916824|Paroxetine|paroxetine|mesh-list
64402348|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64402399|NCT01618708|Hylan|hylan|mesh-list
64402407|NCT02229149|Trastuzumab|trastuzumab|mesh-list
64402408|NCT02229149|Pertuzumab|pertuzumab|mesh-list
64402409|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402410|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402416|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
64352885|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
64352886|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
64352913|NCT03690453|Ivermectin|ivermectin|mesh-list
64402479|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
64402480|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402481|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
64402483|NCT04982549|Paclitaxel|paclitaxel|mesh-list
64402484|NCT04982549|Carboplatin|carboplatin|mesh-list
64402485|NCT04982549|Pemetrexed|pemetrexed|mesh-list
64402486|NCT04982549|Durvalumab|durvalumab|mesh-list
64402487|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402488|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402489|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
64402490|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402491|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402493|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402540|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64402542|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64402543|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64402544|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64402545|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
64402546|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402552|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
64402609|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402610|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402611|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
64402612|NCT02102789|Antidotes|antidotes|mesh-ancestor
64402613|NCT02102789|Protective Agents|protective agents|mesh-ancestor
64402614|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
64402615|NCT02102789|Vitamins|vitamins|mesh-ancestor
64402616|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
64402617|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
64402618|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64402619|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64402675|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64402676|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64402677|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
64402678|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
64402679|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402680|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64402681|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64402682|NCT03945721|Niraparib|niraparib|mesh-list
64402683|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64402684|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402685|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402687|NCT01876355|Clonidine|clonidine|mesh-list
64402688|NCT01876355|Analgesics|analgesics|mesh-ancestor
64402689|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
64402690|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402691|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402692|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64402693|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
64402694|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
64402695|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64402696|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64402697|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64402698|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
64402699|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402700|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402702|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
64402703|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402704|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
64402705|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64402706|NCT01870193|Glycine|glycine|mesh-list
64402716|NCT01870193|Antidotes|antidotes|mesh-ancestor
64402717|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
64402718|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352935|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
64352938|NCT04756791|Anesthetics|anesthetics|mesh-list
64352966|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64352967|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
64352968|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352969|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352970|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64352971|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
64402719|NCT03063905|Buprenorphine|buprenorphine|mesh-list
64402720|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64402721|NCT03063905|Narcotics|narcotics|mesh-ancestor
64402722|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64402723|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402725|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
64402726|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64402727|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64402728|NCT04432415|Fluorides|fluorides|mesh-list
64402729|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
64402730|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
64402731|NCT04432415|Protective Agents|protective agents|mesh-ancestor
64402732|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402733|NCT01402271|Paclitaxel|paclitaxel|mesh-list
64402734|NCT01402271|Carboplatin|carboplatin|mesh-list
64402735|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402736|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402737|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
64360363|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360364|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64360365|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64360366|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64360367|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64360368|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64360369|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64360370|NCT01376167|Chloroquine|chloroquine|mesh-list
64360371|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64360372|NCT01376167|Primaquine|primaquine|mesh-list
64360373|NCT01376167|Tafenoquine|tafenoquine|mesh-list
64360374|NCT01376167|Amebicides|amebicides|mesh-ancestor
64360378|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
64402738|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402739|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402768|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64402769|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402770|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
64402771|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64402772|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
64402773|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64402774|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
64402775|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64402776|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402777|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64402778|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64402779|NCT03079999|Aspirin|aspirin|mesh-list
64402828|NCT04979663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64402829|NCT04979663|Immunologic Factors|immunologic factors|mesh-ancestor
64402830|NCT04979663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402831|NCT04979585|Paclitaxel|paclitaxel|mesh-list
64402832|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64402833|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402834|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
64402835|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
64402836|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
64402895|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64402896|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
64402898|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
64402899|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64352974|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64352975|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
64352976|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352977|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352978|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352979|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
64352980|NCT04937543|Hormones|hormones|mesh-ancestor
64352981|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402900|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
64402901|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64402902|NCT05103007|Estrogens|estrogens|mesh-ancestor
64402903|NCT05103007|Hormones|hormones|mesh-ancestor
64402904|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64402905|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402906|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64402907|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64402908|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
64402909|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64402910|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64402911|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402912|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
64402913|NCT05092555|Coagulants|coagulants|mesh-ancestor
64402914|NCT05036473|Levodopa|levodopa|mesh-list
64402915|NCT05036473|Carbidopa|carbidopa|mesh-list
64402950|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64402951|NCT04834063|Protective Agents|protective agents|mesh-ancestor
64402952|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64402955|NCT04794205|Caryophyllene|caryophyllene|mesh-list
64402956|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64402957|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64402958|NCT04794205|Analgesics|analgesics|mesh-ancestor
64402959|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
64402960|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403015|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64360383|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
64403017|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64403018|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403019|NCT04437017|Dexamethasone|dexamethasone|mesh-list
64403020|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
64403021|NCT04437017|Olanzapine|olanzapine|mesh-list
64403022|NCT04437017|Serotonin|serotonin|mesh-list
64403023|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403024|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
64403025|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
64403026|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403027|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403028|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403029|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
64403030|NCT04437017|Hormones|hormones|mesh-ancestor
64403074|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
64403075|NCT05106751|Protective Agents|protective agents|mesh-ancestor
64403076|NCT04977557|Thiamine|thiamine|mesh-list
64403077|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
64403078|NCT04977557|Vitamins|vitamins|mesh-ancestor
64403079|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
64403080|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403081|NCT04316143|Zamicastat|zamicastat|mesh-list
64403082|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403083|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403084|NCT04530877|Infliximab|infliximab|mesh-list
64403140|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64403141|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64403142|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403143|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
64403144|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403145|NCT04432259|Dexamethasone|dexamethasone|mesh-list
64403146|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403147|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
64403148|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
64403149|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403150|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403153|NCT04432259|Hormones|hormones|mesh-ancestor
64403202|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64403203|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64403204|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64403205|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403206|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403207|NCT04967417|Paclitaxel|paclitaxel|mesh-list
64403208|NCT04967417|Carboplatin|carboplatin|mesh-list
64403209|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
64403210|NCT04967417|Pemetrexed|pemetrexed|mesh-list
64403211|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64403212|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403213|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64403214|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64403225|NCT04210141|Antivenins|antivenins|mesh-list
64403264|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403265|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403266|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64403267|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
64403268|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
64403269|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
64403270|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64403280|NCT03198559|Vorinostat|vorinostat|mesh-list
64403331|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64360449|NCT02511223|Olaparib|olaparib|mesh-list
64403332|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64403333|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64403334|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
64403404|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403405|NCT04952129|Protective Agents|protective agents|mesh-ancestor
64403406|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403408|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
64403409|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64403410|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403411|NCT05007769|Atezolizumab|atezolizumab|mesh-list
64403412|NCT05007769|Ramucirumab|ramucirumab|mesh-list
64403413|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403414|NCT04952051|Folic Acid|folic acid|mesh-list
64403415|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
64403416|NCT04952051|Amlodipine|amlodipine|mesh-list
64403417|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64403418|NCT04952051|Enalapril|enalapril|mesh-list
64403419|NCT04952051|Enalaprilat|enalaprilat|mesh-list
64403420|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64403421|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64403422|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64403423|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403424|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64403425|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403426|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
64403427|NCT04952051|Diuretics|diuretics|mesh-ancestor
64353013|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353014|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353015|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64353016|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64353017|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64353018|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64353019|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64353020|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64403428|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
64403429|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64403430|NCT04952051|Hematinics|hematinics|mesh-ancestor
64403431|NCT04952051|Vitamins|vitamins|mesh-ancestor
64403432|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
64403433|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64403434|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
64403435|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64403436|NCT04960943|Trastuzumab|trastuzumab|mesh-list
64403437|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64403447|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
64403448|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403450|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
64403451|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403452|NCT04436419|Protective Agents|protective agents|mesh-ancestor
64403453|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403454|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
64403455|NCT04436419|Vitamins|vitamins|mesh-ancestor
64403456|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
64403457|NCT03059615|Doxorubicin|doxorubicin|mesh-list
64403458|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64403459|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64403460|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64403461|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64403509|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
64403510|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403511|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
64403512|NCT01675765|Cisplatin|cisplatin|mesh-list
64403513|NCT01675765|Pemetrexed|pemetrexed|mesh-list
64403514|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
64403515|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64403516|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403517|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403519|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
64403577|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64403578|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64403579|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
64403580|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403581|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
64403582|NCT04121299|Protective Agents|protective agents|mesh-ancestor
64403583|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64403584|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64403585|NCT04942769|Selenium|selenium|mesh-list
64403586|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
64403641|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64403642|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403643|NCT04426591|Biotin|biotin|mesh-list
64403644|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
64403645|NCT04426591|Vitamins|vitamins|mesh-ancestor
64403646|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
64403647|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403648|NCT04940273|Remifentanil|remifentanil|mesh-list
64403656|NCT04948385|Propofol|propofol|mesh-list
64403710|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403711|NCT03572413|Bromides|bromides|mesh-list
64403712|NCT03572413|Rocuronium|rocuronium|mesh-list
64403713|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
64403714|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64403715|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64403716|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64403717|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403719|NCT04956419|Fluconazole|fluconazole|mesh-list
64403777|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64403778|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
64403779|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403780|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403781|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64403782|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403783|NCT02655679|Ether|ether|mesh-list
64403784|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64403786|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
64403840|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64403841|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64403843|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
64403844|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403845|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403846|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64403847|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64403907|NCT04299373|Ethanol|ethanol|mesh-list
64403908|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64403909|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64403910|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403977|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64403978|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64403980|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
64403981|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64403982|NCT04931225|Landiolol|landiolol|mesh-list
64403983|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64403984|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64403985|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
64403986|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64403989|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64404041|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
64404042|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
64404043|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64404045|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64404046|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404047|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404048|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64404049|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
64404050|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
64404051|NCT04423107|Acetaminophen|acetaminophen|mesh-list
64404052|NCT04423107|Ibuprofen|ibuprofen|mesh-list
64404053|NCT04423107|Oxycodone|oxycodone|mesh-list
64404054|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64404104|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404105|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64404107|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
64404108|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
64404109|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404116|NCT04912271|Dexamethasone|dexamethasone|mesh-list
64404170|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64404172|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64404173|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
64404174|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404175|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404176|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
64404177|NCT02680561|Hormones|hormones|mesh-ancestor
64404178|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64404179|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
64404180|NCT05025163|Fluorides|fluorides|mesh-list
64353044|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
64353045|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64404181|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
64404185|NCT02592031|Goserelin|goserelin|mesh-list
64404233|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64404234|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404235|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404236|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404237|NCT05122117|Methylene Blue|methylene blue|mesh-list
64404238|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404239|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404240|NCT05117125|Heparin|heparin|mesh-list
64404241|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
64404298|NCT05229991|Lonafarnib|lonafarnib|mesh-list
64404299|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64404300|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64404301|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
64404302|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404303|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404367|NCT01675141|Growth Substances|growth substances|mesh-ancestor
64404368|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
64404369|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404370|NCT05102149|Vildagliptin|vildagliptin|mesh-list
64404371|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64404374|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
64404439|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64404440|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
64404441|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
64404442|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64404443|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64404509|NCT03066739|Narcotics|narcotics|mesh-ancestor
64404510|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404511|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404512|NCT03066739|Analgesics|analgesics|mesh-ancestor
64404513|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
64404514|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64404515|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64404517|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64404518|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64404519|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404520|NCT04875871|Trace Elements|trace elements|mesh-ancestor
64404521|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
64404522|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404570|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64404571|NCT05403307|Vaccines|vaccines|mesh-list
64404572|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
64404573|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404574|NCT04563559|Prednisolone|prednisolone|mesh-list
64404575|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64404576|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
64404577|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64404578|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
64404636|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
64404637|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
64404638|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64404639|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404640|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353046|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353056|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404641|NCT04165993|Docetaxel|docetaxel|mesh-list
64404642|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404643|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64404644|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64404645|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64404646|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404647|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
64404648|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64404649|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64404696|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64404697|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64404698|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404699|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64404705|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64404764|NCT04500847|Emtricitabine|emtricitabine|mesh-list
64404765|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
64404766|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353057|NCT02387762|Methotrexate|methotrexate|mesh-list
64353058|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
64353059|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64404767|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64404768|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64404769|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404770|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404771|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64404772|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64404773|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
64404774|NCT04928495|Bromhexine|bromhexine|mesh-list
64404775|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64404776|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404777|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
64404778|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404779|NCT04928495|Protective Agents|protective agents|mesh-ancestor
64404780|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
64404781|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64404782|NCT04928495|Expectorants|expectorants|mesh-ancestor
64404783|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
64404784|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64404820|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360563|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404822|NCT04918589|Coagulants|coagulants|mesh-ancestor
64404824|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64404825|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
64404826|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404827|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64404828|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404829|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404830|NCT04928651|Clonidine|clonidine|mesh-list
64404882|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64404883|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64404884|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64404885|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64404886|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404887|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64404912|NCT03055793|Budesonide|budesonide|mesh-list
64404948|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64404949|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64404950|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405016|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64405017|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64405018|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64353060|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
64405019|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64405020|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
64405021|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
64405022|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
64405023|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
64405024|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405026|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
64405085|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64405086|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
64405087|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
64405088|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
64405089|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
64405090|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405156|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405157|NCT05125549|Clopidogrel|clopidogrel|mesh-list
64405158|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64405159|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64405160|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64405161|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64405166|NCT04398719|Capsaicin|capsaicin|mesh-list
64405224|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405225|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
64405226|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405227|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64405228|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
64405229|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405230|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405231|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64405232|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64405291|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64405292|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405293|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64405294|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405295|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405296|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64405297|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64405300|NCT04901117|Amoxicillin|amoxicillin|mesh-list
64405359|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64360587|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64405361|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
64405362|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
64405363|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
64405364|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405426|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
64405427|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64405429|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
64405430|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405431|NCT04891679|Misoprostol|misoprostol|mesh-list
64405432|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64405433|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
64405497|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
64405498|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64405499|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64405500|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405501|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405502|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64405503|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64405504|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64405505|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64353067|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
64405560|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294548|NCT04635644|Morphine|morphine|mesh-list
64405562|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64405563|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64405564|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405565|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405567|NCT04898387|Bimatoprost|bimatoprost|mesh-list
64405568|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64405569|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64405626|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64405628|NCT04895657|Piperacillin|piperacillin|mesh-list
64405629|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64405630|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64405695|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64405696|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
64405697|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64405698|NCT04885751|Protective Agents|protective agents|mesh-ancestor
64405700|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64405766|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
64405767|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405768|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64405769|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64405770|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64405771|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64405835|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64405836|NCT04870541|Analgesics|analgesics|mesh-ancestor
64405837|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
64405838|NCT04870073|Mannitol|mannitol|mesh-list
64405839|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64405840|NCT04870073|Diuretics|diuretics|mesh-ancestor
64405904|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64405905|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64405906|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64405907|NCT03049085|Analgesics|analgesics|mesh-ancestor
64405908|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
64405909|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64405910|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64405911|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64405912|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64360600|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
64405913|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64360601|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64405967|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64405968|NCT04874675|Narcotics|narcotics|mesh-ancestor
64405969|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64405970|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
64405971|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
64405972|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
64405973|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64405974|NCT04868513|Fluorides|fluorides|mesh-list
64406038|NCT04383743|Lenograstim|lenograstim|mesh-list
64406039|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406040|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64406041|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64406042|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64406043|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406047|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
64406106|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64406107|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64406108|NCT04969237|Vitamin D|vitamin d|mesh-list
64406109|NCT04969237|Vitamins|vitamins|mesh-ancestor
64406110|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
64406111|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406113|NCT04341467|Olanzapine|olanzapine|mesh-list
64406175|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406176|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64406177|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
64406179|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64406180|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64406181|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406182|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
64406183|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406239|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64406240|NCT02613221|Panitumumab|panitumumab|mesh-list
64406241|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406242|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406243|NCT05304169|Leuprolide|leuprolide|mesh-list
64406244|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64406245|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
64406246|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406250|NCT04732195|Pilocarpine|pilocarpine|mesh-list
64406307|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406308|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64406309|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406310|NCT04682743|Acetaminophen|acetaminophen|mesh-list
64406311|NCT04682743|Ondansetron|ondansetron|mesh-list
64406313|NCT04682743|Analgesics|analgesics|mesh-ancestor
64406378|NCT03020875|Analgesics|analgesics|mesh-ancestor
64406379|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
64406380|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406381|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406382|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
64406451|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
64406452|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
64406453|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
64406454|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64406455|NCT04864379|Molgramostim|molgramostim|mesh-list
64406456|NCT04864379|Sargramostim|sargramostim|mesh-list
64406457|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406458|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406459|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
64406460|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406461|NCT04336241|Nivolumab|nivolumab|mesh-list
64360613|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406462|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64406463|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406464|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64406465|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406510|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353101|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406511|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
64406512|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64406513|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
64406514|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406515|NCT03104959|Expectorants|expectorants|mesh-ancestor
64406516|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
64406517|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64406518|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
64406522|NCT03104959|Antidotes|antidotes|mesh-ancestor
64406578|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406579|NCT04856111|Analgesics|analgesics|mesh-ancestor
64406580|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
64406581|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406582|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406590|NCT03841201|Nivolumab|nivolumab|mesh-list
64406647|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64406648|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406649|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64406650|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64406651|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
64406717|NCT03101995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406718|NCT04848467|Vaccines|vaccines|mesh-list
64353102|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353109|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353110|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353111|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64406719|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
64406720|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406721|NCT03104335|Apatinib|apatinib|mesh-list
64406728|NCT00484471|Valproic Acid|valproic acid|mesh-list
64406788|NCT01729455|Belimumab|belimumab|mesh-list
64406789|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406790|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
64406791|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406792|NCT03103867|Insulin|insulin|mesh-list
64406810|NCT05579769|Busulfan|busulfan|mesh-list
64406861|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
64406862|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406863|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406864|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64406865|NCT02720185|Dasatinib|dasatinib|mesh-list
64406866|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406867|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64406868|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64406869|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406870|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
64406871|NCT04846673|Pregabalin|pregabalin|mesh-list
64406872|NCT04846673|Analgesics|analgesics|mesh-ancestor
64406873|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
64406874|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64406875|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406876|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
64406877|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64406878|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64406879|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406917|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406918|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406919|NCT01660971|Antiviral Agents|antiviral agents|mesh-ancestor
64406920|NCT01660971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64406921|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360625|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64406922|NCT01660971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406923|NCT01660971|Immunologic Factors|immunologic factors|mesh-ancestor
64406924|NCT01660971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406985|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64406986|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64406987|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64406988|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
64406989|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64406990|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64406991|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64406992|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64406993|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
64406994|NCT05564403|Antidotes|antidotes|mesh-ancestor
64406997|NCT05564403|Vitamins|vitamins|mesh-ancestor
64407049|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407050|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64407051|NCT05414877|Phenylephrine|phenylephrine|mesh-list
64407052|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
64407053|NCT05414877|Norepinephrine|norepinephrine|mesh-list
64407054|NCT05414877|Ephedrine|ephedrine|mesh-list
64407055|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64353112|NCT05105633|Tenecteplase|tenecteplase|mesh-list
64407056|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
64407115|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
64407116|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407117|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64407118|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
64407119|NCT04843943|Bevacizumab|bevacizumab|mesh-list
64407120|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64407121|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407122|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64407123|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64407124|NCT04843943|Growth Substances|growth substances|mesh-ancestor
64407125|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407126|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
64407127|NCT04850261|Nafarelin|nafarelin|mesh-list
64407128|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64407129|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
64407177|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407178|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64407179|NCT03594175|Reteplase|reteplase|mesh-list
64407180|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64407181|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64407182|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407183|NCT03103399|Levodopa|levodopa|mesh-list
64407184|NCT03103399|Carbidopa|carbidopa|mesh-list
64407185|NCT03103399|Entacapone|entacapone|mesh-list
64407242|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407243|NCT03043001|Memantine|memantine|mesh-list
64407244|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64407245|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64407246|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
64407247|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64407248|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407249|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407251|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64407310|NCT04860167|Diclofenac|diclofenac|mesh-list
64407311|NCT04860167|Lidocaine|lidocaine|mesh-list
64407312|NCT04860167|Propofol|propofol|mesh-list
64407313|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64360639|NCT02515201|Taurolidine|taurolidine|mesh-list
64407314|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64407315|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407317|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
64407318|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
64407319|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64407320|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64407321|NCT04860167|Analgesics|analgesics|mesh-ancestor
64407322|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
64407323|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407334|NCT04880785|Lamivudine|lamivudine|mesh-list
64407371|NCT04622917|Prednisolone|prednisolone|mesh-list
64407372|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
64407373|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64407374|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
64407375|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407376|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
64407377|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
64407378|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407381|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
64407438|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64407439|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407440|NCT02606279|Valsartan|valsartan|mesh-list
64407510|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407511|NCT03251911|Ivacaftor|ivacaftor|mesh-list
64407512|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64407513|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64407514|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353125|NCT04581447|Metformin|metformin|mesh-list
64353134|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353135|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353136|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353137|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64407515|NCT02643355|Clonidine|clonidine|mesh-list
64407516|NCT02643355|Olanzapine|olanzapine|mesh-list
64407577|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64407578|NCT03099031|Tinzaparin|tinzaparin|mesh-list
64407579|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64407580|NCT03099031|Dalteparin|dalteparin|mesh-list
64407581|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
64407582|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64407583|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64407584|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407585|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64407586|NCT04785287|Nivolumab|nivolumab|mesh-list
64407587|NCT04785287|Antibodies|antibodies|mesh-list
64407588|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
64407589|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64407590|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
64407591|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407592|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407593|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64407594|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407595|NCT03101137|Dexamethasone|dexamethasone|mesh-list
64407596|NCT03101137|Bupivacaine|bupivacaine|mesh-list
64407597|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64407598|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
64407599|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
64407600|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407601|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407626|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407627|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64407628|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
64407629|NCT00783133|Fexofenadine|fexofenadine|mesh-list
64407630|NCT00783133|Desloratadine|desloratadine|mesh-list
64407631|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64407632|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
64407633|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360655|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
64407635|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353138|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64353139|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64353170|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
64353171|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
64407636|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64407691|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407692|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64407693|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64407694|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407696|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64407697|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64407698|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64407699|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64407755|NCT01659567|Ribavirin|ribavirin|mesh-list
64407756|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
64407757|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
64407827|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407829|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
64407830|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407831|NCT04821947|Bupivacaine|bupivacaine|mesh-list
64407854|NCT04470973|Amikacin|amikacin|mesh-list
64407898|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64407899|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64407900|NCT05045443|Analgesics|analgesics|mesh-ancestor
64407901|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
64407902|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407967|NCT04834427|Esketamine|esketamine|mesh-list
64407968|NCT04834427|Analgesics|analgesics|mesh-ancestor
64407969|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
64407970|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64407971|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64407972|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64407973|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64407974|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
64407975|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
64407976|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408031|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
64408032|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408033|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64408034|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64408036|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
64408037|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408038|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408098|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64408099|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
64408100|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
64408101|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408102|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
64408103|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
64408104|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408105|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408106|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408107|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
64408108|NCT04816253|Hormones|hormones|mesh-ancestor
64408109|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64408110|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64408111|NCT04816253|Protective Agents|protective agents|mesh-ancestor
64360672|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
64408113|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408114|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64408115|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
64408126|NCT04816097|Hormones|hormones|mesh-ancestor
64353172|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353173|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
64353174|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353175|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64353176|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353177|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64353178|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
64408157|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
64408159|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408160|NCT03095209|Paclitaxel|paclitaxel|mesh-list
64408161|NCT03095209|Carboplatin|carboplatin|mesh-list
64408162|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64408163|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408164|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64408165|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64408166|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64408167|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408168|NCT05034133|Cisplatin|cisplatin|mesh-list
64408169|NCT05034133|Etoposide|etoposide|mesh-list
64408170|NCT05034133|Durvalumab|durvalumab|mesh-list
64408171|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408172|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64408173|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64408174|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64408175|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408176|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408177|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408178|NCT03096457|Paromomycin|paromomycin|mesh-list
64408179|NCT03096457|Pentamidine|pentamidine|mesh-list
64408180|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64408181|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408182|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64408183|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64408184|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
64408185|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64408186|NCT03096223|KHK4083|khk4083|mesh-list
64408187|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408188|NCT04814303|Morphine|morphine|mesh-list
64408201|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408202|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408203|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408204|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64408205|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64408207|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408208|NCT04813913|Bevacizumab|bevacizumab|mesh-list
64408209|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408210|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408211|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64408212|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64408213|NCT04813913|Growth Substances|growth substances|mesh-ancestor
64408214|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408215|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
64408217|NCT03094663|Dexamethasone|dexamethasone|mesh-list
64408218|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
64408219|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
64408220|NCT03094663|Epinephrine|epinephrine|mesh-list
64408221|NCT03094663|Bupivacaine|bupivacaine|mesh-list
64408222|NCT03094663|BB 1101|bb 1101|mesh-list
64408223|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408224|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
64408225|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
64408226|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408227|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408230|NCT03094663|Hormones|hormones|mesh-ancestor
64408247|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64408248|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64408249|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64360689|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
64408250|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
64408253|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64408254|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64408255|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408257|NCT04814381|Ketamine|ketamine|mesh-list
64408314|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64408315|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64408316|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64408317|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408318|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408319|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64408320|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408321|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64408381|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408382|NCT05028907|Tocopherols|tocopherols|mesh-list
64408383|NCT05028907|Vitamin E|vitamin e|mesh-list
64408384|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
64408385|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
64408386|NCT05028907|Dexamethasone|dexamethasone|mesh-list
64408387|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
64408388|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
64408389|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64408390|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
64408391|NCT05028907|BB 1101|bb 1101|mesh-list
64408392|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408393|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
64408394|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
64408395|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408396|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408397|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64353191|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64353192|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353193|NCT03439787|Epinephrine|epinephrine|mesh-list
64353194|NCT03439787|Bupivacaine|bupivacaine|mesh-list
64353195|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353196|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
64353197|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353198|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353199|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
64353200|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353201|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64353214|NCT05082155|Bupivacaine|bupivacaine|mesh-list
64408398|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
64408437|NCT05028049|Dsuvia|dsuvia|mesh-list
64408442|NCT05028049|Analgesics|analgesics|mesh-ancestor
64408443|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
64408444|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408445|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64408446|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64408447|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
64408448|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
64408449|NCT05023915|Dexamethasone|dexamethasone|mesh-list
64408450|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
64408451|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408452|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
64408453|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
64408454|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408506|NCT03093805|Calcipotriene|calcipotriene|mesh-list
64408507|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408508|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64408509|NCT03093883|Hematinics|hematinics|mesh-ancestor
64408510|NCT05023759|Cannabidiol|cannabidiol|mesh-list
64408511|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
64408512|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
64408513|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64408514|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64408515|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408516|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64408517|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
64408520|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408570|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408571|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64408572|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408573|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64408574|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
64408575|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360721|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64408576|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64408577|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64408578|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408579|NCT05009953|Antidotes|antidotes|mesh-ancestor
64408580|NCT05009953|Protective Agents|protective agents|mesh-ancestor
64408581|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
64408583|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
64408584|NCT03079453|Dexamethasone|dexamethasone|mesh-list
64408585|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353215|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353216|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
64408586|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
64408592|NCT03079453|Hormones|hormones|mesh-ancestor
64408629|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64408630|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
64408631|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
64408632|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408633|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64408634|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
64408635|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408636|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64408637|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64408638|NCT05009017|Bevacizumab|bevacizumab|mesh-list
64408639|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408640|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408641|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64408642|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64408643|NCT05009017|Growth Substances|growth substances|mesh-ancestor
64408644|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408645|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
64408646|NCT05008939|Sevoflurane|sevoflurane|mesh-list
64408647|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64408648|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64408649|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
64408650|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
64408651|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408652|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408653|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
64408654|NCT05008861|Nivolumab|nivolumab|mesh-list
64408655|NCT05008861|Durvalumab|durvalumab|mesh-list
64408656|NCT05008861|Antibodies|antibodies|mesh-list
64408657|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64408658|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
64408659|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408660|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408664|NCT05360277|Capecitabine|capecitabine|mesh-list
64408672|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408673|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408674|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64408675|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64408676|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
64408677|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408678|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408679|NCT05344209|Sargramostim|sargramostim|mesh-list
64408680|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
64408681|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408682|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
64408683|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408684|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408685|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
64408686|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408687|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408688|NCT04253457|Triamcinolone|triamcinolone|mesh-list
64408689|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64408690|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
64408691|NCT04253457|Hormones|hormones|mesh-ancestor
64408726|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64408727|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
64408728|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
64408729|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
64408730|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64408731|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
64360729|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64408732|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64408733|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64353284|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64408734|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64408735|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64408792|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64408793|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64408794|NCT03079219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64408795|NCT03079219|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64408796|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64408861|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408862|NCT03079141|Eplerenone|eplerenone|mesh-list
64408863|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64408864|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
64408865|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353285|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64353286|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64353287|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353288|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64353289|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64353290|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64408866|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64408867|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64408868|NCT03079141|Diuretics|diuretics|mesh-ancestor
64408869|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
64408870|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64408871|NCT03085849|Durvalumab|durvalumab|mesh-list
64408872|NCT03085849|Tremelimumab|tremelimumab|mesh-list
64408873|NCT03085849|Guadecitabine|guadecitabine|mesh-list
64408874|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64408875|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408876|NCT05001529|Antibodies|antibodies|mesh-list
64408879|NCT05001061|Misoprostol|misoprostol|mesh-list
64408921|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64408922|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408923|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
64408924|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
64408925|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64408931|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64408984|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64408986|NCT05305989|Belumosudil|belumosudil|mesh-list
64408987|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64408988|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64408989|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408990|NCT05013697|Paclitaxel|paclitaxel|mesh-list
64408991|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64408992|NCT05013697|Cisplatin|cisplatin|mesh-list
64408993|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64408994|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64408995|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
64408996|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
64408997|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
64408998|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64408999|NCT05509647|Heparin|heparin|mesh-list
64409000|NCT05509647|Calcium heparin|calcium heparin|mesh-list
64409001|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
64409002|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64409003|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64409038|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
64409039|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
64409040|NCT05347173|Nalbuphine|nalbuphine|mesh-list
64409041|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64409042|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409043|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409044|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64409045|NCT05347173|Analgesics|analgesics|mesh-ancestor
64409046|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
64409047|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409048|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64409049|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64409050|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64409055|NCT05347173|Narcotics|narcotics|mesh-ancestor
64409100|NCT05554419|Cytarabine|cytarabine|mesh-list
64409101|NCT05554419|Azacitidine|azacitidine|mesh-list
64409102|NCT05554419|Daunorubicin|daunorubicin|mesh-list
64409103|NCT05554419|Venetoclax|venetoclax|mesh-list
64409104|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64409105|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
64409106|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409107|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409108|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
64409109|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409110|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64409111|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
64409163|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
64409164|NCT05260359|Petrolatum|petrolatum|mesh-list
64409165|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64409166|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409167|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409169|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64409170|NCT05260359|Protective Agents|protective agents|mesh-ancestor
64409230|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
64409232|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409233|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409234|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
64409235|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409237|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
64409238|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409239|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409240|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409241|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
64409242|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
64409243|NCT04925167|Heparin|heparin|mesh-list
64409290|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409292|NCT04998253|Propofol|propofol|mesh-list
64409293|NCT04998253|Sevoflurane|sevoflurane|mesh-list
64409294|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64409295|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409299|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
64409357|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64409358|NCT03075241|Zolpidem|zolpidem|mesh-list
64409359|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64409360|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64409361|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409362|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409363|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64409364|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
64409365|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
64409366|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409367|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409418|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409419|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409489|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64409490|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64360763|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360813|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409493|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
64409494|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
64409495|NCT04992481|Protective Agents|protective agents|mesh-ancestor
64409496|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409498|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409499|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64353291|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409500|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409501|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409502|NCT04911127|Cannabidiol|cannabidiol|mesh-list
64409552|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64409553|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64409554|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64409555|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64409556|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64409557|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409558|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64409568|NCT03072511|Nicotine|nicotine|mesh-list
64409620|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
64409621|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64409622|NCT03072121|Diuretics|diuretics|mesh-ancestor
64409623|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
64409624|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
64409625|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64409626|NCT02597855|Aflibercept|aflibercept|mesh-list
64409627|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64409629|NCT02597855|Growth Substances|growth substances|mesh-ancestor
64409630|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409631|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
64409632|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409634|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409680|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409681|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64409682|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
64409683|NCT04809935|Ethanol|ethanol|mesh-list
64409684|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64409685|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409686|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64409687|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409688|NCT04255927|Triclosan|triclosan|mesh-list
64409689|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64409690|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64409691|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64409692|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64409693|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
64409695|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64409740|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
64409741|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409742|NCT04805957|Sulforaphane|sulforaphane|mesh-list
64409743|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64409744|NCT04805957|Protective Agents|protective agents|mesh-ancestor
64409745|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409746|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409747|NCT01657461|Plasminogen|plasminogen|mesh-list
64409748|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64409806|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64409808|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
64409809|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
64409810|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
64409811|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409812|NCT05279703|Epinephrine|epinephrine|mesh-list
64409813|NCT05279703|Racepinephrine|racepinephrine|mesh-list
64409814|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
64360824|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64353352|NCT03342417|Nivolumab|nivolumab|mesh-list
64353362|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
64353363|NCT02657031|Promethazine|promethazine|mesh-list
64353364|NCT02657031|Ketamine|ketamine|mesh-list
64353365|NCT02657031|Ondansetron|ondansetron|mesh-list
64353366|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
64353367|NCT02657031|Analgesics|analgesics|mesh-ancestor
64353368|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
64353369|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360825|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64409872|NCT05275725|Urological Agents|urological agents|mesh-ancestor
64409873|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
64409874|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64409876|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
64409877|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409878|NCT04785755|Etilefrine|etilefrine|mesh-list
64409879|NCT04785755|Furosemide|furosemide|mesh-list
64409880|NCT04785755|Spironolactone|spironolactone|mesh-list
64409881|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64409882|NCT04785755|Diuretics|diuretics|mesh-list
64409883|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
64409884|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409886|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64409929|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64409931|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64409932|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64409933|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64409934|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64409935|NCT05314101|Bevacizumab|bevacizumab|mesh-list
64409936|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64409937|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409938|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64409939|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64409940|NCT05314101|Growth Substances|growth substances|mesh-ancestor
64409941|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409942|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
64409943|NCT02595749|Oxytocin|oxytocin|mesh-list
64409944|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
64409945|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64409946|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409986|NCT04988191|Bevacizumab|bevacizumab|mesh-list
64409987|NCT04988191|Irinotecan|irinotecan|mesh-list
64409988|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64409989|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64409990|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64409991|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64409992|NCT04988191|Growth Substances|growth substances|mesh-ancestor
64409993|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64409999|NCT03069001|Ribavirin|ribavirin|mesh-list
64410054|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410055|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64410056|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410057|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410059|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410060|NCT02594735|Abatacept|abatacept|mesh-list
64410061|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64410062|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410063|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410119|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410120|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410121|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64410122|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
64410123|NCT05105997|Hormones|hormones|mesh-ancestor
64410124|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410125|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353370|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353377|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64410126|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410128|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64410129|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410130|NCT03424525|Renal Agents|renal agents|mesh-ancestor
64410131|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
64410132|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64410133|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64410134|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64410135|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410136|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410140|NCT05104983|Sirolimus|sirolimus|mesh-list
64410175|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
64410176|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410177|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410178|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64410179|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
64410180|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64410181|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
64410182|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
64410183|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64410184|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410185|NCT05471609|Levodopa|levodopa|mesh-list
64410186|NCT05471609|Carbidopa|carbidopa|mesh-list
64410187|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64410236|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410237|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64410238|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
64410239|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410240|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410242|NCT04340141|Fluorouracil|fluorouracil|mesh-list
64410380|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
64410381|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64410382|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410383|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
64410384|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
64410385|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
64410386|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410387|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64410388|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410389|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64410390|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64410391|NCT05189535|Protective Agents|protective agents|mesh-ancestor
64410392|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410393|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
64410394|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64410395|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
64410396|NCT02633059|Dexamethasone|dexamethasone|mesh-list
64410397|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
64410398|NCT02633059|Ixazomib|ixazomib|mesh-list
64410399|NCT02633059|Ichthammol|ichthammol|mesh-list
64410400|NCT02633059|BB 1101|bb 1101|mesh-list
64410424|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410425|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64410426|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64410427|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410428|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410429|NCT05730439|Lobeline|lobeline|mesh-list
64410430|NCT05730439|Nicotine|nicotine|mesh-list
64410431|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64410432|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
64410433|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360867|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410488|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
64410489|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
64353381|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
64353382|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64353392|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64353393|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353394|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64353395|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
64353396|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
64353397|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64353398|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64410490|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64410491|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
64410492|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
64410493|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64410494|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64410495|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64410496|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64410497|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
64410553|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64410554|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64410555|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64410556|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64410557|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64410558|NCT02866643|Progestins|progestins|mesh-ancestor
64410559|NCT02866643|Hormones|hormones|mesh-ancestor
64410560|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410621|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64410622|NCT01672801|Nimodipine|nimodipine|mesh-list
64410623|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64410624|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64410625|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64410628|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410687|NCT02631577|Lenalidomide|lenalidomide|mesh-list
64410688|NCT02631577|Atezolizumab|atezolizumab|mesh-list
64410689|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
64410690|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
64410691|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410692|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64410693|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64410694|NCT02631577|Growth Substances|growth substances|mesh-ancestor
64410695|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
64410696|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410754|NCT04733963|Capecitabine|capecitabine|mesh-list
64410755|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64410756|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410757|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64410758|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64410759|NCT04733963|Growth Substances|growth substances|mesh-ancestor
64410760|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410761|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
64410762|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64410763|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
64410764|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410796|NCT04716413|Dsuvia|dsuvia|mesh-list
64410818|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
64410819|NCT04990869|Vitamins|vitamins|mesh-ancestor
64410820|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
64410821|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410822|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64410823|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
64410824|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410825|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64410826|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
64410884|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410885|NCT04988217|Interferons|interferons|mesh-list
64410886|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
64410887|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
64410888|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410889|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
64353399|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
64353400|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
64353401|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64353402|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64353403|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64353404|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353405|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410890|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64410891|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
64410892|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360915|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64410894|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64410895|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64410896|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410897|NCT01672723|Naltrexone|naltrexone|mesh-list
64410898|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64410899|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64410900|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64410901|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
64410902|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64410903|NCT04443673|Glycine|glycine|mesh-list
64410904|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
64410938|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64410939|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64410940|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64410941|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
64410942|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
64410943|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
64410944|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411004|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64411005|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64411006|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411007|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411008|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
64411009|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64411010|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411011|NCT04033237|Nicotine|nicotine|mesh-list
64411012|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64411013|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
64411014|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411015|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411016|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64411063|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353406|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64353407|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64411064|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64411065|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64411066|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64411067|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64411068|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411069|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
64411070|NCT04209075|Metformin|metformin|mesh-list
64411071|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64411072|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411130|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64411131|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64411132|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64411133|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353408|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353409|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64411134|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411136|NCT05016609|Velpatasvir|velpatasvir|mesh-list
64411137|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64411138|NCT05016609|Antibodies|antibodies|mesh-list
64411139|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
64411140|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
64411141|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411142|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
64411143|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411144|NCT03763305|Fentanyl|fentanyl|mesh-list
64411145|NCT03763305|Remifentanil|remifentanil|mesh-list
64411146|NCT03763305|Propofol|propofol|mesh-list
64411147|NCT03763305|Sevoflurane|sevoflurane|mesh-list
64411188|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411189|NCT02252887|Gemcitabine|gemcitabine|mesh-list
64411190|NCT02252887|Trastuzumab|trastuzumab|mesh-list
64411191|NCT02252887|Pertuzumab|pertuzumab|mesh-list
64411192|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64411193|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
64360930|NCT02502175|Opium|opium|mesh-list
64411194|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411196|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
64411197|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411198|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411199|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64411203|NCT04431895|Tofacitinib|tofacitinib|mesh-list
64411252|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64411253|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
64411254|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411255|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411256|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64411257|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
64411258|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64411259|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64411260|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64411261|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64411262|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411263|NCT02589665|Mirikizumab|mirikizumab|mesh-list
64411264|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64411265|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411266|NCT02589665|Analgesics|analgesics|mesh-ancestor
64411267|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
64411313|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411314|NCT04426409|Renal Agents|renal agents|mesh-ancestor
64411315|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64411316|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64411317|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64411318|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411381|NCT04373603|Protective Agents|protective agents|mesh-ancestor
64411382|NCT02519595|Ketamine|ketamine|mesh-list
64411383|NCT02519595|Analgesics|analgesics|mesh-ancestor
64411384|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
64411385|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411386|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411387|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64411388|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64411389|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
64411390|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
64411393|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64411444|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
64411445|NCT05612711|Dronabinol|dronabinol|mesh-list
64411446|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
64353411|NCT03433001|Dexamethasone|dexamethasone|mesh-list
64411447|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411448|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64411449|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411450|NCT05612711|Analgesics|analgesics|mesh-ancestor
64411451|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
64411452|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411453|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64411509|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64411510|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64411511|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64411512|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411513|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64411514|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
64411515|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64411516|NCT05700695|Lactulose|lactulose|mesh-list
64411517|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64411518|NCT05555147|Ropivacaine|ropivacaine|mesh-list
64411519|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
64411520|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
64360939|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
64360940|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
64411571|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64411572|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
64411573|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411574|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64411575|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411576|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411577|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64411578|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411580|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411637|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411638|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64411639|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64411640|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64411707|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411708|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
64411709|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
64411710|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64411711|NCT05548283|Lactams|lactams|mesh-list
64411712|NCT05548283|beta-Lactams|beta-lactams|mesh-list
64411713|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411714|NCT02628769|Solithromycin|solithromycin|mesh-list
64411715|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64411716|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64411717|NCT05552807|Paclitaxel|paclitaxel|mesh-list
64411718|NCT05552807|Docetaxel|docetaxel|mesh-list
64411719|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64411720|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411721|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
64411722|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
64411723|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
64411725|NCT05552729|Vitamin D|vitamin d|mesh-list
64411766|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64411767|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411768|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
64411769|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
64411770|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
64411771|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411772|NCT04981327|Apixaban|apixaban|mesh-list
64411773|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64411774|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
64411775|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64411776|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
64411777|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64411778|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411779|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
64411780|NCT05547659|Acetaminophen|acetaminophen|mesh-list
64411781|NCT05547659|Celecoxib|celecoxib|mesh-list
64411782|NCT05547659|Pregabalin|pregabalin|mesh-list
64353428|NCT03433001|Growth Substances|growth substances|mesh-ancestor
64411783|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64411784|NCT05547659|Analgesics|analgesics|mesh-ancestor
64411785|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
64411822|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411823|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
64411824|NCT05541185|Naproxen|naproxen|mesh-list
64411825|NCT05541185|Lidocaine|lidocaine|mesh-list
64411826|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
64411827|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
64360956|NCT02500927|Naquotinib|naquotinib|mesh-list
64411883|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64411884|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64411887|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
64411888|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64411889|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
64411890|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
64411891|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64411892|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411894|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
64411938|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64411939|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64411940|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
64411942|NCT04952727|Vaccines|vaccines|mesh-list
64411943|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
64411945|NCT04433143|Minocycline|minocycline|mesh-list
64412011|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
64412012|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
64412013|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
64412014|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412015|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412062|NCT05699135|Avelumab|avelumab|mesh-list
64412079|NCT03765619|Analgesics|analgesics|mesh-ancestor
64412080|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
64412081|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412082|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412084|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64412085|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64412086|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64412087|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412142|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412143|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
64412144|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
64412145|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412212|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412214|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64412215|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412216|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64412217|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64412218|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412219|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412220|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64412221|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
64412223|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412274|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64412275|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
64412276|NCT04261855|Avelumab|avelumab|mesh-list
64412277|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64412278|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412279|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412280|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64412281|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412282|NCT04224415|Irinotecan|irinotecan|mesh-list
64412288|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
64412340|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
64412341|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
64412342|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
64412343|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
64412344|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64412345|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64412346|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
64412347|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
64412348|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64412349|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412350|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64412351|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
64412352|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
64412353|NCT02450487|Piroxicam|piroxicam|mesh-list
64412354|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64412355|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64412356|NCT02450487|Analgesics|analgesics|mesh-ancestor
64412357|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
64412358|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64412396|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361024|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
64412397|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64412399|NCT03117751|Dexamethasone|dexamethasone|mesh-list
64412400|NCT03117751|Prednisone|prednisone|mesh-list
64412401|NCT03117751|Prednisolone|prednisolone|mesh-list
64412402|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
64412403|NCT03117751|Doxorubicin|doxorubicin|mesh-list
64412404|NCT03117751|Methotrexate|methotrexate|mesh-list
64412405|NCT03117751|Etoposide|etoposide|mesh-list
64412465|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412466|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412467|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64412468|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412469|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
64412470|NCT04924257|Esketamine|esketamine|mesh-list
64412471|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
64412472|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64412473|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
64412474|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64412475|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412529|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64412530|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412531|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
64412532|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412598|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64412599|NCT05696093|Renal Agents|renal agents|mesh-ancestor
64412600|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
64412601|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64412602|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64412603|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
64412604|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
64412605|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64412606|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
64412666|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
64412667|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412668|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412669|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64412670|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64412671|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
64412672|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64412734|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412735|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64412736|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412738|NCT05678933|Hormones|hormones|mesh-ancestor
64412739|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64412740|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64412741|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64412742|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
64412743|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
64412744|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
64412745|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64412746|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
64412747|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412748|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64412749|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64412792|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64412793|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
64412794|NCT04708613|Corticosterone|corticosterone|mesh-list
64412795|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64412796|NCT02627677|Ponatinib|ponatinib|mesh-list
64412797|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412798|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64412799|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412800|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412801|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
64412802|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64412803|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412856|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64412857|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
64412858|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412859|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412860|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64412924|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412925|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64412926|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64412927|NCT04973293|Growth Substances|growth substances|mesh-ancestor
64412928|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64412929|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
64412930|NCT04962451|Ticagrelor|ticagrelor|mesh-list
64412991|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64412992|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64412993|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64412994|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64412995|NCT04425655|Fludarabine|fludarabine|mesh-list
64412996|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64412997|NCT04970719|Remdesivir|remdesivir|mesh-list
64412998|NCT04970719|Dexamethasone|dexamethasone|mesh-list
64412999|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64413000|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413056|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
64413057|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64413058|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413059|NCT04960657|Growth Substances|growth substances|mesh-ancestor
64413060|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
64413061|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413062|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413122|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
64413124|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413125|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
64413126|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413127|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413193|NCT03058939|Letrozole|letrozole|mesh-list
64413194|NCT03058939|Pertuzumab|pertuzumab|mesh-list
64413195|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64413196|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361135|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
64413197|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
64413198|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
64413199|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413202|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64413260|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64413261|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
64413262|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361136|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64413332|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64353475|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
64413333|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
64413334|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
64413335|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64413336|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64413337|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
64413338|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413339|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64413340|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64413341|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413394|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413395|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
64413396|NCT04948957|Esmolol|esmolol|mesh-list
64413397|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
64413398|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64413399|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64413400|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64413401|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
64413402|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413403|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413404|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413405|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
64413406|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64413408|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
64413409|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64413451|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
64413452|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
64413453|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64413454|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64413455|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
64413456|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413457|NCT04946929|Heparin|heparin|mesh-list
64413458|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64413459|NCT04946929|Tinzaparin|tinzaparin|mesh-list
64413460|NCT04946929|Dalteparin|dalteparin|mesh-list
64413461|NCT04946929|Ticagrelor|ticagrelor|mesh-list
64413462|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
64413463|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64413464|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64413465|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413513|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413514|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64413515|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
64413516|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64413517|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413518|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64413519|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64413520|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64413521|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413522|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
64413523|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64413524|NCT02577029|Interferons|interferons|mesh-list
64413526|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
64413527|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
64413528|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64413530|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
64413531|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64413532|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413533|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
64413537|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413568|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64413569|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413570|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
64413571|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
64413572|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413573|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413574|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413575|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64413576|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64413577|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
64413578|NCT03660059|Peficitinib|peficitinib|mesh-list
64413579|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413580|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413624|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
64413626|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
64413627|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64413628|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64413629|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64413630|NCT03057769|Analgesics|analgesics|mesh-ancestor
64413631|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
64413632|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64413633|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64413634|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
64413635|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
64413636|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64413637|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64413638|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413639|NCT04633577|Lidocaine|lidocaine|mesh-list
64413640|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
64413641|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
64413642|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413643|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413644|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
64413645|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64413646|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64413647|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64413676|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
64413677|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413678|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64413679|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64413680|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64413745|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413746|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413747|NCT05421065|Ketamine|ketamine|mesh-list
64413748|NCT05421065|Psilocybin|psilocybin|mesh-list
64413749|NCT05421065|Analgesics|analgesics|mesh-ancestor
64413750|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
64413815|NCT04938583|Oregovomab|oregovomab|mesh-list
64413816|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64413817|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64413818|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
64413819|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
64413820|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
64413821|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413822|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64413823|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64413824|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64413879|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64413880|NCT04937101|Narcotics|narcotics|mesh-ancestor
64413881|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64413882|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413883|NCT04937101|Analgesics|analgesics|mesh-ancestor
64413949|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64413951|NCT04935541|Narcotics|narcotics|mesh-ancestor
64413952|NCT04935073|Cetrorelix|cetrorelix|mesh-list
64413953|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64413954|NCT04935073|Hormones|hormones|mesh-ancestor
64413955|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64413956|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64413969|NCT04917757|Hormones|hormones|mesh-ancestor
64414014|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414015|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64353501|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414016|NCT04916353|Triamcinolone|triamcinolone|mesh-list
64414017|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64414018|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64414019|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64414020|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64414021|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
64414022|NCT04916353|Hormones|hormones|mesh-ancestor
64414081|NCT04915807|Taxane|taxane|mesh-list
64414083|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414084|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
64414085|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
64414086|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
64414087|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414088|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64414089|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64414090|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414091|NCT01360021|Budesonide|budesonide|mesh-list
64414092|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64414093|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64414094|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64414145|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414146|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414147|NCT02496039|Quinidine|quinidine|mesh-list
64414216|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414218|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
64414219|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64414220|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64414221|NCT03054259|Prednisolone|prednisolone|mesh-list
64414222|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
64414223|NCT03054259|Rituximab|rituximab|mesh-list
64414285|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64414286|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64414287|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
64414288|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
64414289|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64414290|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64414291|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64414292|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414293|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414294|NCT04893733|Folic Acid|folic acid|mesh-list
64361235|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361236|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361237|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414295|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
64414296|NCT04893733|Vitamins|vitamins|mesh-ancestor
64414297|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
64414298|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414299|NCT04893733|Hematinics|hematinics|mesh-ancestor
64414347|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
64414348|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414349|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414350|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
64414351|NCT03053167|Irinotecan|irinotecan|mesh-list
64414352|NCT03053167|Raltitrexed|raltitrexed|mesh-list
64414355|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64414413|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64414414|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64414415|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64414416|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414417|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414418|NCT02493777|Methylphenidate|methylphenidate|mesh-list
64414419|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64414420|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414421|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64414422|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64414475|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
64414476|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414477|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64414478|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414479|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414545|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64414546|NCT04899817|Granisetron|granisetron|mesh-list
64414547|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
64414548|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
64414549|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64414550|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414551|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64414553|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
64414554|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414613|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
64414614|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
64414615|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
64414616|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64414617|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
64414618|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64414619|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64414620|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414621|NCT03051841|Dexamethasone|dexamethasone|mesh-list
64414622|NCT03051841|Bortezomib|bortezomib|mesh-list
64414623|NCT03051841|CKD-581|ckd-581|mesh-list
64414678|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
64414679|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64414680|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64414681|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64414682|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
64414684|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
64414747|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414748|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64414749|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414750|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64414751|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64414752|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
64414753|NCT02433483|Cytarabine|cytarabine|mesh-list
64414754|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
64414816|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64414818|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64414819|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
64414820|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64414821|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414822|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64414823|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414824|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
64414825|NCT04913025|Nivolumab|nivolumab|mesh-list
64414826|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64414827|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64414828|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64414847|NCT02486757|Estradiol|estradiol|mesh-list
64414878|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
64414879|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64414880|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
64414881|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64414882|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414883|NCT04882813|Incretins|incretins|mesh-ancestor
64414884|NCT04882813|Hormones|hormones|mesh-ancestor
64414886|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64414945|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64414947|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64414948|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64414949|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64414950|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
64414951|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415010|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64415011|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415012|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
64415013|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415014|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415015|NCT03051373|Gemcitabine|gemcitabine|mesh-list
64415016|NCT03051373|Paclitaxel|paclitaxel|mesh-list
64415017|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64415018|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64415019|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415076|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
64415077|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
64415078|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64415080|NCT01595581|Hormones|hormones|mesh-ancestor
64415081|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64415082|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415083|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64415084|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415085|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
64415086|NCT01954979|Abatacept|abatacept|mesh-list
64415087|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64415088|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415089|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415090|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415091|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
64415092|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415093|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415094|NCT04885153|Fenofibrate|fenofibrate|mesh-list
64415095|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64415096|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
64415098|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64415130|NCT01610687|Analgesics|analgesics|mesh-ancestor
64415131|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
64415132|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415133|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415134|NCT04884919|Chitosan|chitosan|mesh-list
64415135|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64415136|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64415137|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
64415138|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415139|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64415140|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
64415141|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
64415142|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
64415143|NCT04884919|Coagulants|coagulants|mesh-ancestor
64415144|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
64415145|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
64415146|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415147|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64415148|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415149|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415150|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64415151|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
64415153|NCT04878835|Ranibizumab|ranibizumab|mesh-list
64415183|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64415185|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415186|NCT05182385|Venetoclax|venetoclax|mesh-list
64415187|NCT05182385|Blinatumomab|blinatumomab|mesh-list
64415255|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
64415256|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415257|NCT04112095|Norgestrel|norgestrel|mesh-list
64415258|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64415259|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64415260|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64415261|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
64353568|NCT05112471|Erythritol|erythritol|mesh-list
64415262|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64415263|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415264|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64415265|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64415266|NCT05257993|Gemcitabine|gemcitabine|mesh-list
64415267|NCT05257993|Paclitaxel|paclitaxel|mesh-list
64415268|NCT05257993|Folfirinox|folfirinox|mesh-list
64415269|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64415270|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415271|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
64415272|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64415273|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64415276|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
64415310|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64415311|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64415312|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415313|NCT04300049|Glucagon|glucagon|mesh-list
64415314|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64415315|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415316|NCT04300049|Hormones|hormones|mesh-ancestor
64415378|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64415379|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64415381|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
64415382|NCT02574845|Metformin|metformin|mesh-list
64415383|NCT02574845|Furosemide|furosemide|mesh-list
64415384|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64415385|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64415386|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415389|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
64415444|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415445|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64415446|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415447|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415448|NCT04877509|Vitamin D|vitamin d|mesh-list
64415449|NCT04877509|Vitamin A|vitamin a|mesh-list
64415450|NCT04877509|Selenium|selenium|mesh-list
64415451|NCT04877509|Copper|copper|mesh-list
64415452|NCT04877509|Vitamins|vitamins|mesh-ancestor
64415453|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
64415454|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415455|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
64415456|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415457|NCT04877509|Protective Agents|protective agents|mesh-ancestor
64415458|NCT04877509|Trace Elements|trace elements|mesh-ancestor
64415459|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64415462|NCT03044743|Interleukin-2|interleukin-2|mesh-list
64415463|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415464|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
64415465|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415466|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64415467|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64415468|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
64415469|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415470|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415471|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64415472|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64415473|NCT03044743|Analgesics|analgesics|mesh-ancestor
64361259|NCT03334981|Narcotics|narcotics|mesh-ancestor
64415474|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
64415475|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415476|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64415477|NCT03044665|Ezetimibe|ezetimibe|mesh-list
64415488|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415489|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
64415490|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353621|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353622|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64353623|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64353624|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
64353625|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
64353626|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353627|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64353628|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64415491|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
64415492|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415493|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415494|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64415495|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
64415496|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415497|NCT03044587|Antidotes|antidotes|mesh-ancestor
64415498|NCT03044587|Protective Agents|protective agents|mesh-ancestor
64415499|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
64415501|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
64415502|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
64415503|NCT05525351|Alfentanil|alfentanil|mesh-list
64415504|NCT05525351|Propofol|propofol|mesh-list
64415505|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64415548|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
64415549|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
64415550|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
64415551|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64415552|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64415553|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64415554|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64415555|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64415556|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415557|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
64415559|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64415560|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64415561|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64415562|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64415563|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415565|NCT05518409|Donepezil|donepezil|mesh-list
64415605|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64415606|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64415607|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
64415608|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
64415609|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415610|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
64415611|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415613|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415614|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64415615|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
64415616|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64353629|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379982|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415617|NCT02613871|Ledipasvir|ledipasvir|mesh-list
64415618|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
64415619|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415620|NCT04869709|Betamethasone|betamethasone|mesh-list
64415666|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64415667|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64415668|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
64415669|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64415670|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64415675|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64361268|NCT02492503|Paclitaxel|paclitaxel|mesh-list
64415734|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64415736|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
64415737|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415805|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64415806|NCT05512325|Growth Substances|growth substances|mesh-ancestor
64415807|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64415808|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
64415809|NCT04868227|Vitamin D|vitamin d|mesh-list
64415810|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
64415811|NCT04868227|Vitamins|vitamins|mesh-ancestor
64415812|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
64415871|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
64415872|NCT04867993|Amikacin|amikacin|mesh-list
64415873|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64415874|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64415875|NCT04872985|Paclitaxel|paclitaxel|mesh-list
64415876|NCT04872985|Docetaxel|docetaxel|mesh-list
64415877|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
64415878|NCT04872985|Doxorubicin|doxorubicin|mesh-list
64415879|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64415880|NCT04872985|Epirubicin|epirubicin|mesh-list
64415882|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415938|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64415939|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
64415940|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
64415941|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
64415942|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64415943|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64415944|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
64415945|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
64415946|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64416004|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64416005|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
64416006|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416007|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64416009|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64416010|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64416011|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
64416012|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416013|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416014|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416015|NCT04667663|Dexamethasone|dexamethasone|mesh-list
64416016|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
64416017|NCT04667663|Daratumumab|daratumumab|mesh-list
64416018|NCT04667663|Pomalidomide|pomalidomide|mesh-list
64416019|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64416020|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
64416021|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416022|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416023|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64416024|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
64416025|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416026|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416027|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64416028|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416029|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
64416030|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
64416031|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416032|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416033|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
64416034|NCT04667663|Hormones|hormones|mesh-ancestor
64353631|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64416035|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416036|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416037|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64416038|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64416039|NCT04667663|Growth Substances|growth substances|mesh-ancestor
64416040|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
64416042|NCT02570711|Paclitaxel|paclitaxel|mesh-list
64416043|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
64416044|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64416045|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416046|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
64416047|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
64416048|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
64416049|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416050|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64416105|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
64416106|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
64416107|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353640|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64353641|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
64353642|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
64353643|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353644|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416108|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416109|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
64416110|NCT05503667|Bevacizumab|bevacizumab|mesh-list
64416111|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64416112|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416113|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64416114|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64416115|NCT05503667|Growth Substances|growth substances|mesh-ancestor
64416116|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416168|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64416169|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416170|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
64416171|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
64416172|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
64416173|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416175|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64416234|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64416235|NCT03043495|Dexamethasone|dexamethasone|mesh-list
64416236|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416237|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
64416238|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
64416239|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416240|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416241|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416242|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
64416243|NCT03043495|Hormones|hormones|mesh-ancestor
64416244|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416245|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416246|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416247|NCT03043027|Bupivacaine|bupivacaine|mesh-list
64416248|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
64416249|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
64416250|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416251|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416252|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
64416293|NCT03041935|Analgesics|analgesics|mesh-ancestor
64416294|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
64416295|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
64416296|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64416297|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
64416298|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64416299|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64416300|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
64361366|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64416301|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
64416361|NCT04429633|Candesartan|candesartan|mesh-list
64416362|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64416363|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64416367|NCT03042091|Ethanol|ethanol|mesh-list
64416368|NCT03042091|Neomycin|neomycin|mesh-list
64416428|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416430|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
64416432|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416433|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416496|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64416497|NCT04848259|Dexamethasone|dexamethasone|mesh-list
64416498|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
64416499|NCT04848259|BB 1101|bb 1101|mesh-list
64416500|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64416501|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
64416502|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
64416503|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416504|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416505|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64416506|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
64416507|NCT04848259|Hormones|hormones|mesh-ancestor
64416508|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64416509|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64416510|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64416511|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416512|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416513|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416524|NCT04848181|Finasteride|finasteride|mesh-list
64416552|NCT04847245|Esketamine|esketamine|mesh-list
64416553|NCT04847245|Analgesics|analgesics|mesh-ancestor
64416554|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
64416555|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64416556|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64416557|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
64416558|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64416559|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64416560|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64416561|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64416562|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64416563|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64416564|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64416565|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64416566|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64416567|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64416568|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416604|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64416605|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64416607|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64361428|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64416608|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
64416609|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
64416610|NCT03040531|Vitamin D|vitamin d|mesh-list
64423571|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423572|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64423573|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
64353655|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64423574|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423575|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
64423576|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423577|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423578|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423580|NCT05280223|Analgesics|analgesics|mesh-ancestor
64423581|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
64423582|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423583|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64423584|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64423585|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423586|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423587|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423588|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423589|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64423590|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64423591|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423592|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423593|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64423594|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64423595|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423596|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
64423597|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423605|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423606|NCT05248945|Analgesics|analgesics|mesh-ancestor
64423607|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
64423608|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423609|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64423610|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64423624|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64423625|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64423626|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423627|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423628|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64423629|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64423631|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
64423633|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423634|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423635|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
64423636|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423637|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64423638|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64423639|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64294756|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423640|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64423641|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423642|NCT05243563|Clobetasol|clobetasol|mesh-list
64423643|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423644|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
64423645|NCT05243563|Hormones|hormones|mesh-ancestor
64423646|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423647|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423648|NCT05272969|Vitamin D|vitamin d|mesh-list
64423649|NCT05272969|Calcium|calcium|mesh-list
64423650|NCT05272969|Vitamins|vitamins|mesh-ancestor
64423651|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
64423652|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423658|NCT05206747|Methamphetamine|methamphetamine|mesh-list
64353702|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423659|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64423660|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423661|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
64423662|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
64423663|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423664|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
64423665|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423666|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423667|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423668|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64423669|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64423670|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64423671|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64423684|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64423685|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
64423686|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64423687|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64423688|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64423689|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64423690|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423691|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
64423692|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423693|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423694|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64423695|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64423696|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423697|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
64423698|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64423699|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64423700|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64423701|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
64423702|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423703|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64423704|NCT05166343|Epinephrine|epinephrine|mesh-list
64423705|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64294790|NCT04849832|Fesoterodine|fesoterodine|mesh-list
64423706|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423707|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423708|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423709|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423710|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423711|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64423712|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64423713|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
64423714|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361525|NCT05430087|Vitamin D|vitamin d|mesh-list
64361526|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
64423725|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
64423726|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423727|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423728|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64423729|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64423730|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
64423731|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423732|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423733|NCT05236543|Itraconazole|itraconazole|mesh-list
64423734|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
64423735|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423757|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423758|NCT05157841|Bupivacaine|bupivacaine|mesh-list
64353716|NCT03874325|Letrozole|letrozole|mesh-list
64423759|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
64423760|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
64423761|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423762|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423763|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
64423764|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423765|NCT05154487|Fulvestrant|fulvestrant|mesh-list
64423766|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64423767|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423768|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64423769|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64423771|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423772|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423773|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
64423774|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64423775|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423776|NCT05225155|Enoxaparin|enoxaparin|mesh-list
64423777|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
64423778|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64423779|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64423780|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423781|NCT05190445|Paclitaxel|paclitaxel|mesh-list
64423782|NCT05190445|Ramucirumab|ramucirumab|mesh-list
64423783|NCT05190445|Tucatinib|tucatinib|mesh-list
64423784|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64423785|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423786|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
64423787|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
64423802|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
64423803|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64423804|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64423806|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
64423807|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423808|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
64423809|NCT05466799|Irinotecan|irinotecan|mesh-list
64423810|NCT05466799|Folfirinox|folfirinox|mesh-list
64423811|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423812|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64423813|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64423814|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423815|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423817|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
64423818|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
64423819|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64423838|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423839|NCT05185999|Icodextrin|icodextrin|mesh-list
64423840|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
64423841|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64423842|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
64423843|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64423844|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423845|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64423846|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423847|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
64423861|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423862|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64423863|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64423864|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
64423865|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423866|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423872|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
64423873|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423874|NCT05139043|Dexamethasone|dexamethasone|mesh-list
64353788|NCT03430505|Albuterol|albuterol|mesh-list
64423875|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
64423876|NCT05139043|Ichthammol|ichthammol|mesh-list
64423877|NCT05139043|BB 1101|bb 1101|mesh-list
64423878|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423879|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
64423880|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
64423881|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423882|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423883|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64423884|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
64423885|NCT05139043|Hormones|hormones|mesh-ancestor
64423886|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423887|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64423888|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423889|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
64423890|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423891|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423892|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
64423893|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
64423894|NCT05175781|Ketamine|ketamine|mesh-list
64353789|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64353790|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
64423895|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423896|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423897|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423898|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423900|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
64423901|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423902|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64423903|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64423904|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64423905|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423906|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423907|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423908|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64423909|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64423910|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
64423911|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
64423912|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64423913|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64423914|NCT04421911|Diclofenac|diclofenac|mesh-list
64423915|NCT04421911|Ketoprofen|ketoprofen|mesh-list
64423923|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64423924|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64423925|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423926|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423928|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
64423929|NCT05174611|Vitamins|vitamins|mesh-ancestor
64423930|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
64423931|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423932|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64423933|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64423934|NCT05133817|Norepinephrine|norepinephrine|mesh-list
64423935|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64361568|NCT03323671|Analgesics|analgesics|mesh-ancestor
64423941|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423942|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
64423943|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
64423944|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423945|NCT05171335|Lenvatinib|lenvatinib|mesh-list
64423946|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423947|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64423948|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423949|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423950|NCT02522299|Nemiralisib|nemiralisib|mesh-list
64423951|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64353791|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423952|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423953|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423955|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
64423956|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64423957|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
64423958|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423959|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423960|NCT01365091|Metformin|metformin|mesh-list
64423961|NCT01365091|Saxagliptin|saxagliptin|mesh-list
64423962|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64423963|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423964|NCT01365091|Incretins|incretins|mesh-ancestor
64423965|NCT01365091|Hormones|hormones|mesh-ancestor
64423966|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353796|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64423967|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64423968|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
64423969|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423970|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423971|NCT05082025|Fulvestrant|fulvestrant|mesh-list
64423972|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64423973|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423974|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64423975|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64423976|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
64423977|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423978|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423980|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64423981|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
64423988|NCT05081479|Protective Agents|protective agents|mesh-ancestor
64423989|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423990|NCT05081479|Antidotes|antidotes|mesh-ancestor
64423991|NCT05079763|Monolaurin|monolaurin|mesh-list
64423992|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
64423993|NCT05079763|Protective Agents|protective agents|mesh-ancestor
64423994|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423995|NCT05050981|Hormones|hormones|mesh-list
64423996|NCT05050981|Serotonin|serotonin|mesh-list
64423997|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
64361575|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361577|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
64424017|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424018|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424019|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424020|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
64424021|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64424022|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64424023|NCT05123131|Growth Substances|growth substances|mesh-ancestor
64424024|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
64424025|NCT05073679|Naltrexone|naltrexone|mesh-list
64424026|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64424027|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64424028|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424029|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
64424030|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424041|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
64424042|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424043|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
64424044|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424045|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64424046|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64424047|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
64424048|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64424049|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
64353798|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64353806|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
64424055|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
64424056|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64424058|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
64424059|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424060|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424061|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424062|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
64424063|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64424074|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64424076|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424077|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
64424078|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424079|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424080|NCT05062837|Apatinib|apatinib|mesh-list
64424081|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424082|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424083|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424084|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424085|NCT05110417|Bromides|bromides|mesh-list
64294952|NCT00071552|Xhance|xhance|mesh-list
64424086|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64424087|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
64424088|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64424089|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424090|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424091|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
64424092|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424093|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424094|NCT05033665|Benzocaine|benzocaine|mesh-list
64424095|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
64424096|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
64424097|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424098|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424099|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
64424100|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424101|NCT05031481|Butoconazole|butoconazole|mesh-list
64424102|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
64424103|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424104|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
64424105|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64424106|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424107|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64424108|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424109|NCT05057767|Midazolam|midazolam|mesh-list
64424110|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64424111|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64424112|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361616|NCT02488057|Liraglutide|liraglutide|mesh-list
64361619|NCT02488057|Incretins|incretins|mesh-ancestor
64424134|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64424135|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64424136|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424137|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424138|NCT04216693|Protective Agents|protective agents|mesh-ancestor
64424139|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424141|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353809|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
64424142|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
64424143|NCT01364389|Hormones|hormones|mesh-ancestor
64424144|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424145|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424146|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424147|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424148|NCT05054881|Iodine|iodine|mesh-list
64424149|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64424150|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424151|NCT05054881|Trace Elements|trace elements|mesh-ancestor
64424152|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
64424153|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424154|NCT04949425|Adavosertib|adavosertib|mesh-list
64424155|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424156|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424157|NCT04203901|Nivolumab|nivolumab|mesh-list
64424158|NCT04203901|Ipilimumab|ipilimumab|mesh-list
64424159|NCT04203901|Everolimus|everolimus|mesh-list
64424160|NCT04203901|Lenvatinib|lenvatinib|mesh-list
64424161|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424162|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424163|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64424164|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424165|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424167|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424168|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424169|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424170|NCT04421209|Propranolol|propranolol|mesh-list
64424171|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64424172|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64424173|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
64424174|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361645|NCT02488291|Dsuvia|dsuvia|mesh-list
64424175|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424176|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424177|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64424205|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
64424206|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424207|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
64424208|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424210|NCT02291289|Trastuzumab|trastuzumab|mesh-list
64424211|NCT02291289|Cetuximab|cetuximab|mesh-list
64424212|NCT02291289|Pertuzumab|pertuzumab|mesh-list
64424213|NCT02291289|Capecitabine|capecitabine|mesh-list
64424215|NCT02291289|Atezolizumab|atezolizumab|mesh-list
64424216|NCT02291289|Vemurafenib|vemurafenib|mesh-list
64424217|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424218|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424219|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64424220|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64424221|NCT02291289|Growth Substances|growth substances|mesh-ancestor
64424222|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424223|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
64424224|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64424225|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
64424277|NCT02357901|Narcotics|narcotics|mesh-ancestor
64424278|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424279|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424280|NCT02357901|Analgesics|analgesics|mesh-ancestor
64424281|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
64353868|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424282|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424283|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64424285|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
64424286|NCT01601847|Vitamins|vitamins|mesh-ancestor
64424287|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
64424288|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424289|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64424290|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64424291|NCT02515279|Ribavirin|ribavirin|mesh-list
64424292|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64424293|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
64424294|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424295|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
64424296|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424297|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
64424298|NCT02515045|Prednisolone|prednisolone|mesh-list
64424299|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64424300|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
64424301|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64424302|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
64424303|NCT02515045|Nepafenac|nepafenac|mesh-list
64424304|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64424305|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
64424316|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64424317|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64424318|NCT02515045|Protective Agents|protective agents|mesh-ancestor
64424319|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424320|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424321|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64424322|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64424323|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424324|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424325|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64424326|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424328|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
64424329|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424344|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
64424345|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424346|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424347|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424348|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424349|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64424350|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64424351|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424352|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424353|NCT02512861|Bupivacaine|bupivacaine|mesh-list
64424354|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
64424355|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
64424356|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424357|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424358|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
64424359|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424360|NCT04979611|Exenatide|exenatide|mesh-list
64424361|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64424362|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424363|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64353918|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353938|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64353939|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353940|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353941|NCT03422393|Venetoclax|venetoclax|mesh-list
64353942|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353943|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
64353944|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64353945|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
64353946|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64424364|NCT04979611|Incretins|incretins|mesh-ancestor
64424365|NCT04979611|Hormones|hormones|mesh-ancestor
64424366|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424367|NCT04979065|Vitamin D|vitamin d|mesh-list
64424368|NCT04979065|Vitamins|vitamins|mesh-ancestor
64424390|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
64424391|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424392|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424393|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424395|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64424396|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
64424397|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424398|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64361663|NCT03323047|BB 1101|bb 1101|mesh-list
64424399|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424400|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
64424401|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64424402|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64424403|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424405|NCT05010421|Emollients|emollients|mesh-list
64424406|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424408|NCT05010421|Hormones|hormones|mesh-ancestor
64424409|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424410|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424411|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
64424412|NCT02504827|Ceftazidime|ceftazidime|mesh-list
64424413|NCT02504827|Avibactam|avibactam|mesh-list
64424414|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64424415|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424416|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424417|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64424418|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424419|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424420|NCT02504671|Folic Acid|folic acid|mesh-list
64424430|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424431|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424432|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
64424433|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64424434|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424435|NCT05007613|Atezolizumab|atezolizumab|mesh-list
64424436|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424437|NCT04971499|Dapansutrile|dapansutrile|mesh-list
64424438|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
64424439|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424440|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353948|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64353949|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353950|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353951|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64353952|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
64353953|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
64353954|NCT03427385|Ropivacaine|ropivacaine|mesh-list
64353955|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353956|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
64353957|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353958|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353959|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
64353960|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424441|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424442|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
64424443|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64424444|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64424445|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64424446|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64424447|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64424448|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424449|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
64424450|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424451|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424452|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64424453|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424454|NCT02501629|Reslizumab|reslizumab|mesh-list
64424455|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64424457|NCT02501473|Rituximab|rituximab|mesh-list
64424458|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
64424459|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424460|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424461|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
64424462|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424463|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424464|NCT02501161|Insulin|insulin|mesh-list
64424465|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64424466|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
64424467|NCT02501161|Liraglutide|liraglutide|mesh-list
64424468|NCT02501161|Xultophy|xultophy|mesh-list
64424469|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64424470|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424471|NCT02501161|Incretins|incretins|mesh-ancestor
64424472|NCT02501161|Hormones|hormones|mesh-ancestor
64424473|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424474|NCT04966585|Posaconazole|posaconazole|mesh-list
64424475|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
64424478|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64424479|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64424480|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64424481|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64424482|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424483|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424484|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64424485|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
64424486|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424487|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424488|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
64424508|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353961|NCT03427229|Vancomycin|vancomycin|mesh-list
64353989|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353991|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64424509|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424510|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424511|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424512|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64424513|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64424514|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424515|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64424516|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64424517|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424519|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64424520|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
64424521|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64424522|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
64424523|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
64424524|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
64424525|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64424526|NCT02287467|Antibodies|antibodies|mesh-list
64424527|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
64424528|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64424529|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
64424530|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424531|NCT02287233|Cytarabine|cytarabine|mesh-list
64424532|NCT02287233|Venetoclax|venetoclax|mesh-list
64424533|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64424534|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
64424535|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424536|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424537|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
64424538|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424539|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424540|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
64424541|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424542|NCT01646385|Etanercept|etanercept|mesh-list
64424543|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
64424555|NCT02286843|Pertuzumab|pertuzumab|mesh-list
64424556|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424557|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424558|NCT02281773|BI 409306|bi 409306|mesh-list
64424559|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64424560|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424561|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424562|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
64424563|NCT04877613|Fludarabine|fludarabine|mesh-list
64424564|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424565|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
64424566|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424567|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424568|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64424569|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
64424575|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424577|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424578|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64424579|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
64424580|NCT02284893|Saxagliptin|saxagliptin|mesh-list
64424581|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64424582|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424583|NCT02284893|Incretins|incretins|mesh-ancestor
64424584|NCT02284893|Hormones|hormones|mesh-ancestor
64424585|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424586|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64424587|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
64424588|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424589|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424590|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64424591|NCT04965181|Nicotine|nicotine|mesh-list
64424592|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64424593|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
64424594|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424595|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424596|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64424597|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64424598|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
64424599|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424600|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424602|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
64424603|NCT02483611|Cisatracurium|cisatracurium|mesh-list
64424604|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
64424605|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
64424606|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424618|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64424619|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
64424620|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64424621|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64424622|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64424623|NCT02482129|Dexamethasone|dexamethasone|mesh-list
64424624|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64424625|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64424626|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424627|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
64424628|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
64424629|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424630|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424631|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64424632|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
64424633|NCT02482129|Hormones|hormones|mesh-ancestor
64424634|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424635|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424636|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424637|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
64424655|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424656|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424657|NCT02495077|Acetaminophen|acetaminophen|mesh-list
64424658|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
64424659|NCT02495077|Promethazine|promethazine|mesh-list
64424660|NCT02495077|Loratadine|loratadine|mesh-list
64424661|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
64424662|NCT02495077|Prednisone|prednisone|mesh-list
64424663|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
64424664|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64424665|NCT02495077|Infliximab|infliximab|mesh-list
64424666|NCT02495077|Tacrolimus|tacrolimus|mesh-list
64424667|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
64424668|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64424669|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424682|NCT02495077|Analgesics|analgesics|mesh-ancestor
64424683|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
64424684|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424685|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
64424686|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64424687|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64424688|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
64424692|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
64424693|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64424694|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64424695|NCT02495077|Protective Agents|protective agents|mesh-ancestor
64424696|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
64424697|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424698|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64424699|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64424700|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424701|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
64424703|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64424704|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
64424705|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
64424706|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424707|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64424708|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
64424709|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64424710|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
64424711|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
64424712|NCT02278341|Hematinics|hematinics|mesh-ancestor
64424713|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
64424714|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64424715|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64424716|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424717|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
64424724|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64424725|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424726|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424727|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
64424729|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424730|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424731|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424732|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
64424733|NCT01653847|Everolimus|everolimus|mesh-list
64424752|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424753|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424754|NCT02493517|Lanreotide|lanreotide|mesh-list
64424755|NCT02493517|Somatostatin|somatostatin|mesh-list
64424756|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424757|NCT02493517|Hormones|hormones|mesh-ancestor
64424758|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424759|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424760|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
64424761|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424762|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424763|NCT04959799|Dalbavancin|dalbavancin|mesh-list
64424764|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424765|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424766|NCT04959331|Fosfomycin|fosfomycin|mesh-list
64424767|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
64424768|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
64424769|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424770|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424771|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64424772|NCT04959331|Renal Agents|renal agents|mesh-ancestor
64424773|NCT02478463|Cabotegravir|cabotegravir|mesh-list
64424774|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64424775|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64424776|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424777|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424778|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64424779|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64424780|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
64424781|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424782|NCT02491411|Dexamethasone|dexamethasone|mesh-list
64424783|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
64424784|NCT02491411|Ichthammol|ichthammol|mesh-list
64424785|NCT02491411|BB 1101|bb 1101|mesh-list
64424786|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424788|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
64424789|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424790|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354086|NCT02692339|Growth Substances|growth substances|mesh-ancestor
64354094|NCT02535325|Cisplatin|cisplatin|mesh-list
64424799|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424800|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
64424801|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
64424802|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64424803|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
64424804|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64424805|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424806|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64424807|NCT04957615|Nivolumab|nivolumab|mesh-list
64424808|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424809|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361751|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64361753|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
64424829|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64424831|NCT04939987|Oxycodone|oxycodone|mesh-list
64424832|NCT04939987|Gabapentin|gabapentin|mesh-list
64424833|NCT04939987|Tramadol|tramadol|mesh-list
64424834|NCT04939987|Hydrocodone|hydrocodone|mesh-list
64424835|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
64424836|NCT04939987|Analgesics|analgesics|mesh-ancestor
64424837|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
64424838|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424839|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424840|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64424841|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64424843|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
64424844|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424845|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64424846|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64424847|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424848|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424849|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424850|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
64424851|NCT04939987|Narcotics|narcotics|mesh-ancestor
64424852|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
64361759|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
64424853|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64424854|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64361760|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
64361761|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424867|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
64424868|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424870|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64424871|NCT02477215|Ixazomib|ixazomib|mesh-list
64424872|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424873|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
64424874|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
64424875|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424876|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424877|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64424878|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
64424879|NCT02477215|Hormones|hormones|mesh-ancestor
64424880|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424881|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424882|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424883|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64424884|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
64424885|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354095|NCT02535325|Pemetrexed|pemetrexed|mesh-list
64354128|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354129|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
64354130|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354131|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354133|NCT03437785|Ethanol|ethanol|mesh-list
64424886|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
64424887|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424888|NCT02487199|Ritonavir|ritonavir|mesh-list
64424889|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64424890|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64424891|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
64424892|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424893|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424894|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64424895|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64424896|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
64424897|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424898|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64424899|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64424900|NCT02475733|Metronidazole|metronidazole|mesh-list
64424901|NCT02475733|Meropenem|meropenem|mesh-list
64424902|NCT02475733|Ceftazidime|ceftazidime|mesh-list
64424903|NCT02475733|Avibactam|avibactam|mesh-list
64424904|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64424905|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424906|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424907|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64424908|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64424909|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64424910|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424911|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424912|NCT02486653|Tamsulosin|tamsulosin|mesh-list
64424913|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64424914|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64424915|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64424916|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
64424917|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424918|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424929|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64424930|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64424931|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64424932|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64424934|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424935|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
64424936|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
64424937|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
64424938|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424939|NCT02449915|Bupivacaine|bupivacaine|mesh-list
64361787|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64424957|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424959|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424960|NCT02472145|Decitabine|decitabine|mesh-list
64424961|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64424962|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
64424963|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424964|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424965|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424966|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
64424967|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
64424968|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
64424969|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64424970|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64424971|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
64424972|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
64424973|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424974|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424975|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424976|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64424977|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
64424978|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64424979|NCT04912765|Nivolumab|nivolumab|mesh-list
64424980|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424981|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424982|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64424999|NCT02417935|Analgesics|analgesics|mesh-ancestor
64425000|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
64425001|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425002|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425012|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64425013|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64425014|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425015|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
64425016|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
64425017|NCT02447029|Lidocaine|lidocaine|mesh-list
64425018|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
64425019|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
64425020|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425021|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425022|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
64425023|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425024|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64425025|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64425026|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64425027|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425028|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425029|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
64425030|NCT02469961|Propofol|propofol|mesh-list
64425031|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64425032|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425033|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425034|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64425035|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
64425036|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
64425037|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64425038|NCT02469961|Analgesics|analgesics|mesh-ancestor
64425039|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
64425040|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425046|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425047|NCT02415595|BMS-955176|bms-955176|mesh-list
64425048|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64425049|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64425050|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
64425051|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425052|NCT02446717|Ribavirin|ribavirin|mesh-list
64425053|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
64425054|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425055|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
64425056|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425057|NCT02469415|Azacitidine|azacitidine|mesh-list
64425058|NCT02469415|Decitabine|decitabine|mesh-list
64425059|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64425060|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
64425061|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425062|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425063|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425064|NCT02446171|Naloxegol|naloxegol|mesh-list
64354146|NCT03437707|Ibuprofen|ibuprofen|mesh-list
64425065|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64425066|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295156|NCT02808182|Niacin|niacin|mesh-list
64425067|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
64425068|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425069|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64425079|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64425080|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425081|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
64425082|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
64425083|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
64425084|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425085|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425086|NCT02413489|Daratumumab|daratumumab|mesh-list
64425087|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425088|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
64425089|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64425090|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
64425091|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425092|NCT02444533|Bupivacaine|bupivacaine|mesh-list
64425093|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
64425094|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
64425095|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425096|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295178|NCT02051569|Tryptophan|tryptophan|mesh-list
64425097|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
64425098|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425099|NCT01651039|Dexamethasone|dexamethasone|mesh-list
64425100|NCT01651039|Lenalidomide|lenalidomide|mesh-list
64425101|NCT01651039|Panobinostat|panobinostat|mesh-list
64425102|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425103|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
64425104|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
64425105|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425106|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425107|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425108|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
64425109|NCT01651039|Hormones|hormones|mesh-ancestor
64425110|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425111|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64425112|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425130|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64425131|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425132|NCT01642251|Cisplatin|cisplatin|mesh-list
64425133|NCT01642251|Etoposide|etoposide|mesh-list
64425134|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
64425135|NCT01642251|Veliparib|veliparib|mesh-list
64425136|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
64425137|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425143|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64425145|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
64425146|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
64425147|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
64425148|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
64425150|NCT04875585|Lenvatinib|lenvatinib|mesh-list
64425151|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425152|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425153|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64425154|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425155|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425156|NCT02273973|Letrozole|letrozole|mesh-list
64425157|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425158|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64425159|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64425160|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354152|NCT03437707|Analgesics|analgesics|mesh-ancestor
64354166|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64425161|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425162|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64425163|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
64425164|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425165|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425166|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64425167|NCT05649111|Difluprednate|difluprednate|mesh-list
64425168|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64425169|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
64425170|NCT05649111|Hormones|hormones|mesh-ancestor
64425178|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425179|NCT05561361|Spironolactone|spironolactone|mesh-list
64425180|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64425181|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
64425182|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425183|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425184|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64425185|NCT05561361|Diuretics|diuretics|mesh-ancestor
64425186|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
64425187|NCT02412631|Varenicline|varenicline|mesh-list
64425188|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64425189|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64425190|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
64425191|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425192|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425193|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425194|NCT02272803|Dexamethasone|dexamethasone|mesh-list
64425195|NCT02272803|Lenalidomide|lenalidomide|mesh-list
64425196|NCT02272803|Elotuzumab|elotuzumab|mesh-list
64425197|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425198|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
64425199|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
64425200|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425201|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425202|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425203|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
64425204|NCT02272803|Hormones|hormones|mesh-ancestor
64425205|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425206|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64425207|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425208|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
64425209|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64425210|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64425211|NCT02272803|Growth Substances|growth substances|mesh-ancestor
64425212|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
64425213|NCT02272725|Ibuprofen|ibuprofen|mesh-list
64425216|NCT02272725|Analgesics|analgesics|mesh-ancestor
64425217|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
64425218|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425219|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425220|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425221|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425223|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425224|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425225|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
64425226|NCT01650805|Ponatinib|ponatinib|mesh-list
64425227|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425228|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64425229|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425230|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425231|NCT04922827|Infliximab|infliximab|mesh-list
64425232|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
64425233|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425234|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425235|NCT02442349|Osimertinib|osimertinib|mesh-list
64425236|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425237|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64425254|NCT02463409|Theophylline|theophylline|mesh-list
64425255|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64425256|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
64425257|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425258|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425259|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64425260|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
64425261|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64425263|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425264|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
64425265|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64425266|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64425267|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
64425268|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425269|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
64425270|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425271|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425272|NCT04910503|Dexamethasone|dexamethasone|mesh-list
64425273|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64425274|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425275|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
64425276|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
64425277|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425278|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425279|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425280|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
64425281|NCT04910503|Hormones|hormones|mesh-ancestor
64425282|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361867|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361868|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425283|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64425284|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425286|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
64425287|NCT04910425|Protective Agents|protective agents|mesh-ancestor
64425288|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425289|NCT02463331|Chloroquine|chloroquine|mesh-list
64425290|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64425292|NCT02463331|Azathioprine|azathioprine|mesh-list
64425293|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425294|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
64425295|NCT02463331|Hormones|hormones|mesh-ancestor
64425296|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425317|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64295250|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
64425318|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
64425319|NCT02463097|Insulin|insulin|mesh-list
64425320|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64425321|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425322|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
64425323|NCT05427149|Analgesics|analgesics|mesh-ancestor
64425324|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
64425325|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425326|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425327|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
64425328|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425329|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64425330|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
64425331|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64425332|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425333|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425334|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64354179|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
64425335|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
64425336|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64425337|NCT02462473|Olanzapine|olanzapine|mesh-list
64425338|NCT02462473|Risperidone|risperidone|mesh-list
64425339|NCT02462473|Aripiprazole|aripiprazole|mesh-list
64425340|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64425341|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64425342|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64425343|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
64425344|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425345|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425346|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425347|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64425348|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64425349|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425350|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425351|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64425359|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425360|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
64425361|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
64425362|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64425363|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64425370|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425371|NCT02440789|Sirolimus|sirolimus|mesh-list
64425372|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64425373|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425374|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64425375|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425376|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
64425377|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64425378|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
64425379|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425380|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
64425381|NCT02538107|Hematinics|hematinics|mesh-ancestor
64425382|NCT02211755|Bortezomib|bortezomib|mesh-list
64425383|NCT02211755|Clofarabine|clofarabine|mesh-list
64425384|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425385|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64425386|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
64425387|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425388|NCT02272413|Bevacizumab|bevacizumab|mesh-list
64425389|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425390|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425391|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64425392|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64425393|NCT02272413|Growth Substances|growth substances|mesh-ancestor
64425394|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425395|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
64425396|NCT05400863|Metformin|metformin|mesh-list
64425397|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64425398|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425399|NCT02120807|Pemetrexed|pemetrexed|mesh-list
64425400|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
64425401|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425402|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425403|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425404|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64295273|NCT02472717|Liraglutide|liraglutide|mesh-list
64425405|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64425406|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64425407|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
64425408|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425409|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425410|NCT02532647|Midazolam|midazolam|mesh-list
64425411|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64425412|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64425413|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354186|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
64425414|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425415|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64425416|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64425417|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425418|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64361886|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361923|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
64425436|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
64425437|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425438|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64425439|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64425441|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
64425442|NCT01937117|Trastuzumab|trastuzumab|mesh-list
64425443|NCT01937117|Pertuzumab|pertuzumab|mesh-list
64425444|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425445|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425446|NCT04256213|Nivolumab|nivolumab|mesh-list
64425447|NCT04256213|Ipilimumab|ipilimumab|mesh-list
64425448|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425449|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425450|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64425451|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425452|NCT02268045|Rituximab|rituximab|mesh-list
64425453|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425454|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425455|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
64425456|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425457|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425458|NCT02267187|Anesthetics|anesthetics|mesh-list
64425459|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425460|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425461|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
64425462|NCT05388929|Methocarbamol|methocarbamol|mesh-list
64425463|NCT05388929|Narcotics|narcotics|mesh-ancestor
64425464|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425465|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425466|NCT05388929|Analgesics|analgesics|mesh-ancestor
64425467|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
64425468|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425469|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64425470|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64425472|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
64425473|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425474|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425475|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64425477|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425478|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64425479|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425480|NCT01641939|Trastuzumab|trastuzumab|mesh-list
64425481|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64425482|NCT01641939|Maytansine|maytansine|mesh-list
64425483|NCT01641939|Taxane|taxane|mesh-list
64425484|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425485|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425486|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64425487|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
64425507|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425508|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425509|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64354198|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
64354215|NCT04451239|Cyclosporins|cyclosporins|mesh-list
64354216|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361925|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425513|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64425514|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64425515|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64425516|NCT02438371|Analgesics|analgesics|mesh-ancestor
64425517|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
64425518|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425519|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425520|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425521|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
64425522|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64425523|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425524|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64425525|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
64425526|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64425527|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
64425528|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425529|NCT04920565|Polymyxins|polymyxins|mesh-list
64425530|NCT04920565|Polymyxin B|polymyxin b|mesh-list
64425531|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64425532|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425533|NCT04934683|Propofol|propofol|mesh-list
64425534|NCT04934683|Etomidate|etomidate|mesh-list
64425535|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64425536|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425537|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425538|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64425539|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
64425540|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
64425541|NCT04909333|Exenatide|exenatide|mesh-list
64425542|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64425543|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64425544|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430014|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64425557|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64425559|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425560|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64425561|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425563|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64425564|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64425565|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64425566|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64425567|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
64425568|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425569|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425570|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425571|NCT02436889|Urological Agents|urological agents|mesh-ancestor
64425572|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64425573|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64425574|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
64425575|NCT02436577|Ticagrelor|ticagrelor|mesh-list
64425576|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64425577|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64354218|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64354233|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425578|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64425579|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64425580|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
64425581|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425582|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425583|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425584|NCT02459665|Metronidazole|metronidazole|mesh-list
64425585|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425586|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64425587|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64425588|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64425589|NCT02265237|Ritonavir|ritonavir|mesh-list
64425590|NCT02265237|Ribavirin|ribavirin|mesh-list
64425591|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64425592|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64425593|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
64425594|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425595|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425596|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64425597|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64425598|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
64425599|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425600|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64425601|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64425602|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
64425603|NCT04874025|Palbociclib|palbociclib|mesh-list
64425613|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
64425614|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64425615|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425616|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
64425617|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
64425618|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
64425619|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425620|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425621|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
64425622|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64425623|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64425624|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64425625|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425626|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425627|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
64425628|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425629|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425630|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64425631|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425632|NCT02260791|Adalimumab|adalimumab|mesh-list
64425633|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425634|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425635|NCT02260635|Evacetrapib|evacetrapib|mesh-list
64425636|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64425637|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64425638|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
64425639|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425640|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64425641|NCT05646459|Cannabidiol|cannabidiol|mesh-list
64425642|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
64425643|NCT02259231|Nivolumab|nivolumab|mesh-list
64425644|NCT02259231|Ipilimumab|ipilimumab|mesh-list
64425645|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425646|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425647|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64425648|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425649|NCT02258529|Rituximab|rituximab|mesh-list
64425650|NCT02258529|Idelalisib|idelalisib|mesh-list
64425651|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425652|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425653|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
64425654|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361973|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
64425665|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64425666|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
64425667|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425668|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
64425669|NCT02256969|Hormones|hormones|mesh-ancestor
64425670|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425693|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
64425694|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64425695|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425696|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425697|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64425698|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64425699|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64425700|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64425701|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64425702|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64425703|NCT05429463|Paclitaxel|paclitaxel|mesh-list
64425704|NCT05429463|Carboplatin|carboplatin|mesh-list
64425705|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64425706|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64425707|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425708|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
64425709|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
64425710|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
64425711|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425712|NCT02255565|Methylphenidate|methylphenidate|mesh-list
64425713|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64425714|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425715|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64425716|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64425717|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425718|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425720|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362042|NCT02483221|Morphine|morphine|mesh-list
64425724|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
64425733|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425734|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64425735|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64425737|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64425738|NCT01640301|Analgesics|analgesics|mesh-ancestor
64425739|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
64425740|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425741|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64425742|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64425743|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
64425744|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425745|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
64425746|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
64425747|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64425748|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64425749|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354290|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
64354291|NCT03436225|Hormones|hormones|mesh-ancestor
64354306|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
64354307|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354308|NCT03440359|Letrozole|letrozole|mesh-list
64354309|NCT03440359|Progesterone|progesterone|mesh-list
64354310|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354311|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64425750|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425751|NCT01642407|Urological Agents|urological agents|mesh-ancestor
64425752|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
64425753|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425754|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425755|NCT02254551|Bortezomib|bortezomib|mesh-list
64425756|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425757|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
64425758|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64425759|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64425760|NCT05640375|Prednisolone|prednisolone|mesh-list
64425761|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
64425762|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64425763|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
64425764|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425765|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
64425766|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
64425767|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425768|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425769|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425770|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
64425771|NCT05640375|Hormones|hormones|mesh-ancestor
64425772|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425773|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64362046|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362051|NCT02489461|Efavirenz|efavirenz|mesh-list
64425781|NCT01641237|Protective Agents|protective agents|mesh-ancestor
64425782|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425783|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64425784|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425785|NCT05650437|Vitamin D|vitamin d|mesh-list
64425786|NCT05650437|Vitamins|vitamins|mesh-ancestor
64425787|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
64425788|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425789|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64425790|NCT05617209|Thrombin|thrombin|mesh-list
64425813|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425814|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425815|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425816|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64425817|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
64425818|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425819|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425820|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
64425821|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64425822|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
64425823|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425824|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425825|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64425826|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
64425827|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64425828|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64425829|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64425830|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64425831|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354312|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64425832|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425834|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64425835|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64425836|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425837|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
64425838|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
64425839|NCT05369481|Minoxidil|minoxidil|mesh-list
64425840|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
64425841|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
64425842|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64425843|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64425844|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425845|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425846|NCT05369481|Urological Agents|urological agents|mesh-ancestor
64295330|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425847|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64425863|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64425864|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425865|NCT04853355|Spironolactone|spironolactone|mesh-list
64425866|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64425867|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
64362146|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64362148|NCT02485249|Dexamethasone|dexamethasone|mesh-list
64425872|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
64425873|NCT05369091|Simvastatin|simvastatin|mesh-list
64425874|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64425875|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64425876|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
64425877|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425878|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64425879|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64425880|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425882|NCT01601535|Temozolomide|temozolomide|mesh-list
64425883|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64425884|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64425885|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425886|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425887|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425888|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64425889|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
64425890|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64425891|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
64425892|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64425894|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
64425895|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64425896|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
64425897|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425898|NCT04641273|Pregabalin|pregabalin|mesh-list
64425899|NCT04641273|Analgesics|analgesics|mesh-ancestor
64425900|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
64425901|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425902|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425904|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64425905|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64425906|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425907|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64425961|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425964|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425965|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425966|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64425967|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425968|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425969|NCT05329779|Pregnanolone|pregnanolone|mesh-list
64354319|NCT03440359|Progestins|progestins|mesh-ancestor
64425970|NCT05329779|Brexanolone|brexanolone|mesh-list
64425971|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
64425972|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425973|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425974|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
64425975|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425976|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425979|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
64425980|NCT04464759|Nivolumab|nivolumab|mesh-list
64425981|NCT04464759|Ipilimumab|ipilimumab|mesh-list
64425982|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425983|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425984|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64425985|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425986|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
64425987|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64425988|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64425989|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425990|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425991|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425992|NCT04850937|Esketamine|esketamine|mesh-list
64425993|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
64426008|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426009|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426010|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426011|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
64426012|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
64426013|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426014|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
64426015|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64426016|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64426017|NCT04411329|Analgesics|analgesics|mesh-ancestor
64426018|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64426019|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64426020|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64426021|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
64426022|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426023|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426025|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
64426026|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64426027|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64426028|NCT05171673|Analgesics|analgesics|mesh-ancestor
64426029|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
64426030|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426031|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426032|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426033|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426034|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64426035|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426036|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426037|NCT05147415|Metoprolol|metoprolol|mesh-list
64426038|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64426039|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64426040|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
64426041|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
64426042|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354334|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
64426043|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426044|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64426045|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64426046|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64426047|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
64426048|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426049|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426050|NCT04390581|Lidocaine|lidocaine|mesh-list
64426052|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
64426053|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426054|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426055|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
64426061|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426062|NCT05396859|Decitabine|decitabine|mesh-list
64426063|NCT05396859|Entrectinib|entrectinib|mesh-list
64426064|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64426065|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
64426066|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426069|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64426070|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64426071|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426072|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426074|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64426075|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426076|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426077|NCT04225767|Calcium|calcium|mesh-list
64426078|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64426079|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426080|NCT04820673|Sarecycline|sarecycline|mesh-list
64426081|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64426082|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426083|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
64426084|NCT04114539|Ecopipam|ecopipam|mesh-list
64426085|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64426086|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64426087|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426088|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426089|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64426090|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64426091|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
64426092|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426093|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426094|NCT03301857|Denosumab|denosumab|mesh-list
64426095|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
64426096|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
64426097|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
64426098|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426099|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64426100|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64426101|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64426102|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
64426103|NCT03263559|Thiotepa|thiotepa|mesh-list
64426104|NCT03263559|Fludarabine|fludarabine|mesh-list
64426105|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
64426106|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
64426107|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426108|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
64426109|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426110|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426111|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64426112|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
64426113|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426114|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426115|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64426116|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
64426117|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354391|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64354399|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426118|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64426119|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
64426120|NCT03257163|Capecitabine|capecitabine|mesh-list
64426121|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426122|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426123|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64426124|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
64426131|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426132|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426133|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
64426134|NCT03256149|Hormones|hormones|mesh-ancestor
64426135|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362206|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
64426144|NCT01636947|Aprepitant|aprepitant|mesh-list
64426145|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
64426146|NCT01636947|Metoclopramide|metoclopramide|mesh-list
64426147|NCT01636947|Granisetron|granisetron|mesh-list
64426148|NCT01636947|Tropisetron|tropisetron|mesh-list
64426149|NCT01636947|Dolasetron|dolasetron|mesh-list
64426150|NCT01636947|Alizapride|alizapride|mesh-list
64426151|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64426152|NCT01636947|BB 1101|bb 1101|mesh-list
64426153|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426154|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
64426155|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
64426156|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426157|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426158|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426159|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
64426160|NCT01636947|Hormones|hormones|mesh-ancestor
64426161|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426162|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426163|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426164|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
64426165|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426166|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426167|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
64426168|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
64426169|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64426170|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
64426171|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426172|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64426173|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64426174|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426175|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64426176|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64426177|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64426178|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64426179|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64426181|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64426183|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64426184|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
64426185|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
64426186|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426187|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426188|NCT04793919|Tretinoin|tretinoin|mesh-list
64426189|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
64426190|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
64426191|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426192|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
64426193|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
64426194|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426195|NCT02817633|Carboplatin|carboplatin|mesh-list
64426196|NCT02817633|Docetaxel|docetaxel|mesh-list
64426213|NCT02775435|Carboplatin|carboplatin|mesh-list
64426214|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
64362254|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
64426224|NCT02774421|Sargramostim|sargramostim|mesh-list
64426225|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426226|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426227|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
64426228|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426229|NCT04791969|Naltrexone|naltrexone|mesh-list
64426230|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64426231|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64426232|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426233|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
64426234|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426235|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
64426236|NCT05651373|Prednisone|prednisone|mesh-list
64426237|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
64426238|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426239|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
64426240|NCT05651373|Hormones|hormones|mesh-ancestor
64426241|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426242|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426243|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426244|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426245|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
64426246|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64426247|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64426248|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426250|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426251|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426252|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426253|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
64426254|NCT03905889|Sunitinib|sunitinib|mesh-list
64426255|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426256|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64426257|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64426258|NCT03905889|Growth Substances|growth substances|mesh-ancestor
64426267|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64426268|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64426269|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
64426270|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426271|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426273|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64426274|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
64426275|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426276|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64426277|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64426278|NCT04803201|Prednisone|prednisone|mesh-list
64426279|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
64426281|NCT04803201|Etoposide|etoposide|mesh-list
64426282|NCT04803201|Vincristine|vincristine|mesh-list
64426283|NCT04803201|Azacitidine|azacitidine|mesh-list
64426284|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426285|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
64426286|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426292|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64426293|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64426294|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64426295|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64426296|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354429|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354438|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354439|NCT03430297|Dacarbazine|dacarbazine|mesh-list
64354440|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64426297|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426298|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
64426299|NCT04803201|Hormones|hormones|mesh-ancestor
64426300|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426301|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426302|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64426303|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
64426304|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
64426305|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
64426306|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64426307|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
64426308|NCT03846765|Phenylephrine|phenylephrine|mesh-list
64426309|NCT03846765|Dobutamine|dobutamine|mesh-list
64426310|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
64426311|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64426312|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
64426313|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
64426314|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426315|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426316|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
64426317|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64426318|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
64426319|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
64426320|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64426321|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64426322|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64426323|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
64426324|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426325|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426340|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426341|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426342|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64426343|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64426344|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426345|NCT04801953|Nimodipine|nimodipine|mesh-list
64426346|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64426347|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64426348|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426349|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426350|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64426351|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426352|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
64426361|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426362|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426363|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
64426364|NCT05190705|Hormones|hormones|mesh-ancestor
64426365|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426366|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426367|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426368|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
64426369|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426370|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426371|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426373|NCT01635153|Trace Elements|trace elements|mesh-list
64426374|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426375|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64426376|NCT04446039|Vortioxetine|vortioxetine|mesh-list
64426377|NCT04446039|Mirtazapine|mirtazapine|mesh-list
64426379|NCT04446039|Bupropion|bupropion|mesh-list
64426380|NCT04446039|Fluoxetine|fluoxetine|mesh-list
64426381|NCT04446039|Paroxetine|paroxetine|mesh-list
64426382|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64426383|NCT04446039|Sertraline|sertraline|mesh-list
64426384|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64426385|NCT04446039|Tianeptine|tianeptine|mesh-list
64426386|NCT04446039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64426387|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64426388|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426410|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64426411|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64426412|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64426413|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
64426415|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64426416|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64426417|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64426418|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
64426419|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64426420|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64426421|NCT04192773|Lidocaine|lidocaine|mesh-list
64426422|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
64426423|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
64426424|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426425|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426435|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426436|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426446|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
64426447|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426448|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426449|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64426450|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
64426451|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426452|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426453|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64426454|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64426455|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426456|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64426457|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64426458|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
64426459|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64426460|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426462|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64426463|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426464|NCT01582191|Everolimus|everolimus|mesh-list
64426465|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426466|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426467|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
64426468|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426470|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64426471|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
64426472|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426473|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426474|NCT01600053|Lenalidomide|lenalidomide|mesh-list
64426475|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
64426476|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426477|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64426478|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64426479|NCT01600053|Growth Substances|growth substances|mesh-ancestor
64426480|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
64426481|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426482|NCT03573297|Cariprazine|cariprazine|mesh-list
64426483|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64426484|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64426485|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426486|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426487|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64426488|NCT03569241|Androgens|androgens|mesh-list
64426489|NCT03569241|Hormones|hormones|mesh-ancestor
64426490|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354447|NCT03344419|Ketamine|ketamine|mesh-list
64426491|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426492|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
64426493|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
64426503|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64426504|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426513|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426514|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426515|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64426516|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
64426517|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426518|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426519|NCT03560349|Lidocaine|lidocaine|mesh-list
64426520|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
64426521|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
64426522|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426523|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426524|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
64426525|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426526|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64426529|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426530|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426531|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64426532|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64426533|NCT00098475|Thalidomide|thalidomide|mesh-list
64426534|NCT00098475|Dexamethasone|dexamethasone|mesh-list
64426535|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
64426536|NCT00098475|Lenalidomide|lenalidomide|mesh-list
64426537|NCT00098475|Ichthammol|ichthammol|mesh-list
64426538|NCT00098475|BB 1101|bb 1101|mesh-list
64426539|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426540|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
64426541|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
64426542|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426543|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426544|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426545|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
64426546|NCT00098475|Hormones|hormones|mesh-ancestor
64426547|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426548|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426549|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426550|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
64426551|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426552|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426553|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
64426554|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64426555|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64426556|NCT00098475|Growth Substances|growth substances|mesh-ancestor
64426557|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
64362341|NCT05196945|Antacids|antacids|mesh-ancestor
64426596|NCT04274361|Analgesics|analgesics|mesh-ancestor
64426597|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
64426598|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426599|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426600|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64426601|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64426602|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
64426603|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
64426604|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426605|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64426606|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64426607|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426608|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426609|NCT04251819|Baclofen|baclofen|mesh-list
64426610|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64426611|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426612|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64426620|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
64426679|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426682|NCT01632891|Tenofovir|tenofovir|mesh-list
64426683|NCT01632891|Emtricitabine|emtricitabine|mesh-list
64426684|NCT01632891|Nevirapine|nevirapine|mesh-list
64426685|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64426686|NCT01632891|Efavirenz|efavirenz|mesh-list
64426687|NCT01632891|Trimethoprim|trimethoprim|mesh-list
64426688|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
64426689|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64426690|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64426691|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
64426692|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426693|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426694|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64426695|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64426696|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
64426697|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426698|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64426699|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64426700|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64426708|NCT01632891|Renal Agents|renal agents|mesh-ancestor
64426709|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
64426710|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64426711|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64426712|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64426713|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64426714|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64426715|NCT02208843|Afatinib|afatinib|mesh-list
64426716|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426717|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64426718|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426719|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426720|NCT02208063|Vancomycin|vancomycin|mesh-list
64426721|NCT02208063|Cefazolin|cefazolin|mesh-list
64426722|NCT02208063|Daptomycin|daptomycin|mesh-list
64426723|NCT02208063|Penicillins|penicillins|mesh-list
64426724|NCT02208063|Cloxacillin|cloxacillin|mesh-list
64426725|NCT02208063|Oxacillin|oxacillin|mesh-list
64426726|NCT02208063|Nafcillin|nafcillin|mesh-list
64426727|NCT02208063|Telavancin|telavancin|mesh-list
64426728|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64426729|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426730|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64426731|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426732|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426733|NCT02207907|Listerine|listerine|mesh-list
64426734|NCT02207907|Fluorides|fluorides|mesh-list
64426735|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
64426736|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
64426738|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426739|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64362452|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64426763|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426764|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
64426765|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64426766|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64426767|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64426775|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426776|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64426778|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426779|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426780|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64426781|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
64426782|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
64426783|NCT02233803|Hormones|hormones|mesh-ancestor
64426784|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426785|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
64426786|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64426787|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64426788|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64362462|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64426796|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426797|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426798|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
64426799|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426800|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64426801|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64426802|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64426803|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426804|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426805|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
64426806|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426807|NCT01632579|Celecoxib|celecoxib|mesh-list
64426808|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64426809|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64426810|NCT01632579|Analgesics|analgesics|mesh-ancestor
64426811|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
64426812|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426813|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426814|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426815|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426816|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64426817|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64426818|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426819|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426820|NCT01632345|Efavirenz|efavirenz|mesh-list
64426823|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64426824|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426825|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426826|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
64426827|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426828|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64426829|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64426830|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64426865|NCT04776369|Analgesics|analgesics|mesh-ancestor
64426866|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
64426867|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64426868|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64426869|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
64426875|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64426877|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
64426878|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426879|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426880|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426881|NCT03155061|Nivolumab|nivolumab|mesh-list
64354477|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
64354478|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426882|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426883|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426884|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64426885|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426886|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
64426887|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64362471|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426902|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64426903|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
64426904|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426905|NCT02202837|Etanercept|etanercept|mesh-list
64426906|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64426907|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64426908|NCT02202837|Analgesics|analgesics|mesh-ancestor
64426909|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
64426910|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426911|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426912|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426913|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426914|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426915|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426916|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
64426917|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
64426918|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64426919|NCT02226549|Ledipasvir|ledipasvir|mesh-list
64426920|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
64426921|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426922|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64426923|NCT02226003|Glimepiride|glimepiride|mesh-list
64426932|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426933|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426934|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64426935|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426936|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
64426937|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64426938|NCT02469519|Dexamethasone|dexamethasone|mesh-list
64426955|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
64426956|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426957|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426958|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64426959|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
64426960|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
64426961|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64426962|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
64426963|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426964|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426966|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64426967|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426968|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426969|NCT02101281|Mitogens|mitogens|mesh-list
64426970|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64426971|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426972|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
64426973|NCT02224599|Imiquimod|imiquimod|mesh-list
64426974|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426975|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
64295632|NCT02414932|Midazolam|midazolam|mesh-list
64426976|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426978|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64426979|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
64426980|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426981|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426982|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64426983|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64426984|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
64426985|NCT04763577|Bradykinin|bradykinin|mesh-list
64426986|NCT04763577|Kininogens|kininogens|mesh-list
64426987|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
64426988|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64426989|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
64426990|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362549|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
64427020|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427021|NCT02434939|Ketamine|ketamine|mesh-list
64427022|NCT02434939|Morphine|morphine|mesh-list
64427023|NCT02434939|Analgesics|analgesics|mesh-ancestor
64427024|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
64427025|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427026|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427027|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64427028|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64427029|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
64427030|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
64427031|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427032|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64427033|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64427034|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427035|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427036|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64427037|NCT02434939|Narcotics|narcotics|mesh-ancestor
64427038|NCT02457325|Carticaine|carticaine|mesh-list
64427039|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
64427040|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
64427041|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427042|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427044|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427046|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427047|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427048|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64427049|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427050|NCT02222493|Infliximab|infliximab|mesh-list
64427051|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
64427052|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427053|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427054|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64427055|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
64427056|NCT01439997|Coagulants|coagulants|mesh-ancestor
64362562|NCT02475421|Hormones|hormones|mesh-ancestor
64427077|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64427078|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
64427079|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
64427080|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427081|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427082|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427083|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
64427084|NCT02198235|Hormones|hormones|mesh-ancestor
64427085|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427086|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64427087|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427088|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64427089|NCT02198235|Narcotics|narcotics|mesh-ancestor
64427090|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427091|NCT02198235|Analgesics|analgesics|mesh-ancestor
64427092|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
64427093|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64427094|NCT00346125|Doxorubicin|doxorubicin|mesh-list
64354509|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
64427095|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64427096|NCT00346125|Ifosfamide|ifosfamide|mesh-list
64427097|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64427098|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64427099|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427100|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64427101|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64427102|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427103|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427104|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64427105|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
64427106|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64427108|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64427109|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
64427117|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
64427118|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427119|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427120|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64427139|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427140|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
64427141|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
64295653|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
64427142|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
64427143|NCT02399449|Hematinics|hematinics|mesh-ancestor
64427144|NCT02217345|Hormones|hormones|mesh-list
64427145|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427146|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427147|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64427148|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427149|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427150|NCT02428855|Dasatinib|dasatinib|mesh-list
64427151|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427152|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64427153|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427154|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427155|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
64427156|NCT02428699|Liver Extracts|liver extracts|mesh-list
64427157|NCT02428699|Hematinics|hematinics|mesh-ancestor
64427158|NCT02428699|Vitamins|vitamins|mesh-ancestor
64427159|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
64427160|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427161|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64427162|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
64427163|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427164|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
64427165|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427166|NCT02427841|Gemcitabine|gemcitabine|mesh-list
64427167|NCT02427841|Paclitaxel|paclitaxel|mesh-list
64427168|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64427169|NCT02427841|Fluorouracil|fluorouracil|mesh-list
64427170|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64427171|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427172|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
64427173|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
64427174|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
64427175|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427176|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427177|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
64427190|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64362639|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
64362640|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64362641|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64362642|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64427197|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427198|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427199|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64427200|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64427201|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64427202|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64427203|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64427204|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
64354535|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64427205|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
64427207|NCT02396953|Somatostatin|somatostatin|mesh-list
64427208|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427209|NCT02396953|Hormones|hormones|mesh-ancestor
64427210|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427211|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427212|NCT02387983|Posaconazole|posaconazole|mesh-list
64427213|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
64427216|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64427217|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64427218|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64427219|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64427220|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427221|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427222|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64427223|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
64427224|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427225|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427226|NCT05370313|Nicotine|nicotine|mesh-list
64427227|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64427228|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
64427229|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427230|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427231|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64427232|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64427233|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
64362654|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64362655|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362657|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64362658|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64362659|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362660|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
64362661|NCT05713045|Coagulants|coagulants|mesh-ancestor
64362662|NCT05713045|Vitamins|vitamins|mesh-ancestor
64427263|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
64427264|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
64427265|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427266|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427267|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64427268|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64427269|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64427270|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
64427271|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427272|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427274|NCT02426125|Ramucirumab|ramucirumab|mesh-list
64427275|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427276|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
64427277|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
64427278|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
64427279|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427280|NCT02425111|Vedolizumab|vedolizumab|mesh-list
64427281|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427282|NCT02393755|Capecitabine|capecitabine|mesh-list
64427283|NCT02393755|Nintedanib|nintedanib|mesh-list
64427284|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427285|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
64427286|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427287|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427288|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64427289|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427290|NCT02393209|Docetaxel|docetaxel|mesh-list
64427323|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
64427324|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64427325|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64427326|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64427327|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64427328|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427329|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427330|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
64427331|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427332|NCT02422303|Ketamine|ketamine|mesh-list
64427333|NCT02422303|Analgesics|analgesics|mesh-ancestor
64427334|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
64427335|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427347|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64362681|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64362682|NCT05249569|Avelumab|avelumab|mesh-list
64427354|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427355|NCT02384395|Lamivudine|lamivudine|mesh-list
64427356|NCT02384395|Abacavir|abacavir|mesh-list
64427357|NCT02384395|Dolutegravir|dolutegravir|mesh-list
64427358|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64427359|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64427360|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427361|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427362|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
64427363|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427364|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64427365|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64427366|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64427367|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64427368|NCT02391337|Digoxin|digoxin|mesh-list
64427369|NCT02391337|Bisoprolol|bisoprolol|mesh-list
64427370|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64427371|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64427372|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427373|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427374|NCT02391337|Protective Agents|protective agents|mesh-ancestor
64427375|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427376|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64427377|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
64427378|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
64427379|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427380|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64427381|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64427382|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64427383|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
64427384|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427385|NCT01649791|Lenalidomide|lenalidomide|mesh-list
64427386|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
64427387|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427388|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64427390|NCT01649791|Growth Substances|growth substances|mesh-ancestor
64427391|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
64427392|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427393|NCT02347657|Ivacaftor|ivacaftor|mesh-list
64427394|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64427395|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362700|NCT05244577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64427422|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64427423|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64427424|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
64427426|NCT02345161|Albuterol|albuterol|mesh-list
64427427|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
64427428|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64427429|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64427430|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64427431|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
64427432|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427433|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427434|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64427435|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
64427436|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
64427437|NCT02345161|Hormones|hormones|mesh-ancestor
64427438|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427439|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64427440|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64354606|NCT03173053|Rifampin|rifampin|mesh-list
64354607|NCT03173053|Clindamycin|clindamycin|mesh-list
64354608|NCT03173053|Trimethoprim|trimethoprim|mesh-list
64354609|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
64354610|NCT03173053|Mupirocin|mupirocin|mesh-list
64427441|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64427442|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
64427443|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427471|NCT02195583|Trace Elements|trace elements|mesh-ancestor
64427472|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
64427473|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64427474|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427475|NCT02379091|Leucovorin|leucovorin|mesh-list
64427476|NCT02379091|Folic Acid|folic acid|mesh-list
64427477|NCT02379091|Methotrexate|methotrexate|mesh-list
64427478|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
64427479|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64427480|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
64427481|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427482|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427483|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427484|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
64427485|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427486|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362789|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
64362857|NCT02725411|Tanezumab|tanezumab|mesh-list
64427530|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427531|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64427532|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64427533|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64427534|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427535|NCT02213055|Permethrin|permethrin|mesh-list
64427536|NCT02213055|Malathion|malathion|mesh-list
64427537|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427538|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427539|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64427540|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
64427541|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427542|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427543|NCT02309515|Lenalidomide|lenalidomide|mesh-list
64427544|NCT02309515|Vaccines|vaccines|mesh-list
64427545|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
64427552|NCT02309359|Methotrexate|methotrexate|mesh-list
64427553|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64427554|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
64427555|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427556|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427557|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64354611|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
64354645|NCT03109795|Clonidine|clonidine|mesh-list
64427558|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
64427559|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427560|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427561|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
64427562|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427563|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64427564|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427565|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
64427566|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427567|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64427579|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64427580|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427581|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427582|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64295686|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295687|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64295693|NCT02054143|Sevoflurane|sevoflurane|mesh-list
64295694|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64427584|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427585|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427586|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64427588|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64427589|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
64427590|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427591|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427592|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64427593|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427595|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
64427596|NCT02193165|Fluorides|fluorides|mesh-list
64427597|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
64427598|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
64427599|NCT02193165|Protective Agents|protective agents|mesh-ancestor
64427600|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427601|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64427602|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427603|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64427604|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64427605|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
64427606|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427607|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64427608|NCT01617460|Aripiprazole|aripiprazole|mesh-list
64427609|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
64427610|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64427611|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64427612|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64427613|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427641|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
64427643|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427645|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
64427646|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427647|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
64427648|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
64427649|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
64427650|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427651|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427653|NCT01618162|Xultophy|xultophy|mesh-list
64354683|NCT03422575|Etoricoxib|etoricoxib|mesh-list
64354714|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
64354716|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354718|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354719|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64427654|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64427655|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427656|NCT01618162|Incretins|incretins|mesh-ancestor
64427657|NCT01618162|Hormones|hormones|mesh-ancestor
64427658|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427659|NCT04771767|Ketamine|ketamine|mesh-list
64427660|NCT04771767|Analgesics|analgesics|mesh-ancestor
64427661|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
64427662|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427663|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427673|NCT02341417|Cinacalcet|cinacalcet|mesh-list
64427683|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427684|NCT02340949|Antidotes|antidotes|mesh-ancestor
64427685|NCT02340949|Protective Agents|protective agents|mesh-ancestor
64427686|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427687|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
64427688|NCT02340949|Vitamins|vitamins|mesh-ancestor
64427689|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
64362973|NCT05035953|Edaravone|edaravone|mesh-list
64427690|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64427691|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64427692|NCT02340949|Growth Substances|growth substances|mesh-ancestor
64427693|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
64354720|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64354721|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64427694|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
64427695|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427696|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427697|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427698|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
64427699|NCT02374957|Cilostazol|cilostazol|mesh-list
64427700|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64427701|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
64427702|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427703|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427704|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64427705|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
64427706|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64427707|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64427708|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427709|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64427710|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
64427711|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64427712|NCT02374957|Protective Agents|protective agents|mesh-ancestor
64427713|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64427714|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64427715|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427716|NCT02308033|Metronidazole|metronidazole|mesh-list
64427717|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427718|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64427719|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64427720|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64354724|NCT03128203|Oxytocin|oxytocin|mesh-list
64427721|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
64427722|NCT02339155|Promethazine|promethazine|mesh-list
64427726|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427727|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
64363081|NCT05306431|Biguanides|biguanides|mesh-list
64427754|NCT02169219|Prednisone|prednisone|mesh-list
64427755|NCT02169219|Rituximab|rituximab|mesh-list
64427756|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
64354756|NCT03463993|Coagulants|coagulants|mesh-ancestor
64427757|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427758|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427759|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
64427760|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427761|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427762|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64427763|NCT02169219|Hormones|hormones|mesh-ancestor
64354758|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64354759|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354760|NCT03417037|Nivolumab|nivolumab|mesh-list
64354761|NCT03417037|Linrodostat|linrodostat|mesh-list
64354762|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427764|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427765|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64427766|NCT04750473|Edetic Acid|edetic acid|mesh-list
64427767|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64427768|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
64427769|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
64427770|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427771|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
64427772|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64427773|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64427774|NCT02191137|Riociguat|riociguat|mesh-list
64427775|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
64427776|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427777|NCT02168439|Midazolam|midazolam|mesh-list
64427778|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
64427779|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64427780|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427781|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427782|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64427783|NCT02168439|Analgesics|analgesics|mesh-ancestor
64427805|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
64427806|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427807|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427808|NCT02374099|Azacitidine|azacitidine|mesh-list
64427809|NCT02374099|Fulvestrant|fulvestrant|mesh-list
64427811|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427812|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
64427813|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427814|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427815|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427816|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64427817|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64427818|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64427819|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
64427820|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427821|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427823|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64427824|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
64427825|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427826|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427827|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64427829|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
64427830|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
64427831|NCT02374021|Adalimumab|adalimumab|mesh-list
64427832|NCT02374021|Etanercept|etanercept|mesh-list
64427833|NCT02374021|Methotrexate|methotrexate|mesh-list
64427834|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64427835|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
64427836|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427837|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427838|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427868|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
64427870|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64427871|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427872|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427873|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64427874|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64427875|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64427876|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64427877|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64427878|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64427879|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427880|NCT01648699|Hydromorphone|hydromorphone|mesh-list
64427881|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64427882|NCT01648699|Narcotics|narcotics|mesh-ancestor
64427896|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
64427897|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
64427898|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
64427899|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427900|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427901|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64427902|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64427903|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
64427904|NCT01362790|Pentostatin|pentostatin|mesh-list
64427905|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64427906|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427907|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
64427908|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427909|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427923|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427924|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
64427925|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64427926|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64427927|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
64427928|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427929|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427930|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427931|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64427932|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64427933|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64427934|NCT01615198|Olmesartan|olmesartan|mesh-list
64427935|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64427936|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64427937|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64427938|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64427939|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427940|NCT02337907|Donepezil|donepezil|mesh-list
64427941|NCT02337907|BI 409306|bi 409306|mesh-list
64427942|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64427943|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427949|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64427950|NCT01913470|Losartan|losartan|mesh-list
64427951|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64427952|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64354775|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
64354777|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64354814|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354815|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427953|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64427954|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64427964|NCT02132949|Paclitaxel|paclitaxel|mesh-list
64427965|NCT02132949|Docetaxel|docetaxel|mesh-list
64427966|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
64427968|NCT02132949|Fluorouracil|fluorouracil|mesh-list
64427969|NCT02132949|Trastuzumab|trastuzumab|mesh-list
64427970|NCT02132949|Epirubicin|epirubicin|mesh-list
64427971|NCT02132949|Pertuzumab|pertuzumab|mesh-list
64427972|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64427973|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427974|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
64427975|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
64427976|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
64427977|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427978|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427979|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
64427980|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427981|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427982|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64427983|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
64427984|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64427985|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64427986|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64427987|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64427988|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427989|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
64427990|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64427991|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427992|NCT02165397|Rituximab|rituximab|mesh-list
64427993|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427994|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427995|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
64427996|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427997|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427998|NCT02132637|Insulin|insulin|mesh-list
64427999|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64428000|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
64428001|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64428002|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428003|NCT02164929|Acetaminophen|acetaminophen|mesh-list
64428004|NCT02164929|Dexamethasone|dexamethasone|mesh-list
64363292|NCT01141309|Everolimus|everolimus|mesh-list
64363293|NCT01141309|Sorafenib|sorafenib|mesh-list
64363320|NCT03309163|Narcotics|narcotics|mesh-ancestor
64295735|NCT02054299|Thiamine|thiamine|mesh-list
64428013|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
64428014|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
64428015|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428016|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428021|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64428022|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428023|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
64428024|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
64428025|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428026|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
64428027|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64428028|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64428029|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64428030|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64428031|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428032|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64428033|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64428034|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
64428035|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64428036|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64428038|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64428039|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
64428040|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
64428041|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428042|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428043|NCT02164929|Analgesics|analgesics|mesh-ancestor
64428044|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
64428045|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64428046|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64428047|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64428048|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64428049|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428050|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64428051|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64428052|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64428053|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428054|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
64428055|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
64428056|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64428057|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64428058|NCT02164929|Narcotics|narcotics|mesh-ancestor
64428060|NCT01888432|Tacrolimus|tacrolimus|mesh-list
64428061|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428062|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
64428063|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428064|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64428065|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428066|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428067|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428068|NCT02188719|Acetaminophen|acetaminophen|mesh-list
64428069|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
64428070|NCT02188719|Promethazine|promethazine|mesh-list
64428071|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
64428073|NCT02188719|Ganciclovir|ganciclovir|mesh-list
64428074|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
64428075|NCT02188719|Prednisone|prednisone|mesh-list
64428076|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64428077|NCT02188719|Everolimus|everolimus|mesh-list
64428078|NCT02188719|Liver Extracts|liver extracts|mesh-list
64428079|NCT02188719|Tacrolimus|tacrolimus|mesh-list
64428080|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
64428081|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64428082|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428083|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
64428085|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428086|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428087|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64428088|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363411|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428120|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64428121|NCT02188719|Protective Agents|protective agents|mesh-ancestor
64428122|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64428123|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64428124|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428126|NCT01933672|Hormones|hormones|mesh-ancestor
64428127|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428128|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64428129|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
64428130|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428131|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428132|NCT02132247|Diclofenac|diclofenac|mesh-list
64354847|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
64354857|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
64354858|NCT02900443|Azathioprine|azathioprine|mesh-list
64428133|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
64428134|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64428135|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428137|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
64428138|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428139|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428140|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428141|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428142|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64428143|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428144|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428145|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
64428146|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64428147|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
64428148|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64428164|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428165|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64428166|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428167|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
64428169|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428189|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64354859|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64428190|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
64428191|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428192|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64428193|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64428194|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428195|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428196|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64428197|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64428228|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64428229|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428230|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
64428231|NCT02531633|Hormones|hormones|mesh-ancestor
64428232|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428233|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428234|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64428235|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428236|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
64428237|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
64428238|NCT02536313|Velpatasvir|velpatasvir|mesh-list
64428239|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
64428240|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428241|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
64428242|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64428243|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
64428244|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
64428245|NCT05412875|Nicotine|nicotine|mesh-list
64428246|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64428247|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
64428248|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428249|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428250|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64428251|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64428252|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
64428253|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428254|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354860|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428255|NCT02187861|Rituximab|rituximab|mesh-list
64428256|NCT02187861|Venetoclax|venetoclax|mesh-list
64428257|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64428259|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354904|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64354905|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64354906|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428260|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
64428261|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428262|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428263|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64428273|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64428274|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
64428275|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
64428276|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428277|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64428278|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64428279|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428280|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428281|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64428282|NCT05379179|Narcotics|narcotics|mesh-ancestor
64428283|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64428291|NCT05610527|Etonogestrel|etonogestrel|mesh-list
64428292|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64428293|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
64428302|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
64428303|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428304|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64428305|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64428306|NCT05381753|Growth Substances|growth substances|mesh-ancestor
64428307|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428308|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
64428309|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64428310|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428311|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428312|NCT02527421|Betamethasone|betamethasone|mesh-list
64428313|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428314|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
64428316|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428317|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428318|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64428319|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428320|NCT05610371|Lidocaine|lidocaine|mesh-list
64428321|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
64428322|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
64428323|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428324|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428325|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
64428326|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428327|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64428328|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64428333|NCT02163759|Etrolizumab|etrolizumab|mesh-list
64428334|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428335|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428336|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64428337|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
64428338|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354907|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
64428339|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64428340|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64428341|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428342|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
64428343|NCT02163447|Piperaquine|piperaquine|mesh-list
64428344|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
64428345|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64428346|NCT02163447|Artenimol|artenimol|mesh-list
64428347|NCT02163447|Artemisinins|artemisinins|mesh-list
64428348|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
64428349|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64428361|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64428363|NCT01887418|Hormones|hormones|mesh-ancestor
64428364|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428365|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428366|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64428367|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428368|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
64428369|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64428370|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64428371|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64428372|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64428373|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428374|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428375|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428376|NCT01912612|Analgesics|analgesics|mesh-ancestor
64428377|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
64428378|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428379|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
64428380|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64428381|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
64428383|NCT02302807|Docetaxel|docetaxel|mesh-list
64428384|NCT02302807|Atezolizumab|atezolizumab|mesh-list
64428385|NCT02302807|Antibodies|antibodies|mesh-list
64428386|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64428387|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428388|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
64428389|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
64428390|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
64428391|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428392|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
64428393|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428394|NCT05342519|Sirolimus|sirolimus|mesh-list
64428395|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64428396|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428397|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64428423|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64428425|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428426|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64428427|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428428|NCT04251065|Daratumumab|daratumumab|mesh-list
64428429|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428430|NCT01885936|Albuterol|albuterol|mesh-list
64428431|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64428432|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
64428433|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428434|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428435|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64428436|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428437|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
64428438|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64428439|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64428440|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64428441|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64428442|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428443|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428444|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428445|NCT05305859|Azacitidine|azacitidine|mesh-list
64428446|NCT05305859|Venetoclax|venetoclax|mesh-list
64428447|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64428448|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
64428449|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428450|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428451|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428452|NCT05368415|Norepinephrine|norepinephrine|mesh-list
64428453|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64428454|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64428455|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428456|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428457|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363835|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
64428500|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
64428501|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428509|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428510|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428511|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64428513|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428514|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
64428515|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428516|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428518|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64428519|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428520|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
64428521|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
64428522|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
64428523|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428524|NCT05366933|Folic Acid|folic acid|mesh-list
64428525|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
64428526|NCT05366933|Vitamins|vitamins|mesh-ancestor
64428529|NCT05366933|Hematinics|hematinics|mesh-ancestor
64428530|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64428531|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
64428532|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64428533|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428534|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428535|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428536|NCT05500703|Analgesics|analgesics|mesh-ancestor
64428537|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
64428538|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428539|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64355033|NCT03426085|Liraglutide|liraglutide|mesh-list
64428540|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64428541|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64428542|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428543|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428544|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428545|NCT04246151|Vancomycin|vancomycin|mesh-list
64428546|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64428547|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428548|NCT05331521|Vincristine|vincristine|mesh-list
64428549|NCT05331521|Temozolomide|temozolomide|mesh-list
64428550|NCT05331521|Lomustine|lomustine|mesh-list
64428551|NCT05331521|Procarbazine|procarbazine|mesh-list
64428588|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64428589|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64428591|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64428592|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
64428593|NCT05363267|Curcumin|curcumin|mesh-list
64363844|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428595|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428596|NCT05363267|Analgesics|analgesics|mesh-ancestor
64428597|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
64428598|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428599|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428600|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428601|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428602|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428603|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428604|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428606|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428607|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64428608|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
64428609|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428610|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428611|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64428612|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428613|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
64428614|NCT04422275|Hormones|hormones|mesh-ancestor
64428615|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428616|NCT05361941|Tobramycin|tobramycin|mesh-list
64428617|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64428618|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428619|NCT05290025|Nicotine|nicotine|mesh-list
64428620|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64428621|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
64428622|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428623|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428624|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64428625|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64428626|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
64428627|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428628|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428629|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
64428630|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64428631|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428640|NCT05359055|Itraconazole|itraconazole|mesh-list
64428641|NCT05359055|Rifampin|rifampin|mesh-list
64428642|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
64428643|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428644|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64428645|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64428646|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428647|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428648|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64428649|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
64428650|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428651|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428652|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64428653|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64428654|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
64428655|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64428656|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
64428657|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64428666|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64428667|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428668|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
64428669|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428670|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428672|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64428673|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428674|NCT02524145|Isoproterenol|isoproterenol|mesh-list
64428675|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
64428676|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
64428677|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64428678|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428679|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428680|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428681|NCT02524145|Analgesics|analgesics|mesh-ancestor
64428682|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
64428683|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428684|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64428685|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64428686|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64428687|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428688|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428689|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428690|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64428691|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64428692|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64428693|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
64428704|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428705|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64428706|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64428707|NCT05357417|Growth Substances|growth substances|mesh-ancestor
64428708|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428709|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
64428710|NCT01658813|Interferons|interferons|mesh-list
64428711|NCT01658813|Fluorouracil|fluorouracil|mesh-list
64428712|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
64428713|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428714|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64428715|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428716|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363906|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
64428725|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428726|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
64428727|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64428728|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64355065|NCT01239797|Lenalidomide|lenalidomide|mesh-list
64355066|NCT01239797|Elotuzumab|elotuzumab|mesh-list
64355067|NCT01239797|BB 1101|bb 1101|mesh-list
64355068|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64355069|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
64355070|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
64355071|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355072|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355073|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355074|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
64355075|NCT01239797|Hormones|hormones|mesh-ancestor
64428729|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428730|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64428731|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64428732|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64428733|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428734|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64428735|NCT02525471|RNS60|rns60|mesh-list
64428736|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64428737|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428738|NCT02525471|Analgesics|analgesics|mesh-ancestor
64428739|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
64428740|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428741|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428742|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428743|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428744|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64428746|NCT05323487|Diuretics|diuretics|mesh-ancestor
64428747|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
64428748|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428749|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64428750|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64428751|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428752|NCT05284409|Acetaminophen|acetaminophen|mesh-list
64428753|NCT05284409|Dexamethasone|dexamethasone|mesh-list
64428754|NCT05284409|Meperidine|meperidine|mesh-list
64428755|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64428756|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
64428757|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
64428758|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428780|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428781|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
64428782|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64428783|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428784|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428785|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428786|NCT05283083|Analgesics|analgesics|mesh-ancestor
64428787|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
64428788|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428789|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64428790|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64428791|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64428792|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428793|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363930|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
64428794|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428801|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64428802|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64428804|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428805|NCT02187159|Pregabalin|pregabalin|mesh-list
64428806|NCT02187159|Analgesics|analgesics|mesh-ancestor
64428807|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
64428808|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428809|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428810|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
64428811|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64428835|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64428836|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
64428837|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428838|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64428839|NCT02124759|Sevelamer|sevelamer|mesh-list
64428840|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
64428841|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
64428842|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428843|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
64428844|NCT02302339|Nivolumab|nivolumab|mesh-list
64428845|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
64428846|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64428847|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64428848|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428849|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64355112|NCT02735707|Apremilast|apremilast|mesh-list
64355114|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64355115|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64355116|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64355117|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64355118|NCT02735707|Losartan|losartan|mesh-list
64428850|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428851|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
64428852|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428853|NCT04895917|Daratumumab|daratumumab|mesh-list
64428854|NCT04895917|Pomalidomide|pomalidomide|mesh-list
64428855|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428856|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
64428857|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428858|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64428859|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64428860|NCT04895917|Growth Substances|growth substances|mesh-ancestor
64428861|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
64428873|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428874|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64428875|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64428876|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64428877|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64428878|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
64428880|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
64428881|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
64428882|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428883|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428884|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
64428885|NCT02159469|Testosterone|testosterone|mesh-list
64428886|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
64428887|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
64428888|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64363941|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428903|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
64428904|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428905|NCT02123511|Protective Agents|protective agents|mesh-ancestor
64428906|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428907|NCT02123511|Antidotes|antidotes|mesh-ancestor
64428908|NCT04746339|Apixaban|apixaban|mesh-list
64428909|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64428910|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
64428911|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64428912|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
64428913|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428914|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428915|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
64428916|NCT02301403|Nicotine|nicotine|mesh-list
64428917|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64428918|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
64428919|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428920|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428921|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64428922|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64428923|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
64363971|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
64428944|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64428945|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64428946|NCT02120469|Everolimus|everolimus|mesh-list
64428947|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428948|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428949|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
64428950|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428951|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
64428952|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64428953|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428954|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
64428955|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
64428956|NCT02120157|Busulfan|busulfan|mesh-list
64428957|NCT02120157|Tacrolimus|tacrolimus|mesh-list
64428958|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428959|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
64428960|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428961|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428962|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64428963|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
64428964|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428965|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428966|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64428967|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64428968|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428969|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64428970|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64428971|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
64428972|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364023|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428973|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428974|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64428975|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
64428976|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428977|NCT02155881|Ciclesonide|ciclesonide|mesh-list
64428978|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
64428980|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428981|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428982|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64428983|NCT05279807|Amlodipine|amlodipine|mesh-list
64428985|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64428986|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64428987|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64428988|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428989|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64428990|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428991|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
64429019|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64429021|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64429022|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
64429023|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64429024|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429025|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64429026|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64429027|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429028|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429029|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
64429030|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64429031|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
64429032|NCT05268497|Esketamine|esketamine|mesh-list
64429033|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429034|NCT02155647|Avelumab|avelumab|mesh-list
64429035|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429036|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429037|NCT05266859|Calcium|calcium|mesh-list
64429038|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64429039|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429040|NCT05346731|Dexamethasone|dexamethasone|mesh-list
64355123|NCT02735707|Olmesartan|olmesartan|mesh-list
64355176|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64355177|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64355178|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
64355179|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64355180|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64429041|NCT05346731|Ondansetron|ondansetron|mesh-list
64429042|NCT05346731|Olanzapine|olanzapine|mesh-list
64429043|NCT05346731|Aprepitant|aprepitant|mesh-list
64429044|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429045|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
64429046|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
64429047|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429048|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429049|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64429050|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
64429051|NCT05346731|Hormones|hormones|mesh-ancestor
64429052|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429053|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429063|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429064|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429065|NCT05346731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64429066|NCT05346731|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64429067|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64429068|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429069|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64429071|NCT02118597|Ribavirin|ribavirin|mesh-list
64429072|NCT02118597|Simeprevir|simeprevir|mesh-list
64429073|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429082|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64429083|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64429084|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429085|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
64429086|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
64429087|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429088|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429090|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
64429091|NCT05218889|Antiviral Agents|antiviral agents|mesh-ancestor
64429092|NCT05218889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429093|NCT05218889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429094|NCT05218889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429095|NCT05218889|Immunologic Factors|immunologic factors|mesh-ancestor
64429096|NCT05218889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429098|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429099|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64429100|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429101|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429102|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64429103|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64429104|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
64429105|NCT02117349|Coagulants|coagulants|mesh-ancestor
64429106|NCT05211791|Anesthetics|anesthetics|mesh-list
64429107|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429108|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429109|NCT02177175|Carvedilol|carvedilol|mesh-list
64429110|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64429111|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64429112|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429113|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429114|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429115|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429116|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64429117|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
64429118|NCT02177175|Protective Agents|protective agents|mesh-ancestor
64429119|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64429128|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
64355181|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64429129|NCT05254925|Petrolatum|petrolatum|mesh-list
64429130|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64429131|NCT05254925|Protective Agents|protective agents|mesh-ancestor
64429132|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429133|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429135|NCT05205473|Lidocaine|lidocaine|mesh-list
64429136|NCT05205473|Anesthetics|anesthetics|mesh-list
64429137|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
64429138|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364040|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429139|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364041|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429146|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429148|NCT05253053|Atezolizumab|atezolizumab|mesh-list
64429149|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64429150|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429151|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
64429152|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
64429153|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429154|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429155|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64429156|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64429157|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64429158|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429159|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429160|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64429161|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429162|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429163|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
64429164|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429165|NCT05252429|Docetaxel|docetaxel|mesh-list
64429166|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
64429167|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429168|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
64429169|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
64429170|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429171|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429172|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429173|NCT05158517|Vedolizumab|vedolizumab|mesh-list
64429174|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64429175|NCT05157971|Cytarabine|cytarabine|mesh-list
64429176|NCT05157971|Prednisone|prednisone|mesh-list
64429177|NCT05157971|Cortisone|cortisone|mesh-list
64429178|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
64429179|NCT05157971|Methotrexate|methotrexate|mesh-list
64429180|NCT05157971|Vincristine|vincristine|mesh-list
64429181|NCT05157971|Daunorubicin|daunorubicin|mesh-list
64429182|NCT05157971|Venetoclax|venetoclax|mesh-list
64364064|NCT03337087|Leucovorin|leucovorin|mesh-list
64429183|NCT05157971|Asparaginase|asparaginase|mesh-list
64429184|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
64429185|NCT05157971|Pegaspargase|pegaspargase|mesh-list
64364065|NCT03337087|Folic Acid|folic acid|mesh-list
64429246|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429247|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429248|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429249|NCT02116803|Fulvestrant|fulvestrant|mesh-list
64429250|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429251|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429252|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64429253|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64429254|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
64429255|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429256|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429257|NCT02115321|Grazoprevir|grazoprevir|mesh-list
64429258|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
64429259|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429260|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
64429261|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429262|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429263|NCT05248139|Prednisolone|prednisolone|mesh-list
64429264|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64429265|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
64429266|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64429267|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
64429268|NCT05248139|Triamcinolone|triamcinolone|mesh-list
64429278|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429279|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429281|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
64429282|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429283|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64429284|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64429285|NCT05248139|Protective Agents|protective agents|mesh-ancestor
64429286|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429287|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
64429288|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64355196|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355197|NCT01092143|Fluticasone|fluticasone|mesh-list
64355198|NCT01092143|Xhance|xhance|mesh-list
64429289|NCT05247125|Melatonin|melatonin|mesh-list
64429290|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429291|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
64429292|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429312|NCT05245877|Dalteparin|dalteparin|mesh-list
64429313|NCT05245877|Tinzaparin|tinzaparin|mesh-list
64429314|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64429315|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
64429316|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64429317|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64429318|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429319|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
64429320|NCT02367781|Paclitaxel|paclitaxel|mesh-list
64429321|NCT02367781|Carboplatin|carboplatin|mesh-list
64429322|NCT02367781|Pemetrexed|pemetrexed|mesh-list
64429323|NCT02367781|Atezolizumab|atezolizumab|mesh-list
64429324|NCT02367781|Antibodies|antibodies|mesh-list
64429325|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64429326|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64429327|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429328|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
64429329|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
64429330|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429331|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429332|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
64429333|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429334|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429335|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64429336|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64429337|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
64429338|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429339|NCT04242173|Cemiplimab|cemiplimab|mesh-list
64429340|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429341|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429342|NCT05189015|Olmesartan|olmesartan|mesh-list
64429343|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64429344|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64429345|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64429346|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64429347|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429349|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
64429350|NCT05239091|Anesthetics|anesthetics|mesh-list
64429373|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355199|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64355201|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
64429374|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64429375|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
64429376|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429377|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64429379|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64429380|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64429381|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429382|NCT01656395|Montelukast|montelukast|mesh-list
64429383|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64429384|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
64429385|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64429386|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
64429387|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429388|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429389|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64429390|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64429391|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429392|NCT02114931|Adalimumab|adalimumab|mesh-list
64429393|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429394|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64429395|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
64429396|NCT05185739|Lenvatinib|lenvatinib|mesh-list
64429397|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429398|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429399|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64429400|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429408|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429409|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
64429410|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429411|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64429412|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64429413|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429414|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64429415|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64429416|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429417|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429436|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
64429437|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429438|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429439|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429440|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
64429442|NCT02300311|Nonivamide|nonivamide|mesh-list
64429443|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
64429444|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429445|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429446|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
64429447|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429448|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
64429449|NCT02300311|Vitamins|vitamins|mesh-ancestor
64429450|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
64429451|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64429452|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429453|NCT05140499|Bupivacaine|bupivacaine|mesh-list
64429454|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
64429455|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
64429456|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429457|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429458|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
64429459|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429460|NCT04229381|Coal Tar|coal tar|mesh-list
64429461|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
64429462|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429463|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64429464|NCT05178485|Bupivacaine|bupivacaine|mesh-list
64429465|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
64429466|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
64429467|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429487|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355219|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429488|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429489|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64429490|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
64416624|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429491|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429492|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429493|NCT05227937|Amikacin|amikacin|mesh-list
64429494|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64429495|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429496|NCT05174039|Miglustat|miglustat|mesh-list
64429497|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429498|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429499|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64429500|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64429501|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
64429502|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429503|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64429504|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429505|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429506|NCT05138549|Beta Carotene|beta carotene|mesh-list
64429507|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429508|NCT05138549|Provitamins|provitamins|mesh-ancestor
64429510|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
64429511|NCT04241549|Azacitidine|azacitidine|mesh-list
64429512|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64429513|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
64429514|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429515|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429516|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429517|NCT02175225|Deferoxamine|deferoxamine|mesh-list
64429518|NCT02175225|Siderophores|siderophores|mesh-ancestor
64429519|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64429520|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
64429521|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
64429522|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429523|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64429524|NCT05170841|Tramadol|tramadol|mesh-list
64429525|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64429526|NCT05170841|Narcotics|narcotics|mesh-ancestor
64429527|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429528|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429529|NCT05170841|Analgesics|analgesics|mesh-ancestor
64429559|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429560|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429561|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429562|NCT02151591|Varenicline|varenicline|mesh-list
64429563|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64429564|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64429565|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
64429566|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364259|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64429567|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364263|NCT03372473|Loratadine|loratadine|mesh-list
64429593|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
64429594|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64429595|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
64429596|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
64429597|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429598|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429599|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429600|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429601|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64429602|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64429603|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429604|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
64429605|NCT02114385|Vaccines|vaccines|mesh-list
64429606|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
64355222|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429607|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429608|NCT05098457|Lidocaine|lidocaine|mesh-list
64429609|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
64429610|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
64429611|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429612|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429613|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
64429614|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429615|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64429618|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429619|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429620|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
64429621|NCT02114151|Simeprevir|simeprevir|mesh-list
64429622|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
64429623|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429624|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
64429625|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429626|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429627|NCT05220293|Betamethasone|betamethasone|mesh-list
64429628|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
64429629|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64429630|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
64364283|NCT03289429|Atorvastatin|atorvastatin|mesh-list
64429728|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64429729|NCT02112045|Melphalan|melphalan|mesh-list
64429731|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
64429732|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429733|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429734|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64429746|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429747|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429748|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429749|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429750|NCT01655693|Doxorubicin|doxorubicin|mesh-list
64429751|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64429752|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64429753|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429754|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64429755|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64429756|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429757|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429759|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64429760|NCT05090657|Methylene Blue|methylene blue|mesh-list
64429761|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64429762|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429763|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
64429764|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429765|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429766|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429767|NCT05048849|Somatomedin B|somatomedin b|mesh-list
64429768|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64429769|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64429770|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
64429771|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429772|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429773|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64429774|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
64429775|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64429776|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
64429777|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64429778|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429779|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64429780|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429781|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429783|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64364302|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
64429831|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429832|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
64429833|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64429834|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64429835|NCT04751877|Growth Substances|growth substances|mesh-ancestor
64429836|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
64355240|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
64355241|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
64429856|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429857|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429859|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
64429860|NCT02520011|Alvocidib|alvocidib|mesh-list
64429861|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64429862|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
64429863|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429864|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429865|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
64429866|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429867|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429868|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
64429869|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429870|NCT02520011|Analgesics|analgesics|mesh-ancestor
64429871|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
64429872|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429873|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64429874|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64429875|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429876|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
64429877|NCT02520011|Growth Substances|growth substances|mesh-ancestor
64429878|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64429879|NCT05037539|Fentanyl|fentanyl|mesh-list
64429880|NCT05037539|Morphine|morphine|mesh-list
64429881|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64429882|NCT05037539|Narcotics|narcotics|mesh-ancestor
64429883|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429884|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429885|NCT05037539|Analgesics|analgesics|mesh-ancestor
64429886|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
64429887|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429888|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64429889|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64429920|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
64429921|NCT04738149|Bimatoprost|bimatoprost|mesh-list
64429922|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64429923|NCT04218539|Psilocybin|psilocybin|mesh-list
64429924|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
64429925|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429926|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429927|NCT04995497|Lidocaine|lidocaine|mesh-list
64429928|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
64429929|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
64429930|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429931|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429932|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
64429933|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429934|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64429935|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64355242|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
64355243|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
64355359|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429936|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64429937|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429938|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429939|NCT05063201|Cariprazine|cariprazine|mesh-list
64429940|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64429941|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64429942|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429943|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429944|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429945|NCT05060627|Dexamethasone|dexamethasone|mesh-list
64429946|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429947|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
64429948|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
64429949|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429959|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429960|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429962|NCT05025605|Analgesics|analgesics|mesh-ancestor
64429963|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
64429964|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429965|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64364326|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
64429983|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429984|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429985|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64586315|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586316|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64586317|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64586318|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586319|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
64586320|NCT00365417|Bevacizumab|bevacizumab|mesh-list
64586321|NCT00365417|Docetaxel|docetaxel|mesh-list
64586322|NCT00365417|Doxorubicin|doxorubicin|mesh-list
64586323|NCT00365417|Capecitabine|capecitabine|mesh-list
64586324|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586325|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
64586326|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586327|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64586328|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64586329|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
64586330|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586331|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586332|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64586333|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586334|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586335|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586336|NCT00365417|Growth Substances|growth substances|mesh-ancestor
64586337|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586338|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
64586339|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
64364373|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64586340|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
64586341|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64586342|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64586343|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64586344|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586345|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586346|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
64586347|NCT02947685|Trastuzumab|trastuzumab|mesh-list
64586348|NCT02947685|Pertuzumab|pertuzumab|mesh-list
64586349|NCT02947685|Letrozole|letrozole|mesh-list
64586350|NCT02947685|Fulvestrant|fulvestrant|mesh-list
64586351|NCT02947685|Palbociclib|palbociclib|mesh-list
64586352|NCT02947685|Anastrozole|anastrozole|mesh-list
64586353|NCT02947685|Exemestane|exemestane|mesh-list
64586354|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64355369|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
64355370|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
64355371|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
64355417|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
64586355|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586356|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64586357|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64586358|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586359|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586360|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64586361|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
64586362|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586363|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586364|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64586365|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64586366|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586367|NCT00427297|Ritonavir|ritonavir|mesh-list
64586368|NCT00427297|Lopinavir|lopinavir|mesh-list
64586369|NCT00427297|Tenofovir|tenofovir|mesh-list
64586370|NCT00427297|Lamivudine|lamivudine|mesh-list
64586371|NCT00427297|Zidovudine|zidovudine|mesh-list
64586372|NCT00427297|Nevirapine|nevirapine|mesh-list
64586373|NCT00427297|Abacavir|abacavir|mesh-list
64586374|NCT00427297|Stavudine|stavudine|mesh-list
64586375|NCT00427297|Didanosine|didanosine|mesh-list
64586376|NCT00427297|Efavirenz|efavirenz|mesh-list
64586377|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
64586378|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64586379|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64586380|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
64586381|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586382|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586383|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64586384|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64586385|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
64586386|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586387|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64586388|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64586389|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64586390|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64586391|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
64586392|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64586393|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64586394|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64586395|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64586396|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64586397|NCT00427765|Melphalan|melphalan|mesh-list
64586398|NCT00427765|Busulfan|busulfan|mesh-list
64586399|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64586400|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
64586401|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586402|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586403|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64586404|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586405|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
64364383|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586407|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
64586408|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
64586409|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586410|NCT00384865|Aspirin|aspirin|mesh-list
64586411|NCT00384865|Simvastatin|simvastatin|mesh-list
64586412|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64586413|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64586414|NCT00384865|Analgesics|analgesics|mesh-ancestor
64586415|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
64586416|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355419|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
64586417|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586418|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586419|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64586420|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64586421|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64586422|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586423|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64586424|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64586425|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586426|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
64586427|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64586428|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64586429|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
64586430|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64586431|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64586432|NCT00367601|Bevacizumab|bevacizumab|mesh-list
64586433|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64586434|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586435|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586436|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586437|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586438|NCT00367601|Growth Substances|growth substances|mesh-ancestor
64586439|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586440|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586441|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586442|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586443|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586445|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64586446|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
64586447|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586448|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586449|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586450|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64586451|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64586452|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64586453|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586454|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64586455|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
64586457|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64586458|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586459|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
64586460|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64586461|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586462|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64586463|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64586464|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586465|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586466|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364416|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586467|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64586468|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64586469|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64586470|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64586471|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
64586472|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586473|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586474|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64586475|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64586476|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64586477|NCT00429949|Dasatinib|dasatinib|mesh-list
64586478|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586479|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586480|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586481|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586482|NCT02078726|Glucagon|glucagon|mesh-list
64586483|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64586484|NCT02078726|Hormones|hormones|mesh-ancestor
64355429|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
64355430|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355431|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64355432|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64586485|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586486|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586487|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
64586488|NCT00431041|Oxybutynin|oxybutynin|mesh-list
64586489|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64586490|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64586491|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
64586492|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586493|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586494|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586495|NCT00431041|Urological Agents|urological agents|mesh-ancestor
64586496|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
64586497|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
64586498|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586499|NCT00390611|Paclitaxel|paclitaxel|mesh-list
64586500|NCT00390611|Carboplatin|carboplatin|mesh-list
64586501|NCT00390611|Sorafenib|sorafenib|mesh-list
64586502|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64586503|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586504|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
64311800|NCT02094287|Dimethindene|dimethindene|mesh-list
64586505|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
64586507|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586508|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586509|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586510|NCT00391079|Nabiximols|nabiximols|mesh-list
64586511|NCT00391079|Analgesics|analgesics|mesh-ancestor
64586512|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
64586513|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586514|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586515|NCT00387751|Bevacizumab|bevacizumab|mesh-list
64586516|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64586517|NCT00387751|Sorafenib|sorafenib|mesh-list
64586518|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
64586519|NCT00387751|Antibodies|antibodies|mesh-list
64586521|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64586522|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
64586523|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364431|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586524|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586525|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586526|NCT00387751|Growth Substances|growth substances|mesh-ancestor
64586527|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586528|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586529|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
64586530|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586531|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586532|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586534|NCT01795235|Glucagon|glucagon|mesh-list
64586535|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64586536|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64586537|NCT01795235|Hormones|hormones|mesh-ancestor
64586538|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586539|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586540|NCT01795235|Incretins|incretins|mesh-ancestor
64586541|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64586542|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64586543|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
64586544|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
64586545|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355439|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
64586546|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64586547|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64586548|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64586549|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
64586550|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586551|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586552|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64586553|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64586555|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64586556|NCT00387829|Estrogens|estrogens|mesh-ancestor
64586557|NCT00387829|Hormones|hormones|mesh-ancestor
64586558|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586559|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586560|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64586561|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
64586562|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64586563|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64586565|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586566|NCT00392951|Sirolimus|sirolimus|mesh-list
64586567|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64586568|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586569|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64586570|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586571|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
64586572|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586573|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
64586574|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586575|NCT01424930|Prednisone|prednisone|mesh-list
64586576|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586577|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
64586578|NCT01424930|Hormones|hormones|mesh-ancestor
64586579|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364464|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64364465|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64586580|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586581|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64586582|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586584|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
64586585|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586586|NCT01795183|Amisulpride|amisulpride|mesh-list
64586587|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64586588|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64586589|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64586590|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586591|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586592|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64586594|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586595|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586596|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64586597|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
64586598|NCT01424228|Prucalopride|prucalopride|mesh-list
64586599|NCT01424228|Laxatives|laxatives|mesh-ancestor
64586600|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64586601|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64586602|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64586603|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
64586604|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586605|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586606|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586607|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
64355468|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64586608|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
64586609|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586610|NCT04750603|Fluticasone|fluticasone|mesh-list
64586611|NCT04750603|Xhance|xhance|mesh-list
64586612|NCT04750603|Albuterol|albuterol|mesh-list
64586613|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586614|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64355479|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
64355480|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586615|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
64586616|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586617|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355481|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355482|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
64586618|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64586619|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
64586620|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64586621|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64586622|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
64586623|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64586624|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64586625|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64586626|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64586627|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
64586628|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586629|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586631|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64586632|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586633|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64586634|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64586635|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586636|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586637|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586638|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
64586639|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64586640|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
64364480|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364481|NCT03369119|Montelukast|montelukast|mesh-list
64586641|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586642|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
64586643|NCT00436969|Protective Agents|protective agents|mesh-ancestor
64586644|NCT00455689|Leuprolide|leuprolide|mesh-list
64586645|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64586646|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
64586647|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64586648|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586649|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64586650|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586651|NCT00394277|Ribavirin|ribavirin|mesh-list
64586652|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64586653|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
64586654|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
64586655|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586656|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
64586658|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
64586659|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586660|NCT00395057|Ranibizumab|ranibizumab|mesh-list
64586661|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586662|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586663|NCT00395057|Growth Substances|growth substances|mesh-ancestor
64586664|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586665|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586666|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586667|NCT00438451|Lamotrigine|lamotrigine|mesh-list
64586668|NCT00438451|Carbamazepine|carbamazepine|mesh-list
64586669|NCT00438451|Levetiracetam|levetiracetam|mesh-list
64355483|NCT03425617|Olodaterol|olodaterol|mesh-list
64355489|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
64355490|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
64586670|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
64586671|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
64586672|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64586673|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586674|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586675|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64586676|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586677|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64586678|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64586679|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64586680|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586681|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64586682|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
64586683|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64586684|NCT00438451|Analgesics|analgesics|mesh-ancestor
64586685|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
64586686|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586687|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64586688|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64586689|NCT00456625|Vaccines|vaccines|mesh-list
64586690|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
64586691|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586692|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64586693|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64364502|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
64364503|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
64586694|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64586695|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64586696|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64586697|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
64586698|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586699|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586700|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586701|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64586702|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
64586703|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64586704|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
64586705|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64586706|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586707|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64586708|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64586709|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586710|NCT01423604|Capecitabine|capecitabine|mesh-list
64586711|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586712|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
64586713|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586714|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586715|NCT01402544|Ranibizumab|ranibizumab|mesh-list
64586716|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586717|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586718|NCT01402544|Growth Substances|growth substances|mesh-ancestor
64586719|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586720|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586721|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586723|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64586724|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355491|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64586725|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586726|NCT00441883|Latanoprost|latanoprost|mesh-list
64586727|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64586728|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64586729|NCT00461773|Bevacizumab|bevacizumab|mesh-list
64586730|NCT00461773|Letrozole|letrozole|mesh-list
64586731|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586732|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586733|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586734|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586735|NCT00461773|Growth Substances|growth substances|mesh-ancestor
64586736|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586737|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586738|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64586739|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64586740|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586741|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586742|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64586743|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
64586744|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586745|NCT00461851|Gemcitabine|gemcitabine|mesh-list
64586746|NCT00461851|Carboplatin|carboplatin|mesh-list
64586747|NCT00461851|Sorafenib|sorafenib|mesh-list
64586748|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586749|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586750|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
64364576|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
64586751|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586753|NCT00461851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586754|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586755|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586756|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
64586757|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586758|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586759|NCT00442507|Bevacizumab|bevacizumab|mesh-list
64586760|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64586761|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586762|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586763|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64586764|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64586765|NCT00442507|Growth Substances|growth substances|mesh-ancestor
64586766|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586767|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
64586768|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586769|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586770|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586771|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
64586772|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586773|NCT01387022|Tenofovir|tenofovir|mesh-list
64586774|NCT01387022|Lamivudine|lamivudine|mesh-list
64586775|NCT01387022|Efavirenz|efavirenz|mesh-list
64586776|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
64586777|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586778|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64586779|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64586780|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586781|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586782|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64586783|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64586784|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64586785|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64586786|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64586787|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64586788|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64586789|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64586791|NCT00374231|Prednisone|prednisone|mesh-list
64586792|NCT00374231|Tacrolimus|tacrolimus|mesh-list
64586793|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586794|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
64586795|NCT00374231|Hormones|hormones|mesh-ancestor
64586796|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586797|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586798|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64586799|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586800|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586801|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
64586802|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64586803|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64312110|NCT02789657|Paclitaxel|paclitaxel|mesh-list
64586804|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586805|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64586806|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64586807|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
64586808|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64586809|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586811|NCT00400205|Fluorouracil|fluorouracil|mesh-list
64586812|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586813|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
64586814|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
64586815|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
64586816|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586817|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
64586818|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586819|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586820|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
64586821|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586822|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64586823|NCT01386554|Hormones|hormones|mesh-ancestor
64586824|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64586825|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586826|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
64586827|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64586828|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64586829|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
64586830|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586831|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64586832|NCT00448201|Methotrexate|methotrexate|mesh-list
64586833|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
64586834|NCT00448201|Fludarabine|fludarabine|mesh-list
64586835|NCT00448201|Busulfan|busulfan|mesh-list
64586836|NCT00448201|Tacrolimus|tacrolimus|mesh-list
64586837|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64586838|NCT00448201|Sargramostim|sargramostim|mesh-list
64586839|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64586840|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
64586841|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64586842|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586843|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586844|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
64586845|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586846|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586847|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
64586848|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586849|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64586850|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586851|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
64586852|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64586853|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64586854|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64586855|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
64586856|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64586857|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64586859|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
64586860|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586861|NCT05287607|Protective Agents|protective agents|mesh-ancestor
64586862|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586863|NCT00375713|Cetirizine|cetirizine|mesh-list
64586864|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
64586865|NCT00375713|Levocetirizine|levocetirizine|mesh-list
64586866|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64586867|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64586868|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64586869|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64586870|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
64586871|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
64586872|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586873|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586874|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586875|NCT00465595|Psilocybin|psilocybin|mesh-list
64586876|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64586878|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586879|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586880|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64586881|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
64586882|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586883|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586884|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64586885|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
64586887|NCT00376805|Interleukin-2|interleukin-2|mesh-list
64586888|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586889|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
64586890|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586891|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64586892|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64586893|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
64586894|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586895|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586896|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64586897|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64586898|NCT00376805|Analgesics|analgesics|mesh-ancestor
64586899|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
64586900|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586901|NCT00448357|Methotrexate|methotrexate|mesh-list
64586902|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
64586903|NCT00448357|Fludarabine|fludarabine|mesh-list
64586904|NCT00448357|Busulfan|busulfan|mesh-list
64586905|NCT00448357|Tacrolimus|tacrolimus|mesh-list
64586906|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64586907|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
64586908|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64586909|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
64586910|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64586911|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586912|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64586913|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
64586914|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586915|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586916|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
64586917|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586918|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64586919|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64586920|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
64586921|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64586922|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64586923|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64586924|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
64355518|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586925|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64586926|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64586928|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
64586929|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
64586930|NCT00450073|Vitamins|vitamins|mesh-list
64586931|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
64586932|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586933|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64586934|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64586935|NCT00467077|Interferons|interferons|mesh-list
64586936|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
64586937|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
64586938|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64586939|NCT00467077|Gefitinib|gefitinib|mesh-list
64586940|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586941|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
64586942|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586943|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
64586944|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364646|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64586945|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64586946|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586947|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586949|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64586950|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64586951|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586952|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
64586953|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64312248|NCT04864496|Protective Agents|protective agents|mesh-ancestor
64586954|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586955|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
64586956|NCT00377741|Valganciclovir|valganciclovir|mesh-list
64586957|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
64586958|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64586959|NCT00379145|Trabectedin|trabectedin|mesh-list
64586960|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64586961|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
64586962|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586963|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586964|NCT00382031|Zalutumumab|zalutumumab|mesh-list
64586965|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64586966|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64586967|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64586968|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
64586969|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586970|NCT00382265|Tamsulosin|tamsulosin|mesh-list
64586971|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64586972|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64586973|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64586974|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
64586975|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586976|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586977|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586978|NCT00382265|Urological Agents|urological agents|mesh-ancestor
64586979|NCT00383747|Nicotine|nicotine|mesh-list
64586980|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64586981|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
64586982|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64586983|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64586984|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64586985|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64586987|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64586988|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586990|NCT01421342|Bupropion|bupropion|mesh-list
64586991|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
64586992|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64355570|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
64355580|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355581|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64355582|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355586|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355587|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64355590|NCT04753437|Antacids|antacids|mesh-ancestor
64586993|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64586994|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64586995|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64586996|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64586997|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64586998|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
64586999|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587000|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587001|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64587002|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64587003|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587004|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64587005|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64364657|NCT03363815|Digoxin|digoxin|mesh-list
64364658|NCT03363815|Midazolam|midazolam|mesh-list
64587007|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
64587008|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64587009|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64587010|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
64587011|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64587012|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64587013|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64587014|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64587015|NCT00403403|Bevacizumab|bevacizumab|mesh-list
64587016|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587017|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587018|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587019|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587020|NCT00403403|Growth Substances|growth substances|mesh-ancestor
64587021|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587022|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587023|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
64587024|NCT00405353|Testosterone|testosterone|mesh-list
64587025|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
64587026|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
64312327|NCT03042182|Vaccines|vaccines|mesh-list
64587027|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64587028|NCT00405353|Androgens|androgens|mesh-ancestor
64587029|NCT00405353|Hormones|hormones|mesh-ancestor
64587030|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587031|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587032|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587033|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587034|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
64587035|NCT01384292|Naloxegol|naloxegol|mesh-list
64587036|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64587037|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587038|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
64587039|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587040|NCT00450463|Metronidazole|metronidazole|mesh-list
64587041|NCT00450463|Molgramostim|molgramostim|mesh-list
64587042|NCT00450463|Flutamide|flutamide|mesh-list
64587043|NCT00450463|Sargramostim|sargramostim|mesh-list
64587044|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
64587045|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587046|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587047|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587048|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64587049|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64587050|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64587051|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
64587052|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
64587053|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587054|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587055|NCT00407381|Ranibizumab|ranibizumab|mesh-list
64587056|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587057|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587058|NCT00407381|Growth Substances|growth substances|mesh-ancestor
64587059|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587060|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587061|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587063|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64355594|NCT04753437|Expectorants|expectorants|mesh-ancestor
64355595|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
64355596|NCT03411109|Hydromorphone|hydromorphone|mesh-list
64355597|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64587064|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587065|NCT00384449|Growth Substances|growth substances|mesh-ancestor
64587066|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587067|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587068|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587069|NCT00452335|Lubiprostone|lubiprostone|mesh-list
64587070|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64587071|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587072|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587073|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
64587074|NCT00386243|Analgesics|analgesics|mesh-list
64587075|NCT00386243|Narcotics|narcotics|mesh-ancestor
64587076|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64587077|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587078|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
64587079|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587080|NCT01400516|Vitamin D|vitamin d|mesh-list
64587081|NCT01400516|Teriparatide|teriparatide|mesh-list
64587082|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
64587083|NCT01400516|Calcium|calcium|mesh-list
64587084|NCT01400516|Vitamins|vitamins|mesh-ancestor
64587085|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
64587086|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587087|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64587088|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64587089|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64587090|NCT01383356|Metformin|metformin|mesh-list
64587091|NCT01383356|Linagliptin|linagliptin|mesh-list
64587092|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64587093|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587094|NCT01383356|Incretins|incretins|mesh-ancestor
64587095|NCT01383356|Hormones|hormones|mesh-ancestor
64587096|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587097|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64587098|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
64587099|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587100|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587101|NCT02111447|Propofol|propofol|mesh-list
64312397|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64587102|NCT02111447|Sevoflurane|sevoflurane|mesh-list
64587103|NCT02111447|Isoflurane|isoflurane|mesh-list
64587104|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64587105|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64587106|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587107|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64587108|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
64587110|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64587111|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64587112|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
64587113|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64355642|NCT04370379|Aflibercept|aflibercept|mesh-list
64587114|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587115|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
64587116|NCT00453193|Pentostatin|pentostatin|mesh-list
64587117|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587118|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587119|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
64587120|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587121|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587122|NCT00387023|Rituximab|rituximab|mesh-list
64587123|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587124|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587125|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
64587126|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587127|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587128|NCT00472849|Cytarabine|cytarabine|mesh-list
64587129|NCT00472849|Rituximab|rituximab|mesh-list
64587130|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
64587131|NCT00472849|Fludarabine|fludarabine|mesh-list
64587132|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587133|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587134|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
64364681|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
64587135|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587136|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587137|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64587138|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
64587139|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587140|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587141|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
64587142|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587143|NCT00453895|Sunitinib|sunitinib|mesh-list
64587144|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587145|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587146|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587147|NCT00453895|Growth Substances|growth substances|mesh-ancestor
64587148|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587149|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587150|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587152|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587153|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
64587154|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64587155|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64587156|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64587157|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587158|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587159|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
64587160|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587161|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587163|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587164|NCT00409565|Bevacizumab|bevacizumab|mesh-list
64587165|NCT00409565|Cetuximab|cetuximab|mesh-list
64587166|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587167|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587168|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587169|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587170|NCT00409565|Growth Substances|growth substances|mesh-ancestor
64587171|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587172|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587173|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
64587174|NCT00475501|Finasteride|finasteride|mesh-list
64587175|NCT00475501|Testosterone|testosterone|mesh-list
64587176|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
64312501|NCT03189069|Warfarin|warfarin|mesh-list
64587177|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
64587178|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64587179|NCT00475501|Androgens|androgens|mesh-ancestor
64587180|NCT00475501|Hormones|hormones|mesh-ancestor
64587181|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587182|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587183|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587184|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587185|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
64587186|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64587187|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64587188|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587189|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587190|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
64587191|NCT00475501|Urological Agents|urological agents|mesh-ancestor
64587192|NCT00529555|Minocycline|minocycline|mesh-list
64587193|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64587194|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587195|NCT00387335|Sunitinib|sunitinib|mesh-list
64587196|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587197|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587198|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587199|NCT00387335|Growth Substances|growth substances|mesh-ancestor
64364719|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64587200|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587201|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587202|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587203|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587204|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587206|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587207|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587208|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64587209|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64587210|NCT01796899|Brivaracetam|brivaracetam|mesh-list
64587212|NCT00477451|Alprazolam|alprazolam|mesh-list
64587213|NCT00477451|Doxapram|doxapram|mesh-list
64587214|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64587215|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64587216|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587217|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64587218|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64587219|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64587220|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
64587221|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
64587222|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587223|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587224|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64587225|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
64587226|NCT00530803|Lidocaine|lidocaine|mesh-list
64587227|NCT00530803|Tetracaine|tetracaine|mesh-list
64587228|NCT00530803|Prilocaine|prilocaine|mesh-list
64587229|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64587230|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
64587231|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
64587232|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64587233|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587234|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
64587235|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587236|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64587237|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64587238|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64587239|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587240|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587241|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64587242|NCT04372927|Cisplatin|cisplatin|mesh-list
64587243|NCT04372927|Etoposide|etoposide|mesh-list
64587244|NCT04372927|Pemetrexed|pemetrexed|mesh-list
64587245|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
64355650|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64355696|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355697|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64355698|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
64355699|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64355700|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64355701|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64355702|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
64355703|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355704|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355705|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64355706|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64355707|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64355708|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
64355710|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355711|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355716|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355717|NCT04814745|Morphine|morphine|mesh-list
64355718|NCT04814745|Tramadol|tramadol|mesh-list
64355719|NCT04814745|Ropivacaine|ropivacaine|mesh-list
64587246|NCT04372927|Durvalumab|durvalumab|mesh-list
64587247|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
64587248|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
64587249|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64587250|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
64587251|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587252|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64587253|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64587254|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64587255|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587256|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587257|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64587258|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64587259|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64364728|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64587260|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
64587261|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587262|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
64587263|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
64587264|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
64587265|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
64587266|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
64587267|NCT01381874|Prednisone|prednisone|mesh-list
64587268|NCT01381874|Prednisolone|prednisolone|mesh-list
64587269|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64587270|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
64587271|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64587272|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
64587273|NCT01381874|Exemestane|exemestane|mesh-list
64587274|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
64587275|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64587276|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
64587277|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64587278|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
64587279|NCT01381874|Hormones|hormones|mesh-ancestor
64355724|NCT04814745|Analgesics|analgesics|mesh-ancestor
64355725|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
64355726|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355727|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
64355728|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
64355729|NCT04640571|Metformin|metformin|mesh-list
64587280|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587281|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587282|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587283|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587284|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
64587285|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
64587286|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587287|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587288|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64587289|NCT01381874|Protective Agents|protective agents|mesh-ancestor
64587290|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64587291|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64587292|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587293|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587294|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64587295|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
64587296|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64587297|NCT01399190|Bevacizumab|bevacizumab|mesh-list
64587298|NCT01399190|Capecitabine|capecitabine|mesh-list
64587299|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
64587300|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587301|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587302|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587303|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587304|NCT01399190|Growth Substances|growth substances|mesh-ancestor
64587305|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587306|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587307|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64587308|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
64587309|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587310|NCT01381718|Modafinil|modafinil|mesh-list
64587311|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64587312|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587313|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64587314|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64587315|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64587316|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587317|NCT05365178|Fulvestrant|fulvestrant|mesh-list
64587318|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587319|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587320|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64355730|NCT04640571|Valacyclovir|valacyclovir|mesh-list
64355733|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64587321|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64587322|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
64355734|NCT04640571|Pravastatin|pravastatin|mesh-list
64355735|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64355736|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355737|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64355738|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64355739|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
64355740|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355741|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64355743|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355744|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
64355745|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355746|NCT04640571|Cathartics|cathartics|mesh-ancestor
64587323|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587324|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587325|NCT00479089|Dexamethasone|dexamethasone|mesh-list
64364765|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
64587327|NCT00479089|Gefitinib|gefitinib|mesh-list
64587328|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64587329|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
64587330|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
64587331|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587332|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587333|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587334|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
64587335|NCT00479089|Hormones|hormones|mesh-ancestor
64587336|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587337|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587338|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587339|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
64587340|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
64587341|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
64587342|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587343|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587344|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587345|NCT01398956|Levetiracetam|levetiracetam|mesh-list
64587346|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
64587347|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
64587348|NCT00410423|Cytarabine|cytarabine|mesh-list
64587349|NCT00410423|Etoposide|etoposide|mesh-list
64587350|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
64587351|NCT00410423|Bortezomib|bortezomib|mesh-list
64587352|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64587353|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587354|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64355747|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587355|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64587356|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587357|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587358|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64587359|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
64587360|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
64587361|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587362|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587363|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
64355748|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64355750|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64355751|NCT04431141|Empagliflozin|empagliflozin|mesh-list
64355752|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64355753|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355754|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64355755|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355770|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355771|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355772|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587364|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587366|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
64587367|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587368|NCT00387959|Cyclosporine|cyclosporine|mesh-list
64587369|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
64587370|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
64587371|NCT00387959|Rituximab|rituximab|mesh-list
64587372|NCT00387959|Fludarabine|fludarabine|mesh-list
64587373|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
64587374|NCT00387959|Cyclosporins|cyclosporins|mesh-list
64587375|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587376|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
64587377|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587378|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587379|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64587380|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
64587381|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587382|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587383|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64587384|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587385|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64587386|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
64364814|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64587387|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587388|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
64587389|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587390|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
64587391|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64587392|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64587393|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64587394|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
64587395|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64587396|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
64587397|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64587398|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587399|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64587400|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64587401|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64587402|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64587403|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587404|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587405|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587406|NCT01381562|Meropenem|meropenem|mesh-list
64587407|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64587408|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587409|NCT01381016|Hormones|hormones|mesh-list
64587410|NCT01381016|Estradiol|estradiol|mesh-list
64587411|NCT01381016|Progesterone|progesterone|mesh-list
64587412|NCT01381016|Estrogens|estrogens|mesh-list
64587413|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587414|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587415|NCT01381016|Progestins|progestins|mesh-ancestor
64587416|NCT00412451|Plasminogen|plasminogen|mesh-list
64587417|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64587418|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64587419|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587420|NCT01398410|Rabeprazole|rabeprazole|mesh-list
64587421|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64587422|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355773|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355774|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64355775|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
64355776|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
64355777|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
64355778|NCT00148629|Mebendazole|mebendazole|mesh-list
64355779|NCT00148629|Piperazine|piperazine|mesh-list
64355782|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
64587423|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64587424|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587425|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587426|NCT00412529|Entecavir|entecavir|mesh-list
64587427|NCT00412529|Telbivudine|telbivudine|mesh-list
64587428|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
64587429|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587430|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64587431|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587432|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587434|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64587435|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64587436|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
64587437|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587438|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64587439|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64587440|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587441|NCT01796483|Clonidine|clonidine|mesh-list
64587442|NCT01796483|Analgesics|analgesics|mesh-ancestor
64587443|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
64587444|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587445|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587446|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64587447|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
64587448|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
64587449|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64587450|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64355783|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
64355784|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64355785|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355786|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
64355787|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
64355788|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
64355807|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355808|NCT03412721|Analgesics|analgesics|mesh-list
64355809|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
64587451|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64587452|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
64587453|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587454|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587455|NCT00414167|Bupropion|bupropion|mesh-list
64587456|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64587457|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
64587458|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64587459|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64587460|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64587461|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587462|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587463|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
64587464|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587465|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587466|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64587467|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64587468|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587469|NCT01380782|Nintedanib|nintedanib|mesh-list
64587470|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587471|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587472|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587473|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587475|NCT04245865|Tocotrienols|tocotrienols|mesh-list
64587476|NCT04245865|Vitamin E|vitamin e|mesh-list
64587477|NCT04245865|Tocopherols|tocopherols|mesh-list
64587478|NCT04245865|Bevacizumab|bevacizumab|mesh-list
64587479|NCT04245865|Fluorouracil|fluorouracil|mesh-list
64587480|NCT04245865|Capecitabine|capecitabine|mesh-list
64587481|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
64587482|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
64587483|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587484|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587485|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587486|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587487|NCT04245865|Growth Substances|growth substances|mesh-ancestor
64587488|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587489|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587490|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
64587491|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587492|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64587493|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587494|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
64587495|NCT04245865|Antidotes|antidotes|mesh-ancestor
64587496|NCT04245865|Protective Agents|protective agents|mesh-ancestor
64587497|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
64587498|NCT04245865|Vitamins|vitamins|mesh-ancestor
64587499|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
64587500|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
64587501|NCT00534001|Bupropion|bupropion|mesh-list
64355810|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355811|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355812|NCT03418337|Lansoprazole|lansoprazole|mesh-list
64587502|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64355813|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
64355815|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355816|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64355817|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355818|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355819|NCT03411967|Docetaxel|docetaxel|mesh-list
64355820|NCT03411967|Apatinib|apatinib|mesh-list
64355821|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355822|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
64587503|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
64587504|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64587505|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64587506|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64587507|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587508|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587509|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
64587510|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587511|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587512|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64587513|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64587514|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587515|NCT00481351|Simvastatin|simvastatin|mesh-list
64587516|NCT00481351|Ezetimibe|ezetimibe|mesh-list
64587517|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64587518|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64587519|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
64587520|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587521|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64587522|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64587523|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587524|NCT00455975|Bevacizumab|bevacizumab|mesh-list
64587525|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587526|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587527|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587528|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587529|NCT00455975|Growth Substances|growth substances|mesh-ancestor
64587530|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587531|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587532|NCT05366192|Ritonavir|ritonavir|mesh-list
64587533|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64587534|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64355823|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
64587535|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
64587536|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587537|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587538|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64587539|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64587540|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
64587541|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587542|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64587543|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64587544|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
64355824|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
64355825|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355826|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355827|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355828|NCT05228925|Vitamin D|vitamin d|mesh-list
64355829|NCT05228925|Vitamins|vitamins|mesh-ancestor
64355830|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
64355831|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587545|NCT04013672|Sargramostim|sargramostim|mesh-list
64587546|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64587547|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587548|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587549|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
64587550|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587551|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64587553|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64587554|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587555|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587556|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587557|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
64587558|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587559|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587560|NCT00458237|Trastuzumab|trastuzumab|mesh-list
64587561|NCT00458237|Everolimus|everolimus|mesh-list
64587562|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587563|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587564|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587565|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
64587566|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587567|NCT00418457|Anesthetics|anesthetics|mesh-list
64587568|NCT00418457|Propofol|propofol|mesh-list
64587569|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64587570|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587571|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64587572|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64587573|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
64587574|NCT00482677|Temozolomide|temozolomide|mesh-list
64587575|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64587576|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
64587577|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364924|NCT03361319|Nintedanib|nintedanib|mesh-list
64587578|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587580|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
64587581|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64587582|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64587583|NCT01397552|Prednisolone|prednisolone|mesh-list
64587584|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
64587585|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64587586|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
64587587|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64587588|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
64587589|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
64587590|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587591|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587592|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587593|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
64587594|NCT01397552|Hormones|hormones|mesh-ancestor
64587595|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587596|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587597|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587598|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64587599|NCT01397552|Protective Agents|protective agents|mesh-ancestor
64587601|NCT05368376|Labetalol|labetalol|mesh-list
64355833|NCT03412409|Cytarabine|cytarabine|mesh-list
64355835|NCT03412409|Busulfan|busulfan|mesh-list
64355865|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64587602|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64587603|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64587604|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
64587605|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
64587606|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587607|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355866|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64355867|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64355868|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64355869|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64355870|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64355871|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64355873|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64587608|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64587609|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64587610|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64587611|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
64587612|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587613|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587614|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
64587615|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64587616|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64587617|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
64587618|NCT00482911|Lenalidomide|lenalidomide|mesh-list
64587619|NCT00482911|Sunitinib|sunitinib|mesh-list
64587620|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587621|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
64587622|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587623|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587624|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64587625|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
64587626|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587627|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587628|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64587629|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587630|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587631|NCT00482911|Growth Substances|growth substances|mesh-ancestor
64587632|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587633|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587634|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587635|NCT01397162|Fluticasone|fluticasone|mesh-list
64587637|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64587638|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64587639|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
64355898|NCT03905811|Urological Agents|urological agents|mesh-ancestor
64355899|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64355900|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64355902|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355903|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355905|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355906|NCT03409237|Mannitol|mannitol|mesh-list
64355907|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64355908|NCT03409237|Diuretics|diuretics|mesh-ancestor
64355909|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
64587640|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587641|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587642|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64587643|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
64587644|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
64587645|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64587646|NCT05362916|Letermovir|letermovir|mesh-list
64364936|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
64587647|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64587648|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587649|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587650|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587651|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
64587652|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587653|NCT00483223|Carboplatin|carboplatin|mesh-list
64587654|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587655|NCT01397084|Esomeprazole|esomeprazole|mesh-list
64587656|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64587657|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587658|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64587659|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587660|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587661|NCT04221529|Atezolizumab|atezolizumab|mesh-list
64587662|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587663|NCT00420017|Amiodarone|amiodarone|mesh-list
64587664|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64587665|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
64587666|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64587667|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587668|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587669|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64587670|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64587671|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64587672|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587673|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64587674|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64587675|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64587676|NCT04092673|Trastuzumab|trastuzumab|mesh-list
64587677|NCT04092673|Fulvestrant|fulvestrant|mesh-list
64587678|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587679|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587680|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64355910|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587681|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64587682|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64587683|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
64587684|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587685|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587686|NCT00484393|Tetracaine|tetracaine|mesh-list
64587687|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
64587688|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
64355911|NCT03408847|Beclomethasone|beclomethasone|mesh-list
64355913|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
64355914|NCT03408847|Hormones|hormones|mesh-ancestor
64355915|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355916|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355924|NCT03407521|Isosorbide|isosorbide|mesh-list
64355925|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64355926|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64355927|NCT03407521|Misoprostol|misoprostol|mesh-list
64355928|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64355929|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
64355930|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64355931|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355932|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64355933|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355934|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
64587689|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64587690|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587691|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
64587692|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587693|NCT00485485|Docetaxel|docetaxel|mesh-list
64587694|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
64587695|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587696|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
64587697|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
64587698|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
64587699|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587700|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587701|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64313007|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
64587702|NCT00422201|Mifepristone|mifepristone|mesh-list
64587703|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64587704|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
64587705|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64587706|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364990|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64364992|NCT03365765|Fluorouracil|fluorouracil|mesh-list
64587707|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64587709|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64587710|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
64587711|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64587712|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64587713|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
64587714|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587715|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
64587716|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64355935|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64355950|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64355951|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64355952|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
64355953|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64355954|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355955|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355956|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64355957|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64355958|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355959|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
64355960|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
64355961|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
64355962|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
64587717|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64587719|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587720|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587721|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587722|NCT01396148|Growth Substances|growth substances|mesh-ancestor
64587723|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587724|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587725|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587726|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587727|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587728|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
64587729|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64587730|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587731|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587732|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64587733|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587734|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64587735|NCT00486031|Balsalazide|balsalazide|mesh-list
64587736|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64587737|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64587738|NCT00486031|Analgesics|analgesics|mesh-ancestor
64587739|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
64587740|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587741|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587742|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64587743|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587744|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587745|NCT04019834|Bupivacaine|bupivacaine|mesh-list
64587746|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
64587747|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
64355963|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587748|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64587749|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587750|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
64587751|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587752|NCT04017962|Letermovir|letermovir|mesh-list
64587753|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64587754|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587755|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587756|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587757|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
64587758|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587759|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64355964|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64355965|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
64355966|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
64587760|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587761|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587762|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
64587763|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64587764|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355967|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355968|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64355977|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355978|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64355979|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
64355980|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64587765|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587766|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64587767|NCT02108171|Analgesics|analgesics|mesh-ancestor
64587768|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
64587769|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587770|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64365002|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587772|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64313081|NCT04832204|Apatinib|apatinib|mesh-list
64587773|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
64587774|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587775|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587776|NCT03940807|Estradiol|estradiol|mesh-list
64587777|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64587778|NCT03940807|Estrogens|estrogens|mesh-ancestor
64587779|NCT03940807|Hormones|hormones|mesh-ancestor
64587780|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587781|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587782|NCT00535873|Lenalidomide|lenalidomide|mesh-list
64587783|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
64587784|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587785|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587786|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587787|NCT00535873|Growth Substances|growth substances|mesh-ancestor
64587788|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587789|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587790|NCT00487669|Paclitaxel|paclitaxel|mesh-list
64587791|NCT00487669|Pemetrexed|pemetrexed|mesh-list
64587792|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
64587793|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64587794|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587795|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
64587796|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
64587797|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
64587798|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587799|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587800|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64587801|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64587802|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
64355981|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587803|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
64587804|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
64587805|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64587806|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64587807|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587808|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64587809|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64587810|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
64587811|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587812|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355982|NCT03406819|Nitroprusside|nitroprusside|mesh-list
64587813|NCT02120287|Bevacizumab|bevacizumab|mesh-list
64587814|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587815|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587816|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587817|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587818|NCT02120287|Growth Substances|growth substances|mesh-ancestor
64587819|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587820|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587821|NCT00536341|Rituximab|rituximab|mesh-list
64587822|NCT00536341|Fludarabine|fludarabine|mesh-list
64587823|NCT00536341|Lenalidomide|lenalidomide|mesh-list
64587824|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587825|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587826|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
64587827|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587828|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587829|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64587830|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64587831|NCT00536341|Growth Substances|growth substances|mesh-ancestor
64587832|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
64587833|NCT02122471|Plecanatide|plecanatide|mesh-list
64587834|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64587836|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587837|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64587838|NCT00461591|Apaziquone|apaziquone|mesh-list
64587839|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587840|NCT00533117|Fluoxetine|fluoxetine|mesh-list
64587841|NCT00533117|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64587842|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64587843|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587844|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587845|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587846|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
64587847|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587848|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64587849|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
64587850|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64587851|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64587852|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64587853|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587854|NCT00423683|PENTA|penta|mesh-list
64587855|NCT00423683|Fondaparinux|fondaparinux|mesh-list
64587856|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64587857|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
64355985|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
64355986|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64355987|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355988|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64355989|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64355990|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64355991|NCT05170217|Cannabidiol|cannabidiol|mesh-list
64355992|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
64355993|NCT03411551|Anesthetics|anesthetics|mesh-list
64355994|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355995|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355996|NCT05170061|Valsartan|valsartan|mesh-list
64355997|NCT05170061|Nebivolol|nebivolol|mesh-list
64355998|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64355999|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64356004|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64587858|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64587859|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
64587860|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587861|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587862|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
64587863|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64587864|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64587865|NCT00424619|Vitamin D|vitamin d|mesh-list
64587866|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
64587867|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
64587868|NCT00424619|Vitamins|vitamins|mesh-list
64587869|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
64587870|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587871|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64587872|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64587873|NCT00425477|Bexarotene|bexarotene|mesh-list
64587874|NCT00425477|Sargramostim|sargramostim|mesh-list
64587875|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
64587876|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587877|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587878|NCT00427037|Vitamin D|vitamin d|mesh-list
64587879|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
64587880|NCT00427037|Vitamins|vitamins|mesh-ancestor
64587881|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
64587882|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587883|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64587884|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64587885|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
64587886|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64587887|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587888|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64587889|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587890|NCT00427661|Cyclosporine|cyclosporine|mesh-list
64587891|NCT00427661|Fludarabine|fludarabine|mesh-list
64587892|NCT00427661|Busulfan|busulfan|mesh-list
64587893|NCT00427661|Cyclosporins|cyclosporins|mesh-list
64587894|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587895|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587896|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587897|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
64587898|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587899|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587900|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
64587901|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587902|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
64587903|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587904|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64587905|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
64587906|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64587907|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64587908|NCT00427973|Cediranib|cediranib|mesh-list
64587909|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587910|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587911|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587912|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587913|NCT01795703|Prednisolone|prednisolone|mesh-list
64587914|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64587915|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
64356022|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356023|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356024|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356025|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
64356026|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64587916|NCT01795703|Hormones|hormones|mesh-ancestor
64587917|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64587918|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587919|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64587920|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587922|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
64313229|NCT03037892|Narcotics|narcotics|mesh-ancestor
64587923|NCT00429143|Tacrolimus|tacrolimus|mesh-list
64587924|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587925|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
64587926|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587927|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64587928|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64587929|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
64587930|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587931|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587932|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64587933|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64587934|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587935|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64587936|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64587937|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
64587938|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64587939|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587940|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
64587941|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64587942|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64587943|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64587944|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64587945|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587946|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
64587947|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64587948|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587949|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64587950|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587952|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
64587953|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587954|NCT01395758|Gemcitabine|gemcitabine|mesh-list
64587955|NCT01395758|Docetaxel|docetaxel|mesh-list
64587956|NCT01395758|Pemetrexed|pemetrexed|mesh-list
64587957|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64587958|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64587959|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
64587960|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587961|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587962|NCT01395758|Antiviral Agents|antiviral agents|mesh-ancestor
64587963|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64587964|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587965|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64587966|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
64587967|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356027|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587968|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
64587969|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
64587970|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
64587971|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64356028|NCT03423823|Ranibizumab|ranibizumab|mesh-list
64356029|NCT03423823|Aflibercept|aflibercept|mesh-list
64356030|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356032|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64356033|NCT03423823|Growth Substances|growth substances|mesh-ancestor
64356034|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356035|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
64356036|NCT03411161|Paclitaxel|paclitaxel|mesh-list
64356037|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64356038|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64356039|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587972|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64587973|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64587975|NCT00462605|Sargramostim|sargramostim|mesh-list
64587976|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64587977|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
64587978|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587979|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64587980|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64587981|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64587983|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
64587984|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587985|NCT00434993|Albuterol|albuterol|mesh-list
64587986|NCT00434993|Dimercaprol|dimercaprol|mesh-list
64587987|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64587988|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
64587989|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64587990|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64587991|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64587992|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
64587993|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
64587994|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64587995|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64356040|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
64356041|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
64587996|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64365105|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64313308|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
64587998|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
64587999|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588000|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588001|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
64588002|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
64588003|NCT01395524|Naloxegol|naloxegol|mesh-list
64588004|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64588005|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588006|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
64588007|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356044|NCT04737603|Buprenorphine|buprenorphine|mesh-list
64356062|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588008|NCT04338698|Azithromycin|azithromycin|mesh-list
64356084|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64356085|NCT02375295|Renal Agents|renal agents|mesh-ancestor
64356086|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
64356087|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64588009|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
64588010|NCT04338698|Oseltamivir|oseltamivir|mesh-list
64588011|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588012|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588013|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
64588014|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64588015|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64588016|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588017|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588018|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64588019|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
64356088|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64356089|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64356090|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64356091|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64588020|NCT00435539|Plasminogen|plasminogen|mesh-list
64588021|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
64588022|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64588023|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64588024|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588025|NCT00464711|Citalopram|citalopram|mesh-list
64588026|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64588027|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64588028|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64414773|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588029|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588030|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588031|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
64588032|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588033|NCT00464711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64588034|NCT00464711|Antidepressive Agents|antidepressive agents|mesh-ancestor
64588035|NCT00464711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64588036|NCT02078180|Bupropion|bupropion|mesh-list
64588037|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64588038|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
64588039|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64588040|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64588041|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64588042|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64588043|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588044|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
64588045|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588046|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588047|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64588048|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64588049|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356092|NCT03394105|Docetaxel|docetaxel|mesh-list
64356093|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356094|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
64588050|NCT00535613|Propofol|propofol|mesh-list
64588052|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588053|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588054|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64588055|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
64588056|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
64588057|NCT00466661|Acamprosate|acamprosate|mesh-list
64588058|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64588059|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64588060|NCT05360576|Etonogestrel|etonogestrel|mesh-list
64588062|NCT05360576|Estradiol|estradiol|mesh-list
64588063|NCT05360576|Estrogens|estrogens|mesh-ancestor
64588064|NCT05360576|Hormones|hormones|mesh-ancestor
64588065|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588066|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588067|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64588068|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
64588069|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64588070|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64588071|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64588072|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64588074|NCT00535925|Atenolol|atenolol|mesh-list
64588075|NCT00535925|Amlodipine|amlodipine|mesh-list
64588076|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64588077|NCT00535925|Clonidine|clonidine|mesh-list
64588078|NCT00535925|Ramipril|ramipril|mesh-list
64588079|NCT00535925|Irbesartan|irbesartan|mesh-list
64588080|NCT00535925|Doxazosin|doxazosin|mesh-list
64588081|NCT00535925|Furosemide|furosemide|mesh-list
64588082|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
64588083|NCT00535925|Simvastatin|simvastatin|mesh-list
64588084|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588085|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64588086|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588087|NCT00535925|Analgesics|analgesics|mesh-ancestor
64588088|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
64588089|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588090|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588091|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64588092|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64588093|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64588094|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588095|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64588096|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64588097|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588098|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
64588099|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64588100|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64588101|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64588102|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64588103|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
64588104|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64588105|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64588106|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
64588107|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64588108|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64588109|NCT00535925|Diuretics|diuretics|mesh-ancestor
64588110|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
64588111|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64588112|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64588113|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
64588114|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
64588115|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64588116|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64588117|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64588118|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
64588119|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588120|NCT00535925|Hematinics|hematinics|mesh-ancestor
64588121|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64588122|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
64356095|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
64356112|NCT03393949|Hormones|hormones|mesh-ancestor
64356119|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64356121|NCT03818061|Atezolizumab|atezolizumab|mesh-list
64356122|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356123|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356124|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64356125|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64356126|NCT03818061|Growth Substances|growth substances|mesh-ancestor
64356127|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356128|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
64356129|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
64356130|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64588123|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64588124|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64588125|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64588126|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64365219|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
64588127|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64588128|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64588129|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64588130|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64588131|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64588132|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64588133|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
64588134|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588135|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588136|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588137|NCT01796093|Digoxin|digoxin|mesh-list
64588138|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64588139|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64588140|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588141|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356131|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356132|NCT04435743|Lenalidomide|lenalidomide|mesh-list
64588142|NCT01796093|Protective Agents|protective agents|mesh-ancestor
64588143|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588145|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
64588146|NCT00537511|Pomalidomide|pomalidomide|mesh-list
64588147|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588148|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588149|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64588150|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64588151|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588152|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588153|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
64588154|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356133|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
64356134|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588155|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64588156|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64588157|NCT00537511|Growth Substances|growth substances|mesh-ancestor
64588158|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
64588160|NCT00435929|Saquinavir|saquinavir|mesh-list
64588161|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64588162|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64588163|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
64588164|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588165|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588166|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64588167|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64588168|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
64588169|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588170|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64588171|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64588172|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
64588173|NCT00436475|Vitamin D|vitamin d|mesh-list
64588174|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
64588175|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
64588176|NCT00436475|Vitamins|vitamins|mesh-list
64588177|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
64588178|NCT00436475|Calcium|calcium|mesh-list
64588179|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
64588180|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588181|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64588182|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64588183|NCT00436475|Antacids|antacids|mesh-ancestor
64588184|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588185|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588186|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
64588187|NCT00210626|Hematinics|hematinics|mesh-ancestor
64588188|NCT03595514|Dexamethasone|dexamethasone|mesh-list
64588189|NCT03595514|Lidocaine|lidocaine|mesh-list
64588190|NCT03595514|Epinephrine|epinephrine|mesh-list
64588191|NCT03595514|Bupivacaine|bupivacaine|mesh-list
64365238|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588192|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588193|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
64588194|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
64588195|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588196|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588197|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588198|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
64588199|NCT03595514|Hormones|hormones|mesh-ancestor
64588200|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588201|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64588202|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588203|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
64588204|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
64588205|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588206|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
64588207|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64588208|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64588209|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64588210|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64588211|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588212|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64588213|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64356135|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64356136|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64356137|NCT04435743|Growth Substances|growth substances|mesh-ancestor
64356138|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
64356139|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356140|NCT03393715|Perindopril|perindopril|mesh-list
64356169|NCT03393481|Enoxaparin|enoxaparin|mesh-list
64588214|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
64588215|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588216|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64588217|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64588218|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64588219|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
64588220|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
64588221|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
64588222|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64588223|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
64588224|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
64588225|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588226|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
64356173|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356174|NCT01936857|Buprenorphine|buprenorphine|mesh-list
64356175|NCT01936857|Methadone|methadone|mesh-list
64356176|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64356177|NCT01936857|Naloxone|naloxone|mesh-list
64356178|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64588227|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588229|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
64588230|NCT03595046|Ropivacaine|ropivacaine|mesh-list
64588231|NCT03595046|BB 1101|bb 1101|mesh-list
64588232|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588233|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
64588234|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
64588235|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588236|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588237|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588238|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
64588239|NCT03595046|Hormones|hormones|mesh-ancestor
64588240|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588241|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64588242|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588243|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
64588244|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588245|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588246|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
64588247|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
64588248|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588249|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
64588250|NCT00217022|Budesonide|budesonide|mesh-list
64365252|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588251|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588252|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64588253|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
64588254|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588255|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588256|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64588258|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
64588259|NCT00217022|Hormones|hormones|mesh-ancestor
64588260|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588261|NCT03594968|Progesterone|progesterone|mesh-list
64356179|NCT01936857|Narcotics|narcotics|mesh-ancestor
64588262|NCT03594968|Progestins|progestins|mesh-ancestor
64588264|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588265|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588266|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
64588267|NCT00538915|Antibodies|antibodies|mesh-list
64588268|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
64356180|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356181|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356182|NCT01936857|Analgesics|analgesics|mesh-ancestor
64356183|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
64356184|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356185|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64356188|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
64588269|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64588270|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64588272|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588273|NCT00490009|Acetaminophen|acetaminophen|mesh-list
64588274|NCT00490009|Iodine|iodine|mesh-list
64588275|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
64588276|NCT00490009|Promethazine|promethazine|mesh-list
64588277|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
64588278|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
64588279|NCT00490009|Lugol's solution|lugol's solution|mesh-list
64588280|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64588281|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588282|NCT00490009|Analgesics|analgesics|mesh-ancestor
64365387|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
64588283|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
64588284|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588285|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588286|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
64588287|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64588288|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588289|NCT00490009|Trace Elements|trace elements|mesh-ancestor
64588290|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
64365548|NCT03266731|Aspirin|aspirin|mesh-list
64588291|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64588292|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64588293|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588294|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
64588295|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
64588296|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
64588297|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
64588298|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588299|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64588300|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
64365637|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
64588301|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
64588302|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588303|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588304|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64588305|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
64356210|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588306|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
64588307|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588309|NCT00490009|Coagulants|coagulants|mesh-ancestor
64588310|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
64588311|NCT03769532|Azacitidine|azacitidine|mesh-list
64588312|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64588313|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588314|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64356211|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
64356212|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356214|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588315|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
64588316|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588317|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356215|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64356216|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356217|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588318|NCT00490477|Polymyxins|polymyxins|mesh-list
64588319|NCT00490477|Polymyxin B|polymyxin b|mesh-list
64588320|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588322|NCT03997370|Carboplatin|carboplatin|mesh-list
64588323|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588324|NCT00492973|Cefuroxime|cefuroxime|mesh-list
64588325|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
64588326|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64588327|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64588328|NCT00492973|Prednisolone|prednisolone|mesh-list
64588329|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
64588331|NCT00492973|Epinephrine|epinephrine|mesh-list
64588332|NCT00492973|Morphine|morphine|mesh-list
64588333|NCT00492973|Bupivacaine|bupivacaine|mesh-list
64588334|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64588335|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
64588336|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
64588337|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
64588338|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588339|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366006|NCT03348371|Ethanol|ethanol|mesh-list
64588340|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
64588341|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588342|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64588343|NCT00492973|Narcotics|narcotics|mesh-ancestor
64588344|NCT00492973|Analgesics|analgesics|mesh-ancestor
64588345|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588346|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
64588347|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
64588348|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588349|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
64588350|NCT00492973|Hormones|hormones|mesh-ancestor
64588351|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588352|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64588353|NCT00492973|Protective Agents|protective agents|mesh-ancestor
64588354|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64588355|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588356|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64588357|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64588358|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
64588359|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588360|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588361|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64588362|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64588363|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64588364|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
64588365|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
64366151|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366152|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
64366153|NCT05584631|Antibodies|antibodies|mesh-list
64366154|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
64366155|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64366182|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366183|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366184|NCT02454751|Analgesics|analgesics|mesh-ancestor
64366185|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
64366186|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366187|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64366191|NCT02455921|Atropine|atropine|mesh-list
64588366|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
64588367|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64588368|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64588369|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
64588370|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64588371|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588372|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588373|NCT05630534|Minocycline|minocycline|mesh-list
64588374|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588375|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588377|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588378|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588379|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
64588380|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
64588381|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
64588382|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588384|NCT05630222|Ibuprofen|ibuprofen|mesh-list
64588385|NCT05630222|Morphine|morphine|mesh-list
64588386|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64366518|NCT03347513|Glycine|glycine|mesh-list
64588387|NCT05630222|Narcotics|narcotics|mesh-ancestor
64588388|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588389|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588391|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
64588392|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588393|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588394|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
64588395|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64588396|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588397|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64588398|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64588399|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588400|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588401|NCT03594188|Anesthetics|anesthetics|mesh-list
64588402|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588403|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588404|NCT00539695|Aldesleukin|aldesleukin|mesh-list
64588405|NCT00539695|Interleukin-2|interleukin-2|mesh-list
64588406|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588407|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588408|NCT00539695|Analgesics|analgesics|mesh-ancestor
64588409|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
64588410|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588411|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588412|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64588413|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64588414|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
64588415|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588416|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
64588417|NCT03590054|Abexinostat|abexinostat|mesh-list
64588418|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64588419|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588420|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64588421|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588422|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588424|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64588425|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64588426|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
64588427|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588428|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588429|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64588430|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64588431|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
64588432|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588433|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64366678|NCT02454205|Linezolid|linezolid|mesh-list
64588434|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64588436|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64588437|NCT03590210|Nivolumab|nivolumab|mesh-list
64588438|NCT03590210|Trabectedin|trabectedin|mesh-list
64588439|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64588440|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588441|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64588442|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588443|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64588444|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
64588445|NCT05632328|Gemcitabine|gemcitabine|mesh-list
64588446|NCT05632328|Paclitaxel|paclitaxel|mesh-list
64588447|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64588448|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588449|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588450|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
64588451|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
64588452|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
64588453|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64313763|NCT02114645|Progestins|progestins|mesh-ancestor
64588454|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64588455|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
64588456|NCT05632328|Antiviral Agents|antiviral agents|mesh-ancestor
64588457|NCT05632328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588458|NCT05632328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588459|NCT05632328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64588460|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
64588461|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588462|NCT03976310|Benralizumab|benralizumab|mesh-list
64588463|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64588464|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
64588465|NCT03599726|Donepezil|donepezil|mesh-list
64588466|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64588467|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366877|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588468|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588469|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
64588470|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588471|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588473|NCT00466817|Valganciclovir|valganciclovir|mesh-list
64588474|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
64588475|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588476|NCT04406870|Sirolimus|sirolimus|mesh-list
64588477|NCT04406870|Propranolol|propranolol|mesh-list
64588478|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588479|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588480|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64588481|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588482|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
64588483|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64588484|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
64588485|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588486|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64356247|NCT03393325|Tadalafil|tadalafil|mesh-list
64356262|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356263|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64356264|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356266|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
64356307|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
64356308|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
64356309|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
64588487|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64588488|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
64588489|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588490|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588491|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64588492|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64588493|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
64588494|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64588495|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
64588496|NCT03985514|Tazobactam|tazobactam|mesh-list
64588497|NCT03985514|Piperacillin|piperacillin|mesh-list
64588498|NCT03985514|Metronidazole|metronidazole|mesh-list
64588499|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64367065|NCT03121547|Tapentadol|tapentadol|mesh-list
64588500|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64588501|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588502|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
64588503|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64588504|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64588505|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588506|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588507|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588508|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64588509|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64588510|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64588511|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64588512|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64588513|NCT00540007|Lenalidomide|lenalidomide|mesh-list
64588514|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
64588515|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588516|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64588517|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64588518|NCT00540007|Growth Substances|growth substances|mesh-ancestor
64588519|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
64588520|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588521|NCT02982889|Bupivacaine|bupivacaine|mesh-list
64588522|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
64588523|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
64588524|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
64588525|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588526|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588527|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
64313836|NCT03036800|Incretins|incretins|mesh-ancestor
64356310|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380232|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356311|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356312|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
64356334|NCT03397069|Midazolam|midazolam|mesh-list
64356359|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
64356361|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356362|NCT03399019|Analgesics|analgesics|mesh-ancestor
64356363|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
64356364|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356365|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64356366|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64356367|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64356368|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356369|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356370|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588528|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588529|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64588530|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
64588531|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
64588532|NCT02982889|Protective Agents|protective agents|mesh-ancestor
64588533|NCT01867333|Metronidazole|metronidazole|mesh-list
64588534|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367158|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367161|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
64588535|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588536|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64588537|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64588538|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64588539|NCT03592082|Bismuth|bismuth|mesh-list
64588540|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
64588541|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588542|NCT03592082|Antacids|antacids|mesh-ancestor
64588546|NCT03598868|Vortioxetine|vortioxetine|mesh-list
64588547|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
64588548|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356371|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64588549|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64588550|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64588551|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588552|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588553|NCT03598868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64588554|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64588555|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64588556|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588557|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588558|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
64588559|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64588560|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64588561|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64356372|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64356373|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64356374|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356375|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
64356376|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
64356377|NCT04452383|Ketamine|ketamine|mesh-list
64356378|NCT04452383|Propofol|propofol|mesh-list
64356379|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356380|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356381|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356382|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64588562|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64588567|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64588568|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64588569|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367339|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
64588570|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
64588571|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588572|NCT05631704|Midazolam|midazolam|mesh-list
64588573|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64588574|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64588575|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588576|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588577|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64367468|NCT01597245|Ixekizumab|ixekizumab|mesh-list
64367470|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588578|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64588579|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64588580|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64588581|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
64588582|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
64588583|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
64588584|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
64588585|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588586|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588587|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
64588588|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64588589|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588590|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588591|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64588592|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64588593|NCT03591536|Protective Agents|protective agents|mesh-ancestor
64588594|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588595|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
64588596|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64588597|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
64356383|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
64588599|NCT00501943|Interferon-beta|interferon-beta|mesh-list
64588600|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
64588601|NCT00501943|Riluzole|riluzole|mesh-list
64588602|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588603|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
64588604|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588605|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
64588606|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367664|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
64356384|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
64356385|NCT04452383|Analgesics|analgesics|mesh-ancestor
64588607|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64588608|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
64588609|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64356386|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
64356387|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356388|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64356389|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64356390|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64356391|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356392|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356395|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356396|NCT02520947|Desflurane|desflurane|mesh-list
64356397|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64588610|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64588611|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588612|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588613|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64588614|NCT00501943|Protective Agents|protective agents|mesh-ancestor
64588615|NCT03598634|Riboflavin|riboflavin|mesh-list
64588616|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
64588617|NCT03598634|Vitamins|vitamins|mesh-ancestor
64588618|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
64588619|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588620|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64588621|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
64588622|NCT03598556|Vitamin D|vitamin d|mesh-list
64588623|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
64588624|NCT03598556|Vitamins|vitamins|mesh-ancestor
64588625|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
64588626|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588627|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64588628|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64588629|NCT03024476|Olmesartan|olmesartan|mesh-list
64588630|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64588631|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64588632|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64588633|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588634|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
64367842|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367843|NCT04467957|Xenon|xenon|mesh-list
64367844|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64367845|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
64367846|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
64367849|NCT02121405|Capecitabine|capecitabine|mesh-list
64588636|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64588637|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
64588638|NCT03590912|Prednisolone|prednisolone|mesh-list
64588639|NCT03590912|Phenylephrine|phenylephrine|mesh-list
64588640|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
64588641|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
64588642|NCT03590912|Levocetirizine|levocetirizine|mesh-list
64588643|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
64588644|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64588645|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588646|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588647|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
64588648|NCT03590912|Hormones|hormones|mesh-ancestor
64356398|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
64356399|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
64356400|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356401|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356402|NCT03398941|Octreotide|octreotide|mesh-list
64356403|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64356404|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64356405|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356406|NCT03396601|Ketamine|ketamine|mesh-list
64356407|NCT03396601|Analgesics|analgesics|mesh-ancestor
64356408|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
64588649|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588650|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588651|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64588652|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588653|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
64588654|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588655|NCT03590912|Protective Agents|protective agents|mesh-ancestor
64588656|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
64588657|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64588658|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64588659|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
64588660|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588661|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588662|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64588663|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64588664|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
64588665|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
64367923|NCT05051163|Ampicillin|ampicillin|mesh-list
64588666|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64588667|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
64588668|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64588669|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
64588670|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64588671|NCT00503113|Alendronate|alendronate|mesh-list
64588672|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
64588673|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367972|NCT03335579|Sufentanil|sufentanil|mesh-list
64588674|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588675|NCT00542971|Cytarabine|cytarabine|mesh-list
64588676|NCT00542971|Sorafenib|sorafenib|mesh-list
64588677|NCT00542971|Idarubicin|idarubicin|mesh-list
64588678|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64588679|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
64588680|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588681|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588682|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
64588683|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368105|NCT05038059|Ethylene|ethylene|mesh-list
64588684|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64368116|NCT01236547|Paclitaxel|paclitaxel|mesh-list
64588686|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588687|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64588688|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588689|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64588690|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64588691|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64588692|NCT00504751|Dexamethasone|dexamethasone|mesh-list
64588694|NCT00504751|Etoposide|etoposide|mesh-list
64588695|NCT00504751|Bortezomib|bortezomib|mesh-list
64588696|NCT00504751|Ifosfamide|ifosfamide|mesh-list
64356409|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356414|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
64356419|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356420|NCT03392623|Niacinamide|niacinamide|mesh-list
64356422|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
64356423|NCT03392623|Tretinoin|tretinoin|mesh-list
64356424|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
64356426|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
64368221|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588697|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64588698|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588699|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
64588700|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588701|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64588702|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588703|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
64588704|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
64588705|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368306|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588706|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588707|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
64588708|NCT00504751|Hormones|hormones|mesh-ancestor
64588709|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368307|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368308|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368309|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368310|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64588710|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64588711|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588712|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64588713|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64588714|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588715|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588716|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64588717|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
64588718|NCT01013779|Carboplatin|carboplatin|mesh-list
64588719|NCT01013779|Etoposide|etoposide|mesh-list
64588720|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588721|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588722|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64588723|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64588724|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588725|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588727|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
64588728|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588729|NCT05630768|Vitamin D|vitamin d|mesh-list
64588730|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
64588731|NCT05630768|Calcium|calcium|mesh-list
64588732|NCT05630768|Vitamins|vitamins|mesh-ancestor
64368519|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64588733|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
64588734|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368520|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368522|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
64368523|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368526|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
64588735|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64356427|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
64356428|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64588736|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64588737|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64588738|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64588739|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588740|NCT00506155|Bevacizumab|bevacizumab|mesh-list
64588741|NCT00506155|Cisplatin|cisplatin|mesh-list
64588742|NCT00506155|Doxorubicin|doxorubicin|mesh-list
64588743|NCT00506155|Methotrexate|methotrexate|mesh-list
64356429|NCT03392623|Protective Agents|protective agents|mesh-ancestor
64356430|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356431|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
64356432|NCT03392623|Vitamins|vitamins|mesh-ancestor
64356433|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
64356434|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64356435|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
64588744|NCT00506155|Vinblastine|vinblastine|mesh-list
64588745|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64368640|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
64588746|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588747|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64588748|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64588749|NCT00506155|Growth Substances|growth substances|mesh-ancestor
64588750|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588751|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
64588752|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64588753|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64588754|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64588755|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588756|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588757|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64588758|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
64588759|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64588760|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64588762|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
64588763|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64588764|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64588765|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
64588766|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64588767|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64588768|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588769|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
64369046|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64369047|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
64369063|NCT02487407|Simendan|simendan|mesh-list
64369076|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369081|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
64588770|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
64588771|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
64588773|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64588774|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64588775|NCT03590444|Growth Substances|growth substances|mesh-ancestor
64588776|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588777|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
64588778|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356436|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356437|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64356438|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
64356439|NCT03396107|Dexamethasone|dexamethasone|mesh-list
64356440|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64356441|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
64356442|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
64356443|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356444|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356445|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588779|NCT00506857|Fludarabine|fludarabine|mesh-list
64588780|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
64588781|NCT00506857|Busulfan|busulfan|mesh-list
64369298|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
64588782|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588783|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64588784|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
64588785|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588786|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64588787|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
64588788|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588789|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
64588790|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64588791|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64588792|NCT04005170|Paclitaxel|paclitaxel|mesh-list
64588793|NCT04005170|Cisplatin|cisplatin|mesh-list
64588794|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64588795|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588796|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
64588797|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
64588798|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
64588799|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588800|NCT03597308|Acetaminophen|acetaminophen|mesh-list
64588801|NCT03597308|Ibuprofen|ibuprofen|mesh-list
64588802|NCT03597308|Oxycodone|oxycodone|mesh-list
64369299|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588803|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588805|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
64588806|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588807|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588808|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
64588809|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64588810|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588811|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64588812|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64588813|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588814|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588815|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64588816|NCT03597308|Narcotics|narcotics|mesh-ancestor
64588817|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588818|NCT04750135|Metformin|metformin|mesh-list
64588819|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64588820|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588821|NCT04003922|Adalimumab|adalimumab|mesh-list
64588823|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64588825|NCT03781934|Lenvatinib|lenvatinib|mesh-list
64356446|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
64356447|NCT03396107|Hormones|hormones|mesh-ancestor
64588826|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64588827|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588828|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64588829|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588830|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588831|NCT00558571|Empagliflozin|empagliflozin|mesh-list
64588832|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64314137|NCT02123381|Cetuximab|cetuximab|mesh-list
64369364|NCT05004753|Hormones|hormones|mesh-ancestor
64588833|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588834|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64588835|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588836|NCT03970382|Aldesleukin|aldesleukin|mesh-list
64588837|NCT03970382|Nivolumab|nivolumab|mesh-list
64588838|NCT03970382|Interleukin-2|interleukin-2|mesh-list
64588839|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64588840|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588841|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64588842|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588843|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588844|NCT03970382|Analgesics|analgesics|mesh-ancestor
64588845|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
64588846|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588847|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588848|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64588849|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64588850|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
64588851|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588852|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64588853|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64414774|NCT02419755|Cytarabine|cytarabine|mesh-list
64588854|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588855|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
64588856|NCT01797913|Gemcitabine|gemcitabine|mesh-list
64588857|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64588858|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
64588859|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588860|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588861|NCT01797913|Antiviral Agents|antiviral agents|mesh-ancestor
64588862|NCT01797913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588863|NCT01797913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588864|NCT01797913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64588865|NCT01797913|Immunologic Factors|immunologic factors|mesh-ancestor
64588866|NCT01797913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588867|NCT03596294|Rifampin|rifampin|mesh-list
64588868|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64588869|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
64588870|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588871|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588872|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
64380458|NCT04159155|Carboplatin|carboplatin|mesh-list
64380459|NCT04159155|Niraparib|niraparib|mesh-list
64380460|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64380461|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380462|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
64380463|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
64380464|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
64380465|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380466|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64380467|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380468|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
64356448|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356449|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64356450|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356451|NCT03398785|Epinephrine|epinephrine|mesh-list
64356462|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
64356471|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588873|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64588874|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588875|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588876|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64588877|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64369609|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
64369610|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588878|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64588879|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64588880|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64588881|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64588882|NCT00537407|Ribavirin|ribavirin|mesh-list
64588883|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64588884|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
64369667|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369668|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64369669|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64588885|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588886|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
64356473|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64356475|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64356477|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
64356478|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588887|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588888|NCT00214916|Insulin|insulin|mesh-list
64588889|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64588890|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64588891|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588892|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64588893|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64588894|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64588895|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64588896|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588897|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588898|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588899|NCT00438971|Analgesics|analgesics|mesh-ancestor
64588900|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
64588901|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588902|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
64588903|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64588904|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
64588905|NCT00219284|Levodopa|levodopa|mesh-list
64588906|NCT00219284|Carbidopa|carbidopa|mesh-list
64588907|NCT00219284|Entacapone|entacapone|mesh-list
64588908|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64588909|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64588910|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64588911|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
64588912|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369902|NCT05353361|Paclitaxel|paclitaxel|mesh-list
64369903|NCT05353361|Pertuzumab|pertuzumab|mesh-list
64588913|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588915|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64588916|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588917|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64588918|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64588919|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
64588920|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
64588921|NCT00509041|Dasatinib|dasatinib|mesh-list
64588922|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588923|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64588924|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588925|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588926|NCT03781700|Prednisolone|prednisolone|mesh-list
64588927|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588928|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
64588929|NCT03781700|Hormones|hormones|mesh-ancestor
64588930|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64588931|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588932|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64588933|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588934|NCT00439673|Azacitidine|azacitidine|mesh-list
64588935|NCT00439673|Valproic Acid|valproic acid|mesh-list
64588936|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64588937|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
64588938|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588939|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588940|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64588941|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
64588942|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
64588943|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64588944|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588945|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
64588946|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64588947|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588948|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64588949|NCT03596060|Fentanyl|fentanyl|mesh-list
64588950|NCT03596060|Morphine|morphine|mesh-list
64588951|NCT03596060|Propofol|propofol|mesh-list
64588952|NCT03596060|Rocuronium|rocuronium|mesh-list
64588953|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64588954|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64588955|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588957|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
64588958|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
64356479|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356480|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356482|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356483|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356484|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64356485|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356486|NCT04647643|Paclitaxel|paclitaxel|mesh-list
64356487|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64356510|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356511|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356512|NCT04446715|Sufentanil|sufentanil|mesh-list
64588959|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64588960|NCT03596060|Narcotics|narcotics|mesh-ancestor
64370018|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64588961|NCT03596060|Analgesics|analgesics|mesh-ancestor
64588962|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
64588963|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64588964|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64588965|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64588966|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64588967|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64588968|NCT00473837|Chloroquine|chloroquine|mesh-list
64588969|NCT00473837|Amebicides|amebicides|mesh-ancestor
64588970|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64588971|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64588972|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588973|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
64588974|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370066|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370067|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64370068|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64588975|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
64588976|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64588977|NCT00509197|Fluticasone|fluticasone|mesh-list
64588978|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64588979|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64588980|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
64588981|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370157|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64588982|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588983|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64588984|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
64588985|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
64588986|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64588987|NCT00442013|Lansoprazole|lansoprazole|mesh-list
64588988|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
64588989|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64356513|NCT04446715|Meperidine|meperidine|mesh-list
64356514|NCT04446715|Bupivacaine|bupivacaine|mesh-list
64356515|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
64356516|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
64356517|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356519|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
64356543|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356545|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356546|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356547|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64356548|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64356549|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356550|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
64356551|NCT03396523|Losartan|losartan|mesh-list
64356552|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64356553|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64588990|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64588991|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64588992|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370271|NCT04996485|Ustekinumab|ustekinumab|mesh-list
64370272|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370273|NCT02447965|Bupivacaine|bupivacaine|mesh-list
64370274|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
64370368|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588993|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64588994|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
64588995|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64588996|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
64588997|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64588998|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64588999|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64589000|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64589001|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64589002|NCT00509665|Gemcitabine|gemcitabine|mesh-list
64589003|NCT00509665|Doxorubicin|doxorubicin|mesh-list
64370369|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
64380469|NCT05390307|Liraglutide|liraglutide|mesh-list
64370370|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64589004|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64589005|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64589006|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
64589007|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589008|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589009|NCT00509665|Antiviral Agents|antiviral agents|mesh-ancestor
64589010|NCT00509665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589011|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370763|NCT03070665|Ephedrine|ephedrine|mesh-list
64370765|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64370859|NCT02472275|Androgens|androgens|mesh-list
64370880|NCT03070353|Dextrans|dextrans|mesh-list
64589013|NCT00509665|Immunologic Factors|immunologic factors|mesh-ancestor
64589014|NCT00509665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589015|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64589016|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64356554|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64589017|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64589018|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
64589019|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64589020|NCT00513799|Mupirocin|mupirocin|mesh-list
64589021|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64589022|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589023|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
64589024|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
64589025|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64589026|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64589027|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589028|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589030|NCT00216476|Risperidone|risperidone|mesh-list
64589031|NCT00216476|Aripiprazole|aripiprazole|mesh-list
64589032|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64589033|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64589034|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
64589035|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589036|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371189|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
64371190|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371191|NCT03313661|Gliclazide|gliclazide|mesh-list
64371192|NCT03313661|Cabergoline|cabergoline|mesh-list
64589037|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589038|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64589039|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64589040|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589041|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64589042|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64589044|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
64589045|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
64371272|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
64371273|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64589046|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64589047|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64589048|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64589049|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64589050|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64589051|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
64589052|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64589053|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64589054|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64589055|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371379|NCT02468375|Urological Agents|urological agents|mesh-ancestor
64371380|NCT03304457|Olanzapine|olanzapine|mesh-list
64356555|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64356556|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356557|NCT03126097|Drospirenone|drospirenone|mesh-list
64356558|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64356559|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64356560|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64356561|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64356562|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64356563|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
64356564|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64380470|NCT05390307|Glucagon|glucagon|mesh-list
64356565|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356566|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64356567|NCT03126097|Estrogens|estrogens|mesh-ancestor
64356569|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356571|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
64356572|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64356573|NCT03126097|Diuretics|diuretics|mesh-ancestor
64356574|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
64356575|NCT03398083|Alprazolam|alprazolam|mesh-list
64356576|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64371381|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64589056|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589058|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589059|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589060|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64589061|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589062|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64589063|NCT00216086|Capecitabine|capecitabine|mesh-list
64589064|NCT00216086|Irinotecan|irinotecan|mesh-list
64371531|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64371532|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64371533|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371540|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
64371631|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64589065|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64589066|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
64589067|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356577|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356578|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356579|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64356580|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64356581|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356582|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
64356583|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
64589068|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589069|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64589070|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64589071|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589072|NCT00474851|Norethindrone|norethindrone|mesh-list
64589073|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
64371632|NCT00702221|Vaccines|vaccines|mesh-list
64371664|NCT02467595|Propofol|propofol|mesh-list
64589076|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589077|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589078|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64589079|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64589080|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64371772|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589081|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
64589082|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64356584|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356585|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356586|NCT03392311|Calcipotriene|calcipotriene|mesh-list
64356587|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
64356588|NCT03126721|Midazolam|midazolam|mesh-list
64356589|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64356591|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356592|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356593|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64356594|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64356595|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356596|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356597|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
64356598|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
64589083|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64589084|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64589085|NCT00215150|Ziprasidone|ziprasidone|mesh-list
64589086|NCT00215150|Sertraline|sertraline|mesh-list
64589087|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
64589088|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64589089|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64371895|NCT05655689|Vancomycin|vancomycin|mesh-list
64589090|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64589091|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64589092|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589093|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589095|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589096|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64589097|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64371948|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64371949|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372031|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
64372032|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372167|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589098|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64589099|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589100|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64356599|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
64356600|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
64589101|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
64589102|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64589103|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589104|NCT04198844|Warfarin|warfarin|mesh-list
64589105|NCT04198844|Apixaban|apixaban|mesh-list
64589106|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
64589107|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64589108|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
64589109|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64356601|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356626|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64356627|NCT04446637|Albuterol|albuterol|mesh-list
64356628|NCT04446637|Ipratropium|ipratropium|mesh-list
64589110|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589111|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589112|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589113|NCT03023852|Oseltamivir|oseltamivir|mesh-list
64356629|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64356630|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
64356631|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356632|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356633|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64356634|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356635|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
64356636|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64589114|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
64589115|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589116|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589117|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589118|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
64589119|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64589120|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372277|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372278|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64372279|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64372280|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372281|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64372282|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64372283|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
64372293|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64372294|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64372295|NCT05565495|Hydromorphone|hydromorphone|mesh-list
64372296|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64372297|NCT05565495|Narcotics|narcotics|mesh-ancestor
64372298|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372299|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372300|NCT05565495|Analgesics|analgesics|mesh-ancestor
64372301|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
64589122|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589123|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589124|NCT04001504|Vaccines|vaccines|mesh-list
64589125|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
64589126|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589127|NCT00516919|Orlistat|orlistat|mesh-list
64589128|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589129|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589130|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64372459|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372460|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64372486|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
64589132|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64589133|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589134|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64589135|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589136|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589137|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64589138|NCT04195100|Pilocarpine|pilocarpine|mesh-list
64589139|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64589140|NCT04195100|Miotics|miotics|mesh-ancestor
64372561|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372567|NCT03433469|Osimertinib|osimertinib|mesh-list
64589141|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
64589142|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589143|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589144|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64356639|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64589145|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64589146|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
64589147|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589148|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589149|NCT04193774|Anesthetics|anesthetics|mesh-list
64589150|NCT04193774|Benoxinate|benoxinate|mesh-list
64589151|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64372683|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64589152|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
64589153|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589154|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589155|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64589156|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
64589157|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
64589158|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589159|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
64372833|NCT00701363|Lanreotide|lanreotide|mesh-list
64589160|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64589161|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64589162|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64589163|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589164|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64589165|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64589166|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589167|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589168|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589169|NCT02985242|Empagliflozin|empagliflozin|mesh-list
64589170|NCT02985242|Glimepiride|glimepiride|mesh-list
64589171|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64372903|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
64372904|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372905|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373072|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64589172|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589173|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64589174|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589175|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64589176|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64589177|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
64589179|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64589180|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
64373271|NCT04971291|Bupropion|bupropion|mesh-list
64373398|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589181|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589182|NCT04196426|Calcium|calcium|mesh-list
64589183|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64589184|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589185|NCT00518713|Clobazam|clobazam|mesh-list
64589186|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
64589187|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64589188|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64589189|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589190|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589191|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64589192|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64589193|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
64589194|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
64589195|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589196|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589197|NCT03948464|Morphine|morphine|mesh-list
64589198|NCT03948464|Methadone|methadone|mesh-list
64589199|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64589200|NCT03948464|Narcotics|narcotics|mesh-ancestor
64589201|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589202|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589204|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
64589205|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589206|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
64589207|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
64589208|NCT04196270|Ropivacaine|ropivacaine|mesh-list
64589209|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
64589210|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
64589211|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373756|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373757|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64373984|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373985|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374111|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
64374112|NCT01670097|Hormones|hormones|mesh-ancestor
64374114|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64589213|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
64589214|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589216|NCT03948074|Cannabidiol|cannabidiol|mesh-list
64589217|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
64589218|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
64589219|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589220|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64589221|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64589222|NCT03948074|Analgesics|analgesics|mesh-ancestor
64589223|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
64589224|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589225|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64589226|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64589227|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589228|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589229|NCT03948074|Hormones|hormones|mesh-ancestor
64589230|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374243|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
64374244|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374245|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
64374246|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374247|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374397|NCT04965831|Aflutinib|aflutinib|mesh-list
64589231|NCT04020380|Azithromycin|azithromycin|mesh-list
64589232|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64589233|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589234|NCT00521989|Prednisolone|prednisolone|mesh-list
64589235|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64589236|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
64589237|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64589238|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
64589239|NCT00521989|Dipyridamole|dipyridamole|mesh-list
64589240|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64589241|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
64589242|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589243|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
64589244|NCT00521989|Hormones|hormones|mesh-ancestor
64589245|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589246|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589247|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64589248|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589249|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
64589250|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
64589251|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589252|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64589253|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64589254|NCT00521989|Protective Agents|protective agents|mesh-ancestor
64589255|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64589256|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589257|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589258|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64589259|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
64589260|NCT04029350|Osimertinib|osimertinib|mesh-list
64356676|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
64589261|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374490|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64374491|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64374492|NCT04965051|Insulin|insulin|mesh-list
64589262|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64589263|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589264|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589265|NCT00548197|Bevacizumab|bevacizumab|mesh-list
64589266|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64589267|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589268|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64589269|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64589270|NCT00548197|Growth Substances|growth substances|mesh-ancestor
64589271|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589272|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
64589273|NCT04029272|Metformin|metformin|mesh-list
64589274|NCT04029272|Exenatide|exenatide|mesh-list
64589275|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64589276|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589277|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64374816|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374821|NCT04413123|Nivolumab|nivolumab|mesh-list
64589280|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589281|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
64589282|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
64589283|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64314586|NCT02128061|Rituximab|rituximab|mesh-list
64589284|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64589285|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589286|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64589287|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
64589288|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589289|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64589290|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589291|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
64589292|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64374964|NCT03244241|Insulin|insulin|mesh-list
64589293|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64589294|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
64589295|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589296|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64589297|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64589298|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589299|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589301|NCT04028804|Fluorides|fluorides|mesh-list
64589302|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
64589303|NCT04028804|Protective Agents|protective agents|mesh-ancestor
64375138|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64589304|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589306|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589307|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
64589308|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589309|NCT00524017|Cetuximab|cetuximab|mesh-list
64589310|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64589311|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589312|NCT02985554|Nivolumab|nivolumab|mesh-list
64589313|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64589314|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589315|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64375419|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
64589316|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589317|NCT05560165|Listerine|listerine|mesh-list
64589318|NCT05560165|Anesthetics|anesthetics|mesh-list
64589319|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
64589320|NCT05560165|Fluorides|fluorides|mesh-list
64589321|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
64589322|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
64589323|NCT05560165|Protective Agents|protective agents|mesh-ancestor
64589324|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589325|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589326|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
64589327|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375672|NCT04902105|Analgesics|analgesics|mesh-ancestor
64375673|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
64375674|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375675|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589328|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64589329|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589330|NCT00525421|Curcumin|curcumin|mesh-list
64589331|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64589332|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64589333|NCT00525421|Analgesics|analgesics|mesh-ancestor
64589334|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
64589335|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589336|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589337|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589338|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64589339|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589340|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375767|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64375768|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64375770|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
64589341|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589342|NCT04023110|Carvedilol|carvedilol|mesh-list
64589343|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64589344|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64589345|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
64589346|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589347|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589348|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589349|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64589351|NCT04023110|Protective Agents|protective agents|mesh-ancestor
64589352|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64589353|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64589354|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64589355|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
64589356|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64375988|NCT04397991|Furosemide|furosemide|mesh-list
64589357|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64589358|NCT00525733|Ritonavir|ritonavir|mesh-list
64589359|NCT00525733|Darunavir|darunavir|mesh-list
64589360|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
64589361|NCT00525733|Maraviroc|maraviroc|mesh-list
64589362|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64589363|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64589364|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589365|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589366|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589367|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64589368|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64589369|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
64589370|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376120|NCT04569045|Lidocaine|lidocaine|mesh-list
64589371|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64589372|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64589374|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64589375|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64589376|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64589377|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64589378|NCT04025372|Bicalutamide|bicalutamide|mesh-list
64589379|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
64589380|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
64376191|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376204|NCT01595529|Cephalexin|cephalexin|mesh-list
64376289|NCT05214417|Ketamine|ketamine|mesh-list
64376290|NCT05214417|Analgesics|analgesics|mesh-ancestor
64376375|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376376|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376377|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376378|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64376379|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
64376469|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64376470|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64376472|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
64376473|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
64376474|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376475|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376503|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589381|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589382|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589383|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589385|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64589386|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64589387|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589388|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376600|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
64376605|NCT04863183|Triamcinolone|triamcinolone|mesh-list
64589389|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589391|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589392|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64589393|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
64589394|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589395|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
64589396|NCT05559619|Vitamin D|vitamin d|mesh-list
64589397|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
64589398|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
64589399|NCT05559619|Calcium|calcium|mesh-list
64589400|NCT05559619|Vitamins|vitamins|mesh-ancestor
64376694|NCT03233321|Heparin|heparin|mesh-list
64376803|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376834|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376835|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64376836|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376837|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64589401|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
64589402|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589403|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64589404|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64589405|NCT05559619|Antacids|antacids|mesh-ancestor
64589406|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589407|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64589408|NCT04194086|Posaconazole|posaconazole|mesh-list
64589409|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
64589410|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589411|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64589412|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64377144|NCT03043443|Protective Agents|protective agents|mesh-ancestor
64589414|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64589415|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64589416|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589417|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589418|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64589419|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
64589420|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589421|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589422|NCT04021862|Antibodies|antibodies|mesh-list
64589423|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64589424|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
64589425|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589426|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
64589427|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64589428|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
64589429|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589430|NCT04023266|Expectorants|expectorants|mesh-ancestor
64589431|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
64589432|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64589433|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
64589434|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589435|NCT04023266|Protective Agents|protective agents|mesh-ancestor
64589436|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589437|NCT04023266|Antidotes|antidotes|mesh-ancestor
64589438|NCT00475085|Dexamethasone|dexamethasone|mesh-list
64589439|NCT00475085|Aprepitant|aprepitant|mesh-list
64589440|NCT00475085|Palonosetron|palonosetron|mesh-list
64589441|NCT00475085|Granisetron|granisetron|mesh-list
64589442|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
64589443|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589445|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
64589446|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589447|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589448|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64589450|NCT00475085|Hormones|hormones|mesh-ancestor
64589451|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589452|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64589453|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589454|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64589455|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589456|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377345|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
64589457|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64589458|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64589459|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
64589460|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64589461|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64589462|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589463|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64589464|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64589465|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
64589466|NCT00551707|Prednisolone|prednisolone|mesh-list
64589467|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64589468|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
64589469|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64589470|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
64589471|NCT00551707|Dipyridamole|dipyridamole|mesh-list
64589472|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64589473|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
64589474|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589475|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
64589476|NCT00551707|Hormones|hormones|mesh-ancestor
64377613|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377628|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
64377713|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
64377715|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
64589477|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589478|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589479|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64589480|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589481|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
64589482|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
64589483|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589484|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64589485|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64589486|NCT00551707|Protective Agents|protective agents|mesh-ancestor
64589487|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64589488|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589489|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589490|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64377807|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
64589491|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
64589492|NCT04193930|Letrozole|letrozole|mesh-list
64589493|NCT04193930|Menotropins|menotropins|mesh-list
64589494|NCT04193930|Hormones|hormones|mesh-list
64589495|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64589496|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589497|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589498|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589499|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64589500|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64589501|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589502|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589503|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64589504|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
64589505|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64377974|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64589506|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
64589507|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64589508|NCT00445211|Heparin|heparin|mesh-list
64589509|NCT00445211|Calcium heparin|calcium heparin|mesh-list
64589510|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
64589511|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64589512|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64589513|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589514|NCT04193852|Dienogest|dienogest|mesh-list
64589515|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64589517|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64589518|NCT04193852|Estradiol|estradiol|mesh-list
64589519|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64589520|NCT04193852|Nandrolone|nandrolone|mesh-list
64589521|NCT04193852|Estrogens|estrogens|mesh-ancestor
64589522|NCT04193852|Hormones|hormones|mesh-ancestor
64589523|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589524|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589525|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64589527|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64589528|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64589529|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64589530|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64589531|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64589532|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
64589533|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64589534|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589535|NCT04193852|Androgens|androgens|mesh-ancestor
64589536|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
64589537|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
64378294|NCT05616507|Fucoidan|fucoidan|mesh-list
64378295|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64378297|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
64589538|NCT00552409|Vitamin D|vitamin d|mesh-list
64589539|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64589540|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589541|NCT00552409|Vitamins|vitamins|mesh-ancestor
64589542|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
64589543|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64589544|NCT03830918|Temozolomide|temozolomide|mesh-list
64589545|NCT03830918|Atezolizumab|atezolizumab|mesh-list
64589546|NCT03830918|Niraparib|niraparib|mesh-list
64589547|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64589548|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64589549|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
64589550|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378472|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64378473|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
64589551|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589552|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
64589553|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589554|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64589555|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589556|NCT00553735|Cyclosporine|cyclosporine|mesh-list
64589557|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
64589558|NCT00553735|Cyclosporins|cyclosporins|mesh-list
64589559|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589560|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589561|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64589562|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
64589563|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589564|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
64589565|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589566|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
64378474|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378601|NCT03202979|Trazodone|trazodone|mesh-list
64589568|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64589569|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64589570|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64589571|NCT04027166|Methadone|methadone|mesh-list
64589572|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64589573|NCT04027166|Narcotics|narcotics|mesh-ancestor
64589574|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589575|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589576|NCT04027166|Analgesics|analgesics|mesh-ancestor
64589577|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
64589578|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378696|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378697|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64378757|NCT03195569|Paclitaxel|paclitaxel|mesh-list
64589579|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
64378894|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
64379040|NCT04790331|Verapamil|verapamil|mesh-list
64589580|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379173|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589582|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64589583|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64589584|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589585|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589586|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589587|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64589588|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64589589|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
64589590|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589591|NCT00553969|Carvedilol|carvedilol|mesh-list
64589592|NCT00553969|Lisinopril|lisinopril|mesh-list
64589593|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64589594|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64589595|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
64589596|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589597|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589598|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589600|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
64589601|NCT00553969|Protective Agents|protective agents|mesh-ancestor
64589602|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64589603|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64356756|NCT03398837|Lenabasum|lenabasum|mesh-list
64356772|NCT03398759|Narcotics|narcotics|mesh-ancestor
64356773|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356774|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356785|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64356786|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64356787|NCT03391219|Growth Substances|growth substances|mesh-ancestor
64356788|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589604|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64589605|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
64589606|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64589607|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64589608|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64589609|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589610|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589611|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64589612|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64589613|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64589614|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589615|NCT05533567|Sufentanil|sufentanil|mesh-list
64379328|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
64589616|NCT05533567|Dsuvia|dsuvia|mesh-list
64589617|NCT05533567|Propofol|propofol|mesh-list
64589618|NCT05533567|Cisatracurium|cisatracurium|mesh-list
64589619|NCT05533567|Atracurium|atracurium|mesh-list
64589620|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64589621|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589622|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589623|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64589624|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
64589625|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
64589626|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64589627|NCT05533567|Narcotics|narcotics|mesh-ancestor
64589628|NCT05533567|Analgesics|analgesics|mesh-ancestor
64589629|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
64589630|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379472|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589632|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64589633|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64589634|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64589635|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64589636|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64589637|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
64589638|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589639|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589640|NCT04026464|Acetaminophen|acetaminophen|mesh-list
64589641|NCT04026464|Ibuprofen|ibuprofen|mesh-list
64589642|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64589643|NCT04026464|Analgesics|analgesics|mesh-ancestor
64589644|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
64589645|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589646|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379662|NCT01318317|Lenograstim|lenograstim|mesh-list
64379800|NCT02112448|Acetaminophen|acetaminophen|mesh-list
64589647|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
64589648|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64589649|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589650|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64589651|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64589652|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589653|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356789|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
64589654|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
64589655|NCT04192916|Apixaban|apixaban|mesh-list
64589656|NCT04192916|Edoxaban|edoxaban|mesh-list
64589657|NCT04192916|Dabigatran|dabigatran|mesh-list
64379959|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64379964|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
64589659|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
64589660|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64589661|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589662|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589663|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589664|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
64589665|NCT01797991|Dexamethasone|dexamethasone|mesh-list
64589666|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
64589667|NCT01797991|BB 1101|bb 1101|mesh-list
64589668|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589669|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
64589670|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
64589671|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589672|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589673|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64589674|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
64589675|NCT01797991|Hormones|hormones|mesh-ancestor
64380048|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
64589676|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589677|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64589678|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589679|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589680|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589681|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589682|NCT00475319|Rebamipide|rebamipide|mesh-list
64589683|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64380125|NCT05546853|Protective Agents|protective agents|mesh-ancestor
64380126|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
64380127|NCT05546853|Vitamins|vitamins|mesh-ancestor
64380129|NCT05540145|Paclitaxel|paclitaxel|mesh-list
64589684|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64589685|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
64589686|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589687|NCT00475319|Protective Agents|protective agents|mesh-ancestor
64589688|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589689|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589690|NCT04026074|Clonidine|clonidine|mesh-list
64589691|NCT04026074|Fentanyl|fentanyl|mesh-list
64589692|NCT04026074|Remifentanil|remifentanil|mesh-list
64589693|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64589694|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64589695|NCT04026074|Narcotics|narcotics|mesh-ancestor
64589696|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589697|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380352|NCT05696613|Hormones|hormones|mesh-ancestor
64589698|NCT04026074|Analgesics|analgesics|mesh-ancestor
64380446|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589699|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
64589700|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589701|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64589702|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64589703|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
64589704|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
64589705|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64589706|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
64589707|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
64589708|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64589709|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64589710|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64380536|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380538|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
64380539|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
64356790|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64589712|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380632|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
64589713|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589714|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
64589715|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64589716|NCT02704208|Nicotine|nicotine|mesh-list
64589717|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64589718|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
64589719|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589720|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589721|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64589722|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64589723|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
64589724|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589725|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589726|NCT00555997|Ziprasidone|ziprasidone|mesh-list
64589727|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64589728|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
64589729|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589730|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589731|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589732|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64589733|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64589734|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64589735|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64589736|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64589737|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
64589738|NCT00446147|Pyridoxine|pyridoxine|mesh-list
64589739|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
64589740|NCT00446147|Vitamins|vitamins|mesh-ancestor
64589741|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
64589742|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380633|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380634|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589743|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64589744|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64589745|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64589746|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64589747|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589748|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589749|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589750|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
64589751|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64380692|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380704|NCT05674305|Cisplatin|cisplatin|mesh-list
64589752|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
64589753|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64589754|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
64589755|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64589756|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589757|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64589758|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64589759|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64589760|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64589761|NCT04192292|Gliclazide|gliclazide|mesh-list
64589762|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64589763|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64589764|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589765|NCT04192292|Incretins|incretins|mesh-ancestor
64380776|NCT04756557|Protective Agents|protective agents|mesh-ancestor
64380975|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64589766|NCT04192292|Hormones|hormones|mesh-ancestor
64589767|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589768|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
64589769|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356911|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64589770|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589771|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64589772|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64589773|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64589774|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
64589776|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589777|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589778|NCT00448175|Urological Agents|urological agents|mesh-ancestor
64589779|NCT04176835|Oxytocin|oxytocin|mesh-list
64589780|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
64589781|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381053|NCT05534685|Budesonide|budesonide|mesh-list
64589782|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589783|NCT00476645|Fulvestrant|fulvestrant|mesh-list
64589784|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64589785|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589786|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64589787|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64589788|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
64589789|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64589790|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589791|NCT00477191|Etanercept|etanercept|mesh-list
64589792|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64589793|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64381254|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64589794|NCT00477191|Analgesics|analgesics|mesh-ancestor
64589795|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
64589796|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589797|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589798|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589799|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64589800|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64589801|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64589802|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
64589803|NCT04025918|Phenylephrine|phenylephrine|mesh-list
64589804|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
64589805|NCT04025918|Ephedrine|ephedrine|mesh-list
64589806|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64589807|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64589808|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
64589809|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
64589810|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589811|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64315117|NCT05472896|Epirubicin|epirubicin|mesh-list
64589812|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
64589813|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
64589814|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
64589815|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64589816|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64589817|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64589818|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
64589819|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589820|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589821|NCT04025918|Protective Agents|protective agents|mesh-ancestor
64589822|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64589823|NCT05415397|Celecoxib|celecoxib|mesh-list
64589824|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64589825|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64589826|NCT05415397|Analgesics|analgesics|mesh-ancestor
64381622|NCT02429219|Ethanol|ethanol|mesh-list
64381709|NCT05518383|Melphalan|melphalan|mesh-list
64381710|NCT05518383|Ifosfamide|ifosfamide|mesh-list
64381711|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
64381712|NCT05518383|Doxorubicin|doxorubicin|mesh-list
64589827|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
64589828|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589829|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589830|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64589831|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64589832|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64589833|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64589834|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589835|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589836|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
64589837|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64589838|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589839|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
64589840|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64381829|NCT05105841|Venetoclax|venetoclax|mesh-list
64381902|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381993|NCT03183557|Vitamin D|vitamin d|mesh-list
64382141|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64382142|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64382143|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382144|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64382145|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64382146|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64382147|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382148|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382149|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
64382150|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
64382236|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
64382237|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589841|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589842|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64589843|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589844|NCT02115581|Ubiquinone|ubiquinone|mesh-list
64589845|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
64589846|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
64589847|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589848|NCT02115581|Vitamins|vitamins|mesh-ancestor
64589849|NCT00477659|Donepezil|donepezil|mesh-list
64589850|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64589851|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589852|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589853|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
64589854|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589855|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589856|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
64589857|NCT04191278|Varenicline|varenicline|mesh-list
64589858|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64589859|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64382452|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
64382590|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589860|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
64589861|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589862|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589863|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589864|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
64589865|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64589866|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64589867|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589868|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589870|NCT03988387|Emtricitabine|emtricitabine|mesh-list
64589871|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
64589872|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589873|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64589874|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64589875|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382591|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64589876|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589877|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64589878|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64589879|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
64589880|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64589881|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
64589882|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589883|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589884|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64315190|NCT03511118|Metformin|metformin|mesh-list
64589885|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
64382658|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64382659|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
64382660|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
64382775|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
64382815|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382816|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64382817|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
64382818|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
64382819|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382820|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64382821|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
64382939|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
64383052|NCT02414009|Temozolomide|temozolomide|mesh-list
64383053|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
64589886|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64589887|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
64589888|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589889|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589890|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64589891|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
64589892|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
64589893|NCT03748082|Protective Agents|protective agents|mesh-ancestor
64589894|NCT00478361|Gemcitabine|gemcitabine|mesh-list
64589895|NCT00478361|Paclitaxel|paclitaxel|mesh-list
64383273|NCT04871529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383274|NCT04871529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383299|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64589898|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64589899|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589900|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
64589901|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
64589902|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
64589903|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589904|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64589906|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
64589907|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589908|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589909|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64589910|NCT00478361|Immunologic Factors|immunologic factors|mesh-ancestor
64589911|NCT00478361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589912|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64589913|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64589914|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64589915|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
64383631|NCT02408003|Milrinone|milrinone|mesh-list
64589916|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589917|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
64589918|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64589919|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64589920|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357043|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64357045|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589921|NCT02129725|Urological Agents|urological agents|mesh-ancestor
64589922|NCT00483509|Doxorubicin|doxorubicin|mesh-list
64589923|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64383732|NCT04591431|Vemurafenib|vemurafenib|mesh-list
64589924|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589925|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64589926|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64589927|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589928|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589930|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64589931|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589932|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589933|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589934|NCT03842839|Albuterol|albuterol|mesh-list
64589935|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
64589936|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64589937|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
64589938|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64589939|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589940|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64589941|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
64589942|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
64589943|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64589944|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
64383944|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
64383945|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383946|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64384126|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
64589945|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64589946|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589947|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
64589948|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64589949|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64589950|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64589951|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64589952|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
64589954|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
64589955|NCT00450983|Fludarabine|fludarabine|mesh-list
64589956|NCT00450983|Thiotepa|thiotepa|mesh-list
64589957|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
64589958|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64589959|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
64589960|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64589962|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64589963|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
64589964|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589965|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589966|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
64589967|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64589968|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64589969|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64589970|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
64589971|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384465|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589972|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64589973|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64589974|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
64589975|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64589976|NCT01796405|Clofarabine|clofarabine|mesh-list
64589977|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64589978|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
64589979|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589980|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589981|NCT03298295|Insulin|insulin|mesh-list
64589982|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64589983|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64589984|NCT03649321|Gemcitabine|gemcitabine|mesh-list
64589985|NCT03649321|Paclitaxel|paclitaxel|mesh-list
64589986|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64384566|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
64589987|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64384742|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64589988|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64589989|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
64589990|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
64589991|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
64589992|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64589993|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64589994|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
64589995|NCT03649321|Antiviral Agents|antiviral agents|mesh-ancestor
64589996|NCT03649321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64589997|NCT03649321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384744|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
64589998|NCT03649321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385027|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
64589999|NCT03649321|Immunologic Factors|immunologic factors|mesh-ancestor
64590000|NCT03649321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590001|NCT04192370|Cannabidiol|cannabidiol|mesh-list
64590002|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
64590003|NCT04149938|Lidocaine|lidocaine|mesh-list
64590004|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
64590005|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
64385029|NCT05484687|Anesthetics|anesthetics|mesh-list
64590006|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590007|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590008|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
64590009|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590010|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64590011|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64590012|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64590013|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590014|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590015|NCT01797601|Insulin|insulin|mesh-list
64385143|NCT03605901|Methadone|methadone|mesh-list
64385237|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64590016|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64590017|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64590018|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590020|NCT02984930|Mosapride|mosapride|mesh-list
64590021|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64590022|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590023|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64590024|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590025|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590026|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64590027|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
64590028|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590029|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590030|NCT02123017|Lactulose|lactulose|mesh-list
64590031|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590032|NCT04149626|Midazolam|midazolam|mesh-list
64590033|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
64590034|NCT04149626|Remifentanil|remifentanil|mesh-list
64590035|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64590036|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590037|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385405|NCT03167177|Nivolumab|nivolumab|mesh-list
64590038|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64590039|NCT04149626|Analgesics|analgesics|mesh-ancestor
64590040|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
64590041|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590042|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64590043|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64590044|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64590045|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
64590046|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590047|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590048|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64590049|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64590050|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64590051|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64590052|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64590053|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
64590054|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
64590055|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
64590056|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
64385406|NCT03167177|Avelumab|avelumab|mesh-list
64590057|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64590058|NCT04149626|Narcotics|narcotics|mesh-ancestor
64590059|NCT00486863|Praziquantel|praziquantel|mesh-list
64590060|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
64590061|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64590062|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590064|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
64590065|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64590066|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590067|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
64590068|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590069|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590070|NCT05150587|Rifaximin|rifaximin|mesh-list
64590071|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590072|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590073|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590074|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
64590075|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64590076|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590077|NCT00452387|Prednisone|prednisone|mesh-list
64590078|NCT00452387|Sorafenib|sorafenib|mesh-list
64385761|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64590079|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
64590080|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590081|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
64590082|NCT00452387|Hormones|hormones|mesh-ancestor
64590083|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64590084|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590085|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64590086|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590087|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64590088|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590089|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590090|NCT00452387|Analgesics|analgesics|mesh-ancestor
64590091|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
64590092|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590093|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64590094|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64590095|NCT03945656|Insulin|insulin|mesh-list
64590096|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64590097|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
64590098|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64590099|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590100|NCT00452543|Acamprosate|acamprosate|mesh-list
64590101|NCT00452543|Dexetimide|dexetimide|mesh-list
64590102|NCT00452543|Citalopram|citalopram|mesh-list
64590103|NCT00452543|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64590104|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64590105|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64386142|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
64590106|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590107|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590108|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
64590109|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590110|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64590111|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
64590112|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64590113|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64590114|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64590115|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
64380593|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
64590116|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
64386143|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
64590118|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64590119|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64590121|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64590122|NCT04961359|Vaccines|vaccines|mesh-list
64590123|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
64590124|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590125|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64590127|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590128|NCT04765904|Fluorides|fluorides|mesh-list
64590129|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
64590130|NCT04765904|Protective Agents|protective agents|mesh-ancestor
64590131|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590132|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
64590133|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64590134|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590135|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64590136|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590137|NCT00565669|Cyclosporine|cyclosporine|mesh-list
64590138|NCT00565669|Cyclosporins|cyclosporins|mesh-list
64590139|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590140|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590142|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
64590143|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590144|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
64590145|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590146|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
64590147|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590148|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64590149|NCT04165135|Factor VIII|factor viii|mesh-list
64590150|NCT04165135|Coagulants|coagulants|mesh-ancestor
64590151|NCT02132533|Nifedipine|nifedipine|mesh-list
64590152|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64590153|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590154|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590155|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64590156|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590157|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
64590158|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
64590159|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64590160|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64590161|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590162|NCT00567229|Rituximab|rituximab|mesh-list
64590163|NCT00567229|Lenalidomide|lenalidomide|mesh-list
64590164|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64590165|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590166|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
64590167|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590168|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590169|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64590170|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64590171|NCT00567229|Growth Substances|growth substances|mesh-ancestor
64590172|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
64590173|NCT04148846|Dexamethasone|dexamethasone|mesh-list
64590174|NCT04148846|Ketoprofen|ketoprofen|mesh-list
64590175|NCT04148846|Theophylline|theophylline|mesh-list
64590176|NCT04148846|Gabapentin|gabapentin|mesh-list
64590177|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590178|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
64590179|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
64590180|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590181|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590182|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590183|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
64590184|NCT04148846|Hormones|hormones|mesh-ancestor
64590185|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64590187|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590188|NCT04148846|Analgesics|analgesics|mesh-ancestor
64590189|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
64590190|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
64357173|NCT03386201|Methylene Blue|methylene blue|mesh-list
64590191|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64590192|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64590193|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590194|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64590197|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590198|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590200|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64590201|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64590203|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64590204|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590205|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64590206|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64590207|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
64590208|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64590209|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
64590210|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64590211|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64590212|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
64590214|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64590215|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590216|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590217|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
64590218|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64590219|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
64590220|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590221|NCT00568087|Expectorants|expectorants|mesh-ancestor
64590222|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
64590226|NCT00568087|Protective Agents|protective agents|mesh-ancestor
64590227|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590228|NCT00568087|Antidotes|antidotes|mesh-ancestor
64590229|NCT00487721|Silymarin|silymarin|mesh-list
64590230|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
64590231|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590232|NCT00487721|Protective Agents|protective agents|mesh-ancestor
64590233|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590234|NCT03761030|Levodopa|levodopa|mesh-list
64590235|NCT03761030|Carbidopa|carbidopa|mesh-list
64590237|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64590238|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64590240|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590241|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590242|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590243|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64590244|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590245|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64590246|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
64590247|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
64590248|NCT00568633|Cyclosporine|cyclosporine|mesh-list
64590249|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
64590250|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
64590251|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64590252|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64590253|NCT00568633|Prednisolone|prednisolone|mesh-list
64590254|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
64590255|NCT00568633|Cyclosporins|cyclosporins|mesh-list
64590256|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
64590257|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64590258|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64590259|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
64590260|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590261|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590262|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64590263|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
64590264|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590265|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
64590266|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590267|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
64590268|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590269|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64590270|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64590273|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
64590274|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590275|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590276|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
64590277|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
64590278|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590279|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590280|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
64590281|NCT00568633|Hormones|hormones|mesh-ancestor
64590282|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64590283|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64590284|NCT00568633|Protective Agents|protective agents|mesh-ancestor
64590285|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64590286|NCT03022838|Caffeine|caffeine|mesh-list
64590287|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64590288|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590289|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64590290|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590291|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590292|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64590293|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64590294|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
64590295|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590296|NCT05363449|Naftifine|naftifine|mesh-list
64590297|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
64590298|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590299|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
64590300|NCT00489281|Sirolimus|sirolimus|mesh-list
64590301|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
64590302|NCT00489281|Fludarabine|fludarabine|mesh-list
64590303|NCT00489281|Levetiracetam|levetiracetam|mesh-list
64590304|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
64590306|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64590307|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
64590308|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590309|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590310|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64590311|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
64590312|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590313|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590314|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64590315|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64590316|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64590317|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
64590318|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357175|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357177|NCT03391427|Ketamine|ketamine|mesh-list
64357178|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
64357179|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
64357182|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
64357183|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357184|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64357185|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64357186|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64357187|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64357188|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590319|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590320|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590321|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
64590322|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
64590323|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
64590324|NCT05362513|Ivermectin|ivermectin|mesh-list
64590329|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590330|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64590331|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
64590332|NCT04146038|Azacitidine|azacitidine|mesh-list
64590333|NCT04146038|Decitabine|decitabine|mesh-list
64590334|NCT04146038|Venetoclax|venetoclax|mesh-list
64590335|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64590336|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
64590337|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590338|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590339|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590340|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64590341|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64590342|NCT04146038|Analgesics|analgesics|mesh-ancestor
64590343|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
64590344|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590345|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590346|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590347|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590348|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64590349|NCT04457297|Trifluridine|trifluridine|mesh-list
64590350|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
64590351|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590352|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
64590353|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590354|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
64590355|NCT04146116|Povidone|povidone|mesh-list
64590356|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
64590357|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
64590358|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64590359|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590360|NCT04145804|Insulin|insulin|mesh-list
64590361|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64590362|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590363|NCT02120261|Triamcinolone|triamcinolone|mesh-list
64590364|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64590366|NCT02120261|Lidocaine|lidocaine|mesh-list
64590367|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64590368|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
64590369|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
64590370|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590371|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590372|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
64590373|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590374|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64590375|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64590376|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64590377|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590378|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590379|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590380|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
64590381|NCT02120261|Hormones|hormones|mesh-ancestor
64590382|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64590383|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64590384|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
64590385|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590386|NCT03907046|Aspirin|aspirin|mesh-list
64590387|NCT03907046|Apixaban|apixaban|mesh-list
64590388|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64590389|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64590390|NCT03907046|Analgesics|analgesics|mesh-ancestor
64590391|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
64590392|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590393|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590394|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590395|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590396|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64590397|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64590398|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590399|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64590400|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64590401|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590402|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
64590403|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64590404|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
64590405|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64590406|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
64590407|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
64590409|NCT03840421|Cisplatin|cisplatin|mesh-list
64590410|NCT03840421|Fluorouracil|fluorouracil|mesh-list
64590411|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590412|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64590413|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
64590414|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590415|NCT03840421|Antiviral Agents|antiviral agents|mesh-ancestor
64590416|NCT03840421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590418|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64590419|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
64590420|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590422|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64590423|NCT00492089|Antibodies|antibodies|mesh-list
64590424|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
64590425|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64590426|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590427|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64590428|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64590429|NCT00492089|Growth Substances|growth substances|mesh-ancestor
64590430|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590431|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64590432|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
64590433|NCT01798537|Vancomycin|vancomycin|mesh-list
64590434|NCT01798537|Colistin|colistin|mesh-list
64590435|NCT01798537|Neomycin|neomycin|mesh-list
64590436|NCT01798537|Nystatin|nystatin|mesh-list
64590437|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590438|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590439|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64590440|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590441|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590442|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
64590443|NCT01798537|Ionophores|ionophores|mesh-ancestor
64590444|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590445|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64590446|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590447|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590449|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590450|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64590451|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590452|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590453|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64590454|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64590455|NCT01797341|Tacrolimus|tacrolimus|mesh-list
64590456|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64590457|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
64590458|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590459|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64590460|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590461|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590462|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64590463|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590464|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64590465|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590466|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590467|NCT04145492|Vitamin D|vitamin d|mesh-list
64590468|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
64590470|NCT04145492|Vitamins|vitamins|mesh-list
64590471|NCT04145492|Vitamin K|vitamin k|mesh-list
64590472|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
64590473|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
64590474|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590475|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64590476|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64590477|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64590478|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64590479|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590480|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
64590481|NCT04145492|Coagulants|coagulants|mesh-ancestor
64590482|NCT04147754|Morphine|morphine|mesh-list
64590483|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590484|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590485|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64590487|NCT04147754|Analgesics|analgesics|mesh-ancestor
64590488|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
64590489|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590490|NCT05324449|Cannabidiol|cannabidiol|mesh-list
64590491|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
64590492|NCT00492401|Decitabine|decitabine|mesh-list
64590493|NCT00492401|Azacitidine|azacitidine|mesh-list
64590494|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64590495|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
64590496|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590498|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590499|NCT03674827|Vaccines|vaccines|mesh-list
64590500|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
64590501|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590502|NCT04147286|Atorvastatin|atorvastatin|mesh-list
64590503|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64590504|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64590505|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
64590506|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590507|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64590508|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64590509|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590510|NCT00493181|Oprelvekin|oprelvekin|mesh-list
64590511|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590512|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
64590513|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
64590514|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64590515|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
64590516|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64590517|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590519|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64590520|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64590521|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64590522|NCT00493805|Interferons|interferons|mesh-list
64590523|NCT00493805|Ribavirin|ribavirin|mesh-list
64590524|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
64590525|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
64590526|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64590527|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590528|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
64590529|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590530|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
64590531|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590532|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
64590533|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590536|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
64590537|NCT04145102|Protective Agents|protective agents|mesh-ancestor
64590538|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590539|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590540|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64590541|NCT05581706|Calcium|calcium|mesh-list
64357315|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
64590542|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64590543|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590544|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590545|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64590546|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
64590547|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590548|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64590549|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590550|NCT03588494|Endostar protein|endostar protein|mesh-list
64590551|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64590552|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64590553|NCT03588494|Growth Substances|growth substances|mesh-ancestor
64590554|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590555|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
64590556|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590558|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590559|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64590560|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590561|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590563|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64590564|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64590565|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64590566|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590567|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590568|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
64590569|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590570|NCT00550589|Cidofovir|cidofovir|mesh-list
64590571|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
64590572|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590573|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590574|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590576|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
64590577|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590578|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64590579|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590580|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64590581|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590582|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64590583|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64590584|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
64590585|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590586|NCT03588338|Acetaminophen|acetaminophen|mesh-list
64590587|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64590588|NCT03588338|Analgesics|analgesics|mesh-ancestor
64590589|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
64590590|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590591|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590593|NCT05099185|Trace Elements|trace elements|mesh-list
64590594|NCT05099185|Micronutrients|micronutrients|mesh-list
64590595|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590596|NCT05068609|Nivolumab|nivolumab|mesh-list
64590597|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64590598|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590599|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64590600|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590601|NCT00496379|Epothilones|epothilones|mesh-list
64590603|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
64590604|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
64590605|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
64590606|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590607|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590608|NCT02985086|Cefoxitin|cefoxitin|mesh-list
64590609|NCT02985086|Misoprostol|misoprostol|mesh-list
64590610|NCT02985086|Oxytocin|oxytocin|mesh-list
64590611|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
64357323|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
64590612|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64590613|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590614|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64590615|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
64590616|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64590617|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590618|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590619|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590620|NCT00497081|Mirtazapine|mirtazapine|mesh-list
64590621|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
64590622|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64590623|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64590624|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
64590625|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
64590626|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590627|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429986|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64590628|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590629|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64590631|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590632|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64590633|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64590634|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64590635|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64590636|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64590637|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64590638|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
64590639|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64590641|NCT01796951|Celecoxib|celecoxib|mesh-list
64590642|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64590643|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64590644|NCT01796951|Analgesics|analgesics|mesh-ancestor
64590645|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
64590646|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590647|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590648|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590649|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590650|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64590651|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64590652|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590653|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64590654|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64590655|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590657|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64590658|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
64590659|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296069|NCT02926586|Cytarabine|cytarabine|mesh-list
64590660|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64590661|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590662|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590663|NCT03895502|Edoxaban|edoxaban|mesh-list
64590665|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
64590666|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64590667|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
64590668|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590669|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590670|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
64590671|NCT03905798|Lorazepam|lorazepam|mesh-list
64590672|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
64590673|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
64590674|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
64590675|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357328|NCT00225095|Protective Agents|protective agents|mesh-ancestor
64590676|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590677|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590678|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64590679|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590680|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64590681|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64590682|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64590683|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
64590684|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
64590685|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590686|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590687|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
64590688|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64590689|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64590690|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64590691|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590692|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590693|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
64590694|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590695|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590696|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64590697|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590698|NCT03587558|Flecainide|flecainide|mesh-list
64590699|NCT03587558|Carvedilol|carvedilol|mesh-list
64590700|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64590701|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64590702|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
64590703|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590704|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590705|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590706|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64590707|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
64590708|NCT03587558|Protective Agents|protective agents|mesh-ancestor
64590709|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64590710|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590711|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64590712|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
64590713|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64590714|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64590715|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64590716|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64590717|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64590718|NCT04415905|Propofol|propofol|mesh-list
64590719|NCT04415905|Sevoflurane|sevoflurane|mesh-list
64590720|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64590721|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590722|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590723|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64590724|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
64590725|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
64590726|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64590727|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64590729|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64590730|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590731|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64590732|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64590733|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64590734|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590735|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
64590736|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590737|NCT02979704|Atorvastatin|atorvastatin|mesh-list
64590738|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64590739|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64590740|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64590741|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
64590743|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64590744|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64590745|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590746|NCT03587324|Clopidogrel|clopidogrel|mesh-list
64590747|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64590748|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64590749|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64590751|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
64590752|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590753|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590754|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590755|NCT03919292|Valproic Acid|valproic acid|mesh-list
64590756|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
64590757|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590758|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590759|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
64590760|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590761|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590762|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
64590763|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64590764|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590765|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64590766|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
64590767|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64590768|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64590769|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590771|NCT01980355|Coagulants|coagulants|mesh-ancestor
64590772|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
64590774|NCT00555321|Tacrolimus|tacrolimus|mesh-list
64590775|NCT00555321|Basiliximab|basiliximab|mesh-list
64590776|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64590777|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
64590778|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590779|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64590780|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590781|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590782|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64590783|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590784|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64590785|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
64590786|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590787|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590788|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64590789|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590790|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
64590791|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64590792|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590793|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590794|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64590795|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64590796|NCT05583266|Protective Agents|protective agents|mesh-ancestor
64590797|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590798|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
64590799|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64590800|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
64590801|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
64590802|NCT04142840|Propofol|propofol|mesh-list
64296073|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
64590803|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64590804|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590805|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590807|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
64590809|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64590810|NCT04142840|Analgesics|analgesics|mesh-ancestor
64590811|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
64590812|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590813|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64590814|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64590815|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64590816|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
64590817|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590818|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590819|NCT04142762|Itraconazole|itraconazole|mesh-list
64590820|NCT04142762|Rifampin|rifampin|mesh-list
64590821|NCT04142762|Midazolam|midazolam|mesh-list
64590822|NCT04142762|Esomeprazole|esomeprazole|mesh-list
64590823|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
64590824|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64590825|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64590826|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
64590827|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
64590828|NCT04142762|Estradiol|estradiol|mesh-list
64590829|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64590830|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64590831|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590832|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590833|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64590836|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64590837|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
64590838|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
64590839|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
64590840|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
64590841|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590842|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590843|NCT04142762|Estrogens|estrogens|mesh-ancestor
64590844|NCT04142762|Hormones|hormones|mesh-ancestor
64590845|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64590846|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64590847|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64590848|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64590849|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64590850|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64590851|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64590852|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590853|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
64590854|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590855|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64590856|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64590857|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64590858|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
64590859|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64590860|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64590861|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64590862|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
64590863|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590864|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
64590865|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64590866|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64590867|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64590868|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64590869|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64590870|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64296076|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
64590871|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64590872|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64590873|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64590874|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64590875|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64590876|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590877|NCT02139007|Alendronate|alendronate|mesh-list
64590878|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64590879|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590880|NCT01590277|Ethanol|ethanol|mesh-list
64590881|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64590882|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590883|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590884|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590885|NCT03586466|Buprenorphine|buprenorphine|mesh-list
64590886|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64590887|NCT03586466|Naloxone|naloxone|mesh-list
64590888|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64590890|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64590891|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590893|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
64590894|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590895|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64590897|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64590898|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
64590899|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590900|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590901|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64590902|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
64590903|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64590904|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
64590905|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590906|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64590907|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64590908|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
64590909|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
64590910|NCT00570349|Protective Agents|protective agents|mesh-ancestor
64590911|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
64590912|NCT04157985|Nivolumab|nivolumab|mesh-list
64590913|NCT04157985|Ipilimumab|ipilimumab|mesh-list
64590914|NCT04157985|Cemiplimab|cemiplimab|mesh-list
64590915|NCT04157985|Atezolizumab|atezolizumab|mesh-list
64590916|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64590917|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64590918|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590919|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590920|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
64590921|NCT03889418|Narcotics|narcotics|mesh-ancestor
64590923|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590924|NCT03889418|Analgesics|analgesics|mesh-ancestor
64590925|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
64590926|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590927|NCT00609739|Cytarabine|cytarabine|mesh-list
64590928|NCT00609739|Cyclosporine|cyclosporine|mesh-list
64590929|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
64590930|NCT00609739|Methotrexate|methotrexate|mesh-list
64590931|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
64590932|NCT00609739|Tretinoin|tretinoin|mesh-list
64590933|NCT00609739|Isotretinoin|isotretinoin|mesh-list
64590934|NCT00609739|Cyclosporins|cyclosporins|mesh-list
64590936|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
64590937|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64590938|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64590939|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64590940|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
64590941|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590942|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590943|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
64590944|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590945|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64590946|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64590947|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
64590948|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64590949|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64590950|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
64590951|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590952|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
64590953|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64590954|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64590955|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
64590956|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
64590957|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64590959|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
64590961|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64590962|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64590963|NCT00609739|Protective Agents|protective agents|mesh-ancestor
64590964|NCT00609739|Analgesics|analgesics|mesh-ancestor
64590965|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
64357397|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
64590966|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64590967|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64590968|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
64590969|NCT03397004|Doxycycline|doxycycline|mesh-list
64590970|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590971|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590972|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
64590973|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64590974|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64590975|NCT00610987|Cefazolin|cefazolin|mesh-list
64590976|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590977|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590978|NCT04140578|Ertapenem|ertapenem|mesh-list
64590979|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64590980|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64590981|NCT00574171|Capecitabine|capecitabine|mesh-list
64590982|NCT00574171|Lapatinib|lapatinib|mesh-list
64590983|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64590984|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
64590985|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590986|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590987|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64590988|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590989|NCT03585998|Cisplatin|cisplatin|mesh-list
64590990|NCT03585998|Etoposide|etoposide|mesh-list
64590991|NCT03585998|Durvalumab|durvalumab|mesh-list
64590992|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64590993|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64590994|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64590995|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64590996|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64590997|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64590998|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64590999|NCT00612235|Lamotrigine|lamotrigine|mesh-list
64591000|NCT00612235|Carbamazepine|carbamazepine|mesh-list
64591001|NCT00612235|Levetiracetam|levetiracetam|mesh-list
64591002|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
64591003|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
64591004|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64591005|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591006|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591007|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64591008|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591009|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64591010|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64591011|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591012|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64591013|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64591014|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
64591017|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
64591018|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591019|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64591020|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64591021|NCT00575029|Megestrol|megestrol|mesh-list
64591022|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
64591023|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64591024|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64591025|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64591026|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
64591027|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64591028|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591029|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64591030|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64591031|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64591032|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591033|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
64591034|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64591036|NCT00499109|Carboplatin|carboplatin|mesh-list
64591038|NCT00499109|Vinorelbine|vinorelbine|mesh-list
64591039|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
64591040|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591041|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
64591042|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591044|NCT00499109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591045|NCT00499109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591046|NCT00499109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591047|NCT00499109|Immunologic Factors|immunologic factors|mesh-ancestor
64591048|NCT00499109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591049|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
64591050|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
64591051|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591052|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64591053|NCT03585530|Raltitrexed|raltitrexed|mesh-list
64591054|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591056|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591057|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591058|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64591059|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591060|NCT03021590|Amoxicillin|amoxicillin|mesh-list
64591061|NCT03021590|Clarithromycin|clarithromycin|mesh-list
64591062|NCT03021590|Levofloxacin|levofloxacin|mesh-list
64591063|NCT03021590|Ofloxacin|ofloxacin|mesh-list
64591064|NCT03021590|Tinidazole|tinidazole|mesh-list
64591065|NCT03021590|Esomeprazole|esomeprazole|mesh-list
64591066|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64591067|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591068|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64591069|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64591070|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64591071|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591072|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591073|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64591074|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64591075|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64591076|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64591077|NCT03021590|Renal Agents|renal agents|mesh-ancestor
64591078|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64591079|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64591080|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591081|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64591082|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
64591083|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64591084|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64591085|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64591088|NCT02125721|Protective Agents|protective agents|mesh-ancestor
64591089|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591090|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
64591091|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
64591092|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591093|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591094|NCT00552695|Lidocaine|lidocaine|mesh-list
64591095|NCT00552695|Tetracaine|tetracaine|mesh-list
64591096|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
64591097|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
64591098|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591099|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591100|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
64591101|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591102|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64591103|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64591104|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64591105|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591106|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591108|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64591109|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
64591110|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
64591111|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591113|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64591114|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64591115|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64591116|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591117|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64591118|NCT00615433|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64591119|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64591120|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591121|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591122|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591123|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
64591124|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64591125|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64591126|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64591127|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
64591128|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64591129|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64591130|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64591131|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64591132|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
64591133|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
64591134|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64591135|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591136|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64591137|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591138|NCT03585374|Acetaminophen|acetaminophen|mesh-list
64591139|NCT03585374|Ketoprofen|ketoprofen|mesh-list
64591140|NCT03585374|Morphine|morphine|mesh-list
64591141|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
64591142|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64591143|NCT03585374|Narcotics|narcotics|mesh-ancestor
64591144|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591145|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591146|NCT03585374|Analgesics|analgesics|mesh-ancestor
64591147|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
64591148|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591149|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64591150|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
64591151|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64591152|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591153|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591154|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64591155|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591156|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591157|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64591158|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
64591159|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
64591160|NCT00499343|Rituximab|rituximab|mesh-list
64591161|NCT00499343|Etoposide|etoposide|mesh-list
64591162|NCT00499343|Ifosfamide|ifosfamide|mesh-list
64591163|NCT00499343|Isophosphamide mustard|isophosphamide mustard|mesh-list
64591164|NCT00499343|Sargramostim|sargramostim|mesh-list
64591165|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591166|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591167|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
64414775|NCT02419755|Dexamethasone|dexamethasone|mesh-list
64591168|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591170|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64591171|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64591172|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64591173|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591174|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591175|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591176|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
64591177|NCT00615589|Fludarabine|fludarabine|mesh-list
64591178|NCT00615589|Busulfan|busulfan|mesh-list
64591179|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591180|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591181|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591182|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
64591183|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591184|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
64591185|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591186|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591187|NCT00499655|Celecoxib|celecoxib|mesh-list
64591188|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64591189|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591190|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64591191|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591192|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591193|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64591194|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64591195|NCT00499655|Analgesics|analgesics|mesh-ancestor
64591196|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
64591197|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591198|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591199|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591200|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591201|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64591202|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64591203|NCT03585140|Doxycycline|doxycycline|mesh-list
64591205|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64591206|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591207|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
64591208|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64591209|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64591210|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64591211|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64591212|NCT03585140|Analgesics|analgesics|mesh-ancestor
64591213|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
64591214|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591219|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64591221|NCT03584984|Coagulants|coagulants|mesh-ancestor
64591222|NCT00575887|Temozolomide|temozolomide|mesh-list
64591223|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591224|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
64591225|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591226|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591227|NCT00575965|Simvastatin|simvastatin|mesh-list
64591228|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64591229|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64591230|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
64591231|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591232|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64591233|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64591234|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591235|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
64591236|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591237|NCT03623828|Apomorphine|apomorphine|mesh-list
64591238|NCT03623828|Emetics|emetics|mesh-ancestor
64591239|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591240|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
64357471|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
64591241|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591242|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64591243|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
64591244|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
64591245|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591246|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591247|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
64591248|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591249|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
64591250|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591251|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591252|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591253|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
64591254|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591255|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591256|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591257|NCT03589898|Gabapentin|gabapentin|mesh-list
64591258|NCT03589898|Analgesics|analgesics|mesh-ancestor
64591261|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591262|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
64591263|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64591264|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64591265|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591266|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64591267|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64591268|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64591269|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591270|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591271|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
64591272|NCT00577135|Furosemide|furosemide|mesh-list
64591273|NCT00577135|Diuretics|diuretics|mesh-list
64591274|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
64591275|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
64591276|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591277|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591278|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591279|NCT00502853|Rituximab|rituximab|mesh-list
64591280|NCT00502853|Methotrexate|methotrexate|mesh-list
64591281|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591282|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591283|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
64591284|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591285|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591286|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64591287|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
64591288|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64591289|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591290|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
64591291|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591292|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
64591293|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591294|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64591295|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591296|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64591297|NCT00617539|Irinotecan|irinotecan|mesh-list
64591298|NCT00617539|Temozolomide|temozolomide|mesh-list
64591299|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64591302|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591303|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357495|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
64591304|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591305|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
64591306|NCT03620123|Docetaxel|docetaxel|mesh-list
64591308|NCT03620123|Ipilimumab|ipilimumab|mesh-list
64591309|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591310|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
64591311|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
64591312|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591313|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591314|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591317|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
64591318|NCT00578071|Panitumumab|panitumumab|mesh-list
64591319|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591321|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591322|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591323|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591330|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64591331|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
64591332|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591333|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591335|NCT03589430|Protein C|protein c|mesh-list
64591336|NCT03589430|Antithrombins|antithrombins|mesh-list
64591337|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
64591338|NCT03589430|Protein S|protein s|mesh-list
64591339|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64591340|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
64591341|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591342|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591345|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64591346|NCT05702762|Gentamicins|gentamicins|mesh-list
64591347|NCT05702762|Cephalexin|cephalexin|mesh-list
64591348|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
64591349|NCT05702762|Cefdinir|cefdinir|mesh-list
64591350|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64591351|NCT05702762|Trimethoprim|trimethoprim|mesh-list
64591352|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
64591353|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64591354|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591355|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64591356|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591357|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591358|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64591359|NCT05702762|Renal Agents|renal agents|mesh-ancestor
64591360|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
64591361|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64591362|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64591363|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64591364|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64591365|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64591366|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64591367|NCT03580694|Cemiplimab|cemiplimab|mesh-list
64591368|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591370|NCT03583892|Gabapentin|gabapentin|mesh-list
64591371|NCT03583892|Analgesics|analgesics|mesh-ancestor
64591372|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
64591373|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591374|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591375|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
64591376|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64591377|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64591378|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591379|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64591380|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64591381|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64591382|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591383|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591384|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
64591386|NCT03589040|Rilpivirine|rilpivirine|mesh-list
64591387|NCT03589040|Etonogestrel|etonogestrel|mesh-list
64591388|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64591389|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64591390|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
64591391|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591392|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591394|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64591395|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
64591396|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591397|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64591398|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64591399|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64591400|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
64591401|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64591402|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591403|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64591404|NCT03583424|Cytarabine|cytarabine|mesh-list
64591405|NCT03583424|Etoposide|etoposide|mesh-list
64591406|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
64591407|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
64591408|NCT03583424|Melphalan|melphalan|mesh-list
64591409|NCT03583424|Venetoclax|venetoclax|mesh-list
64591410|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
64591411|NCT03583424|Carmustine|carmustine|mesh-list
64591412|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64591413|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64591414|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591415|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64591416|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64591417|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591418|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591419|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591420|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
64591421|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
64591422|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591423|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591424|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
64591425|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591426|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591427|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
64591428|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591429|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
64591430|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
64591431|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
64591432|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
64591433|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591434|NCT00578305|Folic Acid|folic acid|mesh-list
64591435|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
64591436|NCT00578305|Rituximab|rituximab|mesh-list
64591437|NCT00578305|Methotrexate|methotrexate|mesh-list
64591438|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591439|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591441|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591443|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64591444|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
64591445|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64591446|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591447|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
64591448|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591449|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
64591450|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591451|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64591452|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591453|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64591454|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591455|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
64591456|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
64591457|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591458|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64591459|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
64591460|NCT00578305|Hormones|hormones|mesh-ancestor
64591461|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64591464|NCT00578305|Hematinics|hematinics|mesh-ancestor
64591465|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
64591466|NCT00578305|Vitamins|vitamins|mesh-ancestor
64591468|NCT00578461|Cytarabine|cytarabine|mesh-list
64591469|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
64591470|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591471|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
64591472|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591473|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591474|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591475|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
64591476|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591477|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591478|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591479|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591480|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
64591481|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
64591482|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591483|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
64591484|NCT03156296|Bupivacaine|bupivacaine|mesh-list
64591485|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64591486|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
64591487|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591488|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591489|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
64591490|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591491|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64591492|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64591493|NCT03156296|Analgesics|analgesics|mesh-ancestor
64591494|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64591495|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64591496|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64591497|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
64591498|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591499|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591500|NCT00578539|Cytarabine|cytarabine|mesh-list
64591501|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
64591502|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
64591503|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591506|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591507|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591508|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
64591509|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591510|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591511|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591512|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591513|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
64591514|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
64591515|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591516|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591517|NCT05688332|Metformin|metformin|mesh-list
64591518|NCT05688332|Glyburide|glyburide|mesh-list
64591519|NCT05688332|Voglibose|voglibose|mesh-list
64591520|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64591521|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591522|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64591523|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591524|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591525|NCT00578617|Amiodarone|amiodarone|mesh-list
64591526|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591527|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64591528|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
64591529|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64591530|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591531|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64591532|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64591533|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64591534|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591535|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64357519|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
64591536|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64591537|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64591538|NCT00505895|Rituximab|rituximab|mesh-list
64591539|NCT00505895|Fludarabine|fludarabine|mesh-list
64591540|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
64591542|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591543|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591544|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
64591545|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591546|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591547|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591548|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
64591549|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591550|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591551|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591552|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
64591553|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591556|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64591557|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64591559|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
64591560|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591561|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591562|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591563|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591564|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
64591565|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
64591566|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64591567|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64591568|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591569|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591586|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591587|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591588|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
64591589|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591590|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591591|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591592|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591593|NCT00555893|Oseltamivir|oseltamivir|mesh-list
64591594|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
64591595|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591596|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591597|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591598|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64591599|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64591600|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64591601|NCT00578929|Analgesics|analgesics|mesh-ancestor
64591602|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
64591603|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591604|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591605|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591606|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591607|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64591608|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64591609|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64591610|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
64591612|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591613|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591614|NCT00556049|Gemcitabine|gemcitabine|mesh-list
64591615|NCT00556049|Sunitinib|sunitinib|mesh-list
64591616|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591617|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
64591618|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591619|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591620|NCT00556049|Antiviral Agents|antiviral agents|mesh-ancestor
64591621|NCT00556049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591622|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591623|NCT00556049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591624|NCT00556049|Immunologic Factors|immunologic factors|mesh-ancestor
64591625|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591630|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64591631|NCT01797107|Azithromycin|azithromycin|mesh-list
64591632|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64591633|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591634|NCT03155984|Antibodies|antibodies|mesh-list
64591635|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
64591636|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591637|NCT00620191|Metformin|metformin|mesh-list
64591638|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64591639|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591640|NCT00506597|Asparaginase|asparaginase|mesh-list
64591641|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591642|NCT03589976|Sirolimus|sirolimus|mesh-list
64591643|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64591644|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591645|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64591646|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591647|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
64591648|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591649|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
64591650|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591651|NCT03581630|Naltrexone|naltrexone|mesh-list
64591652|NCT03581630|Bupropion|bupropion|mesh-list
64591653|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64591654|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64591655|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591656|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
64591657|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591658|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64591659|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
64591660|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64591661|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64591662|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64591663|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591664|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591665|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
64591666|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591667|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64591668|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64591669|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591670|NCT00506675|Atropine|atropine|mesh-list
64591671|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64591672|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64591673|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64591674|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
64591675|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591676|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591677|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64591678|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
64591679|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
64357542|NCT03383003|Clarithromycin|clarithromycin|mesh-list
64591680|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
64591681|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64591682|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64591683|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
64591684|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591685|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591686|NCT00507767|Dasatinib|dasatinib|mesh-list
64591687|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591688|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64591689|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591690|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591692|NCT00621049|Carboplatin|carboplatin|mesh-list
64591694|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64591695|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591696|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591697|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64591698|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64591699|NCT00621049|Growth Substances|growth substances|mesh-ancestor
64591700|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591701|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
64591702|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
64591703|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
64591704|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591705|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591706|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64591707|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591709|NCT00508469|Travoprost|travoprost|mesh-list
64591710|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64591712|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64591713|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64591714|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
64591715|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591716|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591717|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591718|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64591719|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64591720|NCT05702996|Eculizumab|eculizumab|mesh-list
64591721|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64591722|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591723|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
64591724|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591725|NCT00580333|Paclitaxel|paclitaxel|mesh-list
64591726|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
64591727|NCT00580333|Bevacizumab|bevacizumab|mesh-list
64591728|NCT00580333|Doxorubicin|doxorubicin|mesh-list
64591729|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64591730|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591731|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64591732|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64591733|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591734|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591735|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591736|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
64591737|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591738|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591739|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591740|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
64591742|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591744|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64591745|NCT00580333|Growth Substances|growth substances|mesh-ancestor
64591746|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
64591747|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64591748|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64591749|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64591750|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591751|NCT00580645|Varenicline|varenicline|mesh-list
64591752|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64591753|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64591754|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
64591755|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591756|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591757|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591758|NCT00580957|Trimethaphan|trimethaphan|mesh-list
64591759|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64591760|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64591761|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
64591762|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
64591763|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591764|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591765|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64591766|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64591767|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
64591768|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591769|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591770|NCT00509249|Aflibercept|aflibercept|mesh-list
64591771|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
64591772|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64591773|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64591775|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591776|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
64591777|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591779|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
64591780|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64591781|NCT00624013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64591782|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64591783|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591784|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591785|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591786|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
64591787|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591788|NCT02121041|Losartan|losartan|mesh-list
64591790|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
64591791|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64591792|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64591793|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591794|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591795|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64591796|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591797|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
64591798|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64591799|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64591800|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64591801|NCT02121041|Diuretics|diuretics|mesh-ancestor
64591802|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
64591803|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64591806|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64591807|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64591808|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591809|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64591810|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64591811|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591812|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591813|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591814|NCT02133781|Vaccines|vaccines|mesh-list
64591815|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
64591816|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591817|NCT01855451|Cetuximab|cetuximab|mesh-list
64591818|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591819|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591820|NCT02134951|Ketamine|ketamine|mesh-list
64591821|NCT02134951|Analgesics|analgesics|mesh-ancestor
64591822|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
64591823|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591824|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591825|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64591826|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64591827|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
64591828|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
64591829|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591830|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64591831|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64591832|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591833|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591836|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591837|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591838|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64591839|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591840|NCT00624559|Celecoxib|celecoxib|mesh-list
64591841|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64591842|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64317158|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591843|NCT00624559|Analgesics|analgesics|mesh-ancestor
64591844|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
64591845|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591846|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591847|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591848|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591849|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64591850|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64591851|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382250|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
64591852|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591853|NCT00510809|Ethanol|ethanol|mesh-list
64591854|NCT00510809|Policosanol|policosanol|mesh-list
64591855|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64591856|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64591857|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591858|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591859|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591860|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64591861|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64591862|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
64591863|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591864|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591865|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64591866|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64591867|NCT00625729|Aldesleukin|aldesleukin|mesh-list
64591868|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
64591869|NCT00625729|Rituximab|rituximab|mesh-list
64591870|NCT00625729|Fludarabine|fludarabine|mesh-list
64591871|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
64591872|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591873|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
64591874|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591875|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591876|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64591877|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
64591878|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591879|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591880|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64591881|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64591882|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64591884|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64591885|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64591886|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
64591887|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64591889|NCT00581971|Paclitaxel|paclitaxel|mesh-list
64591890|NCT00581971|Carboplatin|carboplatin|mesh-list
64591891|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64591892|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591893|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
64591894|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
64591895|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591896|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591897|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64591898|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64591899|NCT00581971|Analgesics|analgesics|mesh-ancestor
64591900|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
64591901|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591902|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591903|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591904|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64591905|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64591906|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64591907|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64591908|NCT03029234|Dexamethasone|dexamethasone|mesh-list
64591909|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591910|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
64591911|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
64591912|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591913|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591914|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64591915|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
64591916|NCT03029234|Hormones|hormones|mesh-ancestor
64591917|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64591918|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64591919|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591921|NCT01670318|Everolimus|everolimus|mesh-list
64591922|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591923|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64591924|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
64591926|NCT01670318|Trace Elements|trace elements|mesh-ancestor
64591927|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
64591928|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
64591929|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64591930|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
64591931|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591932|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591933|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64591934|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
64591935|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
64591936|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64591937|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
64591938|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64591939|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591940|NCT03111992|Spartalizumab|spartalizumab|mesh-list
64591941|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64591942|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591943|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591944|NCT00626431|Leuprolide|leuprolide|mesh-list
64591945|NCT00626431|Hormones|hormones|mesh-list
64591946|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64591947|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64591948|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591949|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64591951|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64591952|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64591953|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591954|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64591955|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64591956|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64591957|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591958|NCT00582205|Paclitaxel|paclitaxel|mesh-list
64591959|NCT00582205|Cisplatin|cisplatin|mesh-list
64591961|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64591962|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
64591963|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
64591964|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
64591965|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591966|NCT00626743|Amlodipine|amlodipine|mesh-list
64591967|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64591968|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64591969|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64591970|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64591971|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64591972|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591973|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
64591974|NCT03155048|Estradiol|estradiol|mesh-list
64591975|NCT03155048|Estrogens|estrogens|mesh-list
64591976|NCT03155048|Hormones|hormones|mesh-ancestor
64591977|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64591978|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591979|NCT01661647|Anesthetics|anesthetics|mesh-list
64591980|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591981|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591982|NCT00627367|Hydromorphone|hydromorphone|mesh-list
64591983|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64591984|NCT00627367|Narcotics|narcotics|mesh-ancestor
64591985|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64591986|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591988|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
64591989|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591990|NCT00627679|Budesonide|budesonide|mesh-list
64591991|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64591993|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
64591994|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64591995|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64591996|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64591997|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
64591998|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
64591999|NCT00627679|Hormones|hormones|mesh-ancestor
64592000|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592001|NCT00514709|Vaccines|vaccines|mesh-list
64592002|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
64592003|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592004|NCT03154814|Urinastatin|urinastatin|mesh-list
64592005|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64592006|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64592007|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
64592010|NCT00515021|Eplerenone|eplerenone|mesh-list
64592011|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64592012|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
64592013|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592014|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592015|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64592016|NCT00515021|Diuretics|diuretics|mesh-ancestor
64592017|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
64592018|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64592019|NCT00515177|Eszopiclone|eszopiclone|mesh-list
64592020|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64592021|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592022|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592023|NCT01671410|Morphine|morphine|mesh-list
64592024|NCT01671410|Buprenorphine|buprenorphine|mesh-list
64592025|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64592026|NCT01671410|Narcotics|narcotics|mesh-ancestor
64592027|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592028|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592029|NCT01671410|Analgesics|analgesics|mesh-ancestor
64592030|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
64592031|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592032|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64592033|NCT00630253|Cyclosporine|cyclosporine|mesh-list
64592034|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
64592035|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
64592036|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
64592037|NCT00630253|Fludarabine|fludarabine|mesh-list
64592038|NCT00630253|Cyclosporins|cyclosporins|mesh-list
64592039|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64592040|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64592041|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
64592042|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592043|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64592044|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64592045|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
64592046|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592047|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592048|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64592049|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592050|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
64592051|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592052|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
64592053|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64592054|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64592055|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64592060|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
64592061|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592062|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592063|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
64592065|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592066|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64592067|NCT00630253|Protective Agents|protective agents|mesh-ancestor
64592069|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64592070|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
64592071|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64592072|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
64592073|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592074|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592075|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64592076|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64592077|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592078|NCT00584701|Risperidone|risperidone|mesh-list
64592079|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64592080|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
64592081|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592082|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592083|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592084|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64592085|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64592086|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592087|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592088|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64592089|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
64592092|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592093|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
64592094|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592095|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592096|NCT00630409|Antiviral Agents|antiviral agents|mesh-ancestor
64592097|NCT00630409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592098|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592099|NCT00630409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64592100|NCT00630409|Immunologic Factors|immunologic factors|mesh-ancestor
64592101|NCT00630409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592102|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64592103|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64592104|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64592105|NCT00630955|Memantine|memantine|mesh-list
64592106|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64592107|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64592108|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
64592109|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416786|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592110|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592111|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592112|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64592113|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64592115|NCT00584857|Carboplatin|carboplatin|mesh-list
64592116|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64592117|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592118|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
64592119|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
64592120|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
64592121|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592122|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
64592124|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
64592125|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592126|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592127|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64592128|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
64592129|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64592130|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
64592131|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592132|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592133|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64592134|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
64592135|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
64592136|NCT00585013|Protective Agents|protective agents|mesh-ancestor
64592137|NCT01672112|Oxycodone|oxycodone|mesh-list
64592138|NCT01672112|Codeine|codeine|mesh-list
64592139|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64592140|NCT01672112|Narcotics|narcotics|mesh-ancestor
64592141|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592142|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592144|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
64592145|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592146|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
64592147|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
64592148|NCT00585637|Vitamin D|vitamin d|mesh-list
64592149|NCT00585637|Vitamins|vitamins|mesh-ancestor
64592150|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
64592151|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592152|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64592153|NCT03158792|Enoxaparin|enoxaparin|mesh-list
64592154|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
64592155|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
64592156|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64592157|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64382251|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592158|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592159|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64592160|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64592161|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
64592162|NCT00633919|Prednisone|prednisone|mesh-list
64592163|NCT00633919|Budesonide|budesonide|mesh-list
64592164|NCT00633919|Albuterol|albuterol|mesh-list
64592165|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
64592166|NCT00633919|Desloratadine|desloratadine|mesh-list
64592167|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592168|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
64592169|NCT00633919|Hormones|hormones|mesh-ancestor
64592170|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592171|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592172|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64592173|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592174|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64592175|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
64592176|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592178|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
64592179|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64592180|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64592181|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64592182|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
64592183|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592184|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592185|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
64592186|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64592187|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64592188|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
64592189|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64592190|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64592191|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
64592192|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
64592193|NCT03158246|Vitamin D|vitamin d|mesh-list
64592194|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
64592195|NCT03158246|Calcium|calcium|mesh-list
64592196|NCT03158246|Vitamins|vitamins|mesh-ancestor
64592197|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
64592198|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429988|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592199|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64592200|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64592201|NCT04459117|Acetaminophen|acetaminophen|mesh-list
64592202|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64592203|NCT04459117|Analgesics|analgesics|mesh-ancestor
64592204|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
64592205|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592206|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592207|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
64592208|NCT00515411|Leucovorin|leucovorin|mesh-list
64592209|NCT00515411|Cisplatin|cisplatin|mesh-list
64592210|NCT00515411|Docetaxel|docetaxel|mesh-list
64592211|NCT00515411|Fluorouracil|fluorouracil|mesh-list
64592212|NCT00515411|Trastuzumab|trastuzumab|mesh-list
64592213|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592214|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
64317539|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64592215|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
64592218|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
64592219|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592220|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64592221|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
64592222|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592223|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592225|NCT00515411|Protective Agents|protective agents|mesh-ancestor
64592226|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
64592227|NCT00515411|Vitamins|vitamins|mesh-ancestor
64592228|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
64592229|NCT00586261|Pioglitazone|pioglitazone|mesh-list
64592230|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
64592231|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64592232|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592233|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
64592234|NCT00515723|Olanzapine|olanzapine|mesh-list
64592235|NCT00515723|Risperidone|risperidone|mesh-list
64592236|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64592237|NCT00515723|Ziprasidone|ziprasidone|mesh-list
64592238|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64592239|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
64592240|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592241|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592242|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592243|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64592244|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64382252|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
64592246|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592247|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64592248|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
64592249|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
64592250|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
64592251|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592252|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592253|NCT00515723|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64592254|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64592255|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592258|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592260|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64592261|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64592262|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
64592263|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382253|NCT02423915|Sirolimus|sirolimus|mesh-list
64592264|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592265|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592266|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64592267|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64592269|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592270|NCT00515879|Cycloserine|cycloserine|mesh-list
64592271|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64592272|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592273|NCT00515879|Renal Agents|renal agents|mesh-ancestor
64592274|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64592275|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
64592276|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64592277|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
64592278|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592279|NCT03152942|Aminophylline|aminophylline|mesh-list
64592280|NCT03152942|Progesterone|progesterone|mesh-list
64592281|NCT03152942|Progestins|progestins|mesh-ancestor
64592283|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592284|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592285|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64592286|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
64592287|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592288|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64592289|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
64592290|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64592291|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64592292|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592293|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592294|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64592295|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64592296|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
64592297|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592298|NCT03152942|Protective Agents|protective agents|mesh-ancestor
64592299|NCT00586729|Mafenide|mafenide|mesh-list
64592300|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64592301|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592302|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64592303|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64592305|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592306|NCT01672346|Adenosine|adenosine|mesh-list
64592307|NCT01672346|Analgesics|analgesics|mesh-ancestor
64592308|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
64592309|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592310|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592311|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64592312|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
64592313|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64592314|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
64592315|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
64592316|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592317|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592320|NCT00516503|Baclofen|baclofen|mesh-list
64592321|NCT00516503|Analgesics|analgesics|mesh-ancestor
64592322|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
64592323|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592324|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592325|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64592326|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64592327|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
64592328|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
64592329|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592330|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64592331|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64592332|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592333|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592334|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64592335|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64592336|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64592337|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
64592338|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
64592339|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64592341|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592344|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64592345|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592346|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64592347|NCT03157310|Gefitinib|gefitinib|mesh-list
64592348|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592349|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64592350|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592351|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592352|NCT03157388|Vancomycin|vancomycin|mesh-list
64592353|NCT03157388|Gentamicins|gentamicins|mesh-list
64592354|NCT03157388|Meropenem|meropenem|mesh-list
64592355|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64592356|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592357|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64592358|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592359|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592360|NCT03156920|Sumatriptan|sumatriptan|mesh-list
64592361|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64592362|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64592363|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64357777|NCT03386071|Trametinib|trametinib|mesh-list
64592364|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
64592365|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592366|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592367|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592368|NCT05247385|Ticagrelor|ticagrelor|mesh-list
64592369|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64592370|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64592372|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64592373|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64592374|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
64592375|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592376|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592377|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592378|NCT03156842|Amlodipine|amlodipine|mesh-list
64592379|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64592380|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64592381|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64592382|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592383|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592384|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64592385|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592386|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
64592387|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64592388|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64592389|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
64592390|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64592391|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64592392|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592393|NCT01672580|Vitamins|vitamins|mesh-list
64592394|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
64592395|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592396|NCT00636649|Citalopram|citalopram|mesh-list
64592397|NCT00636649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64592398|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64592399|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592400|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592402|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
64592403|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592404|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64592405|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
64592406|NCT00636649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592407|NCT05061524|Omalizumab|omalizumab|mesh-list
64592408|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64592409|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64592410|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
64592411|NCT00636805|Dexamethasone|dexamethasone|mesh-list
64592412|NCT00636805|Palonosetron|palonosetron|mesh-list
64592413|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592414|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
64592415|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
64592416|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592417|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592418|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592419|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
64592420|NCT00636805|Hormones|hormones|mesh-ancestor
64414776|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
64592421|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592422|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64592423|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592424|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64592425|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64592426|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
64592427|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592428|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592429|NCT05247151|Oxytocin|oxytocin|mesh-list
64592430|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
64592431|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64592432|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592433|NCT01676246|Flupirtine|flupirtine|mesh-list
64592434|NCT01676246|Analgesics|analgesics|mesh-ancestor
64592435|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
64592437|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592439|NCT00517595|Bevacizumab|bevacizumab|mesh-list
64592440|NCT00517595|Pemetrexed|pemetrexed|mesh-list
64592441|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592442|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64317767|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
64592443|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64592444|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64592445|NCT00517595|Growth Substances|growth substances|mesh-ancestor
64592446|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592447|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
64592448|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592449|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
64592450|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592451|NCT00517595|Antiviral Agents|antiviral agents|mesh-ancestor
64592452|NCT00517595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592453|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592454|NCT00517595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64592455|NCT00517595|Immunologic Factors|immunologic factors|mesh-ancestor
64592456|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64592457|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64592458|NCT01672814|Riboflavin|riboflavin|mesh-list
64592459|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64592460|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64592461|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
64592462|NCT01672814|Vitamins|vitamins|mesh-ancestor
64592463|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
64592465|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64592466|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
64592467|NCT00524225|Oprelvekin|oprelvekin|mesh-list
64592468|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592469|NCT00669019|Saracatinib|saracatinib|mesh-list
64592470|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592471|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592472|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592473|NCT05560373|Huperzine A|huperzine a|mesh-list
64592474|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64592475|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592476|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592477|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
64592478|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592479|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592480|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64592482|NCT00670267|Nadolol|nadolol|mesh-list
64592483|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64592484|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64357902|NCT03379987|Bupivacaine|bupivacaine|mesh-list
64357903|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
64592485|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
64592486|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592487|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592488|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592489|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64592490|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64592491|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
64592492|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
64592493|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592494|NCT05621915|Nadroparin|nadroparin|mesh-list
64592495|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
64592496|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64592497|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64592498|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592499|NCT01673204|Calcitriol|calcitriol|mesh-list
64592500|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64592502|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64592503|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592504|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592505|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64592506|NCT01673204|Vitamins|vitamins|mesh-ancestor
64592507|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
64592508|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64592509|NCT04393298|Leucovorin|leucovorin|mesh-list
64592510|NCT04393298|Trifluridine|trifluridine|mesh-list
64592512|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592514|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592515|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592516|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592517|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64592518|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
64592519|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
64592520|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592521|NCT04393298|Antidotes|antidotes|mesh-ancestor
64592522|NCT04393298|Protective Agents|protective agents|mesh-ancestor
64592523|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
64592524|NCT04393298|Vitamins|vitamins|mesh-ancestor
64592525|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
64592527|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
64592528|NCT00641563|Remifentanil|remifentanil|mesh-list
64592529|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64592530|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592531|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592532|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64592533|NCT00641563|Analgesics|analgesics|mesh-ancestor
64592534|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
64592535|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592536|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64592537|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64592538|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64592539|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
64592540|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592541|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592542|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64592543|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64592544|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64592545|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592546|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64592547|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
64592549|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
64592550|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
64592551|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64592552|NCT00641563|Narcotics|narcotics|mesh-ancestor
64592553|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
64592555|NCT05621759|Tacrolimus|tacrolimus|mesh-list
64592556|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64592557|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
64592558|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592559|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64592560|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64592561|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
64592562|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592563|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592564|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64592565|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64592566|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592567|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64592568|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64592570|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592571|NCT00641641|Tenofovir|tenofovir|mesh-list
64592572|NCT00641641|Emtricitabine|emtricitabine|mesh-list
64592573|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
64592574|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
64592575|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592576|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64592577|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64592578|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592579|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592580|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64592581|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64592582|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64592583|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64592584|NCT03152474|Vitamin A|vitamin a|mesh-list
64592585|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
64592586|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64592587|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64592588|NCT03152474|Prednisolone|prednisolone|mesh-list
64592589|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
64592590|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64592591|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
64592592|NCT03152474|Vitamins|vitamins|mesh-ancestor
64592593|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
64592594|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592595|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592596|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
64592597|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
64592598|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592599|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592600|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
64592601|NCT03152474|Hormones|hormones|mesh-ancestor
64592602|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592603|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64592604|NCT03152474|Protective Agents|protective agents|mesh-ancestor
64592605|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64592606|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592607|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
64592608|NCT00641797|Promethazine|promethazine|mesh-list
64592609|NCT00641797|Meclizine|meclizine|mesh-list
64592610|NCT00641797|Lorazepam|lorazepam|mesh-list
64592611|NCT00641797|Ondansetron|ondansetron|mesh-list
64592612|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
64592613|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
64592615|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592616|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592617|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
64592618|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
64592619|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64592620|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
64592621|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592622|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592623|NCT00641797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64592624|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64592625|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592626|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592627|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64592628|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64592629|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64592630|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
64592631|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
64592632|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
64592633|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64592634|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
64592635|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
64592636|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64592637|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
64592638|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
64592639|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
64592640|NCT04333459|Vaccines|vaccines|mesh-list
64592641|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
64592642|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592643|NCT00671515|Pioglitazone|pioglitazone|mesh-list
64592644|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64592645|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592646|NCT01893320|Decitabine|decitabine|mesh-list
64592647|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592648|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
64592649|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592650|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592651|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592652|NCT04157725|Clomiphene|clomiphene|mesh-list
64592653|NCT04157725|Enclomiphene|enclomiphene|mesh-list
64592654|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
64592655|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64592656|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
64592657|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592658|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592659|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64592660|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
64592661|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64592662|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64592663|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64592664|NCT04120766|Nicorandil|nicorandil|mesh-list
64592665|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64592666|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64592667|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
64592668|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
64592669|NCT04120766|Vitamins|vitamins|mesh-ancestor
64592670|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
64592671|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592672|NCT00673075|Carvedilol|carvedilol|mesh-list
64592673|NCT00673075|Nebivolol|nebivolol|mesh-list
64592674|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64592675|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64592676|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
64592677|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592678|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592679|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592680|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64592681|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
64592682|NCT00673075|Protective Agents|protective agents|mesh-ancestor
64592683|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64592684|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592685|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64592686|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
64592687|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64592688|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64592689|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64592690|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64592691|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64592693|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
64592694|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592696|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
64592697|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64592698|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592699|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64592700|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592704|NCT00673153|Calicheamicins|calicheamicins|mesh-list
64592705|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592706|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64592707|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592708|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592709|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592710|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64592711|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64592712|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
64592713|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64592714|NCT00654511|Fentanyl|fentanyl|mesh-list
64592715|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
64592716|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64592717|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592718|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592719|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64592720|NCT00654511|Analgesics|analgesics|mesh-ancestor
64592721|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
64592722|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592723|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64592724|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64592725|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64592726|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
64592727|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592728|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592729|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64592730|NCT00654511|Narcotics|narcotics|mesh-ancestor
64592731|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64592732|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64592733|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
64592734|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
64592735|NCT01670084|Leucovorin|leucovorin|mesh-list
64592738|NCT01670084|Prednisone|prednisone|mesh-list
64592739|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
64592740|NCT01670084|Rituximab|rituximab|mesh-list
64592741|NCT01670084|Doxorubicin|doxorubicin|mesh-list
64592742|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64592743|NCT01670084|Methotrexate|methotrexate|mesh-list
64296125|NCT02332928|Melatonin|melatonin|mesh-list
64592744|NCT01670084|Vincristine|vincristine|mesh-list
64592745|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
64592746|NCT01670084|Mesna|mesna|mesh-list
64592747|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64592748|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
64592749|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592750|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64592751|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64592752|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
64592753|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592754|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592755|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64592756|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592757|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592759|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
64592760|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592761|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592762|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
64592763|NCT01670084|Hormones|hormones|mesh-ancestor
64592764|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64592765|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64592766|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64592767|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64592768|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64592769|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592770|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64592771|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
64592772|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64357944|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592773|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592774|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
64592775|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
64592776|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64592777|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64592778|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
64592779|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592780|NCT01670084|Antidotes|antidotes|mesh-ancestor
64592781|NCT01670084|Protective Agents|protective agents|mesh-ancestor
64592782|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
64592783|NCT01670084|Vitamins|vitamins|mesh-ancestor
64592784|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
64592785|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64592786|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
64592787|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
64592788|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
64592789|NCT01670162|Aflibercept|aflibercept|mesh-list
64592790|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64592791|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64592792|NCT01670162|Growth Substances|growth substances|mesh-ancestor
64592793|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592794|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
64592795|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592796|NCT04345783|Apatinib|apatinib|mesh-list
64592798|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64592799|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592800|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592801|NCT01670240|Adalimumab|adalimumab|mesh-list
64592802|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592803|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64592804|NCT00675259|Paclitaxel|paclitaxel|mesh-list
64592805|NCT00675259|Bevacizumab|bevacizumab|mesh-list
64592806|NCT00675259|Carboplatin|carboplatin|mesh-list
64592807|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64592808|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592809|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
64592810|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
64592811|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
64592812|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592813|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592814|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64592815|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64592816|NCT00675259|Growth Substances|growth substances|mesh-ancestor
64592817|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592818|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
64592820|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64592821|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64592822|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64592823|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64592824|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592825|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64318140|NCT05678036|Analgesics|analgesics|mesh-ancestor
64592826|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592827|NCT04764344|Haloperidol|haloperidol|mesh-list
64592828|NCT04764344|Ondansetron|ondansetron|mesh-list
64592829|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
64592830|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
64592831|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
64592832|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592833|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592834|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64592835|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
64592836|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
64592837|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64592838|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
64592839|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592840|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592841|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64592842|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64592843|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592844|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592845|NCT04764344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64592846|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64592847|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
64592848|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64592849|NCT04404686|Indomethacin|indomethacin|mesh-list
64592850|NCT04404686|Nifedipine|nifedipine|mesh-list
64592851|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64592852|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64382254|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
64592853|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592854|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64592855|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592857|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
64592858|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64592859|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64592860|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64592861|NCT04404686|Analgesics|analgesics|mesh-ancestor
64592862|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
64592863|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592864|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592865|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64592866|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
64592867|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64592868|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592869|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
64592870|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592871|NCT00658411|Deferoxamine|deferoxamine|mesh-list
64592872|NCT00658411|Siderophores|siderophores|mesh-ancestor
64592873|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64592874|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
64592875|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
64592876|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592877|NCT01674530|Lubiprostone|lubiprostone|mesh-list
64592878|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64592879|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592880|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592881|NCT00676897|Simvastatin|simvastatin|mesh-list
64592882|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64592883|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64592884|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
64592885|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592886|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64592887|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64592888|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592889|NCT02115074|Celecoxib|celecoxib|mesh-list
64592890|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64592891|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64592892|NCT02115074|Analgesics|analgesics|mesh-ancestor
64592893|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
64592894|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592895|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592896|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64592898|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64592899|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64592901|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592903|NCT01674686|Atorvastatin|atorvastatin|mesh-list
64592904|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64592905|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64592906|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
64592907|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592908|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64592909|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64592910|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592911|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64592912|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64592913|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64592914|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64592915|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
64592916|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592917|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592918|NCT02082392|Citalopram|citalopram|mesh-list
64592919|NCT02082392|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64592920|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64592921|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64592922|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592923|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64592924|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
64592925|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592926|NCT02082392|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64592927|NCT02082392|Antidepressive Agents|antidepressive agents|mesh-ancestor
64592928|NCT02082392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64592929|NCT03355976|Nivolumab|nivolumab|mesh-list
64592930|NCT03355976|Ipilimumab|ipilimumab|mesh-list
64592931|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592932|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592933|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64592935|NCT01674842|Cisplatin|cisplatin|mesh-list
64592936|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592937|NCT03845894|Bupivacaine|bupivacaine|mesh-list
64592938|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
64592939|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
64592940|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592941|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592942|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
64592943|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64592944|NCT03161132|Doxorubicin|doxorubicin|mesh-list
64592945|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64592946|NCT03161132|Olaparib|olaparib|mesh-list
64592947|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64592948|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592949|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64592950|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64592951|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592952|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592953|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64592954|NCT03844256|Capecitabine|capecitabine|mesh-list
64592957|NCT03844256|Mitomycins|mitomycins|mesh-list
64592958|NCT03844256|Mitomycin|mitomycin|mesh-list
64592959|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64592960|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
64592961|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592962|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592963|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592964|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64592965|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64592966|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
64592967|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64592968|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592969|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
64592970|NCT01675076|Apixaban|apixaban|mesh-list
64592971|NCT01675076|Dabigatran|dabigatran|mesh-list
64592972|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64592973|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
64592974|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64318300|NCT05531942|Aspirin|aspirin|mesh-list
64592975|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
64592976|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592977|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592978|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
64592979|NCT03018080|Paclitaxel|paclitaxel|mesh-list
64592980|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
64592981|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64592982|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592983|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
64592984|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
64592985|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
64357980|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64592986|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592987|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64592988|NCT03838796|Lenvatinib|lenvatinib|mesh-list
64592989|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592990|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64592991|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64592992|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64592993|NCT03719690|Tipifarnib|tipifarnib|mesh-list
64592994|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64592995|NCT01675466|Anesthetics|anesthetics|mesh-list
64592996|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64592997|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64592998|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
64593001|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593002|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593003|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
64593004|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593005|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593006|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
64593007|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64593008|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64593009|NCT02510300|Ledipasvir|ledipasvir|mesh-list
64593010|NCT02510300|Velpatasvir|velpatasvir|mesh-list
64593011|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
64593012|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593013|NCT00678535|Capecitabine|capecitabine|mesh-list
64593014|NCT00678535|Cetuximab|cetuximab|mesh-list
64593015|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593016|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64593017|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
64593018|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593019|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593020|NCT00659737|Scopolamine|scopolamine|mesh-list
64593021|NCT00659737|Aprepitant|aprepitant|mesh-list
64593022|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
64593023|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64593024|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
64593025|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
64593026|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593027|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593028|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64593029|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64593030|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593031|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593032|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64593033|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
64593034|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64593035|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
64593036|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64593037|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
64593039|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64593040|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64593041|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64593042|NCT04763876|Analgesics|analgesics|mesh-ancestor
64593043|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
64593044|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593045|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593046|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593047|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593048|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64593049|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593050|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593051|NCT00680797|Testosterone|testosterone|mesh-list
64593052|NCT00680797|Estrogens|estrogens|mesh-list
64593053|NCT00680797|Androgens|androgens|mesh-ancestor
64593054|NCT00680797|Hormones|hormones|mesh-ancestor
64357994|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
64593055|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593056|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593057|NCT02984852|Tenofovir|tenofovir|mesh-list
64593058|NCT02984852|Emtricitabine|emtricitabine|mesh-list
64593059|NCT02984852|Darunavir|darunavir|mesh-list
64593060|NCT02984852|Cobicistat|cobicistat|mesh-list
64593061|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
64593062|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593063|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64593064|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64593065|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593066|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593067|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64593068|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64593069|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64593070|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64593071|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
64593072|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64593073|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64593074|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
64593075|NCT00557193|Leucovorin|leucovorin|mesh-list
64593076|NCT00557193|Folic Acid|folic acid|mesh-list
64593077|NCT00557193|Cytarabine|cytarabine|mesh-list
64593078|NCT00557193|Dexamethasone|dexamethasone|mesh-list
64593079|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
64593080|NCT00557193|Prednisone|prednisone|mesh-list
64593081|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
64593082|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64593083|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64593084|NCT00557193|Prednisolone|prednisolone|mesh-list
64593085|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
64593086|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
64593087|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64593088|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64593089|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64593090|NCT00557193|Cortisone|cortisone|mesh-list
64593091|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
64593092|NCT00557193|Methotrexate|methotrexate|mesh-list
64593093|NCT00557193|Etoposide|etoposide|mesh-list
64593094|NCT00557193|Vincristine|vincristine|mesh-list
64593095|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
64593096|NCT00557193|Daunorubicin|daunorubicin|mesh-list
64593097|NCT00557193|Asparaginase|asparaginase|mesh-list
64593098|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
64593099|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
64593100|NCT00557193|Pegaspargase|pegaspargase|mesh-list
64593101|NCT00557193|Lenograstim|lenograstim|mesh-list
64593102|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64593103|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
64593104|NCT00557193|BB 1101|bb 1101|mesh-list
64593105|NCT00557193|Calcium|calcium|mesh-list
64593106|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
64593107|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593108|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
64593109|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593110|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593111|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64593112|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
64593113|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593114|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593115|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64593116|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593117|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
64593118|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
64593119|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593120|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64593121|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
64593122|NCT00557193|Hormones|hormones|mesh-ancestor
64358055|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
64593123|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593124|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593125|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
64593126|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593127|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64593128|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64593129|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64593130|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
64593131|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64593132|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64593133|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
64593134|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
64593135|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64593136|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64593137|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593138|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64593139|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64593140|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
64593141|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593142|NCT00557193|Antidotes|antidotes|mesh-ancestor
64593143|NCT00557193|Protective Agents|protective agents|mesh-ancestor
64593144|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
64593145|NCT00557193|Vitamins|vitamins|mesh-ancestor
64593146|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
64593147|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64593148|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
64593149|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
64593150|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
64593151|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64593152|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64593153|NCT00557193|Hematinics|hematinics|mesh-ancestor
64593154|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
64593155|NCT00660517|Fluticasone|fluticasone|mesh-list
64593156|NCT00660517|Xhance|xhance|mesh-list
64593157|NCT00660517|Azelastine|azelastine|mesh-list
64593158|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593159|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64593160|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
64593161|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593162|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593163|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64593164|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
64593165|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
64593166|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64593167|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64593169|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593170|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64593171|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64593172|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
64593173|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
64593174|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593176|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
64593177|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593178|NCT03826628|Sirolimus|sirolimus|mesh-list
64593179|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64593180|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593181|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64593182|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593183|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
64593184|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593185|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
64593186|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593187|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64593188|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64593189|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593190|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593191|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64593192|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64593193|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593194|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
64593195|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593196|NCT03751436|Venetoclax|venetoclax|mesh-list
64593197|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593198|NCT03819530|Micronutrients|micronutrients|mesh-list
64593199|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593200|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64593201|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
64593202|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64593203|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64593204|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64593205|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593206|NCT03750968|Carotenoids|carotenoids|mesh-list
64593207|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
64593208|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593209|NCT03750968|Protective Agents|protective agents|mesh-ancestor
64593210|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593211|NCT03818672|Rifaximin|rifaximin|mesh-list
64593212|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64593213|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593214|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64593216|NCT03749018|Cortisone|cortisone|mesh-list
64593217|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
64593218|NCT03749018|Rituximab|rituximab|mesh-list
64593219|NCT03749018|Doxorubicin|doxorubicin|mesh-list
64593220|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64593221|NCT03749018|Nivolumab|nivolumab|mesh-list
64593222|NCT03749018|Etoposide|etoposide|mesh-list
64593223|NCT03749018|Vincristine|vincristine|mesh-list
64593224|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
64593225|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
64593226|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64593227|NCT03749018|Antibodies|antibodies|mesh-list
64593228|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
64593229|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64593230|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593231|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
64593232|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593233|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593234|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64593235|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
64593236|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593237|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593238|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64593239|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64593240|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64593241|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64593242|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593243|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593244|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
64593245|NCT03749018|Hormones|hormones|mesh-ancestor
64593246|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593247|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593248|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64593249|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593250|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
64593251|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
64593252|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
64593253|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
64593254|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
64593255|NCT01931163|Everolimus|everolimus|mesh-list
64593256|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593257|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593258|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
64593259|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593260|NCT04763486|Cefazolin|cefazolin|mesh-list
64593261|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64593262|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593263|NCT02988063|Polidocanol|polidocanol|mesh-list
64593264|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64593265|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64593266|NCT03877406|Empagliflozin|empagliflozin|mesh-list
64593267|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64593268|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64593269|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593270|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593271|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
64593273|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593274|NCT03745430|Ramucirumab|ramucirumab|mesh-list
64593275|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593276|NCT03874052|Venetoclax|venetoclax|mesh-list
64593277|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64593278|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593279|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64593280|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593281|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593282|NCT03744026|Carboplatin|carboplatin|mesh-list
64318600|NCT00101101|Analgesics|analgesics|mesh-ancestor
64382255|NCT02423915|Rituximab|rituximab|mesh-list
64593284|NCT03802604|Atezolizumab|atezolizumab|mesh-list
64593285|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64593286|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593287|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593288|NCT03869996|Cytarabine|cytarabine|mesh-list
64593289|NCT03869996|Methotrexate|methotrexate|mesh-list
64593290|NCT03869996|Etoposide|etoposide|mesh-list
64593291|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64593292|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
64593293|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593294|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593295|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
64593296|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593297|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593298|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
64593299|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593300|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593301|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64593302|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64593303|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593304|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64593305|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
64593306|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64593307|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
64593308|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64593309|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593310|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64593311|NCT03869450|Lidocaine|lidocaine|mesh-list
64593312|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
64593313|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
64593314|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
64593315|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593316|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593317|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
64593318|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593319|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64593320|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64593321|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64593322|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64593323|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593324|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64593325|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
64593326|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
64593327|NCT03869450|Protective Agents|protective agents|mesh-ancestor
64593328|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
64593329|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
64593330|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593331|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
64593332|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593333|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593334|NCT03864926|Tacrolimus|tacrolimus|mesh-list
64593335|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593336|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
64593337|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593339|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593340|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593341|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64593342|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64593343|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64593344|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64593345|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593346|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
64593347|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593348|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593349|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64593350|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593351|NCT01101464|Asenapine|asenapine|mesh-list
64593352|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64593353|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64593354|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593355|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593356|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64318674|NCT03538327|Silybin|silybin|mesh-list
64593357|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
64593358|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64593359|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
64593360|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
64593361|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593362|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593363|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64593364|NCT03736538|Analgesics|analgesics|mesh-ancestor
64593365|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
64593366|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593367|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64593368|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
64593369|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593370|NCT03725930|Clonidine|clonidine|mesh-list
64593371|NCT03725930|Analgesics|analgesics|mesh-ancestor
64593372|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
64593373|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593374|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593375|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64593376|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
64593377|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
64593378|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64593379|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64593380|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64358144|NCT03373669|Vaccines|vaccines|mesh-list
64593381|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
64593382|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593383|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593384|NCT03781388|Bupivacaine|bupivacaine|mesh-list
64593385|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
64593386|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
64593387|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593388|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593389|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
64593390|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593391|NCT03779048|Phentermine|phentermine|mesh-list
64593392|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64593393|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593394|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
64593395|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64593396|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
64593397|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
64593398|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593399|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
64593400|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593401|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593403|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
64593404|NCT03778580|Vitamins|vitamins|mesh-ancestor
64593405|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
64593406|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593407|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
64593408|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593409|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593410|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
64593411|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
64593412|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
64593413|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593414|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593415|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
64593416|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593417|NCT03722108|Irinotecan|irinotecan|mesh-list
64593418|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64593419|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64593420|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593421|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593422|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593423|NCT03775070|Simvastatin|simvastatin|mesh-list
64593424|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64593425|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64593426|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
64593427|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593428|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64593429|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64593430|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64318744|NCT05438186|Liraglutide|liraglutide|mesh-list
64593431|NCT02083406|Artefenomel|artefenomel|mesh-list
64593432|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
64593433|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64593434|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64593435|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593436|NCT03773666|Durvalumab|durvalumab|mesh-list
64593437|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593438|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593439|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
64593440|NCT04762784|Hormones|hormones|mesh-ancestor
64593441|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593442|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593443|NCT00003644|Paclitaxel|paclitaxel|mesh-list
64593444|NCT00003644|Carboplatin|carboplatin|mesh-list
64593445|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593446|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593447|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
64593448|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
64593449|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
64593450|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593451|NCT02142049|Lenalidomide|lenalidomide|mesh-list
64593452|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
64593453|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593454|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64382256|NCT02423915|Fludarabine|fludarabine|mesh-list
64593455|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64593456|NCT02142049|Growth Substances|growth substances|mesh-ancestor
64593457|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
64593458|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593460|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64593461|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593462|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64593463|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593464|NCT03716180|Paclitaxel|paclitaxel|mesh-list
64593465|NCT03716180|Trastuzumab|trastuzumab|mesh-list
64593466|NCT03716180|Pertuzumab|pertuzumab|mesh-list
64593467|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593468|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593469|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
64593470|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
64593471|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
64593472|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593473|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593475|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
64593476|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593477|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593478|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
64593479|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593480|NCT03714620|Ketamine|ketamine|mesh-list
64593481|NCT03714620|Analgesics|analgesics|mesh-ancestor
64593482|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
64593483|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593484|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593485|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64593486|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64593487|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
64593488|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
64593489|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593490|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64593491|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64593492|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593493|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593494|NCT03632720|Vaccines|vaccines|mesh-list
64593495|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
64593496|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593497|NCT03629288|Azithromycin|azithromycin|mesh-list
64593498|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64593499|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593500|NCT04763096|Tacrolimus|tacrolimus|mesh-list
64593501|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593502|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
64593503|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593504|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64593505|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593506|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593507|NCT00680953|Denosumab|denosumab|mesh-list
64593509|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64593510|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593512|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64593513|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64593514|NCT00660985|Analgesics|analgesics|mesh-ancestor
64593515|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
64593516|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593517|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593518|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593519|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593520|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
64593522|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64593523|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
64380615|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64593524|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593525|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64593526|NCT03704714|Prednisone|prednisone|mesh-list
64593527|NCT03704714|Cortisone|cortisone|mesh-list
64593528|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
64593529|NCT03704714|Rituximab|rituximab|mesh-list
64593530|NCT03704714|Doxorubicin|doxorubicin|mesh-list
64593531|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64593532|NCT03704714|Nivolumab|nivolumab|mesh-list
64593533|NCT03704714|Vincristine|vincristine|mesh-list
64593534|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64593535|NCT03704714|Antibodies|antibodies|mesh-list
64593536|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
64593537|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64593538|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593539|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
64593540|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593541|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593542|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64593543|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
64593544|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593545|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593546|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64593547|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64593548|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64593549|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64593550|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593551|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593552|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
64593553|NCT03704714|Hormones|hormones|mesh-ancestor
64414777|NCT02419755|Doxorubicin|doxorubicin|mesh-list
64414778|NCT02419755|Methotrexate|methotrexate|mesh-list
64593554|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593555|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593556|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64593557|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593559|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
64593560|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
64593561|NCT00661141|Ethanol|ethanol|mesh-list
64593562|NCT00661141|Fomepizole|fomepizole|mesh-list
64593563|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64593564|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593565|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593566|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593567|NCT00661141|Antidotes|antidotes|mesh-ancestor
64593568|NCT00661141|Protective Agents|protective agents|mesh-ancestor
64593569|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593570|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593571|NCT03616574|Trifluridine|trifluridine|mesh-list
64593572|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
64593573|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593574|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
64593575|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593576|NCT00681265|Glycerol|glycerol|mesh-list
64593577|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64593578|NCT00681265|Protective Agents|protective agents|mesh-ancestor
64593579|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593580|NCT01677104|Liraglutide|liraglutide|mesh-list
64593581|NCT01677104|Exenatide|exenatide|mesh-list
64593582|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64593583|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64593584|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593585|NCT01677104|Incretins|incretins|mesh-ancestor
64593586|NCT01677104|Hormones|hormones|mesh-ancestor
64593587|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593588|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64593589|NCT00661453|Valproic Acid|valproic acid|mesh-list
64593590|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
64593591|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593592|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593593|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
64593594|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593595|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593596|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
64593597|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64593598|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593599|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64593600|NCT03547622|Galantamine|galantamine|mesh-list
64593601|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64593602|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593603|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593604|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
64593605|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593606|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593607|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64593608|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
64593609|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593610|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
64593611|NCT00681889|Ranibizumab|ranibizumab|mesh-list
64593612|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64593613|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64593614|NCT00681889|Growth Substances|growth substances|mesh-ancestor
64593615|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593616|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
64593617|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593619|NCT03610490|Fludarabine|fludarabine|mesh-list
64593620|NCT03610490|Interleukin-2|interleukin-2|mesh-list
64593621|NCT03610490|Mitogens|mitogens|mesh-list
64593622|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593623|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
64593624|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593625|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593626|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64593627|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
64593628|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593629|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593630|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64593631|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64593633|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
64593634|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593635|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
64593636|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
64593637|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64593638|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64593639|NCT00682357|Prednisolone|prednisolone|mesh-list
64593640|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
64593641|NCT00682357|Lidocaine|lidocaine|mesh-list
64593642|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64593643|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
64593644|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
64593645|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
64593646|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593647|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593648|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
64593649|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593650|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64593651|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64593652|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64593653|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64593654|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593655|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593656|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
64593657|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
64593658|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64593659|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
64593660|NCT00682357|Hormones|hormones|mesh-ancestor
64593661|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593662|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64593663|NCT00682357|Protective Agents|protective agents|mesh-ancestor
64593664|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593665|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593667|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64593668|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64593669|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593670|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593671|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64593672|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
64593673|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
64593674|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593675|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593677|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593678|NCT00662545|Tenofovir|tenofovir|mesh-list
64593679|NCT00662545|Lamivudine|lamivudine|mesh-list
64593680|NCT00662545|Emtricitabine|emtricitabine|mesh-list
64382257|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
64593681|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64593683|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64593684|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
64593685|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593686|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64593687|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64593688|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593689|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593690|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64593691|NCT03539198|Nivolumab|nivolumab|mesh-list
64593692|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593693|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593694|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64593695|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593696|NCT00663169|Dexamethasone|dexamethasone|mesh-list
64593697|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
64593698|NCT00663169|BB 1101|bb 1101|mesh-list
64593699|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64593700|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593701|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
64593702|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
64593703|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593704|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593705|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64593706|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
64593707|NCT00663169|Hormones|hormones|mesh-ancestor
64593708|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593709|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593710|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593711|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
64593712|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593713|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593714|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
64593715|NCT00663403|Daptomycin|daptomycin|mesh-list
64593716|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64593717|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593718|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
64593719|NCT00663793|Finasteride|finasteride|mesh-list
64593720|NCT00663793|Testosterone|testosterone|mesh-list
64593721|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
64593722|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
64593723|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64593724|NCT00663793|Acyline|acyline|mesh-list
64593725|NCT00663793|Androgens|androgens|mesh-ancestor
64593726|NCT00663793|Hormones|hormones|mesh-ancestor
64593727|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593728|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593729|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593730|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593731|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
64593732|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64296227|NCT03303495|Leucovorin|leucovorin|mesh-list
64593733|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64593734|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593735|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593736|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
64593737|NCT00663793|Urological Agents|urological agents|mesh-ancestor
64593738|NCT03690986|Nivolumab|nivolumab|mesh-list
64593739|NCT03690986|Ipilimumab|ipilimumab|mesh-list
64593741|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593742|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64593743|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593744|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
64593745|NCT03605654|Tacrolimus|tacrolimus|mesh-list
64593746|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64593747|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
64593748|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593749|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64593750|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593751|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593752|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64593753|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593754|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64593755|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
64593756|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64593757|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593758|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
64593759|NCT02336438|Cathartics|cathartics|mesh-ancestor
64593760|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64593761|NCT00667615|Prednisone|prednisone|mesh-list
64593762|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
64593763|NCT00667615|Rituximab|rituximab|mesh-list
64593764|NCT00667615|Etoposide|etoposide|mesh-list
64593765|NCT00667615|Vorinostat|vorinostat|mesh-list
64593766|NCT00667615|Lenograstim|lenograstim|mesh-list
64593767|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593768|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
64593769|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593770|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593771|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64593772|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
64593773|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593774|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593775|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64593776|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593777|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593778|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
64593779|NCT00667615|Hormones|hormones|mesh-ancestor
64593780|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593781|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593782|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593783|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64593784|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64593785|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593786|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64593787|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64593789|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64593790|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593791|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593792|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593793|NCT03683810|Lactoferrin|lactoferrin|mesh-list
64358231|NCT03371797|Valsartan|valsartan|mesh-list
64593794|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
64593795|NCT03683810|Hematinics|hematinics|mesh-ancestor
64593796|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593797|NCT01587235|Simvastatin|simvastatin|mesh-list
64593798|NCT01587235|Ezetimibe|ezetimibe|mesh-list
64593799|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64593803|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593804|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64593805|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64593806|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593808|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64319125|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
64593809|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
64593810|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64593811|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593812|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64593813|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593814|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64593815|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64593816|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64593817|NCT00705133|Treprostinil|treprostinil|mesh-list
64593818|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64593819|NCT00652717|Simvastatin|simvastatin|mesh-list
64593820|NCT00652717|Ezetimibe|ezetimibe|mesh-list
64593821|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64593822|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64593823|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
64593824|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593825|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64593826|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64593827|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593828|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
64593829|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593830|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
64593831|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64593832|NCT03600350|Nivolumab|nivolumab|mesh-list
64593833|NCT03600350|Sargramostim|sargramostim|mesh-list
64593834|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593835|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593836|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64593837|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593838|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
64593839|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593840|NCT00684775|Naltrexone|naltrexone|mesh-list
64593841|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64593842|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64593843|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593844|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
64593845|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593846|NCT03593408|Fentanyl|fentanyl|mesh-list
64593847|NCT03593408|Midazolam|midazolam|mesh-list
64593848|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
64593849|NCT03593408|Morphine|morphine|mesh-list
64593850|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64593851|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593852|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593853|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64593854|NCT03593408|Analgesics|analgesics|mesh-ancestor
64593855|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
64593856|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593857|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64593858|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64593859|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64593860|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
64593861|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593862|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593863|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64593864|NCT03593408|Narcotics|narcotics|mesh-ancestor
64593865|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64593866|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64593868|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
64593869|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64593870|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64593871|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64593872|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
64593873|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
64593874|NCT00395473|Ezetimibe|ezetimibe|mesh-list
64593875|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64593876|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64593877|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
64593878|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593879|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64593880|NCT00393211|Etoricoxib|etoricoxib|mesh-list
64593881|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593882|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593883|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593884|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64593885|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64593886|NCT00393211|Analgesics|analgesics|mesh-ancestor
64593887|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
64593888|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593889|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593890|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64593891|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64593892|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593893|NCT03676556|Lidocaine|lidocaine|mesh-list
64593894|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
64593895|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
64593896|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593897|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593898|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
64593899|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593900|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64593901|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64593902|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64593903|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64593904|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593905|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
64593906|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64593907|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
64593908|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
64593909|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
64593910|NCT03592472|Abexinostat|abexinostat|mesh-list
64593911|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64593912|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593913|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593914|NCT00269191|Ibuprofen|ibuprofen|mesh-list
64593915|NCT00269191|Etoricoxib|etoricoxib|mesh-list
64593916|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64593917|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64593918|NCT00269191|Analgesics|analgesics|mesh-ancestor
64593919|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
64593920|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593921|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593922|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64593923|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593924|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64593926|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593927|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64593929|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64593930|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593931|NCT00092833|Ezetimibe|ezetimibe|mesh-list
64593932|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64593933|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64593934|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
64593935|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593936|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64593937|NCT01799083|Decitabine|decitabine|mesh-list
64593938|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64593939|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
64593940|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593941|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593942|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593943|NCT01799161|Theophylline|theophylline|mesh-list
64593944|NCT01799161|Vaccines|vaccines|mesh-list
64593945|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
64593946|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593947|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64593948|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
64593949|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593950|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64593951|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
64593952|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64593953|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593954|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593955|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
64593956|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64593957|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64593958|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
64593959|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64593960|NCT00006110|Paclitaxel|paclitaxel|mesh-list
64593961|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
64593962|NCT00006110|Doxorubicin|doxorubicin|mesh-list
64593963|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64593964|NCT00006110|Trastuzumab|trastuzumab|mesh-list
64593965|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64593966|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64593967|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
64593968|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
64593969|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
64593970|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64593971|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64593972|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
64593973|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593974|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64593975|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64593976|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
64593977|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64593978|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64593979|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64593980|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64593981|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64593982|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64593983|NCT03591770|Vaccines|vaccines|mesh-list
64593984|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
64593985|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593986|NCT00692185|Olanzapine|olanzapine|mesh-list
64593987|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
64593988|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
64593989|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64593990|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64593991|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64593992|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64593993|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64593994|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64593995|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64593996|NCT00692185|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64593997|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64593998|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64593999|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594000|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594002|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
64594003|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
64594004|NCT00692341|Axitinib|axitinib|mesh-list
64594005|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594006|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64594007|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594008|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594009|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
64594010|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594011|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594012|NCT03511976|Methylphenidate|methylphenidate|mesh-list
64594013|NCT03511976|Amphetamine|amphetamine|mesh-list
64594014|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64594015|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594016|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64594017|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64594018|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594019|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594020|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
64594021|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594022|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
64594023|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
64594024|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594025|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594026|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64594027|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
64594029|NCT03510884|Niacinamide|niacinamide|mesh-list
64594030|NCT03510884|Atorvastatin|atorvastatin|mesh-list
64594031|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64319352|NCT02581982|Paclitaxel|paclitaxel|mesh-list
64594032|NCT03510884|Simvastatin|simvastatin|mesh-list
64594033|NCT03510884|Ezetimibe|ezetimibe|mesh-list
64594034|NCT03510884|Pravastatin|pravastatin|mesh-list
64594035|NCT03510884|Lovastatin|lovastatin|mesh-list
64594036|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
64594037|NCT03510884|Fenofibrate|fenofibrate|mesh-list
64594038|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64594039|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64594040|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
64594041|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594042|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64594043|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64594044|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594045|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
64594046|NCT03510884|Vitamins|vitamins|mesh-ancestor
64594047|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
64594048|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594049|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
64594050|NCT00694603|Cetuximab|cetuximab|mesh-list
64594051|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594052|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594053|NCT03582722|Orlistat|orlistat|mesh-list
64594054|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594055|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594056|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64594057|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64594058|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
64594059|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64594060|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594061|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594062|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64594063|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64594064|NCT00590161|Protective Agents|protective agents|mesh-ancestor
64594065|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594066|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
64594067|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64594068|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
64594069|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64594070|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64594071|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594072|NCT00006170|Bupropion|bupropion|mesh-list
64594073|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64594074|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
64594075|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64296232|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594076|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64594077|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64594078|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594079|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594081|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594082|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594083|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64594084|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64594085|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594086|NCT02123849|Aspirin|aspirin|mesh-list
64594087|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64594088|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64594089|NCT02123849|Analgesics|analgesics|mesh-ancestor
64594090|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
64594091|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594092|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594093|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594094|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594095|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64594096|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64594097|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594098|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64594099|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64594100|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594101|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
64594102|NCT05347160|Calcium|calcium|mesh-list
64594103|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64594104|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594105|NCT00671528|Gentamicins|gentamicins|mesh-list
64594106|NCT00671528|Clotrimazole|clotrimazole|mesh-list
64594107|NCT00671528|Miconazole|miconazole|mesh-list
64594108|NCT00671528|Betamethasone|betamethasone|mesh-list
64594109|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
64594111|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
64594112|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64594113|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594114|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
64594116|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594117|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594118|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64594119|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
64594120|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64594121|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594122|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64594123|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594124|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594125|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64594126|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
64594127|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64594128|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64594129|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64594130|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
64594131|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64594132|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64594133|NCT00590863|Dexetimide|dexetimide|mesh-list
64594134|NCT00590863|Mirtazapine|mirtazapine|mesh-list
64594135|NCT00590863|Citalopram|citalopram|mesh-list
64594136|NCT00590863|Bupropion|bupropion|mesh-list
64594137|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64296237|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
64594138|NCT00590863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64594139|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64594140|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594141|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594142|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594143|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
64594144|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594145|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64594146|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
64594147|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64594148|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64594149|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64594150|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
64594151|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
64594152|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594153|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64594154|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64594155|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
64594156|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64594157|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
64594158|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64594159|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64594160|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594161|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64594162|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64594163|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
64594164|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
64594165|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64594166|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64594167|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594168|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64594169|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64594170|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64594171|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594172|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64594173|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64594174|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64594175|NCT00591019|Modafinil|modafinil|mesh-list
64594176|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64594177|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594178|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64296247|NCT03303495|Protective Agents|protective agents|mesh-ancestor
64594179|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64594180|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64594181|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594183|NCT02996695|Chloroquine|chloroquine|mesh-list
64594184|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
64594185|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64594186|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64594187|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594188|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594189|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
64594190|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
64594191|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64594192|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
64594193|NCT02996695|Amebicides|amebicides|mesh-ancestor
64594194|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594195|NCT00359138|Cetirizine|cetirizine|mesh-list
64594196|NCT00359138|Loratadine|loratadine|mesh-list
64594197|NCT00359138|Levocetirizine|levocetirizine|mesh-list
64594198|NCT00359138|Desloratadine|desloratadine|mesh-list
64594199|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64594200|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64594201|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
64594202|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
64594203|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594204|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594205|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594206|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64594207|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64594208|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
64594209|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
64594210|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
64594211|NCT04738643|Varenicline|varenicline|mesh-list
64594212|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64594213|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64594214|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
64594215|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594216|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594217|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594218|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
64594219|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64594220|NCT05503979|Velpatasvir|velpatasvir|mesh-list
64594221|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
64594222|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594224|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594225|NCT02996227|Bupivacaine|bupivacaine|mesh-list
64594226|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
64594227|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
64594228|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594229|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594230|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
64594231|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594232|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
64594233|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64594234|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64594235|NCT00698035|Testosterone|testosterone|mesh-list
64594236|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
64594237|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
64594238|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64594240|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64594241|NCT00698035|Androgens|androgens|mesh-ancestor
64594242|NCT00698035|Hormones|hormones|mesh-ancestor
64594243|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594244|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594245|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64594246|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594247|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
64594248|NCT00698035|Estrogens|estrogens|mesh-ancestor
64594249|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64594250|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
64594251|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64594252|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64594253|NCT02129075|Poly I-C|poly i-c|mesh-list
64594254|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64594255|NCT02129075|Poly ICLC|poly iclc|mesh-list
64594256|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
64594257|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
64594258|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
64594259|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594260|NCT02129075|Laxatives|laxatives|mesh-ancestor
64594261|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64594262|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
64594263|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594264|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64594265|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64594266|NCT02129075|Protective Agents|protective agents|mesh-ancestor
64594267|NCT02775903|Azacitidine|azacitidine|mesh-list
64594268|NCT02775903|Durvalumab|durvalumab|mesh-list
64594269|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64594270|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
64594271|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594272|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594273|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594274|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594275|NCT01782443|Aflibercept|aflibercept|mesh-list
64594276|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64594277|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64594278|NCT01782443|Growth Substances|growth substances|mesh-ancestor
64594279|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594280|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
64594281|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594282|NCT01933425|Rocuronium|rocuronium|mesh-list
64594283|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64594284|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64594286|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594287|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594288|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
64594289|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594290|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594291|NCT04239599|Leuprolide|leuprolide|mesh-list
64594292|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64594293|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
64594294|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64594295|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594296|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64594297|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594298|NCT03487016|Gemcitabine|gemcitabine|mesh-list
64594299|NCT03487016|Paclitaxel|paclitaxel|mesh-list
64594300|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
64594301|NCT03487016|Irinotecan|irinotecan|mesh-list
64594302|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64594303|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594304|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
64594305|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
64594306|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
64594307|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594308|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64594309|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
64594310|NCT03487016|Antiviral Agents|antiviral agents|mesh-ancestor
64594311|NCT03487016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594312|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594313|NCT03487016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594314|NCT03487016|Immunologic Factors|immunologic factors|mesh-ancestor
64594315|NCT03487016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594316|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64594317|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64594318|NCT05346926|Calpastatin|calpastatin|mesh-list
64594319|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64594320|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
64594321|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594322|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594323|NCT05292209|Riluzole|riluzole|mesh-list
64594324|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
64594325|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64594326|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64594327|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594328|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594329|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594330|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64594331|NCT05292209|Protective Agents|protective agents|mesh-ancestor
64594332|NCT03023319|Pemetrexed|pemetrexed|mesh-list
64594333|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594334|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594335|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594336|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64594337|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64594338|NCT02980653|Megestrol|megestrol|mesh-list
64594339|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
64594340|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64358300|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64594341|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64594342|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64594343|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
64594344|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64594345|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594346|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64594347|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64594348|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64594349|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594350|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
64594351|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64594352|NCT05265065|Vaccines|vaccines|mesh-list
64594353|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
64594354|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594355|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
64594368|NCT02168829|Analgesics|analgesics|mesh-ancestor
64594369|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
64594370|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594371|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594372|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594373|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594374|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64594375|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64594376|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594377|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64594378|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64594379|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594380|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
64594381|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64594382|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
64594383|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64594384|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
64594385|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
64594386|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
64594387|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
64594388|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594389|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594391|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594392|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
64594394|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594395|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594396|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64594397|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594398|NCT03845049|Aflibercept|aflibercept|mesh-list
64594399|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64594400|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64594401|NCT03845049|Growth Substances|growth substances|mesh-ancestor
64594402|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594403|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
64594404|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594405|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64594406|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64594407|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594408|NCT03790839|Incretins|incretins|mesh-ancestor
64594409|NCT03790839|Hormones|hormones|mesh-ancestor
64594410|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594411|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64594412|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
64594413|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594414|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594415|NCT03088046|Progesterone|progesterone|mesh-list
64594416|NCT03088046|Progestins|progestins|mesh-ancestor
64594417|NCT03088046|Hormones|hormones|mesh-ancestor
64594418|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594419|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594420|NCT01677884|Bevacizumab|bevacizumab|mesh-list
64594421|NCT01677884|Capecitabine|capecitabine|mesh-list
64594422|NCT01677884|Irinotecan|irinotecan|mesh-list
64594423|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594425|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64594426|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64594427|NCT01677884|Growth Substances|growth substances|mesh-ancestor
64594428|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594429|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
64594430|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64594431|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
64594432|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594433|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64594434|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64594435|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594436|NCT02124083|Vorinostat|vorinostat|mesh-list
64594437|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594438|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64594439|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594440|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594441|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
64594442|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64594444|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594445|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
64594446|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
64594447|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594448|NCT00701389|Sumatriptan|sumatriptan|mesh-list
64594449|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64594450|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64594451|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64594452|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
64594453|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594454|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594455|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594456|NCT02152995|Iodine|iodine|mesh-list
64594457|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
64594458|NCT02152995|Trametinib|trametinib|mesh-list
64594459|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64594460|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594461|NCT02152995|Trace Elements|trace elements|mesh-ancestor
64594462|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
64594463|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594464|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594465|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64594466|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594467|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594468|NCT02336594|Verinurad|verinurad|mesh-list
64594469|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
64594470|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594471|NCT01799317|Vitamin D|vitamin d|mesh-list
64594472|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
64594473|NCT01799317|Vitamins|vitamins|mesh-ancestor
64594474|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
64594475|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594476|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64594477|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64594478|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
64594479|NCT03925025|Nimodipine|nimodipine|mesh-list
64594480|NCT03925025|Analgesics|analgesics|mesh-ancestor
64594481|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
64594482|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594483|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64319795|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64594484|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
64594485|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594486|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64594487|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
64594488|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64594490|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594492|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
64594493|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64594494|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64594495|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
64594497|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
64594498|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
64594499|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594500|NCT00595153|Budesonide|budesonide|mesh-list
64594501|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594502|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64594503|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
64594504|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594505|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594506|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64594507|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
64594508|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
64594509|NCT00595153|Hormones|hormones|mesh-ancestor
64594510|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594511|NCT02995291|Phentolamine|phentolamine|mesh-list
64594512|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64594513|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64594514|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594515|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594516|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594517|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594518|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64594520|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
64594521|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64594522|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64594523|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594524|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594525|NCT02995057|Nickel|nickel|mesh-list
64594526|NCT02995057|Trace Elements|trace elements|mesh-ancestor
64594527|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
64594528|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594529|NCT02474173|Paclitaxel|paclitaxel|mesh-list
64594530|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64594531|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64594532|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594533|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
64594534|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
64594535|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
64594536|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594537|NCT03482102|Durvalumab|durvalumab|mesh-list
64594538|NCT03482102|Tremelimumab|tremelimumab|mesh-list
64594539|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594540|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594541|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64594542|NCT02402270|Laxatives|laxatives|mesh-ancestor
64594543|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64594544|NCT00701935|Exenatide|exenatide|mesh-list
64594545|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64594546|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594547|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64358398|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594549|NCT00701935|Hormones|hormones|mesh-ancestor
64594550|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594551|NCT02984696|Estradiol|estradiol|mesh-list
64594552|NCT02984696|Estrogens|estrogens|mesh-ancestor
64594553|NCT02984696|Hormones|hormones|mesh-ancestor
64594554|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594555|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594556|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64594557|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
64594558|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594559|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64594561|NCT00596167|Levofloxacin|levofloxacin|mesh-list
64594562|NCT00596167|Gentamicins|gentamicins|mesh-list
64594563|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594564|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64594565|NCT00596167|Renal Agents|renal agents|mesh-ancestor
64594566|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64594567|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64594568|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594569|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594570|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594571|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64594572|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64594573|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64594574|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
64594575|NCT03087032|Liraglutide|liraglutide|mesh-list
64594576|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64594577|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594578|NCT03087032|Incretins|incretins|mesh-ancestor
64594579|NCT03087032|Hormones|hormones|mesh-ancestor
64594580|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594581|NCT02994745|Atorvastatin|atorvastatin|mesh-list
64594582|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64594583|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64594584|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
64594585|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594586|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64594587|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64594588|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594589|NCT00703261|Atorvastatin|atorvastatin|mesh-list
64594590|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64594591|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64594592|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
64594593|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594594|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64594595|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64594596|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594598|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594599|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64594600|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594601|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594602|NCT04912115|Midazolam|midazolam|mesh-list
64594603|NCT04912115|Ketamine|ketamine|mesh-list
64594604|NCT04912115|Analgesics|analgesics|mesh-ancestor
64594605|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
64594606|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594607|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594608|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64594609|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64594610|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
64594611|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
64594612|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594613|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64594614|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64594615|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358415|NCT03369067|Insulin|insulin|mesh-list
64594616|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594617|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64594618|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64594619|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64594620|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64594621|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64594622|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
64594623|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
64594624|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
64594625|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594626|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64594627|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594628|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594629|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64594630|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64319946|NCT04300790|Letrozole|letrozole|mesh-list
64319947|NCT04300790|Fulvestrant|fulvestrant|mesh-list
64594631|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
64594632|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
64594633|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
64594634|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594635|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64594637|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64594638|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594639|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594640|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
64594641|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594642|NCT01678352|Imiquimod|imiquimod|mesh-list
64594643|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64594644|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
64594645|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594646|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594647|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
64594648|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64594649|NCT01678430|Chlorambucil|chlorambucil|mesh-list
64594650|NCT01678430|Ofatumumab|ofatumumab|mesh-list
64594651|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64594652|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
64594653|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594654|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594655|NCT01678664|Doxorubicin|doxorubicin|mesh-list
64594656|NCT01678664|Everolimus|everolimus|mesh-list
64594657|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64594658|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594659|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64594660|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64594661|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594662|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594663|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594664|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
64594665|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594667|NCT00597493|Sorafenib|sorafenib|mesh-list
64594668|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64594669|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
64594670|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594671|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594672|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64594673|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594674|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64594677|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594678|NCT04402112|Pitavastatin|pitavastatin|mesh-list
64594679|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64594680|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64594681|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64594682|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
64594683|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64320042|NCT02180425|Adapalene|adapalene|mesh-list
64320043|NCT02180425|Tretinoin|tretinoin|mesh-list
64320044|NCT02180425|Isotretinoin|isotretinoin|mesh-list
64320045|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
64320046|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64320047|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64320048|NCT02180425|Analgesics|analgesics|mesh-ancestor
64320049|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
64320050|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64320051|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296282|NCT03308487|Vitamin D|vitamin d|mesh-list
64320052|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64320053|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64320054|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64320055|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
64320056|NCT02183467|Linagliptin|linagliptin|mesh-list
64320057|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
64320058|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64320059|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64320060|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64320061|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64320062|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64320063|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594684|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594685|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64594687|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64594688|NCT00597727|Protective Agents|protective agents|mesh-ancestor
64594689|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594690|NCT03952403|Bevacizumab|bevacizumab|mesh-list
64594691|NCT03952403|Carboplatin|carboplatin|mesh-list
64594692|NCT03952403|Pemetrexed|pemetrexed|mesh-list
64594693|NCT03952403|Antibodies|antibodies|mesh-list
64594694|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594695|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594696|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64594697|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64594698|NCT03952403|Growth Substances|growth substances|mesh-ancestor
64594699|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594700|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
64594701|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
64594702|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594703|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594704|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64594705|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64594706|NCT03474770|Huperzine A|huperzine a|mesh-list
64594707|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64594708|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594709|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594710|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
64594711|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594712|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594713|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64594714|NCT03474770|Protective Agents|protective agents|mesh-ancestor
64594715|NCT02998645|Cyclosporine|cyclosporine|mesh-list
64594716|NCT02998645|Cyclosporins|cyclosporins|mesh-list
64594717|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594718|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594719|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594720|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
64594721|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594722|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
64594723|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594724|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
64594725|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594726|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64594727|NCT03450122|Aldesleukin|aldesleukin|mesh-list
64594728|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
64594729|NCT03450122|Interleukin-2|interleukin-2|mesh-list
64594730|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594731|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
64594732|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594733|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594734|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64594735|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
64594736|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594737|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594738|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64594739|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64594740|NCT03450122|Analgesics|analgesics|mesh-ancestor
64594741|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
64594742|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594743|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64594744|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64594745|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
64594746|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594747|NCT00707863|Citalopram|citalopram|mesh-list
64594748|NCT00707863|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64594749|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64594750|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594751|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594752|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594754|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64320096|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
64594755|NCT00707863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64594756|NCT00707863|Antidepressive Agents|antidepressive agents|mesh-ancestor
64594757|NCT00707863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64594758|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64594759|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
64594760|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64594761|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
64594762|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594763|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
64594764|NCT00565643|Protective Agents|protective agents|mesh-ancestor
64594765|NCT00565643|Laxatives|laxatives|mesh-ancestor
64594766|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64594767|NCT01798277|Amiodarone|amiodarone|mesh-list
64594768|NCT01798277|Sotalol|sotalol|mesh-list
64594769|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64594770|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
64594771|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64594772|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594773|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594774|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64594776|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64594777|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594778|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64594779|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64594780|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64594781|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64594782|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64594783|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594784|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594785|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594786|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
64594787|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
64594788|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594790|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594791|NCT00566813|Exenatide|exenatide|mesh-list
64594792|NCT00566813|Etanercept|etanercept|mesh-list
64594793|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64594794|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64594795|NCT00566813|Analgesics|analgesics|mesh-ancestor
64594796|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
64594797|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594798|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594799|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594800|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594801|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64594802|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594803|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
64594804|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64594805|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64594806|NCT00566813|Incretins|incretins|mesh-ancestor
64594807|NCT00566813|Hormones|hormones|mesh-ancestor
64594808|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594809|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
64594810|NCT00088166|Hormones|hormones|mesh-ancestor
64594811|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594812|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594813|NCT00566969|Carvedilol|carvedilol|mesh-list
64594814|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64594815|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64594816|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594817|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594818|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594819|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594820|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64594821|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
64594822|NCT00566969|Protective Agents|protective agents|mesh-ancestor
64594823|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64594824|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594825|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64594826|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
64594827|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64594828|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64594829|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
64594831|NCT03086564|Estrogens|estrogens|mesh-ancestor
64594833|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594834|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594835|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64594836|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594837|NCT00598663|Insulin|insulin|mesh-list
64594838|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64594839|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64594840|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594841|NCT03449108|Aldesleukin|aldesleukin|mesh-list
64594842|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
64594843|NCT03449108|Nivolumab|nivolumab|mesh-list
64594844|NCT03449108|Fludarabine|fludarabine|mesh-list
64594845|NCT03449108|Ipilimumab|ipilimumab|mesh-list
64594846|NCT03449108|Interleukin-2|interleukin-2|mesh-list
64594847|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64594848|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
64594849|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594850|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64594851|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64594852|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
64594853|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594854|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594855|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64594856|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594857|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64594858|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64594859|NCT03449108|Analgesics|analgesics|mesh-ancestor
64594860|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
64594861|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594862|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64594863|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64594864|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
64594865|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64594866|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
64594867|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
64594868|NCT00704353|Hematinics|hematinics|mesh-ancestor
64594869|NCT00087698|Pemetrexed|pemetrexed|mesh-list
64594870|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594871|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594872|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594873|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64594874|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64594875|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
64594876|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594877|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594878|NCT05245721|Nalbuphine|nalbuphine|mesh-list
64594879|NCT05245721|Bupivacaine|bupivacaine|mesh-list
64594880|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
64594881|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
64594882|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594883|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594884|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
64594885|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594887|NCT05245721|Narcotics|narcotics|mesh-ancestor
64594888|NCT05245721|Analgesics|analgesics|mesh-ancestor
64594889|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
64594890|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
64594891|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64594892|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594893|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594895|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64594896|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594897|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594899|NCT03472586|Ipilimumab|ipilimumab|mesh-list
64594900|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64594901|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594902|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64594903|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594904|NCT02987985|Acetaminophen|acetaminophen|mesh-list
64594905|NCT02987985|Dexamethasone|dexamethasone|mesh-list
64594906|NCT02987985|Lidocaine|lidocaine|mesh-list
64594907|NCT02987985|Fentanyl|fentanyl|mesh-list
64594908|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
64320241|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64594909|NCT02987985|Ketamine|ketamine|mesh-list
64594910|NCT02987985|Gabapentin|gabapentin|mesh-list
64594911|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
64594912|NCT02987985|Ondansetron|ondansetron|mesh-list
64594913|NCT02987985|Sevoflurane|sevoflurane|mesh-list
64594914|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64594915|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
64594916|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
64594917|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64594918|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594919|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64594920|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
64594921|NCT02987985|Hormones|hormones|mesh-ancestor
64594922|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594923|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64594924|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594925|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
64594926|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
64594927|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64594928|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
64594929|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64594930|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64594931|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64594932|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64594933|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594934|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64594935|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64594936|NCT02987985|Analgesics|analgesics|mesh-ancestor
64594937|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64594938|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64594939|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64594940|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
64594941|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64594942|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64594943|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64594944|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
64594945|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64594946|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64594947|NCT02987985|Narcotics|narcotics|mesh-ancestor
64594948|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64594949|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
64594950|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64594951|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64594952|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
64594953|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64594954|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64594955|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64594956|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
64594957|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
64594958|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
64594959|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64594960|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
64594961|NCT02987985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64594962|NCT00708721|Clofarabine|clofarabine|mesh-list
64594963|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64594964|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
64594965|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594966|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594967|NCT00087152|Capecitabine|capecitabine|mesh-list
64594968|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
64594969|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64594970|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
64594971|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594972|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594973|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64594974|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594977|NCT05362799|Lactitol|lactitol|mesh-list
64594978|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64594979|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64594980|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594981|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64594982|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64594983|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64594984|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594985|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64594986|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
64594987|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64594988|NCT05362799|Cathartics|cathartics|mesh-ancestor
64594989|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64594990|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
64594991|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64594992|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64594993|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64594994|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
64594995|NCT01940523|Coagulants|coagulants|mesh-ancestor
64594996|NCT04403282|Eflornithine|eflornithine|mesh-list
64594997|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64594998|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64594999|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64595000|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64595001|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595002|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64595003|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595004|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595005|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
64595006|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64595007|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
64595008|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
64595009|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595010|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595011|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64595012|NCT02994433|Analgesics|analgesics|mesh-ancestor
64595013|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
64595014|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595015|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64595016|NCT04388189|Bupropion|bupropion|mesh-list
64595017|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64595018|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
64595019|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64595021|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64595022|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595023|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595024|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
64595025|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595026|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595027|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64595028|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64595029|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595030|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64595031|NCT04388189|Analgesics|analgesics|mesh-ancestor
64595032|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
64595033|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595034|NCT00599053|Azithromycin|azithromycin|mesh-list
64595035|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595036|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595037|NCT01941927|Trametinib|trametinib|mesh-list
64595038|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595039|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64595040|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595041|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595042|NCT05220917|Insulin|insulin|mesh-list
64595043|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64595044|NCT05220917|Metformin|metformin|mesh-list
64595045|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
64595046|NCT05220917|Pioglitazone|pioglitazone|mesh-list
64595047|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64595048|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
64595049|NCT05220917|Liraglutide|liraglutide|mesh-list
64595050|NCT05220917|Empagliflozin|empagliflozin|mesh-list
64595051|NCT05220917|Exenatide|exenatide|mesh-list
64595052|NCT05220917|Glimepiride|glimepiride|mesh-list
64595053|NCT05220917|Linagliptin|linagliptin|mesh-list
64595054|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
64595055|NCT05220917|Canagliflozin|canagliflozin|mesh-list
64595056|NCT05220917|Saxagliptin|saxagliptin|mesh-list
64595057|NCT05220917|Alogliptin|alogliptin|mesh-list
64595058|NCT05220917|Dulaglutide|dulaglutide|mesh-list
64320401|NCT05518994|Bevacizumab|bevacizumab|mesh-list
64595059|NCT05220917|Glyburide|glyburide|mesh-list
64595060|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
64595061|NCT05220917|Lixisenatide|lixisenatide|mesh-list
64595062|NCT05220917|Glipizide|glipizide|mesh-list
64595063|NCT05220917|Xultophy|xultophy|mesh-list
64595064|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64595065|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64595066|NCT05220917|Simvastatin|simvastatin|mesh-list
64595067|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
64595068|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64595069|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595070|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64595071|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64595072|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
64595073|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595074|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64595075|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64595076|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595077|NCT05220917|Incretins|incretins|mesh-ancestor
64595078|NCT05220917|Hormones|hormones|mesh-ancestor
64595079|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595080|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
64595081|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64595082|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64595083|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595084|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
64595085|NCT00086996|Fluorouracil|fluorouracil|mesh-list
64595088|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595089|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64595090|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595091|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595092|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
64595093|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595094|NCT01943565|Hydromorphone|hydromorphone|mesh-list
64595095|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595096|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595097|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64595098|NCT01943565|Narcotics|narcotics|mesh-ancestor
64595099|NCT01943565|Analgesics|analgesics|mesh-ancestor
64595100|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
64595101|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595102|NCT03316859|Naloxegol|naloxegol|mesh-list
64595103|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64595104|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595105|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
64595106|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595107|NCT04401878|Lidocaine|lidocaine|mesh-list
64595108|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
64595109|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
64595110|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595111|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595112|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
64595113|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595114|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64595115|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64595116|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64595117|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595118|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595119|NCT05362019|Norethindrone|norethindrone|mesh-list
64595120|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
64595121|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
64595122|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64595123|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64595124|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64595125|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
64595126|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64595127|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595128|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64595129|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64595130|NCT03654105|Aspirin|aspirin|mesh-list
64595131|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64595132|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64595133|NCT03654105|Analgesics|analgesics|mesh-ancestor
64595134|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
64595135|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595136|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595137|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595138|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64595139|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64595140|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64595141|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595143|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64595144|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595145|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
64595146|NCT04388111|Morphine|morphine|mesh-list
64595147|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64595148|NCT04388111|Narcotics|narcotics|mesh-ancestor
64595149|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595150|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595151|NCT04388111|Analgesics|analgesics|mesh-ancestor
64595152|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
64595153|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595154|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
64595155|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64595156|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595157|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
64595158|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
64595159|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
64595160|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
64595161|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595162|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595163|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
64595164|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595165|NCT01944423|Cycloserine|cycloserine|mesh-list
64595166|NCT01944423|Nicotine|nicotine|mesh-list
64595167|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64595168|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
64595169|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595170|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595171|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64595172|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64595173|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358615|NCT03357133|Tirofiban|tirofiban|mesh-list
64595174|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595175|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595176|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64595177|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595179|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64595180|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
64595181|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595182|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
64595183|NCT05305313|Propofol|propofol|mesh-list
64595184|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64595185|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595186|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595187|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64595188|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
64595189|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
64595190|NCT00600925|Gentamicins|gentamicins|mesh-list
64595191|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595192|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595193|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64595194|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595195|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595196|NCT02338973|Interferons|interferons|mesh-list
64595197|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
64595198|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595199|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
64595200|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595201|NCT00601627|Gemcitabine|gemcitabine|mesh-list
64595202|NCT00601627|Fluorouracil|fluorouracil|mesh-list
64595203|NCT00601627|Capecitabine|capecitabine|mesh-list
64595204|NCT00601627|Panitumumab|panitumumab|mesh-list
64595205|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64595206|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
64595207|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595209|NCT00601627|Antiviral Agents|antiviral agents|mesh-ancestor
64595210|NCT00601627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595211|NCT00601627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595212|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595213|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
64595214|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595215|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64595216|NCT01947153|Metformin|metformin|mesh-list
64595217|NCT01947153|Linagliptin|linagliptin|mesh-list
64595218|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64595219|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595220|NCT01947153|Incretins|incretins|mesh-ancestor
64595221|NCT01947153|Hormones|hormones|mesh-ancestor
64595222|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595223|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64595224|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
64595225|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595226|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595227|NCT02476409|Tolvaptan|tolvaptan|mesh-list
64595228|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64595229|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595230|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
64595231|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595232|NCT01269853|Bevacizumab|bevacizumab|mesh-list
64595233|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64595234|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595235|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64595236|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64595237|NCT01269853|Growth Substances|growth substances|mesh-ancestor
64358619|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64358621|NCT03357055|Analgesics|analgesics|mesh-ancestor
64595238|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595239|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
64595240|NCT02993575|Floxacillin|floxacillin|mesh-list
64595241|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595242|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595243|NCT00603187|Acyline|acyline|mesh-list
64595245|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595246|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595247|NCT01886937|Phentermine|phentermine|mesh-list
64595248|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64595249|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595250|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
64595251|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64595256|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595257|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595258|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
64595259|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64595260|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64595261|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595262|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
64595263|NCT02993341|Coagulants|coagulants|mesh-ancestor
64595264|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
64595265|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64595266|NCT01219075|Estrogens|estrogens|mesh-ancestor
64595267|NCT01219075|Hormones|hormones|mesh-ancestor
64595268|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595269|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595271|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
64595276|NCT02987907|Dexamethasone|dexamethasone|mesh-list
64595277|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595278|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
64595279|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
64595280|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595281|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595282|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64595283|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
64595284|NCT02987907|Hormones|hormones|mesh-ancestor
64595285|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595286|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64595287|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595288|NCT01887171|Tacrolimus|tacrolimus|mesh-list
64320631|NCT02191657|Deferiprone|deferiprone|mesh-list
64595290|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
64595291|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595292|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64595293|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595294|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595295|NCT00713479|Varenicline|varenicline|mesh-list
64595296|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64595297|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64595298|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
64595299|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595300|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595301|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595302|NCT03467750|Ketorolac|ketorolac|mesh-list
64595303|NCT03467750|Morphine|morphine|mesh-list
64595304|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64595305|NCT03467750|Narcotics|narcotics|mesh-ancestor
64595306|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595307|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595308|NCT03467750|Analgesics|analgesics|mesh-ancestor
64595309|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
64595310|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595311|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64595312|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64595313|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595314|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64595315|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64595316|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595317|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595322|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
64595323|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595324|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64595325|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64595326|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64595327|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
64595328|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595329|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595330|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595331|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595332|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
64595333|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595334|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595336|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
64595337|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64595338|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595339|NCT04385719|Remdesivir|remdesivir|mesh-list
64595341|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595342|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
64595343|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595344|NCT00082628|Hormones|hormones|mesh-list
64595345|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595346|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595347|NCT01275859|Letrozole|letrozole|mesh-list
64595348|NCT01275859|Lapatinib|lapatinib|mesh-list
64595349|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595350|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64595351|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64595352|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595353|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595354|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64595355|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
64595356|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595357|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595358|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64320698|NCT02192827|Hormones|hormones|mesh-ancestor
64595362|NCT01950039|Betaine|betaine|mesh-list
64595363|NCT01950039|Glycine|glycine|mesh-list
64595364|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
64595365|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595366|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595367|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595368|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64595369|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
64595370|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64595371|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
64595372|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64595373|NCT01275937|Esomeprazole|esomeprazole|mesh-list
64595374|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64595375|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64595376|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64595377|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595378|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595379|NCT02990455|Nicotine|nicotine|mesh-list
64595380|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64595381|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
64595382|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595385|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64595386|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
64595387|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595388|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595389|NCT01889667|Insulin|insulin|mesh-list
64358731|NCT05123781|Metformin|metformin|mesh-list
64595390|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64595392|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595393|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
64595394|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64595395|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64595396|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64595397|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595398|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595399|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
64595400|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595401|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595402|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64595403|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595404|NCT02130635|Nemiralisib|nemiralisib|mesh-list
64595405|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64595406|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595407|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595408|NCT01276093|Amiodarone|amiodarone|mesh-list
64595409|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64595410|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
64595411|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64595412|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595413|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595414|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64595415|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64595416|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64595417|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595418|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64595419|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64595420|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64595421|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
64595422|NCT00557973|Baclofen|baclofen|mesh-list
64595423|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64595424|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595425|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64595426|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595427|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64595428|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
64595429|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
64595430|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595431|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595432|NCT01892709|Hydromorphone|hydromorphone|mesh-list
64595433|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64595434|NCT01892709|Narcotics|narcotics|mesh-ancestor
64595435|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595436|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595437|NCT01892709|Analgesics|analgesics|mesh-ancestor
64595438|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
64595439|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595440|NCT00726739|Aldesleukin|aldesleukin|mesh-list
64595441|NCT00726739|Interleukin-2|interleukin-2|mesh-list
64595442|NCT00726739|Vaccines|vaccines|mesh-list
64595444|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595445|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595446|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64595447|NCT00726739|Analgesics|analgesics|mesh-ancestor
64595448|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
64595449|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595450|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64595451|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64595452|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
64595453|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595454|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64595455|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
64595456|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595457|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
64595458|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64595459|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64595460|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
64595461|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595462|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595463|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595464|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64595465|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
64595467|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64595468|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64595469|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
64595470|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595471|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595472|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595473|NCT01893801|Gemcitabine|gemcitabine|mesh-list
64595474|NCT01893801|Paclitaxel|paclitaxel|mesh-list
64595475|NCT01893801|Cisplatin|cisplatin|mesh-list
64595476|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64595477|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595478|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
64595479|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
64595480|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
64595481|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595482|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64595483|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
64595484|NCT01893801|Antiviral Agents|antiviral agents|mesh-ancestor
64595485|NCT01893801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595486|NCT01893801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595487|NCT01893801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595488|NCT01893801|Immunologic Factors|immunologic factors|mesh-ancestor
64595489|NCT01893801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595490|NCT00570089|Ranolazine|ranolazine|mesh-list
64595491|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64595493|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595495|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
64595496|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64595497|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64595498|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595499|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595500|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
64595501|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595502|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64595503|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64595504|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64595505|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64595506|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64595508|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64595509|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64595510|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
64595511|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64595512|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64595515|NCT00571259|Citric Acid|citric acid|mesh-list
64595516|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
64595517|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
64595518|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64595519|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
64595520|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
64595521|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595522|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64595523|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64595524|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595525|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595526|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64595527|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595528|NCT01893879|Ketoprofen|ketoprofen|mesh-list
64595529|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64595530|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64595531|NCT01893879|Analgesics|analgesics|mesh-ancestor
64595532|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
64595533|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595534|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595535|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595536|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64595537|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64595539|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595540|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
64595541|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595542|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
64595543|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64595544|NCT00571493|Cytarabine|cytarabine|mesh-list
64595545|NCT00571493|Etoposide|etoposide|mesh-list
64595546|NCT00571493|Bortezomib|bortezomib|mesh-list
64595547|NCT00571493|Melphalan|melphalan|mesh-list
64595548|NCT00571493|Carmustine|carmustine|mesh-list
64595549|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64595550|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595551|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64595552|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64595553|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595554|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595555|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64595556|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
64595557|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
64595558|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595559|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595560|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
64595561|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595562|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64595563|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
64595564|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64595565|NCT00571961|Ritonavir|ritonavir|mesh-list
64595566|NCT00571961|Lopinavir|lopinavir|mesh-list
64595567|NCT00571961|Buprenorphine|buprenorphine|mesh-list
64595568|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64595569|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64595571|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595572|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595573|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64595574|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64595575|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
64595576|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595577|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64595578|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64595579|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64595580|NCT00571961|Narcotics|narcotics|mesh-ancestor
64595581|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595582|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595583|NCT00571961|Analgesics|analgesics|mesh-ancestor
64595584|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
64358810|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64595585|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595586|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64595587|NCT00572117|Topiramate|topiramate|mesh-list
64595588|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
64595589|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64595590|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595591|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
64595592|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64595593|NCT01895127|Antibodies|antibodies|mesh-list
64595594|NCT01895127|Eculizumab|eculizumab|mesh-list
64595595|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
64595596|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595597|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64595598|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595599|NCT01953081|Metoclopramide|metoclopramide|mesh-list
64595600|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
64595601|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
64595602|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595603|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595604|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64595605|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64595606|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64595607|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
64595608|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595609|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595610|NCT00572897|Fludarabine|fludarabine|mesh-list
64595611|NCT00572897|Melphalan|melphalan|mesh-list
64595612|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595613|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595614|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64595615|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
64595616|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595617|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64595618|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
64595619|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64595621|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595622|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64595623|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595624|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595626|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64595627|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64595628|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595629|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595630|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64595631|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595632|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
64595634|NCT04386499|Resveratrol|resveratrol|mesh-list
64595635|NCT04386499|Hematinics|hematinics|mesh-ancestor
64595636|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
64595637|NCT04386499|Vitamins|vitamins|mesh-ancestor
64595638|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
64595639|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595640|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
64595641|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595643|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595644|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64595646|NCT00573287|Clozapine|clozapine|mesh-list
64595647|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64595648|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
64595649|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595650|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595651|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595652|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64595653|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64595654|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595655|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64595656|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64595657|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
64595658|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
64595659|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
64595660|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
64595661|NCT01896921|Maraviroc|maraviroc|mesh-list
64320993|NCT02194855|Rocuronium|rocuronium|mesh-list
64595662|NCT01896921|Dolutegravir|dolutegravir|mesh-list
64595663|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64595664|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64595665|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
64595666|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595667|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64595668|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64595669|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595670|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595671|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64595672|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64595673|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64595674|NCT00749749|Bupivacaine|bupivacaine|mesh-list
64595675|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
64595676|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
64595677|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595678|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595679|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
64595680|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595681|NCT02991937|Tazobactam|tazobactam|mesh-list
64595682|NCT02991937|Piperacillin|piperacillin|mesh-list
64595683|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64595684|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595685|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595686|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64595687|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595688|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595689|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64595690|NCT00420667|Enoxaparin|enoxaparin|mesh-list
64595691|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
64595693|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64595694|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595695|NCT00620425|Sumatriptan|sumatriptan|mesh-list
64595696|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64595697|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64595698|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64595699|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
64595700|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595701|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595702|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595703|NCT01277107|Zaleplon|zaleplon|mesh-list
64595704|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
64595705|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64595706|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595707|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595708|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
64595709|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
64595710|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595711|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595712|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
64595714|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64595715|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595716|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64595717|NCT01274533|Lenalidomide|lenalidomide|mesh-list
64595718|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
64595719|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595720|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64595721|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64595722|NCT01274533|Growth Substances|growth substances|mesh-ancestor
64595723|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
64595724|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595725|NCT01277497|Calcium|calcium|mesh-list
64595726|NCT01277497|Sevelamer|sevelamer|mesh-list
64595727|NCT01277497|Calcium acetate|calcium acetate|mesh-list
64595728|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64595729|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595730|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
64595731|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
64595732|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595733|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
64595734|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595735|NCT01270087|Adalimumab|adalimumab|mesh-list
64595736|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595737|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64595738|NCT01958073|Estradiol|estradiol|mesh-list
64595739|NCT01958073|Estrogens|estrogens|mesh-list
64595740|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64595741|NCT01958073|Hormones|hormones|mesh-ancestor
64595742|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595743|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595744|NCT01270165|Telbivudine|telbivudine|mesh-list
64595745|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
64595746|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595747|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64595748|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595749|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595751|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595752|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64595753|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595754|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595756|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64595760|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64595762|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595763|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
64595764|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
64595765|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595766|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595767|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64595768|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
64595769|NCT01277731|Hormones|hormones|mesh-ancestor
64595770|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595771|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64595772|NCT01277731|Protective Agents|protective agents|mesh-ancestor
64595773|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64595774|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595775|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64595776|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64595777|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595778|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595779|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
64595780|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595781|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595782|NCT05739981|Paclitaxel|paclitaxel|mesh-list
64595783|NCT05739981|Bevacizumab|bevacizumab|mesh-list
64595784|NCT05739981|Carboplatin|carboplatin|mesh-list
64595785|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64595786|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595787|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
64595788|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
64595789|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
64595790|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595791|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64595792|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64595793|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64595794|NCT05739981|Growth Substances|growth substances|mesh-ancestor
64595795|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595796|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
64595797|NCT00751777|Vaccines|vaccines|mesh-list
64595798|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
64595799|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595800|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64595801|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
64595802|NCT01902459|Coagulants|coagulants|mesh-ancestor
64595803|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
64595804|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64595805|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64595806|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64595807|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595808|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595809|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
64595810|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595811|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595812|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64595813|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595815|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64595816|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64595817|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595826|NCT01903005|Narcotics|narcotics|mesh-ancestor
64595827|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595828|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595829|NCT01903005|Analgesics|analgesics|mesh-ancestor
64595830|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
64595831|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595832|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64595833|NCT00614029|Sumatriptan|sumatriptan|mesh-list
64595834|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64595835|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64595836|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64595837|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
64595838|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595839|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595840|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595841|NCT01905423|Albendazole|albendazole|mesh-list
64595842|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
64595843|NCT01905423|Piperazine|piperazine|mesh-list
64595844|NCT01905423|Mebendazole|mebendazole|mesh-list
64595845|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
64595846|NCT01905423|Citric Acid|citric acid|mesh-list
64595847|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
64595848|NCT01905423|DMP 777|dmp 777|mesh-list
64595849|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
64595850|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64595851|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
64595852|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
64595853|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595854|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
64595855|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64595856|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595857|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
64595858|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64595859|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64595860|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
64595861|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
64595862|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
64595863|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595864|NCT01905423|Filaricides|filaricides|mesh-ancestor
64595865|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
64595866|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64595867|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595869|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64595870|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595871|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595872|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595873|NCT01906515|Chrysarobin|chrysarobin|mesh-list
64595874|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64595875|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64595876|NCT01906515|Analgesics|analgesics|mesh-ancestor
64595877|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
64595878|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595879|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595880|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595881|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64595882|NCT00730483|Doxorubicin|doxorubicin|mesh-list
64595883|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64595884|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64595885|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595886|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64595887|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64321221|NCT02751931|Mirabegron|mirabegron|mesh-list
64595888|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595889|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595890|NCT01907607|Palbociclib|palbociclib|mesh-list
64595891|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595892|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64595893|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359001|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64595894|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595895|NCT00753337|Cobalt|cobalt|mesh-list
64595896|NCT00753337|Trace Elements|trace elements|mesh-ancestor
64595897|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
64595898|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595899|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
64595900|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64595901|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
64595902|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
64595903|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595904|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595905|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64595906|NCT01911351|Analgesics|analgesics|mesh-ancestor
64595907|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
64595908|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595909|NCT04385407|Ribavirin|ribavirin|mesh-list
64595910|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
64595911|NCT04385407|Simeprevir|simeprevir|mesh-list
64595912|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
64595913|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595914|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
64595915|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595916|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
64595917|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595918|NCT00573989|Pemetrexed|pemetrexed|mesh-list
64595919|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64595920|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595921|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64595922|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595923|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64595924|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64595925|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64595926|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
64595927|NCT02286921|Testosterone|testosterone|mesh-list
64595928|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
64595929|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
64595930|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64595931|NCT02286921|Androgens|androgens|mesh-ancestor
64595932|NCT02286921|Hormones|hormones|mesh-ancestor
64595933|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595934|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595935|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64595936|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595937|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
64595938|NCT00574067|Buprenorphine|buprenorphine|mesh-list
64595939|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64595940|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64595941|NCT00574067|Narcotics|narcotics|mesh-ancestor
64595942|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595943|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595944|NCT00574067|Analgesics|analgesics|mesh-ancestor
64595945|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
64595946|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595947|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64595948|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64595949|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
64595950|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64595951|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
64595952|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64595953|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595954|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64595955|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64595956|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595957|NCT01913535|Aticaprant|aticaprant|mesh-list
64595958|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64595959|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595960|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
64595961|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64321295|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
64595962|NCT01914159|Ranibizumab|ranibizumab|mesh-list
64595963|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64595964|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64595965|NCT01914159|Growth Substances|growth substances|mesh-ancestor
64595966|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595967|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
64595968|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595969|NCT00576251|Tobramycin|tobramycin|mesh-list
64595970|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
64595971|NCT00576251|Dexamethasone|dexamethasone|mesh-list
64595972|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64595973|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
64595974|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
64595975|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64595976|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595977|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64595978|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
64595979|NCT00576251|Hormones|hormones|mesh-ancestor
64595980|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64595981|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64595982|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64595983|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64595984|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595986|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64595987|NCT00578279|Ethanol|ethanol|mesh-list
64595988|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64595989|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64595990|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64595991|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64595992|NCT00578669|Fluoxetine|fluoxetine|mesh-list
64595993|NCT00578669|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64595994|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64595995|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64595996|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64595997|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64595998|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
64595999|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596000|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64596001|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
64596002|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64596003|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64596004|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64596005|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596007|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596008|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64596009|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596010|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596011|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64596012|NCT05733507|Tenecteplase|tenecteplase|mesh-list
64596013|NCT05733507|Tirofiban|tirofiban|mesh-list
64596014|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64596015|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64596016|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596017|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64596018|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
64596019|NCT00578903|Methotrexate|methotrexate|mesh-list
64596020|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
64596021|NCT00578903|Tacrolimus|tacrolimus|mesh-list
64596022|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596023|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
64596024|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596025|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596026|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64596027|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
64596028|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596029|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596030|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64596031|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64596032|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
64596033|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64596034|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64596035|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
64596036|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
64596037|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596038|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64596039|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64596040|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64596041|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64596043|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596044|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596045|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596046|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64596047|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64596048|NCT00579137|Fludarabine|fludarabine|mesh-list
64596049|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
64596050|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596051|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64596052|NCT00580073|Leucovorin|leucovorin|mesh-list
64596053|NCT00580073|Fluorouracil|fluorouracil|mesh-list
64596054|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
64596055|NCT00580073|Cetuximab|cetuximab|mesh-list
64596056|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
64596057|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596058|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64596059|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596060|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596061|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
64596062|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596065|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
64596067|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
64596068|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64596069|NCT00580151|Clonidine|clonidine|mesh-list
64596070|NCT00580151|Analgesics|analgesics|mesh-ancestor
64596071|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
64596072|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596073|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596074|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64596075|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
64596076|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
64596077|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64596078|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64596079|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64596080|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596081|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596082|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596083|NCT01919697|Plecanatide|plecanatide|mesh-list
64596084|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64596085|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
64596086|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596087|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596088|NCT00580229|Prednisone|prednisone|mesh-list
64596089|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596090|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
64596091|NCT00580229|Hormones|hormones|mesh-ancestor
64596092|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596093|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596094|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64596095|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596096|NCT00580853|Bupropion|bupropion|mesh-list
64596097|NCT00580853|Varenicline|varenicline|mesh-list
64596098|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64596099|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
64596100|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64596101|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64596102|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64596103|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596104|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596105|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
64596106|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596107|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596108|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64596109|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64596110|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596111|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64596112|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64596113|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
64596114|NCT05739045|Nivolumab|nivolumab|mesh-list
64596115|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64596116|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596117|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64596118|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596119|NCT00604019|Dopamine|dopamine|mesh-list
64596120|NCT00604019|Norepinephrine|norepinephrine|mesh-list
64596121|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64596122|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64596123|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596124|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596125|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596126|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596127|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
64596128|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
64596129|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596130|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64596131|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64596132|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
64596133|NCT00604019|Protective Agents|protective agents|mesh-ancestor
64596134|NCT01922115|Trospium chloride|trospium chloride|mesh-list
64596135|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
64596136|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
64596137|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596138|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596139|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64596140|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64596141|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
64596142|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596143|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596144|NCT01922115|Urological Agents|urological agents|mesh-ancestor
64596145|NCT00081770|Ribavirin|ribavirin|mesh-list
64596146|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64596147|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
64596148|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64596149|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
64596150|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596151|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
64596152|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596153|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
64596154|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596155|NCT05731323|Cycloserine|cycloserine|mesh-list
64596156|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64596157|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596158|NCT05731323|Renal Agents|renal agents|mesh-ancestor
64596159|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64596160|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
64596161|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64596162|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
64596163|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596164|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64596165|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596166|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
64596167|NCT00605423|Hormones|hormones|mesh-ancestor
64596168|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596169|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596170|NCT01923129|Prazosin|prazosin|mesh-list
64596171|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64596172|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64596173|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64596174|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64596175|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596176|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596177|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596178|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596179|NCT00581867|Insulin|insulin|mesh-list
64596180|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64596181|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
64596182|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64596183|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596184|NCT01925469|Benzocaine|benzocaine|mesh-list
64321524|NCT02200237|Antacids|antacids|mesh-ancestor
64596185|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
64596187|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596188|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596191|NCT01925781|Nicotine|nicotine|mesh-list
64596192|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64596193|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
64596194|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596195|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596196|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64596197|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64596198|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
64596199|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596200|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596201|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64596202|NCT01927887|Hematinics|hematinics|mesh-ancestor
64596203|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64596204|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64596205|NCT00081458|Teduglutide|teduglutide|mesh-list
64596206|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596207|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64596208|NCT00081458|Protective Agents|protective agents|mesh-ancestor
64596209|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596210|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
64596211|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
64596212|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
64596213|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596214|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596215|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596216|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64359104|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64596217|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64596218|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596219|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64596220|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64596221|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
64596222|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596223|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596224|NCT01929291|Vaccines|vaccines|mesh-list
64596225|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
64596226|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596227|NCT01929759|Tenofovir|tenofovir|mesh-list
64596228|NCT01929759|Emtricitabine|emtricitabine|mesh-list
64596229|NCT01929759|Cobicistat|cobicistat|mesh-list
64596230|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64596231|NCT01929759|Elvitegravir|elvitegravir|mesh-list
64596232|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
64596233|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596234|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64596235|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64596236|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596237|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596238|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64596239|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64596240|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64596241|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64596242|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64596243|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
64596244|NCT03437330|Empagliflozin|empagliflozin|mesh-list
64596245|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64596246|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596247|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64596248|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596250|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596251|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64596252|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596253|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596254|NCT00585377|Bevacizumab|bevacizumab|mesh-list
64596255|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64596256|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64596257|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596258|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64596259|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64596260|NCT00585377|Growth Substances|growth substances|mesh-ancestor
64596261|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596262|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
64596263|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64596264|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596265|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596266|NCT00080288|Modafinil|modafinil|mesh-list
64596267|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64596268|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596269|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64596270|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64596271|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64596272|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596273|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
64596274|NCT00610883|Methotrexate|methotrexate|mesh-list
64596275|NCT00610883|Asparaginase|asparaginase|mesh-list
64596276|NCT00610883|Daunorubicin|daunorubicin|mesh-list
64596277|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596278|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
64596279|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596280|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596281|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64596282|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
64596283|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596284|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596285|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64596286|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64596287|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
64596288|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64596289|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64596290|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
64596291|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
64596292|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596293|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64596294|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64596295|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64596296|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64596297|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64596298|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
64596299|NCT03084380|Fludarabine|fludarabine|mesh-list
64596300|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596301|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
64596302|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596303|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596304|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64596305|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
64596306|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596307|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596308|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64596309|NCT00084344|Afimoxifene|afimoxifene|mesh-list
64596311|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64596312|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
64596313|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596314|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596315|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64596316|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64596317|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
64596318|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
64596319|NCT00611351|Busulfan|busulfan|mesh-list
64596320|NCT00611351|Tacrolimus|tacrolimus|mesh-list
64596321|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64596322|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596323|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
64596324|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596325|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596326|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64596327|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
64596328|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596329|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596330|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64596331|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64596332|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596333|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64596334|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64596335|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
64596336|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64596337|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596338|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
64596339|NCT00611897|Ketamine|ketamine|mesh-list
64596340|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64596341|NCT00611897|Analgesics|analgesics|mesh-ancestor
64596342|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
64596343|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596344|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596345|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64596346|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64596347|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
64596348|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
64596349|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596350|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64596351|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64596352|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596353|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596354|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
64596355|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596356|NCT00611897|Expectorants|expectorants|mesh-ancestor
64596357|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
64596358|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64596359|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
64596360|NCT00611897|Protective Agents|protective agents|mesh-ancestor
64596361|NCT00611897|Antidotes|antidotes|mesh-ancestor
64596362|NCT05711823|Dexamethasone|dexamethasone|mesh-list
64596363|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
64596364|NCT05711823|Aprepitant|aprepitant|mesh-list
64596365|NCT05711823|Granisetron|granisetron|mesh-list
64596366|NCT05711823|BB 1101|bb 1101|mesh-list
64596367|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596368|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
64596369|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
64596370|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596371|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596372|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596373|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
64596374|NCT05711823|Hormones|hormones|mesh-ancestor
64596375|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596376|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64596377|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596378|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
64596379|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596380|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596381|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64596382|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596383|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64596384|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
64596385|NCT03698162|Bevacizumab|bevacizumab|mesh-list
64596386|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64596387|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596388|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64596389|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64596390|NCT03698162|Growth Substances|growth substances|mesh-ancestor
64596391|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596392|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
64596394|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64596395|NCT03080324|Narcotics|narcotics|mesh-ancestor
64596396|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596397|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596398|NCT03080324|Analgesics|analgesics|mesh-ancestor
64596399|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
64596400|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596401|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64596402|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64596403|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
64596404|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
64596405|NCT03083834|Cosyntropin|cosyntropin|mesh-list
64596406|NCT03083834|Hormones|hormones|mesh-ancestor
64596407|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64321749|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
64596408|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596409|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
64596410|NCT03404180|Propofol|propofol|mesh-list
64596411|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64596412|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596413|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596414|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64596415|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
64596416|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
64596417|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64596418|NCT03404180|Analgesics|analgesics|mesh-ancestor
64596419|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
64596420|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596421|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64596422|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64596423|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64596424|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596425|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596426|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596427|NCT02780609|Dexamethasone|dexamethasone|mesh-list
64596428|NCT02780609|Melphalan|melphalan|mesh-list
64596429|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
64596430|NCT02780609|Aprepitant|aprepitant|mesh-list
64596431|NCT02780609|Antiemetics|antiemetics|mesh-list
64596432|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596433|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
64596434|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596435|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596436|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596437|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
64596438|NCT02780609|Hormones|hormones|mesh-ancestor
64596439|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596440|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64596441|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596442|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64596443|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
64596444|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596445|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64596446|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596447|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
64596448|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64596449|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596450|NCT03086096|Irinotecan|irinotecan|mesh-list
64596451|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64596452|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64596453|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596454|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596455|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596456|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64596457|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64596458|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64596459|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596460|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596461|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64596462|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64596463|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64596464|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64596465|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596466|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596467|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596468|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64596469|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64596470|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
64596471|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64596472|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64596473|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
64596474|NCT05346146|Gemcitabine|gemcitabine|mesh-list
64596475|NCT05346146|Paclitaxel|paclitaxel|mesh-list
64596476|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64596477|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596478|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
64596479|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
64484232|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64596480|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
64596481|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596482|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64596484|NCT05346146|Antiviral Agents|antiviral agents|mesh-ancestor
64596485|NCT05346146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596486|NCT05346146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596487|NCT05346146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596488|NCT05346146|Immunologic Factors|immunologic factors|mesh-ancestor
64596489|NCT05346146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596490|NCT00613379|Leronlimab|leronlimab|mesh-list
64596491|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
64596492|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64596493|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64596494|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596495|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64596496|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64596497|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
64596498|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596499|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
64596500|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596501|NCT01271725|Paclitaxel|paclitaxel|mesh-list
64596502|NCT01271725|Vinorelbine|vinorelbine|mesh-list
64596503|NCT01271725|Afatinib|afatinib|mesh-list
64596504|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64596505|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596506|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
64596507|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
64596508|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
64596509|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596510|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64596511|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596512|NCT00587483|Lidocaine|lidocaine|mesh-list
64596513|NCT00587483|Amiodarone|amiodarone|mesh-list
64596514|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
64596515|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
64596516|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596517|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596518|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
64596519|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596520|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64596521|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64596522|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64596523|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596524|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596525|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
64596526|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64596527|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64596528|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64596529|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596530|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64596531|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64596532|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64596533|NCT03401060|Denosumab|denosumab|mesh-list
64596534|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64596535|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596536|NCT01270321|Everolimus|everolimus|mesh-list
64596537|NCT01270321|Pasireotide|pasireotide|mesh-list
64596538|NCT01270321|Somatostatin|somatostatin|mesh-list
64596539|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596540|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596541|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
64596542|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596543|NCT01270321|Hormones|hormones|mesh-ancestor
64596544|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596545|NCT03400826|Simvastatin|simvastatin|mesh-list
64596547|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64596548|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
64596549|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596550|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64596551|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64596552|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596553|NCT01271023|Insulin|insulin|mesh-list
64596554|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64596555|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596556|NCT03086486|Linezolid|linezolid|mesh-list
64596557|NCT03086486|Bedaquiline|bedaquiline|mesh-list
64596558|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64596559|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596560|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64596561|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596562|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596563|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
64596564|NCT02287779|Volixibat|volixibat|mesh-list
64596565|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64596566|NCT00732901|Citalopram|citalopram|mesh-list
64596567|NCT00732901|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64596568|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64596569|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596570|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596571|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596572|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
64596573|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596574|NCT00732901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64596575|NCT00732901|Antidepressive Agents|antidepressive agents|mesh-ancestor
64596576|NCT00732901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64596577|NCT03083210|Lanreotide|lanreotide|mesh-list
64596578|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596579|NCT00616109|Sunitinib|sunitinib|mesh-list
64596580|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596581|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64596582|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64596584|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596585|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
64596586|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64596587|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596588|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596589|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64596590|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
64596591|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596592|NCT00249769|Vaccines|vaccines|mesh-list
64596593|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
64596594|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596595|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
64596596|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64596597|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596598|NCT05737563|Capecitabine|capecitabine|mesh-list
64596599|NCT05737563|Irinotecan|irinotecan|mesh-list
64596600|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64596601|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64596602|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
64596603|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596604|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596605|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64596606|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64596607|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596608|NCT03434678|Fentanyl|fentanyl|mesh-list
64596614|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596615|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596616|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
64596617|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596618|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64596619|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64596620|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
64596621|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64596622|NCT03434678|Narcotics|narcotics|mesh-ancestor
64596623|NCT03434678|Analgesics|analgesics|mesh-ancestor
64596624|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64596625|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64596626|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64596627|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64484233|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64596628|NCT05445921|Mepivacaine|mepivacaine|mesh-list
64596629|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
64596631|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596632|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596633|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
64596634|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596635|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64596636|NCT03390296|Avelumab|avelumab|mesh-list
64596637|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
64596638|NCT03390296|Azacitidine|azacitidine|mesh-list
64596639|NCT03390296|Venetoclax|venetoclax|mesh-list
64596640|NCT03390296|Calicheamicins|calicheamicins|mesh-list
64596641|NCT03390296|Antibodies|antibodies|mesh-list
64596642|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
64596643|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64596644|NCT03390296|Maleic acid|maleic acid|mesh-list
64596645|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
64596646|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596647|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596648|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64596649|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
64596650|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596651|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596652|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64596653|NCT03389750|Oxymorphone|oxymorphone|mesh-list
64596654|NCT03389750|Morphine|morphine|mesh-list
64596655|NCT03389750|Oxycodone|oxycodone|mesh-list
64596656|NCT03389750|Hydromorphone|hydromorphone|mesh-list
64596657|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64596658|NCT03389750|Narcotics|narcotics|mesh-ancestor
64596659|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596660|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596661|NCT03389750|Analgesics|analgesics|mesh-ancestor
64359201|NCT03353857|Dienogest|dienogest|mesh-list
64596662|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
64596663|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596664|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64596665|NCT03837873|Cytarabine|cytarabine|mesh-list
64596666|NCT03837873|Dexamethasone|dexamethasone|mesh-list
64596667|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
64596668|NCT03837873|Rituximab|rituximab|mesh-list
64596669|NCT03837873|Doxorubicin|doxorubicin|mesh-list
64596670|NCT03837873|Etoposide|etoposide|mesh-list
64596671|NCT03837873|Vincristine|vincristine|mesh-list
64596672|NCT03837873|Lenalidomide|lenalidomide|mesh-list
64596673|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64596674|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
64596675|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596676|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596677|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64596678|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
64596679|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596680|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596681|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64596682|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64596683|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596684|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
64596685|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
64596686|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596687|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596688|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
64596689|NCT03837873|Hormones|hormones|mesh-ancestor
64596690|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596691|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64596692|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64596693|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64596694|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64596695|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596696|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64596697|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64596698|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
64596699|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
64596700|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596701|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
64596702|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
64596703|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
64596704|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64596705|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64484234|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64596706|NCT03837873|Growth Substances|growth substances|mesh-ancestor
64596707|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
64596708|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64596709|NCT03082742|Furosemide|furosemide|mesh-list
64596710|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64596711|NCT03082742|Diuretics|diuretics|mesh-ancestor
64596712|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
64596713|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596714|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64596715|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596716|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596717|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64596718|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
64596719|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64359228|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64596720|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64596721|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596722|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
64596723|NCT05434533|Coagulants|coagulants|mesh-ancestor
64596725|NCT03432650|Bupivacaine|bupivacaine|mesh-list
64596726|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596727|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
64596728|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
64596729|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596730|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596731|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596734|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596735|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64596736|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596737|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
64596738|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
64596739|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596740|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
64596741|NCT00248833|Vaccines|vaccines|mesh-list
64596742|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
64596743|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596744|NCT00668525|Dexetimide|dexetimide|mesh-list
64596745|NCT00668525|Citalopram|citalopram|mesh-list
64596746|NCT00668525|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64596747|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64596748|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596749|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596750|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596751|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
64596752|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596753|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64596754|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
64596755|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64596756|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64596757|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64596758|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
64596759|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
64596760|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596761|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64596762|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64596763|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
64596764|NCT05736549|Dexamethasone|dexamethasone|mesh-list
64596765|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
64596766|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64596767|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64596768|NCT05736549|Prednisolone|prednisolone|mesh-list
64596769|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
64596770|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
64596771|NCT05736549|Bupivacaine|bupivacaine|mesh-list
64596772|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64596773|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
64596774|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64596775|NCT05736549|BB 1101|bb 1101|mesh-list
64596776|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596777|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
64596778|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
64596779|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596780|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596781|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596783|NCT05736549|Hormones|hormones|mesh-ancestor
64596784|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596785|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64596786|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596787|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
64596788|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
64596789|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596790|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
64596791|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64596792|NCT05736549|Protective Agents|protective agents|mesh-ancestor
64596793|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
64596794|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596795|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596796|NCT05688488|Curcumin|curcumin|mesh-list
64596797|NCT05688488|Mitomycins|mitomycins|mesh-list
64596798|NCT05688488|Mitomycin|mitomycin|mesh-list
64596799|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64596800|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596801|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
64596802|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596803|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64596804|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596805|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64596806|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64596807|NCT05688488|Analgesics|analgesics|mesh-ancestor
64596808|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
64596809|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596810|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596811|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596812|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596813|NCT00669383|Betamethasone|betamethasone|mesh-list
64596814|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596815|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
64596816|NCT00669383|Hormones|hormones|mesh-ancestor
64596817|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596818|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596819|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64596820|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
64596821|NCT00733993|Caffeine|caffeine|mesh-list
64596822|NCT00733993|Amphetamine|amphetamine|mesh-list
64596823|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64596824|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596825|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64596826|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596827|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596828|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64596829|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64596830|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
64596831|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596832|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
64596833|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
64596834|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596835|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
64596836|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596837|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64596838|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64596839|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596840|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64596841|NCT01271257|Misoprostol|misoprostol|mesh-list
64596842|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64596843|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
64596844|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64596845|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596846|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64596847|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596848|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
64596849|NCT03082352|Metoprolol|metoprolol|mesh-list
64596850|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64596851|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64596852|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
64596853|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
64596854|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596855|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596856|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64322198|NCT02226289|Bevacizumab|bevacizumab|mesh-list
64596857|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64596858|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64596859|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596860|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596861|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596862|NCT03431168|Azithromycin|azithromycin|mesh-list
64596863|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64596865|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596866|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64596867|NCT03431168|Renal Agents|renal agents|mesh-ancestor
64596868|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
64596869|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64596870|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64596871|NCT03398252|Doxazosin|doxazosin|mesh-list
64596872|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64596873|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64596874|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64596875|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64596876|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596877|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596878|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596879|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596880|NCT02285283|Itraconazole|itraconazole|mesh-list
64596881|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
64596882|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596883|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64596884|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64596885|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596886|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596887|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64596888|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
64596889|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596890|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596891|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64596892|NCT05688098|Amlodipine|amlodipine|mesh-list
64596893|NCT05688098|Irbesartan|irbesartan|mesh-list
64596894|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64596895|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64596896|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64596897|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596898|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64596900|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
64596901|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64596902|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64596903|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64596904|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
64596905|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64596906|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
64596907|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596908|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
64596909|NCT03429140|Protective Agents|protective agents|mesh-ancestor
64596910|NCT03081494|Spartalizumab|spartalizumab|mesh-list
64596911|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64596912|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596913|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596914|NCT03081728|Acetaminophen|acetaminophen|mesh-list
64596915|NCT03081728|Diclofenac|diclofenac|mesh-list
64596916|NCT03081728|Ropivacaine|ropivacaine|mesh-list
64596917|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
64596918|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
64596919|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64596920|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596921|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
64596922|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596923|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64596924|NCT03081728|Analgesics|analgesics|mesh-ancestor
64596925|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
64596926|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64596927|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596928|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596929|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64596930|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596931|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596932|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64596933|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64596935|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
64596936|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64596937|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64596938|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596939|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
64596940|NCT05688020|Coagulants|coagulants|mesh-ancestor
64596941|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64596942|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64596943|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
64596944|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64596945|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596948|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
64596949|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596950|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64596951|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
64596953|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
64596954|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64596955|NCT00618917|Manganese|manganese|mesh-list
64596956|NCT00618917|Paclitaxel|paclitaxel|mesh-list
64596957|NCT00618917|Carboplatin|carboplatin|mesh-list
64596958|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
64596959|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64596960|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596961|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
64596962|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
64596963|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
64596964|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596965|NCT00618917|Trace Elements|trace elements|mesh-ancestor
64596966|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
64596967|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596968|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64596969|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
64596970|NCT00618917|Protective Agents|protective agents|mesh-ancestor
64596971|NCT05736081|Dexamethasone|dexamethasone|mesh-list
64596972|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596973|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
64596974|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
64596975|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596976|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596977|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64596978|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
64596979|NCT05736081|Hormones|hormones|mesh-ancestor
64359305|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
64596980|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64596981|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64596982|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64596983|NCT00619073|Aspirin|aspirin|mesh-list
64596984|NCT00619073|Clopidogrel|clopidogrel|mesh-list
64596985|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64596986|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64596987|NCT00619073|Analgesics|analgesics|mesh-ancestor
64596988|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
64596989|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64596990|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64596991|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64596992|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64596993|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64596994|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64596995|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64596996|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64596997|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64596998|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64596999|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
64597000|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64322345|NCT02226991|Efavirenz|efavirenz|mesh-list
64597001|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64597002|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64597003|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
64597004|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597006|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
64597007|NCT00670241|Calcipotriene|calcipotriene|mesh-list
64597008|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64597009|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
64597012|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597013|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64597014|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
64597015|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
64597016|NCT03088670|Metformin|metformin|mesh-list
64597017|NCT03088670|Vildagliptin|vildagliptin|mesh-list
64597018|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64597019|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597020|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64597021|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
64597022|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597023|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597024|NCT03088358|Enoxaparin|enoxaparin|mesh-list
64597025|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
64597026|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64597027|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64597028|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597029|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64597030|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64597031|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64597032|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597033|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597034|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64597035|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64597036|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64597037|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64597038|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
64597039|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597040|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597041|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64597042|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64597043|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
64597044|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64597045|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64597046|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
64597047|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
64597048|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64597049|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64597050|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
64597051|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597052|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597053|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597054|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64597055|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
64597057|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64597059|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64597060|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597061|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64597062|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597063|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
64597064|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
64597065|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64597066|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597067|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597068|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64597069|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597070|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64597071|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64597072|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
64597073|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64597074|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
64597075|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
64597076|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64597077|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64597078|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597079|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597080|NCT03382106|Urological Agents|urological agents|mesh-ancestor
64597081|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
64597082|NCT00622895|Fludarabine|fludarabine|mesh-list
64597083|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
64597084|NCT00622895|Tacrolimus|tacrolimus|mesh-list
64597085|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597086|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597087|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
64296388|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
64597088|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597089|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597090|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
64597091|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597092|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64597093|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597094|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597095|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64597096|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
64597097|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64597098|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597099|NCT03380546|Insulin|insulin|mesh-list
64597100|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64597101|NCT03380546|Acarbose|acarbose|mesh-list
64597102|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
64597103|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64597104|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597105|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64597106|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597107|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597108|NCT00672737|Remifentanil|remifentanil|mesh-list
64597109|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64597110|NCT00672737|Narcotics|narcotics|mesh-ancestor
64597111|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597112|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597113|NCT00672737|Analgesics|analgesics|mesh-ancestor
64597114|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
64597115|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597116|NCT00673127|Ketoconazole|ketoconazole|mesh-list
64597117|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
64597118|NCT00673127|Dutasteride|dutasteride|mesh-list
64597119|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64597120|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
64597121|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597122|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64597123|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64597124|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597125|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597126|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64597127|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
64597128|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64597129|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597130|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64597131|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64597133|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
64597134|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64597135|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
64597136|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597137|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597138|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597139|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64597140|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597141|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64597142|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64597143|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
64597144|NCT00673439|PENTA|penta|mesh-list
64597145|NCT00673439|Warfarin|warfarin|mesh-list
64597146|NCT00673439|Fondaparinux|fondaparinux|mesh-list
64597147|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
64597148|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64597149|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
64597150|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64597151|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
64484235|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64597152|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597153|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597154|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64597155|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64597157|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
64597158|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
64597159|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597160|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597161|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
64597162|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597163|NCT03029013|Apatinib|apatinib|mesh-list
64597164|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597165|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64597166|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597167|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597169|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64597170|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64597171|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
64597172|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597173|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597174|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597175|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64597177|NCT00246025|Dabigatran|dabigatran|mesh-list
64597178|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
64597179|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64597180|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
64597181|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597182|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597183|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
64597184|NCT03311594|Ethanol|ethanol|mesh-list
64597185|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64597186|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597187|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597188|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597189|NCT05069051|Belimumab|belimumab|mesh-list
64597190|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597191|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
64597192|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597193|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64597194|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
64597195|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64597197|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597198|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597199|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597200|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64597201|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
64597202|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64597203|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64597204|NCT00624923|Analgesics|analgesics|mesh-ancestor
64597205|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
64597206|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597207|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597208|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64597209|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64597210|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64597211|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597212|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597213|NCT05593653|Suvorexant|suvorexant|mesh-list
64597214|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64597215|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64597216|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597217|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597218|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64597219|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597220|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597221|NCT04954287|Vaccines|vaccines|mesh-list
64597222|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
64597223|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597224|NCT00735787|Adalimumab|adalimumab|mesh-list
64597226|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64597227|NCT03375788|Hormones|hormones|mesh-list
64597228|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
64597229|NCT03375788|Tesamorelin|tesamorelin|mesh-list
64597230|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64597231|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597232|NCT03375788|Growth Substances|growth substances|mesh-ancestor
64597233|NCT00628589|Loxapine|loxapine|mesh-list
64597234|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64597235|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64597236|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597237|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597238|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64597239|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64597241|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597242|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597243|NCT04953897|Decitabine|decitabine|mesh-list
64597244|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597246|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597247|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597248|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597249|NCT03375242|Crizotinib|crizotinib|mesh-list
64597250|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597251|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64597252|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597253|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597254|NCT01271569|Fospropofol|fospropofol|mesh-list
64597255|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64597256|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597257|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597258|NCT05589597|Nivolumab|nivolumab|mesh-list
64597259|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597260|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597261|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64597262|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597263|NCT05686772|Dopamine|dopamine|mesh-list
64597264|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64597267|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597268|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597269|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
64597270|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597271|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597272|NCT05686772|Protective Agents|protective agents|mesh-ancestor
64597273|NCT04771871|Paclitaxel|paclitaxel|mesh-list
64597274|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
64597275|NCT04771871|Carboplatin|carboplatin|mesh-list
64597276|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64597277|NCT04771871|Epirubicin|epirubicin|mesh-list
64597278|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64597279|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597280|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
64597281|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
64597282|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
64597283|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597284|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597285|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
64597286|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597287|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64597288|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64597290|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64597291|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597293|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64597294|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597295|NCT04386577|Vitamin D|vitamin d|mesh-list
64597296|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
64597297|NCT04386577|Vitamins|vitamins|mesh-ancestor
64597298|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
64597299|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597300|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64597301|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64597303|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64597304|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64597305|NCT04270669|Growth Substances|growth substances|mesh-ancestor
64359399|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
64597306|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597307|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
64597308|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597309|NCT05680454|Vaccines|vaccines|mesh-list
64597310|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
64597311|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597312|NCT04928703|Ketamine|ketamine|mesh-list
64597313|NCT04928703|Analgesics|analgesics|mesh-ancestor
64597314|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
64597318|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64597319|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
64597320|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
64597321|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597322|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64597323|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64597324|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597325|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597326|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
64597327|NCT04278950|Povidone|povidone|mesh-list
64597328|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
64597329|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
64597330|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64597331|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597332|NCT00755755|Iron|iron|mesh-list
64597333|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
64597334|NCT00755755|Trace Elements|trace elements|mesh-ancestor
64597335|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
64597336|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597337|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64597339|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64597340|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64597341|NCT00674609|Nabiximols|nabiximols|mesh-list
64597342|NCT00674609|Analgesics|analgesics|mesh-ancestor
64597343|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
64597344|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597345|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597346|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
64597347|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64597348|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597349|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64597350|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597351|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64597353|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64597354|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64597357|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597358|NCT05567601|Doxorubicin|doxorubicin|mesh-list
64597359|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64597360|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597361|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597362|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64597363|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64597364|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597365|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597366|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64597367|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
64597368|NCT00755911|Coagulants|coagulants|mesh-ancestor
64597372|NCT00737737|Morphine|morphine|mesh-list
64597373|NCT00737737|Oxycodone|oxycodone|mesh-list
64597374|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64597375|NCT00737737|Narcotics|narcotics|mesh-ancestor
64322723|NCT02149901|Ephedrine|ephedrine|mesh-list
64597376|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597377|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597378|NCT00737737|Analgesics|analgesics|mesh-ancestor
64597379|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
64359432|NCT05131893|Tamoxifen|tamoxifen|mesh-list
64597380|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597381|NCT05199051|Cytarabine|cytarabine|mesh-list
64597382|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
64597383|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597384|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
64597385|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597386|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597387|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
64597388|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597389|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597390|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
64597391|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597392|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597394|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
64597395|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597396|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64597397|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
64597398|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597399|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597400|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64597401|NCT00245011|Analgesics|analgesics|mesh-ancestor
64597402|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
64597403|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597406|NCT00244933|Gemcitabine|gemcitabine|mesh-list
64597407|NCT00244933|Genistein|genistein|mesh-list
64597408|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597409|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
64597410|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597411|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597412|NCT00244933|Antiviral Agents|antiviral agents|mesh-ancestor
64597413|NCT00244933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597414|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597415|NCT00244933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597416|NCT00244933|Immunologic Factors|immunologic factors|mesh-ancestor
64597417|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597418|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64597419|NCT00244933|Protective Agents|protective agents|mesh-ancestor
64597420|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64597421|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
64597422|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64597423|NCT00244933|Estrogens|estrogens|mesh-ancestor
64597424|NCT00244933|Hormones|hormones|mesh-ancestor
64597425|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64597428|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
64597429|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597430|NCT05539053|Expectorants|expectorants|mesh-ancestor
64597431|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
64597432|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64597433|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
64597434|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597435|NCT05539053|Protective Agents|protective agents|mesh-ancestor
64597436|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597437|NCT05539053|Antidotes|antidotes|mesh-ancestor
64597438|NCT00629525|Everolimus|everolimus|mesh-list
64597439|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597440|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597441|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
64597442|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597443|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64597444|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
64597445|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597446|NCT05364008|Protective Agents|protective agents|mesh-ancestor
64597447|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597448|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64597449|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64597450|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64322790|NCT02146937|Bicalutamide|bicalutamide|mesh-list
64597451|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64597452|NCT00244855|Dexamethasone|dexamethasone|mesh-list
64597453|NCT00244855|Rituximab|rituximab|mesh-list
64597454|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597455|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597456|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
64597457|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597458|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64597459|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64597460|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
64597461|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
64597462|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597463|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64597464|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
64597465|NCT00244855|Hormones|hormones|mesh-ancestor
64597466|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64597467|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64597468|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
64597469|NCT00737893|Hematinics|hematinics|mesh-ancestor
64597471|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64597472|NCT00631319|Narcotics|narcotics|mesh-ancestor
64597473|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597474|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597475|NCT00631319|Analgesics|analgesics|mesh-ancestor
64597476|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
64597477|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597478|NCT00244621|Candesartan|candesartan|mesh-list
64597479|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
64597480|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64597481|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64597482|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64597483|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597484|NCT00680225|Ranibizumab|ranibizumab|mesh-list
64597485|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64597486|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64597487|NCT00680225|Growth Substances|growth substances|mesh-ancestor
64597488|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359483|NCT02689167|Growth Substances|growth substances|mesh-ancestor
64597489|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
64597490|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597491|NCT04603391|Cannabidiol|cannabidiol|mesh-list
64597492|NCT04603391|Methylphenidate|methylphenidate|mesh-list
64597493|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64597494|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597495|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64597496|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64597497|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597498|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597499|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
64597500|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597501|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
64597502|NCT04575857|Atorvastatin|atorvastatin|mesh-list
64597503|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64597504|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64597505|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
64597506|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597507|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64597508|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64597509|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597510|NCT00738049|Darusentan|darusentan|mesh-list
64597511|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64597512|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597513|NCT04416633|Durvalumab|durvalumab|mesh-list
64597514|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597515|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597516|NCT02291133|Bleomycin|bleomycin|mesh-list
64597517|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597518|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597519|NCT00680459|Ethanol|ethanol|mesh-list
64597520|NCT00680459|Heparin|heparin|mesh-list
64597521|NCT00680459|Anticoagulants|anticoagulants|mesh-list
64597522|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64597523|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64597524|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597525|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64597526|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597527|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597528|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597530|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64597531|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
64597532|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597533|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597534|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64597535|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64597536|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
64597537|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597538|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597540|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
64597541|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597542|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597543|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64597544|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64597545|NCT05685836|Growth Substances|growth substances|mesh-ancestor
64597546|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597547|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
64597548|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64597549|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597551|NCT00632489|Lapatinib|lapatinib|mesh-list
64597552|NCT00632489|Panobinostat|panobinostat|mesh-list
64597553|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597554|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
64597555|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597556|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597557|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64597558|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597559|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64597560|NCT05096481|Temozolomide|temozolomide|mesh-list
64597561|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64597562|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
64597563|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597564|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597565|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
64597566|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
64597567|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597568|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
64597569|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597570|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597571|NCT01798979|Midazolam|midazolam|mesh-list
64597572|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64597573|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64597574|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597575|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597576|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64597577|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64597578|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64597579|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64597580|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
64597581|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
64597582|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
64597583|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
64597584|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597585|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597586|NCT00738361|Paclitaxel|paclitaxel|mesh-list
64597587|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64597588|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64597589|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597590|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
64597591|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
64597592|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
64597593|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597594|NCT05063565|Durvalumab|durvalumab|mesh-list
64597595|NCT05063565|Tremelimumab|tremelimumab|mesh-list
64597596|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
64597597|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597598|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597599|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597600|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64597601|NCT01279213|Clozapine|clozapine|mesh-list
64597602|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64597604|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597605|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597606|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64597607|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64597608|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64597609|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
64597610|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597611|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597612|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64597613|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64597615|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
64597617|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64597618|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64597619|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64597620|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597621|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597622|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597623|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359575|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64597624|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64597625|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
64597626|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64597627|NCT01279291|Gemcitabine|gemcitabine|mesh-list
64597628|NCT01279291|Paclitaxel|paclitaxel|mesh-list
64597629|NCT01279291|Carboplatin|carboplatin|mesh-list
64597630|NCT01279291|Doxorubicin|doxorubicin|mesh-list
64597631|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64597632|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64597633|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597634|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
64597635|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
64597636|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
64597637|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597638|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597639|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
64597640|NCT01279291|Antiviral Agents|antiviral agents|mesh-ancestor
64597641|NCT01279291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597642|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597643|NCT01279291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597644|NCT01279291|Immunologic Factors|immunologic factors|mesh-ancestor
64597645|NCT01279291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597646|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597647|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64597648|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64597649|NCT04367883|Amantadine|amantadine|mesh-list
64597650|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
64597652|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64597653|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64597654|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
64597655|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597656|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
64597657|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597658|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597659|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597660|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64597661|NCT04367883|Analgesics|analgesics|mesh-ancestor
64597662|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
64597663|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597664|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
64597665|NCT04329039|Somatostatin|somatostatin|mesh-list
64597666|NCT04329039|Hormones|hormones|mesh-ancestor
64597667|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64597668|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597669|NCT00635609|Doxycycline|doxycycline|mesh-list
64597670|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64597671|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597672|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
64597673|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64597674|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64597675|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64597676|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64597677|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64597678|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64597679|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64597681|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
64597682|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597683|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64597684|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597685|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597686|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64597687|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64597688|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
64597689|NCT05315336|Antibodies|antibodies|mesh-list
64597690|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
64597691|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597692|NCT04746495|Eplerenone|eplerenone|mesh-list
64597693|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64597694|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
64597695|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64597696|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597697|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64597698|NCT04746495|Diuretics|diuretics|mesh-ancestor
64597699|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
64597700|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64597701|NCT03347786|Verapamil|verapamil|mesh-list
64597702|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64597703|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64597704|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597705|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597706|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64597707|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597708|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
64597709|NCT03288974|Pomalidomide|pomalidomide|mesh-list
64597710|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
64597711|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597712|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64597713|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64597714|NCT03288974|Growth Substances|growth substances|mesh-ancestor
64597715|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
64597716|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597717|NCT03286634|Cytarabine|cytarabine|mesh-list
64597718|NCT03286634|Prednisolone|prednisolone|mesh-list
64597719|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
64597720|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
64597721|NCT03286634|Methotrexate|methotrexate|mesh-list
64597722|NCT03286634|Vincristine|vincristine|mesh-list
64597723|NCT03286634|Daunorubicin|daunorubicin|mesh-list
64597724|NCT03286634|Asparaginase|asparaginase|mesh-list
64597725|NCT03286634|Epirubicin|epirubicin|mesh-list
64597726|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
64597727|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597728|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
64597729|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597730|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64597731|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64597732|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
64597733|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597734|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597735|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64597736|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64597738|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64597739|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597740|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
64597741|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
64597742|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597743|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64597744|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64597745|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
64597746|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597747|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64597748|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
64597749|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
64597750|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
64597751|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64597752|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
64597753|NCT03286634|Hormones|hormones|mesh-ancestor
64597754|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64597755|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64597756|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597757|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64597758|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64597759|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64597760|NCT03286556|Autoantibodies|autoantibodies|mesh-list
64597761|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597762|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
64597763|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597764|NCT05000294|Atezolizumab|atezolizumab|mesh-list
64597765|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597766|NCT00637247|Gemcitabine|gemcitabine|mesh-list
64597767|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597768|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
64597769|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597770|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597771|NCT00637247|Antiviral Agents|antiviral agents|mesh-ancestor
64597772|NCT00637247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597773|NCT00637247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597774|NCT00637247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597775|NCT00637247|Immunologic Factors|immunologic factors|mesh-ancestor
64597776|NCT00637247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597777|NCT04998032|Metformin|metformin|mesh-list
64597778|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64597779|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597780|NCT03267836|Avelumab|avelumab|mesh-list
64597781|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597782|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597783|NCT04388033|Temozolomide|temozolomide|mesh-list
64597784|NCT04388033|Interleukin-12|interleukin-12|mesh-list
64597785|NCT04388033|Vaccines|vaccines|mesh-list
64597786|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
64597787|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597788|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64597789|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
64597790|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597791|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597792|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64597793|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64597794|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64597795|NCT04388033|Growth Substances|growth substances|mesh-ancestor
64597796|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
64597797|NCT03267680|Indomethacin|indomethacin|mesh-list
64597798|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
64597799|NCT03267680|Omeprazole|omeprazole|mesh-list
64597800|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597801|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
64597802|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597803|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64597804|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64359622|NCT03346993|Bupivacaine|bupivacaine|mesh-list
64597805|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
64597806|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597807|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597808|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64597809|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64597810|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64597811|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64597812|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597813|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64597814|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64597815|NCT03267680|Analgesics|analgesics|mesh-ancestor
64597816|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
64597817|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597818|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64597819|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
64597820|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
64597821|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64597822|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64597823|NCT02980731|Venetoclax|venetoclax|mesh-list
64597824|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597825|NCT05564390|Cytarabine|cytarabine|mesh-list
64597826|NCT05564390|Azacitidine|azacitidine|mesh-list
64597827|NCT05564390|Daunorubicin|daunorubicin|mesh-list
64597828|NCT05564390|Venetoclax|venetoclax|mesh-list
64597829|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597830|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
64597831|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597832|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597833|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
64597834|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597835|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597836|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
64597837|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597838|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597839|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597840|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64597841|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64597842|NCT04725591|Insulin|insulin|mesh-list
64597843|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64597844|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597845|NCT02980497|Ethanol|ethanol|mesh-list
64597846|NCT02980497|Listerine|listerine|mesh-list
64597847|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64597848|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
64597849|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597850|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597851|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597853|NCT02980497|Protective Agents|protective agents|mesh-ancestor
64597854|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
64597855|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64597856|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
64597857|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597858|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597859|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64597860|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
64597861|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64597862|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
64597863|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597864|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597865|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64597866|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
64597867|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
64597868|NCT02652429|Protective Agents|protective agents|mesh-ancestor
64597869|NCT02294253|Buprenorphine|buprenorphine|mesh-list
64597870|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64597871|NCT02294253|Naloxone|naloxone|mesh-list
64597872|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64359644|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
64597873|NCT02294253|Narcotics|narcotics|mesh-ancestor
64597874|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597875|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597876|NCT02294253|Analgesics|analgesics|mesh-ancestor
64597877|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
64597878|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597879|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64597880|NCT04926818|Ofatumumab|ofatumumab|mesh-list
64597881|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64597882|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64597883|NCT04926818|Siponimod|siponimod|mesh-list
64597884|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597885|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
64597886|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597887|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64597888|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597889|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597890|NCT00684983|Capecitabine|capecitabine|mesh-list
64597891|NCT00684983|Lapatinib|lapatinib|mesh-list
64597892|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64597893|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64597895|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597896|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597897|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64597899|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
64597900|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484236|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
64597902|NCT03339596|Hematinics|hematinics|mesh-ancestor
64597903|NCT00638651|Imiquimod|imiquimod|mesh-list
64597904|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64597905|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
64597906|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597907|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597908|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
64597909|NCT02584647|Sirolimus|sirolimus|mesh-list
64597910|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64597911|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64597912|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64597913|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597914|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
64597915|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64597916|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
64597917|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597918|NCT00685139|Zonisamide|zonisamide|mesh-list
64597919|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
64597920|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64597921|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597922|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597923|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64597924|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597925|NCT00685295|Fentanyl|fentanyl|mesh-list
64597926|NCT00685295|Oxycodone|oxycodone|mesh-list
64597927|NCT00685295|Lansoprazole|lansoprazole|mesh-list
64597928|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
64597929|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64597930|NCT00685295|Narcotics|narcotics|mesh-ancestor
64597931|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597932|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597933|NCT00685295|Analgesics|analgesics|mesh-ancestor
64597934|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
64597935|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597936|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64597937|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64597938|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
64597939|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
64597940|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64597941|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64597942|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64597943|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597944|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597945|NCT00686231|Lidocaine|lidocaine|mesh-list
64597946|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
64597947|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
64597948|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
64597949|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64597950|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597952|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64597953|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64597954|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64597955|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64597956|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597957|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597958|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
64597959|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64597960|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64597961|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597962|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
64597963|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64597964|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64597965|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64597966|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64597967|NCT03335540|Nivolumab|nivolumab|mesh-list
64597968|NCT03335540|Ipilimumab|ipilimumab|mesh-list
64597969|NCT03335540|Linrodostat|linrodostat|mesh-list
64597970|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64597971|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597972|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64597973|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597974|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64597975|NCT00643097|Temozolomide|temozolomide|mesh-list
64597976|NCT00643097|Sargramostim|sargramostim|mesh-list
64597977|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64597978|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
64597979|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597980|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64597981|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
64597982|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597983|NCT03333668|Guanfacine|guanfacine|mesh-list
64597984|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64597985|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64597986|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64597987|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64597988|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64597989|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64597990|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64597991|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
64597992|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64597993|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64597994|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64359698|NCT03121963|Oxycodone|oxycodone|mesh-list
64597995|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64597996|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64597997|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
64597998|NCT03280160|Ofatumumab|ofatumumab|mesh-list
64597999|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598000|NCT04683315|Gemcitabine|gemcitabine|mesh-list
64598001|NCT04683315|Paclitaxel|paclitaxel|mesh-list
64598002|NCT04683315|Fluorouracil|fluorouracil|mesh-list
64598003|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64598004|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598005|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
64598006|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
64598007|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
64598008|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598009|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64598010|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
64598011|NCT04683315|Antiviral Agents|antiviral agents|mesh-ancestor
64598012|NCT04683315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598014|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598015|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
64598016|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598017|NCT05502146|Norepinephrine|norepinephrine|mesh-list
64598018|NCT05502146|Bupivacaine|bupivacaine|mesh-list
64598019|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
64598020|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
64598021|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598022|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598023|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
64598024|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598025|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598026|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598027|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598028|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598029|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598030|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
64598031|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
64598032|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64598033|NCT04027361|Amphetamine|amphetamine|mesh-list
64598034|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64598035|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598036|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
64598037|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
64598038|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598039|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
64598040|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598041|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598042|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598043|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64598044|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64598045|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598046|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64598047|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64598048|NCT04682847|Hematinics|hematinics|mesh-ancestor
64598049|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64598050|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64598051|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
64598052|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
64598053|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
64598054|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598055|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598056|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
64598057|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598058|NCT03793439|Prednisone|prednisone|mesh-list
64598059|NCT03793439|Tofacitinib|tofacitinib|mesh-list
64598060|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598061|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
64598062|NCT03793439|Hormones|hormones|mesh-ancestor
64598063|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598064|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598065|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64598066|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598067|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64598068|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598069|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598070|NCT00687167|Zonisamide|zonisamide|mesh-list
64598071|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
64598074|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598075|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64598076|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598078|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64598079|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
64598080|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64598081|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64598082|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64598083|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598084|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598086|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598087|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598088|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64598089|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64598090|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598091|NCT02304159|Ribavirin|ribavirin|mesh-list
64598092|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
64598093|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
64598094|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598095|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
64598096|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598097|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
64598098|NCT04670679|Cetuximab|cetuximab|mesh-list
64598099|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598100|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598101|NCT02143973|Nalbuphine|nalbuphine|mesh-list
64598102|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64598103|NCT02143973|Narcotics|narcotics|mesh-ancestor
64598104|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598105|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598106|NCT02143973|Analgesics|analgesics|mesh-ancestor
64598107|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
64598108|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598109|NCT03028701|Budesonide|budesonide|mesh-list
64598110|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
64598111|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598112|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64598113|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
64598114|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598115|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598116|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64598117|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
64598119|NCT03028701|Hormones|hormones|mesh-ancestor
64598120|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598121|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64598122|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64359742|NCT02648217|Insulin|insulin|mesh-list
64598125|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598126|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598127|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64598128|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64598129|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64598130|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64598131|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598132|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598133|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598134|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598135|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
64598136|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598137|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
64598138|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64598139|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
64598140|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598141|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598142|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64598143|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
64598144|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64598145|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
64598146|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598147|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598148|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64598149|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
64598150|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
64598151|NCT02267655|Protective Agents|protective agents|mesh-ancestor
64598152|NCT02209545|Pyridoxine|pyridoxine|mesh-list
64598153|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
64598154|NCT02209545|Misoprostol|misoprostol|mesh-list
64598155|NCT02209545|Vitamins|vitamins|mesh-ancestor
64598156|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
64598157|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598158|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64598159|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
64598160|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64598161|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64598162|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64598163|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
64598164|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
64598165|NCT00690833|Desonide|desonide|mesh-list
64598166|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598167|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
64598168|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
64598169|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64598170|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64598171|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598172|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598173|NCT03686306|Urological Agents|urological agents|mesh-ancestor
64598174|NCT00644657|Clopidogrel|clopidogrel|mesh-list
64598175|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64598176|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64598177|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64598178|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64598179|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
64598180|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598181|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598182|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598183|NCT04613024|Topiramate|topiramate|mesh-list
64598184|NCT04613024|Gabapentin|gabapentin|mesh-list
64598185|NCT04613024|Analgesics|analgesics|mesh-ancestor
64359748|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359754|NCT03122041|Hormones|hormones|mesh-ancestor
64598186|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
64598187|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598188|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598189|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
64598190|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64598191|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64598192|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598193|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64598194|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64598195|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64598196|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64323532|NCT01662986|Bromides|bromides|mesh-list
64598197|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598199|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64598200|NCT02094261|Osimertinib|osimertinib|mesh-list
64598201|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598202|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64598203|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598204|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598205|NCT01933815|Bevacizumab|bevacizumab|mesh-list
64598206|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598207|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598208|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64598209|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64598210|NCT01933815|Growth Substances|growth substances|mesh-ancestor
64598211|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598212|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
64598213|NCT03239210|Ondansetron|ondansetron|mesh-list
64598214|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
64598215|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
64598216|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598217|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598218|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64598219|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
64598220|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
64598221|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64598222|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
64598223|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598224|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598225|NCT03239210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64598226|NCT03239210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64598227|NCT03239210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598228|NCT03239210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64598229|NCT03239210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64598230|NCT04606316|Nivolumab|nivolumab|mesh-list
64598231|NCT04606316|Ipilimumab|ipilimumab|mesh-list
64598232|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598233|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598234|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64598235|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598236|NCT03480971|Tempol|tempol|mesh-list
64598237|NCT03480971|TEMPO|tempo|mesh-list
64598238|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
64598239|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598240|NCT03480971|Protective Agents|protective agents|mesh-ancestor
64598241|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598242|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64598243|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598244|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64598245|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64598246|NCT04023669|Gemcitabine|gemcitabine|mesh-list
64598247|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
64598248|NCT04023669|Lenograstim|lenograstim|mesh-list
64598249|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598250|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
64598251|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598252|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598253|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64598254|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
64598255|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598256|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598257|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64598258|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64598259|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
64598260|NCT04023669|Antiviral Agents|antiviral agents|mesh-ancestor
64598261|NCT04023669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598262|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598263|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64598264|NCT00646763|Lenograstim|lenograstim|mesh-list
64598265|NCT00646763|Sargramostim|sargramostim|mesh-list
64598266|NCT00646763|Mitogens|mitogens|mesh-list
64598267|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64598268|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
64598269|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598271|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598272|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
64598273|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598274|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598275|NCT02986347|Epinephrine|epinephrine|mesh-list
64598276|NCT02986347|Racepinephrine|racepinephrine|mesh-list
64598277|NCT02986347|Anesthetics|anesthetics|mesh-list
64598278|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
64598279|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598280|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598281|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598282|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598283|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598284|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598285|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598286|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64598287|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64598288|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
64598289|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598290|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64598291|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
64598292|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
64598293|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
64598294|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64598295|NCT00649961|Melatonin|melatonin|mesh-list
64598296|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
64598297|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598298|NCT00649961|Protective Agents|protective agents|mesh-ancestor
64598299|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598300|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598301|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64598302|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
64598303|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64598304|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64598305|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64598306|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598307|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598308|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598309|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598310|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64598311|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598312|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598313|NCT01781637|Omalizumab|omalizumab|mesh-list
64598314|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64598315|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64598316|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64598317|NCT00652145|Mesalamine|mesalamine|mesh-list
64598318|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64598319|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64598320|NCT00652145|Analgesics|analgesics|mesh-ancestor
64598321|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
64598322|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598323|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598324|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598325|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598326|NCT03231722|Leucovorin|leucovorin|mesh-list
64598327|NCT03231722|Fluorouracil|fluorouracil|mesh-list
64598328|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
64598329|NCT03231722|Irinotecan|irinotecan|mesh-list
64598330|NCT03231722|Panitumumab|panitumumab|mesh-list
64598331|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
64598332|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
64598333|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598335|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598336|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598337|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
64598338|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296505|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
64598339|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64598340|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64598341|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598343|NCT03231722|Protective Agents|protective agents|mesh-ancestor
64598344|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
64598345|NCT03231722|Vitamins|vitamins|mesh-ancestor
64598346|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
64598347|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598348|NCT02298933|Eculizumab|eculizumab|mesh-list
64598349|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64598350|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598351|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
64598352|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598354|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
64598355|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598356|NCT04761848|Cilostazol|cilostazol|mesh-list
64598357|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64598358|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
64598359|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598360|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598361|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64598362|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
64598363|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64598364|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64598365|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598366|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64598367|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
64598368|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64598369|NCT04761848|Protective Agents|protective agents|mesh-ancestor
64598370|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64598371|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64598372|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598373|NCT03277196|Ivacaftor|ivacaftor|mesh-list
64598374|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64598375|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598376|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598377|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64598378|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
64598379|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598380|NCT04056962|Tacrolimus|tacrolimus|mesh-list
64598381|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598382|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
64598383|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598384|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64598385|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598386|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598387|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64598388|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64598389|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64598390|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598391|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598392|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598393|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598394|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598395|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598396|NCT00693719|Irinotecan|irinotecan|mesh-list
64598397|NCT00693719|Etoposide|etoposide|mesh-list
64598398|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64598399|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64598400|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598401|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598402|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598403|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64598404|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64598405|NCT00653861|Lidocaine|lidocaine|mesh-list
64598407|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
64598408|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598409|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598410|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
64598411|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598412|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64598413|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64598414|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64414779|NCT02419755|Bortezomib|bortezomib|mesh-list
64598415|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598416|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598417|NCT00654329|Fentanyl|fentanyl|mesh-list
64598418|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
64598419|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64598420|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598421|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598423|NCT00654329|Analgesics|analgesics|mesh-ancestor
64598424|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
64598425|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598426|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64598427|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598428|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598429|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598430|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598431|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598432|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64598433|NCT00654329|Narcotics|narcotics|mesh-ancestor
64598434|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64598435|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64598436|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
64598437|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
64598438|NCT00695435|Tobramycin|tobramycin|mesh-list
64598439|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
64598440|NCT00695435|Dexamethasone|dexamethasone|mesh-list
64598441|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64598442|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598443|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
64598444|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
64598445|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598446|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598447|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64598448|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
64598449|NCT00695435|Hormones|hormones|mesh-ancestor
64598450|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598451|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64598452|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598453|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64598454|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64598455|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598457|NCT00654953|Sertraline|sertraline|mesh-list
64598458|NCT00654953|Analgesics|analgesics|mesh-ancestor
64598459|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
64598460|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598461|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598462|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
64598463|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64598464|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64598465|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598466|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64598467|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64598468|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64598469|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598470|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598471|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
64598472|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
64598473|NCT00654953|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64296519|NCT02467647|Growth Substances|growth substances|mesh-ancestor
64598474|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64598475|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598476|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
64598477|NCT01790165|Terbinafine|terbinafine|mesh-list
64598478|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
64598479|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598480|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598481|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598482|NCT02299089|Octreotide|octreotide|mesh-list
64598483|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64598484|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64598485|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598486|NCT00655811|Capsaicin|capsaicin|mesh-list
64598487|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
64598488|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
64598489|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
64598490|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598491|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598492|NCT03931551|Trastuzumab|trastuzumab|mesh-list
64598493|NCT03931551|Olaparib|olaparib|mesh-list
64598494|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598495|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598496|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64598497|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598498|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598499|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64598500|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64598501|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64598502|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598503|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598504|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598505|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598506|NCT00696293|Analgesics|analgesics|mesh-ancestor
64598508|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598509|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
64598510|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64598511|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
64598512|NCT00696449|Adapalene|adapalene|mesh-list
64598513|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64598514|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64598515|NCT00696449|Analgesics|analgesics|mesh-ancestor
64598516|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
64598517|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598518|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598519|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598520|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598521|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
64598523|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64598524|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598526|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64598527|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64598528|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64598529|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598530|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598531|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598532|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598533|NCT00696761|Urological Agents|urological agents|mesh-ancestor
64598534|NCT00656201|Progesterone|progesterone|mesh-list
64598535|NCT00656201|Progestins|progestins|mesh-ancestor
64598536|NCT00656201|Hormones|hormones|mesh-ancestor
64598537|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598538|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598539|NCT00759291|Acipimox|acipimox|mesh-list
64598540|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64598541|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
64598542|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598543|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64598544|NCT00756405|Antioxidants|antioxidants|mesh-list
64598545|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598546|NCT00756405|Protective Agents|protective agents|mesh-ancestor
64598547|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598548|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64598549|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64598550|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64598551|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64598552|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64598553|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598554|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598555|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598556|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359954|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
64359955|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598557|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598558|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598559|NCT03889275|Durvalumab|durvalumab|mesh-list
64598561|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598562|NCT00657917|Gentamicins|gentamicins|mesh-list
64598563|NCT00657917|Paromomycin|paromomycin|mesh-list
64598564|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64598565|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598566|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64598567|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484238|NCT01751113|Hormones|hormones|mesh-ancestor
64598568|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598570|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64598571|NCT01959945|Vaccines|vaccines|mesh-list
64598572|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
64598573|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
64598574|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598575|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
64598576|NCT00700661|Montelukast|montelukast|mesh-list
64598577|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64598578|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
64598579|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64598580|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
64598581|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598582|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598583|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64598584|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64598585|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598587|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64598588|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64598589|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
64598590|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598591|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64598592|NCT00652301|Simvastatin|simvastatin|mesh-list
64598593|NCT00652301|Ezetimibe|ezetimibe|mesh-list
64598594|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64598595|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64598596|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
64598597|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598598|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64598599|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64598600|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598601|NCT01961271|Buprenorphine|buprenorphine|mesh-list
64598602|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64598603|NCT01961271|Narcotics|narcotics|mesh-ancestor
64598604|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598605|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598606|NCT01961271|Analgesics|analgesics|mesh-ancestor
64598607|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
64598608|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598609|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64598610|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
64598611|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64598612|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64598613|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
64598614|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598615|NCT03822351|Durvalumab|durvalumab|mesh-list
64598617|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598618|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598619|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
64598620|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598621|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64598622|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64598623|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598625|NCT01963845|Hormones|hormones|mesh-ancestor
64598626|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598627|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64598629|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598630|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598631|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64598632|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64598633|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64598634|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598635|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598636|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598637|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598638|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598639|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598640|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
64598641|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64598642|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
64598643|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598646|NCT03769155|Ipilimumab|ipilimumab|mesh-list
64598647|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598648|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598649|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64598650|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598651|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64598652|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598653|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
64598654|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64598655|NCT04277702|Montelukast|montelukast|mesh-list
64598656|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64598657|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
64598658|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64598659|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
64598660|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598661|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598662|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64598663|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64598665|NCT03962894|Prednisolone|prednisolone|mesh-list
64598666|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598667|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
64598668|NCT03962894|Hormones|hormones|mesh-ancestor
64598669|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598670|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598671|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64598672|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598673|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64598674|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598676|NCT03726879|Maytansine|maytansine|mesh-list
64598677|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64598678|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
64598679|NCT03726879|Doxorubicin|doxorubicin|mesh-list
64598680|NCT03726879|Trastuzumab|trastuzumab|mesh-list
64598681|NCT03726879|Atezolizumab|atezolizumab|mesh-list
64598682|NCT03726879|Pertuzumab|pertuzumab|mesh-list
64598683|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64598684|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598685|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
64598686|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
64598687|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
64598688|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598689|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598690|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
64598691|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598692|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598693|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64598695|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64598696|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64598697|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64598698|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64598699|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598700|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598707|NCT00699491|Sirolimus|sirolimus|mesh-list
64598708|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64598709|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64598710|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598711|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64598712|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598713|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
64598714|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598715|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
64598716|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598717|NCT04493216|Dolutegravir|dolutegravir|mesh-list
64598718|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64598719|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64598720|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598721|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598722|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64598723|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64598724|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
64598725|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598727|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
64598728|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598729|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
64598730|NCT03721965|Hormones|hormones|mesh-ancestor
64598731|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598732|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598733|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64598734|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598735|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
64598736|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
64598737|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598738|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64598739|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64598740|NCT03721965|Protective Agents|protective agents|mesh-ancestor
64598741|NCT04399148|Ketotifen|ketotifen|mesh-list
64598742|NCT04399148|Aprepitant|aprepitant|mesh-list
64598743|NCT04399148|Desloratadine|desloratadine|mesh-list
64598744|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
64598745|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
64598746|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598747|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598749|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64598750|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598751|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598752|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64598753|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
64598755|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64598756|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
64598757|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
64598758|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
64598759|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
64598760|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64598761|NCT04672382|Morphine|morphine|mesh-list
64598762|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64598763|NCT04672382|Narcotics|narcotics|mesh-ancestor
64598764|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360041|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64598765|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598767|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
64598768|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598769|NCT00699803|Prednisone|prednisone|mesh-list
64598770|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
64598771|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64598772|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
64598773|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64598774|NCT00699803|Prednisolone|prednisolone|mesh-list
64598775|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64598776|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
64598777|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598778|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
64598779|NCT00699803|Hormones|hormones|mesh-ancestor
64598780|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598781|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598782|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64598783|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598784|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
64598785|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
64598786|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598787|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64598788|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64598789|NCT00699803|Protective Agents|protective agents|mesh-ancestor
64598790|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
64598791|NCT01967433|Promethazine|promethazine|mesh-list
64598792|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64598793|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64598794|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598795|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598796|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
64598798|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
64598799|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598800|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
64598801|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
64598802|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64598803|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64598804|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
64598805|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
64598806|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598807|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598808|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64598809|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
64598810|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
64598811|NCT00551447|Simvastatin|simvastatin|mesh-list
64598813|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64598815|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
64598816|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598821|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598822|NCT01968057|Cyclosporine|cyclosporine|mesh-list
64598823|NCT01968057|Cyclosporins|cyclosporins|mesh-list
64598824|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598825|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598826|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64598827|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
64598828|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598829|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
64598830|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64598831|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
64598832|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598833|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64598834|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
64598835|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
64360055|NCT03351205|Estrogens|estrogens|mesh-ancestor
64598836|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64598837|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64598838|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598839|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64598840|NCT00658697|Bevacizumab|bevacizumab|mesh-list
64598842|NCT00658697|Bicalutamide|bicalutamide|mesh-list
64598843|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64598844|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598845|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64598846|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64598847|NCT00658697|Growth Substances|growth substances|mesh-ancestor
64598848|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598849|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
64598850|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
64598851|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
64598852|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
64598853|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598854|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
64598855|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
64598856|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598858|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598859|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598861|NCT04399226|Ketamine|ketamine|mesh-list
64598862|NCT04399226|Propofol|propofol|mesh-list
64598863|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64598864|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598865|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598866|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64598867|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
64598868|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
64598869|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64598870|NCT04399226|Analgesics|analgesics|mesh-ancestor
64598871|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
64598872|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598873|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64598874|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64598875|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64598876|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
64598878|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598879|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64598880|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64598881|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64598882|NCT00659165|Insulin|insulin|mesh-list
64598883|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64598884|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
64598885|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
64598886|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64598887|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598888|NCT00542087|Diclofenac|diclofenac|mesh-list
64598889|NCT00542087|Etoricoxib|etoricoxib|mesh-list
64598890|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64598891|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64598892|NCT00542087|Analgesics|analgesics|mesh-ancestor
64598893|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
64598894|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598895|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598896|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598897|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598898|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64598899|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598900|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598901|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64598902|NCT00541697|Atorvastatin|atorvastatin|mesh-list
64360085|NCT04132791|Analgesics|analgesics|mesh-ancestor
64598903|NCT00541697|Simvastatin|simvastatin|mesh-list
64598904|NCT00541697|Ezetimibe|ezetimibe|mesh-list
64598905|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64598906|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64598907|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
64598908|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598909|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64598910|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64598911|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598912|NCT03223376|Paclitaxel|paclitaxel|mesh-list
64598913|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64598914|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64598915|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598916|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
64598917|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
64598918|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
64598919|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598920|NCT00395603|Atorvastatin|atorvastatin|mesh-list
64598921|NCT00395603|Simvastatin|simvastatin|mesh-list
64598922|NCT00395603|Ezetimibe|ezetimibe|mesh-list
64598923|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64598924|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64598925|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
64598926|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598927|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64598928|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64598929|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598930|NCT00659633|Lidocaine|lidocaine|mesh-list
64598931|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
64598932|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
64598933|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64598934|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598935|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
64598936|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598937|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64598938|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64598940|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64324295|NCT01337635|Vitamin D|vitamin d|mesh-list
64598941|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598943|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64598944|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64598945|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
64598946|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598947|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64598948|NCT00701675|Sertraline|sertraline|mesh-list
64598949|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
64598950|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64598951|NCT00701675|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64598952|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64598953|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598954|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598955|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64598956|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
64598957|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598958|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
64598959|NCT04445714|Saxagliptin|saxagliptin|mesh-list
64598961|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598962|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64598963|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598965|NCT04445714|Hormones|hormones|mesh-ancestor
64598966|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64598967|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64598968|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
64598969|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598970|NCT04639310|Ezogabine|ezogabine|mesh-list
64598971|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
64598972|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64598973|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598974|NCT03246074|Paclitaxel|paclitaxel|mesh-list
64598975|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64598976|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598977|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
64598978|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
64598979|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
64598980|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598981|NCT02300727|Curcumin|curcumin|mesh-list
64598982|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64598983|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64598984|NCT02300727|Analgesics|analgesics|mesh-ancestor
64598985|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
64598986|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64598987|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64598988|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64598989|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64598990|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64598991|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64598992|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64598993|NCT00250445|Diclofenac|diclofenac|mesh-list
64598994|NCT00250445|Etoricoxib|etoricoxib|mesh-list
64598995|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64598996|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64598997|NCT00250445|Analgesics|analgesics|mesh-ancestor
64598998|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
64598999|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599000|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599001|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64599002|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599003|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64599004|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599005|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599006|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64599007|NCT00242489|Diclofenac|diclofenac|mesh-list
64599008|NCT00242489|Etoricoxib|etoricoxib|mesh-list
64599009|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64599010|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64599011|NCT00242489|Analgesics|analgesics|mesh-ancestor
64599012|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
64599013|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599014|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599015|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64599016|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599017|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64599018|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599019|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599020|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64599021|NCT00659945|Ondansetron|ondansetron|mesh-list
64599022|NCT00659945|Aprepitant|aprepitant|mesh-list
64599023|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
64599024|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
64599025|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599026|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599027|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599028|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
64599029|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
64599030|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64599031|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
64599032|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599033|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599034|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64599035|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64599036|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599037|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64599038|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64599039|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64599040|NCT04387565|Vanadium|vanadium|mesh-list
64599041|NCT04387565|Trace Elements|trace elements|mesh-ancestor
64599042|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
64599043|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599044|NCT02141555|Misoprostol|misoprostol|mesh-list
64599045|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64599046|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
64599047|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64599048|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599049|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64599050|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599051|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
64599052|NCT02600117|Tenofovir|tenofovir|mesh-list
64599053|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
64599054|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599055|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64599056|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64599057|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599058|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599059|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64599060|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64599062|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64599063|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599064|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64599065|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
64599066|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599067|NCT00588965|Propranolol|propranolol|mesh-list
64599068|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64599069|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64599070|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
64599071|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599072|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599073|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599074|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64599075|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64599076|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
64599078|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64599079|NCT00702299|Cisplatin|cisplatin|mesh-list
64599080|NCT00702299|Pemetrexed|pemetrexed|mesh-list
64414780|NCT02419755|Asparaginase|asparaginase|mesh-list
64599081|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599082|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599083|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
64599084|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
64599085|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
64599086|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599087|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599088|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64599089|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64599091|NCT00661583|Mitomycins|mitomycins|mesh-list
64599092|NCT00661583|Mitomycin|mitomycin|mesh-list
64599093|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64599094|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64599095|NCT00661583|Growth Substances|growth substances|mesh-ancestor
64599096|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599097|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
64599098|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599099|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64599100|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
64599101|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599102|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64599103|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599104|NCT00661895|Metoprolol|metoprolol|mesh-list
64599105|NCT00661895|Atenolol|atenolol|mesh-list
64599106|NCT00661895|Amlodipine|amlodipine|mesh-list
64599107|NCT00661895|Valsartan|valsartan|mesh-list
64599108|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64599109|NCT00661895|Clonidine|clonidine|mesh-list
64599110|NCT00661895|Lisinopril|lisinopril|mesh-list
64599111|NCT00661895|Doxazosin|doxazosin|mesh-list
64599112|NCT00661895|Hydralazine|hydralazine|mesh-list
64599113|NCT00661895|Nifedipine|nifedipine|mesh-list
64599114|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64599115|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64599116|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64599117|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599118|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64599119|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599120|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
64599121|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64599122|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64599123|NCT00661895|Diuretics|diuretics|mesh-ancestor
64599124|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
64599125|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64599126|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64599129|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599130|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64599131|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64599132|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64599133|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
64599134|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599135|NCT00661895|Analgesics|analgesics|mesh-ancestor
64599136|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
64599137|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64599138|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64599139|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64599140|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
64599141|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64599142|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64599143|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
64599144|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599145|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64599146|NCT00661895|Protective Agents|protective agents|mesh-ancestor
64599147|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64599148|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64599149|NCT02312258|Ixazomib|ixazomib|mesh-list
64599150|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599151|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
64599152|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599153|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599155|NCT02996825|Maytansine|maytansine|mesh-list
64599156|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599157|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
64599158|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360177|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64599159|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599160|NCT02996825|Antiviral Agents|antiviral agents|mesh-ancestor
64599161|NCT02996825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599162|NCT02996825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599163|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599164|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
64599165|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599166|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599167|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
64599168|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
64599169|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
64599171|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599172|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599173|NCT00662675|Pancrelipase|pancrelipase|mesh-list
64599174|NCT00662675|Pancreatin|pancreatin|mesh-list
64599175|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599176|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
64599177|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64599178|NCT00591305|Protective Agents|protective agents|mesh-ancestor
64599179|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599180|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599181|NCT01799603|Simeprevir|simeprevir|mesh-list
64599182|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
64599183|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599184|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
64599185|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599186|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599187|NCT03816176|Isavuconazole|isavuconazole|mesh-list
64599188|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
64599189|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599190|NCT00666029|Atorvastatin|atorvastatin|mesh-list
64599191|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64599192|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64599193|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
64599194|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599195|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64599196|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64599197|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599199|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64599200|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64599201|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599202|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
64599203|NCT04372940|Coagulants|coagulants|mesh-ancestor
64599204|NCT00592475|Conivaptan|conivaptan|mesh-list
64599205|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64599206|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599207|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
64599208|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599209|NCT03221426|Leucovorin|leucovorin|mesh-list
64599210|NCT03221426|Docetaxel|docetaxel|mesh-list
64599211|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
64599212|NCT03221426|Fluorouracil|fluorouracil|mesh-list
64599213|NCT03221426|Capecitabine|capecitabine|mesh-list
64599214|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
64599215|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599216|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
64599217|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
64599218|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
64599219|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599220|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599222|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599223|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599224|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
64599225|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599226|NCT03221426|Antidotes|antidotes|mesh-ancestor
64599227|NCT03221426|Protective Agents|protective agents|mesh-ancestor
64599228|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
64599231|NCT01989195|Manganese|manganese|mesh-list
64599232|NCT01989195|Trace Elements|trace elements|mesh-ancestor
64599233|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
64599234|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599236|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64599237|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599238|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64599239|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64599240|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64599241|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64324587|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
64599243|NCT01973205|Acetaminophen|acetaminophen|mesh-list
64599244|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64599245|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64599246|NCT01973205|Analgesics|analgesics|mesh-ancestor
64599247|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
64599248|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599249|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599250|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64599251|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599252|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64599253|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64599254|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599255|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64599256|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64599257|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599258|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
64599259|NCT01990677|Eplerenone|eplerenone|mesh-list
64599260|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64599261|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
64599262|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599263|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599264|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64599266|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
64599267|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64599268|NCT00593645|Cytarabine|cytarabine|mesh-list
64599269|NCT00593645|Clofarabine|clofarabine|mesh-list
64599270|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
64599271|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64599272|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599273|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
64599274|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599275|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599276|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
64599277|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599278|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599279|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
64599280|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599281|NCT03194126|Misoprostol|misoprostol|mesh-list
64599282|NCT03194126|Mifepristone|mifepristone|mesh-list
64599283|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64599284|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
64599285|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64599286|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599287|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64599288|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599289|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
64599290|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64599291|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64599292|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64599293|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64599294|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
64599295|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64599296|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64599297|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
64599298|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599299|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
64599300|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64599301|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64599303|NCT02999087|Avelumab|avelumab|mesh-list
64599304|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599305|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599306|NCT03219086|Bupivacaine|bupivacaine|mesh-list
64599307|NCT03219086|Prilocaine|prilocaine|mesh-list
64599308|NCT03219086|Anesthetics|anesthetics|mesh-list
64599309|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
64599310|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599311|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599312|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
64599313|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599314|NCT02998385|Cisplatin|cisplatin|mesh-list
64599315|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599317|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64599319|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599320|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599321|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64599322|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
64599323|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64599324|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
64599325|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599326|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599327|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64599328|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
64599329|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
64599330|NCT04398290|Protective Agents|protective agents|mesh-ancestor
64599331|NCT04397510|Heparin|heparin|mesh-list
64599332|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
64599333|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64599334|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64599335|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599337|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64599338|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
64599339|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
64599340|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599341|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
64599342|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599343|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
64599344|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599345|NCT03708224|Atezolizumab|atezolizumab|mesh-list
64599346|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599347|NCT03632642|Floxacillin|floxacillin|mesh-list
64599348|NCT03632642|Penicillin G|penicillin g|mesh-list
64599349|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64599350|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
64360236|NCT03083067|Budesonide|budesonide|mesh-list
64360237|NCT03083067|Bromides|bromides|mesh-list
64599351|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64599352|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599353|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64599354|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64599355|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64599356|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
64599357|NCT04317404|Triamcinolone|triamcinolone|mesh-list
64599358|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64599359|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64599360|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64599361|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64599363|NCT04317404|Hormones|hormones|mesh-ancestor
64599364|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599365|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599366|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599367|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
64599368|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599369|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599370|NCT04399070|Ketamine|ketamine|mesh-list
64599371|NCT04399070|Esketamine|esketamine|mesh-list
64599372|NCT04399070|Analgesics|analgesics|mesh-ancestor
64599373|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
64599374|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599375|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599376|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64599377|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64599378|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
64599379|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
64599380|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599381|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64599382|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64599383|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414781|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
64599384|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599385|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
64599386|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64599388|NCT03650114|Vaccines|vaccines|mesh-list
64599389|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64599390|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
64324742|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
64599391|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
64599392|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599393|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599394|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64599395|NCT00667589|Fluocinonide|fluocinonide|mesh-list
64599396|NCT00667589|Tazarotene|tazarotene|mesh-list
64599397|NCT00667589|Emollients|emollients|mesh-list
64599398|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
64599399|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
64599400|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64599401|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
64599402|NCT00667589|Hormones|hormones|mesh-ancestor
64599403|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599404|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599407|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
64599408|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64599409|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599410|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599411|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
64599412|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64599413|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599414|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599415|NCT03173612|Cytarabine|cytarabine|mesh-list
64599416|NCT03173612|Etoposide|etoposide|mesh-list
64599417|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
64599418|NCT03173612|Idarubicin|idarubicin|mesh-list
64599419|NCT03173612|Dasatinib|dasatinib|mesh-list
64599420|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
64599421|NCT03173612|Lenograstim|lenograstim|mesh-list
64599422|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599423|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599424|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64599425|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64599426|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599427|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599428|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599429|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
64599430|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
64599431|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599432|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599433|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
64599435|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64599436|NCT03173612|Analgesics|analgesics|mesh-ancestor
64599437|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
64599438|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599439|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64599440|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64599441|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64599442|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64599443|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
64599444|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599445|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599446|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64599447|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
64599448|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64599449|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64599450|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64599451|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
64599452|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599453|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599454|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
64599455|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64599456|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599457|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64599458|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64599459|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599460|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599461|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599462|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64599463|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64599464|NCT00705107|Ribavirin|ribavirin|mesh-list
64599465|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64599466|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
64599467|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
64599468|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599469|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
64599470|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599471|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
64599472|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599473|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64599474|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64599475|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64599476|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
64599477|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599478|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64599479|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64599481|NCT00240097|Carboplatin|carboplatin|mesh-list
64599482|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
64599483|NCT00240097|Irinotecan|irinotecan|mesh-list
64599484|NCT00240097|Etoposide|etoposide|mesh-list
64599485|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599486|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64599487|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64599488|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599489|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599490|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599491|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64599492|NCT04270487|Octylonium|octylonium|mesh-list
64599493|NCT04270487|Bromides|bromides|mesh-list
64599494|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
64599495|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64599496|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64599497|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599498|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64599499|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599500|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599501|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
64599502|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
64599503|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599504|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64599505|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64599506|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
64599507|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599508|NCT00739999|Atorvastatin|atorvastatin|mesh-list
64599509|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64599510|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64599511|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
64599512|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599513|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64599514|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64599515|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599516|NCT02997995|Durvalumab|durvalumab|mesh-list
64599517|NCT02997995|Tremelimumab|tremelimumab|mesh-list
64599518|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599519|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599520|NCT03620162|Vaccines|vaccines|mesh-list
64599521|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
64599522|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599523|NCT00248287|Carboplatin|carboplatin|mesh-list
64599524|NCT00248287|Irinotecan|irinotecan|mesh-list
64599525|NCT00248287|Cetuximab|cetuximab|mesh-list
64599526|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599527|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64599528|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64599529|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599530|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599531|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599532|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
64599533|NCT00742573|Bupropion|bupropion|mesh-list
64599534|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64599535|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64599536|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64599537|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599538|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599539|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599540|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64599542|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64599543|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64599544|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64599545|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599546|NCT03809923|Lidocaine|lidocaine|mesh-list
64599547|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
64599548|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
64599549|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
64599550|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599551|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599552|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
64599553|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599554|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64599555|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64599556|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64599557|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64599559|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64599560|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64599561|NCT03809923|Analgesics|analgesics|mesh-ancestor
64599562|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64599563|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64599564|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64599565|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
64599566|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599567|NCT01210625|Psyllium|psyllium|mesh-list
64599568|NCT01210625|Cathartics|cathartics|mesh-ancestor
64599569|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599570|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
64599571|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64599572|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599573|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
64599574|NCT00602225|Cytarabine|cytarabine|mesh-list
64599575|NCT00602225|Clofarabine|clofarabine|mesh-list
64599576|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599577|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
64599578|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599579|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599580|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
64599581|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599582|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599583|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
64599584|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599585|NCT00602771|Etoposide|etoposide|mesh-list
64599586|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
64599587|NCT00602771|Tipifarnib|tipifarnib|mesh-list
64599588|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599589|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599590|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64599591|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64599592|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599593|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599595|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64599596|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599597|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64599598|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599599|NCT04248998|Metformin|metformin|mesh-list
64599600|NCT04248998|Paclitaxel|paclitaxel|mesh-list
64599601|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
64599602|NCT04248998|Doxorubicin|doxorubicin|mesh-list
64599603|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599604|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64324961|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
64324962|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64324963|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64324964|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64324965|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599605|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
64599606|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
64599607|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
64599608|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599609|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599610|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
64599611|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599612|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599613|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64599614|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
64599615|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64599616|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64599617|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64599619|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64599620|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599621|NCT00714233|Metformin|metformin|mesh-list
64599622|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
64599623|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
64599624|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64599625|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64599626|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64599627|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599628|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64599629|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64599630|NCT00746395|Lubiprostone|lubiprostone|mesh-list
64599631|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64599632|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64599633|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599634|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
64599635|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
64599636|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64599637|NCT04205786|Vitamins|vitamins|mesh-ancestor
64599638|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
64599639|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599640|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
64599641|NCT04205786|Hematinics|hematinics|mesh-ancestor
64599642|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64599643|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599644|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599645|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64599646|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
64599647|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599648|NCT00719966|Letrozole|letrozole|mesh-list
64599649|NCT00719966|Anastrozole|anastrozole|mesh-list
64599650|NCT00719966|Exemestane|exemestane|mesh-list
64599652|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64599653|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64599654|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599655|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599656|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64599657|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
64599658|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599659|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599660|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64599661|NCT01276067|Donepezil|donepezil|mesh-list
64599662|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64599663|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599664|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599665|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
64599666|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599667|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599668|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
64599669|NCT02428205|Propranolol|propranolol|mesh-list
64599670|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64599671|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64599672|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
64599673|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599674|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599675|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599676|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64599677|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64599678|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
64296580|NCT03103022|Ibuprofen|ibuprofen|mesh-list
64599680|NCT04183868|Glimepiride|glimepiride|mesh-list
64599681|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64599682|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599683|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64599684|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599685|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64599686|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599687|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
64599688|NCT02997215|Lidocaine|lidocaine|mesh-list
64599689|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
64599690|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
64599691|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599692|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599693|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
64599694|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599695|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64599696|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64599697|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64599698|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64599699|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599700|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
64599701|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64599703|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
64599704|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
64360471|NCT02506231|Vitamins|vitamins|mesh-ancestor
64599714|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64599715|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64599716|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64599717|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64599718|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
64599719|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599720|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599721|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599722|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64599723|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
64599724|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64599725|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
64599726|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599727|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
64599728|NCT00721513|Docetaxel|docetaxel|mesh-list
64599729|NCT00721513|Fluorouracil|fluorouracil|mesh-list
64599730|NCT00721513|Cetuximab|cetuximab|mesh-list
64599731|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599732|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
64599733|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
64599734|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
64599735|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599736|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
64599737|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599738|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599739|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
64599740|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599741|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599742|NCT00706121|Vitamins|vitamins|mesh-list
64599743|NCT00706121|Vitamin E|vitamin e|mesh-list
64599744|NCT00706121|Tocopherols|tocopherols|mesh-list
64599745|NCT00706121|Tocotrienols|tocotrienols|mesh-list
64599746|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
64599747|NCT00706121|Selenium|selenium|mesh-list
64599748|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
64599749|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599750|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
64599751|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599752|NCT00706121|Protective Agents|protective agents|mesh-ancestor
64599753|NCT00706121|Trace Elements|trace elements|mesh-ancestor
64599754|NCT00746863|Bupivacaine|bupivacaine|mesh-list
64599755|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
64599757|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599758|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599759|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
64599760|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599762|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64599763|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64599764|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599765|NCT04385563|Docetaxel|docetaxel|mesh-list
64599766|NCT04385563|Trastuzumab|trastuzumab|mesh-list
64599767|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599768|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
64599769|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
64599770|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
64599771|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599772|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599773|NCT03568838|Enoxaparin|enoxaparin|mesh-list
64599774|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
64599775|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64599776|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64599777|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599778|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
64599779|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
64599780|NCT00726713|Vitamins|vitamins|mesh-ancestor
64599781|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
64599782|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599783|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
64599784|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64599785|NCT00759187|Triclosan|triclosan|mesh-list
64599786|NCT00759187|Fluorides|fluorides|mesh-list
64599787|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
64599788|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
64599789|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
64599790|NCT00759187|Protective Agents|protective agents|mesh-ancestor
64599791|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599792|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64599793|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599794|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
64599795|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
64599796|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64599797|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64599798|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
64599799|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599800|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64599801|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
64599802|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
64599803|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64599804|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64599805|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599806|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599807|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599808|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599809|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
64599810|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64599811|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
64599812|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599813|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599814|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64599815|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
64599816|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64599817|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
64599818|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599819|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64414782|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
64599823|NCT00515281|Protective Agents|protective agents|mesh-ancestor
64599824|NCT01279915|Linaclotide|linaclotide|mesh-list
64599825|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64599826|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
64599827|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599828|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599830|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64599831|NCT03809455|Narcotics|narcotics|mesh-ancestor
64599832|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599833|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599834|NCT03809455|Analgesics|analgesics|mesh-ancestor
64599835|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
64599836|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599837|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64599838|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64599839|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
64599840|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
64599841|NCT03618134|Durvalumab|durvalumab|mesh-list
64599842|NCT03618134|Ipilimumab|ipilimumab|mesh-list
64599843|NCT03618134|Tremelimumab|tremelimumab|mesh-list
64599844|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
64599845|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64599846|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
64599847|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64599848|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599849|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
64599850|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599851|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64599852|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599853|NCT02997059|Fluconazole|fluconazole|mesh-list
64599854|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
64599855|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599856|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64599857|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64599858|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599859|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599860|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64599861|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
64599862|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599863|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599864|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64599865|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64599870|NCT00759811|Methotrexate|methotrexate|mesh-list
64599871|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64599872|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
64599873|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64599874|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599875|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599876|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
64599877|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599878|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599881|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64599882|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599883|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
64599884|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599885|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64599886|NCT03085628|Oxytocin|oxytocin|mesh-list
64599887|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
64599888|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64599889|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599890|NCT01276613|Gemcitabine|gemcitabine|mesh-list
64599891|NCT01276613|Losartan|losartan|mesh-list
64599892|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64599893|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
64599894|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599895|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599896|NCT01276613|Antiviral Agents|antiviral agents|mesh-ancestor
64599897|NCT01276613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64599898|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599899|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64599900|NCT01276613|Immunologic Factors|immunologic factors|mesh-ancestor
64599901|NCT01276613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599902|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64599903|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64599904|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64599905|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64599906|NCT01276691|Aspirin|aspirin|mesh-list
64599907|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64599908|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64599909|NCT01276691|Analgesics|analgesics|mesh-ancestor
64599910|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
64599911|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599912|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599913|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64599914|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599915|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64599916|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64599917|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599918|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64599919|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64599920|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599921|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
64599922|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
64599923|NCT03081416|Dexamethasone|dexamethasone|mesh-list
64599924|NCT03081416|Ketorolac|ketorolac|mesh-list
64599925|NCT03081416|Ketamine|ketamine|mesh-list
64599926|NCT03081416|Metoclopramide|metoclopramide|mesh-list
64599927|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64599928|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
64599929|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
64599930|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64599931|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599932|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64599933|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
64599934|NCT03081416|Hormones|hormones|mesh-ancestor
64599935|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64599936|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64599937|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599938|NCT03081416|Analgesics|analgesics|mesh-ancestor
64599939|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
64599940|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64599941|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64599942|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
64599944|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599945|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64599946|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64599947|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599948|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599949|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64599950|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64599951|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64599952|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64599953|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599954|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64599955|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64599956|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
64599957|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64599958|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64599959|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
64599960|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64599961|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
64599962|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
64599963|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64599965|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
64599966|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64599967|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64599968|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64599969|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64599970|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64599971|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
64599972|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
64599973|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64599974|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599975|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64599976|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64599977|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
64599978|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64599979|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64325337|NCT04719273|Onapristone|onapristone|mesh-list
64599980|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64599981|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64599982|NCT01276769|Paclitaxel|paclitaxel|mesh-list
64599983|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64599984|NCT01276769|Carboplatin|carboplatin|mesh-list
64599985|NCT01276769|Epirubicin|epirubicin|mesh-list
64599986|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64599987|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64599988|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
64599989|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
64599990|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
64599991|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64599992|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64599993|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64599994|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64599995|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64599996|NCT01279681|Leucovorin|leucovorin|mesh-list
64599997|NCT01279681|Bevacizumab|bevacizumab|mesh-list
64599998|NCT01279681|Fluorouracil|fluorouracil|mesh-list
64599999|NCT01279681|Capecitabine|capecitabine|mesh-list
64600000|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
64600002|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
64600003|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600004|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600005|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64600006|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64600007|NCT01279681|Growth Substances|growth substances|mesh-ancestor
64600008|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600009|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
64600010|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64600011|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
64600012|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600013|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600014|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600015|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
64600016|NCT01279681|Antidotes|antidotes|mesh-ancestor
64600017|NCT01279681|Protective Agents|protective agents|mesh-ancestor
64600018|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
64600019|NCT01279681|Vitamins|vitamins|mesh-ancestor
64600020|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
64600021|NCT01276925|Bupivacaine|bupivacaine|mesh-list
64600022|NCT01276925|Ropivacaine|ropivacaine|mesh-list
64600023|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
64600024|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
64600025|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600026|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600027|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
64600028|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600029|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
64600030|NCT00728507|Rifampin|rifampin|mesh-list
64600031|NCT00728507|Isoniazid|isoniazid|mesh-list
64600032|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
64600033|NCT00728507|Ethambutol|ethambutol|mesh-list
64600034|NCT00728507|Rifapentine|rifapentine|mesh-list
64600035|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64600036|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600037|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64600038|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64600039|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600040|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600041|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600042|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64600043|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
64600044|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
64600045|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64600046|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64600047|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64600048|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64600049|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64600050|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64600051|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64600052|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64600053|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64325437|NCT00152971|Enoxaparin|enoxaparin|mesh-list
64600055|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64600056|NCT01279057|Fluticasone|fluticasone|mesh-list
64600057|NCT01279057|Xhance|xhance|mesh-list
64600058|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600059|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64600060|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
64600061|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600062|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600064|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
64600065|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
64600066|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64600067|NCT03187106|Metronidazole|metronidazole|mesh-list
64600068|NCT03187106|Cephalexin|cephalexin|mesh-list
64600069|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600070|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64600071|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64600072|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64600073|NCT04384783|Hormones|hormones|mesh-list
64600074|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600075|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600076|NCT03186326|Bevacizumab|bevacizumab|mesh-list
64600077|NCT03186326|Cetuximab|cetuximab|mesh-list
64600078|NCT03186326|Avelumab|avelumab|mesh-list
64600079|NCT03186326|Panitumumab|panitumumab|mesh-list
64600084|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64600085|NCT03186326|Growth Substances|growth substances|mesh-ancestor
64600086|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600087|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
64600088|NCT02999633|Acetaminophen|acetaminophen|mesh-list
64600089|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
64600090|NCT02999633|Promethazine|promethazine|mesh-list
64600091|NCT02999633|Dexamethasone|dexamethasone|mesh-list
64600092|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
64600093|NCT02999633|Ranitidine|ranitidine|mesh-list
64600094|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
64600095|NCT02999633|BB 1101|bb 1101|mesh-list
64600096|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600097|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
64600098|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
64600099|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600100|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600101|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600102|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
64600103|NCT02999633|Hormones|hormones|mesh-ancestor
64600104|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600105|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600106|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600107|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600108|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600109|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600110|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64600112|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
64600114|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64600115|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64600116|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600117|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
64600118|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
64600119|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64600121|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
64600122|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600123|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64600124|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
64600125|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
64600126|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64600127|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64600130|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
64600131|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600132|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600133|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
64600134|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600135|NCT03036098|Gemcitabine|gemcitabine|mesh-list
64600136|NCT03036098|Carboplatin|carboplatin|mesh-list
64600137|NCT03036098|Nivolumab|nivolumab|mesh-list
64600138|NCT03036098|Ipilimumab|ipilimumab|mesh-list
64600139|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600140|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600141|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
64600142|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600143|NCT03036098|Antiviral Agents|antiviral agents|mesh-ancestor
64600144|NCT03036098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600145|NCT03036098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600146|NCT03036098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600147|NCT03036098|Immunologic Factors|immunologic factors|mesh-ancestor
64600148|NCT03036098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600149|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600150|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64600151|NCT02991599|Vaccines|vaccines|mesh-list
64600152|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
64600153|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600154|NCT02996513|Vitamin A|vitamin a|mesh-list
64600155|NCT02996513|Vitamins|vitamins|mesh-ancestor
64600156|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
64600157|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600158|NCT04276688|Interferons|interferons|mesh-list
64600159|NCT04276688|Ritonavir|ritonavir|mesh-list
64600160|NCT04276688|Ribavirin|ribavirin|mesh-list
64600161|NCT04276688|Lopinavir|lopinavir|mesh-list
64600162|NCT04276688|Interferon-beta|interferon-beta|mesh-list
64600163|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
64600164|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600165|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
64600166|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600167|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64600168|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64600169|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600170|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600171|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600172|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64600173|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64600174|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64600175|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64600176|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
64600177|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
64600178|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600179|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64600181|NCT01277627|Nevirapine|nevirapine|mesh-list
64600182|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64600183|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
64600184|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64600185|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64600186|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600187|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600188|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
64600189|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600190|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64600191|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64600192|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64600193|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64600194|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64600195|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64600196|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64600197|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64600198|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64600199|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64600200|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64600202|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600203|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600204|NCT00706979|Nicotine|nicotine|mesh-list
64600205|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64600206|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
64600207|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600208|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64325562|NCT02153879|Vitamins|vitamins|mesh-ancestor
64600209|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64600210|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64600211|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
64600212|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600213|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600214|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
64600215|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64600216|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600217|NCT00716963|Fluticasone|fluticasone|mesh-list
64600219|NCT00716963|Budesonide|budesonide|mesh-list
64600220|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600221|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64600222|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
64600223|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600224|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600225|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64600226|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
64600227|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
64600228|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64600229|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
64600230|NCT00716963|Hormones|hormones|mesh-ancestor
64600231|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600232|NCT01270997|Etanercept|etanercept|mesh-list
64600233|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64600234|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64600235|NCT01270997|Analgesics|analgesics|mesh-ancestor
64600236|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
64600237|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600238|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600239|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600240|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600241|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600242|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600243|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
64600244|NCT01278745|Rituximab|rituximab|mesh-list
64600245|NCT01278745|Tacrolimus|tacrolimus|mesh-list
64600246|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600247|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600248|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
64600249|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600250|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600251|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600252|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64600253|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296602|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
64600254|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600257|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600258|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
64600259|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600260|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600261|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600262|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
64600263|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64600264|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64600265|NCT01271153|Dobutamine|dobutamine|mesh-list
64600266|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64600267|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
64600268|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
64600269|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600270|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600271|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64600273|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64600274|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
64600275|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600276|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600277|NCT01271153|Protective Agents|protective agents|mesh-ancestor
64600278|NCT03809065|Labetalol|labetalol|mesh-list
64600279|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
64600280|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
64600281|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64600282|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64600283|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
64600284|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600285|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600286|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600287|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64600288|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
64600289|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
64600290|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600291|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64600292|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64600293|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
64600294|NCT03006926|Lenvatinib|lenvatinib|mesh-list
64600295|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600296|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600297|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64600298|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600299|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600300|NCT02995187|Apatinib|apatinib|mesh-list
64600301|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600302|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64600303|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600304|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600305|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64600306|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64600307|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64600308|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64600309|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64600310|NCT01272089|Analgesics|analgesics|mesh-ancestor
64600311|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
64360656|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360657|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600312|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600313|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600314|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600315|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600316|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64600317|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64600318|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64600319|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
64600320|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
64600321|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600322|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600323|NCT00748657|Bevacizumab|bevacizumab|mesh-list
64600324|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64600325|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
64600326|NCT00748657|Antibodies|antibodies|mesh-list
64600327|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
64600328|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64600329|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
64600330|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600331|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64600332|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64600333|NCT00748657|Growth Substances|growth substances|mesh-ancestor
64600334|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600335|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
64600336|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
64600337|NCT02994953|Avelumab|avelumab|mesh-list
64600338|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64600339|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600340|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600341|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
64600342|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600343|NCT01273051|Capecitabine|capecitabine|mesh-list
64600344|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600345|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
64414783|NCT02419755|Vorinostat|vorinostat|mesh-list
64600346|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600347|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600349|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600350|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64600351|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600352|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600353|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
64600354|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64600355|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
64600356|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600357|NCT02994875|Expectorants|expectorants|mesh-ancestor
64600358|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
64600359|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64600360|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
64600361|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600362|NCT02994875|Protective Agents|protective agents|mesh-ancestor
64600363|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600364|NCT02994875|Antidotes|antidotes|mesh-ancestor
64600365|NCT03809143|Buprenorphine|buprenorphine|mesh-list
64600366|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64600367|NCT03809143|Narcotics|narcotics|mesh-ancestor
64600368|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600369|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600370|NCT03809143|Analgesics|analgesics|mesh-ancestor
64600371|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
64600372|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600373|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64600374|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
64600375|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
64600376|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64600377|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64600378|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600379|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600380|NCT02390960|Urological Agents|urological agents|mesh-ancestor
64600381|NCT00720473|Lamotrigine|lamotrigine|mesh-list
64600382|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
64600383|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64600384|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64600385|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600386|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64600387|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600388|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64600389|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64600390|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600391|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64600392|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64600393|NCT00637832|Prednisolone|prednisolone|mesh-list
64600394|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
64600395|NCT00637832|Rituximab|rituximab|mesh-list
64600396|NCT00637832|Doxorubicin|doxorubicin|mesh-list
64600397|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64600398|NCT00637832|Vincristine|vincristine|mesh-list
64600399|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600400|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
64600401|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600402|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600403|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64600404|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
64600405|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600406|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600407|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64600408|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600409|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64600410|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64600411|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64600412|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600413|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64600414|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
64600415|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
64600416|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
64600417|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600418|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
64600419|NCT00637832|Hormones|hormones|mesh-ancestor
64600420|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600422|NCT00720629|Methotrexate|methotrexate|mesh-list
64600423|NCT00720629|Tacrolimus|tacrolimus|mesh-list
64600424|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
64600425|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64600426|NCT00720629|Visilizumab|visilizumab|mesh-list
64600428|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
64600429|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64600430|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600431|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600432|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
64600433|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600434|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600435|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
64600436|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64325789|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64600438|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600439|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
64600440|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600441|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64600442|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64600443|NCT01276327|Pioglitazone|pioglitazone|mesh-list
64600444|NCT01276327|Linagliptin|linagliptin|mesh-list
64600445|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600446|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600447|NCT01276327|Incretins|incretins|mesh-ancestor
64600448|NCT01276327|Hormones|hormones|mesh-ancestor
64600449|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600450|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64600451|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600452|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600453|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600454|NCT05245760|Paclitaxel|paclitaxel|mesh-list
64600455|NCT05245760|Carboplatin|carboplatin|mesh-list
64600456|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64600457|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600458|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
64600459|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
64600460|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
64600461|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600462|NCT02674958|Aspirin|aspirin|mesh-list
64600463|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64600464|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64600465|NCT02674958|Analgesics|analgesics|mesh-ancestor
64600466|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
64600467|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600468|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600469|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600470|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600472|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64600473|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600474|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64600475|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64600476|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600477|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
64600478|NCT00760435|Infliximab|infliximab|mesh-list
64600479|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
64600480|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600481|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600484|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
64600486|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600487|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600488|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
64600489|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600490|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64600491|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64600492|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64414784|NCT02419755|Pegaspargase|pegaspargase|mesh-list
64600493|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64600494|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600496|NCT00749125|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64600497|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64600498|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64600499|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600500|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600501|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
64600502|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600503|NCT00749125|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64600504|NCT00749125|Antidepressive Agents|antidepressive agents|mesh-ancestor
64600505|NCT00749125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64600506|NCT02144675|Cytarabine|cytarabine|mesh-list
64600507|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
64600508|NCT02144675|Salicylates|salicylates|mesh-list
64600509|NCT02144675|Idarubicin|idarubicin|mesh-list
64600510|NCT02144675|Choline|choline|mesh-list
64600511|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64600512|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
64600513|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600514|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600515|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
64600516|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600517|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600518|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
64600519|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600520|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64600521|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64600522|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64600523|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600524|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
64600525|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64600526|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600527|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64600528|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
64600529|NCT02144675|Analgesics|analgesics|mesh-ancestor
64600530|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
64600531|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600532|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64600533|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64600534|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600535|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600536|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64600537|NCT00749515|Deferasirox|deferasirox|mesh-list
64600538|NCT00749515|Deferoxamine|deferoxamine|mesh-list
64600539|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64600540|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
64600541|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
64600542|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600544|NCT01272557|Doxorubicin|doxorubicin|mesh-list
64600546|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64600547|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600548|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64600549|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64600550|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600551|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600552|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64600553|NCT00639002|Dexamethasone|dexamethasone|mesh-list
64600554|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600555|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
64600556|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
64600557|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600558|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600559|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600560|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
64600561|NCT00639002|Hormones|hormones|mesh-ancestor
64600562|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600563|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600564|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600565|NCT00761137|Tropicamide|tropicamide|mesh-list
64600569|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600570|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64600571|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64600572|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
64600573|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600574|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600575|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64600576|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64600577|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600579|NCT01273493|Trabectedin|trabectedin|mesh-list
64600580|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600581|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
64600582|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
64600583|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600584|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600585|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600586|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
64600588|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600589|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600590|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600591|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64600592|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
64600593|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600594|NCT00638456|Budesonide|budesonide|mesh-list
64600595|NCT00638456|Lansoprazole|lansoprazole|mesh-list
64600596|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
64600597|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600598|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64600599|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
64600600|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600601|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600602|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64600603|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
64600604|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
64600605|NCT00638456|Hormones|hormones|mesh-ancestor
64600606|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600607|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64600608|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600609|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64600610|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600611|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600612|NCT01273571|Metformin|metformin|mesh-list
64600613|NCT01273571|Canagliflozin|canagliflozin|mesh-list
64600614|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600615|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600616|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64600617|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600618|NCT02147899|Secnidazole|secnidazole|mesh-list
64600619|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64600620|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64600621|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600622|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
64600623|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600624|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600625|NCT03132116|Gentamicins|gentamicins|mesh-list
64600626|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64600627|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600628|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64600629|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600630|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600631|NCT00762619|Triclosan|triclosan|mesh-list
64600632|NCT00762619|Fluorides|fluorides|mesh-list
64600633|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
64600634|NCT00762619|Protective Agents|protective agents|mesh-ancestor
64600635|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600636|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64600637|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600638|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64600639|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64600640|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
64600641|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600642|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64600643|NCT00735449|Timolol|timolol|mesh-list
64600644|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64600645|NCT00735449|Latanoprost|latanoprost|mesh-list
64600646|NCT00735449|Maleic acid|maleic acid|mesh-list
64600647|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600648|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600649|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64600650|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64600651|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
64600652|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600653|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600654|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64600655|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64600656|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64600657|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64600658|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64600659|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64326020|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
64600660|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64600661|NCT01273831|Cisatracurium|cisatracurium|mesh-list
64600662|NCT01273831|Atracurium|atracurium|mesh-list
64600663|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64600664|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64600665|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600666|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600667|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64600668|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64600669|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64600670|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
64600671|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600672|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600673|NCT00735917|Saracatinib|saracatinib|mesh-list
64600674|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64600675|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64600676|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600677|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600678|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600679|NCT00736073|Aprepitant|aprepitant|mesh-list
64600680|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
64600681|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
64600682|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600683|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600684|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600685|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64600686|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600687|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600688|NCT00736229|Exenatide|exenatide|mesh-list
64600689|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600690|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600691|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64600693|NCT00736229|Hormones|hormones|mesh-ancestor
64600694|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600695|NCT00737243|Paclitaxel|paclitaxel|mesh-list
64600696|NCT00737243|Bevacizumab|bevacizumab|mesh-list
64600697|NCT00737243|Carboplatin|carboplatin|mesh-list
64600698|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64600699|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64600700|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600701|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64600702|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64600703|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64600704|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600705|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600706|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64600707|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64600708|NCT00737243|Growth Substances|growth substances|mesh-ancestor
64600709|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600710|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
64600711|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64600712|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600713|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
64600714|NCT00707759|Prednisone|prednisone|mesh-list
64600715|NCT00707759|Prednisolone|prednisolone|mesh-list
64600716|NCT00707759|Tacrolimus|tacrolimus|mesh-list
64600717|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600719|NCT00707759|Hormones|hormones|mesh-ancestor
64600720|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600721|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600722|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600723|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600724|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600725|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
64600726|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64600727|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600728|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600729|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64600730|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64600731|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
64600732|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64600733|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64326095|NCT04310059|Folic Acid|folic acid|mesh-list
64600735|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
64600736|NCT01273727|BB 1101|bb 1101|mesh-list
64600737|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64600738|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
64600739|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
64600740|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600741|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600742|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64600743|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
64600744|NCT01273727|Hormones|hormones|mesh-ancestor
64600745|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600746|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600747|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600748|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600749|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600750|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600751|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64600752|NCT00708071|Thrombin|thrombin|mesh-list
64600753|NCT00708071|Aprotinin|aprotinin|mesh-list
64600754|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
64600755|NCT00708071|Coagulants|coagulants|mesh-ancestor
64360841|NCT02508805|Diclofenac|diclofenac|mesh-list
64600757|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64600758|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600759|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600760|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600761|NCT02994485|Simvastatin|simvastatin|mesh-list
64600762|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64600763|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64600764|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
64600765|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600766|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64600767|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64600768|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600770|NCT02994173|Oxycodone|oxycodone|mesh-list
64600771|NCT02994173|Esketamine|esketamine|mesh-list
64600772|NCT02994173|Analgesics|analgesics|mesh-ancestor
64600773|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
64600774|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600775|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600776|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64600777|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64600778|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
64600779|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
64600782|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64600783|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600784|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600786|NCT02994173|Narcotics|narcotics|mesh-ancestor
64600787|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
64600788|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64600789|NCT00723749|Buprenorphine|buprenorphine|mesh-list
64600790|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64600791|NCT00723749|Naloxone|naloxone|mesh-list
64600792|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64600793|NCT00723749|Narcotics|narcotics|mesh-ancestor
64600794|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600795|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600796|NCT00723749|Analgesics|analgesics|mesh-ancestor
64600797|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
64600798|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600799|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64600800|NCT00723827|Temozolomide|temozolomide|mesh-list
64600801|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64600802|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
64600803|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600804|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600805|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
64600806|NCT00779311|Bevacizumab|bevacizumab|mesh-list
64600807|NCT00779311|Sorafenib|sorafenib|mesh-list
64600808|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600809|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600810|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64600811|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64600812|NCT00779311|Growth Substances|growth substances|mesh-ancestor
64600813|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600814|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
64600815|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64600816|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600817|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600821|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600834|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64600835|NCT00779701|Insulin|insulin|mesh-list
64600836|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600837|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360871|NCT03121573|Analgesics|analgesics|mesh-ancestor
64600839|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64600840|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600841|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600842|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64600843|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64600844|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64600845|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64600846|NCT03809221|Hormones|hormones|mesh-list
64600847|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64600848|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600849|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600850|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
64600851|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64600852|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
64600853|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64600854|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64600855|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600868|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64600869|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64600870|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64600872|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
64600873|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600874|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
64600875|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64600876|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600877|NCT00762853|Triclosan|triclosan|mesh-list
64600878|NCT00762853|Fluorides|fluorides|mesh-list
64600879|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
64600880|NCT00762853|Protective Agents|protective agents|mesh-ancestor
64600881|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600882|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64600883|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600884|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64600885|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64600898|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64600899|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600901|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
64600902|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
64600903|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64600905|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64600906|NCT01279499|Narcotics|narcotics|mesh-ancestor
64600907|NCT01279499|Analgesics|analgesics|mesh-ancestor
64600909|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64600910|NCT02992925|Vaccines|vaccines|mesh-list
64600911|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
64600912|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600913|NCT00780715|Metformin|metformin|mesh-list
64600914|NCT00780715|Pioglitazone|pioglitazone|mesh-list
64600915|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64600916|NCT00780715|Gliclazide|gliclazide|mesh-list
64600917|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600918|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600919|NCT00780715|Incretins|incretins|mesh-ancestor
64600920|NCT00780715|Hormones|hormones|mesh-ancestor
64600921|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600922|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64600923|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600925|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600927|NCT05318443|Carboplatin|carboplatin|mesh-list
64600928|NCT05318443|Bevacizumab|bevacizumab|mesh-list
64600929|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64600930|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600931|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
64600932|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
64600933|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
64600934|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600935|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64600936|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64600937|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64600938|NCT05318443|Growth Substances|growth substances|mesh-ancestor
64600939|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600940|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
64600941|NCT05313529|Metformin|metformin|mesh-list
64600942|NCT05313529|Liraglutide|liraglutide|mesh-list
64600943|NCT05313529|Empagliflozin|empagliflozin|mesh-list
64600944|NCT05313529|Linagliptin|linagliptin|mesh-list
64600945|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64600946|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600947|NCT05313529|Incretins|incretins|mesh-ancestor
64600948|NCT05313529|Hormones|hormones|mesh-ancestor
64600949|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64600950|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64600951|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600952|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64600953|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
64600954|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600955|NCT00740831|Leuprolide|leuprolide|mesh-list
64600956|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
64600957|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64600958|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
64600959|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64600960|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600961|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64600962|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64600963|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64600964|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
64600965|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64600970|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600972|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64600973|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64600974|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64600975|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600976|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
64600977|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64600978|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64600979|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64600980|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64600981|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64600982|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600983|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64600984|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64600985|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64600986|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64600987|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
64600988|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64600989|NCT00741455|Cyclosporine|cyclosporine|mesh-list
64600990|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
64600991|NCT00741455|Methotrexate|methotrexate|mesh-list
64600992|NCT00741455|Fludarabine|fludarabine|mesh-list
64600993|NCT00741455|Cyclosporins|cyclosporins|mesh-list
64600994|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64600995|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
64600996|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64600997|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64600998|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64600999|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
64601000|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601002|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64601003|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64601004|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
64601005|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64601006|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64601007|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
64601008|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
64601009|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601010|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64601011|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64601012|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
64601013|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601014|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64601015|NCT00742313|Hemostatics|hemostatics|mesh-list
64601016|NCT00742313|Coagulants|coagulants|mesh-ancestor
64601017|NCT00742469|Rifaximin|rifaximin|mesh-list
64601018|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64601019|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601020|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601021|NCT01275599|Buprenorphine|buprenorphine|mesh-list
64601022|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64601023|NCT01275599|Naloxone|naloxone|mesh-list
64601024|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64601025|NCT01275599|Narcotics|narcotics|mesh-ancestor
64601026|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601027|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601028|NCT01275599|Analgesics|analgesics|mesh-ancestor
64601029|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
64601030|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601031|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64601032|NCT02992457|Interferons|interferons|mesh-list
64601033|NCT02992457|Ribavirin|ribavirin|mesh-list
64601034|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
64601035|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
64601036|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64601037|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
64601038|NCT02992457|Ledipasvir|ledipasvir|mesh-list
64601039|NCT02992457|Simeprevir|simeprevir|mesh-list
64601040|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64601041|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601042|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
64601043|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601044|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
64382258|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601045|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601047|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601048|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
64601049|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601051|NCT00782821|Bortezomib|bortezomib|mesh-list
64601052|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
64601053|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64601054|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601055|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601056|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
64601057|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601058|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601059|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601060|NCT00743093|Acetaminophen|acetaminophen|mesh-list
64601061|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601062|NCT00743093|Analgesics|analgesics|mesh-ancestor
64601063|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
64601064|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601065|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601066|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
64601067|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
64601068|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64601069|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601070|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601071|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601072|NCT03805945|Analgesics|analgesics|mesh-ancestor
64601073|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
64601074|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601075|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64601076|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64601077|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64601078|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
64601079|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601080|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601081|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64601082|NCT04270019|Laxatives|laxatives|mesh-ancestor
64601083|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601084|NCT00743717|Cobalt|cobalt|mesh-list
64601085|NCT00743717|Trace Elements|trace elements|mesh-ancestor
64601086|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
64601087|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601088|NCT00744965|Glyburide|glyburide|mesh-list
64601089|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64601090|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601091|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
64601092|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
64601093|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64601094|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64601095|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601096|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601098|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
64601099|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64601100|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
64601101|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601102|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
64601103|NCT00711347|Protective Agents|protective agents|mesh-ancestor
64601104|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
64601105|NCT01276223|Difluprednate|difluprednate|mesh-list
64601107|NCT01276223|Hormones|hormones|mesh-ancestor
64601108|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601109|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601110|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601111|NCT00784225|Vitamins|vitamins|mesh-list
64601112|NCT00784225|Vitamin E|vitamin e|mesh-list
64601113|NCT00784225|Tocopherols|tocopherols|mesh-list
64601114|NCT00784225|Tocotrienols|tocotrienols|mesh-list
64601115|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
64601116|NCT00784225|Selenium|selenium|mesh-list
64601117|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
64601118|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601119|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
64416787|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64601120|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601121|NCT00784225|Protective Agents|protective agents|mesh-ancestor
64601123|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
64601124|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64601125|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601126|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
64601127|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
64601128|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64601129|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64601130|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601131|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601132|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601133|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601134|NCT01273181|Aldesleukin|aldesleukin|mesh-list
64601135|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
64601136|NCT01273181|Fludarabine|fludarabine|mesh-list
64601137|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601138|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
64601139|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601140|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601141|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64601142|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
64360955|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601143|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601144|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601145|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64601146|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64601147|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64601148|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
64601149|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601150|NCT01272947|Diclofenac|diclofenac|mesh-list
64601151|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601152|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601153|NCT01272947|Analgesics|analgesics|mesh-ancestor
64601154|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
64601155|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601156|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601157|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601158|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601159|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64601160|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601161|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601162|NCT01279343|Misoprostol|misoprostol|mesh-list
64601163|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64601164|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
64601165|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64601166|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601167|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64601168|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601169|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
64601170|NCT01278797|Amlodipine|amlodipine|mesh-list
64601171|NCT01278797|Telmisartan|telmisartan|mesh-list
64601172|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64601173|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64601174|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64601175|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64601176|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601177|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64601178|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601179|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
64601180|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64601181|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64601182|NCT01272635|Azithromycin|azithromycin|mesh-list
64601183|NCT01272635|Prednisolone|prednisolone|mesh-list
64601184|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64601185|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
64601187|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
64601188|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64601189|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
64601190|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601191|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
64601193|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601194|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601195|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64601196|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601197|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
64601198|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
64601199|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601200|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601201|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64601202|NCT01272635|Protective Agents|protective agents|mesh-ancestor
64601203|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64601204|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601205|NCT04387097|Remifentanil|remifentanil|mesh-list
64601206|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64601207|NCT04387097|Narcotics|narcotics|mesh-ancestor
64601208|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601209|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601210|NCT04387097|Analgesics|analgesics|mesh-ancestor
64601211|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
64601212|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601213|NCT01270841|Enclomiphene|enclomiphene|mesh-list
64601214|NCT01270841|Clomiphene|clomiphene|mesh-list
64601215|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
64601226|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64601227|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64601228|NCT01278407|Donepezil|donepezil|mesh-list
64601229|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64601230|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601231|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601232|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
64601233|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601234|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601235|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
64601236|NCT01278173|Vigabatrin|vigabatrin|mesh-list
64601237|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
64601238|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601239|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601240|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
64601241|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601242|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601243|NCT00784303|Lenvatinib|lenvatinib|mesh-list
64601244|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601245|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64601246|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601247|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601248|NCT00750815|Dexamethasone|dexamethasone|mesh-list
64601249|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
64601250|NCT00750815|Doxorubicin|doxorubicin|mesh-list
64601251|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64601252|NCT00750815|Bortezomib|bortezomib|mesh-list
64601253|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601254|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
64601255|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601256|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601257|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64601259|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601260|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601261|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64601262|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601263|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
64601264|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
64601265|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601266|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601267|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
64601268|NCT00750815|Hormones|hormones|mesh-ancestor
64601269|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601270|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64601271|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64601272|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64601273|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64601274|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601276|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601277|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601278|NCT00786019|Vitamins|vitamins|mesh-list
64601279|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
64601280|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
64601281|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601282|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
64601283|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601284|NCT00786019|Protective Agents|protective agents|mesh-ancestor
64601285|NCT01277861|Fentanyl|fentanyl|mesh-list
64601286|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64601287|NCT01277861|Narcotics|narcotics|mesh-ancestor
64601288|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601289|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601290|NCT01277861|Analgesics|analgesics|mesh-ancestor
64601291|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
64601292|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601293|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64601294|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64601295|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
64601296|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
64601297|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64601298|NCT00786487|Glycerol|glycerol|mesh-list
64601299|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64601300|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64601301|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64601302|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64601303|NCT00786487|Protective Agents|protective agents|mesh-ancestor
64601304|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601305|NCT03805633|Pancrelipase|pancrelipase|mesh-list
64601306|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601307|NCT01276847|Etanercept|etanercept|mesh-list
64601308|NCT01276847|Ustekinumab|ustekinumab|mesh-list
64601309|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601310|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601311|NCT01276847|Analgesics|analgesics|mesh-ancestor
64601312|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
64601313|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601314|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601315|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601316|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601317|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601318|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601319|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
64601320|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
64601321|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
64601322|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601323|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601324|NCT00945269|Aldesleukin|aldesleukin|mesh-list
64601325|NCT00945269|Interleukin-2|interleukin-2|mesh-list
64601326|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
64601327|NCT00945269|Immunotoxins|immunotoxins|mesh-list
64601328|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601329|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601330|NCT00945269|Analgesics|analgesics|mesh-ancestor
64601331|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
64601332|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601333|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601334|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64601335|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64601336|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
64601337|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601338|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
64326698|NCT00917293|Pyridoxal|pyridoxal|mesh-list
64601340|NCT01272791|Bavituximab|bavituximab|mesh-list
64601341|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64601342|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
64601343|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601344|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361070|NCT03341845|Avelumab|avelumab|mesh-list
64601345|NCT01272791|Antiviral Agents|antiviral agents|mesh-ancestor
64601346|NCT01272791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601347|NCT01272791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601348|NCT01272791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601349|NCT01272791|Immunologic Factors|immunologic factors|mesh-ancestor
64601350|NCT01272791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601351|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601353|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601354|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
64601355|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601356|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64601357|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601358|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601359|NCT00765895|Nortriptyline|nortriptyline|mesh-list
64601360|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64601361|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
64601362|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64601363|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64601364|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64601365|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64601366|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601367|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
64601368|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601369|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601370|NCT01276457|Cyclosporine|cyclosporine|mesh-list
64601371|NCT01276457|Everolimus|everolimus|mesh-list
64601372|NCT01276457|Cyclosporins|cyclosporins|mesh-list
64601374|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601375|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601376|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
64601377|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601378|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
64601379|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601380|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
64601381|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601382|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64601383|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601384|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
64601386|NCT03804931|Mesalamine|mesalamine|mesh-list
64601387|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601388|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
64601389|NCT03804931|Hormones|hormones|mesh-ancestor
64601390|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601391|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601392|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64601393|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601394|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601395|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601396|NCT03804931|Analgesics|analgesics|mesh-ancestor
64601397|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
64601398|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601399|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601400|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
64601401|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64601402|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601403|NCT02991131|Linezolid|linezolid|mesh-list
64601404|NCT02991131|Tedizolid|tedizolid|mesh-list
64601405|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
64601406|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64601407|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601408|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64601409|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601410|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361077|NCT02498977|Cyclosporine|cyclosporine|mesh-list
64601411|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64601412|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
64601413|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64601414|NCT00766753|Vaccines|vaccines|mesh-list
64326778|NCT02261207|Axitinib|axitinib|mesh-list
64601415|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
64601416|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601417|NCT00767767|Thiopental|thiopental|mesh-list
64601418|NCT00767767|Propofol|propofol|mesh-list
64601419|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64601420|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601421|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601422|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64601423|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
64601424|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
64601425|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
64601426|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
64601428|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601429|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601431|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64601432|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64601433|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
64601434|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601435|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601436|NCT00761345|Antiviral Agents|antiviral agents|mesh-ancestor
64601437|NCT00761345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601438|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601439|NCT00761345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601440|NCT00761345|Immunologic Factors|immunologic factors|mesh-ancestor
64601441|NCT00761345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601442|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64601443|NCT00762515|Triclosan|triclosan|mesh-list
64601444|NCT00762515|Fluorides|fluorides|mesh-list
64601445|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
64601446|NCT00762515|Protective Agents|protective agents|mesh-ancestor
64601447|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601448|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64601449|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601450|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64601451|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64601452|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
64430026|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
64601453|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601454|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64601455|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
64601456|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64601457|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64601458|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64601459|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64601460|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64601461|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601462|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
64601463|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601464|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601465|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64601466|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601467|NCT00753935|Aspirin|aspirin|mesh-list
64601468|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601469|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601470|NCT00753935|Analgesics|analgesics|mesh-ancestor
64601471|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
64601472|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601473|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601474|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601475|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601476|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64601477|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64601478|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601479|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64601480|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64601481|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601482|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
64601483|NCT00779285|Doxorubicin|doxorubicin|mesh-list
64601484|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64601485|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64601486|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601487|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64601488|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64601489|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382259|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
64601490|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601493|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
64601494|NCT00786643|Bevacizumab|bevacizumab|mesh-list
64601495|NCT00786643|Fluorouracil|fluorouracil|mesh-list
64601496|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
64601497|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601498|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601499|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64601500|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64601501|NCT00786643|Growth Substances|growth substances|mesh-ancestor
64601502|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601503|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
64601504|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
64601505|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601506|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64601507|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601508|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
64601509|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
64601510|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601511|NCT00786643|Antidotes|antidotes|mesh-ancestor
64601512|NCT00786643|Protective Agents|protective agents|mesh-ancestor
64601513|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
64601514|NCT00786643|Vitamins|vitamins|mesh-ancestor
64601515|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
64601516|NCT01276379|Leucovorin|leucovorin|mesh-list
64601517|NCT01276379|Folic Acid|folic acid|mesh-list
64601518|NCT01276379|Fluorouracil|fluorouracil|mesh-list
64601519|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
64601521|NCT01276379|Cetuximab|cetuximab|mesh-list
64601522|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
64601523|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
64601524|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601525|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64601526|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601527|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601528|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
64601529|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601530|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64601531|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64601532|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601533|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601534|NCT01276379|Antidotes|antidotes|mesh-ancestor
64601535|NCT01276379|Protective Agents|protective agents|mesh-ancestor
64601536|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
64601537|NCT01276379|Vitamins|vitamins|mesh-ancestor
64601538|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
64601539|NCT01276379|Hematinics|hematinics|mesh-ancestor
64601540|NCT01275547|Midazolam|midazolam|mesh-list
64601541|NCT01275547|Ketamine|ketamine|mesh-list
64601542|NCT01275547|Morphine|morphine|mesh-list
64601543|NCT01275547|Esketamine|esketamine|mesh-list
64601544|NCT01275547|Analgesics|analgesics|mesh-ancestor
64361120|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
64601545|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
64601546|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601547|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601548|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64601549|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64601550|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
64601551|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
64601552|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601553|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64601554|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64601555|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601556|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601557|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64601558|NCT01275547|Narcotics|narcotics|mesh-ancestor
64601559|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64601560|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64601561|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64601562|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64601563|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64601564|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
64601565|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
64601566|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
64326923|NCT02938520|Rilpivirine|rilpivirine|mesh-list
64601567|NCT00789685|Interferons|interferons|mesh-list
64601568|NCT00789685|Interferon-beta|interferon-beta|mesh-list
64601569|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601570|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
64601571|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601572|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
64601573|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601574|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
64601575|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64601576|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64601577|NCT03804229|Protective Agents|protective agents|mesh-ancestor
64601578|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601579|NCT05742607|Paclitaxel|paclitaxel|mesh-list
64601580|NCT05742607|Cisplatin|cisplatin|mesh-list
64601582|NCT05742607|Pemetrexed|pemetrexed|mesh-list
64601583|NCT05742607|Durvalumab|durvalumab|mesh-list
64601584|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64601585|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64601586|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601587|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
64601588|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
64601589|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
64601590|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601591|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601592|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64601593|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64601594|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601595|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
64601596|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601597|NCT02149303|Dabigatran|dabigatran|mesh-list
64601598|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
64601599|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64601600|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
64601601|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601602|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601603|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
64601605|NCT03803449|Midazolam|midazolam|mesh-list
64601606|NCT03803449|Propofol|propofol|mesh-list
64601607|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64601608|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601609|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601610|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64601611|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
64601612|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
64601613|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64601614|NCT03803449|Narcotics|narcotics|mesh-ancestor
64601615|NCT03803449|Analgesics|analgesics|mesh-ancestor
64601616|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
64601617|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601618|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64601619|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64601620|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64601621|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64601622|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
64601623|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
64601624|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601625|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601626|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
64601627|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64601628|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601629|NCT00789997|Levofloxacin|levofloxacin|mesh-list
64601630|NCT00789997|Ofloxacin|ofloxacin|mesh-list
64601631|NCT00789997|Prednisone|prednisone|mesh-list
64601632|NCT00789997|Etanercept|etanercept|mesh-list
64601633|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601634|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
64601635|NCT00789997|Hormones|hormones|mesh-ancestor
64601636|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601637|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601638|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64601639|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601640|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601641|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601643|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
64601644|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601645|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601646|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601647|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601648|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
64601649|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64601650|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601651|NCT00789997|Renal Agents|renal agents|mesh-ancestor
64601652|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64601653|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64601654|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64601655|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601656|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601657|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64601658|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64601659|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
64601660|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64601661|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
64601662|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601663|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601664|NCT03803215|Theophylline|theophylline|mesh-list
64601665|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64601666|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
64601667|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601668|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601669|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64601670|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
64601671|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64601672|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601673|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601674|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
64601675|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64601676|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64601677|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
64601678|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601679|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64601680|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64601681|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
64601682|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601683|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601685|NCT03802747|Tremelimumab|tremelimumab|mesh-list
64601686|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64601687|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601688|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601689|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
64601690|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601691|NCT00791323|Ketorolac|ketorolac|mesh-list
64601692|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64601693|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
64601694|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64601695|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601696|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601697|NCT00791323|Analgesics|analgesics|mesh-ancestor
64601698|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
64601699|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601700|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601701|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601702|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601703|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64601704|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601705|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601706|NCT00772915|Dexamethasone|dexamethasone|mesh-list
64601707|NCT00772915|Lenalidomide|lenalidomide|mesh-list
64601708|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601710|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
64601711|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601712|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601713|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601714|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
64601715|NCT00772915|Hormones|hormones|mesh-ancestor
64601716|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601717|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64601718|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601719|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
64601720|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64601721|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64601722|NCT00772915|Growth Substances|growth substances|mesh-ancestor
64601723|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
64601724|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64601725|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601726|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601728|NCT03801733|Atorvastatin|atorvastatin|mesh-list
64601729|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64601730|NCT03801733|Simvastatin|simvastatin|mesh-list
64601731|NCT03801733|Pravastatin|pravastatin|mesh-list
64601732|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64601733|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64601734|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
64430027|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
64601735|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601736|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64601737|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64601738|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601739|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601740|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601743|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
64601744|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601745|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601746|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601747|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601748|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601749|NCT00775411|Dexamethasone|dexamethasone|mesh-list
64601750|NCT00775411|Ranibizumab|ranibizumab|mesh-list
64601751|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601752|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
64601753|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
64601754|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601755|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601756|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601757|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
64601758|NCT00775411|Hormones|hormones|mesh-ancestor
64601759|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601760|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64601761|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601762|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64601763|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64601764|NCT00775411|Growth Substances|growth substances|mesh-ancestor
64601765|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
64601766|NCT03801499|Lenvatinib|lenvatinib|mesh-list
64601767|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601768|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64601769|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601770|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601771|NCT00808405|Acyclovir|acyclovir|mesh-list
64601772|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
64601773|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601774|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
64601775|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
64601776|NCT00775645|Vitamins|vitamins|mesh-ancestor
64601777|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
64601778|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601779|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
64601783|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601784|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64601785|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64601786|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601787|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601788|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64601789|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
64601790|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64601791|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601792|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64601795|NCT00795145|Linezolid|linezolid|mesh-list
64601796|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64601797|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601798|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64601799|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64601800|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601801|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601802|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601803|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64361229|NCT03340597|Olorofim|olorofim|mesh-list
64601804|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
64601805|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64601806|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601807|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
64601808|NCT00809185|Everolimus|everolimus|mesh-list
64601809|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601810|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601811|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
64484239|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484240|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
64484241|NCT00795340|Paclitaxel|paclitaxel|mesh-list
64484242|NCT00795340|Carboplatin|carboplatin|mesh-list
64484243|NCT00795340|Cediranib|cediranib|mesh-list
64484244|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64484245|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484246|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
64484247|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
64484248|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
64484249|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484250|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64484251|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64484252|NCT04753294|Diazepam|diazepam|mesh-list
64484253|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64484254|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
64484255|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
64484256|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
64484257|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484258|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484259|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64484260|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64484261|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64484262|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64484263|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64484264|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64484265|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64484266|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64484267|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64484268|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
64484271|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
64484272|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64484273|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484275|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64484276|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484277|NCT00792142|Thalidomide|thalidomide|mesh-list
64484278|NCT00792142|Dexamethasone|dexamethasone|mesh-list
64484279|NCT00792142|Bortezomib|bortezomib|mesh-list
64484280|NCT00792142|Melphalan|melphalan|mesh-list
64484281|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64484282|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
64484283|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
64484284|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64484285|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484286|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64484287|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
64484289|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64484290|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64484291|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64484292|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64484293|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
64484294|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64484295|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64484296|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64484297|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
64484298|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
64484299|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64601812|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601814|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64601815|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601816|NCT04856215|Antibodies|antibodies|mesh-list
64601817|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64601818|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
64601819|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601820|NCT00795769|Ondansetron|ondansetron|mesh-list
64601821|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
64601822|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
64601823|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601824|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601825|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601826|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
64601827|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
64601828|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64601829|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
64601830|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601831|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601832|NCT00795769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64601833|NCT00795769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64601834|NCT00795769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601835|NCT00795769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64601836|NCT00795769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64601838|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64601839|NCT02305017|Acetaminophen|acetaminophen|mesh-list
64601840|NCT02305017|Opicapone|opicapone|mesh-list
64601841|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601842|NCT02305017|Analgesics|analgesics|mesh-ancestor
64601843|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
64601844|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601845|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601846|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
64601847|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64601848|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601849|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601850|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64601851|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64601852|NCT01976871|Rotigotine|rotigotine|mesh-list
64601853|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
64601854|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
64601855|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601856|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601857|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601858|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
64601859|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64601860|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
64601861|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601862|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601863|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64601864|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
64601865|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64601866|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
64601867|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601868|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601869|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64601870|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
64601871|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
64601872|NCT03602781|Protective Agents|protective agents|mesh-ancestor
64601873|NCT02280239|Acetaminophen|acetaminophen|mesh-list
64601874|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601875|NCT02280239|Analgesics|analgesics|mesh-ancestor
64601876|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
64601877|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601878|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601879|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
64601882|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64601883|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601885|NCT00796705|Etanercept|etanercept|mesh-list
64601886|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601887|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601888|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601889|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601890|NCT00796705|Analgesics|analgesics|mesh-ancestor
64601891|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
64601892|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601893|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601894|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64601895|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64601896|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
64601900|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601902|NCT00248651|Citalopram|citalopram|mesh-list
64601903|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64601904|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64601905|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64601906|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601907|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601908|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
64601909|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601910|NCT00248651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64601911|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
64601912|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64601913|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601914|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64601915|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601916|NCT00248651|Analgesics|analgesics|mesh-ancestor
64601917|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
64601918|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64601919|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
64601920|NCT03800797|Loxoprofen|loxoprofen|mesh-list
64601921|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64601922|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601923|NCT03800797|Analgesics|analgesics|mesh-ancestor
64601924|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
64601925|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601926|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601927|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64601928|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64601929|NCT04383067|Aldesleukin|aldesleukin|mesh-list
64601930|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64601931|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64601932|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64601933|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
64601934|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64601935|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
64601936|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
64601937|NCT01994109|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64601938|NCT01994109|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64601939|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64601940|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64601941|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601942|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
64601943|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601944|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601945|NCT01994109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64601946|NCT01994109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601947|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64601948|NCT04744831|Camptothecin|camptothecin|mesh-list
64601949|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
64601950|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64601951|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361314|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
64601952|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64601953|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64601954|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64601955|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601956|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
64601957|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601958|NCT00248495|Pemetrexed|pemetrexed|mesh-list
64601962|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64601963|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64601964|NCT04739371|Insulin|insulin|mesh-list
64601965|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64601966|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64601967|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601968|NCT03809767|Antibodies|antibodies|mesh-list
64601969|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64601970|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
64601971|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601972|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
64601973|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64601974|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601975|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601976|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64601977|NCT03800641|Analgesics|analgesics|mesh-ancestor
64601978|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
64601979|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601980|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64601981|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64601982|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64601983|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
64601984|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64601985|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64601986|NCT03807011|Fentanyl|fentanyl|mesh-list
64601987|NCT03807011|Remifentanil|remifentanil|mesh-list
64601988|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64601989|NCT03807011|Narcotics|narcotics|mesh-ancestor
64601990|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64601991|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64601992|NCT03807011|Analgesics|analgesics|mesh-ancestor
64601993|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
64601994|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64601995|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64601996|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64601997|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
64601998|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
64601999|NCT02986503|Cisplatin|cisplatin|mesh-list
64602000|NCT02986503|Doxorubicin|doxorubicin|mesh-list
64602001|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64602002|NCT02986503|Methotrexate|methotrexate|mesh-list
64602003|NCT02986503|Ifosfamide|ifosfamide|mesh-list
64602004|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
64602005|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602006|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64602007|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64602008|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64602009|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602010|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602011|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64602012|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
64602014|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602015|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64602017|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
64602018|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64602019|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602020|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
64602021|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602022|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64602023|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64602024|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
64602025|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
64602026|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64602027|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64602028|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
64602029|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602030|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64602031|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64602032|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602033|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602034|NCT00763061|Timolol|timolol|mesh-list
64602035|NCT00763061|Travoprost|travoprost|mesh-list
64602036|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64602037|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64602038|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64602039|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64602040|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
64602041|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602042|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602043|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602044|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64602045|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64602046|NCT03806335|Anesthetics|anesthetics|mesh-list
64602047|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602048|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602049|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
64602050|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64602051|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602052|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602053|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602054|NCT03806777|Analgesics|analgesics|mesh-ancestor
64602055|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
64602056|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602057|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64602058|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64602059|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64602060|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
64602061|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602062|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602063|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
64602064|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64602065|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602067|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
64602068|NCT00754247|Vitamins|vitamins|mesh-ancestor
64602069|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
64602070|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602071|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602072|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
64602073|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602074|NCT00754247|Protective Agents|protective agents|mesh-ancestor
64602075|NCT02305329|Opicapone|opicapone|mesh-list
64602076|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64602077|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602078|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602080|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64602081|NCT01979445|Clopidogrel|clopidogrel|mesh-list
64602082|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64602083|NCT01979445|Cangrelor|cangrelor|mesh-list
64602084|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64602087|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64602088|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
64602089|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602090|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602091|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602092|NCT03802565|Tolperisone|tolperisone|mesh-list
64602093|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64602094|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602095|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64602096|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602097|NCT04382443|Colchicine|colchicine|mesh-list
64602098|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
64602099|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602100|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
64602101|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
64602102|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
64602103|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602104|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602105|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64602106|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64602107|NCT04631029|Carboplatin|carboplatin|mesh-list
64602108|NCT04631029|Etoposide|etoposide|mesh-list
64602109|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
64602110|NCT04631029|Atezolizumab|atezolizumab|mesh-list
64602111|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
64602112|NCT04631029|Entinostat|entinostat|mesh-list
64602113|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64602114|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64602115|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602116|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64602117|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64602118|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64602119|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382260|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602122|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602123|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
64602124|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
64602125|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
64602126|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
64602127|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
64602128|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
64602129|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64602130|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64602131|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602132|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
64602133|NCT01981863|Coagulants|coagulants|mesh-ancestor
64602134|NCT04564885|Meloxicam|meloxicam|mesh-list
64602135|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64602136|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602137|NCT04564885|Analgesics|analgesics|mesh-ancestor
64602138|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
64602139|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602140|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602141|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602142|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602143|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64602144|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64602145|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602146|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602147|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
64602148|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602149|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
64602150|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602152|NCT01995045|Triamcinolone|triamcinolone|mesh-list
64602153|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64602154|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64602156|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64602158|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
64602159|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602160|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602161|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
64602162|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602163|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602164|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
64602165|NCT01995045|Hormones|hormones|mesh-ancestor
64602166|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602167|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602168|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
64602169|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602170|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602171|NCT04894123|Trifluridine|trifluridine|mesh-list
64602172|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
64602173|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602174|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
64602175|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602176|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
64602177|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602178|NCT01982643|Naltrexone|naltrexone|mesh-list
64602179|NCT01982643|Bupropion|bupropion|mesh-list
64602180|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64602181|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64602182|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602183|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
64602184|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602185|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64602186|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
64602187|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64602188|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64602189|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64602190|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602191|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602192|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
64602193|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602194|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64602195|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64602196|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602197|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64602198|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64602199|NCT00797797|Milnacipran|milnacipran|mesh-list
64602200|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
64602201|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64602202|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64602203|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602205|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602206|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602207|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602208|NCT00797797|Analgesics|analgesics|mesh-ancestor
64602209|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
64602210|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602211|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
64602212|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64602213|NCT03496233|Grazoprevir|grazoprevir|mesh-list
64602214|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64602215|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
64602216|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602217|NCT04482673|Vitamin D|vitamin d|mesh-list
64602218|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
64602219|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
64602220|NCT04482673|Vitamins|vitamins|mesh-list
64602221|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
64602222|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602228|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602229|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602230|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602231|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
64602232|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602233|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64602234|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
64602235|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64602236|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64602237|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64602238|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602239|NCT00245063|Cediranib|cediranib|mesh-list
64602240|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382261|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602241|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602242|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602243|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64602244|NCT02151487|Dexamethasone|dexamethasone|mesh-list
64602245|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
64602247|NCT02151487|Ropivacaine|ropivacaine|mesh-list
64602248|NCT02151487|BB 1101|bb 1101|mesh-list
64602249|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602250|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
64602251|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
64602252|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602253|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602254|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64602255|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
64602256|NCT02151487|Hormones|hormones|mesh-ancestor
64602257|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602258|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64602259|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602260|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
64602261|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602262|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602265|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602266|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
64602267|NCT02151487|Analgesics|analgesics|mesh-ancestor
64602268|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64602269|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
64602270|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64602271|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64602272|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64602273|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
64602274|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361476|NCT03324685|Estradiol|estradiol|mesh-list
64602275|NCT05318339|Trastuzumab|trastuzumab|mesh-list
64602276|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64602277|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602278|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
64602279|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64602280|NCT00764309|Dasatinib|dasatinib|mesh-list
64602281|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602282|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64602283|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602284|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602285|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
64602286|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64602287|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
64602288|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602289|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602290|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64602291|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
64602292|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64602293|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
64602294|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602295|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602296|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64602297|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
64602298|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
64602299|NCT02151877|Protective Agents|protective agents|mesh-ancestor
64602300|NCT03970837|Tofacitinib|tofacitinib|mesh-list
64602301|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64602302|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602303|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602306|NCT00799435|Exenatide|exenatide|mesh-list
64602307|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602308|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602309|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64602310|NCT00799435|Incretins|incretins|mesh-ancestor
64602311|NCT00799435|Hormones|hormones|mesh-ancestor
64416788|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64602312|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602313|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
64602314|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64602315|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602316|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602317|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602318|NCT04329091|Analgesics|analgesics|mesh-ancestor
64602319|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
64602320|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602321|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64602322|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64602323|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64602324|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
64602325|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602326|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602327|NCT04382209|Meperidine|meperidine|mesh-list
64602328|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64602329|NCT04382209|Narcotics|narcotics|mesh-ancestor
64602330|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602331|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602332|NCT04382209|Analgesics|analgesics|mesh-ancestor
64602333|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
64602334|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602335|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64602336|NCT04634071|Bupropion|bupropion|mesh-list
64602337|NCT04634071|Nicotine|nicotine|mesh-list
64361486|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64602338|NCT04634071|Varenicline|varenicline|mesh-list
64602339|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64602341|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602342|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602343|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64602344|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64602345|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
64602346|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602347|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602348|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64602349|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
64602350|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64602351|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64602352|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64602353|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602354|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
64602355|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64602357|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602358|NCT03417921|Gemcitabine|gemcitabine|mesh-list
64602359|NCT03417921|Paclitaxel|paclitaxel|mesh-list
64602360|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64602361|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602362|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
64602363|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64602364|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64602365|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602366|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64602367|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
64602368|NCT03417921|Antiviral Agents|antiviral agents|mesh-ancestor
64602369|NCT03417921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602370|NCT03417921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602371|NCT03417921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602372|NCT03417921|Immunologic Factors|immunologic factors|mesh-ancestor
64602373|NCT03417921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602374|NCT03381183|Durvalumab|durvalumab|mesh-list
64602375|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64602376|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602377|NCT03378297|Aspirin|aspirin|mesh-list
64602378|NCT03378297|Metformin|metformin|mesh-list
64602379|NCT03378297|Letrozole|letrozole|mesh-list
64602380|NCT03378297|Olaparib|olaparib|mesh-list
64602381|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602382|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602383|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602384|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64602385|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64602391|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64602392|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64602393|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602394|NCT03378297|Analgesics|analgesics|mesh-ancestor
64602395|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
64602396|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602397|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602398|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602399|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64602400|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64602401|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64602402|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64602403|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
64602404|NCT03367689|Olaparib|olaparib|mesh-list
64602405|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64602406|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602407|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602408|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602409|NCT00243659|Factor VIII|factor viii|mesh-list
64327774|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
64602410|NCT00243659|Coagulants|coagulants|mesh-ancestor
64602412|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
64602413|NCT00243347|Cediranib|cediranib|mesh-list
64602414|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602415|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64602416|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602417|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602418|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
64602419|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64602420|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64602421|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602422|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
64602423|NCT03364491|Coagulants|coagulants|mesh-ancestor
64602424|NCT04294069|Azithromycin|azithromycin|mesh-list
64602425|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64602426|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602427|NCT01997229|Eculizumab|eculizumab|mesh-list
64602428|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64602429|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602430|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
64602431|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602432|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
64602433|NCT00800839|Busulfan|busulfan|mesh-list
64602436|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602437|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
64602438|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602439|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602440|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64602441|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
64602442|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602443|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602444|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64602445|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64602446|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
64602447|NCT00814255|Adalimumab|adalimumab|mesh-list
64602448|NCT00814255|Losartan|losartan|mesh-list
64602449|NCT00814255|Lisinopril|lisinopril|mesh-list
64602450|NCT00814255|Atorvastatin|atorvastatin|mesh-list
64602451|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64602452|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64602453|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
64602454|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602455|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64602456|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64602457|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602458|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602459|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602460|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64602461|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64602462|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64602463|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64602464|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64602465|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
64602466|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64602467|NCT00814255|Protective Agents|protective agents|mesh-ancestor
64602468|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602470|NCT02000973|Bupivacaine|bupivacaine|mesh-list
64602471|NCT02000973|Ropivacaine|ropivacaine|mesh-list
64602472|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
64602473|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
64602474|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602475|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602476|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
64602477|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602478|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64602479|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64602480|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64602486|NCT01985685|Thiamine|thiamine|mesh-list
64602487|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
64602489|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
64602490|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602491|NCT00815347|Bosentan|bosentan|mesh-list
64602492|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64602493|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64602494|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602495|NCT01985763|Genistein|genistein|mesh-list
64602496|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64602497|NCT01985763|Protective Agents|protective agents|mesh-ancestor
64602498|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602499|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602500|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64602501|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602502|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602503|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
64602504|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64602505|NCT01985763|Estrogens|estrogens|mesh-ancestor
64602506|NCT01985763|Hormones|hormones|mesh-ancestor
64602507|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602508|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
64602509|NCT02061969|Linagliptin|linagliptin|mesh-list
64602510|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602511|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602512|NCT02061969|Incretins|incretins|mesh-ancestor
64602513|NCT02061969|Hormones|hormones|mesh-ancestor
64602514|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602515|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64602516|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
64602517|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602518|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602519|NCT02003625|Meloxicam|meloxicam|mesh-list
64602520|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64602521|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602522|NCT02003625|Analgesics|analgesics|mesh-ancestor
64602523|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
64602524|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602525|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602526|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602527|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602528|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64602529|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64602530|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602531|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602532|NCT04037683|Misoprostol|misoprostol|mesh-list
64602533|NCT04037683|Oxytocin|oxytocin|mesh-list
64602534|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
64602535|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64602536|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602537|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64602538|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
64602539|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64602540|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64602541|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
64602542|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64602543|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64602544|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602545|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
64602546|NCT04251247|Coagulants|coagulants|mesh-ancestor
64602547|NCT02396511|Bevacizumab|bevacizumab|mesh-list
64602548|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64602549|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602550|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64602551|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64602552|NCT02396511|Growth Substances|growth substances|mesh-ancestor
64602553|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602554|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
64602555|NCT00816751|Lidocaine|lidocaine|mesh-list
64602556|NCT00816751|Vasopressins|vasopressins|mesh-list
64602557|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
64602558|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
64602559|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
64602560|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602561|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602562|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
64602563|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602564|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64602565|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64602568|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602570|NCT00816751|Coagulants|coagulants|mesh-ancestor
64602571|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64602572|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64602573|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
64602574|NCT00816829|Fenofibrate|fenofibrate|mesh-list
64602575|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64602576|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
64602577|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602578|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64602579|NCT02062359|Aldesleukin|aldesleukin|mesh-list
64602580|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
64602581|NCT02062359|Fludarabine|fludarabine|mesh-list
64602582|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602583|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
64602584|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602585|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64602586|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64602587|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
64602588|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602589|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602590|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64602591|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64602592|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64602593|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
64602594|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602595|NCT02397291|Inositol|inositol|mesh-list
64602596|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
64602597|NCT02397291|Vitamins|vitamins|mesh-ancestor
64602598|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
64602599|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602600|NCT00816907|Metformin|metformin|mesh-list
64602601|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602602|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602603|NCT00817219|Betamethasone|betamethasone|mesh-list
64602604|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
64602605|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64602606|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
64602607|NCT00817219|Calcipotriene|calcipotriene|mesh-list
64602608|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64602609|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602610|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
64602611|NCT00817219|Hormones|hormones|mesh-ancestor
64602612|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602613|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602614|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64602615|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
64602616|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
64602617|NCT00817843|Simvastatin|simvastatin|mesh-list
64602618|NCT00817843|Ezetimibe|ezetimibe|mesh-list
64602619|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64602620|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64602621|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
64602622|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602623|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64602624|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64602625|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602626|NCT00817999|Clopidogrel|clopidogrel|mesh-list
64602627|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64602631|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
64602632|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602633|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602634|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602635|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64602636|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64602638|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
64602640|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
64602641|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
64602642|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602643|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602644|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
64602645|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602646|NCT03839251|Aripiprazole|aripiprazole|mesh-list
64602647|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
64602648|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64602649|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64602650|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64602651|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602652|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602653|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
64602654|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
64602655|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602656|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602657|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64602658|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64602659|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
64602660|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64602661|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64602662|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64602663|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64602664|NCT00819403|Simvastatin|simvastatin|mesh-list
64602665|NCT00819403|Ezetimibe|ezetimibe|mesh-list
64602666|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64602667|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64602668|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64602669|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
64602670|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602671|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64602672|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64602673|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602674|NCT02010021|Letrozole|letrozole|mesh-list
64602675|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602676|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64602677|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64602678|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602679|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602680|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64602681|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
64602682|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602683|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602686|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
64602687|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
64602688|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602689|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602690|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64602691|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
64602692|NCT02062905|Hormones|hormones|mesh-ancestor
64602693|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602694|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64602695|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602696|NCT00820573|Metformin|metformin|mesh-list
64602697|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64602698|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64602699|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602700|NCT00820573|Incretins|incretins|mesh-ancestor
64602701|NCT00820573|Hormones|hormones|mesh-ancestor
64602702|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602703|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64602704|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
64602705|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602706|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602707|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
64602708|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64602709|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64602710|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64602711|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602712|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602714|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602715|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602716|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64602717|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602718|NCT02010645|Decitabine|decitabine|mesh-list
64602719|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64602720|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
64602721|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602722|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602723|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602724|NCT02065479|Ticagrelor|ticagrelor|mesh-list
64602725|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64602726|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64602727|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64602728|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64602729|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64602730|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
64602731|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602732|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602733|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602734|NCT05236621|Dexamethasone|dexamethasone|mesh-list
64602735|NCT05236621|Pomalidomide|pomalidomide|mesh-list
64602736|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602737|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
64602738|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
64602739|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602740|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602741|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64602742|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
64602743|NCT05236621|Hormones|hormones|mesh-ancestor
64602744|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602745|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64602747|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
64602748|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64602749|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64602750|NCT05236621|Growth Substances|growth substances|mesh-ancestor
64602751|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
64602752|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
64602753|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64602754|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602755|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602756|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602757|NCT02066727|Analgesics|analgesics|mesh-ancestor
64602758|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
64602759|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602760|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64602761|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64602762|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64602763|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64602764|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602765|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602766|NCT04349241|Favipiravir|favipiravir|mesh-list
64602767|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
64602768|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602769|NCT02812615|Micronutrients|micronutrients|mesh-list
64602770|NCT02812615|Trace Elements|trace elements|mesh-list
64602771|NCT02812615|Albendazole|albendazole|mesh-list
64602772|NCT02812615|Pyrantel|pyrantel|mesh-list
64602773|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
64602774|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
64602775|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64602776|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602777|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
64602778|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64602779|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64602780|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
64602781|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
64602782|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
64602783|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602784|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602785|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602787|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
64602788|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64602789|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64602790|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602791|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
64602792|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
64602793|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602794|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64602795|NCT02665117|Diuretics|diuretics|mesh-ancestor
64602796|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
64602797|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602798|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64602804|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602805|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64602806|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64602807|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64602808|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602810|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64602811|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64602812|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
64602813|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602815|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64602816|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
64602819|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602820|NCT02070237|Enoxaparin|enoxaparin|mesh-list
64602821|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
64602822|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64602823|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64602824|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602825|NCT02071095|Poly I-C|poly i-c|mesh-list
64602826|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64602827|NCT02071095|Poly ICLC|poly iclc|mesh-list
64602828|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
64602829|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
64602830|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602831|NCT02071095|Laxatives|laxatives|mesh-ancestor
64602832|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64602833|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
64602834|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602835|NCT02348359|Ranibizumab|ranibizumab|mesh-list
64602836|NCT02348359|Aflibercept|aflibercept|mesh-list
64602837|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602838|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64602839|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64602840|NCT02348359|Growth Substances|growth substances|mesh-ancestor
64602841|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602842|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
64602843|NCT02406885|Apixaban|apixaban|mesh-list
64602844|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64602845|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
64602846|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64602847|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
64602848|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64602849|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602850|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
64602851|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
64602852|NCT02408445|Testosterone|testosterone|mesh-list
64602853|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
64602854|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
64602855|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64602858|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602859|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602860|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64602861|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602862|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
64602864|NCT00388921|Vitamins|vitamins|mesh-ancestor
64602865|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
64602866|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602867|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
64602868|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64602869|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64602870|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64602871|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
64602872|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602873|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602874|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602875|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
64602876|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64602877|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602878|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
64602879|NCT00142285|Astringents|astringents|mesh-ancestor
64361651|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
64602880|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602881|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
64602882|NCT02342379|Bevacizumab|bevacizumab|mesh-list
64602883|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64602884|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602885|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64602886|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64602887|NCT02342379|Growth Substances|growth substances|mesh-ancestor
64602888|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602889|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
64602892|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64602894|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602895|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602896|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
64602897|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64602898|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602899|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
64602900|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602908|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602909|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64602910|NCT00821821|Protective Agents|protective agents|mesh-ancestor
64602911|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602912|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
64602913|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64602914|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64602915|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64602916|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64602917|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602918|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
64602919|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602920|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602921|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64602922|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602923|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
64602924|NCT02410707|Propofol|propofol|mesh-list
64602925|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64602926|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64602927|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602928|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64602929|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
64602930|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
64602931|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64602932|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64602933|NCT02410707|Analgesics|analgesics|mesh-ancestor
64328324|NCT02403687|Topiramate|topiramate|mesh-list
64602934|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
64602935|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602936|NCT02343081|Temozolomide|temozolomide|mesh-list
64602937|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64602938|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
64602939|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602940|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602941|NCT00823303|Calcitriol|calcitriol|mesh-list
64602942|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64602943|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602944|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64602946|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602947|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64602948|NCT00823303|Vitamins|vitamins|mesh-ancestor
64602949|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
64602953|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602954|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
64602955|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602956|NCT04994431|Tamsulosin|tamsulosin|mesh-list
64602957|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64602958|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64430028|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
64602959|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64602960|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
64602961|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64602962|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602963|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602964|NCT04994431|Urological Agents|urological agents|mesh-ancestor
64602965|NCT00825565|Allantoin|allantoin|mesh-list
64602966|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
64602967|NCT00803647|Leucovorin|leucovorin|mesh-list
64602968|NCT00803647|Fluorouracil|fluorouracil|mesh-list
64602969|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
64602970|NCT00803647|Cetuximab|cetuximab|mesh-list
64602971|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
64602972|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64602973|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64602974|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64602975|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64602976|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
64602977|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602978|NCT00803647|Antidotes|antidotes|mesh-ancestor
64602979|NCT00803647|Protective Agents|protective agents|mesh-ancestor
64602980|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
64602981|NCT00803647|Vitamins|vitamins|mesh-ancestor
64602982|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
64602983|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64602984|NCT00827983|Progesterone|progesterone|mesh-list
64602985|NCT00827983|Progestins|progestins|mesh-ancestor
64602986|NCT00827983|Hormones|hormones|mesh-ancestor
64602987|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64602988|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602989|NCT02346903|Capsaicin|capsaicin|mesh-list
64602990|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
64602991|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
64602992|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
64602993|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602994|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64602995|NCT02347605|Nicotine|nicotine|mesh-list
64602996|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64602997|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
64602998|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64602999|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603000|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64603004|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603005|NCT02153671|Vaccines|vaccines|mesh-list
64603006|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
64603007|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603008|NCT02413203|Celecoxib|celecoxib|mesh-list
64603009|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64603010|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603011|NCT02413203|Analgesics|analgesics|mesh-ancestor
64603012|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
64603013|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603014|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603015|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603016|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603017|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64603018|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64603019|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603020|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603022|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
64603023|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603024|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
64603025|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
64603026|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
64603027|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603029|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
64603030|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64603031|NCT02348775|Glycine|glycine|mesh-list
64603032|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
64603033|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603034|NCT02348775|Expectorants|expectorants|mesh-ancestor
64603035|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
64603036|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64603037|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
64603038|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603039|NCT02348775|Protective Agents|protective agents|mesh-ancestor
64603040|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603041|NCT02348775|Antidotes|antidotes|mesh-ancestor
64603042|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
64603043|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603044|NCT00828061|Prednisone|prednisone|mesh-list
64603045|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603046|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
64603047|NCT00828061|Hormones|hormones|mesh-ancestor
64603048|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603049|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603050|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64603051|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603052|NCT00849121|Vaccines|vaccines|mesh-list
64603053|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
64603054|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603055|NCT02023125|Esomeprazole|esomeprazole|mesh-list
64603056|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64603057|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64603058|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64603064|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603065|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603066|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
64603067|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64603068|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64603069|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603070|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603071|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64603072|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64603073|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603074|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603075|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
64603076|NCT00828295|Palonosetron|palonosetron|mesh-list
64603077|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
64603078|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
64603079|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603080|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603081|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64603082|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64328454|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
64603083|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64603084|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
64603085|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603086|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603087|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
64603088|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64603089|NCT02350569|Ledipasvir|ledipasvir|mesh-list
64603090|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
64603091|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603092|NCT02351037|Azacitidine|azacitidine|mesh-list
64603093|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64603094|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
64603095|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603096|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603097|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603099|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361707|NCT02487823|Buserelin|buserelin|mesh-list
64603100|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603101|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603102|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64603103|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64603104|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603105|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
64603106|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
64603107|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603110|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64603111|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64603112|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64603113|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603114|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603115|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
64603116|NCT00242567|Androgens|androgens|mesh-list
64603117|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64603118|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603119|NCT00242567|Hormones|hormones|mesh-ancestor
64603120|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603121|NCT00241631|Fluticasone|fluticasone|mesh-list
64603123|NCT00241631|Theophylline|theophylline|mesh-list
64603124|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603125|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64603126|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
64603127|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603128|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603129|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64603130|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
64603131|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64603132|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64603133|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64603134|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603135|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603136|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
64603137|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64603138|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64603139|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
64603140|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603141|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
64603142|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
64603143|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64603144|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603145|NCT00240071|Tamoxifen|tamoxifen|mesh-list
64603146|NCT00240071|Bevacizumab|bevacizumab|mesh-list
64603147|NCT00240071|Letrozole|letrozole|mesh-list
64603148|NCT00240071|Exemestane|exemestane|mesh-list
64603149|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64603150|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603151|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64603152|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64603153|NCT00240071|Growth Substances|growth substances|mesh-ancestor
64603154|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603155|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
64603156|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64603157|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64603158|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603159|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603160|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64603161|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
64603162|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603163|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64603164|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64603165|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64603166|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64361723|NCT04493125|Mosapride|mosapride|mesh-list
64603171|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603172|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603173|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603174|NCT00765947|Amlodipine|amlodipine|mesh-list
64603175|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64603176|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64603177|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64603178|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64603179|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603180|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64603181|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603182|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
64603187|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64603188|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603189|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64603190|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603191|NCT00766649|Sirolimus|sirolimus|mesh-list
64603192|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64603193|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603194|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64603195|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603196|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
64603197|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64603198|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
64603199|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603200|NCT02352831|Capecitabine|capecitabine|mesh-list
64603201|NCT02352831|Tosedostat|tosedostat|mesh-list
64603202|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64603203|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
64603204|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603205|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603206|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603207|NCT02353299|Zolpidem|zolpidem|mesh-list
64603208|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64603209|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64603210|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603211|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603212|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64603213|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
64603214|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
64603215|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603216|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603217|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64603218|NCT00756977|Laxatives|laxatives|mesh-ancestor
64603219|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64603220|NCT03808961|Vitamins|vitamins|mesh-list
64603221|NCT03808961|Niacin|niacin|mesh-list
64603222|NCT03808961|Niacinamide|niacinamide|mesh-list
64603223|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
64603225|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
64603226|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603227|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64603228|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
64382262|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64603231|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
64603232|NCT00783965|Tazarotene|tazarotene|mesh-list
64603233|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
64328599|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
64603234|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
64603235|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
64603236|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64603237|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603238|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603239|NCT00421551|Ritonavir|ritonavir|mesh-list
64603240|NCT00421551|Darunavir|darunavir|mesh-list
64603241|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64603242|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64603243|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
64603244|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603245|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603247|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64603248|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
64603249|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603250|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64603251|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64603252|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
64603253|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64603254|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
64603255|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603256|NCT00767507|Cangrelor|cangrelor|mesh-list
64603257|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64603258|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64603259|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64603260|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64603261|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
64603262|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603263|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603264|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603265|NCT02029755|Anesthetics|anesthetics|mesh-list
64603266|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
64603267|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603268|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603269|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
64603270|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603272|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
64603273|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
64603274|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64603275|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603276|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603277|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64603278|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64603279|NCT02312739|Ketorolac|ketorolac|mesh-list
64603280|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64603281|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
64603282|NCT02312739|Analgesics|analgesics|mesh-list
64603283|NCT02312739|Lorazepam|lorazepam|mesh-list
64603284|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64603285|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603286|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
64603287|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603288|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603289|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603290|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603291|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64603292|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603293|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603294|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64603295|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
64603296|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
64603297|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603298|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
64603299|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
64603300|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
64603302|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64603303|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64603304|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64603305|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603306|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
64603307|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
64603308|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603309|NCT05718609|Amoxicillin|amoxicillin|mesh-list
64603310|NCT05718609|Clarithromycin|clarithromycin|mesh-list
64603311|NCT05718609|Furazolidone|furazolidone|mesh-list
64603312|NCT05718609|Rabeprazole|rabeprazole|mesh-list
64603313|NCT05718609|Bismuth|bismuth|mesh-list
64603314|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64603315|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603316|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64603317|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603318|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603319|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64603320|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64603321|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64603322|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64603323|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64603324|NCT05718609|Antacids|antacids|mesh-ancestor
64603325|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64603326|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64603327|NCT05718609|Renal Agents|renal agents|mesh-ancestor
64603328|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
64603329|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64603330|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64603331|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64603332|NCT02359305|Acetaminophen|acetaminophen|mesh-list
64603333|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603334|NCT02359305|Analgesics|analgesics|mesh-ancestor
64603335|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
64603336|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603337|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603338|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
64603339|NCT02360319|Aripiprazole|aripiprazole|mesh-list
64603340|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
64603341|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
64603342|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603343|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64603344|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603345|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603346|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
64603351|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64603352|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
64603353|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64603354|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64603355|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64603356|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64603358|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
64603359|NCT05718531|Clopidogrel|clopidogrel|mesh-list
64603360|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64603361|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603362|NCT05718531|Analgesics|analgesics|mesh-ancestor
64603363|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
64603364|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603365|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603366|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603367|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603368|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64603369|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64603370|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603371|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64603372|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64603373|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603375|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64603376|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64603377|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64603378|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
64603379|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603380|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64603381|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
64328747|NCT02184299|Nevirapine|nevirapine|mesh-list
64603382|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64603383|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
64603384|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
64603385|NCT02360631|Varenicline|varenicline|mesh-list
64603386|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64603387|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64603388|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
64603389|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603390|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603391|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603392|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
64603393|NCT00355095|Hematinics|hematinics|mesh-ancestor
64603394|NCT02366871|Enoxaparin|enoxaparin|mesh-list
64603395|NCT02366871|Apixaban|apixaban|mesh-list
64603396|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
64603397|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64603398|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64603399|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603400|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64603401|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
64603402|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64603403|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
64603404|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603406|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
64603407|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64603408|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64603409|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603412|NCT03836651|Antioxidants|antioxidants|mesh-list
64603413|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603414|NCT03836651|Protective Agents|protective agents|mesh-ancestor
64603415|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603416|NCT02037555|Antithrombins|antithrombins|mesh-list
64603417|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
64603418|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64603419|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
64603420|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603421|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603422|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
64603423|NCT03804359|Rituximab|rituximab|mesh-list
64603424|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64603425|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603426|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
64603427|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603428|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603429|NCT02369211|Acetaminophen|acetaminophen|mesh-list
64603430|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603431|NCT02369211|Analgesics|analgesics|mesh-ancestor
64603432|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
64603433|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603434|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603435|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
64603439|NCT02038023|Trace Elements|trace elements|mesh-ancestor
64603440|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
64603441|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603442|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
64603443|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
64603444|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
64603445|NCT02038023|Hematinics|hematinics|mesh-ancestor
64603446|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
64603447|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64603448|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
64603449|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603450|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603451|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64603452|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
64603453|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64603454|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
64603455|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603456|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603457|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64603458|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
64603459|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
64328816|NCT02184533|Trace Elements|trace elements|mesh-ancestor
64603460|NCT04384133|Protective Agents|protective agents|mesh-ancestor
64603461|NCT02038179|Allopurinol|allopurinol|mesh-list
64603462|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
64603463|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603464|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603465|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
64603466|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603467|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64603468|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
64603469|NCT02038179|Protective Agents|protective agents|mesh-ancestor
64603471|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64603473|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64603474|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
64603475|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603476|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64603477|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64603478|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64603480|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603481|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603482|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603483|NCT00768521|Urological Agents|urological agents|mesh-ancestor
64603485|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
64603486|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603487|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64603488|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64603489|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603490|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603491|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64603492|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
64603493|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603494|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603495|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
64603496|NCT02370693|Bortezomib|bortezomib|mesh-list
64603499|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64603500|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
64603501|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64603502|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603503|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603504|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603505|NCT02039115|Prednisone|prednisone|mesh-list
64603506|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603507|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
64603508|NCT02039115|Hormones|hormones|mesh-ancestor
64603509|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603510|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603511|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64603512|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603513|NCT00759473|Cycloserine|cycloserine|mesh-list
64603514|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64603515|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603516|NCT00759473|Renal Agents|renal agents|mesh-ancestor
64603517|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64603518|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
64603519|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64603520|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
64603521|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603522|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64603523|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603524|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603525|NCT03809273|Trimetazidine|trimetazidine|mesh-list
64603526|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
64603527|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64603528|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64603529|NCT00354627|Etravirine|etravirine|mesh-list
64603530|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64603531|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64603533|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603534|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
64603535|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64328890|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603536|NCT00770861|Nebivolol|nebivolol|mesh-list
64603537|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64603539|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64603540|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64603541|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64603542|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
64603543|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603544|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603545|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603546|NCT03808805|Aprepitant|aprepitant|mesh-list
64603547|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
64603548|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
64603549|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
64603550|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
64603551|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603552|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603553|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64603554|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64603555|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382263|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
64603556|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603558|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
64603559|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64603560|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
64603561|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
64603562|NCT03803267|Fentanyl|fentanyl|mesh-list
64603563|NCT03803267|Propofol|propofol|mesh-list
64603564|NCT03803267|Atracurium|atracurium|mesh-list
64603565|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
64603566|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603567|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603568|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64603569|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64603570|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
64603571|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64603572|NCT03803267|Narcotics|narcotics|mesh-ancestor
64603573|NCT03803267|Analgesics|analgesics|mesh-ancestor
64603574|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
64603575|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603576|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64603577|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64603578|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64603579|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64603580|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64603581|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64603582|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
64603583|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603584|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603585|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64603586|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
64603587|NCT03808649|Mannitol|mannitol|mesh-list
64603588|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64603589|NCT03808649|Diuretics|diuretics|mesh-ancestor
64603590|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
64603591|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603592|NCT00788255|Oxytocin|oxytocin|mesh-list
64603593|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
64603594|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64603595|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603596|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64603597|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
64603598|NCT02379195|Fludarabine|fludarabine|mesh-list
64603599|NCT02379195|Interleukin-2|interleukin-2|mesh-list
64603600|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64603601|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
64603602|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603603|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603604|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64603605|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
64603606|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603607|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603608|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64603609|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64328963|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64328964|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
64603611|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
64603612|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603613|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
64603614|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603615|NCT00771875|Acetaminophen|acetaminophen|mesh-list
64603616|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
64603617|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
64603619|NCT00771875|Bortezomib|bortezomib|mesh-list
64603620|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
64603626|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
64603627|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603628|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603629|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603631|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
64603632|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603633|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
64603634|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603635|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
64603636|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
64603637|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64603638|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
64603640|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603641|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64603642|NCT00771875|Protective Agents|protective agents|mesh-ancestor
64603643|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64603644|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64603645|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64603646|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603647|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
64603648|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
64603649|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
64603650|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603651|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603652|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64603653|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64603654|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64603655|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603656|NCT00760019|Analgesics|analgesics|mesh-ancestor
64603657|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
64603658|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603659|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603660|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603661|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603662|NCT00789113|Lamotrigine|lamotrigine|mesh-list
64603663|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
64603664|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64603665|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64603666|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603667|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64603668|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603669|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64603670|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64603671|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361834|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64603672|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603673|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64603675|NCT03808259|Esketamine|esketamine|mesh-list
64603676|NCT03808259|Analgesics|analgesics|mesh-ancestor
64603677|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
64603678|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603679|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603680|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64603681|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64603682|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
64603683|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
64603684|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64329041|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
64603685|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64603686|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64603687|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603688|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603689|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
64603690|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603691|NCT02051595|Vancomycin|vancomycin|mesh-list
64603692|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64603693|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603694|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64603695|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
64603696|NCT05742503|Etonogestrel|etonogestrel|mesh-list
64603697|NCT05742503|Norgestrel|norgestrel|mesh-list
64603698|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64603699|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
64603700|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64603701|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603702|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64603703|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64603704|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64603705|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64603706|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64603707|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603708|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64603709|NCT02388321|Fentanyl|fentanyl|mesh-list
64603710|NCT02388321|Ketamine|ketamine|mesh-list
64603711|NCT02388321|Analgesics|analgesics|mesh-ancestor
64603712|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
64603713|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603714|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603715|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64603716|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64603717|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
64603718|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
64603719|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603720|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64603721|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64603726|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64603727|NCT05742425|Bevacizumab|bevacizumab|mesh-list
64603728|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64603729|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603730|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64603731|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64603732|NCT05742425|Growth Substances|growth substances|mesh-ancestor
64603733|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603734|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
64603735|NCT02313675|Acetaminophen|acetaminophen|mesh-list
64603736|NCT02313675|Ketorolac|ketorolac|mesh-list
64603737|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64603738|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64603739|NCT02313675|Analgesics|analgesics|mesh-ancestor
64603740|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
64603741|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603742|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603743|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
64603744|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64603745|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603746|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603747|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64603748|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603749|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603750|NCT05568797|Vaccines|vaccines|mesh-list
64603751|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
64603752|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603753|NCT03801629|Morphine|morphine|mesh-list
64603754|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64603755|NCT03801629|Narcotics|narcotics|mesh-ancestor
64603756|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603757|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603758|NCT03801629|Analgesics|analgesics|mesh-ancestor
64603759|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
64603760|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603761|NCT05741021|Paclitaxel|paclitaxel|mesh-list
64603762|NCT05741021|Carboplatin|carboplatin|mesh-list
64603763|NCT05741021|Pemetrexed|pemetrexed|mesh-list
64603764|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64603765|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603766|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
64603767|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
64603768|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
64603769|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603770|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603771|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64603772|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64603773|NCT04383977|Etoposide|etoposide|mesh-list
64603774|NCT04383977|Apatinib|apatinib|mesh-list
64603775|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64603778|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64603779|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603780|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603781|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64603782|NCT02389959|Bevacizumab|bevacizumab|mesh-list
64603783|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64603784|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603785|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64603786|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64603787|NCT02389959|Growth Substances|growth substances|mesh-ancestor
64603788|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603789|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
64603790|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
64603791|NCT00775931|Busulfan|busulfan|mesh-list
64603792|NCT00775931|Fludarabine|fludarabine|mesh-list
64603793|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
64603794|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
64603795|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64603796|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
64603797|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603798|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603799|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64603800|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
64603801|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603802|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603803|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64603804|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64603805|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
64603806|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64603807|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64603808|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64603809|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64603810|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
64603811|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603812|NCT05734235|Vitamins|vitamins|mesh-list
64603813|NCT05734235|Vitamin E|vitamin e|mesh-list
64603814|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
64603815|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603816|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
64603817|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603818|NCT05734235|Protective Agents|protective agents|mesh-ancestor
64603819|NCT05732129|Irinotecan|irinotecan|mesh-list
64603833|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603835|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64329198|NCT02285101|BCT-100|bct-100|mesh-list
64603836|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64603837|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603838|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64603839|NCT03838367|Leronlimab|leronlimab|mesh-list
64603840|NCT03838367|Carboplatin|carboplatin|mesh-list
64603841|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
64603842|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603843|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64603845|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603847|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64603848|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
64603849|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603850|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
64603851|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603852|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
64603853|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64603854|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
64603855|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603856|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
64603857|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64603858|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64603859|NCT04345445|Prednisolone|prednisolone|mesh-list
64603860|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
64603861|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64603862|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
64603863|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64603864|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
64603865|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
64603866|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603867|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603868|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64603869|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
64603870|NCT04345445|Hormones|hormones|mesh-ancestor
64603871|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603872|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64603873|NCT04345445|Protective Agents|protective agents|mesh-ancestor
64603874|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64603875|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603876|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
64603877|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64603878|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603879|NCT05713877|Melatonin|melatonin|mesh-list
64603880|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
64603881|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603882|NCT05713877|Protective Agents|protective agents|mesh-ancestor
64603883|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603884|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603885|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64603886|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64603887|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603888|NCT00795275|Incretins|incretins|mesh-ancestor
64603889|NCT00795275|Hormones|hormones|mesh-ancestor
64603890|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603891|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64603892|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
64603893|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603894|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603895|NCT00777335|Panobinostat|panobinostat|mesh-list
64603896|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603897|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64603898|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603899|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603900|NCT04896645|Albuterol|albuterol|mesh-list
64603901|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64603904|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603905|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64603906|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
64603908|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64603909|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64603910|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64603911|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64603912|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
64603913|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64603914|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603915|NCT05644587|Buprenorphine|buprenorphine|mesh-list
64603916|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64603917|NCT05644587|Naloxone|naloxone|mesh-list
64603918|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64603919|NCT05644587|Narcotics|narcotics|mesh-ancestor
64603920|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603921|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603922|NCT05644587|Analgesics|analgesics|mesh-ancestor
64603923|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
64603924|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603925|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64603926|NCT03801863|Ropivacaine|ropivacaine|mesh-list
64603927|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
64603928|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
64603929|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64603930|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603931|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
64603932|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64603933|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
64603934|NCT00355407|Hematinics|hematinics|mesh-ancestor
64603935|NCT00355251|Atorvastatin|atorvastatin|mesh-list
64603936|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64603937|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64603938|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
64603939|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603940|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64603941|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64603942|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603943|NCT03832127|Fludarabine|fludarabine|mesh-list
64603944|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603945|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64603946|NCT04876131|Gentamicins|gentamicins|mesh-list
64603947|NCT04876131|Cephalexin|cephalexin|mesh-list
64603949|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64603950|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
64603951|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603952|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64603953|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603954|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603955|NCT04825275|Posaconazole|posaconazole|mesh-list
64603956|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
64603957|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64603958|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64603959|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64603961|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64603962|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64603963|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603964|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603965|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64603966|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
64603967|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603968|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603974|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64603975|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64603976|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603977|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64603978|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
64603979|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64603980|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603981|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64603982|NCT04818489|Colchicine|colchicine|mesh-list
64603983|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
64603984|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64603985|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64603986|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64603987|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64603988|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64603989|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64603990|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
64603991|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64603992|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
64603993|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64603994|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
64603995|NCT00797459|Protective Agents|protective agents|mesh-ancestor
64603996|NCT04807101|Midazolam|midazolam|mesh-list
64603997|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64603998|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64603999|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604000|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604001|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64604002|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64604003|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604004|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64604005|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
64604006|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
64604007|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
64604008|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
64604009|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604010|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604011|NCT00355953|Genistein|genistein|mesh-list
64604012|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64604013|NCT00355953|Protective Agents|protective agents|mesh-ancestor
64604014|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604015|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604016|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64604017|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604018|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604019|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
64604020|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64604021|NCT00355953|Estrogens|estrogens|mesh-ancestor
64604022|NCT00355953|Hormones|hormones|mesh-ancestor
64604023|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604024|NCT05419193|Propranolol|propranolol|mesh-list
64604030|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604031|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64604032|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64604033|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
64604036|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64604037|NCT05416073|Narcotics|narcotics|mesh-ancestor
64604038|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604039|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604040|NCT05416073|Analgesics|analgesics|mesh-ancestor
64604041|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
64604042|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604043|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64604044|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64604045|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
64604046|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
64604047|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
64604048|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604049|NCT05664971|Paclitaxel|paclitaxel|mesh-list
64604050|NCT05664971|Etoposide|etoposide|mesh-list
64604051|NCT05664971|Docetaxel|docetaxel|mesh-list
64604052|NCT05664971|Carboplatin|carboplatin|mesh-list
64604053|NCT05664971|Pemetrexed|pemetrexed|mesh-list
64604054|NCT05664971|Antibodies|antibodies|mesh-list
64604055|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64604056|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64604057|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604058|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
64604059|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
64604060|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
64604061|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604062|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
64604063|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604064|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64604065|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64604066|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362052|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
64604067|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64604068|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64604069|NCT05594667|Psilocybin|psilocybin|mesh-list
64604070|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
64604071|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604072|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604073|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
64604074|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604075|NCT04812509|Denosumab|denosumab|mesh-list
64604076|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64604077|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604078|NCT05446623|Sufentanil|sufentanil|mesh-list
64604079|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
64604080|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64604081|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604082|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604083|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604084|NCT05446623|Analgesics|analgesics|mesh-ancestor
64604085|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
64604086|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604087|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64604088|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64604090|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
64604091|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604092|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604093|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64604094|NCT05446623|Narcotics|narcotics|mesh-ancestor
64604095|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64604096|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64604097|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
64604098|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
64604099|NCT00792077|Lenalidomide|lenalidomide|mesh-list
64604100|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
64604101|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604102|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64604103|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64604104|NCT00792077|Growth Substances|growth substances|mesh-ancestor
64604105|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
64604106|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604107|NCT04647435|Tramadol|tramadol|mesh-list
64604108|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64604109|NCT04647435|Narcotics|narcotics|mesh-ancestor
64604110|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604111|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604112|NCT04647435|Analgesics|analgesics|mesh-ancestor
64604113|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
64604114|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604115|NCT04637529|Ibuprofen|ibuprofen|mesh-list
64604116|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604117|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604118|NCT04637529|Analgesics|analgesics|mesh-ancestor
64604119|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
64604120|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604121|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604122|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604123|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604124|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64604125|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604126|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604127|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64604128|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
64604129|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604130|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604131|NCT00799643|Analgesics|analgesics|mesh-ancestor
64604132|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
64604133|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604134|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604135|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604136|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604137|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64604139|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604141|NCT03835013|Glucagon|glucagon|mesh-list
64604142|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64604143|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64604144|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604145|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64604146|NCT03835013|Incretins|incretins|mesh-ancestor
64604147|NCT03835013|Hormones|hormones|mesh-ancestor
64604148|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604149|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604150|NCT05555823|Repaglinide|repaglinide|mesh-list
64604151|NCT05555823|Celecoxib|celecoxib|mesh-list
64604152|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604153|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604154|NCT05555823|Analgesics|analgesics|mesh-ancestor
64604155|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
64604156|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604157|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604158|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604159|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604160|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64604161|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64604162|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604163|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604164|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64604165|NCT00800345|Topotecan|topotecan|mesh-list
64604166|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64604167|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64604168|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604169|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604170|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604171|NCT03806751|Acetazolamide|acetazolamide|mesh-list
64604172|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
64604173|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64604174|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604175|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604176|NCT03806751|Diuretics|diuretics|mesh-ancestor
64604177|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
64604178|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604180|NCT04383275|Trastuzumab|trastuzumab|mesh-list
64604181|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604182|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
64604183|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604184|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604185|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604186|NCT03973229|Estradiol|estradiol|mesh-list
64604187|NCT03973229|Estrogens|estrogens|mesh-ancestor
64604199|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
64604201|NCT05319015|Lenvatinib|lenvatinib|mesh-list
64604202|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604203|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604204|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64604205|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604206|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604207|NCT00810719|Gemcitabine|gemcitabine|mesh-list
64604208|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64604209|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604210|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
64604211|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604212|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604214|NCT00810719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604216|NCT00810719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604217|NCT00810719|Immunologic Factors|immunologic factors|mesh-ancestor
64604218|NCT00810719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604219|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64604220|NCT03761277|Morphine|morphine|mesh-list
64604221|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64604222|NCT03761277|Narcotics|narcotics|mesh-ancestor
64604223|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604224|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604226|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
64604227|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604228|NCT00810797|Exemestane|exemestane|mesh-list
64604229|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604230|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64604231|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64604232|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604233|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604234|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64604235|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
64604236|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604237|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604238|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64604239|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604240|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
64604241|NCT04340505|Hormones|hormones|mesh-ancestor
64604242|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604243|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604244|NCT04724447|Valganciclovir|valganciclovir|mesh-list
64604245|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
64604246|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604247|NCT04693715|RNS60|rns60|mesh-list
64604248|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604249|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604250|NCT04693715|Analgesics|analgesics|mesh-ancestor
64604251|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
64604252|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604253|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604254|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604255|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604256|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64604257|NCT00355641|Ropinirole|ropinirole|mesh-list
64604258|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64604259|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64604260|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
64604261|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
64604262|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604263|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604264|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604265|NCT05268237|Liraglutide|liraglutide|mesh-list
64604266|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64604267|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604268|NCT05268237|Incretins|incretins|mesh-ancestor
64604269|NCT05268237|Hormones|hormones|mesh-ancestor
64604270|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604271|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
64604272|NCT00356733|Hematinics|hematinics|mesh-ancestor
64604273|NCT04591925|Insulin|insulin|mesh-list
64604274|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64604275|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64604276|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604277|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64604278|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64604284|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604285|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604286|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
64604287|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604288|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604289|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64604290|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604292|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64604293|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64604294|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
64604295|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64416789|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604296|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604297|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604298|NCT04112823|Dexamethasone|dexamethasone|mesh-list
64604299|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
64604300|NCT04112823|BB 1101|bb 1101|mesh-list
64604301|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604302|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
64604303|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
64604304|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604305|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604306|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604307|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
64604308|NCT04112823|Hormones|hormones|mesh-ancestor
64604309|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604310|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64604311|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604312|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
64604313|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604314|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604315|NCT00802685|Ibuprofen|ibuprofen|mesh-list
64604316|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604317|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604318|NCT00802685|Analgesics|analgesics|mesh-ancestor
64604319|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
64604320|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604321|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604322|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604323|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604324|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64604325|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604326|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604327|NCT03496623|Treprostinil|treprostinil|mesh-list
64604328|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64604329|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64604330|NCT00802919|Varenicline|varenicline|mesh-list
64604331|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64604332|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64604333|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
64604334|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604335|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604336|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604337|NCT04467905|Etripamil|etripamil|mesh-list
64604338|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64362249|NCT05245227|Oxytocin|oxytocin|mesh-list
64604339|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604345|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604347|NCT04099641|Bavituximab|bavituximab|mesh-list
64604348|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604349|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604350|NCT05051735|Acetaminophen|acetaminophen|mesh-list
64604351|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604352|NCT05051735|Analgesics|analgesics|mesh-ancestor
64604353|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
64604354|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604355|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604356|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
64604357|NCT04098237|Pancrelipase|pancrelipase|mesh-list
64604358|NCT04098237|Pancreatin|pancreatin|mesh-list
64604359|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604360|NCT04095221|Irinotecan|irinotecan|mesh-list
64604361|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64604362|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64604363|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604364|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604365|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604366|NCT04045431|Hylan|hylan|mesh-list
64604367|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
64604368|NCT04045431|Protective Agents|protective agents|mesh-ancestor
64604369|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604370|NCT03357627|Venetoclax|venetoclax|mesh-list
64604371|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604372|NCT03713645|Tacrolimus|tacrolimus|mesh-list
64604373|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604374|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
64604375|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604376|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64604377|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604378|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604379|NCT03932409|Paclitaxel|paclitaxel|mesh-list
64604380|NCT03932409|Carboplatin|carboplatin|mesh-list
64604381|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
64604382|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64604383|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604384|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
64604385|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
64604386|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
64604387|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604388|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604389|NCT04923113|Amoxicillin|amoxicillin|mesh-list
64604390|NCT04923113|Minocycline|minocycline|mesh-list
64604391|NCT04923113|Rabeprazole|rabeprazole|mesh-list
64604392|NCT04923113|Bismuth|bismuth|mesh-list
64604393|NCT04923113|Antibodies|antibodies|mesh-list
64604394|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
64604395|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604408|NCT03250923|Acemannan|acemannan|mesh-list
64604409|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64604410|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
64604411|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604412|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604413|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
64604414|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604417|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
64604418|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64604419|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64604420|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604421|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604422|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604423|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64604424|NCT00805493|Protective Agents|protective agents|mesh-ancestor
64604425|NCT03236649|Sorafenib|sorafenib|mesh-list
64604426|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604427|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64604428|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604429|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604430|NCT00807209|Fentanyl|fentanyl|mesh-list
64604431|NCT00807209|Bupivacaine|bupivacaine|mesh-list
64604433|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
64604434|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604435|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604436|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
64604437|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604438|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64604440|NCT00807209|Analgesics|analgesics|mesh-ancestor
64604441|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64604442|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64604443|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
64604444|NCT03220035|Vemurafenib|vemurafenib|mesh-list
64604445|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604446|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64604447|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604448|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604449|NCT00807989|Lamotrigine|lamotrigine|mesh-list
64604450|NCT00807989|Carbamazepine|carbamazepine|mesh-list
64604451|NCT00807989|Valproic Acid|valproic acid|mesh-list
64604452|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
64604453|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64604454|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604455|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604456|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64604457|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604458|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64604459|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64604460|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604461|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604462|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64604463|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604464|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
64604465|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604466|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
64604467|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604468|NCT00807989|Analgesics|analgesics|mesh-ancestor
64604474|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
64604475|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64604476|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64604477|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
64604478|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604479|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64604480|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64604481|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604482|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604484|NCT04845490|Mitomycin|mitomycin|mesh-list
64604485|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64604486|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604487|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
64604488|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604489|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64604490|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604491|NCT00357045|Paroxetine|paroxetine|mesh-list
64604492|NCT00357045|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64604493|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64604494|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604495|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604496|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604497|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
64604498|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604499|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64604500|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
64296657|NCT04786340|Pirenzepine|pirenzepine|mesh-list
64604501|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604502|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64604503|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64604504|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604505|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
64604506|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64604507|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64604508|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604509|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604510|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64604511|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604512|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604513|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
64604514|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604515|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64604516|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64604517|NCT04819360|Urological Agents|urological agents|mesh-ancestor
64604518|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64604519|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64604520|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64604521|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
64604522|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604523|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64604524|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64604525|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604527|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
64604528|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64604529|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
64604530|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64604531|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604532|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
64604533|NCT03834753|Bevacizumab|bevacizumab|mesh-list
64604534|NCT03834753|Ranibizumab|ranibizumab|mesh-list
64604535|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604536|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604537|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64604538|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64604539|NCT03834753|Growth Substances|growth substances|mesh-ancestor
64604540|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604541|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
64604542|NCT00845039|Irinotecan|irinotecan|mesh-list
64604543|NCT00845039|Cetuximab|cetuximab|mesh-list
64604544|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64604545|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64604546|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64604547|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604548|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604549|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604550|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604551|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
64604552|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604553|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64604555|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604556|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604557|NCT00845195|Analgesics|analgesics|mesh-ancestor
64604558|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
64604559|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604560|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604561|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604562|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604563|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64604564|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64604565|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64604566|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
64604567|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
64604568|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604569|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604571|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
64604572|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64604573|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
64604574|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64604575|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604576|NCT00845507|Exenatide|exenatide|mesh-list
64604577|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64604578|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604579|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64604580|NCT00845507|Incretins|incretins|mesh-ancestor
64604581|NCT00845507|Hormones|hormones|mesh-ancestor
64604582|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604583|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
64604584|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604585|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604586|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
64604587|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604588|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
64604589|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604590|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604591|NCT03500380|Capecitabine|capecitabine|mesh-list
64604592|NCT03500380|Lapatinib|lapatinib|mesh-list
64604593|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604594|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
64604595|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604596|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604597|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64604598|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604599|NCT00534430|Cyclosporine|cyclosporine|mesh-list
64604600|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
64604601|NCT00534430|Etoposide|etoposide|mesh-list
64604602|NCT00534430|Busulfan|busulfan|mesh-list
64604603|NCT00534430|Cyclosporins|cyclosporins|mesh-list
64604604|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64604605|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604606|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64604607|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64604609|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604610|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604611|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
64604612|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604613|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
64604614|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604615|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
64604616|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604617|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64604618|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64604619|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64362342|NCT05196945|Diuretics|diuretics|mesh-ancestor
64604620|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
64604621|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64604622|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
64604623|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64604624|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64604625|NCT03092895|Apatinib|apatinib|mesh-list
64604626|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604627|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64604628|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604629|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604630|NCT03839771|Ivosidenib|ivosidenib|mesh-list
64604631|NCT03839771|Glycine|glycine|mesh-list
64604632|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604633|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604634|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604635|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
64604636|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604637|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604638|NCT03033225|Verteporfin|verteporfin|mesh-list
64604639|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64604640|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
64604641|NCT02593396|Bupropion|bupropion|mesh-list
64604642|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64604643|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
64604644|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604645|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64604646|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64604647|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604648|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604649|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
64604650|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604651|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604652|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64604653|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64604654|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604655|NCT00848783|Capecitabine|capecitabine|mesh-list
64604656|NCT00848783|Irinotecan|irinotecan|mesh-list
64604657|NCT00848783|Floxuridine|floxuridine|mesh-list
64604658|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604659|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604660|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
64604661|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604662|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64604663|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64604664|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604666|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604667|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
64604668|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604669|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604670|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
64604671|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604672|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604673|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
64604674|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604675|NCT00849251|Dexamethasone|dexamethasone|mesh-list
64604676|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
64604677|NCT00849251|Doxorubicin|doxorubicin|mesh-list
64604678|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64604679|NCT00849251|Bortezomib|bortezomib|mesh-list
64604680|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604681|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
64604683|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604684|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64604685|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
64604686|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604687|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604688|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64604689|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604690|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
64604691|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
64604692|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604693|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604694|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
64604695|NCT00849251|Hormones|hormones|mesh-ancestor
64604696|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604697|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64604698|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64604699|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64604700|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64604701|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604702|NCT05323396|Metronidazole|metronidazole|mesh-list
64604703|NCT05323396|Albendazole|albendazole|mesh-list
64604704|NCT05323396|Praziquantel|praziquantel|mesh-list
64604705|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
64604710|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
64604711|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64604712|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
64604713|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
64604714|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
64604715|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604716|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604717|NCT00850889|Lidocaine|lidocaine|mesh-list
64604718|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
64604719|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
64604720|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
64604721|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604722|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604723|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
64604724|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604725|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64604726|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64604727|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64604728|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604729|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604730|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64604731|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
64604732|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
64604733|NCT00850889|Protective Agents|protective agents|mesh-ancestor
64604734|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
64604735|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64604736|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604737|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
64604738|NCT00851357|Nicotine|nicotine|mesh-list
64604739|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64604740|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
64604741|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604742|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604743|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64604744|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64604745|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
64604746|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604747|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604748|NCT05105074|Morphine|morphine|mesh-list
64604749|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64604750|NCT05105074|Narcotics|narcotics|mesh-ancestor
64604751|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604752|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604753|NCT05105074|Analgesics|analgesics|mesh-ancestor
64604754|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
64604755|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604756|NCT04932382|Misoprostol|misoprostol|mesh-list
64604757|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64604758|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
64604759|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64604760|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604761|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64604762|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64604763|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
64604764|NCT04882774|Treprostinil|treprostinil|mesh-list
64604765|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64604766|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64604767|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604769|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64604770|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604771|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64604772|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64604773|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604774|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604775|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
64604776|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604777|NCT00852761|Clobetasol|clobetasol|mesh-list
64604778|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604779|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
64604780|NCT00852761|Hormones|hormones|mesh-ancestor
64604781|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64604782|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604783|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
64604784|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
64604785|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64604786|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
64604787|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604788|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604789|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64604790|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
64604791|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64604792|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
64604793|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604794|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604795|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64604796|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
64604797|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
64604802|NCT04223765|Fludarabine|fludarabine|mesh-list
64604803|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604804|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
64604805|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604806|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604807|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64604808|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
64604809|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604810|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604811|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64604812|NCT04082806|Trazodone|trazodone|mesh-list
64604813|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64604814|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64604815|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604816|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604817|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604818|NCT04082806|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64604819|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64604820|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64604821|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604822|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604823|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
64604824|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64604825|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
64604826|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64604827|NCT05635786|Tenecteplase|tenecteplase|mesh-list
64604828|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64604829|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64604830|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604831|NCT00365950|Warfarin|warfarin|mesh-list
64604832|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
64604833|NCT02487797|Oxytocin|oxytocin|mesh-list
64604834|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
64604835|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64604836|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604837|NCT01733693|Buprenorphine|buprenorphine|mesh-list
64604838|NCT01733693|Methadone|methadone|mesh-list
64604839|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64604840|NCT01733693|Narcotics|narcotics|mesh-ancestor
64604841|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604842|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604843|NCT01733693|Analgesics|analgesics|mesh-ancestor
64604844|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
64604845|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604846|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64604847|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
64604848|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
64604849|NCT00855413|Ritonavir|ritonavir|mesh-list
64604850|NCT00855413|Darunavir|darunavir|mesh-list
64604851|NCT00855413|Etravirine|etravirine|mesh-list
64604852|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64604853|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64604854|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
64604855|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604856|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604857|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64604858|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64604860|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604861|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64604862|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64604863|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64604864|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64604865|NCT05599984|Carboplatin|carboplatin|mesh-list
64604866|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604867|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
64604868|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64604869|NCT00366262|Naproxen|naproxen|mesh-list
64604870|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604871|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604872|NCT00366262|Analgesics|analgesics|mesh-ancestor
64604873|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
64604874|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604875|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604876|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604877|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64604878|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
64604879|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64604880|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604881|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604882|NCT00818363|Bupivacaine|bupivacaine|mesh-list
64604883|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
64604884|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
64604885|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604886|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604887|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
64604888|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604889|NCT00828841|Gemcitabine|gemcitabine|mesh-list
64604890|NCT00828841|Paclitaxel|paclitaxel|mesh-list
64604891|NCT00828841|Carboplatin|carboplatin|mesh-list
64604892|NCT00828841|Cetuximab|cetuximab|mesh-list
64604893|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64604894|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604896|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
64604897|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
64604898|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604899|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604900|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
64604901|NCT00828841|Antiviral Agents|antiviral agents|mesh-ancestor
64604902|NCT00828841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604903|NCT00828841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604904|NCT00828841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604905|NCT00828841|Immunologic Factors|immunologic factors|mesh-ancestor
64604906|NCT00828841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604907|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64604909|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64604910|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604912|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
64604913|NCT00821795|Protamines|protamines|mesh-list
64604914|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64604915|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604916|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
64604917|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604918|NCT00821795|Coagulants|coagulants|mesh-ancestor
64604919|NCT00833365|Ibuprofen|ibuprofen|mesh-list
64604920|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64604921|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604922|NCT00833365|Analgesics|analgesics|mesh-ancestor
64604923|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
64604924|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604925|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604926|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64604928|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64604929|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604930|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604932|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604933|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64604934|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604935|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604936|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64604937|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
64604938|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604939|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64604940|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64604941|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604942|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604943|NCT00860015|Gemcitabine|gemcitabine|mesh-list
64604944|NCT00860015|Pemetrexed|pemetrexed|mesh-list
64604945|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64604946|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
64604947|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604948|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64604949|NCT00860015|Antiviral Agents|antiviral agents|mesh-ancestor
64604950|NCT00860015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64604951|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604952|NCT00860015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64604953|NCT00860015|Immunologic Factors|immunologic factors|mesh-ancestor
64604954|NCT00860015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604955|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64604956|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64604957|NCT00853333|Midazolam|midazolam|mesh-list
64604958|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
64604959|NCT00853333|Propofol|propofol|mesh-list
64604960|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64362469|NCT02479165|Narcotics|narcotics|mesh-ancestor
64362472|NCT02479165|Analgesics|analgesics|mesh-ancestor
64604961|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64604962|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604964|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
64604965|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
64604966|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64604967|NCT00853333|Analgesics|analgesics|mesh-ancestor
64604969|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64604970|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64604971|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64604972|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64604973|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
64604974|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64604975|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604976|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64604977|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64604978|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64604979|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64604980|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
64604981|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
64604982|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
64604983|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
64604984|NCT05231980|Clomiphene|clomiphene|mesh-list
64604985|NCT05231980|Enclomiphene|enclomiphene|mesh-list
64604986|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
64604987|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64604988|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
64604989|NCT05231980|Protective Agents|protective agents|mesh-ancestor
64604990|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64604991|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
64604992|NCT05231980|Vitamins|vitamins|mesh-ancestor
64604993|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
64604994|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64604995|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64604998|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
64604999|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64605000|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64605001|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
64605002|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64605003|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64605004|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
64605005|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64605006|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64605007|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64605008|NCT05227612|Psilocybin|psilocybin|mesh-list
64605009|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
64605010|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605011|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64605012|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64605013|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64605014|NCT00822107|Diuretics|diuretics|mesh-ancestor
64605015|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
64605016|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605017|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64605018|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605019|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605020|NCT05236907|Midazolam|midazolam|mesh-list
64605021|NCT05236907|Melatonin|melatonin|mesh-list
64605022|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64605023|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64605024|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605025|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605026|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64605027|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64605028|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64605029|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64605030|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
64605031|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
64605032|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
64605033|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
64605034|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296663|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
64605035|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605037|NCT05236907|Protective Agents|protective agents|mesh-ancestor
64605038|NCT05217706|Ketamine|ketamine|mesh-list
64605039|NCT05217706|Analgesics|analgesics|mesh-ancestor
64605040|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
64605041|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605042|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605043|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64605044|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64605045|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
64605046|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
64605047|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605048|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64605049|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64605050|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605051|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605052|NCT00833443|Bupropion|bupropion|mesh-list
64605053|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64605054|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
64605055|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64605056|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64605057|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64605059|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605060|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
64605061|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605062|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605063|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64605064|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64605065|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605066|NCT05207722|Aldesleukin|aldesleukin|mesh-list
64605067|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
64605068|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
64605069|NCT05207722|Trastuzumab|trastuzumab|mesh-list
64605070|NCT05207722|Fludarabine|fludarabine|mesh-list
64605071|NCT05207722|Interleukin-2|interleukin-2|mesh-list
64605072|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605073|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
64605074|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605075|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605076|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64605077|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
64605078|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605079|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605080|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64605081|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64605082|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64605083|NCT05207722|Analgesics|analgesics|mesh-ancestor
64605084|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
64605085|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605086|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64605087|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64605088|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
64605089|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605090|NCT00860171|Iodine|iodine|mesh-list
64605091|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
64605092|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64605093|NCT00860171|Antibodies|antibodies|mesh-list
64605094|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
64605095|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64605096|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
64605097|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605098|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605100|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605101|NCT00860171|Trace Elements|trace elements|mesh-ancestor
64605102|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
64605103|NCT00366418|Rituximab|rituximab|mesh-list
64605104|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64605105|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605106|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
64605107|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605108|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605109|NCT00823043|Timolol|timolol|mesh-list
64362501|NCT05377255|Naloxone|naloxone|mesh-list
64605110|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605111|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64605112|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64605113|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
64605114|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605115|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605116|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64605117|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64605119|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64605120|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64605121|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
64605122|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605123|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605124|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605125|NCT00862745|Urological Agents|urological agents|mesh-ancestor
64605126|NCT02150759|Fentanyl|fentanyl|mesh-list
64605127|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
64605128|NCT02150759|Ketamine|ketamine|mesh-list
64605129|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64605130|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605131|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605132|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64605133|NCT02150759|Analgesics|analgesics|mesh-ancestor
64605134|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
64605135|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605136|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64605137|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64605138|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64605139|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
64605140|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605141|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605142|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64605143|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64605144|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
64605145|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
64605146|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64605147|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64605148|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64605149|NCT02150759|Narcotics|narcotics|mesh-ancestor
64605150|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64605151|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
64605152|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605153|NCT04991350|Bevacizumab|bevacizumab|mesh-list
64605154|NCT04991350|Ranibizumab|ranibizumab|mesh-list
64605155|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64605156|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605157|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64605159|NCT04991350|Growth Substances|growth substances|mesh-ancestor
64605160|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605161|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
64605162|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
64605163|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
64605164|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605165|NCT04952194|Levodopa|levodopa|mesh-list
64605166|NCT04952194|Carbidopa|carbidopa|mesh-list
64605168|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64605169|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64605170|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
64605171|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605172|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605173|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605174|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64605175|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605176|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64605177|NCT00835159|Rivastigmine|rivastigmine|mesh-list
64605178|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64605179|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605180|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605181|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
64605182|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605183|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605184|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64605185|NCT00835159|Protective Agents|protective agents|mesh-ancestor
64605186|NCT04860856|Ropivacaine|ropivacaine|mesh-list
64605187|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
64605189|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605190|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605191|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
64605192|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605193|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
64605194|NCT00827099|Fludarabine|fludarabine|mesh-list
64605195|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
64605196|NCT00827099|Melphalan|melphalan|mesh-list
64605197|NCT00827099|Tacrolimus|tacrolimus|mesh-list
64605198|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64605199|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605200|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64605201|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
64605202|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605203|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605204|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
64605205|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605206|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64605207|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605208|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64605209|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64605210|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
64605211|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64605212|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605213|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64605214|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
64605215|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64605216|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64605217|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64605218|NCT00366652|Desipramine|desipramine|mesh-list
64605219|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64605220|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64605221|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605222|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605223|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605224|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605225|NCT00366652|Analgesics|analgesics|mesh-ancestor
64605226|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
64605227|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605228|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
64605229|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64605230|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
64605231|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64605232|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605233|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64605234|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
64605235|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
64605236|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64605237|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605238|NCT02617888|Bismuth|bismuth|mesh-list
64605239|NCT02617888|Antacids|antacids|mesh-ancestor
64430029|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64605240|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605242|NCT02620774|Tazobactam|tazobactam|mesh-list
64605243|NCT02620774|Ceftolozane|ceftolozane|mesh-list
64605244|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64605245|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64605246|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605247|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64605248|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605249|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605250|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64605251|NCT02620774|Renal Agents|renal agents|mesh-ancestor
64605252|NCT02625298|Pemetrexed|pemetrexed|mesh-list
64605257|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64605258|NCT00858013|Glimepiride|glimepiride|mesh-list
64605259|NCT00858013|Nateglinide|nateglinide|mesh-list
64605260|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64605261|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64605262|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605263|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605264|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
64605265|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
64605266|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64330626|NCT02364765|Analgesics|analgesics|mesh-ancestor
64605268|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64605269|NCT00835861|Metformin|metformin|mesh-list
64605270|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
64605271|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
64605272|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64605273|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605274|NCT00804973|Sumatriptan|sumatriptan|mesh-list
64605275|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64605276|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64605277|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64605278|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
64605279|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605280|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605281|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605282|NCT02628106|Alprostadil|alprostadil|mesh-list
64605283|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64605284|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
64605285|NCT02628106|Urological Agents|urological agents|mesh-ancestor
64605286|NCT02629354|Ibuprofen|ibuprofen|mesh-list
64605287|NCT02629354|Caffeine|caffeine|mesh-list
64605288|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64605289|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64605290|NCT02629354|Analgesics|analgesics|mesh-ancestor
64605291|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
64605292|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605293|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605294|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64605295|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605296|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64605297|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605298|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605299|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64605300|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64605301|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64605302|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64605303|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
64605304|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605305|NCT02834247|Nivolumab|nivolumab|mesh-list
64605306|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64605307|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605308|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64362548|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
64605309|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605310|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
64605311|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
64605314|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605315|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64605316|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605317|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64605318|NCT02630992|Amoxicillin|amoxicillin|mesh-list
64605319|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
64605320|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
64605321|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64605322|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64605323|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605324|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64605325|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605326|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605327|NCT00836407|Ipilimumab|ipilimumab|mesh-list
64605328|NCT00836407|Vaccines|vaccines|mesh-list
64605329|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
64605330|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605331|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64605332|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605333|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64605334|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605336|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
64605337|NCT02631772|Ledipasvir|ledipasvir|mesh-list
64330704|NCT02202473|Lamivudine|lamivudine|mesh-list
64605338|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
64605339|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605340|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
64605341|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605342|NCT02633488|Metformin|metformin|mesh-list
64605343|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64605344|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605345|NCT00859339|Gemcitabine|gemcitabine|mesh-list
64605346|NCT00859339|Sunitinib|sunitinib|mesh-list
64605347|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605348|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64605349|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
64605350|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605351|NCT00859339|Antiviral Agents|antiviral agents|mesh-ancestor
64605352|NCT00859339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605353|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605354|NCT00859339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605355|NCT00859339|Immunologic Factors|immunologic factors|mesh-ancestor
64605356|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605357|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64605358|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64605359|NCT00859339|Growth Substances|growth substances|mesh-ancestor
64605360|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64605361|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64605362|NCT00859495|Doxorubicin|doxorubicin|mesh-list
64605363|NCT00859495|Pemetrexed|pemetrexed|mesh-list
64605364|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605365|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64605366|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64605367|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64605368|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605369|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362560|NCT02475421|Glucagon|glucagon|mesh-list
64605370|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64605371|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64605372|NCT00355719|Ritonavir|ritonavir|mesh-list
64605373|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64605374|NCT00355719|Nevirapine|nevirapine|mesh-list
64605375|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64605376|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64605377|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
64605378|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605381|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64605382|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
64605383|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605384|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64605385|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64605386|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64605387|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64605388|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64605389|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64605390|NCT00859651|Vitamin D|vitamin d|mesh-list
64605391|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
64605392|NCT00859651|Vitamins|vitamins|mesh-ancestor
64605393|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
64605394|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605395|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64605396|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64605397|NCT02633956|Atorvastatin|atorvastatin|mesh-list
64605398|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64605399|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64605400|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
64605401|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605402|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64605403|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64605404|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605405|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64605406|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
64605407|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605408|NCT00806221|Emollients|emollients|mesh-list
64605409|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
64605410|NCT02635828|Promethazine|promethazine|mesh-list
64605411|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
64605412|NCT02635828|Dexamethasone|dexamethasone|mesh-list
64605413|NCT02635828|Palonosetron|palonosetron|mesh-list
64605414|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64605415|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
64605416|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
64605417|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605418|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605419|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64605420|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
64605422|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64605423|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64605424|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605425|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64605426|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64605427|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
64605428|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605429|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605430|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
64605431|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
64605432|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64605433|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
64605434|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
64605435|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64605436|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64605437|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64605438|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605439|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
64605440|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
64605441|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
64605442|NCT02638168|Methylphenidate|methylphenidate|mesh-list
64605443|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64605444|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605445|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64605446|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64605447|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605448|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605449|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
64605450|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605451|NCT04986579|Trastuzumab|trastuzumab|mesh-list
64605452|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64605453|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605454|NCT00837031|Gemcitabine|gemcitabine|mesh-list
64605455|NCT00837031|Lenalidomide|lenalidomide|mesh-list
64605456|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64605457|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
64605458|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605459|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605460|NCT00837031|Antiviral Agents|antiviral agents|mesh-ancestor
64605461|NCT00837031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605462|NCT00837031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605463|NCT00837031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605464|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
64605465|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605466|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64605467|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64605468|NCT00837031|Growth Substances|growth substances|mesh-ancestor
64605469|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
64605470|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64605471|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64605472|NCT04344483|Lidocaine|lidocaine|mesh-list
64605473|NCT04344483|Epinephrine|epinephrine|mesh-list
64605474|NCT04344483|Racepinephrine|racepinephrine|mesh-list
64605475|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
64605476|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
64605477|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
64605478|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605479|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605480|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
64605481|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605482|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64605483|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64605484|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64605485|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605486|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605487|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64605488|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64605489|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
64605490|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605491|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64605492|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64605493|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
64605494|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64605495|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
64605496|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
64605497|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
64605498|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64605499|NCT02154763|Ropivacaine|ropivacaine|mesh-list
64605500|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
64605501|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
64605502|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605503|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605504|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
64605505|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605507|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605508|NCT04964427|Methylphenidate|methylphenidate|mesh-list
64605509|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64605510|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605511|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64605512|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64605513|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605514|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605515|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
64605516|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605517|NCT00357669|Brivaracetam|brivaracetam|mesh-list
64605518|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
64605520|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605521|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
64605522|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
64605523|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
64605524|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605525|NCT00863551|Trospium chloride|trospium chloride|mesh-list
64605526|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
64605527|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
64605528|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605529|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605530|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64605531|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64605532|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
64605533|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605534|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605535|NCT00863551|Urological Agents|urological agents|mesh-ancestor
64605536|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
64605537|NCT03838575|Gentamicins|gentamicins|mesh-list
64605538|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
64605539|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64605540|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64605541|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
64605542|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64605543|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605544|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605545|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64605546|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64605547|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64605548|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
64605549|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605550|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64605551|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64605552|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605553|NCT04339816|Azithromycin|azithromycin|mesh-list
64605554|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
64605555|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64605556|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605557|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
64605558|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64605559|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64605560|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605561|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605562|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605563|NCT05588908|Betamethasone|betamethasone|mesh-list
64605564|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64605565|NCT05588908|Antibodies|antibodies|mesh-list
64605566|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
64605567|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64605568|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
64605569|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605570|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605571|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64605572|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
64605573|NCT05588908|Hormones|hormones|mesh-ancestor
64605574|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64605575|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64605576|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
64605577|NCT05588830|Belimumab|belimumab|mesh-list
64605578|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605579|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
64605580|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605581|NCT04740190|Carboplatin|carboplatin|mesh-list
64605582|NCT04740190|Talazoparib|talazoparib|mesh-list
64605583|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605584|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64605585|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605586|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605587|NCT00865969|Belinostat|belinostat|mesh-list
64605588|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605589|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64605590|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605591|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605592|NCT05588518|Propolis|propolis|mesh-list
64605593|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605594|NCT00866749|Cytarabine|cytarabine|mesh-list
64605595|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
64605596|NCT00866749|Doxorubicin|doxorubicin|mesh-list
64605597|NCT00866749|Methotrexate|methotrexate|mesh-list
64605598|NCT00866749|Vincristine|vincristine|mesh-list
64605599|NCT00866749|Daunorubicin|daunorubicin|mesh-list
64605600|NCT00866749|Asparaginase|asparaginase|mesh-list
64605601|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
64605602|NCT00866749|Thioguanine|thioguanine|mesh-list
64605603|NCT00866749|Pegaspargase|pegaspargase|mesh-list
64605604|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605605|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
64605606|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605607|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605608|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64605609|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
64605610|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605611|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605612|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64605613|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64605614|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64605615|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64605616|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605617|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64605618|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
64605619|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64605620|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64605622|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
64605623|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64605624|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64331016|NCT05791487|Budesonide|budesonide|mesh-list
64331017|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64331018|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64331019|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
64331020|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64331021|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64331022|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64331023|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
64331024|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
64331025|NCT05791487|Hormones|hormones|mesh-ancestor
64331026|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331036|NCT05791409|Venetoclax|venetoclax|mesh-list
64605625|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
64605626|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605627|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64605628|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
64605629|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
64605630|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
64605631|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
64605632|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605633|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
64605634|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605635|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605636|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64605637|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
64605638|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605639|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605640|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64605641|NCT05587426|Iproplatin|iproplatin|mesh-list
64605642|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605643|NCT00867139|Oseltamivir|oseltamivir|mesh-list
64605644|NCT00867139|Ribavirin|ribavirin|mesh-list
64605645|NCT00867139|Zanamivir|zanamivir|mesh-list
64605646|NCT00867139|Amantadine|amantadine|mesh-list
64605647|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
64605648|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
64605649|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64605650|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605651|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605652|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
64605653|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64605654|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64605655|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
64605656|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605657|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605658|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64605659|NCT00867139|Analgesics|analgesics|mesh-ancestor
64605660|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
64605661|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605662|NCT05342818|Ondansetron|ondansetron|mesh-list
64605663|NCT05342818|Metoclopramide|metoclopramide|mesh-list
64605664|NCT05342818|Neostigmine|neostigmine|mesh-list
64605665|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
64605666|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
64605667|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605668|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605669|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64605670|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
64605671|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
64605672|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64605673|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
64605674|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605675|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605676|NCT05342818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64605677|NCT05342818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64605678|NCT05342818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605679|NCT05342818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64605680|NCT05342818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64605681|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64605682|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605683|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
64605684|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64362652|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64605685|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64605686|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64605688|NCT00867217|Vitamin D|vitamin d|mesh-list
64605689|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
64605690|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
64605691|NCT00867217|Vitamins|vitamins|mesh-list
64605692|NCT00867217|Letrozole|letrozole|mesh-list
64605693|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
64605694|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605695|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64605696|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64605697|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605698|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64605699|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64331074|NCT05790720|Propofol|propofol|mesh-list
64605700|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430030|NCT04949867|Glucagon|glucagon|mesh-list
64605701|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605702|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64605703|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
64605704|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64605706|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
64605707|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605708|NCT00867451|Protective Agents|protective agents|mesh-ancestor
64605709|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605710|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605711|NCT00867529|Rituximab|rituximab|mesh-list
64605712|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64605713|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605714|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
64605715|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605716|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605718|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64605719|NCT02456857|Doxorubicin|doxorubicin|mesh-list
64605720|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64605721|NCT02456857|Everolimus|everolimus|mesh-list
64605722|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
64605723|NCT02456857|Antibodies|antibodies|mesh-list
64605724|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
64605725|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64605726|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
64605727|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605728|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64605729|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64605730|NCT02456857|Growth Substances|growth substances|mesh-ancestor
64605731|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605732|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
64605733|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
64605734|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64605735|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64605736|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64605738|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605739|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605740|NCT05197270|Aflibercept|aflibercept|mesh-list
64605741|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64605742|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64605743|NCT05197270|Growth Substances|growth substances|mesh-ancestor
64605744|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605745|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
64605746|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605747|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
64605748|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
64605749|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605750|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605751|NCT00889915|Methylphenidate|methylphenidate|mesh-list
64605752|NCT00889915|Amphetamine|amphetamine|mesh-list
64605753|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64605754|NCT00889915|Adderall|adderall|mesh-list
64605755|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64605756|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605757|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64605758|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64605759|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605760|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605761|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
64605762|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605763|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
64605764|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
64605765|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605766|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
64605767|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64605768|NCT00841087|Insulin|insulin|mesh-list
64605770|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
64605771|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
64605772|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64605773|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605774|NCT02685436|Domperidone|domperidone|mesh-list
64605775|NCT02685436|Omeprazole|omeprazole|mesh-list
64605776|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64605777|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64605778|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64605779|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605780|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605781|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
64605782|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
64605783|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605784|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605785|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64605786|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
64605787|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605789|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64605790|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
64605791|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605792|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605793|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64605794|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
64605795|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
64605796|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
64605797|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605799|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
64605800|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605801|NCT00368134|Vildagliptin|vildagliptin|mesh-list
64605802|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64605803|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605804|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64605805|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
64605806|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605807|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605808|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
64605809|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64605810|NCT02697292|Antibodies|antibodies|mesh-list
64605811|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
64605812|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64605813|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
64605814|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605815|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
64605816|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64605817|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605818|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64605819|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605820|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64605821|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64605822|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64605823|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605824|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605825|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64605826|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64605827|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64605829|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
64605830|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605831|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605832|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64605833|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64605834|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
64605835|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64605836|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64605837|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
64605838|NCT02701582|Phenylephrine|phenylephrine|mesh-list
64605839|NCT02701582|Epinephrine|epinephrine|mesh-list
64605840|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
64605841|NCT02701582|Synephrine|synephrine|mesh-list
64605842|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64605843|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64605844|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
64605845|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605846|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605847|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605848|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64605849|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64605850|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
64605851|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605852|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64605853|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
64605854|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
64605855|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
64605856|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64605857|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64605858|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
64605859|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64605860|NCT02701582|Protective Agents|protective agents|mesh-ancestor
64605861|NCT00869791|Levodopa|levodopa|mesh-list
64605862|NCT00869791|Carbidopa|carbidopa|mesh-list
64605863|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64605864|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64605865|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64605866|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
64605867|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605868|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605869|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605870|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64605872|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64605873|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
64605874|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
64605875|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64605876|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64605877|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64605878|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
64605879|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362732|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64605880|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64605881|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64605882|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605883|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
64605884|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
64605885|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605886|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605887|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64605888|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
64605889|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64605890|NCT01622335|Analgesics|analgesics|mesh-ancestor
64605891|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
64605892|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605893|NCT00895531|Morphine|morphine|mesh-list
64605894|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64605895|NCT00895531|Narcotics|narcotics|mesh-ancestor
64605896|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605897|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605898|NCT00895531|Analgesics|analgesics|mesh-ancestor
64605899|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
64605900|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605901|NCT03215875|Torsemide|torsemide|mesh-list
64605902|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64605903|NCT03215875|Diuretics|diuretics|mesh-ancestor
64605904|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
64605905|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605906|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64605907|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605908|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605910|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
64605911|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64605912|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
64605913|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605914|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605915|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
64605916|NCT02715700|Methadone|methadone|mesh-list
64605917|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64605919|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605920|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605921|NCT02715700|Analgesics|analgesics|mesh-ancestor
64605922|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
64605923|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605924|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
64605925|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
64605926|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
64331304|NCT05660681|Glycerol|glycerol|mesh-list
64605927|NCT00338377|Fludarabine|fludarabine|mesh-list
64605928|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
64605929|NCT00338377|Interleukin-2|interleukin-2|mesh-list
64605930|NCT00338377|Mesna|mesna|mesh-list
64605931|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64605932|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
64605933|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605934|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605935|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64605936|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
64605937|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605938|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605939|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64605940|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64605941|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
64605942|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64605944|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
64362801|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64605945|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605946|NCT00338377|Protective Agents|protective agents|mesh-ancestor
64605947|NCT00895921|Olanzapine|olanzapine|mesh-list
64605948|NCT00895921|Aripiprazole|aripiprazole|mesh-list
64605949|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
64605950|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
64605951|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605952|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605953|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64605954|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64605955|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64605956|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64605957|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64605958|NCT00895921|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64605959|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64605960|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64605961|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605962|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64605963|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
64605964|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
64605965|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
64605966|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
64605967|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64605968|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64605969|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64605970|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64605971|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64605972|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64605974|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64605975|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64605976|NCT05315479|Analgesics|analgesics|mesh-ancestor
64605977|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
64605978|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64605979|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64605980|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64605981|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64605982|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64605983|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64605984|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605985|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605986|NCT05312671|Cisplatin|cisplatin|mesh-list
64605987|NCT05312671|Carboplatin|carboplatin|mesh-list
64605988|NCT05312671|Etoposide|etoposide|mesh-list
64605989|NCT05312671|Atezolizumab|atezolizumab|mesh-list
64605990|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
64605991|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64605992|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64605993|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64605994|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64605995|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64605996|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64605997|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
64605998|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
64605999|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606000|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606001|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606002|NCT00883675|Carboplatin|carboplatin|mesh-list
64606003|NCT00883675|Docetaxel|docetaxel|mesh-list
64606004|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606005|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606006|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606007|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606008|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606009|NCT03215407|Betamethasone|betamethasone|mesh-list
64606010|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64606011|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
64606012|NCT03215407|Hormones|hormones|mesh-ancestor
64606013|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64606014|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606015|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64606016|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606017|NCT05310331|Paclitaxel|paclitaxel|mesh-list
64606018|NCT05310331|Antibodies|antibodies|mesh-list
64606019|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64606020|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606021|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606022|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606023|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606024|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606025|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
64606026|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606027|NCT00885079|Rebamipide|rebamipide|mesh-list
64606028|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64606029|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64606030|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64606031|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64606032|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
64606033|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606034|NCT00885079|Protective Agents|protective agents|mesh-ancestor
64606035|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606036|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606037|NCT00896779|Ranibizumab|ranibizumab|mesh-list
64606038|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64606039|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64606040|NCT00896779|Growth Substances|growth substances|mesh-ancestor
64606041|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606042|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
64606043|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606044|NCT02722564|Ethanol|ethanol|mesh-list
64606045|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64606046|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606047|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64606048|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606050|NCT03376477|Molgramostim|molgramostim|mesh-list
64606051|NCT03376477|Vaccines|vaccines|mesh-list
64606052|NCT03376477|Sargramostim|sargramostim|mesh-list
64606053|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64606054|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
64606055|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606056|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64606057|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64606058|NCT03376477|Growth Substances|growth substances|mesh-ancestor
64606059|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
64606060|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606061|NCT02726620|Lidocaine|lidocaine|mesh-list
64606062|NCT02726620|Atropine|atropine|mesh-list
64606063|NCT02726620|Terlipressin|terlipressin|mesh-list
64606064|NCT02726620|Phenylephrine|phenylephrine|mesh-list
64606065|NCT02726620|Dobutamine|dobutamine|mesh-list
64606066|NCT02726620|Dopamine|dopamine|mesh-list
64606067|NCT02726620|Milrinone|milrinone|mesh-list
64606068|NCT02726620|Isoproterenol|isoproterenol|mesh-list
64606069|NCT02726620|Vasopressins|vasopressins|mesh-list
64606070|NCT02726620|Arginine Vasopressin|arginine vasopressin|mesh-list
64606071|NCT02726620|Epinephrine|epinephrine|mesh-list
64606072|NCT02726620|Norepinephrine|norepinephrine|mesh-list
64606073|NCT02726620|Ephedrine|ephedrine|mesh-list
64606074|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
64606075|NCT02726620|Bupivacaine|bupivacaine|mesh-list
64606076|NCT02726620|Ropivacaine|ropivacaine|mesh-list
64606077|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
64606078|NCT02726620|Tetracaine|tetracaine|mesh-list
64606079|NCT02726620|Prilocaine|prilocaine|mesh-list
64606080|NCT02726620|Mepivacaine|mepivacaine|mesh-list
64606081|NCT02726620|Benzocaine|benzocaine|mesh-list
64606082|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
64606083|NCT02726620|Procaine|procaine|mesh-list
64606084|NCT02726620|Anesthetics|anesthetics|mesh-list
64606085|NCT02726620|Propofol|propofol|mesh-list
64606086|NCT02726620|Sevoflurane|sevoflurane|mesh-list
64606087|NCT02726620|Desflurane|desflurane|mesh-list
64606088|NCT02726620|Isoflurane|isoflurane|mesh-list
64606089|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64606090|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
64606091|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
64606092|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64606093|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606094|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
64606095|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606096|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64606097|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64606098|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64606099|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64606100|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606101|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64606102|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64606103|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
64606104|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64606105|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64606106|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64606107|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64606108|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606109|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606110|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64606111|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64606112|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
64606113|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64606114|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606115|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
64606116|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
64606117|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64606118|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64606119|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
64606120|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64606121|NCT02726620|Protective Agents|protective agents|mesh-ancestor
64606122|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64606123|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
64606124|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64606125|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64606126|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
64606127|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
64606128|NCT02726620|Coagulants|coagulants|mesh-ancestor
64606129|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64606130|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
64606131|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64606132|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64606133|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64606134|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
64606135|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
64606136|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64606137|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64606138|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606139|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64606140|NCT00887575|Paclitaxel|paclitaxel|mesh-list
64606141|NCT00887575|Carboplatin|carboplatin|mesh-list
64606142|NCT00887575|Sunitinib|sunitinib|mesh-list
64606143|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64606144|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606145|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606146|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606147|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606148|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606149|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64606150|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64606151|NCT00887575|Growth Substances|growth substances|mesh-ancestor
64606152|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606153|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
64606154|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64606155|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606156|NCT03352843|Primaquine|primaquine|mesh-list
64606157|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
64606158|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64606159|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64331528|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
64606160|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606161|NCT03238027|Durvalumab|durvalumab|mesh-list
64606162|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606163|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606164|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
64606165|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64606166|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64606167|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
64606168|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606169|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64606170|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64606171|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606172|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606173|NCT00887965|Denosumab|denosumab|mesh-list
64606174|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64606175|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606176|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
64606178|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
64606179|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64606180|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64606181|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606182|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606183|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606184|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606185|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
64606186|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64606187|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64606189|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64606190|NCT03214627|Hematinics|hematinics|mesh-list
64606191|NCT03214627|Trace Elements|trace elements|mesh-ancestor
64606192|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
64606193|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606194|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64606195|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606196|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64606197|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606198|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606199|NCT03214393|Antibodies|antibodies|mesh-list
64606200|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
64606201|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606203|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64606204|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
64606205|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606206|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606207|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64606208|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64606209|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
64606210|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606211|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606212|NCT03214003|Cisplatin|cisplatin|mesh-list
64606213|NCT03214003|Etoposide|etoposide|mesh-list
64606214|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
64606215|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606216|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64606217|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64606218|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64606219|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606220|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606221|NCT03214159|Ritonavir|ritonavir|mesh-list
64606222|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64606223|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64606224|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
64606225|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606226|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606227|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64606228|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64606229|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
64606230|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606231|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64606232|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64606233|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
64606234|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
64606235|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64606236|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64606237|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606238|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606239|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606240|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606241|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64606243|NCT02879695|Ipilimumab|ipilimumab|mesh-list
64606244|NCT02879695|Blinatumomab|blinatumomab|mesh-list
64606245|NCT02879695|Antibodies|antibodies|mesh-list
64606246|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
64606247|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64606248|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
64606249|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64606250|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
64606251|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606252|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606253|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64606254|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606255|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606256|NCT02737072|Durvalumab|durvalumab|mesh-list
64606257|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606258|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606259|NCT02669173|Bevacizumab|bevacizumab|mesh-list
64606260|NCT02669173|Capecitabine|capecitabine|mesh-list
64606261|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606262|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606263|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64606264|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64606265|NCT02669173|Growth Substances|growth substances|mesh-ancestor
64606266|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606267|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
64606268|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64606269|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
64606270|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606271|NCT05446480|Desloratadine|desloratadine|mesh-list
64606272|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64606273|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
64606274|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606275|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606276|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606277|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64606278|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64606279|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
64606280|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
64606281|NCT03213145|Rifampin|rifampin|mesh-list
64606282|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64606283|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
64606284|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64606285|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606286|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
64606287|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64606288|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606289|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606290|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64606291|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64606292|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64606293|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64606294|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64606295|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64606296|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
64606297|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64606298|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
64606299|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606300|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606301|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64606302|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606303|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64606304|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
64606305|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606306|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606307|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64331677|NCT04971785|Firsocostat|firsocostat|mesh-list
64606308|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
64606309|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
64606310|NCT05446090|Protective Agents|protective agents|mesh-ancestor
64606311|NCT05444998|Paclitaxel|paclitaxel|mesh-list
64606312|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64606313|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606314|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606315|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606316|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606317|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606318|NCT05444842|Insulin|insulin|mesh-list
64606319|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64606320|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64363030|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606321|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606322|NCT04381741|Antibodies|antibodies|mesh-list
64606323|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64606324|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
64606325|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606326|NCT05444452|Sirolimus|sirolimus|mesh-list
64606327|NCT05444452|Everolimus|everolimus|mesh-list
64606328|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606329|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606330|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
64606331|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606332|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64606333|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606334|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64606335|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
64606336|NCT05444374|Bevacizumab|bevacizumab|mesh-list
64606337|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606338|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606339|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64606340|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64606341|NCT05444374|Growth Substances|growth substances|mesh-ancestor
64606342|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606343|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
64606344|NCT05444218|Amoxicillin|amoxicillin|mesh-list
64606345|NCT05444218|Metronidazole|metronidazole|mesh-list
64606346|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64606347|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606348|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64606349|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64606350|NCT01830361|Midostaurin|midostaurin|mesh-list
64606351|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606352|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64606353|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606354|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606357|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64606358|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64606359|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64606360|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606361|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64606362|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606363|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
64606364|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64606365|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64606366|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64606367|NCT03212833|Insulin|insulin|mesh-list
64606368|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64606369|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606370|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
64606371|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
64606372|NCT05443360|Calcium|calcium|mesh-list
64606373|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64606374|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606375|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64606376|NCT05443360|Antacids|antacids|mesh-ancestor
64606377|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606378|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64606379|NCT05443282|Hormones|hormones|mesh-list
64606380|NCT05443282|Estradiol|estradiol|mesh-list
64606381|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64606382|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64331755|NCT04887467|Emetics|emetics|mesh-ancestor
64606383|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606384|NCT05443282|Estrogens|estrogens|mesh-ancestor
64606385|NCT00904345|Cetuximab|cetuximab|mesh-list
64606386|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606387|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606388|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
64363083|NCT05306431|Polihexanide|polihexanide|mesh-list
64606389|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64606390|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606391|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64606392|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64606393|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606394|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606395|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606396|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64606397|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64606398|NCT01830829|Tamsulosin|tamsulosin|mesh-list
64606399|NCT01830829|Dutasteride|dutasteride|mesh-list
64606400|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64606401|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64606402|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64606403|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606404|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606405|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606406|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606408|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64606409|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64606410|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606411|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
64606412|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64606413|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
64606414|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64606415|NCT03212755|Antibodies|antibodies|mesh-list
64606416|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
64606417|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
64606418|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606419|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
64606420|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64606421|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64606422|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606423|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
64606424|NCT05437822|Coagulants|coagulants|mesh-ancestor
64606425|NCT03212599|Disulfiram|disulfiram|mesh-list
64606426|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64606427|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64606428|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606429|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606430|NCT03212053|Hemostatics|hemostatics|mesh-list
64606431|NCT03212053|Coagulants|coagulants|mesh-ancestor
64606432|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
64606433|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64606434|NCT05311189|Trastuzumab|trastuzumab|mesh-list
64606435|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606436|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606437|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
64606438|NCT00369772|Hematinics|hematinics|mesh-ancestor
64606439|NCT03211897|Midazolam|midazolam|mesh-list
64606440|NCT03211897|Haloperidol|haloperidol|mesh-list
64606441|NCT03211897|Olanzapine|olanzapine|mesh-list
64606442|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
64606443|NCT03211897|Ziprasidone|ziprasidone|mesh-list
64606444|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64606445|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64606446|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64606447|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606448|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64606450|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64606451|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64606452|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
64606453|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
64606454|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
64606455|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
64606456|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363092|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606457|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64331829|NCT04632238|Metronidazole|metronidazole|mesh-list
64606458|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
64606459|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
64606460|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606461|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64606462|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64606463|NCT03211897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64606464|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64606465|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64606466|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
64606467|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64606468|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
64606469|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64606470|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64606471|NCT01831687|Etodolac|etodolac|mesh-list
64606472|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64606473|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64606474|NCT01831687|Analgesics|analgesics|mesh-ancestor
64606475|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
64606476|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606477|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606478|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64606479|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606480|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64606481|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64606482|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606483|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606484|NCT05441254|Paclitaxel|paclitaxel|mesh-list
64606485|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64606486|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606487|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606488|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606489|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606490|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606491|NCT00369148|Nateglinide|nateglinide|mesh-list
64606492|NCT00369148|Mitiglinide|mitiglinide|mesh-list
64606493|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64606494|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606495|NCT03816982|Bupivacaine|bupivacaine|mesh-list
64606496|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
64606497|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
64606498|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64606499|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606500|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
64606501|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606502|NCT01832467|Cetuximab|cetuximab|mesh-list
64606503|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296713|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
64606505|NCT03211351|Dextrans|dextrans|mesh-list
64606506|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
64606507|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
64606508|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
64606509|NCT01832623|Vitamin D|vitamin d|mesh-list
64606510|NCT01832623|Vitamins|vitamins|mesh-ancestor
64606511|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
64606512|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606513|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64606514|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64606515|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64606516|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606517|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64606518|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606519|NCT05316493|Megestrol|megestrol|mesh-list
64606520|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
64606521|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
64606522|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
64363118|NCT03900949|Staurosporine|staurosporine|mesh-list
64606523|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64606525|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64606526|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64606527|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64606528|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64606529|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64606530|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64606531|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606532|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
64606533|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64606534|NCT02470390|Fentanyl|fentanyl|mesh-list
64606535|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64606536|NCT02470390|Narcotics|narcotics|mesh-ancestor
64606537|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64606538|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606539|NCT02470390|Analgesics|analgesics|mesh-ancestor
64606540|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
64606541|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606542|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64606543|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64606544|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
64606545|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
64606546|NCT00363532|Calcitonin|calcitonin|mesh-list
64606547|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
64606548|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64606549|NCT00363532|Katacalcin|katacalcin|mesh-list
64382655|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64606550|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64606551|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606552|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64606553|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
64606555|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606556|NCT00363688|Penicillins|penicillins|mesh-list
64606557|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64606558|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606559|NCT01832935|Insulin|insulin|mesh-list
64606560|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64606561|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
64606562|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
64606563|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
64606564|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
64606565|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64606566|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606567|NCT03216733|Sirolimus|sirolimus|mesh-list
64606568|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64606569|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606570|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64606571|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606572|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
64606573|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606574|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
64606575|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606577|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606578|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64606579|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606580|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606581|NCT03333616|Nivolumab|nivolumab|mesh-list
64606582|NCT03333616|Ipilimumab|ipilimumab|mesh-list
64606583|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64606584|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606585|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64606586|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606587|NCT04380181|Milrinone|milrinone|mesh-list
64606589|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64606590|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64606591|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606592|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606593|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606594|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606595|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64606596|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64606597|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
64606598|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606599|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64606600|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606601|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
64606602|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
64606603|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64606604|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64606605|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64606606|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
64606607|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64606608|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64331979|NCT04175912|Paclitaxel|paclitaxel|mesh-list
64606610|NCT04380181|Protective Agents|protective agents|mesh-ancestor
64606611|NCT01833559|Insulin|insulin|mesh-list
64606612|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64606613|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
64606614|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64606615|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606616|NCT05394142|Metformin|metformin|mesh-list
64606617|NCT05394142|Pioglitazone|pioglitazone|mesh-list
64606618|NCT05394142|Spironolactone|spironolactone|mesh-list
64606619|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64606620|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606621|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64606622|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
64606623|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64606624|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64606625|NCT05394142|Diuretics|diuretics|mesh-ancestor
64606626|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
64606627|NCT00901225|Plerixafor|plerixafor|mesh-list
64606629|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64606630|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
64606631|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606632|NCT01833715|Morphine|morphine|mesh-list
64606633|NCT01833715|Methadone|methadone|mesh-list
64606634|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64606635|NCT01833715|Narcotics|narcotics|mesh-ancestor
64606636|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64606637|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606638|NCT01833715|Analgesics|analgesics|mesh-ancestor
64606639|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
64606640|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606641|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
64606642|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606643|NCT05393050|Methotrexate|methotrexate|mesh-list
64606644|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64606645|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
64606646|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64606647|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606648|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64606649|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
64606650|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606651|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606652|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
64363188|NCT02299999|Capecitabine|capecitabine|mesh-list
64606653|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606654|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64606655|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606656|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
64606657|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606658|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64606659|NCT03166228|Glycine|glycine|mesh-list
64606660|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
64606661|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606662|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606663|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606664|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
64606665|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64606666|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
64606667|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64606668|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606669|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64606670|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64606671|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64606672|NCT03216187|Pregabalin|pregabalin|mesh-list
64606673|NCT03216187|Analgesics|analgesics|mesh-ancestor
64606674|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
64606675|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606676|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606677|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
64606678|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64606679|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64606680|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606681|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64606682|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64606683|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64606684|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64606685|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64606686|NCT03154996|Topotecan|topotecan|mesh-list
64606687|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64606688|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64606689|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606690|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606691|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606692|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
64606693|NCT02475070|Vildagliptin|vildagliptin|mesh-list
64606694|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64606695|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606697|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606698|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64606699|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
64606700|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606701|NCT00902161|Propranolol|propranolol|mesh-list
64606702|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64606704|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606705|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606706|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606707|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606708|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64606709|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64606710|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
64606711|NCT01834183|Gemcitabine|gemcitabine|mesh-list
64606712|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64606713|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
64606714|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606715|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606716|NCT01834183|Antiviral Agents|antiviral agents|mesh-ancestor
64606717|NCT01834183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606718|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606719|NCT01834183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606720|NCT01834183|Immunologic Factors|immunologic factors|mesh-ancestor
64606721|NCT01834183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606722|NCT02478580|Modafinil|modafinil|mesh-list
64606723|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64606724|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606725|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64606726|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64606727|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64606728|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606729|NCT02994784|Melphalan|melphalan|mesh-list
64606730|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64606731|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
64606732|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606733|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606734|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64606735|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606736|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
64606737|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606738|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64606739|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
64606740|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606741|NCT03210025|Methyldopa|methyldopa|mesh-list
64606742|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64606743|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
64606744|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
64606745|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606746|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606747|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64606748|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64606749|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64606750|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606751|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606752|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606753|NCT03219853|Selenium|selenium|mesh-list
64606754|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
64606783|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
64606784|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64606785|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
64606786|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
64606787|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606788|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606789|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
64606790|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64606791|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
64606792|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606793|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64606794|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64606795|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606796|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606797|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606798|NCT03215797|Protective Agents|protective agents|mesh-ancestor
64606810|NCT02485834|Docetaxel|docetaxel|mesh-list
64606811|NCT02485834|Capecitabine|capecitabine|mesh-list
64606812|NCT02485834|Irinotecan|irinotecan|mesh-list
64606825|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64606826|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64606827|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64606828|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
64606829|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606830|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606831|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64606832|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
64606833|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64606834|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64606835|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64606836|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64606837|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64606838|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
64606839|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64606840|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606841|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
64606843|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64606844|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
64606845|NCT01834963|Interferons|interferons|mesh-list
64606846|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
64606847|NCT01834963|Cisplatin|cisplatin|mesh-list
64606848|NCT01834963|Fluorouracil|fluorouracil|mesh-list
64606849|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606850|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
64606851|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606852|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64606853|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64606854|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
64606855|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606856|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
64606857|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64606858|NCT04380103|Bevacizumab|bevacizumab|mesh-list
64606859|NCT04380103|Capecitabine|capecitabine|mesh-list
64606860|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
64606886|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606903|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
64606904|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606905|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606906|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64606907|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64606908|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64606910|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606911|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64606912|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
64606913|NCT01839097|Hormones|hormones|mesh-ancestor
64606914|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64606915|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64606916|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64606917|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
64606918|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
64606919|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
64606920|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64606921|NCT01835665|Nimodipine|nimodipine|mesh-list
64606922|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64606923|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64606924|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64606925|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606926|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64606927|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606928|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
64606929|NCT01839175|Vaccines|vaccines|mesh-list
64363258|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
64606941|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64606952|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606953|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606954|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64606955|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
64606956|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606957|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64606958|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64606971|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64606972|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64606973|NCT01839643|Analgesics|analgesics|mesh-ancestor
64606974|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
64606975|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64606976|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64606977|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64606978|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64606979|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64606980|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64606981|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64606982|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64606984|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64606985|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
64606986|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607005|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607006|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64607007|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64607008|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64607009|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
64607011|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64607012|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64607013|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64607014|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64607015|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64607051|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64607052|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
64332439|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
64607053|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64607054|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607055|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64607057|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607058|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607059|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
64607060|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607061|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64607062|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607063|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
64607064|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607065|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64607066|NCT01839955|Quinacrine|quinacrine|mesh-list
64607067|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64607068|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607069|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607070|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607071|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607072|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
64607073|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64607074|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
64607075|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64607076|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607077|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
64607078|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64607088|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64607089|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64607090|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64607091|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64607092|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607093|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
64607094|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607095|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607096|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64607097|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607098|NCT01838395|Cytarabine|cytarabine|mesh-list
64607099|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64607100|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
64607101|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607102|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607103|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
64607104|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607105|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607106|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
64607107|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607108|NCT00422578|Tadalafil|tadalafil|mesh-list
64607109|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
64607110|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64607111|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64607112|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607113|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607114|NCT00422578|Urological Agents|urological agents|mesh-ancestor
64607115|NCT02494180|Fentanyl|fentanyl|mesh-list
64607116|NCT02494180|Midazolam|midazolam|mesh-list
64607117|NCT02494180|Diazepam|diazepam|mesh-list
64607118|NCT02494180|Meperidine|meperidine|mesh-list
64607119|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64607120|NCT02494180|Narcotics|narcotics|mesh-ancestor
64607121|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607122|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607123|NCT02494180|Analgesics|analgesics|mesh-ancestor
64607124|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
64607125|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607126|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64607147|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296754|NCT03300531|Betamethasone|betamethasone|mesh-list
64607148|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607149|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
64607150|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607152|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
64607153|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64607154|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64607155|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
64607156|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
64607157|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363318|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607158|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607159|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64607160|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64607161|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64607174|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64607175|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64607176|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
64607177|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607178|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607179|NCT01720303|Insulin|insulin|mesh-list
64607180|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64607181|NCT01720303|Repaglinide|repaglinide|mesh-list
64607182|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
64607183|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
64607184|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
64607185|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64607186|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607187|NCT04956484|Belimumab|belimumab|mesh-list
64607188|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607189|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
64607190|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607191|NCT05450458|Sorbitol|sorbitol|mesh-list
64607192|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
64607193|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64607194|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
64607195|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607196|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
64607197|NCT05450458|Protective Agents|protective agents|mesh-ancestor
64607198|NCT05450458|Cathartics|cathartics|mesh-ancestor
64607199|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64607200|NCT01720615|Remifentanil|remifentanil|mesh-list
64607201|NCT01720615|Propofol|propofol|mesh-list
64607202|NCT01720615|Sevoflurane|sevoflurane|mesh-list
64607203|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64607214|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64607215|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64607216|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
64607217|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
64607218|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64607219|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
64607220|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607221|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607222|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64607223|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
64607224|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
64607225|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64607226|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
64607227|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607228|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607229|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64607230|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64607231|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
64607232|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64363336|NCT03174847|Diuretics|diuretics|mesh-ancestor
64607233|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607234|NCT02504554|Vancomycin|vancomycin|mesh-list
64607235|NCT02504554|Omeprazole|omeprazole|mesh-list
64607236|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607237|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607238|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64607239|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64607240|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64607241|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607242|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607243|NCT01838473|Lobeline|lobeline|mesh-list
64607244|NCT01838473|Nicotine|nicotine|mesh-list
64607245|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64607246|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
64607247|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607248|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607249|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64607250|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64607251|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
64607252|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607263|NCT01838707|Bupivacaine|bupivacaine|mesh-list
64607264|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
64607265|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
64607266|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607267|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607268|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
64607269|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607270|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64607271|NCT01838707|Narcotics|narcotics|mesh-ancestor
64607272|NCT01838707|Analgesics|analgesics|mesh-ancestor
64607273|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64296756|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
64607274|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64607275|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
64607276|NCT02506114|Ipilimumab|ipilimumab|mesh-list
64607277|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64607278|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607279|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64607280|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607281|NCT05449366|Paclitaxel|paclitaxel|mesh-list
64607282|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64607283|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64607284|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607285|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
64607286|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
64607287|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
64607288|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607289|NCT04920994|Bupivacaine|bupivacaine|mesh-list
64607290|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
64607291|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
64607292|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607293|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607294|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
64607295|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607296|NCT02506660|Dexamethasone|dexamethasone|mesh-list
64607297|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
64607298|NCT02506660|Bupivacaine|bupivacaine|mesh-list
64607299|NCT02506660|BB 1101|bb 1101|mesh-list
64607300|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607301|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
64607302|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
64607303|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363370|NCT03089983|Methadone|methadone|mesh-list
64607304|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607312|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607313|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607314|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
64607315|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
64607316|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607317|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
64607318|NCT02509624|Selonsertib|selonsertib|mesh-list
64607319|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607320|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607321|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607322|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64607323|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64607324|NCT01726075|Somatostatin|somatostatin|mesh-list
64607325|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64607326|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64607327|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64607328|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64607329|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64607330|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
64607331|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64607332|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607333|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607334|NCT01726075|Hormones|hormones|mesh-ancestor
64607335|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607336|NCT00369694|Terlipressin|terlipressin|mesh-list
64607337|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64607338|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64607339|NCT01721707|Latanoprost|latanoprost|mesh-list
64607340|NCT01721707|Brinzolamide|brinzolamide|mesh-list
64607341|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64607342|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64607343|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64607344|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607345|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607346|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
64607347|NCT05448586|Narcotics|narcotics|mesh-ancestor
64607348|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607349|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607350|NCT05448586|Analgesics|analgesics|mesh-ancestor
64607351|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
64607352|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607353|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
64607354|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
64607355|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64332740|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64607364|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
64607365|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607366|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607367|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64607370|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607371|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64607372|NCT01726465|Protective Agents|protective agents|mesh-ancestor
64607373|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64607374|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607375|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
64607376|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607377|NCT01726465|Expectorants|expectorants|mesh-ancestor
64607378|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
64607379|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64607380|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
64607381|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607382|NCT01726465|Antidotes|antidotes|mesh-ancestor
64607383|NCT02733042|Rituximab|rituximab|mesh-list
64607384|NCT02733042|Durvalumab|durvalumab|mesh-list
64607385|NCT02733042|Lenalidomide|lenalidomide|mesh-list
64607386|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64607387|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64607388|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607389|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
64607390|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607391|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607392|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64607393|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64607394|NCT02733042|Growth Substances|growth substances|mesh-ancestor
64607395|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
64607396|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64607397|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
64607412|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607413|NCT01726777|Vitamin D|vitamin d|mesh-list
64607414|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
64607415|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
64607416|NCT01726777|Vitamins|vitamins|mesh-list
64607417|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
64607418|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607419|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64607420|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64607421|NCT05532306|Ribavirin|ribavirin|mesh-list
64607422|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
64607423|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607424|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
64607425|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607426|NCT05602038|Morphine|morphine|mesh-list
64607427|NCT05602038|Bupivacaine|bupivacaine|mesh-list
64607428|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
64607429|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
64607430|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607431|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607432|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
64607433|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607434|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64607435|NCT05602038|Narcotics|narcotics|mesh-ancestor
64607436|NCT05602038|Analgesics|analgesics|mesh-ancestor
64607437|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
64607438|NCT01722409|Sevoflurane|sevoflurane|mesh-list
64607439|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64607440|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607441|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607442|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64607443|NCT01722409|Analgesics|analgesics|mesh-ancestor
64607444|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
64607445|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607446|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64607447|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64607457|NCT04307238|Propofol|propofol|mesh-list
64607458|NCT04307238|Sevoflurane|sevoflurane|mesh-list
64607459|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607460|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607461|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64607462|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64607463|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
64607464|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64607465|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64607466|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64607467|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
64607468|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607469|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
64607470|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607472|NCT01727401|Fondaparinux|fondaparinux|mesh-list
64607473|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64607474|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
64607475|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64607476|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
64607477|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607478|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607479|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
64607480|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64607481|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64607482|NCT02513212|Fluorides|fluorides|mesh-list
64607483|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
64607484|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
64607485|NCT02513212|Protective Agents|protective agents|mesh-ancestor
64607486|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607487|NCT02513446|Itraconazole|itraconazole|mesh-list
64607488|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
64607489|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607490|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64607491|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64607492|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607493|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607504|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607505|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64607506|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
64332892|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
64607507|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607508|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607509|NCT04687800|Dexamethasone|dexamethasone|mesh-list
64607510|NCT04687800|Difluprednate|difluprednate|mesh-list
64607511|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607512|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
64607513|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
64607514|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607515|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607516|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64607517|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
64607518|NCT04687800|Hormones|hormones|mesh-ancestor
64607519|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607520|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64607521|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607522|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
64607523|NCT00864383|Rifampin|rifampin|mesh-list
64607524|NCT00864383|Isoniazid|isoniazid|mesh-list
64607525|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
64607526|NCT00864383|Ethambutol|ethambutol|mesh-list
64607527|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607528|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607529|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64607530|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64607531|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607532|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607533|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607534|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64607535|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
64607536|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
64607537|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64607538|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64607539|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64607540|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64607550|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64607551|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64607553|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
64607554|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64607555|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
64607556|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607557|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607558|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64607559|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607560|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
64607561|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607562|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
64607563|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607564|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607565|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
64607566|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
64607567|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607568|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64607569|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
64607570|NCT05532072|Hormones|hormones|mesh-ancestor
64607571|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607572|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64607573|NCT05532072|Protective Agents|protective agents|mesh-ancestor
64607574|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64607576|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64607577|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
64607578|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64607579|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
64607580|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607581|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607582|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64607583|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64607584|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607585|NCT00864539|Vitamin D|vitamin d|mesh-list
64607586|NCT00864539|Calcium|calcium|mesh-list
64607587|NCT00864539|Vitamins|vitamins|mesh-ancestor
64607588|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
64607589|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607590|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64607591|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64607592|NCT00827255|Cyclosporine|cyclosporine|mesh-list
64607593|NCT00827255|Cyclosporins|cyclosporins|mesh-list
64607594|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607595|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607596|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607597|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
64607598|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607599|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
64607600|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607601|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
64607602|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607603|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64607604|NCT04458610|Rituximab|rituximab|mesh-list
64607605|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64607606|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
64607607|NCT04458610|Antibodies|antibodies|mesh-list
64607608|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
64607609|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64607610|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
64607611|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607612|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607613|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607614|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607615|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607616|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607617|NCT02153489|Bromides|bromides|mesh-list
64607618|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
64607619|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
64607620|NCT04627012|Lenvatinib|lenvatinib|mesh-list
64607621|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64607622|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363672|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
64607623|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607624|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607625|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607626|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
64607627|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607628|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607629|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607630|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607631|NCT00866879|Sirolimus|sirolimus|mesh-list
64607632|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64607652|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607653|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64607654|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
64607655|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
64607656|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
64607657|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64607658|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
64607659|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607660|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607661|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607662|NCT02955940|Capecitabine|capecitabine|mesh-list
64607663|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64607664|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
64607665|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607666|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607667|NCT00828191|Progesterone|progesterone|mesh-list
64607668|NCT00828191|Progestins|progestins|mesh-ancestor
64607669|NCT00828191|Hormones|hormones|mesh-ancestor
64607687|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607688|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
64607689|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64607690|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64607691|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607692|NCT00828347|Vitamins|vitamins|mesh-ancestor
64607693|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
64607694|NCT02939872|Aspirin|aspirin|mesh-list
64607695|NCT02939872|Clopidogrel|clopidogrel|mesh-list
64607696|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64607697|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64607698|NCT02939872|Analgesics|analgesics|mesh-ancestor
64607699|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
64607700|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296785|NCT02809820|Protective Agents|protective agents|mesh-ancestor
64607702|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607703|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607704|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64607705|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64607706|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607707|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64607721|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
64607722|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607723|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607724|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607725|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64607726|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
64607727|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
64607729|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607730|NCT04303702|Oxytocin|oxytocin|mesh-list
64607731|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
64607732|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64607733|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607735|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607736|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296812|NCT01673594|Naltrexone|naltrexone|mesh-list
64607737|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64363682|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607738|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607739|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64607741|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
64607742|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
64607743|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607744|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607745|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
64607746|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607747|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64607748|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64607749|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64607764|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64607765|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64607766|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64607767|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64607768|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607770|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64607771|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607772|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
64607773|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
64607774|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
64607775|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607777|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607778|NCT01606176|Nabiximols|nabiximols|mesh-list
64607779|NCT01606176|Analgesics|analgesics|mesh-ancestor
64607781|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607782|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607783|NCT00913081|Quercetin|quercetin|mesh-list
64607784|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
64607785|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607786|NCT00913081|Protective Agents|protective agents|mesh-ancestor
64607787|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607796|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607797|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607798|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607799|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607800|NCT00371020|Heparin|heparin|mesh-list
64607801|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64607802|NCT00371020|Tinzaparin|tinzaparin|mesh-list
64607803|NCT00371020|Dalteparin|dalteparin|mesh-list
64607804|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
64607805|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64607806|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64607807|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607808|NCT04476628|Budesonide|budesonide|mesh-list
64607809|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64607810|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64607811|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
64607812|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607813|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607814|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64607815|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
64607816|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
64607817|NCT04476628|Hormones|hormones|mesh-ancestor
64607818|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64607819|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64607820|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607821|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607822|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607823|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607824|NCT04378231|Amoxicillin|amoxicillin|mesh-list
64607825|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
64607826|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
64607827|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64607843|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64607844|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64607845|NCT00832637|Gemcitabine|gemcitabine|mesh-list
64607846|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64607847|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607848|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64607849|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
64607850|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607851|NCT00832637|Antiviral Agents|antiviral agents|mesh-ancestor
64607852|NCT00832637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607853|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607854|NCT00832637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64607855|NCT00832637|Immunologic Factors|immunologic factors|mesh-ancestor
64607856|NCT00832637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607857|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64607858|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64607859|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607860|NCT00370240|Ropivacaine|ropivacaine|mesh-list
64607861|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
64607862|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
64607863|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64607864|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607865|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
64607866|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607867|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
64607868|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64607869|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
64607883|NCT00915655|Darunavir|darunavir|mesh-list
64333267|NCT04020445|Insulin|insulin|mesh-list
64607884|NCT00915655|Lamivudine|lamivudine|mesh-list
64607885|NCT00915655|Zidovudine|zidovudine|mesh-list
64607886|NCT00915655|Abacavir|abacavir|mesh-list
64607887|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64607888|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64607889|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
64607890|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64607891|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607892|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64607893|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64607894|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
64607895|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607896|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64607897|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64607898|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64607899|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64607900|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
64607901|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
64607922|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64607924|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
64607925|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607926|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
64607927|NCT01728961|Lumefantrine|lumefantrine|mesh-list
64607928|NCT01728961|Artemether|artemether|mesh-list
64607929|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64607930|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
64607931|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64607932|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64607933|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607934|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
64607935|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64607936|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64607937|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
64607938|NCT00872027|Citalopram|citalopram|mesh-list
64607959|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64607960|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64607961|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64607962|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64607963|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
64607964|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363736|NCT04804735|Anesthetics|anesthetics|mesh-list
64607965|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64607966|NCT02576652|Tetracycline|tetracycline|mesh-list
64607977|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
64607978|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607979|NCT01743742|Protective Agents|protective agents|mesh-ancestor
64607980|NCT01723735|Ezetimibe|ezetimibe|mesh-list
64607981|NCT01723735|Fenofibrate|fenofibrate|mesh-list
64607982|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64607983|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64607984|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
64607985|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607986|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64607987|NCT00872729|Cysteamine|cysteamine|mesh-list
64607988|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64607989|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64607990|NCT04640376|Acetaminophen|acetaminophen|mesh-list
64607991|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64607992|NCT04640376|Analgesics|analgesics|mesh-ancestor
64607993|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
64607994|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64607995|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64607996|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
64607997|NCT00832871|Mifepristone|mifepristone|mesh-list
64607998|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64607999|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
64608000|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64608001|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608002|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64608003|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64608004|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64608005|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
64608012|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64608013|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64608014|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608015|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608017|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
64608018|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
64608019|NCT01729663|Molgramostim|molgramostim|mesh-list
64608020|NCT01729663|Sargramostim|sargramostim|mesh-list
64608021|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
64608022|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608023|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
64608024|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608025|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
64608026|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608027|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64608029|NCT05530122|Golimumab|golimumab|mesh-list
64608030|NCT05530122|Infliximab|infliximab|mesh-list
64608032|NCT05530122|Vedolizumab|vedolizumab|mesh-list
64608033|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608034|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297144|NCT02061475|Lidocaine|lidocaine|mesh-list
64608036|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64608037|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64608038|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64608039|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
64608040|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608041|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
64608042|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
64608043|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608044|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
64608062|NCT05518578|Protective Agents|protective agents|mesh-ancestor
64608064|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
64608065|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608067|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608068|NCT03058978|Etonogestrel|etonogestrel|mesh-list
64608069|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64608070|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
64608071|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64608072|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608073|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64608074|NCT00212134|Dipivefrin|dipivefrin|mesh-list
64608075|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608076|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608077|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608078|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608079|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608080|NCT00913627|Ibuprofen|ibuprofen|mesh-list
64608081|NCT00913627|Naproxen|naproxen|mesh-list
64608082|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64608083|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608084|NCT00913627|Analgesics|analgesics|mesh-ancestor
64608085|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
64608093|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
64608095|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608096|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64608097|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608098|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608099|NCT04297176|Vancomycin|vancomycin|mesh-list
64608100|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608101|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608102|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
64608103|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64608104|NCT02425306|Poly ICLC|poly iclc|mesh-list
64608105|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
64608106|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608107|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64608108|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608109|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64608110|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
64608111|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608112|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608113|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64608114|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64608115|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
64608116|NCT04052698|Factor VIII|factor viii|mesh-list
64608117|NCT04052698|Coagulants|coagulants|mesh-ancestor
64608118|NCT05523102|Acetaminophen|acetaminophen|mesh-list
64608119|NCT05523102|Ketorolac|ketorolac|mesh-list
64608120|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608121|NCT05523102|Analgesics|analgesics|mesh-ancestor
64608122|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
64608123|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608124|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608125|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
64608126|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64608127|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608128|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608129|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64363814|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
64608130|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608131|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608133|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
64608134|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64608135|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64608136|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608137|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608138|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64608139|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64608140|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64608141|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64608142|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
64608143|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
64608158|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608159|NCT04141020|Sirolimus|sirolimus|mesh-list
64608160|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608161|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608162|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64608163|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608164|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
64608165|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64608166|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
64608167|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608168|NCT02740114|Oxycodone|oxycodone|mesh-list
64608169|NCT02740114|Bupivacaine|bupivacaine|mesh-list
64608170|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
64608171|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
64608172|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608174|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
64608175|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608176|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64608177|NCT02740114|Narcotics|narcotics|mesh-ancestor
64608178|NCT02740114|Analgesics|analgesics|mesh-ancestor
64608179|NCT03999268|Insulin|insulin|mesh-list
64608180|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64608184|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64608185|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608186|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608188|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
64608189|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608190|NCT01729897|Fentanyl|fentanyl|mesh-list
64608191|NCT01729897|Propofol|propofol|mesh-list
64608192|NCT01729897|Etomidate|etomidate|mesh-list
64608193|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64608194|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608195|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608196|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64608197|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
64608198|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
64608199|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64608200|NCT01729897|Narcotics|narcotics|mesh-ancestor
64608203|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608204|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64608205|NCT01048177|Lidocaine|lidocaine|mesh-list
64608206|NCT01048177|Heparin|heparin|mesh-list
64608207|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
64608208|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
64608209|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608210|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608211|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
64608212|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608213|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64608214|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64608215|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64608216|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363833|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64608217|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608218|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
64608219|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64608220|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64608221|NCT02740582|Tolcapone|tolcapone|mesh-list
64608222|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64608223|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64608224|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64608225|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608226|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608227|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
64608228|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64608229|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64608230|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64608231|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608232|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
64608233|NCT05453266|Coagulants|coagulants|mesh-ancestor
64608234|NCT02740660|Caffeine|caffeine|mesh-list
64608235|NCT02740660|Albuterol|albuterol|mesh-list
64608236|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64608237|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608238|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64608239|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608240|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608241|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64608242|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64608243|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
64608250|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
64608251|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64608252|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64608253|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64608254|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608255|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608257|NCT05516862|Salicylates|salicylates|mesh-list
64608258|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
64608259|NCT05516862|Menthol|menthol|mesh-list
64608260|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64608261|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608262|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
64608263|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
64608264|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64608265|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608266|NCT05516862|Analgesics|analgesics|mesh-ancestor
64608267|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
64608268|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608269|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608270|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608271|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608272|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64608273|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608274|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608275|NCT03929068|Levodopa|levodopa|mesh-list
64608276|NCT03929068|Carbidopa|carbidopa|mesh-list
64608277|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64608278|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64608279|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64608280|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
64608281|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608282|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608283|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608284|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64608285|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608286|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64363846|NCT00702325|Budesonide|budesonide|mesh-list
64608287|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
64608288|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
64608289|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64608290|NCT03910972|Vaccines|vaccines|mesh-list
64608291|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
64608292|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608293|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64608294|NCT03910972|Antacids|antacids|mesh-ancestor
64608295|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608296|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64608297|NCT05516784|Clopidogrel|clopidogrel|mesh-list
64608298|NCT05516784|Ticagrelor|ticagrelor|mesh-list
64608299|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64608300|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64608301|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64608302|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64608303|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
64608312|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
64608313|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
64608314|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
64608315|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608316|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608325|NCT02571972|Timolol|timolol|mesh-list
64608326|NCT02571972|Dorzolamide|dorzolamide|mesh-list
64608327|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64608328|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64608329|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608330|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608331|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608332|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608333|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64608334|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64608343|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608344|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608345|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64608346|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64608347|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
64608348|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608349|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608350|NCT00371332|Minocycline|minocycline|mesh-list
64608351|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608352|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608353|NCT00842075|Pramlintide|pramlintide|mesh-list
64608354|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64608355|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608357|NCT00879359|Bevacizumab|bevacizumab|mesh-list
64608358|NCT00879359|Carboplatin|carboplatin|mesh-list
64608359|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64608360|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608361|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
64608362|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
64608363|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
64608364|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608365|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608366|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64608367|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64608368|NCT00879359|Growth Substances|growth substances|mesh-ancestor
64608369|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608370|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
64608371|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64608372|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
64608373|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64608374|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64608375|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64608376|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608377|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608378|NCT00880997|Doxazosin|doxazosin|mesh-list
64608379|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64608380|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64608381|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64608382|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64608383|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608384|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608385|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608386|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608387|NCT05527548|Alendronate|alendronate|mesh-list
64608388|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64608389|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608390|NCT00883103|Lidocaine|lidocaine|mesh-list
64608407|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64608408|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608409|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64608410|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608411|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608412|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64608413|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64608414|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
64608415|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608416|NCT00370630|Triamcinolone|triamcinolone|mesh-list
64608417|NCT00370630|Bevacizumab|bevacizumab|mesh-list
64608418|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608419|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608420|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64608421|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64608422|NCT00370630|Growth Substances|growth substances|mesh-ancestor
64608423|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608424|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
64608425|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608426|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
64608427|NCT00370630|Hormones|hormones|mesh-ancestor
64608428|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608429|NCT04984980|Gemcitabine|gemcitabine|mesh-list
64608430|NCT04984980|Bevacizumab|bevacizumab|mesh-list
64608431|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
64608432|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608433|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608434|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64608451|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64608453|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608454|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
64608455|NCT04981158|Anesthetics|anesthetics|mesh-list
64608456|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
64608457|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608458|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608459|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64608460|NCT03387670|Simvastatin|simvastatin|mesh-list
64608461|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64608462|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64608463|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
64608464|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608465|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64608466|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64608467|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608468|NCT04979832|Metronidazole|metronidazole|mesh-list
64608469|NCT04979832|Fosfomycin|fosfomycin|mesh-list
64608470|NCT04979832|Molgramostim|molgramostim|mesh-list
64608488|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608489|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64608490|NCT04906096|GDC-0084|gdc-0084|mesh-list
64608491|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608492|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608493|NCT00371410|Triamcinolone|triamcinolone|mesh-list
64608494|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64608495|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64608496|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64608497|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608498|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
64608499|NCT00371410|Hormones|hormones|mesh-ancestor
64608500|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608501|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608502|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64608503|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
64608504|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608505|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608506|NCT04659616|Cytarabine|cytarabine|mesh-list
64608507|NCT04659616|Daunorubicin|daunorubicin|mesh-list
64608508|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64608509|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
64608510|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608524|NCT04295850|Analgesics|analgesics|mesh-ancestor
64608525|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
64608526|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608527|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608528|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608529|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608530|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64608531|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64608532|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608533|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64608534|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64608535|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608536|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
64608537|NCT03338920|Sumatriptan|sumatriptan|mesh-list
64608538|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64608539|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64608540|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64608541|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
64608542|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608543|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608544|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608546|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64608547|NCT02166905|Poly ICLC|poly iclc|mesh-list
64608548|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
64608549|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
64608550|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608551|NCT02166905|Laxatives|laxatives|mesh-ancestor
64608552|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64608553|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
64608554|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608555|NCT02743078|Bevacizumab|bevacizumab|mesh-list
64608556|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608557|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608558|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64608559|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64608560|NCT02743078|Growth Substances|growth substances|mesh-ancestor
64608561|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608562|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
64608573|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608574|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64608575|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64608576|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
64608577|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608579|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608580|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
64608581|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608582|NCT00371488|Lapatinib|lapatinib|mesh-list
64608583|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608584|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64608585|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608586|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608587|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
64608588|NCT00883415|Hematinics|hematinics|mesh-ancestor
64608589|NCT05526690|Metformin|metformin|mesh-list
64608590|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64608591|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608592|NCT03751709|Blinatumomab|blinatumomab|mesh-list
64608593|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608594|NCT04337632|Paclitaxel|paclitaxel|mesh-list
64608595|NCT04337632|Carboplatin|carboplatin|mesh-list
64608596|NCT04337632|Doxorubicin|doxorubicin|mesh-list
64608597|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64608598|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64608599|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608620|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64608621|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
64608622|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
64608623|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64608624|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64608625|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608626|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608627|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608628|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608629|NCT05348980|Protective Agents|protective agents|mesh-ancestor
64608630|NCT00884585|Cyclosporine|cyclosporine|mesh-list
64608631|NCT00884585|Cyclosporins|cyclosporins|mesh-list
64608637|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
64608638|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608639|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
64608640|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608641|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64608642|NCT00884897|Oxytocin|oxytocin|mesh-list
64608643|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
64608644|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64608645|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608646|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
64608647|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64608648|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64608649|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64608650|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64608651|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608652|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
64608653|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608654|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608656|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608657|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
64608658|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64608659|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608660|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608661|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608662|NCT03384563|Analgesics|analgesics|mesh-ancestor
64608663|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
64608664|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608665|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64608666|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64608667|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608668|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608669|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608670|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608671|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
64608672|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
64608673|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608674|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64608675|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608676|NCT02748070|Fluticasone|fluticasone|mesh-list
64608677|NCT02748070|Prednisone|prednisone|mesh-list
64608678|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608679|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
64608680|NCT02748070|Hormones|hormones|mesh-ancestor
64608681|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608682|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608683|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64608684|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608685|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64608686|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
64608687|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608695|NCT05149638|Cosyntropin|cosyntropin|mesh-list
64608696|NCT05149638|Hormones|hormones|mesh-ancestor
64608697|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608698|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608699|NCT05519670|Niraparib|niraparib|mesh-list
64608700|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64608701|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608702|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608703|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608704|NCT05519592|Ropivacaine|ropivacaine|mesh-list
64608705|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
64608706|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
64608707|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608708|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608709|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
64608710|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608711|NCT05519514|Budesonide|budesonide|mesh-list
64608712|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608713|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64608715|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608716|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608717|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64608718|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
64608719|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
64608720|NCT05519514|Hormones|hormones|mesh-ancestor
64608721|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64608722|NCT02756572|Cytarabine|cytarabine|mesh-list
64608723|NCT02756572|Cyclosporine|cyclosporine|mesh-list
64608724|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
64608725|NCT02756572|Sirolimus|sirolimus|mesh-list
64608726|NCT02756572|Fludarabine|fludarabine|mesh-list
64608727|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
64608728|NCT02756572|Melphalan|melphalan|mesh-list
64608729|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
64608730|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
64608731|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64608732|NCT02756572|Cladribine|cladribine|mesh-list
64608733|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64608734|NCT02756572|Cyclosporins|cyclosporins|mesh-list
64608735|NCT02756572|Lenograstim|lenograstim|mesh-list
64608736|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608737|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64608738|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
64608739|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608740|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64608741|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
64608742|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608743|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
64608744|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608745|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64608752|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64608753|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
64608754|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608755|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64608756|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
64608757|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64608758|NCT02756572|Analgesics|analgesics|mesh-ancestor
64608759|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
64608760|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608761|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64608762|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64608763|NCT01049035|Vaccines|vaccines|mesh-list
64608764|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64608765|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
64608766|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608767|NCT05131698|Lenvatinib|lenvatinib|mesh-list
64608768|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608769|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64608770|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608771|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608772|NCT01724983|Fentanyl|fentanyl|mesh-list
64608774|NCT01724983|Analgesics|analgesics|mesh-ancestor
64608775|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
64608776|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608777|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608778|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64608779|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64608780|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
64608781|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
64608782|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608783|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64608784|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64608785|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608786|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608787|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64608788|NCT01724983|Narcotics|narcotics|mesh-ancestor
64608789|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64608790|NCT02973958|Acetaminophen|acetaminophen|mesh-list
64608792|NCT02973958|Ketorolac|ketorolac|mesh-list
64363970|NCT00701779|Urological Agents|urological agents|mesh-ancestor
64608793|NCT02973958|Bupivacaine|bupivacaine|mesh-list
64608794|NCT02973958|Sevoflurane|sevoflurane|mesh-list
64608795|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
64608796|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
64608797|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608798|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608821|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64608822|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64608823|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608824|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608825|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608826|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608827|NCT05513976|Febuxostat|febuxostat|mesh-list
64608828|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
64608829|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608830|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
64608853|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64608854|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
64608855|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64608856|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64608857|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64608858|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
64608859|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608860|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608861|NCT05040360|Capecitabine|capecitabine|mesh-list
64608862|NCT05040360|Temozolomide|temozolomide|mesh-list
64608863|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64608864|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
64608865|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608872|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64608874|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608875|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64608876|NCT02760862|Diuretics|diuretics|mesh-ancestor
64608877|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
64608878|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608879|NCT05720637|Serotonin|serotonin|mesh-list
64608880|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64608881|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
64608882|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64608883|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608884|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608885|NCT05720559|Folic Acid|folic acid|mesh-list
64608886|NCT05720559|Vitamin A|vitamin a|mesh-list
64608887|NCT05720559|Metronidazole|metronidazole|mesh-list
64608888|NCT05720559|Capecitabine|capecitabine|mesh-list
64608889|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
64608890|NCT05720559|Cetuximab|cetuximab|mesh-list
64608891|NCT05720559|Vitamins|vitamins|mesh-ancestor
64608892|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
64608893|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608894|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64608895|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
64608896|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608897|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608898|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64608899|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608900|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608901|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64608902|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64608913|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64608914|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608915|NCT05714475|Pancrelipase|pancrelipase|mesh-list
64608916|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64608917|NCT01047007|Cisplatin|cisplatin|mesh-list
64608918|NCT01047007|Adavosertib|adavosertib|mesh-list
64608919|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64608920|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608921|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608922|NCT05443984|Esomeprazole|esomeprazole|mesh-list
64608923|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64608924|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64608925|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64608926|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608927|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608928|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
64608929|NCT01725607|Anesthetics|anesthetics|mesh-list
64608930|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608931|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608932|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64608933|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608934|NCT01725607|Analgesics|analgesics|mesh-ancestor
64608935|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
64608947|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64608949|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
64608950|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608951|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608952|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64608953|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608954|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64608955|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64608956|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64608957|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608958|NCT00915967|Vancomycin|vancomycin|mesh-list
64608959|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608960|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608961|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
64608962|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
64608963|NCT01044745|Busulfan|busulfan|mesh-list
64608964|NCT01044745|Rituximab|rituximab|mesh-list
64608965|NCT01044745|Fludarabine|fludarabine|mesh-list
64608966|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
64608967|NCT01044745|Tacrolimus|tacrolimus|mesh-list
64608968|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
64608969|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64608970|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64608971|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
64608972|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608973|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64608974|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64608975|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
64608976|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64608984|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64608985|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64608986|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
64608987|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64608988|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608989|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64608990|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64608991|NCT05031078|Lidocaine|lidocaine|mesh-list
64608992|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64608993|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
64608994|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
64608995|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64608996|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
64608997|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64608998|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64608999|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64609000|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64609001|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609002|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609003|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64609004|NCT03270059|Hematinics|hematinics|mesh-ancestor
64609005|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64609006|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64609007|NCT05513664|Osimertinib|osimertinib|mesh-list
64609008|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609009|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64609010|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609011|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609012|NCT03216395|Epinephrine|epinephrine|mesh-list
64380627|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
64609013|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64609014|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64609015|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
64609016|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609017|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609018|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609019|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64609020|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64609021|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
64609022|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609023|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64609024|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
64609025|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
64609026|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
64609027|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64609028|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64609029|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609030|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
64609031|NCT02767492|Hormones|hormones|mesh-ancestor
64609032|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609033|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609034|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609049|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609050|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609051|NCT04334512|Vitamin D|vitamin d|mesh-list
64609052|NCT04334512|Vitamins|vitamins|mesh-list
64609053|NCT04334512|Azithromycin|azithromycin|mesh-list
64609054|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
64609055|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
64609056|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609057|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64609058|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64609059|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609060|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
64609061|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64609062|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64609063|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609064|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609065|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609066|NCT05518812|Carboprost|carboprost|mesh-list
64609067|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
64609068|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64609069|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
64609070|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64609071|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609072|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
64609073|NCT01043185|Lesogaberan|lesogaberan|mesh-list
64609074|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609075|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64609076|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
64609077|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
64609078|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609079|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609080|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609094|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609095|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609096|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64609097|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64609098|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
64609099|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64364029|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609100|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
64609101|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
64609102|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
64609103|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64609104|NCT01042093|Analgesics|analgesics|mesh-ancestor
64609105|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64609106|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
64609107|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64609108|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64609109|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609110|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609111|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609112|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64609113|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609114|NCT03400735|Cefdinir|cefdinir|mesh-list
64609115|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64609116|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609117|NCT05100628|Doxorubicin|doxorubicin|mesh-list
64609118|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64609119|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609120|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64609121|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64609122|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609123|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609124|NCT04737928|Latanoprost|latanoprost|mesh-list
64609125|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64609126|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64609127|NCT01041859|Tapentadol|tapentadol|mesh-list
64609139|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
64609140|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609141|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64609142|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
64609144|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64609145|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
64609146|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609147|NCT03400423|Caffeine|caffeine|mesh-list
64609148|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64609149|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609150|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64609151|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609152|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609153|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64609154|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64609155|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
64609156|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609157|NCT01040845|Colchicine|colchicine|mesh-list
64609158|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64609159|NCT01040845|Norethindrone|norethindrone|mesh-list
64609160|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
64609161|NCT01040845|Estradiol|estradiol|mesh-list
64609162|NCT01040845|Estrogens|estrogens|mesh-ancestor
64609163|NCT01040845|Hormones|hormones|mesh-ancestor
64609164|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609165|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609166|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64609167|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
64609168|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64364045|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64609177|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64609178|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64609179|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64609180|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64609181|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64609182|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
64609183|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609184|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609185|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64609186|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64609187|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64609188|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
64609190|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64609191|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
64609193|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609194|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64609195|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
64609196|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
64609197|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64609198|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
64609199|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609200|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609202|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
64609203|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
64609204|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609205|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609206|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
64609207|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609208|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64609209|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64609210|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64609211|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609212|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609213|NCT03400189|Sulthiame|sulthiame|mesh-list
64609214|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
64609215|NCT04098874|Bupropion|bupropion|mesh-list
64609216|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64609217|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
64609218|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64609219|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64609220|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64609221|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609222|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609223|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
64609224|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609225|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609232|NCT04066348|Etanercept|etanercept|mesh-list
64609233|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64609234|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609235|NCT04066348|Analgesics|analgesics|mesh-ancestor
64609236|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
64609237|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609238|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609239|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609240|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609241|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609242|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609243|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
64609244|NCT04282954|Esomeprazole|esomeprazole|mesh-list
64609245|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64609246|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609247|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64364083|NCT03337087|Antidotes|antidotes|mesh-ancestor
64609248|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609249|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609250|NCT05337436|Calcium|calcium|mesh-list
64609251|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64609252|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609253|NCT04755712|Sufentanil|sufentanil|mesh-list
64609254|NCT04755712|Morphine|morphine|mesh-list
64609255|NCT04755712|Bupivacaine|bupivacaine|mesh-list
64609256|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
64609257|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
64609258|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609259|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609260|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
64609261|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609263|NCT04755712|Narcotics|narcotics|mesh-ancestor
64609264|NCT04755712|Analgesics|analgesics|mesh-ancestor
64609265|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64609266|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64609267|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
64609268|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
64609269|NCT04751812|Narcotics|narcotics|mesh-ancestor
64609271|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609272|NCT04751812|Analgesics|analgesics|mesh-ancestor
64609273|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
64609274|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609275|NCT00372736|Docetaxel|docetaxel|mesh-list
64609276|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609277|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
64609278|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
64609279|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
64609280|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609281|NCT02415712|Fomepizole|fomepizole|mesh-list
64609282|NCT02415712|Antidotes|antidotes|mesh-ancestor
64609283|NCT02415712|Protective Agents|protective agents|mesh-ancestor
64609284|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609285|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609286|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609287|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64609310|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609311|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
64609312|NCT05456542|Hormones|hormones|mesh-ancestor
64609313|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609314|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64609315|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609316|NCT03215693|Ensartinib|ensartinib|mesh-list
64609317|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609331|NCT00889187|Capecitabine|capecitabine|mesh-list
64609332|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64609333|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
64609334|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609337|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64609338|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64609339|NCT04334824|Diuretics|diuretics|mesh-ancestor
64609340|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
64609341|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609342|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64609343|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609344|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609345|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
64609346|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609347|NCT05314127|Fluorouracil|fluorouracil|mesh-list
64609348|NCT05314127|Imiquimod|imiquimod|mesh-list
64609349|NCT05314127|Tazarotene|tazarotene|mesh-list
64609350|NCT05314127|Petrolatum|petrolatum|mesh-list
64609351|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
64609352|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609353|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64609354|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609355|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609356|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
64609357|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609358|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64609359|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
64609360|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
64609361|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
64609362|NCT05314127|Emollients|emollients|mesh-ancestor
64609363|NCT03130127|Terlipressin|terlipressin|mesh-list
64609364|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64609374|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609375|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609376|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609377|NCT00373048|Mefloquine|mefloquine|mesh-list
64609378|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
64609379|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64609380|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64609381|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609382|NCT00372892|Rituximab|rituximab|mesh-list
64609383|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609384|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609385|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
64609386|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609387|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609388|NCT00895817|Fluticasone|fluticasone|mesh-list
64609389|NCT00895817|Esomeprazole|esomeprazole|mesh-list
64609390|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609391|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64609392|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
64609393|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609394|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609395|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64609396|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
64609397|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
64609398|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64609399|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64609400|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609401|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64609402|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609403|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609405|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64609406|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
64609407|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609408|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609410|NCT03020303|Diuretics|diuretics|mesh-ancestor
64609411|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
64609412|NCT04825522|Vancomycin|vancomycin|mesh-list
64609413|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64609414|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609415|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
64609416|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609417|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64609418|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
64609419|NCT00373282|Triamcinolone|triamcinolone|mesh-list
64609420|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64609421|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64609422|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64609423|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609424|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
64609425|NCT00373282|Hormones|hormones|mesh-ancestor
64609434|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64609435|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609436|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
64609437|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
64609438|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
64609439|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609440|NCT04382027|Vitamins|vitamins|mesh-list
64609441|NCT04382027|Vitamin K|vitamin k|mesh-list
64609442|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
64609443|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
64609444|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609445|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64609446|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64609447|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609448|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
64609449|NCT04382027|Coagulants|coagulants|mesh-ancestor
64609450|NCT00896441|Citalopram|citalopram|mesh-list
64609451|NCT00896441|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64609452|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64609453|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609454|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609455|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609456|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
64609457|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609458|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64609459|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
64609460|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64609461|NCT02790515|Sirolimus|sirolimus|mesh-list
64609462|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
64609463|NCT02790515|Melphalan|melphalan|mesh-list
64609464|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
64609465|NCT02790515|Thiotepa|thiotepa|mesh-list
64609466|NCT02790515|Rituximab|rituximab|mesh-list
64609467|NCT02790515|Fludarabine|fludarabine|mesh-list
64334857|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
64609468|NCT02790515|Blinatumomab|blinatumomab|mesh-list
64609469|NCT02790515|Tacrolimus|tacrolimus|mesh-list
64609470|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
64609477|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
64609478|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609479|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609480|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64609481|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609482|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64609483|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609484|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64609485|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609486|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64609487|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
64609489|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609490|NCT03400111|Analgesics|analgesics|mesh-ancestor
64609491|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
64609492|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609493|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609494|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
64609495|NCT03404791|Gemcitabine|gemcitabine|mesh-list
64609496|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64609497|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
64609498|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609499|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609500|NCT03404791|Antiviral Agents|antiviral agents|mesh-ancestor
64609501|NCT03404791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609502|NCT03404791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609503|NCT03404791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609504|NCT03404791|Immunologic Factors|immunologic factors|mesh-ancestor
64609505|NCT03404791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609507|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609508|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609509|NCT03404011|Glycerol|glycerol|mesh-list
64609510|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64609511|NCT03404011|Protective Agents|protective agents|mesh-ancestor
64609512|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609513|NCT01830491|Aspirin|aspirin|mesh-list
64609514|NCT01830491|Clopidogrel|clopidogrel|mesh-list
64609515|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64609516|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609517|NCT01830491|Analgesics|analgesics|mesh-ancestor
64609518|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
64609519|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609520|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609552|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
64609553|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609554|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64609555|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64609556|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609557|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609558|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64609559|NCT02778880|Narcotics|narcotics|mesh-ancestor
64609560|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64609562|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
64609563|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
64609564|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64609565|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64609566|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
64609567|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609568|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609569|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609570|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64609571|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
64609572|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
64609573|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609574|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64609575|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64609576|NCT00891995|Insulin|insulin|mesh-list
64609577|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64609578|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609588|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609589|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
64609590|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609591|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64609592|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609593|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64609594|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609595|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609596|NCT01831193|Curcumin|curcumin|mesh-list
64609597|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64609598|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609599|NCT01831193|Analgesics|analgesics|mesh-ancestor
64609600|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
64609601|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609602|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609603|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609604|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609605|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609606|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609607|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609608|NCT01831505|Prednisolone|prednisolone|mesh-list
64609609|NCT01831505|Rituximab|rituximab|mesh-list
64609610|NCT01831505|Doxorubicin|doxorubicin|mesh-list
64609611|NCT01831505|Vincristine|vincristine|mesh-list
64609612|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64609613|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609614|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609615|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
64609616|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609617|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609618|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64609619|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64380655|NCT03193463|Topotecan|topotecan|mesh-list
64609620|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64609621|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609622|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609623|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64609624|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
64609625|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
64609626|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
64609627|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609628|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
64609629|NCT01831505|Hormones|hormones|mesh-ancestor
64609630|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609631|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64609632|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64609645|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609646|NCT03213977|Prednisone|prednisone|mesh-list
64297189|NCT00795158|Desloratadine|desloratadine|mesh-list
64609648|NCT03213977|Doxorubicin|doxorubicin|mesh-list
64609649|NCT03213977|Etoposide|etoposide|mesh-list
64609650|NCT03213977|Vincristine|vincristine|mesh-list
64609651|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609652|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
64609653|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609654|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609655|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64609656|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
64609657|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609658|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609659|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64609660|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64609661|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64609662|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64609663|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609664|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64609665|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609666|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
64609667|NCT03213977|Hormones|hormones|mesh-ancestor
64609668|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64609669|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64609670|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
64609671|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
64609672|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
64609673|NCT05311085|Nicotine|nicotine|mesh-list
64609674|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64609675|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
64609676|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609677|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609678|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64609689|NCT03400267|Analgesics|analgesics|mesh-ancestor
64609690|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
64609691|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609692|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64609693|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64609694|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
64609695|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
64609696|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609697|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
64609698|NCT01832051|Trastuzumab|trastuzumab|mesh-list
64609699|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609700|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609701|NCT01832129|Vitamins|vitamins|mesh-list
64609702|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
64609703|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
64609704|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
64380663|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64609705|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
64609706|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609707|NCT01832129|Hematinics|hematinics|mesh-ancestor
64609708|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
64609709|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
64609710|NCT03219359|Vedolizumab|vedolizumab|mesh-list
64609711|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
64609712|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64609713|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
64609714|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609715|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64609716|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64609717|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
64609718|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609719|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609720|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64609721|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64609722|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
64609723|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
64609724|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609725|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64609754|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64609755|NCT01832285|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64609756|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64609757|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609758|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609759|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609760|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
64609761|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64609762|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
64609763|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64609764|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64609765|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609766|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64609768|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64609769|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
64609770|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
64609771|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609772|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609773|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
64609774|NCT02903836|Nafithromycin|nafithromycin|mesh-list
64609775|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64609776|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609777|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64609778|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64609779|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609780|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609781|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609782|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64609783|NCT00014911|Sirolimus|sirolimus|mesh-list
64609784|NCT00014911|Pentamidine|pentamidine|mesh-list
64609785|NCT00014911|Trimethoprim|trimethoprim|mesh-list
64609786|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
64609787|NCT00014911|Ganciclovir|ganciclovir|mesh-list
64609808|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64609809|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64609810|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64609811|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
64609820|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609821|NCT03213587|Apatinib|apatinib|mesh-list
64609822|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609823|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64609824|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609825|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609826|NCT00013897|Lamivudine|lamivudine|mesh-list
64609827|NCT00013897|Zidovudine|zidovudine|mesh-list
64609828|NCT00013897|Efavirenz|efavirenz|mesh-list
64609829|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64609830|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64609831|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64609832|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64609833|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609834|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609835|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
64609836|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609837|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64609838|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64609839|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
64609840|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64609841|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64609842|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64335232|NCT02233205|Immunologic Factors|immunologic factors|mesh-ancestor
64609843|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64609844|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64609845|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64609846|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64609847|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64609848|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
64609849|NCT03219983|Bupivacaine|bupivacaine|mesh-list
64609850|NCT03219983|Ropivacaine|ropivacaine|mesh-list
64609851|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
64609852|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
64609853|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609854|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609867|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
64609868|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64609869|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
64609870|NCT03213353|Acetaminophen|acetaminophen|mesh-list
64609871|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
64609872|NCT03213353|Phenylephrine|phenylephrine|mesh-list
64609873|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
64609874|NCT03213353|Guaifenesin|guaifenesin|mesh-list
64609875|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64609876|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64609877|NCT03213353|Analgesics|analgesics|mesh-ancestor
64609878|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
64609879|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64609880|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609881|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
64609882|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64609883|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
64609884|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
64609885|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
64609886|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64609887|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
64609888|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
64609889|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64609890|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64609891|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64609892|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
64609893|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609915|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
64609916|NCT03219593|Apatinib|apatinib|mesh-list
64609917|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609918|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64609919|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609920|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609922|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64609923|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64609924|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609925|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609926|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609927|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64609928|NCT03836807|Ketoprofen|ketoprofen|mesh-list
64609929|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
64609930|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64609946|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64609948|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64609949|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64609950|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64609951|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64609952|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64609953|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
64609954|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609955|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609956|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64609967|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
64609968|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64609969|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609970|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
64609971|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64609972|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64609973|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64609974|NCT03219671|Nivolumab|nivolumab|mesh-list
64609975|NCT03219671|Ipilimumab|ipilimumab|mesh-list
64609976|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64609977|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64609978|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64609979|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609980|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
64609981|NCT03404635|Apixaban|apixaban|mesh-list
64609982|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64609983|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
64609984|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64609985|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
64609986|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64609987|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64609988|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
64609989|NCT01832987|Trimethoprim|trimethoprim|mesh-list
64609990|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64609991|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
64609992|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64609993|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64609994|NCT01832987|Renal Agents|renal agents|mesh-ancestor
64609995|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
64610003|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64610004|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610006|NCT03404479|Diacetylrhein|diacetylrhein|mesh-list
64610007|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64610008|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64610009|NCT03404479|Analgesics|analgesics|mesh-ancestor
64610010|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
64610016|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64430031|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610018|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610020|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
64610021|NCT04380467|Vitamins|vitamins|mesh-ancestor
64610022|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
64610023|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610024|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64610025|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64610026|NCT03218657|Cyclosporine|cyclosporine|mesh-list
64610027|NCT03218657|Levamisole|levamisole|mesh-list
64610028|NCT03218657|Cyclosporins|cyclosporins|mesh-list
64610029|NCT03218657|Androgens|androgens|mesh-list
64610030|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610031|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610032|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610033|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
64610034|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610035|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
64610036|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610037|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
64610038|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610039|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64610041|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610042|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64610043|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
64610044|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
64610045|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64610046|NCT02240719|Everolimus|everolimus|mesh-list
64610047|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64610050|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
64610051|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610052|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64610053|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
64610054|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610055|NCT01833299|Sorafenib|sorafenib|mesh-list
64610056|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
64610057|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610058|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64610059|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610060|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610061|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64610062|NCT01833299|Estrogens|estrogens|mesh-ancestor
64610063|NCT01833299|Hormones|hormones|mesh-ancestor
64610064|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610065|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610066|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64610067|NCT03213041|Carboplatin|carboplatin|mesh-list
64610068|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
64610069|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610070|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610072|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
64610073|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610074|NCT02240953|Warfarin|warfarin|mesh-list
64610075|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
64610076|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
64610077|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64610078|NCT02241031|Oprelvekin|oprelvekin|mesh-list
64610079|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610080|NCT03212807|Lenalidomide|lenalidomide|mesh-list
64610082|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
64610083|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610085|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64610086|NCT03212807|Growth Substances|growth substances|mesh-ancestor
64610087|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
64610088|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610089|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610090|NCT04373941|Lenograstim|lenograstim|mesh-list
64610091|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64610092|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
64610093|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610094|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
64610095|NCT01833767|Interleukin-2|interleukin-2|mesh-list
64610096|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610097|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
64610098|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610099|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610100|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64610101|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
64610102|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610103|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610104|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64610105|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64610106|NCT01833767|Analgesics|analgesics|mesh-ancestor
64610107|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
64610108|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610117|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64610118|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
64610119|NCT01834235|Antiviral Agents|antiviral agents|mesh-ancestor
64610120|NCT01834235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610121|NCT01834235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610122|NCT01834235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610123|NCT01834235|Immunologic Factors|immunologic factors|mesh-ancestor
64610124|NCT01834235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610125|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
64364090|NCT03332095|Tenofovir|tenofovir|mesh-list
64610126|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64610127|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610128|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610129|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64610131|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
64610132|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610133|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64610134|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64610135|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64610136|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
64610137|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610138|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610139|NCT03838133|Bupivacaine|bupivacaine|mesh-list
64610140|NCT03838133|Ropivacaine|ropivacaine|mesh-list
64610141|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
64610142|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
64610143|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610144|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610151|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
64610152|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610153|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64610154|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64610155|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610156|NCT00895193|Aspirin|aspirin|mesh-list
64610157|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64610158|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64610159|NCT00895193|Analgesics|analgesics|mesh-ancestor
64610160|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
64610161|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610162|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610163|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610164|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610165|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64610167|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610169|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64610170|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610171|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
64610172|NCT01834547|Caffeine|caffeine|mesh-list
64610173|NCT01834547|Methylphenidate|methylphenidate|mesh-list
64610174|NCT01834547|Modafinil|modafinil|mesh-list
64610175|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64610176|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610177|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64610178|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610179|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610180|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64610181|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64610182|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
64610183|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610184|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64610185|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64610186|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610187|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
64610188|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64610189|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64610190|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64610191|NCT03216941|Ketamine|ketamine|mesh-list
64610192|NCT03216941|Olanzapine|olanzapine|mesh-list
64610193|NCT03216941|Analgesics|analgesics|mesh-ancestor
64610194|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
64610195|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610196|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610197|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64610198|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64610199|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
64610200|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
64610201|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610202|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64610203|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64610204|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610205|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610206|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
64610207|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
64610208|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610209|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64610210|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64610211|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64610212|NCT03216941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64430032|NCT04949867|Hormones|hormones|mesh-ancestor
64610213|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64610214|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610215|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
64610217|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
64610233|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610234|NCT03211013|Oxytocin|oxytocin|mesh-list
64610235|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
64610236|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610237|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610238|NCT01835561|Thalidomide|thalidomide|mesh-list
64610239|NCT01835561|Pomalidomide|pomalidomide|mesh-list
64610240|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
64610241|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610242|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64610243|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64610244|NCT01835561|Growth Substances|growth substances|mesh-ancestor
64610245|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
64610246|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610247|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610248|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
64610249|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610250|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610251|NCT01835639|Vitamin D|vitamin d|mesh-list
64610252|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
64610271|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
64610272|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610273|NCT00901199|Siderophores|siderophores|mesh-ancestor
64610274|NCT01836341|Carboplatin|carboplatin|mesh-list
64610275|NCT01836341|Pemetrexed|pemetrexed|mesh-list
64610276|NCT01836341|Afatinib|afatinib|mesh-list
64610277|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610278|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610279|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610280|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64610281|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64610282|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64610283|NCT00906503|Dexamethasone|dexamethasone|mesh-list
64610284|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64610285|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610286|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
64610287|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
64610296|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64610297|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610298|NCT01836575|Carboplatin|carboplatin|mesh-list
64610300|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610301|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610302|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610303|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64610304|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64610305|NCT01836653|Bevacizumab|bevacizumab|mesh-list
64610306|NCT01836653|Cetuximab|cetuximab|mesh-list
64610307|NCT01836653|Fluorouracil|fluorouracil|mesh-list
64610308|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
64610309|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610310|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610311|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64610312|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64610313|NCT01836653|Growth Substances|growth substances|mesh-ancestor
64610314|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610315|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
64610316|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
64610317|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610318|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64610319|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610320|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
64610321|NCT03836885|Apremilast|apremilast|mesh-list
64610322|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64610323|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64610324|NCT03836885|Analgesics|analgesics|mesh-ancestor
64610325|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
64610326|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610327|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610328|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610329|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610330|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64610331|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64610332|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610333|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610334|NCT01837043|Cyclosporine|cyclosporine|mesh-list
64610335|NCT01837043|Abatacept|abatacept|mesh-list
64610336|NCT01837043|Tacrolimus|tacrolimus|mesh-list
64610348|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64610350|NCT01839773|Paclitaxel|paclitaxel|mesh-list
64610351|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64610352|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64610353|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610354|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
64610355|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
64610356|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
64610357|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610358|NCT00909155|Fluoxetine|fluoxetine|mesh-list
64610359|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64610360|NCT00909155|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64610361|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64610362|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610363|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610364|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610365|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
64610366|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610367|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64610368|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
64610369|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64610370|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64610371|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64610372|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610373|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64610374|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
64610376|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610378|NCT01839929|Tacrolimus|tacrolimus|mesh-list
64610379|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610380|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
64610381|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610382|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64610383|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610384|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610385|NCT04373083|Cemiplimab|cemiplimab|mesh-list
64610386|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610387|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610388|NCT03210545|Betamethasone|betamethasone|mesh-list
64610389|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610390|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
64610391|NCT03210545|Hormones|hormones|mesh-ancestor
64610395|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
64610397|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64610398|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610399|NCT03403777|Avelumab|avelumab|mesh-list
64364115|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
64610400|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610401|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610402|NCT02241421|Amoxicillin|amoxicillin|mesh-list
64610403|NCT02241421|Vancomycin|vancomycin|mesh-list
64610404|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610405|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610406|NCT01837199|Amoxicillin|amoxicillin|mesh-list
64610407|NCT01837199|Metronidazole|metronidazole|mesh-list
64610408|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610409|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610410|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64610411|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64610412|NCT00926185|Lifitegrast|lifitegrast|mesh-list
64610413|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64610414|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64610415|NCT02241499|Fluorouracil|fluorouracil|mesh-list
64610416|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
64610417|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
64610418|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610419|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64610420|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610421|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610422|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
64610423|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610431|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610432|NCT03833947|Dexamethasone|dexamethasone|mesh-list
64610433|NCT03833947|Lidocaine|lidocaine|mesh-list
64610434|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610435|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
64610436|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
64610437|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610438|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610439|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610440|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
64610441|NCT03833947|Hormones|hormones|mesh-ancestor
64610443|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64610444|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610445|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
64610446|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
64610447|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610448|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
64610449|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64610450|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64610451|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64610452|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610453|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610454|NCT03219437|Methotrexate|methotrexate|mesh-list
64610455|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64610456|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
64610457|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610458|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610459|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64610465|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64610466|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610467|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
64610468|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610469|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64610470|NCT03212963|Clobetasol|clobetasol|mesh-list
64610471|NCT03212963|Halobetasol|halobetasol|mesh-list
64610472|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64610473|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610474|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
64610475|NCT03212963|Hormones|hormones|mesh-ancestor
64610476|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610477|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610478|NCT03218969|Ecopipam|ecopipam|mesh-list
64610479|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64610480|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64610481|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610482|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610483|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64610484|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64610485|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
64610486|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610487|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610488|NCT01830101|Temozolomide|temozolomide|mesh-list
64610489|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64610490|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
64610491|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610492|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610493|NCT01830335|Indomethacin|indomethacin|mesh-list
64610494|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64610495|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64610505|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64610506|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610507|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610509|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64610510|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610511|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610512|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64610513|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64610514|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610515|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610516|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610517|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610518|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
64610519|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
64610520|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64610521|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
64610522|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610523|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610524|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64610525|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
64610526|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
64610527|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64610528|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
64610529|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610530|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610531|NCT04371757|Doxazosin|doxazosin|mesh-list
64610532|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
64610533|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64610534|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64610535|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64610550|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64610551|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64610552|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610553|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610554|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610555|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610556|NCT02242357|Telmisartan|telmisartan|mesh-list
64610557|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64610558|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64610559|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64610560|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610561|NCT03409835|Ramosetron|ramosetron|mesh-list
64610564|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610565|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610566|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610567|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64610568|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
64610569|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610570|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610589|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610591|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
64610592|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
64335989|NCT04463953|Hormones|hormones|mesh-ancestor
64610593|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610594|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610595|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
64610596|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610597|NCT02982577|Pilocarpine|pilocarpine|mesh-list
64610598|NCT02982577|Miotics|miotics|mesh-ancestor
64610599|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
64610600|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610601|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610602|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64610603|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64610612|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610613|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
64610614|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610616|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
64610617|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64610618|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610619|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610620|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64610621|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64610622|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64610623|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64610624|NCT02242825|Telmisartan|telmisartan|mesh-list
64610625|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
64610626|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64610627|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64610628|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64610629|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610630|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64610631|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610632|NCT02242825|Diuretics|diuretics|mesh-ancestor
64610633|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
64610634|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610635|NCT04370977|Artesunate|artesunate|mesh-list
64610636|NCT04370977|Lumefantrine|lumefantrine|mesh-list
64610637|NCT04370977|Artemether|artemether|mesh-list
64610638|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64610639|NCT04370977|Amodiaquine|amodiaquine|mesh-list
64610640|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
64610641|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64610642|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64610643|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610644|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610645|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
64610646|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
64610647|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64610648|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
64610649|NCT01726283|Riboflavin|riboflavin|mesh-list
64610650|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
64610651|NCT01726283|Vitamins|vitamins|mesh-ancestor
64610665|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610667|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610668|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
64610669|NCT03835871|Hormones|hormones|mesh-ancestor
64610670|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610671|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610672|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64610675|NCT03402295|Dexamethasone|dexamethasone|mesh-list
64610676|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
64610677|NCT03402295|Bortezomib|bortezomib|mesh-list
64610678|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610679|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
64610680|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610681|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64610682|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64610683|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
64610684|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610685|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610686|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64610687|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610688|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
64610689|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
64610690|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610691|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610692|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
64610694|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610695|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64610696|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
64610697|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64610698|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610699|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64610700|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64610701|NCT03402295|Growth Substances|growth substances|mesh-ancestor
64610702|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
64610703|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64610704|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64610705|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610706|NCT02244073|Insulin|insulin|mesh-list
64610707|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64610708|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64610709|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610710|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64610711|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
64610712|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64610713|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
64610714|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610715|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610716|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64610717|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64610718|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610719|NCT03401827|Gemcitabine|gemcitabine|mesh-list
64610720|NCT03401827|Paclitaxel|paclitaxel|mesh-list
64610721|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64610722|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610723|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64610724|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64610725|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64610726|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610727|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64610729|NCT03401827|Antiviral Agents|antiviral agents|mesh-ancestor
64610730|NCT03401827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610731|NCT03401827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610732|NCT03401827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64610733|NCT03401827|Immunologic Factors|immunologic factors|mesh-ancestor
64610734|NCT03401827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610735|NCT00909545|Isradipine|isradipine|mesh-list
64610736|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64610737|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64610738|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610739|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610740|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64610741|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64336143|NCT02303587|Hormones|hormones|mesh-ancestor
64610742|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
64610743|NCT02244229|Tamsulosin|tamsulosin|mesh-list
64610744|NCT02244229|Finasteride|finasteride|mesh-list
64610745|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64610746|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64610747|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64610748|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
64610749|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610750|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610751|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610752|NCT02244229|Urological Agents|urological agents|mesh-ancestor
64610753|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64610754|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64610755|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610756|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
64610757|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610758|NCT02157103|Bevacizumab|bevacizumab|mesh-list
64610759|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610760|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610761|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64610773|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64610774|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
64610775|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610776|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610777|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64610778|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64610779|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64610780|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
64610781|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610782|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
64610783|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
64610784|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
64610785|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610786|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610787|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610788|NCT03401593|Fentanyl|fentanyl|mesh-list
64610789|NCT03401593|Midazolam|midazolam|mesh-list
64610790|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64610791|NCT03401593|Narcotics|narcotics|mesh-ancestor
64610792|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610793|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610795|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
64610796|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610797|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64610798|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64610799|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
64610800|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
64610801|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64610802|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64610803|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64610804|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64610805|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
64610806|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
64610814|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610815|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610816|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64610817|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64610818|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
64610820|NCT01726829|Pancreatin|pancreatin|mesh-list
64610821|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610822|NCT03408587|Ipilimumab|ipilimumab|mesh-list
64610823|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610824|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610825|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64610826|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610827|NCT03834233|Nivolumab|nivolumab|mesh-list
64610828|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610829|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610830|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64610831|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610832|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
64610833|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64610834|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64610835|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610836|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
64610837|NCT04367155|Coagulants|coagulants|mesh-ancestor
64610838|NCT01727453|Warfarin|warfarin|mesh-list
64610839|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
64610840|NCT01727531|Chloroquine|chloroquine|mesh-list
64610841|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64610842|NCT01727531|Amebicides|amebicides|mesh-ancestor
64610843|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64610844|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64610866|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610867|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64610868|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
64610869|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64610870|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610871|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64610872|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64610873|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64610874|NCT00929071|Lidocaine|lidocaine|mesh-list
64610875|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
64610876|NCT00929071|Anesthetics|anesthetics|mesh-list
64610877|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64610887|NCT01721525|Paclitaxel|paclitaxel|mesh-list
64610888|NCT01721525|Carboplatin|carboplatin|mesh-list
64610889|NCT01721525|Afatinib|afatinib|mesh-list
64610890|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64610891|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610892|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
64610893|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
64610894|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
64610895|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610896|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
64610897|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
64610898|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610899|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64610904|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610906|NCT01727843|Coagulants|coagulants|mesh-ancestor
64610907|NCT01721915|Vitamin D|vitamin d|mesh-list
64610908|NCT01721915|Vitamins|vitamins|mesh-ancestor
64610909|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
64610910|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610911|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64610912|NCT04357483|Thrombin|thrombin|mesh-list
64610913|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
64610914|NCT04357483|Coagulants|coagulants|mesh-ancestor
64610915|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
64610916|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64610917|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610918|NCT04366609|Methylphenidate|methylphenidate|mesh-list
64610919|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64610920|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610921|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64610922|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64610923|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64610924|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610925|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
64610926|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64610927|NCT03407105|Ipilimumab|ipilimumab|mesh-list
64610928|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610929|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610930|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64610931|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610932|NCT01722227|Liraglutide|liraglutide|mesh-list
64610933|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64610934|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610935|NCT01722227|Incretins|incretins|mesh-ancestor
64610936|NCT01722227|Hormones|hormones|mesh-ancestor
64610937|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610939|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
64610940|NCT01722305|Pomalidomide|pomalidomide|mesh-list
64610941|NCT01722305|Ichthammol|ichthammol|mesh-list
64610942|NCT01722305|BB 1101|bb 1101|mesh-list
64610943|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64610944|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
64610945|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
64610946|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64610947|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610948|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64610949|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
64610950|NCT01722305|Hormones|hormones|mesh-ancestor
64610951|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610952|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64610953|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610954|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
64610955|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610956|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610957|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
64610958|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64610959|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64610960|NCT01722305|Growth Substances|growth substances|mesh-ancestor
64610961|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
64610962|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
64610963|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64610964|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64610965|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610966|NCT04365517|Incretins|incretins|mesh-ancestor
64610967|NCT04365517|Hormones|hormones|mesh-ancestor
64610968|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64610969|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64610970|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
64610971|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64610972|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610973|NCT03406871|Nivolumab|nivolumab|mesh-list
64610974|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64610975|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610976|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64610977|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610979|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
64610980|NCT04357093|Fluorides|fluorides|mesh-list
64610981|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
64610982|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
64610983|NCT04357093|Protective Agents|protective agents|mesh-ancestor
64610984|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610985|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64610986|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64610987|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64610988|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64610989|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
64610990|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64610992|NCT03406793|Zinc|zinc|mesh-list
64610993|NCT03406793|Trace Elements|trace elements|mesh-ancestor
64610994|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
64610995|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64610996|NCT04365127|Progesterone|progesterone|mesh-list
64610997|NCT04365127|Progestins|progestins|mesh-ancestor
64610998|NCT04365127|Hormones|hormones|mesh-ancestor
64610999|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611013|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64611014|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611015|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611016|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64611018|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
64611019|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
64611020|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64611021|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
64611022|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
64611023|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
64611024|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611026|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64611027|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
64611028|NCT04765111|Antibodies|antibodies|mesh-list
64611029|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
64611030|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64611031|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
64611032|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611033|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611034|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611035|NCT03406403|Anesthetics|anesthetics|mesh-list
64611036|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611037|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611038|NCT04378283|Lidocaine|lidocaine|mesh-list
64611039|NCT04378283|Epinephrine|epinephrine|mesh-list
64611040|NCT04378283|Tetracaine|tetracaine|mesh-list
64611041|NCT04378283|Anesthetics|anesthetics|mesh-list
64611042|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
64611043|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611044|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611045|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
64611046|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611047|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64611048|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64611049|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64611050|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64611051|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611060|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
64611062|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
64611063|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64611064|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
64611065|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
64611066|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
64611067|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64611068|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64611069|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611070|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611071|NCT03406169|Urological Agents|urological agents|mesh-ancestor
64611072|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64611073|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64611074|NCT03406169|Protective Agents|protective agents|mesh-ancestor
64611075|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611076|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64611077|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
64611078|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
64611079|NCT04357015|Carbetocin|carbetocin|mesh-list
64611080|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64611081|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64611082|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611083|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
64611084|NCT04357015|Coagulants|coagulants|mesh-ancestor
64611085|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
64611086|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64611087|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611088|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64611089|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64611090|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64611091|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611092|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
64611093|NCT03406091|Plerixafor|plerixafor|mesh-list
64611094|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64611095|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64611096|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
64611097|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611098|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
64611099|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
64611100|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64611101|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64611102|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611103|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611112|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611113|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611114|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64611115|NCT01728935|Tenofovir|tenofovir|mesh-list
64611116|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
64611117|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611118|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64611119|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64611120|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611121|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611122|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64611123|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64611124|NCT04609111|Aspirin|aspirin|mesh-list
64611125|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64611126|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64611127|NCT04609111|Analgesics|analgesics|mesh-ancestor
64611128|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
64611129|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611130|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611131|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611132|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611133|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64611134|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64611135|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611136|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64611137|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64611138|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611139|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
64611140|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
64611141|NCT02904226|Nivolumab|nivolumab|mesh-list
64611142|NCT02904226|Ipilimumab|ipilimumab|mesh-list
64611143|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611144|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611145|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64611146|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611147|NCT03833999|Ondansetron|ondansetron|mesh-list
64611148|NCT03833999|Lactulose|lactulose|mesh-list
64611149|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
64611150|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
64611151|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611152|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611153|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64611154|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
64611164|NCT03833999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64611165|NCT04379219|Methotrexate|methotrexate|mesh-list
64611166|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64611167|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
64611168|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64611169|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611170|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64611171|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
64611172|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611173|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611174|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
64611175|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611176|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64611177|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611178|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
64611179|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611180|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64611181|NCT04347031|Azithromycin|azithromycin|mesh-list
64611182|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
64611183|NCT04347031|Mefloquine|mefloquine|mesh-list
64611184|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64611185|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611186|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
64611187|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64611188|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64611189|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611190|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611191|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611192|NCT02906566|Vitamin A|vitamin a|mesh-list
64611193|NCT02906566|Vitamins|vitamins|mesh-ancestor
64611194|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
64611195|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611196|NCT00913133|Desirudin|desirudin|mesh-list
64611197|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
64611198|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64611199|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64297306|NCT04563338|Growth Substances|growth substances|mesh-ancestor
64611207|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64611208|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
64611209|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611210|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611212|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64611213|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64611214|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64611215|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
64611216|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611217|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611218|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611219|NCT02789410|Morphine|morphine|mesh-list
64611220|NCT02789410|Hydromorphone|hydromorphone|mesh-list
64611221|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64611222|NCT02789410|Narcotics|narcotics|mesh-ancestor
64611223|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611224|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611225|NCT02789410|Analgesics|analgesics|mesh-ancestor
64611226|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
64611227|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611228|NCT01729481|Leucovorin|leucovorin|mesh-list
64611229|NCT01729481|Folic Acid|folic acid|mesh-list
64611230|NCT01729481|Gemcitabine|gemcitabine|mesh-list
64611231|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
64611232|NCT01729481|Irinotecan|irinotecan|mesh-list
64611233|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
64611234|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64611235|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
64611236|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611237|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611238|NCT01729481|Antiviral Agents|antiviral agents|mesh-ancestor
64611239|NCT01729481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611240|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611241|NCT01729481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611242|NCT01729481|Immunologic Factors|immunologic factors|mesh-ancestor
64611243|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611244|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64611245|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64611246|NCT01729481|Antidotes|antidotes|mesh-ancestor
64611247|NCT01729481|Protective Agents|protective agents|mesh-ancestor
64611248|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
64611249|NCT01729481|Vitamins|vitamins|mesh-ancestor
64611250|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
64611251|NCT01729481|Hematinics|hematinics|mesh-ancestor
64611252|NCT02790736|Propranolol|propranolol|mesh-list
64611253|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64611254|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64611255|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
64611267|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64611268|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
64611269|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
64611270|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64611271|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
64611274|NCT02793154|Exenatide|exenatide|mesh-list
64611275|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
64611276|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64611277|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611278|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64611279|NCT02793154|Incretins|incretins|mesh-ancestor
64611280|NCT02793154|Hormones|hormones|mesh-ancestor
64611281|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611282|NCT01723553|Corticosterone|corticosterone|mesh-list
64611283|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611284|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64611285|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64611286|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64611287|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611288|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611289|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64611290|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64611297|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
64611298|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
64611299|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
64611300|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
64611301|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611302|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611303|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
64611304|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611305|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64611306|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64611307|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64611308|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64611309|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611310|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64611311|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64611312|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
64611313|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611314|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64611315|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64611317|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64611318|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
64611320|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
64611321|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64611322|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64611323|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
64611324|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64611325|NCT02909140|Protective Agents|protective agents|mesh-ancestor
64611326|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
64611327|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64611328|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64611329|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
64611331|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611343|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611344|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64611345|NCT03403985|Calcium|calcium|mesh-list
64611346|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64336745|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
64611347|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611349|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64611350|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64611351|NCT04364425|Lidocaine|lidocaine|mesh-list
64611352|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64611353|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
64611354|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
64611355|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611356|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611357|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
64611358|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611359|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64611360|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64611361|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64611362|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64611363|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611364|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611365|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
64611366|NCT04364425|Hormones|hormones|mesh-ancestor
64611367|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611368|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611369|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
64611370|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611371|NCT02911324|Nabilone|nabilone|mesh-list
64611372|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
64611383|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611386|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64611387|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64611388|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611389|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611390|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64611391|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
64611392|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611393|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611394|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64611395|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611396|NCT04355455|Citalopram|citalopram|mesh-list
64611397|NCT04355455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64611398|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64611399|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64611400|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611401|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611402|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
64611403|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611404|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64611405|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
64611406|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64611407|NCT04182373|Antithrombins|antithrombins|mesh-list
64611408|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
64611409|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64611410|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
64611411|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611412|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611413|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
64611414|NCT00913913|Bevacizumab|bevacizumab|mesh-list
64611428|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611429|NCT03403829|Gemcitabine|gemcitabine|mesh-list
64611430|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64611431|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
64611432|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611433|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611434|NCT03403829|Antiviral Agents|antiviral agents|mesh-ancestor
64611435|NCT03403829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611436|NCT03403829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611437|NCT03403829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611438|NCT03403829|Immunologic Factors|immunologic factors|mesh-ancestor
64611439|NCT03403829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611440|NCT04364113|Benzocaine|benzocaine|mesh-list
64611441|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
64611442|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
64611443|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611444|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611445|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
64611446|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611447|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
64611448|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64611449|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611450|NCT03197194|Aspirin|aspirin|mesh-list
64611451|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64611453|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64611454|NCT03197194|Analgesics|analgesics|mesh-ancestor
64611460|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64611461|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64611462|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611463|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64611464|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64611465|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611467|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
64611468|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64611469|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64611470|NCT03834935|Analgesics|analgesics|mesh-ancestor
64611471|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
64611472|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611473|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611474|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611475|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611476|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
64611477|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611478|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
64611479|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64611480|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611481|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611482|NCT02796352|Interleukin-2|interleukin-2|mesh-list
64611483|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611484|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64611485|NCT02796352|Analgesics|analgesics|mesh-ancestor
64611486|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
64611487|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611488|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611489|NCT00939367|Zolpidem|zolpidem|mesh-list
64611490|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64611491|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64611492|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611493|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611494|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64611495|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
64611497|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611498|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611499|NCT03168880|Paclitaxel|paclitaxel|mesh-list
64611500|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64611501|NCT03168880|Carboplatin|carboplatin|mesh-list
64611502|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64611503|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611512|NCT04364035|Vesatolimod|vesatolimod|mesh-list
64611513|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
64611514|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611515|NCT03403439|Itraconazole|itraconazole|mesh-list
64611516|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
64611517|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611518|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64611529|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611530|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
64611531|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611533|NCT01049009|Nebivolol|nebivolol|mesh-list
64611534|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64611535|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64611536|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
64611537|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
64611538|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611539|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611540|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64611541|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64611542|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64611543|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
64611544|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611545|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611546|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
64611547|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64611548|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64611549|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64611550|NCT02850874|Gemcitabine|gemcitabine|mesh-list
64611551|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64611552|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
64611553|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611554|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611555|NCT02850874|Antiviral Agents|antiviral agents|mesh-ancestor
64611556|NCT02850874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611557|NCT02850874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611558|NCT02850874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611559|NCT02850874|Immunologic Factors|immunologic factors|mesh-ancestor
64611560|NCT02850874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611561|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
64611562|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64611563|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64611564|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64611565|NCT02920918|Canagliflozin|canagliflozin|mesh-list
64611566|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64611567|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611580|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64611581|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
64611582|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611583|NCT03403049|Antiviral Agents|antiviral agents|mesh-ancestor
64611584|NCT03403049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611585|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611586|NCT03403049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611587|NCT03403049|Immunologic Factors|immunologic factors|mesh-ancestor
64611588|NCT03403049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611589|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64611590|NCT00944047|Paclitaxel|paclitaxel|mesh-list
64611591|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
64611592|NCT00944047|Doxorubicin|doxorubicin|mesh-list
64611593|NCT00944047|Trastuzumab|trastuzumab|mesh-list
64611594|NCT00944047|Mitogens|mitogens|mesh-list
64611595|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64611596|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611597|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
64611598|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
64611599|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
64611600|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611601|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611602|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
64611603|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611604|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611617|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64611618|NCT02921386|Androgens|androgens|mesh-ancestor
64611619|NCT02921386|Hormones|hormones|mesh-ancestor
64611620|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611621|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611622|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64611623|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611624|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
64611625|NCT03402815|Maraviroc|maraviroc|mesh-list
64611627|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64611628|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611629|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64611630|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64611631|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
64611632|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611633|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64611634|NCT02245555|Tamsulosin|tamsulosin|mesh-list
64611635|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64611636|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64611637|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64611638|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
64611639|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611640|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611641|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611642|NCT02245555|Urological Agents|urological agents|mesh-ancestor
64611643|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
64611644|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
64611645|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64611646|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64611647|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611648|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611649|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611650|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611651|NCT02802514|Exenatide|exenatide|mesh-list
64611652|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
64611665|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64611666|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611667|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64611669|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611670|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64611671|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64611672|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64611673|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
64611675|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611676|NCT00944749|Cyclosporine|cyclosporine|mesh-list
64611677|NCT00944749|Cyclosporins|cyclosporins|mesh-list
64611678|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611679|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611680|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611681|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
64611682|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611683|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
64611684|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611685|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
64611686|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611687|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64611688|NCT01047293|Leucovorin|leucovorin|mesh-list
64611689|NCT01047293|Bevacizumab|bevacizumab|mesh-list
64611690|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
64611691|NCT01047293|Everolimus|everolimus|mesh-list
64611692|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611693|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611694|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64611695|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64611696|NCT01047293|Growth Substances|growth substances|mesh-ancestor
64611697|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611698|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
64611699|NCT01047293|Antidotes|antidotes|mesh-ancestor
64611700|NCT01047293|Protective Agents|protective agents|mesh-ancestor
64611701|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
64611702|NCT01047293|Vitamins|vitamins|mesh-ancestor
64611727|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611736|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64611738|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611739|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
64611740|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64611741|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64611742|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64611743|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364291|NCT03289429|Analgesics|analgesics|mesh-ancestor
64611744|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611745|NCT02812342|Tofacitinib|tofacitinib|mesh-list
64611746|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64611747|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611748|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611749|NCT03871465|Triamcinolone|triamcinolone|mesh-list
64611750|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64611751|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64611752|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64611753|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611754|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
64611755|NCT03871465|Hormones|hormones|mesh-ancestor
64611756|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611757|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611760|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611761|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611762|NCT00931489|Ranibizumab|ranibizumab|mesh-list
64611763|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64611764|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64611765|NCT00931489|Growth Substances|growth substances|mesh-ancestor
64611766|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611767|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
64611768|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611769|NCT04363255|Cisplatin|cisplatin|mesh-list
64611770|NCT04363255|Carboplatin|carboplatin|mesh-list
64611771|NCT04363255|Etoposide|etoposide|mesh-list
64611772|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
64611773|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611774|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64611783|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64611784|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64611785|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64611786|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64611787|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611788|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
64611789|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611790|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611791|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64611792|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611794|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
64611795|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64337197|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64611796|NCT03490825|Protective Agents|protective agents|mesh-ancestor
64611797|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611798|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64611799|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64611800|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611802|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64611803|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
64611804|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611805|NCT04353505|Dexamethasone|dexamethasone|mesh-list
64611807|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611808|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
64611809|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
64611810|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611811|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611812|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64611813|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
64611814|NCT04353505|Hormones|hormones|mesh-ancestor
64611815|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611816|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64611817|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611818|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64611819|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64611820|NCT04353505|Analgesics|analgesics|mesh-ancestor
64611821|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
64611822|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611823|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64611824|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611825|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611826|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64611834|NCT04362241|Prednisolone|prednisolone|mesh-list
64611835|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64611836|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
64611837|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64611838|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
64611839|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64611840|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
64611841|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611842|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
64611843|NCT04362241|Hormones|hormones|mesh-ancestor
64611844|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611845|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611846|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64611847|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611848|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
64611849|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
64611850|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611851|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64611852|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64611853|NCT04362241|Protective Agents|protective agents|mesh-ancestor
64611854|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
64611855|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
64611856|NCT01384513|Busulfan|busulfan|mesh-list
64611857|NCT01384513|Fludarabine|fludarabine|mesh-list
64611858|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
64611859|NCT01384513|Tacrolimus|tacrolimus|mesh-list
64611860|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64611861|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
64611862|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611863|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611864|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64611865|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
64611866|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611867|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611868|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64611869|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64611870|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
64611871|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611872|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64611873|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611874|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64611875|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64611876|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
64611882|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611883|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
64611884|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611885|NCT02933320|Rituximab|rituximab|mesh-list
64611886|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611887|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611888|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
64611889|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611890|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64611891|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
64611892|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64611893|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64611894|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611895|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611896|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64611897|NCT05555251|Trastuzumab|trastuzumab|mesh-list
64611898|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64611899|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611900|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
64611901|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
64611902|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64611903|NCT03035305|Amodiaquine|amodiaquine|mesh-list
64611904|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
64611905|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64611906|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64611907|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611908|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64611909|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611910|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611911|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64611912|NCT03035305|Renal Agents|renal agents|mesh-ancestor
64611913|NCT03034759|Insulin|insulin|mesh-list
64611914|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64611915|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611916|NCT02158273|Fenofibrate|fenofibrate|mesh-list
64611917|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64611918|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
64611919|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611920|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64611938|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64611939|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611940|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611941|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64611942|NCT03002506|Renal Agents|renal agents|mesh-ancestor
64611943|NCT02822950|Ceftazidime|ceftazidime|mesh-list
64297344|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64611944|NCT02822950|Avibactam|avibactam|mesh-list
64297345|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
64611945|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64611946|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64611947|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64611948|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64611949|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611950|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611952|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64611953|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
64611954|NCT02935738|Hormones|hormones|mesh-ancestor
64611955|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64611956|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611957|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64611958|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64611959|NCT05435677|Insulin|insulin|mesh-list
64611960|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64611961|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611962|NCT00939991|Bevacizumab|bevacizumab|mesh-list
64611979|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64611980|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64611981|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64611982|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64611983|NCT04361305|Urological Agents|urological agents|mesh-ancestor
64611984|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
64611985|NCT02245321|Hematinics|hematinics|mesh-ancestor
64611986|NCT04361149|Capsaicin|capsaicin|mesh-list
64611987|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
64611988|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
64611989|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
64611990|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64611991|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64611992|NCT05332483|Megestrol|megestrol|mesh-list
64611993|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
64611994|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64611995|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64611996|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64611997|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
64611998|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64611999|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612000|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64612001|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64612002|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64612003|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612004|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
64612010|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612011|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612012|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
64612013|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612014|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64612015|NCT00947167|Pertuzumab|pertuzumab|mesh-list
64612016|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612017|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64612018|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612019|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612020|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64612021|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
64612022|NCT04360759|Chloroquine|chloroquine|mesh-list
64612023|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
64612024|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64612025|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64612026|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612027|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612028|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612029|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612030|NCT04360759|Amebicides|amebicides|mesh-ancestor
64612031|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64612032|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64612033|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64612034|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
64612035|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612036|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612037|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64612043|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64612044|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64612045|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612046|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612047|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
64612048|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612049|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612050|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64612051|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612052|NCT03033121|Hormones|hormones|mesh-list
64612053|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612054|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612055|NCT03033199|Dexamethasone|dexamethasone|mesh-list
64612056|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612057|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
64612058|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
64612059|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612060|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612061|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612062|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
64612063|NCT03033199|Hormones|hormones|mesh-ancestor
64612064|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612065|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64612066|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612067|NCT00940927|Albuterol|albuterol|mesh-list
64612068|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64612069|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
64612070|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612071|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612072|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64612073|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
64612074|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
64612075|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64612076|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64612077|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64612078|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64612079|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612080|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612081|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612082|NCT00934375|Donepezil|donepezil|mesh-list
64612083|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64612084|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612085|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612086|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
64612102|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612103|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612104|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612105|NCT02245477|Mitogens|mitogens|mesh-list
64612106|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
64612107|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
64612108|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612109|NCT02245477|Growth Substances|growth substances|mesh-ancestor
64612110|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612111|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
64612112|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64612113|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64612115|NCT02825212|Velpatasvir|velpatasvir|mesh-list
64612116|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
64612117|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612118|NCT00373672|Modafinil|modafinil|mesh-list
64612119|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64612120|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612121|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64612122|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64612123|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64612124|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612125|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
64612142|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
64612143|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612144|NCT04359511|Prednisone|prednisone|mesh-list
64612145|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
64612146|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612147|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
64612148|NCT04359511|Hormones|hormones|mesh-ancestor
64612149|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612150|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612151|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64612152|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612153|NCT03032419|Vaccines|vaccines|mesh-list
64612154|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
64612155|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612156|NCT00373906|Bortezomib|bortezomib|mesh-list
64612157|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612158|NCT00955513|Diclofenac|diclofenac|mesh-list
64612159|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64612160|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64612175|NCT00935311|Analgesics|analgesics|mesh-ancestor
64612176|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
64612177|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612178|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612179|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
64612180|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64612181|NCT00935311|Narcotics|narcotics|mesh-ancestor
64612182|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612183|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
64612184|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
64612185|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64612186|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612187|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612188|NCT02946034|Ribavirin|ribavirin|mesh-list
64612189|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
64612190|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612191|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
64612192|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612193|NCT00955747|Tagatose|tagatose|mesh-list
64612194|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64612213|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64612214|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
64612215|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
64612216|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64612217|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64612218|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612219|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612220|NCT03402191|Urological Agents|urological agents|mesh-ancestor
64612222|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
64612223|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64612224|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612225|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612226|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64612229|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612230|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64612231|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64612232|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64612233|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612234|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612235|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612236|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64612237|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64612238|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64612239|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612240|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64612241|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
64612242|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
64612243|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
64612244|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
64612245|NCT01725113|Calcitriol|calcitriol|mesh-list
64612246|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64612247|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612248|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64612249|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612250|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612251|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64612253|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
64612254|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64612255|NCT03031405|Oxytocin|oxytocin|mesh-list
64612256|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
64612257|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64612258|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612259|NCT03031249|Cytarabine|cytarabine|mesh-list
64612260|NCT03031249|Tretinoin|tretinoin|mesh-list
64612261|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
64612262|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64612263|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
64612264|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612265|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612266|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
64612267|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612268|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64612269|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
64612270|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612271|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
64612272|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
64612274|NCT01042535|Vaccines|vaccines|mesh-list
64612275|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
64612276|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612277|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64612278|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
64612279|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612280|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64612281|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
64612282|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64612283|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64612284|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
64612290|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612292|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
64612293|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64612294|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64612295|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612296|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
64612297|NCT04358965|Coagulants|coagulants|mesh-ancestor
64612298|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64612299|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
64612300|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64612301|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612302|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64612303|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612304|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
64612305|NCT01041287|Metoprolol|metoprolol|mesh-list
64612306|NCT01041287|Nebivolol|nebivolol|mesh-list
64612307|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64612308|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64612309|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
64612310|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
64612311|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612316|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612317|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612318|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612319|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
64612320|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64612321|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64612322|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64612323|NCT03016741|Prednisone|prednisone|mesh-list
64612324|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
64612325|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612326|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
64612327|NCT03016741|Hormones|hormones|mesh-ancestor
64612328|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612329|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612330|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64612331|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612332|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64612333|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612334|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612335|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
64612336|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64612337|NCT01042925|Paclitaxel|paclitaxel|mesh-list
64612338|NCT01042925|Trastuzumab|trastuzumab|mesh-list
64612339|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64612340|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612341|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
64612342|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
64612343|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
64612344|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612345|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64612346|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
64612347|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64612348|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
64612349|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612350|NCT03400709|Expectorants|expectorants|mesh-ancestor
64612351|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
64612352|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64612353|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
64612354|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612355|NCT03400709|Protective Agents|protective agents|mesh-ancestor
64612356|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612357|NCT03400709|Antidotes|antidotes|mesh-ancestor
64612358|NCT02049957|Fulvestrant|fulvestrant|mesh-list
64612359|NCT02049957|Exemestane|exemestane|mesh-list
64612360|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64612361|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612362|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64612363|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64612364|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
64612365|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612374|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64612375|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612376|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612377|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612378|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64612379|NCT00950365|Pemetrexed|pemetrexed|mesh-list
64612380|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64612381|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612382|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612383|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612384|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64612385|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64612386|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64612387|NCT01908465|Ebastine|ebastine|mesh-list
64612388|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64612389|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
64612390|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
64612391|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612392|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612393|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612394|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64612395|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
64612399|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612400|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612401|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64612402|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
64612404|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64612405|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612406|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64612407|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612408|NCT00357825|Reboxetine|reboxetine|mesh-list
64612409|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
64612410|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612411|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64612412|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64612413|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612414|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612415|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612416|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612417|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612418|NCT03400241|Bromides|bromides|mesh-list
64612419|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
64612420|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64612421|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
64612422|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612423|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612424|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64612425|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
64612426|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
64612440|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64612441|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64612442|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612443|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612444|NCT00729573|Tenofovir|tenofovir|mesh-list
64612445|NCT00729573|Emtricitabine|emtricitabine|mesh-list
64612446|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64612447|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
64612448|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612449|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64612450|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64612451|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612452|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612453|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64612454|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64612455|NCT02951182|Ivacaftor|ivacaftor|mesh-list
64612456|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64612457|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612458|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612464|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612465|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64612466|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
64612475|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64612476|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612477|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612478|NCT00924209|Gemcitabine|gemcitabine|mesh-list
64612479|NCT00924209|Bevacizumab|bevacizumab|mesh-list
64612480|NCT00924209|Etoposide|etoposide|mesh-list
64612481|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64612482|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612483|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64612484|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64612485|NCT00924209|Growth Substances|growth substances|mesh-ancestor
64612486|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612487|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
64612488|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64612489|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
64612490|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612493|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612494|NCT00924209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64612495|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
64612496|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64612497|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64612498|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64612499|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64612500|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
64612501|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
64612502|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612503|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612504|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64612505|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64612506|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
64612507|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612508|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612509|NCT03408119|Vitamin D|vitamin d|mesh-list
64612510|NCT03408119|Calcium|calcium|mesh-list
64612511|NCT03408119|Vitamins|vitamins|mesh-ancestor
64612512|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
64612513|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612514|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64612515|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64612516|NCT03405155|Nivolumab|nivolumab|mesh-list
64612517|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64612523|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64612524|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612525|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64612526|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612527|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64612528|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
64612529|NCT04374929|Hormones|hormones|mesh-ancestor
64612530|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64612531|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612532|NCT05717361|Lidocaine|lidocaine|mesh-list
64612533|NCT05717361|Ketamine|ketamine|mesh-list
64612534|NCT05717361|Remifentanil|remifentanil|mesh-list
64612535|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
64612536|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
64612537|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612538|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612539|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
64612540|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612541|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64612547|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64364376|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612548|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64612550|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64612551|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64612552|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612553|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64612554|NCT05717361|Narcotics|narcotics|mesh-ancestor
64612555|NCT02951884|Bupivacaine|bupivacaine|mesh-list
64612556|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
64612557|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
64612558|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612559|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612560|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
64612561|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612562|NCT05574387|Metformin|metformin|mesh-list
64612563|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64612564|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612565|NCT02978001|Glycerol|glycerol|mesh-list
64612566|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64612567|NCT02978001|Protective Agents|protective agents|mesh-ancestor
64612568|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612569|NCT02978313|Cetuximab|cetuximab|mesh-list
64612570|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64612571|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612572|NCT05685225|Acetaminophen|acetaminophen|mesh-list
64612573|NCT05685225|Naltrexone|naltrexone|mesh-list
64612574|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64612575|NCT05685225|Analgesics|analgesics|mesh-ancestor
64612576|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
64612577|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612578|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612580|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64612581|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64612582|NCT00014495|Cytarabine|cytarabine|mesh-list
64612583|NCT00014495|Bismuth|bismuth|mesh-list
64612584|NCT00014495|Antibodies|antibodies|mesh-list
64612585|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64612586|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
64612587|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612588|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64612589|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
64612590|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612591|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612592|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
64612593|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612594|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64612595|NCT00014495|Antacids|antacids|mesh-ancestor
64612596|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612597|NCT05566041|Carboplatin|carboplatin|mesh-list
64612598|NCT05566041|Etoposide|etoposide|mesh-list
64612599|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612600|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64612601|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64612602|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64612603|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612604|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612605|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
64612606|NCT05565105|Melphalan|melphalan|mesh-list
64612607|NCT05565105|Busulfan|busulfan|mesh-list
64612608|NCT05565105|Thiotepa|thiotepa|mesh-list
64612609|NCT05565105|Fludarabine|fludarabine|mesh-list
64612610|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64612611|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
64612612|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612613|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612614|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64612615|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
64612616|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612617|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612618|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64612619|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
64612620|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64612621|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64612622|NCT04374071|Prednisolone|prednisolone|mesh-list
64612623|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
64612624|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64612625|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
64612637|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64612639|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
64612640|NCT00357981|Ortho Evra|ortho evra|mesh-list
64612641|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64612642|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612643|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64612644|NCT03030703|Inositol|inositol|mesh-list
64612645|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
64612646|NCT03030703|Vitamins|vitamins|mesh-ancestor
64612647|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
64612648|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612649|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64612650|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64612651|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
64612652|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
64612653|NCT03030469|Analgesics|analgesics|mesh-list
64612654|NCT03030469|Narcotics|narcotics|mesh-ancestor
64612655|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612656|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612657|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
64612658|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612659|NCT00952081|Clevidipine|clevidipine|mesh-list
64612660|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64612661|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64612679|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612680|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612682|NCT02959840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64612683|NCT02959840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612684|NCT02959840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612685|NCT02959840|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64612686|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64612687|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64612688|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
64612689|NCT04358341|Doxorubicin|doxorubicin|mesh-list
64612690|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64612691|NCT04358341|Fluorouracil|fluorouracil|mesh-list
64612692|NCT04358341|Irinotecan|irinotecan|mesh-list
64612710|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
64612711|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612712|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612713|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
64612714|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612715|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
64612716|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64612717|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64612718|NCT00929981|Prednisolone|prednisolone|mesh-list
64612719|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
64612720|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64612721|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
64612722|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612723|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
64612724|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
64612725|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612726|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612727|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64612728|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
64612729|NCT00929981|Hormones|hormones|mesh-ancestor
64612735|NCT00961441|Levetiracetam|levetiracetam|mesh-list
64612736|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
64612749|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
64612750|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
64612751|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612752|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64612753|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64612754|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64612755|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64612756|NCT02240537|Sargramostim|sargramostim|mesh-list
64612757|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64612758|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
64612759|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612760|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64612761|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64612762|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64612763|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612764|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64612784|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64612786|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
64612787|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612788|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612789|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612790|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612791|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64612792|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612793|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612794|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64612795|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64612797|NCT02851108|Phenothiazine|phenothiazine|mesh-list
64612798|NCT02851108|Methylene Blue|methylene blue|mesh-list
64612799|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
64612800|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64612801|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64612813|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612814|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64612815|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
64612816|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612817|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64612818|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64612819|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
64612820|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
64612821|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612822|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64612823|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64612824|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
64612825|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64612826|NCT02855086|Cetuximab|cetuximab|mesh-list
64612827|NCT02855086|Antibodies|antibodies|mesh-list
64612828|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
64612829|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64612830|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
64612831|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612832|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612833|NCT05368857|Afamelanotide|afamelanotide|mesh-list
64612834|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
64612835|NCT04347005|Allopurinol|allopurinol|mesh-list
64612836|NCT04347005|Febuxostat|febuxostat|mesh-list
64612837|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
64612838|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612839|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612854|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
64612855|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
64612856|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64612857|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64612858|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64612859|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612860|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612861|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612862|NCT02241083|Dopamine|dopamine|mesh-list
64612863|NCT02241083|Norepinephrine|norepinephrine|mesh-list
64612864|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64612865|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64612866|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612867|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612868|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612869|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612870|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
64612883|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
64612884|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612885|NCT02982551|Insulin|insulin|mesh-list
64612886|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64612887|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612888|NCT02965924|Phenylephrine|phenylephrine|mesh-list
64612889|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
64612890|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64612891|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
64612892|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
64612893|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612894|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612895|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
64612896|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64612897|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
64612898|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
64612899|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64612900|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64612901|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64612902|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612903|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612904|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612905|NCT02965924|Protective Agents|protective agents|mesh-ancestor
64612906|NCT05344833|Lenalidomide|lenalidomide|mesh-list
64612907|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
64612908|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612909|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64612910|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64612911|NCT05344833|Growth Substances|growth substances|mesh-ancestor
64612912|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
64612913|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64612914|NCT04364321|Diazepam|diazepam|mesh-list
64612915|NCT04364321|Clonazepam|clonazepam|mesh-list
64612916|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64612917|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
64612938|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64612939|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
64612940|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64612941|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64612942|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612943|NCT05528913|Benralizumab|benralizumab|mesh-list
64612944|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64612945|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
64612946|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64612947|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612948|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
64612949|NCT04371965|Povidone|povidone|mesh-list
64612950|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
64612951|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
64612952|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64612953|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612954|NCT02959125|Micronutrients|micronutrients|mesh-list
64612955|NCT02959125|Trace Elements|trace elements|mesh-list
64612956|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612957|NCT02972554|Propranolol|propranolol|mesh-list
64612958|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64612959|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64612974|NCT00359151|Celecoxib|celecoxib|mesh-list
64612975|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64612976|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64612977|NCT00359151|Analgesics|analgesics|mesh-ancestor
64612978|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
64612979|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64612980|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612981|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64612982|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64612983|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64612984|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64612985|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64612987|NCT00374686|Valganciclovir|valganciclovir|mesh-list
64612988|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
64612989|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64612990|NCT04371575|Carbamazepine|carbamazepine|mesh-list
64612991|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
64612992|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
64612993|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
64612994|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64612995|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64612996|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64612997|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64612998|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64612999|NCT04371575|Analgesics|analgesics|mesh-ancestor
64613000|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
64613001|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613002|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64613022|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
64613024|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613025|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613026|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
64613027|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613028|NCT00374764|Risperidone|risperidone|mesh-list
64613036|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613037|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613038|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64613039|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
64613040|NCT04371185|Ustekinumab|ustekinumab|mesh-list
64613041|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
64613042|NCT01005355|Ramucirumab|ramucirumab|mesh-list
64613043|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613044|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
64613045|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64613046|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64613047|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
64613048|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613049|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613050|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64613051|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
64613052|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
64613053|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64613054|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
64613055|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613056|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613057|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64613058|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64613059|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64613060|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
64613061|NCT05285943|Betamethasone|betamethasone|mesh-list
64613062|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
64613063|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64613064|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
64613065|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64613066|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613067|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
64613069|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613070|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613071|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64613072|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
64338474|NCT02526212|Analgesics|analgesics|mesh-ancestor
64613074|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
64613075|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613076|NCT02242331|Telmisartan|telmisartan|mesh-list
64613077|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64613078|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64613079|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64613093|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364392|NCT02460367|Docetaxel|docetaxel|mesh-list
64613094|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
64613095|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613096|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613097|NCT02245789|Remifentanil|remifentanil|mesh-list
64613098|NCT02245789|Propofol|propofol|mesh-list
64613099|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
64613100|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613101|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613102|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64613103|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64613104|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
64613105|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64613106|NCT02245789|Narcotics|narcotics|mesh-ancestor
64613107|NCT02245789|Analgesics|analgesics|mesh-ancestor
64613108|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
64613109|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613110|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
64613111|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
64613112|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64613113|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64613114|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613115|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613116|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613117|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613118|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
64613119|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64613120|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64297359|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
64613121|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613122|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
64613123|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
64613124|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64613125|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64613126|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613127|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382656|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64613128|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613129|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613130|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64613132|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64613133|NCT02242877|Diuretics|diuretics|mesh-ancestor
64613134|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
64613135|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613136|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64613137|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64613138|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613139|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64613140|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64613141|NCT01007071|Hormones|hormones|mesh-list
64613142|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613143|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613144|NCT05475639|Diclofenac|diclofenac|mesh-list
64613145|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64613146|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613147|NCT05475639|Analgesics|analgesics|mesh-ancestor
64613148|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
64613149|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613150|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613151|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64364426|NCT03376529|Aztreonam|aztreonam|mesh-list
64364427|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364432|NCT04132661|Bisacodyl|bisacodyl|mesh-list
64613152|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613153|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64613154|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613155|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613156|NCT02242955|Diazepam|diazepam|mesh-list
64613157|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64613158|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
64613159|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
64613160|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
64613161|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613162|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613163|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64613164|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64613165|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613166|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64613167|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64613168|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64613169|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64613170|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613171|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64613172|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
64613173|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
64613174|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
64613175|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
64613176|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613177|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613178|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
64613179|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64613180|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613181|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64613182|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613184|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
64613185|NCT01008319|Clomiphene|clomiphene|mesh-list
64613186|NCT01008319|Enclomiphene|enclomiphene|mesh-list
64613187|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
64613188|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
64613189|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64613190|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
64613191|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
64613192|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613193|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64613194|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
64613204|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613205|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64613206|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64613207|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613208|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613209|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613211|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64613212|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
64613213|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613214|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613216|NCT00967369|Etoposide|etoposide|mesh-list
64613217|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
64613218|NCT00967369|Bortezomib|bortezomib|mesh-list
64613219|NCT00967369|Ifosfamide|ifosfamide|mesh-list
64613220|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
64613221|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
64613222|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613223|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64613224|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64613225|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64613226|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613227|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613228|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64613229|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
64613230|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
64613231|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
64613232|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
64613233|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
64613234|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
64613235|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
64613236|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64613237|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613238|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613242|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613243|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613244|NCT05238207|Psyllium|psyllium|mesh-list
64613245|NCT05238207|Cathartics|cathartics|mesh-ancestor
64613246|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64613247|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
64613248|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613249|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
64613250|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64613251|NCT00968071|Decitabine|decitabine|mesh-list
64613252|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
64613253|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64613254|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
64613255|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613256|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613257|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613258|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613259|NCT05462613|Aspirin|aspirin|mesh-list
64613260|NCT05462613|Bevacizumab|bevacizumab|mesh-list
64613261|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613262|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613263|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64613264|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64613265|NCT05462613|Growth Substances|growth substances|mesh-ancestor
64613266|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613267|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
64613268|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64613269|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613270|NCT05462613|Analgesics|analgesics|mesh-ancestor
64613271|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
64613272|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613273|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613274|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613275|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64613276|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613277|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613278|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64613279|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64613280|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613281|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
64613282|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
64613283|NCT00971737|Trastuzumab|trastuzumab|mesh-list
64613284|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64613285|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
64613286|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613287|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364468|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
64613288|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64613289|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
64613290|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613291|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613292|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64613293|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613300|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64613303|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
64613304|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613305|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613306|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613307|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64613308|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613309|NCT04368377|Analgesics|analgesics|mesh-ancestor
64613310|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
64613311|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613312|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613313|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613314|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64613315|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613316|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64613317|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613318|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
64613319|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64613320|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
64613321|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64613322|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
64613323|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
64613324|NCT04361513|Triamcinolone|triamcinolone|mesh-list
64613325|NCT04361513|Bupivacaine|bupivacaine|mesh-list
64613326|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
64613327|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
64613328|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613329|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613330|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
64613331|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613332|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613333|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
64613335|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613336|NCT05595993|Cilostazol|cilostazol|mesh-list
64613337|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64613338|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
64613339|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613340|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613341|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64613342|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
64613343|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64613344|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613345|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613346|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64613347|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
64613348|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64613349|NCT05595993|Protective Agents|protective agents|mesh-ancestor
64613350|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64613351|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64613352|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613353|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
64613354|NCT05593341|Narcotics|narcotics|mesh-ancestor
64613355|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613356|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613359|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613360|NCT00972205|Paclitaxel|paclitaxel|mesh-list
64613361|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64613362|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64613363|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613364|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
64613365|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
64613366|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
64613367|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613368|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64613369|NCT00928421|Polidocanol|polidocanol|mesh-list
64613370|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64613371|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64613372|NCT03051256|Methadone|methadone|mesh-list
64613373|NCT03051256|D-methadone|d-methadone|mesh-list
64613374|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64613375|NCT03051256|Narcotics|narcotics|mesh-ancestor
64613376|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613377|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613378|NCT03051256|Analgesics|analgesics|mesh-ancestor
64613379|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
64613380|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613381|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
64613382|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
64613383|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613384|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64613385|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64613386|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64613387|NCT00932321|Norethindrone|norethindrone|mesh-list
64613388|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
64613389|NCT00932321|Estradiol|estradiol|mesh-list
64613390|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64613391|NCT00932321|Estrogens|estrogens|mesh-ancestor
64613392|NCT00932321|Hormones|hormones|mesh-ancestor
64613393|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613394|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613395|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64613396|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
64613397|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64613398|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64613399|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64613400|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64613401|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64613402|NCT05445609|Nivolumab|nivolumab|mesh-list
64613403|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613404|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613405|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64613406|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613407|NCT01011829|Varenicline|varenicline|mesh-list
64613408|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64613409|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64613410|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
64613411|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613412|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613413|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613414|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64613416|NCT00932477|Glycerol|glycerol|mesh-list
64613417|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64613418|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64613419|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64613420|NCT00932477|Protective Agents|protective agents|mesh-ancestor
64613421|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613422|NCT00932477|Laxatives|laxatives|mesh-ancestor
64613423|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64613424|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
64613425|NCT00972439|Norinyl|norinyl|mesh-list
64364491|NCT03287011|Listerine|listerine|mesh-list
64613426|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
64613427|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64613428|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613429|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64613430|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64613431|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64613432|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64613434|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64613435|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613437|NCT02989714|Interleukin-2|interleukin-2|mesh-list
64613438|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613439|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613440|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64613441|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613442|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613443|NCT02989714|Analgesics|analgesics|mesh-ancestor
64613444|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
64613445|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613446|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613447|NCT04361279|Rituximab|rituximab|mesh-list
64338846|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613448|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613449|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613450|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
64613451|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613452|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613453|NCT05585229|Psilocybin|psilocybin|mesh-list
64613454|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
64613455|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613456|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613457|NCT05582499|Paclitaxel|paclitaxel|mesh-list
64613458|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
64613459|NCT05582499|Carboplatin|carboplatin|mesh-list
64613460|NCT05582499|Trastuzumab|trastuzumab|mesh-list
64613461|NCT05582499|Letrozole|letrozole|mesh-list
64613462|NCT05582499|Epirubicin|epirubicin|mesh-list
64613463|NCT05582499|Pertuzumab|pertuzumab|mesh-list
64613464|NCT05582499|Goserelin|goserelin|mesh-list
64613465|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64613466|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613467|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
64613468|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
64613469|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
64613470|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613471|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64613472|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
64613473|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613474|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613475|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64613476|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
64613477|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64613478|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613479|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64613480|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64613481|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613482|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64613483|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
64613484|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613485|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64613486|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64613487|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64613488|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64613489|NCT02881996|Acetaminophen|acetaminophen|mesh-list
64613490|NCT02881996|Ketorolac|ketorolac|mesh-list
64613491|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613492|NCT02881996|Analgesics|analgesics|mesh-ancestor
64613493|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
64613494|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613495|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613496|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
64613497|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64613498|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613499|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613500|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64613501|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613502|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613503|NCT04367831|Heparin|heparin|mesh-list
64613504|NCT04367831|Calcium heparin|calcium heparin|mesh-list
64613505|NCT04367831|Enoxaparin|enoxaparin|mesh-list
64613506|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
64613507|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
64613509|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613510|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613511|NCT03051646|Aspirin|aspirin|mesh-list
64613512|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64613513|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613514|NCT03051646|Analgesics|analgesics|mesh-ancestor
64613515|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
64613516|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613517|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613518|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613519|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613520|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64613521|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613522|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613523|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64613524|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64613525|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613526|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
64613527|NCT04344405|Vitamin D|vitamin d|mesh-list
64613528|NCT04344405|Vitamins|vitamins|mesh-ancestor
64613529|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
64613530|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613531|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64613532|NCT05187429|Nivolumab|nivolumab|mesh-list
64613533|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613534|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613535|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64613536|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613537|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
64613538|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64613539|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64613540|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613541|NCT02993302|Vitamins|vitamins|mesh-ancestor
64613542|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
64613543|NCT00359853|Norfloxacin|norfloxacin|mesh-list
64613544|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64613545|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613546|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64613547|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64613548|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613549|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613550|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613551|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64613552|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64613553|NCT05168709|Vaccines|vaccines|mesh-list
64613554|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
64613555|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613556|NCT04367051|Spironolactone|spironolactone|mesh-list
64613557|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64613558|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
64613559|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613560|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364509|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613561|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64613562|NCT04367051|Diuretics|diuretics|mesh-ancestor
64613563|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
64613564|NCT03111316|Dinoprostone|dinoprostone|mesh-list
64613565|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
64613566|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64613567|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613568|NCT03054844|Lidocaine|lidocaine|mesh-list
64613569|NCT03054844|Midazolam|midazolam|mesh-list
64613570|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
64613571|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
64613572|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613573|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613574|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
64613575|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613576|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64613577|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64613578|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64613579|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64613580|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613582|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64613583|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64613584|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64613585|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613586|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64613587|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
64613588|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
64613589|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
64613590|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613591|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
64613592|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613593|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613594|NCT00359697|Mannitol|mannitol|mesh-list
64613595|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64613596|NCT00359697|Diuretics|diuretics|mesh-ancestor
64613597|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
64613598|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613599|NCT03111628|Omalizumab|omalizumab|mesh-list
64613600|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64613601|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64613602|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
64613603|NCT05120505|Metformin|metformin|mesh-list
64613604|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64613605|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613606|NCT02977533|Acyclovir|acyclovir|mesh-list
64613607|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
64613608|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613609|NCT01012297|Gemcitabine|gemcitabine|mesh-list
64613610|NCT01012297|Bevacizumab|bevacizumab|mesh-list
64613611|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64613612|NCT01012297|Docetaxel|docetaxel|mesh-list
64613613|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
64613614|NCT01012297|Antibodies|antibodies|mesh-list
64613615|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
64613616|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64613617|NCT01012297|Lenograstim|lenograstim|mesh-list
64613618|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
64613619|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613620|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64613621|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64613622|NCT01012297|Growth Substances|growth substances|mesh-ancestor
64613623|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613624|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
64613625|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
64613626|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64613627|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
64613628|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613629|NCT01012297|Antiviral Agents|antiviral agents|mesh-ancestor
64613630|NCT01012297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613631|NCT01012297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613632|NCT01012297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64613633|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
64613634|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
64613635|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
64613636|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64613637|NCT00923117|Sunitinib|sunitinib|mesh-list
64613638|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613639|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64613640|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64613641|NCT00923117|Growth Substances|growth substances|mesh-ancestor
64613642|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613643|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
64613644|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64613645|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613646|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613647|NCT05108259|Adalimumab|adalimumab|mesh-list
64613648|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613649|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613650|NCT02244281|Tamsulosin|tamsulosin|mesh-list
64613651|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64613652|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64613653|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64613654|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
64613655|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613656|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613657|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613658|NCT02244281|Urological Agents|urological agents|mesh-ancestor
64613659|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
64613660|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64613661|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64613662|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64613663|NCT02977611|Hematinics|hematinics|mesh-ancestor
64613664|NCT04360655|Antibodies|antibodies|mesh-list
64613665|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64613666|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
64613667|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613668|NCT00375232|Montelukast|montelukast|mesh-list
64613669|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64613670|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
64613671|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64613672|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
64613673|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613674|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613675|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64613676|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64613677|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613678|NCT00975637|Brodalumab|brodalumab|mesh-list
64613679|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64613680|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
64613681|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
64613682|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613683|NCT02244437|Acetaminophen|acetaminophen|mesh-list
64613684|NCT02244437|Ibuprofen|ibuprofen|mesh-list
64613685|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613686|NCT02244437|Analgesics|analgesics|mesh-ancestor
64613687|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
64613688|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613689|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613690|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
64613691|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64613692|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613693|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64613694|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64613695|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613696|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613697|NCT03023527|Dexamethasone|dexamethasone|mesh-list
64613698|NCT03023527|Nivolumab|nivolumab|mesh-list
64613699|NCT03023527|Pomalidomide|pomalidomide|mesh-list
64613700|NCT03023527|Elotuzumab|elotuzumab|mesh-list
64613701|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613702|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
64613703|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
64613704|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613705|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613706|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64613707|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
64613708|NCT03023527|Hormones|hormones|mesh-ancestor
64613709|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613710|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64613711|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613712|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64613713|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64613714|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613715|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
64613716|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64613717|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64613718|NCT03023527|Growth Substances|growth substances|mesh-ancestor
64613719|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
64613720|NCT04878627|Cannabidiol|cannabidiol|mesh-list
64613721|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
64613722|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
64613723|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64613724|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613725|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613726|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613728|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
64613729|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613730|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64613731|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64613732|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64613733|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
64613734|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613735|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613736|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
64613737|NCT04360031|Tacrolimus|tacrolimus|mesh-list
64613738|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64613739|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
64613740|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613741|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64613742|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613744|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64613745|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613746|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64613747|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
64613748|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64613749|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613750|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
64613751|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
64613752|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
64613753|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613754|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613755|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64613756|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64613757|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64613758|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613759|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613760|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64613761|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
64613762|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613763|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613764|NCT03023059|Levodopa|levodopa|mesh-list
64613765|NCT03023059|Carbidopa|carbidopa|mesh-list
64613766|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64613767|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64613768|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64613769|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
64613770|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613771|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613772|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613773|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64613774|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613775|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64613776|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
64613777|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
64613778|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
64613779|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64613780|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613781|NCT04359485|Glycolic acid|glycolic acid|mesh-list
64613782|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
64613783|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
64613784|NCT05376579|Siponimod|siponimod|mesh-list
64613785|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64613786|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613787|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64613788|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
64613789|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613790|NCT04868565|Caffeine|caffeine|mesh-list
64613791|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
64613792|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613793|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64613794|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613795|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64613796|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613797|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64613798|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64613799|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
64613800|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613801|NCT02976987|Cidofovir|cidofovir|mesh-list
64613802|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
64613803|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613804|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613805|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613806|NCT00361413|Alefacept|alefacept|mesh-list
64613807|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
64613808|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
64613809|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613810|NCT03062488|Acetaminophen|acetaminophen|mesh-list
64613811|NCT03062488|Fentanyl|fentanyl|mesh-list
64613812|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64613813|NCT03062488|Narcotics|narcotics|mesh-ancestor
64613814|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613815|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613816|NCT03062488|Analgesics|analgesics|mesh-ancestor
64613817|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
64613818|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613819|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64613820|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64613821|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
64613822|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
64613823|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613824|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
64613825|NCT00936299|Bupropion|bupropion|mesh-list
64613826|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64339222|NCT03141645|Ondansetron|ondansetron|mesh-list
64613827|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
64613828|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613829|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64613830|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64613831|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64613832|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613833|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
64613834|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613835|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613836|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64613837|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64613838|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613839|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64613840|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64613841|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613842|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613843|NCT03117634|Aflibercept|aflibercept|mesh-list
64613844|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64613845|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64613846|NCT03117634|Growth Substances|growth substances|mesh-ancestor
64613847|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613848|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
64613849|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613850|NCT00937235|Varenicline|varenicline|mesh-list
64613851|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64613852|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64613853|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
64613854|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613855|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613856|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613858|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
64613859|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64613860|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613861|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613862|NCT05405608|Ondansetron|ondansetron|mesh-list
64613863|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
64613864|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
64613865|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613866|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613867|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64613869|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
64613870|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64613871|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
64613872|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613873|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613874|NCT05405608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64613875|NCT05405608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64613876|NCT05405608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613877|NCT05405608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613878|NCT05405608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64613879|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
64613880|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64613881|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64613882|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64613883|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64613884|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613885|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
64613886|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613887|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613888|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64613889|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613890|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
64613891|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64613892|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64613893|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613894|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
64613895|NCT00375466|Coagulants|coagulants|mesh-ancestor
64613896|NCT00976183|Vorinostat|vorinostat|mesh-list
64613897|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613898|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64613899|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613900|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613901|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
64613902|NCT04357535|Giapreza|giapreza|mesh-list
64613903|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64613904|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
64613905|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64613906|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64613907|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613908|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64613909|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64613910|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
64613911|NCT01015807|Clonidine|clonidine|mesh-list
64613912|NCT01015807|Bupivacaine|bupivacaine|mesh-list
64613913|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
64613914|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
64613915|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613916|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613917|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
64613918|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613919|NCT01015807|Analgesics|analgesics|mesh-ancestor
64613920|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64613921|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
64613922|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
64613923|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64613924|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64613925|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64613926|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
64613927|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613928|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613929|NCT01575925|Thalidomide|thalidomide|mesh-list
64364656|NCT03363815|Nintedanib|nintedanib|mesh-list
64613930|NCT01575925|Dexamethasone|dexamethasone|mesh-list
64613931|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
64613932|NCT01575925|Pomalidomide|pomalidomide|mesh-list
64613933|NCT01575925|BB 1101|bb 1101|mesh-list
64613934|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64613935|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
64613936|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
64613937|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613938|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613939|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64613940|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
64613941|NCT01575925|Hormones|hormones|mesh-ancestor
64613942|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64613943|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64613944|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64613945|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
64613946|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613947|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613948|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
64613949|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64613950|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64613951|NCT01575925|Growth Substances|growth substances|mesh-ancestor
64613952|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
64613953|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64613954|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
64613955|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64613956|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613957|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
64613958|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64613959|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613960|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613961|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64613963|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
64613964|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613965|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64613966|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64613967|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64613968|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
64613969|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64613970|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613971|NCT04471233|Pregabalin|pregabalin|mesh-list
64613972|NCT04471233|Analgesics|analgesics|mesh-ancestor
64613973|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
64613974|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64613975|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64613976|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
64613977|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64613978|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64613979|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613980|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64613981|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64613982|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64613983|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64613984|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64613985|NCT04359095|Tenofovir|tenofovir|mesh-list
64613986|NCT04359095|Emtricitabine|emtricitabine|mesh-list
64613987|NCT04359095|Colchicine|colchicine|mesh-list
64613988|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64613989|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
64613990|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64613991|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64613992|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64613993|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64613994|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64613995|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64613996|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64613997|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64613998|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64613999|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
64614000|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64614001|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64614002|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
64614003|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614004|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614005|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614006|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614007|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614009|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614010|NCT02982395|Ethanol|ethanol|mesh-list
64614011|NCT02982395|Docetaxel|docetaxel|mesh-list
64614012|NCT02982395|Mitomycins|mitomycins|mesh-list
64614013|NCT02982395|Mitomycin|mitomycin|mesh-list
64614014|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614015|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614016|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614017|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614018|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614019|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64614020|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
64614021|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64614022|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614023|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64614024|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614025|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614028|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
64614029|NCT04736836|Rifaximin|rifaximin|mesh-list
64614030|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614031|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614032|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614033|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64614034|NCT03126370|Emtricitabine|emtricitabine|mesh-list
64614035|NCT03126370|Tenofovir|tenofovir|mesh-list
64614036|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64614037|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
64614038|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64614039|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64614040|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614041|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614042|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
64614043|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614044|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64614045|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64614046|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64614047|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64614048|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64614049|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64339445|NCT05318066|Norepinephrine|norepinephrine|mesh-list
64614050|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614051|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614052|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614053|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614054|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614055|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64614056|NCT00979615|Azelastine|azelastine|mesh-list
64614057|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64614058|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64614060|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
64614061|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614062|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614063|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614064|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614065|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64614066|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64614067|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64614068|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
64614069|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
64614070|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614071|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614072|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64614073|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
64614074|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64614075|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
64614076|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64614077|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614078|NCT03126682|Bupropion|bupropion|mesh-list
64614079|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64614080|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
64614081|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64614082|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64614083|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64614084|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614085|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614086|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
64614087|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614088|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614089|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64614090|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64614091|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614092|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64614093|NCT05236738|Cobicistat|cobicistat|mesh-list
64614094|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64614095|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64614096|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614097|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614098|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614099|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64614100|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64614101|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
64614102|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364815|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64614103|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64614104|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64614105|NCT00980395|Rituximab|rituximab|mesh-list
64614106|NCT00980395|Bortezomib|bortezomib|mesh-list
64614107|NCT00980395|Cladribine|cladribine|mesh-list
64614108|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614109|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614110|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
64614111|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614112|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614113|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614114|NCT02976597|Morphine|morphine|mesh-list
64614115|NCT02976597|Bupivacaine|bupivacaine|mesh-list
64614116|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
64614117|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
64614118|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614119|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614120|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
64614121|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614122|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64339519|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614123|NCT02976597|Narcotics|narcotics|mesh-ancestor
64614124|NCT02976597|Analgesics|analgesics|mesh-ancestor
64614125|NCT03020329|Paclitaxel|paclitaxel|mesh-list
64614126|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64614127|NCT03020329|Cisplatin|cisplatin|mesh-list
64614128|NCT03020329|Fluorouracil|fluorouracil|mesh-list
64614129|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64614130|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614131|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614132|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614133|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614134|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614135|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
64614136|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64614137|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614138|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
64614139|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614140|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
64614141|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614142|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614143|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64614144|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64614145|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614146|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614147|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614148|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64614149|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64614151|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64614152|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614153|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614154|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614155|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614156|NCT04772547|Vigabatrin|vigabatrin|mesh-list
64614157|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
64614158|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614159|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614160|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
64614161|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614162|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614163|NCT05028153|Azithromycin|azithromycin|mesh-list
64614164|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614165|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364832|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614166|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64614167|NCT03126760|Hormones|hormones|mesh-ancestor
64614168|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614169|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614172|NCT05027919|Morphine|morphine|mesh-list
64614173|NCT05027919|Naloxone|naloxone|mesh-list
64614174|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64614176|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614177|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614178|NCT05027919|Analgesics|analgesics|mesh-ancestor
64614179|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
64614180|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614181|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64614182|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614183|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64614184|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64614185|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64614186|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614187|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614188|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614189|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
64614190|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
64614191|NCT05026905|Leucovorin|leucovorin|mesh-list
64614192|NCT05026905|Gemcitabine|gemcitabine|mesh-list
64614193|NCT05026905|Paclitaxel|paclitaxel|mesh-list
64614194|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64614195|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
64614196|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64614197|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614199|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614200|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614201|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614202|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64614203|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
64614204|NCT05026905|Antiviral Agents|antiviral agents|mesh-ancestor
64614205|NCT05026905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614206|NCT05026905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614207|NCT05026905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614208|NCT05026905|Immunologic Factors|immunologic factors|mesh-ancestor
64614209|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614210|NCT05026905|Antidotes|antidotes|mesh-ancestor
64614211|NCT05026905|Protective Agents|protective agents|mesh-ancestor
64614212|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
64614213|NCT05026905|Vitamins|vitamins|mesh-ancestor
64614214|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
64614215|NCT00982189|Lisinopril|lisinopril|mesh-list
64614216|NCT00982189|Pravastatin|pravastatin|mesh-list
64614217|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64614218|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64614219|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
64614220|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614221|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64614222|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64614223|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614224|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64614225|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614226|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614227|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64614228|NCT00982189|Protective Agents|protective agents|mesh-ancestor
64614229|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614231|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64614232|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614233|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614234|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614235|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
64614236|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614237|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614238|NCT03128008|Paclitaxel|paclitaxel|mesh-list
64614239|NCT03128008|Carboplatin|carboplatin|mesh-list
64614240|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64614241|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614242|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614243|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614244|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614245|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614246|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64614247|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
64614248|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64614249|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64614250|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64614251|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614252|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614254|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
64614255|NCT05017311|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64614256|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64614257|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614258|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614259|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614260|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
64614261|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614262|NCT05017311|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64614263|NCT05017311|Antidepressive Agents|antidepressive agents|mesh-ancestor
64614264|NCT05017311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64614265|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
64614266|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
64614267|NCT00360087|Bosentan|bosentan|mesh-list
64614268|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614269|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64614270|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614271|NCT00982423|Furosemide|furosemide|mesh-list
64614272|NCT00982423|Diuretics|diuretics|mesh-ancestor
64614273|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
64484301|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64614274|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614275|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64614276|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614277|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614278|NCT04719819|Anesthetics|anesthetics|mesh-list
64614279|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614280|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614281|NCT02981719|Gemcitabine|gemcitabine|mesh-list
64614282|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64614283|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
64364937|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
64614284|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614285|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614286|NCT02981719|Antiviral Agents|antiviral agents|mesh-ancestor
64614287|NCT02981719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614288|NCT02981719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614289|NCT02981719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614290|NCT02981719|Immunologic Factors|immunologic factors|mesh-ancestor
64614291|NCT02981719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614292|NCT03073876|Donepezil|donepezil|mesh-list
64614293|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64614294|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614295|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614296|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
64614297|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614298|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614299|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
64614300|NCT04718961|Volixibat|volixibat|mesh-list
64614301|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64614302|NCT03130738|Miconazole|miconazole|mesh-list
64614303|NCT03130738|Clotrimazole|clotrimazole|mesh-list
64614304|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
64614305|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614306|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64614307|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64614308|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614309|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614310|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64614311|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
64614312|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614313|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614314|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64614315|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64614316|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64614317|NCT04996251|Bupivacaine|bupivacaine|mesh-list
64614318|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
64614319|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
64614320|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614321|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614322|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
64614323|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614325|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
64614326|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614327|NCT04672395|Vaccines|vaccines|mesh-list
64614328|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
64614329|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
64614330|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614331|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64614332|NCT05394493|Avelumab|avelumab|mesh-list
64614334|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614335|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614336|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64614337|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614338|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614339|NCT00985543|Ritonavir|ritonavir|mesh-list
64614340|NCT00985543|Lopinavir|lopinavir|mesh-list
64614341|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64614342|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64614343|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614344|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614345|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339748|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64614346|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64614347|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64614348|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
64614349|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614350|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64614351|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64614353|NCT05394415|Carboplatin|carboplatin|mesh-list
64614354|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64614355|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614356|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614357|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614358|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614359|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614360|NCT04352959|Betadex|betadex|mesh-list
64614361|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
64614362|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297403|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
64297404|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64614363|NCT00360945|Temozolomide|temozolomide|mesh-list
64614364|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614365|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64614366|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
64614367|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614368|NCT03019237|Omalizumab|omalizumab|mesh-list
64614369|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64614370|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64614371|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
64614372|NCT00361023|Losartan|losartan|mesh-list
64614373|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64614374|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614375|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64614376|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64614377|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614378|NCT04659369|Nivolumab|nivolumab|mesh-list
64614379|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614380|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614381|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64614382|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614383|NCT03019081|Isoproterenol|isoproterenol|mesh-list
64614384|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64614385|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64614386|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614387|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614388|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614389|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614390|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64614391|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
64614392|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614393|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64614394|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
64614395|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64614396|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
64614397|NCT03019081|Protective Agents|protective agents|mesh-ancestor
64614398|NCT00986401|Metformin|metformin|mesh-list
64614399|NCT00986401|Trospium chloride|trospium chloride|mesh-list
64614400|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64614401|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614402|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
64614403|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
64614404|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614405|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64614406|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64614407|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
64614408|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614409|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614410|NCT00986401|Urological Agents|urological agents|mesh-ancestor
64614411|NCT00375076|Enoxaparin|enoxaparin|mesh-list
64614412|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
64614413|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64614414|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64614415|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614416|NCT00987415|Allopurinol|allopurinol|mesh-list
64614417|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
64614419|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614420|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
64614421|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614422|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64614423|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
64614424|NCT00987415|Protective Agents|protective agents|mesh-ancestor
64614425|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614426|NCT04807504|Ropivacaine|ropivacaine|mesh-list
64614427|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
64614428|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
64614429|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614430|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614431|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
64614432|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614434|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64614435|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64614436|NCT04771156|Analgesics|analgesics|mesh-ancestor
64614437|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
64614438|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614439|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614440|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614441|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614442|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64614443|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614444|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614445|NCT04707118|Paclitaxel|paclitaxel|mesh-list
64614446|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64614447|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64614448|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614449|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614450|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614451|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614452|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614453|NCT03086356|Dabigatran|dabigatran|mesh-list
64614454|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
64614455|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64614456|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614457|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614458|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614459|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
64614460|NCT04564755|Abrocitinib|abrocitinib|mesh-list
64614461|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64614462|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614463|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614464|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
64614465|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64614466|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64614467|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614468|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
64614469|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
64614470|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
64614471|NCT03140722|Hematinics|hematinics|mesh-ancestor
64614472|NCT00375622|Tamoxifen|tamoxifen|mesh-list
64614473|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64614474|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
64365035|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64614475|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614476|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614477|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64614478|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614479|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64614481|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64614483|NCT03087604|Epinephrine|epinephrine|mesh-list
64614484|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
64614485|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
64614486|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614487|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614488|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
64614489|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614490|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64614491|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64614492|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64614493|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614494|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614495|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64614496|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64614497|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614498|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614499|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64614500|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64614501|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
64614502|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64614503|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
64614504|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
64614505|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
64614506|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64614507|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64614508|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
64614509|NCT00987727|Glycerol|glycerol|mesh-list
64614510|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64614511|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
64614512|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614513|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
64614514|NCT00987727|Protective Agents|protective agents|mesh-ancestor
64614515|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64614516|NCT00987727|Laxatives|laxatives|mesh-ancestor
64614517|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614518|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64614519|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64614520|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64614521|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614522|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614523|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64614524|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614525|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614526|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
64614527|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614528|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
64614529|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614530|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614531|NCT05386459|Interferons|interferons|mesh-list
64614532|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
64614533|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614534|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
64614535|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614536|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
64614537|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64614538|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64614539|NCT03018535|Prednisolone|prednisolone|mesh-list
64614540|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
64614541|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
64614542|NCT03018535|Rituximab|rituximab|mesh-list
64614543|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64614544|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
64614545|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614546|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
64614547|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614548|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614549|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64614550|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
64614551|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614553|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64614554|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614555|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614556|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
64614557|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
64614558|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614559|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614560|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
64614561|NCT03018535|Hormones|hormones|mesh-ancestor
64614562|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614563|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64614564|NCT03018535|Protective Agents|protective agents|mesh-ancestor
64614565|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64339935|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64614566|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
64614567|NCT04890873|Antacids|antacids|mesh-ancestor
64614568|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614569|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614571|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
64614572|NCT04889547|BB 1101|bb 1101|mesh-list
64614573|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614574|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
64614575|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
64614576|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614577|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614578|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614579|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
64614580|NCT04889547|Hormones|hormones|mesh-ancestor
64614581|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614582|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64614583|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614584|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614585|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614586|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614587|NCT00989911|Bosentan|bosentan|mesh-list
64614588|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614589|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64614590|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614591|NCT05250895|Misonidazole|misonidazole|mesh-list
64614592|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614593|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64614594|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64614595|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614596|NCT02977065|Atorvastatin|atorvastatin|mesh-list
64614597|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64614598|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64614600|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
64614601|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614602|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64614603|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64614604|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614605|NCT03146806|Ketamine|ketamine|mesh-list
64614606|NCT03146806|Analgesics|analgesics|mesh-ancestor
64614607|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
64614608|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614609|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614610|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64614611|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64614612|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
64614613|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
64614614|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614615|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64614616|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64614617|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614618|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614619|NCT03439293|Dexamethasone|dexamethasone|mesh-list
64614620|NCT03439293|Daratumumab|daratumumab|mesh-list
64614621|NCT03439293|Ixazomib|ixazomib|mesh-list
64614622|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614623|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
64614624|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
64614625|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614626|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614627|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614628|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
64614629|NCT03439293|Hormones|hormones|mesh-ancestor
64614630|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614631|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64614632|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614633|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614634|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614635|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614636|NCT04706806|Acetic Acid|acetic acid|mesh-list
64614637|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614638|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614639|NCT03424005|Gemcitabine|gemcitabine|mesh-list
64614640|NCT03424005|Paclitaxel|paclitaxel|mesh-list
64614641|NCT03424005|Bevacizumab|bevacizumab|mesh-list
64614642|NCT03424005|Carboplatin|carboplatin|mesh-list
64614643|NCT03424005|Capecitabine|capecitabine|mesh-list
64614644|NCT03424005|Atezolizumab|atezolizumab|mesh-list
64614645|NCT03424005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64614646|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614647|NCT03424005|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614648|NCT03424005|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614649|NCT03424005|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614650|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614651|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614652|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64614653|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64614654|NCT03424005|Growth Substances|growth substances|mesh-ancestor
64614655|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614656|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
64614657|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64614658|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
64614659|NCT03424005|Antiviral Agents|antiviral agents|mesh-ancestor
64614660|NCT03424005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614661|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614662|NCT03424005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614663|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
64614664|NCT02975583|Vorapaxar|vorapaxar|mesh-list
64614665|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64614666|NCT03953235|Nivolumab|nivolumab|mesh-list
64614667|NCT03953235|Ipilimumab|ipilimumab|mesh-list
64614668|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614669|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614670|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64614672|NCT03402945|Vancomycin|vancomycin|mesh-list
64614673|NCT03402945|Cefazolin|cefazolin|mesh-list
64614674|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614675|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614676|NCT03095638|Dolutegravir|dolutegravir|mesh-list
64614677|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64614678|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64614679|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614680|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614681|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64614682|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64614683|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
64614684|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614685|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
64614686|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
64614687|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614688|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
64614689|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64614690|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
64614691|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614692|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614693|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64614694|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
64614695|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64614696|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
64614697|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614698|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614699|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64614700|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
64614701|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
64614702|NCT04450108|Protective Agents|protective agents|mesh-ancestor
64614703|NCT03891849|Octreotide|octreotide|mesh-list
64614704|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614705|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64614706|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614707|NCT04341831|Teicoplanin|teicoplanin|mesh-list
64614708|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614709|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614710|NCT00361959|Fluticasone|fluticasone|mesh-list
64614711|NCT00361959|Xhance|xhance|mesh-list
64614712|NCT00361959|Bromides|bromides|mesh-list
64614713|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
64614714|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64614715|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614716|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64614717|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
64614718|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614719|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614720|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64614721|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
64614723|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64614724|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
64614725|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64614726|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
64614727|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614728|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614729|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64614730|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64614731|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64614732|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614733|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
64614734|NCT03158116|Aztreonam|aztreonam|mesh-list
64614735|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64614736|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614737|NCT03096730|Sufentanil|sufentanil|mesh-list
64614738|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
64614739|NCT03096730|Remifentanil|remifentanil|mesh-list
64614741|NCT03096730|Nalmefene|nalmefene|mesh-list
64614742|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64614743|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614744|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614745|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64614746|NCT03096730|Analgesics|analgesics|mesh-ancestor
64614747|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
64614748|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614749|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64614750|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64614751|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64614752|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614753|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614754|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614755|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64614756|NCT03096730|Narcotics|narcotics|mesh-ancestor
64614757|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64614758|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64614759|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
64614760|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
64614761|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64614762|NCT00362037|Irbesartan|irbesartan|mesh-list
64614763|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614764|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64614766|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614767|NCT03161158|Diuretics|diuretics|mesh-list
64614768|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
64614769|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614770|NCT03161938|Dexamethasone|dexamethasone|mesh-list
64614771|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64614772|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
64614773|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
64614774|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614775|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614776|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64614777|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
64614778|NCT03161938|Hormones|hormones|mesh-ancestor
64614779|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614780|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64614781|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614782|NCT03321045|Trastuzumab|trastuzumab|mesh-list
64614783|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614784|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614785|NCT00989989|Ranibizumab|ranibizumab|mesh-list
64614786|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64614787|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64614788|NCT00989989|Growth Substances|growth substances|mesh-ancestor
64614789|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614790|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
64614791|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614792|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
64614793|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614794|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
64614795|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340161|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
64614796|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64614797|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64614798|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
64614799|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614800|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614801|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64614802|NCT03018301|Ketamine|ketamine|mesh-list
64614803|NCT03018301|Analgesics|analgesics|mesh-ancestor
64614804|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
64614805|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614806|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614807|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64614808|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64614809|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
64614811|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614812|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64614813|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64614814|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614815|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614816|NCT00990769|Anesthetics|anesthetics|mesh-list
64614817|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614818|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614819|NCT00991081|Bupropion|bupropion|mesh-list
64614820|NCT00991081|Nicotine|nicotine|mesh-list
64614821|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64614822|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
64614823|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614824|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614825|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64614826|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64614827|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
64614828|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614829|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614830|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64614831|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
64614832|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64614833|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64614834|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64614835|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614836|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
64614837|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64614838|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64614839|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614840|NCT03168022|Amitriptyline|amitriptyline|mesh-list
64614841|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
64614842|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64614843|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
64614844|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64614845|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64614846|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614847|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64614848|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614849|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64614850|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614851|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64614852|NCT03168022|Analgesics|analgesics|mesh-ancestor
64614853|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
64614854|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64614855|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64614856|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614857|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614858|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614859|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614860|NCT03102190|Verapamil|verapamil|mesh-list
64614861|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64614862|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64614863|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614864|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614865|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64614866|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614868|NCT03254667|Brodalumab|brodalumab|mesh-list
64614870|NCT03102736|Nitroprusside|nitroprusside|mesh-list
64614871|NCT03102736|Ketamine|ketamine|mesh-list
64614872|NCT03102736|Analgesics|analgesics|mesh-ancestor
64614873|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
64614874|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64614875|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614876|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64614877|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64614878|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
64614879|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
64614880|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614881|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64614882|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64614883|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614884|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614885|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614886|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
64614887|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64614888|NCT03743103|Nitroprusside|nitroprusside|mesh-list
64614889|NCT03743103|Esmolol|esmolol|mesh-list
64614890|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64614891|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
64614892|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64614893|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614894|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64614895|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64614896|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64614897|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
64614898|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614899|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614900|NCT04049266|Aflibercept|aflibercept|mesh-list
64614901|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64614902|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64614903|NCT04049266|Growth Substances|growth substances|mesh-ancestor
64614904|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614905|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
64614906|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614907|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
64614908|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64614909|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614911|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64614912|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
64614913|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614914|NCT00362505|Clevudine|clevudine|mesh-list
64614915|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
64614916|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614917|NCT00993187|Metformin|metformin|mesh-list
64614918|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64614919|NCT00993187|Glimepiride|glimepiride|mesh-list
64614920|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64614921|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614922|NCT00993187|Incretins|incretins|mesh-ancestor
64614923|NCT00993187|Hormones|hormones|mesh-ancestor
64614924|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614925|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64614926|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
64614927|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614928|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614929|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64614930|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614931|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
64614932|NCT03173170|Itraconazole|itraconazole|mesh-list
64614933|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
64614934|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614935|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64614936|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64614937|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614938|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614939|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64614940|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
64614941|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64614942|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614943|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64614944|NCT03106870|Insulin|insulin|mesh-list
64614945|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64614946|NCT03106870|Metformin|metformin|mesh-list
64614947|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
64614948|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64614949|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614950|NCT03792490|Fasudil|fasudil|mesh-list
64614951|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64614952|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64614953|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614954|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64614955|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614956|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
64614957|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64614958|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614959|NCT00375310|Gemcitabine|gemcitabine|mesh-list
64614960|NCT00375310|Sorafenib|sorafenib|mesh-list
64614961|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64614962|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
64614963|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614964|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614965|NCT00375310|Antiviral Agents|antiviral agents|mesh-ancestor
64614966|NCT00375310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64614967|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614968|NCT00375310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64614969|NCT00375310|Immunologic Factors|immunologic factors|mesh-ancestor
64614970|NCT00375310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614971|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64614972|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64614973|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64614974|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
64614975|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64614976|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64614977|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64614978|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
64614979|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
64614980|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64614981|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614983|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614984|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64614985|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64614986|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614988|NCT00993655|Carboplatin|carboplatin|mesh-list
64614989|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64614990|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64614991|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
64614992|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
64614993|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64614994|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64614995|NCT00362583|Fentanyl|fentanyl|mesh-list
64614996|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64614997|NCT00362583|Narcotics|narcotics|mesh-ancestor
64614998|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64614999|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615000|NCT00362583|Analgesics|analgesics|mesh-ancestor
64615001|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
64615002|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615003|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64615004|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64615005|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
64615006|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
64615007|NCT00657241|Valsartan|valsartan|mesh-list
64615008|NCT00657241|Carvedilol|carvedilol|mesh-list
64615009|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64615010|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64615011|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64615012|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615013|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64615014|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64615015|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64615016|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615017|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615018|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
64615019|NCT00657241|Protective Agents|protective agents|mesh-ancestor
64615020|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64615021|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615022|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64615023|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
64615024|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64615025|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64615027|NCT04342065|Pregabalin|pregabalin|mesh-list
64615028|NCT04342065|Analgesics|analgesics|mesh-ancestor
64615029|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
64615030|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615031|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615032|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
64615033|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64615034|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615035|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615036|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64615037|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64615038|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64615039|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615040|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64615041|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64615042|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64615043|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615044|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615045|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64615046|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64615047|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615048|NCT03179410|Avelumab|avelumab|mesh-list
64615049|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615050|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615058|NCT00478465|Valganciclovir|valganciclovir|mesh-list
64615059|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
64615060|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615061|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
64615062|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64615063|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
64615064|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615065|NCT00421785|Expectorants|expectorants|mesh-ancestor
64615066|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
64615067|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64615068|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
64615069|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615070|NCT00421785|Protective Agents|protective agents|mesh-ancestor
64615071|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615072|NCT00421785|Antidotes|antidotes|mesh-ancestor
64297452|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615073|NCT02519348|Bevacizumab|bevacizumab|mesh-list
64615074|NCT02519348|Durvalumab|durvalumab|mesh-list
64615075|NCT02519348|Tremelimumab|tremelimumab|mesh-list
64615076|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615077|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615078|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64615079|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64615080|NCT02519348|Growth Substances|growth substances|mesh-ancestor
64615081|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615082|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
64615083|NCT03653338|Rituximab|rituximab|mesh-list
64615084|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
64615085|NCT03653338|Fludarabine|fludarabine|mesh-list
64615086|NCT03653338|Thiotepa|thiotepa|mesh-list
64615087|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
64615088|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615089|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615090|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
64615091|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615092|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615093|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615094|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615095|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64615096|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
64615097|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64615098|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
64615099|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615100|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64615101|NCT00421863|Amlodipine|amlodipine|mesh-list
64615102|NCT00421863|Telmisartan|telmisartan|mesh-list
64615103|NCT00421863|Clonidine|clonidine|mesh-list
64615104|NCT00421863|Ramipril|ramipril|mesh-list
64615105|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64615106|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64615107|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615108|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615109|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64615110|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615111|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
64615112|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64615113|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64615114|NCT00421863|Analgesics|analgesics|mesh-ancestor
64615115|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
64615116|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615117|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
64615118|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
64615119|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64615120|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64615121|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64615122|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
64615123|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615125|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
64615126|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615127|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64615128|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64615129|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64615130|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615131|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615134|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615135|NCT05363722|Bevacizumab|bevacizumab|mesh-list
64615136|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615137|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615138|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64615139|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64615140|NCT05363722|Growth Substances|growth substances|mesh-ancestor
64615141|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615142|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
64615143|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64615144|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615145|NCT04736524|Antibodies|antibodies|mesh-list
64615146|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
64615147|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615148|NCT03127137|Triamcinolone|triamcinolone|mesh-list
64615149|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64615150|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64615151|NCT03127137|Lidocaine|lidocaine|mesh-list
64615152|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64615153|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
64615154|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
64615155|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615156|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615157|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
64615158|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615159|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64615160|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64615161|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64615162|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615163|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615164|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615165|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
64615167|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615168|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615169|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
64615170|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615171|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
64615172|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64615173|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64615174|NCT03122847|Prednisolone|prednisolone|mesh-list
64615175|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
64615176|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64615177|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
64615178|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615179|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
64615180|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
64615181|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615182|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615183|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615184|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
64615185|NCT03122847|Hormones|hormones|mesh-ancestor
64615186|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615187|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64615188|NCT03122847|Protective Agents|protective agents|mesh-ancestor
64615189|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64615190|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615191|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
64615192|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
64615193|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64615194|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64615195|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615196|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615197|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615199|NCT03525028|Metformin|metformin|mesh-list
64615200|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64615201|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615202|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64615203|NCT00754312|Entinostat|entinostat|mesh-list
64615204|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615205|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64615206|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615207|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615208|NCT03523312|Capecitabine|capecitabine|mesh-list
64615209|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64615210|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
64615211|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615212|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615213|NCT03623373|Cytarabine|cytarabine|mesh-list
64615214|NCT03623373|Rituximab|rituximab|mesh-list
64615215|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64615216|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
64615217|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615218|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615219|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
64615220|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615221|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615222|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64615223|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
64615224|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615225|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
64615226|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615227|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615228|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64615229|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
64615230|NCT03505762|Prednisone|prednisone|mesh-list
64615231|NCT03505762|Cortisone|cortisone|mesh-list
64615232|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
64615233|NCT03505762|Rituximab|rituximab|mesh-list
64615234|NCT03505762|Doxorubicin|doxorubicin|mesh-list
64615235|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64615236|NCT03505762|Vincristine|vincristine|mesh-list
64615237|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64615238|NCT03505762|Antibodies|antibodies|mesh-list
64615239|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
64615240|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64615241|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615242|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
64615243|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615244|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615245|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64615246|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
64615247|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615248|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615249|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64615250|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64615251|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64615252|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64615253|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615254|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615255|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
64615256|NCT03505762|Hormones|hormones|mesh-ancestor
64615257|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615258|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64615259|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64615260|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615261|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615262|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615263|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
64615264|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64615265|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64615266|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64615267|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615268|NCT03618537|Dexamethasone|dexamethasone|mesh-list
64615269|NCT03618537|Ixazomib|ixazomib|mesh-list
64615270|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615271|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
64615272|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
64615273|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615274|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615275|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615276|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
64615277|NCT03618537|Hormones|hormones|mesh-ancestor
64615278|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615279|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64615280|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615281|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
64615282|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615283|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615285|NCT03410446|Analgesics|analgesics|mesh-ancestor
64615286|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
64615287|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615288|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615289|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64615290|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64615291|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
64615292|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
64615293|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615294|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64615295|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64615296|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615297|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615298|NCT03617445|Vancomycin|vancomycin|mesh-list
64615299|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64615300|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615301|NCT00375388|Metformin|metformin|mesh-list
64615302|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64615303|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615304|NCT00375778|Memantine|memantine|mesh-list
64615305|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64615306|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64615307|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
64615308|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615309|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615310|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615311|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64615312|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64615313|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64615314|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615315|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64615316|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615317|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615319|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
64615320|NCT03001726|Tegafur|tegafur|mesh-list
64615322|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615323|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615324|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615325|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615326|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64615328|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
64615329|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
64615330|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
64615331|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615332|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615333|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
64615334|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615335|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
64615336|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64615337|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615338|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
64615339|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615340|NCT03087903|Protective Agents|protective agents|mesh-ancestor
64615341|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615342|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
64615343|NCT03577431|Everolimus|everolimus|mesh-list
64615344|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615345|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
64615346|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615347|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615348|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64615349|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
64615350|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615351|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615352|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64615354|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64615355|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615356|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64615357|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
64615358|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64615359|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615360|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615361|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615362|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
64615363|NCT04598074|Narcotics|narcotics|mesh-ancestor
64615364|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615365|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615366|NCT04598074|Analgesics|analgesics|mesh-ancestor
64615367|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
64615368|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615369|NCT04353193|Octreotide|octreotide|mesh-list
64615370|NCT04353193|Terlipressin|terlipressin|mesh-list
64615371|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615372|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64615373|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615374|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64615375|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64615377|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64615378|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64615379|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64615380|NCT00635648|Caspofungin|caspofungin|mesh-list
64615381|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
64615382|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615383|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615384|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615385|NCT03056001|Doxorubicin|doxorubicin|mesh-list
64615386|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
64615387|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64615388|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615389|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64615390|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64615391|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615392|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615393|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615394|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
64615395|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
64615396|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
64615397|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
64615398|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
64615399|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64615400|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
64615401|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615402|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615403|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615404|NCT05240456|Urological Agents|urological agents|mesh-ancestor
64615405|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64615407|NCT03574779|Bevacizumab|bevacizumab|mesh-list
64615408|NCT03574779|Carboplatin|carboplatin|mesh-list
64615409|NCT03574779|Niraparib|niraparib|mesh-list
64615410|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64615411|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615412|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615413|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615414|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615415|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615416|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615417|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64615418|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64615419|NCT03574779|Growth Substances|growth substances|mesh-ancestor
64615420|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615422|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64615423|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615425|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64615426|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64615427|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615428|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615429|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615430|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615431|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615432|NCT00995761|Cisplatin|cisplatin|mesh-list
64615433|NCT00995761|Docetaxel|docetaxel|mesh-list
64615434|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615435|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615436|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615437|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615438|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615440|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64615441|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
64615442|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64615443|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64615444|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64615445|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615446|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615447|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
64615448|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
64615449|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615450|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615451|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64615452|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64615453|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
64615454|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64615455|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64615456|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64615457|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64615458|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64615459|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64615460|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615461|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64615462|NCT00635102|Cycloserine|cycloserine|mesh-list
64615463|NCT00635102|Glycine|glycine|mesh-list
64340837|NCT02273050|Metformin|metformin|mesh-list
64615464|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64615465|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615466|NCT00635102|Renal Agents|renal agents|mesh-ancestor
64615467|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64615468|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
64615469|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64615470|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
64615471|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615472|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
64615473|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615474|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615475|NCT03041883|Riboflavin|riboflavin|mesh-list
64615476|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
64615477|NCT03041883|Vitamins|vitamins|mesh-ancestor
64615478|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
64615479|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615480|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64615481|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
64615482|NCT03034005|Budesonide|budesonide|mesh-list
64615483|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615484|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64615485|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
64615486|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615487|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615488|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64615489|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
64615490|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
64615491|NCT03034005|Hormones|hormones|mesh-ancestor
64615492|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615494|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64615495|NCT00635024|Melphalan|melphalan|mesh-list
64365339|NCT03264079|Itraconazole|itraconazole|mesh-list
64615496|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64615497|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64615498|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
64615499|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615500|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615501|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64615502|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615503|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
64615504|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615505|NCT03544281|Dexamethasone|dexamethasone|mesh-list
64615506|NCT03544281|Lenalidomide|lenalidomide|mesh-list
64615507|NCT03544281|Bortezomib|bortezomib|mesh-list
64615508|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615509|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
64615510|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
64615511|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615512|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615513|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615514|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
64615515|NCT03544281|Hormones|hormones|mesh-ancestor
64615516|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615517|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64615518|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615519|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
64615520|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64615521|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64615522|NCT03544281|Growth Substances|growth substances|mesh-ancestor
64615523|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
64615524|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64615525|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64615526|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615527|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
64615528|NCT03182920|Lasmiditan|lasmiditan|mesh-list
64615529|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64615530|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
64615531|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615532|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615533|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615534|NCT05406388|Fentanyl|fentanyl|mesh-list
64615535|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64615536|NCT05406388|Narcotics|narcotics|mesh-ancestor
64340932|NCT05648266|Analgesics|analgesics|mesh-list
64615537|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615538|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615540|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
64615541|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615542|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64615543|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64615544|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
64615545|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
64615546|NCT04165330|Nivolumab|nivolumab|mesh-list
64615547|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615548|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615549|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64615550|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615551|NCT03485547|Venetoclax|venetoclax|mesh-list
64615552|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615553|NCT02947347|Rituximab|rituximab|mesh-list
64615554|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615555|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615556|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
64615557|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615558|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615559|NCT03187678|Selexipag|selexipag|mesh-list
64615560|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64615561|NCT02942355|Palbociclib|palbociclib|mesh-list
64615562|NCT02942355|Anastrozole|anastrozole|mesh-list
64615563|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615564|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64615565|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615566|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615567|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64615568|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64615569|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64615570|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64615571|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
64615572|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615573|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615574|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64615575|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
64615576|NCT03192826|Dipivefrin|dipivefrin|mesh-list
64615577|NCT03192826|Brinzolamide|brinzolamide|mesh-list
64615578|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64615579|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64615580|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64615581|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64615582|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
64615583|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615584|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615585|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615586|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64615587|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64615588|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64615589|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615590|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
64615591|NCT03287674|Nivolumab|nivolumab|mesh-list
64615592|NCT03287674|Fludarabine|fludarabine|mesh-list
64615593|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
64615594|NCT03287674|Ipilimumab|ipilimumab|mesh-list
64615595|NCT03287674|Interleukin-2|interleukin-2|mesh-list
64615596|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615597|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
64615598|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615599|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615600|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64615601|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
64615602|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615603|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615604|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64615605|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615606|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64615607|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64615608|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
64615609|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64615610|NCT03287674|Analgesics|analgesics|mesh-ancestor
64615611|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
64615612|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615613|NCT00634244|Cytarabine|cytarabine|mesh-list
64615617|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
64615618|NCT00634244|Topotecan|topotecan|mesh-list
64615619|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
64615620|NCT00634244|Alvocidib|alvocidib|mesh-list
64615621|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615622|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64615623|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64615624|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64615625|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615626|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615627|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64615628|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
64615629|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
64615630|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615631|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615632|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
64615633|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615634|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64615635|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64615636|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
64615637|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64615638|NCT00634244|Analgesics|analgesics|mesh-ancestor
64615639|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
64615640|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615641|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
64615644|NCT01922804|Vitamins|vitamins|mesh-list
64615645|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
64615646|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615647|NCT03289858|Bupivacaine|bupivacaine|mesh-list
64615648|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
64615649|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
64615650|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615651|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615652|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
64615653|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615654|NCT03418714|Salvinorin A|salvinorin a|mesh-list
64615655|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
64615656|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615657|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64615658|NCT03421210|Nicotine|nicotine|mesh-list
64615659|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64615660|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
64615661|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615662|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615663|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64615664|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64615665|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
64615666|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615667|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615668|NCT03294850|Cholic Acids|cholic acids|mesh-list
64615669|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615670|NCT00996931|Lenalidomide|lenalidomide|mesh-list
64615671|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
64615672|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615673|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64615674|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64615675|NCT00996931|Growth Substances|growth substances|mesh-ancestor
64615676|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
64615677|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615678|NCT00634088|Capecitabine|capecitabine|mesh-list
64615679|NCT00634088|Lapatinib|lapatinib|mesh-list
64615680|NCT00634088|Epothilones|epothilones|mesh-list
64615681|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64615682|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
64615683|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615684|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615685|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64615686|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615687|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615688|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615689|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615690|NCT03428230|Acetaminophen|acetaminophen|mesh-list
64615691|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
64615692|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64615693|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64615694|NCT03428230|Analgesics|analgesics|mesh-ancestor
64615695|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
64615696|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615697|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615698|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
64615699|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
64615700|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
64615701|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615702|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
64615703|NCT03296800|Rifampin|rifampin|mesh-list
64615704|NCT03296800|Probenecid|probenecid|mesh-list
64615705|NCT03296800|Verapamil|verapamil|mesh-list
64615706|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64615707|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
64615708|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64615709|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615710|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
64615711|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64615712|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615713|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615714|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64615715|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64615716|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64615717|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64615718|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64615719|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64615720|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64615721|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64615722|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615723|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64615724|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615725|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
64615726|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
64615727|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
64615728|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615729|NCT03296800|Renal Agents|renal agents|mesh-ancestor
64615730|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64615731|NCT00999037|Sevelamer|sevelamer|mesh-list
64615732|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
64615733|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
64615734|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615735|NCT00634010|Morphine|morphine|mesh-list
64615736|NCT00634010|Methadone|methadone|mesh-list
64615737|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64615738|NCT00634010|Narcotics|narcotics|mesh-ancestor
64615739|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615740|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297491|NCT03098342|Amorolfine|amorolfine|mesh-list
64615741|NCT00634010|Analgesics|analgesics|mesh-ancestor
64615742|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
64615743|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615744|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
64615745|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
64615746|NCT00633932|Esomeprazole|esomeprazole|mesh-list
64615747|NCT00633932|Omeprazole|omeprazole|mesh-list
64615748|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64615749|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615750|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64615751|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615752|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615753|NCT01028677|Oxytocin|oxytocin|mesh-list
64615754|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
64615755|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64615756|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615757|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
64615758|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615759|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
64615760|NCT01000285|Prednisone|prednisone|mesh-list
64615761|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
64615762|NCT01000285|Doxorubicin|doxorubicin|mesh-list
64615763|NCT01000285|Etoposide|etoposide|mesh-list
64615764|NCT01000285|Vincristine|vincristine|mesh-list
64615766|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615767|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
64615768|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615769|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64615770|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64615772|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615773|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615774|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64615775|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64615776|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64615777|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64615778|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615779|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615780|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
64615781|NCT01000285|Hormones|hormones|mesh-ancestor
64615782|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615783|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64615784|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64615785|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615786|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615787|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615788|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64615789|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64615790|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
64615791|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615792|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64615793|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64615794|NCT01000987|Varenicline|varenicline|mesh-list
64615795|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64615796|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64615797|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
64615798|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615799|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615800|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615801|NCT00633464|Cetuximab|cetuximab|mesh-list
64615802|NCT00633464|Epothilones|epothilones|mesh-list
64615803|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64615804|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615805|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
64615806|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
64615807|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
64615808|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615809|NCT03437044|Clopidogrel|clopidogrel|mesh-list
64615810|NCT03437044|Ticagrelor|ticagrelor|mesh-list
64615811|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64615812|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64615813|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64615814|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64615815|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
64615816|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615817|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615818|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615819|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64615820|NCT01923194|Hormones|hormones|mesh-ancestor
64615821|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615822|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615823|NCT03303196|Pancrelipase|pancrelipase|mesh-list
64615824|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615825|NCT00633152|Linezolid|linezolid|mesh-list
64615826|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64615827|NCT00633152|Cephalosporins|cephalosporins|mesh-list
64615828|NCT00633152|Aztreonam|aztreonam|mesh-list
64615829|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64615830|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615831|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64615832|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615833|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615834|NCT01030783|Sorafenib|sorafenib|mesh-list
64615835|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615836|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64615837|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615838|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615839|NCT00633074|Vaccines|vaccines|mesh-list
64615840|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
64615841|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615842|NCT03304054|Amifampridine|amifampridine|mesh-list
64615843|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64615844|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615845|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615846|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64615847|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64615848|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615849|NCT01929278|Clindamycin|clindamycin|mesh-list
64615850|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
64615851|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
64615853|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64615854|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64615855|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64615856|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615857|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615858|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615859|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
64615860|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
64615861|NCT03210376|Neostigmine|neostigmine|mesh-list
64615862|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64615863|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615864|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615865|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
64615866|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615867|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615868|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64615869|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
64615870|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615871|NCT01929512|Metformin|metformin|mesh-list
64615872|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64615873|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64615874|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615875|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64615876|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64615877|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
64615878|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615879|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64615880|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64615881|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615882|NCT03211234|Ranibizumab|ranibizumab|mesh-list
64615883|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64615884|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64615885|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64615886|NCT03211234|Growth Substances|growth substances|mesh-ancestor
64615887|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615888|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
64615889|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615890|NCT03105518|Acetaminophen|acetaminophen|mesh-list
64615891|NCT03105518|Fentanyl|fentanyl|mesh-list
64615892|NCT03105518|Oxycodone|oxycodone|mesh-list
64615893|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64615894|NCT03105518|Narcotics|narcotics|mesh-ancestor
64615895|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615896|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615897|NCT03105518|Analgesics|analgesics|mesh-ancestor
64615898|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
64615899|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615900|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64615901|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64615902|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
64615903|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
64615904|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64615905|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
64615906|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
64615907|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
64615908|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615909|NCT01929668|Protective Agents|protective agents|mesh-ancestor
64615910|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615911|NCT01929668|Vitamins|vitamins|mesh-ancestor
64615913|NCT01929746|Daclizumab|daclizumab|mesh-list
64615914|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615915|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
64615916|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615917|NCT03933397|Morphine|morphine|mesh-list
64615918|NCT03933397|Hydromorphone|hydromorphone|mesh-list
64615919|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64615920|NCT03933397|Narcotics|narcotics|mesh-ancestor
64615921|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615922|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615924|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
64615925|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615926|NCT03506048|Lenvatinib|lenvatinib|mesh-list
64615927|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615928|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64615929|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615930|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615931|NCT02161705|Ropivacaine|ropivacaine|mesh-list
64615932|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
64615933|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
64615934|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64615935|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615936|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
64615937|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615938|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
64615939|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64615940|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
64615941|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615942|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615943|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64615944|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
64615945|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64615946|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
64615947|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615948|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615949|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64615950|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
64615951|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
64615952|NCT01929824|Protective Agents|protective agents|mesh-ancestor
64615953|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
64615954|NCT01031953|Aprepitant|aprepitant|mesh-list
64615955|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
64615956|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
64615957|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615958|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615959|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64615960|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64615961|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64615962|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615963|NCT01923584|Ubiquinone|ubiquinone|mesh-list
64615964|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
64615965|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615966|NCT00630344|Everolimus|everolimus|mesh-list
64615967|NCT00630344|Bicalutamide|bicalutamide|mesh-list
64615968|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64615969|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64615970|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
64615971|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615972|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
64615973|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
64615974|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64615976|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
64615977|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64615978|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64615979|NCT01923818|Analgesics|analgesics|mesh-ancestor
64615980|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
64615981|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64615982|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64615983|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64615985|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64615986|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64615987|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64615989|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64615990|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64615992|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64615993|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
64615994|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64615995|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
64615996|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
64615997|NCT02169115|Omalizumab|omalizumab|mesh-list
64615998|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64615999|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64616000|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64616001|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
64616002|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
64616003|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616004|NCT00376792|Docetaxel|docetaxel|mesh-list
64616005|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616006|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
64616007|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
64616008|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
64616009|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616010|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
64616011|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
64616012|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64616013|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
64616014|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616015|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616016|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64616017|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
64616018|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64616019|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64616020|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64616021|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
64616022|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616023|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616024|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616025|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
64616026|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64616027|NCT03316378|Ropivacaine|ropivacaine|mesh-list
64616028|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
64616029|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
64616030|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297504|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
64616032|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
64616033|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616034|NCT00637130|Travoprost|travoprost|mesh-list
64616035|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64616036|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64616037|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64616038|NCT02847559|Bevacizumab|bevacizumab|mesh-list
64616039|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64616040|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
64616041|NCT02847559|Antibodies|antibodies|mesh-list
64616042|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
64616043|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64616044|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
64616045|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616046|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64616047|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64616048|NCT02847559|Growth Substances|growth substances|mesh-ancestor
64616049|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616050|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
64616051|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
64616052|NCT00637052|Filanesib|filanesib|mesh-list
64616053|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
64616054|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
64616055|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616056|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616057|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
64616058|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
64616059|NCT01921868|Vitamins|vitamins|mesh-ancestor
64616060|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
64616061|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616062|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
64616064|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64616065|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64616066|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616067|NCT01926158|Denosumab|denosumab|mesh-list
64616068|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64616069|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616070|NCT02393859|Dexamethasone|dexamethasone|mesh-list
64616071|NCT02393859|Methotrexate|methotrexate|mesh-list
64616072|NCT02393859|Daunorubicin|daunorubicin|mesh-list
64616073|NCT02393859|Asparaginase|asparaginase|mesh-list
64616074|NCT02393859|Ifosfamide|ifosfamide|mesh-list
64616075|NCT02393859|Blinatumomab|blinatumomab|mesh-list
64616076|NCT02393859|Pegaspargase|pegaspargase|mesh-list
64616077|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616078|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
64616079|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
64616080|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616081|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616082|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616083|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
64616084|NCT02393859|Hormones|hormones|mesh-ancestor
64616085|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616086|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64616087|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616088|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64616089|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
64616090|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64616091|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64616092|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
64616093|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616109|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
64616110|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616111|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616112|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
64616113|NCT00981890|Sunitinib|sunitinib|mesh-list
64616114|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616115|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64616116|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64616117|NCT00981890|Growth Substances|growth substances|mesh-ancestor
64616118|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616119|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
64616120|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64616121|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616122|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616123|NCT03221764|Amiodarone|amiodarone|mesh-list
64616124|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64616125|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
64616126|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64616127|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616128|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616129|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64616130|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64616131|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64616132|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616133|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64616134|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64616135|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64616136|NCT03122444|Imipramine|imipramine|mesh-list
64616137|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64616139|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64616140|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64616141|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64616142|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616143|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616144|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
64616145|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616146|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616147|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
64616148|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
64616150|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64616151|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616152|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
64616153|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64616154|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616155|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616156|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
64616157|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64616158|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616159|NCT05593627|Antacids|antacids|mesh-ancestor
64616160|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616161|NCT02169427|Opicapone|opicapone|mesh-list
64616162|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64616163|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616164|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616165|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64616166|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64616167|NCT02376699|Gemcitabine|gemcitabine|mesh-list
64616168|NCT02376699|Paclitaxel|paclitaxel|mesh-list
64616169|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
64616170|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64616171|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616172|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
64616173|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
64616174|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
64616175|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616176|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64616177|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
64616178|NCT02376699|Antiviral Agents|antiviral agents|mesh-ancestor
64616179|NCT02376699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616180|NCT02376699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616181|NCT02376699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616182|NCT02376699|Immunologic Factors|immunologic factors|mesh-ancestor
64616183|NCT02376699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616184|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616186|NCT03454048|Piperaquine|piperaquine|mesh-list
64616187|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
64616188|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
64616189|NCT03454048|Atovaquone|atovaquone|mesh-list
64616190|NCT03454048|Proguanil|proguanil|mesh-list
64616191|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64616192|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
64616193|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64616194|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64616195|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616196|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64616197|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616198|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616199|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64616200|NCT03454048|Renal Agents|renal agents|mesh-ancestor
64616201|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
64616202|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64616203|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64616204|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
64616205|NCT01924286|Prednisone|prednisone|mesh-list
64616206|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616207|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
64616208|NCT01924286|Hormones|hormones|mesh-ancestor
64616209|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616210|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616211|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64616212|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616213|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
64616214|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64616215|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
64616216|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616217|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616218|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64616219|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
64616220|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64616222|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616223|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616224|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64616225|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
64616226|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
64616227|NCT03455218|Protective Agents|protective agents|mesh-ancestor
64616229|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
64616230|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616231|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616232|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64616233|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64616234|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64616235|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
64616236|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64616237|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64616238|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64616239|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616240|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616241|NCT04433845|Psilocybin|psilocybin|mesh-list
64616242|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
64616243|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616244|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64616245|NCT01920386|Acetaminophen|acetaminophen|mesh-list
64616246|NCT01920386|Tramadol|tramadol|mesh-list
64616247|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616248|NCT01920386|Analgesics|analgesics|mesh-ancestor
64616249|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
64616250|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616251|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616252|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
64616253|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64616254|NCT01920386|Narcotics|narcotics|mesh-ancestor
64616255|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616256|NCT03460990|Ivacaftor|ivacaftor|mesh-list
64616257|NCT03460990|VX-659|vx-659|mesh-list
64616258|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64616259|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616260|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616261|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64616262|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
64616263|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616264|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
64616265|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616266|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
64616267|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64616268|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616269|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616270|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616271|NCT01920542|Analgesics|analgesics|mesh-ancestor
64616272|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
64616273|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616274|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64616275|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64616276|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64616277|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
64616278|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616279|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616280|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
64616281|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64616282|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64616283|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
64616284|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616286|NCT01052701|Abacavir|abacavir|mesh-list
64616287|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
64616288|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616291|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64616292|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64616293|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616294|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64616295|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64616296|NCT01921010|Niacin|niacin|mesh-list
64616297|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
64616298|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64616299|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
64616300|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616301|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64616302|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
64616303|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
64616304|NCT01921010|Vitamins|vitamins|mesh-ancestor
64616305|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
64616306|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616307|NCT03115424|Liraglutide|liraglutide|mesh-list
64616308|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64616309|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616310|NCT03115424|Incretins|incretins|mesh-ancestor
64616311|NCT03115424|Hormones|hormones|mesh-ancestor
64616312|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616313|NCT03325816|Nivolumab|nivolumab|mesh-list
64616314|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64616315|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616316|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616317|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64616318|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616319|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64616320|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
64616321|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64616322|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64616323|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64616324|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616325|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616326|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
64616327|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616328|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616329|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64616330|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616331|NCT00986258|Tapentadol|tapentadol|mesh-list
64616332|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64616333|NCT00986258|Narcotics|narcotics|mesh-ancestor
64616334|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616335|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616336|NCT00986258|Analgesics|analgesics|mesh-ancestor
64616337|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
64616338|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616339|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64616340|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64616341|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616342|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616343|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
64616344|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616345|NCT00986180|Oxycodone|oxycodone|mesh-list
64616346|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64616347|NCT00986180|Narcotics|narcotics|mesh-ancestor
64616348|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616349|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616350|NCT00986180|Analgesics|analgesics|mesh-ancestor
64616351|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
64616352|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616353|NCT01056601|Bortezomib|bortezomib|mesh-list
64616354|NCT01056601|Panobinostat|panobinostat|mesh-list
64616355|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616356|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64616357|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616358|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616359|NCT03014947|Adalimumab|adalimumab|mesh-list
64616360|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616361|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616362|NCT04238767|Dolutegravir|dolutegravir|mesh-list
64616363|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64616364|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64616365|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616366|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616367|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64616368|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64616369|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
64616370|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616371|NCT01057225|Thalidomide|thalidomide|mesh-list
64616372|NCT01057225|Dexamethasone|dexamethasone|mesh-list
64616373|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
64616374|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616375|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
64616376|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616378|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64616379|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
64616380|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616381|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616382|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64616383|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616384|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
64616385|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
64616386|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616388|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
64616389|NCT01057225|Hormones|hormones|mesh-ancestor
64616390|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616391|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64616392|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
64616393|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64616394|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616395|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64616396|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64616397|NCT01057225|Growth Substances|growth substances|mesh-ancestor
64616398|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
64616399|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
64616400|NCT01057381|Morphine|morphine|mesh-list
64616401|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64616402|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616403|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616404|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616405|NCT01057381|Analgesics|analgesics|mesh-ancestor
64616406|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
64616407|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616408|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64616409|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64616410|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64616411|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
64616412|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616413|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616414|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64616415|NCT01057381|Narcotics|narcotics|mesh-ancestor
64616416|NCT00986102|Doripenem|doripenem|mesh-list
64616417|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64616418|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616419|NCT01058239|Rituximab|rituximab|mesh-list
64616420|NCT01058239|Bortezomib|bortezomib|mesh-list
64616421|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616422|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616423|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
64616424|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616425|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616426|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
64616427|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
64616428|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616429|NCT01058941|Protective Agents|protective agents|mesh-ancestor
64616430|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616431|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
64616433|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
64616434|NCT00985946|Panobinostat|panobinostat|mesh-list
64616435|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616436|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64616437|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616438|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616439|NCT02170519|Iloprost|iloprost|mesh-list
64616440|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64616441|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
64616442|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
64616443|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64616444|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616445|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64616446|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
64616447|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616448|NCT01924910|Vitamin D|vitamin d|mesh-list
64616449|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
64616450|NCT01924910|Vitamins|vitamins|mesh-ancestor
64616451|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
64341882|NCT00774761|Xhance|xhance|mesh-list
64616452|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616453|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64616460|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616461|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64616462|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64616463|NCT01921790|Gemcitabine|gemcitabine|mesh-list
64616464|NCT01921790|Dexamethasone|dexamethasone|mesh-list
64616465|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
64616466|NCT01921790|Bevacizumab|bevacizumab|mesh-list
64616467|NCT01921790|Pegaspargase|pegaspargase|mesh-list
64616468|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616469|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
64616470|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
64616471|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616472|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616473|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616474|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
64616475|NCT01921790|Hormones|hormones|mesh-ancestor
64616476|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616477|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64616478|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616479|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64616480|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
64616481|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616482|NCT01921790|Antiviral Agents|antiviral agents|mesh-ancestor
64616483|NCT01921790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616484|NCT01921790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616485|NCT01921790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616486|NCT01921790|Immunologic Factors|immunologic factors|mesh-ancestor
64616487|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616488|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64616489|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64616490|NCT01921790|Growth Substances|growth substances|mesh-ancestor
64616491|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
64616492|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
64616493|NCT04347980|Dexamethasone|dexamethasone|mesh-list
64616494|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616495|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
64616496|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
64616497|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616498|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616499|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616500|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
64616501|NCT04347980|Hormones|hormones|mesh-ancestor
64616502|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616503|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64616504|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616506|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64616507|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64616508|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297521|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
64297522|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616509|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616510|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616511|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616512|NCT01925300|Bisoprolol|bisoprolol|mesh-list
64616513|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64616514|NCT01925300|Calcium|calcium|mesh-list
64616515|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64616516|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616517|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64616518|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64616519|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
64616520|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616521|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64616522|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64616523|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616524|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64616525|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
64616526|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
64616527|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616528|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64616529|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64616530|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64616532|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616533|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64616534|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64616535|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64616536|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
64616537|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616538|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64616539|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64616540|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616541|NCT01925378|Nelfinavir|nelfinavir|mesh-list
64616542|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64616543|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64616544|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
64616545|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616546|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616547|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64616548|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64616549|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
64616550|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616551|NCT01925456|Fesoterodine|fesoterodine|mesh-list
64616552|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64616553|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64616554|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
64616555|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616556|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616557|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616558|NCT01925456|Urological Agents|urological agents|mesh-ancestor
64616559|NCT02255799|Donepezil|donepezil|mesh-list
64616560|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64616561|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616562|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616563|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
64616564|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616565|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616566|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
64616567|NCT02226159|Dexamethasone|dexamethasone|mesh-list
64616568|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
64616569|NCT02226159|Lidocaine|lidocaine|mesh-list
64616570|NCT02226159|BB 1101|bb 1101|mesh-list
64616571|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616572|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
64616573|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
64616574|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616576|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616577|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
64297525|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64616578|NCT02226159|Hormones|hormones|mesh-ancestor
64297526|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64616579|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616581|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616582|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
64616583|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616584|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616585|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
64616586|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
64616587|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616588|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
64616589|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64616590|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64616591|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64616592|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616593|NCT03241030|Acetaminophen|acetaminophen|mesh-list
64616594|NCT03241030|Ibuprofen|ibuprofen|mesh-list
64616595|NCT03241030|Sucralfate|sucralfate|mesh-list
64616596|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616597|NCT03241030|Analgesics|analgesics|mesh-ancestor
64616598|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
64616599|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616600|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616601|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
64616602|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616603|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616604|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616605|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64616606|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616607|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616608|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64616609|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616610|NCT02184195|Olaparib|olaparib|mesh-list
64616611|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64616612|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616613|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616614|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616615|NCT02153541|Antipyrine|antipyrine|mesh-list
64616616|NCT02153541|Benzocaine|benzocaine|mesh-list
64616617|NCT02153541|Glycerol|glycerol|mesh-list
64365435|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
64616618|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64616619|NCT02153541|Protective Agents|protective agents|mesh-ancestor
64616620|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616621|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
64616622|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
64616623|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616624|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
64616625|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616626|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616627|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616628|NCT02153541|Analgesics|analgesics|mesh-ancestor
64616629|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616630|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616631|NCT03241810|Fulvestrant|fulvestrant|mesh-list
64616632|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64616633|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616634|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64616635|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64616636|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
64616637|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616638|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616639|NCT02129751|Bupropion|bupropion|mesh-list
64616640|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64616641|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
64616642|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64616644|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64616645|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616646|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616647|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
64616648|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616649|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616650|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64616651|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64616652|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616653|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
64616654|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64616655|NCT03242590|Testosterone|testosterone|mesh-list
64616656|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
64616657|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
64616658|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64616659|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616660|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
64616661|NCT03242590|Hormones|hormones|mesh-ancestor
64616662|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616663|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616664|NCT03242590|Androgens|androgens|mesh-ancestor
64616665|NCT03247738|Cangrelor|cangrelor|mesh-list
64616666|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64616667|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64616668|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64616669|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64616670|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
64616671|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616672|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616673|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616674|NCT01567605|Lidocaine|lidocaine|mesh-list
64616675|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
64616676|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
64616677|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616678|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616679|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
64616680|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616681|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64616682|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64616683|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64616684|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64616685|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616686|NCT02604537|Ketorolac|ketorolac|mesh-list
64616687|NCT02604537|Betamethasone|betamethasone|mesh-list
64616688|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616689|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616690|NCT02604537|Analgesics|analgesics|mesh-ancestor
64616691|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
64616692|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616693|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616694|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616695|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616696|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64616697|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616698|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616699|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
64616700|NCT02604537|Hormones|hormones|mesh-ancestor
64616701|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616702|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64616703|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
64616704|NCT01384773|Riboflavin|riboflavin|mesh-list
64616705|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64616706|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64616707|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
64616708|NCT01384773|Vitamins|vitamins|mesh-ancestor
64616709|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
64616710|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616711|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64616712|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
64616714|NCT01063075|Cetuximab|cetuximab|mesh-list
64616715|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616716|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616718|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616719|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616720|NCT01341405|Analgesics|analgesics|mesh-ancestor
64616721|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
64616722|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616723|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616724|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616725|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616726|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64616727|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64616728|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616729|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616731|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64616732|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
64616733|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64616734|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616735|NCT03487276|Vilobelimab|vilobelimab|mesh-list
64616736|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64616737|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616738|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
64616739|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616740|NCT03489850|Ibudilast|ibudilast|mesh-list
64616741|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64616742|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
64616743|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616744|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616745|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64616746|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
64616747|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64616748|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342139|NCT00649025|Xhance|xhance|mesh-list
64616749|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616750|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64616751|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
64616752|NCT03490942|Glucagon|glucagon|mesh-list
64616753|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64616754|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616755|NCT03490942|Hormones|hormones|mesh-ancestor
64616756|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616757|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616758|NCT03490942|Incretins|incretins|mesh-ancestor
64616759|NCT00376870|Pioglitazone|pioglitazone|mesh-list
64616760|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64616761|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616762|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
64616763|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
64616764|NCT03256162|Midazolam|midazolam|mesh-list
64616765|NCT03256162|Ketamine|ketamine|mesh-list
64616766|NCT03256162|Analgesics|analgesics|mesh-ancestor
64616767|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
64616768|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616769|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616770|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64616771|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64616772|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
64616773|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
64616774|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616775|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64616776|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64616777|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616778|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616779|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64616780|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64616781|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64616782|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64616783|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64616784|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
64616786|NCT03493828|Bupivacaine|bupivacaine|mesh-list
64616787|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
64616788|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
64616789|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616790|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616791|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
64616792|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616793|NCT03496324|Ibuprofen|ibuprofen|mesh-list
64616794|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616795|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616796|NCT03496324|Analgesics|analgesics|mesh-ancestor
64616797|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
64616798|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616799|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616800|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616801|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616802|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64616803|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616804|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616805|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
64616806|NCT03354598|Probenecid|probenecid|mesh-list
64616807|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64616808|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616809|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64616810|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64616811|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616812|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616813|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616814|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64616815|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64616816|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
64616817|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
64616818|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616819|NCT03354598|Renal Agents|renal agents|mesh-ancestor
64616820|NCT02169895|Opicapone|opicapone|mesh-list
64616821|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
64342182|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64616822|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64616823|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616824|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616825|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64616826|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64616827|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
64616828|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616829|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616830|NCT01072669|Ambrisentan|ambrisentan|mesh-list
64616831|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64616832|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
64616833|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
64616834|NCT03014713|Dezocine|dezocine|mesh-list
64616835|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64616836|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616837|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616838|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616839|NCT03014713|Analgesics|analgesics|mesh-ancestor
64616840|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
64616841|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616842|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64616843|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64616844|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64616845|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
64616846|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616847|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616848|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64616849|NCT03014713|Narcotics|narcotics|mesh-ancestor
64616850|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616851|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616852|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616853|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64616854|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616855|NCT01074463|Pramipexole|pramipexole|mesh-list
64616856|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
64616857|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616858|NCT01074463|Protective Agents|protective agents|mesh-ancestor
64616859|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616860|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64616861|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64616862|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
64616863|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
64616864|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616865|NCT01075087|Ropivacaine|ropivacaine|mesh-list
64616866|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
64616867|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
64616868|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616869|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616870|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
64616871|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616873|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616874|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616875|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
64616876|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616877|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616878|NCT03358576|Amoxicillin|amoxicillin|mesh-list
64616879|NCT03358576|Metronidazole|metronidazole|mesh-list
64616880|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
64616881|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
64616882|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
64616883|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64616884|NCT03358576|Ertapenem|ertapenem|mesh-list
64616885|NCT03358576|Lactams|lactams|mesh-list
64616886|NCT03358576|Probenecid|probenecid|mesh-list
64616887|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64616888|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616889|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64616890|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64616891|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64616892|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64616893|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616894|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616895|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616896|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64616897|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64616898|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64616899|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
64616901|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616902|NCT03358576|Renal Agents|renal agents|mesh-ancestor
64616904|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616905|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616906|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64616907|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64616908|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
64616909|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616910|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64616911|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64616912|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616913|NCT00376324|Tigecycline|tigecycline|mesh-list
64616914|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64616915|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616916|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64616917|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616918|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616919|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
64616920|NCT00376480|Fludarabine|fludarabine|mesh-list
64616921|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
64616922|NCT00376480|Thiotepa|thiotepa|mesh-list
64616923|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64616924|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616925|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64616926|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
64616927|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616928|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64616929|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
64616930|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616931|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616932|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
64616933|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
64616934|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616935|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64616936|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
64616937|NCT00376480|Hormones|hormones|mesh-ancestor
64616938|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64616939|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64616940|NCT00376480|Protective Agents|protective agents|mesh-ancestor
64616941|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64616942|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
64616943|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64616944|NCT03016039|Curcumin|curcumin|mesh-list
64616945|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64616946|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64616948|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
64616949|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616950|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616951|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64616952|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64616953|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616954|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64616955|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616956|NCT03753919|Durvalumab|durvalumab|mesh-list
64616957|NCT03753919|Tremelimumab|tremelimumab|mesh-list
64616958|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616959|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616960|NCT03498196|Avelumab|avelumab|mesh-list
64616961|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64616962|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64616963|NCT03500302|Evolocumab|evolocumab|mesh-list
64616964|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64616965|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64616966|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
64616967|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616968|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64616969|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64616970|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
64616971|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64616972|NCT03503578|Ketamine|ketamine|mesh-list
64616973|NCT03503578|Sevoflurane|sevoflurane|mesh-list
64342332|NCT03483415|Narcotics|narcotics|mesh-ancestor
64616975|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
64616976|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616977|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616978|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64616979|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64616980|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
64616981|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
64616984|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64616985|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64616986|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64616987|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64616988|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64616989|NCT03270514|Bupivacaine|bupivacaine|mesh-list
64616990|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
64616991|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
64616992|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64616993|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64616994|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
64616995|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64616996|NCT02178241|Gemcitabine|gemcitabine|mesh-list
64616997|NCT02178241|Halichondrin B|halichondrin b|mesh-list
64616998|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64617000|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617001|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617002|NCT02178241|Antiviral Agents|antiviral agents|mesh-ancestor
64617003|NCT02178241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617004|NCT02178241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617005|NCT02178241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365441|NCT04444349|Ubiquinone|ubiquinone|mesh-list
64617006|NCT02178241|Immunologic Factors|immunologic factors|mesh-ancestor
64617007|NCT02178241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617008|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
64617009|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
64617010|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
64617011|NCT03015727|Docetaxel|docetaxel|mesh-list
64617012|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617013|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
64617014|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
64617015|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
64617016|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617017|NCT03539731|Piperazine|piperazine|mesh-list
64617018|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
64617019|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
64617020|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64617021|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617022|NCT01077973|Ibuprofen|ibuprofen|mesh-list
64617023|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64617024|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64617025|NCT01077973|Analgesics|analgesics|mesh-ancestor
64617026|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
64617027|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617028|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617029|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617030|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617031|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64617032|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617033|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617034|NCT02973646|Tenofovir|tenofovir|mesh-list
64617035|NCT02973646|Entecavir|entecavir|mesh-list
64617036|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64617037|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
64617038|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617039|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64617040|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64617041|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617042|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617043|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64617044|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64617045|NCT01078363|Ramipril|ramipril|mesh-list
64617046|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64617047|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
64617048|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617049|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617051|NCT03371836|Clobazam|clobazam|mesh-list
64617052|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
64617053|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64617054|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64617055|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617056|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617057|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64617058|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64617059|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
64617060|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
64617061|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617062|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617063|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64617064|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
64617065|NCT01078753|Coagulants|coagulants|mesh-ancestor
64617066|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64617067|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
64617068|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617069|NCT03372382|Acetaminophen|acetaminophen|mesh-list
64617070|NCT03372382|Ibuprofen|ibuprofen|mesh-list
64617071|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64617072|NCT03372382|Analgesics|analgesics|mesh-ancestor
64617073|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
64617074|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617075|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617076|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
64617077|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64617078|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617079|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617080|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64617081|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617082|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617083|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64617084|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64617085|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64617086|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617087|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617088|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64617089|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64617090|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617091|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
64617092|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617093|NCT03374176|Amoxicillin|amoxicillin|mesh-list
64617095|NCT03374176|Clindamycin|clindamycin|mesh-list
64617096|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
64617097|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
64617098|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617099|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617100|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64617101|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64617102|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64617103|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617104|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617105|NCT03281200|Nintedanib|nintedanib|mesh-list
64617106|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
64617107|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
64617108|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617109|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617110|NCT03378076|Triamcinolone|triamcinolone|mesh-list
64617111|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64617112|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64617114|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64617115|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617116|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
64617117|NCT03378076|Hormones|hormones|mesh-ancestor
64617118|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617119|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617120|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617121|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
64617122|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342485|NCT02260492|Fluticasone|fluticasone|mesh-list
64617123|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617125|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
64617126|NCT03520348|Vitamins|vitamins|mesh-ancestor
64617127|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
64617128|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617129|NCT03380026|Triamcinolone|triamcinolone|mesh-list
64617130|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64617131|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64617132|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
64617133|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64617134|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617135|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
64617136|NCT03380026|Hormones|hormones|mesh-ancestor
64617137|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617138|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617139|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617140|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
64617141|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617142|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617143|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
64617144|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617145|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617146|NCT01079143|Cyclosporine|cyclosporine|mesh-list
64617147|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
64617149|NCT01079143|Cyclosporins|cyclosporins|mesh-list
64617150|NCT01079143|Basiliximab|basiliximab|mesh-list
64617151|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365507|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64365510|NCT03277573|Analgesics|analgesics|mesh-ancestor
64617152|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617153|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617154|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
64617155|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617156|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
64617157|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617158|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
64617159|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617160|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64617161|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617162|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64617163|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64617164|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
64617165|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617166|NCT03381742|Clopidogrel|clopidogrel|mesh-list
64617167|NCT03381742|Ticagrelor|ticagrelor|mesh-list
64617168|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64617169|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64617170|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64617171|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64617172|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
64617173|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617174|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617175|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617176|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
64617177|NCT04735042|Empagliflozin|empagliflozin|mesh-list
64617178|NCT04735042|Linagliptin|linagliptin|mesh-list
64617179|NCT04735042|Saxagliptin|saxagliptin|mesh-list
64617180|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64617181|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617182|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64617183|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617184|NCT04735042|Incretins|incretins|mesh-ancestor
64617185|NCT04735042|Hormones|hormones|mesh-ancestor
64617186|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617187|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64617188|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
64617189|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617190|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64617191|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64617192|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617193|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
64617194|NCT00376012|Rifampin|rifampin|mesh-list
64617195|NCT00376012|Isoniazid|isoniazid|mesh-list
64617196|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
64617197|NCT00376012|Ethambutol|ethambutol|mesh-list
64617198|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64617199|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
64617200|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617201|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617203|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64617204|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617205|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617206|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64617207|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64617208|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64617209|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64365549|NCT03266731|Clopidogrel|clopidogrel|mesh-list
64617210|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64617211|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64617212|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64617213|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64617214|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
64617215|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64617216|NCT02171611|Dabigatran|dabigatran|mesh-list
64617217|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
64617218|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64617219|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
64617220|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617221|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617222|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
64617223|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
64617224|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
64617225|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64617226|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64617227|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617228|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64617229|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617230|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617231|NCT00942305|Brincidofovir|brincidofovir|mesh-list
64617232|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
64617233|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617234|NCT01084759|Etoposide|etoposide|mesh-list
64617235|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
64617236|NCT01084759|Testosterone|testosterone|mesh-list
64617237|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
64617238|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
64617239|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64617240|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64617241|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617242|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64617243|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64617244|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617245|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617246|NCT01084759|Androgens|androgens|mesh-ancestor
64617248|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617249|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617250|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617251|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
64617252|NCT01110187|Lacosamide|lacosamide|mesh-list
64617253|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
64617254|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
64617255|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64617256|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64617257|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64617258|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617259|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64617260|NCT01110421|Amoxicillin|amoxicillin|mesh-list
64617261|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
64617262|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
64617263|NCT01110421|Cefepime|cefepime|mesh-list
64617264|NCT01110421|Doripenem|doripenem|mesh-list
64617265|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64617266|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617267|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617268|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64617269|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617270|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617271|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
64617272|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64617273|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617274|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617275|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64617276|NCT04358627|Analgesics|analgesics|mesh-ancestor
64617277|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
64617278|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617279|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64617280|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64617281|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64617282|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64617283|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617284|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617285|NCT04356677|Ribavirin|ribavirin|mesh-list
64617286|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
64617287|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617288|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
64617289|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617290|NCT04356833|Plasminogen|plasminogen|mesh-list
64617291|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64617292|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64617293|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64617294|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617296|NCT05620277|Vitamin E|vitamin e|mesh-list
64617297|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
64617298|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
64617299|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617300|NCT05620277|Protective Agents|protective agents|mesh-ancestor
64617301|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617302|NCT05620277|Vitamins|vitamins|mesh-ancestor
64617303|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
64617304|NCT01110499|Bimatoprost|bimatoprost|mesh-list
64617305|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64617306|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64617307|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64617308|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
64617309|NCT04579523|Fludarabine|fludarabine|mesh-list
64617310|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
64617311|NCT04579523|Daratumumab|daratumumab|mesh-list
64617312|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64617314|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
64617315|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64617316|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617317|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
64617318|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617319|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617320|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617321|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
64617322|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617323|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617324|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64617325|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64617326|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
64617327|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
64617328|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
64617329|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64617330|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64617331|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
64617332|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617333|NCT02174419|Nalbuphine|nalbuphine|mesh-list
64617334|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64617335|NCT02174419|Narcotics|narcotics|mesh-ancestor
64617336|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617337|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617338|NCT02174419|Analgesics|analgesics|mesh-ancestor
64617339|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
64617340|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617341|NCT05620589|Amoxicillin|amoxicillin|mesh-list
64617342|NCT05620589|Tetracycline|tetracycline|mesh-list
64617343|NCT05620589|Esomeprazole|esomeprazole|mesh-list
64617344|NCT05620589|Bismuth|bismuth|mesh-list
64617345|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64484302|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64617346|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617347|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64617348|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617349|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64617350|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617351|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617352|NCT05620589|Antacids|antacids|mesh-ancestor
64617353|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64617354|NCT01086475|Cycloserine|cycloserine|mesh-list
64617355|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64617356|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617357|NCT01086475|Renal Agents|renal agents|mesh-ancestor
64617358|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64617359|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
64617360|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617361|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
64617362|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617363|NCT01112683|Memantine|memantine|mesh-list
64617364|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64617365|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64617366|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
64617367|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617368|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617369|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617370|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64617371|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64617372|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
64617373|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64617374|NCT04355273|Heparin|heparin|mesh-list
64617375|NCT04355273|Calcium heparin|calcium heparin|mesh-list
64617376|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
64617377|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64617378|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64617379|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617380|NCT04355429|Captopril|captopril|mesh-list
64617381|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64617384|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617385|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64617386|NCT01114555|Bevacizumab|bevacizumab|mesh-list
64617387|NCT01114555|Irinotecan|irinotecan|mesh-list
64617388|NCT01114555|Temozolomide|temozolomide|mesh-list
64617389|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64617390|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617391|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64617392|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64617393|NCT01114555|Growth Substances|growth substances|mesh-ancestor
64617394|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617395|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
64617396|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64617397|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64617398|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617399|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617400|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617401|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
64617402|NCT02673931|Exenatide|exenatide|mesh-list
64617403|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64617404|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617405|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64617406|NCT02673931|Incretins|incretins|mesh-ancestor
64617407|NCT02673931|Hormones|hormones|mesh-ancestor
64617408|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617409|NCT01115101|Pirinitramide|pirinitramide|mesh-list
64617410|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64617411|NCT01115101|Narcotics|narcotics|mesh-ancestor
64617412|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617413|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617414|NCT01115101|Analgesics|analgesics|mesh-ancestor
64617415|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
64617416|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617417|NCT02245529|Tamsulosin|tamsulosin|mesh-list
64617418|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64617419|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64617420|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64617421|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
64342787|NCT03480997|Bromides|bromides|mesh-list
64617422|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617423|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617424|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617425|NCT02245529|Urological Agents|urological agents|mesh-ancestor
64617427|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
64617428|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617429|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64617430|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64617431|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617432|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617433|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64617434|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64617435|NCT00947765|Prednisolone|prednisolone|mesh-list
64617436|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64617437|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
64617438|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64617439|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
64617440|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64617441|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
64617443|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
64617444|NCT00947765|Hormones|hormones|mesh-ancestor
64617445|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617446|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617447|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617448|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617449|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
64617450|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
64617451|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617452|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617453|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64617454|NCT00947765|Protective Agents|protective agents|mesh-ancestor
64617455|NCT01089517|Ranibizumab|ranibizumab|mesh-list
64617456|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64617457|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64617458|NCT01089517|Growth Substances|growth substances|mesh-ancestor
64617459|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617460|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
64617461|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617462|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64617463|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64617464|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617465|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
64617466|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617467|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64617468|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617469|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617470|NCT04354961|Paclitaxel|paclitaxel|mesh-list
64617471|NCT04354961|Carboplatin|carboplatin|mesh-list
64617472|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64617473|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617474|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
64617475|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
64617476|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
64617477|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617478|NCT01089751|Trospium chloride|trospium chloride|mesh-list
64617479|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
64617480|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
64617481|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617482|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617483|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64617484|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64617485|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
64617486|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617487|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617488|NCT01089751|Urological Agents|urological agents|mesh-ancestor
64617489|NCT03032315|Amlodipine|amlodipine|mesh-list
64617490|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64617491|NCT03032315|Telmisartan|telmisartan|mesh-list
64617492|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64617493|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64617494|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64617495|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64617496|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617497|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64617498|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617499|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
64617500|NCT03032315|Diuretics|diuretics|mesh-ancestor
64617501|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
64617502|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64617503|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64617504|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64617506|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617507|NCT03537274|Interferons|interferons|mesh-list
64617509|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
64617510|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64617511|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617512|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
64617513|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617514|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
64617515|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617516|NCT00939653|Cytarabine|cytarabine|mesh-list
64617517|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
64617518|NCT00939653|Etoposide|etoposide|mesh-list
64617519|NCT00939653|Clofarabine|clofarabine|mesh-list
64617520|NCT00939653|Lenograstim|lenograstim|mesh-list
64617521|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617522|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
64617523|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617524|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617525|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617526|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
64617527|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617528|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617529|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64617530|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64617531|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64617532|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64617533|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617534|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64617535|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
64617536|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
64617537|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617538|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64617539|NCT04355039|Dexamethasone|dexamethasone|mesh-list
64617540|NCT04355039|Pomalidomide|pomalidomide|mesh-list
64617541|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617542|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
64617543|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
64617544|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617545|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617546|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617547|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
64617548|NCT04355039|Hormones|hormones|mesh-ancestor
64617549|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617550|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617551|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617552|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
64617553|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64617554|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64617555|NCT04355039|Growth Substances|growth substances|mesh-ancestor
64617556|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64617557|NCT02524405|Corticosterone|corticosterone|mesh-list
64617558|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617559|NCT03014323|Galantamine|galantamine|mesh-list
64617560|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64617561|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617562|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617563|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
64617564|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617565|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617566|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64617567|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
64617568|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617569|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
64617570|NCT03393208|Metformin|metformin|mesh-list
64617571|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64617572|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617573|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
64617574|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64617575|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
64617576|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617577|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617579|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
64617580|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64617581|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
64617582|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617583|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617584|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64617586|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
64617587|NCT01092559|Protective Agents|protective agents|mesh-ancestor
64617588|NCT03587428|Zinc|zinc|mesh-list
64617589|NCT03587428|Trace Elements|trace elements|mesh-ancestor
64617590|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
64617591|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617593|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64617594|NCT03398278|Narcotics|narcotics|mesh-ancestor
64617595|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617596|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617597|NCT03398278|Analgesics|analgesics|mesh-ancestor
64617598|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
64617599|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617600|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
64617601|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64617602|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64617603|NCT03593902|Prednisolone|prednisolone|mesh-list
64617604|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
64617605|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
64617606|NCT03593902|Rituximab|rituximab|mesh-list
64617607|NCT03593902|Fludarabine|fludarabine|mesh-list
64617608|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
64617609|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64617610|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64617612|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617613|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
64617614|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617615|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617616|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617617|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
64617618|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617619|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617620|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64617621|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64617622|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617623|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
64617624|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
64617625|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617626|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617627|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
64617628|NCT03593902|Hormones|hormones|mesh-ancestor
64617629|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617630|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64617631|NCT03593902|Protective Agents|protective agents|mesh-ancestor
64617632|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617633|NCT00948935|Gemcitabine|gemcitabine|mesh-list
64617634|NCT00948935|Irinotecan|irinotecan|mesh-list
64617635|NCT00948935|Panitumumab|panitumumab|mesh-list
64617636|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64617637|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
64617638|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617639|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617640|NCT00948935|Antiviral Agents|antiviral agents|mesh-ancestor
64617641|NCT00948935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617642|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617643|NCT00948935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617644|NCT00948935|Immunologic Factors|immunologic factors|mesh-ancestor
64343010|NCT02523547|Entecavir|entecavir|mesh-list
64617645|NCT00948935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617646|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64617647|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64617648|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64617649|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
64617650|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
64617651|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
64617652|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617653|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617654|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617655|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64617656|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64617657|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617658|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64617659|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64617660|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
64617661|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617662|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617663|NCT02516241|Gemcitabine|gemcitabine|mesh-list
64617664|NCT02516241|Carboplatin|carboplatin|mesh-list
64617665|NCT02516241|Durvalumab|durvalumab|mesh-list
64617667|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617668|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64617669|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
64617670|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617671|NCT02516241|Antiviral Agents|antiviral agents|mesh-ancestor
64617672|NCT02516241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617673|NCT02516241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617674|NCT02516241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617675|NCT02516241|Immunologic Factors|immunologic factors|mesh-ancestor
64617676|NCT02516241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617677|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64617678|NCT03944681|Droperidol|droperidol|mesh-list
64617679|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64617680|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
64617681|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
64617682|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617683|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617684|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617685|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64617686|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64617687|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617688|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64617689|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64617690|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64617691|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
64617692|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617693|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617694|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
64617695|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617696|NCT03031691|Trifluridine|trifluridine|mesh-list
64617697|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
64617698|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617699|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
64617700|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617701|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
64617702|NCT01093183|Lenalidomide|lenalidomide|mesh-list
64617703|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617704|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
64617705|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617706|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617707|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617708|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
64617709|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617710|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617711|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64617712|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64617713|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64617714|NCT01093183|Growth Substances|growth substances|mesh-ancestor
64617715|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
64617716|NCT02430103|Goserelin|goserelin|mesh-list
64617717|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617718|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617719|NCT03031535|Octreotide|octreotide|mesh-list
64617720|NCT03031535|Hormones|hormones|mesh-list
64617721|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
64484303|NCT00792142|Growth Substances|growth substances|mesh-ancestor
64617722|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617723|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617725|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617726|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617728|NCT01093417|Vitamins|vitamins|mesh-ancestor
64617729|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
64617730|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617731|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64617732|NCT04744545|Curcumin|curcumin|mesh-list
64617733|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64617734|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64617735|NCT04744545|Analgesics|analgesics|mesh-ancestor
64617736|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
64617737|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617738|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617739|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617740|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617741|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617742|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617743|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617744|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64617745|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64617746|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617747|NCT01093651|Incretins|incretins|mesh-ancestor
64617748|NCT01093651|Hormones|hormones|mesh-ancestor
64617749|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617750|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64617751|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
64617752|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617753|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617754|NCT00362895|Tobramycin|tobramycin|mesh-list
64617755|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
64617756|NCT00362895|Dexamethasone|dexamethasone|mesh-list
64617757|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
64617758|NCT00362895|BB 1101|bb 1101|mesh-list
64617759|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617760|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
64617761|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
64617762|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617763|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617764|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617765|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
64617766|NCT00362895|Hormones|hormones|mesh-ancestor
64617767|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617768|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617769|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617770|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
64617771|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617772|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617773|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617774|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617775|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64617776|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64617785|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
64617786|NCT04744623|Dapsone|dapsone|mesh-list
64617787|NCT04744623|Prednisolone|prednisolone|mesh-list
64617788|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64617789|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
64617790|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64617791|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
64617792|NCT04744623|Triamcinolone|triamcinolone|mesh-list
64617793|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64617794|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64617795|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64617796|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64617797|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
64617798|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64617799|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617800|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64617801|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
64617802|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617803|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617804|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617805|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617806|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64617808|NCT04744623|Hormones|hormones|mesh-ancestor
64617809|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64617810|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617811|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617812|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
64617813|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
64617814|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617815|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617816|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64617817|NCT04744623|Protective Agents|protective agents|mesh-ancestor
64617818|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617819|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
64617820|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
64617821|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64617822|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64617823|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64617824|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
64617826|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617827|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64617828|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617829|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617830|NCT00633945|Lenalidomide|lenalidomide|mesh-list
64617831|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
64617832|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617833|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64617834|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64617835|NCT00633945|Growth Substances|growth substances|mesh-ancestor
64617836|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
64617837|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617838|NCT03609047|Paclitaxel|paclitaxel|mesh-list
64617839|NCT03609047|Docetaxel|docetaxel|mesh-list
64617840|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
64617841|NCT03609047|Doxorubicin|doxorubicin|mesh-list
64617842|NCT03609047|Epirubicin|epirubicin|mesh-list
64617843|NCT03609047|Palbociclib|palbociclib|mesh-list
64617844|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64617845|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617846|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
64617847|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
64617848|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
64617849|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617850|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64617851|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
64617852|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617853|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617854|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617855|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
64617856|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64617857|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64617858|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64617859|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64617860|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617861|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64617862|NCT01118845|Rituximab|rituximab|mesh-list
64617863|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64617864|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64617865|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617866|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
64617867|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617868|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64617869|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617870|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
64617871|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617873|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
64617874|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
64617875|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617876|NCT03162731|Nivolumab|nivolumab|mesh-list
64617877|NCT03162731|Ipilimumab|ipilimumab|mesh-list
64617878|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64617879|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617880|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64617884|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
64617885|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64617886|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617887|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617888|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64617889|NCT03030911|Analgesics|analgesics|mesh-ancestor
64617890|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
64617891|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617892|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64617893|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64617895|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
64617896|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64617897|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617898|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64617899|NCT03030911|Narcotics|narcotics|mesh-ancestor
64617900|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64617901|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64617902|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
64617903|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
64617904|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64617906|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64617907|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
64617908|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
64617909|NCT01120405|Sevoflurane|sevoflurane|mesh-list
64617910|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64617911|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64617912|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
64617913|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
64617914|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617915|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617916|NCT03013387|Octreotide|octreotide|mesh-list
64617917|NCT03013387|Edotreotide|edotreotide|mesh-list
64617918|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64617919|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64617920|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617921|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64617922|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617923|NCT01782989|Doxycycline|doxycycline|mesh-list
64617924|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64617925|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617926|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
64617927|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64617928|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64617929|NCT01120639|Temozolomide|temozolomide|mesh-list
64617930|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64617931|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
64617932|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617933|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617934|NCT01095757|Plerixafor|plerixafor|mesh-list
64617935|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64617936|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64617937|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
64617938|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617939|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64617940|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64617941|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617942|NCT02245451|Ritonavir|ritonavir|mesh-list
64617943|NCT02245451|Tipranavir|tipranavir|mesh-list
64617944|NCT02245451|Methadone|methadone|mesh-list
64617945|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64617946|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64617948|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64617949|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617951|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64617952|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
64617953|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64617954|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64617955|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64617956|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64617957|NCT02245451|Narcotics|narcotics|mesh-ancestor
64617958|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64617961|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
64617962|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64617963|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
64617964|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
64617965|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64617966|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64617967|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64617968|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64617969|NCT00951899|Metformin|metformin|mesh-list
64617970|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64617971|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64617972|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64617973|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64617974|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64617975|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
64617976|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617977|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64617978|NCT01097395|Ribavirin|ribavirin|mesh-list
64617979|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
64617988|NCT00433589|Tamoxifen|tamoxifen|mesh-list
64617989|NCT00433589|Docetaxel|docetaxel|mesh-list
64617990|NCT00433589|Capecitabine|capecitabine|mesh-list
64617991|NCT00433589|Letrozole|letrozole|mesh-list
64617992|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64617993|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
64617994|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
64617995|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
64617996|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64617997|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64617998|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
64617999|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64618000|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64618001|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618002|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64618003|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
64618004|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618005|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618006|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64618007|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64618008|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64618009|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64618010|NCT03013075|Morphine|morphine|mesh-list
64618011|NCT03013075|Bupivacaine|bupivacaine|mesh-list
64618012|NCT03013075|Anesthetics|anesthetics|mesh-list
64618013|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
64618014|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
64618015|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618016|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618017|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
64618018|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618019|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64618020|NCT03013075|Narcotics|narcotics|mesh-ancestor
64618021|NCT03013075|Analgesics|analgesics|mesh-ancestor
64618032|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
64618033|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618034|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618035|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
64618036|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618037|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64618038|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64618039|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64618040|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618041|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618042|NCT01122901|R04929097|r04929097|mesh-list
64618043|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618044|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618045|NCT01097785|Simvastatin|simvastatin|mesh-list
64618046|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64618047|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64618048|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
64618049|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618054|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64618055|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64618056|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618057|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
64618058|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
64618059|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
64618060|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618061|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
64618062|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618063|NCT03035357|Daratumumab|daratumumab|mesh-list
64618064|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618065|NCT00940589|Melatonin|melatonin|mesh-list
64618066|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
64618067|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618068|NCT00940589|Protective Agents|protective agents|mesh-ancestor
64618069|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618070|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618071|NCT02574078|Gemcitabine|gemcitabine|mesh-list
64618072|NCT02574078|Paclitaxel|paclitaxel|mesh-list
64618073|NCT02574078|Docetaxel|docetaxel|mesh-list
64618074|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64618075|NCT02574078|Bevacizumab|bevacizumab|mesh-list
64618076|NCT02574078|Carboplatin|carboplatin|mesh-list
64618077|NCT02574078|Nivolumab|nivolumab|mesh-list
64618078|NCT02574078|Pemetrexed|pemetrexed|mesh-list
64618079|NCT02574078|Crizotinib|crizotinib|mesh-list
64618080|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64618081|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618082|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
64618083|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
64618084|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
64618085|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618086|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64618087|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64618088|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64618089|NCT02574078|Growth Substances|growth substances|mesh-ancestor
64618090|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618091|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
64618092|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64618093|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
64618094|NCT02574078|Antiviral Agents|antiviral agents|mesh-ancestor
64618095|NCT02574078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618096|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618097|NCT02574078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618098|NCT02574078|Immunologic Factors|immunologic factors|mesh-ancestor
64618099|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64618100|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64618101|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64618103|NCT03605914|Acetaminophen|acetaminophen|mesh-list
64618104|NCT03605914|Diclofenac|diclofenac|mesh-list
64618105|NCT03605914|Hydrocodone|hydrocodone|mesh-list
64618106|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618107|NCT03605914|Analgesics|analgesics|mesh-ancestor
64618108|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
64618109|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618110|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618111|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
64618112|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64618113|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618114|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618115|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64618116|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618117|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618118|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64618119|NCT03605914|Narcotics|narcotics|mesh-ancestor
64618120|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618121|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
64618122|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
64618123|NCT04353479|Decitabine|decitabine|mesh-list
64618124|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64618125|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64618126|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
64618127|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618128|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618129|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618130|NCT03608488|Vitamin D|vitamin d|mesh-list
64618131|NCT03608488|Vitamins|vitamins|mesh-ancestor
64618132|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
64618133|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618134|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64618135|NCT05507658|Capecitabine|capecitabine|mesh-list
64618136|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
64618137|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64618138|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
64618139|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618140|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618142|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618143|NCT03035045|Analgesics|analgesics|mesh-ancestor
64618144|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
64618145|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618146|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618147|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
64618148|NCT03034733|Dexamethasone|dexamethasone|mesh-list
64618149|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618150|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
64618151|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
64618152|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618153|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618154|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618155|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
64618156|NCT03034733|Hormones|hormones|mesh-ancestor
64618157|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618158|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64618159|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618160|NCT05512416|Letrozole|letrozole|mesh-list
64618161|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618162|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64618163|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64618164|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618165|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618166|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64618167|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
64618168|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618169|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618170|NCT04290624|Listerine|listerine|mesh-list
64618171|NCT04290624|Fluorides|fluorides|mesh-list
64618172|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
64618173|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
64618174|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
64618175|NCT04290624|Protective Agents|protective agents|mesh-ancestor
64343591|NCT00394199|Xhance|xhance|mesh-list
64618176|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618177|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64618178|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618179|NCT03403504|Oxycodone|oxycodone|mesh-list
64618180|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64618181|NCT03403504|Narcotics|narcotics|mesh-ancestor
64618182|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618183|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618185|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
64618186|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618187|NCT05512728|Midazolam|midazolam|mesh-list
64618188|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64618189|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64618190|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618191|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618192|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64618193|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64618194|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64618195|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618196|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
64618197|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
64618198|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
64618199|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
64618200|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618201|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618202|NCT02565810|Adalimumab|adalimumab|mesh-list
64618203|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618204|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618205|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
64618206|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
64618207|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64618208|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64618209|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618210|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618211|NCT00940901|Urological Agents|urological agents|mesh-ancestor
64618212|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64618213|NCT04353713|Laxatives|laxatives|mesh-ancestor
64618214|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618215|NCT04900038|Lamivudine|lamivudine|mesh-list
64618216|NCT04900038|Dolutegravir|dolutegravir|mesh-list
64618217|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64618218|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64618219|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618220|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618221|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
64618222|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618223|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64618224|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64618225|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64618226|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64618227|NCT03565666|Insulin|insulin|mesh-list
64618228|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64618229|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
64618230|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
64618231|NCT03565666|Pancrelipase|pancrelipase|mesh-list
64618232|NCT03565666|Pancreatin|pancreatin|mesh-list
64618233|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64618234|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618235|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618236|NCT03620890|Protamines|protamines|mesh-list
64618237|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
64618238|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618239|NCT03620890|Coagulants|coagulants|mesh-ancestor
64618240|NCT05507112|Capecitabine|capecitabine|mesh-list
64618241|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64618242|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64618243|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
64618244|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618245|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618246|NCT05511948|Hydroquinone|hydroquinone|mesh-list
64618247|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
64618248|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618249|NCT05511948|Protective Agents|protective agents|mesh-ancestor
64618250|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618261|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618262|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
64618263|NCT00952133|Hormones|hormones|mesh-ancestor
64618264|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618265|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64618266|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618267|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
64618268|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618269|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618270|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64618271|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64618272|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
64618273|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618274|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
64618275|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297545|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
64618276|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618277|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64618278|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64618279|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618280|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
64618281|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64618282|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64618283|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618284|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
64618285|NCT03023189|Coagulants|coagulants|mesh-ancestor
64618286|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
64618287|NCT02561832|Carboplatin|carboplatin|mesh-list
64618289|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618290|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
64618291|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618292|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618293|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64618294|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
64618295|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618296|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618297|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64618298|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64618299|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618300|NCT02982161|Celecoxib|celecoxib|mesh-list
64618301|NCT02982161|Tramadol|tramadol|mesh-list
64618302|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64618303|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618304|NCT02982161|Analgesics|analgesics|mesh-ancestor
64618305|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
64618306|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618307|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618308|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618309|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618310|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64618311|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64618312|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618313|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618314|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64618316|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618319|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618321|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618322|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618323|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
64618324|NCT05506488|Protective Agents|protective agents|mesh-ancestor
64618325|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64484304|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
64618327|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64618328|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618329|NCT03023111|Miltefosine|miltefosine|mesh-list
64618330|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64618332|NCT03023111|Sargramostim|sargramostim|mesh-list
64618333|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
64618334|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618335|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618336|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
64618337|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618338|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64618339|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64618340|NCT03022253|Acetaminophen|acetaminophen|mesh-list
64618342|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64618343|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618345|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
64618346|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618347|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618349|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618350|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64365625|NCT03262363|Curcumin|curcumin|mesh-list
64618351|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618352|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618353|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
64618354|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
64618355|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64618356|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618357|NCT01037881|Analgesics|analgesics|mesh-ancestor
64618358|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
64618359|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618360|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618361|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618362|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618363|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
64618364|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618365|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
64618366|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64618367|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618368|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618369|NCT03017807|Antibodies|antibodies|mesh-list
64618370|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
64618371|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618372|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
64618373|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64618374|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64618375|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64618376|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618377|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618378|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
64618379|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618380|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618381|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64618382|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618383|NCT03017495|Midazolam|midazolam|mesh-list
64618384|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64618385|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64618386|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618387|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618388|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64618389|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64618390|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64618391|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618392|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
64618393|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
64618394|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
64618395|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
64618396|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618397|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618399|NCT01039207|Rilotumumab|rilotumumab|mesh-list
64618400|NCT01039207|Antibodies|antibodies|mesh-list
64618401|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
64618402|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64618403|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
64618404|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618405|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618406|NCT02981615|Levofloxacin|levofloxacin|mesh-list
64618407|NCT02981615|Ofloxacin|ofloxacin|mesh-list
64618409|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618410|NCT02981615|Renal Agents|renal agents|mesh-ancestor
64618411|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64618412|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64618413|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64618414|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618415|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618416|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618417|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64618418|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64618419|NCT01125163|Iron|iron|mesh-list
64618420|NCT01125163|Trace Elements|trace elements|mesh-ancestor
64618421|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
64618422|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618423|NCT03019991|Ritonavir|ritonavir|mesh-list
64297949|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64618424|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64618425|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64618426|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
64618427|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618428|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618429|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64618430|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64618431|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
64618432|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618433|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64618434|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64618435|NCT05307835|Molgramostim|molgramostim|mesh-list
64618436|NCT05307835|Sargramostim|sargramostim|mesh-list
64618437|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
64618438|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618439|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618440|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64618441|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618442|NCT03019835|Neostigmine|neostigmine|mesh-list
64618443|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64618444|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618445|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618447|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618448|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618449|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64618450|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
64618451|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618453|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64618454|NCT00955877|Narcotics|narcotics|mesh-ancestor
64618455|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618458|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
64618459|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618460|NCT03960658|Ketamine|ketamine|mesh-list
64618461|NCT03960658|Analgesics|analgesics|mesh-ancestor
64618462|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
64618463|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618464|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618465|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64618466|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618468|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
64618469|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618470|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64618471|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64618472|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618473|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618474|NCT01005407|Vaccines|vaccines|mesh-list
64618475|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
64618476|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343834|NCT02450552|Ezogabine|ezogabine|mesh-list
64298058|NCT02070679|Vitamins|vitamins|mesh-ancestor
64618477|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
64618478|NCT03633448|Guaifenesin|guaifenesin|mesh-list
64618479|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64618480|NCT03633448|Expectorants|expectorants|mesh-ancestor
64618481|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
64618482|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64618483|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64618484|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
64618485|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618486|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618488|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
64618489|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64618490|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
64618491|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
64618492|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618493|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
64618494|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64618495|NCT05313958|Cytarabine|cytarabine|mesh-list
64618496|NCT05313958|Sorafenib|sorafenib|mesh-list
64618497|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
64618498|NCT05313958|Idarubicin|idarubicin|mesh-list
64618499|NCT05313958|Cladribine|cladribine|mesh-list
64618500|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64618501|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
64618502|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618503|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618504|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
64618505|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618506|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618507|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
64618509|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64618510|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618511|NCT05313958|Analgesics|analgesics|mesh-ancestor
64618512|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
64618513|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618514|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64618515|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64618516|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64618517|NCT01006655|Beclomethasone|beclomethasone|mesh-list
64618519|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
64618520|NCT01006655|Hormones|hormones|mesh-ancestor
64618521|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618522|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618523|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64618524|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
64618526|NCT03633526|VX-659|vx-659|mesh-list
64618527|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64618528|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618529|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618531|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618532|NCT03019523|Caffeine|caffeine|mesh-list
64618533|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64618534|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618535|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64618536|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618537|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618538|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64618539|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64618540|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
64618541|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618543|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64618544|NCT01008059|Narcotics|narcotics|mesh-ancestor
64618545|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618546|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618548|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
64618549|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618550|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618551|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
64618552|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
64618553|NCT01009619|Azithromycin|azithromycin|mesh-list
64618554|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64618555|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618557|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
64618558|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618559|NCT01010009|Protective Agents|protective agents|mesh-ancestor
64618560|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618561|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618562|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64618563|NCT04467424|Lidocaine|lidocaine|mesh-list
64618564|NCT04467424|Ketamine|ketamine|mesh-list
64618565|NCT04467424|Propofol|propofol|mesh-list
64618566|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
64618567|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
64618568|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618569|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618571|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618572|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64618573|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64618574|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64618575|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618576|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618577|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64618578|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618579|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
64618580|NCT04467424|Analgesics|analgesics|mesh-ancestor
64618581|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64618582|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64618583|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64618584|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618586|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64618587|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618588|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64618589|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618590|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
64618591|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618593|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618594|NCT00377104|Alvocidib|alvocidib|mesh-list
64618595|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618596|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
64618597|NCT00377104|Growth Substances|growth substances|mesh-ancestor
64618598|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618599|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64618601|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618602|NCT03016793|Puerarin|puerarin|mesh-list
64618603|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
64618604|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64618605|NCT03928522|Vancomycin|vancomycin|mesh-list
64618606|NCT03928522|Tobramycin|tobramycin|mesh-list
64618607|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618608|NCT01010399|Ritonavir|ritonavir|mesh-list
64618611|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64618612|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
64618613|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618614|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618615|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64618616|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64618617|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
64618618|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618619|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64618620|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64618621|NCT03638908|Fluoxetine|fluoxetine|mesh-list
64618622|NCT03638908|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64618623|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64618624|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618625|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618626|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618627|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
64484305|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
64618628|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618629|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64618630|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
64618631|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64618632|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64618633|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64618634|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618635|NCT01041781|Gemcitabine|gemcitabine|mesh-list
64618636|NCT01041781|Celecoxib|celecoxib|mesh-list
64618637|NCT01041781|Carboplatin|carboplatin|mesh-list
64618639|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618640|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64618642|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618643|NCT01041781|Antiviral Agents|antiviral agents|mesh-ancestor
64618644|NCT01041781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618645|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618646|NCT01041781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618647|NCT01041781|Immunologic Factors|immunologic factors|mesh-ancestor
64618648|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618649|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64618650|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64618651|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64618652|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618654|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
64618655|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618657|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618658|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64618659|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64618660|NCT01010477|Nicotine|nicotine|mesh-list
64618661|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64618662|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
64618663|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618664|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618665|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64618666|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64618667|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
64618668|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618669|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618670|NCT03921190|Anesthetics|anesthetics|mesh-list
64618671|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618672|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618673|NCT00953849|Calcitriol|calcitriol|mesh-list
64618674|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
64618675|NCT00953849|Vitamin D|vitamin d|mesh-list
64618676|NCT00953849|Celecoxib|celecoxib|mesh-list
64618677|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64618678|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618679|NCT00953849|Analgesics|analgesics|mesh-ancestor
64618680|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
64618681|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618682|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618683|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618684|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298605|NCT03558919|Mirabegron|mirabegron|mesh-list
64618686|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64618687|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618688|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618689|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64618690|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64618691|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618692|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64618694|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
64618695|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64618697|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64618698|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618700|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64618701|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64618702|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618703|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618704|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
64618705|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618706|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618707|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64298637|NCT02085577|Narcotics|narcotics|mesh-ancestor
64618708|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618709|NCT01042795|Sunitinib|sunitinib|mesh-list
64618710|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618711|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64618712|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64618713|NCT01042795|Growth Substances|growth substances|mesh-ancestor
64618714|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618715|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
64618716|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64618717|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618718|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618719|NCT03644212|Vitamin D|vitamin d|mesh-list
64618720|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
64618722|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
64618723|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618724|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64618725|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64618726|NCT03906448|Temozolomide|temozolomide|mesh-list
64618727|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64618728|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
64618730|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618731|NCT01011413|Efavirenz|efavirenz|mesh-list
64618732|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64618733|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64618734|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618735|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618736|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
64618737|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618738|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64618739|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64618740|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64618741|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64618742|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64618743|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64618745|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618746|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
64618747|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
64618748|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618749|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618750|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618752|NCT03889444|Hormones|hormones|mesh-ancestor
64618753|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618754|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64618755|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618756|NCT01104025|Dexamethasone|dexamethasone|mesh-list
64618757|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
64618758|NCT01104025|Methotrexate|methotrexate|mesh-list
64618759|NCT01104025|Etoposide|etoposide|mesh-list
64618760|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
64618761|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618762|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
64618763|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
64618764|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618766|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618767|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
64618768|NCT01104025|Hormones|hormones|mesh-ancestor
64618769|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618770|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64618771|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618772|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64618773|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
64618774|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64618775|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64618776|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
64618777|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618778|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
64618779|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618780|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64618781|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618782|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
64298777|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298778|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618783|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618784|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64618785|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64618786|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64618787|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64618788|NCT03649750|Guaifenesin|guaifenesin|mesh-list
64618789|NCT03649750|Expectorants|expectorants|mesh-ancestor
64618790|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
64618791|NCT04343092|Ivermectin|ivermectin|mesh-list
64618792|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64618793|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618794|NCT01105117|Epoprostenol|epoprostenol|mesh-list
64618795|NCT01105117|Tezosentan|tezosentan|mesh-list
64618796|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64618797|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64618798|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
64618799|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
64618800|NCT03885154|Valproic Acid|valproic acid|mesh-list
64618801|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
64618802|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618803|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618804|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
64618805|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618806|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618807|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
64298832|NCT02087683|Vitamins|vitamins|mesh-ancestor
64618808|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64618809|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618810|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64618811|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64618812|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
64618813|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
64618814|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618815|NCT03885154|Analgesics|analgesics|mesh-ancestor
64618816|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
64618817|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618818|NCT01106833|Sirolimus|sirolimus|mesh-list
64618819|NCT01106833|Prednisone|prednisone|mesh-list
64618820|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
64618821|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618822|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
64618823|NCT01106833|Hormones|hormones|mesh-ancestor
64618824|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618825|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618826|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64618827|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618828|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64618829|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618830|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64618831|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
64618832|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64618834|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618835|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618836|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64618837|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
64618838|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64618839|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64618840|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618841|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618843|NCT00957359|Psilocybin|psilocybin|mesh-list
64618844|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64618845|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64618846|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
64618847|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618848|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64618849|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
64618850|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
64618851|NCT00957359|Vitamins|vitamins|mesh-ancestor
64618852|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
64484306|NCT05640778|Taxane|taxane|mesh-list
64618853|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618855|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64618856|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64618857|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
64618858|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618859|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64618860|NCT00957593|Oxytocin|oxytocin|mesh-list
64618861|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
64618862|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64618863|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618864|NCT00957671|Hormones|hormones|mesh-list
64618865|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618866|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618867|NCT04322968|Ketorolac|ketorolac|mesh-list
64618868|NCT04322968|Ketamine|ketamine|mesh-list
64618869|NCT04322968|Analgesics|analgesics|mesh-ancestor
64618870|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
64618871|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618872|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618873|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64618874|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618875|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
64618876|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
64618877|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618878|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64618879|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64365639|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
64618880|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618881|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618882|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64618883|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618884|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64618885|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64618886|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64618887|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618888|NCT03018899|Anesthetics|anesthetics|mesh-list
64618889|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618890|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618891|NCT00958919|Naloxone|naloxone|mesh-list
64618893|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64618894|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618895|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
64618897|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618899|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
64618900|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64618901|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64618903|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
64618904|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64618905|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
64618907|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
64618909|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618910|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618911|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618913|NCT04323592|Hormones|hormones|mesh-ancestor
64618914|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64618915|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64618916|NCT04323592|Protective Agents|protective agents|mesh-ancestor
64618917|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64618918|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64618919|NCT01047241|Sufentanil|sufentanil|mesh-list
64618920|NCT01047241|Ketamine|ketamine|mesh-list
64618921|NCT01047241|Analgesics|analgesics|mesh-ancestor
64618922|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
64618923|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618924|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618925|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64618926|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618927|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
64618928|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
64618929|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618930|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64618931|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64618932|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618933|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618934|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64618935|NCT01047241|Narcotics|narcotics|mesh-ancestor
64618936|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64618937|NCT01012661|Lidocaine|lidocaine|mesh-list
64618938|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
64618939|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
64618940|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618941|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618942|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
64618943|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64618944|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64618945|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64618946|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64618947|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618948|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618950|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64618952|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64618953|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618954|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
64618955|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618956|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618957|NCT03018821|Tenofovir|tenofovir|mesh-list
64618958|NCT03018821|Entecavir|entecavir|mesh-list
64618959|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
64618960|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64618961|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64299313|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
64618962|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64618963|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64618964|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618965|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64618966|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64618970|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64618971|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64618978|NCT00962039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64618979|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64618980|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64618981|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64618982|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64618984|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618985|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64618986|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
64618988|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
64618989|NCT03375385|Propofol|propofol|mesh-list
64618990|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64618991|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64618992|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64618993|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64618994|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
64618995|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
64618996|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64618997|NCT03375385|Analgesics|analgesics|mesh-ancestor
64618998|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
64618999|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619000|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64619001|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64619002|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64619003|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
64619004|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619005|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619008|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64619009|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619010|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64619011|NCT03018665|Incretins|incretins|mesh-ancestor
64619012|NCT03018665|Hormones|hormones|mesh-ancestor
64619013|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619014|NCT03012763|Acetaminophen|acetaminophen|mesh-list
64619015|NCT03012763|Fexofenadine|fexofenadine|mesh-list
64619016|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
64619017|NCT03012763|Valsartan|valsartan|mesh-list
64619018|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619019|NCT03012763|Analgesics|analgesics|mesh-ancestor
64619020|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
64619021|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619022|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619024|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64619025|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64619026|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64619027|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619028|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64299423|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
64619029|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64619030|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64619031|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
64619032|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
64619033|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619034|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619035|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619036|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619037|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619038|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619039|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64619041|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64619042|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619043|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619044|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
64619046|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64619047|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64619048|NCT01048879|Oseltamivir|oseltamivir|mesh-list
64619049|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
64619050|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64619052|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619053|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619054|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619056|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
64619057|NCT04290676|BB 1101|bb 1101|mesh-list
64619058|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619059|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
64619060|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
64619061|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619062|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619063|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619064|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
64619065|NCT04290676|Hormones|hormones|mesh-ancestor
64619066|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619067|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64619068|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619069|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
64619070|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619071|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619072|NCT03112993|Neostigmine|neostigmine|mesh-list
64619073|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64619074|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619075|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619076|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
64619077|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619078|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619079|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64619081|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619083|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64619084|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619085|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64619086|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619087|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
64619088|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619089|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
64619090|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619091|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
64619093|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619094|NCT03859960|Insulin|insulin|mesh-list
64619095|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64619096|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64619097|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619098|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64619099|NCT03857230|Hormones|hormones|mesh-ancestor
64619100|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619101|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619102|NCT02181127|Glucagon|glucagon|mesh-list
64619103|NCT02181127|Pancrelipase|pancrelipase|mesh-list
64619104|NCT02181127|Pancreatin|pancreatin|mesh-list
64619105|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619106|NCT02181127|Hormones|hormones|mesh-ancestor
64424544|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619107|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619108|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619109|NCT04332094|Azithromycin|azithromycin|mesh-list
64619110|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
64619111|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64619112|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619113|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
64619114|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64619115|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64619116|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619117|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619118|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619120|NCT05314270|Trace Elements|trace elements|mesh-ancestor
64619121|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
64619122|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619123|NCT01167829|Testosterone|testosterone|mesh-list
64619124|NCT01167829|Acyline|acyline|mesh-list
64619125|NCT01167829|Androgens|androgens|mesh-ancestor
64619126|NCT01167829|Hormones|hormones|mesh-ancestor
64619127|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64619129|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
64619130|NCT02066623|Everolimus|everolimus|mesh-list
64619131|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619132|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619133|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
64619134|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619135|NCT04974151|Folic Acid|folic acid|mesh-list
64619136|NCT04974151|Amlodipine|amlodipine|mesh-list
64619137|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64619138|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64619139|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64619140|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619141|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64619142|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619143|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
64619144|NCT04974151|Hematinics|hematinics|mesh-ancestor
64619145|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
64619146|NCT04974151|Vitamins|vitamins|mesh-ancestor
64619147|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
64619148|NCT01924819|Leucovorin|leucovorin|mesh-list
64619149|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64619150|NCT01924819|Cisplatin|cisplatin|mesh-list
64619151|NCT01924819|Docetaxel|docetaxel|mesh-list
64619152|NCT01924819|Fluorouracil|fluorouracil|mesh-list
64619153|NCT01924819|Capecitabine|capecitabine|mesh-list
64619154|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
64619155|NCT01924819|Epirubicin|epirubicin|mesh-list
64619156|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
64619157|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619158|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
64619159|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
64619160|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
64299746|NCT05047874|Prednisolone|prednisolone|mesh-list
64619161|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619163|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619164|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619165|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
64619166|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619167|NCT01924819|Antidotes|antidotes|mesh-ancestor
64619168|NCT01924819|Protective Agents|protective agents|mesh-ancestor
64619169|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
64619172|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64619173|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64619174|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64619175|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619176|NCT01168687|Levetiracetam|levetiracetam|mesh-list
64619177|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
64619178|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
64619179|NCT03685396|Hemostatics|hemostatics|mesh-list
64619180|NCT03685396|Coagulants|coagulants|mesh-ancestor
64619181|NCT01126255|Clobetasol|clobetasol|mesh-list
64619182|NCT01126255|Progesterone|progesterone|mesh-list
64619183|NCT01126255|Progestins|progestins|mesh-ancestor
64619184|NCT01126255|Hormones|hormones|mesh-ancestor
64299787|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619186|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619187|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619188|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
64619190|NCT04198948|Omeprazole|omeprazole|mesh-list
64619191|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64619192|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619193|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64619194|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619195|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619196|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64619197|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619198|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
64619199|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64619200|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619201|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619202|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619205|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619206|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64619207|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64619208|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64619209|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
64619210|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619211|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619212|NCT04822363|Aspirin|aspirin|mesh-list
64619213|NCT04822363|Clopidogrel|clopidogrel|mesh-list
64619214|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619215|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619216|NCT04822363|Analgesics|analgesics|mesh-ancestor
64619217|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
64619218|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619219|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619220|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619222|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64619223|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64619224|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619225|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64344588|NCT03530033|Lidocaine|lidocaine|mesh-list
64619227|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619228|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
64299893|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64619229|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64619230|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64619231|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64619232|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
64619233|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619235|NCT01170247|Analgesics|analgesics|mesh-ancestor
64619236|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
64619237|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619238|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619239|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64619240|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64619241|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
64619242|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
64619243|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619244|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64619245|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64619246|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619247|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619248|NCT01126099|Prazosin|prazosin|mesh-list
64619250|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64619251|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64619252|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64619253|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
64619254|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619255|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619256|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619258|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64619259|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619260|NCT01170715|Analgesics|analgesics|mesh-ancestor
64619261|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
64619262|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619263|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619264|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64619265|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64619266|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64619267|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64619268|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
64619269|NCT03809182|Fentanyl|fentanyl|mesh-list
64619271|NCT03809182|Morphine|morphine|mesh-list
64619272|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64619273|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619274|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619275|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64619277|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
64619278|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619279|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64619280|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64619281|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64619282|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
64619283|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64619284|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300052|NCT02107807|Vaccines|vaccines|mesh-list
64619285|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64619286|NCT03809182|Narcotics|narcotics|mesh-ancestor
64619287|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64619288|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64619289|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
64619290|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
64619291|NCT01170949|Miltefosine|miltefosine|mesh-list
64619292|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
64619293|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64619294|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619295|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64619296|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64619298|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
64619299|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
64619300|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64619301|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64619302|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619303|NCT03802864|Bupivacaine|bupivacaine|mesh-list
64619304|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
64619306|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64619307|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300116|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
64619309|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64619310|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
64619311|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
64619312|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64619313|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64619314|NCT03797872|Prednisolone|prednisolone|mesh-list
64619315|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
64619316|NCT03797872|Triamcinolone|triamcinolone|mesh-list
64619317|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64619318|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64619319|NCT03797872|Methotrexate|methotrexate|mesh-list
64619320|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64619321|NCT03797872|Leflunomide|leflunomide|mesh-list
64619322|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64619323|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
64619324|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64619325|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
64619326|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64619327|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619328|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64619329|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
64619330|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64619331|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64619332|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
64619333|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619353|NCT03797872|Analgesics|analgesics|mesh-ancestor
64619354|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
64619356|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
64619357|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64619358|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64619359|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
64619360|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64619361|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64619362|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64619363|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371029|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371031|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
64371033|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64371034|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
64371035|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371036|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
64371037|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371038|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371041|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371042|NCT02470637|Insulin|insulin|mesh-list
64371043|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64371044|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
64371045|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64371046|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371047|NCT03652961|Abatacept|abatacept|mesh-list
64371048|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64371049|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371050|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371051|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371096|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371127|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371128|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
64371129|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371131|NCT00705263|Ribavirin|ribavirin|mesh-list
64371132|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64371133|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
64371134|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371136|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371137|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
64446467|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
64371138|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64371139|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64371140|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371172|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64371173|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64371174|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371175|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371176|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
64371177|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
64371178|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
64371179|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371180|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
64371181|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
64371182|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64371183|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64371184|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
64371185|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
64371186|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371217|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371218|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
64371219|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64371220|NCT03309059|Protective Agents|protective agents|mesh-ancestor
64446534|NCT02137226|Adalimumab|adalimumab|mesh-list
64371222|NCT02469545|Citalopram|citalopram|mesh-list
64371223|NCT02469545|Sertraline|sertraline|mesh-list
64371224|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64371225|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64371226|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371227|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371228|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371229|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
64371265|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64371266|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64371267|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371268|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371294|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371295|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371296|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64371297|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
64371352|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
64371353|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371354|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64371355|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64446825|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371356|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371357|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
64371358|NCT03311321|Coagulants|coagulants|mesh-ancestor
64371360|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64371363|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
64371364|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371395|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371396|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
64371397|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64447168|NCT02140411|Growth Substances|growth substances|mesh-ancestor
64447169|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447170|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
64371434|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371435|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371436|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447174|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447175|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447176|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447178|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64447179|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64447180|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
64447181|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
64447182|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447183|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447184|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447185|NCT02105701|Ribavirin|ribavirin|mesh-list
64447186|NCT02105701|Grazoprevir|grazoprevir|mesh-list
64447187|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
64447188|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447189|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
64447190|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447191|NCT04411225|Cannabidiol|cannabidiol|mesh-list
64447192|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
64371440|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64371441|NCT03303677|Renal Agents|renal agents|mesh-ancestor
64371442|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
64371443|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64371444|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64447193|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64447194|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64447196|NCT04742491|Tenofovir|tenofovir|mesh-list
64447197|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64447198|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64447199|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447200|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447201|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
64447202|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447203|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64447204|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64447205|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64447206|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64447207|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447208|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447209|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64447210|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64447211|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447212|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
64447213|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447214|NCT01502644|Morphine|morphine|mesh-list
64447215|NCT01502644|Oxycodone|oxycodone|mesh-list
64447218|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447219|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447220|NCT01502644|Analgesics|analgesics|mesh-ancestor
64447229|NCT01462318|Daclizumab|daclizumab|mesh-list
64447230|NCT01462318|Vitamins|vitamins|mesh-ancestor
64447231|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
64447232|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447233|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64447234|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64447235|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447236|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64447237|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447238|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447239|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64447240|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
64447242|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
64447243|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
64447244|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447245|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447246|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
64447247|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64447248|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64447249|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447250|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64371446|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64371447|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64371448|NCT02468063|Terlipressin|terlipressin|mesh-list
64371449|NCT02468063|Norepinephrine|norepinephrine|mesh-list
64371450|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64371451|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64371452|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64371454|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371455|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447251|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64447252|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
64447253|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64447254|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64447255|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64447256|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64447257|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64447258|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
64447259|NCT01462318|Coagulants|coagulants|mesh-ancestor
64447260|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
64447261|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
64447262|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64447263|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64447264|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447265|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
64447266|NCT01485094|Pregabalin|pregabalin|mesh-list
64447267|NCT01485094|Analgesics|analgesics|mesh-ancestor
64447268|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
64447269|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447270|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447271|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
64447272|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64447273|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371457|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371459|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
64371460|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371461|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
64447282|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447283|NCT04094584|Naltrexone|naltrexone|mesh-list
64447284|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64447285|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64447286|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447287|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
64447288|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447289|NCT01502410|Sorafenib|sorafenib|mesh-list
64447290|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447291|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64447292|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447293|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447294|NCT04757636|Aflibercept|aflibercept|mesh-list
64447295|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64447296|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64447298|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447299|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
64447300|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447302|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
64447303|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64447304|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
64447305|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
64447306|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447308|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
64447321|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64447322|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447324|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64447325|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64447326|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64447327|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447328|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447329|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447330|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447331|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64447332|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64447334|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447335|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447336|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64447337|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64447338|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371469|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447339|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64447340|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64447341|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64447342|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447343|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
64447344|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447345|NCT02131064|Carboplatin|carboplatin|mesh-list
64447346|NCT02131064|Docetaxel|docetaxel|mesh-list
64447347|NCT02131064|Trastuzumab|trastuzumab|mesh-list
64447348|NCT02131064|Pertuzumab|pertuzumab|mesh-list
64447349|NCT02131064|Maytansine|maytansine|mesh-list
64447350|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64447351|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447352|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
64447353|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
64447354|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
64447355|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447356|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64447357|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64447358|NCT02130284|Insulin|insulin|mesh-list
64447359|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64447360|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447361|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447362|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64447363|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
64447364|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447365|NCT04748822|Ethanol|ethanol|mesh-list
64371472|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371473|NCT03303053|Prednisolone|prednisolone|mesh-list
64371474|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
64371475|NCT03303053|Carbimazole|carbimazole|mesh-list
64371476|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371477|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
64447366|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64447367|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447368|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447369|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447371|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447372|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64447373|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447374|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371515|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371516|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64371517|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64371518|NCT05727761|Metformin|metformin|mesh-list
64371519|NCT05727761|Pioglitazone|pioglitazone|mesh-list
64447377|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64447378|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
64447379|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447382|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64447383|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
64447384|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447385|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447386|NCT02146430|Pregabalin|pregabalin|mesh-list
64447387|NCT02146430|Analgesics|analgesics|mesh-ancestor
64447388|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
64447389|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447390|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447391|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
64447392|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64447393|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64447394|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447395|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64447396|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64447397|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447398|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447399|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447400|NCT02129192|Amlodipine|amlodipine|mesh-list
64447401|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64447402|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64447403|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64447404|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447405|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64371544|NCT05727683|Fludarabine|fludarabine|mesh-list
64371545|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371546|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
64371547|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371548|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371549|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64371550|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
64371551|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447407|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
64447409|NCT02128490|Colchicine|colchicine|mesh-list
64447410|NCT02128490|Febuxostat|febuxostat|mesh-list
64447411|NCT02128490|Lansoprazole|lansoprazole|mesh-list
64447412|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
64447413|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64447414|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64447415|NCT02128490|Analgesics|analgesics|mesh-ancestor
64447416|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
64447417|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447418|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447419|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64447420|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447421|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
64447422|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64447423|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447424|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447425|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
64447426|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
64371552|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371553|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64371556|NCT05727371|Protective Agents|protective agents|mesh-ancestor
64371557|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371558|NCT03302039|Phenylephrine|phenylephrine|mesh-list
64371559|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
64447439|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
64447440|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447441|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64447442|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
64447443|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64447444|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447445|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64447446|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
64447447|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447448|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447449|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64447450|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447451|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
64447452|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447453|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64447454|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64447455|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64447457|NCT04748042|Olaparib|olaparib|mesh-list
64447458|NCT04748042|Androgens|androgens|mesh-list
64371563|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371564|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371565|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
64447459|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64447460|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
64447461|NCT04748042|Hormones|hormones|mesh-ancestor
64447462|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447463|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447464|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64447465|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447466|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64447467|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447468|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447469|NCT01626872|Risperidone|risperidone|mesh-list
64447470|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64447471|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
64447472|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447473|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447474|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447475|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64447476|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447477|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447478|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447479|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64447480|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
64447481|NCT01598090|Ribavirin|ribavirin|mesh-list
64447482|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64371566|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371567|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64371568|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
64447484|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447486|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447487|NCT02145182|Eculizumab|eculizumab|mesh-list
64447488|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64447489|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447490|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
64447491|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447492|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
64447493|NCT02145026|Hematinics|hematinics|mesh-ancestor
64447494|NCT02144012|Docetaxel|docetaxel|mesh-list
64447495|NCT02144012|Trastuzumab|trastuzumab|mesh-list
64447496|NCT02144012|Maytansine|maytansine|mesh-list
64447497|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64447498|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447499|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
64447500|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
64447501|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
64447502|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447503|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64447504|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64447505|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64447506|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447507|NCT02141672|Cyclosporine|cyclosporine|mesh-list
64447508|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
64447509|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447510|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447511|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447512|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447513|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447514|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
64447516|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371600|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64371601|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371602|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371603|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371604|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371605|NCT03301181|Itraconazole|itraconazole|mesh-list
64371606|NCT03301181|Rifampin|rifampin|mesh-list
64371607|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
64371608|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
64371609|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371610|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64371611|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64371612|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371613|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371633|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
64371634|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371636|NCT03301025|Analgesics|analgesics|mesh-ancestor
64371637|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
64371638|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371639|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371640|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
64371641|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64371642|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371643|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371644|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64371645|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64447518|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
64447519|NCT01628120|Hematinics|hematinics|mesh-ancestor
64447520|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64447521|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447522|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447523|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
64447536|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
64447537|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447538|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
64447539|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64447540|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447541|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447542|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64447543|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64447544|NCT02123576|Protective Agents|protective agents|mesh-ancestor
64447545|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447546|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
64447547|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64447549|NCT03368729|Trastuzumab|trastuzumab|mesh-list
64447550|NCT03368729|Niraparib|niraparib|mesh-list
64447551|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64447552|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447553|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64447554|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447555|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447556|NCT02140970|Ibuprofen|ibuprofen|mesh-list
64447557|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64447558|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64447559|NCT02140970|Analgesics|analgesics|mesh-ancestor
64447560|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
64447561|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371654|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371655|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64371656|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64371657|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64371658|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371659|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64371660|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64371661|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64371690|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371691|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64371692|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64371693|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
64371694|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
64371695|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371696|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64371697|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64371698|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371699|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371700|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64371701|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
64371702|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64447562|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447564|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447565|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64447566|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447567|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447568|NCT02101112|Apixaban|apixaban|mesh-list
64447569|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64447570|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
64447571|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64447572|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
64447573|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447574|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447575|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
64447576|NCT02139644|Fluticasone|fluticasone|mesh-list
64447577|NCT02139644|Xhance|xhance|mesh-list
64447578|NCT02139644|Beclomethasone|beclomethasone|mesh-list
64447579|NCT02139644|Albuterol|albuterol|mesh-list
64447580|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64447581|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
64447582|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64447583|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64447584|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
64447585|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371711|NCT02467673|Progesterone|progesterone|mesh-list
64371712|NCT02467673|Estrogens|estrogens|mesh-ancestor
64371740|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64447586|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447588|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
64447589|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447590|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64447591|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64447592|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64371743|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371744|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371745|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64371747|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
64371748|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64365721|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371749|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447593|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447594|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447595|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447596|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
64447597|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64447598|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
64447600|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447601|NCT02100644|Lamotrigine|lamotrigine|mesh-list
64447602|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
64447603|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64447604|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371750|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371751|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371753|NCT04983615|Midazolam|midazolam|mesh-list
64371754|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64371755|NCT04983615|Narcotics|narcotics|mesh-ancestor
64371756|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371757|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371758|NCT04983615|Analgesics|analgesics|mesh-ancestor
64371759|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
64371760|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371761|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64371821|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64371822|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64371823|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371824|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371825|NCT03299387|Gentamicins|gentamicins|mesh-list
64371826|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
64447605|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447606|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64447607|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447608|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64447609|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447610|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447611|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447612|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64447613|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
64447614|NCT04798469|Testosterone|testosterone|mesh-list
64447615|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
64447616|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
64447617|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64371829|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64371830|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371831|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371832|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64371834|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
64371835|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64371836|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371837|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
64371838|NCT02658981|Nivolumab|nivolumab|mesh-list
64371839|NCT02658981|Antibodies|antibodies|mesh-list
64371840|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64447646|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447648|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447650|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64447651|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64447652|NCT04070573|Analgesics|analgesics|mesh-ancestor
64447653|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
64447654|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447655|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447656|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64447657|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447658|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64447659|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64365779|NCT05723627|Propofol|propofol|mesh-list
64447660|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447661|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64447662|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64447663|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447664|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
64447665|NCT02099708|Lansoprazole|lansoprazole|mesh-list
64447666|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
64447667|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64447668|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64447669|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64447670|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371841|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
64371842|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371843|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371844|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371845|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64371878|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371880|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
64371881|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447671|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447672|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
64447673|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64447674|NCT02073656|Ledipasvir|ledipasvir|mesh-list
64447675|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
64447676|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447677|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
64447678|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64447679|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447680|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
64447681|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64447682|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447683|NCT04020341|Renal Agents|renal agents|mesh-ancestor
64447684|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64447685|NCT02209181|Acetaminophen|acetaminophen|mesh-list
64447686|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64447687|NCT02209181|Analgesics|analgesics|mesh-ancestor
64447688|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
64447689|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447690|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447691|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
64447692|NCT02242487|Levodopa|levodopa|mesh-list
64447693|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64447694|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64447695|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
64447696|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371882|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371883|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64371884|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
64371885|NCT04782687|Hormones|hormones|mesh-ancestor
64371886|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371887|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64371888|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371889|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
64371923|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64371924|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
64371925|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447704|NCT02241551|Fluorouracil|fluorouracil|mesh-list
64447705|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
64447706|NCT02241551|Irinotecan|irinotecan|mesh-list
64447707|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64447708|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447709|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
64447710|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
64447711|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
64365785|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
64447712|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447713|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64447714|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
64447715|NCT02241551|Antiviral Agents|antiviral agents|mesh-ancestor
64447716|NCT02241551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447717|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447718|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447719|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
64447720|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447721|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64447722|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64447724|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64447725|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64447726|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447727|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64447728|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64447729|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447730|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447731|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447732|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64447733|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64447734|NCT02240693|BI 409306|bi 409306|mesh-list
64447735|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64371963|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
64371964|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371965|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
64371966|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371967|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371969|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64371970|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64371971|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447736|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447737|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447738|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64447739|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64447740|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447742|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
64447743|NCT02072096|Pioglitazone|pioglitazone|mesh-list
64447744|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64447745|NCT02072096|Liraglutide|liraglutide|mesh-list
64447746|NCT02072096|Exenatide|exenatide|mesh-list
64447747|NCT02072096|Glimepiride|glimepiride|mesh-list
64447748|NCT02072096|Linagliptin|linagliptin|mesh-list
64447749|NCT02072096|Acarbose|acarbose|mesh-list
64447750|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447751|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447752|NCT02072096|Incretins|incretins|mesh-ancestor
64447753|NCT02072096|Hormones|hormones|mesh-ancestor
64372008|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64372009|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64372010|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372011|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372012|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64447754|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447755|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64447756|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
64447757|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447758|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447759|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64447760|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64447761|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447762|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
64447763|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64447765|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
64447767|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372037|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
64372039|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
64372040|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64372041|NCT05635071|Nintedanib|nintedanib|mesh-list
64372042|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372043|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64372044|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372045|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372046|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64372047|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372048|NCT02720081|Albuterol|albuterol|mesh-list
64372049|NCT02720081|Montelukast|montelukast|mesh-list
64372050|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64372051|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
64372052|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64447768|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372059|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64372088|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372089|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447781|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447782|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
64447783|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447784|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64447785|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447786|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447787|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64447788|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447789|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64447790|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
64447791|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64447792|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447794|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
64447795|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64447796|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64447797|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
64447798|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447799|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447800|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64447801|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447802|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
64447803|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447804|NCT02121392|Bupivacaine|bupivacaine|mesh-list
64447805|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
64447806|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
64447807|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447808|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447809|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
64447810|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447811|NCT02097056|Donepezil|donepezil|mesh-list
64447812|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64447813|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447815|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
64447816|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447817|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447818|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
64447819|NCT02121002|Diclofenac|diclofenac|mesh-list
64447820|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64447821|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64447822|NCT02121002|Analgesics|analgesics|mesh-ancestor
64447823|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
64447824|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447825|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447830|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447832|NCT02096900|Zolpidem|zolpidem|mesh-list
64447833|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64447834|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64447835|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447836|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447837|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64447838|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447839|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447840|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64372091|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372093|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372094|NCT04489745|Androgens|androgens|mesh-list
64372095|NCT04489745|Hormones|hormones|mesh-ancestor
64372096|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64372097|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372099|NCT04419519|Antibodies|antibodies|mesh-list
64372100|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64372101|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
64372102|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372103|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372104|NCT02464865|Thiamine|thiamine|mesh-list
64447841|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
64447842|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
64447843|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
64447844|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
64447845|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447846|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447847|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64447848|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64447849|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
64447850|NCT02120924|Azelaic acid|azelaic acid|mesh-list
64447851|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447852|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447853|NCT02096744|Clonidine|clonidine|mesh-list
64447854|NCT02096744|Analgesics|analgesics|mesh-ancestor
64447855|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
64447856|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447857|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447858|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64447859|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
64447860|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
64447861|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64447862|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64447863|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64447864|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
64372105|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
64372106|NCT02464865|Vitamins|vitamins|mesh-ancestor
64372107|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
64372108|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372109|NCT02466035|Caseins|caseins|mesh-list
64372140|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64372141|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64447877|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447879|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
64447880|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447881|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64447882|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64447883|NCT02069366|Analgesics|analgesics|mesh-ancestor
64447884|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
64447885|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447886|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64447887|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64447888|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372145|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64372146|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372147|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
64372148|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372149|NCT04562597|Expectorants|expectorants|mesh-ancestor
64372150|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
64372151|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64372152|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
64372153|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447889|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447890|NCT02069366|Hormones|hormones|mesh-ancestor
64447891|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447892|NCT04732208|Mydriatics|mydriatics|mesh-list
64447893|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
64447894|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64447895|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447912|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372188|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64372190|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447930|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
64447931|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447932|NCT02235311|Pantoprazole|pantoprazole|mesh-list
64447933|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64447934|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64447935|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64447936|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447937|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447938|NCT02235077|Spironolactone|spironolactone|mesh-list
64447939|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64447940|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
64447941|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447942|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447943|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64447944|NCT02235077|Diuretics|diuretics|mesh-ancestor
64447945|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
64447946|NCT02234141|Selonsertib|selonsertib|mesh-list
64447947|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64447948|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447949|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447952|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
64447953|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
64372191|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372193|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
64372221|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64372222|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64372223|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64372224|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64447955|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64447956|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447957|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64447958|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
64447959|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447960|NCT01896531|Antidotes|antidotes|mesh-ancestor
64447961|NCT01896531|Protective Agents|protective agents|mesh-ancestor
64447962|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
64447963|NCT01896531|Vitamins|vitamins|mesh-ancestor
64447964|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
64447965|NCT01618305|Lamivudine|lamivudine|mesh-list
64447966|NCT01618305|Zidovudine|zidovudine|mesh-list
64447967|NCT01618305|Efavirenz|efavirenz|mesh-list
64447968|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
64447969|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
64447970|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64447971|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64447972|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447973|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447974|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
64372229|NCT05582811|Riociguat|riociguat|mesh-list
64372230|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
64372231|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372233|NCT04424225|Psilocybin|psilocybin|mesh-list
64447977|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64447978|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
64447979|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64447980|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64447981|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64447982|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64447983|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64447984|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64447985|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64447986|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64447987|NCT01896297|Dabigatran|dabigatran|mesh-list
64447988|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
64447989|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64447990|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
64372237|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
64372238|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64372239|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
64448002|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448003|NCT01864005|Clopidogrel|clopidogrel|mesh-list
64448004|NCT01864005|Ticagrelor|ticagrelor|mesh-list
64448005|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64448006|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64448007|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64448008|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64448009|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
64448010|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448011|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372242|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
64372243|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
64372244|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64372245|NCT05581719|Nivolumab|nivolumab|mesh-list
64372246|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64448012|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448013|NCT01863771|Golimumab|golimumab|mesh-list
64448014|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64448015|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448016|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448017|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
64448018|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448019|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64448020|NCT01894581|Hormones|hormones|mesh-ancestor
64448021|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448022|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448023|NCT02203331|Anastrozole|anastrozole|mesh-list
64448024|NCT02203331|Leuprolide|leuprolide|mesh-list
64448025|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
64448026|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64448027|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448028|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64448069|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448070|NCT01862991|Protective Agents|protective agents|mesh-ancestor
64448071|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64448072|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64448073|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64448074|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64448075|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
64448076|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64448077|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64448087|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448088|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
64448089|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448090|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448091|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448092|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64448093|NCT02202551|Analgesics|analgesics|mesh-ancestor
64448094|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
64448095|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448096|NCT02118337|Nivolumab|nivolumab|mesh-list
64448097|NCT02118337|Durvalumab|durvalumab|mesh-list
64448098|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64448099|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448100|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64448101|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448102|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
64448103|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64448105|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
64448106|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
64448107|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448123|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448124|NCT03109847|Metformin|metformin|mesh-list
64448125|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448126|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448127|NCT01461928|Rituximab|rituximab|mesh-list
64448128|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64448129|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448130|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
64448131|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448132|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448133|NCT03039413|Copper|copper|mesh-list
64448134|NCT03039413|Trace Elements|trace elements|mesh-ancestor
64448135|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
64448136|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448137|NCT04775381|Vitamin D|vitamin d|mesh-list
64448138|NCT04775381|Vitamins|vitamins|mesh-ancestor
64448139|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
64448140|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448141|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64448143|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64448144|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64448145|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448146|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448147|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448148|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
64448151|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
64448161|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448162|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64448163|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64448177|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
64448178|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448179|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64448180|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64448181|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64448182|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
64448183|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448184|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64448185|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64448186|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448187|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448188|NCT01483690|Dexamethasone|dexamethasone|mesh-list
64448189|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
64448190|NCT01483690|Methotrexate|methotrexate|mesh-list
64448191|NCT01483690|Vincristine|vincristine|mesh-list
64448193|NCT01483690|Asparaginase|asparaginase|mesh-list
64448194|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
64372315|NCT04970121|Analgesics|analgesics|mesh-ancestor
64372316|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
64372317|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372318|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
64372319|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64372320|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
64372321|NCT01918397|Levofloxacin|levofloxacin|mesh-list
64372322|NCT01918397|Ofloxacin|ofloxacin|mesh-list
64372323|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64448212|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448214|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
64448215|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64448216|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64448217|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
64448218|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
64448219|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64448220|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448221|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
64448222|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448223|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64448224|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64448233|NCT01483144|Eflornithine|eflornithine|mesh-list
64372327|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64372328|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64372329|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372330|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372331|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372332|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64448234|NCT01483144|Sulindac|sulindac|mesh-list
64448235|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448236|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64448237|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64448238|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64448239|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448240|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64448241|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448242|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448243|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64448244|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64448245|NCT01483144|Analgesics|analgesics|mesh-ancestor
64448246|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
64448247|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448248|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448249|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448250|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448251|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64448252|NCT01881789|Dexamethasone|dexamethasone|mesh-list
64448253|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
64372335|NCT02463929|Promethazine|promethazine|mesh-list
64372337|NCT02463929|Bupivacaine|bupivacaine|mesh-list
64372338|NCT02463929|Sevoflurane|sevoflurane|mesh-list
64372339|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
64372340|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
64448254|NCT01881789|Lenalidomide|lenalidomide|mesh-list
64448255|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448256|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
64448257|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448258|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448259|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64448260|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
64448261|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448262|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448263|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64448264|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448266|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
64448267|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448268|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448269|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
64448271|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448272|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64448273|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64448274|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64448275|NCT01881789|Growth Substances|growth substances|mesh-ancestor
64448276|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
64448277|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
64448278|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64448279|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
64448280|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372341|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372342|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372343|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
64372344|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372345|NCT02463929|Analgesics|analgesics|mesh-ancestor
64372346|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64372347|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64372348|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
64448281|NCT01892163|Dexamethasone|dexamethasone|mesh-list
64448282|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448283|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
64448284|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
64448285|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448286|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448287|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448288|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
64448289|NCT01892163|Hormones|hormones|mesh-ancestor
64448290|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448291|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64448292|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448293|NCT01500226|Dexamethasone|dexamethasone|mesh-list
64448294|NCT01500226|Granisetron|granisetron|mesh-list
64372351|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372352|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372353|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64372389|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372390|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64372391|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64372392|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64372393|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
64448296|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448297|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
64448298|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
64448299|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448300|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448301|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448302|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
64448303|NCT01500226|Hormones|hormones|mesh-ancestor
64448304|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448305|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64372430|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372431|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372433|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
64372434|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
64372435|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64372436|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64372461|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
64372462|NCT02462525|Hormones|hormones|mesh-ancestor
64372463|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448319|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64448320|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448321|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448322|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64448323|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
64448324|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64448325|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448326|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448327|NCT01859793|Incretins|incretins|mesh-ancestor
64448328|NCT01859793|Hormones|hormones|mesh-ancestor
64448329|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448330|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64448331|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
64448332|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448333|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448334|NCT01859715|Oxycodone|oxycodone|mesh-list
64448335|NCT01859715|Hydrocodone|hydrocodone|mesh-list
64448336|NCT01859715|Ondansetron|ondansetron|mesh-list
64448337|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64448338|NCT01859715|Narcotics|narcotics|mesh-ancestor
64448339|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448340|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448341|NCT01859715|Analgesics|analgesics|mesh-ancestor
64448342|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
64448343|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448344|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
64372464|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64448345|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
64448346|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448347|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
64448348|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
64448349|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64448350|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
64448351|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448352|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448353|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64448355|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448356|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64448357|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
64448358|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
64448359|NCT04599465|Ivacaftor|ivacaftor|mesh-list
64448360|NCT04599465|Elexacaftor|elexacaftor|mesh-list
64448361|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64448363|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448364|NCT04590495|Cannabidiol|cannabidiol|mesh-list
64448365|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
64448366|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64448367|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64448368|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64448369|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448370|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
64448371|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448372|NCT02117479|Capecitabine|capecitabine|mesh-list
64448376|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448377|NCT01482910|Aflibercept|aflibercept|mesh-list
64448378|NCT01482910|Verteporfin|verteporfin|mesh-list
64448379|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64448380|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64448381|NCT01482910|Growth Substances|growth substances|mesh-ancestor
64448382|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448383|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
64448384|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448385|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64448386|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
64372466|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
64372467|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64372468|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64372469|NCT02462525|Growth Substances|growth substances|mesh-ancestor
64372471|NCT04111419|Amlodipine|amlodipine|mesh-list
64372472|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
64372473|NCT04111419|Atorvastatin|atorvastatin|mesh-list
64372474|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64372475|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64372476|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
64448387|NCT04077190|Cortisone|cortisone|mesh-list
64448388|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448389|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64448390|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
64448391|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448392|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
64448393|NCT02229539|Promethazine|promethazine|mesh-list
64448394|NCT02229539|Lidocaine|lidocaine|mesh-list
64448395|NCT02229539|Doxepin|doxepin|mesh-list
64448396|NCT02229539|Antacids|antacids|mesh-list
64448397|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
64448398|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
64448399|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448400|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448401|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
64448402|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448403|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64448404|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64448405|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64448406|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448407|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448408|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64448409|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64448410|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
64448411|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
64448412|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448413|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64448415|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
64448416|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448417|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64448421|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
64448422|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448424|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448425|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448426|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64448427|NCT02229383|Incretins|incretins|mesh-ancestor
64448428|NCT02229383|Hormones|hormones|mesh-ancestor
64372477|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372479|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64372481|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64372484|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64372485|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372521|NCT02462369|Incretins|incretins|mesh-ancestor
64372522|NCT02462369|Hormones|hormones|mesh-ancestor
64448449|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448450|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448451|NCT02229227|Insulin|insulin|mesh-list
64448452|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
64448453|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
64448454|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
64448455|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448456|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448457|NCT02229227|Incretins|incretins|mesh-ancestor
64448458|NCT02229227|Hormones|hormones|mesh-ancestor
64448459|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448460|NCT01499290|Metronidazole|metronidazole|mesh-list
64448461|NCT01499290|Meropenem|meropenem|mesh-list
64448462|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448463|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64448464|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64448465|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64448466|NCT01833897|Cycloserine|cycloserine|mesh-list
64448467|NCT01833897|Ketamine|ketamine|mesh-list
64448468|NCT01833897|Olanzapine|olanzapine|mesh-list
64448469|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64448470|NCT01833897|Fluoxetine|fluoxetine|mesh-list
64448471|NCT01833897|Analgesics|analgesics|mesh-ancestor
64448472|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
64448473|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448474|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448475|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64448476|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64448477|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
64448478|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
64372523|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64372524|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64372584|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64372585|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
64372586|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372587|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64372588|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
64372589|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
64372590|NCT05345457|Amoxicillin|amoxicillin|mesh-list
64448479|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448480|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64448482|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448483|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448484|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
64448485|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
64372591|NCT05345457|Azithromycin|azithromycin|mesh-list
64372592|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64372593|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372594|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64372595|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64372596|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64372597|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372598|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372599|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64372600|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448487|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64448488|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64448489|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448490|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64448491|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64448492|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448494|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
64448495|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64448496|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64448497|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448498|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448499|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64448500|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448501|NCT01833897|Renal Agents|renal agents|mesh-ancestor
64448502|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64448503|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
64448512|NCT02201771|Aspirin|aspirin|mesh-list
64372602|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
64372603|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372604|NCT04729179|Cannabidiol|cannabidiol|mesh-list
64372605|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
64372606|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
64372607|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64372608|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
64372609|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372610|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372611|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64372612|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
64448518|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448519|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448520|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448521|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448522|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64448523|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64448524|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448525|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64448526|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64448527|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448528|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
64448529|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64448530|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64448531|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64372614|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
64372638|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372640|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
64372641|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
64372642|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64372643|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
64372644|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448532|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
64448533|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448534|NCT02200445|Aldesleukin|aldesleukin|mesh-list
64448535|NCT02200445|Interleukin-2|interleukin-2|mesh-list
64448536|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448537|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64448538|NCT02200445|Analgesics|analgesics|mesh-ancestor
64448539|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
64448540|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448541|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372653|NCT03062787|Hormones|hormones|mesh-ancestor
64372654|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64372655|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372656|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64372657|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
64372658|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372659|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372660|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64372661|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
64372662|NCT03062787|Protective Agents|protective agents|mesh-ancestor
64372663|NCT04601883|Colchicine|colchicine|mesh-list
64372664|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
64372665|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372699|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
64372700|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372701|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372702|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64372703|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64372704|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64372705|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448545|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448546|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
64448547|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64448548|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448549|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64448550|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64448551|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448552|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448553|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372708|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
64372709|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
64372737|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372738|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64372739|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
64372740|NCT00379041|Hormones|hormones|mesh-ancestor
64448554|NCT01460290|Asenapine|asenapine|mesh-list
64448555|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64448556|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64448557|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448558|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448559|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448560|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64448561|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64448562|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
64448563|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64448564|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448588|NCT02199509|Levetiracetam|levetiracetam|mesh-list
64448589|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
64372752|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64372753|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64372755|NCT03305445|Ipilimumab|ipilimumab|mesh-list
64372756|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372757|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372758|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64372759|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372760|NCT04436913|Fluorides|fluorides|mesh-list
64372761|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
64372790|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64372791|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448591|NCT01458574|Tofacitinib|tofacitinib|mesh-list
64448592|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64448593|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448594|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448595|NCT02224703|Cannabidiol|cannabidiol|mesh-list
64448596|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
64448597|NCT01458106|Factor VIII|factor viii|mesh-list
64448598|NCT01458106|Coagulants|coagulants|mesh-ancestor
64448599|NCT01457950|Denosumab|denosumab|mesh-list
64448600|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64448601|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448602|NCT01499134|Metoprolol|metoprolol|mesh-list
64448606|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
64448607|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
64448608|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448609|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448610|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64448611|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64448612|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64448613|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
64448614|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448615|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448617|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64448618|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64448619|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64448620|NCT02198651|Adalimumab|adalimumab|mesh-list
64448621|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448644|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64448645|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
64448646|NCT01498822|Levetiracetam|levetiracetam|mesh-list
64448647|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
64448648|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
64448649|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64448650|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64448651|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448652|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372794|NCT03108287|Clarithromycin|clarithromycin|mesh-list
64372795|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64372796|NCT03108287|Rabeprazole|rabeprazole|mesh-list
64372797|NCT03108287|Bismuth|bismuth|mesh-list
64372798|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64372799|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372808|NCT03108287|Antacids|antacids|mesh-ancestor
64448681|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64448682|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448683|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448684|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64448685|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64448686|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64448687|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64448688|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64448689|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64448690|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448691|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64448693|NCT02224157|Terbutaline|terbutaline|mesh-list
64448694|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
64448695|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448696|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64448697|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
64448698|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372841|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
64448700|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64448701|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
64448702|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
64448703|NCT02224157|Hormones|hormones|mesh-ancestor
64448704|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448705|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64448706|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64448707|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64448708|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
64448709|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448710|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448711|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
64448712|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
64448713|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64448714|NCT02196701|Adalimumab|adalimumab|mesh-list
64448715|NCT02196701|Methotrexate|methotrexate|mesh-list
64448716|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64448717|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
64448718|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64448719|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448720|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64448721|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
64448722|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448723|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448724|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
64448725|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448726|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64448727|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448728|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
64448729|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448730|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64448731|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448732|NCT01481116|Glimepiride|glimepiride|mesh-list
64448733|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64448734|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448735|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448736|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448737|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
64448738|NCT02222207|Ranibizumab|ranibizumab|mesh-list
64448739|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64448740|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64448741|NCT02222207|Growth Substances|growth substances|mesh-ancestor
64448742|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448759|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448760|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448786|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64448787|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64448788|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
64448789|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448790|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64448791|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448792|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
64448795|NCT02093390|Relugolix|relugolix|mesh-list
64448796|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64372920|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64372921|NCT03296189|BB 1101|bb 1101|mesh-list
64372922|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64372923|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
64372924|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
64372925|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372926|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372927|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448806|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448807|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64448808|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
64448809|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448810|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448811|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64448812|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64448813|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
64448814|NCT02219087|Bupivacaine|bupivacaine|mesh-list
64448815|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
64448816|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
64448817|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448818|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448819|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
64448820|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448822|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64448823|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64448824|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64372933|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
64372934|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
64372935|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372936|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
64448828|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
64448829|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448830|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64448831|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64448832|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64448833|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448834|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
64448835|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
64448836|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448837|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448838|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64448839|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64448840|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
64448841|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64448842|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64448843|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64448844|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64448846|NCT01456936|Nicotine|nicotine|mesh-list
64448847|NCT01456936|Varenicline|varenicline|mesh-list
64448848|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64448849|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
64448850|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448851|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372940|NCT03295955|Amoxicillin|amoxicillin|mesh-list
64372941|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
64372942|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
64372943|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64372944|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64372945|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372946|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64372947|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448852|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64448853|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64448854|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
64448855|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448856|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448857|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64448858|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
64448859|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448860|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64448861|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64372949|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
64372950|NCT03298373|Nandrolone|nandrolone|mesh-list
64372951|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
64372952|NCT03298373|Androgens|androgens|mesh-ancestor
64372971|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372973|NCT01670721|Protective Agents|protective agents|mesh-ancestor
64448862|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448863|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
64448864|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64448865|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64448866|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448867|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64448868|NCT01456780|Tobramycin|tobramycin|mesh-list
64448869|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
64448870|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64448871|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372975|NCT01670721|Vitamins|vitamins|mesh-ancestor
64372976|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
64372977|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64372978|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64372979|NCT01670721|Growth Substances|growth substances|mesh-ancestor
64372980|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
64372981|NCT04491695|Tirofiban|tirofiban|mesh-list
64372982|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64372983|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64448873|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64448874|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64448875|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64448876|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
64448877|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448878|NCT01479868|Interferons|interferons|mesh-list
64448880|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
64448881|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
64448882|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64448883|NCT01479868|Simeprevir|simeprevir|mesh-list
64448884|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448885|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
64448886|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448887|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
64448888|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448889|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
64448890|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448891|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
64448892|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372985|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64372986|NCT04982055|Nadroparin|nadroparin|mesh-list
64372987|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
64372988|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64372989|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64372990|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372991|NCT04981743|Vitamin D|vitamin d|mesh-list
64372992|NCT04981743|Vitamins|vitamins|mesh-ancestor
64372993|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
64372994|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372995|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64372996|NCT04489121|Omalizumab|omalizumab|mesh-list
64448894|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
64448895|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448896|NCT01454596|Aldesleukin|aldesleukin|mesh-list
64448897|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
64448910|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64448911|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64448912|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
64448913|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448914|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
64448915|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64448916|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448918|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448919|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
64448920|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448921|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64448922|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448923|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448924|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64448925|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
64448926|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448927|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64448928|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64448929|NCT01495000|Denosumab|denosumab|mesh-list
64448930|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64448931|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372999|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
64373000|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
64373001|NCT04982211|Propranolol|propranolol|mesh-list
64373002|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64373003|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64373004|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
64373005|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448932|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64448933|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64448934|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
64448935|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448936|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448937|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64448938|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
64448939|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
64448940|NCT01494610|Hormones|hormones|mesh-ancestor
64448941|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448942|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
64373011|NCT03290963|Ketamine|ketamine|mesh-list
64373012|NCT03290963|Analgesics|analgesics|mesh-ancestor
64373013|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
64373014|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448948|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448949|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64448950|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448952|NCT01494532|Levodopa|levodopa|mesh-list
64448953|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64448954|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
64448955|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448956|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448957|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448958|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64448959|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64448960|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
64448962|NCT02191397|Citalopram|citalopram|mesh-list
64448963|NCT02191397|Bupropion|bupropion|mesh-list
64448964|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64448965|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64448966|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448967|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448968|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448969|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
64448970|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448971|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64373041|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64373043|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373044|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
64373045|NCT04429893|Bupivacaine|bupivacaine|mesh-list
64373046|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
64373047|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
64373048|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373049|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373050|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
64373051|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373052|NCT04429893|Analgesics|analgesics|mesh-ancestor
64373053|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64373054|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
64373055|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64373056|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373057|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373061|NCT03290417|Vitamin D|vitamin d|mesh-list
64373088|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373089|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
64373090|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64373091|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64373092|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373093|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373094|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64373095|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64373096|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448972|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
64373099|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64373100|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64373101|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
64373102|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
64373103|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64373104|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64373105|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64449012|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64449013|NCT02170025|Riociguat|riociguat|mesh-list
64449014|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
64449015|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449016|NCT02169791|Ixazomib|ixazomib|mesh-list
64449017|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449019|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449020|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449021|NCT02216357|Ifetroban|ifetroban|mesh-list
64449040|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64449041|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64373108|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
64373109|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373110|NCT04156581|Dexamethasone|dexamethasone|mesh-list
64449043|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449044|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64449045|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64449046|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449047|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
64449048|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449051|NCT02216123|Tafenoquine|tafenoquine|mesh-list
64449052|NCT02216123|Amebicides|amebicides|mesh-ancestor
64373111|NCT04156581|Bupivacaine|bupivacaine|mesh-list
64373112|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373113|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
64373116|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373117|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449054|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64449055|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449056|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
64449057|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449058|NCT01490866|Leucovorin|leucovorin|mesh-list
64449059|NCT01490866|Bevacizumab|bevacizumab|mesh-list
64449060|NCT01490866|Fluorouracil|fluorouracil|mesh-list
64449061|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
64449062|NCT01490866|Axitinib|axitinib|mesh-list
64449063|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64449064|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449065|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64449066|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64449067|NCT01490866|Growth Substances|growth substances|mesh-ancestor
64373120|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373121|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64373122|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373123|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
64373124|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
64373125|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373126|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
64373127|NCT02983071|Fulvestrant|fulvestrant|mesh-list
64373128|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64373129|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373130|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64373131|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64449073|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449074|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
64449075|NCT01490866|Antidotes|antidotes|mesh-ancestor
64449076|NCT01490866|Protective Agents|protective agents|mesh-ancestor
64449077|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
64449078|NCT01490866|Vitamins|vitamins|mesh-ancestor
64449079|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
64449080|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64449081|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449082|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
64449083|NCT02215967|Fludarabine|fludarabine|mesh-list
64449084|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449085|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
64449086|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449087|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449088|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64449089|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
64449090|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449091|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449092|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64449093|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
64449094|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64449095|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
64449096|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449097|NCT02168387|Expectorants|expectorants|mesh-ancestor
64449098|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
64449099|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64449100|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
64449101|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449102|NCT02168387|Protective Agents|protective agents|mesh-ancestor
64373134|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373135|NCT03294395|Gentamicins|gentamicins|mesh-list
64373136|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
64373137|NCT03294395|Fosfomycin|fosfomycin|mesh-list
64373138|NCT03294395|Ertapenem|ertapenem|mesh-list
64373140|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373141|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64373142|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449118|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64449119|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64449120|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
64449121|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449122|NCT02167451|Maraviroc|maraviroc|mesh-list
64449123|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64449124|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64449125|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449126|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64449130|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64449132|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449133|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449134|NCT02101021|Gemcitabine|gemcitabine|mesh-list
64449135|NCT02101021|Paclitaxel|paclitaxel|mesh-list
64449136|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
64449137|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64449138|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449139|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
64449140|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
64373154|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
64373155|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373156|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373157|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373158|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
64373159|NCT04980105|Hormones|hormones|mesh-ancestor
64373160|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373161|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64373162|NCT04980105|Protective Agents|protective agents|mesh-ancestor
64373163|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64373164|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373165|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64373166|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
64373167|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
64373168|NCT04973319|Trastuzumab|trastuzumab|mesh-list
64373169|NCT04973319|Pertuzumab|pertuzumab|mesh-list
64373170|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64373171|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373172|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
64373173|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64449149|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
64449150|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449151|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64449152|NCT02116309|Indomethacin|indomethacin|mesh-list
64449153|NCT02116309|Epinephrine|epinephrine|mesh-list
64449154|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64449155|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64449156|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
64449157|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449158|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373175|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373177|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
64373178|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373179|NCT03289637|Vitamin D|vitamin d|mesh-list
64373180|NCT03289637|Vitamins|vitamins|mesh-ancestor
64373181|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
64449159|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449161|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64449162|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
64449163|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449164|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64449165|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
64449166|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
64449167|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
64449168|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64449169|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64449170|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64449171|NCT02116309|Analgesics|analgesics|mesh-ancestor
64449172|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
64449173|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449174|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64449175|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
64449176|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
64373182|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373183|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64373184|NCT04854837|Remdesivir|remdesivir|mesh-list
64373185|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
64373186|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373187|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
64373188|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373215|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
64373216|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373217|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373218|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64373219|NCT03293927|Narcotics|narcotics|mesh-ancestor
64373220|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64373221|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64449193|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449194|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449195|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
64449196|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449197|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64449198|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
64449199|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64449200|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
64449201|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373237|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
64373272|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64373273|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
64449216|NCT01490086|Aripiprazole|aripiprazole|mesh-list
64449217|NCT01490086|RP5063|rp5063|mesh-list
64449218|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
64449219|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64449220|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64449221|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64449222|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449223|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449224|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
64449225|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
64449226|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373274|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373303|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373304|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373305|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64449228|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64373317|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64449243|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449244|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449245|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
64449246|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
64449247|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449248|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449250|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64449251|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
64449252|NCT02100475|Liraglutide|liraglutide|mesh-list
64449253|NCT02100475|Xultophy|xultophy|mesh-list
64373318|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373334|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64373335|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64373336|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64373337|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373338|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373339|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373340|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64373341|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
64373342|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373343|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373344|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
64373345|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
64449254|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64449255|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449256|NCT02100475|Incretins|incretins|mesh-ancestor
64449257|NCT02100475|Hormones|hormones|mesh-ancestor
64424545|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64449277|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
64449278|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64373347|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
64373348|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373349|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373351|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64449279|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
64449280|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
64449282|NCT02070757|Tazobactam|tazobactam|mesh-list
64449283|NCT02070757|Ceftolozane|ceftolozane|mesh-list
64449284|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64449285|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64449286|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449340|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64449341|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64449342|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449343|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449344|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
64449345|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449346|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64449347|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64449348|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
64449349|NCT04408144|Progestins|progestins|mesh-ancestor
64449350|NCT04408144|Hormones|hormones|mesh-ancestor
64449351|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449352|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449353|NCT01449682|Dexamethasone|dexamethasone|mesh-list
64449354|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
64449355|NCT01449682|BB 1101|bb 1101|mesh-list
64449356|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424546|NCT01646385|Analgesics|analgesics|mesh-ancestor
64373360|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373361|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373362|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373363|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373364|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64373365|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373366|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373367|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64373368|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
64373369|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373370|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
64449358|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
64449359|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449360|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449361|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449362|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
64449364|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449365|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64449366|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449367|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
64449368|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449369|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449370|NCT01831791|Dutasteride|dutasteride|mesh-list
64449371|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64449372|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64449373|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449374|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449375|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
64449376|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449377|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449378|NCT01857531|Nicotine|nicotine|mesh-list
64449379|NCT01857531|Ganaxolone|ganaxolone|mesh-list
64449380|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64449381|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
64373373|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
64373374|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373375|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373376|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
64373377|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
64373378|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
64373401|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373402|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64373403|NCT03291821|Cetrorelix|cetrorelix|mesh-list
64373404|NCT03291821|Menotropins|menotropins|mesh-list
64373405|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64373406|NCT03291821|Ganirelix|ganirelix|mesh-list
64373407|NCT03291821|Hormones|hormones|mesh-ancestor
64373408|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373409|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373410|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
64449382|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449383|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449384|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64449385|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64449386|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
64449388|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373419|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
64373421|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64373422|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
64373423|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64373424|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
64373425|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449402|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449403|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64449404|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64449405|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64449406|NCT01831089|Growth Substances|growth substances|mesh-ancestor
64449407|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449408|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
64449409|NCT02111785|Dexamethasone|dexamethasone|mesh-list
64449410|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449411|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
64449412|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
64449413|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449414|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449415|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449416|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
64449418|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373429|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64373431|NCT02460341|Ondansetron|ondansetron|mesh-list
64373432|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
64373433|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
64449419|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64449420|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449422|NCT02068495|Candesartan|candesartan|mesh-list
64449423|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
64449424|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64449425|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64449426|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64449427|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449428|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64449438|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449439|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373452|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373453|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373455|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64373456|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
64373457|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373460|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
64373461|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64373462|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64449453|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
64449454|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64449456|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449457|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373465|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373466|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
64373467|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373468|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373469|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64373470|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373471|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
64373472|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
64449479|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64449480|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
64449481|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64449494|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64449495|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
64449496|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64449497|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449498|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64449499|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
64449500|NCT02212379|Etravirine|etravirine|mesh-list
64449501|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64449502|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64449503|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
64449504|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449505|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64373476|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64373478|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373479|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373480|NCT02151981|Osimertinib|osimertinib|mesh-list
64373481|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373482|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64373483|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373484|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373485|NCT02445703|Vaccines|vaccines|mesh-list
64449513|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64449529|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
64449530|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64449531|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
64449532|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449533|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64449534|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64449535|NCT04756505|Growth Substances|growth substances|mesh-ancestor
64449536|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
64449537|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449538|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
64449539|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64449540|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449541|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64449542|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64449543|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449544|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449545|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449547|NCT02162771|Prednisolone|prednisolone|mesh-list
64449548|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
64449549|NCT02162771|Rituximab|rituximab|mesh-list
64449550|NCT02162771|Vincristine|vincristine|mesh-list
64449551|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449552|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
64449553|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449555|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64373488|NCT03194659|Choline|choline|mesh-list
64373489|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
64373490|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64373491|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
64373492|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373493|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373494|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64373495|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
64373496|NCT02445547|Hormones|hormones|mesh-list
64373518|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
64373519|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373520|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64373521|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64373522|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373523|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373524|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
64373525|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
64373526|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373527|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373528|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64373529|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64373530|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
64373531|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64373532|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64373533|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64449574|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449575|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449576|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
64449577|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449578|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64449579|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
64449580|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449582|NCT01830543|Vitamin K|vitamin k|mesh-list
64449583|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
64449584|NCT01830543|Clopidogrel|clopidogrel|mesh-list
64449585|NCT01830543|Ticagrelor|ticagrelor|mesh-list
64449586|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64449587|NCT01830543|Vitamins|vitamins|mesh-ancestor
64449588|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
64449592|NCT01830543|Analgesics|analgesics|mesh-ancestor
64373538|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64373539|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373541|NCT03284645|Lamivudine|lamivudine|mesh-list
64373542|NCT03284645|Zidovudine|zidovudine|mesh-list
64449599|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449600|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64449601|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64449602|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449603|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
64449604|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64449605|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64449606|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64449607|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
64449608|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449622|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
64449623|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
64449624|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
64449625|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449626|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64449627|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
64449628|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
64449629|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365896|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
64449630|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449631|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449632|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
64449633|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449636|NCT02109133|Neostigmine|neostigmine|mesh-list
64449637|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64373546|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373547|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64373548|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64373549|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373550|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373551|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64373552|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64373553|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
64373554|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64373555|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64373593|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373594|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373595|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373596|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373597|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
64373598|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
64373599|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64373600|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
64373601|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449655|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449656|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
64449657|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64449658|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64449659|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449660|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64449661|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64449662|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64373604|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
64373605|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
64373606|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373607|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64373609|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64373626|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64373627|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
64373628|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
64373629|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449663|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449664|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449665|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
64449666|NCT02095951|Ethanol|ethanol|mesh-list
64449667|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64449668|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449669|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449670|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449671|NCT02095873|Resveratrol|resveratrol|mesh-list
64449672|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
64449679|NCT02094937|Xhance|xhance|mesh-list
64449732|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64373630|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373631|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373632|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
64373633|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64373634|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
64373635|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377853|NCT04833777|Lidocaine|lidocaine|mesh-list
64373636|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373637|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64449733|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64449734|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
64449735|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
64449736|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449737|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64449738|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64449739|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449740|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449741|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64449742|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64449743|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
64373641|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64373642|NCT02458547|Bupivacaine|bupivacaine|mesh-list
64373644|NCT02458547|Desflurane|desflurane|mesh-list
64373645|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
64373646|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
64373647|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449744|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
64449745|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
64449746|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449747|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64449748|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
64449749|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
64449750|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64449751|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
64373649|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
64373650|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373651|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64373652|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64373653|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
64373654|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64449770|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449772|NCT02159807|Bupivacaine|bupivacaine|mesh-list
64449773|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
64449774|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
64449775|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64449776|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449777|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
64449778|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449779|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64449781|NCT02159807|Analgesics|analgesics|mesh-ancestor
64449782|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64449783|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64449784|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
64449785|NCT02183675|Amlodipine|amlodipine|mesh-list
64449786|NCT02183675|Telmisartan|telmisartan|mesh-list
64449787|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64449788|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64449789|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64449790|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64449791|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64449792|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449793|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64373661|NCT04978155|Anesthetics|anesthetics|mesh-list
64373662|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373663|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449815|NCT02182895|Saxagliptin|saxagliptin|mesh-list
64449816|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64449817|NCT02182895|Incretins|incretins|mesh-ancestor
64449818|NCT02182895|Hormones|hormones|mesh-ancestor
64449819|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449830|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
64449831|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449832|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64373665|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373666|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373667|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449861|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64449862|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
64449863|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449864|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449865|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449866|NCT02047045|Laxatives|laxatives|mesh-ancestor
64449867|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64449868|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64449912|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64449913|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
64449914|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373668|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64373698|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64449915|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449916|NCT04754399|Cannabidiol|cannabidiol|mesh-list
64449917|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
64449918|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
64449919|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
64449920|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
64449921|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373701|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373702|NCT04369469|Ravulizumab|ravulizumab|mesh-list
64373703|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64373704|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373705|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
64373706|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373708|NCT03269591|Progesterone|progesterone|mesh-list
64373709|NCT03269591|Progestins|progestins|mesh-ancestor
64373711|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373712|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373713|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64373747|NCT03988205|Cytarabine|cytarabine|mesh-list
64449929|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64449930|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449931|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449932|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
64449933|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449934|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
64449936|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64373786|NCT03278483|Isoniazid|isoniazid|mesh-list
64373787|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64373788|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
64373789|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64373790|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373791|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
64373792|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64449956|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64449957|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
64449958|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449959|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449960|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449961|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64449962|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64373794|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373796|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64373797|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64373824|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64373825|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64373826|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373827|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64373828|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64373829|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
64373830|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449966|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
64449967|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64449968|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64449969|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64449970|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449971|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
64373839|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373840|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
64373841|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64373842|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64373843|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64373846|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373847|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64373848|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64373876|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373877|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373878|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64373879|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64449977|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64449978|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64449979|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64449980|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449981|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
64449982|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449983|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
64449984|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449986|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64449987|NCT01827111|Ipilimumab|ipilimumab|mesh-list
64449988|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64449989|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449990|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
64449991|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
64449992|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
64449993|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449994|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64449995|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64449996|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
64449997|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64449998|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
64373882|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64373884|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373885|NCT05074589|Leucovorin|leucovorin|mesh-list
64373886|NCT05074589|Fluorouracil|fluorouracil|mesh-list
64373887|NCT05074589|Irinotecan|irinotecan|mesh-list
64373888|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
64373889|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
64373890|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373921|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373934|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64373961|NCT02458157|Diuretics|diuretics|mesh-ancestor
64373962|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
64373963|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373964|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64373965|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450015|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64450016|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
64450017|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
64450018|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64450019|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
64450020|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450021|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450022|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
64450023|NCT04418089|Simvastatin|simvastatin|mesh-list
64450024|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64450025|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64450026|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
64450027|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450028|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64374007|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
64374008|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64374009|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374010|NCT03259607|Nicotine|nicotine|mesh-list
64374011|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64374012|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
64450032|NCT01825941|Promethazine|promethazine|mesh-list
64450033|NCT01825941|Metoclopramide|metoclopramide|mesh-list
64450034|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64450035|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64450036|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450037|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450038|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
64450039|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
64450040|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
64450042|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
64450043|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
64450044|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64450045|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64374016|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64374017|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
64374018|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374019|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374020|NCT02456129|Itraconazole|itraconazole|mesh-list
64374021|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
64374022|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450046|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
64450047|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
64450050|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64450052|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
64450053|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64450054|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64450055|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
64450056|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
64450058|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450059|NCT02180165|Voriconazole|voriconazole|mesh-list
64450060|NCT02180165|Posaconazole|posaconazole|mesh-list
64450061|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
64450062|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450063|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64450064|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64450065|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450067|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64450068|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
64374026|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374027|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64374028|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
64374029|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450077|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64450078|NCT02155985|Analgesics|analgesics|mesh-ancestor
64450079|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
64374073|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64374078|NCT04976673|Hormones|hormones|mesh-ancestor
64374079|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374081|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64374082|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
64374083|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374117|NCT03257423|Metronidazole|metronidazole|mesh-list
64374118|NCT03257423|Levofloxacin|levofloxacin|mesh-list
64374120|NCT03257423|Ertapenem|ertapenem|mesh-list
64374121|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374142|NCT03262727|Norethindrone|norethindrone|mesh-list
64374143|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
64374144|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
64374146|NCT03262727|Estrogens|estrogens|mesh-ancestor
64374147|NCT03262727|Hormones|hormones|mesh-ancestor
64374148|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374149|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450086|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450088|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64450089|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450091|NCT02155829|Riluzole|riluzole|mesh-list
64450092|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
64450093|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64374167|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374168|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374169|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374170|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
64374171|NCT04975971|Hormones|hormones|mesh-ancestor
64450095|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450096|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450097|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450098|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64450099|NCT02155829|Protective Agents|protective agents|mesh-ancestor
64450100|NCT02178995|Methylphenidate|methylphenidate|mesh-list
64450101|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64450102|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450103|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64450104|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64450105|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450106|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450107|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
64450114|NCT02154347|Mitiglinide|mitiglinide|mesh-list
64450115|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450116|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450117|NCT01627067|Metformin|metformin|mesh-list
64450118|NCT01627067|Everolimus|everolimus|mesh-list
64450119|NCT01627067|Exemestane|exemestane|mesh-list
64450120|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450121|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450122|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450123|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64374172|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374173|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64374174|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374176|NCT03062163|Resveratrol|resveratrol|mesh-list
64374177|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
64374206|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64374207|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64374208|NCT03261635|Analgesics|analgesics|mesh-ancestor
64374209|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
64374210|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374211|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374212|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450125|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64450126|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64450127|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450133|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64450134|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
64450135|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450136|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450137|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64450138|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
64450139|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
64450140|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
64450141|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64450142|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64450143|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64374215|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64374216|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64374218|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374219|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
64374220|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64374221|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64450176|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450177|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64450178|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64450179|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450180|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
64450181|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
64450182|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450183|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
64450184|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
64450185|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64450186|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
64450187|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450188|NCT02125877|Deferasirox|deferasirox|mesh-list
64450189|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64374260|NCT03256487|Narcotics|narcotics|mesh-ancestor
64374261|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374262|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374285|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64374286|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64450191|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
64450192|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450193|NCT01598987|Cyclosporine|cyclosporine|mesh-list
64450194|NCT01598987|Everolimus|everolimus|mesh-list
64450195|NCT01598987|Tacrolimus|tacrolimus|mesh-list
64450196|NCT01598987|Cyclosporins|cyclosporins|mesh-list
64450197|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450198|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
64450199|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450200|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64450201|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450202|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450203|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
64450204|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450205|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
64450206|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450207|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450208|NCT02062879|Ketamine|ketamine|mesh-list
64450213|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450214|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64450215|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64450216|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
64450217|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
64450218|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450219|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64450220|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64374288|NCT03060603|Hematinics|hematinics|mesh-ancestor
64374290|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374291|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64374292|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64374293|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374294|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374300|NCT04974723|Abaloparatide|abaloparatide|mesh-list
64374301|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64374302|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374303|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64374304|NCT03060681|Bupivacaine|bupivacaine|mesh-list
64374305|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
64374306|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
64374307|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374308|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374309|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
64374331|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374332|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64374333|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450264|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
64450265|NCT01824693|Tacrolimus|tacrolimus|mesh-list
64450267|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
64450268|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374338|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64374339|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
64374340|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
64374341|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374342|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374347|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64374348|NCT04963257|Aripiprazole|aripiprazole|mesh-list
64374349|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
64374350|NCT04963257|Sertraline|sertraline|mesh-list
64374351|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
64374353|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64450269|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450270|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64450271|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
64450272|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450273|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450274|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64450275|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450277|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64450278|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450279|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64450280|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64450281|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
64450282|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450283|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450284|NCT02176655|Aspirin|aspirin|mesh-list
64450285|NCT02176655|Sumatriptan|sumatriptan|mesh-list
64450286|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64450288|NCT02176655|Analgesics|analgesics|mesh-ancestor
64450289|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
64450290|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374354|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64374355|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374356|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374357|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
64374358|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
64374359|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374361|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64374362|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64374363|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
64374364|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64374365|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64374366|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64374367|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64374368|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64374369|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64374370|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64374371|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64374372|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64450291|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450292|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450293|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450294|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64450295|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64450297|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64374375|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374376|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64374378|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
64374379|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374380|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
64374381|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374382|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374383|NCT04953741|Fluticasone|fluticasone|mesh-list
64374385|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374386|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64374412|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374413|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374414|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
64374415|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374416|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64374417|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64374418|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
64374419|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374433|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64374434|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64374435|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
64374436|NCT03252665|Vitamins|vitamins|mesh-ancestor
64374471|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64374472|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64374473|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374474|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64374475|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64374476|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
64374477|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64374507|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374508|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374509|NCT04964583|Azithromycin|azithromycin|mesh-list
64374510|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
64374511|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374512|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374515|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64374516|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374517|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374518|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64374519|NCT03251417|Irinotecan|irinotecan|mesh-list
64374520|NCT03251417|Apatinib|apatinib|mesh-list
64374521|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64374522|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64374523|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374524|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374525|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377882|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64374526|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374527|NCT04961931|Empagliflozin|empagliflozin|mesh-list
64374528|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64374529|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374530|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64374560|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64374561|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64374562|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64374563|NCT04951713|Clarithromycin|clarithromycin|mesh-list
64374565|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374566|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374567|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64374568|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374569|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374575|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64374599|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374603|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64374605|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374606|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374607|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374608|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64374609|NCT04950933|Protective Agents|protective agents|mesh-ancestor
64374610|NCT04961307|Trastuzumab|trastuzumab|mesh-list
64450454|NCT02060383|Hormones|hormones|mesh-ancestor
64374615|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374616|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374617|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
64374619|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374620|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64374621|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
64374622|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374623|NCT04415853|Irinotecan|irinotecan|mesh-list
64374624|NCT04415853|Tegafur|tegafur|mesh-list
64374636|NCT03059277|Aflibercept|aflibercept|mesh-list
64374637|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64374638|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64374639|NCT03059277|Growth Substances|growth substances|mesh-ancestor
64374640|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374641|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
64374643|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
64374644|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64374645|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
64374648|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64374650|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374651|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374652|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64374654|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64374655|NCT00700817|Liraglutide|liraglutide|mesh-list
64374656|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64374657|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374658|NCT00700817|Incretins|incretins|mesh-ancestor
64374659|NCT00700817|Hormones|hormones|mesh-ancestor
64374660|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374661|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64374662|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
64374663|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374665|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
64374666|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
64374667|NCT04960293|Coagulants|coagulants|mesh-ancestor
64374669|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374671|NCT04948125|Apatinib|apatinib|mesh-list
64374672|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374673|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374674|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374675|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374676|NCT02455115|Chromium|chromium|mesh-list
64374677|NCT02455115|Norepinephrine|norepinephrine|mesh-list
64374678|NCT02455115|Edetic Acid|edetic acid|mesh-list
64450545|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64450546|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64450547|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64450549|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64450550|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450551|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450552|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
64450553|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450554|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450555|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
64450556|NCT02151149|Paclitaxel|paclitaxel|mesh-list
64450557|NCT02151149|Carboplatin|carboplatin|mesh-list
64450558|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64450559|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374682|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
64374683|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374684|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374685|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374686|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
64374687|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
64374706|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374707|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374709|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
64374710|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64450564|NCT02150213|Dexamethasone|dexamethasone|mesh-list
64450565|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450566|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
64450567|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
64450568|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450569|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450570|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64450571|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
64450573|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450574|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64450575|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450576|NCT02091362|Metformin|metformin|mesh-list
64450577|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450578|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374718|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374721|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
64374722|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
64374723|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64374724|NCT03250481|Narcotics|narcotics|mesh-ancestor
64374725|NCT03250481|Analgesics|analgesics|mesh-ancestor
64374726|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
64374727|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374728|NCT04947267|Epinephrine|epinephrine|mesh-list
64374729|NCT04947267|Mepivacaine|mepivacaine|mesh-list
64374730|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64374731|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64374732|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
64374733|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450601|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450602|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450603|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
64374735|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374736|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64374737|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64374738|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
64374739|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374740|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64374741|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
64374743|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
64374744|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64374745|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
64374746|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
64374747|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374774|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
64374775|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
64374776|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
64374777|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374779|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64374780|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374781|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374782|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64374783|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
64374784|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
64374785|NCT04947189|Dexamethasone|dexamethasone|mesh-list
64374786|NCT04947189|Docetaxel|docetaxel|mesh-list
64374787|NCT04947189|Seviteronel|seviteronel|mesh-list
64450604|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450605|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374795|NCT04947189|Hormones|hormones|mesh-ancestor
64374796|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374797|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64374798|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374799|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
64450648|NCT02111096|Incretins|incretins|mesh-ancestor
64450649|NCT02111096|Hormones|hormones|mesh-ancestor
64450650|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450651|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64450652|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
64450653|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450654|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450655|NCT02110706|Rituximab|rituximab|mesh-list
64450656|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64450657|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450658|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
64450659|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450660|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450661|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
64450662|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64450663|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
64450664|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450665|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
64374861|NCT04938453|Nintedanib|nintedanib|mesh-list
64374862|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374863|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374864|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374865|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374866|NCT03247283|Linrodostat|linrodostat|mesh-list
64374867|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374868|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374870|NCT04938297|Lenalidomide|lenalidomide|mesh-list
64374871|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
64450666|NCT02110238|Protective Agents|protective agents|mesh-ancestor
64450667|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64450668|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
64450669|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450670|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
64450671|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64450672|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64450673|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450674|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450675|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
64450676|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450677|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450678|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64450679|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450680|NCT02107274|Azithromycin|azithromycin|mesh-list
64450681|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450682|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450683|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
64450684|NCT02173769|Olodaterol|olodaterol|mesh-list
64450685|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64450686|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
64450687|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450688|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450689|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64374891|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374892|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64374893|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64374894|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
64374895|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64374897|NCT02625909|Velpatasvir|velpatasvir|mesh-list
64374898|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
64374899|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374900|NCT03246659|Polygeline|polygeline|mesh-list
64374901|NCT03246659|Gastrins|gastrins|mesh-list
64374902|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
64374903|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
64374904|NCT03246659|Hormones|hormones|mesh-ancestor
64450690|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
64450691|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
64450692|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64450693|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
64450694|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450695|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450697|NCT02121509|Linagliptin|linagliptin|mesh-list
64450698|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64450699|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450700|NCT02121509|Incretins|incretins|mesh-ancestor
64450701|NCT02121509|Hormones|hormones|mesh-ancestor
64450702|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450703|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64450704|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
64374905|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374906|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374908|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64374909|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
64374910|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374911|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374912|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64374913|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
64374914|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
64374915|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64374916|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
64450705|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450706|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450707|NCT02149199|Budesonide|budesonide|mesh-list
64450708|NCT02149199|Terbutaline|terbutaline|mesh-list
64450709|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
64450710|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450711|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64450712|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
64450713|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450725|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450726|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
64450727|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
64450728|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64450729|NCT02120417|Capecitabine|capecitabine|mesh-list
64450730|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450731|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
64450732|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450733|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450734|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
64450735|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64450736|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64450737|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64450738|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450739|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450740|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
64450741|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450742|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374918|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374920|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64374921|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
64450759|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450760|NCT02058290|Morphine|morphine|mesh-list
64450761|NCT02058290|Bupivacaine|bupivacaine|mesh-list
64450762|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
64450763|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
64450764|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450765|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450766|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
64450767|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450768|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64450769|NCT02058290|Narcotics|narcotics|mesh-ancestor
64450770|NCT02058290|Analgesics|analgesics|mesh-ancestor
64450771|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
64450772|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64374932|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374933|NCT04944381|Vaccines|vaccines|mesh-list
64374934|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
64374935|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374936|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
64374937|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374938|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374939|NCT03245333|Hormones|hormones|mesh-list
64374940|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374941|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374942|NCT04958187|Mitogens|mitogens|mesh-list
64374943|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
64374944|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374945|NCT03244319|Warfarin|warfarin|mesh-list
64374946|NCT03244319|Edoxaban|edoxaban|mesh-list
64374947|NCT03244319|Anticoagulants|anticoagulants|mesh-list
64374948|NCT03244319|Coagulants|coagulants|mesh-list
64374949|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64374974|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374975|NCT02623959|Doxycycline|doxycycline|mesh-list
64374976|NCT02623959|Fentanyl|fentanyl|mesh-list
64374977|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64374978|NCT02623959|Narcotics|narcotics|mesh-ancestor
64374979|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374981|NCT02623959|Analgesics|analgesics|mesh-ancestor
64450802|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450803|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
64450804|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374989|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374991|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64374992|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64374993|NCT03242993|Folic Acid|folic acid|mesh-list
64374994|NCT03242993|Hematinics|hematinics|mesh-ancestor
64374995|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
64374996|NCT03242993|Vitamins|vitamins|mesh-ancestor
64374997|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
64374998|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374999|NCT04487093|Vaccines|vaccines|mesh-list
64375000|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
64375001|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424547|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
64375028|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375029|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450806|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64450807|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64450808|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450809|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64450810|NCT01625000|Risperidone|risperidone|mesh-list
64450811|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64450812|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
64450813|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375036|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375038|NCT03241901|Artemether|artemether|mesh-list
64375039|NCT03241901|Primaquine|primaquine|mesh-list
64375040|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64450814|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450815|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450816|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64450817|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64450818|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450819|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64450820|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64450821|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
64450822|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64450823|NCT02057198|Metronidazole|metronidazole|mesh-list
64450824|NCT02057198|Vancomycin|vancomycin|mesh-list
64450825|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
64450826|NCT02057198|Amebicides|amebicides|mesh-list
64450827|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450828|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64450829|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64450830|NCT02056340|Atorvastatin|atorvastatin|mesh-list
64375043|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64375044|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375046|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375047|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375048|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64375051|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375052|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64375053|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375054|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375055|NCT03241043|Tacrolimus|tacrolimus|mesh-list
64375056|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375057|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
64375058|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375059|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64375060|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375061|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375062|NCT02453867|Tacrolimus|tacrolimus|mesh-list
64375063|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375064|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
64375065|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375066|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64450831|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64450832|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64450833|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
64450834|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450835|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64450836|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64450837|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450838|NCT04726592|Ketoprofen|ketoprofen|mesh-list
64450839|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
64450840|NCT04726592|Metoclopramide|metoclopramide|mesh-list
64450841|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
64450842|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
64450843|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450856|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450857|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64450858|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450859|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
64450860|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64450861|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64450862|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450863|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64450864|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
64450866|NCT02046122|Cytarabine|cytarabine|mesh-list
64450867|NCT02046122|Idarubicin|idarubicin|mesh-list
64450868|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450869|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
64450870|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450871|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450872|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
64450873|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450882|NCT02080832|Citalopram|citalopram|mesh-list
64450883|NCT02080832|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64450884|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64450885|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64450886|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375071|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
64375072|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375073|NCT03239327|Alprostadil|alprostadil|mesh-list
64375074|NCT03239327|Misoprostol|misoprostol|mesh-list
64375075|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64375076|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
64375077|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64375078|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375079|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64375081|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
64375082|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64375083|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
64375084|NCT03239327|Urological Agents|urological agents|mesh-ancestor
64375085|NCT04930185|Vaccines|vaccines|mesh-list
64375086|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
64450887|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450888|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
64450889|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450891|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
64450892|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64450893|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64450894|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64450895|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
64450896|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
64450897|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450898|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64450899|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64450900|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
64375090|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375092|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64375093|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
64375102|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
64450902|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64450903|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450904|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64450905|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450906|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450907|NCT02078102|Meloxicam|meloxicam|mesh-list
64450908|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450909|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64450910|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64450911|NCT02078102|Analgesics|analgesics|mesh-ancestor
64450912|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
64450913|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450915|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450916|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64450917|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64450918|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450919|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450920|NCT02054702|Aripiprazole|aripiprazole|mesh-list
64450921|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
64450922|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
64450923|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64375108|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64375109|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64450929|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
64450930|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450931|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450932|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64450933|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64450934|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
64450935|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64450936|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64450937|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64450938|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64450939|NCT02044094|Buprenorphine|buprenorphine|mesh-list
64450940|NCT02044094|Hydromorphone|hydromorphone|mesh-list
64450941|NCT02044094|Naloxone|naloxone|mesh-list
64375147|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375148|NCT04485845|Metformin|metformin|mesh-list
64375149|NCT04485845|Vildagliptin|vildagliptin|mesh-list
64375150|NCT04485845|Captopril|captopril|mesh-list
64375151|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64375152|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375153|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64375154|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
64375155|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450943|NCT02044094|Narcotics|narcotics|mesh-ancestor
64450944|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450945|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450946|NCT02044094|Analgesics|analgesics|mesh-ancestor
64450947|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
64450948|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450949|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64450952|NCT02053610|Chlorambucil|chlorambucil|mesh-list
64450953|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64450954|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450955|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
64375159|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64375160|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64375161|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64375162|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375163|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450956|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450957|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450958|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64450959|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
64450960|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450961|NCT02075606|Lanreotide|lanreotide|mesh-list
64450962|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450965|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
64375195|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64375196|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
64375198|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375199|NCT03235973|Fludarabine|fludarabine|mesh-list
64375200|NCT03235973|Busulfan|busulfan|mesh-list
64375201|NCT03235973|Cladribine|cladribine|mesh-list
64375203|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450966|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450967|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450968|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64450969|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64450970|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
64450972|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450973|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64450974|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64450975|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450976|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450977|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
64450978|NCT04700696|Narcotics|narcotics|mesh-ancestor
64450979|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450980|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450981|NCT04700696|Analgesics|analgesics|mesh-ancestor
64450982|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
64450983|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450984|NCT02052440|Baclofen|baclofen|mesh-list
64450985|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64375209|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64375210|NCT02453087|Rituximab|rituximab|mesh-list
64375211|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
64375212|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64450986|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450987|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64450988|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450989|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64450990|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
64450991|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
64450992|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450993|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450994|NCT02049944|Cefazolin|cefazolin|mesh-list
64450995|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450996|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450997|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
64450998|NCT01621880|Bevacizumab|bevacizumab|mesh-list
64375214|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
64375215|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375241|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64375242|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
64375244|NCT05269030|Hormones|hormones|mesh-ancestor
64375245|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375246|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64375247|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451010|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451011|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
64451012|NCT01621880|Hormones|hormones|mesh-ancestor
64451013|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451014|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64451015|NCT01621880|Protective Agents|protective agents|mesh-ancestor
64451016|NCT01621568|Sunitinib|sunitinib|mesh-list
64451017|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451018|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64451019|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64451020|NCT01621568|Growth Substances|growth substances|mesh-ancestor
64451021|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451022|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
64451023|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64451024|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451025|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451026|NCT02041429|Paclitaxel|paclitaxel|mesh-list
64451027|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64451028|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451029|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
64375252|NCT03057015|Dexamethasone|dexamethasone|mesh-list
64375253|NCT03057015|Clonidine|clonidine|mesh-list
64375254|NCT03057015|Epinephrine|epinephrine|mesh-list
64375255|NCT03057015|Ropivacaine|ropivacaine|mesh-list
64375256|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64375258|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
64375259|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375260|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375261|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451035|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451036|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
64451037|NCT02083783|Amphetamine|amphetamine|mesh-list
64451038|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64451039|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451040|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
64451041|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
64451042|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451043|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
64451044|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451045|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451046|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
64375262|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
64375264|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375265|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64375266|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375267|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
64375268|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
64375269|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375298|NCT04922151|Ranibizumab|ranibizumab|mesh-list
64375299|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64375300|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64375301|NCT04922151|Growth Substances|growth substances|mesh-ancestor
64375302|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375303|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
64375304|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375305|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
64375306|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
64375307|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64375308|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
64375309|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375310|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375311|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64375312|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
64375313|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64375314|NCT04920747|Taxane|taxane|mesh-list
64451075|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451076|NCT02081599|Insulin|insulin|mesh-list
64451077|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451078|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451079|NCT02038153|Lenalidomide|lenalidomide|mesh-list
64451080|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
64451081|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451082|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64451083|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64451084|NCT02038153|Growth Substances|growth substances|mesh-ancestor
64451085|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
64451086|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451088|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64451089|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64375317|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64375318|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
64375349|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
64375350|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375351|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64375352|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64375353|NCT04920669|Analgesics|analgesics|mesh-ancestor
64375354|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64375355|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64375356|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64375357|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
64375358|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375359|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375360|NCT04926753|Fluorouracil|fluorouracil|mesh-list
64375381|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
64375382|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375383|NCT04912167|Valsartan|valsartan|mesh-list
64375384|NCT04912167|Enalapril|enalapril|mesh-list
64375385|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64375386|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64375387|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64375388|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64375389|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375390|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64375391|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451109|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451110|NCT02036515|Metformin|metformin|mesh-list
64451111|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64451112|NCT02036515|Glimepiride|glimepiride|mesh-list
64451114|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451115|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451116|NCT02036515|Incretins|incretins|mesh-ancestor
64451118|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451123|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64451124|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451125|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
64451126|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64451127|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
64451128|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64451129|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451130|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
64451131|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64451132|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451133|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64451134|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
64375407|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375408|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
64375409|NCT02158936|Azacitidine|azacitidine|mesh-list
64375410|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64375411|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
64375412|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375438|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64375440|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
64375441|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
64375442|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64375443|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
64451136|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64451137|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
64451138|NCT02034799|Coagulants|coagulants|mesh-ancestor
64451139|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64451140|NCT02057575|Latanoprost|latanoprost|mesh-list
64451141|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64451142|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64451143|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
64451144|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451146|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64451147|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
64451148|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64451149|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451150|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451151|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451152|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
64451153|NCT02075515|Vaccines|vaccines|mesh-list
64451154|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
64451155|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451156|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
64451157|NCT04682587|Avelumab|avelumab|mesh-list
64451158|NCT04682587|Axitinib|axitinib|mesh-list
64451160|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451161|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64451162|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451163|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451164|NCT04417543|Memantine|memantine|mesh-list
64451165|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64451166|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64451167|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
64451168|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451169|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451170|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451171|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64451179|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64451180|NCT02020616|Incretins|incretins|mesh-ancestor
64451181|NCT02020616|Hormones|hormones|mesh-ancestor
64451182|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451183|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64451184|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64451185|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451186|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451187|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
64451188|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375492|NCT04918953|Hormones|hormones|mesh-ancestor
64375493|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375494|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64451189|NCT01622660|Gemcitabine|gemcitabine|mesh-list
64451190|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64451191|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
64451192|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451193|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451194|NCT01622660|Antiviral Agents|antiviral agents|mesh-ancestor
64451195|NCT01622660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451196|NCT01622660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451197|NCT01622660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451198|NCT01622660|Immunologic Factors|immunologic factors|mesh-ancestor
64451200|NCT04697498|Anesthetics|anesthetics|mesh-list
64451201|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451202|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451203|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
64451204|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451205|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
64451206|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375497|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375498|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64375499|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64375501|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
64375502|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64451207|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451208|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64451209|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
64451210|NCT02040428|Coagulants|coagulants|mesh-ancestor
64451211|NCT02018822|Urethane|urethane|mesh-list
64451212|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451213|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64451214|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
64451215|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
64451216|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451217|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451218|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
64451219|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
64451220|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451221|NCT02022007|Metformin|metformin|mesh-list
64451222|NCT02022007|Saxagliptin|saxagliptin|mesh-list
64451223|NCT02022007|Biguanides|biguanides|mesh-list
64451224|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64451225|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451226|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451228|NCT02022007|Hormones|hormones|mesh-ancestor
64451229|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451230|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451231|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451232|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451233|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
64375505|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64375506|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64375507|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64375525|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64375526|NCT03056079|Growth Substances|growth substances|mesh-ancestor
64375527|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375528|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
64451234|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64451235|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
64451236|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64451237|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451238|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451239|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451240|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
64451241|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
64451242|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
64451243|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
64451244|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
64451245|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451246|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451247|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451248|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64451249|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451251|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64451252|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451253|NCT02019979|Metformin|metformin|mesh-list
64451254|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64375529|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375530|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64375531|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64375532|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64375533|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375534|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375535|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64451255|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451256|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
64451257|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64451258|NCT02019667|Protective Agents|protective agents|mesh-ancestor
64451259|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451260|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
64451262|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451263|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451264|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
64451265|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
64451266|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64451267|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64451275|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451276|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
64451277|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
64451278|NCT02019277|Paclitaxel|paclitaxel|mesh-list
64451279|NCT02019277|Docetaxel|docetaxel|mesh-list
64375537|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375538|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
64375539|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375540|NCT02157376|Esomeprazole|esomeprazole|mesh-list
64375541|NCT02157376|Cimetidine|cimetidine|mesh-list
64375542|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64375543|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375544|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64451280|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64451281|NCT02019277|Trastuzumab|trastuzumab|mesh-list
64451282|NCT02019277|Pertuzumab|pertuzumab|mesh-list
64451283|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64451284|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451285|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
64451286|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
64451287|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
64451288|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451289|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64451290|NCT01823835|Palbociclib|palbociclib|mesh-list
64451291|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451292|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64375546|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375547|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64375548|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
64451545|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451546|NCT01628393|Ozanimod|ozanimod|mesh-list
64451547|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64451548|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451549|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451550|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
64451551|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451552|NCT01846221|Clonidine|clonidine|mesh-list
64451553|NCT01846221|Fentanyl|fentanyl|mesh-list
64451554|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64451555|NCT01846221|Narcotics|narcotics|mesh-ancestor
64451556|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451586|NCT01844895|Abatacept|abatacept|mesh-list
64451587|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64451588|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451589|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451590|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451591|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
64451592|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451599|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451600|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
64451601|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451602|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451603|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64451604|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451606|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
64451607|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
64451608|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
64451609|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451610|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451611|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
64451612|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375604|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
64375605|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375606|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375607|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375608|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
64375609|NCT02121262|Hormones|hormones|mesh-ancestor
64375610|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375611|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64375643|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375645|NCT04902027|Analgesics|analgesics|mesh-ancestor
64375646|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
64375647|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375648|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375649|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375650|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64375651|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64375652|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375653|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375654|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
64375655|NCT04902105|Valproic Acid|valproic acid|mesh-list
64375685|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375686|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64375687|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
64375688|NCT02120794|Insulin|insulin|mesh-list
64375689|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64375690|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375691|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
64375692|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
64375693|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
64375695|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64375696|NCT04900311|Trastuzumab|trastuzumab|mesh-list
64375697|NCT04900311|Pertuzumab|pertuzumab|mesh-list
64375698|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64375699|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375700|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
64375744|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
64375745|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375746|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64375747|NCT04899453|Rituximab|rituximab|mesh-list
64375748|NCT04899453|Methotrexate|methotrexate|mesh-list
64375749|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
64375781|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
64375782|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
64375783|NCT04898907|Mitogens|mitogens|mesh-list
64451613|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64451614|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64451615|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64451616|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64451617|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451618|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64451626|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64451627|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
64451628|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375789|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375791|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64375853|NCT04897737|Tenofovir|tenofovir|mesh-list
64375854|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
64451629|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64451630|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64451631|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451632|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451633|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64451634|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64451635|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64451636|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64451637|NCT01814553|Afatinib|afatinib|mesh-list
64451638|NCT01814553|Loperamide|loperamide|mesh-list
64451639|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
64451640|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451641|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64451642|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451643|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451644|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451645|NCT02116205|Vaccines|vaccines|mesh-list
64451646|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
64451647|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451648|NCT01844583|Rifampin|rifampin|mesh-list
64375858|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451654|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451655|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64451656|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
64451657|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64451658|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451659|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
64451660|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64451661|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64451662|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64451663|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64451664|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64375864|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375865|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375867|NCT04897269|Progestins|progestins|mesh-ancestor
64375868|NCT04897269|Hormones|hormones|mesh-ancestor
64375869|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375870|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375871|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64451665|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64451666|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64451668|NCT04742075|Olaparib|olaparib|mesh-list
64451669|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64451670|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64451671|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451672|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
64451673|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451674|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64451675|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451676|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451677|NCT02115113|Everolimus|everolimus|mesh-list
64451678|NCT02115113|Tacrolimus|tacrolimus|mesh-list
64451679|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375904|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64375905|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64375906|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64375907|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64375908|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
64375909|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
64375910|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375911|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375912|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64375913|NCT04906317|Narcotics|narcotics|mesh-ancestor
64375914|NCT04906317|Analgesics|analgesics|mesh-ancestor
64375915|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
64375916|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375917|NCT03051087|Ganirelix|ganirelix|mesh-list
64375918|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
64375919|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375920|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375921|NCT04430361|Dexamethasone|dexamethasone|mesh-list
64375922|NCT04430361|Megestrol|megestrol|mesh-list
64375923|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
64375946|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375948|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64375949|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64375951|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375952|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
64375953|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375954|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64451713|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64375960|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64375961|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375962|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375963|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64375964|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64451716|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451717|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451718|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64451719|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64451721|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
64451722|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451723|NCT01621490|Nivolumab|nivolumab|mesh-list
64451724|NCT01621490|Ipilimumab|ipilimumab|mesh-list
64451725|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64451726|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451727|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64375969|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64375970|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
64451756|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
64451757|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451758|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451759|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451761|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64451762|NCT01994720|Analgesics|analgesics|mesh-ancestor
64451763|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
64451764|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451765|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451766|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451767|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64451768|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64451769|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64451770|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451771|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
64451772|NCT01814397|Letrozole|letrozole|mesh-list
64451773|NCT01814397|Anastrozole|anastrozole|mesh-list
64451774|NCT01814397|Exemestane|exemestane|mesh-list
64451775|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451776|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64451777|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64451778|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451779|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375971|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375972|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
64375973|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376004|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376005|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
64376006|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376008|NCT04906161|Calcium|calcium|mesh-list
64376009|NCT04906161|Vitamins|vitamins|mesh-ancestor
64376010|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
64376011|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376012|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64376013|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64376014|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64376042|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376043|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376044|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376046|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64376047|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376048|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64376049|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376051|NCT04882683|Adalimumab|adalimumab|mesh-list
64376052|NCT04882683|Azathioprine|azathioprine|mesh-list
64376053|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376054|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
64376055|NCT04882683|Hormones|hormones|mesh-ancestor
64451788|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64451789|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64451790|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64451791|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451792|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451793|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
64451794|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451795|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64451796|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64451797|NCT02018042|Abatacept|abatacept|mesh-list
64451798|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64451799|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451800|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451801|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451802|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
64451803|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451804|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451805|NCT02017171|Allopurinol|allopurinol|mesh-list
64451806|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
64376081|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
64451807|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451808|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451809|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
64451810|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451811|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64451812|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
64451813|NCT02017171|Protective Agents|protective agents|mesh-ancestor
64451814|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451815|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
64451831|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64451832|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64451833|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64451834|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
64451835|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451836|NCT04694846|Bupropion|bupropion|mesh-list
64451837|NCT04694846|Nicotine|nicotine|mesh-list
64451838|NCT04694846|Varenicline|varenicline|mesh-list
64451842|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451843|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64451844|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64451845|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
64376084|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376085|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376086|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64376087|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64376088|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64376089|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64376090|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
64376091|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64451846|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451847|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451848|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64451849|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
64451850|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64451851|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64451852|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64451853|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64451854|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
64376095|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376097|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64376098|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376099|NCT04880811|Afatinib|afatinib|mesh-list
64376100|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376101|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64451942|NCT02027311|Meperidine|meperidine|mesh-list
64451943|NCT02027311|Etomidate|etomidate|mesh-list
64451944|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64451945|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64451946|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451947|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451948|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64451949|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64451950|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64451951|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64451952|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
64451954|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
64451955|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
64451956|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451957|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451977|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64451978|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
64451979|NCT02047513|Antiviral Agents|antiviral agents|mesh-ancestor
64451980|NCT02047513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451981|NCT02047513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451982|NCT02047513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451983|NCT02047513|Immunologic Factors|immunologic factors|mesh-ancestor
64451984|NCT02047513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451985|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
64451986|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64451987|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64451988|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451989|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64451990|NCT02026141|Analgesics|analgesics|mesh-ancestor
64451991|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
64451992|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451993|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64451994|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64451995|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64451996|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451997|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451998|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376110|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376111|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376112|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376113|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64376114|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
64376115|NCT02181634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376116|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376150|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376151|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376154|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376155|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
64376157|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
64376159|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376194|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64376195|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64451999|NCT02025907|Canagliflozin|canagliflozin|mesh-list
64452000|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64452001|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452002|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452003|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452004|NCT02025751|Metoclopramide|metoclopramide|mesh-list
64452005|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
64452006|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
64452007|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452008|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452009|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452010|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64452011|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64452012|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
64452013|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376198|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
64376233|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376234|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64376235|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
64376236|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376237|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376238|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64376268|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376269|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
64376270|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376271|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376272|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376274|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64376275|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64376277|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
64376278|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376279|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376280|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376281|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376282|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64452032|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64376283|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452033|NCT01812759|Fentanyl|fentanyl|mesh-list
64452034|NCT01812759|Hydromorphone|hydromorphone|mesh-list
64452035|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64452036|NCT01812759|Narcotics|narcotics|mesh-ancestor
64452037|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452038|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452039|NCT01812759|Analgesics|analgesics|mesh-ancestor
64452040|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
64452051|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452052|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452053|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
64452054|NCT01812057|Hormones|hormones|mesh-ancestor
64452055|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376321|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376323|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452057|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452058|NCT01842633|Acetaminophen|acetaminophen|mesh-list
64452059|NCT01842633|Ibuprofen|ibuprofen|mesh-list
64452060|NCT01842633|Caffeine|caffeine|mesh-list
64452061|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64452062|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64452063|NCT01842633|Analgesics|analgesics|mesh-ancestor
64452064|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
64452065|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452066|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452067|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452068|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452069|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64452070|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452071|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452072|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
64452073|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64452074|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64452075|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64376365|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376397|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376399|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64452077|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
64452078|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452079|NCT01841697|Metformin|metformin|mesh-list
64452080|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64452081|NCT01841697|Glimepiride|glimepiride|mesh-list
64452082|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452083|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452084|NCT01841697|Incretins|incretins|mesh-ancestor
64452085|NCT01841697|Hormones|hormones|mesh-ancestor
64452086|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452087|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64452088|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
64452089|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452090|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452091|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64452092|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64452094|NCT01809327|Metformin|metformin|mesh-list
64452095|NCT01809327|Canagliflozin|canagliflozin|mesh-list
64452096|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64376404|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
64376405|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376406|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376407|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
64376408|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376442|NCT04869579|Trace Elements|trace elements|mesh-ancestor
64376443|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
64376444|NCT03235037|Levodopa|levodopa|mesh-list
64376445|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64376446|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64376448|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376449|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376450|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376452|NCT00700271|Valsartan|valsartan|mesh-list
64376476|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
64452100|NCT03272139|Bupivacaine|bupivacaine|mesh-list
64452101|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
64452102|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
64452103|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452104|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452105|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
64452106|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452107|NCT01808313|Ambrisentan|ambrisentan|mesh-list
64452108|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64452109|NCT01840605|Ketotifen|ketotifen|mesh-list
64452110|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
64452111|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
64452112|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452113|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64452115|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
64452116|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452117|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452118|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452119|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64452120|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64452121|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
64452122|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452123|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64452124|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452125|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452126|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
64452127|NCT02013817|Rituximab|rituximab|mesh-list
64452128|NCT02013817|Fludarabine|fludarabine|mesh-list
64376484|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
64376485|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376487|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452130|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
64452132|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452133|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64452134|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
64452135|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452136|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452137|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64452138|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452139|NCT02023099|Ritonavir|ritonavir|mesh-list
64452140|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64452141|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64452142|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
64452143|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452144|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452145|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64452146|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64452148|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452149|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64452150|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64452151|NCT02013037|Eculizumab|eculizumab|mesh-list
64452152|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64452153|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376491|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
64376492|NCT04875039|BB 1101|bb 1101|mesh-list
64376493|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376494|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
64376495|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
64376496|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376497|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376498|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376499|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
64376500|NCT04875039|Hormones|hormones|mesh-ancestor
64376501|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376502|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64452154|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
64452155|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452156|NCT04416607|Menotropins|menotropins|mesh-list
64452157|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64452158|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
64452159|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64452160|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452161|NCT01967173|Fluticasone|fluticasone|mesh-list
64452162|NCT01967173|Xhance|xhance|mesh-list
64452163|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64452164|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64452165|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
64452166|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452167|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452168|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64452169|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
64452170|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
64452171|NCT01967173|Hormones|hormones|mesh-ancestor
64452172|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452173|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
64452174|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452175|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452176|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64452177|NCT01993927|Voglibose|voglibose|mesh-list
64452178|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452179|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452180|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64376573|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
64376574|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452181|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452182|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452183|NCT02012959|Tolvaptan|tolvaptan|mesh-list
64452184|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64452185|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452186|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
64452187|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452188|NCT02012491|Misoprostol|misoprostol|mesh-list
64452189|NCT02012491|Mifepristone|mifepristone|mesh-list
64452190|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64452191|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
64452192|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64452193|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452194|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64452195|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452196|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
64452197|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64452198|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64452199|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64452200|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64452201|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
64452202|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64376575|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376576|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
64376577|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
64376578|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64376579|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
64376580|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376581|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64376582|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64452203|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64452204|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
64452205|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452206|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
64452207|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64452208|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64452209|NCT02038010|Trastuzumab|trastuzumab|mesh-list
64452210|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64452218|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376584|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64376585|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64376586|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64376589|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64376591|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376592|NCT03226145|Laxatives|laxatives|mesh-ancestor
64452251|NCT02011945|Nivolumab|nivolumab|mesh-list
64452252|NCT02011945|Dasatinib|dasatinib|mesh-list
64452253|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452254|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452255|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64452256|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452257|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64452258|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452259|NCT02013830|Bevacizumab|bevacizumab|mesh-list
64452260|NCT02013830|Capecitabine|capecitabine|mesh-list
64452261|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452262|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452263|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64376593|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64376594|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
64376595|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
64376596|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376626|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376628|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376629|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
64376630|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376631|NCT02453009|Prednisone|prednisone|mesh-list
64376633|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452264|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64452265|NCT02013830|Growth Substances|growth substances|mesh-ancestor
64452266|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452267|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
64452268|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64452269|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
64452270|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452271|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
64452272|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64452273|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64452274|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64452275|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452276|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376636|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376637|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376638|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376639|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
64376672|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64376673|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64376674|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64376675|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64376676|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376678|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64376679|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
64376680|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452278|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452279|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452280|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64452281|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452282|NCT01619059|Metformin|metformin|mesh-list
64452283|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
64452284|NCT01619059|Saxagliptin|saxagliptin|mesh-list
64452285|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452286|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452287|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64452288|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452289|NCT01619059|Incretins|incretins|mesh-ancestor
64452290|NCT01619059|Hormones|hormones|mesh-ancestor
64452292|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64452293|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
64452294|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452295|NCT04691804|Prednisone|prednisone|mesh-list
64452296|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
64452297|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452298|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
64452299|NCT04691804|Hormones|hormones|mesh-ancestor
64452300|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376712|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64376713|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
64376714|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
64376715|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376716|NCT02153788|Temazepam|temazepam|mesh-list
64376717|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376718|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376719|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376720|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64376721|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64376722|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64376723|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
64376724|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
64376725|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376726|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376727|NCT03224039|Sufentanil|sufentanil|mesh-list
64376728|NCT03224039|Morphine|morphine|mesh-list
64376729|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64376751|NCT03045471|Prednisolone|prednisolone|mesh-list
64376752|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64376753|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
64376754|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64376755|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
64376756|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
64376757|NCT03045471|Rituximab|rituximab|mesh-list
64376758|NCT03045471|Etoposide|etoposide|mesh-list
64376759|NCT03045471|Vincristine|vincristine|mesh-list
64376760|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64376761|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
64376762|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376763|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
64452301|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452302|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64452303|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452304|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64452305|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452308|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64452309|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64452310|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452311|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64376767|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
64376768|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376769|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376770|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64452312|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452313|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452314|NCT01807923|Ivacaftor|ivacaftor|mesh-list
64452315|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64452316|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452317|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452318|NCT01966003|Paclitaxel|paclitaxel|mesh-list
64452319|NCT01966003|Bevacizumab|bevacizumab|mesh-list
64452320|NCT01966003|Carboplatin|carboplatin|mesh-list
64452321|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64452322|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452324|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
64452325|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
64452326|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452327|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452328|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64452329|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64452330|NCT01966003|Growth Substances|growth substances|mesh-ancestor
64452331|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452332|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
64452333|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
64452334|NCT01839279|Tizanidine|tizanidine|mesh-list
64452335|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64452336|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452337|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64452338|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64452339|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452344|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
64452345|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452346|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
64452347|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64452348|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64452349|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
64452350|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
64452351|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64452352|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64452353|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64452354|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
64452355|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452356|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
64452357|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64452358|NCT01965535|Ledipasvir|ledipasvir|mesh-list
64452359|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
64452360|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452361|NCT01964755|Leucovorin|leucovorin|mesh-list
64452362|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
64452363|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
64452364|NCT01964755|Zidovudine|zidovudine|mesh-list
64452365|NCT01964755|Rituximab|rituximab|mesh-list
64452366|NCT01964755|Doxorubicin|doxorubicin|mesh-list
64452367|NCT01964755|Methotrexate|methotrexate|mesh-list
64452368|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
64452369|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
64376772|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64376773|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64376775|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376776|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376777|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
64376779|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376780|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64376781|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
64376804|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
64376806|NCT04873479|Ketamine|ketamine|mesh-list
64376807|NCT04873479|Esketamine|esketamine|mesh-list
64376808|NCT04873479|Analgesics|analgesics|mesh-ancestor
64376809|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
64452390|NCT01964755|Protective Agents|protective agents|mesh-ancestor
64376812|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64376813|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64376814|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
64376815|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
64376816|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376817|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64376818|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64376819|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376820|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376821|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
64376822|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64452448|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452449|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
64452450|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64452451|NCT01962493|Listerine|listerine|mesh-list
64452452|NCT01962493|Fluorides|fluorides|mesh-list
64452453|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
64452454|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
64452455|NCT01962493|Protective Agents|protective agents|mesh-ancestor
64452456|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452457|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64452458|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452459|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
64452460|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452461|NCT01989169|Midazolam|midazolam|mesh-list
64452469|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64452470|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
64452471|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
64376824|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64376825|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64376826|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376827|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376828|NCT02451527|Protective Agents|protective agents|mesh-ancestor
64376829|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376831|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
64376832|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64376833|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64376863|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376864|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376865|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
64376867|NCT03043677|Adalimumab|adalimumab|mesh-list
64376868|NCT03043677|Golimumab|golimumab|mesh-list
64376869|NCT03043677|Infliximab|infliximab|mesh-list
64376870|NCT03043677|Ustekinumab|ustekinumab|mesh-list
64376871|NCT03043677|Vedolizumab|vedolizumab|mesh-list
64376872|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376873|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376874|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
64376875|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376876|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64376877|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376878|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
64376879|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452472|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
64452473|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
64452474|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452475|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452476|NCT01988779|Levofloxacin|levofloxacin|mesh-list
64452477|NCT01988779|Ofloxacin|ofloxacin|mesh-list
64452478|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64452479|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452480|NCT01988779|Renal Agents|renal agents|mesh-ancestor
64452481|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64452482|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64452483|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64452484|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452517|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452519|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64452520|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64452521|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64452522|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64452523|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
64452524|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452525|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452526|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452527|NCT01986062|Amphetamine|amphetamine|mesh-list
64452528|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64376913|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376914|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64376915|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376916|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64376917|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376918|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64452530|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
64452531|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
64452537|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64452538|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64452539|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452540|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64452541|NCT02031536|Everolimus|everolimus|mesh-list
64452542|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452543|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64452544|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
64452545|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452546|NCT01985126|Acetaminophen|acetaminophen|mesh-list
64452547|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
64452548|NCT01985126|Promethazine|promethazine|mesh-list
64452549|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
64376919|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64376920|NCT03222167|Grazoprevir|grazoprevir|mesh-list
64376921|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64376922|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
64376923|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376924|NCT03221855|Domperidone|domperidone|mesh-list
64376925|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
64376926|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
64376927|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376928|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376929|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376966|NCT03045393|Maytansine|maytansine|mesh-list
64376967|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64376968|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376969|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
64377034|NCT02504801|Hormones|hormones|mesh-ancestor
64377035|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377036|NCT02504333|Gemcitabine|gemcitabine|mesh-list
64377037|NCT02504333|Paclitaxel|paclitaxel|mesh-list
64452550|NCT01985126|Daratumumab|daratumumab|mesh-list
64452551|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64452552|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64452553|NCT01985126|Analgesics|analgesics|mesh-ancestor
64452554|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
64452555|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452556|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377040|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377041|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
64377042|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
64452608|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64452609|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
64452610|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452611|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452612|NCT04687514|Dulaglutide|dulaglutide|mesh-list
64452613|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64377075|NCT03213743|Analgesics|analgesics|mesh-ancestor
64377076|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
64377077|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377078|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64377079|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64377080|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64377081|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
64377082|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377083|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377084|NCT03212495|Neostigmine|neostigmine|mesh-list
64452614|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452615|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
64452616|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
64452617|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452618|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452619|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452620|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
64452621|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
64452622|NCT01984424|Atorvastatin|atorvastatin|mesh-list
64452623|NCT01984424|Ezetimibe|ezetimibe|mesh-list
64452624|NCT01984424|Evolocumab|evolocumab|mesh-list
64452625|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64452626|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64377087|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377088|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377125|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64377126|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64377127|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452627|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64452628|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
64452629|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452630|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64452631|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64452632|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452633|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
64452634|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452635|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64452636|NCT01837719|Cobicistat|cobicistat|mesh-list
64452637|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64452638|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64452639|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
64452640|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452641|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452642|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64452643|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64452644|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
64452645|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452646|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64377129|NCT04496921|Coagulants|coagulants|mesh-ancestor
64377130|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
64377131|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64377132|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64377149|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377151|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
64452648|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64452650|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452651|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452652|NCT02009384|Ipilimumab|ipilimumab|mesh-list
64452653|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452654|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452655|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64452656|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452657|NCT01805037|Rituximab|rituximab|mesh-list
64452658|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64452659|NCT01805037|Antibodies|antibodies|mesh-list
64452660|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
64452661|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64452662|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
64452663|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
64452664|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452665|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452666|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452667|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452668|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64424548|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377153|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64377154|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
64377155|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377156|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
64377157|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
64377158|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
64377159|NCT03209219|Interferons|interferons|mesh-list
64377160|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
64377161|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
64377162|NCT03209219|Cyclosporine|cyclosporine|mesh-list
64377163|NCT03209219|Cyclosporins|cyclosporins|mesh-list
64377164|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377165|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
64377166|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377167|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452692|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452693|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64452694|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64452695|NCT01836471|Growth Substances|growth substances|mesh-ancestor
64452697|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64452698|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
64452699|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452700|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452701|NCT01802775|Aspirin|aspirin|mesh-list
64452702|NCT01802775|Edoxaban|edoxaban|mesh-list
64452703|NCT01802775|Clopidogrel|clopidogrel|mesh-list
64452704|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64452705|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64452706|NCT01802775|Analgesics|analgesics|mesh-ancestor
64452707|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
64452708|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452709|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452710|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452711|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377169|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377170|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
64377171|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377172|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
64377173|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
64377177|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
64377178|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377179|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64452734|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452735|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452736|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452737|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
64452738|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452739|NCT01773993|Pregabalin|pregabalin|mesh-list
64452740|NCT01773993|Analgesics|analgesics|mesh-ancestor
64452741|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
64452742|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452743|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452744|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
64452745|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64452746|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452747|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452748|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64452749|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64452750|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64452751|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452752|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64452753|NCT01802073|Vancomycin|vancomycin|mesh-list
64452754|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64452755|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452756|NCT01607073|Verapamil|verapamil|mesh-list
64452757|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64452758|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64452759|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452772|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452773|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64452774|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
64452775|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452776|NCT01772823|Tenofovir|tenofovir|mesh-list
64452777|NCT01772823|Emtricitabine|emtricitabine|mesh-list
64377183|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64377184|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377185|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452810|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64452811|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64452812|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64452813|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452814|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64452815|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64452816|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452817|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64452818|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
64452819|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
64452820|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
64452821|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452822|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
64452823|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
64452824|NCT01982942|Ibudilast|ibudilast|mesh-list
64452825|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64452826|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
64452827|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452828|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452829|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64377187|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64377215|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64377217|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
64377218|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
64377219|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64377220|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
64377221|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64377223|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64377224|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
64377225|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
64452830|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
64452831|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64452832|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452833|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452834|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64452835|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
64452836|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64452837|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64452838|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64452839|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452840|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452841|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
64452842|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452843|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64452844|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64452845|NCT01769391|Paclitaxel|paclitaxel|mesh-list
64452846|NCT01769391|Carboplatin|carboplatin|mesh-list
64452847|NCT01769391|Necitumumab|necitumumab|mesh-list
64452848|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64452849|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452850|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
64452851|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
64452852|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
64452853|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452854|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452855|NCT01767987|Ranolazine|ranolazine|mesh-list
64452856|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64452857|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377226|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64377227|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377228|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377229|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64377230|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64377231|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64377232|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64452860|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64452861|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452862|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452863|NCT02029274|Siponimod|siponimod|mesh-list
64452864|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64452865|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452867|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
64452868|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452869|NCT02008370|Bupivacaine|bupivacaine|mesh-list
64452870|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
64452871|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
64452872|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452873|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452874|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
64452875|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452876|NCT01981616|Vedolizumab|vedolizumab|mesh-list
64452877|NCT01981616|Vaccines|vaccines|mesh-list
64452878|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
64377233|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64377234|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64377235|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64377236|NCT01594827|Renal Agents|renal agents|mesh-ancestor
64377267|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377269|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64377270|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377271|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377272|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
64377273|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64452909|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452910|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
64452911|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
64452912|NCT01960855|Upadacitinib|upadacitinib|mesh-list
64452913|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64452914|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64452915|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452916|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452917|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452919|NCT02007434|Ibuprofen|ibuprofen|mesh-list
64452920|NCT02007434|Lidocaine|lidocaine|mesh-list
64452921|NCT02007434|Epinephrine|epinephrine|mesh-list
64452922|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
64452964|NCT01987453|Ledipasvir|ledipasvir|mesh-list
64452965|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
64452966|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452967|NCT01959919|Factor VIII|factor viii|mesh-list
64377276|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64453020|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64453021|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64453022|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
64453023|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453024|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64453025|NCT02111369|Propranolol|propranolol|mesh-list
64453026|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
64453027|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64453028|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453029|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453030|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
64453031|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453032|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453033|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64453034|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64453035|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
64453036|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453037|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64453038|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
64453039|NCT02069093|Dexamethasone|dexamethasone|mesh-list
64453040|NCT02069093|Everolimus|everolimus|mesh-list
64453041|NCT02069093|Exemestane|exemestane|mesh-list
64453042|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453043|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
64453044|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
64377278|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377279|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377315|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
64377316|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64377317|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377318|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64377349|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377351|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
64453050|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453051|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64453052|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453053|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453054|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
64453055|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64453056|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64453057|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453058|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453059|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64453060|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
64453061|NCT02109029|Insulin|insulin|mesh-list
64453062|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64453063|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453064|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453065|NCT02007278|Metformin|metformin|mesh-list
64453066|NCT02007278|Glimepiride|glimepiride|mesh-list
64453067|NCT02007278|Vildagliptin|vildagliptin|mesh-list
64453068|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453069|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453070|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453071|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377352|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377353|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
64377354|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377355|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
64377356|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377357|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64377358|NCT02117050|Interferons|interferons|mesh-list
64377359|NCT02117050|Interferon-beta|interferon-beta|mesh-list
64377360|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
64377361|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377362|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
64377363|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377364|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
64377365|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377389|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64453092|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64453093|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
64453094|NCT02106923|Metformin|metformin|mesh-list
64453095|NCT02106923|Empagliflozin|empagliflozin|mesh-list
64453096|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453097|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453098|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64453099|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453100|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
64453101|NCT02006732|Olodaterol|olodaterol|mesh-list
64453102|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64453103|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
64453104|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453105|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453106|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64453107|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
64453108|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
64453109|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64453110|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
64453111|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453113|NCT02098733|Pioglitazone|pioglitazone|mesh-list
64453149|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453150|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64453151|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
64453152|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453153|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64453154|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64453155|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64453156|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453157|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
64377390|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64377391|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64377392|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
64453169|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453170|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453171|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453172|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453173|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64453174|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453175|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453176|NCT01448824|Ketoconazole|ketoconazole|mesh-list
64453178|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
64453179|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453180|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64453181|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64453182|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453183|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453184|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64453185|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
64453186|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377396|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64453190|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64453191|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
64453192|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64453193|NCT02005562|Cyclosporine|cyclosporine|mesh-list
64453194|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
64453195|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
64453196|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64453197|NCT02005562|Cyclosporins|cyclosporins|mesh-list
64453198|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453199|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453200|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453201|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
64377400|NCT04857801|Teduglutide|teduglutide|mesh-list
64377401|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64377402|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64377403|NCT04857801|Protective Agents|protective agents|mesh-ancestor
64377404|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377405|NCT03208361|Amoxicillin|amoxicillin|mesh-list
64377406|NCT03208361|Penicillins|penicillins|mesh-list
64377407|NCT03208361|Penicillin V|penicillin v|mesh-list
64377408|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64377409|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377410|NCT02501837|Oxytocin|oxytocin|mesh-list
64377413|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453202|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453203|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
64453204|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453205|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453206|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453207|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64453209|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453210|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64453211|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
64453212|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64453213|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453214|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
64453215|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
64453216|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453217|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453218|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
64453219|NCT02005562|Hormones|hormones|mesh-ancestor
64453220|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377416|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
64377417|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377418|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377448|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
64377449|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453221|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64453222|NCT02005562|Protective Agents|protective agents|mesh-ancestor
64453223|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64453224|NCT01448044|Interferons|interferons|mesh-list
64453225|NCT01448044|Ribavirin|ribavirin|mesh-list
64453226|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
64453227|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
64453228|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64453229|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453230|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
64453231|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453232|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
64453233|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453234|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
64453235|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453236|NCT01472380|Efavirenz|efavirenz|mesh-list
64453237|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
64453238|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64453239|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64453240|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453244|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64377450|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64377451|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64377452|NCT03206957|Growth Substances|growth substances|mesh-ancestor
64377453|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377454|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
64377456|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64377457|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64377459|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453261|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453262|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
64453263|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64453264|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453265|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
64453266|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
64453267|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
64453268|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64453269|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453271|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64453272|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
64453273|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64453274|NCT01438840|Maleic acid|maleic acid|mesh-list
64453275|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453276|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453277|NCT01471054|Dexamethasone|dexamethasone|mesh-list
64453278|NCT01471054|Bevacizumab|bevacizumab|mesh-list
64453279|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64453280|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453281|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64377461|NCT03206723|Analgesics|analgesics|mesh-ancestor
64377462|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
64377463|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377464|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
64377472|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64377474|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
64377475|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377476|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64377477|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377478|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377479|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
64377480|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377481|NCT03206177|Paclitaxel|paclitaxel|mesh-list
64377482|NCT03206177|Carboplatin|carboplatin|mesh-list
64377483|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64377484|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377485|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64377486|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64453300|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453301|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453302|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
64453303|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453305|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453306|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
64453307|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453309|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64453310|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64453311|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64453313|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64453314|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377490|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377491|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377492|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
64377493|NCT04839549|Hormones|hormones|mesh-ancestor
64377494|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377495|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64377496|NCT04839627|Progesterone|progesterone|mesh-list
64377497|NCT04839627|Progestins|progestins|mesh-ancestor
64377498|NCT04839627|Hormones|hormones|mesh-ancestor
64377499|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377500|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453315|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64453316|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453317|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
64453318|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453319|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
64453320|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453321|NCT01977794|Amlodipine|amlodipine|mesh-list
64453322|NCT01977794|Bisoprolol|bisoprolol|mesh-list
64453323|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64453324|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64453325|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453326|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453327|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64453328|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453329|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
64453330|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
64453331|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
64453332|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377505|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64377506|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377507|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377510|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64377511|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377512|NCT04839237|Incretins|incretins|mesh-ancestor
64377513|NCT04839237|Hormones|hormones|mesh-ancestor
64377514|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377515|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
64453333|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64453334|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64453335|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64453336|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
64453337|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453338|NCT02005484|Trastuzumab|trastuzumab|mesh-list
64453339|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64453347|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453348|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
64453349|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
64453350|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453351|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453352|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453353|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
64453354|NCT02047253|Hormones|hormones|mesh-ancestor
64424549|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453355|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453356|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64377557|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
64377558|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
64377559|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377560|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377561|NCT03038295|Propranolol|propranolol|mesh-list
64377562|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64377563|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64377564|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
64377565|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377570|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
64377573|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64453357|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453358|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
64453359|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453360|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
64453361|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64453362|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453363|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453364|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453366|NCT02096003|Hydromorphone|hydromorphone|mesh-list
64453367|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64453368|NCT02096003|Narcotics|narcotics|mesh-ancestor
64453369|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453370|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453372|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
64377578|NCT02609607|Cathartics|cathartics|mesh-ancestor
64377579|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64377580|NCT02609607|Laxatives|laxatives|mesh-ancestor
64377581|NCT03040167|Epinephrine|epinephrine|mesh-list
64377582|NCT03040167|Bupivacaine|bupivacaine|mesh-list
64377614|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377615|NCT04843839|Laxatives|laxatives|mesh-ancestor
64377617|NCT04838145|Ribavirin|ribavirin|mesh-list
64377618|NCT04838145|Pleconaril|pleconaril|mesh-list
64453395|NCT01622231|Fluticasone|fluticasone|mesh-list
64453396|NCT01622231|Xhance|xhance|mesh-list
64453398|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64453399|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
64453400|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453401|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453402|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64453403|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
64453404|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453405|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64453406|NCT02042183|Lubiprostone|lubiprostone|mesh-list
64453407|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64453408|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453409|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453410|NCT02058095|Tadalafil|tadalafil|mesh-list
64453411|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
64453412|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64453413|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64453414|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453415|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453416|NCT02058095|Urological Agents|urological agents|mesh-ancestor
64377625|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377651|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377652|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453419|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64453420|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64453421|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
64453422|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453423|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453425|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64453426|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
64453427|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453428|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64453429|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64453430|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
64453431|NCT04670666|Metformin|metformin|mesh-list
64453432|NCT04670666|Empagliflozin|empagliflozin|mesh-list
64453433|NCT04670666|Linagliptin|linagliptin|mesh-list
64453434|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453435|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377654|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64377655|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64377656|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
64377657|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64377659|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64377660|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64377661|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64453436|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64453437|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453439|NCT04670666|Hormones|hormones|mesh-ancestor
64453440|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453441|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64453442|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
64453443|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453444|NCT01976624|Timolol|timolol|mesh-list
64453445|NCT01976624|Bimatoprost|bimatoprost|mesh-list
64453446|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64453447|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64453448|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
64453449|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453450|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453451|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453452|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453453|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64453454|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64453455|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
64453456|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453457|NCT04717973|Vitamin D|vitamin d|mesh-list
64453458|NCT04717973|Vitamins|vitamins|mesh-list
64453459|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
64377664|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64377699|NCT04779645|Volagidemab|volagidemab|mesh-list
64377700|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64377701|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377703|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64377704|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64377705|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
64377706|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377707|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
64377708|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377739|NCT03040791|Nivolumab|nivolumab|mesh-list
64453461|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
64453462|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453463|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64453464|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
64453465|NCT04717973|Hematinics|hematinics|mesh-ancestor
64453466|NCT02057549|Haloperidol|haloperidol|mesh-list
64453467|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
64453468|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
64453469|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
64453474|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64453475|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453476|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64453477|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64377742|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64377743|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377744|NCT04428879|Topotecan|topotecan|mesh-list
64453482|NCT02057393|Methylene Blue|methylene blue|mesh-list
64453483|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453484|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377745|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64377746|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64377747|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377748|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377749|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377750|NCT04836819|Lidocaine|lidocaine|mesh-list
64377751|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
64377752|NCT04836819|Ketamine|ketamine|mesh-list
64377785|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377786|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377787|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64377789|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
64377790|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453487|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
64453488|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
64453489|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453490|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453491|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64453492|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
64453493|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
64453494|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64453495|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64453496|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64453497|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64453498|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
64453499|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453501|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377820|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377821|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377822|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64377823|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377824|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
64377825|NCT03036891|Naloxegol|naloxegol|mesh-list
64377826|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64377827|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377828|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
64453526|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453527|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453528|NCT01976312|Ranibizumab|ranibizumab|mesh-list
64453529|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64453530|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64453531|NCT01976312|Growth Substances|growth substances|mesh-ancestor
64453532|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453533|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
64453534|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453536|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64453537|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64453538|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64453539|NCT02053493|Diuretics|diuretics|mesh-ancestor
64453540|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
64453541|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453542|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
64377830|NCT01668147|Ritonavir|ritonavir|mesh-list
64377872|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453543|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64453544|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453545|NCT02003144|Eculizumab|eculizumab|mesh-list
64453546|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64366073|NCT02517827|Paclitaxel|paclitaxel|mesh-list
64453547|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453548|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
64453549|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453550|NCT02038907|Vaccines|vaccines|mesh-list
64453551|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
64453552|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453553|NCT02052011|Ranolazine|ranolazine|mesh-list
64453554|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64453555|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453556|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453557|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
64453558|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64377874|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64377875|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
64377876|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64377877|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377878|NCT04851015|Renal Agents|renal agents|mesh-ancestor
64377879|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
64377880|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64453560|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64453561|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64453562|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453563|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
64453564|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453565|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453566|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64453567|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453569|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64453570|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64453571|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64453572|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64453573|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453574|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453575|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64453576|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64453578|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
64453579|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453580|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453582|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453583|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64453584|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377950|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64377951|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
64377952|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
64377953|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377986|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378044|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
64378045|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64378046|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378047|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64378048|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64378049|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378050|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378051|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378092|NCT04828395|Carboplatin|carboplatin|mesh-list
64378093|NCT04828395|Pemetrexed|pemetrexed|mesh-list
64378094|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378095|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378096|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
64378097|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
64378138|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64378139|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378140|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64378141|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378172|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378173|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378174|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64378175|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64378176|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378177|NCT02601027|Acetaminophen|acetaminophen|mesh-list
64378178|NCT02601027|Oxycodone|oxycodone|mesh-list
64378179|NCT02601027|Hydromorphone|hydromorphone|mesh-list
64378180|NCT02601027|Ondansetron|ondansetron|mesh-list
64378264|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
64378266|NCT04807413|Protective Agents|protective agents|mesh-ancestor
64378267|NCT04356729|Bevacizumab|bevacizumab|mesh-list
64378268|NCT04356729|Atezolizumab|atezolizumab|mesh-list
64378269|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378270|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378271|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64378272|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64378273|NCT04356729|Growth Substances|growth substances|mesh-ancestor
64378274|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378308|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64378309|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378311|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378312|NCT04805775|Propofol|propofol|mesh-list
64378382|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64378383|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64378384|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64378395|NCT01667679|Sumatriptan|sumatriptan|mesh-list
64378396|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64378397|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64378398|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64378427|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378428|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64378429|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64378430|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64378431|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378478|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64378479|NCT03200561|Antibodies|antibodies|mesh-list
64378480|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378485|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64378541|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378543|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
64378544|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378545|NCT04808739|Adalimumab|adalimumab|mesh-list
64378560|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64378561|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64378563|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
64378567|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
64378568|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378569|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378570|NCT03204071|Metformin|metformin|mesh-list
64378571|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64378572|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378573|NCT04801017|Artemisinins|artemisinins|mesh-list
64378574|NCT04801017|Artemisinin|artemisinin|mesh-list
64378575|NCT04801017|Trabedersen|trabedersen|mesh-list
64378576|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
64378577|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64378578|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64378579|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378580|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378581|NCT03107429|Acetazolamide|acetazolamide|mesh-list
64378582|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
64378583|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64378584|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378585|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378624|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64378626|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
64378628|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64378629|NCT03232307|Lenalidomide|lenalidomide|mesh-list
64378630|NCT03232307|Antibodies|antibodies|mesh-list
64378631|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
64378698|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64378699|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64378700|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378701|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378711|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
64378768|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64378769|NCT03195569|Growth Substances|growth substances|mesh-ancestor
64378770|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378771|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
64378772|NCT02447939|Trametinib|trametinib|mesh-list
64378773|NCT02447939|Dabrafenib|dabrafenib|mesh-list
64378774|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378775|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64378776|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378777|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378778|NCT04785183|Melatonin|melatonin|mesh-list
64378779|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
64378780|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378781|NCT04785183|Protective Agents|protective agents|mesh-ancestor
64378782|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378783|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378784|NCT03195491|Nivolumab|nivolumab|mesh-list
64378785|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378786|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378823|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378825|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
64378857|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378858|NCT04792515|Apatinib|apatinib|mesh-list
64378859|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378860|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64378861|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378862|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378863|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64378864|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64378865|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378867|NCT03195023|Lisinopril|lisinopril|mesh-list
64378868|NCT03195023|Lercanidipine|lercanidipine|mesh-list
64378869|NCT03195023|Furosemide|furosemide|mesh-list
64378929|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378940|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378941|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
64378942|NCT03231215|Hormones|hormones|mesh-ancestor
64378943|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378944|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64378945|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378946|NCT04784481|Ivermectin|ivermectin|mesh-list
64378947|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64378948|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378956|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378957|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378958|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64378959|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378961|NCT02445599|Diclofenac|diclofenac|mesh-list
64378962|NCT02445599|Atropine|atropine|mesh-list
64378963|NCT02445599|Fentanyl|fentanyl|mesh-list
64378964|NCT02445599|Midazolam|midazolam|mesh-list
64378965|NCT02445599|Tramadol|tramadol|mesh-list
64378966|NCT02445599|Nalbuphine|nalbuphine|mesh-list
64378967|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64378968|NCT02445599|Narcotics|narcotics|mesh-ancestor
64378969|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378970|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379002|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
64379003|NCT03194633|Nifedipine|nifedipine|mesh-list
64379004|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64379005|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379006|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379007|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64379008|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379009|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379010|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
64379011|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64379012|NCT03194555|Acetaminophen|acetaminophen|mesh-list
64379013|NCT03194555|Naltrexone|naltrexone|mesh-list
64379014|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64379047|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379081|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
64379082|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379083|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379084|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64379085|NCT03016533|Lamivudine|lamivudine|mesh-list
64379086|NCT03016533|Dolutegravir|dolutegravir|mesh-list
64379087|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64379088|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64379089|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379091|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
64379092|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379093|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64379094|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64379095|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64379096|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64379097|NCT03229889|Tadalafil|tadalafil|mesh-list
64379098|NCT03229889|Tamsulosin|tamsulosin|mesh-list
64379099|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379100|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64379101|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64379102|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379103|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379104|NCT03229889|Urological Agents|urological agents|mesh-ancestor
64379105|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64379106|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64379107|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64379109|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379110|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379111|NCT02444585|Denosumab|denosumab|mesh-list
64379112|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64379153|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64379155|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64379156|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
64379157|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379192|NCT04789005|Protective Agents|protective agents|mesh-ancestor
64379193|NCT02152384|Insulin|insulin|mesh-list
64379194|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64379195|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
64379196|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
64379197|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64379198|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379230|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379231|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64379243|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64379244|NCT04787289|Bevacizumab|bevacizumab|mesh-list
64379311|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379312|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64379313|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64379341|NCT05612607|Antibodies|antibodies|mesh-list
64379342|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
64379343|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379344|NCT04870359|Prednisolone|prednisolone|mesh-list
64379345|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64379346|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379347|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
64379348|NCT04870359|Hormones|hormones|mesh-ancestor
64379349|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379350|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379351|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64379352|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379355|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64379356|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379370|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64379371|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
64379372|NCT00555555|Factor VIII|factor viii|mesh-list
64379373|NCT00555555|Coagulants|coagulants|mesh-ancestor
64379374|NCT05611593|Finasteride|finasteride|mesh-list
64379375|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64379376|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64379393|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379394|NCT02151682|Analgesics|analgesics|mesh-ancestor
64379395|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
64379396|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379397|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64379398|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64379399|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379400|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379401|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
64379402|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379403|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64379404|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64379405|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64379406|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379578|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64379580|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379581|NCT02149108|Nintedanib|nintedanib|mesh-list
64379583|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64379584|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379585|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379586|NCT02148718|Adalimumab|adalimumab|mesh-list
64379587|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379588|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379589|NCT03397953|Vinorelbine|vinorelbine|mesh-list
64379590|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64379591|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379592|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64379593|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
64379594|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
64379595|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379596|NCT05549973|Dexamethasone|dexamethasone|mesh-list
64379597|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379598|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
64379599|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
64379600|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379601|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379602|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379603|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
64379604|NCT05549973|Hormones|hormones|mesh-ancestor
64379605|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379639|NCT02172040|Analgesics|analgesics|mesh-ancestor
64379640|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
64379757|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64379758|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379759|NCT05553093|Incretins|incretins|mesh-ancestor
64379761|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379762|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
64379763|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64379764|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64379765|NCT04757740|Prednisolone|prednisolone|mesh-list
64379766|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
64379767|NCT04757740|Lidocaine|lidocaine|mesh-list
64379768|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64379769|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
64379770|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
64379771|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
64379772|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379773|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379774|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
64379775|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379776|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64379777|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64379778|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64379779|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379805|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
64379806|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379807|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379808|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
64379809|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64379810|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379811|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379812|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64379814|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379816|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64379817|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
64379818|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379819|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379820|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379821|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64377921|NCT04850001|Aspirin|aspirin|mesh-list
64379822|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64379823|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379825|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64379827|NCT02109484|Vaccines|vaccines|mesh-list
64379828|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
64379829|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379830|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
64379831|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64379832|NCT05134792|Antibodies|antibodies|mesh-list
64379833|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
64379834|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64379835|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
64379870|NCT02142712|Famotidine|famotidine|mesh-list
64379871|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64379872|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379873|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64379905|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379906|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379907|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379908|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64379909|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64379910|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
64379911|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
64379912|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379914|NCT02141854|Xhance|xhance|mesh-list
64379915|NCT02141854|Albuterol|albuterol|mesh-list
64379916|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64379917|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
64379918|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379919|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64379920|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
64379921|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379922|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379923|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64379924|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379926|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64379927|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64380015|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380016|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380017|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64380018|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380019|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64380020|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
64380021|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380022|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
64380023|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380024|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380025|NCT02105116|Cytarabine|cytarabine|mesh-list
64380026|NCT02105116|Fludarabine|fludarabine|mesh-list
64380027|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
64380028|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380029|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64380030|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
64380031|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380032|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380033|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
64380034|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380035|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
64380068|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64380073|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380103|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64380104|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380105|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64380106|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64380107|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380108|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380109|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64380113|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
64380116|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
64380117|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64380118|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380147|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
64380148|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64380158|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64380159|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380160|NCT05539521|Propofol|propofol|mesh-list
64380161|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64380162|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380163|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380164|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64380188|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380189|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380190|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64380191|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380192|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64380193|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
64380195|NCT01666119|Buprenorphine|buprenorphine|mesh-list
64380196|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64380197|NCT01666119|Narcotics|narcotics|mesh-ancestor
64380208|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64380209|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380210|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380211|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
64380212|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
64380214|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380215|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64380216|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64380247|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64380248|NCT05545059|Diuretics|diuretics|mesh-ancestor
64380249|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
64380250|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64380251|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64380252|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
64380253|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380254|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64380256|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
64380257|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380290|NCT05536011|Methylphenidate|methylphenidate|mesh-list
64380291|NCT05536011|Modafinil|modafinil|mesh-list
64380292|NCT05536011|Amphetamine|amphetamine|mesh-list
64380293|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64380335|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380336|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
64380372|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64380373|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
64380374|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
64380375|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64380376|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64380377|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64380378|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64380379|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
64380380|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380381|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380382|NCT02584257|Miotics|miotics|mesh-ancestor
64380383|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64380384|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64380385|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64380386|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64380387|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
64380390|NCT04062201|Ofloxacin|ofloxacin|mesh-list
64380422|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
64380423|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
64380424|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
64380425|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380426|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64380427|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
64380428|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
64380429|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380430|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380431|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380432|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
64380433|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380434|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380435|NCT01582269|Lomustine|lomustine|mesh-list
64380436|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64380492|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380494|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380495|NCT03569085|Sevoflurane|sevoflurane|mesh-list
64380496|NCT03569085|Isoflurane|isoflurane|mesh-list
64380499|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
64380501|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380502|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380504|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380505|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380506|NCT03496779|Gemcitabine|gemcitabine|mesh-list
64380507|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64380508|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64380509|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64380516|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380517|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
64380518|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380519|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380520|NCT03398655|Paclitaxel|paclitaxel|mesh-list
64380521|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64380553|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64380554|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64380555|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380556|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380558|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64380559|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
64380560|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
64380561|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380562|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380563|NCT05494437|Gabapentin|gabapentin|mesh-list
64380564|NCT05494437|Nabilone|nabilone|mesh-list
64380565|NCT05494437|Analgesics|analgesics|mesh-ancestor
64380566|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
64380597|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64380598|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
64380599|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380600|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380601|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
64380604|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380605|NCT02581995|Aflibercept|aflibercept|mesh-list
64380606|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64380607|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64380649|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380688|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
64380725|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380726|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
64380727|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
64380728|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380760|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380761|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64380763|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
64380764|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64380765|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64380766|NCT02442791|Exenatide|exenatide|mesh-list
64380767|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380768|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380769|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64380770|NCT02442791|Incretins|incretins|mesh-ancestor
64380771|NCT02442791|Hormones|hormones|mesh-ancestor
64366091|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64366092|NCT05013437|Analgesics|analgesics|mesh-ancestor
64380772|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380773|NCT04756557|Fluorides|fluorides|mesh-list
64380808|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64380850|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380851|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380852|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380853|NCT02441933|Carboplatin|carboplatin|mesh-list
64380882|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380889|NCT02438657|Epinephrine|epinephrine|mesh-list
64380890|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
64380892|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380893|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380894|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
64380895|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380896|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64380897|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64380898|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64380899|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380900|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380901|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64380927|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
64380928|NCT03192059|Lansoprazole|lansoprazole|mesh-list
64380929|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
64380930|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380931|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
64380932|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380933|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380951|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64380952|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64381019|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
64381020|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381022|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
64381023|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381024|NCT05389995|Expectorants|expectorants|mesh-ancestor
64381025|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
64381026|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64381027|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
64381028|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
64381029|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381030|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
64381056|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64381066|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
64381077|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
64381078|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64381098|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64381100|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64381101|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381116|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
64381118|NCT03117335|Endostatins|endostatins|mesh-list
64381119|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381120|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64381121|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64381122|NCT03117335|Growth Substances|growth substances|mesh-ancestor
64381123|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381124|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
64381126|NCT02435927|Fluorouracil|fluorouracil|mesh-list
64381127|NCT02435927|Capecitabine|capecitabine|mesh-list
64381128|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
64381129|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
64381130|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381131|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64381132|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381133|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381134|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
64381135|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381136|NCT02435927|Antidotes|antidotes|mesh-ancestor
64381137|NCT02435927|Protective Agents|protective agents|mesh-ancestor
64381161|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64381162|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
64381168|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64381169|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64381170|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64381171|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64381173|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381174|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
64381175|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381176|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
64381178|NCT02435537|Bupivacaine|bupivacaine|mesh-list
64381179|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
64381180|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
64381181|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381182|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381183|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
64381184|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381185|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64381186|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64381200|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381201|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64381203|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381204|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381205|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
64381206|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381216|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381217|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64381218|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381219|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381220|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
64381221|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
64381222|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64381223|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64381224|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381225|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381226|NCT02435303|Urological Agents|urological agents|mesh-ancestor
64381227|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64381228|NCT02434757|Hormones|hormones|mesh-ancestor
64381276|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381277|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
64381278|NCT04650087|Apixaban|apixaban|mesh-list
64381279|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64381280|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
64381281|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64381282|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
64381283|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381284|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381516|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
64381517|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381553|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64381554|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64381556|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381557|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
64381558|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381559|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64381560|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64381561|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64381562|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64381563|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381564|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381565|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
64381566|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381568|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381637|NCT02428751|Vincristine|vincristine|mesh-list
64381639|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381647|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381649|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
64381650|NCT02428751|Hormones|hormones|mesh-ancestor
64381651|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381652|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64381653|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64381654|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
64381655|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
64381684|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
64381685|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381686|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381687|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381688|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381689|NCT03184805|Aspirin|aspirin|mesh-list
64381690|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64381691|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64381696|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381698|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64381699|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64381700|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381701|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64381702|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64381735|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
64381737|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64381738|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64381739|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
64381740|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381741|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64381742|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64381743|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64381744|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64381745|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
64381746|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64381747|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64381748|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
64381749|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
64381750|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64381808|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
64381809|NCT03186131|Vitamin D|vitamin d|mesh-list
64381810|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
64381811|NCT03186131|Vitamins|vitamins|mesh-ancestor
64381812|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
64381813|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381814|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64381815|NCT03184649|Acetaminophen|acetaminophen|mesh-list
64381816|NCT03184649|Ibuprofen|ibuprofen|mesh-list
64381817|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64381818|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64381819|NCT03184649|Analgesics|analgesics|mesh-ancestor
64381820|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
64381823|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381824|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64381825|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64381968|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64381969|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64381970|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64381971|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64381972|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64381973|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64381974|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
64381975|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
64382003|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382004|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
64382005|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
64382015|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64382016|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64382017|NCT02426723|Growth Substances|growth substances|mesh-ancestor
64382018|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
64366144|NCT04487743|Liraglutide|liraglutide|mesh-list
64382019|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
64382020|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
64382021|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64382022|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64382102|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
64382103|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64382107|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
64382108|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64382109|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382110|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382111|NCT03181919|Letrozole|letrozole|mesh-list
64382112|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382170|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64382171|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382206|NCT03117257|Cisplatin|cisplatin|mesh-list
64382207|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382208|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
64382209|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64382210|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
64382266|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64382267|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64382274|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64382275|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382276|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
64382277|NCT02423837|Rituximab|rituximab|mesh-list
64382278|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64382558|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382559|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64382560|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
64382562|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64382567|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382568|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382569|NCT05511831|Ketotifen|ketotifen|mesh-list
64382570|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
64382697|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64382698|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64382748|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382845|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64382846|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382847|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
64382848|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64382849|NCT04482881|Diuretics|diuretics|mesh-ancestor
64382852|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64382853|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382854|NCT03176693|Doxazosin|doxazosin|mesh-list
64382855|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
64382856|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64382857|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64382858|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64382859|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64382910|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
64382911|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382912|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382913|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
64382914|NCT02415179|Hormones|hormones|mesh-ancestor
64382956|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382963|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
64383392|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383393|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64383394|NCT02410031|Estrogens|estrogens|mesh-ancestor
64383396|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383397|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
64383398|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
64383399|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383400|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64383401|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
64383402|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383403|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383404|NCT05513625|Pritelivir|pritelivir|mesh-list
64383405|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
64384379|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64384381|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64384701|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
64384702|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
64384703|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384704|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
64384705|NCT04480775|Hormones|hormones|mesh-ancestor
64384706|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384707|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64384708|NCT04480775|Protective Agents|protective agents|mesh-ancestor
64384709|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384710|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384712|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
64384713|NCT02416817|Coagulants|coagulants|mesh-ancestor
64384714|NCT02399189|Methotrexate|methotrexate|mesh-list
64384715|NCT02399189|Temozolomide|temozolomide|mesh-list
64384716|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384717|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
64384718|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384719|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384800|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384801|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64384802|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
64384803|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384804|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384913|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64384914|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347760|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347761|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347762|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64347763|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347764|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64347765|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64424608|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
64347812|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64347813|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64347814|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64347815|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347816|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347817|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64347818|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64347819|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347820|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347821|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347832|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64347833|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347834|NCT02307695|Incretins|incretins|mesh-ancestor
64347836|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347837|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
64347838|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347839|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347840|NCT05161975|Vitamin K|vitamin k|mesh-list
64347841|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
64347842|NCT05161975|Vitamins|vitamins|mesh-ancestor
64347843|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
64347844|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347845|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64347846|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64347847|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347848|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
64347849|NCT05161975|Coagulants|coagulants|mesh-ancestor
64347850|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
64347851|NCT05707377|Tacrolimus|tacrolimus|mesh-list
64347852|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347853|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
64347854|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347855|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64347856|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347857|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347858|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347859|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64347860|NCT03504527|Budesonide|budesonide|mesh-list
64347861|NCT03504527|Bromides|bromides|mesh-list
64347892|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64347893|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347895|NCT04579783|Hormones|hormones|mesh-ancestor
64347896|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347897|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347898|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347899|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
64347964|NCT05094375|Misoprostol|misoprostol|mesh-list
64347965|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64347966|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
64347967|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64347968|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347969|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64347970|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64347971|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
64347972|NCT04345861|Azithromycin|azithromycin|mesh-list
64347973|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
64347974|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64347975|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347976|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
64348010|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64348011|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348012|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
64348013|NCT05062174|Mifepristone|mifepristone|mesh-list
64348014|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64348016|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64348017|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348018|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64348019|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64348020|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64348021|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
64348022|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64348029|NCT05095467|Paclitaxel|paclitaxel|mesh-list
64348210|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
64348211|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64348212|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64348213|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
64348214|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64348215|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64348216|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
64348217|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348218|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
64348219|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64348220|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64348221|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348222|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64348223|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348224|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64348226|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
64348227|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64348228|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348229|NCT02226562|Listerine|listerine|mesh-list
64348230|NCT02226562|Fluorides|fluorides|mesh-list
64348231|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
64348232|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
64348233|NCT02226562|Protective Agents|protective agents|mesh-ancestor
64348234|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348235|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64348236|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348237|NCT04430985|Leucovorin|leucovorin|mesh-list
64348238|NCT04430985|Fluorouracil|fluorouracil|mesh-list
64348239|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
64348240|NCT04430985|Nivolumab|nivolumab|mesh-list
64348241|NCT04430985|Ipilimumab|ipilimumab|mesh-list
64348242|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
64348293|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64348294|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64348295|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64348296|NCT02874430|Metformin|metformin|mesh-list
64348297|NCT02874430|Doxycycline|doxycycline|mesh-list
64348298|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64348299|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348300|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348301|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348302|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
64348303|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64348304|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64348306|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64348307|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64348308|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348309|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348310|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348311|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64348312|NCT03506009|Argatroban|argatroban|mesh-list
64348313|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64348315|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348316|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
64348393|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64348394|NCT04658173|Alfentanil|alfentanil|mesh-list
64348395|NCT04658173|Propofol|propofol|mesh-list
64348396|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64348397|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348398|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348399|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64348400|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
64348401|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
64348402|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64348403|NCT04658173|Narcotics|narcotics|mesh-ancestor
64348404|NCT04658173|Analgesics|analgesics|mesh-ancestor
64348405|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
64348406|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348407|NCT02399410|Bevacizumab|bevacizumab|mesh-list
64348408|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
64348409|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348410|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348411|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64348412|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64348413|NCT02399410|Growth Substances|growth substances|mesh-ancestor
64348414|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348415|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
64348416|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
64348417|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64348418|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64348419|NCT03636165|Prednisolone|prednisolone|mesh-list
64348420|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
64348421|NCT03636165|Ropivacaine|ropivacaine|mesh-list
64348422|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64348423|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
64348424|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
64348425|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
64348467|NCT02758431|Acyline|acyline|mesh-list
64348468|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
64348469|NCT02758431|Hormones|hormones|mesh-ancestor
64348470|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348502|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
64348503|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
64348504|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348506|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
64348507|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64348508|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64348509|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348510|NCT02738879|Incretins|incretins|mesh-ancestor
64348511|NCT02738879|Hormones|hormones|mesh-ancestor
64348512|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348513|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64348514|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
64348522|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348524|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64348525|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
64348526|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348527|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
64348528|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348529|NCT03253913|Protective Agents|protective agents|mesh-ancestor
64348530|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348531|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64348532|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
64348533|NCT03237819|Analgesics|analgesics|mesh-ancestor
64348534|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
64348535|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348536|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348537|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
64348538|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348539|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64348550|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348551|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64348552|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64348553|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348554|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348555|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64348556|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64348557|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
64348558|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
64348559|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64348560|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64348561|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64348564|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
64348567|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64348568|NCT05089851|Protective Agents|protective agents|mesh-ancestor
64348569|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
64348570|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64348579|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348580|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64348581|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348582|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348583|NCT05390749|Rituximab|rituximab|mesh-list
64348584|NCT05390749|Methotrexate|methotrexate|mesh-list
64348585|NCT05390749|Pomalidomide|pomalidomide|mesh-list
64348586|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348587|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348588|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
64348589|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348590|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64348591|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64348592|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
64348595|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
64348617|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64348618|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348619|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348620|NCT02314013|Metronidazole|metronidazole|mesh-list
64348621|NCT02314013|Cephalosporins|cephalosporins|mesh-list
64348622|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348623|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348624|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64348625|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64348627|NCT01677195|Antacids|antacids|mesh-ancestor
64348662|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64348663|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348664|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348665|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64348666|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
64348667|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
64348668|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
64348670|NCT03502421|Analgesics|analgesics|mesh-ancestor
64348671|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
64348672|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348673|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348674|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64348675|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64348676|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
64348677|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
64348678|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348679|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64348730|NCT02224846|Urological Agents|urological agents|mesh-ancestor
64348731|NCT03470077|Nalbuphine|nalbuphine|mesh-list
64348732|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348733|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348734|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64348735|NCT03470077|Narcotics|narcotics|mesh-ancestor
64348736|NCT03470077|Analgesics|analgesics|mesh-ancestor
64348737|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
64348738|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348739|NCT03519295|Atezolizumab|atezolizumab|mesh-list
64348740|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348741|NCT02224690|Cannabidiol|cannabidiol|mesh-list
64348742|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
64348743|NCT05150431|Parecoxib|parecoxib|mesh-list
64348744|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64348745|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64348746|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348747|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348771|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
64348772|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348773|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64348774|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64348775|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
64348776|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348777|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348778|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64348779|NCT05390203|Testosterone|testosterone|mesh-list
64348780|NCT05390203|Androgens|androgens|mesh-ancestor
64348781|NCT05390203|Hormones|hormones|mesh-ancestor
64348782|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348783|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348785|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64348786|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
64348787|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348788|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348850|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
64348851|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64348852|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
64348853|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
64348869|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64348870|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348871|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348872|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64348873|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64348874|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
64348875|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348876|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64348877|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64348879|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64348880|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
64348881|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
64348882|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
64348883|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64348884|NCT02724241|Nicotine|nicotine|mesh-list
64348885|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64348886|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
64348887|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348888|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348889|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64348890|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64348891|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
64296064|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296065|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348892|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348893|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348894|NCT02315651|Ubiquinone|ubiquinone|mesh-list
64348895|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
64348896|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
64348897|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348898|NCT02315651|Vitamins|vitamins|mesh-ancestor
64348899|NCT05366725|Avelumab|avelumab|mesh-list
64348900|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348901|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348902|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
64348903|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
64348904|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64348958|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348959|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64348960|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64348961|NCT04454281|Naloxone|naloxone|mesh-list
64348962|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64348963|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348964|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
64348965|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348966|NCT02318225|Misoprostol|misoprostol|mesh-list
64348967|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64348968|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
64348969|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64348970|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349042|NCT02321579|Pyridoxal|pyridoxal|mesh-list
64349043|NCT02321579|Pyridoxine|pyridoxine|mesh-list
64349044|NCT02321579|Vitamins|vitamins|mesh-ancestor
64349045|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
64349046|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349066|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64349114|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64349115|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
64349116|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64349117|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349135|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64349136|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
64349137|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64349138|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64349139|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349141|NCT04691362|Coagulants|coagulants|mesh-ancestor
64349142|NCT03499223|Ranibizumab|ranibizumab|mesh-list
64349143|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64349144|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64349145|NCT03499223|Growth Substances|growth substances|mesh-ancestor
64349166|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
64349167|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
64349168|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349169|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349171|NCT05398393|Amlodipine|amlodipine|mesh-list
64349172|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
64349173|NCT05398393|Atorvastatin|atorvastatin|mesh-list
64349174|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
64349175|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64349176|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
64349177|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349178|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64424609|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349217|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64349218|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64349219|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64349220|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64349221|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349222|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349223|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
64349224|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64349225|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
64349226|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64349227|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349228|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349229|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
64349230|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64349232|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64349233|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
64349265|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349266|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349267|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
64349268|NCT05398081|Cefuroxime|cefuroxime|mesh-list
64349269|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
64349270|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64349271|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349272|NCT02324621|TIC10 compound|tic10 compound|mesh-list
64349273|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349274|NCT03821545|Lidocaine|lidocaine|mesh-list
64349275|NCT03821545|Ketamine|ketamine|mesh-list
64349276|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
64349277|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
64349278|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349279|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349280|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
64349281|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349282|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64349283|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64349284|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64349285|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349286|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349381|NCT02323607|Daunorubicin|daunorubicin|mesh-list
64349382|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64349383|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
64349384|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349385|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349386|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
64349387|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349388|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64349389|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
64349390|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349391|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64349392|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64349393|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64349394|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349396|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
64349397|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349398|NCT03493841|Protective Agents|protective agents|mesh-ancestor
64349399|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349400|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
64349401|NCT03493841|Vitamins|vitamins|mesh-ancestor
64349402|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
64349403|NCT05118737|Colchicine|colchicine|mesh-list
64349404|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
64349405|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64349406|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
64349411|NCT04987931|Talazoparib|talazoparib|mesh-list
64349415|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349417|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64349418|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64349419|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349420|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
64349421|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349422|NCT03491579|Cytarabine|cytarabine|mesh-list
64349423|NCT03491579|Cladribine|cladribine|mesh-list
64349424|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64349425|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
64349426|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349516|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64349517|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
64349518|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349519|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349520|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64349521|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
64349522|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
64349523|NCT02736409|Hormones|hormones|mesh-ancestor
64349524|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349525|NCT05396677|Acetaminophen|acetaminophen|mesh-list
64349526|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64349527|NCT05396677|Analgesics|analgesics|mesh-ancestor
64349528|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
64349529|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349541|NCT05131867|Protective Agents|protective agents|mesh-ancestor
64349542|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349543|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64349544|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64349545|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349546|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349547|NCT02837783|Linaclotide|linaclotide|mesh-list
64349548|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64349549|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
64349550|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349551|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64349552|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64349553|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64349554|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64349566|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349567|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
64349568|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
64349569|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
64349570|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349571|NCT04952857|Vitamin D|vitamin d|mesh-list
64349573|NCT04952857|Vitamins|vitamins|mesh-ancestor
64349574|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
64349575|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349576|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64349577|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349578|NCT02220712|Aripiprazole|aripiprazole|mesh-list
64349579|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
64349580|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64349581|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64349592|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64349593|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64349594|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64349595|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64349596|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
64349597|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64349637|NCT00846430|Analgesics|analgesics|mesh-ancestor
64349638|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
64349639|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349640|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349641|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64349642|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64349643|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64349644|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349645|NCT05439577|Heparinoids|heparinoids|mesh-list
64349646|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
64349647|NCT05439577|Hormones|hormones|mesh-ancestor
64349649|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349712|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
64349713|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64349714|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
64349715|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64349716|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64349717|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64349718|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64349719|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64349720|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64349721|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64349722|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64349723|NCT05438875|Tretinoin|tretinoin|mesh-list
64349724|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349725|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
64349726|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349727|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
64349728|NCT04740307|Lenvatinib|lenvatinib|mesh-list
64349729|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349730|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349731|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64349732|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349733|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349764|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64349765|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64349766|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
64349796|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64349797|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64349798|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349799|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349800|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
64349801|NCT03490487|Prednisolone|prednisolone|mesh-list
64349803|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
64349804|NCT03490487|Levetiracetam|levetiracetam|mesh-list
64349805|NCT03490487|Valproic Acid|valproic acid|mesh-list
64349806|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
64349807|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349808|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
64349809|NCT03490487|Hormones|hormones|mesh-ancestor
64349810|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349811|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349812|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64349826|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
64349827|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64349828|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349829|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64349830|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64349831|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64349832|NCT05271331|Anesthetics|anesthetics|mesh-list
64349833|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
64349834|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349835|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349836|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
64349837|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349838|NCT03466567|Cyclosporine|cyclosporine|mesh-list
64349839|NCT03466567|Probenecid|probenecid|mesh-list
64349840|NCT03466567|Cyclosporins|cyclosporins|mesh-list
64349841|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349842|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349843|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64349844|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
64349845|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349846|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
64349847|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349885|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349886|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64349887|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
64349888|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349889|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
64349890|NCT03492047|Paclitaxel|paclitaxel|mesh-list
64349891|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64349892|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64349893|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349894|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
64349895|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
64349896|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
64349897|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349898|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
64349899|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349900|NCT03492047|Expectorants|expectorants|mesh-ancestor
64349901|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
64349902|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64349903|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
64349904|NCT03492047|Protective Agents|protective agents|mesh-ancestor
64349905|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349906|NCT03492047|Antidotes|antidotes|mesh-ancestor
64349907|NCT02251990|Grazoprevir|grazoprevir|mesh-list
64349908|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64349924|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64349925|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
64349926|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349927|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64349928|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64349929|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349930|NCT03490019|Metformin|metformin|mesh-list
64349931|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64349932|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349939|NCT03491969|Vitamins|vitamins|mesh-ancestor
64349963|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64349964|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64349965|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
64349966|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349967|NCT04108897|Doxycycline|doxycycline|mesh-list
64349968|NCT04108897|Ivermectin|ivermectin|mesh-list
64349969|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64349970|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349971|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
64349972|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64349973|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64349974|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64349975|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
64349976|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349977|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64349978|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64349979|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349980|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
64349981|NCT03489005|Zamicastat|zamicastat|mesh-list
64349982|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64350011|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350012|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64350026|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
64350027|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
64350028|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350029|NCT03461575|Cyclosporine|cyclosporine|mesh-list
64350030|NCT03461575|Cyclosporins|cyclosporins|mesh-list
64350031|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350032|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350033|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64350034|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
64350035|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350036|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
64350037|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350038|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
64350068|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
64350069|NCT03489395|Edoxaban|edoxaban|mesh-list
64350070|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64350071|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
64350089|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64350090|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
64350091|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64350092|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64350093|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350094|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
64350095|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64350125|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350126|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64350127|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350128|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350129|NCT04690673|Acetaminophen|acetaminophen|mesh-list
64350130|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64350131|NCT04690673|Analgesics|analgesics|mesh-ancestor
64350132|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
64350133|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350134|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350135|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
64350137|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64350138|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
64350139|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350140|NCT02907983|Bupivacaine|bupivacaine|mesh-list
64350141|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
64350142|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
64350143|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350144|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350145|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
64350146|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350147|NCT02841215|Ivermectin|ivermectin|mesh-list
64350148|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64350255|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
64350256|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350257|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350258|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64350259|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64350277|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350278|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350293|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64350294|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350295|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64350296|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64350299|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350300|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64350301|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64350302|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64350303|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
64350304|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350305|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350306|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64350307|NCT03876119|Plasminogen|plasminogen|mesh-list
64350308|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64350309|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64350310|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350311|NCT02455076|Exenatide|exenatide|mesh-list
64350312|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
64350313|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64350314|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350315|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64350316|NCT02455076|Incretins|incretins|mesh-ancestor
64350317|NCT02455076|Hormones|hormones|mesh-ancestor
64350318|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350319|NCT02432846|Sunitinib|sunitinib|mesh-list
64350331|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64350332|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350333|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350335|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350336|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64350337|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64350338|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350339|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350340|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64350341|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
64350342|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350343|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350344|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64350346|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350347|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64350348|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64350350|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64350351|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350352|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64350353|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64350354|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350355|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350356|NCT00805961|Bevacizumab|bevacizumab|mesh-list
64350357|NCT00805961|Everolimus|everolimus|mesh-list
64350358|NCT00805961|Temozolomide|temozolomide|mesh-list
64350359|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64350360|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350361|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296070|NCT02926586|Fludarabine|fludarabine|mesh-list
64350362|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64350363|NCT00805961|Growth Substances|growth substances|mesh-ancestor
64350364|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350365|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
64350366|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64350367|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
64350368|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64350370|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350371|NCT02454608|Verapamil|verapamil|mesh-list
64350372|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64350424|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350425|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350426|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350428|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64350429|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350430|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64350431|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350432|NCT02523833|Albuterol|albuterol|mesh-list
64350433|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64350434|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
64350435|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350436|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350437|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64350598|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64350599|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350600|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350601|NCT03478709|Norepinephrine|norepinephrine|mesh-list
64350602|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64350618|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64350619|NCT03475121|Topotecan|topotecan|mesh-list
64350620|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64350621|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64350622|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350623|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350624|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350625|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64350632|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
64350633|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350634|NCT02168842|Isradipine|isradipine|mesh-list
64350635|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64350636|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64350637|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350638|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350639|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64350640|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350641|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
64350642|NCT03347123|Nivolumab|nivolumab|mesh-list
64350643|NCT03347123|Ipilimumab|ipilimumab|mesh-list
64350644|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64350645|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350646|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64350647|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350648|NCT03131141|Lefamulin|lefamulin|mesh-list
64350649|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64350650|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350651|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64350652|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64350653|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350654|NCT03477929|Cetrorelix|cetrorelix|mesh-list
64350655|NCT03477929|Ganirelix|ganirelix|mesh-list
64350656|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
64350665|NCT03474263|Antibodies|antibodies|mesh-list
64350884|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350886|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296072|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64296074|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296075|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296077|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296078|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
64350952|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64350953|NCT03469895|Idelalisib|idelalisib|mesh-list
64350954|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350955|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351029|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
64351072|NCT05390255|Hormones|hormones|mesh-list
64351073|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351074|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351075|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351076|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
64351082|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351083|NCT04456829|Protective Agents|protective agents|mesh-ancestor
64351084|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351085|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351086|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64351088|NCT02492867|Carboplatin|carboplatin|mesh-list
64351089|NCT02492867|Durvalumab|durvalumab|mesh-list
64351090|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64351091|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351092|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
64351093|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
64351094|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
64351098|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64351110|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
64351111|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351112|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64351113|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64351114|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
64351115|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351116|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351117|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
64351118|NCT02522975|Hematinics|hematinics|mesh-ancestor
64351119|NCT04508803|Trastuzumab|trastuzumab|mesh-list
64351120|NCT04508803|Niraparib|niraparib|mesh-list
64351121|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351122|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351123|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64351124|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351126|NCT04492033|Paclitaxel|paclitaxel|mesh-list
64351299|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
64351300|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
64351301|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382871|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64351362|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64351363|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64351364|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64351365|NCT03453541|Analgesics|analgesics|mesh-ancestor
64351366|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
64351367|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351368|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351369|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351370|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351371|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64351372|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351373|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351374|NCT00893789|Modafinil|modafinil|mesh-list
64351375|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64351376|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351413|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351414|NCT04760041|Midazolam|midazolam|mesh-list
64351415|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64351424|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
64351436|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
64351437|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351438|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351439|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351440|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64351441|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64351442|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
64351443|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351444|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64351445|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
64351446|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
64351447|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
64351494|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351495|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
64351496|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351498|NCT05579249|Incretins|incretins|mesh-ancestor
64351499|NCT05579249|Hormones|hormones|mesh-ancestor
64351500|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351501|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64351502|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
64351503|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64351504|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64351505|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64351525|NCT01998529|Cisplatin|cisplatin|mesh-list
64351528|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64351529|NCT01998529|Protective Agents|protective agents|mesh-ancestor
64351530|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351531|NCT03448705|Vaccines|vaccines|mesh-list
64351532|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
64351533|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351534|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
64351535|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64351586|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351587|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
64351588|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351589|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351590|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351591|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64351592|NCT03436199|Analgesics|analgesics|mesh-ancestor
64351593|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
64351594|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351595|NCT02131324|Clobetasol|clobetasol|mesh-list
64351596|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352030|NCT05006599|Insulin|insulin|mesh-list
64352031|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64352042|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352043|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
64352044|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64352045|NCT03130517|Antibodies|antibodies|mesh-list
64352046|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
64352047|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64352048|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
64352049|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352050|NCT03445897|Miltefosine|miltefosine|mesh-list
64352051|NCT03445897|Pentamidine|pentamidine|mesh-list
64352052|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
64352053|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352054|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352055|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64352056|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64352057|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64352058|NCT03237611|Dexamethasone|dexamethasone|mesh-list
64352059|NCT03237611|Ondansetron|ondansetron|mesh-list
64352060|NCT03237611|Aprepitant|aprepitant|mesh-list
64352061|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
64352149|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352150|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64352151|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64352152|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352153|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352154|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64352155|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64352156|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352157|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64352158|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352159|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64352160|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352162|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
64352163|NCT03466775|Giapreza|giapreza|mesh-list
64352164|NCT03466775|Antibodies|antibodies|mesh-list
64352165|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
64352166|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
64352167|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352168|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64352170|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
64352171|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352172|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352174|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352175|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
64352418|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
64352419|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352420|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352440|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352441|NCT04452929|Calcitonin|calcitonin|mesh-list
64352442|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
64352443|NCT04452929|Cilostazol|cilostazol|mesh-list
64352463|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64352464|NCT04452929|Analgesics|analgesics|mesh-ancestor
64352465|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
64352466|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64352484|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352485|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64352486|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64352487|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352488|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
64352489|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64352490|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64352491|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352493|NCT05087199|Coagulants|coagulants|mesh-ancestor
64352494|NCT04628429|Erenumab|erenumab|mesh-list
64352495|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64352496|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352497|NCT04628429|Analgesics|analgesics|mesh-ancestor
64352498|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
64352499|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352500|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352501|NCT03461081|Amlodipine|amlodipine|mesh-list
64352502|NCT03461081|Telmisartan|telmisartan|mesh-list
64352503|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
64352504|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
64352506|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64352507|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64352508|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
64352509|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352510|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64352511|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64352512|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352513|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64352537|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64352538|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64352539|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64352540|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64352541|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352542|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64352543|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64352545|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
64352546|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352547|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64352577|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352578|NCT03460145|Propofol|propofol|mesh-list
64352579|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64352580|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352627|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353442|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353444|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
64353445|NCT03432923|Benzocaine|benzocaine|mesh-list
64353446|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353488|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64353490|NCT03432767|Analgesics|analgesics|mesh-ancestor
64353491|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
64353492|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353493|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353494|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353495|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353496|NCT03437057|Aspirin|aspirin|mesh-list
64353509|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64353510|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353511|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
64353512|NCT03579693|Niacinamide|niacinamide|mesh-list
64353513|NCT03579693|Niacin|niacin|mesh-list
64353514|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
64353515|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
64353516|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
64353517|NCT03579693|Vitamins|vitamins|mesh-ancestor
64353518|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
64353519|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353520|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64353521|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
64353522|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353523|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64353524|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
64353525|NCT03432689|Cycloserine|cycloserine|mesh-list
64353526|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64353527|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353528|NCT03432689|Renal Agents|renal agents|mesh-ancestor
64353729|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353730|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
64353731|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64353733|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353734|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353735|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64353736|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353750|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353751|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353753|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353754|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64353755|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353756|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353757|NCT03430817|Amantadine|amantadine|mesh-list
64353758|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64353759|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64353761|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
64353762|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353763|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
64353764|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353765|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353766|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366468|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353767|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353842|NCT03429101|Trastuzumab|trastuzumab|mesh-list
64353843|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64353844|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64353845|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353846|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
64353847|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
64353848|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
64353849|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353850|NCT04116203|Metformin|metformin|mesh-list
64353851|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64353852|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353853|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64353854|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
64353855|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353856|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
64353857|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64353858|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64353891|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353892|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353893|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353894|NCT03423329|Ibuprofen|ibuprofen|mesh-list
64353895|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64353896|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353897|NCT03423329|Analgesics|analgesics|mesh-ancestor
64353898|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
64353899|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353900|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353901|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353902|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353903|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64353904|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353905|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353906|NCT02380742|Lidocaine|lidocaine|mesh-list
64353907|NCT02380742|Prilocaine|prilocaine|mesh-list
64353908|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64353909|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353910|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
64353911|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353912|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353913|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
64353914|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353915|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64353916|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64353917|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64353984|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353986|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353987|NCT03426527|Analgesics|analgesics|mesh-ancestor
64353995|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353996|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353997|NCT02805257|Mitomycins|mitomycins|mesh-list
64353998|NCT02805257|Mitomycin|mitomycin|mesh-list
64353999|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64354000|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354001|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
64354002|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354003|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64366512|NCT04486651|Irinotecan|irinotecan|mesh-list
64354004|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354005|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64354006|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
64354007|NCT02636387|Coagulants|coagulants|mesh-ancestor
64354008|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64354009|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
64354012|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
64354970|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354971|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354972|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
64354973|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354974|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64354975|NCT03415087|Narcotics|narcotics|mesh-ancestor
64354976|NCT03415087|Analgesics|analgesics|mesh-ancestor
64354977|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64354978|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64355853|NCT02410772|Rifapentine|rifapentine|mesh-list
64355854|NCT02410772|Rifampin|rifampin|mesh-list
64355855|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64355856|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355857|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64355858|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64355859|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355860|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355861|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355862|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64355863|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
64355872|NCT03814317|Treprostinil|treprostinil|mesh-list
64355874|NCT03127319|Docetaxel|docetaxel|mesh-list
64355875|NCT03127319|Apatinib|apatinib|mesh-list
64355876|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355877|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
64355878|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
64355879|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
64355880|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355881|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64355882|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355883|NCT03417947|Vitamin D|vitamin d|mesh-list
64355884|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
64355885|NCT03417947|Vitamins|vitamins|mesh-ancestor
64355886|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
64355887|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355888|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64355889|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64355890|NCT03905811|Terazosin|terazosin|mesh-list
64355891|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64355892|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64355893|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64355894|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
64355895|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355896|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355897|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355901|NCT05171309|Apatinib|apatinib|mesh-list
64356194|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
64356195|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356196|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64356197|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64356198|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64356199|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356200|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356201|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356202|NCT03399955|Amphotericin B|amphotericin b|mesh-list
64356203|NCT03399955|Paromomycin|paromomycin|mesh-list
64356204|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64356205|NCT03399955|Miltefosine|miltefosine|mesh-list
64356206|NCT03399955|Amebicides|amebicides|mesh-ancestor
64356207|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64356208|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64356209|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356504|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356505|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356506|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64356507|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356508|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
64356509|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64356520|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356521|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64356522|NCT04446715|Narcotics|narcotics|mesh-ancestor
64356523|NCT04446715|Analgesics|analgesics|mesh-ancestor
64356524|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64356525|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356526|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
64356612|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356613|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
64356614|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356615|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356617|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
64356618|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356619|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356620|NCT03389659|Vitamin D|vitamin d|mesh-list
64356621|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
64356622|NCT03389659|Vitamins|vitamins|mesh-ancestor
64356623|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
64356809|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356810|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356811|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
64356812|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64356813|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64356814|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356815|NCT04447105|Anesthetics|anesthetics|mesh-list
64356816|NCT04447105|Propofol|propofol|mesh-list
64356817|NCT04447105|Desflurane|desflurane|mesh-list
64356818|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356819|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356820|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356821|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356822|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
64356823|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64356905|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64356906|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356907|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64356908|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
64356909|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356916|NCT00540839|Montelukast|montelukast|mesh-list
64356917|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64356918|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64356919|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
64356920|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356921|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356922|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64356923|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356924|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
64356925|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64356926|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64356927|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
64356928|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356929|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64357007|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357008|NCT03395665|Progestins|progestins|mesh-ancestor
64357009|NCT00535405|Atorvastatin|atorvastatin|mesh-list
64357010|NCT00535405|Simvastatin|simvastatin|mesh-list
64357012|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64357013|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64357014|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
64357015|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357016|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64357017|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64357061|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64357062|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
64357063|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357064|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357082|NCT03858049|Progestins|progestins|mesh-ancestor
64357083|NCT03858049|Hormones|hormones|mesh-ancestor
64357084|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357085|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357086|NCT03388151|Midazolam|midazolam|mesh-list
64357087|NCT03388151|Propofol|propofol|mesh-list
64357088|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64357089|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357090|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357091|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64357092|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
64357094|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64357095|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64357096|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64357097|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64357098|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
64357099|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
64357100|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357101|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357102|NCT03392909|Gentamicins|gentamicins|mesh-list
64357103|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357104|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357105|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64357106|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357107|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357108|NCT04501211|Granisetron|granisetron|mesh-list
64357109|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
64357110|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
64357139|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64357140|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64357141|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
64357142|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357143|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357144|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357145|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
64357146|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64357147|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64357148|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
64357149|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64357150|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357151|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
64357152|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
64357153|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64357154|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
64357155|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357156|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
64357157|NCT04446533|Protective Agents|protective agents|mesh-ancestor
64357205|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357206|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64357208|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
64357209|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357210|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64357211|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64357212|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64357213|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
64357214|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357215|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357216|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64357217|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
64357218|NCT02732015|Dexamethasone|dexamethasone|mesh-list
64357220|NCT02732015|Doxorubicin|doxorubicin|mesh-list
64357221|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64357222|NCT02732015|Vincristine|vincristine|mesh-list
64357223|NCT02732015|Daunorubicin|daunorubicin|mesh-list
64357224|NCT02732015|Ifosfamide|ifosfamide|mesh-list
64357225|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
64357226|NCT02732015|Ondansetron|ondansetron|mesh-list
64357227|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
64357228|NCT02732015|Aprepitant|aprepitant|mesh-list
64357229|NCT02732015|BB 1101|bb 1101|mesh-list
64357230|NCT02732015|Rolapitant|rolapitant|mesh-list
64357231|NCT02732015|Mesna|mesna|mesh-list
64357232|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64357233|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
64357234|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
64357235|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357242|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357243|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
64357244|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357245|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357246|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64357247|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64357248|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64357249|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64357250|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64357251|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
64357252|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64357255|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64357281|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
64357282|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
64357283|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357284|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64357285|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357286|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64357287|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64357288|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64357351|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64357352|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357353|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64357354|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64357355|NCT05174195|Progestins|progestins|mesh-ancestor
64357357|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357568|NCT03378401|Octenidine|octenidine|mesh-list
64357569|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357570|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64357571|NCT03378323|Anesthetics|anesthetics|mesh-list
64357572|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
64357573|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357574|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357575|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
64357576|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357705|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64357706|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382873|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64357720|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
64357721|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64357722|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64357723|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
64357724|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357725|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64357726|NCT02520505|Citric Acid|citric acid|mesh-list
64357727|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
64357728|NCT02520505|Clomiphene|clomiphene|mesh-list
64357729|NCT02520505|Enclomiphene|enclomiphene|mesh-list
64357730|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
64357731|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
64357732|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64357733|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
64357734|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
64357735|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357736|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64357737|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
64357738|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357739|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357740|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64357741|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
64357742|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64357743|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64357744|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64357745|NCT03380689|Bevacizumab|bevacizumab|mesh-list
64357746|NCT03380689|Irinotecan|irinotecan|mesh-list
64357747|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64357814|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357816|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357817|NCT04420741|Iloprost|iloprost|mesh-list
64357818|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64357819|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
64357820|NCT04409041|Naltrexone|naltrexone|mesh-list
64357821|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64357822|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64357823|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357824|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
64382874|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
64357839|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64357840|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64357841|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357842|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357843|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357844|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357845|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64357846|NCT04446091|Growth Substances|growth substances|mesh-ancestor
64357847|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357848|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
64357850|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
64357851|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64357852|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
64357853|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357854|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357855|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
64357856|NCT03385057|Acetaminophen|acetaminophen|mesh-list
64357857|NCT03385057|Ibuprofen|ibuprofen|mesh-list
64357858|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64357859|NCT03385057|Analgesics|analgesics|mesh-ancestor
64357860|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
64357861|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357862|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357863|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
64357864|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64357865|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64357866|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64357867|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64357893|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
64357894|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64357895|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64357896|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64357897|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64357898|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
64357899|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357900|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357951|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64357952|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357953|NCT03375463|Incretins|incretins|mesh-ancestor
64357955|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358009|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64358010|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64358011|NCT03378427|Renal Agents|renal agents|mesh-ancestor
64358012|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64358013|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
64358014|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
64358015|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64358016|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64358017|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64358018|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64358019|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64358020|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64358021|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64358022|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64358023|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64358024|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64358025|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64358026|NCT05172115|Heparin|heparin|mesh-list
64358027|NCT05172115|Enoxaparin|enoxaparin|mesh-list
64358028|NCT05172115|Plasminogen|plasminogen|mesh-list
64358029|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64358030|NCT05172115|Tinzaparin|tinzaparin|mesh-list
64382875|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
64358044|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358045|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64358046|NCT03383185|Hormones|hormones|mesh-ancestor
64358047|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358048|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64358049|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64358050|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64358051|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64358052|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64358053|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358054|NCT03377725|Decitabine|decitabine|mesh-list
64358070|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
64358071|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358072|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358073|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358074|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64358075|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64358076|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64358077|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64358078|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64358079|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64358080|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358096|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64358097|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358098|NCT03373903|Everolimus|everolimus|mesh-list
64358099|NCT03373903|Dactolisib|dactolisib|mesh-list
64358100|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358101|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64358113|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64358114|NCT03373825|Narcotics|narcotics|mesh-ancestor
64358115|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358116|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358117|NCT03373825|Analgesics|analgesics|mesh-ancestor
64358118|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
64358119|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358120|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64358121|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64358122|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
64358194|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
64358195|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358196|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358197|NCT03381703|YH12852|yh12852|mesh-list
64358198|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64358199|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64358200|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
64358201|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358268|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
64358270|NCT04527133|Aprotinin|aprotinin|mesh-list
64358370|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358371|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358372|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
64358379|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
64358645|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
64358646|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
64358647|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
64358649|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64358659|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
64358660|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64358661|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
64358662|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358663|NCT05405049|Lidocaine|lidocaine|mesh-list
64358664|NCT05405049|Fentanyl|fentanyl|mesh-list
64358665|NCT05405049|Morphine|morphine|mesh-list
64358666|NCT05405049|Bupivacaine|bupivacaine|mesh-list
64358667|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
64358669|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358683|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
64358684|NCT04520503|Propofol|propofol|mesh-list
64358685|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64358686|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358687|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358688|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64358689|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
64358690|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
64358691|NCT02871843|Temozolomide|temozolomide|mesh-list
64358692|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64358693|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
64358694|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358702|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358703|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64358704|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
64358705|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64358706|NCT04523467|Growth Substances|growth substances|mesh-ancestor
64358707|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358708|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
64358709|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358724|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64358725|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64358726|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358727|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
64358728|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
64358729|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
64358733|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358734|NCT04523233|Vitamins|vitamins|mesh-list
64358735|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
64358736|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358737|NCT05127369|Fluoxetine|fluoxetine|mesh-list
64358738|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64358739|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64358740|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358741|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358742|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358743|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
64358755|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
64358756|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64358757|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64358758|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358759|NCT03356353|Urological Agents|urological agents|mesh-ancestor
64358760|NCT04520035|Paclitaxel|paclitaxel|mesh-list
64358761|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64358762|NCT04520035|Cisplatin|cisplatin|mesh-list
64358763|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64358764|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358765|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64358766|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64358767|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64358768|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358769|NCT04208997|Amiodarone|amiodarone|mesh-list
64358770|NCT04208997|Sotalol|sotalol|mesh-list
64358771|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64358772|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
64358773|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64358774|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358775|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358776|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64358777|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64358778|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64358779|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358780|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64358844|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358845|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64358846|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
64358847|NCT04523077|Antibodies|antibodies|mesh-list
64358848|NCT04523077|Hormones|hormones|mesh-list
64358849|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
64358850|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358858|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
64358859|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
64358860|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64358861|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358862|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358863|NCT03366259|Misoprostol|misoprostol|mesh-list
64358864|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64358865|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
64358866|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64358867|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358868|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64358869|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64358870|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
64358871|NCT03366025|Progesterone|progesterone|mesh-list
64358872|NCT03366025|Progestins|progestins|mesh-ancestor
64358873|NCT03366025|Hormones|hormones|mesh-ancestor
64358874|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358875|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358876|NCT05115591|Anesthetics|anesthetics|mesh-list
64358877|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358878|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358879|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
64358880|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64358881|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
64358882|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358883|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
64358884|NCT05403099|Protective Agents|protective agents|mesh-ancestor
64358885|NCT03365869|Sirolimus|sirolimus|mesh-list
64358886|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64358887|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358888|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64358889|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358906|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
64358907|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
64358908|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358909|NCT03684213|Protective Agents|protective agents|mesh-ancestor
64358964|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358966|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358967|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
64358968|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
64358970|NCT04509583|Vitamins|vitamins|mesh-ancestor
64358971|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
64358972|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358973|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
64358974|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359123|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359125|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
64359277|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382876|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359827|NCT03346681|Expectorants|expectorants|mesh-ancestor
64359828|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
64359829|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64359830|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
64359831|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359832|NCT03346681|Protective Agents|protective agents|mesh-ancestor
64359833|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359834|NCT03346681|Antidotes|antidotes|mesh-ancestor
64359835|NCT04488315|Dexamethasone|dexamethasone|mesh-list
64359836|NCT04488315|Ropivacaine|ropivacaine|mesh-list
64359837|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359838|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
64359839|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
64359840|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359841|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359852|NCT00709735|Propranolol|propranolol|mesh-list
64359853|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64359854|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64359890|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359891|NCT05135013|Drospirenone|drospirenone|mesh-list
64359892|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64359893|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64359894|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64359895|NCT05135013|Norethindrone|norethindrone|mesh-list
64359896|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
64359897|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
64359899|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64359900|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
64359908|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64359909|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64359910|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64359911|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64359912|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
64359913|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64359915|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
64359917|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64359918|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64359919|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359920|NCT04505917|Misoprostol|misoprostol|mesh-list
64359921|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64359922|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
64359923|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64359924|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359925|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64359926|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376947|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382878|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378677|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378678|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
64378679|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
64378680|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379519|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379943|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379944|NCT02141620|Protective Agents|protective agents|mesh-ancestor
64379945|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379947|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
64379948|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
64379949|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379950|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
64379951|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379952|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64379953|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64379954|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64379955|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379956|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
64379957|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381588|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64381589|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64381590|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
64381591|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381592|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381608|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
64381725|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64381726|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
64382405|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64382406|NCT02100670|Analgesics|analgesics|mesh-ancestor
64382407|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
64382408|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382409|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382410|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382411|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382412|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64382413|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382414|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382415|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
64382416|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
64382417|NCT02100514|Bococizumab|bococizumab|mesh-list
64382418|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64382419|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64382420|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
64382880|NCT02415335|Hormones|hormones|mesh-ancestor
64382447|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
64383075|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
64383076|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383077|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383078|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64383079|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64383080|NCT02413853|Growth Substances|growth substances|mesh-ancestor
64383081|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383082|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
64383083|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64383084|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
64383085|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383086|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64383087|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383088|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
64383089|NCT02413853|Antidotes|antidotes|mesh-ancestor
64383090|NCT02413853|Protective Agents|protective agents|mesh-ancestor
64383091|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
64383092|NCT02413853|Vitamins|vitamins|mesh-ancestor
64383093|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
64383094|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
64383154|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383194|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
64383195|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383196|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64383197|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64383198|NCT02412059|Protective Agents|protective agents|mesh-ancestor
64383199|NCT05090085|Z 350|z 350|mesh-list
64383200|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64383201|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64383202|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383203|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383204|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
64383205|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383206|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383214|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383215|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64383216|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
64383217|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383219|NCT05520645|Etomidate|etomidate|mesh-list
64383220|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64383221|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383222|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383223|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64383224|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
64383226|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64383227|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64383280|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64383282|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64383283|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
64383284|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383285|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383286|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383287|NCT02044510|Urological Agents|urological agents|mesh-ancestor
64383291|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64383292|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64383293|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
64366585|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
64383294|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383295|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64383296|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64383297|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383298|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64383301|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64383307|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383309|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64383311|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
64383312|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64383313|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64383314|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
64383315|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383316|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64383317|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64383318|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383319|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383320|NCT05514405|Propofol|propofol|mesh-list
64383321|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64383322|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383323|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383324|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64383325|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
64383326|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
64383327|NCT02410655|Oxytocin|oxytocin|mesh-list
64383328|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
64383329|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64383330|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383341|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383342|NCT04987775|Expectorants|expectorants|mesh-ancestor
64383343|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
64383344|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64383345|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
64383605|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383606|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
64383608|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383609|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383610|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64383611|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64383612|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
64383613|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64383619|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
64383620|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383706|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64383707|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64383708|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383709|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383719|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64383720|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64383721|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64383723|NCT04591431|Nivolumab|nivolumab|mesh-list
64383875|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383876|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64383877|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383878|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64383879|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
64383880|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383881|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383882|NCT04582305|Bleomycin|bleomycin|mesh-list
64383883|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64383884|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383885|NCT05504967|Dexamethasone|dexamethasone|mesh-list
64383951|NCT04698850|Ranibizumab|ranibizumab|mesh-list
64383952|NCT04698850|Aflibercept|aflibercept|mesh-list
64383953|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64383954|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64383955|NCT04698850|Growth Substances|growth substances|mesh-ancestor
64383956|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383957|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
64383958|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383960|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64383961|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383962|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384083|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64384084|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384085|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64383002|NCT01663857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384086|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384089|NCT02093026|Rituximab|rituximab|mesh-list
64384090|NCT02093026|Methotrexate|methotrexate|mesh-list
64384091|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64384092|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384093|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
64384095|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384117|NCT02093026|Hematinics|hematinics|mesh-ancestor
64384118|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
64384572|NCT04603911|Hormones|hormones|mesh-ancestor
64384573|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384574|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384577|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
64384835|NCT02397863|Cannabidiol|cannabidiol|mesh-list
64384836|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
64384837|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
64384838|NCT04357587|Capecitabine|capecitabine|mesh-list
64384839|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64384840|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384841|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64384842|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
64384843|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384844|NCT04058717|Nicotine|nicotine|mesh-list
64384845|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64384846|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
64384847|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385101|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385102|NCT05478291|Vitamin D|vitamin d|mesh-list
64385103|NCT05478291|Vitamins|vitamins|mesh-ancestor
64385104|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
64385105|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385106|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64385107|NCT04543071|Gemcitabine|gemcitabine|mesh-list
64385108|NCT04543071|Paclitaxel|paclitaxel|mesh-list
64385109|NCT04543071|Cemiplimab|cemiplimab|mesh-list
64385110|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64294196|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294197|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64294198|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294199|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64294200|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294203|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64294204|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385260|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385261|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
64385262|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385263|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
64385264|NCT03434769|Fludarabine|fludarabine|mesh-list
64385265|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385266|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
64385267|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385268|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385269|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64385270|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
64385271|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385272|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294205|NCT05384847|Hormones|hormones|mesh-list
64294206|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294207|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385312|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
64385313|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366603|NCT03246919|Oxytocin|oxytocin|mesh-list
64385314|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64385315|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
64385379|NCT05745233|Nivolumab|nivolumab|mesh-list
64385380|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385381|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385382|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64385383|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385799|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385800|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
64385801|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385802|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385803|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
64385804|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385805|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64385812|NCT05428215|Estradiol|estradiol|mesh-list
64385904|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64385905|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385906|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385908|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385909|NCT03162185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64385910|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
64385911|NCT03162185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64385912|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64385913|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64385914|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385915|NCT05324501|Lomustine|lomustine|mesh-list
64385916|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64385927|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385928|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385929|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64385930|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
64385953|NCT02683187|Hormones|hormones|mesh-ancestor
64385954|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385955|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64385956|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
64385957|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385958|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385959|NCT05515601|Mirikizumab|mirikizumab|mesh-list
64385960|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64385961|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64385962|NCT05515601|Analgesics|analgesics|mesh-ancestor
64385963|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
64386006|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
64386007|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64386008|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386009|NCT05178173|Ethanol|ethanol|mesh-list
64386015|NCT05169437|Niraparib|niraparib|mesh-list
64386162|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
64294231|NCT03070951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294232|NCT03070951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294233|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64294234|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64294238|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
64294239|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
64366611|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
64294240|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294241|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294268|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64294270|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294271|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
64294272|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
64294273|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294274|NCT04574713|Candesartan|candesartan|mesh-list
64294295|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294296|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64294297|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294299|NCT03023462|Oxycodone|oxycodone|mesh-list
64294301|NCT03023462|Ropivacaine|ropivacaine|mesh-list
64294303|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
64294304|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294305|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294306|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
64294307|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294308|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64294309|NCT03023462|Narcotics|narcotics|mesh-ancestor
64294310|NCT03023462|Analgesics|analgesics|mesh-ancestor
64294311|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
64294312|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
64294313|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294314|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
64294315|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
64294316|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64294317|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
64294362|NCT03034538|Zonisamide|zonisamide|mesh-list
64294363|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
64294364|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64294365|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64294366|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294367|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64294368|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294369|NCT02468180|Polidocanol|polidocanol|mesh-list
64294370|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64294371|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64294372|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
64294373|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64294374|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64294385|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
64294387|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294388|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294390|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
64294391|NCT05134298|Meropenem|meropenem|mesh-list
64294392|NCT05134298|Tazobactam|tazobactam|mesh-list
64294393|NCT05134298|Piperacillin|piperacillin|mesh-list
64294411|NCT03954379|Anesthetics|anesthetics|mesh-list
64294412|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
64294413|NCT03954379|BB 1101|bb 1101|mesh-list
64294414|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64294415|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
64294416|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
64294417|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294418|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294419|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294457|NCT05133050|Ramipril|ramipril|mesh-list
64294458|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64294459|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
64294460|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294461|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294462|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64294463|NCT02817841|Drospirenone|drospirenone|mesh-list
64294464|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64294465|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
64294491|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64294492|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294493|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64294494|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
64294495|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64294496|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
64294497|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64294499|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294500|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64294501|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294502|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64294503|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294504|NCT05121038|Leucovorin|leucovorin|mesh-list
64294505|NCT05121038|Fluorouracil|fluorouracil|mesh-list
64294508|NCT05121038|Panitumumab|panitumumab|mesh-list
64294511|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294605|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64294638|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64294639|NCT05080790|Analgesics|analgesics|mesh-ancestor
64294640|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
64294641|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294642|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294643|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64294644|NCT02036827|Bromides|bromides|mesh-list
64294645|NCT02036827|Rocuronium|rocuronium|mesh-list
64294646|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
64294647|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64294660|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
64294661|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
64294662|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294669|NCT05714553|Vitamins|vitamins|mesh-ancestor
64294670|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
64294671|NCT05328440|Fulvestrant|fulvestrant|mesh-list
64294672|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64294673|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294674|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64294675|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64294677|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294678|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294683|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294742|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294743|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294745|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
64294746|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294747|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64294748|NCT02474667|Mitogens|mitogens|mesh-list
64294750|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294757|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294758|NCT01335997|Niacin|niacin|mesh-list
64294759|NCT01335997|Niacinamide|niacinamide|mesh-list
64294760|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
64294761|NCT01335997|Simvastatin|simvastatin|mesh-list
64294762|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64294763|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64294764|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
64294801|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64294802|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294804|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
64294805|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64294806|NCT02050009|Metformin|metformin|mesh-list
64294807|NCT02050009|Paclitaxel|paclitaxel|mesh-list
64294808|NCT02050009|Carboplatin|carboplatin|mesh-list
64294809|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64294810|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294811|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
64294812|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
64294813|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
64294814|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294815|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64294816|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294818|NCT04495088|Folic Acid|folic acid|mesh-list
64294819|NCT04495088|Capecitabine|capecitabine|mesh-list
64294820|NCT04495088|Fluorouracil|fluorouracil|mesh-list
64294821|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
64294822|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
64294823|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64294824|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
64294825|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294826|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294827|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64294833|NCT04495088|Vitamins|vitamins|mesh-ancestor
64294835|NCT04495088|Hematinics|hematinics|mesh-ancestor
64294837|NCT04717154|Ipilimumab|ipilimumab|mesh-list
64294838|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64294839|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294840|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64294841|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294859|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64294860|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294861|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64294862|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64294864|NCT04812002|Bevacizumab|bevacizumab|mesh-list
64294865|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64294867|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64294868|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64294869|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64294870|NCT04812002|Growth Substances|growth substances|mesh-ancestor
64294871|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294872|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
64294873|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294874|NCT03424460|Hemostatics|hemostatics|mesh-list
64294875|NCT03424460|Coagulants|coagulants|mesh-ancestor
64294876|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
64294877|NCT05712837|Salicylates|salicylates|mesh-list
64294878|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64294879|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
64294880|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
64294881|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
64294882|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64294883|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64294885|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
64294910|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64294912|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64294913|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64294914|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
64294915|NCT04821141|Estrogens|estrogens|mesh-list
64294916|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64294917|NCT04821141|Hormones|hormones|mesh-ancestor
64294918|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64294919|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64294921|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64294947|NCT02473887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64294948|NCT02473887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64294949|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
64294950|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64294951|NCT00071552|Fluticasone|fluticasone|mesh-list
64295211|NCT02415556|Insulin|insulin|mesh-list
64295584|NCT02037997|Pemetrexed|pemetrexed|mesh-list
64295585|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64295586|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64295587|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
64295588|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
64295589|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
64295590|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295591|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64295592|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64295593|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64295594|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64295595|NCT02056405|Mosapride|mosapride|mesh-list
64295597|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64295598|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
64295599|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64295600|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64295601|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64295602|NCT02056717|Dexamethasone|dexamethasone|mesh-list
64295603|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64295604|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
64295605|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
64295606|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64295607|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417272|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417688|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417690|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64417691|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
64417692|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64417693|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
64417694|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
64417695|NCT04799743|Resveratrol|resveratrol|mesh-list
64417696|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
64296041|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
64417840|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
64417841|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
64417842|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417843|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417844|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
64417845|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64417846|NCT03497689|Treprostinil|treprostinil|mesh-list
64417847|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64417848|NCT05611879|Paclitaxel|paclitaxel|mesh-list
64417849|NCT05611879|Carboplatin|carboplatin|mesh-list
64417850|NCT05611879|Pemetrexed|pemetrexed|mesh-list
64417851|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64417852|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417853|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
64417854|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
64417855|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
64417856|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417857|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417858|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64417860|NCT04789057|Atorvastatin|atorvastatin|mesh-list
64417881|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64417882|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417883|NCT05611645|Bevacizumab|bevacizumab|mesh-list
64417884|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64417885|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417886|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64417887|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64417888|NCT05611645|Growth Substances|growth substances|mesh-ancestor
64417889|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417890|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
64417891|NCT03267121|Apatinib|apatinib|mesh-list
64417892|NCT03267121|Tegafur|tegafur|mesh-list
64417893|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417894|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64417895|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64417896|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417897|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64417898|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
64417899|NCT02835079|Tamoxifen|tamoxifen|mesh-list
64417900|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64417901|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
64417902|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417903|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417904|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64417905|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64417906|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64417907|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64417908|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64417909|NCT01667107|Posaconazole|posaconazole|mesh-list
64417910|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
64417911|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64417918|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64417920|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
64417921|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64417922|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417924|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
64417925|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64417926|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
64417927|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64417928|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
64417929|NCT04589611|Protective Agents|protective agents|mesh-ancestor
64417930|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64417931|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64417932|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
64418027|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
64418029|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64418030|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64418031|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64418032|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64418033|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
64418034|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
64418035|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418036|NCT04762771|Colchicine|colchicine|mesh-list
64418037|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
64418038|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64418047|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64418084|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
64418149|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
64418150|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418151|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64366661|NCT02513069|Nicotine|nicotine|mesh-list
64418152|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
64418153|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64418172|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
64418200|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64418201|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
64418266|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
64418267|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418268|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64418270|NCT05548465|Remifentanil|remifentanil|mesh-list
64418271|NCT05548465|Dsuvia|dsuvia|mesh-list
64418272|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64418273|NCT05548465|Narcotics|narcotics|mesh-ancestor
64418274|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418275|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418276|NCT05548465|Analgesics|analgesics|mesh-ancestor
64418277|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
64418278|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418279|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64418282|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
64418302|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418303|NCT04326283|Trametinib|trametinib|mesh-list
64418304|NCT04326283|Riluzole|riluzole|mesh-list
64418305|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418306|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64418307|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418308|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418309|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
64418310|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64418361|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418362|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418363|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64418364|NCT05540275|Growth Substances|growth substances|mesh-ancestor
64418365|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418366|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
64418367|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
64418368|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64418369|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64418370|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64418371|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64418372|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418373|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
64418374|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418375|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418376|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64418377|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418378|NCT01666951|Tacrolimus|tacrolimus|mesh-list
64418379|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418418|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64418420|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
64418421|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418425|NCT02586727|Aflibercept|aflibercept|mesh-list
64418474|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
64418476|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64418477|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64418478|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418479|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418480|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
64418481|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
64418482|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
64418483|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418484|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
64418485|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
64418486|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64418487|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64418488|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
64418489|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
64418490|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418491|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418492|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64418493|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
64418494|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64418495|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
64418496|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
64418497|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418498|NCT05679037|Protective Agents|protective agents|mesh-ancestor
64418499|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418500|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
64418502|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
64418503|NCT05243329|Psilocybin|psilocybin|mesh-list
64418507|NCT05197621|Vaccines|vaccines|mesh-list
64418522|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418523|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
64418524|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64418525|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64418526|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418527|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64418528|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64418530|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418531|NCT02582749|Bicalutamide|bicalutamide|mesh-list
64418532|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
64418533|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
64418534|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
64418535|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418536|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418537|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418538|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64418539|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
64418540|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418541|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64418542|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64418543|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
64418544|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418574|NCT02586025|Pertuzumab|pertuzumab|mesh-list
64418575|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418576|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
64418577|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418578|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418579|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418580|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418581|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64418582|NCT05678413|Paclitaxel|paclitaxel|mesh-list
64418583|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64418584|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418585|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
64418586|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418587|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418588|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418589|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
64418590|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64418591|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
64418592|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418594|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
64418595|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64418596|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
64418597|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418598|NCT05123365|Protective Agents|protective agents|mesh-ancestor
64418599|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418600|NCT05123365|Antidotes|antidotes|mesh-ancestor
64418601|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
64418602|NCT05678335|Tacrolimus|tacrolimus|mesh-list
64418603|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418604|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
64418617|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64418618|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
64418619|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418620|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418622|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64418623|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
64418624|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418625|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64418626|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64418681|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64418682|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418683|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
64418684|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64418685|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64418686|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418688|NCT05678257|Protective Agents|protective agents|mesh-ancestor
64418689|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
64418691|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
64418692|NCT05078671|Cobicistat|cobicistat|mesh-list
64418693|NCT05078671|Olaparib|olaparib|mesh-list
64418694|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64418695|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418696|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418697|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418698|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64418699|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64418700|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
64418701|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418702|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64418703|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64418704|NCT02579863|Dexamethasone|dexamethasone|mesh-list
64418705|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
64418707|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64418708|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
64418709|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
64418710|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418711|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418712|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64418713|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
64418714|NCT02579863|Hormones|hormones|mesh-ancestor
64418715|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418716|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64418717|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418720|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418721|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64418722|NCT02579863|Growth Substances|growth substances|mesh-ancestor
64418723|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
64418724|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64418725|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64418727|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418728|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
64418729|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64418730|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64418731|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
64418732|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418733|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64418734|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64418735|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418736|NCT05038735|Fulvestrant|fulvestrant|mesh-list
64418737|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64418738|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418739|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64418740|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64418741|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
64418742|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418744|NCT04964947|Tobramycin|tobramycin|mesh-list
64418769|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
64418770|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
64418771|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
64418772|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418775|NCT02343939|Azacitidine|azacitidine|mesh-list
64418776|NCT02343939|Decitabine|decitabine|mesh-list
64418777|NCT02343939|Daunorubicin|daunorubicin|mesh-list
64418778|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64418779|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
64418780|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418781|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418782|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
64418783|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418784|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418785|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
64418786|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418787|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64418788|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64418789|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64418790|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64418791|NCT02343549|Bevacizumab|bevacizumab|mesh-list
64418792|NCT02343549|Temozolomide|temozolomide|mesh-list
64418793|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64418794|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418795|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418796|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64418797|NCT02343549|Growth Substances|growth substances|mesh-ancestor
64418798|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418799|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
64418800|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64418801|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
64418802|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418803|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64418804|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
64418805|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64418806|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
64418809|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64418810|NCT02395653|Narcotics|narcotics|mesh-ancestor
64418811|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418812|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418813|NCT02395653|Analgesics|analgesics|mesh-ancestor
64418814|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
64418815|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418816|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64418817|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64418818|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
64418819|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
64418820|NCT01664923|Bicalutamide|bicalutamide|mesh-list
64418821|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
64418822|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
64418823|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64418824|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418825|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64418826|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64418830|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418831|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
64418832|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64418833|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64418834|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64418835|NCT04403347|Losartan|losartan|mesh-list
64418845|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418846|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64418847|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64418848|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64418849|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418850|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418851|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64418852|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64418853|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64418854|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
64418855|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64418856|NCT05692297|Denosumab|denosumab|mesh-list
64418857|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64418858|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418859|NCT05696509|Anesthetics|anesthetics|mesh-list
64418860|NCT05696509|Propofol|propofol|mesh-list
64418861|NCT05696509|Sevoflurane|sevoflurane|mesh-list
64418862|NCT05696509|Isoflurane|isoflurane|mesh-list
64418863|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418864|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418865|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64418866|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64418868|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64418869|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64418870|NCT02584855|Ixekizumab|ixekizumab|mesh-list
64418871|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
64418872|NCT02581891|Aflibercept|aflibercept|mesh-list
64418873|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64418887|NCT02581345|Adalimumab|adalimumab|mesh-list
64418890|NCT05579509|Fentanyl|fentanyl|mesh-list
64418891|NCT05579509|Midazolam|midazolam|mesh-list
64418892|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64418893|NCT05579509|Narcotics|narcotics|mesh-ancestor
64418894|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64418895|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418896|NCT05579509|Analgesics|analgesics|mesh-ancestor
64418897|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
64418898|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64418899|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64418900|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64418901|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
64418902|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
64418903|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64418904|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64418905|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64418906|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64418907|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
64418951|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64418952|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64418953|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64418954|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
64418955|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64418956|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419021|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419022|NCT02577523|Levodopa|levodopa|mesh-list
64419023|NCT02577523|Carbidopa|carbidopa|mesh-list
64419024|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64419025|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64419026|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64419027|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
64419028|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419029|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419030|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419031|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64419032|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419085|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419086|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
64419087|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64419088|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419089|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419090|NCT05519839|Vaccines|vaccines|mesh-list
64419092|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419093|NCT05529667|Paclitaxel|paclitaxel|mesh-list
64419094|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419095|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419096|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
64419097|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
64419098|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
64419099|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419100|NCT03571633|Paclitaxel|paclitaxel|mesh-list
64419101|NCT03571633|Trastuzumab|trastuzumab|mesh-list
64419102|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64419138|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64419139|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
64419140|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419141|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419142|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64419143|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
64419144|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419145|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419146|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64419147|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
64419148|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419149|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64419150|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64419151|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419152|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419153|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64419154|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64419156|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64419157|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64419158|NCT03009019|Analgesics|analgesics|mesh-ancestor
64419159|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
64419160|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419161|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419162|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419163|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419164|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64419165|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64419168|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
64419182|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
64419183|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
64419184|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419185|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419186|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
64419187|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419188|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
64419189|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419190|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419191|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
64419247|NCT01610713|Analgesics|analgesics|mesh-ancestor
64419248|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
64419249|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419250|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419251|NCT01606189|Nabiximols|nabiximols|mesh-list
64419252|NCT01606189|Analgesics|analgesics|mesh-ancestor
64419253|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
64419254|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419255|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419256|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
64419257|NCT05525065|Hormones|hormones|mesh-ancestor
64419258|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419259|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419260|NCT01663987|Bromides|bromides|mesh-list
64419261|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
64419262|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64419263|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
64419264|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419265|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419266|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64419267|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
64419269|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64419270|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
64419271|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419272|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419274|NCT05111353|Poly ICLC|poly iclc|mesh-list
64419296|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419298|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64419299|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
64419300|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419301|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
64419302|NCT02342223|Protective Agents|protective agents|mesh-ancestor
64419304|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64419305|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64419306|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
64419307|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419308|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419311|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
64419312|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419313|NCT05531383|Memantine|memantine|mesh-list
64419314|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64419315|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64419316|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
64419317|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419318|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419319|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419320|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64419321|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64419322|NCT02392611|Fulvestrant|fulvestrant|mesh-list
64419323|NCT02392611|Exemestane|exemestane|mesh-list
64419324|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419325|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419326|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64419327|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64419335|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
64419338|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
64419339|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419340|NCT05140525|Macitentan|macitentan|mesh-list
64419341|NCT05140525|Riociguat|riociguat|mesh-list
64419342|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64419343|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64419344|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419345|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64419346|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
64419347|NCT05518513|Bupivacaine|bupivacaine|mesh-list
64419348|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
64419349|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
64419350|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64419351|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419352|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
64419353|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419354|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
64419355|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64419356|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64419357|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419358|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
64419391|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64419392|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
64419393|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419395|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419396|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419397|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64419398|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419399|NCT05525767|Growth Substances|growth substances|mesh-ancestor
64419400|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419401|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
64419402|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64419403|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419404|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419405|NCT05522491|Olaparib|olaparib|mesh-list
64419445|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419447|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64419448|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419449|NCT04903509|Acetaminophen|acetaminophen|mesh-list
64419451|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64419452|NCT04903509|Analgesics|analgesics|mesh-ancestor
64419453|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
64419454|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419455|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419456|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
64419457|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64419458|NCT04903509|Incretins|incretins|mesh-ancestor
64419459|NCT04903509|Hormones|hormones|mesh-ancestor
64419460|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419461|NCT05517499|Dexamethasone|dexamethasone|mesh-list
64419463|NCT05517499|BB 1101|bb 1101|mesh-list
64419464|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419465|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
64419466|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
64419467|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419468|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419469|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419470|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
64419471|NCT05517499|Hormones|hormones|mesh-ancestor
64419472|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419473|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419474|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419475|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
64419476|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419477|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419478|NCT05012371|Everolimus|everolimus|mesh-list
64419479|NCT05012371|Lenvatinib|lenvatinib|mesh-list
64419480|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419481|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419482|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
64419483|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419484|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64419486|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419487|NCT05512351|Bevacizumab|bevacizumab|mesh-list
64419488|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419489|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419490|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64419491|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419492|NCT05512351|Growth Substances|growth substances|mesh-ancestor
64419548|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64419549|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64419550|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419551|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64419553|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
64419554|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419555|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64419556|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64419557|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64419558|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
64419559|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64419560|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64419561|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
64419562|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419563|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64419564|NCT02336607|Protective Agents|protective agents|mesh-ancestor
64419565|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64419566|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64419567|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
64419568|NCT02569801|Fulvestrant|fulvestrant|mesh-list
64419569|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419570|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419571|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64419572|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64419594|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
64419595|NCT04292743|Irinotecan|irinotecan|mesh-list
64419596|NCT04292743|Folfirinox|folfirinox|mesh-list
64419597|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
64419598|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419599|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64419600|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419601|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419602|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
64419603|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419604|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64419605|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64419606|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419608|NCT04292743|Protective Agents|protective agents|mesh-ancestor
64419609|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
64419610|NCT04292743|Vitamins|vitamins|mesh-ancestor
64419652|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419653|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
64419654|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64419655|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
64419656|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419657|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419658|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64419659|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
64419660|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
64419661|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64419662|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
64419667|NCT05515315|Paclitaxel|paclitaxel|mesh-list
64419715|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
64419716|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64419717|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
64419719|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64419720|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
64419721|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419722|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
64419723|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419724|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419725|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64419726|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
64419730|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64419731|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
64419732|NCT05510323|Hormones|hormones|mesh-ancestor
64419733|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419734|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419736|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
64419737|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419738|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64419739|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64419740|NCT05510323|Protective Agents|protective agents|mesh-ancestor
64419741|NCT04843579|Clarithromycin|clarithromycin|mesh-list
64419742|NCT04843579|Dexamethasone|dexamethasone|mesh-list
64419743|NCT04843579|Pomalidomide|pomalidomide|mesh-list
64419747|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64419748|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419751|NCT04843579|Hormones|hormones|mesh-ancestor
64419755|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64419756|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64419757|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64419758|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419759|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419760|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64419761|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64419762|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
64419763|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64419764|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64419766|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
64419767|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
64419768|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64419769|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
64419770|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419771|NCT02568397|Dabigatran|dabigatran|mesh-list
64419772|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
64419773|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64419774|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
64419775|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419776|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419777|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
64419805|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64419806|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
64419807|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64419808|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
64419809|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419810|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419811|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
64419812|NCT05506969|Vaccines|vaccines|mesh-list
64419813|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
64419814|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
64419815|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419816|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64419822|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419823|NCT05513131|Azacitidine|azacitidine|mesh-list
64419824|NCT05513131|Venetoclax|venetoclax|mesh-list
64419825|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
64419826|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64419827|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
64419828|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419829|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419854|NCT04584853|Anastrozole|anastrozole|mesh-list
64419855|NCT04584853|Exemestane|exemestane|mesh-list
64419856|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419857|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64419858|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64419859|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419860|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419861|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64419862|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
64419863|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64419864|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419865|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64419866|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64419867|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64419868|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64419870|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64419871|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419872|NCT02336451|Ceritinib|ceritinib|mesh-list
64419873|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419874|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64419875|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419877|NCT01648101|Ezogabine|ezogabine|mesh-list
64419887|NCT02372799|Fluoxetine|fluoxetine|mesh-list
64419900|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64419901|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419902|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64419903|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64419904|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
64419905|NCT02566993|Doxorubicin|doxorubicin|mesh-list
64419906|NCT02566993|Vincristine|vincristine|mesh-list
64419907|NCT02566993|Topotecan|topotecan|mesh-list
64419908|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64419909|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
64419910|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64419911|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64419912|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64419913|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
64419914|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419915|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64419916|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64419958|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64419959|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419961|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64419962|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64419964|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
64419965|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
64419966|NCT05504863|Hematinics|hematinics|mesh-ancestor
64419967|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
64419968|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64419969|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64419970|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64419971|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
64419972|NCT05507983|Coagulants|coagulants|mesh-ancestor
64420017|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
64420018|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420019|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420020|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64420021|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420022|NCT02310789|Ivacaftor|ivacaftor|mesh-list
64420023|NCT02310789|Pilocarpine|pilocarpine|mesh-list
64420024|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
64420025|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64420026|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64420027|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420028|NCT02310789|Miotics|miotics|mesh-ancestor
64420029|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
64420030|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420031|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420032|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64420033|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64420034|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
64420035|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420036|NCT02372253|Verapamil|verapamil|mesh-list
64420037|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64420038|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64420039|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64420040|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420041|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64420042|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420043|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
64420044|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
64420045|NCT02371629|Bromides|bromides|mesh-list
64420046|NCT02371629|Albuterol|albuterol|mesh-list
64420047|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
64420060|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420061|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420062|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64420063|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64420064|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64420065|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
64420066|NCT02559817|Linaclotide|linaclotide|mesh-list
64420067|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64420068|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
64420069|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420070|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64420076|NCT04577443|Adenosine|adenosine|mesh-list
64420077|NCT04577443|Analgesics|analgesics|mesh-ancestor
64420078|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
64420121|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420122|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420123|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64420124|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64420125|NCT05502991|Growth Substances|growth substances|mesh-ancestor
64420126|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420127|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
64420128|NCT04417621|Trametinib|trametinib|mesh-list
64420129|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420130|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64420131|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420132|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420133|NCT02563561|Apaziquone|apaziquone|mesh-list
64420134|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420135|NCT05498233|Pyridoxine|pyridoxine|mesh-list
64420136|NCT05498233|Doxylamine|doxylamine|mesh-list
64420137|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
64420138|NCT05498233|Vitamins|vitamins|mesh-ancestor
64420139|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
64420140|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420141|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
64420142|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
64420143|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420144|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64420145|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64420146|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
64420147|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
64420148|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420149|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420150|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64420151|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420152|NCT05497843|Chiauranib|chiauranib|mesh-list
64420153|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420154|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64420155|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420156|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420160|NCT05497765|Protective Agents|protective agents|mesh-ancestor
64420161|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420162|NCT04424875|Melatonin|melatonin|mesh-list
64420163|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
64420164|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420165|NCT04424875|Protective Agents|protective agents|mesh-ancestor
64420166|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420167|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420168|NCT04277845|Dexamethasone|dexamethasone|mesh-list
64420169|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
64420170|NCT04277845|Lenalidomide|lenalidomide|mesh-list
64420171|NCT04277845|Bortezomib|bortezomib|mesh-list
64420172|NCT04277845|BB 1101|bb 1101|mesh-list
64420173|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420174|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
64420175|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
64420176|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420177|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420178|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64420179|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
64420180|NCT04277845|Hormones|hormones|mesh-ancestor
64420181|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64420182|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64420183|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420184|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
64420185|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420186|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420187|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
64420188|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64420189|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64420190|NCT04277845|Growth Substances|growth substances|mesh-ancestor
64420191|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
64420203|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
64420204|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
64420205|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64420206|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64420207|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420208|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64420210|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420211|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64420213|NCT05560945|Listerine|listerine|mesh-list
64420214|NCT05560945|Fluorides|fluorides|mesh-list
64420215|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
64420216|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
64420219|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64420220|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420221|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
64420222|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64420223|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64420224|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420225|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
64420226|NCT04424563|Coagulants|coagulants|mesh-ancestor
64420227|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
64420228|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
64420229|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420231|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420232|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64420233|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64420234|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
64420235|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420236|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420237|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64420243|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420245|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420246|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420247|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64420248|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420249|NCT02556307|Ribavirin|ribavirin|mesh-list
64420250|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64420251|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
64420252|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420253|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
64420254|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420255|NCT04352101|Citalopram|citalopram|mesh-list
64420256|NCT04352101|Bupropion|bupropion|mesh-list
64420257|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64420258|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64420260|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420261|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420262|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
64420263|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420264|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64420265|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
64420266|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64420267|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64420268|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
64420269|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64420270|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64420273|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64420274|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420276|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
64420277|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
64420278|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420279|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420280|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
64420281|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420282|NCT05494567|Tadalafil|tadalafil|mesh-list
64420283|NCT05494567|Tamsulosin|tamsulosin|mesh-list
64420284|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
64420285|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
64420286|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64420287|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64420288|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420300|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
64420341|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
64420342|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64420343|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64420344|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420345|NCT04251169|Paclitaxel|paclitaxel|mesh-list
64420346|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
64420347|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64420348|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420349|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
64420350|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
64420351|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
64420352|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420368|NCT05493709|Leuprolide|leuprolide|mesh-list
64420403|NCT04235101|Trastuzumab|trastuzumab|mesh-list
64420404|NCT04235101|Niraparib|niraparib|mesh-list
64420405|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420406|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420407|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64420408|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420409|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420410|NCT04139395|Citric Acid|citric acid|mesh-list
64420411|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
64420412|NCT04139395|Gallium citrate|gallium citrate|mesh-list
64420413|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
64420414|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64420415|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
64420416|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
64420417|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420418|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64420419|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64420420|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
64420421|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420422|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
64420423|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420455|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420456|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64420457|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
64420458|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420459|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
64420460|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420462|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64420463|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64420464|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
64420465|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64420466|NCT02556775|Antibodies|antibodies|mesh-list
64420467|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
64420468|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64420469|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
64420470|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420471|NCT04080739|Ropivacaine|ropivacaine|mesh-list
64420472|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
64420473|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
64420474|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420475|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420476|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
64420477|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420478|NCT04071457|Lenalidomide|lenalidomide|mesh-list
64420479|NCT04071457|Daratumumab|daratumumab|mesh-list
64420480|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
64420481|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420482|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64420483|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64420497|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420499|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420504|NCT05488327|Lenalidomide|lenalidomide|mesh-list
64420505|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
64420506|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420507|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64420508|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64420509|NCT05488327|Growth Substances|growth substances|mesh-ancestor
64420510|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
64420511|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420512|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
64420561|NCT05487391|Pemetrexed|pemetrexed|mesh-list
64420562|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64420563|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420564|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
64420565|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
64420566|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
64420567|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420568|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420569|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64420570|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64420572|NCT05484193|Progestins|progestins|mesh-ancestor
64420573|NCT05484193|Hormones|hormones|mesh-ancestor
64420574|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64420575|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420576|NCT03796195|Bupivacaine|bupivacaine|mesh-list
64420577|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
64420578|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
64420579|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420580|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420582|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64420583|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
64420584|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64420585|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64420586|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420587|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
64420588|NCT04274335|Coagulants|coagulants|mesh-ancestor
64420607|NCT05479123|Timolol|timolol|mesh-list
64420608|NCT05479123|Propranolol|propranolol|mesh-list
64420609|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64420610|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64420611|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
64420612|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420613|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420614|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420615|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64420616|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64420670|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420671|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64420672|NCT03678025|Prednisone|prednisone|mesh-list
64420673|NCT03678025|Cortisone|cortisone|mesh-list
64420674|NCT03678025|Docetaxel|docetaxel|mesh-list
64420675|NCT03678025|Leuprolide|leuprolide|mesh-list
64420676|NCT03678025|Goserelin|goserelin|mesh-list
64420677|NCT03678025|Bicalutamide|bicalutamide|mesh-list
64420678|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64420679|NCT03678025|Flutamide|flutamide|mesh-list
64420680|NCT03678025|Nilutamide|nilutamide|mesh-list
64420681|NCT03678025|Tryptophan|tryptophan|mesh-list
64420682|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420683|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
64420684|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
64420685|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
64420686|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420687|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420688|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
64420689|NCT03678025|Hormones|hormones|mesh-ancestor
64420690|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64420692|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64420693|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64420694|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
64420695|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64420696|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
64420697|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
64420720|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420721|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64420722|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64420723|NCT05477797|Growth Substances|growth substances|mesh-ancestor
64420724|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
64420726|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
64420787|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
64420788|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64420789|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420790|NCT02554903|Macitentan|macitentan|mesh-list
64420791|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64420792|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64420793|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420794|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64420795|NCT03341689|Psilocybin|psilocybin|mesh-list
64420797|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420798|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64420799|NCT02332707|Ribavirin|ribavirin|mesh-list
64420800|NCT02332707|Grazoprevir|grazoprevir|mesh-list
64420801|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
64420802|NCT02332707|Ruzasvir|ruzasvir|mesh-list
64420803|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
64420804|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420805|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
64420806|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420807|NCT02370615|Itraconazole|itraconazole|mesh-list
64420808|NCT02370615|Digoxin|digoxin|mesh-list
64420809|NCT02370615|Midazolam|midazolam|mesh-list
64420810|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
64420811|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64420812|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64420813|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64420817|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64420818|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64420819|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
64420820|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
64420821|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
64420822|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
64420823|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420824|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420825|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
64420826|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64420827|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64420828|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64420829|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420830|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64420831|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
64420832|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64420874|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420876|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420877|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64420878|NCT02551159|Carboplatin|carboplatin|mesh-list
64420879|NCT02551159|Fluorouracil|fluorouracil|mesh-list
64420880|NCT02551159|Cetuximab|cetuximab|mesh-list
64420881|NCT02551159|Durvalumab|durvalumab|mesh-list
64420882|NCT02551159|Tremelimumab|tremelimumab|mesh-list
64420883|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64420884|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420885|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
64420886|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420887|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64420936|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64420937|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420940|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
64420941|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420942|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420943|NCT02553265|Carbidopa|carbidopa|mesh-list
64420944|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64420945|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64420946|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
64420947|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64420948|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64420949|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420950|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64420951|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64420957|NCT03215095|Durvalumab|durvalumab|mesh-list
64420958|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420959|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64420960|NCT01663103|Rilonacept|rilonacept|mesh-list
64420961|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64420978|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64420980|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64420981|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64420982|NCT05284643|Growth Substances|growth substances|mesh-ancestor
64420983|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64420984|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
64420985|NCT05092373|Paclitaxel|paclitaxel|mesh-list
64420986|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64421044|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64421045|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421046|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64421048|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421049|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421050|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
64421051|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421052|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64421053|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421054|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
64421055|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421056|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64421058|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
64421059|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421067|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64421068|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64421069|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64421070|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64421089|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421090|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
64421091|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
64421092|NCT04282109|Paclitaxel|paclitaxel|mesh-list
64421093|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64421157|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64421158|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64421159|NCT02489903|Gemcitabine|gemcitabine|mesh-list
64421160|NCT02489903|Paclitaxel|paclitaxel|mesh-list
64421161|NCT02489903|Etoposide|etoposide|mesh-list
64421162|NCT02489903|Vinorelbine|vinorelbine|mesh-list
64421163|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64421164|NCT02489903|Carboplatin|carboplatin|mesh-list
64421165|NCT02489903|Irinotecan|irinotecan|mesh-list
64421166|NCT02489903|Pemetrexed|pemetrexed|mesh-list
64421168|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64421169|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421170|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
64421171|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
64421172|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
64421173|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421175|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
64421176|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
64421177|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421178|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421179|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421180|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
64421210|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421211|NCT04324463|Aspirin|aspirin|mesh-list
64421212|NCT04324463|Interferons|interferons|mesh-list
64421213|NCT04324463|Interferon-beta|interferon-beta|mesh-list
64421214|NCT04324463|Colchicine|colchicine|mesh-list
64421215|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
64421216|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421217|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
64421218|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421219|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421220|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421221|NCT04324463|Analgesics|analgesics|mesh-ancestor
64421222|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
64421223|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421224|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421225|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421271|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64421273|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421274|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
64421275|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421276|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64421277|NCT02559713|Vedolizumab|vedolizumab|mesh-list
64421278|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421279|NCT05499065|Cetuximab|cetuximab|mesh-list
64421280|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421281|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421282|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
64421334|NCT04273607|Calcium heparin|calcium heparin|mesh-list
64421335|NCT04273607|Enoxaparin|enoxaparin|mesh-list
64421336|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
64421337|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64421338|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64296042|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421339|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421340|NCT05476081|Aspirin|aspirin|mesh-list
64421341|NCT05476081|Clopidogrel|clopidogrel|mesh-list
64421344|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421345|NCT05476081|Analgesics|analgesics|mesh-ancestor
64421346|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
64421347|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421397|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421398|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421399|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
64421401|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64421402|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64421404|NCT05434039|Diclofenac|diclofenac|mesh-list
64421462|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64421463|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
64421464|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421465|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
64421466|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421467|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421468|NCT02545075|Ipilimumab|ipilimumab|mesh-list
64421469|NCT02545075|Dacarbazine|dacarbazine|mesh-list
64421470|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421471|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421473|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421474|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64421475|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
64421476|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
64421477|NCT03007537|Hematinics|hematinics|mesh-ancestor
64421478|NCT03004183|Valacyclovir|valacyclovir|mesh-list
64421479|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
64421480|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421481|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421482|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
64421483|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421484|NCT02544763|Cannabidiol|cannabidiol|mesh-list
64421485|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
64421486|NCT02556203|Aspirin|aspirin|mesh-list
64421514|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64421515|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421516|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
64421517|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64421518|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
64421519|NCT02556203|Coagulants|coagulants|mesh-ancestor
64421520|NCT05485571|Methotrexate|methotrexate|mesh-list
64421521|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64421522|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
64421523|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64421524|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421525|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64421526|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
64421527|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421528|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421529|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
64421530|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421532|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421533|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
64421534|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421535|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64421536|NCT05496725|Micafungin|micafungin|mesh-list
64421537|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
64421538|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421539|NCT05490719|Cisplatin|cisplatin|mesh-list
64421540|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421541|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
64421545|NCT04424459|Analgesics|analgesics|mesh-ancestor
64421546|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
64421547|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421556|NCT05490485|Cisplatin|cisplatin|mesh-list
64421557|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421558|NCT05485103|Glycerol|glycerol|mesh-list
64421559|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64421560|NCT05485103|Protective Agents|protective agents|mesh-ancestor
64421561|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421562|NCT05490407|Carboplatin|carboplatin|mesh-list
64421563|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421564|NCT05490095|Everolimus|everolimus|mesh-list
64421565|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421566|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421567|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
64421568|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421569|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
64421570|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64421571|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
64421572|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64421573|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
64421574|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421575|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421576|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
64421577|NCT05496179|Metoclopramide|metoclopramide|mesh-list
64421578|NCT05496179|Prucalopride|prucalopride|mesh-list
64421579|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
64421580|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
64421581|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421582|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421583|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421584|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64421585|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64421602|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421603|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421604|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421605|NCT05489939|Salicylates|salicylates|mesh-list
64421606|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
64421607|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64421608|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421609|NCT05489939|Analgesics|analgesics|mesh-ancestor
64421610|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
64421611|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421612|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421613|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421614|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421615|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421616|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421617|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421618|NCT05495945|Propofol|propofol|mesh-list
64421619|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64421620|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64421621|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421622|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64421623|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
64421626|NCT03999749|Ipilimumab|ipilimumab|mesh-list
64421627|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421628|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421629|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64421630|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421631|NCT04139213|Naltrexone|naltrexone|mesh-list
64421632|NCT04139213|Buprenorphine|buprenorphine|mesh-list
64421633|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64421634|NCT04139213|Naloxone|naloxone|mesh-list
64421636|NCT04139213|Narcotics|narcotics|mesh-ancestor
64421642|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64421643|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64421650|NCT05488925|Vitamin E|vitamin e|mesh-list
64421715|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64421716|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
64421717|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421718|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421719|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64421720|NCT05494307|Terbutaline|terbutaline|mesh-list
64421721|NCT05494307|Danazol|danazol|mesh-list
64421722|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64421723|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
64421724|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421725|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421726|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64421727|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
64421728|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
64421729|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
64421730|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64421731|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64421732|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64421772|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421773|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64421774|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64421775|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64421776|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421777|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64421778|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64421779|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421780|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
64421781|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64421782|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64421783|NCT05487521|Prednisolone|prednisolone|mesh-list
64421784|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
64421785|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64421786|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
64421787|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421789|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
64421790|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421791|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421792|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64421793|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
64421794|NCT05487521|Hormones|hormones|mesh-ancestor
64424611|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64421795|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64421821|NCT05487443|Gemcitabine|gemcitabine|mesh-list
64421822|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64421823|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
64421824|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421825|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421826|NCT05487443|Antiviral Agents|antiviral agents|mesh-ancestor
64421827|NCT05487443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421828|NCT05487443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421829|NCT05487443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421830|NCT05487443|Immunologic Factors|immunologic factors|mesh-ancestor
64421831|NCT05487443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421833|NCT02558231|Tadalafil|tadalafil|mesh-list
64421834|NCT02558231|Macitentan|macitentan|mesh-list
64421883|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64421884|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421886|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
64421887|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64421888|NCT02554721|Aspirin|aspirin|mesh-list
64421889|NCT02554721|Cilostazol|cilostazol|mesh-list
64421890|NCT02554721|Clopidogrel|clopidogrel|mesh-list
64421891|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64421892|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64421893|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64421894|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64421895|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
64421896|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64421897|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64421900|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64421901|NCT02554721|Analgesics|analgesics|mesh-ancestor
64421902|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
64421903|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421904|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64421905|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64421906|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64421907|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64421908|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64421909|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64421910|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
64421911|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64421929|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64421930|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421931|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64421932|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64421933|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64296043|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64421992|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64421993|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64421994|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64421995|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
64421996|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64421997|NCT02551991|Antidotes|antidotes|mesh-ancestor
64421998|NCT02551991|Protective Agents|protective agents|mesh-ancestor
64421999|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
64422000|NCT02551991|Vitamins|vitamins|mesh-ancestor
64422001|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
64422002|NCT05491811|Bevacizumab|bevacizumab|mesh-list
64422003|NCT05491811|Ensartinib|ensartinib|mesh-list
64422004|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422005|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422006|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422007|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64422008|NCT05491811|Growth Substances|growth substances|mesh-ancestor
64422009|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422010|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
64422011|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64422012|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422013|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422014|NCT05478785|Cisplatin|cisplatin|mesh-list
64422015|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422042|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64422043|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
64422044|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64422045|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422046|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64422048|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
64366842|NCT02512523|Incretins|incretins|mesh-ancestor
64422050|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422051|NCT02544217|Protective Agents|protective agents|mesh-ancestor
64422052|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422053|NCT05427565|Caffeine|caffeine|mesh-list
64422054|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64422055|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422056|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64422057|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422058|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422059|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64422060|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64422061|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
64422062|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422063|NCT02533453|Exenatide|exenatide|mesh-list
64422064|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64422065|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422089|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64422090|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422091|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422092|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
64422093|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422094|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422095|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422096|NCT05470673|Metronidazole|metronidazole|mesh-list
64422097|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422098|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64422099|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64422100|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64422101|NCT05459285|Dulaglutide|dulaglutide|mesh-list
64422103|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422104|NCT02542943|Fluorides|fluorides|mesh-list
64422105|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
64422106|NCT02542943|Protective Agents|protective agents|mesh-ancestor
64422107|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422145|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
64422146|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422147|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64422148|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64422149|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64422150|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422151|NCT02542631|Insulin|insulin|mesh-list
64422152|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64422154|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422155|NCT02549573|Apomorphine|apomorphine|mesh-list
64422210|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422211|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64422212|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64422278|NCT02300259|Diltiazem|diltiazem|mesh-list
64422279|NCT02300259|Tadalafil|tadalafil|mesh-list
64422280|NCT02300259|Simvastatin|simvastatin|mesh-list
64422281|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64422282|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64422283|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
64422284|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422285|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64422286|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64422287|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422288|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
64422289|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422291|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64422292|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64422293|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
64366873|NCT02512055|Atropine|atropine|mesh-list
64366874|NCT02512055|Ketamine|ketamine|mesh-list
64422294|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422295|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422333|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
64422334|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422335|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
64422336|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422337|NCT05476679|Celecoxib|celecoxib|mesh-list
64422338|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422339|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422340|NCT05476679|Analgesics|analgesics|mesh-ancestor
64422341|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
64422342|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422343|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422344|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422345|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422346|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64422347|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64422348|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422349|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422390|NCT03029351|Incretins|incretins|mesh-ancestor
64422391|NCT03029351|Hormones|hormones|mesh-ancestor
64422392|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422393|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64422394|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
64422395|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422397|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64422398|NCT02365233|Pioglitazone|pioglitazone|mesh-list
64422399|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64422406|NCT02365233|Hormones|hormones|mesh-ancestor
64422456|NCT02294019|Ibuprofen|ibuprofen|mesh-list
64422457|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64422458|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422459|NCT02294019|Analgesics|analgesics|mesh-ancestor
64422460|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
64422461|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422462|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422463|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422464|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422465|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64422466|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422468|NCT02320149|Sarecycline|sarecycline|mesh-list
64422518|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64422519|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422521|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64422522|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64422523|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64422524|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
64422525|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422526|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64422527|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
64422529|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
64422530|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
64422531|NCT05447065|Vitamin D|vitamin d|mesh-list
64422532|NCT05447065|Vitamins|vitamins|mesh-ancestor
64422533|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
64422534|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422535|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64422536|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
64422537|NCT01351909|Veliparib|veliparib|mesh-list
64422538|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422539|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
64422540|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422571|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
64422573|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422574|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64422575|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64422576|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64422577|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422578|NCT02954081|Apremilast|apremilast|mesh-list
64422636|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422637|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64422638|NCT05417971|Fludarabine|fludarabine|mesh-list
64422639|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422640|NCT01728259|Dexamethasone|dexamethasone|mesh-list
64422642|NCT01728259|Pomalidomide|pomalidomide|mesh-list
64422643|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422644|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
64422645|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
64422648|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422649|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
64422650|NCT01728259|Hormones|hormones|mesh-ancestor
64422651|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422652|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64422653|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422675|NCT05416021|Dapivirine|dapivirine|mesh-list
64422693|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422695|NCT05415865|Lidocaine|lidocaine|mesh-list
64422696|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
64422697|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
64422698|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422699|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422700|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
64422701|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422707|NCT05415709|Paclitaxel|paclitaxel|mesh-list
64422758|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422759|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422760|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
64422762|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64422766|NCT01660711|Protective Agents|protective agents|mesh-ancestor
64422767|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
64422768|NCT01660711|Vitamins|vitamins|mesh-ancestor
64422769|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
64422770|NCT05475665|Amlodipine|amlodipine|mesh-list
64422771|NCT05475665|Irbesartan|irbesartan|mesh-list
64422821|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422822|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64422823|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64422824|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422825|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64422828|NCT02481635|Gemcitabine|gemcitabine|mesh-list
64422829|NCT02481635|Paclitaxel|paclitaxel|mesh-list
64422830|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64422831|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422832|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
64422833|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
64422834|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
64422835|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422836|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64422837|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
64422838|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
64422839|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422841|NCT02481635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422842|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
64422845|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64422846|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422847|NCT02362503|Fostemsavir|fostemsavir|mesh-list
64422848|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64422849|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64422850|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
64422851|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422852|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64422853|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64422854|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422855|NCT05394103|Pembrolizumab|pembrolizumab|mesh-list
64422860|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64422861|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422862|NCT05411159|Narcotics|narcotics|mesh-ancestor
64422863|NCT05411159|Analgesics|analgesics|mesh-ancestor
64422864|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
64422865|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422866|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
64422867|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64422868|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
64422869|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422871|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
64422872|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64422874|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422875|NCT02362425|Protective Agents|protective agents|mesh-ancestor
64422876|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422877|NCT02362425|Antidotes|antidotes|mesh-ancestor
64422878|NCT02362269|Vitamin D|vitamin d|mesh-list
64422879|NCT02362269|Vitamins|vitamins|mesh-ancestor
64422880|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
64422881|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422882|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64422883|NCT02529995|Osimertinib|osimertinib|mesh-list
64422884|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422886|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422887|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422888|NCT02319759|Ustekinumab|ustekinumab|mesh-list
64422889|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
64422890|NCT02318667|Golimumab|golimumab|mesh-list
64422892|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422905|NCT02291913|Tamoxifen|tamoxifen|mesh-list
64422906|NCT02291913|Everolimus|everolimus|mesh-list
64422907|NCT02291913|Letrozole|letrozole|mesh-list
64422908|NCT02291913|Fulvestrant|fulvestrant|mesh-list
64422909|NCT02291913|Anastrozole|anastrozole|mesh-list
64422910|NCT02291913|Exemestane|exemestane|mesh-list
64422911|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422912|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64422913|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
64422914|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422915|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64422916|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64422917|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422918|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422919|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64422921|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422936|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
64422937|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
64422939|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
64422940|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422941|NCT02360397|Ranolazine|ranolazine|mesh-list
64422942|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64422943|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64422944|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64422945|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64422946|NCT02317809|Hormones|hormones|mesh-ancestor
64422947|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64422948|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422949|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
64422950|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64422951|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422952|NCT01607905|Acetaminophen|acetaminophen|mesh-list
64422953|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64422954|NCT01607905|Analgesics|analgesics|mesh-ancestor
64422955|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
64422956|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422957|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422958|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
64422961|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422962|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
64422963|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
64422964|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64422965|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422966|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64422967|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
64422968|NCT02389543|Hormones|hormones|mesh-ancestor
64422970|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64422971|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64422972|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
64422973|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64422974|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64422975|NCT02389543|Growth Substances|growth substances|mesh-ancestor
64422976|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
64422978|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64422979|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64422986|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64422987|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
64422988|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64422989|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64422992|NCT00602641|Prednisone|prednisone|mesh-list
64422993|NCT00602641|Cortisone|cortisone|mesh-list
64422994|NCT00602641|Lenalidomide|lenalidomide|mesh-list
64422995|NCT00602641|Melphalan|melphalan|mesh-list
64422996|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
64422997|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64422998|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64422999|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
64423000|NCT00602641|Hormones|hormones|mesh-ancestor
64423001|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423002|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423003|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64423004|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423005|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
64423006|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64423007|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64423008|NCT00602641|Growth Substances|growth substances|mesh-ancestor
64423009|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
64423010|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64423011|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
64423058|NCT03929029|Ipilimumab|ipilimumab|mesh-list
64423059|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64423060|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423061|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423127|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64423128|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64423130|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64423131|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64423132|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
64423133|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423134|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423136|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64423137|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
64423138|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423139|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64423140|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64423141|NCT05564611|Omalizumab|omalizumab|mesh-list
64423142|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64423143|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64423184|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64423185|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423186|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423187|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423188|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423190|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
64423191|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423192|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64423193|NCT05304949|Ranibizumab|ranibizumab|mesh-list
64423194|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64423195|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64423196|NCT05304949|Growth Substances|growth substances|mesh-ancestor
64423198|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
64423199|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423203|NCT05334277|Bevacizumab|bevacizumab|mesh-list
64423242|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423243|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423244|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
64423245|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423246|NCT05353933|Pantoprazole|pantoprazole|mesh-list
64423247|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64423248|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64423249|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64423250|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423251|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423252|NCT05352685|Propofol|propofol|mesh-list
64423253|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64423254|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64423255|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423256|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64423257|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
64423299|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64423300|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
64423301|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423302|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64423304|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423305|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423306|NCT05347069|Analgesics|analgesics|mesh-ancestor
64423366|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423367|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
64423368|NCT05318755|Testosterone|testosterone|mesh-list
64423369|NCT05318755|Androgens|androgens|mesh-ancestor
64423370|NCT05318755|Hormones|hormones|mesh-ancestor
64423371|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423372|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423373|NCT05267743|Lansoprazole|lansoprazole|mesh-list
64423374|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
64423376|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64423377|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64423378|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423379|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423380|NCT05291845|Vaccines|vaccines|mesh-list
64423381|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
64423382|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423383|NCT05266807|Vancomycin|vancomycin|mesh-list
64423384|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
64423385|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64423386|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423387|NCT05314621|Fluticasone|fluticasone|mesh-list
64423421|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
64423422|NCT05263609|Axitinib|axitinib|mesh-list
64423423|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423424|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423425|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64423426|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423427|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423491|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423492|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423493|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64423495|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64423496|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64423497|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64423498|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
64423499|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64423500|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423501|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64423502|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64423503|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64423504|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64423505|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
64423550|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423551|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
64423552|NCT05216653|Capecitabine|capecitabine|mesh-list
64423553|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
64423554|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64423555|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
64424612|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64423556|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423558|NCT05214001|Almotriptan|almotriptan|mesh-list
64423611|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423613|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64423614|NCT04239313|Vaccines|vaccines|mesh-list
64423615|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
64423616|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423617|NCT05209867|Cannabidiol|cannabidiol|mesh-list
64423618|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
64423619|NCT05273827|Paclitaxel|paclitaxel|mesh-list
64423622|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423623|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64423673|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64423675|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423676|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423677|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64423678|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64423679|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
64423680|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423681|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423682|NCT05205811|Zonisamide|zonisamide|mesh-list
64423683|NCT05205811|Bupropion|bupropion|mesh-list
64423736|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64423738|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423739|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423740|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64423741|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
64423742|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64423743|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423744|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64423746|NCT05159245|Pertuzumab|pertuzumab|mesh-list
64423747|NCT05159245|Atezolizumab|atezolizumab|mesh-list
64423749|NCT05159245|Vemurafenib|vemurafenib|mesh-list
64423751|NCT05159245|Pralsetinib|pralsetinib|mesh-list
64423752|NCT05159245|Entrectinib|entrectinib|mesh-list
64423754|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423755|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64423756|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423788|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
64423789|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423790|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64423791|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64423793|NCT05189977|Prazosin|prazosin|mesh-list
64423794|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64423795|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64423796|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
64423797|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64423798|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423799|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423800|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64423801|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64423849|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64423850|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64423851|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64423853|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64423854|NCT05183737|Propolis|propolis|mesh-list
64423855|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423859|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
64423860|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
64423916|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64423917|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64423918|NCT04421911|Analgesics|analgesics|mesh-ancestor
64423919|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
64423920|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64423921|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64423922|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64423982|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64423983|NCT05081479|Expectorants|expectorants|mesh-ancestor
64423984|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
64423985|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64423986|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
64423987|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424050|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424052|NCT01364467|Guaifenesin|guaifenesin|mesh-list
64424053|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64424054|NCT01364467|Expectorants|expectorants|mesh-ancestor
64424057|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64424117|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64424118|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
64424119|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
64424120|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
64424121|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
64424122|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424123|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424124|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
64424125|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
64424129|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64424178|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64424179|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
64424181|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64424182|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424183|NCT04984993|Tadalafil|tadalafil|mesh-list
64424188|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424189|NCT04984993|Urological Agents|urological agents|mesh-ancestor
64424190|NCT04984837|Gemcitabine|gemcitabine|mesh-list
64424191|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
64424192|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64424193|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
64424194|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424195|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424196|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
64424197|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424198|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424199|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424200|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
64424201|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424202|NCT04983121|Antibodies|antibodies|mesh-list
64424203|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
64424204|NCT04983121|Mitogens|mitogens|mesh-list
64424209|NCT02291289|Bevacizumab|bevacizumab|mesh-list
64424226|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424227|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424228|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
64424229|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424230|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424231|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
64424232|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64424233|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424234|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64424235|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
64424236|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424237|NCT02358369|Timolol|timolol|mesh-list
64424238|NCT02358369|Bimatoprost|bimatoprost|mesh-list
64424239|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64424240|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64424241|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64424242|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64424243|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
64424244|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424245|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424246|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424247|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64424248|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64424249|NCT02316171|Mitomycins|mitomycins|mesh-list
64424250|NCT02316171|Mitomycin|mitomycin|mesh-list
64424251|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64424252|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424253|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
64424263|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64424264|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64424265|NCT02315625|Growth Substances|growth substances|mesh-ancestor
64424266|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
64424267|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424268|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424269|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424271|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
64424272|NCT02357979|Protective Agents|protective agents|mesh-ancestor
64424273|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424274|NCT02357901|Buprenorphine|buprenorphine|mesh-list
64424275|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64424276|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64424284|NCT01601847|Vitamin D|vitamin d|mesh-list
64424306|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424307|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
64424309|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424310|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424311|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424312|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424313|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
64424314|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
64424315|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424370|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424371|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64424372|NCT02288325|Milnacipran|milnacipran|mesh-list
64424375|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64424376|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64424377|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424378|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64424379|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424380|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
64424381|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64424382|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424384|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
64424385|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64424386|NCT04978051|Icatibant|icatibant|mesh-list
64424387|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64424388|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424389|NCT04978051|Analgesics|analgesics|mesh-ancestor
64424394|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424421|NCT02504671|Hematinics|hematinics|mesh-ancestor
64424422|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
64424423|NCT02504671|Vitamins|vitamins|mesh-ancestor
64424424|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
64424425|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424426|NCT02314143|Trametinib|trametinib|mesh-list
64424427|NCT02314143|Dabrafenib|dabrafenib|mesh-list
64424428|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424429|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424489|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64424490|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64424491|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424492|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424493|NCT04205539|Analgesics|analgesics|mesh-ancestor
64424616|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
64424617|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64424670|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
64424672|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424673|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424674|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424675|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424676|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424677|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
64424678|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64424679|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424680|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424681|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64424734|NCT01653847|Tacrolimus|tacrolimus|mesh-list
64424735|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64424740|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424741|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424742|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64424743|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64424744|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
64424745|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64424746|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424748|NCT02493751|Axitinib|axitinib|mesh-list
64424749|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64424750|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424751|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64424791|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64424793|NCT02491411|Hormones|hormones|mesh-ancestor
64424794|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424795|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64424796|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424797|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
64424798|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424857|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64424858|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64424859|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64424860|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64424861|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424862|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
64424863|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
64424864|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64424865|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64424866|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64424919|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64424920|NCT02486653|Urological Agents|urological agents|mesh-ancestor
64424921|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
64424922|NCT02475265|Estradiol|estradiol|mesh-list
64424923|NCT02475265|Estrogens|estrogens|mesh-ancestor
64424924|NCT02475265|Hormones|hormones|mesh-ancestor
64424925|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64424927|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64424928|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
64424983|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424985|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64424986|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
64424987|NCT02447887|Ixazomib|ixazomib|mesh-list
64424988|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64424989|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
64424990|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64424991|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64424992|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
64424993|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64424994|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64424995|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
64424996|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64424997|NCT02417935|Pregabalin|pregabalin|mesh-list
64424998|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64425041|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64425042|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64425043|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64425044|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
64425045|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425113|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
64425114|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64425115|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64425116|NCT01651039|Growth Substances|growth substances|mesh-ancestor
64425117|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
64425118|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64425119|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425120|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425121|NCT02349633|Palbociclib|palbociclib|mesh-list
64425122|NCT02349633|Avelumab|avelumab|mesh-list
64425123|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425124|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64425127|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64425128|NCT02275611|Oxytocin|oxytocin|mesh-list
64425129|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
64425171|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425174|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64425176|NCT02465515|Hormones|hormones|mesh-ancestor
64425177|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425238|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425239|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425240|NCT02442271|Ritonavir|ritonavir|mesh-list
64425241|NCT02442271|Ribavirin|ribavirin|mesh-list
64425243|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64425244|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
64425245|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425246|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425247|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64425248|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64425249|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
64425250|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425251|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64425252|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64425253|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
64425297|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425298|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64425299|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425300|NCT02463331|Amebicides|amebicides|mesh-ancestor
64425301|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64425302|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64366908|NCT02514941|Analgesics|analgesics|mesh-ancestor
64425303|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425304|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
64425306|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64425307|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64425308|NCT02463331|Analgesics|analgesics|mesh-ancestor
64425309|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
64425310|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425311|NCT02463331|Filaricides|filaricides|mesh-ancestor
64425312|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
64425314|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
64425315|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425316|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64425352|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
64425353|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
64425354|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
64425357|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64425358|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64425421|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
64425422|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
64425423|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425425|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
64425426|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
64425427|NCT02537015|Bimatoprost|bimatoprost|mesh-list
64425428|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64425429|NCT01660763|Sufentanil|sufentanil|mesh-list
64425432|NCT01660763|Narcotics|narcotics|mesh-ancestor
64425488|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
64425489|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
64425490|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425491|NCT02409355|Gemcitabine|gemcitabine|mesh-list
64425492|NCT02409355|Carboplatin|carboplatin|mesh-list
64425493|NCT02409355|Atezolizumab|atezolizumab|mesh-list
64425494|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425495|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64425496|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
64425497|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425498|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
64425499|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425500|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425501|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64425502|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
64425503|NCT02409355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425504|NCT02438371|Indomethacin|indomethacin|mesh-list
64425506|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64425545|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64425546|NCT04909333|Incretins|incretins|mesh-ancestor
64425547|NCT04909333|Hormones|hormones|mesh-ancestor
64425548|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425550|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
64425551|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425552|NCT02460991|Sorafenib|sorafenib|mesh-list
64425553|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425554|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64425555|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425556|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425558|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64425604|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425605|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64425606|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425607|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425608|NCT02263365|Loperamide|loperamide|mesh-list
64425609|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
64425610|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425611|NCT04858269|Paclitaxel|paclitaxel|mesh-list
64425612|NCT04858269|Carboplatin|carboplatin|mesh-list
64425671|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425672|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64425673|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425674|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
64425675|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
64425676|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64425677|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425678|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64425679|NCT02256969|Protective Agents|protective agents|mesh-ancestor
64425680|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64425681|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425682|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64425684|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64425685|NCT02256969|Emollients|emollients|mesh-ancestor
64425686|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
64425687|NCT05645913|Anticoagulants|anticoagulants|mesh-list
64425688|NCT02256267|Rifampin|rifampin|mesh-list
64425690|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
64425691|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64425692|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425725|NCT01640301|Interleukin-2|interleukin-2|mesh-list
64425726|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64425727|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
64425728|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425729|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64425730|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64425731|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
64425732|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425736|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
64425792|NCT05617209|Coagulants|coagulants|mesh-ancestor
64425793|NCT01639833|Hemostatics|hemostatics|mesh-list
64425794|NCT01639833|Coagulants|coagulants|mesh-ancestor
64425795|NCT01639131|Gemcitabine|gemcitabine|mesh-list
64425796|NCT01639131|Docetaxel|docetaxel|mesh-list
64425797|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64425798|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
64425800|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425801|NCT01639131|Antiviral Agents|antiviral agents|mesh-ancestor
64425802|NCT01639131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425803|NCT01639131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425804|NCT01639131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64425805|NCT01639131|Immunologic Factors|immunologic factors|mesh-ancestor
64425806|NCT01639131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425807|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
64425808|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
64425810|NCT01641159|Buspirone|buspirone|mesh-list
64425811|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64425812|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64425848|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
64425849|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64425850|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
64425851|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425852|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
64425853|NCT04853589|Protective Agents|protective agents|mesh-ancestor
64425854|NCT01638429|Rifaximin|rifaximin|mesh-list
64425855|NCT01638429|Neomycin|neomycin|mesh-list
64425856|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64425857|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425858|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64425859|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64425860|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425861|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425862|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64425881|NCT01601535|Irinotecan|irinotecan|mesh-list
64425908|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64425909|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64425910|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425911|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425912|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
64425913|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64425914|NCT04843917|Antibodies|antibodies|mesh-list
64425915|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
64425916|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
64425917|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425918|NCT04586985|Midazolam|midazolam|mesh-list
64425919|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64425920|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64425921|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425922|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425923|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64425924|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64425925|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425926|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64425927|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
64425929|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
64425930|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
64425931|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64425932|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425933|NCT04841343|Triamcinolone|triamcinolone|mesh-list
64425934|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64425935|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
64425936|NCT04841343|Hormones|hormones|mesh-ancestor
64425937|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64425938|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425939|NCT05244057|Interferons|interferons|mesh-list
64425940|NCT05244057|Tenofovir|tenofovir|mesh-list
64425941|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
64425942|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
64425943|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64425944|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425945|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
64425946|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64425947|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64425948|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64425949|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64425950|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64425952|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64425953|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
64425954|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425955|NCT05408403|Anesthetics|anesthetics|mesh-list
64425956|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64425957|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64425958|NCT04830735|Dasatinib|dasatinib|mesh-list
64425959|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64425960|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64425963|NCT05335317|Hormones|hormones|mesh-list
64425994|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64425995|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64425996|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64426002|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
64426003|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426004|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426005|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426006|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
64426056|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426057|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64426058|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64426059|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64426060|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426125|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426126|NCT03256149|Dexamethasone|dexamethasone|mesh-list
64426127|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426128|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
64426129|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
64426130|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426198|NCT02817633|Pemetrexed|pemetrexed|mesh-list
64426199|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426200|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
64426201|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
64426202|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
64426203|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426204|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426205|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64426206|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426209|NCT05651607|Cannabidiol|cannabidiol|mesh-list
64426210|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
64426212|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64426259|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426261|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64426262|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426329|NCT05163405|Bortezomib|bortezomib|mesh-list
64426330|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426331|NCT03822897|Cisplatin|cisplatin|mesh-list
64426332|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426333|NCT02311179|Cimetidine|cimetidine|mesh-list
64426334|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64426335|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426336|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64426337|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
64426338|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
64426389|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426390|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426391|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
64426392|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426393|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64426394|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
64426395|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64426396|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426397|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64426398|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
64426404|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
64426405|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64426406|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64426407|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426408|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64426409|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64426414|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
64426437|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64426438|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426439|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426441|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
64426442|NCT05031897|Melphalan|melphalan|mesh-list
64426443|NCT05031897|Fludarabine|fludarabine|mesh-list
64426444|NCT05031897|Tacrolimus|tacrolimus|mesh-list
64426445|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382870|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
64426505|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426507|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
64426508|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426509|NCT01035099|Letrozole|letrozole|mesh-list
64426510|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426511|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64426512|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64426569|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64426570|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426571|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426572|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
64426573|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426574|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64426575|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64426576|NCT04191447|Budesonide|budesonide|mesh-list
64426577|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
64426578|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64426579|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426580|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64426582|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426583|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426585|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
64426586|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
64426587|NCT04191447|Hormones|hormones|mesh-ancestor
64426588|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426591|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64426621|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
64426622|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426623|NCT02243631|Renal Agents|renal agents|mesh-ancestor
64426624|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
64426625|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64426626|NCT03401073|Antibodies|antibodies|mesh-list
64426627|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
64426628|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64426629|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
64426630|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426631|NCT02242305|Scopolamine|scopolamine|mesh-list
64426632|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64426633|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64426634|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
64426635|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
64426636|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426637|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426638|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64426639|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
64384021|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
64426644|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64426645|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
64426646|NCT02240121|Rifaximin|rifaximin|mesh-list
64426647|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64426648|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426650|NCT03967977|Gemcitabine|gemcitabine|mesh-list
64426651|NCT03967977|Carboplatin|carboplatin|mesh-list
64426652|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426653|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64426654|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
64426655|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426656|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
64426657|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426658|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426659|NCT03967977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64426660|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
64426661|NCT03967977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426662|NCT04780269|Dinoprostone|dinoprostone|mesh-list
64426663|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
64426664|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64426665|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426666|NCT03856515|Nicotine|nicotine|mesh-list
64426667|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64426668|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
64426669|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426670|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426671|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64426672|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64426673|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
64426674|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426675|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426676|NCT02238483|AZD7624|azd7624|mesh-list
64426677|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64426678|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426680|NCT01632891|Ritonavir|ritonavir|mesh-list
64426701|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64426702|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64426703|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64426705|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64426706|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64426707|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64426768|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
64426769|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64426770|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426771|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426773|NCT02233803|Albuterol|albuterol|mesh-list
64426774|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64426777|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
64426831|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64426832|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64426833|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64426834|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64426835|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64426836|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
64426837|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
64426838|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64426839|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64426840|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64426841|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64426842|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426843|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426844|NCT02205333|Rituximab|rituximab|mesh-list
64426845|NCT02205333|Durvalumab|durvalumab|mesh-list
64426846|NCT02205333|Tremelimumab|tremelimumab|mesh-list
64426847|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64426848|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426849|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
64426850|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426851|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64426853|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
64426854|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
64426855|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
64426856|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64426857|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426858|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
64426859|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426860|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64426861|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64426862|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64426863|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64426864|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64426870|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64426871|NCT02230527|Clopidogrel|clopidogrel|mesh-list
64426873|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64426874|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64426939|NCT02469519|Betamethasone|betamethasone|mesh-list
64426940|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64426941|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
64426942|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
64426943|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64426944|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64426946|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
64426948|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64426949|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64426950|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64426951|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64426952|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
64426953|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
64426954|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64426965|NCT02404441|Spartalizumab|spartalizumab|mesh-list
64426997|NCT02224053|Osimertinib|osimertinib|mesh-list
64426998|NCT02224053|Omeprazole|omeprazole|mesh-list
64426999|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64427000|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427001|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64427002|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427003|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427004|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427005|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64427006|NCT04762875|Plerixafor|plerixafor|mesh-list
64427007|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64427008|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64427009|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
64427010|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427011|NCT04774107|Ribavirin|ribavirin|mesh-list
64427012|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
64427058|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
64427059|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427060|NCT02403271|Durvalumab|durvalumab|mesh-list
64427061|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64427062|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427063|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
64427064|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64427065|NCT02219685|Ledipasvir|ledipasvir|mesh-list
64427066|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
64427067|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427068|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
64427069|NCT02457247|Antacids|antacids|mesh-ancestor
64427070|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427072|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64427121|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427122|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64427124|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427129|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64427130|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64427131|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64427132|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
64427133|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427134|NCT01649869|Valganciclovir|valganciclovir|mesh-list
64427136|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427137|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
64427138|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64427178|NCT02427841|Antiviral Agents|antiviral agents|mesh-ancestor
64427179|NCT02427841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427180|NCT02427841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427181|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427182|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
64427183|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427184|NCT02397889|Midazolam|midazolam|mesh-list
64427185|NCT02397889|Ketamine|ketamine|mesh-list
64427186|NCT02397889|Analgesics|analgesics|mesh-ancestor
64427187|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
64427188|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427189|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427241|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64427242|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
64427243|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64427244|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427245|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64427246|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64427247|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64427248|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64427249|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64427250|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427253|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
64427254|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
64427255|NCT02395081|Vitamins|vitamins|mesh-list
64427256|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
64427257|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427258|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64427259|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64427260|NCT04905277|Atenolol|atenolol|mesh-list
64427261|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64427262|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64427273|NCT02426125|Docetaxel|docetaxel|mesh-list
64427291|NCT02393209|Serabelisib|serabelisib|mesh-list
64427292|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427293|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
64427294|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
64427295|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
64427296|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427297|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427299|NCT02424097|Fluorides|fluorides|mesh-list
64427300|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
64427301|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
64427302|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
64427303|NCT02424097|Protective Agents|protective agents|mesh-ancestor
64427304|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427305|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64427306|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427308|NCT02392507|Carboplatin|carboplatin|mesh-list
64427309|NCT02392507|Necitumumab|necitumumab|mesh-list
64427310|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64427311|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427312|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
64427313|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
64427314|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
64427315|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427317|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
64427318|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64427319|NCT04904341|Protective Agents|protective agents|mesh-ancestor
64427320|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427321|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
64427322|NCT02385799|Sertraline|sertraline|mesh-list
64427336|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427338|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64427339|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
64427340|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
64427341|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427342|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64427343|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64427344|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427345|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427346|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
64427396|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427398|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64427399|NCT02346721|Velpatasvir|velpatasvir|mesh-list
64427400|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
64427401|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427402|NCT04902625|Naltrexone|naltrexone|mesh-list
64427403|NCT04902625|Bupropion|bupropion|mesh-list
64427404|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64427405|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64427406|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427407|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
64427408|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427409|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64427410|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
64427411|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64427412|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64427413|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64427414|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64427415|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427416|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
64427417|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427418|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64427420|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427444|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427445|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
64427446|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64427447|NCT02251275|Tolvaptan|tolvaptan|mesh-list
64427448|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64427449|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427450|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
64427451|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427452|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
64427453|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64427454|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
64427455|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427456|NCT02379637|Expectorants|expectorants|mesh-ancestor
64427457|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
64427458|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64427459|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
64427460|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427461|NCT02379637|Protective Agents|protective agents|mesh-ancestor
64427462|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427463|NCT02379637|Antidotes|antidotes|mesh-ancestor
64427464|NCT02195583|Zinc|zinc|mesh-list
64427465|NCT02195583|Listerine|listerine|mesh-list
64427466|NCT02195583|Fluorides|fluorides|mesh-list
64427467|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
64427468|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
64427469|NCT02195583|Protective Agents|protective agents|mesh-ancestor
64427470|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427492|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427493|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64427494|NCT02379091|Antidotes|antidotes|mesh-ancestor
64427495|NCT02379091|Protective Agents|protective agents|mesh-ancestor
64427496|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
64427497|NCT02379091|Vitamins|vitamins|mesh-ancestor
64427498|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
64427499|NCT02379091|Hematinics|hematinics|mesh-ancestor
64427500|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
64427501|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64427502|NCT02378935|Velpatasvir|velpatasvir|mesh-list
64427503|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
64427504|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427505|NCT02250651|Timolol|timolol|mesh-list
64427506|NCT02250651|Bimatoprost|bimatoprost|mesh-list
64427507|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64427508|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64427509|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
64427510|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427511|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427512|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427513|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64427514|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64427515|NCT02214225|Vaccines|vaccines|mesh-list
64427518|NCT02249949|Efatutazone|efatutazone|mesh-list
64427546|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427547|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64427548|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64427549|NCT02309515|Growth Substances|growth substances|mesh-ancestor
64427551|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427594|NCT02193165|Triclosan|triclosan|mesh-list
64427614|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427615|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
64427616|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
64427617|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427618|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427619|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64427620|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64427621|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
64427622|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64427623|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64427624|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64427625|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64427627|NCT01889602|Lorazepam|lorazepam|mesh-list
64427628|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
64427629|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64427630|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427631|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
64427632|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
64427633|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427634|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427635|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64427636|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427637|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64427638|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64427639|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64427664|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64427665|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64427666|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
64427667|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
64427668|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427669|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64427670|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64427672|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427729|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
64427730|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427732|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
64366931|NCT02514629|Androgens|androgens|mesh-ancestor
64427733|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427734|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64427735|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
64427737|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427738|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427739|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64427740|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
64427741|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
64427742|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64427743|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
64427744|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64427745|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64427746|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64427784|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
64427785|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427786|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64427787|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64427788|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64427789|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
64427790|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427791|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427792|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64427793|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64427794|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64427795|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64427796|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64427797|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
64427799|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
64427800|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
64427801|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
64427802|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64427840|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427841|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427842|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
64427843|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64427844|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64427845|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64427846|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
64427847|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64427848|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64427849|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64427850|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
64427851|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64427852|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64427853|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427854|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64427855|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64427857|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
64427858|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427859|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64427860|NCT02372383|Azithromycin|azithromycin|mesh-list
64427861|NCT02372383|Rifampin|rifampin|mesh-list
64427862|NCT02372383|Ethambutol|ethambutol|mesh-list
64427865|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64427866|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64427867|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64427869|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
64427883|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64427884|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427885|NCT01648699|Analgesics|analgesics|mesh-ancestor
64427886|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
64427887|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64427888|NCT02134353|Mannitol|mannitol|mesh-list
64427889|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64427890|NCT02134353|Diuretics|diuretics|mesh-ancestor
64427891|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
64427892|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427893|NCT01646125|Docetaxel|docetaxel|mesh-list
64427894|NCT01646125|Pemetrexed|pemetrexed|mesh-list
64427895|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64427944|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64427946|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64427947|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64427948|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
64428017|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64428018|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
64428020|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428092|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428093|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428094|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428097|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428099|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64428100|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64428102|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64428104|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64428105|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64428106|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428108|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
64428149|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
64428151|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428153|NCT05269017|Vitamin D|vitamin d|mesh-list
64428154|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
64428155|NCT05269017|Budesonide|budesonide|mesh-list
64428156|NCT05269017|Vitamins|vitamins|mesh-ancestor
64428157|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
64428158|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428159|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64428162|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64428163|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
64428209|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64428210|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
64428211|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64428212|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428213|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64428214|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
64428215|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428216|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428217|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
64428218|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428219|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64428220|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428221|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
64428222|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64428223|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64428224|NCT02371759|Anesthetics|anesthetics|mesh-list
64428225|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428226|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428264|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
64428265|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428267|NCT05379179|Ketamine|ketamine|mesh-list
64428268|NCT05379179|Analgesics|analgesics|mesh-ancestor
64428269|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
64428270|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428271|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428272|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64428329|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64428330|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64428331|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428332|NCT02163759|Adalimumab|adalimumab|mesh-list
64428399|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
64428400|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428401|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
64428402|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428404|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64428405|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
64428406|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428407|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64428408|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
64428409|NCT05308901|Lenvatinib|lenvatinib|mesh-list
64428410|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64428418|NCT05372939|Adalimumab|adalimumab|mesh-list
64428462|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64428463|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
64428465|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
64428466|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
64428467|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64428468|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428469|NCT05335109|Xenon|xenon|mesh-list
64428471|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
64428472|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
64428473|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428474|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428475|NCT05300087|Albuterol|albuterol|mesh-list
64428476|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64428477|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
64428478|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64428479|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428480|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64428481|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428482|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
64428485|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64428486|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64428487|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
64428488|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64428489|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428490|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
64428491|NCT05334329|Fludarabine|fludarabine|mesh-list
64428492|NCT05334329|Atezolizumab|atezolizumab|mesh-list
64428493|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
64428494|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64428495|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64428496|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
64428497|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428502|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64428503|NCT05333549|Istradefylline|istradefylline|mesh-list
64428504|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64428505|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64428506|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64428507|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
64428632|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428633|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64428634|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64428635|NCT05324735|Protective Agents|protective agents|mesh-ancestor
64428636|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428637|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
64428638|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64428694|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64428695|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64428696|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
64428697|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64428698|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
64428699|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64428700|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
64428701|NCT02524145|Protective Agents|protective agents|mesh-ancestor
64428702|NCT05357417|Bevacizumab|bevacizumab|mesh-list
64428759|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428761|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
64428762|NCT05284409|Hormones|hormones|mesh-ancestor
64428763|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64428764|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64428765|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428766|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64428767|NCT05284409|Analgesics|analgesics|mesh-ancestor
64428768|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
64428769|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
64428770|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64428771|NCT05284409|Narcotics|narcotics|mesh-ancestor
64428772|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428773|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64428774|NCT02523599|Bupivacaine|bupivacaine|mesh-list
64428775|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
64428776|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
64428777|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428778|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428779|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
64428813|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428814|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64428815|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64428817|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428818|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64428820|NCT02335411|Capecitabine|capecitabine|mesh-list
64428821|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428822|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64428823|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64428824|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
64428825|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428826|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64428827|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428828|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64428829|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428830|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64428832|NCT02161731|Evacetrapib|evacetrapib|mesh-list
64428833|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
64428834|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64428863|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64428864|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64428865|NCT02161575|Growth Substances|growth substances|mesh-ancestor
64428866|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428867|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
64428868|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428869|NCT02161185|Midazolam|midazolam|mesh-list
64428870|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64428871|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64428872|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64428929|NCT02369341|Vaccines|vaccines|mesh-list
64428930|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
64428931|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64428934|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64428935|NCT02158533|Naltrexone|naltrexone|mesh-list
64428936|NCT02158533|Buprenorphine|buprenorphine|mesh-list
64428937|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64428938|NCT02158533|Narcotics|narcotics|mesh-ancestor
64428941|NCT02158533|Analgesics|analgesics|mesh-ancestor
64428994|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64428996|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64428999|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429001|NCT05276531|Progestins|progestins|mesh-ancestor
64429002|NCT05276531|Hormones|hormones|mesh-ancestor
64429003|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429004|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429005|NCT01658579|Insulin|insulin|mesh-list
64429006|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64429007|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
64429008|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429009|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429054|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366965|NCT04499885|Mineral Oil|mineral oil|mesh-list
64429056|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429057|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64429058|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
64429059|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429060|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429061|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64429062|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64429120|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429121|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64429122|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
64429123|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64429126|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64429127|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429187|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
64429188|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429189|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64429190|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64429191|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
64429192|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429193|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429194|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64429195|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429196|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
64429197|NCT05157971|Hormones|hormones|mesh-ancestor
64429198|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429199|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429200|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64429201|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
64429202|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64429203|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64429204|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
64429205|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429206|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429207|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64429208|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64429209|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
64429210|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429211|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64429212|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
64429213|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
64429214|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429215|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64429219|NCT02175771|Xhance|xhance|mesh-list
64429230|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
64429231|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429232|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64429233|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64429234|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64429235|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429236|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429237|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429238|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
64429239|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64429294|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429295|NCT05154383|Vaccines|vaccines|mesh-list
64429296|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
64429297|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429298|NCT05196815|Dobutamine|dobutamine|mesh-list
64429299|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64429300|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
64429301|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
64429302|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429303|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429304|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64429305|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64429306|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64429307|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429309|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429310|NCT05196815|Protective Agents|protective agents|mesh-ancestor
64429311|NCT05245877|Enoxaparin|enoxaparin|mesh-list
64429351|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64429352|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429353|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
64429354|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429355|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64429356|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64429357|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64429358|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429359|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429360|NCT02152371|Metformin|metformin|mesh-list
64429361|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
64429362|NCT02152371|Dulaglutide|dulaglutide|mesh-list
64429363|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429364|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429365|NCT02332291|Citalopram|citalopram|mesh-list
64429366|NCT02332291|Bupropion|bupropion|mesh-list
64429367|NCT02332291|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64429369|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429370|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429401|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429402|NCT05237687|Sirolimus|sirolimus|mesh-list
64429403|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64429404|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64429405|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64429406|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429475|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429476|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
64429478|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
64429479|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64429480|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429530|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
64429532|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64429533|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64429534|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429535|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64429545|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
64429546|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429547|NCT02299375|Albuterol|albuterol|mesh-list
64429548|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64429549|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
64429550|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429551|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429555|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64429556|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64429557|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64429558|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64429574|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64429575|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64429576|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64429577|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64429578|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429579|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429580|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429581|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64429582|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64429583|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
64429584|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64429585|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64429586|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
64429587|NCT04881799|Topiramate|topiramate|mesh-list
64429633|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
64429634|NCT05220293|Hormones|hormones|mesh-ancestor
64429635|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429640|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64429641|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
64429642|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64429643|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429648|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64429649|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
64429650|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
64429651|NCT02297503|Protective Agents|protective agents|mesh-ancestor
64429698|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64429699|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429700|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
64429701|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
64429702|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64429703|NCT02149875|Protective Agents|protective agents|mesh-ancestor
64429704|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429705|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
64429706|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64429707|NCT05095961|Prednisone|prednisone|mesh-list
64429708|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429709|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
64429711|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429713|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429714|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429715|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
64429716|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64429717|NCT05124899|Protective Agents|protective agents|mesh-ancestor
64429719|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
64429735|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429736|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
64429737|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429738|NCT02147691|Azelaic acid|azelaic acid|mesh-list
64429739|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64429740|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64429741|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64429742|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64429743|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64429744|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
64429745|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64429782|NCT05046431|Golimumab|golimumab|mesh-list
64429797|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64429798|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429800|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
64429801|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
64429802|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429803|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64429804|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
64429805|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429806|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64429807|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64429808|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
64429809|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64429810|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64429811|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64429812|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64429813|NCT05075993|Growth Substances|growth substances|mesh-ancestor
64429814|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
64429816|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
64429817|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429818|NCT04751877|Dexamethasone|dexamethasone|mesh-list
64429819|NCT04751877|Lenalidomide|lenalidomide|mesh-list
64429820|NCT04751877|Bortezomib|bortezomib|mesh-list
64429821|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429822|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
64429823|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
64429824|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429825|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429826|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64429827|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
64429828|NCT04751877|Hormones|hormones|mesh-ancestor
64429829|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429830|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429837|NCT02147067|Ranolazine|ranolazine|mesh-list
64429838|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64429839|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429840|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429842|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64429843|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64429844|NCT02107131|Growth Substances|growth substances|mesh-ancestor
64429845|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429846|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
64429847|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429848|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
64429849|NCT02106975|Vitamins|vitamins|mesh-ancestor
64429850|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
64429851|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429852|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
64429853|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429854|NCT02106975|Protective Agents|protective agents|mesh-ancestor
64429894|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64429895|NCT02519231|Analgesics|analgesics|mesh-ancestor
64429896|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
64429897|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64429898|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429899|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64429900|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64429901|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
64429902|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64429903|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64429904|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429905|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
64429909|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64429910|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64429950|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64429952|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
64429953|NCT05060627|Hormones|hormones|mesh-ancestor
64429954|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64429955|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64429956|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64429957|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
64429958|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64429961|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430015|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64430016|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430017|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430018|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64430019|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64430020|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430021|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430022|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64430023|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64430024|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
64430081|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
64430082|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430083|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430084|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
64430085|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430086|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
64430087|NCT05012735|Provitamins|provitamins|mesh-list
64430090|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430091|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
64430093|NCT02519777|Dolutegravir|dolutegravir|mesh-list
64430094|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64430095|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64430097|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64430098|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64430099|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
64430141|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64430142|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430143|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
64430144|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
64430145|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
64430146|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430147|NCT02141217|Amoxicillin|amoxicillin|mesh-list
64430149|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
64430150|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
64430151|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
64430152|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
64430203|NCT05003453|Analgesics|analgesics|mesh-ancestor
64430204|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
64430205|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430206|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430207|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64430208|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430269|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430270|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64430272|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430275|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430276|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64430278|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64430279|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430280|NCT02507219|Analgesics|analgesics|mesh-ancestor
64430281|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
64430282|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430283|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430284|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430324|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64430326|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430327|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430328|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
64430329|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430330|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64430331|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
64430332|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430333|NCT04974281|Lenvatinib|lenvatinib|mesh-list
64430334|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430335|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64430336|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430337|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430338|NCT02503865|Orlistat|orlistat|mesh-list
64430339|NCT02503865|Diltiazem|diltiazem|mesh-list
64430340|NCT02503865|Atorvastatin|atorvastatin|mesh-list
64430341|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64430342|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64430343|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
64430344|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430377|NCT02480621|Bupivacaine|bupivacaine|mesh-list
64430378|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
64430379|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
64430380|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430443|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64430444|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430445|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430446|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430447|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430448|NCT01883362|Midostaurin|midostaurin|mesh-list
64430449|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430450|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64430451|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430452|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430505|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64430506|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64430507|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430508|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430509|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430510|NCT01614886|Rivastigmine|rivastigmine|mesh-list
64430511|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64430512|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430572|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64430573|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
64430574|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64430575|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64430576|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64430578|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
64430579|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64430580|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64430581|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430582|NCT01926886|Trastuzumab|trastuzumab|mesh-list
64430583|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64430585|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64430586|NCT01925950|Beclomethasone|beclomethasone|mesh-list
64430630|NCT02500979|Pramlintide|pramlintide|mesh-list
64430631|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
64430632|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384444|NCT02401295|Tretinoin|tretinoin|mesh-list
64430633|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430634|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
64430635|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64430636|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
64430637|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430638|NCT02500901|Niraparib|niraparib|mesh-list
64430639|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64430640|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430641|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430642|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430643|NCT01877668|Adalimumab|adalimumab|mesh-list
64430644|NCT01877668|Tofacitinib|tofacitinib|mesh-list
64430688|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
64430689|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64430690|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430691|NCT01875250|Metronidazole|metronidazole|mesh-list
64430692|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430758|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430759|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64430760|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
64430761|NCT01613716|Hormones|hormones|mesh-ancestor
64430762|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430763|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64430764|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430765|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
64430767|NCT04415476|Prednisone|prednisone|mesh-list
64430768|NCT04415476|Tacrolimus|tacrolimus|mesh-list
64430769|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430770|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
64430771|NCT04415476|Hormones|hormones|mesh-ancestor
64430772|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430777|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
64430818|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430819|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64430820|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64430821|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430822|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430823|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430824|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64430825|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
64430826|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64430827|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64430828|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64430829|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430830|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
64430831|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64430832|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64430833|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430875|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
64430876|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64430877|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64430878|NCT02065713|Golimumab|golimumab|mesh-list
64430879|NCT02065713|Methotrexate|methotrexate|mesh-list
64430880|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64430881|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
64430882|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64430883|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430884|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64430885|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
64430887|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430888|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
64430890|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64430891|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64430892|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
64430893|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430894|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64430895|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64430896|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430899|NCT02497781|Avibactam|avibactam|mesh-list
64430900|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
64430921|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430922|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430923|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430924|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430925|NCT02476175|Urological Agents|urological agents|mesh-ancestor
64430926|NCT02065557|Adalimumab|adalimumab|mesh-list
64430927|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430928|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430929|NCT02065245|Penicillins|penicillins|mesh-list
64430930|NCT02065245|Streptomycin|streptomycin|mesh-list
64430931|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64430932|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430933|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64430934|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430935|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430936|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
64430980|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430981|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
64430982|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
64430983|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430984|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430985|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64430986|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
64430988|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430989|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64430991|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64430992|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64431040|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64431041|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64431042|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431045|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431046|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431047|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64431048|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431049|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
64431050|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64431051|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431052|NCT01919164|Mitogens|mitogens|mesh-list
64431053|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
64431054|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431056|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431058|NCT01901146|Paclitaxel|paclitaxel|mesh-list
64431059|NCT01901146|Trastuzumab|trastuzumab|mesh-list
64431060|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64431061|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431062|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
64431092|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431093|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64431094|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64431095|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431096|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
64431097|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64431159|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64431160|NCT01653743|Hormones|hormones|mesh-ancestor
64431161|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431162|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431163|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64431164|NCT02293993|Guadecitabine|guadecitabine|mesh-list
64431165|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431166|NCT02322775|Benralizumab|benralizumab|mesh-list
64431169|NCT01646827|Aripiprazole|aripiprazole|mesh-list
64431225|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
64431226|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431227|NCT02319031|Ribavirin|ribavirin|mesh-list
64431228|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
64431229|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
64431230|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431231|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
64431232|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431233|NCT02359435|Amoxicillin|amoxicillin|mesh-list
64431234|NCT02359435|Metronidazole|metronidazole|mesh-list
64431291|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
64431292|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64431293|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64431294|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431295|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
64431296|NCT01613326|Albuterol|albuterol|mesh-list
64431299|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
64431300|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431301|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431302|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64431303|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
64431304|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
64431305|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64431306|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
64431307|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431308|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431309|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
64431310|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64431311|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64431312|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64431313|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64431314|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
64431315|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64431317|NCT01898806|Triamcinolone|triamcinolone|mesh-list
64431338|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64431339|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64431340|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431341|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64431342|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
64431343|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
64431344|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
64431345|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
64431346|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431347|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431405|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64431406|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431407|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64431409|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64431410|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64431411|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431412|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64431413|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
64431414|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
64431471|NCT04696029|Eflornithine|eflornithine|mesh-list
64431472|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431473|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64431474|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64431475|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64431476|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431477|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
64431478|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431479|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431480|NCT02059239|Cytarabine|cytarabine|mesh-list
64431481|NCT02059239|Rituximab|rituximab|mesh-list
64431482|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
64431483|NCT02059239|Etoposide|etoposide|mesh-list
64431484|NCT02059239|Melphalan|melphalan|mesh-list
64431533|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64431534|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
64431535|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431536|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431537|NCT01860040|Gemcitabine|gemcitabine|mesh-list
64431538|NCT01860040|Pemetrexed|pemetrexed|mesh-list
64431539|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431540|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64431601|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64431602|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64431603|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431604|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431605|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431606|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
64431607|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
64431610|NCT01896700|Methylphenidate|methylphenidate|mesh-list
64431666|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64431667|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431668|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431669|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64431670|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
64431671|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
64431672|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64431673|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431674|NCT02491463|Vaccines|vaccines|mesh-list
64431675|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
64431676|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431678|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
64431679|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431681|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64431682|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
64431683|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64431684|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
64431685|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431724|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431725|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431726|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64431727|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
64431728|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
64431729|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64431730|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
64431731|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431732|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431733|NCT02471183|Selexipag|selexipag|mesh-list
64431734|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64431735|NCT04964063|Listerine|listerine|mesh-list
64431736|NCT04964063|Fluorides|fluorides|mesh-list
64431737|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
64431741|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64431742|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431743|NCT04204967|Fentanyl|fentanyl|mesh-list
64431744|NCT04204967|Remifentanil|remifentanil|mesh-list
64431745|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64431746|NCT04204967|Narcotics|narcotics|mesh-ancestor
64431747|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431748|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431749|NCT04204967|Analgesics|analgesics|mesh-ancestor
64431775|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
64431776|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64431777|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64431778|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64431779|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64431781|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431782|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
64431783|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64431784|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
64431785|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431786|NCT02351167|Nicotine|nicotine|mesh-list
64431787|NCT02351167|Varenicline|varenicline|mesh-list
64431788|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64431789|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
64431790|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431833|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431834|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431835|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431836|NCT02037165|Celecoxib|celecoxib|mesh-list
64431837|NCT02037165|Pregabalin|pregabalin|mesh-list
64431838|NCT02037165|Analgesics|analgesics|mesh-ancestor
64431839|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
64431840|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431841|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431842|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
64431843|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64431844|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431845|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431846|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64431847|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64431848|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64431889|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
64431892|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64431893|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64431894|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431895|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64431897|NCT04937699|Clopidogrel|clopidogrel|mesh-list
64431899|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64431901|NCT04937699|Analgesics|analgesics|mesh-ancestor
64431902|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
64431903|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431904|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431906|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431907|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64431944|NCT02469077|Narcotics|narcotics|mesh-ancestor
64431945|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431946|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431948|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
64431949|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431950|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64431952|NCT02486627|Ofloxacin|ofloxacin|mesh-list
64431953|NCT02486627|Meropenem|meropenem|mesh-list
64431954|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64431955|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431956|NCT02486627|Renal Agents|renal agents|mesh-ancestor
64431957|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64431958|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64431959|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64431960|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431961|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431962|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431965|NCT02282293|Piperaquine|piperaquine|mesh-list
64431998|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
64431999|NCT01892020|Insulin|insulin|mesh-list
64432000|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64432001|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
64432002|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
64432003|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432004|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432005|NCT02485691|Prednisone|prednisone|mesh-list
64432006|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
64432007|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432008|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
64432009|NCT02485691|Hormones|hormones|mesh-ancestor
64432010|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432011|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432012|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64432013|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432014|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64432015|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432016|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432017|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
64432018|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64432019|NCT02517515|Ritonavir|ritonavir|mesh-list
64432020|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64432021|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64432022|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
64432023|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432024|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432025|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64432026|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64432032|NCT01891864|GP2015|gp2015|mesh-list
64432044|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432045|NCT02484911|Dexamethasone|dexamethasone|mesh-list
64432047|NCT02484911|Aprepitant|aprepitant|mesh-list
64432048|NCT02484911|Palonosetron|palonosetron|mesh-list
64432049|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432050|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
64432051|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
64432052|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432053|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432110|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432111|NCT04891484|Ondansetron|ondansetron|mesh-list
64432112|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
64432113|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
64432114|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432115|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432116|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432117|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
64432118|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432119|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64432121|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432122|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432123|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64432124|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64385558|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
64432125|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432126|NCT04891484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64432128|NCT02408120|Insulin|insulin|mesh-list
64432129|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64432130|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
64432131|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
64432136|NCT01853254|Ribavirin|ribavirin|mesh-list
64432163|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432164|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
64432165|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432167|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64432168|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64432169|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64432170|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64432171|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432172|NCT01852162|Dabigatran|dabigatran|mesh-list
64432173|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
64432174|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64432175|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
64432176|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432177|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432178|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
64432179|NCT01835470|Abatacept|abatacept|mesh-list
64432180|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64432181|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432182|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432183|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432214|NCT02371616|Fluorides|fluorides|mesh-list
64432215|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
64432216|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
64432217|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64432218|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432219|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
64432220|NCT02371616|Protective Agents|protective agents|mesh-ancestor
64432221|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64432222|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432223|NCT01835158|Sunitinib|sunitinib|mesh-list
64432224|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432225|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64432226|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64432227|NCT01835158|Growth Substances|growth substances|mesh-ancestor
64432228|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432229|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
64432230|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432231|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432232|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432233|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
64432234|NCT01833832|Antidotes|antidotes|mesh-ancestor
64432235|NCT01833832|Protective Agents|protective agents|mesh-ancestor
64432268|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64432270|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
64432271|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432273|NCT01650194|Hormones|hormones|mesh-ancestor
64432274|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432275|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432276|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64432277|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432278|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64432279|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432280|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432281|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
64432282|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64432283|NCT02404220|Dexamethasone|dexamethasone|mesh-list
64432284|NCT02404220|Vincristine|vincristine|mesh-list
64432285|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432286|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
64432287|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
64432288|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432289|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432290|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432291|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
64432292|NCT02404220|Hormones|hormones|mesh-ancestor
64432293|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432294|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64432297|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
64432298|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
64432311|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64432312|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432313|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432314|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432315|NCT02335346|Analgesics|analgesics|mesh-ancestor
64432316|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
64432317|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432318|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
64432319|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64432320|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
64432321|NCT02403674|Tenofovir|tenofovir|mesh-list
64432322|NCT02403674|Lamivudine|lamivudine|mesh-list
64432323|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64432324|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
64432325|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432326|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64432327|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64432328|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432329|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432330|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64432331|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64432332|NCT02401256|Efavirenz|efavirenz|mesh-list
64432333|NCT02401256|Bupropion|bupropion|mesh-list
64432334|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64432335|NCT02401256|Montelukast|montelukast|mesh-list
64432336|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64432337|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64432338|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
64432339|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432340|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64432341|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64432352|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64432353|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64432354|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64432355|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
64432356|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64432357|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
64432358|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432359|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64432360|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64432361|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64432362|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64432363|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
64432364|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432365|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64432366|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64432367|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64432368|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64432372|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432373|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64432374|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
64432375|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432376|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432377|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
64432378|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432382|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
64432395|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432396|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
64432397|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432399|NCT02284009|Hormones|hormones|mesh-ancestor
64432400|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432401|NCT02400476|Budesonide|budesonide|mesh-list
64432402|NCT02400476|Loperamide|loperamide|mesh-list
64432403|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
64432404|NCT02400476|Colestipol|colestipol|mesh-list
64432405|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432406|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64432407|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
64432408|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432409|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432410|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64432453|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
64432454|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432455|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
64432456|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432457|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432458|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432459|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64432460|NCT04906382|Paclitaxel|paclitaxel|mesh-list
64432461|NCT04906382|Carboplatin|carboplatin|mesh-list
64432462|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64432463|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64432464|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432465|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
64432466|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
64432467|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
64432468|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432469|NCT04892875|Cisplatin|cisplatin|mesh-list
64432470|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432471|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64432472|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
64432473|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64432474|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64432475|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64432476|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432477|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432478|NCT02347813|Pioglitazone|pioglitazone|mesh-list
64432479|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432480|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432502|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432503|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432504|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432505|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
64432506|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64432507|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432508|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432509|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432510|NCT02358668|PAZ320|paz320|mesh-list
64432511|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432512|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432513|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
64432514|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64432515|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64432516|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432520|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64432521|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64432522|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
64432523|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432524|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432526|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64432527|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432528|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
64432529|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64432530|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64432531|NCT05650099|Cimetidine|cimetidine|mesh-list
64432532|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64432533|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432534|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64432554|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64432555|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64432556|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64432557|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64432558|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432559|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
64432560|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64432562|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64432564|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
64432565|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64432566|NCT05565235|Nalbuphine|nalbuphine|mesh-list
64432591|NCT02395172|Docetaxel|docetaxel|mesh-list
64432592|NCT02395172|Avelumab|avelumab|mesh-list
64432593|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432594|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
64432595|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
64432596|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
64432597|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432598|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432599|NCT04876027|Dulaglutide|dulaglutide|mesh-list
64432600|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432601|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432602|NCT02358044|Ribavirin|ribavirin|mesh-list
64432603|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
64432604|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64432605|NCT02358044|Grazoprevir|grazoprevir|mesh-list
64432606|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
64432607|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
64432608|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432609|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
64432610|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432611|NCT05536219|Antibodies|antibodies|mesh-list
64432612|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
64432613|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432614|NCT05649241|Nicotine|nicotine|mesh-list
64432615|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64432616|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
64432617|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432618|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432619|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64432620|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64432621|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
64432622|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432623|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432627|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432628|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
64432630|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432631|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432632|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432633|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
64432680|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432682|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432683|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432684|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432685|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432686|NCT02357342|Sirolimus|sirolimus|mesh-list
64432687|NCT02357342|Aflibercept|aflibercept|mesh-list
64432688|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432689|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64432690|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64432691|NCT02357342|Growth Substances|growth substances|mesh-ancestor
64432692|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432693|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
64432694|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64432695|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432696|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64432697|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
64432698|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432700|NCT02325518|Timolol|timolol|mesh-list
64432735|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432736|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432737|NCT05648071|Pemetrexed|pemetrexed|mesh-list
64432738|NCT05648071|Nedaplatin|nedaplatin|mesh-list
64432739|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432740|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432741|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432742|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64432743|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64432744|NCT03689699|Nivolumab|nivolumab|mesh-list
64432745|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432746|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432747|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64432748|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432749|NCT01849276|Metformin|metformin|mesh-list
64432750|NCT01849276|Cytarabine|cytarabine|mesh-list
64432751|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432752|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432753|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64432754|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
64432755|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432789|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432791|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432792|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432793|NCT01844986|Olaparib|olaparib|mesh-list
64432794|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64432795|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432796|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432797|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432798|NCT01827670|Fluorides|fluorides|mesh-list
64432799|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
64432852|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64432853|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64432854|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432856|NCT02356562|Ribavirin|ribavirin|mesh-list
64432857|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
64432858|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64432859|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64432918|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432919|NCT02349542|Bupivacaine|bupivacaine|mesh-list
64432920|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
64432921|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
64432922|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432923|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432924|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
64432925|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432926|NCT02321930|Tofacitinib|tofacitinib|mesh-list
64432927|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432929|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432934|NCT02264821|Ropivacaine|ropivacaine|mesh-list
64432935|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
64432936|NCT02264821|Anesthetics|anesthetics|mesh-list
64432937|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64432938|NCT02264821|Narcotics|narcotics|mesh-ancestor
64432939|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432940|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432941|NCT02264821|Analgesics|analgesics|mesh-ancestor
64432968|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64432969|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64432970|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432971|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432972|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
64432973|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432975|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432976|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432977|NCT02258659|Paclitaxel|paclitaxel|mesh-list
64432978|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64432979|NCT02258659|Carboplatin|carboplatin|mesh-list
64432980|NCT02258659|Fluorouracil|fluorouracil|mesh-list
64432981|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
64432982|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64433019|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64433020|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433021|NCT02092467|Analgesics|analgesics|mesh-ancestor
64433022|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
64433023|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433024|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433025|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433026|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433027|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
64433028|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64433029|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433030|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433031|NCT04951115|Carboplatin|carboplatin|mesh-list
64433032|NCT04951115|Etoposide|etoposide|mesh-list
64433033|NCT04951115|Durvalumab|durvalumab|mesh-list
64433034|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433035|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64433076|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64433077|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
64433078|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433079|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433080|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433081|NCT04716933|Carboplatin|carboplatin|mesh-list
64433082|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
64433083|NCT04716933|Pemetrexed|pemetrexed|mesh-list
64433084|NCT04716933|Lenvatinib|lenvatinib|mesh-list
64433085|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433086|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433087|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433088|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433089|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64433090|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64433091|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64433092|NCT02034513|Insulin|insulin|mesh-list
64433093|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64433094|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
64433095|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
64433096|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433097|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433098|NCT02461745|Ribavirin|ribavirin|mesh-list
64433127|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433128|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433129|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64433130|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433131|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
64433132|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64433133|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433134|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
64433135|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433136|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433138|NCT04594018|Finasteride|finasteride|mesh-list
64433139|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64433140|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
64433141|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64433142|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64433143|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433144|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433145|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
64433147|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433182|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
64433183|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64433184|NCT01843660|Narcotics|narcotics|mesh-ancestor
64433185|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433186|NCT02032173|Ranibizumab|ranibizumab|mesh-list
64433187|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64433188|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64433189|NCT02032173|Growth Substances|growth substances|mesh-ancestor
64433251|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64433252|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64433253|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
64433254|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433255|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64433256|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
64433257|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
64433258|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
64433259|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
64433260|NCT04687761|Cytarabine|cytarabine|mesh-list
64433261|NCT04687761|Azacitidine|azacitidine|mesh-list
64433262|NCT04687761|Venetoclax|venetoclax|mesh-list
64433263|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64433264|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
64433265|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433266|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433267|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
64433268|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433269|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433270|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
64433271|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433272|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433273|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64433274|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64433275|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433276|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433285|NCT04730193|Caffeine|caffeine|mesh-list
64433297|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64433298|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
64433299|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64433300|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64433301|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433302|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433303|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64433304|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64433305|NCT02088177|Naltrexone|naltrexone|mesh-list
64433306|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64433307|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64433308|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433358|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
64433359|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64433360|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433361|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64433362|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64433363|NCT02087943|Growth Substances|growth substances|mesh-ancestor
64433364|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
64433365|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433366|NCT04730037|Warfarin|warfarin|mesh-list
64433367|NCT04730037|Edoxaban|edoxaban|mesh-list
64433368|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
64433369|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64433389|NCT02087241|Adavosertib|adavosertib|mesh-list
64433390|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433401|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433402|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433403|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433404|NCT04685577|Nefopam|nefopam|mesh-list
64433405|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433406|NCT04685577|Analgesics|analgesics|mesh-ancestor
64433407|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
64433408|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433409|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433410|NCT02443337|Necitumumab|necitumumab|mesh-list
64433411|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433412|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433413|NCT02443103|Guanabenz|guanabenz|mesh-list
64433414|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64433415|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64433416|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64433417|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64433418|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
64433419|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433420|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433421|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433452|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64433455|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
64433456|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433457|NCT02441309|Ifosfamide|ifosfamide|mesh-list
64433458|NCT02441309|Mifamurtide|mifamurtide|mesh-list
64433459|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64433460|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
64433461|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433462|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433463|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64433464|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
64433465|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433466|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64433467|NCT01652729|Exenatide|exenatide|mesh-list
64433468|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433469|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433470|NCT01652729|Incretins|incretins|mesh-ancestor
64433508|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433509|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64433514|NCT01843348|Cyclosporine|cyclosporine|mesh-list
64433579|NCT02412761|Protective Agents|protective agents|mesh-ancestor
64433580|NCT01842334|Nicotine|nicotine|mesh-list
64433581|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64433582|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
64433583|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433584|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433585|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64433586|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64433587|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
64433588|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433589|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433590|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
64433591|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64433592|NCT02457611|Ledipasvir|ledipasvir|mesh-list
64433593|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
64433594|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433595|NCT02083653|Fluorouracil|fluorouracil|mesh-list
64433596|NCT02083653|Capecitabine|capecitabine|mesh-list
64433597|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64433598|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
64433599|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433600|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64433601|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433602|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433603|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
64433604|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433605|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64433606|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
64433607|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64433608|NCT02436239|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64433609|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64433610|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433612|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433620|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433621|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
64385559|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
64433622|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433624|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64433625|NCT02456909|Narcotics|narcotics|mesh-ancestor
64433626|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433627|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433628|NCT02456909|Analgesics|analgesics|mesh-ancestor
64433629|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
64433630|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433631|NCT02025621|Simendan|simendan|mesh-list
64433632|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64433633|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
64433634|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64433635|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64433680|NCT02083185|Relugolix|relugolix|mesh-list
64433681|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64433682|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
64433683|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64433684|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433685|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64433686|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433687|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
64433688|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
64433689|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433691|NCT02412371|Carboplatin|carboplatin|mesh-list
64433692|NCT02412371|Veliparib|veliparib|mesh-list
64433693|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64433694|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433695|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
64433696|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
64433697|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
64433739|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433740|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433741|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64433742|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
64433743|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
64433744|NCT01821898|Hormones|hormones|mesh-ancestor
64433745|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433746|NCT02411591|Necitumumab|necitumumab|mesh-list
64433747|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433748|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433749|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64433750|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
64433751|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
64433752|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433753|NCT01838044|Celecoxib|celecoxib|mesh-list
64433754|NCT01838044|Pregabalin|pregabalin|mesh-list
64433755|NCT01838044|Analgesics|analgesics|mesh-ancestor
64433793|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433794|NCT01820572|Cyclosporine|cyclosporine|mesh-list
64433795|NCT01820572|Abatacept|abatacept|mesh-list
64433797|NCT01820572|Cyclosporins|cyclosporins|mesh-list
64433798|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433799|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
64433800|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433801|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64433802|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433803|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433859|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64433860|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
64433861|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64433862|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64433863|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64433864|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64433865|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64433866|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64433867|NCT01816984|Cetuximab|cetuximab|mesh-list
64433868|NCT01816984|Antibodies|antibodies|mesh-list
64433869|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
64433870|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64433871|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
64433872|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433873|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433874|NCT01816594|Paclitaxel|paclitaxel|mesh-list
64433875|NCT01816594|Trastuzumab|trastuzumab|mesh-list
64433916|NCT02452463|Durvalumab|durvalumab|mesh-list
64433918|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
64433919|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64433920|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
64433921|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433922|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433923|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
64433924|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433925|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64433926|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433927|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433928|NCT04916327|Antioxidants|antioxidants|mesh-list
64433929|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433930|NCT04916327|Protective Agents|protective agents|mesh-ancestor
64433931|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433932|NCT03628391|Haloperidol|haloperidol|mesh-list
64433933|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
64433934|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
64433935|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
64433936|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433937|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433970|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433971|NCT01612702|Dexamethasone|dexamethasone|mesh-list
64433972|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433973|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
64433974|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
64433975|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433976|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433977|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433979|NCT01612702|Hormones|hormones|mesh-ancestor
64433980|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433981|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64433982|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433983|NCT02431559|Doxorubicin|doxorubicin|mesh-list
64434030|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64434031|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434032|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434033|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64434035|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434036|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434037|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434038|NCT02387957|Bevacizumab|bevacizumab|mesh-list
64434039|NCT02387957|Ranibizumab|ranibizumab|mesh-list
64434040|NCT02387957|Aflibercept|aflibercept|mesh-list
64434041|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434042|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434043|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64434044|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64434045|NCT02387957|Growth Substances|growth substances|mesh-ancestor
64434046|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434047|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
64434048|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64434049|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64434050|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64434051|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64434052|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434053|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434054|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
64434073|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64434074|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
64434075|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64434076|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434078|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64434079|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434080|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434081|NCT02431247|Tenofovir|tenofovir|mesh-list
64434083|NCT02431247|Darunavir|darunavir|mesh-list
64434084|NCT02431247|Cobicistat|cobicistat|mesh-list
64434085|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64434086|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64434087|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
64434133|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64434134|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434135|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434136|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434138|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64434139|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434140|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
64434152|NCT02383589|Rituximab|rituximab|mesh-list
64434200|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64434201|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
64434202|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434203|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434204|NCT02383433|Antiviral Agents|antiviral agents|mesh-ancestor
64434205|NCT02383433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434206|NCT02383433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434207|NCT02383433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434208|NCT02383433|Immunologic Factors|immunologic factors|mesh-ancestor
64434209|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434210|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
64434211|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434213|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
64434263|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64434264|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64434265|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
64434267|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
64434268|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
64434271|NCT02402933|Glucagon|glucagon|mesh-list
64434332|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434333|NCT02401529|Acetaminophen|acetaminophen|mesh-list
64434334|NCT02401529|Dexamethasone|dexamethasone|mesh-list
64434335|NCT02401529|Prednisolone|prednisolone|mesh-list
64434336|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434337|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
64434403|NCT01788358|Nifedipine|nifedipine|mesh-list
64434404|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64434405|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64434406|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64434407|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434408|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64434410|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64434411|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434412|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
64434413|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
64434414|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64434415|NCT01773070|Ritonavir|ritonavir|mesh-list
64434416|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64434417|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64434461|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64434462|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
64434463|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434464|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434465|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64434466|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
64434467|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
64434468|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64434469|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64434470|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64434471|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64434472|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
64434473|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434474|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434475|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
64434476|NCT02017899|Vaccines|vaccines|mesh-list
64434477|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
64434478|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434479|NCT01993329|Mitomycin|mitomycin|mesh-list
64434480|NCT01993329|Cisplatin|cisplatin|mesh-list
64434481|NCT01993329|Ifosfamide|ifosfamide|mesh-list
64434482|NCT01993329|Mesna|mesna|mesh-list
64434483|NCT01993329|Protective Agents|protective agents|mesh-ancestor
64434484|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434485|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
64434486|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434487|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64377606|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64434501|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434502|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64434503|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64434505|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
64434506|NCT02421419|Lidocaine|lidocaine|mesh-list
64434507|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64434508|NCT02421419|BB 1101|bb 1101|mesh-list
64434509|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434510|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
64434511|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
64434512|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434513|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434514|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434515|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
64434516|NCT02421419|Hormones|hormones|mesh-ancestor
64434517|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434518|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64434519|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434520|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
64434521|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
64434522|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434531|NCT02420717|Leucovorin|leucovorin|mesh-list
64434555|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64434556|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
64434557|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434558|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434559|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64434560|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434562|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
64434563|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434620|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434621|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64434622|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434623|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64434624|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
64434626|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434627|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434628|NCT02015793|Adalimumab|adalimumab|mesh-list
64434629|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434630|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434631|NCT02347631|Dipivefrin|dipivefrin|mesh-list
64434632|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64434633|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
64434634|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434635|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434636|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434637|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
64434638|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434639|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434640|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
64434641|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
64434642|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64434643|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
64434644|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434645|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434646|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64434647|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
64434648|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64434649|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64434650|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64434651|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
64434652|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434653|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434661|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434662|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434663|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64434664|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64434665|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
64434666|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434790|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434792|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
64434793|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
64434794|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
64434795|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
64434796|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434797|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434798|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434799|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
64434800|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
64434801|NCT01988103|Thalidomide|thalidomide|mesh-list
64434802|NCT01988103|Apremilast|apremilast|mesh-list
64434803|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64434804|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434805|NCT01988103|Analgesics|analgesics|mesh-ancestor
64434806|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
64434807|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434809|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434845|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64434846|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64434847|NCT02079519|Growth Substances|growth substances|mesh-ancestor
64434849|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
64434850|NCT02078817|Ketamine|ketamine|mesh-list
64434851|NCT02078817|Analgesics|analgesics|mesh-ancestor
64434858|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
64434912|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434913|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434917|NCT01787188|Analgesics|analgesics|mesh-ancestor
64434980|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434981|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64434982|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64434983|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434984|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434985|NCT01736176|Levodopa|levodopa|mesh-list
64434986|NCT01736176|Carbidopa|carbidopa|mesh-list
64434987|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64434988|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64435046|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435047|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435048|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64435049|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64435050|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64435051|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64435052|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64435053|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64435054|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435055|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64435056|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64435057|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
64435106|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435107|NCT02369159|Oseltamivir|oseltamivir|mesh-list
64435108|NCT02369159|Peramivir|peramivir|mesh-list
64435109|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
64435110|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435111|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435112|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435114|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64435115|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
64435116|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435117|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435118|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
64435119|NCT02367833|NuvaRing|nuvaring|mesh-list
64435120|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
64435121|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64435122|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64435123|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435124|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64435125|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64435126|NCT02338193|Metformin|metformin|mesh-list
64435158|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64435160|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435161|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435162|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435168|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64435169|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
64435170|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64435218|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435219|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435220|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
64435221|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64435222|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64435227|NCT01765582|Vitamins|vitamins|mesh-ancestor
64435288|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435289|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435290|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435291|NCT01607476|Corticosterone|corticosterone|mesh-list
64435292|NCT01607476|Flutemetamol|flutemetamol|mesh-list
64435293|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435294|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64435295|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435296|NCT01765192|Montelukast|montelukast|mesh-list
64435297|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64435298|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
64435299|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64435300|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435301|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435302|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435303|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64435304|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64435305|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435306|NCT01733680|Amiloride|amiloride|mesh-list
64435307|NCT01733680|Diuretics|diuretics|mesh-ancestor
64435308|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
64435309|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435316|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
64435336|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435403|NCT02390531|Bevacizumab|bevacizumab|mesh-list
64435404|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435463|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64435464|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
64435465|NCT02358863|Leucovorin|leucovorin|mesh-list
64435466|NCT02358863|Cisplatin|cisplatin|mesh-list
64435467|NCT02358863|Docetaxel|docetaxel|mesh-list
64435468|NCT02358863|Capecitabine|capecitabine|mesh-list
64435469|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
64435470|NCT02358863|Irinotecan|irinotecan|mesh-list
64435471|NCT02358863|Epirubicin|epirubicin|mesh-list
64435472|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435600|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435601|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435602|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64435603|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435604|NCT04673175|Tazobactam|tazobactam|mesh-list
64435605|NCT04673175|Ceftolozane|ceftolozane|mesh-list
64385672|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435606|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64435607|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64435608|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435609|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64435660|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64435661|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435662|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435664|NCT02353169|Analgesics|analgesics|mesh-ancestor
64435730|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435731|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64435732|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
64435733|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435734|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
64435735|NCT01642615|Lansoprazole|lansoprazole|mesh-list
64435736|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64435737|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435738|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64435739|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435740|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435741|NCT03571945|Anesthetics|anesthetics|mesh-list
64435742|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435743|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435744|NCT02311361|Durvalumab|durvalumab|mesh-list
64435745|NCT02311361|Tremelimumab|tremelimumab|mesh-list
64435746|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435747|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435748|NCT02329223|Omalizumab|omalizumab|mesh-list
64435749|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64435750|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64435751|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
64435798|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435799|NCT04198649|Azithromycin|azithromycin|mesh-list
64435800|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64435801|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435802|NCT02348723|Warfarin|warfarin|mesh-list
64435803|NCT02348723|Dabigatran|dabigatran|mesh-list
64435804|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
64435805|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
64435810|NCT02006667|Gemcitabine|gemcitabine|mesh-list
64435868|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435870|NCT02006121|Emetics|emetics|mesh-ancestor
64435871|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435872|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
64435873|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435874|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435875|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
64435876|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
64435877|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435878|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435879|NCT02005887|Letrozole|letrozole|mesh-list
64435880|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64435881|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435882|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64435883|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64435884|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435886|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64435887|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435922|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435923|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435924|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
64435925|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
64435926|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435927|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435928|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435929|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
64435930|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435931|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64435932|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64435986|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64435987|NCT01641367|Darunavir|darunavir|mesh-list
64435988|NCT01641367|Etravirine|etravirine|mesh-list
64435989|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64435990|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
64435991|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
64435992|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435993|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64435994|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64435995|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435996|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435997|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64435998|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64435999|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64436000|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64436001|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64436044|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436045|NCT01764022|Paclitaxel|paclitaxel|mesh-list
64436046|NCT01764022|Trastuzumab|trastuzumab|mesh-list
64436047|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64436054|NCT02003391|Timolol|timolol|mesh-list
64436055|NCT02003391|Travoprost|travoprost|mesh-list
64436056|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64436057|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64436058|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64436059|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64436060|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436061|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436062|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436063|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436064|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64436065|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64436066|NCT02254681|Gemcitabine|gemcitabine|mesh-list
64436095|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64436098|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64436099|NCT01639729|Narcotics|narcotics|mesh-ancestor
64436100|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436101|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436102|NCT01639729|Analgesics|analgesics|mesh-ancestor
64436103|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
64436104|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436105|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64436106|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64436107|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
64436108|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
64436109|NCT02002221|Metformin|metformin|mesh-list
64436110|NCT02002221|Vildagliptin|vildagliptin|mesh-list
64436111|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64436112|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436113|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64436114|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
64436115|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436116|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436117|NCT05650723|Venetoclax|venetoclax|mesh-list
64436118|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
64436119|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
64436120|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436121|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64436122|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64436124|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436125|NCT05247697|Mirtazapine|mirtazapine|mesh-list
64436126|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
64436140|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436141|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64436142|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64436143|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
64436144|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64436145|NCT05243797|Lenalidomide|lenalidomide|mesh-list
64436146|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
64436147|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436148|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64436149|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64436202|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436203|NCT01732588|Artefenomel|artefenomel|mesh-list
64436204|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
64436205|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64436206|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64436207|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436208|NCT01639339|Belimumab|belimumab|mesh-list
64436209|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436210|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
64436211|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436212|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64436213|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
64436214|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436215|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
64436217|NCT04836637|Calcium|calcium|mesh-list
64436262|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436263|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436264|NCT04625257|Antibodies|antibodies|mesh-list
64436265|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
64436266|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436267|NCT05011513|Ritonavir|ritonavir|mesh-list
64436268|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64436269|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64436270|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
64436271|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436272|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436273|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64436274|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64436275|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
64436276|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436277|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64436278|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64436279|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
64436280|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436316|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436317|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436318|NCT01637077|Pregabalin|pregabalin|mesh-list
64436319|NCT01637077|Analgesics|analgesics|mesh-ancestor
64436320|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
64436321|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436388|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64436389|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64436390|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436391|NCT04880707|Anesthetics|anesthetics|mesh-list
64436392|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
64436393|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436394|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436395|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
64436396|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436397|NCT01999335|Dexamethasone|dexamethasone|mesh-list
64436398|NCT01999335|Pomalidomide|pomalidomide|mesh-list
64436399|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436400|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
64436401|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
64436404|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436449|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436450|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436451|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436452|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
64436453|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64436454|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436455|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436456|NCT01731886|Dexamethasone|dexamethasone|mesh-list
64436457|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
64436459|NCT01731886|Lenalidomide|lenalidomide|mesh-list
64436460|NCT01731886|Lenograstim|lenograstim|mesh-list
64436461|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436462|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
64436463|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436464|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436465|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436466|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
64436467|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436468|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436469|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64436470|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436471|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
64436472|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
64436498|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436499|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64436500|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64436501|NCT01781026|Vemurafenib|vemurafenib|mesh-list
64436502|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436503|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64436504|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436505|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436506|NCT01729156|Metformin|metformin|mesh-list
64436507|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64436508|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436509|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64436510|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64436511|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436512|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436513|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
64436514|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436515|NCT04572256|Montelukast|montelukast|mesh-list
64436516|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64436517|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
64436518|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64436540|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436541|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436542|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64436543|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436544|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436546|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
64436547|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436548|NCT01638013|Peficitinib|peficitinib|mesh-list
64436549|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436594|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436595|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
64436596|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436597|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
64436598|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64436599|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
64436600|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436601|NCT04419025|Expectorants|expectorants|mesh-ancestor
64436602|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64436603|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64436604|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
64436605|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436606|NCT04419025|Protective Agents|protective agents|mesh-ancestor
64436607|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436608|NCT04419025|Antidotes|antidotes|mesh-ancestor
64436609|NCT04781647|Interferons|interferons|mesh-list
64436610|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
64436612|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436613|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
64436614|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436655|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64436656|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64436657|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64436658|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436660|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436662|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
64436663|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64436664|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64436665|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436666|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436667|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436668|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64436670|NCT05221021|Mirabegron|mirabegron|mesh-list
64436671|NCT05221021|Estradiol|estradiol|mesh-list
64436672|NCT05221021|Estrogens|estrogens|mesh-list
64436686|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64436687|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436688|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436689|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64436691|NCT03164473|Azathioprine|azathioprine|mesh-list
64436692|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64436693|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436694|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
64436695|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436750|NCT05814432|Antifungal Agents|antifungal agents|mesh-ancestor
64436751|NCT05814367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64436752|NCT05814367|Lubricant Eye Drops|lubricant eye drops|mesh-list
64436753|NCT05814367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64436754|NCT05814354|Gemcitabine|gemcitabine|mesh-list
64436755|NCT05814354|Paclitaxel|paclitaxel|mesh-list
64436756|NCT05814354|Capecitabine|capecitabine|mesh-list
64436757|NCT05814354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64436758|NCT05814354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436759|NCT05814354|Tubulin Modulators|tubulin modulators|mesh-ancestor
64436760|NCT05814354|Antimitotic Agents|antimitotic agents|mesh-ancestor
64436772|NCT05814302|Ibuprofen|ibuprofen|mesh-list
64436812|NCT05813860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436813|NCT05813860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436814|NCT05813860|Antimetabolites|antimetabolites|mesh-ancestor
64436815|NCT05813860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436816|NCT05813860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436817|NCT05813860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436818|NCT05813860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436819|NCT05813860|Immunologic Factors|immunologic factors|mesh-ancestor
64436820|NCT05813860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436821|NCT05813821|Anti-Infective Agents|anti-infective agents|mesh-list
64436822|NCT05813821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64436823|NCT05813691|Antibodies|antibodies|mesh-list
64436824|NCT05813691|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
64436825|NCT05813691|Immunologic Factors|immunologic factors|mesh-ancestor
64436826|NCT05813691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436827|NCT05813665|Denosumab|denosumab|mesh-list
64436873|NCT05813366|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64436874|NCT05813366|Antidepressive Agents|antidepressive agents|mesh-ancestor
64436875|NCT05813366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64436945|NCT05813106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436946|NCT05813106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436947|NCT05813106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64436949|NCT05813106|Sensory System Agents|sensory system agents|mesh-ancestor
64436950|NCT05813106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436951|NCT05813106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64436952|NCT05813106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64436954|NCT05813106|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436955|NCT05813106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436956|NCT05813106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436957|NCT05813015|Docetaxel|docetaxel|mesh-list
64436958|NCT05813015|Tegafur|tegafur|mesh-list
64436959|NCT05813015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436960|NCT05813015|Tubulin Modulators|tubulin modulators|mesh-ancestor
64436962|NCT05813015|Mitosis Modulators|mitosis modulators|mesh-ancestor
64436963|NCT05813015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436964|NCT05813015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436965|NCT05813015|Antimetabolites|antimetabolites|mesh-ancestor
64436966|NCT05812807|Pembrolizumab|pembrolizumab|mesh-list
64436967|NCT05812807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64436968|NCT05812807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436969|NCT05811403|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64436970|NCT05811403|Eusol|eusol|mesh-list
64436992|NCT05802849|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64436993|NCT05802849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436994|NCT05802849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436996|NCT05802849|Natriuretic Agents|natriuretic agents|mesh-ancestor
64436997|NCT05802849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436998|NCT05796804|Anesthetics|anesthetics|mesh-list
64436999|NCT05796804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437000|NCT05796804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437001|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64437002|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64437003|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437004|NCT05788289|Lenalidomide|lenalidomide|mesh-list
64437005|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
64437006|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437012|NCT05787613|Paclitaxel|paclitaxel|mesh-list
64437050|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64437051|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437052|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437054|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
64437056|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437057|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437118|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64437119|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
64437120|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
64437121|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437122|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437123|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64437124|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64437125|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64437126|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
64437127|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
64437128|NCT05715814|Empagliflozin|empagliflozin|mesh-list
64437129|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64437130|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437131|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64437132|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437133|NCT05690204|Colchicine|colchicine|mesh-list
64437134|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
64437135|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437136|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437137|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437138|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437139|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437140|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437141|NCT05689047|Artesunate|artesunate|mesh-list
64437142|NCT05689047|Pyronaridine|pyronaridine|mesh-list
64437143|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
64437144|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64437145|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64437146|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437164|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
64437165|NCT05674994|Hormones|hormones|mesh-ancestor
64437166|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437167|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437168|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437169|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437172|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
64437173|NCT05664217|Antithrombins|antithrombins|mesh-list
64437174|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64437230|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
64437231|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437232|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437233|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437235|NCT05552222|Hormones|hormones|mesh-ancestor
64437297|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
64437298|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
64437299|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64437300|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64437301|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437302|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437303|NCT05536414|Citalopram|citalopram|mesh-list
64437304|NCT05536414|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64437308|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437362|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64437363|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
64437364|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437365|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437424|NCT05293041|Coagulants|coagulants|mesh-ancestor
64437425|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64437426|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64437427|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
64437428|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437429|NCT05287568|Venetoclax|venetoclax|mesh-list
64437431|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437432|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
64437480|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64437481|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437482|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
64437483|NCT05259046|Coagulants|coagulants|mesh-ancestor
64437484|NCT05259046|Vitamins|vitamins|mesh-ancestor
64437485|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
64437486|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437487|NCT05246670|Palmidrol|palmidrol|mesh-list
64437488|NCT05246670|Analgesics|analgesics|mesh-ancestor
64437489|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
64437490|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437491|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437492|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64437493|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64437494|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437495|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437496|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
64437497|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437498|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64437499|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64437500|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437533|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437534|NCT05197842|Hormones|hormones|mesh-ancestor
64437535|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437536|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437537|NCT05189457|Docetaxel|docetaxel|mesh-list
64437538|NCT05189457|Leuprolide|leuprolide|mesh-list
64437539|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64437540|NCT05189457|Hormones|hormones|mesh-list
64437541|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64437542|NCT05189457|Relugolix|relugolix|mesh-list
64437543|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437544|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437545|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437546|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437708|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437710|NCT04975997|Bortezomib|bortezomib|mesh-list
64437711|NCT04975997|Daratumumab|daratumumab|mesh-list
64437712|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437713|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
64437714|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
64437715|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437716|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437717|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437766|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
64437767|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437768|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437769|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
64437770|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437771|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437772|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
64437773|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437774|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64437779|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
64437818|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437819|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437820|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437821|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
64437822|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437823|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437824|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64437825|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64437826|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437827|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437828|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
64437829|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437830|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437831|NCT04818749|Dexamethasone|dexamethasone|mesh-list
64437872|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437874|NCT04759248|Atezolizumab|atezolizumab|mesh-list
64437875|NCT04759248|Vinorelbine|vinorelbine|mesh-list
64437876|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437877|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437878|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64437879|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437880|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437881|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437882|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437883|NCT04756726|Dexamethasone|dexamethasone|mesh-list
64437934|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
64437935|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64437936|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437937|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64437938|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
64437939|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64437940|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437941|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437942|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437995|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437996|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437997|NCT04504812|Analgesics|analgesics|mesh-ancestor
64437998|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
64437999|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438000|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
64438001|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64438002|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
64438004|NCT04503148|Anesthetics|anesthetics|mesh-list
64438005|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
64438006|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
64438007|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64438008|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438009|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438056|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438057|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438058|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64438059|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64438060|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
64438061|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64438062|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64367066|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438063|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438065|NCT04410042|Coagulants|coagulants|mesh-ancestor
64438066|NCT04405167|Dexamethasone|dexamethasone|mesh-list
64438067|NCT04405167|Lenalidomide|lenalidomide|mesh-list
64438118|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
64438119|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
64438120|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
64438121|NCT04375631|Cladribine|cladribine|mesh-list
64438122|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
64438123|NCT04375631|Cyclosporins|cyclosporins|mesh-list
64438124|NCT04375631|Lenograstim|lenograstim|mesh-list
64438125|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438189|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438190|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
64438191|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438192|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64438197|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
64438198|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
64438199|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438201|NCT04218240|Pregabalin|pregabalin|mesh-list
64438202|NCT04218240|Analgesics|analgesics|mesh-ancestor
64438203|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
64438204|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438205|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438206|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
64438207|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64438211|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64438247|NCT04188119|Avelumab|avelumab|mesh-list
64438248|NCT04188119|Lansoprazole|lansoprazole|mesh-list
64438249|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
64438250|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64438251|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438252|NCT04188119|Analgesics|analgesics|mesh-ancestor
64438253|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
64438254|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438255|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438256|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438257|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438258|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64438259|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64438260|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438261|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64438262|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64438263|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438264|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
64438265|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438266|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438267|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64438268|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438269|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64438270|NCT04154956|Docetaxel|docetaxel|mesh-list
64438271|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438272|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
64438273|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
64438274|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
64438275|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438276|NCT04084951|Nivolumab|nivolumab|mesh-list
64438277|NCT04084951|Ipilimumab|ipilimumab|mesh-list
64438278|NCT04084951|Atezolizumab|atezolizumab|mesh-list
64438288|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438292|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64438294|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438295|NCT04065399|Cobicistat|cobicistat|mesh-list
64438296|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64438297|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64438298|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
64438299|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438300|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64438301|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64438302|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438303|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438304|NCT04035837|Interferons|interferons|mesh-list
64438305|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
64438306|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438308|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438310|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438311|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
64438337|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64438338|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64438339|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64438340|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64438341|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438342|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64438343|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
64438344|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438346|NCT04022135|Hematinics|hematinics|mesh-ancestor
64438347|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
64438457|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64438458|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438459|NCT03832998|Analgesics|analgesics|mesh-ancestor
64438537|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438538|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438539|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438540|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438541|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438542|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438581|NCT03572933|Ganaxolone|ganaxolone|mesh-list
64438582|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
64438583|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438584|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438585|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438586|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
64438587|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
64438588|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
64438589|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438590|NCT03558152|Vedolizumab|vedolizumab|mesh-list
64438591|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438592|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
64438593|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438594|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438595|NCT03511196|Prednisone|prednisone|mesh-list
64438596|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
64438597|NCT03511196|Androgens|androgens|mesh-list
64438598|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438599|NCT03511196|Hormones|hormones|mesh-ancestor
64438601|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438639|NCT03317496|Cisplatin|cisplatin|mesh-list
64438640|NCT03317496|Carboplatin|carboplatin|mesh-list
64438641|NCT03317496|Pemetrexed|pemetrexed|mesh-list
64438642|NCT03317496|Avelumab|avelumab|mesh-list
64438643|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64438644|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438645|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438646|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
64438647|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438648|NCT03317496|Antiviral Agents|antiviral agents|mesh-ancestor
64438649|NCT03317496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438650|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438651|NCT03317496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438652|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
64438653|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438654|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64438655|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64438695|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438697|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438698|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438699|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64438766|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438767|NCT02915744|Gemcitabine|gemcitabine|mesh-list
64438768|NCT02915744|Paclitaxel|paclitaxel|mesh-list
64438769|NCT02915744|Vinorelbine|vinorelbine|mesh-list
64438770|NCT02915744|Docetaxel|docetaxel|mesh-list
64438771|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64438772|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
64438773|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64438774|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438775|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
64438776|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
64438777|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
64438778|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438779|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438780|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
64438781|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
64438782|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438783|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438784|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438785|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
64438786|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438787|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438788|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438789|NCT02782949|Curcumin|curcumin|mesh-list
64438790|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64438791|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64438792|NCT02782949|Analgesics|analgesics|mesh-ancestor
64438793|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
64438794|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438795|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438796|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438797|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438798|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438799|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438800|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438806|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
64438807|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438808|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438809|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438810|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
64438812|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438813|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64438814|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438871|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
64438872|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438873|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438874|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
64438875|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438876|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64438877|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438878|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438879|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438880|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
64438881|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438882|NCT02421939|Analgesics|analgesics|mesh-ancestor
64438883|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
64438884|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438931|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
64438932|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438933|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438934|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438935|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438936|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64438937|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64385811|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64438938|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438939|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64438940|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64438941|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438942|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
64438943|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64438944|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64438945|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64438946|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
64438947|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438948|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
64438949|NCT02175680|Leronlimab|leronlimab|mesh-list
64438950|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64438951|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64438952|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438953|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64438954|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64438955|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
64438956|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438957|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64438958|NCT01983462|Clonidine|clonidine|mesh-list
64438959|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64438974|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
64438975|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438976|NCT01974440|Prednisone|prednisone|mesh-list
64438977|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
64438978|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64438979|NCT01974440|Rituximab|rituximab|mesh-list
64438980|NCT01974440|Doxorubicin|doxorubicin|mesh-list
64438981|NCT01974440|Vincristine|vincristine|mesh-list
64439041|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439042|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64439043|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439044|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
64439057|NCT01358877|Paclitaxel|paclitaxel|mesh-list
64439111|NCT00565851|Bevacizumab|bevacizumab|mesh-list
64439112|NCT00565851|Carboplatin|carboplatin|mesh-list
64439113|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64439117|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
64439118|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64439119|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
64439120|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64439121|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439122|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
64439123|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
64439124|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
64439125|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439192|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
64439193|NCT00001230|Filaricides|filaricides|mesh-ancestor
64439194|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
64439195|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
64439196|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64439197|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439198|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64439199|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439200|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439201|NCT04544293|Molgramostim|molgramostim|mesh-list
64439202|NCT04544293|Sargramostim|sargramostim|mesh-list
64439230|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64439231|NCT02909335|Prednisolone|prednisolone|mesh-list
64439232|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
64439233|NCT02909335|Everolimus|everolimus|mesh-list
64439234|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64439235|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
64439236|NCT02909335|Tacrolimus|tacrolimus|mesh-list
64439237|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439238|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
64439239|NCT02909335|Hormones|hormones|mesh-ancestor
64439240|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439241|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439242|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64439243|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439244|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439245|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
64439246|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64439247|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439248|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439249|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64439250|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64439251|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
64439252|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64439253|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439254|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
64439255|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
64439256|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439277|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439278|NCT03998293|Somatostatin|somatostatin|mesh-list
64439279|NCT03998293|Hormones|hormones|mesh-ancestor
64439280|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439281|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439282|NCT01606306|Fluticasone|fluticasone|mesh-list
64439283|NCT01606306|Xhance|xhance|mesh-list
64439284|NCT01606306|Montelukast|montelukast|mesh-list
64439285|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439286|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64439287|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
64439288|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439289|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439290|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64439291|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
64439334|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439336|NCT04571632|Ipilimumab|ipilimumab|mesh-list
64439337|NCT04571632|Avelumab|avelumab|mesh-list
64439338|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439339|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439340|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64439341|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439342|NCT01975389|Bococizumab|bococizumab|mesh-list
64439343|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64439344|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64439345|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
64439348|NCT01974141|Dapsone|dapsone|mesh-list
64439397|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64439399|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64439400|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64439401|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
64439402|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439403|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64439404|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64439405|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439406|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439458|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
64439459|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439460|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439529|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439530|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64439531|NCT01970475|Adalimumab|adalimumab|mesh-list
64439532|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439533|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439534|NCT04653831|Pirfenidone|pirfenidone|mesh-list
64439535|NCT04653831|Analgesics|analgesics|mesh-ancestor
64439536|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
64439537|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439538|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439539|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64439540|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64439541|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439542|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439543|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439544|NCT01939977|Calcifediol|calcifediol|mesh-list
64439545|NCT01939977|Vitamins|vitamins|mesh-ancestor
64439565|NCT01970241|Insulin|insulin|mesh-list
64439589|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439590|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439591|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64439592|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
64439593|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439595|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64439596|NCT02158507|Lapatinib|lapatinib|mesh-list
64439597|NCT02158507|Veliparib|veliparib|mesh-list
64439598|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439599|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64439600|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439601|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439602|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64439603|NCT04791553|Cenobamate|cenobamate|mesh-list
64439604|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
64439605|NCT05651347|Melatonin|melatonin|mesh-list
64439606|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
64439647|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439648|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64439649|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64439651|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64439653|NCT01939197|Ribavirin|ribavirin|mesh-list
64439654|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64439656|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
64439715|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64439716|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439717|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439718|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439720|NCT03542695|Alendronate|alendronate|mesh-list
64439721|NCT03542695|Copper|copper|mesh-list
64439783|NCT03220477|Guadecitabine|guadecitabine|mesh-list
64439784|NCT03220477|Mocetinostat|mocetinostat|mesh-list
64439785|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439786|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439787|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64439788|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439789|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439850|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439851|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439852|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64439853|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64439854|NCT01937715|Growth Substances|growth substances|mesh-ancestor
64439855|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439856|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
64439857|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64439858|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439859|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439860|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
64439912|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64439913|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439914|NCT01726270|Tamsulosin|tamsulosin|mesh-list
64439915|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64439916|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64439926|NCT00942331|Cisplatin|cisplatin|mesh-list
64439978|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64439979|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439980|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439981|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64439982|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64440047|NCT02246647|Lactulose|lactulose|mesh-list
64440048|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64440049|NCT02246647|Diuretics|diuretics|mesh-ancestor
64440050|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
64440051|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440052|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440053|NCT02244619|Acetaminophen|acetaminophen|mesh-list
64440054|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64440055|NCT02244619|Analgesics|analgesics|mesh-ancestor
64440056|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
64440057|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440058|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440059|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
64440060|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
64440061|NCT02243371|Nivolumab|nivolumab|mesh-list
64440062|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
64440065|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440066|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64440067|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
64440068|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440069|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440070|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64440071|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440072|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64440073|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64440074|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64440075|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64440076|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64440089|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440091|NCT01646177|Ixekizumab|ixekizumab|mesh-list
64440092|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64440093|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64440094|NCT01646177|Analgesics|analgesics|mesh-ancestor
64440095|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
64440096|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440097|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440115|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440116|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440117|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64440118|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64440119|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64440120|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64440121|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440122|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440128|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64440130|NCT02324153|Riboflavin|riboflavin|mesh-list
64440131|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
64440132|NCT02324153|Vitamins|vitamins|mesh-ancestor
64440133|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
64440134|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440135|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64440136|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
64440137|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64440138|NCT02280473|Laxatives|laxatives|mesh-ancestor
64440139|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440140|NCT02308007|Metronidazole|metronidazole|mesh-list
64440141|NCT02308007|Terconazole|terconazole|mesh-list
64440142|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440152|NCT04885907|Vaccines|vaccines|mesh-list
64440190|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440191|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
64440192|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
64440193|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64440205|NCT02243293|Ribavirin|ribavirin|mesh-list
64440261|NCT02251717|Ledipasvir|ledipasvir|mesh-list
64440262|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
64440263|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440264|NCT02242201|Ketorolac|ketorolac|mesh-list
64440265|NCT02242201|Epinephrine|epinephrine|mesh-list
64440266|NCT02242201|Bupivacaine|bupivacaine|mesh-list
64440267|NCT02242201|Ropivacaine|ropivacaine|mesh-list
64440268|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
64440269|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
64440271|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440272|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
64440273|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440274|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64440275|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64440276|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440277|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440278|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440322|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64440323|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440324|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
64367122|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64440325|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
64440326|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
64440394|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440395|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440396|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
64440397|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440398|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64440399|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64440400|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64440459|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440460|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440461|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64440462|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64440463|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64440464|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440466|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
64440467|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440468|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64440469|NCT02318693|Glyburide|glyburide|mesh-list
64440472|NCT02318693|Incretins|incretins|mesh-ancestor
64440473|NCT02318693|Hormones|hormones|mesh-ancestor
64440474|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440475|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64440517|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440518|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440519|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64440520|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
64440521|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64440522|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64440523|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64440524|NCT02316353|Complement C1s|complement c1s|mesh-list
64440525|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64440526|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64440527|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
64440528|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440529|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64440530|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440532|NCT02279732|Carboplatin|carboplatin|mesh-list
64440533|NCT02279732|Ipilimumab|ipilimumab|mesh-list
64440534|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64440535|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440542|NCT05649956|Letrozole|letrozole|mesh-list
64440570|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64440571|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440572|NCT01646255|Levodopa|levodopa|mesh-list
64440573|NCT01646255|Rotigotine|rotigotine|mesh-list
64440574|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64440575|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64440576|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
64440577|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440578|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440579|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440634|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64440636|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
64440637|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440638|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440639|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440698|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64440699|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64440700|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440766|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64440767|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
64440768|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
64440769|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440770|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440771|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64440772|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64440773|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64440774|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440775|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440776|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440777|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
64440778|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64440779|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64440780|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64440781|NCT01605136|Afamelanotide|afamelanotide|mesh-list
64440782|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
64440824|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
64440825|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440826|NCT01749826|Morphine|morphine|mesh-list
64440827|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64440828|NCT01749826|Narcotics|narcotics|mesh-ancestor
64440829|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440830|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440831|NCT01749826|Analgesics|analgesics|mesh-ancestor
64440832|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
64440833|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440834|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
64440835|NCT01724866|Docetaxel|docetaxel|mesh-list
64440836|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440837|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
64440838|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440839|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440849|NCT02266433|Ketorolac|ketorolac|mesh-list
64440884|NCT01745380|Phenylephrine|phenylephrine|mesh-list
64440885|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
64440887|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
64440888|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
64440889|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440890|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440891|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
64440892|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441081|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441082|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64441083|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441084|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441085|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
64441086|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441087|NCT02296112|Trametinib|trametinib|mesh-list
64441088|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441089|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64441090|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441091|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441093|NCT02269670|Everolimus|everolimus|mesh-list
64441094|NCT02269670|Letrozole|letrozole|mesh-list
64441095|NCT02269670|Fulvestrant|fulvestrant|mesh-list
64441096|NCT02269670|Anastrozole|anastrozole|mesh-list
64441097|NCT02269670|Megestrol|megestrol|mesh-list
64441098|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
64441099|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441100|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441101|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441102|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
64441125|NCT02225353|Progestins|progestins|mesh-ancestor
64441131|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
64441132|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64441133|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64441134|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441135|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
64441136|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441137|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
64441138|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441139|NCT02294786|Capecitabine|capecitabine|mesh-list
64441140|NCT02294786|Lapatinib|lapatinib|mesh-list
64441141|NCT02294786|Octreotide|octreotide|mesh-list
64441142|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64441143|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
64441144|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441151|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64441187|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441188|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64441189|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
64441190|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64441191|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64441192|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441193|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64441194|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
64441195|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64441196|NCT02166697|Candesartan|candesartan|mesh-list
64441205|NCT02197897|Tamoxifen|tamoxifen|mesh-list
64441248|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64441249|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
64441250|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64441251|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441252|NCT01908699|Beraprost|beraprost|mesh-list
64441253|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64441254|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
64441255|NCT01363011|Darunavir|darunavir|mesh-list
64441257|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64441314|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441315|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
64441316|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441317|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64441318|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64441319|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441378|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441379|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367209|NCT02509559|Propranolol|propranolol|mesh-list
64441380|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
64441381|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441442|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441443|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64441444|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
64441445|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
64441446|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64441447|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
64441448|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441449|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441510|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
64441511|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441512|NCT01702558|Capecitabine|capecitabine|mesh-list
64441513|NCT01702558|Trastuzumab|trastuzumab|mesh-list
64441526|NCT05650775|Adderall|adderall|mesh-list
64441577|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441578|NCT05645861|Benzocaine|benzocaine|mesh-list
64441579|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
64441580|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
64441581|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441582|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441583|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
64441584|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441585|NCT01719172|Hemostatics|hemostatics|mesh-list
64441586|NCT01719172|Coagulants|coagulants|mesh-ancestor
64441587|NCT02285855|Metformin|metformin|mesh-list
64441588|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441589|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441590|NCT02285153|Aspirin|aspirin|mesh-list
64441591|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
64441592|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64441593|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64441594|NCT02285153|Analgesics|analgesics|mesh-ancestor
64441596|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441597|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441599|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441600|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64441629|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64441630|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441631|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441632|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441633|NCT01740154|Sunitinib|sunitinib|mesh-list
64441634|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441635|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64441636|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64441637|NCT01740154|Growth Substances|growth substances|mesh-ancestor
64441638|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441639|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
64441640|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64441641|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441642|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441643|NCT02287610|Prednisone|prednisone|mesh-list
64441687|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441688|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
64441689|NCT02260934|Hormones|hormones|mesh-ancestor
64441691|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64441759|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441760|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
64441761|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64441762|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64441763|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64441764|NCT01739764|Vemurafenib|vemurafenib|mesh-list
64441765|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441766|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64441767|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441768|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441769|NCT01700530|Simvastatin|simvastatin|mesh-list
64441770|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
64441771|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64441772|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64441773|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
64441774|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441775|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64441815|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
64441816|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64441817|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64441818|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441819|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441820|NCT01697800|Urological Agents|urological agents|mesh-ancestor
64441821|NCT04553770|Trastuzumab|trastuzumab|mesh-list
64441835|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441836|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64441838|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64441839|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
64441840|NCT01644500|Glimepiride|glimepiride|mesh-list
64441876|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441877|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441878|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441879|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64441880|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441881|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441882|NCT01641692|Albuterol|albuterol|mesh-list
64441897|NCT01682512|Rituximab|rituximab|mesh-list
64441911|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64441912|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64441913|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
64441914|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
64441915|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
64441916|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441917|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441919|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
64441920|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64441921|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441922|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441923|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
64441926|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
64441975|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441976|NCT05640596|Betamethasone|betamethasone|mesh-list
64441978|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
64441979|NCT05640596|Hormones|hormones|mesh-ancestor
64441980|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441981|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441982|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64441983|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
64441984|NCT05651126|Psilocybin|psilocybin|mesh-list
64441985|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
64441986|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441987|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64441989|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441990|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441992|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442034|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
64442035|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
64442036|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442037|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64442038|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64442039|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442040|NCT05650268|Vitamin D|vitamin d|mesh-list
64442102|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64442103|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442104|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442105|NCT04652960|Nivolumab|nivolumab|mesh-list
64442106|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442107|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442108|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64442109|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442110|NCT05357846|Paclitaxel|paclitaxel|mesh-list
64442111|NCT05357846|Cisplatin|cisplatin|mesh-list
64442112|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64442113|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442114|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
64442115|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
64442116|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
64442117|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442118|NCT05031494|Gemcitabine|gemcitabine|mesh-list
64442119|NCT05031494|Paclitaxel|paclitaxel|mesh-list
64442120|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64442122|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
64442156|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64442157|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442158|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
64442159|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442160|NCT04419662|Phenylephrine|phenylephrine|mesh-list
64442161|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
64442162|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64442163|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
64442164|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
64442165|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442166|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442167|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
64442168|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64442169|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
64442170|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442171|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64442172|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64442173|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64442174|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
64442175|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442176|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442177|NCT04419662|Protective Agents|protective agents|mesh-ancestor
64442178|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
64442179|NCT04621526|Ketamine|ketamine|mesh-list
64442180|NCT04621526|Propofol|propofol|mesh-list
64442181|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64442182|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442183|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442185|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
64442203|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
64442204|NCT04589546|Vitamins|vitamins|mesh-ancestor
64442205|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
64442206|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442207|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64442208|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
64442209|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442210|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64442211|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
64442212|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
64442215|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
64442268|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442269|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442270|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442271|NCT05341154|Analgesics|analgesics|mesh-ancestor
64442272|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
64442340|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64442341|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64442342|NCT04421378|Growth Substances|growth substances|mesh-ancestor
64442343|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442344|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
64442345|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64442346|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
64442347|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442348|NCT04827446|Methamphetamine|methamphetamine|mesh-list
64442349|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64442350|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442351|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
64442352|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
64442353|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442354|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
64442355|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442396|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64442397|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
64442398|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
64442399|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442403|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
64442404|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442405|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442406|NCT04178642|Idarubicin|idarubicin|mesh-list
64442407|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
64442408|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64442409|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442410|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64442411|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64442412|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442414|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
64442454|NCT04307576|Blinatumomab|blinatumomab|mesh-list
64442455|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64442456|NCT04307576|Thioguanine|thioguanine|mesh-list
64442457|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442458|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
64442459|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
64442460|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442461|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442462|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442463|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
64442464|NCT04307576|Hormones|hormones|mesh-ancestor
64442465|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442466|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442467|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442468|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64442513|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442514|NCT04824638|Vaccines|vaccines|mesh-list
64442515|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
64442516|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442518|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64442519|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442520|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64442521|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64442522|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
64442523|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442524|NCT04076462|Octreotide|octreotide|mesh-list
64442525|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442526|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442528|NCT04818944|Tirofiban|tirofiban|mesh-list
64442574|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64442575|NCT04836962|Dexamethasone|dexamethasone|mesh-list
64442576|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442577|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
64442578|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
64442579|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442580|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442581|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442582|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
64442583|NCT04836962|Hormones|hormones|mesh-ancestor
64442584|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442585|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442586|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442587|NCT05289440|Esketamine|esketamine|mesh-list
64442588|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
64442589|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64442591|NCT04016090|Hematinics|hematinics|mesh-ancestor
64442633|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442634|NCT04816682|Protective Agents|protective agents|mesh-ancestor
64442635|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442636|NCT02162719|Paclitaxel|paclitaxel|mesh-list
64442637|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64442638|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442639|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
64442640|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
64442641|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
64442642|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442698|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64442699|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442700|NCT05651750|Fluticasone|fluticasone|mesh-list
64442701|NCT05651750|Xhance|xhance|mesh-list
64442702|NCT05651750|Montelukast|montelukast|mesh-list
64442703|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442704|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64442705|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
64442706|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442707|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442708|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442709|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442710|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
64442711|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64442712|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64442713|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
64442714|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442715|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64442716|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64442717|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442718|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64442719|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64442720|NCT03740204|Estradiol|estradiol|mesh-list
64442721|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64442722|NCT03740204|Progesterone|progesterone|mesh-list
64442723|NCT03740204|Estrogens|estrogens|mesh-ancestor
64442747|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
64442748|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442749|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442750|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442751|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
64442765|NCT01681576|Valsartan|valsartan|mesh-list
64442812|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442813|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442814|NCT01681186|Lansoprazole|lansoprazole|mesh-list
64442815|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
64442816|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64442817|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442818|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64442819|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442821|NCT01695772|Bevacizumab|bevacizumab|mesh-list
64442822|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442823|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442824|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64442825|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64442826|NCT01695772|Growth Substances|growth substances|mesh-ancestor
64442827|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442828|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
64442829|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64442830|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64442831|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64442864|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
64442865|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
64442866|NCT02159365|Dexamethasone|dexamethasone|mesh-list
64442867|NCT02159365|Lenalidomide|lenalidomide|mesh-list
64442868|NCT02159365|Elotuzumab|elotuzumab|mesh-list
64442869|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442870|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
64442871|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
64442872|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442873|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442874|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442875|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
64442876|NCT02159365|Hormones|hormones|mesh-ancestor
64442877|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442878|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442879|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442880|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
64442881|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64442882|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64442883|NCT02159365|Growth Substances|growth substances|mesh-ancestor
64442884|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
64442885|NCT02072200|Prednisone|prednisone|mesh-list
64442886|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442887|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
64442888|NCT02072200|Hormones|hormones|mesh-ancestor
64442893|NCT01691794|Ritonavir|ritonavir|mesh-list
64442916|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
64442917|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
64442918|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442919|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442920|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
64442921|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442922|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64442923|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64442924|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64442925|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442926|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442927|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64442930|NCT03563222|SMOFlipid|smoflipid|mesh-list
64442976|NCT02158052|Tacrolimus|tacrolimus|mesh-list
64442977|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64442978|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442979|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
64442980|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442981|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64442982|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442983|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442984|NCT01635218|Fluoxetine|fluoxetine|mesh-list
64442985|NCT01635218|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64443109|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64443110|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443111|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
64443113|NCT04216784|Diuretics|diuretics|mesh-ancestor
64443114|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
64443115|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443116|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64443117|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64443118|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443119|NCT05173298|Bevacizumab|bevacizumab|mesh-list
64443120|NCT05173298|Atezolizumab|atezolizumab|mesh-list
64443163|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64443164|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64443237|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64443238|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64443239|NCT03651128|Growth Substances|growth substances|mesh-ancestor
64443240|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
64443299|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64443300|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64443301|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64385983|NCT02544321|Bromocriptine|bromocriptine|mesh-list
64443373|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443375|NCT01710358|Methotrexate|methotrexate|mesh-list
64443376|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64443377|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
64443378|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64443379|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443380|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443381|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
64443382|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443383|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443384|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
64443385|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443386|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64443387|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443388|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
64443389|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443390|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64443391|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443392|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
64443393|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64443394|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
64443397|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443422|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443423|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64443424|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
64443425|NCT01710046|Tofacitinib|tofacitinib|mesh-list
64443426|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443427|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443428|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443429|NCT02154529|Trastuzumab|trastuzumab|mesh-list
64443430|NCT02154529|XL647|xl647|mesh-list
64443431|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443432|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443433|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443434|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443435|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443436|NCT02154139|Leuprolide|leuprolide|mesh-list
64443437|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64443438|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
64443439|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64443440|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443441|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64443442|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443443|NCT02154061|Metronidazole|metronidazole|mesh-list
64443444|NCT02154061|Vancomycin|vancomycin|mesh-list
64443445|NCT02154061|Neomycin|neomycin|mesh-list
64443446|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443447|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443471|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443472|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443473|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443474|NCT04619979|Anesthetics|anesthetics|mesh-list
64443475|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443476|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443477|NCT01630135|Fluticasone|fluticasone|mesh-list
64443478|NCT01630135|Xhance|xhance|mesh-list
64443479|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443480|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64443481|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
64443482|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443483|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443484|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64443485|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
64443486|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
64443487|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64443488|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
64443489|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443490|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443491|NCT01924767|Empagliflozin|empagliflozin|mesh-list
64443492|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64443493|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443494|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64443495|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443496|NCT01691092|Ketamine|ketamine|mesh-list
64443519|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64443520|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443521|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443523|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443524|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443525|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
64443527|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64443528|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443529|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
64443530|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443531|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64443532|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
64443533|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64443534|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64443535|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443536|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64443537|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64443538|NCT01709578|Analgesics|analgesics|mesh-ancestor
64443570|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64443571|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
64443572|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443573|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443574|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64443575|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64443576|NCT02153905|Analgesics|analgesics|mesh-ancestor
64443577|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
64443578|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443579|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64443580|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64443581|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
64443582|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443583|NCT04752631|Tenecteplase|tenecteplase|mesh-list
64443584|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64443585|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64443586|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443587|NCT04546672|Neostigmine|neostigmine|mesh-list
64443588|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64443589|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443590|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443591|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
64443592|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443593|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443594|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64443595|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
64443596|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443597|NCT02244944|Ezetimibe|ezetimibe|mesh-list
64443598|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64443599|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64443600|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
64443601|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443610|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443611|NCT01953003|Capecitabine|capecitabine|mesh-list
64443612|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443613|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
64443614|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443615|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443616|NCT01709500|Atorvastatin|atorvastatin|mesh-list
64443617|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64443618|NCT01709500|Simvastatin|simvastatin|mesh-list
64443619|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64443620|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64443621|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
64443622|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443623|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64443624|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64443625|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443626|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
64443665|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64443666|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
64443667|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443668|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443669|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64443672|NCT02182999|Ropivacaine|ropivacaine|mesh-list
64443673|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
64443674|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
64443675|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443679|NCT01598311|Vancomycin|vancomycin|mesh-list
64443725|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443726|NCT02180659|Analgesics|analgesics|mesh-ancestor
64443727|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
64443728|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443729|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64443731|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
64443732|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443733|NCT05156606|Testosterone|testosterone|mesh-list
64443734|NCT05156606|Androgens|androgens|mesh-ancestor
64443735|NCT05156606|Hormones|hormones|mesh-ancestor
64443736|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443737|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443738|NCT02241512|Ibuprofen|ibuprofen|mesh-list
64443739|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64443740|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64443741|NCT02241512|Analgesics|analgesics|mesh-ancestor
64443742|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
64443743|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443744|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443745|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443746|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443747|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64443777|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
64443778|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64443779|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64443780|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64443781|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64443782|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64443783|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443784|NCT02179177|Apixaban|apixaban|mesh-list
64443785|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64443786|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
64443787|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64443788|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
64443789|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443838|NCT02203838|Risperidone|risperidone|mesh-list
64443839|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64443840|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
64443841|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443843|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443913|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64443914|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64443915|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64443920|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
64443986|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
64443987|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443988|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443991|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
64443992|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443993|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443995|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443996|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443997|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444048|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444049|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444050|NCT04115878|Oxybutynin|oxybutynin|mesh-list
64444051|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64444052|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64444053|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64444054|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444055|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444056|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
64444057|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444058|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444059|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
64444060|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
64444061|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444078|NCT01587274|Narcotics|narcotics|mesh-ancestor
64444079|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444080|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64444081|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64444082|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64444083|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
64444084|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64444085|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444086|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444087|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
64444088|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
64444089|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64444090|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64444091|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64444092|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64444094|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64444095|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64444096|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444097|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444098|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64444099|NCT01905657|Docetaxel|docetaxel|mesh-list
64444100|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
64444101|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444102|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
64444103|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
64444104|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
64444105|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444106|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64444107|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
64444108|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
64444119|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444120|NCT01923363|Tazobactam|tazobactam|mesh-list
64444121|NCT01923363|Piperacillin|piperacillin|mesh-list
64444122|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64444150|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64444151|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64444152|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64444153|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444154|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444155|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444156|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
64444157|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
64444158|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64444159|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444160|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64444189|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444190|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
64444193|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64444194|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
64444195|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444196|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444197|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64444198|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
64444199|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
64444200|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64444201|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
64444202|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444203|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444204|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
64444205|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64444206|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64444250|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
64444251|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444252|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64444253|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64444254|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444270|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64444271|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
64385984|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64444320|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64444321|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
64444322|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
64444323|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444324|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64444325|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64444326|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444327|NCT04859465|Doxorubicin|doxorubicin|mesh-list
64444328|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64444329|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64444330|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64444331|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444332|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64444333|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64444334|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444335|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444340|NCT02121847|Cyclosporins|cyclosporins|mesh-list
64444341|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444342|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444343|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444344|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
64444345|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444346|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
64444347|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444348|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
64444349|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64444350|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64444351|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64444352|NCT02121847|Laxatives|laxatives|mesh-ancestor
64444353|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64444354|NCT01586806|Dexamethasone|dexamethasone|mesh-list
64444355|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
64444356|NCT01586806|Bupivacaine|bupivacaine|mesh-list
64444357|NCT01586806|BB 1101|bb 1101|mesh-list
64444371|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444372|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
64444374|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444375|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
64444376|NCT05631041|Silymarin|silymarin|mesh-list
64444377|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
64444378|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444379|NCT05631041|Protective Agents|protective agents|mesh-ancestor
64444380|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444381|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64444382|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64444383|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64444384|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
64444385|NCT05544071|Sertraline|sertraline|mesh-list
64444386|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
64444387|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64444416|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444417|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444418|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
64444419|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64444420|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444421|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444422|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64444423|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64444424|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64444425|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444426|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64444427|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64444428|NCT05598905|Narcotics|narcotics|mesh-ancestor
64444465|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444466|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444467|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444469|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64444470|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64444471|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64444473|NCT01585246|Urological Agents|urological agents|mesh-ancestor
64444474|NCT01585168|Memantine|memantine|mesh-list
64444475|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64444476|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64444477|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
64444478|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444479|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444480|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444481|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64444482|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64444483|NCT02252042|Docetaxel|docetaxel|mesh-list
64444484|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
64444485|NCT02252042|Methotrexate|methotrexate|mesh-list
64444486|NCT02252042|Cetuximab|cetuximab|mesh-list
64444487|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444488|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
64444489|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
64444490|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
64379302|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64444502|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444503|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
64444504|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64444505|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64444507|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
64444508|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444509|NCT02231918|Protective Agents|protective agents|mesh-ancestor
64444510|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444521|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444522|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
64444523|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64444524|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64444525|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444527|NCT02199080|Coagulants|coagulants|mesh-ancestor
64444528|NCT02197520|Insulin|insulin|mesh-list
64444529|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64444530|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
64444531|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
64444532|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64444557|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
64444558|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
64444559|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
64444560|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444561|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64444562|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
64444563|NCT01683994|Hormones|hormones|mesh-ancestor
64444564|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444625|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444626|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444627|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64444651|NCT05382299|Carboplatin|carboplatin|mesh-list
64444652|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64444653|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444654|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
64444655|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
64444656|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
64444657|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444658|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64444659|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
64444660|NCT05382299|Antiviral Agents|antiviral agents|mesh-ancestor
64444661|NCT05382299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444662|NCT05382299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444663|NCT05382299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64444664|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
64444665|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444667|NCT02227784|Ezetimibe|ezetimibe|mesh-list
64444668|NCT02227784|Evacetrapib|evacetrapib|mesh-list
64444669|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64444683|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64444684|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64444685|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64444686|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444687|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
64444688|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444689|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
64444690|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
64444691|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444692|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
64444693|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64444704|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444705|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64444706|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64444707|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
64444708|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64444709|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64444710|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64444711|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64444712|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
64444714|NCT02193776|Isoniazid|isoniazid|mesh-list
64444715|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
64444716|NCT02193776|Ethambutol|ethambutol|mesh-list
64444717|NCT02193776|Bedaquiline|bedaquiline|mesh-list
64444718|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64444719|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444720|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64444721|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64444722|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444723|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444724|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444725|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64444727|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
64444728|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64444763|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
64444764|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444765|NCT05344625|Ketamine|ketamine|mesh-list
64444766|NCT05344625|Analgesics|analgesics|mesh-ancestor
64444767|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
64444768|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444769|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444770|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64444771|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64444772|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
64444773|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
64444774|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444775|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64444776|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64444777|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444803|NCT05341349|Nivolumab|nivolumab|mesh-list
64444804|NCT05341349|Ipilimumab|ipilimumab|mesh-list
64444806|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444807|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64444808|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444810|NCT04530149|Bupivacaine|bupivacaine|mesh-list
64444811|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
64444812|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
64367257|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
64444813|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444814|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444815|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
64444816|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444817|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64444818|NCT04530149|Analgesics|analgesics|mesh-ancestor
64444819|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
64444820|NCT04525547|Nintedanib|nintedanib|mesh-list
64444821|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444822|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64444823|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64444824|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444825|NCT04524689|Carboplatin|carboplatin|mesh-list
64444826|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
64444827|NCT04524689|Pemetrexed|pemetrexed|mesh-list
64444828|NCT04524689|Maytansine|maytansine|mesh-list
64444843|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444844|NCT02119819|Metformin|metformin|mesh-list
64444845|NCT02119819|Exenatide|exenatide|mesh-list
64444846|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64444847|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444848|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64444849|NCT02119819|Incretins|incretins|mesh-ancestor
64444850|NCT02119819|Hormones|hormones|mesh-ancestor
64444851|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444852|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
64444853|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64444854|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
64444855|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444856|NCT04766450|Expectorants|expectorants|mesh-ancestor
64444857|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
64444858|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64444860|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444861|NCT04766450|Protective Agents|protective agents|mesh-ancestor
64444862|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444863|NCT04766450|Antidotes|antidotes|mesh-ancestor
64444872|NCT02168816|Piperacillin|piperacillin|mesh-list
64444873|NCT02168816|Daptomycin|daptomycin|mesh-list
64444874|NCT02168816|Cefepime|cefepime|mesh-list
64444875|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64444876|NCT02168816|Aztreonam|aztreonam|mesh-list
64444877|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64379303|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64444889|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64444890|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64444891|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64444892|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64444893|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64444894|NCT02168816|Renal Agents|renal agents|mesh-ancestor
64444895|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
64444896|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64444897|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64444898|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64444899|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
64444900|NCT01584232|Dulaglutide|dulaglutide|mesh-list
64444901|NCT01584232|Biguanides|biguanides|mesh-list
64444902|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64444903|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444904|NCT02119663|Capecitabine|capecitabine|mesh-list
64367278|NCT02500511|Vaccines|vaccines|mesh-list
64444905|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64444906|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
64444907|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444908|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444909|NCT04481009|Gemcitabine|gemcitabine|mesh-list
64386097|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
64445013|NCT05219669|Nalmefene|nalmefene|mesh-list
64445014|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64445015|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445016|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
64445017|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445018|NCT04763252|Coal Tar|coal tar|mesh-list
64445019|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
64445020|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
64445021|NCT05369039|Prednisolone|prednisolone|mesh-list
64445022|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64445023|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
64445024|NCT05369039|Hormones|hormones|mesh-ancestor
64445025|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445026|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445027|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64445028|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445029|NCT04373369|Atezolizumab|atezolizumab|mesh-list
64445030|NCT04373369|Vorolanib|vorolanib|mesh-list
64445031|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445032|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64445033|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445034|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445035|NCT04285853|Oxycodone|oxycodone|mesh-list
64445036|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64445037|NCT04285853|Narcotics|narcotics|mesh-ancestor
64445038|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445039|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445040|NCT04285853|Analgesics|analgesics|mesh-ancestor
64445041|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
64445044|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
64445045|NCT04791059|Ketamine|ketamine|mesh-list
64445046|NCT04791059|Esketamine|esketamine|mesh-list
64445047|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64445048|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445049|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445050|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64445051|NCT04791059|Analgesics|analgesics|mesh-ancestor
64445052|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
64445053|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445092|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445093|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
64445094|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
64445095|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64445096|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64445097|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64445098|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64445099|NCT05398913|Rimonabant|rimonabant|mesh-list
64445100|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64445101|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
64445102|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64445103|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445104|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445106|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445107|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445110|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64445111|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445112|NCT01583374|Thalidomide|thalidomide|mesh-list
64445114|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64445115|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64445116|NCT01583374|Analgesics|analgesics|mesh-ancestor
64445117|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
64445118|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445119|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445120|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64445121|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64445122|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64445123|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64445181|NCT02164916|Camptothecin|camptothecin|mesh-list
64445182|NCT02164916|Vemurafenib|vemurafenib|mesh-list
64445183|NCT02164916|Antibodies|antibodies|mesh-list
64445184|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
64445185|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64445186|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
64445188|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
64445189|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445190|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445191|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64445192|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64445193|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445194|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445195|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
64445196|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64445197|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64445198|NCT04091867|Cetuximab|cetuximab|mesh-list
64445199|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445200|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445201|NCT04060277|Acetic Acid|acetic acid|mesh-list
64445202|NCT04060277|Letermovir|letermovir|mesh-list
64445203|NCT04060277|Vaccines|vaccines|mesh-list
64445204|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
64445205|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445248|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445249|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
64445251|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64445252|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64445253|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64445254|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445255|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445264|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445268|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445269|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445270|NCT02975999|Vasopressins|vasopressins|mesh-list
64445271|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
64445272|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
64445283|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445284|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64445286|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445287|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445288|NCT02188784|Iron|iron|mesh-list
64445289|NCT02188784|Trace Elements|trace elements|mesh-ancestor
64445290|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
64445291|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445292|NCT02222246|Morphine|morphine|mesh-list
64445293|NCT02222246|Hydromorphone|hydromorphone|mesh-list
64445294|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64445295|NCT02222246|Narcotics|narcotics|mesh-ancestor
64445296|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445297|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445298|NCT02222246|Analgesics|analgesics|mesh-ancestor
64445299|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
64445319|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
64445364|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445366|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64445367|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445368|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64445369|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64445370|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64445371|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445373|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
64445374|NCT03943901|Hormones|hormones|mesh-ancestor
64445375|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445376|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64445377|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64445378|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
64445379|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
64445382|NCT02696993|Ipilimumab|ipilimumab|mesh-list
64445383|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445384|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445385|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64386105|NCT02055820|Prednisone|prednisone|mesh-list
64445463|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
64445464|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445465|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64445466|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64445467|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445469|NCT01634555|Protective Agents|protective agents|mesh-ancestor
64445470|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
64445472|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
64445473|NCT01634555|Hematinics|hematinics|mesh-ancestor
64445474|NCT05355155|Bevacizumab|bevacizumab|mesh-list
64445475|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445476|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445477|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64445487|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445488|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
64445489|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64445490|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64445491|NCT02321501|Everolimus|everolimus|mesh-list
64445492|NCT02321501|Ceritinib|ceritinib|mesh-list
64445493|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445494|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445495|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
64445496|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445497|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64445498|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445499|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445500|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64445501|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64445502|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
64445504|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64445505|NCT04104646|Narcotics|narcotics|mesh-ancestor
64445506|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445507|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445508|NCT04104646|Analgesics|analgesics|mesh-ancestor
64445509|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
64445510|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445512|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64386137|NCT05408559|Protective Agents|protective agents|mesh-ancestor
64445532|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
64445533|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445534|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445535|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
64445536|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445538|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
64445539|NCT01582282|Cathartics|cathartics|mesh-ancestor
64445541|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
64445542|NCT01599650|Ranibizumab|ranibizumab|mesh-list
64445543|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64445544|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64445545|NCT01599650|Growth Substances|growth substances|mesh-ancestor
64445546|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445547|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
64445548|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445549|NCT03774875|Apremilast|apremilast|mesh-list
64445550|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64445560|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445561|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445562|NCT01563172|Listerine|listerine|mesh-list
64445563|NCT01563172|Fluorides|fluorides|mesh-list
64445564|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
64445565|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
64445566|NCT01563172|Protective Agents|protective agents|mesh-ancestor
64445567|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445568|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64445569|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445572|NCT04755764|Nifedipine|nifedipine|mesh-list
64445573|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64445574|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445575|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445576|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445585|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445586|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64445587|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64445588|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64445589|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
64445590|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445592|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64445593|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64445595|NCT04113616|Decitabine|decitabine|mesh-list
64445596|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64445597|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
64445598|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445599|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445600|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
64445601|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445602|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64445603|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
64445604|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445605|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445606|NCT03774641|Lamotrigine|lamotrigine|mesh-list
64445609|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445610|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445611|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445612|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445613|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64445614|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64445615|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445616|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64445689|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64445690|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
64445706|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64445708|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64445709|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64445750|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64445751|NCT01539538|Narcotics|narcotics|mesh-ancestor
64445752|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445753|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445754|NCT01539538|Analgesics|analgesics|mesh-ancestor
64445795|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445797|NCT04112368|Progestins|progestins|mesh-ancestor
64445798|NCT01539226|Dapivirine|dapivirine|mesh-list
64445799|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64445800|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64445801|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
64445802|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445803|NCT01537120|Vildagliptin|vildagliptin|mesh-list
64445804|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64445805|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445806|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64445807|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
64445808|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445809|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445811|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
64445813|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445814|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445815|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445816|NCT01536574|Ropinirole|ropinirole|mesh-list
64445856|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445857|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64445858|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64445859|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64445860|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445861|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64445862|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64445863|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64445864|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64445865|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64445866|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
64445867|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64445868|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445870|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
64445871|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445872|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
64445874|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64445875|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
64445876|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445877|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445889|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64445890|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64445891|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64445892|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445893|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64445894|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64445895|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
64445896|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64445897|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445898|NCT01575028|Bupivacaine|bupivacaine|mesh-list
64445899|NCT01575028|Ropivacaine|ropivacaine|mesh-list
64445900|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
64445901|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
64445902|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64445903|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64445904|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
64445905|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64445906|NCT04963283|Nivolumab|nivolumab|mesh-list
64445907|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64445947|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64445948|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
64445949|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
64445950|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64445951|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64445994|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
64445995|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
64445996|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446004|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446005|NCT01574716|Gemcitabine|gemcitabine|mesh-list
64446006|NCT01574716|Docetaxel|docetaxel|mesh-list
64446007|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64446008|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
64446009|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446010|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446011|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
64446012|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446013|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446014|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64446042|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
64446043|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446044|NCT01574248|Icatibant|icatibant|mesh-list
64446045|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64446046|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64446047|NCT01574248|Analgesics|analgesics|mesh-ancestor
64446048|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
64446049|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446050|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446051|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446059|NCT04761094|Insulin|insulin|mesh-list
64446060|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64446061|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446062|NCT01557946|Citalopram|citalopram|mesh-list
64446064|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64446065|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64446066|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446067|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446068|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
64446069|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446070|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64446071|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
64446083|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446085|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64446086|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
64446087|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64446088|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
64446171|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
64446173|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446174|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446175|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64446176|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446177|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64446178|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430056|NCT02141997|Adalimumab|adalimumab|mesh-list
64430057|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430058|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430059|NCT04411433|Azithromycin|azithromycin|mesh-list
64430061|NCT04411433|Favipiravir|favipiravir|mesh-list
64430062|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64430063|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430064|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
64430065|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64430066|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64430067|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430068|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430069|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430070|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
64430071|NCT04987463|Sirolimus|sirolimus|mesh-list
64430072|NCT04987463|Vigabatrin|vigabatrin|mesh-list
64430073|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64430074|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430075|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64430076|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430077|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
64430078|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64430079|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
64430080|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430100|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430101|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64430102|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64430103|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64430104|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430105|NCT05008913|Adavosertib|adavosertib|mesh-list
64430106|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430107|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430110|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430111|NCT04982705|Incretins|incretins|mesh-ancestor
64430112|NCT04982705|Hormones|hormones|mesh-ancestor
64430113|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430114|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64430115|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
64430116|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446211|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
64430117|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430119|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
64430120|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430121|NCT02141295|Leucovorin|leucovorin|mesh-list
64430122|NCT02141295|Folic Acid|folic acid|mesh-list
64430123|NCT02141295|Bevacizumab|bevacizumab|mesh-list
64430124|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
64430125|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
64430126|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64430127|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430128|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64430129|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64430130|NCT02141295|Growth Substances|growth substances|mesh-ancestor
64430131|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430132|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
64430133|NCT02141295|Antidotes|antidotes|mesh-ancestor
64430134|NCT02141295|Protective Agents|protective agents|mesh-ancestor
64430135|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
64430137|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
64430138|NCT02141295|Hematinics|hematinics|mesh-ancestor
64430139|NCT02514551|Paclitaxel|paclitaxel|mesh-list
64430153|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64430171|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
64430172|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430173|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430175|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
64430176|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430177|NCT04725201|Heparin|heparin|mesh-list
64430178|NCT04725201|Calcium heparin|calcium heparin|mesh-list
64430180|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64430181|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64430182|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430184|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64430185|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430186|NCT02511431|Ritonavir|ritonavir|mesh-list
64430187|NCT02511431|Lonafarnib|lonafarnib|mesh-list
64430188|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64430189|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64430213|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64430214|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64430215|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430216|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430217|NCT05003453|Hormones|hormones|mesh-ancestor
64430218|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430219|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
64430220|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64430221|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64430222|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430223|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430224|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430225|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430226|NCT01655069|Urological Agents|urological agents|mesh-ancestor
64430227|NCT01654601|Clozapine|clozapine|mesh-list
64430228|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64430229|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
64430230|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430231|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430232|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430233|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64430234|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64430235|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430242|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430244|NCT02068443|Hormones|hormones|mesh-ancestor
64430245|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430246|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64430247|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
64430248|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430252|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64430253|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430254|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430255|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64430256|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430257|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
64430258|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64430259|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64430260|NCT02508935|Narcotics|narcotics|mesh-ancestor
64430261|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430262|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430263|NCT02508935|Analgesics|analgesics|mesh-ancestor
64430264|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
64430265|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430266|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64430267|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430268|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430285|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430286|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64430287|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430288|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430291|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64430292|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
64430293|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64430294|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
64430295|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430296|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430297|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64430298|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64430299|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430300|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64430301|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
64430302|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430303|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
64430304|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64430305|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64430306|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64430307|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64430308|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430309|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430310|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64430318|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430320|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
64430321|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430322|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430323|NCT02101983|Cytarabine|cytarabine|mesh-list
64430345|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64430346|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64430347|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430348|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64430349|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64430350|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430351|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64430352|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430353|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
64430354|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64430355|NCT02481947|Laxatives|laxatives|mesh-list
64430356|NCT02481947|Lubiprostone|lubiprostone|mesh-list
64430357|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64430358|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430359|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430360|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64430361|NCT02503085|Ibuprofen|ibuprofen|mesh-list
64430362|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64430363|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430364|NCT02503085|Analgesics|analgesics|mesh-ancestor
64430365|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
64430366|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430367|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430368|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430369|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430370|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64430371|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430372|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430373|NCT02502149|Factor VIII|factor viii|mesh-list
64430374|NCT02502149|Coagulants|coagulants|mesh-ancestor
64430381|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430382|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
64430385|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64430386|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
64430387|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64430388|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430389|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64430390|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
64430391|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430392|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430393|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
64430394|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430395|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64430396|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64430397|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
64430398|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430399|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64430401|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64430402|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64430403|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430404|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430405|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64430417|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
64430418|NCT02101359|Tetracaine|tetracaine|mesh-list
64430419|NCT02101359|Tropicamide|tropicamide|mesh-list
64430420|NCT02101359|Mydriatics|mydriatics|mesh-list
64430421|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
64430422|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
64430423|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430424|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430426|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430427|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
64430428|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64430429|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64430430|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430431|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430435|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64430436|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64430437|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
64430438|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430439|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64430440|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64430441|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64430442|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64430453|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
64430454|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
64430455|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
64430456|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430457|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430459|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64430460|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
64430461|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
64430462|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430463|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430464|NCT02045979|Adalimumab|adalimumab|mesh-list
64430465|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430466|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430467|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
64430468|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
64430469|NCT04734405|Fluconazole|fluconazole|mesh-list
64430470|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
64430483|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64430484|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64430485|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430486|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430487|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64430488|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64430489|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64430490|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64430491|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
64430492|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430493|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430494|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64430495|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64430497|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64430498|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64430499|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
64430500|NCT01928758|Nicotine|nicotine|mesh-list
64430501|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64430502|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
64430503|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430504|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430513|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430514|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430515|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430516|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430517|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64430518|NCT01614886|Protective Agents|protective agents|mesh-ancestor
64430519|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
64430520|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64430521|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64430522|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64430525|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430526|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430527|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430528|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430529|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64430530|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430532|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64430533|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
64430543|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
64430546|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64430547|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
64430548|NCT02100657|Hormones|hormones|mesh-ancestor
64430549|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430550|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64430551|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430552|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
64430553|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64430554|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
64430555|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64430556|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430557|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64430558|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64430560|NCT01909804|Ribavirin|ribavirin|mesh-list
64430561|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
64430562|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430563|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
64430564|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430565|NCT01880086|Clomiphene|clomiphene|mesh-list
64430568|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64430569|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
64430570|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430571|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430587|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430588|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
64430590|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430591|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430592|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64430593|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
64430594|NCT04415320|Ensartinib|ensartinib|mesh-list
64430595|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430596|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64430597|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430598|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430599|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
64430600|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
64430601|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64430602|NCT01878292|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64430603|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64430604|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430605|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430606|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430607|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
64430608|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430609|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64430610|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64430611|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64430612|NCT01907854|Liraglutide|liraglutide|mesh-list
64430613|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64430614|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430615|NCT01907854|Incretins|incretins|mesh-ancestor
64430616|NCT01907854|Hormones|hormones|mesh-ancestor
64430619|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
64430620|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430621|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430651|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64430652|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64430653|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
64430654|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64430655|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430656|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430657|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430658|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
64430659|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64430660|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430661|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
64430664|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430665|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64430666|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64430667|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64430668|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430670|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
64430671|NCT01876732|Vitamins|vitamins|mesh-ancestor
64430672|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
64430673|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430674|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
64430675|NCT01876732|Hematinics|hematinics|mesh-ancestor
64430676|NCT01905592|Niraparib|niraparib|mesh-list
64430677|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64430678|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430679|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430680|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430681|NCT04627870|Paclitaxel|paclitaxel|mesh-list
64430682|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64430683|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430684|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
64430685|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
64430686|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
64430687|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430702|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64430703|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64430704|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64430705|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64430706|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64430707|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64430708|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430709|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
64430710|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64430711|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430712|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64430713|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430715|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64430716|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430717|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430718|NCT01903720|Dexamethasone|dexamethasone|mesh-list
64430719|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430720|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
64430721|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
64430722|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430723|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430724|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64430725|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
64430729|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430730|NCT02366689|Triclosan|triclosan|mesh-list
64430731|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
64430732|NCT02366689|Fluorides|fluorides|mesh-list
64430733|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
64430734|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
64430735|NCT02366689|Protective Agents|protective agents|mesh-ancestor
64430736|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430737|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64430738|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430739|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64430742|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430743|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64430744|NCT01903252|Mesalamine|mesalamine|mesh-list
64430745|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64430746|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430747|NCT01903252|Analgesics|analgesics|mesh-ancestor
64430748|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
64430749|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430750|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430751|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430752|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430753|NCT01613716|Dexamethasone|dexamethasone|mesh-list
64430754|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430755|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
64430756|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
64430757|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430773|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430774|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64430775|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64430776|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64430778|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64430779|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430781|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64430782|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64430790|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430792|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64430793|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64430794|NCT01872910|Analgesics|analgesics|mesh-ancestor
64430795|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
64430796|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430797|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430798|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430799|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430800|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64430801|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64430802|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430803|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430804|NCT01920568|Vitamin D|vitamin d|mesh-list
64430805|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
64430806|NCT01920568|Denosumab|denosumab|mesh-list
64430807|NCT01920568|Calcium|calcium|mesh-list
64430808|NCT01920568|Vitamins|vitamins|mesh-ancestor
64430809|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
64430810|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430811|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64430812|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64430817|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64430849|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430850|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
64430851|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64430852|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
64430853|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64430854|NCT02499029|Expectorants|expectorants|mesh-ancestor
64430855|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
64430856|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64430857|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
64430858|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430859|NCT02499029|Protective Agents|protective agents|mesh-ancestor
64430860|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430861|NCT02499029|Antidotes|antidotes|mesh-ancestor
64430862|NCT04939883|Carvedilol|carvedilol|mesh-list
64430863|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64430864|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64430904|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64430905|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430907|NCT02497469|Vedolizumab|vedolizumab|mesh-list
64430908|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64430909|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64430910|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64430911|NCT02497391|Evacetrapib|evacetrapib|mesh-list
64430914|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
64430915|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430916|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64430918|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64430919|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64430920|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64430937|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64430938|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64430939|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
64430941|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64430942|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430943|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64430946|NCT04182555|Bilirubin|bilirubin|mesh-list
64430947|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
64430948|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64430949|NCT04182555|Protective Agents|protective agents|mesh-ancestor
64430950|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64430952|NCT02366143|Bevacizumab|bevacizumab|mesh-list
64430953|NCT02366143|Carboplatin|carboplatin|mesh-list
64430954|NCT02366143|Atezolizumab|atezolizumab|mesh-list
64430955|NCT02366143|Antibodies|antibodies|mesh-list
64430956|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64431001|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431002|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431003|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64431004|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
64431005|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431006|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431007|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64431009|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64431010|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64431011|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64431012|NCT02365285|Heparin|heparin|mesh-list
64431013|NCT02365285|Galantamine|galantamine|mesh-list
64431014|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64431015|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
64431016|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64431017|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64431029|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431031|NCT02041299|Deferiprone|deferiprone|mesh-list
64431032|NCT02041299|Deferoxamine|deferoxamine|mesh-list
64431033|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64431034|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
64431035|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
64431036|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431037|NCT02041299|Siderophores|siderophores|mesh-ancestor
64431038|NCT01645735|Vancomycin|vancomycin|mesh-list
64431039|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
64431063|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
64431064|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
64431065|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431066|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64431067|NCT01644643|Metronidazole|metronidazole|mesh-list
64431069|NCT01644643|Avibactam|avibactam|mesh-list
64431070|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431071|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64431072|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64431073|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64431074|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64431075|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431076|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431077|NCT01864174|Metformin|metformin|mesh-list
64431078|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431079|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431081|NCT04420351|Clopidogrel|clopidogrel|mesh-list
64431082|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64431083|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64431084|NCT04420351|Analgesics|analgesics|mesh-ancestor
64431085|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
64431086|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431087|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431088|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431089|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431090|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64431098|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64431100|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
64431101|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431103|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
64431104|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
64431105|NCT01864018|Ixazomib|ixazomib|mesh-list
64431106|NCT01864018|Ichthammol|ichthammol|mesh-list
64431107|NCT01864018|BB 1101|bb 1101|mesh-list
64431117|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64431118|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431120|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
64431121|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431122|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431123|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
64431124|NCT01864018|Hormones|hormones|mesh-ancestor
64431125|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431126|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64431127|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
64431128|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431129|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
64431130|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
64431131|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431132|NCT01900444|Vaccines|vaccines|mesh-list
64431133|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
64431134|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431135|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
64431136|NCT02496221|Incretins|incretins|mesh-ancestor
64431137|NCT02496221|Hormones|hormones|mesh-ancestor
64431138|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431139|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431140|NCT04967495|Sorafenib|sorafenib|mesh-list
64431141|NCT04967495|Lenvatinib|lenvatinib|mesh-list
64431143|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431144|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64431145|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431146|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431147|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64431148|NCT04967495|Estrogens|estrogens|mesh-ancestor
64431149|NCT04967495|Hormones|hormones|mesh-ancestor
64431150|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431151|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431152|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64431153|NCT02475629|Ibalizumab|ibalizumab|mesh-list
64431154|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64431155|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64431156|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
64431157|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431158|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64431167|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64431187|NCT02360995|Triclosan|triclosan|mesh-list
64431188|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
64431189|NCT02360995|Fluorides|fluorides|mesh-list
64431190|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
64431191|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
64431192|NCT02360995|Protective Agents|protective agents|mesh-ancestor
64378357|NCT04796025|Bevacizumab|bevacizumab|mesh-list
64431193|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431194|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64431195|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431196|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64431197|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64431198|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
64431203|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431204|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431205|NCT02291419|Aspirin|aspirin|mesh-list
64431206|NCT02291419|Ticagrelor|ticagrelor|mesh-list
64431207|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64431208|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64431209|NCT02291419|Analgesics|analgesics|mesh-ancestor
64431210|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
64431211|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431212|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431213|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431214|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431215|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64431216|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64431217|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431218|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64431219|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64431220|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431221|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
64431246|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64431247|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431248|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64431249|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
64431250|NCT04599868|Analgesics|analgesics|mesh-ancestor
64431251|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
64431252|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431253|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431254|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
64431255|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431256|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64431257|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
64431258|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64431259|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431260|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431261|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64431262|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
64431263|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64431272|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431273|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64431274|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64431275|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64431276|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431277|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431278|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
64431279|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64431280|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
64431281|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431282|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431283|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64431284|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
64431285|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
64431286|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64431287|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
64431288|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431289|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431316|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64431318|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64431319|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64431320|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64431321|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431322|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
64431323|NCT01898806|Hormones|hormones|mesh-ancestor
64431324|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431325|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431326|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64431327|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
64431328|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431329|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431330|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64431333|NCT02290873|Midazolam|midazolam|mesh-list
64431334|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64431335|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64431336|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431337|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431361|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431362|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431363|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
64431364|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431365|NCT02318095|Gemcitabine|gemcitabine|mesh-list
64431366|NCT02318095|Paclitaxel|paclitaxel|mesh-list
64431402|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431403|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431404|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431438|NCT02316613|Rituximab|rituximab|mesh-list
64431439|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64431440|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431441|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
64431442|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431443|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431444|NCT02492165|Vaccines|vaccines|mesh-list
64431445|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
64431446|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431447|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64431448|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
64431449|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431450|NCT02286895|Vaccines|vaccines|mesh-list
64431451|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
64431452|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431453|NCT02472977|Nivolumab|nivolumab|mesh-list
64431454|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64431455|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431456|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64431457|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431458|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
64431459|NCT02060487|Citric Acid|citric acid|mesh-list
64431460|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
64431461|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
64431462|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64431463|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
64431464|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
64431465|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431466|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
64431467|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64431468|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64431469|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431470|NCT02060487|Urological Agents|urological agents|mesh-ancestor
64431502|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64431503|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
64431504|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64431506|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64431507|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
64431508|NCT02059161|MK-1293|mk-1293|mesh-list
64431509|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431510|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431511|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64431512|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
64431513|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431514|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64431515|NCT01897714|Dexamethasone|dexamethasone|mesh-list
64431516|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431517|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
64431518|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
64431519|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431520|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431521|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64431522|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
64431523|NCT01897714|Hormones|hormones|mesh-ancestor
64431524|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64431525|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64431526|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431527|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
64431528|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64431529|NCT01860976|Abatacept|abatacept|mesh-list
64431530|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64431531|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431532|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431541|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
64431542|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431543|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
64431544|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431550|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64431551|NCT04618744|Insulin|insulin|mesh-list
64431552|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64431553|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431554|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431555|NCT01896934|Sertraline|sertraline|mesh-list
64431556|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
64431557|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64431558|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64431559|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64431560|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431561|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431562|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431563|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
64431564|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431596|NCT02094885|Coagulants|coagulants|mesh-ancestor
64431597|NCT01896856|Trifluridine|trifluridine|mesh-list
64431598|NCT01896856|Irinotecan|irinotecan|mesh-list
64431600|NCT01896856|Azacitidine|azacitidine|mesh-list
64431608|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431609|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64431611|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64431612|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431613|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64431614|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64431615|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64431616|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431617|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
64431626|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64431627|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431628|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431629|NCT02058537|Bethanechol|bethanechol|mesh-list
64431630|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64431631|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
64431632|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431633|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431634|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64431635|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64431639|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
64431640|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
64431641|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
64431642|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431643|NCT02409680|Aspirin|aspirin|mesh-list
64431644|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64431645|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64431646|NCT02409680|Analgesics|analgesics|mesh-ancestor
64431647|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
64431648|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64431649|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431650|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64431651|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431652|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64431653|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64431654|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431655|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64431656|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64431657|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431658|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
64431659|NCT01894984|Risperidone|risperidone|mesh-list
64431660|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
64431661|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64431662|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
64431663|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431664|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431665|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431686|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431688|NCT01857310|Folic Acid|folic acid|mesh-list
64431689|NCT01857310|Hematinics|hematinics|mesh-ancestor
64431690|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
64431691|NCT01857310|Vitamins|vitamins|mesh-ancestor
64431692|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
64431693|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431694|NCT02472353|Metformin|metformin|mesh-list
64431695|NCT02472353|Doxorubicin|doxorubicin|mesh-list
64431696|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64431697|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431698|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64431699|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431700|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64431701|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64431702|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431703|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431704|NCT02314117|Fluorouracil|fluorouracil|mesh-list
64431705|NCT02314117|Capecitabine|capecitabine|mesh-list
64431706|NCT02314117|Ramucirumab|ramucirumab|mesh-list
64431707|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431708|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
64431754|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
64431755|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
64431756|NCT01855828|Paclitaxel|paclitaxel|mesh-list
64431757|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
64431758|NCT01855828|Fluorouracil|fluorouracil|mesh-list
64431759|NCT01855828|Trastuzumab|trastuzumab|mesh-list
64431760|NCT01855828|Epirubicin|epirubicin|mesh-list
64431761|NCT01855828|Pertuzumab|pertuzumab|mesh-list
64431762|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64431763|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64431764|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
64431765|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
64431766|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
64431767|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431768|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64431769|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
64431770|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431771|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64431772|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64431773|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
64431774|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64431791|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431792|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64431793|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64431794|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
64431795|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431796|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431798|NCT02350309|Flurazepam|flurazepam|mesh-list
64431799|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64431800|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431801|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431802|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64431803|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64431804|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64431805|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64431806|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64431807|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64431857|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431858|NCT02470403|Licogliflozin|licogliflozin|mesh-list
64431859|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64431908|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64431909|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431910|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64431911|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64431935|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431937|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64431938|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
64431939|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
64431940|NCT01622673|Protective Agents|protective agents|mesh-ancestor
64431941|NCT02469077|Morphine|morphine|mesh-list
64431942|NCT02469077|Naloxone|naloxone|mesh-list
64431943|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64431963|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64431964|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64431966|NCT02282293|Trimethoprim|trimethoprim|mesh-list
64431967|NCT02282293|Artenimol|artenimol|mesh-list
64431968|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
64431969|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
64431970|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64431971|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64431972|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64431973|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64431974|NCT02282293|Renal Agents|renal agents|mesh-ancestor
64431975|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64431976|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64431987|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64431988|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
64431989|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64431990|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64431991|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64431992|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
64431993|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64431994|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64431995|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64431996|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64431997|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64432027|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
64432028|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432029|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64432030|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64432034|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64432035|NCT01891864|Analgesics|analgesics|mesh-ancestor
64432036|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
64432037|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432038|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432039|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432040|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432041|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432042|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432054|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432055|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
64432056|NCT02484911|Hormones|hormones|mesh-ancestor
64432057|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432058|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64432059|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432060|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64432061|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64432062|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432063|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64432064|NCT02484911|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64432065|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64432066|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64432067|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432068|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432069|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
64432070|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
64432071|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64432072|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64432073|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
64432074|NCT04306367|Olaparib|olaparib|mesh-list
64432075|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432076|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432077|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64432089|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432091|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64432092|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
64432093|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
64432094|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
64432095|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
64432096|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432097|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432098|NCT02349451|Adalimumab|adalimumab|mesh-list
64432099|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432100|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432101|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
64432105|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432106|NCT02409368|Nivolumab|nivolumab|mesh-list
64432107|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432108|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432109|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64432132|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
64432133|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64432134|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432135|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432137|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64432138|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
64432139|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432140|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
64432141|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432142|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64432143|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64432144|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432145|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432146|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
64432147|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432148|NCT01853176|Bupivacaine|bupivacaine|mesh-list
64432149|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
64432150|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
64432151|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432152|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432153|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
64432188|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64432189|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
64432190|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
64432191|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432192|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432195|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432196|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432197|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432198|NCT02406248|Ticagrelor|ticagrelor|mesh-list
64432199|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64432200|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64432201|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64432202|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64432203|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
64432204|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432205|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432206|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432207|NCT02450903|Ceritinib|ceritinib|mesh-list
64432208|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432209|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432210|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432211|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432212|NCT02371616|Listerine|listerine|mesh-list
64432213|NCT02371616|Calcium|calcium|mesh-list
64432236|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432237|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
64432238|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432239|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
64432240|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64432241|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432242|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
64432243|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
64432244|NCT01850602|Sevelamer|sevelamer|mesh-list
64432245|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
64432246|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
64432247|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432248|NCT02405780|Adalimumab|adalimumab|mesh-list
64432249|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432250|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432251|NCT02369510|Epinephrine|epinephrine|mesh-list
64432252|NCT02369510|Racepinephrine|racepinephrine|mesh-list
64432253|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
64432256|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
64432257|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432258|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432259|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432260|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64432261|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64432262|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
64432263|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432264|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64432309|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64432310|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64432343|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64432344|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
64432346|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64432347|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64432348|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64432349|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
64432350|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432351|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432380|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432381|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
64432383|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64432384|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432385|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432386|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64432387|NCT02284243|Analgesics|analgesics|mesh-ancestor
64432388|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
64432389|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432390|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64432391|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64432392|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64432393|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
64432411|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
64432412|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
64432413|NCT02400476|Hormones|hormones|mesh-ancestor
64432414|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432415|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432417|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
64432418|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432419|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64432420|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
64432421|NCT02363738|Infliximab|infliximab|mesh-list
64432422|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432423|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432424|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432425|NCT02331680|Tolvaptan|tolvaptan|mesh-list
64432426|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64432427|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432429|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432430|NCT02349061|Ustekinumab|ustekinumab|mesh-list
64432431|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432432|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
64432433|NCT02331368|Lenalidomide|lenalidomide|mesh-list
64432434|NCT02331368|Melphalan|melphalan|mesh-list
64432435|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432438|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432439|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64432440|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64432441|NCT02331368|Growth Substances|growth substances|mesh-ancestor
64432442|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
64432497|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
64432498|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432499|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432501|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432535|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
64432536|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
64432537|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432538|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432539|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432540|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64432541|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64432542|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432567|NCT05565235|Bupivacaine|bupivacaine|mesh-list
64432568|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
64432569|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
64432570|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432571|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432572|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
64432573|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432574|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64432578|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64432579|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64432580|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432635|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432636|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64432637|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432638|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
64432639|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64432640|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64432642|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
64432643|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
64432644|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432645|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432646|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
64432647|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432648|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432649|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432650|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432651|NCT02357810|Topotecan|topotecan|mesh-list
64432652|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64432653|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64432654|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432655|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432656|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432657|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64432658|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64432665|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432666|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64432667|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
64432668|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432669|NCT04856761|Capecitabine|capecitabine|mesh-list
64432670|NCT04856761|Tegafur|tegafur|mesh-list
64432672|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
64432673|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432674|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432676|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
64432677|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64432678|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64432679|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64432699|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
64432701|NCT02325518|Dorzolamide|dorzolamide|mesh-list
64432702|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64432703|NCT02325518|Maleic acid|maleic acid|mesh-list
64432704|NCT02325518|Brinzolamide|brinzolamide|mesh-list
64432705|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64432706|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446213|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432707|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432708|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64432709|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64432710|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
64432711|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432712|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432731|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432733|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432734|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64432756|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432758|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432759|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432760|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
64432761|NCT02465489|Deferiprone|deferiprone|mesh-list
64432762|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64432763|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
64432764|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
64432765|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432766|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
64432767|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64432768|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432769|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64432770|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64432771|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432772|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432773|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432774|NCT01601821|Sirolimus|sirolimus|mesh-list
64432775|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64432776|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432777|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64432778|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432779|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
64432780|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432781|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
64432782|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432783|NCT01846624|Decitabine|decitabine|mesh-list
64432784|NCT01846624|Azacitidine|azacitidine|mesh-list
64432785|NCT01846624|Midostaurin|midostaurin|mesh-list
64446214|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64432813|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64432814|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64432815|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
64432816|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432817|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432819|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
64432820|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
64432821|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64432822|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
64432825|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64432827|NCT02323334|Itraconazole|itraconazole|mesh-list
64432828|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
64432829|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432830|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64432831|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64432832|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432833|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432834|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64432835|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
64432836|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64432837|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432838|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64432839|NCT02322866|Sarecycline|sarecycline|mesh-list
64432840|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64432841|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432842|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
64432843|NCT01844518|Abatacept|abatacept|mesh-list
64432844|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64432845|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432846|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432847|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432848|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
64432849|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432850|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64432851|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64432860|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
64432861|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432862|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432863|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64432864|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64432865|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
64432866|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64432882|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64432883|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64432884|NCT02354690|Analgesics|analgesics|mesh-ancestor
64432885|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
64432886|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432887|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64432888|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432889|NCT02354222|Canagliflozin|canagliflozin|mesh-list
64432890|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64432891|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432892|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64432893|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432894|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
64432895|NCT02351960|Lansoprazole|lansoprazole|mesh-list
64432896|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64432897|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64432898|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64432899|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432900|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432901|NCT02351180|Beclomethasone|beclomethasone|mesh-list
64432902|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64432904|NCT02351180|Hormones|hormones|mesh-ancestor
64432953|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64432954|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64432955|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432957|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64432958|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432959|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64432960|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64432961|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
64432962|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432983|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64432984|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
64432985|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
64432986|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
64432987|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64432988|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
64432989|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64432990|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64432991|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
64432992|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64432993|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
64432994|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64432995|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64432996|NCT02320058|Nivolumab|nivolumab|mesh-list
64432997|NCT02320058|Ipilimumab|ipilimumab|mesh-list
64432998|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64432999|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433018|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433036|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64433037|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64433038|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433039|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433040|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433041|NCT04420871|Capecitabine|capecitabine|mesh-list
64433042|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64433043|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
64433044|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433045|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433046|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64433047|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64433048|NCT02349386|Estradiol|estradiol|mesh-list
64433049|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64433050|NCT02349386|Estrogens|estrogens|mesh-ancestor
64433051|NCT02349386|Hormones|hormones|mesh-ancestor
64433052|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433053|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433054|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64433055|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
64433056|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64433057|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64433058|NCT04892888|Vaccines|vaccines|mesh-list
64433060|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433062|NCT02036775|Expectorants|expectorants|mesh-ancestor
64433063|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
64433064|NCT02034591|Apixaban|apixaban|mesh-list
64433153|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433154|NCT02054325|Polidocanol|polidocanol|mesh-list
64433155|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64433156|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64433157|NCT02091375|Cannabidiol|cannabidiol|mesh-list
64433158|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
64433159|NCT02032875|Ribavirin|ribavirin|mesh-list
64433160|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
64433161|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
64433162|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433164|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433181|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433192|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433194|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433195|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433196|NCT02461589|Incretins|incretins|mesh-ancestor
64433197|NCT02461589|Hormones|hormones|mesh-ancestor
64433198|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433199|NCT02089737|Panitumumab|panitumumab|mesh-list
64433200|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433201|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433202|NCT02089347|Vaccines|vaccines|mesh-list
64433203|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
64433204|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433205|NCT02419469|Cytarabine|cytarabine|mesh-list
64433206|NCT02419469|Dexamethasone|dexamethasone|mesh-list
64433207|NCT02419469|Prednisone|prednisone|mesh-list
64433208|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
64433209|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
64433210|NCT02419469|Rituximab|rituximab|mesh-list
64433211|NCT02419469|Doxorubicin|doxorubicin|mesh-list
64433212|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64433213|NCT02419469|Methotrexate|methotrexate|mesh-list
64433214|NCT02419469|Vincristine|vincristine|mesh-list
64433215|NCT02419469|Daunorubicin|daunorubicin|mesh-list
64433216|NCT02419469|Asparaginase|asparaginase|mesh-list
64433217|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
64433218|NCT02419469|Ofatumumab|ofatumumab|mesh-list
64433219|NCT02419469|Pegaspargase|pegaspargase|mesh-list
64433220|NCT02419469|Thioguanine|thioguanine|mesh-list
64433221|NCT02419469|BB 1101|bb 1101|mesh-list
64433222|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433223|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
64433224|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433225|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433226|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64433227|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
64433228|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433229|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433230|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64433231|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64433232|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433233|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
64433234|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
64433235|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433236|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433238|NCT02419469|Hormones|hormones|mesh-ancestor
64433239|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433287|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433288|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64433290|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433291|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64433292|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64433293|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
64433294|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433295|NCT02088957|Phenytoin|phenytoin|mesh-list
64433296|NCT02088957|Brivaracetam|brivaracetam|mesh-list
64433309|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
64433310|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433311|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
64433312|NCT02030535|Olodaterol|olodaterol|mesh-list
64433313|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64433314|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
64433315|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433316|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433317|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64433318|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
64433319|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
64433326|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433328|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
64433329|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433330|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433331|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433332|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433334|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64433335|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64433336|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64433337|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64433338|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64433339|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433340|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433341|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433342|NCT02087943|Thalidomide|thalidomide|mesh-list
64433343|NCT02087943|Apremilast|apremilast|mesh-list
64433344|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64433345|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433346|NCT02087943|Analgesics|analgesics|mesh-ancestor
64433347|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
64433348|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433349|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433350|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433351|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433352|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64433353|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64433354|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433355|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433356|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433357|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
64433391|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433392|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433393|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64433394|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64433395|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64433430|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433432|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64433433|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
64433434|NCT02021643|Ribavirin|ribavirin|mesh-list
64433435|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
64433436|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433437|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
64433438|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433439|NCT02415959|Pancrelipase|pancrelipase|mesh-list
64433440|NCT02415959|Pancreatin|pancreatin|mesh-list
64433441|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433442|NCT02021331|Cimetidine|cimetidine|mesh-list
64433443|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64433444|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433445|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64433446|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
64433447|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
64433448|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433449|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433450|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433451|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64433471|NCT01652729|Hormones|hormones|mesh-ancestor
64433472|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433473|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64433474|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
64433475|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433476|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433477|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64433478|NCT02083965|Factor VIII|factor viii|mesh-list
64433479|NCT02083965|Coagulants|coagulants|mesh-ancestor
64433480|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64433482|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433483|NCT04683627|Diclofenac|diclofenac|mesh-list
64433484|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64433485|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433486|NCT04683627|Analgesics|analgesics|mesh-ancestor
64433487|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
64433495|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
64433496|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64433497|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433498|NCT02458469|Buspirone|buspirone|mesh-list
64433499|NCT02458469|Trazodone|trazodone|mesh-list
64433500|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64433501|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64433502|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433503|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433504|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64433505|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64433506|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
64433507|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433510|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64433511|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433512|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64433513|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
64433515|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
64433517|NCT01843348|Tacrolimus|tacrolimus|mesh-list
64433518|NCT01843348|Cyclosporins|cyclosporins|mesh-list
64433519|NCT01843348|Basiliximab|basiliximab|mesh-list
64433520|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433521|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
64433522|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433523|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64433524|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433525|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433526|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
64433527|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433528|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
64433529|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433530|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433531|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64433532|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64433533|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
64433534|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64433535|NCT01825876|Warfarin|warfarin|mesh-list
64433536|NCT01825876|Evacetrapib|evacetrapib|mesh-list
64433537|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
64433539|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64433540|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
64433541|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433542|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64433543|NCT01825798|Metformin|metformin|mesh-list
64433544|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433565|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
64433566|NCT02412761|Diuretics|diuretics|mesh-list
64433567|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
64433568|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64433569|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64433570|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64433571|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433572|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64433573|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433574|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433575|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
64433576|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
64433577|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
64433578|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64433611|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433613|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
64433614|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433615|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64433616|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64433617|NCT02026011|Naltrexone|naltrexone|mesh-list
64433618|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64433619|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64433636|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433637|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433638|NCT02025621|Protective Agents|protective agents|mesh-ancestor
64433639|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433641|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64433642|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433645|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64433646|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64433647|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
64433648|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
64433649|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433664|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433666|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
64433667|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433668|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433669|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
64433670|NCT01840228|Progesterone|progesterone|mesh-list
64433671|NCT01840228|Progestins|progestins|mesh-ancestor
64433673|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433674|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433675|NCT01823146|Oxytocin|oxytocin|mesh-list
64433676|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
64433677|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64433678|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433679|NCT02083185|Leuprolide|leuprolide|mesh-list
64433698|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433699|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64433700|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433701|NCT01822756|Gemcitabine|gemcitabine|mesh-list
64433702|NCT01822756|Paclitaxel|paclitaxel|mesh-list
64433703|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64433704|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433705|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
64433706|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
64433707|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
64433708|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433709|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64433769|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64433770|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433771|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433772|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64433773|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64433774|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433775|NCT02435147|Denosumab|denosumab|mesh-list
64433776|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64433777|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433778|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64433779|NCT02435069|Glycerol|glycerol|mesh-list
64433780|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64433781|NCT02435069|Protective Agents|protective agents|mesh-ancestor
64433782|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433783|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
64433784|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64433785|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64433786|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64433787|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64433788|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433789|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
64433790|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433791|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433792|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64433804|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
64433805|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433806|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
64433807|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64433808|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64433809|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433819|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433820|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433821|NCT01818700|Analgesics|analgesics|mesh-ancestor
64433822|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
64433823|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433824|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64433825|NCT01817764|Fluticasone|fluticasone|mesh-list
64433827|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64433828|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64433829|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64433830|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
64433831|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433832|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433833|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64433834|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
64433835|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
64433836|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64433837|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64433838|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64433839|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64433841|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433842|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433844|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64433845|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
64433846|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
64433847|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433848|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433849|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64433850|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64433851|NCT01817530|Norethindrone|norethindrone|mesh-list
64433852|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
64433853|NCT01817530|Estradiol|estradiol|mesh-list
64433854|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64433855|NCT01817530|Estrogens|estrogens|mesh-ancestor
64433856|NCT01817530|Hormones|hormones|mesh-ancestor
64379305|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64433883|NCT02453711|Liraglutide|liraglutide|mesh-list
64433884|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433885|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433886|NCT02453711|Incretins|incretins|mesh-ancestor
64433887|NCT02453711|Hormones|hormones|mesh-ancestor
64433888|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433889|NCT02453555|Empagliflozin|empagliflozin|mesh-list
64433890|NCT02453555|Linagliptin|linagliptin|mesh-list
64433891|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64433892|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433893|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64433894|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433895|NCT02453555|Incretins|incretins|mesh-ancestor
64433896|NCT02453555|Hormones|hormones|mesh-ancestor
64433897|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433898|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64433899|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
64433900|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433901|NCT02453321|Bupivacaine|bupivacaine|mesh-list
64433902|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
64433903|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
64433904|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433906|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
64433907|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64433908|NCT01610284|Fulvestrant|fulvestrant|mesh-list
64433909|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64433910|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433911|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64433912|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64433913|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
64433914|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64433915|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433938|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64433939|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64433940|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64433941|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64433942|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64433943|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64433944|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
64433945|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64433946|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433947|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64433948|NCT01610206|Gemcitabine|gemcitabine|mesh-list
64433949|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64433950|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
64433951|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64433952|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64433953|NCT01610206|Antiviral Agents|antiviral agents|mesh-ancestor
64433954|NCT01610206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64433955|NCT01610206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64433956|NCT01610206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64433957|NCT01610206|Immunologic Factors|immunologic factors|mesh-ancestor
64433958|NCT01610206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64433959|NCT01816048|Listerine|listerine|mesh-list
64433960|NCT01816048|Fluorides|fluorides|mesh-list
64434008|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434009|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64434010|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64434011|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64434013|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
64434014|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64434015|NCT01652573|Katacalcin|katacalcin|mesh-list
64378379|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
64434016|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64434017|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434018|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64434019|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
64434020|NCT02388191|Naproxen|naproxen|mesh-list
64434021|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64434022|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434023|NCT02388191|Analgesics|analgesics|mesh-ancestor
64434024|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
64434025|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434026|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434027|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434028|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434029|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
64434055|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434056|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434057|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434058|NCT01651403|Tenofovir|tenofovir|mesh-list
64434059|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
64434060|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434061|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64434062|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64434063|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434064|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434065|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434066|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434068|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
64434069|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64434070|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434071|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64434072|NCT04902131|Menotropins|menotropins|mesh-list
64434088|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434089|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64434090|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64434092|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434093|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434120|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64434121|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434122|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64434124|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64434125|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
64434126|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434127|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64434128|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64434129|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434130|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64434131|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64434132|NCT01813474|Olaparib|olaparib|mesh-list
64434141|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64434142|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64434174|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434175|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434176|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
64434177|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434178|NCT02404805|Dolutegravir|dolutegravir|mesh-list
64434179|NCT02404805|Simeprevir|simeprevir|mesh-list
64434180|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64434181|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64434212|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434214|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434215|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64434216|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64434217|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434218|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434219|NCT02404493|Decanoic acid|decanoic acid|mesh-list
64434220|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
64434221|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434222|NCT02379221|Lidocaine|lidocaine|mesh-list
64434223|NCT02379221|Epinephrine|epinephrine|mesh-list
64434224|NCT02379221|Benzocaine|benzocaine|mesh-list
64434225|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
64434226|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
64434227|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434228|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434229|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
64434230|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434231|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64434232|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64434234|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434235|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434236|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64434237|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64434238|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
64434239|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434240|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64434241|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64434242|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
64434243|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64434244|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
64434245|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
64434246|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
64434247|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64434248|NCT02404103|Flunisolide|flunisolide|mesh-list
64434258|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64434259|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434260|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434261|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64434262|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64434269|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434270|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434272|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64434273|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434275|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434276|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434278|NCT01796470|Idelalisib|idelalisib|mesh-list
64434279|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434280|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434281|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434282|NCT04414852|Apatinib|apatinib|mesh-list
64434283|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434284|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64434285|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434286|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434287|NCT04415008|Cytarabine|cytarabine|mesh-list
64434288|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64434289|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
64434290|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434291|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434292|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
64434293|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434294|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434295|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
64434296|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434297|NCT01810042|Ranibizumab|ranibizumab|mesh-list
64434298|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64434299|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64434300|NCT01810042|Growth Substances|growth substances|mesh-ancestor
64434301|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434302|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
64434303|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434304|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
64434305|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
64434306|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434307|NCT01867294|Doxycycline|doxycycline|mesh-list
64434308|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
64434309|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64434310|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64434311|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64434312|NCT01867294|Spironolactone|spironolactone|mesh-list
64434313|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
64434314|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434315|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434316|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434317|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
64434318|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64434319|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64434338|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
64434339|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434340|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434341|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434342|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
64434343|NCT02401529|Hormones|hormones|mesh-ancestor
64434344|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434345|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64434346|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434347|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434348|NCT02401529|Analgesics|analgesics|mesh-ancestor
64434349|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
64434350|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
64434351|NCT01866826|Rifaximin|rifaximin|mesh-list
64434364|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64434365|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434366|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434367|NCT01807234|Ketorolac|ketorolac|mesh-list
64434368|NCT01807234|Sumatriptan|sumatriptan|mesh-list
64434369|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64434370|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434371|NCT01807234|Analgesics|analgesics|mesh-ancestor
64434372|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
64434373|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434374|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434375|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434376|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434377|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64434378|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434379|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434380|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64434381|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64434382|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64434383|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
64434384|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434385|NCT02421887|Antioxidants|antioxidants|mesh-list
64434388|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434390|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64434391|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434392|NCT01789606|Analgesics|analgesics|mesh-ancestor
64434393|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
64434394|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434395|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434396|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434397|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434398|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64434399|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434400|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434401|NCT01788358|Candesartan|candesartan|mesh-list
64434402|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
64434418|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
64434419|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434420|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434421|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64434422|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64434423|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
64434424|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434425|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64434426|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64434427|NCT01772368|Fluticasone|fluticasone|mesh-list
64434429|NCT01772368|Albuterol|albuterol|mesh-list
64434430|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64434431|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64434432|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
64434433|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434445|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434446|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434447|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
64434448|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64434449|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
64434450|NCT01772368|Hormones|hormones|mesh-ancestor
64434451|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434452|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
64434453|NCT01806298|Hormones|hormones|mesh-list
64434454|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434455|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434456|NCT01772134|Fluticasone|fluticasone|mesh-list
64434457|NCT01772134|Xhance|xhance|mesh-list
64434458|NCT01772134|Bromides|bromides|mesh-list
64434459|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64434460|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434495|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64434496|NCT02016183|Diuretics|diuretics|mesh-ancestor
64434497|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
64434498|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434499|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64434500|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434523|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
64434524|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64434525|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64434526|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64434527|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434528|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434529|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
64434549|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64434550|NCT02420717|BB 1101|bb 1101|mesh-list
64434572|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64434573|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64434574|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64434575|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
64434576|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64434577|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64434578|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
64434579|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
64434580|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64434581|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64434582|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
64434583|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434585|NCT02420717|Protective Agents|protective agents|mesh-ancestor
64434586|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
64434587|NCT02420717|Vitamins|vitamins|mesh-ancestor
64434588|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
64434589|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64434590|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
64434591|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
64434592|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
64379306|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64434609|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434610|NCT02420327|Galantamine|galantamine|mesh-list
64434611|NCT02420327|Nicotine|nicotine|mesh-list
64434612|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64434613|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
64434614|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434655|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64434656|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64434657|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
64434658|NCT04898075|Nicotine|nicotine|mesh-list
64434659|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64434660|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
64434669|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64434671|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434672|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434673|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434674|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434675|NCT01621191|Analgesics|analgesics|mesh-ancestor
64434686|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434688|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434689|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
64434690|NCT02343263|Coagulants|coagulants|mesh-ancestor
64434691|NCT02342639|Rifaximin|rifaximin|mesh-list
64434692|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434693|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434694|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434695|NCT01625091|Naltrexone|naltrexone|mesh-list
64434696|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64434697|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64434698|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434699|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
64434700|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434701|NCT02396537|Lidocaine|lidocaine|mesh-list
64434702|NCT02396537|Midazolam|midazolam|mesh-list
64434703|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
64434704|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
64434705|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434706|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434707|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
64434708|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434709|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64434710|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64434711|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64434712|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64434713|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434754|NCT02081079|Ledipasvir|ledipasvir|mesh-list
64434755|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
64434756|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434757|NCT02081001|Glucagon|glucagon|mesh-list
64434758|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434770|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
64434771|NCT04677387|Naloxone|naloxone|mesh-list
64434772|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64434773|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434774|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
64434775|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434776|NCT02014467|Vitamin D|vitamin d|mesh-list
64434777|NCT02014467|Denosumab|denosumab|mesh-list
64434778|NCT02014467|Calcium|calcium|mesh-list
64434779|NCT02014467|Vitamins|vitamins|mesh-ancestor
64434780|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
64434781|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434782|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64434783|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64434784|NCT02013765|Trastuzumab|trastuzumab|mesh-list
64434785|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434786|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434787|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
64434788|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
64434789|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434808|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434810|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434811|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64434828|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434829|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
64434830|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434831|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434832|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64434833|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
64434834|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434835|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434836|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64434837|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64434838|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434839|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64434840|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
64434841|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434843|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64434844|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434852|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
64434853|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434854|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434855|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64434856|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64434857|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
64434859|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434860|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64434861|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64434862|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434863|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434864|NCT02011113|Dexamethasone|dexamethasone|mesh-list
64434865|NCT02011113|Pomalidomide|pomalidomide|mesh-list
64434866|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434867|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
64434868|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
64434869|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64434870|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434871|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64434872|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
64434873|NCT02011113|Hormones|hormones|mesh-ancestor
64434874|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434875|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64434876|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434902|NCT01620489|Hormones|hormones|mesh-ancestor
64434903|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434904|NCT02010567|Capecitabine|capecitabine|mesh-list
64434905|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64434906|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
64434907|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434908|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434909|NCT01806064|Axitinib|axitinib|mesh-list
64434910|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64434911|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64434915|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64434916|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64434930|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64434931|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64434932|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64434933|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434934|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434935|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64434936|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
64434937|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64434938|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434939|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64434940|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64434941|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
64434942|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64434943|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64434944|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64434945|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64434946|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434947|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
64434948|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64434949|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434950|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
64434951|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64434952|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434953|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64434954|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
64434955|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434956|NCT01768858|Adalimumab|adalimumab|mesh-list
64434957|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64434958|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64434991|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64434992|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64434993|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64434994|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64434995|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64434996|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64434997|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
64434998|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
64435000|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
64435001|NCT01735630|Vitamins|vitamins|mesh-ancestor
64435002|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
64435003|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435004|NCT04575922|Nivolumab|nivolumab|mesh-list
64435005|NCT04575922|Ipilimumab|ipilimumab|mesh-list
64435006|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435007|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435008|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64435009|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435010|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
64435011|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435012|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64435073|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64435074|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435075|NCT02370095|Treprostinil|treprostinil|mesh-list
64435076|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64435077|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64435078|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
64435079|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
64435083|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64435084|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64435085|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64435086|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64435087|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
64435088|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435089|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435090|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435091|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
64435092|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64435093|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
64435094|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435095|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
64435096|NCT02340221|Fulvestrant|fulvestrant|mesh-list
64435097|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64435098|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435099|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64435100|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64435101|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435102|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435103|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435104|NCT02395055|Adalimumab|adalimumab|mesh-list
64435105|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435127|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
64435128|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435129|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435130|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64435131|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435132|NCT01783444|Capecitabine|capecitabine|mesh-list
64435133|NCT01783444|Everolimus|everolimus|mesh-list
64435134|NCT01783444|Exemestane|exemestane|mesh-list
64435143|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64435144|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435145|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64435146|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
64435147|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435148|NCT02367131|Empagliflozin|empagliflozin|mesh-list
64435149|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64435150|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435151|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435152|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435153|NCT01608724|Saxagliptin|saxagliptin|mesh-list
64435154|NCT01608724|Incretins|incretins|mesh-ancestor
64435155|NCT01608724|Hormones|hormones|mesh-ancestor
64435156|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435157|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435171|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435172|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64435173|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435174|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
64435175|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64435188|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64435189|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435190|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
64435191|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435193|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
64435194|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435195|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435196|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64435197|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64435198|NCT02337491|Growth Substances|growth substances|mesh-ancestor
64435199|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435200|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
64435201|NCT01765582|Leucovorin|leucovorin|mesh-list
64435202|NCT01765582|Folic Acid|folic acid|mesh-list
64435203|NCT01765582|Bevacizumab|bevacizumab|mesh-list
64435204|NCT01765582|Fluorouracil|fluorouracil|mesh-list
64435205|NCT01765582|Capecitabine|capecitabine|mesh-list
64435206|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
64435207|NCT01765582|Irinotecan|irinotecan|mesh-list
64435208|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
64435209|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435210|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435211|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64435212|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64435213|NCT01765582|Growth Substances|growth substances|mesh-ancestor
64435214|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435215|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
64435216|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
64435217|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435223|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435224|NCT01765582|Antidotes|antidotes|mesh-ancestor
64435225|NCT01765582|Protective Agents|protective agents|mesh-ancestor
64435226|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
64435228|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
64435229|NCT01765582|Hematinics|hematinics|mesh-ancestor
64435230|NCT04413838|Nivolumab|nivolumab|mesh-list
64435231|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435232|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435233|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64435234|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435235|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64435236|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
64435237|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435238|NCT01648283|Methadone|methadone|mesh-list
64435239|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64435240|NCT01648283|Narcotics|narcotics|mesh-ancestor
64435241|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435254|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64435255|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64435256|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435257|NCT02391545|Rituximab|rituximab|mesh-list
64435258|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
64435259|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435260|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435261|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
64378466|NCT03206411|Hormones|hormones|mesh-list
64435262|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435263|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435264|NCT02362451|Vaccines|vaccines|mesh-list
64435267|NCT01765270|Saxagliptin|saxagliptin|mesh-list
64435268|NCT01765270|Incretins|incretins|mesh-ancestor
64435270|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435271|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435272|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64435273|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
64435274|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435275|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435276|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435277|NCT01733758|Liraglutide|liraglutide|mesh-list
64435278|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
64435279|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64435280|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435281|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435282|NCT01733758|Incretins|incretins|mesh-ancestor
64435283|NCT01733758|Hormones|hormones|mesh-ancestor
64435284|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435285|NCT01607554|Irinotecan|irinotecan|mesh-list
64435286|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64435287|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64435323|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
64435324|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435325|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435326|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64435327|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64435328|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435329|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435330|NCT04887506|Prednisone|prednisone|mesh-list
64435331|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
64435332|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435333|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
64435334|NCT04887506|Hormones|hormones|mesh-ancestor
64435335|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435349|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64435350|NCT02336165|Growth Substances|growth substances|mesh-ancestor
64435351|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435352|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
64435353|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
64435354|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435355|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
64435356|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435357|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435358|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64435359|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
64435362|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64435364|NCT02319044|Tremelimumab|tremelimumab|mesh-list
64435365|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64435366|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435367|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435368|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
64435369|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435370|NCT01649765|Belimumab|belimumab|mesh-list
64435371|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435372|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
64435373|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435374|NCT02317016|Osimertinib|osimertinib|mesh-list
64435375|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64435376|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64435377|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64435378|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
64435379|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378488|NCT02449811|Amlodipine|amlodipine|mesh-list
64435380|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64435381|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64435382|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435383|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435384|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64435385|NCT02311478|Copper|copper|mesh-list
64435386|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
64435395|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64435405|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435406|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64435407|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64435408|NCT02390531|Growth Substances|growth substances|mesh-ancestor
64435409|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435410|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
64435412|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64435413|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64435414|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435415|NCT02334215|Methadone|methadone|mesh-list
64435416|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64435417|NCT02334215|Narcotics|narcotics|mesh-ancestor
64435418|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435419|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435420|NCT02334215|Analgesics|analgesics|mesh-ancestor
64435421|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
64435422|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435423|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
64435424|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
64435425|NCT02359877|Interferons|interferons|mesh-list
64435426|NCT02359877|Interferon-beta|interferon-beta|mesh-list
64435427|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
64435428|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435429|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
64435430|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435431|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
64435432|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435433|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64435434|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
64435435|NCT02389829|Promethazine|promethazine|mesh-list
64435436|NCT02389829|Hydromorphone|hydromorphone|mesh-list
64435437|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
64435438|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64435439|NCT02389829|Narcotics|narcotics|mesh-ancestor
64435440|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435441|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435442|NCT02389829|Analgesics|analgesics|mesh-ancestor
64435443|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
64435444|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435445|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64435446|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64435447|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
64435448|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
64435449|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
64435450|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
64435451|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435452|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64435453|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
64435455|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435456|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435457|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64435458|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
64435459|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
64435460|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64435461|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64435462|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64435476|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435477|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435478|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
64435489|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64435490|NCT02358473|Docetaxel|docetaxel|mesh-list
64435491|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
64435492|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435493|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
64435494|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
64435495|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
64435496|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435497|NCT02357459|Triamcinolone|triamcinolone|mesh-list
64435498|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64435499|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64435500|NCT02357459|FX006|fx006|mesh-list
64435501|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64435502|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435503|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
64435504|NCT02357459|Hormones|hormones|mesh-ancestor
64435505|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435506|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435507|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435508|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
64435509|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435510|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435511|NCT02332889|Decitabine|decitabine|mesh-list
64435512|NCT02332889|Poly ICLC|poly iclc|mesh-list
64435513|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435514|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
64435515|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435516|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435517|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435518|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
64435519|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
64435520|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435521|NCT02357147|Pemetrexed|pemetrexed|mesh-list
64435522|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435523|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435524|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435525|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64435526|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64435527|NCT02332655|Cannabidiol|cannabidiol|mesh-list
64435528|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
64435529|NCT02388737|Lansoprazole|lansoprazole|mesh-list
64435530|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
64435540|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435541|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64435542|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64435543|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
64435544|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435545|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435546|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
64435566|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64435567|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
64435568|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
64435569|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435570|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
64435571|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64435572|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
64435573|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435574|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64435575|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
64435576|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
64435577|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64435578|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435579|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64435580|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64435581|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
64435582|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435583|NCT01620177|Ethanol|ethanol|mesh-list
64435584|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64435585|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435586|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435587|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435588|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
64435589|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64435590|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435591|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435592|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435593|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
64435594|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64435595|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64435596|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64435597|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64435611|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435612|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64435613|NCT04673175|Renal Agents|renal agents|mesh-ancestor
64435614|NCT02009397|Ipilimumab|ipilimumab|mesh-list
64435615|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435629|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
64435630|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435631|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64435632|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435633|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
64435634|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435635|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64435636|NCT02312219|Hematinics|hematinics|mesh-ancestor
64435637|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
64435638|NCT02312219|Vitamins|vitamins|mesh-ancestor
64435639|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
64435640|NCT01986231|Glucagon|glucagon|mesh-list
64435641|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435642|NCT01986231|Hormones|hormones|mesh-ancestor
64435643|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435644|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435645|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64435646|NCT02312063|Glimepiride|glimepiride|mesh-list
64435647|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64435648|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435649|NCT02312063|Incretins|incretins|mesh-ancestor
64435650|NCT02312063|Hormones|hormones|mesh-ancestor
64435651|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435652|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64435653|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
64435654|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435655|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435656|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64435657|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435658|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
64435663|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64435665|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
64435668|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64435669|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64435670|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
64435671|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64435672|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435684|NCT01983969|Dexamethasone|dexamethasone|mesh-list
64435685|NCT01983969|Rituximab|rituximab|mesh-list
64435686|NCT01983969|Azacitidine|azacitidine|mesh-list
64435687|NCT01983969|Melphalan|melphalan|mesh-list
64435688|NCT01983969|Busulfan|busulfan|mesh-list
64435689|NCT01983969|Vorinostat|vorinostat|mesh-list
64435690|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435691|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435692|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
64435693|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435694|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435695|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64435696|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
64435697|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
64435698|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435699|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435700|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
64435701|NCT01983969|Hormones|hormones|mesh-ancestor
64435702|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64435703|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64435704|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435705|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
64435706|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435707|NCT01983969|Antiviral Agents|antiviral agents|mesh-ancestor
64435708|NCT01983969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435709|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435710|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435711|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64435712|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
64435713|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64435714|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64435715|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
64435716|NCT01983969|Vitamins|vitamins|mesh-ancestor
64435717|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
64435718|NCT02008773|Valacyclovir|valacyclovir|mesh-list
64435719|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
64435720|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435721|NCT02257567|Rituximab|rituximab|mesh-list
64435722|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
64435723|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64435724|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64435725|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
64435726|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435727|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435728|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
64435729|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435767|NCT05302297|Cemiplimab|cemiplimab|mesh-list
64435776|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
64435777|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435778|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64435780|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64435781|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435782|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435783|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435784|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
64435785|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64435786|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
64435787|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64435788|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
64435789|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435790|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435791|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
64435792|NCT02008227|Docetaxel|docetaxel|mesh-list
64435793|NCT02008227|Atezolizumab|atezolizumab|mesh-list
64435794|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435817|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435818|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435819|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64435820|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
64435821|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435822|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64435823|NCT01983111|Acetaminophen|acetaminophen|mesh-list
64435824|NCT01983111|Buprenorphine|buprenorphine|mesh-list
64435825|NCT01983111|Tramadol|tramadol|mesh-list
64435826|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64435827|NCT01983111|Analgesics|analgesics|mesh-ancestor
64435828|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
64435829|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435830|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435831|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
64435832|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64435833|NCT01983111|Narcotics|narcotics|mesh-ancestor
64435834|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64435835|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64435836|NCT04672941|Bromides|bromides|mesh-list
64435837|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
64435838|NCT04672941|Olodaterol|olodaterol|mesh-list
64435839|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64435840|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
64435841|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64435842|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435843|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64435844|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
64435889|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64435891|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64435892|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
64435893|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64435894|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64435895|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64435897|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
64435898|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64435899|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64435900|NCT02005029|Erythromycin|erythromycin|mesh-list
64435901|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
64435902|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64435903|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
64435904|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64435905|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435962|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435964|NCT02004093|Gemcitabine|gemcitabine|mesh-list
64435965|NCT02004093|Paclitaxel|paclitaxel|mesh-list
64435966|NCT02004093|Carboplatin|carboplatin|mesh-list
64435967|NCT02004093|Pertuzumab|pertuzumab|mesh-list
64435969|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64435970|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
64435971|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
64435972|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
64435973|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64435974|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64435975|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
64435976|NCT02004093|Antiviral Agents|antiviral agents|mesh-ancestor
64435977|NCT02004093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64435978|NCT02004093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64435979|NCT02004093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436006|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
64436007|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64436008|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436009|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436010|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64436012|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
64436013|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436014|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64436016|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64436017|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436018|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436019|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436021|NCT02325401|Cisplatin|cisplatin|mesh-list
64436022|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436023|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64436024|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436025|NCT02324699|Prednisone|prednisone|mesh-list
64436026|NCT02324699|Vedolizumab|vedolizumab|mesh-list
64436027|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436028|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
64436029|NCT02324699|Hormones|hormones|mesh-ancestor
64436030|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436031|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436032|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64436033|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436034|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436035|NCT01979523|Trametinib|trametinib|mesh-list
64436036|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436037|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64436038|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436039|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436040|NCT02255461|Palbociclib|palbociclib|mesh-list
64436041|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436042|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64436043|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436067|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436068|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436069|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
64436070|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436071|NCT02254681|Antiviral Agents|antiviral agents|mesh-ancestor
64436072|NCT02254681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436073|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436074|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436075|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
64436086|NCT04872595|Fludarabine|fludarabine|mesh-list
64436087|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436088|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
64436089|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436090|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436091|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436092|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
64436094|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436127|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64436128|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64436129|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
64436130|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
64436131|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436132|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436133|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436134|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64436135|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64436136|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436137|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64436138|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64436139|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64436150|NCT05243797|Growth Substances|growth substances|mesh-ancestor
64436151|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
64436152|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436153|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64436154|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64436155|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64436156|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436157|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436158|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64436159|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64436160|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436161|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
64436162|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436163|NCT02001987|Methotrexate|methotrexate|mesh-list
64436164|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64436165|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
64436166|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64436167|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436168|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436169|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
64436170|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436171|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436172|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
64436173|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436174|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64436175|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436176|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
64436177|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436178|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64379307|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
64436190|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436191|NCT04561180|Dexamethasone|dexamethasone|mesh-list
64436195|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436196|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436198|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
64436199|NCT04561180|Hormones|hormones|mesh-ancestor
64436200|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436201|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64436216|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
64436218|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64436219|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436220|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64436221|NCT04836637|Antacids|antacids|mesh-ancestor
64436222|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436223|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436224|NCT04419259|Erenumab|erenumab|mesh-list
64436225|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
64436226|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436227|NCT04419259|Analgesics|analgesics|mesh-ancestor
64436228|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
64436229|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436230|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436231|NCT02000427|Blinatumomab|blinatumomab|mesh-list
64436232|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436233|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64436234|NCT04846231|Red yeast rice|red yeast rice|mesh-list
64436235|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64436236|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64436238|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436239|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64436240|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64436241|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436242|NCT04845217|Peppermint oil|peppermint oil|mesh-list
64436243|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
64436244|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
64436245|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436246|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436247|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436248|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
64436281|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64436282|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436283|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436285|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64436286|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64436287|NCT04832269|Prednisolone|prednisolone|mesh-list
64436288|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
64436289|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64436290|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
64436291|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436292|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
64436293|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
64436294|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436295|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436296|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436297|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
64436298|NCT04832269|Hormones|hormones|mesh-ancestor
64436299|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436300|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64436301|NCT04832269|Protective Agents|protective agents|mesh-ancestor
64436302|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64436303|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436304|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
64436305|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64436306|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436307|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436308|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64436322|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436324|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64436329|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64436330|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436331|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64436334|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64436335|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64436336|NCT02308163|Analgesics|analgesics|mesh-ancestor
64436337|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
64436338|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436339|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436340|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64436341|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436342|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436343|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436344|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
64436345|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436346|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436354|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
64436355|NCT04001647|Nitroprusside|nitroprusside|mesh-list
64436356|NCT04001647|Acetylcholine|acetylcholine|mesh-list
64436357|NCT04001647|Vitamins|vitamins|mesh-ancestor
64436358|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
64436359|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436360|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
64436361|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436362|NCT04001647|Protective Agents|protective agents|mesh-ancestor
64436363|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64436364|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
64436365|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64436366|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64436367|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
64436368|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436369|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
64436370|NCT03939637|Antibodies|antibodies|mesh-list
64436371|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
64436372|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64436373|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64436374|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
64436375|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436382|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
64436383|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64436384|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436385|NCT04428385|Artemisinins|artemisinins|mesh-list
64436402|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436403|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436405|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
64436406|NCT01999335|Hormones|hormones|mesh-ancestor
64436407|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436408|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64436409|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436410|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
64436411|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64436412|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64436413|NCT01999335|Growth Substances|growth substances|mesh-ancestor
64436414|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
64436415|NCT01999179|Heparin|heparin|mesh-list
64436416|NCT01999179|Enoxaparin|enoxaparin|mesh-list
64436417|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64436418|NCT01999179|Tinzaparin|tinzaparin|mesh-list
64436419|NCT01999179|Dalteparin|dalteparin|mesh-list
64436444|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64436445|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64436446|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64436447|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64436448|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
64436473|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436474|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436475|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
64436476|NCT01731886|Hormones|hormones|mesh-ancestor
64436477|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436478|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64436479|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64436480|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64436481|NCT01731886|Growth Substances|growth substances|mesh-ancestor
64436482|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
64436483|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64436484|NCT01759420|Ondansetron|ondansetron|mesh-list
64436486|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
64436487|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436488|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436489|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64436490|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
64436491|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
64436492|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64436493|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
64436494|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436495|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436496|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64436497|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64436584|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64436585|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64436586|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64436587|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436588|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436589|NCT04267081|Venetoclax|venetoclax|mesh-list
64436590|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436591|NCT04792567|Siponimod|siponimod|mesh-list
64436592|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64436593|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436623|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64436624|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436625|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436626|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64436627|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
64436629|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
64436630|NCT04196413|Fludarabine|fludarabine|mesh-list
64436631|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436632|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
64436633|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436634|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436635|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436636|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
64436637|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436638|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436639|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64436640|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64436641|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
64436673|NCT05221021|Hormones|hormones|mesh-ancestor
64436674|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64436675|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436676|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64436677|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64436678|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64436679|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
64436680|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436681|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436682|NCT05221021|Urological Agents|urological agents|mesh-ancestor
64436683|NCT03167437|Vorinostat|vorinostat|mesh-list
64436684|NCT03167437|Ustekinumab|ustekinumab|mesh-list
64436685|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436703|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436704|NCT01995201|Methotrexate|methotrexate|mesh-list
64436705|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64436706|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
64436707|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64436708|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436709|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436710|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
64436711|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436712|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436713|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
64436714|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436715|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64436716|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436717|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
64436718|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436719|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64436723|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64436724|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
64436725|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436728|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436729|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
64436730|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436731|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436732|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436733|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
64436734|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436735|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436736|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64436737|NCT05165641|Anesthetics|anesthetics|mesh-list
64436738|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436739|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436740|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64436741|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64436742|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436743|NCT05814432|Amphotericin B|amphotericin b|mesh-list
64436744|NCT05814432|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64436745|NCT05814432|Amebicides|amebicides|mesh-ancestor
64436746|NCT05814432|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64436747|NCT05814432|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64436748|NCT05814432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436749|NCT05814432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64436761|NCT05814354|Mitosis Modulators|mitosis modulators|mesh-ancestor
64436762|NCT05814354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436763|NCT05814354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64436764|NCT05814354|Antimetabolites|antimetabolites|mesh-ancestor
64436765|NCT05814354|Antiviral Agents|antiviral agents|mesh-ancestor
64436766|NCT05814354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436767|NCT05814354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436768|NCT05814354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64436785|NCT05814159|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64436786|NCT05814159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64436787|NCT05814146|Dialysis Solutions|dialysis solutions|mesh-list
64436788|NCT05814146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64436789|NCT05814068|Antihypertensive Agents|antihypertensive agents|mesh-list
64436790|NCT05813964|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64436791|NCT05813964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
64436792|NCT05813964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64436793|NCT05813964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64436794|NCT05813964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436795|NCT05813964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436796|NCT05813964|Antiviral Agents|antiviral agents|mesh-ancestor
64436797|NCT05813964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436798|NCT05813964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64436799|NCT05813964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64436800|NCT05813951|Linezolid|linezolid|mesh-list
64436801|NCT05813951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64436802|NCT05813951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436803|NCT05813951|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64436804|NCT05813951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436805|NCT05813951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436809|NCT05813860|Azathioprine|azathioprine|mesh-list
64436810|NCT05813860|Infliximab|infliximab|mesh-list
64436811|NCT05813860|Dermatologic Agents|dermatologic agents|mesh-ancestor
64436829|NCT05813665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436839|NCT05813600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436840|NCT05813600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64436841|NCT05813600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64436846|NCT05813522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64436847|NCT05813522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436848|NCT05813522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436849|NCT05813496|Thioctic Acid|thioctic acid|mesh-list
64436850|NCT05813496|Antioxidants|antioxidants|mesh-ancestor
64436851|NCT05813496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436852|NCT05813496|Protective Agents|protective agents|mesh-ancestor
64436853|NCT05813496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436854|NCT05813496|Vitamin B Complex|vitamin b complex|mesh-ancestor
64436855|NCT05813496|Vitamins|vitamins|mesh-ancestor
64436856|NCT05813496|Micronutrients|micronutrients|mesh-ancestor
64436859|NCT05813470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64436860|NCT05813470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64436861|NCT05813470|Respiratory System Agents|respiratory system agents|mesh-ancestor
64436862|NCT05813470|Immunologic Factors|immunologic factors|mesh-ancestor
64436863|NCT05813470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436864|NCT05813405|Antihypertensive Agents|antihypertensive agents|mesh-list
64436865|NCT05813366|Vitamin B 6|vitamin b 6|mesh-list
64436866|NCT05813366|Pyridoxal|pyridoxal|mesh-list
64436867|NCT05813366|Pyridoxine|pyridoxine|mesh-list
64436868|NCT05813366|Tryptophan|tryptophan|mesh-list
64436869|NCT05813366|Vitamins|vitamins|mesh-ancestor
64436870|NCT05813366|Micronutrients|micronutrients|mesh-ancestor
64436871|NCT05813366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436872|NCT05813366|Vitamin B Complex|vitamin b complex|mesh-ancestor
64436877|NCT05813327|Mesna|mesna|mesh-list
64436878|NCT05813327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64436879|NCT05813327|Alkylating Agents|alkylating agents|mesh-ancestor
64436880|NCT05813327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436881|NCT05813327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436882|NCT05813327|Protective Agents|protective agents|mesh-ancestor
64436883|NCT05813327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436884|NCT05813314|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
64436894|NCT05813288|Dopamine Agonists|dopamine agonists|mesh-ancestor
64436895|NCT05813288|Dopamine Agents|dopamine agents|mesh-ancestor
64436896|NCT05813288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64436897|NCT05813249|Tocopherols|tocopherols|mesh-list
64436898|NCT05813249|Vitamin E|vitamin e|mesh-list
64436899|NCT05813249|Tocotrienols|tocotrienols|mesh-list
64436900|NCT05813249|alpha-Tocopherol|alpha-tocopherol|mesh-list
64436901|NCT05813249|Antioxidants|antioxidants|mesh-ancestor
64436902|NCT05813249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436904|NCT05813249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436905|NCT05813249|Vitamins|vitamins|mesh-ancestor
64436906|NCT05813249|Micronutrients|micronutrients|mesh-ancestor
64436907|NCT05813184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64436908|NCT05813184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64436909|NCT05813158|Bupivacaine|bupivacaine|mesh-list
64436910|NCT05813158|Anesthetics, Local|anesthetics, local|mesh-ancestor
64436911|NCT05813158|Anesthetics|anesthetics|mesh-ancestor
64436912|NCT05813158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64436913|NCT05813158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64436914|NCT05813158|Sensory System Agents|sensory system agents|mesh-ancestor
64436915|NCT05813158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64436916|NCT05813145|Fenofibrate|fenofibrate|mesh-list
64436917|NCT05813145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64436918|NCT05813145|Antimetabolites|antimetabolites|mesh-ancestor
64436919|NCT05813145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436920|NCT05813145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64436921|NCT05813132|Cytarabine|cytarabine|mesh-list
64436922|NCT05813132|Carboplatin|carboplatin|mesh-list
64436923|NCT05813132|Etoposide|etoposide|mesh-list
64436924|NCT05813132|Etoposide phosphate|etoposide phosphate|mesh-list
64436925|NCT05813132|Melphalan|melphalan|mesh-list
64436926|NCT05813132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64436927|NCT05813132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64436928|NCT05813132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64436929|NCT05813132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64436930|NCT05813132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64436931|NCT05813132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64436932|NCT05813132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64436987|NCT05808582|Hormone Antagonists|hormone antagonists|mesh-ancestor
64379308|NCT02176018|Quinidine|quinidine|mesh-list
64437013|NCT05787613|Carboplatin|carboplatin|mesh-list
64437014|NCT05787613|Pemetrexed|pemetrexed|mesh-list
64437015|NCT05787613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64437016|NCT05787613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437017|NCT05787613|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437018|NCT05787613|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437019|NCT05787613|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437020|NCT05787613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437021|NCT05787613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437022|NCT05787613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64437023|NCT05787613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64437024|NCT05775887|Vaccines|vaccines|mesh-list
64437025|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
64437026|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437027|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64437028|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
64437029|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437032|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
64437033|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437034|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437036|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64437037|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437038|NCT05757388|Acetaminophen|acetaminophen|mesh-list
64437039|NCT05757388|Parecoxib|parecoxib|mesh-list
64437040|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64437041|NCT05757388|Analgesics|analgesics|mesh-ancestor
64437042|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
64437043|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437044|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437045|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
64437046|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64437047|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64437048|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437049|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437058|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
64437059|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437060|NCT05750459|Artesunate|artesunate|mesh-list
64437061|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
64437062|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64437063|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64437069|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
64437071|NCT05749393|Calcium heparin|calcium heparin|mesh-list
64437072|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
64437073|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64437074|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64437075|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437090|NCT05732883|Dexamethasone|dexamethasone|mesh-list
64437091|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437092|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
64437093|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
64437094|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437105|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437106|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64437108|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
64437109|NCT05720455|Ephedrine|ephedrine|mesh-list
64437110|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64437111|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
64437112|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437113|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437114|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64437115|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
64437116|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
64437117|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64437147|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437148|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
64437149|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
64437150|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64437151|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
64437152|NCT05688735|Isosorbide|isosorbide|mesh-list
64437156|NCT05688735|Diuretics|diuretics|mesh-ancestor
64437157|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
64437158|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437159|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
64437160|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64437161|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437162|NCT05674994|Prednisone|prednisone|mesh-list
64437163|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437216|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64437217|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64437218|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
64437219|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
64437220|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64437221|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437222|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437223|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437224|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64437236|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437237|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437238|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437239|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
64437240|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64437241|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64437242|NCT05552222|Growth Substances|growth substances|mesh-ancestor
64437243|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
64437245|NCT05552196|Ponesimod|ponesimod|mesh-list
64437246|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
64437247|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
64437248|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64437249|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437250|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437251|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64437252|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64437253|NCT05552196|Analgesics|analgesics|mesh-ancestor
64437254|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
64437255|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437256|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64437257|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437258|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437259|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64437260|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64437261|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
64437262|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437268|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437270|NCT05546554|Suvorexant|suvorexant|mesh-list
64437271|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64437272|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64437273|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437274|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437275|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64437276|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437277|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437278|NCT05540574|Zolpidem|zolpidem|mesh-list
64437279|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64437280|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64437281|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437282|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437283|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
64437284|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
64437285|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
64437286|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437287|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437288|NCT05538247|Indomethacin|indomethacin|mesh-list
64437289|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64437290|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64437291|NCT05538247|Analgesics|analgesics|mesh-ancestor
64437292|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
64437293|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437294|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437295|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437296|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437305|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64437306|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437307|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437309|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
64437310|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437311|NCT05536414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64437312|NCT05536414|Antidepressive Agents|antidepressive agents|mesh-ancestor
64437313|NCT05536414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64437314|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
64437315|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64437316|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437317|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
64437318|NCT05501678|Promethazine|promethazine|mesh-list
64437319|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64437320|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64437321|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437322|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437323|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
64437324|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
64437325|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
64437326|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437327|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
64437328|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
64437329|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437330|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64437331|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
64437332|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
64437333|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437334|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437335|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64437336|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
64437337|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
64437338|NCT05496192|Nivolumab|nivolumab|mesh-list
64437339|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437380|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64437381|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
64437382|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437383|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437384|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437385|NCT05386030|Lidocaine|lidocaine|mesh-list
64437386|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
64437387|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
64437388|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437389|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437392|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64437393|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64437394|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64437395|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437396|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437397|NCT05382559|Cetuximab|cetuximab|mesh-list
64446218|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64437398|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437399|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437400|NCT05352815|Insulin|insulin|mesh-list
64437401|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64437402|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437403|NCT05324852|Midazolam|midazolam|mesh-list
64437404|NCT05324852|Loxapine|loxapine|mesh-list
64437405|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64437406|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64437407|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437408|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437409|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64437410|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64437411|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64437412|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64437413|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
64437414|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
64437415|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
64437416|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
64437417|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437418|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437419|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64437420|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64437421|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
64437422|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
64437423|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
64437433|NCT05287191|Digoxin|digoxin|mesh-list
64437434|NCT05287191|Amiodarone|amiodarone|mesh-list
64437435|NCT05287191|Analgesics|analgesics|mesh-ancestor
64437436|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
64437437|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437438|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437439|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
64437440|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437441|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64437442|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
64437443|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64437444|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437459|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64437460|NCT05279417|Methotrexate|methotrexate|mesh-list
64437461|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64437462|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
64437463|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64437464|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437465|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64437466|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
64437467|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437468|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437469|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
64437470|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437471|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64437472|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437473|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
64437474|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437475|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64437476|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
64437477|NCT05259046|Vitamin K|vitamin k|mesh-list
64437478|NCT05259046|Vitamin MK 7|vitamin mk 7|mesh-list
64437479|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64437501|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437502|NCT05246670|Hormones|hormones|mesh-ancestor
64437503|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437507|NCT05218499|Doxorubicin|doxorubicin|mesh-list
64437508|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64437509|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437510|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64437511|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64437512|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437513|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437514|NCT05206682|Leuprolide|leuprolide|mesh-list
64437515|NCT05206682|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64437516|NCT05206682|Fertility Agents|fertility agents|mesh-ancestor
64437552|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64437553|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437554|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
64437555|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64437556|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
64437557|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64437558|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
64437559|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
64437561|NCT05173987|Docetaxel|docetaxel|mesh-list
64437562|NCT05173987|Carboplatin|carboplatin|mesh-list
64437563|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
64437564|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64437565|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437566|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437567|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437568|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437570|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437572|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437573|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
64437574|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437575|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64437576|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64437578|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437579|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437580|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64437581|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
64437582|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64437583|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64437584|NCT05150704|Prednisolone|prednisolone|mesh-list
64437585|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
64437586|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64437587|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
64437603|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437604|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437605|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437611|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437612|NCT05129748|Antidotes|antidotes|mesh-ancestor
64437624|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437625|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
64437626|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437627|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437628|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
64437646|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
64437672|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64437673|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437674|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
64437675|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64437676|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64437677|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437678|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
64437679|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
64437680|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437684|NCT05024552|Cytarabine|cytarabine|mesh-list
64437685|NCT05024552|Daunorubicin|daunorubicin|mesh-list
64437686|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64437687|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
64437688|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437689|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437690|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
64437691|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64437692|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437693|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
64437694|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437695|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64437696|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64437697|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64437698|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437699|NCT05004662|Nicotine|nicotine|mesh-list
64437718|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
64437719|NCT04975997|Hormones|hormones|mesh-ancestor
64437720|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437721|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437722|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437742|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437775|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64437776|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64437777|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437778|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437780|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437781|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437783|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64437784|NCT04895358|Doxorubicin|doxorubicin|mesh-list
64437785|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64437786|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
64437787|NCT04895358|Capecitabine|capecitabine|mesh-list
64437788|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64437789|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437790|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437791|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437793|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437794|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64367457|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
64437795|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64437796|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64437797|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437798|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437799|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64437800|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
64437801|NCT04863248|Docetaxel|docetaxel|mesh-list
64437802|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437803|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437814|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437816|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
64437833|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
64437834|NCT04818749|BB 1101|bb 1101|mesh-list
64437835|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437836|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
64437837|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
64437838|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437839|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437840|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437841|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
64437842|NCT04818749|Hormones|hormones|mesh-ancestor
64437843|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437844|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437845|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437846|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
64437847|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437848|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437849|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64437850|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64437851|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64437852|NCT04818749|Analgesics|analgesics|mesh-ancestor
64437853|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
64437854|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64437855|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64437856|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64437857|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
64437861|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64437862|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64437863|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64437864|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437866|NCT04807140|Carboplatin|carboplatin|mesh-list
64437867|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64437868|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437869|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
64437870|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
64437871|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
64437884|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64437885|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
64437886|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
64437887|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64437888|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437889|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64437890|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
64437891|NCT04756726|Hormones|hormones|mesh-ancestor
64437892|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437893|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64437894|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437895|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64437896|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64437897|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437898|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437899|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
64437900|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64437921|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437922|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437927|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437928|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437929|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64437930|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
64437931|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437932|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
64437971|NCT04558918|Eculizumab|eculizumab|mesh-list
64437972|NCT04558918|Ravulizumab|ravulizumab|mesh-list
64437973|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64437974|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64437975|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
64437976|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437977|NCT04529278|Liraglutide|liraglutide|mesh-list
64437978|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64437979|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64437980|NCT04529278|Incretins|incretins|mesh-ancestor
64437981|NCT04529278|Hormones|hormones|mesh-ancestor
64437982|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64437983|NCT04526730|Nivolumab|nivolumab|mesh-list
64437984|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64437985|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64437986|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64437987|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64437990|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64437991|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64437992|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64437993|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64437994|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438010|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64438011|NCT04498832|Vaccines|vaccines|mesh-list
64438012|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
64438013|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438014|NCT04493203|Nivolumab|nivolumab|mesh-list
64438015|NCT04493203|Axitinib|axitinib|mesh-list
64438017|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438018|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64438019|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438020|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438021|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438023|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64438024|NCT04458545|Narcotics|narcotics|mesh-ancestor
64438025|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438026|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438027|NCT04458545|Analgesics|analgesics|mesh-ancestor
64438028|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
64438029|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438030|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
64438031|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
64438032|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438041|NCT04429516|Analgesics|analgesics|mesh-ancestor
64438042|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
64438043|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438044|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
64438045|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438046|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438047|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438048|NCT04412096|Timolol|timolol|mesh-list
64438049|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64438050|NCT04412096|Latanoprost|latanoprost|mesh-list
64438051|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64438052|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64438053|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64438054|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
64438055|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438069|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438070|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
64438071|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
64438072|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438073|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438074|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438075|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
64438076|NCT04405167|Hormones|hormones|mesh-ancestor
64367465|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64438077|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438078|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64438079|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438080|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
64438081|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438082|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438083|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
64438084|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64438085|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64438086|NCT04405167|Growth Substances|growth substances|mesh-ancestor
64438087|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64438088|NCT04388852|Ipilimumab|ipilimumab|mesh-list
64438089|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438090|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438091|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64438092|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438093|NCT04388839|Dactinomycin|dactinomycin|mesh-list
64438094|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
64438095|NCT04388839|Vincristine|vincristine|mesh-list
64438096|NCT04388839|Vinorelbine|vinorelbine|mesh-list
64438097|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438098|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
64438099|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438100|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438101|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64438102|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
64438103|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438104|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438105|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64438106|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64438107|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
64438108|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
64438109|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
64438129|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64438130|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
64438131|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438132|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438133|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64438134|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438135|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
64438136|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
64438137|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438138|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64438139|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438140|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
64438141|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
64438142|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64438143|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438144|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64438145|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
64438146|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64438147|NCT04375631|Analgesics|analgesics|mesh-ancestor
64438148|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
64438149|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438150|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438151|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438152|NCT04357951|Cycloserine|cycloserine|mesh-list
64438153|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64438154|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438155|NCT04357951|Renal Agents|renal agents|mesh-ancestor
64438156|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64438157|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
64438168|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438169|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
64438170|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438171|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438172|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438173|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
64438174|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
64438175|NCT04259060|Hematinics|hematinics|mesh-ancestor
64438176|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
64438177|NCT04259060|Vitamins|vitamins|mesh-ancestor
64438178|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
64438179|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438180|NCT04240002|Cytarabine|cytarabine|mesh-list
64438181|NCT04240002|Fludarabine|fludarabine|mesh-list
64438182|NCT04240002|Lenograstim|lenograstim|mesh-list
64438183|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438184|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438185|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
64438224|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438225|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64438226|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64438228|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438229|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
64438279|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438280|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438281|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64438282|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438283|NCT04083898|Prednisone|prednisone|mesh-list
64438284|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64438285|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438286|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
64438287|NCT04083898|Hormones|hormones|mesh-ancestor
64438312|NCT04024462|Docetaxel|docetaxel|mesh-list
64438313|NCT04024462|Doxorubicin|doxorubicin|mesh-list
64438314|NCT04024462|Trastuzumab|trastuzumab|mesh-list
64438315|NCT04024462|Pertuzumab|pertuzumab|mesh-list
64438316|NCT04024462|Hormones|hormones|mesh-list
64438317|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438319|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438320|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438321|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64438322|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
64438323|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438324|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438325|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64438326|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
64438327|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
64438328|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
64438329|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438330|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438331|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438332|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438333|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438425|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438426|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
64438427|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
64438428|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64438429|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64438430|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438432|NCT03897621|Coagulants|coagulants|mesh-ancestor
64438433|NCT03896269|Cytarabine|cytarabine|mesh-list
64438434|NCT03896269|Daunorubicin|daunorubicin|mesh-list
64438435|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438436|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
64438437|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438438|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438439|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
64438440|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438441|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438442|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
64438443|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438444|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438445|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438446|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438447|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438448|NCT03833154|Durvalumab|durvalumab|mesh-list
64438449|NCT03833154|Osimertinib|osimertinib|mesh-list
64438450|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438451|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438452|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438453|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438454|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438455|NCT03832998|Erenumab|erenumab|mesh-list
64438456|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64438460|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
64438461|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438462|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438463|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
64438464|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
64438465|NCT03809884|Diuretics|diuretics|mesh-ancestor
64438480|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438482|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64438483|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438488|NCT03758781|Nivolumab|nivolumab|mesh-list
64438489|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438490|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438491|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64438492|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438493|NCT03746080|Plerixafor|plerixafor|mesh-list
64438494|NCT03746080|Temozolomide|temozolomide|mesh-list
64438495|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64438496|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
64438497|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438498|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438499|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64438500|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64438501|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
64438502|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438503|NCT03737994|Cisplatin|cisplatin|mesh-list
64438504|NCT03737994|Carboplatin|carboplatin|mesh-list
64438505|NCT03737994|Pemetrexed|pemetrexed|mesh-list
64438506|NCT03737994|Crizotinib|crizotinib|mesh-list
64438507|NCT03737994|Ceritinib|ceritinib|mesh-list
64438508|NCT03737994|Ensartinib|ensartinib|mesh-list
64438509|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438510|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438511|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438512|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64438513|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64438514|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438570|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438571|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438572|NCT03595124|Nivolumab|nivolumab|mesh-list
64438573|NCT03595124|Axitinib|axitinib|mesh-list
64438574|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438575|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438576|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64438577|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438578|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438579|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438580|NCT03572933|Pregnanolone|pregnanolone|mesh-list
64438600|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438602|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64438603|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438604|NCT03502668|Decitabine|decitabine|mesh-list
64438605|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438606|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
64438607|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438608|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438609|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438610|NCT03501368|Trametinib|trametinib|mesh-list
64438611|NCT03501368|Ceritinib|ceritinib|mesh-list
64438612|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438613|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438717|NCT03132454|Decitabine|decitabine|mesh-list
64438718|NCT03132454|Palbociclib|palbociclib|mesh-list
64438719|NCT03132454|Ichthammol|ichthammol|mesh-list
64438720|NCT03132454|BB 1101|bb 1101|mesh-list
64438721|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438722|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
64438723|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
64438724|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438725|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438726|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64438727|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
64438728|NCT03132454|Hormones|hormones|mesh-ancestor
64438729|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64438730|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64438731|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438732|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
64438733|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438734|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438735|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64438736|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438737|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
64438740|NCT02966782|Venetoclax|venetoclax|mesh-list
64438741|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438742|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
64438743|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438744|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438745|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438746|NCT02964078|Aldesleukin|aldesleukin|mesh-list
64438747|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
64438748|NCT02964078|Interleukin-2|interleukin-2|mesh-list
64438749|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438750|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438762|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64438763|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438764|NCT02960659|Incretins|incretins|mesh-ancestor
64438765|NCT02960659|Hormones|hormones|mesh-ancestor
64438801|NCT02773030|Dexamethasone|dexamethasone|mesh-list
64438802|NCT02773030|Bortezomib|bortezomib|mesh-list
64438803|NCT02773030|Daratumumab|daratumumab|mesh-list
64438804|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438805|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
64438816|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64438817|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
64438818|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64438819|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64438820|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64438821|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64438822|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438823|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
64438824|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438825|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438826|NCT02543983|Ketamine|ketamine|mesh-list
64438827|NCT02543983|Analgesics|analgesics|mesh-ancestor
64438828|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
64438829|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438830|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438831|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64438832|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64438833|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
64438834|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
64438835|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64438836|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64438837|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64438838|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64438839|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438840|NCT02506933|Vaccines|vaccines|mesh-list
64438841|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
64438842|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438843|NCT02491632|Dexamethasone|dexamethasone|mesh-list
64438844|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
64438906|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
64438907|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438908|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438909|NCT02286726|Cytarabine|cytarabine|mesh-list
64438910|NCT02286726|Daunorubicin|daunorubicin|mesh-list
64438911|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64438912|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
64438913|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438914|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438915|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
64438916|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64438917|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438918|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
64438919|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438920|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438921|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438922|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438924|NCT02206815|Aspirin|aspirin|mesh-list
64438925|NCT02206815|Warfarin|warfarin|mesh-list
64438926|NCT02206815|Clopidogrel|clopidogrel|mesh-list
64438927|NCT02206815|Ticagrelor|ticagrelor|mesh-list
64438928|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64438964|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64438965|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438967|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
64438968|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64438969|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
64438970|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
64438971|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64438972|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64438982|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64438983|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
64438984|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64438985|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64438986|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64438987|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
64438988|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64438989|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64438990|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64438991|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64438992|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64438993|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64438994|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64438995|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64438996|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64438997|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
64438998|NCT01974440|Hormones|hormones|mesh-ancestor
64438999|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439000|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64439004|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
64439005|NCT01919086|Dexamethasone|dexamethasone|mesh-list
64439006|NCT01919086|Lenalidomide|lenalidomide|mesh-list
64439007|NCT01919086|Bortezomib|bortezomib|mesh-list
64439008|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439009|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
64439023|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
64439024|NCT01779375|Metformin|metformin|mesh-list
64439025|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
64439026|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64439027|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439028|NCT01559935|Clarithromycin|clarithromycin|mesh-list
64439029|NCT01559935|Dexamethasone|dexamethasone|mesh-list
64439030|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
64439031|NCT01559935|Lenalidomide|lenalidomide|mesh-list
64439032|NCT01559935|BB 1101|bb 1101|mesh-list
64439033|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439034|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
64439035|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
64439036|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439037|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439038|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439039|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
64439040|NCT01559935|Hormones|hormones|mesh-ancestor
64439045|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439046|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439047|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
64439048|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64439049|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64439050|NCT01559935|Growth Substances|growth substances|mesh-ancestor
64439051|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
64439052|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64439053|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439054|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64439055|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64439056|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64439059|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
64439060|NCT01358877|Carboplatin|carboplatin|mesh-list
64439061|NCT01358877|Doxorubicin|doxorubicin|mesh-list
64439062|NCT01358877|Fluorouracil|fluorouracil|mesh-list
64439063|NCT01358877|Trastuzumab|trastuzumab|mesh-list
64439064|NCT01358877|Epirubicin|epirubicin|mesh-list
64439065|NCT01358877|Pertuzumab|pertuzumab|mesh-list
64439066|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64439067|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439068|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
64439069|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
64439070|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
64439071|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439072|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439073|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
64439074|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439075|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439076|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64439077|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
64439078|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64439087|NCT00981058|Necitumumab|necitumumab|mesh-list
64439088|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439089|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439090|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
64439091|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439092|NCT00981058|Antiviral Agents|antiviral agents|mesh-ancestor
64439093|NCT00981058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439094|NCT00981058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439095|NCT00981058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439096|NCT00981058|Immunologic Factors|immunologic factors|mesh-ancestor
64439097|NCT00981058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439098|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439099|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64439100|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
64439101|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64439102|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
64439103|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64439135|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439136|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439137|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439138|NCT00445627|Metformin|metformin|mesh-list
64439139|NCT00445627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64439140|NCT00445627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439141|NCT00238563|Triamcinolone|triamcinolone|mesh-list
64439142|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64439143|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
64439144|NCT00238563|Hormones|hormones|mesh-ancestor
64439145|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439146|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439211|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
64439212|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439213|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439214|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64439215|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64439216|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
64439217|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439218|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64439219|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64439221|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
64439222|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439223|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
64439224|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
64439225|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439226|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
64439227|NCT02909335|Prednisone|prednisone|mesh-list
64439228|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
64439229|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64439257|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439258|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64439259|NCT02909335|Protective Agents|protective agents|mesh-ancestor
64439260|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
64439261|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439263|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64439264|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439265|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439266|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439267|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64439276|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439293|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64439294|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64439295|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
64439296|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439297|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64439298|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64439299|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439300|NCT04567108|Benzocaine|benzocaine|mesh-list
64439301|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
64439302|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
64439303|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439304|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439307|NCT01753570|Interferon-beta|interferon-beta|mesh-list
64439308|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439309|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
64439310|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439311|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
64439312|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439313|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
64439314|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64439315|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64439316|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64439317|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64439318|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439319|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
64439320|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439321|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439322|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64439323|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439324|NCT01777282|Biguanides|biguanides|mesh-list
64439325|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64439326|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
64439327|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
64439328|NCT01777282|Incretins|incretins|mesh-ancestor
64439330|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439331|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439332|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64439333|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439346|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439347|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64439349|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439350|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
64439351|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64439352|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64439353|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64439355|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439372|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439373|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439374|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64439375|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439376|NCT01961349|Propofol|propofol|mesh-list
64439377|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64439378|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64439379|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439380|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439381|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64439382|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
64439384|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64439385|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64439386|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64439388|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
64439389|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439390|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439391|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439392|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
64439393|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
64439394|NCT04661397|Tenofovir|tenofovir|mesh-list
64439395|NCT04661397|Emtricitabine|emtricitabine|mesh-list
64439396|NCT04661397|Darunavir|darunavir|mesh-list
64439407|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64439408|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64439409|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64439410|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64439411|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
64439412|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64439431|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439432|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439433|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
64439434|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439435|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64439436|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64439437|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439438|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64439439|NCT01973283|Analgesics|analgesics|mesh-ancestor
64439440|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
64439441|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
64439442|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
64439443|NCT01972659|Analgesics|analgesics|mesh-ancestor
64439444|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
64439445|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439446|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439447|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
64439448|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439449|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64439450|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
64439451|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64439452|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64439453|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439454|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64439466|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439467|NCT01774786|Fluorouracil|fluorouracil|mesh-list
64439468|NCT01774786|Capecitabine|capecitabine|mesh-list
64439469|NCT01774786|Trastuzumab|trastuzumab|mesh-list
64439470|NCT01774786|Pertuzumab|pertuzumab|mesh-list
64439471|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439472|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
64439473|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439474|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439475|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439476|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
64439477|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439478|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439480|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
64439481|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64439482|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64439483|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64439484|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439485|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439486|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
64439487|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
64439488|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439489|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439490|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64439491|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64439492|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
64439493|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64439494|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64439495|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64439496|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64439497|NCT01971645|Dexamethasone|dexamethasone|mesh-list
64439498|NCT01971645|Ropivacaine|ropivacaine|mesh-list
64377607|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64439507|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439508|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64439510|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
64439511|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
64439512|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439513|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
64439514|NCT01941537|Fezakinumab|fezakinumab|mesh-list
64439515|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
64439516|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
64439517|NCT01960413|Montelukast|montelukast|mesh-list
64439518|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64439519|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
64439520|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64439521|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
64439522|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439523|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439524|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64439525|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64439526|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439527|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439528|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
64439546|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
64439547|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439548|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64439549|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64439550|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439560|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64439561|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
64439562|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439563|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
64439564|NCT01970397|Protective Agents|protective agents|mesh-ancestor
64439566|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64439567|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64439568|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439569|NCT01728376|Daptomycin|daptomycin|mesh-list
64439570|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64439571|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439572|NCT02488759|Nivolumab|nivolumab|mesh-list
64439573|NCT02488759|Ipilimumab|ipilimumab|mesh-list
64439574|NCT02488759|Daratumumab|daratumumab|mesh-list
64439575|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439576|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439577|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64439578|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439579|NCT02217709|Phenelzine|phenelzine|mesh-list
64439580|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
64439581|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64439582|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64439583|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439584|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439585|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
64439586|NCT02161783|Fludarabine|fludarabine|mesh-list
64439587|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439588|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
64439607|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439608|NCT05651347|Protective Agents|protective agents|mesh-ancestor
64439609|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439610|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64439611|NCT05651269|Gemcitabine|gemcitabine|mesh-list
64439612|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439613|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
64439614|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439615|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439616|NCT05651269|Antiviral Agents|antiviral agents|mesh-ancestor
64439617|NCT05651269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439618|NCT05651269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439619|NCT05651269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439620|NCT05651269|Immunologic Factors|immunologic factors|mesh-ancestor
64439621|NCT05651269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439622|NCT01707004|Vidarabine|vidarabine|mesh-list
64439633|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
64439634|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439635|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64439636|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64439637|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
64439638|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439639|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439640|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64439641|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64439642|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
64439643|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
64439644|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439645|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64439646|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64439655|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64439657|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439658|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439659|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64439660|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64439661|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
64439662|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64439663|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64439664|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64439665|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
64439666|NCT03734029|Gemcitabine|gemcitabine|mesh-list
64439667|NCT03734029|Paclitaxel|paclitaxel|mesh-list
64439668|NCT03734029|Camptothecin|camptothecin|mesh-list
64439669|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64439670|NCT03734029|Capecitabine|capecitabine|mesh-list
64439671|NCT03734029|Trastuzumab|trastuzumab|mesh-list
64439672|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
64439673|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64439674|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439675|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
64439708|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439709|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64439710|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64439726|NCT04789837|Cilostazol|cilostazol|mesh-list
64439727|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64439728|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
64439729|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439730|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439731|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64439732|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
64439733|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64439734|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64439735|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439736|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64439737|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
64439738|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64439739|NCT04789837|Protective Agents|protective agents|mesh-ancestor
64439740|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64439741|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64439742|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439743|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
64439744|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64439745|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
64439746|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64439747|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
64439748|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439749|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439750|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
64439751|NCT02000089|Secretin|secretin|mesh-list
64439752|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64439754|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64439755|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439756|NCT01937871|Tadalafil|tadalafil|mesh-list
64439757|NCT01937871|Tamsulosin|tamsulosin|mesh-list
64439758|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
64439759|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64439760|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64439761|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439762|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439763|NCT01937871|Urological Agents|urological agents|mesh-ancestor
64439794|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
64439795|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439796|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64439797|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64439798|NCT02740699|Atorvastatin|atorvastatin|mesh-list
64439799|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64439800|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64439801|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64439802|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
64439803|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439804|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64439805|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64439836|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64439837|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
64439838|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64439869|NCT01918371|Growth Substances|growth substances|mesh-ancestor
64439870|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439871|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
64439872|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439873|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64439874|NCT01916967|Desloratadine|desloratadine|mesh-list
64439875|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64439876|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
64439877|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439878|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439879|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439880|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64439881|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64439882|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
64439883|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
64439884|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64439885|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64439886|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64439887|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64439888|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64439889|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64439890|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64439891|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
64439892|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64439893|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64439894|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439895|NCT01916109|Gemcitabine|gemcitabine|mesh-list
64439904|NCT01916109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64439905|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64439906|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
64439907|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439908|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64439910|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
64439911|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64439921|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439922|NCT01726270|Urological Agents|urological agents|mesh-ancestor
64439923|NCT00942331|Gemcitabine|gemcitabine|mesh-list
64439924|NCT00942331|Bevacizumab|bevacizumab|mesh-list
64439925|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64439927|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
64439928|NCT00942331|Antibodies|antibodies|mesh-list
64439929|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
64439930|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64439932|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64439933|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64439934|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64439935|NCT00942331|Growth Substances|growth substances|mesh-ancestor
64439936|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64439937|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
64439938|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
64439995|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64439996|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
64439998|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440006|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440008|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440009|NCT01617447|Aripiprazole|aripiprazole|mesh-list
64440010|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
64440011|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64440012|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64440013|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64440014|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440015|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440016|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
64440017|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
64440018|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440019|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440020|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64440021|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64440022|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
64440023|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64440024|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64440025|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64440026|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64440078|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440079|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440080|NCT01931475|Analgesics|analgesics|mesh-ancestor
64440081|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
64440082|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440083|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
64440084|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64440085|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
64440086|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64440087|NCT04630821|Eusol|eusol|mesh-list
64440088|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
64440123|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440124|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64440125|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64440126|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
64440127|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64440143|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440144|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64440145|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64440146|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
64440147|NCT01910181|Vemurafenib|vemurafenib|mesh-list
64440156|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64440157|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64440159|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
64440160|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440161|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440162|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64440163|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440164|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
64440165|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
64440166|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64440167|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64440168|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440169|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440170|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
64440171|NCT01928433|Finafloxacin|finafloxacin|mesh-list
64440172|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
64440173|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440174|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440203|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64440204|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64440207|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440208|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
64440209|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440211|NCT02322047|Naltrexone|naltrexone|mesh-list
64440212|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64440213|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64440214|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440215|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
64440216|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440217|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64440218|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64440219|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64440220|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64440221|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440222|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440223|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440224|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64440225|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440226|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440227|NCT02254291|Incretins|incretins|mesh-ancestor
64440229|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440230|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64440231|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
64440232|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440233|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440246|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440247|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440248|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440249|NCT04197089|Vitamin D|vitamin d|mesh-list
64440250|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
64440251|NCT04197089|Vitamins|vitamins|mesh-ancestor
64440252|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
64440253|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440254|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64440255|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64440256|NCT02252965|Metformin|metformin|mesh-list
64440257|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440258|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440259|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
64440260|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64440279|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64440280|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64440281|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
64440282|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64440283|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
64440284|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
64440285|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
64440286|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64440287|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64440288|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64440289|NCT02242201|Analgesics|analgesics|mesh-ancestor
64440290|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64440291|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440292|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64440293|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440294|NCT02242045|Idelalisib|idelalisib|mesh-list
64440295|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440296|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440297|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440298|NCT02241889|Pancrelipase|pancrelipase|mesh-list
64440299|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440300|NCT02241187|Cetuximab|cetuximab|mesh-list
64440301|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440302|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440303|NCT02249767|Tretinoin|tretinoin|mesh-list
64440304|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440305|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
64440306|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
64440307|NCT04783675|Rituximab|rituximab|mesh-list
64440308|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440309|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440310|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
64440311|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440312|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440313|NCT04892953|Gemcitabine|gemcitabine|mesh-list
64440314|NCT04892953|Paclitaxel|paclitaxel|mesh-list
64367531|NCT02498171|Bupivacaine|bupivacaine|mesh-list
64440315|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64440316|NCT04892953|Carboplatin|carboplatin|mesh-list
64440318|NCT04892953|Durvalumab|durvalumab|mesh-list
64440345|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64440346|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440347|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64440348|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64440349|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
64440350|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440351|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440352|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64440353|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64440354|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64440355|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
64440356|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
64440357|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440358|NCT02207413|Vaccines|vaccines|mesh-list
64440359|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
64440360|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440361|NCT02276027|Ceritinib|ceritinib|mesh-list
64440362|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440363|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64440364|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440365|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440366|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
64440367|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64440368|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64440369|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64440370|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440371|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440388|NCT02308748|Lidocaine|lidocaine|mesh-list
64440389|NCT02308748|Mexiletine|mexiletine|mesh-list
64440390|NCT02308748|Dofetilide|dofetilide|mesh-list
64440391|NCT02308748|Diltiazem|diltiazem|mesh-list
64440392|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
64440393|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
64440401|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64440402|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440403|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440404|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440405|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64440406|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64440407|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440408|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440409|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64440410|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64440411|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64440412|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
64440413|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64440414|NCT04745689|Carboplatin|carboplatin|mesh-list
64440415|NCT04745689|Etoposide|etoposide|mesh-list
64440416|NCT04745689|Durvalumab|durvalumab|mesh-list
64440417|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440418|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64440419|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64440420|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64440421|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440422|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440423|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440424|NCT02308124|Midodrine|midodrine|mesh-list
64440425|NCT02308124|Bromides|bromides|mesh-list
64440426|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
64440427|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
64440428|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
64440429|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
64440430|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440431|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440432|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64440446|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
64440447|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440448|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
64440449|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
64440450|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64440451|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
64440452|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440453|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440455|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
64440456|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
64440457|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64440458|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440476|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
64440477|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440478|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440479|NCT02230891|Carvedilol|carvedilol|mesh-list
64440481|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64440482|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
64440483|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440484|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440485|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64440486|NCT02230891|Diuretics|diuretics|mesh-ancestor
64440487|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
64440488|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64440489|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64440506|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440508|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64440509|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440510|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440511|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440512|NCT02274311|Clomiphene|clomiphene|mesh-list
64440513|NCT02274311|Enclomiphene|enclomiphene|mesh-list
64440514|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
64440515|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64440516|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
64440536|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
64440537|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
64440538|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
64440539|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440540|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440541|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64440543|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440544|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64440545|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64440546|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440547|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440550|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440551|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440552|NCT04876430|Meropenem|meropenem|mesh-list
64440553|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440554|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440555|NCT02305238|Aflibercept|aflibercept|mesh-list
64440556|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64440557|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64440558|NCT02305238|Growth Substances|growth substances|mesh-ancestor
64440559|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440560|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
64440561|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440586|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440587|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440588|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
64440589|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
64440590|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
64440591|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64440592|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64440593|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440594|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440595|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440596|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440597|NCT01642277|Urological Agents|urological agents|mesh-ancestor
64440598|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
64440599|NCT02230189|Miotics|miotics|mesh-ancestor
64440600|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
64440601|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440602|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440603|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64440604|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
64440605|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
64440607|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64440608|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440609|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440610|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440611|NCT02304302|Memantine|memantine|mesh-list
64440612|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64440613|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64440614|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
64440615|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440616|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440617|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440618|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64440619|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64440620|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64440621|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64440622|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64440623|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
64440624|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440625|NCT02301143|Gemcitabine|gemcitabine|mesh-list
64440626|NCT02301143|Paclitaxel|paclitaxel|mesh-list
64440627|NCT02301143|Capecitabine|capecitabine|mesh-list
64440628|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64440629|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440630|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
64440631|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
64440655|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64440656|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64440658|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64440659|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
64440660|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440661|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440662|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64440663|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
64440664|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
64440665|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64440685|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440686|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440687|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64440688|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440689|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64440690|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440691|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440692|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64440693|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
64440694|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64440695|NCT04883528|Valsartan|valsartan|mesh-list
64440696|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64440708|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64440709|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440710|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64440711|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440712|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
64440713|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440714|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
64440715|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440716|NCT01750918|Fluorouracil|fluorouracil|mesh-list
64440717|NCT01750918|Panitumumab|panitumumab|mesh-list
64440718|NCT01750918|Trametinib|trametinib|mesh-list
64440719|NCT01750918|Dabrafenib|dabrafenib|mesh-list
64440720|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
64440721|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440722|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64440723|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440724|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64440726|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440727|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440728|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64440729|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440730|NCT01750840|Cimetidine|cimetidine|mesh-list
64440731|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64440732|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440733|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64440734|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
64440735|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
64440736|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440737|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440738|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440739|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64440740|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64440741|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440742|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
64440743|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64440744|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64440745|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64440746|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440747|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64440748|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64440749|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64440750|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
64440751|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440752|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440756|NCT02269943|Azacitidine|azacitidine|mesh-list
64440758|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64440759|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
64440760|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440761|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440762|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440763|NCT01605370|Metoprolol|metoprolol|mesh-list
64440764|NCT01605370|Nebivolol|nebivolol|mesh-list
64440765|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64440783|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
64440784|NCT01706146|Apixaban|apixaban|mesh-list
64440785|NCT01706146|Dabigatran|dabigatran|mesh-list
64440786|NCT01706146|Anticoagulants|anticoagulants|mesh-list
64440787|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64440788|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
64440789|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64440790|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
64440802|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64440804|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
64440805|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440806|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64440807|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64440808|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440809|NCT01749982|Choline|choline|mesh-list
64440810|NCT01749982|Betaine|betaine|mesh-list
64440811|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
64440812|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64440813|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
64440814|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440815|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440816|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64440817|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
64440818|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
64440819|NCT02269163|Antibodies|antibodies|mesh-list
64440820|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
64440821|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64440822|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64440823|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
64440840|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64440841|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
64440842|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440843|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440844|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64440845|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
64440846|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
64440847|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
64440848|NCT02266433|Dexamethasone|dexamethasone|mesh-list
64440850|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64440851|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
64440852|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
64440853|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440860|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440861|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64440862|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64440863|NCT02266433|Analgesics|analgesics|mesh-ancestor
64440864|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
64440865|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440866|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64440867|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440868|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440869|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
64440870|NCT02273726|Hematinics|hematinics|mesh-ancestor
64440871|NCT01723228|Rasagiline|rasagiline|mesh-list
64440872|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64440873|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440874|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440875|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64440876|NCT01723228|Protective Agents|protective agents|mesh-ancestor
64440911|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440913|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64440914|NCT01703260|Pioglitazone|pioglitazone|mesh-list
64440915|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440916|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440917|NCT02299388|Liraglutide|liraglutide|mesh-list
64440918|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440919|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440920|NCT02299388|Incretins|incretins|mesh-ancestor
64440921|NCT02299388|Hormones|hormones|mesh-ancestor
64440922|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64440923|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
64440924|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
64440925|NCT02202577|Povidone|povidone|mesh-list
64440926|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64440927|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440928|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
64440929|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
64440930|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
64440931|NCT01723072|Omalizumab|omalizumab|mesh-list
64440932|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64440933|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64440934|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64440935|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
64440936|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
64440937|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440938|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64440939|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64440940|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64440941|NCT01909791|Aflibercept|aflibercept|mesh-list
64440942|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64440943|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64440944|NCT01909791|Growth Substances|growth substances|mesh-ancestor
64440951|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
64440952|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64440953|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440954|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440955|NCT02227849|Canagliflozin|canagliflozin|mesh-list
64440956|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64440957|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440958|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64440959|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440972|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64440973|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64440974|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440975|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
64440976|NCT01644188|Ezetimibe|ezetimibe|mesh-list
64440979|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64440980|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
64440981|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64440982|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64440983|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
64440984|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440985|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
64440986|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
64440987|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64440988|NCT02271854|Diclofenac|diclofenac|mesh-list
64440989|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64440990|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64440991|NCT02271854|Analgesics|analgesics|mesh-ancestor
64440992|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
64440993|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64440994|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64440995|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64440996|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64440997|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64440998|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64440999|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441000|NCT02296892|Midazolam|midazolam|mesh-list
64441026|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441027|NCT01927419|Nivolumab|nivolumab|mesh-list
64441028|NCT01927419|Ipilimumab|ipilimumab|mesh-list
64441029|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441030|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441031|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64441032|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441033|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
64441034|NCT02168491|Lixisenatide|lixisenatide|mesh-list
64441035|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441036|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441037|NCT01721746|Paclitaxel|paclitaxel|mesh-list
64441038|NCT01721746|Carboplatin|carboplatin|mesh-list
64441039|NCT01721746|Nivolumab|nivolumab|mesh-list
64441040|NCT01721746|Dacarbazine|dacarbazine|mesh-list
64441041|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64441042|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441043|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
64441044|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
64441045|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
64441046|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441059|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441060|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64441061|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64441062|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
64441063|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441064|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64441065|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
64441066|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441067|NCT02201251|Topiramate|topiramate|mesh-list
64441068|NCT02201251|Levetiracetam|levetiracetam|mesh-list
64441069|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
64441070|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441071|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441072|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
64441073|NCT02296190|Etripamil|etripamil|mesh-list
64441074|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64441075|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64441076|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441077|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64441078|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441079|NCT04875026|Fluorouracil|fluorouracil|mesh-list
64378510|NCT03204929|Copper|copper|mesh-list
64441103|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441104|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64441105|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64441106|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441107|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64441108|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
64441109|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441110|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64441111|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64441120|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64441121|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64441122|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
64441123|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64441126|NCT02225353|Hormones|hormones|mesh-ancestor
64441127|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441128|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441129|NCT01641926|Interferons|interferons|mesh-list
64441130|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
64441152|NCT01927341|Panitumumab|panitumumab|mesh-list
64441153|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441154|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441155|NCT02294474|Insulin|insulin|mesh-list
64441156|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64441157|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
64441158|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
64441159|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441160|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441161|NCT02168101|Ixazomib|ixazomib|mesh-list
64441162|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441163|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
64441164|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441165|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441166|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64441167|NCT01956123|Hormones|hormones|mesh-ancestor
64441168|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441169|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441170|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
64441171|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
64441172|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64441173|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
64441174|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441175|NCT02298179|Antacids|antacids|mesh-ancestor
64441176|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441177|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64441178|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64441179|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
64441180|NCT02298023|Coagulants|coagulants|mesh-ancestor
64441181|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
64441182|NCT02296931|Analgesics|analgesics|mesh-ancestor
64441206|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64441207|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
64441208|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441209|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441210|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64441211|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441212|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64441213|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64441214|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64441215|NCT02196259|Ketamine|ketamine|mesh-list
64441216|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
64441217|NCT02196259|Anesthetics|anesthetics|mesh-list
64441218|NCT02196259|Analgesics|analgesics|mesh-ancestor
64441219|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
64441220|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441221|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441222|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64441223|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
64441224|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441225|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64441226|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64441227|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441228|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441229|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
64441230|NCT02294396|Mirabegron|mirabegron|mesh-list
64441231|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64441232|NCT02294396|Propiverine|propiverine|mesh-list
64441233|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64441234|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64441235|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
64441236|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441237|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441238|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441239|NCT02294396|Urological Agents|urological agents|mesh-ancestor
64441240|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64441241|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64441242|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64441243|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
64441244|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
64441245|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
64441268|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64441269|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441270|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441271|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64441272|NCT02263547|Teriflunomide|teriflunomide|mesh-list
64441273|NCT02263547|Colestipol|colestipol|mesh-list
64441274|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64441275|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64441276|NCT02263547|Analgesics|analgesics|mesh-ancestor
64441277|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
64441278|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441279|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441280|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441281|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441282|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441283|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
64441284|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64441285|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
64441286|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441287|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64441288|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
64441289|NCT04620759|Psilocybin|psilocybin|mesh-list
64441290|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
64441291|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
64441292|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441293|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64441294|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64441295|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
64441296|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441297|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441298|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64441299|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
64441300|NCT01925703|Hematinics|hematinics|mesh-ancestor
64441301|NCT01617681|Valsartan|valsartan|mesh-list
64441302|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64441303|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64441304|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64441305|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441306|NCT02263079|Interferons|interferons|mesh-list
64441307|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
64441308|NCT02263079|Lamivudine|lamivudine|mesh-list
64441309|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
64441310|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64441311|NCT02263079|Entecavir|entecavir|mesh-list
64441312|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441313|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
64379309|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
64441338|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441339|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64441340|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64441341|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441342|NCT02257385|Albuterol|albuterol|mesh-list
64441343|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
64441344|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64441345|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
64441346|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441347|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441348|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64441349|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
64441350|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
64441351|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64441352|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
64441353|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441354|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441355|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
64441356|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64441357|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64441358|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64441359|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64441360|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
64441361|NCT05647265|Nivolumab|nivolumab|mesh-list
64441362|NCT05647265|Ipilimumab|ipilimumab|mesh-list
64441363|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441364|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441365|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64441366|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441367|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64441368|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
64441369|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441370|NCT01645280|Methotrexate|methotrexate|mesh-list
64441371|NCT01645280|Ustekinumab|ustekinumab|mesh-list
64441372|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64441382|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64441383|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441384|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
64441385|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441386|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64441387|NCT01629589|Vaccines|vaccines|mesh-list
64441395|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441397|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441398|NCT01601873|Heparin|heparin|mesh-list
64441399|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
64441400|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64441401|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64441402|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441403|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
64441404|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
64441405|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441406|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441407|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441408|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
64441409|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
64441410|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
64441411|NCT04420247|Chloroquine|chloroquine|mesh-list
64441412|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
64441413|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64441414|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64441415|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441416|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441417|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441418|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441419|NCT04420247|Amebicides|amebicides|mesh-ancestor
64441421|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64441422|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441423|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
64441424|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
64441425|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
64441426|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441427|NCT04865237|Remdesivir|remdesivir|mesh-list
64441428|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
64441429|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441430|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
64441431|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441432|NCT01628965|Rotigotine|rotigotine|mesh-list
64441433|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
64441434|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
64441435|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441436|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441437|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441438|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
64441439|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64441440|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
64441441|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441450|NCT02255279|Vaccines|vaccines|mesh-list
64441451|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
64441452|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441453|NCT04865159|Tipifarnib|tipifarnib|mesh-list
64441454|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441455|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64441456|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64441464|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64441465|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441466|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441467|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64441468|NCT02266706|Renal Agents|renal agents|mesh-ancestor
64441469|NCT02292719|Ritonavir|ritonavir|mesh-list
64441470|NCT02292719|Ribavirin|ribavirin|mesh-list
64441471|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
64441472|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64441473|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64441474|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
64441475|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441476|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441477|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64441478|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64441479|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
64441480|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441481|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64441482|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64441483|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
64441484|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
64441485|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441486|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
64441487|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64441488|NCT02264990|Paclitaxel|paclitaxel|mesh-list
64441489|NCT02264990|Carboplatin|carboplatin|mesh-list
64441490|NCT02264990|Pemetrexed|pemetrexed|mesh-list
64441491|NCT02264990|Veliparib|veliparib|mesh-list
64441492|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64441493|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441494|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
64441495|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
64441496|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
64441497|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441498|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441499|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64441500|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64441501|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64441502|NCT02289833|Trastuzumab|trastuzumab|mesh-list
64441503|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64441504|NCT02289833|Maytansine|maytansine|mesh-list
64441505|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441506|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441507|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64441508|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
64441509|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
64441515|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64441516|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64441517|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
64441518|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441519|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441520|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441521|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64441522|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
64441523|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
64441524|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
64441525|NCT05650775|Methylphenidate|methylphenidate|mesh-list
64441527|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64441528|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441529|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64441530|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64441531|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64441545|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
64441546|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441547|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441548|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64441550|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
64441551|NCT02194465|Hormones|hormones|mesh-ancestor
64441552|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64441553|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441554|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441555|NCT01720264|Incretins|incretins|mesh-ancestor
64441556|NCT01720264|Hormones|hormones|mesh-ancestor
64441557|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441558|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64441559|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
64441560|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441561|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441562|NCT04564846|Insulin|insulin|mesh-list
64441563|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441564|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441565|NCT01702246|Simvastatin|simvastatin|mesh-list
64441566|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64441567|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64441568|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
64441569|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441570|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64441571|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64441572|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441573|NCT01631227|Eprosartan|eprosartan|mesh-list
64441574|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64441575|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
64441576|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64441601|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64441602|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379310|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
64441618|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441619|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64441620|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
64441621|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64441622|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64441623|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64441624|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441626|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64441627|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441644|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441645|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
64441646|NCT02287610|Hormones|hormones|mesh-ancestor
64441647|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441648|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441649|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64441650|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441651|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
64441652|NCT02262728|Simeprevir|simeprevir|mesh-list
64441653|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
64441654|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441655|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
64441656|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441657|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441658|NCT01717768|Testosterone|testosterone|mesh-list
64441659|NCT01717768|Androgens|androgens|mesh-ancestor
64441660|NCT01717768|Hormones|hormones|mesh-ancestor
64441661|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441662|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441663|NCT02260934|Acetaminophen|acetaminophen|mesh-list
64441664|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
64441665|NCT02260934|Promethazine|promethazine|mesh-list
64441666|NCT02260934|Prednisone|prednisone|mesh-list
64441667|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
64441672|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
64441673|NCT02260934|Rituximab|rituximab|mesh-list
64441674|NCT02260934|Belimumab|belimumab|mesh-list
64441675|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64441676|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
64441677|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441678|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
64441679|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441680|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441681|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64441682|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
64441683|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441684|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441685|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64441686|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441690|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441692|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64441693|NCT02260934|Analgesics|analgesics|mesh-ancestor
64441694|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
64441695|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441696|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
64441697|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
64441698|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
64441699|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64441700|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64441701|NCT02260934|Protective Agents|protective agents|mesh-ancestor
64441702|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64441703|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64441704|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441705|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
64441706|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
64441707|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64441708|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
64441709|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
64441710|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441711|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64441712|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
64441713|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
64441714|NCT02260388|Mexiletine|mexiletine|mesh-list
64441718|NCT02260388|Analgesics|analgesics|mesh-ancestor
64441719|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
64441720|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441721|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441722|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
64441723|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64441724|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64441725|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441726|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64441727|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64441744|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
64441745|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
64441746|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
64441747|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441748|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441749|NCT01643408|Asparaginase|asparaginase|mesh-list
64441750|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441751|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
64441752|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64441753|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64441754|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64441755|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64441756|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64441757|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441758|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441776|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441777|NCT01717456|Loperamide|loperamide|mesh-list
64441778|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
64441779|NCT01717456|Laxatives|laxatives|mesh-list
64441780|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64441781|NCT01716754|Omalizumab|omalizumab|mesh-list
64441782|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64441783|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64441784|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
64441785|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64441786|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64441787|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64441788|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64441789|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64441790|NCT01698814|Analgesics|analgesics|mesh-ancestor
64441791|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
64441792|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441793|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441795|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441796|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64441797|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64441810|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64441811|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441812|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64441813|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
64441841|NCT01644500|Dulaglutide|dulaglutide|mesh-list
64441842|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64441843|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64441844|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441845|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64441846|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
64441847|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
64441848|NCT04877834|Lansoprazole|lansoprazole|mesh-list
64441849|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64441850|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64441851|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64441852|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441889|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
64441890|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64441891|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64441892|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64441893|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64441894|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
64441895|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64441896|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441898|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441899|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441900|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
64441901|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441902|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441903|NCT04863716|Fentanyl|fentanyl|mesh-list
64441904|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64441905|NCT04863716|Narcotics|narcotics|mesh-ancestor
64441906|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441907|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441908|NCT04863716|Analgesics|analgesics|mesh-ancestor
64441909|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
64441910|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441924|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441925|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441927|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441928|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441929|NCT05642702|Vitamins|vitamins|mesh-list
64441930|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
64441931|NCT05642702|Niacinamide|niacinamide|mesh-list
64441932|NCT05642702|Niacin|niacin|mesh-list
64441933|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
64441934|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64441935|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
64441936|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441937|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
64441938|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441942|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
64441943|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64441944|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
64441945|NCT05544734|Acetaminophen|acetaminophen|mesh-list
64441946|NCT05544734|Ibuprofen|ibuprofen|mesh-list
64441947|NCT05544734|Hydrocodone|hydrocodone|mesh-list
64441948|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64441949|NCT05544734|Analgesics|analgesics|mesh-ancestor
64441950|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
64441951|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441952|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441953|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
64441954|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64441955|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441956|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64441957|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64441958|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64441959|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441960|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64441961|NCT05544734|Narcotics|narcotics|mesh-ancestor
64441962|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64441963|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
64441964|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
64441965|NCT02254772|Ipilimumab|ipilimumab|mesh-list
64441966|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441967|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441968|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64441969|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64441970|NCT01682044|Rituximab|rituximab|mesh-list
64441971|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64441972|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64441973|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
64441974|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64441991|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64441993|NCT01696942|Analgesics|analgesics|mesh-ancestor
64441994|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
64441995|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64441996|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64441997|NCT05493566|Aldesleukin|aldesleukin|mesh-list
64441998|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
64441999|NCT05493566|Interleukin-2|interleukin-2|mesh-list
64442000|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442001|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442002|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442003|NCT05493566|Analgesics|analgesics|mesh-ancestor
64442004|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
64442005|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442006|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442007|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64442008|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64442009|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
64442010|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442011|NCT04871594|Nivolumab|nivolumab|mesh-list
64442012|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442013|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442014|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64442015|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442016|NCT04871204|Octreotide|octreotide|mesh-list
64442017|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442018|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442019|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442021|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
64442022|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
64442023|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
64442024|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442025|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442026|NCT05615948|Ketamine|ketamine|mesh-list
64442027|NCT05615948|Analgesics|analgesics|mesh-ancestor
64442028|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
64442029|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442057|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64442058|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64442059|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
64442060|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442061|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442062|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64442063|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442064|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64442065|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64442066|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64442067|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442068|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442069|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
64442072|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442073|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64442074|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
64442075|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
64442076|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
64442077|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64442078|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64442079|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
64442080|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442081|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64442082|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64442084|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
64442085|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
64442086|NCT04834310|Cefazolin|cefazolin|mesh-list
64442087|NCT04834310|Cephalexin|cephalexin|mesh-list
64442088|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64442089|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442090|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64442091|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442092|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442093|NCT04848116|Nivolumab|nivolumab|mesh-list
64442125|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442126|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64442127|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
64442128|NCT05031494|Antiviral Agents|antiviral agents|mesh-ancestor
64442129|NCT05031494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442130|NCT05031494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442131|NCT05031494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442132|NCT05031494|Immunologic Factors|immunologic factors|mesh-ancestor
64442133|NCT05031494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442135|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
64442136|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
64442137|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
64442138|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442139|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442140|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
64442141|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442142|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64442143|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64442144|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64442145|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442146|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442147|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64442148|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
64442149|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
64442150|NCT04844216|Protective Agents|protective agents|mesh-ancestor
64442151|NCT05345678|Durvalumab|durvalumab|mesh-list
64442152|NCT05345678|Tremelimumab|tremelimumab|mesh-list
64442194|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
64442195|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442196|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442197|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64442198|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64442199|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64442200|NCT04589546|Niacinamide|niacinamide|mesh-list
64442201|NCT04589546|Niacin|niacin|mesh-list
64442202|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
64442214|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
64442216|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442217|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442218|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
64442219|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442220|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64442221|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442222|NCT05369468|Analgesics|analgesics|mesh-ancestor
64442223|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64442224|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64442225|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64442226|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
64442227|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442228|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442230|NCT02164513|Xhance|xhance|mesh-list
64442231|NCT02164513|Bromides|bromides|mesh-list
64442232|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442233|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64442234|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
64442235|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442236|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442237|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442238|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442239|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
64442240|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64442241|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
64442242|NCT04562246|Antibodies|antibodies|mesh-list
64442243|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
64442244|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442245|NCT04532372|Leflunomide|leflunomide|mesh-list
64442257|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64442258|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
64442260|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442261|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64442262|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64442263|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442264|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442265|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
64442266|NCT05341154|Ketamine|ketamine|mesh-list
64442267|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64442273|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442274|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64442275|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64442276|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64442277|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
64442278|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442279|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442280|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64442281|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64442282|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
64442283|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
64442284|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64442285|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64442286|NCT04513184|Dexamethasone|dexamethasone|mesh-list
64442287|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
64442288|NCT04513184|BB 1101|bb 1101|mesh-list
64442289|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442290|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
64442291|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
64442292|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442313|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64442314|NCT04464512|Narcotics|narcotics|mesh-ancestor
64442315|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442316|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442317|NCT04464512|Analgesics|analgesics|mesh-ancestor
64442318|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
64442319|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442320|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64442321|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64442322|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64442323|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
64442324|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
64442325|NCT05369234|Sucralfate|sucralfate|mesh-list
64442326|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64442327|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442328|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
64442329|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64442330|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
64442359|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64442360|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442362|NCT02191579|Topiramate|topiramate|mesh-list
64442363|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
64442364|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64442365|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64442366|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64442367|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442386|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64442387|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442388|NCT01363700|Analgesics|analgesics|mesh-ancestor
64442389|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
64442390|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442391|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442392|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442393|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64442394|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64442418|NCT04838288|Tacrolimus|tacrolimus|mesh-list
64442419|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442420|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
64442421|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442422|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64442423|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442424|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442425|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
64442426|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64442427|NCT04327934|Testosterone|testosterone|mesh-list
64442428|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
64442429|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
64442430|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64442431|NCT04327934|Hormones|hormones|mesh-ancestor
64442432|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442433|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442434|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442435|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442436|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
64442437|NCT04327934|Androgens|androgens|mesh-ancestor
64442438|NCT04791566|Dexamethasone|dexamethasone|mesh-list
64442439|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442440|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
64442441|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
64442442|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442443|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442444|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64442445|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
64442446|NCT04791566|Hormones|hormones|mesh-ancestor
64442447|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442448|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64442449|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442450|NCT04307576|Dexamethasone|dexamethasone|mesh-list
64442451|NCT04307576|Doxorubicin|doxorubicin|mesh-list
64442452|NCT04307576|Vincristine|vincristine|mesh-list
64442453|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
64442469|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64442470|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64442471|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442472|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442473|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64442474|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
64442475|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
64442476|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
64442477|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64442478|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442479|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64442480|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
64442481|NCT04129736|Teriflunomide|teriflunomide|mesh-list
64442482|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64442483|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442484|NCT04129736|Analgesics|analgesics|mesh-ancestor
64442485|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
64442486|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442487|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442488|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442489|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64442490|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64442491|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
64442493|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
64442494|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442495|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
64442496|NCT01637402|Hormones|hormones|mesh-ancestor
64442497|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442509|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442510|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
64442511|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442512|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64442527|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442529|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64442530|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64442531|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442532|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64442533|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
64442534|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64442535|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64442536|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442537|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
64442538|NCT04818866|Coagulants|coagulants|mesh-ancestor
64442539|NCT02189941|Deferiprone|deferiprone|mesh-list
64442540|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64442541|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
64442542|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
64442543|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442544|NCT01601132|Colchicine|colchicine|mesh-list
64442545|NCT01601132|Theophylline|theophylline|mesh-list
64442546|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
64442547|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64442548|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
64442549|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
64442550|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
64442551|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442552|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442553|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64442555|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442556|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442557|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442558|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442559|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64442560|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442561|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
64442562|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64442563|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64442564|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
64442565|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442566|NCT04207190|Talazoparib|talazoparib|mesh-list
64442567|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
64442568|NCT04207190|Calicheamicins|calicheamicins|mesh-list
64442569|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64442570|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442571|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442605|NCT04809038|Analgesics|analgesics|mesh-ancestor
64442606|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
64442607|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442608|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442609|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
64442610|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442611|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64442612|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
64442613|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64442614|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442615|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442616|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64442617|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
64442618|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64442619|NCT05221190|Lidocaine|lidocaine|mesh-list
64442620|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
64442621|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
64442622|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442623|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442624|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
64442625|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442626|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64442627|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64442628|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64442629|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442630|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442632|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
64442643|NCT04808882|Tinzaparin|tinzaparin|mesh-list
64442657|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
64442658|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442659|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442660|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442661|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442662|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64442663|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64442664|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64442665|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
64442666|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442667|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442669|NCT04794842|Tetracaine|tetracaine|mesh-list
64442670|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
64442671|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
64442672|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64442673|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442674|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
64442675|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442676|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64442677|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442678|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
64442679|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64442680|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64442681|NCT03029000|Lenograstim|lenograstim|mesh-list
64442682|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64442683|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
64442684|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442685|NCT03783182|Betamethasone|betamethasone|mesh-list
64367572|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442686|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
64442687|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64442688|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
64442689|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64442690|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
64442691|NCT03783182|Hormones|hormones|mesh-ancestor
64442692|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442693|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442694|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442695|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442696|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442725|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442727|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64442728|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
64442729|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64442730|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64442732|NCT02160145|Tolvaptan|tolvaptan|mesh-list
64442733|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64442734|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442735|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
64442773|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
64442774|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64442775|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64442776|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64442786|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64442787|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64442788|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
64442789|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442790|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64442791|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64442792|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442793|NCT04192136|Niacinamide|niacinamide|mesh-list
64442795|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
64442796|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
64442797|NCT04192136|Vitamins|vitamins|mesh-ancestor
64442798|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
64442799|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442800|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64442801|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
64442802|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442804|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
64442805|NCT02214121|Ticagrelor|ticagrelor|mesh-list
64442806|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64442807|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64442808|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64442809|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64442810|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
64442811|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442832|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442833|NCT01636934|Minocycline|minocycline|mesh-list
64442834|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64442835|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442836|NCT01712854|Budesonide|budesonide|mesh-list
64442837|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64442838|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442839|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64442840|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
64442841|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442842|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442843|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442844|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442845|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
64442846|NCT01712854|Hormones|hormones|mesh-ancestor
64442847|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64442848|NCT02986594|Aspirin|aspirin|mesh-list
64442849|NCT02986594|Heparin|heparin|mesh-list
64442850|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64442851|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64442852|NCT02986594|Analgesics|analgesics|mesh-ancestor
64442853|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
64442854|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442855|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442856|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442857|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64442858|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64442859|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64442860|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442861|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64442901|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64442902|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
64442903|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442904|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64442905|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64442906|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64442907|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
64442908|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442910|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442911|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
64442912|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442913|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442914|NCT02158039|Ethanol|ethanol|mesh-list
64442915|NCT02158039|Lidocaine|lidocaine|mesh-list
64442928|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64442929|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64442931|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64442932|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64442933|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64442934|NCT04803734|Albuterol|albuterol|mesh-list
64442935|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64442936|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
64442937|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442938|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442939|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442954|NCT04802408|Protective Agents|protective agents|mesh-ancestor
64442955|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442957|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64442958|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64442959|NCT03341078|Ibudilast|ibudilast|mesh-list
64442960|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64442961|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
64442962|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64442963|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442964|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64442965|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
64442966|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64442967|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442968|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442969|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64442970|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
64442971|NCT04810598|Venetoclax|venetoclax|mesh-list
64442972|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442973|NCT04511078|Panitumumab|panitumumab|mesh-list
64442974|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64442975|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64442987|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64442988|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64442989|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64442990|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
64442991|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64442992|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64442993|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
64442994|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64442995|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64442996|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64442997|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64442998|NCT05351684|Dolutegravir|dolutegravir|mesh-list
64442999|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64443016|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64443017|NCT04787744|Flutamide|flutamide|mesh-list
64443018|NCT04787744|Nilutamide|nilutamide|mesh-list
64443019|NCT04787744|Relugolix|relugolix|mesh-list
64443020|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443021|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
64443022|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
64443023|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
64443024|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443025|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443026|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
64443027|NCT04787744|Hormones|hormones|mesh-ancestor
64443028|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443029|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443030|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64443031|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
64443032|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
64443033|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443034|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443035|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64443036|NCT04787744|Protective Agents|protective agents|mesh-ancestor
64443037|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64443038|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
64443039|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64443040|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
64443054|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64443055|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64443056|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443057|NCT04274894|Testosterone|testosterone|mesh-list
64443058|NCT04274894|Androgens|androgens|mesh-ancestor
64443059|NCT04274894|Hormones|hormones|mesh-ancestor
64443060|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443061|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443062|NCT04786964|Folic Acid|folic acid|mesh-list
64443093|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
64443094|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
64443095|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
64443096|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443097|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443098|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
64443099|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443100|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64443101|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443102|NCT02213263|Rituximab|rituximab|mesh-list
64443127|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
64443128|NCT05168930|Venetoclax|venetoclax|mesh-list
64443129|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
64443130|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443131|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443132|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443133|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443134|NCT01975064|Propofol|propofol|mesh-list
64443135|NCT01975064|Sevoflurane|sevoflurane|mesh-list
64443136|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64443137|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443138|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443139|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64443140|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
64443141|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
64443142|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64443143|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64443144|NCT04062266|Azacitidine|azacitidine|mesh-list
64443145|NCT04062266|Venetoclax|venetoclax|mesh-list
64443146|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443147|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
64443148|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443149|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443150|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443152|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
64443153|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
64443154|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443155|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443156|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64443157|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443158|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443160|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64443161|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
64443165|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64443166|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443167|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
64443187|NCT01469156|Growth Substances|growth substances|mesh-ancestor
64443188|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443189|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
64443190|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443191|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
64443192|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443193|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443194|NCT04191434|Budesonide|budesonide|mesh-list
64443195|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
64443196|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64443197|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443198|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64443199|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
64443200|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443201|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443202|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64443203|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64443204|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
64443206|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443207|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64443208|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64443209|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64443210|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64443211|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443212|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443213|NCT03835676|Treprostinil|treprostinil|mesh-list
64443214|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64443215|NCT03752684|Calcium|calcium|mesh-list
64443216|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64443217|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443218|NCT03651128|Dexamethasone|dexamethasone|mesh-list
64443219|NCT03651128|Lenalidomide|lenalidomide|mesh-list
64443220|NCT03651128|Bortezomib|bortezomib|mesh-list
64443221|NCT03651128|Daratumumab|daratumumab|mesh-list
64443222|NCT03651128|Pomalidomide|pomalidomide|mesh-list
64443223|NCT03651128|Ixazomib|ixazomib|mesh-list
64443224|NCT03651128|Elotuzumab|elotuzumab|mesh-list
64443260|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64443262|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64443263|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443264|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443266|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443267|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443268|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
64443269|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443270|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64443271|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443272|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
64443293|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443294|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443295|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
64443296|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443297|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
64443298|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443302|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
64443303|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443304|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64443306|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
64443307|NCT02246660|Resveratrol|resveratrol|mesh-list
64443308|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
64443309|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443310|NCT02246660|Protective Agents|protective agents|mesh-ancestor
64443311|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443312|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443313|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64443314|NCT03471260|Azacitidine|azacitidine|mesh-list
64443316|NCT03471260|Ivosidenib|ivosidenib|mesh-list
64443317|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443318|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
64443319|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443320|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443321|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443323|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64443324|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443325|NCT02137369|Dexetimide|dexetimide|mesh-list
64443352|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443353|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443354|NCT02155309|Scopolamine|scopolamine|mesh-list
64443355|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64443356|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64443357|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
64443358|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
64443359|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443360|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443361|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443362|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
64443363|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64443364|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
64443365|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443396|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443398|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
64443399|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443400|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64443401|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443403|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443404|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443405|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443406|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443407|NCT01691482|Albuterol|albuterol|mesh-list
64443408|NCT01691482|Ipratropium|ipratropium|mesh-list
64443409|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64443410|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
64443411|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443412|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443413|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64443414|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
64443415|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
64443416|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64443417|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64443418|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64443419|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64443420|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
64443421|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443448|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64443449|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64443450|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64443451|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443452|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443463|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443464|NCT01953783|Ixazomib|ixazomib|mesh-list
64443465|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443466|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
64443467|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443468|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443469|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64443470|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443497|NCT01691092|Analgesics|analgesics|mesh-ancestor
64443498|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
64443499|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443500|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443501|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64443502|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64443503|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
64443504|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
64443505|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443506|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64443507|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64443508|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443509|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443510|NCT02133001|Esketamine|esketamine|mesh-list
64443511|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
64443512|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64443513|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
64443514|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
64443515|NCT01709578|Methotrexate|methotrexate|mesh-list
64443516|NCT01709578|Leflunomide|leflunomide|mesh-list
64443517|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64443518|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
64443539|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
64443540|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443542|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443544|NCT02132767|Amiodarone|amiodarone|mesh-list
64443545|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
64443546|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64443547|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443548|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64443549|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64443550|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443551|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443552|NCT02132767|Protective Agents|protective agents|mesh-ancestor
64443553|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
64443554|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64443555|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64443556|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64443557|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64443558|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64443559|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64443560|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64443561|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64443562|NCT02153905|Aldesleukin|aldesleukin|mesh-list
64443563|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
64443564|NCT02153905|Fludarabine|fludarabine|mesh-list
64443565|NCT02153905|Interleukin-2|interleukin-2|mesh-list
64443566|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443567|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
64443607|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64443608|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64443609|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64443627|NCT01599806|Ceftazidime|ceftazidime|mesh-list
64443628|NCT01599806|Avibactam|avibactam|mesh-list
64443630|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64443632|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
64443633|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443634|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443635|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64443636|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64443637|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443638|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443639|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443640|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64443641|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64443642|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64443643|NCT01599806|Renal Agents|renal agents|mesh-ancestor
64443644|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
64443645|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64443646|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64443647|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64443648|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64443649|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64443650|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64443651|NCT01599325|Azacitidine|azacitidine|mesh-list
64443652|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64443653|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
64443654|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443655|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443656|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443657|NCT01924299|Fluconazole|fluconazole|mesh-list
64443658|NCT01924299|Ketoconazole|ketoconazole|mesh-list
64443659|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
64443660|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443661|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64443662|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64443663|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443664|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443676|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443677|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
64443678|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443680|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443681|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443682|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
64443683|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64443684|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64443685|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443686|NCT02978222|Molgramostim|molgramostim|mesh-list
64443687|NCT02978222|Sargramostim|sargramostim|mesh-list
64443688|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
64443689|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443690|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443691|NCT02181673|Golimumab|golimumab|mesh-list
64443692|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64443693|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64443694|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64443695|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
64443696|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443697|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
64443710|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
64443711|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
64443712|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443713|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443714|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
64443715|NCT02152345|Hormones|hormones|mesh-ancestor
64443716|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64443717|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64443718|NCT02152345|Protective Agents|protective agents|mesh-ancestor
64443719|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64443720|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64443721|NCT02180659|Buprenorphine|buprenorphine|mesh-list
64443722|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64443723|NCT02180659|Narcotics|narcotics|mesh-ancestor
64443724|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443748|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443749|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443750|NCT01709110|Vitamin D|vitamin d|mesh-list
64443753|NCT01709110|Calcium|calcium|mesh-list
64443754|NCT01709110|Vitamins|vitamins|mesh-ancestor
64443755|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
64443756|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443757|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64443758|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64443759|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64443760|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64443761|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443762|NCT02240108|Rifaximin|rifaximin|mesh-list
64443763|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443764|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443765|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64443766|NCT01590082|Doxycycline|doxycycline|mesh-list
64443767|NCT01590082|Temozolomide|temozolomide|mesh-list
64443768|NCT01590082|Ipilimumab|ipilimumab|mesh-list
64443769|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64443770|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
64443771|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443772|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443773|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443774|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64443775|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64443776|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64443790|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443791|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
64443792|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64443793|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64443794|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64443795|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443796|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443797|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64443798|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64443799|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64443800|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64443801|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
64443809|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
64443810|NCT02129647|Axitinib|axitinib|mesh-list
64443811|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443812|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64443813|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443814|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443816|NCT02238626|Riluzole|riluzole|mesh-list
64443817|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
64443818|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64443819|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64443820|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443821|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443822|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443823|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64443824|NCT02238626|Protective Agents|protective agents|mesh-ancestor
64443825|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64443826|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
64443827|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443828|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64443829|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
64443830|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64443831|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443832|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64443833|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
64443834|NCT02151643|Iron|iron|mesh-list
64443835|NCT02151643|Trace Elements|trace elements|mesh-ancestor
64443836|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
64443837|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443842|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443844|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64443845|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64443846|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64443847|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64443848|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64443849|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
64443850|NCT02178709|Leucovorin|leucovorin|mesh-list
64443851|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
64443852|NCT02178709|Irinotecan|irinotecan|mesh-list
64443853|NCT02178709|Folfirinox|folfirinox|mesh-list
64443854|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443856|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64443857|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443858|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443859|NCT02178709|Antidotes|antidotes|mesh-ancestor
64443860|NCT02178709|Protective Agents|protective agents|mesh-ancestor
64443861|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443862|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
64443863|NCT02178709|Vitamins|vitamins|mesh-ancestor
64443864|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
64443865|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
64443866|NCT02238080|Hematinics|hematinics|mesh-ancestor
64443867|NCT02178553|Bupivacaine|bupivacaine|mesh-list
64443868|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
64443892|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
64443893|NCT01627249|Bevacizumab|bevacizumab|mesh-list
64443894|NCT01627249|Ranibizumab|ranibizumab|mesh-list
64443895|NCT01627249|Aflibercept|aflibercept|mesh-list
64443896|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64443897|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64443898|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64443899|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64443900|NCT01627249|Growth Substances|growth substances|mesh-ancestor
64443901|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443902|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
64443903|NCT01688830|Dabigatran|dabigatran|mesh-list
64443905|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64443906|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
64443907|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64443908|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443909|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
64443910|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
64443911|NCT01604278|Bromides|bromides|mesh-list
64443912|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
64443916|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
64443917|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443918|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443919|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443944|NCT01588990|Antidotes|antidotes|mesh-ancestor
64443945|NCT01588990|Protective Agents|protective agents|mesh-ancestor
64443946|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
64443947|NCT01588990|Vitamins|vitamins|mesh-ancestor
64443948|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
64443949|NCT02126839|Albuterol|albuterol|mesh-list
64443950|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64443951|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
64443952|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64443953|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443954|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64443955|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
64443956|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
64443957|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64443958|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64443959|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64443960|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64443961|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
64443962|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64443963|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443964|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
64443965|NCT04747795|Vitamins|vitamins|mesh-ancestor
64443966|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
64443967|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64443968|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
64443969|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64443970|NCT04747795|Protective Agents|protective agents|mesh-ancestor
64443971|NCT02125279|Calcitriol|calcitriol|mesh-list
64443972|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64443999|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64444000|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
64444001|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64444002|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444003|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64444004|NCT04751929|Atezolizumab|atezolizumab|mesh-list
64444005|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444006|NCT02176291|Buprenorphine|buprenorphine|mesh-list
64444007|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64444008|NCT02176291|Narcotics|narcotics|mesh-ancestor
64444009|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444010|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444011|NCT02176291|Analgesics|analgesics|mesh-ancestor
64444012|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
64444013|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444014|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64444015|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
64444016|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
64444017|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64444018|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64444019|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444020|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
64444021|NCT02175277|Hematinics|hematinics|mesh-ancestor
64444022|NCT01568866|Dexamethasone|dexamethasone|mesh-list
64444023|NCT01568866|Bortezomib|bortezomib|mesh-list
64444024|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64444025|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
64444026|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
64444027|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444028|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444029|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64444030|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
64444031|NCT01568866|Hormones|hormones|mesh-ancestor
64444032|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444033|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444034|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444035|NCT01567852|Ketamine|ketamine|mesh-list
64444036|NCT01567852|Methohexital|methohexital|mesh-list
64444037|NCT01567852|Analgesics|analgesics|mesh-ancestor
64444039|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64444040|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444041|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64444042|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64444043|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
64444044|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
64444045|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64444046|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64444047|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64444109|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64444110|NCT01952145|Insulin|insulin|mesh-list
64444741|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
64444742|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64444743|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64444744|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64444745|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64444746|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64446555|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64446556|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
64446557|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446558|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
64446559|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446560|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446561|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446562|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64446564|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
64447828|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64447829|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448989|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
64448990|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
64448991|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64448992|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64448993|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449847|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450419|NCT02124707|Carboplatin|carboplatin|mesh-list
64450420|NCT02124707|Cetuximab|cetuximab|mesh-list
64450421|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64450422|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450423|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
64450424|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
64450425|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
64450426|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450427|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64450428|NCT04723862|Spironolactone|spironolactone|mesh-list
64451321|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64451322|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
64451323|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
64451345|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451346|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451347|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451348|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451349|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64451350|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451351|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451374|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451375|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
64451376|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451377|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
64451378|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451387|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451388|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64451389|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451390|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451391|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
64451392|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451393|NCT01821729|Antidotes|antidotes|mesh-ancestor
64451394|NCT01821729|Protective Agents|protective agents|mesh-ancestor
64451395|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
64451396|NCT01821729|Vitamins|vitamins|mesh-ancestor
64451397|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
64451398|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64451399|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64451400|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64451401|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64451402|NCT01820637|Paclitaxel|paclitaxel|mesh-list
64451414|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
64451415|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64451417|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64451418|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451419|NCT02171429|Adalimumab|adalimumab|mesh-list
64451420|NCT02171429|Etrolizumab|etrolizumab|mesh-list
64451421|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451422|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64451423|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451424|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
64451425|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451426|NCT01818141|Vancomycin|vancomycin|mesh-list
64451427|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
64451428|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64451429|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451430|NCT01849497|Evolocumab|evolocumab|mesh-list
64451431|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64451432|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64451433|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64451434|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
64451435|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451436|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64451437|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
64451438|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451439|NCT04170465|Metformin|metformin|mesh-list
64451440|NCT04170465|Paclitaxel|paclitaxel|mesh-list
64451441|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
64451443|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64451444|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451445|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
64451446|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
64451447|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
64451448|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451462|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451463|NCT01847313|Liraglutide|liraglutide|mesh-list
64451464|NCT01847313|Glucagon|glucagon|mesh-list
64451465|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64451466|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451467|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451468|NCT01847313|Incretins|incretins|mesh-ancestor
64451469|NCT01847313|Hormones|hormones|mesh-ancestor
64451475|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64451476|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
64451477|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451479|NCT02117687|Protective Agents|protective agents|mesh-ancestor
64451480|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64451481|NCT02117687|Laxatives|laxatives|mesh-ancestor
64451482|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451483|NCT04740593|Methamphetamine|methamphetamine|mesh-list
64451484|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64451485|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451486|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
64451487|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
64451488|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451489|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
64451490|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451491|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451492|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451493|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64451494|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64451495|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64451496|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64451497|NCT02141633|Fluticasone|fluticasone|mesh-list
64451499|NCT02141633|Albuterol|albuterol|mesh-list
64451500|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451501|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64451502|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
64451503|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451504|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451505|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64451506|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
64451507|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
64451508|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64451509|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
64451510|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64451511|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64451816|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64451817|NCT02029417|Cytarabine|cytarabine|mesh-list
64451818|NCT02029417|Decitabine|decitabine|mesh-list
64451819|NCT02029417|Azacitidine|azacitidine|mesh-list
64451820|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
64451821|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64451822|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
64451823|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451824|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451825|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
64451826|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451827|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451828|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
64451829|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451830|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452378|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452379|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452380|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64452381|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
64452996|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452999|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64453000|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64453001|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453002|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
64453112|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453115|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453116|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453117|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453118|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64453119|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
64453121|NCT02098109|Lenograstim|lenograstim|mesh-list
64453122|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64453123|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
64453124|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453125|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64453126|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64453127|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
64453128|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453129|NCT02097719|Timolol|timolol|mesh-list
64453130|NCT02097719|Bimatoprost|bimatoprost|mesh-list
64453131|NCT02097719|Travoprost|travoprost|mesh-list
64453132|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453133|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64453134|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64453135|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
64453136|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453137|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453138|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64453139|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64453140|NCT01449370|Serabelisib|serabelisib|mesh-list
64453141|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453142|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453143|NCT02066129|Fluticasone|fluticasone|mesh-list
64453144|NCT02066129|Xhance|xhance|mesh-list
64453145|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453146|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64453147|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
64338436|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338437|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
64338438|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338439|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
64338440|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338441|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
64338465|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64338466|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64338467|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
64338468|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64338469|NCT02526212|Buprenorphine|buprenorphine|mesh-list
64338470|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64338471|NCT02526212|Narcotics|narcotics|mesh-ancestor
64338472|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338473|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338475|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
64338476|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338477|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64338478|NCT05627843|Curcumin|curcumin|mesh-list
64338479|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64338480|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338481|NCT05627843|Analgesics|analgesics|mesh-ancestor
64338482|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
64338483|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338484|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338485|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338486|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338487|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338488|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338489|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338490|NCT01004081|Exemestane|exemestane|mesh-list
64338491|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338527|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64338528|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
64338529|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338530|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338531|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64338532|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
64338533|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338535|NCT05401214|Prednisolone|prednisolone|mesh-list
64338536|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
64338537|NCT05401214|Niraparib|niraparib|mesh-list
64338538|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338539|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
64338570|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
64338672|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338673|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338674|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338675|NCT02289898|Gemcitabine|gemcitabine|mesh-list
64338676|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64338677|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64338678|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
64338679|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338680|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338681|NCT02289898|Antiviral Agents|antiviral agents|mesh-ancestor
64338682|NCT02289898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338683|NCT02289898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338684|NCT02289898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338717|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64338718|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338719|NCT01659320|Minocycline|minocycline|mesh-list
64338720|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64338721|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338722|NCT05354102|Nivolumab|nivolumab|mesh-list
64338723|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64338724|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338725|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64338726|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338779|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64338780|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64338781|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64338782|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64338783|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338784|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338785|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338786|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
64338787|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64338788|NCT05559008|Azacitidine|azacitidine|mesh-list
64338789|NCT05559008|Apatinib|apatinib|mesh-list
64338790|NCT05559008|Dasatinib|dasatinib|mesh-list
64338791|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64338792|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
64338804|NCT05053425|Venetoclax|venetoclax|mesh-list
64338805|NCT05053425|Idarubicin|idarubicin|mesh-list
64338806|NCT05053425|Cladribine|cladribine|mesh-list
64338807|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64338808|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
64338809|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338810|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338811|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
64338812|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338813|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338814|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
64338815|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338822|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338825|NCT05350124|Vitamin E|vitamin e|mesh-list
64338826|NCT05350124|Tocopherols|tocopherols|mesh-list
64338827|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
64338828|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338829|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
64338830|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338831|NCT05350124|Protective Agents|protective agents|mesh-ancestor
64338832|NCT04940637|Niraparib|niraparib|mesh-list
64338833|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64338834|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338835|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338836|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338837|NCT04925427|Naloxone|naloxone|mesh-list
64338838|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64338839|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338840|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
64338841|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338842|NCT00494234|Olaparib|olaparib|mesh-list
64338843|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64338844|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338845|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338847|NCT05556746|Rifampin|rifampin|mesh-list
64338848|NCT05556746|Clofazimine|clofazimine|mesh-list
64338849|NCT05556746|Isoniazid|isoniazid|mesh-list
64338850|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
64338851|NCT05556746|Ethambutol|ethambutol|mesh-list
64338852|NCT05556746|Bedaquiline|bedaquiline|mesh-list
64338853|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64338854|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
64338855|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64338856|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338857|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
64338881|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338882|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338883|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
64338884|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338885|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338886|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64338887|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64338888|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64338889|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
64338890|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64338891|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64338892|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338893|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
64338894|NCT04803591|Coagulants|coagulants|mesh-ancestor
64338895|NCT05536856|Fluorouracil|fluorouracil|mesh-list
64338896|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
64338897|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338898|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64338899|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338900|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338901|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
64338902|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338903|NCT04735263|Atorvastatin|atorvastatin|mesh-list
64338904|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64338905|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64338906|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
64338921|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
64338922|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64338923|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64338924|NCT04662723|Prednisolone|prednisolone|mesh-list
64338929|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64338930|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
64338931|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338933|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
64338934|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338935|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338936|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338937|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
64338938|NCT04662723|Hormones|hormones|mesh-ancestor
64338939|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64338940|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64338941|NCT04662723|Protective Agents|protective agents|mesh-ancestor
64338942|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64338943|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338944|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338945|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64338946|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64338947|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64338948|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64338949|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64338950|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64338951|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
64338952|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338953|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64338955|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
64338956|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338957|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338958|NCT05307926|Lenvatinib|lenvatinib|mesh-list
64338959|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64338960|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338961|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64338962|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338963|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338964|NCT04026945|Lidocaine|lidocaine|mesh-list
64338965|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
64338966|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
64338967|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338975|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338977|NCT02328729|Racepinephrine|racepinephrine|mesh-list
64338978|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
64338979|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64338980|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64338981|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
64338982|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338983|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338984|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338985|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64338986|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64338987|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
64338988|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338989|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64338990|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
64338991|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
64338992|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
64338993|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64338994|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
64338995|NCT02328963|Everolimus|everolimus|mesh-list
64338996|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338997|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338998|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
64338999|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339000|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64339001|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64339002|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
64339003|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339004|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339005|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339006|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339012|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64339013|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
64339014|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339015|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339016|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64339017|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
64339018|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64339019|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64339020|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339022|NCT03353259|Coagulants|coagulants|mesh-ancestor
64339023|NCT04478721|Meropenem|meropenem|mesh-list
64339024|NCT04478721|Temocillin|temocillin|mesh-list
64339025|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339029|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339030|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
64339031|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339032|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64339052|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339053|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
64339054|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64339055|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64339056|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339057|NCT02287402|Voglibose|voglibose|mesh-list
64339058|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64339059|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339060|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64339061|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339062|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339063|NCT05384756|Sirolimus|sirolimus|mesh-list
64339064|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64339065|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
64339066|NCT05384756|Antibodies|antibodies|mesh-list
64339067|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
64339068|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64339069|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
64339070|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339071|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339072|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339073|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339074|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64339075|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
64339076|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339077|NCT02913495|Progesterone|progesterone|mesh-list
64339078|NCT02913495|Progestins|progestins|mesh-ancestor
64339079|NCT02913495|Hormones|hormones|mesh-ancestor
64339080|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339081|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339082|NCT03111069|Doxorubicin|doxorubicin|mesh-list
64339083|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64339084|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64339085|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339086|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64339087|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64339105|NCT05303792|Vincristine|vincristine|mesh-list
64339106|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
64339107|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
64339108|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339109|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
64339111|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339112|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64339113|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
64339114|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339115|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339116|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64339117|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64339118|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339134|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64339135|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
64339136|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339137|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64339138|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64339139|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
64339140|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339141|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64339142|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
64339143|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
64339144|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
64339145|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64339146|NCT05303792|Protective Agents|protective agents|mesh-ancestor
64339173|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64339176|NCT04022967|Dolutegravir|dolutegravir|mesh-list
64339177|NCT04022967|Efavirenz|efavirenz|mesh-list
64339178|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64339179|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64339180|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
64339181|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339182|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339183|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64339184|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64339185|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
64339186|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339187|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64339188|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64339189|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64339190|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64339191|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64339192|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64339193|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64339194|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64339207|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
64339208|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339209|NCT01646320|Metformin|metformin|mesh-list
64339210|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
64339211|NCT01646320|Saxagliptin|saxagliptin|mesh-list
64339212|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64339213|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339214|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64339215|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339216|NCT01646320|Incretins|incretins|mesh-ancestor
64339226|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339227|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339228|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
64339229|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339230|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64339231|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
64339232|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339233|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339234|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64339235|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64339236|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339237|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64339238|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64339240|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64339241|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339242|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64339243|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339244|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339245|NCT05327426|Vaccines|vaccines|mesh-list
64339246|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
64339247|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339248|NCT05327270|Nivolumab|nivolumab|mesh-list
64339249|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64339250|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339251|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64339252|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339253|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
64339254|NCT05297396|Narcotics|narcotics|mesh-ancestor
64339255|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339256|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339258|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
64339259|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339260|NCT05296304|Bexarotene|bexarotene|mesh-list
64339278|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64339280|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
64339281|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
64339282|NCT05292872|Cathartics|cathartics|mesh-ancestor
64339283|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339284|NCT02035137|Irinotecan|irinotecan|mesh-list
64339285|NCT02035137|Vincristine|vincristine|mesh-list
64339286|NCT02035137|Vorinostat|vorinostat|mesh-list
64339299|NCT05321810|Warfarin|warfarin|mesh-list
64339300|NCT05321810|Apixaban|apixaban|mesh-list
64339301|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
64339302|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64339303|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
64339304|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64339305|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
64339306|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339307|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339308|NCT05264870|Norepinephrine|norepinephrine|mesh-list
64339309|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64339310|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64339311|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339312|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339315|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
64339316|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
64339339|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64339340|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64339341|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64339342|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
64339344|NCT02522780|Mesalamine|mesalamine|mesh-list
64339345|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64339346|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64339347|NCT02522780|Analgesics|analgesics|mesh-ancestor
64339348|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
64339349|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339350|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339351|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339352|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339353|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64339354|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64339355|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64339356|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339357|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339358|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339359|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339360|NCT03618225|Analgesics|analgesics|mesh-ancestor
64339361|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
64339362|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339365|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
64339366|NCT03566199|Panobinostat|panobinostat|mesh-list
64339367|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339398|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64339399|NCT05288348|Narcotics|narcotics|mesh-ancestor
64339400|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339401|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339402|NCT05288348|Analgesics|analgesics|mesh-ancestor
64339403|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
64339404|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339405|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64339406|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64339407|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
64339408|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
64339474|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64339475|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64339476|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339477|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339478|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64339479|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64339480|NCT02951013|Chrysarobin|chrysarobin|mesh-list
64339481|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64339482|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64339483|NCT02951013|Analgesics|analgesics|mesh-ancestor
64339484|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
64339485|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339486|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339506|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
64339507|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339508|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339509|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64339510|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
64339511|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339512|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339513|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64339514|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64339515|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64339516|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64339517|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64339518|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339520|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
64339522|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339523|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64339524|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64339525|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
64339526|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
64339527|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
64339528|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64339529|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64339530|NCT02285062|Growth Substances|growth substances|mesh-ancestor
64339531|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
64339532|NCT02431767|Interleukin-12|interleukin-12|mesh-list
64339533|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64339534|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
64339535|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339536|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64339537|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64339546|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339570|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339571|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64339573|NCT05482334|Sargramostim|sargramostim|mesh-list
64339574|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
64339575|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339576|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339577|NCT05253794|Colchicine|colchicine|mesh-list
64339578|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
64339579|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339580|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
64339581|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
64339582|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
64339583|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339584|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339585|NCT03140943|Thalidomide|thalidomide|mesh-list
64339586|NCT03140943|Dexamethasone|dexamethasone|mesh-list
64339587|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339588|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
64339589|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
64339590|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339591|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339592|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339593|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
64339594|NCT03140943|Hormones|hormones|mesh-ancestor
64339595|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339610|NCT05311436|Iron|iron|mesh-list
64339611|NCT05311436|Folic Acid|folic acid|mesh-list
64339612|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339613|NCT05311436|Trace Elements|trace elements|mesh-ancestor
64339614|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
64339615|NCT05311436|Hematinics|hematinics|mesh-ancestor
64339616|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
64339617|NCT05311436|Vitamins|vitamins|mesh-ancestor
64339618|NCT05199753|Antibodies|antibodies|mesh-list
64339619|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
64339620|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339621|NCT01352741|Pregabalin|pregabalin|mesh-list
64339622|NCT01352741|Tapentadol|tapentadol|mesh-list
64339623|NCT01352741|Analgesics|analgesics|mesh-ancestor
64339624|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
64339625|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339626|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339627|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
64339628|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64339629|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339630|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339631|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64339632|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64339633|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64339634|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339635|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64339636|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64339637|NCT01352741|Narcotics|narcotics|mesh-ancestor
64339638|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64339639|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64339640|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339641|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339642|NCT04422392|Paclitaxel|paclitaxel|mesh-list
64339643|NCT04422392|Carboplatin|carboplatin|mesh-list
64339644|NCT04422392|Pemetrexed|pemetrexed|mesh-list
64339645|NCT04422392|Antibodies|antibodies|mesh-list
64339646|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64339647|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339648|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
64339655|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64339656|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64339657|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
64339658|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64339659|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339683|NCT03140553|Docetaxel|docetaxel|mesh-list
64339684|NCT03140553|Trastuzumab|trastuzumab|mesh-list
64339685|NCT03140553|Epirubicin|epirubicin|mesh-list
64339686|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339687|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
64339688|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339689|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339690|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64339691|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
64339692|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339693|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339694|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64339695|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
64339696|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
64339697|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
64339698|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64339699|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64339700|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64339701|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64339702|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339703|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
64339704|NCT05279456|Paraproteins|paraproteins|mesh-list
64339705|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
64339706|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339707|NCT00905567|Topiramate|topiramate|mesh-list
64339708|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
64339709|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64339710|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339711|NCT05277896|Ketamine|ketamine|mesh-list
64339712|NCT05277896|Etomidate|etomidate|mesh-list
64339733|NCT05249972|Betamethasone|betamethasone|mesh-list
64339734|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
64339735|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64339736|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
64339737|NCT05249972|Calcipotriene|calcipotriene|mesh-list
64339738|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64339739|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339740|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
64339742|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339743|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339744|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64339745|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
64339746|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339747|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64339749|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339750|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339751|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64339752|NCT05249972|Vitamins|vitamins|mesh-ancestor
64339753|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
64339754|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64339755|NCT00904943|Topiramate|topiramate|mesh-list
64339756|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
64339757|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64339758|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339759|NCT00902291|Gemcitabine|gemcitabine|mesh-list
64339760|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64339761|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
64339762|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339799|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339800|NCT00901979|Metformin|metformin|mesh-list
64339801|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64339802|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64339803|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339804|NCT00901979|Incretins|incretins|mesh-ancestor
64339805|NCT00901979|Hormones|hormones|mesh-ancestor
64339806|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339807|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64339808|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
64339809|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339810|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339811|NCT03778671|Fentanyl|fentanyl|mesh-list
64339812|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
64339813|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
64339840|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339841|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339842|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64339843|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64339844|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339845|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339846|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339847|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64339848|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64339850|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339891|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339892|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
64339893|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339894|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64339895|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64339896|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64339897|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339898|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339900|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339901|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339902|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64339903|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64339904|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339933|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64339934|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64339991|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339993|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64339994|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64339995|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339996|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339997|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339998|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339999|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64340000|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64340001|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64340002|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64340004|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64340005|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64340032|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340033|NCT00875459|Insulin|insulin|mesh-list
64340034|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64340035|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340036|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340037|NCT03837353|Docetaxel|docetaxel|mesh-list
64340038|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340039|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340040|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340041|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340042|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340044|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
64340045|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64340046|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340047|NCT02283658|Everolimus|everolimus|mesh-list
64340087|NCT00871481|Analgesics|analgesics|mesh-ancestor
64340088|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
64340089|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340090|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64340091|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64340092|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
64340093|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340095|NCT05456165|Atezolizumab|atezolizumab|mesh-list
64340096|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340097|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340098|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64340099|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340100|NCT05083689|Bevacizumab|bevacizumab|mesh-list
64340101|NCT05083689|Timolol|timolol|mesh-list
64340102|NCT05083689|Dorzolamide|dorzolamide|mesh-list
64340103|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
64340104|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340105|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340106|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64340107|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64340108|NCT05083689|Growth Substances|growth substances|mesh-ancestor
64340109|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340142|NCT03079921|Phentolamine|phentolamine|mesh-list
64340150|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340151|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
64340152|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64340153|NCT04473989|Teriparatide|teriparatide|mesh-list
64340183|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64340184|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
64340185|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340186|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340187|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64340188|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64340189|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64340190|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
64340191|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64340192|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340193|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340194|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
64340195|NCT05162222|Itraconazole|itraconazole|mesh-list
64340196|NCT05162222|Diltiazem|diltiazem|mesh-list
64340197|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
64340198|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340199|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64340200|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64340201|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340223|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340224|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64340225|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340226|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340227|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340228|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64340229|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64340230|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64340231|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340234|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64340235|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
64340236|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340237|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340238|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64340239|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340240|NCT00857285|Losartan|losartan|mesh-list
64340241|NCT00857285|Olmesartan|olmesartan|mesh-list
64340242|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64340243|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64340244|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340245|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64340246|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64340247|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340248|NCT04461379|Vaccines|vaccines|mesh-list
64340249|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
64340250|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
64340327|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340328|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340329|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340330|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340331|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340332|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64340333|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64340334|NCT00850577|Growth Substances|growth substances|mesh-ancestor
64340335|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340336|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
64340367|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340368|NCT00950885|Melatonin|melatonin|mesh-list
64340369|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
64340370|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340371|NCT00950885|Protective Agents|protective agents|mesh-ancestor
64340372|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340373|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340374|NCT00849485|Levetiracetam|levetiracetam|mesh-list
64340375|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
64340376|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
64340377|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
64340378|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
64340402|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340404|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64340405|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340406|NCT00840203|Mesalamine|mesalamine|mesh-list
64340407|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64340408|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64340409|NCT00840203|Analgesics|analgesics|mesh-ancestor
64340410|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
64340411|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340412|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340413|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340425|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64340426|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64340427|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340428|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64340429|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
64340457|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340458|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340459|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64340461|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
64340462|NCT05202860|Vaccines|vaccines|mesh-list
64340463|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
64340464|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340465|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
64340466|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340467|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64340468|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340469|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340470|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
64340471|NCT05202080|Narcotics|narcotics|mesh-ancestor
64340472|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340483|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340485|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64340486|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64340487|NCT00927641|Analgesics|analgesics|mesh-ancestor
64340488|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
64340489|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340490|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340491|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340492|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340493|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64340494|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340495|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340496|NCT05200364|Bevacizumab|bevacizumab|mesh-list
64340497|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340498|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340499|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64340500|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64340501|NCT05200364|Growth Substances|growth substances|mesh-ancestor
64340502|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340503|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
64340504|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64340505|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
64340506|NCT00835991|Metformin|metformin|mesh-list
64340507|NCT00835991|Glyburide|glyburide|mesh-list
64340508|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340509|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340510|NCT05200052|Colchicine|colchicine|mesh-list
64340511|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
64340512|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340513|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340514|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340515|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340523|NCT02276872|Treprostinil|treprostinil|mesh-list
64340524|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340525|NCT00835367|Amlodipine|amlodipine|mesh-list
64340526|NCT00835367|Benazepril|benazepril|mesh-list
64340527|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340528|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64340529|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340530|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340531|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340532|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340533|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
64340549|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
64340550|NCT02276560|Antiviral Agents|antiviral agents|mesh-ancestor
64340551|NCT02276560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340552|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340553|NCT02276560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340554|NCT02276560|Immunologic Factors|immunologic factors|mesh-ancestor
64340555|NCT02276560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340556|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64340557|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64340558|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64340559|NCT02276482|Metronidazole|metronidazole|mesh-list
64340561|NCT02276482|Clindamycin|clindamycin|mesh-list
64340562|NCT02276482|Cefazolin|cefazolin|mesh-list
64340563|NCT02276482|Linezolid|linezolid|mesh-list
64340564|NCT02276482|Cephalexin|cephalexin|mesh-list
64340565|NCT02276482|Aztreonam|aztreonam|mesh-list
64340566|NCT02276482|Tedizolid|tedizolid|mesh-list
64340567|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340568|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64340569|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64340570|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64340571|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340572|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340573|NCT05196932|Antibodies|antibodies|mesh-list
64340574|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
64340575|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340576|NCT00924833|Carvedilol|carvedilol|mesh-list
64340577|NCT00924833|Nebivolol|nebivolol|mesh-list
64340578|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64340579|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64340580|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
64340581|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340582|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340583|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340584|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340585|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
64340586|NCT00924833|Protective Agents|protective agents|mesh-ancestor
64340587|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64340588|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340589|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340590|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
64340591|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64340592|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64340593|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64340594|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64340595|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64340622|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64340623|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
64340624|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340625|NCT05227664|Paclitaxel|paclitaxel|mesh-list
64340626|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64340659|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64340660|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340661|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64340662|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64340663|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
64340664|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340665|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340666|NCT00834197|Mirtazapine|mirtazapine|mesh-list
64340667|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
64340668|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64340669|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64340670|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
64340671|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
64340672|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340673|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340674|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340675|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64340676|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64340677|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340678|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64340679|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64340680|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64340681|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
64340682|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64340683|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64340684|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
64340685|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64340686|NCT00833495|Prednisolone|prednisolone|mesh-list
64340687|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64340699|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64340732|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64340733|NCT02274766|Analgesics|analgesics|mesh-ancestor
64340734|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
64340735|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340737|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64340738|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340739|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340740|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
64340741|NCT04757363|Nivolumab|nivolumab|mesh-list
64340742|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340771|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
64340772|NCT05108870|Paclitaxel|paclitaxel|mesh-list
64340773|NCT05108870|Carboplatin|carboplatin|mesh-list
64340774|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64340775|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340776|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340777|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340778|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340779|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340780|NCT05126342|Niraparib|niraparib|mesh-list
64340781|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64340782|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340783|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340784|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340785|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
64340817|NCT05102552|Protective Agents|protective agents|mesh-ancestor
64340818|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
64340819|NCT05096390|Axitinib|axitinib|mesh-list
64340820|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340821|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340822|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64340823|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340824|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340825|NCT05114096|Betamethasone|betamethasone|mesh-list
64340826|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
64340858|NCT02367352|Paclitaxel|paclitaxel|mesh-list
64340869|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
64340870|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340871|NCT05648734|Pirfenidone|pirfenidone|mesh-list
64340872|NCT05648734|Colchicine|colchicine|mesh-list
64340873|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
64340874|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340875|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340895|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64340896|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
64340897|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64340898|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
64340899|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340900|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340901|NCT02270242|Aspirin|aspirin|mesh-list
64340902|NCT02270242|Ticagrelor|ticagrelor|mesh-list
64340903|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64340904|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64340905|NCT02270242|Analgesics|analgesics|mesh-ancestor
64340906|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
64340907|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340909|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340910|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340911|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64340912|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64340913|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340914|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64340915|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64340919|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64340920|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64340921|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
64340922|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340923|NCT04875364|Eszopiclone|eszopiclone|mesh-list
64340924|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64340925|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340927|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
64340928|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64340929|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340959|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340960|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340961|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
64340962|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64340972|NCT05042102|Donepezil|donepezil|mesh-list
64340973|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64340974|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340975|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340989|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
64340990|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340991|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340992|NCT05036798|Lenvatinib|lenvatinib|mesh-list
64340993|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340994|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64340995|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340996|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340997|NCT04982354|Fludarabine|fludarabine|mesh-list
64340998|NCT04982354|Melphalan|melphalan|mesh-list
64340999|NCT04982354|Busulfan|busulfan|mesh-list
64341000|NCT04982354|Midostaurin|midostaurin|mesh-list
64341001|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341002|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341003|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341004|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
64341005|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341006|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64341007|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
64341008|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64341009|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64341010|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341011|NCT04209218|Dexamethasone|dexamethasone|mesh-list
64341012|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
64341013|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341014|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
64341015|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
64341016|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341035|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64341065|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341066|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
64341067|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64341068|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341069|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64341070|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64341072|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341074|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64341076|NCT05025800|Antibodies|antibodies|mesh-list
64341077|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
64341078|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64341079|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
64341080|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341118|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64341119|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341148|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341149|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
64341150|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
64341151|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
64341152|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341153|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341154|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64341159|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341161|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341225|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
64341226|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64341227|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64341228|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
64341229|NCT04947254|Protective Agents|protective agents|mesh-ancestor
64341230|NCT04947254|Vitamins|vitamins|mesh-ancestor
64341231|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
64341232|NCT04947254|Estrogens|estrogens|mesh-ancestor
64341233|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
64341234|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
64341235|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
64341236|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
64341237|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341238|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341239|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341240|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64341241|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
64341242|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
64341243|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341273|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64341274|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341275|NCT02483078|Leronlimab|leronlimab|mesh-list
64341276|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64341277|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64341278|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341279|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64341280|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64341281|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
64341282|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341283|NCT02452190|Reslizumab|reslizumab|mesh-list
64341284|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64341285|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341286|NCT02514122|Ketamine|ketamine|mesh-list
64341287|NCT02514122|Analgesics|analgesics|mesh-ancestor
64341288|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
64341289|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341316|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
64341317|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64341318|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
64341319|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367754|NCT03095001|Paclitaxel|paclitaxel|mesh-list
64341320|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341322|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341323|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
64341324|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64341325|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
64341326|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341327|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341329|NCT04462003|Apixaban|apixaban|mesh-list
64341330|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
64341331|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64341332|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64341333|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341334|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64341335|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
64341336|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64341337|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
64341338|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341339|NCT03489265|Eluxadoline|eluxadoline|mesh-list
64341340|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341341|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
64341342|NCT03344341|Acarbose|acarbose|mesh-list
64341343|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64341348|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341349|NCT03260881|Liraglutide|liraglutide|mesh-list
64341350|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341362|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341363|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
64341364|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
64341365|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
64341366|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341367|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341368|NCT02536339|Trastuzumab|trastuzumab|mesh-list
64341370|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341371|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341372|NCT01869361|Indomethacin|indomethacin|mesh-list
64341373|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64341375|NCT01869361|Analgesics|analgesics|mesh-ancestor
64341376|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
64341377|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341378|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341379|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341380|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64341381|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
64341382|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
64341383|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64341384|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64341385|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341386|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341387|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
64341388|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64341389|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341390|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64341391|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64341392|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341393|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341394|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341395|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64341396|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341403|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
64341404|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341405|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341406|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341407|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341408|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64341409|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64341410|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64341411|NCT03488719|Metoprolol|metoprolol|mesh-list
64341412|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64341413|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64341436|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341437|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64341438|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64341439|NCT03496831|Analgesics|analgesics|mesh-ancestor
64341440|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
64341441|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341442|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341443|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64341444|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341446|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
64341447|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
64341448|NCT03488485|Ledipasvir|ledipasvir|mesh-list
64341449|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341450|NCT00821249|Dexamethasone|dexamethasone|mesh-list
64341451|NCT00821249|Filanesib|filanesib|mesh-list
64341452|NCT00821249|Lenograstim|lenograstim|mesh-list
64341453|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341454|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
64341455|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
64341456|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341457|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341458|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341459|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
64341461|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341462|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341463|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341464|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64341465|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
64341466|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
64341467|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
64341468|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341488|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341489|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
64341490|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341491|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64341492|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
64341493|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341494|NCT00813605|Conatumumab|conatumumab|mesh-list
64341495|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341496|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341497|NCT00724841|Temozolomide|temozolomide|mesh-list
64341517|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64341519|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341520|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64341521|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64341522|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64341523|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64341552|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341553|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341556|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341557|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341558|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64341559|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341560|NCT04750759|Niclosamide|niclosamide|mesh-list
64341561|NCT04750759|Camostat|camostat|mesh-list
64341562|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
64341563|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341564|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341565|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64341566|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64341567|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
64341568|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64341605|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341606|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64341640|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
64341641|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341642|NCT04460521|Protective Agents|protective agents|mesh-ancestor
64341643|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341644|NCT04460521|Antidotes|antidotes|mesh-ancestor
64341646|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341647|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341648|NCT03487783|Aripiprazole|aripiprazole|mesh-list
64341649|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64341650|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
64341682|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64341684|NCT04071613|Tenecteplase|tenecteplase|mesh-list
64341685|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64341687|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341688|NCT00678119|Sunitinib|sunitinib|mesh-list
64341689|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341690|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64341718|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341719|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64341721|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
64341722|NCT03484507|Prednisolone|prednisolone|mesh-list
64341723|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64341724|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
64341725|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64341726|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
64341727|NCT03484507|Povidone|povidone|mesh-list
64341728|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64341729|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
64341730|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341732|NCT03484507|Hormones|hormones|mesh-ancestor
64341733|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341734|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341735|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341736|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341737|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
64341738|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
64341739|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341740|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341741|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64341743|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64341762|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
64341763|NCT03484195|Irinotecan|irinotecan|mesh-list
64341764|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
64341765|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341766|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64341767|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341768|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341769|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
64341770|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341771|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64341772|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64341773|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341774|NCT02713607|Doxycycline|doxycycline|mesh-list
64341775|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64341776|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341777|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
64341778|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64341779|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64341780|NCT04526821|Lactoferrin|lactoferrin|mesh-list
64341781|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341782|NCT02681549|Bevacizumab|bevacizumab|mesh-list
64341783|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
64341784|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341785|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341786|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64341787|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64341788|NCT02681549|Growth Substances|growth substances|mesh-ancestor
64341789|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341790|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
64341791|NCT02323399|Phenylephrine|phenylephrine|mesh-list
64341792|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
64341793|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64341794|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
64341795|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
64341796|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341820|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341822|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
64341823|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64341824|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64341825|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
64341826|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341827|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341828|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64341829|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341830|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64341831|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
64341832|NCT04460963|Protective Agents|protective agents|mesh-ancestor
64341833|NCT00873275|Leucovorin|leucovorin|mesh-list
64341834|NCT00873275|Bevacizumab|bevacizumab|mesh-list
64341835|NCT00873275|Fluorouracil|fluorouracil|mesh-list
64341836|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
64341837|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64341838|NCT00873275|Calcium|calcium|mesh-list
64341839|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
64341840|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341841|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341842|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64341843|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64341845|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341846|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
64341847|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64341848|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
64341849|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341850|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64341851|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341852|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
64341853|NCT00873275|Antidotes|antidotes|mesh-ancestor
64341854|NCT00873275|Protective Agents|protective agents|mesh-ancestor
64341855|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
64341856|NCT00873275|Vitamins|vitamins|mesh-ancestor
64341857|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
64341858|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64341894|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64341895|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64341896|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
64341897|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341935|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341957|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64341958|NCT02274077|Bupivacaine|bupivacaine|mesh-list
64341959|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
64341960|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
64341961|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64341962|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341963|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
64341964|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341965|NCT00765323|Octreotide|octreotide|mesh-list
64341966|NCT00765323|Somatostatin|somatostatin|mesh-list
64341967|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341968|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341969|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341970|NCT00765323|Hormones|hormones|mesh-ancestor
64341971|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341972|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341973|NCT02276495|Ketorolac|ketorolac|mesh-list
64341974|NCT02276495|Clonidine|clonidine|mesh-list
64341975|NCT02276495|Epinephrine|epinephrine|mesh-list
64341976|NCT02276495|Ropivacaine|ropivacaine|mesh-list
64341977|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
64341978|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
64341979|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342038|NCT02266888|Rituximab|rituximab|mesh-list
64342039|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342040|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342041|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
64342042|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342043|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342046|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342047|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
64342048|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342049|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342050|NCT00660881|Epratuzumab|epratuzumab|mesh-list
64342051|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342052|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342053|NCT02359552|Rasagiline|rasagiline|mesh-list
64342054|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
64342055|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342056|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342057|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64342058|NCT02359552|Protective Agents|protective agents|mesh-ancestor
64342059|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342060|NCT02279537|Aflibercept|aflibercept|mesh-list
64342103|NCT02280629|Mesalamine|mesalamine|mesh-list
64342104|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64342105|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342106|NCT02280629|Analgesics|analgesics|mesh-ancestor
64342107|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
64342108|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342137|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64342140|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342141|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64342142|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
64342143|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342144|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342145|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64342146|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
64342147|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
64342148|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64342149|NCT00647231|Ketoprofen|ketoprofen|mesh-list
64342150|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64342151|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342152|NCT00647231|Analgesics|analgesics|mesh-ancestor
64342153|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
64342154|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342155|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342156|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342157|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342158|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64342209|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342210|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342211|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64342219|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342220|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342221|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
64342222|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
64342223|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64342224|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64342227|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342228|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342229|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64342230|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342231|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
64342232|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342233|NCT00728351|Metformin|metformin|mesh-list
64342234|NCT00728351|Vildagliptin|vildagliptin|mesh-list
64342235|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64342236|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342237|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64342239|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342240|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342241|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64342243|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64342244|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342245|NCT00616811|Incretins|incretins|mesh-ancestor
64342246|NCT00616811|Hormones|hormones|mesh-ancestor
64342247|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342248|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64342249|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
64342250|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342251|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342252|NCT00615251|Progesterone|progesterone|mesh-list
64342253|NCT00615251|Progestins|progestins|mesh-ancestor
64342254|NCT00615251|Hormones|hormones|mesh-ancestor
64342255|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342279|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64342280|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64342281|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
64342282|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
64342283|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
64342284|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
64342286|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64342287|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
64342288|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
64342289|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
64342290|NCT02357368|Etonogestrel|etonogestrel|mesh-list
64342291|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64342292|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342293|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64342294|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64342295|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64342296|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64342297|NCT02357368|Trace Elements|trace elements|mesh-ancestor
64342298|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
64342299|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64342300|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64342301|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64342302|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342303|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
64342304|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64342344|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64342345|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342346|NCT02262754|Naproxen|naproxen|mesh-list
64342347|NCT02262754|PF-06372865|pf-06372865|mesh-list
64342348|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64342349|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342350|NCT02262754|Analgesics|analgesics|mesh-ancestor
64342351|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
64342352|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342353|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342354|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342355|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342356|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
64342357|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64342389|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342390|NCT02356588|Sufentanil|sufentanil|mesh-list
64342391|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64342392|NCT02356588|Narcotics|narcotics|mesh-ancestor
64342393|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342394|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342395|NCT02356588|Analgesics|analgesics|mesh-ancestor
64342396|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
64342397|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342398|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64342399|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64342400|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
64342401|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
64342402|NCT04445389|Vaccines|vaccines|mesh-list
64342433|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64342434|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342435|NCT05647330|Amebicides|amebicides|mesh-ancestor
64342436|NCT01643668|Busulfan|busulfan|mesh-list
64342437|NCT01643668|Clofarabine|clofarabine|mesh-list
64342438|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
64342439|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342440|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342441|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
64342442|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342443|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64342444|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342445|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64342446|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64342447|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
64342466|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342467|NCT02260648|Atorvastatin|atorvastatin|mesh-list
64342468|NCT02260648|Ezetimibe|ezetimibe|mesh-list
64342469|NCT02260648|Evacetrapib|evacetrapib|mesh-list
64342470|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64342480|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342481|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342482|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64342483|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342486|NCT02260492|Xhance|xhance|mesh-list
64342487|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64342488|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64342489|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342490|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64342492|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342493|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342494|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64342495|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
64342496|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
64342497|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64342498|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64342499|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64342500|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64342501|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
64342502|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342503|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342535|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
64342536|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342537|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342538|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64342539|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
64342540|NCT02353468|Hormones|hormones|mesh-ancestor
64342541|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342542|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64342543|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342544|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
64342545|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64342546|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64342547|NCT02353468|Growth Substances|growth substances|mesh-ancestor
64342548|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
64342549|NCT02523859|Propofol|propofol|mesh-list
64342577|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342578|NCT00593905|Bosentan|bosentan|mesh-list
64342579|NCT00593905|Ambrisentan|ambrisentan|mesh-list
64342580|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
64342581|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64342582|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64342583|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342584|NCT02259088|Ranibizumab|ranibizumab|mesh-list
64342585|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64342586|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64342587|NCT02259088|Growth Substances|growth substances|mesh-ancestor
64342588|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342589|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
64342590|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342591|NCT02830477|Factor VIII|factor viii|mesh-list
64342592|NCT02830477|Coagulants|coagulants|mesh-ancestor
64342593|NCT02259010|Itraconazole|itraconazole|mesh-list
64342594|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
64342634|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64342636|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342637|NCT00609323|Lidocaine|lidocaine|mesh-list
64342638|NCT00609323|Tetracaine|tetracaine|mesh-list
64342639|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
64342640|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
64342641|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342642|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342643|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
64342644|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342645|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64342668|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
64342669|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342670|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64342671|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
64342672|NCT04473053|Nafamostat|nafamostat|mesh-list
64342673|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64342674|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342675|NCT04473053|Analgesics|analgesics|mesh-ancestor
64342676|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
64342677|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342678|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342679|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342680|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342681|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
64342682|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
64342683|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342684|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342685|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64342686|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64342687|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64342688|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342689|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
64342690|NCT02281643|Doxycycline|doxycycline|mesh-list
64342738|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342802|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
64342803|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342804|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342805|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64342806|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
64342807|NCT04660747|Anticoagulants|anticoagulants|mesh-list
64342808|NCT02348008|Bevacizumab|bevacizumab|mesh-list
64342809|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
64342810|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342811|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342812|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64342813|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64342814|NCT02348008|Growth Substances|growth substances|mesh-ancestor
64342815|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342816|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
64342817|NCT00569387|Vaccines|vaccines|mesh-list
64342818|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
64342819|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342820|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64342821|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64342822|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64342823|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
64342824|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342825|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342861|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
64342862|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342863|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
64342864|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342865|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342866|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342890|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64342891|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64342892|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64342893|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
64342894|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342895|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342896|NCT00489203|Beclomethasone|beclomethasone|mesh-list
64342897|NCT00489203|Methotrexate|methotrexate|mesh-list
64342898|NCT00489203|Tacrolimus|tacrolimus|mesh-list
64342906|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342907|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
64342908|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342909|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64342910|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342911|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
64342913|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64342914|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64342915|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342917|NCT00489203|Hormones|hormones|mesh-ancestor
64342953|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64342954|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342955|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342956|NCT04947631|Urological Agents|urological agents|mesh-ancestor
64342957|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64342958|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64342978|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64342979|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64342980|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342981|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342982|NCT00488267|Ketoprofen|ketoprofen|mesh-list
64342983|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64342984|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342985|NCT00488267|Analgesics|analgesics|mesh-ancestor
64342986|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
64342987|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342988|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342989|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342990|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342991|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64342992|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342993|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342994|NCT00560183|Morphine|morphine|mesh-list
64342995|NCT00560183|Oxycodone|oxycodone|mesh-list
64342996|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64342997|NCT00560183|Narcotics|narcotics|mesh-ancestor
64342998|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342999|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343000|NCT00560183|Analgesics|analgesics|mesh-ancestor
64343001|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
64343002|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343003|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64343004|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
64343005|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343007|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64343008|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64343009|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343011|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
64343012|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343013|NCT00483977|Oxycodone|oxycodone|mesh-list
64343014|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64343015|NCT00483977|Narcotics|narcotics|mesh-ancestor
64343036|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343037|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343039|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64343040|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
64367818|NCT02496455|Analgesics|analgesics|mesh-ancestor
64343041|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343042|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
64343043|NCT03480295|Protective Agents|protective agents|mesh-ancestor
64343044|NCT03472963|Darunavir|darunavir|mesh-list
64343061|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
64343062|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343063|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343064|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64343065|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64343092|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343093|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64343094|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64343095|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64343096|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343097|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343100|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
64343101|NCT00464633|Growth Substances|growth substances|mesh-ancestor
64343102|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343103|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64343104|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343105|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343106|NCT00464555|Sirolimus|sirolimus|mesh-list
64343107|NCT00464555|Lisofylline|lisofylline|mesh-list
64343108|NCT00464555|Tacrolimus|tacrolimus|mesh-list
64343109|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64343110|NCT00464555|Basiliximab|basiliximab|mesh-list
64343111|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343112|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
64343113|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343131|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64343140|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343141|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64343143|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
64343144|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
64343145|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343146|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64343147|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64343148|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343149|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343150|NCT00525941|Indiplon|indiplon|mesh-list
64343151|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64343152|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343153|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343154|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
64343155|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
64343156|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343157|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343158|NCT03476083|Tenofovir|tenofovir|mesh-list
64343159|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
64343160|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343161|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64343162|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64343163|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343164|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343165|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64343166|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64343167|NCT02738203|Lidocaine|lidocaine|mesh-list
64343168|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
64343196|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64343197|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64343198|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343199|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343200|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343201|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64343202|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
64343203|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343204|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343205|NCT00517049|Rituximab|rituximab|mesh-list
64343206|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343207|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343208|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
64343209|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343210|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64343211|NCT02283203|Acetaminophen|acetaminophen|mesh-list
64343212|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64343213|NCT02283203|Analgesics|analgesics|mesh-ancestor
64343245|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343247|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64343248|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64343249|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377612|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343284|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
64343286|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64343287|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64343288|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64343289|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64343290|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
64343291|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343292|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343293|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343294|NCT04470479|Pilocarpine|pilocarpine|mesh-list
64343295|NCT04470479|Miotics|miotics|mesh-ancestor
64343296|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
64343297|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343298|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343299|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64343300|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64343325|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64343326|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64343327|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64343328|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64343329|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343330|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343332|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343333|NCT00440531|Vaccines|vaccines|mesh-list
64343334|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
64343335|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343336|NCT00380159|Lamivudine|lamivudine|mesh-list
64343337|NCT00380159|Emtricitabine|emtricitabine|mesh-list
64343338|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
64343339|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64343340|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64343341|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343342|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343343|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
64343344|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343345|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64343346|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64343347|NCT00375791|Dexamethasone|dexamethasone|mesh-list
64343348|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343349|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
64343379|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343380|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343381|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64343383|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64343384|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343385|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343386|NCT02287259|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64343387|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64343388|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343389|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343390|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343392|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
64343394|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
64343395|NCT00429923|Hormones|hormones|mesh-ancestor
64343415|NCT00372437|Immunologic Factors|immunologic factors|mesh-ancestor
64343416|NCT00372437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343417|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64343418|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64343419|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
64343428|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343429|NCT00364247|Analgesics|analgesics|mesh-ancestor
64343430|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
64343431|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343432|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64343433|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64343434|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343435|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343436|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343437|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343438|NCT00424697|Lorazepam|lorazepam|mesh-list
64343439|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
64343440|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
64343441|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
64343442|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343443|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343444|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64343445|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64343446|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343447|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64343448|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64343449|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343450|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
64343480|NCT00417209|Capecitabine|capecitabine|mesh-list
64343481|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
64343482|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343483|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64343484|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343485|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343486|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
64343487|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343488|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64343489|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64343490|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64343491|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343492|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343493|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
64343494|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343495|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343496|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64343518|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343520|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
64343521|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
64343522|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343523|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343610|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
64343611|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343612|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64343613|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
64343614|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343615|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343616|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64343617|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
64343618|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
64343619|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64343620|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64343621|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64343622|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64343623|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343709|NCT02285699|Citalopram|citalopram|mesh-list
64343710|NCT02285699|Fluoxetine|fluoxetine|mesh-list
64343711|NCT02285699|Paroxetine|paroxetine|mesh-list
64343712|NCT02285699|Sertraline|sertraline|mesh-list
64343713|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64343714|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64343715|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343733|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343734|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
64343735|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343736|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343737|NCT00265655|Satraplatin|satraplatin|mesh-list
64343738|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343740|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64343741|NCT00254891|Carboplatin|carboplatin|mesh-list
64343742|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64343743|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343744|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
64343753|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64343754|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
64343755|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
64343756|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64343757|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64343758|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64343759|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64343760|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343761|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343762|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343763|NCT00254579|Tremelimumab|tremelimumab|mesh-list
64343764|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343765|NCT00252005|Apixaban|apixaban|mesh-list
64343766|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64343767|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
64343768|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64343769|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
64343770|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343771|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343772|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
64343803|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64343804|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64343805|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64343806|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343807|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343808|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343809|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343810|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64343812|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
64343813|NCT02288741|Melphalan|melphalan|mesh-list
64343814|NCT02288741|BB 1101|bb 1101|mesh-list
64343815|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343816|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
64343817|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
64343818|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343841|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343842|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64343843|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343844|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343846|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64343847|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64343848|NCT02448446|Growth Substances|growth substances|mesh-ancestor
64343849|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343850|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
64343851|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343852|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
64343853|NCT02478398|Loratadine|loratadine|mesh-list
64343854|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
64343855|NCT02478398|Epinephrine|epinephrine|mesh-list
64343856|NCT02478398|Albuterol|albuterol|mesh-list
64343857|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64343880|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64343881|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
64343882|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
64343883|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64343884|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64343885|NCT02478398|Analgesics|analgesics|mesh-ancestor
64343886|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
64343887|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64343888|NCT02478164|Ponatinib|ponatinib|mesh-list
64343889|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343890|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64343891|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343892|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343893|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64343894|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64343895|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64343897|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
64343898|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343899|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343900|NCT05259319|Atezolizumab|atezolizumab|mesh-list
64343901|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343902|NCT05259007|Amoxicillin|amoxicillin|mesh-list
64343903|NCT05259007|Clarithromycin|clarithromycin|mesh-list
64343904|NCT05259007|Propolis|propolis|mesh-list
64343906|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
64343907|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343908|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343909|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64343910|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343911|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343912|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64343913|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64343915|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64343922|NCT03472339|Diclofenac|diclofenac|mesh-list
64343923|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64343924|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64343925|NCT03472339|Analgesics|analgesics|mesh-ancestor
64343926|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
64343927|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343928|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343929|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343930|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64343931|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64343932|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343933|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343934|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
64343935|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64343949|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343950|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343951|NCT02255500|Bupivacaine|bupivacaine|mesh-list
64343952|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
64343953|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
64343954|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343955|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343956|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
64343957|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343958|NCT03475693|Acetaminophen|acetaminophen|mesh-list
64343959|NCT03475693|Ondansetron|ondansetron|mesh-list
64343960|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
64343961|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64343962|NCT03475693|Analgesics|analgesics|mesh-ancestor
64343963|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
64343964|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343965|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343966|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
64343967|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
64343968|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
64343969|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64343970|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
64343971|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
64343972|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64343973|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
64343974|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343975|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343976|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64343977|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64343978|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343979|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343980|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64343981|NCT03475693|Antacids|antacids|mesh-ancestor
64343985|NCT05156749|Calpastatin|calpastatin|mesh-list
64343986|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64343987|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344098|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344099|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
64344101|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
64344102|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344103|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344104|NCT00701623|Heparin|heparin|mesh-list
64344105|NCT00701623|Calcium heparin|calcium heparin|mesh-list
64344106|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
64344107|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64344108|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64344109|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344110|NCT04456153|Atovaquone|atovaquone|mesh-list
64344111|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344112|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
64344113|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64344114|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64344115|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344116|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344117|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
64344118|NCT04403971|Listerine|listerine|mesh-list
64344119|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64344120|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344121|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
64344122|NCT02447432|Vaccines|vaccines|mesh-list
64344123|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64344202|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
64344203|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344205|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64344206|NCT05650216|Carboplatin|carboplatin|mesh-list
64344207|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344208|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344209|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
64344210|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
64344211|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
64344212|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344215|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64344216|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344217|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
64344218|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
64344219|NCT05369650|Lidocaine|lidocaine|mesh-list
64344220|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
64344221|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
64344261|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64344262|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344263|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344264|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344265|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344266|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344267|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344268|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
64344269|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344270|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64344271|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64344272|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
64344273|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64344274|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64344275|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64344301|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344302|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64344303|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344304|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344306|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64344307|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64344308|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
64344309|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344310|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344311|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344312|NCT05642182|Vitamin D|vitamin d|mesh-list
64344313|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
64344314|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
64344315|NCT05642182|Vitamins|vitamins|mesh-list
64344316|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
64344317|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344318|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64344319|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64344320|NCT03471559|Cannabidiol|cannabidiol|mesh-list
64344321|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
64344322|NCT05641480|Donepezil|donepezil|mesh-list
64344323|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64344324|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344325|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344326|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
64344327|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344328|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344329|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
64344330|NCT05640934|Melatonin|melatonin|mesh-list
64344331|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
64344332|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344333|NCT05640934|Protective Agents|protective agents|mesh-ancestor
64344334|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344335|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344336|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64344354|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
64344355|NCT04844164|Vitamin D|vitamin d|mesh-list
64344356|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64344357|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344358|NCT04844164|Vitamins|vitamins|mesh-ancestor
64344359|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
64344360|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64344361|NCT05392972|Anesthetics|anesthetics|mesh-list
64344362|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344363|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344364|NCT03474601|Hormones|hormones|mesh-list
64344365|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344366|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344367|NCT04988308|Adalimumab|adalimumab|mesh-list
64344379|NCT05576662|Ritonavir|ritonavir|mesh-list
64344380|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64344381|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344382|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344383|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344384|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344385|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344386|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344387|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
64344388|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344389|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64344390|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64344391|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
64344392|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64344394|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
64344427|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344428|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
64344429|NCT04261049|Hormones|hormones|mesh-ancestor
64344430|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344431|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344432|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344433|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
64344434|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344435|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344474|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
64344544|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64344545|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
64344546|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344547|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344548|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64344549|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344584|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
64344585|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64344586|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344587|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344589|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
64344590|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
64344591|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344592|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344633|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64344634|NCT03529253|Calcium|calcium|mesh-list
64344635|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64344636|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344637|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64344640|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344641|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64344642|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64344643|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344644|NCT00002207|Stavudine|stavudine|mesh-list
64344645|NCT00002207|Didanosine|didanosine|mesh-list
64344646|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
64344677|NCT03529097|Diclofenac|diclofenac|mesh-list
64344678|NCT03529097|Morphine|morphine|mesh-list
64344679|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64344680|NCT03529097|Narcotics|narcotics|mesh-ancestor
64344681|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344682|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344683|NCT03529097|Analgesics|analgesics|mesh-ancestor
64344684|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
64344685|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344687|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64344688|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64344722|NCT03531437|Gestodene|gestodene|mesh-list
64344723|NCT03531437|Estradiol|estradiol|mesh-list
64344724|NCT03531437|Estrogens|estrogens|mesh-ancestor
64344725|NCT03531437|Hormones|hormones|mesh-ancestor
64344726|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344760|NCT03531359|Midazolam|midazolam|mesh-list
64344761|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64344762|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64344763|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344764|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344765|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64344766|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64344767|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64344768|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64344769|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
64344816|NCT04468685|Ondansetron|ondansetron|mesh-list
64344817|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
64344818|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
64344819|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344820|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344821|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64344822|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
64344823|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
64344824|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64344825|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
64344826|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344827|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344828|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64344829|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64344830|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344831|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64344854|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344855|NCT05062031|Atropine|atropine|mesh-list
64344856|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64344858|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64344859|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64344860|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
64344861|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344862|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344863|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64344864|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
64344865|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
64344866|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
64344867|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64344868|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64344869|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
64344870|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344871|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344872|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64344884|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344885|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64344922|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64344923|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64344955|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344956|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64344957|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344958|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344959|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
64344960|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344961|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
64344963|NCT03525509|Methadone|methadone|mesh-list
64344998|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64344999|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
64345000|NCT04221035|Temozolomide|temozolomide|mesh-list
64345001|NCT04221035|Melphalan|melphalan|mesh-list
64345002|NCT04221035|Busulfan|busulfan|mesh-list
64345004|NCT04221035|Thiotepa|thiotepa|mesh-list
64345066|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345067|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345069|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64345070|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64345071|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64345072|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345073|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345074|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345106|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345107|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64345108|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
64345109|NCT05198362|Metoprolol|metoprolol|mesh-list
64345110|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64345111|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64345112|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
64345113|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
64345114|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345115|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345116|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64345117|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64345119|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345150|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345151|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345158|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64345159|NCT04810156|Protective Agents|protective agents|mesh-ancestor
64345160|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64345162|NCT04837924|Tramadol|tramadol|mesh-list
64345163|NCT04837924|Analgesics|analgesics|mesh-list
64345186|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
64345187|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345188|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345189|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
64345190|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
64345191|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64345192|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
64345193|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64345194|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64345195|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345196|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345197|NCT01601470|Urological Agents|urological agents|mesh-ancestor
64345198|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64345200|NCT04418908|Estradiol|estradiol|mesh-list
64345201|NCT04418908|Estrogens|estrogens|mesh-ancestor
64345202|NCT04418908|Hormones|hormones|mesh-ancestor
64345203|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345204|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345205|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64345206|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64345207|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
64345208|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
64345209|NCT04546126|Dexamethasone|dexamethasone|mesh-list
64345210|NCT04546126|Cosyntropin|cosyntropin|mesh-list
64345211|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64345212|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
64345213|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
64345214|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345215|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345216|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345217|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
64345218|NCT04546126|Hormones|hormones|mesh-ancestor
64345234|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345235|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
64345236|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345346|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345348|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
64345349|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64345370|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345371|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
64345392|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345393|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345394|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345395|NCT01637584|Prazosin|prazosin|mesh-list
64345396|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64345397|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64345398|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64345399|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64345400|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345401|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345402|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345403|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345404|NCT03875092|Paclitaxel|paclitaxel|mesh-list
64345405|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64345406|NCT03875092|Carboplatin|carboplatin|mesh-list
64345407|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
64345408|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64345409|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345410|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
64345411|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
64345412|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
64345413|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345459|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64345460|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
64345461|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
64345462|NCT04193878|Hormones|hormones|mesh-ancestor
64345463|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345464|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64345465|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64345467|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345468|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345469|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345471|NCT02473250|Citalopram|citalopram|mesh-list
64345472|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64345508|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64345509|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345510|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345512|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64345545|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
64345546|NCT02456974|Meropenem|meropenem|mesh-list
64345547|NCT02456974|Tazobactam|tazobactam|mesh-list
64345548|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
64345549|NCT02456974|Amikacin|amikacin|mesh-list
64345550|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64345551|NCT02456974|Teicoplanin|teicoplanin|mesh-list
64345552|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345553|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345554|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64345555|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64345591|NCT02499770|Etoposide|etoposide|mesh-list
64345592|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345627|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64345758|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64345760|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345761|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64345762|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64345763|NCT01038778|Aldesleukin|aldesleukin|mesh-list
64345891|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345893|NCT02819141|Analgesics|analgesics|mesh-ancestor
64345894|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
64345895|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345920|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64345921|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64345923|NCT04467125|Prilocaine|prilocaine|mesh-list
64345924|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64345925|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
64345926|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
64345927|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64345928|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345929|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
64345930|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345931|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64345932|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64345933|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64345934|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64345935|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345936|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64345937|NCT02692313|Epinephrine|epinephrine|mesh-list
64346049|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346050|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346051|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64346052|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64346053|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346054|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
64346055|NCT05634785|Fludarabine|fludarabine|mesh-list
64346056|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64346057|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
64346082|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
64346084|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64346085|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
64346086|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346087|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346088|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64346089|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
64346090|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346091|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346092|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64346093|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346094|NCT04551261|Ritonavir|ritonavir|mesh-list
64346095|NCT04551261|Tenofovir|tenofovir|mesh-list
64346096|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64346097|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64346098|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
64346099|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346100|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346101|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64346102|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64346103|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
64346104|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346105|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64346106|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64346136|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
64346137|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346138|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346139|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
64346186|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64346187|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
64346188|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346189|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346190|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64346191|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
64346192|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346193|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346194|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64346195|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346232|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
64346233|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346236|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
64346237|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64346239|NCT02462486|Ranibizumab|ranibizumab|mesh-list
64346260|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64346261|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
64346262|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
64346263|NCT05318157|Hormones|hormones|mesh-ancestor
64346264|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346265|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64346266|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
64346268|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346269|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346270|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64346271|NCT02294279|Beclomethasone|beclomethasone|mesh-list
64346272|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346287|NCT02294357|Lenalidomide|lenalidomide|mesh-list
64346288|NCT02294357|Pomalidomide|pomalidomide|mesh-list
64346289|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64346290|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
64346292|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346293|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
64346294|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
64346295|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346331|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64346332|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346334|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64346335|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
64346336|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346368|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346369|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64346370|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346371|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
64346372|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64346373|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64346374|NCT03520985|Growth Substances|growth substances|mesh-ancestor
64346378|NCT03517943|Ephedrine|ephedrine|mesh-list
64346379|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
64346419|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
64346420|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64346421|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64346422|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346423|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346424|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
64346455|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346456|NCT03520439|Mifepristone|mifepristone|mesh-list
64346457|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64346458|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
64346459|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64346460|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346461|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64346462|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64346463|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64346464|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
64346465|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64346466|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64346467|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
64346493|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64346496|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346497|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346498|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346502|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64346503|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64346504|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64346505|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346506|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
64346507|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346508|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346509|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64346510|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346511|NCT03520049|Oseltamivir|oseltamivir|mesh-list
64346512|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
64346513|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346514|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346515|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346516|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
64346585|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
64346586|NCT02495168|Hormones|hormones|mesh-ancestor
64346587|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346588|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64346589|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64346590|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64346591|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
64346592|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346593|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346594|NCT04934072|Denosumab|denosumab|mesh-list
64346595|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367850|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
64346628|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64346629|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64346631|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
64346632|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346633|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346677|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
64346679|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
64346681|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
64346682|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346683|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64346684|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346715|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
64346716|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346717|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64346718|NCT02297945|Metyrapone|metyrapone|mesh-list
64346719|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
64346720|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346721|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346722|NCT02492984|Factor VIII|factor viii|mesh-list
64346723|NCT02492984|Coagulants|coagulants|mesh-ancestor
64346724|NCT03132623|Andrographolide|andrographolide|mesh-list
64346767|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346768|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
64346769|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
64346770|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
64346771|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346772|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64346773|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64346774|NCT02834403|Analgesics|analgesics|mesh-ancestor
64346775|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
64346800|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346801|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64346802|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64346803|NCT02302469|Growth Substances|growth substances|mesh-ancestor
64346804|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
64346805|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346808|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64346809|NCT02302547|Darunavir|darunavir|mesh-list
64346810|NCT02302547|Indinavir|indinavir|mesh-list
64346811|NCT02302547|Saquinavir|saquinavir|mesh-list
64346812|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
64346813|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
64346814|NCT02302547|Tenofovir|tenofovir|mesh-list
64346815|NCT02302547|Emtricitabine|emtricitabine|mesh-list
64346816|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
64346817|NCT02302547|Nevirapine|nevirapine|mesh-list
64346818|NCT02302547|Maraviroc|maraviroc|mesh-list
64346819|NCT02302547|Dolutegravir|dolutegravir|mesh-list
64346820|NCT02302547|Cobicistat|cobicistat|mesh-list
64346821|NCT02302547|Rilpivirine|rilpivirine|mesh-list
64346822|NCT02302547|Tipranavir|tipranavir|mesh-list
64346823|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
64346824|NCT02302547|Elvitegravir|elvitegravir|mesh-list
64346825|NCT02302547|Efavirenz|efavirenz|mesh-list
64346826|NCT02302547|Etravirine|etravirine|mesh-list
64346827|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
64346828|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
64346829|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
64346830|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64346831|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346862|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346863|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
64346864|NCT01190787|Hormones|hormones|mesh-ancestor
64346865|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346866|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64346867|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64346868|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64346869|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346870|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
64346871|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
64346872|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64346906|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346907|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346908|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64346909|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64346910|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
64346911|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
64346912|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346944|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64346946|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346947|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64346948|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
64346949|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
64347022|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
64347023|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347024|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347025|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
64347026|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347027|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64347028|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
64347029|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64347030|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347031|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347032|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64347033|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
64347069|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
64347070|NCT05378061|Growth Substances|growth substances|mesh-ancestor
64347071|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347072|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
64347104|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64347105|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
64347106|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347107|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347108|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347109|NCT02303951|Atezolizumab|atezolizumab|mesh-list
64347110|NCT02303951|Vemurafenib|vemurafenib|mesh-list
64347111|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347112|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64347130|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64347131|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347132|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
64347133|NCT02304107|Letrozole|letrozole|mesh-list
64347134|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347135|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64347144|NCT03509285|Alprazolam|alprazolam|mesh-list
64347145|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64347146|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347147|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347148|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64347149|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64347150|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64347151|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
64347152|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
64347153|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347154|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347155|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
64347156|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64347157|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64347158|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64347159|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64347160|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
64347161|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347162|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64347163|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64347164|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347165|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64347166|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64347185|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64347186|NCT03135795|Analgesics|analgesics|mesh-ancestor
64347187|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
64347188|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347189|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64347190|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64347191|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64347192|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
64347193|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347194|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347195|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
64347196|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64347197|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
64347198|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
64347199|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64347200|NCT03135795|Narcotics|narcotics|mesh-ancestor
64347201|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64347202|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64347203|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
64347204|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64347205|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64347206|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64347207|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64347208|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64347209|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64347210|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347211|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64347212|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347213|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347215|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
64347216|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347217|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64347258|NCT02239120|Dabigatran|dabigatran|mesh-list
64347259|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
64347260|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64347261|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
64347262|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347263|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347264|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
64347265|NCT04464863|Metronidazole|metronidazole|mesh-list
64347266|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347267|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64347268|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64347269|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64347270|NCT05158699|Dexamethasone|dexamethasone|mesh-list
64347271|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
64347272|NCT05158699|Triamcinolone|triamcinolone|mesh-list
64347273|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64347274|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64347275|NCT05158699|Ketorolac|ketorolac|mesh-list
64347276|NCT05158699|Bromfenac|bromfenac|mesh-list
64347277|NCT05158699|Phenylephrine|phenylephrine|mesh-list
64347278|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64347279|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64347280|NCT05158699|BB 1101|bb 1101|mesh-list
64347304|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64347305|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
64347306|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
64347307|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64347308|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
64347309|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
64347310|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64347311|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64347312|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64347313|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
64347314|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347315|NCT05158699|Protective Agents|protective agents|mesh-ancestor
64347316|NCT04464629|Prednisolone|prednisolone|mesh-list
64347317|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64347318|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
64347319|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64347329|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347330|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
64347331|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
64347364|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64347365|NCT03469375|Folfirinox|folfirinox|mesh-list
64347366|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347367|NCT01603407|Prednisone|prednisone|mesh-list
64347368|NCT01603407|Deflazacort|deflazacort|mesh-list
64347369|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64347370|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
64347371|NCT01603407|Hormones|hormones|mesh-ancestor
64347372|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347399|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64347400|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347401|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347402|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
64347403|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347404|NCT02301221|Vancomycin|vancomycin|mesh-list
64347405|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64347406|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347407|NCT03770416|Nivolumab|nivolumab|mesh-list
64347408|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64347409|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347410|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64347411|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347412|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
64347413|NCT03122431|Thalidomide|thalidomide|mesh-list
64347414|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
64347415|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64347416|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64347417|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64347418|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347419|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347447|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64347448|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64347449|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
64347450|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64347451|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64347452|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64347453|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64347454|NCT05376189|Vitamin D|vitamin d|mesh-list
64347455|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
64347456|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
64347457|NCT05376189|Vitamins|vitamins|mesh-list
64347458|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
64347459|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347460|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64347534|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64347535|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
64347536|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64347537|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64347538|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64347539|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347541|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
64347542|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
64347543|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347544|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347545|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64347546|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64347547|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
64347548|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64347549|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64347550|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64347551|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64347552|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64347553|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64347554|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64347555|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64347556|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64347557|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64347558|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64347559|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64347593|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64347594|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347595|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347596|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
64347597|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347598|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64347599|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
64347600|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347601|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
64347602|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64347603|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
64347604|NCT05091099|Alendronate|alendronate|mesh-list
64347605|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64347606|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347607|NCT05197426|Azacitidine|azacitidine|mesh-list
64347608|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64347609|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
64347610|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347611|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347612|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347614|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64347615|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347616|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347618|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64347619|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347620|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347621|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347654|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347656|NCT00821587|Cyclosporine|cyclosporine|mesh-list
64347657|NCT00821587|Tacrolimus|tacrolimus|mesh-list
64347791|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
64347792|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347794|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64347795|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64347796|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
64347797|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
64347798|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347799|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347800|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64347953|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
64347954|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64347955|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347956|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64347958|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
64347959|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
64347960|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348099|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348100|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64348101|NCT01680861|Protective Agents|protective agents|mesh-ancestor
64348143|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64348145|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
64348146|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348147|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64348148|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64348149|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64348150|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
64348151|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348152|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348153|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348154|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348155|NCT02312609|Minocycline|minocycline|mesh-list
64348156|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348157|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348158|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
64348159|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64348160|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
64348161|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
64348162|NCT03506399|Estradiol|estradiol|mesh-list
64348163|NCT03506399|Estrogens|estrogens|mesh-ancestor
64348164|NCT03506399|Hormones|hormones|mesh-ancestor
64348268|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64348269|NCT02901184|Diuretics|diuretics|mesh-ancestor
64348270|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
64348271|NCT04658277|Clarithromycin|clarithromycin|mesh-list
64348272|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64349118|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64349119|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64349120|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64349122|NCT02322203|Niacinamide|niacinamide|mesh-list
64349123|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
64349124|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64349125|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
64349126|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349127|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64349128|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
64349655|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
64349656|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349696|NCT03530995|Belumosudil|belumosudil|mesh-list
64349697|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64350039|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64350040|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64350041|NCT03131843|Ethanol|ethanol|mesh-list
64350042|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64350043|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350044|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350045|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350047|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350048|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350050|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64350051|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350052|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64350053|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350054|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350055|NCT03797261|Venetoclax|venetoclax|mesh-list
64350056|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350057|NCT02202850|Etanercept|etanercept|mesh-list
64350058|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64350067|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64350446|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350448|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
64350449|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64350450|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350451|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64350452|NCT04234529|Caffeine|caffeine|mesh-list
64350453|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64350454|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350455|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64350456|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350457|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350458|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64350459|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64350460|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
64350461|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350463|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64350464|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350465|NCT03481517|Bupivacaine|bupivacaine|mesh-list
64350466|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
64350467|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
64350468|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350469|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350470|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
64350471|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350472|NCT02429258|Metformin|metformin|mesh-list
64350473|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
64350499|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350500|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64350501|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
64350503|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
64350504|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64350505|NCT02137252|Naltrexone|naltrexone|mesh-list
64350506|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64350507|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64350508|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350509|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
64350510|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350511|NCT05152667|Dienogest|dienogest|mesh-list
64350512|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
64350513|NCT05152667|Progestins|progestins|mesh-list
64350514|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64350515|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
64350516|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64350517|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350518|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64350519|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64350520|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64350521|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64350522|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64350523|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
64350524|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350525|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64350526|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350528|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
64350531|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350532|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64350533|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64350534|NCT05152511|Protective Agents|protective agents|mesh-ancestor
64350535|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350567|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350568|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
64350569|NCT03479411|Itraconazole|itraconazole|mesh-list
64350570|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
64350571|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
64350572|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350573|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64350574|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64350575|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350576|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350577|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64350578|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
64350579|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350830|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350831|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64350832|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
64350914|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64350915|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64350916|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
64350917|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350918|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350919|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350921|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
64350922|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350923|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350924|NCT03668639|Dexamethasone|dexamethasone|mesh-list
64350925|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64350926|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
64350927|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
64350928|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350929|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350930|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350931|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
64350932|NCT03668639|Hormones|hormones|mesh-ancestor
64350933|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350934|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64350935|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350936|NCT03470363|Sufentanil|sufentanil|mesh-list
64350937|NCT03470363|Bupivacaine|bupivacaine|mesh-list
64350938|NCT03470363|Sevoflurane|sevoflurane|mesh-list
64350941|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350942|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350943|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
64350944|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351010|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351011|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
64351012|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64351013|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
64351014|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351015|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351016|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64351017|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64351137|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
64351138|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64351139|NCT03461185|Growth Substances|growth substances|mesh-ancestor
64351140|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351306|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64351307|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64351308|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64351309|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64351310|NCT05153135|Palbociclib|palbociclib|mesh-list
64351311|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351312|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351313|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351314|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351315|NCT02616185|Tremelimumab|tremelimumab|mesh-list
64351316|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351317|NCT04857307|Alprazolam|alprazolam|mesh-list
64351318|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64351319|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351320|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351321|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64351322|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64351572|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351600|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351603|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
64351604|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64351605|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
64351606|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351607|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351608|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351609|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351610|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351611|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
64351612|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64351613|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
64351614|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351615|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351616|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64351617|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
64351618|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351619|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351723|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351724|NCT04923659|Nimodipine|nimodipine|mesh-list
64351725|NCT04923659|Carbamazepine|carbamazepine|mesh-list
64351726|NCT04923659|Lorazepam|lorazepam|mesh-list
64351727|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
64351728|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
64351729|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
64351730|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64351731|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64351732|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351733|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351734|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351735|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
64351736|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
64351737|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
64351738|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351739|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64351740|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64351741|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351742|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64351760|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
64351761|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
64351762|NCT05398679|Levofloxacin|levofloxacin|mesh-list
64351763|NCT05398679|Ofloxacin|ofloxacin|mesh-list
64351764|NCT05398679|Clindamycin|clindamycin|mesh-list
64351765|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
64351815|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64351816|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
64351817|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
64351818|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351821|NCT05398055|Azithromycin|azithromycin|mesh-list
64351822|NCT05398055|Doxycycline|doxycycline|mesh-list
64351823|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64351824|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351825|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
64351826|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64351827|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64351828|NCT04421339|Melatonin|melatonin|mesh-list
64351830|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351831|NCT04421339|Protective Agents|protective agents|mesh-ancestor
64351832|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351833|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351834|NCT04301843|Eflornithine|eflornithine|mesh-list
64351835|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351836|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64352115|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64352116|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64352117|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64352185|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352186|NCT05391971|Bupivacaine|bupivacaine|mesh-list
64352212|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64352213|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
64352214|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352215|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352216|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64352217|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352218|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
64352219|NCT02457221|Hormones|hormones|mesh-ancestor
64352220|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352221|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64352222|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64352266|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352267|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
64352268|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352269|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64352270|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64352271|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352272|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
64352274|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
64352275|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352276|NCT05015387|Protective Agents|protective agents|mesh-ancestor
64352277|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352444|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64352445|NCT04452929|Erenumab|erenumab|mesh-list
64352446|NCT04452929|Katacalcin|katacalcin|mesh-list
64352448|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
64352449|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352450|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352451|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64352452|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
64352453|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64352454|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64352455|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352694|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64352696|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352697|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64352698|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352699|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352700|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
64352701|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
64352702|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352703|NCT04165239|Protective Agents|protective agents|mesh-ancestor
64352704|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352705|NCT03756311|Paclitaxel|paclitaxel|mesh-list
64352706|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64352707|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64352708|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352709|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
64352710|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
64352711|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
64352713|NCT04576767|Anesthetics|anesthetics|mesh-list
64352737|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64352738|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
64352739|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352740|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352742|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64352743|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
64352745|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
64352746|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64352747|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352748|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64352749|NCT02194595|Incretins|incretins|mesh-ancestor
64352750|NCT02194595|Hormones|hormones|mesh-ancestor
64352751|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352752|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64352753|NCT02656329|Lugol's solution|lugol's solution|mesh-list
64352754|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352755|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352756|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352757|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64352758|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
64352759|NCT02656329|Coagulants|coagulants|mesh-ancestor
64352760|NCT02712905|Nivolumab|nivolumab|mesh-list
64352761|NCT02712905|Azacitidine|azacitidine|mesh-list
64352762|NCT02712905|Tretinoin|tretinoin|mesh-list
64352763|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64352764|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352765|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64352795|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352796|NCT03449537|Caseins|caseins|mesh-list
64352797|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
64352798|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
64352799|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352800|NCT03730649|Sulforaphane|sulforaphane|mesh-list
64352801|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64352802|NCT03730649|Protective Agents|protective agents|mesh-ancestor
64352803|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352804|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352805|NCT02237183|Iloprost|iloprost|mesh-list
64352807|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
64352808|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
64352841|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352842|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64352843|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64352844|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352845|NCT05114499|Donepezil|donepezil|mesh-list
64352846|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64352847|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352848|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352849|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
64352850|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352851|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352852|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
64352853|NCT04520997|Hyaluronic Acid|hyaluronic acid|mesh-list
64352854|NCT04520997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64352855|NCT04520997|Immunologic Factors|immunologic factors|mesh-ancestor
64352856|NCT04520997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352858|NCT04520997|Protective Agents|protective agents|mesh-ancestor
64352859|NCT02181413|Ixazomib|ixazomib|mesh-list
64352860|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352889|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64352890|NCT05283161|Analgesics|analgesics|mesh-ancestor
64352891|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
64352892|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352893|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64352894|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64352895|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352896|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352897|NCT05283161|Hormones|hormones|mesh-ancestor
64352898|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352899|NCT03691311|Denosumab|denosumab|mesh-list
64352900|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64352901|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352902|NCT03448835|Docetaxel|docetaxel|mesh-list
64352903|NCT03448835|Capecitabine|capecitabine|mesh-list
64352904|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
64352906|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352907|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
64352908|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
64352909|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
64352910|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352936|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352937|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352939|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352940|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352941|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64352942|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64352943|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352944|NCT01709123|Chromium|chromium|mesh-list
64352957|NCT03443141|Vitamins|vitamins|mesh-ancestor
64352958|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
64352959|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352960|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
64352961|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352962|NCT03443141|Protective Agents|protective agents|mesh-ancestor
64352963|NCT04937543|Beclomethasone|beclomethasone|mesh-list
64352964|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
64352999|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353000|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353002|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64353003|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353075|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353076|NCT02418182|Analgesics|analgesics|mesh-ancestor
64353077|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
64353078|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353079|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353080|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
64353081|NCT02387372|Tazobactam|tazobactam|mesh-list
64353140|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353141|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353142|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64353143|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
64353144|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
64353145|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353146|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353147|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64353148|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64353149|NCT02425826|Growth Substances|growth substances|mesh-ancestor
64353150|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
64353151|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353152|NCT02656173|Tamsulosin|tamsulosin|mesh-list
64353154|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64353155|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64353157|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353158|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353159|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353160|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353161|NCT02656173|Urological Agents|urological agents|mesh-ancestor
64353162|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64353163|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64353164|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64353207|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64353208|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
64353209|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64353210|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353211|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
64353212|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
64353213|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64353228|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64353229|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64353230|NCT04516941|Colchicine|colchicine|mesh-list
64353233|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353234|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
64353235|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
64353236|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
64353237|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353238|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353239|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64353240|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
64353241|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64353242|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
64353243|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353244|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
64353245|NCT03444467|Glucagon|glucagon|mesh-list
64353246|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64353247|NCT03444467|Hormones|hormones|mesh-ancestor
64353248|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353299|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
64353300|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
64353301|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353302|NCT03443843|Fluticasone|fluticasone|mesh-list
64353323|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
64353324|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64353325|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64353326|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
64353327|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353328|NCT03438227|Dextrans|dextrans|mesh-list
64353329|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
64353330|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
64353331|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
64353332|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
64353333|NCT03438227|Hematinics|hematinics|mesh-ancestor
64353334|NCT03433235|Edoxaban|edoxaban|mesh-list
64353335|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64353336|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
64353467|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353468|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353469|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353584|NCT03431909|Kallikreins|kallikreins|mesh-list
64353585|NCT03431909|Clopidogrel|clopidogrel|mesh-list
64353586|NCT03431909|Atorvastatin|atorvastatin|mesh-list
64353587|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64353588|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353589|NCT03431909|Analgesics|analgesics|mesh-ancestor
64353590|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
64353668|NCT02424578|Diclofenac|diclofenac|mesh-list
64353669|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64353670|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353671|NCT02424578|Analgesics|analgesics|mesh-ancestor
64353672|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
64353673|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353674|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353675|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353676|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353677|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64353678|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353679|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353681|NCT03431285|Morphine|morphine|mesh-list
64353682|NCT03431285|Analgesics|analgesics|mesh-ancestor
64353683|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
64353684|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353685|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353686|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64353687|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64353688|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
64353689|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
64353690|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353691|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64353692|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64353693|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353694|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353695|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64353696|NCT03431285|Narcotics|narcotics|mesh-ancestor
64353697|NCT02416934|Dexamethasone|dexamethasone|mesh-list
64353698|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353699|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
64353700|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
64353821|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64353822|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64353823|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64353824|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353825|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353826|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64353827|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353828|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353829|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
64353830|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353831|NCT03429179|Butorphanol|butorphanol|mesh-list
64353832|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64353833|NCT03429179|Narcotics|narcotics|mesh-ancestor
64353834|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353835|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354023|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64354024|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64354025|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354026|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354028|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354030|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
64354031|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64354032|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
64354033|NCT03424733|Acetaminophen|acetaminophen|mesh-list
64354034|NCT03424733|Interferons|interferons|mesh-list
64354035|NCT03424733|Interferon-beta|interferon-beta|mesh-list
64354036|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
64354037|NCT03424733|Prednisone|prednisone|mesh-list
64354038|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354039|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
64354040|NCT03424733|Hormones|hormones|mesh-ancestor
64354041|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354042|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354051|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
64354052|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
64354053|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64354054|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64354055|NCT03441841|Lidocaine|lidocaine|mesh-list
64354056|NCT03441841|Prilocaine|prilocaine|mesh-list
64354057|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64354058|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
64354059|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
64354060|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354061|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354062|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
64354063|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354064|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64354065|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64354066|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64354067|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354068|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354069|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64354070|NCT02692339|Dexamethasone|dexamethasone|mesh-list
64354071|NCT02692339|Lenalidomide|lenalidomide|mesh-list
64354072|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354073|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
64354102|NCT03441529|Piperacillin|piperacillin|mesh-list
64354103|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64354104|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64354105|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354106|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64354117|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64354118|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354119|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
64367859|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354154|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354155|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354156|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354157|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354158|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354248|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64354249|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64354252|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354253|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64354254|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64354255|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64354256|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354257|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64354258|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64354259|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64354260|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354264|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64354265|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64354266|NCT03436693|Canagliflozin|canagliflozin|mesh-list
64354267|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64354268|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354270|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354271|NCT03432637|Anesthetics|anesthetics|mesh-list
64354272|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354336|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64354337|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
64354338|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
64354339|NCT03431623|Hematinics|hematinics|mesh-ancestor
64354340|NCT04451395|Micronutrients|micronutrients|mesh-list
64354341|NCT04451395|Trace Elements|trace elements|mesh-list
64354342|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354343|NCT04451083|Camostat|camostat|mesh-list
64354344|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
64354353|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354354|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
64354355|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
64354356|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
64354365|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354367|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
64354368|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64354369|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64354370|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64354371|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64354372|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
64354373|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354374|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354375|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354376|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
64354377|NCT03431077|Giapreza|giapreza|mesh-list
64354378|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
64354379|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64354380|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64354412|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354414|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354415|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64354416|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64354417|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354418|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354419|NCT03434197|Diclofenac|diclofenac|mesh-list
64354420|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354521|NCT02732327|Meropenem|meropenem|mesh-list
64354522|NCT02732327|Linezolid|linezolid|mesh-list
64354523|NCT02732327|Tazobactam|tazobactam|mesh-list
64354524|NCT02732327|Piperacillin|piperacillin|mesh-list
64354525|NCT02732327|Cefepime|cefepime|mesh-list
64354527|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64354528|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354529|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64354530|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354531|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354549|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
64354550|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
64354551|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354552|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64354553|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354554|NCT03416777|Tocopherols|tocopherols|mesh-list
64354556|NCT03416777|Tocotrienols|tocotrienols|mesh-list
64354557|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
64354558|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
64354559|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354564|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
64354565|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354567|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
64354568|NCT03422887|Nalbuphine|nalbuphine|mesh-list
64354569|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64354570|NCT03422887|Narcotics|narcotics|mesh-ancestor
64354571|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354580|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64354582|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354583|NCT02521207|Ibuprofen|ibuprofen|mesh-list
64354584|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354585|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354586|NCT02521207|Analgesics|analgesics|mesh-ancestor
64354587|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
64354588|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354589|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354590|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354617|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64354618|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354621|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64354622|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
64354623|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64354624|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64354625|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64354626|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64354639|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64354652|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354654|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
64354655|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354656|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
64354657|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
64354658|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64354659|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64354660|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64354661|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
64354662|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354663|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
64354664|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64354665|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64354666|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
64354667|NCT03428191|Remifentanil|remifentanil|mesh-list
64354668|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64354669|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354670|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354671|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354672|NCT03428191|Analgesics|analgesics|mesh-ancestor
64354673|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
64354674|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354675|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64354676|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64354677|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64354678|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
64354679|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354680|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354681|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64354684|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354687|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
64354688|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354689|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354690|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354691|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354692|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64354693|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64354694|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354735|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354736|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354737|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64354738|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354739|NCT02935309|Capecitabine|capecitabine|mesh-list
64354741|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64354742|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
64354743|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354744|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354745|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64354746|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354747|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
64354748|NCT03463993|Oxytocin|oxytocin|mesh-list
64354749|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
64354750|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64354751|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354752|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64354753|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64354754|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354825|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64354829|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
64354830|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354831|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354832|NCT01004029|Progestins|progestins|mesh-ancestor
64354833|NCT01004029|Hormones|hormones|mesh-ancestor
64354834|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
64354835|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
64354836|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354837|NCT03420937|Atropine|atropine|mesh-list
64354838|NCT03420937|Neostigmine|neostigmine|mesh-list
64354839|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64354840|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64354841|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64354842|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
64354863|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64354872|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354873|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
64354874|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64354875|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64354876|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64354877|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64354878|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354879|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354880|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
64354881|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354882|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354883|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64354884|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354886|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64354887|NCT03420703|Narcotics|narcotics|mesh-ancestor
64354888|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354889|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354890|NCT03420703|Analgesics|analgesics|mesh-ancestor
64354891|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
64354892|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354893|NCT03420469|Bupropion|bupropion|mesh-list
64354894|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64354895|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
64354914|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354915|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354916|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354917|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354918|NCT03420313|Buprenorphine|buprenorphine|mesh-list
64354919|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64354920|NCT03420313|Naloxone|naloxone|mesh-list
64354921|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64354922|NCT03420313|Narcotics|narcotics|mesh-ancestor
64354923|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354924|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354925|NCT03420313|Analgesics|analgesics|mesh-ancestor
64354926|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
64354927|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354928|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64354946|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64354947|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64354948|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354949|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354950|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64354995|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354996|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
64354997|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354999|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
64355000|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
64355001|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355002|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355003|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355004|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64355005|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
64355006|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355007|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355009|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64355010|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355011|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64355095|NCT02735707|Lopinavir|lopinavir|mesh-list
64355096|NCT02735707|Interferon-beta|interferon-beta|mesh-list
64355097|NCT02735707|Oseltamivir|oseltamivir|mesh-list
64355099|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
64355104|NCT02735707|Ivermectin|ivermectin|mesh-list
64355105|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
64355106|NCT02735707|Tazobactam|tazobactam|mesh-list
64355107|NCT02735707|Piperacillin|piperacillin|mesh-list
64355108|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
64355109|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64355110|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64355111|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64355136|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64355138|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
64355139|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355140|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355141|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355142|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64355143|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64355144|NCT02735707|Analgesics|analgesics|mesh-ancestor
64355145|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
64355146|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355147|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64355148|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64355149|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64355150|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64355151|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355152|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64355153|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64355154|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
64355155|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64355156|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64355157|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
64355158|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64355159|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64355160|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64355161|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64355162|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64355163|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64355164|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64355165|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
64355166|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355167|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64355246|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64355248|NCT03420911|Analgesics|analgesics|mesh-ancestor
64355249|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
64355250|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355251|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64355252|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64355299|NCT00593567|Levofloxacin|levofloxacin|mesh-list
64355300|NCT00593567|Ofloxacin|ofloxacin|mesh-list
64355301|NCT00593567|Gentamicins|gentamicins|mesh-list
64355302|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64355303|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355304|NCT00593567|Renal Agents|renal agents|mesh-ancestor
64355305|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64355306|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64355307|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64355308|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355309|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355310|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355311|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64355312|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64355313|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64355314|NCT03419975|Latanoprost|latanoprost|mesh-list
64355315|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64355316|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64355317|NCT00006455|Leucovorin|leucovorin|mesh-list
64355318|NCT00006455|Cytarabine|cytarabine|mesh-list
64355319|NCT00006455|Dexamethasone|dexamethasone|mesh-list
64355320|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
64355321|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64355322|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64355323|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64355324|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
64355325|NCT00006455|Ifosfamide|ifosfamide|mesh-list
64355326|NCT00006455|Doxorubicin|doxorubicin|mesh-list
64355327|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64355328|NCT00006455|Methotrexate|methotrexate|mesh-list
64355329|NCT00006455|Etoposide|etoposide|mesh-list
64355330|NCT00006455|Vinblastine|vinblastine|mesh-list
64355334|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355335|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64355336|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64355337|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
64355338|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355339|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355340|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64355341|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64355342|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
64355343|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
64355344|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355345|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64355346|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
64355347|NCT00006455|Hormones|hormones|mesh-ancestor
64355348|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355349|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64355350|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64355351|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64355352|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64355353|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355374|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64355375|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355376|NCT02537197|Naltrexone|naltrexone|mesh-list
64355377|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64355378|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64355379|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355380|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
64355383|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64355384|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64355385|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64355386|NCT03413371|Acetaminophen|acetaminophen|mesh-list
64355387|NCT03413371|Lidocaine|lidocaine|mesh-list
64355388|NCT03413371|Bupivacaine|bupivacaine|mesh-list
64355407|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64355408|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64355409|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64355410|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
64355411|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355412|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355413|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355414|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64355415|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
64355416|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64355440|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
64355441|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
64355443|NCT05116371|Estrogens|estrogens|mesh-ancestor
64355444|NCT05116371|Hormones|hormones|mesh-ancestor
64355445|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355446|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355447|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64355448|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64355449|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64355450|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64355451|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64355452|NCT01328093|Aripiprazole|aripiprazole|mesh-list
64355453|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
64355454|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64355455|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64355463|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64355464|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64355465|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
64355466|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64355467|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64355522|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64355542|NCT03413059|Narcotics|narcotics|mesh-ancestor
64355543|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355544|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355545|NCT03413059|Analgesics|analgesics|mesh-ancestor
64355546|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
64355547|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355548|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64355549|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
64355550|NCT03413059|Hormones|hormones|mesh-ancestor
64355551|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355552|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64355553|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
64355554|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355555|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355556|NCT05122377|Goserelin|goserelin|mesh-list
64355557|NCT05122377|Leuprolide|leuprolide|mesh-list
64355602|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
64355603|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355605|NCT01111565|Citalopram|citalopram|mesh-list
64355606|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64355607|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64355632|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355634|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64355635|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64355658|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
64355659|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355660|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355662|NCT03126877|Mitomycin|mitomycin|mesh-list
64355663|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64355664|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355666|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355667|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64355668|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355669|NCT04260477|Rifampin|rifampin|mesh-list
64355670|NCT04260477|Isoniazid|isoniazid|mesh-list
64355671|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
64355672|NCT04260477|Ethambutol|ethambutol|mesh-list
64355682|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64355683|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64355684|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64355685|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64355686|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64355687|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64355688|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64355689|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
64355690|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64355691|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
64355692|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
64355693|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64355756|NCT05229627|Methylphenidate|methylphenidate|mesh-list
64355757|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64355758|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64355759|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355760|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64355761|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64355762|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64355763|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355764|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
64355765|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355766|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64355767|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64355768|NCT01976169|Palbociclib|palbociclib|mesh-list
64355769|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64356000|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64356001|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356003|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64356005|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64356006|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356042|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
64356043|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356045|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64356047|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64356049|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356050|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356051|NCT04737603|Analgesics|analgesics|mesh-ancestor
64356052|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
64356053|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356054|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64356055|NCT05168137|Colchicine|colchicine|mesh-list
64356056|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
64356057|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356058|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
64356059|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
64356060|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
64356061|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356096|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
64356097|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356098|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
64356099|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64356100|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64356101|NCT03393949|Prednisolone|prednisolone|mesh-list
64356102|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
64356103|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64356104|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
64356105|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64356106|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
64356107|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
64356108|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356109|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356110|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64356111|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
64356113|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356114|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64356115|NCT03393949|Protective Agents|protective agents|mesh-ancestor
64356116|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64356117|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356118|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
64356142|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
64356143|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356144|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356145|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64356146|NCT03397537|Letrozole|letrozole|mesh-list
64356147|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356148|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64356149|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64356150|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356151|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356152|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64356153|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
64356154|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356276|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356277|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64356278|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
64356279|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356280|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356281|NCT03343197|Ivosidenib|ivosidenib|mesh-list
64356282|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356283|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356284|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356285|NCT01602224|Dexamethasone|dexamethasone|mesh-list
64356286|NCT01602224|Bortezomib|bortezomib|mesh-list
64356295|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356296|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64356297|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356298|NCT03399487|Ceritinib|ceritinib|mesh-list
64356299|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356300|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64356303|NCT05161429|Insulin|insulin|mesh-list
64356304|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64356305|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356329|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64356330|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64356331|NCT05060991|Antimetabolites|antimetabolites|mesh-list
64356332|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356333|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64356335|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64356336|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356337|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356338|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356340|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64356341|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356342|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356343|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
64356344|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
64356345|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
64356346|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
64356347|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356348|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356349|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
64356350|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356351|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356352|NCT03399019|Midazolam|midazolam|mesh-list
64356353|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
64356354|NCT03399019|Propofol|propofol|mesh-list
64356355|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356356|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356357|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356452|NCT03398785|Racepinephrine|racepinephrine|mesh-list
64356453|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
64356454|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64356455|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64356456|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356457|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356458|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356658|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
64356659|NCT02678143|Fludarabine|fludarabine|mesh-list
64356660|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
64356661|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64356662|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
64356663|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356664|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356665|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64356666|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
64356669|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64356670|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64356671|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64356672|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
64356673|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64356674|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356712|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356713|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64356714|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64356775|NCT03398759|Analgesics|analgesics|mesh-ancestor
64356776|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
64356777|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356778|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
64356779|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356780|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64356781|NCT03391219|Bevacizumab|bevacizumab|mesh-list
64356782|NCT03391219|Fasudil|fasudil|mesh-list
64356783|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356868|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64356869|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64356870|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356877|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64356878|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356879|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356880|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356881|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64356893|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
64356894|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356895|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64356896|NCT00783263|Ezetimibe|ezetimibe|mesh-list
64356897|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64356898|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64356899|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
64356900|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356901|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64356936|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64356937|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64356938|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356939|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356940|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64356941|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
64356942|NCT03388853|Doxofylline|doxofylline|mesh-list
64356943|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64356944|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
64356946|NCT03388853|Expectorants|expectorants|mesh-ancestor
64356947|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356948|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64356949|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
64356950|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356951|NCT03388853|Protective Agents|protective agents|mesh-ancestor
64356952|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356953|NCT03388853|Antidotes|antidotes|mesh-ancestor
64356954|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
64356955|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64356958|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64356959|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64356960|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356962|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64356963|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
64356964|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64356965|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
64356966|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357414|NCT03387943|Cisplatin|cisplatin|mesh-list
64357415|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357416|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
64357419|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357420|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
64357421|NCT03384095|Protective Agents|protective agents|mesh-ancestor
64357423|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64357424|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64357425|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
64357426|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357427|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357428|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357441|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357442|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357443|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64357480|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357481|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357483|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
64357602|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357603|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357604|NCT03387163|Valsartan|valsartan|mesh-list
64357605|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64357606|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64357607|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64357608|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64357609|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357611|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357612|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357614|NCT05237791|Analgesics|analgesics|mesh-ancestor
64357615|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
64357618|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
64357619|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357620|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64357641|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357642|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357643|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357645|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64357646|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
64357647|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64357648|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
64357649|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357650|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357651|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64357652|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64357653|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357655|NCT03460015|Sevoflurane|sevoflurane|mesh-list
64357656|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64357657|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357658|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357659|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64357785|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357787|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
64357788|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357789|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357790|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
64357791|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64357794|NCT03385135|Protective Agents|protective agents|mesh-ancestor
64357795|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357796|NCT02766335|Docetaxel|docetaxel|mesh-list
64358163|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358164|NCT03376243|Emollients|emollients|mesh-list
64358165|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
64358166|NCT03700411|Morphine|morphine|mesh-list
64358167|NCT03700411|Pirinitramide|pirinitramide|mesh-list
64358168|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64358169|NCT03700411|Narcotics|narcotics|mesh-ancestor
64358170|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358171|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358172|NCT03700411|Analgesics|analgesics|mesh-ancestor
64358173|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
64358174|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358175|NCT03691051|Capecitabine|capecitabine|mesh-list
64358176|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64358177|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
64358178|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358323|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64358324|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358325|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64358326|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64358327|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358328|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358329|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358330|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
64358331|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
64358332|NCT03370705|Captopril|captopril|mesh-list
64358333|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64358334|NCT03370705|Atorvastatin|atorvastatin|mesh-list
64358335|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64358336|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64358337|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64358338|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
64358339|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358340|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64358341|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64358342|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358343|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
64358344|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64358345|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
64358346|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64358347|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64358348|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358349|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358350|NCT03370705|Analgesics|analgesics|mesh-ancestor
64358351|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
64358352|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358353|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64358354|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64358355|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358357|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64358358|NCT03370627|Antibodies|antibodies|mesh-list
64358359|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
64358360|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358361|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
64358362|NCT03369379|Vitamins|vitamins|mesh-ancestor
64358363|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
64358364|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358431|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358432|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358433|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
64358434|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358435|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358436|NCT04525495|Protective Agents|protective agents|mesh-ancestor
64358437|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64358438|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358509|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358510|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64358512|NCT02929485|Tolcapone|tolcapone|mesh-list
64358513|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64358514|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64358515|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
64358516|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358517|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358518|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
64358519|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
64358520|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358554|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358555|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64358556|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64358558|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358559|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358910|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358912|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
64358913|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64358914|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64358915|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
64358916|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358917|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
64358918|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
64358919|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358920|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64359030|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359031|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64359032|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64359033|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359034|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359035|NCT03364075|Propranolol|propranolol|mesh-list
64359036|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64359038|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64359039|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64359042|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359043|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359044|NCT03364075|Analgesics|analgesics|mesh-ancestor
64359045|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
64359054|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64359055|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
64359088|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64359089|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
64359090|NCT04773405|Lidocaine|lidocaine|mesh-list
64359091|NCT04773405|Epinephrine|epinephrine|mesh-list
64359092|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
64359093|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
64359094|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
64359095|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359096|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359097|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
64359098|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359099|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64359100|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64359174|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64359175|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
64359176|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359241|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64359242|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64359245|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359246|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64359247|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
64359248|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64359249|NCT03353857|Diuretics|diuretics|mesh-ancestor
64359250|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
64359309|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359311|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
64359312|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359313|NCT05403489|Dimercaprol|dimercaprol|mesh-list
64359314|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
64359315|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
64359316|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359317|NCT04969731|Gemcitabine|gemcitabine|mesh-list
64359318|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64359319|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
64359320|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359369|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64359370|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64359371|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64359372|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359400|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359401|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359402|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359405|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359406|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359450|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64359452|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64359453|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64359454|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
64359455|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64359456|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64359457|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64359458|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359459|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64359460|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
64359461|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359462|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64359463|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64359464|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64367888|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64359465|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359467|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64359468|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64359469|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
64359470|NCT02889237|Vitamin D|vitamin d|mesh-list
64359484|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359485|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
64359486|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64359487|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359488|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359489|NCT02582697|Cisplatin|cisplatin|mesh-list
64359490|NCT02582697|Etoposide|etoposide|mesh-list
64359491|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
64359492|NCT02582697|Bleomycin|bleomycin|mesh-list
64359509|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359510|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359512|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
64359513|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359514|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64359515|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359516|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64359517|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
64359521|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64359522|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359523|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359524|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64359525|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64359526|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359527|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
64359528|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359529|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
64359530|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359532|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64359607|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64359609|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
64359610|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359663|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359664|NCT03122353|Calcitriol|calcitriol|mesh-list
64359665|NCT03122353|Betamethasone|betamethasone|mesh-list
64359666|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
64359667|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64359668|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
64359682|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359683|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64359684|NCT03122353|Vitamins|vitamins|mesh-ancestor
64359685|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
64359686|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64359687|NCT05303259|Bevacizumab|bevacizumab|mesh-list
64359688|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64359689|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359690|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64359691|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64359692|NCT05303259|Growth Substances|growth substances|mesh-ancestor
64359693|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359694|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
64359695|NCT03121963|Acetaminophen|acetaminophen|mesh-list
64359696|NCT03121963|Celecoxib|celecoxib|mesh-list
64359697|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64359757|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
64359758|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359759|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359760|NCT04943679|Interferons|interferons|mesh-list
64359761|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
64359762|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359763|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
64359764|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359765|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
64359766|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359767|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
64359873|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
64359874|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64359875|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
64359876|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359877|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359878|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359879|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64359880|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64359987|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
64359989|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359990|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359991|NCT05060523|Tolvaptan|tolvaptan|mesh-list
64359992|NCT05060523|Midodrine|midodrine|mesh-list
64359993|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64359994|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359995|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
64359996|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359997|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
64359998|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
64360034|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64360035|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64360036|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360038|NCT03955575|Hormones|hormones|mesh-ancestor
64360068|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
64360069|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64360070|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360071|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64360072|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64360073|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360074|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360075|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360076|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64360077|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64360078|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64360079|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64360080|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
64360081|NCT02449005|Coagulants|coagulants|mesh-ancestor
64360082|NCT04132791|Aspirin|aspirin|mesh-list
64360083|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64360113|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64360115|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64360116|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64360117|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360118|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360119|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64360254|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360255|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360256|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
64360257|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64360258|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
64360259|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
64360262|NCT03218137|Analgesics|analgesics|mesh-ancestor
64360270|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
64360271|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360276|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
64360278|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64360279|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360281|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
64360282|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
64360283|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360284|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360285|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
64360286|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360287|NCT02507479|Thiotepa|thiotepa|mesh-list
64360295|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360296|NCT02512315|Cisplatin|cisplatin|mesh-list
64360297|NCT02512315|Docetaxel|docetaxel|mesh-list
64360298|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360299|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
64360300|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
64360319|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360320|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
64360321|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360322|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64360323|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
64360324|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360325|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64360326|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64360327|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360328|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64360329|NCT05431413|Protective Agents|protective agents|mesh-ancestor
64360330|NCT02507245|Hormones|hormones|mesh-list
64360331|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
64360332|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360333|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360334|NCT02517307|Heparin|heparin|mesh-list
64360335|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
64360336|NCT02517307|Glycerol|glycerol|mesh-list
64360337|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
64360338|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64360339|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64360340|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360341|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64360342|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64360343|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64360344|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64360346|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360347|NCT05431257|Venetoclax|venetoclax|mesh-list
64360348|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360349|NCT05431023|Lactoferrin|lactoferrin|mesh-list
64360350|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360351|NCT03136029|Antioxidants|antioxidants|mesh-list
64360352|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360386|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64360387|NCT01376167|Filaricides|filaricides|mesh-ancestor
64360388|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
64360389|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
64360390|NCT02511613|Squalamine|squalamine|mesh-list
64360391|NCT02511613|Ranibizumab|ranibizumab|mesh-list
64360392|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64360429|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360430|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
64360431|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360432|NCT02516527|Ipilimumab|ipilimumab|mesh-list
64360433|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64360434|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360435|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64360436|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360438|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360439|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64360440|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360441|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360442|NCT02506855|Ropivacaine|ropivacaine|mesh-list
64360494|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64360510|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64360511|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64360512|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64360513|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64360514|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
64360515|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360516|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360517|NCT03345667|Ranibizumab|ranibizumab|mesh-list
64360518|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64360519|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64360520|NCT03345667|Growth Substances|growth substances|mesh-ancestor
64360522|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
64360523|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360525|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
64360526|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64360527|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360528|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64360529|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64360530|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
64360531|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360532|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64360533|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
64360534|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
64360535|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360536|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
64360538|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360539|NCT02505451|Dobutamine|dobutamine|mesh-list
64360568|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360569|NCT03121807|Leucovorin|leucovorin|mesh-list
64360570|NCT03121807|Fluorouracil|fluorouracil|mesh-list
64360571|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
64360572|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
64360573|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360574|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360575|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360576|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360577|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
64360578|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360579|NCT03121807|Antidotes|antidotes|mesh-ancestor
64360580|NCT03121807|Protective Agents|protective agents|mesh-ancestor
64360581|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
64360583|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
64360584|NCT03343873|Midazolam|midazolam|mesh-list
64360691|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64360692|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64360693|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
64360694|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64360695|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
64360696|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
64360697|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
64360699|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
64360701|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360702|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
64360704|NCT02729545|Cyproterone|cyproterone|mesh-list
64360705|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64360707|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64360708|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
64360709|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64360710|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360747|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360748|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360749|NCT02509273|Analgesics|analgesics|mesh-ancestor
64360750|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
64360765|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
64360766|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360767|NCT02514343|Analgesics|analgesics|mesh-ancestor
64360768|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64360769|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
64360770|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64360771|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64360772|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360773|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64360774|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
64360775|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64360776|NCT02514421|Gemcitabine|gemcitabine|mesh-list
64360777|NCT02514421|Paclitaxel|paclitaxel|mesh-list
64360778|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64360779|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360780|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
64360781|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
64360782|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
64360784|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360785|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
64360786|NCT02514421|Antiviral Agents|antiviral agents|mesh-ancestor
64367927|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360787|NCT02514421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360788|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360789|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360790|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
64360791|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360793|NCT04499209|Pregabalin|pregabalin|mesh-list
64360794|NCT04499209|Analgesics|analgesics|mesh-ancestor
64360795|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
64360796|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360797|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360798|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
64360799|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64360853|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360855|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64360856|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64360857|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
64360875|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360876|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
64360877|NCT03121417|Nivolumab|nivolumab|mesh-list
64360878|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64360879|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360880|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64360881|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360882|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64360883|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64360884|NCT02502643|Picibanil|picibanil|mesh-list
64360885|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360900|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64360901|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64360902|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360903|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360904|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
64360906|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64360907|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64360908|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64360909|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64360911|NCT02502877|Propofol|propofol|mesh-list
64360912|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64360913|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360973|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64360974|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
64360975|NCT02500459|Topotecan|topotecan|mesh-list
64360976|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64360977|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64360978|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360979|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360980|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360981|NCT02500225|Sevoflurane|sevoflurane|mesh-list
64360982|NCT02500225|Etomidate|etomidate|mesh-list
64360983|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64360984|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64360985|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
64360986|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
64360987|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360988|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360989|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64360990|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64361029|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64361030|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
64361031|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361032|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64361033|NCT02499445|Sufentanil|sufentanil|mesh-list
64361034|NCT02499445|Remifentanil|remifentanil|mesh-list
64361035|NCT02499445|Propofol|propofol|mesh-list
64361036|NCT02499445|Sevoflurane|sevoflurane|mesh-list
64361037|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361038|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361039|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361040|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64361041|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
64361042|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
64361043|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64361044|NCT02499445|Narcotics|narcotics|mesh-ancestor
64361045|NCT02499445|Analgesics|analgesics|mesh-ancestor
64361046|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
64361047|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361048|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64361049|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64361050|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64361051|NCT04443049|Mebendazole|mebendazole|mesh-list
64361052|NCT04443049|Piperazine|piperazine|mesh-list
64361053|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
64361054|NCT04443049|Lenvatinib|lenvatinib|mesh-list
64361055|NCT04443049|DMP 777|dmp 777|mesh-list
64361056|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361057|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361058|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361059|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361060|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
64361061|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
64361095|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
64361096|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64361097|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
64361098|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64361100|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
64361101|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
64361102|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361103|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361104|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64361105|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64361106|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
64361107|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361108|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361109|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64361110|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
64361111|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
64361141|NCT02493283|Dapsone|dapsone|mesh-list
64361142|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361143|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
64361144|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64361145|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64361146|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64361147|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361148|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361149|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
64361150|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64361151|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
64361152|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361153|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361170|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361171|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64361172|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64361174|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361175|NCT03120715|Heparin|heparin|mesh-list
64361176|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64361177|NCT03120715|Tinzaparin|tinzaparin|mesh-list
64361178|NCT03120715|Dalteparin|dalteparin|mesh-list
64361179|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64361180|NCT03120715|Progesterone|progesterone|mesh-list
64361181|NCT03120715|Estrogens|estrogens|mesh-list
64361182|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
64361183|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64361184|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64361185|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361186|NCT03120715|Progestins|progestins|mesh-ancestor
64361187|NCT03120715|Hormones|hormones|mesh-ancestor
64296047|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361188|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361189|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361190|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361192|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64361193|NCT03120403|Narcotics|narcotics|mesh-ancestor
64361207|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361208|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64361209|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64361210|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
64361211|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361246|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361247|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361249|NCT03335059|Mitomycin|mitomycin|mesh-list
64361250|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64361251|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361269|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64361270|NCT02492503|Carboplatin|carboplatin|mesh-list
64361271|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64361272|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361273|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
64361274|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
64361275|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
64361276|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361278|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361279|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361280|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361281|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361282|NCT03334513|Bevacizumab|bevacizumab|mesh-list
64361283|NCT03334513|Ranibizumab|ranibizumab|mesh-list
64361284|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64361285|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361286|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64361287|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64361289|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361290|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
64361291|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
64361292|NCT02130466|Trametinib|trametinib|mesh-list
64361293|NCT02130466|Dabrafenib|dabrafenib|mesh-list
64361294|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64361295|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361296|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361298|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361299|NCT03339427|Vitamin D|vitamin d|mesh-list
64361300|NCT03339427|Vitamins|vitamins|mesh-ancestor
64361301|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
64361302|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361303|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64361304|NCT03339349|Enoxaparin|enoxaparin|mesh-list
64361305|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
64361306|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64361307|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64361308|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361309|NCT02496715|Fluticasone|fluticasone|mesh-list
64361311|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64361344|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64361345|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64361346|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361347|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361348|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361349|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361350|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64361351|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64361352|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
64361353|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
64361354|NCT02162758|Lansoprazole|lansoprazole|mesh-list
64361356|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64361357|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64361358|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361359|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361360|NCT03333499|Trimetazidine|trimetazidine|mesh-list
64361361|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
64361362|NCT04494529|Betamethasone|betamethasone|mesh-list
64361377|NCT02491879|Analgesics|analgesics|mesh-ancestor
64361378|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
64361379|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361380|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361381|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361382|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361383|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64361384|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361385|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361387|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64361388|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
64361389|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361390|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361391|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64361392|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64361402|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
64361403|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361404|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361406|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
64361407|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361408|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361409|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
64361410|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361411|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64361412|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64361413|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
64361414|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361415|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64361416|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64361417|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361419|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
64361448|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64361449|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361450|NCT03329443|Spironolactone|spironolactone|mesh-list
64361451|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64361452|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
64361453|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361454|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361455|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64361456|NCT03329443|Diuretics|diuretics|mesh-ancestor
64361457|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
64361458|NCT03328975|Dexamethasone|dexamethasone|mesh-list
64361459|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361460|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
64361461|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
64361462|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361463|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361464|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64361465|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
64361466|NCT03328975|Hormones|hormones|mesh-ancestor
64361495|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64361496|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361497|NCT03324061|Fulvestrant|fulvestrant|mesh-list
64361498|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64361507|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
64296048|NCT04741334|Anticoagulants|anticoagulants|mesh-list
64361509|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361510|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64361511|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361512|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64361513|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64361548|NCT03327727|Isavuconazole|isavuconazole|mesh-list
64361549|NCT03327727|VL-2397|vl-2397|mesh-list
64361550|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
64361551|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361552|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64361553|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64361582|NCT03323593|Analgesics|analgesics|mesh-ancestor
64361583|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
64361584|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361585|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64361586|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64361587|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64361588|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361589|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361590|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361591|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
64361592|NCT02499003|Pixantrone|pixantrone|mesh-list
64361593|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64361594|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361595|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64361596|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64361597|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361629|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
64361630|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361631|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
64361632|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361633|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64361634|NCT05253573|Nicotine|nicotine|mesh-list
64361635|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64361636|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
64361642|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361669|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64361671|NCT03323047|Hormones|hormones|mesh-ancestor
64361679|NCT03323047|Analgesics|analgesics|mesh-ancestor
64361680|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
64361681|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
64361683|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64361684|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361685|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
64361686|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
64361687|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
64361688|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361689|NCT05464303|Antibodies|antibodies|mesh-list
64361690|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64361692|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64361693|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
64361724|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361725|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64361726|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64361727|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
64361728|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361729|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296049|NCT04741334|Dicumarol|dicumarol|mesh-list
64361730|NCT03318835|Thalidomide|thalidomide|mesh-list
64361731|NCT03318835|Prednisone|prednisone|mesh-list
64361732|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
64361733|NCT03318835|Vincristine|vincristine|mesh-list
64361734|NCT03318835|Rituximab|rituximab|mesh-list
64361735|NCT03318835|Doxorubicin|doxorubicin|mesh-list
64361736|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64361737|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
64361762|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64361763|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64361764|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64361765|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361767|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
64361768|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
64361769|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361770|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361771|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
64361772|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361851|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361852|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64361865|NCT03316339|Remifentanil|remifentanil|mesh-list
64361866|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361890|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64361891|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
64361892|NCT03318211|Analgesics|analgesics|mesh-ancestor
64361893|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
64361894|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361895|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361896|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
64361897|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361898|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64361899|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
64361901|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64361902|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361903|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64361904|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
64361905|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361906|NCT02483767|Goserelin|goserelin|mesh-list
64361909|NCT02483845|Natalizumab|natalizumab|mesh-list
64361910|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
64361911|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361912|NCT02486341|Insulin|insulin|mesh-list
64361913|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64361914|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361915|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
64361935|NCT02490085|Insulin|insulin|mesh-list
64361936|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64361937|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64361938|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361939|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
64361940|NCT03102021|Hematinics|hematinics|mesh-ancestor
64361941|NCT04916691|Ropivacaine|ropivacaine|mesh-list
64361942|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
64361943|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
64361944|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361945|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361951|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64361953|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64361954|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64361955|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
64361956|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361957|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64361958|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
64361959|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
64361960|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64361961|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361962|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64361963|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361965|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
64361966|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361967|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361968|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361969|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
64361970|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64361971|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361972|NCT03317275|Fluorides|fluorides|mesh-list
64361998|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64361999|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
64362000|NCT02483299|Metformin|metformin|mesh-list
64362001|NCT02483299|Liraglutide|liraglutide|mesh-list
64362002|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64362003|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362004|NCT02483299|Incretins|incretins|mesh-ancestor
64362106|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362107|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64362108|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64362109|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
64362111|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64362113|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
64362114|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64362115|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
64362116|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
64362117|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64362119|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
64362120|NCT02485873|Vitamins|vitamins|mesh-ancestor
64362121|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
64362122|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362123|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64362124|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
64362160|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362161|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64362162|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362163|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
64362164|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362165|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362166|NCT03320707|Daratumumab|daratumumab|mesh-list
64362167|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362169|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362170|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64362171|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362172|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362173|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64362174|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64362175|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64362176|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
64362177|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362178|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64362179|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64362180|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362181|NCT02476981|Ephedrine|ephedrine|mesh-list
64362182|NCT02476981|Midazolam|midazolam|mesh-list
64362183|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
64362184|NCT02476981|Remifentanil|remifentanil|mesh-list
64362185|NCT02476981|Propofol|propofol|mesh-list
64362186|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64362187|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362188|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362189|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64362210|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64362212|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
64362213|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64362214|NCT04248465|Ravulizumab|ravulizumab|mesh-list
64362215|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64362216|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362217|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
64362218|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362220|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64362221|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64362222|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362223|NCT05456269|Cytarabine|cytarabine|mesh-list
64362224|NCT05456269|Decitabine|decitabine|mesh-list
64362225|NCT05456269|Bisantrene|bisantrene|mesh-list
64362226|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64362227|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
64362228|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362229|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362239|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362240|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64362241|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
64362242|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362243|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362244|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64362245|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
64362280|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
64362281|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362283|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
64362284|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
64362285|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362286|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362287|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
64362288|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362289|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64362315|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
64362316|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
64362317|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362318|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
64362319|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362320|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362321|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
64362322|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64362323|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64362334|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64362335|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362336|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64362337|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362365|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
64362366|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362367|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64362368|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64362369|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
64362370|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362371|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362372|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64362374|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
64362376|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
64362377|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362378|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64362379|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64362381|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
64362382|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64362383|NCT02479555|BB 1101|bb 1101|mesh-list
64362384|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362393|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64362394|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362395|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
64362396|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362397|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362398|NCT02476045|Leucovorin|leucovorin|mesh-list
64362399|NCT02476045|Fluorouracil|fluorouracil|mesh-list
64362400|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
64362401|NCT02476045|Panitumumab|panitumumab|mesh-list
64362402|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
64362403|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
64362404|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362405|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64362406|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362407|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362408|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
64362409|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362410|NCT02476045|Antidotes|antidotes|mesh-ancestor
64362411|NCT02476045|Protective Agents|protective agents|mesh-ancestor
64362412|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
64362413|NCT02476045|Vitamins|vitamins|mesh-ancestor
64362414|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
64362415|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64362416|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
64362417|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64362418|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362429|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64362431|NCT02480881|Fostemsavir|fostemsavir|mesh-list
64362432|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
64362433|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
64362434|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
64362435|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64362436|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362437|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64362438|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64362439|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64362440|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
64362441|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362442|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64362443|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64296050|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64362445|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64362446|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64362447|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64362448|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
64362449|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64362476|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64362478|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
64362479|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362480|NCT05714839|Dexamethasone|dexamethasone|mesh-list
64362481|NCT05714839|Lenalidomide|lenalidomide|mesh-list
64362482|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362483|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
64362484|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
64362485|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362486|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362487|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362488|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
64362489|NCT05714839|Hormones|hormones|mesh-ancestor
64362490|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362491|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64362492|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362493|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
64362494|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64362495|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64362496|NCT05714839|Growth Substances|growth substances|mesh-ancestor
64362497|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
64362498|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
64362538|NCT02475499|Incretins|incretins|mesh-list
64362539|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362540|NCT02475499|Hormones|hormones|mesh-ancestor
64362541|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362542|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
64362543|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362544|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362545|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64362618|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362620|NCT05714371|Nivolumab|nivolumab|mesh-list
64362621|NCT05714371|Ipilimumab|ipilimumab|mesh-list
64362622|NCT05714371|Trametinib|trametinib|mesh-list
64362623|NCT05714371|Dabrafenib|dabrafenib|mesh-list
64362624|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64362625|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362626|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64362627|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362628|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64362629|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362631|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64362632|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64362633|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362634|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362635|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362636|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
64362671|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64362673|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362674|NCT03099759|Vitamin D|vitamin d|mesh-list
64362675|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
64362676|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
64362677|NCT03099759|Vitamins|vitamins|mesh-ancestor
64362678|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
64362706|NCT05710237|Risperidone|risperidone|mesh-list
64362707|NCT05710237|Psilocybin|psilocybin|mesh-list
64362708|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64362709|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
64362710|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296051|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362711|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362712|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362713|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64362714|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64362715|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362716|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64362717|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64362718|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
64362719|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
64362720|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64362721|NCT05067699|Calcifediol|calcifediol|mesh-list
64362722|NCT05067699|Vitamins|vitamins|mesh-ancestor
64362723|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
64362724|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362737|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64362738|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362739|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362740|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64362741|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
64362751|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362752|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64362753|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362754|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64362755|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
64362756|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362757|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64362758|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362759|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
64362761|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
64362762|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362763|NCT03098823|Prednisone|prednisone|mesh-list
64362764|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362765|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
64362766|NCT03098823|Hormones|hormones|mesh-ancestor
64362767|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362768|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362769|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64362770|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362771|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
64362772|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64362773|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362774|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362775|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64362776|NCT03108937|Analgesics|analgesics|mesh-ancestor
64362777|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
64362778|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362779|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64362780|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64362833|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64362834|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64362835|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
64362836|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362837|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362838|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362839|NCT05010681|Lenvatinib|lenvatinib|mesh-list
64362840|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362841|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64362842|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362843|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362845|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
64362846|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362863|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362864|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362865|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64362866|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64362867|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64362868|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362869|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362871|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64362872|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362874|NCT05649943|Hormones|hormones|mesh-ancestor
64362875|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362876|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362877|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
64362878|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64362879|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362880|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
64362881|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64362882|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362883|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362884|NCT04474353|Temozolomide|temozolomide|mesh-list
64362885|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64362886|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
64362887|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362888|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362889|NCT03099213|Ramipril|ramipril|mesh-list
64362890|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64362891|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
64362892|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362893|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362894|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64362895|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
64362896|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64362898|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362899|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
64362900|NCT04755634|Protective Agents|protective agents|mesh-ancestor
64362928|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64362929|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362930|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362931|NCT04470843|Diuretics|diuretics|mesh-ancestor
64362932|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
64362933|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362935|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64362936|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362937|NCT02473627|Pioglitazone|pioglitazone|mesh-list
64362938|NCT02473627|Tolbutamide|tolbutamide|mesh-list
64362939|NCT02473627|DS-1971a|ds-1971a|mesh-list
64362940|NCT02473627|Midazolam|midazolam|mesh-list
64362941|NCT02473627|Omeprazole|omeprazole|mesh-list
64362942|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64362943|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64362944|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362945|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362946|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64362947|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64362948|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64362949|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64362950|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
64362951|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
64362952|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
64362953|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
64362954|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362955|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362956|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64362957|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64362958|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362959|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64362960|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362985|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362986|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362987|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
64362988|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64362989|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
64362990|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362991|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
64362992|NCT02476903|Protective Agents|protective agents|mesh-ancestor
64362993|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
64362994|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64362995|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
64362996|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362997|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362998|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64362999|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
64363000|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
64363009|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363010|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363031|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363033|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64363034|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64363035|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363036|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64363037|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
64363038|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
64363039|NCT02472691|Lenalidomide|lenalidomide|mesh-list
64363042|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363043|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64363044|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64363045|NCT02472691|Growth Substances|growth substances|mesh-ancestor
64363046|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
64363047|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363048|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64363050|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363051|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363052|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
64363054|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64363055|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363056|NCT02470663|Antacids|antacids|mesh-ancestor
64363057|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363058|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363059|NCT00705367|Abatacept|abatacept|mesh-list
64363060|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64363061|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363062|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363063|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363064|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
64363140|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64363141|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363150|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363151|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
64363152|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363153|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363154|NCT02693821|Gabapentin|gabapentin|mesh-list
64363155|NCT02693821|Analgesics|analgesics|mesh-ancestor
64363156|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
64363157|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367944|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64363158|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363159|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
64363160|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64363161|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363162|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363163|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64363164|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64363165|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64363166|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363167|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363168|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
64363170|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363171|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363173|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
64363202|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363203|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363204|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
64363205|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363206|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363207|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64363208|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
64363209|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64363210|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363211|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64363212|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64363213|NCT02299999|Growth Substances|growth substances|mesh-ancestor
64363214|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
64363215|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64363216|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
64363217|NCT02299999|Antiviral Agents|antiviral agents|mesh-ancestor
64363227|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64363228|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64363260|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363261|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64363262|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64363263|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64363264|NCT03744793|Pemetrexed|pemetrexed|mesh-list
64363265|NCT03744793|Avelumab|avelumab|mesh-list
64363266|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64363267|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363268|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363269|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363270|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64363301|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
64363302|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64363303|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
64363304|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363306|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64363308|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64363309|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363310|NCT03309163|Tramadol|tramadol|mesh-list
64363311|NCT03309163|Hydromorphone|hydromorphone|mesh-list
64363312|NCT03309163|Ropivacaine|ropivacaine|mesh-list
64363313|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
64363314|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
64363347|NCT03313531|Coagulants|coagulants|mesh-ancestor
64363348|NCT02468167|Polidocanol|polidocanol|mesh-list
64363349|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64363350|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64363351|NCT03308149|Triamcinolone|triamcinolone|mesh-list
64363352|NCT03308149|Bupivacaine|bupivacaine|mesh-list
64363353|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
64363354|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
64363391|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64363392|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
64363394|NCT03302845|Famotidine|famotidine|mesh-list
64363395|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64363396|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363397|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64363398|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363399|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363400|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64363401|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
64363402|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
64363403|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363404|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363406|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
64363407|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64363408|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
64363409|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
64363410|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363416|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363417|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64363418|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363419|NCT02468323|Ondansetron|ondansetron|mesh-list
64363420|NCT02468323|Palonosetron|palonosetron|mesh-list
64363421|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
64363422|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
64363423|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363424|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363425|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363426|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
64363427|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
64363428|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64363429|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
64363430|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363431|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363432|NCT02468323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64363433|NCT02468323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363434|NCT02468323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363435|NCT02468323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64363436|NCT02468323|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64363437|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64363439|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
64363440|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363441|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363442|NCT03307213|Sirolimus|sirolimus|mesh-list
64363443|NCT03307213|Umirolimus|umirolimus|mesh-list
64363444|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64363445|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363446|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
64363447|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363448|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64363449|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363450|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64363451|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363452|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
64363453|NCT03302299|Pyridoxine|pyridoxine|mesh-list
64363463|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64363466|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363467|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64363468|NCT03302221|Ropivacaine|ropivacaine|mesh-list
64363469|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
64363470|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363471|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363472|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
64363473|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
64363474|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363475|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
64363476|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64363477|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
64363478|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363479|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363481|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
64363488|NCT03306745|Hematinics|hematinics|mesh-ancestor
64363489|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
64363490|NCT03306745|Vitamins|vitamins|mesh-ancestor
64363491|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
64363492|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363493|NCT03306667|Dotinurad|dotinurad|mesh-list
64363494|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
64363495|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
64363496|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363497|NCT03306667|Renal Agents|renal agents|mesh-ancestor
64363498|NCT03312283|Ranibizumab|ranibizumab|mesh-list
64367953|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
64363499|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64363500|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64363501|NCT03312283|Growth Substances|growth substances|mesh-ancestor
64363502|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363503|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
64363504|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363505|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
64363506|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64363507|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363516|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363517|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64363518|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363519|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64363520|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64363521|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
64363522|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
64363523|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
64363524|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
64363525|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363526|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363527|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64363528|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
64363529|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64363530|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64363531|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363532|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
64363533|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64363534|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64363535|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363536|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64363537|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
64363538|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363539|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64363540|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64363541|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64363542|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64363543|NCT03301207|Estrogens|estrogens|mesh-ancestor
64363544|NCT03301207|Hormones|hormones|mesh-ancestor
64363545|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363546|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64363547|NCT03311971|Methamphetamine|methamphetamine|mesh-list
64363548|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64363549|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363550|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
64363561|NCT03311737|Anesthetics|anesthetics|mesh-list
64363562|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363563|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363564|NCT02467543|Ethanol|ethanol|mesh-list
64363565|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64363566|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363567|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363568|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363569|NCT03311581|Propofol|propofol|mesh-list
64363570|NCT03311581|Sevoflurane|sevoflurane|mesh-list
64363571|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64363572|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363573|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363574|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64363575|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
64363577|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64363578|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64363580|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
64363581|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64363582|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64363583|NCT03311425|Prednisolone|prednisolone|mesh-list
64363593|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
64363595|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363596|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64363597|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363598|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64363599|NCT03311425|Protective Agents|protective agents|mesh-ancestor
64363600|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
64363601|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
64363602|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64363603|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64363604|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363605|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363606|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363607|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363608|NCT03300115|Abivertinib|abivertinib|mesh-list
64363609|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64363610|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363611|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363612|NCT02916979|Methotrexate|methotrexate|mesh-list
64363613|NCT02916979|Fludarabine|fludarabine|mesh-list
64363614|NCT02916979|Busulfan|busulfan|mesh-list
64363633|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64363635|NCT00702949|Analgesics|analgesics|mesh-ancestor
64363636|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
64363637|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363638|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363639|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
64363640|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64363641|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363642|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363643|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64363644|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64363646|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363648|NCT04791475|Dexamethasone|dexamethasone|mesh-list
64363649|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
64363650|NCT04791475|Bupivacaine|bupivacaine|mesh-list
64363651|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64363652|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
64363653|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
64363654|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363655|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363656|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363657|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
64363658|NCT04791475|Hormones|hormones|mesh-ancestor
64363659|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363660|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64363661|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363696|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363698|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64363700|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363701|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
64363702|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363703|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363704|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
64363706|NCT02466373|Analgesics|analgesics|mesh-ancestor
64363707|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
64363708|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363709|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363710|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64363711|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
64363712|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
64363713|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64363714|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64363715|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64363716|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
64363717|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363718|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363720|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64363721|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64363722|NCT05727397|Growth Substances|growth substances|mesh-ancestor
64363723|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363724|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
64363725|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363740|NCT02466919|Metronidazole|metronidazole|mesh-list
64363741|NCT02466919|Clarithromycin|clarithromycin|mesh-list
64363742|NCT02466919|Levofloxacin|levofloxacin|mesh-list
64363744|NCT02466919|Pantoprazole|pantoprazole|mesh-list
64363745|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64363746|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363747|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64363748|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64363749|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64363750|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363751|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363752|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64363753|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64363775|NCT05727163|Growth Substances|growth substances|mesh-ancestor
64363776|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363777|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
64363778|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64363779|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
64363780|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
64363781|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363782|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363783|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
64363784|NCT05727163|Hormones|hormones|mesh-ancestor
64363816|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363827|NCT05302531|Renal Agents|renal agents|mesh-ancestor
64363850|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64363851|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
64363852|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363853|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363854|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64363855|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
64363856|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
64363857|NCT00702325|Hormones|hormones|mesh-ancestor
64363858|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363859|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64363860|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64363861|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64363862|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
64363863|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363864|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363865|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64363866|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
64363867|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363868|NCT02464813|Pregabalin|pregabalin|mesh-list
64363869|NCT02464813|Oxycodone|oxycodone|mesh-list
64363870|NCT02464813|Analgesics|analgesics|mesh-ancestor
64363871|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
64363872|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363873|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363877|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363910|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
64363911|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363912|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64363914|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
64363915|NCT02464501|Paclitaxel|paclitaxel|mesh-list
64363916|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64363917|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363918|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
64363948|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
64363949|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
64363950|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363951|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
64363952|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363953|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363962|NCT00701779|Tamsulosin|tamsulosin|mesh-list
64363963|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64363964|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64363987|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64363988|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64363989|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363990|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363991|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363992|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64363993|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64363994|NCT04150861|Hormones|hormones|mesh-ancestor
64363995|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363996|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363997|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
64363998|NCT02465359|Antibodies|antibodies|mesh-list
64363999|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
64364000|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64364001|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64364002|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
64364003|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364004|NCT02463019|Tenofovir|tenofovir|mesh-list
64364005|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
64364006|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364007|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64364008|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64364009|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364010|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364011|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64364012|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64364013|NCT02462941|Adenosine|adenosine|mesh-list
64364014|NCT02462941|Analgesics|analgesics|mesh-ancestor
64364015|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
64364016|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364047|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364049|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364051|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
64364052|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
64364053|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364054|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364055|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64364056|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364057|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
64364058|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64364059|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364060|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364094|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364095|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64364096|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64364098|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364121|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364123|NCT04489459|Colistin|colistin|mesh-list
64364124|NCT04489459|Tigecycline|tigecycline|mesh-list
64364125|NCT04489459|Polymyxins|polymyxins|mesh-list
64364126|NCT04489459|Polymyxin B|polymyxin b|mesh-list
64364127|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364128|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364129|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64364130|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364131|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364132|NCT03296137|Aldesleukin|aldesleukin|mesh-list
64364133|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
64364134|NCT03296137|Nivolumab|nivolumab|mesh-list
64364135|NCT03296137|Ipilimumab|ipilimumab|mesh-list
64364136|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
64364137|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364138|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
64364139|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364140|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364141|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64364142|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
64364144|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364145|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64364146|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64364147|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64364148|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64364150|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64364151|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64364152|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
64364153|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364154|NCT03295903|Cannabidiol|cannabidiol|mesh-list
64364155|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
64364156|NCT02460913|Morphine|morphine|mesh-list
64364157|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64364158|NCT02460913|Narcotics|narcotics|mesh-ancestor
64364159|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364160|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364161|NCT02460913|Analgesics|analgesics|mesh-ancestor
64364196|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
64364197|NCT03289819|Epirubicin|epirubicin|mesh-list
64364198|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64364200|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
64364201|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
64364202|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
64364213|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64364214|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64364215|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364217|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64364218|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364220|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64364221|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364222|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64364223|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364224|NCT03372785|Aspirin|aspirin|mesh-list
64364225|NCT03372785|Metoprolol|metoprolol|mesh-list
64364228|NCT03372785|Atorvastatin|atorvastatin|mesh-list
64364229|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64364230|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64364231|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64364260|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64364261|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64364262|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
64364264|NCT03372473|Montelukast|montelukast|mesh-list
64364265|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64364266|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
64364269|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364270|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364271|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64364272|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64364273|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364274|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
64364308|NCT03294967|Vitamin E|vitamin e|mesh-list
64364309|NCT03294967|Caffeine|caffeine|mesh-list
64364310|NCT03294967|Vitamins|vitamins|mesh-ancestor
64364311|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
64364312|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364313|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64364314|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64364315|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364334|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64364335|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64364336|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
64364337|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
64364338|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364339|NCT04307329|Trastuzumab|trastuzumab|mesh-list
64364340|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64364341|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364350|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364351|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
64364353|NCT03294577|Doxorubicin|doxorubicin|mesh-list
64364354|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364355|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
64364356|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364357|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364358|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64364359|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
64364360|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364361|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367960|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64364362|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64364363|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
64364364|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
64364365|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
64364366|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64364391|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64364393|NCT02460367|Tryptophan|tryptophan|mesh-list
64364394|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364395|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
64364396|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
64364397|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
64364398|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364399|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64364400|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
64364401|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64364402|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
64364403|NCT03370601|Azathioprine|azathioprine|mesh-list
64364404|NCT03370601|Infliximab|infliximab|mesh-list
64364405|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364406|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64364407|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364408|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
64364409|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364410|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64364411|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364414|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364456|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64364457|NCT03288259|Anesthetics|anesthetics|mesh-list
64364458|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
64364459|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364460|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364461|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
64364492|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
64364493|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
64364494|NCT03287011|Protective Agents|protective agents|mesh-ancestor
64364495|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364496|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64364497|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364498|NCT03293641|Folic Acid|folic acid|mesh-list
64364499|NCT03293641|Penicillins|penicillins|mesh-list
64364500|NCT03293641|Penicillin V|penicillin v|mesh-list
64364501|NCT03293641|Proguanil|proguanil|mesh-list
64364514|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364515|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364516|NCT03293641|Astringents|astringents|mesh-ancestor
64364520|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64364521|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
64364523|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64364524|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364525|NCT03293407|Iloprost|iloprost|mesh-list
64364526|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64364527|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
64364528|NCT02519699|Norepinephrine|norepinephrine|mesh-list
64364529|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64364530|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64364531|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
64364532|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364533|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364534|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364535|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
64364536|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
64364537|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364538|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64364539|NCT00701311|Apremilast|apremilast|mesh-list
64364540|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64364541|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64364542|NCT00701311|Analgesics|analgesics|mesh-ancestor
64364543|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
64364544|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364545|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364546|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64364547|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364551|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364552|NCT03375671|Midazolam|midazolam|mesh-list
64364553|NCT03375671|Ketamine|ketamine|mesh-list
64364554|NCT03375671|Haloperidol|haloperidol|mesh-list
64364555|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
64364556|NCT03375671|Analgesics|analgesics|mesh-ancestor
64364602|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
64364603|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
64364604|NCT04525235|Tolbutamide|tolbutamide|mesh-list
64364605|NCT04525235|Rifampin|rifampin|mesh-list
64364606|NCT04525235|Digoxin|digoxin|mesh-list
64364607|NCT04525235|Midazolam|midazolam|mesh-list
64364608|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
64364609|NCT04525235|Caffeine|caffeine|mesh-list
64364610|NCT04525235|Omeprazole|omeprazole|mesh-list
64364611|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64364612|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64364613|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364614|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364615|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64364616|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64364651|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64364652|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64364653|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64364654|NCT03363815|Vitamin K|vitamin k|mesh-list
64364682|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64364683|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64364684|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364685|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
64364686|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64364687|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64364688|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64364689|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64364690|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64364691|NCT03363815|Protective Agents|protective agents|mesh-ancestor
64364692|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64364693|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64364704|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364705|NCT03363659|Trace Elements|trace elements|mesh-ancestor
64364706|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
64364707|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364736|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
64364737|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
64364738|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64364739|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64364740|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364741|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364742|NCT02519153|Urological Agents|urological agents|mesh-ancestor
64364744|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364745|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364746|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64364747|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64364748|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364749|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364750|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364751|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64364767|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64364768|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64364769|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64364770|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
64364771|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364773|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
64364774|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64364775|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364776|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364777|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
64364778|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364779|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364780|NCT03285607|Paclitaxel|paclitaxel|mesh-list
64364781|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
64364782|NCT03285607|Doxorubicin|doxorubicin|mesh-list
64364808|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64364809|NCT04527055|Esomeprazole|esomeprazole|mesh-list
64364811|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364812|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364833|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364834|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364836|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364837|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364838|NCT02460289|Minoxidil|minoxidil|mesh-list
64364839|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64364840|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
64364841|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
64364842|NCT03291457|Hormones|hormones|mesh-ancestor
64364843|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364845|NCT03361709|Dexamethasone|dexamethasone|mesh-list
64364846|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64364847|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
64364848|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
64364849|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364850|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364852|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
64364853|NCT03361709|Hormones|hormones|mesh-ancestor
64364854|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364855|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64364856|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364858|NCT03284749|Trace Elements|trace elements|mesh-ancestor
64364895|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
64364896|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364897|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364898|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364900|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
64364901|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
64364902|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364903|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364904|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
64364905|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364906|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64364907|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64364908|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64364909|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364910|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364911|NCT03109379|Trospium chloride|trospium chloride|mesh-list
64364912|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
64364913|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
64364914|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364915|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364916|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64364917|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64364918|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
64364919|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364920|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364921|NCT03109379|Urological Agents|urological agents|mesh-ancestor
64364938|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64364968|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
64364969|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64364970|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64364971|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64364972|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
64364973|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364974|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64364975|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
64364976|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364977|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364978|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64364979|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64364980|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64365067|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
64365068|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365069|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365070|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64365071|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64365072|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64365073|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
64365074|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365075|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365076|NCT03107923|Protective Agents|protective agents|mesh-ancestor
64365077|NCT03536455|Acetazolamide|acetazolamide|mesh-list
64365078|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
64365079|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64365080|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365081|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365082|NCT03536455|Diuretics|diuretics|mesh-ancestor
64365083|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
64365084|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365085|NCT03529825|Rifaximin|rifaximin|mesh-list
64365086|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64365087|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365088|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64365089|NCT03281941|Capsaicin|capsaicin|mesh-list
64365107|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365108|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365109|NCT03264781|CycloProvera|cycloprovera|mesh-list
64365110|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64365111|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64365112|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64365113|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
64365114|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64365115|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365116|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64365117|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64365118|NCT03281863|Antibodies|antibodies|mesh-list
64365119|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
64365120|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
64365121|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365122|NCT03264625|Vitamin D|vitamin d|mesh-list
64365123|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
64365124|NCT03264625|Vitamins|vitamins|mesh-ancestor
64365125|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
64365126|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365127|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64365128|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64365129|NCT03269929|Midazolam|midazolam|mesh-list
64365130|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64365131|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64365140|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
64365141|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
64365142|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365143|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365144|NCT02730377|Liraglutide|liraglutide|mesh-list
64365145|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64365146|NCT02730377|Meglitinide|meglitinide|mesh-list
64365173|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64365174|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365175|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
64365176|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365177|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64365178|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365179|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365180|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365181|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
64365182|NCT03365141|Hormones|hormones|mesh-ancestor
64365183|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365184|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
64365185|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64365186|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365187|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64365188|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365189|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
64365190|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64365191|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64365192|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64365193|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
64365194|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365228|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365229|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64365230|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64365231|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365232|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64365233|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64365234|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64365235|NCT03358277|Methylphenidate|methylphenidate|mesh-list
64365236|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365255|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64365257|NCT03359057|Hematinics|hematinics|mesh-ancestor
64365285|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365287|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365288|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
64365289|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64365290|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
64365291|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365369|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64365370|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365371|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365372|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
64365373|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365374|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365400|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64365401|NCT03263689|Narcotics|narcotics|mesh-ancestor
64365402|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365403|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365404|NCT03263689|Analgesics|analgesics|mesh-ancestor
64365405|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
64365406|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365407|NCT03279679|Ropivacaine|ropivacaine|mesh-list
64365408|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365409|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
64365410|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365411|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365412|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
64365413|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365414|NCT02518451|Valsartan|valsartan|mesh-list
64365415|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64365416|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64365417|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64365418|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365419|NCT03263299|Aspirin|aspirin|mesh-list
64365420|NCT03263299|Cabergoline|cabergoline|mesh-list
64365421|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64365422|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365423|NCT03263299|Analgesics|analgesics|mesh-ancestor
64365438|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
64365439|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
64365440|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365442|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
64365443|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
64365444|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365447|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365448|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64365449|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365450|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365451|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
64365452|NCT03123107|Vitamins|vitamins|mesh-ancestor
64365453|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
64365454|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365455|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
64365456|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365457|NCT03123107|Protective Agents|protective agents|mesh-ancestor
64365458|NCT04516655|Rituximab|rituximab|mesh-list
64365459|NCT04516655|Methotrexate|methotrexate|mesh-list
64365460|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64365461|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365462|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
64365463|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365464|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365508|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64365509|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365511|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
64365512|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365513|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365514|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365515|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365516|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
64365517|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64365518|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
64365519|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365520|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
64365538|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365573|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64365576|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
64365577|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365578|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64365607|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365608|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
64365609|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
64365610|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
64365611|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64365612|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64365613|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365614|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365615|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365616|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365617|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
64365618|NCT04507217|Carboplatin|carboplatin|mesh-list
64365619|NCT04507217|Pemetrexed|pemetrexed|mesh-list
64365620|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365621|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365622|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365654|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365656|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
64365657|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365658|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365659|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365660|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365661|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
64365662|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365663|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365665|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64365666|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
64365667|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
64365668|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365700|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64365710|NCT03252457|Dexamethasone|dexamethasone|mesh-list
64365726|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365727|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365728|NCT03258931|Cytarabine|cytarabine|mesh-list
64365729|NCT03258931|Midostaurin|midostaurin|mesh-list
64365730|NCT03258931|Crenolanib|crenolanib|mesh-list
64365731|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365732|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
64365733|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365734|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365735|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
64365736|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365737|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365738|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
64365739|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365740|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64365741|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365742|NCT04506125|Chrysarobin|chrysarobin|mesh-list
64365746|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
64365747|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365748|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365749|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365750|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365752|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64365753|NCT03261349|Ledipasvir|ledipasvir|mesh-list
64365754|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
64365756|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
64365758|NCT02455609|Bupivacaine|bupivacaine|mesh-list
64365759|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365760|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
64365761|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365762|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365763|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
64365764|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365765|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64365767|NCT02455609|Analgesics|analgesics|mesh-ancestor
64365768|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64365769|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64365770|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64365823|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365824|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
64365825|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
64365905|NCT03348917|Povidone|povidone|mesh-list
64365906|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64365907|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365908|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
64365909|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
64365910|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
64365911|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
64365943|NCT05350943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365944|NCT03261427|Pregabalin|pregabalin|mesh-list
64365945|NCT03261427|Analgesics|analgesics|mesh-ancestor
64365946|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
64365947|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365948|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365949|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
64365950|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64365951|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64365952|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365953|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64365954|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64365985|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
64365986|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365987|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365988|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64365989|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
64365990|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
64365991|NCT03260569|Protective Agents|protective agents|mesh-ancestor
64365992|NCT04503629|Rabeprazole|rabeprazole|mesh-list
64365993|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64365994|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64365995|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64365996|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365997|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365998|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
64366033|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64366035|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366036|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64366074|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64366076|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
64366077|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
64366078|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
64366104|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64366105|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64366106|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366107|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
64366108|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
64366109|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
64366110|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
64366111|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366112|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64366113|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
64366114|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
64366115|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366116|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64366117|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
64366118|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
64366119|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64366120|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64366121|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64366122|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64366123|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
64366124|NCT03246295|Insulin|insulin|mesh-list
64366125|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366126|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366127|NCT03346733|Psyllium|psyllium|mesh-list
64366128|NCT03346733|Cathartics|cathartics|mesh-ancestor
64366129|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366130|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64366156|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64366157|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
64366160|NCT03249259|Choline|choline|mesh-list
64366161|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
64366162|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64366163|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
64366164|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366212|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64366214|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366215|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
64366216|NCT04786613|Protective Agents|protective agents|mesh-ancestor
64366218|NCT04767191|Artemether|artemether|mesh-list
64366219|NCT04767191|Piperaquine|piperaquine|mesh-list
64366220|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64366221|NCT04767191|Artenimol|artenimol|mesh-list
64366222|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
64366223|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64366224|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64366225|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366226|NCT00700999|Paroxetine|paroxetine|mesh-list
64366227|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64366228|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64366229|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64366230|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366233|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366234|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64366235|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
64366236|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64366237|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64366238|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64366239|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366240|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
64366241|NCT04502771|Clotrimazole|clotrimazole|mesh-list
64366242|NCT04502771|Miconazole|miconazole|mesh-list
64366243|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366248|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366249|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64366250|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
64366251|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366252|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366253|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64366264|NCT04761887|Ropivacaine|ropivacaine|mesh-list
64366265|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
64366266|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
64366267|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366268|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366269|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
64366270|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366271|NCT05584007|Floxacillin|floxacillin|mesh-list
64366272|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64366273|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366274|NCT03249025|Lidocaine|lidocaine|mesh-list
64366275|NCT03249025|Ketamine|ketamine|mesh-list
64366276|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
64366277|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
64366278|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366279|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366280|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
64366281|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366282|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64366283|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64366284|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64366285|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64366286|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366287|NCT03249025|Analgesics|analgesics|mesh-ancestor
64366288|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64366289|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64366290|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
64366291|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64366292|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64366293|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366294|NCT03248713|Mifepristone|mifepristone|mesh-list
64366295|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64366296|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
64366297|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64366298|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366299|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64366300|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64366301|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64366302|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
64366311|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
64366312|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64366313|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64366315|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64366316|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
64366317|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
64366318|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366319|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366320|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366321|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
64366329|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64366330|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
64366331|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64366332|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64366333|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366334|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64366335|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64366336|NCT03245515|Branebrutinib|branebrutinib|mesh-list
64366337|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64366338|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366339|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366340|NCT03363503|Fluticasone|fluticasone|mesh-list
64366342|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64366374|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
64366375|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64366376|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64366377|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64366378|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
64366379|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366380|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366381|NCT03248791|Protective Agents|protective agents|mesh-ancestor
64366382|NCT03254173|Mirtazapine|mirtazapine|mesh-list
64366383|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
64366384|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64366385|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64366386|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
64366401|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64366402|NCT03248401|Aspirin|aspirin|mesh-list
64366403|NCT03248401|Cilostazol|cilostazol|mesh-list
64366404|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64366405|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64366406|NCT03248401|Analgesics|analgesics|mesh-ancestor
64366407|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
64366408|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366409|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366410|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64366411|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64366412|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64366413|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64366414|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366415|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64366416|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64366417|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366418|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
64366419|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64366420|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
64366421|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64366422|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
64366423|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
64366424|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64366425|NCT03248401|Protective Agents|protective agents|mesh-ancestor
64366426|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64366427|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64366446|NCT02516423|Growth Substances|growth substances|mesh-ancestor
64366447|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
64366469|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64366470|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64366471|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64366472|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64366473|NCT03345797|Testosterone|testosterone|mesh-list
64366474|NCT03345797|Androgens|androgens|mesh-ancestor
64366475|NCT03345797|Hormones|hormones|mesh-ancestor
64366476|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366477|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366478|NCT04500743|Leuprolide|leuprolide|mesh-list
64366479|NCT04500743|Dienogest|dienogest|mesh-list
64366480|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64366481|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
64366482|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64366483|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366484|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64366485|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366486|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64366487|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
64366488|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64366489|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64366490|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64366491|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64366492|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
64366493|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366543|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
64366544|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64366545|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
64366614|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64366615|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64366616|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
64366617|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366618|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366619|NCT02513147|Lopinavir|lopinavir|mesh-list
64366620|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64366621|NCT02513147|Darunavir|darunavir|mesh-list
64366622|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
64366623|NCT02513147|Dolutegravir|dolutegravir|mesh-list
64366624|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64366625|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64366626|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
64366662|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
64366663|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64366664|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
64366665|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366688|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366689|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366690|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64366692|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64366693|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64366694|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
64366703|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366704|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64366705|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64366706|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
64366707|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366708|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
64366709|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64366710|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64366711|NCT03297593|Nivolumab|nivolumab|mesh-list
64366712|NCT03297593|Ipilimumab|ipilimumab|mesh-list
64366713|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64366714|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366715|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64366716|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366717|NCT03234673|Calcipotriene|calcipotriene|mesh-list
64366718|NCT03234673|Tacrolimus|tacrolimus|mesh-list
64366719|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64366720|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
64366721|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366722|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64366752|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64366753|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
64366755|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366756|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64366757|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
64366758|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
64366759|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64366760|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64366761|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64366762|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64366763|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
64366764|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366765|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366767|NCT03237637|Atenolol|atenolol|mesh-list
64366792|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366793|NCT03237715|Protective Agents|protective agents|mesh-ancestor
64366794|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366888|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64366889|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64366890|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64366940|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64366941|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366942|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
64366971|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
64366972|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366973|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366974|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366975|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
64366977|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366978|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64366979|NCT03233035|Ketamine|ketamine|mesh-list
64366980|NCT03233035|Analgesics|analgesics|mesh-ancestor
64366981|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
64366982|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366983|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366984|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64366985|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64366986|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
64366987|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
64367083|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367084|NCT03241303|Acarbose|acarbose|mesh-list
64367085|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64367086|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367087|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367088|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64367089|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367090|NCT02510963|Tenofovir|tenofovir|mesh-list
64367165|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367166|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367167|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64367168|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
64367223|NCT00707993|Incretins|incretins|mesh-ancestor
64367225|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367226|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64367227|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
64367228|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367229|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367230|NCT02509091|Amikacin|amikacin|mesh-list
64367231|NCT02509091|Dimercaprol|dimercaprol|mesh-list
64367232|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367265|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
64367266|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367267|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367268|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
64367269|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64367270|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367271|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367308|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367309|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64367310|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
64367311|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64367312|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64367313|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64367314|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64367315|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367316|NCT04498325|Antibodies|antibodies|mesh-list
64367317|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
64367320|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
64367321|NCT02507843|Vitamins|vitamins|mesh-ancestor
64367322|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
64367323|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367324|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367325|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367326|NCT02425891|Paclitaxel|paclitaxel|mesh-list
64367351|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367352|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
64367353|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367354|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367355|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367356|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367357|NCT05504057|Analgesics|analgesics|mesh-ancestor
64367358|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
64367359|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367360|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
64367361|NCT03344003|Factor VIII|factor viii|mesh-list
64367362|NCT03344003|Coagulants|coagulants|mesh-ancestor
64367363|NCT03235531|Valproic Acid|valproic acid|mesh-list
64367364|NCT03235531|Lorazepam|lorazepam|mesh-list
64367365|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
64367366|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367367|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367368|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
64367369|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367370|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367371|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
64367372|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64367373|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367374|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64367379|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64367380|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64367381|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
64367382|NCT02506829|Nicotine|nicotine|mesh-list
64367383|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64367384|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
64367385|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367413|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
64367414|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
64367415|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367416|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64367417|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64367418|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367419|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367420|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64367421|NCT02499341|Narcotics|narcotics|mesh-ancestor
64367422|NCT02495285|Polygeline|polygeline|mesh-list
64367423|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
64367424|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
64367425|NCT02495363|Bupivacaine|bupivacaine|mesh-list
64367426|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
64367427|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
64367428|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367429|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367430|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
64367431|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367432|NCT03121079|Interferons|interferons|mesh-list
64367433|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
64367469|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64367471|NCT01597245|Analgesics|analgesics|mesh-ancestor
64367472|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
64367473|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367474|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367543|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
64367544|NCT03120533|Treprostinil|treprostinil|mesh-list
64367545|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64367546|NCT03342443|Memantine|memantine|mesh-list
64367547|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64367548|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64367549|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
64367550|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367551|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367566|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
64367567|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64367568|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64367569|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64367602|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367603|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367604|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367606|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64367607|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367635|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367638|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64367686|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64367687|NCT03095079|Growth Substances|growth substances|mesh-ancestor
64367688|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367689|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
64367690|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367691|NCT03120923|Triamcinolone|triamcinolone|mesh-list
64367692|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64367693|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64367694|NCT03120923|Lidocaine|lidocaine|mesh-list
64367695|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64367696|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
64367697|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
64367698|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367699|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367700|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
64367725|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
64367726|NCT02639247|Velpatasvir|velpatasvir|mesh-list
64367727|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
64367728|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367729|NCT05033535|Olmesartan|olmesartan|mesh-list
64367730|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
64367731|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64367732|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64367733|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64367734|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367735|NCT05053893|Valsartan|valsartan|mesh-list
64367736|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64367737|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64367783|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367786|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367787|NCT05032287|Tamsulosin|tamsulosin|mesh-list
64367788|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64367821|NCT02496299|Dexamethasone|dexamethasone|mesh-list
64367907|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367908|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367910|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64367911|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64367912|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367913|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367914|NCT03336281|Ustekinumab|ustekinumab|mesh-list
64367915|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
64367985|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367986|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64367988|NCT05050071|Calcium|calcium|mesh-list
64367989|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367990|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367991|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367992|NCT03335501|Pancrelipase|pancrelipase|mesh-list
64367993|NCT03335501|Hormones|hormones|mesh-list
64367994|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367995|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367996|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64367997|NCT02492945|Lidocaine|lidocaine|mesh-list
64367998|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64367999|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
64368000|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
64368026|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64368038|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368040|NCT03095547|Posaconazole|posaconazole|mesh-list
64368041|NCT03095547|Olorofim|olorofim|mesh-list
64368042|NCT03095547|Pantoprazole|pantoprazole|mesh-list
64368043|NCT03095547|Tacrolimus|tacrolimus|mesh-list
64368044|NCT03095547|Cyclosporins|cyclosporins|mesh-list
64368045|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64368046|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
64368047|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368048|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64368049|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368073|NCT04968951|Vancomycin|vancomycin|mesh-list
64368074|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368075|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64368076|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64368077|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64368078|NCT05049681|Apatinib|apatinib|mesh-list
64368079|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368080|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64368081|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368082|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368083|NCT03334487|Dexamethasone|dexamethasone|mesh-list
64368084|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368085|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
64368086|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
64368087|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368088|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368090|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
64368091|NCT03334487|Hormones|hormones|mesh-ancestor
64368092|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368093|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64368094|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368095|NCT05038449|Colchicine|colchicine|mesh-list
64368096|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
64368172|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368173|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368174|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368175|NCT02452879|Urological Agents|urological agents|mesh-ancestor
64368176|NCT01191697|Bevacizumab|bevacizumab|mesh-list
64368179|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
64368180|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64368181|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368182|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64368183|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64368184|NCT01191697|Growth Substances|growth substances|mesh-ancestor
64368185|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368186|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
64368187|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64368188|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
64368189|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368190|NCT05024799|Fentanyl|fentanyl|mesh-list
64368191|NCT05024799|Butorphanol|butorphanol|mesh-list
64368192|NCT05024799|Propofol|propofol|mesh-list
64368193|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64368194|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368195|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368196|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64368198|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
64368199|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64368231|NCT03327701|Benralizumab|benralizumab|mesh-list
64368232|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64368233|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368234|NCT01991977|Temozolomide|temozolomide|mesh-list
64368235|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64368236|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
64368278|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64368322|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368323|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64368324|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64368325|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368326|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368327|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64368328|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368351|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
64368352|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64368353|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368354|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
64368355|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368356|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368357|NCT05023941|Acetazolamide|acetazolamide|mesh-list
64368358|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
64368359|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64368360|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368361|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368362|NCT05023941|Diuretics|diuretics|mesh-ancestor
64368363|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
64368364|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368365|NCT03332069|Cisplatin|cisplatin|mesh-list
64368366|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368375|NCT03326609|Ropivacaine|ropivacaine|mesh-list
64368412|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
64368413|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64368414|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64368415|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368416|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368417|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
64368418|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
64368419|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64368420|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
64368422|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64368423|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
64368455|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
64368457|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64368458|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64368459|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368460|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
64368461|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368462|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368463|NCT03331523|Betamethasone|betamethasone|mesh-list
64368464|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
64368465|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64368509|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
64368510|NCT03331445|Protective Agents|protective agents|mesh-ancestor
64368511|NCT05008029|Anesthetics|anesthetics|mesh-list
64368512|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368513|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368514|NCT05008263|Liver Extracts|liver extracts|mesh-list
64368515|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
64368516|NCT05008263|Hematinics|hematinics|mesh-ancestor
64368518|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368537|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64368538|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368539|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64368541|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368542|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368543|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64368544|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
64368545|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
64368546|NCT03078933|Protective Agents|protective agents|mesh-ancestor
64368547|NCT03092193|Naproxen|naproxen|mesh-list
64368548|NCT03092193|Esomeprazole|esomeprazole|mesh-list
64368549|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64368550|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64368551|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64368552|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368553|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368568|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368570|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368571|NCT05015595|Memantine|memantine|mesh-list
64368572|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64368573|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64368607|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64368608|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368609|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64368610|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64368611|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
64368613|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
64368614|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368615|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368616|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64368617|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64368618|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
64368619|NCT03087201|Nabiximols|nabiximols|mesh-list
64368651|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
64368652|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368653|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
64368654|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368656|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
64368657|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
64368658|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368659|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368692|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64368693|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
64368694|NCT05006469|Hormones|hormones|mesh-ancestor
64368695|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368701|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64368702|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64368703|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64368704|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
64368705|NCT03084783|Dexamethasone|dexamethasone|mesh-list
64368706|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368707|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
64368708|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
64368709|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368744|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368745|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64368746|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64368747|NCT03324503|Protective Agents|protective agents|mesh-ancestor
64368748|NCT03324425|Simvastatin|simvastatin|mesh-list
64368749|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64368750|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64368775|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368776|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64368778|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368779|NCT03119857|Docetaxel|docetaxel|mesh-list
64368781|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368782|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
64368783|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
64368784|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
64368785|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368786|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
64368787|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368788|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368789|NCT03320603|Thrombin|thrombin|mesh-list
64368790|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
64368791|NCT03320603|Coagulants|coagulants|mesh-ancestor
64368792|NCT03227653|Ritonavir|ritonavir|mesh-list
64368793|NCT03227653|Lopinavir|lopinavir|mesh-list
64368794|NCT03227653|Nevirapine|nevirapine|mesh-list
64368795|NCT03227653|Efavirenz|efavirenz|mesh-list
64368796|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64368810|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64368811|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64368812|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64368813|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64368816|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
64368817|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64368818|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64368819|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
64368820|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
64368821|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368822|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368823|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
64368824|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368825|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64368826|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64368827|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64368846|NCT03078777|Fexofenadine|fexofenadine|mesh-list
64368847|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64368848|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64368849|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64368850|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
64368851|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
64368852|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368853|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368854|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368858|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64368859|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368860|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368861|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64368862|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
64368863|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368864|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368865|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
64368866|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368867|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
64368868|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
64368869|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
64368899|NCT05006235|Epinephrine|epinephrine|mesh-list
64368901|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64368902|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64368903|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
64368904|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368905|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368908|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64368943|NCT03091569|Coagulants|coagulants|mesh-ancestor
64368961|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
64368962|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368964|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64368965|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368966|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64368967|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64368968|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368969|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
64368994|NCT03206671|Ifosfamide|ifosfamide|mesh-list
64368995|NCT03206671|Rituximab|rituximab|mesh-list
64368996|NCT03206671|Doxorubicin|doxorubicin|mesh-list
64368997|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64368998|NCT03206671|Methotrexate|methotrexate|mesh-list
64368999|NCT03206671|Etoposide|etoposide|mesh-list
64369000|NCT03206671|Vincristine|vincristine|mesh-list
64369001|NCT03206671|Vindesine|vindesine|mesh-list
64369002|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64369003|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
64369004|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369005|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369006|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64369007|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
64369008|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369009|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369017|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
64369018|NCT03206671|Hormones|hormones|mesh-ancestor
64369019|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369020|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64369021|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64369022|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64369023|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64369048|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369049|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369050|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64369051|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
64369052|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64369053|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369054|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369055|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
64369056|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64369057|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64369072|NCT03221569|Ketorolac|ketorolac|mesh-list
64369073|NCT03221569|Ketamine|ketamine|mesh-list
64369074|NCT03221569|Analgesics|analgesics|mesh-ancestor
64369075|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
64369089|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369090|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369091|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64369094|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
64369095|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369096|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64369097|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
64369098|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369099|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369114|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64369115|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64369116|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64369117|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369118|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369119|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
64369120|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369121|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64369122|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
64369123|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64369124|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64369125|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64369126|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369164|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64369165|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64369166|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369167|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369168|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64369169|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
64369170|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369171|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369172|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64369173|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
64369175|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64369176|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369207|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
64369208|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369209|NCT03318419|Cytarabine|cytarabine|mesh-list
64369252|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
64369253|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369254|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
64369255|NCT05001243|Protective Agents|protective agents|mesh-ancestor
64369256|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64369257|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64369258|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64369259|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64369260|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
64369261|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369262|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369263|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
64369264|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
64369265|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369266|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
64369306|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369307|NCT02490839|Antacids|antacids|mesh-ancestor
64369308|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64369341|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369342|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64369343|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64369344|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369345|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64369346|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64369375|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369376|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369377|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369378|NCT05004519|Analgesics|analgesics|mesh-ancestor
64369379|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
64369380|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369381|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64368010|NCT03335423|Metformin|metformin|mesh-list
64369382|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64369383|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64369384|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
64369385|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369386|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369387|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64369388|NCT05004519|Narcotics|narcotics|mesh-ancestor
64369389|NCT02486549|Bupivacaine|bupivacaine|mesh-list
64369390|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
64369391|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
64369392|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369393|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369394|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
64369395|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369396|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
64369402|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
64369403|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369404|NCT04485403|Ibuprofen|ibuprofen|mesh-list
64369405|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64369423|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64369424|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369428|NCT03318029|Vitamin D|vitamin d|mesh-list
64369429|NCT03318029|Vitamins|vitamins|mesh-ancestor
64369430|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
64369431|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369432|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64369433|NCT03076281|Metformin|metformin|mesh-list
64369434|NCT03076281|Doxycycline|doxycycline|mesh-list
64369435|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64369436|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369437|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64369438|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369439|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
64369440|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64369441|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64369442|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
64369443|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64369444|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64369445|NCT02452255|Propranolol|propranolol|mesh-list
64369446|NCT02452255|Metoprolol|metoprolol|mesh-list
64369447|NCT02452255|Fenofibrate|fenofibrate|mesh-list
64369448|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64369449|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64369450|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
64369451|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369452|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369453|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369454|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64369455|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64369456|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
64369457|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
64369458|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
64369459|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369460|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64369461|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64369462|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
64369463|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64369541|NCT03204331|Estradiol|estradiol|mesh-list
64369542|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64369543|NCT03204331|Relugolix|relugolix|mesh-list
64369544|NCT03204331|Estrogens|estrogens|mesh-ancestor
64369545|NCT03204331|Hormones|hormones|mesh-ancestor
64369546|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369547|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369548|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64369549|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
64369550|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64369551|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64369573|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369575|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64369576|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369577|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
64369578|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
64369579|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64369580|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369584|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369585|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369586|NCT03075657|Haloperidol|haloperidol|mesh-list
64369588|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
64369589|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64369590|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
64369591|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369592|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369593|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369595|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64369596|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369597|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64369598|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64369599|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
64369600|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
64369629|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
64369630|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
64369631|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64369632|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
64369633|NCT03317015|Hormones|hormones|mesh-ancestor
64369634|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369635|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
64369636|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64369637|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
64369638|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369639|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
64369640|NCT03204565|Protective Agents|protective agents|mesh-ancestor
64369641|NCT03224377|Antibodies|antibodies|mesh-list
64369642|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
64369685|NCT02488889|Ethanol|ethanol|mesh-list
64369686|NCT02488889|Varenicline|varenicline|mesh-list
64369687|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64369688|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369689|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369690|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369691|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64369692|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64369693|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
64369694|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369740|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
64369741|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369774|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64369776|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369777|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64369778|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369779|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369782|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
64369783|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64369784|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
64369805|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
64369806|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369807|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369808|NCT03203317|Insulin|insulin|mesh-list
64369809|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64369810|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369811|NCT03316313|Antibodies|antibodies|mesh-list
64369812|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
64369813|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
64369814|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369815|NCT03201601|Inositol|inositol|mesh-list
64369816|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
64369817|NCT03201601|Vitamins|vitamins|mesh-ancestor
64369818|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
64369819|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369820|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
64368017|NCT03335423|Analgesics|analgesics|mesh-ancestor
64369821|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64369822|NCT02480387|Ledipasvir|ledipasvir|mesh-list
64369823|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
64369824|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369825|NCT04999293|Clopidogrel|clopidogrel|mesh-list
64369826|NCT04999293|Ticagrelor|ticagrelor|mesh-list
64369827|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64369829|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64369830|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64369831|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
64369832|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369833|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369834|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369835|NCT03315923|Rituximab|rituximab|mesh-list
64369836|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
64369837|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
64369861|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369862|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
64369863|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
64369864|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64369865|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
64369876|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369878|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64369931|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369932|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
64369933|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64369962|NCT05713721|Dopamine|dopamine|mesh-list
64369963|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
64369964|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64369965|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
64369966|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
64369967|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369968|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369969|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
64369970|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369971|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369972|NCT05713721|Protective Agents|protective agents|mesh-ancestor
64369973|NCT05002725|Lidocaine|lidocaine|mesh-list
64369974|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
64369975|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
64369976|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369977|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369989|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369990|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369991|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370020|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370021|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64370023|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
64370024|NCT04997967|Analgesics|analgesics|mesh-ancestor
64370025|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
64370026|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370035|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64370037|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370038|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370039|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64370041|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
64370074|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370075|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370076|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
64370077|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
64370078|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370080|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
64370111|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370112|NCT03212677|Iron|iron|mesh-list
64370113|NCT03212677|Trace Elements|trace elements|mesh-ancestor
64370114|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
64370115|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370116|NCT03199339|Midazolam|midazolam|mesh-list
64370117|NCT03199339|Bupropion|bupropion|mesh-list
64370118|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64370119|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64370120|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370121|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370122|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64370123|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64370197|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370199|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370201|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
64370202|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64370210|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64370211|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370212|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370213|NCT03071289|Cisplatin|cisplatin|mesh-list
64370214|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370215|NCT03199105|Tetracaine|tetracaine|mesh-list
64370216|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
64370217|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
64370218|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370219|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370249|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64370250|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
64370251|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370252|NCT02478047|Dexamethasone|dexamethasone|mesh-list
64370253|NCT02478047|Ramosetron|ramosetron|mesh-list
64370254|NCT02478047|Antiemetics|antiemetics|mesh-list
64370255|NCT02478047|Tropisetron|tropisetron|mesh-list
64370256|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370257|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
64370258|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370259|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370260|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64370261|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
64370262|NCT02478047|Hormones|hormones|mesh-ancestor
64370263|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370295|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
64370296|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
64370297|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370298|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370299|NCT03198403|Epinephrine|epinephrine|mesh-list
64370300|NCT03198403|Bupivacaine|bupivacaine|mesh-list
64370301|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
64370302|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
64370303|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370304|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370305|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
64370306|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370307|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64370308|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64370345|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64370346|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370347|NCT02447809|Analgesics|analgesics|mesh-ancestor
64370348|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
64370349|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370350|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370351|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370388|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64370389|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
64370392|NCT02481791|Narcotics|narcotics|mesh-ancestor
64370393|NCT02481791|Analgesics|analgesics|mesh-ancestor
64370394|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
64370395|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370396|NCT04484467|Menthol|menthol|mesh-list
64370397|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
64370398|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370399|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
64370400|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64370401|NCT02726399|Capecitabine|capecitabine|mesh-list
64370402|NCT02726399|Trastuzumab|trastuzumab|mesh-list
64370403|NCT02726399|Ramucirumab|ramucirumab|mesh-list
64370404|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370409|NCT02477969|Metformin|metformin|mesh-list
64370445|NCT03197779|Analgesics|analgesics|mesh-ancestor
64370446|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
64370447|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370448|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370449|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370485|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370487|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370520|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
64370521|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370522|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
64370523|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370524|NCT03197233|Protective Agents|protective agents|mesh-ancestor
64370525|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64370526|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370527|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64370528|NCT02447185|Triamcinolone|triamcinolone|mesh-list
64370529|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64370530|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64370564|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370565|NCT05633771|Adalimumab|adalimumab|mesh-list
64370566|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370570|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370571|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370573|NCT03208465|Hormones|hormones|mesh-ancestor
64370587|NCT02477501|Norepinephrine|norepinephrine|mesh-list
64370588|NCT02477501|Ephedrine|ephedrine|mesh-list
64370589|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64370590|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64370591|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
64370592|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370613|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64370614|NCT02477267|Narcotics|narcotics|mesh-ancestor
64370615|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370616|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370617|NCT02477267|Analgesics|analgesics|mesh-ancestor
64370618|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
64370619|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370620|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64370622|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64370623|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
64370624|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370625|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370626|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64370627|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370628|NCT02476955|Paclitaxel|paclitaxel|mesh-list
64370629|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64370651|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370652|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64370653|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
64370654|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370655|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370656|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370657|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370658|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64370659|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64370660|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
64370661|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370662|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64370663|NCT03196531|Loratadine|loratadine|mesh-list
64370664|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
64370665|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370666|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64370667|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64370668|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64370669|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
64370670|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
64370680|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370686|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64370687|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64370688|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
64370689|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64370690|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370691|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370692|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370693|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64370694|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370695|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370720|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
64370721|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64370722|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370723|NCT03192943|Nivolumab|nivolumab|mesh-list
64370724|NCT03192943|Linrodostat|linrodostat|mesh-list
64370735|NCT04986813|Coagulants|coagulants|mesh-ancestor
64370738|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370740|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370741|NCT02475863|Warfarin|warfarin|mesh-list
64370742|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
64370743|NCT03071055|Ranibizumab|ranibizumab|mesh-list
64370744|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64370745|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64370746|NCT03071055|Growth Substances|growth substances|mesh-ancestor
64370747|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370779|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
64370780|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370781|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370782|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64370783|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
64370785|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370786|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64370821|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370822|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370825|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64370826|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64370827|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370828|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370829|NCT04988607|Bevacizumab|bevacizumab|mesh-list
64370830|NCT04988607|Osimertinib|osimertinib|mesh-list
64370831|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64370864|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370865|NCT02472275|Protective Agents|protective agents|mesh-ancestor
64370866|NCT02472275|Vitamins|vitamins|mesh-ancestor
64370867|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
64370868|NCT02472275|Estrogens|estrogens|mesh-ancestor
64370869|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64370870|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370871|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
64370872|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
64370873|NCT04491773|Tadalafil|tadalafil|mesh-list
64370874|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
64370875|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64370876|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64370877|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370912|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370913|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64370945|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64370946|NCT04450953|Diuretics|diuretics|mesh-ancestor
64370947|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
64370948|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64370949|NCT04983849|Metronidazole|metronidazole|mesh-list
64370950|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370951|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64370952|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64370953|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64370954|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64296128|NCT02332928|Protective Agents|protective agents|mesh-ancestor
64296129|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296130|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296131|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64296132|NCT03738878|Valsartan|valsartan|mesh-list
64296133|NCT03738878|Bradykinin|bradykinin|mesh-list
64296134|NCT03738878|Kininogens|kininogens|mesh-list
64296143|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64296144|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
64296145|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296146|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296147|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64296148|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64296149|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64296150|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
64296151|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64296152|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296153|NCT04682834|Probenecid|probenecid|mesh-list
64296155|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
64296156|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296157|NCT04682834|Renal Agents|renal agents|mesh-ancestor
64296158|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
64296159|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
64296160|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64296161|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296162|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296165|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296167|NCT05426252|Sirolimus|sirolimus|mesh-list
64296168|NCT05426252|Abatacept|abatacept|mesh-list
64296169|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64296170|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296171|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64296172|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296173|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
64296174|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296175|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
64296176|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296190|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296191|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64296192|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64296194|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64296195|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64296196|NCT05422664|Lacosamide|lacosamide|mesh-list
64296197|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
64296209|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64296210|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296212|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
64296213|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
64296214|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
64296225|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
64296226|NCT03303573|Hematinics|hematinics|mesh-ancestor
64296228|NCT03303495|Bevacizumab|bevacizumab|mesh-list
64296229|NCT03303495|Fluorouracil|fluorouracil|mesh-list
64296230|NCT03303495|Irinotecan|irinotecan|mesh-list
64296231|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296233|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296234|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64296246|NCT03303495|Antidotes|antidotes|mesh-ancestor
64296248|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
64296250|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
64296251|NCT03308955|Tramadol|tramadol|mesh-list
64296252|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64296253|NCT03308955|Narcotics|narcotics|mesh-ancestor
64296254|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296269|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64296271|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64296272|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64296273|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296274|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
64296275|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296276|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296277|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64296278|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296279|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
64296280|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64296281|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296283|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
64296284|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
64296287|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296356|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64296395|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296396|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64296398|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296430|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
64296431|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296432|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64296433|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64296434|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64296435|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
64296436|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296453|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296454|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296455|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64296456|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
64296457|NCT01362140|Hematinics|hematinics|mesh-ancestor
64296458|NCT03307941|Fluorouracil|fluorouracil|mesh-list
64296459|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
64296465|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
64296466|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296468|NCT03307863|Carbamazepine|carbamazepine|mesh-list
64296469|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
64296470|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64296471|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296472|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
64296473|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64296474|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296475|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64296492|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296508|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64296509|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296510|NCT02467647|Thalidomide|thalidomide|mesh-list
64296511|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296512|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
64296513|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296514|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
64296550|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296551|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
64296560|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64296561|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64296562|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64296576|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64296577|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
64296578|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296590|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64296591|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296592|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296593|NCT00702507|Miconazole|miconazole|mesh-list
64296644|NCT03113942|Thalidomide|thalidomide|mesh-list
64296645|NCT03113942|Pomalidomide|pomalidomide|mesh-list
64296646|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
64296647|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296648|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64296649|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64296650|NCT03113942|Growth Substances|growth substances|mesh-ancestor
64296651|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
64296652|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296653|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64296654|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
64296698|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64296699|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64296700|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64296701|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64296702|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64296703|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
64296704|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64296705|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64296706|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64296707|NCT04688294|Valsartan|valsartan|mesh-list
64296708|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64296709|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64296710|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64296711|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64296773|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64296774|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64296777|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296778|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296779|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64296780|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64296781|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
64296782|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296797|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64296798|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
64296806|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64296807|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
64296808|NCT04491357|Calcium|calcium|mesh-list
64296853|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64296854|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64296855|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64296856|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64296857|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64296937|NCT03104036|Mesalamine|mesalamine|mesh-list
64296938|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64296939|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64296940|NCT03104036|Analgesics|analgesics|mesh-ancestor
64296941|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
64296942|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64296943|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296944|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64296945|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64296946|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
64296947|NCT03449888|Calcium|calcium|mesh-list
64296948|NCT03449888|Regadenoson|regadenoson|mesh-list
64296949|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64296950|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296989|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
64296990|NCT00015002|Hormones|hormones|mesh-ancestor
64296992|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64296993|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64296994|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
64296995|NCT03103412|Tofacitinib|tofacitinib|mesh-list
64296996|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64296997|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297002|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64297003|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297004|NCT02086604|Lenalidomide|lenalidomide|mesh-list
64297005|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64297006|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
64297007|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297008|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64297009|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64297010|NCT02086604|Growth Substances|growth substances|mesh-ancestor
64297011|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
64297012|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297013|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64297165|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
64297166|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297197|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
64297199|NCT02063269|Rivastigmine|rivastigmine|mesh-list
64297200|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64297201|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297314|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297315|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297614|NCT03080883|Apixaban|apixaban|mesh-list
64297615|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64297616|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
64297617|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64297618|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
64297619|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297620|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297621|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
64297636|NCT02976753|Factor VIII|factor viii|mesh-list
64297637|NCT02976753|Coagulants|coagulants|mesh-ancestor
64297638|NCT04559529|Levetiracetam|levetiracetam|mesh-list
64297639|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
64297640|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
64297641|NCT04490421|Etoposide|etoposide|mesh-list
64297642|NCT04490421|Apatinib|apatinib|mesh-list
64297643|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64297644|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64297645|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64297646|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64297647|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297648|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297649|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64297651|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64297652|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297653|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64297654|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297655|NCT02462109|Lorazepam|lorazepam|mesh-list
64297656|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
64297657|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
64297658|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
64297659|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297660|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297661|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64297662|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64297668|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
64297676|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
64297677|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64297678|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64297679|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297680|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297681|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64297693|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64297694|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64297695|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297696|NCT02461875|Cabergoline|cabergoline|mesh-list
64297727|NCT01682187|Lomustine|lomustine|mesh-list
64297780|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297782|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64297783|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64297784|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64297785|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297786|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64297787|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64297804|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64297805|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
64297806|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297807|NCT02065063|Palbociclib|palbociclib|mesh-list
64297857|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
64297858|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
64297859|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297860|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
64297861|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297866|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297867|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297868|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64297869|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64297870|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64297871|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297872|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64297873|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
64297874|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64297875|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
64297876|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
64297877|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64297878|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64297879|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64297880|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64297881|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
64297882|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297884|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64297888|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
64297889|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64297890|NCT04938856|Lamotrigine|lamotrigine|mesh-list
64297891|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
64297892|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64297909|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297910|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64297911|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64297912|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
64297913|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64297914|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297915|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64297931|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64297932|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64297933|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64297934|NCT04490031|Ketamine|ketamine|mesh-list
64297935|NCT04490031|Analgesics|analgesics|mesh-ancestor
64297936|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
64297937|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64297987|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
64297988|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64297989|NCT02412670|Antiviral Agents|antiviral agents|mesh-ancestor
64297990|NCT02412670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64297991|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64297992|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64297993|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
64297994|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64297995|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64297996|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64297997|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64298008|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
64298009|NCT01370005|Empagliflozin|empagliflozin|mesh-list
64298010|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64298024|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
64298025|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298026|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298180|NCT02071459|Droxidopa|droxidopa|mesh-list
64298181|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64298182|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64298183|NCT02463747|Vancomycin|vancomycin|mesh-list
64298184|NCT02463747|Meropenem|meropenem|mesh-list
64298185|NCT02463747|Tazobactam|tazobactam|mesh-list
64298186|NCT02463747|Piperacillin|piperacillin|mesh-list
64298187|NCT02463747|Ceftazidime|ceftazidime|mesh-list
64298188|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64298189|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298190|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298191|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64298192|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298193|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298194|NCT02071537|Gemcitabine|gemcitabine|mesh-list
64298348|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298349|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298350|NCT05036421|Empagliflozin|empagliflozin|mesh-list
64298351|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64298353|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64298354|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298355|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
64298356|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
64298517|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64298518|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298519|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64298520|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64298522|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64298523|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298524|NCT02079727|Analgesics|analgesics|mesh-ancestor
64298525|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
64298536|NCT02082067|Anesthetics|anesthetics|mesh-list
64298537|NCT02082067|Ropivacaine|ropivacaine|mesh-list
64298538|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
64298539|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
64298540|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64298541|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298542|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64298543|NCT02082067|Narcotics|narcotics|mesh-ancestor
64298544|NCT02082067|Analgesics|analgesics|mesh-ancestor
64298545|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
64298546|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64298547|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64298548|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64298549|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64298550|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298577|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
64298578|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64298583|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64298584|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64298585|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64298586|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298587|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298615|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64298616|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
64298618|NCT02085577|Sufentanil|sufentanil|mesh-list
64298619|NCT02085577|Ketamine|ketamine|mesh-list
64298620|NCT02085577|Morphine|morphine|mesh-list
64298621|NCT02085577|Dsuvia|dsuvia|mesh-list
64298648|NCT02085577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64298649|NCT02085577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64298650|NCT02085577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64298651|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64298676|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
64298677|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64298678|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
64298679|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64298680|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
64298681|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64298682|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64298683|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64298684|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
64298824|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298826|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
64298827|NCT02087527|Hormones|hormones|mesh-ancestor
64298828|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64298829|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64298830|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298831|NCT02087683|Vitamin D|vitamin d|mesh-list
64298833|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
64298834|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298847|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298848|NCT03558139|Avelumab|avelumab|mesh-list
64298849|NCT03558139|Magrolimab|magrolimab|mesh-list
64298850|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64298851|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64298852|NCT02089867|Ezetimibe|ezetimibe|mesh-list
64298853|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64298854|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64298855|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
64298856|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64298857|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64298858|NCT02092597|Exenatide|exenatide|mesh-list
64298859|NCT02092597|Linagliptin|linagliptin|mesh-list
64298860|NCT02092597|Gliclazide|gliclazide|mesh-list
64298861|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64298862|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64298863|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64298887|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64298934|NCT02094157|Calcium heparin|calcium heparin|mesh-list
64298935|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64298999|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64299000|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
64299001|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299003|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
64299004|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
64299005|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299006|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299007|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299008|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64299009|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64299010|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
64299011|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299012|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299013|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
64299037|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64299038|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299039|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
64299040|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299041|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
64299042|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64299043|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299044|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
64299045|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64299046|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299047|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
64299048|NCT02095717|Curcumin|curcumin|mesh-list
64299049|NCT02095717|Docetaxel|docetaxel|mesh-list
64299050|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299139|NCT02463513|Riboflavin|riboflavin|mesh-list
64299140|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
64299141|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
64299142|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299143|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64299144|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
64299145|NCT04990323|Vidarabine|vidarabine|mesh-list
64299146|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
64299147|NCT04990323|Busulfan|busulfan|mesh-list
64299148|NCT04990323|Thiotepa|thiotepa|mesh-list
64299149|NCT04990323|Fludarabine|fludarabine|mesh-list
64299150|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
64299151|NCT04990323|Clofarabine|clofarabine|mesh-list
64299152|NCT04990323|Tacrolimus|tacrolimus|mesh-list
64299153|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299154|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
64299155|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299156|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64299157|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64299158|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
64299159|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299160|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299161|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64299162|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64299163|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
64299164|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
64299165|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64299166|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64299168|NCT04155008|Dexamethasone|dexamethasone|mesh-list
64299175|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299176|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299177|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
64299178|NCT04155008|Hormones|hormones|mesh-ancestor
64299179|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299180|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64299185|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
64299186|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
64299187|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64299188|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299189|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64299252|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64299253|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299376|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299377|NCT04727307|Bevacizumab|bevacizumab|mesh-list
64299378|NCT04727307|Atezolizumab|atezolizumab|mesh-list
64299379|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64299380|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64299381|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299382|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64299383|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64299384|NCT04727307|Growth Substances|growth substances|mesh-ancestor
64299385|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299386|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
64299387|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
64299388|NCT05066360|Hormones|hormones|mesh-list
64299389|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299390|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299391|NCT02439970|Valganciclovir|valganciclovir|mesh-list
64299395|NCT03290859|Propofol|propofol|mesh-list
64299396|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64299472|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299497|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64299498|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299499|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299509|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299511|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
64299513|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64299514|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64299515|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299516|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
64299520|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
64299521|NCT02465853|Protective Agents|protective agents|mesh-ancestor
64299522|NCT02465385|Linaclotide|linaclotide|mesh-list
64299523|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
64299524|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
64299525|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299526|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299527|NCT05050604|Choline|choline|mesh-list
64299528|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
64299529|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64299569|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299570|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64299652|NCT04718805|Cobicistat|cobicistat|mesh-list
64299653|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
64299654|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64299655|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64299656|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
64299657|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299658|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299659|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64299660|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64299661|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
64299663|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64299664|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64299666|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299667|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64299668|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299669|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299679|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299680|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299721|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299722|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64299724|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64299804|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299805|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64299806|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64299807|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64299808|NCT02106793|Mitomycins|mitomycins|mesh-list
64299809|NCT02106793|Mitomycin|mitomycin|mesh-list
64299810|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64299811|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299812|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
64299844|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299846|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
64299847|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64299848|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64299849|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299850|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64299851|NCT02106871|Urological Agents|urological agents|mesh-ancestor
64299861|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64299862|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
64299863|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299864|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64299865|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299890|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299899|NCT05036174|Promethazine|promethazine|mesh-list
64299900|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64299901|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64299902|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64299906|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
64299907|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64299909|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
64299910|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64299911|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64299912|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
64299913|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
64299928|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64299929|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64299930|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64299931|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64299959|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64299960|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64299968|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64299969|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
64299970|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64299971|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64299972|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
64300087|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300180|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64300182|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
64300183|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64300184|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64300185|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64300186|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64300187|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64300188|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
64300189|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
64300190|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64300191|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64300192|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64300193|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64446219|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446220|NCT01632020|Metformin|metformin|mesh-list
64446221|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64446222|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446223|NCT02181296|Ropivacaine|ropivacaine|mesh-list
64446224|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
64446225|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
64446226|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64446227|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446228|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
64446229|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446230|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
64446231|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
64446232|NCT02158442|Ticarcillin|ticarcillin|mesh-list
64446233|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64446234|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446235|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446236|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64446237|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446238|NCT02158364|Vaccines|vaccines|mesh-list
64446239|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
64446240|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446241|NCT02180672|Fluticasone|fluticasone|mesh-list
64446242|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446270|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64446271|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64446273|NCT02157116|Docetaxel|docetaxel|mesh-list
64446274|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446275|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
64446276|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
64446277|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
64446278|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446280|NCT01920555|Ketamine|ketamine|mesh-list
64446281|NCT01920555|Analgesics|analgesics|mesh-ancestor
64446282|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
64446283|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446284|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446285|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64446354|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64446355|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
64446356|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446357|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446359|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64446360|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
64446361|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446362|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64446363|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
64446364|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64446365|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446366|NCT02178956|Paclitaxel|paclitaxel|mesh-list
64446367|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64446368|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446369|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
64446370|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
64446371|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
64446372|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446373|NCT02211638|Candesartan|candesartan|mesh-list
64446374|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
64446375|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64446376|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64446377|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64446378|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446379|NCT02178566|Treprostinil|treprostinil|mesh-list
64446380|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64446381|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
64446382|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446383|NCT01631864|Amlodipine|amlodipine|mesh-list
64446384|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64446385|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64446386|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64446387|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64446388|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446389|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64446390|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446391|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
64446392|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64446394|NCT01557244|Oxybutynin|oxybutynin|mesh-list
64446395|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64446396|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64446450|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446451|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446453|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
64446454|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
64446455|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64446456|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64446457|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64446458|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64446459|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
64446460|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64446461|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
64446462|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64446463|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
64446464|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
64446465|NCT02985736|Desoximetasone|desoximetasone|mesh-list
64446466|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446469|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446470|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446471|NCT02985658|Cisplatin|cisplatin|mesh-list
64446481|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446482|NCT02177786|Selonsertib|selonsertib|mesh-list
64446483|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64446484|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446485|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446486|NCT02153918|Metronidazole|metronidazole|mesh-list
64446504|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446506|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64446507|NCT01571284|Aflibercept|aflibercept|mesh-list
64446508|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64446509|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64446510|NCT01571284|Growth Substances|growth substances|mesh-ancestor
64446549|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446550|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64446551|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446552|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446567|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64446568|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64446581|NCT01553188|Trebananib|trebananib|mesh-list
64446582|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446583|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
64446584|NCT01553188|Hormones|hormones|mesh-ancestor
64446585|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64446586|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446587|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64446588|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446590|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64446591|NCT01553188|Growth Substances|growth substances|mesh-ancestor
64446592|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
64446593|NCT02175758|Ribavirin|ribavirin|mesh-list
64446594|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
64446596|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446597|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
64446598|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446599|NCT01599104|Olmesartan|olmesartan|mesh-list
64446600|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64446601|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64446602|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64446603|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64446615|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446616|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64446617|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64446618|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64446619|NCT01552408|Ranibizumab|ranibizumab|mesh-list
64446620|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64446622|NCT01552408|Growth Substances|growth substances|mesh-ancestor
64446623|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446624|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
64446625|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446626|NCT04099888|Gemcitabine|gemcitabine|mesh-list
64446627|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64446628|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64446629|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
64446630|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446631|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
64446632|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446640|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
64446641|NCT04098718|Hormones|hormones|mesh-ancestor
64446650|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64446651|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64446652|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64446653|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446654|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446655|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64446656|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64446658|NCT01527682|Latanoprost|latanoprost|mesh-list
64446659|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64446660|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64446661|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64446662|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64446663|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64446664|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446665|NCT01516216|Vitamin D|vitamin d|mesh-list
64446666|NCT01516216|Leucovorin|leucovorin|mesh-list
64446667|NCT01516216|Bevacizumab|bevacizumab|mesh-list
64446668|NCT01516216|Fluorouracil|fluorouracil|mesh-list
64446669|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
64446748|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64446749|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64446750|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446751|NCT01512160|Ibuprofen|ibuprofen|mesh-list
64446752|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64446753|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64446755|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
64446756|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64446757|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64446758|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64446759|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64446760|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64446813|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447010|NCT01888497|Gabapentin|gabapentin|mesh-list
64447034|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
64447035|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64447036|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
64447037|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447038|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64447047|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447049|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64447050|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64447051|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447052|NCT01887717|Sorafenib|sorafenib|mesh-list
64447053|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447110|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64447111|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
64447112|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64447133|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447134|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
64447135|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64447136|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64447137|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64447149|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64447151|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
64447152|NCT02118961|Vaccines|vaccines|mesh-list
64447156|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64447157|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447307|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447309|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64447310|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
64447311|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
64447312|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64447313|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64447314|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64447315|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
64447316|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64447317|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64447318|NCT02132312|Protective Agents|protective agents|mesh-ancestor
64447515|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447517|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64447618|NCT04798469|Androgens|androgens|mesh-ancestor
64447620|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64447621|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447622|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64447623|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64447624|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
64447625|NCT02074982|Ustekinumab|ustekinumab|mesh-list
64447626|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64447627|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
64447628|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447629|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
64447630|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64447631|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64447632|NCT04798001|Vaccines|vaccines|mesh-list
64447633|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
64447634|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447635|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
64447636|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
64447637|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64447638|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
64447639|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64447640|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64447641|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64447913|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
64447914|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
64447916|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64447917|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
64447918|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64447922|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447923|NCT03631043|Lenalidomide|lenalidomide|mesh-list
64447924|NCT03631043|Vaccines|vaccines|mesh-list
64447925|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
64447926|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64447927|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64447928|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64447929|NCT03631043|Growth Substances|growth substances|mesh-ancestor
64447954|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448116|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448117|NCT02202161|Incretins|incretins|mesh-ancestor
64448118|NCT02202161|Hormones|hormones|mesh-ancestor
64448119|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64448120|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64448121|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
64448122|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448149|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448150|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64448152|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448153|NCT01500694|Guanfacine|guanfacine|mesh-list
64448154|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64448155|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64448156|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64448157|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64448158|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
64448159|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448195|NCT01483690|Vorinostat|vorinostat|mesh-list
64448196|NCT01483690|Pegaspargase|pegaspargase|mesh-list
64448197|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64448198|NCT01483690|BB 1101|bb 1101|mesh-list
64448199|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64448200|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
64448201|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
64448202|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448203|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448204|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64448205|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
64448206|NCT01483690|Hormones|hormones|mesh-ancestor
64448517|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
64448622|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64448623|NCT03026842|Cytarabine|cytarabine|mesh-list
64448624|NCT03026842|Decitabine|decitabine|mesh-list
64448625|NCT03026842|Daunorubicin|daunorubicin|mesh-list
64448626|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
64448627|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
64448628|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64448630|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448632|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
64448633|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448634|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64448635|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
64448636|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448637|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64448638|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64448639|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64448640|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448641|NCT03026842|Analgesics|analgesics|mesh-ancestor
64448642|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
64448743|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
64448744|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64448749|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64448750|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448751|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
64448752|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64448753|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64448755|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64448756|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
64448799|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64448800|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64448801|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64448802|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64448803|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
64448804|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64448805|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64448973|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64448974|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64448975|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64448976|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
64449008|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64449009|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64449010|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64449011|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64449322|NCT01473940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64449323|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64449325|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64449326|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
64449335|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449459|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64449460|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449510|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64449511|NCT02187809|Clobazam|clobazam|mesh-list
64449556|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
64449685|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64449686|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
64449687|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
64449688|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64449689|NCT04724629|Aldesleukin|aldesleukin|mesh-list
64449690|NCT04724629|Colchicine|colchicine|mesh-list
64449691|NCT04724629|Ixekizumab|ixekizumab|mesh-list
64449692|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64449693|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64449844|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64449845|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
64449846|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449848|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449849|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
64449850|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
64449851|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449852|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
64449853|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64449854|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
64449855|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64449856|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
64449857|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64449859|NCT02047045|Prucalopride|prucalopride|mesh-list
64449935|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64449937|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
64449938|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64449939|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64449940|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64449941|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
64449942|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64449943|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64449944|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64449945|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449949|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
64449950|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64449951|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450258|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
64450259|NCT01824693|Melphalan|melphalan|mesh-list
64450260|NCT01824693|Busulfan|busulfan|mesh-list
64450305|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450324|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64450325|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450326|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450327|NCT04747301|Dinoprostone|dinoprostone|mesh-list
64450328|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
64450329|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64450330|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450331|NCT02152163|Ibuprofen|ibuprofen|mesh-list
64450332|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64450333|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64450334|NCT02152163|Analgesics|analgesics|mesh-ancestor
64450335|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
64450347|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450348|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
64450349|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450350|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
64450351|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450362|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
64450363|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450364|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64450365|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450382|NCT02042443|Leucovorin|leucovorin|mesh-list
64450383|NCT02042443|Folic Acid|folic acid|mesh-list
64450384|NCT02042443|Fluorouracil|fluorouracil|mesh-list
64450385|NCT02042443|Capecitabine|capecitabine|mesh-list
64450386|NCT02042443|Trametinib|trametinib|mesh-list
64450387|NCT02042443|Calcium|calcium|mesh-list
64450388|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
64450404|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64450405|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450406|NCT04747145|Temozolomide|temozolomide|mesh-list
64450407|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64450408|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
64450409|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450410|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450411|NCT02118896|Tacrolimus|tacrolimus|mesh-list
64450412|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64450413|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
64450414|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450415|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64450416|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450417|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450433|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64450464|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64450465|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64450466|NCT02065622|Adalimumab|adalimumab|mesh-list
64450467|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450468|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64450469|NCT02117648|Clarithromycin|clarithromycin|mesh-list
64450470|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64450471|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64450472|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64450473|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64450474|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450480|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450482|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
64450483|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450484|NCT02123459|Cephalexin|cephalexin|mesh-list
64450495|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64450496|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
64450497|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64450498|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377728|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64450510|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64450511|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64450512|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
64450513|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450514|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450515|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64450516|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
64450517|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
64450519|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450520|NCT02117024|Gemcitabine|gemcitabine|mesh-list
64450522|NCT02117024|Vinorelbine|vinorelbine|mesh-list
64450523|NCT02117024|Docetaxel|docetaxel|mesh-list
64450524|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
64450525|NCT02117024|Pemetrexed|pemetrexed|mesh-list
64450526|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64450527|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64450528|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450529|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
64450583|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
64450584|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64450585|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450586|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64450587|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64450588|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
64450589|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
64450590|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64450591|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64450592|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64450593|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64450616|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64450617|NCT02090114|Androgens|androgens|mesh-ancestor
64450619|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64450620|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64450621|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64450622|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450623|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
64450628|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64450630|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64450631|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64450632|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
64450633|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
64450634|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
64450635|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64450636|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
64450637|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64450638|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
64451053|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64451054|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451055|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451056|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451057|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
64451058|NCT04720105|Halobetasol|halobetasol|mesh-list
64451066|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64451068|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451090|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64451091|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64451092|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451094|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64451095|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451302|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451303|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64451304|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64451325|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64451327|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64451328|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451329|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451335|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
64451336|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451337|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451339|NCT01822665|Acetaminophen|acetaminophen|mesh-list
64451341|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64451386|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
64451449|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64451453|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64451454|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
64451455|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64451456|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64451457|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64451458|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64451459|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64451460|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451461|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64451512|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64451517|NCT01846611|Dexamethasone|dexamethasone|mesh-list
64451518|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64451519|NCT01846611|Doxorubicin|doxorubicin|mesh-list
64451520|NCT01846611|Trabectedin|trabectedin|mesh-list
64451521|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64451522|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
64451523|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
64451524|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64451525|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64451526|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64451527|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
64451528|NCT01846611|Hormones|hormones|mesh-ancestor
64451529|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64451570|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64451571|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451572|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451583|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451687|NCT02114177|Simeprevir|simeprevir|mesh-list
64451688|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
64451689|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64451690|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
64451691|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451699|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64451700|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64451701|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
64451702|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64451703|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451737|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64451738|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64451739|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
64451740|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451741|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64451742|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64451743|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64451745|NCT01844505|Ipilimumab|ipilimumab|mesh-list
64451746|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64451747|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451748|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64451749|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64451867|NCT02017015|Paclitaxel|paclitaxel|mesh-list
64451972|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64451973|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
64451974|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
64451975|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
64451976|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452014|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452015|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
64452016|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64452017|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452019|NCT02024971|Pioglitazone|pioglitazone|mesh-list
64452020|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452021|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452022|NCT01843023|Naltrexone|naltrexone|mesh-list
64452023|NCT01843023|Buprenorphine|buprenorphine|mesh-list
64452024|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64452025|NCT01843023|Narcotics|narcotics|mesh-ancestor
64452026|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452027|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452230|NCT01989572|Sargramostim|sargramostim|mesh-list
64452231|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
64452232|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452233|NCT01988402|Allopurinol|allopurinol|mesh-list
64452234|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
64452235|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452236|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452237|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
64452238|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452239|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64452240|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
64452241|NCT01988402|Protective Agents|protective agents|mesh-ancestor
64452242|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452243|NCT01988090|Vitamin D|vitamin d|mesh-list
64452244|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
64452245|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
64452246|NCT01988090|Vitamins|vitamins|mesh-list
64452247|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
64452248|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452249|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64452250|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64452370|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64452371|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452372|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
64452373|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452374|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452375|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64452376|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64452377|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64452384|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
64452385|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452386|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64452387|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64452388|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64452389|NCT01964755|Antidotes|antidotes|mesh-ancestor
64452391|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
64452392|NCT01964755|Vitamins|vitamins|mesh-ancestor
64452393|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
64452394|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64452395|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
64452396|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452400|NCT01991743|Bupivacaine|bupivacaine|mesh-list
64452401|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
64452402|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
64452403|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452404|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452405|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
64452406|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452407|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64452409|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452410|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452411|NCT01991197|Incretins|incretins|mesh-ancestor
64452412|NCT01991197|Hormones|hormones|mesh-ancestor
64452413|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452414|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64452415|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
64452416|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452417|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452418|NCT01990573|Methadone|methadone|mesh-list
64452419|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64452420|NCT01990573|Narcotics|narcotics|mesh-ancestor
64452421|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452422|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452423|NCT01990573|Analgesics|analgesics|mesh-ancestor
64452424|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
64452425|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452426|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
64452427|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
64452428|NCT01990339|Lansoprazole|lansoprazole|mesh-list
64452429|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
64452430|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64452431|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452432|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64452433|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452434|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452435|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
64452436|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64452437|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64452438|NCT02007577|Analgesics|analgesics|mesh-ancestor
64452439|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
64452440|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452441|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452442|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452443|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452444|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64452445|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452446|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64452447|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452485|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452486|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452487|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64452488|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64452489|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64452490|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64452491|NCT01987232|Carboplatin|carboplatin|mesh-list
64452492|NCT01987232|Etoposide|etoposide|mesh-list
64452493|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452494|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64452495|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64452496|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64452497|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452498|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452559|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
64452560|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
64452561|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452562|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
64452564|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452565|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64452566|NCT01985126|Protective Agents|protective agents|mesh-ancestor
64452567|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452568|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
64452569|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64452570|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64452571|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452572|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
64452573|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
64452578|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452579|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64452580|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
64452581|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452583|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
64452584|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
64452585|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452586|NCT01807221|Eplerenone|eplerenone|mesh-list
64452587|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64452588|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
64452589|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64452590|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452591|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64452592|NCT01807221|Diuretics|diuretics|mesh-ancestor
64452593|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
64452594|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64452595|NCT02031458|Atezolizumab|atezolizumab|mesh-list
64452596|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452597|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64452598|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
64452599|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452600|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
64452601|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64452602|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
64452603|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452604|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452670|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64452671|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64452672|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452673|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452674|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452675|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
64452681|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64452682|NCT01836471|Fluticasone|fluticasone|mesh-list
64452683|NCT01836471|Xhance|xhance|mesh-list
64452684|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
64452685|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452686|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64452687|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
64452688|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452689|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452690|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64452691|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
64452712|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64452713|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64452714|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452715|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64452716|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64452717|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452719|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64452720|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64452721|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64452722|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
64452723|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452724|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64452725|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
64452726|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64452727|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
64452728|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
64452729|NCT01802385|Sertraline|sertraline|mesh-list
64452730|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
64452731|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64452732|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64452733|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64452760|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452761|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64452762|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452763|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
64452778|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64452779|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
64452780|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452781|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64452782|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64452783|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452794|NCT04177004|Sirolimus|sirolimus|mesh-list
64452795|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
64452796|NCT04177004|Etoposide|etoposide|mesh-list
64452797|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
64452798|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
64452799|NCT04177004|Tacrolimus|tacrolimus|mesh-list
64452800|NCT04177004|Mitogens|mitogens|mesh-list
64452801|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64452802|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
64452803|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452804|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452805|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64452806|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
64452807|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452808|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452809|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64377729|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
64452858|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452859|NCT01767909|Insulin|insulin|mesh-list
64452879|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452880|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64452881|NCT01962103|Paclitaxel|paclitaxel|mesh-list
64452882|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64452883|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64452884|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452885|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
64452886|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
64452887|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
64452888|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452889|NCT01961323|Nebivolol|nebivolol|mesh-list
64452890|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64452891|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
64452892|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64452893|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64452894|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64452895|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
64452898|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452899|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
64452900|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64452901|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64452902|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452903|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
64452904|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452905|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
64452906|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
64452907|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452908|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452925|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64452926|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452927|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
64452928|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64452929|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64452930|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64452931|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64452933|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64452934|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64452935|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64452936|NCT02007434|Analgesics|analgesics|mesh-ancestor
64452937|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64452938|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64452939|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64452940|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64452941|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64452942|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64452943|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
64452944|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64452945|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64452946|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64452947|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
64452948|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64452949|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64452950|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
64452951|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
64452952|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64452953|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
64452954|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
64452955|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64452956|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64452957|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64452958|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
64452968|NCT01959919|Coagulants|coagulants|mesh-ancestor
64452969|NCT01986907|Ranibizumab|ranibizumab|mesh-list
64452970|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64452971|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64452972|NCT01986907|Growth Substances|growth substances|mesh-ancestor
64452973|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452974|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
64452975|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64452976|NCT01959841|Valacyclovir|valacyclovir|mesh-list
64452977|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
64452978|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64452979|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
64452980|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64452982|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64452983|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453003|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453005|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64453006|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
64453007|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453008|NCT02104505|Tocopherols|tocopherols|mesh-list
64453009|NCT02104505|Vitamin E|vitamin e|mesh-list
64453010|NCT02104505|Tocotrienols|tocotrienols|mesh-list
64453011|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
64453012|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
64453013|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
64453014|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453015|NCT02104505|Protective Agents|protective agents|mesh-ancestor
64453016|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453017|NCT02104505|Vitamins|vitamins|mesh-ancestor
64453018|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
64453019|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
64453045|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453046|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453047|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64453048|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
64453074|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
64453075|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453076|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453077|NCT02028338|Dapivirine|dapivirine|mesh-list
64453080|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
64453081|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453082|NCT01625897|Risperidone|risperidone|mesh-list
64453083|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64453084|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
64453085|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64453086|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453087|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453088|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64453089|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64453090|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453091|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64453187|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453188|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64453189|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64453245|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64453246|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64453247|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64453248|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64453249|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64453250|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64453251|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64453252|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
64453253|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64453254|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
64453255|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64453256|NCT01447420|Ribavirin|ribavirin|mesh-list
64453257|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64453258|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
64453259|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453282|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64453283|NCT01471054|Growth Substances|growth substances|mesh-ancestor
64453284|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453285|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
64453286|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64453287|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
64453288|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
64453289|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453298|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64453373|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453374|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
64453375|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64453376|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64453377|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64453378|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
64453379|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
64453381|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64453382|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
64453383|NCT02059187|MK-1293|mk-1293|mesh-list
64453384|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64453385|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453386|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64453387|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
64453388|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453389|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64453390|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
64453391|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453392|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64453393|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453394|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64453500|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64453502|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
64453503|NCT02040779|Hormones|hormones|mesh-ancestor
64453504|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64453505|NCT02056301|Morphine|morphine|mesh-list
64453506|NCT02056301|Hydromorphone|hydromorphone|mesh-list
64453507|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64453508|NCT02056301|Narcotics|narcotics|mesh-ancestor
64453509|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64453510|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64453511|NCT02056301|Analgesics|analgesics|mesh-ancestor
64453512|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
64453513|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64453514|NCT01967576|Axitinib|axitinib|mesh-list
64453515|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64453516|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64338276|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64338277|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64338278|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338279|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
64338280|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
64338281|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
64338282|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338283|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64338300|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338301|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64338303|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338304|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64338305|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64338306|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338308|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64338309|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
64338310|NCT01183949|Bortezomib|bortezomib|mesh-list
64338311|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338312|NCT01092065|Levodopa|levodopa|mesh-list
64338313|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64338314|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64338315|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
64338316|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338317|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338318|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338319|NCT05626829|Tranilast|tranilast|mesh-list
64338320|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64338321|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338322|NCT05626829|Analgesics|analgesics|mesh-ancestor
64338323|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
64338324|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379476|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338332|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64338333|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
64338334|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
64338335|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338345|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64338346|NCT01171313|Carbidopa|carbidopa|mesh-list
64338347|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
64338348|NCT01171313|Levodopa|levodopa|mesh-list
64338349|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64338350|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64338351|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
64338352|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338353|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338354|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338355|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64338356|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338357|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64338358|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
64338363|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64338364|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338365|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338366|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
64338367|NCT01071239|Busulfan|busulfan|mesh-list
64338368|NCT01071239|Fludarabine|fludarabine|mesh-list
64338369|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338370|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
64338371|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338372|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338373|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64338374|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
64338375|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338376|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338377|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64338378|NCT01156415|S 20098|s 20098|mesh-list
64338379|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64338386|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
64338387|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338388|NCT01027013|Rebamipide|rebamipide|mesh-list
64338420|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338421|NCT01128335|Tacrolimus|tacrolimus|mesh-list
64338422|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64338423|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
64338424|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338442|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338443|NCT01009775|Docetaxel|docetaxel|mesh-list
64338444|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338448|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338449|NCT02319148|Itraconazole|itraconazole|mesh-list
64338450|NCT02319148|Verapamil|verapamil|mesh-list
64338451|NCT02319148|Diltiazem|diltiazem|mesh-list
64338452|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
64338453|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338454|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64338455|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64338456|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338513|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338514|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
64338515|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64338516|NCT05401916|Narcotics|narcotics|mesh-ancestor
64338517|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64338518|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
64338519|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64338520|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
64338521|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338522|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338523|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64338524|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
64338525|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64338543|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64338545|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64338546|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338547|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338548|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
64338549|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64338550|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64338592|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338593|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338594|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
64338595|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64338596|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338597|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64338606|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338607|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
64338608|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
64338611|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64338614|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64338615|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338616|NCT05360732|Folfirinox|folfirinox|mesh-list
64338617|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338618|NCT00152477|Paclitaxel|paclitaxel|mesh-list
64338619|NCT00152477|Carboplatin|carboplatin|mesh-list
64338620|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64338625|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338626|NCT01111955|Metformin|metformin|mesh-list
64338627|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64338628|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338629|NCT01106807|Adapalene|adapalene|mesh-list
64338630|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
64338631|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64338632|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
64338633|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64338634|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64338635|NCT01106807|Analgesics|analgesics|mesh-ancestor
64338636|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
64338637|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64338638|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338639|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64338651|NCT05533229|Narcotics|narcotics|mesh-ancestor
64338652|NCT05533229|Analgesics|analgesics|mesh-ancestor
64338653|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64338654|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64338655|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
64338656|NCT00153179|Acipimox|acipimox|mesh-list
64338657|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64338658|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
64338659|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338660|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64338661|NCT02743949|Esomeprazole|esomeprazole|mesh-list
64338662|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64338663|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338664|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64338669|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338670|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64338671|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64338685|NCT02289898|Immunologic Factors|immunologic factors|mesh-ancestor
64338686|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338687|NCT01659554|Cisplatin|cisplatin|mesh-list
64338688|NCT01659554|Doxorubicin|doxorubicin|mesh-list
64338689|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64338690|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338691|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64338692|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64338693|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64338694|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338695|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338696|NCT05355350|Meropenem|meropenem|mesh-list
64338697|NCT05355350|Tazobactam|tazobactam|mesh-list
64338698|NCT05355350|Piperacillin|piperacillin|mesh-list
64338699|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64338701|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64338702|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64338703|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338712|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
64338713|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338714|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64338715|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
64338716|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338746|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64338747|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64338748|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
64338749|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338750|NCT01660256|Protective Agents|protective agents|mesh-ancestor
64338751|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338756|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64338757|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
64338758|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64338759|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338760|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64338761|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64338767|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64338768|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338769|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338770|NCT02318602|Cannabidiol|cannabidiol|mesh-list
64338775|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338776|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64338777|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338778|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338793|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338794|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338797|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64338798|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338799|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64338801|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338802|NCT05053425|Cytarabine|cytarabine|mesh-list
64338803|NCT05053425|Azacitidine|azacitidine|mesh-list
64338858|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64338859|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64338860|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338861|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64338862|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64338863|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64338864|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64338865|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64338866|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64338867|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64338868|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64338869|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
64338870|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64338874|NCT05554406|Daunorubicin|daunorubicin|mesh-list
64338875|NCT05554406|Venetoclax|venetoclax|mesh-list
64338876|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64338877|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
64338878|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338879|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64338880|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
64338907|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64338908|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64338909|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64338912|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
64338913|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338914|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64338915|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64338916|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64338917|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
64338918|NCT04662723|Empagliflozin|empagliflozin|mesh-list
64338972|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64338973|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64338974|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339033|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64339034|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64339035|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64339043|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
64339044|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339045|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339046|NCT02328495|Misoprostol|misoprostol|mesh-list
64339047|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64339048|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
64339049|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64339050|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339051|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64339088|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339089|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339124|NCT05303792|Hormones|hormones|mesh-ancestor
64339147|NCT05080569|Progesterone|progesterone|mesh-list
64339148|NCT05080569|Progestins|progestins|mesh-ancestor
64339149|NCT05080569|Hormones|hormones|mesh-ancestor
64339150|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339151|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339152|NCT03145467|Acetaminophen|acetaminophen|mesh-list
64339153|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
64339160|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64339161|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64339163|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339164|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339165|NCT05302856|Antibodies|antibodies|mesh-list
64339166|NCT05302856|Testosterone|testosterone|mesh-list
64339167|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
64339168|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339169|NCT05302856|Androgens|androgens|mesh-ancestor
64339170|NCT05302856|Hormones|hormones|mesh-ancestor
64339171|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339172|NCT04022967|Ritonavir|ritonavir|mesh-list
64339174|NCT04022967|Tenofovir|tenofovir|mesh-list
64339195|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64339196|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64339197|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64339198|NCT02328183|Polymyxins|polymyxins|mesh-list
64339199|NCT02328183|Polymyxin B|polymyxin b|mesh-list
64339200|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339201|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339202|NCT01646398|Vaccines|vaccines|mesh-list
64339203|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64339204|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
64339205|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339261|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339263|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64339264|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64339265|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339266|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339267|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64339268|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339269|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
64339270|NCT02285998|Vaccines|vaccines|mesh-list
64339271|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
64339272|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339273|NCT02285920|Spironolactone|spironolactone|mesh-list
64339274|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64339275|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
64339276|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339277|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339323|NCT05079087|Ketamine|ketamine|mesh-list
64339324|NCT05079087|Analgesics|analgesics|mesh-ancestor
64339325|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
64339326|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339327|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339328|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64339329|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64339330|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
64339368|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64339369|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339370|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339372|NCT03561831|Sevoflurane|sevoflurane|mesh-list
64339373|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64339374|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339375|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339376|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64339377|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
64339379|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64339380|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64339381|NCT05289830|Citalopram|citalopram|mesh-list
64339382|NCT05289830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64339383|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64339390|NCT05289830|Antidepressive Agents|antidepressive agents|mesh-ancestor
64339391|NCT05289830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64339392|NCT03144843|Apatinib|apatinib|mesh-list
64339393|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339394|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64339395|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339396|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339397|NCT05288348|Sufentanil|sufentanil|mesh-list
64339413|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64339414|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
64339415|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339423|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64339424|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
64339425|NCT05259800|Emollients|emollients|mesh-ancestor
64339426|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339427|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
64339428|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64339429|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339430|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339431|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64339432|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64339433|NCT05387187|Protective Agents|protective agents|mesh-ancestor
64339434|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339435|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
64339436|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64339437|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
64339438|NCT03199755|Lumefantrine|lumefantrine|mesh-list
64339439|NCT03199755|Artemether|artemether|mesh-list
64339440|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64339451|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339452|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
64339453|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
64339454|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339455|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64339456|NCT02327793|Labetalol|labetalol|mesh-list
64339457|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
64339458|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
64339459|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64339460|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64339461|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339462|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339466|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
64339467|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
64339468|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339469|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64339470|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64339471|NCT02327715|Emtricitabine|emtricitabine|mesh-list
64339472|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
64339473|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339487|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64339488|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64339489|NCT05080803|Bevacizumab|bevacizumab|mesh-list
64339490|NCT05080803|Ranibizumab|ranibizumab|mesh-list
64339491|NCT05080803|Aflibercept|aflibercept|mesh-list
64339492|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64339493|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339494|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64339495|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64339496|NCT05080803|Growth Substances|growth substances|mesh-ancestor
64339497|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339567|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64339568|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339569|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
64339572|NCT05482334|Molgramostim|molgramostim|mesh-list
64339596|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64339597|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339598|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339599|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
64339600|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
64339601|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339602|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339603|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64339604|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64339605|NCT03140943|Growth Substances|growth substances|mesh-ancestor
64339606|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
64339607|NCT02038257|Petrolatum|petrolatum|mesh-list
64339608|NCT02038257|Emollients|emollients|mesh-ancestor
64339609|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339660|NCT00911963|Ribavirin|ribavirin|mesh-list
64339661|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64339662|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
64339663|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339664|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
64339665|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339667|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339668|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64339669|NCT04167033|Hormones|hormones|mesh-list
64339670|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64339671|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339672|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
64339674|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339675|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64339676|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
64339677|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339678|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339679|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339680|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339681|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
64339682|NCT03140553|Carboplatin|carboplatin|mesh-list
64339713|NCT05277896|Analgesics|analgesics|mesh-ancestor
64339714|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
64339715|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339716|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339717|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64339718|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64339719|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
64339720|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
64339721|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339722|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64339723|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64339724|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339725|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339726|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64339727|NCT02282020|Olaparib|olaparib|mesh-list
64339728|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64339729|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339730|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339731|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339732|NCT05249972|Calcitriol|calcitriol|mesh-list
64339741|NCT05249972|Hormones|hormones|mesh-ancestor
64339766|NCT00902291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339767|NCT00902291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64339768|NCT00902291|Immunologic Factors|immunologic factors|mesh-ancestor
64339769|NCT00902291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339770|NCT05217680|Bevacizumab|bevacizumab|mesh-list
64339771|NCT05217680|Ranibizumab|ranibizumab|mesh-list
64339772|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64339773|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339774|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64339775|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64339776|NCT05217680|Growth Substances|growth substances|mesh-ancestor
64339777|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339778|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
64339779|NCT02281552|Tofacitinib|tofacitinib|mesh-list
64339780|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64339781|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339782|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339783|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
64339784|NCT03832647|Salicylates|salicylates|mesh-list
64339785|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339786|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
64339787|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
64339788|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
64339814|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64339815|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339816|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339817|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64339818|NCT03778671|Analgesics|analgesics|mesh-ancestor
64339819|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
64339827|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64339829|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64339830|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64339831|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
64339832|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
64339833|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
64339834|NCT00978497|Ribavirin|ribavirin|mesh-list
64339835|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
64339836|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339837|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
64339838|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339839|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
64339849|NCT03558789|Lactoferrin|lactoferrin|mesh-list
64339873|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339874|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
64339875|NCT00890591|Diuretics|diuretics|mesh-ancestor
64339876|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
64339877|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64339878|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64339879|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64339880|NCT05248334|Ranibizumab|ranibizumab|mesh-list
64339881|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64339882|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64339883|NCT05248334|Growth Substances|growth substances|mesh-ancestor
64339908|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64339910|NCT03317223|Clarithromycin|clarithromycin|mesh-list
64339911|NCT03317223|Lansoprazole|lansoprazole|mesh-list
64339912|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64339913|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64339914|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64339915|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64339916|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339917|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64339922|NCT02284906|Pioglitazone|pioglitazone|mesh-list
64339923|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64339924|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339925|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
64339926|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64339927|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64339928|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339929|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64339930|NCT02566863|Analgesics|analgesics|mesh-ancestor
64339931|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
64339932|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64339938|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339939|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
64339940|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64339941|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
64339942|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64339943|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64339962|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339963|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339964|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
64339965|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339966|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64339967|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
64339968|NCT01657760|Citalopram|citalopram|mesh-list
64339969|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64339970|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64339971|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64339972|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64339973|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64339974|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
64339975|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64339976|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64339977|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
64339978|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64339979|NCT00966953|Honokiol|honokiol|mesh-list
64339980|NCT00966953|Triclosan|triclosan|mesh-list
64339981|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64339982|NCT00966953|Fluorides|fluorides|mesh-list
64339989|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64340006|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
64340007|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340008|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340009|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340010|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64340012|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
64340013|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340014|NCT05084079|Insulin|insulin|mesh-list
64340015|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64340016|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340017|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340018|NCT05084001|Listerine|listerine|mesh-list
64340019|NCT05084001|Fluorides|fluorides|mesh-list
64340020|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
64340021|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
64340022|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
64340023|NCT05084001|Protective Agents|protective agents|mesh-ancestor
64340024|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340025|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64340026|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340027|NCT05245916|Rituximab|rituximab|mesh-list
64340028|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340029|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340030|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
64340031|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340057|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64340058|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
64340059|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340060|NCT00872885|Morphine|morphine|mesh-list
64340061|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64340062|NCT00872885|Narcotics|narcotics|mesh-ancestor
64340063|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340064|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340065|NCT00872885|Analgesics|analgesics|mesh-ancestor
64340066|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
64340067|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340068|NCT00871481|Aldesleukin|aldesleukin|mesh-list
64340069|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
64340070|NCT00871481|Ipilimumab|ipilimumab|mesh-list
64340071|NCT00871481|Interleukin-2|interleukin-2|mesh-list
64340072|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64340073|NCT00871481|Antibodies|antibodies|mesh-list
64340074|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
64340075|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64340076|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340113|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
64340114|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340115|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340116|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64340117|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340118|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64340119|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64340120|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64340121|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340123|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
64340124|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340125|NCT05165732|Vaccines|vaccines|mesh-list
64340126|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
64340127|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340132|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340133|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340134|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340135|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340158|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64340159|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340160|NCT05209490|Trace Elements|trace elements|mesh-ancestor
64340162|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340163|NCT05083455|Enoxaparin|enoxaparin|mesh-list
64340164|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
64340165|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64340166|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
64340167|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64340168|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
64340169|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340171|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
64340172|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64340173|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64340174|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
64340175|NCT04473911|Sirolimus|sirolimus|mesh-list
64340176|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
64340177|NCT04473911|Melphalan|melphalan|mesh-list
64340178|NCT04473911|Fludarabine|fludarabine|mesh-list
64340179|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340180|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
64340181|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340182|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340202|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340203|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64340204|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
64340205|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340206|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340207|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64340208|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340209|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64340210|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340211|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340212|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
64340213|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
64340214|NCT05088057|Docetaxel|docetaxel|mesh-list
64340215|NCT05088057|Doxorubicin|doxorubicin|mesh-list
64340216|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340217|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
64340218|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340219|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340220|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64340221|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
64340222|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340233|NCT03132025|Apatinib|apatinib|mesh-list
64340252|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64340254|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340255|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64340256|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340257|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340258|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
64340259|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64340260|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64340261|NCT04876534|Prednisolone|prednisolone|mesh-list
64340262|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
64340263|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64340264|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64340265|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
64340266|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64340267|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
64340268|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
64340269|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340270|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340271|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64340273|NCT04876534|Hormones|hormones|mesh-ancestor
64340274|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340275|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64340276|NCT04876534|Protective Agents|protective agents|mesh-ancestor
64340277|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64340278|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340279|NCT05082753|Ivermectin|ivermectin|mesh-list
64340280|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64340281|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340282|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
64340283|NCT02443831|Fludarabine|fludarabine|mesh-list
64340284|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340296|NCT00851045|Irinotecan|irinotecan|mesh-list
64340297|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64340298|NCT00851045|Calcium|calcium|mesh-list
64340299|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
64340300|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340301|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340302|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64340303|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64340304|NCT00851045|Growth Substances|growth substances|mesh-ancestor
64340305|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340306|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
64340307|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340308|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
64340309|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340310|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64340311|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340312|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
64340313|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64340314|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64340315|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340316|NCT00851045|Antidotes|antidotes|mesh-ancestor
64340317|NCT00851045|Protective Agents|protective agents|mesh-ancestor
64340318|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
64340319|NCT00851045|Vitamins|vitamins|mesh-ancestor
64340320|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
64340321|NCT00850577|Paclitaxel|paclitaxel|mesh-list
64340322|NCT00850577|Bevacizumab|bevacizumab|mesh-list
64340338|NCT00838981|Modafinil|modafinil|mesh-list
64340339|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64340340|NCT00838981|Narcotics|narcotics|mesh-ancestor
64340344|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
64340345|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340346|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
64340347|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
64340348|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64340349|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64340350|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64340351|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64340352|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340353|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
64340354|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
64340356|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64340357|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340358|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340359|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64340360|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64340361|NCT05082441|Bupivacaine|bupivacaine|mesh-list
64340362|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
64340363|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
64340364|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340365|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340366|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
64340379|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64340380|NCT03140397|Estrogens|estrogens|mesh-ancestor
64340382|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340383|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340384|NCT05047445|Vaccines|vaccines|mesh-list
64340389|NCT05235542|Capecitabine|capecitabine|mesh-list
64340390|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
64340391|NCT05235542|Irinotecan|irinotecan|mesh-list
64340392|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64340393|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340394|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340395|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340396|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340397|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340398|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64340399|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
64340434|NCT00836069|Paroxetine|paroxetine|mesh-list
64340435|NCT00836069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64340436|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64340437|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340438|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340439|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340440|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
64340441|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340447|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340449|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
64340450|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
64340451|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64340452|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340453|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
64340454|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340455|NCT03134651|Propofol|propofol|mesh-list
64340477|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
64340479|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340480|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340481|NCT05155124|Cetuximab|cetuximab|mesh-list
64340482|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340484|NCT00927641|Ketoprofen|ketoprofen|mesh-list
64340534|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64340535|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
64340536|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340537|NCT02276560|Gemcitabine|gemcitabine|mesh-list
64340543|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340544|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
64340545|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340546|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340547|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340548|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64340596|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
64340597|NCT05142254|Tadalafil|tadalafil|mesh-list
64340598|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
64340599|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64340600|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64340601|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340602|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340603|NCT05142254|Urological Agents|urological agents|mesh-ancestor
64340604|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340605|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
64340612|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340613|NCT00834977|Amlodipine|amlodipine|mesh-list
64340614|NCT00834977|Benazepril|benazepril|mesh-list
64340615|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64340616|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64340617|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340618|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340619|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340620|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340621|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
64340643|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64340644|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340651|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340653|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64340654|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340655|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
64340656|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340691|NCT00833495|Prednisone|prednisone|mesh-list
64340702|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
64340703|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340704|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64340705|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64340706|NCT00833495|Protective Agents|protective agents|mesh-ancestor
64340707|NCT00830219|Ropinirole|ropinirole|mesh-list
64340708|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64340709|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64340710|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
64340711|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
64340712|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340713|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340721|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
64340722|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64340723|NCT02274766|Amantadine|amantadine|mesh-list
64340724|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64340725|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64340727|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340729|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340730|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340731|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340743|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64340749|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64340750|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64340751|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64340752|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340753|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
64340754|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64340755|NCT05221658|Cisplatin|cisplatin|mesh-list
64340756|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340757|NCT05132114|Lugol's solution|lugol's solution|mesh-list
64340758|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
64340759|NCT05132114|Coagulants|coagulants|mesh-ancestor
64340760|NCT02370238|Paclitaxel|paclitaxel|mesh-list
64340761|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64340762|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340769|NCT05109104|Protective Agents|protective agents|mesh-ancestor
64340770|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340786|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64340787|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340788|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
64340789|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
64340790|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340791|NCT05473910|Protective Agents|protective agents|mesh-ancestor
64340792|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340793|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64340794|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340795|NCT05180708|Sirolimus|sirolimus|mesh-list
64340796|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64340797|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64340798|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64340802|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
64340803|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340804|NCT02273752|Everolimus|everolimus|mesh-list
64340805|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340806|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64340807|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
64340808|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340809|NCT05102552|Huperzine A|huperzine a|mesh-list
64340833|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340835|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64340836|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
64340838|NCT02273050|Saxagliptin|saxagliptin|mesh-list
64340839|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340840|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64340841|NCT02273050|Incretins|incretins|mesh-ancestor
64340842|NCT02273050|Hormones|hormones|mesh-ancestor
64340843|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64340844|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64340845|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
64340846|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340847|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340848|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64340849|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64340850|NCT02272816|Carboplatin|carboplatin|mesh-list
64340851|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340852|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64340876|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
64340877|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
64340889|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64340890|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64340891|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64340892|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64340893|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340894|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64340930|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64340939|NCT04993352|Antibodies|antibodies|mesh-list
64340940|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64340941|NCT04993352|Mitogens|mitogens|mesh-list
64340946|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64340947|NCT04993352|Growth Substances|growth substances|mesh-ancestor
64340948|NCT04992026|Prednisone|prednisone|mesh-list
64340949|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
64340950|NCT04992026|Hormones|hormones|mesh-list
64340956|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64340957|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64340958|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64340976|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
64341048|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
64341049|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341051|NCT04421300|Protective Agents|protective agents|mesh-ancestor
64341052|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64341053|NCT05026736|Antibodies|antibodies|mesh-list
64341054|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
64341055|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64341056|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
64341093|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
64341094|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
64341095|NCT02267746|Vitamins|vitamins|mesh-ancestor
64341096|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
64341097|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341098|NCT04970108|Empagliflozin|empagliflozin|mesh-list
64341103|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341104|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64341105|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64341106|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64341107|NCT04421534|Lactoferrin|lactoferrin|mesh-list
64341108|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341109|NCT05060744|Antacids|antacids|mesh-list
64341110|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
64341111|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341112|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341120|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341121|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64341122|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341123|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64341124|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64341125|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64341126|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341127|NCT04215848|Budesonide|budesonide|mesh-list
64341128|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
64341129|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341130|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64341131|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
64341132|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341133|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341134|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64341135|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341136|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
64341137|NCT04215848|Hormones|hormones|mesh-ancestor
64341138|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341139|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64341140|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64341141|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64341142|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
64341162|NCT05010200|Poly ICLC|poly iclc|mesh-list
64341163|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
64341164|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
64341165|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341166|NCT04959266|Itraconazole|itraconazole|mesh-list
64341167|NCT04959266|Rifampin|rifampin|mesh-list
64341168|NCT04959266|Omeprazole|omeprazole|mesh-list
64341169|NCT04959266|Adavosertib|adavosertib|mesh-list
64341170|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64341171|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341182|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341183|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64341184|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64341194|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64341196|NCT05008484|Vitamins|vitamins|mesh-ancestor
64341197|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
64341198|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341199|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64341200|NCT04212416|Leflunomide|leflunomide|mesh-list
64341201|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341202|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341203|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341204|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
64341205|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341206|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
64341207|NCT04947254|Prednisone|prednisone|mesh-list
64341208|NCT04947254|Cortisone|cortisone|mesh-list
64341209|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
64341210|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
64341211|NCT04947254|Niraparib|niraparib|mesh-list
64341212|NCT04947254|Hormones|hormones|mesh-list
64341213|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64341214|NCT04947254|Androgens|androgens|mesh-list
64341215|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
64341251|NCT04945148|Temozolomide|temozolomide|mesh-list
64341252|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341253|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341254|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64341255|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
64341256|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341257|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341258|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64341259|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64341260|NCT05003570|Fentanyl|fentanyl|mesh-list
64341266|NCT05003570|Analgesics|analgesics|mesh-ancestor
64341267|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
64341268|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341269|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64341270|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64341271|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
64341272|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
64341294|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
64341295|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64341299|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341301|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341302|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341303|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64341304|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341344|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341345|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341346|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341347|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64341421|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
64341422|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379477|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341423|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341425|NCT03496831|Etanercept|etanercept|mesh-list
64341426|NCT03496831|Golimumab|golimumab|mesh-list
64341427|NCT03496831|Abatacept|abatacept|mesh-list
64341428|NCT03496831|Infliximab|infliximab|mesh-list
64341429|NCT03496831|Ustekinumab|ustekinumab|mesh-list
64341430|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341431|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
64341432|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341433|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64341434|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341475|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64341477|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341478|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341479|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64341480|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341481|NCT04472585|Ivermectin|ivermectin|mesh-list
64341482|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64341483|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341484|NCT03496519|Durvalumab|durvalumab|mesh-list
64341485|NCT03496519|Trabectedin|trabectedin|mesh-list
64341529|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64341530|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341531|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
64341532|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341533|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341534|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64341535|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341536|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
64341537|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
64341538|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
64341539|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341540|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341541|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64341542|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64341543|NCT00805805|Growth Substances|growth substances|mesh-ancestor
64341544|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341545|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
64341546|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341547|NCT03488173|Lansoprazole|lansoprazole|mesh-list
64341551|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64341554|NCT03420521|Nivolumab|nivolumab|mesh-list
64341569|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
64341570|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64341571|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341572|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
64341573|NCT03382925|Triamcinolone|triamcinolone|mesh-list
64341574|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64341575|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64341576|NCT03382925|Lidocaine|lidocaine|mesh-list
64341577|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64341578|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
64341579|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
64341580|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64341581|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341582|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
64341583|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341584|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64341585|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64341586|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64341587|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64341588|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341589|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341590|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
64341591|NCT03382925|Hormones|hormones|mesh-ancestor
64341592|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341593|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341594|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
64341595|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341597|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
64341598|NCT03487939|Irinotecan|irinotecan|mesh-list
64341599|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
64341600|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341601|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64341602|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341603|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341604|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
64341607|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64341608|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341609|NCT00796289|Citric Acid|citric acid|mesh-list
64341610|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
64341612|NCT00796289|Enclomiphene|enclomiphene|mesh-list
64341613|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
64341614|NCT00796289|Hormones|hormones|mesh-list
64341615|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
64341616|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
64341617|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64341618|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
64341619|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
64341620|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341621|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341622|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341623|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64341624|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
64341625|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64341626|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
64341627|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64341628|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64341629|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64341630|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
64341631|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
64341632|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341637|NCT04460521|Expectorants|expectorants|mesh-ancestor
64341638|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341645|NCT00698789|Metformin|metformin|mesh-list
64341651|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64341652|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64341653|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64341654|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64341655|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341656|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
64341657|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
64341658|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341659|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341660|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64341661|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64341662|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
64341663|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64341664|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64341665|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64341666|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64341667|NCT03495739|Dabigatran|dabigatran|mesh-list
64341668|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
64341669|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64341670|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
64341671|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341672|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341673|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
64341674|NCT03298061|Prednisolone|prednisolone|mesh-list
64341675|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341676|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
64341677|NCT03298061|Hormones|hormones|mesh-ancestor
64341678|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341679|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341680|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341681|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341683|NCT04071613|Plasminogen|plasminogen|mesh-list
64341693|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341694|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
64341695|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64341696|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341697|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341698|NCT02812667|Nivolumab|nivolumab|mesh-list
64341699|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341700|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341701|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64341707|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64341708|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64341709|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341712|NCT03916627|Cemiplimab|cemiplimab|mesh-list
64341744|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64341747|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
64341748|NCT02773355|Liraglutide|liraglutide|mesh-list
64341749|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341750|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341751|NCT02773355|Incretins|incretins|mesh-ancestor
64341752|NCT02773355|Hormones|hormones|mesh-ancestor
64341753|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341754|NCT02744183|Benzocaine|benzocaine|mesh-list
64341755|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
64341756|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
64341757|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64341758|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341759|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
64341760|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64341761|NCT03484195|Fluorouracil|fluorouracil|mesh-list
64341806|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64341807|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341808|NCT02323399|Protective Agents|protective agents|mesh-ancestor
64341814|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
64341816|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
64341818|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64341859|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64341860|NCT04403243|Colchicine|colchicine|mesh-list
64341861|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
64341862|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64341863|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
64341864|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
64341865|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
64341866|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341867|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341868|NCT05648032|Triamcinolone|triamcinolone|mesh-list
64341869|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64341870|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64341871|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64341872|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64341873|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
64341874|NCT05648032|Hormones|hormones|mesh-ancestor
64341875|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341876|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341877|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64341878|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
64341879|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341880|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341888|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341889|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64341890|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341891|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
64341892|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64341893|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64341898|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341899|NCT00772343|Vaccines|vaccines|mesh-list
64341900|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
64341901|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341902|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
64341903|NCT05647954|Temozolomide|temozolomide|mesh-list
64341904|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
64341905|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64341906|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341907|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64341908|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
64341909|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341910|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64341911|NCT05647954|Estrogens|estrogens|mesh-ancestor
64341912|NCT05647954|Hormones|hormones|mesh-ancestor
64341913|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341914|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341915|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64341916|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64341917|NCT00770081|Vildagliptin|vildagliptin|mesh-list
64341918|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64341919|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341920|NCT00770081|Incretins|incretins|mesh-ancestor
64341921|NCT00770081|Hormones|hormones|mesh-ancestor
64341922|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64341923|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64341924|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
64341925|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341926|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341927|NCT02360098|Anesthetics|anesthetics|mesh-list
64341928|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64341931|NCT02273609|Warfarin|warfarin|mesh-list
64341932|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
64341933|NCT02273609|Vitamins|vitamins|mesh-ancestor
64341934|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
64341936|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
64341937|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64341938|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64341939|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341940|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
64341941|NCT02273609|Coagulants|coagulants|mesh-ancestor
64341942|NCT02273843|Vitamin D|vitamin d|mesh-list
64341943|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
64341944|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
64341945|NCT02273843|Vitamins|vitamins|mesh-list
64341946|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
64341947|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64341948|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64341949|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64341950|NCT00666497|Azacitidine|azacitidine|mesh-list
64341951|NCT00666497|Mocetinostat|mocetinostat|mesh-list
64341952|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64341953|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
64341954|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64341955|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64341956|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64341988|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64341989|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64341990|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
64341991|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64341992|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
64341993|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
64341994|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
64341995|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64341996|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64341997|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64341998|NCT02276495|Analgesics|analgesics|mesh-ancestor
64341999|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342000|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342001|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64342002|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342003|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64342004|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
64342005|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64342006|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
64342007|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64342008|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64342009|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64342010|NCT02277587|Cortisone|cortisone|mesh-list
64342011|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
64342028|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342029|NCT00662597|Paclitaxel|paclitaxel|mesh-list
64342030|NCT00662597|Carboplatin|carboplatin|mesh-list
64342031|NCT00662597|Vadimezan|vadimezan|mesh-list
64342032|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64342068|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64342069|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64342070|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64342071|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342081|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64342082|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342083|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342084|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
64342085|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342086|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342087|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64342088|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342089|NCT00656357|Cocaine|cocaine|mesh-list
64342090|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
64342091|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
64342092|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342093|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342094|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
64342095|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342109|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342110|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342112|NCT03134573|Interferons|interferons|mesh-list
64342113|NCT03134573|Interferon-beta|interferon-beta|mesh-list
64342114|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
64342115|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342116|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
64342117|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342118|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
64342119|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342126|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342127|NCT04232033|Mitogens|mitogens|mesh-list
64342128|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
64342129|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342130|NCT03134417|Vitamin D|vitamin d|mesh-list
64342131|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
64342132|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
64342133|NCT03134417|Vitamins|vitamins|mesh-list
64342134|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
64342135|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342136|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64342159|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342160|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342161|NCT00739349|Cyclosporine|cyclosporine|mesh-list
64342162|NCT00739349|Cyclosporins|cyclosporins|mesh-list
64342163|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342164|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342165|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342166|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
64342167|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342168|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
64342169|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342170|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
64342171|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342172|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64342173|NCT00152009|Guanfacine|guanfacine|mesh-list
64342174|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64342175|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64342176|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64342177|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64342178|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
64342179|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342180|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342181|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342183|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342184|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342185|NCT04158635|Gemcitabine|gemcitabine|mesh-list
64342186|NCT04158635|Paclitaxel|paclitaxel|mesh-list
64342187|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64342188|NCT04158635|Bosentan|bosentan|mesh-list
64342189|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64342190|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342191|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
64342192|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
64342193|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
64342194|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342195|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64342197|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
64342198|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342199|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342200|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342201|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
64342202|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342203|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64342204|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64342205|NCT00734435|Zonisamide|zonisamide|mesh-list
64342206|NCT00734435|Olanzapine|olanzapine|mesh-list
64342207|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
64342208|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
64342257|NCT02265796|Ranolazine|ranolazine|mesh-list
64342258|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64342259|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342260|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342261|NCT05647642|Midazolam|midazolam|mesh-list
64342269|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342270|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64342271|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64342273|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
64342274|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342275|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342276|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64342277|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64342278|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64342306|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64342307|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64342308|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342309|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342310|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342311|NCT05647408|Dexamethasone|dexamethasone|mesh-list
64342312|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342313|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
64342314|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
64342315|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342316|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342317|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64342318|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
64342319|NCT05647408|Hormones|hormones|mesh-ancestor
64342320|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342321|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64342322|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342323|NCT03483415|Morphine|morphine|mesh-list
64342327|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342328|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342358|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342359|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342360|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
64342361|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
64342362|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342363|NCT03483181|Enoxaparin|enoxaparin|mesh-list
64342364|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
64342365|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64342366|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
64342367|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64342368|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
64342369|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342370|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342371|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
64342372|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64342373|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64342374|NCT03069937|Docetaxel|docetaxel|mesh-list
64342375|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342376|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
64342377|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64342378|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
64342379|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342380|NCT00309985|Docetaxel|docetaxel|mesh-list
64342381|NCT00309985|Androgens|androgens|mesh-list
64342382|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342383|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
64342384|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
64342385|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
64342386|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342387|NCT00309985|Hormones|hormones|mesh-ancestor
64342388|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342403|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
64342404|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342405|NCT02355028|Ranibizumab|ranibizumab|mesh-list
64342406|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64342407|NCT02355028|Acrizanib|acrizanib|mesh-list
64342408|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64342409|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64342410|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64342411|NCT02355028|Growth Substances|growth substances|mesh-ancestor
64342412|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342413|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
64342414|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342415|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64342416|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342417|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342418|NCT05647330|Gemcitabine|gemcitabine|mesh-list
64342419|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
64342420|NCT05647330|Chloroquine|chloroquine|mesh-list
64342421|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64342422|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
64342423|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342424|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342425|NCT05647330|Antiviral Agents|antiviral agents|mesh-ancestor
64342426|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342427|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342428|NCT05647330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342429|NCT05647330|Immunologic Factors|immunologic factors|mesh-ancestor
64342450|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342451|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
64342452|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
64342453|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342454|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342455|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64342456|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
64342457|NCT02260804|Rituximab|rituximab|mesh-list
64342458|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342459|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342460|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
64342461|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342462|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342463|NCT03486457|Tofacitinib|tofacitinib|mesh-list
64342464|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64342465|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342504|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
64342505|NCT02260492|Hormones|hormones|mesh-ancestor
64342506|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342507|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
64342508|NCT03966625|Autoantibodies|autoantibodies|mesh-list
64342509|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
64342510|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342511|NCT02260258|Rocuronium|rocuronium|mesh-list
64342512|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64342513|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64342514|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64342515|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342516|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342517|NCT05151679|Iron|iron|mesh-list
64342518|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
64342519|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
64342520|NCT05151679|Trace Elements|trace elements|mesh-ancestor
64342521|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
64342522|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342523|NCT05151679|Hematinics|hematinics|mesh-ancestor
64342524|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
64342525|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
64342526|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342527|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
64342528|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64342529|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342530|NCT02353468|Dexamethasone|dexamethasone|mesh-list
64342531|NCT02353468|Lenalidomide|lenalidomide|mesh-list
64342551|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342552|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342553|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64342554|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
64342555|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
64342556|NCT04459663|Axitinib|axitinib|mesh-list
64342557|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342558|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64342559|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342560|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342561|NCT05150899|Fexofenadine|fexofenadine|mesh-list
64342562|NCT05150899|Tamsulosin|tamsulosin|mesh-list
64342563|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64342564|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64342565|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64342566|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
64342567|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342568|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342569|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342570|NCT05150899|Urological Agents|urological agents|mesh-ancestor
64342571|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64342572|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64342573|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64342574|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
64342575|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
64342576|NCT01530997|Cisplatin|cisplatin|mesh-list
64342597|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64342598|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342599|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342600|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64342601|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
64342602|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342603|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342604|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64342605|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64342606|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
64342607|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342608|NCT05153785|Lidocaine|lidocaine|mesh-list
64342611|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342612|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342613|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
64342614|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342615|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64342616|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64342617|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64342646|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64342647|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64342648|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64342649|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342651|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64342652|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64342653|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
64342654|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342655|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342656|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
64342658|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342659|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342660|NCT02258074|Niacinamide|niacinamide|mesh-list
64342661|NCT02258074|Niacin|niacin|mesh-list
64342662|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
64342663|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
64342664|NCT02258074|Vitamins|vitamins|mesh-ancestor
64342665|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
64342666|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342667|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64342698|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342699|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64342700|NCT01642732|Everolimus|everolimus|mesh-list
64342701|NCT01642732|Leuprolide|leuprolide|mesh-list
64342702|NCT01642732|Bicalutamide|bicalutamide|mesh-list
64342703|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342704|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64342705|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
64342706|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342707|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64342708|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
64342709|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64342710|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64342711|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
64342712|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
64342713|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342714|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
64342715|NCT02281799|Azathioprine|azathioprine|mesh-list
64342716|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
64342722|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342723|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64342724|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342725|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342726|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64342727|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64342739|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342740|NCT00589823|Analgesics|analgesics|mesh-ancestor
64342741|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
64342742|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342743|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64342744|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64342745|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
64342746|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
64342747|NCT02190721|Lenograstim|lenograstim|mesh-list
64342748|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64342749|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
64342750|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342752|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64342753|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64342754|NCT03134339|Nicotine|nicotine|mesh-list
64342755|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64342756|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
64342757|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342758|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342759|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64342760|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64342761|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
64342762|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64342763|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342764|NCT02282267|Gefitinib|gefitinib|mesh-list
64342765|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342766|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64342769|NCT02283905|Voriconazole|voriconazole|mesh-list
64342770|NCT02283905|Amphotericin B|amphotericin b|mesh-list
64342771|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64342772|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
64342773|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342774|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64342775|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64342777|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342778|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64342779|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
64342780|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342781|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342782|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64342783|NCT02283905|Amebicides|amebicides|mesh-ancestor
64342784|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64342785|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64342786|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64342789|NCT03480997|Ipratropium|ipratropium|mesh-list
64342790|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
64342791|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64342792|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
64342793|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379478|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64342794|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342795|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64342796|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
64342797|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
64342798|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64342799|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64342800|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64342826|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64342827|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64342828|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
64342829|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342830|NCT00495131|Interferons|interferons|mesh-list
64342831|NCT00495131|Ribavirin|ribavirin|mesh-list
64342832|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
64342833|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
64342834|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64342835|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342836|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
64342837|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64342838|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
64342839|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342840|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
64342841|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342842|NCT02257372|Albuterol|albuterol|mesh-list
64342843|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64342844|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
64342845|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342846|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342847|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64342848|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
64342849|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
64342850|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64342851|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64342852|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64342853|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64342857|NCT02256982|Gemcitabine|gemcitabine|mesh-list
64342858|NCT02256982|Cisplatin|cisplatin|mesh-list
64342859|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342860|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64342868|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342869|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
64342870|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64342871|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
64342872|NCT03480607|Dexamethasone|dexamethasone|mesh-list
64342873|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
64342874|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342875|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
64342876|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
64342877|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342878|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342879|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64342880|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
64342881|NCT03480607|Hormones|hormones|mesh-ancestor
64342882|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342883|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64342884|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342885|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64342886|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64342887|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342888|NCT03480607|Analgesics|analgesics|mesh-ancestor
64342889|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
64342918|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342919|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64342920|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
64342921|NCT05646394|Aspirin|aspirin|mesh-list
64342922|NCT05646394|Vitamins|vitamins|mesh-list
64342923|NCT05646394|Vitamin K|vitamin k|mesh-list
64342924|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64342925|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
64342926|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342927|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64342928|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64342929|NCT05646394|Analgesics|analgesics|mesh-ancestor
64342930|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
64342931|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342932|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342933|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64342934|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64342935|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64342936|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64342937|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64342938|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64342939|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
64342948|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
64342949|NCT04947631|Tadalafil|tadalafil|mesh-list
64342950|NCT04947631|Dutasteride|dutasteride|mesh-list
64342951|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
64342952|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64342959|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
64342960|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342961|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342962|NCT00561743|Dexamethasone|dexamethasone|mesh-list
64342963|NCT00561743|Doxorubicin|doxorubicin|mesh-list
64342964|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64342965|NCT00561743|Bortezomib|bortezomib|mesh-list
64342966|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64342967|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
64342968|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
64342969|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64342970|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64342971|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64342972|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
64342973|NCT00561743|Hormones|hormones|mesh-ancestor
64342974|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64342975|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64342976|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64342977|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64343016|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343017|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343018|NCT00483977|Analgesics|analgesics|mesh-ancestor
64343019|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
64343020|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343021|NCT00481325|Citalopram|citalopram|mesh-list
64343022|NCT00481325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64343023|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64343024|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343025|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343026|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343034|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64343035|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343038|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
64343066|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
64343067|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343068|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343069|NCT00465959|Urological Agents|urological agents|mesh-ancestor
64343070|NCT00465803|Timolol|timolol|mesh-list
64343071|NCT00465803|Travoprost|travoprost|mesh-list
64343072|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64343073|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64343074|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343075|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64343076|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64343077|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343078|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343079|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343080|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64343081|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64343082|NCT02282891|Ketamine|ketamine|mesh-list
64343083|NCT02282891|Propofol|propofol|mesh-list
64343084|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64343085|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343086|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343087|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64343088|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
64343089|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
64343090|NCT02282891|Analgesics|analgesics|mesh-ancestor
64343091|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
64343098|NCT00464633|Alvocidib|alvocidib|mesh-list
64343114|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64343115|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343116|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343117|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343118|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343119|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64343120|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343121|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
64343122|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64343123|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64343124|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64343125|NCT00464555|Analgesics|analgesics|mesh-ancestor
64343126|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
64343127|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343128|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343129|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64343130|NCT00464243|Volinanserin|volinanserin|mesh-list
64343169|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
64343170|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343171|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343172|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
64343173|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343174|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64343175|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64343176|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64343177|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343181|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64343182|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64343183|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343184|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343185|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343186|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343187|NCT00457457|Urological Agents|urological agents|mesh-ancestor
64343188|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64343189|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
64343190|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
64343191|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343192|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
64343193|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343195|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
64343214|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
64343215|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343216|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343217|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
64343218|NCT02536183|Doxorubicin|doxorubicin|mesh-list
64343219|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64343220|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64343221|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343222|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64343223|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64343224|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343225|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343227|NCT02523313|Ipilimumab|ipilimumab|mesh-list
64343228|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343229|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343230|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64343231|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343232|NCT02452034|Posaconazole|posaconazole|mesh-list
64343233|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
64343234|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343235|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64343236|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64343237|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64343238|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64343239|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64343240|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343241|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343242|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64343243|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
64343244|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64343246|NCT02283359|Irinotecan|irinotecan|mesh-list
64343254|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343255|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343256|NCT00508625|Paclitaxel|paclitaxel|mesh-list
64343257|NCT00508625|Bevacizumab|bevacizumab|mesh-list
64343258|NCT00508625|Carboplatin|carboplatin|mesh-list
64379479|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64343259|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64343260|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343261|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
64343262|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
64343263|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
64343264|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343265|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343266|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64343267|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64343268|NCT00508625|Growth Substances|growth substances|mesh-ancestor
64343269|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343270|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
64343272|NCT02284529|Fluorouracil|fluorouracil|mesh-list
64343273|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
64343274|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343275|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64343276|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343277|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343278|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
64343279|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343302|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343303|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343304|NCT00383513|Epratuzumab|epratuzumab|mesh-list
64343305|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343306|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343307|NCT00382811|Carboplatin|carboplatin|mesh-list
64343308|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343309|NCT02286635|Clarithromycin|clarithromycin|mesh-list
64343310|NCT02286635|Rifampin|rifampin|mesh-list
64343311|NCT02286635|Deflazacort|deflazacort|mesh-list
64343312|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343313|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343314|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64343355|NCT00375791|Hormones|hormones|mesh-ancestor
64343356|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64343357|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64343358|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343359|NCT00431873|Mocetinostat|mocetinostat|mesh-list
64343360|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64343361|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343362|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343363|NCT02287181|Remifentanil|remifentanil|mesh-list
64343364|NCT02287181|Propofol|propofol|mesh-list
64343365|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64343366|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343367|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343369|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
64343370|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
64343371|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64343372|NCT02287181|Narcotics|narcotics|mesh-ancestor
64343373|NCT02287181|Analgesics|analgesics|mesh-ancestor
64343374|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
64343375|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343376|NCT02287259|Olanzapine|olanzapine|mesh-list
64343377|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
64343378|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
64343391|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
64343396|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64343397|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343398|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343399|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
64343400|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64343401|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64343402|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343403|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
64343404|NCT04470557|Coagulants|coagulants|mesh-ancestor
64343405|NCT00372437|Gemcitabine|gemcitabine|mesh-list
64343406|NCT00372437|Mocetinostat|mocetinostat|mesh-list
64343407|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64343408|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
64343409|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343410|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343411|NCT00372437|Antiviral Agents|antiviral agents|mesh-ancestor
64343412|NCT00372437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343413|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343414|NCT00372437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343452|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343453|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343454|NCT00360035|Obatoclax|obatoclax|mesh-list
64343455|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343456|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343457|NCT00356681|Niacinamide|niacinamide|mesh-list
64343458|NCT00356681|Paclitaxel|paclitaxel|mesh-list
64343459|NCT00356681|Bevacizumab|bevacizumab|mesh-list
64343460|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
64343461|NCT00356681|Imetelstat|imetelstat|mesh-list
64343462|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64343463|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343464|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
64343465|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
64343466|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
64343467|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343468|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343469|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64343470|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64343471|NCT00356681|Growth Substances|growth substances|mesh-ancestor
64343472|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343473|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
64343474|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64343475|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343476|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
64343477|NCT00356681|Vitamins|vitamins|mesh-ancestor
64343478|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
64343479|NCT00417209|Fluorouracil|fluorouracil|mesh-list
64343497|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343499|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343500|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64343501|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
64343502|NCT00407303|Bortezomib|bortezomib|mesh-list
64343503|NCT00407303|Obatoclax|obatoclax|mesh-list
64343508|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64343509|NCT00344045|Analgesics|analgesics|mesh-ancestor
64343510|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
64343511|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343512|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343513|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
64343515|NCT02256436|Docetaxel|docetaxel|mesh-list
64343516|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
64343517|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64343519|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
64343554|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
64343555|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343556|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
64343557|NCT00332657|Anecortave|anecortave|mesh-list
64343558|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64343559|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64343560|NCT00332657|Growth Substances|growth substances|mesh-ancestor
64343573|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343575|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343576|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343577|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
64343578|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343581|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343582|NCT00398879|Capecitabine|capecitabine|mesh-list
64343583|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64343584|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
64343585|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343586|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343587|NCT00309179|Cetuximab|cetuximab|mesh-list
64343588|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64343589|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343590|NCT00394199|Fluticasone|fluticasone|mesh-list
64343592|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
64343593|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343594|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64343595|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
64343596|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343597|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343598|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64343599|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
64343600|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
64343601|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64343602|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64343603|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64343604|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64343605|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
64343626|NCT02480114|Acetaminophen|acetaminophen|mesh-list
64343627|NCT02480114|Ibuprofen|ibuprofen|mesh-list
64343628|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64343629|NCT02480114|Fentanyl|fentanyl|mesh-list
64343630|NCT02480114|Oxycodone|oxycodone|mesh-list
64343631|NCT02480114|Hydrocodone|hydrocodone|mesh-list
64343632|NCT02480114|Gabapentin|gabapentin|mesh-list
64343633|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64343634|NCT02480114|Narcotics|narcotics|mesh-ancestor
64343635|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343636|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343638|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
64343639|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343648|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64343649|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64343650|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343651|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343652|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
64343653|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64343654|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64343655|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343656|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64343657|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64343663|NCT00299507|Anecortave|anecortave|mesh-list
64343670|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343672|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64343673|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
64343674|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64343675|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64343676|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343677|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343678|NCT02285309|Protective Agents|protective agents|mesh-ancestor
64343679|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343680|NCT02479880|Tenofovir|tenofovir|mesh-list
64343681|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
64343682|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343683|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64343684|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64343685|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343686|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343687|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64343688|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64343689|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
64343690|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343691|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343692|NCT00297089|Pemetrexed|pemetrexed|mesh-list
64343693|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343694|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343695|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343698|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
64343716|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343717|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343718|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
64343719|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343720|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64343721|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
64343722|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343723|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64379480|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64343724|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64343725|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343726|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64343727|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64343728|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64343729|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64343730|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64343731|NCT02288429|Colistin|colistin|mesh-list
64343773|NCT02288507|Sorafenib|sorafenib|mesh-list
64343774|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343775|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64343776|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343777|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343778|NCT00231257|Sirolimus|sirolimus|mesh-list
64343779|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64343780|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64343781|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64343783|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
64343784|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343785|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
64343786|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343787|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
64343788|NCT00224003|Hematinics|hematinics|mesh-ancestor
64343789|NCT00216593|Galantamine|galantamine|mesh-list
64343790|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64343791|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64343792|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343793|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
64343794|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343795|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343796|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64343797|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
64343798|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343799|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
64343800|NCT00389675|Guanfacine|guanfacine|mesh-list
64343801|NCT00389675|Darusentan|darusentan|mesh-list
64343802|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64343819|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343820|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64343821|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
64343822|NCT02288741|Hormones|hormones|mesh-ancestor
64343823|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64343824|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64343825|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64343826|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
64343832|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64343833|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
64343835|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
64343836|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343837|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343838|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
64343839|NCT02508428|Diuretics|diuretics|mesh-ancestor
64343840|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
64343871|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64343872|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
64343873|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64343874|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64343875|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64343876|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
64343877|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64343878|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
64343879|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64343936|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64343937|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64343938|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64343939|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343940|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
64343941|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64343942|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64343943|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64343944|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64343945|NCT03951025|Melatonin|melatonin|mesh-list
64343946|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
64343947|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343948|NCT03951025|Protective Agents|protective agents|mesh-ancestor
64343998|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64343999|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64344000|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
64344002|NCT03478423|Hydromorphone|hydromorphone|mesh-list
64344003|NCT03478423|Codeine|codeine|mesh-list
64344004|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64344005|NCT03478423|Narcotics|narcotics|mesh-ancestor
64344006|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344011|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
64344012|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
64344013|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
64344014|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344015|NCT03130933|Amoxicillin|amoxicillin|mesh-list
64344016|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64344017|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344018|NCT05155969|Ketamine|ketamine|mesh-list
64344019|NCT05155969|Esketamine|esketamine|mesh-list
64344020|NCT05155969|Analgesics|analgesics|mesh-ancestor
64344025|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64344026|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
64344027|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
64344028|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344029|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64344030|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64344031|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344032|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344033|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
64344034|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64344035|NCT05112913|Vaccines|vaccines|mesh-list
64344036|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
64344037|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344038|NCT03475459|Melatonin|melatonin|mesh-list
64344039|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
64344040|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344041|NCT03475459|Protective Agents|protective agents|mesh-ancestor
64344042|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344043|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344044|NCT03478111|Methotrexate|methotrexate|mesh-list
64344045|NCT03478111|Infliximab|infliximab|mesh-list
64344046|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64344047|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
64344048|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64344049|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344050|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64344051|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
64344052|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344053|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344054|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
64344055|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344067|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344068|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
64344069|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64344070|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344071|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344072|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64344073|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64344074|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64344075|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64344076|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64344077|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64344078|NCT03477955|Silicon|silicon|mesh-list
64344079|NCT03477955|Trace Elements|trace elements|mesh-ancestor
64344080|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
64344081|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344082|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
64344083|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344084|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64344085|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344086|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344128|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64344138|NCT05008003|Vitamin D|vitamin d|mesh-list
64344139|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
64344140|NCT05008003|Vitamins|vitamins|mesh-ancestor
64344141|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
64344142|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344143|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64344144|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64344146|NCT03475225|Vitamin D|vitamin d|mesh-list
64344147|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64344148|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344149|NCT03475225|Vitamins|vitamins|mesh-ancestor
64344150|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
64344151|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64344152|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64344153|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
64344154|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
64344155|NCT02504294|Hematinics|hematinics|mesh-ancestor
64344156|NCT02446418|Fluticasone|fluticasone|mesh-list
64344157|NCT02446418|Xhance|xhance|mesh-list
64344158|NCT02446418|Budesonide|budesonide|mesh-list
64344170|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
64344171|NCT02446418|Hormones|hormones|mesh-ancestor
64344172|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344173|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64344174|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64344175|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64344176|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
64344177|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344178|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344179|NCT04859062|Lidocaine|lidocaine|mesh-list
64344180|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
64344181|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
64344182|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344183|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344184|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
64344185|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344186|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64344187|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64344224|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
64344225|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344226|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64344227|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64344228|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64344229|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64344230|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344231|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64344232|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64344233|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64344234|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64344235|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344236|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
64344237|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344282|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64344283|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64344284|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64344285|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64344286|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64344287|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64344288|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
64344289|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64344291|NCT05428150|Analgesics|analgesics|mesh-ancestor
64344292|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
64344293|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344294|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344295|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64344296|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64344339|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344341|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64344342|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344343|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
64344344|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
64344345|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344346|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
64344347|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344348|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344349|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
64344350|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64344351|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64344352|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64344353|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64344395|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344396|NCT02230319|Paclitaxel|paclitaxel|mesh-list
64344397|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344398|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344399|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
64344400|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
64344401|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
64344402|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344403|NCT00135395|Ritonavir|ritonavir|mesh-list
64344404|NCT00135395|Lopinavir|lopinavir|mesh-list
64344405|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64344406|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64344407|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344408|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344409|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344411|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344412|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344413|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
64344414|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344415|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64344416|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64344417|NCT02230553|Lapatinib|lapatinib|mesh-list
64344418|NCT02230553|Trametinib|trametinib|mesh-list
64344419|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344420|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64344421|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344422|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344423|NCT04261049|Triamcinolone|triamcinolone|mesh-list
64344424|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64344425|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64344426|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64344437|NCT00057473|Irinotecan|irinotecan|mesh-list
64344438|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344439|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64344440|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64344441|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344442|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344443|NCT00035789|Entecavir|entecavir|mesh-list
64344444|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
64344445|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344446|NCT00035633|Entecavir|entecavir|mesh-list
64344447|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
64344448|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344449|NCT00028301|Ritonavir|ritonavir|mesh-list
64344450|NCT00028301|Lopinavir|lopinavir|mesh-list
64344451|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64344453|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344454|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344455|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344456|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344457|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344458|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344459|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
64344460|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344461|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64344462|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64344463|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64344464|NCT00028067|Nelfinavir|nelfinavir|mesh-list
64344465|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64344466|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344467|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344468|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344469|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344470|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344480|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
64344481|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344482|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344483|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64344484|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
64344485|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344486|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344487|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64344488|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344489|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64344490|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64344491|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344492|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
64344493|NCT04469777|Hematinics|hematinics|mesh-ancestor
64344494|NCT00004895|Octreotide|octreotide|mesh-list
64344495|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64344496|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64344497|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344498|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
64344499|NCT00004181|Busulfan|busulfan|mesh-list
64344500|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344501|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
64344502|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344503|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344504|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64344505|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
64344506|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344507|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344508|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64344509|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
64344510|NCT00004175|Docetaxel|docetaxel|mesh-list
64344511|NCT00004175|Doxorubicin|doxorubicin|mesh-list
64344512|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64344513|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344514|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
64344515|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344516|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344517|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64344518|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
64344519|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344520|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344521|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64344522|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
64344523|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
64344524|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
64344525|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64344526|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64344527|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64344528|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344529|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64344530|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64344531|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64344532|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
64344533|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344534|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64344535|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64344536|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344537|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
64344538|NCT00004169|Carboplatin|carboplatin|mesh-list
64344539|NCT00004169|Etoposide|etoposide|mesh-list
64344540|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344541|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
64344542|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344543|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344550|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64344551|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64344552|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344554|NCT00002429|Zidovudine|zidovudine|mesh-list
64344555|NCT00002429|Stavudine|stavudine|mesh-list
64344562|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344563|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
64344564|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344565|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344566|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344567|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
64344568|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64344569|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64344570|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
64344571|NCT00002411|Lamivudine|lamivudine|mesh-list
64344572|NCT00002411|Zidovudine|zidovudine|mesh-list
64344573|NCT00002411|Stavudine|stavudine|mesh-list
64344574|NCT00002411|Didanosine|didanosine|mesh-list
64344575|NCT00002411|Nelfinavir|nelfinavir|mesh-list
64344576|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64344577|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64344578|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344579|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344580|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
64344581|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344582|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344596|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64344597|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64344598|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64344599|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344600|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
64344601|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64344602|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344603|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344604|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64344605|NCT03529643|Analgesics|analgesics|mesh-ancestor
64344606|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
64344607|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344608|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64344609|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64344610|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64344612|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344613|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344614|NCT03529331|Acetaminophen|acetaminophen|mesh-list
64344615|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
64344616|NCT03529331|Morphine|morphine|mesh-list
64344647|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344648|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64344649|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64344650|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344651|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
64344652|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344653|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64344654|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64344655|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
64344656|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64344657|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
64344658|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344660|NCT03529175|Paclitaxel|paclitaxel|mesh-list
64368228|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64344661|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64344662|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344663|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344664|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
64344665|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
64344666|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
64344667|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344668|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64344670|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
64344671|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64344672|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344673|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64344674|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
64344675|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344676|NCT03529097|Dipyrone|dipyrone|mesh-list
64344689|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64344690|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64344691|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344692|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344693|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
64344694|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
64344695|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
64344696|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344697|NCT03531749|Protective Agents|protective agents|mesh-ancestor
64344698|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344699|NCT03531749|Vitamins|vitamins|mesh-ancestor
64344700|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
64344701|NCT05258747|Olaparib|olaparib|mesh-list
64344702|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64344703|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344704|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344705|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344706|NCT03528785|Leucovorin|leucovorin|mesh-list
64344707|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
64344708|NCT03528785|Irinotecan|irinotecan|mesh-list
64344709|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
64344710|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344711|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64344712|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64344713|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344714|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344715|NCT03528785|Antidotes|antidotes|mesh-ancestor
64344716|NCT03528785|Protective Agents|protective agents|mesh-ancestor
64344717|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344718|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
64344719|NCT03528785|Vitamins|vitamins|mesh-ancestor
64344720|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
64344721|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64344732|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64344734|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64344736|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
64344737|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64344738|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
64344739|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344740|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344741|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64344742|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
64344743|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64344744|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
64344745|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344746|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344747|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64344748|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
64344749|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
64344750|NCT03527381|Protective Agents|protective agents|mesh-ancestor
64344751|NCT04441385|Maraviroc|maraviroc|mesh-list
64344752|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64344753|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64344787|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
64344788|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344789|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344790|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64344791|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344792|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64344793|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64344799|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
64344800|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
64344801|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
64344802|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
64344803|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
64344804|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
64344805|NCT05179499|Norepinephrine|norepinephrine|mesh-list
64344806|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64344807|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64344808|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
64344809|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344810|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344811|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344812|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
64344813|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
64344814|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344815|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64344832|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64344833|NCT03531047|Riboflavin|riboflavin|mesh-list
64344834|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
64344835|NCT03531047|Vitamins|vitamins|mesh-ancestor
64344836|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
64344837|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344838|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64344839|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
64344840|NCT04440917|Apatinib|apatinib|mesh-list
64344841|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64344842|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344843|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64344844|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64344845|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344846|NCT04192019|Glucagon|glucagon|mesh-list
64344847|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64344848|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64344850|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344851|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344852|NCT04192019|Incretins|incretins|mesh-ancestor
64344853|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
64344886|NCT05439005|Analgesics|analgesics|mesh-ancestor
64344887|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
64344888|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344889|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64344890|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64344891|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64344892|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
64344893|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344894|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344895|NCT04468139|Quercetin|quercetin|mesh-list
64344896|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344897|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
64344898|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344899|NCT04468139|Protective Agents|protective agents|mesh-ancestor
64344900|NCT03526445|Glucagon|glucagon|mesh-list
64344901|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64344902|NCT03526445|Hormones|hormones|mesh-ancestor
64344903|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64344904|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344905|NCT04939649|Midazolam|midazolam|mesh-list
64344906|NCT04939649|Ketamine|ketamine|mesh-list
64344907|NCT04939649|Analgesics|analgesics|mesh-ancestor
64344908|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
64344909|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344910|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344911|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64344912|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64344913|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
64344914|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
64344915|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344916|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64344917|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64344918|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344919|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344920|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64344921|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64344925|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
64344926|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
64344927|NCT04927949|Cangrelor|cangrelor|mesh-list
64344928|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64344929|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64344930|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64344931|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64344932|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
64344933|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344934|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344935|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344936|NCT04589819|Teriparatide|teriparatide|mesh-list
64344937|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64344938|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344939|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64344940|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64344941|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64344942|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64344943|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
64344944|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344945|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64344948|NCT04467983|Denosumab|denosumab|mesh-list
64344949|NCT04467983|Abaloparatide|abaloparatide|mesh-list
64344950|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64344967|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344969|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
64344970|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344971|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
64344972|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
64344973|NCT04699721|Paclitaxel|paclitaxel|mesh-list
64344974|NCT04699721|Carboplatin|carboplatin|mesh-list
64344975|NCT04699721|Nivolumab|nivolumab|mesh-list
64344976|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64344977|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64344978|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
64344979|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
64344980|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
64344981|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64344982|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64344983|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64344984|NCT03525821|Ketamine|ketamine|mesh-list
64344985|NCT03525821|Analgesics|analgesics|mesh-ancestor
64344986|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
64344987|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64344988|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64344989|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64344990|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64344991|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
64344992|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
64344993|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64344994|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64344995|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64344996|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64344997|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345005|NCT04221035|Dacarbazine|dacarbazine|mesh-list
64345006|NCT04221035|Carboplatin|carboplatin|mesh-list
64345007|NCT04221035|Doxorubicin|doxorubicin|mesh-list
64345008|NCT04221035|Irinotecan|irinotecan|mesh-list
64345009|NCT04221035|Etoposide|etoposide|mesh-list
64345010|NCT04221035|Vincristine|vincristine|mesh-list
64345011|NCT04221035|Vindesine|vindesine|mesh-list
64345012|NCT04221035|Dinutuximab|dinutuximab|mesh-list
64345013|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345014|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
64345015|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345016|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345017|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64345018|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
64345019|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345020|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345021|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64345022|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64345023|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64345024|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64345025|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345026|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64345027|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64345028|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
64345029|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
64345030|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
64345043|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64345044|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64345045|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64345046|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64345047|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64345048|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64345049|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
64345050|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
64345051|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
64345052|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
64345053|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345054|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345056|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
64345057|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345058|NCT04969198|Nicotine|nicotine|mesh-list
64345059|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64345060|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
64345061|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345062|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345063|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64345064|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64345065|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
64345068|NCT04666636|Mirabegron|mirabegron|mesh-list
64345076|NCT04666636|Urological Agents|urological agents|mesh-ancestor
64345077|NCT04925284|Bevacizumab|bevacizumab|mesh-list
64345079|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345080|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345081|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64345082|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64345083|NCT04925284|Growth Substances|growth substances|mesh-ancestor
64345084|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345085|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
64345086|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64345087|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345088|NCT04890106|Bimatoprost|bimatoprost|mesh-list
64345089|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64345090|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64345091|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64345092|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64345093|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64345094|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64345095|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345096|NCT05214664|Anesthetics|anesthetics|mesh-list
64345097|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64345098|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345099|NCT05206084|Sirolimus|sirolimus|mesh-list
64345100|NCT05206084|Everolimus|everolimus|mesh-list
64345101|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345102|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345103|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
64345104|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345105|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345120|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345121|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345122|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64345130|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
64345131|NCT04810156|Prednisone|prednisone|mesh-list
64345132|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
64345133|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64345134|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64345135|NCT04810156|Prednisolone|prednisolone|mesh-list
64345136|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
64345137|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64345138|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64345139|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
64345140|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64345141|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
64345142|NCT04810156|Hormones|hormones|mesh-ancestor
64345143|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345144|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345145|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64345146|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345147|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64345148|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64345149|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
64345164|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
64345165|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64345166|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
64345167|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345168|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345170|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64345171|NCT04837924|Narcotics|narcotics|mesh-ancestor
64345172|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64345173|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
64345174|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
64345175|NCT05406466|Lenvatinib|lenvatinib|mesh-list
64345181|NCT05152420|Apixaban|apixaban|mesh-list
64345182|NCT05152420|Edoxaban|edoxaban|mesh-list
64345183|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64345184|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
64345185|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64345199|NCT04418908|Cetrorelix|cetrorelix|mesh-list
64345219|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345220|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64345221|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345222|NCT04762498|Methotrexate|methotrexate|mesh-list
64345223|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64345224|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
64345225|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64345226|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345227|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64345228|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
64345229|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345230|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345231|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
64345232|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345233|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64345277|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345278|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
64345279|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345280|NCT05298202|Capsaicin|capsaicin|mesh-list
64345281|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
64345282|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64345283|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
64345285|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345286|NCT01637272|Pasireotide|pasireotide|mesh-list
64345287|NCT01637272|Hormones|hormones|mesh-ancestor
64345288|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345289|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345295|NCT03178864|Heparin|heparin|mesh-list
64345296|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
64345297|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
64345298|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64345299|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64345300|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345301|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64345302|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
64345303|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64345304|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
64345305|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345306|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64345307|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
64345308|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345309|NCT05323552|Curare|curare|mesh-list
64345310|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64345311|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64345312|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64345315|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64345316|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64345317|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
64345318|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345319|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345321|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345322|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
64345323|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345325|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64345326|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64345327|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345328|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345329|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345331|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
64345374|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345375|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64345376|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345377|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345378|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64345379|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
64345380|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64345381|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
64345382|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64345391|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345430|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64345431|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345432|NCT02502734|Fluticasone|fluticasone|mesh-list
64345434|NCT02502734|Albuterol|albuterol|mesh-list
64345435|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64345436|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64345437|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
64345438|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345439|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345440|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64345441|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
64345442|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
64345443|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64345444|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
64345445|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64345446|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64345447|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64345448|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64345449|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345450|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345451|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345452|NCT04193878|Budesonide|budesonide|mesh-list
64345453|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
64345454|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64345455|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64345456|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
64345481|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64345482|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64345483|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64345484|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345487|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64345488|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64345491|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345492|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345493|NCT02667418|Vancomycin|vancomycin|mesh-list
64345494|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
64345495|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64345496|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345497|NCT02611024|Irinotecan|irinotecan|mesh-list
64345498|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64345499|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64345500|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345505|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
64345506|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345507|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64345511|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64345514|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64345515|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
64345516|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
64345517|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64345518|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64345519|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345520|NCT04201496|Empagliflozin|empagliflozin|mesh-list
64345521|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64345522|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345523|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64345524|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345525|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
64345534|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
64345535|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345536|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345537|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
64345538|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64345541|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345542|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64345543|NCT02456974|Amoxicillin|amoxicillin|mesh-list
64345544|NCT02456974|Vancomycin|vancomycin|mesh-list
64345556|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345557|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345558|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345559|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64345560|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64345561|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64345562|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
64345563|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
64345564|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64345565|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64345566|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345567|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345568|NCT04797286|Urological Agents|urological agents|mesh-ancestor
64345570|NCT03682276|Ipilimumab|ipilimumab|mesh-list
64345571|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64345572|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345573|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64345574|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345575|NCT05653024|Albuterol|albuterol|mesh-list
64345576|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64345577|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
64345578|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345581|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
64345582|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
64345583|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64345584|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64345585|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64345586|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64345587|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345588|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345589|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345590|NCT02499770|Carboplatin|carboplatin|mesh-list
64345593|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64345594|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64345595|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64345596|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345598|NCT04418674|Fentanyl|fentanyl|mesh-list
64345599|NCT04418674|Ketamine|ketamine|mesh-list
64345600|NCT04418674|Analgesics|analgesics|mesh-ancestor
64345601|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
64345602|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345603|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345604|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64345605|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64345606|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
64345607|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
64345608|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64345609|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64345612|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345614|NCT04418674|Narcotics|narcotics|mesh-ancestor
64345615|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64345616|NCT02442284|Ritonavir|ritonavir|mesh-list
64345617|NCT02442284|Ribavirin|ribavirin|mesh-list
64345618|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64345619|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64345626|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345633|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64345634|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345635|NCT05178550|Heparin|heparin|mesh-list
64345636|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
64345637|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64345642|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345643|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64345644|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64345645|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345646|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345647|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64345684|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
64345685|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345693|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345694|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
64345701|NCT05235256|Lidocaine|lidocaine|mesh-list
64345702|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64345703|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
64345708|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
64345729|NCT04810546|Lactoferrin|lactoferrin|mesh-list
64345730|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345732|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
64345733|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345739|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64345740|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64345741|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345742|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345743|NCT04596826|Hormones|hormones|mesh-ancestor
64345744|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345745|NCT02440568|Cytarabine|cytarabine|mesh-list
64345746|NCT02440568|Idarubicin|idarubicin|mesh-list
64345747|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
64345748|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64345782|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
64345783|NCT00679120|Cimetidine|cimetidine|mesh-list
64345784|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64345785|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64345791|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345792|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64345793|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64345794|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345798|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
64345799|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
64345800|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
64345801|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345802|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345804|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
64345805|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
64345806|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64345807|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345808|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
64345809|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64345810|NCT00646204|Memantine|memantine|mesh-list
64345811|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64345812|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64345815|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345816|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345817|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64345818|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64345819|NCT00434434|Omalizumab|omalizumab|mesh-list
64345820|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64345821|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64345822|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64345823|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
64345841|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345842|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
64345843|NCT04002401|Rituximab|rituximab|mesh-list
64345844|NCT04002401|Fludarabine|fludarabine|mesh-list
64345845|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345846|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
64345847|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345848|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345852|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345857|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345859|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64345860|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
64345861|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345867|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64345868|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64345869|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64345870|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345871|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64345875|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
64345876|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64345877|NCT01633060|Fulvestrant|fulvestrant|mesh-list
64345878|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64345879|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345880|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64345882|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
64345883|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64345884|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345885|NCT03878459|Pioglitazone|pioglitazone|mesh-list
64345886|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64345887|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345896|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64345897|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64345898|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64345909|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64345916|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64345917|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
64345918|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64345919|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64345959|NCT02465528|Ceritinib|ceritinib|mesh-list
64345960|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345961|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64345962|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64345970|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
64345971|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64345972|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64345973|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64345974|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64345995|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64345996|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64345997|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
64345998|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
64345999|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
64346000|NCT02462720|Polidocanol|polidocanol|mesh-list
64346001|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64346002|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64346004|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64346005|NCT02246218|Protective Agents|protective agents|mesh-ancestor
64346012|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64346013|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
64346014|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346015|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
64346016|NCT04192630|Protective Agents|protective agents|mesh-ancestor
64346018|NCT00159783|Asenapine|asenapine|mesh-list
64346026|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346027|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64346036|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
64346059|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346060|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64346061|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
64346062|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346063|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346073|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346074|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346075|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64346076|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64346077|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
64346078|NCT00692939|Melphalan|melphalan|mesh-list
64346079|NCT00692939|Thiotepa|thiotepa|mesh-list
64346080|NCT00692939|Rituximab|rituximab|mesh-list
64346081|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
64346107|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64346131|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64346132|NCT03138681|Protective Agents|protective agents|mesh-ancestor
64346133|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346135|NCT05392257|Lenalidomide|lenalidomide|mesh-list
64346154|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346155|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64346164|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346166|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64346167|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
64346210|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64346211|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346213|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
64346214|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64346215|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346216|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
64346223|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346224|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64346225|NCT02239510|Laxatives|laxatives|mesh-ancestor
64346226|NCT04507581|Anesthetics|anesthetics|mesh-list
64346227|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346228|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346230|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
64346231|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346240|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64346298|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
64346299|NCT02294357|Hormones|hormones|mesh-ancestor
64346300|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346326|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346327|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
64346328|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346329|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
64346330|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64346333|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
64346337|NCT02294591|Expectorants|expectorants|mesh-ancestor
64346338|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
64346344|NCT02294591|Antidotes|antidotes|mesh-ancestor
64346345|NCT03521063|Budesonide|budesonide|mesh-list
64346346|NCT03521063|Poractant alfa|poractant alfa|mesh-list
64346356|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346388|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346393|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
64346395|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64346396|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64346397|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
64346398|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
64346399|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
64346400|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64346401|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64346402|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64346403|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64346408|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346425|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64346427|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346428|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346429|NCT03138447|Insulin|insulin|mesh-list
64346430|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64346431|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346432|NCT03517631|Busulfan|busulfan|mesh-list
64346433|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
64346441|NCT03109977|Pertuzumab|pertuzumab|mesh-list
64346442|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346443|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346444|NCT03520595|Diclofenac|diclofenac|mesh-list
64346445|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64346446|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64346447|NCT03520595|Analgesics|analgesics|mesh-ancestor
64346448|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
64346449|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346450|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346470|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64346488|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346489|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64346490|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64346538|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346539|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346540|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64346542|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
64346543|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346544|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64346545|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64346546|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64346547|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
64346578|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346579|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64346580|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
64346581|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346582|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346583|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64346584|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
64346596|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346605|NCT04933526|Dasatinib|dasatinib|mesh-list
64346606|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
64346607|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346608|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64346614|NCT02293889|Vitamins|vitamins|mesh-list
64346615|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
64346616|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346617|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64346618|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346619|NCT02298335|Prednisone|prednisone|mesh-list
64346620|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346621|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
64346622|NCT02298335|Hormones|hormones|mesh-ancestor
64346623|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346648|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346650|NCT02493764|Tazobactam|tazobactam|mesh-list
64346651|NCT02493764|Piperacillin|piperacillin|mesh-list
64346660|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64346661|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
64346662|NCT02297477|Artesunate|artesunate|mesh-list
64346663|NCT02297477|Atovaquone|atovaquone|mesh-list
64346664|NCT02297477|Proguanil|proguanil|mesh-list
64346665|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
64346666|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
64346667|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64346686|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64346702|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346738|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64346747|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
64346748|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346749|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64346750|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
64346751|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64346752|NCT02491892|Pertuzumab|pertuzumab|mesh-list
64346753|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64346754|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346755|NCT03476811|Analgesics|analgesics|mesh-list
64346756|NCT03476811|Bupivacaine|bupivacaine|mesh-list
64346757|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
64346758|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
64346759|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346760|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346761|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
64346762|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346763|NCT02834403|Aspirin|aspirin|mesh-list
64346776|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346777|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346778|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64346779|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346780|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64346781|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64346782|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64346783|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64346784|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346785|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
64346786|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64346787|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64346788|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64346789|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64346790|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
64346791|NCT02299271|Ropivacaine|ropivacaine|mesh-list
64346793|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
64346794|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346795|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346796|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
64346797|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346798|NCT02302469|Lenalidomide|lenalidomide|mesh-list
64346799|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
64346832|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346833|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64346834|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64346835|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
64346840|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64346841|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64346842|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64346860|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64346861|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64346873|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346884|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346885|NCT02299817|Denosumab|denosumab|mesh-list
64346886|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64346887|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346888|NCT01679613|Ketoconazole|ketoconazole|mesh-list
64346889|NCT01679613|Nintedanib|nintedanib|mesh-list
64346890|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
64346891|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64346892|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64346893|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64346894|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64346895|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346896|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64346897|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
64346905|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
64346913|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64346914|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64346915|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64346916|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346917|NCT05089539|Valsartan|valsartan|mesh-list
64346918|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64346924|NCT05089383|Progestins|progestins|mesh-ancestor
64346926|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346927|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346928|NCT03510533|Autoantibodies|autoantibodies|mesh-list
64346929|NCT03510533|alpha-MSH|alpha-msh|mesh-list
64346930|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
64346931|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346932|NCT03510533|Hormones|hormones|mesh-ancestor
64346933|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64346934|NCT03512873|Tranilast|tranilast|mesh-list
64346935|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64346942|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64346943|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64346951|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64346953|NCT01678911|Gabapentin|gabapentin|mesh-list
64346954|NCT01678911|Analgesics|analgesics|mesh-ancestor
64346955|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
64346956|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64346957|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64346958|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
64346959|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64346960|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64346961|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64346966|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64346968|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
64346969|NCT03132701|Analgesics|analgesics|mesh-ancestor
64346970|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
64346971|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64347036|NCT02303327|Hormones|hormones|mesh-ancestor
64347042|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347043|NCT03509831|Irsogladine|irsogladine|mesh-list
64347044|NCT03509831|Nizatidine|nizatidine|mesh-list
64347045|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347248|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64347302|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64347303|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64347373|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64347374|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64347376|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64347377|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
64347379|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64347426|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64347427|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64347428|NCT03122431|Growth Substances|growth substances|mesh-ancestor
64347482|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347483|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64347484|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
64347485|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64347521|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
64347522|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64347523|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64347524|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64347586|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64347587|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64347588|NCT05091177|Acetylcholine|acetylcholine|mesh-list
64347589|NCT05091177|Antibodies|antibodies|mesh-list
64347591|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
64347631|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
64347632|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347633|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64347634|NCT02311439|Folfirinox|folfirinox|mesh-list
64347635|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64347636|NCT02311517|Ropivacaine|ropivacaine|mesh-list
64347637|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
64347638|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
64347639|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347775|NCT02660229|Oxycodone|oxycodone|mesh-list
64347906|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
64347907|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
64347908|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347909|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64347910|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64347911|NCT03506789|Dexamethasone|dexamethasone|mesh-list
64347943|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64347944|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64347945|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64347946|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64347947|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64347948|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64347950|NCT02378805|Spironolactone|spironolactone|mesh-list
64347951|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64348026|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
64348027|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64348028|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64348030|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64348031|NCT05095467|Tegafur|tegafur|mesh-list
64348032|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64348033|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64348034|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
64348035|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
64348036|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
64348037|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348044|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64348045|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348046|NCT05095077|Urological Agents|urological agents|mesh-ancestor
64348047|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
64348048|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64348049|NCT02312531|Antibodies|antibodies|mesh-list
64348050|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
64348051|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348052|NCT04234477|Metoprolol|metoprolol|mesh-list
64348053|NCT04234477|Verapamil|verapamil|mesh-list
64348054|NCT04234477|Diltiazem|diltiazem|mesh-list
64348055|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
64348056|NCT04234477|Calcium|calcium|mesh-list
64348057|NCT04234477|Esmolol|esmolol|mesh-list
64348058|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64348059|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64348060|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348061|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64348062|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64348063|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
64348064|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
64348065|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348066|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64348067|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64348068|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
64348069|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348088|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64348089|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
64348090|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348091|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348092|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64348093|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
64348172|NCT02228590|Apomorphine|apomorphine|mesh-list
64348173|NCT02228590|Emetics|emetics|mesh-ancestor
64348174|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348175|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
64348176|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348177|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348178|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
64348179|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
64348180|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348181|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348182|NCT03503201|Chromium|chromium|mesh-list
64348183|NCT03503201|Trace Elements|trace elements|mesh-ancestor
64348184|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
64348185|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348186|NCT02309177|Gemcitabine|gemcitabine|mesh-list
64348187|NCT02309177|Paclitaxel|paclitaxel|mesh-list
64348188|NCT02309177|Carboplatin|carboplatin|mesh-list
64348189|NCT02309177|Nivolumab|nivolumab|mesh-list
64348324|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
64348493|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64348494|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64348495|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348549|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
64348562|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64348563|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64348565|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64348566|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348593|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64348609|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348610|NCT03468829|Gontivimab|gontivimab|mesh-list
64348611|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
64348612|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348613|NCT04912791|Anesthetics|anesthetics|mesh-list
64348614|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348615|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348616|NCT02316197|Peposertib|peposertib|mesh-list
64348626|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
64348654|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348655|NCT02314481|Trastuzumab|trastuzumab|mesh-list
64348656|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64348657|NCT02314481|Atezolizumab|atezolizumab|mesh-list
64348719|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64348720|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348797|NCT02315495|Acarbose|acarbose|mesh-list
64348798|NCT02315495|Incretins|incretins|mesh-ancestor
64348799|NCT02315495|Hormones|hormones|mesh-ancestor
64348800|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64348801|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348836|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348837|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
64348838|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348921|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
64348922|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
64348923|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
64348924|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64348925|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64348926|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64348927|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64348931|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64348933|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64348934|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64348935|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64348936|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
64348937|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64348938|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
64348939|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349011|NCT04462523|Hormones|hormones|mesh-ancestor
64349012|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349013|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349014|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64349015|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349016|NCT04642261|Empagliflozin|empagliflozin|mesh-list
64349017|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64349023|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349067|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349068|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
64349069|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
64349070|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349075|NCT03497351|Nicardipine|nicardipine|mesh-list
64349077|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64349078|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64349079|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379481|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64379484|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
64379485|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
64379488|NCT05557149|Cocaine|cocaine|mesh-list
64379495|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64379496|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64379497|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64379498|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379499|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379500|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
64379501|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379502|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
64379503|NCT02115256|Terbutaline|terbutaline|mesh-list
64379504|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379505|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64379506|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
64379507|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379508|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379509|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64379510|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379511|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
64379512|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
64379513|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64379526|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379527|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379528|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379529|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
64379531|NCT04225221|Estradiol|estradiol|mesh-list
64379532|NCT04225221|Progesterone|progesterone|mesh-list
64379533|NCT04225221|Estrogens|estrogens|mesh-ancestor
64349080|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349081|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64349083|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
64349084|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64349085|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
64349086|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349087|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64379535|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379536|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379537|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64379539|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64379540|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
64379541|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64379542|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379544|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64379545|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379546|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379548|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
64379554|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64379555|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64379556|NCT04425993|Analgesics|analgesics|mesh-ancestor
64379557|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
64379558|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379559|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379560|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379561|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379562|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
64349088|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64349089|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64349090|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64349091|NCT02223364|Bupivacaine|bupivacaine|mesh-list
64349092|NCT02223364|Ropivacaine|ropivacaine|mesh-list
64349093|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
64349094|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
64349095|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349098|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349100|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349101|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64349102|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349103|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349105|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64349106|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64349107|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349108|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
64349109|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349110|NCT03499457|Amoxicillin|amoxicillin|mesh-list
64349111|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64349112|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349113|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
64349146|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349147|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
64349148|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349149|NCT02319707|Oxytocin|oxytocin|mesh-list
64349152|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349153|NCT05398861|Bevacizumab|bevacizumab|mesh-list
64349154|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349155|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349156|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64349157|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64349158|NCT05398861|Growth Substances|growth substances|mesh-ancestor
64349160|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
64349161|NCT02448329|Paclitaxel|paclitaxel|mesh-list
64349162|NCT02448329|Adavosertib|adavosertib|mesh-list
64379563|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
64349163|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64349164|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349165|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
64349234|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64349235|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
64349236|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349237|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349238|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64349239|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64349240|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349241|NCT05096143|Valsartan|valsartan|mesh-list
64368433|NCT05464979|Analgesics|analgesics|mesh-ancestor
64349242|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64349244|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64349245|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64349246|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349247|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
64349248|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
64349249|NCT03494387|Antioxidants|antioxidants|mesh-list
64349250|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
64349251|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349252|NCT03494387|Expectorants|expectorants|mesh-ancestor
64349253|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
64349254|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64349255|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349257|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349258|NCT03494387|Vitamins|vitamins|mesh-ancestor
64349259|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
64349260|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64349261|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64349263|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349264|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
64349288|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64349289|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64349290|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
64349291|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64349292|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64349293|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349294|NCT02324933|Fentanyl|fentanyl|mesh-list
64349297|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349298|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349299|NCT02324933|Analgesics|analgesics|mesh-ancestor
64349300|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
64349301|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349303|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64349304|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
64349305|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
64349306|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
64349307|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64349327|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
64349328|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64349329|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64349330|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349332|NCT02323373|Coagulants|coagulants|mesh-ancestor
64349333|NCT02325479|Enoxaparin|enoxaparin|mesh-list
64349334|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
64349335|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64349336|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64349337|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349338|NCT05236231|Tadalafil|tadalafil|mesh-list
64349339|NCT05236231|Macitentan|macitentan|mesh-list
64349340|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
64349341|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64349342|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64349343|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349344|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349345|NCT05236231|Urological Agents|urological agents|mesh-ancestor
64349346|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
64349347|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64349348|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64349349|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
64349350|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349407|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
64349408|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
64349409|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349410|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349412|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64349413|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349414|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349427|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349428|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
64349429|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349430|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64349431|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
64349432|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349433|NCT04600895|Favipiravir|favipiravir|mesh-list
64349434|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
64349436|NCT03492593|Beta Carotene|beta carotene|mesh-list
64349437|NCT03492593|Lycopene|lycopene|mesh-list
64349438|NCT03492593|Carotenoids|carotenoids|mesh-list
64349439|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349440|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
64349441|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349442|NCT03492593|Protective Agents|protective agents|mesh-ancestor
64349443|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349444|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64349445|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64349446|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349447|NCT03492593|Provitamins|provitamins|mesh-ancestor
64349448|NCT03492593|Vitamins|vitamins|mesh-ancestor
64349449|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
64349456|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349457|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
64349458|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
64349459|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64349460|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64349461|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349462|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349463|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349464|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64349466|NCT04034459|Folic Acid|folic acid|mesh-list
64349467|NCT04034459|Bevacizumab|bevacizumab|mesh-list
64349468|NCT04034459|Cetuximab|cetuximab|mesh-list
64349469|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
64349470|NCT04034459|Irinotecan|irinotecan|mesh-list
64349472|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349473|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349474|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64349475|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64349476|NCT04034459|Growth Substances|growth substances|mesh-ancestor
64349477|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349478|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
64349480|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64349481|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349482|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349483|NCT04034459|Antidotes|antidotes|mesh-ancestor
64349484|NCT04034459|Protective Agents|protective agents|mesh-ancestor
64349485|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
64349487|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
64349488|NCT04034459|Hematinics|hematinics|mesh-ancestor
64349489|NCT03914885|Fludarabine|fludarabine|mesh-list
64349490|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64349491|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349492|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349493|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64349494|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
64349495|NCT03779243|Melatonin|melatonin|mesh-list
64349496|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
64349555|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349556|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349557|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
64349558|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349559|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349560|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64349561|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349564|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64349565|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64349603|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
64349604|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349605|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349606|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64349607|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64349608|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
64349609|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
64349610|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349611|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349612|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
64349613|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64349614|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64349615|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349616|NCT00846430|Interferons|interferons|mesh-list
64349618|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
64349619|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64349620|NCT00846430|Celecoxib|celecoxib|mesh-list
64349621|NCT00846430|Vincristine|vincristine|mesh-list
64349622|NCT00846430|Temozolomide|temozolomide|mesh-list
64349623|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349624|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
64349625|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349626|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64349627|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
64349628|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
64349629|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
64349630|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349631|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64349632|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
64349633|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
64349634|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349635|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64349636|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64349657|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349658|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64349659|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
64349660|NCT05385523|Hormones|hormones|mesh-ancestor
64349661|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349662|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64349663|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349664|NCT03910621|Miglustat|miglustat|mesh-list
64349665|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349666|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349667|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64349668|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64349669|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
64349670|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349671|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64349673|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349674|NCT02218372|Vancomycin|vancomycin|mesh-list
64349675|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
64349676|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64349679|NCT02217982|Loperamide|loperamide|mesh-list
64349680|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
64349681|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64349682|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
64349683|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349684|NCT02217982|Emollients|emollients|mesh-ancestor
64349685|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349686|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
64349687|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64349688|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
64349689|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349690|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
64349691|NCT02207608|Protective Agents|protective agents|mesh-ancestor
64349695|NCT03530995|Rabeprazole|rabeprazole|mesh-list
64349698|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64349699|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64349700|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349701|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349702|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
64349703|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349704|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64349705|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64349706|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64349707|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
64349708|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64349709|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349710|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64349711|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64349767|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349768|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64349769|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64349770|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
64349771|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
64349772|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64349774|NCT03466645|Vancomycin|vancomycin|mesh-list
64349775|NCT03466645|Cefazolin|cefazolin|mesh-list
64349780|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
64349782|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
64349783|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349813|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64349814|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349815|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
64349816|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64349817|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349818|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
64349819|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64349820|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
64349821|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64349822|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64349823|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64349824|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64349849|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64349850|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64349851|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
64349852|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
64349853|NCT03466567|Renal Agents|renal agents|mesh-ancestor
64349855|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
64349856|NCT03130153|Salicylates|salicylates|mesh-list
64349857|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64349858|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64349859|NCT03130153|Analgesics|analgesics|mesh-ancestor
64349860|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
64349861|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64349862|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349863|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64349866|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64349867|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349933|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
64349935|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64349936|NCT03491969|Protective Agents|protective agents|mesh-ancestor
64349937|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349940|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
64349941|NCT02251912|Oxytocin|oxytocin|mesh-list
64349942|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
64349943|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64349944|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349945|NCT01976273|Glycolic acid|glycolic acid|mesh-list
64349946|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
64349947|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349948|NCT02206048|Proflavine|proflavine|mesh-list
64349949|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64349950|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64349951|NCT03466021|Liraglutide|liraglutide|mesh-list
64349952|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64349953|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64349954|NCT03466021|Incretins|incretins|mesh-ancestor
64349957|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64349958|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
64349959|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
64349960|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
64349962|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350096|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
64350097|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350098|NCT02212678|Expectorants|expectorants|mesh-ancestor
64350099|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
64350100|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64350101|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
64350102|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350106|NCT03489239|Tenofovir|tenofovir|mesh-list
64350107|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
64350108|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350109|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64350150|NCT02799641|Lidocaine|lidocaine|mesh-list
64350151|NCT02799641|Diazepam|diazepam|mesh-list
64350152|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
64350153|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
64350154|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350155|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350156|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
64350157|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350158|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64350159|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64350194|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350195|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
64350196|NCT04006769|Entacapone|entacapone|mesh-list
64350197|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350198|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64350200|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350201|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64350202|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64350203|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64350204|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64350205|NCT03487211|Citalopram|citalopram|mesh-list
64350206|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64350207|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64350208|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350209|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350210|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350211|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
64350212|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350213|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64350214|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
64350215|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64350216|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350217|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64350219|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
64350225|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
64350226|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350227|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350228|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350229|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
64350230|NCT03487133|Hormones|hormones|mesh-ancestor
64350231|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350232|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64350233|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350279|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64350280|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64350281|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379564|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64350282|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350283|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
64350284|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
64350286|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64350287|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64350288|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350289|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
64350290|NCT03317795|Coagulants|coagulants|mesh-ancestor
64350291|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64350292|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
64350417|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350438|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
64350440|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64350441|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64350442|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64350443|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64350444|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
64350445|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350481|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350482|NCT05153603|Olaparib|olaparib|mesh-list
64350483|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64350485|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350486|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350487|NCT05152901|Epinephrine|epinephrine|mesh-list
64350488|NCT05152901|Racepinephrine|racepinephrine|mesh-list
64350489|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
64350493|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350494|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350495|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350496|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64350497|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64350498|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
64350537|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64350538|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
64350539|NCT02568449|Nintedanib|nintedanib|mesh-list
64350540|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350541|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64350542|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350551|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64350552|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350553|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64350554|NCT04884893|Analgesics|analgesics|mesh-ancestor
64350555|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
64350556|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350557|NCT03479879|Misoprostol|misoprostol|mesh-list
64350558|NCT03479879|Estradiol|estradiol|mesh-list
64350559|NCT03479879|Estrogens|estrogens|mesh-ancestor
64350560|NCT03479879|Hormones|hormones|mesh-ancestor
64350674|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64350691|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350692|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
64350693|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64350694|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64350695|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350696|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64350697|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64350698|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64379620|NCT05549583|Hormones|hormones|mesh-ancestor
64379621|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379622|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64379623|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
64379624|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379783|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
64379784|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379785|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
64379787|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379788|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64350811|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350812|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64350813|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
64379790|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64379791|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379792|NCT05552937|Lenalidomide|lenalidomide|mesh-list
64379793|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
64379794|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379795|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64379796|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64379797|NCT05552937|Growth Substances|growth substances|mesh-ancestor
64379798|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
64379799|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379802|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
64379803|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377730|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377731|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377732|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
64377733|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377734|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64377735|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377736|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
64379836|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379837|NCT04738318|Dexamethasone|dexamethasone|mesh-list
64379838|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
64379839|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
64379840|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379841|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
64379842|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
64350814|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64350816|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64350817|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
64350819|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64350820|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64350821|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
64350824|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350825|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350826|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
64350827|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64350829|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64350837|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350839|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
64350840|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64350841|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350842|NCT02523053|Fluorouracil|fluorouracil|mesh-list
64350843|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
64350844|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350845|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64350846|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350847|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64350848|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
64350849|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350850|NCT04457609|Azithromycin|azithromycin|mesh-list
64350851|NCT04457609|Oseltamivir|oseltamivir|mesh-list
64350852|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64350853|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350854|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
64350855|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350856|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350857|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
64350858|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64350859|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350860|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
64350861|NCT04457765|Povidone|povidone|mesh-list
64350862|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
64350863|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
64350864|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64350865|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64350889|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350890|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
64350891|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350892|NCT04351061|Acetazolamide|acetazolamide|mesh-list
64350893|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
64350894|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64350895|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64350896|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64350897|NCT04351061|Diuretics|diuretics|mesh-ancestor
64350898|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
64350899|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64350900|NCT03130829|Fucoidan|fucoidan|mesh-list
64350902|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350904|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64350905|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64350907|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
64350908|NCT04206761|Bromides|bromides|mesh-list
64350909|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
64350910|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64350947|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
64350948|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64350949|NCT03470363|Narcotics|narcotics|mesh-ancestor
64350950|NCT03470363|Analgesics|analgesics|mesh-ancestor
64350951|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64350981|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64350982|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379843|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379844|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379845|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64350984|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64350985|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64350986|NCT05096039|Valsartan|valsartan|mesh-list
64350987|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64350988|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64350989|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64350990|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64350991|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351024|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351025|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
64379846|NCT04738318|Hormones|hormones|mesh-ancestor
64351026|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351027|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64351028|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64351030|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
64351031|NCT02149121|Rituximab|rituximab|mesh-list
64351032|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351033|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351034|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
64351035|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351036|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351037|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
64351039|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351040|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351042|NCT05162417|Coagulants|coagulants|mesh-ancestor
64351043|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
64351044|NCT05162183|Liraglutide|liraglutide|mesh-list
64351045|NCT05162183|Glimepiride|glimepiride|mesh-list
64351046|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64351048|NCT05162183|Incretins|incretins|mesh-ancestor
64351049|NCT05162183|Hormones|hormones|mesh-ancestor
64351051|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64351052|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64351053|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
64351054|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
64351055|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64351056|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
64351057|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351058|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
64351063|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
64351065|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351141|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
64351142|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351143|NCT04453423|Carboplatin|carboplatin|mesh-list
64351146|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351147|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351148|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64351149|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64351150|NCT04453189|Lansoprazole|lansoprazole|mesh-list
64351151|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
64351152|NCT04453189|Famotidine|famotidine|mesh-list
64351154|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64351155|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64351156|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351157|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351158|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64351159|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
64351160|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
64351161|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64351162|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351163|NCT03465085|Heparin|heparin|mesh-list
64351164|NCT03465085|Calcium heparin|calcium heparin|mesh-list
64351165|NCT03465085|Streptokinase|streptokinase|mesh-list
64351166|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
64351167|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64351168|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64351169|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351170|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
64351171|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351172|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
64351188|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351190|NCT04453111|Protective Agents|protective agents|mesh-ancestor
64351191|NCT03468595|Listerine|listerine|mesh-list
64351192|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64351193|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351194|NCT04453345|Thalidomide|thalidomide|mesh-list
64351195|NCT04453345|Prednisone|prednisone|mesh-list
64351197|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351198|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
64351199|NCT04453345|Hormones|hormones|mesh-ancestor
64351200|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64351201|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351202|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64351209|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351210|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
64351212|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64351213|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64351214|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
64351215|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351216|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64351217|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
64351218|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64351219|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351220|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64351227|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64351228|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64351229|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
64351230|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351231|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64351233|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
64351234|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
64351235|NCT03464539|Coagulants|coagulants|mesh-ancestor
64351236|NCT01633541|Carboplatin|carboplatin|mesh-list
64351237|NCT01633541|Docetaxel|docetaxel|mesh-list
64351238|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351240|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
64351241|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
64351242|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351243|NCT03460405|Vaccines|vaccines|mesh-list
64351244|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
64351271|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64351272|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64351273|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
64351274|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
64351275|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64351280|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351281|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351282|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
64351283|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351284|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64351285|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64351286|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64351341|NCT01857115|Dexamethasone|dexamethasone|mesh-list
64351342|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
64351343|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64351344|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
64351345|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351346|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64351347|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64351348|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
64351349|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351350|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351351|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64351352|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64351353|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
64351354|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
64351355|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64351377|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64351378|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64351379|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64351380|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351381|NCT03449251|Verapamil|verapamil|mesh-list
64351382|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
64351383|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64351384|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64351385|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64351386|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351387|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64351388|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351389|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
64351390|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351391|NCT05322499|Paclitaxel|paclitaxel|mesh-list
64351392|NCT05322499|Docetaxel|docetaxel|mesh-list
64351393|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64351416|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64351417|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64351879|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351979|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351980|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
64351981|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
64351982|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351983|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64351984|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351985|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64351987|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
64351988|NCT03446599|Methylene Blue|methylene blue|mesh-list
64351989|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64351990|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64351991|NCT03446599|Hematinics|hematinics|mesh-ancestor
64351992|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
64351993|NCT03446599|Vitamins|vitamins|mesh-ancestor
64351994|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
64351995|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64351996|NCT02856451|Nivolumab|nivolumab|mesh-list
64351997|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64351998|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64351999|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64352000|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352001|NCT03446443|Metronidazole|metronidazole|mesh-list
64352002|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352003|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64352004|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64352005|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64352006|NCT02087423|Durvalumab|durvalumab|mesh-list
64352007|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64352008|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352009|NCT05102071|Metformin|metformin|mesh-list
64352032|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64352033|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352034|NCT04742777|Sirolimus|sirolimus|mesh-list
64352035|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64352036|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352037|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64352040|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352041|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
64352071|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64352072|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352073|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
64352074|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
64352075|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64352076|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
64352077|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352078|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352079|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64352087|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64352088|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352089|NCT01961063|Busulfan|busulfan|mesh-list
64352090|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
64352091|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352104|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352105|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352107|NCT02951377|Hormones|hormones|mesh-ancestor
64352108|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352109|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64352110|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352111|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
64352113|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352114|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
64352118|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64352119|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352120|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
64352121|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64352123|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
64352124|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352125|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352126|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
64352127|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64352128|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64352129|NCT03442621|Cortisone|cortisone|mesh-list
64352134|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64352135|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
64352136|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352139|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352140|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352141|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
64352142|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352176|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64352178|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64352179|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64352180|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352183|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352184|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64352228|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352230|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64352231|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64352232|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
64352233|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352234|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64352235|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64352237|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
64352238|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64352239|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
64352240|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
64352241|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
64352242|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352243|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352244|NCT03268083|Vaccines|vaccines|mesh-list
64352245|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
64352246|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352248|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352249|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64352250|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352252|NCT03170817|Regadenoson|regadenoson|mesh-list
64352278|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64352279|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64352281|NCT00003857|Tamoxifen|tamoxifen|mesh-list
64352283|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
64379979|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64352284|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64352285|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352286|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64352287|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352288|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64352289|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64352290|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64352291|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
64352292|NCT03464435|Tobramycin|tobramycin|mesh-list
64352293|NCT03464435|Tacrolimus|tacrolimus|mesh-list
64352294|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352295|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
64352296|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352297|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64352298|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352299|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352300|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64352301|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352302|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64352304|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352305|NCT03463967|Lycopene|lycopene|mesh-list
64352306|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352307|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
64352318|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352319|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352320|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
64352321|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352322|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64352323|NCT04222595|Vaccines|vaccines|mesh-list
64352324|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
64352325|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352326|NCT03468023|Calpastatin|calpastatin|mesh-list
64352327|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
64352328|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
64352345|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352346|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352348|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352349|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64352360|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352361|NCT05096715|Bevacizumab|bevacizumab|mesh-list
64352362|NCT05096715|Atezolizumab|atezolizumab|mesh-list
64352363|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64352364|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352389|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64352391|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
64352392|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352394|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352396|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64352421|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64352422|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
64352423|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
64352424|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64352425|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64352426|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64352427|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64352428|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
64352429|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379980|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
64352581|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352582|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64352583|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
64352584|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
64352585|NCT04125771|Diclofenac|diclofenac|mesh-list
64352586|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64352587|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64352588|NCT04125771|Analgesics|analgesics|mesh-ancestor
64352589|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
64352590|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352591|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352592|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352593|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64352594|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64352595|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352596|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352597|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64352598|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64352599|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64352600|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64352601|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352606|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352608|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64352609|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
64352610|NCT04636671|Dexamethasone|dexamethasone|mesh-list
64352611|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
64352612|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64352613|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64352614|NCT04636671|Prednisolone|prednisolone|mesh-list
64352615|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
64352616|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64352617|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
64352618|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352624|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
64352625|NCT04636671|Hormones|hormones|mesh-ancestor
64352678|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
64352679|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352680|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64352685|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64352687|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64352688|NCT04771689|Narcotics|narcotics|mesh-ancestor
64352689|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352690|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352692|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
64352695|NCT04674345|Sorafenib|sorafenib|mesh-list
64352714|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352715|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352717|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64352718|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64352719|NCT03866525|Irinotecan|irinotecan|mesh-list
64352720|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64352721|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64352722|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352723|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352724|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352725|NCT03129347|Nalmefene|nalmefene|mesh-list
64352726|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64352727|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352728|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
64352729|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352730|NCT02262923|Metoclopramide|metoclopramide|mesh-list
64352731|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
64352732|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
64352733|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352734|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352735|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352736|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64352741|NCT02194595|Insulin|insulin|mesh-list
64352766|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352767|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64352769|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352770|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
64352771|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
64352773|NCT01166633|Pitavastatin|pitavastatin|mesh-list
64352779|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64352780|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352781|NCT04315311|Pancrelipase|pancrelipase|mesh-list
64352782|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64352784|NCT03596073|Petrolatum|petrolatum|mesh-list
64352785|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
64352786|NCT03596073|Emollients|emollients|mesh-ancestor
64352787|NCT05320757|Olaparib|olaparib|mesh-list
64352788|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64352789|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352790|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352791|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352792|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
64352793|NCT03449693|Antacids|antacids|mesh-ancestor
64352794|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352815|NCT03179943|Guadecitabine|guadecitabine|mesh-list
64352816|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352817|NCT04528173|Ketorolac|ketorolac|mesh-list
64352818|NCT04528173|Fentanyl|fentanyl|mesh-list
64352819|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
64352820|NCT04528173|Morphine|morphine|mesh-list
64352821|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64352822|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352823|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352824|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64352825|NCT04528173|Analgesics|analgesics|mesh-ancestor
64352826|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
64352827|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352829|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64352830|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64352831|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
64352832|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64352833|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64352835|NCT04528173|Narcotics|narcotics|mesh-ancestor
64352836|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64352837|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64352838|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
64352839|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
64352840|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64368473|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352861|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64352863|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64352865|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
64352866|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
64352867|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
64352868|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352869|NCT02142803|Bevacizumab|bevacizumab|mesh-list
64352870|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64352871|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
64352872|NCT02142803|Antibodies|antibodies|mesh-list
64352873|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
64352874|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64352875|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
64352878|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64352879|NCT02142803|Growth Substances|growth substances|mesh-ancestor
64352880|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352881|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
64352882|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
64352887|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352888|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64352911|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64352912|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
64352914|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64352915|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64352916|NCT04527393|Morphine|morphine|mesh-list
64352917|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64352918|NCT04527393|Narcotics|narcotics|mesh-ancestor
64352919|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352920|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352922|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
64352923|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352924|NCT05211635|Vitamin D|vitamin d|mesh-list
64352925|NCT05211635|Vitamins|vitamins|mesh-ancestor
64352926|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
64352927|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352928|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64352930|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64352931|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64352932|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352933|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352934|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64352972|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64352973|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64352982|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64352983|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64352984|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64352985|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
64352986|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64352987|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
64352988|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64352989|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64352990|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64352991|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64352993|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
64352994|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64352995|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64352996|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64353004|NCT04921943|Azithromycin|azithromycin|mesh-list
64353005|NCT04921943|Rifampin|rifampin|mesh-list
64353006|NCT04921943|Ethambutol|ethambutol|mesh-list
64353007|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353008|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353009|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64353010|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
64353011|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
64353012|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64353022|NCT02419508|Bimatoprost|bimatoprost|mesh-list
64353023|NCT02419508|Travoprost|travoprost|mesh-list
64353024|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64353025|NCT02419508|Latanoprost|latanoprost|mesh-list
64353027|NCT02419508|Brinzolamide|brinzolamide|mesh-list
64353028|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64353029|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64353030|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64353031|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64353032|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353033|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353034|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353035|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353036|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64353037|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353038|NCT03442283|Vitamins|vitamins|mesh-list
64353039|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
64353040|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353041|NCT03441815|Histamine|histamine|mesh-list
64353042|NCT03441815|Glutarimide|glutarimide|mesh-list
64353043|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
64353047|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353048|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64353049|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353050|NCT02426918|Vancomycin|vancomycin|mesh-list
64353051|NCT02426918|Linezolid|linezolid|mesh-list
64353052|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353053|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353054|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64353055|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353061|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64353062|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353063|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64353064|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
64353065|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353066|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353068|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353069|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64353070|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64353071|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
64353072|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353073|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64353074|NCT02418182|Acetaminophen|acetaminophen|mesh-list
64353082|NCT02387372|Ceftolozane|ceftolozane|mesh-list
64353083|NCT02387372|Cephalosporins|cephalosporins|mesh-list
64353084|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
64353085|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
64353086|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353087|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353088|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64353089|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379981|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353090|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353091|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64353092|NCT02387372|Renal Agents|renal agents|mesh-ancestor
64353093|NCT03446495|Trabectedin|trabectedin|mesh-list
64353094|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64353096|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353097|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353098|NCT02657343|Trastuzumab|trastuzumab|mesh-list
64353099|NCT02657343|Fulvestrant|fulvestrant|mesh-list
64353100|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64353103|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64353104|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64353105|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
64353106|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353107|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353108|NCT03441035|Anesthetics|anesthetics|mesh-list
64353113|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64353114|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64353115|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353116|NCT04807673|Paclitaxel|paclitaxel|mesh-list
64353117|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
64353118|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64353119|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353120|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
64353121|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
64353122|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
64353123|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353124|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64353126|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64353127|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353128|NCT02425826|Thalidomide|thalidomide|mesh-list
64353129|NCT02425826|Apremilast|apremilast|mesh-list
64353130|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64353131|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353132|NCT02425826|Analgesics|analgesics|mesh-ancestor
64353133|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
64353179|NCT04418895|Antidotes|antidotes|mesh-ancestor
64353180|NCT04418895|Protective Agents|protective agents|mesh-ancestor
64353181|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
64353182|NCT04418895|Vitamins|vitamins|mesh-ancestor
64353183|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
64353184|NCT04715633|Apatinib|apatinib|mesh-list
64353185|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64353186|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353187|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64353188|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353189|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353190|NCT03439943|Lixisenatide|lixisenatide|mesh-list
64353217|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353218|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353219|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
64353220|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353221|NCT02656017|Metformin|metformin|mesh-list
64353222|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64353223|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353225|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353226|NCT04451447|SMOFlipid|smoflipid|mesh-list
64353227|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
64353278|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353279|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353280|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
64353281|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64353282|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353283|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353292|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353337|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64353338|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
64353339|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353340|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353341|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
64353342|NCT03783351|Clopidogrel|clopidogrel|mesh-list
64353344|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64353345|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64353346|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64353347|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64353348|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
64353349|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353350|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353351|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353353|NCT03342417|Ipilimumab|ipilimumab|mesh-list
64353354|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64353355|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353356|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64353357|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353358|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64353359|NCT03234309|Hematinics|hematinics|mesh-ancestor
64353360|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64353361|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64353383|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
64353384|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
64353385|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64353386|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
64353387|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64353388|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64353389|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64353390|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64353391|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64353410|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353412|NCT03433001|Lenalidomide|lenalidomide|mesh-list
64353414|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353415|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
64353416|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
64353417|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353418|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353419|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64353420|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
64353421|NCT03433001|Hormones|hormones|mesh-ancestor
64353422|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353423|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353424|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353425|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
64353426|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64353427|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64353429|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
64353430|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
64353447|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
64353448|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353449|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353450|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
64353451|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353452|NCT02384577|Budesonide|budesonide|mesh-list
64353453|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
64353454|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353455|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64353456|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
64353457|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353458|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353459|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64353460|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353462|NCT02384577|Hormones|hormones|mesh-ancestor
64353463|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353464|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64353465|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64353466|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64353470|NCT03437213|Anesthetics|anesthetics|mesh-list
64353471|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353472|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353473|NCT02030457|Beclomethasone|beclomethasone|mesh-list
64353474|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353476|NCT02030457|Hormones|hormones|mesh-ancestor
64353477|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353478|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353479|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64353480|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353481|NCT04489433|Trametinib|trametinib|mesh-list
64353482|NCT04489433|Dabrafenib|dabrafenib|mesh-list
64353483|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353484|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64353485|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353486|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353487|NCT03432767|Chrysarobin|chrysarobin|mesh-list
64353497|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64353498|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64353499|NCT03437057|Analgesics|analgesics|mesh-ancestor
64353500|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
64353502|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353503|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353504|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353505|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64353506|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64353507|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353508|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64353545|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353547|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64353548|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64353549|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353550|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353551|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353552|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353553|NCT05018013|Analgesics|analgesics|mesh-ancestor
64353554|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
64353555|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353556|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
64353557|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64353558|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
64353559|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
64353560|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64353561|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64353562|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64353563|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353564|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353565|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353566|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
64353567|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64353569|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
64353570|NCT04360421|Bupivacaine|bupivacaine|mesh-list
64353571|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353572|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
64353573|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353608|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64353609|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64353610|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
64353611|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353612|NCT03431909|Coagulants|coagulants|mesh-ancestor
64353613|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
64353614|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
64353615|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64353616|NCT03436121|Midazolam|midazolam|mesh-list
64353617|NCT03436121|Ketamine|ketamine|mesh-list
64353618|NCT03436121|Analgesics|analgesics|mesh-ancestor
64353619|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
64353620|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353630|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353632|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64353633|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64353634|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64353635|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64353636|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
64353637|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
64353639|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64353645|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64353646|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64353647|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64353648|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353649|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353650|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353651|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
64353652|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353653|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353654|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64353656|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353657|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353658|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353659|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64353660|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64353661|NCT02424734|Ampicillin|ampicillin|mesh-list
64353662|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
64353701|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353703|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64353704|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
64353705|NCT02416934|Hormones|hormones|mesh-ancestor
64353706|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64353707|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64353708|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353710|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64353711|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64353712|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64353713|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353714|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64353715|NCT03874325|Durvalumab|durvalumab|mesh-list
64353717|NCT03874325|Anastrozole|anastrozole|mesh-list
64353718|NCT03874325|Exemestane|exemestane|mesh-list
64353768|NCT03430817|Analgesics|analgesics|mesh-ancestor
64353769|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
64353770|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353771|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
64353772|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
64353773|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64353774|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353775|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64353776|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353777|NCT03799835|Atezolizumab|atezolizumab|mesh-list
64353778|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
64353779|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353780|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64353781|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
64353782|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353783|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64353784|NCT03735095|Trioxsalen|trioxsalen|mesh-list
64353785|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64353786|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
64353787|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64353792|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353793|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64353794|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
64353795|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
64353797|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64353799|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64353800|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353801|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64353802|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353803|NCT03434951|Morphine|morphine|mesh-list
64353804|NCT03434951|Bupivacaine|bupivacaine|mesh-list
64353805|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353807|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353808|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353810|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353811|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64353812|NCT03434951|Narcotics|narcotics|mesh-ancestor
64353813|NCT03434951|Analgesics|analgesics|mesh-ancestor
64353814|NCT02234323|Factor VIII|factor viii|mesh-list
64353815|NCT02234323|Coagulants|coagulants|mesh-ancestor
64353818|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64353819|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353820|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
64353841|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64353864|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64353865|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
64353866|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64353869|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
64353870|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64353871|NCT03428633|Morphine|morphine|mesh-list
64353872|NCT03428633|Ropivacaine|ropivacaine|mesh-list
64353873|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64353874|NCT03428633|Narcotics|narcotics|mesh-ancestor
64353875|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353876|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353877|NCT03428633|Analgesics|analgesics|mesh-ancestor
64353878|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
64353879|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353880|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353881|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
64353882|NCT02412878|Dexamethasone|dexamethasone|mesh-list
64353883|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64353919|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353920|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
64353921|NCT02944019|Edoxaban|edoxaban|mesh-list
64353922|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64353923|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
64353924|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64353927|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64353928|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
64353930|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
64353931|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
64353932|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64353933|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64353934|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
64353935|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64353936|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64353937|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64353988|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
64353990|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64353992|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64353993|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
64353994|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354010|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354013|NCT03425747|Calcium|calcium|mesh-list
64354014|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64354015|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354016|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64354017|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354018|NCT03425747|Antacids|antacids|mesh-ancestor
64354019|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64354074|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
64354075|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354076|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354078|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
64354080|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354081|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64354082|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354083|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
64354084|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64354085|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64354087|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
64354088|NCT03444025|Goserelin|goserelin|mesh-list
64354089|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64354090|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354091|NCT03438253|Anesthetics|anesthetics|mesh-list
64354092|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354093|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354096|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354097|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354098|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354099|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64354100|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64354120|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
64354121|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
64354122|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64354123|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354124|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
64354125|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354126|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64354127|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354132|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64354134|NCT03437785|Rebamipide|rebamipide|mesh-list
64354135|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64354136|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354137|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354138|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354139|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64354140|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64354141|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
64354142|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354143|NCT03437785|Protective Agents|protective agents|mesh-ancestor
64354144|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354145|NCT03437707|Acetaminophen|acetaminophen|mesh-list
64354147|NCT03437707|Morphine|morphine|mesh-list
64354148|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64354149|NCT03437707|Narcotics|narcotics|mesh-ancestor
64354150|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354151|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354153|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
64354159|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64354160|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354161|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354162|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
64354163|NCT03437629|Calcium|calcium|mesh-list
64354164|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64354165|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354167|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
64354168|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354169|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354170|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354171|NCT03441217|Scopolamine|scopolamine|mesh-list
64354172|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
64354173|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64354174|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
64354175|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
64354176|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354177|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354178|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64354180|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64354181|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
64354182|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354183|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354184|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64354185|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
64354187|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354188|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
64354189|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354190|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354191|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64354194|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
64354195|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354197|NCT03432871|Niacin|niacin|mesh-list
64354199|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
64354200|NCT03432871|Vitamins|vitamins|mesh-ancestor
64354201|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
64354202|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354203|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64354204|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
64354205|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354206|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64354207|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
64354208|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
64354209|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
64354210|NCT04420585|Coagulants|coagulants|mesh-ancestor
64354211|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64354212|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
64354213|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354214|NCT04451239|Cyclosporine|cyclosporine|mesh-list
64354217|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354219|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
64354220|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354221|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
64354222|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354223|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
64354224|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354225|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64354226|NCT03440515|Prednisone|prednisone|mesh-list
64354227|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354228|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
64354229|NCT03440515|Hormones|hormones|mesh-ancestor
64354230|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354231|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354232|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64354234|NCT03432793|Itraconazole|itraconazole|mesh-list
64354235|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
64354236|NCT03432793|Caffeine|caffeine|mesh-list
64354237|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64354238|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354239|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64354240|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354287|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354288|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354289|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64354292|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354293|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64354294|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354295|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
64354296|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354297|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354298|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64354299|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64354300|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
64354302|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64354303|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64354305|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64354313|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354314|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354315|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64354316|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
64354317|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354318|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354320|NCT03440359|Hormones|hormones|mesh-ancestor
64354321|NCT04294225|Letrozole|letrozole|mesh-list
64354322|NCT04294225|Anastrozole|anastrozole|mesh-list
64354323|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354324|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64354325|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64354326|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354327|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354328|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64354329|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
64354330|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354331|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354332|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64354333|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64354335|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354381|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
64354382|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354383|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354384|NCT03439501|Avelumab|avelumab|mesh-list
64354385|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64354386|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354387|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
64354388|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64354389|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354390|NCT04255381|Pancrelipase|pancrelipase|mesh-list
64354392|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
64354393|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64354394|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354395|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354396|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354397|NCT03757897|Analgesics|analgesics|mesh-ancestor
64354398|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
64354400|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64354401|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64354402|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64354403|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
64354404|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354409|NCT03434275|Analgesics|analgesics|mesh-ancestor
64354410|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
64354411|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354413|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354421|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64354422|NCT03434197|Analgesics|analgesics|mesh-ancestor
64354423|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
64354424|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354425|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354426|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354427|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354428|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64354430|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354432|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354433|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354434|NCT03438955|Telmisartan|telmisartan|mesh-list
64354435|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64354436|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64354437|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64379983|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64354441|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
64354442|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354443|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354444|NCT04219735|Minocycline|minocycline|mesh-list
64354445|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64354446|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354448|NCT03344419|Analgesics|analgesics|mesh-ancestor
64354449|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
64354450|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354452|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64354453|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64354454|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
64354455|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
64354456|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354457|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64354458|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64354459|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354461|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64354462|NCT03621553|Vitamin D|vitamin d|mesh-list
64354463|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
64354464|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
64354465|NCT03621553|Vitamins|vitamins|mesh-list
64354466|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
64354467|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354468|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64354469|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64354470|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
64354471|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64354472|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
64354473|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354474|NCT03423667|Expectorants|expectorants|mesh-ancestor
64354475|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
64354476|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64354479|NCT03423667|Protective Agents|protective agents|mesh-ancestor
64354480|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354481|NCT03423667|Antidotes|antidotes|mesh-ancestor
64354486|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354488|NCT03605719|Nivolumab|nivolumab|mesh-list
64354489|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354491|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
64354492|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354493|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354494|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64354495|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
64354496|NCT03605719|Hormones|hormones|mesh-ancestor
64354497|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354498|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64354499|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354500|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64354501|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64354502|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354503|NCT03569839|Propofol|propofol|mesh-list
64354504|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64354505|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354506|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354507|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64354508|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
64354510|NCT01504919|Nicotine|nicotine|mesh-list
64354511|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64354512|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
64354513|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354514|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354515|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64354516|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64354517|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
64354518|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354519|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354520|NCT02732327|Vancomycin|vancomycin|mesh-list
64354532|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64354533|NCT03428503|Acetaminophen|acetaminophen|mesh-list
64354534|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64354536|NCT03428503|Analgesics|analgesics|mesh-ancestor
64354537|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
64354538|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64354539|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354540|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
64354541|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64354542|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354543|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354544|NCT03428425|Paclitaxel|paclitaxel|mesh-list
64354545|NCT03428425|Apatinib|apatinib|mesh-list
64354546|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64354547|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354548|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
64354555|NCT03416777|Vitamin E|vitamin e|mesh-list
64354591|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64354592|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64354593|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354594|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354596|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64354597|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
64354598|NCT03179605|Hormones|hormones|mesh-ancestor
64354599|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64354600|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354601|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
64354602|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
64354603|NCT03173053|Clarithromycin|clarithromycin|mesh-list
64354604|NCT03173053|Doxycycline|doxycycline|mesh-list
64354605|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
64354612|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64354613|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64354614|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354615|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
64354616|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64354641|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64354642|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64354643|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64354644|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64354646|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64354647|NCT03109795|Diuretics|diuretics|mesh-ancestor
64354648|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
64354649|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354650|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64354651|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354702|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354703|NCT01912651|Cephalexin|cephalexin|mesh-list
64368492|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
64354704|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64354705|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354706|NCT03422419|Heparin|heparin|mesh-list
64354707|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
64354708|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64354709|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64354710|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354711|NCT04449289|Lidocaine|lidocaine|mesh-list
64354712|NCT04449289|Ropivacaine|ropivacaine|mesh-list
64354713|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
64354757|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
64354763|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354764|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64354765|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354766|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354767|NCT02378480|Linezolid|linezolid|mesh-list
64354768|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64354769|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64354770|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64354771|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354772|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354773|NCT02345330|Interleukin-12|interleukin-12|mesh-list
64354774|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64354776|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354778|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64354779|NCT02345330|Growth Substances|growth substances|mesh-ancestor
64354805|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64354806|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64354807|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64354808|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
64354809|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
64354810|NCT01025089|Doxorubicin|doxorubicin|mesh-list
64354811|NCT01025089|Cetuximab|cetuximab|mesh-list
64354812|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64354813|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
64354816|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64354817|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
64354818|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354819|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354820|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64354821|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64354822|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64354823|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64354827|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
64354844|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354845|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64354846|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
64354848|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
64354849|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64354850|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64354851|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
64354852|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354853|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354854|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64354855|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64354856|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64354861|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64354862|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
64354896|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64354897|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64354898|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64354899|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354900|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354902|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64354903|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354908|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354909|NCT03415711|Mesalamine|mesalamine|mesh-list
64354979|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
64354980|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
64354981|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64354982|NCT03419767|Melatonin|melatonin|mesh-list
64354983|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
64354984|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64354985|NCT03419767|Protective Agents|protective agents|mesh-ancestor
64354986|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64354987|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64354988|NCT03414931|Sertraline|sertraline|mesh-list
64354989|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
64354990|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64354991|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64354992|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64354993|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64354994|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355008|NCT04448821|Metformin|metformin|mesh-list
64355017|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
64355018|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355019|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355020|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64355021|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64355022|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64355023|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64355024|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64355025|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355026|NCT04448587|Incretins|incretins|mesh-ancestor
64355027|NCT04448587|Hormones|hormones|mesh-ancestor
64355028|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355029|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64355030|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
64355031|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379984|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64355032|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355034|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64355035|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355036|NCT03426085|Incretins|incretins|mesh-ancestor
64355038|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355040|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355041|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355042|NCT03425929|Oxytocin|oxytocin|mesh-list
64355043|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
64355044|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64355045|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355046|NCT03127189|Rilpivirine|rilpivirine|mesh-list
64379985|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355047|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64355056|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64355057|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355058|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64355059|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64355060|NCT02521051|Growth Substances|growth substances|mesh-ancestor
64355061|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355062|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
64355063|NCT01239797|Dexamethasone|dexamethasone|mesh-list
64355076|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64355077|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64355078|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355113|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
64355119|NCT02735707|Valsartan|valsartan|mesh-list
64355120|NCT02735707|Telmisartan|telmisartan|mesh-list
64355121|NCT02735707|Candesartan|candesartan|mesh-list
64355122|NCT02735707|Ramipril|ramipril|mesh-list
64355124|NCT02735707|Enalapril|enalapril|mesh-list
64355125|NCT02735707|Lisinopril|lisinopril|mesh-list
64355126|NCT02735707|Irbesartan|irbesartan|mesh-list
64355127|NCT02735707|Perindopril|perindopril|mesh-list
64355128|NCT02735707|Captopril|captopril|mesh-list
64355129|NCT02735707|Trandolapril|trandolapril|mesh-list
64355130|NCT02735707|Clopidogrel|clopidogrel|mesh-list
64355131|NCT02735707|Ticagrelor|ticagrelor|mesh-list
64355132|NCT02735707|Simvastatin|simvastatin|mesh-list
64355133|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64355134|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
64355135|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
64355137|NCT02735707|Cysteamine|cysteamine|mesh-list
64355169|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64355170|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
64355171|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64355172|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64355173|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64355174|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64355175|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
64355182|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
64355183|NCT02735707|Protective Agents|protective agents|mesh-ancestor
64355185|NCT02735707|Renal Agents|renal agents|mesh-ancestor
64380230|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
64355186|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64355187|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64355188|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
64355189|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64355190|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64355191|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64355192|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
64355194|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
64355195|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355200|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64355206|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
64355213|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64355214|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355215|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64355216|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
64355217|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355218|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355220|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355221|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64355223|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
64355224|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64355225|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64355226|NCT00950989|Hematinics|hematinics|mesh-ancestor
64355227|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
64355229|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
64355230|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
64355231|NCT03420911|Midazolam|midazolam|mesh-list
64355232|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64355233|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64355234|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355235|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355236|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64355237|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64355238|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64355239|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64355244|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355289|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64355290|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
64355291|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355292|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355293|NCT03415763|Antidotes|antidotes|mesh-ancestor
64355294|NCT03415763|Protective Agents|protective agents|mesh-ancestor
64355295|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355296|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
64355297|NCT03415763|Vitamins|vitamins|mesh-ancestor
64355298|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
64355356|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64355357|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64355358|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
64355360|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64355361|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64355362|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64355363|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
64355364|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355365|NCT00006455|Antidotes|antidotes|mesh-ancestor
64355366|NCT00006455|Protective Agents|protective agents|mesh-ancestor
64355367|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
64355368|NCT00006455|Vitamins|vitamins|mesh-ancestor
64355418|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64355420|NCT02344004|Amikacin|amikacin|mesh-list
64355421|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64355422|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355423|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
64355424|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64355425|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355426|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355427|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64355428|NCT03677115|Analgesics|analgesics|mesh-ancestor
64355433|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64355434|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
64355435|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355436|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355437|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
64355438|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64355469|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64355471|NCT03417427|Decitabine|decitabine|mesh-list
64355472|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64355473|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
64355474|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355475|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355476|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
64355477|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64355478|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64355484|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64355485|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
64355486|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355487|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355488|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64355492|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
64355493|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355494|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355495|NCT03419429|Simvastatin|simvastatin|mesh-list
64355496|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64355497|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64355498|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
64355499|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355500|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64355504|NCT02654145|Albuterol|albuterol|mesh-list
64355505|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64355506|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
64355507|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355508|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355509|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64355510|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
64355511|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
64355512|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64355513|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64355514|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64355515|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64355516|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
64355517|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64355519|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64355520|NCT05122455|Edoxaban|edoxaban|mesh-list
64355521|NCT05122455|Clopidogrel|clopidogrel|mesh-list
64355558|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64355559|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355560|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64355561|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
64355562|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64355563|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355564|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64355565|NCT03425461|Nivolumab|nivolumab|mesh-list
64355566|NCT03425461|Ipilimumab|ipilimumab|mesh-list
64355567|NCT03425461|Antibodies|antibodies|mesh-list
64355568|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
64355569|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64355571|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355573|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64355574|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355576|NCT04753437|Clarithromycin|clarithromycin|mesh-list
64355577|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
64355578|NCT04753437|Esomeprazole|esomeprazole|mesh-list
64355579|NCT04753437|Bismuth|bismuth|mesh-list
64355588|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64355589|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64355591|NCT04753437|Diuretics|diuretics|mesh-ancestor
64355592|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
64355593|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355598|NCT03411109|Narcotics|narcotics|mesh-ancestor
64355599|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355600|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355601|NCT03411109|Analgesics|analgesics|mesh-ancestor
64355639|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355641|NCT03412513|Urological Agents|urological agents|mesh-ancestor
64355643|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64355644|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64355645|NCT04370379|Growth Substances|growth substances|mesh-ancestor
64355646|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355647|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
64355648|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64355649|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
64355651|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64355652|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355653|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
64355654|NCT03413891|Coagulants|coagulants|mesh-ancestor
64355655|NCT03317613|Capsaicin|capsaicin|mesh-list
64355661|NCT03126877|Mitomycins|mitomycins|mesh-list
64355694|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
64355695|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64355720|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64355721|NCT04814745|Narcotics|narcotics|mesh-ancestor
64355722|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64355834|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
64355836|NCT03412409|Semustine|semustine|mesh-list
64355837|NCT03412409|Fludarabine|fludarabine|mesh-list
64355838|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64355864|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
64355936|NCT03407521|Diuretics|diuretics|mesh-ancestor
64355937|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
64355939|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64355940|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64355941|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
64355942|NCT03424135|Promethazine|promethazine|mesh-list
64355944|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64355945|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64355946|NCT03424135|Analgesics|analgesics|mesh-ancestor
64355947|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
64355949|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64355984|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64356016|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64356017|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
64356018|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356019|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356020|NCT03404947|Ethanol|ethanol|mesh-list
64356021|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64356141|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64356170|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
64356171|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64356172|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64356218|NCT05188053|Ketorolac|ketorolac|mesh-list
64356219|NCT05188053|Epinephrine|epinephrine|mesh-list
64356220|NCT05188053|Ropivacaine|ropivacaine|mesh-list
64356221|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
64356222|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
64356223|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356224|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356225|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
64356226|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356227|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64356248|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
64356249|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64356250|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64356251|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356252|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356253|NCT03393325|Urological Agents|urological agents|mesh-ancestor
64356254|NCT03399643|Atezolizumab|atezolizumab|mesh-list
64356255|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356256|NCT03393247|Azathioprine|azathioprine|mesh-list
64356257|NCT03393247|Infliximab|infliximab|mesh-list
64356258|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
64356259|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64356260|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64356261|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
64380231|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64356410|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356411|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64356412|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356413|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
64356415|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356417|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64356418|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380457|NCT04159155|Paclitaxel|paclitaxel|mesh-list
64356637|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64356638|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64356640|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356641|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356642|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356643|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64356644|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
64356645|NCT03395171|Vitamin D|vitamin d|mesh-list
64356646|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
64356675|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356677|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64356679|NCT03395093|Midazolam|midazolam|mesh-list
64356680|NCT03395093|Propofol|propofol|mesh-list
64356681|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356682|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356683|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356684|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356685|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
64356686|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
64356687|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64356688|NCT03395093|Narcotics|narcotics|mesh-ancestor
64356689|NCT03395093|Analgesics|analgesics|mesh-ancestor
64356690|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
64356691|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356692|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64356693|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64356694|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64356695|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356696|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
64356697|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
64356698|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356699|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356700|NCT03389191|Acyclovir|acyclovir|mesh-list
64356701|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
64356702|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64356703|NCT04330183|Ketamine|ketamine|mesh-list
64356704|NCT04330183|Analgesics|analgesics|mesh-ancestor
64356705|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
64356706|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356707|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356708|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64356709|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64356710|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
64356711|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
64356716|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356717|NCT03398993|Clomiphene|clomiphene|mesh-list
64356718|NCT03398993|Enclomiphene|enclomiphene|mesh-list
64356719|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
64356720|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64356724|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356725|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64356726|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
64356727|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64356728|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64356729|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64356742|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356743|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64356744|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356745|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356746|NCT03391609|Analgesics|analgesics|mesh-ancestor
64356747|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
64356748|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356749|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64356750|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64356751|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64356752|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64356753|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356754|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356757|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64356758|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64356759|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64356760|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356761|NCT03398837|Hormones|hormones|mesh-ancestor
64356763|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356764|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
64356765|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64356766|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64356767|NCT03398837|Analgesics|analgesics|mesh-ancestor
64356768|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
64356769|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64356770|NCT03398759|Butorphanol|butorphanol|mesh-list
64356771|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64356791|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64356792|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356793|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64356794|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
64356796|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64356797|NCT04446923|Propranolol|propranolol|mesh-list
64356798|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64356910|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356912|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64356913|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356930|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64356931|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356933|NCT03389087|Apatinib|apatinib|mesh-list
64356934|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64356935|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64356967|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356968|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64356969|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64356970|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64356972|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64356973|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356974|NCT03987919|Tirzepatide|tirzepatide|mesh-list
64356975|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64356976|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64356977|NCT03987919|Incretins|incretins|mesh-ancestor
64356978|NCT03987919|Hormones|hormones|mesh-ancestor
64356979|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64356980|NCT03388957|Propranolol|propranolol|mesh-list
64356981|NCT03388957|Midazolam|midazolam|mesh-list
64356982|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64356983|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64356984|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357038|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
64357040|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64357041|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
64357042|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357044|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64357046|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
64357047|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
64357048|NCT00271817|Vitamins|vitamins|mesh-ancestor
64357049|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
64357050|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357051|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
64357124|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64357125|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64357126|NCT03126071|Growth Substances|growth substances|mesh-ancestor
64357127|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357161|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
64357162|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357165|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357166|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357167|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64357168|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64357169|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380471|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64380594|NCT00328601|Vitamins|vitamins|mesh-ancestor
64380595|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
64380596|NCT00189293|Imiquimod|imiquimod|mesh-list
64380610|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
64380611|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380612|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
64380613|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
64380614|NCT03193307|BI 409306|bi 409306|mesh-list
64368672|NCT03324815|Morphine|morphine|mesh-list
64357170|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357171|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357172|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357174|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357189|NCT03391427|Analgesics|analgesics|mesh-ancestor
64357190|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64357191|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64357192|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
64357304|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357305|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357306|NCT00999401|Roscovitine|roscovitine|mesh-list
64357307|NCT00999401|Sapacitabine|sapacitabine|mesh-list
64357308|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357309|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
64357310|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357311|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357312|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357313|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357314|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
64357316|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357317|NCT04446065|Protective Agents|protective agents|mesh-ancestor
64357318|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357319|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
64357320|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64357321|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357322|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64357324|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64357325|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
64357326|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357327|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
64357329|NCT02732119|Everolimus|everolimus|mesh-list
64357330|NCT02732119|Exemestane|exemestane|mesh-list
64357331|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357332|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64357333|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
64357334|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357380|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357381|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357382|NCT03727633|Idarubicin|idarubicin|mesh-list
64357383|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
64357384|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64357385|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357389|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357390|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
64357391|NCT03380039|Fludarabine|fludarabine|mesh-list
64357392|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64357393|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
64357394|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357395|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64357396|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64357398|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357399|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357400|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64357401|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64357402|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
64357403|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357405|NCT02520817|Vitamin E|vitamin e|mesh-list
64357406|NCT02520817|Vitamin A|vitamin a|mesh-list
64357407|NCT02520817|Lactulose|lactulose|mesh-list
64357408|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
64357409|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357410|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
64357411|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357412|NCT02520817|Protective Agents|protective agents|mesh-ancestor
64368688|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
64357413|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64357444|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
64357445|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
64357446|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64357447|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64357448|NCT03387631|Lumefantrine|lumefantrine|mesh-list
64357449|NCT03387631|Artemether|artemether|mesh-list
64357450|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
64357451|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
64357452|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64357453|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64357454|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357456|NCT03383393|Eptifibatide|eptifibatide|mesh-list
64357457|NCT03383393|Analgesics|analgesics|mesh-ancestor
64357458|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
64357459|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357460|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357461|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64357462|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
64357463|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64357464|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
64357465|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
64357466|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357469|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
64357470|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
64357472|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357473|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357474|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
64357475|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357476|NCT03383315|Tramadol|tramadol|mesh-list
64357477|NCT03383315|Metoclopramide|metoclopramide|mesh-list
64357478|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64357479|NCT03383315|Narcotics|narcotics|mesh-ancestor
64357484|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357485|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
64357486|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
64357492|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357494|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357496|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64357497|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
64357498|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357499|NCT03252925|Expectorants|expectorants|mesh-ancestor
64357500|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
64357501|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64357502|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
64357503|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357504|NCT03252925|Protective Agents|protective agents|mesh-ancestor
64357505|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357506|NCT03252925|Antidotes|antidotes|mesh-ancestor
64357507|NCT03383237|Apatinib|apatinib|mesh-list
64357508|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357510|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357511|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357513|NCT03387241|Xhance|xhance|mesh-list
64357514|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
64357515|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64357516|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
64357517|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64357518|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64357520|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357521|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357522|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64357523|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
64357524|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
64357525|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64357526|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64357527|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64357528|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64357529|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
64357530|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357531|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357532|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
64357533|NCT03387241|Hormones|hormones|mesh-ancestor
64357534|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64357535|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
64357536|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
64357537|NCT03378791|Trace Elements|trace elements|mesh-ancestor
64357538|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
64357540|NCT03383003|Amoxicillin|amoxicillin|mesh-list
64357541|NCT03383003|Metronidazole|metronidazole|mesh-list
64357543|NCT03383003|Esomeprazole|esomeprazole|mesh-list
64357544|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357545|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357546|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64357547|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64357548|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64357549|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64357550|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64357577|NCT01327885|Dacarbazine|dacarbazine|mesh-list
64357578|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64357579|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
64357586|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357587|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
64357588|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357589|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
64357590|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
64357592|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357593|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357594|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357595|NCT03381755|Ticagrelor|ticagrelor|mesh-list
64357596|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64357597|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64357598|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64357599|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64357600|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
64357601|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357621|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
64357622|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64357623|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64357624|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357625|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64357626|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
64357627|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64357628|NCT03381599|Lenograstim|lenograstim|mesh-list
64357629|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64357630|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
64357631|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357632|NCT03394573|Aflibercept|aflibercept|mesh-list
64357633|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64357634|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64357635|NCT03394573|Growth Substances|growth substances|mesh-ancestor
64357636|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357637|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
64357638|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357640|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357673|NCT03375515|Narcotics|narcotics|mesh-ancestor
64357674|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357675|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357676|NCT03375515|Analgesics|analgesics|mesh-ancestor
64357677|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
64357678|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357680|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64357750|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64357772|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
64357773|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357774|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357775|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64357776|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64357778|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357779|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357798|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
64357799|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64357800|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
64357801|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357802|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
64357803|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
64357804|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
64357805|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357806|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64357807|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
64357808|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357809|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
64357810|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64357811|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357812|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64357904|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
64357905|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357906|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357907|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
64357908|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357909|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64357910|NCT03379987|Narcotics|narcotics|mesh-ancestor
64357911|NCT03379987|Analgesics|analgesics|mesh-ancestor
64357912|NCT02730793|Aztreonam|aztreonam|mesh-list
64357913|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357914|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357916|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64357917|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357918|NCT02678533|Plerixafor|plerixafor|mesh-list
64357919|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64357920|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64357921|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
64357922|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357923|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
64357925|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357926|NCT03384511|Apatinib|apatinib|mesh-list
64357927|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64357928|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64357929|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357930|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357931|NCT03385525|Valproic Acid|valproic acid|mesh-list
64357932|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
64357933|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357934|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357935|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
64357936|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64357937|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357938|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
64357939|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64357940|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64357941|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64357942|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
64357943|NCT05172739|Anesthetics|anesthetics|mesh-list
64357947|NCT05172739|Analgesics|analgesics|mesh-ancestor
64357948|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
64357949|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64357950|NCT03375463|Tirzepatide|tirzepatide|mesh-list
64357967|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64357968|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64357969|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64357970|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64368728|NCT03324503|Prednisolone|prednisolone|mesh-list
64357971|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64357972|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64357973|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64357974|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64357975|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64357977|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64357978|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
64357979|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64357981|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64357982|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64357983|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64357985|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
64357986|NCT03378427|Levofloxacin|levofloxacin|mesh-list
64357987|NCT03378427|Ofloxacin|ofloxacin|mesh-list
64357988|NCT03378427|Minocycline|minocycline|mesh-list
64357989|NCT03378427|Rifampin|rifampin|mesh-list
64357990|NCT03378427|Clindamycin|clindamycin|mesh-list
64357991|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
64357995|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
64357996|NCT03378427|Trimethoprim|trimethoprim|mesh-list
64357997|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
64357998|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64357999|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358000|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
64358001|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64358002|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64358031|NCT05172115|Dalteparin|dalteparin|mesh-list
64358058|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358061|NCT03374293|Antibodies|antibodies|mesh-list
64358062|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
64358063|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358064|NCT02730871|Timolol|timolol|mesh-list
64358065|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64358066|NCT02730871|Travoprost|travoprost|mesh-list
64358067|NCT02730871|Brinzolamide|brinzolamide|mesh-list
64358068|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64358069|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64358102|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
64358103|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358105|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
64358106|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64358107|NCT04445857|Katacalcin|katacalcin|mesh-list
64358108|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64358109|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358110|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64358111|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
64358133|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64358134|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64358135|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
64358136|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358137|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358138|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64358139|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358140|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358142|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
64358143|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358145|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
64358146|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358147|NCT03382717|Amorolfine|amorolfine|mesh-list
64358148|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
64358149|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358150|NCT03125473|Vaccines|vaccines|mesh-list
64358151|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
64358152|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358153|NCT03376789|MYL-1501D|myl-1501d|mesh-list
64358160|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358161|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358162|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358186|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
64358187|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64358188|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
64380616|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380617|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380618|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64380619|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
64380620|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64380621|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380622|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64358189|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358190|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358191|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
64358192|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358193|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64358209|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
64358210|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358212|NCT03372109|Turmeric extract|turmeric extract|mesh-list
64358213|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64358214|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358215|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
64358216|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358217|NCT03372109|Protective Agents|protective agents|mesh-ancestor
64358218|NCT03371953|Atracurium|atracurium|mesh-list
64358219|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
64358220|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64358221|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64358222|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64358223|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358224|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358225|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64358226|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64358227|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358228|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358232|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64358233|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64358234|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358235|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358236|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64358237|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358238|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
64380623|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64358239|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64358240|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64358269|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358271|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
64358272|NCT04527133|Coagulants|coagulants|mesh-ancestor
64358273|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
64358274|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64358275|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
64358276|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358277|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358278|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64358279|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358280|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64358281|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
64358283|NCT03369847|Beclomethasone|beclomethasone|mesh-list
64358284|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358285|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64358286|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
64358287|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358288|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358289|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64358290|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
64358291|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
64358292|NCT03369847|Hormones|hormones|mesh-ancestor
64358293|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358294|NCT04526353|Oxybutynin|oxybutynin|mesh-list
64358296|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
64358297|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358298|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358299|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64358301|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358302|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358303|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358305|NCT03371173|Ferric maltol|ferric maltol|mesh-list
64358373|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358374|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64358375|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64358376|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64358377|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358378|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358380|NCT03370159|Docetaxel|docetaxel|mesh-list
64358381|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358382|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
64358383|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
64358384|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
64358385|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358386|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
64358395|NCT04522297|Norepinephrine|norepinephrine|mesh-list
64358396|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64358397|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64358399|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358400|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358401|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358402|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64358403|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64358404|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
64358405|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358406|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64358407|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
64358408|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
64358409|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
64358410|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64358411|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64358412|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64358413|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358414|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64358439|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64358440|NCT03362281|Amoxicillin|amoxicillin|mesh-list
64358441|NCT03362281|Clarithromycin|clarithromycin|mesh-list
64358442|NCT03362281|Omeprazole|omeprazole|mesh-list
64358443|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64358444|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358445|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64358455|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64358456|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358457|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
64358458|NCT02518789|Fentanyl|fentanyl|mesh-list
64358459|NCT02518789|Midazolam|midazolam|mesh-list
64358460|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
64358461|NCT02518789|Remifentanil|remifentanil|mesh-list
64358462|NCT02518789|Propofol|propofol|mesh-list
64358463|NCT02518789|Etomidate|etomidate|mesh-list
64358464|NCT02518789|Atracurium|atracurium|mesh-list
64358465|NCT02518789|Rocuronium|rocuronium|mesh-list
64358466|NCT02518789|Cisatracurium|cisatracurium|mesh-list
64358467|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64358468|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358469|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358470|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64358471|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
64358472|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
64358473|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64358474|NCT02518789|Analgesics|analgesics|mesh-ancestor
64358475|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
64358476|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358477|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64358478|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64358479|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64358480|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
64358481|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358482|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358483|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64358485|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64358486|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64358487|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64358488|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64358489|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
64358490|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
64358491|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64358492|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64358493|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64358494|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
64358495|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64358496|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358497|NCT03357757|Avelumab|avelumab|mesh-list
64358498|NCT03357757|Valproic Acid|valproic acid|mesh-list
64358499|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64358500|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358501|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
64358502|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358503|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358504|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
64358505|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358506|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358507|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
64358508|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64358521|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358522|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
64358523|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358524|NCT04523623|Ibuprofen|ibuprofen|mesh-list
64358526|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64358528|NCT04523623|Analgesics|analgesics|mesh-ancestor
64358529|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
64358530|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358531|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358532|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358533|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64358547|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64358548|NCT04521751|Acarbose|acarbose|mesh-list
64358549|NCT04521751|Orlistat|orlistat|mesh-list
64358550|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64358551|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358552|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358553|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358560|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358561|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358562|NCT01675167|Buprenorphine|buprenorphine|mesh-list
64358563|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64358564|NCT01675167|Narcotics|narcotics|mesh-ancestor
64358565|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358566|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358567|NCT01675167|Analgesics|analgesics|mesh-ancestor
64358568|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
64358571|NCT03367663|Prednisone|prednisone|mesh-list
64358572|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358573|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
64358574|NCT03367663|Hormones|hormones|mesh-ancestor
64358575|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64358576|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358577|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64358578|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358579|NCT03123289|Gallium citrate|gallium citrate|mesh-list
64358580|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358581|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64358582|NCT04521049|Saxagliptin|saxagliptin|mesh-list
64358583|NCT04521049|Incretins|incretins|mesh-ancestor
64358596|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358597|NCT03123445|Gemcitabine|gemcitabine|mesh-list
64358598|NCT03123445|Endostar protein|endostar protein|mesh-list
64358599|NCT03123445|Endostatins|endostatins|mesh-list
64358600|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358601|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64358602|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
64358603|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358605|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358606|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358607|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64358608|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
64358609|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358610|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64358611|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64358612|NCT03123445|Growth Substances|growth substances|mesh-ancestor
64358613|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
64358614|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64358616|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64358617|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64358618|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358622|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
64358623|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358624|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358625|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64358626|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64358627|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
64358628|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
64358629|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358635|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
64358636|NCT03367585|Vitamins|vitamins|mesh-ancestor
64358668|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
64358695|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358696|NCT03356899|Bupivacaine|bupivacaine|mesh-list
64358697|NCT03356899|Anesthetics|anesthetics|mesh-list
64358698|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
64358699|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64358700|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358701|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
64358730|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358732|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358781|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64358782|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64358783|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64358784|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64358785|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
64358786|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358787|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358789|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
64358790|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358791|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
64358792|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64358793|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64358794|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64358795|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358796|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358797|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
64358798|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358799|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358800|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64358801|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358803|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64358804|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358805|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
64358806|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358807|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64358808|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
64358811|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64358812|NCT05125575|Metformin|metformin|mesh-list
64358813|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64358814|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358815|NCT03366883|Paclitaxel|paclitaxel|mesh-list
64358816|NCT03366883|Cisplatin|cisplatin|mesh-list
64358817|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64358818|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358819|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
64358820|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
64358821|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
64358822|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358823|NCT03366571|Entecavir|entecavir|mesh-list
64358824|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
64358825|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64358827|NCT05052099|Atezolizumab|atezolizumab|mesh-list
64358828|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64358829|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358830|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64358831|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64358832|NCT05052099|Growth Substances|growth substances|mesh-ancestor
64358833|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358834|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
64358890|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
64358891|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64358892|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
64358893|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358894|NCT04932213|Tropicamide|tropicamide|mesh-list
64358895|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
64358896|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
64358897|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358898|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358899|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64358900|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64358902|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358903|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358926|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64358927|NCT03355027|Simvastatin|simvastatin|mesh-list
64358929|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64358930|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64358931|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
64358932|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358934|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64358936|NCT03828045|Apremilast|apremilast|mesh-list
64358937|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64358938|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64358939|NCT03828045|Analgesics|analgesics|mesh-ancestor
64358940|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
64358941|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358942|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358943|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64358946|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64358947|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64358948|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358949|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
64358950|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64358951|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358952|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
64358953|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
64358954|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64358955|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
64358956|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358957|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
64358958|NCT02519335|Razoxane|razoxane|mesh-list
64358959|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64358960|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64358975|NCT04509583|Protective Agents|protective agents|mesh-ancestor
64358976|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
64358977|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
64358978|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358979|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358980|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64358981|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
64358982|NCT03350737|Heparin|heparin|mesh-list
64358983|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
64358984|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64358985|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64358986|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358987|NCT03350659|Midodrine|midodrine|mesh-list
64358990|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64358991|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64358992|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64358993|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
64358994|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64358995|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64358996|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
64358997|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
64358998|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64358999|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64359000|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64359002|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64359004|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
64359005|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359006|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359007|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64359008|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64359010|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
64359011|NCT03350347|Hematinics|hematinics|mesh-ancestor
64359012|NCT03350191|Exenatide|exenatide|mesh-list
64359013|NCT03350191|Glucagon|glucagon|mesh-list
64359014|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359015|NCT03350191|Hormones|hormones|mesh-ancestor
64359016|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359017|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359018|NCT03350191|Incretins|incretins|mesh-ancestor
64359019|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359020|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64359021|NCT02649231|Ketamine|ketamine|mesh-list
64359022|NCT02649231|Analgesics|analgesics|mesh-ancestor
64359023|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
64359024|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359025|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359026|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64359027|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64359028|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
64359029|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
64359057|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
64359058|NCT03349957|Idarubicin|idarubicin|mesh-list
64359059|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64359060|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359061|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64359062|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64359063|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359064|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359065|NCT04524169|Thymalfasin|thymalfasin|mesh-list
64359066|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64359067|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
64359068|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359069|NCT03568929|Idelalisib|idelalisib|mesh-list
64359070|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359072|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359074|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64359075|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359076|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64359077|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359078|NCT04841499|Niacinamide|niacinamide|mesh-list
64359079|NCT04841499|Niacin|niacin|mesh-list
64359080|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
64359081|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
64359082|NCT04841499|Vitamins|vitamins|mesh-ancestor
64359083|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
64359084|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359085|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64359086|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
64359087|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359101|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64359102|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64359103|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359105|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64359108|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64359109|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64359110|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
64359111|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64359112|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
64359113|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
64359114|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
64359115|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64359116|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
64359117|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64359118|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359119|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359120|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378817|NCT04338399|Paclitaxel|paclitaxel|mesh-list
64359121|NCT01376245|Fluticasone|fluticasone|mesh-list
64359122|NCT01376245|Xhance|xhance|mesh-list
64359124|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64359126|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359127|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359129|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
64359130|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
64359131|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64359132|NCT04754061|Psilocybin|psilocybin|mesh-list
64359133|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
64359134|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359135|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359136|NCT03349489|Insulin|insulin|mesh-list
64359137|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64359138|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359139|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359141|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359142|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359143|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
64359144|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64359145|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64359146|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
64359147|NCT03349177|Docetaxel|docetaxel|mesh-list
64359148|NCT03349177|Fluorouracil|fluorouracil|mesh-list
64359149|NCT03349177|Epirubicin|epirubicin|mesh-list
64359150|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359151|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
64359152|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359153|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359154|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64359155|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
64359156|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359157|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359158|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64359159|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64359160|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64359161|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64359162|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
64359163|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64359164|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64359165|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64359166|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64359167|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359168|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
64359169|NCT04691505|Methotrexate|methotrexate|mesh-list
64359170|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64359171|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
64359172|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64359173|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359177|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359178|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
64359179|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359180|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64359181|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359182|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
64359183|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359184|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64359185|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
64359186|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64359187|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64359188|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359189|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64359190|NCT05400265|Antibodies|antibodies|mesh-list
64359191|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
64359192|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64359193|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
64359194|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359195|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359196|NCT05364619|Bismuth|bismuth|mesh-list
64359197|NCT05364619|Antacids|antacids|mesh-ancestor
64359198|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359199|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359200|NCT03353857|Rifampin|rifampin|mesh-list
64359202|NCT03353857|Drospirenone|drospirenone|mesh-list
64359203|NCT03353857|Midazolam|midazolam|mesh-list
64359214|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64359215|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359216|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64359217|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
64359219|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
64359221|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359222|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359223|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64359224|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
64359225|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64359226|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64359227|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64359229|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64359230|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
64359231|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359232|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359233|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
64359234|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64359235|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359236|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64359237|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64359238|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64359239|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64359240|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64359252|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359253|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359255|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64359256|NCT04499859|Ezetimibe|ezetimibe|mesh-list
64359257|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64359258|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64359259|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
64359260|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359261|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64359262|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64359264|NCT05306899|Ketamine|ketamine|mesh-list
64359265|NCT05306899|Analgesics|analgesics|mesh-ancestor
64359266|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
64359267|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359268|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359269|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64359278|NCT00807651|Insulin|insulin|mesh-list
64359279|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64359280|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359281|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359282|NCT00700791|Vitamins|vitamins|mesh-list
64359283|NCT00700791|Vitamin E|vitamin e|mesh-list
64359284|NCT00700791|Tocopherols|tocopherols|mesh-list
64359285|NCT00700791|Tocotrienols|tocotrienols|mesh-list
64359286|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
64359287|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
64359288|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359289|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
64359290|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359291|NCT00700791|Protective Agents|protective agents|mesh-ancestor
64359292|NCT05344365|Iloperidone|iloperidone|mesh-list
64359293|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64359294|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64359295|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359296|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359297|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359298|NCT05129085|Dexamethasone|dexamethasone|mesh-list
64359299|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359300|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
64359301|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
64359302|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359303|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359304|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359306|NCT05129085|Hormones|hormones|mesh-ancestor
64359307|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359308|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359330|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
64359331|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359332|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359333|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359334|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64359336|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
64359337|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359338|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359339|NCT01674621|Abaloparatide|abaloparatide|mesh-list
64359340|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
64359341|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64359342|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359343|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64359344|NCT04644705|Niclosamide|niclosamide|mesh-list
64359345|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
64359346|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64359347|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
64359348|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64359349|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359350|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
64359352|NCT04038489|Tamoxifen|tamoxifen|mesh-list
64359353|NCT04038489|Paclitaxel|paclitaxel|mesh-list
64359354|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
64359355|NCT04038489|Doxorubicin|doxorubicin|mesh-list
64359356|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64359357|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359358|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
64359359|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
64359360|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
64359362|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359373|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64359375|NCT04038489|Analgesics|analgesics|mesh-ancestor
64359376|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
64359377|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359378|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359379|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64359380|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64359381|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64359382|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64359383|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
64359384|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64359385|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
64359386|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359387|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359388|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64359389|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64359390|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64359391|NCT04468425|Tofacitinib|tofacitinib|mesh-list
64359392|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359394|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359395|NCT04287855|Dexamethasone|dexamethasone|mesh-list
64359396|NCT04287855|Pomalidomide|pomalidomide|mesh-list
64359397|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359398|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
64359403|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
64359418|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64359419|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
64359420|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359421|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359422|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64359423|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64359424|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
64359425|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359426|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64359427|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64359428|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
64359429|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64359430|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64359431|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359433|NCT05131893|Docetaxel|docetaxel|mesh-list
64359434|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
64359435|NCT05131893|Capecitabine|capecitabine|mesh-list
64359436|NCT05131893|Trastuzumab|trastuzumab|mesh-list
64359437|NCT05131893|Letrozole|letrozole|mesh-list
64359438|NCT05131893|Epirubicin|epirubicin|mesh-list
64359439|NCT05131893|Pertuzumab|pertuzumab|mesh-list
64359440|NCT05131893|Goserelin|goserelin|mesh-list
64359442|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
64359471|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
64359472|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
64359474|NCT02889237|Calcium|calcium|mesh-list
64359475|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
64359476|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359477|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64359478|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64359479|NCT02689167|Sunitinib|sunitinib|mesh-list
64359480|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359481|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64359482|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64359533|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359536|NCT05185167|Desflurane|desflurane|mesh-list
64359537|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
64359538|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64359539|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359540|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359541|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64359542|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64359543|NCT05133453|Pirfenidone|pirfenidone|mesh-list
64359544|NCT05133453|Analgesics|analgesics|mesh-ancestor
64359545|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
64359546|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359547|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359548|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64359549|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64359550|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359552|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359553|NCT05125185|Insulin|insulin|mesh-list
64359554|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359555|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359556|NCT04244877|Rifaximin|rifaximin|mesh-list
64359557|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359558|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359559|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359560|NCT05128617|Paclitaxel|paclitaxel|mesh-list
64359561|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
64359562|NCT05128617|Epirubicin|epirubicin|mesh-list
64359563|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64359564|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359565|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
64359566|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
64359567|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
64359568|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359569|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359570|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
64359571|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359572|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359573|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64359574|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
64359576|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64359577|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64359578|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64359579|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359580|NCT04495179|Durvalumab|durvalumab|mesh-list
64359581|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64359582|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359583|NCT05118945|Insulin|insulin|mesh-list
64359584|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64359585|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64359586|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359587|NCT05305131|Gemcitabine|gemcitabine|mesh-list
64359590|NCT05305131|Cisplatin|cisplatin|mesh-list
64359591|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64359592|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359593|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64359594|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64359595|NCT05305131|Growth Substances|growth substances|mesh-ancestor
64359596|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359598|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64359599|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
64359600|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359601|NCT05305131|Antiviral Agents|antiviral agents|mesh-ancestor
64359602|NCT05305131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359603|NCT05305131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359604|NCT05305131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64359605|NCT05305131|Immunologic Factors|immunologic factors|mesh-ancestor
64359606|NCT03122665|Nefopam|nefopam|mesh-list
64359611|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359612|NCT05099913|Flupenthixol|flupenthixol|mesh-list
64359613|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64359614|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64359615|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359616|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359617|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359618|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64359619|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
64359620|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359621|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359623|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
64359624|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
64359625|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359626|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359627|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
64359628|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359630|NCT03346837|Rifampin|rifampin|mesh-list
64359631|NCT03346837|Linrodostat|linrodostat|mesh-list
64359632|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
64359633|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359634|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64359635|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64359636|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359637|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359638|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64359639|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
64359640|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359641|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359642|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64359643|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64359645|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359646|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
64359647|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64359648|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64359649|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64359650|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64359651|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64359652|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64359653|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64359654|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
64359655|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
64359656|NCT05303961|Rebamipide|rebamipide|mesh-list
64359657|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64359658|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359659|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
64359660|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359661|NCT05303961|Protective Agents|protective agents|mesh-ancestor
64359662|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359699|NCT03121963|Gabapentin|gabapentin|mesh-list
64359700|NCT03121963|Hydrocodone|hydrocodone|mesh-list
64359701|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64359702|NCT03121963|Analgesics|analgesics|mesh-ancestor
64359709|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359710|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64359711|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359712|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64359713|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64359715|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64359716|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359717|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
64359718|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64359719|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64359720|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64359721|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64359722|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64359723|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359724|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
64359725|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
64359726|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
64359727|NCT04502251|Naltrexone|naltrexone|mesh-list
64359728|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64359729|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64359730|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359732|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359733|NCT04502017|Clopidogrel|clopidogrel|mesh-list
64359734|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64359735|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64359736|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64359737|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64359738|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
64359739|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359740|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359741|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359743|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64359744|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
64359745|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
64359746|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64359747|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
64359749|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359752|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359753|NCT03122041|Incretins|incretins|mesh-ancestor
64359755|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359776|NCT04475991|Favipiravir|favipiravir|mesh-list
64359777|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
64359778|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
64359779|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359781|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64359782|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
64359783|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359784|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
64359785|NCT03387475|Deferasirox|deferasirox|mesh-list
64359786|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64359787|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
64359789|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359791|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
64359792|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
64359793|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
64359794|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
64359795|NCT05302713|Calcium|calcium|mesh-list
64359796|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64359797|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359798|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64359799|NCT05302713|Antacids|antacids|mesh-ancestor
64380624|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64359800|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359801|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64359802|NCT04921033|Prednisolone|prednisolone|mesh-list
64359803|NCT04921033|Budesonide|budesonide|mesh-list
64359804|NCT04921033|Azathioprine|azathioprine|mesh-list
64359805|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359806|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
64359807|NCT04921033|Hormones|hormones|mesh-ancestor
64359808|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359809|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359810|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64359811|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64359812|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
64359813|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359815|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64359816|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
64359817|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
64359901|NCT05135013|Estrogens|estrogens|mesh-ancestor
64359902|NCT05135013|Hormones|hormones|mesh-ancestor
64359903|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64359904|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359905|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64359929|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64359930|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359931|NCT05576155|Compound 21|compound 21|mesh-list
64359932|NCT05576155|Losartan|losartan|mesh-list
64359933|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64359934|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64359935|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64359936|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64359937|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359938|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359939|NCT04501783|Favipiravir|favipiravir|mesh-list
64359940|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
64359941|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64359944|NCT03351751|PF-06372865|pf-06372865|mesh-list
64359945|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
64359946|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
64359947|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64359948|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64359949|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359951|NCT03347461|Dexamethasone|dexamethasone|mesh-list
64359952|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64359953|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
64359974|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64359975|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64359976|NCT03351517|Analgesics|analgesics|mesh-ancestor
64359977|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
64359978|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64359979|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64359980|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64359981|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64359985|NCT03346525|Penicillins|penicillins|mesh-list
64359999|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360000|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64360001|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64360002|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64360007|NCT04502641|Fluorouracil|fluorouracil|mesh-list
64360008|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360009|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
64360010|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
64360011|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
64360012|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360014|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360015|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360016|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
64360017|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360018|NCT05555797|Betamethasone|betamethasone|mesh-list
64360019|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
64360020|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64360021|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
64360022|NCT05555797|Tazarotene|tazarotene|mesh-list
64360023|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64360024|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64360025|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
64360026|NCT05555797|Hormones|hormones|mesh-ancestor
64360027|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360028|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360029|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64360030|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
64360031|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
64360032|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
64360033|NCT03955575|Liraglutide|liraglutide|mesh-list
64360039|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360040|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64360043|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360044|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64360045|NCT04163419|Tanezumab|tanezumab|mesh-list
64360046|NCT04163419|Analgesics|analgesics|mesh-ancestor
64360047|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
64360048|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360049|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360050|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64360051|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
64360052|NCT03351205|Estradiol|estradiol|mesh-list
64360053|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64360056|NCT03351205|Hormones|hormones|mesh-ancestor
64360057|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360058|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360059|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64360060|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
64360061|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64360062|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64360063|NCT03351205|Progestins|progestins|mesh-ancestor
64360064|NCT04698057|Amoxicillin|amoxicillin|mesh-list
64360065|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
64360066|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
64360067|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
64360086|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
64360087|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360088|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360089|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64360090|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64360091|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64360092|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64360093|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360094|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64360095|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64360096|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360097|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
64360098|NCT04065009|Ropivacaine|ropivacaine|mesh-list
64360099|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
64360100|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
64360101|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360102|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360103|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
64360104|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360105|NCT04250493|Insulin|insulin|mesh-list
64360107|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360108|NCT01868451|Doxorubicin|doxorubicin|mesh-list
64360109|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64360110|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64360111|NCT01868451|Dacarbazine|dacarbazine|mesh-list
64360138|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
64360139|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64360140|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64360141|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
64360142|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64360143|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64360144|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
64360145|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
64360146|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360147|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360148|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64360149|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
64360151|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360152|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64360153|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360154|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64360155|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64360156|NCT02517619|Protective Agents|protective agents|mesh-ancestor
64360157|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
64360176|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360178|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64360179|NCT03376659|Growth Substances|growth substances|mesh-ancestor
64360180|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360181|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
64360182|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360183|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
64360184|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360185|NCT03322215|Capecitabine|capecitabine|mesh-list
64360186|NCT03322215|Fulvestrant|fulvestrant|mesh-list
64360187|NCT03322215|Palbociclib|palbociclib|mesh-list
64360188|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360189|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
64360190|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360191|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360192|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64360193|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64360194|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64360195|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
64360196|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360197|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360198|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64360199|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360200|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
64360201|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64360212|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360214|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360215|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64360216|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64360217|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64360218|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
64360219|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64360220|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
64360221|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64360222|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360223|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64360224|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64360225|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360226|NCT01285557|Cisplatin|cisplatin|mesh-list
64360227|NCT01285557|Fluorouracil|fluorouracil|mesh-list
64360228|NCT01285557|Tegafur|tegafur|mesh-list
64360230|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
64360231|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360232|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360233|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360234|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
64360235|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360238|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
64360239|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
64360240|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64360241|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64360242|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
64360243|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360244|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360245|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64360246|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
64360247|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
64360248|NCT03083067|Hormones|hormones|mesh-ancestor
64360250|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64360301|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
64360302|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360303|NCT02507323|Ticagrelor|ticagrelor|mesh-list
64360305|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64360306|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64360307|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64360308|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64360309|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
64360310|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360311|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360312|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360313|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
64360314|NCT05431413|Fluoxetine|fluoxetine|mesh-list
64360315|NCT05431413|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64360316|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64360317|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64360318|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360354|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360355|NCT02507167|Rifampin|rifampin|mesh-list
64360356|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64360357|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
64360358|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64360359|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360360|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
64360361|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64360362|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360375|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64360376|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64360377|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360379|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64360380|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64360381|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64360382|NCT01376167|Analgesics|analgesics|mesh-ancestor
64360384|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360385|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360395|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64360396|NCT02511613|Growth Substances|growth substances|mesh-ancestor
64360397|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360398|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
64360399|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360400|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64360401|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360402|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64360403|NCT02511613|Protective Agents|protective agents|mesh-ancestor
64360405|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
64360406|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360407|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360408|NCT02506777|Metformin|metformin|mesh-list
64360409|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
64360410|NCT02506777|Doxorubicin|doxorubicin|mesh-list
64360411|NCT02506777|Fluorouracil|fluorouracil|mesh-list
64360412|NCT02506777|Melatonin|melatonin|mesh-list
64360413|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360414|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
64360415|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360416|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64360417|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64360418|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
64360419|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360420|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360421|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64360443|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
64360444|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
64360445|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360446|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360447|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
64360448|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360450|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64360451|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360452|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360453|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360454|NCT02516059|Oxycodone|oxycodone|mesh-list
64360455|NCT02516059|Naloxone|naloxone|mesh-list
64360456|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64360457|NCT02516059|Narcotics|narcotics|mesh-ancestor
64360458|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360459|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360460|NCT02516059|Analgesics|analgesics|mesh-ancestor
64360461|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
64360462|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360463|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64360464|NCT02506231|Leucovorin|leucovorin|mesh-list
64360465|NCT02506231|Folic Acid|folic acid|mesh-list
64360466|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
64360467|NCT02506231|Antidotes|antidotes|mesh-ancestor
64360468|NCT02506231|Protective Agents|protective agents|mesh-ancestor
64360469|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360470|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
64360472|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
64360473|NCT02506231|Hematinics|hematinics|mesh-ancestor
64360474|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
64360475|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64360479|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64360480|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360481|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360482|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360483|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64360484|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360485|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64360486|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
64360488|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
64360489|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
64360490|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360491|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360492|NCT02511067|Ranibizumab|ranibizumab|mesh-list
64360493|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64360540|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64360541|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
64360542|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
64360543|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360544|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360545|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64360546|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64360547|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64360548|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
64360549|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360550|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360551|NCT02505451|Protective Agents|protective agents|mesh-ancestor
64360552|NCT02505295|Selenium|selenium|mesh-list
64360553|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
64360554|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360555|NCT02505295|Protective Agents|protective agents|mesh-ancestor
64360556|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360557|NCT02505295|Trace Elements|trace elements|mesh-ancestor
64360558|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
64360559|NCT02510911|Caffeine|caffeine|mesh-list
64360560|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64360561|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360562|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64360564|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360565|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64360566|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64360567|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
64360588|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360589|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360590|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64360591|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
64360592|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
64360593|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64360594|NCT03343873|Analgesics|analgesics|mesh-ancestor
64360595|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
64360596|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360597|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64360598|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64360599|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64360602|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360603|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64360604|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360605|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64360606|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360608|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
64360609|NCT03343795|Progesterone|progesterone|mesh-list
64360610|NCT03343795|Progestins|progestins|mesh-ancestor
64360611|NCT03343795|Hormones|hormones|mesh-ancestor
64360612|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360614|NCT02510287|Lidocaine|lidocaine|mesh-list
64360615|NCT02510287|Fentanyl|fentanyl|mesh-list
64360616|NCT02510287|Bupivacaine|bupivacaine|mesh-list
64360617|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
64360618|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
64360619|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360620|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360621|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
64360622|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360623|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64360624|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64360626|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64360627|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360628|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64360629|NCT02510287|Narcotics|narcotics|mesh-ancestor
64360630|NCT02510287|Analgesics|analgesics|mesh-ancestor
64360631|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64360632|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64360633|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
64360634|NCT02515435|Apatinib|apatinib|mesh-list
64360635|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360636|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64360637|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360638|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360640|NCT02515201|Heparin|heparin|mesh-list
64360641|NCT02515201|Calcium heparin|calcium heparin|mesh-list
64360642|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
64360643|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64360644|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64360645|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360646|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360647|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64360648|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360649|NCT02504983|Sorafenib|sorafenib|mesh-list
64360650|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360651|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64360652|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360653|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360654|NCT02510053|Caspofungin|caspofungin|mesh-list
64360661|NCT02504359|Etoposide|etoposide|mesh-list
64360662|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
64360663|NCT02504359|Melphalan|melphalan|mesh-list
64360664|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
64360665|NCT02504359|Carmustine|carmustine|mesh-list
64360666|NCT02504359|Ixazomib|ixazomib|mesh-list
64360667|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
64360668|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
64360669|NCT02504359|Tacrolimus|tacrolimus|mesh-list
64360670|NCT02504359|Glycine|glycine|mesh-list
64360671|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64360673|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64360674|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360675|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64360676|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
64360677|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360678|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360679|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
64360680|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360681|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64360682|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64360683|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
64360684|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64360685|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64360686|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64360711|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64360712|NCT02729545|Estrogens|estrogens|mesh-ancestor
64360713|NCT02729545|Hormones|hormones|mesh-ancestor
64360714|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64360715|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
64360716|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
64360717|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360718|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64360719|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
64360720|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64360722|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360723|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
64360724|NCT02504125|Coagulants|coagulants|mesh-ancestor
64360725|NCT02509429|Insulin|insulin|mesh-list
64360726|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64360727|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
64360728|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
64360730|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
64360731|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64360732|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360733|NCT02509273|Clonidine|clonidine|mesh-list
64360734|NCT02509273|Midazolam|midazolam|mesh-list
64360735|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64360736|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64360737|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360738|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360739|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360740|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64360741|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360742|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64360743|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
64360744|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
64360745|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
64360746|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
64360752|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64360753|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
64360754|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
64360755|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64360756|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64360757|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64360758|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
64360759|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
64360760|NCT02514343|Bupivacaine|bupivacaine|mesh-list
64360761|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
64360762|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
64360764|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360812|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64360814|NCT02513875|Vitamin D|vitamin d|mesh-list
64360815|NCT02513875|Vitamins|vitamins|mesh-ancestor
64360816|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
64360817|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360818|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64360819|NCT02509351|Misoprostol|misoprostol|mesh-list
64360820|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64360821|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
64360822|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64360823|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360827|NCT02509195|Lamivudine|lamivudine|mesh-list
64360828|NCT02509195|Abacavir|abacavir|mesh-list
64360829|NCT02509195|Dolutegravir|dolutegravir|mesh-list
64360830|NCT02509195|Triumeq|triumeq|mesh-list
64360831|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64360832|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64360833|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360834|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360835|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
64360836|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64360837|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64360838|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64360839|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64360840|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64360859|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64360860|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64360861|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64360862|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
64360863|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360864|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64360865|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64360866|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64360868|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360869|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360870|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360872|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
64360873|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360874|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
64360914|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360916|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
64360918|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64360919|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64360920|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64360921|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64360922|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
64360923|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
64360924|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360925|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360926|NCT03121339|Vaccines|vaccines|mesh-list
64360927|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
64360928|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360929|NCT02502175|Methadone|methadone|mesh-list
64360931|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64360932|NCT02502175|Narcotics|narcotics|mesh-ancestor
64360933|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360934|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360935|NCT02502175|Analgesics|analgesics|mesh-ancestor
64360936|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
64360937|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360938|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
64360941|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64360942|NCT02501941|Ketamine|ketamine|mesh-list
64360943|NCT02501941|Analgesics|analgesics|mesh-ancestor
64360944|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
64360945|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360946|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360947|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64360948|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64360949|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
64360950|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
64360951|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360952|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64360953|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64360954|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64360957|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64360958|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64360959|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64360960|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64360961|NCT02501863|Fentanyl|fentanyl|mesh-list
64360962|NCT02501863|Ropivacaine|ropivacaine|mesh-list
64360963|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
64360964|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
64360965|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64360966|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64360967|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
64360968|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64360969|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64360970|NCT02501863|Narcotics|narcotics|mesh-ancestor
64360971|NCT02501863|Analgesics|analgesics|mesh-ancestor
64360972|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64361006|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64361007|NCT02500069|Caseins|caseins|mesh-list
64361008|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
64361009|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
64361010|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361011|NCT03344029|Vaccines|vaccines|mesh-list
64361012|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
64361013|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361014|NCT03120637|Methylene Blue|methylene blue|mesh-list
64361015|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361016|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361017|NCT02499757|Nicotine|nicotine|mesh-list
64361018|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64361019|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
64361020|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361021|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361022|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64361023|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64361027|NCT00706849|Mipomersen|mipomersen|mesh-list
64361063|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361064|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
64361065|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
64361066|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
64361067|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64361068|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
64361069|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361071|NCT03341845|Axitinib|axitinib|mesh-list
64361072|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64361073|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361074|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361075|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380625|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64361076|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361078|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
64361079|NCT02498977|Azathioprine|azathioprine|mesh-list
64361080|NCT02498977|Tacrolimus|tacrolimus|mesh-list
64361081|NCT02498977|Cyclosporins|cyclosporins|mesh-list
64361082|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64361083|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
64361084|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361085|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64361086|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361087|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361112|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361113|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361114|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64361115|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64361116|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361117|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64361118|NCT03341767|Clofazimine|clofazimine|mesh-list
64361119|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361121|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64361122|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361123|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
64361124|NCT02498509|Levocabastine|levocabastine|mesh-list
64361125|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361126|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
64361127|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64361128|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64361129|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64361130|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
64361131|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
64361132|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361133|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361134|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361137|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
64361138|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361139|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361140|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64361154|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361155|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361156|NCT03335527|Analgesics|analgesics|mesh-ancestor
64361157|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
64361158|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361159|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64361160|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64361161|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64361162|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361163|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361164|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361165|NCT02493049|Domperidone|domperidone|mesh-list
64361166|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361167|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
64361168|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
64361169|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361173|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
64361212|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64361213|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
64361214|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
64361215|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
64361216|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64361217|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
64361218|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64361220|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361221|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361222|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
64361223|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64361224|NCT03340753|Diuretics|diuretics|mesh-ancestor
64361225|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
64361226|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64361227|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64361228|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361230|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
64361231|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361232|NCT00707161|Cisplatin|cisplatin|mesh-list
64361233|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361234|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
64361238|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361239|NCT03120247|Analgesics|analgesics|mesh-ancestor
64361240|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
64361241|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361242|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64361243|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64361244|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64361245|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361252|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
64361253|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361254|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64361255|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361256|NCT03334981|Buprenorphine|buprenorphine|mesh-list
64361257|NCT03334981|Methadone|methadone|mesh-list
64361258|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64361260|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361261|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361262|NCT03334981|Analgesics|analgesics|mesh-ancestor
64361263|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
64361264|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361265|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64361266|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
64361267|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
64361312|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361313|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64361315|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361316|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361317|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64361318|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
64361319|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
64361320|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64361321|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64361322|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64361323|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64361324|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361325|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361326|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361327|NCT02492581|Nalmefene|nalmefene|mesh-list
64361328|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64361329|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361330|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
64361331|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361332|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
64361333|NCT03342079|Anesthetics|anesthetics|mesh-list
64361334|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
64361337|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
64361363|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
64361364|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
64361365|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
64361367|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361368|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
64361369|NCT04494529|Hormones|hormones|mesh-ancestor
64361370|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361371|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361372|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64361373|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
64361374|NCT02491879|Ketoprofen|ketoprofen|mesh-list
64361375|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64361376|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361386|NCT03332953|Nicotine|nicotine|mesh-list
64361420|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361421|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361422|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64361423|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
64361424|NCT03330613|Anesthetics|anesthetics|mesh-list
64361425|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361426|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361429|NCT03332329|Molgramostim|molgramostim|mesh-list
64361430|NCT03332329|Vaccines|vaccines|mesh-list
64361431|NCT03332329|Sargramostim|sargramostim|mesh-list
64361432|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
64361433|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361434|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
64361435|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361436|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361437|NCT03330223|Clopidogrel|clopidogrel|mesh-list
64361438|NCT03330223|Ticagrelor|ticagrelor|mesh-list
64361439|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64361440|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64361441|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64361442|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64361443|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
64361444|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361445|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361446|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361447|NCT03331861|Metformin|metformin|mesh-list
64361467|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361468|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64361469|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361470|NCT05430711|Dinoprostone|dinoprostone|mesh-list
64361471|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
64361472|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361473|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361474|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
64361475|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64361477|NCT03324685|Estrogens|estrogens|mesh-ancestor
64361478|NCT03324685|Hormones|hormones|mesh-ancestor
64361479|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361480|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361481|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64361482|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
64361483|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361484|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64361485|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64361487|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64361488|NCT03324139|Heparin|heparin|mesh-list
64361489|NCT03324139|Calcium heparin|calcium heparin|mesh-list
64361490|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64361492|NCT03324139|Dalteparin|dalteparin|mesh-list
64361493|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
64361494|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64361514|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64361515|NCT02579811|Axitinib|axitinib|mesh-list
64361516|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361517|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361518|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361519|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361520|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
64361521|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361522|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361523|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361524|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361527|NCT05430087|Curcumin|curcumin|mesh-list
64361528|NCT05430087|Piperine|piperine|mesh-list
64361529|NCT05430087|Vitamins|vitamins|mesh-ancestor
64361530|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
64361531|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361532|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64361533|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64361534|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64361535|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361536|NCT05430087|Analgesics|analgesics|mesh-ancestor
64361537|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
64361538|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361539|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361540|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361542|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361543|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361544|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64361545|NCT03327727|Voriconazole|voriconazole|mesh-list
64361546|NCT03327727|Amphotericin B|amphotericin b|mesh-list
64361547|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64361554|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361555|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361556|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64361557|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
64361558|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361559|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361560|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64361561|NCT03327727|Amebicides|amebicides|mesh-ancestor
64361562|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64361563|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64361564|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64361566|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64361567|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361569|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
64361570|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361571|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361572|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361573|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361574|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64361576|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361578|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361579|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361580|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361581|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361598|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361599|NCT04492813|Remifentanil|remifentanil|mesh-list
64361600|NCT04492813|Propofol|propofol|mesh-list
64361601|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64361602|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361603|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361604|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64361605|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
64361606|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
64361607|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64361608|NCT04492813|Narcotics|narcotics|mesh-ancestor
64361609|NCT04492813|Analgesics|analgesics|mesh-ancestor
64361610|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
64361611|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361612|NCT03102801|Insulin|insulin|mesh-list
64361613|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64361614|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64361615|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361617|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64361618|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361620|NCT02488057|Hormones|hormones|mesh-ancestor
64361621|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361622|NCT04039347|Cyclosporine|cyclosporine|mesh-list
64361623|NCT04039347|Cyclosporins|cyclosporins|mesh-list
64361624|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361625|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361626|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64361627|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
64361628|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361643|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361646|NCT02488291|Ropivacaine|ropivacaine|mesh-list
64361647|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
64361648|NCT02488291|Anesthetics|anesthetics|mesh-list
64361649|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361650|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361652|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361653|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64361654|NCT02488291|Narcotics|narcotics|mesh-ancestor
64361655|NCT02488291|Analgesics|analgesics|mesh-ancestor
64361656|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64361657|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64361658|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
64361659|NCT03323047|Acetaminophen|acetaminophen|mesh-list
64361660|NCT03323047|Dexamethasone|dexamethasone|mesh-list
64361661|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
64361662|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64361664|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361665|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
64361666|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
64361667|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361668|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361694|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361695|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
64361696|NCT03322735|Fludarabine|fludarabine|mesh-list
64361697|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64361698|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
64361699|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361700|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361701|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64361702|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
64361703|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361704|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361705|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64361706|NCT02487823|Bicalutamide|bicalutamide|mesh-list
64361708|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
64361709|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
64361710|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361711|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361712|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361713|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64361714|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
64361715|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361716|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64361717|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64361718|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361719|NCT02487433|Tofacitinib|tofacitinib|mesh-list
64361720|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64361721|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64361722|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361738|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361739|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
64361740|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64361741|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64361742|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64361743|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64361744|NCT03318835|Growth Substances|growth substances|mesh-ancestor
64361745|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
64361746|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64361747|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361748|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64361749|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
64361750|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361752|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361754|NCT03318835|Hormones|hormones|mesh-ancestor
64361755|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361756|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64361758|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
64361821|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361822|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64361823|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361825|NCT03321955|Protective Agents|protective agents|mesh-ancestor
64361826|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361827|NCT03321955|Analgesics|analgesics|mesh-ancestor
64361828|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
64361829|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361830|NCT04493281|Edaravone|edaravone|mesh-list
64361831|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64361832|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
64361833|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361835|NCT04493281|Protective Agents|protective agents|mesh-ancestor
64361836|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361837|NCT01764711|Cosyntropin|cosyntropin|mesh-list
64361838|NCT01764711|Hormones|hormones|mesh-ancestor
64361839|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64361840|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361841|NCT04493515|Oxytocin|oxytocin|mesh-list
64361842|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
64361843|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64361844|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361845|NCT03318445|Irinotecan|irinotecan|mesh-list
64361846|NCT03318445|Rucaparib|rucaparib|mesh-list
64361847|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64361848|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64361853|NCT02485015|Apatinib|apatinib|mesh-list
64361869|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361871|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
64361872|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361873|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64361874|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64361875|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64361876|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361877|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361878|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361879|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64361880|NCT03316339|Narcotics|narcotics|mesh-ancestor
64361881|NCT02490865|RNS60|rns60|mesh-list
64361882|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64361883|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64361884|NCT02490865|Analgesics|analgesics|mesh-ancestor
64361885|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
64361887|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361888|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64361889|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64361917|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64361918|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64361919|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64361920|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361922|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
64361924|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361926|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
64361927|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361928|NCT02483689|Bupivacaine|bupivacaine|mesh-list
64361929|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
64361930|NCT02483689|Anesthetics|anesthetics|mesh-list
64361931|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64361932|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361933|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
64361934|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361974|NCT03317275|Protective Agents|protective agents|mesh-ancestor
64361975|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361976|NCT03317197|Vasopressins|vasopressins|mesh-list
64361977|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
64361978|NCT03317197|Epinephrine|epinephrine|mesh-list
64361979|NCT03317197|Racepinephrine|racepinephrine|mesh-list
64361980|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
64361981|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64361982|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64361983|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
64361984|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64361985|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64361986|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64361987|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64361988|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64361989|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
64361990|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64361991|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64361992|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
64361993|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
64361994|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
64361995|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64361996|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
64361997|NCT03317197|Coagulants|coagulants|mesh-ancestor
64362025|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64362026|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
64362027|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362028|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362029|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362030|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
64362031|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
64362032|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
64362033|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
64362034|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362035|NCT02483143|Expectorants|expectorants|mesh-ancestor
64362036|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
64362037|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64362038|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
64362039|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362040|NCT02483143|Protective Agents|protective agents|mesh-ancestor
64362041|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362043|NCT02483221|Hydromorphone|hydromorphone|mesh-list
64362044|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64362045|NCT02483221|Narcotics|narcotics|mesh-ancestor
64362047|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362049|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
64362050|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362053|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64362054|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64362055|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64362056|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362057|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362065|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64362066|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64362067|NCT05129475|Ritonavir|ritonavir|mesh-list
64362068|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64362069|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64362070|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
64362071|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362072|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362136|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362137|NCT03315091|Adavosertib|adavosertib|mesh-list
64362138|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362139|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362141|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64362142|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362143|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362144|NCT02485327|Insulin|insulin|mesh-list
64362145|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64362147|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362149|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
64362150|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
64362151|NCT02485249|BB 1101|bb 1101|mesh-list
64362152|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362153|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
64362154|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
64362155|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362156|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362191|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
64362192|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64362193|NCT02476981|Analgesics|analgesics|mesh-ancestor
64362194|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
64362195|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362196|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64362197|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64362198|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64362199|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
64362200|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362201|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362202|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64362203|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64362204|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64362205|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64362207|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
64362208|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64362209|NCT02476981|Narcotics|narcotics|mesh-ancestor
64362211|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
64362246|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
64362247|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64362250|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
64362251|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64362252|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362253|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64362255|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64362256|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362257|NCT02479867|Cefadroxil|cefadroxil|mesh-list
64362258|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64362259|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362260|NCT05244837|Paclitaxel|paclitaxel|mesh-list
64362261|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64362262|NCT05244837|Carboplatin|carboplatin|mesh-list
64362263|NCT05244837|Pemetrexed|pemetrexed|mesh-list
64362264|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64362265|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362266|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
64362267|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
64362268|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
64362269|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362270|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362271|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64362272|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64362274|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64362275|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362276|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64362277|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362278|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
64362279|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362282|NCT02479789|Lidocaine|lidocaine|mesh-list
64362290|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64362291|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64362292|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362293|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362294|NCT02726113|Vitamin D|vitamin d|mesh-list
64362295|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
64362296|NCT02726113|Vitamins|vitamins|mesh-ancestor
64362297|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
64362298|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362299|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64362300|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64362301|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64362302|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64362303|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362304|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
64362305|NCT05243355|Endostatins|endostatins|mesh-list
64362306|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362307|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64362308|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64362309|NCT05243355|Growth Substances|growth substances|mesh-ancestor
64362310|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362311|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
64362312|NCT02479711|Methamphetamine|methamphetamine|mesh-list
64362313|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64362314|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362338|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64362339|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64362340|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64362343|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
64362344|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362345|NCT05196945|Expectorants|expectorants|mesh-ancestor
64362346|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
64362347|NCT03800979|Tofacitinib|tofacitinib|mesh-list
64362348|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64362349|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362350|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362351|NCT02476123|Nivolumab|nivolumab|mesh-list
64362352|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
64362353|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64362354|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362355|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64362356|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362357|NCT02481193|Cisatracurium|cisatracurium|mesh-list
64362358|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64362359|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64362360|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362361|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362362|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
64362363|NCT03101709|Fludarabine|fludarabine|mesh-list
64362364|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362373|NCT03101319|Vitamin D|vitamin d|mesh-list
64362385|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
64362386|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
64362387|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362388|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362389|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362390|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
64362391|NCT02479555|Hormones|hormones|mesh-ancestor
64362392|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362450|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
64362451|NCT02480647|Etonogestrel|etonogestrel|mesh-list
64362453|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
64362454|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64362455|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362456|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64362457|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64362458|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64362459|NCT03100071|Apixaban|apixaban|mesh-list
64362460|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64362461|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
64362463|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
64362464|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362465|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362466|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
64362467|NCT02479165|Oxycodone|oxycodone|mesh-list
64362468|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64362470|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362473|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
64362474|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362475|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
64362499|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64362500|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362502|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64362503|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362504|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
64362505|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362506|NCT02475499|Metformin|metformin|mesh-list
64362507|NCT02475499|Pioglitazone|pioglitazone|mesh-list
64362508|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64362509|NCT02475499|Liraglutide|liraglutide|mesh-list
64362510|NCT02475499|Exenatide|exenatide|mesh-list
64362511|NCT02475499|Glimepiride|glimepiride|mesh-list
64362512|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
64362513|NCT02475499|Vildagliptin|vildagliptin|mesh-list
64362514|NCT02475499|Saxagliptin|saxagliptin|mesh-list
64362515|NCT02475499|Acarbose|acarbose|mesh-list
64362516|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
64362517|NCT02475499|Repaglinide|repaglinide|mesh-list
64362518|NCT02475499|Gliclazide|gliclazide|mesh-list
64362519|NCT02475499|Glipizide|glipizide|mesh-list
64362520|NCT02475499|Biguanides|biguanides|mesh-list
64362521|NCT02475499|Tolbutamide|tolbutamide|mesh-list
64362522|NCT02475499|Voglibose|voglibose|mesh-list
64362523|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
64362524|NCT02475499|Nateglinide|nateglinide|mesh-list
64362525|NCT02475499|Miglitol|miglitol|mesh-list
64362526|NCT02475499|Meglitinide|meglitinide|mesh-list
64362527|NCT02475499|Troglitazone|troglitazone|mesh-list
64362528|NCT02475499|Acetohexamide|acetohexamide|mesh-list
64362529|NCT02475499|Phenformin|phenformin|mesh-list
64362530|NCT02475499|Buformin|buformin|mesh-list
64362531|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
64362532|NCT02475499|Glibornuride|glibornuride|mesh-list
64362533|NCT02475499|Tolazamide|tolazamide|mesh-list
64362534|NCT02475499|Carbutamide|carbutamide|mesh-list
64362535|NCT02475499|Gliquidone|gliquidone|mesh-list
64362536|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64362537|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
64362547|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362550|NCT03375645|Narcotics|narcotics|mesh-ancestor
64362551|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362552|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362553|NCT03375645|Analgesics|analgesics|mesh-ancestor
64362554|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
64362555|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362557|NCT03136809|Trace Elements|trace elements|mesh-ancestor
64362558|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
64362559|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362561|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362563|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362564|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362565|NCT03646617|Nivolumab|nivolumab|mesh-list
64362566|NCT03646617|Ipilimumab|ipilimumab|mesh-list
64362567|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64362568|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362569|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64362570|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362571|NCT02475343|Riboflavin|riboflavin|mesh-list
64362572|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
64362573|NCT02475343|Vitamins|vitamins|mesh-ancestor
64362574|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
64362575|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362576|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64362577|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
64362578|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64362579|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64362580|NCT04492501|Remdesivir|remdesivir|mesh-list
64362581|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
64362582|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362583|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
64362584|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362587|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
64362588|NCT03101085|Estrogens|estrogens|mesh-ancestor
64362589|NCT03101085|Hormones|hormones|mesh-ancestor
64362590|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362591|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362592|NCT05070195|Midazolam|midazolam|mesh-list
64362593|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64362594|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64362595|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362596|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362597|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64362598|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64362599|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64362600|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64362601|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
64362602|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
64362603|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
64362604|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
64362605|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362606|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362607|NCT02474953|Curcumin|curcumin|mesh-list
64362608|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64362609|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64362637|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362638|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64362643|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362644|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
64362645|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64362646|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
64362647|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64362648|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
64362649|NCT02478229|Ledipasvir|ledipasvir|mesh-list
64362650|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
64362651|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362653|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64362663|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
64362664|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362665|NCT00653835|Simvastatin|simvastatin|mesh-list
64362666|NCT00653835|Ezetimibe|ezetimibe|mesh-list
64362667|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64362668|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64362669|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
64362670|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362679|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362680|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64362683|NCT05249569|Bavituximab|bavituximab|mesh-list
64362684|NCT05249569|Axitinib|axitinib|mesh-list
64369036|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
64362685|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64362686|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362687|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64362688|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362689|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362690|NCT05244577|Olanzapine|olanzapine|mesh-list
64362691|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
64362692|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
64362693|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362694|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362695|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64362696|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64362697|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64362698|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362699|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64362701|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64362702|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362703|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362704|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64362705|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
64362725|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64362727|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64362728|NCT05067153|Tinzaparin|tinzaparin|mesh-list
64362729|NCT05067153|Dalteparin|dalteparin|mesh-list
64362730|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
64362731|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64362733|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362734|NCT05067309|Letrozole|letrozole|mesh-list
64362735|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362790|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
64362791|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64362792|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362793|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
64362794|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362795|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64362796|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64362797|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64362798|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362799|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362800|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64362802|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
64362806|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
64362848|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362849|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64362850|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64362851|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
64362852|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362853|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362854|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64362855|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64362858|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64362859|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64362860|NCT02725411|Analgesics|analgesics|mesh-ancestor
64362861|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
64362862|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64362870|NCT05058105|Meropenem|meropenem|mesh-list
64362903|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
64362904|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362905|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362906|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64362907|NCT02127970|Dalbavancin|dalbavancin|mesh-list
64362908|NCT02127970|Teicoplanin|teicoplanin|mesh-list
64362909|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64362910|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362911|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
64362912|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362913|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64362914|NCT02471677|Hormones|hormones|mesh-ancestor
64362915|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64362916|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362917|NCT05395507|Interferons|interferons|mesh-list
64362918|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
64362919|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
64362920|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
64362922|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
64362961|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64362962|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64362963|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64362964|NCT03095703|Sirolimus|sirolimus|mesh-list
64362965|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64362966|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64362967|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64362968|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64362969|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
64362970|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64362971|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
64362972|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362974|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64362975|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
64362976|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64362977|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64362978|NCT05035953|Protective Agents|protective agents|mesh-ancestor
64362979|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64362980|NCT02471209|Sevoflurane|sevoflurane|mesh-list
64362981|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64362982|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64362983|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
64363011|NCT03403621|Pentamidine|pentamidine|mesh-list
64363012|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
64363013|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363014|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64363015|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64363016|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64363017|NCT04220125|Midazolam|midazolam|mesh-list
64363018|NCT04220125|Ketamine|ketamine|mesh-list
64363019|NCT04220125|Analgesics|analgesics|mesh-ancestor
64363020|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
64363021|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363022|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363023|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64363024|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64363025|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
64363026|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
64363027|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363028|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64363029|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64363032|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64363067|NCT03043729|Leucovorin|leucovorin|mesh-list
64363068|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
64363069|NCT03043729|Aflibercept|aflibercept|mesh-list
64363070|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363071|NCT03043729|Antidotes|antidotes|mesh-ancestor
64363072|NCT03043729|Protective Agents|protective agents|mesh-ancestor
64363073|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363074|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
64363075|NCT03043729|Vitamins|vitamins|mesh-ancestor
64363076|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
64363077|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64363078|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64363079|NCT03043729|Growth Substances|growth substances|mesh-ancestor
64363080|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
64363082|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
64363084|NCT05306431|Eusol|eusol|mesh-list
64363085|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
64363086|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363087|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64363088|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363089|NCT03108313|Fluorides|fluorides|mesh-list
64363090|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
64363091|NCT03108313|Protective Agents|protective agents|mesh-ancestor
64363093|NCT03108625|Vortioxetine|vortioxetine|mesh-list
64363094|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
64363095|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64363110|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
64363112|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363113|NCT03900949|Cytarabine|cytarabine|mesh-list
64363114|NCT03900949|Daunorubicin|daunorubicin|mesh-list
64363115|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
64363116|NCT03900949|Midostaurin|midostaurin|mesh-list
64363117|NCT03900949|Calicheamicins|calicheamicins|mesh-list
64363119|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64363120|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
64363121|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363122|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363123|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
64363124|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363125|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363174|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363175|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363177|NCT02299999|Vincristine|vincristine|mesh-list
64363178|NCT02299999|Vinorelbine|vinorelbine|mesh-list
64363179|NCT02299999|Vinblastine|vinblastine|mesh-list
64363180|NCT02299999|Docetaxel|docetaxel|mesh-list
64363181|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
64363182|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
64363183|NCT02299999|Bevacizumab|bevacizumab|mesh-list
64363184|NCT02299999|Cisplatin|cisplatin|mesh-list
64363185|NCT02299999|Carboplatin|carboplatin|mesh-list
64363186|NCT02299999|Doxorubicin|doxorubicin|mesh-list
64363187|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64363189|NCT02299999|Methotrexate|methotrexate|mesh-list
64363190|NCT02299999|Durvalumab|durvalumab|mesh-list
64363191|NCT02299999|Epirubicin|epirubicin|mesh-list
64363192|NCT02299999|Olaparib|olaparib|mesh-list
64363193|NCT02299999|Mitomycins|mitomycins|mesh-list
64363194|NCT02299999|Mitomycin|mitomycin|mesh-list
64363195|NCT02299999|Bicalutamide|bicalutamide|mesh-list
64363196|NCT02299999|Taxane|taxane|mesh-list
64363197|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64363198|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363199|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
64363200|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
64363201|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
64363229|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64363230|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
64363231|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
64363232|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363234|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
64363235|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363236|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363237|NCT02263729|Losartan|losartan|mesh-list
64363238|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64363239|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64363240|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64363241|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64363242|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363243|NCT03309865|Vedolizumab|vedolizumab|mesh-list
64363244|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363245|NCT02111941|Vaccines|vaccines|mesh-list
64363246|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
64363247|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363248|NCT02038777|Cytarabine|cytarabine|mesh-list
64363249|NCT02038777|Azacitidine|azacitidine|mesh-list
64363250|NCT02038777|Daunorubicin|daunorubicin|mesh-list
64363251|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64363252|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
64363253|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363254|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363255|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
64363256|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363257|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363259|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363271|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64363272|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363273|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
64363274|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363275|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
64363276|NCT03713593|Lenvatinib|lenvatinib|mesh-list
64363277|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363278|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363279|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64363280|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363281|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363282|NCT03309709|Progesterone|progesterone|mesh-list
64363283|NCT03309709|Progestins|progestins|mesh-ancestor
64363284|NCT03309709|Hormones|hormones|mesh-ancestor
64363285|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363286|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363287|NCT01720147|Quercetin|quercetin|mesh-list
64363288|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
64363289|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363290|NCT01720147|Protective Agents|protective agents|mesh-ancestor
64363291|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363294|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363295|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363296|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
64363297|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363298|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64363299|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363315|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363316|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363317|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
64363319|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64363321|NCT03309163|Analgesics|analgesics|mesh-ancestor
64363322|NCT03304093|Nivolumab|nivolumab|mesh-list
64363323|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363324|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363325|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64363326|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363327|NCT03174847|Eplerenone|eplerenone|mesh-list
64363328|NCT03174847|Amiloride|amiloride|mesh-list
64363329|NCT03174847|Spironolactone|spironolactone|mesh-list
64363330|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
64363331|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
64363332|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
64363333|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363334|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363335|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64363337|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
64363338|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64363339|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64363340|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64363341|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363342|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363343|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64363344|NCT03174847|Hormones|hormones|mesh-ancestor
64363345|NCT03313531|Thrombin|thrombin|mesh-list
64363346|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
64363358|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363359|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64363360|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
64363361|NCT03308149|Hormones|hormones|mesh-ancestor
64363362|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363363|NCT03303235|Methylergonovine|methylergonovine|mesh-list
64363364|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
64363365|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363366|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363367|NCT03089983|Isoniazid|isoniazid|mesh-list
64363368|NCT03089983|Rifapentine|rifapentine|mesh-list
64363369|NCT03089983|Buprenorphine|buprenorphine|mesh-list
64363371|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64363372|NCT03089983|Naloxone|naloxone|mesh-list
64363373|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64363374|NCT03089983|Narcotics|narcotics|mesh-ancestor
64363375|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363376|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363377|NCT03089983|Analgesics|analgesics|mesh-ancestor
64363378|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
64363412|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
64363413|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363414|NCT03307603|Nivolumab|nivolumab|mesh-list
64363415|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64363482|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
64363483|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64363484|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
64363485|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363486|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363487|NCT03306745|Folic Acid|folic acid|mesh-list
64363551|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
64363552|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363553|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
64363554|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363555|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363556|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
64363557|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64363558|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64363559|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64363560|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64363615|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
64363616|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64363617|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
64363618|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363619|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363620|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64363621|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
64363622|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363623|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363624|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
64363625|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363626|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64363627|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363628|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
64363629|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363630|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64363671|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64363673|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363674|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363675|NCT03299725|Bismuth|bismuth|mesh-list
64363676|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363677|NCT03299725|Antacids|antacids|mesh-ancestor
64363678|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363679|NCT02466997|Tacrolimus|tacrolimus|mesh-list
64363680|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363681|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
64363683|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64363684|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363685|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363686|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
64363687|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64363688|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64363689|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64363697|NCT03299257|Donepezil|donepezil|mesh-list
64363726|NCT05378269|Tamoxifen|tamoxifen|mesh-list
64363727|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64363728|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
64363729|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363730|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363731|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64363732|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363733|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64363734|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64363735|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64363737|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363738|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363739|NCT02466919|Amoxicillin|amoxicillin|mesh-list
64363743|NCT02466919|Ofloxacin|ofloxacin|mesh-list
64363785|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64363786|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64363787|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
64363788|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363789|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64363790|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64363791|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
64363792|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64363793|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64363794|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363795|NCT05727163|Antidotes|antidotes|mesh-ancestor
64363796|NCT05727163|Protective Agents|protective agents|mesh-ancestor
64363797|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
64363798|NCT05727163|Vitamins|vitamins|mesh-ancestor
64363799|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
64363800|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64363801|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64363802|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
64363803|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363804|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64363805|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64363806|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64363808|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
64363809|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64363810|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64363811|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
64363812|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
64363813|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64363815|NCT05259709|Cemiplimab|cemiplimab|mesh-list
64363817|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363828|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64363829|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64363830|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363831|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363832|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363834|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64363836|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64363837|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64363839|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64363840|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64363841|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
64363842|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363843|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64380626|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64363845|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363847|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
64363848|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
64363849|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64363878|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64363879|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64363880|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363881|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363882|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64363883|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64363884|NCT02464813|Narcotics|narcotics|mesh-ancestor
64363885|NCT05726929|Capsaicin|capsaicin|mesh-list
64363886|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
64363887|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
64363888|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
64363889|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363890|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363891|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
64363892|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
64363893|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64363894|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
64363895|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64363896|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363897|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64363898|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
64363899|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64363900|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64363901|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64363902|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64363903|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64363904|NCT05122351|Acetaminophen|acetaminophen|mesh-list
64363905|NCT05122351|Bupivacaine|bupivacaine|mesh-list
64363907|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
64363908|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363909|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363919|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
64363920|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
64363921|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363923|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
64363924|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
64363925|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363926|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363927|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
64363928|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64363929|NCT04368403|Brodalumab|brodalumab|mesh-list
64363931|NCT04298203|Topiramate|topiramate|mesh-list
64363932|NCT04298203|Phentermine|phentermine|mesh-list
64363933|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
64363934|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64363935|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363936|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64363937|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
64363938|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64363939|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
64363940|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
64363942|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
64363943|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363944|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363945|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
64363946|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64363947|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64363965|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64363966|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
64363967|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64363968|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363969|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363972|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
64363973|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64363974|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363975|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64363976|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
64363977|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64363978|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64363979|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64363980|NCT02463643|Rabeprazole|rabeprazole|mesh-list
64363981|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64363982|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64363983|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64363984|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64363985|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364017|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364018|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64364019|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
64364020|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64364021|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
64364022|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
64364024|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364025|NCT04042831|Olaparib|olaparib|mesh-list
64364026|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
64364027|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380628|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64380629|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64380630|NCT02910843|Capecitabine|capecitabine|mesh-list
64380631|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64380635|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64380636|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
64380637|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64380651|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364028|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364030|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
64364031|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64364032|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64364033|NCT04824391|Vaccines|vaccines|mesh-list
64364034|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
64364035|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364036|NCT03297073|Acetaminophen|acetaminophen|mesh-list
64364037|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64364038|NCT03297073|Analgesics|analgesics|mesh-ancestor
64364039|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
64364042|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
64364043|NCT02462317|Baclofen|baclofen|mesh-list
64364044|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64364046|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64364048|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64364061|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
64364062|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364063|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
64364066|NCT03337087|Fluorouracil|fluorouracil|mesh-list
64364067|NCT03337087|Irinotecan|irinotecan|mesh-list
64364068|NCT03337087|Rucaparib|rucaparib|mesh-list
64364069|NCT03337087|Calcium|calcium|mesh-list
64364070|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
64364071|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64364072|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364073|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64364074|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
64364075|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364076|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64364077|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364078|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364079|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
64364080|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64364081|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64364082|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364084|NCT03337087|Protective Agents|protective agents|mesh-ancestor
64364085|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
64364086|NCT03337087|Vitamins|vitamins|mesh-ancestor
64364087|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
64364088|NCT03337087|Hematinics|hematinics|mesh-ancestor
64380652|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380653|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64380654|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380656|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64380657|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64380658|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380659|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380660|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380661|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64380662|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
64380664|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380665|NCT02577003|Incretins|incretins|mesh-ancestor
64380666|NCT02577003|Hormones|hormones|mesh-ancestor
64380667|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380668|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64380670|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380671|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380672|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64380673|NCT05487417|Minocycline|minocycline|mesh-list
64380674|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364089|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64364091|NCT03332095|Lamivudine|lamivudine|mesh-list
64364092|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
64364093|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
64364108|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364109|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364110|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
64364111|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
64364112|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64364113|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64364114|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364116|NCT04488367|Coagulants|coagulants|mesh-ancestor
64364117|NCT03734653|Testosterone|testosterone|mesh-list
64364119|NCT03734653|Hormones|hormones|mesh-ancestor
64364175|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364177|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64364178|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
64364179|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364180|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
64364181|NCT03290365|Protective Agents|protective agents|mesh-ancestor
64364182|NCT02764489|Thrombin|thrombin|mesh-list
64364183|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
64364184|NCT02764489|Coagulants|coagulants|mesh-list
64364185|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
64364186|NCT02462161|Insulin|insulin|mesh-list
64364187|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64364188|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
64364189|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
64364190|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
64364191|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64364192|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364193|NCT03289819|Paclitaxel|paclitaxel|mesh-list
64364232|NCT03372785|Analgesics|analgesics|mesh-ancestor
64364233|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
64364234|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364235|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364236|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64364237|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64364238|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64364239|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64364240|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364241|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64364242|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64364243|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364244|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
64364245|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64364246|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64364248|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64364249|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64364250|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64364251|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64364252|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64364253|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
64364254|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364255|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64364256|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64364257|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
64364258|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
64364275|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364276|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64364277|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64364278|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64364279|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
64364280|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
64364281|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364282|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
64364284|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64364285|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64364286|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
64364287|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364288|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64364289|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64364290|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364292|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
64364293|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364294|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364295|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
64364296|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364297|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64364298|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
64364299|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64364300|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364301|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64364303|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64364304|NCT03372239|Tryptophan|tryptophan|mesh-list
64364305|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64364306|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
64364307|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64364316|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364317|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64364318|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64364319|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
64364320|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364321|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
64364322|NCT03294967|Protective Agents|protective agents|mesh-ancestor
64364323|NCT03371849|Montelukast|montelukast|mesh-list
64364324|NCT03371849|Levocetirizine|levocetirizine|mesh-list
64364325|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64364327|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64364328|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377760|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64377761|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64377762|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377763|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377764|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64377765|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377766|NCT04836819|Analgesics|analgesics|mesh-ancestor
64364329|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364330|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364331|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64364332|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64364333|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364367|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64364368|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64364369|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364371|NCT03370835|Carvedilol|carvedilol|mesh-list
64364372|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64364374|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
64364375|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
64364377|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364378|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64364379|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64364380|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64364381|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
64364382|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364384|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
64364385|NCT03370835|Protective Agents|protective agents|mesh-ancestor
64364386|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64364387|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364388|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64364389|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
64364390|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64364418|NCT03370367|Isotretinoin|isotretinoin|mesh-list
64364419|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364420|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
64364421|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364422|NCT03376529|Tazobactam|tazobactam|mesh-list
64364423|NCT03376529|Piperacillin|piperacillin|mesh-list
64364424|NCT03376529|Ceftazidime|ceftazidime|mesh-list
64364425|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
64364428|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364429|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64364430|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364433|NCT04132661|Cathartics|cathartics|mesh-ancestor
64364434|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64364435|NCT04132661|Laxatives|laxatives|mesh-ancestor
64364436|NCT03700541|Morphine|morphine|mesh-list
64364437|NCT03700541|Pirinitramide|pirinitramide|mesh-list
64364438|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64364439|NCT03700541|Narcotics|narcotics|mesh-ancestor
64364440|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364441|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364442|NCT03700541|Analgesics|analgesics|mesh-ancestor
64364443|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
64364444|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364445|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64364462|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364466|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364467|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364469|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364470|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364471|NCT02730455|Natalizumab|natalizumab|mesh-list
64364472|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
64364473|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364474|NCT03376139|Zonisamide|zonisamide|mesh-list
64364475|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
64364476|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64364477|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364478|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364479|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64364482|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64364483|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
64364484|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64364485|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
64364486|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364487|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364488|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64364489|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64364490|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364504|NCT03293641|Hematinics|hematinics|mesh-ancestor
64364505|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
64364507|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
64364508|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364510|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
64364511|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364512|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364513|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64364522|NCT02519543|Metformin|metformin|mesh-list
64364565|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64364566|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64364567|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364568|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364569|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64364570|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64364571|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64364572|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64364573|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64364575|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
64364577|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
64364578|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64364579|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64364580|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64364581|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
64364582|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64364583|NCT03375593|Acetaminophen|acetaminophen|mesh-list
64364584|NCT03375593|Ibuprofen|ibuprofen|mesh-list
64364585|NCT03375593|Oxycodone|oxycodone|mesh-list
64364586|NCT03375593|Hydrocodone|hydrocodone|mesh-list
64364587|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64364588|NCT03375593|Analgesics|analgesics|mesh-ancestor
64364589|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
64364590|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364591|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364600|NCT03375593|Narcotics|narcotics|mesh-ancestor
64364617|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64364618|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64364619|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
64364620|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
64364621|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
64364622|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
64364623|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364624|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364625|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64364626|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64364627|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364628|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64364629|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64364630|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
64364631|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64364632|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64364633|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64364634|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64364635|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
64364636|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64364637|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64364638|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
64364639|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64369138|NCT05019417|Protective Agents|protective agents|mesh-ancestor
64364640|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64364641|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64364642|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64364643|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64364644|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64364645|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64364647|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64364648|NCT04525235|Protective Agents|protective agents|mesh-ancestor
64364649|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
64364650|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
64364655|NCT03363815|Metformin|metformin|mesh-list
64364659|NCT03363815|Omeprazole|omeprazole|mesh-list
64364660|NCT03363815|Warfarin|warfarin|mesh-list
64364661|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64364662|NCT03363815|Vitamins|vitamins|mesh-ancestor
64364663|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
64364664|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364665|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64364666|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64364667|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64364668|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364669|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64364670|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64364671|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64364672|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64364673|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
64364674|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
64364675|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
64364676|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
64364677|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364678|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364679|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64364680|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64364708|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64364709|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64364710|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364712|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
64364713|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
64364714|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
64364715|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64364716|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364717|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
64364718|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364720|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64364721|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64364722|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64364723|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364724|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64364725|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64364726|NCT03363425|Analgesics|analgesics|mesh-ancestor
64364727|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64364729|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64364730|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
64364731|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364732|NCT02459977|Basiliximab|basiliximab|mesh-list
64364733|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64364734|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
64364735|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364752|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64364753|NCT03363191|Fluticasone|fluticasone|mesh-list
64364754|NCT03363191|Xhance|xhance|mesh-list
64364755|NCT03363191|Albuterol|albuterol|mesh-list
64364756|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64364757|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64364758|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
64364759|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64364760|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364761|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64364762|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
64364763|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64364764|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64364766|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64364813|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64364816|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64364817|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64364818|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364819|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364820|NCT04527055|Antacids|antacids|mesh-ancestor
64364821|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64364822|NCT02518763|Vitamin D|vitamin d|mesh-list
64364823|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
64364824|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
64364825|NCT02518763|Vitamins|vitamins|mesh-list
64364826|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
64364827|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364828|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64364829|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64364830|NCT04019093|Ethanol|ethanol|mesh-list
64364831|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64364835|NCT03362411|Linrodostat|linrodostat|mesh-list
64364869|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364870|NCT04523675|Protective Agents|protective agents|mesh-ancestor
64364871|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364872|NCT04523675|Antidotes|antidotes|mesh-ancestor
64364873|NCT03298009|Canagliflozin|canagliflozin|mesh-list
64364874|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64364875|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364876|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64364877|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364878|NCT03291145|Spironolactone|spironolactone|mesh-list
64364879|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
64364880|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64364881|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
64364882|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64364883|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364884|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64364885|NCT03291145|Diuretics|diuretics|mesh-ancestor
64364886|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
64364923|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64364925|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64364926|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364927|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
64364928|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
64364929|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
64364930|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364931|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64364932|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64364933|NCT04489147|Metformin|metformin|mesh-list
64364934|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64364935|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364984|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64364985|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64364986|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
64364987|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64364988|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364989|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64364991|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64364993|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
64364994|NCT03365765|Apatinib|apatinib|mesh-list
64364995|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
64364996|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64364997|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64364998|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64364999|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365000|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
64365001|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365003|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365004|NCT03297463|Ipilimumab|ipilimumab|mesh-list
64365005|NCT03297463|Interleukin-2|interleukin-2|mesh-list
64365006|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64365007|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365008|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64365009|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365010|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365011|NCT03297463|Analgesics|analgesics|mesh-ancestor
64365012|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
64365013|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365028|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365029|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
64365030|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365031|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
64365032|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
64365033|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
64365034|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64365036|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365037|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
64365038|NCT02458729|Coagulants|coagulants|mesh-ancestor
64365039|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64365040|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
64365041|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64365042|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
64365091|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
64365092|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
64365093|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365094|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365095|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
64365096|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64365097|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365098|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365099|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365100|NCT02459509|Analgesics|analgesics|mesh-ancestor
64365101|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
64365102|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365103|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64365104|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64365106|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
64365147|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64365148|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
64365149|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
64365150|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64365151|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365152|NCT02730377|Incretins|incretins|mesh-ancestor
64365153|NCT02730377|Hormones|hormones|mesh-ancestor
64365154|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365155|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365156|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
64365157|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365158|NCT03264547|Paclitaxel|paclitaxel|mesh-list
64365159|NCT03264547|Docetaxel|docetaxel|mesh-list
64365160|NCT03264547|Trastuzumab|trastuzumab|mesh-list
64365161|NCT03264547|Pertuzumab|pertuzumab|mesh-list
64365162|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64365163|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365164|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
64365165|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
64365166|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
64365167|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365168|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64365169|NCT03365141|Triamcinolone|triamcinolone|mesh-list
64365170|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64365171|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64365195|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365196|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365197|NCT03359837|Insulin|insulin|mesh-list
64365198|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64365199|NCT03359837|Metformin|metformin|mesh-list
64365200|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
64365201|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
64365202|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
64365203|NCT03359837|Acarbose|acarbose|mesh-list
64365204|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64365205|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
64365206|NCT03359837|Repaglinide|repaglinide|mesh-list
64365207|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64365208|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365209|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
64365210|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365211|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365212|NCT03359681|Metformin|metformin|mesh-list
64365213|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64365214|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365215|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
64365216|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64365217|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64365218|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365220|NCT03359525|Coagulants|coagulants|mesh-ancestor
64365221|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
64365222|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64365223|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64365224|NCT03359291|Macitentan|macitentan|mesh-list
64365225|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64365226|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64365227|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
64365237|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
64365239|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365240|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64365241|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64365242|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64365243|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64365245|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
64365246|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
64365247|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
64365248|NCT03359057|Estradiol|estradiol|mesh-list
64365249|NCT03359057|Estrogens|estrogens|mesh-ancestor
64365250|NCT03359057|Hormones|hormones|mesh-ancestor
64365251|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365253|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64365254|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
64365294|NCT03280927|Efinaconazole|efinaconazole|mesh-list
64365295|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
64365296|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365297|NCT03269383|Bupivacaine|bupivacaine|mesh-list
64365298|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365299|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
64365300|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365301|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365302|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
64365303|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365304|NCT03280849|Chitosan|chitosan|mesh-list
64365305|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64365306|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64365307|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
64365308|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365309|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64365310|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
64365311|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
64365312|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
64365313|NCT03280849|Coagulants|coagulants|mesh-ancestor
64365314|NCT04521491|Leucovorin|leucovorin|mesh-list
64365315|NCT04521491|Fluorouracil|fluorouracil|mesh-list
64365316|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
64365317|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
64365318|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365319|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365320|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365321|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365322|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
64365323|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365324|NCT04521491|Antidotes|antidotes|mesh-ancestor
64365325|NCT04521491|Protective Agents|protective agents|mesh-ancestor
64365326|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
64365327|NCT04521491|Vitamins|vitamins|mesh-ancestor
64365328|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
64365329|NCT04509635|Cetuximab|cetuximab|mesh-list
64365330|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64365335|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365336|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64365337|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365338|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365340|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
64365341|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365342|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64365343|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64365344|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365345|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365346|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64365347|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
64365348|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365349|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365350|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64365351|NCT04509323|Huperzine A|huperzine a|mesh-list
64365352|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64365353|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365354|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365355|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
64365356|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365357|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365358|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64365359|NCT04509323|Protective Agents|protective agents|mesh-ancestor
64365360|NCT04443647|Oxytocin|oxytocin|mesh-list
64365361|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
64365362|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64365363|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365366|NCT02458339|Methotrexate|methotrexate|mesh-list
64365375|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
64365376|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365377|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64365378|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365379|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
64365380|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365381|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64365382|NCT03268525|Bupivacaine|bupivacaine|mesh-list
64365383|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365384|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
64365385|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365388|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365389|NCT02456935|Esomeprazole|esomeprazole|mesh-list
64365390|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64365391|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64365392|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64365393|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365394|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365395|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64365396|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64365397|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369195|NCT05004909|Tretinoin|tretinoin|mesh-list
64365398|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
64365425|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365426|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365427|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365428|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365429|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64365430|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64365431|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365432|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64365433|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64365434|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365436|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64365437|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64365486|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64365487|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365488|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365489|NCT03984955|Mannitol|mannitol|mesh-list
64365490|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
64365491|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64365492|NCT03984955|Diuretics|diuretics|mesh-ancestor
64365493|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
64365494|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365495|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64365496|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
64365497|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
64365498|NCT03984955|Protective Agents|protective agents|mesh-ancestor
64365499|NCT03946969|Paclitaxel|paclitaxel|mesh-list
64365500|NCT03946969|Cisplatin|cisplatin|mesh-list
64365501|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64365502|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365503|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
64365504|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
64365505|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
64365506|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365539|NCT03266965|Carbidopa|carbidopa|mesh-list
64365540|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64365541|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64365542|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
64365543|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365544|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365545|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365546|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
64365547|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365550|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64365551|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365552|NCT03266731|Analgesics|analgesics|mesh-ancestor
64365553|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
64365554|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365555|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365556|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365557|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365558|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64365559|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64365560|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365561|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64365562|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64365564|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
64365565|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64365566|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64365567|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64365568|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
64365569|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365570|NCT02458963|Menotropins|menotropins|mesh-list
64365571|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64365575|NCT04507607|Tenofovir|tenofovir|mesh-list
64365579|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64365580|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365581|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365582|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64365583|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64365584|NCT03353441|Glycine|glycine|mesh-list
64365585|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
64365586|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365587|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365588|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365589|NCT03353363|Bupivacaine|bupivacaine|mesh-list
64365590|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365591|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
64365592|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365593|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365594|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
64365595|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365596|NCT04511195|Diclofenac|diclofenac|mesh-list
64365597|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64365598|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365599|NCT04511195|Analgesics|analgesics|mesh-ancestor
64365600|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
64365601|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365602|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365603|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365604|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365605|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64365606|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365624|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64365626|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64365627|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365628|NCT03262363|Analgesics|analgesics|mesh-ancestor
64365629|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
64365630|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365631|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365632|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365633|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64365634|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365635|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365636|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365638|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64365640|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365641|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
64365642|NCT04506827|Protective Agents|protective agents|mesh-ancestor
64365643|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
64365644|NCT03352895|Resveratrol|resveratrol|mesh-list
64365645|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
64365646|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365647|NCT03352895|Protective Agents|protective agents|mesh-ancestor
64365648|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365649|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365650|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64365651|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64365655|NCT03350633|Azathioprine|azathioprine|mesh-list
64365669|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365671|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
64365672|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365673|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
64365674|NCT03350321|Hematinics|hematinics|mesh-ancestor
64365675|NCT03352349|Terlipressin|terlipressin|mesh-list
64365676|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64365677|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64365678|NCT03265171|Plasminogen|plasminogen|mesh-list
64365679|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64365680|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64365681|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365682|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
64365683|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365684|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64365685|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365686|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365687|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64365688|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64365689|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64365690|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
64365691|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365692|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64365693|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64365694|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365695|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64365696|NCT04669561|Lifitegrast|lifitegrast|mesh-list
64365697|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64365698|NCT02729909|Lubiprostone|lubiprostone|mesh-list
64365699|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64365711|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
64365712|NCT03252457|Decitabine|decitabine|mesh-list
64365713|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64365714|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
64365715|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
64365716|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365717|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365718|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64365719|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
64365720|NCT03252457|Hormones|hormones|mesh-ancestor
64365722|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64365723|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365724|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365725|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
64365772|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365773|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365774|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64365775|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64365776|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
64365777|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64365778|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64365780|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64365781|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365782|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365783|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64365784|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
64365786|NCT03349619|Resveratrol|resveratrol|mesh-list
64365787|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
64365788|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365789|NCT03349619|Protective Agents|protective agents|mesh-ancestor
64365790|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365793|NCT04505657|Celecoxib|celecoxib|mesh-list
64377767|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64377768|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64377769|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64377770|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
64377771|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377772|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64377773|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64377774|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
64377775|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64377776|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64365827|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365828|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
64365829|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
64365831|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365832|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365833|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
64365834|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365835|NCT02456701|Vemurafenib|vemurafenib|mesh-list
64365836|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365837|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64365838|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365839|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365840|NCT03252067|Azithromycin|azithromycin|mesh-list
64365841|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64365842|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64365843|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365844|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64365845|NCT03252223|Hormones|hormones|mesh-list
64365846|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64365847|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365848|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365849|NCT05513807|Niacinamide|niacinamide|mesh-list
64365850|NCT05513807|Niacin|niacin|mesh-list
64365851|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
64365852|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
64365853|NCT05513807|Vitamins|vitamins|mesh-ancestor
64365854|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
64365855|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365856|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64365870|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365872|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64365873|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
64365874|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
64365875|NCT05505617|Protective Agents|protective agents|mesh-ancestor
64365876|NCT04504877|Cannabidiol|cannabidiol|mesh-list
64365877|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
64365878|NCT02518295|Sulfalene|sulfalene|mesh-list
64365879|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377777|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
64377778|NCT04836507|Fludarabine|fludarabine|mesh-list
64377779|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377780|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
64377781|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377782|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377783|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64377784|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
64377788|NCT04835259|Selenium|selenium|mesh-list
64377792|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377793|NCT04835259|Trace Elements|trace elements|mesh-ancestor
64377794|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
64377795|NCT04853901|Remdesivir|remdesivir|mesh-list
64377796|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377797|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377798|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
64377799|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
64377800|NCT04834791|Letrozole|letrozole|mesh-list
64377801|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377802|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64365880|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64365881|NCT02518295|Renal Agents|renal agents|mesh-ancestor
64365882|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
64365883|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64365884|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64365885|NCT03257683|Ranolazine|ranolazine|mesh-list
64365886|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64365887|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64365888|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365889|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
64365890|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64365891|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377803|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64377804|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377805|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377806|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64377808|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377809|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377810|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64377811|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377812|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377813|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
64377814|NCT03038919|Testosterone|testosterone|mesh-list
64377815|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
64377816|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
64377818|NCT03038919|Androgens|androgens|mesh-ancestor
64377838|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377839|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64377840|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64377841|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
64377842|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377843|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64377844|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377845|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64377846|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64377847|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64377848|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
64377849|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64377850|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64377851|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64365892|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365893|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
64365894|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64365895|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365897|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64365898|NCT03351569|Antibodies|antibodies|mesh-list
64365899|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
64365900|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64365901|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
64365913|NCT03251365|Gemcitabine|gemcitabine|mesh-list
64365914|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365915|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
64377852|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64377854|NCT04833777|Bupivacaine|bupivacaine|mesh-list
64377855|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
64377856|NCT04833777|Anesthetics|anesthetics|mesh-list
64377857|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64377858|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377859|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
64377860|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377861|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64377862|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64377863|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64377864|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377881|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64377883|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377884|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377885|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64377886|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64377887|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377888|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64377890|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
64377891|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
64377892|NCT04365933|Entecavir|entecavir|mesh-list
64377893|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64377894|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377895|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
64377896|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365916|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365917|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365918|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
64365919|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365920|NCT03251365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365921|NCT03251365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365922|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
64365923|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365924|NCT03251443|Apatinib|apatinib|mesh-list
64365925|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365926|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64365927|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365928|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365929|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64365930|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64365931|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365932|NCT05350943|Gemcitabine|gemcitabine|mesh-list
64365933|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
64365934|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64365935|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
64365936|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365937|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64365938|NCT05350943|Antiviral Agents|antiviral agents|mesh-ancestor
64365939|NCT05350943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64365940|NCT05350943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64365941|NCT05350943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64365942|NCT05350943|Immunologic Factors|immunologic factors|mesh-ancestor
64365955|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64365956|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365957|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64365958|NCT03261115|Anesthetics|anesthetics|mesh-list
64365959|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64365960|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365961|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
64365962|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
64365963|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377897|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
64377898|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377899|NCT04824261|Clotrimazole|clotrimazole|mesh-list
64377900|NCT04824261|Miconazole|miconazole|mesh-list
64377901|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64377902|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377903|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
64377904|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64377905|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377906|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377907|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377908|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64365964|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64365965|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365966|NCT05320133|Bismuth|bismuth|mesh-list
64365967|NCT05320133|Antacids|antacids|mesh-ancestor
64365968|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64365969|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64365970|NCT03122561|Acetaminophen|acetaminophen|mesh-list
64365971|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64365972|NCT03122561|Analgesics|analgesics|mesh-ancestor
64365973|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
64365974|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365975|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365976|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
64365977|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
64365978|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64365979|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
64365980|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64365981|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64365982|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64365983|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
64365984|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64365999|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64366000|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
64366001|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
64366002|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366003|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366004|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
64366005|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64366007|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64366008|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366009|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366010|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366011|NCT05231603|Ivermectin|ivermectin|mesh-list
64366012|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64366013|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366014|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64366015|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64366016|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366017|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
64366018|NCT03467113|Cannabidiol|cannabidiol|mesh-list
64366019|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
64366020|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64366021|NCT03434041|Citalopram|citalopram|mesh-list
64366022|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
64366023|NCT03434041|Sertraline|sertraline|mesh-list
64366024|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
64366025|NCT03434041|Esketamine|esketamine|mesh-list
64366026|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64366027|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64366028|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64366029|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366030|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366031|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
64366032|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366034|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64366040|NCT03250741|Rotigotine|rotigotine|mesh-list
64366041|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
64366042|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
64366043|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366044|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366045|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366046|NCT03255811|Apatinib|apatinib|mesh-list
64366047|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366048|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64366049|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366050|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366051|NCT02015117|Trametinib|trametinib|mesh-list
64366052|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366053|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64366054|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366055|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366056|NCT01842035|Regadenoson|regadenoson|mesh-list
64366057|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
64366058|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64366059|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
64366060|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
64366061|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366062|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366063|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366064|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
64366065|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366066|NCT05585177|Hormones|hormones|mesh-list
64366067|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366068|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366069|NCT03250039|Abrocitinib|abrocitinib|mesh-list
64366079|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366080|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64366081|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
64366082|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366083|NCT03246451|Metformin|metformin|mesh-list
64366084|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366085|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366086|NCT05013437|Acetaminophen|acetaminophen|mesh-list
64366087|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
64366088|NCT05013437|Promethazine|promethazine|mesh-list
64366089|NCT05013437|Melphalan|melphalan|mesh-list
64366090|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
64377909|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377910|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377911|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377912|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64377913|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64377919|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
64377920|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377922|NCT04850001|Clopidogrel|clopidogrel|mesh-list
64377923|NCT04850001|Atorvastatin|atorvastatin|mesh-list
64366093|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
64366094|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366095|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366097|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64366098|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
64366099|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366100|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366101|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64366102|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64366103|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
64366131|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64366132|NCT03346187|Atorvastatin|atorvastatin|mesh-list
64366133|NCT03346187|Fenofibrate|fenofibrate|mesh-list
64366134|NCT03346187|Calcium|calcium|mesh-list
64366135|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64366136|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366137|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64366138|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64366139|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
64366140|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366141|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64366142|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64366143|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366145|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366146|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366147|NCT04487743|Incretins|incretins|mesh-ancestor
64366148|NCT04487743|Hormones|hormones|mesh-ancestor
64366149|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366150|NCT05010629|Carboplatin|carboplatin|mesh-list
64366188|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64366189|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
64366190|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
64366192|NCT02455921|Neostigmine|neostigmine|mesh-list
64366193|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64366194|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64366195|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64366196|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
64366197|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366198|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366199|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64366200|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
64366201|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
64366202|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
64366203|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64366204|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64366205|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
64366206|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366207|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366217|NCT04767191|Lumefantrine|lumefantrine|mesh-list
64366232|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
64366303|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64366304|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64366305|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
64366306|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366307|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
64366308|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64366309|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64366310|NCT03245671|Dexamethasone|dexamethasone|mesh-list
64366314|NCT03245671|BB 1101|bb 1101|mesh-list
64366343|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64366344|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64366345|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
64366346|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366347|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366348|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64366349|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
64366350|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
64366351|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64366352|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64366353|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64366354|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64366355|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
64366356|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366357|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366358|NCT03248791|Phenylephrine|phenylephrine|mesh-list
64366359|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
64366360|NCT03248791|Norepinephrine|norepinephrine|mesh-list
64366361|NCT03248791|Bupivacaine|bupivacaine|mesh-list
64366362|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
64366363|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
64366364|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366365|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366366|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
64366367|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366368|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64366369|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
64366370|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
64366371|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
64366372|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64366373|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
64366387|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
64366388|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366389|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366390|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366391|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64366392|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64366393|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366394|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
64366395|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64366396|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64366398|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64366399|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64366400|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
64366448|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64366449|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
64366450|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366451|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366452|NCT03245281|Diuretics|diuretics|mesh-list
64369301|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64366453|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
64366454|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366455|NCT02515955|Minocycline|minocycline|mesh-list
64366456|NCT02515955|Amphetamine|amphetamine|mesh-list
64366457|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
64366458|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64366459|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366460|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64366461|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366462|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
64366463|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
64366464|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366465|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
64366466|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366467|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366502|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64366503|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
64366504|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366505|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64366506|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366507|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
64366508|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366509|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
64366510|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64366511|NCT03347591|Protective Agents|protective agents|mesh-ancestor
64366513|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64366514|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64366516|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366517|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366519|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
64366520|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366521|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366522|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366523|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
64366524|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
64366525|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366526|NCT04088591|Protective Agents|protective agents|mesh-ancestor
64366527|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366528|NCT04088591|Vitamins|vitamins|mesh-ancestor
64366529|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
64366530|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
64366546|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64366547|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64366548|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366549|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
64366550|NCT03244423|Coagulants|coagulants|mesh-ancestor
64366551|NCT04501367|Dexamethasone|dexamethasone|mesh-list
64366552|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
64366553|NCT04501367|Prednisone|prednisone|mesh-list
64366554|NCT04501367|BB 1101|bb 1101|mesh-list
64366555|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64366556|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
64366557|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
64366558|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366559|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366560|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366561|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
64366562|NCT04501367|Hormones|hormones|mesh-ancestor
64366563|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366564|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64366565|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366566|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
64366567|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366568|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366569|NCT03347357|Tacrolimus|tacrolimus|mesh-list
64366570|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64366571|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
64366572|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366573|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64366574|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366575|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366576|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
64366577|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366578|NCT02515877|Carboplatin|carboplatin|mesh-list
64366579|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366580|NCT03952091|Dexamethasone|dexamethasone|mesh-list
64366581|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
64366583|NCT03952091|BB 1101|bb 1101|mesh-list
64366584|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64366586|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
64366587|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366588|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366589|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64366590|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
64366591|NCT03952091|Hormones|hormones|mesh-ancestor
64366592|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366593|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64366594|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366595|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
64366596|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366597|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366598|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
64366599|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64366600|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64366601|NCT03952091|Growth Substances|growth substances|mesh-ancestor
64366602|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
64366604|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
64366605|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64366606|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366607|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
64366608|NCT04502537|Hematinics|hematinics|mesh-ancestor
64366609|NCT02453659|Nicotine|nicotine|mesh-list
64366610|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64366612|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366613|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366627|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366628|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366629|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64366630|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64366631|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
64366632|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366633|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64366634|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64366635|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64366636|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64366637|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
64366638|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64366639|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
64378039|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
64378040|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378041|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378055|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378056|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64378057|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64378058|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64378059|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
64378060|NCT03976245|Etanercept|etanercept|mesh-list
64378061|NCT03976245|Tofacitinib|tofacitinib|mesh-list
64378062|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64378063|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64378064|NCT03976245|Analgesics|analgesics|mesh-ancestor
64378065|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
64378066|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378067|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378068|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378069|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378070|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378071|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64366640|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366641|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64366642|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
64366643|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64366644|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366645|NCT02453893|Risperidone|risperidone|mesh-list
64366646|NCT02453893|Iloperidone|iloperidone|mesh-list
64366647|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64366648|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
64366649|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366650|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366651|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366652|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64366653|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64366654|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366655|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64366656|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64366657|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
64366659|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64366660|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366666|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366667|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64366668|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64366669|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
64366670|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366671|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366672|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
64366673|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
64366674|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
64366675|NCT02454205|Levofloxacin|levofloxacin|mesh-list
64366676|NCT02454205|Ofloxacin|ofloxacin|mesh-list
64366677|NCT02454205|Isoniazid|isoniazid|mesh-list
64366679|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
64366680|NCT02454205|Bedaquiline|bedaquiline|mesh-list
64366681|NCT02454205|Ethionamide|ethionamide|mesh-list
64366682|NCT02454205|Kanamycin|kanamycin|mesh-list
64366683|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64366684|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366685|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64366686|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64366691|NCT02454205|Renal Agents|renal agents|mesh-ancestor
64366723|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366724|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366725|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
64366726|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
64366727|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
64366728|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366729|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
64366731|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366732|NCT03243643|Apatinib|apatinib|mesh-list
64366733|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366734|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64366735|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366736|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366737|NCT03234517|Clindamycin|clindamycin|mesh-list
64366738|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
64366739|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
64366740|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64366741|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366742|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64366743|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366744|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366745|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
64366746|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64366747|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
64366748|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366749|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
64366750|NCT03238183|Protective Agents|protective agents|mesh-ancestor
64366751|NCT02729051|Albuterol|albuterol|mesh-list
64366768|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64366769|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64366770|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
64366771|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366772|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366773|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366774|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64366775|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64366776|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
64366778|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
64366779|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378072|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
64378073|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64378074|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378075|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378076|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
64378077|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
64378078|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
64378079|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378080|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64378081|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
64378082|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
64378083|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378084|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378085|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378087|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
64378098|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
64380675|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380676|NCT03471611|Lenograstim|lenograstim|mesh-list
64380677|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64380678|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
64380679|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380680|NCT05694819|Goserelin|goserelin|mesh-list
64380681|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64380682|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380690|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
64380691|NCT02600897|Lenalidomide|lenalidomide|mesh-list
64380693|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380694|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
64380695|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380696|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64366780|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
64366781|NCT03243331|Gedatolisib|gedatolisib|mesh-list
64366782|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64366783|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366784|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366785|NCT03345095|Temozolomide|temozolomide|mesh-list
64366786|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64366787|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
64366788|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366789|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366790|NCT03237715|Bilirubin|bilirubin|mesh-list
64366791|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
64366817|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366818|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64366819|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64366820|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64366821|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366822|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366823|NCT03233815|Propofol|propofol|mesh-list
64366824|NCT03233815|Sevoflurane|sevoflurane|mesh-list
64366825|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64366826|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366827|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366828|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64366829|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
64366830|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
64366831|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64366832|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64366833|NCT02507609|Rocuronium|rocuronium|mesh-list
64366834|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366835|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64366836|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64366837|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64366838|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366839|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64366840|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366841|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366843|NCT02512523|Hormones|hormones|mesh-ancestor
64366844|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366845|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64366858|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369318|NCT02490449|Lansoprazole|lansoprazole|mesh-list
64366859|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366860|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366861|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64366862|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64366863|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
64366864|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64366865|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
64366866|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366867|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
64366868|NCT03242707|Protective Agents|protective agents|mesh-ancestor
64366869|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
64366870|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64366871|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366872|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366875|NCT02512055|Analgesics|analgesics|mesh-ancestor
64366876|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
64366878|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366879|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64366880|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64366881|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
64366882|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
64366883|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64366884|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64366885|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64366886|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366891|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
64366902|NCT02514941|Acetaminophen|acetaminophen|mesh-list
64366903|NCT02514941|Amoxicillin|amoxicillin|mesh-list
64366904|NCT02514941|Talinolol|talinolol|mesh-list
64366905|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64366906|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64366907|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64366909|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
64366910|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64366911|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366912|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
64366913|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64366914|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64366915|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
64366916|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64366917|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366918|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64366919|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64366920|NCT02511665|Metformin|metformin|mesh-list
64366921|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366922|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366923|NCT02514629|Metformin|metformin|mesh-list
64366924|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
64366925|NCT02514629|Testosterone|testosterone|mesh-list
64366926|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
64366927|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
64366928|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
64366929|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64366930|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366932|NCT02514629|Hormones|hormones|mesh-ancestor
64366933|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366934|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64366935|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366936|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
64366937|NCT02511353|Ivermectin|ivermectin|mesh-list
64366938|NCT02511353|Piperaquine|piperaquine|mesh-list
64366943|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64366944|NCT03242317|Mitomycins|mitomycins|mesh-list
64366945|NCT03242317|Mitomycin|mitomycin|mesh-list
64366946|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64366947|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366948|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
64366949|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366950|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64366951|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366952|NCT02453503|Triamcinolone|triamcinolone|mesh-list
64366953|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64366954|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64366955|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64366956|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64366957|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
64366958|NCT02453503|Hormones|hormones|mesh-ancestor
64366959|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64366960|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64366961|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64366962|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
64366963|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64366964|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366966|NCT04499885|Emollients|emollients|mesh-ancestor
64366967|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64366968|NCT02453425|Norepinephrine|norepinephrine|mesh-list
64366969|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64366970|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64366990|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64366991|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378204|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64378205|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
64378206|NCT04411875|Amlodipine|amlodipine|mesh-list
64378207|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64378208|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64378209|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378210|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378211|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64378212|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378213|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
64378234|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
64378235|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64378236|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64378237|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64378238|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64378239|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
64378240|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378241|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
64378242|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64378243|NCT04807569|Tamsulosin|tamsulosin|mesh-list
64366992|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64366993|NCT03242239|Trastuzumab|trastuzumab|mesh-list
64366994|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64366995|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64366996|NCT03232957|Morphine|morphine|mesh-list
64366997|NCT03232957|Bupivacaine|bupivacaine|mesh-list
64366998|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
64366999|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
64367000|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367001|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367002|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
64367003|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367004|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64367005|NCT03232957|Narcotics|narcotics|mesh-ancestor
64367006|NCT03232957|Analgesics|analgesics|mesh-ancestor
64367007|NCT02513849|Tamoxifen|tamoxifen|mesh-list
64367008|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64367009|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
64367017|NCT02513927|Metoprolol|metoprolol|mesh-list
64367044|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367045|NCT03236233|PC-786|pc-786|mesh-list
64367046|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
64367047|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367048|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378343|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369329|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
64367049|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367050|NCT02513693|Rocuronium|rocuronium|mesh-list
64367051|NCT02513693|Neostigmine|neostigmine|mesh-list
64367052|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64367053|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64367054|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64367055|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367056|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367057|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64367058|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367059|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367060|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
64367061|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367062|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64367063|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
64367064|NCT03121547|Tramadol|tramadol|mesh-list
64367068|NCT03121547|Narcotics|narcotics|mesh-ancestor
64367096|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367098|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64367099|NCT02513381|Vitamin D|vitamin d|mesh-list
64367100|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
64367101|NCT02513381|Vitamins|vitamins|mesh-ancestor
64367102|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
64367103|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367104|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367105|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367106|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
64367108|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367109|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367110|NCT03236155|Analgesics|analgesics|mesh-ancestor
64367111|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
64367112|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367113|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
64367114|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
64367115|NCT03232021|Pregabalin|pregabalin|mesh-list
64367116|NCT03232021|Analgesics|analgesics|mesh-ancestor
64367117|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
64367118|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367119|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367120|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
64367121|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64378344|NCT04352439|Analgesics|analgesics|mesh-ancestor
64367123|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367124|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367125|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64367126|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64367128|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64367139|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367140|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64367141|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64367142|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367143|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367144|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64367145|NCT03235609|Narcotics|narcotics|mesh-ancestor
64367146|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64367147|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
64367148|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64367149|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367150|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367151|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367152|NCT02509949|Analgesics|analgesics|mesh-ancestor
64367153|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
64367154|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367155|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64367156|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64367157|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64367159|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367160|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367162|NCT03344705|Fludarabine|fludarabine|mesh-list
64367163|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367164|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
64367184|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367185|NCT02501213|Furosemide|furosemide|mesh-list
64367186|NCT02501213|Spironolactone|spironolactone|mesh-list
64367187|NCT02501213|Diuretics|diuretics|mesh-ancestor
64367188|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
64367189|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367190|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64367191|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64367192|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367193|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64367194|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
64367195|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367196|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64367197|NCT02501291|Thalidomide|thalidomide|mesh-list
64367198|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367199|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
64367200|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367201|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
64367202|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367203|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367204|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64367205|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64367206|NCT02501291|Growth Substances|growth substances|mesh-ancestor
64367234|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
64367235|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
64367236|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367237|NCT02508857|Ketorolac|ketorolac|mesh-list
64367238|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
64367239|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64367240|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367241|NCT02508857|Analgesics|analgesics|mesh-ancestor
64367242|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
64367243|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367244|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367245|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367246|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367247|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64367248|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367249|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367250|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
64367251|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367252|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64367253|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
64367254|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64367255|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64367256|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367258|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64367259|NCT02508623|Rifaximin|rifaximin|mesh-list
64367260|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367261|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367262|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64367263|NCT02500667|Rifampin|rifampin|mesh-list
64367264|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64367273|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64367274|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64367275|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64367276|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64367277|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64367279|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
64367280|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367281|NCT03344393|Ketamine|ketamine|mesh-list
64367282|NCT03344393|Analgesics|analgesics|mesh-ancestor
64367283|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
64367284|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367285|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367286|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64367287|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64367288|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
64367289|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
64367290|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367291|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64367327|NCT02425891|Atezolizumab|atezolizumab|mesh-list
64367328|NCT02425891|Antibodies|antibodies|mesh-list
64367329|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64367330|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64367331|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367332|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
64367333|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
64367334|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
64367335|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367336|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
64367337|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367338|NCT02499965|Anesthetics|anesthetics|mesh-list
64367340|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367341|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367342|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
64367343|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
64367344|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367386|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367387|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64367388|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64367389|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
64367390|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367391|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367393|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
64367394|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
64367395|NCT02506439|Vitamins|vitamins|mesh-list
64367396|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
64367397|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367398|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64378346|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378347|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378348|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378349|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378350|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64378351|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64378352|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378353|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64378354|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64378355|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378356|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
64378358|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378359|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378360|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64378361|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64378362|NCT04796025|Growth Substances|growth substances|mesh-ancestor
64378363|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378364|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
64378365|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
64378366|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64378367|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378368|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64378369|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64378370|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378371|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378372|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378373|NCT02595723|Megestrol|megestrol|mesh-list
64378374|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
64378375|NCT02595723|Phenytoin|phenytoin|mesh-list
64378376|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64367399|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367400|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
64367401|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367402|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64367403|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367404|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367405|NCT02499341|Ketamine|ketamine|mesh-list
64367406|NCT02499341|Tramadol|tramadol|mesh-list
64367407|NCT02499341|Analgesics|analgesics|mesh-ancestor
64378377|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64367408|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
64367409|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367410|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367411|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64367412|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64367434|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367435|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
64367436|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367437|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
64367438|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367439|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
64367440|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367441|NCT02494895|Aspirin|aspirin|mesh-list
64367442|NCT02494895|Ticagrelor|ticagrelor|mesh-list
64367443|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64367444|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367445|NCT02494895|Analgesics|analgesics|mesh-ancestor
64367446|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
64367447|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367448|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367449|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367451|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64367452|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64378378|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64378400|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378401|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378402|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378403|NCT02597049|Metformin|metformin|mesh-list
64378404|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
64378405|NCT02597049|Empagliflozin|empagliflozin|mesh-list
64378406|NCT02597049|Canagliflozin|canagliflozin|mesh-list
64378407|NCT02597049|Dulaglutide|dulaglutide|mesh-list
64378408|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
64378409|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64378410|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378411|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378412|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
64378413|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378414|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
64378415|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
64378416|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
64378417|NCT04802967|Ketoprofen|ketoprofen|mesh-list
64378418|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
64378419|NCT04802967|Gabapentin|gabapentin|mesh-list
64378420|NCT04802967|Analgesics|analgesics|mesh-ancestor
64378421|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
64378422|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378423|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378424|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
64378425|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64378426|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64378446|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64378447|NCT02594163|Rituximab|rituximab|mesh-list
64378448|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64378449|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64378450|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378451|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378452|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
64378453|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378454|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378455|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64378456|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
64378457|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378463|NCT03206255|Vaccines|vaccines|mesh-list
64378464|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
64378465|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378467|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378468|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378469|NCT03206021|Carboplatin|carboplatin|mesh-list
64378470|NCT03206021|Azacitidine|azacitidine|mesh-list
64378471|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378475|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378476|NCT03200561|Prednisolone|prednisolone|mesh-list
64378477|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
64378487|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
64378489|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64378490|NCT02449811|Olmesartan|olmesartan|mesh-list
64378491|NCT02449811|Perindopril|perindopril|mesh-list
64378492|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64378493|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64378494|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378495|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378496|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367453|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367454|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64367455|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64367456|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367458|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64367459|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64367460|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64367461|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
64367462|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367463|NCT03341741|Tobramycin|tobramycin|mesh-list
64367464|NCT03341741|Colistin|colistin|mesh-list
64367466|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367467|NCT01597245|Etanercept|etanercept|mesh-list
64367475|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367476|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367477|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64367478|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367479|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
64367480|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
64367482|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64367483|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367484|NCT03341429|Incretins|incretins|mesh-ancestor
64367485|NCT03341429|Hormones|hormones|mesh-ancestor
64367486|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367487|NCT04494659|Rifampin|rifampin|mesh-list
64367488|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64367489|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
64367490|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367491|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367492|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
64367493|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64367494|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367495|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367496|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64367497|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64367498|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64367499|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64367500|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64367501|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64367502|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
64367503|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
64367504|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367505|NCT03342599|Protective Agents|protective agents|mesh-ancestor
64367506|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367516|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367517|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367518|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367519|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367520|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64367521|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64378497|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367522|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367523|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64367524|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64367525|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367527|NCT03341117|Antacids|antacids|mesh-ancestor
64367528|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64367529|NCT02498171|Fentanyl|fentanyl|mesh-list
64367530|NCT02498171|Morphine|morphine|mesh-list
64367532|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
64367533|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
64367534|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367535|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367536|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
64367537|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367539|NCT02498171|Narcotics|narcotics|mesh-ancestor
64367570|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367571|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378498|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
64378499|NCT02449811|Diuretics|diuretics|mesh-ancestor
64378500|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
64378501|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64378502|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64378503|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64378504|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64378505|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
64378506|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378507|NCT03200093|Vancomycin|vancomycin|mesh-list
64378508|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64378509|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378511|NCT03204929|Trace Elements|trace elements|mesh-ancestor
64378512|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
64378513|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378514|NCT02596971|Prednisone|prednisone|mesh-list
64378515|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
64378516|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64378517|NCT02596971|Rituximab|rituximab|mesh-list
64378518|NCT02596971|Doxorubicin|doxorubicin|mesh-list
64378519|NCT02596971|Vincristine|vincristine|mesh-list
64378520|NCT02596971|Atezolizumab|atezolizumab|mesh-list
64378521|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
64378522|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64378523|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
64378524|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378525|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378526|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64378527|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
64378528|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378529|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378530|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64378531|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378532|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64378533|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64378534|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64378587|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
64378588|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378589|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
64378590|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64378591|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64378592|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378593|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
64378594|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
64378596|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64378597|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64378598|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64378599|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64378727|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378728|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378729|NCT02593305|Methamphetamine|methamphetamine|mesh-list
64378730|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64378731|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378732|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
64378733|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
64378734|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378735|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
64378736|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378737|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378738|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
64378739|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64378740|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64378750|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64378751|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64378752|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367573|NCT05035485|Protective Agents|protective agents|mesh-ancestor
64367574|NCT02498015|Ribavirin|ribavirin|mesh-list
64367575|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
64367576|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367577|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
64367578|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367579|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
64367580|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64367581|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367582|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64367583|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
64367584|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367585|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367586|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367587|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367588|NCT03340493|Tenecteplase|tenecteplase|mesh-list
64367589|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64367590|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64367591|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367592|NCT03098199|Menotropins|menotropins|mesh-list
64367593|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367594|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64367595|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
64367596|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64367597|NCT00707057|Ibuprofen|ibuprofen|mesh-list
64367598|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64367599|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367600|NCT00707057|Analgesics|analgesics|mesh-ancestor
64367601|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
64367605|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367608|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367609|NCT02494349|Tamsulosin|tamsulosin|mesh-list
64367610|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
64367611|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64367612|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64367613|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64367614|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367615|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367616|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367617|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367618|NCT02494349|Urological Agents|urological agents|mesh-ancestor
64367619|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64367620|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64367621|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
64367622|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
64367623|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64367624|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367625|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367626|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367627|NCT03095469|Analgesics|analgesics|mesh-ancestor
64367628|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
64367629|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367630|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64367631|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64367632|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64367633|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367634|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367636|NCT02497547|Oxytocin|oxytocin|mesh-list
64367654|NCT02497157|Calcium|calcium|mesh-list
64367655|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
64367656|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64367657|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367658|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64367659|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64367660|NCT02497157|Growth Substances|growth substances|mesh-ancestor
64367661|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367662|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
64367663|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367665|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367666|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64367667|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367668|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
64367669|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64367670|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64367671|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367672|NCT02497157|Antidotes|antidotes|mesh-ancestor
64367673|NCT02497157|Protective Agents|protective agents|mesh-ancestor
64367674|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
64367675|NCT02497157|Vitamins|vitamins|mesh-ancestor
64367676|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
64367678|NCT03095235|Vitamins|vitamins|mesh-ancestor
64367679|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
64367680|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367681|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
64367682|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64367683|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
64367684|NCT03095079|Endostatins|endostatins|mesh-list
64367701|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367702|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64367703|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64367704|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64367705|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64367706|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367707|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367708|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
64367710|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367711|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367712|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
64367713|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367714|NCT02497079|Formaldehyde|formaldehyde|mesh-list
64367715|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
64367716|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367717|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
64367718|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64367719|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
64367720|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64367721|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
64367722|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367723|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367724|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
64367749|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64378754|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64378755|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378756|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378758|NCT03195569|Bevacizumab|bevacizumab|mesh-list
64378759|NCT03195569|Carboplatin|carboplatin|mesh-list
64378760|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378761|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378762|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
64378763|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
64378764|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378767|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64378787|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64378788|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378789|NCT03195413|Lidocaine|lidocaine|mesh-list
64378790|NCT03195413|Epinephrine|epinephrine|mesh-list
64378791|NCT03195413|Racepinephrine|racepinephrine|mesh-list
64378792|NCT03195413|Bupivacaine|bupivacaine|mesh-list
64378793|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
64378794|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
64378795|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
64378796|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378797|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378798|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
64378799|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378800|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64378801|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64378802|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64378803|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378804|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367750|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367753|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367755|NCT03095001|Bevacizumab|bevacizumab|mesh-list
64367756|NCT03095001|Carboplatin|carboplatin|mesh-list
64367757|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64367758|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367759|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
64367760|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
64367761|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
64367762|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367763|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64367764|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64367765|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64367766|NCT03095001|Growth Substances|growth substances|mesh-ancestor
64367767|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367768|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
64367769|NCT05042271|Meropenem|meropenem|mesh-list
64367770|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367771|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367772|NCT02138955|Curcumin|curcumin|mesh-list
64367773|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64367774|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367775|NCT02138955|Analgesics|analgesics|mesh-ancestor
64367776|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
64367777|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367778|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367779|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64367780|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367781|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367782|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367784|NCT03096405|Methicillin|methicillin|mesh-list
64367789|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64367790|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64367791|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
64367792|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367793|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367794|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367796|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64367797|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64367798|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367799|NCT02493959|Incretins|incretins|mesh-ancestor
64367800|NCT02493959|Hormones|hormones|mesh-ancestor
64367801|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367802|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64367803|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
64367804|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367805|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367806|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
64367807|NCT02496377|Glycine|glycine|mesh-list
64367808|NCT02496377|Hematinics|hematinics|mesh-ancestor
64367809|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
64367810|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64367811|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367812|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367813|NCT02496455|Tramadol|tramadol|mesh-list
64367814|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64367815|NCT02496455|Narcotics|narcotics|mesh-ancestor
64367816|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367817|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367819|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
64367820|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367831|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64367832|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64367833|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367834|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
64367835|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
64367836|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367837|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
64367838|NCT02493725|Eculizumab|eculizumab|mesh-list
64367839|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64367840|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64367841|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
64367847|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367848|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367851|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64367852|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
64367853|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367854|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367855|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
64367856|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64367857|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367858|NCT02493335|Budesonide|budesonide|mesh-list
64367860|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64367861|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
64367862|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367873|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64367874|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64367875|NCT03337607|Eperisone|eperisone|mesh-list
64367876|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
64367877|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367878|NCT03337607|Analgesics|analgesics|mesh-ancestor
64367879|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
64367880|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367881|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367882|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64367883|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64367884|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64367885|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367886|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367887|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
64367889|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64367890|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64367891|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64367892|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64367893|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
64367894|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
64367895|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
64367896|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64367897|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64367898|NCT02493179|Analgesics|analgesics|mesh-ancestor
64367899|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
64367900|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367901|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367904|NCT03336437|Estradiol|estradiol|mesh-list
64367916|NCT03336125|Vitamin D|vitamin d|mesh-list
64367917|NCT03336125|Vitamins|vitamins|mesh-ancestor
64367918|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
64367919|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367920|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64367921|NCT05051163|Gentamicins|gentamicins|mesh-list
64367922|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
64367924|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64367925|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64367926|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64367928|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367929|NCT03331211|Dasatinib|dasatinib|mesh-list
64367930|NCT03331211|Ponatinib|ponatinib|mesh-list
64367931|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64367932|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64367933|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369416|NCT03220867|Risperidone|risperidone|mesh-list
64367934|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367935|NCT01929915|Fentanyl|fentanyl|mesh-list
64367936|NCT01929915|Morphine|morphine|mesh-list
64367937|NCT01929915|Bupivacaine|bupivacaine|mesh-list
64367938|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
64367939|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
64367940|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367941|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367942|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
64367943|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64367945|NCT01929915|Narcotics|narcotics|mesh-ancestor
64367946|NCT01929915|Analgesics|analgesics|mesh-ancestor
64367947|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64367948|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64367949|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
64367950|NCT05464745|Perindopril|perindopril|mesh-list
64367951|NCT05464745|Indapamide|indapamide|mesh-list
64367952|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64367954|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64367955|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64367956|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64367957|NCT05464745|Diuretics|diuretics|mesh-ancestor
64367958|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
64367959|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367961|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64367962|NCT03094533|Propofol|propofol|mesh-list
64367963|NCT03094533|Sevoflurane|sevoflurane|mesh-list
64367964|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64367965|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367966|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367967|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64367968|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
64367969|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
64367970|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64367971|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64367973|NCT03335579|Remifentanil|remifentanil|mesh-list
64367974|NCT03335579|Propofol|propofol|mesh-list
64367975|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
64367976|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64367977|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64367979|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64367980|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
64367981|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64367982|NCT03335579|Narcotics|narcotics|mesh-ancestor
64368001|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368002|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368003|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
64368004|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368005|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64368006|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64368007|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64368008|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64368009|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368011|NCT03335423|Codeine|codeine|mesh-list
64368012|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64368013|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368014|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64368015|NCT03335423|Narcotics|narcotics|mesh-ancestor
64368016|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368018|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
64369465|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
64368019|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368020|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
64368021|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368022|NCT05038605|Metronidazole|metronidazole|mesh-list
64368023|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368024|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64368025|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64368050|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368051|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
64368052|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368053|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
64368054|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368055|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64368056|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64368057|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64368058|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
64368059|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64368060|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64368061|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64368062|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64368063|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64368064|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
64368065|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368066|NCT03329651|Metformin|metformin|mesh-list
64368067|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64368068|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368069|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
64368070|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64368071|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368099|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
64368100|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
64368101|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368102|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368103|NCT05038059|Acetic Acid|acetic acid|mesh-list
64368104|NCT05038059|Retinol acetate|retinol acetate|mesh-list
64368106|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64368107|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368108|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64368109|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
64368110|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368111|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64368112|NCT05038059|Protective Agents|protective agents|mesh-ancestor
64368113|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368114|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
64368115|NCT05038059|Growth Substances|growth substances|mesh-ancestor
64368117|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64368118|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64368119|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368120|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
64368121|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
64368122|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
64368123|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368124|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
64368125|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
64368126|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368127|NCT03329339|Protective Agents|protective agents|mesh-ancestor
64368128|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368129|NCT03329339|Vitamins|vitamins|mesh-ancestor
64368143|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368144|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368145|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368146|NCT05048511|Vitamin D|vitamin d|mesh-list
64368147|NCT05048511|Vitamins|vitamins|mesh-ancestor
64368148|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
64368149|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368150|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64368151|NCT02167945|Ritonavir|ritonavir|mesh-list
64368152|NCT02167945|Ribavirin|ribavirin|mesh-list
64368153|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64368154|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64368155|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
64368156|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368157|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368158|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64368159|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64368160|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
64368161|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368200|NCT05024799|Narcotics|narcotics|mesh-ancestor
64368201|NCT05024799|Analgesics|analgesics|mesh-ancestor
64368202|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
64368203|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368204|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64368205|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
64368206|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368207|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64368208|NCT05018637|Teriparatide|teriparatide|mesh-list
64368209|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64368210|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368211|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64368212|NCT03333395|Heparin|heparin|mesh-list
64368213|NCT03333395|Albuterol|albuterol|mesh-list
64368214|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
64368215|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64368216|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64368217|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368218|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64368219|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
64368220|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368222|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64368223|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368224|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
64368225|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64368226|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64368227|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64368229|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
64368230|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368243|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64368244|NCT03327389|Analgesics|analgesics|mesh-ancestor
64368245|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
64368246|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368247|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64368248|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64368249|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64368250|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
64368251|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369495|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
64368252|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368253|NCT03333083|Lamivudine|lamivudine|mesh-list
64368254|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
64368255|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64368256|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64368257|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368258|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368259|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
64368260|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368261|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64368262|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64368263|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64368264|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64368265|NCT03093597|Petrolatum|petrolatum|mesh-list
64368266|NCT03093597|Emollients|emollients|mesh-ancestor
64368267|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
64368268|NCT05465135|Artenimol|artenimol|mesh-list
64368269|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
64368270|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64368271|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64368272|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368273|NCT03327155|Tenofovir|tenofovir|mesh-list
64368274|NCT03327155|Emtricitabine|emtricitabine|mesh-list
64368275|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
64368276|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368286|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368287|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368288|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
64368289|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
64368290|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64368291|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64368292|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64368293|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64368294|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368295|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
64368296|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368297|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368298|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64368299|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368300|NCT03230851|Aspirin|aspirin|mesh-list
64368301|NCT03230851|Indobufen|indobufen|mesh-list
64368302|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64368303|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64368304|NCT03230851|Analgesics|analgesics|mesh-ancestor
64368305|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
64368311|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64368312|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368315|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368329|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64368330|NCT05024565|Lactams|lactams|mesh-list
64368331|NCT05024565|beta-Lactams|beta-lactams|mesh-list
64368332|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368333|NCT03228901|Oxytocin|oxytocin|mesh-list
64368334|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
64368335|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64368336|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368337|NCT03228823|Amiodarone|amiodarone|mesh-list
64368338|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
64368339|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
64368340|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
64368341|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64368342|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368343|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64368344|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64368345|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64368346|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368347|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
64368348|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64368349|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64368350|NCT03332225|Interferons|interferons|mesh-list
64368381|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368382|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
64368383|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64368384|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64368385|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64368386|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64368387|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368388|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
64368389|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368390|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368391|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64368392|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368393|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
64368394|NCT03090009|Analgesics|analgesics|mesh-ancestor
64368395|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
64368396|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368397|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368398|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64368399|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64368400|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368401|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368402|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64368403|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368404|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368405|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
64368406|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64368407|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64368408|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368409|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
64368410|NCT02492087|Coagulants|coagulants|mesh-ancestor
64368424|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368425|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368426|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
64368427|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64368428|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368429|NCT05464979|Fentanyl|fentanyl|mesh-list
64368430|NCT05464979|Midazolam|midazolam|mesh-list
64368431|NCT05464979|Ketamine|ketamine|mesh-list
64368432|NCT05464979|Esketamine|esketamine|mesh-list
64368434|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
64368435|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368436|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368437|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64368438|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64368439|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
64368440|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
64368441|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368442|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64368443|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64368444|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368445|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368446|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64368447|NCT05464979|Narcotics|narcotics|mesh-ancestor
64368448|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64368449|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64368450|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64368451|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64368452|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64368453|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
64368454|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
64368456|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
64368468|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
64368469|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368470|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
64368471|NCT03331523|Hormones|hormones|mesh-ancestor
64368472|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368474|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64368475|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368476|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
64368477|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
64368478|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
64368479|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368480|NCT05023863|Protective Agents|protective agents|mesh-ancestor
64368481|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368482|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
64368483|NCT05023863|Vitamins|vitamins|mesh-ancestor
64368484|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
64368485|NCT05463809|Oxycodone|oxycodone|mesh-list
64368486|NCT05463809|Analgesics|analgesics|mesh-list
64368487|NCT05463809|Ropivacaine|ropivacaine|mesh-list
64368488|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
64368489|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
64368490|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368491|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368524|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368525|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64368527|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368528|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368529|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64368530|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
64368531|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64368532|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
64368533|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64368534|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
64368535|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368540|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
64368576|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368577|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368578|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64368579|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64368581|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64368582|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
64368583|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
64368584|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368585|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368586|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64368587|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64368588|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64368589|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
64368590|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368591|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368592|NCT05015829|Protective Agents|protective agents|mesh-ancestor
64368593|NCT05015361|Propofol|propofol|mesh-list
64368594|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64368595|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368596|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368597|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64368598|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
64368599|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
64368600|NCT01375075|Atorvastatin|atorvastatin|mesh-list
64368601|NCT01375075|Evacetrapib|evacetrapib|mesh-list
64368602|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64368603|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64368604|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
64368606|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64368620|NCT03087201|Analgesics|analgesics|mesh-ancestor
64368621|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
64368622|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368623|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368624|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
64368625|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64368626|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
64369515|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368627|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64368628|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368629|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64368630|NCT03239743|Midazolam|midazolam|mesh-list
64368631|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64368632|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64368633|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368634|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368635|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64368636|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64368637|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64368638|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64368639|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
64368641|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
64368642|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
64368643|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368644|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368645|NCT03239821|Codeine|codeine|mesh-list
64368646|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64368647|NCT03239821|Narcotics|narcotics|mesh-ancestor
64368648|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368649|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368650|NCT03239821|Analgesics|analgesics|mesh-ancestor
64368663|NCT03078465|Ticagrelor|ticagrelor|mesh-list
64368664|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64368665|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64368666|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64368667|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64368668|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
64368669|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368670|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368671|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368673|NCT03324815|Methadone|methadone|mesh-list
64368674|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64368675|NCT03324815|Narcotics|narcotics|mesh-ancestor
64368676|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368677|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368678|NCT03324815|Analgesics|analgesics|mesh-ancestor
64368679|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
64368680|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368681|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
64368682|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368683|NCT05006469|Dexamethasone|dexamethasone|mesh-list
64368684|NCT05006469|Doxorubicin|doxorubicin|mesh-list
64368685|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64368686|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64368687|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368689|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
64368690|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368691|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368710|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368711|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64368712|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
64368713|NCT03084783|Hormones|hormones|mesh-ancestor
64378805|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64368714|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368715|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64368716|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368717|NCT03228355|Cromakalim|cromakalim|mesh-list
64368718|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64368719|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64368720|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
64368721|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368722|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368723|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64368724|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
64368725|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
64368726|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
64368727|NCT03324503|Prednisone|prednisone|mesh-list
64368729|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64368730|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
64368731|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64368732|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
64368733|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64368734|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
64368735|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
64368736|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64368737|NCT03324503|Hormones|hormones|mesh-ancestor
64378806|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64378807|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
64378808|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378809|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64378810|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64378811|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
64378812|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64378813|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
64378814|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
64378815|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
64378816|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64378818|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378819|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378820|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
64378821|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
64378822|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378824|NCT02447705|Telbivudine|telbivudine|mesh-list
64378826|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368738|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64368739|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368740|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64368741|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368742|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
64368743|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
64368751|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
64368752|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368753|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64368754|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64368755|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368756|NCT05006001|Colchicine|colchicine|mesh-list
64368757|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
64368758|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64368759|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
64368760|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
64368761|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
64368762|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368763|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368764|NCT04493489|Propranolol|propranolol|mesh-list
64368765|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64368766|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64368767|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
64368768|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368769|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368770|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368771|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64368772|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64368773|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
64368774|NCT03228043|Apatinib|apatinib|mesh-list
64368802|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64368803|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
64368814|NCT03320447|Lidocaine|lidocaine|mesh-list
64368870|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368871|NCT03323567|Lidocaine|lidocaine|mesh-list
64368872|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64368873|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
64368874|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
64368875|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368876|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368877|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
64368878|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368879|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64368880|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64368881|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64368882|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64368883|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368884|NCT04492709|Midazolam|midazolam|mesh-list
64368885|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64368886|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64368887|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64368888|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368889|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64368890|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64368891|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64368892|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64368893|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
64368894|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
64368895|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
64368896|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
64368897|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64368898|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368900|NCT05006235|Albuterol|albuterol|mesh-list
64368913|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
64368914|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
64368915|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64368916|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
64368917|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64368918|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64368919|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
64368920|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64368921|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368922|NCT03319823|Diuretics|diuretics|mesh-ancestor
64368923|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
64368924|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368926|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64368927|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
64368928|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64368929|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64368930|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64368931|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64368970|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
64368971|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64368973|NCT03221881|Doxorubicin|doxorubicin|mesh-list
64368974|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64368975|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368976|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
64368977|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
64368978|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
64368979|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368980|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64368981|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64368982|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64368983|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368984|NCT03091257|Trametinib|trametinib|mesh-list
64368985|NCT03091257|Dabrafenib|dabrafenib|mesh-list
64368986|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64368987|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64368988|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64368989|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64368990|NCT03206671|Cytarabine|cytarabine|mesh-list
64368991|NCT03206671|Dexamethasone|dexamethasone|mesh-list
64368992|NCT03206671|Prednisolone|prednisolone|mesh-list
64368993|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
64369024|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369025|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64369026|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
64369027|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64369028|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64369029|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
64369030|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
64369031|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64369032|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64369033|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64369035|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369037|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
64369038|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
64369039|NCT03078231|Mydriatics|mydriatics|mesh-list
64369040|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
64369041|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369042|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369043|NCT03319121|Theophylline|theophylline|mesh-list
64369044|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
64369045|NCT03319121|Lansoprazole|lansoprazole|mesh-list
64369077|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369078|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64369079|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64369082|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369083|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64369084|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64369085|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369086|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369087|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64369088|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369093|NCT03319043|Budesonide|budesonide|mesh-list
64369132|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369133|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64369134|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
64369135|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
64369136|NCT05019417|Glycerol|glycerol|mesh-list
64369137|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64369139|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369140|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369141|NCT03225937|Trastuzumab|trastuzumab|mesh-list
64369142|NCT03225937|Pertuzumab|pertuzumab|mesh-list
64369143|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
64369144|NCT03225937|Lapatinib|lapatinib|mesh-list
64369145|NCT03225937|Maytansine|maytansine|mesh-list
64369146|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369147|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369148|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64369149|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369150|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369151|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64369152|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
64369153|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
64369154|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
64369155|NCT03318887|Ribavirin|ribavirin|mesh-list
64369156|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
64369157|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
64369158|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369159|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
64369174|NCT02487329|Calcium|calcium|mesh-list
64369177|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64369179|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64369180|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369181|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64369182|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369183|NCT04493099|Decitabine|decitabine|mesh-list
64369184|NCT04493099|Venetoclax|venetoclax|mesh-list
64369185|NCT04493099|Alvocidib|alvocidib|mesh-list
64369186|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64369187|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
64369188|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369189|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369190|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369191|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
64369192|NCT04493099|Growth Substances|growth substances|mesh-ancestor
64369193|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369194|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64369196|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369197|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
64369198|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
64369199|NCT03119623|Valsartan|valsartan|mesh-list
64369200|NCT03119623|Enalapril|enalapril|mesh-list
64369201|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64369202|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64369203|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64369204|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64369205|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369206|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64369221|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369222|NCT03321773|Amoxicillin|amoxicillin|mesh-list
64369223|NCT03321773|Metronidazole|metronidazole|mesh-list
64369224|NCT03321773|Clarithromycin|clarithromycin|mesh-list
64369225|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
64369226|NCT03321773|Pantoprazole|pantoprazole|mesh-list
64369227|NCT03321773|Bismuth|bismuth|mesh-list
64369228|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64369229|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369230|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64369231|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64369232|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64369233|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369234|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369235|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64369236|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64369237|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64369238|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369239|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64369240|NCT03321773|Antacids|antacids|mesh-ancestor
64369241|NCT03077217|Rifaximin|rifaximin|mesh-list
64369242|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64369243|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369244|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369245|NCT05001243|Bromfenac|bromfenac|mesh-list
64369246|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
64369247|NCT05001243|Phenylephrine|phenylephrine|mesh-list
64369248|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
64369249|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
64369250|NCT05001243|Pilocarpine|pilocarpine|mesh-list
64369251|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64369268|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
64369269|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64369270|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
64369271|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64369272|NCT05001243|Miotics|miotics|mesh-ancestor
64369273|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64369274|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64369275|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
64369276|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64369277|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369278|NCT05001243|Analgesics|analgesics|mesh-ancestor
64369279|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
64369280|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369281|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369282|NCT03225781|Bleomycin|bleomycin|mesh-list
64369283|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64369284|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369285|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64369286|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369287|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369288|NCT03221023|Vancomycin|vancomycin|mesh-list
64369289|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64369290|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369291|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64369292|NCT02490839|Amoxicillin|amoxicillin|mesh-list
64369293|NCT02490839|Metronidazole|metronidazole|mesh-list
64369294|NCT02490839|Tetracycline|tetracycline|mesh-list
64369295|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64369296|NCT02490839|Rabeprazole|rabeprazole|mesh-list
64369297|NCT02490839|Bismuth|bismuth|mesh-list
64369300|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
64369302|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64369303|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64369304|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369305|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369309|NCT02490527|Simvastatin|simvastatin|mesh-list
64369310|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64369311|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64369312|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
64369313|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369314|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64369315|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64369316|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369317|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
64369319|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64369320|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369321|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64369322|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369323|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369324|NCT02452177|Vitamin D|vitamin d|mesh-list
64369325|NCT02452177|Vitamins|vitamins|mesh-ancestor
64369326|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
64369327|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369328|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64369330|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369331|NCT03224923|Aspirin|aspirin|mesh-list
64369332|NCT03224923|Clopidogrel|clopidogrel|mesh-list
64369333|NCT03224923|Ticagrelor|ticagrelor|mesh-list
64369334|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64369335|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369336|NCT03224923|Analgesics|analgesics|mesh-ancestor
64369337|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
64369338|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369339|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369340|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369352|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
64369353|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369354|NCT05004753|Artemisinins|artemisinins|mesh-list
64369355|NCT05004753|Artemisinin|artemisinin|mesh-list
64369356|NCT05004753|Dexamethasone|dexamethasone|mesh-list
64369357|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369358|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
64369359|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
64369360|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369361|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369362|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369363|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
64369365|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369366|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64369367|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369368|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
64369369|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64369370|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64369371|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369372|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
64369373|NCT05004519|Remifentanil|remifentanil|mesh-list
64369374|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64369406|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369407|NCT04485403|Analgesics|analgesics|mesh-ancestor
64369408|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
64369409|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369410|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369411|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369412|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369413|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64369414|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369415|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369417|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64369418|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
64369419|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369420|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369421|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369422|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64369466|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369467|NCT03205033|Protective Agents|protective agents|mesh-ancestor
64369468|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369469|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369470|NCT03076905|Olorofim|olorofim|mesh-list
64369471|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
64369472|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369473|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
64369474|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
64369475|NCT02452099|Protective Agents|protective agents|mesh-ancestor
64369476|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369477|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64369478|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
64369479|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369480|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64369481|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64369482|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369483|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369484|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64369485|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64369486|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369487|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
64369489|NCT03220789|Methamphetamine|methamphetamine|mesh-list
64369490|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64369491|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369492|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
64369493|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
64369494|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369496|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369497|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369501|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64369502|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64369503|NCT03220555|Lidocaine|lidocaine|mesh-list
64369504|NCT03220555|Prilocaine|prilocaine|mesh-list
64369505|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
64369506|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
64369507|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369508|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369509|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
64369510|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369511|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64369512|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64369513|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64369514|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64369516|NCT03204877|Melatonin|melatonin|mesh-list
64369517|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
64369518|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369519|NCT03204877|Protective Agents|protective agents|mesh-ancestor
64369520|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369521|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369552|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64369553|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64369554|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64369555|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
64369556|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
64369557|NCT03072849|Fluticasone|fluticasone|mesh-list
64369558|NCT03072849|Azithromycin|azithromycin|mesh-list
64369559|NCT03072849|Montelukast|montelukast|mesh-list
64369560|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369561|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64369562|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
64369563|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369564|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369565|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64369566|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
64369567|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
64369568|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64369569|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64369570|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369571|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64369572|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
64369574|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64369602|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369603|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369604|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64369605|NCT02451865|Docetaxel|docetaxel|mesh-list
64369606|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377440|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
64377441|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377442|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377443|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64377444|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377445|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377446|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377447|NCT03206957|Endostatins|endostatins|mesh-list
64377455|NCT03206723|Hydrocodone|hydrocodone|mesh-list
64377465|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
64377466|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64377468|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
64377469|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
64377470|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377471|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377473|NCT04856787|Fluorouracil|fluorouracil|mesh-list
64377531|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64377532|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64377533|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377534|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
64377535|NCT03038451|Amlodipine|amlodipine|mesh-list
64377536|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64377537|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64377538|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377539|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377540|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64377541|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377542|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
64377626|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
64377627|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377629|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377630|NCT03041259|Protective Agents|protective agents|mesh-ancestor
64377631|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377633|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
64377634|NCT04429035|Vitamins|vitamins|mesh-ancestor
64377635|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
64377636|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377637|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64377638|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64377639|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377641|NCT04429035|Coagulants|coagulants|mesh-ancestor
64377642|NCT04843449|Itraconazole|itraconazole|mesh-list
64377643|NCT04843449|Rifampin|rifampin|mesh-list
64377644|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
64377645|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377646|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64377647|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377648|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377649|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377650|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64377667|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
64377668|NCT03037593|Vitamins|vitamins|mesh-ancestor
64377669|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
64377670|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377671|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64377672|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64377673|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
64377674|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64377675|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64377676|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377677|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
64377678|NCT03037515|Coagulants|coagulants|mesh-ancestor
64377679|NCT04842825|Cetrorelix|cetrorelix|mesh-list
64377680|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
64377681|NCT04842825|Hormones|hormones|mesh-ancestor
64377682|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377683|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377684|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64377685|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
64377686|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64377687|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377688|NCT02606253|Metolazone|metolazone|mesh-list
64377689|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
64369607|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
64369608|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
64369611|NCT05004207|Lactulose|lactulose|mesh-list
64369612|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369613|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
64369614|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
64369615|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64369616|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369617|NCT02489513|Ivosidenib|ivosidenib|mesh-list
64369618|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369619|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369620|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369621|NCT03317015|Fluticasone|fluticasone|mesh-list
64369622|NCT03317015|Triamcinolone|triamcinolone|mesh-list
64377690|NCT02606253|Tolvaptan|tolvaptan|mesh-list
64377691|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
64377692|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377693|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
64377694|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377695|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64377696|NCT02606253|Diuretics|diuretics|mesh-ancestor
64377697|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64377698|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377709|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377710|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377711|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377714|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377716|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64377717|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
64377718|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377719|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
64377720|NCT02607735|Velpatasvir|velpatasvir|mesh-list
64377721|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
64377722|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377723|NCT04772313|Methotrexate|methotrexate|mesh-list
64377724|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64377725|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
64377726|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64377727|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377924|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64377926|NCT04850001|Analgesics|analgesics|mesh-ancestor
64377927|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
64377928|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377929|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377930|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377931|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377932|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64377933|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64377934|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377935|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64377936|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64377937|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377938|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
64377939|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64377940|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64377941|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
64377942|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64377943|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64377944|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64377945|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64369623|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369624|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64369625|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
64369626|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369627|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369628|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64369652|NCT03224221|Fluorouracil|fluorouracil|mesh-list
64369653|NCT03224221|Apatinib|apatinib|mesh-list
64369654|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
64369655|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369656|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64369657|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369658|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377946|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64377947|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
64377948|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377949|NCT03036111|Trimebutine|trimebutine|mesh-list
64377961|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377962|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377963|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377964|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64377965|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64377966|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377967|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377968|NCT04816461|Piperaquine|piperaquine|mesh-list
64377969|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
64377970|NCT04816461|Amodiaquine|amodiaquine|mesh-list
64377972|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
64377973|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64377975|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377976|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64377977|NCT04816461|Renal Agents|renal agents|mesh-ancestor
64377978|NCT04427865|Lactoferrin|lactoferrin|mesh-list
64377979|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377980|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
64377981|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64377982|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377983|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64378013|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378014|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378015|NCT04821765|Paclitaxel|paclitaxel|mesh-list
64378016|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64378017|NCT04821765|Antibodies|antibodies|mesh-list
64378018|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378019|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378020|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
64378021|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
64378022|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378023|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378024|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
64378025|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378026|NCT04829097|Temozolomide|temozolomide|mesh-list
64378027|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64378028|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
64378029|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378030|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378031|NCT04829019|Osimertinib|osimertinib|mesh-list
64378032|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378033|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64378034|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378035|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378036|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
64378037|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378038|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378099|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378100|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64378101|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64378102|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378103|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64378104|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64378105|NCT04820439|Pertuzumab|pertuzumab|mesh-list
64378106|NCT04820439|Antibodies|antibodies|mesh-list
64378107|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64378108|NCT04820439|Mitogens|mitogens|mesh-list
64378109|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
64378110|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378111|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378112|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378113|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64378114|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378115|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
64378116|NCT05619315|Calcium|calcium|mesh-list
64378117|NCT05619315|Charcoal|charcoal|mesh-list
64378118|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64378119|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378120|NCT05619315|Antacids|antacids|mesh-ancestor
64378121|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378122|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378123|NCT05619315|Antidotes|antidotes|mesh-ancestor
64378124|NCT05619315|Protective Agents|protective agents|mesh-ancestor
64378134|NCT04814511|Permethrin|permethrin|mesh-list
64378135|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378136|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378137|NCT04814043|Lenvatinib|lenvatinib|mesh-list
64378142|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378143|NCT04814589|Ezetimibe|ezetimibe|mesh-list
64378144|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64378145|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64378146|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
64378147|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378148|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64378149|NCT04819503|Anesthetics|anesthetics|mesh-list
64378150|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378151|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378152|NCT04826679|Paclitaxel|paclitaxel|mesh-list
64378153|NCT04826679|Cisplatin|cisplatin|mesh-list
64378154|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378155|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378156|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
64378157|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
64378158|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378159|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378160|NCT02601573|Ribavirin|ribavirin|mesh-list
64378161|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
64378162|NCT02601573|Grazoprevir|grazoprevir|mesh-list
64378163|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
64378164|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378165|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
64378166|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64378167|NCT04818723|Montelukast|montelukast|mesh-list
64378168|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64378169|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
64378170|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64378171|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
64378187|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378188|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64378189|NCT02601027|Narcotics|narcotics|mesh-ancestor
64378190|NCT02601027|Analgesics|analgesics|mesh-ancestor
64378191|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
64378192|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
64378193|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378194|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
64378195|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
64378196|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64378197|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
64378198|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378199|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378200|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64369659|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
64369660|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369661|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64369662|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369663|NCT03204097|Alendronate|alendronate|mesh-list
64369664|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64369665|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369666|NCT03223519|Ibuprofen|ibuprofen|mesh-list
64369670|NCT03223519|Analgesics|analgesics|mesh-ancestor
64369671|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
64369672|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369673|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369674|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369675|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64369702|NCT02485613|Dexamethasone|dexamethasone|mesh-list
64369703|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369704|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
64369705|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
64369706|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369707|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369708|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64369709|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
64369710|NCT02485613|Hormones|hormones|mesh-ancestor
64369711|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369712|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64369713|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369714|NCT02484833|Cetuximab|cetuximab|mesh-list
64369715|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369716|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369717|NCT03204019|Thalidomide|thalidomide|mesh-list
64369718|NCT03204019|Temozolomide|temozolomide|mesh-list
64369719|NCT03204019|Tegafur|tegafur|mesh-list
64369720|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64369721|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
64369722|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369723|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369724|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64378201|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64378202|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64378203|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64378245|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64378246|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64378247|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
64378248|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378249|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378250|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378251|NCT04807569|Urological Agents|urological agents|mesh-ancestor
64378252|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
64378253|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64378254|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
64378255|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378256|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378257|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64378258|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
64378259|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64378260|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
64378261|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378262|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378263|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64378275|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
64378278|NCT04807335|Analgesics|analgesics|mesh-ancestor
64378279|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
64378280|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378281|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378282|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64378283|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64378284|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
64378285|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
64378286|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378287|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64378288|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64378289|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378290|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378291|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64378292|NCT04807335|Narcotics|narcotics|mesh-ancestor
64378293|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64378296|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378298|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378299|NCT04806945|Paclitaxel|paclitaxel|mesh-list
64378300|NCT04806945|Carboplatin|carboplatin|mesh-list
64378301|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64378302|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378303|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
64378304|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
64378305|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
64378306|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378307|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
64378318|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
64378319|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
64378320|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64378321|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
64378322|NCT04805229|Narcotics|narcotics|mesh-ancestor
64378323|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378324|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378325|NCT04805229|Analgesics|analgesics|mesh-ancestor
64378326|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
64378327|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378328|NCT04811313|Bupivacaine|bupivacaine|mesh-list
64378329|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
64378330|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
64378331|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
64378332|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378333|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378334|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
64378335|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378336|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64378337|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64378338|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378339|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
64378340|NCT04811313|Coagulants|coagulants|mesh-ancestor
64378341|NCT04352439|Aspirin|aspirin|mesh-list
64378342|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64378600|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378602|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64378603|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64378604|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378605|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378606|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64378607|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64378608|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64378609|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378610|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378611|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378612|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
64378613|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64378615|NCT04799925|Febuxostat|febuxostat|mesh-list
64378632|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64378633|NCT03232307|BB 1101|bb 1101|mesh-list
64378634|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
64378635|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378636|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378637|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378638|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378639|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
64378640|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
64378641|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378642|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378643|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
64378645|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378646|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64378647|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64378648|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64378649|NCT03232307|Growth Substances|growth substances|mesh-ancestor
64378650|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
64378651|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
64378652|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378653|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378654|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
64378655|NCT05615727|Zolpidem|zolpidem|mesh-list
64378656|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64378657|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378658|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378659|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64378660|NCT05615727|Analgesics|analgesics|mesh-ancestor
64378661|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
64378662|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378663|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64378664|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64378665|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64378666|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
64378667|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378681|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64378682|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
64378683|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64378684|NCT03231683|Ketamine|ketamine|mesh-list
64378685|NCT03231683|Remifentanil|remifentanil|mesh-list
64378686|NCT03231683|Propofol|propofol|mesh-list
64378687|NCT03231683|Esketamine|esketamine|mesh-list
64378688|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64378689|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378690|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378691|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64378692|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
64378693|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
64378694|NCT03231683|Analgesics|analgesics|mesh-ancestor
64378695|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
64378715|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
64378716|NCT04798443|Protective Agents|protective agents|mesh-ancestor
64378717|NCT02450045|Bupivacaine|bupivacaine|mesh-list
64378718|NCT02450045|Ropivacaine|ropivacaine|mesh-list
64378719|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
64378720|NCT02450045|Anesthetics|anesthetics|mesh-list
64378721|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378722|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378723|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
64378724|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378725|NCT02593539|Nemiralisib|nemiralisib|mesh-list
64378726|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64369725|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
64369726|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369727|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
64369728|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64369729|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369730|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64369731|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64369732|NCT03204019|Growth Substances|growth substances|mesh-ancestor
64369733|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
64369734|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64369735|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
64369736|NCT02484677|Docetaxel|docetaxel|mesh-list
64369742|NCT02485145|Diclofenac|diclofenac|mesh-list
64369743|NCT02485145|Orphenadrine|orphenadrine|mesh-list
64369744|NCT02485145|Bupivacaine|bupivacaine|mesh-list
64369745|NCT02485145|Baclofen|baclofen|mesh-list
64378841|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64378842|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64378843|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
64378844|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
64378845|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378846|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378847|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378848|NCT02447315|Pilocarpine|pilocarpine|mesh-list
64378849|NCT02447315|Miotics|miotics|mesh-ancestor
64378850|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
64378851|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378852|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378853|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
64378854|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64378855|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
64378856|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378870|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
64378871|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
64378872|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64378873|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64378874|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64378875|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378876|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64378877|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378878|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
64378879|NCT03195023|Diuretics|diuretics|mesh-ancestor
64378880|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
64378881|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64378882|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
64378883|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64378884|NCT03195023|Protective Agents|protective agents|mesh-ancestor
64378885|NCT02446301|Nalbuphine|nalbuphine|mesh-list
64378886|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64378887|NCT02446301|Narcotics|narcotics|mesh-ancestor
64378888|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64378889|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378890|NCT02446301|Analgesics|analgesics|mesh-ancestor
64378891|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
64378892|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378893|NCT04791345|Dexamethasone|dexamethasone|mesh-list
64378895|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
64378896|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64378897|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64378898|NCT04791345|Prednisolone|prednisolone|mesh-list
64378899|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
64378900|NCT04791345|Deflazacort|deflazacort|mesh-list
64378901|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64378902|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
64378912|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378913|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64378914|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64378915|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
64378916|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378917|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378918|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64378919|NCT04791345|Protective Agents|protective agents|mesh-ancestor
64378920|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64378921|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
64378922|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
64378924|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64378925|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378926|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64378927|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
64378972|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
64378973|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378974|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64378975|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64378976|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
64378977|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
64378978|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64378979|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64378980|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64378981|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64378982|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
64378983|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
64379141|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379158|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379159|NCT01626118|Indomethacin|indomethacin|mesh-list
64379160|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64379161|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64379162|NCT01626118|Analgesics|analgesics|mesh-ancestor
64379163|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
64379164|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379165|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379166|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379167|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379168|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
64379169|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
64379170|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64379171|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64379172|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379174|NCT04789005|Phenylephrine|phenylephrine|mesh-list
64379175|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
64379176|NCT04789005|Norepinephrine|norepinephrine|mesh-list
64379177|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64379178|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
64379179|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
64379180|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379181|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379182|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
64379183|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64379184|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
64379185|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379186|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64379187|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64379188|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64379189|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
64379190|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379191|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379199|NCT05469243|Hallucinogens|hallucinogens|mesh-list
64379200|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379201|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64379202|NCT02177266|Colchicine|colchicine|mesh-list
64379203|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
64379204|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379205|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
64379206|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
64379207|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
64379208|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379209|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379210|NCT04788381|Bevacizumab|bevacizumab|mesh-list
64379211|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64379212|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379213|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64379214|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64379215|NCT04788381|Growth Substances|growth substances|mesh-ancestor
64379216|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379217|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
64379218|NCT05474937|Midazolam|midazolam|mesh-list
64379219|NCT05474937|Ketamine|ketamine|mesh-list
64379220|NCT05474937|Propofol|propofol|mesh-list
64379221|NCT05474937|Sevoflurane|sevoflurane|mesh-list
64379222|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64379223|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379224|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379225|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64379226|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
64379227|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
64379228|NCT05474937|Analgesics|analgesics|mesh-ancestor
64379229|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
64379245|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64379246|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379247|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64379248|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64379252|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
64379254|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379256|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
64379257|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64379258|NCT02177032|Antibodies|antibodies|mesh-list
64379259|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
64379315|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379316|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379317|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64379319|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
64379320|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64379322|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64379323|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64379324|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379325|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379326|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64379327|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64379329|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64379330|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64379331|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379332|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64379333|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64379334|NCT05611827|Quercetin|quercetin|mesh-list
64379335|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
64379336|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379337|NCT05611827|Protective Agents|protective agents|mesh-ancestor
64379338|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379339|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
64379340|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64379358|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379359|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64379360|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64379361|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64379362|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379363|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379364|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379365|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379366|NCT05611749|Analgesics|analgesics|mesh-ancestor
64379367|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
64379368|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379415|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379417|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
64379418|NCT04331691|Diuretics|diuretics|mesh-ancestor
64379419|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
64379420|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
64379421|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64379422|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379423|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379424|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
64369746|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
64369747|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
64369748|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369749|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369750|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
64369751|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369752|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64369753|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64369754|NCT02485145|Analgesics|analgesics|mesh-ancestor
64369755|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64369756|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379425|NCT05304273|Letrozole|letrozole|mesh-list
64379426|NCT05304273|Misoprostol|misoprostol|mesh-list
64379427|NCT05304273|Mifepristone|mifepristone|mesh-list
64379428|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379429|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64379430|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64379431|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379432|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379433|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64379434|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
64379435|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379436|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379437|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64379438|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
64379439|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64379440|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64379441|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379442|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
64379443|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64379444|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64379445|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64379446|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64379452|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64379470|NCT02149264|Hormones|hormones|mesh-ancestor
64379471|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379473|NCT05610969|Midazolam|midazolam|mesh-list
64379626|NCT05554731|Hemostatics|hemostatics|mesh-list
64379627|NCT05554731|Coagulants|coagulants|mesh-ancestor
64379628|NCT02172040|Celecoxib|celecoxib|mesh-list
64379629|NCT02172040|Amlodipine|amlodipine|mesh-list
64379630|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64379631|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64379632|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379633|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379634|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64379635|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379636|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379637|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64379638|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64379646|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379647|NCT02367105|Testosterone|testosterone|mesh-list
64379648|NCT02367105|Androgens|androgens|mesh-ancestor
64379649|NCT02367105|Hormones|hormones|mesh-ancestor
64379650|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379651|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379652|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
64379653|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379654|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
64379655|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
64379656|NCT01318317|Plerixafor|plerixafor|mesh-list
64379657|NCT01318317|Rituximab|rituximab|mesh-list
64379658|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
64379659|NCT01318317|Antibodies|antibodies|mesh-list
64379660|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
64379661|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64379663|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
64379664|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379665|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379666|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379667|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64379668|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64379669|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64379670|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
64379671|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379688|NCT05554185|Aspirin|aspirin|mesh-list
64379689|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64379690|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64379691|NCT05554185|Analgesics|analgesics|mesh-ancestor
64379692|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
64379693|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379694|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379695|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379696|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64379697|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64379698|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64379699|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379700|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64379701|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64379702|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379703|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
64379704|NCT05558397|Morphine|morphine|mesh-list
64379705|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64379706|NCT05558397|Narcotics|narcotics|mesh-ancestor
64379707|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379708|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379709|NCT05558397|Analgesics|analgesics|mesh-ancestor
64379710|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
64379711|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379712|NCT05558319|Dexamethasone|dexamethasone|mesh-list
64379713|NCT05558319|Lenalidomide|lenalidomide|mesh-list
64379714|NCT05558319|Bortezomib|bortezomib|mesh-list
64379715|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379716|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
64379717|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
64379718|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379722|NCT05558319|Hormones|hormones|mesh-ancestor
64379725|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379726|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
64379727|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64379728|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64379729|NCT05558319|Growth Substances|growth substances|mesh-ancestor
64379847|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379848|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64379849|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379850|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64379852|NCT02105974|Fluticasone|fluticasone|mesh-list
64379853|NCT02105974|Xhance|xhance|mesh-list
64379854|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379855|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64379856|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
64379857|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379858|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379859|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64379860|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379861|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
64379862|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64379863|NCT02105662|Grazoprevir|grazoprevir|mesh-list
64379864|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
64369757|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64369758|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369759|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369760|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64369761|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64369762|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
64369763|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
64369764|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
64369765|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369766|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64369767|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64369768|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
64369769|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
64369770|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64369771|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64369772|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
64369773|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
64369775|NCT02484755|Gefitinib|gefitinib|mesh-list
64379865|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379866|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
64379867|NCT02142712|Promethazine|promethazine|mesh-list
64379868|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
64379869|NCT02142712|Pantoprazole|pantoprazole|mesh-list
64379879|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379880|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
64379881|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
64379882|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
64379883|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379884|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
64379885|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
64379886|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64379887|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
64379888|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
64379889|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379890|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64379891|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
64379892|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
64379893|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
64379894|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379895|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64379896|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64379897|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
64379898|NCT02105272|Carteolol|carteolol|mesh-list
64379899|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64379900|NCT02105272|Latanoprost|latanoprost|mesh-list
64379901|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64379902|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64379903|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64379913|NCT02141854|Fluticasone|fluticasone|mesh-list
64379929|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
64379930|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379931|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379932|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
64379933|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64379934|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
64379935|NCT02141620|Cocaine|cocaine|mesh-list
64379936|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64379937|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
64379938|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369785|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64369788|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
64369789|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64369790|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64369791|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64369792|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
64369793|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64369794|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64369795|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
64369796|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379939|NCT02141620|Expectorants|expectorants|mesh-ancestor
64379940|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
64379958|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64379960|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
64379961|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64379963|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379965|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
64379966|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
64379967|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379968|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379969|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
64379970|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379971|NCT02587065|Interferons|interferons|mesh-list
64379972|NCT02587065|Interferon-beta|interferon-beta|mesh-list
64379973|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
64379974|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379975|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
64379976|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379977|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
64379986|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379987|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379988|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64379991|NCT05552391|Ketamine|ketamine|mesh-list
64379992|NCT05552391|Bupivacaine|bupivacaine|mesh-list
64379993|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
64379994|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
64379995|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379996|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379997|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
64379998|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379999|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64380000|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64380001|NCT05552391|Analgesics|analgesics|mesh-ancestor
64380002|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64380003|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64380004|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64380005|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
64380006|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380007|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380008|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64380009|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64380010|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
64380011|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64380012|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64380013|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
64380014|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64380037|NCT05551767|Cisplatin|cisplatin|mesh-list
64380038|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
64380039|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380040|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380041|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64380042|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64369797|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369798|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369799|NCT02485067|Urological Agents|urological agents|mesh-ancestor
64369800|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64369801|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64369802|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64369803|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64369804|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369838|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369839|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369840|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
64369841|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369842|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64369843|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64369844|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64369845|NCT03315845|Anesthetics|anesthetics|mesh-list
64369846|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380043|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380044|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64380045|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64380046|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380047|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380049|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380050|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
64380051|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
64380052|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64380053|NCT05547789|Analgesics|analgesics|mesh-ancestor
64380054|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
64380055|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380056|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380057|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380058|NCT05542095|Simvastatin|simvastatin|mesh-list
64380059|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64380060|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64380061|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
64380062|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380063|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64380064|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64380065|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380066|NCT05551221|Tamsulosin|tamsulosin|mesh-list
64380067|NCT05551221|Silodosin|silodosin|mesh-list
64380071|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
64380074|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380075|NCT05551221|Urological Agents|urological agents|mesh-ancestor
64380076|NCT02104804|Insulin|insulin|mesh-list
64380077|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64380078|NCT02104804|Metformin|metformin|mesh-list
64380079|NCT02104804|Saxagliptin|saxagliptin|mesh-list
64380080|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
64380081|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380082|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380083|NCT02104804|Incretins|incretins|mesh-ancestor
64380084|NCT02104804|Hormones|hormones|mesh-ancestor
64380085|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380086|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64380087|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
64380088|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380697|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64380089|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380091|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64380092|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380093|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380094|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380095|NCT05550207|Meloxicam|meloxicam|mesh-list
64380096|NCT05550207|Rizatriptan|rizatriptan|mesh-list
64380097|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64380098|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64380099|NCT05550207|Analgesics|analgesics|mesh-ancestor
64380100|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
64380101|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380110|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
64380119|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380120|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64380121|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64380122|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380123|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380124|NCT05546853|Antidotes|antidotes|mesh-ancestor
64380128|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
64380130|NCT05540145|Antibodies|antibodies|mesh-list
64380131|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64380132|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380133|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
64380134|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
64380135|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
64380136|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380137|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
64380138|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380139|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
64380140|NCT05699655|Apatinib|apatinib|mesh-list
64380141|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380142|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64380143|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380144|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380145|NCT05592327|Citric Acid|citric acid|mesh-list
64380146|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
64380154|NCT05592171|Estrogens|estrogens|mesh-ancestor
64380165|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
64380166|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
64380167|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64380168|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64380169|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380170|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380171|NCT05538507|Memantine|memantine|mesh-list
64380172|NCT05538507|Donepezil|donepezil|mesh-list
64380173|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64380174|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380175|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380176|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
64380177|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380178|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380179|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
64380180|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64380181|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64380182|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
64380183|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64380184|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64380185|NCT05591235|Metformin|metformin|mesh-list
64380186|NCT05591235|Pioglitazone|pioglitazone|mesh-list
64380187|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
64380194|NCT05545527|Hematinics|hematinics|mesh-ancestor
64380217|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
64380218|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64380219|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64380220|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64380221|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64380223|NCT04425681|Osimertinib|osimertinib|mesh-list
64380224|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380225|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380226|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64380227|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64380228|NCT04425681|Growth Substances|growth substances|mesh-ancestor
64380229|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380233|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380234|NCT05545059|Amlodipine|amlodipine|mesh-list
64380235|NCT05545059|Valsartan|valsartan|mesh-list
64380236|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64380237|NCT05545059|Spironolactone|spironolactone|mesh-list
64380238|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64380239|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64380240|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64380241|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380242|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380243|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64380244|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380245|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
64380246|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64380258|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380260|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64380261|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
64380262|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380263|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380264|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64380265|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380266|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64380267|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64380268|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64380269|NCT04991025|Gemcitabine|gemcitabine|mesh-list
64380270|NCT04991025|Carboplatin|carboplatin|mesh-list
64380271|NCT04991025|Nivolumab|nivolumab|mesh-list
64380272|NCT04991025|Pemetrexed|pemetrexed|mesh-list
64380273|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
64380274|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380275|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64380276|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
64380277|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380278|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
64380279|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380280|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380281|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380282|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
64380283|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380284|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380285|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64380286|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64380287|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64380288|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380289|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
64380298|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380299|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
64380300|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380301|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
64380302|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64380303|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64380304|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
64380305|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
64380306|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380307|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
64380308|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64380309|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64380310|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64380311|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
64380312|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
64380313|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380314|NCT04809051|Metronidazole|metronidazole|mesh-list
64380315|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380316|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64380317|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64380318|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64380319|NCT04015869|Pregnanolone|pregnanolone|mesh-list
64380320|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
64380321|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380322|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380323|NCT04677855|Prednisone|prednisone|mesh-list
64380324|NCT04677855|Dutasteride|dutasteride|mesh-list
64380325|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382646|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
64380344|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380346|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64380347|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380348|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380349|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
64380350|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380351|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380353|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380354|NCT02584959|Complement C1s|complement c1s|mesh-list
64380355|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
64380356|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
64380357|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
64380358|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380359|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
64380360|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64380361|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
64380362|NCT05544045|Antacids|antacids|mesh-ancestor
64380363|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380364|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64380365|NCT02584257|Albuterol|albuterol|mesh-list
64380366|NCT02584257|Procaterol|procaterol|mesh-list
64380367|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
64380368|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64380369|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
64380370|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380391|NCT04062201|Isoniazid|isoniazid|mesh-list
64380392|NCT04062201|Linezolid|linezolid|mesh-list
64380393|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
64380394|NCT04062201|Ethambutol|ethambutol|mesh-list
64380395|NCT04062201|Bedaquiline|bedaquiline|mesh-list
64380396|NCT04062201|Clofazimine|clofazimine|mesh-list
64380397|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64380398|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380399|NCT04062201|Renal Agents|renal agents|mesh-ancestor
64380400|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64380401|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64380402|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64380403|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380404|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380405|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380406|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64380407|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64380408|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
64380409|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64380410|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64380411|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
64380412|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64380413|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64380414|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64380415|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
64380416|NCT02583477|Gemcitabine|gemcitabine|mesh-list
64380417|NCT02583477|Paclitaxel|paclitaxel|mesh-list
64380418|NCT02583477|Durvalumab|durvalumab|mesh-list
64380419|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64380420|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64380421|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380437|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
64380438|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380439|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380441|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64380442|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64380443|NCT02583399|Analgesics|analgesics|mesh-ancestor
64380444|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
64380445|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380447|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64380448|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64380449|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64380450|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380451|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380452|NCT02580591|Empagliflozin|empagliflozin|mesh-list
64380453|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64380454|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380455|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380456|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380472|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64380473|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380474|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380475|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380476|NCT05390307|Incretins|incretins|mesh-ancestor
64380477|NCT05390307|Hormones|hormones|mesh-ancestor
64380478|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64380479|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64380480|NCT05319249|Talazoparib|talazoparib|mesh-list
64380481|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64380482|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64380483|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380484|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380485|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
64380486|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
64380487|NCT02577315|Metformin|metformin|mesh-list
64380488|NCT02577315|Empagliflozin|empagliflozin|mesh-list
64380489|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64380490|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380491|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64380493|NCT05529069|Venetoclax|venetoclax|mesh-list
64380522|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64380523|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380524|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
64380525|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
64380526|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
64380527|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380528|NCT03391479|Avelumab|avelumab|mesh-list
64380529|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64380530|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380531|NCT05695287|Propofol|propofol|mesh-list
64380532|NCT05695287|Sevoflurane|sevoflurane|mesh-list
64380533|NCT05695287|Isoflurane|isoflurane|mesh-list
64380534|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64380535|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380540|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64380541|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64380542|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
64380543|NCT03808025|Narcotics|narcotics|mesh-ancestor
64380544|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380545|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380546|NCT03808025|Analgesics|analgesics|mesh-ancestor
64380547|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
64380548|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380549|NCT03009201|Doxorubicin|doxorubicin|mesh-list
64380550|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64380551|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64380552|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380567|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380568|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380569|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
64380570|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64380571|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64380572|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380573|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64380574|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64380575|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64380576|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380577|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380578|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
64380579|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
64380580|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
64380581|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64380582|NCT00408473|Flecainide|flecainide|mesh-list
64380583|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64380584|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64380585|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64380586|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380587|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380588|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
64380589|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
64380590|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380591|NCT00328601|Protective Agents|protective agents|mesh-ancestor
64380592|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380701|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64380702|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
64380703|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380705|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380707|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
64380708|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64380709|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380710|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
64380711|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
64380712|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64380713|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
64380714|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
64380715|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
64380716|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380717|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64380718|NCT05691933|Morphine|morphine|mesh-list
64380719|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64380720|NCT05691933|Narcotics|narcotics|mesh-ancestor
64380721|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380722|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380723|NCT05691933|Analgesics|analgesics|mesh-ancestor
64380724|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
64380729|NCT00977483|Protective Agents|protective agents|mesh-ancestor
64380730|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380731|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
64380732|NCT00977483|Vitamins|vitamins|mesh-ancestor
64380733|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
64380734|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
64380735|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64380736|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380737|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380738|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64380739|NCT02439905|Analgesics|analgesics|mesh-ancestor
64380740|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
64380741|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64380742|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64380743|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64380744|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64380745|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
64380746|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380747|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380749|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
64380750|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380751|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
64380752|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64380753|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64380754|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
64380756|NCT05663073|Irbesartan|irbesartan|mesh-list
64380757|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64380758|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64380759|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380774|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
64380775|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
64380777|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380778|NCT04742673|Guanfacine|guanfacine|mesh-list
64380779|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64380780|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64380781|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64380782|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64380783|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
64380784|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64380785|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64380786|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380787|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
64380788|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64380789|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64380790|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64380791|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64380792|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64380793|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64380794|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64380795|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64380796|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381911|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381912|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64381913|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64381914|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381915|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64381916|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
64381917|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64381918|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381919|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64381920|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
64381921|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64381922|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64381923|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64381924|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
64381925|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64381926|NCT02431013|Protective Agents|protective agents|mesh-ancestor
64381927|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64381928|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64381929|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
64381930|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
64381931|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381936|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381937|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64381938|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64381939|NCT02430545|Rifampin|rifampin|mesh-list
64381940|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64381941|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
64381942|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64381943|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381944|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
64381945|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64381946|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64381947|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381948|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64381949|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64381950|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64381951|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64381952|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64381953|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64381954|NCT03117725|Melatonin|melatonin|mesh-list
64381955|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
64381956|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381957|NCT03117725|Protective Agents|protective agents|mesh-ancestor
64381958|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381959|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381960|NCT03185351|Midazolam|midazolam|mesh-list
64381961|NCT03185351|Bupivacaine|bupivacaine|mesh-list
64381962|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
64381963|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
64381964|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64381965|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381966|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
64381977|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64381978|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64381979|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
64381980|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64381981|NCT02707601|Ledipasvir|ledipasvir|mesh-list
64381982|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
64381983|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
64381984|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64381985|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64381986|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64381988|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
64381989|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64381990|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64381991|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
64381992|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64381994|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
64381995|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
64369847|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369848|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
64369849|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64369850|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
64369851|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64369852|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
64369853|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369854|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369855|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
64369856|NCT04998903|Dimercaprol|dimercaprol|mesh-list
64369857|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
64381996|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
64381997|NCT03183557|Vitamins|vitamins|mesh-ancestor
64381998|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
64382264|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382265|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382306|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64382307|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
64382308|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
64382309|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382310|NCT02421029|Antidotes|antidotes|mesh-ancestor
64382311|NCT02421029|Protective Agents|protective agents|mesh-ancestor
64382313|NCT02139982|Ropivacaine|ropivacaine|mesh-list
64382314|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
64382315|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
64382316|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382317|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382318|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
64382319|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382320|NCT03178643|Piperaquine|piperaquine|mesh-list
64382321|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
64382322|NCT03178643|Amodiaquine|amodiaquine|mesh-list
64382323|NCT03178643|Artenimol|artenimol|mesh-list
64382324|NCT03178643|Proguanil|proguanil|mesh-list
64382325|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
64382326|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64382327|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64382328|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382329|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64382330|NCT03178643|Renal Agents|renal agents|mesh-ancestor
64382331|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
64382332|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382333|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64382354|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
64382355|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64382356|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382357|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382358|NCT04725994|Irinotecan|irinotecan|mesh-list
64382359|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64382360|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64382361|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382362|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382363|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382364|NCT02139046|Naproxen|naproxen|mesh-list
64382365|NCT02139046|Colchicine|colchicine|mesh-list
64382366|NCT02139046|Febuxostat|febuxostat|mesh-list
64382367|NCT02139046|Lansoprazole|lansoprazole|mesh-list
64382368|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
64382448|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64382449|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382450|NCT02046616|Methotrexate|methotrexate|mesh-list
64382451|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64382456|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
64382468|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
64382469|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382470|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382471|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64382472|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382473|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
64382474|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
64382475|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64382476|NCT04706026|Anesthetics|anesthetics|mesh-list
64382477|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64382478|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382479|NCT02068222|Ritonavir|ritonavir|mesh-list
64382480|NCT02068222|Ribavirin|ribavirin|mesh-list
64382481|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64382482|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64382483|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382484|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382485|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382486|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64382487|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64382488|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
64382489|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382490|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64382491|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64382516|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
64382648|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
64382517|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382518|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64382519|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382521|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
64382522|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64382523|NCT02099110|Glimepiride|glimepiride|mesh-list
64382524|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
64382525|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64382526|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382527|NCT02099110|Incretins|incretins|mesh-ancestor
64382528|NCT02099110|Hormones|hormones|mesh-ancestor
64382529|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382576|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382577|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382578|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64382580|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
64382581|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64382582|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382583|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64382584|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382585|NCT05521347|Caffeine|caffeine|mesh-list
64382586|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64382587|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382588|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64382589|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382592|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64382593|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
64382594|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382595|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64382596|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
64382597|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382598|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
64382599|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382600|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
64382601|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
64382602|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
64382603|NCT05093517|Volagidemab|volagidemab|mesh-list
64382604|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64382605|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382606|NCT02420171|Insulin|insulin|mesh-list
64382607|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64382608|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382614|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382615|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
64382616|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
64382617|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64382618|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64382619|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
64382620|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382621|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382622|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
64382623|NCT02423759|Gentamicins|gentamicins|mesh-list
64369858|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
64369859|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369860|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64369891|NCT03200821|Gemcitabine|gemcitabine|mesh-list
64369892|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64369893|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
64369894|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369895|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369896|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
64369897|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64369898|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369899|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64369900|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
64382624|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64382625|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382626|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64382627|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64382628|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382629|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382630|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382631|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64382632|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64382633|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64382634|NCT01623310|Fluticasone|fluticasone|mesh-list
64382636|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382637|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64382638|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
64382639|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382640|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382641|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64382642|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
64382643|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
64382644|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64382645|NCT03180125|Lidocaine|lidocaine|mesh-list
64382661|NCT03180125|Protective Agents|protective agents|mesh-ancestor
64382663|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64382664|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382665|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
64382666|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
64382667|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
64382668|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382669|NCT03178409|Liver Extracts|liver extracts|mesh-list
64382670|NCT03178409|Hematinics|hematinics|mesh-ancestor
64382671|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64382672|NCT03180281|Glimepiride|glimepiride|mesh-list
64382673|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64382674|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382707|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382708|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
64382709|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382710|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
64382711|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64382712|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382713|NCT02419859|Insulin|insulin|mesh-list
64382714|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64382715|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64382716|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382717|NCT02419235|Ethanol|ethanol|mesh-list
64382718|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64382719|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382720|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369901|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369904|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64369905|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64369906|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
64369907|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
64369908|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
64369909|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369910|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64369911|NCT02483897|Tetracaine|tetracaine|mesh-list
64369912|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64369913|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
64369914|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
64369915|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369916|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64369937|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64382721|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382722|NCT02422823|Epinephrine|epinephrine|mesh-list
64382723|NCT02422823|Carticaine|carticaine|mesh-list
64382724|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64382725|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64382726|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
64382727|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382728|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382729|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382730|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64382731|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64382732|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
64382733|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382734|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64382756|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
64382757|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
64382758|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382759|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382761|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382762|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64382763|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382764|NCT02422199|Capecitabine|capecitabine|mesh-list
64382765|NCT02422199|Lapatinib|lapatinib|mesh-list
64382766|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64382767|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
64382768|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382769|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382770|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64382771|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382772|NCT02416739|Niacinamide|niacinamide|mesh-list
64382774|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
64382822|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382823|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382824|NCT02415881|Panitumumab|panitumumab|mesh-list
64382825|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64382826|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382827|NCT02415803|Clopidogrel|clopidogrel|mesh-list
64382828|NCT02415803|Ticagrelor|ticagrelor|mesh-list
64382829|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64382830|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64382831|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64382832|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64382833|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
64382834|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64382869|NCT02415335|Dexamethasone|dexamethasone|mesh-list
64382881|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382883|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382884|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382885|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382886|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382887|NCT02415257|Gentamicins|gentamicins|mesh-list
64382888|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64382889|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64382891|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382920|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382921|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
64382922|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
64382923|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
64382924|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382925|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
64382926|NCT02414945|Fludarabine|fludarabine|mesh-list
64382927|NCT02414945|Interleukin-2|interleukin-2|mesh-list
64382928|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382929|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
64382930|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382931|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382932|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64382933|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
64382934|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382935|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382936|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64382937|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64382938|NCT02414945|Analgesics|analgesics|mesh-ancestor
64382940|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382941|NCT02414555|Phenylephrine|phenylephrine|mesh-list
64382942|NCT02414555|Norepinephrine|norepinephrine|mesh-list
64382943|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64382944|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64382945|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
64382946|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
64382947|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382948|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382949|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
64382950|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
64382959|NCT02414399|Azithromycin|azithromycin|mesh-list
64382965|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64382966|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
64382967|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64382968|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64382969|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64382970|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
64382971|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382972|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382973|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64382974|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64382975|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
64382976|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
64382977|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64382978|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64382979|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
64382980|NCT02046070|Hormones|hormones|mesh-ancestor
64382981|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64382982|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64382983|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
64382984|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64382985|NCT04992065|Evolocumab|evolocumab|mesh-list
64382986|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64382988|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
64382989|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382990|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64382991|NCT01663857|Gemcitabine|gemcitabine|mesh-list
64382992|NCT01663857|Carboplatin|carboplatin|mesh-list
64382993|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64382994|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64382995|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
64382996|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382997|NCT01663857|Antiviral Agents|antiviral agents|mesh-ancestor
64382998|NCT01663857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383539|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
64369938|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64369939|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64369940|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64369941|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64369942|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64369943|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369944|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
64383540|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64383541|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64383542|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64383543|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64383544|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
64383545|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383546|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64383547|NCT02566005|Misoprostol|misoprostol|mesh-list
64383548|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64383549|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
64383550|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64383551|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383552|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64383553|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64383554|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
64383555|NCT02408393|Ropivacaine|ropivacaine|mesh-list
64383556|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
64383557|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
64383558|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383559|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383560|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
64383561|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383562|NCT05041335|Heparin|heparin|mesh-list
64383563|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
64383564|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64383579|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383580|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64383581|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64383582|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
64383583|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383584|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383585|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64383586|NCT03173339|Remifentanil|remifentanil|mesh-list
64383587|NCT03173339|Sevoflurane|sevoflurane|mesh-list
64383588|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64383589|NCT03173339|Narcotics|narcotics|mesh-ancestor
64383590|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383591|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383592|NCT03173339|Analgesics|analgesics|mesh-ancestor
64383593|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
64383594|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383595|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64383596|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64383597|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
64383621|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
64383622|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
64383623|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64383624|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
64383625|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
64383626|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383627|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383628|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383629|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64383632|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64383633|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
64383634|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64383635|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64383636|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64383637|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369946|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369947|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369948|NCT04492319|Neostigmine|neostigmine|mesh-list
64369949|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64369950|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64369951|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64369952|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
64369953|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64369993|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
64369994|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64369995|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
64369996|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64369997|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
64369998|NCT05437835|Ropivacaine|ropivacaine|mesh-list
64369999|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
64370000|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
64370001|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370002|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383638|NCT02408003|Protective Agents|protective agents|mesh-ancestor
64383639|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383640|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64383642|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64383643|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383644|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383645|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64383646|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
64383647|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
64383648|NCT02406911|Ticagrelor|ticagrelor|mesh-list
64383649|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64383856|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383857|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383858|NCT04701034|Prednisolone|prednisolone|mesh-list
64383859|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
64383860|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64383861|NCT04701034|Antibodies|antibodies|mesh-list
64383862|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
64383863|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64383864|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383865|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
64383866|NCT04701034|Hormones|hormones|mesh-ancestor
64383867|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383868|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383869|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64383870|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383871|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
64383872|NCT01663623|Azathioprine|azathioprine|mesh-list
64383873|NCT01663623|Belimumab|belimumab|mesh-list
64383886|NCT05504967|Ropivacaine|ropivacaine|mesh-list
64383887|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383888|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
64383889|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
64383890|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64383891|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383892|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64383893|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
64383894|NCT05504967|Hormones|hormones|mesh-ancestor
64370003|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
64370004|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370006|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
64370007|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370008|NCT05429489|Morphine|morphine|mesh-list
64370009|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64370010|NCT05429489|Narcotics|narcotics|mesh-ancestor
64370011|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370012|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370013|NCT05429489|Analgesics|analgesics|mesh-ancestor
64370014|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
64370015|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370016|NCT04997967|Ketamine|ketamine|mesh-list
64370017|NCT04997967|Propofol|propofol|mesh-list
64370019|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370042|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64383895|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383896|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64383897|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64383898|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
64383899|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
64383900|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64383901|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
64383902|NCT02565147|Heparin|heparin|mesh-list
64383903|NCT02565147|Bivalirudin|bivalirudin|mesh-list
64383920|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64383921|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64383922|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
64383923|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
64383924|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64383925|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64383926|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64383927|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64383928|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
64383929|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383930|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383931|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
64383932|NCT02061280|Hormones|hormones|mesh-ancestor
64383933|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64383934|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
64383935|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
64383936|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64383937|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
64383938|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64383939|NCT04664361|Niacinamide|niacinamide|mesh-list
64383940|NCT04664361|Niacin|niacin|mesh-list
64383941|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
64383942|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
64383943|NCT04664361|Vitamins|vitamins|mesh-ancestor
64383947|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
64383963|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64383964|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64383965|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64383966|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
64383967|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
64383968|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64383969|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64383970|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
64383971|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
64383972|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64383973|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64383975|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
64384015|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384016|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
64384017|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384019|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64384020|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64384324|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384325|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384326|NCT02700815|Diclofenac|diclofenac|mesh-list
64384327|NCT02700815|Capsaicin|capsaicin|mesh-list
64384328|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64384329|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64384330|NCT02700815|Analgesics|analgesics|mesh-ancestor
64384334|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384344|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384345|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384346|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64384347|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64384348|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64384350|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64384351|NCT02402621|Narcotics|narcotics|mesh-ancestor
64384352|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384353|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384354|NCT02402621|Analgesics|analgesics|mesh-ancestor
64384355|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
64384356|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384357|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64384358|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64384359|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
64384360|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
64384361|NCT04481789|Furosemide|furosemide|mesh-list
64384362|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
64384363|NCT04481789|Edaravone|edaravone|mesh-list
64384364|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
64384365|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64384366|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64384367|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
64384369|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64384395|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384396|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64384397|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
64384398|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384399|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384400|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
64384401|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64384402|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
64384403|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
64384404|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384405|NCT02402231|Omalizumab|omalizumab|mesh-list
64384406|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64384407|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64384408|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
64384409|NCT02402543|Acetaminophen|acetaminophen|mesh-list
64384410|NCT02402543|Dexamethasone|dexamethasone|mesh-list
64384411|NCT02402543|Ketamine|ketamine|mesh-list
64384412|NCT02402543|Gabapentin|gabapentin|mesh-list
64384413|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384414|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
64384415|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
64384416|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384417|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384418|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64384419|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
64384420|NCT02402543|Hormones|hormones|mesh-ancestor
64384421|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384422|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384423|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384424|NCT02402543|Analgesics|analgesics|mesh-ancestor
64384425|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
64384426|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64384427|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64384428|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
64384429|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
64384430|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384433|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384434|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384435|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370043|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
64370044|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
64370045|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64370046|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370047|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370048|NCT02483195|Urological Agents|urological agents|mesh-ancestor
64370049|NCT02450773|Furosemide|furosemide|mesh-list
64370050|NCT02450773|Diuretics|diuretics|mesh-ancestor
64384437|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
64384438|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64384439|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64384440|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64384441|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
64384442|NCT02401295|Itraconazole|itraconazole|mesh-list
64384443|NCT02401295|Celecoxib|celecoxib|mesh-list
64384445|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64384446|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64384447|NCT02401295|Analgesics|analgesics|mesh-ancestor
64384448|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
64384449|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384450|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384451|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384452|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384453|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64384454|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64384455|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384456|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384457|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
64384458|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384459|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64384460|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64384461|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64384462|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
64384463|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384464|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64384466|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
64384467|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
64384468|NCT00708305|Listerine|listerine|mesh-list
64384469|NCT00708305|Fluorides|fluorides|mesh-list
64384470|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
64384471|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
64384472|NCT00708305|Protective Agents|protective agents|mesh-ancestor
64384473|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384474|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64384475|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384476|NCT03169127|Ibuprofen|ibuprofen|mesh-list
64384477|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64384478|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64384479|NCT03169127|Analgesics|analgesics|mesh-ancestor
64384480|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
64384481|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384482|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384483|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384484|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384485|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64384486|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384487|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384488|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64384500|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384501|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384502|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
64384503|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
64384504|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64384505|NCT02418065|Testosterone|testosterone|mesh-list
64384506|NCT02418065|Androgens|androgens|mesh-ancestor
64384507|NCT02418065|Hormones|hormones|mesh-ancestor
64370051|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
64370052|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370053|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64370054|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64370055|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370056|NCT02450149|Sorafenib|sorafenib|mesh-list
64370057|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370058|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64370059|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384508|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384509|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384510|NCT05058443|Denosumab|denosumab|mesh-list
64384511|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64384539|NCT02055976|Ezetimibe|ezetimibe|mesh-list
64384540|NCT02055976|Bococizumab|bococizumab|mesh-list
64384541|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64384542|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64384543|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
64384544|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384545|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64384546|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
64384547|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64384548|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64384549|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
64384550|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
64384551|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384552|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384553|NCT04406259|Verapamil|verapamil|mesh-list
64384554|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64384555|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64384556|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384751|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64384557|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384558|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64384559|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384560|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
64384561|NCT04603911|Dexamethasone|dexamethasone|mesh-list
64384562|NCT04603911|Clonidine|clonidine|mesh-list
64384563|NCT04603911|Epinephrine|epinephrine|mesh-list
64384564|NCT04603911|Bupivacaine|bupivacaine|mesh-list
64384565|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384567|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
64384568|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384575|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384576|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
64384578|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384579|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
64384580|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64384581|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64384582|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
64384583|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384584|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384585|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64384586|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64384587|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64384588|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
64384589|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
64384590|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
64384591|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64384592|NCT04603911|Analgesics|analgesics|mesh-ancestor
64384593|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64384594|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
64384595|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64384596|NCT05498025|Charcoal|charcoal|mesh-list
64384619|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384620|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384621|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
64384622|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384623|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384624|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64384625|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64384626|NCT02400047|Analgesics|analgesics|mesh-ancestor
64384627|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
64384628|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384629|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64384630|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
64384631|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64384632|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
64384633|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384634|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
64384635|NCT02698865|Protective Agents|protective agents|mesh-ancestor
64384636|NCT05499897|Anesthetics|anesthetics|mesh-list
64384676|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384677|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384678|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384679|NCT03177239|Nivolumab|nivolumab|mesh-list
64384680|NCT03177239|Ipilimumab|ipilimumab|mesh-list
64384681|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64384682|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384683|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64384684|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384685|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
64384686|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64384689|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
64384737|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
64384738|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384739|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64384740|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64384741|NCT03106571|Methamphetamine|methamphetamine|mesh-list
64384743|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384745|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
64384746|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384747|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
64384748|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384749|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384750|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
64384752|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64384753|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384754|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64384755|NCT03177083|Interferons|interferons|mesh-list
64384756|NCT03177083|Interferon-beta|interferon-beta|mesh-list
64384757|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
64384758|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
64384759|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384760|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
64384761|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384762|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
64384763|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384764|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64384765|NCT03629925|Gemcitabine|gemcitabine|mesh-list
64384766|NCT03629925|Carboplatin|carboplatin|mesh-list
64384767|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384768|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64384769|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
64384770|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384771|NCT03629925|Antiviral Agents|antiviral agents|mesh-ancestor
64384772|NCT03629925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384773|NCT03629925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384774|NCT03629925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64384775|NCT03629925|Immunologic Factors|immunologic factors|mesh-ancestor
64384776|NCT03629925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384777|NCT02398487|Nicotine|nicotine|mesh-list
64384778|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64384779|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
64384780|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384781|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384782|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64384783|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64384784|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
64378827|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64378828|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378829|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378830|NCT03195257|Glucagon|glucagon|mesh-list
64378831|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
64378832|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
64378833|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64378834|NCT03195257|Hormones|hormones|mesh-ancestor
64378835|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64378836|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64378837|NCT03195257|Incretins|incretins|mesh-ancestor
64378838|NCT02447393|Cetirizine|cetirizine|mesh-list
64378839|NCT02447393|Levocetirizine|levocetirizine|mesh-list
64384785|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384786|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384787|NCT02697617|Pioglitazone|pioglitazone|mesh-list
64384788|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64384789|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384790|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
64384794|NCT02396225|Voriconazole|voriconazole|mesh-list
64384817|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64384818|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384819|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64384850|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64384851|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
64384852|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384853|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384854|NCT03168035|NC-4016|nc-4016|mesh-list
64384855|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384856|NCT02397395|Simeprevir|simeprevir|mesh-list
64384857|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
64384858|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64384890|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64384891|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384892|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384893|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
64384894|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384895|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64384896|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
64384897|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64384898|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64384899|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64384900|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64384901|NCT04311723|Anesthetics|anesthetics|mesh-list
64384902|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64384903|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384904|NCT05498337|Calcium|calcium|mesh-list
64384905|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64384906|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384944|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384945|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384946|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64384947|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64384948|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64384949|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64384950|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64384951|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64384952|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64384953|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370060|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370061|NCT02479217|Docetaxel|docetaxel|mesh-list
64370062|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370063|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
64370064|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
64370065|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
64370069|NCT02479529|Norepinephrine|norepinephrine|mesh-list
64370070|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64370071|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64370072|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
64370073|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370082|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
64370083|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370084|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370085|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64370086|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
64370087|NCT03213769|Ubiquinone|ubiquinone|mesh-list
64370088|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
64384955|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64384956|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64384957|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64384958|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
64384959|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64384960|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
64384962|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64384963|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64384964|NCT05493267|Analgesics|analgesics|mesh-ancestor
64384965|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
64384966|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64384967|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64384968|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64384993|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64384994|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64384995|NCT04176705|Lidocaine|lidocaine|mesh-list
64384996|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64384997|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
64384998|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
64384999|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385000|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385001|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
64385002|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385003|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64385004|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64385005|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64385006|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64385007|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385008|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385009|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
64385012|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385013|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
64385014|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385015|NCT05492019|Doxycycline|doxycycline|mesh-list
64385016|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64385017|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385018|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
64385019|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64385020|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64385022|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64370089|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
64370090|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370091|NCT03213769|Vitamins|vitamins|mesh-ancestor
64370093|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
64370094|NCT05002101|Trace Elements|trace elements|mesh-ancestor
64370095|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
64370096|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370097|NCT05002101|Astringents|astringents|mesh-ancestor
64370098|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370099|NCT03201913|Estrogens|estrogens|mesh-list
64370100|NCT03201913|Hormones|hormones|mesh-ancestor
64370101|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370102|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370103|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
64370104|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
64385023|NCT05491785|Narcotics|narcotics|mesh-ancestor
64385024|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385025|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385026|NCT05491785|Analgesics|analgesics|mesh-ancestor
64385028|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385030|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385031|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385032|NCT05484375|Capecitabine|capecitabine|mesh-list
64385033|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64385034|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
64385035|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385036|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385037|NCT05480007|Metformin|metformin|mesh-list
64385038|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64385039|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64385040|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385041|NCT05480007|Incretins|incretins|mesh-ancestor
64385042|NCT05480007|Hormones|hormones|mesh-ancestor
64385048|NCT05489601|Oxycodone|oxycodone|mesh-list
64385077|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385079|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64385080|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
64385081|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385082|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385083|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64385084|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
64385085|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
64385086|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
64385087|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385088|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64385089|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64385090|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64385091|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385092|NCT03748095|Tazobactam|tazobactam|mesh-list
64385093|NCT03748095|Piperacillin|piperacillin|mesh-list
64385094|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64385095|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385096|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
64385097|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385098|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385099|NCT04275375|Anesthetics|anesthetics|mesh-list
64385100|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385111|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385116|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64385118|NCT04543071|Antiviral Agents|antiviral agents|mesh-ancestor
64385119|NCT04543071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370105|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64370106|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
64370107|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64370108|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370109|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64370110|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64370131|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370133|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
64370134|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64385120|NCT04543071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385121|NCT04543071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385122|NCT04543071|Immunologic Factors|immunologic factors|mesh-ancestor
64385123|NCT04543071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385124|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385125|NCT05487963|Tofacitinib|tofacitinib|mesh-list
64385126|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385127|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64385128|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385129|NCT05487885|Ketamine|ketamine|mesh-list
64385130|NCT05487885|Analgesics|analgesics|mesh-ancestor
64385131|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
64385132|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385133|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385134|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64385135|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64385136|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
64385137|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
64385138|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385139|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64385140|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64385141|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385142|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385144|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64385146|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385147|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385148|NCT03605901|Analgesics|analgesics|mesh-ancestor
64385149|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
64385150|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385151|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
64385152|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
64385153|NCT05487807|Nicotine|nicotine|mesh-list
64385154|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
64385155|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
64385156|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385157|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385158|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
64385159|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64385160|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
64385161|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385162|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385163|NCT05487261|Valsartan|valsartan|mesh-list
64385164|NCT05487261|Enalapril|enalapril|mesh-list
64385197|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
64385198|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
64385199|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385200|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385201|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
64385202|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385203|NCT05481957|Vortioxetine|vortioxetine|mesh-list
64385204|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
64385205|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64385206|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64385207|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64385208|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385209|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385210|NCT05481957|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64385211|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64385212|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64385213|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385214|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385215|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
64385216|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64385217|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64385218|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64385219|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64385220|NCT05475561|Bupivacaine|bupivacaine|mesh-list
64385221|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
64385222|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
64385223|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385224|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385225|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
64385226|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385227|NCT05476341|Bevacizumab|bevacizumab|mesh-list
64385228|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385229|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385230|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64385231|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64385232|NCT05476341|Growth Substances|growth substances|mesh-ancestor
64385233|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385234|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
64385235|NCT05481723|Norepinephrine|norepinephrine|mesh-list
64385236|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64385238|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
64385239|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385240|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385241|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385242|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
64385243|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
64385244|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385245|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64385247|NCT05481645|Carboplatin|carboplatin|mesh-list
64385248|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64385249|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385250|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
64385251|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
64385252|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
64385253|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385254|NCT04272021|Methylphenidate|methylphenidate|mesh-list
64385255|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64385256|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385257|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64385258|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64385259|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64385273|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64385274|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
64385275|NCT03426891|Temozolomide|temozolomide|mesh-list
64385276|NCT03426891|Vorinostat|vorinostat|mesh-list
64385277|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
64385278|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385279|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385280|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64385281|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
64385282|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385283|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385284|NCT02697773|Tanezumab|tanezumab|mesh-list
64385285|NCT02697773|Analgesics|analgesics|mesh-ancestor
64385286|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
64385287|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385288|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385289|NCT02394821|Metronidazole|metronidazole|mesh-list
64385290|NCT02394821|Polihexanide|polihexanide|mesh-list
64385291|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385292|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64385293|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64385294|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64385295|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
64370135|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64370136|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64370137|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
64370138|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64370139|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64370140|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370141|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
64370142|NCT03071679|Imiquimod|imiquimod|mesh-list
64370143|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64370144|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
64370145|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370146|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370147|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
64385296|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64385297|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64385557|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
64385298|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385299|NCT05745857|Bevacizumab|bevacizumab|mesh-list
64385300|NCT05745857|Cetuximab|cetuximab|mesh-list
64385301|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385302|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385303|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64385304|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64385305|NCT05745857|Growth Substances|growth substances|mesh-ancestor
64385306|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385307|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
64385308|NCT05745779|Vitamin D|vitamin d|mesh-list
64385309|NCT05745779|Vitamins|vitamins|mesh-list
64385310|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
64385316|NCT05745779|Hematinics|hematinics|mesh-ancestor
64385317|NCT02394197|Chloroquine|chloroquine|mesh-list
64385318|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
64385319|NCT02394197|Primaquine|primaquine|mesh-list
64385320|NCT02394197|Amebicides|amebicides|mesh-ancestor
64385321|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64385322|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64385323|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385324|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
64385325|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385333|NCT02394197|Filaricides|filaricides|mesh-ancestor
64385334|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
64385335|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
64385336|NCT02394119|Rituximab|rituximab|mesh-list
64385337|NCT02394119|Ofatumumab|ofatumumab|mesh-list
64385338|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385339|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385340|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
64385341|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385342|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385343|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
64385344|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64385345|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
64385346|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385347|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
64385348|NCT03167333|Protective Agents|protective agents|mesh-ancestor
64385349|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
64385350|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64385351|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64385352|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385353|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
64385354|NCT02393963|Coagulants|coagulants|mesh-ancestor
64385355|NCT03115619|Pirfenidone|pirfenidone|mesh-list
64385356|NCT03115619|Analgesics|analgesics|mesh-ancestor
64385357|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
64385358|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370148|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370149|NCT03199261|Exenatide|exenatide|mesh-list
64370150|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370151|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370152|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64370153|NCT03199261|Incretins|incretins|mesh-ancestor
64370154|NCT03199261|Hormones|hormones|mesh-ancestor
64370155|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370158|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370159|NCT04990713|Ropivacaine|ropivacaine|mesh-list
64370160|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
64385359|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385360|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64385361|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64385362|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385363|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385364|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385365|NCT02393573|Metformin|metformin|mesh-list
64385366|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64385367|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385368|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
64385369|NCT05745467|Povidone|povidone|mesh-list
64385370|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
64385371|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
64385372|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64385373|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385374|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
64385375|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64385376|NCT02693171|Dinutuximab|dinutuximab|mesh-list
64385377|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385387|NCT02392793|Lenograstim|lenograstim|mesh-list
64385388|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64385389|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64385390|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385391|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385392|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385393|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64385394|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
64385395|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385396|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64385397|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
64385398|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64385399|NCT03167177|Leucovorin|leucovorin|mesh-list
64385400|NCT03167177|Paclitaxel|paclitaxel|mesh-list
64385401|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
64385402|NCT03167177|Bevacizumab|bevacizumab|mesh-list
64385403|NCT03167177|Fluorouracil|fluorouracil|mesh-list
64385404|NCT03167177|Capecitabine|capecitabine|mesh-list
64385407|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64385408|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385409|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64385410|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64385411|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64385431|NCT03167177|Vitamins|vitamins|mesh-ancestor
64385438|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64385439|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385440|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
64385441|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385442|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
64385443|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64385444|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
64385445|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385446|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
64385447|NCT03166865|Protective Agents|protective agents|mesh-ancestor
64385448|NCT03166787|Tadalafil|tadalafil|mesh-list
64385449|NCT03166787|Charcoal|charcoal|mesh-list
64385450|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
64370161|NCT04990713|Anesthetics|anesthetics|mesh-list
64370162|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370163|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370164|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
64370165|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370166|NCT04990791|Aspirin|aspirin|mesh-list
64370167|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
64370168|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64370169|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370170|NCT04990791|Analgesics|analgesics|mesh-ancestor
64370171|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
64370172|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64378840|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64385451|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385452|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385453|NCT03166787|Protective Agents|protective agents|mesh-ancestor
64385454|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
64385455|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64385456|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64385457|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385458|NCT03166787|Urological Agents|urological agents|mesh-ancestor
64385459|NCT03166787|Antidotes|antidotes|mesh-ancestor
64385460|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
64385461|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
64385462|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385463|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
64385490|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64385491|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385492|NCT05232227|Primaquine|primaquine|mesh-list
64385493|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
64385494|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64385495|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64385496|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385497|NCT05744375|Trastuzumab|trastuzumab|mesh-list
64385498|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385499|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385500|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
64385501|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385502|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385503|NCT02552355|Metformin|metformin|mesh-list
64385504|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64385505|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385506|NCT02551731|Cannabidiol|cannabidiol|mesh-list
64385507|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
64385508|NCT04479657|Cefuroxime|cefuroxime|mesh-list
64385509|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
64385510|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64385511|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385512|NCT05475873|Ondansetron|ondansetron|mesh-list
64385513|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
64385514|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
64385540|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385541|NCT02542605|Analgesics|analgesics|mesh-ancestor
64385542|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
64385543|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385544|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385545|NCT02542605|Growth Substances|growth substances|mesh-ancestor
64385546|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
64385547|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385548|NCT02723955|Gemcitabine|gemcitabine|mesh-list
64385549|NCT02723955|Paclitaxel|paclitaxel|mesh-list
64385550|NCT02723955|Docetaxel|docetaxel|mesh-list
64385551|NCT02723955|Carboplatin|carboplatin|mesh-list
64385552|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
64385553|NCT02723955|Fluorouracil|fluorouracil|mesh-list
64370173|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370174|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370175|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370176|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64370177|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64370178|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370179|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64370180|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64370181|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370182|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
64385555|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64385556|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385560|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385561|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64385563|NCT02723955|Antiviral Agents|antiviral agents|mesh-ancestor
64385564|NCT02723955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385565|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385566|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385567|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
64385568|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385569|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385570|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64385571|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64385572|NCT03299049|Rilpivirine|rilpivirine|mesh-list
64385573|NCT03299049|Cabotegravir|cabotegravir|mesh-list
64385574|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64385575|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64385576|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385578|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
64385579|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385580|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64385581|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64385582|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64385583|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64385584|NCT02550795|Dexamethasone|dexamethasone|mesh-list
64385585|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
64385586|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385587|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
64385588|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
64385589|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385590|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385591|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64385592|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
64385593|NCT02550795|Hormones|hormones|mesh-ancestor
64385594|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385595|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64385596|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385597|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64385598|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385599|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64385600|NCT02550795|Analgesics|analgesics|mesh-ancestor
64385601|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
64385602|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64385603|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64385604|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64385605|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
64385606|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385607|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385608|NCT02541903|Afatinib|afatinib|mesh-list
64385609|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385610|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64385611|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385613|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
64370183|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64370184|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
64370185|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64370186|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
64370187|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
64370188|NCT03201835|Nabiximols|nabiximols|mesh-list
64370220|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
64370221|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370222|NCT02482649|Methylphenidate|methylphenidate|mesh-list
64370223|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
64370224|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64370225|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370226|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64370227|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64385625|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64385626|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385627|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385628|NCT05453799|Antibodies|antibodies|mesh-list
64385629|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
64385630|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
64385631|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
64385632|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385633|NCT05453487|Vaccines|vaccines|mesh-list
64385634|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
64385635|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385660|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385661|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
64385663|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64385664|NCT05451615|Abatacept|abatacept|mesh-list
64385665|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
64385666|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64385667|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385668|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385669|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385670|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
64385671|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385673|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64385674|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385676|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385677|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385678|NCT02534883|Misoprostol|misoprostol|mesh-list
64385679|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64385680|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
64385681|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64385682|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385683|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64385684|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64385685|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
64385686|NCT05626439|Alprazolam|alprazolam|mesh-list
64385687|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64385688|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385689|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385690|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64385691|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64385692|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64385693|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
64385694|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
64385695|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385696|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385697|NCT02547987|Carboplatin|carboplatin|mesh-list
64370229|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370230|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
64370231|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370232|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
64370233|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
64370235|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64370236|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64370237|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370238|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370239|NCT02478281|Methylene Blue|methylene blue|mesh-list
64370240|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385698|NCT02547987|Docetaxel|docetaxel|mesh-list
64385699|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385700|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
64385701|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
64385702|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
64385703|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385705|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385706|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385707|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
64385708|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64385709|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385710|NCT02540265|Meloxicam|meloxicam|mesh-list
64385713|NCT02540265|Analgesics|analgesics|mesh-ancestor
64385752|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64385753|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64385754|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385755|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385756|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64385757|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385758|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385759|NCT03206073|Durvalumab|durvalumab|mesh-list
64385760|NCT03206073|Tremelimumab|tremelimumab|mesh-list
64385762|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385763|NCT03190941|Aldesleukin|aldesleukin|mesh-list
64385764|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
64385765|NCT03190941|Fludarabine|fludarabine|mesh-list
64385766|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385767|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
64385768|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385769|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385770|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64385771|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
64385772|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385773|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385774|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64385775|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64385776|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64385777|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
64385778|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385780|NCT03142893|Dexamethasone|dexamethasone|mesh-list
64385781|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
64385782|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
64385783|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
64385784|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64385785|NCT03142893|Hormones|hormones|mesh-list
64385786|NCT03142893|Cosyntropin|cosyntropin|mesh-list
64385806|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64385807|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64385808|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
64385809|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64385810|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
64385813|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
64385814|NCT05428215|Estrogens|estrogens|mesh-ancestor
64385815|NCT05428215|Hormones|hormones|mesh-ancestor
64385816|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385817|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385818|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64385819|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
64385820|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64385821|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64385822|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64385823|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
64385824|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64385825|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
64385826|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
64385827|NCT03073785|Fluorouracil|fluorouracil|mesh-list
64385828|NCT03073785|Capecitabine|capecitabine|mesh-list
64385829|NCT03073785|Imidazole|imidazole|mesh-list
64385830|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
64385831|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385832|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64385833|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385834|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64385835|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
64385836|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385837|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64385838|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64385839|NCT02420613|Sirolimus|sirolimus|mesh-list
64385885|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64385886|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64385887|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385888|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385889|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
64385890|NCT03165383|Morphine|morphine|mesh-list
64385891|NCT03165383|Bupivacaine|bupivacaine|mesh-list
64385892|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
64385893|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
64385894|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64385895|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385896|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
64385897|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385898|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64385899|NCT03165383|Narcotics|narcotics|mesh-ancestor
64385900|NCT03165383|Analgesics|analgesics|mesh-ancestor
64385901|NCT03162185|Citalopram|citalopram|mesh-list
64385933|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64385934|NCT05426031|Protamines|protamines|mesh-list
64385935|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
64385936|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385937|NCT05426031|Coagulants|coagulants|mesh-ancestor
64385938|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
64385939|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
64385940|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64385941|NCT05464173|Fulvestrant|fulvestrant|mesh-list
64385942|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64385943|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64385944|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64385945|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64385946|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
64385965|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385966|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64385967|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64385968|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64385969|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64385970|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
64385971|NCT02683109|Olodaterol|olodaterol|mesh-list
64385972|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64385973|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
64385974|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64385975|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385976|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64385977|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
64385978|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
64385979|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64385980|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
64385981|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64385982|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64385985|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64385986|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
64385987|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64385988|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64385989|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
64385990|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
64386010|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
64386011|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64386012|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386013|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386014|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386016|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64386017|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386018|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386019|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386020|NCT02536833|Lorecivivint|lorecivivint|mesh-list
64386021|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64386022|NCT02680847|Naltrexone|naltrexone|mesh-list
64386023|NCT02680847|Oxycodone|oxycodone|mesh-list
64386024|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64386025|NCT02680847|Narcotics|narcotics|mesh-ancestor
64386026|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386027|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386028|NCT02680847|Analgesics|analgesics|mesh-ancestor
64386044|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386045|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386046|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64386047|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
64386048|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64386049|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386050|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
64386051|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
64386052|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386053|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64386054|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64386055|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64386056|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64386057|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64386058|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
64386059|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64386060|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386061|NCT05127395|Acyclovir|acyclovir|mesh-list
64386062|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
64386063|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64386064|NCT02532855|Metformin|metformin|mesh-list
64386065|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64386066|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
64386067|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64386068|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386069|NCT02532855|Incretins|incretins|mesh-ancestor
64386070|NCT02532855|Hormones|hormones|mesh-ancestor
64386071|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386072|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64386073|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
64386074|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386075|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386076|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64386077|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
64386078|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
64386082|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64386083|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64386084|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
64386085|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386086|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386087|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64386088|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386089|NCT02530125|Pidilizumab|pidilizumab|mesh-list
64386090|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386091|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386092|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
64386093|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64386094|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386095|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
64386096|NCT05421819|Vitamin D|vitamin d|mesh-list
64386150|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64386151|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386152|NCT02055352|Fluticasone|fluticasone|mesh-list
64386153|NCT02055352|Budesonide|budesonide|mesh-list
64386154|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64386155|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64386156|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64386157|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
64386158|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386159|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386160|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64386161|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
64386163|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64386164|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
64386165|NCT02055352|Hormones|hormones|mesh-ancestor
64386166|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64386167|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64386168|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64386169|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64386170|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
64386171|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64386172|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386173|NCT02034916|Talazoparib|talazoparib|mesh-list
64386174|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64386175|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386176|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386177|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386178|NCT04693156|Bupivacaine|bupivacaine|mesh-list
64386179|NCT04693156|Prilocaine|prilocaine|mesh-list
64386180|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
64386181|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
64386182|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64386183|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386184|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
64386185|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386186|NCT01374425|Leucovorin|leucovorin|mesh-list
64386187|NCT01374425|Bevacizumab|bevacizumab|mesh-list
64386188|NCT01374425|Fluorouracil|fluorouracil|mesh-list
64386189|NCT01374425|Capecitabine|capecitabine|mesh-list
64386190|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
64386191|NCT01374425|Irinotecan|irinotecan|mesh-list
64386192|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64386193|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386194|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64386195|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64386196|NCT01374425|Growth Substances|growth substances|mesh-ancestor
64386197|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386198|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
64386199|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
64386200|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64386201|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64386202|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64386203|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
64386204|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64386205|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64386206|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64386210|NCT01374425|Vitamins|vitamins|mesh-ancestor
64378984|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64378985|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64378986|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64378987|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64378988|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64378989|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64378990|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64378991|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64378992|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64378993|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64378994|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
64378995|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64378996|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
64378997|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
64378998|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
64378999|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64379000|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64370241|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370243|NCT02478125|Lenograstim|lenograstim|mesh-list
64370244|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370245|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
64370246|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
64370247|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
64370248|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370264|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64379001|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
64379015|NCT03194555|Analgesics|analgesics|mesh-ancestor
64379016|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
64379017|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379018|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379019|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
64379020|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64379021|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64379022|NCT04344717|Apixaban|apixaban|mesh-list
64379024|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
64379025|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64379026|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
64379027|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379028|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379029|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
64370265|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370266|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64370267|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
64370268|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370269|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370270|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64370275|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
64370276|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370277|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370278|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
64370279|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370280|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64370281|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
64370282|NCT03070275|Coagulants|coagulants|mesh-ancestor
64370283|NCT05713019|Adenosine|adenosine|mesh-list
64370284|NCT05713019|Capsaicin|capsaicin|mesh-list
64370285|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
64370286|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
64370287|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
64370288|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
64370289|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370290|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370291|NCT05713019|Analgesics|analgesics|mesh-ancestor
64370292|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64370293|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
64370294|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
64370309|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
64370310|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370311|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370312|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64370313|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64370314|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
64370315|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64370316|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
64370317|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
64370318|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
64370319|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64370330|NCT03198949|Everolimus|everolimus|mesh-list
64370331|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370332|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64370333|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
64370334|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370335|NCT02447809|Aspirin|aspirin|mesh-list
64370336|NCT02447809|Clopidogrel|clopidogrel|mesh-list
64370337|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64370338|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64370339|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64370340|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64370341|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
64370342|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370343|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370344|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370356|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
64370357|NCT04915287|Maleic acid|maleic acid|mesh-list
64370358|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370359|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370360|NCT05709353|Methamphetamine|methamphetamine|mesh-list
64370361|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64370362|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370363|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
64370364|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
64370365|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370366|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
64370367|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370371|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64370372|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64370373|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64370374|NCT03195673|Terazosin|terazosin|mesh-list
64370375|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64370410|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370411|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370413|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
64370414|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370415|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64370416|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
64370417|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370418|NCT02481323|Cilostazol|cilostazol|mesh-list
64370419|NCT02481323|Isosorbide|isosorbide|mesh-list
64370420|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
64370421|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
64370422|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64370423|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
64370424|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370425|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370426|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64370427|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
64370428|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64370429|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64370430|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370431|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64370432|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
64370433|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64370434|NCT02481323|Protective Agents|protective agents|mesh-ancestor
64370435|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
64370436|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64370437|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370438|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64370439|NCT02481323|Diuretics|diuretics|mesh-ancestor
64370440|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
64370441|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
64370442|NCT03197779|Aspirin|aspirin|mesh-list
64370443|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64370444|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370451|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64370452|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64370453|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370454|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64370455|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64370456|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370457|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
64370458|NCT03197623|Alendronate|alendronate|mesh-list
64370459|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64370460|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370461|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
64370462|NCT02449603|Exenatide|exenatide|mesh-list
64370463|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
64370464|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
64370465|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370466|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370467|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
64370468|NCT02449603|Incretins|incretins|mesh-ancestor
64370470|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370471|NCT02481479|Saxagliptin|saxagliptin|mesh-list
64370472|NCT02481479|Incretins|incretins|mesh-ancestor
64370473|NCT02481479|Hormones|hormones|mesh-ancestor
64370474|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370475|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370476|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64370477|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
64370478|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370479|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370480|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370481|NCT03195049|Bilirubin|bilirubin|mesh-list
64370482|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
64370483|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370486|NCT03198013|Prednisolone|prednisolone|mesh-list
64370488|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
64370489|NCT03198013|Hormones|hormones|mesh-ancestor
64370490|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370491|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370492|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64370493|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370494|NCT05651399|Propofol|propofol|mesh-list
64370495|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64370496|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370497|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370498|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64370499|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
64370500|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
64370501|NCT02477891|Daratumumab|daratumumab|mesh-list
64370502|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370503|NCT02477813|Temozolomide|temozolomide|mesh-list
64370504|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64370505|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
64370506|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370507|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370508|NCT02480543|Misoprostol|misoprostol|mesh-list
64370509|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64370510|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
64370511|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64379030|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
64370512|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370513|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64370514|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64370515|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
64370516|NCT03197233|Vitamin D|vitamin d|mesh-list
64370517|NCT03197233|Vitamins|vitamins|mesh-list
64370518|NCT03197233|Vitamin A|vitamin a|mesh-list
64370519|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
64370532|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64370533|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64370534|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64370535|NCT02447185|Growth Substances|growth substances|mesh-ancestor
64370536|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370537|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
64370538|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379031|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
64379032|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
64379033|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64379034|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
64379035|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
64379036|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379037|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379038|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379039|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64379041|NCT04790331|Diltiazem|diltiazem|mesh-list
64379042|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64370539|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370540|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
64370541|NCT02447185|Hormones|hormones|mesh-ancestor
64370542|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370544|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
64370545|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370546|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370547|NCT03196921|Amphotericin B|amphotericin b|mesh-list
64370548|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
64370549|NCT03196921|Amebicides|amebicides|mesh-ancestor
64370550|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64370551|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64370552|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370553|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64370554|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
64370555|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
64370556|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370557|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370558|NCT02480465|Incretins|incretins|mesh-ancestor
64370559|NCT02480465|Hormones|hormones|mesh-ancestor
64370560|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370561|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64370562|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
64370563|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370574|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370575|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64370576|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
64370577|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370578|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370579|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64370580|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
64370581|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370582|NCT04484779|Insulin|insulin|mesh-list
64370583|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
64370584|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
64370585|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370586|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370635|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
64370636|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
64370637|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370638|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64370639|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64370640|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64370641|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370642|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64370643|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
64370644|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64370645|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370646|NCT02634801|Methotrexate|methotrexate|mesh-list
64370696|NCT02449369|Acetaminophen|acetaminophen|mesh-list
64370697|NCT02449369|Oxycodone|oxycodone|mesh-list
64370698|NCT02449369|Hydromorphone|hydromorphone|mesh-list
64370699|NCT02449369|Orphenadrine|orphenadrine|mesh-list
64370700|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370701|NCT02449369|Analgesics|analgesics|mesh-ancestor
64370702|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
64370703|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370704|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370705|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
64370706|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64370707|NCT02449369|Narcotics|narcotics|mesh-ancestor
64370708|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370709|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64370710|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64370711|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
64370712|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64370713|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
64370714|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
64370715|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64370716|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64370718|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370719|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370748|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
64370749|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370750|NCT04433559|Tadalafil|tadalafil|mesh-list
64370751|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
64370752|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64370753|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64370754|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370755|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370756|NCT04433559|Urological Agents|urological agents|mesh-ancestor
64370757|NCT04911959|Lenvatinib|lenvatinib|mesh-list
64370758|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370759|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64370760|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370761|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370764|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64370766|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
64370767|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370768|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370769|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370770|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
64370771|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
64370772|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370773|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64370774|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64370775|NCT04891809|Dexamethasone|dexamethasone|mesh-list
64370776|NCT04891809|Lenalidomide|lenalidomide|mesh-list
64370777|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370778|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
64370789|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64370790|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64370791|NCT04891809|Growth Substances|growth substances|mesh-ancestor
64370792|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
64370793|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
64370794|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
64370795|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64370797|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64370798|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64370799|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64370800|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370801|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370802|NCT03074097|Bupivacaine|bupivacaine|mesh-list
64370803|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
64370804|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
64370805|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64370806|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370807|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
64370808|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370809|NCT04433481|Dabigatran|dabigatran|mesh-list
64370810|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
64370811|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64370812|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
64370813|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370814|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370815|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
64370817|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64370818|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64370819|NCT04860635|Analgesics|analgesics|mesh-ancestor
64370832|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370833|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64370834|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64370835|NCT04988607|Growth Substances|growth substances|mesh-ancestor
64370836|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370837|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
64370838|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64370839|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370840|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370841|NCT02475317|Volixibat|volixibat|mesh-list
64370842|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64370843|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
64370844|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64370845|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370846|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64370847|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64370848|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64370849|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370850|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
64370851|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370852|NCT05322473|Adalimumab|adalimumab|mesh-list
64370853|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64370854|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370855|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
64370856|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
64370857|NCT02472275|Hormones|hormones|mesh-list
64370858|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
64370878|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370879|NCT04491773|Urological Agents|urological agents|mesh-ancestor
64370881|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
64370882|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
64370883|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
64370884|NCT03073863|Atorvastatin|atorvastatin|mesh-list
64370885|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64370886|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64370887|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
64370888|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370889|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64370890|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64370891|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370892|NCT02471963|Empagliflozin|empagliflozin|mesh-list
64370893|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64370894|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370895|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370896|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370897|NCT01375751|Evolocumab|evolocumab|mesh-list
64370898|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64370899|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64370900|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
64370901|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370902|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64370903|NCT05249621|Mannitol|mannitol|mesh-list
64370904|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64370906|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
64370907|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370908|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
64370909|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64370910|NCT00705575|Diuretics|diuretics|mesh-ancestor
64370911|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
64370917|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64370918|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64370919|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64370920|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370921|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64370922|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370924|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
64370925|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64370926|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
64370927|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64370928|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
64370929|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
64370930|NCT03108833|Saruplase|saruplase|mesh-list
64370931|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64370932|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64370933|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370934|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
64370935|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64370936|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370937|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
64370938|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64370939|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370940|NCT04450953|Eplerenone|eplerenone|mesh-list
64370942|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
64370960|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370961|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64370962|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64370963|NCT02474225|Bevacizumab|bevacizumab|mesh-list
64370964|NCT02474225|Ranibizumab|ranibizumab|mesh-list
64370965|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
64370966|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64370967|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370968|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64370969|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64370970|NCT02474225|Growth Substances|growth substances|mesh-ancestor
64370971|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370972|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
64370973|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
64370974|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64370975|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370977|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64370978|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64370979|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64370980|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64370981|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
64370982|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64370983|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
64370984|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64370985|NCT04430855|Upadacitinib|upadacitinib|mesh-list
64370986|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
64370987|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64370988|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64370989|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64370990|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64370991|NCT02471105|Bimatoprost|bimatoprost|mesh-list
64370992|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64371001|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
64371002|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371004|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64371005|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64371006|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64371007|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371008|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371010|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
64371011|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
64371012|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371013|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371014|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
64371015|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371016|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64371017|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64371018|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64371019|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371056|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64371057|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371058|NCT03948347|Incretins|incretins|mesh-ancestor
64371059|NCT03948347|Hormones|hormones|mesh-ancestor
64371060|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371061|NCT03899987|Aspirin|aspirin|mesh-list
64371062|NCT03899987|Interferons|interferons|mesh-list
64371063|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
64371064|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
64371065|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
64371066|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371067|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
64371068|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371069|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64371070|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64371071|NCT03899987|Analgesics|analgesics|mesh-ancestor
64371072|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
64371073|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371074|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371075|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371076|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371077|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64371078|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64371079|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371080|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64371081|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64371082|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371083|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
64371084|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
64371085|NCT02723591|Tacrolimus|tacrolimus|mesh-list
64371086|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371087|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
64371088|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371089|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64371097|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371098|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64371099|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
64371100|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371101|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64371103|NCT03847649|Durvalumab|durvalumab|mesh-list
64371104|NCT03847649|Tremelimumab|tremelimumab|mesh-list
64371105|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371106|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
64371107|NCT03847649|Hormones|hormones|mesh-ancestor
64371108|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371109|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371110|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64371111|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371112|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371113|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
64371114|NCT03193931|Methotrexate|methotrexate|mesh-list
64371115|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371116|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371117|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64371118|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
64371119|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64371120|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371121|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371122|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
64371123|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371124|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371125|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371126|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64371142|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371143|NCT02215265|Cisplatin|cisplatin|mesh-list
64371144|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371146|NCT00704405|Ribavirin|ribavirin|mesh-list
64371147|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371148|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
64371149|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371150|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
64371151|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371152|NCT01470755|Albuterol|albuterol|mesh-list
64371153|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64371154|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
64371155|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371156|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371157|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64371158|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
64371159|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
64371160|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64371161|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64371162|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64371163|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371164|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371165|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371166|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371167|NCT03310073|Vaccines|vaccines|mesh-list
64371168|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
64371169|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371170|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
64371171|NCT03309527|Promethazine|promethazine|mesh-list
64371187|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371188|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64371193|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64371194|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64371195|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
64371196|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
64371197|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371198|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371199|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371200|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64371201|NCT00703781|Bromfenac|bromfenac|mesh-list
64371202|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64371203|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64379043|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64379044|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379045|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379046|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64379058|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
64379059|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64379060|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379061|NCT02444897|Fentanyl|fentanyl|mesh-list
64379062|NCT02444897|Nefopam|nefopam|mesh-list
64379063|NCT02444897|Ramosetron|ramosetron|mesh-list
64379064|NCT02444897|Ropivacaine|ropivacaine|mesh-list
64379065|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
64379066|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
64379067|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64379068|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379069|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
64379070|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379071|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64379072|NCT02444897|Narcotics|narcotics|mesh-ancestor
64379073|NCT02444897|Analgesics|analgesics|mesh-ancestor
64379074|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64371204|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64371205|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64371206|NCT00703781|Analgesics|analgesics|mesh-ancestor
64371207|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
64371208|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371209|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371210|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371211|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371212|NCT03309215|Nickel|nickel|mesh-list
64371214|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
64371215|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371216|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
64371230|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371231|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64371232|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
64371233|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64371234|NCT03308357|Infliximab|infliximab|mesh-list
64371235|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371236|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64371237|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371238|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
64371239|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64371240|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64371241|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371242|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
64371243|NCT03308201|Letrozole|letrozole|mesh-list
64371244|NCT03308201|Fulvestrant|fulvestrant|mesh-list
64371245|NCT03308201|Exemestane|exemestane|mesh-list
64371246|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371247|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64371248|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64371249|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371250|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371251|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64371252|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
64371253|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371254|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371255|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64371256|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
64371257|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
64371258|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64371259|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371260|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371261|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64371262|NCT03312413|Analgesics|analgesics|mesh-ancestor
64371263|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
64371269|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371270|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371271|NCT02722967|Aripiprazole|aripiprazole|mesh-list
64371274|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64371275|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64371276|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371277|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371278|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
64371279|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
64371280|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371281|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371282|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64371283|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64371284|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
64371285|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
64371286|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64371287|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
64371288|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64371289|NCT04442633|Miconazole|miconazole|mesh-list
64371290|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
64371291|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371292|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64371293|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64371302|NCT03312335|Aldesleukin|aldesleukin|mesh-list
64371315|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
64371316|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371317|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371318|NCT03311945|Lamivudine|lamivudine|mesh-list
64371319|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
64371320|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64371321|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64371322|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371323|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371324|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
64371325|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371326|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64371327|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64371328|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
64371329|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
64371330|NCT03311789|Gemcitabine|gemcitabine|mesh-list
64371331|NCT03311789|Nivolumab|nivolumab|mesh-list
64371332|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64371333|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371334|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371335|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
64371336|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371337|NCT03311789|Antiviral Agents|antiviral agents|mesh-ancestor
64371338|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371339|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371341|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
64371365|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371366|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371367|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371368|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64371369|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371370|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371371|NCT02468375|Mirabegron|mirabegron|mesh-list
64371372|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64371373|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64371374|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371375|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371376|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371377|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371378|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371382|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
64371383|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
64371384|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371385|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371386|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64371387|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64371388|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64371389|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371390|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64371391|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64371392|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64371393|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371394|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371406|NCT04490837|Antibodies|antibodies|mesh-list
64371407|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
64371409|NCT03305471|Sevelamer|sevelamer|mesh-list
64371479|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371480|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371481|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64371482|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371483|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64371484|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64371485|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
64371486|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371487|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64371488|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
64371489|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
64371490|NCT02467907|Paclitaxel|paclitaxel|mesh-list
64371491|NCT02467907|Bevacizumab|bevacizumab|mesh-list
64371492|NCT02467907|Carboplatin|carboplatin|mesh-list
64371493|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64371494|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371495|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
64371496|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
64371497|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
64371498|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371499|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371500|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64371501|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64371502|NCT02467907|Growth Substances|growth substances|mesh-ancestor
64371503|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371504|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
64371505|NCT02467127|Vitamin D|vitamin d|mesh-list
64371506|NCT02467127|Vitamins|vitamins|mesh-ancestor
64371507|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
64371508|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371509|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64371510|NCT03302585|Vitamin D|vitamin d|mesh-list
64371520|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64371521|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371522|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
64371523|NCT03302351|Ketamine|ketamine|mesh-list
64371524|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64371525|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371526|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371527|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64371528|NCT03302351|Analgesics|analgesics|mesh-ancestor
64371529|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
64371530|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371534|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371535|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371536|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371537|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64371538|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64371539|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
64371541|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64371542|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64371543|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
64371554|NCT05727371|Hylan|hylan|mesh-list
64371570|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
64371571|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64371572|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
64371573|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
64371574|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64371575|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64371576|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371577|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371578|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371579|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371580|NCT03302039|Protective Agents|protective agents|mesh-ancestor
64371581|NCT02721875|Azacitidine|azacitidine|mesh-list
64371582|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371583|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
64371584|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371585|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371586|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371587|NCT02466503|Fluticasone|fluticasone|mesh-list
64371588|NCT02466503|Xhance|xhance|mesh-list
64371589|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64371590|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371591|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64371592|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
64371593|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371594|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371595|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64371596|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
64371597|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371598|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64371599|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64371614|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64371615|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
64371616|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371617|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371618|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64371619|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64371620|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
64371621|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64371622|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
64371623|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64371624|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64371625|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64371626|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64371627|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64371628|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64371629|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64371665|NCT02467595|Sevoflurane|sevoflurane|mesh-list
64371666|NCT02467595|Rocuronium|rocuronium|mesh-list
64371667|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64371668|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371669|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371670|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64371671|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
64371672|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
64371673|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64371674|NCT02467595|Narcotics|narcotics|mesh-ancestor
64371675|NCT02467595|Analgesics|analgesics|mesh-ancestor
64371676|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
64371677|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371678|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64371679|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64371680|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64371681|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
64371682|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64371683|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64371684|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64371685|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
64371686|NCT02467517|Ketamine|ketamine|mesh-list
64371687|NCT02467517|Analgesics|analgesics|mesh-ancestor
64371688|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
64371689|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371709|NCT02467673|Estradiol|estradiol|mesh-list
64371714|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371715|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371716|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64371717|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
64371718|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64371719|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64371720|NCT02467673|Progestins|progestins|mesh-ancestor
64371721|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
64371722|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
64371723|NCT02953145|Coagulants|coagulants|mesh-ancestor
64371724|NCT03300089|Anesthetics|anesthetics|mesh-list
64371725|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64371726|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371727|NCT02634333|Aflibercept|aflibercept|mesh-list
64371728|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
64371729|NCT02634333|Mitogens|mitogens|mesh-list
64371730|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64371731|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64371732|NCT02634333|Growth Substances|growth substances|mesh-ancestor
64371733|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371734|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
64371735|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371736|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64371737|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371738|NCT05725031|Ephedrine|ephedrine|mesh-list
64371739|NCT05725031|Rocuronium|rocuronium|mesh-list
64371752|NCT04983615|Fentanyl|fentanyl|mesh-list
64371762|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64371764|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
64371765|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64371766|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64371767|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64371768|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64371769|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
64371770|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
64371771|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371773|NCT00702923|Tremelimumab|tremelimumab|mesh-list
64371774|NCT00702923|Bicalutamide|bicalutamide|mesh-list
64371775|NCT00702923|Ipilimumab|ipilimumab|mesh-list
64371776|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64371777|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371778|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
64371779|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371780|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
64371781|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
64371782|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371783|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371784|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64371785|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371786|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
64371787|NCT05294055|Etoposide|etoposide|mesh-list
64371788|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371789|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
64371790|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371791|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371792|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64371793|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
64371794|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371795|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371796|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64371797|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64371798|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64371799|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64371800|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371801|NCT04975919|Decitabine|decitabine|mesh-list
64371802|NCT04975919|Venetoclax|venetoclax|mesh-list
64371803|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371804|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
64371805|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371806|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371807|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371808|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
64371809|NCT03103971|Fludarabine|fludarabine|mesh-list
64371810|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371811|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
64371812|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371813|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64371814|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64371815|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
64371816|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371817|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371818|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64371819|NCT03299621|Rocuronium|rocuronium|mesh-list
64371820|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
64371846|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371847|NCT05635929|Betaine|betaine|mesh-list
64371848|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64371849|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
64371850|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64371851|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
64371852|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371853|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64371854|NCT04794699|Gemcitabine|gemcitabine|mesh-list
64371855|NCT04794699|Paclitaxel|paclitaxel|mesh-list
64371856|NCT04794699|Docetaxel|docetaxel|mesh-list
64371857|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
64371858|NCT04794699|Pemetrexed|pemetrexed|mesh-list
64371859|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64371860|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371861|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
64371862|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
64371863|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
64371864|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371865|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371866|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
64371867|NCT04794699|Antiviral Agents|antiviral agents|mesh-ancestor
64371868|NCT04794699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371869|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371870|NCT04794699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371871|NCT04794699|Immunologic Factors|immunologic factors|mesh-ancestor
64371872|NCT04794699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371873|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64371874|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64371875|NCT04782687|Dexamethasone|dexamethasone|mesh-list
64371876|NCT04782687|Lenalidomide|lenalidomide|mesh-list
64371877|NCT04782687|Daratumumab|daratumumab|mesh-list
64371890|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64371891|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64371892|NCT04782687|Growth Substances|growth substances|mesh-ancestor
64371893|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
64371894|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
64371896|NCT05655689|Gentamicins|gentamicins|mesh-list
64371897|NCT05655689|Ceftazidime|ceftazidime|mesh-list
64371898|NCT05655689|Natamycin|natamycin|mesh-list
64371899|NCT05655689|Voriconazole|voriconazole|mesh-list
64371900|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64371901|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64371902|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64371903|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64371904|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64371905|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64371906|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64371907|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371908|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371909|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371910|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64371911|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
64371912|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64371913|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64371914|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64371915|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
64371916|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64371917|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64371918|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64371919|NCT02466347|Fluticasone|fluticasone|mesh-list
64371920|NCT02466347|Xhance|xhance|mesh-list
64371921|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
64371922|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64371931|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64371932|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64371933|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64371934|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
64371935|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371936|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371937|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
64371938|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64371939|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371940|NCT02466191|Gabapentin|gabapentin|mesh-list
64371941|NCT02466191|Memantine|memantine|mesh-list
64371942|NCT02466191|Analgesics|analgesics|mesh-ancestor
64371943|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
64371944|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64371945|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371946|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
64371947|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64371950|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64371951|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64371952|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64371953|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64371954|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371955|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
64371956|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
64371957|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64371958|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
64371959|NCT05555069|Menthol|menthol|mesh-list
64371960|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
64371961|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
64371973|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371974|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371975|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64371976|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
64371977|NCT03069339|Protective Agents|protective agents|mesh-ancestor
64371978|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64371979|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64371980|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64371981|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
64379075|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64379076|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
64379077|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
64379078|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
64379113|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379114|NCT03120221|Iodine|iodine|mesh-list
64379115|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64379116|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379117|NCT03120221|Trace Elements|trace elements|mesh-ancestor
64379118|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
64371982|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64371983|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
64371984|NCT05546411|Leucovorin|leucovorin|mesh-list
64371985|NCT05546411|Fluorouracil|fluorouracil|mesh-list
64371986|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
64371987|NCT05546411|Irinotecan|irinotecan|mesh-list
64371988|NCT05546411|Camptothecin|camptothecin|mesh-list
64371989|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
64371990|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64371991|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
64371992|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64371993|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64371994|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64371995|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64371996|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
64371997|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64371998|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64371999|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372000|NCT05546411|Antidotes|antidotes|mesh-ancestor
64372001|NCT05546411|Protective Agents|protective agents|mesh-ancestor
64372002|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
64372003|NCT05546411|Vitamins|vitamins|mesh-ancestor
64372004|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
64372006|NCT05542589|Phenytoin|phenytoin|mesh-list
64372013|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64372014|NCT03069027|Lidocaine|lidocaine|mesh-list
64372015|NCT03069027|Epinephrine|epinephrine|mesh-list
64372016|NCT03069027|Racepinephrine|racepinephrine|mesh-list
64372017|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
64372018|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
64372019|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
64372020|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372021|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372022|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
64372023|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372024|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64372025|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64372026|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64372027|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372028|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372029|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64372030|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64372033|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64372034|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64372035|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
64372036|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64372061|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372062|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
64372063|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64372064|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64372065|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64372066|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64372067|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
64372068|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372069|NCT04552197|Tofacitinib|tofacitinib|mesh-list
64372070|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64372071|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372072|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372073|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
64372074|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372075|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372076|NCT05634759|Azithromycin|azithromycin|mesh-list
64372077|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64372078|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372079|NCT04809233|Tipifarnib|tipifarnib|mesh-list
64372080|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372081|NCT02310269|Pasireotide|pasireotide|mesh-list
64372082|NCT02310269|Hormones|hormones|mesh-ancestor
64372083|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64372084|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372086|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
64372087|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
64372090|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
64372110|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
64372111|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
64372112|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372113|NCT05173337|Nefopam|nefopam|mesh-list
64372114|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64372115|NCT05173337|Analgesics|analgesics|mesh-ancestor
64372116|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
64372117|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372118|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372119|NCT02464631|Ribavirin|ribavirin|mesh-list
64372120|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
64372121|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
64372122|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372123|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
64372124|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372125|NCT04880577|Tenofovir|tenofovir|mesh-list
64372126|NCT04880577|Rituximab|rituximab|mesh-list
64372127|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
64372128|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372129|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372130|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
64372131|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372132|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372133|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
64372134|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372135|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64372136|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64372137|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372138|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372139|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64372155|NCT04562597|Antidotes|antidotes|mesh-ancestor
64372156|NCT04562129|Aldesleukin|aldesleukin|mesh-list
64372157|NCT04562129|Nivolumab|nivolumab|mesh-list
64372158|NCT04562129|Ipilimumab|ipilimumab|mesh-list
64372159|NCT04562129|Interleukin-2|interleukin-2|mesh-list
64372160|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372161|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372162|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64372163|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372164|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64372165|NCT04562129|Analgesics|analgesics|mesh-ancestor
64372166|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
64372168|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372169|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64372170|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64372171|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
64372172|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372173|NCT04447911|Empagliflozin|empagliflozin|mesh-list
64372174|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
64372175|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372176|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64372177|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372178|NCT04504175|Ketamine|ketamine|mesh-list
64372179|NCT04504175|Analgesics|analgesics|mesh-ancestor
64372180|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
64372181|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372182|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372183|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64372184|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64372185|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
64372186|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
64372187|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372189|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64372194|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372195|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372196|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
64372197|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372198|NCT03853395|Antibodies|antibodies|mesh-list
64372199|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
64372200|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372201|NCT04433169|Tretinoin|tretinoin|mesh-list
64372202|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372203|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
64372204|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
64372205|NCT02717195|Olanzapine|olanzapine|mesh-list
64372206|NCT02717195|Risperidone|risperidone|mesh-list
64372207|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64372208|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
64372209|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372210|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372211|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372232|NCT04424225|Niacin|niacin|mesh-list
64372252|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
64372253|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372254|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372255|NCT05626101|Antiviral Agents|antiviral agents|mesh-ancestor
64372256|NCT05626101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372257|NCT05626101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372258|NCT05626101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64372259|NCT05626101|Immunologic Factors|immunologic factors|mesh-ancestor
64372260|NCT05626101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372261|NCT05537883|Bupivacaine|bupivacaine|mesh-list
64372262|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
64372263|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
64372264|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372265|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372266|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
64372267|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372268|NCT02465801|Lenograstim|lenograstim|mesh-list
64372269|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64372270|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
64372271|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372272|NCT02465645|Carvedilol|carvedilol|mesh-list
64372273|NCT02465645|Simvastatin|simvastatin|mesh-list
64372274|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64372275|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64372276|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
64372302|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372303|NCT04872257|Vitamin D|vitamin d|mesh-list
64372304|NCT04872257|Vitamins|vitamins|mesh-ancestor
64372305|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
64372306|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372354|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64372355|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64372356|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64372357|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
64372358|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
64372359|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64372360|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64372361|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
64372362|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
64372363|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64372364|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
64372365|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
64372366|NCT02465255|Acetaminophen|acetaminophen|mesh-list
64372367|NCT02465255|Ketorolac|ketorolac|mesh-list
64372368|NCT02465255|Tramadol|tramadol|mesh-list
64372369|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64372370|NCT02465255|Analgesics|analgesics|mesh-ancestor
64372371|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
64372372|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372373|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372374|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
64372375|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64372376|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64372377|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372378|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64372379|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372380|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372381|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64372382|NCT02465255|Narcotics|narcotics|mesh-ancestor
64372383|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372384|NCT05533125|Rituximab|rituximab|mesh-list
64372385|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372386|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372387|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
64372388|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372396|NCT02462915|Propofol|propofol|mesh-list
64372397|NCT02462915|Cisatracurium|cisatracurium|mesh-list
64372398|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
64372399|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
64372400|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372401|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372402|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
64372403|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372404|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64372405|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64372406|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64372407|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372408|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372409|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64372410|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64372411|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
64372412|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64372414|NCT02462915|Analgesics|analgesics|mesh-ancestor
64372415|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64372416|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
64372417|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64372419|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
64372420|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64372421|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64372422|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
64372423|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372424|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372425|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372426|NCT02462837|Urological Agents|urological agents|mesh-ancestor
64372427|NCT05505123|Propofol|propofol|mesh-list
64372428|NCT05505123|Sevoflurane|sevoflurane|mesh-list
64372429|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64372432|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64372437|NCT03732677|Gemcitabine|gemcitabine|mesh-list
64372438|NCT03732677|Durvalumab|durvalumab|mesh-list
64372439|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372440|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64372441|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
64372442|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372443|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
64372444|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372445|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372446|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64372447|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
64372448|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372449|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372450|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
64372451|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372452|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372453|NCT02462525|Dexamethasone|dexamethasone|mesh-list
64372454|NCT02462525|Pomalidomide|pomalidomide|mesh-list
64372455|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64372456|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
64372457|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
64372458|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372487|NCT02462447|Choline|choline|mesh-list
64372488|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
64372489|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64372490|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
64372491|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372492|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64372493|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64372494|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
64372495|NCT02462681|Ketamine|ketamine|mesh-list
64372496|NCT02462681|Analgesics|analgesics|mesh-ancestor
64372497|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
64372498|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372499|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372500|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64372501|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64372502|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
64372503|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
64372504|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372505|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64372506|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64372507|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372508|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372509|NCT04129151|Palbociclib|palbociclib|mesh-list
64372510|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372511|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64372512|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372513|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372514|NCT02462369|Glimepiride|glimepiride|mesh-list
64372515|NCT02462369|Saxagliptin|saxagliptin|mesh-list
64372516|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64372517|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64372518|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372519|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64372526|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372527|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372528|NCT04072835|Etripamil|etripamil|mesh-list
64372529|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64372530|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372531|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372532|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64372533|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372534|NCT04083963|Paclitaxel|paclitaxel|mesh-list
64372535|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
64372536|NCT04083963|Carboplatin|carboplatin|mesh-list
64372537|NCT04083963|Doxorubicin|doxorubicin|mesh-list
64372538|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64372539|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372540|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
64372541|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
64372542|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
64372543|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372544|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64372545|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
64372546|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372547|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372548|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64372549|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
64372550|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64372551|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64372552|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64372553|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64372554|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372555|NCT02463383|Ibuprofen|ibuprofen|mesh-list
64372556|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64372557|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64372558|NCT02463383|Analgesics|analgesics|mesh-ancestor
64372559|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
64372560|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372562|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64372563|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372564|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64372565|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372566|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372568|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372569|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64372570|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372571|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372572|NCT04008797|Lenvatinib|lenvatinib|mesh-list
64372573|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372574|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64372575|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372576|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372577|NCT04006457|Vaccines|vaccines|mesh-list
64372578|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
64372579|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372580|NCT03108365|Hemostatics|hemostatics|mesh-list
64372581|NCT03108365|Chitosan|chitosan|mesh-list
64372582|NCT03108365|Coagulants|coagulants|mesh-ancestor
64372583|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64372615|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372616|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372617|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
64372618|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
64372619|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
64372620|NCT02760329|Protective Agents|protective agents|mesh-ancestor
64372621|NCT04706715|Cemiplimab|cemiplimab|mesh-list
64372622|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372623|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372624|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
64372625|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
64372626|NCT03064191|Calcium|calcium|mesh-list
64372627|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64372628|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372629|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64372630|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64372631|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372632|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
64372633|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
64372634|NCT02629965|Olodaterol|olodaterol|mesh-list
64372635|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64372636|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
64372637|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372639|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64372666|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
64372667|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
64372668|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
64372669|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372670|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372671|NCT05223075|Lidocaine|lidocaine|mesh-list
64372672|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
64372673|NCT05223075|Carticaine|carticaine|mesh-list
64372674|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
64372675|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
64372676|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372677|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372678|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
64372679|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64372680|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64372681|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64372682|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64372684|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372685|NCT03064035|Thrombin|thrombin|mesh-list
64372686|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
64372687|NCT03064035|Coagulants|coagulants|mesh-ancestor
64372688|NCT03719313|Interferons|interferons|mesh-list
64372689|NCT03719313|Ritonavir|ritonavir|mesh-list
64372690|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
64372691|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
64372692|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
64372693|NCT03719313|Lonafarnib|lonafarnib|mesh-list
64372694|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372695|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
64372696|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372697|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64372698|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64372710|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372711|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
64372712|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
64372713|NCT03063723|Ledipasvir|ledipasvir|mesh-list
64372714|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
64372715|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372716|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
64372717|NCT04338321|Esketamine|esketamine|mesh-list
64372718|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
64372719|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64372720|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64372721|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64372722|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64372723|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372724|NCT00379041|Prednisone|prednisone|mesh-list
64372725|NCT00379041|Doxorubicin|doxorubicin|mesh-list
64372726|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
64372727|NCT00379041|Bleomycin|bleomycin|mesh-list
64372728|NCT00379041|Vincristine|vincristine|mesh-list
64372729|NCT00379041|Vinblastine|vinblastine|mesh-list
64372730|NCT00379041|Procarbazine|procarbazine|mesh-list
64372731|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
64372732|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64372733|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372734|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64372735|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64372736|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372762|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
64372763|NCT04436913|Protective Agents|protective agents|mesh-ancestor
64372764|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372765|NCT02487095|Topotecan|topotecan|mesh-list
64372766|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64372767|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64372768|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372769|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372770|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372771|NCT03837899|Durvalumab|durvalumab|mesh-list
64372772|NCT03837899|Tremelimumab|tremelimumab|mesh-list
64372773|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64372774|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372775|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372776|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
64372777|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372785|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
64372786|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
64372787|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372788|NCT03742193|Apatinib|apatinib|mesh-list
64372789|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372810|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
64372811|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
64372812|NCT02461121|Fludarabine|fludarabine|mesh-list
64372813|NCT02461121|Cyclosporins|cyclosporins|mesh-list
64372814|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64372815|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64372816|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
64372817|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372818|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64372819|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64372820|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
64372821|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372822|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372823|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64372824|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372825|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
64372826|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64372827|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
64372828|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
64372829|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64372830|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64372831|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
64372832|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64372834|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372835|NCT02461043|Paclitaxel|paclitaxel|mesh-list
64372836|NCT02461043|Cisplatin|cisplatin|mesh-list
64372837|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64372839|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
64372858|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64372859|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
64372860|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64372861|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64372862|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372863|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64372864|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
64372865|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64372866|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64372867|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
64372868|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64372869|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
64372870|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64372871|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64372872|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64372873|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
64372874|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64372875|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64372876|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
64372877|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64372878|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64372879|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372880|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64372881|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64372882|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
64372883|NCT03296579|Protective Agents|protective agents|mesh-ancestor
64372884|NCT02461667|Alendronate|alendronate|mesh-list
64372886|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64372887|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372888|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64372889|NCT01670877|Trastuzumab|trastuzumab|mesh-list
64372890|NCT01670877|Fulvestrant|fulvestrant|mesh-list
64372891|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372892|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372893|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64372897|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64372898|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372899|NCT00701129|Rituximab|rituximab|mesh-list
64372900|NCT00701129|Methotrexate|methotrexate|mesh-list
64372901|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64372902|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372906|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64372907|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
64372908|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64372909|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64372910|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
64372911|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372912|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
64372913|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64372954|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64372955|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64372956|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
64372957|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64372958|NCT01670721|Leucovorin|leucovorin|mesh-list
64372959|NCT01670721|Fluorouracil|fluorouracil|mesh-list
64372960|NCT01670721|Irinotecan|irinotecan|mesh-list
64372961|NCT01670721|Aflibercept|aflibercept|mesh-list
64372962|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
64372963|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64372964|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64372965|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64372966|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373015|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373016|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64373018|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
64373019|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
64373020|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373021|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64373022|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64373023|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373024|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373025|NCT03294707|Coal Tar|coal tar|mesh-list
64373026|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
64373027|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
64373028|NCT03062319|Anticoagulants|anticoagulants|mesh-list
64373029|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
64373030|NCT03290495|Ketamine|ketamine|mesh-list
64373031|NCT03290495|Analgesics|analgesics|mesh-ancestor
64373032|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
64373033|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373034|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373035|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64373036|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64373037|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
64373038|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
64373039|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373040|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64373062|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
64373063|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
64373064|NCT03290417|Vitamins|vitamins|mesh-list
64373065|NCT03290417|Curcumin|curcumin|mesh-list
64373066|NCT03290417|Turmeric extract|turmeric extract|mesh-list
64373067|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
64373068|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373069|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64373070|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64373071|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64373073|NCT03290417|Analgesics|analgesics|mesh-ancestor
64373074|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
64373075|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373076|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373077|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373078|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373080|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373081|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
64373082|NCT03290417|Protective Agents|protective agents|mesh-ancestor
64373083|NCT04429347|Gabapentin|gabapentin|mesh-list
64373084|NCT04429347|Tizanidine|tizanidine|mesh-list
64373085|NCT04429347|Analgesics|analgesics|mesh-ancestor
64373086|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
64373087|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373114|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
64373115|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373189|NCT02460497|Minoxidil|minoxidil|mesh-list
64373190|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64373191|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
64373192|NCT03289559|Testosterone|testosterone|mesh-list
64373193|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
64373194|NCT03289559|Androgens|androgens|mesh-ancestor
64373195|NCT03289559|Hormones|hormones|mesh-ancestor
64373196|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373197|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373198|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64373199|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373200|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373201|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
64373202|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
64373203|NCT03293927|Fentanyl|fentanyl|mesh-list
64373204|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
64373205|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64373206|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373207|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373208|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373209|NCT03293927|Analgesics|analgesics|mesh-ancestor
64373210|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
64373211|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373212|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64373213|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64373214|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64373238|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
64373239|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64373240|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373241|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373242|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373243|NCT04971759|Analgesics|analgesics|mesh-ancestor
64373244|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
64373245|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373246|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64373247|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64373248|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64373249|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
64373250|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373251|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373252|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64373253|NCT04971759|Narcotics|narcotics|mesh-ancestor
64373254|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64373255|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64373256|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
64373257|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
64373258|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
64373259|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64373260|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64373261|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373262|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373263|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64373264|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373265|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373266|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
64373267|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373268|NCT04979091|Hormones|hormones|mesh-list
64373269|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373270|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373275|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64373276|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64373277|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373278|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373279|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
64373280|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373281|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373282|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64373283|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64373284|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373285|NCT03107507|Levetiracetam|levetiracetam|mesh-list
64373286|NCT03107507|Phenobarbital|phenobarbital|mesh-list
64373287|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
64373288|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
64373289|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64373290|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373291|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373292|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64373293|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64373294|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373295|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373296|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
64373297|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
64373298|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64373299|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64373300|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64373301|NCT03062631|Amifampridine|amifampridine|mesh-list
64373302|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64373319|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64373320|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
64373321|NCT02711137|Antiviral Agents|antiviral agents|mesh-ancestor
64373322|NCT02711137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373323|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373324|NCT02711137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373325|NCT02711137|Immunologic Factors|immunologic factors|mesh-ancestor
64373326|NCT02711137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373327|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64373328|NCT04155411|Dasatinib|dasatinib|mesh-list
64373329|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373330|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64373331|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373332|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373350|NCT03288077|Tryptophan|tryptophan|mesh-list
64373379|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373380|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373381|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64373382|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
64373384|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64373385|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64373386|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
64373387|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373388|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64373389|NCT03291899|Folfirinox|folfirinox|mesh-list
64373390|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373391|NCT03194815|Rituximab|rituximab|mesh-list
64373392|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
64373393|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64373394|NCT03194815|Antibodies|antibodies|mesh-list
64373395|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
64373396|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
64373397|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64373399|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
64373400|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373435|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373436|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373437|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
64373438|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
64373439|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64373440|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
64373503|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
64373504|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373505|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373506|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373507|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373508|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
64373509|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64373510|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373511|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373512|NCT05233579|Sulforaphane|sulforaphane|mesh-list
64373513|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
64373514|NCT05233579|Protective Agents|protective agents|mesh-ancestor
64373515|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373516|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373517|NCT03285503|Aripiprazole|aripiprazole|mesh-list
64373561|NCT03190447|Laxatives|laxatives|mesh-ancestor
64373562|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373563|NCT03284177|Calcium|calcium|mesh-list
64373564|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64373565|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373566|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
64373567|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
64373568|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64373569|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64373570|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373571|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373572|NCT03192709|Urological Agents|urological agents|mesh-ancestor
64373573|NCT03283943|Durvalumab|durvalumab|mesh-list
64373574|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64373575|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373576|NCT02710045|Vaccines|vaccines|mesh-list
64373577|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
64373578|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373579|NCT02444767|Bimatoprost|bimatoprost|mesh-list
64373580|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64373581|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
64373582|NCT02443285|Cefotaxime|cefotaxime|mesh-list
64373583|NCT02443285|Cefoxitin|cefoxitin|mesh-list
64373584|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64373585|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373586|NCT03193957|Etanercept|etanercept|mesh-list
64373587|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64373588|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373603|NCT02444611|Vaccines|vaccines|mesh-list
64373610|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373611|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373612|NCT03536429|Acetazolamide|acetazolamide|mesh-list
64373613|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
64373614|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
64373615|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373616|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373617|NCT03536429|Diuretics|diuretics|mesh-ancestor
64373618|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
64373619|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373620|NCT02438683|BI 409306|bi 409306|mesh-list
64373621|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64373622|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373623|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373624|NCT03270839|Meclizine|meclizine|mesh-list
64373625|NCT03270839|Scopolamine|scopolamine|mesh-list
64373669|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64373671|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
64373672|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
64373673|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373674|NCT04432233|Metronidazole|metronidazole|mesh-list
64373675|NCT04432233|Levofloxacin|levofloxacin|mesh-list
64373676|NCT04432233|Ofloxacin|ofloxacin|mesh-list
64373677|NCT04432233|Esomeprazole|esomeprazole|mesh-list
64373678|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373679|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64373680|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64373681|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64373683|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373684|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64373685|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373686|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373687|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64373688|NCT04432233|Renal Agents|renal agents|mesh-ancestor
64373689|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64373690|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64373691|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373692|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64373693|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64373694|NCT03269747|Prednisone|prednisone|mesh-list
64373695|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373696|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
64373697|NCT03269747|Hormones|hormones|mesh-ancestor
64373699|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373714|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373715|NCT03269591|Analgesics|analgesics|mesh-ancestor
64373716|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
64373717|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373718|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373719|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373720|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64373721|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373722|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373723|NCT03989609|Midazolam|midazolam|mesh-list
64373724|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
64373725|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64373726|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373727|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373728|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64373729|NCT03989609|Analgesics|analgesics|mesh-ancestor
64373730|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
64373731|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373732|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64373733|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64373734|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64373735|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
64373736|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373737|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373738|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64373739|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64373740|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64373741|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64373742|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64373743|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
64373744|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
64373745|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
64373746|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
64373759|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
64373760|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64373761|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
64373762|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64373763|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373764|NCT03269279|Misoprostol|misoprostol|mesh-list
64373765|NCT03269279|Mifepristone|mifepristone|mesh-list
64373766|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64373767|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
64373768|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64373769|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373770|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64373771|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373773|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
64373774|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64373775|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64373776|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64373777|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
64373778|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
64373779|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
64373780|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
64373781|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64373782|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
64373783|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64373784|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
64373785|NCT03278483|Rifampin|rifampin|mesh-list
64373798|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64373799|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64373800|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64373801|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
64373802|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64373804|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64373805|NCT03268733|Folic Acid|folic acid|mesh-list
64373806|NCT03268733|Hematinics|hematinics|mesh-ancestor
64373807|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
64373808|NCT03268733|Vitamins|vitamins|mesh-ancestor
64373809|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
64373810|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373811|NCT03277391|Droperidol|droperidol|mesh-list
64373812|NCT03277391|Morphine|morphine|mesh-list
64373813|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64373814|NCT03277391|Narcotics|narcotics|mesh-ancestor
64373815|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373816|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373817|NCT03277391|Analgesics|analgesics|mesh-ancestor
64373818|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
64373819|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373820|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64373821|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
64373822|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
64373823|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64373849|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373850|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373851|NCT03272711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64373852|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64373853|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373854|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373855|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373856|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
64373857|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64373858|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64373859|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
64373860|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
64373861|NCT03961919|Fludarabine|fludarabine|mesh-list
64373862|NCT03961919|Treosulfan|treosulfan|mesh-list
64373863|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373864|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373865|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64373866|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
64373867|NCT03267407|Fluconazole|fluconazole|mesh-list
64373868|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
64373869|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373870|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
64373871|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64373872|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373873|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373874|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64373875|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
64373891|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64373892|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373893|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64373894|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
64373895|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373896|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64373897|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64373898|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373900|NCT05074589|Protective Agents|protective agents|mesh-ancestor
64373901|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
64373902|NCT05074589|Vitamins|vitamins|mesh-ancestor
64373903|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
64373904|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
64373905|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373906|NCT05073965|Vitamin D|vitamin d|mesh-list
64373907|NCT05073965|Vitamins|vitamins|mesh-ancestor
64373908|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
64373909|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373910|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64373911|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
64373912|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64373913|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64373914|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373915|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
64373916|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373917|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373918|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
64373919|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64373920|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373936|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373937|NCT02458781|Metronidazole|metronidazole|mesh-list
64373938|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
64373939|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
64373940|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64373941|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64373942|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64373943|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64373944|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64373945|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64373946|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64373947|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373948|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64373949|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64373950|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64373951|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64373952|NCT04647383|Lemborexant|lemborexant|mesh-list
64373953|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
64373954|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64373955|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64373956|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
64373957|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64373958|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64373959|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373960|NCT02458157|Furosemide|furosemide|mesh-list
64373982|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
64373983|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
64373986|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
64373987|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64373988|NCT03851159|Mannitol|mannitol|mesh-list
64373989|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
64373990|NCT03851159|Diuretics|diuretics|mesh-ancestor
64373991|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
64373992|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64373993|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
64373994|NCT02456363|Adalimumab|adalimumab|mesh-list
64373995|NCT02456363|Etanercept|etanercept|mesh-list
64373996|NCT02456363|Golimumab|golimumab|mesh-list
64373997|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64373998|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64373999|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64374000|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64374039|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
64374040|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374041|NCT02456207|Rituximab|rituximab|mesh-list
64374042|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374043|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374044|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
64374045|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374046|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64374047|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
64374048|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
64374049|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64374050|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
64374051|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374052|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374053|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64374054|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
64374055|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
64374056|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64374058|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
64374059|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374060|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374061|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
64374062|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64374063|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
64374064|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
64374065|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374066|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374067|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64374084|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374085|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
64374086|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
64374087|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64374088|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
64374089|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374090|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374091|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374092|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
64374093|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374094|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
64374095|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374096|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374097|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
64374098|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374099|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
64374100|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64374101|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64374102|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374103|NCT03262961|Urological Agents|urological agents|mesh-ancestor
64374104|NCT01670097|Dexamethasone|dexamethasone|mesh-list
64374105|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374106|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
64374107|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
64374108|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374109|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374110|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374113|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374115|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374116|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
64374119|NCT03257423|Ofloxacin|ofloxacin|mesh-list
64374123|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64374124|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64374126|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374127|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374128|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64374129|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64374130|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64374131|NCT03257423|Renal Agents|renal agents|mesh-ancestor
64374132|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64374133|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64374134|NCT01670019|Asenapine|asenapine|mesh-list
64374135|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64374136|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64374137|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374138|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374139|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64374140|NCT03262727|BMS-986165|bms-986165|mesh-list
64374145|NCT03262727|Estradiol|estradiol|mesh-list
64374178|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374179|NCT03062163|Protective Agents|protective agents|mesh-ancestor
64374180|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374181|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374182|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64374183|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
64374185|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
64374186|NCT02456597|Lidocaine|lidocaine|mesh-list
64374187|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
64374188|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
64374189|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374190|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374191|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
64374192|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374193|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64374194|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64374195|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64374196|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64374197|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374198|NCT03261635|Indomethacin|indomethacin|mesh-list
64374199|NCT03261635|Ranibizumab|ranibizumab|mesh-list
64374200|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64374201|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64374202|NCT03261635|Growth Substances|growth substances|mesh-ancestor
64374203|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374204|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
64374205|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374222|NCT03059979|Prednisolone|prednisolone|mesh-list
64374223|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
64374224|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64374225|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
64374226|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64374227|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
64374228|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
64374229|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374230|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374231|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374232|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
64374233|NCT03059979|Hormones|hormones|mesh-ancestor
64374234|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374235|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64374236|NCT03059979|Protective Agents|protective agents|mesh-ancestor
64374237|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64374238|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374239|NCT03256721|Docetaxel|docetaxel|mesh-list
64374240|NCT03256721|Pemetrexed|pemetrexed|mesh-list
64374241|NCT03256721|Apatinib|apatinib|mesh-list
64374242|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374248|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64374249|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64374250|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374251|NCT04967859|Gentamicins|gentamicins|mesh-list
64374252|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374253|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374254|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64374255|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374257|NCT03256487|Morphine|morphine|mesh-list
64374263|NCT03256487|Analgesics|analgesics|mesh-ancestor
64374264|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
64374265|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374266|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64374267|NCT03061227|Glucagon|glucagon|mesh-list
64374268|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374269|NCT03061227|Hormones|hormones|mesh-ancestor
64374270|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64374271|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374272|NCT03261791|Apatinib|apatinib|mesh-list
64374273|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374274|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374275|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374276|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374277|NCT03643367|Propofol|propofol|mesh-list
64374278|NCT03643367|Sevoflurane|sevoflurane|mesh-list
64374279|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64374280|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374281|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374282|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64374283|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
64374284|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
64374316|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
64374317|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64374318|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374320|NCT04967469|Vitamins|vitamins|mesh-ancestor
64374387|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
64374388|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374389|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374390|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64374391|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
64374392|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
64374393|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
64374394|NCT03259919|Metformin|metformin|mesh-list
64374395|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64374396|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374398|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374399|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374400|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374401|NCT04953117|Paclitaxel|paclitaxel|mesh-list
64374402|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64374403|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374404|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
64374405|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374406|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
64374407|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374408|NCT03259529|Gemcitabine|gemcitabine|mesh-list
64374409|NCT03259529|Rituximab|rituximab|mesh-list
64374410|NCT03259529|Nivolumab|nivolumab|mesh-list
64374411|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64374438|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374439|NCT03059667|Carboplatin|carboplatin|mesh-list
64374440|NCT03059667|Etoposide|etoposide|mesh-list
64374441|NCT03059667|Atezolizumab|atezolizumab|mesh-list
64374442|NCT03059667|Topotecan|topotecan|mesh-list
64374443|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374444|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64374445|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64374446|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64374447|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374448|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374449|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64374450|NCT03058419|Midazolam|midazolam|mesh-list
64374451|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
64374452|NCT03058419|Caffeine|caffeine|mesh-list
64374453|NCT03058419|Bupropion|bupropion|mesh-list
64374454|NCT03058419|Omeprazole|omeprazole|mesh-list
64374455|NCT03058419|Warfarin|warfarin|mesh-list
64374456|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64374457|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64374458|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374459|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374460|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64374461|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64374462|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64374463|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64374464|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
64374465|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
64374466|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
64374467|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
64374468|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379119|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379120|NCT03193073|Mitogens|mitogens|mesh-list
64379121|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
64379122|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379123|NCT02715609|Copper|copper|mesh-list
64379124|NCT02715609|Temozolomide|temozolomide|mesh-list
64379125|NCT02715609|Disulfiram|disulfiram|mesh-list
64379126|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64379127|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
64379128|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379129|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64379130|NCT02715609|Trace Elements|trace elements|mesh-ancestor
64379131|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
64379132|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379133|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
64379134|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
64379135|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379136|NCT02444507|Esomeprazole|esomeprazole|mesh-list
64379137|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64379138|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64379139|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64374469|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374470|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
64374481|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
64374482|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
64374483|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64374484|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64374485|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
64374486|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64374487|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64374488|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
64374489|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
64374493|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64374494|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
64374495|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64374496|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374497|NCT04952571|Bevacizumab|bevacizumab|mesh-list
64374498|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374499|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374500|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64374501|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64374503|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374504|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
64374505|NCT02455271|Eszopiclone|eszopiclone|mesh-list
64374531|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374532|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
64374533|NCT02454881|Oxycodone|oxycodone|mesh-list
64374534|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64374535|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374536|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374537|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64374538|NCT02454881|Analgesics|analgesics|mesh-ancestor
64374539|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
64374540|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374541|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64374542|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64374543|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64374544|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
64374545|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374546|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374547|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64374549|NCT03058341|Propofol|propofol|mesh-list
64374550|NCT03058341|Sevoflurane|sevoflurane|mesh-list
64374551|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64374552|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374553|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374554|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64374555|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
64374556|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
64374557|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64374558|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64374559|NCT04951791|SMOFlipid|smoflipid|mesh-list
64374576|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
64374577|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64374578|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
64374579|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
64374580|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
64374581|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
64374583|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374584|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374585|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64374586|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64374587|NCT04944069|Growth Substances|growth substances|mesh-ancestor
64374588|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374589|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
64374590|NCT04951167|Norepinephrine|norepinephrine|mesh-list
64374591|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64374592|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64374593|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
64374594|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379140|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374595|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374596|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374597|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
64374598|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
64374600|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64374625|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64374626|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64374627|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374628|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374629|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374630|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64374631|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
64374632|NCT04415151|Tofacitinib|tofacitinib|mesh-list
64374633|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374634|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374635|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374653|NCT00700817|Metformin|metformin|mesh-list
64374688|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374689|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64374690|NCT02455115|Trace Elements|trace elements|mesh-ancestor
64374691|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
64374692|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
64374693|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
64374694|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
64374695|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
64374696|NCT02455115|Antidotes|antidotes|mesh-ancestor
64374697|NCT02455115|Protective Agents|protective agents|mesh-ancestor
64374698|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
64374699|NCT03094247|Amoxicillin|amoxicillin|mesh-list
64374700|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374701|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374702|NCT04947423|Scopolamine|scopolamine|mesh-list
64374703|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64374704|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
64374705|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
64374708|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374748|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
64374749|NCT04423731|Leucovorin|leucovorin|mesh-list
64374750|NCT04423731|Gemcitabine|gemcitabine|mesh-list
64374751|NCT04423731|Paclitaxel|paclitaxel|mesh-list
64374752|NCT04423731|Fluorouracil|fluorouracil|mesh-list
64374753|NCT04423731|Folfirinox|folfirinox|mesh-list
64374754|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64374755|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374756|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
64374757|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
64374758|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
64374759|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374760|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64374761|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
64374762|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
64374763|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374764|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374765|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64374766|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
64374767|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374768|NCT04423731|Antidotes|antidotes|mesh-ancestor
64374769|NCT04423731|Protective Agents|protective agents|mesh-ancestor
64374770|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
64374771|NCT04423731|Vitamins|vitamins|mesh-ancestor
64374772|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
64374773|NCT04947111|Antibodies|antibodies|mesh-list
64374801|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
64374802|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374803|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64374804|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374805|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
64374807|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
64374808|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
64374809|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64374810|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64374811|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374812|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374813|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374814|NCT03249311|Analgesics|analgesics|mesh-ancestor
64374815|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
64374817|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
64374818|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64374819|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
64374820|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64374822|NCT04413123|Ipilimumab|ipilimumab|mesh-list
64374823|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64374824|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64374825|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
64374826|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374827|NCT02454491|Verapamil|verapamil|mesh-list
64374828|NCT02454491|Heparin|heparin|mesh-list
64374829|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
64374830|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64374831|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64374832|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374833|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64374834|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64374835|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64374836|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64374837|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374840|NCT03248765|Narcotics|narcotics|mesh-ancestor
64374841|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64374842|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374843|NCT03248765|Analgesics|analgesics|mesh-ancestor
64374844|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
64374845|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64374846|NCT04939857|Trimetazidine|trimetazidine|mesh-list
64374847|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
64374848|NCT04939779|Delpazolid|delpazolid|mesh-list
64374849|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
64374850|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64374851|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374852|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64374853|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374854|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374855|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
64374856|NCT03247595|Bisacodyl|bisacodyl|mesh-list
64374857|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
64374881|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64374882|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374883|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374884|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
64374886|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
64374887|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64374888|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64374889|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64374951|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64374952|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
64374953|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64374954|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374955|NCT03244553|Prucalopride|prucalopride|mesh-list
64374956|NCT03244553|Laxatives|laxatives|mesh-ancestor
64374957|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64374958|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
64374959|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64374960|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
64374961|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64374962|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64374963|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374965|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64374966|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374967|NCT03243851|Metformin|metformin|mesh-list
64374968|NCT03243851|Temozolomide|temozolomide|mesh-list
64374969|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64374970|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64374971|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64374972|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
64374973|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375002|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
64375003|NCT04936971|Everolimus|everolimus|mesh-list
64375004|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375005|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375006|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
64375007|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375008|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64375009|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
64375010|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
64375011|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64375012|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375013|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375014|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375015|NCT04931433|Lidocaine|lidocaine|mesh-list
64375016|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
64375017|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
64375018|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375019|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375020|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
64375021|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375022|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64375023|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64375024|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64375025|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375026|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375027|NCT04931355|Cetrorelix|cetrorelix|mesh-list
64375049|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375122|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375123|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375124|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
64375125|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375126|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64375127|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64375128|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64375129|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375130|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375132|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
64375133|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
64375134|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375135|NCT05387681|Endostatins|endostatins|mesh-list
64375136|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375137|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64375139|NCT05387681|Growth Substances|growth substances|mesh-ancestor
64375140|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375141|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
64375142|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
64375143|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64375144|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
64375145|NCT03238157|Hormones|hormones|mesh-ancestor
64375146|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375167|NCT03237533|Promethazine|promethazine|mesh-list
64375168|NCT03237533|Doxycycline|doxycycline|mesh-list
64375169|NCT03237533|Nystatin|nystatin|mesh-list
64375170|NCT03237533|Dexamethasone|dexamethasone|mesh-list
64375171|NCT03237533|Triamcinolone|triamcinolone|mesh-list
64375172|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64375173|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
64375174|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
64375175|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375176|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375177|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375178|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
64375179|NCT03237533|Hormones|hormones|mesh-ancestor
64375180|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375181|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64375182|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375183|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375184|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64375185|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375186|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
64375187|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64375188|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64375189|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
64375190|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
64375191|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
64375192|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
64375193|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
64375194|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375216|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64375217|NCT02124772|Trametinib|trametinib|mesh-list
64375218|NCT02124772|Dabrafenib|dabrafenib|mesh-list
64375219|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375220|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64375221|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375222|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375226|NCT02159482|Interferons|interferons|mesh-list
64375227|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
64375228|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
64375229|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375230|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
64375231|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375232|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
64375233|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375234|NCT05269030|Ivermectin|ivermectin|mesh-list
64375235|NCT05269030|Budesonide|budesonide|mesh-list
64375236|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64375237|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64375238|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
64375239|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375240|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375270|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
64375271|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64375272|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64375273|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
64375274|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375275|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375276|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64375277|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64375278|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64375279|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
64375280|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
64375281|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
64375282|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64375283|NCT03057015|Analgesics|analgesics|mesh-ancestor
64375284|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64375285|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
64375286|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64375287|NCT04934475|Lenalidomide|lenalidomide|mesh-list
64375288|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
64375289|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375290|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64375291|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64375292|NCT04934475|Growth Substances|growth substances|mesh-ancestor
64375293|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
64375294|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375295|NCT03057483|Vaccines|vaccines|mesh-list
64375296|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
64375297|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375319|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64375320|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64375321|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64375322|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64375323|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375324|NCT04927299|Diuretics|diuretics|mesh-ancestor
64375325|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
64375326|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375327|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
64375328|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375330|NCT03056625|Vitamins|vitamins|mesh-ancestor
64375331|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
64375332|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375333|NCT04913103|Rituximab|rituximab|mesh-list
64375334|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
64375335|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375336|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375337|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
64375338|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375339|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64375340|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64375341|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
64375342|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375343|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
64375344|NCT04920669|Bupivacaine|bupivacaine|mesh-list
64375345|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
64375346|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
64375347|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375348|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375361|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375362|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
64375363|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375364|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64375365|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375366|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
64375367|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375369|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
64375370|NCT02621931|Katacalcin|katacalcin|mesh-list
64375371|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64375372|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375373|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64375374|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
64375375|NCT04925973|Tofacitinib|tofacitinib|mesh-list
64375376|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64375377|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375378|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375379|NCT04400175|Silicon|silicon|mesh-list
64375380|NCT04400175|Trace Elements|trace elements|mesh-ancestor
64375413|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375414|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375415|NCT04924647|Dexamethasone|dexamethasone|mesh-list
64375416|NCT04924647|Lenalidomide|lenalidomide|mesh-list
64375417|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64375418|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
64375420|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375421|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375422|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375423|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
64375424|NCT04924647|Hormones|hormones|mesh-ancestor
64375425|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375426|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64375427|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375428|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
64375429|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64375430|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64375431|NCT04924647|Growth Substances|growth substances|mesh-ancestor
64375432|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
64375433|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
64375434|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
64375435|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
64375436|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375437|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375462|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375463|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
64375464|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375465|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375466|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
64375467|NCT04918563|Acetylcholine|acetylcholine|mesh-list
64375468|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
64375469|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
64375470|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
64375471|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375472|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375473|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375474|NCT02123446|Cephalexin|cephalexin|mesh-list
64375475|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64375476|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375477|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
64375478|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
64375479|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
64375480|NCT04918953|Prednisolone|prednisolone|mesh-list
64375481|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
64375482|NCT04918953|Budesonide|budesonide|mesh-list
64375483|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
64375484|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
64375485|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64375486|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
64375487|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
64375488|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375489|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375490|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375491|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
64375508|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64375509|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64375510|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
64375511|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375512|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375513|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375514|NCT02185534|Clopidogrel|clopidogrel|mesh-list
64375515|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64375516|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
64375517|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
64375518|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64375519|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
64375520|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375521|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375522|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375523|NCT03056079|Aflibercept|aflibercept|mesh-list
64375524|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64375561|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375562|NCT03054285|Levetiracetam|levetiracetam|mesh-list
64375563|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
64375564|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
64375565|NCT04917627|Vancomycin|vancomycin|mesh-list
64375566|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64375567|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375568|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
64375569|NCT04903743|Bupivacaine|bupivacaine|mesh-list
64375570|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
64375571|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
64375572|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375573|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375574|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
64375575|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375576|NCT04903743|Analgesics|analgesics|mesh-ancestor
64375577|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64375578|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
64375579|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64375580|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375581|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375582|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64375583|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
64375584|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64375585|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
64375612|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375613|NCT03053739|Bosentan|bosentan|mesh-list
64375614|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
64375615|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
64375616|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
64375617|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
64375618|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375619|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375620|NCT03053739|Urological Agents|urological agents|mesh-ancestor
64375621|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64375622|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
64375623|NCT04916925|Vitamin D|vitamin d|mesh-list
64375624|NCT04916925|Vitamins|vitamins|mesh-ancestor
64375625|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
64375626|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375627|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64375628|NCT04902261|Gemcitabine|gemcitabine|mesh-list
64375629|NCT04902261|Paclitaxel|paclitaxel|mesh-list
64375630|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64375631|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375632|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
64375633|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
64375634|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
64375635|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375636|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64375637|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
64375638|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
64375639|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375640|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375641|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375642|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
64375657|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
64375658|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375659|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375660|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
64375661|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375662|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375663|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
64375664|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64375665|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375666|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64375667|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64375668|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64375669|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
64375670|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64375671|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64375676|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64375677|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
64375678|NCT02120950|Aflibercept|aflibercept|mesh-list
64375679|NCT02120950|Verteporfin|verteporfin|mesh-list
64375680|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64375681|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64375682|NCT02120950|Growth Substances|growth substances|mesh-ancestor
64375683|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375684|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
64375704|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375706|NCT04900155|Ezetimibe|ezetimibe|mesh-list
64375707|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
64375708|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
64375709|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
64375710|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375711|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64375712|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64375713|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375714|NCT02155738|Acetaminophen|acetaminophen|mesh-list
64375715|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64375716|NCT02155738|Analgesics|analgesics|mesh-ancestor
64375717|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
64375718|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375719|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375720|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
64375721|NCT03053505|Vancomycin|vancomycin|mesh-list
64375722|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
64375723|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64375724|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375725|NCT02181790|Acitretin|acitretin|mesh-list
64375726|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
64375727|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
64375728|NCT03051945|Ketamine|ketamine|mesh-list
64375729|NCT03051945|Analgesics|analgesics|mesh-ancestor
64375730|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
64375731|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375732|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375733|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64375734|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64375750|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375751|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375752|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
64375753|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375754|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64375755|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
64375756|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
64375757|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64375758|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64375759|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
64375760|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375761|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
64375762|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375763|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64375764|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375765|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64375766|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64375769|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375771|NCT04898751|Nivolumab|nivolumab|mesh-list
64375772|NCT04898751|Ipilimumab|ipilimumab|mesh-list
64375773|NCT04898751|Durvalumab|durvalumab|mesh-list
64375774|NCT04898751|Avelumab|avelumab|mesh-list
64375775|NCT04898751|Cemiplimab|cemiplimab|mesh-list
64375776|NCT04898751|Atezolizumab|atezolizumab|mesh-list
64375777|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
64375778|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375779|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375780|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375792|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
64375793|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64375802|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64375803|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
64375804|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375805|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375806|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64375807|NCT03051711|Pyrazole|pyrazole|mesh-list
64375808|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375809|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375810|NCT04908345|Fentanyl|fentanyl|mesh-list
64375811|NCT04908345|Methadone|methadone|mesh-list
64375812|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64375813|NCT04908345|Narcotics|narcotics|mesh-ancestor
64375814|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375815|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375816|NCT04908345|Analgesics|analgesics|mesh-ancestor
64375817|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
64375818|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375819|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64375820|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64375821|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
64375822|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
64375823|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
64375824|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
64375825|NCT04893993|Thiamine|thiamine|mesh-list
64375826|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
64375828|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
64375829|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375830|NCT04893525|Buprenorphine|buprenorphine|mesh-list
64375831|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
64375832|NCT04893525|Naloxone|naloxone|mesh-list
64375833|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
64375834|NCT04893525|Narcotics|narcotics|mesh-ancestor
64375835|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375836|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375837|NCT04893525|Analgesics|analgesics|mesh-ancestor
64375838|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
64375839|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375840|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
64375841|NCT03051243|Insulin|insulin|mesh-list
64375842|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64375843|NCT03051243|Linagliptin|linagliptin|mesh-list
64375844|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64375845|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375846|NCT03051243|Incretins|incretins|mesh-ancestor
64375847|NCT03051243|Hormones|hormones|mesh-ancestor
64375848|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375849|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
64375850|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
64375851|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375852|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375874|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
64375875|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375876|NCT04896177|Sirolimus|sirolimus|mesh-list
64375877|NCT04896177|Paclitaxel|paclitaxel|mesh-list
64375878|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64375879|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375880|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
64375881|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
64375882|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
64375883|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375884|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64375885|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64375886|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64375887|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
64375888|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64375889|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
64375890|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375891|NCT03052569|Agerafenib|agerafenib|mesh-list
64375892|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64375893|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64375894|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375895|NCT04906317|Midazolam|midazolam|mesh-list
64375896|NCT04906317|Dezocine|dezocine|mesh-list
64375897|NCT04906317|Propofol|propofol|mesh-list
64375898|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64375899|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64375924|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64375925|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
64375926|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
64375927|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375928|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375929|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64375930|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
64375931|NCT04430361|Hormones|hormones|mesh-ancestor
64375932|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375933|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64375934|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64375935|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
64375936|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64375937|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
64375938|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
64375939|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64375940|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64375941|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64375942|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
64375943|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64375944|NCT04906083|Mitogens|mitogens|mesh-list
64375945|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
64375947|NCT02616783|Lamivudine|lamivudine|mesh-list
64375956|NCT04895007|Vaccines|vaccines|mesh-list
64375974|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375975|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375976|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64375977|NCT04894617|Analgesics|analgesics|mesh-ancestor
64375978|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
64375979|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64375980|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
64375981|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
64375982|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
64375983|NCT04398537|Hormones|hormones|mesh-ancestor
64375984|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64375985|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375986|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64375987|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375989|NCT04397991|Diuretics|diuretics|mesh-ancestor
64375990|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
64375991|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64375992|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
64375993|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64375994|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64375995|NCT04397679|Chloroquine|chloroquine|mesh-list
64375996|NCT04397679|Temozolomide|temozolomide|mesh-list
64375997|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64375998|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
64375999|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376000|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376001|NCT04397679|Amebicides|amebicides|mesh-ancestor
64376002|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64376003|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64376015|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
64376016|NCT03051009|Coagulants|coagulants|mesh-ancestor
64376017|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
64376018|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
64376019|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376020|NCT04889781|Dexamethasone|dexamethasone|mesh-list
64376021|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
64376022|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376023|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
64376024|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
64376025|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376026|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376027|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376028|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
64376029|NCT04889781|Hormones|hormones|mesh-ancestor
64376030|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376031|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64376032|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376033|NCT02616393|XL647|xl647|mesh-list
64376034|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376035|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64376036|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376037|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376038|NCT04905147|Mosapride|mosapride|mesh-list
64376039|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376040|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
64376041|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
64376062|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376063|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64376064|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376065|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
64376067|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64376068|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
64376069|NCT04753372|Aspirin|aspirin|mesh-list
64376070|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
64376071|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64376072|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
64376073|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64376074|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
64376075|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376076|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376077|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
64376078|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64376079|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64376080|NCT04753372|Analgesics|analgesics|mesh-ancestor
64376117|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376118|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
64376119|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376121|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
64376122|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
64376123|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376124|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376125|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
64376126|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376127|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64376128|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64376129|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64376130|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64376131|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376132|NCT04425291|Vaccines|vaccines|mesh-list
64376133|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
64376134|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376135|NCT04879407|Warfarin|warfarin|mesh-list
64376136|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
64376137|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
64376138|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
64376139|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
64376140|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
64376141|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
64376142|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376143|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376144|NCT04886193|Leucovorin|leucovorin|mesh-list
64376145|NCT04886193|Docetaxel|docetaxel|mesh-list
64376146|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
64376147|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376148|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
64376149|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376156|NCT04886193|Vitamins|vitamins|mesh-ancestor
64376160|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376161|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376162|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64376163|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
64376164|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
64376165|NCT04885803|Vitamin D|vitamin d|mesh-list
64376166|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
64376167|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
64376168|NCT04885803|Vitamins|vitamins|mesh-list
64376169|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
64376170|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376171|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
64376172|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64376173|NCT03049059|Hydroquinone|hydroquinone|mesh-list
64376174|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
64376175|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376176|NCT03049059|Protective Agents|protective agents|mesh-ancestor
64376177|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376178|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64376179|NCT04885413|Niraparib|niraparib|mesh-list
64376180|NCT04885413|Antibodies|antibodies|mesh-list
64376181|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
64376182|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376183|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
64376184|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376185|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376186|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376187|NCT03049293|Midazolam|midazolam|mesh-list
64376188|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64376189|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376190|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376192|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64376193|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64376199|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
64376200|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376201|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376202|NCT01595529|Trimethoprim|trimethoprim|mesh-list
64376203|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
64376205|NCT01595529|Cefixime|cefixime|mesh-list
64376206|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
64376207|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376208|NCT01595529|Renal Agents|renal agents|mesh-ancestor
64376209|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
64376210|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64376211|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64376212|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
64376213|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376214|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376215|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64376216|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64376217|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64376219|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
64376220|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376221|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
64376222|NCT04147533|Dasatinib|dasatinib|mesh-list
64376223|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376224|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64376225|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376226|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376227|NCT05257395|Letrozole|letrozole|mesh-list
64376228|NCT05257395|Anastrozole|anastrozole|mesh-list
64376229|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376230|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
64376231|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64376232|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376240|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64376241|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376243|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64376244|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376245|NCT03047109|Phenylephrine|phenylephrine|mesh-list
64376246|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
64376247|NCT03047109|Ephedrine|ephedrine|mesh-list
64376248|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
64376249|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
64376250|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
64376251|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376252|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376253|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
64376254|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64376255|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
64376256|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
64376257|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
64376258|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64376259|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64376260|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
64376261|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376262|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376263|NCT03047109|Protective Agents|protective agents|mesh-ancestor
64376264|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
64376265|NCT03047265|Paclitaxel|paclitaxel|mesh-list
64376266|NCT03047265|Cisplatin|cisplatin|mesh-list
64376267|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64376273|NCT05256147|Ibuprofen|ibuprofen|mesh-list
64376287|NCT05255913|Protective Agents|protective agents|mesh-ancestor
64376288|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376291|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
64376292|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376293|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376294|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
64376295|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64376296|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
64376297|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
64376298|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376299|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
64376300|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
64376301|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376302|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376303|NCT04870671|Tenofovir|tenofovir|mesh-list
64376304|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
64376305|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376306|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64376307|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64376308|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376309|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376310|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64376311|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64376312|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
64376313|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64376314|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376315|NCT03046719|Bupivacaine|bupivacaine|mesh-list
64376316|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
64376317|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
64376325|NCT04146207|Hormones|hormones|mesh-ancestor
64376328|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64376329|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376330|NCT04876755|TEMPO|tempo|mesh-list
64376331|NCT04876755|TEMPOL-H|tempol-h|mesh-list
64376332|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
64376333|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376334|NCT04876755|Protective Agents|protective agents|mesh-ancestor
64376335|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376336|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
64376337|NCT04876521|Olanzapine|olanzapine|mesh-list
64376338|NCT04876521|Amisulpride|amisulpride|mesh-list
64376339|NCT04876521|Fluoxetine|fluoxetine|mesh-list
64376340|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
64376341|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
64376342|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376343|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376344|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376345|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
64376346|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64376347|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376348|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64376349|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
64376350|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
64376351|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64376352|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376353|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376354|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
64379260|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379261|NCT02116972|FX006|fx006|mesh-list
64379262|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64379263|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
64379264|NCT02116972|Hormones|hormones|mesh-ancestor
64379265|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64379266|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379267|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64379268|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
64379269|NCT02176642|Oxybutynin|oxybutynin|mesh-list
64379270|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
64379271|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
64379272|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64379273|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64379274|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64379275|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64379276|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
64379277|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64379278|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379279|NCT02176642|Urological Agents|urological agents|mesh-ancestor
64379280|NCT02116660|Ritonavir|ritonavir|mesh-list
64379281|NCT02116660|Lopinavir|lopinavir|mesh-list
64379282|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
64379283|NCT02116660|Darunavir|darunavir|mesh-list
64379284|NCT02116660|Tenofovir|tenofovir|mesh-list
64379285|NCT02116660|Lamivudine|lamivudine|mesh-list
64379286|NCT02116660|Emtricitabine|emtricitabine|mesh-list
64376355|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
64376356|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
64376357|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
64376358|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64376359|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376360|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64376361|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
64376362|NCT02119156|Belimumab|belimumab|mesh-list
64376366|NCT02181556|Aflibercept|aflibercept|mesh-list
64376367|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64376368|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64376369|NCT02181556|Growth Substances|growth substances|mesh-ancestor
64376370|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376371|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
64376372|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376373|NCT04865991|Propofol|propofol|mesh-list
64376374|NCT04865991|Sevoflurane|sevoflurane|mesh-list
64376380|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
64376381|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64379287|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
64379288|NCT02116660|Nevirapine|nevirapine|mesh-list
64379289|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
64379290|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
64379291|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
64379292|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64379293|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379294|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64379295|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64379296|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
64379297|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64379298|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
64379299|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64379300|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
64379301|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
64376382|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
64376383|NCT04870203|Adalimumab|adalimumab|mesh-list
64376384|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376385|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376386|NCT04381143|Aspirin|aspirin|mesh-list
64376387|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
64376388|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64376389|NCT04381143|Analgesics|analgesics|mesh-ancestor
64376390|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
64376391|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376392|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376393|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376394|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376395|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64376396|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64376398|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
64376409|NCT04865445|Midazolam|midazolam|mesh-list
64376410|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64376411|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376412|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376413|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376414|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
64376415|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
64376416|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64376417|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64376418|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
64376419|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
64376420|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
64376421|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
64376422|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376423|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376424|NCT04875819|Vaccines|vaccines|mesh-list
64376425|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
64376426|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
64376427|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376428|NCT04864977|Insulin|insulin|mesh-list
64376429|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64376430|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376433|NCT03046173|Mitogens|mitogens|mesh-list
64376434|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376435|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376436|NCT04869579|Selenium|selenium|mesh-list
64376437|NCT04869579|Selenious Acid|selenious acid|mesh-list
64376438|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
64376439|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376440|NCT04869579|Protective Agents|protective agents|mesh-ancestor
64376441|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376453|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64376454|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
64376455|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64376456|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376457|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
64376458|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376459|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
64376460|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
64376461|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
64376464|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376465|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
64376466|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376467|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376468|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376504|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
64376505|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376506|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376507|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376508|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376509|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64376511|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
64376512|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64376513|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64376514|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64376515|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
64376516|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376518|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64376519|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376520|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376521|NCT03045783|Cefotiam|cefotiam|mesh-list
64376522|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64376523|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376524|NCT01375049|Aztreonam|aztreonam|mesh-list
64376525|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64376526|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376527|NCT04863807|Anesthetics|anesthetics|mesh-list
64376528|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376529|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376530|NCT02452307|Imiquimod|imiquimod|mesh-list
64376531|NCT02452307|Molgramostim|molgramostim|mesh-list
64376532|NCT02452307|Protamines|protamines|mesh-list
64376533|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64376534|NCT02452307|Sargramostim|sargramostim|mesh-list
64376535|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64376536|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
64376542|NCT02452307|Coagulants|coagulants|mesh-ancestor
64376544|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
64376545|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376546|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376547|NCT04485299|Listerine|listerine|mesh-list
64376548|NCT04485299|Fluorides|fluorides|mesh-list
64376549|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
64376550|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
64376551|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
64376552|NCT04485299|Protective Agents|protective agents|mesh-ancestor
64376553|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376554|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
64376555|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376556|NCT01594749|Dexamethasone|dexamethasone|mesh-list
64376557|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
64376558|NCT01594749|Ondansetron|ondansetron|mesh-list
64376559|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
64376560|NCT01594749|Aprepitant|aprepitant|mesh-list
64376561|NCT01594749|BB 1101|bb 1101|mesh-list
64376562|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376563|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
64376564|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
64376565|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376566|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376567|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376568|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
64376569|NCT01594749|Hormones|hormones|mesh-ancestor
64376572|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376597|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376598|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
64376599|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
64376601|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376602|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376603|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
64376604|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
64376606|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
64376607|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
64376608|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
64376609|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376610|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
64376611|NCT04863183|Hormones|hormones|mesh-ancestor
64376612|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376613|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376614|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376615|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
64376616|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376617|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376618|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
64376619|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64376620|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64376621|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64376622|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64376623|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376624|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
64376625|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376627|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64376640|NCT02453009|Hormones|hormones|mesh-ancestor
64376641|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376642|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376643|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64376644|NCT04868175|Timolol|timolol|mesh-list
64376645|NCT04868175|Travoprost|travoprost|mesh-list
64376646|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64376647|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64376648|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
64376649|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376650|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376651|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376652|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64376653|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64376654|NCT02452775|Poly ICLC|poly iclc|mesh-list
64376655|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
64376656|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
64376657|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
64376658|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376659|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64376660|NCT03045627|Cytarabine|cytarabine|mesh-list
64376661|NCT03045627|Aclarubicin|aclarubicin|mesh-list
64376662|NCT03045627|Lenograstim|lenograstim|mesh-list
64376663|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64376664|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
64376665|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376666|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376667|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
64376668|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376669|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376670|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
64376671|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376677|NCT04868019|Fenofibrate|fenofibrate|mesh-list
64376681|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
64376682|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
64376683|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376684|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64376685|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376686|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376687|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
64376688|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376689|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376690|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64376692|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64376693|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376695|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
64376696|NCT03233321|Tinzaparin|tinzaparin|mesh-list
64376697|NCT03233321|Dalteparin|dalteparin|mesh-list
64376698|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
64376699|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
64376700|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64376701|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376702|NCT04868253|Oxazepam|oxazepam|mesh-list
64376703|NCT04868253|Metyrapone|metyrapone|mesh-list
64376704|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
64376705|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376706|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376707|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376731|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376732|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376733|NCT03224039|Analgesics|analgesics|mesh-ancestor
64376734|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
64376735|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376736|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
64376737|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
64376738|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
64376739|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
64376740|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
64376741|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376742|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
64376743|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376744|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376745|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
64376746|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376747|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376748|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64376749|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
64376750|NCT03223961|Hematinics|hematinics|mesh-ancestor
64376782|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
64376783|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376784|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376785|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
64376786|NCT03045471|Protective Agents|protective agents|mesh-ancestor
64376787|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
64376788|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376789|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376790|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
64376791|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
64376792|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
64376793|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64376794|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64376795|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376796|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
64376797|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376798|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376799|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64376800|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376801|NCT03223025|Hormones|hormones|mesh-list
64376802|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64376838|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376839|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64376840|NCT04873011|Analgesics|analgesics|mesh-ancestor
64376841|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
64376842|NCT02451605|Analgesics|analgesics|mesh-list
64376843|NCT02451605|Ropivacaine|ropivacaine|mesh-list
64376844|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
64376845|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
64376846|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376847|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376848|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
64376849|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376850|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
64376851|NCT03222323|Ropivacaine|ropivacaine|mesh-list
64376852|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64376853|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64376854|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376855|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64376856|NCT03222323|Analgesics|analgesics|mesh-ancestor
64376857|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
64376858|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376859|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64376860|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64376861|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64376862|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
64376866|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
64376880|NCT03222089|Leucovorin|leucovorin|mesh-list
64376881|NCT03222089|Fluorouracil|fluorouracil|mesh-list
64376882|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
64376883|NCT03222089|Irinotecan|irinotecan|mesh-list
64376884|NCT03222089|Interleukin-2|interleukin-2|mesh-list
64376885|NCT03222089|Molgramostim|molgramostim|mesh-list
64376886|NCT03222089|Sargramostim|sargramostim|mesh-list
64376887|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
64376888|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
64376889|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376890|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64376891|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376892|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376893|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
64376894|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376895|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64376896|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64376897|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376898|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64376899|NCT03222089|Analgesics|analgesics|mesh-ancestor
64376900|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
64376901|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376902|NCT03222089|Antidotes|antidotes|mesh-ancestor
64376903|NCT03222089|Protective Agents|protective agents|mesh-ancestor
64376904|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
64376905|NCT03222089|Vitamins|vitamins|mesh-ancestor
64376906|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
64376907|NCT03043989|Clarithromycin|clarithromycin|mesh-list
64376908|NCT03043989|Docetaxel|docetaxel|mesh-list
64376909|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64376930|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
64376931|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
64376932|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376933|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376934|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
64376935|NCT03043521|Lansoprazole|lansoprazole|mesh-list
64376936|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
64376937|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64376938|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
64376939|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64376940|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376948|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
64376949|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
64376950|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
64376951|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376952|NCT03221231|Expectorants|expectorants|mesh-ancestor
64376953|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
64376954|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
64376955|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
64376956|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376957|NCT03221231|Protective Agents|protective agents|mesh-ancestor
64376958|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376959|NCT03221231|Antidotes|antidotes|mesh-ancestor
64376960|NCT03221621|Adalimumab|adalimumab|mesh-list
64376961|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376962|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376963|NCT03220841|Adalimumab|adalimumab|mesh-list
64376964|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376965|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376970|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
64376971|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
64376972|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376973|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
64376974|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64376975|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
64376976|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376977|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64376978|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
64376979|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64376980|NCT02505971|Propranolol|propranolol|mesh-list
64376981|NCT02505971|Nadolol|nadolol|mesh-list
64376982|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
64376983|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64376984|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
64376985|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64376986|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64376987|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64376988|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64376989|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64376990|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
64376991|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
64376992|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
64376993|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64376994|NCT02505581|Metronidazole|metronidazole|mesh-list
64376995|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
64376996|NCT02505581|Cefuroxime|cefuroxime|mesh-list
64376997|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
64376998|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64376999|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
64377000|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
64377001|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
64377002|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64377003|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64377004|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377005|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377006|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377007|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
64377008|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377009|NCT02451293|Melatonin|melatonin|mesh-list
64377010|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
64377011|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377012|NCT02451293|Protective Agents|protective agents|mesh-ancestor
64377013|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377014|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64377015|NCT02505113|Montelukast|montelukast|mesh-list
64377016|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64377017|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
64377018|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
64377019|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377020|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377021|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377022|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
64377023|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
64377024|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377025|NCT02504801|Budesonide|budesonide|mesh-list
64377026|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377027|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64377028|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
64377029|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377030|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377031|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64377032|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
64377043|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
64377044|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377045|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64377046|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
64377047|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
64377048|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377049|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377050|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377051|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
64377052|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377053|NCT02504177|Anticoagulants|anticoagulants|mesh-list
64377054|NCT02450981|Bevacizumab|bevacizumab|mesh-list
64377055|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
64377056|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377057|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64377058|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64377059|NCT02450981|Growth Substances|growth substances|mesh-ancestor
64377060|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377061|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
64377062|NCT02503943|Metformin|metformin|mesh-list
64377063|NCT02503943|Liraglutide|liraglutide|mesh-list
64377064|NCT02503943|Mitiglinide|mitiglinide|mesh-list
64377065|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64377066|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377067|NCT02503943|Incretins|incretins|mesh-ancestor
64377068|NCT02503943|Hormones|hormones|mesh-ancestor
64377069|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377070|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
64377089|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
64377090|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377091|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
64377092|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
64377093|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
64377094|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
64377096|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
64377097|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
64377098|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377099|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
64377100|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
64377101|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377102|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
64377103|NCT02503319|Coagulants|coagulants|mesh-ancestor
64377104|NCT02610777|Azacitidine|azacitidine|mesh-list
64377105|NCT02610777|Pevonedistat|pevonedistat|mesh-list
64377106|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
64377107|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
64377108|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377109|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377110|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377112|NCT01628692|Simeprevir|simeprevir|mesh-list
64377113|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
64377114|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377115|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
64377116|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377117|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
64377118|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377119|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64377120|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
64377121|NCT04496921|Vitamins|vitamins|mesh-list
64377122|NCT04496921|Vitamin K|vitamin k|mesh-list
64377123|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
64377133|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
64377134|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377135|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377136|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
64377137|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377138|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377139|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64377140|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377141|NCT03043443|Melatonin|melatonin|mesh-list
64377142|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
64377143|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377145|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377146|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64377147|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
64377148|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
64377150|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377189|NCT04860531|Lidocaine|lidocaine|mesh-list
64377190|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
64377191|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
64377192|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64377193|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377194|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
64377195|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377196|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
64377197|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
64377198|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
64377199|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
64377200|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377201|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377202|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
64377203|NCT04860531|Hormones|hormones|mesh-ancestor
64377204|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377205|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64377206|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
64377207|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
64377208|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
64377209|NCT01594827|Vancomycin|vancomycin|mesh-list
64377210|NCT01594827|Doxycycline|doxycycline|mesh-list
64377211|NCT01594827|Rifampin|rifampin|mesh-list
64377212|NCT01594827|Trimethoprim|trimethoprim|mesh-list
64377213|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
64377214|NCT01594827|Mupirocin|mupirocin|mesh-list
64377238|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
64377239|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
64377240|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
64377241|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
64377243|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
64377244|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64377245|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377246|NCT04429191|Antibodies|antibodies|mesh-list
64377247|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
64377248|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
64377249|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377250|NCT02610231|Istradefylline|istradefylline|mesh-list
64377251|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
64377252|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
64377253|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
64377254|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
64377255|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377256|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377257|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377258|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
64377259|NCT04849533|Prednisone|prednisone|mesh-list
64377260|NCT04849533|Everolimus|everolimus|mesh-list
64377261|NCT04849533|Abatacept|abatacept|mesh-list
64377262|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
64377263|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
64377264|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377265|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
64377266|NCT04849533|Hormones|hormones|mesh-ancestor
64377268|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377282|NCT03040635|Risdiplam|risdiplam|mesh-list
64377283|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
64377284|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377285|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377286|NCT02178358|Sorafenib|sorafenib|mesh-list
64377287|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377288|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64377289|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377290|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377291|NCT01598896|Clonidine|clonidine|mesh-list
64377292|NCT01598896|Dronabinol|dronabinol|mesh-list
64377293|NCT01598896|Analgesics|analgesics|mesh-ancestor
64377294|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
64377295|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377296|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377297|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
64377298|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
64377299|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
64377300|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
64377301|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64377302|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64377303|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
64377304|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377305|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377306|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
64377307|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
64377308|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377309|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
64377310|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
64377311|NCT01598896|Hormones|hormones|mesh-ancestor
64377312|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
64377313|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
64377314|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
64377319|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
64377320|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
64377321|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
64377322|NCT03042429|Ifosfamide|ifosfamide|mesh-list
64377323|NCT03042429|Cisplatin|cisplatin|mesh-list
64377324|NCT03042429|Doxorubicin|doxorubicin|mesh-list
64377325|NCT03042429|Etoposide|etoposide|mesh-list
64377326|NCT03042429|Topotecan|topotecan|mesh-list
64377327|NCT03042429|Vindesine|vindesine|mesh-list
64377328|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377329|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
64377330|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377331|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377332|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
64377333|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
64377334|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377335|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377336|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
64377337|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
64377338|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
64377339|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
64377340|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377341|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
64377342|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
64377343|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
64377344|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
64377347|NCT04849299|Cyclosporins|cyclosporins|mesh-list
64377348|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377350|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
64377366|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
64377367|NCT04860219|Lactoferrin|lactoferrin|mesh-list
64377368|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377369|NCT02728895|Vedolizumab|vedolizumab|mesh-list
64377370|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64377371|NCT04847895|Ranibizumab|ranibizumab|mesh-list
64377372|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64377373|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64377374|NCT04847895|Growth Substances|growth substances|mesh-ancestor
64377375|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377376|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
64377377|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377378|NCT02450513|Adalimumab|adalimumab|mesh-list
64377379|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
64377380|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
64377381|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
64377382|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
64377383|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64377384|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377385|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377386|NCT04859283|Analgesics|analgesics|mesh-ancestor
64377387|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
64377388|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377419|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
64377420|NCT04496141|Antibodies|antibodies|mesh-list
64377421|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
64377422|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377423|NCT03039075|Metformin|metformin|mesh-list
64377424|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
64377425|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377426|NCT04857177|Ranibizumab|ranibizumab|mesh-list
64377427|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
64377428|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
64377429|NCT04857177|Growth Substances|growth substances|mesh-ancestor
64377430|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377431|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
64377432|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377433|NCT02606877|Pirfenidone|pirfenidone|mesh-list
64377434|NCT02606877|Nintedanib|nintedanib|mesh-list
64377435|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377436|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
64377437|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
64377438|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377439|NCT02606877|Analgesics|analgesics|mesh-ancestor
64377543|NCT03040401|Aldesleukin|aldesleukin|mesh-list
64377544|NCT03040401|Interleukin-2|interleukin-2|mesh-list
64377545|NCT03040401|Histamine|histamine|mesh-list
64377546|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
64377547|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64377548|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
64377549|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
64377550|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
64377551|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
64377552|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64377553|NCT03040401|Analgesics|analgesics|mesh-ancestor
64377554|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
64377583|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
64377584|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
64377585|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
64377586|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64377587|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
64377588|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64377589|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
64377590|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
64377591|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
64377592|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
64377593|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64377594|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
64377595|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
64377596|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
64377597|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
64377598|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
64377599|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
64377600|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
64377601|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
64377602|NCT04843839|Nepafenac|nepafenac|mesh-list
64377603|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
64377604|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
64377605|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
64377632|NCT04429035|Vitamin K|vitamin k|mesh-list
64377925|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
64378244|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
64379142|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
64379318|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
64379625|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64379851|NCT04738318|Protective Agents|protective agents|mesh-ancestor
64380090|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
64380706|NCT03192449|Albendazole|albendazole|mesh-list
64382305|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
64382520|NCT02099110|Metformin|metformin|mesh-list
64382657|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
64382662|NCT02423603|Paclitaxel|paclitaxel|mesh-list
64382882|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
64383537|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
64384961|NCT05493267|Interleukin-2|interleukin-2|mesh-list
64385562|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
64385675|NCT05727527|Anesthetics|anesthetics|mesh-list
64386138|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386139|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
64386140|NCT05435547|Dexamethasone|dexamethasone|mesh-list
64386144|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
64386145|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
64386146|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
64386147|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
64386148|NCT05435547|Hormones|hormones|mesh-ancestor
64386149|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
